<SEC-DOCUMENT>0001628280-23-028672.txt : 20230809
<SEC-HEADER>0001628280-23-028672.hdr.sgml : 20230809
<ACCEPTANCE-DATETIME>20230809172010
ACCESSION NUMBER:		0001628280-23-028672
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		118
CONFORMED PERIOD OF REPORT:	20230630
FILED AS OF DATE:		20230809
DATE AS OF CHANGE:		20230809

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apollo Medical Holdings, Inc.
		CENTRAL INDEX KEY:			0001083446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		IRS NUMBER:				870042699
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37392
		FILM NUMBER:		231156315

	BUSINESS ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801
		BUSINESS PHONE:		(626) 282-0288

	MAIL ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SICLONE INDUSTRIES INC
		DATE OF NAME CHANGE:	19990413
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ameh-20230630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:3040ecaa-d98f-42d5-9854-9c1a7ec98864,g:10a2b015-69d1-478c-967c-e01a9974c48a,d:cc2b852b4b5148b8aaf9d319f2f34464--><html xmlns:ameh="http://www.apollomed.net/20230630" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2023" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ameh-20230630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-26">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-27">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-28">Q2</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-29">0001083446</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" id="f-30">--12-31</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ameh-20230630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ameh:HealthCareCapitationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ameh:HealthCareCapitationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ameh:HealthCareCapitationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ameh:HealthCareCapitationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>ameh:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApcLsmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:AmgIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:DMGAndSunLabsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:DmgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ameh:MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:CommercialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:CommercialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:CommercialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:CommercialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:OtherThirdPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:OtherThirdPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:OtherThirdPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:OtherThirdPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:CollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:CollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:CollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:CollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:ContingentEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:ContingentEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:ContingentEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:ContingentEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:ForYourBenefitIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:OrmaHealthIncAndProviderGrowthSolutionsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:JadeHealthCareMedicalGroupIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="clinic"><xbrli:measure>ameh:clinic</xbrli:measure></xbrli:unit><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:NetworkRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:NetworkRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:NetworkRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:MemberRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:MemberRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:MemberRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:PatientManagementPlatformMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:NetworkRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:NetworkRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:NetworkRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:MemberRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:PatientManagementPlatformMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:JamesSongMDAProfessionalCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:JamesSongMDAProfessionalCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:JamesSongMDAProfessionalCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:JamesSongMDAProfessionalCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:JamesSongMDAProfessionalCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APAMH2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:JamesSongMDAProfessionalCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:Pacific6EnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:LmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ApcLsmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ameh:ConstructionLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ameh:ConstructionLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ameh:SecuredOvernightFinancingRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ameh:SecuredOvernightFinancingRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="financial_ratio"><xbrli:measure>ameh:financial_ratio</xbrli:measure></xbrli:unit><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-03</xbrli:startDate><xbrli:endDate>2020-07-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-03</xbrli:startDate><xbrli:endDate>2020-07-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AMGPropertiesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AMGPropertiesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-05</xbrli:startDate><xbrli:endDate>2020-08-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AMGPropertiesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-05</xbrli:startDate><xbrli:endDate>2020-08-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ZLLPartnersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ZLLPartnersLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-27</xbrli:startDate><xbrli:endDate>2020-07-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ZLLPartnersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-27</xbrli:startDate><xbrli:endDate>2020-07-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:A120HellmanLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:A120HellmanLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:A120HellmanLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-25</xbrli:startDate><xbrli:endDate>2022-01-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:A120HellmanLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-25</xbrli:startDate><xbrli:endDate>2022-01-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:Tag8MedicalInvestmentGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:ConstructionLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:Tag8MedicalInvestmentGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:ConstructionLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:Tag8MedicalInvestmentGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SubordinatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:SubordinatedLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SubordinatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:SubordinatedLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ameh:PreferredBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:ApcBusinessLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialSupportToNonconsolidatedLegalEntityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ameh:TruistBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialSupportToNonconsolidatedLegalEntityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ameh:TruistBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ameh:PreferredBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlphaCareMedicalGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ameh:PreferredBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlphaCareMedicalGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:CDSCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:CDSCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:CDSCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:CDSCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ameh:StockAwardsAndUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ameh:StockAwardsAndUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ameh:StockAwardsAndUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ameh:StockAwardsAndUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ameh:ApcStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ameh:PerformanceBasedRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ameh:PerformanceBasedRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialSupportToNonconsolidatedLegalEntityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlphaCareMedicalGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialSupportToNonconsolidatedLegalEntityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:LmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:LmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:LmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:LmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:PmiocMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:PmiocMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:PmiocMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:PmiocMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PmiocMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PmiocMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SongPCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SongPCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:DiagnosticAndSurgicalCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:RentPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:DiagnosticAndSurgicalCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:RentPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:DiagnosticAndSurgicalCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:RentPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:DiagnosticAndSurgicalCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:RentPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:FulgentGeneticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:FulgentGeneticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:FulgentGeneticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:FulgentGeneticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SunnyVillageCareCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SunnyVillageCareCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SunnyVillageCareCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SunnyVillageCareCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SunnyVillageCareCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:RentPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SunnyVillageCareCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:RentPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:OneMSOInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:OfficeLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:OneMSOInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:OfficeLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:OneMSOInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:OfficeLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:OneMSOInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:OfficeLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:HSMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:HSMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:HSMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:HSMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AurionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AurionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AurionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AurionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-434"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:BoardMembersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:BoardMembersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-436"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:BoardMembersWhoAreAlsoOfficersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-437"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:BoardMembersWhoAreAlsoOfficersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-438"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ApcShareholdersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ApcShareholdersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ShareholdersAndOfficersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ShareholdersAndOfficersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-442"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-443"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-445"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-446"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-447"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-448"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-450"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-451"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-452"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-453"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-455"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-459"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-460"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-462"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-463"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-464"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-465"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-466"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-467"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-468"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-469"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-470"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-471"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-473"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-476"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-477"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-479"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-481"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-482"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-484"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-485"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-486"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-487"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-488"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-489"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-490"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-491"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-492"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-493"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-494"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-495"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-496"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-497"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-498"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-499"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-500"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-506"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-520"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-524"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-528"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-530"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-532"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-533"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-534"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-535"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-536"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-537"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-538"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-539"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-540"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-541"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-542"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-543"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-544"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-545"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-12</xbrli:startDate><xbrli:endDate>2023-07-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="careprovider"><xbrli:measure>ameh:careProvider</xbrli:measure></xbrli:unit><xbrli:unit id="primary_care_service"><xbrli:measure>ameh:primary_care_service</xbrli:measure></xbrli:unit><xbrli:context id="c-546"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-27</xbrli:startDate><xbrli:endDate>2023-07-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-547"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-27</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-69 f-101 f-102 f-70" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship></ix:resources></ix:header></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">June 30, 2023</ix:nonNumeric> </span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from &#160;___&#160;to ___.</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File No. <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-37392</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><img src="ameh-20230630_g1.jpg" alt="B_montserrat (002).jpg" style="height:62px;margin-bottom:5pt;vertical-align:text-bottom;width:350px"/></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">Apollo Medical Holdings, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">95-4472349</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identification Number)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">1668 S. Garfield Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-10" continuedAt="i21b2d56575a84d74995723963cfe5e1f">2</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"><ix:continuation id="i21b2d56575a84d74995723963cfe5e1f" continuedAt="i9352f66c7b334ddead614bd2cb4bb815">nd</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i9352f66c7b334ddead614bd2cb4bb815"> Floor</ix:continuation>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">Alhambra</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-12">California</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">91801</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices and zip code)</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">626</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">282-0288</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)&#160;</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.997%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.890%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Title of Each Class</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trading Symbol</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name of Each Exchange on Which Registered</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common Stock, $0.001 par value per share</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">AMEH</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nasdaq Capital Market</span></td></tr></table></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:&#160;&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric>&#160;&#160;&#160;&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric>&#160;&#160;&#160;&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Large accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accelerated filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-accelerated filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smaller reporting company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; No</span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of August&#160;1, 2023, there were <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">57,562,198</ix:nonFraction> shares of common stock of the registrant, $0.001 par value per share, issued and outstanding which includes <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-25">10,299,259</ix:nonFraction> treasury shares that are owned by Allied Physicians of California, a Professional Medical Corporation d.b.a. Allied Pacific of California IPA (&#8220;APC&#8221;), a consolidated affiliate of Apollo Medical Holdings, Inc. These shares are legally issued and outstanding, but treated as treasury shares for accounting purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APOLLO MEDICAL HOLDINGS, INC.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO FORM 10-Q FILING</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PAGE</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_13">Introductory Note</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_13">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_13">Note About Forward-Looking Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_13">5</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_16">PART I</a></span></div><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_16">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_19">Item 1.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_19">Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_19">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_22">Consolidated Balance Sheets as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_22">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_22">, 2023 and December 31, 2022</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_22">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_25">Consolidated Statements of Income for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_25">Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_25">Six</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_25"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_25">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_25">, 2023 and 2022</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_25">10</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_31">Consolidated Statements of Mezzanine and Stockholders</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_139">&#8217;</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_31"> Equity for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_31">and Six </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_31">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_31">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_31">, 2023 and 2022</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_31">11</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_34">Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_34">Six</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_34"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_34">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_34">, 2023 and 2022</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_34">13</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_37">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_37">15</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_139">Item 2.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_139">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_139">48</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_190">Item 3.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_190">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_190">61</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_193">Item 4.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_193">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_193">1</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_196">PART II</a></span></div><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_196">OTHER INFORMATION</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_199">Item 1.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_199">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_199">63</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_202">Item 1A.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_202">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_202">63</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_205">Item 2.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_205">Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_205">63</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_208">Item 3.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_208">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_208">63</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_211">Item 4.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_211">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_211">64</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_214">Item 5.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_214">Other Information</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_214">64</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_217">Item 6.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_217">Exhibits</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icc2b852b4b5148b8aaf9d319f2f34464_217">64</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Glossary</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following abbreviations or acronyms that may be used in this document shall have the adjacent meanings set forth below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"></td><td style="width:28.661%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:69.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 Hellman </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 Hellman LLC</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accountable Health Care</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accountable Health Care IPA, a Professional Medical Corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AAMG</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All-American Medical Group</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AHMC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AHMC Healthcare Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AIPBP</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All-Inclusive Population-Based Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AKM</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AKM Medical Group, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alpha Care</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alpha Care Medical Group, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMG</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMG, a Professional Medical Corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMG Properties</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMG Properties, LLC</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ApolloMed Hospitalists, a Medical Corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMM</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Apollo Medical Management, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AP-AMH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AP-AMH Medical Corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AP-AMH 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AP-AMH 2 Medical Corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAACO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APA ACO, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allied Physicians of California, a Professional Medical Corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APCMG</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Access Primary Care Medical Group</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APC-LSMA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APC-LSMA Designated Shareholder Medical Corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BAHA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bay Area Hospitalist Associates</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDSC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Concourse Diagnostic Surgery Center, LLC</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CMS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centers for Medicare &amp; Medicaid Services</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DMHC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California Department of Managed Healthcare</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DMG</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Medical Group of Southern California</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GPDC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global and Professional Direct Contracting </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HSMSO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Source MSO Inc., a California corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AHMC International Cancer Center, a Medical Corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">independent practice association</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jade</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jade Health Care Medical Group, Inc. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LMA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LaSalle Medical Associates</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MMG</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maverick Medical Group, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MPP</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Property Partners, LLC</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MSSP</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Shared Savings Program </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NGACO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Next Generation Accountable Care Organization</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NMM</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Network Medical Management, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PMIOC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pacific Medical Imaging and Oncology Center, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCHC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southern California Heart Centers</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun Labs</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun Clinical Laboratories </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tag 6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tag-6 Medical Investments Group, LLC</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tag 8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tag-8 Medical Investments Group, LLC</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UCAP</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Universal Care Acquisition Partners, LLC</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UCI</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Universal Care, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VIE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">variable interest entity</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZLL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZLL Partners, LLC</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_13"></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTRODUCTORY NOTE</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context dictates otherwise, references in this Quarterly Report on Form 10-Q to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and similar words are references to Apollo Medical Holdings, Inc., a Delaware corporation (&#8220;ApolloMed&#8221;), and its consolidated subsidiaries and affiliated entities, as appropriate, including its consolidated variable interest entities (&#8220;VIEs&#8221;).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) have not reviewed any statements contained in this Report, including statements describing the participation of APA ACO, Inc. (&#8220;APAACO&#8221;) in the Global and Professional Direct Contracting Model or the ACO Realizing Equity, Access, and Community Health Model.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names and trademarks of ApolloMed and its subsidiaries referred to herein, and their respective logos, are our property. This Quarterly Report on Form 10-Q may contain additional trade names and/or trademarks of other companies, which are the property of their respective owners. We do not intend our use or display of other companies&#8217; trade names and/or trademarks, if any, to imply an endorsement or sponsorship of us by such companies, or any relationship with any of these companies.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">NOTE ABOUT FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Quarterly Report on Form 10-Q contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). All statements other than statements of historical fact are &#8220;forward-looking statements&#8221; for purposes of federal and state securities laws, including, but not limited to, any statements about our business, financial condition, operating results, plans, objectives, expectations, and intentions, any projections of earnings, revenue, earnings before interest, taxes, depreciation, and amortization (&#8220;EBITDA&#8221;), Adjusted EBITDA, or other financial items, such as our projected capitation from CMS and our future liquidity; any statements of any plans, strategies, and objectives of management for future operations, such as the material opportunities that we believe exist for our Company; any statements concerning proposed services, developments, mergers, or acquisitions; any statements regarding the outlook on the GPDC Model, ACO REACH Model, or strategic transactions; any statements regarding management&#8217;s view of future expectations and prospects for us; any statements about prospective adoption of new accounting standards or effects of changes in accounting standards; any statements regarding our efforts to remediate the material weakness in our internal control over financial reporting and the timing of remediation; any statements regarding future economic conditions or performance; any statements of belief; any statements of assumptions underlying any of the foregoing; and other statements that are not historical facts. Forward-looking statements may be identified by the use of forward-looking terms, such as &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;can,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;should,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;believe,&#8221; &#8220;think,&#8221; &#8220;plan,&#8221; &#8220;envision,&#8221; &#8220;intend,&#8221; &#8220;continue,&#8221; &#8220;target,&#8221; &#8220;seek,&#8221; &#8220;contemplate,&#8221; &#8220;budgeted,&#8221; &#8220;will,&#8221; or &#8220;would,&#8221; and the negative of such terms, other variations on such terms or other similar or comparable words, phrases, or terminology. These forward-looking statements present our estimates and assumptions only as of the date of this Quarterly Report on Form 10-Q and are subject to change.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                Forward-looking statements involve risks and uncertainties, many of which are difficult to predict and are outside of our control, and are based on the current beliefs, expectations, and certain assumptions of management. Some or all of such beliefs, expectations, and assumptions may not materialize or may vary significantly from actual results. Such statements are qualified by important economic, competitive, governmental, and technological factors that could cause our business, strategy, or actual results or events to differ materially from those in our forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed in our Annual Report on Form 10-K/A for the year ended December 31, 2022, filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on August&#160;9, 2023, including the risk factors discussed under the heading &#8220;Risk Factors&#8221; in Part I, Item IA thereof. Although we believe the expectations reflected in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change, and significant risks and uncertainties that could cause actual conditions, outcomes, and results to differ materially from those indicated by such statements. Any forward-looking statement made by the Company in this Form 10-Q speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.</span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_16"></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_22"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APOLLO MEDICAL HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">293,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-32">288,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCash" scale="3" id="f-33">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCash" format="ixt:fixed-zero" scale="3" id="f-34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-35">3,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">5,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-37">66,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-38">49,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net &#8211; related parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-39">82,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-40">65,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-41">1,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-42">1,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-43">15,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-44">14,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="f-45">973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="f-46">996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan receivable &#8211; related party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:fixed-zero" scale="3" id="f-47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-48">2,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-49">465,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-50">428,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, property, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-51">123,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-52">108,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-53">74,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-54">76,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-55">274,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-56">269,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">15,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">15,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in other entities &#8211; equity method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-59">45,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-60">40,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in privately held entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ameh:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-61">2,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ameh:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" scale="3" id="f-62">896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-63">17,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-64">20,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-65">7,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-66">6,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-67">562,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-68">538,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-69">1,027,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-70">966,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities, mezzanine equity and equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Current liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-71">49,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-72">49,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiduciary accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ameh:FiduciaryAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-73">8,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ameh:FiduciaryAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-74">8,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-75">100,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-76">81,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-77">20,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-78">4,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DividendsPayableCurrent" scale="3" id="f-79">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DividendsPayableCurrent" scale="3" id="f-80">664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-81">591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-82">594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-83">3,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-84">3,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="f-85">2,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="f-86">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As restated</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-87">185,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-88">148,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-89">12,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-90">14,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-91">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-92">1,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-93">17,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-94">19,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion and deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-95">205,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-96">203,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-97">21,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-98">20,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-99">257,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-100">259,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-101">443,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-102">407,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and contingencies (Note 12)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-103"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="text-align:right"><span><br/></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-104"></ix:nonFraction>Mezzanine equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-105">13,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-106">14,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-107"><ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-108">0.001</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-109"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-110">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized (inclusive of all preferred stock, including Series B Preferred stock); <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-111"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-112">1,111,111</ix:nonFraction></ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-113"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-114">zero</ix:nonFraction></ix:nonFraction> outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-115">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-116">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-117"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-118">0.001</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-119"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-120">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized (inclusive of all preferred stock, including Series A Preferred stock); <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-121"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-122">555,555</ix:nonFraction></ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-123"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-124">zero</ix:nonFraction></ix:nonFraction> outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-125">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-126">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-127"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-128">0.001</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-129"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-130">100,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-131"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-132">46,553,517</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-133"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-134">46,575,699</ix:nonFraction></ix:nonFraction> shares issued and outstanding, excluding <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-135">10,569,340</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-136">10,299,259</ix:nonFraction> treasury shares, as of June&#160;30, 2023 and December&#160;31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-137">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-138">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-139">357,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-140">360,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-141">208,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-142">182,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-143">566,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-144">542,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-145">3,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-146">1,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-147">569,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-148">544,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total liabilities, mezzanine equity and equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-149">1,027,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-150">966,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:footnote id="fn-1" footnoteRole="http://www.xbrl.org/2003/role/footnote">The Company&#8217;s consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The consolidated balance sheets include total assets that can be used only to settle obligations of the Company&#8217;s consolidated VIEs totaling $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-151">520.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-152">523.7</ix:nonFraction>&#160;million as of June&#160;30, 2023 and December&#160;31, 2022, respectively, and total liabilities of the Company&#8217;s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-153">136.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-154">131.8</ix:nonFraction>&#160;million as of June&#160;30, 2023 and December&#160;31, 2022, respectively. The VIE balances do not include $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="f-155">325.5</ix:nonFraction>&#160;million of investment in affiliates and $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-156">5.4</ix:nonFraction>&#160;million of amounts due to affiliates as of June&#160;30, 2023 and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="f-157">304.8</ix:nonFraction>&#160;million of investment in affiliates and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-158">30.3</ix:nonFraction>&#160;million of amounts due from affiliates as of December&#160;31, 2022 as these are eliminated upon consolidation and not presented within the consolidated balance sheets. See Note 16 &#8212; &#8220;Variable Interest Entities (VIEs)&#8221; for further detail.</ix:footnote></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:10pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APOLLO MEDICAL HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(UNAUDITED)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitation, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-159">300,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-160">227,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-161">600,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-162">449,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk pool settlements and incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-163">20,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-164">18,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-165">33,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-166">36,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-167">12,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-168">9,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-169">22,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-170">20,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-171">13,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-172">11,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-173">25,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-174">22,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-175">1,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-176">1,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-177">3,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-178">3,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-179">348,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-180">269,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-181">685,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-182">532,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-183">292,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-184">230,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-185">582,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-186">450,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-187">24,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-188">19,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-189">45,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-190">31,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-191">4,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-192">4,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-193">8,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-194">8,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-195">321,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-196">254,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-197">636,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-198">491,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-199">27,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-200">15,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-201">49,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-202">41,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-203">2,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-204">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-205">5,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-206">2,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-207">3,632</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-208">1,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-209">6,901</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-210">2,927</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-211">3,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-212">421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-213">6,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-214">467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="f-215">859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="f-216">1,866</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="f-217">5,533</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="f-218">10,829</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-219">1,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-220">3,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-221">2,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-222">3,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-223">4,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-224">1,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-225">1,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-226">6,697</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-227">31,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-228">16,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-229">50,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-230">34,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-231">14,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-232">5,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-233">20,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-234">12,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-235">17,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-236">11,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-237">29,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-238">22,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-239">4,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-240">673</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-241">3,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-242">2,987</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Apollo Medical Holdings, Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-243">13,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-244">11,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-245">26,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-246">25,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share &#8211; basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-36" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-247">0.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-37" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-248">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-249">0.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-38" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-250">0.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share &#8211; diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-36" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-251">0.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-37" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-252">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-253">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-38" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-254">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APOLLO MEDICAL HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(IN THOUSANDS, EXCEPT SHARE DATA)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(UNAUDITED)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.125%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.125%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.185%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine<br/>Equity&#160;&#8211;<br/>Non-controlling<br/>Interest&#160;in&#160;APC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common&#160;Stock&#160;Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional<br/>Paid-in&#160;Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling<br/>Interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023 (restated)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-255">14,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-40" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-256">46,575,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-257">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-258">360,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-259">182,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-260">1,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-261">544,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income (restated)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" sign="-" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="f-262">1,729</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-263">13,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-264">1,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-265">14,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for vesting of restricted stock awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-48" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="f-266">57,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="f-267">109</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="f-268">109</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for exercise of options and warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-48" decimals="INF" name="ameh:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-269">125,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="3" id="f-270">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="3" id="f-271">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of treasury shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-48" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-272">270,081</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="f-273">9,539</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="f-274">9,539</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-275">3,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-276">3,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" sign="-" name="ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" scale="3" id="f-277">120</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" sign="-" name="ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" scale="3" id="f-278">120</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer of common control entities (restated)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="ameh:TemporaryEquityTransferOfCommonControlEntities" format="ixt:num-dot-decimal" scale="3" id="f-279">1,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" sign="-" name="ameh:TransferOfCommonControlEntities" format="ixt:num-dot-decimal" scale="3" id="f-280">2,447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" sign="-" name="ameh:TransferOfCommonControlEntities" format="ixt:num-dot-decimal" scale="3" id="f-281">2,447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023 (restated)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-282">14,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-283">46,488,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-284">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-285">352,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-286">195,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-287">2,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-288">551,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="f-289">3,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-290">13,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-291">1,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-292">14,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-293">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-294">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="f-295">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="f-296">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for vesting of restricted stock awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-59" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="f-297">42,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="f-298">464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="f-299">464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-300">4,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-301">4,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares for business acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-59" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-302">22,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="f-303">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="f-304">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" sign="-" name="us-gaap:TemporaryEquityAccretionOfDividends" scale="3" id="f-305">601</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" sign="-" name="ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" scale="3" id="f-306">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" sign="-" name="ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" scale="3" id="f-307">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact from dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" sign="-" name="ameh:TemporaryEquityDividendsImpact" format="ixt:num-dot-decimal" scale="3" id="f-308">3,076</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-309">13,845</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-62" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-310">46,553,517</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-311">47</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-312">357,246</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-313">208,719</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-314">3,741</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-315">569,753</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.428%"></td><td style="width:0.1%"></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine<br/>Equity&#160;&#8211;<br/>Non-controlling<br/>Interest&#160;in&#160;APC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:19pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common&#160;Stock&#160;Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional<br/>Paid-in&#160;Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling<br/>Interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022 (restated)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-316">56,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-67" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-317">44,630,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-318">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-319">310,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-320">137,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-321">5,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-322">454,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income (restated)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" sign="-" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="f-323">3,252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-324">13,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" scale="3" id="f-325">938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-326">14,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-327">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-328">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="f-329">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="f-330">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share buy back</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="f-331">230</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for vesting of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-76" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="f-332">81,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for exercise of options and warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-76" decimals="INF" name="ameh:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-333">124,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="3" id="f-334">1,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="3" id="f-335">1,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-336">3,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-337">3,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares for business acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-76" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-338">18,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-339">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-340">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-76" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" format="ixt:num-dot-decimal" scale="0" id="f-341">11,084</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="f-342">457</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="f-343">457</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:TemporaryEquityAccretionOfDividends" format="ixt:fixed-zero" scale="3" id="f-344">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" sign="-" name="ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" format="ixt:num-dot-decimal" scale="3" id="f-345">1,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" sign="-" name="ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" format="ixt:num-dot-decimal" scale="3" id="f-346">1,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022 (restated)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-347">53,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-79" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-348">44,845,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-349">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-350">316,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-351">151,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-352">5,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-353">472,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income (restated)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" sign="-" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="f-354">2,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-355">11,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-356">1,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-357">13,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for vesting of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-87" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="f-358">108,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="f-359">253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="f-360">253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for exercise of options and warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-87" decimals="INF" name="ameh:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-361">15,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" scale="3" id="f-362">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" scale="3" id="f-363">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of treasury shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-87" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-364">250,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="f-365">9,250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="f-366">9,250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-367">3,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-368">3,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="f-369">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="f-370">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" sign="-" name="us-gaap:TemporaryEquityAccretionOfDividends" format="ixt:num-dot-decimal" scale="3" id="f-371">10,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" sign="-" name="ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" format="ixt:num-dot-decimal" scale="3" id="f-372">1,374</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" sign="-" name="ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" format="ixt:num-dot-decimal" scale="3" id="f-373">1,374</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2022 (restated)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-374">41,034</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-90" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-375">44,719,710</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-376">45</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-377">310,629</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-378">162,960</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-379">5,879</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-380">479,513</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APOLLO MEDICAL HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(IN THOUSANDS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(UNAUDITED)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-381">29,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-382">22,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-383">8,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-384">8,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="f-385">474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="f-386">474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-387">7,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-388">6,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-389">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-390">2,272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized loss on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ameh:UnrealizedGainLossFromInvestmentInEquitySecurities" format="ixt:num-dot-decimal" scale="3" id="f-391">5,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="ameh:UnrealizedGainLossFromInvestmentInEquitySecurities" format="ixt:num-dot-decimal" scale="3" id="f-392">13,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-393">5,207</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-394">2,945</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss (gain) on interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="3" id="f-395">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-396">2,830</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="f-397">3,746</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="f-398">3,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of business combinations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-399">17,296</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-400">56,202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables, net &#8211; related parties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInDueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="f-401">17,673</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:IncreaseDecreaseInDueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="f-402">12,151</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="f-403">1,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="f-404">3,580</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ameh:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-405">2,277</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="ameh:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-406">4,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ameh:IncreaseDecreaseInOperatingLeaseAssets" format="ixt:num-dot-decimal" scale="3" id="f-407">3,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="ameh:IncreaseDecreaseInOperatingLeaseAssets" format="ixt:num-dot-decimal" scale="3" id="f-408">2,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="f-409">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-410">1,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-411">2,864</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-412">14,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiduciary accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" scale="3" id="f-413">538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-414">4,464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ameh:IncreaseDecreaseInMedicalLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-415">13,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="ameh:IncreaseDecreaseInMedicalLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-416">55,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable/receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="f-417">15,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="f-418">14,010</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-419">3,309</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-420">2,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:fixed-zero" scale="3" id="f-421">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="f-422">370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-423">33,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-424">33,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for business and asset acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="f-425">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="f-426">858</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from repayment of loans receivable &#8211; related parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="3" id="f-427">2,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="3" id="f-428">4,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-429">2,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-430">1,750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of investments - privately held</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-431">2,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment" format="ixt:fixed-zero" scale="3" id="f-432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of investments - equity method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="f-433">325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-435">17,367</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-436">18,845</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:fixed-zero" scale="3" id="f-437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-438">6,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution from investment - equity method</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" format="ixt:fixed-zero" scale="3" id="f-439">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" scale="3" id="f-440">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution to investment - equity method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ameh:PaymentsToEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-441">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="ameh:PaymentsToEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-442">1,685</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-443">19,221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-444">12,228</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDividends" scale="3" id="f-445">842</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="f-446">12,556</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="f-447">312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="f-448">200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" scale="3" id="f-449">303</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" scale="3" id="f-450">283</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from the exercise of stock options and warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-451">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-452">1,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-453">9,539</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-454">9,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="3" id="f-455">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" scale="3" id="f-456">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ameh:PurchaseOfNonControllingInterest" scale="3" id="f-457">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="ameh:PurchaseOfNonControllingInterest" scale="3" id="f-458">199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings on loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-459">1,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-460">1,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-461">8,062</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-462">19,705</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-463">6,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-464">1,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and cash equivalents beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-465">288,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-466">233,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and cash equivalents end of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-467">294,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-468">234,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplementary disclosures of cash flow information</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="f-469">7,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="f-470">22,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-471">6,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-472">2,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosures of non-cash investing and financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="f-473">701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact from dividends</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ameh:TemporaryEquityDividendsImpact" format="ixt:num-dot-decimal" scale="3" id="f-475">3,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="ameh:TemporaryEquityDividendsImpact" format="ixt:fixed-zero" scale="3" id="f-476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed asset obtained in exchange for finance lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-477">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="f-478">398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued in business combination</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-479">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="3" id="f-480">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:MortgageLoanRelatedToPropertySales1" format="ixt:fixed-zero" scale="3" id="f-481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:MortgageLoanRelatedToPropertySales1" format="ixt:num-dot-decimal" scale="3" id="f-482">16,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total amounts of cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-483"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-484">293,921</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-485">234,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash &#8211; current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashEquivalentsCurrent" scale="3" id="f-486"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashEquivalentsCurrent" scale="3" id="f-487">345</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:RestrictedCashEquivalentsCurrent" format="ixt:fixed-zero" scale="3" id="f-488">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-489">294,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-490">234,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.913%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited consolidated financial statements.</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APOLLO MEDICAL HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_40"></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:NatureOfOperations" id="f-491" continuedAt="i92f0ac546f7c4abd9dc928bde6200084" escape="true">Description of Business</ix:nonNumeric></span></div><ix:continuation id="i92f0ac546f7c4abd9dc928bde6200084" continuedAt="i630055bece47458187e9d910b321d2a6"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Apollo Medical Holdings, Inc. (&#8220;ApolloMed&#8221;) is a leading physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to participate successfully in value-based care arrangements, thus empowering them to deliver high-quality care to patients in a cost-effective manner. ApolloMed was merged with Network Medical Management (&#8220;NMM&#8221;) in December 2017 (the &#8220;2017 Merger&#8221;). As a result of the 2017 Merger, NMM became a wholly owned subsidiary of ApolloMed, and the former NMM shareholders own a majority of the issued and outstanding common stock of ApolloMed and maintain control of the board of directors. Unless the context dictates otherwise, references in these notes to the financial statements, the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and similar words are references to ApolloMed and its consolidated subsidiaries and affiliated entities, as appropriate, including its consolidated variable interest entities (&#8220;VIEs&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Headquartered in Alhambra, California, ApolloMed&#8217;s subsidiaries and VIEs include management services organizations (&#8220;MSOs&#8221;), affiliated independent practice associations (&#8220;IPAs&#8221;), an accountable care organization (&#8220;ACO&#8221;) participating in the ACO Realizing Equity, Access, and Community Health (&#8220;ACO REACH&#8221;) model, and clinical operations. Together, ApolloMed provides value-based care enablement services and care delivery with our consolidated care partners. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company&#8217;s physician network consists of primary care physicians, specialist physicians, and hospitalists. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable segments changed from <ix:nonFraction unitRef="segment" contextRef="c-95" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-492">one</ix:nonFraction> to <ix:nonFraction unitRef="segment" contextRef="c-47" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-493">three</ix:nonFraction> in the first quarter of 2023 as a result of certain changes to the information regularly provided to the Company&#8217;s chief operating decision makers (&#8220;CODMs&#8221;) when reviewing the Company&#8217;s performance as well as an effort to provide additional transparency to investors and other financial statement users. The <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-494">three</ix:nonFraction> segments identified by the Company are Care Enablement, Care Partners and Care Delivery, which are described as follows:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Care Enablement</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Enablement segment is an integrated, end-to-end clinical and administrative platform, powered by our proprietary technology suite, which provides operational, clinical, financial, technology, management, and strategic services in order to enable success in the delivery of high-quality, value-based care for providers and payers. We provide solutions to providers, including independent physicians, provider and medical groups, and accountable care organizations, and payers, including health plans and other risk-bearing organizations. Our platform meets providers and payers where they are, with a wide spectrum of solutions across the total cost of care risk spectrum, ranging from solutions for fee-for-service entities to global risk-bearing entities, and across patient types, including Medicare, Medicaid, commercial, and exchange-insured patients. This segment includes our wholly owned subsidiaries which operate as management services organizations, NMM and Apollo Medical Management (&#8220;AMM&#8221;), which enter into long-term management and/or administrative services agreements with providers and payers. By leveraging our care enablement platform, providers and payers can improve their ability to deliver high-quality care to their patients and achieve better patient outcomes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Care Partners</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners with a shared vision for coordinated care delivery. By leveraging our unique care enablement platform and ability to recruit, empower, and incentivize physicians to effectively manage total cost of care, we are able to organize partnered providers into successful multi-payer risk-bearing organizations which take on varying levels of risk based on total cost of care across membership in all lines of business, including Medicare, Medicaid, commercial, and exchange. Through our network of IPAs, ACOs, and Restricted Knox-Keene licensed health plan, our healthcare delivery entities are responsible for coordinating and delivering high-quality care to our patients.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="i630055bece47458187e9d910b321d2a6"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated IPAs consist of the following: (i) Allied Physicians of California, a Professional Medical Corporation d.b.a. Allied Pacific of California IPA (&#8220;APC&#8221;), (ii) Alpha Care Medical Group, Inc. (&#8220;Alpha Care&#8221;), (iii) Accountable Health Care IPA, a Professional Medical Corporation (&#8220;Accountable Health Care&#8221;), (iv) Jade Health Care Medical Group, Inc. (&#8220;Jade&#8221;), (v) Access Primary Care Medical Group (&#8220;APCMG&#8221;), and (vi) All American Medical Group (&#8220;AAMG&#8221;).  The Company&#8217;s ACO operates under the APA ACO, Inc. (&#8220;APAACO&#8221;) brand and participates in the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) program that allows provider groups to assume higher levels of financial risk and potentially achieve a higher reward from participation in the program&#8217;s attribution-based risk-sharing model. The Company&#8217;s Restricted Knox-Keene licensed health plan is held by For Your Benefit Inc. (&#8220;FYB&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Care Delivery</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients. Our care delivery organization includes primary care, multi-specialty care, and ancillary care services. This segment includes our primary care clinics, operating under the AMG, a Professional Medical Corporation (&#8220;AMG&#8221;) and Valley Oaks Medical Group (&#8220;VOMG&#8221;) brands, our multi-specialty care clinics and medical groups, operating under the ApolloMed Hospitalists, a Medical Corporation (&#8220;AMH&#8221;), Southern California Heart Centers, a Medical Corporation (&#8220;SCHC&#8221;), and AllCare Women&#8217;s Health brands, and our ancillary service providers, operating under the 1 World Medicine Urgent Care Corporation (&#8220;1 World&#8221;), DMG, Concourse Diagnostic Surgery Center, LLC (&#8220;CDSC&#8221;), and Sun Clinical Laboratories (&#8220;Sun Labs&#8221;) brands.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2023, AP-AMH 2 purchased <ix:nonFraction unitRef="number" contextRef="c-96" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-495">100</ix:nonFraction>% of the shares of capital stock of AMG,1 World, and Eleanor Leung M.D., a Professional Medical Corporation from APC-LSMA. As a result of these purchases, these entities are consolidated entities of AP-AMH 2. AMG provides professional and post-acute care services to patients through its network of doctors and nurse practitioners, 1 World is an urgent care center, and Eleanor Leung M.D. provides specialized care for women&#8217;s health operating as AllCare Women&#8217;s Health.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a financing obligation to purchase the remaining equity interest in DMG and Sun Labs within <ix:nonNumeric contextRef="c-97" name="ameh:BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" format="ixt-sec:durwordsen" id="f-496">three years</ix:nonNumeric> from the date the Company consolidated DMG and Sun Labs. The purchase of the remaining DMG equity value is considered a financing obligation with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-497">8.5</ix:nonFraction>&#160;million as of June&#160;30, 2023 and December&#160;31, 2022. The purchase of the remaining Sun Labs equity value is considered a financing obligation with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-498">7.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-499">5.8</ix:nonFraction> million as of June&#160;30, 2023 and December&#160;31, 2022, respectively. For the six months ended June&#160;30, 2023, the change in the fair value of  Sun Labs equity value obligation is $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="ameh:BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" format="ixt:num-dot-decimal" scale="6" id="f-500">1.8</ix:nonFraction> million and is presented in unrealized loss on investments in the accompanying consolidated statement of income. As the financing obligations are embedded in the non-controlling interest, the non-controlling interests are recognized in other long-term liabilities in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Affiliates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our other affiliates are not included as a reportable segment and primarily consist of real estate operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APC owns a <ix:nonFraction unitRef="number" contextRef="c-102" decimals="INF" name="ameh:AssetAcquisitionPercentageOfSharesAcquired" scale="-2" id="f-501">100</ix:nonFraction>% equity interest in each of Medical Property Partners, LLC (&#8220;MPP&#8221;), AMG Properties, LLC (&#8220;AMG Properties&#8221;), ZLL Partners, LLC (&#8220;ZLL&#8221;)&#8221;), Tag-8 Medical Investment Group, LLC (&#8220;Tag 8&#8221;), and Tag-6 Medical Investment Group, LLC (&#8220;Tag 6&#8221;), and a <ix:nonFraction unitRef="number" contextRef="c-103" decimals="INF" name="ameh:AssetAcquisitionPercentageOfSharesAcquired" scale="-2" id="f-502">50</ix:nonFraction>% interest in each of One MSO, LLC (&#8220;One MSO&#8221;). These entities are deemed Excluded Assets that are solely for the benefit of APC and its shareholders. As such, any income pertaining to APC&#8217;s interests in these properties has no impact on the Series A Dividend payable by APC to AP-AMH Medical Corporation, and consequently will not affect net income attributable to ApolloMed.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="f-503" continuedAt="i46d66ee0ffa8404181f77f0991a8033c" escape="true">Basis of Presentation and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i46d66ee0ffa8404181f77f0991a8033c" continuedAt="ib3bcc7c050a348abb24d55bfb7f088f8"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-504" continuedAt="idb4cbbc354464ce2b214a9b49a65a0ac" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idb4cbbc354464ce2b214a9b49a65a0ac">The accompanying consolidated balance sheet at December&#160;31, 2022 has been derived from the Company&#8217;s audited consolidated financial statements, but does not include all annual disclosures required by generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;). The accompanying unaudited consolidated financial statements as of June&#160;30, 2023, and for the three and six months ended June&#160;30, 2023 and 2022, have been prepared in accordance with U.S. GAAP for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, these unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes to the financial statements included in the Company&#8217;s Annual Report on Form 10-K/A for the year ended December&#160;31, 2022, as filed with the SEC on August&#160;9, 2023. In the opinion of management, all material adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been made to make the consolidated financial statements not misleading, as required by Regulation S-X, Rule 10-01.</ix:continuation> Operating results for the three and six months ended June&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023, or any future periods.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-505" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated balance sheets as of June&#160;30, 2023 and December&#160;31, 2022, and the consolidated statements of income for the three and six months ended June&#160;30, 2023 and 2022, include (i) ApolloMed, ApolloMed&#8217;s consolidated subsidiaries, NMM, AMM, APAACO, Orma Health Inc, Provider Growth Solutions, LLC, and FYB and its VIEs, AP-AMH, AP-AMH 2, Sun Labs, DMG, and Valley Oaks Medical Group (&#8220;VOMG&#8221;); (ii) AP-AMH 2&#8217;s consolidated subsidiaries, APCMG, Jade, AAMG, AMG, 1 World, and Eleanor Leung M.D., a Professional Medical Corporation; (iii) AMM&#8217;s consolidated VIEs, SCHC and AMH; (iv) NMM&#8217;s VIE, APC;(v) APC&#8217;s consolidated subsidiaries, Universal Care Acquisition Partners, LLC (&#8220;UCAP&#8221;), MPP, AMG Properties, ZLL, ICC, 120 Hellman LLC (&#8220;120 Hellman&#8221;) and its VIEs, CDSC, APC-LSMA, Tag 8, and Tag 6; and (vi) APC-LSMA&#8217;s consolidated subsidiaries, Alpha Care and Accountable Health Care.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited consolidated interim financial statements have been prepared under the assumption that users of the interim financial data have either read or have access to our audited consolidated financial statements for the fiscal year ended December&#160;31, 2022. Accordingly, certain disclosures that would substantially duplicate the disclosures contained in our December&#160;31, 2022, audited consolidated financial statements have been omitted. These unaudited consolidated interim financial statements should be read in conjunction with our audited consolidated financial statements for the fiscal year ended December&#160;31, 2022.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restatement of Previously Issued Financial Statements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed Amendment No. 1 on Form 10-K (&#8220;Form 10-K/A&#8221;)  and Amendment No. 1 on Form 10-Q (&#8220;Form 10-Q/A&#8221;) with the SEC on August&#160;9, 2023 to restate previously issued consolidated financial statements and financial information as of December 31, 2022 and 2021 and for the fiscal years ended December 31, 2022, 2021 and 2020 in the Form 10-K/A and unaudited consolidated financial statements and financial information as of March 31, 2023 and for each of the three months ended March 31, 2023 and 2022 in the Form 10-Q/A. The Form 10-K/A also provided restated interim financial information for the quarterly fiscal 2022 periods.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-506" continuedAt="i471a0eecdb204a7fbdbaf904fda69dc1" escape="true">Use of Estimates</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="ib3bcc7c050a348abb24d55bfb7f088f8" continuedAt="i5114fc50086948aa82f809a3056e4e19"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i471a0eecdb204a7fbdbaf904fda69dc1">The preparation of the consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combination and goodwill valuation and impairment, accrual of medical liabilities (incurred but not reported (&#8220;IBNR&#8221;) claims), determination of full-risk and shared-risk revenue and receivables (including constraints, completion factors and historical margins), income tax-valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.</ix:continuation></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="f-507" continuedAt="idbe59953b3f240d09d5bc319b7b37179" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, as circumstances indicate the need for reconsideration, the Company evaluates each legal entity that is not wholly owned by the Company in accordance with the consolidation guidance. The evaluation considers all of the Company&#8217;s variable interests, including equity ownership, as well as management services agreements. To fall within the scope of the consolidation guidance, an entity must meet both of the following criteria:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity has a legal structure that has been established to conduct business activities and to hold assets; such entity can be in the form of a partnership, limited liability company, or corporation, among others; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company has a variable interest in the legal entity; i.e., variable interests that are contractual, such as equity ownership, or other financial interests that change with changes in the fair value of the entity&#8217;s net assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity does not meet both criteria above, the Company applies other accounting guidance, such as the cost or equity method of accounting. If an entity does meet both criteria above, the Company evaluates such entity for consolidation under either the variable interest model if the legal entity meets any of the following characteristics to qualify as a VIE, or under the voting model for all other legal entities that are not VIEs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A legal entity is determined to be a VIE if it has any of the following three characteristics:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity does not have sufficient equity to finance its activities without additional subordinated financial support;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity is established with non-substantive voting rights (i.e., where the entity deprives the majority economic interest holder(s) of voting rights); or</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The equity holders, as a group, lack the characteristics of a controlling financial interest. Equity holders meet this criterion if they lack any of the following:</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The power, through voting rights or similar rights, to direct the activities of the entity that most significantly influence the entity&#8217;s economic performance, as evidenced by:</span></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Substantive participating rights in the day-to-day management of the entity&#8217;s activities; or</span></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Substantive kick-out rights over the party responsible for significant decisions;</span></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The obligation to absorb the entity&#8217;s expected losses; or</span></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The right to receive the entity&#8217;s expected residual returns.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company determines that any of the three characteristics of a VIE are met under Accounting Standards Codification (&#8220;ASC&#8221;) 810, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company will conclude that the entity is a VIE and evaluate it for consolidation under the variable interest model.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="i5114fc50086948aa82f809a3056e4e19" continuedAt="i9c5c8c7b5c7d43ac84883b7684070e74"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="idbe59953b3f240d09d5bc319b7b37179" continuedAt="i7fd1e25ec18541878bcff99af8860af3">Variable Interest Model</ix:continuation></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7fd1e25ec18541878bcff99af8860af3">If an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company consolidates a VIE if both power and benefits belong to the Company; that is, the Company (i) has the power to direct the activities of a VIE that most significantly influence the VIE&#8217;s economic performance (power), and (ii) has the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE (economics). The Company consolidates VIEs whenever it is determined that the Company is the primary beneficiary. Refer to Note 16 &#8212; &#8220;Variable Interest Entities (VIEs)&#8221; to the consolidated financial statements for information on the Company&#8217;s consolidated VIEs. If there are variable interests in a VIE, but the Company is not the primary beneficiary, the Company may account for the investment using the equity method of accounting.</ix:continuation><br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationsPolicy" id="f-508" continuedAt="ib39c2a1de845423b8c0ca569a2cc2eaf" escape="true">Business Combinations</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib39c2a1de845423b8c0ca569a2cc2eaf">The Company uses the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination.</ix:continuation></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-509" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reportable Segments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the Company operates in <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-510">three</ix:nonFraction> reportable segments: Care Enablement, Care Partners, and Care Delivery. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; and Note 18 &#8212; &#8220;Segments&#8221; to the consolidated financial statements for information on the Company&#8217;s segments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-511" continuedAt="ibfe78fecf6b44dc186cc3975133a9789" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cash and cash equivalents primarily consist of money market funds and certificates of deposit. The Company considers all highly liquid investments that are both readily convertible into known amounts of cash and mature within ninety days from their date of purchase to be cash equivalents.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibfe78fecf6b44dc186cc3975133a9789">The Company maintains its cash in deposit accounts with several banks, which at times may&#160;exceed the insured limits of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). The Company believes it is not exposed to any significant credit risk with respect to its cash and cash equivalents.</ix:continuation> As of June&#160;30, 2023 and December&#160;31, 2022, the Company&#8217;s deposit accounts with banks exceeded the FDIC&#8217;s insured limit by approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashUninsuredAmount" format="ixt:num-dot-decimal" scale="6" id="f-512">326.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CashUninsuredAmount" format="ixt:num-dot-decimal" scale="6" id="f-513">324.7</ix:nonFraction> million, respectively. The Company has not experienced any losses to date and performs ongoing evaluations of these financial institutions to limit the Company&#8217;s concentration of risk exposure.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:MarketableSecuritiesPolicy" id="f-514" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Marketable Securities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in marketable securities consist of equity securities and certificates of deposit with various financial institutions. The appropriate classification of investments is determined at the time of purchase, and such designation is reevaluated at each balance sheet date.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certificates of deposit are reported at par value, plus accrued interest, with maturity dates greater than <ix:nonNumeric contextRef="c-104" name="ameh:MarketableSecuritiesCurrentMaturityPeriod" format="ixt-sec:durwordsen" id="f-515">ninety days</ix:nonNumeric>. As of June&#160;30, 2023 and December&#160;31, 2022, certificates of deposit amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-516">2.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-517">0</ix:nonFraction>, respectively. Investments in certificates of deposit are classified as Level 1 investments in the fair value hierarchy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities are reported at fair value. These securities are classified as Level 1 in the valuation hierarchy, where quoted market prices from reputable third-party brokers are available in an active market and unadjusted. Equity securities with low trading volume are determined to not have an active market with buyers and sellers ready to trade. Accordingly, we classify such equity securities as Level 2 in the valuation hierarchy, and their valuation is based on weighted average share prices from observable market data.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="i9c5c8c7b5c7d43ac84883b7684070e74" continuedAt="ie578529372c54059bad916d4dfb5e36f"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company are primarily comprised of common stock of a payor partner that completed its initial public offering (&#8220;IPO&#8221;) in June 2021 and Nutex Health Inc. (formerly known as Clinigence Holdings, Inc.) (&#8220;Nutex&#8221;). In May 2022, the Company exercised warrants from Nutex and subsequently recognized the shares within investments in marketable securities in the accompanying consolidated balance sheet. In March 2023, the contingent equity securities were settled and the Company received additional Nutex common stock. The additional common stock received from the contingent equity securities is included in investments in marketable securities in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023 and December&#160;31, 2022, the equity securities were approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="f-518">1.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="f-519">5.6</ix:nonFraction>&#160;million, respectively, in the accompanying consolidated balance sheets. Gains and losses recognized on equity securities sold are recognized in the accompanying consolidated statements of income under other income. <ix:nonNumeric contextRef="c-1" name="us-gaap:GainLossOnInvestmentsTextBlock" id="f-520" continuedAt="i67186ecea17b4a0eba30619f9cd8351e" escape="true">The components comprising total gains and losses on equity securities are as follows (in thousands) for the periods listed below:</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><ix:continuation id="i67186ecea17b4a0eba30619f9cd8351e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Total losses recognized on equity securities  </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-521">1,348</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-522">4,331</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-523">5,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-524">14,886</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Gains recognized on equity securities sold  </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-525">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-526">2,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-527">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-528">2,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Unrealized losses recognized on equity securities held at end of period  </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-529">1,348</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-530">2,059</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-531">5,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-532">12,614</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="c-1" name="ameh:ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock" id="f-533" continuedAt="idbef3b6a71144778bdfc8ef59030749d" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables,  Receivables &#8211; Related Parties, Other Receivables and Loan Receivable - Related Party</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables are comprised of accounts receivable, capitation and claims receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivable are recorded and stated at the amount expected to be collected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables &#8211; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#8211; related parties are recorded and stated at the amount expected to be collected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s loan receivable and loan receivable &#8211; related party consists of promissory notes that accrue interest per annum. As of June&#160;30, 2023, promissory notes are expected to be collected within <ix:nonNumeric contextRef="c-1" name="ameh:PromissoryNotesExpectedToBeCollectedWithinPeriod" format="ixt-sec:durmonth" id="f-534">12</ix:nonNumeric> months.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitation and claims receivables relate to each health plan&#8217;s capitation and are received by the Company in the month following the month of service. Risk pool settlements and incentive receivables mainly consist of the Company&#8217;s full risk pool receivable, which is recorded quarterly based on reports received from the Company&#8217;s hospital partners and management&#8217;s estimate of the Company&#8217;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately <ix:nonNumeric contextRef="c-1" name="ameh:RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" format="ixt-sec:durmonth" id="f-535">18</ix:nonNumeric> months after the risk pool performance year is completed. Other receivables consist of receivables from fee-for-services (&#8220;FFS&#8221;) reimbursement for patient care, certain expense reimbursements, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains reserves for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer creditworthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected and adjustments are recorded when necessary. Reserves are recorded primarily on a specific identification basis.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idbef3b6a71144778bdfc8ef59030749d">Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided and collection is reasonably likely to occur. In regard to the credit loss standard, the Company continuously monitors its collections of receivables and our expectation is that the historical credit loss experienced across our receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#8220;CECL&#8221;) model.</ix:continuation> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-536" continuedAt="id8aa7a37151145a0b403d8e7f4a73fd8" escape="true">Concentrations of Credit Risks</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="ie578529372c54059bad916d4dfb5e36f" continuedAt="id90e5f2891634d6c82f78b7016921a72"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id8aa7a37151145a0b403d8e7f4a73fd8">The Company disaggregates revenue from contracts by service type and payor type. This level of detail provides useful information pertaining to how the Company generates revenue by significant revenue stream and by type of direct contracts. The consolidated statements of income present disaggregated revenue by service type.</ix:continuation> <ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-537" continuedAt="id6ee8d225aa34a0d82e7e3bae0685a51" escape="true">The following table presents disaggregated revenue generated by payor type for the three and six months ended June&#160;30, 2023 and 2022 (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="id6ee8d225aa34a0d82e7e3bae0685a51"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-538">38,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-539">42,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-540">78,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-541">84,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-542">222,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-543">142,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-544">438,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-545">276,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-546">69,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-547">70,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-548">136,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-549">142,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other third parties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-550">18,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-551">14,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-552">31,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-553">30,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-554">348,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-555">269,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-556">685,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-557">532,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" id="f-558" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had major payors that contributed the following percentages of net revenue:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payor A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-123" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-559">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-124" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-560">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payor B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-125" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-561">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-126" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-562">31.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-127" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-563">39.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-128" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-564">30.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> *Less than 10% of total net revenues</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had major payors that contributed to the following percentages of receivables and receivables &#8211; related parties:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payor B</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-129" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-565">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-130" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-566">26.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payor C</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-131" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-567">50.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-132" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-568">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-569" continuedAt="i10400779b8fa4a658efb3f0813b05c30" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements of Financial Instruments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments consist of cash and cash equivalents, fiduciary cash, investment in marketable securities, receivables, loans receivable, accounts payable, certain accrued expenses, finance lease obligations, and long-term debt. The carrying values of the financial instruments classified as current in the accompanying consolidated balance sheets are considered to be at their fair values, due to the short maturity of these instruments. The carrying amounts of finance lease obligations and long-term debt approximate fair value as they bear interest at rates that approximate current market rates for debt with similar maturities and credit quality.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 820&#8221;), applies to all financial assets and financial liabilities that are measured and reported on a fair value basis and requires disclosure that establishes a framework for measuring fair value and expands disclosure about fair value measurements. ASC&#160;820 establishes a fair value hierarchy for disclosure of the inputs to valuations used to measure fair value.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in Level 1, Level 2, or Level 3 classification and no changes in valuation techniques for the six months ended June&#160;30, 2023. This hierarchy prioritizes the inputs into three broad levels as follows:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that can be accessed at the measurement date.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="id90e5f2891634d6c82f78b7016921a72" continuedAt="icbe69c59436f476697f04e631ddd2f5b"><ix:continuation id="i10400779b8fa4a658efb3f0813b05c30"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates and yield curves), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Unobservable inputs that reflect assumptions about what market participants would use in pricing the asset or liability. These inputs would be based on the best information available, including the Company&#8217;s own data.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="f-570" continuedAt="i29642542df3f485dbfb12395b92f6848" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company&#8217;s financial instruments as of June&#160;30, 2023, are presented below (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market accounts*</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-571">78,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-572">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-573">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-574">78,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-575">2,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-576">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-577">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-578">2,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-579">1,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-580">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-581">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-582">1,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-583">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-584">3,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-585">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-586">3,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate collar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-587">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-588">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-589">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-590">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-591">82,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-592">4,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-593">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-594">86,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APCMG contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-595">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-596">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-597">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-598">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AAMG contingent consideration (see Note 3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-600">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-601">5,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-602">5,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VOMG contingent consideration (see Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-603">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-604">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="f-605">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="f-606">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DMG remaining equity interest purchase (see Note 1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-607">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-608">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-609">8,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-610">8,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sun labs remaining equity interest purchase (see Note 1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-611">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-612">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-613">7,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-614">7,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-615">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-616">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-617">22,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-618">22,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="icbe69c59436f476697f04e631ddd2f5b" continuedAt="ib735bf853f3a4702b3dbebf727009fea"><ix:continuation id="i29642542df3f485dbfb12395b92f6848"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Included in cash and cash equivalents</span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company&#8217;s financial instruments as of December&#160;31, 2022, are presented below (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market accounts*</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-619">135,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-620">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-621">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-622">135,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-623">5,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-624">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-625">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-626">5,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-627">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-628">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-629">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-630">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-631">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-632">3,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-633">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-634">3,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-635">140,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-636">3,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-637">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-638">145,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APCMG contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-639">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-640">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-641">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-642">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AAMG contingent consideration (see Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-643">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-644">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-645">5,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-646">5,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VOMG contingent consideration (see Note 3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-647">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-648">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="f-649">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="f-650">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DMG remaining equity interest purchase (see Note 1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-651">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-652">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-653">8,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-654">8,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun labs remaining equity interest purchase (see Note 1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-655">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-656">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-657">5,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-658">5,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-659">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-660">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-661">21,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-662">21,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Included in cash and cash equivalents</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-663" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of Level 3 liabilities for the six months ended June&#160;30, 2023 was as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="f-664">21,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain recognized from change in fair value of existing Level 3 liabilities*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="f-665">987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="f-666">22,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* The change in the fair value of existing Level 3 liabilities is presented in unrealized loss on investments in the accompanying consolidated statement of income.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativesPolicyTextBlock" id="f-667" continuedAt="iffb1c0124e424b3087621dc1c29d4e63" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Swap and Collar Agreements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to interest rate risk on its floating-rate debt. The Company has entered into interest rate swap and collar agreements to effectively convert its floating-rate debt to a fixed-rate basis or to a rate within the agreed-upon range. The principal objective of these contracts is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#8217;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit&#8221; for further information on our debt. Interest rate swap and collar agreements are not designated as hedging instruments. Changes in the fair value on these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and reflected in the accompanying consolidated statements of cash flows as unrealized gain or loss on interest rate swaps.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the interest rate swap was determined using Level 2 inputs. As of June&#160;30, 2023 and December&#160;31, 2022, the fair value of the interest rate swap was $<ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="6" id="f-668">3.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="6" id="f-669">3.2</ix:nonFraction>&#160;million, respectively, and are presented within other assets in the accompanying consolidated balance sheets.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="ib735bf853f3a4702b3dbebf727009fea" continuedAt="i7f259386f87c473d93a1411852e4da01"><ix:continuation id="iffb1c0124e424b3087621dc1c29d4e63" continuedAt="i5b890e6677c54860bc8ea9d5209f650f"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s collar agreement is designed to limit the interest rate risk associated with the Company&#8217;s Revolver Loan.  Under the terms of the agreement, the ceiling is <ix:nonFraction unitRef="number" contextRef="c-143" decimals="3" name="ameh:DerivativeCeilingInterestRate" scale="-2" id="f-670">5.0</ix:nonFraction>% and the floor is <ix:nonFraction unitRef="number" contextRef="c-143" decimals="4" name="us-gaap:DerivativeFloorInterestRate" scale="-2" id="f-671">2.34</ix:nonFraction>%.  The estimated fair value of the collar is determined using Level 2.  As of June&#160;30, 2023 the fair value of the collar is  $<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="6" id="f-672">1.2</ix:nonFraction>&#160;million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Contingent Equity Securities</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5b890e6677c54860bc8ea9d5209f650f">In addition to the common stock and warrants purchased under the stock purchase agreement between ApolloMed and Nutex, ApolloMed is entitled to additional common stock if Nutex did not pay NMM management fees exceeding a threshold by the end of December 31, 2022. The contingent equity securities are considered to be derivatives but are not designated as hedging instruments. Changes in the fair value of these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and the accompanying consolidated statements of cash flows. The Company determined the fair value of the contingent equity security using a probability-weighted model, which includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of recognizing management fees and assigned probabilities to each such scenario in determining fair value.</ix:continuation> Based on the outcome, the metric was not achieved and the Company received additional common stock during the six months ended June&#160;30, 2023. As of June&#160;30, 2023, the common stock from the contingent equity securities is recognized within investments in marketable securities in the accompanying consolidated balance sheet. See Note 2 &#8212; &#8220;Basis of Presentation and Summary of Significant Accounting Policies - Investment in Marketable Securities&#8221; in the accompanying consolidated financial statements for information on the treatment of the marketable securities. As of December&#160;31, 2022, the contingent equity securities were valued at $<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-673">1.9</ix:nonFraction> million, and were presented within prepaid and other current assets in the accompanying consolidated balance sheets.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-674" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company receives payments from the following sources for services rendered: (i) commercial insurers; (ii) the federal government under the Medicare program administered by CMS; (iii) state governments under the Medicaid and other programs; (iv) other third-party payors (e.g., hospitals and IPAs); and (v) individual patients and clients.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue primarily consists of capitation revenue, risk pool settlements and incentives, GPDC/ACO REACH revenue, management fee income, and FFS revenue. Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GPDC/ACO REACH Capitation Revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS contracts with Direct Contracting Entities (&#8220;DCEs&#8221;), which are composed of healthcare providers operating under a common legal structure and accept financial accountability for the overall quality and cost of medical care furnished to Medicare FFS beneficiaries aligned to the entity. The combination of the FFS model and the GPDC and ACO REACH model changes the distribution of responsibilities, risks, costs, and rewards among CMS, DCEs, and providers. By entering into a contract with CMS, a DCE voluntarily takes on operational, financial, and legal responsibilities and risks that no party has, individually or collectively, under the existing FFS model. Each DCE bears the economic costs, and reaps the economic rewards of fulfilling its responsibilities and managing its risks as a DCE. APAACO participated in the GPDC Model for Performance Year 2022 and is currently participating in the ACO REACH model for Performance Year 2023, beginning January 1, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each performance year, CMS will pay a total benchmark amount, determined unilaterally by CMS in advance but subject to prospective adjustments throughout the year, for the totality of care provided to the DCE&#8217;s population of aligned beneficiaries over the course of that year. The benchmark is net of a quality withholding applied by CMS. At the end of each performance year, a portion, or all, of the quality withholding can be earned based on APAACO&#8217;s performance. GPDC/ACO REACH capitation revenue is recognized based on the estimated transaction price to transfer the service for a distinct increment of the series (i.e., month) and is recognized net of quality incentives/penalties.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-675" continuedAt="if696c26d93b448f8964b9636d0268175" escape="true">Income Taxes</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="i7f259386f87c473d93a1411852e4da01"><ix:continuation id="if696c26d93b448f8964b9636d0268175"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted for both items that do not have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the consolidated financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the consolidated financial statements.</span></div></ix:continuation></ix:continuation><div id="icc2b852b4b5148b8aaf9d319f2f34464_52"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-676" continuedAt="ib0382fb66d544211ac6aeda316d268cc" escape="true">Business Combinations, Asset Acquisitions, and Goodwill</ix:nonNumeric></span></div><ix:continuation id="ib0382fb66d544211ac6aeda316d268cc" continuedAt="if43b03a09fcd46c9b6e2bd08318cb11c"><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FYB</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;1, 2023, the Company acquired <ix:nonFraction unitRef="number" contextRef="c-197" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-677">100</ix:nonFraction>% equity interest in FYB. FYB is licensed by the California Department of Managed Health Care as a full-service Restricted Knox-Keene licensed health plan, which enables FYB to assume full financial responsibility, including both professional and institutional risk, for the medical costs of its members under the Knox-Keene Health Care Service Plan Act of 1975.</span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Chinese Community Health Care Association (&#8220;CCHCA&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;1, 2023, the Company acquired certain healthcare assets from CCHCA. CCHCA is a non-profit independent physician association in the San Francisco Community. The purchase price consists of cash funded on May&#160;1, 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Orma Health</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 27, 2022, the Company acquired <ix:nonFraction unitRef="number" contextRef="c-198" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-678">100</ix:nonFraction>% of the capital stock of Orma Health, Inc., and Provider Growth Solutions, LLC (together, &#8220;Orma Health&#8221;). The purchase was paid in cash and the Company&#8217;s capital stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Jade Health Care Medical Group, Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(&#8220;Jade&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 19, 2022, the Company acquired <ix:nonFraction unitRef="number" contextRef="c-199" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-679">100</ix:nonFraction>% of the capital stock of Jade. The purchase was paid in cash. Jade is a primary and specialty care physicians&#8217; group focused on providing high-quality care to its patients in the San Francisco Bay Area in Northern California. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">VOMG</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 14, 2022, VOMG was determined to be a VIE of ApolloMed and is consolidated by the Company. VOMG owns <ix:nonFraction unitRef="clinic" contextRef="c-200" decimals="INF" name="ameh:NumberOfPrimaryCareClinics" format="ixt-sec:numwordsen" scale="0" id="f-680">nine</ix:nonFraction> primary care clinics in Nevada and Texas. The purchase price consists of cash funded upon the close of transaction and additional cash consideration (&#8220;VOMG contingent consideration&#8221;) contingent on VOMG meeting financial metrics for fiscal years 2023 and 2024. The Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). The contingent consideration is included within other long-term liabilities in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AAMG </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2022, AP-AMH 2, a VIE of the Company, acquired <ix:nonFraction unitRef="number" contextRef="c-201" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-681">100</ix:nonFraction>% of the equity interest in AAMG. AAMG is an IPA operating in Northern California. The purchase price consists of cash funded upon close of the transaction and additional  consideration (&#8220;AAMG contingent consideration&#8221;) and stock consideration (&#8220;AAMG stock contingent consideration&#8221;) contingent on AAMG meeting revenue and capitated member metrics for fiscal years 2023 and 2024. The Company determined the fair value of the contingent considerations using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of revenue and assigned probabilities to each such scenario in determining fair value. As of June&#160;30, 2023, the contingent consideration is valued at $<ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-682">5.1</ix:nonFraction> million and was included within other long-term liabilities in the accompanying consolidated balance sheets. The stock contingent consideration is valued at $<ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-683">5.6</ix:nonFraction> million and is included in additional paid-in capital in the accompanying consolidated balance sheets. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="if43b03a09fcd46c9b6e2bd08318cb11c"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisitions were accounted for under the acquisition method of accounting. The fair value of the consideration for the acquired companies was allocated to acquired tangible and intangible assets and liabilities based on their fair values. The excess of the purchase consideration over the fair value of the net tangible and identifiable intangible assets acquired was recorded as goodwill. Determining the fair value of assets and liabilities acquired requires the Company to make estimates and use valuation techniques when market value is not readily available. The results of operations from the acquisitions have been included in the Company&#8217;s financial statements from the date of acquisition. Transaction costs associated with business acquisitions are expensed as they are incurred.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time of acquisition, the Company estimates the amount of the identifiable intangible assets based on a valuation and the facts and circumstances available at the time. The Company determines the final value of the identifiable intangible assets as soon as information is available, but not more than one year from the date of acquisition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is not deductible for tax purposes. The Company had <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-684"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-685">no</ix:nonFraction></ix:nonFraction> impairment of its goodwill or indefinite-lived intangible assets during the six months ended June&#160;30, 2023 and 2022. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfGoodwillTextBlock" id="f-686" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the carrying value of goodwill for the six months ended June&#160;30, 2023 was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2023  (restated)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-687">269,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-688">3,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="f-689">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-690">274,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="icc2b852b4b5148b8aaf9d319f2f34464_55"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="f-691" continuedAt="ib765ffb693a34c0498907b07c81d3353" escape="true">Intangible Assets, Net</ix:nonNumeric></span></div><ix:continuation id="ib765ffb693a34c0498907b07c81d3353" continuedAt="iefba14847a214552a0bb777ff6b79d7e"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-692" continuedAt="i3c108a12b53b4b5da089c76e93ea1ec2" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2023, the Company&#8217;s intangible assets, net, consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Useful</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Life</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net June 30,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite lived assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-693">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-694">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortized intangible assets:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Network relationships</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-204" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-695">11</ix:nonNumeric>-<ix:nonNumeric contextRef="c-205" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-696">21</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-697">150,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-698">100,244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-699">50,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-207" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-700">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-701">22,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-702">15,982</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-703">6,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Member relationships</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-208" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-704">10</ix:nonNumeric>-<ix:nonNumeric contextRef="c-209" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-705">14</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-706">20,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-707">6,302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-708">14,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient management platform</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-211" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-709">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-710">2,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-711">2,060</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="f-712">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tradename/trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-212" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-713">20</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-714">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="f-715">282</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-716">729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-213" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-717">6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="f-718">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="f-719">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-720">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-721">199,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-722">124,895</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-723">74,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="iefba14847a214552a0bb777ff6b79d7e"><ix:continuation id="i3c108a12b53b4b5da089c76e93ea1ec2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the Company&#8217;s intangible assets, net, consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Useful</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Life</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite lived assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-724">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-725">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Network relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-215" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-726">11</ix:nonNumeric>-<ix:nonNumeric contextRef="c-216" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-727">21</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-728">150,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-729">95,451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-730">55,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-218" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-731">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-732">22,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-733">15,208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-734">7,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-219" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-735">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-736">16,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-737">5,619</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-738">11,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient management platform</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-220" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-739">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-740">2,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-741">2,060</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="f-742">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tradename/trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-221" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-743">20</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-744">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="f-745">257</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-746">754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-222" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-747">6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="f-748">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="f-749">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-750">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-751">195,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-752">118,611</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-753">76,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2023 and 2022, the Company recognized amortization expense of $<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-754">3.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-755">3.5</ix:nonFraction> million, respectively, in depreciation and amortization on the accompanying consolidated statements of operations.  For the six months ended June&#160;30, 2023 and 2022, the Company recognized amortization expense of  $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-756">6.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-757">7.2</ix:nonFraction> million, respectively, in depreciation and amortization on the accompanying consolidated statements of operations. The Company determined that there was <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="0" id="f-758"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="0" id="f-759">no</ix:nonFraction></ix:nonFraction> impairment of its finite-lived intangible or long-lived assets during the during the six months ended June&#160;30, 2023 and 2022. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="f-760" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future amortization expense is estimated to be as follows for the following years ending December&#160;31 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (excluding the six months ended June 30, 2023)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="f-761">6,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-762">12,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-763">11,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="f-764">9,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="f-765">8,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ameh:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="f-766">24,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-767">72,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="icc2b852b4b5148b8aaf9d319f2f34464_61"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="ameh:EquityMethodAndOtherEquityInvestmentsTextBlock" id="f-768" continuedAt="if66707e1a7934e438f952f2783b7ab7c" escape="true">Investments in Other Entities</ix:nonNumeric></span></div><ix:continuation id="if66707e1a7934e438f952f2783b7ab7c" continuedAt="i1706b115fa2f4753a90c3b7bf2436497"><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Equity Method</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:EquityMethodInvestmentsTextBlock" id="f-769" continuedAt="i496857eb5be84c81bdea64bbe94cc5a5" escape="true">For the six months ended June&#160;30, 2023 and 2022, the Company&#8217;s equity method investment balance consisted of the following (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="i1706b115fa2f4753a90c3b7bf2436497" continuedAt="i3dc3204d6ab240638329af5ca502374c"><ix:continuation id="i496857eb5be84c81bdea64bbe94cc5a5" continuedAt="i1dcaf051168c4315bd6616e5da6e9fa9"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:19.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.745%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Initial Investment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allocation of Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distribution </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-223" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-770">25</ix:nonFraction>%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-771">5,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="ameh:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="0" id="f-772">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-773">4,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="0" id="f-774">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-775">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-776">10,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-226" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-777">40</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-778">1,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="ameh:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="3" id="f-779">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-780">223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-781">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-782">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-783">1,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-229" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-784">50</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-785">17,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="ameh:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="3" id="f-786">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-787">211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-788">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-789">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-790">17,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-232" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-791">50</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-792">2,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="ameh:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="3" id="f-793">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-794">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-795">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-796">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-797">2,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-235" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-798">30</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-799">12,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="ameh:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="3" id="f-800">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-801">451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-802">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-803">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-804">13,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James Song, M.D., A Professional Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-238" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-805">25</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-806">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="ameh:EquityMethodInvestmentAdditionalInvestment" scale="3" id="f-807">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-808">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-809">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-810">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="f-811">420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-812">40,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ameh:EquityMethodInvestmentAdditionalInvestment" scale="3" id="f-813">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-814">5,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-815">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-816">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-817">45,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:20.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.421%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.910%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allocation of Net Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding Reclassified To Loan Receivable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distribution</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-241" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-818">25</ix:nonFraction>%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-819">3,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-820">2,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-3" name="ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:num-dot-decimal" scale="3" id="f-821">2,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="0" id="f-822">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-823">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-824">3,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-244" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-825">40</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-826">1,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-827">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-3" name="ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:fixed-zero" scale="3" id="f-828">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-829">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-831">1,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-247" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-832">50</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-833">17,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-834">305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:fixed-zero" scale="3" id="f-835">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" scale="3" id="f-836">250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-837">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-838">17,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-250" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-839">50</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-840">2,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-841">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-3" name="ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:fixed-zero" scale="3" id="f-842">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-843">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" scale="3" id="f-844">400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-845">2,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tag-6 Medical Investment Group, LLC*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-253" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-846">50</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-847">4,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-848">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:fixed-zero" scale="3" id="f-849">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:num-dot-decimal" scale="3" id="f-850">1,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-851">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-852">6,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-256" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-853">30</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-854">11,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-855">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:fixed-zero" scale="3" id="f-856">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-857">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-858">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-859">12,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-860">41,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-861">2,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:num-dot-decimal" scale="3" id="f-862">2,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:num-dot-decimal" scale="3" id="f-863">1,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" scale="3" id="f-864">400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-865">43,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Investment is deemed Excluded Assets that are solely for the benefit of APC and its shareholders. </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2023 and 2022, the Company&#8217;s equity method investment balance consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:19.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Initial Investment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allocation of Net Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distribution</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-223" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-866">25</ix:nonFraction>%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-867">7,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="ameh:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="0" id="f-868">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-869">2,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="0" id="f-870">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-871">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-872">10,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-226" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-873">40</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-874">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="ameh:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="3" id="f-875">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-876">231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-877">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-878">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-879">1,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-229" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-880">50</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-881">17,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" name="ameh:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="3" id="f-882">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-883">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-884">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-885">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-886">17,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-232" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-887">50</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-888">2,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="ameh:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="3" id="f-889">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-890">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-891">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-892">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-893">2,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-235" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-894">30</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-895">12,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="ameh:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="3" id="f-896">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-897">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-898">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-899">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-900">13,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James Song, M.D., A Professional Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-238" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-901">25</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="f-902">362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="ameh:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="3" id="f-903">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-904">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-905">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-906">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="f-907">420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-908">43,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="ameh:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="3" id="f-909">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-910">2,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-911">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-912">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-913">45,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="i3dc3204d6ab240638329af5ca502374c"><div style="margin-top:5pt;text-align:center"><ix:continuation id="i1dcaf051168c4315bd6616e5da6e9fa9" continuedAt="i1d6b5bca8de1481e978a504ce50102c0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:19.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.503%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.945%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.240%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allocation of Net Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding Reclassified To Loan Receivable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distribution</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-241" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-914">25</ix:nonFraction>%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-915">4,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-916">1,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:num-dot-decimal" scale="3" id="f-917">2,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="0" id="f-918">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-919">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-920">3,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-244" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-921">40</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-922">1,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-923">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-3" name="ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:fixed-zero" scale="3" id="f-924">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-925">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-926">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-927">1,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-247" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-928">50</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-929">17,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-930">123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-3" name="ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:fixed-zero" scale="3" id="f-931">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" scale="3" id="f-932">250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-933">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-934">17,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-250" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-935">50</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-936">2,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-937">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:fixed-zero" scale="3" id="f-938">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-939">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" scale="3" id="f-940">200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-941">2,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tag-6 Medical Investment Group, LLC*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-253" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-942">50</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-943">6,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-944">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:fixed-zero" scale="3" id="f-945">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-946">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-947">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-948">6,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-256" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-949">30</ix:nonFraction>%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-950">12,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-951">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:fixed-zero" scale="3" id="f-952">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-953">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-955">12,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-956">44,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-957">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:num-dot-decimal" scale="3" id="f-958">2,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="ameh:EquityMethodInvestmentsContribution" scale="3" id="f-959">250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" scale="3" id="f-960">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-961">43,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1d6b5bca8de1481e978a504ce50102c0">* Investment is deemed Excluded Assets that are solely for the benefit of APC and its shareholders.</ix:continuation> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">James Song, M.D., A Professional Corporation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, AP-AMH 2 purchased a <ix:nonFraction unitRef="number" contextRef="c-283" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-962">25</ix:nonFraction>% interest in James Song, M.D., a Professional Corporation (&#8220;Song PC&#8221;), a medical corporation located in Hacienda Heights, California. AP-AMH 2 accounts for its investment in Song PC under the equity method of accounting as AP-AMH 2 has the ability to exercise significant influence, but not control over Song PC&#8217;s operations. For the three months ended June&#160;30, 2023, AP-AMH 2 recognized income of $<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="0" id="f-963">58,000</ix:nonFraction> in the accompanying consolidated statements of income. For the six months ended June&#160;30, 2023, AP-AMH 2 recognized income of $<ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="0" id="f-964">95,000</ix:nonFraction> in the accompanying consolidated statements of operations. The accompanying consolidated balance sheets include the related investment balances of $<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-965">0.4</ix:nonFraction> million as of June&#160;30, 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There was <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" format="ixt:fixed-zero" scale="0" id="f-966"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="INF" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" format="ixt:fixed-zero" scale="0" id="f-967">no</ix:nonFraction></ix:nonFraction> impairment loss recorded related to equity method investments for the six months ended June&#160;30, 2023 and 2022.</span></div></ix:continuation><div id="icc2b852b4b5148b8aaf9d319f2f34464_67"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="ameh:LoanReceivableTextBlock" id="f-968" continuedAt="i95b0c21667de4f9283bb5c706b093cf3" escape="true">Loan Receivable and Loan Receivable &#8211; Related Parties</ix:nonNumeric></span></div><ix:continuation id="i95b0c21667de4f9283bb5c706b093cf3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan receivable</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pacific6</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, NMM received a promissory note from 6 Founder LLC, a California limited liability company doing business as Pacific6 Enterprises totaling $<ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-5" name="us-gaap:NotesReceivableNet" format="ixt:num-dot-decimal" scale="6" id="f-969">0.5</ix:nonFraction>&#160;million as a result of the sale of the Company&#8217;s interest in an equity method investment. Interest accrues at a rate of <ix:nonFraction unitRef="number" contextRef="c-284" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-970">5</ix:nonFraction>% per annum and is payable monthly through the maturity date of December 1, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the outstanding loan receivable under the CECL model by assessing the party&#8217;s ability to pay by reviewing their interest payment history quarterly, financial history annually, and reassessing any identified insolvency risk. If a failure to pay occurs, the Company assesses the terms of the notes and estimates an expected credit loss based on the remittance schedule of the note</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> related party</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LaSalle Medical Associates Loan (&#8220;LMA Loan&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LaSalle Medical Associates (&#8220;LMA&#8221;) issued a promissory note to APC-LSMA for a principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-5" name="us-gaap:NotesReceivableNet" format="ixt:num-dot-decimal" scale="6" id="f-971">2.1</ix:nonFraction> million with an August 2023 maturity date. The contractual interest rate on the LMA Loan is <ix:nonFraction unitRef="number" contextRef="c-285" decimals="3" name="ameh:FinanceReceivableInterestRateStatedPercentage" scale="-2" id="f-972">1.0</ix:nonFraction>% above the prime rate of interest for commercial customers. In March 2023, LMA paid off the full balance of the promissory note and all interest. APC&#8217;s investment in LMA is accounted for under the equity method based on the <ix:nonFraction unitRef="number" contextRef="c-286" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-973"><ix:nonFraction unitRef="number" contextRef="c-287" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-974">25</ix:nonFraction></ix:nonFraction>% equity ownership interest held by APC-LSMA in LMA&#8217;s IPA line of business (see Note 5 &#8212; &#8220;Investments in Other Entities &#8212; Equity Method&#8221;)..</span></div></ix:continuation><div id="icc2b852b4b5148b8aaf9d319f2f34464_73"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="f-975" continuedAt="ibfafde3e6b074ff4b3614879aafe1628" escape="true">Accounts Payable and Accrued Expenses</ix:nonNumeric></span></div><ix:continuation id="ibfafde3e6b074ff4b3614879aafe1628"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="f-976" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounts payable and accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other accruals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-977">9,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-978">10,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitation payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ameh:SpecialtyCapitationPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-979">4,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ameh:SpecialtyCapitationPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-980">4,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subcontractor IPA payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ameh:SubcontractorIPAPayable" format="ixt:num-dot-decimal" scale="3" id="f-981">3,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ameh:SubcontractorIPAPayable" format="ixt:num-dot-decimal" scale="3" id="f-982">2,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-983">2,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-984">2,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to related parties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-985">3,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-986">3,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="f-987">647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="f-988">531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-989">13,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-990">15,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other provider payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-991">12,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-992">10,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-993">49,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-994">49,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="icc2b852b4b5148b8aaf9d319f2f34464_76"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" id="f-995" continuedAt="icfe04765a83b4508ac3c0277be19c3fe" escape="true">Medical Liabilities</ix:nonNumeric></span></div><ix:continuation id="icfe04765a83b4508ac3c0277be19c3fe"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="f-996" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s medical liabilities consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical liabilities, beginning of period (restated)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-997">81,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-998">55,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired (see Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-999">4,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-1000">1,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of medical care costs related to claims incurred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1001">441,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1002">313,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1003">12,066</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="3" id="f-1004">950</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical care costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="3" id="f-1005">429,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="3" id="f-1006">312,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for medical care costs related to claims incurred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="3" id="f-1007">336,231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="3" id="f-1008">204,032</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="3" id="f-1009">81,165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="3" id="f-1010">53,978</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1011">417,396</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1012">258,010</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-1013">2,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" scale="3" id="f-1014">742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical liabilities, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1015">100,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1016">112,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="icc2b852b4b5148b8aaf9d319f2f34464_79"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-1017" continuedAt="iea9f988089b84b279af05df230329e4f" escape="true">Credit Facility, Bank Loans, and Lines of Credit</ix:nonNumeric></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="iea9f988089b84b279af05df230329e4f" continuedAt="ic1c93f0599ff4ae59852290ed99870cd"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facility</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="f-1018" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s debt balance consists of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1019">180,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1020">180,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate Loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1021">22,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1022">23,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1023">5,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1024">4,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promissory Note Payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1025">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-1026">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1027">210,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1028">207,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1029">2,630</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="f-1030">619</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-1031">2,845</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-1032">3,319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1033">205,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1034">203,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our long-term debt was determined using Level 2 inputs primarily related to comparable market prices. As of June&#160;30, 2023 and December&#160;31, 2022, the carrying value was not materially different from fair value, as the interest rates on the Company&#8217;s debt approximated rates currently available to the Company.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="f-1035" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the future commitments of the Company&#8217;s debt for the years ending December 31 (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (excluding the six months ended June 30, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" id="f-1036">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-1037">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-1038">7,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="f-1039">180,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="f-1040">472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ameh:LongTermDebtMaturityAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1041">19,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-1042">210,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amended Credit Agreement</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement provides for a <ix:nonNumeric contextRef="c-296" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-1043">five-year</ix:nonNumeric> revolving credit facility to the Company of $<ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1044">400.0</ix:nonFraction> million, which includes a letter of credit sub-facility of up to $<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1045">25.0</ix:nonFraction> million and a swingline loan sub-facility of $<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1046">25.0</ix:nonFraction> million, which expires on June&#160;16, 2026. The Company is required to pay an annual agent fee of $<ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" format="ixt:num-dot-decimal" scale="0" id="f-1047">50,000</ix:nonFraction> and an annual facility fee of <ix:nonFraction unitRef="number" contextRef="c-301" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-1048">0.175</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-302" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-1049">0.350</ix:nonFraction>% on the available commitments under the Amended Credit Agreement, regardless of usage, with the applicable fee determined on a quarterly basis based on the Company&#8217;s leverage ratio. The Company will pay fees for standby letters of credit at an annual rate equal to <ix:nonFraction unitRef="number" contextRef="c-303" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-1050">1.25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-304" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-1051">2.50</ix:nonFraction>%, as determined on a quarterly basis based on the Company&#8217;s leverage ratio, plus facing fees and standard fees payable to the issuing bank on the respective letter of credit. The Company is also required to pay customary fees between the Company and Truist Bank, the lead arranger of the Amended Credit Agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amended Credit Agreement, the debt bears interest at an annual rate equal to either, at the Company&#8217;s option, (a) the Term SOFR Reference Rate, calculated two U.S. Government Securities Business Days prior to the first day of such interest period, as such rate is published by the Term SOFR Administrator (Federal Reserve Bank of New York), adjusted for any Term SOFR Adjustment, plus a spread of from <ix:nonFraction unitRef="number" contextRef="c-305" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1052">1.25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-306" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1053">2.50</ix:nonFraction>%, as determined on a quarterly basis based on the Company&#8217;s leverage ratio, or (b) a base rate, plus a spread of <ix:nonFraction unitRef="number" contextRef="c-307" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1054">0.25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-308" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1055">1.50</ix:nonFraction>%, as determined on a quarterly basis based on the Company&#8217;s leverage ratio.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the interest rate on the Credit Agreement was <ix:nonFraction unitRef="number" contextRef="c-309" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="f-1056">6.68</ix:nonFraction>%. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="ic1c93f0599ff4ae59852290ed99870cd" continuedAt="i68908954e9bf4272bfe65b9887921698"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement requires the Company to comply with <ix:nonFraction unitRef="financial_ratio" contextRef="c-310" decimals="INF" name="ameh:DebtInstrumentNumberOfKeyFinancialRatios" format="ixt-sec:numwordsen" scale="0" id="f-1057">two</ix:nonFraction> key financial ratios, each calculated on a consolidated basis. The Company must maintain a maximum consolidated total net leverage ratio of not greater than <ix:nonFraction unitRef="number" contextRef="c-310" decimals="INF" name="ameh:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="f-1058">3.75</ix:nonFraction> to 1.00 as of the last day of each fiscal quarter, provided that for any fiscal quarter during which the Company or certain subsidiaries consummate a permitted acquisition or investment, the aggregate purchase price is greater than $<ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-5" name="ameh:DebtCovenantAggregatePurchasePriceMaximum" format="ixt:num-dot-decimal" scale="6" id="f-1059">75.0</ix:nonFraction>&#160;million, the maximum consolidated total net leverage ratio may temporarily increase by <ix:nonFraction unitRef="number" contextRef="c-310" decimals="INF" name="ameh:DebtInstrumentCovenantLeverageRatioIncrementalChange" scale="0" id="f-1060">0.25</ix:nonFraction> to 1.00 to <ix:nonFraction unitRef="number" contextRef="c-310" decimals="INF" name="ameh:DebtInstrumentCovenantLeverageRatioAdjustedMaximum" scale="0" id="f-1061">4.00</ix:nonFraction> to 1.00. The Company must maintain a minimum consolidated interest coverage ratio of not less than <ix:nonFraction unitRef="number" contextRef="c-311" decimals="INF" name="ameh:DebtInstrumentCovenantInterestCoverageRatioMinimum" scale="0" id="f-1062">3.25</ix:nonFraction> to 1.00 as of the last day of each fiscal quarter. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Financing Costs</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, the Company recorded deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-5" name="us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet" format="ixt:num-dot-decimal" scale="6" id="f-1063">6.5</ix:nonFraction> million related to its entry into the Credit Facility. In June 2021, the Company recorded additional deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-5" name="us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet" format="ixt:num-dot-decimal" scale="6" id="f-1064">0.7</ix:nonFraction>&#160;million related to its entry into the Amended Credit Facility. Deferred financing costs are recorded as a direct reduction of the carrying amount of the related debt liability using straight-line amortization. The remaining unamortized deferred financing costs related to the Credit Facility and the new costs related to the Amended Credit Facility are amortized over the life of the Amended Credit Facility. At June&#160;30, 2023 and December&#160;31, 2022, the unamortized deferred financing cost was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="f-1065">2.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="f-1066">3.3</ix:nonFraction>&#160;million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Real Estate Loans</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MPP</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 3, 2020, MPP entered into a loan agreement with East West Bank with a maturity date of August 5, 2030. As of June&#160;30, 2023, the principal on the loan was $<ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1067">5.8</ix:nonFraction> million with a variable interest rate of <ix:nonFraction unitRef="number" contextRef="c-315" decimals="INF" sign="-" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1068">0.50</ix:nonFraction>% less than the independent index, which is the daily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Prime Rate.&#8221; If the index is unavailable, East West Bank may designate a substitute index after notifying MPP. Monthly payments on the principal and any accrued interest rate not yet paid began in September 2020. MPP must maintain a Debt Coverage Ratio (defined as net operating income divided by current portion of long-term debt, plus interest expense) of not less than <ix:nonFraction unitRef="number" contextRef="c-316" decimals="INF" name="ameh:DebtInstrumentCovenantDebtCoverageRatioMinimum" scale="0" id="f-1069">1.25</ix:nonFraction> to 1. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AMG Properties</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 5, 2020, AMG Properties entered into a loan agreement with East West Bank with a maturity date of August 5, 2030. As of June&#160;30, 2023, the principal on the loan was $<ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1070">0.6</ix:nonFraction> million with a variable interest rate of <ix:nonFraction unitRef="number" contextRef="c-318" decimals="INF" sign="-" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1071">0.30</ix:nonFraction>% less than the independent index, which is the daily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Prime Rate.&#8221; If the index is unavailable, East West Bank may designate a substitute index after notifying AMG Properties. Monthly payments on the principal and any accrued interest rate not yet paid began in September 2020. AMG Properties must maintain a Debt Coverage Ratio (defined as net operating income divided by current portion of long-term debt, plus interest expense) of not less than <ix:nonFraction unitRef="number" contextRef="c-319" decimals="INF" name="ameh:DebtInstrumentCovenantDebtCoverageRatioMinimum" scale="0" id="f-1072">1.25</ix:nonFraction> to 1.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ZLL</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 27, 2020, ZLL entered into a loan agreement with East West Bank with a maturity date of August 5, 2030. As of June&#160;30, 2023, the principal on the loan was $<ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1073">0.6</ix:nonFraction> million with a variable interest rate of <ix:nonFraction unitRef="number" contextRef="c-321" decimals="INF" sign="-" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1074">0.50</ix:nonFraction>% less than the independent index, which is the daily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Prime Rate.&#8221; If the index is unavailable, East West Bank may designate a substitute index after notifying ZLL. Monthly payments on the principal and any accrued interest rate not yet paid began in September 2020. ZLL must maintain a Debt Coverage Ratio (defined as net operating income divided by current portion of long-term debt, plus interest expense) of not less than <ix:nonFraction unitRef="number" contextRef="c-322" decimals="INF" name="ameh:DebtInstrumentCovenantDebtCoverageRatioMinimum" scale="0" id="f-1075">1.25</ix:nonFraction> to 1.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">120 Hellman LLC </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;25, 2022, 120 Hellman LLC (&#8220;120 Hellman&#8221;), a subsidiary of APC, entered into a loan agreement with MUFG Union Bank N.A. with the principal on the loan of $<ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1076">16.3</ix:nonFraction> million and a maturity date of March&#160;1, 2032. The loan was used to purchase property in Monterey Park, California. As of June&#160;30, 2023, the principal on the loan was $<ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1077">15.8</ix:nonFraction> million. The variable interest rate is <ix:nonFraction unitRef="number" contextRef="c-325" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1078">2.0</ix:nonFraction>% in excess of Daily Simple SOFR, which is the daily rate per annum equal to the secured overnight financing rate as administered by the Federal Reserve Bank of New York. If the index is unavailable, MUFG Union Bank N.A. may designate a substitute index after notifying 120 Hellman. Monthly payments on the principal and interest began on April 1, 2022. Should interest not be paid when due, it shall become part of the principal and bear interest. 120 Hellman must maintain a Cash Flow to Debt Service ratio (defined as net profit after taxes, to which depreciation, amortization and other non-cash items are added and divided by the current portion of long-term debt and capital leases) of not less than <ix:nonFraction unitRef="number" contextRef="c-326" decimals="INF" name="ameh:DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum" scale="0" id="f-1079">1.25</ix:nonFraction> to 1 and <ix:nonFraction unitRef="number" contextRef="c-323" decimals="INF" name="ameh:DebtCovenantThresholdPercentageForOccupationOfProperty" scale="-2" id="f-1080">35</ix:nonFraction>% or more of the property must also be occupied by APC. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="i68908954e9bf4272bfe65b9887921698"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Construction Loans</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, Tag 8 entered into a construction loan agreement with MUFG Union Bank N.A. (&#8220;Construction Loan&#8221;). Tag 8 is a VIE consolidated by the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Construction Loan allows Tag 8 to borrow up to $<ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1081">10.7</ix:nonFraction> million. In December 2022, the Construction loan was amended to extend the maturity date to March&#160;1, 2024 (&#8220;Construction Loan Term&#8221;). If construction is completed and there are no events of default or substantial deterioration in the financial condition of Tag 8 or APC, guarantor on the loan agreement, at the maturity date of the Construction Loan Term, the loan shall convert to an amortizing loan with an amended extended maturity date of March&#160;1, 2034 (&#8220;Permanent Loan Term&#8221;). Under the amended Construction Loan, upon conversion to the Permanent Loan Term, monthly principal and interest payments shall be made beginning April&#160;1, 2024. The principal balance will bear interest at the SOFR reference rate. As of June&#160;30, 2023, the likelihood of the construction being completed by the maturity date is probable. The loan balance as of June&#160;30, 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1082">5.7</ix:nonFraction> million and was recorded as long-term debt, net of current portion and deferred financing costs in the accompanying consolidated balance sheets. Once the loan converts to the Permanent Loan Term, APC, as Tag 8&#8217;s guarantor, must maintain a Cash Flow Coverage Ratio (defined as consolidated EBITDA minus unfinanced capital expenditures and distributions paid divided by the sum of current portion of long-term debt, plus interest expense) of not less than <ix:nonFraction unitRef="number" contextRef="c-329" decimals="INF" name="ameh:DebtInstrumentCovenantCashFlowCoverageRatioMinimum" scale="0" id="f-1083">1.25</ix:nonFraction> to 1.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Promissory Note Payable</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, FYB entered into a promissory note agreement with CCHCA. The principal on the promissory note is $<ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1084">2.0</ix:nonFraction>&#160;million, with a maturity date of May&#160;9, 2024. The interest rate is the prime rate plus <ix:nonFraction unitRef="number" contextRef="c-331" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1085">1.0</ix:nonFraction>%. The prime rate is updated annually on the effective date of the note and published by the Wall Street Journal.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effective Interest Rate</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s average effective interest rate on its total debt during the six months ended June&#160;30, 2023 and 2022, was <ix:nonFraction unitRef="number" contextRef="c-311" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="f-1086">5.93</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-332" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="f-1087">2.16</ix:nonFraction>%, respectively. Interest expense in the consolidated statements of operations included amortization of deferred debt issuance costs for the three months ended June&#160;30, 2023 and 2022, of $<ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-1088">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-1089">0.2</ix:nonFraction> million, respectively, and for the  six months ended June&#160;30, 2023 and 2022, of $<ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-1090">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-332" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-1091">0.5</ix:nonFraction> million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lines of Credit</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">APC Business Loan</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;10, 2019, the APC Business Loan Agreement with Preferred Bank (the &#8220;APC Business Loan Agreement&#8221;) was amended to, among other things, decrease loan availability to $<ix:nonFraction unitRef="usd" contextRef="c-335" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1092">4.1</ix:nonFraction> million, limit the purpose of the indebtedness under the APC Business Loan Agreement to the issuance of standby letters of credit, and include as a permitted lien, the security interest in all of its assets that APC granted to NMM under a Security Agreement dated on or about September 11, 2019, securing APC&#8217;s obligations to NMM under their management services agreement dated as of July 1, 1999, as amended.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standby Letters of Credit</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company established irrevocable standby letters of credit with Truist Bank under the Amended Credit Agreement for a total of $<ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1093">21.1</ix:nonFraction> million for the benefit of CMS. Unless the institution provides notification that the standby letters of credit will be terminated prior to the expiration date, the letters will be automatically extended without amendment for additional <ix:nonNumeric contextRef="c-337" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durwordsen" id="f-1094">one-year</ix:nonNumeric> periods from the present, or any future expiration date.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APC established irrevocable standby letters of credit with Preferred Bank under the APC Business Loan Agreement for a total of $<ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1095">0.1</ix:nonFraction> million for the benefit of certain health plans. The standby letters of credit are automatically extended without amendment for additional <ix:nonNumeric contextRef="c-339" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durwordsen" id="f-1096">one-year</ix:nonNumeric> periods from the present or any future expiration date, unless notified by the institution in advance of the expiration date that the letter will be terminated.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alpha Care established irrevocable standby letters of credit with Preferred Bank under the APC Business Loan Agreement for a total of $<ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1097">3.8</ix:nonFraction> million for the benefit of certain health plans. The standby letters of credit are automatically extended without amendment for additional <ix:nonNumeric contextRef="c-341" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durwordsen" id="f-1098">one-year</ix:nonNumeric> periods from the present or any future expiration date, unless notified by the institution in advance of the expiration date that the letter will be terminated.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-1099" continuedAt="iac94f8fed963423c8124de0d4805d461" escape="true">Mezzanine and Stockholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="iac94f8fed963423c8124de0d4805d461"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Mezzanine Equity</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">APC</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the redemption feature of the APC shares is not solely within the control of APC, the equity of APC does not qualify as permanent equity and has been classified as non-controlling interests in APC as mezzanine or temporary equity. APC&#8217;s shares were not redeemable, and it was not probable that the shares would become redeemable as of June&#160;30, 2023 and December&#160;31, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Stockholders&#8217; Equity</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="ameh:StockIssuedDuringPeriodSharesMerger" format="ixt:num-dot-decimal" scale="0" id="f-1100">140,954</ix:nonFraction> holdback shares have not been issued to certain former NMM shareholders who were NMM shareholders at the time of closing of the 2017 Merger, as they have yet to submit properly completed letters of transmittal to ApolloMed in order to receive their pro rata portion of ApolloMed common stock and warrants as contemplated under the 2017 merger agreement. Pending such receipt, such former NMM shareholders have the right to receive, without interest, their pro rata share of dividends or distributions with a record date after the effectiveness of the 2017 Merger. The consolidated financial statements have treated such shares of common stock as outstanding, given the receipt of the letter of transmittal is considered perfunctory and the Company is legally obligated to issue these shares in connection with the 2017 Merger.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APC owned <ix:nonFraction unitRef="shares" contextRef="c-342" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-1101">10,299,259</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-1102">10,299,259</ix:nonFraction> shares of ApolloMed&#8217;s common stock, respectively, as of June&#160;30, 2023 and December&#160;31, 2022. While such shares of ApolloMed&#8217;s common stock are legally issued and outstanding, they are treated as treasury shares for accounting purposes and excluded from shares of common stock outstanding in the consolidated financial statements. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023 the Company bought back <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-1103">270,081</ix:nonFraction> of its common stock. These are included as treasury stock. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023 and December&#160;31, 2022, the total treasury stock was <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-1104">10,569,340</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-1105">10,299,259</ix:nonFraction>, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, APC paid dividends of $<ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-5" name="us-gaap:Dividends" scale="0" id="f-1106">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-344" decimals="-5" name="us-gaap:Dividends" format="ixt:num-dot-decimal" scale="6" id="f-1107">10.0</ix:nonFraction>&#160;million, respectively. During the six months ended June&#160;30, 2023 and 2022, APC paid dividends of $<ix:nonFraction unitRef="usd" contextRef="c-345" decimals="-5" name="us-gaap:Dividends" scale="0" id="f-1108">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-346" decimals="-5" name="us-gaap:Dividends" format="ixt:num-dot-decimal" scale="6" id="f-1109">10.0</ix:nonFraction> million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, CDSC paid dividends of $<ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-5" name="us-gaap:Dividends" scale="0" id="f-1110">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="us-gaap:Dividends" format="ixt:num-dot-decimal" scale="6" id="f-1111">1.5</ix:nonFraction>&#160;million, respectively. During the six months ended June&#160;30, 2023 and 2022, CDSC paid dividends of $<ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-5" name="us-gaap:Dividends" scale="0" id="f-1112">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-5" name="us-gaap:Dividends" format="ixt:num-dot-decimal" scale="6" id="f-1113">2.9</ix:nonFraction>&#160;million, respectively.</span></div></ix:continuation><div id="icc2b852b4b5148b8aaf9d319f2f34464_91"></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-1114" continuedAt="i10de0b54b61f4685995bb7487f02b003" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i10de0b54b61f4685995bb7487f02b003" continuedAt="i2d3ea5c1d9814945b42d6cdd040dc8d7"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-1115" continuedAt="i1088c312b34f4593815faad573ea437c" escape="true">The following table summarizes the stock-based compensation expense recognized under all of the Company&#8217;s stock plans for the three and six months ended June&#160;30, 2023 and 2022, and associated with the issuance of restricted shares of common stock and vesting of stock options that are included in general and administrative expenses in the accompanying consolidated statements of income (in thousands):</ix:nonNumeric></ix:continuation></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="i2d3ea5c1d9814945b42d6cdd040dc8d7"><div><ix:continuation id="i1088c312b34f4593815faad573ea437c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-1116">422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422000</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1117">1,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-1118">988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1119">1,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1120">3,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-356" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1121">2,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-357" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1122">6,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-358" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1123">5,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1124">4,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1125">3,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1126">7,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1127">6,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized compensation expense related to total share-based payments outstanding as of June&#160;30, 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="f-1128">37.7</ix:nonFraction> million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-1129" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s outstanding stock options consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.917%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aggregate<br/>Intrinsic<br/>Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options outstanding at January&#160;1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1130">859,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1131">25.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-95" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1132">2.19</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="f-1133">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="0" id="f-1134">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-1135">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options exercised</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1136">125,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1137">10.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="f-1138">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options forfeited</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1139">50,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-1140">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at June 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1141">684,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1142">30.66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1143">2.16</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="f-1144">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at June 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-1145">589,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="f-1146">21.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-1147">1.72</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="f-1148">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023, options were exercised for <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1149">125,000</ix:nonFraction> shares of the Company&#8217;s common stock, resulting in proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="f-1150">1.3</ix:nonFraction> million. During the six months ended June&#160;30, 2022, options were exercised for <ix:nonFraction unitRef="shares" contextRef="c-38" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1151">38,500</ix:nonFraction> shares of the Company&#8217;s common stock, resulting in proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-359" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="f-1152">0.7</ix:nonFraction> million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants restricted stock to officers and employees, which are earned based on service conditions. The grant date fair value of the restricted stock is that day&#8217;s closing market price of the Company&#8217;s common stock. During the six months ended June&#160;30, 2023, the Company granted <ix:nonFraction unitRef="shares" contextRef="c-360" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1153">279,501</ix:nonFraction> shares of restricted stock with performance based conditions and <ix:nonFraction unitRef="shares" contextRef="c-360" decimals="INF" name="ameh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" format="ixt:num-dot-decimal" scale="0" id="f-1154">359,527</ix:nonFraction> shares of restricted stock without performance based conditions. During the six months ended June&#160;30, 2023, the weighted average grant date fair value of restricted stock with and without performance based conditions was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-361" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1155">32.95</ix:nonFraction> and <ix:nonFraction unitRef="usdPerShare" contextRef="c-360" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1156">33.15</ix:nonFraction>, respectively. As of June&#160;30, 2023, unvested restricted stock awards, including performance based restricted stock awards totaled <ix:nonFraction unitRef="shares" contextRef="c-362" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:num-dot-decimal" scale="6" id="f-1157">1.3</ix:nonFraction> million shares. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All warrants issued by the Company have expired as of December 31, 2022. As a result, there are <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:fixed-zero" scale="0" id="f-1158"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:fixed-zero" scale="0" id="f-1159">no</ix:nonFraction></ix:nonFraction> outstanding warrants as of June&#160;30, 2023 and December&#160;31, 2022. During the six months ended June&#160;30, 2022, common stock warrants were exercised for <ix:nonFraction unitRef="shares" contextRef="c-38" decimals="INF" name="ameh:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1160">101,953</ix:nonFraction> shares of the Company&#8217;s common stock, which resulted in proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="ameh:WarrantIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="f-1161">1.1</ix:nonFraction> million. The exercise price ranged from $<ix:nonFraction unitRef="usdPerShare" contextRef="c-363" decimals="2" name="ameh:ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" scale="0" id="f-1162">10.00</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-364" decimals="2" name="ameh:ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" scale="0" id="f-1163">11.00</ix:nonFraction> per share for the exercises during the six months ended June&#160;30, 2022.</span></div></ix:continuation><div id="icc2b852b4b5148b8aaf9d319f2f34464_100"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-1164" continuedAt="i3e5eb4baa8554dbb8df875d3758689bb" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i3e5eb4baa8554dbb8df875d3758689bb"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Matters</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laws and regulations governing the Medicare program and healthcare generally are complex and subject to interpretation. The Company believes it complies with all applicable laws and regulations and is unaware of any pending or threatened investigations involving allegations of potential wrongdoing. While no regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action, including fines, penalties, and exclusion from the Medicare and Medi-Cal programs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a risk-bearing organization, the Company is required to follow regulations of the Department of Managed Health Care (&#8220;DMHC&#8221;). The Company must comply with a minimum working capital requirement, tangible net equity (&#8220;TNE&#8221;) requirement, cash-to-claims ratio, and claims payment requirements prescribed by the DMHC. TNE is defined as net assets less intangibles, less non-allowable assets (which include amounts due from affiliates), plus subordinated obligations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the Company&#8217;s payor and provider contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of medical services. Such differing interpretations may not come to light until a substantial period of time has passed following contract implementation. Liabilities for claims disputes are recorded when the loss is probable and can be estimated. Any adjustments to reserves are reflected in current operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standby Letters of Credit</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company established irrevocable standby letters of credit with Truist Bank for a total of $<ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1165">21.1</ix:nonFraction> million for the benefit of CMS (see Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit &#8212; Standby Letters of Credit&#8221;). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APC and Alpha Care established irrevocable standby letters of credit with a Preferred Bank for a total of $<ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-1166">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-1167">3.8</ix:nonFraction>&#160;million, respectively, for the benefit of certain health plans (see Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit &#8212; Standby Letters of Credit&#8221;). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is involved in various legal proceedings and other matters arising in the normal course of its business. The resolution of any claim or litigation is subject to inherent uncertainty and could have a material adverse effect on the Company&#8217;s financial condition, cash flows, or results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liability Insurance</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that its insurance coverage is appropriate based upon the Company&#8217;s claims experience and the nature and risks of the Company&#8217;s business. In addition to the known incidents that have resulted in the assertion of claims, the Company cannot be certain that its insurance coverage will be adequate to cover liabilities arising out of claims asserted against the Company, the Company&#8217;s affiliated professional organizations or the Company&#8217;s affiliated hospitalists in the future where the outcomes of such claims are unfavorable. The Company believes that the ultimate resolution of all pending claims, including liabilities in excess of the Company&#8217;s insurance coverage, will not have a material adverse effect on the Company&#8217;s financial position, results of operations, or cash flows; however, there can be no assurance that future claims will not have such a material adverse effect on the Company&#8217;s business. Contracted physicians are required to obtain their own insurance coverage.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company currently maintains liability insurance policies on a claims-made basis, which are intended to cover malpractice liability and certain other claims, the coverage must be renewed annually, and may&#160;not continue to be available to the Company in future years at acceptable costs, and on favorable terms.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-1168" continuedAt="ia5ea3e1e785447ccac32a70d96502eb5" escape="true">Related-Party Transactions</ix:nonNumeric></span></div><ix:continuation id="ia5ea3e1e785447ccac32a70d96502eb5" continuedAt="id06380d17ff447d782440efdcd93c5fa"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, NMM recognized approximately $<ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1169">6.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1170">4.8</ix:nonFraction> million, respectively in management fees from LMA. During the six months ended June&#160;30, 2023 and 2022, NMM recognized approximately $<ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1171">11.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-370" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1172">11.1</ix:nonFraction> million, respectively. LMA is  accounted for under the equity method based on the <ix:nonFraction unitRef="number" contextRef="c-286" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-1173"><ix:nonFraction unitRef="number" contextRef="c-287" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-1174">25</ix:nonFraction></ix:nonFraction>% equity ownership interest held by APC in LMA&#8217;s IPA line of business (see Note 5 &#8212; &#8220;Investments in Other Entities - Equity Method&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, NMM recognized approximately $<ix:nonFraction unitRef="usd" contextRef="c-371" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1175">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1176">0.4</ix:nonFraction> million, respectively in management fees from Arroyo Vista Family Health Center (&#8220;Arroyo Vista&#8221;). During the six months ended June&#160;30, 2023 and 2022, NMM recognized approximately $<ix:nonFraction unitRef="usd" contextRef="c-373" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1177">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-374" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1178">0.9</ix:nonFraction> million, respectively. During the three months ended June&#160;30, 2023 and 2022, the Company paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-375" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1179">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-376" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1180">0.1</ix:nonFraction> million, respectively, to Arroyo Vista for services as a provider. During the six months ended June&#160;30, 2023 and 2022, the Company paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-377" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1181">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-378" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1182">0.1</ix:nonFraction> million, respectively. Arroyo Vista&#8217;s chief executive officer is a member of the Company&#8217;s board of directors. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APC and PMIOC have an Ancillary Service Contract together whereby PMIOC provides covered services on behalf of APC to enrollees of the plans of APC. During the three months ended June&#160;30, 2023 and 2022, APC paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1183">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1184">0.7</ix:nonFraction> million, respectively, to PMIOC for provider services. During the six months ended June&#160;30, 2023 and 2022, APC paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1185">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-382" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1186">1.4</ix:nonFraction> million, respectively. PMIOC is accounted for under the equity method based on the <ix:nonFraction unitRef="number" contextRef="c-383" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-1187"><ix:nonFraction unitRef="number" contextRef="c-384" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-1188">40</ix:nonFraction></ix:nonFraction>% equity ownership interest held by APC (see Note 5 &#8212; &#8220;Investments in Other Entities &#8212; Equity Method&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2023, the Company paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-385" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1189"><ix:nonFraction unitRef="usd" contextRef="c-386" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1190">0.4</ix:nonFraction></ix:nonFraction> million to Song PC for provider services. As of January 2023, Song PC is accounted for under the equity method accounting as AP-AMH 2 has the ability to exercise significant influence, but not control over Song PC&#8217;s operations (see Note 5 &#8212; &#8220;Investments in Other Entities &#8212; Equity Method&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, APC paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-387" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1191">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1192">0.1</ix:nonFraction> million, respectively, to Advanced Diagnostic Surgery Center for services as a provider. During the six months ended June&#160;30, 2023 and 2022, APC paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1193">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1194">0.1</ix:nonFraction> million, respectively. During the three months ended June&#160;30, 2023 and 2022, Advanced Diagnostic and Surgical Center paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1195">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-392" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1196">0.1</ix:nonFraction> million, respectively, to MPP for rent. During the six months ended June&#160;30, 2023 and 2022, rent to MPP was approximately $<ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1197">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1198">0.3</ix:nonFraction> million, respectively. Advanced Diagnostic Surgery Center shares common ownership with certain board members of ApolloMed and APC.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, APC paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="0" id="f-1199">1,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1200">0.2</ix:nonFraction> million, respectively, to Fulgent Genetics, Inc. for services as a provider. During the six months ended June&#160;30, 2023 and 2022, APC paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="0" id="f-1201">10,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-398" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1202">0.3</ix:nonFraction> million, respectively. One of the Company&#8217;s board members is a board member of Fulgent Genetics, Inc.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, the Company paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1203">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-400" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1204">0.1</ix:nonFraction> million, respectively, to Sunny Village Care Center for services as a provider. During the six months ended June&#160;30, 2023 and 2022, the Company paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1205">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1206">1.0</ix:nonFraction> million, respectively. During the three and six months ended June&#160;30, 2023, Sunny Village Care Center paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1207">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1208">0.5</ix:nonFraction> million, respectively, to Tag 6 for rent. Tag 6 was consolidated by APC in August 2022. Sunny Village Care Center shares common ownership with certain ApolloMed officers and board members of ApolloMed and APC.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023, ApolloMed paid $<ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-1209">9.5</ix:nonFraction> million to purchase ApolloMed&#8217;s stock from a board member. During the six months ended June&#160;30, 2022, APC paid $<ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-1210">9.3</ix:nonFraction> million, respectively, to purchase ApolloMed&#8217;s stock from a board member.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, NMM paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1211">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1212">0.4</ix:nonFraction> million, respectively, to One MSO for an office lease. During the six months ended June&#160;30, 2023 and 2022, NMM paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1213">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1214">0.7</ix:nonFraction> million, respectively. One MSO is accounted for under the equity method based on <ix:nonFraction unitRef="number" contextRef="c-411" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-1215">50</ix:nonFraction>% equity ownership interest held by APC (see Note 5 &#8212; &#8220;Investments in Other Entities &#8212; Equity Method&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with Health Source MSO Inc., a California corporation (&#8220;HSMSO&#8221;), Aurion Corporation (&#8220;Aurion&#8221;), and AHMC for services provided to the Company. One of the Company&#8217;s board members is an officer of AHMC, HSMSO, and Aurion. Aurion is also partially owned by one of the Company&#8217;s board members. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" id="f-1216" continuedAt="i451c2e011f6148e791508638cf5a8b3b" escape="true">The following table sets forth fees incurred and income recognized related to AHMC, HSMSO, and Aurion (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="id06380d17ff447d782440efdcd93c5fa"><div style="margin-top:5pt"><ix:continuation id="i451c2e011f6148e791508638cf5a8b3b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:29.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.764%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AHMC &#8211; Risk pool, capitation, claims payment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-412" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1217">11,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1218">14,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-414" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1219">19,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1220">25,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HSMSO &#8211; Management fees, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-416" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1221">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-417" decimals="-3" sign="-" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1222">649</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-418" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1223">389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-419" decimals="-3" sign="-" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1224">728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aurion &#8211; Management fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-420" decimals="-3" sign="-" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1225">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-421" decimals="-3" sign="-" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1226">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-422" decimals="-3" sign="-" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1227">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" sign="-" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1228">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1229">11,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-425" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1230">13,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-426" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1231">19,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1232">24,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and AHMC have a risk-sharing agreement with certain AHMC hospitals to share the surplus and deficits of each of the hospital pools. Under this agreement, during the three months ended June&#160;30, 2023 and 2022, the Company has recognized risk pool revenue of $<ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1233">15.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1234">13.3</ix:nonFraction> million, respectfully. During the six months ended June&#160;30, 2023 and 2022, the Company has recognized risk pool revenue of  $<ix:nonFraction unitRef="usd" contextRef="c-430" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1235">28.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-431" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1236">25.3</ix:nonFraction> million, respectfully. The Company has a risk pool receivable balance of $<ix:nonFraction unitRef="usd" contextRef="c-432" decimals="-5" name="us-gaap:DeferredCreditsAndOtherLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1237">73.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-433" decimals="-5" name="us-gaap:DeferredCreditsAndOtherLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1238">58.7</ix:nonFraction> million as of June&#160;30, 2023 and December&#160;31, 2022, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, APC paid an aggregate of approximately $<ix:nonFraction unitRef="usd" contextRef="c-434" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1239">9.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1240">12.3</ix:nonFraction> million, respectively, to board members for provider services which included approximately $<ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1241">1.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-437" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1242">3.3</ix:nonFraction> million, respectively, to APC board members who are also officers of APC. During the six months ended June&#160;30, 2023 and 2022, APC paid an aggregate of approximately $<ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1243">18.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1244">21.6</ix:nonFraction> million, respectively, to board members for provider services which included approximately $<ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1245">2.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1246">5.2</ix:nonFraction> million, respectively, to board members who are also officers of APC. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, affiliates wholly owned by the Company&#8217;s officers, including Dr. Thomas Lam, ApolloMed&#8217;s Co-CEO and President, are reported in the accompanying consolidated statements of operations on a consolidated basis, together with the Company&#8217;s subsidiaries, and therefore, the Company does not separately disclose transactions between such affiliates and the Company&#8217;s subsidiaries as related-party transactions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For equity method investments and loans receivable from related parties, see Note 5 &#8212; &#8220;Investment in Other Entities &#8212; Equity Method&#8221; and Note 6 &#8212; &#8220;Loan Receivable and Loan Receivable &#8212; Related Parties,&#8221; respectively.</span></div></ix:continuation><div id="icc2b852b4b5148b8aaf9d319f2f34464_109"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1247" continuedAt="i978daed214064ccb9511d5b4890a2dbf" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i978daed214064ccb9511d5b4890a2dbf" continuedAt="i6d6c7a7b26c94b29af995fed4cf60c86"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the liability method of accounting for income taxes as set forth in ASC 740</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under the liability method, deferred taxes are determined based on differences between the financial statement and tax bases of assets and liabilities using enacted tax rates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an interim basis, the Company estimates what its anticipated annual effective tax rate will be and records a quarterly income tax provision in accordance with the estimated annual rate, plus the tax effect of certain discrete items that arise during the quarter. As the fiscal year progresses, the Company refines its estimates based on actual events and financial results during the quarter. This process can result in significant changes to the Company&#8217;s estimated effective tax rate. When this occurs, the income tax provision is adjusted during the quarter in which the estimates are refined so that the year-to-date provision reflects the estimated annual effective tax rate. These changes, along with adjustments to the Company&#8217;s deferred taxes and related valuation allowance, may create fluctuations in the overall effective tax rate from quarter to quarter.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, due to the overall cumulative losses incurred in recent years, the Company maintained a full valuation allowance against its deferred tax assets related to loss entities the Company cannot consolidate under the federal tax consolidation rules, as realization of these assets is uncertain.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective income tax rate for the six months ended June&#160;30, 2023 and 2022, was <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1248">41.1</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-38" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1249">34.9</ix:nonFraction>%, respectively. The tax rate for the six months ended June&#160;30, 2023, differed from the U.S. federal statutory rate primarily due to state income taxes, tax on dividend distributions and income from flow-through entities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the Company does not have any unrecognized tax benefits related to various federal and state income tax matters. The Company will recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6d6c7a7b26c94b29af995fed4cf60c86">The Company is subject to U.S. federal income tax as well as income tax in California. The Company and its subsidiaries&#8217; state and federal income tax returns are open to audit under the statute of limitations for the years ended December 31, 2019 through December&#160;31, 2022, and for the years ended December 31, 2018 through December&#160;31, 2022, respectively.</ix:continuation> </span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_112"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-1250" continuedAt="i7a4bc524c1824985b39af856b0faf898" escape="true">Earnings Per Share</ix:nonNumeric></span></div><ix:continuation id="i7a4bc524c1824985b39af856b0faf898" continuedAt="i949f7c91f08944109f7f6569203fe2b2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated using the weighted average number of shares of the Company&#8217;s common stock issued and outstanding during a certain period, and is calculated by dividing net income attributable to ApolloMed by the weighted average number of shares of the Company&#8217;s common stock issued and outstanding during such period. Diluted earnings per share is calculated using the weighted average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period, using the as-if converted method for secured convertible notes, preferred stock, and the treasury stock method for options and common stock warrants.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023 and December&#160;31, 2022, APC held <ix:nonFraction unitRef="shares" contextRef="c-345" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1251">10,299,259</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-442" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1252">10,299,259</ix:nonFraction> shares of ApolloMed&#8217;s common stock, respectively, which are treated as treasury shares for accounting purposes and not included in the number of shares of common stock outstanding used to calculate earnings per share. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2023 and 2022, restricted stock of  <ix:nonFraction unitRef="shares" contextRef="c-443" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1253">238,096</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-444" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1254">394,606</ix:nonFraction>, respectively, were excluded from the computation of diluted weighted average common shares outstanding because the assumed proceeds, as calculated under the treasury stock method, resulted in these awards being antidilutive. For the six months ended June&#160;30, 2023 and 2022, restricted stock of  <ix:nonFraction unitRef="shares" contextRef="c-445" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1255">246,431</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-446" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1256">257,193</ix:nonFraction> were excluded from the computation of diluted weighted average common shares outstanding for being antidilutive.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended June&#160;30, 2023, <ix:nonFraction unitRef="shares" contextRef="c-447" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1257"><ix:nonFraction unitRef="shares" contextRef="c-448" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1258">838,628</ix:nonFraction></ix:nonFraction> of contingently issuable shares were excluded from the computation of diluted weighted average common shares outstanding because these conditions were not achieved as of June&#160;30, 2023. For the three and six months ended June&#160;30, 2022, 242,899 of contingently issuable shares were excluded from the computation of diluted weighted average common shares outstanding because these conditions were not achieved as of June&#160;30, 2022.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-1259" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the earnings per share computations:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share &#8211; basic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-36" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1260">0.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-37" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1261">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share &#8211; diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-36" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1262">0.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-37" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1263">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding &#8211; basic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1264">46,482,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1265">44,858,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding &#8211; diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1266">46,778,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1267">46,023,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share &#8211; basic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1268">0.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-38" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1269">0.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share &#8211; diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1270">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-38" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1271">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding &#8211; basic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1272">46,517,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1273">44,815,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding &#8211; diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1274">46,844,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1275">46,082,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="f-1276" continuedAt="i51462bffd509496790da22753251e0d5" escape="true">Below is a summary of the shares included in the diluted earnings per share computations:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:5pt"><ix:continuation id="i949f7c91f08944109f7f6569203fe2b2"><ix:continuation id="i51462bffd509496790da22753251e0d5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding &#8211; basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1277">46,482,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1278">44,858,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-449" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1279">252,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-450" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1280">418,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-451" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="0" id="f-1281">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-452" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1282">651,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-443" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1283">40,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-444" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1284">94,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" format="ixt:num-dot-decimal" scale="0" id="f-1285">3,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" format="ixt:fixed-zero" scale="0" id="f-1286">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding &#8211; diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1287">46,778,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1288">46,023,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding &#8211; basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1289">46,517,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1290">44,815,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-453" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1291">254,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-454" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1292">455,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-455" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="0" id="f-1293">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-456" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1294">689,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-445" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1295">70,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-446" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1296">122,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" format="ixt:num-dot-decimal" scale="0" id="f-1297">1,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" format="ixt:fixed-zero" scale="0" id="f-1298">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding &#8211; diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1299">46,844,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1300">46,082,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_118"></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="f-1301" continuedAt="ie058349ac94442f3afbf9256355bc684" escape="true">Variable Interest Entities (VIEs)</ix:nonNumeric></span></div><ix:continuation id="ie058349ac94442f3afbf9256355bc684" continuedAt="i17625196be2d458f8026e80b589623b6"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A VIE is defined as a legal entity whose equity owners do not have sufficient equity at risk, or, as a group, the holders of the equity investment at risk lack any of the following three characteristics: decision-making rights, the obligation to absorb losses, or the right to receive the expected residual returns of the entity. The primary beneficiary is identified as the variable interest holder that has both the power to direct the activities of the VIE that most significantly affect the entity&#8217;s economic performance and the obligation to absorb expected losses or the right to receive benefits from the entity that could potentially be significant to the VIE.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows guidance on the consolidation of VIEs that requires companies to utilize a qualitative approach to determine whether it is the primary beneficiary of a VIE. See Note 2 &#8212; &#8220;Basis of Presentation and Summary of Significant Accounting Policies &#8212; Variable Interest Entities&#8221; to the accompanying consolidated financial statements for information on how the Company determines VIEs and their treatment.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="f-1302" continuedAt="i7b2ea7592d424291973f3743af2f4963" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes assets that can only be used to settle the liabilities of APC and its consolidated entities and VIEs, including Alpha Care and Accountable Health Care, and to which the creditors of ApolloMed have no recourse, and liabilities to which the creditors of APC, including Alpha Care and Accountable Health Care, have no recourse to the general credit of ApolloMed, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of the investment in a privately held entity that does not report net asset value per share and amounts due to affiliates, which are eliminated upon consolidation with NMM, are included in the accompanying consolidated balance sheets (in thousands). The assets and liabilities of the Company&#8217;s other consolidated VIEs were not considered significant. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-1303">79,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-1304">97,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1305">1,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1306">4,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1307">15,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1308">11,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net &#8211; related party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1309">76,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-462" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1310">62,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:fixed-zero" scale="3" id="f-1311">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-1312">8,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="f-1313">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1314">1,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div><ix:continuation id="i17625196be2d458f8026e80b589623b6" continuedAt="iee8c6128a663446d84e4c52027d19add"><ix:continuation id="i7b2ea7592d424291973f3743af2f4963" continuedAt="ia400c71174e34abd8726eb8a3b1cd3e7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1315">9,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1316">9,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:fixed-zero" scale="3" id="f-1317">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="f-1318">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan receivable &#8211; related party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:fixed-zero" scale="3" id="f-1319">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-462" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1320">2,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount due from affiliates*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:fixed-zero" scale="3" id="f-1321">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1322">30,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current assets</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1323">182,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1324">227,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, property, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-1325">121,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-1326">106,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1327">49,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1328">53,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1329">110,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1330">111,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1331">15,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1332">15,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in affiliates*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1333">325,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1334">304,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in other entities &#8211; equity method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1335">32,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1336">27,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in privately held entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" scale="3" id="f-1337">405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" scale="3" id="f-1338">405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1339">4,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1340">6,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1341">4,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1342">4,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1343">663,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1344">631,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total assets</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1345">846,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1346">858,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1347">22,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1348">23,632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiduciary accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="ameh:FiduciaryAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1349">8,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="ameh:FiduciaryAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1350">7,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1351">42,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1352">48,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1353">13,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:fixed-zero" scale="3" id="f-1354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:DividendsPayableCurrent" scale="3" id="f-1355">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:DividendsPayableCurrent" scale="3" id="f-1356">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount due to affiliates*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1357">5,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="f-1358">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="f-1359">630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="f-1360">619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-1361">591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-1362">594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1363">1,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1364">1,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1365">95,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1366">83,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion and deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1367">27,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1368">26,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-1369">2,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-1370">4,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1371">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1372">1,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1373">6,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1374">7,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1375">8,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1376">8,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1377">46,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1378">48,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total liabilities</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1379">141,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1380">131,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><ix:continuation id="iee8c6128a663446d84e4c52027d19add"><ix:continuation id="ia400c71174e34abd8726eb8a3b1cd3e7"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Investment in affiliates includes APC&#8217;s investment in ApolloMed, which is reflected as treasury shares and eliminated upon consolidation. Amount due from affiliates are receivables with ApolloMed&#8217;s subsidiaries and consolidated VIEs. Amount due to affiliates are payables with ApolloMed&#8217;s subsidiaries and consolidated VIEs. As a result, these balances are eliminated upon consolidation and are not reflected on ApolloMed&#8217;s consolidated balance sheets as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2023 and December&#160;31, 2022.</span></ix:continuation></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-1381" continuedAt="ia01ffddd75c64d8cae5c9537cc81649b" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeFinanceLeasesTextBlock" id="f-1382" continuedAt="i09eea60eec9b4296ab18ebba45147224" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="ia01ffddd75c64d8cae5c9537cc81649b" continuedAt="ifa609a48387142d19c097a3f77585a23"><ix:continuation id="i09eea60eec9b4296ab18ebba45147224" continuedAt="ia173aec9dc104f91b0b443b78778d162"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating and finance leases for corporate offices, physicians&#8217; offices, and certain equipment. These leases have remaining lease terms of <ix:nonNumeric contextRef="c-463" name="us-gaap:LesseeFinanceLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="f-1383"><ix:nonNumeric contextRef="c-463" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="f-1384">two months</ix:nonNumeric></ix:nonNumeric> to <ix:nonNumeric contextRef="c-464" name="us-gaap:LesseeFinanceLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="f-1385"><ix:nonNumeric contextRef="c-464" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="f-1386">fifteen years</ix:nonNumeric></ix:nonNumeric>. Some of the leases may include options to extend the lease terms for up to <ix:nonNumeric contextRef="c-4" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="f-1387"><ix:nonNumeric contextRef="c-4" name="us-gaap:LesseeFinanceLeaseRenewalTerm1" format="ixt-sec:durwordsen" id="f-1388">ten years</ix:nonNumeric></ix:nonNumeric>, and some of the leases may include options to terminate the leases within <ix:nonNumeric contextRef="c-1" name="ameh:LesseeFinanceLeaseTerminationPeriodIfApplicable" format="ixt-sec:durwordsen" id="f-1389"><ix:nonNumeric contextRef="c-1" name="ameh:LesseeOperatingLeaseTerminationPeriodIfApplicable" format="ixt-sec:durwordsen" id="f-1390">one year</ix:nonNumeric></ix:nonNumeric>. As of June&#160;30, 2023 and December&#160;31, 2022, assets recorded under finance leases were $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-1391">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-1392">1.8</ix:nonFraction> million, respectively, and accumulated depreciation associated with finance leases were $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1393">1.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1394">1.0</ix:nonFraction> million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, the Company rents or subleases certain real estate to third parties, which are accounted for as operating leases.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases with an initial term of 12 months or less are not recorded on the balance sheets.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-1395" continuedAt="i9e7fb1794dd14ccab03ef7914d6cfb99" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.551%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1396">1,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1397">1,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of lease expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-1398">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-1399">142</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-1400">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-1401">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="f-1402">252</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="f-1403">206</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1404">1,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1405">1,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1406">3,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1407">3,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-1408">303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-1409">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-1410">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-1411">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="f-1412">499</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="f-1413">332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1414">3,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1415">3,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="ifa609a48387142d19c097a3f77585a23" continuedAt="ie4f857e3bc3a418da65ee534ee3b9af0"><ix:continuation id="ia173aec9dc104f91b0b443b78778d162" continuedAt="ifb06f26a136a4e5da62cba3beb2ce95e"><ix:continuation id="i9e7fb1794dd14ccab03ef7914d6cfb99"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1416">1,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1417">1,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-1418">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-1419">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-1420">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-1421">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1422">3,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1423">3,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-1424">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-1425">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-1426">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-1427">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1428">6.77</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-94" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1429">6.55</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-4" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1430">3.12</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-94" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1431">3.11</ix:nonNumeric> years</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1432">5.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-94" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1433">4.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1434">5.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-94" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1435">4.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="ie4f857e3bc3a418da65ee534ee3b9af0"><ix:continuation id="ifb06f26a136a4e5da62cba3beb2ce95e"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-1436" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="f-1437" escape="true"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are future minimum lease payments under non-cancellable leases for the years ending December 31 (in thousands) below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance Leases</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (excluding the six months ended June 30, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="f-1438">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="f-1439">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-1440">3,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="f-1441">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-1442">3,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="f-1443">469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-1444">3,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="f-1445">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1446">3,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="f-1447">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ameh:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1448">9,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ameh:FinanceLeaseLiabilityToBePaidAfterYearFour" scale="3" id="f-1449">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease payments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-1450">25,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-1451">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-1452">4,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="f-1453">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1454">20,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1455">1,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: current portion</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1456">3,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-1457">591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term lease liabilities</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1458">17,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1459">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the Company does not have additional operating and finance leases that have not yet commenced.</span></div></ix:continuation></ix:continuation><div id="icc2b852b4b5148b8aaf9d319f2f34464_130"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1460" continuedAt="i342e129fe4274a81b4a4e18b5488899b" escape="true">Segments</ix:nonNumeric></span></div><ix:continuation id="i342e129fe4274a81b4a4e18b5488899b" continuedAt="ifb75c3f01aa242c986ca98e4ccbd12e2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its operating segments in accordance with ASC 280, &#8220;Segment Reporting&#8221; (&#8220;ASC 280&#8221;). The Company currently has <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-1461">three</ix:nonFraction> reportable segments consisting of: 1) Care Enablement; 2) Care Partners; and 3) Care Delivery (See Note 1 &#8211; Description of Business). The Company&#8217;s reportable segments changed from <ix:nonFraction unitRef="segment" contextRef="c-95" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-1462">one</ix:nonFraction> to <ix:nonFraction unitRef="segment" contextRef="c-47" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-1463">three</ix:nonFraction> in the first quarter of 2023 as a result of certain changes to the information regularly provided to the Company&#8217;s chief operating decision makers (&#8220;CODMs&#8221;) when reviewing the Company&#8217;s performance as well as an effort to provide additional transparency to investors and other financial statement users which the Company believes will assist in the evaluation of changes in the operating results of the Company&#8217;s segments separate from non-operational factors that affect net income, thus providing insight into both operations and other factors impacting reported results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the performance of its operating segments based on segment revenue growth as well as operating income.  Management uses revenue growth and total segment operating income as a measure of the performance of operating businesses separate from non-operating factors. The Company&#8217;s operations are based in the United States. All revenues of the Company are derived from the United States. Our segments are not evaluated using asset information.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Enablement segment is an integrated, end-to-end clinical and administrative platform powered by our proprietary technology suite, which provides operational, clinical, financial, technology, management, and strategic services to enable success in the delivering of high-quality, value-based care for providers and payers. Revenue for this segment is primarily comprised of management and software fees, charged as a percentage of gross revenue or on a per-member-per-month basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners with a shared vision for coordinated care delivery. Under relevant accounting guidance, while our IPAs and ACO are two operating segments, they share similar economic characteristics and meet other criteria which permit us to aggregate them into a single reportable segment, which we have done. Revenue for this segment is primarily comprised of capitation and risk pool settlements and incentives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients. Our care delivery organization includes primary care, multi-specialty care, and ancillary care services. Revenue is primarily earned based on fee-for-service reimbursements, capitation, and performance-based incentives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other is not a reportable segment and primarily consists of real estate operations and other entities that are individually immaterial. Revenue is primarily comprised of equipment sales and real estate revenue is presented in other income.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="ifb75c3f01aa242c986ca98e4ccbd12e2" continuedAt="i2ea90b2367fa49319828ff1b8ff80cc2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, our reportable segments enter into transactions with each other. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues recognized by a segment and expenses incurred by the counterparty are eliminated in consolidation and do not affect consolidated results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate costs are unallocated and primarily include corporate initiatives, corporate infrastructure costs and corporate shared costs, such as finance, human resources, legal, and executives.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-1464" continuedAt="i1223391ee78443c4b7c288bdf2d6eed9" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about our segments and prior periods have been recast to conform to the current presentation (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1465">12,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1466">321,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1467">13,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-468" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1468">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-469" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1469">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-470" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1470">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1471">348,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1472">22,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1473">3,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-474" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1474">13,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-475" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1475">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-476" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1476">38,887</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-477" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1477">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1478">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-479" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1479">34,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-480" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1480">325,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-481" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1481">26,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-482" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1482">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1483">38,887</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1484">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1485">348,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-479" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1486">15,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-480" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1487">292,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-481" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1488">22,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-482" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="f-1489">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-3" sign="-" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1490">36,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="3" id="f-1491">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1492">292,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-479" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1493">12,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-480" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1494">5,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-481" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1495">3,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-482" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" scale="3" id="f-1496">926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-3" sign="-" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1497">2,933</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1498">9,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1499">28,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-479" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1500">27,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-480" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1501">297,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-481" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1502">26,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-482" decimals="-3" name="us-gaap:CostsAndExpenses" scale="3" id="f-1503">996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-3" sign="-" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1504">39,931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1505">9,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1506">321,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-479" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1507">7,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-480" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1508">27,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-481" decimals="-3" name="us-gaap:OperatingIncomeLoss" scale="3" id="f-1509">569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-482" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="f-1510">839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1511">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1512">9,212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1513">27,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-485" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1514">10,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-486" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1515">247,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-487" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1516">11,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-488" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1517">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-489" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1518">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-490" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1519">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-491" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1520">269,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-492" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1521">19,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-493" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1522">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-494" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1523">11,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-495" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1524">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-496" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1525">30,781</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-497" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1526">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-498" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1527">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-499" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1528">29,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-500" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1529">247,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-501" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1530">23,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-502" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1531">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-503" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1532">30,781</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-504" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1533">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1534">269,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-499" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1535">10,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-500" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1536">233,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-501" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1537">17,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-502" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="f-1538">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-503" decimals="-3" sign="-" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1539">31,690</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-504" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="3" id="f-1540">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1541">230,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-499" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1542">11,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-500" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1543">5,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-501" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1544">2,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-502" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" scale="3" id="f-1545">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-503" decimals="-3" sign="-" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" scale="3" id="f-1546">896</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-504" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1547">4,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1548">24,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-499" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1549">22,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-500" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1550">239,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-501" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1551">19,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-502" decimals="-3" name="us-gaap:CostsAndExpenses" scale="3" id="f-1552">825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-503" decimals="-3" sign="-" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1553">32,586</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-504" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1554">4,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1555">254,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-499" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1556">7,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-500" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1557">7,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-501" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1558">3,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-502" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="f-1559">552</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-503" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1560">1,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-504" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1561">4,526</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1562">15,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><ix:continuation id="i2ea90b2367fa49319828ff1b8ff80cc2" continuedAt="i30758653541c4b48b5dcd40a52c1316a"><ix:continuation id="i1223391ee78443c4b7c288bdf2d6eed9" continuedAt="ia3540a586db74bfe92d4c15b32b4fc0a"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-505" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1563">22,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-506" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1564">636,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-507" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1565">25,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-508" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1566">316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-509" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1567">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-510" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1568">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-511" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1569">685,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-512" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1570">42,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-513" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1571">3,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-514" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1572">26,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-515" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1573">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-516" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1574">72,486</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-517" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1575">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-518" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1576">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-519" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1577">65,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-520" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1578">639,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-521" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1579">52,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-522" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1580">398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-523" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1581">72,486</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-524" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1582">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1583">685,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-519" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1584">30,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-520" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1585">578,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-521" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1586">43,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-522" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="f-1587">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-523" decimals="-3" sign="-" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1588">70,726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-524" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="3" id="f-1589">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1590">582,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-519" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1591">21,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-520" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1592">11,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-521" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1593">8,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-522" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1594">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-523" decimals="-3" sign="-" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1595">3,967</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-524" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1596">14,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1597">53,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-519" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1598">52,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-520" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1599">589,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-521" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1600">52,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-522" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1601">1,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-523" decimals="-3" sign="-" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1602">74,693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-524" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1603">14,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1604">636,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-519" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1605">13,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-520" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1606">50,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-521" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="f-1607">397</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-522" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1608">1,319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-523" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1609">2,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-524" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1610">14,621</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1611">49,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-525" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1612">20,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-526" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1613">488,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-527" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1614">23,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-528" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1615">331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-529" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1616">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-530" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1617">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-531" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1618">532,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-532" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1619">38,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-533" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1620">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-534" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1621">20,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-535" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1622">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-536" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1623">58,621</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-537" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1624">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-538" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1625">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-539" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1626">58,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-540" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1627">488,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-541" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1628">43,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-542" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1629">362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-543" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1630">58,621</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-544" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1631">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1632">532,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-539" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1633">24,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-540" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1634">452,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-541" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1635">33,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-542" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="f-1636">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-543" decimals="-3" sign="-" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1637">59,387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-544" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="3" id="f-1638">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1639">450,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-539" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1640">15,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-540" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1641">10,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-541" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1642">5,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-542" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1643">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-543" decimals="-3" sign="-" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1644">1,515</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-544" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1645">8,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1646">40,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-539" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1647">40,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-540" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1648">463,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-541" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1649">39,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-542" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1650">1,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-543" decimals="-3" sign="-" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1651">60,902</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-544" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1652">8,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1653">491,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-539" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1654">18,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-540" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1655">25,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-541" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1656">4,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-542" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="f-1657">983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-543" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1658">2,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-544" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1659">8,203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1660">41,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Balance includes general and administrative expenses and depreciation and amortization. </span></div></ix:continuation></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"><ix:continuation id="i30758653541c4b48b5dcd40a52c1316a" continuedAt="id510a6eb276e4f67bb713d664d43cdc4"><ix:continuation id="ia3540a586db74bfe92d4c15b32b4fc0a" continuedAt="ifd0d5e0082584b1398f03781f7bdd269">(2)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id510a6eb276e4f67bb713d664d43cdc4"><ix:continuation id="ifd0d5e0082584b1398f03781f7bdd269"> Income from operations for the intersegment elimination represents rental income from segments renting from other segments. Rental income is presented within other income which is not presented in the table.</ix:continuation></ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-1661" continuedAt="i3ee3c4fafe7e402bad398b5e5287591a" escape="true">Subsequent Events</ix:nonNumeric></span></div><ix:continuation id="i3ee3c4fafe7e402bad398b5e5287591a" continuedAt="i81e4531feabc403d9f5334867ae462c2"><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Texas Independent Providers, LLC</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 12, 2023, the Company entered into a definitive agreement to acquire assets relating to Texas Independent Providers, LLC (&#8220;TIP&#8221;). Through its coordinated network of over <ix:nonFraction unitRef="careprovider" contextRef="c-545" decimals="INF" name="ameh:NumberOfPrimaryCareProvider" scale="0" id="f-1662">120</ix:nonFraction> primary care providers, TIP provides high-quality primary care services to over <ix:nonFraction unitRef="primary_care_service" contextRef="c-545" decimals="INF" name="ameh:NumberOfPrimaryCareServices" format="ixt:num-dot-decimal" scale="0" id="f-1663">4,500</ix:nonFraction> Medicare Advantage patients in communities throughout Harris County, home to Houston, the largest city in Texas and the fourth-largest city in the United States. The Company anticipates closing this transaction in the third quarter of 2023 and will fund the transaction with cash on hand.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IntraCare Convertible Promissory Note Receivable</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i81e4531feabc403d9f5334867ae462c2">On July 27, 2023, the Company entered into a <ix:nonNumeric contextRef="c-546" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-1664">five-year</ix:nonNumeric> convertible promissory note with IntraCare as the borrower. The principal on the note is $<ix:nonFraction unitRef="usd" contextRef="c-547" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1665">25.0</ix:nonFraction> million with interest on the outstanding principal amount and unpaid interest at a rate per annum equal to <ix:nonFraction unitRef="number" contextRef="c-547" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1666">8.81</ix:nonFraction>%, compounded annually. In the event that the convertible promissory note remains outstanding on or after maturity date of July 27, 2028, then the outstanding principal balance and any unpaid accrued interest shall, upon the election of the Company, convert into shares.</ix:continuation> </span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_139"></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><br/>The following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the unaudited consolidated financial statements and the notes thereto included in Part I, Item 1, &#8220;Financial Statements&#8221; of this Quarterly Report on Form 10-Q. The financial information for the three and six months ended June 30, 2022 included herein has been restated as more fully described in Note 2 to the unaudited consolidated financial statements included in Item 1 of this Quarterly Report on Form 10-Q. In addition, reference is made to our audited consolidated financial statements and notes thereto and related Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K/A for the year ended December 31, 2022, filed with the SEC on August&#160;9, 2023.</span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_142"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Apollo Medical Holdings, Inc. is a leading physician-centric, technology-powered, risk-bearing healthcare management company. Leveraging its proprietary population health management and healthcare delivery platform, ApolloMed operates an integrated, value-based healthcare model, which aims to empower the providers in its network to deliver the highest quality of care to its patients in a cost-effective manner. Together with our affiliated physician groups and consolidated entities, we provide coordinated outcomes-based medical care in a cost-effective manner.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our patients are covered by private or public insurance provided through Medicare, Medicaid, and health maintenance organizations (&#8220;HMOs&#8221;). However, a small portion of our revenue comes from non-insured patients. We provide care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Our physician network consists of primary care physicians, specialist physicians, physician and specialist extenders, and hospitalists. We operate primarily through Apollo Medical Holdings, Inc. (&#8220;ApolloMed&#8221;) and the following subsidiaries: NMM, AMM, and APAACO and their consolidated entities, including consolidated VIEs. Refer to Note 2 &#8212; &#8220;Basis of Presentation and Summary of Significant Accounting Policies&#8221; to our consolidated financial statements under Item 1 in this Quarterly Report on Form 10-Q for all consolidated entities. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Led by a management team with several decades of experience, we focus on physicians providing high-quality medical care, population health management, and patient care coordination. As a result, we are well-positioned to take advantage of the shift in the U.S. healthcare industry toward providing value-based and results-oriented healthcare with a focus on patient satisfaction, high-quality care, and cost efficiency.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our accountable care organization and a network of IPAs with more than 12,000 contracted physicians, we are responsible for coordinating care in value-based care arrangements for approximately 1.3&#160;million patients primarily in California as of June&#160;30, 2023. </span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_145"></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Recent and Other Developments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Texas Independent Providers, LLC</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 12, 2023, the Company entered into a definitive agreement to acquire assets relating to Texas Independent Providers, LLC (&#8220;TIP&#8221;). Through its coordinated network of over 120 primary care providers, TIP provides high-quality primary care services to over 4,500 Medicare Advantage patients in communities throughout Harris County, home to Houston, the largest city in Texas and fourth-largest city in the United States. The Company anticipates closing this transaction in the third quarter of 2023 and will fund the transaction with cash on hand.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IntraCare Convertible Promissory Note Receivable</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 27, 2023, the Company entered into a five-year convertible promissory note with IntraCare as the borrower. The principal on the note is $25.0 million with interest on the outstanding principal amount and unpaid interest at a rate per annum equal to 8.81%, compounded annually. In the event that the convertible promissory note remains outstanding on or after maturity date of July 27, 2028, then the outstanding principal balance and any unpaid accrued interest shall, upon the election of the Company, convert into shares. </span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_148"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Financial Measures and Indicators</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Revenues</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue, which is recorded in the period in which services are rendered and earned, primarily consists of capitation revenue, risk pool settlements and incentives, GPDC/ACO REACH revenue, management fee income, and fee-for-services (&#8220;FFS&#8221;) revenue. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our largest expenses consist of the cost of: (i) patient care paid to contracted providers; (ii) information technology equipment and software, and; (iii) hiring staff to provide management and administrative support services to our affiliated physician groups, as further described in the following sections. These services include claims processing, utilization management, contracting, accounting, credentialing, and administrative oversight.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Apollo Medical Holdings, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitation, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk pool settlements and incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-services, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,209&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,697&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,512&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of services, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,865&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,632)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gain (loss) on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,866)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,247&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,657&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(673)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net income attributable to Apollo Medical Holdings, Inc.</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,170&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,950&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Percentage change of over 500%</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.893%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitation, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk pool settlements and incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-services, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685,453&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532,954&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,499&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of services, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other income (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,901)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,927)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,974)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,533)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,829)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,697)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,987)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net income attributable to Apollo Medical Holdings, Inc.</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,302&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,714&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Percentage change of over 500%</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Physician Groups and Patients</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023 and 2022, we managed a total of 15 and 13 independent physician groups that are affiliated and non-affiliated, respectively. The total number of patients for whom we managed the delivery of healthcare services was approximately 1.3&#160;million and 1.2&#160;million as of  June&#160;30, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue for the three months ended June&#160;30, 2023 was $348.2 million, as compared to $269.7 million for the three months ended June&#160;30, 2022, an increase of $78.5 million, or 29%. The increase in revenue was primarily attributable to the capitation revenue. Capitation revenue increased by approximately $72.9 million, driven by organic membership growth in our consolidated IPAs and increased participation in a value-based Medicare fee-for-service model.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue for the six months ended June&#160;30, 2023, was $685.5 million, as compared to $533.0 million for the six months ended June&#160;30, 2022, an increase of $152.5 million, or 29%. The increase in revenue was primarily attributable to an increase in capitation revenue as a result organic membership growth in our consolidated IPAs and increased participation in a value-based Medicare fee-for-service model.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Services, Excluding Depreciation and Amortization</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses related to cost of services for the three months ended June&#160;30, 2023 were $292.9 million, as compared to $230.1 million for the same period in 2022, an increase of $62.8 million. The overall increase was primarily due to increased participation in a value-based Medicare fee-for-service model and growth in membership, which was commensurate to our increase in revenue.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses related to cost of services for the six months ended June&#160;30, 2023, were $582.3 million, as compared to $450.8 million for the same period in 2022, an increase of $131.5 million. The overall increase was primarily due to increased participation in a value-based Medicare fee-for-service model and growth in membership, which was commensurate to our increase in revenue.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses for the three months ended June&#160;30, 2023 were $24.1 million, as compared to $19.9 million for the same period in 2022, an increase of $4.2 million, or 21%. The increase is primarily due to an increase in headcount and other general and administrative expenses to support operational growth.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses for the six months ended June&#160;30, 2023, were $45.2 million, as compared to $31.8 million for the same period in 2022, an increase of $13.4 million, or 42%. The increase is primarily due to an increase in headcount and other general and administrative expenses to support operational growth.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and Amortization</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expenses for the three months ended June&#160;30, 2023 were $4.2 million, as compared to $4.4 million for the same period in 2022. This amount includes depreciation of property and equipment and the amortization of intangible assets.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expenses for the six months ended June&#160;30, 2023, were $8.5 million, as compared to $8.7 million for the same period in 2022. This amount includes depreciation of property and equipment and the amortization of intangible assets.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income From Equity Method Investments</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from equity method investments for the three months ended June&#160;30, 2023 was $2.7 million, as compared to $1.5 million for the same period in 2022, an increase of $1.2 million. The increase in income from equity method investments was primarily due to APC&#8217;s equity method investment in LMA. For the three months ended June&#160;30, 2023 and 2022, APC recognized income from this investment of $2.7 million and $1.3 million, an increase of $1.4 million. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from equity method investments for the six months ended June&#160;30, 2023, was $5.2 million, as compared to income from equity method investments of $2.9 million for the same period in 2022, an increase of $2.3 million. The increase was due to APC&#8217;s equity method investment in LMA. For the six months ended June&#160;30, 2023 and 2022, APC recognized income from this investment of $4.9 million and $2.5 million, an increase of $2.4 million. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the three months ended June&#160;30, 2023 was $3.6 million, as compared to $1.9 million for the same period in 2022, an increase of $1.8 million. The increase in interest expense was due to higher interest rates. On June&#160;30, 2023, the interest rate on the Amended Credit Agreement was 6.68% compared to 2.38% on June&#160;30, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the six months ended June&#160;30, 2023, was $6.9 million, as compared to $2.9 million for the same period in 2022, an increase of $4.0 million. The increase in interest expense was due to higher interest rates. On June&#160;30, 2023, the interest rate on the Amended Credit Agreement was 6.68% compared to 2.38% on June&#160;30, 2022.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income for the three months ended June&#160;30, 2023 was $3.3 million compared to $0.4 million for the three months ended June&#160;30, 2022. The increase in interest income is due to more bank accounts becoming interest-bearing. Interest income reflects interest earned on cash held in bank accounts, money market and certificate of deposit accounts and the interest from notes receivable.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income for the six months ended June&#160;30, 2023, was $6.3 million compared to $0.5 million for the six months ended June&#160;30, 2022. The increase in interest income is due to more bank accounts becoming interest-bearing. Interest income reflects interest earned on cash held in bank accounts, money market and certificate of deposit accounts and the interest from notes receivable.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unrealized Gain (Loss) on Investments</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gain for the three months ended June&#160;30, 2023 was $0.9 million, as compared to unrealized loss of $1.9 million for the same period in 2022, a decrease in unrealized loss of $2.7 million. The decrease in unrealized loss on investments was primarily driven by a $1.7 million decrease due to fluctuations in the stock price of equity securities we hold. The change in the stock price was smaller for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022, resulting in the decrease. The change was also driven by a $0.5 million unrealized gain due to the change in the fair value of our collar and interest rate swaps. The unrealized gain from the change in fair value of the collar and interest rate swap for the three months ended June&#160;30, 2023 was greater than the unrealized gain for the three months ended June&#160;30, 2022.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized loss for the six months ended June&#160;30, 2023 was $5.5 million, as compared to $10.8 million for the same period in 2022, a decrease in unrealized loss of $5.3 million. The decrease in unrealized loss on investments was primarily driven by a $8.0 million decrease due to fluctuations in the stock price of equity securities we hold. The change in the stock price was smaller for the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022, resulting in the decrease. This was partially offset by a $1.7 million decrease in unrealized gain related to the change in the fair value of the collar and interest rate swap. The unrealized gain from the change in fair value of the collar and interest rate swap for the six months ended June&#160;30, 2023 was less than the unrealized gain for the six months ended June&#160;30, 2022.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income for the three months ended June&#160;30, 2023 was $1.2 million, as compared to other income of $3.0 million for the same period in 2022, an decrease of $1.8 million. The decrease in other income was primarily due to a $2.3 million gain recognized on equity securities sold during the three months ended June 30, 2022. No securities were sold for the three months ended June 30, 2023. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income for the six months ended June&#160;30, 2023 was $2.4 million, as compared to other income of $3.6 million for the same period in 2022, a decrease of $1.3 million. The decrease in other income was primarily due to a $2.3 million gain recognized on equity securities sold during the six months ended June 30, 2022. No securities were sold for the six months ended June 30, 2023. The decrease was offset by $0.9 million increase in rental income due to APC&#8217;s consolidated subsidiaries leasing their properties. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes was $14.0 million for the three months ended June&#160;30, 2023 as compared to a provision for income taxes of $5.4 million for the same period in 2022, an increase of $8.7 million. The increase in provision for income taxes was due to an increase in pretax income. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes was $20.9 million for the six months ended June&#160;30, 2023 as compared to a provision for income taxes of $12.2 million for the same period in 2022, an increase of $8.8 million. The increase in provision for income taxes was due to an increase in pretax income. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Attributable to Non-controlling Interests</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to non-controlling interests for the three months ended June&#160;30, 2023 was $4.3 million, as compared to net loss attributable to non-controlling interests for the three months ended June&#160;30, 2022 of $0.7 million, respectively, an increase in net income attributable to non-controlling interest of $5.0 million. The increase was primarily driven by a decrease in unrealized loss resulting from the change in the fair value of equity securities held by APC and increase in income from equity method investments held by APC.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to non-controlling interests for the six months ended June&#160;30, 2023 was $3.7 million, as compared to net loss attributable to non-controlling interests for the six months ended June&#160;30, 2022 of $3.0 million, respectively, an increase in net income attributable to non-controlling interest of $6.7 million. The increase was primarily driven by a decrease in unrealized loss resulting from the change in the fair value of equity securities held by APC and increase in income from equity method investments held by APC.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to Apollo Medical Holdings, Inc.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net income attributable to Apollo Medical Holdings, Inc. for the three months ended June&#160;30, 2023 was $13.2 million, as compared to $12.0 million for the same period in 2022, an increase of $1.2 million. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net income attributable to Apollo Medical Holdings, Inc. for the six months ended June&#160;30, 2023, was $26.3 million, as compared to $25.7 million for the same period in 2022, an increase of $0.6 million. </span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_1507"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Financial Performance</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently has three reportable segments consisting of Care Enablement, Care Partners and Care Delivery. The Company evaluates the performance of its operating segments based on segment revenue growth as well as operating income.  Management uses revenue growth and total segment operating income as a measure of the performance of operating businesses separate from non-operating factors. For more information about our segments, Refer to Note 1 &#8212; &#8220;Description of Business&#8221; and Note 18 - &#8220;Segments&#8221; to our consolidated financial statements under Item 1 in this Quarterly Report on Form 10-Q for additional information. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our revenue and operating income by segment for the three and six months ended June 30, 2023 and 2022 (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Revenue</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Enablement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Partners</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Delivery</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Enablement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Partners</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Delivery</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,815)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Revenue</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Enablement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Partners</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Delivery</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income (Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Enablement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Partners</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Delivery</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,872)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Care Enablement Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/>&#160;&#160;&#160;&#160;Revenue for the three months ended June&#160;30, 2023 was $35.0 million, as compared to $29.6 million for the three months ended June&#160;30, 2022, an increase $5.4 million, or 18%. Operating income for the three months ended June&#160;30, 2023 was $7.6 million, as compared to $7.3 million for the three months ended June&#160;30, 2022, an increase in operating income of $0.3 million, or 4%. The increase in revenue and operating income was primarily due to an increase in more managed independent physician groups. As of June&#160;30, 2023 and 2022, we managed a total of 15 and 13 independent physician groups that are affiliated and non-affiliated, respectively. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for the six months ended June&#160;30, 2023 was $65.5 million, as compared to $58.9 million for the six months ended June&#160;30, 2022, an increase of $6.6 million, or 11%. Operating income for the six months ended June&#160;30, 2023 was $13.4 million, as compared to $18.7 million for the six months ended June&#160;30, 2022, a decrease of $5.3 million, or 28%. The increase was due to an increase in more managed IPAs. As of June&#160;30, 2023 and 2022, we managed a total of 15 and 13 independent physician groups that are affiliated and non-affiliated, respectively. The decrease in operating income was primarily due to more expenses incurred for the six months ended June&#160;30, 2023 as a result of increase in headcount to support the increase in our managed independent physician groups. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Care Partners Segment</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for the three months ended June&#160;30, 2023 was $325.2 million, as compared to $247.3 million for the three months ended June&#160;30, 2022, an increase $78.0 million, or 32%. Operating income for the three months ended June&#160;30, 2023 was $27.8 million, as compared to $7.9 million for the three months ended June&#160;30, 2022, an increase operating income of $19.9 million, or 250%. The increase in revenue and operating income was primarily due to organic membership growth in our consolidated IPAs and increased participation in a value-based Medicare fee-for-service model.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for the six months ended June&#160;30, 2023 was $639.9 million, as compared to $488.6 million for the six months ended June&#160;30, 2022, an increase of $151.3 million, or 31%. Operating income for the six months ended June&#160;30, 2023 was $50.2 million, as compared to $25.4 million for the six months ended June&#160;30, 2022, an increase of $24.8 million, or 98%. The increase in revenue and operating income was primarily due to driven by organic membership growth in our consolidated IPAs and increased participation in a value-based Medicare fee-for-service model.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><br/>Care Delivery Segment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/><br/>&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for the three months ended June&#160;30, 2023 was $26.7 million, as compared to $23.4 million for the three months ended June&#160;30, 2022, an increase $3.4 million, or 14%. Operating income for the three months ended June&#160;30, 2023 was $0.6 million, as compared to $3.4 million for the three months ended June&#160;30, 2022, a decrease of $2.8 million, or 83%. The increase in revenue was primarily due the acquisition of VOMG in November 2022 and increase in services provided.  The decrease in operating income was primarily due to  the Company&#8217;s ongoing investment in expanding its care delivery footprint in Nevada and Texas.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for the six months ended June&#160;30, 2023 was $52.1 million, as compared to $43.7 million for the six months ended June&#160;30, 2022, an increase of $8.4 million, or 19%. Operating loss for the six months ended June&#160;30, 2023 was $0.4 million, as compared to operating income of $4.5 million for the six months ended June&#160;30, 2022, a decrease of $4.9 million, or 109%. The increase in revenue was primarily due the acquisition of VOMG in November 2022 and increase in services provided. The decrease in operating income was primarily due to the Company&#8217;s ongoing investment in expanding its care delivery footprint in Nevada and Texas.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_1531"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EBITDA</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Set forth below are reconciliations of Net Income to EBITDA and Adjusted EBITDA for the three and six months ended June&#160;30, 2023 and 2022:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.846%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,327)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(467)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(297)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(546)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(328)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,618)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APC excluded assets costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,570)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,772&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,906&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,599&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other, net for the three and six months ended June&#160;30, 2023 relates to non-cash changes in the fair value of our financing obligation to purchase the remaining equity interests, changes in the fair value of our contingent liabilities, and changes in the fair value of the Company's Collar Agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Adjusted EBITDA under the historical method for the three and six months ended June&#160;30, 2022 was $36.9 million and $75.1 million, respectively. See &#8220;Use of Non-GAAP Financial Measures&#8221; below for additional information on change of methodology. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Non-GAAP Financial Measures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains the non-GAAP financial measures EBITDA and Adjusted EBITDA, of which the most directly comparable financial measure presented in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) is net income. These measures are not in accordance with, or alternatives to GAAP, and may be calculated differently from similar non-GAAP financial measures used by other companies. The Company uses Adjusted EBITDA as a supplemental performance measure of our operations, for financial and operational decision-making, and as a supplemental means of evaluating period-to-period comparisons on a consistent basis. Adjusted EBITDA is calculated as earnings before interest, taxes, depreciation, and amortization, excluding income or loss from equity method investments, non-recurring and non-cash transactions, stock-based compensation, and APC excluded assets costs. Beginning in the third quarter ended September 30, 2022, the Company has revised the calculation for Adjusted EBITDA to exclude provider bonus payments and losses from recently acquired IPAs, which it believes to be more reflective of its business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the presentation of these non-GAAP financial measures provides investors with relevant and useful information, as it allows investors to evaluate the operating performance of the business activities without having to account for differences recognized because of non-core or non-recurring financial information. When GAAP financial measures are viewed in conjunction with non-GAAP financial measures, investors are provided with a more meaningful understanding of the Company&#8217;s ongoing operating performance. In addition, these non-GAAP financial measures are among those indicators the Company uses as a basis for evaluating operational performance, allocating resources, and planning and forecasting future periods. Non-GAAP financial measures are not intended to be considered in isolation, or as a substitute for, GAAP financial measures. To the extent this Form 10-Q contains historical or future non-GAAP financial measures, the Company has provided corresponding GAAP financial measures for comparative purposes. The reconciliation between certain GAAP and non-GAAP measures is provided above.</span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_163"></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and investment in marketable securities at June&#160;30, 2023 totaled $297.7 million as compared to $293.6 million at December&#160;31, 2022. Working capital totaled $279.3 million at June&#160;30, 2023, as compared to $279.5 million (restated) at December&#160;31, 2022, a decrease of $0.2 million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically financed our operations primarily through internally generated funds. We generate cash primarily from capitation contracts, risk pool settlements and incentives, fees for medical management services provided to our affiliated physician groups, and FFS reimbursements. We generally invest cash in money market accounts, which are classified as cash and cash equivalents. We believe we have sufficient liquidity to fund our operations through at least the next 12 months.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Activities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash flows are summarized as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,221)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,062)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,705)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net increase in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,239&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities for the six months ended June&#160;30, 2023 was $33.5 million, as compared to cash provided by operating activities of $33.1 million for the six months ended June&#160;30, 2022. The increase in cash provided by operating activities was primarily driven by changes in net income and working capital. For the six months ended June&#160;30, 2023, net income exclusive of depreciation and amortization, amortization of debt issuance cost, share-based compensation, unrealized gains or losses, income or loss from equity method investments, and deferred tax was $43.2 million compared to $47.9 million for the six months ended June&#160;30, 2022. Working capital for the six months ended June&#160;30, 2023 decreased operating cash flow by $9.7 million, compared to a $14.8 million decrease in operating cash flow at June&#160;30, 2022. The change in working capital for the six months ended June&#160;30, 2023 was mainly driven by an increase in receivables, net, and increase in medical liabilities related to the Company&#8217;s participation in value-based Medicare fee-for-service model, increase in related party receivables primarily due to timing of risk pool settlements that occur approximately 18 months after the risk pool performance year is completed, and decrease in accounts payable and accrued liabilities and income tax receivable due to timing of payments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities during the six months ended June&#160;30, 2023 was $19.2 million, primarily due to purchases of property and equipment of $17.4 million, purchases of marketable securities of $2.0 million, purchase of a privately held investment of $2.0 million, and purchase of an equity method investment of $0.3 million. The cash used in investing activities was partially offset by proceeds from repayment of a loan receivable of $2.1 million and payments for business and asset acquisitions, net of cash acquired of $0.4 million. Cash used in investing activities during the six months ended June 30, 2022 was $12.2 million, primarily due to purchases of property and equipment of $18.8 million, payments for business acquisition, net of cash, of $0.9 million, purchase of marketable securities of $1.8 million, and funding for an equity method investment of $1.7 million. The cash used in investing activities was partially offset by proceeds from the repayment of a loan receivable of $4.0 million, the sale of marketable securities of $6.5 million, and distributions from an equity method investment of $0.4 million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Financing Activities</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in financing activities during the six months ended June&#160;30, 2023 was $8.1 million, primarily due to repurchase of treasury stock of $9.5 million, dividend payments of $0.8 million, repayment of debt of $0.3 million, a repayment of finance lease obligations of $0.3 million, and purchase of non-controlling interest of $0.1 million. This was partially offset by borrowings from bank loans totaling $1.7 million and proceeds from the exercise of options of $1.3 million. Cash used in financing activities during the six months ended June 30, 2022 was $19.7 million, primarily due to dividend payments of $12.6 million, repurchase of shares of $9.5 million, repayment of debt of $0.2 million, and a repayment of finance lease obligations of $0.3 million. This was partially offset by borrowings from the Construction Loan totaling $1.2 million and proceeds from the exercise of options and warrants of $1.7 million. </span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_169"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Excluded Assets</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, APC and AP-AMH entered into Second Amendment to Series A Preferred Stock Purchase Agreement, which clarified the term excluded assets (&#8220;Excluded Assets&#8221;). Excluded Assets means (i) assets received from the sale of shares of the Series A Preferred Stock equal to the Series A Purchase Price (as defined in the purchase agreement), (ii) the assets of APC that are not Healthcare Services Assets (as defined in the purchase agreement), including APC&#8217;s equity interests in Apollo Medical Holdings, Inc., and any entity that is primarily engaged in the business of owning, leasing, developing, or otherwise operating real estate, (iii) any assets acquired with the proceeds of the sale, assignment, or other disposition of any of the assets described in clauses (i) or (ii), and (iv) any proceeds of the assets described in clauses (i), (ii), and (iii). </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Excluded Assets as of June&#160;30, 2023 are primarily comprised of assets and liabilities from operating real estate and proceeds from the sale of UCI. Any dividends issued to APC shareholders are paid using cash from Excluded Assets. As of June&#160;30, 2023 and December&#160;31, 2022, the Excluded Assets balance consisted of the following (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, property, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in other entities &#8211; equity method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables and assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,754)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,552)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Excluded Assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,191&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,943&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,495)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,544)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded Assets net income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_172"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s debt balance consisted of the following (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate Loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promissory Note Payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,611&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,136&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the future commitments of the Company&#8217;s debt for the years ending December 31 (in thousands) below:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (excluding the six months ended June 30, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,611&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement provides for a five-year revolving credit facility to the Company of $400.0 million, which includes a letter of credit sub-facility of up to $25.0 million and a swingline loan sub-facility of $25.0 million, which expires on June&#160;16, 2026. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit&#8221; to our consolidated financial statements under Item 1 in this Quarterly Report on Form 10-Q for additional information. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Real Estate Loans</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, using cash comprised solely of Excluded Assets, APC purchased a 100% interest in MPP, AMG Properties, and ZLL. As a result of the purchase on the date of acquisition, APC assumed $6.4 million, $0.7 million, and $0.7 million of existing loans held by MPP, AMG Properties, and ZLL, respectively. Refer to Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit&#8221; to our consolidated financial statements under Item 1 in this quarterly report on Form 10-Q for additional information. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;25, 2022, 120 Hellman entered into a real estate loan agreement with  MUFG Union Bank N.A. and borrowed $16.3 million. Refer to Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit&#8221; to our consolidated financial statements under Item 1 in this quarterly report on Form 10-Q for additional information.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Construction Loans</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, Tag 8 entered into a construction loan agreement with MUFG Union Bank N.A. (&#8220;Construction Loan&#8221;) that allows Tag 8 to borrow up to $10.7 million. Tag 8 is a VIE consolidated by the Company. Refer to Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit&#8221; to our consolidated financial statements under Item 1 in this quarterly report on Form 10-Q for additional information.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Promissory Note Payable</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, FYB entered into a promissory note agreement with CCHCA. The principal on the promissory note is $2.0&#160;million with a maturity date of May&#160;9, 2024. Refer to Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit&#8221; to our consolidated financial statements under Item 1 in this quarterly report on Form 10-Q for additional information.</span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_178"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires our management to make judgments, assumptions, and estimates that affect the amounts of revenue, expenses, income, assets, and liabilities, reported in our consolidated financial statements and accompanying notes. Actual results and the timing of recognition of such amounts could differ from those judgments, assumptions, and estimates. In addition, judgments, assumptions, and estimates routinely require adjustment based on changing circumstances and the receipt of new or better information. Understanding our accounting policies and the extent to which our management uses judgment, assumptions, and estimates in applying these policies, therefore, is integral to understanding our financial statements. Critical accounting policies and estimates are defined as those reflect significant judgments and uncertainties, potentially resulting in materially different results under different assumptions and conditions.&#160;We summarize our most significant accounting policies in relation to the accompanying consolidated financial statements in Note 2 &#8212; &#8220;Basis of Presentation&#8221; thereto. Please also refer to the Critical Accounting Policies section of Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K/A for the fiscal year ended December&#160;31, 2022.</span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_184"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, we had no off-balance sheet arrangements that are or have been reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_190"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under our Amended Credit Agreement exposed us to interest rate risk. As of June&#160;30, 2023, we had $180.0&#160;million in outstanding borrowings under our Amended Credit Agreement. The amount borrowed under the Amended Credit Agreement bears interest at an annual rate equal to either, at the Company&#8217;s option, (a) the Term SOFR Reference Rate, calculated two U.S. Government Securities Business Days prior to the first day of such interest period, as such rate is published by the Term SOFR Administrator (Federal Reserve Bank of New York), adjusted for any Term SOFR Adjustment, plus a spread of from 1.25% to 2.50%, as determined on a quarterly basis based on the Company&#8217;s leverage ratio, or (b) a base rate, plus a spread of 0.25% to 1.50%, as determined on a quarterly basis based on the Company&#8217;s leverage ratio. In addition, as of June&#160;30, 2023, Tag 8, a VIE consolidated by the Company, had $5.7&#160;million in outstanding borrowings for the Construction Loan. Interest rate on the Construction Loan is equal to an index rate determined by the bank. Furthermore, as of June&#160;30, 2023, APC had $22.9 million in outstanding borrowings for real estate loans related to ZLL, MPP, AMG Properties, and 120 Hellman (&#8220;Real Estate Loans&#8221;). These loans bear interest that is subject to change from time to time based on changes in an independent index, which is the daily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Prime Rate,&#8221; as quoted in the &#8220;Money Rates&#8221; column of The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Western edition) as determined by the Lender (the &#8220;Index&#8221;). Under no circumstances will the interest rate on these loans be less than 3.50% per annum or more than the maximum rate allowed by applicable law. 120 Hellman&#8217;s Real Estate Loan has a variable interest rate of 2.0% in excess of Daily Simple SOFR, which is the daily rate per annum equal to the secured overnight financing rate as administered by the Federal Reserve Bank of New York. The Company has entered into interest rate swap agreements and collar agreements for certain agreements to effectively convert its floating-rate debt to a fixed-rate basis or to a rate within the agreed-upon range. The principal objective of these contracts is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#8217;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. A hypothetical 1% change in our interest rates for our outstanding borrowings under our Credit Agreement, Construction Loans, and Real Estate Loans would have increased or decreased our interest expense for the year ended June&#160;30, 2023 by $2.1 million.</span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_1099511629325"></div><div style="margin-top:10pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;CONTROLS AND PROCEDURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, designed to ensure that information required to be disclosed by a company in the reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of a material weakness in internal control over financial reporting associated with income taxes that is described below, our Co-Chief Executive Officers and Chief Financial and Strategy Officer determined that our disclosure controls and procedures were not effective as of June 30, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Material Weakness in Internal Control over Financial Reporting Associated with Company&#8217;s Tax Provision </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company&#8217;s annual and interim financial statements will not be detected or prevented on a timely basis. As disclosed in the Company&#8217;s Annual Report on Form 10-K/A for the year ended December 31, 2022, management has identified a material weakness in internal controls relating to the inadequate design of controls associated with income taxes resulting in insufficient analysis, documentation, and review regarding the completeness and accuracy of the Company&#8217;s tax filing structure with related impact on intercompany transactions and consolidated tax filing groups.<br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This material weakness resulted in errors in the unaudited consolidated financial statements for the three and six months ended June 30, 2022 that are restated in this Form 10-Q. Additionally, this material weakness could result in misstatements of the related accounts or disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Remediation Plans</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is actively engaged in the implementation of remediation plans to address the controls contributing to the material weakness associated with the tax provision. The Company&#8217;s remediation actions include, but are not limited to, the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">We have hired additional personnel that are experienced in tax matters and are implementing controls to ensure the completeness and accuracy of the Company&#8217;s tax filing structure.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">We continue to design and implement relevant controls to enable an effective and timely review of the income tax consequences of intercompany transactions and consolidated tax group determinations. This includes the identification of relevant supporting documentation and the retention of sufficient detailed evidence of review procedures performed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe these measures will remediate the material weakness, but management is assessing the need for any additional steps to remediate the underlying causes that gave rise to this weakness. The material weakness will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. There is no assurance that additional remediation steps will not be necessary. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the identified material weakness, management believes the consolidated financial statements included in this Form 10-Q fairly present, in all material respects, our results of operations and cash flows for the three and six months ended June 30, 2023 and our financial condition as of such date, in accordance with GAAP.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during the quarter ended June 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We began to implement the measures described above to remediate the material weakness following the quarter ended June 30, 2023.</span></div><div><span><br/></span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_196"></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_199"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we, from time to time, become involved in pending and threatened legal actions and proceedings. Many of the Company&#8217;s payor and provider contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of medical services, which may not come to light until a substantial period of time has passed following contract implementation. We may also become subject to other lawsuits which could involve significant claims and/or significant defense costs, but as of the date of this Quarterly Report on Form 10-Q, except as disclosed, we are not a party to any lawsuit or proceeding which management expects to, individually or in the aggregate, have a material adverse effect on us or our business. The resolution of any claim or litigation is subject to inherent uncertainty and could have a material adverse effect on the Company&#8217;s financial condition, cash flows, or results of operations.</span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_202"></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business, financial condition, and operating results are affected by a number of factors, whether currently known or unknown, including risks specific to us or the healthcare industry, as well as&#160;risks that affect businesses in general. In addition to the information and risk factors set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A, &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K/A for the year ended December&#160;31, 2022, filed with the SEC on August&#160;9, 2023. The risks disclosed in such Annual Report and in this Quarterly Report could materially adversely affect our business, financial condition, cash flows, or results of operations and thus our stock price. We believe there have been no material changes in our risk factors from those disclosed in the Annual Report, other than with respect to the risk factor discussed below. However, additional risks and uncertainties not currently known or which we currently deem to be immaterial may also materially adversely affect our business, financial condition, or results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risk factors may be important to understanding other statements in this Quarterly Report and should be read in conjunction with the consolidated financial statements and related notes in Part I, Item 1, &#8220;Financial Statements&#8221; and Part I, Item 2, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; of this Quarterly Report on Form 10-Q. Because of such risk factors, as well as other factors affecting the Company&#8217;s financial condition and operating results, past financial performance should not be considered to be a reliable indicator of future performance, and investors should not use historical trends to anticipate results or trends in future periods.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We currently, and may in the future, have assets held at financial institutions that exceed the insurance coverage offered by the Federal Deposit Insurance Corporation; the loss of such assets would have a severe negative affect on our operations and liquidity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain our cash assets at certain financial institutions in the U.S. in amounts that are significantly in excess of the FDIC insurance limit of $250,000. As of June&#160;30, 2023, our deposit accounts with banks exceeded the FDIC&#8217;s insured limit by approximately $326.8 million. In the event of a failure of any financial institutions where we maintain our deposits or other assets, we may incur a significant loss to the extent such loss exceeds the FDIC insurance limitation, which could have a material adverse effect on our liquidity, financial condition and our results of operations.<br/></span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_205"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ITEM 2.&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS, AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/>During the three months ended June&#160;30, 2023 the Company issued an aggregate of 22,340 shares of common stock. The foregoing issuances were exempt from the registration provisions of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof, and/or Regulation D promulgated thereunder.<br/><br/>During the three months ended June&#160;30, 2023, no shares were repurchased under the Company&#8217;s share repurchase plan. In December 2022, ApolloMed&#8217;s Board of Directors approved a share repurchase plan authorizing the Company to repurchase up to $50.0 million of its shares of common stock on the open market and through privately negotiated transactions. This share repurchase plan does not have an expiration date. The Board may suspend or discontinue the repurchase program at any time. This repurchase program does not obligate the Company to make additional repurchases at any specific time or in any specific situation. As of June&#160;30, 2023, $40.5 million remained available for repurchase under the repurchase plan.</span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_208"></div><div style="margin-top:10pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_211"></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_214"></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;OTHER INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rule 10b5-1 Trading Plans </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/>During the quarter ended June 30, 2023, none of the Company&#8217;s directors or executive officers <ix:nonNumeric contextRef="c-36" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1667"><ix:nonNumeric contextRef="c-36" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1668">adopted</ix:nonNumeric></ix:nonNumeric>, modified or <ix:nonNumeric contextRef="c-36" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1669"><ix:nonNumeric contextRef="c-36" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1670">terminated</ix:nonNumeric></ix:nonNumeric> any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any &#8220;non-Rule 10b5-1 trading arrangement&#8221; (as defined in Item 408(c) of Regulation S-K).</span></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_217"></div><div style="-sec-extract:summary;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;EXHIBITS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following exhibits are either incorporated by reference into or filed or furnished with this Quarterly Report on Form 10-Q, as indicated below.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.460%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.673%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">Agreement and Plan of Merger, dated December 21, 2016, among Apollo Medical Holdings, Inc., Network Medical Management, Inc., Apollo Acquisition Corp., and Kenneth Sim, M.D. (the &#8220;Merger Agreement&#8221;) (incorporated herein by reference to Annex A to the joint proxy statement/prospectus filed pursuant to Rule 424(b)(3) on November 15, 2017, that is a part of a Registration Statement on Form S-4)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">Amendment to the Merger Agreement, dated March 30, 2017, among Apollo Medical Holdings, Inc., Network Medical Management, Inc., Apollo Acquisition Corp., and Kenneth Sim, M.D. (incorporated herein by reference to Annex A to the joint proxy statement/prospectus filed pursuant to Rule 424(b)(3) on November 15, 2017 that is a part of a Registration Statement on Form S-4)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">Amendment No. 2 to the Merger Agreement, dated October 17, 2017, among Apollo Medical Holdings, Inc., Network Medical Management, Inc., Apollo Acquisition Corp. and Kenneth Sim, M.D. (incorporated herein by reference to Annex A to the joint proxy statement/prospectus filed pursuant to Rule 424(b)(3) on November 15, 2017 that is a part of a Registration Statement on Form S-4)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420419025049/tv520199_ex2-4.htm">Stock purchase agreement dated March 15, 2019 (incorporated herein by reference to Exhibit 2.4 to the Company&#8217;s Quarterly Report on Form 10-Q filed on May 10, 2019)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420415002897/v398912_ex3-1.htm">Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on January 21, 2015)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420415025170/v408340_ex3-1.htm">Certificate of Amendment of Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on April 27, 2015)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420417063540/tv481301_ex3-1.htm">Certificate of Amendment of Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on December 13, 2017)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420418035195/tv496923_ex3-1.htm">Certificate of Amendment of Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed June 21, 2018)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420415066090/v423843_ex3-2.htm">Restated Bylaws (incorporated herein by reference to Exhibit 3.2 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 16, 2015)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.460%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.673%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420417063540/tv481301_ex3-2.htm">Amendment to Sections 3.1 and 3.2 of Article III of Bylaws (incorporated herein by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K filed on December 13, 2017)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420418035195/tv496923_ex3-2.htm">Amendment to Sections 3.1 and 3.2 of Article III of Bylaws (incorporated herein by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K filed on June 21, 2018)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420415059991/v422440_ex3-1.htm">Certificate of Designation of Series A Convertible Preferred Stock (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on October 19, 2015).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420416092455/v436045_ex3-1.htm">Amended and Restated Certificate of Designation of Apollo Medical Holdings, Inc. (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on April 4, 2016).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420418018690/tv489499_ex4-1.htm">Form of Certificate for Common Stock of Apollo Medical Holdings, Inc., par value $0.001 per share (incorporated herein by reference to Exhibit 4.1 to the Company&#8217;s Annual Report on Form 10-K filed on April 2, 2018).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420418018690/tv489499_ex4-3.htm">Form of Warrant issued as Merger Consideration pursuant to the Merger Agreement for the purchase of Common Stock of Apollo Medical Holdings, Inc., exercisable at $11.00 per share (incorporated herein by reference to Exhibit 4.3 to the Company&#8217;s Annual Report on Form 10-K filed on April 2, 2018).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420418018690/tv489499_ex4-4.htm">Form of Warrant issued as Merger Consideration pursuant to the Merger Agreement for the purchase of Common Stock of Apollo Medical Holdings, Inc., exercisable at $10.00 per share (incorporated herein by reference to Exhibit 4.4 to the Company&#8217;s Annual Report on Form 10-K filed on April 2, 2018).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420415059991/v422440_ex4-1.htm">Common Stock Purchase Warrant (&#8220;Series A Warrant&#8221;) dated October 14, 2015, originally issued by Apollo Medical Holdings, Inc. to Network Medical Management, Inc. to purchase 1,111,111 shares of common stock and subsequently issued as Merger Consideration pursuant to the Merger Agreement (incorporated herein by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on October 19, 2015).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420418018690/tv489499_ex4-6.htm">Form of Assignment of Series A Warrant as Merger Consideration pursuant to the Merger Agreement (incorporated herein by reference to Exhibit 4.6 to the Company&#8217;s Annual Report on Form 10-K filed on April 2, 2018).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420416092455/v436045_ex4-1.htm">Common Stock Purchase Warrant (&#8220;Series B Warrant&#8221;) dated March 30, 2016, originally issued by Apollo Medical Holdings, Inc. to Network Medical Management, Inc. to purchase 555,555 shares of common stock and subsequently issued as Merger Consideration pursuant to the Merger Agreement (incorporated herein by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on April 4, 2016).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420418018690/tv489499_ex4-8.htm">Form of Assignment of Series B Warrant as Merger Consideration pursuant to the Merger Agreement (incorporated herein by reference to Exhibit 4.8 to the Company&#8217;s Annual Report on Form 10-K filed on April 2, 2018).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923072288/tm2318926d1_ex10-1.htm">Apollo Medical Holdings, Inc. Employee Stock Purchase Plan (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on June 16, 2023). </a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2+*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ameh-nonqualifieddeferre.htm">Nonqualified Deferred Compensation Plan (effective July 1, 2023). </a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex3112023063010-q.htm">Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex3122023063010-q.htm">Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.3*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex3132023063010-q.htm">Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex322023063010-q.htm">Certification of Principal Executive Officers and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.INS*</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.SCH*</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.CAL*</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.DEF*</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Definition Linkbase</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.LAB*</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.PRE*</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith.</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furnished herewith</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.460%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.673%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management contract or compensatory plan, contract or arrangement</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The schedules and exhibits thereof have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule or exhibit will be furnished to the SEC upon request.</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="icc2b852b4b5148b8aaf9d319f2f34464_220"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:27pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURE</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:39.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.367%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APOLLO MEDICAL HOLDINGS, INC.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: August 9, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas Lam</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas Lam, M.D., M.P.H.<br/>Co-Chief Executive Officer &amp; President<br/>(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: August 9, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Brandon Sim</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brandon Sim<br/>Co-Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: August 9, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Chandan Basho</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chandan Basho<br/>Chief Financial Officer<br/>(Principal Financial Officer)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>ameh-nonqualifieddeferre.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ameh-nonqualifieddeferre</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ameh-nonqualifieddeferre001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  1      APOLLO MEDICAL HOLDINGS, INC.  NONQUALIFIED DEFERRED COMPENSATION PLAN      RECITALS  This Nonqualified Deferred Compensation Plan (the &#8220;Plan&#8221;) is adopted by Apollo Medical Holdings, Inc.  (the &#8220;Company&#8221;), a Delaware corporation, for the benefit of its Eligible Individuals. The purpose of the Plan is to  offer selected Eligible Individuals who contribute significantly to the future business success of the Company an  opportunity to elect to defer a portion of their Base Salary, Bonus Compensation, and/or Independent Contractor  Compensation, and to provide a deferred compensation vehicle to which the Company may credit Company  Contribution amounts pursuant to the terms of the Plan.    The Plan is an unfunded plan maintained primarily for the purpose of providing deferred compensation for  a select group of management or highly-compensated Employees, and as such, is intended to be exempt from the  provisions of Parts 2, 3, and 4 of Title I of the Employee Retirement Income Security Act of 1974 by operation of  Sections 201(2), 301(a)(3) and 401(a)(1) thereof. The Plan will be administered, operated and construed in accordance  with this intention.    The Plan is intended to comply in form and operation with all applicable law, including, to the extent  applicable, the requirements of Internal Revenue Code Section 409A and will be administered, operated and  construed in accordance with this intention.  Accordingly, the Plan is adopted and made effective as of July 1, 2023.  ARTICLE 1  DEFINITIONS     The words and phrases defined in this Article shall have the meaning set out in the definition, unless the  context in which the word or phrase appears reasonably requires a broader, narrower or different meaning.  1.1 &#8220;Account&#8221; shall mean all bookkeeping accounts pertaining to a Participant which are maintained by  the Plan Administrator or Plan recordkeeper to reflect the Company&#8217;s obligation to the Participant under the Plan,  including a Deferral Account, a Company Contribution Account (if any), and Scheduled Withdrawal Account(s) (if  any). The Plan Administrator or Plan recordkeeper shall establish additional subaccounts that the Plan Administrator  considers necessary to reflect the entire interest of the Participant under the Plan.  1.2 &#8220;Affiliate&#8221; shall mean any business entity other than the Company that is a member of a controlled  group of corporations, within the meaning of Section 414(b) of the Code, of which such Company is a member; any  other trade or business (whether or not incorporated) under common control, within the meaning of Section 414(c)  of the Internal Revenue Code.     1.3 &#8220;Base Salary&#8221; shall mean a Participant&#8217;s base annual salary excluding incentive and discretionary  bonuses and other non-regular forms of compensation, before reductions for contributions to or deferrals under any  pension, deferred compensation or benefit plans sponsored by the Company.    1.4 &#8220;Beneficiary&#8221; or &#8220;Beneficiaries&#8221; shall mean one or more persons, trusts, estates or other entities,  designated by a Participant in accordance with the Plan, that are entitled to receive benefits under the Plan upon the  death of a Participant.  DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  2      1.5 &#8220;Beneficiary Designation Form&#8221; shall mean the form established from time to time by the Plan  Administrator that a Participant completes, signs, and returns to the Plan Administrator to designate one or more  Beneficiaries.    1.6 &#8220;Bonus Compensation&#8221; shall mean amounts paid to a Participant by the Company in the form of  incentive compensation or any other bonus designated by the Company before reductions for contributions to or  deferrals under any pension, deferred compensation or benefit plans sponsored by the Company.    1.7 &#8220;Cause&#8221; shall mean conduct by a Participant determined by the Company to be: (a) gross negligence  or willful malfeasance in the performance of his or her duties; (b) actions or omissions that harm the Company and  are undertaken or omitted knowingly or are criminal or fraudulent or involve material dishonesty or moral  turpitude; (c) being indicted in a court of law for any felony or for a crime involving misuse or misappropriation of  Company funds; or (d) breach of fiduciary duty to the Company.  1.8 &#8220;Change in Control&#8221; shall mean and shall include a change in ownership of the Company, a change  in effective control of the Company, or a change in the ownership of a substantial portion of the assets of the  Company, within the meaning of Internal Revenue Code Section 409A and as described in Treasury Regulation  &sect;&sect;1.409A-3(i)(5)(v), (vi) and (vii).  1.9 &#8220;Claimant&#8221; shall mean a Participant or a Beneficiary who believes that he or she is entitled to a  benefit under this Plan or being denied a benefit to which he or she is entitled hereunder.   1.10 &#8220;Code&#8221; shall mean the U.S. Internal Revenue Code of 1986, as amended, or any successor statue,  and the Treasury Regulations and other authoritative guidance issued thereunder.    1.11 &#8220;Company&#8221; shall mean Apollo Medical Holdings, Inc., and its successors and assigns, unless  otherwise provided in this Plan, or any other corporation or business organization which, with the consent of Apollo  Medical Holdings, Inc., or its successors or assigns, assumes the Company&#8217;s obligations under this Plan, or any  Affiliate which agrees, with the consent of Apollo Medical Holdings, Inc., or its successors or assigns, to become a  party to the Plan.    1.12 &#8220;Company Contribution&#8221; shall mean the deferred compensation amount credited on behalf of a  Participant by the Company to the Company Contribution Account, as described in Section 5.2.  1.13 &#8220;Company Contribution Account&#8221; shall mean a subaccount of a Participant&#8217;s Account consisting  of: (a) the sum of the Company Contribution amounts (if any) for any Plan Year, plus (b) Deemed Investment gains  or losses credited or debited thereon, less (c) any distributions made to the Participant or his or her Beneficiary that  relate to the Participant&#8217;s Company Contribution Account, and tax withholding amounts deducted (if any) from said  Account.   1.14 &#8220;Deemed Investment&#8221; shall mean the notional conversion of the balance held in a Participant&#8217;s  Account(s) into shares or units of the Deemed Investment Options that are used as measuring devices for  determining the value of a Participant&#8217;s Account(s).         1.15 &#8220;Deemed Investment Options&#8221; shall mean the hypothetical securities or other investments  described under Section 6.1 from which the Plan Administrator may select to be used as measuring devices to  determine the Deemed Investment gains or losses of a Participant&#8217;s Account(s). A Participant shall have no real or  beneficial ownership in the security or other investment represented by the Deemed Investment Options.    1.16  &#8220;Deferral Account&#8221; shall mean a subaccount of a Participant&#8217;s Account consisting of: (a) the sum of  a Participant&#8217;s Deferral Amounts for any Plan Year or Performance Period that may be allocated, in whole or in part,  DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  3      by a Participant pursuant to his or her Deferral Election to the Deferral Account, plus (b) Deemed Investment gains  or losses credited or debited thereon, less (c) any distributions made to the Participant or his or her Beneficiary that  relate to the Participant&#8217;s Deferral Account, and tax withholding amounts deducted (if any) from said Account.    1.17 &#8220;Deferral Amount&#8221; shall mean that portion of a Participant&#8217;s Base Salary, Bonus Compensation,  and/or Independent Contractor Compensation that a Participant elects to defer for any Plan Year or Performance  Period.   1.18 &#8220;Deferral Election&#8221; shall mean an election by an Eligible Individual on an Election Form approved  by the Plan Administrator (in a paper or electronic format) to defer a portion of his or her Base Salary, Bonus  Compensation, and/or Independent Contractor Compensation in accordance with the provisions of Article 3.    1.19 &#8220;Disability&#8221; or &#8220;Disabled&#8221; shall be defined as a condition of a Participant whereby he or she has  been deemed disabled by the Social Security Administration or has been determined to be disabled in accordance  with a disability insurance program of the Company, provided that the disability insurance program covers the  Participant and the definition of disability applied under such program complies with Code Section 409A. Upon the  request of the Plan Administrator, the Participant must submit proof to the Plan Administrator of the Social Security  Administration&#8217;s or disability insurance provider&#8217;s determination.  1.20 &#8220;Effective Date&#8221; shall mean July 1, 2023.   1.21 &#8220;Election Form&#8221; shall mean the form or forms established from time to time by the Plan  Administrator (in a paper or electronic format) on which the Participant makes certain designations as required  under the terms of this Plan.  1.22 &#8220;Eligibility Date&#8221; shall mean the date designated by the Plan Administrator on which an Eligible  Individual shall become eligible to participate in the Plan.  1.23 &#8220;Eligible Individual&#8221; shall mean an Employee or Independent Contractor who is selected by the  Company to participate in the Plan. Participation in the Plan is limited to a select group of the Company&#8217;s key  management or highly compensated employees and independent contractors.   1.24 &#8220;Employee&#8221; shall mean an individual who provides services to the Company in the capacity of a  common law employee of the Company.  1.25 &#8220;ERISA&#8221; shall mean the Employee Retirement Income Security Act of 1974, as amended from time  to time.  1.26 &#8220;Independent Contractor&#8221; shall mean an individual providing services to the Company who has  been designated by the Company as an independent contractor, as reflected by the fact that the individual receives  1099 income from the Company.  1.27 &#8220;Independent Contractor Compensation&#8221; shall mean the total amount of cash remuneration that is  paid by the Company to an Independent Contractor with respect to his or her service for the Company.  1.28 &#8220;Participant&#8221; shall mean an Eligible Individual of the Company who is designated as eligible to  participate in this Plan in accordance with the provisions of Article 2.   1.29 &#8220;Performance Period&#8221; shall mean, with respect to any Bonus Compensation, the period of time over  which such Bonus Compensation is earned.  DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  4      1.30 &#8220;Plan&#8221; shall mean this Nonqualified Deferred Compensation Plan, as evidenced by this written  instrument, Participation Agreements, Election Forms, and any other forms as may be required by the Plan  Administrator, as amended from time to time. For purposes of Section 409A, the portion of the amounts deferred by  a Participant and Deemed Investment gains or losses credited or debited thereon, shall be considered an elective  account balance plan as defined in Treasury Regulations &sect;1.409A-1(c)(2)(i)(A), or as otherwise provided by the Code;  the portion of the amounts deferred as Company Contributions together with Deemed Investment gains or losses  credited or debited thereon, shall be considered a nonelective account balance plan as defined in Treasury  Regulations &sect;1.409A-1(c)(2)(i)(B), or as otherwise provided in the Code.   1.31 &#8220;Plan Administrator&#8221; shall mean the Company or its designee. The Plan Administrator shall  appoint delegates and service providers as it, in its sole discretion, deems necessary to properly administer the Plan,  and may from time to time consult with legal counsel. No person who is a Plan Administrator shall participate in an  action on a matter which applies solely to that person.  1.32 &#8220;Plan Year&#8221; shall mean for the first Plan Year, the period beginning on the Effective Date and ending  December 31 of the same calendar year; and thereafter shall mean a twelve (12) month period beginning January 1  of each calendar year and continuing through December 31 of such calendar year during which the Plan is in effect.    1.33 &#8220;Scheduled Withdrawal Account&#8221; shall mean a subaccount of a Participant&#8217;s Account consisting of:  (a) the sum of a Participant&#8217;s Deferral Amounts for any Plan Year or Performance Period that may be allocated, in  whole or in part, by the Participant pursuant to his or her Deferral Election to a Scheduled Withdrawal Account, plus  (b) Deemed Investment gains or losses credited or debited thereon less (c) any distributions made to the Participant  or his or her Beneficiary, and tax withholding amounts that relate to the Participant&#8217;s Scheduled Withdrawal  Account, and tax withholding amounts deducted (if any) from said Account.   1.34 &#8220;Section 409A&#8221; shall mean Code Section 409A and the Treasury Regulations or other authoritative  guidance issued thereunder.  1.35 &#8220;Separation from Service&#8221; or &#8220;Separates from Service&#8221; shall mean a Participant has experienced a  termination of employment or service with the Company. Whether a termination of employment or service has  occurred is determined based on whether the facts and circumstances indicate that the Company and the Participant  reasonably anticipated that no further services would be performed after a certain date or that the level of bona fide  services the Participant would perform after such date (whether as an Employee or as an Independent Contractor)  would permanently decrease to no more than twenty percent (20%) of the average level of bona fide services  performed (whether as an Employee or an Independent Contractor) over the immediately preceding thirty-six (36)  month period (or the full period during which the Participant performed services for the Company, if that is less  than thirty-six (36) months).    1.36 &#8220;Specified Time&#8221; shall mean, with respect to a Participant&#8217;s Scheduled Withdrawal Account, the  date on which the Scheduled Withdrawal Account shall be paid to the Participant.   1.37 &#8220;Treasury Regulation&#8221; or &#8220;Treasury Regulations&#8221; shall mean regulations promulgated by the  Internal Revenue Service for the U.S. Department of the Treasury, as they may be amended from time to time.  1.38 &#8220;Unforeseeable Emergency&#8221; shall mean: (a) a severe financial hardship to a Participant resulting  from an illness or accident of the Participant, the Participant&#8217;s spouse, the Participant&#8217;s Beneficiary, or the  Participant&#8217;s dependents (as defined in Code Section 152 (without regard to Code Sections 152(b)(1), (b)(2), and  (d)(1)(B)); (b) loss of the Participant&#8217;s property due to casualty; or (c) other similar extraordinary and unforeseeable  circumstances arising as a result of events beyond the control of the Participant. The Plan Administrator will  determine whether a Participant incurs an Unforeseeable Emergency based on the relevant facts and circumstances  and in accordance with Treasury Regulations &sect;1.409A-3(i)(3).  DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  5      1.39 &#8220;Valuation Date&#8221; shall mean the date a Participant&#8217;s Account is to be valued for purposes of  providing benefits under the terms of the Plan. The Valuation Date shall be interpreted as each day at the close of  business of the New York Stock Exchange (currently 4:00 p.m. Eastern Time), on days that the New York Stock  Exchange is open for trading or any other day on which there is sufficient trading in securities of the applicable fund  to materially affect the unit value of the fund and the corresponding unit value of the Participant's Deemed  Investment Option(s).  ARTICLE 2  ELIGIBILITY AND PARTICIPATION    2.1 Requirements for Participation. Every Eligible Individual selected by the Company on the Effective  Date shall be eligible to become a Participant on the Effective Date. Before the beginning of each Plan Year, or such  other times as determined by the Company, the Company shall select those Employees and Independent Contractors  who shall be Eligible Individuals for such Plan Year.   2.2 Election to Participate; Benefits of Participation. Each Eligible Individual may become a Participant  in the Plan by executing and submitting to the Plan Administrator, a Participation Agreement, a Deferral Election,  and any other Election Form within the time period specified by the Plan Administrator and Section 409A. If an  Eligible Individual fails to meet all requirements contained in this Section 2.2 within the period required, that Eligible  Individual shall not be entitled to participate in the Plan during such Plan Year. In addition, the Plan Administrator may  establish from time to time such other enrollment requirements permitted by Section 409A as it determines in its sole  discretion are necessary or desirable.  2.3 Re-employment. The re-employment of a former Participant or re-engagement of a former  Independent Contractor by the Company shall not entitle such individual to become a Participant hereunder. Such  individual shall not become a Participant until the individual is again designated as an Eligible Individual in  accordance with Section 2.1. If a Participant who has experienced a Separation from Service is receiving installment  distributions and is re-employed or re-engaged by the Company, distributions due to the Participant shall not be  suspended.  2.4 Ceasing to be an Eligible Individual. The Plan Administrator may remove an Eligible Individual  from further active participation in the Plan at its discretion. If this occurs, the Participant shall not have additional  amounts credited to the Company Contribution Account and shall be prevented from making Participant Deferral  Elections for subsequent Plan Years or Performance Periods. Any existing Deferral Election shall continue in effect  for the remainder of the Plan Year or Performance Period and may only be cancelled in accordance with Section  3.4(b) hereof.   2.5 Termination of Participation. A Participant will cease to be a Participant as of the date on which his  or her entire Account balance has been distributed or forfeited.  ARTICLE 3  DEFERRAL ELECTIONS    3.1 Minimum and Maximum Deferral Limits. For each Plan Year and/or Performance Period (as  applicable), a Participant shall specify the percentage of Base Salary, Bonus Compensation, and/or Independent  Contractor Compensation to be deferred subject to the minimums or maximums established by the Plan  Administrator and communicated to the Participant on the Election Form.   3.2 Deferral Elections &#8211; First Year of Eligibility.  (a) Application. This Section 3.2 applies to each Eligible Individual who first becomes eligible  to participate in the Plan. The Plan Administrator shall determine (in accordance with Treasury Regulation  DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  6      &sect;1.409A-2(a)(7)(ii)) the date upon which a Participant who ceased being eligible to participate in the Plan,  can again become eligible to participate in the Plan.   (b) Deferral Election. An Eligible Individual described in Section 3.2(a) may elect to defer  receipt of Base Salary or Independent Contractor Compensation earned during such Plan Year or his or her  Bonus Compensation earned during a Performance Period by filing a Deferral Election with the Plan  Administrator in accordance with the following rules:  (i) Timing; Irrevocability. The Deferral Election must be filed with the Plan  Administrator by, and shall become irrevocable as of, the thirtieth (30th) day following the  Participant&#8217;s Eligibility Date (or such earlier date as specified by the Plan Administrator).  (ii) Base Salary and Independent Contractor Compensation. The Deferral Election  shall only apply to Base Salary and Independent Contractor Compensation earned during such  calendar year beginning with the first payroll period that begins immediately after the date the  Deferral Election becomes irrevocable. Base Salary and Independent Contractor Compensation  payable after the last day of a calendar year solely for services performed during the final payroll  period, described in Section 3401(b) of the Code, containing December 31 of such year shall be treated  as earned during the subsequent calendar year.  (iii) Bonus Compensation. Where a Deferral Election is filed in the first year of eligibility  but after the commencement of the Performance Period, then, except as otherwise provided in  Section 3.3 below, the Deferral Election shall only apply to that portion of Bonus Compensation  earned for such Performance Period equal to the total amount of the Bonus Compensation earned  during such Performance Period multiplied by a fraction, the numerator of which is the number of  days beginning on the day immediately after the date that the Deferral Election becomes irrevocable  and ending on the last day of the Performance Period, and the denominator of which is the total  number of days in the Performance Period.  3.3 Annual Deferral Elections. Unless Section 3.2 applies, each Eligible Individual may elect to defer  receipt of Base Salary and Independent Contractor Compensation for a Plan Year or his or her Bonus Compensation  for a Performance Period, by filing a Deferral Election with the Plan Administrator in accordance with the following  rules:  (a) Base Salary and Independent Contractor Compensation. The Deferral Election with respect  to Base Salary and Independent Contractor Compensation must be filed with the Plan Administrator by, and  shall become irrevocable following, December 31 (or such earlier date as specified by the Plan Administrator  on the Deferral Election ) of the calendar year next preceding the calendar year for which such amounts  would otherwise be earned.  (b) Bonus Compensation. The Deferral Election with respect to Bonus Compensation must be  filed with the Plan Administrator by, and shall become irrevocable following, December 31 (or such earlier  date as specified by the Plan Administrator on the Deferral Election) of the calendar year next preceding the  first day of the Performance Period for which such Bonus Compensation would otherwise be earned. If the  Company has a fiscal year other than the calendar year, Bonus Compensation relating to services in the fiscal  year of the Company, of which no amount is paid or payable during the fiscal year, may be deferred at the  Participant&#8217;s election if the Deferral Election is made not later than the close of the Company&#8217;s fiscal year  next preceding the first fiscal year in which the Participant performs any services for which such Bonus  Compensation is payable. Any Deferral Election with respect to Bonus Compensation that constitutes  &#8220;performance-based compensation&#8221; under Treasury Regulation &sect;1.409A-1(e)(1), must be filed with the Plan  Administrator by, and shall become irrevocable as of, the date that is six (6) months before the end of the  applicable Performance Period (or such earlier date as specified by the Plan Administrator on the Deferral  DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  7      Election), provided that in no event may such Deferral Election be filed after such Bonus Compensation has  become &#8220;readily ascertainable&#8221; within the meaning of Section 409A.  3.4 Duration and Cancellation of Deferral Elections.   (a) Duration. Once irrevocable, a Deferral Election shall only be effective for the Plan Year or  Performance Period with respect to which such election was timely filed with the Plan Administrator. Except  as provided in Section 3.4(b), a Deferral Election, once irrevocable, cannot be cancelled or altered during a  Plan Year or Performance Period.   (b) Cancellation.   (i) The Plan Administrator may cancel a Participant&#8217;s Deferral Election where such  cancellation occurs by the later of: (A) the end of the Participant&#8217;s taxable year, or (B) the fifteenth  (15th) day of the third (3rd) month following the date the Participant incurs a &#8220;disability,&#8221; in  accordance with Treasury Regulation &sect;1.409A-3(j)(4)(xii). For purposes of this Section 3.4(b)(i), a  disability refers to any medically determinable physical or mental impairment resulting in the  Participant&#8217;s inability to perform duties of his or her position or any substantially similar position,  where such impairment can be expected to result in death or can be expected to last for a continuous  period of not less than six (6) months, in accordance with Treasury Regulation &sect;1.409A-3(i)(3).  (ii) The Plan Administrator must cancel a Participant's Deferral Election due to an  Unforeseeable Emergency distribution. If a Participant&#8217;s Deferral Election is cancelled with respect  to a particular calendar year or Performance Period, the Participant may complete a new Deferral  Election for a subsequent Plan Year or Performance Period, only in accordance with Section 3.3.  3.5 Withholding and Crediting of Deferral Amounts. For each Plan Year, the Base Salary and  Independent Contractor Compensation portions of the Deferral Amount shall be withheld from each regularly  scheduled payroll in approximately equal amounts (or as otherwise specified by the Plan Administrator), as adjusted  from time to time for increases and decreases in Base Salary or Independent Contractor Compensation (if the  Participant&#8217;s Deferral Election is expressed as a percentage). The Bonus Compensation portion of the Deferral  Amount shall be withheld as soon as administratively feasible following the time the Bonus Compensation otherwise  would be paid to the Participant, whether or not this occurs during the Plan Year or Performance Period as the case  may be. Deferral Amounts shall be credited to the Participant&#8217;s Deferral Account and/or to a Scheduled Withdrawal  Account as soon as administratively feasible following the time such amounts would otherwise have been paid to a  Participant.    ARTICLE 4  ACCOUNT ALLOCATION AND DISTRIBUTION ELECTIONS    4.1 Establishment of Account(s). The Plan Administrator shall establish and maintain a Deferral  Account, a Company Contribution Account, and Scheduled Withdrawal Accounts for each Plan Year, as applicable,  in the name of each Participant.   4.2 Account Allocation. Concurrent with any Deferral Election, a Participant may make an irrevocable  election to allocate all or a portion of his or her elected Deferral Amount to the Plan Year Deferral Account and/or a  Plan Year Scheduled Withdrawal Account. To the extent that a Participant does not designate the Account to which  Deferral Amounts will be allocated for a Plan Year, or such designation is ambiguous or does not comply with the  terms of the Plan, such Deferral Amounts shall be allocated and credited to the Participant&#8217;s Deferral Account.  Company Contributions shall not be allocated to a Scheduled Withdrawal Account, and instead shall be allocated to  a Plan Year Company Contribution Account.   DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  8      4.3 Scheduled Withdrawal Account Elections. If a Participant elects to allocate Deferral Amounts for a  Plan Year into a Scheduled Withdrawal Account in accordance with Section 4.2, the Participant shall make an election  as to the year in which payment will commence to be paid from that Scheduled Withdrawal Account (the &#8220;Specified  Time&#8221;). A Participant may elect to receive a distribution of a Scheduled Withdrawal Account no sooner than January  15th of the fifth (5th) Plan Year following the Plan Year of the deferral unless otherwise stated in the Election Form.  (For example: If a Participant elects to allocate 2023 Deferral Amounts into a Scheduled Withdrawal Account, the  earliest date these Deferral Amounts could be distributed would be January 15, 2028). A Participant must also elect  whether a Scheduled Withdrawal Account will be paid in a lump sum or in annual installments of up to four (4)  years. To the extent that the designations are ambiguous or do not comply with the terms of this Section, then that  Scheduled Withdrawal Account shall be paid at the earliest permissible date in accordance with this Section and/or  in a lump sum.    4.4 Other Distribution Elections. Within thirty (30) days following a Participant&#8217;s Eligibility Date, and  during each subsequent annual enrollment thereafter, a Participant must elect whether to be paid in a lump sum or  in five (5), ten (10), fifteen (15), or twenty (20) installments for a Separation from Service; and shall make a one-time  election within thirty (30) days following the initial Eligibility Date to be paid in a lump sum or five (5) annual  installments for Disability and death. To the extent that a Participant does not designate the form of payment or such  designation is ambiguous or does not comply with the terms of the Plan, the Participant shall be deemed to have  elected to be paid in a lump sum.  ARTICLE 5  COMPANY CONTRIBUTIONS    5.1  Company Contributions. Each Plan Year, the Company may make Company Contributions to the  Plan on behalf of a Participant in such amount as the Company shall determine in its sole discretion. The Company  is under no obligation to make a Company Contribution for a Plan Year, and Company Contributions, if made, need  not be uniform among Participants. Any Company Contribution shall be credited to the Participant's Company  Contribution Account on such date as determined by the Company.  ARTICLE 6  DEEMED INVESTMENT GAINS OR LOSSES  6.1 Deemed Investment Options. The Plan Administrator will determine the available Deemed  Investment Options for purposes of crediting or debiting the Deemed Investment gains or losses to the Account. The  Plan Administrator may discontinue, substitute, or add Deemed Investment Options in its sole discretion on a  prospective basis. Any discontinuance, substitution, or addition of a Deemed Investment Option will take effect as  soon as administratively practicable. The Deemed Investment Options are to be used for measurement purposes  only, and the Plan Administrator&#8217;s selection of any such Deemed Investment Option, the allocation of such Deemed  Investment Options to the Account, the calculation of additional amounts, and the crediting or debiting of such  amounts to the Account shall not be considered or construed in any manner as an actual investment of the Account.  The Plan Administrator will not be responsible in any manner to any Participant, Beneficiary or other person for any  damages, losses, liabilities, costs or expenses of any kind arising in connection with any designation or elimination  of a Deemed Investment Option. Without limiting the foregoing, the Account shall at all times be a bookkeeping  entry only and shall not represent any investment made on his or her behalf by the Plan Administrator. A Participant  (or Beneficiary) shall at all times remain an unsecured creditor of the Company. Any liability or obligation of the  Company to any Participant, former Participant, or Beneficiary with respect to a right to payment shall be based  solely upon contractual obligations created by this Plan.  6.2 Participant&#8217;s Allocation of Deemed Investment Options. Each Participant shall have the right to  direct the Plan Administrator as to how the Participant&#8217;s Deferral Amounts and Company Contributions shall be  deemed to be invested among the Deemed Investment Options offered under the Plan, subject to any rule, policy,  DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  9      practice or procedure adopted by the Plan Administrator. As of each Valuation Date, the Participant&#8217;s Account(s)  will be credited or debited to reflect the performance of the Deemed Investment Options elected by the Participant.  If a Deemed Investment Option selected by a Participant sustains a loss, the Participant&#8217;s Account(s) shall be reduced  to reflect such loss. If the Participant fails to elect a Deemed Investment Option the Deemed Investment shall be based  on an investment as may be established by the Plan Administrator.    6.3 Participant Responsibilities. Each Participant is solely responsible for any and all consequences of  his or her investment directions made pursuant to this Article 6. Neither the Company, any of its directors, officers  or employees, nor the Plan Administrator has any responsibility to any Participant or other person for any damages,  losses, liabilities, costs or expenses of any kind arising in connection with any investment direction made by a  Participant pursuant to this Article 6.  6.4 No Required Investment of Company Assets. Notwithstanding anything contained herein to the  contrary, the Company reserves the right to invest its assets, including any assets that may have been set aside for  the purpose of funding the benefits to be provided under the Plan, at its own discretion, and such assets shall remain  the property of the Company, or may be held in a trust, as the case may be, subject to the claims of the general  creditors of the Company, and no Participant shall have any right to any portion of such assets other than as an  unsecured general creditor of the Company.    ARTICLE 7  VESTING / FORFEITURES / TAXES    7.1 Participant Accounts. A Participant shall at all times be one hundred percent (100%) vested in his or  her Deferral Account and Scheduled Withdrawal Account(s).  7.2  Company Contribution Account. Unless otherwise described in a Participant&#8217;s Participation  Agreement, Company Contributions shall be tracked separately for each Plan Year and shall become one hundred  percent (100%) vested on December 31st of the fifth (5th) Plan Year following the year the contribution is credited to  the Participant&#8217;s Account. For example: Company Contributions credited in 2023 will 100% vest on December 31,  2028; contributions credited in 2024 will 100% vest on December 31, 2029; contributions credited in 2025 will 100%  vest on December 31, 2030; and so on.    7.3 Accelerated Vesting. Notwithstanding the foregoing vesting schedule, a Participant&#8217;s Company  Contribution Account shall become one hundred percent (100%) vested upon the earliest of the following events to  occur while employed by the Company: (a) Disability; (b) death; (c) a Change in Control; or (d) at the discretion of  the Company.     7.4 Forfeiture. Notwithstanding any other provision to the contrary herein, in the event a Participant&#8217;s  employment is terminated for Cause, no benefits of any kind will be due or payable by the Company under the terms  of this Plan from the Participant&#8217;s Company Contribution Account and all rights of the Participant, his or her  designated Beneficiary, executors, or administrators, or any other person, to receive payments thereof shall be  forfeited. Additionally, a Participant will forfeit any portion of an Account that is not vested upon Separation from  Service.   7.5 Taxes and Withholding. Deferral Amounts, Company Contributions, and Deemed Investment gains  and/or losses on each are subject to the Federal Insurance Contribution Act (FICA), the Federal Unemployment Tax  Act (FUTA), and the Self-Employment Contributions Act (SECA) for Independent Contractors, to the extent provided  under applicable Code provisions, and benefits payable under the Plan are subject to all applicable federal, state,  city, income, employment or other taxes as may be required to be withheld or paid. A Participant is solely responsible  for the payment of all individual tax liabilities relating to any such benefits.  DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  10        ARTICLE 8  PAYMENT OF ACCOUNT(S)    8.1 Payments in General.   (a) Payment Events.  (i) A Participant (or, in the event of the death of the Participant, the Participant&#8217;s  Beneficiary) shall be entitled to a benefit equal to the Participant&#8217;s vested Account(s) balance upon  the earliest to occur of Separation from Service, Disability, or death.   (ii) Unless the vested balance of a Participant&#8217;s Scheduled Withdrawal Account has  been paid earlier in accordance with this Section 8.1(a)(i), the Participant shall be entitled to a benefit  equal to such vested balance at the Specified Time.   (b) Source of Payments. The Company will pay, from its general assets, the portion of any  benefit payable pursuant to this Article 8 that is attributable to a Participant&#8217;s Account, and all costs, charges  and expenses relating thereto.   (c) Minimum Threshold for Installment Payments. If the vested Account balance at the due  date of the first installment is fifty thousand dollars ($50,000) or less, payment of the vested Account shall be  made instead in a lump sum and no installments shall be available hereunder. This lump sum minimum  threshold does not apply to Scheduled Withdrawal Accounts.   (d) Subsequent Deferral Elections. Upon the Company&#8217;s approval, a Participant may delay the  time of a payment or change the form of payment as expressly provided under this Section 8.1(d) and Section  409A (hereinafter, a &#8220;Subsequent Deferral Election&#8221;). Notwithstanding the foregoing, a Subsequent Deferral  Election cannot accelerate any payment. A Subsequent Deferral Election which delays payment or changes  the form of payment is permitted only if all of the following requirements are met:   (i) The Subsequent Deferral Election does not take effect until at least twelve (12)  months after the date on which the Subsequent Deferral Election is made and approved by the Plan  Administrator;  (ii) If the Subsequent Deferral Election relates to a payment based on Separation from  Service or at a Specified Time, the Subsequent Deferral Election must result in payment being  deferred for a period of not less than five (5) years from the date the first amount was scheduled to  be paid;   (iii)  If the Subsequent Deferral Election relates to a payment at a Specified Time, the  Participant must make the Subsequent Deferral Election not less than twelve (12) months before the  date the first amount was scheduled to be paid.     For purposes of applying this Section 8.1(d), installment payments shall be treated as a &#8220;single payment.&#8221;  Any election made pursuant to this Section shall be made on such Election Forms or electronic media as is required  by the Plan Administrator, in accordance with the rules established by the Plan Administrator and shall comply with  all requirements of Section 409A.    8.2 Separation from Service. In the event of a Participant&#8217;s Separation from Service (other than for  death), the Company shall pay the Participant in the form of payment elected in accordance with Section 4.4.   Payment shall be made or commence on January 15th of the calendar year following the date of Separation from  DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  11      Service and each January 15th thereafter in the case of installment payments. The amount of each payment shall be  determined by dividing the value of the Participant&#8217;s vested Account balance(s) as of December 31st prior to the  January 15th payment date by the number of payments remaining to be paid.      (a) Required Delay for Specified Employee of a Public Company. If a Participant is  considered a &#8220;specified employee&#8221; of a public company, pursuant to Code Section 409A(a)(2)(B)(i), then solely to the  extent necessary to avoid penalties under Section 409A, payments to be made as a result of a Separation from Service  under this Article may not commence earlier than six (6) months after the Participant&#8217;s Separation from Service. In  the event a distribution is delayed pursuant to this paragraph, any amounts otherwise payable during the six months  shall be accumulated and paid in a lump sum on the first day of the seventh month following Separation from Service.    8.3 Disability. In the event a Participant becomes Disabled while employed by the Company, the  Company shall pay to the Participant his or her Account balance in the form of payment elected by the Participant  in accordance with Section 4.4. Payment shall be made or commence within ninety (90) days following the date of  Disability. The amount of each payment shall be determined by dividing the value of the Participant&#8217;s Account  balance as of the Disability (and each anniversary of Disability for subsequent installment payments) by the number  of payments remaining to be paid.     8.4 Death.     (a) While Employed. In the event of a Participant&#8217;s death while employed by the Company, the  Company shall pay the Participant&#8217;s vested Account balance in the form of payment elected by the  Participant in accordance with Section 4.4. Payment shall be made or commence within ninety (90) days  following the date of the Participant&#8217;s death. The amount of each payment shall be determined by dividing  the value of the Participant&#8217;s Account balance as of the date of death (and each anniversary of the date of  death for subsequent installment payments) by the number of payments remaining to be paid.      (b) During Installments. In the event of a Participant&#8217;s death after installments have  commenced, as applicable, but before receiving all installments owed, the Company shall continue to pay  any remaining installments to the Participant&#8217;s Beneficiary in accordance with the schedule the installments  would have otherwise been paid to the Participant.    (c) During a Delay. In the event of a Participant&#8217;s death after becoming entitled to a benefit but  before payment is made or commences, as applicable, the Company shall pay the Participant&#8217;s Beneficiary  the same benefit the Participant would have received in accordance with the schedule the payment would  have otherwise been paid to the Participant.    8.5 Payment at a Specified Time. A Participant shall be paid a Scheduled Withdrawal Account on  January 15th (and each January 15th thereafter in the case of installment payments) of the year elected and in the form  of payment elected by the Participant in accordance with Section 4.3. The amount of each payment shall be  determined by dividing the value of the Participant&#8217;s Scheduled Withdrawal Account balance as of December 31st  prior to the January 15th payment date by the number of payments remaining to be paid.  Notwithstanding anything  contained herein to the contrary, should an event occur that triggers a payment under Separation from Service,  Disability, or death, any Account balances subject to a Participant&#8217;s Scheduled Withdrawal Account(s) that have not  yet begun to be paid shall not be paid under the election as to time and form of the Participant&#8217;s Scheduled  Withdrawal Account, but instead shall be paid, in time and form, in accordance with the event that triggers the  distribution and as permitted under Section 409A. Any Scheduled Withdrawal Accounts already in payout will  continue to be paid in accordance with the Participant&#8217;s Deferral Election for that Scheduled Withdrawal Account.    DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  12      8.6 Payment due to an Unforeseeable Emergency. A Participant shall have the right to request, on a  form provided by the Plan Administrator, a payment of all or a portion of his or her vested Account balance, in a  lump sum payment due to an Unforeseeable Emergency. The Plan Administrator shall have the sole discretion to  determine, in accordance with the standards under Section 409A, whether to grant such a request and the amount to  be paid pursuant to such request.     (a) Determination of Unforeseeable Emergency. Whether a Participant is faced with an  Unforeseeable Emergency permitting a lump sum payment is to be determined based on the relevant facts  and circumstances of each case, but, in any case, a payment on account of an Unforeseeable Emergency may  not be made to the extent that such emergency is or may be relieved through reimbursement or compensation  from insurance or otherwise, by liquidation of the Participant&#8217;s assets, to the extent the liquidation of such  assets would not cause severe financial hardship, or by cessation of deferrals under the Plan. Payments  because of an Unforeseeable Emergency must be limited to the amount reasonably necessary to satisfy the  emergency need (which may include amounts necessary to pay any federal, state, local, or foreign income  taxes or penalties reasonably anticipated to result from the payment).    (b) Payment of Account. Payment shall be made within thirty (30) days following the  determination by the Plan Administrator that a payment will be permitted under this Section 8.6.   8.7 Permissible Payment Accelerations. Except as specifically permitted herein or in other sections of  this Plan, no acceleration of the time or schedule of any payment may be made hereunder. Notwithstanding the  foregoing, payments may be accelerated hereunder by the Company (without any direct or indirect election on the  part of any Participant), in accordance with the provisions of Treasury Regulation &sect;1.409A-3(j)(4) and any subsequent  guidance issued by the United States Treasury Department. Accordingly, payments may be accelerated, in  accordance with the provisions of Treasury Regulation &sect;1.409A-3(j)(4) in the following circumstances: (a) in limited  cashouts (but not in excess of the limit under Code Section 402(g)(1)(B)); (b) to pay employment-related taxes; or (c)  to pay any taxes that may become due at any time that the Plan fails to meet the requirements of Section 409A (but  in no case shall such payments exceed the amount to be included in income as a result of the failure to comply with  the requirements of Section 409A).  8.8 Rights of Participant and Beneficiary.  (a) Creditor Status of Participant and Beneficiary. The Plan constitutes the unfunded,  unsecured promise of the Company to make payments to a Participant or Beneficiary in the future and shall  be a liability solely against the general assets of the Company. The Company shall not be required to  segregate, set aside or escrow any amounts for the benefit of a Participant or Beneficiary. A Participant and  Beneficiary shall have the status of a general unsecured creditor of the Company and may look only to the  Company and its general assets for payment of benefits under the Plan.    (b) Investments. In its sole discretion, the Company may acquire insurance policies, annuities  or other financial vehicles for the purpose of providing future assets of the Company to meet its anticipated  liabilities under the Plan. Such policies, annuities or other investments shall at all times be and remain  unrestricted general property and assets of the Company. A Participant and his or her designated Beneficiary  shall have no rights, other than as general creditors, with respect to such policies, annuities or other acquired  assets. In the event that the Company purchases an insurance policy or policies insuring the life of a  Participant or Employee, to allow the Company to recover or meet the cost of providing benefits, in whole  or in part, hereunder, no Participant or Beneficiary shall have any rights whatsoever in said policy or the  proceeds therefrom. The Company shall be the sole owner and beneficiary of any such insurance policy or  property and shall possess and may exercise all incidents of ownership therein. No insurance policy with  regard to any director, &#8220;highly compensated employee,&#8221; or &#8220;highly compensated individual,&#8221; as defined in  DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  13      Code Section 101(j) shall be acquired before satisfying the Code Section 101(j) &#8220;Notice and Consent&#8221;  requirements.    8.9 Discharge of Obligations. The payment to a Participant or his or her Beneficiary of the Account  balance in full shall discharge all obligations of the Company to such Participant or Beneficiary under the Plan.  ARTICLE 9  BENEFICIARY DESIGNATION    9.1 Designation of Beneficiaries.   (a) Each Participant may designate any person or persons (who may be named contingently or  successively) to receive any benefits payable under the Plan upon the Participant&#8217;s death, and the designation  may be changed from time to time by the Participant by filing a new designation. Each designation will  revoke all prior designations by the same Participant, shall be in the form prescribed by the Company, and  shall be effective only when signed by the Participant and filed with the Company during the Participant&#8217;s  lifetime.  (b) In the absence of a valid Beneficiary designation, or if, at the time any benefit payment is  due to a Beneficiary, there is no living Beneficiary validly named by the Participant, the Company shall pay  the benefit payment to the Participant&#8217;s spouse, if then living, and if the spouse is not then living to the  Participant&#8217;s then living descendants, if any, per stirpes, and if there are no living descendants, to the  Participant&#8217;s estate. In determining the existence or identity of anyone entitled to a benefit payment, the  Company may rely conclusively upon information supplied by the Participant&#8217;s personal representative,  executor, or administrator.  (c) A Participant&#8217;s designation of a Beneficiary will not be revoked or changed automatically  by any future marriage or divorce.  Should the Participant wish to change the designated Beneficiary in the  event of a future marriage or divorce, the Participant will have to do so by means of filing a new designation.   (d) If a question arises as to the existence or identity of anyone entitled to receive a death benefit  payment under the Plan, or if a dispute arises with respect to any death benefit payment under the Plan, the  Company may distribute the payment to the Participant&#8217;s estate without liability for any tax or other  consequences, or may take any other action which the Company deems to be appropriate.  9.2 Information to be furnished by Participants and Beneficiaries; Inability to Locate Participants or  Beneficiaries. Any communication, statement or notice addressed to a Participant or to a Beneficiary at his or her  last post office address as shown on the Company&#8217;s records shall be binding on the Participant or Beneficiary for all  purposes of the Plan. The Company shall not be obliged to search for any Participant or Beneficiary beyond the  sending of a registered letter to such last known address.  9.3 Facility of Payment. If the Plan Administrator determines in its discretion that a benefit is to be paid  to a minor, to a person legally declared incompetent, or to a person legally deemed incapable of handling the  disposition of that person&#8217;s property, the Plan Administrator may direct payment of such benefit to the guardian,  legal representative or person having care or custody of such minor, incompetent person or incapable person. The  Plan Administrator may require proof of incompetence, minority or guardianship as it may deem appropriate prior  to payment of the benefit. Any distribution of a benefit shall be a distribution for the account of the Participant and  the Beneficiary, as the case may be, and shall be a complete discharge of any liability under the Plan for such  distribution amount.    DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre014.jpg" title="slide14" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  14      ARTICLE 10  PLAN AMENDMENT    10.1 Right to Amend. Subject to Section 409A, the Company, by action of its board of directors or similar  governing body, shall have the right to amend the Plan, at any time and with respect to any provisions hereof, and  all parties hereto or claiming any interest hereunder shall be bound by such amendment; provided, however, that no  such amendment shall deprive a Participant or a Beneficiary of a benefit amount accrued hereunder prior to the date  of the amendment without written consent of the Participant or Beneficiary.   10.2 Amendments Required By Law. Notwithstanding the provisions of Section 10.1, the Plan may be  amended by the Company at any time, retroactively if required, if found necessary, in the opinion of the Company,  in order to ensure that the Plan is characterized as a &#8220;top-hat&#8221; plan of deferred compensation maintained for a select  group of management or highly compensated employees as described under ERISA sections 201(2), 301(a)(3), and  401(a)(1), to conform the Plan to the provisions of Section 409A, and to conform the Plan to the requirements of any  other applicable law (including but not limited to ERISA and the Code). No such amendment shall be considered  prejudicial to any interest of a Participant or a Beneficiary hereunder.  ARTICLE 11  PLAN TERMINATION    11.1 Company&#8217;s Right to Suspend Plan. The Company reserves the right to suspend the operation of the  Plan for a fixed or indeterminate period of time, in its sole discretion.  In the event of a suspension of the Plan, during  the period of the suspension, the Company shall continue all aspects of the Plan other than crediting of Company  Contributions, and Deferral Amounts shall be suspended effective with the first day of the Plan Year following the  date the Plan is suspended. Payments of distributions will continue to be made during the period of the suspension  in accordance with Article 8.  11.2 Plan Termination and Liquidation under Section 409A. Notwithstanding anything to the contrary  in Section 11.1, any acceleration of the payment of benefits due to Plan termination and liquidation shall comply with  the following subparagraphs, but only as permitted in accordance with Section 409A and Treasury Regulation  &sect;1.409A-3(j)(4)(ix). The Company may distribute all Participants&#8217; vested Account balances, determined as of the date  of the termination of the Plan, subject to the terms below:  (a) Upon the Company&#8217;s termination of this and all other arrangements that would be  aggregated with this Plan pursuant to Treasury Regulation &sect;1.409A-1(c) if a Participant participated in such  arrangements (&#8220;Similar Arrangements&#8221;), provided that: (i) the termination does not occur proximate to a  downturn in the financial health of the Company; (ii) all termination  distributions are made no earlier than  twelve (12) months and no later than twenty-four (24) months following such termination; and (iii) the  Company does not adopt any new arrangement that would be a Similar Arrangement for a minimum of  three (3) years following the date the Company takes all necessary action to irrevocably terminate and  liquidate the Plan.  (b) Upon the Company&#8217;s dissolution taxed under Code Section 331, or with approval of a  bankruptcy court, provided that the amounts deferred under the Plan are included in the Participant&#8217;s gross  income in the latest of: (i) the calendar year in which the Plan terminates; (ii) the calendar year in which the  amount is no longer subject to a substantial risk of forfeiture; or (iii) the first calendar year in which the  payment is administratively practicable; or  (c) Within thirty (30) days before or twelve (12) months after a Change in Control, provided  that all distributions are made no later than twelve (12) months following such termination of the Plan and  further provided that all the Company&#8217;s Similar Arrangements are terminated so the Participant and all  DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre015.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre015.jpg" title="slide15" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  15      participants in the Similar Arrangements are required to receive all amounts of compensation deferred under  the terminated arrangements within twelve (12) months of the termination of the Plan.  ARTICLE 12  PLAN ADMINISTRATION    12.1 Plan Administrator Duties. The Plan Administrator shall be responsible for the management,  operation, and administration of the Plan. When making a determination or calculation, the Plan Administrator shall  be entitled to rely on information furnished by the Company, the Participants, or Beneficiaries. No provision of this  Plan shall be construed as imposing on the Plan Administrator any fiduciary duty under ERISA or other law, or any  duty similar to any fiduciary duty under ERISA or other law.  12.2 Plan Administrator Authority. The Plan Administrator shall enforce this Plan in accordance with  its terms, shall be charged with the general administration of this Plan, and shall have all powers necessary to  accomplish its purposes, including, but not by way of limitation, the following:  (a) To construe and interpret the terms and provisions of this Plan and to reconcile any  inconsistency, in its sole and absolute discretion;  (b) To compute and certify the amount payable to a Participant and his or her Beneficiaries; to  determine the time and manner in which such benefits are paid; and to determine the amount of any  withholding taxes to be deducted;  (c) To maintain all records that may be necessary for the administration of this Plan;  (d) To provide for the disclosure of all information and the filing or provision of all reports and  statements to a Participant, Beneficiaries, and governmental agencies as shall be required by law;  (e) To make and publish such rules for the regulation of this Plan and procedures for the  administration of this Plan so long as such rules or procedures are not inconsistent with the terms hereof;  (f) To administer this Plan&#8217;s claims procedures;  (g) To approve the forms and procedures for use under this Plan; and  (h) To employ such persons or organizations, including without limitation, actuaries, attorneys,  accountants, independent fiduciaries, recordkeepers and administrative consultants, to render advice or  perform services with respect to the responsibilities of the Plan Administrator under the Plan.  12.3 Binding Effect of Decision. The decision or action of the Plan Administrator with respect to any  question arising out of or in connection with the administration, interpretation, and application of this Plan and the  rules and regulations promulgated hereunder shall be final and conclusive and binding upon all persons having any  interest in this Plan.  12.4 Compensation and Expenses. The Plan Administrator shall serve without compensation for services  rendered hereunder. The Plan Administrator is authorized at the expense of the Company to employ such legal  counsel and/or Plan recordkeeper as it may deem advisable to assist in the performance of its duties hereunder.  Expense and fees in connection with the administration of this Plan shall be paid by the Company.    12.5 Compliance with Section 409A.  DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre016.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre016.jpg" title="slide16" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  16      (a) Notwithstanding anything contained herein to the contrary, the interpretation and  distribution of Participants&#8217; benefits under the Plan shall be made in a manner and at such times as to comply  with all applicable provisions of Section 409A and the regulations and guidance promulgated thereunder, or  an exception or exclusion therefrom to avoid the imposition of any accelerated or additional taxes. Any  defined terms shall be construed consistent with Section 409A and any terms not specifically defined shall  have the meaning set forth in Section 409A.   (b) The intent of this Section is to ensure that the Participants are not subject to any tax liability  or interest penalty, by reason of the application of Code Section 409A(a)(1) as a result of any failure to comply  with all the requirements of Section 409A, and this Section shall be interpreted in light of, and consistent  with, such requirements. This Section shall apply to distributions under the Plan, but only to the extent  required in order to avoid taxation of, or interest penalties on, a Participant under Section 409A. These rules  shall also be deemed modified or supplemented by such other rules as may be necessary, from time to time,  to comply with Section 409A.  ARTICLE 13  CLAIMS PROCEDURES    13.1 Claims Procedure. This Article is based on Department of Labor Regulation Section 2560.503-1. If  any provision of this Article conflicts with the requirements of those regulations, the requirements of those  regulations will prevail. A Claimant who has not received benefits under the Plan that he or she believes should be  paid shall make a claim for such benefits as follows:     (a) Initiation - Written Claim. The Claimant initiates a claim by submitting a written request  for the benefits to the Plan Administrator. The Plan Administrator will, upon written request of a Claimant,  make available copies of all forms and instructions necessary to file a claim for benefits or advise the Claimant  where such forms and instructions may be obtained. If the claim relates to Disability benefits, then the Plan  Administrator shall designate a sub-committee to conduct the initial review of the claim (and applicable  references below to the Plan Administrator shall mean such sub-committee).    (b) Timing of Company Response. The Plan Administrator shall respond to such Claimant  within ninety (90) days after receiving the claim. If the Plan Administrator determines that special  circumstances require additional time for processing the claim, the Plan Administrator can extend the  response period by an additional ninety (90) days by notifying the Claimant in writing prior to the end of  the initial 90-day period that an additional period is required. In the event that the claim for benefits pertains  to Disability, the Plan Administrator shall provide written response within forty-five (45) days, but can  extend this response period by an additional thirty (30) days, if necessary, due to circumstances beyond the  Plan Administrator&#8217;s control. Any notice of extension must set forth the special circumstances requiring an  extension of time and the date by which the Plan Administrator expects to render its decision.    (c)  Notice of Decision. If the Plan Administrator denies the claim, in whole or in part, the Plan  Administrator shall notify the Claimant in writing of such denial. The Plan Administrator shall write the  notification in a manner calculated to be understood by the Claimant. The notification shall set forth:     (i) The specific reasons for the denial;   (ii) A reference to the specific provisions of the Plan on which the denial is based;  (iii) A description of any additional information or material necessary for the Claimant  to perfect the claim and an explanation of why it is needed;   (iv) An explanation of the Plan's review procedures and the time limits applicable to  such procedures; and   (v) A statement of the Claimant&#8217;s right to bring a civil action under ERISA Section 502(a)  DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre017.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre017.jpg" title="slide17" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  17      following an adverse benefit determination on review.     13.2  Review Procedure. If the Plan Administrator denies the claim, in whole or in part, the Claimant shall  have the opportunity for a full and fair review by the Plan Administrator of the denial, as follows:     (a) Initiation - Written Request. To initiate the review, the Claimant, within sixty (60) days after  receiving the Plan Administrator&#8217;s notice of denial, must file with the Plan Administrator a written request  for review.     (b) Review of a Disability Benefit Claim. If the Claimant&#8217;s initial claim is for Disability benefits,  any review of a denied claim shall be made by members of the Plan Administrator other than the original  decision maker(s) and such person(s) shall not be a subordinate of the original decision maker(s).    (c) Additional Submissions - Information Access. The Claimant shall then have the  opportunity to submit written comments, documents, records and other information relating to the claim.   The Plan Administrator shall also provide the Claimant, upon request and free of charge, reasonable access  to, and copies of, all documents, records and other information relevant (as defined in applicable ERISA  regulations) to the Claimant&#8217;s claim for benefits.    (d) Considerations on Review. In considering the review, the Plan Administrator shall take into  account all comments, documents, records and other information submitted by the Claimant relating to the  claim, without regard to whether such information was submitted or considered in the initial benefit  determination. Additional considerations shall be required in the case of a claim for Disability benefits. For  example, the claim will be reviewed without deference to the initial adverse benefits determination and, if  the initial adverse benefit determination was based in whole or in part on a medical judgment, the Plan  Administrator will consult with a health care professional with appropriate training and experience in the  field of medicine involving the medical judgment. The health care professional who is consulted on appeal  will not be the same individual who was consulted during the initial determination or the subordinate of  such individual. If the Plan Administrator obtained the advice of medical or vocational experts in making  the initial adverse benefits determination (regardless of whether the advice was relied upon), the Plan  Administrator will identify such experts.    (e) Timing of Company Response. The Plan Administrator shall respond in writing to such  Claimant within sixty (60) days after receiving the request for review. If the Plan Administrator determines  that special circumstances require additional time for processing the claim, the Plan Administrator can  extend the response period by an additional sixty (60) days by notifying the Claimant in writing, prior to the  end of the initial 60-day period that an additional period is required. The notice of extension must set forth  the special circumstances and the date by which the Plan Administrator expects to render its decision.     (f) Notice of Decision. The Plan Administrator shall notify the Claimant in writing of its  decision on review. The Plan Administrator shall write the notification in a manner calculated to be  understood by the Claimant. The notification shall set forth:    (i) The specific reasons for the denial;   (ii) A reference to the specific provisions of the Plan on which the denial is based;  (iii) A statement that the Claimant is entitled to receive, upon request and free of charge,  reasonable access to, and copies of, all documents, records and other information  relevant (as defined in applicable ERISA regulations) to the Claimant's claim for  benefits; and   (iv) A statement of the Claimant's right to bring a civil action under ERISA Section  DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre018.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre018.jpg" title="slide18" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  18      502(a).     13.3 Calculation of Time Periods. For purposes of the time periods specified in this Article, the period  of time during which a benefit determination is required to be made begins at the time a claim is filed in accordance  with the Plan procedures without regard to whether all the information necessary to make a decision accompanies  the claim. If a period of time is extended due to a Claimant's failure to submit all information necessary, the period  for making the determination shall be tolled from the date the notification is sent to the Claimant until the date the  Claimant responds.    13.4 Exhaustion of Remedies.  A Claimant must follow the claims review procedures under this Plan  and exhaust his or her administrative remedies before taking any further action with respect to a claim for benefits.    13.5 Failure of Plan to Follow Procedures. If the Plan fails to establish or follow the claims procedures  required by this Article, a Claimant shall be deemed to have exhausted the administrative remedies available under  the Plan and shall be entitled to immediately pursue any available remedy under ERISA Section 502(a) on the basis  that the Plan has failed to provide a reasonable claims procedure that would yield a decision on the merits of the  claim. The Claimant may request a written explanation of the violation from the Plan, and the Plan must provide  such explanation within ten (10) days, including a specific description of its bases, if any, for asserting that the  violation should not cause the administrative remedies to be deemed exhausted. If a court rejects the Claimant&#8217;s  request for immediate review on the basis that the Plan met the standards for the exception, the claim shall be  considered as re-filed on appeal upon the Plan&#8217;s receipt of the decision of the court. Within a reasonable time after  the receipt of the decision, the Plan shall provide the claimant with notice of the resubmission.      13.6 Arbitration. If a Claimant continues to dispute the benefit denial based upon completed  performance of the Plan or the meaning and effect of the terms and conditions thereof, then the Claimant must submit  the dispute to an arbitrator for final arbitration. The arbitrator shall be selected by mutual agreement of the Company  and the Claimant. The arbitrator shall operate under any generally recognized set of arbitration rules. The parties  hereto agree that they and their heirs, personal representatives, successors and assigns shall be bound by the decision  of such arbitrator with respect to any controversy properly submitted to it for determination. Where a dispute arises  as to the Company&#8217;s discharge of a Participant for Cause, such dispute shall likewise be submitted to arbitration as  above described and the parties hereto agree to be bound by the decision thereunder.    ARTICLE 14  MISCELLANEOUS    14.1 Validity. In case any provision of this Plan shall be illegal or invalid for any reason, said illegality or  invalidity shall not affect the remaining parts hereof, but this Plan shall be construed and enforced as if such illegal  or invalid provision had never been inserted herein.   14.2 Nonassignability. Neither any Participant nor any other person shall have any right to commute,  sell, assign, transfer, pledge, anticipate, mortgage, or otherwise encumber, transfer, hypothecate, alienate, or convey  in advance of actual receipt, the amounts, if any, payable hereunder, or any part hereof, which are, and all rights to  which are expressly declared to be, unassignable and non-transferable. No part of the amounts payable shall, prior  to actual payment, be subject to seizure, attachment, garnishment or sequestration for the payment of any debts,  judgments, alimony, or separate maintenance owed by a Participant or any other person, be transferable by operation  of law in the event of a Participant&#8217;s or any other person&#8217;s bankruptcy or insolvency, or be transferable to a spouse  as a result of a property settlement or otherwise. If any Participant, Beneficiary, or successor in interest is adjudicated  bankrupt or purports to commute, sell, assign, transfer, pledge, anticipate, mortgage or otherwise encumber transfer,  hypothecate, alienate, or convey in advance of actual receipt, the amount, if any, payable hereunder, or any part  thereof, the Plan Administrator, in its discretion, may cancel such distribution or payment (or any part thereof) to or  DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ameh-nonqualifieddeferre019.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ameh-nonqualifieddeferre019.jpg" title="slide19" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  19      for the benefit of such Participant, Beneficiary, or successor in interest in such manner as the Plan Administrator shall  direct.  14.3 Not a Contract of Employment. The terms and conditions of this Plan shall not be deemed to  constitute a contract of employment between the Company and the Employee. Nothing in this Plan shall be deemed  to give the Employee the right to be retained in the service of the Company as an Employee or otherwise or to  interfere with the right of the Company to discipline or discharge the Employee at any time.   14.4 Governing Law. The Plan shall be administered, construed and governed in all respects under and  by the laws of State of Delaware, without reference to the principles of conflicts of law (except and to the extent  preempted by applicable federal law).   14.5 Notice. Any notice, consent or demand required or permitted to be given under the provisions of  this Plan shall be in writing and shall be signed by the party giving or making the same.  If such notice, consent or  demand is mailed, it shall be sent by United States certified mail, postage prepaid, addressed to the addressee&#8217;s last  known address as shown on the records of the Company. The date of such mailing shall be deemed the date of notice  consent or demand.  Any person may change the address to which notice is to be sent by giving notice of the change  of address in the manner aforesaid.  14.6 Coordination with Other Benefits. The benefits provided for a Participant or a Participant&#8217;s  Beneficiary under this Plan are in addition to any other benefits available to such Participant under any other plan  or program for employees of the Company. This Plan shall supplement and shall not supersede, modify, or amend  any other such plan or program except as may otherwise be expressly provided herein.  14.7 Unclaimed Benefits. In the case of a benefit payable on behalf of such Participant, if the Plan  Administrator is unable to locate the Participant or Beneficiary to whom such benefit is payable after reasonable  efforts have been undertaken by the Plan Administrator to locate such party(ies), such Plan benefit may be forfeited  to the Company upon the Plan Administrator&#8217;s determination. Notwithstanding the foregoing, if, subsequent to any  such forfeiture, the Participant or Beneficiary to whom such Plan benefit is payable makes a valid claim for such Plan  benefit, such forfeited Plan benefit shall be paid by the Plan Administrator to the Participant or Beneficiary, without  interest, from the date it would have otherwise been paid.  The Company executes this Plan as of the date first written above.          APOLLO MEDICAL HOLDINGS, INC.:          By:                 Title:                 Printed Name:        DocuSign Envelope ID: 1730505F-FBA4-4E0E-8223-4464BA551268 Chandan Basho Chief Strategy and Financial Officer </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>ex3112023063010-q.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia5a461e182f1443bae6efd61ef92a2de_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">PURSUANT TO</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thomas Lam, M.D., certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this quarterly report on Form 10-Q of Apollo Medical Holdings, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:6.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.699%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 9, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas Lam</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thomas Lam</font></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer and President</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>ex3122023063010-q.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic753ae64745b48eb9c0b74326c188c82_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> EXHIBIT 31.2</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">PURSUANT TO</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brandon Sim, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this quarterly report on Form 10-Q of Apollo Medical Holdings, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:6.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.699%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 9, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brandon Sim</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brandon Sim</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.3
<SEQUENCE>5
<FILENAME>ex3132023063010-q.htm
<DESCRIPTION>EX-31.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i4503661c61fb4e2e8f17af5ee632bea6_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> EXHIBIT 31.3</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">PURSUANT TO</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Chandan Basho, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this quarterly report on Form 10-Q of Apollo Medical Holdings, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:6.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.699%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 9, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Chandan Basho</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chandan Basho</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial and Strategy Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>6
<FILENAME>ex322023063010-q.htm
<DESCRIPTION>EX-32
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib51bc6ad4aa9404bb8cf7bcf8f69c934_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICERS AND PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thomas Lam, M.D., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Apollo Medical Holdings, Inc. for the quarter ended June&#160;30, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Apollo Medical Holdings, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.391%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 9, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas Lam</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thomas Lam</font></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer and President</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brandon Sim, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Apollo Medical Holdings, Inc. for the quarter ended June&#160;30, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Apollo Medical Holdings, Inc.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.391%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 9, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brandon Sim</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brandon Sim</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Chandan Basho, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Apollo Medical Holdings, Inc. for the quarter ended June&#160;30, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Apollo Medical Holdings, Inc.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.391%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 9, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Chandan Basho</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chandan Basho</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial and Strategy Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>ameh-20230630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:3040ecaa-d98f-42d5-9854-9c1a7ec98864,g:10a2b015-69d1-478c-967c-e01a9974c48a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ameh="http://www.apollomed.net/20230630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.apollomed.net/20230630">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ameh-20230630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ameh-20230630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ameh-20230630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ameh-20230630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Coverpage" roleURI="http://www.apollomed.net/role/Coverpage">
        <link:definition>0000001 - Document - Cover page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOME" roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME">
        <link:definition>0000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY" roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY">
        <link:definition>0000005 - Statement - CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusiness" roleURI="http://www.apollomed.net/role/DescriptionofBusiness">
        <link:definition>0000007 - Disclosure - Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>0000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsAssetAcquisitionsandGoodwill" roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwill">
        <link:definition>0000009 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNet" roleURI="http://www.apollomed.net/role/IntangibleAssetsNet">
        <link:definition>0000010 - Disclosure - Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinOtherEntities" roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntities">
        <link:definition>0000011 - Disclosure - Investments in Other Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoanReceivableandLoanReceivableRelatedParties" roleURI="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedParties">
        <link:definition>0000012 - Disclosure - Loan Receivable and Loan Receivable &#8211; Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsPayableandAccruedExpenses" roleURI="http://www.apollomed.net/role/AccountsPayableandAccruedExpenses">
        <link:definition>0000013 - Disclosure - Accounts Payable and Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalLiabilities" roleURI="http://www.apollomed.net/role/MedicalLiabilities">
        <link:definition>0000014 - Disclosure - Medical Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditFacilityBankLoansandLinesofCredit" roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCredit">
        <link:definition>0000015 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MezzanineandStockholdersEquity" roleURI="http://www.apollomed.net/role/MezzanineandStockholdersEquity">
        <link:definition>0000016 - Disclosure - Mezzanine and Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.apollomed.net/role/StockBasedCompensation">
        <link:definition>0000017 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.apollomed.net/role/CommitmentsandContingencies">
        <link:definition>0000018 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.apollomed.net/role/RelatedPartyTransactions">
        <link:definition>0000019 - Disclosure - Related-Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.apollomed.net/role/IncomeTaxes">
        <link:definition>0000020 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.apollomed.net/role/EarningsPerShare">
        <link:definition>0000021 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesVIEs" roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEs">
        <link:definition>0000022 - Disclosure - Variable Interest Entities (VIEs)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.apollomed.net/role/Leases">
        <link:definition>0000023 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Segments" roleURI="http://www.apollomed.net/role/Segments">
        <link:definition>0000024 - Disclosure - Segments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.apollomed.net/role/SubsequentEvents">
        <link:definition>0000025 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9954701 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>9954702 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsAssetAcquisitionsandGoodwillTables" roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillTables">
        <link:definition>9954703 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetTables" roleURI="http://www.apollomed.net/role/IntangibleAssetsNetTables">
        <link:definition>9954704 - Disclosure - Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinOtherEntitiesTables" roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesTables">
        <link:definition>9954705 - Disclosure - Investments in Other Entities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsPayableandAccruedExpensesTables" roleURI="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesTables">
        <link:definition>9954706 - Disclosure - Accounts Payable and Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalLiabilitiesTables" roleURI="http://www.apollomed.net/role/MedicalLiabilitiesTables">
        <link:definition>9954707 - Disclosure - Medical Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditFacilityBankLoansandLinesofCreditTables" roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditTables">
        <link:definition>9954708 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.apollomed.net/role/StockBasedCompensationTables">
        <link:definition>9954709 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsTables" roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsTables">
        <link:definition>9954710 - Disclosure - Related-Party Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.apollomed.net/role/EarningsPerShareTables">
        <link:definition>9954711 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesVIEsTables" roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEsTables">
        <link:definition>9954712 - Disclosure - Variable Interest Entities (VIEs) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.apollomed.net/role/LeasesTables">
        <link:definition>9954713 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsTables" roleURI="http://www.apollomed.net/role/SegmentsTables">
        <link:definition>9954714 - Disclosure - Segments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails">
        <link:definition>9954715 - Disclosure - Description of Business - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>9954716 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails" roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails">
        <link:definition>9954717 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Gain (Loss) on Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails" roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails">
        <link:definition>9954718 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Each Payor Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails" roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails">
        <link:definition>9954719 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Contributions to Revenue and Receivables by Payor (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails" roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails">
        <link:definition>9954720 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails">
        <link:definition>9954721 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails">
        <link:definition>9954722 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsAssetAcquisitionsandGoodwillScheduleofGoodwillDetails" roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillScheduleofGoodwillDetails">
        <link:definition>9954723 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetScheduleofIntangibleAssetsDetails" roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails">
        <link:definition>9954724 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1" roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1">
        <link:definition>9954724 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails">
        <link:definition>9954725 - Disclosure - Intangible Assets, Net - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails" roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails">
        <link:definition>9954726 - Disclosure - Intangible Assets, Net - Schedule of Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails" roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails">
        <link:definition>9954727 - Disclosure - Investments in Other Entities - Schedule of Equity Method Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinOtherEntitiesAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails">
        <link:definition>9954728 - Disclosure - Investments in Other Entities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails">
        <link:definition>9954729 - Disclosure - Loan Receivable and Loan Receivable &#8211; Related Parties - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsPayableandAccruedExpensesDetails" roleURI="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails">
        <link:definition>9954730 - Disclosure - Accounts Payable and Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalLiabilitiesDetails" roleURI="http://www.apollomed.net/role/MedicalLiabilitiesDetails">
        <link:definition>9954731 - Disclosure - Medical Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails" roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails">
        <link:definition>9954732 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails" roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails">
        <link:definition>9954733 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails">
        <link:definition>9954734 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MezzanineandStockholdersEquityAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails">
        <link:definition>9954735 - Disclosure - Mezzanine and Stockholders' Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails" roleURI="http://www.apollomed.net/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails">
        <link:definition>9954736 - Disclosure - Stock-Based Compensation - Schedule of Share-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails">
        <link:definition>9954737 - Disclosure - Stock-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails" roleURI="http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails">
        <link:definition>9954738 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Transactions Under Stock Option Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails">
        <link:definition>9954739 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails">
        <link:definition>9954740 - Disclosure - Related-Party Transactions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails" roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails">
        <link:definition>9954741 - Disclosure - Related-Party Transactions - Schedule of Fees Incurred and Revenue Earned from Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails">
        <link:definition>9954742 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails">
        <link:definition>9954743 - Disclosure - Earnings Per Share - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareScheduleofEarningsPerShareComputationsDetails" roleURI="http://www.apollomed.net/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails">
        <link:definition>9954744 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share Computations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails" roleURI="http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails">
        <link:definition>9954745 - Disclosure - Earnings Per Share - Schedule of Shares Included in the Diluted Earnings Per Share Computations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesVIEsDetails" roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails">
        <link:definition>9954746 - Disclosure - Variable Interest Entities (VIEs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalinformationDetails" roleURI="http://www.apollomed.net/role/LeasesAdditionalinformationDetails">
        <link:definition>9954747 - Disclosure - Leases - Additional information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofComponentsofLeaseExpenseDetails" roleURI="http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails">
        <link:definition>9954748 - Disclosure - Leases - Schedule of Components of Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofOtherInformationRelatedtoLeasesDetails" roleURI="http://www.apollomed.net/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails">
        <link:definition>9954749 - Disclosure - Leases - Schedule of Other Information Related to Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails" roleURI="http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails">
        <link:definition>9954750 - Disclosure - Leases - Schedule of Future Minimum Payments Under Non-cancelable Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1" roleURI="http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1">
        <link:definition>9954750 - Disclosure - Leases - Schedule of Future Minimum Payments Under Non-cancelable Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsNarrativeDetails" roleURI="http://www.apollomed.net/role/SegmentsNarrativeDetails">
        <link:definition>9954751 - Disclosure - Segments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsScheduleofInformationaboutourSegmentsDetails" roleURI="http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails">
        <link:definition>9954752 - Disclosure - Segments - Schedule of Information about our Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails">
        <link:definition>9954753 - Disclosure - Subsequent Events - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ameh_TemporaryEquityDividendsImpact" abstract="false" name="TemporaryEquityDividendsImpact" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_DmgMember" abstract="true" name="DmgMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_NumberOfPrimaryCareServices" abstract="false" name="NumberOfPrimaryCareServices" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_AmgIncMember" abstract="true" name="AmgIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_CareEnablementMember" abstract="true" name="CareEnablementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_PayorBMember" abstract="true" name="PayorBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_FinanceLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="FinanceLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" abstract="false" name="BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_DebtCovenantAggregatePurchasePriceMaximum" abstract="false" name="DebtCovenantAggregatePurchasePriceMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" abstract="false" name="ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="ameh_OtherThirdPartiesMember" abstract="true" name="OtherThirdPartiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_EarningsPerShareTable" abstract="true" name="EarningsPerShareTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ameh_PreferredBankMember" abstract="true" name="PreferredBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_LmaMember" abstract="true" name="LmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_DMGAndSunLabsMember" abstract="true" name="DMGAndSunLabsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ameh_SummaryOfSignificantAccountingPoliciesTable" abstract="true" name="SummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ameh_AMGPropertiesLLCMember" abstract="true" name="AMGPropertiesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_ContingentEquitySecuritiesMember" abstract="true" name="ContingentEquitySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_FiduciaryAccountsPayableCurrent" abstract="false" name="FiduciaryAccountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_CashPaidForLeaseLiabilitiesAbstractAbstract" abstract="true" name="CashPaidForLeaseLiabilitiesAbstractAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_PacificMedicalImagingAndOncologyCenterIncMember" abstract="true" name="PacificMedicalImagingAndOncologyCenterIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" abstract="false" name="BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ameh_MedicalPropertyPartnersLLCMember" abstract="true" name="MedicalPropertyPartnersLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum" abstract="false" name="DebtInstrumentCovenantInterestCoverageRatioMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" abstract="false" name="BusinessCombinationEquityInterestPurchaseObligationNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_DebtInstrumentCovenantLeverageRatioMaximum" abstract="false" name="DebtInstrumentCovenantLeverageRatioMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ameh_IntraCareConvertiblePromissoryNoteReceivableMember" abstract="true" name="IntraCareConvertiblePromissoryNoteReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ameh_AssetAcquisitionPercentageOfSharesAcquired" abstract="false" name="AssetAcquisitionPercentageOfSharesAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" abstract="false" name="NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_DescriptionOfBusinessTable" abstract="true" name="DescriptionOfBusinessTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ameh_MedicalCareCostsAbstract" abstract="true" name="MedicalCareCostsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_MedicaidMember" abstract="true" name="MedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_AlliedPacificOfCaliforniaIPAMember" abstract="true" name="AlliedPacificOfCaliforniaIPAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_EquityMethodInvestmentsRollForward" abstract="true" name="EquityMethodInvestmentsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_DerivativeCeilingInterestRate" abstract="false" name="DerivativeCeilingInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" abstract="false" name="RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ameh_LasalleMedicalAssociatesIpaMember" abstract="true" name="LasalleMedicalAssociatesIpaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_StockIssuedDuringPeriodSharesMerger" abstract="false" name="StockIssuedDuringPeriodSharesMerger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_SummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="SummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_PmiocMember" abstract="true" name="PmiocMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_LongTermDebtMaturityAfterYearFour" abstract="false" name="LongTermDebtMaturityAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_CollarMember" abstract="true" name="CollarMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_TransferOfCommonControlEntities" abstract="false" name="TransferOfCommonControlEntities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_PerformanceBasedRestrictedStockMember" abstract="true" name="PerformanceBasedRestrictedStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable" abstract="false" name="LesseeOperatingLeaseTerminationPeriodIfApplicable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ameh_MarketableSecuritiesCurrentMaturityPeriod" abstract="false" name="MarketableSecuritiesCurrentMaturityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ameh_DescriptionOfBusinessLineItems" abstract="true" name="DescriptionOfBusinessLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ameh_DebtInstrumentNumberOfKeyFinancialRatios" abstract="false" name="DebtInstrumentNumberOfKeyFinancialRatios" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ameh_AmendedCreditAgreementMember" abstract="true" name="AmendedCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_MezzanineEquityAbstract" abstract="true" name="MezzanineEquityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_Tag6MedicalInvestmentGroupLLCMember" abstract="true" name="Tag6MedicalInvestmentGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_NumberOfPrimaryCareClinics" abstract="false" name="NumberOfPrimaryCareClinics" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum" abstract="false" name="DebtInstrumentCovenantDebtCoverageRatioMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" abstract="true" name="ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_SongPCMember" abstract="true" name="SongPCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ameh_MezzanineMember" abstract="true" name="MezzanineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_CAIPAMSOLLCMember" abstract="true" name="CAIPAMSOLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_BoardMembersMember" abstract="true" name="BoardMembersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable" abstract="false" name="LesseeFinanceLeaseTerminationPeriodIfApplicable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ameh_ArroyoVistaMember" abstract="true" name="ArroyoVistaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_Tag8MedicalInvestmentGroupLLCMember" abstract="true" name="Tag8MedicalInvestmentGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_CareDeliveryMember" abstract="true" name="CareDeliveryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_EarningsPerShareLineItems" abstract="true" name="EarningsPerShareLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_BoardMembersWhoAreAlsoOfficersMember" abstract="true" name="BoardMembersWhoAreAlsoOfficersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ameh_ApcBusinessLoanAgreementMember" abstract="true" name="ApcBusinessLoanAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_ApcStockOptionMember" abstract="true" name="ApcStockOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_ApcShareholdersMember" abstract="true" name="ApcShareholdersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_TemporaryEquityTransferOfCommonControlEntities" abstract="false" name="TemporaryEquityTransferOfCommonControlEntities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_OneMSOInc.Member" abstract="true" name="OneMSOInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_HealthCareCapitationRevenueMember" abstract="true" name="HealthCareCapitationRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_JadeHealthCareMedicalGroupIncMember" abstract="true" name="JadeHealthCareMedicalGroupIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_PatientManagementPlatformMember" abstract="true" name="PatientManagementPlatformMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_AAMGMember" abstract="true" name="AAMGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_AdvanceDiagnosticSurgeryCenterMember" abstract="true" name="AdvanceDiagnosticSurgeryCenterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_AHMCMember" abstract="true" name="AHMCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_LoanReceivableTextBlock" abstract="false" name="LoanReceivableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="ameh_PaymentsForMedicalCareCostsAbstract" abstract="true" name="PaymentsForMedicalCareCostsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_FiveThreeOneW.CollegeLLCMember" abstract="true" name="FiveThreeOneW.CollegeLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember" abstract="true" name="MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_UnrealizedGainLossFromInvestmentInEquitySecurities" abstract="false" name="UnrealizedGainLossFromInvestmentInEquitySecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange" abstract="false" name="DebtInstrumentCovenantLeverageRatioIncrementalChange" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable" abstract="false" name="EquityMethodInvestmentFundingReclassifiedToLoanReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_StockAwardsAndUnitsMember" abstract="true" name="StockAwardsAndUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_DiagnosticAndSurgicalCenterMember" abstract="true" name="DiagnosticAndSurgicalCenterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_IncreaseDecreaseInMedicalLiabilities" abstract="false" name="IncreaseDecreaseInMedicalLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_DebtCovenantThresholdPercentageForOccupationOfProperty" abstract="false" name="DebtCovenantThresholdPercentageForOccupationOfProperty" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" abstract="false" name="StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ameh_FinanceReceivableInterestRateStatedPercentage" abstract="false" name="FinanceReceivableInterestRateStatedPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ameh_ApolloSunLabsManagementLLCMember" abstract="true" name="ApolloSunLabsManagementLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_IncreaseDecreaseInOperatingLeaseAssets" abstract="false" name="IncreaseDecreaseInOperatingLeaseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_ZLLPartnersLLCMember" abstract="true" name="ZLLPartnersLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_TruistBankMember" abstract="true" name="TruistBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod" abstract="false" name="PromissoryNotesExpectedToBeCollectedWithinPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ameh_Pacific6EnterprisesMember" abstract="true" name="Pacific6EnterprisesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_AlphaCareMedicalGroupInc.Member" abstract="true" name="AlphaCareMedicalGroupInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_ConstructionLoanMember" abstract="true" name="ConstructionLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_AccountsReceivableAndNetRevenueLineItems" abstract="true" name="AccountsReceivableAndNetRevenueLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum" abstract="false" name="DebtInstrumentCovenantCashFlowCoverageRatioMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ameh_A120HellmanLLCMember" abstract="true" name="A120HellmanLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_MemberRelationshipsMember" abstract="true" name="MemberRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" abstract="false" name="NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_SpecialtyCapitationPayableCurrent" abstract="false" name="SpecialtyCapitationPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_FulgentGeneticsIncMember" abstract="true" name="FulgentGeneticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_RentPaymentMember" abstract="true" name="RentPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ameh_JamesSongMDAProfessionalCorporationMember" abstract="true" name="JamesSongMDAProfessionalCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_CarePartnersMember" abstract="true" name="CarePartnersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_PurchaseOfNonControllingInterest" abstract="false" name="PurchaseOfNonControllingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_LeaseWeightedAverageRemainingLeaseTermAbstract" abstract="true" name="LeaseWeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_ProviderServicesMember" abstract="true" name="ProviderServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ameh_NetworkMedicalManagementMember" abstract="true" name="NetworkMedicalManagementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_ManagementContractsMember" abstract="true" name="ManagementContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_FeesIncurredAndIncomeRecognizedMember" abstract="true" name="FeesIncurredAndIncomeRecognizedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ameh_APCMGMember" abstract="true" name="APCMGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_SecuredOvernightFinancingRateMember" abstract="true" name="SecuredOvernightFinancingRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised" abstract="false" name="WarrantIssuedDuringPeriodValueStockOptionsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_EquityMethodInvestmentsContribution" abstract="false" name="EquityMethodInvestmentsContribution" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_SubordinatedLoanAgreementMember" abstract="true" name="SubordinatedLoanAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ameh_PayorCMember" abstract="true" name="PayorCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_PaymentsToEquityMethodInvestments" abstract="false" name="PaymentsToEquityMethodInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum" abstract="false" name="DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ameh_ShareholdersAndOfficersMember" abstract="true" name="ShareholdersAndOfficersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_CommitmentsAndContingenciesLineItems" abstract="true" name="CommitmentsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_ApcLsmaMember" abstract="true" name="ApcLsmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_OfficeLeaseMember" abstract="true" name="OfficeLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ameh_VOMGMember" abstract="true" name="VOMGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_SunnyVillageCareCenterMember" abstract="true" name="SunnyVillageCareCenterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" abstract="false" name="StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_ForYourBenefitIncMember" abstract="true" name="ForYourBenefitIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ameh_OneMSOLLCMember" abstract="true" name="OneMSOLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" abstract="false" name="IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_FinanceLeaseCostsAbstract" abstract="true" name="FinanceLeaseCostsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_EquityMethodInvestmentAdditionalInvestment" abstract="false" name="EquityMethodInvestmentAdditionalInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" abstract="false" name="InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_MedicareMember" abstract="true" name="MedicareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_PayorAMember" abstract="true" name="PayorAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_CommercialMember" abstract="true" name="CommercialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_AurionMember" abstract="true" name="AurionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" abstract="false" name="GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock" abstract="false" name="ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="ameh_APAMH2Member" abstract="true" name="APAMH2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" abstract="false" name="DebtInstrumentCovenantLeverageRatioAdjustedMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ameh_HSMSOMember" abstract="true" name="HSMSOMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_EquityMethodAndOtherEquityInvestmentsTextBlock" abstract="false" name="EquityMethodAndOtherEquityInvestmentsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="ameh_SubcontractorIPAPayable" abstract="false" name="SubcontractorIPAPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ameh_NetworkRelationshipsMember" abstract="true" name="NetworkRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember" abstract="true" name="OrmaHealthIncAndProviderGrowthSolutionsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_LeaseWeightedAverageDiscountRateAbstract" abstract="true" name="LeaseWeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ameh_CDSCMember" abstract="true" name="CDSCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ameh_AccountsReceivableAndNetRevenueTable" abstract="true" name="AccountsReceivableAndNetRevenueTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ameh_CommitmentsAndContingenciesTable" abstract="true" name="CommitmentsAndContingenciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ameh_NumberOfPrimaryCareProvider" abstract="false" name="NumberOfPrimaryCareProvider" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>ameh-20230630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:3040ecaa-d98f-42d5-9854-9c1a7ec98864,g:10a2b015-69d1-478c-967c-e01a9974c48a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ameh-20230630.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_89d8bd63-ca1c-4412-80a8-4007209082e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_4a419997-8696-44b2-bf63-ebf86c7e2d19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_89d8bd63-ca1c-4412-80a8-4007209082e6" xlink:to="loc_us-gaap_PreferredStockValue_4a419997-8696-44b2-bf63-ebf86c7e2d19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f33a6854-2018-4b1c-a4d6-91bfc7d5ef20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_89d8bd63-ca1c-4412-80a8-4007209082e6" xlink:to="loc_us-gaap_CommonStockValue_f33a6854-2018-4b1c-a4d6-91bfc7d5ef20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_8ff5d1f1-6666-45c4-9e74-928ecde3cb81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_89d8bd63-ca1c-4412-80a8-4007209082e6" xlink:to="loc_us-gaap_AdditionalPaidInCapital_8ff5d1f1-6666-45c4-9e74-928ecde3cb81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_39daa558-0411-45d2-baf3-e318b803c8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_89d8bd63-ca1c-4412-80a8-4007209082e6" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_39daa558-0411-45d2-baf3-e318b803c8b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e8e65b8b-0220-41d8-99d7-21bf71ad6204" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7705408f-9b58-4292-b6fa-31f1bb56e168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e8e65b8b-0220-41d8-99d7-21bf71ad6204" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7705408f-9b58-4292-b6fa-31f1bb56e168" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_95aead48-2ef9-46d3-946e-bdbc8a7eebc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e8e65b8b-0220-41d8-99d7-21bf71ad6204" xlink:to="loc_us-gaap_RestrictedCash_95aead48-2ef9-46d3-946e-bdbc8a7eebc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_d65d8e4e-6860-46e3-848c-764f631892a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e8e65b8b-0220-41d8-99d7-21bf71ad6204" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_d65d8e4e-6860-46e3-848c-764f631892a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b7897b9f-c355-49e0-a7f3-3ab65a4f15f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e8e65b8b-0220-41d8-99d7-21bf71ad6204" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b7897b9f-c355-49e0-a7f3-3ab65a4f15f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_585c9339-089f-4273-9234-fa7588fdb2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e8e65b8b-0220-41d8-99d7-21bf71ad6204" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_585c9339-089f-4273-9234-fa7588fdb2ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_27e3d4eb-f8c0-4df0-a68d-04239b70abd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e8e65b8b-0220-41d8-99d7-21bf71ad6204" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_27e3d4eb-f8c0-4df0-a68d-04239b70abd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_9b37c27f-8059-4fa8-80ca-a0ddc6d50bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e8e65b8b-0220-41d8-99d7-21bf71ad6204" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_9b37c27f-8059-4fa8-80ca-a0ddc6d50bcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_be5e96f4-2d99-4d19-b71f-bf83e63ba544" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_3185c8b7-c36e-4604-8f46-52b4abf14c88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_be5e96f4-2d99-4d19-b71f-bf83e63ba544" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_3185c8b7-c36e-4604-8f46-52b4abf14c88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d26402f5-d36f-4094-aef5-fe4c394a8822" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_be5e96f4-2d99-4d19-b71f-bf83e63ba544" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d26402f5-d36f-4094-aef5-fe4c394a8822" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0374ab01-b10f-458e-bbe2-3ec0ab2ebfeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_be5e96f4-2d99-4d19-b71f-bf83e63ba544" xlink:to="loc_us-gaap_Goodwill_0374ab01-b10f-458e-bbe2-3ec0ab2ebfeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_bfb68acf-bb41-4573-9db1-75d8500fbb01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_be5e96f4-2d99-4d19-b71f-bf83e63ba544" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_bfb68acf-bb41-4573-9db1-75d8500fbb01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_dae3cb5f-3ebd-4a1d-906b-83c0d981ae2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_be5e96f4-2d99-4d19-b71f-bf83e63ba544" xlink:to="loc_us-gaap_EquityMethodInvestments_dae3cb5f-3ebd-4a1d-906b-83c0d981ae2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_2d44b1bd-53f8-4ce9-975d-2cdb6ae09660" xlink:href="ameh-20230630.xsd#ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_be5e96f4-2d99-4d19-b71f-bf83e63ba544" xlink:to="loc_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_2d44b1bd-53f8-4ce9-975d-2cdb6ae09660" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_696b8008-8618-4854-b7d9-da34c8963bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_be5e96f4-2d99-4d19-b71f-bf83e63ba544" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_696b8008-8618-4854-b7d9-da34c8963bd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_733327f3-e16f-4402-96c1-2a520863c90b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_be5e96f4-2d99-4d19-b71f-bf83e63ba544" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_733327f3-e16f-4402-96c1-2a520863c90b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_57d48c51-eb6c-49dd-8575-e984b2894664" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f51a1905-adf4-43ef-869e-b70f2036c283" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_57d48c51-eb6c-49dd-8575-e984b2894664" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f51a1905-adf4-43ef-869e-b70f2036c283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_27a3ca28-b26a-4b61-b17c-9cfc2f6ece85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_57d48c51-eb6c-49dd-8575-e984b2894664" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_27a3ca28-b26a-4b61-b17c-9cfc2f6ece85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_02b5c32d-504e-458c-9c89-ea1f70a833d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_57d48c51-eb6c-49dd-8575-e984b2894664" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_02b5c32d-504e-458c-9c89-ea1f70a833d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2fe3c260-94ee-421a-b238-5f99f1276e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_57d48c51-eb6c-49dd-8575-e984b2894664" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2fe3c260-94ee-421a-b238-5f99f1276e3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_164c7bb8-ddf2-486c-a44f-a5ce2d7ca981" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_57d48c51-eb6c-49dd-8575-e984b2894664" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_164c7bb8-ddf2-486c-a44f-a5ce2d7ca981" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e73ab77b-9fb3-4081-8302-e7e9f746c007" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6de79a47-a011-431b-9d18-57f15836d091" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e73ab77b-9fb3-4081-8302-e7e9f746c007" xlink:to="loc_us-gaap_LiabilitiesCurrent_6de79a47-a011-431b-9d18-57f15836d091" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_3536a19b-2802-4635-93b6-51761662d7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e73ab77b-9fb3-4081-8302-e7e9f746c007" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_3536a19b-2802-4635-93b6-51761662d7dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4358e639-3d25-4601-8978-89763169641e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_9b30f744-0277-4dc8-b199-cdf0dac86256" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4358e639-3d25-4601-8978-89763169641e" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_9b30f744-0277-4dc8-b199-cdf0dac86256" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FiduciaryAccountsPayableCurrent_48498ca3-e6bd-4d21-8e00-968c1c56ed42" xlink:href="ameh-20230630.xsd#ameh_FiduciaryAccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4358e639-3d25-4601-8978-89763169641e" xlink:to="loc_ameh_FiduciaryAccountsPayableCurrent_48498ca3-e6bd-4d21-8e00-968c1c56ed42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_ca3a4ecd-7b43-45aa-9196-3be7188ab579" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4358e639-3d25-4601-8978-89763169641e" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_ca3a4ecd-7b43-45aa-9196-3be7188ab579" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_c39051cd-5d2a-4267-bb6d-959ce4e20ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4358e639-3d25-4601-8978-89763169641e" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_c39051cd-5d2a-4267-bb6d-959ce4e20ee8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_d2223770-60f7-478d-95f4-f22da23886a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4358e639-3d25-4601-8978-89763169641e" xlink:to="loc_us-gaap_DividendsPayableCurrent_d2223770-60f7-478d-95f4-f22da23886a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_c3d0a925-1ff0-4e31-999d-52c7597c716d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4358e639-3d25-4601-8978-89763169641e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_c3d0a925-1ff0-4e31-999d-52c7597c716d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_23b83827-2a15-4fc2-8847-6164d7f6b78e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4358e639-3d25-4601-8978-89763169641e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_23b83827-2a15-4fc2-8847-6164d7f6b78e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3c8f393a-4c73-436d-aa3c-744f5c793910" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4358e639-3d25-4601-8978-89763169641e" xlink:to="loc_us-gaap_LongTermDebtCurrent_3c8f393a-4c73-436d-aa3c-744f5c793910" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5accd0b3-037a-4bdb-ae59-f2ce2102da2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3f9e6312-d67e-4abb-b1d2-91e8467d7b40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5accd0b3-037a-4bdb-ae59-f2ce2102da2e" xlink:to="loc_us-gaap_Liabilities_3f9e6312-d67e-4abb-b1d2-91e8467d7b40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_07a26295-47e1-4e45-9f0b-ca50e3316028" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5accd0b3-037a-4bdb-ae59-f2ce2102da2e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_07a26295-47e1-4e45-9f0b-ca50e3316028" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_f282ae53-8b41-4cda-8846-da5c2bcbb0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5accd0b3-037a-4bdb-ae59-f2ce2102da2e" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_f282ae53-8b41-4cda-8846-da5c2bcbb0cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3564ec08-164f-42b9-8319-63e675cbc995" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5accd0b3-037a-4bdb-ae59-f2ce2102da2e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3564ec08-164f-42b9-8319-63e675cbc995" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a99501f0-da09-4b97-940a-0848eb9c47d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_35586a70-3429-4cec-97d0-108abd316bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a99501f0-da09-4b97-940a-0848eb9c47d1" xlink:to="loc_us-gaap_StockholdersEquity_35586a70-3429-4cec-97d0-108abd316bbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_cb73e4a7-b37c-4ff6-9450-85dd9453932f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a99501f0-da09-4b97-940a-0848eb9c47d1" xlink:to="loc_us-gaap_MinorityInterest_cb73e4a7-b37c-4ff6-9450-85dd9453932f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_60bc8408-c8a2-40a1-94de-4d575d185c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_96907e61-361c-4a3c-8df3-4a0119c59720" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_60bc8408-c8a2-40a1-94de-4d575d185c2e" xlink:to="loc_us-gaap_AssetsCurrent_96907e61-361c-4a3c-8df3-4a0119c59720" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_5683d7a0-80f9-4852-b6cf-248bbe73eae9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_60bc8408-c8a2-40a1-94de-4d575d185c2e" xlink:to="loc_us-gaap_AssetsNoncurrent_5683d7a0-80f9-4852-b6cf-248bbe73eae9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="ameh-20230630.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_be0c4483-8154-4669-a0f9-2c347049d7df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_086f76f0-40a3-4394-bbe9-4952af2816c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_be0c4483-8154-4669-a0f9-2c347049d7df" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_086f76f0-40a3-4394-bbe9-4952af2816c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_6ca66889-0d52-4dfe-ae98-776b0c03a914" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_be0c4483-8154-4669-a0f9-2c347049d7df" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_6ca66889-0d52-4dfe-ae98-776b0c03a914" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_b580c54b-fd74-45f5-94b5-2f2c15fa4399" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_be0c4483-8154-4669-a0f9-2c347049d7df" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_b580c54b-fd74-45f5-94b5-2f2c15fa4399" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_aa0054df-f147-46ca-8bca-a9d2d2136ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9be40ec4-abc2-465e-8665-990f3be13c22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_aa0054df-f147-46ca-8bca-a9d2d2136ae1" xlink:to="loc_us-gaap_ProfitLoss_9be40ec4-abc2-465e-8665-990f3be13c22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_56fcf1ad-dab8-487e-9f7d-992f6ed232c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_aa0054df-f147-46ca-8bca-a9d2d2136ae1" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_56fcf1ad-dab8-487e-9f7d-992f6ed232c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_51c27610-a53e-419c-add4-5e4bf28673fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_27081961-3eff-40b0-9bed-457011473380" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_51c27610-a53e-419c-add4-5e4bf28673fe" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_27081961-3eff-40b0-9bed-457011473380" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_c851848f-49f4-47c3-ae39-a9ffc11dde3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_51c27610-a53e-419c-add4-5e4bf28673fe" xlink:to="loc_us-gaap_CostsAndExpenses_c851848f-49f4-47c3-ae39-a9ffc11dde3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_dd70f6fb-295b-4bf2-9b40-93485a44b48e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_063b2c50-a282-4e42-abe0-6ed14c0cacfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_dd70f6fb-295b-4bf2-9b40-93485a44b48e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_063b2c50-a282-4e42-abe0-6ed14c0cacfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_847d9ca0-af1c-427d-89a0-700382ec0628" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_dd70f6fb-295b-4bf2-9b40-93485a44b48e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_847d9ca0-af1c-427d-89a0-700382ec0628" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c3cf4dc8-e7da-4060-a35c-4f607e5f3ada" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_052c2494-0111-408f-833a-26cefe9cd592" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c3cf4dc8-e7da-4060-a35c-4f607e5f3ada" xlink:to="loc_us-gaap_OperatingIncomeLoss_052c2494-0111-408f-833a-26cefe9cd592" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4dd1381e-458a-4b41-9be4-5dd961ff7325" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c3cf4dc8-e7da-4060-a35c-4f607e5f3ada" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_4dd1381e-458a-4b41-9be4-5dd961ff7325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_061afadf-5222-4eb1-aae1-fcdd36a0d364" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_163e3995-3b26-4eb9-a5d0-e2333e391d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_061afadf-5222-4eb1-aae1-fcdd36a0d364" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_163e3995-3b26-4eb9-a5d0-e2333e391d4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_489b776f-9fd5-4881-a425-03e70b19d37d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_061afadf-5222-4eb1-aae1-fcdd36a0d364" xlink:to="loc_us-gaap_InterestExpense_489b776f-9fd5-4881-a425-03e70b19d37d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_3e383c12-4bea-4a28-9ec0-09f8818202ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_061afadf-5222-4eb1-aae1-fcdd36a0d364" xlink:to="loc_us-gaap_InvestmentIncomeInterest_3e383c12-4bea-4a28-9ec0-09f8818202ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_e5a5a7c9-43e0-4e6f-aa00-d0bdf449dde7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_061afadf-5222-4eb1-aae1-fcdd36a0d364" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_e5a5a7c9-43e0-4e6f-aa00-d0bdf449dde7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9ad0ac21-afce-4795-b8fe-023ed0ed5fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_061afadf-5222-4eb1-aae1-fcdd36a0d364" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9ad0ac21-afce-4795-b8fe-023ed0ed5fa6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ameh-20230630.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e92491b8-6f7b-4efd-a272-12766c8a15cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1f932f33-8896-4821-9f31-671479c4af47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e92491b8-6f7b-4efd-a272-12766c8a15cc" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1f932f33-8896-4821-9f31-671479c4af47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_343caff8-9f52-43c1-8a91-597ab36eb5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e92491b8-6f7b-4efd-a272-12766c8a15cc" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_343caff8-9f52-43c1-8a91-597ab36eb5aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_9b8e35ea-4ffc-4950-ae7d-b1fd0169fcb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e92491b8-6f7b-4efd-a272-12766c8a15cc" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_9b8e35ea-4ffc-4950-ae7d-b1fd0169fcb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_bb36da29-6e6b-4eb9-9e25-50457149c8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e92491b8-6f7b-4efd-a272-12766c8a15cc" xlink:to="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_bb36da29-6e6b-4eb9-9e25-50457149c8e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_1f676284-d2d1-41fa-97d3-86a3b077fe0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e92491b8-6f7b-4efd-a272-12766c8a15cc" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_1f676284-d2d1-41fa-97d3-86a3b077fe0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_607f5463-735e-451e-b21e-a90f769ffe6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e92491b8-6f7b-4efd-a272-12766c8a15cc" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_607f5463-735e-451e-b21e-a90f769ffe6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_a6a25641-0bfe-45be-b192-46eacd425f69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e92491b8-6f7b-4efd-a272-12766c8a15cc" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_a6a25641-0bfe-45be-b192-46eacd425f69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_d09c85d1-c6ee-4c94-ab3a-2cd1192ee26a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e92491b8-6f7b-4efd-a272-12766c8a15cc" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_d09c85d1-c6ee-4c94-ab3a-2cd1192ee26a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PaymentsToEquityMethodInvestments_35bf4c74-476c-42f9-8a01-cc7d9fbd1460" xlink:href="ameh-20230630.xsd#ameh_PaymentsToEquityMethodInvestments"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e92491b8-6f7b-4efd-a272-12766c8a15cc" xlink:to="loc_ameh_PaymentsToEquityMethodInvestments_35bf4c74-476c-42f9-8a01-cc7d9fbd1460" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_74724038-3d27-444e-8b02-21a161722880" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d3c555dc-41c2-495e-830a-7545475216e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_74724038-3d27-444e-8b02-21a161722880" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d3c555dc-41c2-495e-830a-7545475216e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsCurrent_b769c951-36da-4e1e-8c22-0bad50e11349" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashEquivalentsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_74724038-3d27-444e-8b02-21a161722880" xlink:to="loc_us-gaap_RestrictedCashEquivalentsCurrent_b769c951-36da-4e1e-8c22-0bad50e11349" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9e252eb5-85aa-486b-97e2-c91df5b046ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_dd57f719-55d3-4e81-ac7d-0c088e773c85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9e252eb5-85aa-486b-97e2-c91df5b046ac" xlink:to="loc_us-gaap_PaymentsOfDividends_dd57f719-55d3-4e81-ac7d-0c088e773c85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2ba7082b-9fa4-4c40-9e60-97a861bd2021" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9e252eb5-85aa-486b-97e2-c91df5b046ac" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2ba7082b-9fa4-4c40-9e60-97a861bd2021" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_4da17967-47a4-4525-b580-a98d7d29f6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9e252eb5-85aa-486b-97e2-c91df5b046ac" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_4da17967-47a4-4525-b580-a98d7d29f6d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_dc3246bc-bade-40a3-814b-e5869b7c6a35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9e252eb5-85aa-486b-97e2-c91df5b046ac" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_dc3246bc-bade-40a3-814b-e5869b7c6a35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_07ac0e26-7eaa-43a8-a18f-8f6791ca0d90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9e252eb5-85aa-486b-97e2-c91df5b046ac" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_07ac0e26-7eaa-43a8-a18f-8f6791ca0d90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders_4608ce0a-a594-4802-a975-59142796d47f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9e252eb5-85aa-486b-97e2-c91df5b046ac" xlink:to="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders_4608ce0a-a594-4802-a975-59142796d47f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PurchaseOfNonControllingInterest_fc25e705-43fa-403d-83f1-fdf77e5f8d89" xlink:href="ameh-20230630.xsd#ameh_PurchaseOfNonControllingInterest"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9e252eb5-85aa-486b-97e2-c91df5b046ac" xlink:to="loc_ameh_PurchaseOfNonControllingInterest_fc25e705-43fa-403d-83f1-fdf77e5f8d89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_b652eb53-9dde-43f2-9c12-41c37c83942e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9e252eb5-85aa-486b-97e2-c91df5b046ac" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_b652eb53-9dde-43f2-9c12-41c37c83942e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0a799cff-c310-4d22-baca-d1787576ef1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d20ff21f-a70f-48f0-8225-714b5c3996a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0a799cff-c310-4d22-baca-d1787576ef1e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d20ff21f-a70f-48f0-8225-714b5c3996a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ea55959f-f19c-4280-95b6-abc56372a997" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0a799cff-c310-4d22-baca-d1787576ef1e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ea55959f-f19c-4280-95b6-abc56372a997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_794e9be2-9540-4ff5-a8e2-fbcbbb3631ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0a799cff-c310-4d22-baca-d1787576ef1e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_794e9be2-9540-4ff5-a8e2-fbcbbb3631ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1d233b9e-1284-40af-9e8c-ac9c0ae812d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_ProfitLoss_1d233b9e-1284-40af-9e8c-ac9c0ae812d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8b91be0a-04fb-41c1-bc0b-363443407e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8b91be0a-04fb-41c1-bc0b-363443407e6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_cfc474e0-f071-4b05-bf86-d2484504d8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_cfc474e0-f071-4b05-bf86-d2484504d8b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_30dbdc72-5455-4b68-b832-4ccfccc553b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_ShareBasedCompensation_30dbdc72-5455-4b68-b832-4ccfccc553b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_ad7b93c8-d745-472e-8a0e-3ec8e6e041b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_ad7b93c8-d745-472e-8a0e-3ec8e6e041b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_UnrealizedGainLossFromInvestmentInEquitySecurities_fcd18a81-28d1-4393-895a-9c0936d95d7c" xlink:href="ameh-20230630.xsd#ameh_UnrealizedGainLossFromInvestmentInEquitySecurities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_ameh_UnrealizedGainLossFromInvestmentInEquitySecurities_fcd18a81-28d1-4393-895a-9c0936d95d7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4f149bd4-b386-45ae-80d3-c5920497c1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4f149bd4-b386-45ae-80d3-c5920497c1c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_72c59487-d42d-43ad-b68c-6b8d67679e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_72c59487-d42d-43ad-b68c-6b8d67679e8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_f42ba5d8-761f-46a8-9346-0983edcb1620" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_f42ba5d8-761f-46a8-9346-0983edcb1620" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a1202846-d507-437a-86af-d540150f04a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a1202846-d507-437a-86af-d540150f04a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueFromRelatedParties_40b42a41-b9d8-489b-a266-0c6129f735b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_IncreaseDecreaseInDueFromRelatedParties_40b42a41-b9d8-489b-a266-0c6129f735b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_7c8550fb-0033-40dd-95fb-fa1ec6178d75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_7c8550fb-0033-40dd-95fb-fa1ec6178d75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_01559522-335b-4d1c-a731-03a2f194c835" xlink:href="ameh-20230630.xsd#ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_01559522-335b-4d1c-a731-03a2f194c835" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_IncreaseDecreaseInOperatingLeaseAssets_d696ca8b-774f-419e-a0a5-35a520b28aa0" xlink:href="ameh-20230630.xsd#ameh_IncreaseDecreaseInOperatingLeaseAssets"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_ameh_IncreaseDecreaseInOperatingLeaseAssets_d696ca8b-774f-419e-a0a5-35a520b28aa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_7e0cda0d-9138-4e30-863b-947d20234d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_7e0cda0d-9138-4e30-863b-947d20234d8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_da2a0b79-2e88-4b4b-867e-7d61c18bdd77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_da2a0b79-2e88-4b4b-867e-7d61c18bdd77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable_6b5200f7-b327-4f0e-80b5-47e4ef9d4137" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable_6b5200f7-b327-4f0e-80b5-47e4ef9d4137" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_IncreaseDecreaseInMedicalLiabilities_b788ab18-59cc-4f1d-a7df-7f564f5fc65a" xlink:href="ameh-20230630.xsd#ameh_IncreaseDecreaseInMedicalLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_ameh_IncreaseDecreaseInMedicalLiabilities_b788ab18-59cc-4f1d-a7df-7f564f5fc65a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_a988864b-8108-4a03-9bcc-0577ee0b52b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_a988864b-8108-4a03-9bcc-0577ee0b52b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_9708788d-33e4-4cdc-8174-4b063cf12b84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_9708788d-33e4-4cdc-8174-4b063cf12b84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_3f82fc99-ecfe-45f9-933b-3c2f6a3c10fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1413c15b-7589-450b-b62b-8239e1443ec0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_3f82fc99-ecfe-45f9-933b-3c2f6a3c10fc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_96ddb15e-0015-46c2-8ad2-31750d76ea59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_1025ead7-2709-4179-9884-cbc27e4e60b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss_96ddb15e-0015-46c2-8ad2-31750d76ea59" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_1025ead7-2709-4179-9884-cbc27e4e60b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_086a5d03-932b-404b-9956-ac58100b775b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss_96ddb15e-0015-46c2-8ad2-31750d76ea59" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_086a5d03-932b-404b-9956-ac58100b775b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2cb483e5-4ad9-4925-aa5a-c27e53683555" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0d72e267-dda1-4fd6-8a93-c8c7e5c19636" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_2cb483e5-4ad9-4925-aa5a-c27e53683555" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0d72e267-dda1-4fd6-8a93-c8c7e5c19636" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cf5fa9f0-24c4-4c99-b974-e6d97413f299" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_2cb483e5-4ad9-4925-aa5a-c27e53683555" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cf5fa9f0-24c4-4c99-b974-e6d97413f299" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_0400f374-6526-4dd6-95f9-1914315f3cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_2cb483e5-4ad9-4925-aa5a-c27e53683555" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_0400f374-6526-4dd6-95f9-1914315f3cc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_7c814e09-e3ff-4c6d-9ebd-b9c83a03f102" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_2cb483e5-4ad9-4925-aa5a-c27e53683555" xlink:to="loc_us-gaap_DerivativeAssets_7c814e09-e3ff-4c6d-9ebd-b9c83a03f102" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_93fcdf55-0cbf-4f1f-b04e-523ecdd5016c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c919f08a-504a-4275-9c94-1a6706902408" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_93fcdf55-0cbf-4f1f-b04e-523ecdd5016c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c919f08a-504a-4275-9c94-1a6706902408" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_0f939292-2d8f-4091-a1ed-9486d977b972" xlink:href="ameh-20230630.xsd#ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_93fcdf55-0cbf-4f1f-b04e-523ecdd5016c" xlink:to="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_0f939292-2d8f-4091-a1ed-9486d977b972" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#IntangibleAssetsNetScheduleofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0b1f80f0-21d4-48b0-a273-7da3c2bd891c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_dd5897b5-b34a-49be-ba3a-650adb7f5a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0b1f80f0-21d4-48b0-a273-7da3c2bd891c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_dd5897b5-b34a-49be-ba3a-650adb7f5a1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_07c273b7-2c24-47df-92a3-3b6020b19235" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0b1f80f0-21d4-48b0-a273-7da3c2bd891c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_07c273b7-2c24-47df-92a3-3b6020b19235" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_fb25fd87-e7e0-43e5-86f8-94e77f4328a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4db1ef81-b44f-4b99-8d5d-b429af301c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_fb25fd87-e7e0-43e5-86f8-94e77f4328a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4db1ef81-b44f-4b99-8d5d-b429af301c5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5c91c067-5c9b-4fc2-9b35-a52ad69cd772" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8ac3eaad-bebe-462c-956b-569f9445c3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5c91c067-5c9b-4fc2-9b35-a52ad69cd772" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8ac3eaad-bebe-462c-956b-569f9445c3dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f5581ab4-203d-4d20-bd56-7c752ab04425" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5c91c067-5c9b-4fc2-9b35-a52ad69cd772" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f5581ab4-203d-4d20-bd56-7c752ab04425" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="ameh-20230630.xsd#IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5c630eba-ec1c-4e8f-ad91-9ae30e05f287" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4d6ff757-f1a4-4385-beee-39f29e9ae7da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5c630eba-ec1c-4e8f-ad91-9ae30e05f287" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4d6ff757-f1a4-4385-beee-39f29e9ae7da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ab1fcdf2-9b98-416d-95fa-0aba965bf317" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5c630eba-ec1c-4e8f-ad91-9ae30e05f287" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ab1fcdf2-9b98-416d-95fa-0aba965bf317" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d9c6348c-5645-4632-a0c7-5b05be162a11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_fadd6234-9e5e-46d1-9699-749d5600bc20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d9c6348c-5645-4632-a0c7-5b05be162a11" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_fadd6234-9e5e-46d1-9699-749d5600bc20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_63fe2754-75fb-4d2b-9b20-f392883b81ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d9c6348c-5645-4632-a0c7-5b05be162a11" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_63fe2754-75fb-4d2b-9b20-f392883b81ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_12510604-c60f-44bf-aa4f-2ae593fb21e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d9c6348c-5645-4632-a0c7-5b05be162a11" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_12510604-c60f-44bf-aa4f-2ae593fb21e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0e15fec8-aacd-4516-8927-70b5ee1fc479" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d9c6348c-5645-4632-a0c7-5b05be162a11" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0e15fec8-aacd-4516-8927-70b5ee1fc479" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d766c2f7-35a1-4f69-9fad-eda7cc3d697e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d9c6348c-5645-4632-a0c7-5b05be162a11" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d766c2f7-35a1-4f69-9fad-eda7cc3d697e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_34994720-e640-4507-a1c5-02c32fe5c264" xlink:href="ameh-20230630.xsd#ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d9c6348c-5645-4632-a0c7-5b05be162a11" xlink:to="loc_ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_34994720-e640-4507-a1c5-02c32fe5c264" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#AccountsPayableandAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_b050af98-1310-41db-9582-0b0f34b977ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_93422754-7b79-43d2-af54-55aaefa2a33a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_b050af98-1310-41db-9582-0b0f34b977ef" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_93422754-7b79-43d2-af54-55aaefa2a33a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SpecialtyCapitationPayableCurrent_a45e8dad-5459-459c-b02c-3a9438ac1bc2" xlink:href="ameh-20230630.xsd#ameh_SpecialtyCapitationPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_b050af98-1310-41db-9582-0b0f34b977ef" xlink:to="loc_ameh_SpecialtyCapitationPayableCurrent_a45e8dad-5459-459c-b02c-3a9438ac1bc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SubcontractorIPAPayable_f2e91979-50dc-42c5-8737-1c706999caf8" xlink:href="ameh-20230630.xsd#ameh_SubcontractorIPAPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_b050af98-1310-41db-9582-0b0f34b977ef" xlink:to="loc_ameh_SubcontractorIPAPayable_f2e91979-50dc-42c5-8737-1c706999caf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_cfe73326-3ccc-429e-9bf0-65d52616b968" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_b050af98-1310-41db-9582-0b0f34b977ef" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_cfe73326-3ccc-429e-9bf0-65d52616b968" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_005fe7b9-3c27-4285-be01-fcc0fcee5aad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_b050af98-1310-41db-9582-0b0f34b977ef" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_005fe7b9-3c27-4285-be01-fcc0fcee5aad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_62b850ce-f813-4833-83bc-c5f21f567080" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_b050af98-1310-41db-9582-0b0f34b977ef" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_62b850ce-f813-4833-83bc-c5f21f567080" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_bc811299-4c11-4b41-828f-602695ae1f42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_b050af98-1310-41db-9582-0b0f34b977ef" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_bc811299-4c11-4b41-828f-602695ae1f42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2c49bd7e-3a74-489f-89c8-754236cd7bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_b050af98-1310-41db-9582-0b0f34b977ef" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2c49bd7e-3a74-489f-89c8-754236cd7bdb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/MedicalLiabilitiesDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#MedicalLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/MedicalLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_d5affa36-93ea-480b-a8a7-02c94232b848" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_a9bdfa25-4bd9-4ab2-bf0b-6ac2cb8a75a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_d5affa36-93ea-480b-a8a7-02c94232b848" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_a9bdfa25-4bd9-4ab2-bf0b-6ac2cb8a75a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_68dc3279-63d3-4dec-a707-b7fa082afc72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_d5affa36-93ea-480b-a8a7-02c94232b848" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_68dc3279-63d3-4dec-a707-b7fa082afc72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_b7c291c0-2aba-4b9f-82c7-d6875a211c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_27c21ee7-3855-437e-b5a2-d453be20e81d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_b7c291c0-2aba-4b9f-82c7-d6875a211c3c" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_27c21ee7-3855-437e-b5a2-d453be20e81d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_183907df-33c1-4999-af08-15313162f0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_b7c291c0-2aba-4b9f-82c7-d6875a211c3c" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_183907df-33c1-4999-af08-15313162f0f2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_bf9377a5-c7c1-400b-b6c2-933a612cdf95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_67d5747e-f6b1-4b68-993c-ea9988e8abca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCredit_bf9377a5-c7c1-400b-b6c2-933a612cdf95" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_67d5747e-f6b1-4b68-993c-ea9988e8abca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2be97dd9-bce1-4e23-aa1b-4f943c1826a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCredit_bf9377a5-c7c1-400b-b6c2-933a612cdf95" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2be97dd9-bce1-4e23-aa1b-4f943c1826a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_61e14537-d2b9-4eec-ab40-ddf9c5eb87e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCredit_bf9377a5-c7c1-400b-b6c2-933a612cdf95" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_61e14537-d2b9-4eec-ab40-ddf9c5eb87e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_7953cae4-e561-42b5-9425-81a29120e940" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCredit_bf9377a5-c7c1-400b-b6c2-933a612cdf95" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_7953cae4-e561-42b5-9425-81a29120e940" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_ef088ba4-b5ba-4526-b4c9-66c3adca9c39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCredit_bf9377a5-c7c1-400b-b6c2-933a612cdf95" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_ef088ba4-b5ba-4526-b4c9-66c3adca9c39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LongTermDebtMaturityAfterYearFour_7f2fb435-3d62-4c7f-ac8e-dda87e0f5d25" xlink:href="ameh-20230630.xsd#ameh_LongTermDebtMaturityAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCredit_bf9377a5-c7c1-400b-b6c2-933a612cdf95" xlink:to="loc_ameh_LongTermDebtMaturityAfterYearFour_7f2fb435-3d62-4c7f-ac8e-dda87e0f5d25" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6450f85-d5f1-409d-b51c-8a69a18c69d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e4c886f2-9424-43a9-baab-279d611a8433" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6450f85-d5f1-409d-b51c-8a69a18c69d9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e4c886f2-9424-43a9-baab-279d611a8433" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_1ff2723b-41cf-4502-9da8-c6fecf420cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6450f85-d5f1-409d-b51c-8a69a18c69d9" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_1ff2723b-41cf-4502-9da8-c6fecf420cc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_64cf8c7f-1c66-475d-af4a-20ff318b30b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6450f85-d5f1-409d-b51c-8a69a18c69d9" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_64cf8c7f-1c66-475d-af4a-20ff318b30b3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#VariableInterestEntitiesVIEsDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_b7047d76-220a-409f-8abd-becec3790383" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_764559c9-4a7c-4a77-b7e3-880d698bcbf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_b7047d76-220a-409f-8abd-becec3790383" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_764559c9-4a7c-4a77-b7e3-880d698bcbf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0c90def1-753c-4310-8339-29a4b0c92464" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_b7047d76-220a-409f-8abd-becec3790383" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0c90def1-753c-4310-8339-29a4b0c92464" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c0c7961a-6249-4eb4-8858-b1079546cdf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_b7047d76-220a-409f-8abd-becec3790383" xlink:to="loc_us-gaap_Goodwill_c0c7961a-6249-4eb4-8858-b1079546cdf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_bffb891e-5047-495c-adba-deb2303feedb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_b7047d76-220a-409f-8abd-becec3790383" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_bffb891e-5047-495c-adba-deb2303feedb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_d8cdaa7a-2683-466a-894c-c40701f9fd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_b7047d76-220a-409f-8abd-becec3790383" xlink:to="loc_us-gaap_OtherLongTermInvestments_d8cdaa7a-2683-466a-894c-c40701f9fd5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ad538263-419a-4162-9d71-f4d689523318" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_b7047d76-220a-409f-8abd-becec3790383" xlink:to="loc_us-gaap_EquityMethodInvestments_ad538263-419a-4162-9d71-f4d689523318" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_eb7c8cd2-4c84-486a-bb9a-abd897af8084" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_b7047d76-220a-409f-8abd-becec3790383" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_eb7c8cd2-4c84-486a-bb9a-abd897af8084" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e55f0834-d02f-4289-bff7-1de4376c8694" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_b7047d76-220a-409f-8abd-becec3790383" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e55f0834-d02f-4289-bff7-1de4376c8694" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8051896e-4ac1-426d-a209-3ae7f9816b00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_b7047d76-220a-409f-8abd-becec3790383" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8051896e-4ac1-426d-a209-3ae7f9816b00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3ad323d4-084b-429c-99c8-25a09debfdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e9003906-572c-4b6b-9651-1ee7feed229e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3ad323d4-084b-429c-99c8-25a09debfdd5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e9003906-572c-4b6b-9651-1ee7feed229e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_e62b7ac9-dfcf-4c05-a84f-6c24910b49db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3ad323d4-084b-429c-99c8-25a09debfdd5" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_e62b7ac9-dfcf-4c05-a84f-6c24910b49db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_df4b1e12-3e44-4ace-81c1-ec33c3d4c0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3ad323d4-084b-429c-99c8-25a09debfdd5" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_df4b1e12-3e44-4ace-81c1-ec33c3d4c0a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_5d2fed13-1900-4397-a808-ebe80371cdc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3ad323d4-084b-429c-99c8-25a09debfdd5" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_5d2fed13-1900-4397-a808-ebe80371cdc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d1063e98-5c8c-43d4-b5e8-f6b0d14a6ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3ad323d4-084b-429c-99c8-25a09debfdd5" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d1063e98-5c8c-43d4-b5e8-f6b0d14a6ab3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_02e4bb22-b9af-4c87-b368-9079196e129d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3ad323d4-084b-429c-99c8-25a09debfdd5" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_02e4bb22-b9af-4c87-b368-9079196e129d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_af2a33a7-7f9e-4cde-81f5-832b0d4e76b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3ad323d4-084b-429c-99c8-25a09debfdd5" xlink:to="loc_us-gaap_OtherAssetsCurrent_af2a33a7-7f9e-4cde-81f5-832b0d4e76b6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#LeasesScheduleofComponentsofLeaseExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_c5a7784f-7884-435a-8ae9-288261074718" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_6f724535-186a-4d2a-a7ac-6a988fe26fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_c5a7784f-7884-435a-8ae9-288261074718" xlink:to="loc_us-gaap_OperatingLeaseCost_6f724535-186a-4d2a-a7ac-6a988fe26fa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_ae2e89e6-f86f-4951-a29f-dd8b03546ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_c5a7784f-7884-435a-8ae9-288261074718" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_ae2e89e6-f86f-4951-a29f-dd8b03546ba4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_9450882d-8ff0-4cb8-aab2-1b47582023bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_c5a7784f-7884-435a-8ae9-288261074718" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_9450882d-8ff0-4cb8-aab2-1b47582023bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_48175468-a116-4be1-beae-448c47e44ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_c5a7784f-7884-435a-8ae9-288261074718" xlink:to="loc_us-gaap_SubleaseIncome_48175468-a116-4be1-beae-448c47e44ea7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ff36901c-57c3-45eb-9bea-1231600cf5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1aed79ae-0a67-438e-ad1a-2e620491727e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ff36901c-57c3-45eb-9bea-1231600cf5a2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1aed79ae-0a67-438e-ad1a-2e620491727e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a12648e1-b4f8-4212-ac53-6a8ce16838cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ff36901c-57c3-45eb-9bea-1231600cf5a2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a12648e1-b4f8-4212-ac53-6a8ce16838cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a15aa252-4eb1-466e-9781-1b02601e07a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ff36901c-57c3-45eb-9bea-1231600cf5a2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a15aa252-4eb1-466e-9781-1b02601e07a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_826b06e6-4469-446b-ae6a-6336c6f4f3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ff36901c-57c3-45eb-9bea-1231600cf5a2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_826b06e6-4469-446b-ae6a-6336c6f4f3e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_500187ac-b3c4-434c-a2be-b5e15b9e51f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ff36901c-57c3-45eb-9bea-1231600cf5a2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_500187ac-b3c4-434c-a2be-b5e15b9e51f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_2eceddbc-ed05-4fe1-99d9-947d4dd8872b" xlink:href="ameh-20230630.xsd#ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ff36901c-57c3-45eb-9bea-1231600cf5a2" xlink:to="loc_ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_2eceddbc-ed05-4fe1-99d9-947d4dd8872b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_8597fc65-4be2-406b-b79e-66665271480f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_9d7cc822-b34c-4510-904d-0d9681425c23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_8597fc65-4be2-406b-b79e-66665271480f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_9d7cc822-b34c-4510-904d-0d9681425c23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_f332ecb8-4c22-4b60-95dc-bd690cbfc610" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_8597fc65-4be2-406b-b79e-66665271480f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_f332ecb8-4c22-4b60-95dc-bd690cbfc610" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_56cbc519-d483-4413-9cdf-58d3e3f9772d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_77f9f945-27ad-4c3d-a138-0142a3138160" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_56cbc519-d483-4413-9cdf-58d3e3f9772d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_77f9f945-27ad-4c3d-a138-0142a3138160" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_a1c3f1a4-8e6f-48a7-851b-caa4c3259ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_56cbc519-d483-4413-9cdf-58d3e3f9772d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_a1c3f1a4-8e6f-48a7-851b-caa4c3259ca7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_1050d99b-a3a3-44dd-b537-63c3732fc98e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_56cbc519-d483-4413-9cdf-58d3e3f9772d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_1050d99b-a3a3-44dd-b537-63c3732fc98e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_3bc088d9-46e6-4918-bfb8-db4170109ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_56cbc519-d483-4413-9cdf-58d3e3f9772d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_3bc088d9-46e6-4918-bfb8-db4170109ca7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_f12736bf-bd21-4fc5-a431-e7d2b99701fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_56cbc519-d483-4413-9cdf-58d3e3f9772d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_f12736bf-bd21-4fc5-a431-e7d2b99701fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FinanceLeaseLiabilityToBePaidAfterYearFour_09088341-af30-4d85-9574-75e3cca8ed2e" xlink:href="ameh-20230630.xsd#ameh_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_56cbc519-d483-4413-9cdf-58d3e3f9772d" xlink:to="loc_ameh_FinanceLeaseLiabilityToBePaidAfterYearFour_09088341-af30-4d85-9574-75e3cca8ed2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a0d4d5e0-5e2e-41e4-850a-4c8266b896f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_44b3c93c-634c-41c1-ab70-526785cf4a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a0d4d5e0-5e2e-41e4-850a-4c8266b896f5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_44b3c93c-634c-41c1-ab70-526785cf4a4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cf52b9ef-fc8f-4bc8-94b1-de38113d91b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a0d4d5e0-5e2e-41e4-850a-4c8266b896f5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cf52b9ef-fc8f-4bc8-94b1-de38113d91b6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1" xlink:type="simple" xlink:href="ameh-20230630.xsd#LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_cc6ff7a1-4881-41a8-898c-aecd02c6fca8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f7b6cd4e-7127-4a24-8e81-69cda59b0149" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_cc6ff7a1-4881-41a8-898c-aecd02c6fca8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f7b6cd4e-7127-4a24-8e81-69cda59b0149" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_b0abd83c-2bf1-46df-8053-4e6e28d44842" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_cc6ff7a1-4881-41a8-898c-aecd02c6fca8" xlink:to="loc_us-gaap_FinanceLeaseLiability_b0abd83c-2bf1-46df-8053-4e6e28d44842" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d653ca3-834a-40b3-84fa-6cedca09a02d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1bdcce38-ccd5-4245-82e3-149f233cd1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d653ca3-834a-40b3-84fa-6cedca09a02d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1bdcce38-ccd5-4245-82e3-149f233cd1f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_84fb4fb2-fb51-492b-b523-e05ccbbe8e29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d653ca3-834a-40b3-84fa-6cedca09a02d" xlink:to="loc_us-gaap_OperatingLeaseLiability_84fb4fb2-fb51-492b-b523-e05ccbbe8e29" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>ameh-20230630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:3040ecaa-d98f-42d5-9854-9c1a7ec98864,g:10a2b015-69d1-478c-967c-e01a9974c48a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ameh-20230630.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="i2778008da4f04683b3786552026c2384_CONSOLIDATEDBALANCESHEETS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ea900206-6851-46b4-ba9b-596e0a6344ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_a7b665da-9604-4045-9f21-dedf19c1e3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ea900206-6851-46b4-ba9b-596e0a6344ca" xlink:to="loc_us-gaap_AssetsAbstract_a7b665da-9604-4045-9f21-dedf19c1e3a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_a7b665da-9604-4045-9f21-dedf19c1e3a5" xlink:to="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_784c146d-2c34-4006-b0eb-0b0095910700" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_784c146d-2c34-4006-b0eb-0b0095910700" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_587cc27a-a522-4095-bc62-a595fcf3686d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_RestrictedCash_587cc27a-a522-4095-bc62-a595fcf3686d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_85c00dab-9d7e-437b-8f27-c85a9a079fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_85c00dab-9d7e-437b-8f27-c85a9a079fc9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d7d519fa-8adb-4fdf-b7fb-a692a6217cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d7d519fa-8adb-4fdf-b7fb-a692a6217cb7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_28c9a1da-235d-4923-bf8a-5faf34a7fc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_28c9a1da-235d-4923-bf8a-5faf34a7fc7a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_50df45bd-4a12-409a-9e46-efc55096f900" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_50df45bd-4a12-409a-9e46-efc55096f900" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_b6366124-b3e9-4719-9190-5d602ff96240" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_b6366124-b3e9-4719-9190-5d602ff96240" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3ec58feb-86fb-4d07-9780-07c7b660ddbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_AssetsCurrent_3ec58feb-86fb-4d07-9780-07c7b660ddbf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_a7b665da-9604-4045-9f21-dedf19c1e3a5" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7b460599-bf39-4dcb-b149-76a0bbcff32e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7b460599-bf39-4dcb-b149-76a0bbcff32e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c5a9a5b4-e199-4f26-bf32-53b338dd9a10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c5a9a5b4-e199-4f26-bf32-53b338dd9a10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dc7a8846-f63b-4990-97ad-4f508271dc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_Goodwill_dc7a8846-f63b-4990-97ad-4f508271dc5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_9a3d5bc2-12c9-43ec-ae3f-afee2e754b23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_9a3d5bc2-12c9-43ec-ae3f-afee2e754b23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_48ddf905-be0e-4664-beca-4147f0da28fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_EquityMethodInvestments_48ddf905-be0e-4664-beca-4147f0da28fb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_3d23ab42-520a-4055-9c58-b80c2e4c41af" xlink:href="ameh-20230630.xsd#ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_3d23ab42-520a-4055-9c58-b80c2e4c41af" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c5664100-7f45-4e0a-acb4-54b5afc5ee12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c5664100-7f45-4e0a-acb4-54b5afc5ee12" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1e337d9d-bee0-4d47-bfdf-b208305e98eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1e337d9d-bee0-4d47-bfdf-b208305e98eb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_c8ca53d7-2658-4732-8815-82cee9c312db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_AssetsNoncurrent_c8ca53d7-2658-4732-8815-82cee9c312db" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_741f2e45-1dd0-4925-b95d-b9247d26e443" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_a7b665da-9604-4045-9f21-dedf19c1e3a5" xlink:to="loc_us-gaap_Assets_741f2e45-1dd0-4925-b95d-b9247d26e443" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ea900206-6851-46b4-ba9b-596e0a6344ca" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_beaf98b5-9910-45c2-98a3-6244c038ce02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_beaf98b5-9910-45c2-98a3-6244c038ce02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FiduciaryAccountsPayableCurrent_34c6c7aa-9abd-486d-97e3-afd900845e63" xlink:href="ameh-20230630.xsd#ameh_FiduciaryAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_ameh_FiduciaryAccountsPayableCurrent_34c6c7aa-9abd-486d-97e3-afd900845e63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_f7011aec-ea6a-43eb-967e-6a6f4cbeb0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_f7011aec-ea6a-43eb-967e-6a6f4cbeb0ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_c71f6aa3-deaf-47f0-94a7-347996876cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_c71f6aa3-deaf-47f0-94a7-347996876cb9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_2674baf2-33e3-4e05-9eb8-cd731afd367c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_DividendsPayableCurrent_2674baf2-33e3-4e05-9eb8-cd731afd367c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_a81ab4ce-2b41-4c93-b8b7-a3568ce25581" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_a81ab4ce-2b41-4c93-b8b7-a3568ce25581" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_37b1f7cd-58f4-45af-b696-6230c0cf803a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_37b1f7cd-58f4-45af-b696-6230c0cf803a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_5b00e9eb-470f-40bb-bb4c-0ebe11a91713" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_LongTermDebtCurrent_5b00e9eb-470f-40bb-bb4c-0ebe11a91713" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_389562ab-8591-4bfa-ae4f-5e8373c9b86c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_LiabilitiesCurrent_389562ab-8591-4bfa-ae4f-5e8373c9b86c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_12d33c58-546c-444f-bf69-c08d7cc8c03f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_12d33c58-546c-444f-bf69-c08d7cc8c03f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_528b8823-4e71-4969-9902-e71f87b475d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_528b8823-4e71-4969-9902-e71f87b475d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e8e746d6-405d-4139-8bfc-6a55bc49e0ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e8e746d6-405d-4139-8bfc-6a55bc49e0ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c1be59f1-b7f6-44e1-a8bb-abbb214054ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c1be59f1-b7f6-44e1-a8bb-abbb214054ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b515949a-c3c4-4b65-98fe-90e3dd7eeb47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b515949a-c3c4-4b65-98fe-90e3dd7eeb47" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_7f56ebec-f1e6-438d-8b20-9bcf541df0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_7f56ebec-f1e6-438d-8b20-9bcf541df0ad" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_91c1df4f-75b7-4e46-a8ce-73f14eb035c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:to="loc_us-gaap_Liabilities_91c1df4f-75b7-4e46-a8ce-73f14eb035c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a5e7cecc-d496-45b9-90cb-6cc12bbbac85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a5e7cecc-d496-45b9-90cb-6cc12bbbac85" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MezzanineEquityAbstract_d24c23d3-bb83-43e8-8ec5-291ec1a16f33" xlink:href="ameh-20230630.xsd#ameh_MezzanineEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:to="loc_ameh_MezzanineEquityAbstract_d24c23d3-bb83-43e8-8ec5-291ec1a16f33" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_b9e79dde-6def-47d3-b88e-b87ee7fff0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_MezzanineEquityAbstract_d24c23d3-bb83-43e8-8ec5-291ec1a16f33" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_b9e79dde-6def-47d3-b88e-b87ee7fff0ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_e6986bc8-db20-4dc1-bb54-0e40d0acc775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:to="loc_us-gaap_PreferredStockValue_e6986bc8-db20-4dc1-bb54-0e40d0acc775" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_85db6eb3-ed89-4c11-9d29-99ad343dd998" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:to="loc_us-gaap_CommonStockValue_85db6eb3-ed89-4c11-9d29-99ad343dd998" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_25481962-deca-4777-a672-9a8b89a4ffca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:to="loc_us-gaap_AdditionalPaidInCapital_25481962-deca-4777-a672-9a8b89a4ffca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ae6e235d-2f8f-4910-8048-f4efd4c6f3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ae6e235d-2f8f-4910-8048-f4efd4c6f3c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_762cf318-c2ff-4729-981e-29023091f5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:to="loc_us-gaap_StockholdersEquity_762cf318-c2ff-4729-981e-29023091f5f5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_39177d80-ca20-4cde-8c1c-6fce54b15bec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:to="loc_us-gaap_MinorityInterest_39177d80-ca20-4cde-8c1c-6fce54b15bec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0fedcfac-81fd-49a3-9c3a-aceeba896eea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0fedcfac-81fd-49a3-9c3a-aceeba896eea" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a3c6cc28-4570-49a3-93de-7dd36d88499c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_a3c6cc28-4570-49a3-93de-7dd36d88499c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_fd1de983-9958-4cc6-89d1-9ca19385f259" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ea900206-6851-46b4-ba9b-596e0a6344ca" xlink:to="loc_us-gaap_StatementTable_fd1de983-9958-4cc6-89d1-9ca19385f259" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_160d4703-a620-4be9-b184-553a1ea24258" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_fd1de983-9958-4cc6-89d1-9ca19385f259" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_160d4703-a620-4be9-b184-553a1ea24258" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_160d4703-a620-4be9-b184-553a1ea24258_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_160d4703-a620-4be9-b184-553a1ea24258" xlink:to="loc_us-gaap_RelatedPartyDomain_160d4703-a620-4be9-b184-553a1ea24258_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_fec576b6-57bb-4dc1-ada7-63db8556919a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_160d4703-a620-4be9-b184-553a1ea24258" xlink:to="loc_us-gaap_RelatedPartyDomain_fec576b6-57bb-4dc1-ada7-63db8556919a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember_31ca593d-feff-47ab-a0ed-5b277b092422" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_fec576b6-57bb-4dc1-ada7-63db8556919a" xlink:to="loc_us-gaap_NonrelatedPartyMember_31ca593d-feff-47ab-a0ed-5b277b092422" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_50684a26-76b0-46a5-b22c-0dd21af01bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_fec576b6-57bb-4dc1-ada7-63db8556919a" xlink:to="loc_us-gaap_RelatedPartyMember_50684a26-76b0-46a5-b22c-0dd21af01bb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4ecf2e95-afad-4fc6-9ba6-65cd0903ebc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_fd1de983-9958-4cc6-89d1-9ca19385f259" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4ecf2e95-afad-4fc6-9ba6-65cd0903ebc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4ecf2e95-afad-4fc6-9ba6-65cd0903ebc0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4ecf2e95-afad-4fc6-9ba6-65cd0903ebc0" xlink:to="loc_us-gaap_ClassOfStockDomain_4ecf2e95-afad-4fc6-9ba6-65cd0903ebc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_be72b786-5ecb-4f8c-a09c-1e333a4427bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4ecf2e95-afad-4fc6-9ba6-65cd0903ebc0" xlink:to="loc_us-gaap_ClassOfStockDomain_be72b786-5ecb-4f8c-a09c-1e333a4427bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_ce2a1f3b-dcb1-413d-8a29-dc1110773a42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_be72b786-5ecb-4f8c-a09c-1e333a4427bf" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_ce2a1f3b-dcb1-413d-8a29-dc1110773a42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_3c753739-f56f-42bb-b5e9-60e9883386fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_be72b786-5ecb-4f8c-a09c-1e333a4427bf" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_3c753739-f56f-42bb-b5e9-60e9883386fd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="ameh-20230630.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="i4d57180dfff64367ba30a90d8a1d3b2f_CONSOLIDATEDBALANCESHEETSParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a9baac67-d741-4745-a2e3-7739ab996774" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a9baac67-d741-4745-a2e3-7739ab996774" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_505709b4-a92a-4222-b71d-92ef994a6f30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_505709b4-a92a-4222-b71d-92ef994a6f30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4337b261-1006-4258-aae8-781d8ca8a422" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4337b261-1006-4258-aae8-781d8ca8a422" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_6bb0c491-272c-40dc-8c3b-3af55124accb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_6bb0c491-272c-40dc-8c3b-3af55124accb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5d9a778a-f2d8-4abe-8687-1407fed58257" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5d9a778a-f2d8-4abe-8687-1407fed58257" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_434ec6df-56e1-4d9c-af9a-75ea7584a158" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_434ec6df-56e1-4d9c-af9a-75ea7584a158" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b42b30fb-3afc-45f6-aabf-bcc8759deb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_CommonStockSharesIssued_b42b30fb-3afc-45f6-aabf-bcc8759deb1c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_05e66b3c-3097-4608-a7be-78c2cf95e3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_05e66b3c-3097-4608-a7be-78c2cf95e3ee" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_1236b8d3-e57d-47b9-bc83-499e2879701d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_TreasuryStockCommonShares_1236b8d3-e57d-47b9-bc83-499e2879701d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5636a97c-6663-4692-a788-5a8fbfb1ffc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_Assets_5636a97c-6663-4692-a788-5a8fbfb1ffc6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_50f77b6f-fdba-4be5-84bc-ac21e1c0c345" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_Liabilities_50f77b6f-fdba-4be5-84bc-ac21e1c0c345" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_15433970-7686-4cdb-8885-ca67bfa4d83d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_15433970-7686-4cdb-8885-ca67bfa4d83d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_3968fce1-9e4c-4926-b1d0-11df3b30da59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_OtherLiabilities_3968fce1-9e4c-4926-b1d0-11df3b30da59" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_5905a9f5-ebaa-4e20-bdfe-95efab8444a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_OtherReceivables_5905a9f5-ebaa-4e20-bdfe-95efab8444a6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5606f1c1-20a9-467b-bc7a-d7384dcf09ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_StatementTable_5606f1c1-20a9-467b-bc7a-d7384dcf09ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2acd98b6-dca8-4323-954f-f51615840153" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5606f1c1-20a9-467b-bc7a-d7384dcf09ec" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2acd98b6-dca8-4323-954f-f51615840153" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2acd98b6-dca8-4323-954f-f51615840153_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2acd98b6-dca8-4323-954f-f51615840153" xlink:to="loc_us-gaap_ClassOfStockDomain_2acd98b6-dca8-4323-954f-f51615840153_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_156da92d-33b7-466c-b8cb-9cff55e96987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2acd98b6-dca8-4323-954f-f51615840153" xlink:to="loc_us-gaap_ClassOfStockDomain_156da92d-33b7-466c-b8cb-9cff55e96987" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_d434cef5-ff1f-4008-b2ff-07d201d3ef68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_156da92d-33b7-466c-b8cb-9cff55e96987" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_d434cef5-ff1f-4008-b2ff-07d201d3ef68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_a8f89bfc-c6a5-45ed-8635-878b5ebf54dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_156da92d-33b7-466c-b8cb-9cff55e96987" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_a8f89bfc-c6a5-45ed-8635-878b5ebf54dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_ec32831a-86f1-4f2a-bed0-16355b09bfbe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5606f1c1-20a9-467b-bc7a-d7384dcf09ec" xlink:to="loc_srt_ConsolidatedEntitiesAxis_ec32831a-86f1-4f2a-bed0-16355b09bfbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ec32831a-86f1-4f2a-bed0-16355b09bfbe_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ec32831a-86f1-4f2a-bed0-16355b09bfbe" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ec32831a-86f1-4f2a-bed0-16355b09bfbe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e41fa349-ce42-408c-b774-d5e3614a863c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ec32831a-86f1-4f2a-bed0-16355b09bfbe" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e41fa349-ce42-408c-b774-d5e3614a863c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_7f269a2b-fc17-43e2-9adf-b92151e3fd14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e41fa349-ce42-408c-b774-d5e3614a863c" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_7f269a2b-fc17-43e2-9adf-b92151e3fd14" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="ameh-20230630.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended" id="i41797459cee345f38b070a81ac0d8489_CONSOLIDATEDSTATEMENTSOFINCOME">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_f5e563e0-deb3-41cd-ae82-98ee699fd1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_RevenuesAbstract_f5e563e0-deb3-41cd-ae82-98ee699fd1cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6ac974e4-cc83-466d-81ae-4445c14b5d45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_f5e563e0-deb3-41cd-ae82-98ee699fd1cb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6ac974e4-cc83-466d-81ae-4445c14b5d45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_7c95ef26-f32f-4f94-b5de-3e3e1db111a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_OperatingExpensesAbstract_7c95ef26-f32f-4f94-b5de-3e3e1db111a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_38ecc062-cfd8-4eec-9d66-94c4673c63fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c95ef26-f32f-4f94-b5de-3e3e1db111a3" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_38ecc062-cfd8-4eec-9d66-94c4673c63fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_09c7430b-13a3-4ec1-ba98-6d9157de0785" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c95ef26-f32f-4f94-b5de-3e3e1db111a3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_09c7430b-13a3-4ec1-ba98-6d9157de0785" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_da919e2c-8fa4-4301-891b-bc26d2d4ec40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c95ef26-f32f-4f94-b5de-3e3e1db111a3" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_da919e2c-8fa4-4301-891b-bc26d2d4ec40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f5e78674-121a-4ad5-a06c-ecad8931d570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c95ef26-f32f-4f94-b5de-3e3e1db111a3" xlink:to="loc_us-gaap_CostsAndExpenses_f5e78674-121a-4ad5-a06c-ecad8931d570" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_594390d2-420b-4502-bbae-f86a38c87c06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_OperatingIncomeLoss_594390d2-420b-4502-bbae-f86a38c87c06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8ff3e454-9dd3-4b9c-b3b2-ba49f03cf3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8ff3e454-9dd3-4b9c-b3b2-ba49f03cf3c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f2f5a56c-629e-4a65-9e95-0f285a9ad87f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:to="loc_us-gaap_InterestExpense_f2f5a56c-629e-4a65-9e95-0f285a9ad87f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_e1cc87ff-2f13-4583-b4a0-4c0130781e63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:to="loc_us-gaap_InvestmentIncomeInterest_e1cc87ff-2f13-4583-b4a0-4c0130781e63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_7727cd82-d416-493e-baff-7c06c68a5801" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_7727cd82-d416-493e-baff-7c06c68a5801" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_132031d9-46a9-45ed-b4df-7bcaef25172b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_132031d9-46a9-45ed-b4df-7bcaef25172b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_e6896887-ee03-451b-a531-484ee4a958de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_e6896887-ee03-451b-a531-484ee4a958de" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dd3aa01c-39ba-4636-9d7c-2aa586768a74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dd3aa01c-39ba-4636-9d7c-2aa586768a74" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d83b4f43-2dbf-4e99-baf5-52d9dc71b259" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d83b4f43-2dbf-4e99-baf5-52d9dc71b259" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d925108f-f456-4246-9c36-1987071a7a19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_ProfitLoss_d925108f-f456-4246-9c36-1987071a7a19" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_aac2d036-9f30-49aa-9f8c-006809a716df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_aac2d036-9f30-49aa-9f8c-006809a716df" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2187effb-5949-44cb-b6e0-7e84c15c3f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_NetIncomeLoss_2187effb-5949-44cb-b6e0-7e84c15c3f0a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2cc11fad-e558-4c1f-9d79-c1ddadd1862c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_EarningsPerShareBasic_2cc11fad-e558-4c1f-9d79-c1ddadd1862c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_562a6305-41ad-4ad2-9435-1069acbe0e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_EarningsPerShareDiluted_562a6305-41ad-4ad2-9435-1069acbe0e0e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7a798d7f-269b-488a-a335-ce131a374e82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_StatementTable_7a798d7f-269b-488a-a335-ce131a374e82" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e2c1decd-6af3-4000-9ab8-5e652a0dd019" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7a798d7f-269b-488a-a335-ce131a374e82" xlink:to="loc_srt_ProductOrServiceAxis_e2c1decd-6af3-4000-9ab8-5e652a0dd019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e2c1decd-6af3-4000-9ab8-5e652a0dd019_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e2c1decd-6af3-4000-9ab8-5e652a0dd019" xlink:to="loc_srt_ProductsAndServicesDomain_e2c1decd-6af3-4000-9ab8-5e652a0dd019_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_62faad1a-a982-4e07-bc6e-b6be2985d4d4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e2c1decd-6af3-4000-9ab8-5e652a0dd019" xlink:to="loc_srt_ProductsAndServicesDomain_62faad1a-a982-4e07-bc6e-b6be2985d4d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_HealthCareCapitationRevenueMember_4343890c-c048-4a1c-b049-c2dac481e057" xlink:href="ameh-20230630.xsd#ameh_HealthCareCapitationRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_62faad1a-a982-4e07-bc6e-b6be2985d4d4" xlink:to="loc_ameh_HealthCareCapitationRevenueMember_4343890c-c048-4a1c-b049-c2dac481e057" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_e90791cc-d26c-4f43-add5-926d8264d92e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_62faad1a-a982-4e07-bc6e-b6be2985d4d4" xlink:to="loc_us-gaap_HealthCareOtherMember_e90791cc-d26c-4f43-add5-926d8264d92e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementServiceMember_9ef6c3cd-c9f5-4f58-a3e5-a5ab23e37aad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_62faad1a-a982-4e07-bc6e-b6be2985d4d4" xlink:to="loc_us-gaap_ManagementServiceMember_9ef6c3cd-c9f5-4f58-a3e5-a5ab23e37aad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_dd3653b7-6524-4b26-9035-be7635860a79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_62faad1a-a982-4e07-bc6e-b6be2985d4d4" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_dd3653b7-6524-4b26-9035-be7635860a79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_f4a9c722-2ddf-472f-8218-8e52b633bdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_62faad1a-a982-4e07-bc6e-b6be2985d4d4" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_f4a9c722-2ddf-472f-8218-8e52b633bdcf" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ameh-20230630.xsd#CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY" xlink:type="extended" id="i14f0dca1349a4cdf9ea594035df0c13e_CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a08a57ad-98a6-466b-93b8-1d07b8f5e945" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a08a57ad-98a6-466b-93b8-1d07b8f5e945" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_cf62ab51-7319-4f6f-9bda-9323143192e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_cf62ab51-7319-4f6f-9bda-9323143192e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_8e9e280b-89fe-4b7e-b5df-db270e7b2276" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_8e9e280b-89fe-4b7e-b5df-db270e7b2276" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_554ca463-73a6-43f6-ac9f-b0deec23f660" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_554ca463-73a6-43f6-ac9f-b0deec23f660" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionOfDividends_892c2028-911a-43b3-8937-9b61b29d9557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:to="loc_us-gaap_TemporaryEquityAccretionOfDividends_892c2028-911a-43b3-8937-9b61b29d9557" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_TemporaryEquityDividendsImpact_80c069f8-0b3e-4de8-80f8-fbdb27cdf45c" xlink:href="ameh-20230630.xsd#ameh_TemporaryEquityDividendsImpact"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:to="loc_ameh_TemporaryEquityDividendsImpact_80c069f8-0b3e-4de8-80f8-fbdb27cdf45c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_TemporaryEquityTransferOfCommonControlEntities_e71a5d5a-6b52-4854-a9b6-f6bdda23ee1e" xlink:href="ameh-20230630.xsd#ameh_TemporaryEquityTransferOfCommonControlEntities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:to="loc_ameh_TemporaryEquityTransferOfCommonControlEntities_e71a5d5a-6b52-4854-a9b6-f6bdda23ee1e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_61de7f3d-f86d-441f-9daa-622104867a16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a08a57ad-98a6-466b-93b8-1d07b8f5e945" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_785019cd-eeca-41f6-b40c-73dd53a6d129" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_SharesOutstanding_785019cd-eeca-41f6-b40c-73dd53a6d129" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_878745ca-1b97-49e2-b16e-a6f15b9d31c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_878745ca-1b97-49e2-b16e-a6f15b9d31c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_009dba7b-0079-4f5e-833b-ba56b23ff23d" xlink:href="ameh-20230630.xsd#ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_009dba7b-0079-4f5e-833b-ba56b23ff23d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_aeabd2b5-d690-44fe-b337-725cbb622321" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_aeabd2b5-d690-44fe-b337-725cbb622321" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_ad95bad8-b56e-49e9-bb3f-a42ce476f1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_ad95bad8-b56e-49e9-bb3f-a42ce476f1e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_b6c181c9-9fe4-4c2f-8b4c-2aa504be006a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_b6c181c9-9fe4-4c2f-8b4c-2aa504be006a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_9909ead5-f796-4907-b5d2-3d9b68ce3f16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_9909ead5-f796-4907-b5d2-3d9b68ce3f16" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants_92a760ec-de44-4d66-9aa4-7a0400968ec5" xlink:href="ameh-20230630.xsd#ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants_92a760ec-de44-4d66-9aa4-7a0400968ec5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants_3d6934c1-d0ed-4508-a67c-9d3a5ea3b56c" xlink:href="ameh-20230630.xsd#ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants_3d6934c1-d0ed-4508-a67c-9d3a5ea3b56c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_43556d2d-5309-48cb-98b7-abaac9d5deb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_43556d2d-5309-48cb-98b7-abaac9d5deb5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_016d2db5-be5b-4f46-8707-cba034842117" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_016d2db5-be5b-4f46-8707-cba034842117" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2270d35d-0fe8-4370-a977-8ed5d594693d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2270d35d-0fe8-4370-a977-8ed5d594693d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_a5ab7b99-077d-4a99-a895-86fdf9ff63e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_a5ab7b99-077d-4a99-a895-86fdf9ff63e1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_f0625cd8-0f1d-4b63-b3ef-7a160e56a9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_f0625cd8-0f1d-4b63-b3ef-7a160e56a9d7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_ca5f60a6-c08f-43b0-88d2-e6c8b61aabdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_ca5f60a6-c08f-43b0-88d2-e6c8b61aabdb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_baff2341-75d2-4f31-9045-3d850a5499d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_baff2341-75d2-4f31-9045-3d850a5499d8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_bce1c48b-4e8b-4a61-8dc9-fbc8ddf52bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_bce1c48b-4e8b-4a61-8dc9-fbc8ddf52bfa" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_f231f433-8b7f-4df6-8001-fbca0cbaf156" xlink:href="ameh-20230630.xsd#ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_f231f433-8b7f-4df6-8001-fbca0cbaf156" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_TransferOfCommonControlEntities_2141c797-209d-4adb-8870-bc2ef5fbc2d4" xlink:href="ameh-20230630.xsd#ameh_TransferOfCommonControlEntities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_ameh_TransferOfCommonControlEntities_2141c797-209d-4adb-8870-bc2ef5fbc2d4" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_84b430d0-6902-4d62-8adf-7806c06cd4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2453b3cb-0729-443a-bc10-1d253ceb0570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6d488273-3198-4d76-8f38-91ded461b9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a08a57ad-98a6-466b-93b8-1d07b8f5e945" xlink:to="loc_us-gaap_StatementTable_6d488273-3198-4d76-8f38-91ded461b9cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e8cdb618-1cc0-4723-bba9-0733a7a1c199" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6d488273-3198-4d76-8f38-91ded461b9cc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e8cdb618-1cc0-4723-bba9-0733a7a1c199" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e8cdb618-1cc0-4723-bba9-0733a7a1c199_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e8cdb618-1cc0-4723-bba9-0733a7a1c199" xlink:to="loc_us-gaap_EquityComponentDomain_e8cdb618-1cc0-4723-bba9-0733a7a1c199_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e2977fc4-5bf5-4554-8746-0d70aabfa478" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e8cdb618-1cc0-4723-bba9-0733a7a1c199" xlink:to="loc_us-gaap_EquityComponentDomain_e2977fc4-5bf5-4554-8746-0d70aabfa478" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e2a560ad-9f36-42d0-a772-f1c5cc59f22f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e2977fc4-5bf5-4554-8746-0d70aabfa478" xlink:to="loc_us-gaap_CommonStockMember_e2a560ad-9f36-42d0-a772-f1c5cc59f22f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_667d787f-45a7-4f97-aff7-a1240d2c34bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e2977fc4-5bf5-4554-8746-0d70aabfa478" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_667d787f-45a7-4f97-aff7-a1240d2c34bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9c8bdc49-8029-4b1e-9cfe-d791d5f47b99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e2977fc4-5bf5-4554-8746-0d70aabfa478" xlink:to="loc_us-gaap_RetainedEarningsMember_9c8bdc49-8029-4b1e-9cfe-d791d5f47b99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_2748f8fd-00b8-4946-bd25-c296182ff4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e2977fc4-5bf5-4554-8746-0d70aabfa478" xlink:to="loc_us-gaap_NoncontrollingInterestMember_2748f8fd-00b8-4946-bd25-c296182ff4bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_491a7e1b-fa23-4559-8f83-a76034559ee3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6d488273-3198-4d76-8f38-91ded461b9cc" xlink:to="loc_dei_LegalEntityAxis_491a7e1b-fa23-4559-8f83-a76034559ee3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_491a7e1b-fa23-4559-8f83-a76034559ee3_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_491a7e1b-fa23-4559-8f83-a76034559ee3" xlink:to="loc_dei_EntityDomain_491a7e1b-fa23-4559-8f83-a76034559ee3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0a810c70-ad3b-4415-ad27-6e53e84753d3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_491a7e1b-fa23-4559-8f83-a76034559ee3" xlink:to="loc_dei_EntityDomain_0a810c70-ad3b-4415-ad27-6e53e84753d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MezzanineMember_bb06a08b-3c65-41bc-b735-1d72c8dd7bac" xlink:href="ameh-20230630.xsd#ameh_MezzanineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_0a810c70-ad3b-4415-ad27-6e53e84753d3" xlink:to="loc_ameh_MezzanineMember_bb06a08b-3c65-41bc-b735-1d72c8dd7bac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#DescriptionofBusinessAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails" xlink:type="extended" id="i89b604fb4dc243c4ab2ef747845cc4dc_DescriptionofBusinessAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:href="ameh-20230630.xsd#ameh_DescriptionOfBusinessLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_feaafa70-d110-43c6-a9d4-03a71460e3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:to="loc_us-gaap_NumberOfReportableSegments_feaafa70-d110-43c6-a9d4-03a71460e3b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_03c0c0b8-89b8-4f4a-b4f9-79fe2cdcb697" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_03c0c0b8-89b8-4f4a-b4f9-79fe2cdcb697" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_fde09f3d-eb8e-4931-aa0a-3ab5d58245ee" xlink:href="ameh-20230630.xsd#ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:to="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_fde09f3d-eb8e-4931-aa0a-3ab5d58245ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_d9dc6018-4acd-436c-9c62-341f1765d1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:to="loc_us-gaap_EquityMethodInvestments_d9dc6018-4acd-436c-9c62-341f1765d1bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_50047e52-69f5-46b8-a5f2-9e3c6468ad24" xlink:href="ameh-20230630.xsd#ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:to="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_50047e52-69f5-46b8-a5f2-9e3c6468ad24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation_56a92a0e-f2bc-434f-b121-bcf5a564bec0" xlink:href="ameh-20230630.xsd#ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:to="loc_ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation_56a92a0e-f2bc-434f-b121-bcf5a564bec0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AssetAcquisitionPercentageOfSharesAcquired_5d319792-e90a-4efa-81ae-f90f95d4ab1c" xlink:href="ameh-20230630.xsd#ameh_AssetAcquisitionPercentageOfSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:to="loc_ameh_AssetAcquisitionPercentageOfSharesAcquired_5d319792-e90a-4efa-81ae-f90f95d4ab1c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DescriptionOfBusinessTable_18c822ac-a7b7-4a12-beb4-c745e6931a4d" xlink:href="ameh-20230630.xsd#ameh_DescriptionOfBusinessTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:to="loc_ameh_DescriptionOfBusinessTable_18c822ac-a7b7-4a12-beb4-c745e6931a4d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3b152815-cf43-449e-9f1d-efd1b5b1b5af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_DescriptionOfBusinessTable_18c822ac-a7b7-4a12-beb4-c745e6931a4d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3b152815-cf43-449e-9f1d-efd1b5b1b5af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b152815-cf43-449e-9f1d-efd1b5b1b5af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3b152815-cf43-449e-9f1d-efd1b5b1b5af" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b152815-cf43-449e-9f1d-efd1b5b1b5af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6506c3cc-4610-4091-9420-bb3c08f6b766" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3b152815-cf43-449e-9f1d-efd1b5b1b5af" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6506c3cc-4610-4091-9420-bb3c08f6b766" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AmgIncMember_ed935f11-fedc-4754-9924-49bd4216d7dc" xlink:href="ameh-20230630.xsd#ameh_AmgIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6506c3cc-4610-4091-9420-bb3c08f6b766" xlink:to="loc_ameh_AmgIncMember_ed935f11-fedc-4754-9924-49bd4216d7dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApolloSunLabsManagementLLCMember_17645eae-0438-41a4-83f2-96fc58e8eabe" xlink:href="ameh-20230630.xsd#ameh_ApolloSunLabsManagementLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6506c3cc-4610-4091-9420-bb3c08f6b766" xlink:to="loc_ameh_ApolloSunLabsManagementLLCMember_17645eae-0438-41a4-83f2-96fc58e8eabe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6754a74f-823d-462d-b93d-8d596753aacc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_DescriptionOfBusinessTable_18c822ac-a7b7-4a12-beb4-c745e6931a4d" xlink:to="loc_dei_LegalEntityAxis_6754a74f-823d-462d-b93d-8d596753aacc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6754a74f-823d-462d-b93d-8d596753aacc_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_6754a74f-823d-462d-b93d-8d596753aacc" xlink:to="loc_dei_EntityDomain_6754a74f-823d-462d-b93d-8d596753aacc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fc5bbf7f-be61-4d2f-a97a-f449231d1a4f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_6754a74f-823d-462d-b93d-8d596753aacc" xlink:to="loc_dei_EntityDomain_fc5bbf7f-be61-4d2f-a97a-f449231d1a4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApcLsmaMember_376ebe6f-2b36-4521-b7f4-6276360dfc92" xlink:href="ameh-20230630.xsd#ameh_ApcLsmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_fc5bbf7f-be61-4d2f-a97a-f449231d1a4f" xlink:to="loc_ameh_ApcLsmaMember_376ebe6f-2b36-4521-b7f4-6276360dfc92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlliedPacificOfCaliforniaIPAMember_032e8257-17a4-42cd-9f74-bdb192f9230e" xlink:href="ameh-20230630.xsd#ameh_AlliedPacificOfCaliforniaIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_fc5bbf7f-be61-4d2f-a97a-f449231d1a4f" xlink:to="loc_ameh_AlliedPacificOfCaliforniaIPAMember_032e8257-17a4-42cd-9f74-bdb192f9230e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f7337109-a349-45f6-ac3f-2f2696a824e9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_DescriptionOfBusinessTable_18c822ac-a7b7-4a12-beb4-c745e6931a4d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f7337109-a349-45f6-ac3f-2f2696a824e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_f7337109-a349-45f6-ac3f-2f2696a824e9_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f7337109-a349-45f6-ac3f-2f2696a824e9" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_f7337109-a349-45f6-ac3f-2f2696a824e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_f9dfaa44-c679-4f16-a503-9adb7990bf14" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f7337109-a349-45f6-ac3f-2f2696a824e9" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_f9dfaa44-c679-4f16-a503-9adb7990bf14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DmgMember_cec6a592-1937-41f7-90bd-13b6f7e1fe5a" xlink:href="ameh-20230630.xsd#ameh_DmgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_f9dfaa44-c679-4f16-a503-9adb7990bf14" xlink:to="loc_ameh_DmgMember_cec6a592-1937-41f7-90bd-13b6f7e1fe5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DMGAndSunLabsMember_f3a636d5-97aa-4c26-8375-5b8419da4e47" xlink:href="ameh-20230630.xsd#ameh_DMGAndSunLabsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_f9dfaa44-c679-4f16-a503-9adb7990bf14" xlink:to="loc_ameh_DMGAndSunLabsMember_f3a636d5-97aa-4c26-8375-5b8419da4e47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_9db588c5-e697-4ce3-90c4-810ca5c81862" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_DescriptionOfBusinessTable_18c822ac-a7b7-4a12-beb4-c745e6931a4d" xlink:to="loc_us-gaap_AssetAcquisitionAxis_9db588c5-e697-4ce3-90c4-810ca5c81862" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_9db588c5-e697-4ce3-90c4-810ca5c81862_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_9db588c5-e697-4ce3-90c4-810ca5c81862" xlink:to="loc_us-gaap_AssetAcquisitionDomain_9db588c5-e697-4ce3-90c4-810ca5c81862_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_cd515588-e0ba-42bc-ab7b-545e101cb09f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_9db588c5-e697-4ce3-90c4-810ca5c81862" xlink:to="loc_us-gaap_AssetAcquisitionDomain_cd515588-e0ba-42bc-ab7b-545e101cb09f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember_3a34c826-92b8-49d5-8503-6ebb215ba298" xlink:href="ameh-20230630.xsd#ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_cd515588-e0ba-42bc-ab7b-545e101cb09f" xlink:to="loc_ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember_3a34c826-92b8-49d5-8503-6ebb215ba298" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OneMSOLLCMember_d8ce134b-e934-40eb-8555-7396b4ef61d5" xlink:href="ameh-20230630.xsd#ameh_OneMSOLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_cd515588-e0ba-42bc-ab7b-545e101cb09f" xlink:to="loc_ameh_OneMSOLLCMember_d8ce134b-e934-40eb-8555-7396b4ef61d5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended" id="id7bd9b6dc55d48b2a4c51e9b6cfe98a5_BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:href="ameh-20230630.xsd#ameh_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_92d1d234-1ae8-4b3b-97a1-e169b8980a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_us-gaap_NumberOfReportableSegments_92d1d234-1ae8-4b3b-97a1-e169b8980a6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount_0fd3a47c-d8a6-4b94-aa5d-cfc9979c297e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashUninsuredAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_us-gaap_CashUninsuredAmount_0fd3a47c-d8a6-4b94-aa5d-cfc9979c297e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MarketableSecuritiesCurrentMaturityPeriod_6d672797-ad7e-403c-99a9-f47728612da7" xlink:href="ameh-20230630.xsd#ameh_MarketableSecuritiesCurrentMaturityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_ameh_MarketableSecuritiesCurrentMaturityPeriod_6d672797-ad7e-403c-99a9-f47728612da7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b3679a1e-6421-4a9b-a1b9-22f029182abf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b3679a1e-6421-4a9b-a1b9-22f029182abf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_9666f53d-b4ee-48a1-a847-b0eddd0cacf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_9666f53d-b4ee-48a1-a847-b0eddd0cacf5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod_2a13ebcc-4c45-42b0-9873-0f4741a84457" xlink:href="ameh-20230630.xsd#ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod_2a13ebcc-4c45-42b0-9873-0f4741a84457" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_56b3ee74-9510-46f1-b752-75752665b98e" xlink:href="ameh-20230630.xsd#ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_56b3ee74-9510-46f1-b752-75752665b98e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0757f6c6-3af9-40e1-8a98-0a48ce4b0e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0757f6c6-3af9-40e1-8a98-0a48ce4b0e5c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DerivativeCeilingInterestRate_733aed8c-3ebe-4198-8b43-237754c0a8c9" xlink:href="ameh-20230630.xsd#ameh_DerivativeCeilingInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_ameh_DerivativeCeilingInterestRate_733aed8c-3ebe-4198-8b43-237754c0a8c9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFloorInterestRate_05b22b60-b1af-45d3-9acd-26b5658650f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFloorInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_us-gaap_DerivativeFloorInterestRate_05b22b60-b1af-45d3-9acd-26b5658650f3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_f8264d8b-07b4-4bc9-84a9-07cbe9d42cda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_f8264d8b-07b4-4bc9-84a9-07cbe9d42cda" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SummaryOfSignificantAccountingPoliciesTable_d87642c7-444b-4a23-ab11-cf3b928838a0" xlink:href="ameh-20230630.xsd#ameh_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_ameh_SummaryOfSignificantAccountingPoliciesTable_d87642c7-444b-4a23-ab11-cf3b928838a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cfb89fe8-0a15-4b24-b158-8301d023d62f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesTable_d87642c7-444b-4a23-ab11-cf3b928838a0" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cfb89fe8-0a15-4b24-b158-8301d023d62f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cfb89fe8-0a15-4b24-b158-8301d023d62f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cfb89fe8-0a15-4b24-b158-8301d023d62f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cfb89fe8-0a15-4b24-b158-8301d023d62f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_58c083b7-1178-4c04-9dd0-63eaddc0178b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cfb89fe8-0a15-4b24-b158-8301d023d62f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_58c083b7-1178-4c04-9dd0-63eaddc0178b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_f1e6760d-21a5-45e5-84e5-db42d042c679" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_58c083b7-1178-4c04-9dd0-63eaddc0178b" xlink:to="loc_us-gaap_CertificatesOfDepositMember_f1e6760d-21a5-45e5-84e5-db42d042c679" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ebcdedd0-57b7-438c-b4be-27e9e5f5cd65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesTable_d87642c7-444b-4a23-ab11-cf3b928838a0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ebcdedd0-57b7-438c-b4be-27e9e5f5cd65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ebcdedd0-57b7-438c-b4be-27e9e5f5cd65_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ebcdedd0-57b7-438c-b4be-27e9e5f5cd65" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ebcdedd0-57b7-438c-b4be-27e9e5f5cd65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1177c0fa-060d-4e29-a993-b135ddb25f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ebcdedd0-57b7-438c-b4be-27e9e5f5cd65" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1177c0fa-060d-4e29-a993-b135ddb25f3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_81ee046e-f4b9-4e5f-be67-e88010933806" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1177c0fa-060d-4e29-a993-b135ddb25f3f" xlink:to="loc_us-gaap_CashFlowHedgingMember_81ee046e-f4b9-4e5f-be67-e88010933806" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c66f84ac-3165-4cca-949d-c7c77fce2a48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesTable_d87642c7-444b-4a23-ab11-cf3b928838a0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c66f84ac-3165-4cca-949d-c7c77fce2a48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c66f84ac-3165-4cca-949d-c7c77fce2a48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c66f84ac-3165-4cca-949d-c7c77fce2a48" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c66f84ac-3165-4cca-949d-c7c77fce2a48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_45cd1942-74d9-4d61-a985-58e203d44792" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c66f84ac-3165-4cca-949d-c7c77fce2a48" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_45cd1942-74d9-4d61-a985-58e203d44792" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ff1efca3-a387-42df-8183-239fc3e32c21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45cd1942-74d9-4d61-a985-58e203d44792" xlink:to="loc_us-gaap_InterestRateSwapMember_ff1efca3-a387-42df-8183-239fc3e32c21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CollarMember_53f78043-26b3-453f-8f1d-d8afc3d24045" xlink:href="ameh-20230630.xsd#ameh_CollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45cd1942-74d9-4d61-a985-58e203d44792" xlink:to="loc_ameh_CollarMember_53f78043-26b3-453f-8f1d-d8afc3d24045" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ContingentEquitySecuritiesMember_e900f4f3-0ab2-4559-be0d-2e97316cb441" xlink:href="ameh-20230630.xsd#ameh_ContingentEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45cd1942-74d9-4d61-a985-58e203d44792" xlink:to="loc_ameh_ContingentEquitySecuritiesMember_e900f4f3-0ab2-4559-be0d-2e97316cb441" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fcfce369-b999-47fe-9706-85beb746add4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesTable_d87642c7-444b-4a23-ab11-cf3b928838a0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fcfce369-b999-47fe-9706-85beb746add4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fcfce369-b999-47fe-9706-85beb746add4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fcfce369-b999-47fe-9706-85beb746add4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fcfce369-b999-47fe-9706-85beb746add4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d65d5e4c-e8b0-40fc-a688-0bdb456c0edc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fcfce369-b999-47fe-9706-85beb746add4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d65d5e4c-e8b0-40fc-a688-0bdb456c0edc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_f13ef2ee-73dd-4e06-87ad-076e4df0cf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d65d5e4c-e8b0-40fc-a688-0bdb456c0edc" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_f13ef2ee-73dd-4e06-87ad-076e4df0cf5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_9f0f272a-dc63-49c1-b552-0f288fafec1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesTable_d87642c7-444b-4a23-ab11-cf3b928838a0" xlink:to="loc_us-gaap_HedgingDesignationAxis_9f0f272a-dc63-49c1-b552-0f288fafec1d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9f0f272a-dc63-49c1-b552-0f288fafec1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_9f0f272a-dc63-49c1-b552-0f288fafec1d" xlink:to="loc_us-gaap_HedgingDesignationDomain_9f0f272a-dc63-49c1-b552-0f288fafec1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1594adad-1782-4c66-b042-262666b9b733" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_9f0f272a-dc63-49c1-b552-0f288fafec1d" xlink:to="loc_us-gaap_HedgingDesignationDomain_1594adad-1782-4c66-b042-262666b9b733" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_66b0471d-8dce-4039-bb98-e64f6b734e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_1594adad-1782-4c66-b042-262666b9b733" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_66b0471d-8dce-4039-bb98-e64f6b734e9a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails" xlink:type="extended" id="ie531895694724237b84280ebde50fa6d_BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_4d62741b-8456-4bc9-aa27-3741a40dcd19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ab81ca3-360f-41e2-9b58-5db27b1cce56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_4d62741b-8456-4bc9-aa27-3741a40dcd19" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ab81ca3-360f-41e2-9b58-5db27b1cce56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b7c7fa9e-3285-487b-baf8-bfdc5d0dab42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_4d62741b-8456-4bc9-aa27-3741a40dcd19" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b7c7fa9e-3285-487b-baf8-bfdc5d0dab42" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_e93979e1-ae91-442a-b974-6365e39ab633" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b7c7fa9e-3285-487b-baf8-bfdc5d0dab42" xlink:to="loc_srt_MajorCustomersAxis_e93979e1-ae91-442a-b974-6365e39ab633" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e93979e1-ae91-442a-b974-6365e39ab633_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_e93979e1-ae91-442a-b974-6365e39ab633" xlink:to="loc_srt_NameOfMajorCustomerDomain_e93979e1-ae91-442a-b974-6365e39ab633_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_07fa8103-91dc-4d46-9b0d-94e7e9d8471d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_e93979e1-ae91-442a-b974-6365e39ab633" xlink:to="loc_srt_NameOfMajorCustomerDomain_07fa8103-91dc-4d46-9b0d-94e7e9d8471d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CommercialMember_eb5b692c-5777-44bc-bc32-bc914a15aad6" xlink:href="ameh-20230630.xsd#ameh_CommercialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_07fa8103-91dc-4d46-9b0d-94e7e9d8471d" xlink:to="loc_ameh_CommercialMember_eb5b692c-5777-44bc-bc32-bc914a15aad6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MedicareMember_8c8a618e-f3c1-467b-8fea-40630c58a29d" xlink:href="ameh-20230630.xsd#ameh_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_07fa8103-91dc-4d46-9b0d-94e7e9d8471d" xlink:to="loc_ameh_MedicareMember_8c8a618e-f3c1-467b-8fea-40630c58a29d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MedicaidMember_5ade0e8f-e5d5-41a4-b049-ec3b1c84143e" xlink:href="ameh-20230630.xsd#ameh_MedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_07fa8103-91dc-4d46-9b0d-94e7e9d8471d" xlink:to="loc_ameh_MedicaidMember_5ade0e8f-e5d5-41a4-b049-ec3b1c84143e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OtherThirdPartiesMember_b6b182a6-5eb1-4f7e-8a54-3126c65b0042" xlink:href="ameh-20230630.xsd#ameh_OtherThirdPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_07fa8103-91dc-4d46-9b0d-94e7e9d8471d" xlink:to="loc_ameh_OtherThirdPartiesMember_b6b182a6-5eb1-4f7e-8a54-3126c65b0042" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails" xlink:type="extended" id="ib0e7d5d78f8d46fea9ccf0c01526a334_BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AccountsReceivableAndNetRevenueLineItems_2af70cb8-2a1d-4ba6-b428-9ab03b7d27af" xlink:href="ameh-20230630.xsd#ameh_AccountsReceivableAndNetRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_f7772b62-83e2-4813-8fbf-ca5a659045d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_AccountsReceivableAndNetRevenueLineItems_2af70cb8-2a1d-4ba6-b428-9ab03b7d27af" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_f7772b62-83e2-4813-8fbf-ca5a659045d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AccountsReceivableAndNetRevenueTable_a3df9d98-de2b-49ab-84cc-6e20774a1212" xlink:href="ameh-20230630.xsd#ameh_AccountsReceivableAndNetRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ameh_AccountsReceivableAndNetRevenueLineItems_2af70cb8-2a1d-4ba6-b428-9ab03b7d27af" xlink:to="loc_ameh_AccountsReceivableAndNetRevenueTable_a3df9d98-de2b-49ab-84cc-6e20774a1212" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8c388c45-7a43-4a23-b680-f583c61cd64c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_AccountsReceivableAndNetRevenueTable_a3df9d98-de2b-49ab-84cc-6e20774a1212" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8c388c45-7a43-4a23-b680-f583c61cd64c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8c388c45-7a43-4a23-b680-f583c61cd64c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8c388c45-7a43-4a23-b680-f583c61cd64c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8c388c45-7a43-4a23-b680-f583c61cd64c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_131c7cf2-344b-4791-b2a7-c17aadfa9735" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8c388c45-7a43-4a23-b680-f583c61cd64c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_131c7cf2-344b-4791-b2a7-c17aadfa9735" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_aa3a5263-0275-4d3d-b794-354f59e39928" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_131c7cf2-344b-4791-b2a7-c17aadfa9735" xlink:to="loc_us-gaap_SalesRevenueNetMember_aa3a5263-0275-4d3d-b794-354f59e39928" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_7867b2da-4674-4182-988c-4723a67556d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_131c7cf2-344b-4791-b2a7-c17aadfa9735" xlink:to="loc_us-gaap_AccountsReceivableMember_7867b2da-4674-4182-988c-4723a67556d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_dafe8141-596e-480c-acbd-7f59660939ca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_AccountsReceivableAndNetRevenueTable_a3df9d98-de2b-49ab-84cc-6e20774a1212" xlink:to="loc_srt_MajorCustomersAxis_dafe8141-596e-480c-acbd-7f59660939ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_dafe8141-596e-480c-acbd-7f59660939ca_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_dafe8141-596e-480c-acbd-7f59660939ca" xlink:to="loc_srt_NameOfMajorCustomerDomain_dafe8141-596e-480c-acbd-7f59660939ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8c9568fe-bc74-4d10-8575-1a4b33dd86e7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_dafe8141-596e-480c-acbd-7f59660939ca" xlink:to="loc_srt_NameOfMajorCustomerDomain_8c9568fe-bc74-4d10-8575-1a4b33dd86e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PayorAMember_9ff514f7-bc98-4204-9cc0-8f0056a9e7e5" xlink:href="ameh-20230630.xsd#ameh_PayorAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_8c9568fe-bc74-4d10-8575-1a4b33dd86e7" xlink:to="loc_ameh_PayorAMember_9ff514f7-bc98-4204-9cc0-8f0056a9e7e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PayorBMember_e12ac7ba-1236-4447-aeaa-70f81d8cf349" xlink:href="ameh-20230630.xsd#ameh_PayorBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_8c9568fe-bc74-4d10-8575-1a4b33dd86e7" xlink:to="loc_ameh_PayorBMember_e12ac7ba-1236-4447-aeaa-70f81d8cf349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PayorCMember_d6659a23-5ca7-4ee0-8544-9ec62549953d" xlink:href="ameh-20230630.xsd#ameh_PayorCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_8c9568fe-bc74-4d10-8575-1a4b33dd86e7" xlink:to="loc_ameh_PayorCMember_d6659a23-5ca7-4ee0-8544-9ec62549953d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_7db5777a-c0ea-4655-b9b6-a6b5cd0e3a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_AccountsReceivableAndNetRevenueTable_a3df9d98-de2b-49ab-84cc-6e20774a1212" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_7db5777a-c0ea-4655-b9b6-a6b5cd0e3a8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7db5777a-c0ea-4655-b9b6-a6b5cd0e3a8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7db5777a-c0ea-4655-b9b6-a6b5cd0e3a8d" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7db5777a-c0ea-4655-b9b6-a6b5cd0e3a8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_41ecced8-df14-41fc-97f3-ad5c7e32ddf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7db5777a-c0ea-4655-b9b6-a6b5cd0e3a8d" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_41ecced8-df14-41fc-97f3-ad5c7e32ddf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_57998e73-c654-4c02-b882-084da039cc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_41ecced8-df14-41fc-97f3-ad5c7e32ddf4" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_57998e73-c654-4c02-b882-084da039cc6d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails" xlink:type="extended" id="i6c556c397bf142a09a85f1caa31f3c87_BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6da18970-5129-4645-bc68-bd0c2aa8190c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6da18970-5129-4645-bc68-bd0c2aa8190c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2fcfafed-f7cf-4866-acb2-792fb1f38e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2fcfafed-f7cf-4866-acb2-792fb1f38e7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_10ef9215-ecd2-440a-ba6a-27e5b458d258" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_10ef9215-ecd2-440a-ba6a-27e5b458d258" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_9e283940-57d0-48fe-8989-730e9c8bcbef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_us-gaap_DerivativeAssets_9e283940-57d0-48fe-8989-730e9c8bcbef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ef208598-619d-40d9-b2a4-79a3fc568c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ef208598-619d-40d9-b2a4-79a3fc568c6b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3c957f3a-4286-4561-b4d7-89f5b4e69405" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3c957f3a-4286-4561-b4d7-89f5b4e69405" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_f2cca449-e5c1-425c-9379-dac612405e9d" xlink:href="ameh-20230630.xsd#ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_f2cca449-e5c1-425c-9379-dac612405e9d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_85563185-e211-4cec-9cc2-a56546afcd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_85563185-e211-4cec-9cc2-a56546afcd3a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_41d74ab8-b81d-42e1-8090-559ed76cd53f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_41d74ab8-b81d-42e1-8090-559ed76cd53f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8fcb0549-efbe-4a7d-8d61-8fced3d7564d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_41d74ab8-b81d-42e1-8090-559ed76cd53f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8fcb0549-efbe-4a7d-8d61-8fced3d7564d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fcb0549-efbe-4a7d-8d61-8fced3d7564d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8fcb0549-efbe-4a7d-8d61-8fced3d7564d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fcb0549-efbe-4a7d-8d61-8fced3d7564d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f8b88e0f-b8fc-4cfe-aa08-e3d9ed42b1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8fcb0549-efbe-4a7d-8d61-8fced3d7564d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f8b88e0f-b8fc-4cfe-aa08-e3d9ed42b1d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_72a5ec6d-07c0-4f95-80ab-b46f210243a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f8b88e0f-b8fc-4cfe-aa08-e3d9ed42b1d2" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_72a5ec6d-07c0-4f95-80ab-b46f210243a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4ef9e87f-6a3d-4ba6-bbb8-8ca476086d76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f8b88e0f-b8fc-4cfe-aa08-e3d9ed42b1d2" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4ef9e87f-6a3d-4ba6-bbb8-8ca476086d76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_452659f8-7c5c-46fd-aabf-3dc9366aa191" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f8b88e0f-b8fc-4cfe-aa08-e3d9ed42b1d2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_452659f8-7c5c-46fd-aabf-3dc9366aa191" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_fbb78d5f-2bf1-4d09-829c-3ffcc7c0c0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_41d74ab8-b81d-42e1-8090-559ed76cd53f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_fbb78d5f-2bf1-4d09-829c-3ffcc7c0c0fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fbb78d5f-2bf1-4d09-829c-3ffcc7c0c0fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fbb78d5f-2bf1-4d09-829c-3ffcc7c0c0fa" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fbb78d5f-2bf1-4d09-829c-3ffcc7c0c0fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_add589f4-fffc-4d8d-84e8-b6340a0dc8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fbb78d5f-2bf1-4d09-829c-3ffcc7c0c0fa" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_add589f4-fffc-4d8d-84e8-b6340a0dc8ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_bd733dbb-39b9-451f-8617-7725c151918a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_add589f4-fffc-4d8d-84e8-b6340a0dc8ef" xlink:to="loc_us-gaap_InterestRateSwapMember_bd733dbb-39b9-451f-8617-7725c151918a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CollarMember_4e78c5c8-9604-48d1-b304-55f2ff87bfc9" xlink:href="ameh-20230630.xsd#ameh_CollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_add589f4-fffc-4d8d-84e8-b6340a0dc8ef" xlink:to="loc_ameh_CollarMember_4e78c5c8-9604-48d1-b304-55f2ff87bfc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ContingentEquitySecuritiesMember_0f5b6f8f-7e54-4592-846a-1535616c35a5" xlink:href="ameh-20230630.xsd#ameh_ContingentEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_add589f4-fffc-4d8d-84e8-b6340a0dc8ef" xlink:to="loc_ameh_ContingentEquitySecuritiesMember_0f5b6f8f-7e54-4592-846a-1535616c35a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b5afa867-4981-4280-a247-72540802c290" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_41d74ab8-b81d-42e1-8090-559ed76cd53f" xlink:to="loc_dei_LegalEntityAxis_b5afa867-4981-4280-a247-72540802c290" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b5afa867-4981-4280-a247-72540802c290_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_b5afa867-4981-4280-a247-72540802c290" xlink:to="loc_dei_EntityDomain_b5afa867-4981-4280-a247-72540802c290_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_49d578e9-ed9f-43e5-ad81-6babe4e5ebe3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_b5afa867-4981-4280-a247-72540802c290" xlink:to="loc_dei_EntityDomain_49d578e9-ed9f-43e5-ad81-6babe4e5ebe3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_APCMGMember_3607c36e-18cf-4fae-bda6-d1b61ef4d906" xlink:href="ameh-20230630.xsd#ameh_APCMGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_49d578e9-ed9f-43e5-ad81-6babe4e5ebe3" xlink:to="loc_ameh_APCMGMember_3607c36e-18cf-4fae-bda6-d1b61ef4d906" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AAMGMember_c01fc105-be49-44af-9f3c-1cb28a02bf36" xlink:href="ameh-20230630.xsd#ameh_AAMGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_49d578e9-ed9f-43e5-ad81-6babe4e5ebe3" xlink:to="loc_ameh_AAMGMember_c01fc105-be49-44af-9f3c-1cb28a02bf36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_VOMGMember_79c39d94-241d-49d1-a2c0-3bb15dff8b8f" xlink:href="ameh-20230630.xsd#ameh_VOMGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_49d578e9-ed9f-43e5-ad81-6babe4e5ebe3" xlink:to="loc_ameh_VOMGMember_79c39d94-241d-49d1-a2c0-3bb15dff8b8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DmgMember_b664fdf9-1da3-4bf1-ac3b-d828fd4220d0" xlink:href="ameh-20230630.xsd#ameh_DmgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_49d578e9-ed9f-43e5-ad81-6babe4e5ebe3" xlink:to="loc_ameh_DmgMember_b664fdf9-1da3-4bf1-ac3b-d828fd4220d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApolloSunLabsManagementLLCMember_54ad2e2e-3a95-4784-845c-b83dcc2d3afc" xlink:href="ameh-20230630.xsd#ameh_ApolloSunLabsManagementLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_49d578e9-ed9f-43e5-ad81-6babe4e5ebe3" xlink:to="loc_ameh_ApolloSunLabsManagementLLCMember_54ad2e2e-3a95-4784-845c-b83dcc2d3afc" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails" xlink:type="extended" id="i9e88f4c1ddb6414d99da69201481348e_BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1edecdcf-07cd-4e20-a896-7acafd6d80b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_4622b96e-a3d0-4522-b0fb-070b6d8e4c18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1edecdcf-07cd-4e20-a896-7acafd6d80b2" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_4622b96e-a3d0-4522-b0fb-070b6d8e4c18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NumberOfPrimaryCareClinics_afd4b392-9211-447e-83a2-113d408e95ae" xlink:href="ameh-20230630.xsd#ameh_NumberOfPrimaryCareClinics"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1edecdcf-07cd-4e20-a896-7acafd6d80b2" xlink:to="loc_ameh_NumberOfPrimaryCareClinics_afd4b392-9211-447e-83a2-113d408e95ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e53818d7-fad0-4737-99ad-f6abfcf3275f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1edecdcf-07cd-4e20-a896-7acafd6d80b2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e53818d7-fad0-4737-99ad-f6abfcf3275f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_a16c1a27-e9ab-4eb3-8d19-7c30b3bf1a25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1edecdcf-07cd-4e20-a896-7acafd6d80b2" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_a16c1a27-e9ab-4eb3-8d19-7c30b3bf1a25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_39e24cbf-3c74-4bfb-982c-39d9fd7f1353" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1edecdcf-07cd-4e20-a896-7acafd6d80b2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_39e24cbf-3c74-4bfb-982c-39d9fd7f1353" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0b516e36-50e3-498a-ab50-ac44cfa90539" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_39e24cbf-3c74-4bfb-982c-39d9fd7f1353" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0b516e36-50e3-498a-ab50-ac44cfa90539" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0b516e36-50e3-498a-ab50-ac44cfa90539_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0b516e36-50e3-498a-ab50-ac44cfa90539" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0b516e36-50e3-498a-ab50-ac44cfa90539_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00f3dfe0-67a9-4e6d-b927-e7dc86005667" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0b516e36-50e3-498a-ab50-ac44cfa90539" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00f3dfe0-67a9-4e6d-b927-e7dc86005667" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ForYourBenefitIncMember_217d3126-7927-48ef-adbf-1649a2bc197c" xlink:href="ameh-20230630.xsd#ameh_ForYourBenefitIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00f3dfe0-67a9-4e6d-b927-e7dc86005667" xlink:to="loc_ameh_ForYourBenefitIncMember_217d3126-7927-48ef-adbf-1649a2bc197c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember_90eb8bb7-4fa0-41c4-849b-c22e125c40c3" xlink:href="ameh-20230630.xsd#ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00f3dfe0-67a9-4e6d-b927-e7dc86005667" xlink:to="loc_ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember_90eb8bb7-4fa0-41c4-849b-c22e125c40c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_JadeHealthCareMedicalGroupIncMember_103523d3-0a2b-43e1-8dce-1c9cccfbe55b" xlink:href="ameh-20230630.xsd#ameh_JadeHealthCareMedicalGroupIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00f3dfe0-67a9-4e6d-b927-e7dc86005667" xlink:to="loc_ameh_JadeHealthCareMedicalGroupIncMember_103523d3-0a2b-43e1-8dce-1c9cccfbe55b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AAMGMember_47f34ef2-3072-4330-ad71-d8a27b25fcf1" xlink:href="ameh-20230630.xsd#ameh_AAMGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00f3dfe0-67a9-4e6d-b927-e7dc86005667" xlink:to="loc_ameh_AAMGMember_47f34ef2-3072-4330-ad71-d8a27b25fcf1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#IntangibleAssetsNetScheduleofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="extended" id="i60d03937f8894c09840d6235678bd64d_IntangibleAssetsNetScheduleofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7516a7b9-442e-42aa-b343-19db7045c511" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_39bf9b35-bcd9-44f6-af98-86533018be58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7516a7b9-442e-42aa-b343-19db7045c511" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_39bf9b35-bcd9-44f6-af98-86533018be58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5c48bd16-c6f0-48f3-a64a-f8561455bd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7516a7b9-442e-42aa-b343-19db7045c511" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5c48bd16-c6f0-48f3-a64a-f8561455bd5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8aa20105-9fbf-46b1-811c-c72db312e81f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7516a7b9-442e-42aa-b343-19db7045c511" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8aa20105-9fbf-46b1-811c-c72db312e81f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_030c690b-8aab-41e8-b1d5-0b8f6a814684" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7516a7b9-442e-42aa-b343-19db7045c511" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_030c690b-8aab-41e8-b1d5-0b8f6a814684" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d1d088a-c8e8-4ef8-98be-d14a2e46d7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7516a7b9-442e-42aa-b343-19db7045c511" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d1d088a-c8e8-4ef8-98be-d14a2e46d7e1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9811244d-6197-4237-b32f-10bd3ebbf739" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d1d088a-c8e8-4ef8-98be-d14a2e46d7e1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9811244d-6197-4237-b32f-10bd3ebbf739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9811244d-6197-4237-b32f-10bd3ebbf739_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9811244d-6197-4237-b32f-10bd3ebbf739" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9811244d-6197-4237-b32f-10bd3ebbf739_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9811244d-6197-4237-b32f-10bd3ebbf739" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NetworkRelationshipsMember_029fd404-a672-47c9-9844-72112edef26e" xlink:href="ameh-20230630.xsd#ameh_NetworkRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:to="loc_ameh_NetworkRelationshipsMember_029fd404-a672-47c9-9844-72112edef26e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ManagementContractsMember_508cae52-902d-4ca1-a84a-67da08699329" xlink:href="ameh-20230630.xsd#ameh_ManagementContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:to="loc_ameh_ManagementContractsMember_508cae52-902d-4ca1-a84a-67da08699329" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MemberRelationshipsMember_b8c4b97b-ebf4-43f9-a39a-0f6bf7b15a42" xlink:href="ameh-20230630.xsd#ameh_MemberRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:to="loc_ameh_MemberRelationshipsMember_b8c4b97b-ebf4-43f9-a39a-0f6bf7b15a42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PatientManagementPlatformMember_ab3fd042-aa0e-44af-984c-025fc53129e6" xlink:href="ameh-20230630.xsd#ameh_PatientManagementPlatformMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:to="loc_ameh_PatientManagementPlatformMember_ab3fd042-aa0e-44af-984c-025fc53129e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_85022137-5300-46ba-854c-eb049bd2c79e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_85022137-5300-46ba-854c-eb049bd2c79e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_3ac9ea3e-7195-408d-9496-0bb32c5d59dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_3ac9ea3e-7195-408d-9496-0bb32c5d59dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6f5faa0b-54d8-49aa-bad0-6ae9368cccf2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d1d088a-c8e8-4ef8-98be-d14a2e46d7e1" xlink:to="loc_srt_RangeAxis_6f5faa0b-54d8-49aa-bad0-6ae9368cccf2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f5faa0b-54d8-49aa-bad0-6ae9368cccf2_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6f5faa0b-54d8-49aa-bad0-6ae9368cccf2" xlink:to="loc_srt_RangeMember_6f5faa0b-54d8-49aa-bad0-6ae9368cccf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8f85b486-f3e4-47a3-a4a8-601defb6e5f4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6f5faa0b-54d8-49aa-bad0-6ae9368cccf2" xlink:to="loc_srt_RangeMember_8f85b486-f3e4-47a3-a4a8-601defb6e5f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8d3ea9e7-8519-4e79-9cb4-676a8bb8d8d6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8f85b486-f3e4-47a3-a4a8-601defb6e5f4" xlink:to="loc_srt_MinimumMember_8d3ea9e7-8519-4e79-9cb4-676a8bb8d8d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e2f47c99-5610-4d82-b2c9-02dbc5ab456d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8f85b486-f3e4-47a3-a4a8-601defb6e5f4" xlink:to="loc_srt_MaximumMember_e2f47c99-5610-4d82-b2c9-02dbc5ab456d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_5c25f9fc-6a1b-49f6-8a4d-46be0cd23ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_50db263d-acba-40a8-b037-26970b909ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_5c25f9fc-6a1b-49f6-8a4d-46be0cd23ac9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_50db263d-acba-40a8-b037-26970b909ed0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e898b7e8-e82e-4a87-9c9d-6e5313eebcd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_5c25f9fc-6a1b-49f6-8a4d-46be0cd23ac9" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e898b7e8-e82e-4a87-9c9d-6e5313eebcd7" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2f09777a-7b45-46c6-8cda-5ea6e21c38c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e898b7e8-e82e-4a87-9c9d-6e5313eebcd7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2f09777a-7b45-46c6-8cda-5ea6e21c38c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2f09777a-7b45-46c6-8cda-5ea6e21c38c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2f09777a-7b45-46c6-8cda-5ea6e21c38c3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2f09777a-7b45-46c6-8cda-5ea6e21c38c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a711ffb0-0999-4017-ad58-ab09c490960b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2f09777a-7b45-46c6-8cda-5ea6e21c38c3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a711ffb0-0999-4017-ad58-ab09c490960b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_e33f9fd7-376b-42db-9d9b-e0ec18b26cca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a711ffb0-0999-4017-ad58-ab09c490960b" xlink:to="loc_us-gaap_TrademarksMember_e33f9fd7-376b-42db-9d9b-e0ec18b26cca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails" xlink:type="extended" id="i95c17c90531e47919cf946188ffdf0a7_InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_578c68d9-f69c-4ca8-8a10-9621776634a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_abfb7e15-70b9-411f-a06b-d38da142b98a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_578c68d9-f69c-4ca8-8a10-9621776634a2" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_abfb7e15-70b9-411f-a06b-d38da142b98a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:href="ameh-20230630.xsd#ameh_EquityMethodInvestmentsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_578c68d9-f69c-4ca8-8a10-9621776634a2" xlink:to="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_895f0695-3e75-4c27-a854-01851423c354" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:to="loc_us-gaap_EquityMethodInvestments_895f0695-3e75-4c27-a854-01851423c354" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EquityMethodInvestmentAdditionalInvestment_ea9a320e-87db-4db2-857a-48264347a74d" xlink:href="ameh-20230630.xsd#ameh_EquityMethodInvestmentAdditionalInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:to="loc_ameh_EquityMethodInvestmentAdditionalInvestment_ea9a320e-87db-4db2-857a-48264347a74d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_92975032-13e2-4c03-839f-8457cef84137" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_92975032-13e2-4c03-839f-8457cef84137" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable_4ea3ff64-113c-452d-ae3a-c72d8466c8f7" xlink:href="ameh-20230630.xsd#ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:to="loc_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable_4ea3ff64-113c-452d-ae3a-c72d8466c8f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EquityMethodInvestmentsContribution_07f36a69-89ce-43cd-858f-715579999ac8" xlink:href="ameh-20230630.xsd#ameh_EquityMethodInvestmentsContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:to="loc_ameh_EquityMethodInvestmentsContribution_07f36a69-89ce-43cd-858f-715579999ac8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSoldCarryingAmount_e802b0b6-ec78-4f44-9a27-b27e48e84aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentSoldCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:to="loc_us-gaap_EquityMethodInvestmentSoldCarryingAmount_e802b0b6-ec78-4f44-9a27-b27e48e84aa6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_52ca2f1c-0850-42ca-9f9b-c77fccd006d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_915a411f-07ae-4b2d-a72d-3b8f37654ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_578c68d9-f69c-4ca8-8a10-9621776634a2" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_915a411f-07ae-4b2d-a72d-3b8f37654ec8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ab9890eb-3462-4616-aa42-b56a836e99e2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_915a411f-07ae-4b2d-a72d-3b8f37654ec8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ab9890eb-3462-4616-aa42-b56a836e99e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ab9890eb-3462-4616-aa42-b56a836e99e2_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ab9890eb-3462-4616-aa42-b56a836e99e2" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ab9890eb-3462-4616-aa42-b56a836e99e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ab9890eb-3462-4616-aa42-b56a836e99e2" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LasalleMedicalAssociatesIpaMember_0c1175ac-203b-47db-8580-50b47cc492df" xlink:href="ameh-20230630.xsd#ameh_LasalleMedicalAssociatesIpaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:to="loc_ameh_LasalleMedicalAssociatesIpaMember_0c1175ac-203b-47db-8580-50b47cc492df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PacificMedicalImagingAndOncologyCenterIncMember_4b3afe70-d9ce-409b-9ad3-0ec017800053" xlink:href="ameh-20230630.xsd#ameh_PacificMedicalImagingAndOncologyCenterIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:to="loc_ameh_PacificMedicalImagingAndOncologyCenterIncMember_4b3afe70-d9ce-409b-9ad3-0ec017800053" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FiveThreeOneW.CollegeLLCMember_49d75148-563a-4866-a32f-52e39852c721" xlink:href="ameh-20230630.xsd#ameh_FiveThreeOneW.CollegeLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:to="loc_ameh_FiveThreeOneW.CollegeLLCMember_49d75148-563a-4866-a32f-52e39852c721" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OneMSOLLCMember_4730fc4e-28a1-4e55-bd87-ea6df855c962" xlink:href="ameh-20230630.xsd#ameh_OneMSOLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:to="loc_ameh_OneMSOLLCMember_4730fc4e-28a1-4e55-bd87-ea6df855c962" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CAIPAMSOLLCMember_35b162f1-cf22-46cf-b4db-561d05763047" xlink:href="ameh-20230630.xsd#ameh_CAIPAMSOLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:to="loc_ameh_CAIPAMSOLLCMember_35b162f1-cf22-46cf-b4db-561d05763047" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_JamesSongMDAProfessionalCorporationMember_2a516afa-f6ac-43ab-8fbe-9c71f3c9a487" xlink:href="ameh-20230630.xsd#ameh_JamesSongMDAProfessionalCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:to="loc_ameh_JamesSongMDAProfessionalCorporationMember_2a516afa-f6ac-43ab-8fbe-9c71f3c9a487" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_Tag6MedicalInvestmentGroupLLCMember_4ad6faa5-b504-48b7-84b7-84683df26899" xlink:href="ameh-20230630.xsd#ameh_Tag6MedicalInvestmentGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:to="loc_ameh_Tag6MedicalInvestmentGroupLLCMember_4ad6faa5-b504-48b7-84b7-84683df26899" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#InvestmentsinOtherEntitiesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails" xlink:type="extended" id="i88f788cdfa2242f4af4d8e6c23f1bbc6_InvestmentsinOtherEntitiesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0cd9cbbd-1177-488f-960d-020c28e69c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_27867ca8-8f54-42aa-95a1-6cf241467f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0cd9cbbd-1177-488f-960d-020c28e69c7d" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_27867ca8-8f54-42aa-95a1-6cf241467f1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e90bdaa8-198d-42d2-831a-625c3ed9792e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0cd9cbbd-1177-488f-960d-020c28e69c7d" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e90bdaa8-198d-42d2-831a-625c3ed9792e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_8d899060-be7a-4fef-8b69-742b652cac19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0cd9cbbd-1177-488f-960d-020c28e69c7d" xlink:to="loc_us-gaap_EquityMethodInvestments_8d899060-be7a-4fef-8b69-742b652cac19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_804dd6cd-0b32-4f25-aa2d-cc8fa6a5b5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0cd9cbbd-1177-488f-960d-020c28e69c7d" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_804dd6cd-0b32-4f25-aa2d-cc8fa6a5b5ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f73559ea-4858-42e9-be7d-7de7620b7fef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0cd9cbbd-1177-488f-960d-020c28e69c7d" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f73559ea-4858-42e9-be7d-7de7620b7fef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a0c01cf0-06d2-4b46-b3f5-d7b5b66b4ef2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f73559ea-4858-42e9-be7d-7de7620b7fef" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a0c01cf0-06d2-4b46-b3f5-d7b5b66b4ef2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a0c01cf0-06d2-4b46-b3f5-d7b5b66b4ef2_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a0c01cf0-06d2-4b46-b3f5-d7b5b66b4ef2" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a0c01cf0-06d2-4b46-b3f5-d7b5b66b4ef2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3782a488-5888-4e96-b99a-63de4464321d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a0c01cf0-06d2-4b46-b3f5-d7b5b66b4ef2" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3782a488-5888-4e96-b99a-63de4464321d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_JamesSongMDAProfessionalCorporationMember_95d92025-300a-4f04-b035-62e376d3ba8a" xlink:href="ameh-20230630.xsd#ameh_JamesSongMDAProfessionalCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3782a488-5888-4e96-b99a-63de4464321d" xlink:to="loc_ameh_JamesSongMDAProfessionalCorporationMember_95d92025-300a-4f04-b035-62e376d3ba8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_77919c4c-0cf5-4b56-8d3e-85d18ab25bfd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f73559ea-4858-42e9-be7d-7de7620b7fef" xlink:to="loc_dei_LegalEntityAxis_77919c4c-0cf5-4b56-8d3e-85d18ab25bfd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_77919c4c-0cf5-4b56-8d3e-85d18ab25bfd_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_77919c4c-0cf5-4b56-8d3e-85d18ab25bfd" xlink:to="loc_dei_EntityDomain_77919c4c-0cf5-4b56-8d3e-85d18ab25bfd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a604fdf0-4e8b-4080-92c1-bb2ffeb7e8cf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_77919c4c-0cf5-4b56-8d3e-85d18ab25bfd" xlink:to="loc_dei_EntityDomain_a604fdf0-4e8b-4080-92c1-bb2ffeb7e8cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_APAMH2Member_80f6692f-9ad2-4e47-bab0-91a2e413a2a2" xlink:href="ameh-20230630.xsd#ameh_APAMH2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a604fdf0-4e8b-4080-92c1-bb2ffeb7e8cf" xlink:to="loc_ameh_APAMH2Member_80f6692f-9ad2-4e47-bab0-91a2e413a2a2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails" xlink:type="extended" id="i7289b64bae664ab4b18901ccd111429f_LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_50753d31-dff5-4587-8744-708f2cd12232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_361c811e-c3c0-4fc4-a079-b0877d71fe7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_50753d31-dff5-4587-8744-708f2cd12232" xlink:to="loc_us-gaap_NotesReceivableNet_361c811e-c3c0-4fc4-a079-b0877d71fe7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e5ef6c78-db02-44c6-a930-cbc64a61f2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_50753d31-dff5-4587-8744-708f2cd12232" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e5ef6c78-db02-44c6-a930-cbc64a61f2e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FinanceReceivableInterestRateStatedPercentage_e15a73a5-20be-48ad-a5c4-22d412eb6dd4" xlink:href="ameh-20230630.xsd#ameh_FinanceReceivableInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_50753d31-dff5-4587-8744-708f2cd12232" xlink:to="loc_ameh_FinanceReceivableInterestRateStatedPercentage_e15a73a5-20be-48ad-a5c4-22d412eb6dd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0d8bf184-5966-4635-bac0-dbacf87357ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_50753d31-dff5-4587-8744-708f2cd12232" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0d8bf184-5966-4635-bac0-dbacf87357ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c3ba34fa-a9a0-4d81-a21e-27e5279db587" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_50753d31-dff5-4587-8744-708f2cd12232" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c3ba34fa-a9a0-4d81-a21e-27e5279db587" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ceef93e1-318e-4a64-b969-1921ff752154" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c3ba34fa-a9a0-4d81-a21e-27e5279db587" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ceef93e1-318e-4a64-b969-1921ff752154" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_ceef93e1-318e-4a64-b969-1921ff752154_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ceef93e1-318e-4a64-b969-1921ff752154" xlink:to="loc_us-gaap_ReceivableTypeDomain_ceef93e1-318e-4a64-b969-1921ff752154_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_c0a353b6-903e-4f31-832f-c7f8da3c6826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ceef93e1-318e-4a64-b969-1921ff752154" xlink:to="loc_us-gaap_ReceivableTypeDomain_c0a353b6-903e-4f31-832f-c7f8da3c6826" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_4292bd84-721f-42f2-b6bc-7dd8e89a888b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_c0a353b6-903e-4f31-832f-c7f8da3c6826" xlink:to="loc_us-gaap_NotesReceivableMember_4292bd84-721f-42f2-b6bc-7dd8e89a888b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_721eace6-6bc5-4f33-9dd0-da7ef148baf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c3ba34fa-a9a0-4d81-a21e-27e5279db587" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_721eace6-6bc5-4f33-9dd0-da7ef148baf6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_721eace6-6bc5-4f33-9dd0-da7ef148baf6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_721eace6-6bc5-4f33-9dd0-da7ef148baf6" xlink:to="loc_us-gaap_RelatedPartyDomain_721eace6-6bc5-4f33-9dd0-da7ef148baf6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d8c8424c-ffed-46bc-8f47-c3b39cc55a49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_721eace6-6bc5-4f33-9dd0-da7ef148baf6" xlink:to="loc_us-gaap_RelatedPartyDomain_d8c8424c-ffed-46bc-8f47-c3b39cc55a49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_56593247-7253-4170-ab79-2385f60c1e27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_d8c8424c-ffed-46bc-8f47-c3b39cc55a49" xlink:to="loc_us-gaap_RelatedPartyMember_56593247-7253-4170-ab79-2385f60c1e27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_4f95c345-d521-45cc-aba2-71b6c58c1aef" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c3ba34fa-a9a0-4d81-a21e-27e5279db587" xlink:to="loc_dei_LegalEntityAxis_4f95c345-d521-45cc-aba2-71b6c58c1aef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4f95c345-d521-45cc-aba2-71b6c58c1aef_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_4f95c345-d521-45cc-aba2-71b6c58c1aef" xlink:to="loc_dei_EntityDomain_4f95c345-d521-45cc-aba2-71b6c58c1aef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_57811314-01fc-4f34-88ae-3e0e4ec78069" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_4f95c345-d521-45cc-aba2-71b6c58c1aef" xlink:to="loc_dei_EntityDomain_57811314-01fc-4f34-88ae-3e0e4ec78069" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NetworkMedicalManagementMember_33485b5b-3090-4822-8575-f486400fb133" xlink:href="ameh-20230630.xsd#ameh_NetworkMedicalManagementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_57811314-01fc-4f34-88ae-3e0e4ec78069" xlink:to="loc_ameh_NetworkMedicalManagementMember_33485b5b-3090-4822-8575-f486400fb133" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LmaMember_3f7e015f-5d8c-4f2a-b0b2-319f9282f25a" xlink:href="ameh-20230630.xsd#ameh_LmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_57811314-01fc-4f34-88ae-3e0e4ec78069" xlink:to="loc_ameh_LmaMember_3f7e015f-5d8c-4f2a-b0b2-319f9282f25a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5e95923b-084b-4d64-a96b-9a6dc2bf98d9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c3ba34fa-a9a0-4d81-a21e-27e5279db587" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5e95923b-084b-4d64-a96b-9a6dc2bf98d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5e95923b-084b-4d64-a96b-9a6dc2bf98d9_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5e95923b-084b-4d64-a96b-9a6dc2bf98d9" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5e95923b-084b-4d64-a96b-9a6dc2bf98d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5b370957-b7fa-4815-a63a-22aea4326e85" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5e95923b-084b-4d64-a96b-9a6dc2bf98d9" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5b370957-b7fa-4815-a63a-22aea4326e85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LmaMember_7f0a814a-0c06-4035-a7c6-e7b3b798e1f8" xlink:href="ameh-20230630.xsd#ameh_LmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5b370957-b7fa-4815-a63a-22aea4326e85" xlink:to="loc_ameh_LmaMember_7f0a814a-0c06-4035-a7c6-e7b3b798e1f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1cec0daa-7957-4b24-b8d5-2c91aad64b94" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c3ba34fa-a9a0-4d81-a21e-27e5279db587" xlink:to="loc_srt_CounterpartyNameAxis_1cec0daa-7957-4b24-b8d5-2c91aad64b94" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1cec0daa-7957-4b24-b8d5-2c91aad64b94_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_1cec0daa-7957-4b24-b8d5-2c91aad64b94" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1cec0daa-7957-4b24-b8d5-2c91aad64b94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03db0907-a753-4995-ab1d-9fd2331a788c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_1cec0daa-7957-4b24-b8d5-2c91aad64b94" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03db0907-a753-4995-ab1d-9fd2331a788c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_Pacific6EnterprisesMember_02015444-76ff-4e13-8c1b-911618030bd5" xlink:href="ameh-20230630.xsd#ameh_Pacific6EnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03db0907-a753-4995-ab1d-9fd2331a788c" xlink:to="loc_ameh_Pacific6EnterprisesMember_02015444-76ff-4e13-8c1b-911618030bd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApcLsmaMember_5fce9186-f641-4894-90a4-4b0572a061fc" xlink:href="ameh-20230630.xsd#ameh_ApcLsmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03db0907-a753-4995-ab1d-9fd2331a788c" xlink:to="loc_ameh_ApcLsmaMember_5fce9186-f641-4894-90a4-4b0572a061fc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails" xlink:type="extended" id="ia932e895f3d443d5b651a2b0124b3e4f_CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_1a4a2a74-f3b7-4572-a297-de7ebb28621e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a222a15f-c5e0-48c7-a3dc-e57d240311a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1a4a2a74-f3b7-4572-a297-de7ebb28621e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a222a15f-c5e0-48c7-a3dc-e57d240311a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_64d6467e-a52b-467c-b610-1e341225ebf8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1a4a2a74-f3b7-4572-a297-de7ebb28621e" xlink:to="loc_us-gaap_LongTermDebtCurrent_64d6467e-a52b-467c-b610-1e341225ebf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_5147dcf5-236d-4569-a288-f4ba875ea894" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1a4a2a74-f3b7-4572-a297-de7ebb28621e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_5147dcf5-236d-4569-a288-f4ba875ea894" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_58a030a1-4caa-4567-a976-67405e8c014b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1a4a2a74-f3b7-4572-a297-de7ebb28621e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_58a030a1-4caa-4567-a976-67405e8c014b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_cf565cbd-b8fb-4ace-bb93-3e06093cebac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1a4a2a74-f3b7-4572-a297-de7ebb28621e" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_cf565cbd-b8fb-4ace-bb93-3e06093cebac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ae829471-5605-4fee-b99a-05e6b8744086" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cf565cbd-b8fb-4ace-bb93-3e06093cebac" xlink:to="loc_us-gaap_CreditFacilityAxis_ae829471-5605-4fee-b99a-05e6b8744086" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ae829471-5605-4fee-b99a-05e6b8744086_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_ae829471-5605-4fee-b99a-05e6b8744086" xlink:to="loc_us-gaap_CreditFacilityDomain_ae829471-5605-4fee-b99a-05e6b8744086_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e9c4927f-c789-443a-8a6e-c7c0ebd32690" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_ae829471-5605-4fee-b99a-05e6b8744086" xlink:to="loc_us-gaap_CreditFacilityDomain_e9c4927f-c789-443a-8a6e-c7c0ebd32690" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_941e41ec-ac7c-43b6-b79c-3bdc1fcc1962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_e9c4927f-c789-443a-8a6e-c7c0ebd32690" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_941e41ec-ac7c-43b6-b79c-3bdc1fcc1962" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c5d511ae-e0f4-4ca2-a7dd-c670c34b76cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cf565cbd-b8fb-4ace-bb93-3e06093cebac" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c5d511ae-e0f4-4ca2-a7dd-c670c34b76cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c5d511ae-e0f4-4ca2-a7dd-c670c34b76cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c5d511ae-e0f4-4ca2-a7dd-c670c34b76cf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c5d511ae-e0f4-4ca2-a7dd-c670c34b76cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_02966352-a251-4f0a-ba8b-8894b6c4320e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c5d511ae-e0f4-4ca2-a7dd-c670c34b76cf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_02966352-a251-4f0a-ba8b-8894b6c4320e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLoanMember_d7dc75d9-2bb7-45b3-bfce-f65d3bd0ac4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_02966352-a251-4f0a-ba8b-8894b6c4320e" xlink:to="loc_us-gaap_RealEstateLoanMember_d7dc75d9-2bb7-45b3-bfce-f65d3bd0ac4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ConstructionLoanMember_7fd912e8-7fd9-4263-b61f-8a22cc09c9da" xlink:href="ameh-20230630.xsd#ameh_ConstructionLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_02966352-a251-4f0a-ba8b-8894b6c4320e" xlink:to="loc_ameh_ConstructionLoanMember_7fd912e8-7fd9-4263-b61f-8a22cc09c9da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_37cb1b28-e77a-457a-aac1-aeb51dd3502d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_02966352-a251-4f0a-ba8b-8894b6c4320e" xlink:to="loc_us-gaap_NotesPayableToBanksMember_37cb1b28-e77a-457a-aac1-aeb51dd3502d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails" xlink:type="extended" id="i021e67aaafb5472fb16c21a1983f9258_CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_621c8c69-7c5c-4a18-8e85-09236fdf7168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_DebtInstrumentTerm_621c8c69-7c5c-4a18-8e85-09236fdf7168" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_583c72ba-3e4f-46d2-92ae-50217abe7586" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_583c72ba-3e4f-46d2-92ae-50217abe7586" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_93821f52-1d73-46b5-b432-9352d73327c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_93821f52-1d73-46b5-b432-9352d73327c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5785bd04-6e0c-4983-8a25-74330b7e4962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5785bd04-6e0c-4983-8a25-74330b7e4962" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a7a0592f-2992-4660-be8b-15d5d7ee17ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a7a0592f-2992-4660-be8b-15d5d7ee17ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_78e71a8c-f63e-41e6-9049-f3cb2c0a89c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_78e71a8c-f63e-41e6-9049-f3cb2c0a89c5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentNumberOfKeyFinancialRatios_ec5b6ad5-01fc-429c-b175-d1fa9ec276c6" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentNumberOfKeyFinancialRatios"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentNumberOfKeyFinancialRatios_ec5b6ad5-01fc-429c-b175-d1fa9ec276c6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantLeverageRatioMaximum_c6b7edb6-2f9d-43db-b976-b8e416eec391" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentCovenantLeverageRatioMaximum_c6b7edb6-2f9d-43db-b976-b8e416eec391" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtCovenantAggregatePurchasePriceMaximum_255ee3c7-6315-4f5d-a5b4-d8fee826d2d9" xlink:href="ameh-20230630.xsd#ameh_DebtCovenantAggregatePurchasePriceMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtCovenantAggregatePurchasePriceMaximum_255ee3c7-6315-4f5d-a5b4-d8fee826d2d9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange_d89b0023-cf5c-492b-80ed-f31bade06f22" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange_d89b0023-cf5c-492b-80ed-f31bade06f22" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_4399916c-042f-4740-927e-0ee8aef80924" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_4399916c-042f-4740-927e-0ee8aef80924" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum_3781eea4-b447-430c-9650-fcc93d0cbf4d" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum_3781eea4-b447-430c-9650-fcc93d0cbf4d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_b703ac99-79ac-419f-8ad0-61c8735424d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_b703ac99-79ac-419f-8ad0-61c8735424d2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_36a8dde4-409b-436c-beee-1389e583097d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_36a8dde4-409b-436c-beee-1389e583097d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_70327227-dba5-487e-b12d-e45070acbadf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_LongTermDebt_70327227-dba5-487e-b12d-e45070acbadf" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum_bfd83790-d5f4-414e-8b28-2b8caa418388" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum_bfd83790-d5f4-414e-8b28-2b8caa418388" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8da56cad-c977-473e-b6a2-257141eb7e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8da56cad-c977-473e-b6a2-257141eb7e4f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum_b940e147-b6a7-47a0-9979-7259e7f8e77f" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum_b940e147-b6a7-47a0-9979-7259e7f8e77f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtCovenantThresholdPercentageForOccupationOfProperty_0b66e31f-d59c-43b5-8e2d-569845fc36ce" xlink:href="ameh-20230630.xsd#ameh_DebtCovenantThresholdPercentageForOccupationOfProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtCovenantThresholdPercentageForOccupationOfProperty_0b66e31f-d59c-43b5-8e2d-569845fc36ce" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum_16063854-5638-4f7f-af1d-9338ef9cb7bc" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum_16063854-5638-4f7f-af1d-9338ef9cb7bc" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_18d8f1be-2e85-44a7-83d7-acf1f624326b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_18d8f1be-2e85-44a7-83d7-acf1f624326b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b9d8b975-bdba-4153-89a2-a1eba0d2458e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_InterestExpense_b9d8b975-bdba-4153-89a2-a1eba0d2458e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_f360bff2-0e92-403f-8a69-6008265e9c54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_f360bff2-0e92-403f-8a69-6008265e9c54" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2e473fbc-baa4-4726-86cd-b5f5aabc9722" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_us-gaap_CreditFacilityAxis_2e473fbc-baa4-4726-86cd-b5f5aabc9722" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2e473fbc-baa4-4726-86cd-b5f5aabc9722_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_2e473fbc-baa4-4726-86cd-b5f5aabc9722" xlink:to="loc_us-gaap_CreditFacilityDomain_2e473fbc-baa4-4726-86cd-b5f5aabc9722_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f7ab077d-f51d-42c5-8aac-8cdcd5915578" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_2e473fbc-baa4-4726-86cd-b5f5aabc9722" xlink:to="loc_us-gaap_CreditFacilityDomain_f7ab077d-f51d-42c5-8aac-8cdcd5915578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_03908b25-5750-4065-9e50-22d39166ae5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f7ab077d-f51d-42c5-8aac-8cdcd5915578" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_03908b25-5750-4065-9e50-22d39166ae5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_35a44f94-d7fa-40f4-aa61-460fec93e5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f7ab077d-f51d-42c5-8aac-8cdcd5915578" xlink:to="loc_us-gaap_LineOfCreditMember_35a44f94-d7fa-40f4-aa61-460fec93e5d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_8b7059e1-8a3e-4569-9fb3-90b18b92567e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f7ab077d-f51d-42c5-8aac-8cdcd5915578" xlink:to="loc_us-gaap_LetterOfCreditMember_8b7059e1-8a3e-4569-9fb3-90b18b92567e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_44453758-803f-4c21-b468-53507f44bf36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BridgeLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f7ab077d-f51d-42c5-8aac-8cdcd5915578" xlink:to="loc_us-gaap_BridgeLoanMember_44453758-803f-4c21-b468-53507f44bf36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_115f06c3-5c41-4eed-b009-190c7db6678d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f7ab077d-f51d-42c5-8aac-8cdcd5915578" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_115f06c3-5c41-4eed-b009-190c7db6678d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_532e1590-6017-41ec-8d8f-206cdfc45dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_us-gaap_DebtInstrumentAxis_532e1590-6017-41ec-8d8f-206cdfc45dc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_532e1590-6017-41ec-8d8f-206cdfc45dc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_532e1590-6017-41ec-8d8f-206cdfc45dc7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_532e1590-6017-41ec-8d8f-206cdfc45dc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_532e1590-6017-41ec-8d8f-206cdfc45dc7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AmendedCreditAgreementMember_6c8520db-6a77-4f49-8b59-2d4899875969" xlink:href="ameh-20230630.xsd#ameh_AmendedCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:to="loc_ameh_AmendedCreditAgreementMember_6c8520db-6a77-4f49-8b59-2d4899875969" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CreditAgreementMember_3ad6a6d3-ae01-4b89-b484-a9288a1f10d6" xlink:href="ameh-20230630.xsd#ameh_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:to="loc_ameh_CreditAgreementMember_3ad6a6d3-ae01-4b89-b484-a9288a1f10d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ConstructionLoanMember_3462e4d9-75a0-4bc9-87f4-443472e7de03" xlink:href="ameh-20230630.xsd#ameh_ConstructionLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:to="loc_ameh_ConstructionLoanMember_3462e4d9-75a0-4bc9-87f4-443472e7de03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionLoansMember_31afdd07-b770-42d8-be95-5a2b82f9907c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:to="loc_us-gaap_ConstructionLoansMember_31afdd07-b770-42d8-be95-5a2b82f9907c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SubordinatedLoanAgreementMember_41097c21-9579-4c2f-adb3-a39b82a642e7" xlink:href="ameh-20230630.xsd#ameh_SubordinatedLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:to="loc_ameh_SubordinatedLoanAgreementMember_41097c21-9579-4c2f-adb3-a39b82a642e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApcBusinessLoanAgreementMember_e4d4eca3-ab1c-4ade-afed-2760d03bf1ff" xlink:href="ameh-20230630.xsd#ameh_ApcBusinessLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:to="loc_ameh_ApcBusinessLoanAgreementMember_e4d4eca3-ab1c-4ade-afed-2760d03bf1ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_52e13bb3-7adf-419e-9379-17bbc3a18403" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_52e13bb3-7adf-419e-9379-17bbc3a18403" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_52e13bb3-7adf-419e-9379-17bbc3a18403_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_52e13bb3-7adf-419e-9379-17bbc3a18403" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_52e13bb3-7adf-419e-9379-17bbc3a18403_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9ad06bfc-df07-411a-b4b6-c0a8f6839bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_52e13bb3-7adf-419e-9379-17bbc3a18403" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9ad06bfc-df07-411a-b4b6-c0a8f6839bcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubordinatedDebtMember_8a2be505-cc0a-471a-9fd7-9fa8baf48063" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubordinatedDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9ad06bfc-df07-411a-b4b6-c0a8f6839bcb" xlink:to="loc_us-gaap_SubordinatedDebtMember_8a2be505-cc0a-471a-9fd7-9fa8baf48063" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_3786a3c5-3bc4-42df-9ef9-f7230df74be9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9ad06bfc-df07-411a-b4b6-c0a8f6839bcb" xlink:to="loc_us-gaap_LineOfCreditMember_3786a3c5-3bc4-42df-9ef9-f7230df74be9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_582512f4-b2d1-4d79-91de-7047c551300a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_srt_RangeAxis_582512f4-b2d1-4d79-91de-7047c551300a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_582512f4-b2d1-4d79-91de-7047c551300a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_582512f4-b2d1-4d79-91de-7047c551300a" xlink:to="loc_srt_RangeMember_582512f4-b2d1-4d79-91de-7047c551300a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_60d79b7e-879d-4ad5-9099-cca280f3aeb3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_582512f4-b2d1-4d79-91de-7047c551300a" xlink:to="loc_srt_RangeMember_60d79b7e-879d-4ad5-9099-cca280f3aeb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4daf8029-7501-426b-a815-387c3150accf" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_60d79b7e-879d-4ad5-9099-cca280f3aeb3" xlink:to="loc_srt_MinimumMember_4daf8029-7501-426b-a815-387c3150accf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4956c07b-4102-4294-b7b4-74b43fde3141" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_60d79b7e-879d-4ad5-9099-cca280f3aeb3" xlink:to="loc_srt_MaximumMember_4956c07b-4102-4294-b7b4-74b43fde3141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_97075898-3834-470d-9e91-d3ef9bf2fd67" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_dei_LegalEntityAxis_97075898-3834-470d-9e91-d3ef9bf2fd67" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_97075898-3834-470d-9e91-d3ef9bf2fd67_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_97075898-3834-470d-9e91-d3ef9bf2fd67" xlink:to="loc_dei_EntityDomain_97075898-3834-470d-9e91-d3ef9bf2fd67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_97075898-3834-470d-9e91-d3ef9bf2fd67" xlink:to="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MedicalPropertyPartnersLLCMember_f07b418b-b601-460c-b0bd-9da6c32dbe69" xlink:href="ameh-20230630.xsd#ameh_MedicalPropertyPartnersLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:to="loc_ameh_MedicalPropertyPartnersLLCMember_f07b418b-b601-460c-b0bd-9da6c32dbe69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AMGPropertiesLLCMember_ff46577f-daae-41b8-8ce8-dd43d8527eb9" xlink:href="ameh-20230630.xsd#ameh_AMGPropertiesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:to="loc_ameh_AMGPropertiesLLCMember_ff46577f-daae-41b8-8ce8-dd43d8527eb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ZLLPartnersLLCMember_3b79beb0-c81d-44ec-b253-6755c1589bcb" xlink:href="ameh-20230630.xsd#ameh_ZLLPartnersLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:to="loc_ameh_ZLLPartnersLLCMember_3b79beb0-c81d-44ec-b253-6755c1589bcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_A120HellmanLLCMember_3e968ab9-c8af-4ae7-b89d-8950d44bfc56" xlink:href="ameh-20230630.xsd#ameh_A120HellmanLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:to="loc_ameh_A120HellmanLLCMember_3e968ab9-c8af-4ae7-b89d-8950d44bfc56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_Tag8MedicalInvestmentGroupLLCMember_5675d386-10a3-4cf1-9fac-c9f7d5b67192" xlink:href="ameh-20230630.xsd#ameh_Tag8MedicalInvestmentGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:to="loc_ameh_Tag8MedicalInvestmentGroupLLCMember_5675d386-10a3-4cf1-9fac-c9f7d5b67192" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlliedPacificOfCaliforniaIPAMember_8329d5c4-290a-4432-b696-3689035fd607" xlink:href="ameh-20230630.xsd#ameh_AlliedPacificOfCaliforniaIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:to="loc_ameh_AlliedPacificOfCaliforniaIPAMember_8329d5c4-290a-4432-b696-3689035fd607" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlphaCareMedicalGroupInc.Member_55385571-b4b5-474b-b906-9eac46cc3975" xlink:href="ameh-20230630.xsd#ameh_AlphaCareMedicalGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:to="loc_ameh_AlphaCareMedicalGroupInc.Member_55385571-b4b5-474b-b906-9eac46cc3975" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_4b8869bb-c5f8-49cf-8d14-3964d6737119" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_us-gaap_VariableRateAxis_4b8869bb-c5f8-49cf-8d14-3964d6737119" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4b8869bb-c5f8-49cf-8d14-3964d6737119_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_4b8869bb-c5f8-49cf-8d14-3964d6737119" xlink:to="loc_us-gaap_VariableRateDomain_4b8869bb-c5f8-49cf-8d14-3964d6737119_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1b6e9955-5b72-450e-8962-50cabd5fd0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_4b8869bb-c5f8-49cf-8d14-3964d6737119" xlink:to="loc_us-gaap_VariableRateDomain_1b6e9955-5b72-450e-8962-50cabd5fd0d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SecuredOvernightFinancingRateMember_e7c0872f-7d12-4711-a278-89a12806fa91" xlink:href="ameh-20230630.xsd#ameh_SecuredOvernightFinancingRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1b6e9955-5b72-450e-8962-50cabd5fd0d7" xlink:to="loc_ameh_SecuredOvernightFinancingRateMember_e7c0872f-7d12-4711-a278-89a12806fa91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_7aaf5a4f-d509-4519-8acf-e5545fbdef2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1b6e9955-5b72-450e-8962-50cabd5fd0d7" xlink:to="loc_us-gaap_BaseRateMember_7aaf5a4f-d509-4519-8acf-e5545fbdef2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_618066fd-9dcb-4032-a589-815c2735857c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1b6e9955-5b72-450e-8962-50cabd5fd0d7" xlink:to="loc_us-gaap_PrimeRateMember_618066fd-9dcb-4032-a589-815c2735857c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_e75d35c5-805e-48ef-ac62-9b223c7eb12a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_e75d35c5-805e-48ef-ac62-9b223c7eb12a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_e75d35c5-805e-48ef-ac62-9b223c7eb12a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e75d35c5-805e-48ef-ac62-9b223c7eb12a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_e75d35c5-805e-48ef-ac62-9b223c7eb12a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_49e80cb8-8e77-4e6b-8408-17e84b9fd44b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e75d35c5-805e-48ef-ac62-9b223c7eb12a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_49e80cb8-8e77-4e6b-8408-17e84b9fd44b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PreferredBankMember_ef04e90e-221e-430d-9265-eaa7ab39c6ab" xlink:href="ameh-20230630.xsd#ameh_PreferredBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_49e80cb8-8e77-4e6b-8408-17e84b9fd44b" xlink:to="loc_ameh_PreferredBankMember_ef04e90e-221e-430d-9265-eaa7ab39c6ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_TruistBankMember_2723e5ee-bbb9-4bff-9afd-fbfebcda1bb4" xlink:href="ameh-20230630.xsd#ameh_TruistBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_49e80cb8-8e77-4e6b-8408-17e84b9fd44b" xlink:to="loc_ameh_TruistBankMember_2723e5ee-bbb9-4bff-9afd-fbfebcda1bb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_583cdc9f-6c74-476c-ac5e-43a6a2c36981" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_583cdc9f-6c74-476c-ac5e-43a6a2c36981" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_583cdc9f-6c74-476c-ac5e-43a6a2c36981_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_583cdc9f-6c74-476c-ac5e-43a6a2c36981" xlink:to="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_583cdc9f-6c74-476c-ac5e-43a6a2c36981_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_fe6634e2-26f3-47cb-9098-ea0c2131ad5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_583cdc9f-6c74-476c-ac5e-43a6a2c36981" xlink:to="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_fe6634e2-26f3-47cb-9098-ea0c2131ad5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_6576d48a-622f-4565-a4fe-2e3d321f6cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_fe6634e2-26f3-47cb-9098-ea0c2131ad5f" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_6576d48a-622f-4565-a4fe-2e3d321f6cd2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#MezzanineandStockholdersEquityAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails" xlink:type="extended" id="i86ac3a03bf644b7a932ba061c1b212f5_MezzanineandStockholdersEquityAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_4dc31648-1709-49cd-8848-cdfa818757a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_StockIssuedDuringPeriodSharesMerger_c2ea0754-5045-43cb-8337-a7f7887aadf1" xlink:href="ameh-20230630.xsd#ameh_StockIssuedDuringPeriodSharesMerger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4dc31648-1709-49cd-8848-cdfa818757a0" xlink:to="loc_ameh_StockIssuedDuringPeriodSharesMerger_c2ea0754-5045-43cb-8337-a7f7887aadf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_41d8b93c-6534-4973-909d-646f9b67a9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4dc31648-1709-49cd-8848-cdfa818757a0" xlink:to="loc_us-gaap_TreasuryStockCommonShares_41d8b93c-6534-4973-909d-646f9b67a9ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_d874c827-4db9-470d-a62a-0a0b6ebc52d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4dc31648-1709-49cd-8848-cdfa818757a0" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_d874c827-4db9-470d-a62a-0a0b6ebc52d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_add85ef0-efab-4058-b54b-21f1638cd711" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4dc31648-1709-49cd-8848-cdfa818757a0" xlink:to="loc_us-gaap_Dividends_add85ef0-efab-4058-b54b-21f1638cd711" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ac4c703a-3bcf-4334-a9da-d08da755c14c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_4dc31648-1709-49cd-8848-cdfa818757a0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ac4c703a-3bcf-4334-a9da-d08da755c14c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_03048eae-5eb7-4b07-8454-9fcefccbf750" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac4c703a-3bcf-4334-a9da-d08da755c14c" xlink:to="loc_dei_LegalEntityAxis_03048eae-5eb7-4b07-8454-9fcefccbf750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_03048eae-5eb7-4b07-8454-9fcefccbf750_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_03048eae-5eb7-4b07-8454-9fcefccbf750" xlink:to="loc_dei_EntityDomain_03048eae-5eb7-4b07-8454-9fcefccbf750_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_49b4b083-5fa2-45bd-8063-27ea61305cad" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_03048eae-5eb7-4b07-8454-9fcefccbf750" xlink:to="loc_dei_EntityDomain_49b4b083-5fa2-45bd-8063-27ea61305cad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlliedPacificOfCaliforniaIPAMember_c57a121d-638a-4bb1-96f5-aaa44c20006e" xlink:href="ameh-20230630.xsd#ameh_AlliedPacificOfCaliforniaIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_49b4b083-5fa2-45bd-8063-27ea61305cad" xlink:to="loc_ameh_AlliedPacificOfCaliforniaIPAMember_c57a121d-638a-4bb1-96f5-aaa44c20006e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CDSCMember_0653b029-713b-4c66-b8ee-2bd5075422e7" xlink:href="ameh-20230630.xsd#ameh_CDSCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_49b4b083-5fa2-45bd-8063-27ea61305cad" xlink:to="loc_ameh_CDSCMember_0653b029-713b-4c66-b8ee-2bd5075422e7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails" xlink:type="extended" id="i76a419e57738434ba0e2ed750757a2d7_StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0d8cde5-c6e1-461c-93ff-a7b121b497b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_596db328-a701-412b-a912-30e6847a048d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0d8cde5-c6e1-461c-93ff-a7b121b497b5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_596db328-a701-412b-a912-30e6847a048d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31b4af5f-1231-4f0f-8273-879dbce0cab1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0d8cde5-c6e1-461c-93ff-a7b121b497b5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31b4af5f-1231-4f0f-8273-879dbce0cab1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a80e270a-53cb-403f-9cc6-577b4aacaf1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31b4af5f-1231-4f0f-8273-879dbce0cab1" xlink:to="loc_us-gaap_AwardTypeAxis_a80e270a-53cb-403f-9cc6-577b4aacaf1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a80e270a-53cb-403f-9cc6-577b4aacaf1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a80e270a-53cb-403f-9cc6-577b4aacaf1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a80e270a-53cb-403f-9cc6-577b4aacaf1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65f1b127-146a-49f1-aa04-9222e8d490c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a80e270a-53cb-403f-9cc6-577b4aacaf1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65f1b127-146a-49f1-aa04-9222e8d490c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2c1f2a00-e1d0-4fe9-9127-ea6dc8dee7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65f1b127-146a-49f1-aa04-9222e8d490c8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2c1f2a00-e1d0-4fe9-9127-ea6dc8dee7c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_StockAwardsAndUnitsMember_ad7d040e-dc32-4c80-860e-cac9d0885eea" xlink:href="ameh-20230630.xsd#ameh_StockAwardsAndUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65f1b127-146a-49f1-aa04-9222e8d490c8" xlink:to="loc_ameh_StockAwardsAndUnitsMember_ad7d040e-dc32-4c80-860e-cac9d0885eea" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#StockBasedCompensationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="extended" id="i6a82dde627f747c29b3a86846c22d923_StockBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_315f0c57-1e7b-436e-9d06-79be9e140027" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_315f0c57-1e7b-436e-9d06-79be9e140027" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_05d85d26-5a37-4d16-8070-755a49cafd79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_05d85d26-5a37-4d16-8070-755a49cafd79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_28b6706b-e78b-47fa-b94f-d5d9fa326547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_28b6706b-e78b-47fa-b94f-d5d9fa326547" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cec5143e-2eb0-4c2a-aae1-f8b92a7a1999" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cec5143e-2eb0-4c2a-aae1-f8b92a7a1999" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_46032084-0a72-4d9c-ad06-ae1ccf018b40" xlink:href="ameh-20230630.xsd#ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_46032084-0a72-4d9c-ad06-ae1ccf018b40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ac76ae1c-11f4-4c36-affb-6b185c048285" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ac76ae1c-11f4-4c36-affb-6b185c048285" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_7ffaab43-37d4-4629-b2d6-da0d3563e1ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_7ffaab43-37d4-4629-b2d6-da0d3563e1ee" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_d340ff68-09fc-410e-820b-838165212714" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_d340ff68-09fc-410e-820b-838165212714" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod_c291abde-9dc2-4982-9ed0-967373183df2" xlink:href="ameh-20230630.xsd#ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod_c291abde-9dc2-4982-9ed0-967373183df2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised_e5c5e493-4279-491b-8529-304b9a8fdf36" xlink:href="ameh-20230630.xsd#ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised_e5c5e493-4279-491b-8529-304b9a8fdf36" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice_f46e0488-315e-45c6-b98b-642e4aed21a8" xlink:href="ameh-20230630.xsd#ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice_f46e0488-315e-45c6-b98b-642e4aed21a8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_97d054ad-1ce6-474e-a369-d8cda43e8446" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_97d054ad-1ce6-474e-a369-d8cda43e8446" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_e6f526f5-389b-43a0-8024-7f333be330fd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_97d054ad-1ce6-474e-a369-d8cda43e8446" xlink:to="loc_srt_TitleOfIndividualAxis_e6f526f5-389b-43a0-8024-7f333be330fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e6f526f5-389b-43a0-8024-7f333be330fd_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_e6f526f5-389b-43a0-8024-7f333be330fd" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e6f526f5-389b-43a0-8024-7f333be330fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_0f929bc3-83d4-4b68-946e-e8094a8b69ce" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_e6f526f5-389b-43a0-8024-7f333be330fd" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_0f929bc3-83d4-4b68-946e-e8094a8b69ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApcStockOptionMember_b22960c8-8049-4673-9912-783c42333856" xlink:href="ameh-20230630.xsd#ameh_ApcStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_0f929bc3-83d4-4b68-946e-e8094a8b69ce" xlink:to="loc_ameh_ApcStockOptionMember_b22960c8-8049-4673-9912-783c42333856" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_be9f983e-8747-43bd-ac59-0aaaaa414aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_97d054ad-1ce6-474e-a369-d8cda43e8446" xlink:to="loc_us-gaap_AwardTypeAxis_be9f983e-8747-43bd-ac59-0aaaaa414aa4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be9f983e-8747-43bd-ac59-0aaaaa414aa4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_be9f983e-8747-43bd-ac59-0aaaaa414aa4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be9f983e-8747-43bd-ac59-0aaaaa414aa4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4e53d1b-255b-4f88-8453-4a451fe1cea2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_be9f983e-8747-43bd-ac59-0aaaaa414aa4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4e53d1b-255b-4f88-8453-4a451fe1cea2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_42dd8ae1-8294-4204-a513-2dc8d4be0b26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4e53d1b-255b-4f88-8453-4a451fe1cea2" xlink:to="loc_us-gaap_RestrictedStockMember_42dd8ae1-8294-4204-a513-2dc8d4be0b26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PerformanceBasedRestrictedStockMember_da684b0b-cfb2-48b5-a66f-ca87195fcbeb" xlink:href="ameh-20230630.xsd#ameh_PerformanceBasedRestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4e53d1b-255b-4f88-8453-4a451fe1cea2" xlink:to="loc_ameh_PerformanceBasedRestrictedStockMember_da684b0b-cfb2-48b5-a66f-ca87195fcbeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_236d9470-a364-4bc0-966b-806bd7371ee0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_97d054ad-1ce6-474e-a369-d8cda43e8446" xlink:to="loc_srt_RangeAxis_236d9470-a364-4bc0-966b-806bd7371ee0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_236d9470-a364-4bc0-966b-806bd7371ee0_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_236d9470-a364-4bc0-966b-806bd7371ee0" xlink:to="loc_srt_RangeMember_236d9470-a364-4bc0-966b-806bd7371ee0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ffac8773-ea14-490a-b2a1-6f467de8b399" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_236d9470-a364-4bc0-966b-806bd7371ee0" xlink:to="loc_srt_RangeMember_ffac8773-ea14-490a-b2a1-6f467de8b399" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7723be1c-58fd-4ac3-b3d3-bdededd0d716" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ffac8773-ea14-490a-b2a1-6f467de8b399" xlink:to="loc_srt_MinimumMember_7723be1c-58fd-4ac3-b3d3-bdededd0d716" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d02c1652-6628-4737-bc62-fcbb87f3af9a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ffac8773-ea14-490a-b2a1-6f467de8b399" xlink:to="loc_srt_MaximumMember_d02c1652-6628-4737-bc62-fcbb87f3af9a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#CommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended" id="i879d572379534393954dd9e919d9cf40_CommitmentsandContingenciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CommitmentsAndContingenciesLineItems_6e38416e-aabe-4178-964b-57fa0a631bb1" xlink:href="ameh-20230630.xsd#ameh_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c53c468e-caf9-4fac-a26f-079cf1dcecb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_CommitmentsAndContingenciesLineItems_6e38416e-aabe-4178-964b-57fa0a631bb1" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c53c468e-caf9-4fac-a26f-079cf1dcecb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_82038271-d609-4ad2-bd50-2744247001b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_CommitmentsAndContingenciesLineItems_6e38416e-aabe-4178-964b-57fa0a631bb1" xlink:to="loc_us-gaap_LineOfCredit_82038271-d609-4ad2-bd50-2744247001b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CommitmentsAndContingenciesTable_041bddcc-9fdd-4dbc-bfa5-c7fd491f2d15" xlink:href="ameh-20230630.xsd#ameh_CommitmentsAndContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ameh_CommitmentsAndContingenciesLineItems_6e38416e-aabe-4178-964b-57fa0a631bb1" xlink:to="loc_ameh_CommitmentsAndContingenciesTable_041bddcc-9fdd-4dbc-bfa5-c7fd491f2d15" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b5cf2c05-c0e7-4608-a64a-27e08f143ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_CommitmentsAndContingenciesTable_041bddcc-9fdd-4dbc-bfa5-c7fd491f2d15" xlink:to="loc_us-gaap_DebtInstrumentAxis_b5cf2c05-c0e7-4608-a64a-27e08f143ba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b5cf2c05-c0e7-4608-a64a-27e08f143ba9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b5cf2c05-c0e7-4608-a64a-27e08f143ba9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b5cf2c05-c0e7-4608-a64a-27e08f143ba9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f2834b3e-1621-48ad-a961-bd7845d79946" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b5cf2c05-c0e7-4608-a64a-27e08f143ba9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f2834b3e-1621-48ad-a961-bd7845d79946" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AmendedCreditAgreementMember_34d3d41f-2431-43d2-869e-f2fd737de6d5" xlink:href="ameh-20230630.xsd#ameh_AmendedCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2834b3e-1621-48ad-a961-bd7845d79946" xlink:to="loc_ameh_AmendedCreditAgreementMember_34d3d41f-2431-43d2-869e-f2fd737de6d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_6b25e2fa-74e5-4052-8d56-521075e4d741" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_CommitmentsAndContingenciesTable_041bddcc-9fdd-4dbc-bfa5-c7fd491f2d15" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_6b25e2fa-74e5-4052-8d56-521075e4d741" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_6b25e2fa-74e5-4052-8d56-521075e4d741_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_6b25e2fa-74e5-4052-8d56-521075e4d741" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_6b25e2fa-74e5-4052-8d56-521075e4d741_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_a9f04c4a-f19d-4e3e-9fc5-51be74cf1967" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_6b25e2fa-74e5-4052-8d56-521075e4d741" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_a9f04c4a-f19d-4e3e-9fc5-51be74cf1967" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_TruistBankMember_2bea873d-3ac1-4e23-ad4a-3be675f80b3d" xlink:href="ameh-20230630.xsd#ameh_TruistBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_a9f04c4a-f19d-4e3e-9fc5-51be74cf1967" xlink:to="loc_ameh_TruistBankMember_2bea873d-3ac1-4e23-ad4a-3be675f80b3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_229f422f-da53-46fc-af46-a2cc9627aa5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_CommitmentsAndContingenciesTable_041bddcc-9fdd-4dbc-bfa5-c7fd491f2d15" xlink:to="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_229f422f-da53-46fc-af46-a2cc9627aa5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_229f422f-da53-46fc-af46-a2cc9627aa5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_229f422f-da53-46fc-af46-a2cc9627aa5c" xlink:to="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_229f422f-da53-46fc-af46-a2cc9627aa5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_2feb99a6-31bb-43a9-9b65-6cc5f283efb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_229f422f-da53-46fc-af46-a2cc9627aa5c" xlink:to="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_2feb99a6-31bb-43a9-9b65-6cc5f283efb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_5a85d52d-c2de-4c56-be0e-812fe2588106" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_2feb99a6-31bb-43a9-9b65-6cc5f283efb5" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_5a85d52d-c2de-4c56-be0e-812fe2588106" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6da6aa5a-9a46-4f6e-951a-5bf10a9ff983" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_CommitmentsAndContingenciesTable_041bddcc-9fdd-4dbc-bfa5-c7fd491f2d15" xlink:to="loc_dei_LegalEntityAxis_6da6aa5a-9a46-4f6e-951a-5bf10a9ff983" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6da6aa5a-9a46-4f6e-951a-5bf10a9ff983_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_6da6aa5a-9a46-4f6e-951a-5bf10a9ff983" xlink:to="loc_dei_EntityDomain_6da6aa5a-9a46-4f6e-951a-5bf10a9ff983_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_45d1ad9e-1370-4bd1-ae58-29ea67217757" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_6da6aa5a-9a46-4f6e-951a-5bf10a9ff983" xlink:to="loc_dei_EntityDomain_45d1ad9e-1370-4bd1-ae58-29ea67217757" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlliedPacificOfCaliforniaIPAMember_83b5ede6-2c88-4ae0-8841-0b236d8a0410" xlink:href="ameh-20230630.xsd#ameh_AlliedPacificOfCaliforniaIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_45d1ad9e-1370-4bd1-ae58-29ea67217757" xlink:to="loc_ameh_AlliedPacificOfCaliforniaIPAMember_83b5ede6-2c88-4ae0-8841-0b236d8a0410" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlphaCareMedicalGroupInc.Member_e7a2661a-63c4-4703-9895-3c4d17027b91" xlink:href="ameh-20230630.xsd#ameh_AlphaCareMedicalGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_45d1ad9e-1370-4bd1-ae58-29ea67217757" xlink:to="loc_ameh_AlphaCareMedicalGroupInc.Member_e7a2661a-63c4-4703-9895-3c4d17027b91" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#RelatedPartyTransactionsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="extended" id="i2a9c0df8c453450e98b769fee50a6dac_RelatedPartyTransactionsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_3bb0fdff-6406-4daa-bc61-a234173ab97f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_68f7b8c9-1e98-4601-9ff1-06a723752fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3bb0fdff-6406-4daa-bc61-a234173ab97f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_68f7b8c9-1e98-4601-9ff1-06a723752fd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_bc43784b-24ae-4039-8cc1-2131336b9e03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3bb0fdff-6406-4daa-bc61-a234173ab97f" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_bc43784b-24ae-4039-8cc1-2131336b9e03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9ce9cf02-b9f9-4e81-9c65-778a78a46dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3bb0fdff-6406-4daa-bc61-a234173ab97f" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9ce9cf02-b9f9-4e81-9c65-778a78a46dd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7849dbe6-4f09-478e-a155-dcf9e209658a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3bb0fdff-6406-4daa-bc61-a234173ab97f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7849dbe6-4f09-478e-a155-dcf9e209658a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCreditsAndOtherLiabilities_e77b7aff-3d1d-4625-b344-f21dc9d3771b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCreditsAndOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3bb0fdff-6406-4daa-bc61-a234173ab97f" xlink:to="loc_us-gaap_DeferredCreditsAndOtherLiabilities_e77b7aff-3d1d-4625-b344-f21dc9d3771b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3bb0fdff-6406-4daa-bc61-a234173ab97f" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4b1044b0-1bda-450e-9c29-5300d89b2de8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4b1044b0-1bda-450e-9c29-5300d89b2de8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4b1044b0-1bda-450e-9c29-5300d89b2de8_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4b1044b0-1bda-450e-9c29-5300d89b2de8" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4b1044b0-1bda-450e-9c29-5300d89b2de8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d6417800-60fb-4350-85f9-b10627a0301d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4b1044b0-1bda-450e-9c29-5300d89b2de8" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d6417800-60fb-4350-85f9-b10627a0301d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LmaMember_55808dcc-00bd-4d67-8e79-7abdad3ddff6" xlink:href="ameh-20230630.xsd#ameh_LmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6417800-60fb-4350-85f9-b10627a0301d" xlink:to="loc_ameh_LmaMember_55808dcc-00bd-4d67-8e79-7abdad3ddff6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PmiocMember_7d8f0cbd-1143-417f-9831-0c06b39a7126" xlink:href="ameh-20230630.xsd#ameh_PmiocMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6417800-60fb-4350-85f9-b10627a0301d" xlink:to="loc_ameh_PmiocMember_7d8f0cbd-1143-417f-9831-0c06b39a7126" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OneMSOInc.Member_e420845d-885d-4852-858c-58579e2f324e" xlink:href="ameh-20230630.xsd#ameh_OneMSOInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6417800-60fb-4350-85f9-b10627a0301d" xlink:to="loc_ameh_OneMSOInc.Member_e420845d-885d-4852-858c-58579e2f324e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_79da9f35-5066-405a-a02f-306664922e9d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:to="loc_dei_LegalEntityAxis_79da9f35-5066-405a-a02f-306664922e9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_79da9f35-5066-405a-a02f-306664922e9d_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_79da9f35-5066-405a-a02f-306664922e9d" xlink:to="loc_dei_EntityDomain_79da9f35-5066-405a-a02f-306664922e9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ac77f567-9510-4b93-995e-b98de9b7a882" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_79da9f35-5066-405a-a02f-306664922e9d" xlink:to="loc_dei_EntityDomain_ac77f567-9510-4b93-995e-b98de9b7a882" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NetworkMedicalManagementMember_765ca09e-6b57-4efd-af43-74eb35e071bc" xlink:href="ameh-20230630.xsd#ameh_NetworkMedicalManagementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ac77f567-9510-4b93-995e-b98de9b7a882" xlink:to="loc_ameh_NetworkMedicalManagementMember_765ca09e-6b57-4efd-af43-74eb35e071bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlliedPacificOfCaliforniaIPAMember_eede976b-6bca-4079-9450-1cacf0e9ffaf" xlink:href="ameh-20230630.xsd#ameh_AlliedPacificOfCaliforniaIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ac77f567-9510-4b93-995e-b98de9b7a882" xlink:to="loc_ameh_AlliedPacificOfCaliforniaIPAMember_eede976b-6bca-4079-9450-1cacf0e9ffaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MedicalPropertyPartnersLLCMember_fcb9df15-691a-40f5-84cc-ac62d167a679" xlink:href="ameh-20230630.xsd#ameh_MedicalPropertyPartnersLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ac77f567-9510-4b93-995e-b98de9b7a882" xlink:to="loc_ameh_MedicalPropertyPartnersLLCMember_fcb9df15-691a-40f5-84cc-ac62d167a679" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_Tag6MedicalInvestmentGroupLLCMember_09f5876e-b92e-48d4-b9b7-9c74cee2ff0d" xlink:href="ameh-20230630.xsd#ameh_Tag6MedicalInvestmentGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ac77f567-9510-4b93-995e-b98de9b7a882" xlink:to="loc_ameh_Tag6MedicalInvestmentGroupLLCMember_09f5876e-b92e-48d4-b9b7-9c74cee2ff0d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f4faf2a0-4c05-4ece-a70c-18eb758b1fd1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:to="loc_srt_CounterpartyNameAxis_f4faf2a0-4c05-4ece-a70c-18eb758b1fd1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f4faf2a0-4c05-4ece-a70c-18eb758b1fd1_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_f4faf2a0-4c05-4ece-a70c-18eb758b1fd1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f4faf2a0-4c05-4ece-a70c-18eb758b1fd1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_f4faf2a0-4c05-4ece-a70c-18eb758b1fd1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LmaMember_7e68240a-1802-46d6-b9af-112276894e82" xlink:href="ameh-20230630.xsd#ameh_LmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_LmaMember_7e68240a-1802-46d6-b9af-112276894e82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ArroyoVistaMember_4145ff77-ef4f-42d3-b48e-dbdc14a72da4" xlink:href="ameh-20230630.xsd#ameh_ArroyoVistaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_ArroyoVistaMember_4145ff77-ef4f-42d3-b48e-dbdc14a72da4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PmiocMember_b41df9d3-5948-4fbd-a8a0-d6b0b288c1c1" xlink:href="ameh-20230630.xsd#ameh_PmiocMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_PmiocMember_b41df9d3-5948-4fbd-a8a0-d6b0b288c1c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SongPCMember_9d1380a2-6c8c-4b3c-a28c-314ce580da84" xlink:href="ameh-20230630.xsd#ameh_SongPCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_SongPCMember_9d1380a2-6c8c-4b3c-a28c-314ce580da84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AdvanceDiagnosticSurgeryCenterMember_a1a3331c-d780-4f55-8c53-e9271c9517fd" xlink:href="ameh-20230630.xsd#ameh_AdvanceDiagnosticSurgeryCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_AdvanceDiagnosticSurgeryCenterMember_a1a3331c-d780-4f55-8c53-e9271c9517fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DiagnosticAndSurgicalCenterMember_7ef7d02d-8262-4239-9502-e8a01950135d" xlink:href="ameh-20230630.xsd#ameh_DiagnosticAndSurgicalCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_DiagnosticAndSurgicalCenterMember_7ef7d02d-8262-4239-9502-e8a01950135d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FulgentGeneticsIncMember_5a6fc228-4436-45bf-b72c-9fd0e4781fe5" xlink:href="ameh-20230630.xsd#ameh_FulgentGeneticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_FulgentGeneticsIncMember_5a6fc228-4436-45bf-b72c-9fd0e4781fe5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SunnyVillageCareCenterMember_2b724a30-4d01-4d5a-b3c5-b8d27750deab" xlink:href="ameh-20230630.xsd#ameh_SunnyVillageCareCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_SunnyVillageCareCenterMember_2b724a30-4d01-4d5a-b3c5-b8d27750deab" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OneMSOInc.Member_15be8fc6-fdf8-46a3-b7c5-7720c2b41686" xlink:href="ameh-20230630.xsd#ameh_OneMSOInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_OneMSOInc.Member_15be8fc6-fdf8-46a3-b7c5-7720c2b41686" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AHMCMember_4289e6c1-7b9a-4a29-948b-70b11b41e030" xlink:href="ameh-20230630.xsd#ameh_AHMCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_AHMCMember_4289e6c1-7b9a-4a29-948b-70b11b41e030" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApcShareholdersMember_fce56aa9-ee9c-4d90-92d7-955c5e2ab2b7" xlink:href="ameh-20230630.xsd#ameh_ApcShareholdersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_ApcShareholdersMember_fce56aa9-ee9c-4d90-92d7-955c5e2ab2b7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareholdersAndOfficersMember_766b86ce-52c5-4289-97df-087eb0be7ff7" xlink:href="ameh-20230630.xsd#ameh_ShareholdersAndOfficersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_ShareholdersAndOfficersMember_766b86ce-52c5-4289-97df-087eb0be7ff7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BoardMembersMember_9afbcbe8-8355-45c5-8e61-e2e20a19a4a5" xlink:href="ameh-20230630.xsd#ameh_BoardMembersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_BoardMembersMember_9afbcbe8-8355-45c5-8e61-e2e20a19a4a5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BoardMembersWhoAreAlsoOfficersMember_5ebbca75-c4ff-41c9-915e-09fe56ea906e" xlink:href="ameh-20230630.xsd#ameh_BoardMembersWhoAreAlsoOfficersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_BoardMembersWhoAreAlsoOfficersMember_5ebbca75-c4ff-41c9-915e-09fe56ea906e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ec63a175-878c-4a50-85bc-3136cb6a1a61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ec63a175-878c-4a50-85bc-3136cb6a1a61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ec63a175-878c-4a50-85bc-3136cb6a1a61_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ec63a175-878c-4a50-85bc-3136cb6a1a61" xlink:to="loc_us-gaap_RelatedPartyDomain_ec63a175-878c-4a50-85bc-3136cb6a1a61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4aa7f79e-dc57-451f-a003-e11351c798da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ec63a175-878c-4a50-85bc-3136cb6a1a61" xlink:to="loc_us-gaap_RelatedPartyDomain_4aa7f79e-dc57-451f-a003-e11351c798da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_ae095fef-d773-4695-8233-7a8c85c6944e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4aa7f79e-dc57-451f-a003-e11351c798da" xlink:to="loc_us-gaap_RelatedPartyMember_ae095fef-d773-4695-8233-7a8c85c6944e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_7a429323-0cbd-4978-b8ce-9ae7af4a856a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4aa7f79e-dc57-451f-a003-e11351c798da" xlink:to="loc_srt_DirectorMember_7a429323-0cbd-4978-b8ce-9ae7af4a856a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_0c06aa00-9b31-47bb-8571-4e8379fa552a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_0c06aa00-9b31-47bb-8571-4e8379fa552a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_0c06aa00-9b31-47bb-8571-4e8379fa552a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_0c06aa00-9b31-47bb-8571-4e8379fa552a" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_0c06aa00-9b31-47bb-8571-4e8379fa552a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_70a9f81f-a44f-4510-8963-53772d3cd774" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_0c06aa00-9b31-47bb-8571-4e8379fa552a" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_70a9f81f-a44f-4510-8963-53772d3cd774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ProviderServicesMember_476ef76c-0ad4-4847-ad95-926b0371f745" xlink:href="ameh-20230630.xsd#ameh_ProviderServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_70a9f81f-a44f-4510-8963-53772d3cd774" xlink:to="loc_ameh_ProviderServicesMember_476ef76c-0ad4-4847-ad95-926b0371f745" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_RentPaymentMember_26c01fef-6af0-48af-a8dd-fe927bd6f64a" xlink:href="ameh-20230630.xsd#ameh_RentPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_70a9f81f-a44f-4510-8963-53772d3cd774" xlink:to="loc_ameh_RentPaymentMember_26c01fef-6af0-48af-a8dd-fe927bd6f64a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OfficeLeaseMember_7ecbba6c-e1fb-45da-8d68-a5ffe8ef435c" xlink:href="ameh-20230630.xsd#ameh_OfficeLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_70a9f81f-a44f-4510-8963-53772d3cd774" xlink:to="loc_ameh_OfficeLeaseMember_7ecbba6c-e1fb-45da-8d68-a5ffe8ef435c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2c53ce8b-4c30-4849-a090-51c95044196a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:to="loc_srt_ProductOrServiceAxis_2c53ce8b-4c30-4849-a090-51c95044196a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2c53ce8b-4c30-4849-a090-51c95044196a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_2c53ce8b-4c30-4849-a090-51c95044196a" xlink:to="loc_srt_ProductsAndServicesDomain_2c53ce8b-4c30-4849-a090-51c95044196a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_74cf46a9-c9c2-405a-9d79-dc3b02e20254" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_2c53ce8b-4c30-4849-a090-51c95044196a" xlink:to="loc_srt_ProductsAndServicesDomain_74cf46a9-c9c2-405a-9d79-dc3b02e20254" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_361eed09-819f-4b00-96d5-a439fd606c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_74cf46a9-c9c2-405a-9d79-dc3b02e20254" xlink:to="loc_us-gaap_HealthCareOtherMember_361eed09-819f-4b00-96d5-a439fd606c1b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails" xlink:type="extended" id="i8b79e0d7fce54bbdac1f00221cda5414_RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_ff457a1f-01df-44ec-a282-f080558fa4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_cac6d59a-6bb9-4966-a102-b6e11de45e71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ff457a1f-01df-44ec-a282-f080558fa4b6" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_cac6d59a-6bb9-4966-a102-b6e11de45e71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eae26146-b822-4511-b8b8-62ef8e915973" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ff457a1f-01df-44ec-a282-f080558fa4b6" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eae26146-b822-4511-b8b8-62ef8e915973" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_172cd485-8765-466d-8cc6-e210394e0791" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eae26146-b822-4511-b8b8-62ef8e915973" xlink:to="loc_srt_CounterpartyNameAxis_172cd485-8765-466d-8cc6-e210394e0791" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_172cd485-8765-466d-8cc6-e210394e0791_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_172cd485-8765-466d-8cc6-e210394e0791" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_172cd485-8765-466d-8cc6-e210394e0791_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8bfefb82-7c7b-4385-9913-11806ca25ea1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_172cd485-8765-466d-8cc6-e210394e0791" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8bfefb82-7c7b-4385-9913-11806ca25ea1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AHMCMember_86c0c943-a251-4094-9ade-50a884d10aa9" xlink:href="ameh-20230630.xsd#ameh_AHMCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8bfefb82-7c7b-4385-9913-11806ca25ea1" xlink:to="loc_ameh_AHMCMember_86c0c943-a251-4094-9ade-50a884d10aa9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_HSMSOMember_2c0d1e48-8dcb-4047-ada1-64ebd47c82da" xlink:href="ameh-20230630.xsd#ameh_HSMSOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8bfefb82-7c7b-4385-9913-11806ca25ea1" xlink:to="loc_ameh_HSMSOMember_2c0d1e48-8dcb-4047-ada1-64ebd47c82da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AurionMember_47e8c561-fa6c-4a4b-b220-016ec83dc780" xlink:href="ameh-20230630.xsd#ameh_AurionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8bfefb82-7c7b-4385-9913-11806ca25ea1" xlink:to="loc_ameh_AurionMember_47e8c561-fa6c-4a4b-b220-016ec83dc780" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_05d4c42c-e098-486a-b07f-b2fdf4228676" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eae26146-b822-4511-b8b8-62ef8e915973" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_05d4c42c-e098-486a-b07f-b2fdf4228676" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_05d4c42c-e098-486a-b07f-b2fdf4228676_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_05d4c42c-e098-486a-b07f-b2fdf4228676" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_05d4c42c-e098-486a-b07f-b2fdf4228676_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_a52a8a77-7b90-44f9-a5be-4859fb19e76e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_05d4c42c-e098-486a-b07f-b2fdf4228676" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_a52a8a77-7b90-44f9-a5be-4859fb19e76e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FeesIncurredAndIncomeRecognizedMember_d2b150ef-a561-4191-a658-ad9e802515a8" xlink:href="ameh-20230630.xsd#ameh_FeesIncurredAndIncomeRecognizedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_a52a8a77-7b90-44f9-a5be-4859fb19e76e" xlink:to="loc_ameh_FeesIncurredAndIncomeRecognizedMember_d2b150ef-a561-4191-a658-ad9e802515a8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#EarningsPerShareAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails" xlink:type="extended" id="i65744075ca344b1da0343db359a11481_EarningsPerShareAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EarningsPerShareLineItems_5bff2b21-5c75-4b95-afb5-44806944a170" xlink:href="ameh-20230630.xsd#ameh_EarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_42ae35e4-144e-4348-bc3b-2fd92638b88d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_EarningsPerShareLineItems_5bff2b21-5c75-4b95-afb5-44806944a170" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_42ae35e4-144e-4348-bc3b-2fd92638b88d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EarningsPerShareTable_71a83c09-05a3-4c9c-96c6-9e645068cfb4" xlink:href="ameh-20230630.xsd#ameh_EarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ameh_EarningsPerShareLineItems_5bff2b21-5c75-4b95-afb5-44806944a170" xlink:to="loc_ameh_EarningsPerShareTable_71a83c09-05a3-4c9c-96c6-9e645068cfb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8cf42cf1-c3e4-48cb-ad7f-ce929762fb0d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_EarningsPerShareTable_71a83c09-05a3-4c9c-96c6-9e645068cfb4" xlink:to="loc_dei_LegalEntityAxis_8cf42cf1-c3e4-48cb-ad7f-ce929762fb0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8cf42cf1-c3e4-48cb-ad7f-ce929762fb0d_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_8cf42cf1-c3e4-48cb-ad7f-ce929762fb0d" xlink:to="loc_dei_EntityDomain_8cf42cf1-c3e4-48cb-ad7f-ce929762fb0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8a179663-0c95-46f0-bace-dcde26cfc986" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_8cf42cf1-c3e4-48cb-ad7f-ce929762fb0d" xlink:to="loc_dei_EntityDomain_8a179663-0c95-46f0-bace-dcde26cfc986" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlliedPacificOfCaliforniaIPAMember_19369892-0f89-46d9-ad1c-889f63658a8d" xlink:href="ameh-20230630.xsd#ameh_AlliedPacificOfCaliforniaIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8a179663-0c95-46f0-bace-dcde26cfc986" xlink:to="loc_ameh_AlliedPacificOfCaliforniaIPAMember_19369892-0f89-46d9-ad1c-889f63658a8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d5b2fadf-7eda-4e4e-bfed-27a37c1c466d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_EarningsPerShareTable_71a83c09-05a3-4c9c-96c6-9e645068cfb4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d5b2fadf-7eda-4e4e-bfed-27a37c1c466d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d5b2fadf-7eda-4e4e-bfed-27a37c1c466d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d5b2fadf-7eda-4e4e-bfed-27a37c1c466d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d5b2fadf-7eda-4e4e-bfed-27a37c1c466d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_36703dca-3edd-4f76-9043-e031486f102b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d5b2fadf-7eda-4e4e-bfed-27a37c1c466d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_36703dca-3edd-4f76-9043-e031486f102b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_92d3b811-7378-45e0-8875-072e16b8802f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_36703dca-3edd-4f76-9043-e031486f102b" xlink:to="loc_us-gaap_RestrictedStockMember_92d3b811-7378-45e0-8875-072e16b8802f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_1dbc044d-3d67-4613-8d96-6fdea482e549" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_36703dca-3edd-4f76-9043-e031486f102b" xlink:to="loc_us-gaap_PerformanceSharesMember_1dbc044d-3d67-4613-8d96-6fdea482e549" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails" xlink:type="extended" id="i9b034cbf00db4cbeabb3f7633883ba0d_EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EarningsPerShareLineItems_4408ca33-5865-456c-9c70-81b957dde2a0" xlink:href="ameh-20230630.xsd#ameh_EarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5d9fdb29-da76-4dff-97e3-05420e525ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_EarningsPerShareLineItems_4408ca33-5865-456c-9c70-81b957dde2a0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5d9fdb29-da76-4dff-97e3-05420e525ee1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c5b07874-e269-4db0-9dd9-2c47190da068" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_EarningsPerShareLineItems_4408ca33-5865-456c-9c70-81b957dde2a0" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c5b07874-e269-4db0-9dd9-2c47190da068" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_3e19b169-4a6b-4028-8c85-082cf7070d57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_EarningsPerShareLineItems_4408ca33-5865-456c-9c70-81b957dde2a0" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_3e19b169-4a6b-4028-8c85-082cf7070d57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d4fdc736-d841-4694-9b2f-0c462f4823cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ameh_EarningsPerShareLineItems_4408ca33-5865-456c-9c70-81b957dde2a0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d4fdc736-d841-4694-9b2f-0c462f4823cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EarningsPerShareTable_0257994d-f49b-493b-b861-7657691d62c8" xlink:href="ameh-20230630.xsd#ameh_EarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ameh_EarningsPerShareLineItems_4408ca33-5865-456c-9c70-81b957dde2a0" xlink:to="loc_ameh_EarningsPerShareTable_0257994d-f49b-493b-b861-7657691d62c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_731b2c25-14c4-4a76-957f-326f603f97dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_EarningsPerShareTable_0257994d-f49b-493b-b861-7657691d62c8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_731b2c25-14c4-4a76-957f-326f603f97dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_731b2c25-14c4-4a76-957f-326f603f97dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_731b2c25-14c4-4a76-957f-326f603f97dc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_731b2c25-14c4-4a76-957f-326f603f97dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_154f9ee7-7aab-411b-beeb-ccb147ebfffe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_731b2c25-14c4-4a76-957f-326f603f97dc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_154f9ee7-7aab-411b-beeb-ccb147ebfffe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b178cbb0-dc6e-41e7-b6d5-03933334a6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_154f9ee7-7aab-411b-beeb-ccb147ebfffe" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b178cbb0-dc6e-41e7-b6d5-03933334a6b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_7c7c4a9c-0ca2-4c4d-a9fa-ac56ed2ce1be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_154f9ee7-7aab-411b-beeb-ccb147ebfffe" xlink:to="loc_us-gaap_RestrictedStockMember_7c7c4a9c-0ca2-4c4d-a9fa-ac56ed2ce1be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c7dfea90-e8aa-4045-9b83-2662267b8234" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ameh_EarningsPerShareTable_0257994d-f49b-493b-b861-7657691d62c8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c7dfea90-e8aa-4045-9b83-2662267b8234" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c7dfea90-e8aa-4045-9b83-2662267b8234_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c7dfea90-e8aa-4045-9b83-2662267b8234" xlink:to="loc_us-gaap_EquityComponentDomain_c7dfea90-e8aa-4045-9b83-2662267b8234_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_16d08a5f-8d6d-4652-86af-4ba0cc620bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c7dfea90-e8aa-4045-9b83-2662267b8234" xlink:to="loc_us-gaap_EquityComponentDomain_16d08a5f-8d6d-4652-86af-4ba0cc620bfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_4980ba98-3dad-4e62-b8a3-3727050b8cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_16d08a5f-8d6d-4652-86af-4ba0cc620bfd" xlink:to="loc_us-gaap_WarrantMember_4980ba98-3dad-4e62-b8a3-3727050b8cd5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#VariableInterestEntitiesVIEsDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails" xlink:type="extended" id="if81a44a9fe1440cda3bc16a7ffae97ed_VariableInterestEntitiesVIEsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_d9cfca96-817f-498c-beef-afa46a6bb39d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e4fad303-ca16-4f1e-8e5f-24787527de85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9cfca96-817f-498c-beef-afa46a6bb39d" xlink:to="loc_us-gaap_AssetsAbstract_e4fad303-ca16-4f1e-8e5f-24787527de85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_e4fad303-ca16-4f1e-8e5f-24787527de85" xlink:to="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_52d4d46b-960f-4210-8402-756600f26525" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_52d4d46b-960f-4210-8402-756600f26525" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_6f4c05dd-e9e9-4ad6-8c34-89238c0bdbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_6f4c05dd-e9e9-4ad6-8c34-89238c0bdbaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_edd6bccf-cf50-4d16-8ecf-33fe176d87a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_edd6bccf-cf50-4d16-8ecf-33fe176d87a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_48b97611-76e3-493e-be8b-b03e68bcd240" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_IncomeTaxesReceivable_48b97611-76e3-493e-be8b-b03e68bcd240" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_3a9134f2-9705-4b76-97b8-e1fa13a10b48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_3a9134f2-9705-4b76-97b8-e1fa13a10b48" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_570a0844-c568-48bf-98e9-724b0b100838" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_570a0844-c568-48bf-98e9-724b0b100838" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_c2023582-ce19-4689-b0de-9bc6303fcd53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_c2023582-ce19-4689-b0de-9bc6303fcd53" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_85c37102-b7dd-422c-8279-b91b5b1ae4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_OtherAssetsCurrent_85c37102-b7dd-422c-8279-b91b5b1ae4c9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_43292dfb-e00d-4531-b49d-8ab10abf7988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_AssetsCurrent_43292dfb-e00d-4531-b49d-8ab10abf7988" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_e4fad303-ca16-4f1e-8e5f-24787527de85" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6036957f-29f6-4086-89a2-3129241fd716" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6036957f-29f6-4086-89a2-3129241fd716" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a1c3e86-2e49-496b-a102-812c99cd4a73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a1c3e86-2e49-496b-a102-812c99cd4a73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e91abaed-aeb1-4d76-a4dc-63a3b7a537e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_Goodwill_e91abaed-aeb1-4d76-a4dc-63a3b7a537e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_854d5e80-c1c6-4227-a7c2-fb8e15060ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_854d5e80-c1c6-4227-a7c2-fb8e15060ca4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_5c127c8b-afc3-4b5b-b00b-0446ec2afa53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_OtherLongTermInvestments_5c127c8b-afc3-4b5b-b00b-0446ec2afa53" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ca2e2e9d-d645-4ac4-a9c1-adf27019c66d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_EquityMethodInvestments_ca2e2e9d-d645-4ac4-a9c1-adf27019c66d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_8f642586-7372-4735-a3b9-607bb96faef5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_8f642586-7372-4735-a3b9-607bb96faef5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_def8d5de-39d2-416d-9e44-163ec310d764" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_def8d5de-39d2-416d-9e44-163ec310d764" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2b747099-960c-452c-b18b-9cf4659c6fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2b747099-960c-452c-b18b-9cf4659c6fe1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_07af3e20-c15a-4cbd-9eb2-da4788a42fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_AssetsNoncurrent_07af3e20-c15a-4cbd-9eb2-da4788a42fbf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8c988e5d-71b4-44b8-899b-f657f1203dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_e4fad303-ca16-4f1e-8e5f-24787527de85" xlink:to="loc_us-gaap_Assets_8c988e5d-71b4-44b8-899b-f657f1203dcd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9cfca96-817f-498c-beef-afa46a6bb39d" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_57ee0046-b8eb-4e3d-b5f8-eaaab7778f03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_57ee0046-b8eb-4e3d-b5f8-eaaab7778f03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FiduciaryAccountsPayableCurrent_bef3719d-074c-4238-86d8-f57b97d987b8" xlink:href="ameh-20230630.xsd#ameh_FiduciaryAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_ameh_FiduciaryAccountsPayableCurrent_bef3719d-074c-4238-86d8-f57b97d987b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1607a69b-51e3-44c6-b5f7-e8c38ff2515a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1607a69b-51e3-44c6-b5f7-e8c38ff2515a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_69a72089-c826-44f7-a802-3d4cda6ac2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_TaxesPayableCurrent_69a72089-c826-44f7-a802-3d4cda6ac2ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_0d8d63e3-56b9-45ba-a3fc-ad8e79d362f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_DividendsPayableCurrent_0d8d63e3-56b9-45ba-a3fc-ad8e79d362f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_550577cb-f039-4254-8b1a-5fd01de3c765" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_550577cb-f039-4254-8b1a-5fd01de3c765" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_24ddcaa1-f9a0-4817-a919-6d4e6ba93c09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_LongTermDebtCurrent_24ddcaa1-f9a0-4817-a919-6d4e6ba93c09" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_76ca59cd-439e-46dd-aac6-a9dc5d3cf7af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_76ca59cd-439e-46dd-aac6-a9dc5d3cf7af" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5907e610-291a-4ae2-9a28-5a53d7c34377" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5907e610-291a-4ae2-9a28-5a53d7c34377" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2ebf1828-b972-4923-bb96-8e6cea12d8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_LiabilitiesCurrent_2ebf1828-b972-4923-bb96-8e6cea12d8e1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9cfca96-817f-498c-beef-afa46a6bb39d" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_58832e5f-06fb-40c1-996c-bc961da055c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_58832e5f-06fb-40c1-996c-bc961da055c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_17396cf0-3e6f-413c-81d4-cd12332a7724" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_17396cf0-3e6f-413c-81d4-cd12332a7724" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_db710b42-d8e7-4930-a31e-df14aa9c94c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_db710b42-d8e7-4930-a31e-df14aa9c94c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1946482f-809b-4377-aeac-dd0ef83c7e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1946482f-809b-4377-aeac-dd0ef83c7e2d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2dee748a-b6ce-41b1-a49e-a716ddabdaf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2dee748a-b6ce-41b1-a49e-a716ddabdaf9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_0bae284f-ca3d-41f7-bf60-419a61df6e95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_0bae284f-ca3d-41f7-bf60-419a61df6e95" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_01f278b0-6ba1-4cdd-8f3b-e255cfa7a3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9cfca96-817f-498c-beef-afa46a6bb39d" xlink:to="loc_us-gaap_Liabilities_01f278b0-6ba1-4cdd-8f3b-e255cfa7a3b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b2a72e7b-9be9-4ee3-8b0a-be524fc0798f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9cfca96-817f-498c-beef-afa46a6bb39d" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b2a72e7b-9be9-4ee3-8b0a-be524fc0798f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_bf3628c4-0bec-4c13-9f0b-21afe278aa48" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b2a72e7b-9be9-4ee3-8b0a-be524fc0798f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_bf3628c4-0bec-4c13-9f0b-21afe278aa48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_bf3628c4-0bec-4c13-9f0b-21afe278aa48_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_bf3628c4-0bec-4c13-9f0b-21afe278aa48" xlink:to="loc_srt_ConsolidatedEntitiesDomain_bf3628c4-0bec-4c13-9f0b-21afe278aa48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1d7c3044-ba39-44c8-bd44-e098d3c77d8b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_bf3628c4-0bec-4c13-9f0b-21afe278aa48" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1d7c3044-ba39-44c8-bd44-e098d3c77d8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_6c88bd49-4f6e-48ed-abd0-cc596afebcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1d7c3044-ba39-44c8-bd44-e098d3c77d8b" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_6c88bd49-4f6e-48ed-abd0-cc596afebcaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_722c0024-9a6c-4f07-8cbd-f8c31bd862ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b2a72e7b-9be9-4ee3-8b0a-be524fc0798f" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_722c0024-9a6c-4f07-8cbd-f8c31bd862ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_722c0024-9a6c-4f07-8cbd-f8c31bd862ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_722c0024-9a6c-4f07-8cbd-f8c31bd862ff" xlink:to="loc_us-gaap_RelatedPartyDomain_722c0024-9a6c-4f07-8cbd-f8c31bd862ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_49b30f87-c83d-4a2f-8634-6835923bce1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_722c0024-9a6c-4f07-8cbd-f8c31bd862ff" xlink:to="loc_us-gaap_RelatedPartyDomain_49b30f87-c83d-4a2f-8634-6835923bce1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember_14e969d6-0c1a-4819-bbe5-86680dabce7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_49b30f87-c83d-4a2f-8634-6835923bce1e" xlink:to="loc_us-gaap_NonrelatedPartyMember_14e969d6-0c1a-4819-bbe5-86680dabce7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_395d4e9b-26e6-43b9-91ec-b121daf0c5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_49b30f87-c83d-4a2f-8634-6835923bce1e" xlink:to="loc_us-gaap_RelatedPartyMember_395d4e9b-26e6-43b9-91ec-b121daf0c5b1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesAdditionalinformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#LeasesAdditionalinformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/LeasesAdditionalinformationDetails" xlink:type="extended" id="i3d619640cd5f43eca40514748ba7aa60_LeasesAdditionalinformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_1edf5fab-601f-4e63-978d-85876354d8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_1edf5fab-601f-4e63-978d-85876354d8ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_d54d794b-1c8b-4515-84cc-243acd2d5ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_d54d794b-1c8b-4515-84cc-243acd2d5ccb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_6e5fd436-8da2-48c1-8c8f-cb25e8c1fa4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_6e5fd436-8da2-48c1-8c8f-cb25e8c1fa4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_e19eea8a-595a-442c-8ec8-2732f76b8d73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_e19eea8a-595a-442c-8ec8-2732f76b8d73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable_756c5d4f-7a82-4c04-ad95-c97b3edd2c37" xlink:href="ameh-20230630.xsd#ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable_756c5d4f-7a82-4c04-ad95-c97b3edd2c37" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable_4fc9b1e2-9152-4e41-b73e-f53e1de7ae74" xlink:href="ameh-20230630.xsd#ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable_4fc9b1e2-9152-4e41-b73e-f53e1de7ae74" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_779e728b-6734-44a9-8071-bd8b174a726e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_779e728b-6734-44a9-8071-bd8b174a726e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_eac5c020-dc8d-4415-a866-019b2b90822c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_eac5c020-dc8d-4415-a866-019b2b90822c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_01ba914b-4f3c-4f71-9fbf-4767838327ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_01ba914b-4f3c-4f71-9fbf-4767838327ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cbb5c1df-7c1e-495e-b332-c3e6896a6c0f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_01ba914b-4f3c-4f71-9fbf-4767838327ba" xlink:to="loc_srt_RangeAxis_cbb5c1df-7c1e-495e-b332-c3e6896a6c0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cbb5c1df-7c1e-495e-b332-c3e6896a6c0f_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cbb5c1df-7c1e-495e-b332-c3e6896a6c0f" xlink:to="loc_srt_RangeMember_cbb5c1df-7c1e-495e-b332-c3e6896a6c0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_29b51038-4010-44ca-8f84-8c1f5e8a9895" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cbb5c1df-7c1e-495e-b332-c3e6896a6c0f" xlink:to="loc_srt_RangeMember_29b51038-4010-44ca-8f84-8c1f5e8a9895" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dcc20fd6-0a54-4a17-911d-a94bf2c3f2ba" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_29b51038-4010-44ca-8f84-8c1f5e8a9895" xlink:to="loc_srt_MinimumMember_dcc20fd6-0a54-4a17-911d-a94bf2c3f2ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_86ae8ac9-8b9d-4eff-b86b-025784421f41" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_29b51038-4010-44ca-8f84-8c1f5e8a9895" xlink:to="loc_srt_MaximumMember_86ae8ac9-8b9d-4eff-b86b-025784421f41" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#SegmentsScheduleofInformationaboutourSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails" xlink:type="extended" id="i3986e365017648c3a385f4cb5708cc60_SegmentsScheduleofInformationaboutourSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_dc42d5bf-afb3-4a07-9256-01851663c8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_07df1ca4-fd8a-4f86-96b6-21c01ba18c34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dc42d5bf-afb3-4a07-9256-01851663c8cf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_07df1ca4-fd8a-4f86-96b6-21c01ba18c34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_d245e8d6-d97f-4307-aa8f-7ccbf87e4777" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dc42d5bf-afb3-4a07-9256-01851663c8cf" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_d245e8d6-d97f-4307-aa8f-7ccbf87e4777" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_38f6ca3b-5fcd-4bb4-bb9b-ba143e89ebf7" xlink:href="ameh-20230630.xsd#ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dc42d5bf-afb3-4a07-9256-01851663c8cf" xlink:to="loc_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_38f6ca3b-5fcd-4bb4-bb9b-ba143e89ebf7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b95e0210-b99d-420b-8fe0-8a9e87181ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dc42d5bf-afb3-4a07-9256-01851663c8cf" xlink:to="loc_us-gaap_CostsAndExpenses_b95e0210-b99d-420b-8fe0-8a9e87181ee0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8868cdc9-1964-4340-af05-c3d7d57285f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dc42d5bf-afb3-4a07-9256-01851663c8cf" xlink:to="loc_us-gaap_OperatingIncomeLoss_8868cdc9-1964-4340-af05-c3d7d57285f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_58bafea5-936d-4c9a-91d2-83e437e5e559" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dc42d5bf-afb3-4a07-9256-01851663c8cf" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_58bafea5-936d-4c9a-91d2-83e437e5e559" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3978f50f-3dcd-4d20-aa40-4988c0e35f42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_58bafea5-936d-4c9a-91d2-83e437e5e559" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3978f50f-3dcd-4d20-aa40-4988c0e35f42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3978f50f-3dcd-4d20-aa40-4988c0e35f42_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3978f50f-3dcd-4d20-aa40-4988c0e35f42" xlink:to="loc_us-gaap_SegmentDomain_3978f50f-3dcd-4d20-aa40-4988c0e35f42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_234213bd-c640-45c2-847a-c406454297e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3978f50f-3dcd-4d20-aa40-4988c0e35f42" xlink:to="loc_us-gaap_SegmentDomain_234213bd-c640-45c2-847a-c406454297e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CareEnablementMember_c1a0f975-114f-4a50-b3fc-2d74f0bccd1b" xlink:href="ameh-20230630.xsd#ameh_CareEnablementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_234213bd-c640-45c2-847a-c406454297e3" xlink:to="loc_ameh_CareEnablementMember_c1a0f975-114f-4a50-b3fc-2d74f0bccd1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CarePartnersMember_e61125ee-bec9-475e-91c2-af3656597aff" xlink:href="ameh-20230630.xsd#ameh_CarePartnersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_234213bd-c640-45c2-847a-c406454297e3" xlink:to="loc_ameh_CarePartnersMember_e61125ee-bec9-475e-91c2-af3656597aff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CareDeliveryMember_bffb643e-af72-4c72-ad59-f4219d09bedd" xlink:href="ameh-20230630.xsd#ameh_CareDeliveryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_234213bd-c640-45c2-847a-c406454297e3" xlink:to="loc_ameh_CareDeliveryMember_bffb643e-af72-4c72-ad59-f4219d09bedd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_ee4a357e-17c3-4d6a-80e1-af2a085167ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_234213bd-c640-45c2-847a-c406454297e3" xlink:to="loc_us-gaap_AllOtherSegmentsMember_ee4a357e-17c3-4d6a-80e1-af2a085167ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_889b5685-d585-4eaf-bdb2-6b8e32fff991" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_58bafea5-936d-4c9a-91d2-83e437e5e559" xlink:to="loc_srt_ConsolidationItemsAxis_889b5685-d585-4eaf-bdb2-6b8e32fff991" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_889b5685-d585-4eaf-bdb2-6b8e32fff991_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_889b5685-d585-4eaf-bdb2-6b8e32fff991" xlink:to="loc_srt_ConsolidationItemsDomain_889b5685-d585-4eaf-bdb2-6b8e32fff991_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2078c77a-6617-4a8e-bd9e-a8df482036f9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_889b5685-d585-4eaf-bdb2-6b8e32fff991" xlink:to="loc_srt_ConsolidationItemsDomain_2078c77a-6617-4a8e-bd9e-a8df482036f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1f4ff5e8-a4b2-41ec-9bf2-d1f86503f633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2078c77a-6617-4a8e-bd9e-a8df482036f9" xlink:to="loc_us-gaap_OperatingSegmentsMember_1f4ff5e8-a4b2-41ec-9bf2-d1f86503f633" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_5d9a1a6d-0136-4378-b1c2-444bbc79f6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2078c77a-6617-4a8e-bd9e-a8df482036f9" xlink:to="loc_us-gaap_IntersegmentEliminationMember_5d9a1a6d-0136-4378-b1c2-444bbc79f6fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e4d476d6-4dcc-465a-a1ce-f11149307bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2078c77a-6617-4a8e-bd9e-a8df482036f9" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e4d476d6-4dcc-465a-a1ce-f11149307bb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_1065644e-612b-4ce1-9efc-29e3da29a580" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_58bafea5-936d-4c9a-91d2-83e437e5e559" xlink:to="loc_us-gaap_SubsegmentsAxis_1065644e-612b-4ce1-9efc-29e3da29a580" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_1065644e-612b-4ce1-9efc-29e3da29a580_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_1065644e-612b-4ce1-9efc-29e3da29a580" xlink:to="loc_us-gaap_SubsegmentsDomain_1065644e-612b-4ce1-9efc-29e3da29a580_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_b014461f-54fb-4fc4-bade-66d704494203" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_1065644e-612b-4ce1-9efc-29e3da29a580" xlink:to="loc_us-gaap_SubsegmentsDomain_b014461f-54fb-4fc4-bade-66d704494203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_d00aff50-692d-476f-a264-1cfbc440e0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_b014461f-54fb-4fc4-bade-66d704494203" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_d00aff50-692d-476f-a264-1cfbc440e0b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_e13002c6-bce3-4b14-af36-8b18b1ea10ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_b014461f-54fb-4fc4-bade-66d704494203" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_e13002c6-bce3-4b14-af36-8b18b1ea10ae" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#SubsequentEventsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails" xlink:type="extended" id="i6b1d3f2e55f049a0b59ef3f147bd6eea_SubsequentEventsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_db029837-d4ee-46fb-b133-75a84c5ccc38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NumberOfPrimaryCareProvider_496a652b-9fb4-4f7f-8c55-da738791b50a" xlink:href="ameh-20230630.xsd#ameh_NumberOfPrimaryCareProvider"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_db029837-d4ee-46fb-b133-75a84c5ccc38" xlink:to="loc_ameh_NumberOfPrimaryCareProvider_496a652b-9fb4-4f7f-8c55-da738791b50a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NumberOfPrimaryCareServices_ea36b135-9df6-493f-93d7-e791f555f3c0" xlink:href="ameh-20230630.xsd#ameh_NumberOfPrimaryCareServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_db029837-d4ee-46fb-b133-75a84c5ccc38" xlink:to="loc_ameh_NumberOfPrimaryCareServices_ea36b135-9df6-493f-93d7-e791f555f3c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_041d94b1-16d1-4153-96f9-08d010e6c560" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_db029837-d4ee-46fb-b133-75a84c5ccc38" xlink:to="loc_us-gaap_DebtInstrumentTerm_041d94b1-16d1-4153-96f9-08d010e6c560" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_86391862-3e4e-4efa-924e-3b877b00bbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_db029837-d4ee-46fb-b133-75a84c5ccc38" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_86391862-3e4e-4efa-924e-3b877b00bbb8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f478b4cf-7e11-4c07-a29b-bf71ed2927fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_db029837-d4ee-46fb-b133-75a84c5ccc38" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f478b4cf-7e11-4c07-a29b-bf71ed2927fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_f9e5be88-335d-43a6-a2a5-b32fb796c403" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_db029837-d4ee-46fb-b133-75a84c5ccc38" xlink:to="loc_us-gaap_SubsequentEventTable_f9e5be88-335d-43a6-a2a5-b32fb796c403" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9149721d-8cfa-48e0-991b-284dd1bb9e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_f9e5be88-335d-43a6-a2a5-b32fb796c403" xlink:to="loc_us-gaap_DebtInstrumentAxis_9149721d-8cfa-48e0-991b-284dd1bb9e1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9149721d-8cfa-48e0-991b-284dd1bb9e1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9149721d-8cfa-48e0-991b-284dd1bb9e1e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9149721d-8cfa-48e0-991b-284dd1bb9e1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fa3b920b-0b28-4798-a73b-33ff73b3c29a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9149721d-8cfa-48e0-991b-284dd1bb9e1e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fa3b920b-0b28-4798-a73b-33ff73b3c29a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_IntraCareConvertiblePromissoryNoteReceivableMember_2998ec12-fd56-407b-a25b-50fff8fb50e0" xlink:href="ameh-20230630.xsd#ameh_IntraCareConvertiblePromissoryNoteReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa3b920b-0b28-4798-a73b-33ff73b3c29a" xlink:to="loc_ameh_IntraCareConvertiblePromissoryNoteReceivableMember_2998ec12-fd56-407b-a25b-50fff8fb50e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ccf60463-bd9b-4842-9070-f783d7b77ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_f9e5be88-335d-43a6-a2a5-b32fb796c403" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ccf60463-bd9b-4842-9070-f783d7b77ef2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ccf60463-bd9b-4842-9070-f783d7b77ef2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ccf60463-bd9b-4842-9070-f783d7b77ef2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ccf60463-bd9b-4842-9070-f783d7b77ef2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_221b4713-616a-4fa1-b0de-0e6d5d62de0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ccf60463-bd9b-4842-9070-f783d7b77ef2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_221b4713-616a-4fa1-b0de-0e6d5d62de0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_784d14f4-40bf-4808-ae7e-5e822ba34ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_221b4713-616a-4fa1-b0de-0e6d5d62de0b" xlink:to="loc_us-gaap_SubsequentEventMember_784d14f4-40bf-4808-ae7e-5e822ba34ee4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ac48e0c1-4af9-4b6c-8912-337f02b8cbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_f9e5be88-335d-43a6-a2a5-b32fb796c403" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ac48e0c1-4af9-4b6c-8912-337f02b8cbc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ac48e0c1-4af9-4b6c-8912-337f02b8cbc0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ac48e0c1-4af9-4b6c-8912-337f02b8cbc0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ac48e0c1-4af9-4b6c-8912-337f02b8cbc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3e2c3233-d4f9-44bc-9421-bea3da7d373d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ac48e0c1-4af9-4b6c-8912-337f02b8cbc0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3e2c3233-d4f9-44bc-9421-bea3da7d373d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_4f331df7-faa1-4808-8848-9f8614c648d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3e2c3233-d4f9-44bc-9421-bea3da7d373d" xlink:to="loc_us-gaap_NotesReceivableMember_4f331df7-faa1-4808-8848-9f8614c648d2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_StockAwardsAndUnitsMember_82f66b1f-3531-4447-9a51-f8eaa893a5b7" xlink:href="ameh-20230630.xsd#ameh_StockAwardsAndUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ameh_StockAwardsAndUnitsMember_82f66b1f-3531-4447-9a51-f8eaa893a5b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockMember" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PerformanceBasedRestrictedStockMember_0ae3124b-5a22-486f-96eb-17dbf1752899" xlink:href="ameh-20230630.xsd#ameh_PerformanceBasedRestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ameh_PerformanceBasedRestrictedStockMember_0ae3124b-5a22-486f-96eb-17dbf1752899" xlink:type="arc" order="6"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>ameh-20230630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:3040ecaa-d98f-42d5-9854-9c1a7ec98864,g:10a2b015-69d1-478c-967c-e01a9974c48a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_APCMGMember_3a690661-1e25-4f1b-bd45-396de992b3ca_terseLabel_en-US" xlink:label="lab_ameh_APCMGMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APCMG</link:label>
    <link:label id="lab_ameh_APCMGMember_label_en-US" xlink:label="lab_ameh_APCMGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APCMG [Member]</link:label>
    <link:label id="lab_ameh_APCMGMember_documentation_en-US" xlink:label="lab_ameh_APCMGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APCMG</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_APCMGMember" xlink:href="ameh-20230630.xsd#ameh_APCMGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_APCMGMember" xlink:to="lab_ameh_APCMGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0056859b-6948-4edd-b32b-fc865d8eac7f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum loan availability</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fccb353-4d3e-450c-b929-8e82c05a33aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of business combinations:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_TransferOfCommonControlEntities_414304d8-246b-4d95-ba96-26cb5cb839eb_terseLabel_en-US" xlink:label="lab_ameh_TransferOfCommonControlEntities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of common control entities (restated)</link:label>
    <link:label id="lab_ameh_TransferOfCommonControlEntities_label_en-US" xlink:label="lab_ameh_TransferOfCommonControlEntities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Common Control Entities</link:label>
    <link:label id="lab_ameh_TransferOfCommonControlEntities_documentation_en-US" xlink:label="lab_ameh_TransferOfCommonControlEntities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Common Control Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_TransferOfCommonControlEntities" xlink:href="ameh-20230630.xsd#ameh_TransferOfCommonControlEntities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_TransferOfCommonControlEntities" xlink:to="lab_ameh_TransferOfCommonControlEntities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_1d50ac69-55e8-48d3-bca8-9da72d284083_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aecedd3a-cfc8-410e-87ca-3c3528807cd3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_4ef98d6d-0572-4435-b80e-e6d124da4c8c_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_6e1ce02b-8938-4004-a72f-46fbe9f82692_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_MedicaidMember_53f6f0c9-1676-47ea-a051-62218d68ed21_terseLabel_en-US" xlink:label="lab_ameh_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid</link:label>
    <link:label id="lab_ameh_MedicaidMember_label_en-US" xlink:label="lab_ameh_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid [Member]</link:label>
    <link:label id="lab_ameh_MedicaidMember_documentation_en-US" xlink:label="lab_ameh_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ameh:MedicaidMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MedicaidMember" xlink:href="ameh-20230630.xsd#ameh_MedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_MedicaidMember" xlink:to="lab_ameh_MedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_be1f76db-1094-43d7-9980-b83f6ccf63bb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in affiliates</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestments" xlink:to="lab_us-gaap_OtherLongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1_a31f9696-28f4-46bb-aef3-38a433bf1f09_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease option to extend (up to)</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:to="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_5fb88332-32c6-4e58-be64-924354f9668a_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_477caf29-c762-4093-a34e-851f1b1b4128_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9803e9db-b495-4df2-8100-6a378a7e571c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_57e71c28-2cc4-4e95-8f05-89009d98033e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent equity securities</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsCurrent" xlink:to="lab_us-gaap_DerivativeAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_2ef981c3-d532-4f0b-b96b-54fb1f899561_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_90f78051-cc68-46d5-a7f6-64549c257a15_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_CommercialMember_f9427ea8-73bc-4a05-8568-7c8ae9c3bccd_terseLabel_en-US" xlink:label="lab_ameh_CommercialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial</link:label>
    <link:label id="lab_ameh_CommercialMember_label_en-US" xlink:label="lab_ameh_CommercialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial [Member]</link:label>
    <link:label id="lab_ameh_CommercialMember_documentation_en-US" xlink:label="lab_ameh_CommercialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ameh:CommercialMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CommercialMember" xlink:href="ameh-20230630.xsd#ameh_CommercialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_CommercialMember" xlink:to="lab_ameh_CommercialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_fc1551c4-6e0e-4ca0-bbcc-d4f2bdae7933_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_bb387f19-ab23-49e8-be3f-3b11c9b9c1db_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_d1bb41eb-ec5e-4d18-9ae0-18a099f943d3_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubordinatedDebtMember_ac222942-2ca9-4a7e-b63d-7d8885813c94_terseLabel_en-US" xlink:label="lab_us-gaap_SubordinatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subordinated Debt</link:label>
    <link:label id="lab_us-gaap_SubordinatedDebtMember_label_en-US" xlink:label="lab_us-gaap_SubordinatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subordinated Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubordinatedDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubordinatedDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubordinatedDebtMember" xlink:to="lab_us-gaap_SubordinatedDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_b3630589-d854-4e42-b5e1-c14bdc040393_totalLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_0c580384-9f1d-47b9-9a42-a1147c51d6ae_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board members</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_CDSCMember_fd85fe05-6e4a-44e8-8d5a-d5c431b8e7b4_terseLabel_en-US" xlink:label="lab_ameh_CDSCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CDSC</link:label>
    <link:label id="lab_ameh_CDSCMember_label_en-US" xlink:label="lab_ameh_CDSCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CDSC [Member]</link:label>
    <link:label id="lab_ameh_CDSCMember_documentation_en-US" xlink:label="lab_ameh_CDSCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CDSC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CDSCMember" xlink:href="ameh-20230630.xsd#ameh_CDSCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_CDSCMember" xlink:to="lab_ameh_CDSCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_64752c3f-a5d5-4ccd-8157-6e10a90836c8_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_de176725-7e92-4de3-9ecf-8ba5c0aca281_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_e3dd167c-6e35-429c-bab2-7e05ab585565_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_IncreaseDecreaseInMedicalLiabilities_9751df38-a931-450a-aa3f-80f2edb490b4_verboseLabel_en-US" xlink:label="lab_ameh_IncreaseDecreaseInMedicalLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical liabilities</link:label>
    <link:label id="lab_ameh_IncreaseDecreaseInMedicalLiabilities_label_en-US" xlink:label="lab_ameh_IncreaseDecreaseInMedicalLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Medical Liabilities</link:label>
    <link:label id="lab_ameh_IncreaseDecreaseInMedicalLiabilities_documentation_en-US" xlink:label="lab_ameh_IncreaseDecreaseInMedicalLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in the aggregate amount of medical liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_IncreaseDecreaseInMedicalLiabilities" xlink:href="ameh-20230630.xsd#ameh_IncreaseDecreaseInMedicalLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_IncreaseDecreaseInMedicalLiabilities" xlink:to="lab_ameh_IncreaseDecreaseInMedicalLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManagementServiceMember_d4efa5b8-ea05-47ae-a3d1-41de21ce7b19_terseLabel_en-US" xlink:label="lab_us-gaap_ManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fee income</link:label>
    <link:label id="lab_us-gaap_ManagementServiceMember_label_en-US" xlink:label="lab_us-gaap_ManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManagementServiceMember" xlink:to="lab_us-gaap_ManagementServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_8ca72ed2-9abd-4049-a66e-8249cf03c8f6_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_53fcafb1-8a65-415c-913e-b507c54d6fbf_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Elimination</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_b22dbdab-80ac-424d-9132-e2d3cdf268a6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_1b2b877e-c178-42c9-9548-8408849d1860_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share &#8211; diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_c3c64a3d-031c-4ad2-82a3-c115387ed06d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e7135be1-90d7-488d-8093-b9b1c177c5cc_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_c1b764a1-8cbf-45a9-b760-8a1d83077d93_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_40ae6264-b92b-40fe-82df-593af4517d5c_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_10828f4e-e80b-4a04-a970-5669aed816fb_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_6cb9c0cf-66cd-4e4a-8065-24fbd52462c9_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_98c16dfe-fd79-4628-9dba-eaa9808d3e94_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_1e8f3d6d-2dbe-41a9-95c6-7858e2d16238_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_2afc0866-2fbd-47f8-ad67-03231081730b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investments - equity method</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsCurrent_aff3f411-e2ed-46fc-a5a0-afb82befa4e8_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash &#8211; current</link:label>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashEquivalentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashEquivalentsCurrent" xlink:to="lab_us-gaap_RestrictedCashEquivalentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_80546698-43a1-4637-8539-fb83003ca416_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7bd636d4-7833-4d1c-87b5-9c004a4065d2_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a428d432-6d55-48e4-8f3b-bea7bd04c8cd_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_35bd6036-3d35-4948-a9d6-692a094a3a39_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_fd0aefc7-278e-4704-a99d-731027d32c16_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share Computations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_d2dbb1d3-a407-4800-9c6b-d4ec1665a8a5_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, amount of transaction</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DebtCovenantThresholdPercentageForOccupationOfProperty_13fee888-92be-49a9-a1ff-e96098b6627b_terseLabel_en-US" xlink:label="lab_ameh_DebtCovenantThresholdPercentageForOccupationOfProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt covenant, threshold percentage for occupation of property</link:label>
    <link:label id="lab_ameh_DebtCovenantThresholdPercentageForOccupationOfProperty_label_en-US" xlink:label="lab_ameh_DebtCovenantThresholdPercentageForOccupationOfProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Threshold Percentage for Occupation of Property</link:label>
    <link:label id="lab_ameh_DebtCovenantThresholdPercentageForOccupationOfProperty_documentation_en-US" xlink:label="lab_ameh_DebtCovenantThresholdPercentageForOccupationOfProperty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Threshold Percentage for Occupation of Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtCovenantThresholdPercentageForOccupationOfProperty" xlink:href="ameh-20230630.xsd#ameh_DebtCovenantThresholdPercentageForOccupationOfProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DebtCovenantThresholdPercentageForOccupationOfProperty" xlink:to="lab_ameh_DebtCovenantThresholdPercentageForOccupationOfProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_69755644-33da-447b-9ccd-bc53e1561b56_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shares Included in the Diluted Earnings Per Share Computations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease_efdbc581-bf32-47bc-8da6-691055f5bc30_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_463d5e24-f8f8-408a-bde7-8d35948d4743_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_d55fcbe8-ff6e-48ef-9aca-b086084e5ea0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_TruistBankMember_ae873650-002b-4b34-b8fd-e75793f304e4_terseLabel_en-US" xlink:label="lab_ameh_TruistBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truist Bank</link:label>
    <link:label id="lab_ameh_TruistBankMember_label_en-US" xlink:label="lab_ameh_TruistBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truist Bank [Member]</link:label>
    <link:label id="lab_ameh_TruistBankMember_documentation_en-US" xlink:label="lab_ameh_TruistBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truist Bank</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_TruistBankMember" xlink:href="ameh-20230630.xsd#ameh_TruistBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_TruistBankMember" xlink:to="lab_ameh_TruistBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_4e2ea6a3-f768-4ccf-842f-ddb281b561ed_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_d8985a88-074b-45e4-ba7b-74aa3bd6b672_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_SubcontractorIPAPayable_8c10b01f-2c3b-4a60-9966-cea28cc1a9fc_verboseLabel_en-US" xlink:label="lab_ameh_SubcontractorIPAPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subcontractor IPA payable</link:label>
    <link:label id="lab_ameh_SubcontractorIPAPayable_label_en-US" xlink:label="lab_ameh_SubcontractorIPAPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subcontractor IPA Payable</link:label>
    <link:label id="lab_ameh_SubcontractorIPAPayable_documentation_en-US" xlink:label="lab_ameh_SubcontractorIPAPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subcontractor IPA Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SubcontractorIPAPayable" xlink:href="ameh-20230630.xsd#ameh_SubcontractorIPAPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_SubcontractorIPAPayable" xlink:to="lab_ameh_SubcontractorIPAPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_31bdbb9d-2c4d-46f4-a817-0ad18d677816_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b2cfc3bc-82ad-408b-ba1f-e86624e5ec60_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_b7a6fa3a-3bd9-41e7-bb10-8e127237f3ca_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_dc18bf7e-5887-4d0c-afa6-2cedd3b0db58_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_4ca1b6d6-287a-4dcd-b900-b432543b08fe_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current period</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3f3443b3-3c40-4393-9a88-40b5be991a3e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7a3e262f-2e01-4046-9f51-cd4730327aa9_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_09fc4fd0-dbd2-4b11-9a90-a82826aca919_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_8c760599-ac93-4b4e-a5a8-a05cf9c46dfc_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_d636bf52-9408-44f6-bbac-653afa2727a1_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_29b00fe9-01da-4cc1-bee0-dd74dce0d2ff_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables and Receivables-Related Parties</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_MarketableSecuritiesCurrentMaturityPeriod_5d93c072-fc26-46f4-8915-76e99dfd2f45_terseLabel_en-US" xlink:label="lab_ameh_MarketableSecuritiesCurrentMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term marketable securities, maturity period</link:label>
    <link:label id="lab_ameh_MarketableSecuritiesCurrentMaturityPeriod_label_en-US" xlink:label="lab_ameh_MarketableSecuritiesCurrentMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current, Maturity Period</link:label>
    <link:label id="lab_ameh_MarketableSecuritiesCurrentMaturityPeriod_documentation_en-US" xlink:label="lab_ameh_MarketableSecuritiesCurrentMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current, Maturity Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MarketableSecuritiesCurrentMaturityPeriod" xlink:href="ameh-20230630.xsd#ameh_MarketableSecuritiesCurrentMaturityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_MarketableSecuritiesCurrentMaturityPeriod" xlink:to="lab_ameh_MarketableSecuritiesCurrentMaturityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_c299c6c8-76c3-45ef-a4d1-63c8eb4bebb0_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_PmiocMember_53c93038-6da7-4f89-9cfa-26f512e093f8_terseLabel_en-US" xlink:label="lab_ameh_PmiocMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PMIOC</link:label>
    <link:label id="lab_ameh_PmiocMember_label_en-US" xlink:label="lab_ameh_PmiocMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PMIOC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PmiocMember" xlink:href="ameh-20230630.xsd#ameh_PmiocMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_PmiocMember" xlink:to="lab_ameh_PmiocMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_582d49c2-f783-4732-afc4-5788f89f7bc9_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_BoardMembersMember_4089823b-820e-41a0-9701-d18f55db2c83_terseLabel_en-US" xlink:label="lab_ameh_BoardMembersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Members</link:label>
    <link:label id="lab_ameh_BoardMembersMember_label_en-US" xlink:label="lab_ameh_BoardMembersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Members [Member]</link:label>
    <link:label id="lab_ameh_BoardMembersMember_documentation_en-US" xlink:label="lab_ameh_BoardMembersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Members</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BoardMembersMember" xlink:href="ameh-20230630.xsd#ameh_BoardMembersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_BoardMembersMember" xlink:to="lab_ameh_BoardMembersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_d54b07c4-18e3-4219-805d-83013968c54d_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashUninsuredAmount_6478df16-5118-4558-835b-b46e52c9b876_terseLabel_en-US" xlink:label="lab_us-gaap_CashUninsuredAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount deposit accounts exceeded FDIC insured limit</link:label>
    <link:label id="lab_us-gaap_CashUninsuredAmount_label_en-US" xlink:label="lab_us-gaap_CashUninsuredAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Uninsured Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashUninsuredAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashUninsuredAmount" xlink:to="lab_us-gaap_CashUninsuredAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_58c4f026-fc03-4ff4-9879-566ba6ac4667_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_5247c861-ec74-4a64-8dbc-067bf33b3a59_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_ee697bc2-7243-4a88-94e6-e38969af539f_terseLabel_en-US" xlink:label="lab_ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk pool surplus or deficits, settlement period after risk pool performance year</link:label>
    <link:label id="lab_ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_label_en-US" xlink:label="lab_ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Pool Surplus Or Deficits, Settlement Period After Performance Year</link:label>
    <link:label id="lab_ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_documentation_en-US" xlink:label="lab_ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Pool Surplus Or Deficits, Settlement Period After Performance Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:href="ameh-20230630.xsd#ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:to="lab_ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_de4edbc4-bc41-43d5-82e3-f7b433c88b29_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_AmendedCreditAgreementMember_f2db5b58-fc61-45b9-956d-a9de3328dd2c_terseLabel_en-US" xlink:label="lab_ameh_AmendedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Credit Agreement</link:label>
    <link:label id="lab_ameh_AmendedCreditAgreementMember_label_en-US" xlink:label="lab_ameh_AmendedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Credit Agreement [Member]</link:label>
    <link:label id="lab_ameh_AmendedCreditAgreementMember_documentation_en-US" xlink:label="lab_ameh_AmendedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AmendedCreditAgreementMember" xlink:href="ameh-20230630.xsd#ameh_AmendedCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_AmendedCreditAgreementMember" xlink:to="lab_ameh_AmendedCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c529c13f-610c-49ed-a160-79427cc3f0ec_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities not included in the calculation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_8ab17f98-d55e-41db-996f-6fe6d5e819c9_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_07e74168-3683-4a43-bbf4-3e472cce7005_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock awards granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_AlliedPacificOfCaliforniaIPAMember_22f53cb1-c323-4660-b16d-fd94002e169c_terseLabel_en-US" xlink:label="lab_ameh_AlliedPacificOfCaliforniaIPAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allied Pacific Of California IPA</link:label>
    <link:label id="lab_ameh_AlliedPacificOfCaliforniaIPAMember_9e30ad3d-834f-443d-b762-5081cbb07b30_verboseLabel_en-US" xlink:label="lab_ameh_AlliedPacificOfCaliforniaIPAMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC</link:label>
    <link:label id="lab_ameh_AlliedPacificOfCaliforniaIPAMember_label_en-US" xlink:label="lab_ameh_AlliedPacificOfCaliforniaIPAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allied Pacific Of California IPA [Member]</link:label>
    <link:label id="lab_ameh_AlliedPacificOfCaliforniaIPAMember_documentation_en-US" xlink:label="lab_ameh_AlliedPacificOfCaliforniaIPAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allied Pacific Of California IPA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlliedPacificOfCaliforniaIPAMember" xlink:href="ameh-20230630.xsd#ameh_AlliedPacificOfCaliforniaIPAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_AlliedPacificOfCaliforniaIPAMember" xlink:to="lab_ameh_AlliedPacificOfCaliforniaIPAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_795e892c-1f65-41bb-af66-7732f99be7ea_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_AMGPropertiesLLCMember_b32b9504-467f-4800-9a35-9873623ae668_terseLabel_en-US" xlink:label="lab_ameh_AMGPropertiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMG Properties LLC</link:label>
    <link:label id="lab_ameh_AMGPropertiesLLCMember_label_en-US" xlink:label="lab_ameh_AMGPropertiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMG Properties LLC [Member]</link:label>
    <link:label id="lab_ameh_AMGPropertiesLLCMember_documentation_en-US" xlink:label="lab_ameh_AMGPropertiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMG Properties LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AMGPropertiesLLCMember" xlink:href="ameh-20230630.xsd#ameh_AMGPropertiesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_AMGPropertiesLLCMember" xlink:to="lab_ameh_AMGPropertiesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_6f05f75b-f12d-4efa-97b3-5e59be7a62f8_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0717b2aa-0ad9-44b1-beb1-c6c922019b21_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_2a9f89b3-0bd7-43cb-8873-81f770f8780a_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_22dd2fad-28dc-4fff-9450-ac31258ac336_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_56526826-c1d7-498f-95e9-7e5acd51626e_verboseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related-Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a1f659d2-255e-4a5b-8778-4178614ab217_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_ac512423-75ac-4690-9bc5-b0c0b4b944a6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_a5331536-60d2-4663-90dd-6c72c864b78b_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_52440e17-4b67-4adb-a292-5f421b33a504_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_374b271d-2f36-4baa-9eb1-1f2122c67639_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ApcShareholdersMember_95960824-070f-4ee6-813a-09e1a3c5970b_terseLabel_en-US" xlink:label="lab_ameh_ApcShareholdersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC Shareholders</link:label>
    <link:label id="lab_ameh_ApcShareholdersMember_label_en-US" xlink:label="lab_ameh_ApcShareholdersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC Shareholders [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApcShareholdersMember" xlink:href="ameh-20230630.xsd#ameh_ApcShareholdersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ApcShareholdersMember" xlink:to="lab_ameh_ApcShareholdersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_58d0cb7e-fd6e-4ec1-9647-8b6346c0316f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_9cc27641-d763-407e-897b-c251832fcace_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_bca9f412-fc3a-419f-85dc-eae027ef534f_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_78ab02bb-31e9-4eff-9e11-e4cc36e62a07_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5ee8a6fb-e183-4f89-84b6-fec8a006376a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_PayorAMember_2b1be5cc-dd56-4cc9-9a95-d58671272871_terseLabel_en-US" xlink:label="lab_ameh_PayorAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor A</link:label>
    <link:label id="lab_ameh_PayorAMember_label_en-US" xlink:label="lab_ameh_PayorAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor A [Member]</link:label>
    <link:label id="lab_ameh_PayorAMember_documentation_en-US" xlink:label="lab_ameh_PayorAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PayorAMember" xlink:href="ameh-20230630.xsd#ameh_PayorAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_PayorAMember" xlink:to="lab_ameh_PayorAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_09c32a55-af65-4cd9-a6ef-9b33a6364243_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_dac43552-f7ee-48f0-a302-31fe2a2a04da_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required annual facility fee</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_34de9f21-40ca-422d-be3a-4f30b051ae2a_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2306f1ed-e3ba-418e-a5a7-91522ac684fa_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares, performance based restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_1113047f-6377-4729-9326-bd00c6df6955_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DebtInstrumentNumberOfKeyFinancialRatios_13f2639b-361a-4f89-a679-f670e67000ec_terseLabel_en-US" xlink:label="lab_ameh_DebtInstrumentNumberOfKeyFinancialRatios" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of key financial ratios</link:label>
    <link:label id="lab_ameh_DebtInstrumentNumberOfKeyFinancialRatios_label_en-US" xlink:label="lab_ameh_DebtInstrumentNumberOfKeyFinancialRatios" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Key Financial Ratios</link:label>
    <link:label id="lab_ameh_DebtInstrumentNumberOfKeyFinancialRatios_documentation_en-US" xlink:label="lab_ameh_DebtInstrumentNumberOfKeyFinancialRatios" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Key Financial Ratios</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentNumberOfKeyFinancialRatios" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentNumberOfKeyFinancialRatios"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DebtInstrumentNumberOfKeyFinancialRatios" xlink:to="lab_ameh_DebtInstrumentNumberOfKeyFinancialRatios" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_400ec7db-5186-447d-a875-cb8b3a68c582_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_16e3bac0-fa99-4286-b20a-74029847c18b_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_A120HellmanLLCMember_9566a1d7-e343-4bba-ad18-9cc2e31f34d7_terseLabel_en-US" xlink:label="lab_ameh_A120HellmanLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">120 Hellman LLC</link:label>
    <link:label id="lab_ameh_A120HellmanLLCMember_label_en-US" xlink:label="lab_ameh_A120HellmanLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">120 Hellman LLC [Member]</link:label>
    <link:label id="lab_ameh_A120HellmanLLCMember_documentation_en-US" xlink:label="lab_ameh_A120HellmanLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">120 Hellman LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_A120HellmanLLCMember" xlink:href="ameh-20230630.xsd#ameh_A120HellmanLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_A120HellmanLLCMember" xlink:to="lab_ameh_A120HellmanLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_f375ba71-8742-449c-9097-6654651d409b_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_3bda245f-6294-4705-9f7f-c676d9688015_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_9df43153-1b80-4eff-a029-8f047eadfa32_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_e47ff448-d55a-4fca-a360-a0f9e4dc0313_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_d26317b2-7079-4150-a412-de96d196c9c6_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fees Incurred and Revenue Earned from Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_837478bf-dfda-4ed7-890a-91c358d42980_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_782dc93a-579b-4d9d-a352-43239460b6b3_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services, excluding depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_62b5c07f-3316-4285-9330-91b9ded48e3c_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_d54e92e0-0392-495b-b65d-7255d68a8c94_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_98cd278d-dfa1-410e-a8fc-668cfbeb0113_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_StockIssuedDuringPeriodSharesMerger_0922d028-6d2a-49b8-b26d-1bbfabb7eb59_terseLabel_en-US" xlink:label="lab_ameh_StockIssuedDuringPeriodSharesMerger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback shares not issued to former shareholders (in shares)</link:label>
    <link:label id="lab_ameh_StockIssuedDuringPeriodSharesMerger_label_en-US" xlink:label="lab_ameh_StockIssuedDuringPeriodSharesMerger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Merger</link:label>
    <link:label id="lab_ameh_StockIssuedDuringPeriodSharesMerger_documentation_en-US" xlink:label="lab_ameh_StockIssuedDuringPeriodSharesMerger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares of stock issued during the period pursuant to merger.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_StockIssuedDuringPeriodSharesMerger" xlink:href="ameh-20230630.xsd#ameh_StockIssuedDuringPeriodSharesMerger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_StockIssuedDuringPeriodSharesMerger" xlink:to="lab_ameh_StockIssuedDuringPeriodSharesMerger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_47a36ecb-fdec-40d8-8501-f98db457141f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c45e8c43-4155-4ced-88be-cfa298d7410c_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_8980fa13-dc7d-4ffb-8b2c-73c418a7fcc1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_ddcb0242-bb6f-44e6-b43c-0843a290366d_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tradename/trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_9f9a0a6a-e1d3-4ddb-ab3f-46285188b9a7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Credit Facility</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_f3f6ef13-a119-4bf9-a926-80be47e677b7_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_101882f5-40cf-4361-b856-3eebd932f1b3_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9e92f787-20ac-4ada-92e7-f6f0801fd6f9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_05c02689-9e83-4904-99db-b19e17721150_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_55a80cea-666f-40f7-bc5d-7c883428f5e3_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_fec8fc4a-d36a-4ff1-bd48-4f8437884bce_negatedLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_c9f1db81-53c2-4676-98b1-31747585631c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Asset Acquisitions, and Goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_37030cba-6805-489b-bd08-052cf7caf030_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c4c24eb6-bac3-4f12-9059-0333cd3828e1_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite lived assets:</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised_e7d98aab-235d-49c9-967a-1aefeeb33e24_terseLabel_en-US" xlink:label="lab_ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from warrants exercised</link:label>
    <link:label id="lab_ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Issued During Period Value Stock Options Exercised</link:label>
    <link:label id="lab_ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised_documentation_en-US" xlink:label="lab_ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Issued During Period Value Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised" xlink:href="ameh-20230630.xsd#ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_44b68328-7ec6-4d32-9042-7abb45469366_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_eb41e918-4c72-4417-91c2-46d2be9fb9c8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_FulgentGeneticsIncMember_7ce4740b-48eb-40f4-8eb8-72f2217ed128_terseLabel_en-US" xlink:label="lab_ameh_FulgentGeneticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fulgent Genetics, Inc.</link:label>
    <link:label id="lab_ameh_FulgentGeneticsIncMember_label_en-US" xlink:label="lab_ameh_FulgentGeneticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fulgent Genetics, Inc. [Member]</link:label>
    <link:label id="lab_ameh_FulgentGeneticsIncMember_documentation_en-US" xlink:label="lab_ameh_FulgentGeneticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fulgent Genetics, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FulgentGeneticsIncMember" xlink:href="ameh-20230630.xsd#ameh_FulgentGeneticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_FulgentGeneticsIncMember" xlink:to="lab_ameh_FulgentGeneticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_2e64e44a-69eb-4baa-b1d1-bfaefc7f3077_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_OtherThirdPartiesMember_1a74b903-4f21-4846-b668-6c32ee5f6bff_terseLabel_en-US" xlink:label="lab_ameh_OtherThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other third parties</link:label>
    <link:label id="lab_ameh_OtherThirdPartiesMember_label_en-US" xlink:label="lab_ameh_OtherThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Third Parties [Member]</link:label>
    <link:label id="lab_ameh_OtherThirdPartiesMember_documentation_en-US" xlink:label="lab_ameh_OtherThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ameh:OtherThirdPartiesMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OtherThirdPartiesMember" xlink:href="ameh-20230630.xsd#ameh_OtherThirdPartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_OtherThirdPartiesMember" xlink:to="lab_ameh_OtherThirdPartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_12e1bd65-7960-44bf-82a1-887d6d02aca9_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost, net</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_ca2d47c8-493b-4425-8c10-653bbfb20b5c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_RentPaymentMember_3dda3855-9401-4242-bc4d-da189d4779e0_terseLabel_en-US" xlink:label="lab_ameh_RentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent Payment</link:label>
    <link:label id="lab_ameh_RentPaymentMember_label_en-US" xlink:label="lab_ameh_RentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent Payment [Member]</link:label>
    <link:label id="lab_ameh_RentPaymentMember_documentation_en-US" xlink:label="lab_ameh_RentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_RentPaymentMember" xlink:href="ameh-20230630.xsd#ameh_RentPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_RentPaymentMember" xlink:to="lab_ameh_RentPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_54544d33-0e08-4085-9636-361740cfec53_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_78174783-6408-4c24-aebd-91711a20205f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_ac466a53-c4cc-4c05-bfb0-c22926810efd_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_8ef8856b-9f99-401e-9435-3019c421a764_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8410504e-be9d-4b3b-8362-1999228a284e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c41e7834-9af0-406b-8415-745cb3e47f32_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_37e21c8b-1f63-4bf1-8995-bb5df96358c0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_43fe18f5-6c85-4f0d-b794-99de086b20d4_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_234f2528-e392-4e52-b050-967a5d90d52e_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other accruals</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_4a612c1c-296d-48d3-a615-f4e490375320_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_3ba6fe97-62b9-4cb7-808b-958077600c00_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eb6cdfa2-e33b-4e29-b48a-71c98ea72f9c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c135b0af-e676-4da5-a1ed-b4e3705e2d69_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_7c9d2307-1f1e-43b8-81a4-ebdc0a263d80_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_76a49124-3613-453a-a867-1a41698bee81_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_CommitmentsAndContingenciesTable_53f1f395-3047-40f2-9b15-a4df881ba7cc_terseLabel_en-US" xlink:label="lab_ameh_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_ameh_CommitmentsAndContingenciesTable_label_en-US" xlink:label="lab_ameh_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CommitmentsAndContingenciesTable" xlink:href="ameh-20230630.xsd#ameh_CommitmentsAndContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_CommitmentsAndContingenciesTable" xlink:to="lab_ameh_CommitmentsAndContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_0067b8df-7228-485c-b44d-be6ad716c0a7_verboseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_7461049b-f59a-4add-8e34-968bdb2fc809_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risks</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_278ce579-7048-4d7d-9450-30011f527897_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-current assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_ba9a4caf-ea23-4f71-93cf-30ceecba2310_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_a2fad313-3f09-419d-86b2-e51cdf88f28e_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_006dfd2e-ea4e-4227-aa01-0e4f9bc93e96_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_eb4295b0-85e9-424b-8701-82ff1ac20ede_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_612b1859-bb4e-4091-9388-ca73b8409309_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_c24b43d2-8b48-4224-903e-d375fe9bf0d7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_25afad63-a0ba-46be-91ad-aa9f13f71efd_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_f707ef0d-7a79-41a1-bd01-d30ff4c680fb_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities &#8211; equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_cb9f228f-8ca1-48fe-b684-22e70320be3b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_4009f42a-ae9f-41ee-b89e-3d5f4badaebf_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_91a1c767-2d10-4f73-b8b4-79af304ea78e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_NetworkRelationshipsMember_a29ee703-1aba-42ef-9900-683ab2952b04_terseLabel_en-US" xlink:label="lab_ameh_NetworkRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Network relationships</link:label>
    <link:label id="lab_ameh_NetworkRelationshipsMember_label_en-US" xlink:label="lab_ameh_NetworkRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Network Relationships [Member]</link:label>
    <link:label id="lab_ameh_NetworkRelationshipsMember_documentation_en-US" xlink:label="lab_ameh_NetworkRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Network Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NetworkRelationshipsMember" xlink:href="ameh-20230630.xsd#ameh_NetworkRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_NetworkRelationshipsMember" xlink:to="lab_ameh_NetworkRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ZLLPartnersLLCMember_c916fbee-1cec-4b5f-9802-a32d9daae6ed_terseLabel_en-US" xlink:label="lab_ameh_ZLLPartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZLL Partners LLC</link:label>
    <link:label id="lab_ameh_ZLLPartnersLLCMember_label_en-US" xlink:label="lab_ameh_ZLLPartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZLL Partners LLC [Member]</link:label>
    <link:label id="lab_ameh_ZLLPartnersLLCMember_documentation_en-US" xlink:label="lab_ameh_ZLLPartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZLL Partners LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ZLLPartnersLLCMember" xlink:href="ameh-20230630.xsd#ameh_ZLLPartnersLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ZLLPartnersLLCMember" xlink:to="lab_ameh_ZLLPartnersLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_MedicalPropertyPartnersLLCMember_b3f17d4e-232f-49c4-b2fd-6d71313aedcd_terseLabel_en-US" xlink:label="lab_ameh_MedicalPropertyPartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Property Partners LLC</link:label>
    <link:label id="lab_ameh_MedicalPropertyPartnersLLCMember_label_en-US" xlink:label="lab_ameh_MedicalPropertyPartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Property Partners LLC [Member]</link:label>
    <link:label id="lab_ameh_MedicalPropertyPartnersLLCMember_documentation_en-US" xlink:label="lab_ameh_MedicalPropertyPartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Property Partners LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MedicalPropertyPartnersLLCMember" xlink:href="ameh-20230630.xsd#ameh_MedicalPropertyPartnersLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_MedicalPropertyPartnersLLCMember" xlink:to="lab_ameh_MedicalPropertyPartnersLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_6b40b5ea-34d7-43ef-9d05-c25e044bc0ea_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 (excluding the six months ended June 30, 2023)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_6c5d1945-f851-47a4-a9a8-bfa2e6cd4366_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_JamesSongMDAProfessionalCorporationMember_84df407a-887d-4942-8858-dc77e1ad2217_terseLabel_en-US" xlink:label="lab_ameh_JamesSongMDAProfessionalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">James Song, M.D., A Professional Corporation</link:label>
    <link:label id="lab_ameh_JamesSongMDAProfessionalCorporationMember_label_en-US" xlink:label="lab_ameh_JamesSongMDAProfessionalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">James Song, M.D., A Professional Corporation [Member]</link:label>
    <link:label id="lab_ameh_JamesSongMDAProfessionalCorporationMember_documentation_en-US" xlink:label="lab_ameh_JamesSongMDAProfessionalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">James Song, M.D., A Professional Corporation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_JamesSongMDAProfessionalCorporationMember" xlink:href="ameh-20230630.xsd#ameh_JamesSongMDAProfessionalCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_JamesSongMDAProfessionalCorporationMember" xlink:to="lab_ameh_JamesSongMDAProfessionalCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4100ccd6-649c-400b-82bd-bc4dd41a5359_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Commitments of Credit Facility</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_ff066703-973a-4a88-8f41-3616dbec74e5_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_55cd3eb8-34ff-433d-a020-152a742cc3d1_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_122641dd-8ed5-4083-b805-5b714ece3c7a_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_7ef3a90c-b86f-47b4-845d-e57d4fbafc5e_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_5e449e5c-c108-4d73-b7d6-b7e060011813_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_96f241ed-b3bb-422c-8661-3f455576540e_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_CarePartnersMember_5854c2fc-0411-4a5e-97d8-78b6a68c92bc_terseLabel_en-US" xlink:label="lab_ameh_CarePartnersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Partners</link:label>
    <link:label id="lab_ameh_CarePartnersMember_label_en-US" xlink:label="lab_ameh_CarePartnersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Partners [Member]</link:label>
    <link:label id="lab_ameh_CarePartnersMember_documentation_en-US" xlink:label="lab_ameh_CarePartnersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Partners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CarePartnersMember" xlink:href="ameh-20230630.xsd#ameh_CarePartnersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_CarePartnersMember" xlink:to="lab_ameh_CarePartnersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_bb81a72a-ce4f-4307-90a9-da0b6311c226_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ApolloSunLabsManagementLLCMember_4f834e90-aa4f-4371-b341-58b271abe740_terseLabel_en-US" xlink:label="lab_ameh_ApolloSunLabsManagementLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo-Sun Labs Management, LLC</link:label>
    <link:label id="lab_ameh_ApolloSunLabsManagementLLCMember_1fe427aa-990c-4427-a440-c97bb3ecdfd8_verboseLabel_en-US" xlink:label="lab_ameh_ApolloSunLabsManagementLLCMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sun Labs</link:label>
    <link:label id="lab_ameh_ApolloSunLabsManagementLLCMember_label_en-US" xlink:label="lab_ameh_ApolloSunLabsManagementLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo-Sun Labs Management, LLC [Member]</link:label>
    <link:label id="lab_ameh_ApolloSunLabsManagementLLCMember_documentation_en-US" xlink:label="lab_ameh_ApolloSunLabsManagementLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo-Sun Labs Management, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApolloSunLabsManagementLLCMember" xlink:href="ameh-20230630.xsd#ameh_ApolloSunLabsManagementLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ApolloSunLabsManagementLLCMember" xlink:to="lab_ameh_ApolloSunLabsManagementLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_ba0422ff-5836-4649-b661-897fc5f2213d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_88aaacb7-35d5-4fc8-a2fb-c86ce8ecae7d_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_72397327-ab40-485e-9d43-c227440fab9c_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_b64153a9-ea83-46d3-8fb6-4fe59941d7d4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investments - privately held</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Acquisition, Trading Security, Held-for-Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:to="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_a7ff6f4f-13d9-482b-a5fa-da5b0e953370_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_SongPCMember_4d70cd63-fc29-4b1b-a9b5-a823bada2823_terseLabel_en-US" xlink:label="lab_ameh_SongPCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Song PC</link:label>
    <link:label id="lab_ameh_SongPCMember_label_en-US" xlink:label="lab_ameh_SongPCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Song PC [Member]</link:label>
    <link:label id="lab_ameh_SongPCMember_documentation_en-US" xlink:label="lab_ameh_SongPCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Song PC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SongPCMember" xlink:href="ameh-20230630.xsd#ameh_SongPCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_SongPCMember" xlink:to="lab_ameh_SongPCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_8fea3bb4-64bf-4ba3-a991-633e5c316b2d_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_d6c72d97-5575-4655-acba-58bb0fdf449a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_AdvanceDiagnosticSurgeryCenterMember_3b40b355-058d-4d0c-abd7-28a2ea2ad7c7_terseLabel_en-US" xlink:label="lab_ameh_AdvanceDiagnosticSurgeryCenterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Diagnostic Surgery Center</link:label>
    <link:label id="lab_ameh_AdvanceDiagnosticSurgeryCenterMember_label_en-US" xlink:label="lab_ameh_AdvanceDiagnosticSurgeryCenterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Diagnostic Surgery Center [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AdvanceDiagnosticSurgeryCenterMember" xlink:href="ameh-20230630.xsd#ameh_AdvanceDiagnosticSurgeryCenterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_AdvanceDiagnosticSurgeryCenterMember" xlink:to="lab_ameh_AdvanceDiagnosticSurgeryCenterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_792a45f6-d1f9-4634-a33a-c46f3885b360_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in affiliates</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_3854be41-8596-4708-a569-d32b2d7fb7a6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_641c5f62-c033-4917-a64f-87ac129cb0f7_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration, liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_b62a491b-1f6f-4fbc-9a56-1d0ceac5fb59_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplementary disclosures of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_OneMSOInc.Member_b6a3af5e-37a1-4d57-bba0-b11bf753ba12_terseLabel_en-US" xlink:label="lab_ameh_OneMSOInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One MSO, Inc.</link:label>
    <link:label id="lab_ameh_OneMSOInc.Member_label_en-US" xlink:label="lab_ameh_OneMSOInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One MSO, Inc. [Member]</link:label>
    <link:label id="lab_ameh_OneMSOInc.Member_documentation_en-US" xlink:label="lab_ameh_OneMSOInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One MSO, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OneMSOInc.Member" xlink:href="ameh-20230630.xsd#ameh_OneMSOInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_OneMSOInc.Member" xlink:to="lab_ameh_OneMSOInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilities_a2bd16d2-a95c-416e-80fa-ead4fd0ecf8f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to affiliates</link:label>
    <link:label id="lab_us-gaap_OtherLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_9ad04535-7fa6-494e-a0e5-bade18dde3ab_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_9d5e5dee-56fc-4182-bf13-283fff952f0d_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, carrying amount, beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_32a07924-3c0f-4a59-a8fb-3b77bb0f3f0f_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, carrying amount, ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DescriptionOfBusinessTable_9128466c-14a6-4339-adf5-ff646ba75196_terseLabel_en-US" xlink:label="lab_ameh_DescriptionOfBusinessTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Business [Table]</link:label>
    <link:label id="lab_ameh_DescriptionOfBusinessTable_label_en-US" xlink:label="lab_ameh_DescriptionOfBusinessTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Business [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DescriptionOfBusinessTable" xlink:href="ameh-20230630.xsd#ameh_DescriptionOfBusinessTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DescriptionOfBusinessTable" xlink:to="lab_ameh_DescriptionOfBusinessTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum_ddc5d4a2-1ea6-4799-a1ab-c9ff1b3fadad_terseLabel_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, cash flow to debt service ratio, minimum</link:label>
    <link:label id="lab_ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum_label_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Cash Flow To Debt Service Ratio, Minimum</link:label>
    <link:label id="lab_ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum_documentation_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Cash Flow To Debt Service Ratio, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum" xlink:to="lab_ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_c1ce3b6e-48d6-4305-a116-0b5f38e02fce_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_acf2bca7-8b9d-434f-b989-05c0f9a058a8_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_70350307-866d-48e5-b88a-9c3941dd039c_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_d8a8070d-6cb7-4d64-89d0-895acc4d2874_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice_f99f3669-03b7-4cef-97f1-b30469553815_terseLabel_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of warrants exercised (in dollars per share)</link:label>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice_label_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share based Payment Award, Warrant Exercised, Exercise Price</link:label>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice_documentation_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share based Payment Award, Warrant Exercised, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" xlink:href="ameh-20230630.xsd#ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" xlink:to="lab_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_NumberOfPrimaryCareClinics_356976e4-dd38-4a20-8cf3-8ecc982a070f_terseLabel_en-US" xlink:label="lab_ameh_NumberOfPrimaryCareClinics" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of primary care clinics</link:label>
    <link:label id="lab_ameh_NumberOfPrimaryCareClinics_label_en-US" xlink:label="lab_ameh_NumberOfPrimaryCareClinics" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Primary Care Clinics</link:label>
    <link:label id="lab_ameh_NumberOfPrimaryCareClinics_documentation_en-US" xlink:label="lab_ameh_NumberOfPrimaryCareClinics" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Primary Care Clinics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NumberOfPrimaryCareClinics" xlink:href="ameh-20230630.xsd#ameh_NumberOfPrimaryCareClinics"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_NumberOfPrimaryCareClinics" xlink:to="lab_ameh_NumberOfPrimaryCareClinics" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_TemporaryEquityTransferOfCommonControlEntities_aa279a2e-0920-4682-9c2e-73b778d5b89a_terseLabel_en-US" xlink:label="lab_ameh_TemporaryEquityTransferOfCommonControlEntities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of common control entities (restated)</link:label>
    <link:label id="lab_ameh_TemporaryEquityTransferOfCommonControlEntities_label_en-US" xlink:label="lab_ameh_TemporaryEquityTransferOfCommonControlEntities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Transfer Of Common Control Entities</link:label>
    <link:label id="lab_ameh_TemporaryEquityTransferOfCommonControlEntities_documentation_en-US" xlink:label="lab_ameh_TemporaryEquityTransferOfCommonControlEntities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Transfer Of Common Control Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_TemporaryEquityTransferOfCommonControlEntities" xlink:href="ameh-20230630.xsd#ameh_TemporaryEquityTransferOfCommonControlEntities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_TemporaryEquityTransferOfCommonControlEntities" xlink:to="lab_ameh_TemporaryEquityTransferOfCommonControlEntities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2dc40941-b03b-451c-863e-827c53a68dd2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_c343f405-9847-4f1d-9a5c-f387fc8ec4ed_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term, finance</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_81c4194c-a6ac-43d4-9348-71e394ae9b49_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1525c2bc-6e95-489f-a5ed-b974aa564016_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2c76d5b0-3f52-40bd-8831-52b9788541dd_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_5c49db67-1675-458d-9b45-e523a1709f68_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_352e46d3-9648-4579-911c-6b4f5e8b0de4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_6d2b2e57-8440-481a-9ac9-6c2196318a0c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation of restricted stock awards</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_FinanceLeaseCostsAbstract_e820c4e5-e839-456f-88dc-bed882f6264f_terseLabel_en-US" xlink:label="lab_ameh_FinanceLeaseCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost</link:label>
    <link:label id="lab_ameh_FinanceLeaseCostsAbstract_label_en-US" xlink:label="lab_ameh_FinanceLeaseCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Costs [Abstract]</link:label>
    <link:label id="lab_ameh_FinanceLeaseCostsAbstract_documentation_en-US" xlink:label="lab_ameh_FinanceLeaseCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FinanceLeaseCostsAbstract" xlink:href="ameh-20230630.xsd#ameh_FinanceLeaseCostsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_FinanceLeaseCostsAbstract" xlink:to="lab_ameh_FinanceLeaseCostsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum_2384b9db-7ade-41d7-96b4-072ade1b1627_terseLabel_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, debt coverage ratio, minimum</link:label>
    <link:label id="lab_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum_label_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Debt Coverage Ratio, Minimum</link:label>
    <link:label id="lab_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum_documentation_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Debt Coverage Ratio, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum" xlink:to="lab_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_ca768df5-62ca-461d-adf1-dce327d2625b_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_a6fa6302-3780-42be-a5ec-02f1b02e9e99_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the exercise of stock options and warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableNet_d9589ee2-ad92-4061-af26-edfec14712e1_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loan</link:label>
    <link:label id="lab_us-gaap_NotesReceivableNet_label_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableNet" xlink:to="lab_us-gaap_NotesReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_5fd5b5ec-623f-4ff1-aa56-db66598634a4_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_25ba5e72-c6a4-4fe7-8028-f19cac17d8f2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_702ceac6-8a89-4aa6-8ae1-626b01894b19_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_cc109c82-e52f-4885-a198-0982b254a70f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_384a8c11-affa-4fc6-842b-414c591f13f3_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_7e5d7f0b-a0dc-46f6-9bd5-dccb09632c72_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual agent fee</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_f57c586b-7d44-4d12-be8f-fa54f9a7a63f_verboseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities (VIEs)</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_FinanceLeaseLiabilityToBePaidAfterYearFour_b8fcff93-ab92-4fc7-b9f9-c0618fc38b77_terseLabel_en-US" xlink:label="lab_ameh_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_ameh_FinanceLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_ameh_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:label id="lab_ameh_FinanceLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_ameh_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:href="ameh-20230630.xsd#ameh_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_ameh_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_65f2a031-b8b0-4bcb-af32-5a4e8e6ba058_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCreditsAndOtherLiabilities_c0c20d2e-c8c1-4fb7-abd9-30bfaac77596_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCreditsAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount outstanding under agreement</link:label>
    <link:label id="lab_us-gaap_DeferredCreditsAndOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredCreditsAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Credits and Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCreditsAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCreditsAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCreditsAndOtherLiabilities" xlink:to="lab_us-gaap_DeferredCreditsAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_1e02f9af-d915-4e0d-9a48-9f56c48ddfa0_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionOfDividends_40ea7edf-e3c7-4835-b7e0-ca228ecc76ce_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionOfDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionOfDividends_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionOfDividends" xlink:to="lab_us-gaap_TemporaryEquityAccretionOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_4a698e19-15cb-4632-856b-138d10312f17_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_38d13383-73e1-4f60-9998-5f77b3df2a66_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_231aad60-cf54-4c19-9284-bb2805901c4d_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_a2468ce2-ab1d-4a60-982d-e9000ca82b29_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_a995ac07-98f6-40b7-ba91-f0fdd388c624_verboseLabel_en-US" xlink:label="lab_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in privately held entities</link:label>
    <link:label id="lab_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_label_en-US" xlink:label="lab_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment In Privately Held Entity That Does Not Report Net Asset Value</link:label>
    <link:label id="lab_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_documentation_en-US" xlink:label="lab_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total of Investment in privately held entity that does not report net asset value per share .</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:href="ameh-20230630.xsd#ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:to="lab_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5d58d48c-e1e7-4d3a-9aeb-68ec349683f4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b93e02bb-0411-48bb-a96f-11ecff410f4d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable_46aa9831-2a91-4e91-92be-c0e8db980c48_terseLabel_en-US" xlink:label="lab_ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, termination period, if applicable</link:label>
    <link:label id="lab_ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable_label_en-US" xlink:label="lab_ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Termination Period, If Applicable</link:label>
    <link:label id="lab_ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable_documentation_en-US" xlink:label="lab_ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Termination Period, If Applicable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable" xlink:href="ameh-20230630.xsd#ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable" xlink:to="lab_ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_ed1a8c3e-3f70-4ab1-b2a6-49c4e59dfc46_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common&#160;Stock&#160;Outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_d21add72-d17d-44cc-8e3b-a91065d06e15_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_SummaryOfSignificantAccountingPoliciesLineItems_ab5d6922-0f82-417f-ba97-398972b078a3_terseLabel_en-US" xlink:label="lab_ameh_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_ameh_SummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_ameh_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_ameh_SummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_ameh_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="ameh-20230630.xsd#ameh_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_ameh_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c2448288-cc9e-4f6a-a231-82e2d9514d50_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_1d620f12-be1b-490f-a5a3-44ad93e0d20e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_64267cde-f1ea-4daf-ac21-5f9cb2ce2d04_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Amounts and Fair Values of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9408ad08-0d12-4cf8-a906-327cc0c89db1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_11e10896-d467-44ce-85fa-1d9e4cbe26b3_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Support to Nonconsolidated Legal Entity [Domain]</link:label>
    <link:label id="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_label_en-US" xlink:label="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Support to Nonconsolidated Legal Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:to="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7607a142-7e4b-4a6a-8a48-8b6cbd85e4a5_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6db71215-f8aa-412a-a2ea-aaf01c7f385e_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f6dc68ae-d5e1-4e92-b82e-5a0b6f4a328d_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ForYourBenefitIncMember_d038fb86-d6c8-4eb6-85d9-8b2a10a110cf_terseLabel_en-US" xlink:label="lab_ameh_ForYourBenefitIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For Your Benefit Inc. (FYB)</link:label>
    <link:label id="lab_ameh_ForYourBenefitIncMember_label_en-US" xlink:label="lab_ameh_ForYourBenefitIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For Your Benefit Inc. [Member]</link:label>
    <link:label id="lab_ameh_ForYourBenefitIncMember_documentation_en-US" xlink:label="lab_ameh_ForYourBenefitIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For Your Benefit Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ForYourBenefitIncMember" xlink:href="ameh-20230630.xsd#ameh_ForYourBenefitIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ForYourBenefitIncMember" xlink:to="lab_ameh_ForYourBenefitIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_870f0977-0d3d-408a-ba48-e0546ea4a5a4_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_726a1530-4f27-4cf6-9b5e-a2f3fbb6f988_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, property, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_53d28e24-dbea-4600-87b7-d6a020020b13_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_6436fa8b-d068-405a-9d2c-a765f679c742_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_4db9703a-a73d-428b-8686-55e9cd7cc9e9_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_7f4cd1ae-d098-413d-b623-c867072a71ec_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total medical care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_23ec9a24-476e-49d7-8725-2abd37549a3d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_EquityMethodAndOtherEquityInvestmentsTextBlock_6b23829b-1af1-4958-9a87-e3c68f180b48_verboseLabel_en-US" xlink:label="lab_ameh_EquityMethodAndOtherEquityInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Other Entities</link:label>
    <link:label id="lab_ameh_EquityMethodAndOtherEquityInvestmentsTextBlock_label_en-US" xlink:label="lab_ameh_EquityMethodAndOtherEquityInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method And Other Equity Investments [Text Block]</link:label>
    <link:label id="lab_ameh_EquityMethodAndOtherEquityInvestmentsTextBlock_documentation_en-US" xlink:label="lab_ameh_EquityMethodAndOtherEquityInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method And Other Equity Investments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EquityMethodAndOtherEquityInvestmentsTextBlock" xlink:href="ameh-20230630.xsd#ameh_EquityMethodAndOtherEquityInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_EquityMethodAndOtherEquityInvestmentsTextBlock" xlink:to="lab_ameh_EquityMethodAndOtherEquityInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_0b05f769-bc01-4ad0-9627-823cceba5705_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of finance lease obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_53bd95d0-6fa6-4efe-b7e8-f87319903125_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_aed4a181-6cbd-441f-9229-c5f4ba14de67_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2c6c5387-a557-49ac-8b66-1545285ef596_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_e121f3a2-cdc4-497f-8eeb-8b99c3e96aae_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable_d59e730b-03ce-420f-b7c0-e9865fe007d9_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiduciary accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_07111c4f-2ab3-4736-af33-ea31c41e1ee2_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_98ff6d36-df82-47bf-93d8-6a5220d9f7bb_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_e9dc8c91-5698-4de0-b325-0c7683711a8a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion of debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_d96743ff-59e6-492c-bb20-511f332758f4_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_624fa568-56f1-452f-a980-807b5e53dca7_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service, net</link:label>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_b5c83cdc-a2fe-4d3a-a4f8-a1f5e77f1ed7_verboseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party</link:label>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_label_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCarePatientServiceMember" xlink:to="lab_us-gaap_HealthCarePatientServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_HealthCareCapitationRevenueMember_403d1540-7074-4a51-86dc-527843431843_verboseLabel_en-US" xlink:label="lab_ameh_HealthCareCapitationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation, net</link:label>
    <link:label id="lab_ameh_HealthCareCapitationRevenueMember_label_en-US" xlink:label="lab_ameh_HealthCareCapitationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Capitation Revenue [Member]</link:label>
    <link:label id="lab_ameh_HealthCareCapitationRevenueMember_documentation_en-US" xlink:label="lab_ameh_HealthCareCapitationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ameh_HealthCareCapitationRevenueMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_HealthCareCapitationRevenueMember" xlink:href="ameh-20230630.xsd#ameh_HealthCareCapitationRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_HealthCareCapitationRevenueMember" xlink:to="lab_ameh_HealthCareCapitationRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DiagnosticAndSurgicalCenterMember_d66dfb00-9bf9-4256-af0e-3d2e9aa4d4b0_terseLabel_en-US" xlink:label="lab_ameh_DiagnosticAndSurgicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic and Surgical Center</link:label>
    <link:label id="lab_ameh_DiagnosticAndSurgicalCenterMember_label_en-US" xlink:label="lab_ameh_DiagnosticAndSurgicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic and Surgical Center [Member]</link:label>
    <link:label id="lab_ameh_DiagnosticAndSurgicalCenterMember_documentation_en-US" xlink:label="lab_ameh_DiagnosticAndSurgicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic and Surgical Center</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DiagnosticAndSurgicalCenterMember" xlink:href="ameh-20230630.xsd#ameh_DiagnosticAndSurgicalCenterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DiagnosticAndSurgicalCenterMember" xlink:to="lab_ameh_DiagnosticAndSurgicalCenterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_SunnyVillageCareCenterMember_5f668fda-6c04-4927-99de-1fc885623c7b_terseLabel_en-US" xlink:label="lab_ameh_SunnyVillageCareCenterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sunny Village Care Center</link:label>
    <link:label id="lab_ameh_SunnyVillageCareCenterMember_label_en-US" xlink:label="lab_ameh_SunnyVillageCareCenterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sunny Village Care Center [Member]</link:label>
    <link:label id="lab_ameh_SunnyVillageCareCenterMember_documentation_en-US" xlink:label="lab_ameh_SunnyVillageCareCenterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sunny Village Care Center</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SunnyVillageCareCenterMember" xlink:href="ameh-20230630.xsd#ameh_SunnyVillageCareCenterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_SunnyVillageCareCenterMember" xlink:to="lab_ameh_SunnyVillageCareCenterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_5450f4ee-e0e1-496c-a92d-c20168cb82b5_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_68282924-127b-4183-a0af-ab41de59ca7e_terseLabel_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_label_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_documentation_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:href="ameh-20230630.xsd#ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_97fd2777-6a20-4c1f-bebb-1b376e56ee3b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share &#8211; basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_7e41cba8-1e01-40f1-be1f-c71e38da73b0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivableNoncurrent_fecce63f-a853-4fb2-955d-3e5db9d3dc89_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable, non-current</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivableNoncurrent_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:to="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8ae86190-c876-406e-a5d4-678985a8fecd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_594206e4-176a-406f-9b10-25a88ba7d5f2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued in business combination</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_40ad00db-8c7a-4ba9-9550-3b141b18e298_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_6e328b47-13eb-49d3-b777-ffef0a4c77e1_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_00d0727d-7a5e-4875-927d-5a6697467f35_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_JadeHealthCareMedicalGroupIncMember_c212b1ab-da73-4ab0-a9ef-94a60d6a399e_terseLabel_en-US" xlink:label="lab_ameh_JadeHealthCareMedicalGroupIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jade Health Care Medical Group, Inc.</link:label>
    <link:label id="lab_ameh_JadeHealthCareMedicalGroupIncMember_label_en-US" xlink:label="lab_ameh_JadeHealthCareMedicalGroupIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jade Health Care Medical Group, Inc. [Member]</link:label>
    <link:label id="lab_ameh_JadeHealthCareMedicalGroupIncMember_documentation_en-US" xlink:label="lab_ameh_JadeHealthCareMedicalGroupIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jade Health Care Medical Group, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_JadeHealthCareMedicalGroupIncMember" xlink:href="ameh-20230630.xsd#ameh_JadeHealthCareMedicalGroupIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_JadeHealthCareMedicalGroupIncMember" xlink:to="lab_ameh_JadeHealthCareMedicalGroupIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_360f3067-ff89-49e5-8164-5f299a1c8a54_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_3f62103b-d161-4c66-807b-fe12e7819363_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOtherMember_7eb27ee1-ae94-4a46-9128-ac98b892b4f6_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk pool settlements and incentives</link:label>
    <link:label id="lab_us-gaap_HealthCareOtherMember_label_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOtherMember" xlink:to="lab_us-gaap_HealthCareOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_PreferredBankMember_df19744b-b43f-4afa-8d43-cdef93edd563_terseLabel_en-US" xlink:label="lab_ameh_PreferredBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Bank</link:label>
    <link:label id="lab_ameh_PreferredBankMember_label_en-US" xlink:label="lab_ameh_PreferredBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Bank [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PreferredBankMember" xlink:href="ameh-20230630.xsd#ameh_PreferredBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_PreferredBankMember" xlink:to="lab_ameh_PreferredBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fd9e4864-54e6-407e-895c-6eb3cf8c65e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_CareEnablementMember_b62c1496-009e-44a1-923b-e2af0bbddbae_terseLabel_en-US" xlink:label="lab_ameh_CareEnablementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Enablement</link:label>
    <link:label id="lab_ameh_CareEnablementMember_label_en-US" xlink:label="lab_ameh_CareEnablementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Enablement [Member]</link:label>
    <link:label id="lab_ameh_CareEnablementMember_documentation_en-US" xlink:label="lab_ameh_CareEnablementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Enablement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CareEnablementMember" xlink:href="ameh-20230630.xsd#ameh_CareEnablementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_CareEnablementMember" xlink:to="lab_ameh_CareEnablementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_283ef4c6-68ee-4a5e-9ebd-a2b18a86a192_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Support to Nonconsolidated Legal Entity [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_label_en-US" xlink:label="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Support to Nonconsolidated Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:to="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_AccountsReceivableAndNetRevenueTable_b782eba8-1e62-4118-94c7-6cad71fc1b05_terseLabel_en-US" xlink:label="lab_ameh_AccountsReceivableAndNetRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable And Net Revenue [Table]</link:label>
    <link:label id="lab_ameh_AccountsReceivableAndNetRevenueTable_label_en-US" xlink:label="lab_ameh_AccountsReceivableAndNetRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable And Net Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AccountsReceivableAndNetRevenueTable" xlink:href="ameh-20230630.xsd#ameh_AccountsReceivableAndNetRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_AccountsReceivableAndNetRevenueTable" xlink:to="lab_ameh_AccountsReceivableAndNetRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_AmgIncMember_f39775d2-b887-4148-84bb-53585300d4f2_terseLabel_en-US" xlink:label="lab_ameh_AmgIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMG, Inc</link:label>
    <link:label id="lab_ameh_AmgIncMember_label_en-US" xlink:label="lab_ameh_AmgIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMG, Inc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AmgIncMember" xlink:href="ameh-20230630.xsd#ameh_AmgIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_AmgIncMember" xlink:to="lab_ameh_AmgIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9fff814f-1350-4ef7-b4c9-1ac6283b968a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_2b278a6a-dc61-49ce-95de-90ce50b3db71_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contributions to Revenue and Receivables by Payor</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_be881536-283c-48c5-86f9-fa31967d2b36_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_9e56354c-1932-4d68-a7ec-7d5c67b30f94_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableMember_8d39f927-a5a0-4ba7-a125-cc5a6fd13e24_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Secured Promissory Note</link:label>
    <link:label id="lab_us-gaap_NotesReceivableMember_label_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableMember" xlink:to="lab_us-gaap_NotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_CAIPAMSOLLCMember_18e0e35a-00cd-4c72-904c-5c895f65623a_terseLabel_en-US" xlink:label="lab_ameh_CAIPAMSOLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAIPA MSO, LLC</link:label>
    <link:label id="lab_ameh_CAIPAMSOLLCMember_label_en-US" xlink:label="lab_ameh_CAIPAMSOLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAIPA MSO, LLC [Member]</link:label>
    <link:label id="lab_ameh_CAIPAMSOLLCMember_documentation_en-US" xlink:label="lab_ameh_CAIPAMSOLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAIPA MSO, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CAIPAMSOLLCMember" xlink:href="ameh-20230630.xsd#ameh_CAIPAMSOLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_CAIPAMSOLLCMember" xlink:to="lab_ameh_CAIPAMSOLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_MemberRelationshipsMember_6e2cd504-88c5-4137-b95a-394efec6666e_terseLabel_en-US" xlink:label="lab_ameh_MemberRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Member relationships</link:label>
    <link:label id="lab_ameh_MemberRelationshipsMember_label_en-US" xlink:label="lab_ameh_MemberRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Member Relationships [Member]</link:label>
    <link:label id="lab_ameh_MemberRelationshipsMember_documentation_en-US" xlink:label="lab_ameh_MemberRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Member Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MemberRelationshipsMember" xlink:href="ameh-20230630.xsd#ameh_MemberRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_MemberRelationshipsMember" xlink:to="lab_ameh_MemberRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DMGAndSunLabsMember_e22a35e4-b21a-46f5-a702-5cb87654a1ef_terseLabel_en-US" xlink:label="lab_ameh_DMGAndSunLabsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG And Sun Labs</link:label>
    <link:label id="lab_ameh_DMGAndSunLabsMember_label_en-US" xlink:label="lab_ameh_DMGAndSunLabsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG And Sun Labs [Member]</link:label>
    <link:label id="lab_ameh_DMGAndSunLabsMember_documentation_en-US" xlink:label="lab_ameh_DMGAndSunLabsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG And Sun Labs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DMGAndSunLabsMember" xlink:href="ameh-20230630.xsd#ameh_DMGAndSunLabsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DMGAndSunLabsMember" xlink:to="lab_ameh_DMGAndSunLabsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_de74e19e-59c4-49fb-a463-711d991deec2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_e284b17e-cba4-45a7-bdc6-4720e10237fa_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued for vesting of restricted stock awards</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_a5e40743-3578-4887-a59a-04cd54dc1d61_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_16da18ee-b488-4370-9ffa-9788db546b38_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_d8c55e79-1737-4a44-b1c3-4f48b308c5c6_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_7ae87763-ffd5-4c9e-8092-70c31db9a1d3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired (see Note 3)</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_48f645d1-6d6d-403f-a4d4-6531a267e48b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum_a442d5a1-e4c9-4952-b5e1-b235836818bb_terseLabel_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, cash flow coverage ratio, minimum</link:label>
    <link:label id="lab_ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum_label_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Cash Flow Coverage Ratio, Minimum</link:label>
    <link:label id="lab_ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum_documentation_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Cash Flow Coverage Ratio, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum" xlink:to="lab_ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_530349c4-8893-4ac3-b405-03ef4684f936_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution from investment - equity method</link:label>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_label_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution, Return of Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:to="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e4666645-f261-4440-8b19-d1065ab16725_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ShareholdersAndOfficersMember_234313cd-9c18-45e6-b5ca-7c3e51bbd37f_terseLabel_en-US" xlink:label="lab_ameh_ShareholdersAndOfficersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC Shareholders and Officers</link:label>
    <link:label id="lab_ameh_ShareholdersAndOfficersMember_label_en-US" xlink:label="lab_ameh_ShareholdersAndOfficersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders And Officers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareholdersAndOfficersMember" xlink:href="ameh-20230630.xsd#ameh_ShareholdersAndOfficersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ShareholdersAndOfficersMember" xlink:to="lab_ameh_ShareholdersAndOfficersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_00cadd55-49e3-4c6d-8c48-13db7bf527ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_0c47f1ee-52c7-42c6-8453-c6b4d100e613_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_10c33167-e3d1-4e90-afc9-2ea47c27e4c5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from repayment of loans receivable &#8211; related parties</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Long-Term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_6746e341-0da8-4b42-8b49-f0f11d6314ab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses recognized on equity securities held at end of period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_989614e0-c9aa-4470-8b18-f993427dc00f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares for business acquisition (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_09644e56-12d0-4d28-9497-b5b211f169d8_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_1f4f07fd-2c29-462a-938d-6a5badec6942_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_c9dfe19e-26d2-4b8a-a8e1-3025367859c1_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_a0473354-0144-4a74-a476-7e87d4d333bc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_CashPaidForLeaseLiabilitiesAbstractAbstract_8940fcd8-546a-434f-ad0a-f682e510a928_verboseLabel_en-US" xlink:label="lab_ameh_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_ameh_CashPaidForLeaseLiabilitiesAbstractAbstract_label_en-US" xlink:label="lab_ameh_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Lease Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:href="ameh-20230630.xsd#ameh_CashPaidForLeaseLiabilitiesAbstractAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:to="lab_ameh_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_NetworkMedicalManagementMember_443071d9-405e-412e-be54-77e2a05a6165_terseLabel_en-US" xlink:label="lab_ameh_NetworkMedicalManagementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NMM</link:label>
    <link:label id="lab_ameh_NetworkMedicalManagementMember_label_en-US" xlink:label="lab_ameh_NetworkMedicalManagementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Network Medical Management [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NetworkMedicalManagementMember" xlink:href="ameh-20230630.xsd#ameh_NetworkMedicalManagementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_NetworkMedicalManagementMember" xlink:to="lab_ameh_NetworkMedicalManagementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_93ec6ddb-3e01-4893-a219-b1c1bbadd3a0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d170f77a-8f86-4201-9b6b-98292eeceac4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable_3b2809d6-48b9-411f-9e35-015834b63fbf_negatedTerseLabel_en-US" xlink:label="lab_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding Reclassified To Loan Receivable</link:label>
    <link:label id="lab_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable_label_en-US" xlink:label="lab_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Funding Reclassified to Loan Receivable</link:label>
    <link:label id="lab_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable_documentation_en-US" xlink:label="lab_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Funding Reclassified to Loan Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable" xlink:href="ameh-20230630.xsd#ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable" xlink:to="lab_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_ad76a4b6-03b2-456a-aee2-7299866e547e_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ArroyoVistaMember_400820e5-3f83-4dc0-96f3-b2861889f0ea_terseLabel_en-US" xlink:label="lab_ameh_ArroyoVistaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arroyo Vista</link:label>
    <link:label id="lab_ameh_ArroyoVistaMember_label_en-US" xlink:label="lab_ameh_ArroyoVistaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arroyo Vista [Member]</link:label>
    <link:label id="lab_ameh_ArroyoVistaMember_documentation_en-US" xlink:label="lab_ameh_ArroyoVistaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arroyo Vista</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ArroyoVistaMember" xlink:href="ameh-20230630.xsd#ameh_ArroyoVistaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ArroyoVistaMember" xlink:to="lab_ameh_ArroyoVistaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_8b9cf07a-0da9-4c82-9e30-0c265e7f7b22_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets recorded under finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_UnrealizedGainLossFromInvestmentInEquitySecurities_b9e5c8d3-b00d-41d9-8d20-352914e48c0c_negatedLabel_en-US" xlink:label="lab_ameh_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on investments</link:label>
    <link:label id="lab_ameh_UnrealizedGainLossFromInvestmentInEquitySecurities_label_en-US" xlink:label="lab_ameh_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (Gain) Loss from Investment in Equity Securities</link:label>
    <link:label id="lab_ameh_UnrealizedGainLossFromInvestmentInEquitySecurities_documentation_en-US" xlink:label="lab_ameh_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (Gain) Loss from Investment in Equity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:href="ameh-20230630.xsd#ameh_UnrealizedGainLossFromInvestmentInEquitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:to="lab_ameh_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_b8e6c182-9089-424a-8211-f6fcd4814a35_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_9c3625ad-216e-4f48-a9fe-5e2f842209cd_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_a3142555-7720-422e-af55-bae43d4ca05a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_636fb68e-decf-43c8-956b-72141ee9d4e1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_PaymentsForMedicalCareCostsAbstract_138efc6f-1480-4da5-a627-72975751c781_terseLabel_en-US" xlink:label="lab_ameh_PaymentsForMedicalCareCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for medical care costs related to claims incurred:</link:label>
    <link:label id="lab_ameh_PaymentsForMedicalCareCostsAbstract_label_en-US" xlink:label="lab_ameh_PaymentsForMedicalCareCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Medical Care Costs [Abstract]</link:label>
    <link:label id="lab_ameh_PaymentsForMedicalCareCostsAbstract_documentation_en-US" xlink:label="lab_ameh_PaymentsForMedicalCareCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Medical Care Costs [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PaymentsForMedicalCareCostsAbstract" xlink:href="ameh-20230630.xsd#ameh_PaymentsForMedicalCareCostsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_PaymentsForMedicalCareCostsAbstract" xlink:to="lab_ameh_PaymentsForMedicalCareCostsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange_a97270f5-a469-44c5-87ef-6ef622231404_terseLabel_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated leverage ratio, annual decrease</link:label>
    <link:label id="lab_ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange_label_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Incremental Change</link:label>
    <link:label id="lab_ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange_documentation_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Incremental Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:to="lab_ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_76d50b3a-f8d3-4278-b49a-2413c871dda6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss (gain) on interest rate swaps</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_EarningsPerShareTable_482385fb-1182-4ee4-b615-81049fc53af6_terseLabel_en-US" xlink:label="lab_ameh_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_ameh_EarningsPerShareTable_label_en-US" xlink:label="lab_ameh_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_ameh_EarningsPerShareTable_documentation_en-US" xlink:label="lab_ameh_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EarningsPerShareTable" xlink:href="ameh-20230630.xsd#ameh_EarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_EarningsPerShareTable" xlink:to="lab_ameh_EarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7ccd2ea6-242a-4ec9-8a79-e553eb20da44_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_edbb5218-9420-44ba-b44e-7dc1ea3c6af3_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f496e552-fa93-46a1-99f1-8a7077a66bf5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for business and asset acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_0747e4c6-c4cf-4f68-9e81-808836e8af81_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_ed714367-0106-4519-a617-7d46eeaa2e50_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_678b6bd3-a80a-482b-8e63-37927ecc38d6_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_72882c3f-3273-478a-be5b-64f1ad8d1bab_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable_3b61aab6-abbd-496c-94d2-6264469cd1d8_terseLabel_en-US" xlink:label="lab_ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, termination period, if applicable</link:label>
    <link:label id="lab_ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable_label_en-US" xlink:label="lab_ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Termination Period, If Applicable</link:label>
    <link:label id="lab_ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable_documentation_en-US" xlink:label="lab_ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Termination Period, If Applicable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable" xlink:href="ameh-20230630.xsd#ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable" xlink:to="lab_ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_Pacific6EnterprisesMember_354d68dd-13f3-4d0c-803a-1556cb529de9_terseLabel_en-US" xlink:label="lab_ameh_Pacific6EnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pacific6 Enterprises</link:label>
    <link:label id="lab_ameh_Pacific6EnterprisesMember_label_en-US" xlink:label="lab_ameh_Pacific6EnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pacific6 Enterprises [Member]</link:label>
    <link:label id="lab_ameh_Pacific6EnterprisesMember_documentation_en-US" xlink:label="lab_ameh_Pacific6EnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pacific6 Enterprises [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_Pacific6EnterprisesMember" xlink:href="ameh-20230630.xsd#ameh_Pacific6EnterprisesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_Pacific6EnterprisesMember" xlink:to="lab_ameh_Pacific6EnterprisesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_003842c7-764c-4a35-8390-8ae6075a6369_terseLabel_en-US" xlink:label="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest purchase obligation, noncurrent</link:label>
    <link:label id="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_00fc23ef-99be-433a-90b8-673c29e138f8_verboseLabel_en-US" xlink:label="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining equity interest purchase</link:label>
    <link:label id="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_label_en-US" xlink:label="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Equity Interest Purchase Obligation, Noncurrent</link:label>
    <link:label id="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_documentation_en-US" xlink:label="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Equity Interest Purchase Obligation, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:href="ameh-20230630.xsd#ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:to="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_c7d3d8e5-b326-4e08-b60d-06da98cce160_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed asset obtained in exchange for finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_3ca6e8a6-016d-4566-b5a1-a0810a89774a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_bc81b568-30e7-4f8f-b0e6-8d8ee929c3ca_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in&#160;Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_228d8f2f-7dec-4d64-8cce-4aad64fe14ca_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_f826b978-1351-46b9-a2f8-d74c21b1d839_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_eee8b401-40a3-495e-9738-b2b5f23db788_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains recognized on equity securities sold</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_d5709d14-c7b9-42cf-9038-7221eaae15f6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_c06414f2-f60d-42cd-9de5-45da7f30dc42_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_92a4693a-6ce0-49f4-bc39-5eac5dcb3e5a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocation of Income (Loss)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_2f8daab2-8f77-4ee4-b89e-2bc2a3cd54a1_netLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_1e8415ed-071f-4ac6-b833-966216bd7a04_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_95d18547-eb1d-4f12-9e58-2023ef77e746_verboseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_97f677d2-35b6-470b-8b74-8d5e3bb37ef9_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance cost</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DerivativeCeilingInterestRate_c323c015-70b8-451f-9aba-bff1ac217731_terseLabel_en-US" xlink:label="lab_ameh_DerivativeCeilingInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, ceiling interest rate</link:label>
    <link:label id="lab_ameh_DerivativeCeilingInterestRate_label_en-US" xlink:label="lab_ameh_DerivativeCeilingInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Ceiling Interest Rate</link:label>
    <link:label id="lab_ameh_DerivativeCeilingInterestRate_documentation_en-US" xlink:label="lab_ameh_DerivativeCeilingInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Ceiling Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DerivativeCeilingInterestRate" xlink:href="ameh-20230630.xsd#ameh_DerivativeCeilingInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DerivativeCeilingInterestRate" xlink:to="lab_ameh_DerivativeCeilingInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_c52aebd1-1a1c-40a4-a97d-573f0b2856ed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_0c95b15a-02dd-4c8f-ad43-bdc2a04c846c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ff851517-4893-486e-a579-d40d6e7f3e1e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_071cb81e-d4b2-4e9d-a68d-7688d6dc9cca_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_d869ede2-6379-4855-86ea-fc5151741fc4_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges:</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_f0fd1d4d-dbee-4b8d-be42-f850da0b3822_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of lease expense</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_6d87457e-694a-4738-9845-f8f9914e5906_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants_38fea862-6172-460b-93f2-733ada6d0100_verboseLabel_en-US" xlink:label="lab_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued for exercise of options and warrants (in shares)</link:label>
    <link:label id="lab_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants_label_en-US" xlink:label="lab_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during the period shares of exercise of option and warrants</link:label>
    <link:label id="lab_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants_documentation_en-US" xlink:label="lab_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">It represents number of share issued exercise of option and warrants during the period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" xlink:href="ameh-20230630.xsd#ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" xlink:to="lab_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2363aaf5-db6c-459c-8092-3b70a08b1975_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_e8a4b38e-b031-4023-b076-4927cf634b9d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease option to extend (up to)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_30e869a5-5834-4fca-bc01-4acea1bf65dc_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_13c41eda-e652-40b0-ba1a-c6e9a524360c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_0d2d17b9-82ad-4131-b914-48815ab2e54c_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_6f07bae7-aea6-43d5-b747-a4af069553a9_netLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_69dfb0a9-bb6e-40c8-ab23-107858038a30_verboseLabel_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_label_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_documentation_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:href="ameh-20230630.xsd#ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:to="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_9b38c12a-5201-4043-a3b8-dfbf10fb0afc_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_824dbccf-9650-4963-88c1-00eb41197690_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_13afe84d-7802-46ed-b3a8-96122931f2ec_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f99759bf-8dd9-4679-91c5-7f944573a2f1_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_MedicalCareCostsAbstract_51a200ec-a2c1-4930-9cce-f3bbda3dc891_terseLabel_en-US" xlink:label="lab_ameh_MedicalCareCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of medical care costs related to claims incurred:</link:label>
    <link:label id="lab_ameh_MedicalCareCostsAbstract_label_en-US" xlink:label="lab_ameh_MedicalCareCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Care Costs [Abstract]</link:label>
    <link:label id="lab_ameh_MedicalCareCostsAbstract_documentation_en-US" xlink:label="lab_ameh_MedicalCareCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Care Costs [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MedicalCareCostsAbstract" xlink:href="ameh-20230630.xsd#ameh_MedicalCareCostsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_MedicalCareCostsAbstract" xlink:to="lab_ameh_MedicalCareCostsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_9c4bbc03-f5a2-4a38-9983-a3b300e9605e_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_8c656029-9a1a-480e-9b1b-6f5aafe739a3_terseLabel_en-US" xlink:label="lab_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_label_en-US" xlink:label="lab_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Cash Cash Equivalents And Restricted Cash [Abstract]</link:label>
    <link:label id="lab_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_documentation_en-US" xlink:label="lab_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Cash Cash Equivalents And Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:href="ameh-20230630.xsd#ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:to="lab_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_PerformanceBasedRestrictedStockMember_0168a863-29c2-4de7-907c-17af2dc3f988_terseLabel_en-US" xlink:label="lab_ameh_PerformanceBasedRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Restricted Stock</link:label>
    <link:label id="lab_ameh_PerformanceBasedRestrictedStockMember_label_en-US" xlink:label="lab_ameh_PerformanceBasedRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Restricted Stock [Member]</link:label>
    <link:label id="lab_ameh_PerformanceBasedRestrictedStockMember_documentation_en-US" xlink:label="lab_ameh_PerformanceBasedRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PerformanceBasedRestrictedStockMember" xlink:href="ameh-20230630.xsd#ameh_PerformanceBasedRestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_PerformanceBasedRestrictedStockMember" xlink:to="lab_ameh_PerformanceBasedRestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_1ba01816-775d-42cd-b440-48acb6d30f1f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_EquityMethodInvestmentsRollForward_e7676023-9c39-4585-a6e6-5c4d5f8a4690_terseLabel_en-US" xlink:label="lab_ameh_EquityMethodInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Roll Forward]</link:label>
    <link:label id="lab_ameh_EquityMethodInvestmentsRollForward_label_en-US" xlink:label="lab_ameh_EquityMethodInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Roll Forward]</link:label>
    <link:label id="lab_ameh_EquityMethodInvestmentsRollForward_documentation_en-US" xlink:label="lab_ameh_EquityMethodInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EquityMethodInvestmentsRollForward" xlink:href="ameh-20230630.xsd#ameh_EquityMethodInvestmentsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_EquityMethodInvestmentsRollForward" xlink:to="lab_ameh_EquityMethodInvestmentsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFloorInterestRate_3d092453-2a48-40f3-818f-2097bd4fbe98_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, floor interest rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFloorInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Floor Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFloorInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFloorInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFloorInterestRate" xlink:to="lab_us-gaap_DerivativeFloorInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_5d78d9d9-a2dd-4517-987a-1c001d694316_totalLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_3152cc1e-6acd-4ccd-83df-7b1d37918d20_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_EquityMethodInvestmentAdditionalInvestment_4cac52c6-d8e4-47e1-9425-10a0bb91d425_terseLabel_en-US" xlink:label="lab_ameh_EquityMethodInvestmentAdditionalInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Investment</link:label>
    <link:label id="lab_ameh_EquityMethodInvestmentAdditionalInvestment_label_en-US" xlink:label="lab_ameh_EquityMethodInvestmentAdditionalInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Additional Investment</link:label>
    <link:label id="lab_ameh_EquityMethodInvestmentAdditionalInvestment_documentation_en-US" xlink:label="lab_ameh_EquityMethodInvestmentAdditionalInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Additional Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EquityMethodInvestmentAdditionalInvestment" xlink:href="ameh-20230630.xsd#ameh_EquityMethodInvestmentAdditionalInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_EquityMethodInvestmentAdditionalInvestment" xlink:to="lab_ameh_EquityMethodInvestmentAdditionalInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_703d41c7-ce0b-43df-8445-b00d43163432_terseLabel_en-US" xlink:label="lab_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income (restated)</link:label>
    <link:label id="lab_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_label_en-US" xlink:label="lab_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable To Noncontrolling Interest And Temporary Equity</link:label>
    <link:label id="lab_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_documentation_en-US" xlink:label="lab_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable To Noncontrolling Interest And Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:href="ameh-20230630.xsd#ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:to="lab_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_06a24754-a7bf-4683-8b19-eee11ebfe43b_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_CreditAgreementMember_8e3a52c1-8311-4c0f-85e4-82e2c7fdc063_terseLabel_en-US" xlink:label="lab_ameh_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_ameh_CreditAgreementMember_label_en-US" xlink:label="lab_ameh_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_ameh_CreditAgreementMember_documentation_en-US" xlink:label="lab_ameh_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CreditAgreementMember" xlink:href="ameh-20230630.xsd#ameh_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_CreditAgreementMember" xlink:to="lab_ameh_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_09ba80ec-ba1f-422b-a8d2-5340b8fed13f_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_6cec9c10-3904-4d5e-b7db-10b7991cf56a_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_ce485741-0fc6-4533-994e-48377a5932b3_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f9d34654-b97a-4603-8f4d-e70be475d056_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain recognized from change in fair value of existing Level 3 liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9c4c122b-6743-4071-9a91-de3f49dbf433_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_a60c8c80-9178-4553-9a7a-239135a02e97_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_b9d55fcf-63ca-4247-9dd3-b9dbac8ea12a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term, operating</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_599b1961-7270-42f5-b6ab-de6526726823_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Bank Loans, and Lines of Credit</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_02796b2c-e2ad-4098-bcf7-778c8f5c294c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_c766df3c-6e85-4401-a3b7-f7437b81af13_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_672f3b90-7b81-4b98-87c4-78fd4d416729_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver Loan</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_039132c6-ea99-4524-b22b-cdbc2fa99c76_verboseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver Loan</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_d595ea66-ffd4-46a8-b13a-ee83c4a3105a_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_95fe79fe-8859-4fb3-8de8-0d7f069d89e0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_f89afd35-52ff-4d38-989d-63477e73460b_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b4ef59e3-1fb4-49d4-8817-e69b0ab1ccd4_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_5ef246c4-99c0-4896-a4eb-960640ef40e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_c0939b13-0313-47e4-a73e-68f5b09b8b6c_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_3b2e3861-a594-4584-a036-ea4c2c22d90e_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_631008d3-2f23-423c-b862-3c46ee14eb25_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_NumberOfPrimaryCareProvider_b7c7a2a3-e131-46c5-9751-ef015f8e1354_terseLabel_en-US" xlink:label="lab_ameh_NumberOfPrimaryCareProvider" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of primary care provider</link:label>
    <link:label id="lab_ameh_NumberOfPrimaryCareProvider_label_en-US" xlink:label="lab_ameh_NumberOfPrimaryCareProvider" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Primary Care Provider</link:label>
    <link:label id="lab_ameh_NumberOfPrimaryCareProvider_documentation_en-US" xlink:label="lab_ameh_NumberOfPrimaryCareProvider" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Primary Care Provider</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NumberOfPrimaryCareProvider" xlink:href="ameh-20230630.xsd#ameh_NumberOfPrimaryCareProvider"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_NumberOfPrimaryCareProvider" xlink:to="lab_ameh_NumberOfPrimaryCareProvider" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_28260044-b929-4d6d-860a-7fae61e2e00b_terseLabel_en-US" xlink:label="lab_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:to="lab_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_StockAwardsAndUnitsMember_d9137160-14fe-41ab-a95f-e61fed3a04e5_terseLabel_en-US" xlink:label="lab_ameh_StockAwardsAndUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_ameh_StockAwardsAndUnitsMember_label_en-US" xlink:label="lab_ameh_StockAwardsAndUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Awards And Units [Member]</link:label>
    <link:label id="lab_ameh_StockAwardsAndUnitsMember_documentation_en-US" xlink:label="lab_ameh_StockAwardsAndUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Awards And Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_StockAwardsAndUnitsMember" xlink:href="ameh-20230630.xsd#ameh_StockAwardsAndUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_StockAwardsAndUnitsMember" xlink:to="lab_ameh_StockAwardsAndUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_94714ec3-12da-4e77-adb5-ba6e3173fe69_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c30d6cf8-9cb4-493d-8dd8-cfe9bae340fb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c8fe747e-7cb2-4ef3-9ac2-1d98d0fc3798_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical liabilities, beginning of period (restated)</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_04c1af2d-66d0-485a-8b69-266959073f33_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical liabilities, end of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_72415fee-9014-48b6-8b57-c7892369b54e_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember_7dddaa81-ca79-4555-9a29-a03f0f09b45f_terseLabel_en-US" xlink:label="lab_ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orma Health, Inc., and Provider Growth Solutions LLC</link:label>
    <link:label id="lab_ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember_label_en-US" xlink:label="lab_ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orma Health, Inc., and Provider Growth Solutions LLC [Member]</link:label>
    <link:label id="lab_ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember_documentation_en-US" xlink:label="lab_ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orma Health, Inc., and Provider Growth Solutions LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember" xlink:href="ameh-20230630.xsd#ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember" xlink:to="lab_ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_EquityMethodInvestmentsContribution_8fc833d7-f594-4d3a-b676-14579b39861a_terseLabel_en-US" xlink:label="lab_ameh_EquityMethodInvestmentsContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding</link:label>
    <link:label id="lab_ameh_EquityMethodInvestmentsContribution_label_en-US" xlink:label="lab_ameh_EquityMethodInvestmentsContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Contribution</link:label>
    <link:label id="lab_ameh_EquityMethodInvestmentsContribution_documentation_en-US" xlink:label="lab_ameh_EquityMethodInvestmentsContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Contribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EquityMethodInvestmentsContribution" xlink:href="ameh-20230630.xsd#ameh_EquityMethodInvestmentsContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_EquityMethodInvestmentsContribution" xlink:to="lab_ameh_EquityMethodInvestmentsContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_e8df03b4-e81d-47f5-b276-2d2708f1922a_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_4e0cb8b7-9e15-40a9-a8ee-55485a961f9b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4b4fb2d-0d84-49fd-9689-8334038de08d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DmgMember_dbff5cda-06b3-4f3b-9730-93460b84eeaa_terseLabel_en-US" xlink:label="lab_ameh_DmgMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG</link:label>
    <link:label id="lab_ameh_DmgMember_label_en-US" xlink:label="lab_ameh_DmgMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DmgMember" xlink:href="ameh-20230630.xsd#ameh_DmgMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DmgMember" xlink:to="lab_ameh_DmgMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b915fdd6-e53d-497a-8608-65c4f8f71e39_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_35dcffa6-f8a0-43b7-84b3-fd0a277cfd4f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_143e83c8-33f1-4971-90eb-60a2847ddecb_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_175b9355-291e-4988-83b5-1d5a584df860_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_85b56fc5-f4b5-45eb-81c9-71ce6e49c063_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_925c7711-c45f-4caf-9015-7b4829b1afb7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2a69bb37-132f-46d9-a568-eb383d1fe656_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a62778f9-270c-4759-a751-45e4487d7e2d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price adjustment from merger</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDueFromRelatedParties_b800d1b3-cd75-4605-8834-02f1492b5ec5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net &#8211; related parties</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Due from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:to="lab_us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_09a74803-db49-44b9-9804-664f60859aa1_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Apollo Medical Holdings, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_5a9a510f-7e65-4d0a-ae46-af23ded57ee0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_520fb294-56f8-419d-901d-e24f6733232b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_0ab50d5f-ef96-4bbc-9341-5e801e2c1bdd_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_d428535b-0d7b-4cdd-9869-ab55f67a0191_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0116740f-e3c2-47ae-844b-17f9fd9ba6f0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, property, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e0315da7-f720-4682-a7da-ed46995c84e4_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, mezzanine equity and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_809ab748-1268-48e2-ac85-d2a24bf32db1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_109425bb-0fe8-47ca-8370-5c9737935eea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share buy back</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ProviderServicesMember_3259ff55-f34b-4f38-8f09-bf08d2eebb2c_terseLabel_en-US" xlink:label="lab_ameh_ProviderServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Services</link:label>
    <link:label id="lab_ameh_ProviderServicesMember_label_en-US" xlink:label="lab_ameh_ProviderServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Services [Member]</link:label>
    <link:label id="lab_ameh_ProviderServicesMember_documentation_en-US" xlink:label="lab_ameh_ProviderServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ProviderServicesMember" xlink:href="ameh-20230630.xsd#ameh_ProviderServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ProviderServicesMember" xlink:to="lab_ameh_ProviderServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_bfea505e-c76c-430f-bd40-821603059d6c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8cc389d1-fcac-431f-907e-a0430d92032a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued for exercise of options and warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f4961307-e036-4db0-9a87-0a6cf8cecbd8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_94613a9b-9ad0-435b-8493-6545238cbd6f_terseLabel_en-US" xlink:label="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest purchase obligation, period to purchase</link:label>
    <link:label id="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_label_en-US" xlink:label="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Equity Interest Purchase Obligation, Period to Purchase</link:label>
    <link:label id="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_documentation_en-US" xlink:label="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Equity Interest Purchase Obligation, Period to Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:href="ameh-20230630.xsd#ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:to="lab_ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_0a6801c2-f4ac-4975-a8fb-2bb59e34f15e_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_c3441789-a5c6-4dc0-9732-643cdd4f0d24_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_787301e8-ff8c-4536-86bc-1960dd747442_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_9468945c-f01d-4d10-aaf5-038b58a55308_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_adc783d7-48d6-4850-ac05-d43927e253c2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ManagementContractsMember_2c29e944-83d0-486e-a179-455e351bc9a4_verboseLabel_en-US" xlink:label="lab_ameh_ManagementContractsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management contracts</link:label>
    <link:label id="lab_ameh_ManagementContractsMember_label_en-US" xlink:label="lab_ameh_ManagementContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Contracts [Member]</link:label>
    <link:label id="lab_ameh_ManagementContractsMember_documentation_en-US" xlink:label="lab_ameh_ManagementContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ManagementContractsMember" xlink:href="ameh-20230630.xsd#ameh_ManagementContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ManagementContractsMember" xlink:to="lab_ameh_ManagementContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_8e103276-2784-42fe-abf8-ddeca38906b6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_LasalleMedicalAssociatesIpaMember_133d08e2-1d62-4502-bd9a-29d2b092b5bc_terseLabel_en-US" xlink:label="lab_ameh_LasalleMedicalAssociatesIpaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LaSalle Medical Associates &#8211; IPA Line of Business</link:label>
    <link:label id="lab_ameh_LasalleMedicalAssociatesIpaMember_label_en-US" xlink:label="lab_ameh_LasalleMedicalAssociatesIpaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LaSalle Medical Associates IPA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LasalleMedicalAssociatesIpaMember" xlink:href="ameh-20230630.xsd#ameh_LasalleMedicalAssociatesIpaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_LasalleMedicalAssociatesIpaMember" xlink:to="lab_ameh_LasalleMedicalAssociatesIpaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_ff63a576-c0af-4cd8-aca7-c11490b5f0ca_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior periods</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_0168ff50-ed9f-419b-b7e3-0016f010951b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_eb63e18b-4a1e-4f55-8f7c-57f838e1c2da_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 (excluding the six months ended June 30, 2023)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_4d55c522-c59e-455a-830a-6803c5bb2814_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_cd09dfb4-7e46-4bff-bfed-151146b2d0b6_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_7a7ad1a8-f45e-4f55-8c78-7b663d450013_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_dbeb5167-f3e7-4826-b9f2-82ff0e57aab4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_5df0b9cb-e988-4c78-a513-e073d201eada_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_HSMSOMember_b94e3b08-54d5-40c4-90de-d99684555b09_verboseLabel_en-US" xlink:label="lab_ameh_HSMSOMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HSMSO</link:label>
    <link:label id="lab_ameh_HSMSOMember_label_en-US" xlink:label="lab_ameh_HSMSOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HSMSO [Member]</link:label>
    <link:label id="lab_ameh_HSMSOMember_documentation_en-US" xlink:label="lab_ameh_HSMSOMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xxx_HSMSO Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_HSMSOMember" xlink:href="ameh-20230630.xsd#ameh_HSMSOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_HSMSOMember" xlink:to="lab_ameh_HSMSOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_67a6a51a-7cc7-4757-8154-d48528a2ae5a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_SummaryOfSignificantAccountingPoliciesTable_7a32b251-949f-4f0e-ad0f-667e556d7e46_terseLabel_en-US" xlink:label="lab_ameh_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_ameh_SummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_ameh_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_ameh_SummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_ameh_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SummaryOfSignificantAccountingPoliciesTable" xlink:href="ameh-20230630.xsd#ameh_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_ameh_SummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_fa4081ea-4ee3-464c-b145-1c88359ff6ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Unamortized financing costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_d7211995-1bba-434e-8e21-c2727973ab0a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized financing costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_AurionMember_6a209530-de81-425c-845d-037fd7d77ab7_verboseLabel_en-US" xlink:label="lab_ameh_AurionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurion</link:label>
    <link:label id="lab_ameh_AurionMember_label_en-US" xlink:label="lab_ameh_AurionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurion [Member]</link:label>
    <link:label id="lab_ameh_AurionMember_documentation_en-US" xlink:label="lab_ameh_AurionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xxx_Aurion Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AurionMember" xlink:href="ameh-20230630.xsd#ameh_AurionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_AurionMember" xlink:to="lab_ameh_AurionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_e0e21b52-842e-4718-b4f4-0d48ab7a5cbb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Operating Lease Payments After Adoption of 842</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_99153988-d496-4ef4-a6ea-d06cc9c28b8d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to weighted average shares of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_FeesIncurredAndIncomeRecognizedMember_a14cafe9-8e66-4e8f-84c0-d0cb783bfff4_terseLabel_en-US" xlink:label="lab_ameh_FeesIncurredAndIncomeRecognizedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fees Incurred and Income Recognized</link:label>
    <link:label id="lab_ameh_FeesIncurredAndIncomeRecognizedMember_label_en-US" xlink:label="lab_ameh_FeesIncurredAndIncomeRecognizedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fees Incurred and Income Recognized [Member]</link:label>
    <link:label id="lab_ameh_FeesIncurredAndIncomeRecognizedMember_documentation_en-US" xlink:label="lab_ameh_FeesIncurredAndIncomeRecognizedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fees Incurred and Income Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FeesIncurredAndIncomeRecognizedMember" xlink:href="ameh-20230630.xsd#ameh_FeesIncurredAndIncomeRecognizedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_FeesIncurredAndIncomeRecognizedMember" xlink:to="lab_ameh_FeesIncurredAndIncomeRecognizedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_2ef18c76-8582-4d6a-8fde-f38d9da1c425_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_97dc3e2d-724a-4959-808e-968ebfd310eb_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_e4077903-5ee6-461f-af60-e5fc2a1ffd6f_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_2511a989-1030-4063-95c3-4d625b9c2cb9_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Information Related to Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_029da11c-52c4-429b-a3e9-e592c827fa10_terseLabel_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit</link:label>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_label_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandbyLettersOfCreditMember" xlink:to="lab_us-gaap_StandbyLettersOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f0f3d870-1ce2-4227-9d35-1bf875bbc69a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_53581db4-35de-4e1a-af7a-b27f5918c389_verboseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Sale of Parent Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_MezzanineEquityAbstract_1527d71f-1124-491e-9bcc-79ce9fa6cdfd_verboseLabel_en-US" xlink:label="lab_ameh_MezzanineEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine equity</link:label>
    <link:label id="lab_ameh_MezzanineEquityAbstract_label_en-US" xlink:label="lab_ameh_MezzanineEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MEZZANINE EQUITY [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MezzanineEquityAbstract" xlink:href="ameh-20230630.xsd#ameh_MezzanineEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_MezzanineEquityAbstract" xlink:to="lab_ameh_MezzanineEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_7628dd57-ce53-44e9-a7e1-3a7661abb153_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_FiduciaryAccountsPayableCurrent_7e656eda-cd69-4c13-9860-b06f17f090a9_terseLabel_en-US" xlink:label="lab_ameh_FiduciaryAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiduciary accounts payable</link:label>
    <link:label id="lab_ameh_FiduciaryAccountsPayableCurrent_5e322748-6f6a-48f3-8732-c6c553c0f8fa_verboseLabel_en-US" xlink:label="lab_ameh_FiduciaryAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiduciary accounts payable</link:label>
    <link:label id="lab_ameh_FiduciaryAccountsPayableCurrent_label_en-US" xlink:label="lab_ameh_FiduciaryAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiduciary Accounts Payable Current</link:label>
    <link:label id="lab_ameh_FiduciaryAccountsPayableCurrent_documentation_en-US" xlink:label="lab_ameh_FiduciaryAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of fiduciary accounts payable, due after one year or beyond the normal operating cycle, if longer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FiduciaryAccountsPayableCurrent" xlink:href="ameh-20230630.xsd#ameh_FiduciaryAccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_FiduciaryAccountsPayableCurrent" xlink:to="lab_ameh_FiduciaryAccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_3fbf389f-e112-4934-af3f-4b79cdd672c7_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_4e6880b5-cf36-44f3-99dd-7897534a3ce9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_a1cf3325-fd97-4822-919c-243effc29d80_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_OfficeLeaseMember_7b6a83c4-c811-45bc-8bd7-af78af094cbd_terseLabel_en-US" xlink:label="lab_ameh_OfficeLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Lease</link:label>
    <link:label id="lab_ameh_OfficeLeaseMember_label_en-US" xlink:label="lab_ameh_OfficeLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Lease [Member]</link:label>
    <link:label id="lab_ameh_OfficeLeaseMember_documentation_en-US" xlink:label="lab_ameh_OfficeLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OfficeLeaseMember" xlink:href="ameh-20230630.xsd#ameh_OfficeLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_OfficeLeaseMember" xlink:to="lab_ameh_OfficeLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8c51c583-3d46-40bc-83e9-0a5fe4b86376_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_b9469412-ffe6-4873-82b7-c65491acb191_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 (excluding the six months ended June 30, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_c221bf0c-e44e-4bc8-b4f6-456da17e542e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum_01dd3dd6-1f2b-4b43-8e19-e3bac06192a2_terseLabel_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum consolidated interest coverage ratio (not less than)</link:label>
    <link:label id="lab_ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum_label_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Interest Coverage Ratio, Minimum</link:label>
    <link:label id="lab_ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum_documentation_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Interest Coverage Ratio, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:to="lab_ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_4a03517c-f157-4273-9420-a22b3f96b139_verboseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_PayorCMember_8befb1cf-7cfc-4372-9865-5b860db9a014_terseLabel_en-US" xlink:label="lab_ameh_PayorCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor C</link:label>
    <link:label id="lab_ameh_PayorCMember_label_en-US" xlink:label="lab_ameh_PayorCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor C [Member]</link:label>
    <link:label id="lab_ameh_PayorCMember_documentation_en-US" xlink:label="lab_ameh_PayorCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor C [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PayorCMember" xlink:href="ameh-20230630.xsd#ameh_PayorCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_PayorCMember" xlink:to="lab_ameh_PayorCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_c36219a1-a0c0-4fc8-953d-0e449461896b_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_AccountsReceivableAndNetRevenueLineItems_dc622cff-121a-443e-99dc-dce98f30c12c_terseLabel_en-US" xlink:label="lab_ameh_AccountsReceivableAndNetRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable And Net Revenue [Line Items]</link:label>
    <link:label id="lab_ameh_AccountsReceivableAndNetRevenueLineItems_label_en-US" xlink:label="lab_ameh_AccountsReceivableAndNetRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable And Net Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AccountsReceivableAndNetRevenueLineItems" xlink:href="ameh-20230630.xsd#ameh_AccountsReceivableAndNetRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_AccountsReceivableAndNetRevenueLineItems" xlink:to="lab_ameh_AccountsReceivableAndNetRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_aeceaac1-9c3d-4c88-bc85-81193bc45f89_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_014d2689-61cf-4bbd-865f-e84774e030b3_terseLabel_en-US" xlink:label="lab_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_label_en-US" xlink:label="lab_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expenses and Depreciation and Amortization</link:label>
    <link:label id="lab_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_documentation_en-US" xlink:label="lab_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expenses and Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:href="ameh-20230630.xsd#ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:to="lab_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c8f833e2-338e-454c-9a3c-093c66b88efd_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ApcStockOptionMember_0061682d-a2d7-4002-989c-02242ca1211c_terseLabel_en-US" xlink:label="lab_ameh_ApcStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC Stock Option</link:label>
    <link:label id="lab_ameh_ApcStockOptionMember_label_en-US" xlink:label="lab_ameh_ApcStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApcStockOptionMember" xlink:href="ameh-20230630.xsd#ameh_ApcStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ApcStockOptionMember" xlink:to="lab_ameh_ApcStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_5f6ba56f-43a0-4e29-b30b-9aa5d914b883_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_e63d584a-fb87-4fa8-be78-f9aae810df33_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSoldCarryingAmount_ae28642a-689a-4256-93fb-94bb66429d09_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSoldCarryingAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSoldCarryingAmount_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSoldCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Amount Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSoldCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentSoldCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentSoldCarryingAmount" xlink:to="lab_us-gaap_EquityMethodInvestmentSoldCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_7411357f-77f6-4b85-a863-9076f2c28467_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_d2fc324d-9674-4cac-8ca4-8498ff22c395_terseLabel_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent on performance (in shares)</link:label>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_label_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Contingent on Performance</link:label>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_documentation_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Contingent on Performance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:href="ameh-20230630.xsd#ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:to="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_38960d81-cfad-4687-9fe4-baab384cefd1_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable/receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9e899144-6a29-4e3f-818c-5959e9f403fc_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3d032752-0b9f-40a4-af63-9ad0ce05f75c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_daea7d85-6d7d-4238-b5be-6fd0bcd73bb9_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_AHMCMember_bf9c74a5-676f-45d0-afca-fd0114425251_terseLabel_en-US" xlink:label="lab_ameh_AHMCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AHMC</link:label>
    <link:label id="lab_ameh_AHMCMember_bbcb916c-cceb-4876-81cb-bbfa37d09b72_verboseLabel_en-US" xlink:label="lab_ameh_AHMCMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AHMC</link:label>
    <link:label id="lab_ameh_AHMCMember_label_en-US" xlink:label="lab_ameh_AHMCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AHMC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AHMCMember" xlink:href="ameh-20230630.xsd#ameh_AHMCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_AHMCMember" xlink:to="lab_ameh_AHMCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_81511ebe-e182-41c4-ad61-5591de583781_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c9e797d8-22a0-439b-ac6a-c6b64aaeeafc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_b1fd19a7-9f5c-4d6c-bef5-4c7ca907b8f2_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_fb0c61c4-b03c-4e78-8f42-be1111a24651_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d43014ba-d588-47ef-a7c9-4b602a9567a3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_VOMGMember_06cb7180-a266-4076-80df-1ff7aa24e9d7_terseLabel_en-US" xlink:label="lab_ameh_VOMGMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VOMG</link:label>
    <link:label id="lab_ameh_VOMGMember_label_en-US" xlink:label="lab_ameh_VOMGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VOMG [Member]</link:label>
    <link:label id="lab_ameh_VOMGMember_documentation_en-US" xlink:label="lab_ameh_VOMGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VOMG</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_VOMGMember" xlink:href="ameh-20230630.xsd#ameh_VOMGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_VOMGMember" xlink:to="lab_ameh_VOMGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_779916ab-01e9-4db2-9a23-bffbc9267148_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promissory Note Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable to Banks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableToBanksMember" xlink:to="lab_us-gaap_NotesPayableToBanksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_bb471c42-f76f-4116-8f48-108c7af82e95_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares for business acquisition</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e257ba37-c77c-41df-825e-17ae442e2490_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_4bee4a10-04e7-4b85-84a7-57545eca0d66_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_51822d23-bb04-4526-bf3a-13e0d4d8d01d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_f1841b13-9187-4298-b9d9-6032033b9ee9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_AlphaCareMedicalGroupInc.Member_137f8922-5d5a-4aa2-b66d-6507906caf5d_terseLabel_en-US" xlink:label="lab_ameh_AlphaCareMedicalGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Care Medical Group, Inc.</link:label>
    <link:label id="lab_ameh_AlphaCareMedicalGroupInc.Member_label_en-US" xlink:label="lab_ameh_AlphaCareMedicalGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Care Medical Group, Inc. [Member]</link:label>
    <link:label id="lab_ameh_AlphaCareMedicalGroupInc.Member_documentation_en-US" xlink:label="lab_ameh_AlphaCareMedicalGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Care Medical Group, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlphaCareMedicalGroupInc.Member" xlink:href="ameh-20230630.xsd#ameh_AlphaCareMedicalGroupInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_AlphaCareMedicalGroupInc.Member" xlink:to="lab_ameh_AlphaCareMedicalGroupInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f148193d-aba2-45d6-ac7c-fc1f5d9d890e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_039666a1-c410-4013-9986-44ee4a0a586f_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_75aaa56b-51a7-418a-8329-e4a84e27b838_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_c11b1d38-03b9-4965-8371-fd2553663f70_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to related parties</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_457ef26b-41b2-4a68-8f21-3c1c4b1a5248_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount due to affiliate</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3100f722-94be-4642-adf0-cf7216ffee77_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod_e8a874cd-5f93-4af9-95a2-fb6cef126d03_terseLabel_en-US" xlink:label="lab_ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promissory notes expected to be collected within period</link:label>
    <link:label id="lab_ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod_label_en-US" xlink:label="lab_ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promissory Notes Expected To Be Collected Within Period</link:label>
    <link:label id="lab_ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod_documentation_en-US" xlink:label="lab_ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promissory Notes Expected To Be Collected Within Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod" xlink:href="ameh-20230630.xsd#ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod" xlink:to="lab_ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_8157a569-7ffd-4fbf-a37c-3037e81387ae_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Operations</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_OneMSOLLCMember_8ff79269-7d05-4457-a71d-1c3304726919_terseLabel_en-US" xlink:label="lab_ameh_OneMSOLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One MSO, LLC</link:label>
    <link:label id="lab_ameh_OneMSOLLCMember_label_en-US" xlink:label="lab_ameh_OneMSOLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One MSO, LLC [Member]</link:label>
    <link:label id="lab_ameh_OneMSOLLCMember_documentation_en-US" xlink:label="lab_ameh_OneMSOLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One MSO, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OneMSOLLCMember" xlink:href="ameh-20230630.xsd#ameh_OneMSOLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_OneMSOLLCMember" xlink:to="lab_ameh_OneMSOLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_PurchaseOfNonControllingInterest_ce9c506d-f407-44c7-97d1-0a28bc35b076_negatedTerseLabel_en-US" xlink:label="lab_ameh_PurchaseOfNonControllingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of non-controlling interest</link:label>
    <link:label id="lab_ameh_PurchaseOfNonControllingInterest_label_en-US" xlink:label="lab_ameh_PurchaseOfNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of Non-Controlling Interest</link:label>
    <link:label id="lab_ameh_PurchaseOfNonControllingInterest_documentation_en-US" xlink:label="lab_ameh_PurchaseOfNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of Non-Controlling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PurchaseOfNonControllingInterest" xlink:href="ameh-20230630.xsd#ameh_PurchaseOfNonControllingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_PurchaseOfNonControllingInterest" xlink:to="lab_ameh_PurchaseOfNonControllingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_07779ac4-4204-44e3-8398-f2cf8fa92c8a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_IncreaseDecreaseInOperatingLeaseAssets_e10062b7-e66d-491f-b12e-2b72d047eca8_verboseLabel_en-US" xlink:label="lab_ameh_IncreaseDecreaseInOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_ameh_IncreaseDecreaseInOperatingLeaseAssets_label_en-US" xlink:label="lab_ameh_IncreaseDecreaseInOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Assets</link:label>
    <link:label id="lab_ameh_IncreaseDecreaseInOperatingLeaseAssets_documentation_en-US" xlink:label="lab_ameh_IncreaseDecreaseInOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents increase in operating lease assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_IncreaseDecreaseInOperatingLeaseAssets" xlink:href="ameh-20230630.xsd#ameh_IncreaseDecreaseInOperatingLeaseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_IncreaseDecreaseInOperatingLeaseAssets" xlink:to="lab_ameh_IncreaseDecreaseInOperatingLeaseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_a13a1cdb-1ce1-4169-ae4f-308dbb9d160a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount due from affiliates</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d569c442-1dba-4f8e-bbcf-05bee4a368f1_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_2e4c3d8f-9f9b-466f-88b9-6aedd0add823_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_e73730ca-f93d-45f4-ac1d-414d6a7c7875_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_16309092-97a8-4eda-b3f2-52564f5e456e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_60fb4c13-67fe-4515-bd89-c72ebc8ae845_terseLabel_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, leverage ratio, adjusted maximum</link:label>
    <link:label id="lab_ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_label_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Adjusted Maximum</link:label>
    <link:label id="lab_ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_documentation_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Adjusted Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:to="lab_ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_8e043b99-3155-4dca-bce7-4e124c95a8b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Medical Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_LoanReceivableTextBlock_511e9332-425d-4b98-8b22-55517afceabb_verboseLabel_en-US" xlink:label="lab_ameh_LoanReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable and Loan Receivable &#8211; Related Parties</link:label>
    <link:label id="lab_ameh_LoanReceivableTextBlock_label_en-US" xlink:label="lab_ameh_LoanReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable [Text Block]</link:label>
    <link:label id="lab_ameh_LoanReceivableTextBlock_documentation_en-US" xlink:label="lab_ameh_LoanReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LoanReceivableTextBlock" xlink:href="ameh-20230630.xsd#ameh_LoanReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_LoanReceivableTextBlock" xlink:to="lab_ameh_LoanReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_CollarMember_1a5c7c36-2cb3-4e10-823d-fcd476c8d91f_terseLabel_en-US" xlink:label="lab_ameh_CollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate collar</link:label>
    <link:label id="lab_ameh_CollarMember_label_en-US" xlink:label="lab_ameh_CollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collar [Member]</link:label>
    <link:label id="lab_ameh_CollarMember_documentation_en-US" xlink:label="lab_ameh_CollarMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collar</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CollarMember" xlink:href="ameh-20230630.xsd#ameh_CollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_CollarMember" xlink:to="lab_ameh_CollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_b915a011-3a44-4d4f-bbe1-9e8b190d93af_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in other entities &#8211; equity method</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_0c52e7eb-44c1-4051-bfe3-525a3a47e132_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in other entities &#8211; equity method</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_d09c2935-3916-49c7-b080-3618dc6dc7f3_periodStartLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_bd97c887-4827-4a71-bf27-9c3f7606e9f9_periodEndLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsToMinorityShareholders_0c47878d-9fdb-4701-ae06-fb6c06ff3736_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of non-controlling interest</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments to) Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_6f12b911-4f71-4971-b9e1-3504fd2111a8_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_LongTermDebtMaturityAfterYearFour_7ead6666-9824-4092-af10-732fb8a2dd61_terseLabel_en-US" xlink:label="lab_ameh_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_ameh_LongTermDebtMaturityAfterYearFour_label_en-US" xlink:label="lab_ameh_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, After Year Four</link:label>
    <link:label id="lab_ameh_LongTermDebtMaturityAfterYearFour_documentation_en-US" xlink:label="lab_ameh_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LongTermDebtMaturityAfterYearFour" xlink:href="ameh-20230630.xsd#ameh_LongTermDebtMaturityAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_LongTermDebtMaturityAfterYearFour" xlink:to="lab_ameh_LongTermDebtMaturityAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_CommitmentsAndContingenciesLineItems_8e4ef89f-7a4e-42ec-a291-7cd941af4323_terseLabel_en-US" xlink:label="lab_ameh_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_ameh_CommitmentsAndContingenciesLineItems_label_en-US" xlink:label="lab_ameh_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CommitmentsAndContingenciesLineItems" xlink:href="ameh-20230630.xsd#ameh_CommitmentsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_CommitmentsAndContingenciesLineItems" xlink:to="lab_ameh_CommitmentsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0f8f69ea-7789-484d-9b91-36ef7116bb8c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_d7eeb8ce-5739-4a7d-ad86-8a8245048506_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for repurchase of shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_74a7e576-8ec6-4206-bf15-1be24253c322_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_LmaMember_9f72e985-70a0-4ebb-af0a-86638989ec3c_terseLabel_en-US" xlink:label="lab_ameh_LmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LMA</link:label>
    <link:label id="lab_ameh_LmaMember_label_en-US" xlink:label="lab_ameh_LmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LMA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LmaMember" xlink:href="ameh-20230630.xsd#ameh_LmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_LmaMember" xlink:to="lab_ameh_LmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4810fa5c-50da-4ba5-bb7e-8fd0714924bf_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of non-cash investing and financing activities</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_c1c8d2dd-5e4d-4bf3-9604-4426adbe8c90_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_3ffced75-33dc-4ad1-bbb2-f0859e54f192_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_086a691c-78f8-4f7b-a80b-cbb4e1eeebf2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_dc9d8a39-28da-4cd6-bbf4-a4bde4fd6d1a_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_af02992b-161d-4385-b89b-2347b36cf9e8_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_4302b197-0e7f-42ef-a3d5-35caad1924eb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued for vesting of restricted stock awards (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_46d6b647-c23b-4dfb-94e5-b2cd4b505b55_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, principal sum</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_83106378-fd84-4a86-954b-2a7b0ed252ee_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_aaff5868-0fad-4666-b1b0-c35b8d6426ba_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_IntraCareConvertiblePromissoryNoteReceivableMember_5e96987b-22b2-40d2-b198-722cb372a465_terseLabel_en-US" xlink:label="lab_ameh_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IntraCare Convertible Promissory Note Receivable</link:label>
    <link:label id="lab_ameh_IntraCareConvertiblePromissoryNoteReceivableMember_label_en-US" xlink:label="lab_ameh_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IntraCare Convertible Promissory Note Receivable [Member]</link:label>
    <link:label id="lab_ameh_IntraCareConvertiblePromissoryNoteReceivableMember_documentation_en-US" xlink:label="lab_ameh_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IntraCare Convertible Promissory Note Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:href="ameh-20230630.xsd#ameh_IntraCareConvertiblePromissoryNoteReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:to="lab_ameh_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_16eccefc-9106-4ca1-a79d-b135fb99f8f8_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_ae2d8981-bf03-46d2-9b83-cc43fb6cfaa0_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior periods</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c5f87a22-988b-4d5e-9f39-0fd8772ff2b3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_95aef0bb-b184-4824-b584-83e931d15553_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_af18f452-e563-45c0-94b2-0c907f037ecb_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivables_309de4f7-1fa6-47b5-ad1a-6081f11d6d7e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from affiliates</link:label>
    <link:label id="lab_us-gaap_OtherReceivables_label_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivables" xlink:to="lab_us-gaap_OtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_MedicareMember_54ac2cc6-43ff-4c7d-a16c-8f508095f0f5_terseLabel_en-US" xlink:label="lab_ameh_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_ameh_MedicareMember_label_en-US" xlink:label="lab_ameh_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:label id="lab_ameh_MedicareMember_documentation_en-US" xlink:label="lab_ameh_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ameh:MedicareMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MedicareMember" xlink:href="ameh-20230630.xsd#ameh_MedicareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_MedicareMember" xlink:to="lab_ameh_MedicareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a19bff2f-853a-4b3c-bddd-67b1d342f164_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_9cd0c3b0-5e1c-4d72-94c0-7ee1c56ffbae_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_CareDeliveryMember_ac1ca192-7c12-4c78-8253-2c0cbc6612d1_terseLabel_en-US" xlink:label="lab_ameh_CareDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Delivery</link:label>
    <link:label id="lab_ameh_CareDeliveryMember_label_en-US" xlink:label="lab_ameh_CareDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Delivery [Member]</link:label>
    <link:label id="lab_ameh_CareDeliveryMember_documentation_en-US" xlink:label="lab_ameh_CareDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Delivery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CareDeliveryMember" xlink:href="ameh-20230630.xsd#ameh_CareDeliveryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_CareDeliveryMember" xlink:to="lab_ameh_CareDeliveryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_f3f6bde7-7c8f-49af-8003-0054eb2c0b2d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_f6fc310b-1136-4c01-8ed1-ef4466a725c6_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e8c3d436-d0b0-43d9-882a-c825b42fbcf1_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_46730313-6286-420a-8adc-3bf963220c07_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_8a49324d-c87f-482e-97a4-4b9260ec00b9_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_71397c17-6e1c-4fa0-9f17-82e749dbad52_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Subsidiary Equity Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_a0cdf82b-d045-4ada-b77a-9c5911262946_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_42c3af24-7abc-4b0b-8103-5bdab6d9146e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_a16d6874-9614-42e9-b9c5-3dc723c71885_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_f6f072ff-5ec3-4d2c-9e86-301326e821f7_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_2ea1b901-5d59-4e1d-8b77-3cb499f8da66_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_9615b7de-8187-419d-81ec-4bdfec07047e_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities, Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember_31e3ad66-0c2c-4cf7-a90e-5520a39e6f8f_terseLabel_en-US" xlink:label="lab_ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MPP, AMG Properties, and ZLL Asset Acquisition</link:label>
    <link:label id="lab_ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember_label_en-US" xlink:label="lab_ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MPP, AMG Properties, and ZLL, Tag 8, Tag 6 Asset Acquisition [Member]</link:label>
    <link:label id="lab_ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember_documentation_en-US" xlink:label="lab_ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MPP, AMG Properties, and ZLL, Tag 8, Tag 6 Asset Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember" xlink:href="ameh-20230630.xsd#ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember" xlink:to="lab_ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_87aa9c57-a86c-446e-ac93-68fc09da2140_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value per share; 100,000,000 shares authorized, 46,553,517 and 46,575,699 shares issued and outstanding, excluding 10,569,340 and 10,299,259 treasury shares, as of June&#160;30, 2023 and December&#160;31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67fda44e-3064-4361-b060-4bf4b00133e2_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_FinanceReceivableInterestRateStatedPercentage_f5f0e574-8ff1-4f40-8dc5-05d90f93ffa7_terseLabel_en-US" xlink:label="lab_ameh_FinanceReceivableInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note receivable, interest rate</link:label>
    <link:label id="lab_ameh_FinanceReceivableInterestRateStatedPercentage_label_en-US" xlink:label="lab_ameh_FinanceReceivableInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Receivable, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_ameh_FinanceReceivableInterestRateStatedPercentage_documentation_en-US" xlink:label="lab_ameh_FinanceReceivableInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Receivable, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FinanceReceivableInterestRateStatedPercentage" xlink:href="ameh-20230630.xsd#ameh_FinanceReceivableInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_FinanceReceivableInterestRateStatedPercentage" xlink:to="lab_ameh_FinanceReceivableInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_1000c127-e7e8-45ee-8bb4-fd1090a28e4d_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_7f64e894-1dbc-4cf1-b893-326249c03614_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Finance Lease Payments After Adoption of 842</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_1ba9ed1d-8315-44d6-8406-01e92c1456a0_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2416c5c3-7f79-4d0a-869c-0ece6f1d4372_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_b0f5d805-da4f-41b8-aace-e5b0ca4ead09_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7167f933-29e6-4e09-8882-2b669c1fe30e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_8f0bdfe2-1a71-46c9-8536-aa5fedca15d9_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_e527a50f-4026-441a-a565-00f70550c9e4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_f301e877-e7ff-4818-a9ce-d7e1963efb20_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_f918df29-d078-496c-8f9d-1b26d03c67d4_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_5e90d342-b061-4d61-a344-fd759c066c0b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_964c9ae3-dc84-43d0-a073-88f6ca52cab6_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_Tag6MedicalInvestmentGroupLLCMember_b1cfbd24-2026-4d28-91c0-7a08e57fd05c_terseLabel_en-US" xlink:label="lab_ameh_Tag6MedicalInvestmentGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tag-6 Medical Investment Group, LLC</link:label>
    <link:label id="lab_ameh_Tag6MedicalInvestmentGroupLLCMember_label_en-US" xlink:label="lab_ameh_Tag6MedicalInvestmentGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tag-6 Medical Investment Group, LLC [Member]</link:label>
    <link:label id="lab_ameh_Tag6MedicalInvestmentGroupLLCMember_documentation_en-US" xlink:label="lab_ameh_Tag6MedicalInvestmentGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tag-6 Medical Investment Group, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_Tag6MedicalInvestmentGroupLLCMember" xlink:href="ameh-20230630.xsd#ameh_Tag6MedicalInvestmentGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_Tag6MedicalInvestmentGroupLLCMember" xlink:to="lab_ameh_Tag6MedicalInvestmentGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_3a92a1a7-e4c0-45b4-a3d0-d622bd8e8ab2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Change in Carrying Value of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_e156db82-4822-4a11-9e59-2607c227cb7c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation_2bcce93e-c866-4f70-b3f7-2bd5b4601f80_terseLabel_en-US" xlink:label="lab_ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of equity interest</link:label>
    <link:label id="lab_ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation_label_en-US" xlink:label="lab_ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Change in Fair Value Of Equity Interest Purchase Obligation</link:label>
    <link:label id="lab_ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation_documentation_en-US" xlink:label="lab_ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Change in Fair Value Of Equity Interest Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" xlink:href="ameh-20230630.xsd#ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" xlink:to="lab_ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_b71d647e-353c-42a8-989b-7d05747252d8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other provider payable</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_b3aaa7d7-5cab-4410-b910-be187e956a5e_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Costs</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_b1667bb2-15c4-475f-b3d1-2782d3ad2aaa_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_1ab26ebf-7c14-4f2e-bce1-bae89d97bb80_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_d66fd3bb-7913-4f2d-bce7-abce70e05a0c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on loan receivable</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_199c7c87-565e-4c7a-acf1-4bff8b550502_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_35cc96b8-5ecc-4584-a020-67f69840f398_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_84541cb2-9bb6-437e-8724-6bd6977b8e42_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_f7b79457-c881-40f1-b8d9-a45ecc3be44e_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_6b70cb77-b99a-4895-9ee9-70022c18e627_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_6b812947-6ef6-40c5-b692-29a4e7a187cd_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8e727680-c462-4225-9069-586a2dfd68d2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_db637846-d085-40f8-8796-aede542a8352_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income (restated)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_LeaseWeightedAverageDiscountRateAbstract_f40a7bcd-aa55-4d28-9e68-26839460c62a_verboseLabel_en-US" xlink:label="lab_ameh_LeaseWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Discount Rate</link:label>
    <link:label id="lab_ameh_LeaseWeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_ameh_LeaseWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Weighted Average Discount Rate [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LeaseWeightedAverageDiscountRateAbstract" xlink:href="ameh-20230630.xsd#ameh_LeaseWeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_LeaseWeightedAverageDiscountRateAbstract" xlink:to="lab_ameh_LeaseWeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_c9a791f7-403c-43cc-9bf2-e9c43b94fda1_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_9a3e6e81-a0fc-406b-8e3a-35d00ea89513_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_491e38aa-39d0-406d-ad4f-caf5de0e4248_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation associated with finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_87516f36-7d6d-4235-99e2-d046e6ee7538_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_c0dd0a0d-0276-426d-87df-fcb011c3b3ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_99f8ed90-20aa-4d5e-92ec-bf61e681356e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_92dcf1ee-29b6-4ea4-a393-a758680c8cba_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d935aa6d-ce66-4fdd-8055-3961353a0c7b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_EarningsPerShareLineItems_becdd6ac-b9b1-404d-8cd1-5c739dd83fa5_terseLabel_en-US" xlink:label="lab_ameh_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_ameh_EarningsPerShareLineItems_label_en-US" xlink:label="lab_ameh_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_ameh_EarningsPerShareLineItems_documentation_en-US" xlink:label="lab_ameh_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EarningsPerShareLineItems" xlink:href="ameh-20230630.xsd#ameh_EarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_EarningsPerShareLineItems" xlink:to="lab_ameh_EarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_fe8cc59a-3781-4fea-8dd8-97a5629f99a8_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_1e5bad37-9c05-4afa-8825-49b0b1deb578_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_61459f30-d5de-49b6-9018-8e017f823aa7_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current period</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_AssetAcquisitionPercentageOfSharesAcquired_6dec3d47-1a83-41b9-a265-38cb0f89a461_terseLabel_en-US" xlink:label="lab_ameh_AssetAcquisitionPercentageOfSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset acquisition, percentage of shares acquired</link:label>
    <link:label id="lab_ameh_AssetAcquisitionPercentageOfSharesAcquired_label_en-US" xlink:label="lab_ameh_AssetAcquisitionPercentageOfSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Percentage Of Shares Acquired</link:label>
    <link:label id="lab_ameh_AssetAcquisitionPercentageOfSharesAcquired_documentation_en-US" xlink:label="lab_ameh_AssetAcquisitionPercentageOfSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Percentage Of Shares Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AssetAcquisitionPercentageOfSharesAcquired" xlink:href="ameh-20230630.xsd#ameh_AssetAcquisitionPercentageOfSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_AssetAcquisitionPercentageOfSharesAcquired" xlink:to="lab_ameh_AssetAcquisitionPercentageOfSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_9c001eb5-73f5-4af1-a061-18b95a0ba64d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_label_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Line of Credit Arrangements, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:to="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_83a4da5b-95df-4cda-951a-ce2c02b59cf5_terseLabel_en-US" xlink:label="lab_ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:label id="lab_ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="ameh-20230630.xsd#ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_00cd092a-99c3-48db-8e52-3bf583ec1ea3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings on loans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Other Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fe914f22-95ae-4a31-9ba1-f9e13ece4e15_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_8fa91d4a-acbe-4a51-b1dd-fbd5d1fd7d0b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9d6e30fa-b450-44c6-8c37-670c3c6a6acd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_46cafb3b-561f-4dc2-a0e6-1010187fd78f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cdf025e5-5878-4fb9-a9cf-be04d0c5e71e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_931af7af-0511-432e-8c4f-1276fa6970ed_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_009e6c17-b97f-4b48-baa7-19a67a4fbe09_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ed606732-9530-4719-ad72-e66289d136f5_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_c97765d9-6be6-4d85-9ae7-ade1ca363f4e_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_42da803b-94ae-4db1-a7b2-918672fa836d_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_757dbe50-be42-4e29-b8c4-3143fff382d7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_4d19ad03-261c-4d47-b109-8ad8c29302aa_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_LeaseWeightedAverageRemainingLeaseTermAbstract_8898cd70-f0ca-4dbc-8471-c0d4f4d317fb_verboseLabel_en-US" xlink:label="lab_ameh_LeaseWeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_ameh_LeaseWeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_ameh_LeaseWeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LeaseWeightedAverageRemainingLeaseTermAbstract" xlink:href="ameh-20230630.xsd#ameh_LeaseWeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_LeaseWeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_ameh_LeaseWeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_bbe2234f-e38d-4142-a2b2-eab2b627a2b9_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_60796bc1-6226-48a6-9692-b30d128b1975_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Transactions Under Stock Option Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4e4734df-9419-457d-9968-de28a0a0c2be_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_BoardMembersWhoAreAlsoOfficersMember_59068ad1-f760-4f5b-b579-7c1ffdae2e76_terseLabel_en-US" xlink:label="lab_ameh_BoardMembersWhoAreAlsoOfficersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Members Who Are Also Officers</link:label>
    <link:label id="lab_ameh_BoardMembersWhoAreAlsoOfficersMember_label_en-US" xlink:label="lab_ameh_BoardMembersWhoAreAlsoOfficersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Members Who Are Also Officers [Member]</link:label>
    <link:label id="lab_ameh_BoardMembersWhoAreAlsoOfficersMember_documentation_en-US" xlink:label="lab_ameh_BoardMembersWhoAreAlsoOfficersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Members Who Are Also Officers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BoardMembersWhoAreAlsoOfficersMember" xlink:href="ameh-20230630.xsd#ameh_BoardMembersWhoAreAlsoOfficersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_BoardMembersWhoAreAlsoOfficersMember" xlink:to="lab_ameh_BoardMembersWhoAreAlsoOfficersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_PayorBMember_f486185b-c557-4257-bf0d-9232f3fac22c_terseLabel_en-US" xlink:label="lab_ameh_PayorBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor B</link:label>
    <link:label id="lab_ameh_PayorBMember_label_en-US" xlink:label="lab_ameh_PayorBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor B [Member]</link:label>
    <link:label id="lab_ameh_PayorBMember_documentation_en-US" xlink:label="lab_ameh_PayorBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PayorBMember" xlink:href="ameh-20230630.xsd#ameh_PayorBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_PayorBMember" xlink:to="lab_ameh_PayorBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e19fedbf-52c9-40b3-ac43-3ed0b6ec5e1d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonrelatedPartyMember_2dc09967-6c13-490b-b31a-185d4a77e403_terseLabel_en-US" xlink:label="lab_us-gaap_NonrelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrelated Party</link:label>
    <link:label id="lab_us-gaap_NonrelatedPartyMember_label_en-US" xlink:label="lab_us-gaap_NonrelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrelated Party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrelatedPartyMember" xlink:to="lab_us-gaap_NonrelatedPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants_a63be9bf-ca4f-4a02-a367-ddbbbfa18e2f_verboseLabel_en-US" xlink:label="lab_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued for exercise of options and warrants</link:label>
    <link:label id="lab_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants_label_en-US" xlink:label="lab_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during the period value of exercise of option and warrants</link:label>
    <link:label id="lab_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants_documentation_en-US" xlink:label="lab_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">It represents value of stock issued during the period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" xlink:href="ameh-20230630.xsd#ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" xlink:to="lab_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_APAMH2Member_77160bea-cfe7-435d-a8bf-21c1e0423e01_terseLabel_en-US" xlink:label="lab_ameh_APAMH2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AP-AMH 2</link:label>
    <link:label id="lab_ameh_APAMH2Member_label_en-US" xlink:label="lab_ameh_APAMH2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AP-AMH 2 [Member]</link:label>
    <link:label id="lab_ameh_APAMH2Member_documentation_en-US" xlink:label="lab_ameh_APAMH2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AP-AMH 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_APAMH2Member" xlink:href="ameh-20230630.xsd#ameh_APAMH2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_APAMH2Member" xlink:to="lab_ameh_APAMH2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_ad0623d2-acce-4255-8a0f-7ed6b4a92129_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenue</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_5ba7fcd3-9501-4ff8-89ad-8d468ea9e3f0_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_bbcc7d56-a6ef-4df0-a680-9ceb5ebf6dbf_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_b7f7644d-0950-4d76-86be-6aeee16eae32_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_eaa49c68-432e-42cc-a60c-5fa6e745dd1f_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_a7d3421a-5846-4e04-b242-5f33effd8629_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_eef5ff0f-6c2f-42c7-9b32-b9f8d1f80df3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, mezzanine equity and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_411cb10d-ccc4-4981-83aa-d93d6f9ae32c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_1676fc7a-d8aa-42d0-9b34-0f61f4fb8992_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_deec6f11-995f-4ead-a332-72ef8aa82335_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_32a7d526-b322-48a0-98b4-54a528dbbc16_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_NumberOfPrimaryCareServices_621da058-c51a-4f85-9d47-763cb7325fb0_terseLabel_en-US" xlink:label="lab_ameh_NumberOfPrimaryCareServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of medicare advantage patients</link:label>
    <link:label id="lab_ameh_NumberOfPrimaryCareServices_label_en-US" xlink:label="lab_ameh_NumberOfPrimaryCareServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Primary Care Services</link:label>
    <link:label id="lab_ameh_NumberOfPrimaryCareServices_documentation_en-US" xlink:label="lab_ameh_NumberOfPrimaryCareServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Primary Care Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NumberOfPrimaryCareServices" xlink:href="ameh-20230630.xsd#ameh_NumberOfPrimaryCareServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_NumberOfPrimaryCareServices" xlink:to="lab_ameh_NumberOfPrimaryCareServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_8b6d47be-75a9-4c6b-aba1-23e951fa1075_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in privately held entities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI and without Readily Determinable Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:to="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_SpecialtyCapitationPayableCurrent_18f93785-59ad-4d40-a4ad-c8b326c7be90_verboseLabel_en-US" xlink:label="lab_ameh_SpecialtyCapitationPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation payable</link:label>
    <link:label id="lab_ameh_SpecialtyCapitationPayableCurrent_label_en-US" xlink:label="lab_ameh_SpecialtyCapitationPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Capitation Payable Current</link:label>
    <link:label id="lab_ameh_SpecialtyCapitationPayableCurrent_documentation_en-US" xlink:label="lab_ameh_SpecialtyCapitationPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of specialty capitation payable current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SpecialtyCapitationPayableCurrent" xlink:href="ameh-20230630.xsd#ameh_SpecialtyCapitationPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_SpecialtyCapitationPayableCurrent" xlink:to="lab_ameh_SpecialtyCapitationPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_68f8567a-fbd4-487b-abb2-a7fd667fe208_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_649df69f-a427-4632-8ca6-a00903f2f1e7_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_AAMGMember_08498061-59d5-436d-b9dc-dd811e6f75bb_terseLabel_en-US" xlink:label="lab_ameh_AAMGMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AAMG</link:label>
    <link:label id="lab_ameh_AAMGMember_label_en-US" xlink:label="lab_ameh_AAMGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AAMG [Member]</link:label>
    <link:label id="lab_ameh_AAMGMember_documentation_en-US" xlink:label="lab_ameh_AAMGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AAMG</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AAMGMember" xlink:href="ameh-20230630.xsd#ameh_AAMGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_AAMGMember" xlink:to="lab_ameh_AAMGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_2048d2b6-965b-4065-bf2e-e20f16c1f45c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 (excluding the six months ended June 30, 2023)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_ef91545d-534f-4812-85a6-c40cfe9fc3b7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_c157f8e6-3355-492d-b9b0-49460a521ef5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Information about our Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyMember_13364f2c-0de1-4f53-975b-3c13883a5b9e_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyMember_label_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyMember" xlink:to="lab_us-gaap_RelatedPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_FiveThreeOneW.CollegeLLCMember_97fc3b8e-7ef0-4fbc-8caa-710e332eebb7_verboseLabel_en-US" xlink:label="lab_ameh_FiveThreeOneW.CollegeLLCMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">531 W. College, LLC</link:label>
    <link:label id="lab_ameh_FiveThreeOneW.CollegeLLCMember_label_en-US" xlink:label="lab_ameh_FiveThreeOneW.CollegeLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Three One W. College LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FiveThreeOneW.CollegeLLCMember" xlink:href="ameh-20230630.xsd#ameh_FiveThreeOneW.CollegeLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_FiveThreeOneW.CollegeLLCMember" xlink:to="lab_ameh_FiveThreeOneW.CollegeLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_ebd0515c-b2ba-4cba-a206-aae1aed3b9d2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_17a6feb6-9b0f-4884-afdc-6f4e83f4e59f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_f7e59d4d-0e88-4d91-9d11-5bbd7fb21539_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_ca7a3902-8232-4899-962d-bf3de5978e82_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionLoansMember_791a6566-7063-458e-ac3f-d1b047c7610b_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loans</link:label>
    <link:label id="lab_us-gaap_ConstructionLoansMember_label_en-US" xlink:label="lab_us-gaap_ConstructionLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionLoansMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionLoansMember" xlink:to="lab_us-gaap_ConstructionLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8dd47d9f-1edd-4cb8-bad7-bdfc54a97d30_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities &#8211; certificates of deposit</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_65b0b509-15f2-475a-9a28-83d3bd02f902_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities &#8211; certificates of deposit</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateLoanMember_9a20ef11-d3c9-47a4-a3f7-3f02588b889b_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Loans</link:label>
    <link:label id="lab_us-gaap_RealEstateLoanMember_label_en-US" xlink:label="lab_us-gaap_RealEstateLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLoanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateLoanMember" xlink:to="lab_us-gaap_RealEstateLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_da4367b7-a8c1-4044-a0e3-5346356fe6dc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_86e755ca-a3f6-463c-9681-65184f1fae4d_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total losses recognized on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_SubordinatedLoanAgreementMember_d799db0d-a6f7-4ea7-844a-12866047238b_terseLabel_en-US" xlink:label="lab_ameh_SubordinatedLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subordinated Loan Agreement</link:label>
    <link:label id="lab_ameh_SubordinatedLoanAgreementMember_label_en-US" xlink:label="lab_ameh_SubordinatedLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subordinated Loan Agreement [Member]</link:label>
    <link:label id="lab_ameh_SubordinatedLoanAgreementMember_documentation_en-US" xlink:label="lab_ameh_SubordinatedLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subordinated Loan Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SubordinatedLoanAgreementMember" xlink:href="ameh-20230630.xsd#ameh_SubordinatedLoanAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_SubordinatedLoanAgreementMember" xlink:to="lab_ameh_SubordinatedLoanAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_1d2dbfc0-24db-4696-87c5-aab72e935a94_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b6892630-1579-46e4-a169-2d917b6a6de9_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_788eef5e-8b8e-4e8c-9535-dde6ecf6b7b5_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BridgeLoanMember_1cd13589-e43e-42b3-bb24-8e91fdd21592_terseLabel_en-US" xlink:label="lab_us-gaap_BridgeLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bridge Loan</link:label>
    <link:label id="lab_us-gaap_BridgeLoanMember_label_en-US" xlink:label="lab_us-gaap_BridgeLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bridge Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BridgeLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BridgeLoanMember" xlink:to="lab_us-gaap_BridgeLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_07be7218-f473-45e0-98a2-698a254800ba_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b1b9fe4e-8a98-452f-a547-14ed82e6aac1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_5b28c1c9-a9e2-44fb-89bb-32b65ffc753d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoanRelatedToPropertySales1_38390c3d-5ef1-4a2e-b8d1-9b3c65db90ef_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan</link:label>
    <link:label id="lab_us-gaap_MortgageLoanRelatedToPropertySales1_label_en-US" xlink:label="lab_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Related to Property Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgageLoanRelatedToPropertySales1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:to="lab_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ContingentEquitySecuritiesMember_bdd5d269-faf6-40d9-b510-f295f4cdd2c8_verboseLabel_en-US" xlink:label="lab_ameh_ContingentEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent equity securities</link:label>
    <link:label id="lab_ameh_ContingentEquitySecuritiesMember_f353df00-1824-4078-90a3-dda13b958d23_terseLabel_en-US" xlink:label="lab_ameh_ContingentEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent equity securities</link:label>
    <link:label id="lab_ameh_ContingentEquitySecuritiesMember_label_en-US" xlink:label="lab_ameh_ContingentEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Equity Securities [Member]</link:label>
    <link:label id="lab_ameh_ContingentEquitySecuritiesMember_documentation_en-US" xlink:label="lab_ameh_ContingentEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Equity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ContingentEquitySecuritiesMember" xlink:href="ameh-20230630.xsd#ameh_ContingentEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ContingentEquitySecuritiesMember" xlink:to="lab_ameh_ContingentEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_308bd4b5-739b-431a-a537-fdcc05e71609_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_daef9958-b58f-4233-b340-c9b27b914a36_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8cddd020-13d1-477c-954f-d5f9e5a863e5_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0cf00ca7-e6c5-47f9-a2e3-e9a3011ff5be_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ac4f9807-fd38-4d33-b540-10f0579d2a17_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e3ed13c6-7eac-4e77-bc27-d7444f8ae0ba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_e5fe92e7-20c1-4042-9685-9f912c53c621_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationPeriod_d527f3c2-6135-42f8-ae7d-5b6f44b69b96_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_6b65c1c4-c247-4222-8378-b7b7908dcbb0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3068b4be-0a25-4c56-8ba0-d5dd4b96bebd_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_f9020b95-0873-45a7-8f88-574feed1022c_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_PatientManagementPlatformMember_445a51fd-d0a6-438f-82af-a66ed90ffc8e_terseLabel_en-US" xlink:label="lab_ameh_PatientManagementPlatformMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient management platform</link:label>
    <link:label id="lab_ameh_PatientManagementPlatformMember_label_en-US" xlink:label="lab_ameh_PatientManagementPlatformMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Management Platform [Member]</link:label>
    <link:label id="lab_ameh_PatientManagementPlatformMember_documentation_en-US" xlink:label="lab_ameh_PatientManagementPlatformMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Management Platform</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PatientManagementPlatformMember" xlink:href="ameh-20230630.xsd#ameh_PatientManagementPlatformMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_PatientManagementPlatformMember" xlink:to="lab_ameh_PatientManagementPlatformMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_c7cb69ba-fc08-40a8-9d3c-657491941dbe_terseLabel_en-US" xlink:label="lab_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_label_en-US" xlink:label="lab_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Value, Release Of Hold Back Shares</link:label>
    <link:label id="lab_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_documentation_en-US" xlink:label="lab_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Value, Release Of Hold Back Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:href="ameh-20230630.xsd#ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:to="lab_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_7b2091b8-97ee-4e8a-87c2-6cd4afbd969b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a5581fd2-f223-4d83-8980-c6adaa021641_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b9872079-1dbe-47d4-b715-34789fe1d1ae_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_bd602a63-9c69-46e3-9946-4f1b3a131302_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized intangible assets, Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_06ec3e62-4efa-40d2-8acc-270ae9027c80_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingently issuable shares (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_b892794d-cd60-4d0a-97d8-ec01d7cf4c9f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_5ec78419-3942-4c0b-8668-d469d3ff27a4_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_MezzanineMember_07617f64-23f0-4f34-8002-bf2eb24f37b1_terseLabel_en-US" xlink:label="lab_ameh_MezzanineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine</link:label>
    <link:label id="lab_ameh_MezzanineMember_label_en-US" xlink:label="lab_ameh_MezzanineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MezzanineMember" xlink:href="ameh-20230630.xsd#ameh_MezzanineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_MezzanineMember" xlink:to="lab_ameh_MezzanineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ApcBusinessLoanAgreementMember_c346e73f-4408-4938-a3fe-c87f5c4065e6_terseLabel_en-US" xlink:label="lab_ameh_ApcBusinessLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC Business Loan Agreement</link:label>
    <link:label id="lab_ameh_ApcBusinessLoanAgreementMember_label_en-US" xlink:label="lab_ameh_ApcBusinessLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC Business Loan Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApcBusinessLoanAgreementMember" xlink:href="ameh-20230630.xsd#ameh_ApcBusinessLoanAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ApcBusinessLoanAgreementMember" xlink:to="lab_ameh_ApcBusinessLoanAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_7bd8f695-1957-4224-8c9b-9352decc4e62_verboseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_b37f145d-f4de-4f05-a8c8-4ccea9a480b7_verboseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregated Revenue by Each Payor Type</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0ae5e14d-a28c-4a40-91dd-c3407767f1e0_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f3759080-0101-4bc0-b9bd-8f8697af2033_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_f56123ff-82e7-426c-8783-bb080fcc5230_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_f8b0028a-473c-4705-847c-4f117288e667_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_d852026f-0ac9-4bc6-beef-4b50fe781587_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_06de0a8e-448e-4d70-90ee-9a0dac68974d_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_963592b7-5c45-4d3b-89e4-130b98fb596e_negatedLabel_en-US" xlink:label="lab_ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_label_en-US" xlink:label="lab_ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Prepaid Expenses And Other Current Assets</link:label>
    <link:label id="lab_ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_documentation_en-US" xlink:label="lab_ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in the value of prepaid expenses and other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:href="ameh-20230630.xsd#ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:to="lab_ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_60cb5f93-1b34-428b-8699-4c6ddf829713_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_SecuredOvernightFinancingRateMember_b0be2dc1-ffbd-417e-b055-680083e33828_terseLabel_en-US" xlink:label="lab_ameh_SecuredOvernightFinancingRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate</link:label>
    <link:label id="lab_ameh_SecuredOvernightFinancingRateMember_label_en-US" xlink:label="lab_ameh_SecuredOvernightFinancingRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate [Member]</link:label>
    <link:label id="lab_ameh_SecuredOvernightFinancingRateMember_documentation_en-US" xlink:label="lab_ameh_SecuredOvernightFinancingRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SecuredOvernightFinancingRateMember" xlink:href="ameh-20230630.xsd#ameh_SecuredOvernightFinancingRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_SecuredOvernightFinancingRateMember" xlink:to="lab_ameh_SecuredOvernightFinancingRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_80dde0ea-45b4-465b-af3c-84b065658c3d_terseLabel_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value (in millions)</link:label>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_label_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]</link:label>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_documentation_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:href="ameh-20230630.xsd#ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_dee8f58a-5cfb-4a68-b3d3-d6bad087a355_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_76905239-d978-4659-8e5d-5b9d056cfaab_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_PaymentsToEquityMethodInvestments_fd84cbd5-602c-4115-93c7-6215a670d80a_negatedLabel_en-US" xlink:label="lab_ameh_PaymentsToEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution to investment - equity method</link:label>
    <link:label id="lab_ameh_PaymentsToEquityMethodInvestments_label_en-US" xlink:label="lab_ameh_PaymentsToEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Equity Method Investments</link:label>
    <link:label id="lab_ameh_PaymentsToEquityMethodInvestments_documentation_en-US" xlink:label="lab_ameh_PaymentsToEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PaymentsToEquityMethodInvestments" xlink:href="ameh-20230630.xsd#ameh_PaymentsToEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_PaymentsToEquityMethodInvestments" xlink:to="lab_ameh_PaymentsToEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ApcLsmaMember_a3a3d0fe-a399-4408-b9bb-236388200563_terseLabel_en-US" xlink:label="lab_ameh_ApcLsmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC LSMA</link:label>
    <link:label id="lab_ameh_ApcLsmaMember_label_en-US" xlink:label="lab_ameh_ApcLsmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC LSMA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApcLsmaMember" xlink:href="ameh-20230630.xsd#ameh_ApcLsmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ApcLsmaMember" xlink:to="lab_ameh_ApcLsmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_Tag8MedicalInvestmentGroupLLCMember_9acd0f7d-61a5-42a0-805f-fe03db187d25_terseLabel_en-US" xlink:label="lab_ameh_Tag8MedicalInvestmentGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tag-8 Medical Investment Group, LLC</link:label>
    <link:label id="lab_ameh_Tag8MedicalInvestmentGroupLLCMember_label_en-US" xlink:label="lab_ameh_Tag8MedicalInvestmentGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tag-8 Medical Investment Group, LLC [Member]</link:label>
    <link:label id="lab_ameh_Tag8MedicalInvestmentGroupLLCMember_documentation_en-US" xlink:label="lab_ameh_Tag8MedicalInvestmentGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tag-8 Medical Investment Group, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_Tag8MedicalInvestmentGroupLLCMember" xlink:href="ameh-20230630.xsd#ameh_Tag8MedicalInvestmentGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_Tag8MedicalInvestmentGroupLLCMember" xlink:to="lab_ameh_Tag8MedicalInvestmentGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_2b205086-5e06-462a-a708-3793359f76d9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Liabilities [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_560e2468-96ac-4d69-9d13-20470df7b257_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_7580dabb-33ac-4fb9-b3c7-95fbab1e8c29_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion and deferred financing costs</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_c2845f78-2bda-4a70-bf21-177241ddcb07_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion and deferred financing costs</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_d2bf3904-46cd-45a6-a5e6-c49eb4401fa1_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_abe9ad4e-33d3-4b22-9c36-9f6f5839e24f_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain (Loss) on Securities</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:to="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0cec0fb1-7964-4369-bc83-35c9c303c6b5_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding &#8211; diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_16daf71b-0e96-4c3d-abef-2b0c9200b29e_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding &#8211; diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod_808c75e5-3519-4540-8e10-8f80b5ffc6ee_terseLabel_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants exercised (in shares)</link:label>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod_label_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based Compensation Arrangement By Share based Payment Award Warrants Exercises In Period</link:label>
    <link:label id="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod_documentation_en-US" xlink:label="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based Compensation Arrangement By Share based Payment Award Warrants Exercises In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" xlink:href="ameh-20230630.xsd#ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" xlink:to="lab_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_96af377f-fcb4-4997-bb7d-f3885dba1954_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2ff6fd43-8d3e-415a-866f-4c0f2a672f97_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_14a99bb7-c611-4787-954f-1bacf31d41a0_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_9e27ed6f-9a30-4d3f-905d-9d22d4d3bbb6_verboseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ConstructionLoanMember_c9fb89c1-2b9a-4d21-ba57-0f9ce78e6b0b_terseLabel_en-US" xlink:label="lab_ameh_ConstructionLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loans</link:label>
    <link:label id="lab_ameh_ConstructionLoanMember_cbf178a9-e5a0-4080-b64d-8199878b6205_verboseLabel_en-US" xlink:label="lab_ameh_ConstructionLoanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loan</link:label>
    <link:label id="lab_ameh_ConstructionLoanMember_label_en-US" xlink:label="lab_ameh_ConstructionLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loan [Member]</link:label>
    <link:label id="lab_ameh_ConstructionLoanMember_documentation_en-US" xlink:label="lab_ameh_ConstructionLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ConstructionLoanMember" xlink:href="ameh-20230630.xsd#ameh_ConstructionLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ConstructionLoanMember" xlink:to="lab_ameh_ConstructionLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock_a45c846d-654d-420b-a663-0e84b76e6f21_verboseLabel_en-US" xlink:label="lab_ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Receivables &#8211; Related Parties, Other Receivables and Loan Receivable - Related Party</link:label>
    <link:label id="lab_ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock_label_en-US" xlink:label="lab_ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Receivables &#8211; Related Parties, Other Receivables And Loan Receivable - Related Party [Policy Text Block]</link:label>
    <link:label id="lab_ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock_documentation_en-US" xlink:label="lab_ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Receivables and receivables from related parties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock" xlink:href="ameh-20230630.xsd#ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock" xlink:to="lab_ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_185cd7bc-6afb-4722-bf2a-3d52f615c8be_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_TemporaryEquityDividendsImpact_49cce37c-b4c1-4113-888c-98e618b0aac6_terseLabel_en-US" xlink:label="lab_ameh_TemporaryEquityDividendsImpact" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax impact from dividends</link:label>
    <link:label id="lab_ameh_TemporaryEquityDividendsImpact_label_en-US" xlink:label="lab_ameh_TemporaryEquityDividendsImpact" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Dividends Impact</link:label>
    <link:label id="lab_ameh_TemporaryEquityDividendsImpact_documentation_en-US" xlink:label="lab_ameh_TemporaryEquityDividendsImpact" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Dividends Impact</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_TemporaryEquityDividendsImpact" xlink:href="ameh-20230630.xsd#ameh_TemporaryEquityDividendsImpact"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_TemporaryEquityDividendsImpact" xlink:to="lab_ameh_TemporaryEquityDividendsImpact" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_c87efc80-c452-48fb-8e22-6801622a4900_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_4ef114db-8eb3-42d8-a785-9a701bf990fc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_56e549e0-6e8a-4b66-9c3f-5ffbafadef25_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrimeRateMember_8466e0f3-69a7-4010-a19a-57da90b0cb0d_terseLabel_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate</link:label>
    <link:label id="lab_us-gaap_PrimeRateMember_label_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrimeRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrimeRateMember" xlink:to="lab_us-gaap_PrimeRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_66798e1d-df0d-441b-b0bf-63f6a2e1c081_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_ccef3699-e092-4d32-ae0e-0c79caa9ad01_terseLabel_en-US" xlink:label="lab_ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:label id="lab_ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="ameh-20230630.xsd#ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4133090b-49ae-4a97-9654-73e783419ef6_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding &#8211; basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_d0b270fd-244b-42c0-9c57-f7869e071476_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_5bdedff9-9829-4ce9-aae0-19ac2d570b35_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_37037a1d-c069-4bba-8896-12e0fe90e48e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_281b4d67-2fe5-4135-a7f5-80f9443fa202_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DebtInstrumentCovenantLeverageRatioMaximum_f8422925-ddc6-4f90-9610-3343cdea1a00_terseLabel_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum consolidated leverage ratio (not greater than)</link:label>
    <link:label id="lab_ameh_DebtInstrumentCovenantLeverageRatioMaximum_label_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:label id="lab_ameh_DebtInstrumentCovenantLeverageRatioMaximum_documentation_en-US" xlink:label="lab_ameh_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantLeverageRatioMaximum" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DebtInstrumentCovenantLeverageRatioMaximum" xlink:to="lab_ameh_DebtInstrumentCovenantLeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_8c97392b-a2eb-4e4e-a96d-944a1b0798b8_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation of restricted stock awards (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_b3c992c1-986d-4679-8656-054702b61a1a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_3c60ab41-e5d2-46e9-b41e-754857fbe4c6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_PacificMedicalImagingAndOncologyCenterIncMember_8a757dce-2c2c-4140-8682-703fcf1569b3_terseLabel_en-US" xlink:label="lab_ameh_PacificMedicalImagingAndOncologyCenterIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pacific Medical Imaging &amp; Oncology Center, Inc.</link:label>
    <link:label id="lab_ameh_PacificMedicalImagingAndOncologyCenterIncMember_label_en-US" xlink:label="lab_ameh_PacificMedicalImagingAndOncologyCenterIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pacific Medical Imaging and Oncology Center, Inc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PacificMedicalImagingAndOncologyCenterIncMember" xlink:href="ameh-20230630.xsd#ameh_PacificMedicalImagingAndOncologyCenterIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_PacificMedicalImagingAndOncologyCenterIncMember" xlink:to="lab_ameh_PacificMedicalImagingAndOncologyCenterIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DebtCovenantAggregatePurchasePriceMaximum_35eda4e7-11bf-4c96-9170-4564e57bd5d7_terseLabel_en-US" xlink:label="lab_ameh_DebtCovenantAggregatePurchasePriceMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt covenant, aggregate purchase price, maximum</link:label>
    <link:label id="lab_ameh_DebtCovenantAggregatePurchasePriceMaximum_label_en-US" xlink:label="lab_ameh_DebtCovenantAggregatePurchasePriceMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Aggregate Purchase Price, Maximum</link:label>
    <link:label id="lab_ameh_DebtCovenantAggregatePurchasePriceMaximum_documentation_en-US" xlink:label="lab_ameh_DebtCovenantAggregatePurchasePriceMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Aggregate Purchase Price, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtCovenantAggregatePurchasePriceMaximum" xlink:href="ameh-20230630.xsd#ameh_DebtCovenantAggregatePurchasePriceMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DebtCovenantAggregatePurchasePriceMaximum" xlink:to="lab_ameh_DebtCovenantAggregatePurchasePriceMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_ameh_DescriptionOfBusinessLineItems_97944730-c5d8-445a-ac8a-d32ba96b8d31_terseLabel_en-US" xlink:label="lab_ameh_DescriptionOfBusinessLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Business [Line Items]</link:label>
    <link:label id="lab_ameh_DescriptionOfBusinessLineItems_label_en-US" xlink:label="lab_ameh_DescriptionOfBusinessLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Business [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DescriptionOfBusinessLineItems" xlink:href="ameh-20230630.xsd#ameh_DescriptionOfBusinessLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ameh_DescriptionOfBusinessLineItems" xlink:to="lab_ameh_DescriptionOfBusinessLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_e978ae43-1038-44e6-8083-c3e318a782b1_verboseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>ameh-20230630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:3040ecaa-d98f-42d5-9854-9c1a7ec98864,g:10a2b015-69d1-478c-967c-e01a9974c48a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.apollomed.net/role/Coverpage" xlink:type="simple" xlink:href="ameh-20230630.xsd#Coverpage"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/Coverpage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_320e5b4c-6d50-4dc1-ad72-45594515d2c1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_DocumentType_320e5b4c-6d50-4dc1-ad72-45594515d2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_a0b80848-f862-4de4-af82-625cbe8a024d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_DocumentQuarterlyReport_a0b80848-f862-4de4-af82-625cbe8a024d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_857d1bb3-eb99-49dc-8dc2-b3f1d2541b54" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_DocumentPeriodEndDate_857d1bb3-eb99-49dc-8dc2-b3f1d2541b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_ea76412a-561e-406c-8678-d3d30474cc7d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_DocumentTransitionReport_ea76412a-561e-406c-8678-d3d30474cc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_98d5c59a-5771-4737-b2ce-9be59380a9fc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityFileNumber_98d5c59a-5771-4737-b2ce-9be59380a9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a68f63fc-a1f6-45c7-af74-69d6275dba8e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityRegistrantName_a68f63fc-a1f6-45c7-af74-69d6275dba8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8e84efa6-6192-444a-ac69-34d647bb9639" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8e84efa6-6192-444a-ac69-34d647bb9639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8731a40c-0c5d-495e-88a5-c91fcecff9d1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityTaxIdentificationNumber_8731a40c-0c5d-495e-88a5-c91fcecff9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_71cfd631-53e1-4ee8-9507-1bced18179dd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityAddressAddressLine1_71cfd631-53e1-4ee8-9507-1bced18179dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_0052a83e-68a1-4cf4-a787-ef8f1af2bf75" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityAddressAddressLine2_0052a83e-68a1-4cf4-a787-ef8f1af2bf75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c92c3fa8-fbe7-44f9-a300-586d06a8c200" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityAddressCityOrTown_c92c3fa8-fbe7-44f9-a300-586d06a8c200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_979ed060-c86f-4276-ae33-d74f8bbcf7b1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityAddressStateOrProvince_979ed060-c86f-4276-ae33-d74f8bbcf7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_439b4186-6fd7-49a2-9013-93a8a5190009" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityAddressPostalZipCode_439b4186-6fd7-49a2-9013-93a8a5190009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_92b2dfe8-898e-44ec-b367-6bc0019bf267" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_CityAreaCode_92b2dfe8-898e-44ec-b367-6bc0019bf267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_728b50a3-fe6b-4811-92fb-1c79402ae2fb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_LocalPhoneNumber_728b50a3-fe6b-4811-92fb-1c79402ae2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f5e002da-e6c4-4226-bae5-8df10f184fd1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_Security12bTitle_f5e002da-e6c4-4226-bae5-8df10f184fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_21230ce1-61aa-47d1-8594-2e79be56802a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_TradingSymbol_21230ce1-61aa-47d1-8594-2e79be56802a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_3452d8b9-44e0-410d-a4bb-01a5ca728161" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityCurrentReportingStatus_3452d8b9-44e0-410d-a4bb-01a5ca728161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_65d3872b-8e3a-45b4-b2b8-7d1cca5bf9cc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityInteractiveDataCurrent_65d3872b-8e3a-45b4-b2b8-7d1cca5bf9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_36643d9a-294e-4349-bd9a-71785cf37dad" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityFilerCategory_36643d9a-294e-4349-bd9a-71785cf37dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_74b16e09-5ec7-432f-a71c-00e8b0d6e946" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntitySmallBusiness_74b16e09-5ec7-432f-a71c-00e8b0d6e946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_962210c4-795d-477e-a75a-a2b5bcc1b1b1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityEmergingGrowthCompany_962210c4-795d-477e-a75a-a2b5bcc1b1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_671b3d03-b1a0-4487-9875-1cb6e8590306" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityShellCompany_671b3d03-b1a0-4487-9875-1cb6e8590306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_394a06f4-b979-46bc-94d9-6be155f801e9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_394a06f4-b979-46bc-94d9-6be155f801e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_7242a107-da41-44a2-a063-61a14ff259bb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_AmendmentFlag_7242a107-da41-44a2-a063-61a14ff259bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_b4f9321d-0683-498a-acf2-164ac16a9bbb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_DocumentFiscalYearFocus_b4f9321d-0683-498a-acf2-164ac16a9bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_8b1cd6e9-06ca-4964-a4b6-4a79adcaeca8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_DocumentFiscalPeriodFocus_8b1cd6e9-06ca-4964-a4b6-4a79adcaeca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_fea76a5b-3cae-467d-b6df-90359d970117" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_EntityCentralIndexKey_fea76a5b-3cae-467d-b6df-90359d970117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c86907ca-5dab-49e0-a892-88a8a589476d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f934f1-e319-4929-b4d6-b6ace931c942" xlink:to="loc_dei_CurrentFiscalYearEndDate_c86907ca-5dab-49e0-a892-88a8a589476d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ameh-20230630.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d9c11f2d-1f86-4d20-9eb0-810ae56302a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_fd1de983-9958-4cc6-89d1-9ca19385f259" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9c11f2d-1f86-4d20-9eb0-810ae56302a3" xlink:to="loc_us-gaap_StatementTable_fd1de983-9958-4cc6-89d1-9ca19385f259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_160d4703-a620-4be9-b184-553a1ea24258" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fd1de983-9958-4cc6-89d1-9ca19385f259" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_160d4703-a620-4be9-b184-553a1ea24258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_fec576b6-57bb-4dc1-ada7-63db8556919a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_160d4703-a620-4be9-b184-553a1ea24258" xlink:to="loc_us-gaap_RelatedPartyDomain_fec576b6-57bb-4dc1-ada7-63db8556919a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember_31ca593d-feff-47ab-a0ed-5b277b092422" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_fec576b6-57bb-4dc1-ada7-63db8556919a" xlink:to="loc_us-gaap_NonrelatedPartyMember_31ca593d-feff-47ab-a0ed-5b277b092422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_50684a26-76b0-46a5-b22c-0dd21af01bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_fec576b6-57bb-4dc1-ada7-63db8556919a" xlink:to="loc_us-gaap_RelatedPartyMember_50684a26-76b0-46a5-b22c-0dd21af01bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4ecf2e95-afad-4fc6-9ba6-65cd0903ebc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fd1de983-9958-4cc6-89d1-9ca19385f259" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4ecf2e95-afad-4fc6-9ba6-65cd0903ebc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_be72b786-5ecb-4f8c-a09c-1e333a4427bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4ecf2e95-afad-4fc6-9ba6-65cd0903ebc0" xlink:to="loc_us-gaap_ClassOfStockDomain_be72b786-5ecb-4f8c-a09c-1e333a4427bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_ce2a1f3b-dcb1-413d-8a29-dc1110773a42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_be72b786-5ecb-4f8c-a09c-1e333a4427bf" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_ce2a1f3b-dcb1-413d-8a29-dc1110773a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_3c753739-f56f-42bb-b5e9-60e9883386fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_be72b786-5ecb-4f8c-a09c-1e333a4427bf" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_3c753739-f56f-42bb-b5e9-60e9883386fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ea900206-6851-46b4-ba9b-596e0a6344ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fd1de983-9958-4cc6-89d1-9ca19385f259" xlink:to="loc_us-gaap_StatementLineItems_ea900206-6851-46b4-ba9b-596e0a6344ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_a7b665da-9604-4045-9f21-dedf19c1e3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ea900206-6851-46b4-ba9b-596e0a6344ca" xlink:to="loc_us-gaap_AssetsAbstract_a7b665da-9604-4045-9f21-dedf19c1e3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a7b665da-9604-4045-9f21-dedf19c1e3a5" xlink:to="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_784c146d-2c34-4006-b0eb-0b0095910700" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_784c146d-2c34-4006-b0eb-0b0095910700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_587cc27a-a522-4095-bc62-a595fcf3686d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_RestrictedCash_587cc27a-a522-4095-bc62-a595fcf3686d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_85c00dab-9d7e-437b-8f27-c85a9a079fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_85c00dab-9d7e-437b-8f27-c85a9a079fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d7d519fa-8adb-4fdf-b7fb-a692a6217cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d7d519fa-8adb-4fdf-b7fb-a692a6217cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_28c9a1da-235d-4923-bf8a-5faf34a7fc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_28c9a1da-235d-4923-bf8a-5faf34a7fc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_50df45bd-4a12-409a-9e46-efc55096f900" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_50df45bd-4a12-409a-9e46-efc55096f900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_b6366124-b3e9-4719-9190-5d602ff96240" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_b6366124-b3e9-4719-9190-5d602ff96240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3ec58feb-86fb-4d07-9780-07c7b660ddbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b59456a-60cc-42b3-b369-c62c6552a73b" xlink:to="loc_us-gaap_AssetsCurrent_3ec58feb-86fb-4d07-9780-07c7b660ddbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a7b665da-9604-4045-9f21-dedf19c1e3a5" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7b460599-bf39-4dcb-b149-76a0bbcff32e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7b460599-bf39-4dcb-b149-76a0bbcff32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c5a9a5b4-e199-4f26-bf32-53b338dd9a10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c5a9a5b4-e199-4f26-bf32-53b338dd9a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dc7a8846-f63b-4990-97ad-4f508271dc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_Goodwill_dc7a8846-f63b-4990-97ad-4f508271dc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_9a3d5bc2-12c9-43ec-ae3f-afee2e754b23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_9a3d5bc2-12c9-43ec-ae3f-afee2e754b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_48ddf905-be0e-4664-beca-4147f0da28fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_EquityMethodInvestments_48ddf905-be0e-4664-beca-4147f0da28fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_3d23ab42-520a-4055-9c58-b80c2e4c41af" xlink:href="ameh-20230630.xsd#ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_3d23ab42-520a-4055-9c58-b80c2e4c41af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c5664100-7f45-4e0a-acb4-54b5afc5ee12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c5664100-7f45-4e0a-acb4-54b5afc5ee12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1e337d9d-bee0-4d47-bfdf-b208305e98eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1e337d9d-bee0-4d47-bfdf-b208305e98eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_c8ca53d7-2658-4732-8815-82cee9c312db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eeee1da4-205f-477a-b9be-f1614ba4d34b" xlink:to="loc_us-gaap_AssetsNoncurrent_c8ca53d7-2658-4732-8815-82cee9c312db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_741f2e45-1dd0-4925-b95d-b9247d26e443" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a7b665da-9604-4045-9f21-dedf19c1e3a5" xlink:to="loc_us-gaap_Assets_741f2e45-1dd0-4925-b95d-b9247d26e443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ea900206-6851-46b4-ba9b-596e0a6344ca" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_beaf98b5-9910-45c2-98a3-6244c038ce02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_beaf98b5-9910-45c2-98a3-6244c038ce02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FiduciaryAccountsPayableCurrent_34c6c7aa-9abd-486d-97e3-afd900845e63" xlink:href="ameh-20230630.xsd#ameh_FiduciaryAccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_ameh_FiduciaryAccountsPayableCurrent_34c6c7aa-9abd-486d-97e3-afd900845e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_f7011aec-ea6a-43eb-967e-6a6f4cbeb0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_f7011aec-ea6a-43eb-967e-6a6f4cbeb0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_c71f6aa3-deaf-47f0-94a7-347996876cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_c71f6aa3-deaf-47f0-94a7-347996876cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_2674baf2-33e3-4e05-9eb8-cd731afd367c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_DividendsPayableCurrent_2674baf2-33e3-4e05-9eb8-cd731afd367c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_a81ab4ce-2b41-4c93-b8b7-a3568ce25581" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_a81ab4ce-2b41-4c93-b8b7-a3568ce25581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_37b1f7cd-58f4-45af-b696-6230c0cf803a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_37b1f7cd-58f4-45af-b696-6230c0cf803a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_5b00e9eb-470f-40bb-bb4c-0ebe11a91713" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_LongTermDebtCurrent_5b00e9eb-470f-40bb-bb4c-0ebe11a91713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_389562ab-8591-4bfa-ae4f-5e8373c9b86c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44d9ff63-7dae-41bc-b8df-24676ed003d5" xlink:to="loc_us-gaap_LiabilitiesCurrent_389562ab-8591-4bfa-ae4f-5e8373c9b86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_12d33c58-546c-444f-bf69-c08d7cc8c03f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_12d33c58-546c-444f-bf69-c08d7cc8c03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_528b8823-4e71-4969-9902-e71f87b475d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_528b8823-4e71-4969-9902-e71f87b475d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e8e746d6-405d-4139-8bfc-6a55bc49e0ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e8e746d6-405d-4139-8bfc-6a55bc49e0ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c1be59f1-b7f6-44e1-a8bb-abbb214054ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c1be59f1-b7f6-44e1-a8bb-abbb214054ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b515949a-c3c4-4b65-98fe-90e3dd7eeb47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b515949a-c3c4-4b65-98fe-90e3dd7eeb47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_7f56ebec-f1e6-438d-8b20-9bcf541df0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_58f60d11-7fa7-4825-bc95-dc8412550f90" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_7f56ebec-f1e6-438d-8b20-9bcf541df0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_91c1df4f-75b7-4e46-a8ce-73f14eb035c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:to="loc_us-gaap_Liabilities_91c1df4f-75b7-4e46-a8ce-73f14eb035c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a5e7cecc-d496-45b9-90cb-6cc12bbbac85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a5e7cecc-d496-45b9-90cb-6cc12bbbac85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MezzanineEquityAbstract_d24c23d3-bb83-43e8-8ec5-291ec1a16f33" xlink:href="ameh-20230630.xsd#ameh_MezzanineEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:to="loc_ameh_MezzanineEquityAbstract_d24c23d3-bb83-43e8-8ec5-291ec1a16f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_b9e79dde-6def-47d3-b88e-b87ee7fff0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_MezzanineEquityAbstract_d24c23d3-bb83-43e8-8ec5-291ec1a16f33" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_b9e79dde-6def-47d3-b88e-b87ee7fff0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_e6986bc8-db20-4dc1-bb54-0e40d0acc775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:to="loc_us-gaap_PreferredStockValue_e6986bc8-db20-4dc1-bb54-0e40d0acc775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_85db6eb3-ed89-4c11-9d29-99ad343dd998" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:to="loc_us-gaap_CommonStockValue_85db6eb3-ed89-4c11-9d29-99ad343dd998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_25481962-deca-4777-a672-9a8b89a4ffca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:to="loc_us-gaap_AdditionalPaidInCapital_25481962-deca-4777-a672-9a8b89a4ffca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ae6e235d-2f8f-4910-8048-f4efd4c6f3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ae6e235d-2f8f-4910-8048-f4efd4c6f3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_762cf318-c2ff-4729-981e-29023091f5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:to="loc_us-gaap_StockholdersEquity_762cf318-c2ff-4729-981e-29023091f5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_39177d80-ca20-4cde-8c1c-6fce54b15bec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:to="loc_us-gaap_MinorityInterest_39177d80-ca20-4cde-8c1c-6fce54b15bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0fedcfac-81fd-49a3-9c3a-aceeba896eea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e5089b33-b4fa-4f85-b8b3-30d1647dde87" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0fedcfac-81fd-49a3-9c3a-aceeba896eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a3c6cc28-4570-49a3-93de-7dd36d88499c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aa442ae4-acff-4cd4-8fd3-edd887307387" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_a3c6cc28-4570-49a3-93de-7dd36d88499c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="ameh-20230630.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3c0ddbc8-878f-47be-a237-54f15aca7c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5606f1c1-20a9-467b-bc7a-d7384dcf09ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3c0ddbc8-878f-47be-a237-54f15aca7c3a" xlink:to="loc_us-gaap_StatementTable_5606f1c1-20a9-467b-bc7a-d7384dcf09ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2acd98b6-dca8-4323-954f-f51615840153" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5606f1c1-20a9-467b-bc7a-d7384dcf09ec" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2acd98b6-dca8-4323-954f-f51615840153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_156da92d-33b7-466c-b8cb-9cff55e96987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2acd98b6-dca8-4323-954f-f51615840153" xlink:to="loc_us-gaap_ClassOfStockDomain_156da92d-33b7-466c-b8cb-9cff55e96987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_d434cef5-ff1f-4008-b2ff-07d201d3ef68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_156da92d-33b7-466c-b8cb-9cff55e96987" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_d434cef5-ff1f-4008-b2ff-07d201d3ef68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_a8f89bfc-c6a5-45ed-8635-878b5ebf54dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_156da92d-33b7-466c-b8cb-9cff55e96987" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_a8f89bfc-c6a5-45ed-8635-878b5ebf54dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_ec32831a-86f1-4f2a-bed0-16355b09bfbe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5606f1c1-20a9-467b-bc7a-d7384dcf09ec" xlink:to="loc_srt_ConsolidatedEntitiesAxis_ec32831a-86f1-4f2a-bed0-16355b09bfbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e41fa349-ce42-408c-b774-d5e3614a863c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ec32831a-86f1-4f2a-bed0-16355b09bfbe" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e41fa349-ce42-408c-b774-d5e3614a863c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_7f269a2b-fc17-43e2-9adf-b92151e3fd14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e41fa349-ce42-408c-b774-d5e3614a863c" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_7f269a2b-fc17-43e2-9adf-b92151e3fd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5606f1c1-20a9-467b-bc7a-d7384dcf09ec" xlink:to="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a9baac67-d741-4745-a2e3-7739ab996774" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a9baac67-d741-4745-a2e3-7739ab996774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_505709b4-a92a-4222-b71d-92ef994a6f30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_505709b4-a92a-4222-b71d-92ef994a6f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4337b261-1006-4258-aae8-781d8ca8a422" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4337b261-1006-4258-aae8-781d8ca8a422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_6bb0c491-272c-40dc-8c3b-3af55124accb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_6bb0c491-272c-40dc-8c3b-3af55124accb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5d9a778a-f2d8-4abe-8687-1407fed58257" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5d9a778a-f2d8-4abe-8687-1407fed58257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_434ec6df-56e1-4d9c-af9a-75ea7584a158" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_434ec6df-56e1-4d9c-af9a-75ea7584a158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b42b30fb-3afc-45f6-aabf-bcc8759deb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_CommonStockSharesIssued_b42b30fb-3afc-45f6-aabf-bcc8759deb1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_05e66b3c-3097-4608-a7be-78c2cf95e3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_05e66b3c-3097-4608-a7be-78c2cf95e3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_1236b8d3-e57d-47b9-bc83-499e2879701d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_TreasuryStockCommonShares_1236b8d3-e57d-47b9-bc83-499e2879701d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5636a97c-6663-4692-a788-5a8fbfb1ffc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_Assets_5636a97c-6663-4692-a788-5a8fbfb1ffc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_50f77b6f-fdba-4be5-84bc-ac21e1c0c345" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_Liabilities_50f77b6f-fdba-4be5-84bc-ac21e1c0c345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_15433970-7686-4cdb-8885-ca67bfa4d83d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_15433970-7686-4cdb-8885-ca67bfa4d83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_3968fce1-9e4c-4926-b1d0-11df3b30da59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_OtherLiabilities_3968fce1-9e4c-4926-b1d0-11df3b30da59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_5905a9f5-ebaa-4e20-bdfe-95efab8444a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6cc00ff0-b3fd-44f6-bcbc-333b35526f76" xlink:to="loc_us-gaap_OtherReceivables_5905a9f5-ebaa-4e20-bdfe-95efab8444a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="ameh-20230630.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_031c8022-f6b1-45c4-bcf1-a5515398ea70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7a798d7f-269b-488a-a335-ce131a374e82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_031c8022-f6b1-45c4-bcf1-a5515398ea70" xlink:to="loc_us-gaap_StatementTable_7a798d7f-269b-488a-a335-ce131a374e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e2c1decd-6af3-4000-9ab8-5e652a0dd019" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7a798d7f-269b-488a-a335-ce131a374e82" xlink:to="loc_srt_ProductOrServiceAxis_e2c1decd-6af3-4000-9ab8-5e652a0dd019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_62faad1a-a982-4e07-bc6e-b6be2985d4d4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e2c1decd-6af3-4000-9ab8-5e652a0dd019" xlink:to="loc_srt_ProductsAndServicesDomain_62faad1a-a982-4e07-bc6e-b6be2985d4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_HealthCareCapitationRevenueMember_4343890c-c048-4a1c-b049-c2dac481e057" xlink:href="ameh-20230630.xsd#ameh_HealthCareCapitationRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_62faad1a-a982-4e07-bc6e-b6be2985d4d4" xlink:to="loc_ameh_HealthCareCapitationRevenueMember_4343890c-c048-4a1c-b049-c2dac481e057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_e90791cc-d26c-4f43-add5-926d8264d92e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_62faad1a-a982-4e07-bc6e-b6be2985d4d4" xlink:to="loc_us-gaap_HealthCareOtherMember_e90791cc-d26c-4f43-add5-926d8264d92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementServiceMember_9ef6c3cd-c9f5-4f58-a3e5-a5ab23e37aad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_62faad1a-a982-4e07-bc6e-b6be2985d4d4" xlink:to="loc_us-gaap_ManagementServiceMember_9ef6c3cd-c9f5-4f58-a3e5-a5ab23e37aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_dd3653b7-6524-4b26-9035-be7635860a79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_62faad1a-a982-4e07-bc6e-b6be2985d4d4" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_dd3653b7-6524-4b26-9035-be7635860a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_f4a9c722-2ddf-472f-8218-8e52b633bdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_62faad1a-a982-4e07-bc6e-b6be2985d4d4" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_f4a9c722-2ddf-472f-8218-8e52b633bdcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7a798d7f-269b-488a-a335-ce131a374e82" xlink:to="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_f5e563e0-deb3-41cd-ae82-98ee699fd1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_RevenuesAbstract_f5e563e0-deb3-41cd-ae82-98ee699fd1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6ac974e4-cc83-466d-81ae-4445c14b5d45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_f5e563e0-deb3-41cd-ae82-98ee699fd1cb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6ac974e4-cc83-466d-81ae-4445c14b5d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_7c95ef26-f32f-4f94-b5de-3e3e1db111a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_OperatingExpensesAbstract_7c95ef26-f32f-4f94-b5de-3e3e1db111a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_38ecc062-cfd8-4eec-9d66-94c4673c63fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c95ef26-f32f-4f94-b5de-3e3e1db111a3" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_38ecc062-cfd8-4eec-9d66-94c4673c63fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_09c7430b-13a3-4ec1-ba98-6d9157de0785" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c95ef26-f32f-4f94-b5de-3e3e1db111a3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_09c7430b-13a3-4ec1-ba98-6d9157de0785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_da919e2c-8fa4-4301-891b-bc26d2d4ec40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c95ef26-f32f-4f94-b5de-3e3e1db111a3" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_da919e2c-8fa4-4301-891b-bc26d2d4ec40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f5e78674-121a-4ad5-a06c-ecad8931d570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c95ef26-f32f-4f94-b5de-3e3e1db111a3" xlink:to="loc_us-gaap_CostsAndExpenses_f5e78674-121a-4ad5-a06c-ecad8931d570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_594390d2-420b-4502-bbae-f86a38c87c06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_OperatingIncomeLoss_594390d2-420b-4502-bbae-f86a38c87c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8ff3e454-9dd3-4b9c-b3b2-ba49f03cf3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8ff3e454-9dd3-4b9c-b3b2-ba49f03cf3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f2f5a56c-629e-4a65-9e95-0f285a9ad87f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:to="loc_us-gaap_InterestExpense_f2f5a56c-629e-4a65-9e95-0f285a9ad87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_e1cc87ff-2f13-4583-b4a0-4c0130781e63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:to="loc_us-gaap_InvestmentIncomeInterest_e1cc87ff-2f13-4583-b4a0-4c0130781e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_7727cd82-d416-493e-baff-7c06c68a5801" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_7727cd82-d416-493e-baff-7c06c68a5801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_132031d9-46a9-45ed-b4df-7bcaef25172b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_132031d9-46a9-45ed-b4df-7bcaef25172b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_e6896887-ee03-451b-a531-484ee4a958de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_dc19f365-42e3-4f79-8bfd-288de3e8a1dd" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_e6896887-ee03-451b-a531-484ee4a958de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dd3aa01c-39ba-4636-9d7c-2aa586768a74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dd3aa01c-39ba-4636-9d7c-2aa586768a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d83b4f43-2dbf-4e99-baf5-52d9dc71b259" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d83b4f43-2dbf-4e99-baf5-52d9dc71b259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d925108f-f456-4246-9c36-1987071a7a19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_ProfitLoss_d925108f-f456-4246-9c36-1987071a7a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_aac2d036-9f30-49aa-9f8c-006809a716df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_aac2d036-9f30-49aa-9f8c-006809a716df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2187effb-5949-44cb-b6e0-7e84c15c3f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_NetIncomeLoss_2187effb-5949-44cb-b6e0-7e84c15c3f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2cc11fad-e558-4c1f-9d79-c1ddadd1862c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_EarningsPerShareBasic_2cc11fad-e558-4c1f-9d79-c1ddadd1862c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_562a6305-41ad-4ad2-9435-1069acbe0e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0ba9925-9c60-4830-99ed-643f8f12c3ee" xlink:to="loc_us-gaap_EarningsPerShareDiluted_562a6305-41ad-4ad2-9435-1069acbe0e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ameh-20230630.xsd#CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_30dfc0c0-b912-480b-8951-9173a7cd7fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6d488273-3198-4d76-8f38-91ded461b9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_30dfc0c0-b912-480b-8951-9173a7cd7fd4" xlink:to="loc_us-gaap_StatementTable_6d488273-3198-4d76-8f38-91ded461b9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e8cdb618-1cc0-4723-bba9-0733a7a1c199" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6d488273-3198-4d76-8f38-91ded461b9cc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e8cdb618-1cc0-4723-bba9-0733a7a1c199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e2977fc4-5bf5-4554-8746-0d70aabfa478" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e8cdb618-1cc0-4723-bba9-0733a7a1c199" xlink:to="loc_us-gaap_EquityComponentDomain_e2977fc4-5bf5-4554-8746-0d70aabfa478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e2a560ad-9f36-42d0-a772-f1c5cc59f22f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e2977fc4-5bf5-4554-8746-0d70aabfa478" xlink:to="loc_us-gaap_CommonStockMember_e2a560ad-9f36-42d0-a772-f1c5cc59f22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_667d787f-45a7-4f97-aff7-a1240d2c34bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e2977fc4-5bf5-4554-8746-0d70aabfa478" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_667d787f-45a7-4f97-aff7-a1240d2c34bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9c8bdc49-8029-4b1e-9cfe-d791d5f47b99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e2977fc4-5bf5-4554-8746-0d70aabfa478" xlink:to="loc_us-gaap_RetainedEarningsMember_9c8bdc49-8029-4b1e-9cfe-d791d5f47b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_2748f8fd-00b8-4946-bd25-c296182ff4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e2977fc4-5bf5-4554-8746-0d70aabfa478" xlink:to="loc_us-gaap_NoncontrollingInterestMember_2748f8fd-00b8-4946-bd25-c296182ff4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_491a7e1b-fa23-4559-8f83-a76034559ee3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6d488273-3198-4d76-8f38-91ded461b9cc" xlink:to="loc_dei_LegalEntityAxis_491a7e1b-fa23-4559-8f83-a76034559ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0a810c70-ad3b-4415-ad27-6e53e84753d3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_491a7e1b-fa23-4559-8f83-a76034559ee3" xlink:to="loc_dei_EntityDomain_0a810c70-ad3b-4415-ad27-6e53e84753d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MezzanineMember_bb06a08b-3c65-41bc-b735-1d72c8dd7bac" xlink:href="ameh-20230630.xsd#ameh_MezzanineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_0a810c70-ad3b-4415-ad27-6e53e84753d3" xlink:to="loc_ameh_MezzanineMember_bb06a08b-3c65-41bc-b735-1d72c8dd7bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a08a57ad-98a6-466b-93b8-1d07b8f5e945" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6d488273-3198-4d76-8f38-91ded461b9cc" xlink:to="loc_us-gaap_StatementLineItems_a08a57ad-98a6-466b-93b8-1d07b8f5e945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a08a57ad-98a6-466b-93b8-1d07b8f5e945" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_cf62ab51-7319-4f6f-9bda-9323143192e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_cf62ab51-7319-4f6f-9bda-9323143192e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_8e9e280b-89fe-4b7e-b5df-db270e7b2276" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_8e9e280b-89fe-4b7e-b5df-db270e7b2276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_554ca463-73a6-43f6-ac9f-b0deec23f660" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_554ca463-73a6-43f6-ac9f-b0deec23f660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionOfDividends_892c2028-911a-43b3-8937-9b61b29d9557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionOfDividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:to="loc_us-gaap_TemporaryEquityAccretionOfDividends_892c2028-911a-43b3-8937-9b61b29d9557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_TemporaryEquityDividendsImpact_80c069f8-0b3e-4de8-80f8-fbdb27cdf45c" xlink:href="ameh-20230630.xsd#ameh_TemporaryEquityDividendsImpact"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:to="loc_ameh_TemporaryEquityDividendsImpact_80c069f8-0b3e-4de8-80f8-fbdb27cdf45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_TemporaryEquityTransferOfCommonControlEntities_e71a5d5a-6b52-4854-a9b6-f6bdda23ee1e" xlink:href="ameh-20230630.xsd#ameh_TemporaryEquityTransferOfCommonControlEntities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:to="loc_ameh_TemporaryEquityTransferOfCommonControlEntities_e71a5d5a-6b52-4854-a9b6-f6bdda23ee1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_61de7f3d-f86d-441f-9daa-622104867a16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_82329b00-cf68-4eea-a2db-f5a652ccdd86" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_61de7f3d-f86d-441f-9daa-622104867a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a08a57ad-98a6-466b-93b8-1d07b8f5e945" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_785019cd-eeca-41f6-b40c-73dd53a6d129" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_SharesOutstanding_785019cd-eeca-41f6-b40c-73dd53a6d129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_878745ca-1b97-49e2-b16e-a6f15b9d31c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_878745ca-1b97-49e2-b16e-a6f15b9d31c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_009dba7b-0079-4f5e-833b-ba56b23ff23d" xlink:href="ameh-20230630.xsd#ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_009dba7b-0079-4f5e-833b-ba56b23ff23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_aeabd2b5-d690-44fe-b337-725cbb622321" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_aeabd2b5-d690-44fe-b337-725cbb622321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_ad95bad8-b56e-49e9-bb3f-a42ce476f1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_ad95bad8-b56e-49e9-bb3f-a42ce476f1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_b6c181c9-9fe4-4c2f-8b4c-2aa504be006a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_b6c181c9-9fe4-4c2f-8b4c-2aa504be006a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_9909ead5-f796-4907-b5d2-3d9b68ce3f16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_9909ead5-f796-4907-b5d2-3d9b68ce3f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants_92a760ec-de44-4d66-9aa4-7a0400968ec5" xlink:href="ameh-20230630.xsd#ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants_92a760ec-de44-4d66-9aa4-7a0400968ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants_3d6934c1-d0ed-4508-a67c-9d3a5ea3b56c" xlink:href="ameh-20230630.xsd#ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants_3d6934c1-d0ed-4508-a67c-9d3a5ea3b56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_43556d2d-5309-48cb-98b7-abaac9d5deb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_43556d2d-5309-48cb-98b7-abaac9d5deb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_016d2db5-be5b-4f46-8707-cba034842117" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_016d2db5-be5b-4f46-8707-cba034842117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2270d35d-0fe8-4370-a977-8ed5d594693d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2270d35d-0fe8-4370-a977-8ed5d594693d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_a5ab7b99-077d-4a99-a895-86fdf9ff63e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_a5ab7b99-077d-4a99-a895-86fdf9ff63e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_f0625cd8-0f1d-4b63-b3ef-7a160e56a9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_f0625cd8-0f1d-4b63-b3ef-7a160e56a9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_ca5f60a6-c08f-43b0-88d2-e6c8b61aabdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_ca5f60a6-c08f-43b0-88d2-e6c8b61aabdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_baff2341-75d2-4f31-9045-3d850a5499d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_baff2341-75d2-4f31-9045-3d850a5499d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_bce1c48b-4e8b-4a61-8dc9-fbc8ddf52bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_bce1c48b-4e8b-4a61-8dc9-fbc8ddf52bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_f231f433-8b7f-4df6-8001-fbca0cbaf156" xlink:href="ameh-20230630.xsd#ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_f231f433-8b7f-4df6-8001-fbca0cbaf156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_TransferOfCommonControlEntities_2141c797-209d-4adb-8870-bc2ef5fbc2d4" xlink:href="ameh-20230630.xsd#ameh_TransferOfCommonControlEntities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_ameh_TransferOfCommonControlEntities_2141c797-209d-4adb-8870-bc2ef5fbc2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_84b430d0-6902-4d62-8adf-7806c06cd4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_SharesOutstanding_84b430d0-6902-4d62-8adf-7806c06cd4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2453b3cb-0729-443a-bc10-1d253ceb0570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c31cdf5a-727e-4136-9049-0a6ad16101df" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2453b3cb-0729-443a-bc10-1d253ceb0570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ameh-20230630.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_6c104858-c826-453b-9081-88121d7f5732" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c5dbe873-1786-4a02-88e8-27c115d1dc0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c104858-c826-453b-9081-88121d7f5732" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c5dbe873-1786-4a02-88e8-27c115d1dc0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_27dbef19-53ac-4530-a758-632addef328f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c5dbe873-1786-4a02-88e8-27c115d1dc0c" xlink:to="loc_us-gaap_ProfitLoss_27dbef19-53ac-4530-a758-632addef328f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f84108-6f4d-46f5-b74f-41614d30bbed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c5dbe873-1786-4a02-88e8-27c115d1dc0c" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f84108-6f4d-46f5-b74f-41614d30bbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9f4f0f3b-ea2e-442c-acef-55f603029312" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f84108-6f4d-46f5-b74f-41614d30bbed" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9f4f0f3b-ea2e-442c-acef-55f603029312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_fbb0ab3b-8094-4307-8fdd-c6faaec68e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f84108-6f4d-46f5-b74f-41614d30bbed" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_fbb0ab3b-8094-4307-8fdd-c6faaec68e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_eda60c7c-5a2e-4d92-badb-5403dc5e079d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f84108-6f4d-46f5-b74f-41614d30bbed" xlink:to="loc_us-gaap_ShareBasedCompensation_eda60c7c-5a2e-4d92-badb-5403dc5e079d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_aa3a09d0-812d-43f0-adc7-c1fadf56b17a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f84108-6f4d-46f5-b74f-41614d30bbed" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_aa3a09d0-812d-43f0-adc7-c1fadf56b17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_UnrealizedGainLossFromInvestmentInEquitySecurities_2f9155f8-1e1c-4262-ab57-341a2a3473ff" xlink:href="ameh-20230630.xsd#ameh_UnrealizedGainLossFromInvestmentInEquitySecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f84108-6f4d-46f5-b74f-41614d30bbed" xlink:to="loc_ameh_UnrealizedGainLossFromInvestmentInEquitySecurities_2f9155f8-1e1c-4262-ab57-341a2a3473ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5dc08987-c89e-46f9-9ff0-b0bffeb7aa81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f84108-6f4d-46f5-b74f-41614d30bbed" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5dc08987-c89e-46f9-9ff0-b0bffeb7aa81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_f99fc64f-7ad2-4131-9e0c-596ebe32b1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f84108-6f4d-46f5-b74f-41614d30bbed" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_f99fc64f-7ad2-4131-9e0c-596ebe32b1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_969bccc9-7dd9-480d-80fa-f9c085ee4bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f84108-6f4d-46f5-b74f-41614d30bbed" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_969bccc9-7dd9-480d-80fa-f9c085ee4bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e6d21558-e945-44b5-89d6-e66940c4dd2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f84108-6f4d-46f5-b74f-41614d30bbed" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e6d21558-e945-44b5-89d6-e66940c4dd2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_24707275-bfb5-4948-bc7b-dc0e32ba0704" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e6d21558-e945-44b5-89d6-e66940c4dd2e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_24707275-bfb5-4948-bc7b-dc0e32ba0704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueFromRelatedParties_06b54602-b11e-4375-bea4-dd7e6aa3408e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e6d21558-e945-44b5-89d6-e66940c4dd2e" xlink:to="loc_us-gaap_IncreaseDecreaseInDueFromRelatedParties_06b54602-b11e-4375-bea4-dd7e6aa3408e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_248048fc-8683-46c9-81e6-42b289d7f40d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e6d21558-e945-44b5-89d6-e66940c4dd2e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_248048fc-8683-46c9-81e6-42b289d7f40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_b985af72-ff71-4a3b-bfc3-5637345ed6d8" xlink:href="ameh-20230630.xsd#ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e6d21558-e945-44b5-89d6-e66940c4dd2e" xlink:to="loc_ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_b985af72-ff71-4a3b-bfc3-5637345ed6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_IncreaseDecreaseInOperatingLeaseAssets_9d1a896e-c265-4eee-9de3-16008ffc7687" xlink:href="ameh-20230630.xsd#ameh_IncreaseDecreaseInOperatingLeaseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e6d21558-e945-44b5-89d6-e66940c4dd2e" xlink:to="loc_ameh_IncreaseDecreaseInOperatingLeaseAssets_9d1a896e-c265-4eee-9de3-16008ffc7687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_459bf71e-3485-4cb3-90c4-63918265bead" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e6d21558-e945-44b5-89d6-e66940c4dd2e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_459bf71e-3485-4cb3-90c4-63918265bead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4c41c254-6452-4e72-a9cc-91c468cbd1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e6d21558-e945-44b5-89d6-e66940c4dd2e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4c41c254-6452-4e72-a9cc-91c468cbd1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable_a4840ad1-3cf3-43b3-a0cb-fa6b35a6e5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e6d21558-e945-44b5-89d6-e66940c4dd2e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable_a4840ad1-3cf3-43b3-a0cb-fa6b35a6e5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_IncreaseDecreaseInMedicalLiabilities_bdac0264-6b6c-493e-bb1d-5676bde02511" xlink:href="ameh-20230630.xsd#ameh_IncreaseDecreaseInMedicalLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e6d21558-e945-44b5-89d6-e66940c4dd2e" xlink:to="loc_ameh_IncreaseDecreaseInMedicalLiabilities_bdac0264-6b6c-493e-bb1d-5676bde02511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5b578e51-1acf-4f6f-ae15-d2b589ab5c22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e6d21558-e945-44b5-89d6-e66940c4dd2e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5b578e51-1acf-4f6f-ae15-d2b589ab5c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_15c6957d-e894-4947-82b4-7553699c12ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e6d21558-e945-44b5-89d6-e66940c4dd2e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_15c6957d-e894-4947-82b4-7553699c12ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_a79f93fe-4edb-4c1b-955d-eb6034607523" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e6d21558-e945-44b5-89d6-e66940c4dd2e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_a79f93fe-4edb-4c1b-955d-eb6034607523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3478506-6eb0-4900-ad21-073afc2b537e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c5dbe873-1786-4a02-88e8-27c115d1dc0c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3478506-6eb0-4900-ad21-073afc2b537e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e5afdc73-5eb4-464f-8435-7ca13c1e6dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c104858-c826-453b-9081-88121d7f5732" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e5afdc73-5eb4-464f-8435-7ca13c1e6dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b83a1a7c-32ae-417e-80a5-371f3e51f5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e5afdc73-5eb4-464f-8435-7ca13c1e6dc0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b83a1a7c-32ae-417e-80a5-371f3e51f5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_78fda11f-d26e-4237-887d-f102fd5498d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e5afdc73-5eb4-464f-8435-7ca13c1e6dc0" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_78fda11f-d26e-4237-887d-f102fd5498d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_f4a5a2c6-bac0-4f4d-adc5-52797c25cf07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e5afdc73-5eb4-464f-8435-7ca13c1e6dc0" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_f4a5a2c6-bac0-4f4d-adc5-52797c25cf07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_fc344d14-599b-4207-8f3e-c596b4a32b97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e5afdc73-5eb4-464f-8435-7ca13c1e6dc0" xlink:to="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_fc344d14-599b-4207-8f3e-c596b4a32b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_205d79cc-6c73-4904-9d8e-786508d754dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e5afdc73-5eb4-464f-8435-7ca13c1e6dc0" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_205d79cc-6c73-4904-9d8e-786508d754dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_69a36e62-5026-4802-98dc-1479a0bf98f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e5afdc73-5eb4-464f-8435-7ca13c1e6dc0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_69a36e62-5026-4802-98dc-1479a0bf98f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1f7e4ed4-aa43-42f6-9ef2-65f808a6c423" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e5afdc73-5eb4-464f-8435-7ca13c1e6dc0" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1f7e4ed4-aa43-42f6-9ef2-65f808a6c423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_7d9d53c4-1cfe-4462-a9a8-3d12b336bc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e5afdc73-5eb4-464f-8435-7ca13c1e6dc0" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_7d9d53c4-1cfe-4462-a9a8-3d12b336bc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PaymentsToEquityMethodInvestments_cda8dc5a-7a94-4f09-b533-b12ad624b6e4" xlink:href="ameh-20230630.xsd#ameh_PaymentsToEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e5afdc73-5eb4-464f-8435-7ca13c1e6dc0" xlink:to="loc_ameh_PaymentsToEquityMethodInvestments_cda8dc5a-7a94-4f09-b533-b12ad624b6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_75d1dca6-5745-4df0-b72f-e95b2bad9431" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e5afdc73-5eb4-464f-8435-7ca13c1e6dc0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_75d1dca6-5745-4df0-b72f-e95b2bad9431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_73634e6c-ebdd-489c-89f0-83617010599c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c104858-c826-453b-9081-88121d7f5732" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_73634e6c-ebdd-489c-89f0-83617010599c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_4b8e7bf5-d1ff-4ab8-a554-de41edb01e73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_73634e6c-ebdd-489c-89f0-83617010599c" xlink:to="loc_us-gaap_PaymentsOfDividends_4b8e7bf5-d1ff-4ab8-a554-de41edb01e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_01766bc9-91f4-4f46-b0a3-1c3e2e9c70bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_73634e6c-ebdd-489c-89f0-83617010599c" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_01766bc9-91f4-4f46-b0a3-1c3e2e9c70bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_bef71703-ab16-4f87-8d2d-792e7a6fdc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_73634e6c-ebdd-489c-89f0-83617010599c" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_bef71703-ab16-4f87-8d2d-792e7a6fdc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_f4cbfbf8-97f7-4516-ab12-40e71ffe641d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_73634e6c-ebdd-489c-89f0-83617010599c" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_f4cbfbf8-97f7-4516-ab12-40e71ffe641d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_60bc941f-53b4-43ef-8add-1d00a4dd1aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_73634e6c-ebdd-489c-89f0-83617010599c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_60bc941f-53b4-43ef-8add-1d00a4dd1aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders_dd055af8-9ff2-4503-89aa-d632244cc23d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_73634e6c-ebdd-489c-89f0-83617010599c" xlink:to="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders_dd055af8-9ff2-4503-89aa-d632244cc23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PurchaseOfNonControllingInterest_f2211c12-c6f9-4204-a60a-8cfcb41c4bd0" xlink:href="ameh-20230630.xsd#ameh_PurchaseOfNonControllingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_73634e6c-ebdd-489c-89f0-83617010599c" xlink:to="loc_ameh_PurchaseOfNonControllingInterest_f2211c12-c6f9-4204-a60a-8cfcb41c4bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_788309d5-4e51-436a-9129-c624ae2db4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_73634e6c-ebdd-489c-89f0-83617010599c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_788309d5-4e51-436a-9129-c624ae2db4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00c6647-944e-48c9-99d1-1f1a3abf20a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_73634e6c-ebdd-489c-89f0-83617010599c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a00c6647-944e-48c9-99d1-1f1a3abf20a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_adaab83b-ed3a-48e5-890c-d36071b9e42c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c104858-c826-453b-9081-88121d7f5732" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_adaab83b-ed3a-48e5-890c-d36071b9e42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1037f3ee-533e-452f-989a-b27368b37295" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c104858-c826-453b-9081-88121d7f5732" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1037f3ee-533e-452f-989a-b27368b37295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5a2f8c93-49a5-49e9-9867-0778501c8a97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c104858-c826-453b-9081-88121d7f5732" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5a2f8c93-49a5-49e9-9867-0778501c8a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_58aa4166-63e7-4872-832d-e9e8a781008d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c104858-c826-453b-9081-88121d7f5732" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_58aa4166-63e7-4872-832d-e9e8a781008d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_1ca2c485-27dc-4b36-85a1-a92c89c9afd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_58aa4166-63e7-4872-832d-e9e8a781008d" xlink:to="loc_us-gaap_IncomeTaxesPaid_1ca2c485-27dc-4b36-85a1-a92c89c9afd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_2f12a26f-516a-4af1-afb0-e69ba8fee0da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_58aa4166-63e7-4872-832d-e9e8a781008d" xlink:to="loc_us-gaap_InterestPaidNet_2f12a26f-516a-4af1-afb0-e69ba8fee0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_5efc76a7-32a8-4ff6-bea3-84c87cf586ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c104858-c826-453b-9081-88121d7f5732" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_5efc76a7-32a8-4ff6-bea3-84c87cf586ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_836168a7-23d7-4ef1-9294-4b4f01c036a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_5efc76a7-32a8-4ff6-bea3-84c87cf586ed" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_836168a7-23d7-4ef1-9294-4b4f01c036a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2bea0045-cecf-4fe2-8684-6b6e445a6a97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_5efc76a7-32a8-4ff6-bea3-84c87cf586ed" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2bea0045-cecf-4fe2-8684-6b6e445a6a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_dd41b535-981c-48ae-b9d0-53e61527b223" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_5efc76a7-32a8-4ff6-bea3-84c87cf586ed" xlink:to="loc_us-gaap_StockIssued1_dd41b535-981c-48ae-b9d0-53e61527b223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoanRelatedToPropertySales1_d70da422-ad06-49e1-a350-3c7db940ffeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgageLoanRelatedToPropertySales1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_5efc76a7-32a8-4ff6-bea3-84c87cf586ed" xlink:to="loc_us-gaap_MortgageLoanRelatedToPropertySales1_d70da422-ad06-49e1-a350-3c7db940ffeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_27b3123a-ee0b-422a-b342-09c4d1551bf6" xlink:href="ameh-20230630.xsd#ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c104858-c826-453b-9081-88121d7f5732" xlink:to="loc_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_27b3123a-ee0b-422a-b342-09c4d1551bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5ddf5705-4886-4663-96dc-518c6230275b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_27b3123a-ee0b-422a-b342-09c4d1551bf6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5ddf5705-4886-4663-96dc-518c6230275b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsCurrent_59f05102-ee89-4c91-9947-07ca471c4bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashEquivalentsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_27b3123a-ee0b-422a-b342-09c4d1551bf6" xlink:to="loc_us-gaap_RestrictedCashEquivalentsCurrent_59f05102-ee89-4c91-9947-07ca471c4bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_84c32f80-cb13-40c8-87b0-89c3b2568e86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_27b3123a-ee0b-422a-b342-09c4d1551bf6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_84c32f80-cb13-40c8-87b0-89c3b2568e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/DescriptionofBusiness" xlink:type="simple" xlink:href="ameh-20230630.xsd#DescriptionofBusiness"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/DescriptionofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_da674102-3b32-42a3-aecf-fd6d13e87eae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_cde6e3bf-2335-446b-b952-3dae36e87672" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_da674102-3b32-42a3-aecf-fd6d13e87eae" xlink:to="loc_us-gaap_NatureOfOperations_cde6e3bf-2335-446b-b952-3dae36e87672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="ameh-20230630.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8ee9a55b-02f3-4eea-b541-4dca846e405a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_527aeaed-2fe1-4d60-8f38-24050f28eb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8ee9a55b-02f3-4eea-b541-4dca846e405a" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_527aeaed-2fe1-4d60-8f38-24050f28eb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwill" xlink:type="simple" xlink:href="ameh-20230630.xsd#BusinessCombinationsAssetAcquisitionsandGoodwill"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d91fc020-b6c5-4894-9294-904079e694bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_6ff40342-51c3-4bd6-bdab-42c052eb901a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d91fc020-b6c5-4894-9294-904079e694bf" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_6ff40342-51c3-4bd6-bdab-42c052eb901a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNet" xlink:type="simple" xlink:href="ameh-20230630.xsd#IntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_acd9bd36-3fc8-4285-9fad-354061f4264b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_a454a194-2c09-43b0-aeea-63c58d70e426" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_acd9bd36-3fc8-4285-9fad-354061f4264b" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_a454a194-2c09-43b0-aeea-63c58d70e426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntities" xlink:type="simple" xlink:href="ameh-20230630.xsd#InvestmentsinOtherEntities"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/InvestmentsinOtherEntities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a2014ac0-6858-4f50-b2ba-b65b194c95b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EquityMethodAndOtherEquityInvestmentsTextBlock_ab65f064-59f2-435e-a4e3-1ce7f3acf7aa" xlink:href="ameh-20230630.xsd#ameh_EquityMethodAndOtherEquityInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a2014ac0-6858-4f50-b2ba-b65b194c95b8" xlink:to="loc_ameh_EquityMethodAndOtherEquityInvestmentsTextBlock_ab65f064-59f2-435e-a4e3-1ce7f3acf7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedParties" xlink:type="simple" xlink:href="ameh-20230630.xsd#LoanReceivableandLoanReceivableRelatedParties"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedParties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_cf30c152-d813-414c-afe9-7d7034b46ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LoanReceivableTextBlock_0ed5c515-a5a1-4800-945f-be4ca7135cbb" xlink:href="ameh-20230630.xsd#ameh_LoanReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_cf30c152-d813-414c-afe9-7d7034b46ffb" xlink:to="loc_ameh_LoanReceivableTextBlock_0ed5c515-a5a1-4800-945f-be4ca7135cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/AccountsPayableandAccruedExpenses" xlink:type="simple" xlink:href="ameh-20230630.xsd#AccountsPayableandAccruedExpenses"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/AccountsPayableandAccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_550aa30b-60ae-4bdd-b24e-0d234ec80b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_5a313b55-8500-4dac-9b9e-daee5e5efd2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_550aa30b-60ae-4bdd-b24e-0d234ec80b6a" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_5a313b55-8500-4dac-9b9e-daee5e5efd2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/MedicalLiabilities" xlink:type="simple" xlink:href="ameh-20230630.xsd#MedicalLiabilities"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/MedicalLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_442193f4-dbd8-43ec-be11-39ef1654bd27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_e356c629-b6a5-4027-a17f-f14f6ff88342" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_442193f4-dbd8-43ec-be11-39ef1654bd27" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_e356c629-b6a5-4027-a17f-f14f6ff88342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCredit" xlink:type="simple" xlink:href="ameh-20230630.xsd#CreditFacilityBankLoansandLinesofCredit"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCredit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4ec99abd-6114-49f5-8a67-40c483565640" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_35870a54-16ff-41ad-b35d-d06d9bfb9a56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4ec99abd-6114-49f5-8a67-40c483565640" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_35870a54-16ff-41ad-b35d-d06d9bfb9a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/MezzanineandStockholdersEquity" xlink:type="simple" xlink:href="ameh-20230630.xsd#MezzanineandStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/MezzanineandStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_eafb9508-d304-4a03-ae3e-ff25756e1422" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f466d1dd-b5a8-4bf5-b94a-c866729be5df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_eafb9508-d304-4a03-ae3e-ff25756e1422" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f466d1dd-b5a8-4bf5-b94a-c866729be5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensation" xlink:type="simple" xlink:href="ameh-20230630.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_82ab6c28-7892-4f23-b4ee-df903ea8ac97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1c0a87f0-99a5-40e4-8327-d7b1abd9fd2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_82ab6c28-7892-4f23-b4ee-df903ea8ac97" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1c0a87f0-99a5-40e4-8327-d7b1abd9fd2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="ameh-20230630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b09fa5ea-d153-459a-96d3-ee257bf8b843" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_99ee8c18-9650-4094-b523-d937b09461f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b09fa5ea-d153-459a-96d3-ee257bf8b843" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_99ee8c18-9650-4094-b523-d937b09461f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="ameh-20230630.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_80bea831-e7fa-4ac7-8c1d-4d2cd873da7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_3b2f2f18-8b61-41cb-9a7e-27ac2cedbfec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_80bea831-e7fa-4ac7-8c1d-4d2cd873da7e" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_3b2f2f18-8b61-41cb-9a7e-27ac2cedbfec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IncomeTaxes" xlink:type="simple" xlink:href="ameh-20230630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ca1ab9e6-3116-48a8-ac6f-4eccc45822f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_affe401e-98c9-4079-becc-ed0762b37f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ca1ab9e6-3116-48a8-ac6f-4eccc45822f8" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_affe401e-98c9-4079-becc-ed0762b37f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShare" xlink:type="simple" xlink:href="ameh-20230630.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_462a0e57-fa30-4171-914a-a743da5fd184" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_f73a4d9e-c199-4f9b-bb49-e889a13d4824" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_462a0e57-fa30-4171-914a-a743da5fd184" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_f73a4d9e-c199-4f9b-bb49-e889a13d4824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEs" xlink:type="simple" xlink:href="ameh-20230630.xsd#VariableInterestEntitiesVIEs"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/VariableInterestEntitiesVIEs" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2ae0e336-2369-4b13-87a4-17744370035d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_5eb67b84-54eb-4f88-aa64-2e9445ddb648" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2ae0e336-2369-4b13-87a4-17744370035d" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_5eb67b84-54eb-4f88-aa64-2e9445ddb648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/Leases" xlink:type="simple" xlink:href="ameh-20230630.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d2c9c699-e1d9-4380-9e74-f7de218a910f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_530df18b-c8b8-4baa-bd95-0491112f2c99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d2c9c699-e1d9-4380-9e74-f7de218a910f" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_530df18b-c8b8-4baa-bd95-0491112f2c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_619d04ce-a45c-4b99-a223-1e3bcd97d270" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d2c9c699-e1d9-4380-9e74-f7de218a910f" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_619d04ce-a45c-4b99-a223-1e3bcd97d270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/Segments" xlink:type="simple" xlink:href="ameh-20230630.xsd#Segments"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/Segments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0b3f924e-d14a-44f6-ba8a-fdc5e7c87792" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_10f04104-3188-4976-ac12-7996287c8e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0b3f924e-d14a-44f6-ba8a-fdc5e7c87792" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_10f04104-3188-4976-ac12-7996287c8e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/SubsequentEvents" xlink:type="simple" xlink:href="ameh-20230630.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_e616965b-55c3-4d69-b079-1377a513b549" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_5645e6e7-26df-40d0-8f62-8c8bc8cfd136" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_e616965b-55c3-4d69-b079-1377a513b549" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_5645e6e7-26df-40d0-8f62-8c8bc8cfd136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="ameh-20230630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1b6d8ff1-3f90-46f2-8d37-deb939cd23a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_df3359b8-cb2f-4a6c-8197-75b537b94b87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b6d8ff1-3f90-46f2-8d37-deb939cd23a0" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_df3359b8-cb2f-4a6c-8197-75b537b94b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_5b1bf948-564a-4407-97e9-3c940c0fb96b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b6d8ff1-3f90-46f2-8d37-deb939cd23a0" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_5b1bf948-564a-4407-97e9-3c940c0fb96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_9722e5be-1523-4075-8506-3da6db0f2413" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b6d8ff1-3f90-46f2-8d37-deb939cd23a0" xlink:to="loc_us-gaap_UseOfEstimates_9722e5be-1523-4075-8506-3da6db0f2413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_897e37ac-0f9a-407e-b105-df548a31889e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b6d8ff1-3f90-46f2-8d37-deb939cd23a0" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_897e37ac-0f9a-407e-b105-df548a31889e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_079dc874-5d34-4584-af33-14e39174ea60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b6d8ff1-3f90-46f2-8d37-deb939cd23a0" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_079dc874-5d34-4584-af33-14e39174ea60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_5f63a338-be5e-4cd7-a94e-8c3030d9df62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b6d8ff1-3f90-46f2-8d37-deb939cd23a0" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_5f63a338-be5e-4cd7-a94e-8c3030d9df62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c9672d86-ba86-43d6-9e69-ee3602de82e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b6d8ff1-3f90-46f2-8d37-deb939cd23a0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c9672d86-ba86-43d6-9e69-ee3602de82e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_c03009b1-6318-4484-97b0-0c9cf41ad962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b6d8ff1-3f90-46f2-8d37-deb939cd23a0" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_c03009b1-6318-4484-97b0-0c9cf41ad962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock_dd0d20b8-925d-4c42-964d-09c98d2bcc30" xlink:href="ameh-20230630.xsd#ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b6d8ff1-3f90-46f2-8d37-deb939cd23a0" xlink:to="loc_ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock_dd0d20b8-925d-4c42-964d-09c98d2bcc30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_43dd14fa-4032-4ecd-bf3e-329092a6c1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b6d8ff1-3f90-46f2-8d37-deb939cd23a0" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_43dd14fa-4032-4ecd-bf3e-329092a6c1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_4aa7fee2-5c2b-4199-aa5c-7098afbfabf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b6d8ff1-3f90-46f2-8d37-deb939cd23a0" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_4aa7fee2-5c2b-4199-aa5c-7098afbfabf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_e23713de-7450-400d-a737-abaad1c291e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b6d8ff1-3f90-46f2-8d37-deb939cd23a0" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_e23713de-7450-400d-a737-abaad1c291e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_adfb16b9-4cef-4424-b864-feecb66eee6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b6d8ff1-3f90-46f2-8d37-deb939cd23a0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_adfb16b9-4cef-4424-b864-feecb66eee6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_45e9ecd0-7b71-4fb2-b24a-773e116680e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b6d8ff1-3f90-46f2-8d37-deb939cd23a0" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_45e9ecd0-7b71-4fb2-b24a-773e116680e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="ameh-20230630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c7cbf69d-c823-4d54-8bc8-48ca477a355f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock_36e8e81b-556f-49a8-b7df-51889d101af5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7cbf69d-c823-4d54-8bc8-48ca477a355f" xlink:to="loc_us-gaap_GainLossOnInvestmentsTextBlock_36e8e81b-556f-49a8-b7df-51889d101af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c34ab02e-586e-4c9c-82d3-7520be215ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7cbf69d-c823-4d54-8bc8-48ca477a355f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c34ab02e-586e-4c9c-82d3-7520be215ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_ba6dd126-2b0f-47f7-a5ac-46d456308aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7cbf69d-c823-4d54-8bc8-48ca477a355f" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_ba6dd126-2b0f-47f7-a5ac-46d456308aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_52c36b61-fc8a-4417-a465-a55cb9b546ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7cbf69d-c823-4d54-8bc8-48ca477a355f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_52c36b61-fc8a-4417-a465-a55cb9b546ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_847f6cc0-a4f9-4cbc-8fec-6491c46bf507" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7cbf69d-c823-4d54-8bc8-48ca477a355f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_847f6cc0-a4f9-4cbc-8fec-6491c46bf507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillTables" xlink:type="simple" xlink:href="ameh-20230630.xsd#BusinessCombinationsAssetAcquisitionsandGoodwillTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_27c0c247-0c4b-4ced-8862-859627f7d74c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_94891656-d08f-48bd-a5c9-8cbaf0726236" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_27c0c247-0c4b-4ced-8862-859627f7d74c" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_94891656-d08f-48bd-a5c9-8cbaf0726236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetTables" xlink:type="simple" xlink:href="ameh-20230630.xsd#IntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9e3d4bae-07a2-496a-bab9-91653634397a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_17b863e6-e53a-423f-9a36-c7ef9e7e1640" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9e3d4bae-07a2-496a-bab9-91653634397a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_17b863e6-e53a-423f-9a36-c7ef9e7e1640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a359d478-cebb-4ccb-ac6b-d94ff32f21c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9e3d4bae-07a2-496a-bab9-91653634397a" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a359d478-cebb-4ccb-ac6b-d94ff32f21c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesTables" xlink:type="simple" xlink:href="ameh-20230630.xsd#InvestmentsinOtherEntitiesTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/InvestmentsinOtherEntitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_6268b60f-ab2d-4ac2-9236-55c6bbefc917" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_94779ef8-eb70-4506-aa0d-caadb8556627" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_6268b60f-ab2d-4ac2-9236-55c6bbefc917" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_94779ef8-eb70-4506-aa0d-caadb8556627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesTables" xlink:type="simple" xlink:href="ameh-20230630.xsd#AccountsPayableandAccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_39660551-5934-426e-9c55-a20e3e659894" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_96e9da0d-41c5-4a00-a6d6-c1b365ed30bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_39660551-5934-426e-9c55-a20e3e659894" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_96e9da0d-41c5-4a00-a6d6-c1b365ed30bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/MedicalLiabilitiesTables" xlink:type="simple" xlink:href="ameh-20230630.xsd#MedicalLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/MedicalLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_73c2e3f4-b149-40e2-bc56-bf8a14f108fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_3056201b-d267-4652-be1f-4a424e766f36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_73c2e3f4-b149-40e2-bc56-bf8a14f108fc" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_3056201b-d267-4652-be1f-4a424e766f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditTables" xlink:type="simple" xlink:href="ameh-20230630.xsd#CreditFacilityBankLoansandLinesofCreditTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_89fadf00-4882-43de-94b8-7845ce13fe68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_f86575ec-7194-42ab-9e74-9d08df326775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_89fadf00-4882-43de-94b8-7845ce13fe68" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_f86575ec-7194-42ab-9e74-9d08df326775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_52fd3ce4-ffb8-4dbc-a2bb-fb6ed04e400a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_89fadf00-4882-43de-94b8-7845ce13fe68" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_52fd3ce4-ffb8-4dbc-a2bb-fb6ed04e400a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="ameh-20230630.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_56de4033-4194-4cd2-9789-4359c6b769e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_c3a6f251-c0fd-4828-af9d-7c766b73edf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_56de4033-4194-4cd2-9789-4359c6b769e6" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_c3a6f251-c0fd-4828-af9d-7c766b73edf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_380d6572-5ad8-41d0-a2f7-e0ec4e29efbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_56de4033-4194-4cd2-9789-4359c6b769e6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_380d6572-5ad8-41d0-a2f7-e0ec4e29efbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsTables" xlink:type="simple" xlink:href="ameh-20230630.xsd#RelatedPartyTransactionsTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/RelatedPartyTransactionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_7d36c629-2634-4a86-ad90-69d35074b7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_193ccb54-dbf1-4e24-834e-56de9d15e0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_7d36c629-2634-4a86-ad90-69d35074b7d7" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_193ccb54-dbf1-4e24-834e-56de9d15e0e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShareTables" xlink:type="simple" xlink:href="ameh-20230630.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_240c6807-f88e-4b37-bd6f-c5f3bfeae5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2df4f60a-2da7-4190-abe2-0e4ef98f2043" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_240c6807-f88e-4b37-bd6f-c5f3bfeae5ac" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2df4f60a-2da7-4190-abe2-0e4ef98f2043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_82db8321-4ac9-4d86-8495-47f1386ce621" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_240c6807-f88e-4b37-bd6f-c5f3bfeae5ac" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_82db8321-4ac9-4d86-8495-47f1386ce621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEsTables" xlink:type="simple" xlink:href="ameh-20230630.xsd#VariableInterestEntitiesVIEsTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/VariableInterestEntitiesVIEsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d985f004-9e9f-455b-b588-0fbb54fc9233" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_e0cc0838-734b-476b-be28-24a01482d5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d985f004-9e9f-455b-b588-0fbb54fc9233" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_e0cc0838-734b-476b-be28-24a01482d5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesTables" xlink:type="simple" xlink:href="ameh-20230630.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1de1199e-f5e1-440f-99ad-9ce868843345" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_31fd0083-826f-4aad-b097-14ce971afc89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1de1199e-f5e1-440f-99ad-9ce868843345" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_31fd0083-826f-4aad-b097-14ce971afc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_59fc8a8d-b892-49c8-a3c6-9c4c122ed764" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1de1199e-f5e1-440f-99ad-9ce868843345" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_59fc8a8d-b892-49c8-a3c6-9c4c122ed764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_34ddfac7-ed35-491f-8d96-0a9b847236b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1de1199e-f5e1-440f-99ad-9ce868843345" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_34ddfac7-ed35-491f-8d96-0a9b847236b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/SegmentsTables" xlink:type="simple" xlink:href="ameh-20230630.xsd#SegmentsTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/SegmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_619353bd-c19f-4276-83bb-ecf1eddec468" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_f0e4e27f-dfc3-4d75-b87b-8ab17c9bb544" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_619353bd-c19f-4276-83bb-ecf1eddec468" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_f0e4e27f-dfc3-4d75-b87b-8ab17c9bb544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#DescriptionofBusinessAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7564a706-df51-4ca2-a347-94aad729448e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DescriptionOfBusinessTable_18c822ac-a7b7-4a12-beb4-c745e6931a4d" xlink:href="ameh-20230630.xsd#ameh_DescriptionOfBusinessTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7564a706-df51-4ca2-a347-94aad729448e" xlink:to="loc_ameh_DescriptionOfBusinessTable_18c822ac-a7b7-4a12-beb4-c745e6931a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3b152815-cf43-449e-9f1d-efd1b5b1b5af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_DescriptionOfBusinessTable_18c822ac-a7b7-4a12-beb4-c745e6931a4d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3b152815-cf43-449e-9f1d-efd1b5b1b5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6506c3cc-4610-4091-9420-bb3c08f6b766" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3b152815-cf43-449e-9f1d-efd1b5b1b5af" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6506c3cc-4610-4091-9420-bb3c08f6b766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AmgIncMember_ed935f11-fedc-4754-9924-49bd4216d7dc" xlink:href="ameh-20230630.xsd#ameh_AmgIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6506c3cc-4610-4091-9420-bb3c08f6b766" xlink:to="loc_ameh_AmgIncMember_ed935f11-fedc-4754-9924-49bd4216d7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApolloSunLabsManagementLLCMember_17645eae-0438-41a4-83f2-96fc58e8eabe" xlink:href="ameh-20230630.xsd#ameh_ApolloSunLabsManagementLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6506c3cc-4610-4091-9420-bb3c08f6b766" xlink:to="loc_ameh_ApolloSunLabsManagementLLCMember_17645eae-0438-41a4-83f2-96fc58e8eabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6754a74f-823d-462d-b93d-8d596753aacc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_DescriptionOfBusinessTable_18c822ac-a7b7-4a12-beb4-c745e6931a4d" xlink:to="loc_dei_LegalEntityAxis_6754a74f-823d-462d-b93d-8d596753aacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fc5bbf7f-be61-4d2f-a97a-f449231d1a4f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_6754a74f-823d-462d-b93d-8d596753aacc" xlink:to="loc_dei_EntityDomain_fc5bbf7f-be61-4d2f-a97a-f449231d1a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApcLsmaMember_376ebe6f-2b36-4521-b7f4-6276360dfc92" xlink:href="ameh-20230630.xsd#ameh_ApcLsmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_fc5bbf7f-be61-4d2f-a97a-f449231d1a4f" xlink:to="loc_ameh_ApcLsmaMember_376ebe6f-2b36-4521-b7f4-6276360dfc92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlliedPacificOfCaliforniaIPAMember_032e8257-17a4-42cd-9f74-bdb192f9230e" xlink:href="ameh-20230630.xsd#ameh_AlliedPacificOfCaliforniaIPAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_fc5bbf7f-be61-4d2f-a97a-f449231d1a4f" xlink:to="loc_ameh_AlliedPacificOfCaliforniaIPAMember_032e8257-17a4-42cd-9f74-bdb192f9230e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f7337109-a349-45f6-ac3f-2f2696a824e9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_DescriptionOfBusinessTable_18c822ac-a7b7-4a12-beb4-c745e6931a4d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f7337109-a349-45f6-ac3f-2f2696a824e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_f9dfaa44-c679-4f16-a503-9adb7990bf14" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f7337109-a349-45f6-ac3f-2f2696a824e9" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_f9dfaa44-c679-4f16-a503-9adb7990bf14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DmgMember_cec6a592-1937-41f7-90bd-13b6f7e1fe5a" xlink:href="ameh-20230630.xsd#ameh_DmgMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_f9dfaa44-c679-4f16-a503-9adb7990bf14" xlink:to="loc_ameh_DmgMember_cec6a592-1937-41f7-90bd-13b6f7e1fe5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DMGAndSunLabsMember_f3a636d5-97aa-4c26-8375-5b8419da4e47" xlink:href="ameh-20230630.xsd#ameh_DMGAndSunLabsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_f9dfaa44-c679-4f16-a503-9adb7990bf14" xlink:to="loc_ameh_DMGAndSunLabsMember_f3a636d5-97aa-4c26-8375-5b8419da4e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_9db588c5-e697-4ce3-90c4-810ca5c81862" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_DescriptionOfBusinessTable_18c822ac-a7b7-4a12-beb4-c745e6931a4d" xlink:to="loc_us-gaap_AssetAcquisitionAxis_9db588c5-e697-4ce3-90c4-810ca5c81862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_cd515588-e0ba-42bc-ab7b-545e101cb09f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_9db588c5-e697-4ce3-90c4-810ca5c81862" xlink:to="loc_us-gaap_AssetAcquisitionDomain_cd515588-e0ba-42bc-ab7b-545e101cb09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember_3a34c826-92b8-49d5-8503-6ebb215ba298" xlink:href="ameh-20230630.xsd#ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_cd515588-e0ba-42bc-ab7b-545e101cb09f" xlink:to="loc_ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember_3a34c826-92b8-49d5-8503-6ebb215ba298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OneMSOLLCMember_d8ce134b-e934-40eb-8555-7396b4ef61d5" xlink:href="ameh-20230630.xsd#ameh_OneMSOLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_cd515588-e0ba-42bc-ab7b-545e101cb09f" xlink:to="loc_ameh_OneMSOLLCMember_d8ce134b-e934-40eb-8555-7396b4ef61d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:href="ameh-20230630.xsd#ameh_DescriptionOfBusinessLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_DescriptionOfBusinessTable_18c822ac-a7b7-4a12-beb4-c745e6931a4d" xlink:to="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_feaafa70-d110-43c6-a9d4-03a71460e3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:to="loc_us-gaap_NumberOfReportableSegments_feaafa70-d110-43c6-a9d4-03a71460e3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_03c0c0b8-89b8-4f4a-b4f9-79fe2cdcb697" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_03c0c0b8-89b8-4f4a-b4f9-79fe2cdcb697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_fde09f3d-eb8e-4931-aa0a-3ab5d58245ee" xlink:href="ameh-20230630.xsd#ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:to="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_fde09f3d-eb8e-4931-aa0a-3ab5d58245ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_d9dc6018-4acd-436c-9c62-341f1765d1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:to="loc_us-gaap_EquityMethodInvestments_d9dc6018-4acd-436c-9c62-341f1765d1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_50047e52-69f5-46b8-a5f2-9e3c6468ad24" xlink:href="ameh-20230630.xsd#ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:to="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_50047e52-69f5-46b8-a5f2-9e3c6468ad24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation_56a92a0e-f2bc-434f-b121-bcf5a564bec0" xlink:href="ameh-20230630.xsd#ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:to="loc_ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation_56a92a0e-f2bc-434f-b121-bcf5a564bec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AssetAcquisitionPercentageOfSharesAcquired_5d319792-e90a-4efa-81ae-f90f95d4ab1c" xlink:href="ameh-20230630.xsd#ameh_AssetAcquisitionPercentageOfSharesAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_DescriptionOfBusinessLineItems_93c94d93-b167-4d04-ab17-8cc4542b99bd" xlink:to="loc_ameh_AssetAcquisitionPercentageOfSharesAcquired_5d319792-e90a-4efa-81ae-f90f95d4ab1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5f9c0fef-e26f-4793-9d66-40995e1c63ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SummaryOfSignificantAccountingPoliciesTable_d87642c7-444b-4a23-ab11-cf3b928838a0" xlink:href="ameh-20230630.xsd#ameh_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5f9c0fef-e26f-4793-9d66-40995e1c63ce" xlink:to="loc_ameh_SummaryOfSignificantAccountingPoliciesTable_d87642c7-444b-4a23-ab11-cf3b928838a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cfb89fe8-0a15-4b24-b158-8301d023d62f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesTable_d87642c7-444b-4a23-ab11-cf3b928838a0" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cfb89fe8-0a15-4b24-b158-8301d023d62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_58c083b7-1178-4c04-9dd0-63eaddc0178b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cfb89fe8-0a15-4b24-b158-8301d023d62f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_58c083b7-1178-4c04-9dd0-63eaddc0178b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_f1e6760d-21a5-45e5-84e5-db42d042c679" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_58c083b7-1178-4c04-9dd0-63eaddc0178b" xlink:to="loc_us-gaap_CertificatesOfDepositMember_f1e6760d-21a5-45e5-84e5-db42d042c679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ebcdedd0-57b7-438c-b4be-27e9e5f5cd65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesTable_d87642c7-444b-4a23-ab11-cf3b928838a0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ebcdedd0-57b7-438c-b4be-27e9e5f5cd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1177c0fa-060d-4e29-a993-b135ddb25f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ebcdedd0-57b7-438c-b4be-27e9e5f5cd65" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1177c0fa-060d-4e29-a993-b135ddb25f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_81ee046e-f4b9-4e5f-be67-e88010933806" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1177c0fa-060d-4e29-a993-b135ddb25f3f" xlink:to="loc_us-gaap_CashFlowHedgingMember_81ee046e-f4b9-4e5f-be67-e88010933806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c66f84ac-3165-4cca-949d-c7c77fce2a48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesTable_d87642c7-444b-4a23-ab11-cf3b928838a0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c66f84ac-3165-4cca-949d-c7c77fce2a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_45cd1942-74d9-4d61-a985-58e203d44792" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c66f84ac-3165-4cca-949d-c7c77fce2a48" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_45cd1942-74d9-4d61-a985-58e203d44792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ff1efca3-a387-42df-8183-239fc3e32c21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45cd1942-74d9-4d61-a985-58e203d44792" xlink:to="loc_us-gaap_InterestRateSwapMember_ff1efca3-a387-42df-8183-239fc3e32c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CollarMember_53f78043-26b3-453f-8f1d-d8afc3d24045" xlink:href="ameh-20230630.xsd#ameh_CollarMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45cd1942-74d9-4d61-a985-58e203d44792" xlink:to="loc_ameh_CollarMember_53f78043-26b3-453f-8f1d-d8afc3d24045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ContingentEquitySecuritiesMember_e900f4f3-0ab2-4559-be0d-2e97316cb441" xlink:href="ameh-20230630.xsd#ameh_ContingentEquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45cd1942-74d9-4d61-a985-58e203d44792" xlink:to="loc_ameh_ContingentEquitySecuritiesMember_e900f4f3-0ab2-4559-be0d-2e97316cb441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fcfce369-b999-47fe-9706-85beb746add4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesTable_d87642c7-444b-4a23-ab11-cf3b928838a0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fcfce369-b999-47fe-9706-85beb746add4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d65d5e4c-e8b0-40fc-a688-0bdb456c0edc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fcfce369-b999-47fe-9706-85beb746add4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d65d5e4c-e8b0-40fc-a688-0bdb456c0edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_f13ef2ee-73dd-4e06-87ad-076e4df0cf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d65d5e4c-e8b0-40fc-a688-0bdb456c0edc" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_f13ef2ee-73dd-4e06-87ad-076e4df0cf5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_9f0f272a-dc63-49c1-b552-0f288fafec1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesTable_d87642c7-444b-4a23-ab11-cf3b928838a0" xlink:to="loc_us-gaap_HedgingDesignationAxis_9f0f272a-dc63-49c1-b552-0f288fafec1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1594adad-1782-4c66-b042-262666b9b733" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_9f0f272a-dc63-49c1-b552-0f288fafec1d" xlink:to="loc_us-gaap_HedgingDesignationDomain_1594adad-1782-4c66-b042-262666b9b733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_66b0471d-8dce-4039-bb98-e64f6b734e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_1594adad-1782-4c66-b042-262666b9b733" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_66b0471d-8dce-4039-bb98-e64f6b734e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:href="ameh-20230630.xsd#ameh_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesTable_d87642c7-444b-4a23-ab11-cf3b928838a0" xlink:to="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_92d1d234-1ae8-4b3b-97a1-e169b8980a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_us-gaap_NumberOfReportableSegments_92d1d234-1ae8-4b3b-97a1-e169b8980a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount_0fd3a47c-d8a6-4b94-aa5d-cfc9979c297e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashUninsuredAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_us-gaap_CashUninsuredAmount_0fd3a47c-d8a6-4b94-aa5d-cfc9979c297e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MarketableSecuritiesCurrentMaturityPeriod_6d672797-ad7e-403c-99a9-f47728612da7" xlink:href="ameh-20230630.xsd#ameh_MarketableSecuritiesCurrentMaturityPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_ameh_MarketableSecuritiesCurrentMaturityPeriod_6d672797-ad7e-403c-99a9-f47728612da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b3679a1e-6421-4a9b-a1b9-22f029182abf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b3679a1e-6421-4a9b-a1b9-22f029182abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_9666f53d-b4ee-48a1-a847-b0eddd0cacf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_9666f53d-b4ee-48a1-a847-b0eddd0cacf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod_2a13ebcc-4c45-42b0-9873-0f4741a84457" xlink:href="ameh-20230630.xsd#ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod_2a13ebcc-4c45-42b0-9873-0f4741a84457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_56b3ee74-9510-46f1-b752-75752665b98e" xlink:href="ameh-20230630.xsd#ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_56b3ee74-9510-46f1-b752-75752665b98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0757f6c6-3af9-40e1-8a98-0a48ce4b0e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0757f6c6-3af9-40e1-8a98-0a48ce4b0e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DerivativeCeilingInterestRate_733aed8c-3ebe-4198-8b43-237754c0a8c9" xlink:href="ameh-20230630.xsd#ameh_DerivativeCeilingInterestRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_ameh_DerivativeCeilingInterestRate_733aed8c-3ebe-4198-8b43-237754c0a8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFloorInterestRate_05b22b60-b1af-45d3-9acd-26b5658650f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFloorInterestRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_us-gaap_DerivativeFloorInterestRate_05b22b60-b1af-45d3-9acd-26b5658650f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_f8264d8b-07b4-4bc9-84a9-07cbe9d42cda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_SummaryOfSignificantAccountingPoliciesLineItems_946d0e3b-d07b-4f26-899a-801ea26b89cc" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_f8264d8b-07b4-4bc9-84a9-07cbe9d42cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_546277d0-a8de-4abf-b692-8b6dd7960d04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_add87e27-f495-4d71-bc8f-aa80f934b609" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_546277d0-a8de-4abf-b692-8b6dd7960d04" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_add87e27-f495-4d71-bc8f-aa80f934b609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_9781b36c-302c-467f-a8a3-89e5b2ec64c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_546277d0-a8de-4abf-b692-8b6dd7960d04" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_9781b36c-302c-467f-a8a3-89e5b2ec64c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_e9b75b03-97ab-4446-86c8-4a59ae7faf02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_546277d0-a8de-4abf-b692-8b6dd7960d04" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_e9b75b03-97ab-4446-86c8-4a59ae7faf02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c944fb29-5901-497b-813f-af84cf532b93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b7c7fa9e-3285-487b-baf8-bfdc5d0dab42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c944fb29-5901-497b-813f-af84cf532b93" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b7c7fa9e-3285-487b-baf8-bfdc5d0dab42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_e93979e1-ae91-442a-b974-6365e39ab633" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b7c7fa9e-3285-487b-baf8-bfdc5d0dab42" xlink:to="loc_srt_MajorCustomersAxis_e93979e1-ae91-442a-b974-6365e39ab633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_07fa8103-91dc-4d46-9b0d-94e7e9d8471d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_e93979e1-ae91-442a-b974-6365e39ab633" xlink:to="loc_srt_NameOfMajorCustomerDomain_07fa8103-91dc-4d46-9b0d-94e7e9d8471d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CommercialMember_eb5b692c-5777-44bc-bc32-bc914a15aad6" xlink:href="ameh-20230630.xsd#ameh_CommercialMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_07fa8103-91dc-4d46-9b0d-94e7e9d8471d" xlink:to="loc_ameh_CommercialMember_eb5b692c-5777-44bc-bc32-bc914a15aad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MedicareMember_8c8a618e-f3c1-467b-8fea-40630c58a29d" xlink:href="ameh-20230630.xsd#ameh_MedicareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_07fa8103-91dc-4d46-9b0d-94e7e9d8471d" xlink:to="loc_ameh_MedicareMember_8c8a618e-f3c1-467b-8fea-40630c58a29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MedicaidMember_5ade0e8f-e5d5-41a4-b049-ec3b1c84143e" xlink:href="ameh-20230630.xsd#ameh_MedicaidMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_07fa8103-91dc-4d46-9b0d-94e7e9d8471d" xlink:to="loc_ameh_MedicaidMember_5ade0e8f-e5d5-41a4-b049-ec3b1c84143e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OtherThirdPartiesMember_b6b182a6-5eb1-4f7e-8a54-3126c65b0042" xlink:href="ameh-20230630.xsd#ameh_OtherThirdPartiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_07fa8103-91dc-4d46-9b0d-94e7e9d8471d" xlink:to="loc_ameh_OtherThirdPartiesMember_b6b182a6-5eb1-4f7e-8a54-3126c65b0042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_4d62741b-8456-4bc9-aa27-3741a40dcd19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b7c7fa9e-3285-487b-baf8-bfdc5d0dab42" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_4d62741b-8456-4bc9-aa27-3741a40dcd19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ab81ca3-360f-41e2-9b58-5db27b1cce56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_4d62741b-8456-4bc9-aa27-3741a40dcd19" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ab81ca3-360f-41e2-9b58-5db27b1cce56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1665fefe-2e6f-4e3a-ba4c-5bde02d66595" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AccountsReceivableAndNetRevenueTable_a3df9d98-de2b-49ab-84cc-6e20774a1212" xlink:href="ameh-20230630.xsd#ameh_AccountsReceivableAndNetRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1665fefe-2e6f-4e3a-ba4c-5bde02d66595" xlink:to="loc_ameh_AccountsReceivableAndNetRevenueTable_a3df9d98-de2b-49ab-84cc-6e20774a1212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8c388c45-7a43-4a23-b680-f583c61cd64c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_AccountsReceivableAndNetRevenueTable_a3df9d98-de2b-49ab-84cc-6e20774a1212" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8c388c45-7a43-4a23-b680-f583c61cd64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_131c7cf2-344b-4791-b2a7-c17aadfa9735" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8c388c45-7a43-4a23-b680-f583c61cd64c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_131c7cf2-344b-4791-b2a7-c17aadfa9735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_aa3a5263-0275-4d3d-b794-354f59e39928" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_131c7cf2-344b-4791-b2a7-c17aadfa9735" xlink:to="loc_us-gaap_SalesRevenueNetMember_aa3a5263-0275-4d3d-b794-354f59e39928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_7867b2da-4674-4182-988c-4723a67556d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_131c7cf2-344b-4791-b2a7-c17aadfa9735" xlink:to="loc_us-gaap_AccountsReceivableMember_7867b2da-4674-4182-988c-4723a67556d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_dafe8141-596e-480c-acbd-7f59660939ca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_AccountsReceivableAndNetRevenueTable_a3df9d98-de2b-49ab-84cc-6e20774a1212" xlink:to="loc_srt_MajorCustomersAxis_dafe8141-596e-480c-acbd-7f59660939ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8c9568fe-bc74-4d10-8575-1a4b33dd86e7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_dafe8141-596e-480c-acbd-7f59660939ca" xlink:to="loc_srt_NameOfMajorCustomerDomain_8c9568fe-bc74-4d10-8575-1a4b33dd86e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PayorAMember_9ff514f7-bc98-4204-9cc0-8f0056a9e7e5" xlink:href="ameh-20230630.xsd#ameh_PayorAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_8c9568fe-bc74-4d10-8575-1a4b33dd86e7" xlink:to="loc_ameh_PayorAMember_9ff514f7-bc98-4204-9cc0-8f0056a9e7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PayorBMember_e12ac7ba-1236-4447-aeaa-70f81d8cf349" xlink:href="ameh-20230630.xsd#ameh_PayorBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_8c9568fe-bc74-4d10-8575-1a4b33dd86e7" xlink:to="loc_ameh_PayorBMember_e12ac7ba-1236-4447-aeaa-70f81d8cf349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PayorCMember_d6659a23-5ca7-4ee0-8544-9ec62549953d" xlink:href="ameh-20230630.xsd#ameh_PayorCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_8c9568fe-bc74-4d10-8575-1a4b33dd86e7" xlink:to="loc_ameh_PayorCMember_d6659a23-5ca7-4ee0-8544-9ec62549953d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_7db5777a-c0ea-4655-b9b6-a6b5cd0e3a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_AccountsReceivableAndNetRevenueTable_a3df9d98-de2b-49ab-84cc-6e20774a1212" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_7db5777a-c0ea-4655-b9b6-a6b5cd0e3a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_41ecced8-df14-41fc-97f3-ad5c7e32ddf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7db5777a-c0ea-4655-b9b6-a6b5cd0e3a8d" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_41ecced8-df14-41fc-97f3-ad5c7e32ddf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_57998e73-c654-4c02-b882-084da039cc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_41ecced8-df14-41fc-97f3-ad5c7e32ddf4" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_57998e73-c654-4c02-b882-084da039cc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AccountsReceivableAndNetRevenueLineItems_2af70cb8-2a1d-4ba6-b428-9ab03b7d27af" xlink:href="ameh-20230630.xsd#ameh_AccountsReceivableAndNetRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_AccountsReceivableAndNetRevenueTable_a3df9d98-de2b-49ab-84cc-6e20774a1212" xlink:to="loc_ameh_AccountsReceivableAndNetRevenueLineItems_2af70cb8-2a1d-4ba6-b428-9ab03b7d27af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_f7772b62-83e2-4813-8fbf-ca5a659045d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_AccountsReceivableAndNetRevenueLineItems_2af70cb8-2a1d-4ba6-b428-9ab03b7d27af" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_f7772b62-83e2-4813-8fbf-ca5a659045d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f7b3df71-f032-4ea8-8b3b-341fb4706b39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_41d74ab8-b81d-42e1-8090-559ed76cd53f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f7b3df71-f032-4ea8-8b3b-341fb4706b39" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_41d74ab8-b81d-42e1-8090-559ed76cd53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8fcb0549-efbe-4a7d-8d61-8fced3d7564d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_41d74ab8-b81d-42e1-8090-559ed76cd53f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8fcb0549-efbe-4a7d-8d61-8fced3d7564d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f8b88e0f-b8fc-4cfe-aa08-e3d9ed42b1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8fcb0549-efbe-4a7d-8d61-8fced3d7564d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f8b88e0f-b8fc-4cfe-aa08-e3d9ed42b1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_72a5ec6d-07c0-4f95-80ab-b46f210243a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f8b88e0f-b8fc-4cfe-aa08-e3d9ed42b1d2" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_72a5ec6d-07c0-4f95-80ab-b46f210243a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4ef9e87f-6a3d-4ba6-bbb8-8ca476086d76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f8b88e0f-b8fc-4cfe-aa08-e3d9ed42b1d2" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4ef9e87f-6a3d-4ba6-bbb8-8ca476086d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_452659f8-7c5c-46fd-aabf-3dc9366aa191" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f8b88e0f-b8fc-4cfe-aa08-e3d9ed42b1d2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_452659f8-7c5c-46fd-aabf-3dc9366aa191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_fbb78d5f-2bf1-4d09-829c-3ffcc7c0c0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_41d74ab8-b81d-42e1-8090-559ed76cd53f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_fbb78d5f-2bf1-4d09-829c-3ffcc7c0c0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_add589f4-fffc-4d8d-84e8-b6340a0dc8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fbb78d5f-2bf1-4d09-829c-3ffcc7c0c0fa" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_add589f4-fffc-4d8d-84e8-b6340a0dc8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_bd733dbb-39b9-451f-8617-7725c151918a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_add589f4-fffc-4d8d-84e8-b6340a0dc8ef" xlink:to="loc_us-gaap_InterestRateSwapMember_bd733dbb-39b9-451f-8617-7725c151918a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CollarMember_4e78c5c8-9604-48d1-b304-55f2ff87bfc9" xlink:href="ameh-20230630.xsd#ameh_CollarMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_add589f4-fffc-4d8d-84e8-b6340a0dc8ef" xlink:to="loc_ameh_CollarMember_4e78c5c8-9604-48d1-b304-55f2ff87bfc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ContingentEquitySecuritiesMember_0f5b6f8f-7e54-4592-846a-1535616c35a5" xlink:href="ameh-20230630.xsd#ameh_ContingentEquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_add589f4-fffc-4d8d-84e8-b6340a0dc8ef" xlink:to="loc_ameh_ContingentEquitySecuritiesMember_0f5b6f8f-7e54-4592-846a-1535616c35a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b5afa867-4981-4280-a247-72540802c290" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_41d74ab8-b81d-42e1-8090-559ed76cd53f" xlink:to="loc_dei_LegalEntityAxis_b5afa867-4981-4280-a247-72540802c290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_49d578e9-ed9f-43e5-ad81-6babe4e5ebe3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_b5afa867-4981-4280-a247-72540802c290" xlink:to="loc_dei_EntityDomain_49d578e9-ed9f-43e5-ad81-6babe4e5ebe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_APCMGMember_3607c36e-18cf-4fae-bda6-d1b61ef4d906" xlink:href="ameh-20230630.xsd#ameh_APCMGMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_49d578e9-ed9f-43e5-ad81-6babe4e5ebe3" xlink:to="loc_ameh_APCMGMember_3607c36e-18cf-4fae-bda6-d1b61ef4d906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AAMGMember_c01fc105-be49-44af-9f3c-1cb28a02bf36" xlink:href="ameh-20230630.xsd#ameh_AAMGMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_49d578e9-ed9f-43e5-ad81-6babe4e5ebe3" xlink:to="loc_ameh_AAMGMember_c01fc105-be49-44af-9f3c-1cb28a02bf36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_VOMGMember_79c39d94-241d-49d1-a2c0-3bb15dff8b8f" xlink:href="ameh-20230630.xsd#ameh_VOMGMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_49d578e9-ed9f-43e5-ad81-6babe4e5ebe3" xlink:to="loc_ameh_VOMGMember_79c39d94-241d-49d1-a2c0-3bb15dff8b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DmgMember_b664fdf9-1da3-4bf1-ac3b-d828fd4220d0" xlink:href="ameh-20230630.xsd#ameh_DmgMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_49d578e9-ed9f-43e5-ad81-6babe4e5ebe3" xlink:to="loc_ameh_DmgMember_b664fdf9-1da3-4bf1-ac3b-d828fd4220d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApolloSunLabsManagementLLCMember_54ad2e2e-3a95-4784-845c-b83dcc2d3afc" xlink:href="ameh-20230630.xsd#ameh_ApolloSunLabsManagementLLCMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_49d578e9-ed9f-43e5-ad81-6babe4e5ebe3" xlink:to="loc_ameh_ApolloSunLabsManagementLLCMember_54ad2e2e-3a95-4784-845c-b83dcc2d3afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_41d74ab8-b81d-42e1-8090-559ed76cd53f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6da18970-5129-4645-bc68-bd0c2aa8190c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6da18970-5129-4645-bc68-bd0c2aa8190c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2fcfafed-f7cf-4866-acb2-792fb1f38e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2fcfafed-f7cf-4866-acb2-792fb1f38e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_10ef9215-ecd2-440a-ba6a-27e5b458d258" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_10ef9215-ecd2-440a-ba6a-27e5b458d258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_9e283940-57d0-48fe-8989-730e9c8bcbef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_us-gaap_DerivativeAssets_9e283940-57d0-48fe-8989-730e9c8bcbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ef208598-619d-40d9-b2a4-79a3fc568c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ef208598-619d-40d9-b2a4-79a3fc568c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3c957f3a-4286-4561-b4d7-89f5b4e69405" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3c957f3a-4286-4561-b4d7-89f5b4e69405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_f2cca449-e5c1-425c-9379-dac612405e9d" xlink:href="ameh-20230630.xsd#ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_f2cca449-e5c1-425c-9379-dac612405e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_85563185-e211-4cec-9cc2-a56546afcd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7251405-25d1-4b9b-8c04-4d449d8436b8" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_85563185-e211-4cec-9cc2-a56546afcd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0bbcb1d1-0a6d-446f-8582-2fbf18d80cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_616add3d-db9e-498a-976d-90df1e457047" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0bbcb1d1-0a6d-446f-8582-2fbf18d80cf9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_616add3d-db9e-498a-976d-90df1e457047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ff45f561-e4ed-46d5-abcb-44fcb8796dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_616add3d-db9e-498a-976d-90df1e457047" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ff45f561-e4ed-46d5-abcb-44fcb8796dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f71b4c1d-b91f-4372-b06f-fa0312aca5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_616add3d-db9e-498a-976d-90df1e457047" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f71b4c1d-b91f-4372-b06f-fa0312aca5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d8b10944-ed17-4211-ad45-05bbf4fdae90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_616add3d-db9e-498a-976d-90df1e457047" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d8b10944-ed17-4211-ad45-05bbf4fdae90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_00ad7328-a942-4150-b8d7-93666444ce1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_39e24cbf-3c74-4bfb-982c-39d9fd7f1353" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_00ad7328-a942-4150-b8d7-93666444ce1b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_39e24cbf-3c74-4bfb-982c-39d9fd7f1353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0b516e36-50e3-498a-ab50-ac44cfa90539" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_39e24cbf-3c74-4bfb-982c-39d9fd7f1353" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0b516e36-50e3-498a-ab50-ac44cfa90539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00f3dfe0-67a9-4e6d-b927-e7dc86005667" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0b516e36-50e3-498a-ab50-ac44cfa90539" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00f3dfe0-67a9-4e6d-b927-e7dc86005667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ForYourBenefitIncMember_217d3126-7927-48ef-adbf-1649a2bc197c" xlink:href="ameh-20230630.xsd#ameh_ForYourBenefitIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00f3dfe0-67a9-4e6d-b927-e7dc86005667" xlink:to="loc_ameh_ForYourBenefitIncMember_217d3126-7927-48ef-adbf-1649a2bc197c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember_90eb8bb7-4fa0-41c4-849b-c22e125c40c3" xlink:href="ameh-20230630.xsd#ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00f3dfe0-67a9-4e6d-b927-e7dc86005667" xlink:to="loc_ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember_90eb8bb7-4fa0-41c4-849b-c22e125c40c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_JadeHealthCareMedicalGroupIncMember_103523d3-0a2b-43e1-8dce-1c9cccfbe55b" xlink:href="ameh-20230630.xsd#ameh_JadeHealthCareMedicalGroupIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00f3dfe0-67a9-4e6d-b927-e7dc86005667" xlink:to="loc_ameh_JadeHealthCareMedicalGroupIncMember_103523d3-0a2b-43e1-8dce-1c9cccfbe55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AAMGMember_47f34ef2-3072-4330-ad71-d8a27b25fcf1" xlink:href="ameh-20230630.xsd#ameh_AAMGMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00f3dfe0-67a9-4e6d-b927-e7dc86005667" xlink:to="loc_ameh_AAMGMember_47f34ef2-3072-4330-ad71-d8a27b25fcf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1edecdcf-07cd-4e20-a896-7acafd6d80b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_39e24cbf-3c74-4bfb-982c-39d9fd7f1353" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_1edecdcf-07cd-4e20-a896-7acafd6d80b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_4622b96e-a3d0-4522-b0fb-070b6d8e4c18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1edecdcf-07cd-4e20-a896-7acafd6d80b2" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_4622b96e-a3d0-4522-b0fb-070b6d8e4c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NumberOfPrimaryCareClinics_afd4b392-9211-447e-83a2-113d408e95ae" xlink:href="ameh-20230630.xsd#ameh_NumberOfPrimaryCareClinics"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1edecdcf-07cd-4e20-a896-7acafd6d80b2" xlink:to="loc_ameh_NumberOfPrimaryCareClinics_afd4b392-9211-447e-83a2-113d408e95ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e53818d7-fad0-4737-99ad-f6abfcf3275f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1edecdcf-07cd-4e20-a896-7acafd6d80b2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e53818d7-fad0-4737-99ad-f6abfcf3275f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_a16c1a27-e9ab-4eb3-8d19-7c30b3bf1a25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1edecdcf-07cd-4e20-a896-7acafd6d80b2" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_a16c1a27-e9ab-4eb3-8d19-7c30b3bf1a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillScheduleofGoodwillDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#BusinessCombinationsAssetAcquisitionsandGoodwillScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6f4219dd-676c-4982-95a0-1ff55eab4255" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_6a8694da-faae-436b-bdcb-567c69cd2e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6f4219dd-676c-4982-95a0-1ff55eab4255" xlink:to="loc_us-gaap_GoodwillRollForward_6a8694da-faae-436b-bdcb-567c69cd2e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0c2d56a5-22db-468e-96b9-fcdb303a76af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6a8694da-faae-436b-bdcb-567c69cd2e3a" xlink:to="loc_us-gaap_Goodwill_0c2d56a5-22db-468e-96b9-fcdb303a76af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_f14f0d7f-2c6b-4e22-b272-b9e1661200ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6a8694da-faae-436b-bdcb-567c69cd2e3a" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_f14f0d7f-2c6b-4e22-b272-b9e1661200ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_3c18dbe1-e60f-4fea-98bf-19763dfcf102" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6a8694da-faae-436b-bdcb-567c69cd2e3a" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_3c18dbe1-e60f-4fea-98bf-19763dfcf102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_382b0471-e1d0-4ce3-8a8b-42149f1de7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6a8694da-faae-436b-bdcb-567c69cd2e3a" xlink:to="loc_us-gaap_Goodwill_382b0471-e1d0-4ce3-8a8b-42149f1de7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#IntangibleAssetsNetScheduleofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_309330fc-b74e-4650-9261-29dae2cc0f06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d1d088a-c8e8-4ef8-98be-d14a2e46d7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_309330fc-b74e-4650-9261-29dae2cc0f06" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d1d088a-c8e8-4ef8-98be-d14a2e46d7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9811244d-6197-4237-b32f-10bd3ebbf739" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d1d088a-c8e8-4ef8-98be-d14a2e46d7e1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9811244d-6197-4237-b32f-10bd3ebbf739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9811244d-6197-4237-b32f-10bd3ebbf739" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NetworkRelationshipsMember_029fd404-a672-47c9-9844-72112edef26e" xlink:href="ameh-20230630.xsd#ameh_NetworkRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:to="loc_ameh_NetworkRelationshipsMember_029fd404-a672-47c9-9844-72112edef26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ManagementContractsMember_508cae52-902d-4ca1-a84a-67da08699329" xlink:href="ameh-20230630.xsd#ameh_ManagementContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:to="loc_ameh_ManagementContractsMember_508cae52-902d-4ca1-a84a-67da08699329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MemberRelationshipsMember_b8c4b97b-ebf4-43f9-a39a-0f6bf7b15a42" xlink:href="ameh-20230630.xsd#ameh_MemberRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:to="loc_ameh_MemberRelationshipsMember_b8c4b97b-ebf4-43f9-a39a-0f6bf7b15a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PatientManagementPlatformMember_ab3fd042-aa0e-44af-984c-025fc53129e6" xlink:href="ameh-20230630.xsd#ameh_PatientManagementPlatformMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:to="loc_ameh_PatientManagementPlatformMember_ab3fd042-aa0e-44af-984c-025fc53129e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_85022137-5300-46ba-854c-eb049bd2c79e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_85022137-5300-46ba-854c-eb049bd2c79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_3ac9ea3e-7195-408d-9496-0bb32c5d59dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ab2bcbe-14d5-4801-9c77-d6adb76212b7" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_3ac9ea3e-7195-408d-9496-0bb32c5d59dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6f5faa0b-54d8-49aa-bad0-6ae9368cccf2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d1d088a-c8e8-4ef8-98be-d14a2e46d7e1" xlink:to="loc_srt_RangeAxis_6f5faa0b-54d8-49aa-bad0-6ae9368cccf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8f85b486-f3e4-47a3-a4a8-601defb6e5f4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6f5faa0b-54d8-49aa-bad0-6ae9368cccf2" xlink:to="loc_srt_RangeMember_8f85b486-f3e4-47a3-a4a8-601defb6e5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8d3ea9e7-8519-4e79-9cb4-676a8bb8d8d6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8f85b486-f3e4-47a3-a4a8-601defb6e5f4" xlink:to="loc_srt_MinimumMember_8d3ea9e7-8519-4e79-9cb4-676a8bb8d8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e2f47c99-5610-4d82-b2c9-02dbc5ab456d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8f85b486-f3e4-47a3-a4a8-601defb6e5f4" xlink:to="loc_srt_MaximumMember_e2f47c99-5610-4d82-b2c9-02dbc5ab456d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7516a7b9-442e-42aa-b343-19db7045c511" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d1d088a-c8e8-4ef8-98be-d14a2e46d7e1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7516a7b9-442e-42aa-b343-19db7045c511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_39bf9b35-bcd9-44f6-af98-86533018be58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7516a7b9-442e-42aa-b343-19db7045c511" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_39bf9b35-bcd9-44f6-af98-86533018be58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5c48bd16-c6f0-48f3-a64a-f8561455bd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7516a7b9-442e-42aa-b343-19db7045c511" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5c48bd16-c6f0-48f3-a64a-f8561455bd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8aa20105-9fbf-46b1-811c-c72db312e81f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7516a7b9-442e-42aa-b343-19db7045c511" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8aa20105-9fbf-46b1-811c-c72db312e81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_030c690b-8aab-41e8-b1d5-0b8f6a814684" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7516a7b9-442e-42aa-b343-19db7045c511" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_030c690b-8aab-41e8-b1d5-0b8f6a814684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e898b7e8-e82e-4a87-9c9d-6e5313eebcd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_309330fc-b74e-4650-9261-29dae2cc0f06" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e898b7e8-e82e-4a87-9c9d-6e5313eebcd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2f09777a-7b45-46c6-8cda-5ea6e21c38c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e898b7e8-e82e-4a87-9c9d-6e5313eebcd7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2f09777a-7b45-46c6-8cda-5ea6e21c38c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a711ffb0-0999-4017-ad58-ab09c490960b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2f09777a-7b45-46c6-8cda-5ea6e21c38c3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a711ffb0-0999-4017-ad58-ab09c490960b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_e33f9fd7-376b-42db-9d9b-e0ec18b26cca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a711ffb0-0999-4017-ad58-ab09c490960b" xlink:to="loc_us-gaap_TrademarksMember_e33f9fd7-376b-42db-9d9b-e0ec18b26cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_5c25f9fc-6a1b-49f6-8a4d-46be0cd23ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e898b7e8-e82e-4a87-9c9d-6e5313eebcd7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_5c25f9fc-6a1b-49f6-8a4d-46be0cd23ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_50db263d-acba-40a8-b037-26970b909ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_5c25f9fc-6a1b-49f6-8a4d-46be0cd23ac9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_50db263d-acba-40a8-b037-26970b909ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_cd8c2ce4-5eca-45cc-a42b-6ccf54f4c4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_309330fc-b74e-4650-9261-29dae2cc0f06" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_cd8c2ce4-5eca-45cc-a42b-6ccf54f4c4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_758a5984-5319-4c75-82dc-cc6d4e71ab2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_309330fc-b74e-4650-9261-29dae2cc0f06" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_758a5984-5319-4c75-82dc-cc6d4e71ab2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="ameh-20230630.xsd#IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#IntangibleAssetsNetAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d50dcbe7-494d-4ec8-b33c-2676d8fcfdc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6bfbbb21-f6b8-452d-9d39-cd3bddb7c4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d50dcbe7-494d-4ec8-b33c-2676d8fcfdc4" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6bfbbb21-f6b8-452d-9d39-cd3bddb7c4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_5917f04b-6bfc-4674-924d-198ea17c1d85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d50dcbe7-494d-4ec8-b33c-2676d8fcfdc4" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_5917f04b-6bfc-4674-924d-198ea17c1d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_06bf9413-9f5d-4819-a05e-635f39f13026" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_fbb6e833-1f91-48fd-8557-82e51c0bfb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_06bf9413-9f5d-4819-a05e-635f39f13026" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_fbb6e833-1f91-48fd-8557-82e51c0bfb8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_3a172f80-0f7e-4e00-8f7d-08d8d7f32e43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_06bf9413-9f5d-4819-a05e-635f39f13026" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_3a172f80-0f7e-4e00-8f7d-08d8d7f32e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c2d9b47e-afb5-47fd-95e5-33d7dda7afa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_06bf9413-9f5d-4819-a05e-635f39f13026" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c2d9b47e-afb5-47fd-95e5-33d7dda7afa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_62690e91-cc4a-4b95-b837-a970b9ed837c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_06bf9413-9f5d-4819-a05e-635f39f13026" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_62690e91-cc4a-4b95-b837-a970b9ed837c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d2be331e-8016-49ec-820d-58c8e8e12338" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_06bf9413-9f5d-4819-a05e-635f39f13026" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d2be331e-8016-49ec-820d-58c8e8e12338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_14e13356-8516-477b-875b-d3036c0b3f2a" xlink:href="ameh-20230630.xsd#ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_06bf9413-9f5d-4819-a05e-635f39f13026" xlink:to="loc_ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_14e13356-8516-477b-875b-d3036c0b3f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_dd4c5d51-ded9-4de8-9118-ad52964cc0de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_06bf9413-9f5d-4819-a05e-635f39f13026" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_dd4c5d51-ded9-4de8-9118-ad52964cc0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_55c5ba6f-c2bb-4887-9406-4d769bac37fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_915a411f-07ae-4b2d-a72d-3b8f37654ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_55c5ba6f-c2bb-4887-9406-4d769bac37fc" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_915a411f-07ae-4b2d-a72d-3b8f37654ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ab9890eb-3462-4616-aa42-b56a836e99e2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_915a411f-07ae-4b2d-a72d-3b8f37654ec8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ab9890eb-3462-4616-aa42-b56a836e99e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ab9890eb-3462-4616-aa42-b56a836e99e2" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LasalleMedicalAssociatesIpaMember_0c1175ac-203b-47db-8580-50b47cc492df" xlink:href="ameh-20230630.xsd#ameh_LasalleMedicalAssociatesIpaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:to="loc_ameh_LasalleMedicalAssociatesIpaMember_0c1175ac-203b-47db-8580-50b47cc492df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PacificMedicalImagingAndOncologyCenterIncMember_4b3afe70-d9ce-409b-9ad3-0ec017800053" xlink:href="ameh-20230630.xsd#ameh_PacificMedicalImagingAndOncologyCenterIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:to="loc_ameh_PacificMedicalImagingAndOncologyCenterIncMember_4b3afe70-d9ce-409b-9ad3-0ec017800053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FiveThreeOneW.CollegeLLCMember_49d75148-563a-4866-a32f-52e39852c721" xlink:href="ameh-20230630.xsd#ameh_FiveThreeOneW.CollegeLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:to="loc_ameh_FiveThreeOneW.CollegeLLCMember_49d75148-563a-4866-a32f-52e39852c721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OneMSOLLCMember_4730fc4e-28a1-4e55-bd87-ea6df855c962" xlink:href="ameh-20230630.xsd#ameh_OneMSOLLCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:to="loc_ameh_OneMSOLLCMember_4730fc4e-28a1-4e55-bd87-ea6df855c962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CAIPAMSOLLCMember_35b162f1-cf22-46cf-b4db-561d05763047" xlink:href="ameh-20230630.xsd#ameh_CAIPAMSOLLCMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:to="loc_ameh_CAIPAMSOLLCMember_35b162f1-cf22-46cf-b4db-561d05763047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_JamesSongMDAProfessionalCorporationMember_2a516afa-f6ac-43ab-8fbe-9c71f3c9a487" xlink:href="ameh-20230630.xsd#ameh_JamesSongMDAProfessionalCorporationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:to="loc_ameh_JamesSongMDAProfessionalCorporationMember_2a516afa-f6ac-43ab-8fbe-9c71f3c9a487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_Tag6MedicalInvestmentGroupLLCMember_4ad6faa5-b504-48b7-84b7-84683df26899" xlink:href="ameh-20230630.xsd#ameh_Tag6MedicalInvestmentGroupLLCMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bcde9528-1cde-4c64-86fa-fe9cde11d15d" xlink:to="loc_ameh_Tag6MedicalInvestmentGroupLLCMember_4ad6faa5-b504-48b7-84b7-84683df26899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_578c68d9-f69c-4ca8-8a10-9621776634a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_915a411f-07ae-4b2d-a72d-3b8f37654ec8" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_578c68d9-f69c-4ca8-8a10-9621776634a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_abfb7e15-70b9-411f-a06b-d38da142b98a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_578c68d9-f69c-4ca8-8a10-9621776634a2" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_abfb7e15-70b9-411f-a06b-d38da142b98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:href="ameh-20230630.xsd#ameh_EquityMethodInvestmentsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_578c68d9-f69c-4ca8-8a10-9621776634a2" xlink:to="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_895f0695-3e75-4c27-a854-01851423c354" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:to="loc_us-gaap_EquityMethodInvestments_895f0695-3e75-4c27-a854-01851423c354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EquityMethodInvestmentAdditionalInvestment_ea9a320e-87db-4db2-857a-48264347a74d" xlink:href="ameh-20230630.xsd#ameh_EquityMethodInvestmentAdditionalInvestment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:to="loc_ameh_EquityMethodInvestmentAdditionalInvestment_ea9a320e-87db-4db2-857a-48264347a74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_92975032-13e2-4c03-839f-8457cef84137" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_92975032-13e2-4c03-839f-8457cef84137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable_4ea3ff64-113c-452d-ae3a-c72d8466c8f7" xlink:href="ameh-20230630.xsd#ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:to="loc_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable_4ea3ff64-113c-452d-ae3a-c72d8466c8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EquityMethodInvestmentsContribution_07f36a69-89ce-43cd-858f-715579999ac8" xlink:href="ameh-20230630.xsd#ameh_EquityMethodInvestmentsContribution"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:to="loc_ameh_EquityMethodInvestmentsContribution_07f36a69-89ce-43cd-858f-715579999ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSoldCarryingAmount_e802b0b6-ec78-4f44-9a27-b27e48e84aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentSoldCarryingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:to="loc_us-gaap_EquityMethodInvestmentSoldCarryingAmount_e802b0b6-ec78-4f44-9a27-b27e48e84aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_52ca2f1c-0850-42ca-9f9b-c77fccd006d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EquityMethodInvestmentsRollForward_4999f3cd-a19e-43be-914d-02d75bdd544f" xlink:to="loc_us-gaap_EquityMethodInvestments_52ca2f1c-0850-42ca-9f9b-c77fccd006d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#InvestmentsinOtherEntitiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_540a98c2-bab3-4f60-9925-b17603c741c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f73559ea-4858-42e9-be7d-7de7620b7fef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_540a98c2-bab3-4f60-9925-b17603c741c5" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f73559ea-4858-42e9-be7d-7de7620b7fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a0c01cf0-06d2-4b46-b3f5-d7b5b66b4ef2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f73559ea-4858-42e9-be7d-7de7620b7fef" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a0c01cf0-06d2-4b46-b3f5-d7b5b66b4ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3782a488-5888-4e96-b99a-63de4464321d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a0c01cf0-06d2-4b46-b3f5-d7b5b66b4ef2" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3782a488-5888-4e96-b99a-63de4464321d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_JamesSongMDAProfessionalCorporationMember_95d92025-300a-4f04-b035-62e376d3ba8a" xlink:href="ameh-20230630.xsd#ameh_JamesSongMDAProfessionalCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3782a488-5888-4e96-b99a-63de4464321d" xlink:to="loc_ameh_JamesSongMDAProfessionalCorporationMember_95d92025-300a-4f04-b035-62e376d3ba8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_77919c4c-0cf5-4b56-8d3e-85d18ab25bfd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f73559ea-4858-42e9-be7d-7de7620b7fef" xlink:to="loc_dei_LegalEntityAxis_77919c4c-0cf5-4b56-8d3e-85d18ab25bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a604fdf0-4e8b-4080-92c1-bb2ffeb7e8cf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_77919c4c-0cf5-4b56-8d3e-85d18ab25bfd" xlink:to="loc_dei_EntityDomain_a604fdf0-4e8b-4080-92c1-bb2ffeb7e8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_APAMH2Member_80f6692f-9ad2-4e47-bab0-91a2e413a2a2" xlink:href="ameh-20230630.xsd#ameh_APAMH2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a604fdf0-4e8b-4080-92c1-bb2ffeb7e8cf" xlink:to="loc_ameh_APAMH2Member_80f6692f-9ad2-4e47-bab0-91a2e413a2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0cd9cbbd-1177-488f-960d-020c28e69c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f73559ea-4858-42e9-be7d-7de7620b7fef" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0cd9cbbd-1177-488f-960d-020c28e69c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_27867ca8-8f54-42aa-95a1-6cf241467f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0cd9cbbd-1177-488f-960d-020c28e69c7d" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_27867ca8-8f54-42aa-95a1-6cf241467f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e90bdaa8-198d-42d2-831a-625c3ed9792e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0cd9cbbd-1177-488f-960d-020c28e69c7d" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e90bdaa8-198d-42d2-831a-625c3ed9792e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_8d899060-be7a-4fef-8b69-742b652cac19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0cd9cbbd-1177-488f-960d-020c28e69c7d" xlink:to="loc_us-gaap_EquityMethodInvestments_8d899060-be7a-4fef-8b69-742b652cac19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_804dd6cd-0b32-4f25-aa2d-cc8fa6a5b5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0cd9cbbd-1177-488f-960d-020c28e69c7d" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_804dd6cd-0b32-4f25-aa2d-cc8fa6a5b5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_6b7a1dbc-5823-41b7-aecb-bc827c077adc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c3ba34fa-a9a0-4d81-a21e-27e5279db587" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_6b7a1dbc-5823-41b7-aecb-bc827c077adc" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c3ba34fa-a9a0-4d81-a21e-27e5279db587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ceef93e1-318e-4a64-b969-1921ff752154" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c3ba34fa-a9a0-4d81-a21e-27e5279db587" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ceef93e1-318e-4a64-b969-1921ff752154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_c0a353b6-903e-4f31-832f-c7f8da3c6826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ceef93e1-318e-4a64-b969-1921ff752154" xlink:to="loc_us-gaap_ReceivableTypeDomain_c0a353b6-903e-4f31-832f-c7f8da3c6826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_4292bd84-721f-42f2-b6bc-7dd8e89a888b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_c0a353b6-903e-4f31-832f-c7f8da3c6826" xlink:to="loc_us-gaap_NotesReceivableMember_4292bd84-721f-42f2-b6bc-7dd8e89a888b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_721eace6-6bc5-4f33-9dd0-da7ef148baf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c3ba34fa-a9a0-4d81-a21e-27e5279db587" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_721eace6-6bc5-4f33-9dd0-da7ef148baf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d8c8424c-ffed-46bc-8f47-c3b39cc55a49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_721eace6-6bc5-4f33-9dd0-da7ef148baf6" xlink:to="loc_us-gaap_RelatedPartyDomain_d8c8424c-ffed-46bc-8f47-c3b39cc55a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_56593247-7253-4170-ab79-2385f60c1e27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_d8c8424c-ffed-46bc-8f47-c3b39cc55a49" xlink:to="loc_us-gaap_RelatedPartyMember_56593247-7253-4170-ab79-2385f60c1e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_4f95c345-d521-45cc-aba2-71b6c58c1aef" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c3ba34fa-a9a0-4d81-a21e-27e5279db587" xlink:to="loc_dei_LegalEntityAxis_4f95c345-d521-45cc-aba2-71b6c58c1aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_57811314-01fc-4f34-88ae-3e0e4ec78069" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_4f95c345-d521-45cc-aba2-71b6c58c1aef" xlink:to="loc_dei_EntityDomain_57811314-01fc-4f34-88ae-3e0e4ec78069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NetworkMedicalManagementMember_33485b5b-3090-4822-8575-f486400fb133" xlink:href="ameh-20230630.xsd#ameh_NetworkMedicalManagementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_57811314-01fc-4f34-88ae-3e0e4ec78069" xlink:to="loc_ameh_NetworkMedicalManagementMember_33485b5b-3090-4822-8575-f486400fb133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LmaMember_3f7e015f-5d8c-4f2a-b0b2-319f9282f25a" xlink:href="ameh-20230630.xsd#ameh_LmaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_57811314-01fc-4f34-88ae-3e0e4ec78069" xlink:to="loc_ameh_LmaMember_3f7e015f-5d8c-4f2a-b0b2-319f9282f25a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5e95923b-084b-4d64-a96b-9a6dc2bf98d9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c3ba34fa-a9a0-4d81-a21e-27e5279db587" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5e95923b-084b-4d64-a96b-9a6dc2bf98d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5b370957-b7fa-4815-a63a-22aea4326e85" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5e95923b-084b-4d64-a96b-9a6dc2bf98d9" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5b370957-b7fa-4815-a63a-22aea4326e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LmaMember_7f0a814a-0c06-4035-a7c6-e7b3b798e1f8" xlink:href="ameh-20230630.xsd#ameh_LmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5b370957-b7fa-4815-a63a-22aea4326e85" xlink:to="loc_ameh_LmaMember_7f0a814a-0c06-4035-a7c6-e7b3b798e1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1cec0daa-7957-4b24-b8d5-2c91aad64b94" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c3ba34fa-a9a0-4d81-a21e-27e5279db587" xlink:to="loc_srt_CounterpartyNameAxis_1cec0daa-7957-4b24-b8d5-2c91aad64b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03db0907-a753-4995-ab1d-9fd2331a788c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_1cec0daa-7957-4b24-b8d5-2c91aad64b94" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03db0907-a753-4995-ab1d-9fd2331a788c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_Pacific6EnterprisesMember_02015444-76ff-4e13-8c1b-911618030bd5" xlink:href="ameh-20230630.xsd#ameh_Pacific6EnterprisesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03db0907-a753-4995-ab1d-9fd2331a788c" xlink:to="loc_ameh_Pacific6EnterprisesMember_02015444-76ff-4e13-8c1b-911618030bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApcLsmaMember_5fce9186-f641-4894-90a4-4b0572a061fc" xlink:href="ameh-20230630.xsd#ameh_ApcLsmaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03db0907-a753-4995-ab1d-9fd2331a788c" xlink:to="loc_ameh_ApcLsmaMember_5fce9186-f641-4894-90a4-4b0572a061fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_50753d31-dff5-4587-8744-708f2cd12232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c3ba34fa-a9a0-4d81-a21e-27e5279db587" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_50753d31-dff5-4587-8744-708f2cd12232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_361c811e-c3c0-4fc4-a079-b0877d71fe7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_50753d31-dff5-4587-8744-708f2cd12232" xlink:to="loc_us-gaap_NotesReceivableNet_361c811e-c3c0-4fc4-a079-b0877d71fe7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e5ef6c78-db02-44c6-a930-cbc64a61f2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_50753d31-dff5-4587-8744-708f2cd12232" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e5ef6c78-db02-44c6-a930-cbc64a61f2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FinanceReceivableInterestRateStatedPercentage_e15a73a5-20be-48ad-a5c4-22d412eb6dd4" xlink:href="ameh-20230630.xsd#ameh_FinanceReceivableInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_50753d31-dff5-4587-8744-708f2cd12232" xlink:to="loc_ameh_FinanceReceivableInterestRateStatedPercentage_e15a73a5-20be-48ad-a5c4-22d412eb6dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0d8bf184-5966-4635-bac0-dbacf87357ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_50753d31-dff5-4587-8744-708f2cd12232" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0d8bf184-5966-4635-bac0-dbacf87357ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#AccountsPayableandAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_79d080ce-c23b-45eb-a9d9-961cbfa91dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_20c65e4c-b553-4faa-8331-059834da0605" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_79d080ce-c23b-45eb-a9d9-961cbfa91dcb" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_20c65e4c-b553-4faa-8331-059834da0605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SpecialtyCapitationPayableCurrent_5120bfb5-8a0a-4642-9ebe-670d4ff6773f" xlink:href="ameh-20230630.xsd#ameh_SpecialtyCapitationPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_79d080ce-c23b-45eb-a9d9-961cbfa91dcb" xlink:to="loc_ameh_SpecialtyCapitationPayableCurrent_5120bfb5-8a0a-4642-9ebe-670d4ff6773f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SubcontractorIPAPayable_3ea2af0f-1c5e-4650-8468-b7e3e5e07d28" xlink:href="ameh-20230630.xsd#ameh_SubcontractorIPAPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_79d080ce-c23b-45eb-a9d9-961cbfa91dcb" xlink:to="loc_ameh_SubcontractorIPAPayable_3ea2af0f-1c5e-4650-8468-b7e3e5e07d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_bf4050bf-c199-4f7b-9588-ad1adaadc550" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_79d080ce-c23b-45eb-a9d9-961cbfa91dcb" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_bf4050bf-c199-4f7b-9588-ad1adaadc550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_acdfed0a-2018-4484-bcaa-15cb4dd81e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_79d080ce-c23b-45eb-a9d9-961cbfa91dcb" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_acdfed0a-2018-4484-bcaa-15cb4dd81e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7b07eea2-405e-4aa7-8eb6-e13988d70528" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_79d080ce-c23b-45eb-a9d9-961cbfa91dcb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7b07eea2-405e-4aa7-8eb6-e13988d70528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0b8c609a-affe-47da-af56-c54b12d0f5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_79d080ce-c23b-45eb-a9d9-961cbfa91dcb" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0b8c609a-affe-47da-af56-c54b12d0f5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_37486cd1-9130-4f8e-a2de-f2573b17113e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_79d080ce-c23b-45eb-a9d9-961cbfa91dcb" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_37486cd1-9130-4f8e-a2de-f2573b17113e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_5ea834be-ac1a-4a82-8ac2-313c43efa6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_79d080ce-c23b-45eb-a9d9-961cbfa91dcb" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_5ea834be-ac1a-4a82-8ac2-313c43efa6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/MedicalLiabilitiesDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#MedicalLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/MedicalLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_b0685aec-90c6-4deb-9bda-99e912ab6545" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_a89f4fa1-0f94-4631-b882-7540c4b948a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_b0685aec-90c6-4deb-9bda-99e912ab6545" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_a89f4fa1-0f94-4631-b882-7540c4b948a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_9915aa4c-9de1-45ca-a72a-979deea8007b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_a89f4fa1-0f94-4631-b882-7540c4b948a4" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_9915aa4c-9de1-45ca-a72a-979deea8007b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_b891bd72-3149-44cd-9d49-b80587376414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_a89f4fa1-0f94-4631-b882-7540c4b948a4" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_b891bd72-3149-44cd-9d49-b80587376414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MedicalCareCostsAbstract_cd79bcc2-0706-43ec-94a7-f5570873ddbc" xlink:href="ameh-20230630.xsd#ameh_MedicalCareCostsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_a89f4fa1-0f94-4631-b882-7540c4b948a4" xlink:to="loc_ameh_MedicalCareCostsAbstract_cd79bcc2-0706-43ec-94a7-f5570873ddbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_4a0d3268-f80d-40b8-ba99-3b74ea44a13f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_MedicalCareCostsAbstract_cd79bcc2-0706-43ec-94a7-f5570873ddbc" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_4a0d3268-f80d-40b8-ba99-3b74ea44a13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_4af68702-c317-4dc2-bd53-c9709a4067c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_MedicalCareCostsAbstract_cd79bcc2-0706-43ec-94a7-f5570873ddbc" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_4af68702-c317-4dc2-bd53-c9709a4067c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_8d431977-2854-444d-aed2-0aeecf9a14ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_MedicalCareCostsAbstract_cd79bcc2-0706-43ec-94a7-f5570873ddbc" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_8d431977-2854-444d-aed2-0aeecf9a14ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PaymentsForMedicalCareCostsAbstract_26f8ac7c-61cc-4c47-8b7b-daca68dde204" xlink:href="ameh-20230630.xsd#ameh_PaymentsForMedicalCareCostsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_a89f4fa1-0f94-4631-b882-7540c4b948a4" xlink:to="loc_ameh_PaymentsForMedicalCareCostsAbstract_26f8ac7c-61cc-4c47-8b7b-daca68dde204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_a32a0198-214b-42b0-ba98-51c6135dbe55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_PaymentsForMedicalCareCostsAbstract_26f8ac7c-61cc-4c47-8b7b-daca68dde204" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_a32a0198-214b-42b0-ba98-51c6135dbe55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_c2a6b97d-74c7-4962-93fd-ea025c8614ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_PaymentsForMedicalCareCostsAbstract_26f8ac7c-61cc-4c47-8b7b-daca68dde204" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_c2a6b97d-74c7-4962-93fd-ea025c8614ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_40e7f456-aa33-4cab-b7b1-459cd29b0923" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_PaymentsForMedicalCareCostsAbstract_26f8ac7c-61cc-4c47-8b7b-daca68dde204" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_40e7f456-aa33-4cab-b7b1-459cd29b0923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease_705f5a4e-d8ef-404b-a49a-606b5a87f6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_a89f4fa1-0f94-4631-b882-7540c4b948a4" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease_705f5a4e-d8ef-404b-a49a-606b5a87f6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_182ef011-1e84-4ed7-b4a5-ffa203b8910d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_a89f4fa1-0f94-4631-b882-7540c4b948a4" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_182ef011-1e84-4ed7-b4a5-ffa203b8910d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_89854e35-48df-497f-939a-76f32af08924" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_cf565cbd-b8fb-4ace-bb93-3e06093cebac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_89854e35-48df-497f-939a-76f32af08924" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_cf565cbd-b8fb-4ace-bb93-3e06093cebac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ae829471-5605-4fee-b99a-05e6b8744086" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cf565cbd-b8fb-4ace-bb93-3e06093cebac" xlink:to="loc_us-gaap_CreditFacilityAxis_ae829471-5605-4fee-b99a-05e6b8744086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e9c4927f-c789-443a-8a6e-c7c0ebd32690" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_ae829471-5605-4fee-b99a-05e6b8744086" xlink:to="loc_us-gaap_CreditFacilityDomain_e9c4927f-c789-443a-8a6e-c7c0ebd32690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_941e41ec-ac7c-43b6-b79c-3bdc1fcc1962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e9c4927f-c789-443a-8a6e-c7c0ebd32690" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_941e41ec-ac7c-43b6-b79c-3bdc1fcc1962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c5d511ae-e0f4-4ca2-a7dd-c670c34b76cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cf565cbd-b8fb-4ace-bb93-3e06093cebac" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c5d511ae-e0f4-4ca2-a7dd-c670c34b76cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_02966352-a251-4f0a-ba8b-8894b6c4320e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c5d511ae-e0f4-4ca2-a7dd-c670c34b76cf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_02966352-a251-4f0a-ba8b-8894b6c4320e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLoanMember_d7dc75d9-2bb7-45b3-bfce-f65d3bd0ac4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_02966352-a251-4f0a-ba8b-8894b6c4320e" xlink:to="loc_us-gaap_RealEstateLoanMember_d7dc75d9-2bb7-45b3-bfce-f65d3bd0ac4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ConstructionLoanMember_7fd912e8-7fd9-4263-b61f-8a22cc09c9da" xlink:href="ameh-20230630.xsd#ameh_ConstructionLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_02966352-a251-4f0a-ba8b-8894b6c4320e" xlink:to="loc_ameh_ConstructionLoanMember_7fd912e8-7fd9-4263-b61f-8a22cc09c9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_37cb1b28-e77a-457a-aac1-aeb51dd3502d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_02966352-a251-4f0a-ba8b-8894b6c4320e" xlink:to="loc_us-gaap_NotesPayableToBanksMember_37cb1b28-e77a-457a-aac1-aeb51dd3502d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_1a4a2a74-f3b7-4572-a297-de7ebb28621e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cf565cbd-b8fb-4ace-bb93-3e06093cebac" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_1a4a2a74-f3b7-4572-a297-de7ebb28621e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a222a15f-c5e0-48c7-a3dc-e57d240311a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1a4a2a74-f3b7-4572-a297-de7ebb28621e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a222a15f-c5e0-48c7-a3dc-e57d240311a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_64d6467e-a52b-467c-b610-1e341225ebf8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1a4a2a74-f3b7-4572-a297-de7ebb28621e" xlink:to="loc_us-gaap_LongTermDebtCurrent_64d6467e-a52b-467c-b610-1e341225ebf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_5147dcf5-236d-4569-a288-f4ba875ea894" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1a4a2a74-f3b7-4572-a297-de7ebb28621e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_5147dcf5-236d-4569-a288-f4ba875ea894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_58a030a1-4caa-4567-a976-67405e8c014b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1a4a2a74-f3b7-4572-a297-de7ebb28621e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_58a030a1-4caa-4567-a976-67405e8c014b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_78d340ed-8d93-4732-8f9b-42c1c7a39c95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_ee769241-17f2-4d6d-83d9-9f7ce696076e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_78d340ed-8d93-4732-8f9b-42c1c7a39c95" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_ee769241-17f2-4d6d-83d9-9f7ce696076e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_bb20cd0c-353d-4e20-9663-1cd666d0181e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_78d340ed-8d93-4732-8f9b-42c1c7a39c95" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_bb20cd0c-353d-4e20-9663-1cd666d0181e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_234f62c3-e0ca-4e43-bcc7-0d851e247d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_78d340ed-8d93-4732-8f9b-42c1c7a39c95" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_234f62c3-e0ca-4e43-bcc7-0d851e247d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_b30e8972-511f-4619-839f-a20acfe4534a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_78d340ed-8d93-4732-8f9b-42c1c7a39c95" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_b30e8972-511f-4619-839f-a20acfe4534a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_afcfa05d-6288-4792-ac34-f08890c7838e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_78d340ed-8d93-4732-8f9b-42c1c7a39c95" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_afcfa05d-6288-4792-ac34-f08890c7838e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LongTermDebtMaturityAfterYearFour_cf9fc3f5-47c2-4832-a22f-48001a23b772" xlink:href="ameh-20230630.xsd#ameh_LongTermDebtMaturityAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_78d340ed-8d93-4732-8f9b-42c1c7a39c95" xlink:to="loc_ameh_LongTermDebtMaturityAfterYearFour_cf9fc3f5-47c2-4832-a22f-48001a23b772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_c55d1485-9c7e-44e0-8a22-29b57b8ea4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_78d340ed-8d93-4732-8f9b-42c1c7a39c95" xlink:to="loc_us-gaap_LineOfCredit_c55d1485-9c7e-44e0-8a22-29b57b8ea4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_804d1998-c3a5-4d25-a969-4563ec266276" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_804d1998-c3a5-4d25-a969-4563ec266276" xlink:to="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2e473fbc-baa4-4726-86cd-b5f5aabc9722" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_us-gaap_CreditFacilityAxis_2e473fbc-baa4-4726-86cd-b5f5aabc9722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f7ab077d-f51d-42c5-8aac-8cdcd5915578" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_2e473fbc-baa4-4726-86cd-b5f5aabc9722" xlink:to="loc_us-gaap_CreditFacilityDomain_f7ab077d-f51d-42c5-8aac-8cdcd5915578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_03908b25-5750-4065-9e50-22d39166ae5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f7ab077d-f51d-42c5-8aac-8cdcd5915578" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_03908b25-5750-4065-9e50-22d39166ae5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_35a44f94-d7fa-40f4-aa61-460fec93e5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f7ab077d-f51d-42c5-8aac-8cdcd5915578" xlink:to="loc_us-gaap_LineOfCreditMember_35a44f94-d7fa-40f4-aa61-460fec93e5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_8b7059e1-8a3e-4569-9fb3-90b18b92567e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f7ab077d-f51d-42c5-8aac-8cdcd5915578" xlink:to="loc_us-gaap_LetterOfCreditMember_8b7059e1-8a3e-4569-9fb3-90b18b92567e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_44453758-803f-4c21-b468-53507f44bf36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BridgeLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f7ab077d-f51d-42c5-8aac-8cdcd5915578" xlink:to="loc_us-gaap_BridgeLoanMember_44453758-803f-4c21-b468-53507f44bf36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_115f06c3-5c41-4eed-b009-190c7db6678d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f7ab077d-f51d-42c5-8aac-8cdcd5915578" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_115f06c3-5c41-4eed-b009-190c7db6678d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_532e1590-6017-41ec-8d8f-206cdfc45dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_us-gaap_DebtInstrumentAxis_532e1590-6017-41ec-8d8f-206cdfc45dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_532e1590-6017-41ec-8d8f-206cdfc45dc7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AmendedCreditAgreementMember_6c8520db-6a77-4f49-8b59-2d4899875969" xlink:href="ameh-20230630.xsd#ameh_AmendedCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:to="loc_ameh_AmendedCreditAgreementMember_6c8520db-6a77-4f49-8b59-2d4899875969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CreditAgreementMember_3ad6a6d3-ae01-4b89-b484-a9288a1f10d6" xlink:href="ameh-20230630.xsd#ameh_CreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:to="loc_ameh_CreditAgreementMember_3ad6a6d3-ae01-4b89-b484-a9288a1f10d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ConstructionLoanMember_3462e4d9-75a0-4bc9-87f4-443472e7de03" xlink:href="ameh-20230630.xsd#ameh_ConstructionLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:to="loc_ameh_ConstructionLoanMember_3462e4d9-75a0-4bc9-87f4-443472e7de03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionLoansMember_31afdd07-b770-42d8-be95-5a2b82f9907c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionLoansMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:to="loc_us-gaap_ConstructionLoansMember_31afdd07-b770-42d8-be95-5a2b82f9907c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SubordinatedLoanAgreementMember_41097c21-9579-4c2f-adb3-a39b82a642e7" xlink:href="ameh-20230630.xsd#ameh_SubordinatedLoanAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:to="loc_ameh_SubordinatedLoanAgreementMember_41097c21-9579-4c2f-adb3-a39b82a642e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApcBusinessLoanAgreementMember_e4d4eca3-ab1c-4ade-afed-2760d03bf1ff" xlink:href="ameh-20230630.xsd#ameh_ApcBusinessLoanAgreementMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b301e013-4ace-4d61-8f76-d44fc5351483" xlink:to="loc_ameh_ApcBusinessLoanAgreementMember_e4d4eca3-ab1c-4ade-afed-2760d03bf1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_52e13bb3-7adf-419e-9379-17bbc3a18403" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_52e13bb3-7adf-419e-9379-17bbc3a18403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9ad06bfc-df07-411a-b4b6-c0a8f6839bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_52e13bb3-7adf-419e-9379-17bbc3a18403" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9ad06bfc-df07-411a-b4b6-c0a8f6839bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubordinatedDebtMember_8a2be505-cc0a-471a-9fd7-9fa8baf48063" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubordinatedDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9ad06bfc-df07-411a-b4b6-c0a8f6839bcb" xlink:to="loc_us-gaap_SubordinatedDebtMember_8a2be505-cc0a-471a-9fd7-9fa8baf48063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_3786a3c5-3bc4-42df-9ef9-f7230df74be9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9ad06bfc-df07-411a-b4b6-c0a8f6839bcb" xlink:to="loc_us-gaap_LineOfCreditMember_3786a3c5-3bc4-42df-9ef9-f7230df74be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_582512f4-b2d1-4d79-91de-7047c551300a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_srt_RangeAxis_582512f4-b2d1-4d79-91de-7047c551300a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_60d79b7e-879d-4ad5-9099-cca280f3aeb3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_582512f4-b2d1-4d79-91de-7047c551300a" xlink:to="loc_srt_RangeMember_60d79b7e-879d-4ad5-9099-cca280f3aeb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4daf8029-7501-426b-a815-387c3150accf" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_60d79b7e-879d-4ad5-9099-cca280f3aeb3" xlink:to="loc_srt_MinimumMember_4daf8029-7501-426b-a815-387c3150accf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4956c07b-4102-4294-b7b4-74b43fde3141" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_60d79b7e-879d-4ad5-9099-cca280f3aeb3" xlink:to="loc_srt_MaximumMember_4956c07b-4102-4294-b7b4-74b43fde3141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_97075898-3834-470d-9e91-d3ef9bf2fd67" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_dei_LegalEntityAxis_97075898-3834-470d-9e91-d3ef9bf2fd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_97075898-3834-470d-9e91-d3ef9bf2fd67" xlink:to="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MedicalPropertyPartnersLLCMember_f07b418b-b601-460c-b0bd-9da6c32dbe69" xlink:href="ameh-20230630.xsd#ameh_MedicalPropertyPartnersLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:to="loc_ameh_MedicalPropertyPartnersLLCMember_f07b418b-b601-460c-b0bd-9da6c32dbe69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AMGPropertiesLLCMember_ff46577f-daae-41b8-8ce8-dd43d8527eb9" xlink:href="ameh-20230630.xsd#ameh_AMGPropertiesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:to="loc_ameh_AMGPropertiesLLCMember_ff46577f-daae-41b8-8ce8-dd43d8527eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ZLLPartnersLLCMember_3b79beb0-c81d-44ec-b253-6755c1589bcb" xlink:href="ameh-20230630.xsd#ameh_ZLLPartnersLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:to="loc_ameh_ZLLPartnersLLCMember_3b79beb0-c81d-44ec-b253-6755c1589bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_A120HellmanLLCMember_3e968ab9-c8af-4ae7-b89d-8950d44bfc56" xlink:href="ameh-20230630.xsd#ameh_A120HellmanLLCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:to="loc_ameh_A120HellmanLLCMember_3e968ab9-c8af-4ae7-b89d-8950d44bfc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_Tag8MedicalInvestmentGroupLLCMember_5675d386-10a3-4cf1-9fac-c9f7d5b67192" xlink:href="ameh-20230630.xsd#ameh_Tag8MedicalInvestmentGroupLLCMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:to="loc_ameh_Tag8MedicalInvestmentGroupLLCMember_5675d386-10a3-4cf1-9fac-c9f7d5b67192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlliedPacificOfCaliforniaIPAMember_8329d5c4-290a-4432-b696-3689035fd607" xlink:href="ameh-20230630.xsd#ameh_AlliedPacificOfCaliforniaIPAMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:to="loc_ameh_AlliedPacificOfCaliforniaIPAMember_8329d5c4-290a-4432-b696-3689035fd607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlphaCareMedicalGroupInc.Member_55385571-b4b5-474b-b906-9eac46cc3975" xlink:href="ameh-20230630.xsd#ameh_AlphaCareMedicalGroupInc.Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_25865275-9f8b-4d4b-bbe6-3cd66bdab93a" xlink:to="loc_ameh_AlphaCareMedicalGroupInc.Member_55385571-b4b5-474b-b906-9eac46cc3975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_4b8869bb-c5f8-49cf-8d14-3964d6737119" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_us-gaap_VariableRateAxis_4b8869bb-c5f8-49cf-8d14-3964d6737119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1b6e9955-5b72-450e-8962-50cabd5fd0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_4b8869bb-c5f8-49cf-8d14-3964d6737119" xlink:to="loc_us-gaap_VariableRateDomain_1b6e9955-5b72-450e-8962-50cabd5fd0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SecuredOvernightFinancingRateMember_e7c0872f-7d12-4711-a278-89a12806fa91" xlink:href="ameh-20230630.xsd#ameh_SecuredOvernightFinancingRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1b6e9955-5b72-450e-8962-50cabd5fd0d7" xlink:to="loc_ameh_SecuredOvernightFinancingRateMember_e7c0872f-7d12-4711-a278-89a12806fa91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_7aaf5a4f-d509-4519-8acf-e5545fbdef2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1b6e9955-5b72-450e-8962-50cabd5fd0d7" xlink:to="loc_us-gaap_BaseRateMember_7aaf5a4f-d509-4519-8acf-e5545fbdef2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_618066fd-9dcb-4032-a589-815c2735857c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1b6e9955-5b72-450e-8962-50cabd5fd0d7" xlink:to="loc_us-gaap_PrimeRateMember_618066fd-9dcb-4032-a589-815c2735857c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_e75d35c5-805e-48ef-ac62-9b223c7eb12a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_e75d35c5-805e-48ef-ac62-9b223c7eb12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_49e80cb8-8e77-4e6b-8408-17e84b9fd44b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e75d35c5-805e-48ef-ac62-9b223c7eb12a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_49e80cb8-8e77-4e6b-8408-17e84b9fd44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PreferredBankMember_ef04e90e-221e-430d-9265-eaa7ab39c6ab" xlink:href="ameh-20230630.xsd#ameh_PreferredBankMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_49e80cb8-8e77-4e6b-8408-17e84b9fd44b" xlink:to="loc_ameh_PreferredBankMember_ef04e90e-221e-430d-9265-eaa7ab39c6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_TruistBankMember_2723e5ee-bbb9-4bff-9afd-fbfebcda1bb4" xlink:href="ameh-20230630.xsd#ameh_TruistBankMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_49e80cb8-8e77-4e6b-8408-17e84b9fd44b" xlink:to="loc_ameh_TruistBankMember_2723e5ee-bbb9-4bff-9afd-fbfebcda1bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_583cdc9f-6c74-476c-ac5e-43a6a2c36981" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_583cdc9f-6c74-476c-ac5e-43a6a2c36981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_fe6634e2-26f3-47cb-9098-ea0c2131ad5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_583cdc9f-6c74-476c-ac5e-43a6a2c36981" xlink:to="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_fe6634e2-26f3-47cb-9098-ea0c2131ad5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_6576d48a-622f-4565-a4fe-2e3d321f6cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_fe6634e2-26f3-47cb-9098-ea0c2131ad5f" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_6576d48a-622f-4565-a4fe-2e3d321f6cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7aac1d3d-5191-4b43-a68f-0c7326ea9947" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_621c8c69-7c5c-4a18-8e85-09236fdf7168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_DebtInstrumentTerm_621c8c69-7c5c-4a18-8e85-09236fdf7168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_583c72ba-3e4f-46d2-92ae-50217abe7586" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_583c72ba-3e4f-46d2-92ae-50217abe7586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_93821f52-1d73-46b5-b432-9352d73327c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_93821f52-1d73-46b5-b432-9352d73327c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5785bd04-6e0c-4983-8a25-74330b7e4962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5785bd04-6e0c-4983-8a25-74330b7e4962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a7a0592f-2992-4660-be8b-15d5d7ee17ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a7a0592f-2992-4660-be8b-15d5d7ee17ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_78e71a8c-f63e-41e6-9049-f3cb2c0a89c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_78e71a8c-f63e-41e6-9049-f3cb2c0a89c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentNumberOfKeyFinancialRatios_ec5b6ad5-01fc-429c-b175-d1fa9ec276c6" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentNumberOfKeyFinancialRatios"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentNumberOfKeyFinancialRatios_ec5b6ad5-01fc-429c-b175-d1fa9ec276c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantLeverageRatioMaximum_c6b7edb6-2f9d-43db-b976-b8e416eec391" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentCovenantLeverageRatioMaximum_c6b7edb6-2f9d-43db-b976-b8e416eec391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtCovenantAggregatePurchasePriceMaximum_255ee3c7-6315-4f5d-a5b4-d8fee826d2d9" xlink:href="ameh-20230630.xsd#ameh_DebtCovenantAggregatePurchasePriceMaximum"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtCovenantAggregatePurchasePriceMaximum_255ee3c7-6315-4f5d-a5b4-d8fee826d2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange_d89b0023-cf5c-492b-80ed-f31bade06f22" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange_d89b0023-cf5c-492b-80ed-f31bade06f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_4399916c-042f-4740-927e-0ee8aef80924" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_4399916c-042f-4740-927e-0ee8aef80924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum_3781eea4-b447-430c-9650-fcc93d0cbf4d" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum_3781eea4-b447-430c-9650-fcc93d0cbf4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_b703ac99-79ac-419f-8ad0-61c8735424d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_b703ac99-79ac-419f-8ad0-61c8735424d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_36a8dde4-409b-436c-beee-1389e583097d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_36a8dde4-409b-436c-beee-1389e583097d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_70327227-dba5-487e-b12d-e45070acbadf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_LongTermDebt_70327227-dba5-487e-b12d-e45070acbadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum_bfd83790-d5f4-414e-8b28-2b8caa418388" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum_bfd83790-d5f4-414e-8b28-2b8caa418388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8da56cad-c977-473e-b6a2-257141eb7e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8da56cad-c977-473e-b6a2-257141eb7e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum_b940e147-b6a7-47a0-9979-7259e7f8e77f" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum_b940e147-b6a7-47a0-9979-7259e7f8e77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtCovenantThresholdPercentageForOccupationOfProperty_0b66e31f-d59c-43b5-8e2d-569845fc36ce" xlink:href="ameh-20230630.xsd#ameh_DebtCovenantThresholdPercentageForOccupationOfProperty"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtCovenantThresholdPercentageForOccupationOfProperty_0b66e31f-d59c-43b5-8e2d-569845fc36ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum_16063854-5638-4f7f-af1d-9338ef9cb7bc" xlink:href="ameh-20230630.xsd#ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum_16063854-5638-4f7f-af1d-9338ef9cb7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_18d8f1be-2e85-44a7-83d7-acf1f624326b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_18d8f1be-2e85-44a7-83d7-acf1f624326b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b9d8b975-bdba-4153-89a2-a1eba0d2458e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_InterestExpense_b9d8b975-bdba-4153-89a2-a1eba0d2458e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_f360bff2-0e92-403f-8a69-6008265e9c54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b0562df-5910-450b-90be-bda7d6087645" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_f360bff2-0e92-403f-8a69-6008265e9c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#MezzanineandStockholdersEquityAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_e195e0ef-bcc8-42c5-ba3a-0d004d40d189" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ac4c703a-3bcf-4334-a9da-d08da755c14c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_e195e0ef-bcc8-42c5-ba3a-0d004d40d189" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ac4c703a-3bcf-4334-a9da-d08da755c14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_03048eae-5eb7-4b07-8454-9fcefccbf750" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac4c703a-3bcf-4334-a9da-d08da755c14c" xlink:to="loc_dei_LegalEntityAxis_03048eae-5eb7-4b07-8454-9fcefccbf750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_49b4b083-5fa2-45bd-8063-27ea61305cad" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_03048eae-5eb7-4b07-8454-9fcefccbf750" xlink:to="loc_dei_EntityDomain_49b4b083-5fa2-45bd-8063-27ea61305cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlliedPacificOfCaliforniaIPAMember_c57a121d-638a-4bb1-96f5-aaa44c20006e" xlink:href="ameh-20230630.xsd#ameh_AlliedPacificOfCaliforniaIPAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_49b4b083-5fa2-45bd-8063-27ea61305cad" xlink:to="loc_ameh_AlliedPacificOfCaliforniaIPAMember_c57a121d-638a-4bb1-96f5-aaa44c20006e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CDSCMember_0653b029-713b-4c66-b8ee-2bd5075422e7" xlink:href="ameh-20230630.xsd#ameh_CDSCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_49b4b083-5fa2-45bd-8063-27ea61305cad" xlink:to="loc_ameh_CDSCMember_0653b029-713b-4c66-b8ee-2bd5075422e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_4dc31648-1709-49cd-8848-cdfa818757a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac4c703a-3bcf-4334-a9da-d08da755c14c" xlink:to="loc_us-gaap_ClassOfStockLineItems_4dc31648-1709-49cd-8848-cdfa818757a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_StockIssuedDuringPeriodSharesMerger_c2ea0754-5045-43cb-8337-a7f7887aadf1" xlink:href="ameh-20230630.xsd#ameh_StockIssuedDuringPeriodSharesMerger"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4dc31648-1709-49cd-8848-cdfa818757a0" xlink:to="loc_ameh_StockIssuedDuringPeriodSharesMerger_c2ea0754-5045-43cb-8337-a7f7887aadf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_41d8b93c-6534-4973-909d-646f9b67a9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4dc31648-1709-49cd-8848-cdfa818757a0" xlink:to="loc_us-gaap_TreasuryStockCommonShares_41d8b93c-6534-4973-909d-646f9b67a9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_d874c827-4db9-470d-a62a-0a0b6ebc52d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4dc31648-1709-49cd-8848-cdfa818757a0" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_d874c827-4db9-470d-a62a-0a0b6ebc52d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_add85ef0-efab-4058-b54b-21f1638cd711" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4dc31648-1709-49cd-8848-cdfa818757a0" xlink:to="loc_us-gaap_Dividends_add85ef0-efab-4058-b54b-21f1638cd711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6ad96329-967b-46d3-b083-0f17518cfacf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31b4af5f-1231-4f0f-8273-879dbce0cab1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6ad96329-967b-46d3-b083-0f17518cfacf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31b4af5f-1231-4f0f-8273-879dbce0cab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a80e270a-53cb-403f-9cc6-577b4aacaf1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31b4af5f-1231-4f0f-8273-879dbce0cab1" xlink:to="loc_us-gaap_AwardTypeAxis_a80e270a-53cb-403f-9cc6-577b4aacaf1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65f1b127-146a-49f1-aa04-9222e8d490c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a80e270a-53cb-403f-9cc6-577b4aacaf1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65f1b127-146a-49f1-aa04-9222e8d490c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2c1f2a00-e1d0-4fe9-9127-ea6dc8dee7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65f1b127-146a-49f1-aa04-9222e8d490c8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2c1f2a00-e1d0-4fe9-9127-ea6dc8dee7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_StockAwardsAndUnitsMember_ad7d040e-dc32-4c80-860e-cac9d0885eea" xlink:href="ameh-20230630.xsd#ameh_StockAwardsAndUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65f1b127-146a-49f1-aa04-9222e8d490c8" xlink:to="loc_ameh_StockAwardsAndUnitsMember_ad7d040e-dc32-4c80-860e-cac9d0885eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0d8cde5-c6e1-461c-93ff-a7b121b497b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31b4af5f-1231-4f0f-8273-879dbce0cab1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0d8cde5-c6e1-461c-93ff-a7b121b497b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_596db328-a701-412b-a912-30e6847a048d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0d8cde5-c6e1-461c-93ff-a7b121b497b5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_596db328-a701-412b-a912-30e6847a048d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#StockBasedCompensationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fe83b8c7-b9d9-4c64-bd89-6ccc9db681cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_97d054ad-1ce6-474e-a369-d8cda43e8446" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fe83b8c7-b9d9-4c64-bd89-6ccc9db681cb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_97d054ad-1ce6-474e-a369-d8cda43e8446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_e6f526f5-389b-43a0-8024-7f333be330fd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_97d054ad-1ce6-474e-a369-d8cda43e8446" xlink:to="loc_srt_TitleOfIndividualAxis_e6f526f5-389b-43a0-8024-7f333be330fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_0f929bc3-83d4-4b68-946e-e8094a8b69ce" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_e6f526f5-389b-43a0-8024-7f333be330fd" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_0f929bc3-83d4-4b68-946e-e8094a8b69ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApcStockOptionMember_b22960c8-8049-4673-9912-783c42333856" xlink:href="ameh-20230630.xsd#ameh_ApcStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_0f929bc3-83d4-4b68-946e-e8094a8b69ce" xlink:to="loc_ameh_ApcStockOptionMember_b22960c8-8049-4673-9912-783c42333856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_be9f983e-8747-43bd-ac59-0aaaaa414aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_97d054ad-1ce6-474e-a369-d8cda43e8446" xlink:to="loc_us-gaap_AwardTypeAxis_be9f983e-8747-43bd-ac59-0aaaaa414aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4e53d1b-255b-4f88-8453-4a451fe1cea2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_be9f983e-8747-43bd-ac59-0aaaaa414aa4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4e53d1b-255b-4f88-8453-4a451fe1cea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_42dd8ae1-8294-4204-a513-2dc8d4be0b26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4e53d1b-255b-4f88-8453-4a451fe1cea2" xlink:to="loc_us-gaap_RestrictedStockMember_42dd8ae1-8294-4204-a513-2dc8d4be0b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PerformanceBasedRestrictedStockMember_da684b0b-cfb2-48b5-a66f-ca87195fcbeb" xlink:href="ameh-20230630.xsd#ameh_PerformanceBasedRestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4e53d1b-255b-4f88-8453-4a451fe1cea2" xlink:to="loc_ameh_PerformanceBasedRestrictedStockMember_da684b0b-cfb2-48b5-a66f-ca87195fcbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_236d9470-a364-4bc0-966b-806bd7371ee0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_97d054ad-1ce6-474e-a369-d8cda43e8446" xlink:to="loc_srt_RangeAxis_236d9470-a364-4bc0-966b-806bd7371ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ffac8773-ea14-490a-b2a1-6f467de8b399" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_236d9470-a364-4bc0-966b-806bd7371ee0" xlink:to="loc_srt_RangeMember_ffac8773-ea14-490a-b2a1-6f467de8b399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7723be1c-58fd-4ac3-b3d3-bdededd0d716" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ffac8773-ea14-490a-b2a1-6f467de8b399" xlink:to="loc_srt_MinimumMember_7723be1c-58fd-4ac3-b3d3-bdededd0d716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d02c1652-6628-4737-bc62-fcbb87f3af9a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ffac8773-ea14-490a-b2a1-6f467de8b399" xlink:to="loc_srt_MaximumMember_d02c1652-6628-4737-bc62-fcbb87f3af9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_97d054ad-1ce6-474e-a369-d8cda43e8446" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_315f0c57-1e7b-436e-9d06-79be9e140027" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_315f0c57-1e7b-436e-9d06-79be9e140027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_05d85d26-5a37-4d16-8070-755a49cafd79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_05d85d26-5a37-4d16-8070-755a49cafd79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_28b6706b-e78b-47fa-b94f-d5d9fa326547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_28b6706b-e78b-47fa-b94f-d5d9fa326547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cec5143e-2eb0-4c2a-aae1-f8b92a7a1999" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cec5143e-2eb0-4c2a-aae1-f8b92a7a1999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_46032084-0a72-4d9c-ad06-ae1ccf018b40" xlink:href="ameh-20230630.xsd#ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_46032084-0a72-4d9c-ad06-ae1ccf018b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ac76ae1c-11f4-4c36-affb-6b185c048285" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ac76ae1c-11f4-4c36-affb-6b185c048285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_7ffaab43-37d4-4629-b2d6-da0d3563e1ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_7ffaab43-37d4-4629-b2d6-da0d3563e1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_d340ff68-09fc-410e-820b-838165212714" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_d340ff68-09fc-410e-820b-838165212714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod_c291abde-9dc2-4982-9ed0-967373183df2" xlink:href="ameh-20230630.xsd#ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod_c291abde-9dc2-4982-9ed0-967373183df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised_e5c5e493-4279-491b-8529-304b9a8fdf36" xlink:href="ameh-20230630.xsd#ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised_e5c5e493-4279-491b-8529-304b9a8fdf36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice_f46e0488-315e-45c6-b98b-642e4aed21a8" xlink:href="ameh-20230630.xsd#ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edc973f0-5593-4ce0-ab73-966419c9da3f" xlink:to="loc_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice_f46e0488-315e-45c6-b98b-642e4aed21a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f84ba164-4bcf-45c7-ae9a-1e5819ad5f62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ceca44bd-2ba3-40c6-b8ec-3e1d238dbf2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f84ba164-4bcf-45c7-ae9a-1e5819ad5f62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ceca44bd-2ba3-40c6-b8ec-3e1d238dbf2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_32bc2f4c-e1ec-4027-927e-8c2620f4a305" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ceca44bd-2ba3-40c6-b8ec-3e1d238dbf2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_32bc2f4c-e1ec-4027-927e-8c2620f4a305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_f1d5f604-87f8-4f8f-8153-203badcc1dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ceca44bd-2ba3-40c6-b8ec-3e1d238dbf2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_f1d5f604-87f8-4f8f-8153-203badcc1dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_799a0dce-4ced-4637-8c01-99925e80bec1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ceca44bd-2ba3-40c6-b8ec-3e1d238dbf2d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_799a0dce-4ced-4637-8c01-99925e80bec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_216a77e4-cafc-4313-8960-c1e44ee16400" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ceca44bd-2ba3-40c6-b8ec-3e1d238dbf2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_216a77e4-cafc-4313-8960-c1e44ee16400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e28f3076-70f6-4b6a-b2c8-040308e785c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ceca44bd-2ba3-40c6-b8ec-3e1d238dbf2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e28f3076-70f6-4b6a-b2c8-040308e785c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_477ce102-3a2d-492e-97ae-d9384cda699c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f84ba164-4bcf-45c7-ae9a-1e5819ad5f62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_477ce102-3a2d-492e-97ae-d9384cda699c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_6a689f94-732e-4da0-87e6-3f35c864d491" xlink:href="ameh-20230630.xsd#ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f84ba164-4bcf-45c7-ae9a-1e5819ad5f62" xlink:to="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_6a689f94-732e-4da0-87e6-3f35c864d491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8e5d8f3b-1289-41b9-a7b6-80ed7a7d62c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_6a689f94-732e-4da0-87e6-3f35c864d491" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8e5d8f3b-1289-41b9-a7b6-80ed7a7d62c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_f2378325-e8ed-4159-ab0c-28414d0cef56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_6a689f94-732e-4da0-87e6-3f35c864d491" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_f2378325-e8ed-4159-ab0c-28414d0cef56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b87c7c5c-f8d9-4150-80cf-ff0f4b5758e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_6a689f94-732e-4da0-87e6-3f35c864d491" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b87c7c5c-f8d9-4150-80cf-ff0f4b5758e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_08be6c61-63f2-42ae-849e-01b36c698c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_6a689f94-732e-4da0-87e6-3f35c864d491" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_08be6c61-63f2-42ae-849e-01b36c698c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_43386c7c-62d0-4b4d-b706-19f1677f58d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_6a689f94-732e-4da0-87e6-3f35c864d491" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_43386c7c-62d0-4b4d-b706-19f1677f58d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_86b89195-0eb4-48ac-970b-2637bc2eb83c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f84ba164-4bcf-45c7-ae9a-1e5819ad5f62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_86b89195-0eb4-48ac-970b-2637bc2eb83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_92634afc-7d0d-4a5b-a2c8-709552f57e87" xlink:href="ameh-20230630.xsd#ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f84ba164-4bcf-45c7-ae9a-1e5819ad5f62" xlink:to="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_92634afc-7d0d-4a5b-a2c8-709552f57e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5aa93695-ea1d-49a2-81d2-bad4cc92253f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_92634afc-7d0d-4a5b-a2c8-709552f57e87" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5aa93695-ea1d-49a2-81d2-bad4cc92253f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_50ba1941-1aa6-4c4f-8f8c-80bd9b7afc44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_92634afc-7d0d-4a5b-a2c8-709552f57e87" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_50ba1941-1aa6-4c4f-8f8c-80bd9b7afc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_bc35d0b8-fb1e-4359-9ee8-8a695349258e" xlink:href="ameh-20230630.xsd#ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f84ba164-4bcf-45c7-ae9a-1e5819ad5f62" xlink:to="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_bc35d0b8-fb1e-4359-9ee8-8a695349258e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7719aef1-d7d1-42e6-bac8-708e6e4f750b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_bc35d0b8-fb1e-4359-9ee8-8a695349258e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7719aef1-d7d1-42e6-bac8-708e6e4f750b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f1f9733a-b07e-4c2b-a80b-7927460da69e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_bc35d0b8-fb1e-4359-9ee8-8a695349258e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f1f9733a-b07e-4c2b-a80b-7927460da69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9305bd41-9554-4258-8206-1bcdfa7dc804" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_bc35d0b8-fb1e-4359-9ee8-8a695349258e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9305bd41-9554-4258-8206-1bcdfa7dc804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#CommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f8919c5d-dc0a-4a19-ae14-1a602b32a58d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CommitmentsAndContingenciesTable_041bddcc-9fdd-4dbc-bfa5-c7fd491f2d15" xlink:href="ameh-20230630.xsd#ameh_CommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f8919c5d-dc0a-4a19-ae14-1a602b32a58d" xlink:to="loc_ameh_CommitmentsAndContingenciesTable_041bddcc-9fdd-4dbc-bfa5-c7fd491f2d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b5cf2c05-c0e7-4608-a64a-27e08f143ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_CommitmentsAndContingenciesTable_041bddcc-9fdd-4dbc-bfa5-c7fd491f2d15" xlink:to="loc_us-gaap_DebtInstrumentAxis_b5cf2c05-c0e7-4608-a64a-27e08f143ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f2834b3e-1621-48ad-a961-bd7845d79946" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b5cf2c05-c0e7-4608-a64a-27e08f143ba9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f2834b3e-1621-48ad-a961-bd7845d79946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AmendedCreditAgreementMember_34d3d41f-2431-43d2-869e-f2fd737de6d5" xlink:href="ameh-20230630.xsd#ameh_AmendedCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2834b3e-1621-48ad-a961-bd7845d79946" xlink:to="loc_ameh_AmendedCreditAgreementMember_34d3d41f-2431-43d2-869e-f2fd737de6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_6b25e2fa-74e5-4052-8d56-521075e4d741" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_CommitmentsAndContingenciesTable_041bddcc-9fdd-4dbc-bfa5-c7fd491f2d15" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_6b25e2fa-74e5-4052-8d56-521075e4d741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_a9f04c4a-f19d-4e3e-9fc5-51be74cf1967" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_6b25e2fa-74e5-4052-8d56-521075e4d741" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_a9f04c4a-f19d-4e3e-9fc5-51be74cf1967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_TruistBankMember_2bea873d-3ac1-4e23-ad4a-3be675f80b3d" xlink:href="ameh-20230630.xsd#ameh_TruistBankMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_a9f04c4a-f19d-4e3e-9fc5-51be74cf1967" xlink:to="loc_ameh_TruistBankMember_2bea873d-3ac1-4e23-ad4a-3be675f80b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_229f422f-da53-46fc-af46-a2cc9627aa5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_CommitmentsAndContingenciesTable_041bddcc-9fdd-4dbc-bfa5-c7fd491f2d15" xlink:to="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_229f422f-da53-46fc-af46-a2cc9627aa5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_2feb99a6-31bb-43a9-9b65-6cc5f283efb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_229f422f-da53-46fc-af46-a2cc9627aa5c" xlink:to="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_2feb99a6-31bb-43a9-9b65-6cc5f283efb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_5a85d52d-c2de-4c56-be0e-812fe2588106" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_2feb99a6-31bb-43a9-9b65-6cc5f283efb5" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_5a85d52d-c2de-4c56-be0e-812fe2588106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6da6aa5a-9a46-4f6e-951a-5bf10a9ff983" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_CommitmentsAndContingenciesTable_041bddcc-9fdd-4dbc-bfa5-c7fd491f2d15" xlink:to="loc_dei_LegalEntityAxis_6da6aa5a-9a46-4f6e-951a-5bf10a9ff983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_45d1ad9e-1370-4bd1-ae58-29ea67217757" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_6da6aa5a-9a46-4f6e-951a-5bf10a9ff983" xlink:to="loc_dei_EntityDomain_45d1ad9e-1370-4bd1-ae58-29ea67217757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlliedPacificOfCaliforniaIPAMember_83b5ede6-2c88-4ae0-8841-0b236d8a0410" xlink:href="ameh-20230630.xsd#ameh_AlliedPacificOfCaliforniaIPAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_45d1ad9e-1370-4bd1-ae58-29ea67217757" xlink:to="loc_ameh_AlliedPacificOfCaliforniaIPAMember_83b5ede6-2c88-4ae0-8841-0b236d8a0410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlphaCareMedicalGroupInc.Member_e7a2661a-63c4-4703-9895-3c4d17027b91" xlink:href="ameh-20230630.xsd#ameh_AlphaCareMedicalGroupInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_45d1ad9e-1370-4bd1-ae58-29ea67217757" xlink:to="loc_ameh_AlphaCareMedicalGroupInc.Member_e7a2661a-63c4-4703-9895-3c4d17027b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CommitmentsAndContingenciesLineItems_6e38416e-aabe-4178-964b-57fa0a631bb1" xlink:href="ameh-20230630.xsd#ameh_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_CommitmentsAndContingenciesTable_041bddcc-9fdd-4dbc-bfa5-c7fd491f2d15" xlink:to="loc_ameh_CommitmentsAndContingenciesLineItems_6e38416e-aabe-4178-964b-57fa0a631bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c53c468e-caf9-4fac-a26f-079cf1dcecb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_CommitmentsAndContingenciesLineItems_6e38416e-aabe-4178-964b-57fa0a631bb1" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c53c468e-caf9-4fac-a26f-079cf1dcecb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_82038271-d609-4ad2-bd50-2744247001b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_CommitmentsAndContingenciesLineItems_6e38416e-aabe-4178-964b-57fa0a631bb1" xlink:to="loc_us-gaap_LineOfCredit_82038271-d609-4ad2-bd50-2744247001b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#RelatedPartyTransactionsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_de16fd9f-b842-445b-8ea8-fb68d47f741b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_de16fd9f-b842-445b-8ea8-fb68d47f741b" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4b1044b0-1bda-450e-9c29-5300d89b2de8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4b1044b0-1bda-450e-9c29-5300d89b2de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d6417800-60fb-4350-85f9-b10627a0301d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4b1044b0-1bda-450e-9c29-5300d89b2de8" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d6417800-60fb-4350-85f9-b10627a0301d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LmaMember_55808dcc-00bd-4d67-8e79-7abdad3ddff6" xlink:href="ameh-20230630.xsd#ameh_LmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6417800-60fb-4350-85f9-b10627a0301d" xlink:to="loc_ameh_LmaMember_55808dcc-00bd-4d67-8e79-7abdad3ddff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PmiocMember_7d8f0cbd-1143-417f-9831-0c06b39a7126" xlink:href="ameh-20230630.xsd#ameh_PmiocMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6417800-60fb-4350-85f9-b10627a0301d" xlink:to="loc_ameh_PmiocMember_7d8f0cbd-1143-417f-9831-0c06b39a7126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OneMSOInc.Member_e420845d-885d-4852-858c-58579e2f324e" xlink:href="ameh-20230630.xsd#ameh_OneMSOInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6417800-60fb-4350-85f9-b10627a0301d" xlink:to="loc_ameh_OneMSOInc.Member_e420845d-885d-4852-858c-58579e2f324e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_79da9f35-5066-405a-a02f-306664922e9d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:to="loc_dei_LegalEntityAxis_79da9f35-5066-405a-a02f-306664922e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ac77f567-9510-4b93-995e-b98de9b7a882" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_79da9f35-5066-405a-a02f-306664922e9d" xlink:to="loc_dei_EntityDomain_ac77f567-9510-4b93-995e-b98de9b7a882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NetworkMedicalManagementMember_765ca09e-6b57-4efd-af43-74eb35e071bc" xlink:href="ameh-20230630.xsd#ameh_NetworkMedicalManagementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ac77f567-9510-4b93-995e-b98de9b7a882" xlink:to="loc_ameh_NetworkMedicalManagementMember_765ca09e-6b57-4efd-af43-74eb35e071bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlliedPacificOfCaliforniaIPAMember_eede976b-6bca-4079-9450-1cacf0e9ffaf" xlink:href="ameh-20230630.xsd#ameh_AlliedPacificOfCaliforniaIPAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ac77f567-9510-4b93-995e-b98de9b7a882" xlink:to="loc_ameh_AlliedPacificOfCaliforniaIPAMember_eede976b-6bca-4079-9450-1cacf0e9ffaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_MedicalPropertyPartnersLLCMember_fcb9df15-691a-40f5-84cc-ac62d167a679" xlink:href="ameh-20230630.xsd#ameh_MedicalPropertyPartnersLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ac77f567-9510-4b93-995e-b98de9b7a882" xlink:to="loc_ameh_MedicalPropertyPartnersLLCMember_fcb9df15-691a-40f5-84cc-ac62d167a679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_Tag6MedicalInvestmentGroupLLCMember_09f5876e-b92e-48d4-b9b7-9c74cee2ff0d" xlink:href="ameh-20230630.xsd#ameh_Tag6MedicalInvestmentGroupLLCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ac77f567-9510-4b93-995e-b98de9b7a882" xlink:to="loc_ameh_Tag6MedicalInvestmentGroupLLCMember_09f5876e-b92e-48d4-b9b7-9c74cee2ff0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f4faf2a0-4c05-4ece-a70c-18eb758b1fd1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:to="loc_srt_CounterpartyNameAxis_f4faf2a0-4c05-4ece-a70c-18eb758b1fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_f4faf2a0-4c05-4ece-a70c-18eb758b1fd1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LmaMember_7e68240a-1802-46d6-b9af-112276894e82" xlink:href="ameh-20230630.xsd#ameh_LmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_LmaMember_7e68240a-1802-46d6-b9af-112276894e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ArroyoVistaMember_4145ff77-ef4f-42d3-b48e-dbdc14a72da4" xlink:href="ameh-20230630.xsd#ameh_ArroyoVistaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_ArroyoVistaMember_4145ff77-ef4f-42d3-b48e-dbdc14a72da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PmiocMember_b41df9d3-5948-4fbd-a8a0-d6b0b288c1c1" xlink:href="ameh-20230630.xsd#ameh_PmiocMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_PmiocMember_b41df9d3-5948-4fbd-a8a0-d6b0b288c1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SongPCMember_9d1380a2-6c8c-4b3c-a28c-314ce580da84" xlink:href="ameh-20230630.xsd#ameh_SongPCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_SongPCMember_9d1380a2-6c8c-4b3c-a28c-314ce580da84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AdvanceDiagnosticSurgeryCenterMember_a1a3331c-d780-4f55-8c53-e9271c9517fd" xlink:href="ameh-20230630.xsd#ameh_AdvanceDiagnosticSurgeryCenterMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_AdvanceDiagnosticSurgeryCenterMember_a1a3331c-d780-4f55-8c53-e9271c9517fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_DiagnosticAndSurgicalCenterMember_7ef7d02d-8262-4239-9502-e8a01950135d" xlink:href="ameh-20230630.xsd#ameh_DiagnosticAndSurgicalCenterMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_DiagnosticAndSurgicalCenterMember_7ef7d02d-8262-4239-9502-e8a01950135d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FulgentGeneticsIncMember_5a6fc228-4436-45bf-b72c-9fd0e4781fe5" xlink:href="ameh-20230630.xsd#ameh_FulgentGeneticsIncMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_FulgentGeneticsIncMember_5a6fc228-4436-45bf-b72c-9fd0e4781fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_SunnyVillageCareCenterMember_2b724a30-4d01-4d5a-b3c5-b8d27750deab" xlink:href="ameh-20230630.xsd#ameh_SunnyVillageCareCenterMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_SunnyVillageCareCenterMember_2b724a30-4d01-4d5a-b3c5-b8d27750deab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OneMSOInc.Member_15be8fc6-fdf8-46a3-b7c5-7720c2b41686" xlink:href="ameh-20230630.xsd#ameh_OneMSOInc.Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_OneMSOInc.Member_15be8fc6-fdf8-46a3-b7c5-7720c2b41686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AHMCMember_4289e6c1-7b9a-4a29-948b-70b11b41e030" xlink:href="ameh-20230630.xsd#ameh_AHMCMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_AHMCMember_4289e6c1-7b9a-4a29-948b-70b11b41e030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ApcShareholdersMember_fce56aa9-ee9c-4d90-92d7-955c5e2ab2b7" xlink:href="ameh-20230630.xsd#ameh_ApcShareholdersMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_ApcShareholdersMember_fce56aa9-ee9c-4d90-92d7-955c5e2ab2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ShareholdersAndOfficersMember_766b86ce-52c5-4289-97df-087eb0be7ff7" xlink:href="ameh-20230630.xsd#ameh_ShareholdersAndOfficersMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_ShareholdersAndOfficersMember_766b86ce-52c5-4289-97df-087eb0be7ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BoardMembersMember_9afbcbe8-8355-45c5-8e61-e2e20a19a4a5" xlink:href="ameh-20230630.xsd#ameh_BoardMembersMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_BoardMembersMember_9afbcbe8-8355-45c5-8e61-e2e20a19a4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_BoardMembersWhoAreAlsoOfficersMember_5ebbca75-c4ff-41c9-915e-09fe56ea906e" xlink:href="ameh-20230630.xsd#ameh_BoardMembersWhoAreAlsoOfficersMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_59807cfb-a16b-4fe9-b148-20f3de9a2afb" xlink:to="loc_ameh_BoardMembersWhoAreAlsoOfficersMember_5ebbca75-c4ff-41c9-915e-09fe56ea906e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ec63a175-878c-4a50-85bc-3136cb6a1a61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ec63a175-878c-4a50-85bc-3136cb6a1a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4aa7f79e-dc57-451f-a003-e11351c798da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ec63a175-878c-4a50-85bc-3136cb6a1a61" xlink:to="loc_us-gaap_RelatedPartyDomain_4aa7f79e-dc57-451f-a003-e11351c798da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_ae095fef-d773-4695-8233-7a8c85c6944e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4aa7f79e-dc57-451f-a003-e11351c798da" xlink:to="loc_us-gaap_RelatedPartyMember_ae095fef-d773-4695-8233-7a8c85c6944e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_7a429323-0cbd-4978-b8ce-9ae7af4a856a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4aa7f79e-dc57-451f-a003-e11351c798da" xlink:to="loc_srt_DirectorMember_7a429323-0cbd-4978-b8ce-9ae7af4a856a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_0c06aa00-9b31-47bb-8571-4e8379fa552a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_0c06aa00-9b31-47bb-8571-4e8379fa552a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_70a9f81f-a44f-4510-8963-53772d3cd774" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_0c06aa00-9b31-47bb-8571-4e8379fa552a" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_70a9f81f-a44f-4510-8963-53772d3cd774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_ProviderServicesMember_476ef76c-0ad4-4847-ad95-926b0371f745" xlink:href="ameh-20230630.xsd#ameh_ProviderServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_70a9f81f-a44f-4510-8963-53772d3cd774" xlink:to="loc_ameh_ProviderServicesMember_476ef76c-0ad4-4847-ad95-926b0371f745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_RentPaymentMember_26c01fef-6af0-48af-a8dd-fe927bd6f64a" xlink:href="ameh-20230630.xsd#ameh_RentPaymentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_70a9f81f-a44f-4510-8963-53772d3cd774" xlink:to="loc_ameh_RentPaymentMember_26c01fef-6af0-48af-a8dd-fe927bd6f64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_OfficeLeaseMember_7ecbba6c-e1fb-45da-8d68-a5ffe8ef435c" xlink:href="ameh-20230630.xsd#ameh_OfficeLeaseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_70a9f81f-a44f-4510-8963-53772d3cd774" xlink:to="loc_ameh_OfficeLeaseMember_7ecbba6c-e1fb-45da-8d68-a5ffe8ef435c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2c53ce8b-4c30-4849-a090-51c95044196a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:to="loc_srt_ProductOrServiceAxis_2c53ce8b-4c30-4849-a090-51c95044196a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_74cf46a9-c9c2-405a-9d79-dc3b02e20254" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_2c53ce8b-4c30-4849-a090-51c95044196a" xlink:to="loc_srt_ProductsAndServicesDomain_74cf46a9-c9c2-405a-9d79-dc3b02e20254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_361eed09-819f-4b00-96d5-a439fd606c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_74cf46a9-c9c2-405a-9d79-dc3b02e20254" xlink:to="loc_us-gaap_HealthCareOtherMember_361eed09-819f-4b00-96d5-a439fd606c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_3bb0fdff-6406-4daa-bc61-a234173ab97f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0a8b95c7-e764-49c7-b6ce-849d95829c32" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_3bb0fdff-6406-4daa-bc61-a234173ab97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_68f7b8c9-1e98-4601-9ff1-06a723752fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3bb0fdff-6406-4daa-bc61-a234173ab97f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_68f7b8c9-1e98-4601-9ff1-06a723752fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_bc43784b-24ae-4039-8cc1-2131336b9e03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3bb0fdff-6406-4daa-bc61-a234173ab97f" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_bc43784b-24ae-4039-8cc1-2131336b9e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9ce9cf02-b9f9-4e81-9c65-778a78a46dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3bb0fdff-6406-4daa-bc61-a234173ab97f" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9ce9cf02-b9f9-4e81-9c65-778a78a46dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7849dbe6-4f09-478e-a155-dcf9e209658a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3bb0fdff-6406-4daa-bc61-a234173ab97f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7849dbe6-4f09-478e-a155-dcf9e209658a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCreditsAndOtherLiabilities_e77b7aff-3d1d-4625-b344-f21dc9d3771b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCreditsAndOtherLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_3bb0fdff-6406-4daa-bc61-a234173ab97f" xlink:to="loc_us-gaap_DeferredCreditsAndOtherLiabilities_e77b7aff-3d1d-4625-b344-f21dc9d3771b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_ec5ad0ff-35bf-493d-bb7b-1b23ded96adf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eae26146-b822-4511-b8b8-62ef8e915973" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_ec5ad0ff-35bf-493d-bb7b-1b23ded96adf" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eae26146-b822-4511-b8b8-62ef8e915973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_172cd485-8765-466d-8cc6-e210394e0791" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eae26146-b822-4511-b8b8-62ef8e915973" xlink:to="loc_srt_CounterpartyNameAxis_172cd485-8765-466d-8cc6-e210394e0791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8bfefb82-7c7b-4385-9913-11806ca25ea1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_172cd485-8765-466d-8cc6-e210394e0791" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8bfefb82-7c7b-4385-9913-11806ca25ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AHMCMember_86c0c943-a251-4094-9ade-50a884d10aa9" xlink:href="ameh-20230630.xsd#ameh_AHMCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8bfefb82-7c7b-4385-9913-11806ca25ea1" xlink:to="loc_ameh_AHMCMember_86c0c943-a251-4094-9ade-50a884d10aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_HSMSOMember_2c0d1e48-8dcb-4047-ada1-64ebd47c82da" xlink:href="ameh-20230630.xsd#ameh_HSMSOMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8bfefb82-7c7b-4385-9913-11806ca25ea1" xlink:to="loc_ameh_HSMSOMember_2c0d1e48-8dcb-4047-ada1-64ebd47c82da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AurionMember_47e8c561-fa6c-4a4b-b220-016ec83dc780" xlink:href="ameh-20230630.xsd#ameh_AurionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8bfefb82-7c7b-4385-9913-11806ca25ea1" xlink:to="loc_ameh_AurionMember_47e8c561-fa6c-4a4b-b220-016ec83dc780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_05d4c42c-e098-486a-b07f-b2fdf4228676" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eae26146-b822-4511-b8b8-62ef8e915973" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_05d4c42c-e098-486a-b07f-b2fdf4228676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_a52a8a77-7b90-44f9-a5be-4859fb19e76e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_05d4c42c-e098-486a-b07f-b2fdf4228676" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_a52a8a77-7b90-44f9-a5be-4859fb19e76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FeesIncurredAndIncomeRecognizedMember_d2b150ef-a561-4191-a658-ad9e802515a8" xlink:href="ameh-20230630.xsd#ameh_FeesIncurredAndIncomeRecognizedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_a52a8a77-7b90-44f9-a5be-4859fb19e76e" xlink:to="loc_ameh_FeesIncurredAndIncomeRecognizedMember_d2b150ef-a561-4191-a658-ad9e802515a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_ff457a1f-01df-44ec-a282-f080558fa4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eae26146-b822-4511-b8b8-62ef8e915973" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_ff457a1f-01df-44ec-a282-f080558fa4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_cac6d59a-6bb9-4966-a102-b6e11de45e71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ff457a1f-01df-44ec-a282-f080558fa4b6" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_cac6d59a-6bb9-4966-a102-b6e11de45e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_47c097c6-3043-4159-bd8a-f4e465ab5820" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ea9577e5-61e2-40d2-9fe4-ed1614a2cb92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_47c097c6-3043-4159-bd8a-f4e465ab5820" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ea9577e5-61e2-40d2-9fe4-ed1614a2cb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#EarningsPerShareAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8dd5dfe4-484d-4453-89ef-f481b3d066fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EarningsPerShareTable_71a83c09-05a3-4c9c-96c6-9e645068cfb4" xlink:href="ameh-20230630.xsd#ameh_EarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8dd5dfe4-484d-4453-89ef-f481b3d066fa" xlink:to="loc_ameh_EarningsPerShareTable_71a83c09-05a3-4c9c-96c6-9e645068cfb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8cf42cf1-c3e4-48cb-ad7f-ce929762fb0d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EarningsPerShareTable_71a83c09-05a3-4c9c-96c6-9e645068cfb4" xlink:to="loc_dei_LegalEntityAxis_8cf42cf1-c3e4-48cb-ad7f-ce929762fb0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8a179663-0c95-46f0-bace-dcde26cfc986" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8cf42cf1-c3e4-48cb-ad7f-ce929762fb0d" xlink:to="loc_dei_EntityDomain_8a179663-0c95-46f0-bace-dcde26cfc986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_AlliedPacificOfCaliforniaIPAMember_19369892-0f89-46d9-ad1c-889f63658a8d" xlink:href="ameh-20230630.xsd#ameh_AlliedPacificOfCaliforniaIPAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8a179663-0c95-46f0-bace-dcde26cfc986" xlink:to="loc_ameh_AlliedPacificOfCaliforniaIPAMember_19369892-0f89-46d9-ad1c-889f63658a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d5b2fadf-7eda-4e4e-bfed-27a37c1c466d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EarningsPerShareTable_71a83c09-05a3-4c9c-96c6-9e645068cfb4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d5b2fadf-7eda-4e4e-bfed-27a37c1c466d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_36703dca-3edd-4f76-9043-e031486f102b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d5b2fadf-7eda-4e4e-bfed-27a37c1c466d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_36703dca-3edd-4f76-9043-e031486f102b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_92d3b811-7378-45e0-8875-072e16b8802f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_36703dca-3edd-4f76-9043-e031486f102b" xlink:to="loc_us-gaap_RestrictedStockMember_92d3b811-7378-45e0-8875-072e16b8802f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_1dbc044d-3d67-4613-8d96-6fdea482e549" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_36703dca-3edd-4f76-9043-e031486f102b" xlink:to="loc_us-gaap_PerformanceSharesMember_1dbc044d-3d67-4613-8d96-6fdea482e549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EarningsPerShareLineItems_5bff2b21-5c75-4b95-afb5-44806944a170" xlink:href="ameh-20230630.xsd#ameh_EarningsPerShareLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EarningsPerShareTable_71a83c09-05a3-4c9c-96c6-9e645068cfb4" xlink:to="loc_ameh_EarningsPerShareLineItems_5bff2b21-5c75-4b95-afb5-44806944a170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_42ae35e4-144e-4348-bc3b-2fd92638b88d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EarningsPerShareLineItems_5bff2b21-5c75-4b95-afb5-44806944a170" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_42ae35e4-144e-4348-bc3b-2fd92638b88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#EarningsPerShareScheduleofEarningsPerShareComputationsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8eaded1b-3a9e-48e9-a513-5df6fa48ec1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_13ad4e19-b8a4-455b-ab79-62efa71378c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8eaded1b-3a9e-48e9-a513-5df6fa48ec1e" xlink:to="loc_us-gaap_EarningsPerShareBasic_13ad4e19-b8a4-455b-ab79-62efa71378c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_cdcbb3d7-93f5-4bba-b2eb-514982c414d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8eaded1b-3a9e-48e9-a513-5df6fa48ec1e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_cdcbb3d7-93f5-4bba-b2eb-514982c414d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8b8a454d-5616-4ff8-a60e-722937f155c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8eaded1b-3a9e-48e9-a513-5df6fa48ec1e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8b8a454d-5616-4ff8-a60e-722937f155c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_810ea1b9-64f0-4fc6-b544-84f86b25b385" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8eaded1b-3a9e-48e9-a513-5df6fa48ec1e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_810ea1b9-64f0-4fc6-b544-84f86b25b385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1e0a8f32-8df5-49c7-a797-0d463983420b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EarningsPerShareTable_0257994d-f49b-493b-b861-7657691d62c8" xlink:href="ameh-20230630.xsd#ameh_EarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1e0a8f32-8df5-49c7-a797-0d463983420b" xlink:to="loc_ameh_EarningsPerShareTable_0257994d-f49b-493b-b861-7657691d62c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_731b2c25-14c4-4a76-957f-326f603f97dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EarningsPerShareTable_0257994d-f49b-493b-b861-7657691d62c8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_731b2c25-14c4-4a76-957f-326f603f97dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_154f9ee7-7aab-411b-beeb-ccb147ebfffe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_731b2c25-14c4-4a76-957f-326f603f97dc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_154f9ee7-7aab-411b-beeb-ccb147ebfffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b178cbb0-dc6e-41e7-b6d5-03933334a6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_154f9ee7-7aab-411b-beeb-ccb147ebfffe" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b178cbb0-dc6e-41e7-b6d5-03933334a6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_7c7c4a9c-0ca2-4c4d-a9fa-ac56ed2ce1be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_154f9ee7-7aab-411b-beeb-ccb147ebfffe" xlink:to="loc_us-gaap_RestrictedStockMember_7c7c4a9c-0ca2-4c4d-a9fa-ac56ed2ce1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c7dfea90-e8aa-4045-9b83-2662267b8234" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EarningsPerShareTable_0257994d-f49b-493b-b861-7657691d62c8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c7dfea90-e8aa-4045-9b83-2662267b8234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_16d08a5f-8d6d-4652-86af-4ba0cc620bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c7dfea90-e8aa-4045-9b83-2662267b8234" xlink:to="loc_us-gaap_EquityComponentDomain_16d08a5f-8d6d-4652-86af-4ba0cc620bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_4980ba98-3dad-4e62-b8a3-3727050b8cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_16d08a5f-8d6d-4652-86af-4ba0cc620bfd" xlink:to="loc_us-gaap_WarrantMember_4980ba98-3dad-4e62-b8a3-3727050b8cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_EarningsPerShareLineItems_4408ca33-5865-456c-9c70-81b957dde2a0" xlink:href="ameh-20230630.xsd#ameh_EarningsPerShareLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EarningsPerShareTable_0257994d-f49b-493b-b861-7657691d62c8" xlink:to="loc_ameh_EarningsPerShareLineItems_4408ca33-5865-456c-9c70-81b957dde2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5d9fdb29-da76-4dff-97e3-05420e525ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EarningsPerShareLineItems_4408ca33-5865-456c-9c70-81b957dde2a0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5d9fdb29-da76-4dff-97e3-05420e525ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c5b07874-e269-4db0-9dd9-2c47190da068" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EarningsPerShareLineItems_4408ca33-5865-456c-9c70-81b957dde2a0" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c5b07874-e269-4db0-9dd9-2c47190da068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_3e19b169-4a6b-4028-8c85-082cf7070d57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EarningsPerShareLineItems_4408ca33-5865-456c-9c70-81b957dde2a0" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_3e19b169-4a6b-4028-8c85-082cf7070d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d4fdc736-d841-4694-9b2f-0c462f4823cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_EarningsPerShareLineItems_4408ca33-5865-456c-9c70-81b957dde2a0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d4fdc736-d841-4694-9b2f-0c462f4823cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#VariableInterestEntitiesVIEsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3527ecb8-aa83-4e8c-9560-e46e74d954c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b2a72e7b-9be9-4ee3-8b0a-be524fc0798f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3527ecb8-aa83-4e8c-9560-e46e74d954c4" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b2a72e7b-9be9-4ee3-8b0a-be524fc0798f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_bf3628c4-0bec-4c13-9f0b-21afe278aa48" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b2a72e7b-9be9-4ee3-8b0a-be524fc0798f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_bf3628c4-0bec-4c13-9f0b-21afe278aa48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1d7c3044-ba39-44c8-bd44-e098d3c77d8b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_bf3628c4-0bec-4c13-9f0b-21afe278aa48" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1d7c3044-ba39-44c8-bd44-e098d3c77d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_6c88bd49-4f6e-48ed-abd0-cc596afebcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1d7c3044-ba39-44c8-bd44-e098d3c77d8b" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_6c88bd49-4f6e-48ed-abd0-cc596afebcaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_722c0024-9a6c-4f07-8cbd-f8c31bd862ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b2a72e7b-9be9-4ee3-8b0a-be524fc0798f" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_722c0024-9a6c-4f07-8cbd-f8c31bd862ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_49b30f87-c83d-4a2f-8634-6835923bce1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_722c0024-9a6c-4f07-8cbd-f8c31bd862ff" xlink:to="loc_us-gaap_RelatedPartyDomain_49b30f87-c83d-4a2f-8634-6835923bce1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember_14e969d6-0c1a-4819-bbe5-86680dabce7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_49b30f87-c83d-4a2f-8634-6835923bce1e" xlink:to="loc_us-gaap_NonrelatedPartyMember_14e969d6-0c1a-4819-bbe5-86680dabce7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_395d4e9b-26e6-43b9-91ec-b121daf0c5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_49b30f87-c83d-4a2f-8634-6835923bce1e" xlink:to="loc_us-gaap_RelatedPartyMember_395d4e9b-26e6-43b9-91ec-b121daf0c5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_d9cfca96-817f-498c-beef-afa46a6bb39d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b2a72e7b-9be9-4ee3-8b0a-be524fc0798f" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_d9cfca96-817f-498c-beef-afa46a6bb39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e4fad303-ca16-4f1e-8e5f-24787527de85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9cfca96-817f-498c-beef-afa46a6bb39d" xlink:to="loc_us-gaap_AssetsAbstract_e4fad303-ca16-4f1e-8e5f-24787527de85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e4fad303-ca16-4f1e-8e5f-24787527de85" xlink:to="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_52d4d46b-960f-4210-8402-756600f26525" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_52d4d46b-960f-4210-8402-756600f26525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_6f4c05dd-e9e9-4ad6-8c34-89238c0bdbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_6f4c05dd-e9e9-4ad6-8c34-89238c0bdbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_edd6bccf-cf50-4d16-8ecf-33fe176d87a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_edd6bccf-cf50-4d16-8ecf-33fe176d87a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_48b97611-76e3-493e-be8b-b03e68bcd240" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_IncomeTaxesReceivable_48b97611-76e3-493e-be8b-b03e68bcd240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_3a9134f2-9705-4b76-97b8-e1fa13a10b48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_3a9134f2-9705-4b76-97b8-e1fa13a10b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_570a0844-c568-48bf-98e9-724b0b100838" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_570a0844-c568-48bf-98e9-724b0b100838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_c2023582-ce19-4689-b0de-9bc6303fcd53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_c2023582-ce19-4689-b0de-9bc6303fcd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_85c37102-b7dd-422c-8279-b91b5b1ae4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_OtherAssetsCurrent_85c37102-b7dd-422c-8279-b91b5b1ae4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_43292dfb-e00d-4531-b49d-8ab10abf7988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_457ad5df-04fc-41f8-97b3-f457705a715a" xlink:to="loc_us-gaap_AssetsCurrent_43292dfb-e00d-4531-b49d-8ab10abf7988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e4fad303-ca16-4f1e-8e5f-24787527de85" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6036957f-29f6-4086-89a2-3129241fd716" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6036957f-29f6-4086-89a2-3129241fd716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a1c3e86-2e49-496b-a102-812c99cd4a73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a1c3e86-2e49-496b-a102-812c99cd4a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e91abaed-aeb1-4d76-a4dc-63a3b7a537e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_Goodwill_e91abaed-aeb1-4d76-a4dc-63a3b7a537e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_854d5e80-c1c6-4227-a7c2-fb8e15060ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_854d5e80-c1c6-4227-a7c2-fb8e15060ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_5c127c8b-afc3-4b5b-b00b-0446ec2afa53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_OtherLongTermInvestments_5c127c8b-afc3-4b5b-b00b-0446ec2afa53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ca2e2e9d-d645-4ac4-a9c1-adf27019c66d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_EquityMethodInvestments_ca2e2e9d-d645-4ac4-a9c1-adf27019c66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_8f642586-7372-4735-a3b9-607bb96faef5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_8f642586-7372-4735-a3b9-607bb96faef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_def8d5de-39d2-416d-9e44-163ec310d764" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_def8d5de-39d2-416d-9e44-163ec310d764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2b747099-960c-452c-b18b-9cf4659c6fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2b747099-960c-452c-b18b-9cf4659c6fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_07af3e20-c15a-4cbd-9eb2-da4788a42fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7ac5471c-d459-408b-894b-382b46d0ed32" xlink:to="loc_us-gaap_AssetsNoncurrent_07af3e20-c15a-4cbd-9eb2-da4788a42fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8c988e5d-71b4-44b8-899b-f657f1203dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e4fad303-ca16-4f1e-8e5f-24787527de85" xlink:to="loc_us-gaap_Assets_8c988e5d-71b4-44b8-899b-f657f1203dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9cfca96-817f-498c-beef-afa46a6bb39d" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_57ee0046-b8eb-4e3d-b5f8-eaaab7778f03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_57ee0046-b8eb-4e3d-b5f8-eaaab7778f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FiduciaryAccountsPayableCurrent_bef3719d-074c-4238-86d8-f57b97d987b8" xlink:href="ameh-20230630.xsd#ameh_FiduciaryAccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_ameh_FiduciaryAccountsPayableCurrent_bef3719d-074c-4238-86d8-f57b97d987b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1607a69b-51e3-44c6-b5f7-e8c38ff2515a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1607a69b-51e3-44c6-b5f7-e8c38ff2515a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_69a72089-c826-44f7-a802-3d4cda6ac2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_TaxesPayableCurrent_69a72089-c826-44f7-a802-3d4cda6ac2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_0d8d63e3-56b9-45ba-a3fc-ad8e79d362f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_DividendsPayableCurrent_0d8d63e3-56b9-45ba-a3fc-ad8e79d362f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_550577cb-f039-4254-8b1a-5fd01de3c765" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_550577cb-f039-4254-8b1a-5fd01de3c765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_24ddcaa1-f9a0-4817-a919-6d4e6ba93c09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_LongTermDebtCurrent_24ddcaa1-f9a0-4817-a919-6d4e6ba93c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_76ca59cd-439e-46dd-aac6-a9dc5d3cf7af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_76ca59cd-439e-46dd-aac6-a9dc5d3cf7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5907e610-291a-4ae2-9a28-5a53d7c34377" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5907e610-291a-4ae2-9a28-5a53d7c34377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2ebf1828-b972-4923-bb96-8e6cea12d8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d0f5f78-e5cd-4f83-81d7-603848121d00" xlink:to="loc_us-gaap_LiabilitiesCurrent_2ebf1828-b972-4923-bb96-8e6cea12d8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9cfca96-817f-498c-beef-afa46a6bb39d" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_58832e5f-06fb-40c1-996c-bc961da055c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_58832e5f-06fb-40c1-996c-bc961da055c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_17396cf0-3e6f-413c-81d4-cd12332a7724" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_17396cf0-3e6f-413c-81d4-cd12332a7724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_db710b42-d8e7-4930-a31e-df14aa9c94c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_db710b42-d8e7-4930-a31e-df14aa9c94c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1946482f-809b-4377-aeac-dd0ef83c7e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1946482f-809b-4377-aeac-dd0ef83c7e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2dee748a-b6ce-41b1-a49e-a716ddabdaf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2dee748a-b6ce-41b1-a49e-a716ddabdaf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_0bae284f-ca3d-41f7-bf60-419a61df6e95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_67ca97f8-752c-414a-ba60-466d33273b56" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_0bae284f-ca3d-41f7-bf60-419a61df6e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_01f278b0-6ba1-4cdd-8f3b-e255cfa7a3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9cfca96-817f-498c-beef-afa46a6bb39d" xlink:to="loc_us-gaap_Liabilities_01f278b0-6ba1-4cdd-8f3b-e255cfa7a3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesAdditionalinformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#LeasesAdditionalinformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LeasesAdditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1161f265-db53-438b-aaa3-3a5eb275ac09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_01ba914b-4f3c-4f71-9fbf-4767838327ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1161f265-db53-438b-aaa3-3a5eb275ac09" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_01ba914b-4f3c-4f71-9fbf-4767838327ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cbb5c1df-7c1e-495e-b332-c3e6896a6c0f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_01ba914b-4f3c-4f71-9fbf-4767838327ba" xlink:to="loc_srt_RangeAxis_cbb5c1df-7c1e-495e-b332-c3e6896a6c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_29b51038-4010-44ca-8f84-8c1f5e8a9895" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cbb5c1df-7c1e-495e-b332-c3e6896a6c0f" xlink:to="loc_srt_RangeMember_29b51038-4010-44ca-8f84-8c1f5e8a9895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dcc20fd6-0a54-4a17-911d-a94bf2c3f2ba" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_29b51038-4010-44ca-8f84-8c1f5e8a9895" xlink:to="loc_srt_MinimumMember_dcc20fd6-0a54-4a17-911d-a94bf2c3f2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_86ae8ac9-8b9d-4eff-b86b-025784421f41" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_29b51038-4010-44ca-8f84-8c1f5e8a9895" xlink:to="loc_srt_MaximumMember_86ae8ac9-8b9d-4eff-b86b-025784421f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_01ba914b-4f3c-4f71-9fbf-4767838327ba" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_1edf5fab-601f-4e63-978d-85876354d8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_1edf5fab-601f-4e63-978d-85876354d8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_d54d794b-1c8b-4515-84cc-243acd2d5ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_d54d794b-1c8b-4515-84cc-243acd2d5ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_6e5fd436-8da2-48c1-8c8f-cb25e8c1fa4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_6e5fd436-8da2-48c1-8c8f-cb25e8c1fa4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_e19eea8a-595a-442c-8ec8-2732f76b8d73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_e19eea8a-595a-442c-8ec8-2732f76b8d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable_756c5d4f-7a82-4c04-ad95-c97b3edd2c37" xlink:href="ameh-20230630.xsd#ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable_756c5d4f-7a82-4c04-ad95-c97b3edd2c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable_4fc9b1e2-9152-4e41-b73e-f53e1de7ae74" xlink:href="ameh-20230630.xsd#ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable_4fc9b1e2-9152-4e41-b73e-f53e1de7ae74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_779e728b-6734-44a9-8071-bd8b174a726e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_779e728b-6734-44a9-8071-bd8b174a726e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_eac5c020-dc8d-4415-a866-019b2b90822c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32238da0-af98-4b4b-9945-55594cd626a6" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_eac5c020-dc8d-4415-a866-019b2b90822c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#LeasesScheduleofComponentsofLeaseExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3d2254cd-8069-480c-b7a5-f830f1e29843" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_359e7473-4854-4816-8217-0d4ecf461e81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d2254cd-8069-480c-b7a5-f830f1e29843" xlink:to="loc_us-gaap_OperatingLeaseCost_359e7473-4854-4816-8217-0d4ecf461e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FinanceLeaseCostsAbstract_2714c4c0-5f97-4c8f-ad90-db17f3f2b5cf" xlink:href="ameh-20230630.xsd#ameh_FinanceLeaseCostsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d2254cd-8069-480c-b7a5-f830f1e29843" xlink:to="loc_ameh_FinanceLeaseCostsAbstract_2714c4c0-5f97-4c8f-ad90-db17f3f2b5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e6967566-1310-4d61-b13a-3841bbe40251" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_FinanceLeaseCostsAbstract_2714c4c0-5f97-4c8f-ad90-db17f3f2b5cf" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e6967566-1310-4d61-b13a-3841bbe40251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_e5cc3086-6120-40e1-8f1a-72bab809282c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_FinanceLeaseCostsAbstract_2714c4c0-5f97-4c8f-ad90-db17f3f2b5cf" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_e5cc3086-6120-40e1-8f1a-72bab809282c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_f7df9543-136a-4cad-b0c4-01b9b26ebb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d2254cd-8069-480c-b7a5-f830f1e29843" xlink:to="loc_us-gaap_SubleaseIncome_f7df9543-136a-4cad-b0c4-01b9b26ebb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_4f5e4e0d-5891-4886-a13f-55c9738ca4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d2254cd-8069-480c-b7a5-f830f1e29843" xlink:to="loc_us-gaap_LeaseCost_4f5e4e0d-5891-4886-a13f-55c9738ca4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#LeasesScheduleofOtherInformationRelatedtoLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_dd9b2f5e-f44e-4458-b95e-be107efa68c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CashPaidForLeaseLiabilitiesAbstractAbstract_2a453645-4d12-4a5e-898e-4309c6ca97da" xlink:href="ameh-20230630.xsd#ameh_CashPaidForLeaseLiabilitiesAbstractAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dd9b2f5e-f44e-4458-b95e-be107efa68c4" xlink:to="loc_ameh_CashPaidForLeaseLiabilitiesAbstractAbstract_2a453645-4d12-4a5e-898e-4309c6ca97da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_615db2c1-e5f8-4799-9155-0945b0388b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_CashPaidForLeaseLiabilitiesAbstractAbstract_2a453645-4d12-4a5e-898e-4309c6ca97da" xlink:to="loc_us-gaap_OperatingLeasePayments_615db2c1-e5f8-4799-9155-0945b0388b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_904b24a8-96e3-450b-817c-8a4b5c1e263f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_CashPaidForLeaseLiabilitiesAbstractAbstract_2a453645-4d12-4a5e-898e-4309c6ca97da" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_904b24a8-96e3-450b-817c-8a4b5c1e263f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_1b946ece-9b76-4704-9d80-2a8ce5abc5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_CashPaidForLeaseLiabilitiesAbstractAbstract_2a453645-4d12-4a5e-898e-4309c6ca97da" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_1b946ece-9b76-4704-9d80-2a8ce5abc5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LeaseWeightedAverageRemainingLeaseTermAbstract_660ccc6c-da9a-4412-b479-730e3d5f4951" xlink:href="ameh-20230630.xsd#ameh_LeaseWeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dd9b2f5e-f44e-4458-b95e-be107efa68c4" xlink:to="loc_ameh_LeaseWeightedAverageRemainingLeaseTermAbstract_660ccc6c-da9a-4412-b479-730e3d5f4951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_045e39a5-5980-4b86-8e6f-84bcf9d4ca9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_LeaseWeightedAverageRemainingLeaseTermAbstract_660ccc6c-da9a-4412-b479-730e3d5f4951" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_045e39a5-5980-4b86-8e6f-84bcf9d4ca9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_48fd7a0c-42ef-41f2-ac1b-ef456c4e523a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_LeaseWeightedAverageRemainingLeaseTermAbstract_660ccc6c-da9a-4412-b479-730e3d5f4951" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_48fd7a0c-42ef-41f2-ac1b-ef456c4e523a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LeaseWeightedAverageDiscountRateAbstract_2705f745-541e-4c1b-8465-b7981e9d2a5a" xlink:href="ameh-20230630.xsd#ameh_LeaseWeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dd9b2f5e-f44e-4458-b95e-be107efa68c4" xlink:to="loc_ameh_LeaseWeightedAverageDiscountRateAbstract_2705f745-541e-4c1b-8465-b7981e9d2a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a176d461-4eb4-41b7-be27-ec85e483807c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_LeaseWeightedAverageDiscountRateAbstract_2705f745-541e-4c1b-8465-b7981e9d2a5a" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a176d461-4eb4-41b7-be27-ec85e483807c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_8773612e-b9eb-4b4f-b8de-9a8c378942d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ameh_LeaseWeightedAverageDiscountRateAbstract_2705f745-541e-4c1b-8465-b7981e9d2a5a" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_8773612e-b9eb-4b4f-b8de-9a8c378942d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_286c6971-5cc5-48da-ac22-865bb7c382f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e8678694-5828-4c81-8240-3f600317c196" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_286c6971-5cc5-48da-ac22-865bb7c382f8" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e8678694-5828-4c81-8240-3f600317c196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_64396f6d-558d-4f7b-88b8-6f44b6843260" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e8678694-5828-4c81-8240-3f600317c196" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_64396f6d-558d-4f7b-88b8-6f44b6843260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a5d06ad1-709e-468f-ad93-605c43a348c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e8678694-5828-4c81-8240-3f600317c196" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a5d06ad1-709e-468f-ad93-605c43a348c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b09f1ded-92ef-423b-89d4-d3465811013b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e8678694-5828-4c81-8240-3f600317c196" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b09f1ded-92ef-423b-89d4-d3465811013b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c7263ebb-39ec-4af4-bd77-080881583dec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e8678694-5828-4c81-8240-3f600317c196" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c7263ebb-39ec-4af4-bd77-080881583dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3548fa33-7625-4134-9d0d-3cf96943219e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e8678694-5828-4c81-8240-3f600317c196" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3548fa33-7625-4134-9d0d-3cf96943219e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_50026e83-3bfd-4226-8192-f54e2c6cc8af" xlink:href="ameh-20230630.xsd#ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e8678694-5828-4c81-8240-3f600317c196" xlink:to="loc_ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_50026e83-3bfd-4226-8192-f54e2c6cc8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d7d6587c-20bc-4cd1-9e37-f5a4b5ce7753" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e8678694-5828-4c81-8240-3f600317c196" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d7d6587c-20bc-4cd1-9e37-f5a4b5ce7753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_94558992-7de1-4ede-ac3d-7d648567d544" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e8678694-5828-4c81-8240-3f600317c196" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_94558992-7de1-4ede-ac3d-7d648567d544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_be935b21-aa43-43fe-a013-328cbeb3e6a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e8678694-5828-4c81-8240-3f600317c196" xlink:to="loc_us-gaap_OperatingLeaseLiability_be935b21-aa43-43fe-a013-328cbeb3e6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b2687014-927b-4a0c-9f04-f1f443ae2902" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e8678694-5828-4c81-8240-3f600317c196" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b2687014-927b-4a0c-9f04-f1f443ae2902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f4eb7ef7-10e9-4db8-ae67-78a436938891" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e8678694-5828-4c81-8240-3f600317c196" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f4eb7ef7-10e9-4db8-ae67-78a436938891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e2ad83b-3226-42e7-99b6-4a7403c58110" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_286c6971-5cc5-48da-ac22-865bb7c382f8" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e2ad83b-3226-42e7-99b6-4a7403c58110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_83ff75b2-4789-4723-8231-99cb7227b0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e2ad83b-3226-42e7-99b6-4a7403c58110" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_83ff75b2-4789-4723-8231-99cb7227b0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d660fda6-b4b2-4703-a88b-1eb25ea2f402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e2ad83b-3226-42e7-99b6-4a7403c58110" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d660fda6-b4b2-4703-a88b-1eb25ea2f402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_f34e2ae6-c91f-45af-8c06-b11c28d9e481" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e2ad83b-3226-42e7-99b6-4a7403c58110" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_f34e2ae6-c91f-45af-8c06-b11c28d9e481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_e12dce03-21c2-4c69-8d46-8a1e61f93c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e2ad83b-3226-42e7-99b6-4a7403c58110" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_e12dce03-21c2-4c69-8d46-8a1e61f93c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_b443fe3b-d3b8-471f-92bf-035770831b76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e2ad83b-3226-42e7-99b6-4a7403c58110" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_b443fe3b-d3b8-471f-92bf-035770831b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_FinanceLeaseLiabilityToBePaidAfterYearFour_ccda3b3e-43c7-4908-bf2e-a56c9953a8b7" xlink:href="ameh-20230630.xsd#ameh_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e2ad83b-3226-42e7-99b6-4a7403c58110" xlink:to="loc_ameh_FinanceLeaseLiabilityToBePaidAfterYearFour_ccda3b3e-43c7-4908-bf2e-a56c9953a8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_9fba2883-6c38-440c-9369-4b2496ee5d96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e2ad83b-3226-42e7-99b6-4a7403c58110" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_9fba2883-6c38-440c-9369-4b2496ee5d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_b568012b-f30e-44b7-afe5-2ed4a94d295c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e2ad83b-3226-42e7-99b6-4a7403c58110" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_b568012b-f30e-44b7-afe5-2ed4a94d295c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_1649944c-7a62-4d07-a4e4-5cff9a321d69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e2ad83b-3226-42e7-99b6-4a7403c58110" xlink:to="loc_us-gaap_FinanceLeaseLiability_1649944c-7a62-4d07-a4e4-5cff9a321d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_20a28bf9-4843-4546-8fd9-5c9c0e8454f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e2ad83b-3226-42e7-99b6-4a7403c58110" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_20a28bf9-4843-4546-8fd9-5c9c0e8454f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_fa948e03-6787-45fb-9cb1-ac62f68ab460" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e2ad83b-3226-42e7-99b6-4a7403c58110" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_fa948e03-6787-45fb-9cb1-ac62f68ab460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1" xlink:type="simple" xlink:href="ameh-20230630.xsd#LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.apollomed.net/role/SegmentsNarrativeDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#SegmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/SegmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_45a074f7-9806-4c7c-8b60-80807d33c063" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_e7baebd0-bfb0-4fd8-89ca-eda45a2e471a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_45a074f7-9806-4c7c-8b60-80807d33c063" xlink:to="loc_us-gaap_NumberOfReportableSegments_e7baebd0-bfb0-4fd8-89ca-eda45a2e471a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#SegmentsScheduleofInformationaboutourSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f470b040-d53b-40f8-b902-702012dd5e95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_58bafea5-936d-4c9a-91d2-83e437e5e559" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f470b040-d53b-40f8-b902-702012dd5e95" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_58bafea5-936d-4c9a-91d2-83e437e5e559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3978f50f-3dcd-4d20-aa40-4988c0e35f42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_58bafea5-936d-4c9a-91d2-83e437e5e559" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3978f50f-3dcd-4d20-aa40-4988c0e35f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_234213bd-c640-45c2-847a-c406454297e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3978f50f-3dcd-4d20-aa40-4988c0e35f42" xlink:to="loc_us-gaap_SegmentDomain_234213bd-c640-45c2-847a-c406454297e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CareEnablementMember_c1a0f975-114f-4a50-b3fc-2d74f0bccd1b" xlink:href="ameh-20230630.xsd#ameh_CareEnablementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_234213bd-c640-45c2-847a-c406454297e3" xlink:to="loc_ameh_CareEnablementMember_c1a0f975-114f-4a50-b3fc-2d74f0bccd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CarePartnersMember_e61125ee-bec9-475e-91c2-af3656597aff" xlink:href="ameh-20230630.xsd#ameh_CarePartnersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_234213bd-c640-45c2-847a-c406454297e3" xlink:to="loc_ameh_CarePartnersMember_e61125ee-bec9-475e-91c2-af3656597aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_CareDeliveryMember_bffb643e-af72-4c72-ad59-f4219d09bedd" xlink:href="ameh-20230630.xsd#ameh_CareDeliveryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_234213bd-c640-45c2-847a-c406454297e3" xlink:to="loc_ameh_CareDeliveryMember_bffb643e-af72-4c72-ad59-f4219d09bedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_ee4a357e-17c3-4d6a-80e1-af2a085167ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_234213bd-c640-45c2-847a-c406454297e3" xlink:to="loc_us-gaap_AllOtherSegmentsMember_ee4a357e-17c3-4d6a-80e1-af2a085167ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_889b5685-d585-4eaf-bdb2-6b8e32fff991" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_58bafea5-936d-4c9a-91d2-83e437e5e559" xlink:to="loc_srt_ConsolidationItemsAxis_889b5685-d585-4eaf-bdb2-6b8e32fff991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2078c77a-6617-4a8e-bd9e-a8df482036f9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_889b5685-d585-4eaf-bdb2-6b8e32fff991" xlink:to="loc_srt_ConsolidationItemsDomain_2078c77a-6617-4a8e-bd9e-a8df482036f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1f4ff5e8-a4b2-41ec-9bf2-d1f86503f633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2078c77a-6617-4a8e-bd9e-a8df482036f9" xlink:to="loc_us-gaap_OperatingSegmentsMember_1f4ff5e8-a4b2-41ec-9bf2-d1f86503f633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_5d9a1a6d-0136-4378-b1c2-444bbc79f6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2078c77a-6617-4a8e-bd9e-a8df482036f9" xlink:to="loc_us-gaap_IntersegmentEliminationMember_5d9a1a6d-0136-4378-b1c2-444bbc79f6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e4d476d6-4dcc-465a-a1ce-f11149307bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2078c77a-6617-4a8e-bd9e-a8df482036f9" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e4d476d6-4dcc-465a-a1ce-f11149307bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_1065644e-612b-4ce1-9efc-29e3da29a580" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_58bafea5-936d-4c9a-91d2-83e437e5e559" xlink:to="loc_us-gaap_SubsegmentsAxis_1065644e-612b-4ce1-9efc-29e3da29a580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_b014461f-54fb-4fc4-bade-66d704494203" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_1065644e-612b-4ce1-9efc-29e3da29a580" xlink:to="loc_us-gaap_SubsegmentsDomain_b014461f-54fb-4fc4-bade-66d704494203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_d00aff50-692d-476f-a264-1cfbc440e0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_b014461f-54fb-4fc4-bade-66d704494203" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_d00aff50-692d-476f-a264-1cfbc440e0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_e13002c6-bce3-4b14-af36-8b18b1ea10ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_b014461f-54fb-4fc4-bade-66d704494203" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_e13002c6-bce3-4b14-af36-8b18b1ea10ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_dc42d5bf-afb3-4a07-9256-01851663c8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_58bafea5-936d-4c9a-91d2-83e437e5e559" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_dc42d5bf-afb3-4a07-9256-01851663c8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_07df1ca4-fd8a-4f86-96b6-21c01ba18c34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dc42d5bf-afb3-4a07-9256-01851663c8cf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_07df1ca4-fd8a-4f86-96b6-21c01ba18c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_d245e8d6-d97f-4307-aa8f-7ccbf87e4777" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dc42d5bf-afb3-4a07-9256-01851663c8cf" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_d245e8d6-d97f-4307-aa8f-7ccbf87e4777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_38f6ca3b-5fcd-4bb4-bb9b-ba143e89ebf7" xlink:href="ameh-20230630.xsd#ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dc42d5bf-afb3-4a07-9256-01851663c8cf" xlink:to="loc_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_38f6ca3b-5fcd-4bb4-bb9b-ba143e89ebf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b95e0210-b99d-420b-8fe0-8a9e87181ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dc42d5bf-afb3-4a07-9256-01851663c8cf" xlink:to="loc_us-gaap_CostsAndExpenses_b95e0210-b99d-420b-8fe0-8a9e87181ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8868cdc9-1964-4340-af05-c3d7d57285f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dc42d5bf-afb3-4a07-9256-01851663c8cf" xlink:to="loc_us-gaap_OperatingIncomeLoss_8868cdc9-1964-4340-af05-c3d7d57285f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails" xlink:type="simple" xlink:href="ameh-20230630.xsd#SubsequentEventsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_f480b358-5370-4856-bca4-9a3f14a00ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_f9e5be88-335d-43a6-a2a5-b32fb796c403" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_f480b358-5370-4856-bca4-9a3f14a00ed6" xlink:to="loc_us-gaap_SubsequentEventTable_f9e5be88-335d-43a6-a2a5-b32fb796c403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9149721d-8cfa-48e0-991b-284dd1bb9e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_f9e5be88-335d-43a6-a2a5-b32fb796c403" xlink:to="loc_us-gaap_DebtInstrumentAxis_9149721d-8cfa-48e0-991b-284dd1bb9e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fa3b920b-0b28-4798-a73b-33ff73b3c29a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9149721d-8cfa-48e0-991b-284dd1bb9e1e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fa3b920b-0b28-4798-a73b-33ff73b3c29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_IntraCareConvertiblePromissoryNoteReceivableMember_2998ec12-fd56-407b-a25b-50fff8fb50e0" xlink:href="ameh-20230630.xsd#ameh_IntraCareConvertiblePromissoryNoteReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa3b920b-0b28-4798-a73b-33ff73b3c29a" xlink:to="loc_ameh_IntraCareConvertiblePromissoryNoteReceivableMember_2998ec12-fd56-407b-a25b-50fff8fb50e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ccf60463-bd9b-4842-9070-f783d7b77ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_f9e5be88-335d-43a6-a2a5-b32fb796c403" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ccf60463-bd9b-4842-9070-f783d7b77ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_221b4713-616a-4fa1-b0de-0e6d5d62de0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ccf60463-bd9b-4842-9070-f783d7b77ef2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_221b4713-616a-4fa1-b0de-0e6d5d62de0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_784d14f4-40bf-4808-ae7e-5e822ba34ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_221b4713-616a-4fa1-b0de-0e6d5d62de0b" xlink:to="loc_us-gaap_SubsequentEventMember_784d14f4-40bf-4808-ae7e-5e822ba34ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ac48e0c1-4af9-4b6c-8912-337f02b8cbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_f9e5be88-335d-43a6-a2a5-b32fb796c403" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ac48e0c1-4af9-4b6c-8912-337f02b8cbc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3e2c3233-d4f9-44bc-9421-bea3da7d373d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ac48e0c1-4af9-4b6c-8912-337f02b8cbc0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3e2c3233-d4f9-44bc-9421-bea3da7d373d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_4f331df7-faa1-4808-8848-9f8614c648d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3e2c3233-d4f9-44bc-9421-bea3da7d373d" xlink:to="loc_us-gaap_NotesReceivableMember_4f331df7-faa1-4808-8848-9f8614c648d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_db029837-d4ee-46fb-b133-75a84c5ccc38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_f9e5be88-335d-43a6-a2a5-b32fb796c403" xlink:to="loc_us-gaap_SubsequentEventLineItems_db029837-d4ee-46fb-b133-75a84c5ccc38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NumberOfPrimaryCareProvider_496a652b-9fb4-4f7f-8c55-da738791b50a" xlink:href="ameh-20230630.xsd#ameh_NumberOfPrimaryCareProvider"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_db029837-d4ee-46fb-b133-75a84c5ccc38" xlink:to="loc_ameh_NumberOfPrimaryCareProvider_496a652b-9fb4-4f7f-8c55-da738791b50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_NumberOfPrimaryCareServices_ea36b135-9df6-493f-93d7-e791f555f3c0" xlink:href="ameh-20230630.xsd#ameh_NumberOfPrimaryCareServices"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_db029837-d4ee-46fb-b133-75a84c5ccc38" xlink:to="loc_ameh_NumberOfPrimaryCareServices_ea36b135-9df6-493f-93d7-e791f555f3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_041d94b1-16d1-4153-96f9-08d010e6c560" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_db029837-d4ee-46fb-b133-75a84c5ccc38" xlink:to="loc_us-gaap_DebtInstrumentTerm_041d94b1-16d1-4153-96f9-08d010e6c560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_86391862-3e4e-4efa-924e-3b877b00bbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_db029837-d4ee-46fb-b133-75a84c5ccc38" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_86391862-3e4e-4efa-924e-3b877b00bbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f478b4cf-7e11-4c07-a29b-bf71ed2927fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_db029837-d4ee-46fb-b133-75a84c5ccc38" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f478b4cf-7e11-4c07-a29b-bf71ed2927fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_StockAwardsAndUnitsMember" xlink:href="ameh-20230630.xsd#ameh_StockAwardsAndUnitsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ameh_StockAwardsAndUnitsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ameh_PerformanceBasedRestrictedStockMember" xlink:href="ameh-20230630.xsd#ameh_PerformanceBasedRestrictedStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ameh_PerformanceBasedRestrictedStockMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ameh-20230630_g1.jpg
<TEXT>
begin 644 ameh-20230630_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
M   !    2@,#  $    !     %$0  $    ! 0   %$1  0    !   2=%$2
M  0    !   2=        8:@  "QC__; $,  @$! @$! @(" @(" @(#!0,#
M P,#!@0$ P4'!@<'!P8'!P@)"PD(" H(!P<*#0H*"PP,# P'"0X/#0P."PP,
M#/_; $,! @(" P,#!@,#!@P(!P@,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( O /T ,!(@ "$0$#$0'_
MQ  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#
M!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*"
M"0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$!
M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /W\HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M??VN--U+2=:\8?\ "/>%]4PLVA>'(/[.M&C,!@DA>0%KF6&17<O%--)&S/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#!E)!!!'%7*_/VFG9GUE[ZH**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!]=?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^Z8/!T<)1CA\/'EC'9?UU[L_,,1B*E>HZM5W;"BBBNHP"BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-(RJ,(B1QIX7117[UAL/2P]*-&C'EC'1)'Y76K3JS=2H[M[L****V,PHHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)JNM6=V_ZT"BBBNTY@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7Y+_P#!R+^WO-I5E8? 'PU>6;1ZE;Q:KXR*
MQQ3.BB5);*S#;RT+[HOM$BE%<H;4J^QW5OTB_:X_:0TG]D3]FSQA\1]9C^T6
M?A6P:XCMMSI]NN698K:WWHCE/-G>*/>4*IYFYOE4FOY=?B#X\U;XI^/=<\3Z
M]=?;M<\1ZA/JFHW/E)%]HN9Y&EE?8@"+N=F.% 49P !Q7Z#P#DBQ.)>.JKW:
M;T\Y?_:[^K1\EQ5F7L:*PL/BGOY+_@[>ES'HHHK]G/S@**** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7X+_M@_P#!:+]I;X6_M;?%+PQH
M/Q)^PZ'X<\7ZMI>G6W_"/:5+]GMH+V:*)-[VQ=MJ*HRQ+'&22>:_>BOY<_\
M@H#_ ,GY?&[_ +'[7O\ TXSU^@>'^#P^(Q%6.(IQFE%6YDGU\SY/BS$UJ-&F
MZ4G'5[-KIY'KW_#]W]JS_HJG_EM:/_\ (E'_  _=_:L_Z*I_Y;6C_P#R)7R+
M17ZG_866_P#0/3_\ C_D?"_VIC?^?TO_  )_YGUU_P /W?VK/^BJ?^6UH_\
M\B4?\/W?VK/^BJ?^6UH__P B5\BT4?V%EO\ T#T__ (_Y!_:F-_Y_2_\"?\
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M$(8>"@N1.T4DK\TM=#] X5Q%6MA)2JR<GS/5MOHNX4445\0?3!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5\!_\%M/VROB?^RMXT^#.F_#KQ9-X5@\7
M?VW_ &HT6FV5X]Q]F2S:''VF&4+M,LGW0,[N<X&/ORORV_X.,O\ DJ?[.G_<
MR_\ HG3Z^DX1H4ZV;4J=:*E%\UTU=?#)[,\7B*M.EE]2=-M-6U6C^)'A'_#T
MG]I#_HK^K?\ A/:'_P#(-'_#TG]I#_HK^K?^$]H?_P @UX/17[1_8>7?] \/
M_ (_Y'Y;_:V._P"?T_\ P)_YGO'_  ])_:0_Z*_JW_A/:'_\@T?\/2?VD/\
MHK^K?^$]H?\ \@UX/11_8>7?] \/_ (_Y!_:V._Y_3_\"?\ F>\?\/2?VD/^
MBOZM_P"$]H?_ ,@T?\/2?VD/^BOZM_X3VA__ "#7@]%']AY=_P! \/\ P"/^
M0?VMCO\ G]/_ ,"?^9[Q_P /2?VD/^BOZM_X3VA__(-'_#TG]I#_ **_JW_A
M/:'_ /(->#T4?V'EW_0/#_P"/^0?VMCO^?T__ G_ )GO'_#TG]I#_HK^K?\
MA/:'_P#(-'_#TG]I#_HK^K?^$]H?_P @UX/11_8>7?\ 0/#_ , C_D']K8[_
M )_3_P# G_F?JQ_P1I_:D^)'[2O_  LC_A8/C"\\5_V+_9GV#S]/L;3[+YOV
MSS,?98(MV[RX_O[L;>,9.?N"OSC_ .#?S_FK7_<'_P#;^OT<K\6XMH4Z.;5:
M=&*C%<MDDDOACT1^H\.UIU<NISJ-R;OJ]7\3"BBBOG#VPHHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MOQH_X.:?VL9O$'Q)\'_!C3;JSDTOP_;KXEUD0W$4S_;Y1+%;PRJ%WPO%;EY,
M;_WB7Z,4PJ,?V ^('CS2?A9X"USQ/KUU]AT/PY83ZIJ-SY3R_9[:"-I97V("
M[;45CA06., $\5_+1^TY\==0_:;_ &AO&GQ U(7D=QXMU>XU%+>YO6O'L87<
M^3;"5@"R0Q;(E^50$C4!5  'W_A_E?M\:\7->[36G^)[?<KORT\CY/BW'>RP
MRH1>LW^"_P"#;\3A:***_:3\W"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBC- !1110 449HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ K6\ ^.]6^%WCO1?$V@WG]GZYX=OX-4TZZ$22_9KF"198I-CAD;:ZJ=K*5.
M,$$<5DT4I14ERRV'&33NC^J[]F'XZV/[3?[._@OX@:>MG%!XNT>WU%[>UO5O
M8[&9T!FM3*H4,\,N^)OE4AXV!52"H[JOSG_X-I_CS_PL#]C+Q!X'NM5^UZC\
M/=?<V]E]E\O[!IUZOG0_O @63?=+J#<LSKC!VKY8K]&*_FO.L#]3QU7#=(MV
M]-U^#1^S9;BOK&%A6[K7UZ_B%%%%>8=H4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5^6W_!QE_P E3_9T_P"YE_\ 1.GU^I-?EM_P
M<9?\E3_9T_[F7_T3I]?4<%_\CFC_ -O?^D2/!XF_Y%E7Y?\ I2/A"BBBOW@_
M(0HHHH **** "BBB@ HHHH _1S_@W\_YJU_W!_\ V_K]'*_./_@W\_YJU_W!
M_P#V_K]'*_!^-/\ D<UO^W?_ $B)^N\+_P#(LI?]O?\ I3"BBBOESWPHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** /@O_@X7_:OA^ _[$4G@JSNKRW\2?%:X_LRW-M<2V\D-A \<M[(6
M52KHRF*V>)G3>EXQ^95=3^!=?>G_  <6_'6_^)?_  4'NO"<@O+?2_AQI%GI
MUO UXTMO--<Q+>RW*18"Q.RW$,38R6%K&2V-JK\%U^_<&9>L+E=-]9^^_GM_
MY+;YW/RCB/&.OCI+I'W5\M_QN%%%%?5'A!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445<\/^'[_P 6:]8Z
M5I5C>:GJFIW$=I9V=I"TUQ=S2,%2.-%!9W9B%"J"22 !FANRNPWT13HK[&_9
MV_X(1?M&?M!V4=]+X5L_ .EW%O)-#=>+KEK!W9)?+,1M422[C<_,RF2%$*+N
M#89-WWI\$O\ @V.^%OA$6]QX\\<^+_&EY:Z@MQY.GQ1:-875LNP_9IH_WTQW
M$.&>.>-MK@+L9=Y^;Q_%N5X1\LZJD^T?>_+1?-GLX7(,=B-8PLN[T_X/W(_$
M6O4?A)^Q'\8OCO9:/>>#_AAXZU[2]>N!:V.J6VBW!TV9_-,))NRH@1%D#*[N
MX1-K;BH4D?T7?LZ_\$Z_@C^RA>QWG@/X;^'='U2"XDN8-4FC?4-2MGDB$+B*
M[N6DGC0QY4HCA/G?C+L3[37R.,\25>V$H_.3_1?_ "1]#A^#7O7J?)+]7_D?
M@7\,?^#<?]HSQ[H$UYJL?@7P3<1W#0K8ZUK9EN)4"J1*ILHKB/82Q4!G#Y1L
MJ!M+?1GPB_X-<+""[T>Z\>_%J\NH#;AM5TS0-&6W=9C$<I!>32."B2D?.]L"
MZ*?DC+97]:**^9Q/'6;5=(S4/\*7YN[_ !N>Q1X7R^GO%R]6_P!+(^"_AC_P
M;C_LY^ M>FO-5C\=>-K>2 PK8ZUK8AMX6+*1*ILHK>3> I4!G*8=LJ3M(]1\
M"?\ !%C]E_X<^*[76=/^$ND7%Y9[S''JFH7VJVC;D9#OM[J>2&3AB1O0[6 8
M8901]1T5XU;/\RJWYZ\]?[S2^Y.QZ5/*L'#X:4?N5_O/(O\ AWY\!?\ HB/P
MB_\ ".T[_P",UZ/X%\ :#\+O"MKH7AG1-)\.Z'8[_LVGZ99QV=K;[W9WV11@
M(NYV9C@#)8GJ36M17G5,36J+EJ2;7FVSLA1IP=X12]$%%%%8F@5Y&?\ @G]\
M!F//P2^$9_[D[3O_ (S7KE%:T\15I_PY->C:,ZE*$_C2?JCYS^*O_!(_]FSX
MR&P_M?X/^$;/^S?,\K^PXI-"W[]F[S/L+0^;C8-OF;MN6VXW-GR_XF_\&]G[
M,WCW0(;/2O#?B+P3<1W"S-?:+K]S-<2J%8&)A>M<1["6#$A ^47# ;@?MRBN
M^CGF8TK*G7FDNG,[?=>QRU,LPE3XZ47\E?[S\N?BI_P:[> ]7^P?\(1\4O%W
MA[R_,^V_VYI]OK/VC.WR_+\DVGE[</NW;]VY<;=IW?/_ ,7/^#97XQ>%;W6)
MO!_C#P+XNTNQMS-8I<R3Z7J6I.L08Q"$QR01NTFY%+7.P_*S,@)"_N-17L8?
MC;-Z6CJ<R[-)_C9/\3SZW#.7U/L6?DW^6WX'\R_Q-_X)6?M&?"37X=-U7X-^
M.KJXFMUNE?1=.;6[<(690&FLO.B5\H<H6#@%20 RD_/]?UT5R/Q4_9^\!_'7
M[!_PF_@CPCXR_LOS/L7]N:/;ZA]C\S;YGE^<C;-VQ-VW&=BYZ"OI,+XE5%IB
M:*?G%V_!W_/[SQ\1P;!ZT*C7JK_BK?D?RBT5^]'QN_X-P/@%\1C<7'A6;Q?\
M/;S^SVM[6&PU'[?IZW/SE+B6.Z$DTG+*&1)XU98P!L8LY^(OVB?^#;KXW?#&
M]EF\!W_ASXG:6UQ'# D-PFD:EM,19Y98;EQ B+("@"7,CMN1MH!8)]=@>-,J
MQ+M[3D?:6GXZK\3Y_%<-X^CKR\R_NZ_AO^!^>E%=%\3O@_XN^">O0Z5XS\+>
M(_".J7%N+N*SUK39M/N)(2S()52558H61U# 8)1AU!KG:^HC.,ES1=T>'*+B
M[26H44451(4444 %%%% !111F@#]EO\ @UP^&6H:5\)?BYXRDFLVTO7M7L-%
MMXE=OM"364,LTK.NW:$*W\(4AB25DR% 4M^J5?.?_!*O]C3_ (8:_8O\->$;
MV'RO%&I9USQ+\^[&HW"IOBXDDC_<QI#;[HF"2?9_, !<U]&5_.7$F.CB\RK8
MBF[INR?=)))_@?L63X:6'P5.E+1I:^KU?YA1117B'I!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M17YR?8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %?RY_\ !0'_ )/R^-W_ &/VO?\ IQGK
M^HROY<_^"@/_ "?E\;O^Q^U[_P!.,]?I7AM_O-;_  K\SXWC+^!3]7^1Y'11
M17Z\?GH4444 %%%% !1110 4'I10>E ']=%%%%?RN?N@4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1D_L)R_3\V?.<55W3P#BOM-+]?T/B*BBBOW8_+@HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "ORV_X.,O\ DJ?[.G_<R_\ HG3Z_4FO
MRV_X.,O^2I_LZ?\ <R_^B=/KZC@O_D<T?^WO_2)'@\3?\BRK\O\ TI'PA111
M7[P?D(4444 %%%% !1110 4444 ?HY_P;^?\U:_[@_\ [?U^CE?G'_P;^?\
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MD$'N#7AUL/4I/EJ*QZU&O"HKP=QU%%%8FP4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ<,"!D_\/WOV4S_S53_RV=8_^1*[HY)F,ES1P\[?X)?Y'*\SP:=G5C_X$O\
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17G/CO\
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M7?\ TW3UU8'_ 'FG_B7YHPQ7\&?H_P C^76BBBOZ>/Q(**** "BBB@ HHHH
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MFF_\%C?V==6N&CB\>7RLJ[B9O"VL0KC@?>>U SSTSFNY9)F+5UAY_P#@$O\
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MKYNM_P#@KG^SW<P1R+X_<+(H8!] U-& //(-L"#[$9%9G_#Z']F\?\SUJ_\
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M/UC*\MIX*BJ4-^K[O^MD%%%%>*>D%%%% !1110 4444 %%%% !1110 4444
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MZV863)QA@HPN,_>X&.N,9/I-?*8C#U*,N6HO^"?14<1"K'F@%%%%8&P4444
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M ,GY?&[_ +'[7O\ TXSU^E>&W^\UO\*_,^-XR_@4_5_D>1T445^O'YZ%%%%
M!1110 4444 %!Z44'I0!_711117\KG[H%%%% !1110 4444 %>0_\% _^3"_
MC=_V(.N_^FZ>O7J\A_X*!_\ )A?QN_[$'7?_ $W3UU8'_>:?^)?FC#%?P9^C
M_(_EUHHHK^GC\2"BBB@ HHHH **** "BBB@#ZZ_X(1?\I6/A7_W%O_3/?5_1
M=7\Z/_!"+_E*Q\*_^XM_Z9[ZOZ+J_%O$;_D90_Z]K_TJ1^D<'_[E+_$_RB%%
M%%? 'U@4444 %%%% !1110 4444 %%%% !1110 4444 %%>+_M>?\%!OA/\
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MM#_^0:\(HH_L3+O^@>'_ (!'_(/[6QW_ #^G_P"!/_,]W_X>D?M(?]%@U?\
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M^N\/B%KT?1KNGV_IGZ+@,PHXRDJU!Z?BGV84445YQVGYS_\ !S@,_L&^$?\
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M_"-WW]E^-+'3X[W6_"]V6^U:9ES&QCD*JES"' _>Q=%EA\Q8GD$=?1E?R7^
M_B#KWPL\5VNO>&-<U?PYKECO^S:CI=Y)9W=OO1HWV2QD.NY&93@C*L0>":_;
MC_@E7_P76T']IP^&?AO\4F_L/XGWFZSM]8\N.'2?$<J[!"O##R+R;<P\H((G
M>/Y&5I8[<?D'$W!-3"7Q.!O*GNUNX_YK\5UON?H62\30Q%J.*M&?1]'_ )/\
M/38_1BBBBOS\^L"BBB@ HHHH **** "BBB@ HHHH **** /Y%QTHH'2BOZH/
MPL**** "BBB@ HHHH **** /UT_X-7?^:[?]R_\ ^Y.OUTK\B_\ @U=_YKM_
MW+__ +DZY#_@M/\ \%J/^%O?VM\'O@]JW_%(?/9^)?$MI)_R'^JO9VKC_ESZ
MB24?\?'*J?(R;C\9SS)<1F?$5:A0V]V[Z)<D=?\ )=?O:_1\LS*E@LHIU:O]
MZRZM\S_IOH>N_P#!3#_@X1TKX9D^$?@!>Z/XFUQOM$&J>)Y[9YK#2V'F1*MF
MK;4N9@X$HF.^VVJF!.)&\O\ '7QY\0=>^*?BNZU[Q/KFL>(]<OMGVG4=4O)+
MR[N-B*B;Y9"7;:BJHR3A5 ' %8]%?IN3Y#A,MI\F'CKUD]WZO]%H?$YAFF(Q
ML^:L].B6R"BBBO9/."BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KU+]D
M_P#;*^(?[%?Q)M?$O@'Q!>:9(MQ%-?::\KMINM+&'417< 8+,FV64 G#IYA:
M-D?##RVBLZU&G6@Z55*47NGLRZ=25.2G!V:V9^^G_!.'_@NYX%_;"O--\(^.
MH;/X>_$B^N(+"QMS+)+IOB&9HN3;RE<6[M*K*L$S$GS(4229V(7[TK^1>OT7
M_P""5G_!=;7OV8_^$:^&_P 4F_MSX7V>;*WUCRY)M6\.1'8(AD$^?9PX8>5L
M,J(_[MF6*. _EO$7 ?*GB,L^</\ Y%_H]>SV1]SD_%5VJ.-^4O\ /_/\.I^Z
M-%<W\(OB[X:^/7PTT;QAX/UBTU[PWX@MQ=6-];D[)DR0058!D=6#*Z. Z.K*
MP5E('25^7SA*$G&2LUHT^A]M&2DN:.J84445)04444 %%%% !1110 4444 %
M%%% !1110 4444 %<C\;OC[X+_9M\!7'B?QYXFTCPKH=ON7[3?SB/SY%C>7R
M84^_-,4C<K%&&D?:0JD\5\M_\%.O^"S7@O\ 8'^W>$=(M_\ A+?BI+8&>VTY
M"&L-&D?9Y3:@X<.NY&,JPQ@R.J+N,*RQRG\.OVL/VROB'^VI\2KKQ-X^\07F
MIR-<2S6.FK*ZZ;HJ2!%,5I 6*PIMBB!(R[^6&D9WRQ^TX?X,Q.8)5ZWN4GUZ
MOT7;S>G:Y\WFW$E'"-TJ7O3[=%ZO]#] /V[/^#D7Q+KNO:IX<^!%A9Z%H]K<
M-#%XMU&W%S?:@BM$1+;VLJ>7;HQ69<3K*[QR(VV"0%1^8OCOX@:]\4O%=UKW
MB;6]8\1ZY?;/M.HZI>27EW<;$6--\LA9VVHJJ,DX50.@%9%%?L&5Y+@\OAR8
M6"7=[M^KW^6W9(_/<=F6(Q<N:O*_ET7HOZ?<****]0X0HHHH **** "BBB@
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M=[7L?H>4\14<9:G/W9]NC]'^F_KN?5U%%%?'GT04444 %%%% !1110 4444
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MZDX Y.2<5;HHK[H^1"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*FTW4;C1M4M+ZSGFM;W3[B.[M;B%S'+;31N'CD1ARKHZJRL"""H(P14-%#5U
M9@FUJC[._8]_X++^-O@O+9Z-\26OOB#X4MX9$%X$C/B"UVQ(L"+(S1QW*@QD
M,;@^<QG:1KAM@C?]./@7^T%X-_:5\#GQ'X'UVVU[2$NI+*26..2&2WGC(W1R
M12*LD;8*N Z@LDD;C*.K'^?FND^$OQ@\5? ;QS#XF\%ZY>>'/$%O;S6L=[;+
M'(?*E7#H\<BM%*F0C[)$90\<;XW(I'P^><$X7%WJX2U.?_DK]4MO5?<SZO*>
M*J^':IXCWX?^3+T?7T?WH_H4HKY1_8%_X*F>&_VM[G3_  EKUNOAGXD&Q\Z2
MVX73M:D0R>;]A=G+[A&BS-!)\Z*[!&G6&65?JZOR/'8&O@ZSH8B/+)?U==UY
MGZ3A<72Q--5:+NG_ %KYA1117&= 4444 %%%% !1110 4444 %%%% !1110
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M^TMSYC&85T9VZ/8;1117<<@4444 %%%% !1110 4444 %%%% !1110 4444
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MHH **** "BBB@#T;X6?M4^-/@K\%_'_@7PSJ7]DZ/\3/L46OS0 K=W-M;"Y
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M<NVBBIC&,?A5ARDWN%%%%4(**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH AU#3K?5K-[>ZMX;JWDX>*5 Z/SGD'@\U^OW_!+W_@I+)^UQ:7
M'@KQ="D'Q%T.Q:_-S;P[;77;%)(XFN0!Q#,CRQ+)'PK&17BX9XH/R'K5\#^.
M]<^&/B[3_$'AO5[[0==TF87%G?6;A98''L0592,JR.&1U9D=65F4^%Q!D=+,
M\-[*6DUK%]G_ )/K]^Z1Z^39M4P%?G6L7\2[K_-=#^B.ORI_X*B?\%0_^%Z?
MVC\-?AKJ'_%"_-;:YKEL_P#R,_9K:W8?\N/4/(/^/KE5_P!'R;K+_;Y_X*R7
M'[4OP6\.^$?!MOJGA:SURQE;QU:RK\[/N")IT-R"/.MG EDE98T\V.2W1BNZ
MZME^,:^2X3X0=*7US'Q]Y/W8OI9[ON^W3KVM]'Q%Q+[1?5L&]&M9=[]%^O7I
MZE%%%?I1\*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% #+BWCNX)(I8TDBD4HZ.NY7!X(([@U^J__  2,_P""@O\ PN#PK#\-?'WB
M9K[Q[I[2?V'/?(5GUNPCB5MCSEC]HNXL2EB0LCPJKGS6CN):_*NKGA[Q!?>$
M?$>FZQI=Q]CU71;R#4;"Y\F.8VMS#(LL,H2161F21%8!E8949!'%>+GV2TLR
MPSHSTDM8OL_\GU/4RC-*F!KJK'5;-=U_FNA_1917CW["_P"U=9?MB?L]:9XI
MB1X-8M6&F:]!]C>VB@U&..-IO)#.^Z%O,22,B1R$D57(D5T7V&OY_P 1AZE"
MK*C55I1=FC]CHUH5::JTW=-704445B:A1110 4444 %%%% !1110 4444 %%
M%?E5_P %;/\ @I'?_%O7O$_P5\$OJ^B^%])N'TKQ5JP1K6XU^9&*3Z?"6PZ6
M:D%)9  ;@ED5A"K&X];)<GKYEB%0H[;M]$N_^2Z_>SS<TS.E@:/M:OR7=_UN
M^GX'I/\ P5+_ ."I<GA:?5/A9\+=4:/6(V>S\2>)+.7:VE$962QLY%/%T.5E
MF4_Z/RB'S]S6WYKW=W-J%[<75U<7-Y=WDTES<W-Q,TT]S-(Q>2621B6>1W9F
M9V)9F8DDDDU'17[GD^2X?+:"HT5KU?5O_+LNGXGY/FF:5L=5]I5VZ+HE_74*
M***]<\T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@"2UNYM/O;>ZM;BYL[NSF2YMKFVF:&>VEC8/'+'(I#)(C*K*ZD,K*"""
M :_2C_@EE_P5*?Q/-I7PK^*6J22:Q(4L_#?B2\E+-JI.%CLKR1CDW1X6*=C_
M *1PCGS]K7/YITVX@CNX'BEC62.12CHXW*X/!!'<&O(SC)</F5!T:RUZ/JG_
M )=UU_$]+*\TK8&JJE/;JNC7];,_HZHK\\_^"6G_  5+D\4SZ7\+?BEJC2:Q
M(R6?AOQ)>2[FU4G"QV-Y(W6Z/"Q3,?\ 2.$<^?M:Y_0ROPC-,KQ&7UWA\0M>
MCZ-=U_7DS]=R_,*.,HJM1>G7NGV84445YIVA1110 4444 %%%% !1110 444
M4 %?'O\ P40_X*RZ/^R#XF3P-X3TVS\8?$::W,U[!)<%+#PO$\1,$MX5!:21
MV*,MJI1WCW,TD*M&S])_P4P_;^TW]D/X876AZ+>^9\3O$UA*NB6\'ER-HZN&
MC74[@.K((XW!,<;J?/DC* ;%FDB_&"WMWCFN9Y[F\U"^U"XDO+V]O)FGNK^X
MD8M)/-(V6DD=B2S$Y)-??<(\*K&?[7C%^[Z+;F??T7EN_1W^/XDX@>%_V?#/
MW^KWMY>K_!>NFOXS\::Q\2/&.J>(O$6J7FMZ_K=P;K4-0NF!FNI2 N3M 55"
MJJ*B!41$1$5455&;117[!&,8Q48JR6R/S64G)\TG=L****HD**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *KW6DV][>VMQ+"KW%DS-!(?O
M1EE*M@^A!Z=.G<"K%% !1110 4444 %%%% !1110 4444 ?HY_P;^?\ -6O^
MX/\ ^W]?HY7YQ_\ !OY_S5K_ +@__M_7Z.5^#\:?\CFM_P!N_P#I$3]=X7_Y
M%E+_ +>_]*84445\N>^%%%% !1110 4444 %%%% !1110 4444 %%%% !7XJ
M_P#!2[]M/_AL+XW@Z1/YG@?POOMM!WVGV>6?>(_/N'W$O^\>,;0VW$:1Y1',
MF?M[_@LE^U[+\$O@S!X$T.ZME\0^/89H+X%(YFM=**M',2I;*-,S>6CE&!5+
MC!5T5A^2=?JG 61J,?[2K+5Z0\ELW\]EY7[GY[QAFUY?4:;T6LOT7ZOY=@HH
MHK],/A0HHHH **** "BBB@#]UO\ @GSXZL_B)^Q/\,K^QBN(8+70;?2V6=55
MO,LQ]DD(VDC:9('*G.2I4D*<@>Q5\S_\$A-:L]4_8"\&06MW:W$VFS:A;W<<
M4JNUK*;Z>41R '*L8Y(WVG!VR*>C GZ8K^<<XIJGCZU-;*<E\KL_;LMJ.>#I
M3?6,?R1SGQA^&-A\;/A)XI\&:K->6^E^+M(N]%O);1E6XCAN87A=HRRLH<*Y
M(+*P!QD$<5_)U7]=%?RH_M1?#&P^"?[3'Q$\&:5+>3Z7X1\3ZEHMG+=LK7$D
M-M=2PQM(555+E4!)"J"<X '%?H'AK6UKT7_=:_%/]#Y3C2GI2J>J_*WZG"T4
M45^K'P@4444 %%%% !1110 4444 %%%% !77? /X(Z]^TE\:/#/@/PQ;_:-<
M\5:A%86VZ.1XX-Q^>:7RU=UAB0-)(X4[(XW8C -<C7[+?\&W7[">GZ'\-K_X
M[^(M+L[K6=<N)=.\)2S(LCZ?:1%X;JYB(D(5YI?,@.Z-9$2V?#&.X8'Q<_S:
M&6X*6)EOM%=Y/;_-^29Z64Y?+&8F-%;;OT6_^2\V?H9^R-^S?I7[(G[-?@_X
M;Z/)]HM/"NGK;R7.UT^W7+,TMS<;'>0Q^;.\LGE[V">9M7Y5 KT:BBOYUK5I
MU9NK4=Y2;;?=O5G[!3IQA%0@K):(****S*"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS[XW?#S^V+)M7LT
MB6XM4+7(^ZTT8'WL],J ?<COP ?0:*VP^(E1J*I QKT8U8.$CY?HKM/C-X"7
MPKK*WEK&L>GWS':B(0L#@#*^F#R0!CN  !7%U]I0K1JP52.S/E:U.5.;A+=!
M1116QF%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>K?!'
MXD+<P0:#=^9YZ!A:RY9O,498HW7&T9QVP .,#/E-.@GDM9TDC=HY(V#(ZG#*
M1R"#V(KFQ6%C7I\DOEY,Z,/B)49\Z/IZBN9^%_CU/'&A?-N%]9JJ7((X8D<.
M, ##8)QV.1TP3TU?&5:<J<W">Z/J:=2,XJ<=F%%%%9EA1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?B[_P<K_L9_\ "%?%
M7P_\;M(AQI_C+R]#U_YON:C#"?LTOS2$GS;6(IMCC5$^Q98EIN?VBKSG]K?]
MG#2?VNOV;?&'PXUJ3[/9^*K!K>.YVN_V*X5EEM[C8KH7\J=(I-A8*_E[6^4D
M5[?#N;/+L=#$?9VE_A>_W;KS2/,S? +&865'KNO5;??MZ,_E=HKKOCY\$=>_
M9M^-'B;P'XGM_L^N>%=0EL+G;'(D<^T_)-%YBH[0RH5DC<J-\<B,!AA7(U_1
M=.I&<5.#NGJGY,_()1<9.,MT%%%%42%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %=S^S5^T1XE_9/^.?AWXB>$)+*
M/Q#X9N&GMOMEN+BWE5XWBEBD3()22*22-BI5P')5D8!APU%14IQJ0=.:NFK-
M/JGNBH3E"2G%V:U1_5U\ _C=H/[27P7\,^//#%Q]HT/Q581W]MNDC>2#</GA
ME\MG19HG#1R(&.R2-U)R#775^+7_  ;4?ME_\(-\6_$'P1U:;;IOC;S-<T'Y
M/]7J4$(^TQ_)$6/G6L0?=)(J)]A"J"\W/[2U_.G$&42RW&RPSVWB^Z>WW:I^
M:9^P93F"QF&C66^S\FOZOZ,****\4](**** "BBB@ HHHH **** /Y%QTHH'
M2BOZH/PL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#[<_X(P?\ !4R#]@#XDZEX
M>\8+>W7PS\:3PM?2Q/-,_AZY0%1>Q0*2KHRLJSJB>:R11%2QA$4G]!E?R+U^
MUW_!O1_P4>A^*/PVC^!GC#4K.'Q)X1M\^%9KF[E:ZURPS(\EL/,RN^T4*%57
M&;?:%C"V\CG\QX\X=4HO,\.M5\:[K92^6S\M=+-O[;A7.'&7U*L]'\/KV^?3
MSTZH_3JBBBOR4^^"BBB@ HHHH **** "BBB@ K\B_P#@OW_P54S]H^!?PQ\2
M_P#/>U\>WEBO^ZHTM+@-_P!=!<JJ_P!R(O\ \?$5?1G_  7 _P""F/\ PQ1\
M%X_!?A@^9\1/B)87,%M<0WWDR>'+,CRGOL1NLRS,69;=AM7S(I'+'R3')_/_
M %^F<#\,JJUF6*7NKX5W?=^CV\]>FOQ7$^=<B>"H[OXGV\OGU\M HHHK]</@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "OU<_X(.?\%;=6T[Q9X=^ /Q$NSJ&CZ@?L/A#6KJY1)-*
M=4)CTZ9I&'F0OM$=O@F1)&CA >-XQ!^4=%>7G&4T,QPTL/67H^J?1K^M=CNR
M_'U<'65:G\UW7;^MC^NBBOS^_P""%'_!3K_AKCX5)\,O&%]K&H?%#P38/<R:
MC>_O_P"W]-6942<RJHQ-#YT,+B4EY/DEWR,\OE_H#7\\YEEU; XF6&KK6/W-
M=&O)_P!:GZY@\93Q5%5J6S_#R?F@HHHKA.H**** "BBB@ HHHH *_ES_ ."@
M/_)^7QN_['[7O_3C/7]1E?RY_P#!0'_D_+XW?]C]KW_IQGK]*\-O]YK?X5^9
M\;QE_ I^K_(\CHHHK]>/ST**** "BBB@ HHHH *#THH/2@#^NBBBBOY7/W0*
M*** "BBB@ HHHH *\A_X*!_\F%_&[_L0==_]-T]>O5Y#_P % _\ DPOXW?\
M8@Z[_P"FZ>NK _[S3_Q+\T88K^#/T?Y'\NM%%%?T\?B04444 %%%% !1110
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M<84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% '[1?\$6?^"U(^+8TGX/_ !BU?'B[Y+/PUXEO)?\ D/\
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MSUH FHJO=:O:6,$TLUU;PQ6[!97>0*L1." Q)X)W+U_O#UJQ0 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKR,VP?M8>TANOQ1Z678KV<_9RV?YGLM%%%?+'T04444 %%%% !1110 4444
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M%%?KQ^>A1110 4444 %%%% !0>E%!Z4 ?UT4445_*Y^Z!1110 4444 %%%%
M!7D/_!0/_DPOXW?]B#KO_INGKUZO(?\ @H'_ ,F%_&[_ +$'7?\ TW3UU8'_
M 'FG_B7YHPQ7\&?H_P C^76BBBOZ>/Q(**** "BBB@ HHHH **** /KK_@A%
M_P I6/A7_P!Q;_TSWU?T75_.C_P0B_Y2L?"O_N+?^F>^K^BZOQ;Q&_Y&4/\
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MX(3^./"SWE]\/_$^B^++%6O+E-.U%&TS4(XE :UMHGS)#<3/\R-)(UK&&"G
M#'9Z&#XVRJNU%S<&_P"96_%77X_B<F)X5S"DKJ*DO[K_ $=F?"M%;'Q#^&GB
MKX-Z\NE>-?"GB3P;J4UQ<6MO#K%@]LM^\#;93;2G,5TBY5M\#R)M=&SAE)QZ
M^IIU(SBIP::?5:H^>J4Y0ERS5GV844459 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 >#_%OPA_PB7BV7RX]EG>9G@P,*N?O(.
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M-'+'=^((XB^^32DEB'F0OMC"W$JK'B8,JS&-XA^RW[)O[&?P[_8I^&MKX:\
M^'[/356WB@OM3>)&U/6VC+L);N<*&F?=+*0#A$\PK&J)A1^M9[QMA,''DPUJ
ME3R^%>K_ $7SL? Y7PS7Q+YJWN1_%^B_7\S\\_\ @G__ ,&X.EZ3IL?B+]H2
M;^U-0E\N2U\*Z1J3QVMO&\!WK>W$85WF61^%MI!&I@SYLRR%5_2_X'_ 'P7^
MS7X"M_#'@/PSI'A70[?:WV:P@$?GR+&D7G3/]^:8I'&&ED+2/M!9B>:Z^BOR
M/-,\QN83<L3-M?RK2*]%M\]_,^_P.6X;"1Y:,;/OU?S_ *04445Y)WA1110
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M[KHUW7SW7334_,<\R.6!DIP=X/9]O)_H^IYS1117UQ\^%%%% !1110 4444
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M0 5-IND:EXAU&'3]&TC6/$&K76\6NFZ5927M]>LJ-(RQ0Q@N[!$=C@<*K,<
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M[U^\8#'4<90CB:#O&7]-/S1^18S!U,+6="JM4%%%%=ARA1110 4444 %%%%
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MG6!%</%&+6,RPVD,L>S9.DLXFF #YBDTZ-BN6C8>KDN6O'8VGAELWKY):O\
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M'S'%F*]E@7!;S:7RW?Y6^9\]T445^W'Y4%%%% !1110 4444 %%%% !1110
M5^@'_!!7XLWEI\1_''@5Q<3:?J&FIKT):Z;R;.6"5()-L.-NZ5;B/<X(.+9
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M<OT_-GSG%5=T\ XK[32_7]#XBHHHK]V/RX**** "BBB@ HHHH **** /=/\
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M_L?M>_\ 3C/7]1E?RY_\% ?^3\OC=_V/VO?^G&>OTKPV_P!YK?X5^9\;QE_
MI^K_ "/(Z***_7C\]"BBB@ HHHH **** "@]**#TH _KHHHHK^5S]T"BBB@
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M4_MS0K*]\OROMD"3[-V[9N4-C/?&>M?JO_Q$ ?"__HGOQ>_\!-(_^6-?DO\
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MOY'M</8/ZQCX1>RU?R_X-C[UHHHK\ /V(**** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% &;XOT$>)O#-]8D*6N(B$W$JH<<H21S@, ?P[U\XU]05X
M)\7-";0?'M\OS>7=M]JC+,"6#Y+=.@#[@,\X'?J?>R2M:4J3]3Q\VI:*HO0Y
MJBBBOHCPPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH =%,\$JR1N\<B$,KHQ5D(Z$$<@CU%?27AW64\1:%:7T>T+=1+(55]^PD<KG
MU!R#[BOFNO8?V?->:_\ #-S8L69M/EW)\H"JCY( /4G<'//J/P\?.J/-251?
M9?X/^D>IE57EJ.'?]#OZ***^7/H HHHH **** "BBB@ HHHH **** "BBB@
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M -OZ_1ROP?C3_D<UO^W?_2(GZ[PO_P BRE_V]_Z4PHHHKY<]\**** "BBB@
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M&7G;[]#EQM/GHR7S^X\'HHHK[0^5"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KK/@IJ_P#97Q M5+0I'>(]N[2<=1N4 Y')95'?
M.<=2*Y.K&EZC)I&IV]W&JM):RK,@<?*2I!&?;BLJ]/VE.4.Z-*-3DJ*?9GTQ
M138)TNH$DC=9(Y%#(ZG*L#R"#W!IU?"'V 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 445\H_\%2_^"I?AO\ X)U_#58(%L]>^)FO6[-H
M6A,YV1+DK]MN]I#);*P("@AYG4HA4+))%U8/!UL76CA\/'FE+9?UT[LPQ.)I
MX>FZM5V2/1OVWOV^/AY^P!\-K7Q%X\O+QI-3N/LVF:1IL:3:EJC@KYAAC=T7
M9$K!G=V5%RJYWO&C_A%^W_\ \%;/BE^WYJ4ECJEY_P (IX'CWQP^&-(N95M+
MF/SQ+&UZ2W^ES)LA 9E6-6BW1Q1EGW>%?&[X^>-/VDO'MQXG\>>)M8\4ZY<;
ME^TW]P9/(C:1Y?)A3[D,(>1RL486--Q"J!Q7(U^W<.\'X;+DJM6TZO?HO\*_
M7?TV/S/-^(*V,;A#W8=NK]?\M@HHHK[ ^>"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _='_@V0_P"3
M#/%W_8_7G_INTVOT7K\Z/^#9#_DPSQ=_V/UY_P"F[3:_1>OYWXJ_Y&U?_$?K
MV1_[A2] HHHKY\]8**** "BBB@ HHHH _D7'2B@=**_J@_"PHHHH **** "B
MBB@ HHHH ^HO^"+/@/2?B-_P4^^$NGZU:_;+.WU"YU2./S7CVW-G97%W;/E"
M#\D\$3X)VMMPP*D@_P!(U?S7?\$=?B?I_P (O^"F7PAU;4H;R:WN]8?146V5
M6<3:A;S6$+$,RC8LMRA8YR$#$!B I_I1K\9\2%/Z_3;VY%;UYI7_ $_ _1N#
MK?5)]^;]%_P0HHHK\]/K@HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_
M.?\ X.</^3#/"/\ V/UG_P"F[4J_1BOSG_X.;_\ DPSPC_V/UG_Z;M2KW^%O
M^1M0_P 1Y.>?[A5]#\+Z***_HD_(0HHHH **** "BBB@ HHHH _1?_@V0_Y/
MS\7?]B#>?^G'3:_=&OPN_P"#9#_D_/Q=_P!B#>?^G'3:_=&OPOC[_D;/_#$_
M4.%/]P7JPHHHKXL^D"OY%U^[7]=%?R+KTK]4\,_^8G_MS_VX^%XT_P"7/_;W
M_MH4445^J'PH4444 %%%% !1110 4444 ?U<_L^_"K_A1/P%\$>!_M_]J_\
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M:+_UX0?^BUK6K^H#\$EN%%%% @HHHH **** "BBB@#)\??\ (B:U_P!>$_\
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MCMYOJ_T7EZA1117VA\X%%%% !1110 4444 %%%% !1110 4449H **-U&Z@
MHHW4;J "BC=1NH **-U&<T %%%% !1110 4444 %%%% !1110!^Z/_!LA_R8
M9XN_['Z\_P#3=IM?HO7YT?\ !LA_R89XN_['Z\_]-VFU^B]?SOQ5_P C:O\
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M_&?_ (-</AA8:M\7OBUXTDFO%U3P_H]AHMO"KK]G>&]FEFE9QMW%U;3X0I#
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MHHHK^83]L"BBB@ HHHH *_ES_P""@/\ R?E\;O\ L?M>_P#3C/7]1E?RY_\
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M^V"BBB@ HHHH **** "BBB@ HHHH **** /YL? /_(B:+_UX0?\ HM:UJR?
M/_(B:+_UX0?^BUK6K^H#\#"BBB@ HHHH **** "BBB@#T?\ 8Z_Y.Z^%?_8W
MZ3_Z6PU^^-?@=^QU_P G=?"O_L;])_\ 2V&OWQK\E\1O]YH_X7^9^C<$_P "
MIZK\@HHHK\Y/M@HHHH **** "BBB@ HHHH **** "BBB@#^;'P#_ ,B)HO\
MUX0?^BUK6K)\ _\ (B:+_P!>$'_HM:UJ_J _!);A1110(**** "BBB@ HHHH
M R?'W_(B:U_UX3_^BVK^DZOYL?'W_(B:U_UX3_\ HMJ_I.K\O\2/^8;_ +?_
M /;#] X'VK?]N_\ MP4445^7GW@4444 %%%% 'X=_P#!3O2K30O^"A/Q6L[&
M"QM;5=1LYQ!:VXA5))],L[B9F"J TDDTLLK-R6:4DDDG'A=?3W_!8WX>Q^ O
M^"@7B6Z%\]Y)XTTG3?$31F#RULE\DZ<(@VX^83_9ID+87'G!<';N/S#7]%9#
M44\MH26ON1^]))_B?BN<0<,=63_F?XNZ"BBBO6/-"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *_5K_ ((+:@M[^R?XNC79FT\:W$1VDDY.GZ>_.0,'YQT)&,<Y
MR!^4M?KQ_P $0OAC_P ()^Q2VLB_:\7QUXAO=:$+6IA-CY0BTXQ9)/F FP,@
M?"C$H !"AF^+X]G&.5V?622_%_DF?4\'Q;Q]UTB_T7ZGV!1117XF?J84444
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M_7Z.5^#\:?\ (YK?]N_^D1/UWA?_ )%E+_M[_P!*84445\N>^%%%% !1110
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MY:'RN,CRUY+S_/4****[#E"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#T#]G:]EC\47UNK?N9;7S'7 Y974*<]> [?G7L%>#_!I<
M_$O3/]DRD?\ ?IZ]XKY7.8VQ%^Z7^7Z'T65RO1MV84445Y)Z04444 %%%% !
M1110 4444 %%%% !1110 4444 %?+O\ P6/_ &JKG]DC]@7QAK6DZE_9?BCQ
M#Y?AS0IE$XD6YN<B1XI(2IBFCM4N9HY"RJLD*?>)"-]15^(W_!SA\;_^$O\
MVH_ _@.WN-)N;/P7H#ZA-]GDWW5M>7TO[R&?#$+B"UM)$0JK;9RQ+*Z8^BX5
MRU8W,Z=*7PI\S]%K;YNR^9X^?8QX;!3G'=Z+U?\ DKL_-"BBBOZ&/R,****
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M:7N_?M^-E\S]TJ***_!3]4"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPO7Z_?\ !KA\))H-#^+GCRZT:S-O=3V&@:9JS+$UP'C66>]MT.?-1");!VR
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M )$31?\ KP@_]%K6M63X!_Y$31?^O"#_ -%K6M7]+'X4%%%% !1110 4444
M%%%% 'H_['7_ "=U\*_^QOTG_P!+8:_?&OP._8Z_Y.Z^%?\ V-^D_P#I;#7[
MXU^2^(W^\T?\+_,_1N"?X%3U7Y!1117YR?;!1110 4444 %%%% !1110 444
M4 %%%% '\V/@'_D1-%_Z\(/_ $6M:U9/@'_D1-%_Z\(/_1:UK5_4!^!A1110
M 4444 %%%% !1110!Z/^QU_R=U\*_P#L;])_]+8:_?&OP._8Z_Y.Z^%?_8WZ
M3_Z6PU^^-?DOB-_O-'_"_P S]&X)_@5/5?D%%%%?G)]L%%%% !1110 4444
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M /&:];HH^O8G_GY+[W_F'U6C_(ON1Y)_PP'\"/\ HBGPD_\ "/T__P",T?\
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M /C-'_# ?P(_Z(I\)/\ PC]/_P#C->MT4?7L3_S\E][_ ,P^JT?Y%]R/)/\
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M?,]C(<8L-CH5);;/T>GX;G[K4445_/I^R!1110 4444 %%%% !1110 4444
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M_;W_ *4PHHHKY<]\**** "BBB@ HHHH **** "BBB@#^<>BBBOZ@/P,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _7[_@DI^VW+^TI\)I
M?"?B2]N;OQMX-A7SKN\N8WFUFT9V$<P'#LT0V12,P;),3L[-*0/KJOYZ_A!\
M5-7^"'Q/T+Q=H,WDZMX?O$O(,NZI+M/S12;&5C'(NY'4,-R.RYP:_<W]D_\
M:5TC]K/X'Z3XTTF'[%]LWP7M@UPDTNFW,9VR0N5_!U+!6:.2-BJ[L#\7XSX>
M^IU_K=!?NYO_ ,!EV]'JUT6W8_4>%\Z^M4OJ]5^_%?>N_JMG]_<]'HHHKX<^
MK"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'Z\_]-VFU^B]?SOQ5_R-J_\ B/U[(_\ <*7H%%%%?/GK!1110 4444 %%%%
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M32N5CC0L-\DB*#EA7\RW[9/[6'B7]M3]H;Q!X^\375XTFIW#KIMC-<"9-%L
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MIK9GZEP[FRQ=#V<W[\='YKH_\_/U1T=%%%?&GT04444 %%%% !1110 4444
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M'I;ZAXET*[LM.?45W6UK>M$QM;AB%8J8IQ%*'52R-&&4;E%?@'87T6J6$-U
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MR[6>$LT4;K(@)5XD++(@:)_W4^%7Q5\/?&[X>Z5XK\*:K;:UX?UJ'S[2[@R
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M@ HHHH _D7'2B@=**_J@_"PHHHH **** "BBB@ HHHH **** "OU&_X(K_\
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MJDMWT]%Y>>[\M$OS'.LZGCYI6M!;+]7Y_E^(4445]0>&%%%% !1110 4444
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M]"BBB@ HHHH **** "@]**#TH _KHHHHK^5S]T"BBB@ HHHH **** "O(?\
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MWC#XS:E:WD>J>(+AO#6C&:WEA06$1BEN)HF+;)DEN-D>=A\M[!U#Y9U'Y+?
M/X(Z]^TE\:/#/@/PQ;_:-<\57\=A;;HY'C@W'YYI?+5W6&) TDCA3LCC=B,
MU_49\ _@CH/[-OP7\,^ _#%O]GT/PK81V%MNCC22?:/GFE\M41II7+22.%&^
M21V(RQK\^\0,V]AA%@H/WJF_^%?YO\F?6\)X#VF(>)DM(;>K_P E^AUU%%%?
MC!^CA1110 4444 %>0_\% _^3"_C=_V(.N_^FZ>O7J\A_P""@?\ R87\;O\
ML0==_P#3=/75@?\ >:?^)?FC#%?P9^C_ "/P/\ _\B)HO_7A!_Z+6M:LGP#_
M ,B)HO\ UX0?^BUK6K^EC\*"BBB@ HHHH **** "BBB@#T?]CK_D[KX5_P#8
MWZ3_ .EL-?OC7X'?L=?\G=?"O_L;])_]+8:_?&OR7Q&_WFC_ (7^9^C<$_P*
MGJOR"BBBOSD^V"BBB@ HHHH **** "BBB@ HHHH **** /YL? /_ "(FB_\
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M_JG_  3F_P""F.J?LCZ];^&?%DUYJWPOOI,/&D9FN?#4C,2US;JH+20DDF6
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!P7[0_P#R)EI_
MU_)_Z+DKQRO7/VBM2CB\/Z?9E6\R>X,RG'R@(I!S[_./UKR.OK,H7^S+U9\W
MF3_?OY!1117J'GA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5]05\OYKZ@KY_/?L?/\ 0]K)_M_+]0HHHKY\]H**** "BBB@ HHH
MH **** "BBB@ HHHH **** "OY4?VH?AC8?!/]ICXB>#-*FO+C2_"/B?4M%L
MY;ME:XDAMKJ6%&D*JJERJ DJJ@G. !Q7]5U?ST_\%^?@E_PIW_@I-XFO(;?2
M;33_ !UI]GXEM(+"/R]F]#;3M*H50)I+JUN)6(W;O-#%MS,!^B>'&*4,94H/
M[4;_ #B_\FSX_C&CS8>%5?9=OO7_  $?%M%%%?LA^=A1110 4444 %%%% !0
MRAU((R#P0>]%% ']*'_!*/\ ;KL?V[/V3-#UBYU2TNO'F@6\>F^+;1747$5V
MNY%NG18XU5+I4,R^6GEJ6DC5B87Q],5_*[^RM^U5XT_8T^-&F^.O NI?V?K&
MGYBFAE!>TU.V8@R6MS&"/,A?:,C(96571D=$=?W_ /V ?^"MGPM_;[TV.QTN
M\_X1/QPFR.;PQJ]S$EW<R>099&LB&_TN%-DP+*JR*L6Z2*(,F[\/XKX3JX*K
M+$X:-Z3N]/L^3\NS^3[O].R'/J>)@J-9VJ+3_%Y^O=?=Y?4=%%%?#GTP4444
M %%%% !117(_&[X^^"_V;? 5QXG\>>)M(\*Z';[E^TW\XC\^18WE\F%/OS3%
M(W*Q1AI'VD*I/%53IRG)0@KM[);DRG&*YI.R.NKXB_X*M?\ !8?PE^Q!H&N>
M!?#]Q>:M\7-0TB0V*6*PR6_AJ:55$$]XTFY0X5S.D'ER%Q&H<1I*DA^7/V]_
M^#D6;5;.]\-? '3[S3'6X53XRU6WB9W6.63>+6RD1UV2JL166XPX2213 CA7
M7\H_$'B"_P#%FO7VJZK?7FIZIJ=Q)=WEY=S--<7<TC%WED=B6=V8EBS$DDDG
MFOTKAO@6I.:Q&9*T5M'J_P#%V7EN^MNOQN=<40C%T<$[OK+HO3S\]OT/$'B#
M4/%NO7VJZK?7FIZIJ=Q)=WEY=S--<7<TC%GDD=B6=V8EBS$DDDGFJ=%%?KB2
M2LC\_"BBB@ HHHH **** "BBB@ HHHH _='_ (-D/^3#/%W_ &/UY_Z;M-K]
M%Z_.C_@V0_Y,,\7?]C]>?^F[3:_1>OYWXJ_Y&U?_ !'Z]D?^X4O0****^?/6
M"BBB@ HHHH **** /Y%QTHH'2BOZH/PL**** "BBB@ HHHH **** "BBB@ H
MHHH *Z[X(_'WQI^S;X]M_$_@/Q-K'A77+?:OVFPG,?GQK(DODS)]R:$O&A:*
M0-&^T!E(XKD:*FI3C.+A-73W3U1492B^:+LS]:/V1/\ @YJFT;0%TOXW>#[S
M5KBTMPL6O>%HXEN+UU6)0)[261(P[D32/+%(B9**L"C+#]#/@C_P4T^ /[1'
MV=/"OQ6\(W%Y>:@NEVMA?W7]E7]Y<MLV)#;78BFEW&154HA5F)4$LI _F+HK
MXG,> <NQ#<Z-Z;\M5]S_ $:/I,'Q5C**Y:EIKSW^_P#S3/ZZ**_E%^%7[0'C
MSX%&_P#^$'\;>+O!O]J^7]M_L/6+C3OMGE[_ "_,\EUW[=[[=V<;VQC)KNO#
M_P#P4<_: \,Z_8ZE;?&KXI27&GW$=S$EWXGO+NW=D8,!)#+(T4J$@92161AD
M,""17S=3PUKIOV==->::_5GM0XSI->]3?R:?^1_4!17\T7Q5_P""MW[27QD^
MP_VO\8/%]G_9OF>5_8<R:#OW[=WF?85A\W&P;?,W;<MMQN;/"^(/VX?C5XLT
M"^TG5?C!\4M3TO4[>2TO+.[\5W\UO=PR*5>.1&E*NC*2I5@002#Q6=/PWQ;2
M]I6BGY)O_+]"I\98=/W:;^=E_F?TT?%7]H+P%\"?L'_"<>-_"'@W^U?,^Q?V
MYK%OIWVSR]OF>7YSKOV[TW;<XWKGJ*^(OVB?^#D7X(_#&REA\!V'B/XG:HUO
M'- \-N^D:;N,I5XI9KE!.CK&"^4MI$8LB[@2Q3\(Z*][ ^'6"IOFQ,W4\OA7
MX7?XK_+R\5QAB9JU&*C^+_1?@?5W[7G_  6@^._[8V@MHFK>(+/PCX;N+<V]
MYI'A:*33[?40RRH_GR-))/(DD<Q1X6E\E@B$Q[AN/RC117W&$P6'PL/9X>"B
MNR5CYC$8FK7ESUI.3\PHHHKJ, HHHH **** "BBB@ HHHH ***[K]FC]G;Q)
M^UE\=/#OP\\(Q6<GB#Q-<-#;F[G$%O"J1O+++(_)"1Q1R.0H9R$(568A3%2I
M&G!U)NR2NV^B6[*IPE.2A!7;T1^G7_!M1^Q'_P C!\>/$&G_ //30/"?VB#Z
M?;;V/?%_NVZ2Q2?\_L;"OUTKD?@'\$=!_9M^"_AGP'X8M_L^A^%=/BL+;='&
MDD^T?/-+Y:HC32N6DD<*-\DCMC)-==7\Y9]FDLPQL\2]GHEVBMO\WYMG[%E>
M!6$PT:*WZ^KW_KL%%%%>.>@%%%% !1110 5^-/\ P<B_L)ZAH?Q)L/COX<TN
M\NM'URWBT[Q;+"C2)I]W$$AM;J4F0E4FB\N#Y8TC1[9,L7N #^RU<Y\7/A'X
M;^//PUUCP?XPT>SU[PWKUN;:^L;D'9,N00000R.K!71T(='564JR@CV<AS>>
M6XR.)CJMI+O%[K]5YI'G9KE\<9AG1>^Z?9K;_)^3/Y.J*]2_;*_9/\2?L5?M
M#>(/ /B6VO%DTRX=]-OIK<0IK5@7807L0#.NR15R5#ML</&QWHP'EM?T71K0
MK4U5I.\9*Z?=,_'ZE.5.;A-6:T:"BBBM" HHHH **** "BBB@ HHHH N>'_$
M&H>$M>L=5TJ^O-,U33+B.[L[RTF:&XM)HV#))&ZD,CJP#!E(((!'-??_ .R%
M_P '&'Q8^ V@KHOC_2K/XLZ7:VXBL[F[N_[.U>$JL2()+I8Y%G0*DA)EB:9W
ME+-,0-I_/2BO/S#*\)CH<F*IJ2_%>C6J^3.O"X[$8:7-0DX_E]VQ_1%^SM_P
M7=_9S_:#O(K&7Q5>> =4N+B2&&U\76RV".B1"3S3=(\EI&A^95$DRN73:%RR
M;OJ_P'\0=!^*?A2UU[PQKFD>(]#OM_V;4=+O([RTN-CLC[)8R4;:ZLIP3AE(
MZ@U_)=5SP_K]_P"$]>L=5TN]O--U33+B.[L[RTF:&XM)HV#QRQNI#(ZL P92
M"" 0<U\/C/#?#3=\-5<?)KF7Z/\ ,^GP_&5:.E>"EZ:?Y_H?UN45_+F?^"@/
MQY/_ #6[XO?^%CJ/_P >KN]$_P""Q7[3/A_X:OX3M_B]XCDTN2WFMC/<Q6]U
MJ024N7(OY(VNPXWG:XEWQX4(5"KCQ:GAOC$O<JQ?K=?H_P"NIZ4>,L/]JG+\
M'^J/Z4:I^(?$.G^$= OM6U:^L]+TO2[>2[O+R[F6&WM(8U+O+([$*B*H+%F(
M  ))Q7\O_P#P\!^//_1;OB]_X6.H_P#QZO+O$&OWWBS7[[5M4O;O4M4U2XDN
M[R\NYFFN+N:1BSRR2,2SNS$DLQ)))).:Z:/AK5;_ 'M=)>46_P VOU,:G&D$
MO<I/YNWZ,_HN_:*_X+8?LY_LZ6<HE\>VGC35%MX[F'3O"(&KO<J\IC(%PC"T
M1UPSLDDZ.$7(!+(&_-S]MS_@XI^)7QP_M#0?A79_\*S\+S>9!_:.Y;C7KV(^
M='N\W'EVF^-XFVPAI8I(\I<D&OSIHKZG+.",MPC4Y)U)=Y;?=M]]SPL=Q-C,
M0N5/D7EO]^_W6+GB#Q!?^+=>OM5U6^O-3U34[B2[O+R[F::XNYI&+O)([$L[
MLQ+%F))))/-4Z**^P225D?/!1110 4444 %%%% !1110 4444 %?J+_P;3_L
M:_\ ";_%?Q!\;M6AW:?X+\S0] ^?[^HSPC[3+\LH8>5:RA-LD;(_V[<I#0\?
M!?[&W[)_B7]M3]H;P_X!\,VMXTFIW"-J5]#;B9-%L ZB>]E!9%V1*V=I==[E
M(U.]U!_II^ ?P1T']FWX+^&? ?ABW^SZ'X5T^*PMMT<:23[1\\TOEJB--*Y:
M21PHWR2.V,DU\#QWGJPV%^HTG[]1:^4>O_@6WI<^LX6RMUJ_UF:]V&WF_P#@
M;^MCKJ***_%3]("BBB@ HHHH **** "OY<_^"@/_ "?E\;O^Q^U[_P!.,]?U
M&5_+G_P4!_Y/R^-W_8_:]_Z<9Z_2O#;_ 'FM_A7YGQO&7\"GZO\ (\CHHHK]
M>/ST**** "BBB@ HHHH *#THH/2@#^NBBBBOY7/W0**** "BBB@ HHHH *\A
M_P""@?\ R87\;O\ L0==_P#3=/7KU>0_\% _^3"_C=_V(.N_^FZ>NK _[S3_
M ,2_-&&*_@S]'^1_+K1117]/'XD%%%% !1110 4444 %%%% 'UU_P0B_Y2L?
M"O\ [BW_ *9[ZOZ+J_G1_P""$7_*5CX5_P#<6_\ 3/?5_1=7XMXC?\C*'_7M
M?^E2/TC@_P#W*7^)_E$****^ /K HHHH **** "BBB@#\(_^#@_]@B']F_\
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MO_L;])_]+8:_?&OR7Q&_WFC_ (7^9^C<$_P*GJOR"BBBOSD^V"BBB@ HHHH
M**** "BBB@ HHHH **** /YL? /_ "(FB_\ 7A!_Z+6M:LGP#_R(FB_]>$'_
M *+6M:OZ@/P,**** "BBB@ HHHH **** /1_V.O^3NOA7_V-^D_^EL-?OC7X
M'?L=?\G=?"O_ +&_2?\ TMAK]\:_)?$;_>:/^%_F?HW!/\"IZK\@HHHK\Y/M
M@HHHH **** "BBB@ HHHH **** "BBB@#^;'P#_R(FB_]>$'_HM:UJR? /\
MR(FB_P#7A!_Z+6M:OZ@/P26X4444""BBB@ HHHH **** ,GQ]_R(FM?]>$__
M *+:OZ3J_FQ\??\ (B:U_P!>$_\ Z+:OZ3J_+_$C_F&_[?\ _;#] X'VK?\
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MT"BBBO!/8"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\N_^#F_]FO\
MX2CX+>!_BII]GOO/">H/H>K26^F^9(UG=#?#+/<+RD,,\1C17!4R:@<%6;#_
M *B5R/Q\^".@_M)?!?Q-X#\3V_VC0_%5A)87.V.-Y(-P^2:+S%=%FB<+)&Y4
M[)(T8#*BO5R3,7@<=3Q72+U]'H_P9PYE@UBL-.AW6GJM5^)_*+177?'SX(Z]
M^S;\:/$W@/Q/;_9]<\*ZA+87.V.1(Y]I^2:+S%1VAE0K)&Y4;XY$8#!%<C7]
M(TZD9Q4X.Z>J?DS\;E%QDXRW044451(4444 %%%% !1110 4444 ?8W[.O\
MP7=_:,_9[LHK&7Q59^/M+M[>2&&U\76S7[HSR^893=(\=W(X^95$DSHJ/M"X
M5-OVY\*_^#HGP'J_V_\ X3?X6^+O#WE^7]B_L/4+?6?M&=WF>9YPM/+VX3;M
M\S=N;.W:-WXNT5\YCN$\JQ3YITDGWC[OY:/YIGL87/L=0TC4;79Z_GK]S/Z(
MO#__  7P_99UG0+&\N?B'>:1<7=O'-+8W?AS4VN+)V4$Q2&&"2,NA)4F-W3(
M.UF&";?_  _?_93_ .BJ'_PF=8_^1*_G2HKQ'X<Y9?XY_?'_ .1/4_UPQO\
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M*ORGCSB)2_X3,._\;_*/ZOY+NC[SA7)VO]MK+_"OU_R^_L%%%%?EI]P%%%%
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M5_!GZ/\ (_EUHHHK^GC\2"BBB@ HHHH **** "BBB@#ZZ_X(1?\ *5CX5_\
M<6_],]]7]%U?SH_\$(O^4K'PK_[BW_IGOJ_HNK\6\1O^1E#_ *]K_P!*D?I'
M!_\ N4O\3_*(4445\ ?6!1110 4444 %%%% !7PO_P %P/\ @F=_PVQ\&(_&
MGA@>5\1/AW87,UM;PV7G2>)+,#S7L28T,S3*59K=1N7S)9$*CSC)']T45VY?
MF%;!8B.)H.TH_P!-?-:'-C,+3Q-&5&KL_P"K_(_D7HK]=/\ @OY_P2LP+CXZ
M_#'PU_SVN?'MG8M_NL-42W"_]=/M+*W]R8I_Q\2U^1=?T-DV;T<RPRQ-'YKJ
MGV?Z=U9GY'F67U,'6=&I\GW7?^NH4445ZIP!1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4449Q0!K_#_ ,":
MM\4O'NA^&-!M?MVN>(]0@TO3K;S4B^T7,\BQ1)O<A%W.RC+$ 9R2!S7](O\
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M .QOTG_TMAK]\:_)?$;_ 'FC_A?YGZ-P3_ J>J_(****_.3[8**** "BBB@
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M[2%8;>TAC4*D<:* J(J@*%4    <5<HHK\6;;=V?I&VB"BBB@ HHHH ****
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M***]@\X**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHKH_A'\)/$GQX^).C^#_!^CWFO>)->N!;6-C; ;YFP2222%1%4,SN
MQ"(BLS%54D3*<8Q<I.R6[*C%R?+'<YPG K]HO^"*_P#P17_X5'_9/QB^,6D_
M\5=\EYX:\-7D?_( _B2\ND/_ "^=#'$?^/?AF'GX%OZE_P $=O\ @CQ8_L2:
M!;>/O'UM9ZE\7-4MR$C#+-;^$X9%PT$+#*O<LI*RSJ2 "8HR4\R2?[TK\CXL
MXT=92P6 ?N[.7?R7EW?7IIO^@9#PW[*V)Q2][I'MYOS\NGKL4445^:GV0444
M4 %%%% !1110 4444 %>0_\ !0/_ ),+^-W_ &(.N_\ INGKUZO(?^"@?_)A
M?QN_[$'7?_3=/75@?]YI_P")?FC#%?P9^C_(_ _P#_R(FB_]>$'_ *+6M:LG
MP#_R(FB_]>$'_HM:UJ_I8_"@HHHH **** "BBB@ HHHH ]'_ &.O^3NOA7_V
M-^D_^EL-?OC7X'?L=?\ )W7PK_[&_2?_ $MAK]\:_)?$;_>:/^%_F?HW!/\
M J>J_(****_.3[8**** "BBB@ HHHH **** "BBB@ HHHH _FQ\ _P#(B:+_
M ->$'_HM:UJR? /_ "(FB_\ 7A!_Z+6M:OZ@/P,**** "BBB@ HHHH ****
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MGX\T445^]'Y"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/X9KHPM/VE:,/,PQ53DI2EY'C=%%%?<'R04444 %%%% !1110 4444 %%%%
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MWT_X+#_\$>+#]MS0;CQ]X"M[/3/BYIEN Z%EAM_%D,:X6"9CA4N54!8IV(!
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M-LCKX)\WQ0[_ .?;]3R*BBBOJ#PPHHHH **** "BBB@ HHHH **** "BBB@
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MX,_1_D?@?X!_Y$31?^O"#_T6M:U9/@'_ )$31?\ KP@_]%K6M7]+'X4%%%%
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M2]5^JNO,_,\PRG$X*5JT=.C6S^?Z/4IT445ZQYH4444 %%%% !1110 4444
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MI:^NS_$_$LRP;PN)G0?1Z>G3\ HHHKTCA"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH [[X+?M2_$3]G
M>ZC?P9XPUO0H8YGN#9Q3^98RRO'Y;/);/NAD;: ,NA(VJ1@JI'WA^S]_P7<T
M_5[ZQT[XE^%/[)\W*3ZSHDC36Z.TH"LUJ^9$C6,DLRRRN2GRH=V%_-&BO%S+
MA_ 8]7Q%-<W=:/[UO\[H]3 YSB\)_!GIV>J^[I\K,_?KX+?M2_#O]HBUC?P9
MXPT77)I(7N#9Q3^7?11))Y;.]L^V:-=Q49= #N4C(92>^K^=#1]9O/#NKVNH
M:?=7-C?V,R7%M<V\K136\J,&1T=2"K*P!!!!! (KZ-^"W_!6SXV?!NVCM9/$
M%OXPT^&%XH[?Q' ;QE9Y-_F&=62X=A\R@/*RA6QMX7;\%F'AW5C[V"J*2[2T
M?WK1_<C[#!\:4WIBH6?>.J^YZK[V?M%17P?\)_\ @O%X,\2ZO]F\8>#=;\*P
MRS0Q0W=E=IJD,:LQ$DDPV0NBH-IQ&LK,"V%R &^EOA9^W;\'_C-Y*^'_ (A>
M&YKBZO%T^WM+RX_L^\N9VV!4C@N!'+)N+JJE5(9B5!)! ^-QF0YCA?X]&27=
M*Z^]77XGTV%SC!8C^%43\MG]SLSUJBBBO(/2"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HKF_B#\8_"/PE^Q_\ "5>*O#?AG^T-_P!E_M;4X;+[3LV[
M]GF,N[;O7.,XW#/45\O_ !4_X+<?"#P49H?#\/B3QG<?8S/;RVEE]CLVG^<+
M!(]P4E3E5+.L+@*X(W$%1Z&#RG&8O_=Z4I>:6GW[?B<>*S'#8?\ C34?*^OW
M;GV)17Y)_&K_ (+=?%3QY=21^$;71? >GK.DL310+J5]M$>UHY)9U,3*SDOE
M8$884;CABWCOQ"_X*+?'#XFFS_M+XE>)+;[#O\O^R95TC=OVYW_9%B\S[HQO
MW;<MC&YL_58?P_S&:3JRC'RNVU]RM^)\]6XRP4&U34I?))?B[_@?N=17XNZ-
M_P %>?C]IFKVMS-XTM]1AMYDEDM+C1+%8;I58$QN8X4<*P&"496P3A@<$?3'
M[/O_  7<T_5[ZQT[XF>$_P"R?-RD^LZ)(TUNCM* K-:OF1(UC)+,LLKDI\L9
MW87EQG ^:4(\\4I_X7K]S2O\KG1A>+,!6ERMN/\ B6GWIO\ &Q^A5%8OPY^(
MVA_%SP/IOB3PWJ5OJ^AZQ")[2[@)VR+D@@@X*LK JR, RLK*P!! VJ^1E&49
M.,E9K='T<9*2YHZIA1114E!1110 5XQ\?=>;4?&"62EO+TZ( J5&-[X8D'J0
M5V#GN#]3[+/.EK \DCK''&I9W8X50.22>P%?-OB'69/$.NW=])N#74K2!6?>
M4!/"Y] , >PKV<EH\U5U'T7XO^F>5FU2U-077]"G1117TYX 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %6-+TZ35]3M[2(JLEU*
ML*%ON@L0!GVYJO77_ _1H]7\>Q-)L9;&)KD*R;MQ&%'T(+!@>Q4?6L<14]G3
ME/LC2C3YYJ'=GM\$"6L"1QHL<<:A411A5 X  [ 4ZBBOA3[ **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YS_;,_P""5?P7
M_;E\Z]\7>&O[-\43;?\ BI=#9;'5CCR5_>/M:.X_=P)$OVB.7RT+!-A.:_(O
M]LO_ ((!_&C]F;SM3\(V_P#PMKPO'M_?Z':,FK0Y\E?WFG[GD;,DCA?L[3X2
M)G?RAP/Z **^ER?BO,,OM"$N:'\LM5\NJ^6G=,\;,,APF+]Z:Y9=UH_GT?SU
M\S^1?.:*_J6_:*_8G^$_[65E)'\0_ /ASQ-<26\=H-0FMO*U*&&.4RK'%>1[
M;B) Y8[4D4'>X.0[ _"_QT_X-B?AYXPUX7GP_P#B%XC\#V\UQ<37%CJ-BFMV
M\2NP,45N?,@D1(QO7,KS.P*98%6+_HN \0LOJZ8F+IO_ ,"7WK7_ ,E/C\5P
MCBZ>M%J:^Y_CI^)^*-%?='Q4_P"#=G]I+X>_8?[)TSPCXZ^V>9YO]AZZD/V'
M;MV^9]N6VSOW';Y>_&QMVWY=WRYX[_8_^+7PL\)W6O>)_A;\1O#>AV.S[3J.
MJ>&KVSM;?>ZQIOEDC55W.RJ,D99@.I%?6X7-\%B?X%6,O1J_W;Z].YX%?+\5
M1_BTVOD[??L>=4445Z)QA1110 4444 %%>T?"+_@G1\=OCI>:/'X9^$WCJ\M
MO$%N+O3]0N=*DL=,N83$9EE%Y<!+<(Z#*,9 'W*%R64'Z8^"'_!N!\??B-]G
MN/%4WA'X>6?V];>ZAO\ 4?M]^MO\A>XBCM1)#)PS!4>>-F:,@[%(<^7BL\R_
M#?QJT4^UU?[EK^!W4<LQ=;^'3D_EI]^Q^?\ 6MX%\ :]\4?%5KH/AG1-8\1Z
MY?;_ +-IVEV<EY=W.Q&D?9%&&=MJ(S' .%4GH#7[7?LZ_P#!M!\)_AW>Q7OQ
M$\5>(_B1<07$C"S@3^Q--GA:((J2I&\EP720M('CN(P<(I4@-O\ O7X(? +P
M7^S9X!M_"_@/PSI'A;0[?:?LUA (_/D6-(O.F?[\TQ2- TLA:1]H+,3S7R.8
M^(F"I+EPD74?=^ZOQU^5EZGT&#X0Q$]<1)179:O_ "_%GY+?L)_\&W7B;7=?
MTOQ'\=[^ST'1;6X6:7PEIUP+J^U%%:4&*XNHG\JW1BL+9@>5WCD==T$@##]:
M?@A\ O!?[-G@.W\,^ _#.C^%=#M]K?9K"W$?GR+&D7G3/]^:8I'&&ED+2/M!
M9B>:Z^BOS/-^(,;F4[XF6G2*TBOE^KN_,^UR_*L-@XVHQU[O5OY_HM HHHKQ
M3T3^='_@N[_RE8^*G_<)_P#3/8U\BU^Q?_!2K_@A9\7/VR/VU_&GQ(\,>(OA
MS8Z'XC^P_9H-4O[V*[3R+"WMGWK':R(,O"Q&'/RD9P<@>%?\0R'QZ_Z&WX0_
M^#74?_D&OWC)^),LI8"A2J5HJ481379J*3/RW,,FQL\55G"FVG*37HVS\Z:*
M_1;_ (AD/CU_T-OPA_\ !KJ/_P @T?\ $,A\>O\ H;?A#_X-=1_^0:]#_6K*
M?^?\3C_L/'_\^F?G317Z+?\ $,A\>O\ H;?A#_X-=1_^0:/^(9#X]?\ 0V_"
M'_P:ZC_\@T?ZU93_ ,_XA_8>/_Y],_.FBOT6_P"(9#X]?]#;\(?_  :ZC_\
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M-+S6/BEKEAEVAU!5L]%>59UDBD%G'EVVH@C:.:>6*0-)NC(953[T\/>'M/\
M".@6.DZ38V>EZ7I=O':6=G:0K#;VD,:A(XHXU 5$50%"J    !BKE%?GN/S3
M%XV7/BJCD_/9>BV7R1]=A<#0PT>6A%17];O=A1117 =04444 %%%% !1110
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MCG,,/C,?"KAIJ45!*Z[\TG^J/NN%\+6P^%E"M'E?,WKVL@HHHKXP^D"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#D?C=\ _!?[27@*X\,>//#.D>*M#N
M-S?9K^W$GD2-&\7G0O\ ?AF"2.%EC*R)N)5@>:_-O]K#_@V5\-^(+*ZU+X,^
M,+SP_JDEQ+,-&\2R&ZTW8\J%8HKB./SX4BC,N#(MR\F(P64[G/ZI45ZV6YYC
ML [X6HTNVZ?R>GZG!C,LPV*5J\$WWZ_>?S%_M5?\$VOC1^QOJ6I_\)IX'UA=
M#TS#MXBTZ![W17B:=H(I#=("D7F.!MCF\N7$D>Z-2Z@^%U_717A?QM_X)E?
M']H<7#^*OA3X0N+N\U!M4NK_ $^T_LJ_O+E]Y>2:YM#%-+O,C,P=R&8AB"P!
M'WV \2-.7&TOG%_H_P#,^4Q7!NM\-4^4O\U_D?S%T5^T7Q4_X-=O 6K_ &#_
M (0CXI>+O#WE^9]M_MS3[?6?M&=OE^7Y)M/+VX?=NW[MRXV[3N^4?B=_P;C_
M +1G@+08;S2D\"^-KB2X6%K'1=;,-Q$A5B96-[%;Q[ 5"D*Y?+KA2-Q7Z["\
M8937VK*+[2O'\7I^)\_B.'L?2WIM^FOY:_@?!=%>Z>._^"8_[0WPY\5W>BZA
M\&/B-<7EEL\R32]#GU2T;<BN-ES:K)#)PP!V.=K94X92!XOX@\/ZAX2UZ^TK
M5;&\TS5-,N)+2\L[N%H;BTFC8J\<B, R.K J58 @@@\U[]'%4:RO1FI==&G^
M1Y52A5IZ5(M>J:*=%%%;F04444 %%%7/#_A^_P#%FNV.EZ58WFI:GJ5Q':6=
MG:0M-<74TC!(XHT4%G=F8*JJ"22 !DT-I*[!7>B*=%?0'PQ_X)5?M&?%S79M
M-TKX-^.K2XAMS<L^M:>=$@*AE4A9KWR8V?+#"*Q<@,0"%8CZ ^"'_!N#\?OB
M.;>X\53>$?AY9C4%M[J&_P!1%_?BV^0O<0QV@DADX9@J//&S-&0=BE7/DXC/
MLNH+][6BO*Z;^Y:_@=]'*\95_ATY?<[?>]#\_P"BOVZ^"/\ P;(?"WPA]GN/
M'GCCQ=XVO+:_6X\FPBBT:PN;9=A^SRQ_OICN(<,\<\9VN NQEWG[$_9U_P""
M=7P1_91O8KSP'\-_#NCZI;W$EU!JD\;ZAJ5J\D7DN(KNY:2>-#'E2B.$^=^,
MNV?F,;XA9=236'4JC]++[WK_ .2GMX;A'%SUJM17WO\ #3\3\%_V3O\ @D;\
M=OVP+VUDT/P;>>'?#]U;Q7:>(/$L<NF:9)#-$\D,L3,ADN4D" !K>.4+YD9;
M:K!J_2/]E7_@VG^&_@73-+U'XL>(-8\=:XF9;O2].G;3M%^> *82R@74OES%
MW6998-X6/=$H#*WZ7T5\/F?'.98J\:3]G'^[O_X%O]UCZC!<,8.AK-<[\]ON
MV^^YD> _A_H/PL\*6N@^&-#TCPYH=CO^S:=I=G'9VEOO=I'V11@(NYV9C@#+
M,2>2:UZ**^.E)R?-+<^ABDE9!1114C"BBB@ HHHH **** "BBB@ HHHH ***
M* "O(?\ @H'_ ,F%_&[_ +$'7?\ TW3UZ]7"_M1?#'4/C;^S-\1?!FDS6=OJ
MGB[PQJ6BV<MV[);QS7-K+"C2%59@@9P255B!G )XKHP<E&O"4MDU^9CB(N5*
M45O9_D?SU^ ?^1$T7_KP@_\ 1:UK5]9Z!_P0<^/6AZ#8V/\ :GPAE^QV\<&_
M^W]17?M4+G']G<9QTJW_ ,.,/CU_T$?A#_X4.H__ "NK][_UGRK_ )_Q/R'^
MP,P_Y],^0:*^OO\ AQA\>O\ H(_"'_PH=1_^5U'_  XP^/7_ $$?A#_X4.H_
M_*ZE_K/E7_/^(?ZOYA_SZ9\@T5]??\.,/CU_T$?A#_X4.H__ "NH_P"'&'QZ
M_P"@C\(?_"AU'_Y74?ZSY5_S_B'^K^8?\^F?(-%?7W_#C#X]?]!'X0_^%#J/
M_P KJ/\ AQA\>O\ H(_"'_PH=1_^5U'^L^5?\_XA_J_F'_/IGR#17U]_PXP^
M/7_01^$/_A0ZC_\ *ZC_ (<8?'K_ *"/PA_\*'4?_E=1_K/E7_/^(?ZOYA_S
MZ9X1^QU_R=U\*_\ L;])_P#2V&OWQK\M?V?/^"-7QK^%_P >_ _B;5;_ .%K
MZ7X=\06&IWBVFNW\EPT,-Q'(XC5K!59]JG 9E!. 6 Y'ZE5^;<<YCAL77I2P
MTU)).]O4^XX3P-?#4:D:\7%MK?T"BBBOACZP**** "BBB@ HHHH **** "BB
MB@ HHHH _FQ\ _\ (B:+_P!>$'_HM:UJ^L] _P""#GQZT/0;&Q_M3X0R_8[>
M.#?_ &_J*[]JA<X_L[C..E6_^'&'QZ_Z"/PA_P#"AU'_ .5U?T'_ *SY5_S_
M (GXW_8&8?\ /IGR#17U]_PXP^/7_01^$/\ X4.H_P#RNH_X<8?'K_H(_"'_
M ,*'4?\ Y74O]9\J_P"?\0_U?S#_ )],^0:*^OO^'&'QZ_Z"/PA_\*'4?_E=
M1_PXP^/7_01^$/\ X4.H_P#RNH_UGRK_ )_Q#_5_,/\ GTSY!HKZ^_X<8?'K
M_H(_"'_PH=1_^5U'_#C#X]?]!'X0_P#A0ZC_ /*ZC_6?*O\ G_$/]7\P_P"?
M3/D&BOK[_AQA\>O^@C\(?_"AU'_Y74?\.,/CU_T$?A#_ .%#J/\ \KJ/]9\J
M_P"?\0_U?S#_ )],\(_8Z_Y.Z^%?_8WZ3_Z6PU^^-?EK^SY_P1J^-?PO^/?@
M?Q-JM_\ "U]+\.^(+#4[Q;37;^2X:&&XCD<1JU@JL^U3@,R@G + <C]2J_-N
M.<QPV+KTI8::DDG>WJ?<<)X&OAJ-2->+BVUOZ!1117PQ]8%%%% !1110 444
M4 %%%% !1110 4444 ?S8^ ?^1$T7_KP@_\ 1:UK5]::#_P0;^/6AZ%96/\
M:OPBF^QP)!O_ +?U%=^U0N<?V<<9QTR:M?\ #C#X]?\ 01^$/_A0ZC_\KJ_H
M/_6?*O\ G_$_&WD&87_A,^0:*^OO^'&'QZ_Z"/PA_P#"AU'_ .5U'_#C#X]?
M]!'X0_\ A0ZC_P#*ZE_K/E7_ #_B'^K^8?\ /IGR#17U]_PXP^/7_01^$/\
MX4.H_P#RNH_X<8?'K_H(_"'_ ,*'4?\ Y74?ZSY5_P _XA_J_F'_ #Z9\@T5
M]??\.,/CU_T$?A#_ .%#J/\ \KJ/^'&'QZ_Z"/PA_P#"AU'_ .5U'^L^5?\
M/^(?ZOYA_P ^F?(-%?7W_#C#X]?]!'X0_P#A0ZC_ /*ZC_AQA\>O^@C\(?\
MPH=1_P#E=1_K/E7_ #_B'^K^8?\ /IGQ7X^_Y$36O^O"?_T6U?TG5^//B'_@
M@Y\>]<T"^LAJGPAC-Y;R0!SX@U$[=RE<X_L[MFOV&K\_X\S3"XSV'U::ER\U
M[=+\MOR9]GPE@,1AE5]O!QORVO\ ,****_/3[$**** "BBB@ HHHH **** "
MBBB@ HHHH **** *?B#P_8>+= OM*U6QL]3TO4[>2TO+.[A6:WNX9%*/'(C
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M:,J_Y_Q/QQ\/YA?^$SY!HKZ^_P"'&'QZ_P"@C\(?_"AU'_Y74?\ #C#X]?\
M01^$/_A0ZC_\KJ/]9\J_Y_Q%_J_F/_/IGR#17U]_PXP^/7_01^$/_A0ZC_\
M*ZC_ (<8?'K_ *"/PA_\*'4?_E=1_K/E7_/^(?ZOYC_SZ9\@T5]??\.,/CU_
MT$?A#_X4.H__ "NH_P"'&'QZ_P"@C\(?_"AU'_Y74?ZSY5_S_B'^K^8_\^F?
M(-%?7W_#C#X]?]!'X0_^%#J/_P KJ/\ AQA\>O\ H(_"'_PH=1_^5U'^L^5?
M\_XA_J_F/_/IGKW_  ;^?\U:_P"X/_[?U^CE?(?_  2I_88\>_L6_P#">?\
M"<7'A&X_X27^S_L7]AZA<7>WR/M7F>9YUM#M_P!<FW;NS\V<8&?KROQWBK%4
ML1FE6M0ES1?+9KRBE^9^E\/X>I0P%.E55I*]U_V\V%%%%?/GLA1110 4444
M%%%% !1110 4444 %%%% 'BG_!03]F3_ (:O_9@USP[:Q>9KUCC5M#^;;F]A
M5ML?+HG[U&DAW2':GG;\$J*_#+-?T<5^,_\ P5Q_9^G^"G[8&LZI!8_9]!\=
M?\3NQE0RNCSM@7:L[C'F?:-\A16(1+B+[H8*/TSP]S5J<\OF]'[T?7JOFM?D
M^Y\'QGEZ<8XR&^S_ $?Z?-'R_1117ZH?GX4444 %%%% !1110 4444 %%%%
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MQ%6I_$DW;NVRZ=*$/@27H@HHHK$T"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^1<=**!THK^J#\+"BBB@ H
MHHH **** "BBB@ /2OZZ*_D7/2OZZ*_*_$S_ )AO^W__ &P^[X+VK?\ ;O\
M[<%%%%?E9]R%%%% !1110 4444 >6^(?V'O@KXNUZ^U75O@_\+=4U34KB2[O
M+R[\*6$UQ=S2,6>21VB+.[,22S$DDDFJG_#OWX"_]$1^$7_A':=_\9KUVBNI
M8[$I6527WLQ^K47JX+[D>1#_ ()^_ 4?\T1^$7_A':=_\9H_X=^? 7_HB/PB
M_P#".T[_ .,UZ[11]>Q/_/R7WO\ S%]5H_R+[D4_#^@6'A/0;'2]+L;/3=+T
MVWCM+.SM(5AM[6&-0J1QHH"HBJ  H    '%7***Y6VW=F^VB"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "O.?'?['OPD^*7BNZU[Q-\+?ASXCUR_*&YU'
M5/#5E>7=QL18TWRR1EVVHB*,DX55'0"O1J*TIUITWS4VT_)V)G3C-6FK^IY%
M_P ._?@+_P!$1^$7_A':=_\ &:/^'?GP%_Z(C\(O_".T[_XS7KM%;?7L3_S\
ME][_ ,S+ZK1_D7W(\B_X=^_ 7_HB/PB_\([3O_C-:_@/]C[X2?"OQ7:Z]X7^
M%OPY\-ZY8[_LVHZ7X:L[.[M]Z,C[)8XU==R,RG!&0Q!X)KT:BE+&8B2Y93E;
MU8XX>DG=17W(****YC8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&UO[B*$,S"-7EC9@@9W8*#@%F/4FLF?]B/X+W.FBSD^$/PODLPJH(&\*V)C
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% '\BXZ44#I17]4'X6%%%% !1110 4444 %%%%  >E?UT5_(N>E?UT5^5
M^)G_ ##?]O\ _MA]WP7M6_[=_P#;@HHHK\K/N0HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 ?R+CI10.E%?U0?A84444 %%%% !1110
M4444 !Z5_717\BYZ5_717Y7XF?\ ,-_V_P#^V'W?!>U;_MW_ -N"BBBORL^Y
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
M(N.E% Z45_5!^%A1110 4444 %%%% !1110 'I7]=%?R+GI7]=%?E?B9_P P
MW_;_ /[8?=\%[5O^W?\ VX****_*S[D**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3R2<UX^;8SV</91W?Y?\$]3+<+SR]I+9?F6****^7/H HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^1<=**!THK^J#\+"BBB@
M HHHH **** "BBB@ /2OZZ*_D7/2OZZ*_*_$S_F&_P"W_P#VP^[X+VK?]N_^
MW!1117Y6?<A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBZ-9:='U3[H_G'HK]/\ _@J)_P $N_\ A8W]H_$KX:Z=_P 5)\USKFAVR?\
M(8[M<VZC_EYZEXQ_KN67][D3?F!7[QDV<T,RH>VH[]5U3_K9]?O1^1YIE=;
MUO95=NCZ-?UNN@4445ZQYH4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 445^@/_!-/_@E)>>)M7A\=?%K0[JQTNQF/]F>&M1MVBFU"
M5&QYUW$X!6!6'RQ, 92,L/*P)O-S3-L/E]!U\0_1=6^R_K3J=V7Y?6QE54J*
M]7T2[LK?\$O?^"77_"R1I_Q*^)>FY\-G;<:'H5S'_P ACNMS<(?^7;H4C/\
MKN&;]U@3?J!117X/G.<U\RK^VK;=%T2_K=]?N1^NY9EE' T?94OF^K?];+H%
M%%5]4U2WT73Y;JZE6&WA7<[MT _J3T ')/%>2DV[(]!M)79!XE\2VGA/2)+R
M\DV11\ #EI&[*H[D_P#US@ FO O&/BF;QEXAFOYE\OS,*D88L(D'11G\2<8R
M23@9K2^(_P 2+CQY?[5#0:?"Q\F$GD]M[?[1'X ' [D\S7UF6X'V,>>?Q/\
M ^<QV,]M+EC\*_$****]0\\**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "G0Q/<3+'&C222,%1%7<S$\  =R?2FU[#\&/AI)X=B;4
M]0A1;R90((V7Y[9><D^C-GIC( QGD@<N,Q4:%/GEOT7<Z,-AY5I\J^;-[X;^
M!$\!Z$82ZS75PWF3R!<#.,!0<9VCMGN2>,X'0T45\;4J2J2<Y;L^JITU"*C'
M9!1116904444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!_(N.E% Z45_5!^%A1110 4444 %%%% !1110 'I7]=%?R+GI7]=%?E?B
M9_S#?]O_ /MA]WP7M6_[=_\ ;@HHHK\K/N0HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^*O^"@G
M_!)G2/CO_;GC?P O]D^/+C%U/IN](]/UN0;C(>0/*N9,J?,W"-F7YU5I'F'V
MK17?EN98C UE7PTK/\&NS75''CL#1Q=+V5=77XKS7F?SH:QH]YX=U>ZT_4+6
MYL;^QF>WN;:XB:*:WE1BKHZ, 596!!! (((JM7[9?M^_L Z'^VGX(6:%K;1_
M'6CPE=)U9E.V1<EOLMSM!+0,Q)! +1,Q900723\@OV@?V?O%'[,GQ/OO"?BR
MQ^QZE9_O(I(R6M[Z DA+B!R!OC;!P< @AE8*ZLH_;L@XDP^9PLO=J+>/ZKNO
MR_/\JSC(ZV G=^]#I+]'V9Q5%%%?1GB!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 59T?1[SQ%J]KI^GVMS?7]],EO;6UO$TLUQ*[!41$4$LS,0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZD9Q4X.Z?5;'PTHRB^62LT%%%%42%%%% !1110 4444 %%%% !1110 4444
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M\9CW5]V&B_/_ ( 4445ZYYH4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%>B_"'X3#6%BU;5(_]$X>V@8?\?'H[#^YZ#^+K]W[V
M&(Q$*,.>9M1HRJRY(F9\*_A9)XTG6\O T>DQMC@X:Z8'E5/90>"WX#G)7VRW
M@CM($BBC6..-0B(@VJ@'  '8"DM[>.SMXX88TBBB4(B(NU44<  #H!Z4^ODL
M9C)XB?,]NB/I<+A8T8V6_5A1117&=(4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRJDIXA7Z:_U\S@S*HXT&EUT.-HHHKZX^:"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBN@\&_#;5/&=Q$88)(;)FP]U(N$4<Y*YQO.5(
MPO?&<#FHJ5(PCS3=D5"G*;Y8J[.?)P*[WP9\";[6'6;5B^GVC*3L5A]H8D#;
MP00HY.=W(*XV\Y'>^"OA3I?@J5+B-9+J^52/M$I^[D ':O11P?5@&(R0:Z:O
M Q><-^[0^_\ R/:PV5I>]6^XKZ7I=OHNGQ6MK"L-O"NU$7H!_4GJ2>23FK%%
M%>$VV[L]A*RL@HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!B^//AKX<^*>D1Z?XG\/Z+XCT^&87$=MJEC%>0I*%90X216
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M*S'%8G_>*DI>K;7W'K8?!8>A_!@H^B2"BBBN,Z@HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI)YI"0D<:EF; ). .>@)_"O>-&^$OA_157;I\=Q(L8C9[C][OZ98J?E!..H
M[XP.*WK&P@TNU6"VAAMX4R5CB0(JY.3@#CDDG\:XJF>07P1;]=/\SKIY3)_'
M+[CQ'1O@IX@U9EWVT=E&\>\/<2 >F 57+ \]"!C!S@\5VVA?L^:98N'OKFXU
M!E8_(!Y,9&, $ EL@\Y##MQZ]]17FULUQ%31.WH=]/+J,-6K^I3T;P[8^'8?
M+L;.WM5*JK&- &<+TW'JQY/)R>35RBBO/E)R=V=L8I*R"BBBI&%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ameh-nonqualifieddeferre001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ!AU4.[*&/\ NYJYX?\ &>D>)H;S^SFF-W9DK<6,T?ESQ,,_*5;'IC.<9[T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'BV7QSX(TOPK+(XU5W-GJF>'2VBQO8]QO4K'GU=O2O19O#]Y+XPAUY=5VI%
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M.:RFC>.+ACDLH !^7ZY'K7GEAH_Q(^'4%^/#L6E:[H4D\EVBNQ\T*>3CE<G
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>X_9PNM7FOKY]1,%Q/\ :C=R^8'21U4@[N,#C'2M/X?/HFI6'A<_VGJ4NN-
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M.IP2<=J -;^PM'\GR?[*L?*#;MGV=-N[UQCK4J:7I\=TMTEA:K<*H591"H<
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MF7L,< TIBZ6\F\^:[([(Q*XP%)4XY)QUQG  +']@Z,9(Y/[)L-\8"HWV9,J
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MS*O/J2K<>U "V^C:7:01P6VFV<,,4GFQQQP*JH_]X #@^]7:,\X[T4 %%%%
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M;2#2;2WT]M3@WQR(L965HR74!MW7OC;V%:UF\.F^.?"-A-JRW\T.AW,?VAB
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MI,@9@4.00O\ >'8$9KTK%8%UI%ZOB=]7MQ;74<EJMN;>Z<IY)5F;<A"M][<
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MHD(P6QR1]:!%&)#($7S",%L<X^M 'DWA^/\ MNQABU37-/L/$EMJA>826_\
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MZJW(YP#QD8(/>K6H?V;I/Q%\':;;&"WB@L;V..!"!M!$.T >^#CUP:[O HH
M\<M-7TN_UCPGKMF;"RFN=1DAN4C)-PJ-%+\EQ+GDDJIV,.#T)Q5>73]%N_A_
MXYOX5AEN]/U"]EM)DDR]L5.4,9!^0<=L9QWKVH*JYPH&3DX'4TN* *UK/%=Z
M=%.)$DBDB#%P05((Y.>E>6:8;6\\*3VMEJ]A:LOB:Z\A;K$EO,!)*R12 ,/D
M*KD?[JXKURFO&DB%7164]0PR#0!S/@6=Y=+ODDTZSLFBO7C)L7+6\QVJ2\>0
M, DD$?W@U8-[%:Q?%35RK1+JDNC0/IZS2D&28--]T$\X^7('2O10 JA5  '
M [4;06!P,CH: /)E%O>>!?#EUI14>*TN;578<7)FWJ+D2_Q8QYA8-Q@?2O6J
M8(HUD:0(H=N&8#D_4T^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *J+JFGO>_8EO[4W?/[@3+OXZ_+G-27B3R6-PELXCG:)A&Y
M_A8C@_G7F8M9M2^&VB:#!;3P>(K*>U#*\9#V\T<BF68M_=(#G=G#;L#)- '9
MIK<M[XKNM,M;FW@BTWR_M:2Q[GG+H6 0[AM"C:2<'.<<8R6>&]?.LZ4VNS7E
MI'IMPBR01;=C0+D_ZQRQ!)^4]!CD<]:Q-(M=/7QOXRN+C31LD,)CE>S.)!Y.
MV3:=OS<Y!QUKF=.L+JP\%>![N&RNK:&QG#:JD-F3,C>6RK(T97+!2P)X)&<]
MJ /6%U73FM!=KJ%J;8MM$PF783TQG.,U-;7=M>([VMQ%.J.8V,3A@K#JIQT(
M]*\S\4:58R^#==NK)M0U&;4[VUE93:,,NCQ!FC4(#]Q<EAGH>:]'TZSL+.UV
MZ=:PV\$A\S9#&(P20.< #G@4 %QJFG6MREM<7]K#<2$!(I)E5FSP, G)S2RZ
ME8P7<=K->VT=S(0$A>50[$], G)K@=9CO[77-5N-$O#/-/=PF?1KVR+K.RK&
MH>.08*@*JG/*@J>E4K33FNXM?\/>(;O5+::ZU26=?(L]WG(9 T4D<FQN@"CK
M\NWMB@#M-'UB_N_%GB'2[O[.8-/^SM T495B)%9CNRQR1@#(Q]*V+74K&^>1
M+2]M[AX\;UBE5RN>F<'BO-?$-KJ>HW'Q#M]+@N?M-S:VBVY\ME$X12)%1B,$
MXRO'K5N\LO\ A(-.O-1T6_U,ZU'I%Q:V\<EI]F";P/D8[%PP*C SQR?>@#M)
M_$6DPB]5=0MII[*)YIK>&9&E55&3E<Y'XTZPUVQOM"M-7::.WM[B&.7]](HV
M;U#!6.<9YKEXY=*\0>#9+:WTJ5;^'2I(5M9K)T:$E!F/YEQG<JX]<9%<];!K
M2+P3J-M!>6>EVUI)!>/#I[;H+DQQKO="F2/E9=^#C)YYH ]42^M)++[:EU U
MKMW^>L@*;?7=TQ7/:!XEDUCQ9K=A'=6-U86D-O+;S6O.?,,FX,VX@D;!TQ7-
MW5FFAS:/J=M_:5_HC:M<7E^#;,2CR1X201!03&KY;@'EMW-:OAJ1)?B+XCO(
MK&XM[>\M+-H99+9HQ.5\W<W('(RHYP>G;% &IXZUV]\,^$[O6;%+>22V*$Q3
MJ2'#.J]01C[V>_2K49U]=0$$MSIDD30NQ=+=U:-^-N5,AW*?F].G6L?XIPRW
M/PZU.W@MYKB64PJL4,;.S?O4)P%&>@)_"I=/N=$L-8WZ=#J!DND$<QDAGV1I
M&KN&)=?4XP#SD4 ,T#Q+J6J>$M#U.7^S4N[VX"3K)*8EV;V4^6#DL_"X4GG/
M6NDNM4T^QE2*[OK6WDD("+-,J%L\# )YKRVSC=?A]X,CEL+H7-KK,+R(UJ^^
M%!,S,Q&W(&"#GWJ?Q#-9KKOB[1+ZYD6SU6*!Y9VL9IFA!CVD)L5@0 H(W%=K
M$\&@#T&;4+A]7@M;2;3S!)!(S,\V90XQMP@^\O7/(K+\)>*X]6T.RDU:\L(=
M3N99T6!'$9?9,Z#:C,6/"^]9%N^ER^./"MWHL(?3?[,N46Y@@/E_.8B@+ 8!
M.U^O?-<_8:1;ZO\ #NX\/1:9-%K\EW*X>6S>-H6-PSI-YA4# 0@@@\]!SQ0!
MW^CZQ?7?BOQ#I=V;<P:?]G,#11E6(D5F.[+')& ,C'TK8M=2L;YY$M+VWN'C
MQO6*57*YZ9P>*\U\06NIZA/\0[;2X+G[3<VUHL!\ME$X12)51B,$XRO'K71:
M!%8:KKEIK,5[J,EU;V;V_E2V?V=41BI*/\@^8%1@9]>* +_CC7+WPUX2O=9L
MD@DDM K&*920X+!<9!&.N>]:;:G:V4174=1LHYHX_,E)<1 +D#=AF) Y Y/<
M5SGQ462;X<ZM:P033W$Z*L44,32,QWJ> H/8&J\L5G?_ !6L+LV32P_V/*GG
MO:ML$AEC*@DC ;:&Z]J .TCN[::T%W%<1/;%=XF5P4*^N[IBN;TWQ2=0\:W^
MFPWNGW.F0:?'=I-;G)5FD=2K,&(.-F>@ZUQT45UIEDI&G79TNP\57,UU:16[
M'_1R9/+=4 ^9%<JV%!Z9[5O:=<6UQ\2]1U%;&>.PNM&A GDM'19V624MG*YS
MMP,'D@#'&* .ET[6XSI=I+JUYID%W/N&V"Z#1L0Q'R,<%NV>.O%/U76([:RO
M18W>G-J$$9817-R$53VWD9*C\*X'3='NKKX/:<UK:2Q:QH\S7MK#+$R.)(Y&
M;9@@'YT)7_@5:7B6V;4/AKXAU%["8WVKVK-%;F$M*HV8B3: 2"!R1V9FH [>
MXO[:RLA=7MU;6T6!F624*@)_VCBL#PMXG;4]-U*[U.[L%CMM2FM(YXCY<;HA
M 5OF8\GKUK+DU!M.\;6&H7]M>2:5/I*P6LL=K)*(9]Y+JRJ"5++LY(YVXKGY
M=/EF^'/C"VBTBXCF76);J&U^S$-Y?FHP*#'/RJWW: /6#=6XNA:F>+[05W"+
M>-Y'KCKBH8M4T^>]DL8;^UDO(AEX$F5I$^J@Y%<:=0AU'XDZ1JEE97;VO]EW
M47VEK5XU=R\15,L <X4]>/R.,33[FXU+5/!6I26%S;2P74R7,$>GO%'9!H9!
ML+%=Q^;:"<[2>>,B@#M/#6O7-]:ZS+J\MI&-/U*:T$J*8DV(%PQW,<'GUK=M
M+ZTU"$S65U!<Q!BI>&0.N1U&1WKS6VA2[TK7(IYK_3B_B1[FWNUM6/EXVM'(
M59<-&2F/3D=.M=7X.DU22/4_[2-O.!=#R;Z"W, NU\M!O*$GD8VY'!V\4 ;K
M:A9)>"S>\MUNFY$)E4.?^ YS1-J-C;0B:>\MXHBY0/)*JC<"01DGJ"",>U<M
MXSMK^UUK0==TJU:XNXI9+&1%'6.9<!F_V5D6,GT&:H:'H5WIWB*Y\.2QSSZ/
M'<)J\5S+\P=CUC)_O><OFT :^E>*<:OKUIK=[I]M'8WL=M;2$^2) T228.YC
MEOGQQZ=*Z*ZOK2QB$MW=06\9. \T@0$_4UP,&GV]_?\ Q",^FM*;DCR6EMC^
M]06R*=A(Y^8$<=Q47AR:YT_5/#=_JD=PEBWAR&S666-L6]TI!D5\CY"P"\G&
M=F* /1X9XKF%)H)4EB<;D>-@RL/4$=:BOM0LM,M_M%_>6]I #CS)Y5C7/U)Q
M7/>!M.GL+?6G:-X;.[U6:XLH74J4B;;SM/W06#L!Z'WJIJ%V^D_$DWFIP3MI
M=QIJP6MPD+2)#*)&+JVT':6!0Y/!VX[4 =1-K&F6]M%<S:C:1V\J[HY7G4*X
M]02<$5))J%E$(C)>6Z>:-T>Z4#>,9R.>>.:XW3&AT7QIJ$MS!)#I5YI]LFF2
M-"P2-4W[XB",HQ+!MIP3^%<[::(]E'X1M[[3Y6ACUJZN$B:W9_LUJZS>4K\'
M:,LG!Z9QVH ]'O/$>F6OAV^UV&YCO+*SADF=K219,A!D@$'&?QJ>/6+!K:":
M2[MX?.CWJLDJ@XV[CW[#.?I7GFMZ0TG_  LJQM],=A=6$4MM&EN=LL@@8$IQ
M@MG;TYSBIM2M](OK[P.\.DL;%)Y7G!T]U5%,#J"X*C +XZ]: .S_ +3N+O4C
M#I]SICVKV7G12B;S)"^X8.P$9CVD'<&ZFJ/A#Q7#KGA[2)[^[L8M5OK83FU2
M0*QSG[J$EL5GPVMO8?%*-+6Q:"UCT(VZO%;D1AA*I5-P&,A1T]!7+Z#H\&K?
M#O0=%M=-FMM<M)[:6666S>)[5DD5G<NRCDH"!@G.1VS@ ]6&HV1BEE%Y;F.%
MMLKB5<(>N&.>#R.OK5&\\165GJ^E:>Q+-J22R12JR^6%C4$DG/?<,8K@[DI9
M:?\ $/17TRZ>ZO)9[BTABLW994:U10RL!M^\K=\Y]ZLSVMJ=6\!7MYIDDL"6
M$UM,QLFD*2%(@BN I(Y#XR..: /0'U*QCO$LY+VV2Z?A86E4.W&>%SFK5>5:
M/IS7>GW?A[Q!=ZI;WPU5[@K%9Y\T^?YD<J2[#D8VC.?E (. *]'UH1MH6H+*
MD[QFVD#K "9"-IR%Q_%Z>] $;ZW8S6UW]@U#3Y[B&,ML-RNU3VWD9*C/&:?!
MJ4<>C6M[J5S9P&2)&DD2<&'<5R=KG&5ZX/<5P-M'J$%M>6,MU%KFDQZ/+'%=
M?8#'-"WRA(3CAR<9P%!!7G&1F WIT;2OAYJ#K.LMO9&TDMI;64A28%W%@JEE
M92F!\I^\1P.: /2!JVFM;+<#4+0P-C;*)EVG/3!SCFE@U33[I[A+:_M9GMSB
M98YE8Q'T;!^7\:\KO[709?AOJUIHX_M"]?4HYKI(;%TD5WN%E(\LKN50I;&>
MP-=1<6MK9_$C3KR&Q\NQET6XBDDCMCL/[R)D5L#'0/@'WH T;CQ+/8>&+*^O
M/L/VR[NH[-#;2F6!9'DV!MW!( Y(XZ$>]7=.O-0.I)975UIMTBV@D>6!RDK2
M;NHBR<)M*\[CR:\W@M$?X;>$[6XTN=I(-:B:6"2S<M%&+@LY*E<A=I!/;!KH
M[BW8?$2Z&E6[6Y?P\;>"=("L2R[R47=C&0,''I0!V2ZOIC:D=-74;0WP&3;"
M=?-QU^[G/Z46^K:;=RSQ6VH6DTEO_KECF5C'_O 'C\:XKP]J-L/!%E;MHUT^
MNZ58OFREMI%<W"Q,K?/C!WDM\V3NW=S6?IDOVGQ7X9U.2WN/(.EW4-R1IS00
MQ'$1$0!7=@8;[Q(XXYS0!Z&FM:5)<0VZ:G9M/."8HUG4M( 2"5&<GD$<>AJK
M'KL5YK>IZ);$17ME%$WF3*&1C(&(PH8$X"\].M><6FE)'\(=,:/294U"UU."
M8K]D831D78);&-W^K/7TKI-,BL;'XE^(;FXT]D:Y@MI[6X%FS!@$<2$.%P#D
M@'D$Y% &KX4\4IJOA/2-2U:YLK:\OHM_EAP@)W$84,<GMZUOQWMI-<R6T5U"
M\\7^LB60%D^HZBO,;'3;J3X,Z/=0VLL>K:%MOHH9HRCAXV)9"" ?F0LO_ A7
M>>'8O.M9=7DB:.?4V%P5<89(\ 1J?0A0"1_>+4 2ZQKMMHLVFQ7"N3J%T+6,
MK@!6VLV6R>F$/XXJS<ZKIUDR+=W]K T@!02S*I;/ QD\UROCZTMWO?#%[<V!
MN;>VU3-PRVQF*1F&0<JH)V[BO;KBJVG&&PO?%MCKEI*ZW\_FVW[AF%Q:F%46
M) !R5PPV=1G..<T =]7-WWB@-'XCMM/V)?:/&"3<+N21O*$N  P)&"!G(Y^G
M,W@JPU#2_!.C6.J,6OH+5$ERVXJ0/NY[X&!^%<D;6UL=:\?*^ER)<W">;:R)
M9,?,5K95.QPN,E]PQG).: .P\/>(+;5M+TWSKRT_M.>RAN9K:.0;U+(&)V9R
M!S6BVI6*7JV37MLMTWW8#*H<\9X7.>G->=II\5MH'PZNH--DCGM;F!;ADMF$
MD0-M(LF_C(&[&<]\5!H&G-=:4- \07>J6^HP:HURR1V>?,<3F1)4EV'*GC+9
MX&0<4 >JUS7AWQ(NL68U>:_LX["\VBTMR DB?,R_,Q8[BWRD  8Z<]:Z"Y\D
M6TOVA0T.T[U*[@5[C'?Z5Y)9::EM\(M!G72)4NK&^M)[Q%LV$RJDZEB5QN.%
MY^E 'K0NK=KEK87$1G5=S1!QN ]2.N*R]$\4:;K>BVFIQS+;QW1Q''/(JOG<
M5 QGJ<=/>N>LI;?4_B?-=I8SFQNM$6(336C(DS>:Q*_,!V]>H]JY>PL8K;X8
M:$ZZ//'=Z5J=I+?J+%UE41S@N?NY?"\_+GB@#US[9:B:2$W,/FQKO=/,&Y5]
M2.P]ZCAU33KB0QP7]K*XC,I5)E8[ <%L ],C&?6N.LKJWNOB9>:@MG<+83Z)
M&@GDM'5)F$LA(Y')QV/)[<8KF+30)?\ A3L#Z=I,L>JQ2*;N-;;;<RPBX#NF
M&&6RJC"G@@8]J /6K34+*_#FSO+>Y$9PYAE5]I]#@\5C>(]:O=(U70(X6MA:
M7][]FN/-0[E'EN^Y6W #[F.0>M5_#\%A?:_+KL&H7]S<O9K;/YMJ8(]H8L,@
MHN7!)[\ GBJOQ!2,R^&9KFTEN+.WU99;D1P-,$3R95W,J@G;EE[4 =-%K>DS
M6;WD6IV4EJC;6G2X0HI]"V< U9:ZMUN4MFGB$[@E8BXW,!W ZFO+_$WAQM1T
MSQEJFE:<WV6^TR&.&!8"K7$T9=FD"$ YVLJ@XR<''&,Z\VHV^K?$'PMJ5E:7
M9M5MKR.2Z>SDC4,PBVJ2R@CH>O'XYP =DFK:;)=O:IJ%HUR@)>%9E+J!UR,Y
M&*K:9JIETRWGU*XTZ*>:5HU^SW(>-CO*J%8XR>F1ZY%<5X:CO+*]TBVMKO\
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MU<&J6!U1M,%Y ;]8C,UN'!=4R!N(Z@<C\Z +=%9]GK>FZA<BWM;I99&C,J
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M:2&<A-K#MA_+;VP:[:LZ32GGUB.^FOIW@B ,5GM01J^"-^<;B<$\$X'7&<8
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M,)GE;]V<_.0'5@/5<=:]3HH Y2UL9=0^(2^(889H;.+2S9LTT31-,[2!P-K
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M-L:J,E-Q4;CD8QSUPVWT+6#;16&A7>IP65Q!<+-9:G;?+8,\3A3%*4#$AV
M!;@DUZC10!Y_X4TTW%KX?M]5L]:BO]'10(YHE6"%UC,9*R*H#J02  3U&176
M:[<BVLD\W39-0M99!'<Q1P^:1&0?FV?Q#.W(P>#6I10!YE/X>-CJ&HZYX,T
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MXBE4@XPJG+KP<'GIP<>FT4 <#<FZO)_ \Z:5J$:V=P7N!);,#$OV=X\D#/\
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MUV]NS(\HDRPSCNO.>G;.>*[BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>4;EB!!9I".^U0>.YQ5[0;"&S@N)8]-EL9+F7S95GF\V5VV@;G;<W. !]X\
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MMMK*WIB\V/YHQ=F;@[L9VG&#CF@#J+GQEI-M?WU@!?37ED$::""RED<!LX(
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M&NZI9OL.E:;>2/IP!^ZTZK(RX[;-[ >TA]*[6@ HHHH **** "BBB@ HHHH
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MXZ/I.IVFK,DSI=2[7MY @1ER8VWH< ]B.>*[%XI(-+\BSMX Z1!(X0WEQCC
M P#@#Z5;HH YWP+H]_X>\':=H^HB#[19Q^47@D+JXSG/*@CKTK&NO#GB5E\7
M/936MK/JT\,UK(EPX90B1HRL0H*EE1AN&<;O:N[HH X2'POJ\6KZIJ$5AI=L
MM]I"V:P13M\DH:0Y9MGS9#CYL9XQ@XR93X9U?_A&/!]B%L_M6B7-M)./.;8Z
MQQ-&=IVYR<@X(%=M10!2T]M2+7?]HI:J!<,+;[.S',/&TOD</UR!QTJ[110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!%/<P6L?F7$T<29QND8*,_4U
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M\UBMU ;M4WM )!Y@7CDKUQR.?<5RL7C:6)KBVN+19KC[?#8VDT09(;HRKN#
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M+,YT6X\M[<,"1YT.0P/IZYYST% '=T5C:OK3V>J:=I%K&C7^H"5HC*3LC2,
MLQQR?O* !C.>HK/AUW5SK4/AZ>*R35'AENFG0,T0@5E56"YR68MC&1C!.>F0
M#J:*X.\\=ZA9Z3JK'3;=]1TK4(;*YC\XJCB5D"2)P>HD!P>F#R:MC7O$[>(K
MS0!8Z4+Q+1+V"?SI/*\MF9=K#;G=E>HXP<^Q .QHKAQXXU"X\/>&=4M-,@+:
MO=K:2PR3$>4YWYP0.1E#SZ=CTJ._\=WWAJ[U.V\0V-NQM['[=;2V4C;95\P1
M[&##*MN9>>1@Y[4 =Y17&R>+=0ANY[>.WM;X"PDNTF@WI'&Z$9B<D-U!R&XS
M@\"HK/Q=K+1^&+Z]T^R33]<,40$4S&6&1XC(I.1@K\I&.HXY- ';T5QVD^-%
MU7Q =.%S803I=302Z=.62Z1$W!9!DX?=M4X X#=3BB;QA=6WB+3;.1+":UO;
MMK,BVF9Y+=PK,I<XVG.PY7@C/?% '8,P52S$!0,DD\ 4H((!!R#WKS:UU/5W
MTGQY+?65I?65O=7*F&>\<C8L$9,0'EX"D9/4<D\=ZWK#7WGFTC1--@M[>XET
MI+YRZEHX(OE555006R21U& OX4 =717!3>/-1AM)4&EV[7]IK$6E749G(4^8
MR!)$..A5P<'I[ULZ5KFIOXJN]!U:VM$E2T2\AFM78JR,Y0JP8 A@1UZ'/:@#
M=O;ZTTZU>ZOKJ&VMTQNEFD"*N>!DGBIZXKQ'/J+?$+PY96]O:SVSVMW(T4\S
M*K,/+4L0$;D!CCUW-T[OF\77\OAO4O$>G6MO+I]A),/(<D23QPL5D8-G"GY6
MP"#G Y&> #LJ*XNZ\6:U=:Y%IVA:=93K<Z6NHV\US.R94LHPP"\'G@?F17:4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRMD@\'!;';@CZUUEYX.LM7L+Z'6)I+RXOK<6TMP (RB [E" <+AOF[DD#.<
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M<<UVMEX?AL==U+5TN[IY]05%F1RFP! 0NW"@C )[\]\UFP^!+"VTW1;*WO\
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MLKEP(S'YG'*'YMW3MZ:EUX,T^ZTY+/[1=Q 7JW\DL;)OFG#!@[DJ1U X  P
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M$<VI3Q7$KJ8\J\>W:5^3'1%&#D$5H:?H\-A>75Z9I;B\N@BRSR[0Q5,[5PH
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M9T\Q6,OFG!"XY?GD'K4K^$+4ZW+JL.H:A;3W*(EXD$JJEWM& 7&WAL<93::
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MGID\$%Q]H:6=6:-(+66<D+M#$B-3@#<O7UKF?!D-W_PE'B^62^+Q#5=IA$8
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M5BRG*Y ]_?U=IVM:W]O\&WUQJ?G6_B"(_:+/R46.%OLYF4QD#=U7!W,V<]J
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MG;T[<U&?"&B'P_%H7V60:?"R-#']IDW1%""I1]VY<$#&#6Y10!B1^$=$C&H
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M$,SQK"I&" JL!R..16Q110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQQX/M'YMVENIRO8R)#A,_3>Q_"I/$]O#K=I=>&+;RT^V+_ITHP!#$Q^;ZR,
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M%M!N]1FU"?2;22[F39+*8QF08Q\WJ<<9/- $.B3RVW@/39X+=[F6/3(G2!"
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ML=8LIY9([V97:3:J,L@1<B/.[H#CGH,5U?\ 8IB\1W&H1")[;4(!#?0R?Q%
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MKPD%RL@C8QLQ&6V[\9Z\C)K?NGNM(\1:-X?DUB]F@U>6ZGDN9W D^1$Q"C*
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MX3LH-0U(&1M0N;&V:YFR\FR:0(F3RQVJ/RKM: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** *.I_P!IF.!-+:V21I<2R7$9D5$VL<[0RDG(4=>]<OHN
ML^*=8EU4)+I/_$NU7["R"TD!E1=A9P3+\IVN3C!^[[UVI. 2>U<9X#:2.[\5
M&:UNX!/K,US$9K:2,21%(P&7<!GE3^5 $_AKQ=%<P31:YJ6G07_]I7-G!&'$
M7FB*0H-JLQ))QZGK717FJ:?IQ47M];6Q89'G2JF1T[FO,)]+ENOACXSBCTBZ
M-]/J-Y<0QM9NLLFZ<M&R@KD\8(QTK0DBE7Q=XC75)-6AT_6(8?LLEO8F5)(A
M%L:-OW;%&!+':<9W$T >E Y&1TKDO[8UVX\=7^@6\^G10P64=W'+):.['>[*
M%.)0.-O7OGH*Z'2+.+3M&L;&%IFBM[>.)#.?WA55 &[IS@<UR"6RWOQ7U0W%
MG>&SETN"!9C!*L;2))(67?@#HP[X.: (;#QKK-\VA%X+2$7&L3Z7=A$9A(8E
MD/F1,3PI,>,$'OS7:2:SI<.HIITNI6:7TGW+9IU$C?1<Y-<SXHMDM-3\'P6-
MA*+:TU+S&6UMF*0Q^3*F3M&%&6 _&N<\0S:CJMI?POIM_%/::[#)';VVGMM,
M27"?OS)M)<E03\AR!P1@$T >B77B+1++S?M6L:?!Y+A)/-N478QS@')X)P>/
M8^E:".DD:R1LKHP!5E.00>X-<5I%G!<?$+Q7-/ILAAN+>UCCEFM&"2@*XD 9
MEP>JY'>KWPWCG@^'FB6]U!/!<06RQ213QLCJ1V(8 ^E &NU_+_PD<=BD^GF#
M[,TCQ&;_ $D/N7!"?W,'D^I%2V^KZ;=7;6EOJ%K+<J"3%',K. #@G .>#P:Y
MK4 R?%&RN19W3PII%Q"\T=NY3>TD3*N\#&2%;O6=X2MM2T_4](L[.\FU#18[
M5UVWU@89[!0J[4\S"[B3@$$9XS0!VVK73V6DW5Q%+:13)&QB:[DV1;\?+O;L
M,XS40UO3[>VA-_J6GPS- )G_ -(4+MQDLI)&5]_2JGC1#+X(UR%())Y);":.
M.**,R,[LA"@  G.2*Y>. 7'B;P++)IMTR6VG3I,[V<F(9"L04,2ORG*MUH Z
MG5O%>F:9X9DUZ*>.^LU9%5K:56#EG"##9QP3S]#5^XU?3+6!)[C4+2*%P2LC
MS*JL!UP2>U>9ZII,W_"->-+5=(N&QKL5Y!$MJQWQ[K<N\8Q\WW9,[??UK2<R
M6?CFXOW_ +3M='O].ACLY+;3RZH59R\;H8V:,G<&&0,_44 =Q/K>DVN?M&J6
M4.(_./F7"KA./FY/W>1STYJ:WU"RO+$7UM=V\UHREA/'(&0@=3N!QBN!L=$M
M-,\8>$[6UL[^>QL=,N8DN+FU8E&9HS&&;: IP&P#C XXK.DL]0L;6_:'2KQ[
M.T\6&]GM8K=LRVI4?-&N/G ?#87/W: .MT[Q2=2\?3Z39W]A>::FG?:0UL0S
M))Y@4JS!B#QST'6N@BU73I[PV<5_;270!)A652_!P>,YX[UPTS7&K>.;V\TR
MSO;9;OP\]O;7LMI)$&F\PD9+*"N.,;L>W&,Q>%=/COM,\.6UY)K5MJFCH-MM
M+9>7'#*L1C;,@C 9""<?-\W'4T ;GC?Q8N@:6YL-1TY=26:%?LL[!G=7D53A
M0P((#9S@].E=;7C\SW<OPI30)]#U-];LYH#=*;*1LNMPK/,KXP^[D_*2>3Q@
M&O7D<21JZYVL 1D$'\CR* ,FT\16=WXDU+1%^2XL5B)+.O[PNI;"C.> .?K5
MN#6-,N;O[);ZA:2W&"?*296; X/ .>*X.^TJX?Q'XXM;.RE@U#4K%#IUT+9@
MA?R65B)0-JG<<')!YJ66%M=TSP=;Z?97%K>Z;>V\LZR0-&;2.-")4)( Y'R@
M#.[((R!F@#T2J(UO2CJ@TP:E9F_.<6HG7S3@9/RYSP.:GOHYY;"YCMG\NX>)
MEB<_PL0<'\ZX+0V>^^']OH L;RQ\16EA) GG6LBB*Y\ID,HEV[?F))W9YW>M
M ';Q:QID]Y]CAU"TDN>?W*3*7XZ\9SQW]*AF\2:%;N$FUK3HV,GE!7ND!W_W
M>3U]JXEK:36?#/A'3K.RN;74].N[1Y5D@9/L@B&)<L1C! 91@_-N&,BJM]8K
M/8_$P?V1<O)>J1:_Z#(3.1;*J[/EY_> ]._/O0!Z-#J^F7%Y<6<&HVDMU;C,
M\*3*SQ#_ &E!R/QJLWBCP^GD[]<TU?.<I%F[0;V'!"\\D'TKEH[3RO$/@2[A
MT^>.-+*X@G=;5QY>4CPLG'R_,#]['.:QM)6QU+PYXPT)-*EN;^[U/4$13:-Y
M;L9'"'S2NP!3WSD8XYQD [1];O+?Q])I5Q+;+I@TIKT,4*LC"0*=S%L$8R>@
MK4_MW2/L:7?]JV/V9W\M9OM";&;T#9P3[5RNEV=QI_Q!TZWE2ZG2V\/+9O>&
M!_+>4.IP7QC) )ZU%X:TN>UUJ[\,26[#2M)O#?VKD?*R2Y:*/WV.93[;$H [
MXD $DX [UCZ?KD1LY;C4=0TE4^U/%#);W(*%<_("3CY\8R!WK8) !)Z5Y'>6
MLLW@+Q!9_P!DWSR3>(S/%#]AER\1NT?>!M^[L#&@#U"RU?3-2EGBL-0M+J2!
MMLR03*YC/HP!X_&GZE?1:7IEW?SY\FVA>9\=<*"3C\JYDVPA^*.GWD%E*EK+
MHLL)F2W8)N\V-D5B!@' ; ..]:OC",3>#=9B\A[AI+.5$B2(R,SE2% 4 DG.
M* (]"UG[1HJZMJ.IV1@N=DB!,(MON4'RRQ8[F&>O&<]!6C_;6E?8#?\ ]I6?
MV,$J;CSU\L$=1NSC-<-!!+I\G@C4A8SIIMI:R17D:VS!H)WB15D9,9_A=2V.
M-WH:H^(])NI]'^(-Y:V5S):ZM%"EG ENY:698\/(J 9&?E&<<[,],$@'HO\
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MBU6:RMAN$/FJFW&%9B2?F]3UK.OH8?\ A+O".HSZ9<26YL+BW>063N4D/D[
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M^U*YTZRC=EM(HG:95'D_.,JJG/)VX/3@$>M !XCUR#PWH%UJUS&\D=N 2B$
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MUYC4+F**9D52T22%4X4 ?= ["MW5=6L=$T^2_P!1F\BUCQOEV,P7W. <#WH
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MFU,*%/+?>P.,'(89Y)]:Y_P];WX\*>!=7M=/FO4T^YN6N(;<J7"R"5-P#$9
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MSQAI>J:JNFHE[;W,D1F@6[M)(1.@QED+ 9QD<=>>E;] !1110 4444 %%%%
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ME2)*8I+AI ^Z9F7!."H&.F<Y!S6"FLZ_>Z!X=+ZO/!<2:_)I<MQ$B#[3$IE
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MH^GRZ@U_):1M=/!]G>0\EXN?D;U'S'@^M9]MX,\.6:1+;:1;Q"*431; 08W
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MD@=AG'7UJA9^ O">GSM-::!8PR-&T19(L95@58'V()% &=JS:A8_$#P]//\
M9KV&Y:XM88TA9)+52N\R9W$-PBJ20/;&2*[*.6.9-\;JZY(W*<C(.#^M4=/T
M33M+(:TM]K!=BN[M(RK_ '06)(7@<#CBIM/TVRTFT%II]M%;6X9G$<:X&6))
M/XDDT 6J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK-U_4FTC0[F\B027
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ;9A#D(K;,DD=\"O0** .5OHO$VL:3K5G<6%E:K/8/!;(EV9-TKA@69M@V@
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M+$X'7&!0!0\$6NCWR:>JV>I)<G1T-PUSYJQS[PF3\_WCE3R/[WO7*>"X3>?
MOQ%=SS3R78:Z*W#3,74HOR8.<C&37K6BV%_I?AJTL)'M9+RUME@210P1MJ@
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MEF..V23QVH VJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[9Q%/+D<KM+@E2R$C&=I&<5KZ'I2:'HEEI44\L\5I"L$;RXW;%  S@ =!Z4
M<T=6N+37/&;0:?IR75A:V\ZSA"&N!LD($AZG 7 ],TVT\4Z\K>%[N_M].^P:
MYY<1C@WB6"1H6D!W$X8':1C QD<FM2;PBDM]KEW_ &E=JVL0+;SJ%CPB*& V
M?+P<,W7/6E;PC VEZ#9?;[K_ (DLL<MO+A-S;(VC ?Y<$;6/0"@"7QK<7-KX
M&UVXLVV3QV$[HX<H4PA.X$<Y'4>_I7)W/]J_VE\/RRVIO<3B-B[,F#:GYFXR
M3WQW]1UKOM4T^'5])O--N2X@NX'@D*'#;64J<'UP:Q(O"!6XT.XFUJ^GET?=
MY)=(@'W)L(8!!_#QQCUH P-7\2:B?"?B^#5=/TN\N=%($L91C;W,;1K(OR$D
M@X89&3R.M:/B+QBVAZDEC+/9Z9$UFDL%U>V[M!-(2P,>]654VX7J?XQQQS;U
M+P1;:D/$"-J%Y%'KH072IL^7;&(_D)4XR%'7-7+KP]/=Q3P/J]P;>YMQ;SQM
M%&<@ @LO'#$'G@C@<4 ;4,GFP1R95MZALH<@Y'8]Q7FGC^[;4;FZELI+C[;X
M>\NXLECAD99;D$.ZDJ"/]7A.O_+1L]*]&@M([33XK*U_<Q0Q"*+'.P 8'7KC
MCK531]'_ +'TV2S2]GN&>624SS*F_<[%B3@ 'DD]/:@#%USQ=)!X C\4:-'#
M<)(D,J1S$\K(RKC@]1N_2LSQ!<^*8]1\,Q7'V".6;6& 6WGD$;QB"1E5^,GD
M$GW4<5?C^'MM'X3G\-KJU^+"6?SQQ'NC_>>9M7Y,!=W.,&M?6?#PUF/36;4+
MFWNM/N!<0W,*INW;60Y5E*X*L>U & WB--$U?QC>7^GV:'3;.VN))K5");@%
M9,*Q/7&W ^M3>(SKTGA37'OFT]K";1KIRD,;"2&3R^%W%B'&"W.U>@XYK0?P
M=9W%_K5Q>7-Q=1ZQ;I;74$@4)L4,%VX (.&/.:8GA.X_X1^XT2X\0:A<6<MJ
MUHI=(MZQD;>6V<MMXR?7G)YH S;3Q.ULVD:!;;8IQHT-X\[VTDX4'"*H1"#R
M0QR2,8'7/'1>&M3N]7T*"\O[&2RNF+I)"Z,O*L5W , =K8W#/8BLYO!B1W&F
MWMGJEW:ZA8VOV(7*JC>= #D)(I7!P1D$8.:Z*VB>"W2.2XDN'7K+(%#-]=H
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M:-:WAN+6X,J9\ZT;=$_/5>3Q^)Q6=:^&#IS"33]1F@D>2:6XS&C+.\I4LQ7
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M<D+@8!5ATX.,="*KWOA:RU+2AIU[<WT\/G),S/<,69U(93GL 5!P,#(K<HH
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MZ$*\>'A%Q'(6R6XX0\'FMJW35-%\::W>2:3=7VGZNL$L,EN4+0LD81HW5F&
M<9!'')S0!#:>+XM/\4^(DU3599=.ACM9K11!O,:.CLQQ&F[;TY;..,FNTM;J
MWOK2&[M9DFMYD$D<B'*NI&00:YC1+*]B\;>)+N;3);>SNX;5+>1BF&\M6##
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M*%-@.<[N>N!CIFKMYXMTRQBNKB3SWLK.0Q75W'&6CA8<$,1R<9Y(! YR1@T
M;M%<YJGC?1M)OFLIC=RW(MOM0CM[223?'D#<I PPYR2.!@YQ6W?7UMIMC->W
MDRPV\*[Y)&Z ?U^E %BBL>+Q)9-J4>G7$=S:W<L3301SQ$&9%^]LQG)&1E?O
M<]*KZ/XRTG7KU;;3Q=R$B7,C6LB1J8VVLI9@ &S_  ]<<XH Z"BN-\:W5W::
MUX92WU*XM(+R^-O<B-P T8B=^XXY4<^E<]KFI:Q'IWC)M.UFZN-)L]-%Q:7J
MN-T5R Q:-)% WJ %)ZX)QF@#U.BL:[UZ#2;&)IX;RX<0"5Q;P-*RH!RQQ_\
MK/. :@F\::+&^FHDMQ.VI0&XLQ!;2/YR!0WRD#DX(XZC/.* .@HK,T37K+7[
M6::S,JF"9H)XIHC')%(,$JRGH<$'\:HZOXTTC1=1DT^Y%X]VEO\ :?*@M))"
MT>0"5P,'&><=,'.* .AHK#O/%>EV2SRRM*;6VF%O<W2)F*"0D##'KP2 2 0.
MY'-.U'Q18Z<;D>5=70M/^/HVL)D$' ;YL=\$' R0"#CD4 ;5%8=[XJTZQCO)
MG%Q+:V+E+RXAB+I 0 3NQR< @G:#COBH=4\;Z+I-REM*]U--);&[B2VM9)?-
MC&,E"HPWW@>.@R3C% '145SNN^(+6/3;^* WLLL,1,K643.UN2NX;L=#@@X&
M3@@XP:YFTU'4'T#X;7CZC=&2]D@2[)E.)PUM(YW^OS*#0!Z1160/$NF_8Y+S
MS7%JLJPQS>6=L[L< 1]WR2 ".#VS4?\ PE>EQF]2Z>2TGLO+\Z"9/G'F'$>T
M+G=N/ VYYXZT ;=%8%QXPTRRCU$WJW5O+I\ N;B%H2SB(YPX"Y!7Y6Y!XQSB
MF0^-M(EU"QM&%Y#]OP+2>:V=(9V(W;5<C&<=/7MF@#HJ*Q#XKTL/ VZ4VMQ<
M_9(KP)F%IMQ79GK]X$9QM)XSFH;?QII%WK#:7;B]DN4N#;2?Z)(%B<)O^<D
M*".A/7MG% '0T5SOB[Q(_AR+2VCA:0WFH0VSX@DDPC'YB @^]CH._H:M2^)+
M-&D2"&[NI(85FGCA@.^%&&5W*V"&(!^3[WM0!L455T[4;35M.@U"PG2>UN$#
MQ2IT8'_/2L:W\<:+=:D]A$UV98IWMYG:UD1(66/S#O9@ HV]">N#CI0!IZWI
M,6NZ+=Z5/--#!=Q-#*T)4,488(!8$#(/I5FRMOL5E#:B6241($#R8W$#IG
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MBTN[F-I;9+B/;YRK][:>>0""5.& [54\7^(Y/#=C8310F5[F_M[4CR7DPKN
MQ 09W8)P.Y['I0!L:G8KJFF7-@\TL*7$;1.\6-P4C!QD$=/:FZ3IR:1I-IIT
M4TLT5K$L,;S;=VU1@9P .@':N0/B%K'XA7JE]4N;272(+J*R2"1G5FED5B(R
M,KPJYR!^9KH;?Q5I5[I]A>6<SW U#<+6)$(DD*YW#:<8VX.<X [T ;5%4-*U
M>TUFWEFM6?,,S031R+M>*1?O*P]>GL001P:Y"6\D7XAZS8WVO7-GID-A!/&#
M.L:I)(S@X8C_ &1@=* .^HKCO"VNZE%X7BFUM+N[N9+B9;4I;'SKB!6.R1D
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M;.TLI4@@E6!!Y!!!!!]*O4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK;B,J0 01D]>*ZVB@##\'Z"_AKPO9Z5)(LDL6]Y"GW=SNSL%]@6('L*QM/\
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M>EK"DBF:Z6=9%>,2^9A .=Q^[R !U!.,&Y+H^L-<^-W73R5U>)4L_P!ZG)$
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MQZE*TEND[A%\N%D*C =1@.3CC/6@#T^[N?LELTWDRS$$ 1PKEF)(  [=3U)
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M6S)+=$#<TS=9?-V;MV3NSCKQ0!TNI:Q!ITUM;>7)<7EUN^SVT6-TFT98Y8@
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MV<VG16A7>?,5TD=LXVX(^<#J* '6OBBWO;?1)[:RNY$U=/,AV^7^[3;NW/\
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MD8;<(0P._&3C&,X/2L2Q\%ZS9Z)HO[RR_M31]0GNX@LKF*9)6D+HQV J=LA
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M2/Y4\-PSED8A<HP##! ;D4 6_"MW<7/Q"\5+/;WUJ$@LR+>ZE#[2?.R4PS*
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M--IW !NN1R"*YVQO+S0?$?CJ72=%BNHX;N&>5//$ Q]EC9MORG+$Y.#@<]:
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M)/15&<G@\ X!Z4YOB"T>D>(KI]-AEN-#59)H[:]$D4L;*6#))M'/!!!48(H
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M,$T4F-R,N_=_"I#!NHZ=J?<>'M0DUJPUZ.]MEU6"![68"%A#/"S!MN-Q*D$
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M/_"4VVN'4;8F#3WLO)^S-AMS*V_._CE!QZ=ZST\#70\ GPR^JQ%Q<B=+H6Q
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MZW\.3VWC#^VHKN!;46"6"V@@.516+ []W7)QTZ5T-%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 A52P8@$CH<=*6BB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH 8\4<N/,C5\=-PS3Z** "BBB@ HHHH **** "BBB@ HHHH
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MV]Q-:_+Y-S+;E&8%CY;E"V >A(./:I(+^677;RU,U@UM#"C*L<V9U8D[MZ]
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MQ.X.0WR\KCE?QKK: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT9&(4JNW<!QZ@&MX*N@2Z3!I\6I/87UU=W$U_)I[22P2.0=J($'EAR6P2N,
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M3&ZN!C<,<J,T <]>VHU#7[7Q)HFF2%-.TVZ1@]NT#7;,J^7#M8!B 5)SC )
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M$R,Y>,X!VEMRMSUQZBNPHH \D;0YK+1]#BN=,GD@/B>2\AMQ:-(;6S9I" P
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M,.!DX8XY&*?XIT+4-2M?&>HV5C<,-5L(+.VM_+*O.Z;LR,IY4?,%&['W3[9
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MQ#K,2I::F;>W:557;'Y4;?-M'3+GYC^=;]SJJIXCL+--4L$CD@EDDM6&9I
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M"6_M3?6%Q:B5HO.C,9=0"5!&#C/%5]#TI=#T.RTJ.>2>*SA6"-Y -Q10 ,X
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MR A!(SS5B/P[J$?B%;[2X-2TJ1]2::\4W:/9W$6\EF\O>Q#NN.@4ACDUWU%
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M'TN58=.L9K>Z8RQ?NW=8U& 'Y'R$\=B*Q]=TN]L=,\1B6RD^U7NO0WFD&.9
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MK>MMDMY-@5E!\MMZ' /;'/%=3J.BV>K>'Y]%NH5%I/;F!TB&T*I&/E],=O3
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFI(DA8(ZL5.UL'.#Z&@!U%%% !1110 44R.:*8N(I$<QML?:P.UO0^AY%/H
M**K6VH65Y-/#:W<$\ENP69(I QC/HP'0\'K5F@ HHHH **** "BBB@ HHHH
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M]I>FUDAD+G,>])!M(VL,C(YSP1R!46BZ+;Z);W$<)W/<W#W,[[0H:1L9( X
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M%H-EQ ) ZDYR0"/F'(STYY!J&V\!V^DW-G=:'J$^GSV]J+20[%D2>/<6&]2
M-P8L05QC)'3B@#9\.ZI/K7A^SU"YLI+*>9"9+>0$%&!(/4 XXR..016#J?B^
M[T[6;.("PN+6?44T^6&%F>6$NVU79Q\H.<$H0" >IKKH(WB@2.29YG48,C@
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MIN/+RF5VEB55<G;D9/J>_-2:OX?AU?4--OS=W5K=:>[M%);LO(<896#*P((
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M>5DWE8PP^8 9.X9& 3G%78_%6ERQ$H\IG%T;,VOED2^<%WE-O^Z-V>F.<XH
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MX&H+*;;S2!A4V [<A022S #DGG(!T,GQ$TF*SN;PV>IFTL[A[>[G%J=MNRD
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%4-6UO3-"M&NM3O(K:)59LN>2%&3@#DX'/ H OT5'!,EQ!'/$<QR*'
M4XQD$9%24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7-?$+ ^'
M/B0G&?[-N!G_ ( :Z6J6JZ39:W826.H1O+;2 B2-970.#P0=I&1['B@!VE_\
M@BRQT\A/_015NH+.SAL+6.VM]XBC&%#R,Y ],L2:GH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
K"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ameh-nonqualifieddeferre002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCW%O##%I\5O+'*LA)D$OF=<@8QLZ<]>M &]12,RHI9F"J.I)P!1D8SD8ZYH
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MBN2TC1M '[/5UJ<L4+:R;:6W+22EG5C.S*@4GY3@;@  >2>YKZ)5%0810H]
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M52!0"2  3UP.M %/5X!<Z->PLA</ XVC.6X/'%>36CZ!%X"\ S6S6:W$>H6
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M1@<,'SD$*<X*\4ZTM8(_B%87>K:*D$USH,"C;:F5([A7)==X! *C R3T YH
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MIDJVKS(T83#Q< A3O))!QD$>E<O#:(WPO\-6=SIDHE@UJ(R6S6S%HHQ=EGR
M.%V'KTQ0!ZE_;NC_ &5KK^U;'[.K^6TOVA-@?^Z3G&?:DO;Z>&^TZ*W-FT5Q
M(1*9I]K[=I(,8Q\QR!^%<?::5IDWQ%\1AM+C-M/IMNBEK;]W(X\T. <8)V[
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MS@#=PQ/?!ZU@Z=:367@WPQ):V%U;#3=2SK"Q6#>8N/,"N5*_O A8'C..#VH
M]CM;NVO8?.M+B*XBR1OB<.N1U&13+S4++3T#WMY;VR-T::0(#^9K%\,65DEW
MJFJ6E[<W3:A)&\K20^5'N5-N4&T9R ,GGI5#SFTOXC:I<:L&%E>6,$=C<,I,
M:;"_F19Z*Q+*V/XO?% '5/?6D8C+W4"B49C+2 ;QC/'KQS1::A97]N;BSNX+
MB $@R0R!UR.O(.*\IM]$-G%X5@O;"1K==>NKB*%X&8V]FRS>6K\?*,LO!Z9
M/2G^)-,ODO/&MOI-C.JRMIUSY,$.!<(A_?!!C#-M R._3O0!ZG::A97X<V=W
M!<!#AS#('VGT.#Q3KFZM[.$S75Q%!$#C?*X49^IKFO#\-A?^()->M]1O+JX:
MS%LX>U,,>T/N&04'S@D\9R 3Q4>NO-8^/M$U.[5VTA;2>#S I*6]PQ0J[XZ
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MRG2M/:\L;_P]X@O=1MKXZK)<$169+2GSO,CECDV'(P%&?X0,' %>K4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !139 S1LJ-L8
M@@-C.#ZXKS"V\9^(I?"@U:&\T^ZU(7[VR:6MN0UPJSF/"X?<#M!;."!CD8H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *QKS1)W\0Q:U97B0W"VQM9$
MFA,B,F[<",,I5L]\\CMP#6S10!F:5HZ:;-?73R^=>7\HEN)0NT$A0BA5YP J
M@=2>O/-:=%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-0@EDDL;FS*3/$$N  7"G <8)^4]15VB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG&$B4M%-N(*.N[.>#]T'./>@#N:*XVQ^)&E7$'B!KVRO]-ET)1)>074:[PK
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MA?1MHK;;F-Q&&;Y0X*#?R"I!&<9[<\5O0S-+:I.\$L)9=QB< NOL=I(S]":
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MWC[3DTF/4)+'454WXTZ:'RE,D$Y<)M8!N>2.5W9JU:^+$N+Z_L)-(U*WO[2
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M\$<4-P['!CC"E7&PC:WS<C...*QX/AGJUA:^(G\.R0^'9-0M$@M[6"\DE1)
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MA@%/'S#D$GVIVF^*=0EGUK3]1TZV@U+2Q$[;+K]Q+')G:^]E!4#:V01QCC-
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M.XA!R 4W@@@\@ANYX.:Z6B@#D;GP1YEO L&H".<:JNK7$S0;O.G!&!C<-JX
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M_ /BIQ?!DU"^2[!,>#$[RQ C.<,!M'8=Z](J*>UM[I EQ!%,H.0)$# 'UYH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML.-WW#GCL:L^-[J36-/\7V"6$BRI;H]H(;%I)+O]VK"3S""H4'@ 8(*]<G%
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M/A:X>&&1QQ-E?W##_=A?!]V'I5KXAVEK*_AN[O+$7-M;:LAG;[.9MD9CD!R
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MS$\CPNJPSL%V2," 0I =0Q&!NZX-<OXETMI-"\<7,5J\FG:A=VKV$*1%C)*
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MIVVC:3=ZG>,5M[6)I9"!DX S@>I/05RUUXBU/2M>\/+J]W:6EI?6US-=QLH
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MTY+>\BMOL=]%>$O"9-YC;<%X88![FKC:]I27:VK:A;B9Y/)4%^#)_<!Z;O\
M9Z^U5[OQ;X=L6G6YUNPB:W<),&G7,;'/#<\'@T ;(S@9ZT51N-9TVUBAEEO(
M@DR>9$5.[>G!+#&<KR.>G(JS'<P36B74<T;V[H)%E5@5*$9# ],8YS0!+69;
MZ=>?VO)>WUY'.B;EM(HX=GE*V,[B6.YN ,X&!GCDUR-WX].I^%+/6-&NK:&0
MZE#;W$!9966-[GRLG^[D98<=Z[#3M?TC5Y+B/3M3M;I[?_7+%*&*>A/M[]*
M-&BLVS\0Z-J%Q-!::I:32PIYDB)*"53^]_N^_2JGA7Q39>*])%[:O$K[W#P+
M,KM& [*I;'3<%R/KWH W:*XY/%:Z9XM\06FN:I:P:?:QVKVQD CP9!(6!/\
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MMBDE>/NO]/;-=Q10!YG:'5]&TVYBM]+NT1O$MR\KQV9DDAMG9R)8E((.3@9
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MBEM;W9$\<F"4=?,7:5Z9QR,4 >D5G:CKEAI;%+AY7E">88K>"2>0)TW%8U)
MX/)&.*OHBQHJ*,*HP![5R'DZKH?CO5=173+C4-.U2" *]LR;[>2(,-K*S+\I
MW9!'0YS0!?N/'7ANUD2.;4@LCQ1S*GDR$LC\*P 7D'].<]*9:^)K&VLM:U&^
MUE)[.SNV1F6T=/LH"*?+;@EB,YW8_BJM;6-[_P +(DU)M)EBT]](BLUE)CPK
MB1W*X#$XPP' QD5AWNC:W<>&/'MDFCW'GZM<RO9J9(OWBM#&@)._CE#U]J .
MI7QOX>:XDMUOG,Z1^:L0MI=TJ9QNB&W,H]TW5'J'B>PN?#UKJ>G:W%;6\]S'
M&ERULTH)\P*T97@JQ.5YQ@FJ<MGJ,WC?P[J TJ=;6UL+B">0M'^[>0Q;1C=D
M_<;IFL.ZT+7!X5U;3H]'F>>;Q&;V(+)$ T/VM9=V2_'RJ>#SS0!V%WXQT*QN
MKNUFO)#<6@5IX8[:61T4YPVU5)*_*>1P._459?Q%I:Z=;7Z7+3V]TGF0&VB>
M9I%QG*J@+$#(SQQGFLG2+2_3Q_KNH3Z=-#9W=K:QPS.R'+1^9N! 8D??':N>
MT&Q\3:5HGAG39M*O5LX(IXKV*UGB602%@8R7WC$>"V=ISD#/N ;.O>(&N;7P
MQJ6AZH397NJPP2>6JE9HV+;@=R[@05QQ@CD&NRKR^TT'7+3PQH-B=&G,]GX@
M>]F59XV"P^=*X8,6&[AU]^N17J% &=>ZYI]A-)#-)(TL48ED2"!YFC0YPS!
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ML8]=Q4-P6"D<'T-,U#QKI^GZN^EFTU&YNTA2XV6UL9-T;-MW@Y^Z"#D^WTH
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M8@<%DV%LX) *\-R.*YS3O&+:OX,\/ZEJ,FH6-Q>75L'>SMMJ.[N $R^?W9R
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M#M4Y&2.1@UG:3X-O]"O_  G';^3/9Z1;7,5Q*7VL[S%22JX/ *G@GH17>44
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MXV)Z*-V>I "#O5K6="NY_$6EZ_ILD/VNRCE@DAG8JDT4F"1N )4@J"#@]Q]
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M4[.V,\]<XXZT <]\0M<.I_#O79M.L;BYM(HIH_MD<JH%="5+*"0656!!/L<
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M6KLW$\;K^XC#@<!F!8 >G0?E77WGB>*.ZO[:QMGO9K"%9KE5<)M# LJKGJY
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%0W5Q]EMVF$,LQ& (X5W,Q)QQ_B>!WK.
M\-Z]'XDTC^T8K:6W7SY8?+E(+ QNR'."1U4]": ->BLB[UIDU=]*L;7[5>16
MZW,JM*(U5&8JO.#DDJV!C'')'&;6D:I!K6CVFIVRNL-S$)%6089<]C[B@"[1
M110 4444 %%8^N>(;?1)=-MV0S76HW2VUO"K8)[LQ]%5<D_@.]9#_$71X?"]
MQXBF$HT\7;VMH8QO>\93M'EK[L& ]ESQ0!U]%<M)XDU^VMH;R[\+-':R.BLJ
M7R/-&&8*"R;0O&1D!C3O#OBN;6_$OB+1I]/2U;1Y(4\Q9_,\WS S9^Z,< >O
M6@#IZ*** "BBB@ HHK*\0ZEJ&E:/)=Z9I$FJW2NJK:QRB,L"P!.3Z#F@#5HH
M'(&1CVHH **Y:?QD;CQ'=:#H.FOJ=[9*IO)#,(H+<MT5GP26/H >_H:T=&U>
M]O[R]L]0TIK"XM1&V1,)8Y5?=@JP /\ "<@@4 ;%%%% !1659^(=/OO$.HZ'
M;O(U[IR1O<@H0J^8,J >YQSQ6K0 44R5I!"[0HKR!3L5FV@GL"<''UP:X73_
M (E"[\#-XCDTB03-??88+"&8.\LA<( &('4Y/3H* .]HK#T'Q$==O]6@2R>*
M'3IQ:FX+@K+*!EPO'13@9[GZ5N4 %%8GA[79M:FU>&>S2V?3KYK,[)C('PB/
MNR5&/O\ 3':MN@ HK$U#79K#Q3HVD?8T>'4A-B?SB&C,:;B-FWG/'.?7BCPY
MKLVMG55GLTMI-/OWLB$F,@?:J-NR57KOZ8[4 ;=%%% !1110 4444 %%%% !
M14<[2I;R-!&DDH4E4=RH)]"0#C\C69X7UL^(_#.GZR;?[/\ ;(A+Y6_?LSVS
M@9_*@#7HILAD$3F)5:0 [59MH)[ G!P/?!K)\*ZXWB3PY:ZL]L+9IS(#")-^
MW:[)][ S]W/2@#8HHK".O7/_  F$^@"QB^73_ML4YG/S_/L"L-OR\YY!/':@
M#=HK&\*ZX_B3P[;ZJ]J+5I7E4PB3?MV2,GWL#/W<].]7K"[GNQ<^?8RVGE3O
M$GF,I\U!TD&"< ^AYH MT44R8RK"Y@1'E ^17?:"?0D X_(T /HK(\+:X?$G
MABPUDV_V;[7'YGD[]^SDC&<#/3TK7H **Q-;UV;2-4T6U%FDT6I7?V4R^<5:
M)MC/G;M.1A#W%;= !1110 445B:+KLVJ:MK=A-9I ^F7"0[DF+B3=&L@/W1C
MAAQS0!MT444 %%%% !1152YNYX;^SMX[&6:*<N)9T90L&%R"P)R<G@8!H MT
M444 %%%% !1110 4444 %%4-:OY=+T2]U"&!9WM87F\II-@8*,D;L'!P#VI^
MD7QU31;'4#'Y1NK>.<Q[L[=RAL9[XS0!<HJI8W<]TUT)[&6U$,[11F1E/G*
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M2_/&2, CH?UKE#X$GU-=&@U&RT6R@TRXBN=^GH3).T8^5>5&Q2>2,L3C&>]
M'!^&EE\17B2:EK^GZ7XDL==+2M.2+MQNP( "PS&00H4<<=*[+XY-%'\,KR1I
M?+G$L0BPY4G,BA@.>?ES7H)LK0W8NS:PFY P)O+&_'^]UJ22*.4 21HX'3<H
M.* /*?$]OI&K_&;P[:37"R6MUIT_FQQW)59.,*#M/<=N_O6C\&)%7PQJM@MP
MTD=EJ]Q!"C2;C'$"-HYYQU_6O0Q;6X8,((@PQ@[!D8IR0Q1%C'&B%NNU0,T
M>3>#]0M_!/Q$\6Z1X@F2R.JWIO[&ZN#LCG1BQ*ASQD;@,>N:T?BMKT=SX$N#
MHVHI/!%>0)J+V<NXQP,?F!*GC/&?8^AKT6YM+:\B\JZMXIX\YVRH&'Y&ECMH
M(;?[/%!&D.,>6J +CTQTH \E%MIUI\3-5@T0V\/AY_#WFWR6KA+=9=Q"'Y>
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MNV.-47.<*,"@#S7PZ\^GZWHQN8],U."],SP:Q:2E+@IL9\W"D'*XP,[L!MO
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M,05W.1D'#$=JWO"]OI]QKUUK&FZUI]VDUHD,L&FQ!(LJQ*NV';Y\$KV.![4
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MC)^0'.,$]: -2YN;N+4+*&&R$UM,7$]QYP7R,+E?E/+9/''3K5HNBD LH).
M">IKB_$[V47Q(\&R2&!)]UTK,Q ;:86"@GT+$@>YKCVTG0[SP/\ $"XBM+66
MYM+V]FM'0 M!A 4:+'W1E>"N,X]J /9JS?[8BFU6^TFU7??VEO'.RR95,.6"
MC=S_ '#VJ?2[A;O2K2X642B2%6W@YR<<\UQ4":/9?%K6Y;\6\-P]C:S6SSG!
M;'G>8RD^@QGTH Z7PGKK^(O#&G:K/''!-=Q>:85;.WDCC/6MDR(KJC.H9ONJ
M3R?I7B^F6.EV_P -/"&M10PIJ-OJ5FLEX,>;&IG =6?J%V$Y4\8[5>1$U>;Q
M)I.MZU8Z=J,NIN]L\]N3<^5N!@>!RXR  ,!0<'/<T >N4TR(KJA=0[=%)Y-*
M 0 "<GUKRF3[+=^#O%-EJX7_ (2=;FZ,:G_CX:3<3;-#_$1CRPNWCCZT >KY
M&<9I,CU%>;ZC9W^C>)_#VJ"V1]5U33SI=S,L8.RYVAUE./0"7/L,4_PUI1?5
M#X:U*!KF#PY=O<07%PN\R1R#, W'J0'D!]XEH ]$+HI +J"3@ GJ:'D2, NZ
MKDX&XXR?2O&FTG0[SP+X^N(;2UEN;2]O9K1T +084%&BQ]P97@KC.*TI+Z.[
M\5ZE%KFHZ;#87NG6PL)=1A\R*1"A$HC;>JAMYY'4_+Z4 >J,RJ,LP ZY)IIE
MC#JAD4.PRJYY/TKRVYT+19/%OA32-2N(]1C_ +'G@FEG.UKG_4B/S.<DGD@'
MN,T^^0Z?KMQ+82:3J\)U. -IMPI%[;NC1H/*<$Y5=H< @<9YQF@#L_#FO3ZO
M)K$=[!!;R6&I/9*(Y"P<"-&!R0.3O].U:;W-VNK0VRV0:S>%G>Z\X#8X(PFS
MJ<@DY[8]Z\O?3M&UC0?B/<306UW<PW=U-;NV':+%M'M>/^[\RGYAU*^U:>GW
M=A=>/?#%PTMO)/<:!*D[[E)D<F' 8]SP_!]#0!Z,98PP4NH). ,]3Z4^O%[#
M3_"^I>$_$FE"VM+C78]0U!+*W0#[1$_G/Y7E=T4':<C"CG/>O7M-BN(-*LX;
MR7S;J.!%FD_ON% 8_B<T 6&D1&4.ZJ6.%!.,GVK(UO5Y[2[L],T]('U.^61H
M!<%A&%C +%BHS_$HP/7VKDHVTV:]\8V7BH0_:9+AC;BX W/:&-1'Y.>N&#<+
MR&)[FLNTM%DUOX?6_B<12ZDNEW"W*W+ L'Q%Y8;/\7WOJ0>M 'K0Z<]:;O4N
M4##<!DKGFG'I7CMKJFGZAJWA36K6.RLKF357BN8XHV\^%6CEREQ*3R20IVD#
MGIG&: /8J8LL;NR*ZEU^\H/(^M).XCMY'8L%5"25Z@8[5Y?X<MB+NQTPC1=>
MLI=/F1+^VCVW$:84_P"D#+*Q8A><@E@3CK0!ZGD8SD8K!T+7I]2U+7+2\A@M
MSIUXMLA20L'!C1P<D#GY^E>;VFJ:3/X'^'\(FA>]L-0LH[D8^>U(R'$A_@Y7
MH<9QGM6D;?PO?>)/&MGKL-M<74UTK6MO,NZ5U^S1KF!3R6W C*<Y ]!0!ZD\
ML<6/,=4W' W'&3Z5375[5M??107-VEJMTWR_*$9BHY]<J>/:O,+NRU#3].M5
MO=2TBZU2WT*&"]TS5UW^;C>28G#9WDY4D Y*K[5K6:Z</B?#<:C8I;7=QH=K
M);P3?,XE#R%E4GJRC:#CTS0!Z,'4N4##<.2,\B@NBD NH). ">IKQ_3M2T_4
M-<\'ZS:QV-G+->RQ7,<,;>;$&AD_=W$I/S,6"\, <],]:C.DZ'>^"/B#/%:6
MDMQ:WE[-:.@!: B-2C18^Z-R\%<9Q[4 >KMJ]JNOQZ+E_M;VK70^7Y1&K*O7
MURPXI^GW-W<1SM>60M&2=T1?.$F^,'Y7R.FX<XZBN"_XE%Q\2-&O-1^SR?:]
M$'D2RX(DF$J'"GH6 R<#WK.T_5],TSPGJ\8@M);.3Q-+"0[8@@C:;*R.!_RS
M 7IP#P,XH [_ ,5:W-H7A34-9LX8;EK2!IMCR%58*,GD UKP.9;>.1@ 64,0
M/<5XY=2VEIX;^)5G!-;+;R0(]O%!%Y,;L]N,F.,D\,<<C(/7O7KVGS1W&G6T
ML,BR1M$I5E.0>/6@"=I$3.]U7 R<G'%+N7;NW#;C.<\8KSC65\-0?%J1==&G
MQPW.BQG;=A1',XF?[P;Y6; &,\\<=*S;>PGT :6+J.2'PFVO7,GDR@A((&C(
M@W@_=C\W+ '@;ESB@#UA'21 Z,K*>A4Y!JCJVM6>C68NKIF*--% !&-QWR.$
M48^K"O.]:M;4+X[GLQ =!FT<$!<&%KW;)S'VW8\O./XB.]1ZSHF@6OPXTS48
M+>$QR76FRWTX8L&"R('9SGL"P)H ],%S=_VP;8V0%EY D%WYPYDW8*;.O3!W
M=.<5:$B&0QAU+@9*YY'X5YN391?$&\7PZ;1+B7PT1:^5M >7>2GU.-I^F#TJ
MDBVM_P"#O"_]D;5\307-KY@'%S'("!<^=_%C'F;MW!XZY% 'JK.BD!G4$G R
M>_I3J\BCT?0-1TSXBEK.SG>&YGEML*&,6+9"'C_NG>#\RXR1[5Z1X9NOMOA;
M2;@S><TEI$7?=G+;1NR?7.<^] &F\B1XWNJY.!N.,FLK6]7DL)K&PM%B?4=0
M=X[83$B,%$+LS$<X '0=21TZCFA+8?\ "<>)+;Q0+;R)88/L'VW'EO;[,2!-
MW&=^[<!SRO;%<Q8V,1D^'UIXC"R2@WHV7C?,("K^3O#=#C8.><C'44 >PQ^9
MY2>;M\S:-VWIGOCVKF-:\8"T\,:_JNEP+<2:-))%,DY,:LR*&;! .>H].]=3
M7C-TFD6?A'XCP!8(M4\^\0(>)3&ZKLZ\D,>GK0![#!,)HD.5WE064'ID4\2(
M9#&'7>!DKGG'TKSF]M-.TSQ9X3OM&CMH)KZWNHGN$('V@^4"GF-_&=^.3DYK
M/\'Q0:MI_A];S6;2VUW3[D2W-O\ 9RM\THW"1)"7)*MDY.W!&#VH ]8IH=68
MJ&!9>H!Y%1W<YM;.>X$;RF*-G\M!EFP,X'N:\GT.^TZ?Q1X/U2R^P6PNH+B.
MX2SC8%28@PBFE)_>.&QU .><<T >MK+&TC1JZEU^\H/(^HH26.0L$=6*G#!3
MG!]Z\ETIOL45O#]LTW4K!M/NF75K%2E]:1^66+S8)#$G SD$M@XJK?'6K30M
M3LM*72M1GBTG]UJFB(4D\M9(PR2*I(W,F\KM;/RMC&: /8I+F&.":8R I""7
MVG.,#)JOINJVNJ:-::K"Q2UNH4GC:7Y3M8 C/IP:X>TLM*UEKK4=-U?3KL'2
M9;=[/3;?RPZG!7S%WL0RD$ '!^9AZUC:5%IDO@WPBVDZKI-E=PVP>2.]C#V\
M\RQ(DB2?,")!NX[CYN* /700P!!!!Y!%(\B1*6D=44=V.!6#X*FDG\+6SR:?
M!8GS)1Y-N28B!(WSQY .QOO+[$=JRM2GA@^)2+KAB72Y-,"V37./)\_S#YHY
MXWE=GO@''>@#H];UB/1K&.=EWR3SQ6T"9P&DD8*N3V&3DGT!Z]*M67VO['%]
MO\C[5C]YY&=F?;/->17MG!#X:MH+[9_9;>+4;38Y3\HL_-7.T'_EG]_';:1V
M(KV"VB@@M8HK946!$ C5/NA<<8]J ,]];CEO=4T^R3S+[3X8Y9%DRJ'>&*C=
M@_W3V]*9X7UIM?\ #.F:I*D<,U[;).85;.W<,\5R=NNC6/Q,\4RWHMX;MK:W
MFMFFX8CRY [*3V['TXKG=-L=+L_ /@+6888(K^*]LHI[P8$BJ?ED1WZ[<'!4
MG 'TH ]D,B"01EU#D9"YY/X4ZO(M,C75X+_2]9UJRT_7$U9Y1YEN?MF1-NB:
M)BXW*4"J-JXVY%>NT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !137=8XVD=@J*"68] !7+Z+J^L^*M/&K:?)::?ILQ;[()[=II
M94!($C8=0H.,A>3C'/:@#JJ*R[.]N;/3?,\0364$PE:,2(?+C<9.T@,QP2.<
M9-2G7-)%@+\ZI9"S+;!.9U";O3=G&>.E %\ #H**RCXGT 1W4AUS3?+M&"W#
M?:DQ"3P QS\I^M3OK.EQQ6LKZE:+'=D+;.9UQ,3C 0Y^;.1T]: +V >U& >H
MJAI^N:3JQF&FZI97AA.)1;SK)L/O@\4VVU_1KS[1]EU:QG^S#,_EW"-Y0]6P
M>/QH T:*S(?$6B7%W#:0ZQI\ES.N^*%+E"\B^J@')'!Z5*FLZ7(]RB:E9LUK
MG[0%G4F+'7=S\OXT 7J  .@J*VN;>\MTN+6>*>"0926)PRL/4$<&FWE]::=;
MFXO;J"V@4X,DT@11^)XH GHP , <5 E[:R^7Y=S"_FH9(]K@[T&,L/4#<.?<
M5EW6O02/8#3-3T>19;L0R^;=#++@[ECVYS)G;P: -H  8  'H*6N<G\413ZA
MKFDV<D45_IL2,K3$,LC,A? 0,"< <\CK[4WPIXKL]8T;1Q=ZE8_VS>6,5S):
M)*HDRR!B0F<XY_*@#I:*Q;;7(5;4YK_4M(2SMYPD<D5R/D7:#B4GA6SGCTQ5
MNUUO2KZ^EL;34[.>[A&9((IU9T'J5!R* +P  P!@>@I:@O;J.QL;B[E_U<$;
M2-CT SWKD+CQG)<0>$]1L9K6.PU:=$NHY,,\*M \N"P;"D;<'(H [4@'J ?K
M2U2L=8TS5+1[K3]1M+NW0D/+!,KHI'7)!P*=9ZG8:@TBV5[;W#18WB*4,5ST
MSCIF@"W15>[O[.P17O+N"V1V"JTT@0,3T SU-4/^$J\/?9I[G^W=,\BW<1S2
M_:X]L;'HK'. >#P: ->C SG'-5I-0LHK1+N2[@6VD *2F0;6STP>AS49U?3!
MIW]HG4+06/\ S\F9?+ZX^]G'7B@"[2$!A@@'ZU077=(:QBOEU6R-I,VV.<7"
M;'.<8#9P3FBVUW2+TW(M-5L9S:_\?'E7"MY7^]@_+T[T :! (P1Q0!@8%8NF
M:Y"=)L9M5U+25NKC(!M;D&&1@2/W9;EO\<U=T_6-,U6WDGT[4;2\AC)5Y+>9
M9%4CL2#Q0!=K \7:->Z[I4%I9/ C)=P7+-,Q Q%(LF!@'KMQ[>]7[?7M'NKC
MR+?5;*6;C]VEPI;GIP#WK0) !). * $7.P;@ V.0#D TM4K76-,OIS!::A:S
MS!=YCBF5FV],X!Z>]9'A_7F\0:I?307UN+2UFFM!9A09"T;[?-+;NA(; QT(
MYH Z2LJ*ROYM9-U?RVQMK<M]CBB5MP+#!=R3]X#(&.S'UXS_ !MK>I>'])MK
MS3OLI9[R&V=;B)G&))%3(PRXQG/?/M6C/X@TC3TD74-9TZ&2 +YY>=8PA/J"
MWRY/3)H MI86R:E+J CS=2QK$9"<X122%'H,DGW_  %6:Q-6\4:?I,>DRM(D
ML.IW2V\,J2KL *LV_.<%<+V]15ZXUG3+1HUN-1M(6D"E!),J[@W (R>YZ>M
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MT$Y=%1M0F\N(Y8;AD<YVYQ[XIUWX@T;3VF6\U:PMVA ,HEN$0Q@\#=D\9]Z
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ML@FF7_7;"K9&XN#@$@/536M(M%LK&6SMM6U!+SQ%;WUUY]BY("[0[[!&-JX
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ML>F37+(3$H94:,,  J+C=@J2>".OJ]8-OH%UI\^H?V?J7DP7T[7+J\ =XY&
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M[@NMHO\ 3[EK2YVC 9@ 5<#L&5E;';..U7-8U2WT31KS5+LD06D+3/CJ0!G
M]STKC=/U.33=1\2:M;VINVU/6HK.R@#[?-:.-(G;.#@ I(2<=(S6U\0;"XU+
MP#K-M:H9)_L_F)&.KE"'VCW.W'XT 6+;6UL(M,M=<GV:IJ&3'"D+%=WWC&I
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M'%(X+<8#!_\ O@T =Q1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+&TBM;6)8H(E"HB] !4U% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK5UI$5T1G4,^=JD\MCT]: '4444 %%%% !1110 4444 %%%% !1110 4444
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M<6^&D:(/ND\TY()(&!C@'G/2WIVJZMKVKWFD7%PVDW-A96LMQ]F$;N9I58L
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MQ7H-<Y'X%\/1!%6TF"17/VN%/M<VV&7).8QNPF222%P#FNCH **** "BBB@
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MFJFL:]JOA./Q?;V^H7-U'91V,MM)=L)'M_/=DD.XCD #<,Y ^E 'J+,%4LQ
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M/FQD#Z?_ %CC:9XGUB>W\*:9/-+=&]N-0AGG$@BDF^SNRHN\8P2.3C!.WZT
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M%/Y+2N!&H <8/R@DX!&<C/ J_!>ZY9ZIH7AO6;S9]N:]?[1')^]DCC(,49?
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !5&STBRL;RZNX(W%Q<MND=Y7?OG"[B=HR2<+@>U7J* "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4*$%<#M@@5YU=^//$-UH_BS7M+:QAM- O7M4M9H"YN!'C>S-N&W(/&!QCG-
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MVFP^(8=9.GRP"V<HL:@LTF/,SC:K$'."0!WS6ZWP^L9[IY[NX:=I]4&IW0*
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M;IBL$+, TAP3P._ -3Q75O/)-'#/%))"VR54<$QMC.& Z'!!Y]:X7Q"FK_\
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M^TE.$'('KG)Z#FGJ7CJ\LID6_":")+.&>![^TDDB>5P2\;R*0$VG"G//?VH
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M)O\ E[98XX]*?9:+>0:S;2RZA=2V5C9+;0)+.6:>0_>EEZ!FP ![ECZ5O44
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M<+W4=SJ%W<:A-%;R6T;3A%VH^-_W%7D[1S[<8R<ZT\R6\#S2;]B#<=B%CCV
M!)_"H-+U.SUG3+?4;"7SK2X7?%)M*[E]<$ T <Y;^ +:"TTJV?6=6FCTF9);
M$2/%^YVJ5"\1C<,-C+9/'4<YO0>%(K'5[R_T[4[^R2]F\^YM8C&T4DG +8="
M5)P,[2,UKV^HV=U>7=G!<QR7-H56XB5LM&6&Y<CMD<U'J^K66AZ9-J.H2M%:
M0+NDD6-GVCU(4$X]Z ,RQ\*1:5J5S<Z=J=_:VUU<&YFLD,;0M(3EB-R%EW=P
M&'MBDTGPG%H<K)IVJ:A#IYF:9=/!C,2$G<0I*;PI))VAL5OHZR1JZG*L 1]*
M=0!ACPS&\MO]JO[N[@MKHW4,,WEX23)*\A02%+'&3Z9S3(?"EM_H0O[RYU%+
M)&2!;H1_*&0H2=JC<=I*\^I[\UOU'//%:V\MQ/(L<,2%W=C@*H&23^% &#9^
M#[2TM;&Q>\N[G3["19+6UF*E8ROW!D*&8+_""3T&<X%3V7AJ&RO]7O%OKR1]
M5(:X5RF P0("N%!&%4#J:U;:[M[RT@N[:9);>X19(I%/#J1D$?4<U6T_6K'5
M+J]MK25VFL9!%<(T3(48C<!\P&>"#D>M %:T\/)#?6EY=7US?3V<316[SA!L
M#8#'Y%7)(4#)_K6E=VL5[9SVDX)AGC:-P#C*L,'GZ&IJS]1UO3]*:T6\F9/M
MEPMM"5C9PTC' 4E00,GUQW]* ,:R\#V]E)I,HU?5)9=*C>*U:5XSMC90NT@(
M < #G&?4FG+X'L%\)W'AQKV^>SGF,Q=F3S%8R^:<$)CE^>0>M=/10!STOA&!
MM<DU>WU+4;2YN(TCO!!(BK=A!A2X*G#8XW)M.*N>'=!M_#6C0Z59S3RVT);R
M_.*EE!).,@#C)/7FM6B@#(UWP_#KRV3/=7-I<65P+FWGMBNY'VE>C*RD$,1@
MBJ=OX0BLIKJ:SU74H9;F\%Z[EXW_ 'GE^6?O(>"N,CMCC%='10!@Q>&$M[A[
MJVU*\AO)9FFN)U$9,Y*JN&!3& $4# '3W.8&\%6/F:?(EY>1O97DE\&0Q_O9
MWW;W?*=][# P!V'%=+10!YD8;B6[\0:B?$&J:3JSW,J1Z?#'%*S*GRQ%%DC9
MG#@!L(0OS$=<FNITC0+E[[3O$.JW<XUE=.2UN88]GDY.UG &W/WQG.?TKI*0
M$,,@@C..* .>M/"<>GO(]CJNH0&2[FNR!Y3#=*=SK@I]W/([C'6FVOAJ2SUF
MS>"ZF2P@::ZF EPUW<RGEI N!A1DXQC+# &VNDJEJ&JVNF"+[09"TK;42*)I
M6/(!.U02%&1EN@R,F@"[7)W?@&RO(]9MFU/4X[#5W>2YLXY$""1P S*=FX9P
M#C=CVKK*K6FH6E^;@6MPDQMIC!-L.=D@ )4^XR* ,Q?#,0UNPU9M0O7N+*W:
MVC4^7M9&*EMP"9R=J]".E4KKP+8W5GJ-H=0U"."_OQJ$JHT?$H96&TE"0,HO
M'/3ZUU-% '/R>%(UUJ?5K+5+^QNKI$2[\CRBMQL&%9E=& 8#C*XXJ2]\-+?Q
MWMO-J5Z;*]0)<6V4*L-@0@,5W#<!S@^XP:NZSK-CH&FR:CJ4K16L>-\BQ,^W
M/J%!('O0NM6+ZZVBB5_MZP?:#$8F \O(&X,1M/) X/\ *@"A/X6@N4DMI[ZZ
MDT^299C9,(_+!5@P4';NVY4'&?QQQ6]110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 0WERMG93W3*S+#&TA5>I &<#\JX2X\2Z
MS;>"-)\8BZ65+DVTMQ8"-?+$4S*NU#C=O7>.22"0>.>/02 1@C(K"M/".EV4
M<5O$)C8P3>?!9/)F&)P=P*CK@'D*20#@@# H Y6VAO3XB^(<CW4)@"HKQB @
ML/L@*X;=QC//'/M3-$OM:T;0O <QU"*:QU!+6RDL_( "!K<LK*_WMPV#.>#G
MH*ZZ;PIILVH:C>[KJ.748Q'=+'<.J287;G;G&=HQGT]Z#X4TPZ7I6G?O_(TJ
M5);/]\=T912J\]P Q&#F@#F;#Q1X@UW2(]8TJUN)'-^T:V?EQB%H%F,;9<G<
M'V@MG(&1C![W;"Z\2:IXOURP75X(++3+N%0JVH+R(\*N5R2=N-W7!S@=.^S:
M^$].L;^>ZLY+RV2>8W$MM#<NL+2$Y+;0>,GJ!@'N#5BPT&STW5;_ %&!I_M%
M^RO<;Y2RN54*IQVPH XH XAO&>MV'A^_,F+W5=,U"47R[%4"TA=69U '4Q.F
M,]V)[5L:MJFHMH/B?6+#4(WLK6T=[-7A5T=DBWL<X&5SA>3P0W7C'0PZ#IL&
MI:EJ"6R_:-25%NF//F!%V@8^G%0+X8TR/PJ/#<4<D>F>0;<QI(0QC((8%NO.
M3D^] '/:MXCU.QBTV6=-1BTV73EFEO=-M%G:.8XSO3:Q5,<\+Z\C%0VOBR_U
MV^O[+3;B9A9V5M)'=6<".)Y)HRX8A^B=, 8/WN173#PU;1B,0WE_"JVRVK!)
M_OQJ6V@Y'4;C\PP?>HG\':2+R"[LUN-/FAMUM0UE,T0>)?NHP'! ['J/6@"6
M*ZU:7P<MU>1+8:M]C\R:, .L4H7) Y((S[UR(UOQ1;^#_#WBEM3AN?M0LA<Z
M?]E51*)BBDHP^8/E\^G'2NXU-5MM ND19I ENR*H#2NWRX'JS'\S7-?#_P /
M06WA#0WNEOVN(+6(FWOGD(MY0@#;4?[I!R!Z=!@4 -MM1\0W7BO7H#J<":?H
M]Q"QC6T!>:-H@[)G/'7KR3QT[TI_%.L1?#^Q\:I<K(LAAGFTX1J8S%(X78K8
MW;P&'))!(/'.!V%CH%GIVJW^I0-/]HOV5KC?*65RH"J<=!@ #BJMMX1TNTC6
MVC$WV!)_M$=BTF8(Y-VX$+UP&^8+G:#R ,"@#(GUS4M-\3:YIE[=NZM9+=:2
MJ1H"^3L9,XY82% ,]G&?6ITO-6L?&>A:7>WD-RL^G7$L[B!58R(8LX(Z*=YX
M]AG-;U]HFGZEJ6GZA=0;[G3W9[=LGY2PP<COV//< ]J9<:#9W.O6VLR-/]LM
MHVBB(D(55;&X;>ASM'Y4 >>^)]0O_$WPFE\0B_\ L]M<['%DL2LGE^<H4%B-
MV_@9(.,\8KH[SQ!J%]XIUG1+(W4 TZWA99+:%)"\DH9ANW\;0 .!R>>15B3X
M>>'Y+6[LS%="QN7,C6BW4@A1RVXLB9PISSQT[8J]=>%;"ZU*/4A+>6]^L(@>
MXMYVC:6,'(5\<-SGDC(SQ0!D:9KFM:QJ,&B7BC2-0CTN*\O3$$=A([,NU-VY
M=HV$D\]0/>CX<)+'INMI/.)YEUR\#RA-N]M_)QV^E:]_X3TS4+VTO6-W#>6L
M7DI<P74D<C1]2CL#EAGGG)SSUJSHV@6&@)=1Z>CQQ7,[7#QERRAV.6(STS0!
MRMYKNL6J^/3%<VXETB)9K9OLX_Y]_,PW//IGT%2V^JZ]9ZUX6-WJ,5U:ZTK)
M- +<((G$!E#(PY/W2#G/7C'2MF;P?ID[:PTC71_MA EZ//.)%"[0/]GY>.,<
M5._AJPD720QG+:4VZT?S3N7Y2G/K\I(YH POB!'=RW7A1+:XBBSK<>"\1?#>
M5*0?O#@8/'TY&.:=M9ZK<^//%<5EJJ64XM; O.MN'+/LEQ\K$@+UR.3[BNOU
MK0K+7K>WBO/.4V\ZW$,D,K1O'(H(!##GHQ'XTRR\/V5AJ]YJ<+7!N;Q$2<O,
MS!@@(3@^@)_/G- '*:=XHU34[?P'?2-;H-6=TNHUBS\P@D;*DG*\KT]#UJ6#
MQ/>Q^)H[+6);[3I)+^2"!'LPUI<QY81A)@I(<C:>6'.1CI6Q;>"=(M(=*AA-
MTL>E.7LU\]CY1((/UX8CG/6K<7ANSCFB9Y;F>*&<W,,$TFY(Y"2=PXR<%C@$
MD#L!@4 8?Q#^_P"$L8S_ ,)%:XS_ +LE0>)- F:U\2^)-0:%;EM!GL8H("65
M(]K.2S$ L2<=A@#OFNEUGP[9:])9O>M<9LYUN(!%*4"RKG#<=2,GKQ5K4=-@
MU72[C3KHR&WN(S%+L?:S*1@C(]10!S"7\_\ 8VA:98ZC+;WDNFI*(K:V664@
M*@#'=\BIDD'=C)Q@CFLNQ\4^(-5LO!4J7-M;2:QYT5T/(W ,D<C;ER>.4SC^
M8KJ/^$.TH7%C<*;M);.W^R(Z7+J7ASD1O@_, 1WJ.U\$Z19KI2V_VE$TIG:S
M43MB(L"&^N0Q'.>M $?A;4=2DU?7]'U.Z6\?39XEBN1$(V=)(U<!@.,C)&1C
M-6O&&N2>'?#5QJ,*(\P>*&/?]U6DD5 S8[#=D_2JVK^#[?4);UH)9(/[4FA.
MHD2M^\CC PJCL2%"GIP6[XK<U#3;/5=-GTZ^MTFM)TV21-T(_#I]1TH YR\U
M'5='\7:+I;7K7EKJZ3Q[I8D#V\L:;PPV@ J0""#SG'-1>![WQ#K5JFJZEJ=O
M):[[JW^S1VP4LR3LBN6SZ*1CZ&MVUT"VMYHYWGNKFXAB:&&:XDWO$AQD*<=3
M@98Y)P,DT_1-"L_#]D;.Q,P@+M($DD+X9F+,03SR6)H YWQ?KE]:1ZK_ &1J
M++=:;9_:FMXK59%! 9OWS-P%(48"D-U//%1C5]<U3Q1I^GVU_%9VU]HIOCMM
MP[Q/NC'RDG!^\>HQ[5LW_@[2-1OK^[G6X#:A (+N..X=(YE"E064'!(!(!J2
MU\+:?9ZI:ZC$]S]HM;7['$6F) AR#M(Z'E0<]>* .2F\2>((_!ESJC7JF71]
M5EMM0DB@7]_;1R['D"D':P7YO3@\=,=?IMQ=7NM:A.MWOTR/9%!&%7#28R[!
M@,E>5 YZA_;%*[LK#0+&^M+6PO+LZO-,[6ZH\L;2R9+;F (C4YY)(%:VA:3!
MH.A66E6Y)BM85C#'JQ Y8^Y.3^- &/%J5]KGB37M*M;U[!-*$,:O'&CM))(F
M_<V\'Y0"  ,'AN>F.235]6\47/@*^:2VM+MKN]CD_<%T\V**5"P&X?*=IP.V
M>IQ7?W/AZTFU5]3BDN+2\EB$,\EM)M\Y!G 8<@D9.&X89X-17/A/2;FVTV!8
M9;9=,??:&VF:)H\J5(W Y.02#ZYH Y&./5QK_CV?3-32RDMYX9<_9Q)YC"TC
M.#GHO';GW'>U8^,K[6[[3;&..XMS/H<&IS26<2.^^7@*-^0%&#V).1R,<]/;
M>&K"UN-4G0SL^J?\?6^4D.=H0$>F% '%5!X(TF--.^SM=VTVG0?9K:XAN&61
M8>/W9/\ $O X;.,4 8,NK^+R_A2SGDM]/OM2DN8+I7@$F-D<C+(,-W"JVW/4
MX-;^O:S=>%/ TNI7;QWE[:P1J\A78DDK%4W$#HNYLD#M5FY\,V-U=Z;=22W9
MFTXLUL_VAB59@58DDG<2"1SGBM#4+"TU73Y["^@2>UN$,<L3]&4]10!R_B&_
MUGPM8OJ#:H+U)WAMHXYX$589I)40.-H!* ,3@DG@<\YJ6YU'5=(\8Z5I#WK7
MEKJT%P$DEB0/;RQ*&S\@4%2#T(SD#GFKT?A'31I$VE7,EY>V4L8B,5W<O(%4
M<@ DY!&!ANHP.:LVV@V]O.MP\]S<W20F"*XGDW/$AQD*<8!.!DXR<#).* .-
MTO5O%5YX'OO$<VL6P\FTO?+@2S'^LBE8*Y)/HA&/<=35F75?$NGVWAG5Y-2A
MNX=2GM;>YL?LRJ )0/G1ASE3R<\$9X%:6IZ%;:!\/=9TW3([J2-[.X$4 W3,
M7=6.%')Y9OUJ3PAH-K:Z#I,\GVZ6:*W38E]([&W;9M8*K\J>HSUP<9Q0!C2>
M)=8O? >H^+[*Z6(VK7$L=B\:F-HH792KG&[<P0G((P2...9YM4\1:KXM73=-
MU*"QM9M)BU!?,M1(Z,TA&SD]P.O;GCN-T^$=+S=Q@3+9WDIFN;(2?N97)R25
MZC)Y(! /.0<FK(T"S'B$ZX&G%Z8!;D^8=OE@DA=O3&23ZT <KK?B?4+6[BO=
M-OS<VT>JQ6%Q"ML! %>58R/,/S&0%NJD@$8(ZT[2(-2;XA^,9(KZWC4"U!!M
MBQ(\IBO._MGGCGVK6?P'HCB=2MV(I;L7HB%T^R.;?OWHN<*2W/Y]B:O'PU8C
M6+K58Y+J*ZNHECG,=PRJ^T;58KG&X XSB@#E?#WBG4-4L?"%@TB6]QJUC+=S
MSQ1J-HCV_)&I!4$EQU!P%/KD5]8\5>(-,LO%%G'=1/=:-/:&&ZDA'[Z*<J K
M 8 9<GD#!XXKJ8?!>D6VFZ=96XN(1IC%K&99CYD&1@@,<Y4C@@Y![T^\\(Z5
M?Z9<V-RL[I=S+-=2>:1).ZXVEF'/&U< 8 P !B@"C;7VL6'CR#2+W4([VTO;
M&6Z3_1Q&T+QNBD @\J1)WR>.M6;W5KFX\:P^'+>=K51I[7TLZ*K.W[P(JKN!
M [DG![=*T9-#M)=6LM4<S&\M(6@CD\P\HQ4L&'0Y*C\J34="M-1OK6_9I8+Z
MU#+#<P-M=5;&Y3G(93@<$$9 /6@#B;WQ9X@MM UE4GM_M^DZQ#8>>T/RW$<C
MQ!21T5MLO..,C@#-=WI-OJ-M:-'J=^E[.9&82I (AM)X7:">G3J:H7?A'2KS
M2CITJ3"![@74I65@TLH8,'9NI.X _@!T&*VT39$L>YFP,;F/)]S[T >2^';S
M7]"^%_AO6;2_ADM8_L\+Z=]G'[R.241\/G=O^;/IVQW/2)KVL_V)XVF:[A-Q
MH]Q*ML_D#:%2!) ",\\L1G-;&C^#=)T2*""U^U/;6S!K>WN+AY8X3ZJK$\^G
M7';%-N_!6CWMWJ4\OVL)J2[;NW2Y=8I3LV;B@.,[0!^ H Q-0\2ZK;6FDW%P
MNHQZ?/IJ3SWVFVBSLDQ )WIM8JF,GA?Q&*M:=K5[?^+;&VAO[:XL[O03>1S1
MP8R^^-0P)YVG<3MXZUL)X8M84B2WN[Z%([9;0A)_O1*3M!R.HW$;AAO>B+PK
MIEOJ4%_;":WFM[3[%"(I"$CAX^4+TZ@'/7B@#C+?Q'XF'@O3O%$VJ0/_ *<L
M$]H+50DL;77DYW9R& ((QQQR#UJ_+XEUW5AXB;18;C[3IEX]I:0)%&T4[QJI
M(D9CD;B2."N!@\UOIX,TB/PW_P (^%N#IXE$RH9V+*PD$@PW7[XS3SX2TX:G
M/J$$M[;37.W[4+>Y>-9R!@,P!^]C^(8- '/:GXJU#3M9F35C?Z3:"6 6]PEH
ML]HRL$WK+(%8JVXNO50,*>:?_P )/>V_B;['JTM]IN_4?L]KNLP]G<QDX0"4
M*2)&'JPYXQ71S^&[.YEG\Z6Y>WN)5FEM6ES$[#&..N/E&1G![@T)X;LQ,K22
MW,T*W)NTMY9-T:2EB^X#&>&)(!) .,#@4 5M=UB>V\0Z%H=L_DOJ;3L]QM!*
M)$@8A0>-Q)'4'@'BN=U7Q+KFE0>,K);J.2XT:R2_M+N2%271D<['487(*'D
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M6N;&X2^^'UL-3N#(YGVSLD>^-?LC<* H7CL2#UYS0!Z!J6HVVDZ=/?WCLEO
MN^1EC9R!_NJ"3^ JRK!E##H1D5YEJ>K:WI7AWQW;1:W=/-HA62TNI$C,NUH5
MDV-\N" 2><9]ZU/%.IZQ8WLDOD:E-I"6*MYVE/&9K:;+%G>-B"Z[=I &1PV0
M: .ZKGAXRTQKO4+5(=0DFTXJ+M([.1C'N7<.@YR.>,ULV%S'>:?;74,AEBFB
M61)"N-P(!!QVSFN*T6.]E\>>.TL;F&WE,]F#)+"9<?Z,O0!EY^N: -^T\7Z1
M?WVEVUG+).NIP//:SHG[MT3&[D]",@8QFMZN BT2T\-^+O!&CV6XP6UE?JI<
MY9B?*))]R23^-02>(+U]4T#4].U&^GT_4=4:S8SK$L$T9$F/+0?.-I088XSC
MG.: /1J*\PGNM>D\-^,]2'B2]6?1+NZ-KMCA (BB5PKC9AAU'&.I[UZ+8W8N
M;*TD=D$L\*R[ ?4 G ].: +5%<[XSUFYT72+9[5O*>ZO[>S:<J#Y"R2!6?!X
MR 3C/&2,YJE+/J&F>.[#1XKVXFL-3L;B1A(0[VTD13YU8@\'?C!R,@8[B@#K
MZ*XKX>G5]3TBVUO4]<N+OS%N(3;M'&J96=@K_* =V%(],'H,<[7B/4$LXK*W
M%S<Q3WMP(8H[5%,LIVLQ52_RKPI)8] /4B@#;HKRN?7=?@\):Z5U:XCNM,UV
M&RAEE6)W:)W@&V3 P2!*PRN#P.:Z"$:E:>.Y-#;6[VXM;W2I+H-*(]\$JR(F
M4(4#&'Z$$<4 =I17 >&]2U75[/3]+N-3G75K"\FCU:10@W+$<=-N 'W1$8 X
M+8Z5W] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M UT$D;(Q8!@0=K$'\".16='X>TJ.P^P_9=]J)EG$<LC2 2!PX8;B<?,,_7ZU
MIUD:QXCT_0KS2[6]=EDU*Y^SPX&0&QU/H,[5^KK0!*^@Z=)K2:PT,AOT3RUF
M\YQA,@E<9QM) )&,$U#9>%M&TZ[:YL[,P,TAE,:2N(MYZL(\[ ?<"KNI:C;:
M3ITU]=OLAB )/<DG  ]R2 /<UFSZ_=6]O;1/I3?VO<^88=/%PF2B'EB_W0,%
M?Q8#WH 9-X(\-SR7KR:3"WVTDW";F".QZMM!VAC_ '@,^]7O[ TXZC;:@8I6
MN[:,QQ2M/(2JG&1RW(.!G/7 S5#6?%:Z/H>KZH^E7[1Z8Q5U953S5"@ET)/S
M+SC/J#Q6H-0SJ<5C]DNOWEN9_M C_<K@@;"W][G.,= : *=MX5T6SO)KJVL_
M*:9VDDC25Q$['JQBSLR?7%1V?@WP_8-:M:Z>(FM'+V[+*^8LC!"G=D+@D;>G
M)XYK=JM9ZA::A]H^R3K+]GF:"7;_  R+C*_49H ATS1K#1Q<"PA:(7$IFES*
M[[G/5OF)Y/<]^]-U70M.UHVYU"!Y?L\@EAQ,Z!''1@%(^8=CU%:-% &=JFA:
M=K5M%;:C \\,3!E0S.!N&""<$9((!!/2F3^'M-N;J.Z>&47,<7D>?'<2)(T?
M]UF5@7'?YB>>:U*Q],UY=2UW5]*^R2P2::T09W92)/,4L",$\8'?UH DD\.Z
M3)/83?9 CZ>,6@C=D6$8P=H4@#(X/'(XZ56N/!GAVZNKVYFTN)I+U66Y&Y@L
MN1@EE!VEL?Q8S[UI7-]]GO[.U^R74OVHN/.BCW1P[5S^\.?EST'J:M$D*2!D
M^@[T 97_  C>E?:K.Y\B7S[.,Q6[_:),QJ<9 ^;H<#/K@>E-3PKHJ:5=Z6++
M=97C%YX7E=@[$Y8G)ZD\GUI?#VNKX@M+J=;62V-M=S6CQR,"=T;;2>..H-:]
M '!WGAJ"X\4ZA<ZOI5[=1>3%#I\UK.ZDQ!?F1V5PQ;>6.7.,$8/6M+P]X4^S
M:+:IJDMV]Y%YJJPO90\<32,R1,ZL-^U2!DYZ<5U5% &-9>'+2RUQ]314!2U2
MRM8D3:MO"#DJ/<MU/HJCL2;^H:?;:K8RV5XC26\JE9$#LN]3P0=I&01U'>K5
M% &/'X6T>*73Y$MI ^G@K:$W$A\D$8(7YN!CC'IQTI\WAK1[DZCY]A'*NI8^
MV(Y++-@  E2<9 4<XSQ6K10!BCPGHOV#[#):/-;;XY EQ<22X*'*8+L2 #V'
M%3:3HL>FW>I7K.);S49_-FEVX^50%C0#T50![G)[UJ44 4]2TNRU>V%O?0"6
M-761.2K(XZ,K#!5AZ@@U WA_3'L;NS>W9X;P8N2TSEYAC&&<G<PQQ@GIQTK3
MK+_M^TBTRYU"^CN-/M[>9H6:[CV$X?:& YRK$C:>^10!=LK.#3[.*TME98(E
MVHK.S;0.@R23BJ]UHMA>ZE::C<0LUW:9\B02NOEYZX ..1P?4<&JTFO+'XM@
MT!K24/-:2727&Y=A",JD8SG.7%;% &,_A317FO9OL>R2]D66=HY70LZD$,,$
M;6RJG(P3@5>LM-M=/,IMXV#RD&2221I'? P,LQ).!TYXI)-2MEOY-/2027R0
M?:/LZGYBF2H// R01R>U5O#>N1^)-!M]5CMY+=)C(!%(067:[)SCC^&@">]T
MBSO[B*XG$XFB5D1X;B2(A6QD?(PR.!U]*JWGA71+Z&QBFL5"V.?LIB=HFBR,
M$!D(.#W&>>];%% &,GA30DL;ZR&FP_9+YM]S;G)CD;CG:3@'@<C'0>E'_"*:
M*VE3:9+:-<6<P4/'<S23<+]W!=B1CJ,$8[5LT4 8TGA319]-.GW%H]Q;EUD'
MVB>25U9?NE79BRD=L$8I_P#PC>F?9HH/+N,12^<DGVN7S0^TKGS-VX\$CKT-
M:U% &4?#>EXBVPS1O$SLLD5S(CDOC<6=6#-G:,Y)Z#THE\.:3-!:1&T""T8O
M;O$[1R1LWWB'4ALMDYYYSSFM6B@#)N?#6D7>EMIL]IOM&D\UX_,<>8^=VYB#
MECD Y)/(!J6XT2RNI())/M(D@0QI(EU*C;3C(+*P+=!USTJQ=:A:64]K#<3K
M'+=R>5 IZR/M+8'X G\*LT 16MK!96L=M;1)%!$H5$08"BJ%UX>TN\OI+R6W
M87$L8BE>*9X_-0=%<*0' R?O9ZFM2LNSU@ZAJMQ;VML9+2W9XI;OS%P)EQF,
M+U/7D],@B@!9_#^F7-W973VQ$MBI6U,<CH(01@A0I &1P?4<=*TZ:[K&C.[!
M44$LQ. !ZUF>'?$%CXGT:/5-/+^0[NFV1=K*RL5((['C]10!6/@OP]OD<::@
M:2X%U\LCC;*&W;TP?D.[GY<9-6H_#VF1W/GB&1F\XW 1YY&C$A))<(6*@Y).
M0.O-:E% &5;>'-+M&C,4,O[K=Y0>XD<19!!*!F(0X)&5Q@$BL#7_  G;QZ98
M:=8Z:\VD?;Q<7]M'*3(1AF#(6;(/F%6.TAB,XY/.YKNO+H3Z:'M)9EOKV.S#
MHR@1LYP"<G..O0=J-,UY=1UW5]*^R2P2::8@SNRD2"0$@C!/&!W]: ,#3O"%
MN^LWI2"^@T*YL?L\MG<W<K"XD+9W;2Y*@+E3G&=QXP.>D;P_IC1:?&UNQ&GM
MNM#YK[HC@KP<YZ$CGMQ6G63XEU^+PSHD^K7%I<W,$&#(ML%+@$@9 9AGDCI0
M U?#EE:QYL5:.>)7-LTTLDR0.P(W*C-@=3TQP2.,U9T31[70-&M=+LP1!;IM
M!;JQZEC[DDD^YJ:RO[;4--M]0MI5>UGB6:.3/!0C(/Y5E>%_%5IXMM+F[L+:
MYCMH9W@$DX5?,93@D ,3CZ@4 6+WPSHVHZB=0N[%)+HQ>2SEF =.<!@#AL9.
M,@X[4U/"VDQ1PQQ0SQ)# +=%BNY4'E G"'##(&3@'..U;%8\^O+!XKL]":TE
MW75O+<)<;EV8C*@C&<Y^<4 +)X9TB0L#:LL;1K"\,<SI$Z*,!6C5@I&.,$=.
M*6[\,Z/?:I'J5Q9*UVD8BWJ[*&0'(5@" RY)X8$5;L+[[>D[?9+JV\J=X<7$
M>POM.-Z\\J>H/>K= &&OA#0TLK.S2S9;:RE\ZVC6XD B?^\OS<$9./3)]35E
M/#^F1WE_=K;MYU^FRZ8RN?-7& ""<< D#T!P,5%XHUY?#/AZZU=[26ZCMEW/
M'$R@XZ9Y-:[$A20I8@< =Z ,67PAH<MM8P&R*BP79:/'/(DD*XQM5U8,%P ,
M9QP*GD\/Z=(8"(YXV@1HT:&YEC.UCD@E6!;)YYSSS4'A[Q)'XB^W^38W5N+&
MZDM)#/LYD0X8#:QXYZTFA^)8]<O]2M(["[MVTZ;R)VF,>W?@-@;6)/# YH U
M[:V@L[:*VMHDB@B4*D:# 4#L*H3^'M+N-5?4WM2+UXO)>:.1T+(,X!VD<C)P
M>HS6E(S)$[*AD8 D(I +'TYXK,\-ZY'XDT&WU6.WDMTG+@12$%EVNR<XX_AH
M 8OA;1DTBWTI;/%E;2++!$)7_=.IRI4YR,'D8/%#^%M&?4I=0^R%+F8@S&.9
MT68C@&10P5S_ +P--@\0K-XDU'1393I)96T=SYF5(E5RP&T _P"P>N*T=.O/
M[0TZWO/LUQ;><@?R;E-DB9[,O8^U %FL:]\*Z-?ZB=0EM&BO64*US:SR6\C@
M= S1LI;\<ULT4 94GAK2)K)+22TW1I*)U<R/YBR#@.),[]V.-V<XXHF\.:3<
M:=<V$UJ9+>Z.ZX#2N6F.,?.V=S< #DG@ =JU:* ,L>'M,%_:WWDR&YM(S'!(
MUQ(2BG&1RW0X&<]<#-<UXV\-P'PK<V&EZ9-,;[48+FXAB+,&_?I)*W)P,@-T
MQFM[0_$L>NWNI6L=A=V[:=.;>9IC'CS,!L#:Q)X8'-;= &=8:-IUE:/'!;'9
M,FU_/9I'9<?=8N2Q')X)XJG:>#= L&M6M;#RGM,_9W6:3=&",%0=V0N.-O0>
ME;M% &.GA714TF[TO[%NL;MB\\+RNP=B=Q/)ZD\G'4U4N;%=7UJQM9]+G%II
M$XN8[JY(82R!"$V'<6.-Y))QRHZYKHZ* "LNR\/:9820O!#)F#(A$L\DBQ9&
M#L#,0O&1QC@XZ5J54FO_ "M3MK+[)=/YZ._GI'F*/;CAVSP3GCUP: )KFV@O
M+:6VN84F@E4I)'(H964\$$'J*IV&A:=IKQO;0OOCC\J-I9GE,:<952Y.T<#@
M8Z#T%6+/4+34/M'V2=9?L\S02E?X9%^\OU&:LT 8VF^$]$TB826-B(L-O5/,
M=D5N[*A)56//S 9.3ZT]O#.DM-J$IMY/,U%0MVWVB3]\!P ?F[#CZ9'3BM:B
M@#B-9\+VS:KHUO+ID\^@6-M(L*VTK>9;S':%Y#!]FS( 4X'&1TP_2/!EM)'J
M4.HV]Q_9DMW'<6%I<73O);%$ +J^XLA9LG ;@>F2!VE% &-_PBFABWO[?^SH
M_(U!0MU'EMLN%"@D9QG '/7BG)X9TF.YL;A;=_.L%*VSF>0F,'[W\7.>^>O?
M-:]% &2/#.D+<RS+9X\Z83R1"1Q$\F<[S'G86R <XSD ]:GM]%L+75;C5(86
M6\N5"S2>:YW@9P""<8&3CCC)Q5^B@#$M_"6C6D,$5K!/;I K)&(;N:/:K')7
MAAQD9QTS6M;6T%G;16UM$D4$2A$C08"@= !4M% &1=^&-&OM5_M.XL@UX8Q&
MSAV42*,X#J#AP,G[P-1Q>$=$@BL(HK1TCT]MUHHN),0G&/E^;C@D?0D5MT4
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M81';(OEENI7 XS@9QZ4 >>KKMYI?AR^8W]S]F'BMK&XNI9F=K>U\T*?G8DJ
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MDNW>,1@[0K D[L=B>1@>^=?Q1?6XO]*T=_/:>^,K1QI=M;1E8URQ=U^; W#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK.L<J.R'#A6!*GT/I3Z "BBB@ HIDTT5O$99I4CC7JSL !^)I] !12$@ DG
M'4FFQ2QSQB2*1)$.<,C @]NM #Z**8)HFF,(E0RJ-Q0,-P'KB@!]%1K<0O/)
M DT;31@%XPP+*#TR.V<&I* "B@D 9)P!4<$\-S"LT$J2Q.,J\;!E/T(H DHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@"&ZMDO+=H)&E5&QDQ2-&W!S]Y2"/P-<K\,D">#0!G'V
M^]')STN9 /T%=;*)6B80NB2$?*SJ6 /N 1G\Q7.:%X9O]"\,W6D0ZPAED::2
M"Z6UPT+R.SEBI8AL,W XZ<YH S_B/9QOIVFW1:;S!JMC& )6"8-PN?DSMSSU
MQFM3Q+H&@ZDCW_B&-;BSMH"!'*3LCY)+  _>/ !Z\<=:3Q#X<O==TNPLSJD<
M36T\%Q)*UKN,LD3!@<!E"@D<C\L4W7O#^M:O=V,UMK\5FMJ-QB^P"57E_OX9
M^W8<XZY)Q@ ?X%LM0T_P7IEKJC3&Z1&R)FW.B%B45CZJA53]*Z*J&D6NHV=E
MY6IZD-0N-Y/G"W$/R]AM!/YU?H **** .=\2Z'J&MW^D>3<PQV%G<?:IX'!S
M<2(,Q*2.BAOF/7H..*\^\7PZMX5\*Z'H4FJ-]M\0:T$U34H,H2)'^;:>J_+M
M7Z)BO8ZP_%OA33O&6A2:5J/F*A82131'#PR#HRGUY/X$T 59?A_X8:R@MX-&
ML[9H)$DBGBA42J58'._[Q)Q@DGG)S7/WOQ(O_L/B/5M,TJWGTO0;HVL_FSE9
M9RF/,*84A0,\9SGVK?TS1_%EI'#;7GBBUNK>/ ,O]F[;AP.Q;S"N??96-<?#
M64Q>(;"RUA;?2->N#<74#6V^2-F(W^6^X !L=U.* 'W/C[4I_$6EZ3HVCVUR
M-4TW^T+6>>[,8VD @. AV]>Q;MT[9%I\5]4FT;1M9F\.PQZ?=Z@--N2+O,D<
MI8KN5=N"O'<YSQ[GI&\#RP^*]-UJQU&&WCTVP^P6UJUJ7 CQCYFWC)S]./SK
M(B^%DL7A.VT'^W5*VVJ+J44WV/G<"6*D;^1D^W2@"]>^,M>/C/4O#6EZ#:7%
MQ:V:W4<LM\45U+ #/R<'KQSSW%+I'CRYU[P/%KEII]K:W)F>WGCO[P10P,N<
MEGVDD9   &<MVP37/9OKGX\:G%INL6=I<#1XDE,EOYN\[N0J[QAAUZG'<&M^
M]^&MO]F\.PZ1J4EA_8MR]PK21"?SV?[[,"0-Q.2#VSP* ,Q_BM=#X93^+8]%
MA>6VNC:W%O\ :_E#;PH9&"G<,L/3ZUL:;XRU>?QM=^%]0T6"TNO[/-_:.MUO
M5TW; 'PORG/7&<8/7@G-F^%DTO@K4/#!UX?9KV^-X\[6>9 2X?'#@=0.<>O%
M;DOAI[?QK%XQN=5B5H-+^Q7$7V<A&0,9&<'?E>>QSP* ,G1OB'J6LZ0TL>C6
MT6J)J_\ 9;6+W;95ARS%MG90S=.BGOQ7:ZM>/IVBWU\D?F26]O),J?WBJDX_
M2N)\)Z+IE[\1-?\ %>EW0N-/G6-(FC;="UQM_>NA'!XVC<.[..U>@LH92K %
M2,$'O0!YE\+]$TWQ)X,@\2:];6^KZKJ;RO//>1K+M D90BA@0J@+T&*U9]0B
M\&ZAHG@W0;..2YU*6XFB$SE8K:,%I&S@$D#.U5'IU%)I'@34_"D]S%X7U^*V
MTN>4RC3[ZS-PD+'KY;+(A ]CFK>J^#;O4-2T36EUA5UO2FDVW#VH,4J2##(8
MPP(&.AW9'O0!A77Q2O++PMXBU"31H&U#0+P6MW +HA&!8*LB-L)()/0XXSS6
MKIGC;59?&H\.ZIH<=JUQ8&^M'BNO,+*#C:_  ;KT) ]^M5;WX8?;O#.N:6^K
M!;K7;L75_=BVSDA@P6-=_P H&!U+'KZ\:X\(7'_"9:;XD;4XS-::?]ADA%L0
ML@+$E@=^5/3UZ4 <1X4\:>(-,^&NM^(;ZS&HBUO)GWSWYW, ^TJ!L. O&.QY
MZ5;\1^(;N^T?0;WQ%X1MVM;C5[060:_(9&=<K*0@YQ\_RD^G7MIQ?#.Y@\(Z
MSX:3Q!FPU&=Y$WV8+0*S;F&0PW'..3QUXYXT-;\$7FMZ#H>F/K$,1TJXBN!*
MMF3YK1#"<>9P,'GDY/3'2@#FKC[?8?'+6)-!TNVN;V30T<I)*(4),HRS, 22
M< =/J15T?%6XD\&V&NQZ(JR3:D--NH)+D@P2[L9&%.\?E^-;-WX.U0^-7\3Z
M=KL-M<36BV<T4EEYBE <Y7YP0V>1G(^M1ZO\-[&\\$P^'=/O);(P7*W<=V5$
MKF8,6+N.-Q))].W88H >WB^^F\4>(O#ZZ=&CZ;8?:8IDN,F7</EX*C;[]?QK
MS]=<NYO@!;ZCXDT>/6K8R*S-<:BZR3$S$!CA<C#$#&>@_"O0-)\#W=CXFOM<
MO==-]-J%FMK=*UJ(\[1@%-K87Z$'Z]ZRC\+KM_AS_P (9)XCWVBRADF-D R(
M'WA1A^3NZDYX["@#;U'Q7>MXS/A71+2VEO(;$WL\UU(RQHNX*J *"222.>@'
MK7/?\+8N)O"VBZS:Z$LCW^IKI<UNUUAH9B3]WY<," >21U%=!=^#[W_A+(?%
M&G:I;V^J&R^Q70DM"\,RYW!@HD!4@@?Q'@8K*?X6I'X=T72++5O*73=175'F
MEMM[3W ).3AP OS'@<\#GU )K#Q)K7B6Y\4^%+FQM]+U>S@58YHYS-'ME4X;
M.T'(!S[^U7?#W@*UT'7(+Y7#PV-@EA81XY09+2R-_MNQZCM]:MZ=X5DT_P <
M:OXD%^KC4XH8Y+<P8V>6H4%6W?4\CO72T 8WB?Q!#X:TI+Z<((WGC@,DC;8X
MMYQO=L'"CU^G3.:Y+Q1?-JECX=O_ "+*ZDB\06ZVTUG.LJ2J03E7_AR>"/\
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M]G968UQ6M['4_P"T+<&S&YB79R)6W_.<N?F&WW![=O0 4444 %%%% !1110
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MWP0<@KN<G'IQ[U<O_!EGK&GWL.K7$MS=7D21/=H!&T81MZ>6!PN&^;OD]<C
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M>SO-L;>7C?S!D'=]PCL30!+;>+M-TW1=6U6[OM1N;6WU*2&0S6N&@8E1Y8
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M'& 9 =I.& 8''OP33U\4H-0L[.?3;J*6_@>:S!*$R[ &9#\WRO@@X)QUYXH
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MPM$,?)QG=G\,>]='XHTV^U?PU>V&FW8M+R9 (Y22 /F!()7D @%<CD9K7HH
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M<VKB19I LD<#*P_@X9MO(Z#U-;=KHVI1>--2UF46HMKNRAME196+J8RYR?E
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M9UN#$KAMA4(H8E1LY8C'/M7;T44 %%%% !1110 4444 %%%% !1110 4444
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M&S:9"1SSDD].E9EEX-;3+4VUE-I_V:::::YM)K'= [2%<;$#C8%"XQSG<>E
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M3PVD=VDTUZ8T9'9EP<1D@Y0] 1[BJ.J> [K41XC@36EAM-<*M(#:;Y8V"*F
M^_!3"_=V@C)P:U[30+N#Q=-KTVH0R>=91VC0);%<!&9@P8N>[GMTQ]: .;U#
MQ?J6IZ3X1U#3+22W-_JODW$!F4<HLH:(MCD;HR<@=%]Z['6-:@T'P_<ZOJ",
ML=M%YDB1G<<_W1TR22 .E<Y'X%N[?0M+L+?6(EGTS4GO[>=[0LIW&0E'3>,_
MZUAD$=!71ZYHEOXA\/W>CW[,8;J+RW=."#V8>A! (^E &;/XCO--UC2['5-/
MAB34V:*"6&X+A)@I8(^5'4 X89Y'3O4/A[Q1JNNW\R?V$D%G;W=Q:3W'VP-A
MXCCY5V@L"1UXQ5E/#UY=W.ESZS?PW;Z8QD@\JW,>^784$CY8\@,W P,G/H!+
MX9T&XT"*_CFOH[H7=Y+>96 Q[&D8LP^\V1SQ0!A>)TD@^)'A:YLK**:]>UOD
M&]Q&&PL6-[X) &3T!Z]*KZQXH^W^"=:DU70D=]-OEM+VT2]95)#1LK)(%!(^
M=#@@=Q]>EU#0;B]\5:3K*7T<::<DR" P%C()=H;YMPQ]P8X]>M9&H^!KF]T_
MQ#91ZO'%%K-XEVQ-H6:(@1C:/G&?]6O/N: +.J^,5LM?N-&@6Q^VPP),D5Y=
M^0USNW?+%E3G&WKZG'O6SKVLVWA_1+K5+H.T4"@[4^\[$A54>Y8@?C61KOA6
MX\0VMW9:A<V$]I=1A<26.Z2 [0K&-BY /&1Q\I]:TM;\/VFN^&[C0[AI%MYH
MA&'5OG0J058$]P0#^% %*;Q'>:?KNFZ9J=A#'_:8D6VFAN"ZB5%W&-\H,9 .
M&&>AX%0^&_$^J>(+ERVAK;6,4]Q;2W'VL.1)$Y3Y5V@E3@\\8].]65T"\N[_
M $V]U>^@N9]-#M;^3;F-3*R[/,8%CGY2< 8')]L2>&-!N/#]E<VTU['=B:ZF
MN@RP&,J9'9V'WFR,MQTH P=?66W^*.A7&GV4,U[+IEXOSOY2G#0X+N 3@9/0
M$\]*FC^($4>FA]1M([.__M1M*:%KD>4)5&XMYA ^3;SG;GMC-;%WH-Q<^+]/
MUQ;Z-([.WE@%N8"2XD*%CNW#!^08XK&N/ ,DINY8M6\JZ.KG5[.86^?(D*A"
MK#=\ZE1@CY3S0!'>?$)K32-?NX["WNY-&,;2?9[O,4T<@X9'VGD'(*XXQUKJ
M=)NM1NXKAM1TU;%EF*PH)Q*7CP"&. -IR2".<8ZGK65K?A[5?$/A:]T>]U:U
M26Z 5IH+)@J*#DX4R$Y)'7/X5T4(E6)1,Z/)CYF1"H)]@2<?F: /')-*MI5^
M(4$'AF.]<7K+%.J1#[-F!#N7)WY4DMA1DGIS77:=XSTZ"RT;2K/4K:[E?2H[
MD7E]<>0LB#" G()+L0Q(QQ@Y]#9@\(ZI:7&NM;:Y#%%K%RT\N+(F2+*!,(QD
MQG"CDJ>>W:B/P.-(OM.O/#EZEC)9V(T]H[B SQS0AMPR RD,&).X'N>* *]M
MX]NM0.A+9:*KMJPN$7?=[1%)#D,"=ARA(X8<D'.WM3QX_6TL;S^UK*.SU"UU
M*/33$+D-$TCJK*PD*C";6W$E<@ \&M.[\/W]YKVB:K+J<&_3!+N06A F,@VM
MCY_E &,=?<FLW4/ 37]SJEP-5,,MUJ$&I6KK!EK:>)%13RV'4A>1@=3S0!G^
M(?&UR_AGQ9#9"$7NGZ?Y\5U9W DC*NK#<&P,,I4\?0]^+49@L-;\*6\WAVVM
MI;F6?RI+>Z(\EQ Q9BJJ Y95 R>GX5JZMH&K:[X7U'1]0U:T#WL)A,L%DRJB
MD$$[3(22<^N!Z4MYX=OKS5- OFU*!6TEG8J+4XF+(8S_ ,M/E^5O?G\J $@\
M0ZAJ@^U:-IL%SIZ7AM9));DQR-MD\N1T4(054ACR1G:>G&:OAW4E&GZ_/:Z2
MEO/!JTL<T9O"R22?)ND+L/E7G) ' 7@$\5/HWAK4- N[J/3M5@_LFXNGNOLL
M]H7DB+MN=4<.!M))(RIQGO5"7P)>2Z9J-J=9B\R[U9=51OL9V*X96V.GF?.G
MR#C(H =!XZEDT[Q'*;"TEN=#B$[K;7OF0SQE"X*R;,@X5A@KU'7FFW7C76;+
M0X]:NO#D45A));_.U_RD<N 9& 0X"DC(]#GU FF\&WUP/$;2ZS$TFN6:6TK?
M8\"+",A*#?TPYP#DCCD][U_:V%EX+?2-=O(9+=K0VK,%\LRC9C"J6)+8[ GF
M@"_;:E<W&O7EB+2/[+:QH6N1,23(PSLV[>H&"3GHR^O&'K&J:M%\1='TZTB,
MEG)8W,LL33!%<AHAN/!/RACQWW>U:_A;2[C2/#EE:WLS3WWE*UU,W627 R3]
M. /8"HM3T&YN_$VF:W9WZ6\EI#+;R1R0>8)8Y"A.#N7:V4'//TH XK1]9O/"
MNB^*;VQT6"?3;'6;R6X'VCR66,,,^6@4@X'."5Z8%=AXB\1W.C6;75M:V4L:
MP></M=\+<R\$E(QM;+8'? Y'/7%)?!4[>&O$>CSZI&XUJ6>7S4M2ODF4?,,%
MSN [<BB;P??OJES>)K42"[TY+"X!L]S +NPT1+_)G?R"&SCMV *ESXEU*^\3
M>$9-+@<V.HZ?/>-"\P0/E8BN[@\J'_'/M7=5R4'@^[M#X8DM]6B6;1+5K-F:
MT)6>)E13QO\ E;$:\Y(SGCM76T %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !12/NV-L +8XSTS7GT/CO68?#U[XBU#3K%-,LVN(
M&2*5C+),DWE)C(P%)ZGD^U '?3W$-K \]Q-'#"@R\DC!54>I)Z4EM<P7EM'<
MVLT<T$JAHY8V#*X/0@C@BN7CU^]N=2ETR:%+FUGL9)A=6]O)&L+K@&-]V0<A
ML@\?=/%4/"^HS6'PS\*I;SV4$DVGQ*KW1+9(C!PL:D,Y/H#QC- '>45YG?\
MBC5]9\-^'+VVACMKF37DM+E!.\:LT<CJ5^[G8Q3)!Y'3!K5NO&EV9M9M[.*W
M^U:2JJ\+1R2_:9O+#E$*XVCD*&())/W>.0#MZ*Y;Q;J=Y_PK'5=4LXY;6Y;2
MY)U5W,4D!,9/4#(=?3CD=14=CKFI?:]*T#R[6/49;%KN24LTR)$FQ0<?*69F
M;U&,$Y- '6U#=WEK86SW-Y<PV\"?>EF<(J_4G@5C>'->GU6ZU;3KZ".*_P!*
MN1!,8L[)%90Z.N>1E3TR<$=37(2W6K7>D_$I;ORGM(_M,2YN'<Q@6B$*JE0
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MCEP,L"P4#('K6I<:S<W6OW6AZ7Y"7-K;QW$\]PI=%WE@BA0023L8DY&..N>
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MCO!&I /\38'S-COP.>E9=MX%6RAT%;76+N*71H7MH91'&Q>%@H*L"",_(N&
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M 81E14&T]<84=:JW?AEM1_T>_OFN+ 78NUA>(;U97\Q5#_W0P],XXSBN@HH
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MS"8J)8P2P#@8!P23^-6]*TR'1]/2RMY)Y(T9F#3RM(_S,6.6;D\F@"[1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%0W4!N;=H1/+!NQEX2 P&>0"0<
M9Z>O/&#S7,?#>2:7P@'GGFG?[=>+OFD+L0MQ(H!8DDX  H ZVBN,^(23Q6&G
MW4-]=Q$ZG90^7%*40AIU#9 P6R#C!)''2M/Q7>W":5=65C,T5T]K+*\R'F&-
M5.6'HQ.%'U)YVF@#H**Q/!LDDO@;P_)*[22/IMNS.YR6)C7))/4UMT %%%%
M!17.>)M.UG4[[28["2*/3H+C[3>@RE'FV#,<0P#\I;!;..!WZ5YW\1--U?1/
M@[=7FIWQ;7GOA<2W%K,X5#)(!L0\':$"KCVH ]GHKS/X@>&[?1_ ]WKNB7-W
MINIZ?$L\<T-U)A\$95E)(8$9ZBKUO\1MVEZ3&MFMSK%SHZ:I/"9E@1$(&?F.
M>2Q.%Q]2* .^HKB(/B7INH6&B2Z;;M-=:Q#)-!!-*L2QK'D/O<Y PP*C .3[
M<U4;XK6K>&])UF#1[N9;_4!IK1+(@:&<DC:3GGH2"..F<9H ]"HKSB;XHWL"
MZ_$_A*\^V:%MDO(OM<6U(64L'W=SM&=H!^M;5QX]LO*T1+* SWFLVOVNVAEE
M6%5BVALNYSMZ@< Y/YT =;17$V/Q,TW4/#^G7]O:SM>ZA=-906&X;S,I^8%N
M@4=2WH1QGBL3X?-</\5?'1NK'[#*%L\VWG"4)E&)(8=F/S=NM 'J-%<C\3U_
MXMQK<RLZ2P6S2Q.C%61QT((K$T[Q8OA+P/X+#:9=WSZO';0^9'*I8S2("2=Q
MR2>3Z>XH ])HKB-.^(%Q?Q>)(7\/7,&J:"%>>R:=&,B,I8%6'!)52<?3GFK&
MC^.#KEIX?N;/3MZ:P)' %P,P(GWF;CG!P..Y [YH Z^BN!B^*>G37&FRQV;-
MI6HWYT^WO!,NXRY*AC%U"$@X.<^PJ[I'CQ-<UF2TL+.*2WCO)+21OM:^>A0'
M+F'&0A(P#G/(XH [&BO+O"_CC6?LGC;4=3T^]N[?2]1NO+^>%1%'%M_<X#?>
M"Y)."#ZDU=MOBA<W%YHD'_"*WJ_VY:M/I["YB/FLJ!BI&1M !^\?RH ]$HKA
M;+XG6$OA*_UR_L+BSEL;YM/FL]RNYN 0-JMP#]X<\#KZ4J_$>-!X@AN-*?[;
MHEL+N6*"X21982NXLK\<@#D$?3- '<T5P6E_$LWVK>'K2Z\/W=E;Z] 9;*Y>
M9'#,$#$%1R!R,$XSD<5D:#K/BKQ3#XXTV(3Q3"^GL[2ZFDC1+-?E79A#NWJK
M%L@$$C[V: /5**Y/P]X3N-)UZ:]GO)9;:"TBL;"%IF?" 9DE<'CS&?//H.O.
M!L:]KEMX?TU;RYQM>:.!=S!%W.P4;F/"KD\GT]>E &I17GWC*ZEN].T6[N;
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M5R\LH4Q[6!P0P<')QCG/2LSQ=KD.I^%_%NC75O''?6FCR7J&.7S49"C[65L
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M"C;M'/W!G)YJK/X(U5]+U6Q2]LC]NU:+4A)L9 FPQ'9M&>,Q 9ST/?'/>T4
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M@#C&T\X]<BCJ/CN;2K;Q MSI2F_T6!;J2%+GY)H&!(='*YSE2""O!'4U=O\
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ML2EQ=371=].8NID<L0/WV.">,C\Z ,'1?%0\+W6M:'>7#7$%KJT=EILES/C
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MV]J];=0Z,A) 8$<5Q-OX&U.'P[H6CG6K5DT>[BGAD^PL"ZQ?=5OWG7GDC\J
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M+]E*B,S.S,"N\Y W<<B@#.L?%+V>E>#[73=$W0ZQ9K]F1KPY@VP>8%9F4E@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MISSD#/3N*X2XUKQ7H.F>%="U^]$-WJFHO;3WZ.ID6 <H-V-H=LA<X[>O-6/
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MIKK49;6"[6:Y9XIDDA8G*'Y000/F SZDU=CFUB:#QE:6&I.US!JL,-K]JN&
M"E(6:(/R4W;G4$="V:[,Z#I!LH+(Z79?9;=Q)#!Y"[(F'1E7& 1D\CUJ,^&]
M$*W"_P!D6(%RP>;$"CS&!!#-QR00"#U&* /-_$-W)>^#]>L;JWU33+JVO+!I
MK>XO/M* /,@!20DG:<$XXP1TYK>UO3[J7QKHVBQZ]JT%M=:?=M,8KHJ[%&BV
MD'L1O/(%=>=$TMM/GL'T^V>TN.9HGC#+*>.6S]X\#KZ"F1^'M&BGMYX])L5F
MME"02"!0T2^BG&0/I0!P'C'5I8](UR^TJ_OTN-$ECA^TR7S1() L9*"(<2YW
M<EQR6.#P,:<\$B_%75KJ*XN7F@T.":.!' #GS9L)@#D9 _$UU4_AK0[J[N+J
MXT>PFN+E-D\DENK-*OHQ(YZ#KZ5,VBZ6]];7S:=:M=VJ>7!.85WQ+Z*<9 H
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MRQV\:M=XQYY"CY^IZ]>IZUQ?P\U_1[+PO>M=:I90;=4O6(DG53@SN1P3W!H
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MD05BNX@Y7GOGKS65=K;?\*\OK2:YD^R:9XH%NNZX8>3 MXH 8Y^Z%)QGI^%
M'LE%5K%;8:?$+*426^S]U()#("/7<2<_G7E&A+INN#0H;O5K"/4K*[E2^O$U
M )/J&"Z;  1(0S;6PP&-HP""* /8*J0W=Q)J=S:O8RQP1(C1W3,I24MG( !R
M,8'4=Z\K\5ZO8WBZG?VKV]IJ.EZO# DCRLUU\LL2,0,CRXB">#E2#G@FMJ66
MR_X3'QM"UT!&=)MI"///#?OB2.>/X>GM0!Z+17D=C;V5AX:^'6N6\K)?3SV=
MO<71G),B/ VY&)/(R!P>F.*OV1N+'Q)8W+Q:9K%M>:K,L%]!(4O82QDRL@((
M=$&5P",!1QQ0!Z;17)^/KN>STS3'#,FGMJENFI.#@+;$G=N/9=VP-[$YXK,E
MM8+;QO?1:>4BT631FDOXX6VPI-O'EMQPKE=_3&0!GM0!W]8DFNS1>-+?0&LT
M\J>RDNTN!*<_(R*5*;>/O]<]JPOA=IEBG@_2M7B>2:^NM/A2YF>=GR5&0,$X
M&,GIBI-4N53XKZ9'')&;C^Q;L(C,!EC)"5'XX/Y4 =I17D>XWGPQT_4[1S_P
MF"7$2F3.+DW?F@21OWVXW94\!1TP!5^^-Q9^()=1\K3-:LY=8CC5A(8[^T?>
MJ;%X(9%*D[?ERI8G@DT >FT5Y;;O?:?J]G<Q0:7K0N[VX^QWT$A2\1F60[95
M((9%^Z<$8 7CBF^#T_MO3?#E\^M6%OJ]O,&O/E(NYW 82P2@L#R23@CC:"!@
M"@#U2BO,O#)N++7-$6:+3-5BOO.>WU>SD*W+)L9\SH0=P/ SNP&V\#BM_P 9
MW3V^I^&TN6VZ+-?-'?L3A"3&WE*_^P9-N<\$X!ZT =/>W<&GV-Q>W+[+>WB:
M65\9VJHR3^0JMH][>:A9_:KJUBMTE(>W6.4N3$5!!?Y1M;DY R!ZFO.]?MTM
M%\>V]F_EZ%_8F]HXW*Q1W>V3*I@X!*A"RCKD9'//=^$[>UM_"^G"S8M$\$;D
MF5I,DJ,\DG\J -FH+V:6WLIIH(DEDC4L$=]@;'O@X_*O)_$FL6-[)<ZE:O;V
MFH:?KL-N':5FNB!.D;D\CRXB">#E2".A->JZA-%%IES+)(B1B)B78X X]: .
M2B^($H\,Z;XDN]&,6DWK1*7CN=\D(D8*K,FT<9(S@D\]*[>O/OA[I-EK/PZ\
M,R74[W,-M!$ZVN\>4LJ<@L ,D@X.&)&<'%8.LZQ87UW!JEH]O:7MKXBBM69I
MF:[*"X$;[^1Y<9!.%.1@CH30!Z_61_;T5SI>H7>E6\NH264LEN8(\(SRH<,H
M+8'!XSTXKDM.TK2]6^)WB5+B:24VCV-Q!$MRP"2@.Q;:#SSVZ#)]:YN6/2[?
MX<^.]EVRZA!>:A\AO'WI^];82I;J>.<9/O0![.I+*"5*DC)![55-W<#5ULQ8
MRFV,!E-YN78'W >7C.[.#G.,<5Q=Y?Z?<^-[?3=>>W;1I](22Q2Y(\B:7>?,
MZ_*SA=F!U R1U--T^'2[/XEZ?86-RKVK>'I55?/WAAYT07'./NYZ=J /0:*\
M7L[#1=1\ :K%%<&7Q%;7=\EBD-R3<PS">3RE0 Y4?=)[8Y/%7?&>H6UW8>([
M.Z:VCUC2-.1Q<2RL9C-Y)D#6Z @J,]7!Z@Y&!0!ZW5+4=5L]*2W>\D*"YN([
M6+"EMTCG"CCISWK@X[?3=;^(UO;WLHNH[CP\DLL!F)21_,')4'!X&<>V>U83
M_9'\&Z5#=W<GV33O%C6V][EAY4*W#A0S;N %P 3T[4 >IP:O]I\17>E16SF.
MTA1Y;G<-HD<G$8'<[1N/H&7UK3K#U>*UC\'7ZVM^+&"2S8)?(VXQY3 DW9RV
M.#G.>.M87@\W-IXBN].N]+TN*<64<IO-)D/DRKN(4.A&5<\G.3D#KQ0!V\DB
M11O)(P1$!9F8X  ZDUC^%O$MKXJTAK^VBDAV3R020RC#QLK8PP[$C#8_VA5/
MQ;=BY^R>';>>W6[U)\.DK<>0O,F0#DAN$X_O^U8-G<3>%OB>\&HW%FD'B2'S
M$6$E52YB '0GC>G?N4H ]$HKSKPZ^CZZ]T/$4D \0V>KR#$\@6:';-F%8\\A
M"NP#'#9/4DTWPG)I.NZ=%<:S);_\)5:WT@E\^0+/%*LK%(QGD(5V@*."#ZT
M>CT5Y"7>]^%L&I0L1XSCN%7S <7(O/.PT9[[<9&T\;.V!6W#>:;I_C#QI97]
MVL/GPVTD4,DQ#2 QMGRQG)^;LO>@#T.JFIZE:Z/I=SJ5])Y5K;1F65PI;:H&
M2<#DUY5IC6E[I7PN6YNV)GC>.?%P5+C[+)PV#SEL#\<4FNVEM9Z#\3-%M"\=
MG:0Q3P6J2MB+= &; SPI/)'2@#U#4-7BL4LPJ&6XO91%;P@X+D@L2?0*H+$^
M@[G .C7!VPLO^$^\-_89UGTXZ7>-;R+.9E:7?#NPQ)R=N>_K6<YN++Q&MZ8M
M,UFTN-:\J.=)"E]:OYFPIC!#(F#D CY03B@#OM+U2/4EN4V&*YM9C!<0L<E&
M !'/<%2K ]P1T.15^N*BO[?2_B#XIOKF98-/@TRSDNI&^ZK@S<_7;C]*[))H
MY8%G1U,3*'#YX*D9S0!B^(_%-EX:?3A=J["]N5@W+TB4D+YC>BAF0$^KBMVO
M/[NQE\=0Z]);W-@^FW$;:;"\F7**A.Z1<' )DR1ZB-#6O\/_ !"=?\+0FYF1
M]2LF:SOE5@2)HSM)^C8W#ZT 3ZGXCO+'Q38Z%!IL4\E[#+-%*]R44"/;NW#8
M<?>&,9_"IM \1C6KO5+&:S>TO],F6&YB9PZ_,H965AU!!ST!]JY_Q!-"WQ8\
M-6_VP02FPO5RK+N4GRL<'(R<'&14_B%-(\,6-M#) LIU?456>>\N"D<DA1CN
MF;NN$P$Z<*.!0!VM4M0U6STMK1;N0HUY<+:P *3ND8$@<=.%)R?2O(;Z:"'X
M=>/+6.^006=__H?DNR)&&CB;$8+$A26; S@Y..*Z'Q=HFAZ5'X=E69XK.?7T
MFN)GO9-I9H7!8ONXR57G/4G'4T =_%=W#ZI<6K6,L<$4:.ET679*3G*@9R",
M#J.]3SR/%;RR1Q-,Z(66-2 7(' &>,GWKSB>ZDL_$_C%-!F\V\CT""2TC$ID
M)E FP5!)R>$^O%3V:>$]1\++K%K<VQOFTM_-F$X$[G8-WFG.XL& Z\@T =[9
M3RW-C;SSVSVTLD:N\#D%HR1DJ2."1TXJ>O)))M/;PW\,+N^O%BA<10SSM<%
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MXI%<E597!#'T'KT/Y4Q=0LFW;;NW.U@K8D'!/ !YZT 6*A6UMT<.L$2L.A"
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MUJ:B@",P0F3S#$A?KNVC/YU)110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %>-:#I%CJ_PZT?2[&Q,7B."X@D:5[9HY;5EF#,[
M,P! V @<\\ 5[+10!Y186;7UMK'A_7]0N+.^EU:2X 6T+2RCS0\4D3X.0 %
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M-"Q>-?-<D;0-W(QQCD5[/6%XFT.ZUQ=,6VNXK?[%?17I\R(OO,9R%X(QGUH
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M!H!<[[2W>8"(\ASM!P, _7!]* -FBL&X\8Z+;S64/VB:62^@-Q:+!;22>>@
M.4*J0QPPX'/-9NL^/;.V\'7.N:6&F>&Y2T:&:"16CE,BHRNF-P(#9P>O'J*
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M% !1110 R5VCB9TB>5@,A$(!;V&2!^9KD?"%IK6A^#KJVFTDG48I;FXAA:=
MLQDE>15W G;]X DCCWKL:* .1\8V>KZOHNF0VNF,]RM[:W<Z+-'MC$<BNRY8
MC)X(&!@^U2WNF7<?C6Q\2PZ?)<J=.>RF@#1B6$EU=6&Y@IZ,IP?3&:ZFB@#
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M""/(^<;6R6'?[W05Z310!RUG9:@/B+>ZK)I\B64^G0VJ2EXR0Z/(YR Q./G
M^H_&J,>EZS:OXSMAIAFCU.5Y[6=)D <M D>P@D$$%223QCIGI7;T4 >?6FC:
M]I,WA758=-:YDL=*_LR^LA-&) ,1G?&2VP_-'T+#@BM2^M=3OO%WAK4TTF:*
MVM%N?M :6+,?F *O ;D\9.,]>,UUM% 'G7AV;4I9_&&GVFEF1)]7N56\>5!$
MC%$!#KG?QQT!SGM4K>'-:T[R=$MH9KS1H-(CM+5DN_(5)E#!FE (9MPVX W
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MYI%?=MQT^7'7--\8>';O5-3T35K*&&ZDTR27?:32&,31R*%;# '## (SP>:
M)[CQUI%II\MW<+=1""\%C<1F'+P2DJ &QD8.Y2""00>*R-=\6I=RZ'8BSU>W
MM=2N9XKE%MIH[C9'&YPNSYERP4\$':.PJ76/#EY>>'TM].T:SLKB34;>\F03
MCYA%(C9=MO+$)COT'-:.MZ=J=[XE\-ZC;VJ&#3WEEN TH#?/$R +ZX)R>E $
M\WB6QT^VN_*@O;NWTP!+N>)0_DD*&(;)W,0I!.T,>?6H=0\<:382VD2I>WCW
MMLUU:BSMVE\] %)V8ZG# _SJE::+J^CMXBLK:WBN[;5;F6[MYFE"^2\J@,L@
M/.T$9!7.0<8%16/A6^T?6?"JVJ)/8:-ITME)*\@5W+^7\P7T'EGOWXH OS^.
M]/AGO;=+#59Y[*&.>>.*U)*QN&(;D@'[I]_3-2VGC;2KV]TZ")+L0ZFN;*[>
M K#.=N[:">0=H)Y S@XS55-*U:+Q3XDU$6L36^H6<$%O^^&[=&) 2PQP#YGO
MTK/M?#.L0>'O!-HT,!N-#GC:Y42\,JP/&2AQSRP.#B@#H+OQ596-_;V]Q;7L
M<-Q<BTCNS#^Y,Q. F<YY/ .-N>]5+GQUIUO+J<:V.J3OICA;L0VI/E J'W<D
M9&T@\<^@-<_=^%_$E\!]L@M;FYM]:CO4NI+IF+P+-O5$0KB/" #'0D=\YK:L
MM%U1=1\7S301)'JY5K;$N2-L"Q8;CC)7/?B@#6D\26)BM39K+?S7=N+J""V
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M-LETUHVP2ABH0XYR2N!@$9('7BM/3?%%EJ4^HVYAN[6YT]5>X@N82KA&!*N
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MA9D"NCK@AD^7@C/4C%;OBKP])KGA.32K)XK6=#%);<?NU>)U=5('\.5 Z=*
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M19_VO_:A21KK9L!:9RBCIE4)VJ<<9 SCO5ZBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH BN;>.[M9K:7?Y<J%&V.4;!&#A@00?<'-1V%A;:99
MI:VJ,L29/S.SL23DDLQ)8DDDDDDU9HH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,_6=%L?$&FOI^I1O):N
M071)6CW8.1DJ0>H!_"KT:".-4!8A0 "S%B?J3R:=10 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 445EZSXBTS0$B;49W1IL^7'%"\KMC&2%0$X&1DXP,B@#4HJGI
M>JV.MZ;#J&FW,=S:3#*2IT.#@_0@C&#TJY0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4-3NK;3U6\DA,MS@PP1H,R2,V#L7Z[03V &3@ FK]8
MVM^%=&\12P2:K:-<- "(OW\B!<]>%8#G H 9X4T-]!T9H)F0W-Q<2W<XC^XL
MDKERJ_[(S@>N,]ZW*S=%T'3?#UK);:7;F"*23S&4R.^6P!G+$GH!6E0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
' %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ameh-nonqualifieddeferre003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW"GK5V@ HHK#\2:[/H0TQHK2.>.\U""RD+2E#'YCA0P&T[NIXR* -RBBCI0
M445R>M>,I+#3;W4+&P2ZM;2\BLWD><IN=I%C?: IR%9@#R,D,.W(!UE%1W#R
MQVTKP1"695)2,MM#G' SVSZU!I>I6^KZ;!?VI8PS+D!AAE(."K#L0001V(-
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M4TM?A5I=F]Y$=1L]6B66'S,RP?Z;\V\=5&WC)XY'K7M"0Q1NSQQ(K/\ >*J
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MP#NSTK0^&*/#\/=*MY8)+>:%722&1"C(=['&#[$4 =)/J=A:W"6]Q?6T,\F
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MN@8>4Q8;F^; )S@D9XR*@DT>WN?AQXZ6'26-V]]>2VZ_92)&!?,3(,9QW&*
M/5O[1L?M+VWVRW\]!EHO-7<HQGD9R.*?;7=M>1>;:W$4\><;XG##/ID5Q&OM
M<Z9XAT;Q+I=NT\FH0'2YUVGEF&^!V'8*X()[!_:NRTO3H=)TRWL8,^7"@7<>
MK'NQ]R<D^YH PO'/BC_A&O#=_=VEYIZZE! TT5O=')E [!0RG\:UFO;D:S:6
MJ_8S;R0.\NZ;$P88V[4QRO)R<\<5Y?J$DLWPP\1Z!?Z3>W'B(-<O*ILW?SF,
MA*2J^-I&TKCG(V@ =!75W<D,GQ)\-W<4,A3^S[I))Q"V 6,6Q6;'!.UL ^]
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M-+ZV:Z&<P"52XQU^7.:X>2%6^($IT>W:U\[PZ\,$PMFB192X9%/RC! P<'G
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M_-E2!ANA )K<T72M,N_B-XHGN=,1SYEJ]M++;G:66/YF1B,9#8R1Z<T ;?\
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M:H^%)?[8M3XFEMV@EU.*,QQR#YHX5'RJ?JS.W_ AZ5D^(+2S3XF:#>WNG>=
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M#+-;*-<L?]*;;"?.&'.2N >G)! ]<<4 ;M%9M]XAT?3+E+>^U*VMY7*J%DD
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M5MT6R0P$F;_1A'VR =W8GCOT->GT4 <3=V<QUGP-=PV$X@M/.28K P, : H
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MNC$\?WRO3Z^]+K.AZM<3>,4LK&8M+J-E?01E=J7:1+"9%#'C)*$8)Y->G44
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MN7)V$$YV]#[U>HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BH;J&2>W:.&YDMG;&)8U4LO/.
M-P(]N0:YOX>75U>>%/.O;J:ZF^VW:>9,VYBJSR*H_  "@#JJ*X_Q]+?VEE87
M5IJ=S;*VHV<#11;5#!YU5LG&[D'& 0*N>(M&^UW#ZE=Z]J6FV%K;986=T8AD
M$EF?@YXQC\: .DHK!\(Z?=6&A@WEU?3S7$C3@7LQDDB1ONH2>X4#/^T36]0
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MB6=W-&@CF9!DC ;<OMN S6/X">8>//'EN]S<S1075NL2SSO)L!1B0"Q) R:
M/0J*CN+B*UMI;B=Q'#$A=W;HJ@9)/X5YCX(\3:U'\0]2T;Q#+(%U>W35-,CD
M8_ND(YB /0@=0.Z,>] 'J5%<EJWCR#2_$LGA]-%U6\U!;,WB+;HA62,';P2_
M'.>N.G?(SG6/Q8TF_30[A-,U2.QUB<6L-W)$HC6<DJ(S\V>H/(!'OP< '?45
MQ^I_$&TLKK68K33+W4(]$17U&6WV!8@06P-S L0 20.F.N:FC\?:9<:QH>GV
MUM=S?VU;O<V=PJH(V14+D'+9!Z#!'4T =517%CXE::?#&KZ__9NI?9M)O'L[
MF/9'YBNNW<<;\8RP'7/M4FE?$.QU/Q%;Z+)IFIV4]W:_:[62YA 2= ,G;@DY
MZ\$#I],@'845Y7H'B3Q1XQ\,^)+2U%Q#J']I2VMK>&-8H[:(,B]0<EU7<V,$
MY/7TZWP[HFJV6MZC=W]_=R6BQQVEA;RW!D_=HHW2OS@N[ G)Y ^IH Z>BL[5
M=8@TI[.)T>6XO9O(MXD*@N^UF/+$ #"D]?ID\5R?B'4YCKWA"_\ LVI6[-?W
M$$EEOYDVPRX&U6*'+*"&)Z8)('0 [VBL'3?%4.HQZBITZ_M[S3Y%CGLI44R@
ML 4QL9E((/7=CKG%9^HZ_'J^C^)--:VO]-U"QLS*\<CA'"LC%'5XG((RIZ'L
M010!UU%>=6SS?:?AE+]IN,SVY69?.;;)BS9@67."<\Y(S7?7MT+*RFNC%)*(
MD+E(\;B!UQD@?K0!/17'V_Q"L[A=*D&CZND&K1[K&5HH\3/LW^7@.2K8SRP"
M\$YQS5RV\:Z?+87UQ<V]W93V5TMG-:3HOF^<^W8HVL5;=O7!!QSVH Z2BL2/
MQ- ;^\T^:RNX;ZU@6Y^SE5=I8V)4,FUB#\P((.,'VYJ"/Q?"9=4M[C3-0MKS
M3H%N9+:01EWB;.'0JY4CY6[@\4 =%17+6?CFTNY='+:9J5O::NJ_8[N:-!&[
MLF\(0'+*< \E<''!(YKHKVX^RV,]P$9S'&6"JN2<#TH GHKRR;Q#>ZMX5\$Z
MU=K>PW,NI6IF$6Y$G#HS$*BMAAD#&1_6NUTWQ3#?W&I6LVG7]E>:=&LLUM.B
ML[1L&*LGELP;.UA@'.1B@#>HK!MO%$<VKW&E7&FW]G>Q6WVM(YE1O.B!VDJ4
M9AD$@8.#R*K^ M?O/$?A*QU&_@DCN98@[N4"H^2?N<G@#'6@#IJ*PM4\3QZ9
MKEMI']FW]S=74,DT'D*A639MW+DN,'YARV![U5M/'6FW%M<F:VO+2]MKI+.2
MPG11-YSXV*,,5(8'(.[&,DD &@#IZ*PD\40_VG<Z9/8W<&H0VWVI;=MA,T6<
M%D(;:<'@@D$?0@US>K?$=IO VH:WHVF:A%MLUN+6YNK8>4Y8XQPW4=^WUH ]
M!HKF)=7BE\5:'!-'K%I-/%<&*$[%ADV@;O, ).1P5_WJ=<^-K"VTU]6-M=OH
M\<QBDOT"F-</L+XW;B@;() [9Y'- '2T5S4_C%$U34-,M=%U2]N[&..61(%B
MPZ/NPRLS@'[IX)!.> ><:^C:M:Z[H]IJEBS-;748DCWKA@#V([$=* +U%8]S
MXAC2\O;2SL;J_GLE5KE;?9\A8;@OS,,L1S@=B,XR*YG7/%=MJP\+QV$=W>:5
MK3S&86P*O(B1.=F<J0=P&1D'Y2.G! .^HID,:PP1Q("$10J@DD@ >IZUAP>*
MH9-:L],N--O[-[Z-Y+26X1 LVT L,!BRG!SA@#^/% &_16;X@4MX=U';)+&R
MVTCJ\4C1LI"D@AE((Y%>>Z=_:5SX7\'7&DW^K2ZW-]DFNVDN9I8FB90TIE#D
MH!@G&,'. * /5**P+OQ5#8ZC:VUUIM_%;W5U]CBO&1/*,N2 "-V\ D$!BN#Q
MS@@U OC2!]=N=(BTG59+BUGCAN'2%62(.NY7)#?=QCWYZ=: .FHKSA?&,U_X
M#U;4-4BU:VBBNYHS<Z>J1ND:3E%VEFZ_* WU-=C?:ZEM>R6%I9W&H7T<2S26
M]N4!1&)"EF=E49*M@9SP>W- &M17+6.N0WOBD!8M8CN)-(2Z6RE,:PE"W!V[
MN)<G:<D#C\:J_P#"R+(:)%K;:-JZZ279)KLQ1[;?#E"67?N(!&25# >N<@ '
M9T5@:YXJAT&WFNY].OYK"WVFXNX40I$IQ\V"P9@ 025!Q^!IEWXM2WUNXT>#
M2-2O+Z&V6Z"0+'MDC9BH(9G '*G@X/'&: .BHKB-3\<F32O#>HZ/!</#JFHK
M;R(T'[Q5 ?>F"<!]R8Z]C]:U&N)-';6/$NL74T=B(4,-KN)$,:KDDKT\QF)S
M[!1GK0!T=%4+#49;R>:*73[FU,:HZM*499 V?NE&/(V\CW'7-<M\0IGM;OPN
MZ75_#'/JR6\ZV<TJF2,QR,5VQG)Y4=!GB@#N**X3PKJ+1^(/$VV\OWT^W2*2
M"PO&DDN4PK%W59,R;&XV@]2#@#OLKXPM(KR_M=1LKS39;*S-^XN C!X!D,ZF
M-F'!'(.#TXH Z*BL!O%5O;V,M]?V5U9V:0+.LS['60,0 HV,WS$D#'?(QFK%
MIK\4^N-H\]I<6E[]G^U1I-L(DCW;2058C() (/J.M &O17)^.KN]LX-+DCBO
MWTO[9_Q,CIZL9A%L;&-GS;=^W=MYQ3/#6M:#<+J=UH>I7E]%$L?F6+F5Y87^
M;HDIW+NR..!\N?6@#KZ*Y2[U^/5K+7M)DM;_ $V_M+,S%)'".48-L='B<\94
MCKGC!I?#NJ7%MX$\..MC>ZC<S:9 Y6$KN.(TR6:1E7))[G)Y]#0!U5%<L_CW
M3$T32M66UOY+;4K@6L82(%XY=Q78R[LYRK#C/3Z5-9>+XKK5M/TV?2-3LKF^
MBEEB%TD:@"-MK X<G/(.!G@@T ='16?I.JKJ\$TR6MQ D<SP@S;/G*,58KM8
M\9!&?:K=S$L]M+&Q=592"8W*,/H001^% $M%>+:)JUQ+X0\(WBZMK$.ISW<7
MVJ]O)[C[*R;R&5BY\MBP^50.<XY'->FW7B:&)]06TL;N_&G<71M@GR-M#%1N
M8;F"D' ]1WXH W**Y@^.;"2YTZ"QL[Z_.I6C7=FUNB;947;D99AM(W#[V![T
MU?'=@='_ +1>QU! E\-/GA9$\RWF+J@#?-C&67E2>#0!U-%8\OB2TM]?GTB>
M*>*2&R:^:9E7RS$"%."#G.3TQV/M2Z3KO]K&!X]/NXK>YM_M$%PY0HZ_+Q\K
M$AOF!P1TSZ&@#7HKEO&VM7FG1:1IVGR^1=ZO?I9K<;03 A!9W /!;"X&>,GV
MJU-X3MFMU%O?ZI#=*0RW!U"9F)!S\P+X8'T(QSTH WZ*YZ\\7VMK;:A>165Y
M=66G2-'=W$"H1&4^_@%@S;>^ >A R013+CQE;)JD.G6>G7^H3W%E]NMS;"/9
M-%E1D,S@#[P^]C^60#I**Y&W^(6GW%K87JZ;J:6%Y<+:FZ>)%2"8OLV.-V[[
MWRD@%<]ZMW'BX1ZSJ&DV^B:G=WME''*R0B(!T?=AE9G _A/!(/H#S@ Z.BN;
ML/&VF:K:V+V,=S+<WK2JEFR!)4,1Q('!("[3@'GN,9S4+^/=/2*V8V.H%YK]
MM-:)8U9HKA03L;#>@R",C&.: .JHKF(_'%@MOJSWUG>Z?/I?EFXM[A4WXDXC
M*E692&((^]P1SBM--8E\NY,VE7T3P[-J81S-O.!L*L1UZY(QU/'- &I17(:A
MXU\O0?$LL-A=6NJ:-:M*UM<HK8)1FC?*,5*G:<\\8.<4R/7OM4WA0WJ:O:W%
MVY"B,(D4TGDLQ$@R3MP"1CN!0!V5%<[>>,+2UM+^^CL[RYL-/D:.ZN8%4K&4
M^^0"P9@O.< ]#C.#39O&5N-5.F6>F:A?W)LUO8OLPCV31,<!E9G '?KCIQGB
M@#I**SM"UNU\0Z/#J=FLJ12%E,<R[71E8JRL.Q#*1^%:- !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !112 A@"""
M#W% "T444 ,E,JQ,841Y /E5VV@GW(!Q^1KEO#&CZ]H'A*ZT]AIQU 27$UL_
MG.\1>21Y '^12 "P!QG//2NLHH Y;Q5H^M:YH^FVUNM@+B&ZMKJX:29T7=$Z
MN57",<$C )JWK.E:AK,^E02-;Q:;'*)[^(.S-*R<I&/E *;\$YQG:!CDUO=*
M* "BBB@ HHHH *X_XE^%M0\9>#9M%TV2VBFEEC8O<.RJJJ<_PJ<G@5V%% '%
M:YX>\0^+=*&BZHVGZ;IDA3[6;.=YY9D4@[%+(@0$@9/S5F>(?A_<'Q?I^NZ1
MIVD7]K#8#3Y=,U+A!&IRK(VUL$=.G0>]>D44 <!KOA#5[\>%?[.L]&LX]'O%
MO)+>*5HX\@G*(%CZ<_>P.>U5=8\":@?'UYXBMM+T/6+;4;>..YL]3)'E.@"A
MD;8W&!R,5Z310!PUWX5U=_&_AK6;6#2H;+2;:2!X$E=,^8NT[%$9 "]AGGVJ
M?3/#FL6GQ(UKQ#+]A%EJ$$<"*D[F1!&,!B"@!SZ9X]37944 >2:3\._%4&J>
M']1U.XTJ[O-,O9IKBZ::4S72/P"6*G& >%Z#'7FNJ\*^'-7T?Q;XFU6^%E]G
MU>6.6-8)W9XRBE<$% #D'.<\8[UV-% &!XNTW4M8T<:=I\=H\4\B"[%Q,T>Z
M$,"Z#:C?> *GT![URWBCX<SS:SH.K>$[;3;"]TV?S7DEE=!(G>,A4.0>F<]S
MQS7I%% '$3>'=??XE)XI2+3?)3238>0;I]Q8N9-V?*QC/'TY]JYVR^&_B&T\
M$>&-$,NEM<:)K*:@6\^0),@9VVY\O*G+XZ'IGVKUFB@#S>X\%:]97_C!=+^P
M3V?B6/[T\S(UK(R,KG 0[U^8D=.F/>DNO &L:7<>"[GP]<6,TGA^"2VD2^+(
MLHD0*S#:#@]3CZ5Z310!Y8OP^\2)X(\5: TVER3ZUJ,MVEQYTB*H<J3E=AP1
ML'&3][KQSL+X3UG_ (2[POK3&P\O2[!K2YC$SY)88W(=G/'.#CT]Z[NB@#CO
M OAO5_#$NMVU[)926-UJ,U[;/"S&0^80<." !C'8GK[<]C110!A>)M'_ +;M
MK>UFTRQU*S\PM-!=N5(X^5D.TX8'Z<$\USUIX-U>PFT#R);>2WT[4)[LQ37<
MCF*.1'18D8J2P4/G)Q7?44 <-J_A;7Y[WQ-/IMU:P_VF;1H29G1L18#HQ5<J
M'&X;@21GI38O">K17FOW,-KI%L-4TR.T2""5E6*1?,!)/E_,/WF=V >,8[UW
M=% '%0^&]:C;P82M@?[#0K<8N'_>9@,/R?N_?=SCT]ZZO48IY]-N8;98VFDB
M9$$C%5R1CD@'^56J* .$MO"NN0:5X+M"-/+:"Z&=OM#XD"PM%\O[O_:SSZ8]
MZBUKP)J&K3^(F$MDHO;ZUO[(R%G >%(UV2IMQM;8>A/!Z5Z!10!QEYX>U6[\
M.W\-CIVCZ)JDT:(DMG*WS@.&92ZQJRJ0". 2-V>U5XO"FK1:IJM]#9Z1;"_T
ME+);>"5P(Y TAR6\OYAAQ\V >,8[UW=% '%GPQJW_"-^$+(&R^U:)<6[S?OF
MV2+'$T9VG9G)W X(_&NPGC\ZWDB!QO0KGTR*DHH \^M_"OB./PQX7TN1-+\S
M1+N"1G6ZDQ+'$I48_=\,<].V.ISQ?UGPUK=UK&OWNF7L%JVHZ5'9P3>8PDAE
M0R'=@+T/F=0<C&<5V5% '%Z-X8U&T\5VVL2V>E6D0TU[.:&UE=V#EU8/N*#?
MG;SG!Y[UI>"=)U+0?"]GI&I"U+V2>3');R,PD4=&(*C:?;GZUT5% '#^)I-0
MC^)7AEM-@MIYOL-]NCN)FB4KN@SA@K<].WK3M3\$W-Z)=4CN(%UMM1M]14'/
MD@PKL6(G&=NTL"V,Y;..U=-/HMA<:O!JLL3M>VZE(I!,XV*<9  .,' SQS@5
MH4 <PVBW]YX@_M^XBMHKF&P>SMK<3%ER[!F9GV\?=   /<]\#.7PAJC_  D_
MX1.66S2^2S6V2579HF*XP3\H(SCT./>NXHH Y6YTK7+[Q-X=U>:'3XEL(YUN
M8TN78YE"CY"8QG&W/.,Y[5FP^#M4A\&7?@W?;-ILIDBBO?,/F+ [EB"FW!<!
MB <X/!]J[RB@#FM(T._T_P 8:MJ+K:BPN[:V@A5)6,BB'?R05 YW^O&.]3>"
M]'O?#_A.QTF_,#3VRLI:!RRL"Q(/*@CKTK?HH Y>#1M4T?Q-K&HZ>EM=6NJF
M.5HYIFC:&9$"=E;*D!?<$=\\9MGX+U#2'\)Q6+VLT&CR7$UPTLC1M*\RN&V@
M*P #2$\GIQ[UW5% $5U'++:31P2^5,\;*DF,[&(X./8UPFD>$-;MM1\-7UY#
MI0GTP2)=S1SR22W1:/9YI=D!))R=I_[Z]/0** *.LV]S=Z->6UHL33S0M&GF
MN44;AC)(!/?TJGX2TV\T7PIIFE7P@\^RMH[<M!(75]B@;N5!&<=,5M44 ><G
MP9X@F%JUT-*GNK36%OOMTDTAEN(A(SA#E/W>%(4*"PX[5T>BZ1J5CXJ\0:C<
MK:?9=2DA>(1S,SIY<83Y@4 YQG@\>]='10!Y[/X0\0/X&UKPVG]F_P"DW4TE
MM<-.XRDDS2G>OE\$9Q@$Y]1WUI-'URQ\73:]IL=C.E_:Q07MI/<-'L>,MM='
M"-D8<@@J/7VKK** .:BTG53X\77)DLUM3I@LW1)V9P^_>2 4 (SQU'K[5RW@
M_3=3\0?#HZ-<1VD.DW4ES&US',S3-&9WW+L*  GYANW'&0<=J],D021LC%@&
M!!VL5/X$<C\*IZ3I%CH=B++3H3#;!BPC\QF ).3C<3C))/U)H XKQ#X*UK6$
M\1V@_LR:"_B5;">ZD<M:*$5?+5-I"C()W YYY!K=LM'U6/QQ-K5PEFMK+IL5
MGLCG9G#([OG!0 CY\=>V?:NFHH \_B\(:[:^'-(M(CI\EYIFLOJ"JT[K',C/
M*=I;82I E]#TKL=5M[B[T::WC@M)YI$"M#<G]S(,C<K':>",CH>O2K])D @9
M&3T% '+>%O"HT#4[VYMH$T^RGBC1=.AN'EC5P6+2#< %)! PHQ\N>_$GBW1-
M2U>ZT&?3A:'^S=0%Y(MQ*T>\!&4*"$;^_P#I7344 <1J'A/6M2N=;UA;Z"PU
MF[TX:?9BW=F2! Q?)? 8L2>H4;1TS45OX5U>'69=4BL-$MS)I$ED;9)'=?-+
M;@78Q_.#@ D@'G^+OW9( ))P!W-+0!YI>?#$7MEJ5O91P:+!=6R*MG!,\T!G
M259%D*$!0!LVX Y#'I76:!ID]M+Y]WH6BZ?.(_+,E@V]GY&1DQJ0O&<9/;TK
M?HH S=4.L1S6LNEQ6TZ*6$\,\QBW C@JP5N0>W&<US6K>%=9U,:OJD$]M8ZQ
M>6T%I"L4K[%BCD+L&D"ALN&9<@?*,8SUKMZ* .%@\*ZM#JFK7T-GI%LM_I26
M:V\$K@1R!I#DMY?S##CYL \8QWI(/"^O06OAFWD73;NVTVP^QW5I+.XB9PJ*
MLP&SYR K?*P&-W![UW=% 'GMMX-URT\-Z%IB?V:TFFZN;]V$SHKIYCN%4;#@
M_O,8Z#'4YK8\;:=<WEGI=UI\T=OJ]K?Q-:NPW#+_ "2+[CRV<G_=]JZJJ1TF
MP.KC56MU:^$?E+*Q)VKST&< \GD#/)H S[EKO3)=$T?1H$,9<"XDF4L(K=%Y
M.01\[$J!GU8X.#6U,',$@C"F3:=H8X!..,G!Q3Z* /.;+P-K4W@#3_!NIMI\
M=E$8Q<W-O.\DDBI()-JJ44*20!G)QSP:W+/1=7T35=<?3EM+BTU6?[6OGRLC
M03%%5@0%.Y3M!&,$<CWKJJ* .(TCP9>:%JOAL6CV\NGZ1I\UF[R2,LLC2%"6
M"A2!RAXSW]JAO/!VL3:-X@M89+(37>LIJEFS2-M.UXF"2?+\O^KZC/7VKO:*
M .._L;Q)/XH?7)4TN$OI+V2P+.\@CD+[E))0;UX&>!^..3P_X/&D>(5U.TL;
M?1X#;O'/96=R\D4\C%2&VE55=N&P0,G=VQSV-% &#XL\-+XFTR&&.Z:TOK2X
M2[LKI5W>3,G0D=QR01Z&BSN/%91(KS3M($@P'N(KV0J?]H1F//\ P'=^-;U%
M '%P>&M7TZPU[1[0VDMEJ<\\T,\LC![?SLEU9-IW8))'(SG!QUJ6Q\+WVD^)
M=,N;,6SZ;I^C?V9&))F$K8*$,0$(_@QU[Y]JZ^B@#@(_!^M#P.-&=K 7::J+
MY6$SE&7[5YY4G9D'''0T^"75T^*>N_V?:V4RMI]D)Q/<M&4.9L%<(V[OP<=J
M[RL^#1;"VU>XU6*)UO;A0DLAF<[U&< @G&!DXXXR<4 <?=?#Z2UO-,U*Q2QU
M"ZMY;J2[@OUV1W)N'WNRD!MA# 8X/'!/>K^H>'-1N%T,V.G:18BRU,7\\,,K
M*K81DP"(QECNSD@=,<]:[ D#&2!GI2T <A?>'-2DU[7KV.WTV[M-3MK2#[/=
M.P#")GWJPV,,,KD \X('%9?_  @VI66G:E'H<D6G17,ML\>FB\E,.V-RT@WX
MS'Y@.TA1C"CKGCT.B@#@T\&:BW_"5J8M,LXM;TU+6..U+8@D"2+R-HW#]YG=
MP>.E69-#\073>%)9H=-C?2)C).J73L''DM%\I\L?WL\X]/>NSHH XJ#PQJ]A
MI&NZ#:M:26&HRW$D%S)(P> 3Y+JR;?FVEF(^89Z''6K.E>&;S2?%D%W"+?\
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MN(6.-#PN !DXR3G)K962T\+S6NC6$;S7&HS2R6UN\I"1JJ@O\QSM0<< 'E@
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M*65U:0VCZKM=FB9I4;[/#EEYVGC&,C@C//2@#:_X2[[7X=M-:TJP-S;7%O\
M: 9YU@"C^YDY^?J,=..M5U\=I=#P^;#2KFY&N6[SVQ+HFTJFXJV3QU&3^6>A
MC3P3+I^K:=+I5S;)86FG"P2&YA,C0X8GS(SD#>V0"2.PZ]*ATGP9J6F'PFIO
M;5X]!ADA;",#.'4+G_9P!GOGVH KZ_XUU ^!_$%S:64]AJ^FSK:RH&CD\ICL
M(<$\,I5QVSSTKNK2:6XMEEFM9+:0YS%(REEY[E21[]:Y'4O!5W?6GBNV6^A1
M=:FCGB8QDF%D2-0&&>0?+'3'6NMLQ="TC%ZT+7./WAA4JF?8$DT <O<_$"QA
MM)=12-)-,AO/LDLHG E!\SRRZQXY0,>N0< D C&<VQU*P\+^(/'NHW"^7:PW
M%HQ2-1DLT*  #@99F_,\UI:)X3OO#]S<6]G+ITNFR73W$1GMR9X [;F0$'##
M)."<$9[XJOJ/@6?6#XHCO+V*.+6G@EB:)"6MWA50AYX890$CCT]Z +DOCJRT
M^]NK;55BMQ!8M?B6"?ST:)2%8< $."5XP<YX--UWQ#KECH>K7(T5[<1:;/=6
M]PDZ2,CJHP)%("@C.[ + A3UI\_AF\UGP[?Z/K)TZ..[MS TEA R,6/1^3Q@
MC.WGZU+_ &/KNH>&K[1M8OK)_M%E):?:;>)@S%E*^803@<') SD]Q0!4M/%\
ML-GHEG=VZQ:G?VIE0WURD*2[%3<=R[OF8N,*!G )XQ74V4\MS8P3S6[6\LB!
MGA8@E"1R,CKBN9?PYJ-UI-C8:K!HFJ0PP>5)#/ P3<,!77.XYP#GIUZC%;7A
MW1U\/^'[+24F:9;6/8';//.>,DX S@#)P,4 <Q8>,KFTN_%MUK$%RNFZ9>;(
MW_=?NU$49" *V69F;(Z_> R.@VF\22V6M:;IVJZ?]E_M+<MM*DWF+YBKN,;\
M#:V <8R#@\^N9=^!YK]?$]C<WT7]F:W(+@;(CYT,NQ%!SG! ,8/2M :%?ZE?
M:1=:W-;,VENTR"V#8FE*% YS]T ,QVC/)'/'(!JZOJUMHNG/>W9;8&2-5099
MW=@JJH]2Q _&N/N&NY/BUH$EWID5HQL;S$L<PD\T#RL!N 05R?4?-P3S72^*
M=!_X2/0I+!+IK6<21SV]P%W>5+&X=6QW&1R/2LQ/#^N7/B/2-:U*^L7DLH9X
M)(((61&639E@22<_)WXZ#U) &1^/[&6'3[V.)'TR_NUM(9EG!E#,Q1&,>.$+
M#KG.""1UQCV/B&"WU+Q/KVN:9)MTJ^>WM[MO*+1)Y<2B%/FR"S/GTRW)]-CP
MQX4O_#,$6F12Z=/IMO(3!,]N?M"QEB0A(."1G ;Z<57E\"W%_HWB73+^]B6/
M6+PWJ20H=T$@$>T8/# &('MGI0!H#Q>$U2;39;-'NA9->PK;7*RK(BD!E)(7
M:PW#CH0>#4WA;Q)<^);2.].CSV5E/;13P32R*WF[P20 .1CCD]<TMGINLKIU
MQ#=?V2DSPF(/:P,@9CQN.3P.OR\_6K/A?2KC0O#.G:3<2QS/90);B2,$!PJ@
M X/0\4 8/C.[FD\2>']%?2WU'3[T7#W%MF/9-L0;00[#(!.[!XZ=2*NS^*_*
MT[4K_3]--UIVE220SLLH5V\K_6>6N,-MY')7)4X[9LZKHE[?>*=%U:">!(=.
M$P:)P=TGF*%/(Z8QGOGVJA%X5O[&VUO3+&[MQIVJS33!I%/F6K2_ZP*!PXR2
M1DC&>] !>^.'6^M;32=%N=4>\TXZA:M%*B+*@*?WCQPXZ_3O76;B(]Y4Y SM
M')^E<Q:^%IM.\2:7>V4L*V&GZ8=-C@<$N4)C.[=TR/+ Q6_J=I)?Z5>6<5P]
MM)/ \23I]Z,LI 8>XSF@#"M_%LC>(8]%NM,,-S<6SW%NJ7"2%MF,HX&-C?,/
M4=>>*SX/B#)-I%CK+Z#<Q:5<W(MI)VG0M$QE,0.SNN[&3G//0]:72_!^J6%Y
MH5VUSIN[2[6:W\F"!HTDWA!O)R3G*9/U_&DC\$WZ_#Z/PV]];F>*Z2=+@1G:
M0MP)L%<_AU]Z -1?%)&K:YI\]FMNVE6ZW)>2;Y9HV#$,/EX'RL">Q&.>M;6G
M7$]WIUO<W-JUK-*@=H&;<8\\X)]?7WKF=:T9-5\8Z+<17"I*D$B:A&G(EMPR
ML$/_ &U"CGJ"_O77T >:6EEI;>.?&L5[I\EU!&;,0PPPLY0O"6;8%^X2>=W'
M/>H]'TK4=,USP!'K3F755M[Y9I'?>^W:"BL_\156QGUSZUU>C:#?Z?XLUS6)
M[BV>+5/)_=(K!HO*38.3USU[5+JFB7E]XKT75HIX$@TX3!HF!+2>8H4X/;&,
M^_M0!!>^+6TW6["RO-.:*WOKHVD,OGJ9-_S;6,?4(VWA@3U&0,U4G\;WB_VV
M;;P[<3C1I=MSFXC7*B,2$KUR=K#C]:I6_@758;>RA?4;*3['JO\ : F^SL);
MGYG;$K9//SXR/0?2M6U\,WT9\4>==6Y&MLSIL4_N285B /KPH/:@#H;"]BU+
M3K:^@SY-S$DT>X8.U@",_@:X6\EF\ ^*FD@CGN='UT^7#;;BWDWX'RJI/W5D
M QZ KV%=CH-A-I7A_3].GD222TMXX"Z @-L4*#@],XK-\5:#?:[+HYM;BWA7
M3[^.^/FJS&0H&&WCH#NZ_I0!"E]%X7%CID\RW.KZH\L[O++Y:,X ,C$G.U!E
M54 $_='J:FT[Q4=5TZZEM+$O=6MX]E/%YR^6CJNXL9/[A!4@XS\P&*9XC\,S
MZMJ>DZO9S6R:AIWF*([F(R0S1R !U;'(^Z"".F.AJ+5_#FJ:G;Z6RSZ='+97
M9N'MC QMY1L*@,,Y)4G<#Z@<4 5F^(4*>%-0ULZ9,YTZ[-G=012JX5\J,JP^
M\OSJ>!GGI72Z3>WE]!,][IDNGNDQ1(Y)%<NF 0V5) SGIDXQ7)W7@?4YO#^O
M:6-1M=VJZ@MYYQA($>/+RNT'_IF,<]#WQSW$7F>4OFA1)CYMAXS[4 8DOB&:
M:ZU.#2=/%\VFD)<9F\O=(5#^6G!W,%(ZX&6 SUQF/X_AGBT*32M+NM036HI'
MM=KHGS(A8HVX\$8P3T'/7H;D&@:AI.MZM>:3/;&#576:2*X#?N)@H0NN/O @
M+E3CD=>:I6W@J72Y_"Z:;<Q?9=#24%9@2\YD4JQR.!R2WXXXH ZJTDDN]/@E
MN;8P231*TENY#&,D<J3T..E>6:=IMM=:'XQMX["YN-1.L7L%@UNK!X2 OEA9
M!Q$H)SR0.O6O6FSM.W&['&>F:YWPIH-]H+:O]JN+>9;_ %"6^'E*RE"^,KSU
M QU_2@"A!XHFTO3Y--F,5_J>CV4)U)WN!%YDACW$)D'<Q SS@?,.>N"?QXTE
MQ9P:3H=WJ+WVF_VE:[)4C\Q/DX.3\I^<=>_'.:EE\*WEKXKU#6=-DL)(]2$9
MN8+V$MLD1=H=&![J!E3Z=15MM"OSXRL];^T6OE06#V31!&4MN9&+#DXY3 '/
M7K0!AIJJS>.]=FUC36:RT6&&6&YE\LK9CRG=W W;LMTR!G  .*UW\7-;+I%S
M?:<UO8:M+'#!,)0SQO(,QB1,?+NZ9!;!(!]:8/"DUSJOB:2^FADL-=@2W>*,
M$/&JQLG7H20V?;WID7A:_N=-T?2]6NK>:UTJ>*998E(>Y,7^KW \)R 3@G..
MV: 'V?B^\U#6;S3[7P]=.+*Z-M<S&>,*A\L.IZ\YR!@=,\XJA#\1)9=.T[5&
M\/7:Z?>W1LUD$\9=9?,:-1LSR"RXSD8)].:V-#T74-)U#7;J2:VE&I7/VI%4
M,/+;RT0*3W&$!S^E8L7@G5(O"FEZ*+ZT+V.I+?>=Y;8<+,9@N,\<G&<]J -K
M3/$TUY?:MI]WI,UM?Z=&DQ@219?.C<-M*'CDE&&#CGO45GXLDGUZ\T6?3ME]
M#:_:XUAN4E61-VT@GC:P)'!]>IJKK/A"_P!3OM?G@U);7^UM-CL@R*=\+(7.
MX'/(/F$8XI;#PQJEGKL&K&;35:/36L1;6\#1Q)EPP9>2>J_YQR 0V7C^2[L=
M$U-]#N(=+U:6.".X:9"T<DAPF4'.TG SGOTQS6I+XDN9VO#H^EG4(K&<V]PW
MG>62ZXW"-<'>5SSG;R,#-94'@J^A\$Z)H7VZW,^E75O.LWEG;*(G#@$9R"<8
M[U<TSP_J^AZMJ3Z=>6;Z=J-TUX\5Q&Q>"5\>9M(.&4D9P<8S0!%<_$"Q@M)=
M12))-,@O/LDLHG ESY@C+K'CE QZY!P"0",9Z^N0T3PG?>'[FXM[.73I=-DN
MGN8C/;DSP;VW,@(.&&2<$X(SWQ77T %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% "$@ DD #J348N8&8*)HRQZ ,,FI&4,I5@"I&"
M"."*\BTK0(=5\(>*]-M-"AN+JYUG4(8)RL:+;MYA",6)W#;P1M!/'% 'KU%<
M*WC'^S+:_P!.AN+2YNM"@CBG-W<>7)>2B(,P0<G)!')SECC'&:FN/&&L3ZO#
MIVD:'#.]QI:ZC"UQ=&(A2R@JZ[/E;D\9/.,XYH [3-%<,/$EEH=YXSO[C2D@
MEL9K?SG@F+M=L\:B/J %/S(N.GN:U+CQ'=Z3KNF6&KVUND.IB18IX)"1%*B[
MRC @9!4'##TZ"@#H)[F"U3?<3QPH3C=(X49_&I:\Q\::K=^(? $&JV]C:_V5
M<7-I)$\LA\]4-Q'M<+MQSQQGHW7M7IU !1110 4444 4Y=)TZ;4(]0EL;=[V
M(8CN&C!D0>@;J*N444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!4O]+T_58TCU"RM[I$8.BSQAPK#H0#WJTJA%"J % P
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS2,BLAE,9 V[L\;#G'X9H H^$_'%I9>%;-M<N[V61KJ>"6^DMW>)#]H=4#R
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M*2=K*22",@XQ]* (M)\1R#P9XIO[K6M0M8[?4YXH;R6T:66V10F 8RO&.>H
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M<()(I "-RGV/(^AK/?Q5I<6IV]C(UQ&UQ,UO#,]NXB>5<Y0.1C/RM]<'%5O
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MX]R<@;06[G/MQSW% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 44R:)9X7B<N%<8)1RC?@001]17G'@SQHFG>!_#[:K;ZI)#,%A
MDU210\0E9R!O8MOY) W;2,GK0!Z517.Q^,+1X-<D-E>QG1F*W4;B,,?E#Y4;
M^05((/&>W/%;UO*T]O'*T,D+.H8QR8W+['!(S^- $E%<E%K\]_XVUGP_)!<?
M8X+:#9)"C(59_,W$N""!\HP1[UC>"/&"VO@[PS'J5OJ<@O0EO_:4BAHVG=B
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MUK?VC^9;7,2S1/C&Y& (/Y&LW7/$::%#//)INH74%M%Y]Q+;(A6).<D[F!;
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M9X(YX[BXAV)('SPIR<D8Y_K0!O450U'5[?39;2!P\MS=R&.W@C WR$*6;&2
M  "220/Q(%<?XJUR/5-#62TDO;.[L-;L[6YA,IC92TT>58(VUE9'!')&#ZT
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M(\,L<J[7BD0X9&'8@TM_J\%C<PV:QRW-[.C/%:P[=[*N-S98A0!D<DCD@=:
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MZ[M<1K*CS>65=6ST*,W(QR#ZBGZIJMMI%O'+<%B9I5@AC09:61CA54>I]\
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M3R .N$.6R/Q]*A\/7Q'CO5+>VO[X:7'8(_V+47E,QEWG=)&LO[SR]N!Z%NE
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MDE1C'&"Q]^:U**\IN[T1:]XXM[B\\0.+,P_8EM)[EA"6@#'E3M4;CGY^!]*
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MH*E&(!(!5F&<'!Q7044 <M+H=_>Z]/KTL,$5RNFO86UOYQ(^=@S,[!>.0H
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M;B0054ALGD=,' I:MX(GU32]=07L,6H:U)"9YO*+)&D0 1%7()QCJ3R6)P.
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M'&8T\A&*@J<Y.XL#VR.1BFP^!-3BM;:V.K6K):ZL-220VI\V<[V?$K;N3\V
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MLTBLT8(62,AP5.#C!R.E5-)\*W^E6FBZ++.+RRM;V:^FN-NPM\S.BL,\GS)
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MIEAX7U'1=5U)]-O+(V-_=->&.ZMF>2"1\;]K!AE21G!QC/>L^V357^*GB/\
MLVYLXD%E8B9;B%G)_P!=@KAAC'/!ZY'(QR 6K+XAV-_!81I +?4+IIU>VO)A
M$(&A;;('?!_B( P#G/;G#$^(2RP630:5)/)/J;Z5(L4ZD).H9N&.-RD+D'C@
M\XIT_@3[)=:9J&C7<<=]9&?S3>1>8EV)FWR;\$8.[Y@1TZ8Q5W5?#^J:HVB2
M/>V4;Z=?"\94MV"N0CH$'S<<.>?4=!0!%#XU2W36UUJP:PGTA8GF2.43+(LF
M?+*' R201@@<UE:LU[-\3/!TUYI4%M\UT(YTG$CD>0WR.-HP1G/!8=>:T-8\
M#G6;SQ"TM]Y=OJ]M;Q )'\\#PEF1P<X/S-G&!TZT[_A&]?N]7T+5-2U>REGT
MMY24@M&1)@\90DY<D-SGCCVH BF^(E@EK_:$:0R::+P6C.+D";/F^5O$6.5W
M^X..<43^-[]8=<EM_#KS+HLS)=9NU7<JQK(2G!R=K=#CZU/H/A?4?#CR6=E>
M63Z4;EYX5FMF,T(=R[1A@P!&2<$C(ST-.MO"MY';^*(IKZ!AKCR2*4B(\DM$
ML7][YAA0>U %6Z\2W\WC/P]!IUO/+IU[ILUVR9C7?S%M8Y.1M#G(_P!KOBI?
M'FIW5LFAZ5:7$EJ=8U*.TEN(SM>.+!9MI[,0N >V21S3H/"NHVM[X<NX=1MO
M-TJR>QF#V[%9HV\OYEPPVM^['7(YK4\3>'+7Q/I0LKB26"2*5;BVN83B2"93
ME77W'\B: (9O!>@26ZI%IL%O,A#)<Q)MF!!SGS/O$^N3SWJO<^+9?L.JZCI^
MF_;+'2Y9(IV\_9(YC_UGEKM(;;R.2N2#[$V;.W\51HD-WJ.E2A< W*6CJ[CU
MV;\ _CCV[50C\*7UE#K6GV%["NG:K-+.?,C)DMFE'[S;SA@3DC.,$]QQ0 H\
M9RWFK0V&D:2;S[3IJZC;3M<".-XV( SP2O7T/;CJ1EZIXTO[OP_HE]IMG<6\
M\^M1V-U!NC)4I*4DCW$XY*D CMZ5LZ=X4?2_$UI?VMQ$NGVNEKID5L4)<(I#
M!MV>O&.E9[>"+]='-K!J5N)XM:;5[=W@)7)E:38X#9(^8C((H MWOB[4;?73
MHUMX<GN;P627FT7** A?:03TR"#TSGC'J)->\7/X?NHC=:>GV)[F.W,ANE$W
MSL%#K%CYD#, >0>IQ4\.A:@OC/\ MZ6\MF0V"V3PK"RDX<N7!W'')/'/'>L2
M[\":E<P:Q;+JUJ(;[4DU!9&M2TN5E201NV[E1LVC !QCTP0#:NO$=W))J4>B
M:8NHMIK^7<A[CRLOL#E(_E;<P#+UP,D#/7&3:^*[NT\2^+FU.*9=(TL1-O)C
MQ @@WMP#EMQ.1U/(''2K]MX=U;2=>U*]TK4+1;74Y%GN+>Y@9_*F"A6="K#(
M(494]QUIESX.DO=2\1BXO(GTO7852>$1$2QL(A'E7W8Q@ \J>: )Y/%4UE<:
M1_:>F_9K7595@@E2?>T<K*61)%VC;D C(+#/'O4>D>*[[6-8N+.+0)D@M+V2
MSNKIKA-L96,."!U;)(''3(Y[!8_#5]>0Z-;ZS>03Q:3,DZ/#&5:XD12J,P)(
M7&<D#.2!R!P;/AO0[S1;C5Y+BZ@G74+Y[P".,J8RRJNWDG(PG7CK0!E>(KN7
M4O'NC>%VFDAL);6:^NA&Y0W&TA5CW#G;DDD#K@#IFM@^%]"L[JVU"VL;:PDM
M&,ADMHQ%N7:00^W&5YSSW J/Q)X8&MW%AJ%I>/8:OISLUK=J@< ,,,CJ<;D8
M=1D'T(J:WMM>N%\G59],-NRE95MX),R@C! W-\O_ (]_6@#,E\;^1HMEX@ET
MXKH=W)&HN!-^]C21@J2-'MP%)*]&) (XZ@1WWC2_M[O7K>U\/O<'1E22=C=J
M@=&0OE>#EL#H<?4=VP>"[K_A&;;PM>7L4^CVTD>UPA$TD,;ATC;G QM4%AU
MZ G(L/X7U WOBBX%]; :W$D2*86_<;8_+!/S?-P2>W- "V7C&2ZU71X)=)E@
MLM9B:2QN3,K,Q$?F8=!]S*Y(Y/3G%5AXTU6>SU6XL_#+3C2[J6WN%^V*I;8
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MA"JML4*"1DD=!WKF(/ ^IV_AW1=*&J6K'3-2^W^:;=OWN'9PF-W'+D9R>@H
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M-RK/')(<)E,?=)P,YSSTK4?0KV]U:VU>_EM?MMG;2P6J1*QC5I-N]SDY.0H
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M6X0212 $!E/0\U9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M  ]LM(O-(N!J%[<_V7Y[QK,5/F33%C)*Y Y;#8'H*POAH!_PGWQ&Q_T$H_\
MV>O3:Y2W\ :=9ZCJ5_9ZAJMM/J4OFW1AN=OF-S[<=3TQ0!P^FQS6'Q1^(C:)
MY,=E'IZ2RJT>^'[3L5L%01DD>9GGJ35J'QEK%I\.O">I16<B6MX'^WSZ99"0
MVJ#.W9%]T G R00 /4BN_M_"NE6.AW.D6,3VL%UN,\D;DRR%OO,SMDLQZ$G)
MJE9^"+/3-.T^STW4M2LUT\2);O'(C,J/C<AW(01E0>1D'O0!B0^,#J7A32Y+
M#Q/;?:[Z6:.*==/>6:;8QP%@&"& V[CC Y[$&N/U[Q%J'BKX-:%JFH)"+]M:
MAB8JI5&9)64'';..?QKT0_#?0!_9!A^VV\NER2R0RP7+)(YE.9-[#D[N^,>@
MP*C;X9Z"?"Z>'=]\NGQW/VJ(+/AXY.3D-C/5B?K0!4TG6_$MC\37\,:S<VFH
M6MQIYOH)[>V,)AP^TJ1N/'N23T]ZXOP?XJF\+_";P^EI&#<:EK,EDKF,R>4&
ME?+!!RS8' [D_A7K&G>&[73A/*MS=SW\\8BDU"X</.5&< '& !G. ,9YQFL8
M?#'P\/"W_".D7;6"3_:8"9OWD$N2=Z,!D')/7/6@#"NO'?B'PYX;UZ^U;3WF
M%M=10Z9<W$!M_M"R'&77J-IZX S[=:@-GJEO\<])34-42\E?1IS%*ML(O+^;
MI@$Y&>1_6NRF\%:??>'+O0]5N]0U2VN@ [WEQO<8Y4J0  01G('/?-5]+^'N
MDZ5JMCJD5WJ<U_9PF!)[FZ,K-&3]UMW;M@8Q]>: )-(\":5H]SI,T32RG2X)
M8[<2$']Y*<R3,<<NW3T )K1\37]_IN@S7>FVDEU<(\8,<2;W"%P'95R-S!2Q
M [D5KU4U&P74;983/- RR+(DL) 964Y'4$'Z$&@#SG7==36_"LGV;4?MDEOK
M>GJL=S;-;S0DS1$+*I4=\\@=/7%=%!K.K:;XJOM*U6^LI[==,.HQ7!A\@0[7
M*LK?,<KT.>HYZU=O/!MA?Q2+<W-V\LMQ%<RS[D#R/$08\X7 "X&  !USG)J;
M4O"NG:M>RW5XT[O-8/ITRAP%EA;E@1C@YYR,=* ,;2/$>I2^+[/3IKA;NPO[
M"6YCE-FUN4=&0';N.60B3N/3DUS5J!_PJ[P[[>(XL?\ @Q:NXM/!UG97=G>1
MWVH/=V=N]M%/+,';RVV\$$8XVKCCMSGFHE\#:<FB6VD+=WPM+:Z%W$-ZY$@?
MS <[<G#DMCW].* -O5AG1KX'_GWD_P#037GFAZCX@T/P9X*OEN;2?3[B.QLY
M+(6Y#JDBJBNLF[E@2"1C&,^F3Z5/;K<6DEM(S%9(S&Q'!((P?QK&TCPE8:/%
M:PQSWES;V>/L<-U+YBVV!@;>,\ X!;) Z8H YS3?%^L:YI=EK.F6T\HGO?+:
MR^R-Y?V?S2A;S2,;PHW=<<$8[UU/BC7!X<\.7>J^4)6A"JB%MH+.X1<GL,L,
MGTJ'3_"=GI5U(]A=WUO:R3&=K))OW(<G<2!C<H)Y*@A>>E:>J:99ZSI=SINH
M0B:TN4,<L9.,@^XY!]Z ..U6VU&'XC>#WO-0BN8V>[Q&MOY>QO(.<')^7V.3
M[U%9^+]8UG2TU?2K:>5C?-$MB+5MCP+,8V)E(P'V@OG.!C;@]:W;?P78P7FF
MWC7^I7%WIS-]GFN+CS&567:5Y&""/;/OP,367A.STV]GGL+N^MK>><W$EG%-
MB$R$Y) QE<GDA2 ?2@#G])_M<^+/'#QWMGY<<\0"26K/_P NR%>?,' !Y&.3
MD\9Q45GXCUN;1_ AM'T^ :U&%G7[,=L9^SM)E &  &W[OZBNH@\,V]M=:K<Q
M7EX)=4(-R<H<D*%!'R\84 ?_ %^:K0>"["VAT6**[O1'HQS9#>AV?*4Y^7YO
ME)'/KZ\T <_<^,]6T%-:LK]H+V[L[ZTM;:X2 H&%QMP70$Y*Y;H1NP!QFK6H
M>*]5T&/5+J>UGO--AMHGM[BX@-NWGO)Y?EMP,K\RMN X&>M;5]X-TG4IM6DN
MUFD75!%]HC\S W1@!'4CE6&.H-2GPQ:W.DW6F:G=7FIVUS'Y4BWDH/R^VT+S
M_M?>]Z .>U6VU&'XC^#WO-0BN8V:[Q&MOY>QO(.<')^7V.3[UUVL7RZ;I%S=
MM<06XC3/FS@E%).!D#D\GH.2>*R;?P7907FFWC7^I7%WIS-]GFN+CS&567:5
M.1@@CVS[\#&IK>C6GB#2)],OA)Y$VTDQN592K!E8'L0P!_"@#D8O$WB"&]\0
M6$,)U*>UTZ.^L=]J8)'+%UV%"03RF1]TGI[UJ^%/$46LWM[;C4)Y9(8XV:UO
M+-K:X@)W9W*5 *G"X(ST/)J;_A#;+[5/=_;=0-U/;QP2SF8%F".75N1P0Q/3
M ]JTK+2(K.]EOGGFNKV6-8FN)]N[8I)"@*  ,L3P.<\]!0!G^(-1N8[N/3[#
M44M[MX&E6-+1KB0X( ) X5,\$G&3T(J?PCK,WB'PCI>K7,:1SW5NLDB)]T-W
MQGMFEOO#-E?:Y'J[37<-TL'V9_(F*++%NW!6 ]"2>,'FK.B:/;:!H]OI=FTI
MMK==D0D()5?3( S0!A6.IZOXD%_<Z7>P6<=EJ$EHL+P[_-$3!7+G.1G!QC&.
M.M4'\3:O>^#=5\5:?-#&ED]RT5E)&"LD4#LK!V^\&8(Q&" ,C@XYWH?"EI::
MO=:A8W=]9_:Y?.N;>"4"*:3C+%2"5)P,E2,]Z:W@_3B+Z%);F.POY&ENK%7'
MDRLWWCTW -W 8 \\<G(!CV^MZ]K?B6;3[&]M;*T?2K?4(9&M"\D?FLXVD%\'
M[O7CZ=PS1_&6H:II_ARUD6WBU+56NDEF52406[%795)Y)(7 )XR3SC!Z6#0+
M:W\0RZTDT_VF6!;=DROE^6I)50,<8+$]<\UFGP%I/]FVMDDM[%]BN'N;2>.;
M;+;NY)?:P'0EFR#D<_2@#%TA-1M/%/COS+R"XNDM[1DEDM\*1Y<A 9 PSQQP
M1]*ISW6I:M8_#.ZAFL[:2Z99F7[,3&KFTD;A0Z_*.0!].>,'KK;PC96EQJ-Q
M!=7JS:E$D5T[2!S)M! ;+ X."1QQSTX&&'P7IQTK2-/6XO8UTAPUG+'*%DC
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M>$H;2;_3XC'$L4+E8\MS(TF, J3O^8Y)'<FNEMK:*SM8;:!=L4*"-%]% P*
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MGUQVH U'E2/.YN0I?:HRQ ] .3^%4]'UBRUW3EO]/D:2W9WC#-&R'<C%6&&
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MSY:8S_UT6LWQ#KNO>#M4CN)[[^U;*XLKR=[8VZQ^0\,?F H5YV'[OS$D9'-
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M8#<" 3D9%:%<!!9:E?>/_%\>G:LVFL([(^;' DK%O+?'#@C;ZC&3ZCO2\/\
MC76O$$]AITT-Q%.=,^USRV"1;G?SGB#+YO 0A-W0_>'0#D ],JIJ>I6ND:;<
M:A>LZ6UNADE9(VD*J.2<*"<#Z55\-RZO-H%LVNP+#J0W+*JE<'#$*WRD@$J
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M MF9?E4Y4.V >X&&XZ4 >AT5QTEYJMEX@T[PQ+J\DCWJ7%R+]HHQ,(X]@5
MH3=ER2=IX7IDY!%>ZM%XHM/"T^JR.YLY[Y[[RHQ+(HE"1H!MV @-EB%[#&*
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M23UK6C<2Q)(H8!E# ,"",^H/2G4 8DGA32WU6?48_M=O<7.W[1]FNI(EG(&
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M;8>5'%(+3S_M"V9E8P+)NW;@G0?-\V.F><9K<HH R[;P]IUIJ.HW\23?:-1
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M*^MX[BVF7;)%*NY6'N* .+U;3GD^(?AZR;4;S/\ 9E]OG#JLKCS(>-R@8^H
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MF6\;661;%5QY.>NS^[GVI+R!=)>?4-+T7[7?7<BB?R72,OQ@.Y8@$# '<XZ
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MVL]#TNP2Y2UL88DN26G55XE)ZEAW)[D]:K6WA/0+-81;:3:P^1N\HQIM*;@
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M#>BW5Y<WD^F6SW-U&(IY2@W2*.,,>_ Q]..E/.@Z4;2TM#80>19N'MH]O$+
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MHSOHCF>8>'9Y!&)VE4R>;&5 R3@GC('L>],\)?VAKND>&=:34+:*YW*U]/\
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M(.:SX=?FL?#5]/'J-PU@?%9M+B[>=G:&T+J#B1B2%Z+NSP&R#WH ] \1:\=
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MS00E0(H\X#2,Q 4$Y ZDX. <&L?P>IL?$?BK1XIYWLK.Y@:WCFF:4Q"2%68
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M2WM@TB,80/+CE0.&>,E1P'4%20.];A=%(!902< $TGFQF4Q>8OF 9*9YQ]*
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MP#HK %\X1\#N*V+6Z^V?$U-6CTR_CL9-%:$7,MC(F]Q*&VD%<@X!P& SV[9
M.FC\2:%-<P6T6M:<\\^3#&MTA:3!(.T9R<$$<>A]*6+7M,O;"ZN=.U33[A;?
M*O(MRK1QMV#D$XKS)=,+?#:SM7T.\-TNO_:'A.GR;]GVPN7(VYQY1Z^G'M73
MS0FV\>:Y<BPN?LMWHD #QVCLLDBO+\O"_>"E>.N,4 =%9:Y:KIEA)J>IZ6EU
M<0"0^3<CRI,+EFC+'++@$Y]!4=WXALY_#MUJ6CZKI$P166*XFNA]G$@[.ZGC
M^=<+IUG*=,^&<-SI-Z6L.+M7L9#Y!%LZ#=\O'SE?YU+K]A<(GQ)MH=,O&^WV
ML?V416CLL\AM]IVD+@G=C- 'H-QK&GV$$3ZAJ%G;ETWY>8*I'&2">W/6J;^*
M+!/$ZZ&\B+(;,78F:10I!?:%'/)."?IBN5UB&Y>[CO\ 2[W4M.U$:5'$8Y-,
M:>"Z4%R(RI7(8'.<$'##C%365O+;>/["\U/1VBDN="@C9[>U:6*.X5V+KN4$
M+@$8)/('6@#KX-=TBZG2"WU6QFF=698X[A&9@OWB #V[^E+9:WI6I-,MCJ=G
M=&#_ %H@G5_+_P![!X_&N#T2T:Q\(^*+VW\.-/JHO-0F@@N;-D:=)'<H!N +
M*5Q\H^G>K&D)->_$&TU":#49[6?1);=Y[K3S!&7\V-MFTH"HP&QO_ F@#8L_
M&4.L^'=.U33;C3K9[N:,&&_N I"%\$#;_&1T'J:W[W5]-TT@7VH6MJ2-W[Z9
M4X]>3T]Z\ML[62+X6:#8+HVH)J%G?V?VF(:?*'!CG5G;[OS *"=PR/>NHL)'
MTOQ7XF.K6MS+;ZD89K25;9Y%DB$00Q8 .""&^4XSNSZT =1<ZSI=FP6ZU*S@
M8QF4"6=5)0#);D],<YJAJ.NO/H4=WX:>UU*>YF2&W=&\V');YF8H>BKN)Y[8
MZFN(T30[S2[SX?V>HV%Q+)8P7?G/Y#2I;;\>4C. 5! ^7KQMKI_"-M)9:[XL
MB:TFMXIM4^T0EH61)%,,0+*<8/S!LX[T =!=:QIMA,L%YJ%K!,V,)+*JDY.!
MP3W/ JW)(D4;22.J(@+,S'  '4DUYYXCMM1AUG6;K0;J[%[,8EDTVZL#-;7Q
M$:@%7P-@P=I(; *DFM[Q[9W][X8 L87N&ANK>XFMH^6GB256= .^0.G?&.]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ IL@9HV"-L<@A6QG!]<4ZB@#/TG3IK"*1K
MN\-Y>3,&FN#&$W8&  H^Z !T]23WK0HHH **** "BBB@ HHHH **** "L3Q!
MH4^MSZ5)%>I;#3[Q;P!H2^]E5E /S# PY_2MNB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8\ #T R2>P!K!U3XBZ+I.B7&LRQ7DVFP7;6CW$,:LN]2 2,L"5W97([J?8D
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M +5%,BE2>%)8SN1U#*<8R#R*S=9\06>ARZ?#<K-)-J%RMK;Q0IN9G()R>>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<W!E>%63'WWR>"K,.<#><@XK:,MW;_&33M'&JW\UA)H32M$]P<,X;9OXQ\Q
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+Y*@8.[[V,=ZSOB5?^+K;P)?+?\ V*!OMMM''/8321[XV89!SDGG@]!CGVH
M]2DO;6*[AM)+F%+F8,T4+2 /(!U*KU..^*GKS^_U"XB^)_A*TU/1]+:]N;>Y
M*W<3N[P;4)94)"\'CDCH3TS6;=?$G67\.:YXIT^SL&TG2;\VIMI0_G3HK*K.
M'#;4^]D#:>AYH ]2HKSVY\:>(;OQD- T2PTQUGT<:I;S74KKA68* P ^O ]1
MSQ6YX!\42^,?!UGK4]LMM/*722-#E0RL5)&>QQF@#HY98X(FEFD2.-1EG=@
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MGS/*QY@^_P#W>O7D<=>:L5Q.B?#FSTF\T:>2Y^TC2TFD7='@S74Q'F3MSZ#
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M233K>"]T8:E"]U [-&2R#:V&YSN]!C/?&#VEY=)96-Q=R@F."-I& ZX49/\
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M'M(IM,GDU75;B?3)"]K+/.KE 4*%?NX(P3R1N]^*ZB@ HHHH **** "BBB@
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M-=7MO9I(XRL7FR!"Y'? )/UQ5&:_U72O&VGZ.;YKRTU2TG>-YXDWV\L6WGY
MH*$..#SD=>: -^SU6VO[RXM[<3-Y& TIB81,<D$*Y&&(((."<&I;R_M[&UGN
M)W.R!/,D$:%V5?7:H)['MVKE/A7'=+X TV2XN_/62,E%\L+L^=L\]\UGV=O=
MGQ;X^E:[3R@D0>(0@;Q]F^7G/&,_C[4 =WIU_;ZKIEKJ%HY>VNHEFB8J02C
M$'!Y'!IMIJ5G?SW<-K<)+):2^3.J]8WP&P?P(KSS0KO6=&\,^ ;I=4\VSODM
M+*6Q:! BH\!*LK8W[AM&<D@\\"M-=9\0?9O%R6C?;;O3]0BAMD5(T?RV2)G
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M9E+QLV&W @KGVSP.1SG?\(ZM/KO@_2-5N519[NTCED"#"[BHSCVS0!M4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:L@#LJN!V#* WXUT%9VB3WMQIRF_TI=,E5MBVRS+* HQ@@J,?A[5HT %%%%
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MOPP5B<_*W!XS5ZSL-8T[QQ>7\EF;RVO-.MHFN8Y$7;)$9"P*D@_-O&,<>I%
M%K3O'.@ZJ7-I<3O&D$L[2&UD50L;[&&2OW@2/EZ\CCD5*OBW3I4U)(_M$=U8
M0>?);W%M)&Y0YVL 1DJ2",C/2L#2]+\2Z;\,KG3+*V^R:VCS/#F6,A@\[/\
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MYX)9+>Y?=M*VTJ8D(_V@50CW%0Z)X7N-)\57WEI$F@B3[;9Q*>4N'39( .P
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MG)(/3 SG"W,<VK^#]:\-:7H5[;ZK!=Q37$5U+$2[22B9I2X;:=V&Z=#@8 H
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M5]$^R&:-I5!# /N*L.FY<'MU&0#T*BN<358U\7:I;JVIRW$%C'*;/">45W.
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M+)L9LX) P<'D<5D^%O&YU+PKI5]J4$HO[]MD44<.T3N=S8CR>@5222<#')H
M[.BLS2M;M]6FO;=(YH+JQE$5Q;S !T)4,I^4D$%2""":R8]?M;35O$\SR:I+
M_9\<,D]LZ*8XEVL<P@<G(4L<GTQZ4 =317-6?C:QO+S2X38ZC;Q:J@:SN9X0
ML<K;-^SAB0=H/4 '!P32^-=?N/#NCV]S:1EYIKVWM\>47^5Y55NG?!.,]\4
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M+V!)K>3&Y&Z<'(/L00"#U!%0VND6=I<"XC21YPA199YGE=5.,@,Y) .!G'7
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;:Q\9_$EI<ZG=V,?]D0,SVMSY#<'KN'.!U]/7-85[<ZM<_![PM+K4\T\YU^
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M17K->RLMP<;FR"QR-W0>F!0!Z)KFJKH>B7FJ/;37$=I$TSQP[=Q51DD;B!P
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M?^*=>FFUC5&BTS5BEO;F[8Q[3;QDJP.=PRY(!Z$<=ZL_%D@?"[7<_P#/)/\
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M8QR>=V[K7IM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 445SMGXDNM;22?0=-CNK)':-;NYN?)28J<$QX5RP!!&2 #CC/6@#HJ
M*HZ3?3ZA9&:YLI+.99'C>)V#<J2,@CJ#C(-7J "BBB@ HHHH 9-#%<1-%-&D
MD;C#(XR"/<52@T+1[6TGM+?2K&&VN%*S0QVZ*D@.<AE P>IZ^M:%% &1<^%?
M#M[*);K0=+GD"! \MG&Y"@8 R1T X I3X7T QV\?]BZ>$MPRPJ+9 (PQR0!C
M@$\D>M:U4X-4L[C5;O38I=UW:)').FTC:'W;>>ASM/2@"VB+&BHBA548"@8
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MZ*=$(#C?MRK#(X*_C6YH>I?VSH&G:IY7D_;+6.X\O=NV;U#8S@9QGKB@"/\
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MCV') EV[\D=!@GJ,PZ)+9MX\MDM[BTBL]0T6:2Y@L[IGC+J\6TM)D;G =N0
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MO-6L-.U>VU218;BX8BXM8U<&$IDCY"H'0X;+9SDUZE]CM?+6/[-#L5MZKL&
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M1/\ B>V)^9@.!*"3796]M!:1"*V@CAC!R$C0*/R%$UM;W!!F@BD(Z;T!Q^=
M&!J>CV=I8:KK$T\ES>-I\D(N9V7Y(L$[5"@* 3R<#)XR3@5REEJ>F2^&_!FC
M7BVS+<Z*LN^\N"EN J1 _*/OOD\#(P-QS7IC0Q/#Y31HT6 -A4$8'3BH_L5K
MB,?9H<1MO0>6/E;U'H: /([2<7/@OP3]IU&X+_V\]HS_ &AT9HEDG 4\YZ*@
MYY&!S73:/+IWA?QGXIMOM M-*@L;6],;RDI$3YH=@"3C(5<XKM386;?>M(#R
M3S&.IZ]J>]M;R.SO!&S,NTED!)'I]* '0S1W$$<T+J\4BAT=3D,",@BN$L=E
MW\5_%%O%?O;R&PLAN@9-_'FY'S ^H[9KO@   !@"H5M+9)O.2WB67).\( <G
MKS0!Q>M)H>B3:-X8^S6\=M/%/*IO;DI -I4LS9_UDA+Y )[L<URL4PN/ 'AA
M9]2GW)XC%H)1<.C>4+EU"G)SPJKC.2.*]@E@AG*&6*.0QMN0NH.T^H]#4;6%
MFWWK2 \D\QCJ>IH \^U71=%T?QOX1M#-+;60MK\1[[Z11N+1, &W=26;C/(
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MWN5M!<OL25O-#.!NX;"IS^-5-*U)KO3?A?>7-](]S.VR9FF/[S%M)]X9P3N
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MOX+QC+GYO*<,%&!WQU[>AK?HH 09P,XSWQ2T44 %%%% !1110 4444 %%%%
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MXZXH =14%Y>VFGVS7-[=0VT"_>EFD"*/J3Q4J.LB*Z,&1AE6!R"/6@!U%%%
M!1110 4444 %%-21) 2CJP!*G:<X(ZBG4 %%%% !1110 4456N-0LK6X@M[B
M\MX9YVVPQR2!6D/HH/)_"@"S1110 44A(52S$ #DD]JH6VNZ/>7/V:UU6QGG
M_P">45PC-^0.: -"BBB@ HHHH **** "BBB@ HIKR)$NZ1U1<@98X&2< ?G3
MJ "BBF3316T+S3RI%$@RSNP55'J2>E #Z*BMKJWO;:.YM9XYX)!N26)PRL/4
M$<&I: "BBB@ HHHH **** "BFB1#(T8=2Z@$KGD ]#C\#^5.H **** "B@G
MR>E5[*_L]2MA<V-U#=0%BHEAD#J2#@C(XX((H L4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!#
M=6L-[;M;W";XGQN7<1G!S@X[>W?I7*?#"-(O!:I&BH@O[T!5&  +F0 "NNE6
M1XF6*3RW(^5RN<'Z5S^C^%I-%\.76CV^K7.V8RM'<!%$D+R,S,P.,'YFR.*
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MQHUI*DD%M(@W81MR(S_Q(I P, _* 21G(!M:S+/!HE]+;!3,D#LFYRHR%/<
MX_*O-_/U6?P?\.+FZCAFNWO[1HW:X9C+NM)3ND8KD$DY.-WU->HW,"75K+;R
M9V2H4;!P<$8-<M#X(>/2]"L&UNYECT6=)K9GACR=B&-%; &0%8^Y/>@"G<>.
M;W0X_$$>MVEL]QI8MFB:T9E2<3L40$-DJ0PYZ\<^U:VE:_>77B-],EB2XMS:
M_:$O(()(T1@P4QMN)YY!!SR >.*9JO@BQUF\UB6[N)_*U6WAAEC3 ,9B):-T
M;J&!;/.>@K5TNPU"S7%]J\M^0NU=T*1_B=HY;\A[4 <SXSE^V>,_"/A^Z/\
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M"O0\4 =917%:)XFUK6=)TL#[#%JLEY+;W\/D.5@$1(DP-^>"% ))SYB\5VM
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  1D8/2D"A>@
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M@*#@<M[#O4BG<H;!&1G!&#5'7(DG\/ZE#):R7:26LJ-;QG#2@J04![$]/QH
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M"[D:,A@0.1MQG/%>:R:7>O\ #FXT\Z/=F[?73="$VS9,?VSS=W3'^K_PZ\4
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MWE\IED4';N+%W&%4G SDXQZ5T]% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF=UDM3]NF.[A%<N-T9!Q@+@ #M0![V\T<>=\B+C&<L!C/2E=UC0N[!5'4DX
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MW*\L$<B18S*N3NV[B G R!TVC&+8WMWIGPJUN"QDF-I9^)F2[BMPR/'8EAN
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M^#R%ZKR.J^G/2KDFBV%[XR\.Z1XD:"YNF\//#?AI<>?,&A #$'+'AB/ID=*
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MOL_+$GVN#RR=H;S!C/IFK!( R3@4 %)@ DXY/6HH+NVNHFEM[B*:-206C<,
M1U&126M[:7JLUI=0SJIPQBD#@'T.* )B >H!I>M0W%W;6@0W-Q%"'.U3(X7<
M?09[TZ6XA@_ULT<?!/SL!P.2: '+&B)L5%5?[H&!0\:2*%=%8#G!&:;#/%<P
MK-!*DL3#*NC!@?H155;JZ.M2VSPP+9K LB3>?F0OD@@IC@ 8YSWH O45 E]:
M23+"EU TKKN5!("S#U ]*H^(=6&D:-=7,<]JETD+R0QW#8$A49QC()Z=J -6
MDVJ&+!1N/4XYK+TG5UNO#&G:M?R06YN;6*>0EMJ*SH"0"3TR?6M#[5;A8F,\
M6V7_ %9WC#_3UH EHP,YQS4-M=VUY&9+6XBG0':6B<, ?3(I(;ZTN5D:"Z@E
M$9PY20-M/OCI0!/14$=[:S3>3%<PO+M#[%D!;:>AQZ>]8OC/Q"_ASPU?W]K+
M9F]M[=YXX+AO]8%&2  0: .AHJJU]!;V45Q>3PP*ZKEI'"KDCIDU+)<P1*&D
MGC0%2P+.!D 9)^F* )"H)!(!(Z>U+@9SCFLO5]?L='\/W&MR,9[.%-Y-N0Y<
M9 &WG!Y/K6IUH **KM?6B7:VCW4"W+C*PF0!V'J%ZTJWMHUV;1;J$W*C)A$@
MW@?3K0!/@9SCFBJ\M_9P'$UW!&=P3YY /F/0<]ZK7>LVUGK>G:3(LAN+])7B
M*@;5$84MN.?]H8H T:*A-W;"41&XB$C-L"%QDMC.,>N.:([NVFGD@BN(GFC^
M_&K@LOU':@":C SG'(JNU]:)=K:/=0+<N,K"9 '8>H7K571M;M=<TO\ M&V#
MQP>9+'^] 4_NW9&/7IE3^% &E14%O>6MY$9+:YAGC4X+12!@#]12Q75O,Y2*
M>*1PH8JK@G!Z'Z4 348&<XYHJ&"[MKII%M[B*4QG:XC<-M/H<=* )2 <9 ..
ME*0",$9JO;WUI=R21VUU!,\9PZQR!BI]P.E22SPPX\V5(\YQN8#.!D_H": )
M*#TXJM)J%E%'#))>6Z)-CRF:4 29Z;3GG\*S-4U>Y76[;0]--NE]+;O=M)<H
MS(L2.BD8!!W$OQSQ@GGH0"+PKHU]HXU7[=]F)O-0FO(S"[-M$ASM.5'3'7OZ
M"NAKG_"^MW>K0:LVH+;QO8ZC-:!H@0I5,?,<D\\FMJWNK>\B\VVN(IX\XWQ.
M&&?3(H E*J6#%02.A(Z4M8^J>)]+TO1[W4S<+<Q6>/.2V=7<$D*!C/!R>]:5
MQ=VUG$);FXB@C)QNE<*,^F30!-1@9SCD5'+<0P0&>::..$#)D=@% ^IK"\*:
M[=:X-9^TBV/V'47M(GM\[9$$<;!N2>3O- '0T5S@\0SP>-;[2+UK2*Q@L(KQ
M)R2I&^1TPQ)Q_!^M;AO;4&,&YA!D * R#Y@>A'K0!DWNDWO_  DT6M6K03@6
MAM6MKABH7YMV]& ;!/0C'("\C%2Z'H@TF;4KIVC:ZU&X^T3^4NU%(14"J/8*
M,GN23QT&I'<0RNZ1S1NZ'#*K E?KZ51?68/^$@.AHK_;#9F[#E?D"[]@!.<Y
MSV]!0!HE5+!BH+#H<<B@J"02 2.A]*YWPMXD?5].9]2DM(+O[;<VJ1QMMW^5
M(R9 8DD_+FMV>\M;5HUN+F&%I#M02.%+'T&>M $U%%8/A[6Y=9L'UIY+:/29
MTWVJX*R(H+ M(Q..< @ #'(YZT ;U(% )( R>IID,\-S"LT$L<L3<JZ,&4_B
M*R]1\3Z7IVER:@+A;J*.:.!A:NLA#R.$4'GCEA0!KA0"2  3U]Z%55SM4#//
M I:X_4_&<G_"*0:]I$*&)[]+1DND.2#<" D;3ZY(]J .P(SUI"JL064$CD$C
MI4<-U;W+2+!/%*8VVN$<-M/H<=#217=M/-)#%<122Q<2(C@LGU':@":C SGO
M6=HNLVVNV+W=JLBQ+/+!^\ !+1N48\$\94XIK:S"VORZ'&KB\2S%WO9?W85F
M**.N<Y4\>G>@#3I-HW;L#/3-<[X3\2-K6BP7&HO:07LMQ<0K#&VW<(Y7CRH)
MR>%S6[/>6MM)''/<PQ/*<1K(X4N?0 ]: )J:41F#%5+#H2.11(S+$[( 6 )
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M@'C@A36AK=LT^D:QKFBWTNIO<-9_;8+* HLL,<F7"CG<Y0L&&<[0!CI7J%%
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M!3W.>,4:?XDT75KN>TT_5+6YN(!NDCCD!95]<=Q[]*\WU:VET[X>ZO!=Z?.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#'\2:%_PD6G1V1NVMD2>*<LB!B6C<.HY[949K74,$ 8@MCD@8R:6B@
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MVLEDD>%1L[=V]UP3@\>QH ZBBLGP_KG]OV4UR-.O+$1SO!Y=V$#$KPQ&QF&
M<CKU!K6H **** "BLK6M>M=$:PBF5Y+B_NDM;>&/&YF/4\_PJ 23Z#UQ7/ZI
M\2M/TWPM=>)$L+NZTNWNVMO-A*?/A@F]02,J7R!],T =K15>QN'N[&&X>!X&
ME0-Y3D$KGU(R*L4 %%<W>>+/L?CK3?##:?(3?0R3)=>8-H"*21MZYSQVKI*
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MU)M#TEX(H6TNR:*$;8D-NA5!Z*,<#Z5,NGV279NTL[=;DC:9A$H<C&,;L9Z
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MXV32P*SKCIAB,B@#R*>&]USQ1X LM7U'4;>74M&E:_CBNGC+N(?[N<*3DYP
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M*,WJ5Q@F@#@+F[6>^^) M]2NFBM]/AEB:.\D_<OY4K'80WR\@<#CC%.M[?\
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MCT;2X0HBTVS0+)YP"P*,/_>Z?>]^M*^D:9*TS2:=:.TY#3%H%)D(Z%N.<>]
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M1;XTV-$S'A6[@'K]:T_&NN[O!NKC0;Y)]0B@$A6TE#R)%O4.PV\@["V#Z]*
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MHWWE*C!^HJ2B@!@BC5MRHH;&,@<XJ":V$5K<"RMX%FD4\'Y S>K$ _R-6J*
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MCC1411@*HP /I3&MH'G2=X(VF0860H"R_0]14M% ###$7WF-"_7=M&:5XTD
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MJ%C8W,CI<7TACMP(G*NP!8C<!M!P">3VJ:VU*SO;F[MK:YCEFM'$=PBGF-B
MP!_ @T 6J**Q6\6:((K&5;WS(KZY^R6\D4;NC2[BNTL!@'(/7'0T ;5%5=2U
M&VTC3I[^]=TMK=#)*Z1LY51R3A03@?2I;6YBO+2&Z@8M#-&LB$C&5(R./H:
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M?18(61S"DAN)9$+#=N!P@X!P,\YSVI]AJ>JR_%C6-#DO4-O'I*31,+= R.S
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MECFM5$[[HF3[F&SD@>AH PY=:U>QUKQ%I%Q?.]R(8I](_=QC>LAV 'Y>2)<
MD_PL#79VL<L-I%'/.;B95 >4J%WGN<#@5@):6VN^+;;5'T^XB.CK-#'-<0M&
M9'<A3MS]Y0%)W=#N&#P:Z6@#@+C7M>M;_P 2Z-#<"ZU9#&=(21$5622-F#'
M&=ICESV.T#O6OX?UN;Q-<6>I6ETZ:<;%))[?8I'G/_!G&05PVX9ZE??.R=&L
M&UU=:, .H+;&U$N>1&6W8Q]:;I^A6&E6=S:V$1MXKF:2XD\MB#O<Y8@]OZ4
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MR3G!S[=]6'9>$]+L$MX8EF:UM9/-MK624M% W."H/IDX!R%[8P*W* "BBB@
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MWVB.?4)5'$8$@EV#_IHY /L"6/5<@'4T4T.K,RA@67J >13J "BBB@ HHHH
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M@JIQD  XP<#([XYJ.Z\/:5>7DMW-:_OYD$<S)(R"9!T60*0'')&&SP<5J44
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MA:(?.LC*SDD$8.Y1C  '3% ":;XJN[S0KVXN;>RM+VROGL;@RW.V!64CYPQ
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M,+@MT;J!U&:EEU_7KGQ+JVB:=IVG^9900SI-<7+[7$A? ("9!^3W'OVJO=^
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ME<AASQTR.O-:DMY<)XB\(0ZII%DUQ,9UBNENGE> B$DD91<[@ #_ )-6)?!
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M.!G'J1795AKH$R^+SK_VX$FS6S,!AX*!B^<Y^]DGG&,=N];E !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44UPYC81LJO@[2PR
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M $$8(/>F100P B*)(P>H10,U)10 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%9NKZ
M[8:''&][)+NE)$<<$#S2/CKA$!8@=SC S0!I453TK5K'6]-AU'3;A;BTF!*2
M*",X.""#R""""#R*N4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!5.[5Y&(LY+5+]4^5YH]^Q"1GY00<';ZCD>U7*S[_1;+4KF"YN!.L\"LL<D%
MS)"P5L9!*,,@[1P<]* ,'X>RO_9&HV,MND<]CJ=Q!-+&24N)"WF-(N>F2YX[
M$$=JZZH;2TM[&V6WM8EBB7)"KZDY)/J2222>234U !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
J444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ameh-nonqualifieddeferre004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ,EFBMXFEFD2.-!EG=@ ![DUPOP\UG3[7P#=7DUU&(;2ZO9Y]IW&-#/*
MP)49/*\CCGM7>T4 <MJVK>'=9@ETZ^U9[0/ )0@N# \T4B\,HR"PZC&.HP1T
MSS7AF;4M,\0:)?>*76WENM":V\Z8",>8DV]4;H%<QL#CC[K>E>FD D$@9'0T
M,H888 CT(H YGP-;/%I>HW3*52_U2ZNX01C,;R'8W_ @ P]B*Z>BB@ HHHH
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M1GH<'J!0!:KQS4M5T[4+VPU2&.RLKVV\21Q3*(R;N)//*,9I<_(C+D[2,;2
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MDEC)<[HF!R&."IX.<+7H6DR/-HUC+);/:N]O&S6[G+1$J,H3W(Z?A5LJ"02
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MNL?9[RWES'YH\N56RG][@]/>O.M2MM&O;CP.T&EYLEN9'G'V!D55\AURX*C
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M(9#YOFH7 .'^7&,9Y]<=JZ^N T>UM]1^(/C!+J&Y^S7/V3RFQ)$DVR(JX##
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M9(1;3VHX=73<<G<02.F1CI7#Z#+<:3I7@NXOK.].E6)O(;J,6[N;>4M^Y=D
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MSIEK#;Q3'S&$<>S>V ,D>N !D\\5SWQ.@CNO!CPFU-S(;NU9(UA,C<3QEB
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M2[;5+66^4$F!9!N('7 [X[XZ4]M?TE;M+9K^$2O+Y*Y;Y6D_N!NA;_9SGVH
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MS!\I(Q. %/<D\5J4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,\\-_#GD>G-9WA+PW<6.G:3I.LZ'=23:6R>7>'4/,MB4!"R(ADR#CML&,^E
M$GQ#\5):>$-0ETJ]O8KF)MB75K SQAPVTH9-I4=P>1@C&0>*[RO+9= \4I\-
M[_P<FD)-+&&2"^^TH([A#+O!P3N#X/(( ZG/:O3XG:2)7:-HV(R4<C*^QP2/
MR- &/=>+-(LTDFFGD%K%-Y$MT(F,,;YVD,X&!@\$] >"0:BU+QIH>DZC)I]W
M<3K=QQK*8DM96.QFVAAA<%<YR1P,'-<W#X<UF'P)JG@QK(R^<;B*WU R)Y1C
MF=F#N-VX,N\Y 4Y(&#SD:UCI-]9^/Q>"RE;3TT>*P6Y:2/)='9B2-V[&".W7
M\Z .L=UC1G=@J*,LS'  ]37#>(O$_F:QX8CTR[OHX[K4XXW86[+!<0E&)PY7
M!Y"XP>1R,BNG\2:7)K?AC5-*BF\F2\M)8$D/12RD GVYKDKFV\3ZG9>&EG\/
M_9Y-*U"&:Z"W43"14C=2T7S?=YZ-@].#R: .HO?%&DZ?]H:>=_)M7$=S,D;-
M' QQ@.P&!]X9] 03@5S=KXJ31O$_BN#5+R^NK>TF@:%(K9YS!&T*NQ(C4[5R
M3R?3OBJ]MX6NK._U^PU#1KS5-/U.]ENHY8=0\N+;+@F.6,R+T.>0K9'TQ6E9
MVNLZ1XO\0S0Z(UQ::BT!MIUGC")LA5") 6W 9'8,?:@#137[.]\0:2MGK),%
MW9R3QVRVI*7*_*1()2,#;G[H/\7-5="\<6>I6NJ7%X?LT=G?36ZMY,@#(LGE
MIR1@NQQ\HYR<8K.TSPM>Z%K7A*"WMGN+'2;"XMI[H,B@O*8SD*6SC*-VXR.M
M9]WX5UZZT+5=/2RV30Z^^K6KFY")=H9S*$#*=R'!QD@8.,>H .XB\1Z8\E['
M+.;62RC$MPETIB*1G.'^;JIP>1W!'6N=O/$$D_Q%\.65K/J$-O.ER9H)K9XH
MY0L>58%E&<$GC/IQ5?5_#$^N^']1:STBYT_5Y(H5CDU*\\YI/+E$HCR)'PA*
MD=1][I5F6+7]5\4^&M5GT%[.WLOM"W,;7,3NID0*&&&P5S[Y]AW .JU>_72M
M'O+]AN%O"TF,'D@9 XYKAKGQ;/=VG@K6%NKBUCO;E([VW2%E1RUN\FU05W-\
MP &W.>G-=SJ]K)>Z-?6D.WS9[>2--QXRRD#/YUQ,6F:[)I?@B&31)HI-'GC-
MTIGA.%2W:+(P_.2V1[#L>* .GM/%NC7EI?7 N7@6P8+=)=0O#)$2,KE& /.1
MCCGM3F\4Z7&UVD[W$,MI +F6*2VDW^421O"@99<@YQG'?%<CXF\(ZSJ]_P"*
M/LL(1;Q;":TD:8*LCV[%F1L'<N> #CW[5J#2Y+G3M1NT\.7]OJDFGR6B&[OE
MF=MW\"DRL-N<$DD=.E &E9>-M!U"%YK:[D:-1"58P.OF&7.P)D?.3@C"YP00
M>E64\3Z28KQY;AH&LG2.XBEC99$9\;!MQEMV1MQG)X'-<KJ'AK5[KP/X5@BL
MW6_T.2VDEL_M(B,PCB,;JDB-A3\Q(.1TYQFI-4\,3ZA8#4=-TBXL]3AO;2\,
M=_=B22Z$#$B-F#N ,,V.>O7'6@#I#XJTJ.6[AG>>">U@^TRPR6[B3RLXWJH!
M++GJ1G'?%06?C;0[^ZL(()Y_^)@@:TE>UD2*;*[MJN5"EL=LYX(ZBLK6-(U'
M6M7_ +973I[<VVEW%I%;R/'YDTDVWKABH5=O<\D^W,+:'J__  BW@>W&GM]I
MTBYMFNXO-CRJQP/&Q4[L'DC'.<&@#O*S;_7+/3[AK>03RSK%Y[Q6\+2,D>2-
MQ '3(..YP< X-,T#5IM:LY[Q[406QN)$M6W[C-$IP)>@P&P2!Z8.>:P?%6@R
MZGJ[W5O8ZI%>):".VU'3;Q86W;F)CD!<94':>5(Y- $+^)#8?$"\CEN[VYT^
M32(+N"UA@:5@S22 E41=V,*O7I^-=%%XETNXT>UU6VGDN+6[.(/)A=WD(SD!
M -V1M;((XP<UBZ-IFM6_C47VHP&5#HMO92WBL@62='=G8*#D*=W''X"LK3M*
M\4:7H>DV*Z?<&WBU"[>^@MKJ..22*221XBK[AA074L,@\=QU +_B?Q&M]X0B
MU;0M1GAV:C;V\@"&-@3<)')&ZL-RD D8X-7K>ZO%^*%[8->3/9?V1%<) V-J
M.974D8'HHZYKFI/#6NIX6U73DTIVN+C7DOXPMRCJ8A-')G<S DX0CD9R1730
M66HGXD3:J^GRQV$FE1VHE:2/B19'<Y 8G&& SCK[<T ,\?7]SI>E:=>6]]):
M*NJ6D<Q4@*T3S*KALCI@GIBKMKXRT2YGO8&N9;66SA^T3)>V\EN1%_ST D R
MON*@\<:=J&I:);)IMJ+FX@O[:Z\HR*FY8I%<C)XR=N/QK#\4^$=0\:6U[=F%
MM,N3IK6=K#.ZERQD20ES&6 7]VH&"?O,?:@#KK37K&[U$:>IFBNFA\](YX6C
M,D>0"R[AS@D9'49&0,U:OK^UTZ 374HC5F"*,%F=CT55'+$^@YK T&P,U]!?
M7V@7UE?00L@FN[_[2%W8W+&?,8X.!R0O0<4OC'2]2O/['U#2HEN+G2[];HVK
M.$\]-C(R@G@-AR1GCB@"[%XITV2-RWVJ&5;@6P@FMG25Y"NX!5(RWR\Y'& 2
M>AJ.7QEHEO8ZA=7%Q-"NFD"\C:WD\R#(R"R@$[2.0W0^M9FKVFJZCJ6A>(+;
M29XI=,N9#+8S2Q"2:.2/864JY3<N00"PS@]*S/$?AG5=7A\5:A;V+K<ZIIJ:
M=;6K21AOEWDR.=VT<O@8).![X !U5GXKTF^U9-,BEG6YEC,L/G6\D:3H,9,;
M,H5P,CH3USTI;?Q-IUWL,'VIHYHFE@F6VD9)57J4('/7(]1R,UF:EI^I7'B'
MPKJ,5@YCLEN%N4,B!H]\85?XL$9'8FLSP]X>U#1]2L;C3K75-/L(X9#>:9->
M)- 6*_*L"EVV?-SG*C QWH WM$UVT_X1;3KZXU<Z@+@;([K[,8WN6R?NQ 9S
M@'@#H":RO#WB!KKQEXK%Q>W2:?96]K*([V,PBWW><7X8#C"J<\\#K61IOAWQ
M'I?A_P (7*:9YM]H<DRW%@9XP94D5E+(V=N1D8!(SSTJQ?>&M;UZZ\7K<6?V
M&+6],@M[:0S(_EL@ERLFTYZN/NY'7D]P#K8O$VFS74=ONN$EE@:X@5[=P9XU
MQDH,98C(X'/(XJG9>/?#FH1O+;WS&!83.9G@D1-H<)@$J,MN(&T<\CCFJ>@Z
M?+OL[O4?#E_#J-C"P66;4!.H8J PBS*?O8_B"\5BQ^$M:N?A+;Z$UM]EU2TG
M6X6)Y@$E*3^:%WH3C(XSQ@T =K%XCTR2>Z@EF:UFM81<3)=(8ML1S^\^; V\
M'GMCG%<YJ/B)YO'_ (6L[.XU"&"Y>X$T,EL\<4ZK [*0649PV.,^G%0:KX7F
M\0^']36#2+O3=6FM!#'-J-[YY.'$GEY$C_(2O)XZ]*GGC\1:OX@\+ZG<: ]G
M%I\\QNHS=1.P+PL@9<-@KEO7=[#N =I//%:V\MQ.X2*)"[N>BJ!DG\JR(/%>
ME3W5U:[KJ.XMH?M#PRV<J.8LXWJI7+#/' .*L>(EU5_#NH+H;(NJ&!A;,^,!
M\<=>/SX]:Y.RTK5X_%*:PVCWJPMH\EH5GODFF$ID5OFRY !VG[I(Y'3H #<M
M/'6@7TFGK!<SF/42%M;AK65896(R$$A7;NP#QG/&.O%=!-+';PO--(L<4:EW
M=S@*!R23V%>?0>'M9C\ ^$=.;3F^VZ3>6<EQ")8\[(C\Q4[L'VYS77>)])DU
M_P *ZII,4HADO+62%7/12RD#..WK0 V+Q!IU_<Q6$<\\$UY"TML[PLGFH ,L
MA88)&0<=<'.,5C>#-?/_  @VD7.K7DEQ>W3RQH2-TDSAWX  YPJ_0 =@*3P_
MILR_8)]2\.WT6HZ?"P6674!.FXIM;RLRG[P_O!>*YVT\)Z];Z)X5GDTZ9KG1
MI[D7-E%>+$\L<Q/S1R*X&1D<$C/(^H!WL7B;29K.6Y%P5$5Q]E>)HV$HF_YY
M[,;BV""  <CD<5C:OX]MK&*R:WM[@/+JD5C/'<6LJ/&&&YB%VY)VD8QUS[8J
MCJ/AR\ T[6=%T>6&]M-3%[/9W5T&ENE,1B8ER[*'"MQEL<=15[Q'!JNL:?I5
MY:Z)<)/9:K#=O:2RPK+(B@@D$.4S\W0MVH O0:[!)XBO4&HW+I%81SG3S8.K
M("6_>!BNYMW3:,XVGO4\'BS2+K2;+4X)IY+2]D$5NZ6TA+L>G&W([\D8XJC:
M66I?\+%N=5ET^2.RETN&U$IDC.)%D=SP&SCYP,XZU!X<\-WNE:W>P2JG]BVU
MS)=:8 V2&F&77'\(0F0#U$GM0!KR^*=)AD >=_)-Q]E-P(V,0FW;=A?& =WR
M^F>,YXK9KSG0/"EQI]G)H.K:+>7]LEX\L5VNH?Z/(AF,JL\1D!5E)Z!""1G-
M>C4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M6%#XJMI-9L]-FLKZV:^5VLYIXU"3[1N(&&+*=O.&"G H W:*PH_%$$\T!M;&
M]N;*:8P"_B5/)#ABISE@^,@C<%(]Z2'Q7:W$EL\%E>2:?<LPCU$!/(X#$DY;
M>%^4X;;@^O(H WJ*YX>,=/":=<2V]W#8:C(L5K>R(HBD9_N=&W*&[%E Y'3(
MIZ^+;%[+6;H6]X%T>1H[I#$-V0@<E1GD;6!H WJ*YR;QG8Q3Z7 MG?S3:I;&
MYM4BA!WJ%#$9S@'#+UXYZUEZWX\$?@K4-7TRWN([RUNTLI+>ZMR6AE+H&#!2
M1]UP0<X.1USB@#M74LC*&*$@@,N,CW&>*SM"T.V\/:=]@M)9W@$CR*)F#$%V
M+-R .K$G\:I^)+AKKP+J]S$;NTD6QFDC(9H94958@\$$<@&LS0?&-M'9^'["
M]M=1B-];Q1P7T\7[J>7RP=N[.[)P<;@,XX)H [*BL*7Q5;6^JVEE<65]!'>3
MM;6]W)&HBDE&?E^]N&=K8)4 XX-97AF[>TU'QAY\UY<Q6VIJD2,[S,JF"([5
MR2<;F/'3F@#LJ*YL^-+*.+5S=6.H6T^E0BXN;:2-2_E$$AUVL58?*W0]J6S\
M9V5WJ6G6;66H6XU*,O9W$\(6.8A-Y4$$D';D\@9P<9H Z.BL+_A*+>26,VUC
M>W5D]Q]F-]"J&%'W[#G+!B W!8*1[TR+QAITIT^017(LM1F\BTO2J^5*YSM
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MC-KDNHZJ9&^R?:9+2TB!^79$Q1G/J6<-SV 7WR =!17!W?B'4+7QU87CS?\
M%.W4[Z.%["X'*R_BX>+_ (#[UN>)-1FT2XTW4Q(QM&NH[.[B)^7;*P57'H5<
MK]03[8 .@HHK!O/%EG:0ZA<):WEU:Z<Y2[GMT5EB*@%A@L&;:""=H..G4$4
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M/G:=Q90"<' !W=P*YWP+KZP> M%DO9KNYO+VXGB@CD8O/,PEE."6/95))8\
M=: .ZHK 3Q;9-'<YM;X7%K=QV=Q;+!ODB=]I4D(2-I# [@2,>_%;] !1110
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MLWMHF80S1MN#,6(W@XQC XSSZ3?V+>W>MVVMWYM1>65M)!:PQ%C&&DV[W9B
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M0'Y54L#R!T!.1D&QU#4]>\1ZQIW]CBSCNA"\6H)(@\R!0"SA&VMSR&8$X [
M4 =/+XK'V]].AM$74(;=;B:"ZN5B$88L%7<-P+':3@< =2,BL4>-;K5==\*2
MZ3:W4FFZE97-Q)%^Z4L5\L $LV1L+-G'7(QGLNFZ3J.KW-EXQM8;.WN-4T^%
M;VPOHBZ@C)5D8<@@,1@CD8Z&MF_T#49]=T+5;:[LTEL(IH)T:!MCI+LR4 ;*
MD>6,9)ZT <KHNM2^%K'Q=<VNBR7-A9ZS<RW!BD2/RXPD9.Q3]X@ G' ]^U=5
M<^+K?[;<66GQPW%Q;6T=S*)K@0C:X)15)!RQ"DXP .,GFJ<7A&^/A_Q5ID]Y
M;[M<DN)4D1&Q"98PF"#U P#GC-10^#]0L-:_M6SFTZ62YM(;>\@NH692T0*K
M(C#E3@X*D<^M #G^( G71_[*T6[OSJ]G)=6@$B1YV!2RMD_*1N')X],\5UBR
MSO8K,MOB=HPWDN^,-C.TG'X9Q6'<Z%J$_BC1=6%Q:!-/MY87C6-E\SS-FXCD
M[<;.!SUZUT= '(6WQ LI-%TC4KFVDMQJ5Y]D6+=N:$[S&3)Q@ /A3[L.>:C\
M5:\$\-^(VO-,N7L; B.1[2[\MY/E5R5;@KC<H.#UR.<&@^ ()+7Q-:S71:'5
MGD:W7;_QZ;\,Q7W\WY_P7TJSJOA:[U#X?S^'5O8_M5U"4N+N1#AG8[G?:/5B
M3CMF@"/4-:U*'XAZ=I$-K/-82Z;--+&IBPS"2-0Q+,#A0Q!'?/0]N<T'Q!)X
M3\/Z[=)HTDVEV>M7OVB6.14\J/SB/D0_>"CMQQTS7776AZG)XGTS7+>ZM$D@
MM)+2YBDC9@RLR-E"",'*8Y]:S#X*OIO!OB+0IKZW#ZM/<3I,D9Q'YS%B",\X
MSU[T =HZ+)&R.H9&&"",@BO/? >@:7J?A^_:]M%FD&J7D2R,Q#JJS,JA6!R
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MG.2<U<N/#UQ/XEL=;745CFAM6M+B(0 I-&65CC+90Y7WX/XUJKJ%D]DUZMW
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M-W<16\"#+2RN$5?J3P* '0))' B2R^;(!\S[0NX^N!TK'U_0)M7OM*OK6_\
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MZ<(22>N<"H(/%^IS'1;/488=$N;ZTGFFFNXSM62-@H10Q&"P)?DY"C\1I?\
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MFGU H;A9?+V,47:N J C ]#]:MV.EM8:8UFFHWTK%W<7$\@DE&YBV,L",#.
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M[9WDN/L$UL()5*X4^9]X,"<=QM]^,S4Y!>?&32=.OL-9V^E27EI&_P!UKGS
MI;'=E3IZ9)KI=(T:;2D6-]9U&^CC39&MV8SM'U5%+'CJQ--UWPWI_B%+8W7F
MQ7-J_F6MW;R>7- W0E6]QU!R#W% %G53:6UH=3NXMXTY7N5(ZKA&!(_X"6'X
MURMQXJU>Q\.:+XEG6TDL;Z2W^T6J1L'ACG("E7W?,5++G(YYQBNAM=$N(R!>
MZW?ZA%M*F*X6%48$$?,$C7=P>AX]JIV?@ZRM+2TL&N[N?3;*59;:SF92D94Y
M09V[F"G! )/0=<"@#&US5M2\0^$/%$^G2VEM:6@N[0I/"TC3>6I5SD,-F3N
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MG(D01^1(SN&#$@$<*IY]:U8?&OAF>6../6[)FEC,D9\T ,H&20>AP.<=<<T
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MJH-(U&+1/LLFDWK/_P )8+]HVB,A^SB8.7)&0>,]#S7K%% '+1VMPGQ0EO\
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MC"TN?%FL:)(\,0L%BVR;R=Y*,SYXPNT =_6N8UG3?$VK6]Y#=:7>33PZS%/
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MXPZAA\N",^AYQ46HZ'+:0Z#>:1H5WMM]9>_NK5IT:<[XY59\O)@DLX)&[^M
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M+YS_ -H+#YYA\E_]7TW;L8QGCKUXZU+INIVFK6S7%F[O$LC1DO$T?S*<,,,
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ML'W!_ED 93T(#9X!Q4M]H4EO)X8_LK0;I+:TU22^N8WF1W3<DH)):0Y8LX;
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MPVE<$A@0>A!!!^E9\/BNTGDMG2TNSI]R&:+42J"W(5&<G.[<!A20Q7!['D4
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M>1$O2$\DE-V[/S;@/D;DJ!Q[B@#:HK B\5Z?<R:<ABNH[;5<K973*%CG.TL
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M*[T4IE21UY&,GK7-:/-?^'_#VFZM>>'Q<Z1:R^;9>7J&?L\4K%4:.)D#$[)
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MTKLRV[/0>N!3+_Q[;:9I^L3W6G7)GTAXUNH861\+( 4=22,J<^F<@\54U?P
MU\JW\4]L^L#45U%VN(MT$I$?E>45ZA-@ !Y.1GO5C6?#.HZMX0OM*AM-(T^X
MNR@(MRVQ0K!LD[ 6/&,8&,]30!;/BYEN;>SFTJ>TO;J:5+6&[E2,2I&JL7W
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M9SC-3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %&#1]/M=2N-1AME2
M\N !-,"=T@'0'GG&3CTSQ1?:/I^I3V\]Y;+++;-OA9B<QMZCG@\GFKU% !11
M10 4444 %%%% !1110!'<6\5U;2V\\:R0RH4D1APRD8(/X4RRLK73K..TLK>
M.WMXQA(XUVJO?I]:GHH **** "BBB@ HHHH *HOH]A)JR:HULIOD3RUGR=P7
MNHYZ<#BKU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%0W37*V[&TCB>?C:LKE5Z\DD GID].>G'6L7P
M9K-[KWA[[=?K")_M5Q"1"I5<1RN@X))Z+ZT =!17.^))?$4,=S<:5=:;9VUK
M;F8O>0-+YSC)*\.NQ0 .>3S[<PFZ\6:MIFG3Z='8Z7++9QW%P+Z%Y=LK#/E
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M['Q+9)87E[J.MZ0]LMZ\,,T$F$ XVQL23F3GG'Y5>T_Q!H^JWD]G8:E;7%S
M,R11R LHSC..XSW'% &E16._BO0(ITAEUBSB:3/EF24(LF#@[6/#8/!P3BMB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ;?Q6FR*[L;;[1'*"Q)C="C#@@'DK][KQ570K;4QXWTRZU33C',GA]+::6&
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M!D *2V>>*]<K!C\,AK&TT^\U"XN[&T:-DAD5!O\ +(*>80!NP54\8SCG-;U
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ML[R*Z::WO)3#!)#"\@=P2,?*#CD'KZ&DF\3Z3!,$DN2$^T"U,PB<Q+*3C89
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MGX2\.36FF:1I.M:#?-<:4Z>7=?;]]J6CR%E1?-R./X=G!/IS6QX_A;^Q+*_
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M-"\0DC&,LI8 $#(SCID>M<IXH\+W_CFWEN#;2:5(FFW-K;QW+(7>279][8S
M( F.I)W'@8YGM-/M9[(7>OZ#?V4EG93+-<7NH^;%$K)B38?-8X('4@<#L>*
M-L>,M#-S:6YNI0UXN^U8VTH6X''*-MPW4'CL<]*JV_BK3[*QUK4M0UEI[*SO
M6C<_89$-H-BGRV !+8SG=C^+%<EX?OI=+M?#5SXAT36U2U"6=E<2?9VB@,N(
MT+;&$AX*KN*CKR 35C4]"UZZ\+^.;&+19C/J]ZTMHIFA 9#'$F2=_',9_,4
M=G;>*]'N]2DT^*XE^U)$TRH]M(OFQCJT9*@2#D<KGK56+Q[X;G6U>.^D,-U+
MY$<YM91$)-Q38SE=JL2,88@]/45#JUGJ,_B[PUJT&FS206L%VMPHDC#Q&18]
MHP6P>5/0GI7/IX=UQOA,=&;2G74DOA,(#-%\R_;/.R&#;?N>I'(H ZJ/7;>'
M6];$VJM)#8PPO):"R<-; [\ON RX;';IMHL_&N@7]U8P6]Y(3?H&M)&MY$CF
MRN["R%0I;'\.<CD8R*R'L=7/B3Q1>C1[CR+_ $V"WMSYL.6=!+D$;^/]8.3Z
M&J_]B:P/!_@>U_LR0W6D7-HUW")8LHL<+(S [MI&2.ASSTH Z._\7:)IID-U
M=.L44PMY)E@D>..0XPC.JD Y('7J0.M:RNMY9B2"5T65,I(%PP!'! 8=?J*\
MM+&/_A(,Z+K&H>'!JCWI%F]N\<C(P>0Y=E<CS58E5!Y7&3R*]0L;V#4=.MKZ
MW8F"YB2:,L,$JP!''T(H Y3P1KMU/X..KZYJ$MS(UU-"#Y*Y^29HU"K&H))P
M.,$DUJGQGH2Z3>ZD]W)';6+^7=>9;2J\#8S\Z%=PX(.2,<UR'A^#78/AGIW]
ME6\KN^J32W$<+(DKVK7$C'RRY"@D%2#D<'@@XIFH>&]<FTGQS;P:-<%]9CB%
MF)+R.0G$*H=[,^000<]1Z$CF@#MK;Q9HUWJ1T^*XE^T^4TR*]M(@F0=6C)4"
M0#(^Z3UI#XOT-=#76C>-_9[2F'SO(DX<.4((VY'S#'(ZU0U&PU&Y\4^%-2CT
M^3R+1+E;H%XPT.]%5<C=SR#]W/2N7GT7Q'_P@FI>&8M!E>X74'GCN#<0B*:,
MW?G K\^=VT]& Z'G. 0#N]7\3:5H>_[?-,BQJ'E>.WDD6)3G#.R*0@X/)QT-
M0:KXRT'19Q#?WICD: W"*L$C[XQC)7:IW?>' S7.^);'Q)J[^(;+^SKN6TNM
M.\O3?+NTAC1S&P=9<.&9MQ '#+C'(Y-6;33-53Q7X;O)-(F%M9Z3):32&2(^
M7(QB[;\D (V2,]>] '0VOB32[V]OK.WFF>XL462XC^S2 HK#*GE><@'&,Y[5
M<T[4+;5=/@O[-V>VG0/&[1LA93T.& .#]*Y3Q+I%V?%^G7.GX":K;OINH8;!
M$(S()![@"10?605V:(L<:QHH5% "J!@ #M0!R]EJ>KCXB3Z1>7,$EHNEK=I'
M##LVLTK+R223POL.>E=57)16NI_\+/GU1M+G73FTQ+-9S)%C>LK,3MW[MN&'
M;/M76T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXT;"C'0X]2#0!WM%</H/BJ:POM=T37KHW-QI5W!!!<B,![I9UW1*54 %^H.
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M@6FH.8[.[*#RYWP2 N#NY"L02 #C@G(S2_X6'H_V3[;]GU$627#6TUR;5A'
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M2?#V7P>EO8.MOL2WO3<$>?&LH< IM^5L#!.2/K7<Z[I9\0>%]0TMV-NU]:/
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M+!';R"V5_,6V,\AA4YW<1EMN,\@8P#T% ">*--FU[P?JVFVK*D][920Q&3(
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MQTKT*B@#CX-.U_2_%VIZC9V=K<V>L"%Y%EN-CVLJ($/13O4@ \<YS]:R]/\
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M]E-U=L(PAC##=CEG+9&U>GJ<<@';T5Y<_P 3=6;X6)XQATRU\R"<PWEN68@
M2;-Z'KC)!P?7KQ5ZX^)L<'B6_P!(985A@TU[F"^*MY<\T:[I549Y 4^N00U
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MX(P6W$Y) PIZTVS\2WL_B#2--EM[)HK_ $Z2\\^WN#(NY#&"%XP5_><')Z4
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M[7VHV0N<@XY/8=: /0Z*R-;UO^RI=.M8XA+>:C<?9[=6;"@A&=F8^@53TZG
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M(]VTCDG^-L]:VZCN+B&T@>>XFCAA09>21@JJ/4D\"@#(T'PZFB>&%T+[5)/
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M1);5&B"N2@Q'YC _-MZC 7) )S6O9ZSI6HS-#9:E9W,JKN*03J[ >N >E7J
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M(9#%(T+APK@ E21WP1^=6Z ,K2=(ETZZU&XGO/M4E[,)F)B"E<*%"CG[H"C
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MZ7,]XK*)3*A4HPXP-NQ !C&!]:6W\)^3K::U)K.HSZB+-K-I9/*PR%MV=H0
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M6IZFE[=2R:DZO-'+LV JH1=N%!&% '4T>)O#T'BG1)M)NKJYM[:?'F&WV!F
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M\S*)&>OS8SN !]0#OJ0LH8*6 )Z#/6O-X_%'B*\\)>%+Z*ZMX+W4-2^P7.Z
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M7)N/M5B6-LR3LHC+#:W .#D<<UI7%Q!:6\EQ<S1PP1J6>21@JJ/4D\ 5(""
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M;K[9(ZW+[O.QC>,GC( !'0CM6]10!3L-,M].,[Q;WFN'#S32-N>1@ !D^P
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MW>DOIEY<:C=6KE"5GOI&/R'<O.>Q /J<#.:N^(-=MO#>BW&JWD4\EM ,R"!
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M&X#(W9'"],"MFQ\-:1IUO);V]F/)>,PF.61I5$9ZH Y.%/\ ='%-LO"^CZ=
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MX(BGCD:.1 >H#H0<'TSBA/#^F1ZE#J"6Y6[AB$,<HE?*Q\?+UQC(!([D9/-
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M<]0, <#H/:LVZL1JVKV5E-I<PLM*G6ZCNKAE999 F$V?,6)!<DE@.5[YKHJ
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M&*Y678'&W;D, Q;=GL>W3L-0T2SM+;5[^RLY&O[RW9)"CLS2G:0HP3CC.!Z
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MN+XP:C9V@L[J47._,\: QP[1GYSGC/0<')KS^?Q)>1ZK::O&\LNB:[;-9:?
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M6UAM[M8##+N(=VRZ]<IM;G&TX[YZOPOI]QIOARRM[R^DOKL1*;BX>9I1))M
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M_M$!W*<&,G&W.WE<#L>] &WK.LV^B6<<\R22O-,EO!#$!OED<X51D@>^20
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M1-5GD@,5Y(3);Q2AFC+Y!D4QA@,^U 'K5%>:W6NZ@NM"Y$TCZ9XCM#;Z4F6
MBF0_NFR.0)%=GSUPH]*TM6^PQWUIX8::ZD>#3FN'EN-3D@79N"[V<99WR">>
M!SR.* .@U37AI>M:/IS6DD@U.9H5F# *C*C/R.IX4UL5Y9I-_<ZCI/PPN[ZX
M:>YEN9-\KG+.1;3#)/<].:]3H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "J<6DZ;!>/>0Z?:1W3L6:=(5#L3U)8#)-7*P?$/BJ
MT\.WNDVUS&[?VA<B$NO2%3\H=O;>R+_P+VH U(=,T^WNY+N"QMHKF3.^9(E5
MVSZL!DU995=2K*&5A@@C((I: 0>E %)-&TN*UEM8]-LTMI3F2%8%".?<8P::
M-$TD2-(-+L@[(8V;[.F2F,;2<=,<8]*O@@C(-% %6RTRPTU66QL;:U#8#"")
M4SCIG JR0&!! (/!!I:* *=II&FZ>KK9:=:6P<8<0PJFX>AP.>M/L].L=/#B
MRLK>V#G+B&)4W?7 YZFHQJUH=<.CAV-ZML+HIM.!&6*@YZ=0>/:KM $5S;6]
MY T%U!%/"WWHY4#*?J#Q4!TK3C!! =/M3# VZ&/R5VQGU48X//:KE% %'^Q=
M*&I?VE_9EE]N/_+SY"^;_P!]8S^M26VF:?93236MC;02R??>*)59OJ0.:LG.
M#CK[UB^&==GUVVU![BT2VDM+^:S*)*9 ?+.-V2!U^E &T0""",@]0:H6VA:/
M93B>TTJQ@F'22*W16'X@9I\6K6DVLW.DQNQN[:&.:5=IPJN6"\]#G8WY5=H
MHWNBZ5J-Q%/?:99W4T7^KDG@5V3Z$C(J1--L([TWJ65LMVPP9Q$H<_\  L9J
MU10!0DT/2);-[.32K%[61][PM;H49O4KC!/O0VAZ0UM#;-I=B8("3%$;=-L>
M?[HQ@?A5^JES<W,-]9PPV+SP3,PFG610( %R"03ELGCB@ 32]/CO!>)8VJW0
M&T3B%0^,8QNQGIQ4"^'M%2XFN%T?3UFG!$T@MD#29Z[CC)_&J&J>*HK;1=?O
MM/A%W-HH<7$4C&(%EC$A4-M.?E([8YZUL6-R]YIEM=;%5YH5DV9X!*@XS0!
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M5ITB0(]A:LEO_J5,*D1_[O''X5;K#\1Z[/H;:5Y5I'/'>W\-G(S2E3'YC8#
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MU5-*DM&N(\6L\P@:?=Q$['"9'HS?+GL2OJ2+EQ/':VTMQ,VR*)"[L>R@9)H
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MDMNC"(_[((X_"DDT3295E632[)UE?S) UNA#OS\QXY/)Y]ZOT4 4+O0](OQ
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MXUU@V++Y*IY;A"^SA4+%-V>",9X->CA% ("C!ZC'6D6&)(O+2-%C_NA0!^5
M'G>I)H>G:MH9TPV2^&[K4)#J0MF7[.)C"!"'"_*%+ '!XW;2:R_$5@18?$"/
M2TSHZZ:DL20_ZN.["N7\L#@':$+8[GUS7JX@B$/DB)!%C&S:-N/I3DC2.,1H
MBJ@& JC % 'G=UK.BZAX[\&SV5_;3I)!=(\D4H*']TNU20<9Y/'7GWKF9['2
M9OAOXOU2#8]]IVI7DEG<)*2]MME^0H<_*, =.H]:]I6&)%"I&BJ.@"@ 4H1
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MNPB $!5P>O%->"&7;YD2/L.5W*#M/J* /*=-N;BVM?AY'JURWG#4[DQ&Y?\
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M?2@(HQA0,# P* .5O-W_  MC2?-_U/\ 8]UY&>GF>;#NQ[[<5R]S-IP@^*4
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MADYZU#IVKQV7@729!<XT@>(;B/4I$?(2W,TVW>1T0GR\GI@^AKUT11JH58U
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M27 GFL6L5=' \J-SERG'#-P"?0#&*U;.SM]/L8+*TB6*W@C6.*->BJ!@#\J
M)9'$4;2,&(4$D*I8\>@')^@JGH^L66O:7%J6GR-):RLZHS(4)*L5/# $<J>M
M<CIGB34%\16EGK;ZE8SSW<L<:-;(UE<IAS&(Y5!(;:%;YF!.&&.F,#2+O6-$
M^&]EK=GJFR&#47C:Q\A#'+&]\T;;F(W!OF)!! X P>M 'K=9G]OV']LW&D[I
MC>V]M]JDC%N_^KS@%3CYN<C"YZ5R7C/Q)J&GV>LW^CZC.\FD%#+!';QFW7A6
M*2L_S%B&S^[(P"N1ZZ:?\E>E]?[!3_T>] &_H^KV>O:5#J6GR-):S;MC,A0G
M:Q4\$ CD'K5ZN2^&?_)/]-Q_>G_]'/65?W_B*;4/&45MKS6R:/''-:A;6)LD
MPF0JY*G*YXXP??U /0J*X.PUG6QK'A*XN=16:VU^!VFM/(54@80>:#&P&[L0
M=Q.<]JKZ)XB\2^(M&TO7-/MKDBYNQYMNP@%N+?S"K8)/F;E49SW8'C!Q0!Z)
M17G^I>)-0BU#3[[3=1GNK*764T^9/L\:VQ5I3&0K']X74_Q E20?P;)>^([M
MO& AU]K<:/-_HNRUB;=^X27:^5.5RV.,'WH ]"K)G\2:9!=S6BR3W,\)Q,EI
M;23F(]<-L4A3CG!YI=*O[G5/"=EJ*JBW5U8QSA1]T.R!L?3)KGOA-+#-\.=.
M93FY#2B\W??^T;V\S?WW9]>V* .JTW5+35[4W-E(SQARC;HV1E8=058 @CT(
MJY7,ZOJ4MMXIT;0;-A:#4A<7$TZ(I8^6%^5<@C)+ DD'A3ZY&#<>+]5T;4-9
MTB>1+J2WOK&WM+R9 N%NCC]X%P"4PW3&?EZ=: .S?6[&/7HM%9Y!?2PM.B&)
M@I12 2&QM."PX!SS6C7!3V]Q8?%72I+C4[B^3^R;QU26.,-'AX<XV*N0?<=N
MM1Z#K_B;7]*T+6[2WN&2\G5KJ%O(%NENQ()4Y\S<HP>>I!XY  !V^H:E::5:
M_:;V811;@@^4LS,3@*JC)9B>@ )-0Z?K-GJ<\\$'GK/ JM)'/;R0L%;.TX=1
MD':>1Z&L_P 6:+-K5K8"SU".QU"TO$NK1Y4WHTBJPVLN02"I;H<CKVKD=8\:
M^(O#!U.WUC3M,?45LX9K>\L=WELK3K#AU<Y!4R%@-V#SR.: /3J0D*"20 .2
M37!ZQX@\0^&K;5=4EM;FXTNWTYI5-[Y 9;D, J_NCDH0Q)R.-O7FI/%]AJL7
M@SQ!='7I+JW?1[G?#+!'L#;,YCVJ"!C>/F+=0><4 =;<:K8VMQ9037,:2WSE
M+9<Y\TA2QQ^ )JY7"K<ZKI+^"K7^T1+#>S>1,GD(,H+=W !Y(P5'(J%O$&L:
MCX)UGQ/9WYMI;&2Z:&S,2&,I S#9)D;LL$))##&X8Z<@'H%%<';:EK>N^*9+
M&#5I=/M)='MM014MXVDA>1G!4%E((^09R#^%;G@C5;S6O"5I>Z@Z/=[Y8I71
M=H<QRO'NQVSMSCWH U;S5++3Y[2&ZN8XI;N7R;=&/,CXS@#Z"J]]X@TK397C
MN[L1F/:96V,4B#'"EV P@/;<17G/B/7[>?Q%X?O[JRU9)H]:VHC:7<#9"L4P
M 3Y/F9B=Q"Y.,?W<UI6[)=>%/B.USSNN[U9-XY""V0+G/^R!0!VU]KNFZ;*\
M=U<[6CC\V0*C/Y2<_,^T'8O!Y; X/H:OHZ21K(C*R,-RLIR"/4&O,K&/7/#.
MF:CJUQ:V]U8W^F6TTLTT^QK>2.W5&5E()8'&1CG)([YK0LUO](^&/A_0Y8;A
M]3N[6&T:*(@2(FS,N,D %4# '/WMOK0!VNFZE9ZQI\5_I]PEQ:RY,<J=&P2#
M^H-6J\_\$S'1?%6L^&7LIK&TG/\ :>FPS;1A&($J#:Q  ?D#/1JZKQ#J":?I
M\9-XUK)/.D$31Q>9([,?NHO(W$ \D$#J>!0!K45Y??>)?$5CX;\7C[=*MYHU
MQ%]GGN(8?,9)$1MKA!L.-YY ';WK=N-2U;0?&-K;7FI-?V-[8W5R83 B&%X=
MAQ&5 )4AR,,6/'6@#HM7UNQT*WBGOWD2.69(49(F<;W8*H)4'&20,G K1KRW
MQ#<7^M^ -$U^;5&1+R[T^=K&..,P@//&0H;;ORN1D[N<'@9X])U$2'3;H1.J
M2>4VUF7< <>F1F@"M?Z]IVFRV$=Q,^;^<6]NR1LZM(>@+ 8'0]2.AK2KR"RM
MKR/X<_#P?;$9I+^Q:'=",1 Q/QP?FZUK:KXJUGPE_P )3#<7G]J?8+2UN;22
M>)$93-(T9#[ H905#= <9&>] 'I-9.I^)=+T>:6.]EG4PPBXE,=K+*L<?S?,
MS(I"CY6ZGL:H:9)X@7Q$B317<FDO:L9)+SR \<P8;=OEGE6!;.1P0.:G\91H
M/!7B*0(H=M+N%9L<D"-\ GT&3^9H LZ;XCTS5YHXK.2<M)#Y\9EM98EDC^7Y
ME+J P^9>GJ*U:XYII['X3PZE92+#>V>AB6&4QJQ&V$-CD="5&?I6;)K?B#34
MT".YOVO9=>E0#R;>-#;*(6=U3<0&+$#EO? Z"@#T.BN,&J:S80WL6K3W%K%+
M>Q0Z;.\44ES,'7+($3*[@0P!(QCDC@FLZVU[Q,MCK]HB7%[=Z;J,$2$I"MRU
MNZ1R/@+^[:0*S8['C(SQ0!Z)17G$GBN\:P@DL=4OA,FNVEG<V^H621311RM&
M"C#:!T+$,.S=3BN@74-0;XAWFC?;2+3^R4NHU$:YCD:5DR#CGA>A]30!T]%>
M<:'+XSUSP.VM0Z^OVZ6TF^SVZ6<84RK(=I)(.<A=I''4=QD[?A_6+CQ')I-[
M9W\WV'[ L]TC)'\\K\*A.W((VR;@,?P^M &UK&O:=H$$<^I3/#%(XC5UA>0%
MB0 /E!P22 ,]:;9^(M+OM2;38IW2^6/S?L\\$D+E,XW .H)&>,BL#XG?\BS9
M_P#86L?_ $>E4M-O#>^,=2O]=C$.LZ%:R)!90CY'MWPWG*QY?=M"]MIR",\T
M >@45P6@ZUXFUFP\/:Q!!</%?,DE[$X@6!(74G,9!\S*G;USGG(]*\.M>)=5
M2R-G=S6^J'4WM[ZP:T5HK: ,WS$E<Y"!&#;L,6X'.  >BUG:EK=CI-Q8P7CR
M(]].+>#;$S*TAZ L!A> >I'0UCZ9?:G/XP\0Z1-J!:"VM;62W;RD!C:3S=QZ
M<_<'6N:&J7>M^#_ .I7\JRW5QK,#R.%"@G$HZ#B@#TZF[T\SR]R[\9VYYQZX
MK@?%/B34+*._U'2-1GF33KR*":!;>/[,,M&KQNS?.6^<G*' R 1P:GL[6]F^
M*_B!X[\0JNG68(6$$E2T^!DD\@C.>_I0!UVFZG9ZQ81WVGW"7%K+G9*G1L$@
M_J"*MUYWH_BO5+O1O"EM-<@7>L7EU#+=K&HV)$93A5QMW$(JC(/<\FF:_P"(
M==T5O%>GQW[2O8:4NJ6=V\*%USO!C<!0IY3(. <>M 'H]%<6E]K6G>*O#T-S
MJWVRUU>*82P- B+"Z1[P8RHW8Z@ABW6J_AWQ)J$VMV-AKCZE9:C.L@-M-:H;
M6=@"W[B5!S@#/+9(ZT =Y17.:WJ]S'XIT30;>4VXOTN)I)U4%@L07Y5W C)+
M@DD'@'UR.8UGQ+KVF:;XVM$OMUSH<,5S:7C0IN=)$+;'&-N05/( R"/Q /2J
M*S=&MM3MX9VU/4A>O+)YD>V!8Q"I4?(,=1G)R>>:YA=8U;6=%\2:G9:@UE+I
MEU<V]O (D9#Y'_/3<"QW$'.", C'/) .V>5$.UF&[:6"CDD#K@=3U%4M(UFR
MUVTDNK!W>))G@8O&T9#H=K#:P!&"".E</IMW>Z_X^\/ZLLRVGVKPW]I,7E;B
MH:6$LF2>Y/7VK,BNM8T;P7XCUW3M4\@6&LWTHM/(1HYE%RVX.2"W/."I7'O0
M!ZW17"W6O:UJFM^)--TM+N-]+\N*W-NL!#R-$'S)YASMR0,#' /.3Q'<7GBR
M_P#$MEI$>J1Z3-=:&;N=!;QS?9[@/&I"D]1EB.21C/L0 =]16=KNH1Z5HMQ=
MS7:VJH /.:,R8+$*,*.6))  ]2*XW^W->M;CQ18O>W6;/2TU"TFNX81*A/F9
M4B,;2N8QU (R: /0ZJ7^IVFF65S>7,C"&V3S)O+1I&1?7:H)_2N5DUS5%7P-
M*+P8U5D2[3RU_>9MWD)'''S*.E9$=O=_;_B5,]VIB&5>)80-W^A)CG.1@$?7
M% 'HME>0ZA86U[;L6@N(EEC)&"58 CCMP:GKSG2KO6-&LO TIU3S[+4DALY;
M)H$"1@VS.K(P&[(*<Y)!ST%/?Q%K%]X U/Q=9W_D2VC7,L=DT2&+RX)&78^1
MNRRH22&&">..H!Z'52VU2RO)[R"WN4DELI!'<*/^6;%0V#^!!KCI=0\0ZOXN
M73M/U?\ LZVFT>+4 KVJ2/&[28V\CI@<YSW]L4M<U#4KOPU\2;*>\61+&)XX
M2T*@A&M5<@XQD_,1D^U 'I"LKJ&4AE(R"#D$4CNB %V5<D*,G&2>@KCUGNK7
M3='TA=8N?ML]J9(TLK6,S%%5!GYP451GDMU)&#Z\W/J&K>(O#O@:[NKJ.*\;
M7FAD<0 Y>,7"!\9P.$Y XR>.E 'I<6IV<VIW&G1W"->6R))-$.J*^=I/UP:M
MUR5I=:M<>+]>T9M3(6'3[:6WE6! T;N903TY'R#@U2\.:SJVMZ=I%O+?RQ:I
M!/-'JX$<?!B)5EQMP-S%"N/X23DXH [JBO/-%\1>)?$6C:7KFGVUR1<7G[VW
M80"W%OYA1L$GS-RJ,Y[L#Q@XKT.@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBJESJ5O:W]E92B7SKPNL6V)F7*KN.Y@
M,+QZXS0!;HJAK>K0Z%HUWJES%-);VL;2RB%06"J,DX)'0"K5M.MU:PW"!@DJ
M*ZANH!&>: ):*** &2Q":)HV9U##!*,5(^A'(K'L_">D6&B76CV\4ZV%TKK+
M$US(WWR2V"6)4DL22"*VZ* ,9O"^G><)(VO(AY*0.D5W(JR(HPNX!N2!QGJ>
MYJY<:397.E?V68C%9>7Y7E0.8@$QC:-I&!CC IT>I6\FJS::HE^T0Q+,V8F"
M;6) PV,$_*>,U;H IZ7IEMH^G0V%FLBVT"!(D>1GVJ   "Q)P *N444 %%%9
M?B'7;?PUHL^JW<,\MO!@R"!0S $XS@D=\?G0!J5FZQH5EKD4"7?GJ]O+YT$M
MO.\3QO@C(92#T)'IS6E6-?\ B?3[&/3)@7NK?4;I+6">V*NF]C@9.>G7D9Z&
M@!=.\,:7ILUU.L4EQ<W:".XN+N5II)$'1"6)PO/W1@>U5-"\#Z+X;N/,TL7D
M42EFCMC>RM!&6ZE8RVT=3VKHZ* .<T;P1HGA_49;O2TNK99':0VJ7<@MP[#!
M;RMVW]..W056C^&_A>/0[K14LIQIMU+YLML+N4*3G( PW"YYP.,UUE% &!=^
M#M(NY;"<K<Q7>GH8K:ZBN7694/!4OG+#V.:AG\ ^&[G1;72)+&06-M+YZ1I<
MR)F3.=[$,"S9YR2372T4 9$/AG2[?Q"^NQPRC4GA6!YC/(=Z <!ES@_4C.>:
MN:EIUOJUA+977F^1*"KB*9HRP/!&5(.*LNQ5&8*6(&=J]3["L[0=;MO$.F?;
M[6.:.+S9(2LR@,&1RC< GNIH S5\!Z FCV>EQ6\\=O8S">T*W4A>W<=T8L2!
M[=.>E7K;PW866EOI]H;BWCDE::62*=A+(['+,SYW$GN<_E@5KT4 8T_A31I_
M#YT(VK1Z:V=T,,SQ[\G)W,I#-DG)R>>^:-;\*Z3XCT=-*U:&:YLDVGRVN) 6
M(Z%B&!;\2:V:* *]C90Z=8PV=OYGDPJ$3S)&D8#MEF))_$U8HHH QX/#.GP&
M$ W4B6Y+6Z2W+N(205RN3P0&(![ \8J%/!VB)X=?01;2_P!FO()3";F0D-YG
MF9#;MP^<;N#6]10!SEUX%T"]:_\ M-M/(FH ?:HOM4HCE8 #>5#8WX4?-C/%
M71X;TY=7.J@7/VXVWV4R_:I,^5UQC=CJ2<]<\UK44 9^C:+8^'].33].C>.U
M1F94>5I-I)R<%B3U)/XU5;PII+S:K,8[C?JJA+P_:I/W@ P!][CCCC'%;5%
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M66AV1L]/C>.W\QY C2,^&9BS8W$XR23CWJ_10!EZIX>T_6+JTN;U9VEM)!+
M4N)(PCX(W *0,X8C\:CN?#&EW5U<SR12?Z6%%U$LK".XVC WKG!X !]0,'(X
MK8HH HW6DVE[=Q7%TC3>20T<3N3&K Y#;.A8=B0<8XQ22Z-9S:S#JSB8W<,;
M11L)W"JK$%ALSMY*KGCL*OT4 95[X=TV_P!:LM7N$F-[9!A;R+<2*$#?>&T$
M @X&<CFI-9T2QUZUBM[])&6&99XGBE:-XY%Z,K*00>3^=:-% '.3^!M N+?4
M+>2UG,6H%&NU%U*/.*  %CNSG &3W/)S6C-H5A<:A87\J2M=6"/'!(9GR%?;
MN!Y^;.T=<]*TJ* .77X>^&UMGM5M)Q:F59DMQ=R^7"X;>&C7=B,[N?EQW'0F
MNF\M?*\H@LNW:=QSD>_K3J* .<B\#:%#865DD=W]GL9Q/:H;Z8B%P,+M^;@
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MMTV_8V,HS;LLORCY3D<4'P5H7]D6^EI;316MM=&[MUBN9$:&4EB61@V5^\W
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M%Y<W<UH'GNH3!.[.W[R,Y^0\_=Y/';--_P"$<THP2Q/;-*)556:69W?:IW*
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M(.#G!':H[JUAO;=K>=6:)\;@'*YP<XR"#CU'?H:Y3X81I%X+"1J%07]Z JC
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MCK&B:_<Z:NIL'O+801RJ[CC>FX?*>O8]:[$< #.?>F2RQP1/+-(L<:*6=W.
MH'4DGH*5'22-9(V5D8 JRG((/<&@"&^LH-2T^YL;I-]O<Q-#*N?O*P((_(UQ
M^G?#F.U70[:]U::]L-"E,UA T*HP8?<,C _-MSQ@+[YKK;'5+#4_/^PWD%R(
M)/*E,+A@CX!VDCO@BK= '->'/"9\/ZQJ^HC49+EM5F\^>-XE4*_0%<=!CM72
MTR::*VA>:>5(HD&YW=@JJ/4D]*CLKVUU*SBO+*>.XMI1NCEC;*L/4'O0!GZU
MH]UJ4]E=6.IR6%U:,Q5A$LB.&&"K*>H^A%9D7@>TGGU:[UFY?4;W5+7[%/+L
M$2I!@_)&HSM&3G)).>]=510!ROAKPW>^$[*.WN/$T]UI-E$5ABN(8T\N,#C?
M)U(4?3\JX/X5Z%%XD\'36M]JGVC3!J$DLNEJB#)$FY-[#YMA(#8XSCKCBO6+
M[6M+TR18[[4;2VD8;E2:958CU )SBI;+4++4[87%A=P74!.!)!('7/ID<4 <
M7KGPP@UK4?$%P=:O;:#7(X4NK>-$(S%@*0Q!(&!T&.3^%:,G@MY?$VCZZ^K2
M^?I=N;>-!"NUU88;=[GVZ5UE% 'GNH?"J"^FU?\ XGM]%;:E?IJ#6ZQQD),I
MSG<1DCC@9 'O6VW@\'QLOB9-3GCE>S%I=6ZQH4N%!R,Y!*\^GIUKIZ* ..\,
M>![GPF_V33O$-U_8BS-+'I\D$;%,G)42$9VY/3&?>G+X&^T:MI=[JFI?;1I<
MS36N;=4E+'( DDR2P&>  .@SFNOHH YWQEX43QCHRZ9-?2VL E65C$@+,5.5
MZ].:AU3PA+JOB+0];FU9TN=($GDJD"[7,BA7+#W 'TKJ** ..OO ?F:SK6H:
M9JLEA_;<"P:A%Y(D#84J'0DC:V"1GD<YQ2/\/+1+KPU)97TUK!X>5EM(0BMN
MW !BY/4D#MCG-=;<W5O96SW%U/%! @R\LKA54>Y/ J*/4K&:S2\BO;>2U<A5
MF252C$D  -G')('U- '%2_"^"XT#Q%I$^L7+0Z[=_;;AQ$@9)-ZN=OL=H&#7
M87&F_;-!FTNYN'/GVS6\DR *V&4J6 Y /-276J:?93I#=W]K!*X+)'+,JLP'
M4@$\]#^5.L-0L]4LTO+"YBN;9RP26)@RMM)4X(Z\@C\* .;F\&W>JBQ@U_7'
MU&SLIDN$A6V6(RNGW3*P)W =< *">M1OX&GM/%%_K>B:_<Z9_:6TWMN($E1V
M48#KN^ZWY]:[&FR2)%&TDCJB("S,QP !U)- '-GPDQ\=IXJ_M.7STLQ8^08E
MVF+=OZ]<[N<_I2WW@G3[[QS8^*G>1;JU@,)B7[DO)*EO4J22/?'I6Y8:A9ZI
M9I>6%S%<VSE@DL3!E;!(.".O((JS0!S<_A,S>.H/%/\ :,BS0VQM%M_*788R
M=Q!/7.>]4O#7@63PK--:V&MSG0I)7E7398$8)NZJ).NWV_7KGL:* ./\+^"+
MKPF19V'B&Z.B)*TD5A)!&Q3))*^81G;DYZ9]Z["BB@"GJ-K=720&TO/LLL4O
MF9*;U<8(*LN1D<YZCD"N=G\"QRE98[T0W!U--4F:. !7F10J@+GA<#D9))YS
M7744 <MKG@J#7;S5)YKZ:)=1TY;"9(U'RJK,P93ZY<Y!R"*EMO"]U!K2:Q)K
M,D]\+)K)C) H3:6# A5Q@Y ]>_MCI** ./A\"FWT'0M)CU5_*T:Y2X@=H06<
MKG:&YZ?,<XQVZ=]OQ)HH\1^'[S1WN&MXKN,Q22*H9@IZXSWK1^T0"Y%MYT?G
ME/,$6X;BN<;L=<9XS4E &"?#LTGB+3M9DU#=+96SVPC$.%=7*EB>>OR+C^M9
MK> 8O((BU.>&ZBU.74[2Y1%W022,Q=2#PR'<1@]N]=A10!SFJ>&;O5[&S6YU
MF07MG>)>0SQVZ!%=05QLYRN&/4YSSGBJ%[X"^V6>MVK:Q/MUB:*:XD:)2X:-
M4'RD8 !V+V]:ZZ"X@N4+P31RH&*%HV# ,#@CCN#Q4E &-<:$USX@TO66NR+B
MQ@E@*"/Y9!)L+'KD?<&.?SIFL^'GU35],U2#4)K.ZL/-52D:N'20*&!##@_*
M,'MSUK<HH R/#NA+X>LKBU2ZDN(Y;J6Y#2 ;@9'+D$CKR34&E^')--\2:MK)
MOS,^I^5YT1B"JOEKM7:<YZ=<YS[5O54DU.RAU*'3I+J);R92\<!;YF4=3CTX
M/Y&@#-U'PX]WXDM=;MM2GM)XK9K61417#QLP;C<#M;*CFLR#P*;;2]$L(=5<
M1Z/=F[@9H02[$.,/SR/WC=,=J["B@#%OO#[77B6QUR"_EMI[:![:1%1666-F
M5B.1P<H.164W@*&?2=2L;G49F-Y?_P!I1SQ($>WN,A@R=1@%1@'WY.:Z^B@#
MF=4\,7^M^'Y=*U'6VD\UXV:6.U5"-C!Q@9ZDJ,^W0"L6^6YN/B[!!:ZPEK=)
MH?[S$2N)/WW(VDY'J,'\Q7>7%Q!:6[W%S-'##&-SR2,%51ZDGI45G/9ZA;Q7
M]H\,\,RAXYTP0X(X(/?B@#!O?!D$HL9+*^FM+RTO7OOM!59#+*ZLCEU(P<AB
M!C&,#& ,55F\!^;8W]F-7G\N\U)-2=WB5G\U2A R,#;F->,>N,=NQHH QGT'
M?XH@UTW1\U+)K)XMGRNI8,2.<@Y ]>*/"^@MX:T.#2A?RW<%N-D!E15*1CHO
M Y/O6S10!SUKX7,$^OR/?M)_;)W2CRP/+/EB,;>?[JCKWJI9^"GL+G2;BVUF
MXCDL-/&FDB)#YL(((ZYVM\HR1U]*ZRB@#E]*\*76B:79Z=9:L&M[>)X2ES;>
M8LBLV[) 8?,.1GT/2M*P\.Z?8>&5\/I&7L/):!U?^-6SNSC &<GICKQ6M10!
M@:%H%_HEI!8C7)KFRMH_+MTE@3>% PH=Q]X 8Z!3QR34)\'0KJ-AJL-[-'JM
ML[M-=[03=*_WDD'0KPN!_#M&*Z6B@#SKPI:RZKK'C!8-::.R?6)$EMH40L1Y
M48+*_5<]/^ \8/-;\G@^.UU>#4M#O#IDT=HED\2Q"2*2%/N J<$%<G!!Z'O7
M1I%'&24C52?[HQ3Z ,&\\.S7>M:/J;:FYETQ9 H:%3YID7:Q;&.P&,8Q[U'=
M^$XM0UZ_U"\N3+!?:?\ V=-:^7A3#ECP<YSEVY__ %UT5% &#HVAZEH]G%9_
MV[+<V]O'Y5N)K=-P &%WL/O8&.FW..<U0B\#I%X.M/#O]I2M':7$<\,YC&[*
M2"0!AT/S#VXKJ7N((YXH'FC667/EQLP#/CDX'?%24 <U;^%I].UB^OM,U>2U
MBU"03W=L85=#+@ NA/*D@#.=PI=/\+3Z1?7C:9J\UO87=PUU):&%'V2,<OY;
M'[H)YP0>IQBNDJ*XN8+2W>XN9HX88QN>21@JJ/4D]* .;?P84O\ 59+/6+NU
MLM5+27=FBH09&7:S(Q&4R ,X_#%;&@Z7_8>@V.E"<SI9P)!'(5VDHH"C/O@5
M;M+NWO[.&[M)DFMYE#QRH<JZGH0?2IJ .,L_ !L[/2[1=:N9(-*O?M=HCQ)@
M??\ E<C!;_6'G(KLZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@!'W!&V %L< G S7E_AWQ/J6C>#-.FO#'<2ZEJTUI VV25U8
MSS%F8#E@ AP!R>!D=:]1KDAX L!H[:8=0U P)>?;;-MZ![*7>SYC8+D\NWWM
MW!Q0!GZIXNU[3=#\27BV<;?V7"EQ;7,]G+#'<*0=R;6(.Y2.2#C!' JSJNM^
M*M(AL))X](9K[58K2.-5D^2*0#&6SRP(;D#!XX%:FH^%VUCP]>:/J6LW]Q'=
MILEE"Q(VWN!A,#/KC-2:KX:36(--CN-2O%-A<I=1O&(P7D3[I;*$8Y/  H Y
M_P#MWQ:;KQ!IROHQN](CCN!<&WE"3HZ,P39YF4/RL"VYNW%3+K[ZEJG@:]-A
M9&/5H))E:6,M-;,;<R'8^>,\*>.1]>-F+PQ!'JVL:@;Z[=]5B6&>-MFU54,%
MVX7((#'J3[U5M_!5M:_\(_Y>IW^-"C,=J#Y7S*4\OY_DY^7CC'YT 8<_BKQ2
MNA^(]5B72-FA74Z/&T,F;F.)58X._P"0X)Y^;/' QDZWB'Q)?6EH\VF7%BDR
M6(O!;2V\EQ(XP3@B,CRUX WG(R3QQS9B\&6D>CZ[ICW][+!K3RO<%S&&5I%V
ML4P@QQCKGI43>!K8W-Q*NJZD@N[)+*Z1&C G1 P0D[,J0'/W2,]Z ,>;5=4U
M;Q?X-NK/RH(;S2;B[,,CL5RP@)R!@$@/@'W-.@\4OI-EXAF:PL5NH]<33XOL
M\9C6>2180LDG))/[SD^BXK;3P=;POH4D&I7T4NC0-;0R*8R98B%!1P4Q_ O(
M /'6F'P-I\MGK%K<W5Y<1:K<B[EWLBF.8!=KQE5!!&Q<=>E #;C6M6T[Q58Z
M)=-9S#4[>9[2XCA9/+EB +*Z[SE2&R"".F/>L33_ !CXBF\/^'/$-S%IGV+4
M[F"WFM8XY!(GFOL#JY;'!(^4KZ\UU4?A_-Y'?7>H7%S?0P-!!.ZQ@PAL;F50
MN-QVKDD'IP!SFC%X'LH?"VGZ M]??9M/GBGMY28_,4QL'4$[,$9'I0!TLTJ0
M0232'"1J68^P&37#W'C+5+?P99^,3%:MILQBEELPC>:D$CA00^[!<!@2-N#R
M/>NZV@IM;YAC!R.M<U;>"K*VTZ/2?M5S)HT4PEBL'VE%P^]4W8W% P! )[8)
M(XH HZ++J<OQ-\3JSVYM(DM$*DL7"['*[>PY))^M;'BOQ /#>D1W0B\V6>YA
MM85P2-\CA02!R0,DX')Q@=:DL/#\=AX@U+6$O;J274/+\Z)]FP; 0NW"@C )
M[U-KVAV?B+29-.O?,$;,KK)$VUXW4AE=3V((!H YG4/%.NV-GK\J6J2Q6&FF
M_@NY;&:"-V4,6A96.2WR@@@]&Z<<@U[Q0NLZ/82'2-NLVDDT+K#)_HKHJ,0P
MW_O00W&-E;5QX;EO]"O=*U#7-0N8[R V\DA6%6","&QMC R0>I!]L4@\*Q?V
MEHU\VI7K2:3$\,"GR]KJP ;?\G.0H'&.E '/7'C+7(/!6I:EY-@=2TS4C83+
ML?RIOWJIN4;LIPX/);I6H=9U[3/&&F:9J:V%Q8ZJ)A"]K&Z/;NB;]K;F(<$
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MIALM9E@@EMHHW$D1E!PX<L01G'R[?Q-7/#LNJ2_$'Q8LLD)M(I[=-A9F*CR
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M00:J:GX6.LZ!/I.HZSJ$R3LIDE B1\*00!A, 9 /3/O0!FG5O%(\5R^'S)I
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M"]K&\:3>?MV90EB,%CG!.<<5I1>!+2#1]$TR/4]0$&C3K/:G,6[<H(7<=G(
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M]\<5NT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ)?!VDQ2W4L/VN*:Z:)Y95NI-S/'C8Q))YXY]>^:U["\CU#3[:]A#"*XB65
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MH8BG6[@MUN69E 1D9BH(.>>5/;M6I0!6L;%+" Q)+<2Y.YGGF:1B?J3QTZ#
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MK6^A#"*YB29 XP0K $9]^:L4 8L'A72X+75K94G:+5BYO%>=V\PNNQCR>"5
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MB3P)H,OVD-#<^7/="\,0NI B3;P^]%W84EAGCW[$U?M?#NGV=_J-[$)S/J(
MNF>9F#X&T<$X&!QQBK-EJEM?W-U;1"99K4HLRR1,NTLH8 $C#<'L3BH+[7;:
MPUO3-*FBG,VHLZP.J@IE$9R"<\<*>U %-?!>C1VNDV\:74:Z3D6;1W4BO&I&
M"NX')4@ 8)[5T%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 CJ61E#%21@,,9'OSQ7E"ZSK^G> ]5\5R:W=7<]G+=VL=O)''Y
M>!<F-9& 4990,^F.PY)]790Z%3G!&#@X/YBLZS\/Z586,]C;V:"TN-WFP.Q=
M'W9W9#$CG)SZYYH YV6YU32)KG5)[BXM=#CTZ62YDNY4G9)1@K(@4GMNRO Z
M8%4+;4]8MO%<MG'=W*0W6AS7L::I)&WES(Z*KG9]Q3OY&<<=!756OA31+.SF
MLXK!3;2Q&!HI7:11&>J ,3M4^@P.!3(?!^@0*HCTY%(@>VW;V+-$_#(3G+ X
M'!ST'H* .'N_%VJ^'](U%[RRU6UUN#2WG\F\=9[>9E9%:9&4D#:7R5PHP1P*
MZ#59K_1=<\-BRU*YNH-3G:TN4D8/NS$SB9<C"D;,X'RX/2NCM]"TZW\S%N93
M)%Y+&XD:8F/NF7).WVZ4RR\/:7I^S[-;LOEQF*+=,[^2AZK'N)V#@<+CH/04
M >>-J.NQ^ +OQ(?$-Z]Y8:C-&B%8Q')&MT8]KJ%YRO<8QQC'?8\::Q<K;>(7
MTG4+^.[T:S\]C"8TAA?89 'W<R%ACC!&,=":ZA/"^BII-QI0L5-A<.7E@9V*
MLQ;<3R>I;D^IIEQX1T&[N9[BYTV.:6XA$$S2,S>:@7:-V3\QQQN//O0!R[03
MZS\1;;_3I[)IO#B22/:[0YS-G + X&3Z9]ZSOM>HW%AH,6I7+7;6GBXVL%VZ
M@-/$@E"L<  GJI(Z[:[FX\):'=3VT\MEF>VB$,4HE=76,$G9N!R5Y/!X-6+S
M0-+ODM(Y[12EFX>V1&9!$PX#*%(P0,X/;)H Y.[U'4=*\3:YI$U_<2O?6J3Z
M,&8#:Q;RW3('\+E&SSA6]JZ]G31]">2\O7=+2W+S74PRQ"KEG('T)P*STM6U
M?Q+!?W>E26ZZ5YR6TL^PM([X4NFTDA=H[X)W=.*VYX8KF"2">-9(95*.CC(9
M2,$$=QB@#@M-U/4_^$NT6%;[439:OI\\K"\,1;<@C*RHJ@[,[S\IX]N*R8]1
MUQ/AY'XG;Q!>R7EMJ#1^65C$4L8O#$5=0O.5[C&.,8[]Y:^$-"L3;-:V"PO;
M*R0R)(X=%8 %0V<XP!QG QQ4B>%]%31Y=(%BO]GROYC6Y=BN[=OSR>/FYX[\
MT <[8V,\WQ5\1NFJ7<.VPL_EC6(@@F? ^9"<#J/KSD<5G:/XFU*?P_X0MKJ_
M?S=8O+F"XOB%#X0RE5'&T,Q55Z=,XYP1V[^'M+DU)=1:U_TU8?(%P)&#E.<
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MJRL.C.@.UC[D$UKT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5)/[/UBXAMXS?2%40PH""">?O9&>A QCG(!UFC:P=:62Y@ML:<P!M;KS ?M
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M2>.&65F5D$A&]0Y55..A;(KI/!]U.=4U;3[S2I-.N[=87DC2\-Q;L&WX:,D
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M_#'93VCK<^3J,LKWH9 0>B[75AG(.1R* .]JKJ=XVGZ9<WBP-.8(VD\M6 +
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M4445]IMG=1Q?ZM)X%<)] 1Q5TD 9)P!2 A@"I!!Z$4 )'&D4:QQHJ(H 55&
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M1F6*.8S95'.]0'$.U02>S =:]"T;1KZQ\4:]J5P;8P:D\3QK&[%H_+C"<Y4
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M!N+XVX&<[L]!FH+R&_N])\8K96MS+NUZ*Z: 1,&NK91!Y@3(^8$(XP.N".]
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MNZWJ6G^*_#^E6HM3!JKS(SRQL6B\N,R$C# '.,=L>];$FM:5"5$NIV:%I/*
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MMJ5C>M,MI>6]PT!VRB*57*'T;!X/UKS;Q+I6GOX7U&ZM&O-1DU'5;.=PUHP
M*21!VC4(."BY8C.>>:W'TZUB^)D+1:>BV5WH4D+E;?$4C>:I56XQG;NP#VS0
M!TGA_7+;Q'H=KJMHKI#<IO5),;U&3C(!.#Q6>VOWFI>(;W1M%2W!T\)]LO+D
M%DC=AE8U12"S8Y)W #(ZGIG?"V&WMO FG6Z63VMW#"L5VKVS1-YJ]<Y W$>O
M-5+1IO!?C379;^VN'T;69DNX;V"%I1#*%"ND@4$J#@$-C'O0!U5A)K,5]<1:
MH;*2V6-7CN;=&BR<G*E69L8 !SGO5JVU33[P2FUO[6<1?ZPQ3*VSZX/%<IXP
MOVU[PG<IHD=Q>"*6":>..!P)X5E4R1J2 &)4'Y1G(X[\MO%M]7\;Z+K&G_/9
M6ME<IJ$WED*\;!?+B8$<D-EMO48.<9&0#JTU?3);F*WCU&T>>52T<2SJ6<#J
M0,Y(X/Y57MO$%G<ZWJFEC='+IPB\UY" K;U+#;SV'7.*\TT_2HX?A3X9E32I
M([ZTU.TDE_T5A-'BX&\D8W?<SGVKH=-MM-M?B!XJ>[TP W"P3P2FR+*Z>3AR
M'"XY;((SDDT =K%J=A<.R0WUM(RQ^:P2520G]XX/3@\TMEJ%EJ432V-Y;W4:
MMM9X)5< ^F0>M>9Z!;0Z'\'[6]M] 275$MXH;J.6T8R8,B[C(H 9P@.[;Z+C
M@5!?VFIW=UXR;1EO'N+_ $:V:"4VQMQ<.K2[PG YVD 9YY'.,&@#T2^\4:/9
M6&IW0OH+EM-MY+BX@MY4>550$D;<\'C'..:MQZK9MID-_-<1002(K;I9%4*2
M,X)SC-<;KCZ1XG\!ZN-,TN1KU='GBBMWLG1XLID1X*@;@RK@=<CBH+62WL]<
M\,:K%:/#H(L9H"1:M$MO<MLQ(ZE01E59=Q&.2,\T =X-2L39K>"]MOLK?=G\
MU=A^C9Q6?J/B""Q>VN%E@FL#="SNI8W#&"5B%3.. -Q"D'D;@>@->>^(M)D;
MPUXWFBM)GL-1OX)-/@2%BS.!'YLB*!D!F#'/?!/0@GH_'%A8V_PUU.WTBUAM
M_MK1+"D$80/,\B(IP!USM_*@#N:J0:II]S</;P7]K+-&"7CCF5F4#C) .15#
MQ=:ZA>^#]8M=)8K?RVDB0%6P=Q4X /8GIFN8N%CUT>#3HUO)!=:?=QR3J8C&
MUI (V62-\@;<_*NWOU' S0!VBZQICP/.NHVC0QD!Y!.I52>F3G ITVJ:?;F$
M37]K&9@#%OF4>9GIMR><^U<7#H]Q:^*M5\.K:.VBZK,NJ&0+\B<_OXB>GS.J
M<>DC^E9\UJ[:YXNTG7KF]MX-5E'D/'9F59[<Q*@5&"MAE(;Y?4Y YS0!Z+<:
MGI]HS+<WUM"R %A),JE02 ,Y/J0/QJ+6]6@T+0[[5KE9'@LX&F=8P"Q"C) R
M0,UQ0T73)_B8D%Y8-=VZ:'' )KJW+*\HD/WF(QYFW!SU&:W_ (A6+ZC\/=>M
MHK4W,S64GE1*FYBX4XVCU],<T 1WWB6>U\3:%;B2T73-0@N)9FD&'B,:*WW]
MVW'S<\=NM=#!?V=S9_;(+N"6UP3YT<@9,#J=P.*X&=-+O?%'@LVFG-]@2.Z9
M@;)XT1F1 I8%0 2P.,]Q6-J=C?6CZW'86=S%9V_B>WOIHK>V+;[?RH][HF,.
M!( Q S]TT >L6M[:7T9DL[J&XC5MI:&0. ?3([U5>]G77DM ;/[+]F:1R9\3
M!PPQA,?=P>3GKBLKPW:V,NK:CK5K?W=U+>1PI,9(#%&=F[:0-HRV#@\GH.E4
M;P1)\6+2=K=O*_L>>*680DIN,D156;&,[5;B@#IUUC3'N(K==2LVFESY<8G4
ML^.#@9R<8-/M]2L+R.62VO;:=(6*R-%*K!".Q(/!KR)M,M#\-W3^R7^V#Q!Y
MRJ+-O,"?;=VX#;G'E9Y]*["&WM+'XE7\BV8BT^ZT2 LR6Y\J1UDDX.!@L%(X
MZXH ZJ/6-,FG6"/4;-YF0R"-9U+%1U;&<X]ZEM+^SOX#/9W<%S""09(9 ZY'
M49'%>0Z?I=I'X#\!)+I+K=0:E$;I3:-OC3#AR_RY"\KG/'2KWB+2[\2^/;31
M[*9&N%L)TBAB(%PJX\X)QAF*C!'?..] 'I]IJ%E?[_L=Y;W'ED!_)E5]I/K@
M\5SVK^*3;>*-#TRPO-/G6[NWM[N$'?+%B)W!X;Y>4QR*Y[5;)];TK5]6T'4=
M0N-9;2'M(D^S&W&TL&VGY!B08( SD;CQ2WFH:?JFK^"KO3M*NXH;.\99G>P>
M,VJFWD7RVRHQ\Q&<9' R>1D [FQO9Y[W48YC9^1!(HA:&?>^W:"?,&/E.<_A
M3X]8TZXL[BZM;R"ZBMPQD-O*K[<#)'!ZUP$MS)IL_P 0KFTTAKH236[10-;.
M4F7R8TD8 #YPIW$@=<'UHMK7[=XMUJ189[F"_P! 10\ED88YY \G 4J.@QC=
MD^Y&* .YTS7K'4_#]IK7F+;VMS DP\]U4H' (#'. >1WK.\1^(9[&ST>\TF:
MSN+:[U*WM)&(,@9)) I*,K  CGUK@[!'LM*\!WUK;75G864#0ZDT>GMNBN3"
MBAW0KEL$.I?!QNZUJ:M8VMEI%I+82WUXMYXDMK^4M;, N'0R,JA1A,+DGIDG
MF@#T,:GI[231B^MB\ )E42KF,#J6&>,>]2P7,%U )[>:.:)LXDC<,I_$5Q&N
MV]WI7C:.ZTR-]GB2V^PS21C_ %4\8+1S'Z1F7_O@5VMG9V]A8P65K$L=O!&L
M4<8Z*H& /RH K/KNCQ[-^JV*^8YC3=<(-SC&5'/)Y''O4USJ=A9EQ=7MM 43
M>WFRJNU<@9.3P,D<^XKS#2HM&O=-\9Z,VE_:K^XU.]2.'[(QWY/RXD(VJ >^
M1M//%78_#]J/&?A[3]9M%OQ;^'VM+F>2W+QR3;H0-S$8)(#D9H ]"EU*QM[B
M*":]MHYI<>7&\JAGSTP"<FDOM5T[3/+^WW]K:>8<)]HF6/<?09/->:QZ>;B7
MQ5H'B"ZU"U^WZC)+%Y-F9/.@;;Y1C<(W*A0,=5VUJV4L%EXB\3Z;XDM;B5;^
M5&M9GMWE2XMO*5?+4J#RK!LKP<L2.N: .WFU&QM[F.VFO;>.>7 CB>50SYZ8
M!.34&KZG!IMFQDO[.TG<$0FZ8!6;TQN!/T!KSJ*P-T_BC0/$%WJ-J;[4I)H_
M)LRYFA8J8FCD"-RH"C'5=M:MM=?8=?\ %&GZUI]W=3WTH:R<VK2QW%OY2J(@
MP!488/D,0,L3W)H UM#\1:AJGA?PUJ3KIZSZD(WN5>4QA5923Y8.2S9P "?Q
MK<GUG2[7/VC4K.'#B,^9.JX8]%Y/7VKS2S3R_!7PX62SG%S9WEOYX-N^^!5B
M<,6XRH!*]?:M*STNQN];\?B32U=;C9Y)DMCB11;JK;,CGYP<X[T =_=7UI8P
M>=>74%O%_?FD"+^9J2"X@N8Q)!-'*A (:-@P(/0Y%>56VI/HD7@74)S,9CHK
M64T%Q;2L(V"1%F.Q697W*!@K@C/(QSUOP]@T*U\-?9=#N8K@0RNMS(L!B;S2
MQ<AE(##&[ !Z#% &I_;L=QK6I:);'R[VSMXI?,F4-&3)OV@ ,"<;#GIU%4O"
M'BF+7?#VDW%]=64>J7MN)S:QR!3@Y^ZA);'%9%O!8Z?\4->N;O3RK3V=M+;7
M LV8$J)1(0X4@'E0>03D5SNGZ6D'PP\'S+IDB7UGJ5F\Y^S,)H\2CS"W&X#;
MG/M0!Z9;:C*U_J27+V*6ELR>4\=QN?!7YO,&,)\V0.>15;5_%6EZ3I%SJ'GI
M=+;^5OCMI%9AYK!4/7@'<#GTSC-<FJP?VK\0@;1_)N(83%_H[;9B(-IV\?,=
MQ X[U0O- L!\%K5K?1@;Q;?3S=*MH3,3&\9?<,;B0#)GO@F@#TQ=2L6NA:K>
MVQN#R(A*N\]^F<T^VO+6]1GM+F&=%.TM%(& /IQ7$^(5CTBZT#Q9HFGL\<1-
MA+;Q0F(R0SD!/E(&,2[#T_B-;8T#4[?2K2UTS6182H7DNI!:K+Y\KG<S?-TR
MQ8_C[4 :]SJFGV<Z0W5];02R8V1RS*K-DX& 3SS56/53'?:G]MGT^&QM1&4E
M%R-XR#N\T' 3D8'/-<3KT.HV>IZO/I.HBZOI!#'<:3>V6]+YEC4!HV7!4$'D
MC*J02<<U?TY[2V\9>-9;JRD-G-%;;@+5F6?",KA0!\YR0"!GK0!V_P!I@W0K
MY\>Z8$Q#>,N ,_+Z\<\51US5AI-G$4C$MU<S+;6L1. \K=,GL  6)]%-<EX*
ML[OP]K4FD:E9W'EO#OTJ=LRK;V^<FU9L85D..<_,,<G:*U/%*LGBSP;=/_Q[
M)?S1N>P=[>0)^N1^- !XEUSQ'HUI?:C::=836&GQB2833.DMP H9_+ ! QG
MR3D@CZZ=[KK+?6NF6-OYNI7,/GF.0[5@BX!>0\GJ< #DG/0 D8WBB?3M8M-2
MTV:&_&J6RLMK% 949WP&C>,KA3SM^;HI!SC!K"M]!2+Q#,WC53=_:M&LXA,=
MQC>:,.)5^7^/<P9>YR=O>@#N;S59-,U'38+P1FWO6^SB= 5VW&"P!!)^5@&
M]" .=W&M7F=Q9:E;?#CPMIU^TS:FVJV8C\YLR*!/Y@W'U6)>?H:],H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $?<4;80'Q\I(
MR ?I6+X5T*?PYHQT^:\2ZQ/+,)%A,?\ K)&D((W'H6-;+NL<;2.P5%!+,3@
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M]CXQ@TW7/$D&NZPGV2TN8EM6= -L;0HY)V#H"WWCTXYH [BBJ-QK%A;)"[7
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MW\US$UHP,,\4F/E8Y!1EQMY(& ,&NV\.:'%X;T&UTB"XFG@M5V1O-MW;?0X
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MO_"=E#8ZB\5O?ZFUU&8Y;.YU*61)$9@6"J\FU3C.",8]10 _6?$EM'H>JO\
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M!D0Q&*21F#L-V\,H8Y&TY('/.0 =-=^,M'M+Z\L6:\EO+15>:""RFD<*V<,
M%Y7Y3R,CISR*HZIXYLK8^')K%A=6>L3E1*D4CD1B-WW!5&<Y4#'4<\<&ET72
MKZQ\;ZK=26<HL)K*UMH9VD0EC%YF20&SSO&./7I6#IWA_7M.\/\ @\'26EN=
M'OI7N+=9XP2CI*H926VG'F#@D'@\4 7;/Q4FD^)O%*:E=W]S:6SV[PQI;/*8
M(VAWL2J+E5R3R1V]JZA_$6G>7:-!))=F[@^TP+;1F1GBX^? [?,OUSQ6-IFG
M:DGB3Q9=3V#Q0:BL/V9S(AW[(MA! 8D9/3(Z>G2L.S\*W1\/>'[34-(U2&^T
M[35MUO-,OHXI8G& RD^8 RG:I&01P<XH ZB?7C;ZMHEPLK2:5K($,6Y-ICE*
M&2,\@$!E# @]"%Z9-=%7!W]EJ4L7@C1]0N!<ZK%>)>7<J_W88VW,< ?Q,BYP
M,EJZ_3KB^N!=?;K%;3R[AXX<3"3S8A]V3@?+GGY>U %VBBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BNH!=6DUN9)8A*A3S
M(FVNN1C*GL?0U+10!5T_3X=,LUMH#(R@EF>5R[NQ.2S,>22:M444 %%%% !4
M*6L$=W+=)$JSRJJ2..K!<XSZXR?SJ:B@ IDT*7$$D,HW1R*489(R",'D4^B@
M!D44<$211(L<:*%1%& H'0 =A3Z** "BBB@ HHHH **** (5M8%NWNQ$OVAT
M$;2=RH)('TR3^=3444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M RL2 0<'!P>AI: "BBB@ HHI"RKC<0,G R>IH 6BBB@ HHHH **** "BBB@
MHHHH **.E(K!E#*05(R".] "T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!#=6ZW=NT#22QJV,M
M#(4;&<X##D>G'-<M\--Q\' O))(?M]X-TCEFP+B0#)/)X KK)A*8F$+(LF/E
M+J2 ?< BN;T#PWJF@^&+K2H]6@:X=IY+>Z6U(\IY'9\E2Y# ,W3(Z4 0>-=$
ML+ZTN+N]L+_49A;E+:&V9_W3 $[U"D88DCGK\H K!A\2R7]MX9T2QNKW5HY-
M+^V7EQ9?)-="/;'M#.5V;GW%B2I^7&<FNQ^Q>((IR8M5M'BDB0/YULQ9) N&
M90' P< [>QSR<UGV7@N/0KG3+G1)E22RM'LG6X!83QLX<DD8PV\%L@8^8C'3
M !I^&=6T[6-%2?3('MH8I'@>VDC\MX)$)#(RCH0:V*R]"T9-$LIHA)YLUQ<2
MW5Q+MVAY9&W,0.<#L!SP!R>M:E !1110!SOB71]5UB^TE;6>"/3K6X^U743N
MP:=D&8DX!&W=@G/H.#7%^)-!\3Z5X$M%"2ZS>R:N+W6X;)F#7418DQIWVX$:
MX'8>E>K5DZY8:G>"RFTF_AM;BUG\TK/$9(YE*,I1@&!'WLY]0* .'\&>(?"]
MUKNHQZ#H=WH^LI9;I-*N;<6HD"M][ R,\@9QG!J./XNWA\,:;XGF\+21Z'=3
MF&:X6]5GA_>% P3;EAQ[<\>A/3V7AF>+Q)=>*M9NX)M0^Q?8XDMXC'%#$"6/
M4DLQ/<XXXQ7"_"SPY<>)/A?HMKJ=Y;/HD=P\XM(H2)79)F(5W+$%=PW8"@G@
M9]0#I?$?Q1MM%N]8AMK6WN1H_E_:Q->"&1RW.(5VG>0.3DKZ<U?NO',MS=M9
M>&]*_M2[BLDOIDEG\A4C<910=K$N1VQCWJO)X)U33_&6I:[H.IV44>J;#=VU
M]9F8*ZC ="KJ0?;W^F)+SP=JUOXU?Q/H6K6T%Q=6R6U[!=VQDCEV]'&UE((Q
MTS0!5LK^UF^+YCFT.2#5VT$3FY^UEAY7F*/+\O  .XGGV]ZYKPY>W&L0^-]8
MU?0!?2V]U>VWGO<JCQP*J@VRD9( 4L<C@DYZ\UVZ^$]1'Q"_X2LZI;%O[._L
M\V_V1AE=^_=NW]=WMT_.JFC>!M2TG1/$FG#5[64ZU<3W)D^QL/)>8 ,,>9R
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M&IZ9,D4MNEP'C;>JLKB0@?+ALG(R,'@UBZAXAB\2>'/&&DWEG:B?3[!G8PW
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MMD\MW1-A#*IW=6&0I]LI/H>J:S#;6VNWEE):PS1SNEK R&=XV#+DLQVKN )
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M.+:/?M4A5W,S-@X4#'(!.2.*H#Q'?Q7$&FW.EQ1ZQ<O*((%NBT+1QJI,ADV
MA?G4?=)R<8ZD9L?@G5(M)\/@:Y&^KZ"2MM=O:G9+$4V,DB;\G*@<@@\ U=U/
MPYJM_>Z5K":E:P:QIS2!66V8P212 !HV7?G^$$,#P1TH EA\27SW]OI,NEQ1
MZQ*DLS0_:28DA1@OF;]F2&++@;?7IBJ$WCTP6-V\FEL+NPU&*PO+?SQA#(R*
MCJVWYE(=3T!Z\5>N/#VHRZSI^O)>VJZK;0R6TH$+"&>%R&V8W$J05!#9/?CG
MBKJ'@@WVCZO&+Y8]4U*[AO7NO*RBO$4,:A,_= C4=<G)/M0!IR:_,OBR305L
M-S_8&O8YC-@/AU3:1CCD]?:L*T\?W=QI.DZS+H!ATJ_N$MFE^UAI(F>3RU.S
M;RN['.0>>G<Z-OX=U@>*$\076J6DEP-/:R:!+1EC&7#AA\Y/4#.2<^U4X? ]
MU%X%L?#AU2)I+.ZBN$N?LQ ;RYA* 5W]R,9S0!-HNL:K=>/_ !'82P2-86QM
MTB+.@$.8RQ( Y.XD?3CITKKJY.YTC5])U77=:TZ>&X?4((]MH8#N\]$V(0^[
M 3)!.0< &NCTZ&ZM]-MHKVY^U721J)I]@7S'QR0!P!GM0!P=UJ.H:M/X^TV^
MM#+IUM'Y<0E9"L(^S!_NCKECNSVR/2K/AOQ)>:=I'A"RN](\NPU"U@MK>Z6X
M#.)!!N >/' (1L$,>V0*T9O"VH?VAXDEMM2MTMM;C&Y)+9F>)Q$L60P< C:N
M<8Z]Z'\)W3:/X8L_[1A\[0YXI?,^SG;,$B:/&-WRY#9SD]* *K?$:P-M'?PI
M;RZ>]Z+0D70\\9D\KS!%CE=WOG;SCM7:URN@>&=2\-[K"RU"T?2!</-#'-:D
MS1*[EFC#AP",DX)&1GO754 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<MY;0365QL7S))ODC?>I*E<*<L,GY3QTH [>YOK2R$9N[J" 2,$3S9 NYCT
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M@>M<O?:PWB3P[X&UF>W2"6XUJ!_+4[@G$HP#^% 'I%,EEC@B:6:1(XU&6=V
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M5_X$M]0GU65[^>-[Z\AOHGC4![:>)55&4G((PG(([FM_3;6_MT;[?J(O)"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*VE2JDKRX53(YRO  /&1GG-3ZQ:7MM8?$G0ET#4IKG4+O[59^39LT;H2/F#
M8X]!SS]: /1]<\3ZC8^._">EV<EG+I>M>>7;RR7 CCW@J^[!!R.W;KS71R:]
MI$6JII4FJ62:B_W;5IU$K?1<YKSK4?/E\7?#6YCL-0:"Q@G%TXLI<0EX510W
MR\?,"*Y_Q#-JVMZG;RRZ!>6TFF^*HFV6NF,1Y ))F:4 ERV,_+QTR.E 'J%O
MXSL9O&>J>''"P2:=#'*\\LJJ'+KNPH]AR33O#>MW$WAJ34=>U#1MT4L@DN+"
M?-NBAN,L3P<8SS7*Z;:0Z=\9_$EU=Z//Y%W:02VMRMDSI\L9\T[@IPQR01U/
M3G-<;!H^KO\ ""VMH]*OP]CKXO+NR:U='DM]['A2!N'*G STH ]LM/$6B7]O
M/<6FKV,T-OCSG2X4B//3<<\?C26_B30KN[AM+;6=/FN)UWQ11W*,\B\\J <D
M<'IZ5YU<VSZGX]\1^(;*UN7TA_#_ -D=_LK_ .DW!.5"H5RQ P,@<=*Y^PT%
M[/PQ\-KA-"NX;RRU,&_9+"02QKDEB^%W8Z<]* .ZU#QIKQOM0ATK3;65/[1C
MTS3C*'S-)C,\C8/W(\,..X/-=\,X&2">^*6B@#-U'Q%HNCS+#J6K6-G*PW!)
MYU0D9QG!/3/>GW.MZ39R1QW.IV4+RIOC62=5+K@G(!/(P"<^U>8W<$VE>+/B
M&NKV-U.FLV48T^1+=Y1.HB93$I4'#9(&/Q]ZRSX<N;<?#"PUK2;B[^P1S?V@
M/L;SI$K*/+1R%(X/&.V/2@#VRVN8+RUBN;:5)H)D$D<D;!E=2,@@CJ"*XKQ#
M\0QH^I:Q#!:?:(=+M4WX!+37<I_=0ICVR6/.,^QKM;:VAL[6*VMHDA@A01QQ
MH,*B@8  [ "I: //_%OB7Q?X7\-:GKDD&D-!9"$+$8Y"TQ81AF!#\ .[@ C.
M%]\ULZ5J^KQPPW^OSZ3#IDUHLPGCS%Y;G:0K%W.>">?:LSXP0SWGPSU6QM+6
MYNKNY\I8H;>!Y68B5&/"@XX!.33/$H:]^"]S!'9W4MQ+I@ACM_LLAE\S9C&S
M;N!R.N* .LCU_1I;>>X35;)H;=5::07"[8PPRI8YP,@@C/7-/BUO2I],;4X=
M3LY+! 2UTLZF)<=<MG KR+6=$FT[P9X*U+2-)N;>.RGMY=5CM;+$^Y8]OF-&
MRY<J2W)!Z_C5^<Q>'_#=UJGA^UU'5QJNLQ2WDE[IKD09Y::. (A;&!VQG'/%
M 'IMMKFDWFFOJ5MJEE-81YWW,<ZM&N.N6!P,5#'XFT&6RDO4UK3VM8WV/-]I
M38K8S@G. <<XKR/3]#+Z%XUT^_@UBQM[O6(9X9TL&5@N]2)0BKM*@C) [#M4
M]]8^)]9^'WC>SO%_M@_N?L-\ECY$EYMP7(CQSM  ! YYQF@#UU=8TQKM+1=1
MM#<NGF+")EWE<9W!<YQCG-56\5^'4&6U[3%&YDR;N/&Y0"PSGJ 03]1ZUYQI
M5U)J'Q*\-:NNC:I!9)HK6TD\UC(H\S^Z>,CIC)X/:K7PV\.Z?/+XI?4M":.>
M?5[MX)+JR:-FMI!M&UF4?*06&!Z]* /0T\0:+(ENZ:O8,ERYC@87*$2L,#:O
M/S'D<#UK0;.T[2 <<$C->5?#+2]2CNY=#U.-C:>%+N:&TD;_ );-)RC?\!C=
MOPE'I7JK$*I8YP!G@9H \J3Q_P"*IK'QA=1IHH'AN>2)U>&4?: F[)!\SY20
MO YY.,UWFC^(8KWPC8:]J0CTU+BV2>03R!5CW '&XXXYXKQR'PMJ6OIXY-K;
M:A:7_P#:YU/3#/;21QW05B0I# *P/& >^#TS6YXGU76==TKP;XC&EZK9QV%X
M6U.U2S8RP.5 $BQNOSJOS$'!Z^M 'J2:WI4FEG5$U.S;3P,FZ$ZF(<X^]G'6
MHH/$NA74,DT&LZ?)%&2)&6Y0A,>O/'4=:\I\0:1IFG^ ;C4]+NM8N/-U^'4<
MW%BRAYRPS^ZVH?+.>PZ@8S4NCS:+K.H^,MIDE\2ZW8,Z6DNGR0*J)$4 C,@R
M2202>,GMQ0!ZJNNZ0[6JIJEDQN\&W N%)FSTV<_-T/3TKGO#7B/5-1\=>+-$
MOS:FWT@VWD-#$4)$J,YW98Y(&!VZ5YSI+W5Q%\-!_86KQG1Y7AOI9+"0"([
M/3)&><XQ^.:W[:>_L?%WQ,U&#1;N[%S;6[6<<MI(L=T8X65U!*\\G&!U[4 >
MD6&O:/JLD\>G:K97<D'^M6WN%<Q_[P!XKDH/B ?$'P_N-=T273+"]WE(8]5N
M0J* Y&7((P2JL0*YGP?!=7WQ-M=5O=+NDMK_ ,.^3.7TQH(/.,@)BQCH%4@;
MSD@=2"*P[33)D_9^U71/[ OUUM9O*>,:>^^1O/WK@A?F 7//0=.] 'MMUKFG
M:796\^JZC96HF4;6>8*KG&3MSU'?Z4K:_HR64%X^K6*VMQ_J9C<($D[?*<X/
M/I7GTYFL?B;X>\07EM='1FT0VB2FW<_9Y]Q)W+C*$CC)'/2N0NO#NH0_#$VT
MND7L@N_$IO;6T6T=WBM=P^\H!*# )P<=: /<['6=+U-[A+#4K2Z:W;;,()U<
MQGT;!XZ'KZ5G77C#1$TK4KRRU.SO7L;=IWBMYU=N <# )/)X'O7!7&D16WQ!
M\6/#I%]%IE]X<,:FSM'02OMR50A<"3;P ><\=:N> (=:LO$ZV!U ZQH-MI@2
M"]FT\VTD!W*%AR0-W"Y/4C SCN ;WA[Q#XCU/7+?3[_3[2!8;!;G470-^ZFD
M),<"Y/W@N"QY_#(KLB0!DG %%9WB".*;PYJ<5PEQ)#):2I(EN"964H00@ )W
M8Z>] &9X@\310>%]8O\ 0]0T^XO-/M'N=FX3#"J6&0K C.,9S^=:&DZY8Z@D
M5N+^TDU 0))/;QRJ73(!)*YR!SWKSZ]CUE- U^Q^TOKEDVA30VUTNG-'<+*1
MM2'Y1A\C). ""!GK6K+91PZIX O+;3I8T@,L<SQVK Q*UNRX? RH+[>O>@#M
M$U?3)-1;3DU&T:^4$M;+,ID ]USFN.N?%6N0>'/&=Z&L3=:'<2) ?L[;'184
MDY&_.?F/.?PK$%Q>ZK)X8O9M-OK:YM=;+7-K%IS)':*1,#EBNYLY!+ E3G)
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M1UH ]5CD26-9(W5T<!E93D$'H0:IW.M:5922QW6IV<#PIYDJRSJI1<@;F!/
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MDW*I#-@*6^Z&/12<\9QGM5:[\5^'[%[E+G6;*)[4J)U,PS&6S@$=C\K<>QH
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M6//0"I>^+-/L/%MIH%Q+!%+<6KW'F23JN"'153!ZEMV1]#5V77M*ANA;2:A
MDID\D O@>9V3/3=_L]: -&BL_7-6AT+0K[5;C!CM('F*E@N[:"=H)[GH/K67
M!XG@U)]#:QU32%%X29K=YP\K?NRVV/:?O XSD= : .DHK$G\8>&[9V2;7=.1
MED\ILW"_*_'!YX/(Z^HJU:Z]I-]J4VG6NI6LU["-TD$<H+J,X)Q['@^AH T:
M9*KM"ZQ.(Y"I"N5W;3V..]4UUO3'O4LUOH#<.S(B;OOLOWE!Z%A@Y Y&*OT
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M(R<2+,$ 92"3@ODY((-=_IE^^HVC3O8W5F1*\?E7*A6(5B-V 3P<9'L:NT4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7/J#Z5+?O-'IUT]N,S+$YC'^U@X_6N$TS4K33/A-X6#F9OMT5G OESF'=+(
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MX=PVXA$?<,=L.*Y'6)M2T[6KK5+BV75-*_M* 1SVMZT5Q9D-&GE>61M=2_4
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MXQ'#=HIR8W*J<9P.<'[H!XKJJY@^)-3D\67V@6NDVKR6MLET)9+UD#H[,JC
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M90C30I(5!SC< <59SSCO0!6.FV+&W)LK<FV_U&8E_==/N\?+T'3TJ&+1-)A
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M$8>:*1C&I)3S -VT_P // /4#Z7-#U!M6T#3M2>,1-=VL5P8P<A2ZAL9[]:
M.+'@-+W0K/3;G0].MK^)X6N-53:TC,C!FD1MN\NQ!Y;&-QZXP?0Z,\X[T4 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #9"HC8NV
MU #N;.,#USVKQ3R='3X':_<121>>9KL;O.RV?M$FS'/7:>/4>M>V]:;L7^Z/
MRH \]U.RTS1=7\/&!4'AZ_O)I=0E:4R12W!B"Q-(Q)!!*GKQNVGK6)XE@AM=
M(^((M6C31/L<;6RHP$27FQMXBQP#]PD#N?7->NM&CH49%9",%2,@T+&BH$5%
M"#@*!P* /,I-+\.#Q_H-M"EJUOJ6F3F[B$F4NV4Q&,R#.)#R^"V2?PK=^'#Q
M1Z-J>GPRYBL-6O+:*,ON,4:RML7U  Z5V.Q?[H_*@ #. !F@#*\4:BFD>%=5
MU"6":=+>UD=HX7*.PVG@,.5^HZ=:\]TR72(_&DXAN-)33[[09)9DL!LMWD61
M<'=G:[@%OF !QU%>L4T1H%"A% '0 =* /'--MM,L_ W@'7H3''J'VRRAGO?,
M^<JV0Z.V?NX/W3P*]EZTFU<8VC'IBEH XC4+BRM_B]I6Z>*.1])NO,!<#)WQ
M;<^^-V/;-<G'J5D/AW8G[7!_R-0;_6#I_:!;/TV\_2O8BJDY*@GZ4FQ?[H_*
M@#SNTTO0=<^)/BJSO(K:\B:ULV\AWW*7_>[F"YQN&1SU&>V:YO0]8FELO!8U
M'4;4:2^GSPF:_4RPFZ5U"K)\P ;RP=NX]SCDU[2%4'( !^E(T4;H49%9#U4C
M(- 'F,VDFUMM,M[#Q%HUX%FO+BWM;^/_ $.2)F7*+ACCRRV%/. Q&.*J[Y+Z
MPTZ[@CT*V:#3Y/,T75F+0&,RN!)"_8'9P=I&TK7JSP12J%DB1U7H&4$"E>&*
M0J7C1BIRI90<'VH S_#DYN?#.ES&TDLR]I$WV:5B6B^4?*2>21TYK"\87!@\
M0^&%O<#0I)YDO#)_JO-\O]R).VTMNQGC=M[XKL*1T61"CJ&4C!!&0: /)?$$
M$-KI7Q#%JT::&+%&ME1@(DO/+?>(L< _ZLD#^(^N:[[PKI6EZ?I:W&F '[8J
M2S2B4OYKA0-Q))YXK;6-%0(J*$' 4#@4X  8 P* ,7Q?J<>C>$M3OYH))XXH
M#NCC<H2#Q]X<J.<DCH,FO.?M#V6M>(1X7FL//N/#IN+>/2X]L+SJ[@,@R0[@
M<9'7&"*]@(!&#R*:$50 J@ # P.E 'F5Y-HMQX*NM:\(-;/XA72GVM;,INB#
MM\PN/O%QCJW(;W-)XB'@J[\":UJVC2:;]J;1Y@KP2*)6RH*E\?,7# <MSDGU
MKTY8XT9F1%5F.6(&,_6D6*--VV-!N.3A1R: /.[C5]-7Q)I%OKUQ;#P_<:,I
MM6N67[-)<!OG#$_*6"!<9]6Q7.QW2Z?X1UQ-'(M[&'Q4/M:*C'RK,M'N)0$-
MLP.1Q\N1TKV<HC*%95(!R 12[1SP.>M 'D'BZSTR/PAXFU*VUO3)X)[6!1;:
M>H2))0QQ(,.WSLI(XQD+WQ70SV6E:3\2= ?3O+MTU:RO%N'BE(^U%?**,QS\
MS?,V&Z\]:[Q(HT38D:*N<X P*=M'' XZ<=* .%^%4>FQ^%VCM7C-['<W"748
MD+/&?/DVAE)^4X_.NE\4MJ*>$]7;2 QU$6DIMMHRWF;3MQ[YZ>]:H55S@ 9.
M3@=:6@#S1EL+F'P9>^&6B&H-=PB=H2/,>WV'SQ-W..^[D/CN:O?#R'3&U7Q5
M<6SI)<#6)T#"8N3&5C.>IR,YYKNDACC=W2-%9SEB% +?6G!5'0 ?04 !&Y2#
MG!XX.*\2G.CVGPO\41+<11WZZI/'-&9_WBC[9E<@G(RHSGOC->W4W8F2=JY)
MR>.M 'FVL6T&A^,[>3PXL4%UJ6B7S*(VXNIU\LQ,><.V6/S').3S3/!T-IJR
M>&K^'7=/CU&VC_TF"*$K=3L8R)(YLR%B0WS$D=5S7INT<<#CIQ2+'&KLZHH=
MOO,!R?K0 ZO/H9;6\^,.LVJ:AY4C:3;)^YE4/N624LH]P#R.HKT&DVKG.T9]
M<4 <)KZZ#HUUHOAN2SL(K2Y2>19-18O &!4G*L?WLK%B1DY^\<\UR,<ME+X
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MM+:V%S<74$4!QB620*ISTY/%<QXFU%(_$FE64UK&+>>WF(O7M&N/FR@\I .
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MAWQ/K=IK%Q/)-8Q><8+0B-A$Q< KQN8C*-SPIYQ3],U+0M0\4W&O'[%-KO\
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M<&W<"-B0,?,1QT!QGJ,^ET %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !116)HFM_P!JV=WJKO%%IGFNELS'&4C)5I&)[,0<?[(!
M[T ;=%<=#XH-[\1[;2;'4HIK)].FGE@" ,CJ\84Y/."&;'8XJY%XKCL]'UF?
M5<+<Z*S)=+&/]9\H9&4?[:LN!V)(YQF@#I:*Y#Q1K?B'0/ MQJZ0V!O8+=II
MA(6*QMD815&-V,XW%A]W..<#6U[5I=#L[?4I-ALHY$2\!'*(Y"B0'_98@D?W
M<^@H V:P=#T.[TO6=;OI[N&9-3N%G$:1%3&5C6,#))SP@/:I)-4FN_$LFCV3
M*@M;<3W<Q7=M+[A&@'K\K,?90/XLCB+;QGXBF\*+JT-[876IB_>V32UM\-.J
MSF/"X;<#M&[/(&.1B@#U&BL=]6DM/%$6E76WRKZ%I;.0#!#1X\R,^^"&!_WO
M3F'3?$4(M-3&KSP6T^DRF*\D8[(\;0R2<] RLIQV.1SB@#>HJ&6Z@@LWNY)5
M%ND9E:3/RA0,DY],5Q5YXGU.&W\,:K+<Q6=CJM]B6&1%'EV[0R2+N8]&P@)]
M-Q';- '=T5A'Q#;ZMI%Y=>&[RUO[BT.6B5L[B.3&>ZE@" ?7GGI6EIFHVVL:
M5::E9ONM[J)9HV(YVL,C/O0!;HKEO#&MW$MIKLNLWL12PU2:V69E6,+&H7;G
MMGG]:V;?6],NC<B.\B#6J[YTD.QHEQG<P;! P#R>.* *.AZ'=Z5K&MWT]W#,
MFIW"W 1(BIC(C5,9).>$'I6]6;%X@TJ5)W%[&JVZ"24R93:ASM;Y@.#@X/0U
M/9:G9ZCYHM9M[0L%D0J59"1D94@$<4 6Z*H7VM:=IK,MW=)&RIYCC!8HG]YL
M?=7@\G XK$\3^++/3CI%I'JMK9C5G8)?/(A6&,1L_F#=\IR0JC/'S=^A .JH
MK'UW6H_#/A6[U:[=;@6=L9"2PC\Y@O0=@6/\ZPKSQ>J>(/#LT.JVG]CWL-RU
MSM9'56C12!O'NV,>PH [6BLZTU_2+[3&U*UU&VELD8H\RR#:K X*GT.2.#SS
M4UEJ=EJ)F6UG61X&"RQD%7C)&0&4X(R.1D<T 6Z9+%'/"\,J*\<BE71AD,#P
M017*ZMJFKQ>/=+T6UO(8K2]M)YV+0;G0Q[!@'/?=W%&@>)[AI=>@UN:U$6EW
MHMH[V-3&D^4#;=I)^=2=I /7M0!T>FV*:9IT-E'+))%"NR,R'+!1]U<]\# R
M>>.<GFK59(\3Z%_9#:L=6LUL$8HT[2A55AU4YZ-[=:S-5\?:'IR6KQ7UI<++
MJ2Z?*PN5586QER2?[HQD>XZ4 =316-8:NE_K]S;V^J:;<VJ6T<B0V[;ID+$_
M,Q!(VD8QQZTDWBG1@\UO'JUFEPL3NK2MB/Y>IW< @'&<&@#:HK"M/$FGP:3I
M<FJ:QIOVB\A5EDB?;',=NXL@)SMP"<^E6=/\2:+JL%S-9:I:S1VO_'P1(!Y7
M&<MG[HP#R?2@#4HK)@\3Z'<0W<L>JVGEV>#<,T@7R@>A;., ]CT-):>*=!OK
M^&QM=6M);J>/S(HED!,BXW?+Z\<X':@#7HKD%\;IJ4'B"VT=;>?5;"=[:UM_
M.#F=]J8<J.1&&?!/8*>16Y-J]KI-M#'JE[']I$(>4HA[##/M&2JY[G@>M &G
M144EU;Q6INI)XTMPN\RLP"A?7/I61%XR\-S7%K!'K5DTEWCR )1^\)Z 'ID]
MAU- &Y161+XIT"&_^POK%D+OSTM_)$P+^:^=J8'<X/%2OX@TF*Z6V>_A61I?
M(!)^4R?W-WW=_P#LYS[4 :5%8UWXLT"PEN8KG5[2.2UVB=/,!:,MG ('?Y6_
M(U:76],>PM[Z*^AEMKG_ %#Q-O\ -ZG" 9+'@\#T/I0!?HK*;Q-H<=K;W+ZM
M9I#<R&*%GF5=[@X*C/<'@CMWK*F^(&A+JFCVL-_9R6VIQS2+=&Y5401D#OUW
M,2!_NGK0!U5%9<?B31I;.[O(]2MVMK-BMS*&^6$CJ&/8COGIWK1BE2>%)8V#
M1NH96'<'H: 'T5QGB3Q:EMJV@VFEZK 9+K4X[>>$*&\R,YW;2?0@ XZ9KI%U
MO2G:]5=2M";''VK$RX@SG&\Y^7H>M %^BJ UK338V]ZEY%);W(S \9W^=QGY
M .6X!/':I[*^M=1M$NK.XCG@?.UXVR,@X(^H((([$4 6**Y[2?&&FZKK6KZ:
MMQ;1RZ=-Y7-PI:4!%=F"]@-V#[@UH6NNZ7>W2VMO>QO.Z>9&G(,B?WDS]Y>1
MR,CF@#1HJ&ZN[>R@:>ZF2&)>KNV!ST'UK/C\3Z)+9/>+J,/D)*86)R") ,E-
MIYW8(.,9QS0!K45G)KVE2Z;#J$-_#+:3MMADB;?YC<_*H')/!X'/!]*;%XAT
M>>2UCCU*V,MVS)!&7 >1ESN 4\Y&UL\<8- &G2,JNA1U#*PP01D$53AUC3;B
M2\CAO[:1K+_CZVR@^3P3\_\ =X!ZU7M];T_6%N[;2M3A>ZA7Y@F&://1MIZ@
M]CT- %G2].BTG3XK&!Y&@ARL0<Y*)GY4!]%' SS@#K5RN"TSQZMIX,\*:CK,
MT#76LO''([RK"J;E9FDQZ#:!^(YKJ[;7])O)KF&UU"">2V0/,L;;C&I&03CL
M1R/4=* -*BL^WUS2KHV0@U&VD-\K-:@2#,X498H/X@!SQ5F[O;:QA$MU,L2%
M@J[CRS'H .I)]!S0!/168/$>C?8+B^;4[:.VMV*3R2R!/*8?PN&P5/L>:ET[
M6M-U=K@:=?071MW$<WE/NV-C.#[T 7J*QX=6DO?$]SIMMM$&GQ(UTY&29)!E
M$'IA?F/^\OO2OK^G75R^FV.IVXU&1'\G(+J6 Y]FQW .?I0!KT5F:!K"ZWI*
M7?E^5,KO!<0YSY4R,5=<]\,#@]Q@TZ]U[2M.D=+N^BB,>/-+'Y8L]-YZ)GMN
MQ0 SQ!HW]NZ7]D%P8'6:*>.3;O >-PZ[ER-RY49&1QW%1#19[O6+'4M2N(99
M+ .;>."(HJNZ[68DL2?ER ..IZ\8KW_B[3['Q59Z#-<6\4EU:O.)I+A5VD,J
MJNT]2V[(_P!T]:RO#OC.V2&\@\0:Q:I=IJMS9P^9MCW(DA1,@<#..IZF@#MJ
M*H7^LZ=IA87EW'$53S'SD[$_O-C[J\'YC@56O_%?A_2V=;[6;&!DB\]E>=<B
M,D -CT)9<>N10!L45%/=06UJ]U/,D4"+N:1VPH'J36'J_B6TCT6[GLM6T^SN
M(61-^HAD1&)!PRG:V2N<>M '0T5E7_B;0],N9+:]U6TAN(X_->%I1O"\#.WK
MW%1Q>+/#\UQ9P1:S9/)> &W"S ^9GH![GL.M &S17.S:K<3R^(8K35=/<V4*
M-#' -\MN^UBPER2.2O P, '-)H?B.'_A"=$U76KR*.>\L89G8@#>[(&;"CZY
MX'% '1T5E/XFT**TM;J36+%;>[YMY#.H$O\ NG/.._I5S3]0M-5L(KZPN$N+
M689CEC.589QQ^5 %FBLZ/7M*ENEMDOHC*X8H,\2;?O;3T;'<#..]+;Z[I5W9
M0WEO?P2V\TODQR(^0\F2-H]\@\>U &A17,:9XZT6_FUA)KZRM1IET\+&2[3Y
MT54)DQV7+[?J/PK0@\4Z#=17$D&K6DB6VSSF60$(7&5!]SV'6@#7HK/M==TF
M]TZ74+?4+=[.)BLLWF +&1U#9^Z1Z&D@UW2[AKA4O8E>V4/,DI\MHU/1F#8(
M4X//2@#1HK*L?$^AZG*\5CJUG</'")W$4H;;&?XB>PK"E\5"X^(.C:5I^IPS
M6EQ;W#W, 09&P+L8$\[3N;D<';0!V5%<]9>);*.QOKW4=<TE[6.]>&*:"3"*
M.-L;$DYDYYQ^57[#Q#H^J7L]E8ZE;7%S -TD4<@+ 9QG'<9XR.* -*BLRU\1
MZ->WS65MJ=M+<JAD\M9!DH.K#U [D=*J_P#"9^&BY1=<L&8*[G9,&PJ<,W'8
M=S['TH W:*SAKNE&&RF%]"8[YMMJV[B8]?E]>.?IS5NZNK>RMVN+J:.&%<9=
MVP!DX'Z\4 0:IID.JVR12LR/%(LT,J?>BD4\,/Y8Z$$@\&KM8X\5: =,EU$Z
MO9K9Q2&*25Y0H1_[IST;VZU-9>(='U'4)M/L]2MI[N$;I(4D!8#.,X[C/&10
M!*=,A?65U21FDFCA,,*M]V($Y8J/5L+D^BC&.<D.F0V^K7&H0LR/<HJSH/NN
MR\*Y']X#C/<8ST%<SXW\6QZ381KINJP1W_VR"'RRH?>&E5'4$\;@I)QU&*ZZ
MXN(+2W>XN9HX88QN>21@JJ/4D]* %GC::WDC25H7=2HD3&Y"1U&<C(]ZI6FA
MZ=8Q6,<%N +%&2W+$DIN&&;GJQYRQYY//)R?V_I AL93J5J$ORJVA,H_?ENF
MS^]U[55NO&'ARR,PN-;L4,#^7+^^!\MNN&QT]_3O0!MU2L],AL+N\GMV95NY
M!+)%_"),89AZ%L#/;(SU)S@^)_%-K87>E:8FKVNGMJ@D=;YWC(B15R& ;Y3N
M) &>.M;%SKVEZ<QBO=0B1X]JRNW"HQQC>>B9R,9(ZT 7KB)I[:6))GA9T*B5
M,;D)'49R,CWJDV@Z<V@#1/(VV(B$80,<@#D$-UW \[NN>>M1ZEXHT'1Y)(M1
MU>RMI(X_-=))@&5,@9(ZXRP'OFI;G7M+LY?+N+Z*,Y56)/RH6^Z&/1<Y&,XS
MVH O0HT4$<;RM*ZJ%:1@ 7('4XXR?:JLNF0SZO!J,Q9Y+>-D@0_=C+?>8#^\
M1@9[#..IRR?7--MKP6LMVBS>8L1&"0KMC:K$<*QR, D$Y'K1-KFF6]T+::]B
M24R"+D_*)#T0MT#'(PI.3D4 6;.RM]/M5MK6(1Q*20H).22222>22222>234
M]9]SKFF6EQY%Q>Q1OO6-LGY5=L;59NBDY& 2"<C%,N_$.CV%['9W6I6T-P[K
M&$=P/F;[JGT)R, ]: -.BN,7Q8FE>+_$%IKFJV\.GVT-K);>8H0J9/,+#CEO
MN#Z8JSJ&N7!\4^%4TZ^BETO5#/Y@C57$@6%G5E?TSCIZ4 =516?)KFF17BVK
MWL2S-)Y(!/'F?W-W3?\ [.<^U:% !1110 4444 %%%% !1110 4444 %%%%
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M6/=MP>N?G;/K[5LT ><ZQHL*:7I8L=.U*X2?Q#%J5T)X"S$!LR2%0/E'3Y<
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MUD^60*P/((W9Z'M1>^%K5UL1;:+K%@4$\J7-A?*MQ#)(X+*Y,A#;\;C]X9%
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MB,JP<\CH1R,<U@MX7U>RL=.\G3WGED\2-K%Q%'+&!;QLS'9EF ) (Z<9S[9
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MX8++Y=7LXTLI3(@61UAV%3SD'/'( ]ZZFRO]3=M,C?0YH(9HG^TO+<1[K9E
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M)HTWVC2;U);M1-#A56.1<@[^>7'Y&O3* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HH)P,FO//&_B+[9X=M+K3(M3%M)?VHBU&
MWDV0NIG16!PX8J1N )7:<C!Y% 'H=%8M_P");6REOHH[:ZO'T^,2W8ME4^2I
M!89W,,G:"<+DXQQR,Y2>,?M'C6QTZT22XTRZTL7B2Q0,22[J%;=TV;2<^YH
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MY!*_*V#R.*SK?XAZ9<6=C?"PU--/O)Q;K>/ !''(7,8#?-N&6&,@$<C)!R*
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M*&$9RLD;[.N<Y! X-:>H:;KH\5:9K]I9V,KI8RV=S;/=,@3>Z.&5]AW8V8/
MZUUE% 'G<_A#Q!)X,UW1_P#B7O=ZAJDEY')YS*@1IA)R-I(/&,<]>M;OB30O
M[?-BM_HEK?01HY;_ $DQRP2';@HX .,!LX(/3@UT]% &3X<TV[TCP[:6%Y>/
M=7,2$--(Y<\DD#<>6V@A<GDXKC[#PEXB$GAZYOXM.EOM,O6FNKLW+O+=@QR+
MN!*?+RX.SIZ8QSZ-10!P1\)ZS/X+\6:/*+..YU:XNIK9EF9D43'(#':""/8&
MNWM!*MI"LZJLH0!U5MP!QV.!G\JFHH X?P[IGBCPGIG]AVVGZ=?V<,LK6MT]
MZT)".[.!(GEMR-Q'!.:FU3PUJCZ5H-K:-:SS66I)?W4DKF,.0S.X0!6ZLYQG
MI7944 <EJ.@ZK+XDUG4;9+5X;[2$L8P\Q5ED5I#D_*?E_>#WXZ53A\+ZO:Z?
MX0N4%LVH^'X?L\D'G'R[B-HEC?:VWAOE!&1VP>N:[FB@#A]7\)ZCJEMXINT6
MWCO]:L%L(87E.R) KC<S!3EB7)P > .:?KWA?4-4MO#MXEO8RWVD.2]G<2$P
MSHR;&&[;P>A!V]:[6B@#CKWPU'?:8D$_A72/)EN1)<VT<H#$!"%<.$'S@X'T
M[]JQCX U&UETN_B$%^;&>YVZ=?W+R*MO+MPBRL"=RE 1D8Y(SP#7I5% '!:M
MX-GN9M'U2RT;2(;BPN)I)=.+8BN$E158EPG^L&U2#M(XQFK.H:!JC6EBVF:7
MIMDHO?/OK"&X,2W4?EE1OD5.2#M)&""% R:[2B@#SF3P5K::#K-G;Q:9'+<Z
MU#J=LB2,D05#$VPX3(_U6,@'KGCI6]+H^HZE>_VS>6UO#?0V,MI:VJSEU4R%
M2S,^T?W%  ' SUSQU%% 'FT'@?5;2V\+7+VFG7MUI&GG3KFTEE/ERIA<.CE.
M&!7H1R"1D5W.CV26-B473K2P+NTCPVF"NX]R=JY)[G'YUH44 <=;:/KECXL\
M2:DECIUU9ZJ8 D<EVR,%CCV'</+8<Y]:=/I'B"\UWPWJ-Q%8@:?+<O<(L[<+
M(&1%3Y!NVJ5R3C.*Z^B@#@9_">M77AOQIIKK9)+K<\LULPF8JN^-$ ?Y./N9
MXSUIS^%;^#Q5=:S_ &7IFI1:C;PI<07$NUK>2-2N48H0R$8R, Y%=Y10!R;:
M!?Q^*M!OK2RT^WT_3[.:V>&*0KL,AC/R*$QM78?3.>U8-W97VI^*O$DFEZ5;
MW^FRF*UO8FU![83S(GS*XV-N^5D7(V@@8.><>E5F2^']-ENKBY,,B27.#/Y4
M\D:RD#&756 8X &2.@Q0!Q=KI]QXBU+3O&EGH]G<0WFGBTN-.O9 K0E)&*M&
MP4@CEAT&1@CTK8;P]?)XA\-W=GI^FV=CIR7(F@@E*A3-C[@" '!!)SC)-=9#
M#';PI##&D<4:A41!A5 X  '04^@#S_4?!FLW,NLSVTUI'.^LP:O8,[L59HT1
M=D@V\ [3R,]170WUG/X@\,:E8:]:6]C%<0-&QCN?-V<'+9VKC!P1].U;]4M2
MTBQU=(4OH3*D4GF*GF,JDX(^8 @,,$\'(]J ,SP;;7T7ARVNM697U2[C26Z<
M CYM@4#!Z84#(]<^M5]?TS5Y/%6BZUIEO:W*6,-Q#+#-.8F82^7@J0K#C9WQ
MUKJ** .'U#PMK 9[^S>"2ZO=22[U&U^T-#'+$L7EK$'"DD#"DY'S$'( XJ&V
M\(7L%GK5I=Z3I-Y9:CJ2W1M%D*KY7E(NT97AE9 0>_\ LUWU% 'FDOP\OHQ:
MW=IY4HL=0-S:Z5?7+S1+"T0C>/S&#$$G+#@@'CWK4U/PM>W>GVMUIFFZ7I>J
M6>H17R0J^4N"BE"LCJ@()5F .#C KMZ* .3L=+UU_'":_?P64,#Z;]C:"*X9
MVB;S-^<E &S^&/?K5KQ%HMY=ZQHFM:<8WN=+DES;RMM6:*1=K@-@X88!';C'
M&<UT5% ' >(/!VJ:U9>)KF);:*_UFTBLHHI)3LAC3<=S,%.6)8\ < #FMO4-
M)U*\\4>'-62.W6.QCN$ND,IR/,5 -GR_-C:>N*Z2B@#GO%^DW^JV%@=-6![F
MRU""\$<\A19!&V2NX X)'?!J+3]*U6/QQ?:S=0VB6MU8P6P6.=G96C9V)P4&
M0=^.O;I7344 >8VO@/5[.VT&YDMM-O;G2VNHI;664^7-%-)O#*Q3Y74XX(P>
M>:[W1K)+&R95TVST]I)#(\-H05)./F)VKEC@9X_$UHT4 <MINA:@GB+Q-<WJ
M6ZV6K>6(S%,3(H2(1G(*@#/7@FL[PIX4NM$LK'3;[0]&N?[/($6HJ_SN%SL?
M84RKXP#\WJ<]J[JB@#S:7P-K%QHP66/3FO+;79=6@A>5FAF21G)C<[,J=KGG
M!Y%=58Z';SZ=?V]YH6GV"7T7DSQVS!S*F",.P5>F3CKUK?HH Y#2/#NN6/@V
M\LI=1B_MQ[4VMO>+G"*BE82>,YYWGCJQZU3TKPUK-KXATK6)+'3HFMM/FM9T
M2Z>2221C&0[2%,MG8>O(SU.<#NZ* //XO".MCX:6_A]Q9#4(+R.<$3,8V5;D
M3==F0<#'3K6W8:7JEEXWU34C%:O8:E!;AF\XB2)XU88V[<,#N'.1WKI:* .;
M\3Z5J6I:EH$]C';-'IU]]JE\Z4H6'ENF%PIY^?/..E<_XD\(^(-<C\26CKI]
MPE^!]@N;F=_]&7:H\L1[2%.0QW@Y.[D'I7HE% '(0Z5KND^+-2U:RM[2[MM6
MCA,\$ER8VMYHTV94["&4C'H<CI3Y=(UN'Q7JFI6L%A+!J.G10'SIF'E2Q^9@
M%=AWJ3(.<C@'BNLHH XWP[X2_L?7UO[*S_LBS^SO'/80W;2Q2R%E(8(?E4*
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M+C2+6ZEL=6CEN)(1Y2F0>26526;@J3DX...IJ[+X7U1]=M=26_L\)IXLG26
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MN!$=O_'R)\%<_5>OO4VK^#I-?GSJ,.FEUN(YH;^.(BYA56#;%;'L1NST/0T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM8Z=9:7:
MK:Z?9P6ENI)$4$8103U.!Q5FB@ HHHH *I7&CZ9=W!N+G3K2:8J%,DD*LQ Z
M DCI5VB@   & , 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 8YS1CG-%% !BCJ,&BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ***9++'!$\LKJD:*6=V. H'))- #Z*J:9J=GK.FP:C83":TG7?%(%(W#
MUP>:MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7->)M1:&ZM+
M.33]0N+)@9IVM;9I0VTC;&<=B>3[+CHU=+45S;QW5N\,ID"-P?+D9#^:D$4
M<?\ ">[%S\-=%00SQ^3;*A,L94/QG*D]1SUKM:HZ3I%CH>GQV&G1-#:QC"1&
M1G"#T&XG ]A5Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
5HHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ameh-nonqualifieddeferre005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNS3G)!'.PDXY*\9KU*D"@$D  GK[T >*V5EI4?PKT3788H1J5KJ<'^F#'FQ
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M43? A<JO8%NN.,UVU% ''_%&".?X>:F98RZQF*0XR< 2+D\=@,UD7\?AV_\
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MQ6=XEM8(O#?Q#: 1?V))'$VGJ,>7]I\L^:8NW7;]W^+=WS7L) 8$$ @]0:4
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M*T_6#IT-M=07DLLBJR[1"RA6W%R &5P2"./6NHBOK.>S%Y%=P26I!;STD!3
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MH3N(&?,4L..<C@YH ]5M[F"\@6>VGCGA?[LD3AE/T(J*[U.PL&1;R]MK8O\
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M[E=QQL7 !P"<GJ.X!UU%<M=^+%\/W&A:?KL]FEW?M(LT_FB&.,(C-OPQ/!(
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MOO"&DWNLWD(O;UY(QP$\Q@[ !5'LOZ5T=Y<?9+&XN?+:3R8VDV+U; S@>YH
MGHKCO#6K:IX@TO2]7MM9L+@7(26YLXHP5B1ADJ"&W!ESC)SD@\#M?T7QCIFL
MWNKVJW-K$^G7+PD&Y4ET55+28[+EB,^W6@#HJ*H6FMZ;?71M;:\C>?9YHCZ,
MR?WU!^\ON,BH9=>TM[X:9%J<*7TI9(P/F^< D@=BPP3MZ\4 :M%<MX/\1M?>
M$-)O=9O(1>WKO&O 3S&#L %4>R_I74T %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7E>B:-=:I\-M,\*2Z1>6-]!-"\\EQ 8TAV
M3"0NK]&8@$#:2<MS@9KU2B@#SBYCU"SD\=Z<NCW\\NIEYK.2*+,4H:V1,;^@
M(93P>3V!IS:;+)9:#,DVN:1J=II20K<VEFTRDX >*2,HPX* C.,YX->BT4 >
M?Z='JT?BGPS=ZI82++;Z+-!=O;6S&*.5FB(4;01T1NF0#QZ5F#2+Z3X1:G8)
MI5R+]M0DG$!@*NP-YYBL,CGY,'VQ[5ZG10!YJNG7,>N>)[75(]:?3M;D$L+V
MEL)$EB:)8S&^4+1L-N/FVC![4:KHU]9W5^WAN75K2_V00K:3VWVBSO0L2*I=
MF4A>/D8AQ]S//?TJB@#SR;3M2@UR6XT.?4X9)]462[TV[M/,M)%$@#2K(R#9
M\J[QACS@8S77^)+"YU3PQJNGV<OE7-U:2PQ.3C:S(0#GMR:U** //YK.ZU_2
M?"=E'IUU97FFWMM/<^="R+;B)2'"OC:^[[HVDY#9Z9K3\&1S0ZAXE\^TN(!<
MZJ]Q TL+('C,<:A@2/53QUKK:* .6\>6MS<:+92VUI-=&UU.TN9(X5W.8TE5
MF*CN<#H*KVB2S_%"746T^ZCMWT:*W2:6W8 2"5W9,XP."OMVZUV-% 'D5CI&
ML:=#X<N_L>I16^FWNI)<Q6L ,L:3RLT<BHRD.N.#M!(#?6O0O#6GVMG;WD]J
MEZ#>W+7,K7B;'D<JJEMF!M&%'&!TZ5MT4 8=Z[CQ?I9%O<-&MK<(\JPL40LT
M6T%@,<[&^F.>HKEKCP_JGASQ#;6FD6K7'AS4+^*X:%/^8=,'#,0/^>38)Q_"
MWH#7HM% 'F46C7"77BC1=;AUF2TU2^EGB-G"LD-Q%(% 4OM)1EQM^8J, 8-:
MVL:#>_\ ":6KV4+-IVJ6!LM2DS]Q8F#*3ZEE:1/^!9[5V]% '%^#-%O]-N)K
M&^A86>C/);:9(QSYL,A#@_\  5VQ@^S5VE%% '$6MHR_&"^U(:?<+;RZ7';B
MY-LP1IED8L-V/[NWYNAP!FIK);G1/&'B26_L[JXM=2:&:UF@@:8$+$$:)MH.
MT@C(S@'=UZUV-% 'EVG>'KW1H/ -E>V,\XTZ>XGN?+B:5;=727RU) (.TNJ\
M9QC/3FIO%'A_4M4\<K_9226T5OI:1Q^9;$VD\B2E_(DX^X5].,XZD8KTNB@#
M/T34)]3TN*XNM.GTZXY66VFQE&'!P1PR^A'45A:['HFJW]Q9>(/#,E\(L"VF
M_LYK@2*5!.UU4[#N+#DCH#76T4 >96.A:GX>C\&O-97=S%8W5YOCB_?/;1RJ
MXB0G/(4,JDYP,=<5<MK2\L-,\6Z+?:;=74VH75U/:O'"7CN8YE^52X^52OW3
MN(P #TKT&B@#SK1++5/!VO6QU*VN]0M)-%M+(7=K"TYAEAW;E*J"P5MV<X[<
MU5\0Z%J6K^,H7TF&>SAATF-(EGM3]EF=9"_V>7C[A7&<' ..I&*]/HH S]$U
M"?4]+BN+K3I].N.5EMI\91AP<$<,OH1U%<EXAT^*?XEV%[J&BRW^FPZ5+$S?
M8S.BRM(A48P><*W/^-=[10!Q=Q:V^J>%;OP_;Z%<16<TIM;=)X&C5%(#F7&!
MM5"QV]"2H ]1BSZ?XA7PA_9KZ=-<ZCI&JP74S#IJL22!]X8G!<C!*D\,N!QB
MO3J* .#\83+X@\,XL]'U!YI+NS,B2V+H[1QSJ[ @C)"C=[<\9S5C4XK^+QZ=
M4L=/DF#:!-#$S1D(\WF!TC<_PYP>N.OO7:44 >:Z8FIW/B/PGJMY8ZH!;VES
M'=--:"-89&2/Y%1!D+D$ G.<#DU6_LB^E^$FK6":5<B_?4)9U@,!5W#7?F*P
MR.?DP?;%>IT4 >8:S+GQ1XDM((M2EL=5L85O#;Z>URR,49-JX(,3;,'#J>2#
MCU<DGF^(='\1:0=4?P])I)T]'LK?S);=TEY#QLK-@[=I(&04YKLTT!K74;^Z
ML-0FM1?R"6XC"(X$@4)O3(X)"KG.1QTZU?TS3;;2-.AL;1"L,0.,G))))+$]
MR222?4T 5/#>FVNE:+';V<=S'"TDDVVYX?+N6)([9))QQC/0=*Q]-BDM_B/X
MFC=MCWUE:36[>JH)$;'T;!_X$/6NNJM/86]S>6MVZ$7%L6\J13@@,,,I]0>.
M/4 ]0* .2\"//8Z!IN@:MI-Y%J-AF-I&MV:%R,_O5E^Z=P.>N<D\5S4=OJB?
M#RQT#^PM1^V6&IPO/^X.S8MV)-R'^,;>?ES7K=% '&Q6HN/BC=WLVG3-:R:1
M#;1SR6S;"XDD=ER1QPR]>.W6J>FZ3->7OCA!9RVUQJ$Y:RN9K=E!'V=(PP8C
MC#;O?J:[ZB@#SOPMIXDT[0+?5[77([[1$4B&2W AB=(BA*NB@2*02  S$Y&1
M5"/2+YO@]+8+I5RNH)J/GF P$.1]M\P,!CGY,'CZ5ZG10!R$7GVGQ)OKY["\
M:SO=+MUCN(X"5#1O*S!NZG#KP1D].M8VG:!>:A\)Y=.>WFM-5MKB>[M?/C*&
M.9;AYHF&>QRN<=B17I%9VK:9)JD<<(OY[:WR1<1Q*O[]".4)()4>ZX//6@"G
MX5:6^TT:Y=6Y@NM45)VB;DQ1[0$3\OF(]7:G^(--NKUK2YMM3DL_L;-)M2U$
M^]B-H.WKD MT_O>U;(    P!T I: /-_!D&H:1X-N(]7TZ^U)OMS.M@UBJLF
M^X=A(-V WW@YY^7%6C:7^F0>,M+6QN9I=4GEN+"2.)FCD,L*IM9P,)M=3G<1
MQ@C-=]10!P>AZ?<^#-6U2)K2ZNH+BSM/LLEO"T@>2&$1,C8'R$[$(+8'S=>#
M71>$-'ET#PAI.E3LK3VULB2E>F_&6Q[9)K:HH X&SU&*P^*/B=6T^\N'FM[)
M5>WMS(!\K_*S#[N?4X'')K2\+V5QX4TK3='DL)Y/M4]S-(UL T-F&9I0A.0<
M?-M& <D5IZ?H)L?$FJ:Q]L:1M16)7A* *@C!"X/7HQSGK[5LT >3WNF7=Q\/
M_%-D-'O'N;S6Y;F&$VKYE1KA75^1_=4GGIC'4@5U3PS)\2H=42RN&M)-$:$2
MK"1E_-#JAS]TXS]['IWKKJ* *FF7CZAIMO=R6=Q9O,@8V]P )(_9@">:XS6]
M/AF^*$5]J6B2W^FIHQ@#FR,Z"8S!L8P>=N>?>N^HH X2YO;ZUL]*M]*T:_MM
M*M[TP-)':;IXH1#\K)&P.T%V*9P<*#ZUDVFBRFQU""_M]<LI&\127EO=6L9:
M:',6%E^565@2&4@ CYOQKU&B@#S6ZM=?_LG2KK4(+C439>(%N!+%:".>2V",
MHD>)<?-N;L < ' H&FW<6N>)[35H=9-AK4@EB:S@65)(VB6-HG(5BC#:1R0,
M<@UZ510!P]OI<<7Q&A+:;</81:$EBDTT#.H82$["V"#\N,GIVSFJEMIUQ/IO
MQ"C.FW DU&69[826[+YZ&V1%QD<_,&X_QKT.B@#+\-B1?#&E)-')'+':1)(D
MB%65E4 @@^X-87CF.XFO_#!M[2ZG%IJT=U.T,#N(X@DBEB0/5AP.?:NQHH Y
M/Q;'/-K?A62&UN9DMM1,\[QPLPC3R9$R<#U9>.M8=W97$L?Q( TR[9M2BVVG
M^BO^_P 6JQ@#C^_GK]>G->D44 <#]@NCJ'@6>*RN(DM;2>WG<0,#;EH54!AC
M(&X?3C/3FJ'A+191HVCZ'KL&M"\TJY20)Y2_9R\;$K*LH494YS@MGD@@UZ;1
M0!PDNIII7C'Q9KK12RVUI9V=H8X0"TT^78(OJW[V,?\  A7<1,[Q(TB;'*@L
MF<[3Z9[U5M=)L;2W6%(%8"8W&Z0;F,I))<D_Q9/7MVJ[0!YU#8WUKX;\5^'K
MW3KJYN[ZXO'MI%A+1W*SY*$R8VH1G:=Q&-OIBK.D:5=:=XYT=;F">=;/P\MB
M][Y+%&F#(3\V.X!.>G;KQ7>44 <MX%M)["PU6VN+66W/]K7DL:O&5!C>9F0K
MV((/:J^J-?:3\0X=7?3KR]TV?3?LBM:Q^8UO*)"QRHYVL"O([H,UV-% 'FEH
M==TW0==:'1[E+B;Q ;AH_LXD=;9Y$)EC'W7< $@#.",\\9T- TF2Z\1>*UU&
MSOC9:K;6RA[R, SJ(W5\[1@'Y@,<'VX..[JMJ%O<7=D\-K>R64S$;9XT5V7!
M!. P(Y QR.] ''^"[74#IK?VM"TLNC1RZ7;G/_'P$;!D'^\JQCU!5O6H?"FG
M:CINJ:;;V%UJ4VAQVKK);:K:;'L^%V)'(55FY&,?,,+UZ9[>QLX["RBM8BS*
M@Y=SEG).2S'N222?<U8H YGX@V-UJ/@?4K:SMGN;@B-EBC&6;;(K$ =S@&J-
MV9-0\?\ AK45TV]6VAL[I7>6V8>4\ACV9XX)"M].^*[2B@#S95UG2+7Q +32
M[D^?XC$[,EMYC"V81[I8E(PS J<=2#SBJE]HNJ7FF_$**.POWEU*UB:T^T(
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M5_?:5::GIFKR+&L%];7B+#)A%QY\>\AMK%@?E.0!@F@#M;Z_M=-M&N;R411
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M-P^PGMD#\\5#)I]YJGBS3-?ET^>TCTRTN$$,CQF6=Y=GR_*Q4 !#U(Y([<T
M7=$\7Z+XBG6+2[B2?="9@Y@=$*AMI^9@!D'''49%2:MXITK1"_VZ2=(XMOG2
MI;R/'#GH7900O4=3QG)XJEX TZ^TCP;8Z;J-H;:ZMPX==Z,#EV;(*D^M8/BS
M1_$VM1^*-/\ L<UQ!=6VS3'6]$4* Q@,KH&!+E\GY@1C'(H ZF]\6:38:F^F
M2O<O?+!]H$$-I+(SID#*[5.[D]LXYSTJ(>-=":PTZ]6ZE:WU&?[-;LMO(<RY
M(V,-N5;((PV.AJE:6&I?\)_;ZF^FRQV2Z.+-I&DC.V3>'Q@,3C QD=_;FLH^
M&;UO 7B#3[R,6=R+^ZU"SG+J55O.::)\@G&"!G..] ':PZK:W&J7.FQF4W-L
MBO*#"X4!NGS$;3G!X![5!>Z_8V,T\+&>:6WC$DZ6\+2F)3G!;:#UP3CJ?2F>
M&X;D:2M[?PB+4+[%S<QC^!BH 3_@*A5_#/>LFSL=3T+Q5KUVEA+?V>JO%<1/
M#(@:*18Q&R,'8<':"",]P?< 74O&]G:ZIX=BM66YLM6$LAGAC>0B-8RRE0H.
M<G ]AFLW3?%L6C:EXI36;V^N(+/4 $9;9YOL\)AC?+>6ORKEFY..A]#4-AX3
MU7P[;^#5M[47YTM[G[4D,JIL,X)RN\C*J6QZX[=JO6FD:J4\;K+I[Q?VK(\E
MH6DC.\&W6, X8X.5/7L: .CGUZPB:)(Y'N998/M"1VT9E8Q=GPO8]O7MFJ%Q
MXY\/6T-A*UZ[I?Q-+:M%;R.)0H)(7"GYN/N_>SQBN5T_PWK&EZIINHS:7?7,
M3Z/;V%S!:7XAE@EASSQ(JNAW'^+(].:U9-"N+36_"3Z;HCPZ?IIN7E19D)B\
MU" /F;).22<9Z\$T =9%J=G+I,>J&98[)X!<>;+\@6,KNRV>G'KTKDM1\1/-
M\0/"UG9W&H0V]R]QYT,ML\<4RK [*0649P<<9].*V_&>C7/B#PAJ.F64B1W4
MR Q&3[I96# 'V.W!]C6+/'XBU?Q#X7U.XT![.+3YIC=1FZB=P7A9 RX;!7+>
MN[V'< W;CQ5I-KJ$-G-+,C33_9DF-O)Y)FS@)YF-N[((Z]>.O%/A\2Z9/=:G
M:QR3&;3 #=H;>0&,$9'5?FR.1C.17&:CHWBC4T(O=/GGN+?6XKI91>J(7MDG
M#J(X]P&X( #O .>YK4U_1KF7QM9R6846^KVCVFJ(3@^5&0X? ZG#/'GMY@]*
M .KM=2M;O2X]2CD*6CQ^:'F0QX3&<D, 0,<\U1B\4Z5+<V<!DFC-Z";1Y8'1
M)\#.%)&"<<@=2.1FI?$>DMKGAC4](CE\EKRUD@5^REE(!^G-<[-I6JZ]8^&[
M2^TU[&32[R"[N)3(C*S0J1B/:Q)W$CJ!A<YYXH O2?$'P[%#+.US<^1!.UO<
M3?8IMENX(!$AV_)R0/FQ6_?W\&F:?/?7)<6\"&21DC9R%'4X4$G\!7"'P]K-
MSX%\9:6VG-%=ZE<W<UJCRQX=93E<D,0#ZY_6N\ME,NGQI<0%"T85XGP<<8(.
M"0?SH IV_B+2[D:7Y=T =45GLE=2K3*%W$@$9QMYY]:YOQ7XC'V33KO3K^ZM
MHX-;MK2[S$8U=3( ZG<O('3Y?>LF#P3K=KX40*L<FL:+=*=&!D&&@BD;8I/8
MO&Q4^VW/2MSQ!H>H?V)H=G8VC7DUMJ=O>73HZ)NV2>9(WS,.6)8@>_:@#3B\
M5Z9?Q:E%!/=6]S9Q;Y4FLI5EC5L[9!&RY8<'H#TIVG:]:1^'-)NIM1>_>[MT
M:&5+<K)=G;N++$HR,CDC''?%9NH:;J8\:7VIPZ?)-;3Z(MHK))&#YHDD;:0S
M#LPYZ5CZ?H7B#2+3P9?IIK3SZ/8-I][8B:,.59$&^-BVTX,8X)&0: +>H^*1
M_P )3X;NH+N^BT^X^V17%FUNRLTD:\#R]N\MDG@9SQBNJT;7;#7[:6:PDD/D
MRF&:.6)HI(I!@E65@"#@CMWK"OK;5+_Q;X9U)-&GAMK3[3]HWRP[H_,4*O <
MYZ9.,\'N>*M^'M.O;#Q'XFFN;8I;WUXD]O*'4AE$,:'@'(.5/44 00^)_P"T
M_$NO>'U,L!LTB6&>*)R2S(S,2Q4JN, #/7WK/\%^-K2?PSX<BU2[N7O[^"-?
MM,EN_E2S$9V>;MV;N#QGMCKQ5ZVL]5T_QCXBNQICSV>H10/#-'+&/F2,J4*L
MP.<XP>F.]8]OX=UJ+X>^%--;3F^W:5>6<EQ")8_N1-EBIW8/'3D4 =9=^*=)
MLFE,T[^3!,()[A8V:*&0D *S 8') /IGG%0S^--#M]8?27N)_MT<T4+Q"UE^
M5I"0A)VXVDC[W3D<\BN8T_PK<6LFL:3JFBWFI6-[?2W,4T>H;8621]^V6,R#
M!4GDA6SBMW2]/OX?'7B*^GL9(K.^AMHH)Q(ASY8D#$@-D?>&./KB@#0'BG23
M-;H)W\NYG-M#<>6WE22@D; ^,9R"!V)& <TWQ#J*6#:6C:E)8-<7\40*VIF$
M^3CRB<$)NS]XXQCBN5\)^%KC3-,T_0]8T6[N3ITX:*]&H;K9MC[DD$9DRK#C
MY=F,]ZWO&=AJ&H1:,MA9/<FWU2WNY=KHNV.-LM]YAD^@_E0!I2^(K"*\>WS/
M(8YTMI9(H6=(Y7V[59@, _.OL,C.*LW^IVVFB'SV8R3R>5#$BEGD?!;  ]E8
M^P!-<;?^'-0FUN>_TFWU+2M1DO$>2XBNU^R7$8906DBWG)V#'"@Y YQS6YXL
MTI-7@LH9=-NKN..<R"6SN!#-;L%(#HV]?4@X/?I0!93Q3I;36,+/<1S7TSP0
M));2+F1-VY22N 1L;J><9&:9=>*M/AM];:%I))]'BWW$30NF"5+*!D<YQU&1
M7,2:'XDM;'0KITN=5ETW5Y+D033Q_:/LS1R(H+DA6<;P>OMDXJ8:9KDEYXSN
M9=)=?[6M(DM$6>,G<(BA5OF&#EN>W!P3QD I_P#"6?9_#&CWIOM0>?7+J"*X
M=H7S;[H][^2NSIV&,]<Y)!KI='U" :W/8+K5S.EM80N;:[MF1D&6_>M*R@L6
MQ@^FTUC7.E:R_A[P7;)I4S3Z5<VTMVGFQ?*L<3(V#OP<EN/;TJ;4] U+5O$W
MB$FVDM[/4M$73H[HNAVR9E).T-NQ^\';M0!L2>*]-D!CB>\198'DANEL97C<
M 9W(0N&XY'J.F12Z7KUH-!T>6347U&:]MP\,J6Y22ZPH)<1@?*.03T R/452
MT:;6U\-QZ=J'A^:*\MK3R3(D\+12L%V@H=^X9Z_,!C^?-6GA;6[&T\(7CZ=<
MS2:7IS:?>V=O>B&7!"?O(V5PK#*<@L,C'I0!V#^-M!CAM97NY%%S.UK&/LTF
M?.7.Z,C;\KC:?E/)QQFJUYXXTY?#FN:E9^:UQI,+/+:W,$D+J^PL@964, V.
MN,8^E9M]H-P)= DTO09X4AU@ZC=K)<H[\Q.A9B7.6)8'@G@=>U+JWA[5;R_\
M;K#:CR]8TJ.VM93(H4R+'*I##.1RXYQZT =1H^K1ZIHL%^0R[H@T@:)TPVT$
MX##)'/6N>T;XAZ?<^%9-<U7S+6*.:5)"EK,R*HE=$.[;SD*,GH"<'%=%H+71
MT.S6]LGLYTB5&A=U<J0 .JDCMZ_X5PDGA_7S\+]0\-?V.S7GVF3RF$\6R96N
M&EW#+<#:<8.#GMWH ["+Q9I5Q:R3P&ZE"3M $2TE+NRJ&.U=N2N"#NZ<]:FM
MO$VD7>D0ZG#=[K::0Q1YC8.T@)!39C=O!!&W&>#6=X@&N3WVCO96=T^G9D^W
M6T-RD,P) \LEMP^4'=D*V>G7I7,6GAGQ%IMKI][#IRRW6FZW=WALS<J1<0S&
M091R?O!7R-^,\YH U]&U^6[\=>(83<:@;.VL;>1;>>V=6B=FDW;4V@MD*O3.
M:NZ=XNTNS\/:-<7^L2WO]H?NX+W[$\8N7Y_A5<*2%.%ZG'%0Z9;ZROC;4]:N
MM(DBMKK3H(HD6:-G5HVD)5OFQGYQT)'O6)IV@:];>%_!5A)I$GVC2;]9[L":
M(@($D7*G?S_K!^1_$ ["S\6Z->6VH3_:7MQIW-XEW"\#P@C(+*X!P1R#WI8?
M%6ES:PNDDW4=\Z"5(9;252T9.-^=N ,\'.,'KBN5\3Z6\,_C2\U&SWZ;J.G6
MT,#B8)OF3S $XRP)>1 #M/-2:+J%S8^(=+D\0Z/JT>IW\/V"&]N'MWC!"F1D
MQ$WR[MA.2/X1TH Z76-22TUC1;4ZE):-<W#*(1:F1;KY&.S?C"$8W9SGY:JW
M'CW0+87I>:[86,GEW92QF;[.<!LOA/E7!!R>.N.AIOBBQU"\UGPW-9V3SQ6-
M^;F=U=%VKY4B<!F!)RX/TK/M='U5K;QO')I[Q'59))+3=)&=X-ND8!PQP<J>
MO8T ==+?VD&FOJ,EQ&MFD1G:8GY1&!G=GTQS5$>)-.6.YDN&GM4MXEF=KF!H
MQL8D C(YR1C'7...15.WL+D?#R'3;K3//N%TY;:6RD=<2$)M9=P;&#SSGOVK
MD-1\#ZU>:3J%EIEQJ4%CY4$EM9:I>"4^='*LF%=69D3:NW[W4@]J .\C\2:8
MUQ=033-:RVT'VF5;I#%B'G]Y\V!MX.3V[XJI<^-='LDN)+O[=;Q00&X:22PF
M"M&" 6'R\@9&?J*P-4\+2^(_#^IQQZ1=Z9JLUE]GCGU"]^T'[ZOL!$C_ "%E
M&3Q]*TM5CUCQ1X+U;3)]$ETZ_N-/EA4S31/&9&7&%9&)VY[D#MQ0!N2:[I\6
MIV&G22R+=7Z,]NODOAPJ[C\V-H('8G/2LZ'QQH5U?FQ@GN9+E9I(&1;*;*.B
M;R"-O!QG'K@XSBLD6^O:CX@\*:A-H4MI!IXG2Y62XB9U+Q!0P"L05S[Y]AWO
M^%+/4=-F\127FF31?:]2DO( )(R70HB@<-PWRGKQ[T 4'\9KIGA?P[>+?'5_
M[1O8[9KPVC1F1"S;G$:C(( P!6S::W;3^([Z/^U9!%#8QSM9S6C0B%26_>F1
M@"00,8[;3[URMIX?UZU\!>&;4Z4SW^DZE'<36PGCRZ*SDE&W;<X<=2.AJ[K'
MAW5=<UWQ #:/:VVIZ$NGQW#2(0DH,I.0&SM_> =.QH Z6'Q1I4MQ#"9GB-Q"
MT\#S1-&DT:@%F5B,' (/KCGIS4NGZ]9ZE/'% MP#+#Y\320.BRQY W*2,?Q+
MQUY'%<OI6CW#Z=;?VAX9N?[3L;61(WNM1\^!G,90B/,A.&SCE5P#4WACP]>:
M1K43V7]JV6BK:LDEAJ%VLZK)E=@BPSE0 'S\V.5P/0 Z6\UJTL[HVI\Z:Z$?
MG-#;Q-(ZIG&X@#@$@X]<'&<&N=\0^,[)='T:XTZ[=[;5[Q;87%O&S.B88N5
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ME:W@GEW+&5^Z>F6QQC<6P0#U&:V*YB;QWI5M8K=30WJ@7XTZ:,0AG@G+ ;6
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MQ_A_Q F@Z!K%UJ,E]=01:]<VJ.6:9D4S".,$L<X&5'6NJ?Q!9Q>(3HLJS1W
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MBLV\N7'Q*T5X+FX>UN-*NI6A69C&Y5H=K!,[<X8\X[T =A17-/XWTQ/#$GB
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M0P^7C)SCFMR7Q=IUE<SP:I'/IKPVC7N;D+AH5(#,"C-R"1D=>1Q0!OT5A_\
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MP#QQ74:=IM[ILUI;17<1TFVL4MU@,7[PR+@!]^>FT8QCKSF@#6HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *;)&DT;1R*'1P596&01Z4ZB@"K8:;8Z5:BVT^S@M+<$D1
M01A%!/7@<5:HHH **** "C SG'-%% !@9Z=**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD]I.UO<VMT@62*0=00": .AHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOBTT^5]6FAB,/S@1^:I93G/.,<U=\4>+O$'@FUAU75]/L+W1_-6.YDLG=)8
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M40':-NTD\#D>HJ'2]"U>/XP:UKUUHT@TJ]M8[>*5I86(9-OS%=^0#M..">G
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M5B1DD=CQGZ5IV:^(;WX>W6CWWA:>WU2+2GL4<3P,DK%-@V'?D*>&.<8QQDT
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M&XMI(6*$X#J'4;ER,9%4=1\51V/C.RT!E.RXM)9WE2-W96#(J@  C!W$Y/3
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M6*216B5"T;JX&05S@L,@GI0!VT7B729K.2Z6Y(6.<VKQM&PD$W_//9C<6[@
M<CD<5BZOX]M+&*Q:"&??-J<=C/'<6TL;Q@KN9@I7)^4C&.#FJ&H^';M/[.UK
M1=&FBN[74_MEQ975TK2W2F(Q,=Y=E#A3QEL<=JO^(X=4U>QTF]M=#N5FLM5A
MNI+226%97C56!((<IGYAP6'2@"]!KMO)X@OE&I3R10V,<YL/L#JT8);]X&VY
M?=TVC.-I[U8@\5Z/<Z79:G!/-):7T@CMY$MI3YC'IQMR!UY(QQ5"SL]2_P"%
MBW>JRZ=)%93:9#;"4R1G$BO(Y& V<?.!G'45!X;\.7NDZS>6TR)_8MI<R7.E
MX8$@S#+KCL$)D ]1)[4 ;$OBC28955[AO+:X^R^>(F,0FSMV%\;0=WR]<9XZ
M\5L5YQX?\*W&GV3:!K&BWM];QWCRQ7::A_H\B&8RJS1F0%64D9 0\C/.:]'H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BFR()
M(V1BP# @E6*G\".1]17!>";"77?"S75[JVK&Z-W=1"9+Z0%529T7 SM. HZ@
M^] '?T5Q?A;Q+?&WU?3]5$M]?Z5J!LED@B :Y4J&1B.%5MIYZ#CMFDUWQVL'
M@S5M5TVWFCOK&<6LEO<P$M%*2O#!21C:P((.#D<]J .UHK&/B2W:86]O:7MQ
M>>3]H:U6,)(D>XJ&8.5 R0<#.3@X%7=)U2TUO2K;4K&3S+:X3>C$$'W!!Z$'
M((]J +E%8EIKUMK2Q)!:WILKS>D5XA"H^W.<%6WKG!P2!TKE?!7C&.U\(>'T
MU1=3F-TXMSJ,J%XS,TC!59R=V2<#.",\9H ]%HK"UGQ5::%YDEW:7IM(75+B
M[2(&*$MC!;)#$?,,E00,\]#6<@E;XHZA9-=71M)-%BE,/VA]JN9I%+*,_*<*
M.5QTH ZZBN6^'%Q<77@'2IKJXEN)V63?+,Y=V_>,.2>36'I'B?\ L&?Q7]JA
MUC4(+357RT8:?[-#Y,1ZLV=H)8X&2.3B@#T6BL)O%FGR1N]A'/J(CMDNY/LB
MJ=D3@E&.XC)(!( R>.G(K2M-3L[[2H=4MYT:RFA$Z3'@%",Y.>G'K0!;HK!A
M\4V%W-I\+1744&JJ197+J%2?Y2V 0=RDJ"PW!<XXYKE=*U4V?@1YK_4]53;K
M<T N86\Z0 791$9GS\I^5>>QH ](HK$U/Q/::=+>Q+;W5W)80K<7:VRJ3"AR
M03N89.%8X&3@=.1G/_X2.QU36/#K07.J0Q7ZS/;H(-D5ROEELN6&X8 RN,=1
M0!U=9VN:):>(=)FTR_,OV688E6*0H77T)'.*XC0/%\>@Z5K#ZE'J]Y;6FKW<
M<MV%:=;:)92%W,QW$!<=-V!UK5MM02U^(>M2RZA)_9B:-;WA$D[-%'EY=S@$
MX4;4'3TH ZG3;"'2M-M["W:0P6Z"./S&W,%'09[X'%6JQ;;Q-:7&H65F]O=6
M[7\32V;S( LZJ QQ@DJ=I!PP!Q]#53Q;XCGT";0XX(7D^W:BMO+M@>0^7L=C
MMV_Q?*,#TSQQP =+16'/XGMH_M?V>SO;LV2*UT((US#E=VTAF!+;2#M7)Y''
M(K1L[RSUK2H;RSG\ZSNX@\<L;%=RL.H(P0?R(H MT5YMX2\:PZ5X-L)-775)
MXOM$T,VI2(TD<9-PZKO<G=C[HR 0.A-=5?>+].L8KRY=+B2RL9O(N[N)08X'
MXSG)#'&X9*@X_ X -^BL/4/%%M9&[\BSO-0^Q?\ 'V;-%;R/E#8.YAD[2#A<
MG!''(I+SQ79VD=_,EM=W5MIS%;R>W166$@!F&"P+;003M!Q]<B@#=HKG;GQG
MI\5_;65O;WM]-=VAO+;[+#N6:,;>58D#^(=2!56'XA:1-:VEXMMJ*V=Q.+9[
MA[8JEO,7V;),G(.[C(! )ZT =916'J'BJQT\:@_DW-S%IH!OI(%#"W&W<<Y(
M)(4AB%!(!K6%U";/[6K[X#'YH= 6RN,Y&.O% $U%8MCXEMKS6CI$MI>V=X8#
M<Q+<Q@":,$ LI!/0D9!P1D<5C_$*6XM[31'M;NZMGFUBUM9#!,R;HI'PRG![
MCOU':@#LJ*XFPNKFW\:7+V%]=W?AR+3FDN3([SJDX;@1N<LQVALJ"<<=R*VK
M7Q1;W&J3Z9)8WUM>Q6_VI89HQF:+.W<FUB#S@8.#R.* -RBN%O?B1:S>$]2U
M?2+*^;R+"6Z@GGM&\EF0E=I(/.#C/8#.2,'%Y=>CNM4\-)+-JEK/=>9B$6^R
M*=A$6(?<,@#!(QWQ0!UE%8<OBBW6?;;65[>0+<BTEN;=%,<4A8(0<L&.&."5
M! YST-95OXLL-,T'7=8GFU6[MK*_E2=9HEWP$!244<?(,C&>>: -?7O"VG>)
M);&34#<;K&87%OY4Q39*.C\=2*V57:H7).!C)ZFL"/Q?9'7;;2;BTO[22[W?
M9)KB#;%<%1DA3G(.,G# &G#Q7:#5K2PFM+Z#[:7%I/+"!'.RJ6*CG<#@$C<!
MG'% &]17(R?$32HK.YO6LM4^QVER]M=W MOEMV5MI+<YP#Z X[XJ:3Q/,GQ#
M&@>1(]K]@6?>ENY/F-)M!+=-@ Z^N>>* .HHJCJ6JVVEBW$V]YKF40V\,8R\
MKX)P,X'0$DD@  Y-9-QXVTVSM]5>[@O()M*C$UU;-&&D6,@D.-I(92 >0>,8
M.* .DHKG[3Q=976KVNFM:7]L]Y&TEI+<0;8YPH!8*<Y! .<$#VS3/&GB"?PY
MI%M<VT9DEFOK>WQY+285Y%5ON]\$XSWQUH Z.BN"?6I;/XCSM'%JUS#-HL<Z
M6";B0_G,I8(Y"H<*/3\S6_:>+]+O].T^[M//E?4'>.WMMFV5G3/F*0Q 7;M.
M22!QUY&0#>HK.TC6K;68KDP+)'+:SM;W$,H >*08)!P2#P0002""*XNYOK>'
MXEZQ9:GK%[;V"6$$\40O)4579GW$;3Z*..E ';6^D0V^J3ZB9KF:>4%5$TI9
M85.,JB]%!*@GZ5?K@M9U<Z5H?ARSCGU&[M]6O-CS*)&G\AEDE"AE.0V-JY!S
M@$CU#SJ4,OC:#P_(NI+8Z=86US$P,RGS"[#,SY^90J ?,2"2V<D< '=45@P>
M+=/GETW]U<I:ZFVRRNW0"*=MI8 <[AE02-P&<?2E3Q5;32V[6UE?7%E/(8DO
MH8U:(L,YXW;R,J1D*0>Q- %S4-&M]0O+6]+S07EJ&6&XA8!E5L;E((((.T<$
M'H#VJ6QTRWL'GECWO<7#!IIY&W/(0,#)[ #H!@#GCFN'@\:'4_ 4^I:@^I6#
M"Z9#<V-J5VJ+@H@7>"#D*%;TR>E==_PD%O\ \),= -O<B[^S?:@Q"A&CSMR#
MNR?FXQC(R.W- &M16%!XJM+E+81VMV;BZ:46]MA-\BQG#N/FVA0<<DC.1C.1
MF[H^L6NMV;W%KYBF*9X)HI%P\4B'#*PZ9!]"0>H- &A17":':2:GXL\6VESJ
M.IF"RNH8[9$OI5$8:%'.,-S\S'KFI=)UJ]T;Q;J_AS4KJ>_M[>R34;2=DW3"
M(L4:-MH^<AAP<9(/.: .VHKG&\76Y758&L[RUO\ 3[7[2;>XBR70[MKKL+!E
MRI'!R,<XJOX?\8)?^'-$N+N"<ZEJ,",MND)3S7\L.Y3<0-@!^\3CH,Y(H ZN
MBL[2-9MM:AN'MUDCDMIVMKB&4 /%(N,J<$CH0<@D$$5C?$BYN++X?:Q>V=S-
M;75M 98I89"A5A].HYZ'B@#JJ*\^L+]QX[T:UT[4K]+:2TF:]M]2>4><0J[/
M*$WS%@<DE> .M=$OB_36^QRA+C[#>W'V6WO=J^4\A) '7=@D$!BN#QSR,@&_
M17":5XEM+K5_$&J:HU[;Q:1<RP1R$2I L*I'D%?NLY9B>06Y&*Z%?$ULNJVV
MFW=I=V=S=1O):K.JXGVC+*I5C\P'.TX/Y&@#:HKE;7X@:/=+/+Y5_#:VPG^T
M74UL5BB,3896;^]Z 9)K3MO$-O-J\6ES6UU:74T#7$"W"J!*BD!L;6."-RY!
MP>>E &O17,>)/$TVB^(?#]A'!)+%?RS"?R[=Y&VK$S#;CC.X#/7C-8EAXC.A
MZ[XP^T1:O?VUK=Q.$CW3?9XC;H['YVX&2QVC)]!0!Z%16/\ \)+92M;1V*37
M\UQ:B\CBMPH8PG[KDN5 !S@ G)YXX.+.E:I9Z_I$-_92,UM<*=IP488)!![@
M@@CV(H OT5YMX<\91:'X>NY-435KJWM]3NXIKXHTR6Z"=E7>S'<0!CIG ZUU
M=]XMT^RCOYA'<7-MIV/ML]NJLL'RACG)!;"D,0H. : -ZBL"_P#%UA9)>/%#
M<WJ6,"W%TUJJL(8V!8$Y89^4%L+DX[<C-67Q#9WVH^&Y(;G4X([Z5S BP;([
M@>4S8DW#(& 6&,=J .IJA<:1#=:I!?337+>2!LM_-(AW G#E.A89ZGT'<"L*
M?X@:;#!J,PT_598M-F:*]>.UR(-JABQR>0 V>,GVQ5RY\86,&J1Z;%:WUW=3
M6GVR%;>'<)8\J/E)('\0ZX'OTH Z"BN/O?%>G:AH5C?0W.IV<<FI1VKB*$"1
M)1*$,4@;.T%N#^AJ]<^,;2#5+_38=.U.[O+)$DEBM[?)*-NP5)(!^Z>_/;-
M'145AP^+-,N[+2[FR,MT=41GM(8U >0*,L?F("X[Y(YP.IJ30?$=IXACN&M8
M;N)K:5H9EN(2FR120R9Z$@CG!- &Q163=:_##>7-I;6MU?7%K&LEQ':A28PV
M2H.YADD G R<=N1GF]>\76E_#X;2P:[N--UJ:02R6:2"1HUB=MJE<,K;E&0"
M" &H [JBJ%U>V6AZ,;JZE:*TMXU!:0EF[ #N68G ]2351/$MJ+^XL;FWNK6Z
M@M3>>5(@9I(0<%EV%LX/&.O(XY% &U65I^@P:=K.HZI'<7#SZ@4,ZR%2N4&U
M< *,8''7ZY/-06OBJRFU"\L;N"YTZXM;?[4ZWBJH,.2/,#*Q& 0<\Y'<5EZ]
MX@%]X?U&*"TU2V673IKFTOE/E*VU-P(*OO4\@X8#- '845Q_ASQ;;FS\/:==
MP:@DU]:1K!>3Q'R[B01!F ;.<X#') S@X)J?XCW%Q9?#_6+ZTN9[:ZM;=I89
M89"A5A]#R/8\4 =!?V?V^RDMOM%Q;[\?O;=]CK@@\'MTQ]*?:6D-C:16MNI6
M*-=J@DD_4D\DGJ2>2:XF1;M?$F@V^BZC?7$;[UU:-[AY8TB\L_,6))1]V,!2
M">>,"K/@G4YH/!,4UR;V_G-]=PH-QEE?;<2A1N8]E7JQ &.M '9T5R\GCS2H
M=&N-3F@OHDM;L6=S"T&9()25 # $C!WKR"0<BKNG>)[74-;FTAK2]M+Q(?M"
M)=0[/-BW;=ZD$\9(!!P1D<4 ;=%<WXRLM8DTQ=1T"ZG34;!A.EJ'/EW:CEHG
M7_:&0#U!Q4&E:['XKEM=6L;IX=%M8O-E;.WS9F7.QC_=C!^8?WB!_"10!U=%
M85OXLL+BXTU/*N8X-3S]AN9$ CG.TN .=RDJ"1N R!1_PE5HNKV=A-:7L O7
M:.UN98@(IG4$E1SN!PI(W 9QQF@#=HKG+'QG8:CK#Z9;66I--'=-:S.;8B.%
MUCW_ #MT (X'O71T %%<[=>,]-M+*747BN6TN&8PRWZ(IB0AMC$\[BH;@L%(
MX/.!FFZAXTT_3]8DTHV>HW%XD23[+:V+YC9BN\'/W00<GVH Z2BJ6J:I;Z3:
MI/<;CYDJ01H@&Z21V"JHS@9)/<@>M9UQXKMK)(3>V-_;-+?1V(5XU.)'V[22
MK%=IWCG/KW% &]164/$-B-<NM)D\V*>UM1=R/(NV/RB2-P;Z@_E61JGB%-0T
M>YB@M-3AAN;.6:UU!/W:-M0N""K;UZ9&0,T =917$^%?%\ T7PQ97T.H"6^L
MX8XKZ>,F.>;R@Q7<3G<<,<D8.#@FNVH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ****  ]*XGPKIWB?P[H!TTZ=I\LQN9YEE-\P0"21
MG&0(R>-V/PKMJ* .&N/">K:?I4"Z=<+=7<^J&_U8&5K;[6&!!16&2J@[,+W"
M8)Y.:<W@O5W\/^++"*#3X9-3NX[NU2*0B,;5BRA^7CF,\XYSG Z5Z+10!PMW
MX<U1O%@\1-I5C=B[LTM[JS>Y(:!T9BK(Y7###$$8'MFNOTRSCL--@MHK.VLT
M0?\ 'O;?ZM"3D@<#N>N!5NB@#@M*\)75AK%EJEGIXTJ:/S'U"&VO&-O>,R$8
M6/[H&\AMQ (QC!SD1V_A/6H_AOI6ANEK]OL;R"9L3'RW6.<2G!VYR0,=.M>@
MT4 ><^(O"GB/7+?Q%:2Q65P+UE:PGN+EL6Z83]V(]N%.0QW@\[N_2MZ/3M67
MQY/KAM8?LKZ6EH$\_P"?S%=W],8^;&<]JZBB@#GO ^DWVA>$K/3-12%;FWWA
MC"^]6!8L""0/7T[5EVFC>(+.\\26T=M9&UU>Z>XBNS<$F$-&L?S1[?F(V9 !
MP<X)%=K10!YY:>!9?#VN2RV.G6NJ:;<6=M;>7<3>7) T*>6#]TAE90,]\CH:
M["71X;CPS+HRPQ6<,UHUMY=L/DB#*5(3@<#/' K3HH XGPOX=N],M-.M-1T#
M2WGTY B7T<VXN54JKHI3*L1UY&,G!/2J#>%=?;P/<:-Y%I]JDU8WP;[0=@0W
M7GXSMSG QTZUZ+10!YQJ=M?ZAXUU<Z3IJ7$)LH;74XTOS;EY""P1B4;.(W7#
M)M/S')Z 6M/^V^([OPMK%EI<=E::5+=0W%L\PS&0&@VI@88 KG/'%=7-H.GS
M7TM[Y<T5Q,H65X+B2+S .!N", Q X!/..*NVUM!9VT=M;0I#!&NU(T& H]A0
M!Q%IX<UW^S/$.@SP6D=EJMW=RB]2X+,D4['(\LJ/G /KCWXP5U#P9=ZAJFM6
MX6*WTN^T1-*AD63=)&4,F&*XZ?.._:N[HH Y+PSHES:?8?[2T#2X;NSCV?;8
M9MY+;=I:,% 5W#.<D=<<U:\6Z5J.H_V+<:;'!--IVI)=M%-*8PZB.1" P!P?
MGST[5T=% '):?I6L:%K&MRVMM!=VVJS"[3,VTP3%%1E;(Y3Y000,]1MK5\+:
M$OAGPOI^C)+YOV2((9,8W-U) [#)/%;%% 'GVF>%-9E\'MX2U6WM(K-I6:6[
MAN"Y>-IC*5"%1AN=N2<#J,]*=9>#[C3M0UBWFT73=6T_4+V2[CFN)=I02'+1
MR(5.0#G!&<@\XKOZ* .0T[2M<\/:_K+65K:WNFZG<B\0O<&)X)"BJRL-IROR
M @CD=,5':Z%J^DQ^(=/M88+FVU2YFNK>=Y=ODM*/G61<9(!R05SD'''6NSHH
M XK3?"U]HNOZ$]JD<VG:7I#Z=O>7;([$QD-MQC'[OU[U2/A/7'\"W^D-':+>
M2ZM]NC_?$H4-V)\$[>"!D=.M>A44 <%'X3O+/7]9G;1]/U2QU:47&+B?8T#E
M KHPVD,AVY!'N,5U>J6=X_AJ[LM(DBLKPVK16K@82%]N%Q@< '';\*TJ* .&
MT;PYJUOXITK5[BQM+=(=/EM+@+=--*SLT9#L[*"_W#UY&>IS@:/C72-3UJ#2
M8M.A@<VNI6][(9I=GRQ/N*C@\FNHHH S->M]3OO#=];Z7.MIJ4UNRP2L>(Y"
M..0/UQ[US6D^']6M/%5MK;Z;9P(NER6DD2732RF0NC!FD91NSLQD\C/?MW%%
M '#6'A751\)KKPM<BVBOWLY[='60M&6?=@YP"!\W/%6)]+UV]U3PI?2V-I#_
M &8\C7,:W1;[T31C:=@SUSVKL:* .1\-:7KOAN2ZTO[-;7>FO>RW%O=?:"CI
M'(Y=E=-IRP+-@@X/'2N=\1:7J6E_#CQT;^*%/MMQ->0^7+NPK[  W P1M]^M
M>H51UC1['7M,ET[4HFFM)N)(UE>/</0E2#CVH QSI>I:[>Z7>:M;6]E_9LK3
MQQ13&;S)2C(&SM7"@,QQU)QTQSSUAX5\1B?PY=ZC;V4M[IEV\EW=&Z:26Z#1
MR)N4E1M&7!V=/ICGT2*)88DB0L548!=BQ_$GD_C3Z . ;PIK5QX'\5Z/)':Q
MW6J7-U/;$3$J!,Q8!CMX([\&M9=+U>/QQ;:RMM;-:RZ:MG<!IR&A99"^0-IW
M [L=NE=310!SOB;1;R^OM%U;3C&UWI-RTHAE;:LR.A1US@X;#9!Z9'OFL;7O
M"NI:VOB'4$ABAO=2TD:5;P/+PB9<EY& (SE^@SPO7GCNZ* .5N]&U.XU7PG?
M+% /[,,OVI#+SAXC'\IQSR<]N*M>,=)OM7T6&/3EA>YM[VVNUCF<HLGE2JY7
M=@XR%ZXKH** .8M=,U8^/3K=Q;6\=K)I:6C!)R[+('9R?NC*_-CU]JYE/ VL
M0)I5T;:RNI],O[Z7[+),0D\-S(6X;;\KK\O48Z\UZ;10!F:)8I96LI&EVNGO
M-)YCQV[!MQP!N8[1EN,=^ .:Q!I>MV?CS5=;M[.UN+6[M(+>-6N3&P*%B21L
M/'S_ *5UU% '%ZAI.OWQ\/R_8K*+^SM1-RT"3_*D(22-$4[1DX<'H!VJQ-H-
M_=^,=5O)HXUTZ^TM-/WI+^\4AI"6VXZ?O,=>U=910!PWA7PO=:78Z=INIZ'I
M<K:>H1-027);:I59%0KE7QUYXR<$]*N>#=-UWPYI=MX?NK6UGL[,F.&^2X(+
MQ9)7,>WA@" 1G'&<UUM% 'G+^%?$)^'E[X9%O8F;[6SP3_:3MD0W!FRPV?*<
M<8YYK>\3Z#J&JS:1J6ERQVFIV<A1G<Y AE7;*..I'RL/=!7444 <9K_A.9M;
MT75=,L[6ZBT^W>S>QGD,8:)MN"C8.&4J.#U'<5T>C626-D533K6P:21I'AMS
MN!8_Q,=HRQP,_P S6A10!QVFZ;K^D^)O$E_'86=Q!J=S'+#F\*%0D2Q_,-AZ
M[<\9J.]\+:U+8:[J4%Y#'XDU**.*-XW98[>)#D1(^-W(+Y? .6S@8%=K10!P
MUGX7U(:_?W[65E907ND"RV13&1DDW.<NQ4;^&'/\^M4!X0UMM-\)W$]CI\MY
MH,#6DEFUR2EQ$8T0NK[/E;* @$$8ZFO2** ,"TM+_3[:#^S=&TRS:>\#WD8E
M/^J(PSY51NDX48/&!UI/'&CWGB#P7JNDV'E?:KN'RD,K%5&2,DD ]O:N@HH
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M$XEP?EX;"X].>M;VF:7J4'CC6-6G@A6SO;:WACVRY=3%YF<C'0[_ %[5TM%
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MVEQ<07CSF=(1%F0+$2%!=EQ@X8].!U[5'#XAM[&Y\6WGV35I'TUDDN8))D<
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M_*%P5!<)DG:#V')_.KE%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6_BG_M1XWDB6W*;"B!%P=YXP.<CKZ=*Z"B@##O\ 09[WQ5I>M+>I&NGQRQB
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M3G(X/3%7:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(Q#<LICN81_RRF0E9%_!@?PQ69XX\6KH.DR&PU+3DU-98E^RS,&=U:15.%W
M@@-GH>G2@#KJ*SKS7]&TYY4O=6L;9XEWR+-<(A1<@9()X&2/S%":_HTEU;6J
M:M8M<7*"2");A"TJG^)1G+#W% &-9>%+VT^(.H>)VU&!X[V!;=K46Q!5%^Z0
M^_KGKQ^5=56/#K"C4]56YO\ 2ELK18L%+C][$3N#><#PHR/E]<&I[?7]&O+U
M;*VU:QFNVC$JP1W",Y0C(8*#G!!!SZ&@#1HK(T[5Q,FI3W5]I;6MO<%$DMI]
MPCC"J<2D\*^2<CI@BJ^K^+]*TS0YM5CN(KR**>*W98)5.'=U4 G/&-X)]N:
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M+N+3I+8Q7>GF+"L5)0J(EW-N X&<<U@2:,(O@,;.#1+E=5DTR.VDA6Q<3M*
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M6"2ZBN7B5IHE98W(Y4-C./K@5+0 4444 %%%% !1110 4444 %%%% !1110
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MHW$DYY*KC/6J/A30WCTW1-/UG0M3%[HX3;*UYOMU>-"@D3]YR""<#;QNP0*
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M-96ZDB\R+B(79FSG?C[IZ9SF@#J=(U!/[<M].C\0F]06#3^3/!^^D_>#$ID
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M:43LU"U;1[UMV&6)5+K*/]I0L@!]7% '9:?J%MJMA#?6<ADMIEW1N49=P[$
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ME'EO#8^7]F=F2<#)C; (#8Y'/(Z9H Z2LOQ%H4'B31IM+NKBXA@F*ES 5#$
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MI#;6 &<J2I&1TP<XJ_X9U@Z[X=L=0>.2.:6"-I0T#Q#>4#':' )7)X(R/<T
M:]%>;?VS!;>./%=GK'B:>RLK..VEM8VNEC(WHS2;<\MR!QSBM.X:]L/%/@V
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MGX)TRWLF;7],M7258+E%<0!%1RI8,A4OY?WAGT'4CU.L^^T:SO[R"\D$D=W
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M-2NKF-E<,&225G7IT.#SFL^;2M8M_$GB:XAL4N+75;2)8I%G561TC9-I4^[
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MXS\F#G?^&.] &58>+K/3/#\5V+/6KB*?5Y+$_:)$EEBE:<I@_/\ =#9 "YX
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M/7VY &^*M2NI;SP]/<Z5>6EQ;Z[#$$60.)T:*1L+M.",@=<8(].:ZC1/$?\
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M3O\ 2/!US=::76Y\Z",2(5!0-*BGKZ@X_'- '445S\?B&[NM3GTNTTZ(W]K
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MD\<\WKVL6_B&'2&FLEM]1TOQ/:VD\;$.8WW@Y1\#*L"I!P,]QQ0!Z2'4L5#
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MPD(7"D-DD@8 /%5]1^(PTZWUAA86]W-IL$=T1:WH>.2)V*\/MX8,.5(Z$'-
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MASUP ;ZLKKN1@R^H.:6O-?!?B6UT3P%X1TYS MU?6KM&)YA%&JIRQ9L'^\
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MV.2UN/.CE7 .X-@=R1C'4&@#1HKCGUA+'Q)XHECTIFO+*P@N)'-XVV>/]YM
M4C"$!6Z#G-.L_&=[++H$MYH@MK#6PJV\RW0=XY&B,@5TVC (5L$$].0,XH Z
M^BN;\?7<%CX)U.YNK%KVUCBW30)<- S*#V=>1SBJ5QK6J0_$PZ='!+)IT>E+
M,T8=0,F7!D ZD@#&/\: .QHKF?#'BP>)U@N+6.R:SFM_.+0WHDEA;Y<1R)M&
MUL$]S@J1[U8\0^)X-!N].M)6MHY+XR".6[G\F$; #@O@_,<C QSSZ4 ;U17,
M<,UN\%P%:*4&-E8\,#QC\<UA1>)+BYO[?2X;&$ZF]H;N9&N?W44>\HI#A26W
M$''RC@$G' /+ZUK%MXB_L">2R%OJ&G>)XK.XC;#F)P&)"O@94@J0>,\<<4 >
MA6-A::99QV=C;QV]O'G9'&N ,G)_7FK%<3>?$>QM[:ZO8EMI;.TO#:RC[4!<
M'#A&=(L'< 2>I!(!/IGMJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5B/[U)@@8J=WRD;..O6I="TG7=)L(;"?5;*YAMHO*BD^QLLC@#"[SYF..,X
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M7*MG?S]\Y&!6=;>"+JV\-^&]*&J1,^AW4<Z3&V.)51&4*5W\'Y^N>W2NSHH
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MW19$9'4,K#!!Z$5Q@^'4(T0:*-<U/^S(9HY;2 F,_9RD@=0&VY901@!B<#W
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%4=7GOX+ G3+:.XO'=4C65BJ+D\LQ )P!D^^,=ZQ_#NNZK=:
MYJFAZW:VL=[8QQ3+-9LQBECDW8X;E2"A&#0!TU%<]XAO?$5L)Y-'@TT06T'G
M/)?,_P"\/)*+M^[@ ?,<]>G!K4T:_?5=$L-0DMWMGNK>.9H'^]&64':?<9Q0
M!=HHHH **** "BN*^(GBK5O"=MI-QIR64JWM_'8LEQ&Q*EP2&!5ATV],?C2:
M-XIUMOB->>$]4@LITALA>)>6:.@4%@ KJS-@G)[]O?@ [:BJ']N:1_:@TO\
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M/&]99U4KD@#()XR2!^-7J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>N_HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M&N"R,JL5)& PZCWYKB_#7BIETS5K_P 1:K!'%;:K<6$3.JQKB-]J].K'_P#4
M*[1V"(S$$A1G"C)_ 5Y1+I>J2^ /$VG'1[TW5[K<MU!"T7^LB>Y60'/0?*#P
M?IWH ]%T_P 1Z/JM]-96.H0S74*[WB4\[<XW#/5<]QD5SWB[Q:ED^E0Z7J@2
MXFU2VMG58@Z2HTJJZABI&0,]#D<TNNZ=?7WC"PN[.&:**71KNU^TA"/)DD,9
M3=W'W2?;%831ZU/X)\/Z.?#=[!=:3>6'VKA2FR&1=S1D$[\A<\=L]\ @'H%_
MKNF:8TBW=VL?E*'E.TL(E/1G(!"#@\M@<'TJ"[\5:'8W4EM<:E"EQ'&)6B&6
M;:>A  Y_#W]*Y$Z3=V_B/Q+#J-KJ]QIVM.LL,EF RNAB6-HI!U0C;@$X&#U%
M/,L6A?$ZU@ATR]FBC\/10((4$K1*)F #'.>P&>>>OK0!V%OXBTB[TN+4K;4(
M9K29MD4D1W;W_N@#DMP?EQGCI43>*M"CMXYY=4MXDDG^S 2ML82Y V%3@AN1
MP0,9%<-=^$]6TS4++7(;>X:/^V;J_NK.R93+$DT0C5ESPS#;E@,_?;&>M6]9
MT97L+>XT_2M3EEN=<M+V[-PF7=(F3<Y7^'"J!C )QT- '9Z9XATG69+B/3[Z
M*>2V(\Y 2&3/0D'G!P<'H:YW7_%B)KWARTTK5!_IFH+#-$(@5FBV.25<KS@J
MHRI[U4\3Z'J>J>(];6QADB74/#9LX;G&%\[?(=K'MPPY]ZBO)]5U6W\)G_A&
M[^T_LW48I+Q'53Y06*1#L"D[E!8<CMC\ #L[O7]+L9FBN;Q(RCJDC8)2-FQM
M#L!M0G(P&(SD>M5;OQCX=L9+F.XU>V5[5@LZAMQC)SU SCISZ=ZX^VT"=)O$
M>BZW9:O<V>I:A-<Q-:%3#/%(00I;@HR]#DCH,&MS1[*=/&GBN>2PG2WNXK=(
M)7CXE$<;*PS]3WZ]1F@"YJWC32]*U30[:2ZM/L^JB1Q<O<JJI&L997YZAC@
MY'6KOB;7[?PQX;O=9N$:6.W0%8T/,C$A54?5B!^-</H^G:KIVE_#Z6;2+QVT
MN.6WNXD4;XF:'8IP2,KGOG KL?&GAT^*_"-_HZ3""6=5:*4]$D1@ZD^V5&?:
M@!D6G^([BQ$USKBVM\R[O(M[9&@C/]T[@7;'3.Y<^@JX=:AT^T@359D6^%NL
MMQ';QL^SCYFPH)5,@\GCCK6;IGB;4/LL<&L>']2@U) %D6"'S89&]4D4XVGK
M\V".]5;%;W2/&FM:A>6-V]IJT-M) T4?FF%XT*M"X7..3N!^[R>: -N?Q1H5
ML+0RZM:*+M#);_O0?-4 G<N.HP#6=JGCG2+/PAJ7B"RN8;V*R5@8Q)Y9,@_Y
M9G(RK'(X(SSTKF-*\.:AHTW@R":QE=+.\O+JX$:[TM5F638F1P<%P.,XZ].:
MDU[0M4N[?XC6MMI\K-J44369P LY6!%8 ],Y&.: .NE\8^';>&&2?6[!1,C.
MA6=6!"@EL$=<8/\ *GW/BO0K.T@NKC4H4@FB2=)#G C;[KMQ\JGU; ZUAZJ;
MC4_%/A#41I%\MO;-<23^;#\T&^(HF0"><^G(ZG%5?$\.M7EQX@TI--NVL9=,
M\JP%HJ+'*Q1PPD?[PP2 %&!CL<T =C?:QI^FQH]S<@;U+(J*9&91U(5020,C
MD#O6-'XYTB;Q1::1'=VICNK$7<4[7"KN+.JH@4\DL"3Z^U8>E1:IH6OV&HW&
MEWMQ8W&BV]DQACWR6LT18E63KM;=U&>1^-:36]U!\0+&_BTJZ6QGT@VBM&BX
MMW\T-AQGY0!]>F* -U_$6DQW"0/>HI>;R%D*GRS+G&SS,;=V>-N<YXJ*Y\6Z
M!:7YL9]6M4NUECA,._+!W)"+@=R0?RKB$T+4[GX6GP3/8SIJB$6_V@H?)($H
M83B3IT^;&=V>,5T.FV<H^)&MWD]A-]GGL[6&&X>+Y6:,R%QGMU3GOCB@"QXV
MU2\T>RTNZM+P6RMJEK!/N52K122JK9+#C@GD8JY!XP\/W,5[)#JD#K8KON<9
MS&G]XC&=O^UT]ZH>/K.ZO-$LOLEC+>M!J5K<R01 %FCCD#O@$@'A3QWZ4MOI
M9UGQ:/$$UG);VHTU['RKE-LDV]PQW+V4;<#/)+'C&"0#8&O:8T=A(+H%-0.+
M5MC8E.,\<>@)^@)Z55\6>)(/"N@R:G,L;XDCB2-Y1'N+NJ]3Z EC[ UA>!M,
MO;9I+&^0F#0))+&QD)SYJ'#*WU6,HG_?8K2\?65W?^#[F&RMGN9UGMYA#'C<
MRI.CMC/4[5/% %&;Q7':^.(U?6(7T*;27N4"!74RB5$^5E&YN-W )[^G'1PZ
M_I5SI<.IP7\,MG,=L4D9W>8V<;5 Y+9!&T<Y'2N?C6YNOB79ZHVFW<5K_8[P
M>;+%C9(TJ.%.,X^4'V[=>*Y<Z%K5M/;7R6%]Y6G^(;^YD@M\"1X)BX26//#8
MW9QUP30!Z=8:E9ZG$\EG.)!&YCD&"K1N.JLIP5/(X([U@IK-_KWB;4M)TN=+
M.STLI'=77EAY))67=LC!^4!1C)(/)P!WJ[X=L+6!K^_@M[Z.:^E5YGO>'E*H
M%!V_P\ #H.GXUA1V>I^$O&.KZC!I\^HZ+K#)/)]E :6UG5=I)0D%D8 '(R0>
MU '06RZAI5Q=2ZGJL<^EI"'$UQ&D;QL"=VYEPI7&.PJ>#7]+N)Y8%N@DT47G
M/',K1,(_[^& )7_:'%<_XJ%_XG\,7$&EZ=>++#+!<JET@A%QY<JN8\,<C(7J
M0!G'-.N;>76O%^A:Y#:W=O;Z7;W)G,T#([F1541!3RV,%B1D<#!.: -&+QOX
M8FD@2/6[,^?N\MM^$8KG(W=,\'C.>]6+7Q1HEY:7EU!J4#0V9Q<L208NXW \
MC/;UK@;;2=13P!X<L)-'NOM5IK<=U/#Y.2D:W+2,WH?E;MR<D>M;UU:7,'B?
MQ;>/:RK:7FCPK'-M^5G19MP/H0&7K0!MP>,O#MS=VEK%JUNTUXH:W&2!+D9
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MT5-0BEF\][E5"*H7;P>NXMQSV/6JUUXNBTS0O$>L2ZA8:A#ITC^5%;MY>W"
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MA0L:%V9B<  #D\UBMXWT6+2-0U*=[J&+3G\N\C>UD\R%L!OF4#.""#GISUH
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MTM(-&:QD8R(2LA>-N@;D80C/K73Z@DDFFW20PQSRM"X2*7[CG!PK>QZ&K-%
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M1[SO( 88V<X'/<=[110!YM>Z#XGU!4^VV9N+BVUN*\$YO1L>W2?>JQ1YPI"
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MR6TTXD6XM7+P31.4>,D8.".H(Z@Y!]*?9:9;6,LTT0=KB?'FS2.7=\9P"3T
MR< 8 R>.30!RK66MVGBG2M9ATAKF&+238SQ+<1K(CEU;(R=I V>O\0^E5K_P
MKJ4,%M);6PN+F?Q FL7:QR*%C5<#:I8C<=JKV&2">*[^B@#SV#PM>66JZ];7
M6DS:IIVJW;W4;I?F-%$@ :.:,L 0"#R V0>E>@1QK%$D:*%1 %51T ':G44
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M3[@K<%@Q"L<$@''/7!QSGA+2M2\0_#CP[I^IPV<.F);6<VZ&9I'G2/8Z*5*
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MYB"E86&-W!8,VW<,X!QSU((J*;QI$E_J=E;:+JMY<:<$>98$BP4<%@REG /
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M=P)9_)!5PQ55^5LMA&ZX'(YZX .CHKD8?'=O/%I2FV2UNM3MC>0QWERL2K"
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MR0:#::H=(**VHG3;Q)+@#[)+YGE;BP4ADW=^.HXZXZ*UU*>YUN_LA:H+:T"
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M%N<':,,,?DW7K736_B2['BB#1M1TDV@NX))[29;@2;Q&5W*Z@#8V&!X+#WH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!''!#"28HD0GKM4#-24
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>H:;$\L2>9/#./L[.1_ Q/()Z55UGQ+"_AB[OO#^KZ+)<A/W$MS=+Y&[/\3
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MH+;S;'5I[%/L\912L87G!8G))/>NFU!KM-.N7L$CDO!$Q@23[K/C@'D<9]Z
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M9QNP#TSQGUI;K4["Q?9=WUM;L5+XEE5#M R3R>@ //M0!:HK.&OZ,RVK#5[
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MDGZUHT >265O)KGB_P"'UUI-G<P)I-C*NHN]N\0A!C55B.X#)W;AM'UZ5O\
MQCLKO4/A?JEI8VLUU<R-"$B@C+LV)4)P!ST!KO** /+8M"@UWQMIOB#PM9'3
MK2STV>&6<VK6WFRNI6--I )VDDDXP, 9STQ?A_I,5TGAVQUM];M=;T*XE9+3
M[ 5C#$DLQF$>"C#J2W)_#/ME% '+?$+4KW2O",]S8:4NI2B6(&%H3,$&\'>4
M'+;< XKS>TL;B*V^)Z-INI,NI6<;60?37C\]S"P)5%7 .YAQU'?D&O<:* /%
M;'1197_PIO;?1;FW>VMI8]1DCL75HW\E5_>X7(RY;D^I/2O4/&"N_@K7(XHY
M)9)+"=$CC0NS,4(  ')))%;5% 'D?P^BTS1] \-B31]7CUZ(""1&L;A%'F/M
M8NS)L 53NZCIBHM.CF.D_$])=-O_ /3YKB2T5[&7,X:,JI4%>?FQ_.O8:* /
M$KZ632?!_P -K]X+Z.]TV00M;264C+N\K#[T W9 '! />J9_L2Z^'GC33]+6
MYO\ 7[Z=KNX@&F2QR*TK JJ(06V#:>3]>,BO7-:\.MJ>K:=JUI?O9W]@LB1M
MY8DC9) -RLIQ_='((-/T?P['INIWVJW%R]WJ=\$6:=D" (@^5$4?=49)ZDDG
MD]* /.O$:Q'6/AKJ%]IEW-IEE;SB\W6,D@A)BC1=Z;21\X[CMFFR^')[#PS\
M1+^ST^>&SUQ-NG6$5NV\XC(+^6!E=[,3@@$ #.*]AHH \4O!J>GW/@#5IH]3
M@TNUTG['<O%8F5[2;RPK%HV4D XVYQV/X^C> ]'T_0_"L%GI<U]+9F222-KV
M(Q/\S$G"%5*KG)''>NEHH \OM#+'\>]4U"2QOA8/I M1<FSE\MI%=25#;<'@
M'GH<5Q%SX;DN/A7XK6+P]=_VJVNF>V!T]Q,8FD3:4RN<;=_3ISZU]#T4 >7Z
MC>7&G?%J+4[_ $K4+_2+[2%MK)X;5I1%(7!964CY"W<G';/ ../?2[X_L_:C
MH_\ 8NH+J1U F*T^PR%P//5L@!>FT'D<5] 44 >:>/K:^MK_ ,,^-M!T^>\O
M+*3[/-;)&RO+!*",$$9&#ZCC=GM53QYH<NG^$/#5A%:7%]>PZO!=W,EM;/*2
M=S/-(=H. 68G\?:O5J* /+;NYN=.^+6I7&IZ/?ZAIVJ:;%!ISQ6IE1?[\9SP
MFXY)W8'3-<I'I.HC]G[2+=M'OC?:=J(FFMC:N)53SV8D*1D_*PZ?TKWVB@#R
M6POKIOB1XCUZST'43#<:&#:+/9O&+F11NVYQP3C&#@_I6=X4:]N?B!X<URXT
MJ[M8WTB2&X\K2W@AA?/$0X)(&."QY[>E>UT4 >4>"M7G\+^'/%=]<Z)K$S-K
M\]S%;163B26*1D"NH8#(Z_3%>K*=RAL$9&<'J*6B@#BH78_&.YG^SW/V=M%C
MMA.;=Q&95FD8KOQC."#UHTZT@NOB9XDDNK!WBDL[6&*6:V;RWV^;YBJQ&#]Y
M<UVM% 'C?A^+4M,@\'WEVFIVEA:V%Q9RE+-G:UF,BE2Z,A(4H-H8#CU ->D^
M%M-M-,TN5;*:[EAN+F6Y)NH_+8,[%FVKM7"YR0,=ZVZ* .#AMTO?BMJ_VBVO
M/LLNFP0K+Y4J(TB/(64.  >&'?!S5C7K:*R\4^#(;.QD2TM+B<L+>W8QPH8)
M$7.T84;B!7:44 >3ZK<7NJ1P-)IM[!/9>)(I6M8-/8+'$MQS,TA4ERRY8E#T
M;I@$UIV>FV]UJ_Q ,FE.RW6WR6DM& F46R*VTE>?G!Z=Z]%HH PO!1E'@?0D
MGCECGCL((Y4F1D=75 &!!&<Y!K+@MIO$^MZI=_:;NSMXD^P1126@ DB(R[_O
M$Z,W'':-3WKL:* /)K5-9'PRUCPS;VM_/<Z3,(;9G@>,WMDLBMA20 28]R8'
MI[UL7%_;ZMXW\(ZC8Z9?+:PK=123R6$D7E%HU"H=R@@9[_=SWKT&B@#Q_4=.
M2?P5\08X]'N&NKK4)7M%%B^^4;(]C)\N2-P;!'3FNHDMX+;X@Z'?6UA)'9OI
M%S!))':L%'SQ%$; XZ-@'WKN** /'TM-_@'2+.;2KMGC\1^<\#64A*P_;&<L
M1M^[L(/TKI+VVBM/'VIS+I\HM+G0$4M%:L4DD623"G P6VD<=<8KO** /+=-
MM)AX8\'-'J%]HFJV.EF$226#21YVQAXY$8##$J".0>#C-2+;S'6/!6HZYH:H
M_P!FNX)_L]B[HCL4\K*@$ID G#?=)(XKTZB@#@/#MA:CQ/XMOSHS/<B]$]D\
MMJ4WA8$7]VS# RVX<5E:5)<:CKG@G4);&[B,2SQ74*Z:T,-F6AQY7*[B V!D
MDKD=J]4HH \BCTR>+POJMK9Z1.MU:>(&NKNW6S9#<6@N_,V(VT!P4P0H)R!C
M%=3/&FJ>/-,UNP5S8VVGW$=],8F E5BACCP1EB"';&.._45VE% '$?"_2[6S
M\'V,C:8;34561)C+;&.7!D)P2P!(P%_(5)XEMXY_B#X2D>QDG2$W)DE%NSI'
MNC 3<P! ^;IFNSHH \@NM(6;P-\0(;;1Y_M$NH336B?8V5W7"%&C!7)&[<1C
MOGUK9\37MQJ5SKNG'3[I(9M(46SPZ>TCWI*R$H792J!2?NG!RQ.:]&HH \XO
MX[C3/#G@_P 406EQ+>:7%#;74&PB62&55C=<'!W!]C<_W37;Z-IYTW34BDVF
MXD9IKAUZ-*Y+.?IDG'H !VIEUIMU>:K#++?#^SHMK_8Q#RTJDD,7ST!VG;CJ
MH.>HK3H X6XTVROOBS.]YI9GMSI$<2RRVK-%YHE=B-Q&W<%(YSWK%TK3&N;'
M4?#WB&YUB"Z?5)+C$-GN6;]]YD<J2B-N.%'7Y<8.!7JE% 'F%Y8V\UU\26?2
MIG^U0(MN39.?.(MPN$^7YOG]._-6+2R$&H?#N[BTZ:/RK>6&Y=;9@8R8 ,2<
M9&7'?O7H]% 'E L;RZ^%5UX6N+6<^)5E=<&-@6G,Q=;@/C&WD-OSQR.O%;^M
MV.IZ3XNM=2TN*24ZQ;?V;>21ID12KEHIV'HH,@/_  $5W%% 'GFHV<OA_P =
M:?*KWMKHBZ0+*WFM;?SUAD63)5QM8KN79\V.2N,UU?A?2[71_#UO964ET]LK
M.Z&Z38_S.S$;=JX&2<# P,5L44 >3Z[<7NJV]PCZ;>0W%EX@AD6WM]/; B6X
M7]^9"IWEER<H>AQC )K=TJPM+KQWXP>?3&:*XAMUCDFM&"2@1L) I(P>2,XZ
MUW=% ',?#I9H_AYH4%S%-#<06B121SQLCJRC&"& -<RUAIUQX[\9-K-CJ'V>
MZ2UB@FBM9RK@0D/M**0<$UZ;10!PE]>M?^)_!EW'8WRP13W>]GMI/D3RWC1G
M^7Y=Q (!QUK$NX!_PBOQ!5H;RU1M2-Y"1:,/-14AQM5MH96:,J0#R,UZM69K
MVC)KFFBU:=H'CGBN(I5 ;;)&X=20>",J,C^76@#C]&U/0-1\8/JE_*HUBXL1
M#%;-I\\8V1[F<J94!=OG[#(48P>:PM/@-OX.\ &_TN],&GWKM>1-92,T(\N4
M LFW.-SISCO7I*Z-+<:M9ZEJ5S'<362O]G6&$Q(K.-K,068DXR!SC!/!K7H
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MC-G.7"$@=,$8SC)[!V"QLS E0"2 "3^0ZUY8]A>O\&=:TM=*O?[0FEN@EO\
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M45Q-YK(3<;B^8QN/R@*F21S\PZ <[7_"0:-]CMKO^U;/[-=/Y=O+YZ[9FSM
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M(!QM).6YP,U8UX:WJMG?03:9J*RVVMPRQP06@$)@2X0B4/C=(Q4$G:<CT&*
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M6HD:V5\W*/NY9AG 3!&.,YK@I=)O+KX9^,[./2KK[9=W]Y/#$UNRO*'E+1L
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M2TGMH"5FE24;8R.S'^'\:X*\G73V^&TEW87;M;JZ20+:L\J.ML5/R8W'!&>
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MO2],MDN+[4+:"&1=R.\@ 8>H]1R.:Y6PLY)=?\=/)I\X2^$8A>2W8"=5MPA
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M3P[86ES?Q6\\=R9[>:U:*.0+'E6!9 3R3T/IQ0!V]%<5>^,%TKPKXEUJ._\
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MW/RDA?E/!X.#P?2LX^/K&77]'L[8.]KJ%O/,TC02!T,;*@79MR,DMG(XQ[T
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M1#'ELPV@,3G()('%-\+:++'!H\&KZ!?1WNEH%6YEU#SH ZH4WQKYA/()X*#
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M%T8*<$CKZ<YKU>N)T'1O$NAV.I6YL-&NC=:C<7T9>^D4*9)-Z@CR#R#CGVH
ME,_V+XHW;2W<RV:Z$+B1))F,:$2D%PI.%^51G&.E:<'BRRFNM-BDM[JWBU-&
M:RN)E4)-A=^.&+*2N6 8#@'OQ61=^%=5U37;N:_DM?L=YH1TJ:2.5O-WDL6<
M+L"XRW3/^%'A[PM<6NGVNGZIH6AJUM 8/[0M3^\?Y"F]5,8*L0>?F[GK0!K0
M>*HKJ2TDMM,U":PN]WDW\:(8GPK-G;NWX(4X.W!X]17,V7C"75/ -CJFJC5+
M1Y;J(/<6,:H"6GVHHW$_(?E5OK6[X0T_7]"TJRT._AL9[6QC\B.]BN&#R1J,
M)F,IPV, _-COGM6&GA+Q&/A];>&]FF>=:W<+I-]J?;)''.)<D>7\I.,8Y^M
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M>48E .3M8L#A@0" >O<8JDNBZOJB:7)JL%E;2Z46E@CAG:599O+:-68E%VJ
MS'&"3D>G.%+\-1>PW4,-O%H4-W8S6]U#97+R132.!M81X"@*03D $YQQ0!UD
M?BJT^WVMI=V]S8F[@>XMY+D(%D5 "W1B5(!!PP''T.(9?&-K$VF.=/OS::G-
M'#:W81/+=GY7@OO (R<E1P/IG.L?"LUUI$FGZIH>B6<S6<EJU]8G+G>FPL@,
M:E<@Y/S>W/6L?4+?7;#3_!NGZPEA_HFL6L"SVTK,9PL;@,5*C9P.1EN: .L7
MQ=9MI^M7GV2]"Z/*T=U&47?E45R5&[!&U@>M3+XFM9C9Q6EO<7-U=6@O4MHP
M@=8CC#,68*.3C&>3GT)KG[KPYXA63Q;9V2Z<UIKF^6*YFG</"[0+$5*!#D94
M<[N >AQ@P?\ "&:C;ZGI&JFPTK498-*CTV[M+F0[1L.5DC<QGGDY!4<'K0!K
MIX]TV;^RQ;6>H7#:FLWV=8XESOBSOC;+#:P(QSQ[XYJCKGCPQ^"M9U/3K2YM
M]1T^86TEM=P@M#*2OW@I*D;6!!!(Y'TJU)X=U :_X;O+2QTJSL]-^T&>""5E
M ,HQ\@$8!QU).,DFJ.J^#]7O;+QC;Q260_MB>*XM&:1N"B1+M<;>,F/J">M
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M*I\@% ^#N8$D(0Q"Y.#Z\5DWFMQ:OX[L]*,5W/IJV$5_&]N712[2?*[,",H
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M*Q@_>8*0><#D#.<XKW7CAO[3CL=,T.\U&2:P74(6C>-%DB9@,\GCKT/)[ T
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MQOBC63J7AOQ!!I^FF_@M(YH+B0RJFV14R=@/WBI(STY'!)%;/A#_ )$K0?\
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M@@YP^1]*@L/#]_;ZOXDO)YK<IJX0HJ;LQ%(A&,YZYQGVZ<]:WUOK1[K[*MU
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M/'7IQSVTUY;6TL,4]S#%).VR)9'"F1L9PH/4X["IJ .:U7PW/JVOV>H321"
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MXT"O<R*%:0^I X% %NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,*3*KXW*&4$ X[\T 6:*@6]M'NVM$NH6N4&6A$@+J/4KUIHU"R:]-FMY;FZ
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MS-QC:!M!/3L:T](M(--^)^M16ULMM;W.G6K@1Q[$DD5I0Q&."P7;GVQ79T4
M<1=6]G>_%Q%NK=)XTT8H/-CW()/-W;>>-VWG'7%<HD-O:^&],M3;;&L?%Q:*
M/RCF" 7;-N Q\J;<'/3%>Q44 >::E]KMM<O[C2+VVOOM&I023Z+>VQ,A=3&O
MF12*<A0%5@2"HP>G->ET44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!)Z&LS1]..K6.E^8==MM8TVTDCA2[M!#%;2-$8S\ZQJKKTQAFZ ]JS':_G\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#F_&^I&Q\/FVC:83ZA(MG&8(FDD4-G>ZJH+$K
M&';@?PUQ'PEU"/1?$7B#P3_I"6T,IOM,%S"\3F!SRNUP&X)';D[C7H]WH45Y
MKMEJSW=TLMFK+%$C+Y?S?>R"O)( &<_3&36??>"M/O\ Q=;>)WN;V/4K5/+A
M:*1554YRI&WD'+=<]>,4 >6ZEJMUHGC+XJ7MIIHOMMO:K+&6QLC:+#/C'S 9
MR1QQGFO2_A_H>D:9X)T./3+C[=;PP,\%VPP6\P[G..W)Z=L8J;3O!.FZ=K^H
MZREQ=S7.I+MO%F=628 8 *[>@'IBIO#GA*Q\*Z5/IFE7%Y':2,S1H\H?R"<Y
MV9''7.#D9_'(!QGP:MX;KP[XBCGC#H/$D\@!_O+Y3*?P(!_"J7AZ:ZM?%GQ=
MN+ $WD2QO  ,GS!%*5_7%=_X7\(6'A&*[BTV>[:*ZF-Q*D\@8&0XRPX!R<#V
MXINB>#;'0=;U'5[6ZO9+K42&N_.D5EE(S@X"C&,GICK0!@_!>.T/PRTZYMR'
MN+EY9+N4G+R3;VR6/4G&.O;%97Q.L+;3[OP);VL0CB_X26*3:.F7D+M^;,37
M30?#S3M-O[FZT34M4T9;E_,FM[*91"S=SL=6"GZ8JQK'@;3=<M]+BO+O46.F
MS_:()1<9?S<Y#EB"20>@Z#TZ4 7?%Q7_ (0W75)&?[.N#CV\MJXGX7-JLG@?
MPI%-IUC_ &4J._V@7#/(&!;:2A0!?F[AF_6NO'A&V:'4([C4M2NC?6QM9'GF
M5BL9SD+\N!G<>:JZ;X!L-*M+*RM]3U7[#9R))%:M< QY1PZ@C;DC< >M &IX
MBTNWU33T$^F0ZF]N_GPV<[ 1R.%*C=D$8 8GD'G!KCOA"\5M;>(]).FOIU[:
MZK)+<VH<-%$9.56(C^$*H_GWP.SUC0UU=[25;^]L;BU<M'/:,H;!&"I#*P*G
MC@CL/2I-'T2ST2&=;4.TMQ*9KB>5MTDTAZLQ_ # P !@ 4 :-%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %9^MZ'IWB+3'T[5;;[39N
MP9XB[*&(.1G:1GGG'L*T** ,&V\&:!;3V\PL6F>V(,'VJ>2<1$="@D9@I'J*
MEUKPKHWB&XM+C5+1IYK0EK=Q/)&8B<9(VL,'@<]>*V:* .>?P/X?EL[NTEM9
MY(;P(+@27L[&0+NVJ27R5&YN.G-:>F:19Z1IJ:=8I)':QKM1#,[[%Q@!2Q)
M Z 'CM5ZB@#E8?AQX6M[62U@T^:*VD),D*7TZHY/7*A\'/?-7T\):+'XA;7U
MMI1JC#:;C[3+DK_=QNQM_P!G&/:MNB@#GAX'\.JNII'8-$FJ,6O4BN)468GK
ME58#G)SCJ"11)X&\.2^'DT"731)I<<@DCMY)I&$;#IM);*]^ 0.3ZFNAHH R
M[3P[IMEJ9U*!+C[685@,DEU*^47HI#,0<9)^I)ZDU!!X1T2V\12Z_%:R+JLP
M(DN/M,I+C^Z1NP5X&!C P,=!6W10!RT?P[\,0QSQPV,\27#L\RQWTZB1CU+
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MXCFDL63RVC-Q)EE_NEMVXC'&">G%5XO">AP^'FT :>DFE,,?99G:50/0;B2
M,9&.AY%;5% '/6_@C0;>2V<V]S<"T8-;1W=Y-<1PD="J2.5!'8XR.U:,NB6,
MVLQ:NZ3&]A0QHXN) H4XR-@;;@X!(QS@>@K0HH SKO0=+OM8L=7N+-'U"PW?
M9KC)#(&!!'!Y&">#FLZX\#:#<S73R07(CNY#+<VZ7LR0S,3DEHPX4Y[\<]ZZ
M*B@!D44<$*0PQK'%&H5$08"@<  =A3Z** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH IZG?'3K%[A+::ZDRJ1P0XWR,Q
M&2 .O))P!DUG:#XC?5[[4-.N],N-.U"P\MI8975P4D!V,K*2"#M;Z8K1U&_M
M;"&,W=P+=)I!"LI( 5F!QR>!SP,]R!WKDM-N'T7QEKLLNI&YT5+!+J[O;@)F
M&<$C9O4#(\L;MO\ #D=-W(!N^(?$T7AX6_FV-W.)IX8-\:@(AD<(N6)'<]!D
M^W-;E<1\0[^T?PWI$ZW$1BFU:PDC?<,,OGHV1[8YKM@0RAE((/(([T +1110
M 4444 <GX[\;+X%TR#49]-FO+:67R3Y,@#*VUFZ$<C"MS6M>>(M/M/"\GB'S
M/,L5MOM*,G612,J![G( 'J:R/&RZ?<W7AW3]1>'R+K4)(Y(Y' W(UI<*?_0@
M/Q%<!X2M]3M+75?!^L<:7X7FDG%U*<+,K#=;J<]@2TGL504 =MI?CR]USP(?
M$^D^&[BZ+OM@LEG422 /L8YQ@8P3WZ5VJDE02,$CH>U?.T=Q O[*R,EULNH)
M2%$<Q5@6NCD8!YRI/![5V7B>#3=4^+OA2SENF:UN[&X\Z.*Z95D^3"CY6'49
MZ=?>@#T?7M0O-*T2YO;#3)=3NHE!CM(G"M)R!P3Z D_A5Z%WD@CDDC,3LH+1
MD@E21TX]*\!29(/@CXTM/MTO_$MUB:"S!N&WQH'0*H.<D8+\=^:Z'Q&NGWOC
M/X;P279^SW5O.MPL=TRAU$*[ =K#J2P]\D4 >P45\TW=K90?#CQ;>6MY.+G0
M_$31Z8RW;G[/%YL8&T;L8(+<]\>U>@Z[J&FZ=\9]*N-0OE@T^]T60&22<K$[
MEL?*<X!*@#CV[F@#U6BOG2:[CD_9WU&8WDGVI-38(3.PDYF48/.3\F>#702Z
M'H4WQ4UC1EGE?3;O0/M<D(OI")9P_#D[LL=O//UH ]KHKA_@_>R7_P +-$EF
MN&GF5)(W9GW,-LC  _1<?ABF_$;6=+M9=%T;5+>.6/5)I%#7-TUO;)L7DRL.
MOWAA>YQR,4 =U17SG/>!O@ RR:C(9K;5C!"WGL&6/S0-O)R1M)X/:NSTV&+0
M/C-JMGHTTABNO#WVQ8)+AI1-<>8 &RQ))(_F: .S\:>*Y?"-E8W2Z>+Q+J[C
MM#^^\LQLYP#]TY'7TKIJ^:[O4]$U?P)X>U*ZNQ/XJ&LQ?V@\CGSE_>MD..BH
M!MQP .@[U])@A@"""#R".] '&ZK\0[;1?'EAX7U"PEC^W!3#>"0&/YBP4,.H
M)9",59\>>.K'P%H\5_>6\MRTLHC2&(@,?5N>PX_$CUKE_'N@P>+M5\0Z7;3Q
M_P!JP:79W-F%<;UFCDN2 .X)!Q[;@:XOQIJEUXE^#DGB;6(Q!=W M[2UB8X)
M5'!E<#MO<=/[J+0!] 6DLLUI%+/"(9'4%HP^[;[9[U-7D7Q)UO1M0E;0IEA>
M;^Q9+Z"YGO&CB!Y"^4J_ZR7*\>@!Z\BJ5^UUJ7PS\(:GI5Y-/XNM;>.XM!&^
M]YE1?W@D&>5QD$GJ<+U;% 'JNO:G?:7:VTMAI$VIR2W,<+QQ2!#&C'F0YZ@>
MGOVK5KP_Q)J.CW?PR\,ZIIUX_F7.K0/<N\^)'D8YF$F" 3D#M@ #&!BM77+/
M2-5^-SV%_<EK";PZTDL8NV1"_F]\,/X0#CV!H ];HKYPT,PQ>"OAUX@^W3_V
MG_;J64T[W3'; 9),QD$X"[57C'0^]=/J]_I^F?$+QW:7UZUN+G2(Y+1'G8%W
MVECY?.<[N<+[T >T45X'=3VTWPZ^&+R7SK))JEM%.R7+(Q0LQ?.#ZXYZBJ][
MI&DC_A:%A%-+]GTM(KJPA6\<K%*8R6<#=R=P R<XZ4 ?0E<GXG\:2>'-?T?2
M1I+W<FK.T=LZSJ@W+C(;(X^\.>:TO"%TU]X+T.ZDG\^26P@:20MN+-L&XD^N
M<YKA_B;=06WQ%^'<D\T<2)>3L[.P4*,1C))Z"@#HKCQW_9&NZ?I?B#1[C31J
M+^5:W8E2:%Y/[I(P5)R.HKL*\M^(3P>.=2\/>'="FCO98=2CO;RXMV#I:Q("
M#N8<!CNX&<G%<YJ33>(/%'B_2]5UNQTG4+:\C>PNKV9HY+:!<%6AY P0.<==
MW/:@#U/6_$TEEK5MH6EV:WVKSPFY,+R^4L< 8*7+8/.3@#OSTKHJ\FO+&PN?
MC_9PWET\DG]@AV*W3IF83<  -P"!G9T.<X-<_I9N?$FI:B-0UZPTK7[#7F99
MKJ5EN5C# )$BD@&,C@ <'\: />:*\AT[2-*UKXR^*[>\NYFALS9W,$*WC!1(
MJ[V.,\X.>.@R?;&3X2.D6'AKQ9XHNYKZZFTO4KZ.%(+QMRQ,JH-O/!((^?J-
MHYXH ]QF:1()&AC624*2B,VT,>PS@X_*L#P1XI_X3+PS%K/V+[&))9$$)DWD
M;6*YS@>E>>?#R_LHOB=J/V*>TM].O-&CO&M[:[::%9-XR=S8RP&<D =_>M_X
M'RQR?#.T5'5F6XN-P!R1F5B,_A0!TOC3Q2/!OAR;6Y;%[NV@91*J2!64,P4$
M9Z\D5K:==RWNF07<MOY+RQB3R@X;&>0,\=L5Q'QO95^$>L@D LT  )ZGSD/]
M#6Y8>(= NM,T_3?[3M)I+BV"-'#<*2JB/+%L'*@ 8SZD4 :7A[4K[5]&BO-1
MTF72KEV8-:RR!V4!B <CU S6I7SI+>1R?LTM.UZYO$O6 ;SSO)-Q@@\Y/RGO
MVK?GT/0YOBGKNC+/*^FW.@_:WA%](1+.'X<G=ECMYYSZT >KZ[J=]I<%K)8:
M1-J;S74<,B12!#$C9S(<]0/3W[4J^(-/?Q._AU)'.HI:_:W38=JQ[@H^;IDD
M]!Z&O%)-2$_P7\"75QJ#-=+JL4+L9SDH)7RK#/( "=>G%=1+'I:?M 7$EY=&
M%Y=&CEM2UTRAY/,Z*-V&& 3MY'!.* /5Z*\4\$W%UHGB?1(-1ATK4$O;6YN(
M];L9F,TD87>7N0>3U &>AX%>MZ)K>G^(M(@U72K@7%E/GRY-I7."5/! (Y!H
M H>(_$<V@W6EPIIXNO[1NA:1D3[-LA5F&>#QA3S^E7].O;VYFN8KW3C:-$5V
ML)?,60$=0<#I7*?$=HS?>#X3=FV=M<C(=64,H\J49&X$=QU'>CQ1'>:#IUH9
M=0N)["ZUN#[?<2D!DMF4*0Q4 !-ZJ"0!PW/4T =W17 SVJ6GC;4+:P;R='DT
M5I;V*%RD44V_]VPVGY69=V<8R%!-6/AEIEK'X0TG5UEGFO;S3X%N)9)VDR0N
M0,$X&,D<8]Z .VHKCOB-J%WINC:=+#((K1]3@COI6)") 2<[R.0A;8"?0GUK
M)NYK;P]::K?M?6<UC>RV<*V%C.8H;>1GV[V<$[$?(W8'(4]<T >CUC^*M;D\
M-^&K[6([1;K['$96B,OEY4=<'!Y_"O-9-2NM'M?':Z+<J8K>&RGCCL69DA5R
MPG:+)/(12<C R.@-;'C"V\-)\/\ Q'J6C3VI>YTIPQ@F#"53R&89Y;/\1YYH
M ](C;?&CD8+ '%*Q8(2H!;' )P"?K7!26EIH_CWPM-8RR)_:<-RERQG9A<[8
MU92V3@D'H??%=\2 "2< 4 <9%XYNY=(UC5%T)GMM(N9[>Z5+I3(3#]]D!4!A
MW&2":T-*\5KJWB%=.BM0+:73(M2@N?,Y>.1B "FT;3P>Y[5S?@W3K77]/\4V
M<MY*;237[Y9X()% F1G'#$#< 1Z$9!-7)[RTTGXDZ@X $5GX:1_)A W!4ED.
MU1ZX' H [NBO*=%N[2?Q=X:N+.>"&'5-/N/M4-O=M*7 1&7S7R 9!D\X!'/)
MK.AM[:/X4P>(8[F<ZE9ZE^ZNC<N61?M^PKUQM*D@@]<T >SU@P^)E'BY_#MY
M926LSPF>SF9PR72 X;;CHR\$J><'-;P((!!R#WKA?BQY=MX0&KQS_9M1TZZA
MEL[A2 R,TBHV,]04=LCI^5 '5:=J@U*ZODA@86]M+Y*W!/$KC[X4>BGY<^H(
M[5H5POC:=M!T'0(;!XX-)&H0P7<C,?+6#:V-[#G:7V!CWSSU-5+J:W\.:?J]
MY)>VMQ8WMS:1)8V4YBAM79@I9G!.Q'^4M@= >N: /1:*\E@DA@MOB':07D2V
M<.GQW,"6DS+%%(8I-QC.?55SC R.E=KX(TJSLM M+ZWDEEGOK2W>XEDG:3>P
M3KR3CKT&!P.* .EHKF_&>JVNFZ?8Q7<8=+V]CM5$DYAB!(9OWC#^'"GCN<#O
M7G-]-'!X-\:6T6H;;>SU2V^R?9YF5(@X@+!,L?E)9N.G)(% 'M58OB779?#]
MM97"6:W*7%[!:/F784\UP@8?*<X)Z<5S%Y N@>/X!HN\27VC7<K0M,SK<3(T
M9C8@DY;YF&>I!KF[V^T'4_!OA;4S=QW&MG4-/-W*9/WRR><GFB49X4-D8(VC
MC&.* /5=1U,V5WIMK'$)9;VX\H#=C8H1G9OP"X^I%:%<O.]Q>^)-4NK-1))I
M5@;>V!Z&XE D8?\ ?*P?]]&N2W"X^'_AO6-+E9O$KW%JKR@_OIIBZBXCD[D
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MVYD^UB<9W@@!0F,D$$G=GM[U8-S &53-&&8E5&\9)'4"@!@L+-49%M( K8W
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MNC;0FX P)C&-X'IGK4LGF>4_E!3)@[0QP,]LU@>$/$5SXCT:34;JUAM%%Q+
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M6)/;[P_.M"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8T5$4*JC 4#  ]*\FEATBRM/B7$]O!#J;&Y:',6)#$]K&%VG'1GR!ZFO6J*
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M6.MV,E[)9:9/#>2&V::))&6((K-@J?NL.?3->GQQI#$D4:A(T4*JJ,  = *
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MS";@.".N#5ZYT6QM-0\*K:VNHWEK_:]Q>S/<63'R_,CER2 @"+YC# ('K[T
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M,08J7AD#@$=1D=Z\QT>*6UT3P%>IIMW'::6/*U2$V4B.DQM_+$A0J"X5L@L
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MVK&L:?\ Z(,W'^DI^Y'^WS\OXUE_$.%[GX?:Y;Q6\MQ/-9R1Q111-(S.5(&
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M>*],N_#.I7^G:S!;&V#1O<3P,?L\F,_/&<-[X.* .EHK+N-=L+&.,7-PSR&
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MC.".#]#3M&L=2;QW9:O-I^I);MI$MM)/>R(7\TRQM@HK$*"%/W0![#C/>44
M>7:3HVN6OA;PCOTFY6X\/77^DVK,F9T*/&SQX8ABN_(SC/..:UM2TB]O]7U_
M7;>SG5+C1/[.@@90LEQ(2[;BI(P!N"C=@_>[8SW=% &-X3MI+3PGI-M/:M;7
M%O9PP21L!E65 ".,@C.:XOQ38>)-:L/$=A+IE[,YN8VL1#+'';M #&03\P9G
MX;(;@8&,5Z;10!R>DVUX/B'K>H2Z?/%:75E:Q0S.%PS(9"PQG(^^O:N8T32=
M>T.S\)7SZ-<SC3([NUN[.-D\R,2L&61 6PV-H!YS@_6O4Z* .2\,6^I1^+/$
MU[>Z=+:0W\EO+;EF5LJL*J0=I.&!'(Z>A/6F746IZ/\ $&XU<:=<7^FW]A%;
MEK;:SV\D;N<%20=K!SR,\CFNPHH XVQM[W1O&.IZB^FW+Z?JEK;>4(55FMGB
M5E,3*I. =V01E<YR16+:^&M4TNV\,1?8)9?(UJ?4;A(BI6UCD$V$Z\D>8N<9
MYSBO3** //Y-)U&<_$11IDRC58<69;:!.1:B/'7CY@>N/6I;:RU+_A(?!UR^
MEW(BL=-F@NG.W]U(ZQ #KS]QN1FN[HH \PFT/5Y_ 7BJP32)EN[O5Y+NWA8H
M#*C3JZD'. <#."1BMZZ&H67Q#CUB/2+RZL[O2DM=T&S,4BRL^'#,,##=?:NQ
MHH \NAT?6D\#:5ITVC3F\@U\7DT2%& B%XTQ8'(!&T_7VKH;ZSOD\>W.III\
M\MI+H8MA(FWF42,VPC.>A^G-=A10!YEIFE:[I&G>!K]M*N)CI%G)97]FC(94
MWH@\Q!NPV"F#@YPW%;NI7.L3:SIC6^DZA'I,T4WVA;?RHYO-++LWDME4(#'*
MD'(&?2NPHH \OL=%UG3_  CX6C;1[EY]+UR6YN+>-T9_+8W&&4E@&'[U.^>M
M68M"NH-5\26>JZ7JMY8:Q<-<1M:7 ".CQJC12#>-I&W&>A'?BO1Z* .(T^VU
M/PYXNU;R]&N;S3]16W-I-#(A$'EQ",QR;F! &-P(SU/>M#X>V5[IO@FPL-1M
M7MKN#>LD;$'DNQR"#R,$5T]% 'F^I>'=8U"S\=:-%9RPOJDXN;2[9E\F0>5$
MNPG.X$F-@>.AK7O+6[\3:OX:N_[/N+ Z;<-=7)G !0^6R>4I!^;)89(XPO7H
M*[&B@#E_&UI>SPZ+<V5E+>?8=5AN98H2N_RPK@D!B 2"PXS4>CVUZ/B#KFH3
MZ=/#:W5G:Q0RR;>6C\PN."<??7V.*ZRB@#R31O#VMZ5#X7OKC3-0,=C:7%C=
M6UK*JRP[Y ZR* V&4X (!STXXKT7P]IUKIUA+]EL[FT%S.]Q(ES)O=G8Y9C\
MS8SUQG\!6M10!Q/AC2IF\3>);G4M'=(;N^2YM)+A$88$2(2.25.5/I4FOKKE
MQX@NK1;&[FTN;3PL#6LB1JTV7W"5\AP "N ..3P3Q7944 >;Z;I6IVX^':S:
M1<_\2BT:.\/R'R7,'EC^+GY@>F>*W&MKVR^),M^NFSRV%QI,5LLT.S;&\<DK
M$,"P(X=<8!KK** /+K;1=?M_#.DS1Z5,;G2]=GOY;%G0--#)),<H=VTL%E!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO"(QM:;'?<3RW.: /9Z,U\S3VFGGX7:WKD%S(=3T_P 0M]EG6Y8F%3(@&!G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDW]S#;V]RQDG!:#?"Z+, ,DHS !QCGY2>*U: "BBJU]J%GIEE)>7UU%;6T9
M>65@JKD@#)/N0/QH LT444 %%%96K^)M#T&2./5=4M;-Y!E5FD )&<9]AGOT
MH U:*:LB/$LJ.K1LNX.#D$>N?2LK3/%6@:U>RV>F:Q97=S&"6BAF5FP."0!U
M'N* ->BBB@ HHHH **H)K-@^MOHRS'[>D/V@Q&-A^[R!N#$8(R<<'^536&H6
M>J64=[87,5S:R@E)8F#*V#@X(]P: +-%%% !11D9QGFB@ HHHH ***H:KK-A
MHENEQJ$QAB>18E?RV8;F("@[0<9) Y]: +]%%9^JZYINB)"^I7(MUF<1QLRL
M0SGHN0.I[#O0!H45DKXETEQ<;;ELV\7G2KY+[E3.-V-N2/I4L&O:5<6VFW$=
M]%Y>I@&S+G:9\KN&T'!^[S0!HT452GU:PMKN2TDN4^U1P?:6@7+2>5G&_:.2
M,\=* +M%5=-U*TUC3;?4+"836EPF^*0*1N7UP<&HM.UFPU62[CLIC(]G+Y,Z
MF-D*/@''S =B#QZT 7Z**SK[7=-TV]M[.\N?*N+DX@C\MB93W"X') YP* -&
MBBD8A5+'. ,\#- "T5DP^)]%FTJ?5!?QQV,$Q@EFF!C"2!MI4[@,'<0/K6M0
M 456N=0L[*6VBN;F*&2ZD\J!78 R/@G:/4X!I;Z]M]-L9KRZ<I;PJ7D8(6VJ
M.IP 30!8HJ"SNX-0L;>]M7\RWN(UEB?!&Y6&0<'D<&IZ "BH+V\@T^RFN[EB
MD$*[W8(6P.YP 3197EOJ-A;WUI)YEM<Q+-$^"-R,,@X/(X(ZT 3T45#=W<-C
M:2W5PQ6&)=SLJEB!ZX )H FHJO87UMJ>GVU_9R>;:W,2RQ28(W(PR#@\]#5B
M@ HHK*F\2:1;RW*3WBPK;%5EED5EB#,VT*)"-I.[@@$D'KB@#5HHHH **,@Y
MYZ5036;!];?1A,?MZ0_:#$8V'[O(&X,1@\D#@_RH OT444 %%%% !1110 44
M44 %%%9L>OZ7+=ZE;"Z"RZ:BR7@D1D$2L&(8D@ C",<C/2@#2HJ*VN8+RUAN
MK:5)8)D$D<B'*NI&00?0BH[[4+/3+1KJ^N8K:W5E4R2L%4%B% R?4D#\: +-
M%4+?6;"ZU6ZTN&8F]M45YHC&R[58D*<D8(.T],]*+K6;"RU.RTZXF*75ZS+;
MIY;$.0I8C<!@<*3R: +]%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU3P1HFJZ-9Z1)#)!I]FXDA@MI#& P.03CDD')^I)-2'PEI[>)H/$+S7C:C!
M+=)#-QY?=2O3D\GW- '/>$==U[Q?:67BB+4;>UTB2XF673C"I*PIO4$R'G?N
M"D]!@_GFZ;XTU:;X@:!:1:K%J6CZTER,K8F&.-XD+9B<\R+D8R<CK^'4:9X
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M"ECHUR[Z?/>06SRM-]B6<^0KL<DA>H!))V@X]JK/X%TA](O=)\R]%A>3&:2
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M+$^N !QP  !P* .*;Q5KFJ6NLW6C6T[W.GZA):V]HL ,4XB8*P=SR"WS8((
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M.=H#-DD!@N\# .#\I['D CDMM2NOB?KL>FW\=BYTJS+3- )6^_/@ $@?7/\
M]<9]KJ][K=YX&NM22);R/5KZVE:($)(T<,\9=0>QVYKKI_"EG/K']K"[U"&\
M:%()7AN2@FC7. P''4DY&#R>:DN/"^G3SZ7*@E@&EL6M$A8*J$J5)QCG()'/
MKZT <Q:^*]<UG2Y-5TFVN))$OVACLA /*DA2;RVW2'D/M#-G( .!@]_0:PK;
MPG86.H7%U93WMK'<S&XFM8;@K"\AY+;>H)/7! />MV@ HHHH **** "BBB@
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M$7\>2Z,-.NK#3-9MQ-:)<,A_TF%0L@&QFY9 K$GJ5- '?:A?0:9I\]]<EQ!
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MJS1I!:RS$A=H8D(IP!N7KZU@?:=7TKQSI-C/JKWMGJEO<,\,D*(('C"$&,J
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M  "0,XSW(SQQ5_4=1U?2O%0TA=1EGMKW3)[J*62.,R6TL17/10"K!QP0>>]
M';45YO8:SX@CT;P7KEQK37']KR6T%W:-;QK$1+&3N4A=P8$ ]<'T'2O2* "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH JZEIUIJ^FW&G7\(FM+F,QRQDD;E/49'(_"J#^%],9;+BY$U
MD&%O<_:I#,H;[P,A8LP/'!)' ]!6S10!6L=/M=-MS!:1;$9VD8DEF=B<EF)Y
M)/J:XVWT5-0^)FNWEU!J<41MK6.":-YX(Y2OF>8I*D!@,KUS[=Z[NB@#'O?#
M&D7TEA));-$]@&6V:VF> QJV 5^0CY3@<=.*K_\ "$Z +**S6TE2VANS>QQ1
MW4JJDV[=N #<?-R!T'I7044 9FH>'].U2YL+FZCF,]BQ-O+'<21NN0 P)5@2
M" ,@Y!Q4 \)Z*(]3C>S,L>J'-XDTSR+*< 9(9B < #(QT%;5% & W@[2)-(F
MTJ<7UQ8S((WBFU"=QL'102^0/I6'K6B)>_$#0$:#4_L=I8W$?VF"2=-DC-%M
M!E4Y.0K9R<>M=W10!D7OAC2+_3HK&:V80Q3"XC:.5XY%E'_+0.I#;N3ELY.3
MFH?^$.T(V^IVYLF:+4U"WBM/(?.PH4$Y;[V /F')/.<UNT4 84_A#2+C[$[K
M=BXLU*0W2WDPG"GDJ9-VY@?0DBM>"VCMK9;>/?L48!>1F;ZEB22?<FIJ* .>
M;P1H+:?/8-;7!M9[G[7)&;R;YIMV_?G?G.[!^HK1;1;%M7M]5,<AO8(#;I+Y
MS_ZLD$J1G#<@'D'I6A10!G:OH=AKD=NM]'(QMIA/"\4SQ/&X!&0R$$<$CKWI
MEKX=TVRO[^]@BE%Q?@"Y9KB1A( ,#@L0,#@8Q6I10!SW_"$:$MKI\$5O/!_9
MRE+26&ZE26%#U4.&W;>!\I.*V[6VCM+=((MY1>ADD9V/?EF))_$U-10!E:9X
M=TW2+Z\O;*.=9[Q@]PSW,D@D8  $AF(S@ 9]*?/H6GW.M0:O+%(;Z"-HHY!.
MX"HV-PV@[2#@9X[5I44 <Y:^!?#]FMHL%I,HLYC-:@W<I\AB""$RWRKAC\HX
M]N!5B/PEHL>EZEIHMI&M-29WNXWN9&\QG^\<EL@GOC%;=% &=:Z'I]GJ/]H0
MQ2?:OLRVOF/,[YC4D@<DCJ3SU]ZFU+3K;5M/FL;Q7>VG4I(B2M'N4C!&5(."
M*MT4 9$OAG2IO#O]@2PS/IGEB+R3<R9V 8V[MV[&.,9J230-.FN--N)(I6FT
MW=]E<SR93<,')W?-D#'S9K3HH Q=.\*:3I-P9+".X@C\PR"W2ZE\A6)R2(MV
MP<G.,8SS5G6]#T_Q%IKZ=JD3S6DF-\2S/&&P<\[2"1D5HT4 0I;(EK]F#2E-
MNW<96+X_WB=V??.:PU\#Z!'I]G916UQ%%93--;&.\F5X6;.[:X;< <G(S@YK
MHJ* .>;P1X?:WEM_L<JPRW0O'C2ZE53,""'P&X.0#^%:1T6Q.LQ:OY;_ &Z.
MW^S++YK\QYSM(S@\\Y(S5^B@"A>:-97VH6E]<+,;BS8M 5GD15)!!.T$ Y!(
MY!X.*BU7P[INM75G<WT4SRV<GFV[)<21^6_(W#:PYP2*U** ,&Y\&:%=:A=W
MLEHXDO%VW2)<2)'/QC+QJP5CCN1FGKX2T=1I8$,X&E#%E_I<O[GY=O'S<_*2
M.<\<5MT4 8H\*:,(=5B-O*T>K!A>JUS(WFY7:>K<': .,<4J^%M*2^M;U8[@
M7-I ;>"3[7+E(SC*_>YZ#KZ"MFB@#"7P?H::#<:(+60Z=<2&22%KF4Y8OO)#
M%LC+<\&GR>%-(EN[J[DBN&GN[;[).YNY<O%@C;][C[QY'.3GK6U10!E)X>TX
M+.)HY;DSP&VD:YF:5C$>J98\ ]\=>,YP*JCP9HHM-/MC'=M'I\GFVNZ^G)B8
M J"#OSP"0,]!Q6_10!C7WA71]1U-]0N;>1KB6 6\NV>1%FC&<*ZJP5\;CC(/
M6F'PCHWDZ5$L$R#2@5LV2ZE5HU( *[@V2I  P21@"MRB@#%D\*Z1)/=N8'$=
MZ_F74"S.(9V[ED!VDG SQ\W?-6#H&G'71K7ERB_6'R!()Y /+SG;LW;<9&>E
M:59>M>(M+\/I"^ISO$)V*Q[(7D+$#)X12: +6H:?!J=K]GN/-"!UD!BE:-@R
MG((92#U%9MSX1T:]MWANH)IA),D\CM<R!W=,;"6# G;@8'0>E7M)U>RUNR^V
M6$CR0;BFYXGC.1UX< _I5Z@#+NO#NEWM^+VYMVDG^RM9EFE?#PM]Y&&<,#[@
MFJ=GX+T.QDLI8(+CS;)&CMI'O)G:-& !0$L3MP!@=!VKH** .?\ ^$)T'^RC
MI?V:?[$;C[3Y7VR;_6[]^[._/WOF^O-;CV\4MLUM*@EA=#&R2?,&4C!!SUR/
M6I** .:@\!>';>*VBCM;C9:3":U#7LS?9V ('EY?Y!R?E& >,C@5;D\*:2^J
M3ZBD=Q!<7)!N/L]U+$DQ P"ZJP#''&2*VJ* ,M_#NF2:U)J[0/\ :Y81!-B9
MPDJ#. \>=K8W-C(/6H=+\+:7HR".Q%W%"H*QPF\F:.('J$4MA>O&.G;%;5%
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M.ZE6$N>K>5NV<_3%&F>%=*T:4-I\=Q!$&+I;+=2^0A/7;&6VCJ3@# [5M44
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *QM9TRZU&[M6L=5%A/;J^YEA61\-@ @-P/NGD@]ZV:H7^C6>I3P3S_:%
MFA#*DEO<R0M@XR"489' X/I0!E>#-2U2^LM1M]7>.:YT_4);,74<>P7"J%(?
M;T!^;! XRIKI*AM;6"RMTM[:)8XESA5]SDGW))))[DU-0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ameh-nonqualifieddeferre006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
MSC.!VSQGUK/USQ4NBWE[;FS,WV72)M4W"3;N$9QLZ<9]?TKG/"GA_5+?5-%:
M^LM4B&EVKQ%[FZMS"I*A=L2QC<RG&?FVXP.IK0\5Z#J6I:GJLUI;>9'/X<NK
M&,[U&Z9V!5>3W]>GO0!8A\6ZE;OI\FLZ$EG97\D<,=S!>"<(\GW XV*0"2!D
M9Y(KI[>[MKL2FVGCF$4C12;&!V.O53Z$>E<5+;Z]XAL=)T>XT"?3+2WGMIKJ
MXN;B%MPA97"HL;L22RJ,G&!FNRLY)9!/YMFUMMF95#,I\Q1T?Y2< ^AY]: ,
MFT\507WBV?08+2XS!;O,US(A1&97"%$R/FP3RPXXQSSBE!XIUG_A)+31[SPZ
MD+SQ/,[PWPE,4:_Q,H0=6(4<\GZ&K[Z?='Q[%J0B_P!#73'MS)N'^L,JL!C.
M>@//2H]%TR]AU?Q!JEW$J7-W<".V+,& MXT CZ'@%C(V.OS4 5K;QA,EY#'K
M&DOIL5S:2WD#-,'=8X]I;S4P/+;# X!8=1G/%%AXQDDDM_[4TLZ?#>6;WMH_
MGB0O&@#,KC V/M8'&6'7GBL.?0-5\0ZLD\VB'1[N6RGMM5NQ,C1W0>(HJH%8
MLRAMK@L%("XZDU,FEZYJ_P#9R7>BK;'2],G@874J-%=3O&L85=C$^7@,22 >
M1QUP :&G>-YY]#NM:U'2XK33[>S^U,8KY9Y!P&"% HPQ![GKQ4DGC.?3X-1_
MMK2?L5S::>VHI$EP)1+&O5=VT8<':",$?,,$US=YX1O-<29;'P]'X="Z3-:.
MK&(+<3,4,:XC8Y1"A^8X/S<#K6G?:?K'B&]N]2G\.I$(M+:SCL-0F0BY=Y$=
MQE&8!<1@ DC)/3 H NS>,=0M/#>I:Q=Z-;JEHJE(X=167>Q8 J2%^4C(]:V=
M+O->N+IDU/1K6S@"$B2*_,Q+9'&WRU]^<]JX;5?"U_J]KKLNG>'CI,-UI\5J
MMBS0HUQ(LNXN0C% %7*@DY.3V KLX?">FV%K<Q:1YNES7"JK7%LP9U .>/,#
M+ZCIWH AU;Q#J5MXCBT72](AO9FM#=L\UYY 50X3'W&R<FJ]SXEUR'4[#2H_
M#]K)J-Q:S74D9U':D:(Z)P_E_,3O4]!CFJ<_@H7_ (MM)=76;5+*#3&A^U7+
MJKM*9MP!";?X<]!CCUJKXE\+J?$6D2Q^&)=7TJTT^:V$$,\:F)V>,J?WDBY&
M%;N>M &Y!XPB/A74M9NK.2WDTYYH9[;>'S+&<;58<-DX /OTJ]H>O1:OH7]I
M31BR:(R1W4,C@_9Y(V*NI;CH5//I@UQ%GX1UR?3K71O(FTG2)-5>^$:3QRO9
MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZXA02LA?<V-P 7. ,FNEH **IW-U=Q7]K!!8--#*LAEN/-55A*@%00>3N/'
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MMJ:MHZ+>Z7?6UI=Q-<Y3;.RA)$8)\P^<'!"F@#N:*** "BBB@ HHHH ****
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M<$*S(BE\?*"< GZXXH \7L-.\/ZI\/-0M;<Q3>)K>YO5L4AF_P!*@F\^0Q!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5DZUHK:I/IUU!<BWNM/N#/"SQ^8A)1D(9<C/RN>000<5K44 9-IHS)K3Z
MQ>SI/>FW^S1F./RTCCW;B "222<9)/\ ", <YUJ** "BBB@ HHHH **** "B
MBB@ HHHH **** ,:^T6:77[?6K*[2&YBMWM62:(R(\;,K< ,I5LJ.<\CJ.F)
MM+T==/NKZ]DE$U[?2*\\H38ORJ%557)P !W).2>:TZ* "BBB@ HHHH ****
M,+P]H5SHMSJ\L][%<C4;UKS:D!C\MBBKMR6.1A!Z=ZW:** "BBB@ HHHH PK
M70KF#QE?:ZU[$T5U;16WV<0$%1&SL#NW<G+GM6[110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4[B.:2"UC,L@A7<P4#).,CH.: +U%4=%U6#7=$LM5M4D2"\A6:-9  P5AD9
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M %%(2 "2< =2:P;?Q;9W26]Q#:7S6%S*L4-\(1Y3EFVJ1SN"DD ,5P<CG!H
MWZ*** "BJDNIV<4%[*)UD%DI-PD/[QTPN[!5<G.,''4Y'K4MK<QWEG#=1;_+
MFC61-ZE6P1D9!Y!YZ&@":BBB@ HJ&[NX+"SFN[E]D$*%W;!. /8<GZ"LK1_%
M6G:U?SV$*W=O>PQB5K>\MG@<QDX#@,!E<\9[=Z -NBL?6O$VGZ"\<=REY-*Z
MF3R[2TDG94'5F" X'N:EB\0Z5/H$>N07:RZ=(@>.5 3OR<  ==Q/&W&<\=:
M-.BD4[E!(*Y&<'J*K)?V[ZC+8;BMS&BR[&&-R'C<OJ,@@^A^HR 6J*** "BB
MB@ HHHH ***R]'UVWUJ;48H89XI+"Y^S3+,H'S[5;C!.1AA0!J445%<7$%I;
MR7%S-'#!$I9Y)&"JH'4DG@"@"6BD5@ZAE(*D9!'>HGNK=+J.U>>-;B569(BP
MW,!C) ZD#(S]10!-1110 457OKH6-C-=-%)*L*%V2, L0.N,D5%I&IP:UHUE
MJELKK!>0)/&)  P5@",@9YP: +M%5=0U"#3;7SYR3EECC1<;I'8X55'<D_\
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MLZ\'&!7HC>"_#CZ$VB-I-N=,+A_LW.Q6!SD<\?AZFB/P9X<ABNXH=(MHHKQ
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ML[$Y"DY.]O,'NI6O3)HDGA>*0$HXPP#$''U'-5K32K*PTT:=:0F&T5=BQH[
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M" #W.22: /3Z*\ZL[G4].\0Z?)JEO)>6]YJ,JVNJ6=^Q#AQ(4CE@.,*J\<9
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M)^\8 JK,HQ_=WG&.* .O&O*?%Y\/M:2J_P!B-XMP67:RAU3  .<Y;OCI6Q7
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M*8R.#D<=* /4JI:QJ/\ 9&CWFHFWDN%M8FF:.,@,P49.,D#H*X>ZUF\LM?\
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MH38% 7&-N.,>E 8,,J01ZBL_7-:L_#^DS:C?,_E1X4)&NYY'8X5%'=B2 !0
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M0ZGI=E>F/[AN8%D*_3<#BKP((R""#W%+0!1&C:6-.;3AIMF+%NML(%\L_P#
M<8I?['TPV361TZT-JQW- 85V$^I7&":N@@]#FHYVF6!VMXTDE ^5)'**3[D
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MAQD8%VMYYIV!?XL$8QVV>U;&GZ1H>M?$/Q79:E;V=WFVLR\#$,GF8EWL%_O
MD<]1GMFO1O+3S/,V+OQC=CG'UIV!Z4 >.Z)J5I%I?PTUK4+R-4B,]M<7DT@
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M)'TH \DL[5+G5_ %KXH6*349=*N5O8KDC=(=L6Q90?O'&>&[YK-DL]'3X?\
MB6]M/*:XT?6)!83+)N>TC$ZE1&<Y1.3P.#S7M^!Z4F!Z4 >;:M_PC!^*CC6I
M-.%K>:)&ZK=.HBN&\YN3GY7. ,9ST]JQC;WOA\:5'+*+3PM)K5V8_ML;/##"
M4Q )%+ B,OO*[C@90GM7H*Z+??\ "?2:VPM38MIZV83>QD!5V?=C;C^+&,^_
MM70D!@00"#U!H \DURPTJQTNRD&LV5U;W/B2UEC%J1%'; LGFK&0YP.-QP>"
M>U7[RUTK1/%OB+3K*XCT:SO/#HG=K;"!)-\JF95! W!<'(]*],"JJA0H '
M'2C /:@#R==4?P]9:R;S3-(O8X=-C+7NBNT22*9 BK*!G8?F+9!/RAJ6P2P/
MB3Q%9Z?+8M:7F@+,(M,0Q0RR!I060!B'.  67KC!Z&O5EC1%VHBJI[ 8%*
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M%XEW$<D+RIP373/::5I/C+P=>Z8((&U"*XBGG1_^/K]T"N]OXSN P3DYKT;
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M0V#T##UJ[K"&TT;6];\/:S:7:20VPN;;18]JK&LN9)1M=L.8BPR,'"CTKU3
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M3H([,D7(!M46 _O7^RHN4&.3O!&1WH ]0AU"RN+E[>"\MY9XP&>)) S*#T)
M.12'4K%;S[&;VV%UC/D&5=^/]W.:XB6RL[7Q'X%O;*R6)-L\4TT4.,!H. Y
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MVM'$8Y8M+SDQB09/)YSQ0!VU%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3.L3RLHR$3&6]AD@?K7+1_$+27T.+7)+:_ATAWV&]>$;$._9E@"6 W#&<8H
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MOC)J&]GF*Y$D0 _=D-P0, >G%9_A#4-6U*Y;PAJ&IZ@VLZ;JLK7UR+AU9[1
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MVS0!R?C,W$/P\O;6_NX[F]BO+=Y71=HVM>(4XYQ\N!C)QBB?4-6UOQ3XGTB
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M@X2[D#.//EP3(&W'\_KVK"TW7=4^Q^$+">Y-Q:7%WJ-M-)=W+1^<T,C+"CR
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MSX5V12>6-R+Z ]0/851_MV.W@TD:E!)9WFI.(DMB1(4DV%RI9>. K<].*UJ
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M>DS6S6TNEV3P.Q=HFMT*ECU)&,9/K4C:7I[6*V+6%J;-.%MS"OEK]%QBK=%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?"-SK'@G4M&ELWE;40)KE&!?!@EXF;KO)Q]_YL@^]>KTT11@$!%&3DX'4^M
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M+9 SDY(P*F\&>(-9N/'FJZ+?7UW>:?\ 8([VV>]MXXI5W''1 .#UY (QT'<
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MJWLXO-N9XH(\A=\KA1D]!DU+7D/Q)TO6K3P_I<%]KS7ROXCM?L\TUO&)$4J
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M>IVF[,-Y)(R0N2?FC1B44D'[RCN?4UT%YX$T*\UV76?+N[:]G4+</9WDL G
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MD2**-2[N[!551R22>@H YZX\#:)>Z!_8M\M[>6HE68-<WLLDBNOW2KEMRX]
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M'17V,,CI^0]*LGPGHY\0P:Z8)O[1@B$,4OVJ7"Q_W=N[;CVQR>:VJ* .:M_
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M7XLQ<Z;;N++BV&S B! !48_A( R.AQ41\*:&T,</]GQB*.<W,<:LP5)2<EP
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M@]* .6:SU >/I-"_X2'5#8W6F->./,7S%D64)\C;?E4AN@[@=LBLN/6-9NO
M_AJZ.L7"7CZXMA-.H4&9!<O%EAC!)5!]3FO0$T/3DU./4A;_ .FQQ>2LY=BP
M3^[DGIP#CUYZURWC#PO#)I&FZ;IFBM/:'5H;JZ@B("B,/ND.&8<G).!U.: ,
MKQ)JFM^"]0U5]/U"[U*W719KUHKPB3[-,KJJ," #M.6.WI\AQTK>L+;7)[^R
MN8+FXBTV:T<7;RW2RL[D*8Y8A@A3][(&%P1QQ71V>DV%C9O;6]JBPR#$BL-Q
M?(Q\Q.2W''.:JV/A?1=-C:.RL5@1E*!4=L(IZA.?D'LN* . TS4-97P=X/\
M$<FNWLUW>7EI!<QN5\F2.638P*XZ\YSUS[<5JW&JZGI_B'?JT&H?8Y=46&TU
M&QN5>W",X18I8MP*_-E2VTG<>O:NL7PUHR:5#IBV$8LH)%EBA!.V-E.5*\_+
M@\C'0TZ+P_ID-SYZ6QW^:9PK2.R"0DDN$)VALDG.,\T <3J6O73W>F:MI=_?
M-;2:XE@[32(L,R&4QLB1C).W!PQP<KGD5/I5G<_\)5X[GCU>\B*3Q<(L6,_9
M4()RF>,X'/;G)YKI_P#A#_#WF2R#2;</+,+AF4$$29W;AC[ISSD8YYJ>3P[I
M$M_<W[V,7VNZC$<THR&D4#&"0?3C/7''2@#CM%UZ_P!1@\#:==W<P35-*:[N
M9U;:\\B(AV!AR/OLQQ@_*.V:HZYJ^N:=8>+K*WU6Y1-*N[+['='#/MF*;HF8
MC+;=W!^]AADUWQ\-:/\ V=;6 L46VM6#VZJS*8". 48'*<<<$<4L_AS2+K3V
ML)[))+5Y/->-B3YCYSN8YRQR <G/0>E &%;&]TKXC6^FG5;R[L[[39KAXKEE
M;9+')& 4P!M!#G@<<"KWCS6[KP[X*U+5+(#[1"J!&(R$W.JEL'CY0Q//'%:S
M:38O>VUZUN#=6T9BAF+'<JG&1G/(.!G/7%69X(;JWDM[B))895*/&ZAE93P0
M0>HH XVXN-3T1[W5KFYGM-"CTV1IVGG%S(LP(*R1CGMNRN0"<8%0Z3=:DGCQ
MM*>[OXK2[TAKL174R2RQ2"15## (7(8_+DCBNDMO"NAVEG-:1:;#]FFB,+Q/
MEU\L]4 8G"^PXHM?"VB63QO:Z?'#)'$T*R1LROL;JI;.2.!U]!Z"@#@K&;7'
M^$]YXID\2Z@]\-+N'5?W>Q61F*L!MZ_+@GWXQ6P9M2TCQ'X8D&K7MXFJ0S+<
MV\Q4HQ2 R*4 'RG*XXZ@\YZUU$?AK1XM&?1TL473G!#6P9MA!ZC&>A[CH:E;
M0]-?["6M5)L"3:L6.Z+(P<'.>G'TXH XGPS?^(_$>BZ!KML[K-/.LEZSW(\A
MX22'C6,9VE>,< Y7D\FLGQ)>R>)?@[KFNW>HW$$VVYC^SQ2A8XPLK(L3+T)(
M R3SD\8XKT:V\,:+9WSWEMI\44SR&5MF0I<]7V9V[O?&:AF\'>';BYN[B71[
M1I+P$7!*<29X)(Z9/<]: -J/_5K]!7)Q7DFO^)?$6F3W]Q91:4T*1+;2^6_S
MQAS*Q[C)( /R_*<@UU4,*6\*0Q@A$&%!).!]36?>>&]&U#4XM2N]-MY;R)=J
MS,OS;<Y /J,]CF@#SS0+R[LOAWX#DM+^6))M3BMY@NW$R-(^0>,]AT(ZUU%M
M=WD_C_Q#IG]J3_9XM/MI8T&S]P[M+G;\OHJ]<UKMX6T-]&_LAM.A.G[_ #!
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MM;"**8Q"%G7.73DX;^]R2><]:@MO".@V<$T%MIT<4$JE&B1F"!2<D*N<*#W
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MN1;OYC*=Y**X(P3QAA6Q7F#:9%?77Q"G-Y>PR6UR)(6MKIX=CK:1D-\A&XY
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MT<%](#O695#9).#CKZ]\Y.85GDUC0?&-W?7US:ZAIUW=1PM'.T9M4C7,1 !
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M<\'AT2SRQ)_;EJI,<I3J3SD=_0T ;MGKRW?B?4-#-I+%)9P13F5F4K(LA8#
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M.67ALIM;L0<8HN;/4-$T?P4EWK%Y<7\FJV\5Y,+R1DF+1L67!."N5';MVR:
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MGIQZ4 >R5CW6O+:^*-/T1[24M?0RRI<;EV#R]NX8SG/S"N4,UU=>.;_P[O\
M/M(-/BDM$GU*6)Y-S/YD@958N00JY)^7''4TL$%[;>*O UKJE\E[>II]\DMS
M&3B4@1#.>N<=_6@#T*BO-[%+E=4U;P9-?W[71OTNX+@W<OF"Q;YSAMV?E*O%
MUZLIKT=5"(JC. ,#)R?SH 6LM]9W:W_9EI;&X:':;R02*HMPP)7(/+$[>@Z
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MT329;6"UDTNR>W@</#$UNA2-AT*C& ?<5?JH]S=KJT5LMB6M&A9WN_-4!'!
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MR <\ 'L*]#HP/2@#QZRU*/2=(M+268IX?LO$EY:WRAB5AMPTHA5_2+=MSGC
M /%61)91>)_%I\();1W%QX>CDL_L@"K-,#-\T>.&_AY'&1]:]8P,8Q1@#H*
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M2MGGHASD1[LX[8V]L5L7>FZ?IOB#QEHVGV\=M;7.@QW"V=O\BM+^^!947')
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MKY#0;5\K?CY<[B<9YQN[ UWRJJ*%10JCH ,"D5$0$(JJ"<D 8H \.L;70H_
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!XX[L6ODSV:@Q[8W(.UBV!Q@-\F:L?$O[#%%X:N+^$/!'K</F?NC(=NR3(P
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M"\B@33+AKCRWA+F0F-DQD,,<.>QK=K/U#7-+TJ>""_OX+:6?/E+(^"V 2?R
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M"2258O.+LJE\@8Z$N<#& >@K-D\6Q6GC9TGUB!M#DTH7414*P,GF[/E91EN
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M&I)92[X@^%9';</?Y?IS4'B#6-9\'QP:I>74&H:/Y\<-V#!Y<T =@HD5@<,
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M^(%I'IEX;C4[N9[-/)8&57AC0$>G*GKBNF\76EUJ_P -M3L[*VEDN[FQ:*.
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M(WD.6!Y*D2=5!/'2@#3MO%6DWNF65_;3/+'?.T=J@C823,I8$!2 1C:Q.<8
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MIN(VN)VMH9GMW$3RKG*!R,9^5OK@XK(\,V6M>'9+S29],:[LY+^:XM[Z*:,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5G7NBVM[?PWY
M:6&]A1HDG@<JVPD$J>S#(!P0<'I6C10!5L=.MM.246Z$-,_F2R.Q9Y&P!EF/
M). ![  #@5:HHH **** "BBB@ HHHH **** ,[7-%M?$.D3Z7?&7[+.-LJQM
MM+#TSU_*KT,9BA2,N\FT8W/C)^N*?10 4444 %%%% !1110 4444 %%%% !1
M110!6O[-=0LI+5YIX5?'[RWE,;C!!X8<CI3[2TAL;2*UMTVQ1KM4$DGZDGDD
M]23R34U% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM+ =AQ[T =;15:XU&QM)HX;F]MX99/N))*JLWT!/-22W,$! FGCC)!(#N!D
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MG+("F/KTH GHJ&*[MIY7BBN(I)$ +(C@E0>F1VJ23S/*?RMOF8.W=TSVS[4
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MS1W$4;0N5Z2QGG:WT;!![<^IJ]0!Q.CM9I\5]?-OY*^=I]KDI@>8X:4MTZD
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MW ]BP!3/?I7HE% 'D%CI^G67@?X?ZI#:PQ7L-Y9I<704"1 4*R*[=0,<$'@
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M%;>1X9(D:*=&(8/(L?!!&,;L]\XJ)]=U73O&&E:)?QVES#J<,SQSVR-&T31
M$[E+-E3N !!Z]JJ?%,/+X#N[:"&>>>6:W*10Q-(S!9XV;A0>@!/X5<U[1A=>
M&-9N-#C(U:\L)8X)V9O,R5)"AF.5&>W !H W(=4T^XFEAAOK:26(;I$292R#
MU(!XJM=>(=*MK*YN1?6\PM[:2Z:.&56<QIG<0 >F01GUXKDO#L&G:DVB7EQ<
MZDMSI5J\9LY;$Q+$&C"O')^[&0,# SR0",UE:)HUA'\(=39M'*ZDUK?1%7LV
M$S;Y'9%P5W'.(R!["@#N]%U62;1AJFIW]BL%QMECV#RU@5E!$;,6.Y@3UXSG
MH*T!JFGFQ^W"_M3:?\]Q,OE_]]9Q7!6\(TR?P3J"V31:1!:R1W82W*^1</&@
M6210,CHZEB.-W/6LWQ-I4TVA?$&ZMK2:6RU,0_884A9C+.L>))$4#/)P-V.=
MI/O0!Z=_:^FEF7^T+3*R^2P\Y>)./D//WN1QUYJ+_A(-%^R"[_M>P^S&3RA-
M]I387_N[LXS[5QWBW2](2S\.BQTE# ^M07$RPVA/R %6=P%X& H)/M4,>DV,
MWBCQTATH&*XLX1$6M3LD81N)-A(P3G9G'7 H [^]U&QTZ 3WUY;VL).!)/*J
M*3Z9)HDU&RB$9DO+=!*NZ/=*HWC&<CGD8!/T%>>:5J%PEAX2TZ[L;B%&T18Y
M;HV#S2^=B-6@P5(0G;DE@0=OXUE:+8K_ &;\/(+S3;@M9W5P+A9K5B84V2A
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M8VU@Q8[3C.[.*D_L#2_^$XT*PN+&:]L8-">U,UY;%PS;H@@D.W&_:&ZX[]*
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MXHI8Y!@JZH 1^8-:]% '#^*+(>)]*U/3'\/N-7(>"UNY(!LC&X^7,LW8#(;
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M@'2[>$QE7N)CYAW%3@J!N5<MCOVP3Z-10!Q-S8W;:AX&NH["<16+2+<@)@P
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MYO#,P))7CD YZXKI=4LM0NO''AW48K"0VEG#<I/(9(P4,H0+QNR<;3G'X9H
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M-RMCMLP#WK&U:RUK0/A9J&@7VGAH;69?+U 3KLFC:Y5@=OW@_P V"",<$YH
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MDA9H\XWKO W+GC(KD-9\+:M=6NOWEO8LUUK&HV4ZVWFH/*CMVCY8EL;F",<
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M[LYRXX(%9\WCNP@\/W6LR6&H"WM+UK*= B%TD#B,\!^1N('&3[4 =317+?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** .9\0:+JLOB'2M?T5K5[JRCEMY;:[=D2:*3:3AU5BK H#T.:H1>%=7G_
M .$P2^FLPNOPA8WA9B83Y BP05&0/7/..@S@=K1GG% '#0:!XFGN?"T]Y'I4
M0T5V$L<5Q(_G PF+<"8QCKG;@_6M70-)U72]4\0W5REFR:C=_:H1'.Q*XC1
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH S-2UE+*_M-.AB\_4+M7>&'=M7:F-S,V#A1N4="<D<=:Y3P=)-;>(/'$
MSZ7Y$Z74+&TMW5]Q^SJ?E/ .X\\X^]SCFMO7_#][>ZUIFMZ3>PVVH6*R1%;B
M(O%-%)MW*P!!!!4$$'M65<>"=4N;;Q1&^L1K)K@B;S4A*^4R(J%<;N4(7&,Y
MP>IZT 7K;Q?//J>IZ4=,1M2L[4721078D29"2-N[:-KY&-I'<<XYJ73O%;ZK
MIV@7EI8K(-6!;9Y_,"!<DM\O./NGT8@<YS4>F>'KVP\2+K5W=6*Q_P!GK9M;
MV\!BCCPY<%<D\<XYJ/P=HB6%YK%U#/YMB]Y*+!,<0HS!I0OL9=_X(* +.A^*
MQK\T;V5O!)9M))&SK= S0E=PS)'M^4$K_>)Y'%97BG=:_$;PK=6MC]INV@O4
M"J0A?"QXW,>@&3Z]3@$G%6K;P<SZ[IFKWL6G1W]BS.]Y9Q%);LE&3$G3 ^;<
M1ELD#IWNZ_H>HWVNZ/J^F7=K%-IPG4Q7,3,LHD"@\J05QM]Z ,^'X@VZF:TU
M"Q:QU:*^2Q-I),I4NZ>8KB3ILV G.,\8QG ,H\>6B&^@G@'VVTNK>T$<$PD2
M5YR!$5? XR3G(&-IZ\9AU3P(;_&H1WD2:XM\E_\ :'AW1,RQ^6(RF<[-G'7.
M3G-0^+H+T^$QIET-.2[U.[AM;<Q6Y,,3EMV6);/13AA@@D8YP: -"/Q+=W.I
M:OHT^B3">QA6222"Y4QLCJQ7:QVL"=K#IQCKTJAIOBR.RT#PFECI-Y-#JT2I
M;![D,Z8B9P'9CDG"\FDT\ZYIVO/H4T&DR&^LY;@W5L)=Z,I1 9=[,6!#8!SG
MY2.@I]EX,U*SL?"=K]OM6'A]L[O*8>>/*:/U^7AB>] $S^.);;2O$%Q>:-+%
M>:&H>YMDG5PR%-X97XR,9XQGBK-OXKN3K>GZ?>Z-+:QZE$[V<WGJ^YD7>5=1
M]TXY')Z=JJ:OX.OK]_%8AOK=(]>MHX/GC),&V,H3P?FSDGM5ZZ\/WMQ?^'+X
M7, ETGS/,0H=LN^/R^#GCKGO0!CVOBN#1O#%]J<.DWKI'K$EK-"]UYCB1IA&
M2"Q/R[VX Z"M>#Q8\>M7>F:MICV#PV37\<@F657A5MK9QT8$CCGKP363)X)U
M23P[?Z4=0M UWJW]I>;Y3?)^_$VS&>>5 SGIVK2UJQDL-8?Q9/(CVUEH\\%Q
M;+$79QE9"5YY^YC!ZYH CC\9W#W6AH-%E>#6XC+9O%<*64! _P"\4X"_*<\,
MW3'I6UJVM1Z7-86JQF:]OYC#;0[MH8A2[$GLH522<'Z'-<#HUMKOA/3-"NFB
MT6^CGEAME$*RB81S,,^5EBB@#YBJ@+A/0"NT\0Z!)JUQI=_9W"P:AI=P9[=I
M%+(P92CHP'.&4D9'(.#STH S;_QS_9<>N1WFEN+[2+87DD$4P998"#\Z.0,X
M*D$$ @CO5FV\57#:[IVG7NCRVD>IQN]I/YRON**&974?=..1R>G:JFL>#KK6
MH-<GFN((M0U6P&G JI9+>'YB<="S$N3GCL,<9-ZY\/WEQJ/AN^-S )-),GFI
ML.)0\?E\'/'KWH K^,-:U+2]3\-P:?#-(MYJ!CF6,QCS$$4C;,L1@Y4'/'"G
MGL<2PN[S2O&?C*73-$-U(?LDTD(F2(+^Y)(SR"Q.?8G.2._4>)-$O-6FTBZL
M+J&"YTV\^TKY\9='!C="" 0>CDCGM4>FZ#?6GB'7=2FNK=TU18@J(A!C,:;!
MR3SG.?;WH @@\<V-\FEK8K&;C4+$7Z)=3"%4B. -S8;YB3@  ]#Z5I>'O$%M
MX@T1=2B4PJ'DBE1V!\MXV*L,C@C(.#W&*Y?3O -_I"Z)<VE[92WNG6']FRK<
M0$Q7$((93URC YYYZUVL%L[:=]GO/)=G4K((4*)@YX ))Z<=?RH \]\<:J^N
M^#K/4+;2UDTR:]LW@NWE D53<1X?81PK#C[V<-R!S76^)?$4_A^TGNUTY9[>
MWB\Z5Y+E8=PYRL>0=S@+G!QU'-<\? NN?\(G%X:.N6K6-G+"UI(;4^:4BD5U
M20[L$ +C*@9P#Z@W]3\(ZE?ZQJMXFH6BQZE8+:'S;<R/;$*P/E'< %8MDY':
M@"]'XK6;7M)T]+,BVU6T:[MKIY,;@H4E-N/O88'&<8SSQBM'1=2FU6R>YDM1
M GFO''B3?YBJQ7>.!P<9'J,&N9US09&\.>'M*BOTAUFPN+=+:>$?-\HV2$ ]
MC%YAQ[5VEO;Q6MM%;P($BB0(BCHJ@8 H XB'Q5!HOAGQ)K,6E7C"QU*9;F"2
MZWL7^7<RDDA5R1A1T]*T&\6:DNNOHI\.RB]DMC=6H-TFR2-6"MO;^ @LO #=
M>M4+GP3J=SX9\1Z0VH6JMK-X]SYHB8^2'VY7&?FQM'/'4ULG1-0D\96>O27%
ML$@L7M'A5&RV]D8L#GU0#&.] % ^/5_X1S3M732+ES=7XT^2W$B!X9O-\HC.
M<-\P.,=?:A?&&J->ZEIJ^&I&U*PC2=HA>)Y;Q.&VE7Q]XE6&W'4=:K'P3J2Z
M+#IT>H6N(=:_M59&B;G]^9@A&?4XS^E;%MH5[%XMU/69+F Q7MI%;")4.4\L
MN0<YYSO/&.U %>+QQ87D.C_8PAGU6S-[$ES*(E2(;<EVP<'+   ')SV&:-/\
M;VNIP6T=M;LVI7%Q/;+:^8-H>$XD)<<;!\OS $G<.,\5DV/@&^TNVT":UOK.
M2_TFS:P?SX"T5S"2#@C.48%001FM75?#>IWESH^JVE]9VVK::TH4?9V,$D<@
M 9"N[/\ "I#9ZCISB@#!T1Y8-=^($MSI7D/LMVDMK:<?,/);+*XVX)Y.< Y]
MZZ+3M7>+P;HUWIM@SQ36$4R"[N]JQ)L4@/*026Y S@YP<XJ"V\,:K!>^(KN3
M4+::7688T/[DJ(65-G R<K@DXSGCKS5:W\&ZI:IX9\O4+*0Z-9FS9)[=GC<;
M442JNX8<!,=3PQYH JZAXWN[_0_"^IZ/:W*KJ.JK;SQ Q$D+Y@>/)..6C.&'
M8=1FM*^\=P6L.JRQ6T<@TD?Z;')<JD@8('98QR'95([@$\ FJL?@C4;;P[IE
MA!J5NUUINJOJ,4TL)*R;GD8JR@C'^M/(]!5FW\*ZCIFNZC>Z?<Z=)!J4BW$\
M=U;,QBFVA69"&Y4X!VGH>] %2TDBD^)MY?Z= DAN?#T$Z#.SS297P2<=2 !G
MV%:.F^+Y-5T32=0MM-!?4;AH!;M/AHBN[=N^7^'8V1[<9S5A-%NX?&DWB"6Z
MMQ;-8+9F+800%9GWYSCJQ&/3O5/PSHL=KXCU[4()_,L9+MC;1@?+'(ZH;@@]
MP74?0AAW- '1:C=3VEL'M[;[1(6P 9 B+P3N9CT7CJ >HXKA];\;7%]\/M8O
MM/MI(;VTO%T^813(X1BZ LKY&05<8(Y!/08KH_%&@W>M_P!F26ES C6-T+AH
M;F(R0S#:RX8 CINW#W K$NO ^I3Z)KNFC4[;=JNHI?><8"/+QY>5V@]/W0QS
MT/?'( G]HWFD>+- T;3=#DLK":TNIYK&'R%7>'C ;(;MO)..NX=>UMOB#8_9
MH=0CCBDTR2\%GYHN!YH)D\L/Y>/N;N^<XYQ6AJ&AZC<^)-'UJWNK:*6TAEMY
MXI(F=720H25((P08QU]:I>'?"M_X:S86MQI\NEI.\L+2VQ\^)&<L8\AL-@DX
M;MZ'% $UIXLO+[Q%>:3;Z!<,ME=)!=7!G0+&K1AU?'5N&' Z=\5'XGUO4].\
M4^&;.QMYYH;N6?SXXS&/-"PL0N6(Q@X;MTZ]JNZ)HE[IFO:YJ$]Q!)%J<Z3!
M$0@QE8UC R3SPN>U&OZ'>ZCJNBZE87<$$^FS2/MGB+HZNA1NA!R,Y'- '*:=
MJ%SH&M^.)M.T0W44%['/*B2K$%7[-&S;<]6ZG' ]^:Z/_A-+.YFM;?3Q"]Q<
M6":@!=3B!5B?[@)PWS'G@#L<D<92T\-7L-QXGDFNX&76CN4(A'DGREB&>>>%
M![5F67@?4-*N=,OK.[L9;JVTV+3;F.Y@8QS)']QUP<HPY]0<^V: .DT3Q%9:
MWX:AUV/=#:O&[OYF,Q["0X)''!4\^U<;XOU&;6;/PM?II*BPFUFPD@NGE'FJ
MK3(02F/E##'1B>F0.W>26'VO1I=/OC&XGA:&7R4**0P(. 2<<'UKD/\ A#/$
M$FAZ7I-QK=G)#I-W;3VT@M65Y5A8%5D^8CH ,KCGGV(!L^*/%$OAJTGOGTX3
M6=LGF3.URL;,O4^6I^^0.<$K[9JC+XAU _$6TL+>">73)-)-R0#&JY,J#S"2
M0V%!(Q[]#4.L>"]2U.\\1,FI6J0ZS9BWW26Y>6W_ '90JC;L;"26/'4GUR+X
M\-7Z>(=-U1+NUVQ:>=/NHGA8[TW!LH0PP>,<YZT 5X/B!97$>EW<<4;:=J5T
MMK!*MP#*&8D(S1XX5B/7(R,@<XF\;:SJ.D#0AIT4SFZU6&&41^7\Z88E/G(Q
MNQU'H>13/"_A?4?#-M!ID=SI\^G6S$02O;$7'EY)",0V"1G&[VZ5H>*-$NM:
MM]/-E<Q07-C?1WD9FC+HY4,-I (/(8T <U'-=V7Q,UB73M&\Z[GTBTE> RI$
M WF39W/R,\ <9SCTYKH++Q0^J^&;/6+#3V/V@-NCN9EB6$J2K!WYQ\RD# .:
M=9:'?0>,;O7)[JW>.XLXK4Q)&RD>6SMNR2>I<\=O4UA6G@75+&WT../4;*7^
MRY[E]D]NS1R"9BP;;N&'3) .>YZ9H CU+QQ=WWAO1=2TFUGCDN-9BLKB)6B;
M&V4JZ!B<$-M(##L>U=%XKU6]TSP)JVJ6T,D-[!82S(OR,8G"$@G)VG:>3USC
MC-8W_"$:A'H0LXM2MVNH=:.K0RR0G:Q,IDV.H(_O$9%=)K6E2:WX7O\ 2)IU
MCDO;.2W>9$X4NA4L%)Z<YQG\: .+U.XN9=<\!:C-IDIU#S9TVLT>^7_17.2P
M) &23[<\5M+X\@M[74O[5L'LKVPNX;1[<2JXD>7:8]K\#!W#DXQ@YZ4YO#FL
MSW?AJZN;VQ,FCL[.(X742[HVCP,L<8#9SZU4UCP%-JU[K<_]H1PF^N+6[M7$
M6XV\T"J%)!.'4X.1QP: -G2O$T=_KUUHLL<*7<%NERK03^=')&S%<AL @@J<
M@CN.M8!TNPO?B]J,%U:130_V-#-Y;J"OF&:0%L=,D #/M75:1;:C C'4/[/5
MB  MG"RC/<DD_ICCU-94_A_5D\:W/B&RN[,+-91V?D3Q,<!69MV0P[L>,4 8
MM[=Q>!O'5G%%<2IH5_875Q<VSNSI;-  YD0'.T$$@J.,]LUL6GC6&?4=*MI+
M9 NJQN]KY5RLCAE3?LD7@*2N>A(R",T^7P='JAU&?7+K[7=WUD]ANAC\I((&
M^\L:DL<D\EB23@= ,4_P]H^LZ19PVES<:9.MM%Y23QVS))-@84M\V%/3.,Y]
MJ .9\+^)8;;0DU_5=-\O4M1OI+..[=HPUPQGD"H6!)545._0*<9[Z]Y\0(K&
MQUZ62P$UQHT23S1VUPKH\3@D,KD#^ZP(QD8[U63P#=GPC8Z3)J-O]LTZ_.H6
MER("4\PR.^UT)Y7$C+P?>M+6/#VJZWX1U+1YYM.MI;Z+R=UO VV,'J>3\Q_+
M'O0 R^\97NFVD-S>>'+N-+C4(K.%1-&6<2;=KXSQDDC;ZCG%6Y=?U6'2([N7
M0A!<D2-)#<7J(D85BH'F8(+,,$#&/4BDU_0M1UJPTJ);FVAEL[V&\D8HS*YB
M8,%'/&?7M3=1\/:A=>*[36H+RU58[0VS0SP&3RB6W&2+D88].1T ^E &%>ZE
M9>(M5^'NO6L)07=U*RF10'53;2G:3[$?2K?Q;1?^%<ZA,%/FQ20&-U^\I,R
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MXW;MWR_P[&!'K@<YJ*Y\;"+0KCQ!!I[7&B6TCK).LN)2B.4>18\8*@@_Q D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MIY8_+%[$JLSH#]W>.2,]LU>KS[P3?RZ;\*/#K1/90L\?E^9=R[$3ECP.K'(
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M0 4444 %%%% &%JWAU]0U[3]7MM1EL[FSCDA^6-7#QR%2PPPX;Y!@_H:RX/
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MB ,]0<=*U]2U6PT>U-UJ5W%:VX.#+,VU1]3VJ&TU_2+Z\%G;:C;R713S!"'
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M2(D8;&0001P000:I7O@_3]0TO4K&YFN6_M,C[;.&423 # 4G;@   84#]3D
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M.PD:*1E#'Y_ND*1MS[Y/0='H_AB+0X8[:TU/4C9PJ5M[:6562$8P #MW$ =
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 452U:U>\TZ2!;N:T5L%Y8#B0(#E@I'()
M (R.1GCFN6\%S)'XAU^PM]4O;BSB\A[>UU&21IXB0=[#S?G\LG;C/<-CCJ =
MM17(^-;*)K2XO;K4]9A6.W(MHM,>5"L@!)<^7][^$?/\HQ[FMGPS<R7GA?2K
MB>]AO9WM8S+<P$%)7VC<P([$YH U:*** "BBB@ HJCK.I)H^C7>H2*7$$998
MQUD;^%1[DX ]S7!?#+6=7M]<\0>$?$EVUQJME-]KBE9B?,ADP3MS_"I(X[;L
M=J /2Z*X74OB9#8:GKFGQ^'M6N9]&C6:Y$8CQY9!;>#OZ;<''7GIP<3WOQ(T
MZTTWP_?QZ?J%S;ZZ\:6S1(A*LW\+#=G/7H"..M '9T5QFG?$2VOK+Q!))H^I
M6]WH.&O+-Q'Y@4@L&4[]IX4GKVXSD4Z'XAV4S>& -.O57Q"NZVD.S:G&2&^;
M.0,'@8YZT =C17)ZUXX30=7L[6]T;44L;N[6R34,)Y?FMT&W=NV_[6,<'&:Q
M]*WQ_';6H1-.T/\ 8\<@C>5F56:09(!.!T[4 >B45PWQ?FN+/X9ZK?6=W=6M
MW;"-XIK:=XF4F15/*D9X)&#6;KF@2V_PU;7=,UG6+35;33A>B8ZE-(LC+'O8
M,CL5(.#V[T >ET5PF@_$ W_A[P\7LI;S7-3LC<?9;<JG"<.Y+$!5)Z?6L;Q9
M\0_[2\#Z)J&AQ7JPZOJ<5E.%4+*B;B)(P=WRN=N 0?4Y'!H ]4HKBD\3:?X<
MM(]%TS1K^2>TL6OI+'>N^W@W'[S,Y!8G.%!)^E,N_BAID,6@RVVF:G>1ZY&S
MV9@C4EBHRR$;LA@<#ICGK@&@#N**X-_B8J:K'I/_  C&MG4FL8[TVZQ*S*CE
M1@X8D8R<Y Y7&,D5H7_CA-,\16&F7NC:C!;7]T;.VOG">6\H)&-N[< 2."0,
M]1QS0!UE%>=^%]Z?&3QI!YT[PQP6C(DDK.$+*6;;DG SV'%)\;+FZT_X=7.H
M6-[=V=W!-$(Y;:X>(X9P"#M(SQZT >BT5PVBV^D7M[>1V-UKX,6GA9X[RXNU
M5O-)VLHF;(8>4W*@?>ZUC_#CQ/#H_P (?#MUJ#W%U=WUS);01@[I)YGGDP,L
M<=NI(  H ]1HKD(/B+I(L=7FU"&XL;C2KA;:YM7 =S(WW FTD-N[?KBL#QQX
M\UK3_"%_/:Z3?:1J,-S!"&F$4OR2'[P(9ESCCV)% 'IU%<)?:M:3_$7PI'=6
MNNV=[<0W)MX6EC6!@$)?S55B2PP,?4=<4M[\3K*VM-3U*'2[RYT?2[O['=WL
M93Y7R Q5"<LH+#)XZ\9H [JBN-O_ (A06OB'^Q+31-3O[M['[?#]G$96:(D
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M@8M&X+ JPV$>G?..:T]"\1)K5Q?VCV-S8WMA(J7%O<;21N7<K HQ4@CT/8T
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MU@D:V,B&)E/F;3"N[ACM.<XS@5+8^+K?4=)T;4;2PO)(M6?9"@,>Y/E+$O\
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MQX_M%NH;>QTG4]1>XT]=1MS:QH1-"2HR,L"#\W0@=.,DC/74 %%%% !1110
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MS8F7[5%>R31OY^]"TC,@?>-G?.0.HQ6J^AZ_;^(-+UBTCTV5[?3383V\MPZ
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METVUU:]LK*VL+JV\R-8I6:0/NP=V1@#'3&3ZXSB@#JJH:C8Z3-Y=WJ=K9/\
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M^(T:.GA8.@;_ (J*SX(]VJGJS/X<UO4O'=Q8_98$L([%;3>N^YE:8;7?9E0
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MV;0=!U^XT_3UT_4;F&VEA21S*GF2>6K@XQ@$CCT[CH._=TBC:21@J*"S,QP
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M32*=V=K$X4%<<;NIQF@#KZ*Y#3/%E[>ZEH\9MXYK;4HV9_L\4F;)@F\!V/#
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MCQD'+MG&,^U9T'@."#1+6P&HW'G65Z]]:7>Q0\4K,S-D=&4[V!!['UYKKJ*
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M4 >3Z-'J&EZ/IUWH?B*WOK^[GB:6Q-I$TD@>0&42.H#@H&8EFQC;R!TKUBD
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M[&# C" $Y49+ YIDWA:WN$O&EO\ 4/M=V(DDO(Y1%,$C8LJ HH &2V<#G<:
M-VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MRK=MI4D-DG QWH [*BO-_&'CK6[#P7KUW;Z+?:3>VL,,EO--Y4HVR.5W$ D
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MXB\\6ZLOB'P[:IH][$EW]K^TVN(B[&+Y1ABX&,_-G/((^E=O0 4444 %%%%
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M3UL?L[7-L'DG=P\;?9H^0H&''L2OUKOJHV>CV%A>W5Y:V_EW%T09Y-[$R$<
MG)Y( P/0<4 <<_P\&F:CI=[I4-A?"ULC93VVICY907,GF!@K;7W,Q/RD'=VK
M0N_#6I1:KI&MZ0NFP7MG#+;SV?S)!+%(P8@,JDJ05!SMYYX%=?10!S&I:/K-
M[K.@:Q&;".XL//2>%G<H4E"C*MM!)&T=0,Y[5T](652H+ %C@ GK2T %%%%
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M^]U."XDGL4M)88[8HJ['=@4)<D#YNASWY[  R?%=E:S?$CP2TEO$YDDNP^Y
M=X6 E<^N#R/0T^;QSJ:6&N7L/AU9(=$N)(KO-\%+(B*[-&-GS'#=#MZ#DDX&
MKK/AZ\U/Q/HFKPW\$*:6TK+"]N7,AD38<L'&,#IQ56#PC=+I'BFPFU*)_P"W
M7GD#I;E?(:2(1]"YW !0>W>@"\_B$7MV-/TJUCN[IK-+MUN)3%&D;Y"!F"L=
MQPW&#P#DCC/(^$M=MO#/A2ZDN[:*UDN?$5U:Q6PD58XY&E;Y2^,!5 /..B\#
MM6Y%X1U2PU2TU/3-7MXKI;&.QO%FM"\4Z1D['"AP589/<CFJW_"OI_[(DM/[
M8S=1:NVKV=T;?F.5F9L.N[#C#$'&WKVH 6]^(?V/3M>G2PM[J?1XXYI%M[S=
M'+&X."K[/O J05(_&KUQXLO-,URQM-8T@6EC?LZ6]VET)"KJA?;*NT;255NA
M8<=:S_'L>HQ?"_Q"=2N;1Y#:_+]F@:-5Y']YF)_2ME/#]SJ,EI-X@NK>\:TW
MF%+> PIN9"A=@68EMK,!@@#<>O! !F6OQ#M;L:1/%#;O:ZK,(8 EV&G0L"4,
MD8'R@XP>21D9'7$#_$"_CT2ZUIO#X&GV-W);7;?;!YB[)/+9T7;A@#SR5]LU
MJ>&_#VK>';&#2TU2UN--M1LMR]H1/Y8^ZC,'VG' SMY Z#K5(^![J3P7K7A^
M;58B=2N)IQ<);$>69)#(1MWG."<#D4 ;%WK$ESJ-[I&FV4-[<6L2-=+<S>5$
M!)G:F0K$D@$XQC!&3S7(>"_$%KX=^'^C13Q10SWNH7=O#"\H2-&$\S'<_0*H
M4\@'L .:Z-O#>J6_B6;6M-U:W@>^ABBOX9;4R)(8\A7C^<%&P2.=PZ>E9L'P
M_N;;0]-M(=87[?I5]+>6=V]MD'S&<LDB[OF!$A!(*]CQ0 ZX^(?V>SU"1=-2
MYEL+VWM9EMKH.CB8J$='VC/WL$'&"#]:U+3Q+?-X@N=%O]'$%TMF;VW\FZ$J
MS1AMI!)5=K D<<CGK3-;\/:MKVA+87.I64,OVF&<O%:-M'ENKA<&3/)7DYZ=
MJMR:%._B^WUW[7& E@UE)!Y1^;<X?<&W<<J.,&@"C\.M4U/6/!&F7NJJS3S0
M+(9V=29B<DG ^[]*R_ UO:^,-'E\2:W;Q7US=W4ZQQ7*B1+6-)&18T4\+PN2
M<9)/-=#X1T.[\-^';;1[F]ANX[11%!)' 8SY8Z;LLV3[C'TJA;>%=0T+4KRX
M\.:E!!9WLQGFL+N R1I*WWFC964IGJ0<CTQ0!.?[.\(SP:=IEHOGZQ>,;>T5
MO+C0K$"Y& =J!8R> >6Z<U3U#QS+I<>O17>EC[?I%J+UH4N,I/ 0?G1RH.05
M(((Z^M7-2\.:AJ;:=?3:C;IJVG7)GMI8[8B(*RE'C92Y)# GG(/0]L&MJW@V
M;6;;6Y)[V&/4-5LA8&582R00#=PJ[@2<NQR3Z<<4 30>*;T:[INGW^C?9H=3
MB=[25+D2-N1=Y5UV@*<9Q@L.*P],\8ZQ9>$?$&N7^GO=)8WEX1NN%4^7'*RA
M!@'[H&,]ZZ.Y\.W5QJ'AV]-]$)=(,F\>0<3!X]AQ\WR\<]ZRI?!%_)X:U_0%
MU>W%IJDT\D;FT)>$3.7<$[\-@M@<"@#5CUS5C837,^B1VG[T+#]IO55#&4W>
M9(P4[.?EP QSCMR*6G^.X+[2HYS:;;V346TQ+>.82(\ZY.5DQRFT%MV,X'3/
M%6=8\.ZAJ3:)<QZA;)=:9,TA66V,D,N4*9*;P00#D'=P:S)/ %RUG.%UD+?+
MJYU>TN?LW^KD(P5==V&4@D<;>M #/$VO>)+*UL%.G):S/K-K;[K:Z$B31,P)
M7<R*1G[IX]>:VT\07=Y?WNGZ=IT4MW811M=+-<^6JR.NY8PP5LG'). .1UYQ
M#J^@:OK6DVT=QJ-E%?VM[#>0R16K>5F,YVLIDR0>>A%.B\/7]AK][J]A>VPD
MU&*);V*6!BAEC7:LB8;(XX*DG.!R.X!G?\+!^T:=H5YI^D2W(U:=[98FF$;P
MS(KED8$$<&-@3GWJ;QAXCU/0_AG?ZY]D6TU..W7]R7$H@D=@O7&&VEL].U(/
M [VL.@0Z?J$<::3=27;&: NUQ*X<.3AAMR9&/Y5TNIZ;::QIESIU]$)K6YC,
M<J'NI_E]: ,FT\&:"FG)#=:?;ZA*R#S;J[C$LLS8Y8NV3DGGKQVQ3;747M;E
M_#FCVZWDVDVD(FDNK@Q@;@0BE@K$L0A)..,CKFHM+T7Q+HUI'I]OK=G=V4("
M0R7MHS3H@X 9E=0^!WP#ZU(GAV^LO$,^LV%]#Y][;Q0WT<T)*2/&"%D7#?*<
M$@CD$8Y&,T 9Z^/S<:?HUU9Z1)*VHWKZ>\+SA&MYU#[E;@@@>6W([8X[5')X
MXU>.VULGPVANM$.Z^C%^-AC\L2!HFV9<E3G!"_6ISX'DA@T:.SU"-/[/U!]2
MF>6 L;B9]^_HPV@^8WKC J?_ (1.Z>?Q4\FHQ%=>BV!5MR# 1#Y0.=_S<#)Z
M<T .O/%EPFJ:-9V&EBZ75[62XMY&N/+V[55L.-IP/G7D9/7@U1'Q"CM!>VNL
M:>+#4[6[@M#!]H#Q.9@3&XE('RX5B21D!3P3Q5#4]/U.P\4>!=.L[ZU%Y;65
MW%YLMNS)(JI"/NAP02!_>ZUKZIX'34[:6=KXQZR]Y#?+>K%E4EB&$ C)^X!N
M&TG/S'G)H J7_P 1186>MR"P@NIM*BBG86MX'CECD) *OMX8%2"I'H<FM1/$
M]Y;^(XM*U/2/LRW-O+<6DL5P)2XCV[E=0HVMAP< L/>H];\/:QXA\*WVCWFI
MV,,EVJIYL%FVU #D\&3DG [\>]6-4\/WFH:UI.J1ZA%!/8V]Q"P$!8.90@W#
MYOEQLSWZT 1>&_%O_"21175K#:26DML9\V]Z)98F^7$<B;1M8@GN<%2/>H[+
MQ?++XE31+JQMTFFMI+B$VMZLQRA7='(-J[&^8=R.O/%5IO OVZZDO;F6TM+]
M[&>S-SIUOY3R&50#(YR2<8R!V)SFI-*\(:A9:CH5Y<:G:/\ V5:RV@A@LS$C
M(^SD?.2&^09ZCG@#N <[#XAO;OX3W6HZ]ILM]")I#(1>>2TBBY8  H,KMPH]
MP*[:;79IM;N](TNUBN+JSA26X,TQB1-^[8N0K$D[2>G QZUA-X%U%O!%[X7_
M +8MQ;RS,T,WV,[XT:4R$-^\PQR<9&.!TK5/A^]M?$<VN6%W;I/>6\<%[#+$
MQCD*9V2+ALJ1N(QSD8Z8S0!FQ_$ W,&D26FCR227]Y+820O.J-;W$8<LK<8(
M^0\@].<=JU] U^XU2_U33;_3ULK_ $YXQ*D<_G1NKKN5E;:I['@@8Q68O@>2
MW?1VM-0C4V-_+J,[26Y8W$TH<.>&&T?O#@<XP.M:]AH<MCXIU?5_M2/%J*0K
MY'E$-&8U(SNSSG)[4 9MYXKU5-;U;2[#08[F;3H([DL]Z(UD1]^ /D)#?(<#
MIZD=XK'QQ->/H%P^CM#I>N82VN#< R+(8RX#Q@8 (5L$,?<"KJ^';Z/Q'K&K
M1ZA;_P#$PMHK=8FMR?*\O?M.=_S??.>!VJE;^"KJWT#PQIHU.(R:#<1RK*;8
MXF5(WC"E=_!P_7)Z=* )QXPF.A^(]0.EX?0YY8I(?M'^M$<:R%@VWCANF.U)
M=>-8X;NQLDCLXKN[L5O46]O/(1MQP$1MIW-G.>!@8/>JUWX,U*5?$MG;:Q!#
MIVNF2216M"\L3O$(SAMX!7Y0?NYZC(ZBS=^%;N]TV+3KN32[VT6S2VV75D7"
M.NX>8HW=P5X_V>M $"ZWK$GQ(@T\6D@LSI*3R0M*@".TH!?U. -N/KBH/%*O
M;_$;PI=6=BEQ>M!?(!N$>[Y8\;GP2%&3V/4X'-:%EX2FTK6]+O;#4%^SVFF)
MIDL5Q"9'DC0Y5@P88;UR"/:K&O:#?ZAK>D:OIU_;VUQIPF7R[BW,J2B0*#G#
M*1@+0!E)\0XH'FL=4L5L=7BODLC;O<@Q$NGF+)YN!\FP$YVYR,8S6QX?\2QZ
MY>ZG9>7$L^GNBNT$WG12*Z[E96P/<$8X([UG:CX&^V[;^*_$6N)?)?B\,.Y"
MZIY>PQY_U>SY<;L]\YS71Z?'?QPG^T)[:64G@6T)C51^+,3^E '%VMS<ZAXS
M\4M=:/'=#372*UDDE56@4VZL0A )7?O8Y'/.#TJG*;&^TCX:ZA:67V='OH?)
M1W,KQQFWE.TN>3T'Y5U%GX=O[/4_$-Z-1MV.KLKA?LS#R2L:QCG?\PPN>W-9
M\'@J^@T;POIRZM;D:#,DJN;0_OMD;( 1O^7ACZT -O\ XCV-I;W]Y$EO+::?
M=&VG4W06=BK!79(\'< 2>I!.TX[9MZSJ\FKZ=K=GINF6^H0V>^WNOM,WEJS[
M Q5!M;<0&'7:,\9ZX=I?AG4M"O[X:9J5J--O+I[OR;BU+R0NYRX1@X!!.2,C
MC/>HQX3U&UU+6&TW6(X-.U=VFN+>2VWR12L@5FC?< ,X!PRM@B@"QX"W+\-O
M#OEJK.-+@VAC@$^6.IP<?E5!/B%#%X?BU34+ V['4382P)+YA@*R^6[N=HPJ
M]?H5YYK?\-:3+H/AO3])EN$N#90) )5C*;E4  XR>>/6LI? ]DUYXC>XE:6U
MUE67[.5P(-Z*LI4^KE%8^ZB@"/Q+K,G]B^)TN=)6XT[3[9O.,=XT;3#R][*,
M+E2%(Y![CWQ7O]:U.'Q7X5LK"VD-G<V,\TD'G* ^U8PN6/)V[C]<]\5??PI<
M/\/Y_#1U+?<W-J\%Q?2Q;B[."'?;N'// SQQ1/X:OVU'P_J$.I6Z7&EPR6\H
M>V+),CA <#>"K?NQCD]: .6T?5KKPM8>,+O3]$CN+"RUBYGN LXA*QB.,MY:
M[2&( )P=H]">W;Z_J<MOX-U'5+ ,94L7GA(QD'82&YXXZ_A67#X/NAH?BC39
M]2B?^W))Y!(EN5\@RQA",%SN P#VK8?1WN/"LFBW%P"TEFUHTT:;>"FW<%)/
MY9H X2YN+RYG^'>I7.G>9J1E9 QD4O,#9N=Q;L">2.<8/!Z5OGQZMC:ZM_;-
M@+.]TZXAMVBCN!)'*TV/+*N0O!SSD#&#2Q>$]6(\-&XU:S=]$<L-EFRB8>48
M@#^\.#M8G/KVIFK^ SJU[K<[:EY/]H26L\!2'+VTT &QLEL,,CD8'UH TM(\
M4QZEX@N=&=+8SQ6RW22VESY\;H6*D$X&&!'3'0@USFH6&FM\8)#=:;%=1'0?
M-:+[.)-S_:-N[;CDXXSUQ7::7#JL2'^U+JRF;  %K;M$,]R=SM^7;WK-_P"$
M>O/^$\_X23[?!Y7V'[#]F^SG.S?OW;]_7/'2@#B7T"XTJST)KV'RP_BQ9K&"
M1@[VENX;;%G)QTSM!(&0.U==XE\7R^&G,T]C UDDL:.6O L[*Q4;XXMIW %L
M'+ \'CIF[XDT*ZUQM+-O>Q6WV&^CO#OA,GF% <+PPP.3ZUAZAX#O[V'7[5-9
MACMM6NENMS6F^9&!3"%]^"@V<# (SU]0#0F\3ZK)K^JZ/IVA1W%Q810S!Y;T
M1I(LF_ SL)#?)TP1ZD=];P]K47B+P_9:O!$\4=U$'\M^J'H0?H0:IZ;H-Y9^
M*]3UJ:^AE6_@AA:!("NSRM^"&+'.=Y[>E/\ "^A7'ASPM;Z.;R*XDMU98YO)
M*@Y)(RNX]SZT <?\0=<\J^-Y9ZG#%+X:>.[:T,RJUTS?ZQ,$YXA)QZF3VKM+
MSQ'96VFZ?>0DW U*2.*R5#_K6<;EY[#:"Q/H#UZ4W1M$FT[2)K:[GMKRZFEE
ME>?[.5#LY)^92QX&<8ST ':N>MOA_>V_A2QT<:VOVC2[P7>FW*VI_<X+81E+
MG>N'*]1Q]* ([ 7H^+M[+<Z9:V]RVA@KY$^]9L3<$L44@]N0>@ZT^'XA7TFE
MZ=JS^'6&GWEY]AREXK2K*96B7"E0"I8 9+ C/3 R=6T\.ZM'XH_M^ZU6VFN&
ML/L;PI:%(Q\Y<,OSDCGJ"3GGD< 9T7@6_B\+:=HHUBW)LM16_$QM#\Y68S!<
M>9Q\QQG/2@"['XCNKMM>TK4-(6&\L+99C%%>%DGAD#8*R;5*GY&!XX.,&J=A
MXI:STCPA;:=HK/#J]JHMD:\R8<0F0*S,"6&  6Z]>">#IW'AN[?7M5U.&_A0
MZA81V9C>W+;"A<[@=PS_ *P\>W6J5IX-OK5/"B?VK;LOA]"@_P!%(\\>48N?
MG^7Y3GOS0!3UCQ2;KPGXIBU?0R)M)&R]M(;XA9(R@<,DH4'D'T!K4U'Q='I^
MJQZ/!':"\-FETD=Y>>0)02RA(R5;<WRG/IE?7BMJW@JZU$>*HXM4BBBU^.-&
M#6Q8P[8Q&<'>-V0,]JLZOX7NM:M7L[Y]+NK:2V$.+BR+F)^09$RW<$<=BO6@
M"LNM:P_Q)ETY+5VLDTJ&;R6E155VD<%_4_="X]NG-3:'XMU/6Q-,GAV1+2%K
MF)Y1=(Q:6)RNQ5(&=V#R2 #^=2VWA:YT[Q#:ZC8:@@@CTV+3I(;B$R,ZQEBK
M!PPP?F.<@U6@\%W:^#-7\/2ZLO\ Q,'N)%N88"AC,SL[ @L<C+8ZCB@":Q\7
MRW6NWNC2V5N;N&S-W$;*\$ZNH;:58E5VL"1P>,'K67X3\77\GA#PVVHP-<:I
MJRJENSRJ//.QI'=L#Y%"J>Q[ "M73_#%_!X@M]6N]0M7,>GM8-;VUH8HPI8,
M"GSDCH.#G\*HV7@6]M-"T.T_M:!KW0I0UA<K:E04VE"DB[SNW*2"01V/U +<
M_C*:RDUNTNM,5=0TNT%]Y27&4N(,-\RN5!!!5@01U[GK6CX=UB^URT-S=Z0;
M&VEABEMV:=9#*KKDY 'RXXZ]0>W2J-[X4GU'^V;N>[A74M2L/[/$BQ$QP0_-
MP!N!8Y=CDD=N..=O1K*;3=&L[&>9)GMH4A\Q$*!@H !P2<=/6@#SS0M7OO#.
MB^);G3]!2ZTZQUF]DGV7"Q,L8?)\M-I#;0.A*^@S756GB[[5KESIYM(HH5T]
M=1MKE[@@3Q-GG&SY<'&[DXR.M5K;P?J$4>LZ?+JL#Z3JMS/<2HML5G42D[D#
M[\8QQG;GK[83Q!HMEJNOZ#;6=PD4UDTB7$,1!S9E!OC8=E+>4/QXH Z/1[VY
MU'2+:\NK,6<LZ"3R/,WE >0"<#G'48XJ/6=1N=.@5[>WMG)R3)=70@B3&."V
MUCDYXX['D5'-_:LWB>V6%S#I5O [W&44_:)&X103R H#,2,<E1ZU5UKP_>7_
M (ATK5[.^AA>R26,Q7%N94(?;EEPR[7&W //!- &5%X_:XT;0M1MM'>4:K>M
M8^6+A<Q2J9 ><89<Q-SQQBK,7C;[*NN)KEA]AGTA8I)%@F\]94ESY>P[5.20
M5P0.<54M_ M];:?I%FNL0NNFZK)J2N]H=TI<R':<. /]:W('8<"K.L>!QK-[
MK[SWY2WU>U@@*)'\\+PEF1PV<'YFSC';K0!FZO\ ;I?B9X.FO=+M;?Y[H1SQ
M7'F.1Y#G8PV#'KP6'7\?0*Y(>&=<N=6T/4]2URUFN-*>0A8K(QI,KQE"2/,)
M#<YR./:NMH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ JO<WUI9>7]JNH(/-<)'YL@7>Q. !GJ<D<5
MG^)];_X1[0Y=1\DR*DD:.=I(C5G"F1@.2J@ECCT[=:XWQ'K(UOPK:7<%UIVI
M+%KUB()K%_E<>=&<,"6V-DD8)]#WH ]*IKND4;22.J(H)9F. !ZDUS-EX@U5
M/$=]HNJ6=GYL=B+ZWDMIFVLFXJ4;<!@@@<],'M4.D^*[B]\5)HUPMA<0W-F]
MU#<64C.@V,JLA)&&^^/F'Y"@#H1K.EF&"8:E9F*X?RX7\]=LK9V[5.>3GC [
MU+=WUI81K)>74%NC-M#32! 3Z9/>O*[*-!\,?"7RCY/$,&WCI_IK5UGQ/&?
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M2Z3$SL;<Y$SP*Y1I V< \%@N.G\0-7V\0:AJT^IP>'8K1VT[8KO=%L32-&)
MB@8QPR_,>YZ<9H Z>J\%]:7,\T$%U!+- 0)HXY S1DYQN Y'0]?0URGB?QC>
M>'DFN!%I\L=JT7GVHF+3LC;<L !A,%CC=UV]1FJ5N=7C^(7BX:);V33-#9,S
M7;LJ9V28&%!))]>WO0!V-_\ V3>2QZ9J/V*>27YDM;C8Q? /(0]<#/;UJY%%
M'!$L4,:QQH,*B# 4>@ KSRVUI?$OB'P%K!M3;2S+?K)$3N*.J;&7/<;E.#5N
MV^(#7]G9:G8PQ7%I<W@M_LB*S7"QF0Q^;D<?[17'"_Q4 =TS*BEF8*JC)).
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M  J*UO+6^@$]G<PW$))7S(7#KD'!&1Z&LB?6;F[UN]T;2D@^T64,<MQ+<Y*
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M#C^%AD9!^HKG+OP+'=K/)]M6&YN;Z"^GDAMPJL\)4Q@+G@97G)).3STQU]%
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M:0.8V$;*LA!VEER >V1D9_,5ST?@O38O#MAH:378M;":.>V;>N^-HVW)SMY
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M2.,AI&+.00 02QS[=J *&B>(-1F\9/I%S,+FTFT\WL,S6;6SJ1($*[6.2IW
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPM.BF)@I12 2&Q@\L. >]8^F2^(CKMDSI=R:7+;/]I>[-N-D@VE&C\HDX/S
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MD88 ]Q6C7%_#F.2&V\11RW+7,B:[<JTS*JER G)"@#/T KM* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH,BL&(/?).:VJ* ,(>#=!73-0TU;)EL]0D,MS"L\@5F."2/F^7H/NXZ5N
M =!2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***:SHF-S*N>!DXS0
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M'4A<^A% '/\ A/XAO>^'=#@OI;0:O<:>;J:2[N!!&560QJV<'+.5)P!C&3Z
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MKX0D$$'H&SQT[2:SX;N];AEMKRXTZYM9K<1,ES8[_+?YMTB?/@9R..VT<FL
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M!.,G Y)QSQ6I-XWFTUM2%[:_:H;>.!K:YMX7BCF>63RQ$=^<,&VDG)X;..*
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M)^5LG(QQP<\53XROWN+_ $X1VD&IZ;;0O<HT<DJ23NF_RTVG@ 8^8Y^]TXY
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M.E2^8GF&/>OF ;MN><>N*X!;33-%^)&C&/1#HZ2V]Q9V\EO'&([IN&"OL.0
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M%+7[*K*,=02#^%=#J/C2;[9KEMIJ0F72,+Y<L3N;J38'**5^[P0,G=R3QQR
M=G17$W'BGQ%=:W!IFDZ59K)<Z4-1C^W2.C1G<H*. .#R1C\R,8KMJ "BBB@
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M;)[YRHJSX;T$>'-+:P2[DN8S-),&D4 @R.78<=MS&MBFR2)%$\DC!40%F)[
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M<&))_O9'7I[5MT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!C^)=;_L#2!=K$)9I9X;:%&.%+R.$
M4D]@"V3]*YRZ@U&'XJ>&S?7L%S&UC?&,1VYC*']SN!^8Y'3'<<\FNLUK1K+Q
M!I$^F:A&7MI@,[6*LI!!5E(Y!! (/M69;^#[:#5-/U.34M2N;ZR22-)KB56+
MH^W*L-N,?*.0 >O)H R+CQ9?P:WI1AN[6\T^]U%K!TBM) J</M99B=KL"F&
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MIM-*VEM+9"!O-V2,L8=9-W+98';MQV[9/IMI9+::;%8B:61(X_*#OC=@# Z
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M6@N  !)&P&0<*!@Y'MR:T#H7FZ>]G>:I?W:2,OFM*R*9$'\!"(H"GO@ GUH
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M2.A *J15&2WNKO3/'<[:WJR/I5W,;+R[UU\DK;QN.A^8;B?E;(]N37=Q>&-
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MXOXK^:PMI+R(8CN'B4R(/9L9%0IX>T:/4VU)-*LUOG;>UP(5#EO[Q..OOUH
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M=C:0W+W,5K D\GWY5C 9OJ>IITMU;V[QI-/%&\APBNX!8^@SUJ6@"*>UM[D
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M>G/>I8:8TJH7^P"5RYP,[1*!C=V^[C/?O6W+>6]N8UN)X87DX57D +'T&>M
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MSVT+2@@AR@+#'3FE^UVVT-]HBVDX!WC!-9^E:M-J,FI2RVZ06-M<-#;S,_\
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M8PE.':,8P"RL0IP 7&<$8KLAHEY_PG1U[SX/LQL/L7DX._[^_=GIUXQ^M;]
M'B=];VB^$O%5H\0X\06\UM$8#$P5C;EGC3JH.)#QZ-[UV(T[2[/XGV@M;.VA
MLK_1)HY!%&%BG;S8R@..&.TOCOC-=W45T+AK286KQI<%"(FE4LH;'!(!!(SV
MR* //O">E8N?^$6NK3-KX;O7EBD=,B5'&ZWY[D*[9]#&OK72>-88;GP]Y,VH
M'3PUQ"R71C#I&ZN&7>I(!3*@$$]ZT]*L9K."1KN9)[R>3S9Y8T**6P  JDG
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MGC#F+>&://0-CH:Y#PWI^HVEU8:?:W%SJ&AK921^5J6G^5+9*%4)&)"J[\X
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M;>.>"1)895#I(ARK*1D$'N"*Q[+Q!;"UOKO4=5T=;6.[:&&:"Y&U5P"JR$G
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M%X&"<X?#J"5XQD9%8%AXWAUOPQHFI+J$.F3WMQ )(S TX.]O]2#Q@MD#=VH
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MR.Y0G&5"J2W.?NYZ'T-.M_%.C7FDQ:I:WOGVLKF-##&[NSC.4" ;MPP21C(
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M/7%6KV_N+3XFZ3,NDW=R[:',KQ0F/?%^^CY.Y@",C'!/6N_K)?0(7\41Z_\
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M#S^YT'45UN6\T5=5TV\DU!9)XS*CV,\8<!I"K$X)C'\.&W8^M>@444 %%%%
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M5?I/<+%=!_. B="R9  'S9P>>?;D [.^O[73+-[N\F$4*8!8@GDD   <DDD
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MQ6C6'XQTBXU_P=JVE6C(MQ=6S1Q%SA=W;)["@"S<:]96NM6FDR^<+NZBDEB
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MVP#AN<G 8$[0<9YQ44>K/8^+I=+NIM]K=VC7UI(Q^YL(65,]Q\R,/]YAT K
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MX)N[-@'VX(SFNFK@U\.:NG@WP?8?94-WHUS:/<()5PRQ(58J>ASVSC\*[R@
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MRZ-9/8W"N7*NC+&N]"!U_= X/KC/&:Z^>XAM8C+<31Q1@@%Y&"C).!R?>I*
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M)IUF\(^TQLWFS10L&12A7"D[5!(8]#@<\=C)/%"4$LJ)O8*NY@-Q/0#U-24
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M]&N["2Z>XAN+B,_:(0[;BA&TA\$G!W+VKN*C>>*.5(GE19),A$+ %L#/ [\
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M9.TD8&!\Q/IC#/P]O1X9;PVOB)_[*BDC>T1K0&2()('5'?=\ZC&!PIZ<G&*
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M,;B0J"JX5RV1D;3UZ5G7VA2Z'XD\#Z/HU[%;200WY22:W\Q&R$9AL#+@9)P
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M8-IPPY4L.O7K6-IWBRQT3PE%>#3X--AFU>>S?S+EFAAD\R3=(\A&0I9#V'+
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M&C,?/S\?*WY_E794 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5'/;P74)AN(8YHCU210RG\#4E% $
M<$$-M"L-O%'%$OW4C4*H^@%1VVGV5FSM:VD$#/\ >,484M]<#FK%% !1110
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@4 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ameh-nonqualifieddeferre007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HK,\0ZI)H?AZ_P!5CMEN/L<#W#Q-)LW*BEC@X/.!
MQQ5+3=9UF^BTNY?1[9+2^4.7CO6=H0T9<%E,0'8+UZD4 =!16)X9UV?78=1:
MXM([:2ROY;,K'*9 VS'S9*CKGTK;H **HZOJUIH>E3ZE?.R6T !<JI8\D #
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M^(^AV*""V73([B&RA8J%=H9-Q10>,E4R!P>_6O4MBX VC & ,=*7 SG SZT
M<_X*_LQO!^GMIDT4MNT"%VCEWC?L4,"<G!]NU>77T&B#P-XKU.*:%;ZQUV7[
M'<I/^\@_?)M\LY^4$ ].H'M7N*JJ*%50JCL!@4FQ?[H_*@#@(1IGA[XE$Z<J
MQV]WH4ES)% V?M,B2KA@,_,Y4MSU-86B7VF7?BGP?J-BVG0#4H9X[J*V8N[
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MRJ>F V3MQR!G(SBN;O++Q%IOC+PO#)J%A.8'NGEN$TR;:K.@W-(?,(RQ)QR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M15'<T 6Z*RHM?M9?$\^@+#="ZAMEN6E,)$14G& _<^W^!K5H **** "BBB@
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M:&PB2_V;//7(;;_=Z_=]NE5[3P;X>L;U+NVTN&.2.4S1J"QCCD/5T0G:K>X
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M]G =*MS'9W'VJ#<N2LV<^9D\EL\DG.: -FBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M17,:'Y"4W@AAD\AN_2NLHH YG_A%[VUUZXUC3-76"XO8HTOHYK7S8YF0860
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M\U?,"A=Z'<NUB ,YW#CI6SJ.J6&D6INM1O(+2#(7S)G"@D] ,]3[5;H P/\
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M4A@2<$'O6[ DD<")-*9I /FDVA=Q^@Z42SPP!#-*D>]PB;V W,>@&>I/I4E
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M<@QF5"JLH!RFTC#L.5[UHV'AR+3]=U'5EO[R6;4$C29)?+V ("%QA 1@$]Z
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MKR/)<I*4 #.@0E2J@CY5 ZT 9%AXLU&7Q-IEA))87EIJ=O,\4MM!*BQO&H;
ME8E95.2-R@=,XYK)\.>(=4TOPI'/=&">;4-;FL;8LSL5D>ZD7+D_PJ%. .2
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M<K&!Y:QIN(1>FXY &<@ $X-9SZI=>$=5^(>J2W#:E/9V=E)&945"3MEVAM@
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MNI5PQX*G@@UQVJ2W%G\1/#LU_90203?:;.R>WD.^%F7>6=2O(*QXX/R\]<C
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M[G:&^7<< <^_!H ]3I&94&68*.F2<5PDWB#Q!I4B6E]$R)?ZM#96%Y<K'O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:W2&407CQG8"6\MMC8(!8\C\#3=8T+^T(--T:WMTATF.=)[C;@ K$P=(P/\
M:<*2?13W(I\7B_2WNM/MYA=6K:C_ ,>C7%NR),<;@H;H"1R <$UO4 9.DZ,;
M'4-4U&>02W>H3!F(SM2-!MC0?0<GU9FI+[PUINH:Q%JLR3"[2'R&:*=T$D>=
MVQP" RY).#ZFM<G S533-1MM7TZ"_M#(;>9=R&2-HVQG'*L 1T[B@!FCZ19Z
M#I4&F:>CI:6Z[8D=R^T>F22:SQX0TQ=1OK^*2_AN+YQ)<M#?2H)"!@<!AC
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M#MBK::+IZ:])K:VX&H2VZVSRY/,88L!CIU/7KTJ_10!C3^%]-FO+RY7SX3?
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M&6*1?NLCYRI&>HQGOFMVB@#$N_"NG:AI#Z9?27MS;R.KR>;=R%F*D%><Y !
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MC:%8D8QTSG';%9Z?#WP]':K:+!="UCF6>"#[9*4MW5MP,:[L)SZ>XZ&NIHH
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M+<#GK0!QMH]Q'K6I^$=-BO8K+1;&VBL_LLR(P+(Q\QBQ!;& ,<C@Y!S1=?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M (S*B%W8*JC)). !4,%[:W3RI;W,,SQ';(L<@8H?0XZ5SWB6X:Y\1^'=!/\
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MT&#5/".H>(/#NHZ1K7B"29+R$1 V]JD*H0P;=C)).1C&[&">.]=910!Q>E^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR..:QKR'Q#/JMM$VG7;:6VG*BQPW:0^5<Y.3*RON*[=N-NX=>*S-!T+6[%O
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M8^?YAD9X[>_%1_V!K-QX'\:Z:VEO%=ZE<WDMHCRQ?O!*/EY#$ \<YQ0!U/\
M:D?_  F+6']J;0E@9FL6MB!PX_?>:>",$+M'U[4J>*=,EA:2)YBOV5KN-WMY
M$26-<?,K%<$?,O3DY!'%89L=7;QC#J)T:4VRZ$]F?,EBP9BZL%(#YQ\I&?\
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M0NX$GDXQW.!4?BOQ+%K7@S56M/[1TW4=-N[:.>WD<PRQEI8^NQB&5E8XY(-
M'HM%8U]XDMK2>]@AM;F]EL(EENEM@O[I2"1G<PR2 3@9./J,W[2_@O\ 2X=1
MLB;BWGA$T)3@R*1D8SCJ/7% %JBN<M?&5I>Z#%J]O87[1R7?V18=L8E\S?Y9
MRI?C##!YR.N,<TZ]\8Z?8V]Y=M#<RV-C-Y%W=1JI2!N-V06#$+N&2H..?0X
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MR<@@=N:](HH J:9:)8Z=#;I9VUF%R?(M1^[0DDG' [G.<#)KE[30-;@T[Q;
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M%K.IWMS;SC4Q"Q$:E/*:--N #G(]\YX]^-V[MDO+*>UDSLFC:-L>A&#_ #H
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MC/HEQ;R%OFVS+$A7'3*DY]\>]//AG58G\4Q07-FUKK3-)'O5@\3M$D1R1P0
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MJMHUI=6L3FZMM.MW;'R62$#CJ2Q S],<>IJY>I/)93);",S,A5?,)"\^N :
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M$?\ 3-002.[*#CDXOW7V^'4](TW2HE@L(P7NI#'E5B482->VXDCZ!3TXK:H
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MC/6@#KBZCJP'(')[GH*=7(:5'::OJWB_3+C2X;9Q<11W$L,Q8SEH597R0-K
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M;9M8_O(1*)8F*L<C(PV5!R./;%12> G?PWJFB#5W\G4+YKQIG@!D4M()".&
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MC<O ;(!(&!TS6[H_AZYTS7]6U674(YVU-HWFC%N4"E$"+M.XX& ,YS^%;]%
M&-'H3-IBPW\\&IWJ,Y6ZO;1&P"Q(&T8X P.".F:Q-.^'T6F>']/TZ"]C%QIU
MT+JUNUM@K;QNSY@#?."'9>W!]>:[2H_M$!N3;>='YX3S#%N&[;G&['7&>,T
M9=IHT]F^H7B743:G?,ADG: [%"#:JA-V< 9/WNK$^U,3P^UMIM_%9WTD>HWV
M6GU"1 \A;&T$ 8 VCA0.!CH><[=% &'=>'$NO!C^'&DA$3VGV0MY)VA,;>%W
M=<=.>O/M5W1K&?3=(M;&YO#>26\:Q^>R;6< 8!;D\^IJ2UU2POKFYMK2\@GF
MM6"SI&X8Q$YP&QT/!XH?5+"+4HM->\@6^E4O';EQYC*.IV]<>] &1=>'+S4+
M:]TV^U7SM)NW<O#Y&)=C-DQ^9NQMY(^[G'&>]0"V3P]XQN]18"/3=2M(TDDZ
M+!+ &QN]%9&X/3*8[BNIIKHLB[74,OH1D4 >;Z3I%W>_#GPOX;DMY$-P8;F[
M+*1Y4"2"4@^C,0B@=>2>QKH[33?[/\7ZNDT'FV&M+'.I*;D$R($=&^JJC#/7
M#>E=/51=4L'U1M+6\@:_6/SFM@X+JF0-Q'4#D?G0!@Q^#K>W\7+X@C-E&([?
M[.+=+(*JKOW[L[OO]MWIVK*E\,W6NZ%XDO@GDWVK7,=U9I*-I18-GD;AU&XQ
M[CW ?'45WU% '/W&E6OBZRBDU*-VL)8&4Z?+'M*R,-K%_5EY [ Y/)P14_X1
M&]:#08YM;:=M&G\Z*6:WR\OR,@#D,,_*QY&"3@^N>GGN(;6!Y[B:.&%!EY)&
M"JH]23TJ0'(R* .;BTZ7P[>:_KCSM>-?LDOV:* AMZHL:*OS'J !SW.>!3/#
MOAR^TC1-$M3J30O:M)->Q1HK+</)N9ER1D .Y((]*Z>JCZI8)J<>FM>0"^D0
MR);[QYA4=3MZX]Z +$PE:%Q"Z)(1\K.NX ^XR,_G6-X2\/OX6T"'2/MGVJ*
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MN?EV-$2K,6&W.?D!^7% &-HOB;6-9TG2B!91:K+=RV]] 87*P"(D2?QYX(4
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M]CJY4MN 3.257H1TJII7@Z'1[>2PM-4OETAR^W3V\LQQA\Y56V;PN22!NXH
MSK+Q;?OXGT>R>6QN[+5%F"O:P2*(71-_RRDE9EX(R /7VKF[U1_PKOQ2,?\
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M?Y@D\T9/EX(WDG&*MW_@W3=4OM2N;V2XF34;)+*Y@)4(R*6*D87(8%R<@^E
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M9+P;Y$,LL/DR JY&UTP,,,8/ Y&:Y=_$>L7W@+4_%MG?>1):/<RQV+1(8C'
M[+L<D;]S!"<AA@L/3D ]!JAK.LV6@:5-J6HR/':0C=(Z1-)M'J0H)Q[]*Y*;
M4O$.K^+(].T[54TZVN-'CU!0]JLCQN9,;>?;J3[\="-+XE_\DT\1?]>4G\J
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MY(-5A>.Y,>K$F]7[5)^]RH4_Q<?* .,<58_X1S3OM&EW!28S:6CI:N9WRJL
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUEJ.BZ!JMRT*ZE>78CN0RF;[.B;HXRP&T.<X)&3A.N3FHO$.C75OX@\)6O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX$AUF\U"VGU+2KEK^&&Y>'S2J1;254C:WS$DC!Y(Z<4 >HS.\<+O'&97 )5
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M. 2,CFEFTRPN+I+J>RMI;A,;)7B5G7'3!(R*M44 59]-L;F[ANY[*VEN8/\
M5321*SQ_[K$9'X5$VAZ0UJMJVEV1MT?S%B-NFP/_ '@,8S[U?HH H2:)I,S,
MTNEV3EW,C%K=#EO[QXZ^]6#8VANDNC:P?:$38DOEC>J^@/4#D\>]3T4 4;31
M=*L)99;/3+.WDFR)7A@5"^?4@<_C3K'2--TLR'3].M+0R'+FWA6/=]< 9JY1
M0 R6&*= DT22*&5P'4$!@00>>X(!'N*/)B\\3^4GG!=GF;1NVYSC/IGM3Z*
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M_5+#5H9)M/NXKF*.1HF>)MP#CJ,^V:MT %%%% !1110 4444 %%%% !1110
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MM9W?F6DRQ+8R$+"V\KMP&5).O_+1J[Z_UFX;Q+#X?L#%%<O9M>23S(75$#A
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M;?VVMZ:(KBRO+"\U(V#I!;2_N\[\,)\[&8%<,N/4=LU:\(@#Q)XSQ_T%4_\
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MKQ$VF>%-9O/[-:SUJ2"&6UBA=7B,J$AU<N0>1]TKT.,GK7H%<X/!EDN@Z1I
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MGB0W$-_)##>1PZ?%:X,DD<S*CD@Y/"D;1UX[T >C45PUKK6JR:Q]ILM5&HZ
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M.44_O8NI ./R-/2P/AD74TNIB+4M>U$R/]FM_,8GRSB.%3D9 0$LPQ]XD#C
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M8G)S\H.!R"-'Q#-XBGT2PBOS]F=/$MI';331*7GA\U#&[*C  AB01QG;T&:
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M!- &]<>+]$M-,NM1GN9DMK5Q'.QM9<QL0" 5VY'4<XQR*W*X#QK]K/PPU_\
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M?:O1!G R<F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2;>'R9?-B* @QM@@%3G(X)X'')]:?)X1\/S374LFDVQ>ZD$LQV_><$-N]CD
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MN^X0HDSC[0G=5 'X =*R;3Q-K$::1H\MQ-="77+[3I+DNL<LD<&_RU+\ ,V
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MKR@#Y]L5PH/''( KU&L=?"NB+%;1+I\:QVLAEMU5F B<YRRC/!Y/3U/K6Q0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!A>(_$G_"//IJM8377]H7:6<?
ME.HQ(P)&<D<?*>:;<^(;VTL]4GGT2>,V-L+G!F0K*OS9"D9Y 0]?4>M8OQ*7
M?_PB<?VAK<MX@M\2IMRGR2<C<"/S!JSJ+)9:!XDM)M8DU">XL[BZ0R[-T<:P
MJA!V*J@;N1QSD]<&@#I=*OAJFCV6H",QBZMXY]A.=NY0V,]\9JW7EUGJ-R^I
M^$])F%L^FW'AU)88KF8Q1SSC8",A3N94P0I]2>H%3Q27.FZKX=T#6M5%QI=T
M+T"59FVR2!QY4#R9RVU"XP?O%>1Q0!W]QJ5G:7UG93S!+F]9UMX\$ERJEF^F
M .]%K>O<WEY UE<P+;.J++*H"394'*8/(&<'..17 ZSH^D6/BOPA;B]N([/S
M+[##4)$V$INVA@PQ@DCKG QT%5-6U.^TI?'C6=W=%;:^LE9C,\C6\#I$960D
MDK@,YXZ=>U 'JE%<1>6HM/'6@P:1)(ME?VMS_:$4,S;3$J QR\'AMY WCD[N
MO%<I81F+X<>&O$:ZA?/J0U"W0W#W<C;T>ZV,C G!!4GJ/?K0!ZSJ%_;:7IUS
M?WD@BMK:)I97(SM51DG\A4>F75W>6S37=D+0ESY:>:)"R8!#' X//(YQCJ:P
M?B8BO\-/$6]F %C(1M<KR!QTZCVZ&L\JD'B_0M$N))VT>XTZ::)9[AY1<7(9
M/E9G)+80L0I..^.!@ [NBO(]:>^MO"GB^&*_O([&QU:WCTZX6X<,@9HO,C!S
M\RJSLN#D#D=N/3=*TFVT:VEAMI+ATDE:9C/.TK;CC/S,2<<9Q[T 7Z*\GM=9
MAOM9\):SIL[PKJ-_)$ZO?/++-"8Y3^]3[JX*# YQT&*[3QA!J%U!IT.FS6OV
MC[5O-I=NR1WB!'S&64$CLW0CY>: .DK.U[5&T30;[5!;&X%G \[1!PI95!)P
M3["O/5U+8?#,[Q7.DB+Q!-97,#7S209\N4[0<A63?@#(X(QVJ2^O(YS\4(X;
MR2XMX],0J&G:1$)@E+!<D@#/8<?E0!Z/877VW3K:[V;//B63;G.W< <9_&K%
M>:6MC%!+X.O]#U"XEO)MGVTB[:5)+7R6+LZY*@!@H& ,$@"L];W7="L4+645
M]J,VF74MCJUC<L_VMEBWJTT+#.3\N.2 2 ,9H ];HKS?1_MMS8:-K^EWEF7%
MC(TD<=V\SZBQA)"N"!\X< YY(Y'%9[:A9ZAX8\&ZK%JDDFK7>HV274BW3*[E
MG'G1LH.-H.1MQ@>E 'K%%><?;8;6X^(5I<ZG/'Y+(\"O>.)$!ME8;#NW %\X
M ^GM5+3]5O+B\\':;=M#-8W?AV.9%O+AD2XN,)NR<'>P7D _WB>H% 'JE5M1
MU"UTG3KC4+Z80VMNADED()"J.IXYKSJ33;FVU;P?IUYK5Q<)->7L;?9[R3:T
M(CD98R<_,5X7=PW':L[Q! MMX5^)6CQSW)LK$1R6\;W#L8M\"LR@DYV[LG:3
MCDT >N%R8=\8W$KE1TSZ?2N0C\>L^C:GJPT*]:STR>:"Z*21EU,1Q(RKNY P
M3USQTKIM+CM(M/C6RG>>#DK(]RTY/_ V))_.N%\'Z3#KVB>([.>[N%LY==U!
M)X(64"9#*<JQP6 (X^4C@T =/IGBB/5/$+Z9#;$1?8(M0AN=_$L<A(7Y<9'W
M3UK?KA_/MM+^)6J/MV06GAR!]D:\JB2S' 'T'2L31[U+CQ9X7FL[AHH=6LIS
M<1+J+SR2+Y:LC2= KCGE>1R <4 >IU4U.[FL=.FN;>RFO98U+"WA*AWQV&X@
M9KR=(3%\+5\1+J%^VI6>I.(;AKR1MJ_;BFT@MA@5.#G.<_2O8Z ,"W\7:=>>
M$H?$-JLLT$RCRH% \UI2=HBQ_?W?+Z9]N:W4+-&I9=K$ E<YP?2N T2PM[?X
MK:Y8Q.19PQQZE%:Y&Q+F8,DC@>N%_P#'V]:I/+?^(-3\8:=<7-M:WMK<%+.:
M:[:)[.+RU,<J*!TW;F)R,\@\ 4 >G45Y1XSU1)],\1HMV5U/1K2-OM9O7B(G
M\KS 88EZ@\9)//(Y K3U+3TUWQ_8Z?=W]^EO=Z!+--%!>21AG$D0! !^7J3Q
MC..<C((!Z)17+>/K^YTOPRDUO))#";RWCNYXR0T5NTBB1@1R/ER,]LD]JIS6
MIL_B%IMII;R+I][I]PVH012L$0*4\N08/RL2S#(P3@^E ':US]_XFDL_%%OH
M,>ES3W%Q;O<12+*BH40@-G)R#EAVK#^&&GI+X9T_7);V]NKV:&6%WGNGD4KY
MS$?*3@$8Z]3DYS4FKCS?B[HT27#0NVCW0#IM++^\BZ;@1V/44 ;^@>(H->:_
MA%M/:W>GS_9[FWGQE&P"""I(((((.:V:\[\20_\ ",7VAP6S_P"B:KJ<C:G<
MW4VSSY#$?+61U7A20!@ #Y0,8)JGXFL;W2_".LR#5C"C:E:-:PV=TY^QAY(E
M=,\94Y9MI&!NZ4 =_J^K)I<=NJQB:[NY?(M8"^WS9-I;!;L %8D^@[G J[;O
M+);1//$(IF0%XPVX(V.1GO@]Z\^\1^';"RUGPA9I/?\ ES:M,Y+7\V_+6\A.
M'W;NH'.<\D=#BI[,0ZQ=>+[;6[B2&:PN#' 3,RM;6WE*4E0YR"3O)?J2,$\8
MH [ZBO*;=-0UN7P!#KEW?PW&H:=<_;8H[F2'SML:%20I&UOFR2,'DCVK170[
M2[\>:KHUQ>:A)90:-:LL1OI1M;=*I;AA@X5>G&><4 >BT5Y)H\DR^'/A_P"(
M&U"\DU&]O(;6YFDN7831LD@*LI.W^%>V<C/4DT_Q%K,-TTNJ:?.]O=66NQ6@
MD>^?S6(G2.11$/E$>">#U'.,F@#UBBO.H])M]7\4^-K2[N[]X;?[.T,8O90(
M6:$L2N&XYY Z#L*IZ%K<NJMX.L==NG-EJ&A>=N>0J+JZ&P%68$;B%W''<DGL
M* /4:1RP1BJ[F X&<9->;'_1O&Z>&U:&?2AIIELH;R\8+(YF?S,-AMS(-J@'
ME0.*[/PO:W5CX;L[:]U!=0GB5E-RK%MXW';R>20, D]2,T 8L?CUGT?5-5&A
M7K6FESS076R2,N#$<2,J[OF P3UR<=*ZJSNX;^QM[RV??!<1K+&V,95AD'\C
M7 >#])AUW1O$MG/>7"V<NO7\<\,+*!,ADY5C@L 1Q\I'!J!OM.J>(/%.A2-:
MVQLTBCT\2730FUA,0VRQ!5[-NRP(/ '04 >FU4M[UY]0O+5K*YB6VV;9Y% C
MFW#/R$')QT.0.:X*?2#JOCJTTG4=6O9DD\/"6X^S7<D:2RB5%\Q0&PN>N!P>
M^:AU?4=3TRX^(\FE3W,ES:VMK) C2-+Y)9&+% Q.,#+8'''2@#TZL;Q3KQ\-
M:!/JOV0W20E0\:R!#AF"YR0>Y%<[?(EGKGA&Z\.SNZWLS)<*LI=;FV\IF,CY
M)R00F'/.6QGG%<CK%_I^N?"2;5-2O"^O"4+/'Y[*\4HG ,7E@\*H[$8P-QYY
MH ]IHJL-0M#J1TX7$9O!")S"#\PC)P&([ D$?@?2N9O)C>?$I-'U'G3SI7GV
ML+'"32^81(2/XF5=F!VW$T =?534[Q]/TNZO$@,Y@B:3RPVW< ,GGZ5Y:[WW
M]GV<$NHWPM8O%XLK*9;IP9+7/W2<_. P903D_+P:VEA31_$?BS2K:><6)T6.
M[$,L[R!)"9E8KN)(R%7- ':Z+J0UG0=.U18C$+VVCN!&6R4#J&QGOC-7J\O;
M.F^!? OB=991;Z;;68O8UD8(UN\:H690<'8S*_M@UVWARTVV]SJ3&7?J,QN
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M** *]U86=\%%W:07 7E1-&'Q],U"FB:5&DB)IEDJ2 !U6W4!@#D \<\U>HH
MI2Z/ID]FMG-IUI):J<K \"E ?4*1BGS:;87-D+*>RMI;0  0/$K(,=/E(Q5J
MB@"H=+T\V\%N;"U,,#!H8_)7;&1T*C& ?I3HM.L8)9)8;*WCDE!$CI$H+@]<
MD#FK-% %.WTG3;2"2&VT^UABE&)$CA55<>X YI1I6G+:M:K86HMV;<8A"NPG
MUQC&>!5NB@"&>SM;F 03VT,L(QB.1 RC'3@\5%+I>GS6:V<MA:R6R'<L+0J4
M4]<A<8JW10!5DTVPFMH[:2RMGMX_N1-$I5?H,8%6(XXX8UCB14C4855& !Z
M4ZB@"DND:8@(73K1=TOG'$"C,G][I][WZU+=V%GJ$:QWMI!<HK;E6:,. ?4
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MT;2YK,6<NFV;VH;<(&@4IGUVXQFKM% %*?1],NK6*UN-.M)K>+_5Q20*R)]
M1@5:$,0A\D1H(MNW9M&W'3&/2GT4 5K73K&Q+&TL[>W+_>,,2IGZX%-N]*TZ
M_ECEO+"UN9(N8WFA5RGT)'%6Z* *QTZQ:[%VUG;FY&/WQB7?_P!]8S1%I]E!
M<O<PV=O'/)G?*D0#-GDY(&35FB@"K::986#.UG8VULS_ 'S#$J%N_.!S37TG
M37FFF?3[1I9QMF<PJ3(/1CCGH.M7** ,^PT>TTZ\N[N!/WUUL#$@ *B#"(H
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M/4;0,5,B+&BHBA44 *JC  ]!3J* "BBB@ HHHH **** "BBB@ HHHH ****
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MTJTUBUTB>_A34;K)AMB?G< $DX], T :-%%,FFBMX))II%CBC4L[L<!0.I-
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MFCA@C&7DD8*JCU)/2J%KXFT&^N(;>TUFPGFG!,21W"DR <_*,\_A0!JT444
M%%%% !15"_UK3=,E2*]O88974NL;-\Q4=6QUQ[]*M6MU;WMM'<VL\<\$J[HY
M8F#*P]01P: ):*IWNK6&G36L-Y=1PRW<HA@1CS(YZ 5<H **** "BBB@ HHH
MH **ISZM86VIVVFS74:7MT&,$)/S.%!)('L :N4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!6OK2"
M]M3%<0).@99!&Y^5F4[ES^(!_"N2\.N+3XBZ];7=@EGJ-[:070%O)OA>%"R
MYPIW[F.<CIMQG&3U&J::-3MDC^TW%K+%(LL4]N5#HP]-P(.02""#D$U4_P"$
M<@:*^,EW>/>WL'V>2^#A)U09P$*@!,%B1@=3DYH S]?T75KO5I+W3K;19O\
M14C7^THVD^96<D #H#N'.3TZ&KWA#5TUWPII^HI9BR\U"&MUQB-E8JP&.V5.
M/:G'P^RRAH-8U*!#$D<J*Z-YI48WEF0L&(P"5(S@=^:TK.SM]/LX;.TB6*WA
M0)'&O15'04 3T444 %%%% 'FGQQM9/\ A!8=7@7,^D7\%VI[CYMO\V!_"N:\
M2:O=6WB/0OBC'-(='-X=/,>.!9L-OF8]W\QO?]W7L&N:-:>(=#O-(O@_V:[C
M,<FPX8 ]P?4=:J:IX3TK5O"+>&)XF733 D"K&0&14QMP<=1M% '!>([^XTGX
M-WOB&*UT^Y:^N?[0E@O[;SD=9IAY?&0 50Q]<_=Z59UT:G)\;_#BVLUL@73)
M742HS#&</P&')' /\Z['Q#X2T_Q)X;&@74MQ#I^$5H[=E4LJ$%1DJ< $ \8Z
M5%>^#+*_UO2=8EOM06_TV,Q++'*J&9#U60!<$?3% 'F"ZIX@T*Z^).L:)+81
MK8ZD)I4N8F<R@+RHP1MXYSSGVZUM>*;N]U3QO\,KVR$$-Y=V]W*GG LD9:!"
M<@$%L9/&1G'4=:ZD?#K2_LNO6\E]J,L>N'=>[GC&YO[RX08../3VJ5O EDU]
MH5XVI:B9M$C,=F=T6%4C:=WR<Y4 ?AZ\T <=_P +-UO2_ WB6]U&"SN-5TC5
M&TR-XU9(I6R '89R,9)QGG@<=:Z&U\0ZUI7Q'LO"^J7$%_!?V#7,5Q'!Y31R
M*3N7 )!7 X[\U<?X<Z'-8:]8SM=36NMW+75S$[KA92V[<A"Y!! QR1Q5JQ\&
MV]IJ1U2;4K^\U-;3['#=W!C+P1YS\H"!<YY)()/TH \[\$^)V\*?!K2YX(4E
MNKW57L;<2'"+))*^&;'.  3@=<8XZUJ:7;ZK!\>KN._O[:ZN3X;S%,EL8U \
M\8#)N.<'/0C(Q70+\,-"'@Z3PN\M])IYF\^(O(OF029)W(P4<Y)ZYZU8TWP#
M9:7K::U%JNKRZD+,V;W%Q<+*TB9SD[E/(.#Q@<#CKD XNT\9:OIWPCUSQ!8V
MVD6MW8ZC+&8H;,I$X\Q4)"AQAB6W9)/I6_I/B;Q)#\1+/0=8;3Y[74---[$;
M:)D:%@<%223N'O@9ST'2KH^&>DCPO?>'?[0U,Z=?3_:)T,D>XMG<<-LR 2 ?
MPXQSG0;PA:IKFGZXMU>R:AI]H;2++H%E3DX8;>I]1B@#A+;XA>)M2&ER6,E@
M-1O-6>QGT:2W+/9Q L/,?#!OE !). =W:O7DW;%WD%L<D# S7AD&D:N/#4LN
ME:QXLM/%$\[2?V7L<01RM)DAF9,% "3O+X/7OBO<(!(MO&LS!Y0H#L!@%L<F
M@#B?B!XGU'0[>Y_LG4["&[M;-KS[(]I)<2RJN<[@I'EIQ]\\9/;'-#4O&GB%
MV\"G31IT2^(X0\J3PNQB;R@Y((;E?FZ8!XZ\\;NM?#[2==UJ[U2>YU"&6\LC
M8W$=O<;$EC.>HQG(SZXXY!YH/@"P)\/G^T=1_P")"@2Q^:/Y1C;\WR?-\H"\
M]AZY) .;LOB-JFD^&_&%WK\-M=W/AZ[%NK6JF)9]Q 3().WDC/L?;FK>)K!^
M,'@&?5KVTN?.M[R2-;>W,?E$P99<EFW#D8/!ZUV!^'^C.GB"*9KF:WUUS)>0
MNZ[=_9EP,@CMSVJKIWPTTS3;_2+]=5UBXN])#K;2W-R),(PVE""N-NWC@ \]
M<XP =I7ENBN-2_: \1#4\/-IUE$--CDY$:,%+L@]23U]R*]2KF]?\$Z9K^J6
MNK&6[L-6M1MBOK&41RA?[IR"&')X(/4^M $OB=6TO2M4\16"6ZZI::?*4DFC
M+JR*-^T@$'G;USQGOTKAD\>^)M/\*:/K.J#3W.O2V=O9+;PR.8#(&,CNHY<X
M"X53UX]SV[^%6N=+O;&^U[5KQ;R$V\DDCQ*1&W# *L84$CC.,^A%5+KX?:1>
M^#[;PS<S7DEI:,C6DWF*LUN4X4JRJ.0,\D'K0!STWQ!UO0/#WB&_U?3))DL9
MXH].N)+5[078DX&Y7Y&T]3WJNUOJ\'QST$:I?VMW(VE7!C:&V,03GD$;FR,]
M#FNPN/!5IJ/AJ\T/6=1U'58+H*'DNY%WKMY4KM50"",YQSWS533?AWI^FZMI
M^JKJNL7%_8PM D]S<B4M&?X2"N,?3'Y\T </?:M?7WPT^(P,&G6TUGJ5Q;.]
MG;F$2A=H9R,DEV]236I<ZAJFE6'P[ANHM'NDNKJW@!-FQ>%=@PR,SG:VW@G'
MTQ73V_P]TJ#2]=TY[J^GMM;DDFO!*Z9,C_>=2JC!Z<=..E-E^'MC/::+;R:K
MJS_V-(LMK(TJ,P=>C,2AS@8&.F!TH YW4_%?C$Z_XST[3[C28X]!MH[J-Y+5
MR75HS)L(W]<#&[IQTYXGF\?ZC+HW@JX;[-IL6O*3>7\BYBMB$W!1DX!=N!N)
MQ[UT0\#6']IZYJ#7M^\VMV_V>\#.FTIMV+M 3@JIP/US7*^(_#$>FGPMHBW>
MN6VB6 E9=0M,O)$X4*D;;$( (+?,5/IWH Z'X>ZYKOB#3;V[U?[*UO'=R6]I
M-#"R?:8T.!-RQ&UNV!V-;7BG6QX;\+:GK/E><;.W:58\XW,!P"?3.*YSP'::
MS;ZOK;7&IZK?:&3$MA)JJXF9@#YA *J=N2 ,@9QQZGL=0L+;5=.N=/O8A+:W
M,;12QG^)2,$4 >>6_C#Q#I^H>"WU*>TN[7Q+'^\CB@\LVTC(K+L.3N7YL'/I
MFF_#=M7G\8>,Y+BXM'A75F28>6Y<D)A0C%L!0,#!!KH]+\ Z?IUSI4TM]?WZ
MZ1&T>G1W3(5MPP XVJI8@  %B<"K?A_PE:^';_4;RVO;V9]1E,]RLY0JTA_B
M&U!@]L#CVH Z"O,?AN!_PL3XC\?\O\/\I*].KDK7P#:V&JZIJ-CK.KVL^J2^
M;=>5)%AR,XQF,XQD]* ."M]2C\&_$SXA7^GV^[2K33H[J>VB.U/M)"E1Z G+
MY^IKJ/#7BGQ-JFM64<EJ;C3K[3_M!N3ITUM':SXR$W/_ *Q".XKIK3PAHEGH
ME[I*6>^VO]_VPRNSR7!889G<G<2?7/';%5O#W@Y?#EL+6VUW6)K6.(Q6\-Q+
M&ZP ]-OR#..V[('I0!YMX2\4ZIX5^%VN>([HVMXD=_/LCV.)'G>95W,^X_+S
MG&,\=:ZNT\3>*C=:S$T EM(---Y:ZA/I<UM&)5^]$4=@6&.00>/>M:S^'6BV
MGA?4/#DDEW=:9?,7DBG=25<G<64JH(.0#SG! J>P\'?8M'GTM_$&LW4$L'V=
M3<2QLT4?0A?DY..,MDXZ8H X67QMXW@^%DWC6271@AMXGA@$#L<M+L8GYAC[
MP(Z],<]:Z6\U;Q+9:;'%?ZQH]GJ5[,[VB16LMRYC"*0BQ+AF(.[<W( QQSQ=
ME^'FF3^"%\(R7VH'201\N^/?M#!@F[9T##/K[XXJQJ/@BQU/4-'OY[_4EO-+
M5XXYX9A&TB,,%7VJ.,?W<&@#SGQ#XCNO%WP6T#6;^**.YGU6!9%B!"Y69DR
M>F=N:]LKB?\ A6&D#PM:>'!?ZD--M+@W,2"2/<'W;A\VS) 8D_B>V,=I&I2)
M$:1I&50"[8RWN< #/T H P_&.K/I'AN>2!G6[N"MM;F.-G82.<!@J@D[1E\
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M)  VY."<]!BNE\.ZCJ=[/J4%_;N(K>91:W36[0?:(V4'[C<@J<J3T. :J3>
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M.2P4]OE; S5K4M6\6Z=:1&64VX?7+:UMI;F*)GGMY60'>J' ()8<;21CIUH
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M;0_$.@VW]HR7MKJLLEI*)8HPT4@C9UD3:HX^4Y!SQC\0#KZ*\O77_$R>!_\
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M6:1PT>?0A,9Y]J-&O=>O=?UIKK7(H]-TC46B>,VR RQ>0CX9OX0"^<CG@YH
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MVTX3?CY?3OCL0#NM:UNQ\/Z8^HZC))';(0&=(FDQDX&0H.!GC)XJ^S!$9CG
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M2>2VNI(O/"C"[PI&2!P#U]ZY^\T==0^*BR21:K#;0Z0L*7-NTT2%Q*S%#(N
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M6V,=R+?5'9[N%;N4(Y?[Y"AL+N[XQFI[[PQINH6%E:7 N=MC();:5+F198V
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MT$Q3*L02".A^Z.<9':KYZ5E:'KL&O0WDD-O<0&TNY+25)PH8.F-V-I(QSZT
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MD]I?+<:3&LUW:&-1*L9SAQEMK+P>58T ;D6CV$.LW.KQVZB^N84AEE_O(A)
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M>@T[7-*TJ6WN&DU)W2&5 IC#(C.0W.1PI[&M6@ HHHH **** "BBB@ HHHH
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MN.7]*F^&R)'8:_''<O<JFN72B:1@S/@KR2.I]ZZ"^\-:)J4=K'>:7:S+:?\
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MPZ=#&]DNRV*@_N5[A?0<#@>E &7X(N+MO[?T^ZO9[Q=.U5[:"6X;=)Y?EQN
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M'FOV\NOZ@EIIL]I+% CJ%.Y"S*W'*GT&/?.!C/AURYFUKPMJFGWU\UCJUY)
MPNIQMN(_+D8,L(R$ *+@C!YY'-=Y;:-IUGJ$]_;VD<=U<8\Z5<[I,=-WKCMZ
M53M_"/AZT*&WTBTB,<WGQE(\;'YY7T^\W3U/K0!P$5[?>'?#OC35[74+AI4U
MN2$[UC*1[FA1I2 H^95)/IQR*Z>_-YI'C/P_9V-Y=R6>J)<1744LS2[=D>Y9
M5+9VD'@XX.X<9KH$T#2([J]N5TVV$U\I6Z;RP?.!&"&]<X&?7'-.LM#TW3P1
M:VH3]WY0)9F*I_<4DDJOL,"@#E_A_#J%_8C6+[6[^[*S7EL+>1E\LJMPRJQ
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M.U\NPE5)+.<R F=&&=VW'R]B >Q'3I6I7E.A.=/\-?#JT\^Y73-31!>.]P[
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M5O$6A:)J[7MM;:A'>@WT[7CF1R'(DMVBV@#(X"YXP"* /4**X'PH+;Q1IO\
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MX6(#>6^ X")ELY( 6J%[K,=Y?Z-K&FW$L+2Z^MINDOW:66/SFC=##]U4]!U
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M\Q_=!R!C)'.*35M.LK2W^)FC6-M'#!_9T=Q!90+M4.87W,B#W"YP.N*];HH
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M-O=6=E=+B!EC=58!O)(=E'9@QY8<@GK73_#V[:\^'N@2R3&646,2R,6RVX*
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MU*SMS& 7\Z=4V@\#.3Q3EU73GNX[1;^U:YE3S(X1,I=TZ[@N<D>]<>\%C/\
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MG?1[PW4=QJZO<Z/>V1+*1(JM,DHP54!0X)R. !SQ0!WS:E8)>K9->VPNV^[
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M9*LJE"BGHY#8)7W'!]:;I.L1'PS9:A>ZG:7/FH/])MT*QS,?[BY).>P&2>U
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M(UWF(9!*YP67/WAGC(R*6/Q#I4MW%;)>(7F+")BI"2E?O!'(VL1@Y )Q@^E
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M0:7%=K;/>*':;[.&VG9YO_//?C:'_P!G.?:M*@ HHHH **** "BBB@ HHHH
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M[IMT;25H[R"9 I24+;QIL'.=Y92 ,=Q7<4R2*.90LL:.H8, R@@$'(/U! -
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M1R#],5F^$]&<:5H6FZUI>KK>:,4*[G!MTDC0H)%8$;E()P.3\W(KT6B@#DO
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MWEM)/-:36D!N94O;=[<^2.L@W@97W[5;M-?L;O45T\>=#=20F>*.>%HS+&"
M67(YP2,CJ,C(KD_%'A&_\;6MW<R0MI=P=-DL[:&9U9M[NCDN4+ +^[4#!/#,
M?:M32;*X:1-0N?#=U!JEK;R+&UWJ/GJ78#*1MO<A6(&20O0<4 =3*ADB= [1
ME@1O3&5]QFN%\%QZSXB\%6FI7/B748[V9IAYB1P;1ME=1\ICP>%&:[2RFNI=
M-@FO+46]VT0:6W20/L?'*AN <'C-<=X-A\0>'O!]KI$OA^5[V)I3O:ZA$/SR
M,XRP8MC##.%- %GPQXQ:ZTZY@UHQC5++49-,<0(?])D0;@R+R>5^8CM@] *7
MQ%XVMK/PU=7EBT@N8KR*QEC:%O,@=W13E<'D*^X=0>,9S6-=^!-0L%TG4K;.
MH:A!J-Q?:A%#.;8W#3KM?RVR,;1M"@D9 Y/-7-;T"YN_#LRZ7H-Q!>76H6MS
M,MQ=(\CB*2-MSL9",[4V@!CT'2@#=M=9T_3;%+6.?4;V2.$W#"2)Y)UC+-AG
M! 8=" ",D+P#BF7?CKP_9I9LUW+(+VW-S:^1;22>>@ )V;5.3@C@<C/(K'NM
M$U&V\;7NM+IU]>V6IVL"/%:WP@EMI(PPPP\Q592&ZAC@@X'-3G0KBS\3>%I=
M/T8PZ;IMK<1.L<J$1&4)@#+ G&TY/OQF@#0F\=Z##=K:--<FY*12>4MG*3LD
M.%;[OW<]6Z#N:M7'BK2K34(;2=YT,UP+5)C;OY)F)P$\S&W.>.O7CK5&UL+]
M/B/?ZH]BXL9]/AM4GWI]Y'D8DC=G!W@#CK7.ZCHGBC4D(O;"6XN+?6XKM)?M
MJB)[9)PZB./< &"#!W '/<YH Z'0+F[?QOXJLY[N::WMS:F".0@B+?&S,!@=
M,ULZU?OINE33Q*'N#B.W0]'E<A4!]BQ&?09-9&B6.H6_C7Q'?W%D\5I?"W^S
MR%T.[RT*MD!B1DGCCIZ5)JVGW.L>([&"XL[I=)M5>;SXK@1EIR,*?E<. %+C
MW+#L,T 1^!]9N]2T&6#57WZMID[V5\57&]T/#@#LRE6X]::?B%X<5/-:YN4M
MUN3:RW#V<JQ0RAMNV1BH"'=QSC]:IV6AWV@_$&XO=,L;J72=0M52]>6Z$C>>
MA^20;W+'Y25/T&,UDW'A[79O VN:6NDO]KO-8>\A4S18\MKD2@D[N"%&,>N/
MK0!V>G^)]+U&^NK*.2:&YM8Q-)'=6[P'RSD!QO RN0>1Z4R+Q7I4DUBADFCC
MOSMLYY(66.<XR K$8R0"1G&X=,UBZWX=O]9\2W<HA>&SO_#\NG-/O3=#([$\
MC.3@'MGG\ZB;1=6UG0_#VD7^GFSDTRZMIKBX\U&C;R.?W6#N^8@=0, GN,$
MWAXNT;^R=1U/SYQ::;*\5TQM9=T;*H9LKMW8 (YQBDNO%^D6EY!9R/<M=7%N
M;F&&.TE=I4&,[<+\Q^89 Y'?&*Y:]T7Q"FE^-=&MM)$RZQ)<36MV;A%CQ)"J
M;6!.X,"#VQ[BM2VTW5?^$MT"_?394MK32Y;2=S)'\LCF(C@-DC]V>GJ* ':Q
MX]L[?PLFLZ8&GW7L5F8Y8) T;F54=63&X,H)X/4X]16M/XJTV!9&Q=R"&$3S
MA+5RT,9S@NI&1]UN,9P,XQ7)W?AO6SHFNP16 >=_$*:G;IYR 3Q++&^ <_*V
M$/WL=15CQ!H%_JUW=7]IIVI:;K+P*EM?6=^D:9VY59UWX8*Q.?E;CIF@#M;^
M_MM,LI+R[D\N"/&YL$\D@  #DDD@ #J37(^-M?D3PK>7-E<7FG7-E<VOF[T\
ML['F13R1@J5+<@]O:MW7[!K_ ,,R6-S8_P!J>8(TF@5A&9!N7<5)90K 98<C
MD#FN-O\ POKY\/ZK86@U&ZM;B>S>SM=0NTEDA\N4/(2Y8_*0H &XG([9H [3
M3_$^F:CJD^FQ-<17D47G>5<VTD)>/.-Z[P-RYXR*9:^)]+U'4$TV*2YBN)X6
MFMS+;O$)D&,M&67#8R/S!Z5F:MIVLR^+[?5].M@N-'N;57D=/W4[LC)N&>0"
MG.,UE:9H^OG7/#6JWVF77F6=O/'>M-?+*[2NB#<HW;0I(.-N/H.* *1U75A\
M-_MW]JW?VN'7#;F7<-SQ_;O*VGCILXXQ75?$*YN[+P#K5Y8W<MK<VUJ\L<L1
M (('N*YMO#^O'P#+I/\ 93_;&UC[8%\Z+'E_;//Z[NNWC'K[<UU?C'3;O7/!
M&K:;9Q#[7>6K11I(P&&88Y/3B@!++Q?I%QJ,&F&:>.YEB,D+3V\D:7 498QN
MP"O@<\'ISTJQ;^*-+N;JRA260"^!-G*T3".XP-QV-C!X!(]0,C(K"U'0;[QA
M#8C4+*32!9Q3@!Y$D=I)(6B!4HQ&P!R>2"2!P*B\*:#<6]II%EK&A7 NM+55
M6[?4/.M]R(4$D:ER02.Q08R: .NO]4M=-$0G=C),2L4,:%Y)"!DA5')P.3V'
M>L>7QSHEO';-<O>0-<R20QQR64H8R("63&W[WRG ZGC&<U#XET[55\2Z'K^F
M6WVT6*SP7%H)%1WCE"_,A8A=P*#@D9!ZU%K5MJFI:OX9OXM&G2.QO)+BXC>6
M'<JF)XQT?!.6!X)X[YXH TE\6Z6]HMS$;F4?9ENI$CMV9XHFR0SKC*YP>.IP
M<#BIY?$.F_9X'@G>Z-S +B%+2,RNT1Z.  <#GJ?I7-76@7]GXWU;4_[/O-1T
M_58H<BSOO(>!XU*$,ID0,I&#G)(.>.:?;Z-J?AOQ.E]I.C)<:9<Z=!9M;17"
MJUFT3,5P7P&3#G..<C.#0!GZ1XDE/@'4=0N]<O;8+JT\,-])9M-)'&L^U%9"
MORY4!?F P3ZUT<_BI;?Q['X>:%S$UCYYD2"1SYAD"J,@$!<9))X]Q7,S^'?$
M#^ ==TAM-#7]YJLMS'LFC\MD>X\W()8$# [C.2..N-^\T[4Y/'4&IQV+M97.
ME&RE<2HKVS&3=DC//!_ASR/3F@#33Q3I4DUHBS/Y5Y*8+:Y\L^5+(,_*K],G
M:<'H<<$USGQ$\4I:>#-5ETN[O8[B!65;NTA9HTD!P59PI YR#Z'@D&H?"7AB
MYT[3=,T?6-$N)WTR13%>_;]]LVP_)(L9?*MCMLP#WJC-X>\4Q_#S5?!T>EQ3
M/B9;:_-R@2=&D+C*D[@_S8.1CC.>Q /2IIUMK-YY,[8T+'"ECP/0<FN:\-^-
M;;5O"FG:K>JT%Q=A (4@D&^1@2%CR/GX!.1D8!)P*Z5=\UG\T;1.Z8*.02IQ
MT."1^1KSS2_#NOVF@>$)'T[;>^')/+DM?/0_:8S$8F9#G .&R Q'<'% '<:;
MK=EJES=6L#.EW:%1<6\J%'CW#*D@]01T(R#SSQ63/XH'_"=2>&BDBQFP6;SH
MX)&82.Y4#(!4* ,[CQGOQ3]-TBXD\9WWB.XA:U66RBLHK=V4N0K.Y=MI(ZL
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MQGJH_*NRKS;2/#VN6.E>!K632WWZ/.[W>V:+ !CD0;?FYY<'Z9KTF@ HHHH
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M(,JY8-]W&/?VX-3?\)5%'K-CI]SIM_:K?LZ6MS,J".1E4L5P&+*2H)&Y1G%
M&_17GT7BZXOO#_BV74+?5(K:QN+J-;BQ1(Y(H4 'REF^^.6_SBNB/B6WL[_0
M],>UOG;5(LV]PVPJ2J;B'.X'=MYX'/.,XH WZ*P3XKM5D>-[2[60WIL;="$)
MN90"S;,-T !R6QC!'48KF_&FN1ZEX2UB*'[98ZCIEW:I-%YI1EWRQD'*-AE9
M&/ZY (H ]"HK&7Q%"WBB;0#97:W4=K]K61@@CDCSMRIW9)SQR!CCUJUH^J+K
M.EQ7\=M/;Q3<QK/MW,O9OE8C!ZCGI0!?HKS_ $GQ);2:CK^M:O;WD8TV\EM8
M)CD1K&/+41A W+LS9Y7/(YX '2IXFA&I7&G7-E=V]Y%:&]6(JKF6('!V;"<L
M#@8Z\C&: -NBN<'C*S@N=1M]2LKS3I;"S-^ZW 1M\ R"ZF-F!P001UZ5'J>O
M[_#VIS3Z?JMK;I8M<?:+9XB_EE3EHV#D!U'/Y8S0!T]%>>SZB]KXV\.7-JFJ
M7J76B3.ML)=S2,##M+!F$:M@G+9 ]^13-?\ $,.OZ)8W-J+ZQNK/7[2TN;:5
MS&\;&9-RN%8JP*L".2"#0!Z+16!J'BRTL5U.2.UN;N'2AF^D@"XA^4.1RP+$
M*0Q SP?7BM*ZU%(]$EU*W!GC%N9X]@SO&W(Q]: +M%<+X2UVW3P[I6H7-K>M
MJ^MI$2K-DW4OE;V= 6VJ@&X_P@  8Z"HO&7B"+4O!?BRS07EAJFF6;2O$9-C
MKE24=61L,IP>_;! H [^BN,)>/XF:.!/-Y4NB7#O&96*;E>$ [2< X)Y J[)
MXWL(M/M]5>VNAH]Q*L2:AA?+&YMJN1NW!"< -CN#TYH Z:BN?/B^R2[URWGM
M;N Z-$LUP\@3#JREE*88DY ..!R,=:FA\2V]TVE_8[2ZNH]2M3=PR1;-HC 4
M_-E@1]]1T/)H VJ*XK3O%UAIGA>SOF36KNWN=1>S#W 229)#.R88!N5#9 VY
M. *T8O&=DL^IP:G9WFE2Z=:_;)5NPAW0<_.IC9@?ND8ZY[4 =)17.Q^+HSK=
MEI4NDZC%/>P^?;LRQE60$!B<.<;=RY'N.M,\::]=Z#9:;)91/))<ZE;6SA8]
MQV/( P&2 "1P/<T =(P+(5#%21C(ZBLW0]#MO#]G):6DD[Q/*\Q$K!B'=BS$
M' ZDDUR:ZI<V7Q'U)H+#5+PRZ/;3K8I("48RRAC\[A%X5> ><< UO6?C'3M1
ML=+N+..XEFU,2&WMBH63]WQ)NR<+M/!YZXQG- '0T5FZ+K=OK=O</#'+%+:W
M#VUQ#*!NCD7&0<$@\$$$$Y!%<W;>*;N[O_%MK<6E]]ET^3RHI+:-4>-?)5F.
M68?-EB1[8H [:BN2M_%MI8:/X95+75KX:M;H+21A&\LA\K>!(=P^<J.3TSU(
M&343_$.VCL+^[?0]8 TR0IJ,?EQ;K0 !MQ^?#C:=WR%N.>* .RHK'F\0P?;&
ML[&WGO[I+=;EXX-HVQMG9DL0,MM; ]N<58TO6;+6-#M]8M)";.>+S59A@@=\
MCL1@@_2@#0HKG[7Q4EY8)?PZ5?/92VANX9E\LB1!MX^_PQ#9 .. >XQ2#QA9
M'3M OQ:WAM];>)+=MJ?(9%W*'&[C@'IGI0!T-%8-UXG2-[K[%IM[J,=G+Y5U
M);>7B)@ 2/F92Q ()V@^G7BN6TCQ"WAUO%\LMCJNHVMGJ\CR21N)/L\(@B/6
M1P2!\QPN2/09&0#T>BHX+B*YMHKB%M\4J!T8#JI&0:Q+?Q5')K-MIEQI>H6<
MMY"\UHTZH!.$ + 88E6 8'# ?TH WZ*XU_B-8QVDE[)I&K)807C6-S<F*,K!
M*'\OD!RS#=QE0U:5IXMM9=2OK"^L[O3)[2V^V-]K";7@R1Y@*,PP"#D'!'I0
M!T%%<[_PF%JATN2YLKRVM-4D6*TNI0NQG890, Q92PZ9'L<'BF_\)G9C0]9U
M8V%\(M'FDANHML?F QJ&8CY\$ 'U[4 =)17.7/B^&#4[33H]+U&YNKRT:[MU
MB6/#J-N1DN I&\?>P/?IG)UGQTY\(_VGI=K<Q72ZE%8303P@O"_G*CJ0#MS@
M\$$C)% '<T5S\OBI!/<6]OI=]<7-K EQ<0)Y8DC5MV!@N-S84G S^?%:FK:B
MNDZ3=:@]O/<);1M*\< 4N5 R< D \=LT 7**PK?Q;ID]QHEN3)'-K,+3VJ/M
M/RA=WS$$@$KR.><'TIJ^*[4VR2O9WD;RWC65O"P3?<2J6#;,,1@;&Y)'"F@#
M?HKFKCQI:68U9+NQO8KK2[?[7/;80NT&"?,0[MK+\I'7((QCI5I_$UM'>Z);
M-:W6=8!-O( NU2(S(0WS9!VJ>@- &W17#^'-1@T=_&-Q?W<WV6VUC8IED>4J
M###A5SDG+-@ =S3+J_NI_BEX>CDLM1LD:UNRRS3*8IL!-I"H[ $9/4 \CK0!
MW=%4-4U>WTH6RRJ\D]U,(+>", O*^"<#) X )))  %86J>,UMM+\0I':SV^K
MZ59-<_9YD#;E*L4D&TD,F0<\@C!SB@#K**\WO-8NIM3\"ZE+!J(FF:5);=3C
M[0WV5F!"!MG+'@G&.Y %=';^-K![2^DN[6\LKJRN8[26SG53*99-OEJNUBK;
MMPP0<>N* .EHKF[KQE:V']J)=V%[%<:;:B]E@'ELSP?-\ZD-@@;6!&0<CITS
M6?Q[;Q:>NH2Z)K"6;RP1),\4:JWG$!&Y<?+D@$]OI0!UM%8S>)]/&J:EIH+M
M=Z?:I=3QC:/E;/ )(&0 "><#<.>:SQK<-WXD\/B2+6+.6]M9Y8;=S&(F "D^
M:H8G<H*X]-Q]\ '4T5@V/BJWOXH[N*TN/[-D,FV^)3RQLW9+ -N4':<$CZXS
M3;?Q;:33Z4K6MU#;ZMG[%<R!0DIV%P" =REE!(R!TYP>* .@HKC?'<S6EYX6
MND>ZS_;$<31P.W[Q3'(=I4'#<JO7I[5IZ;XJBOY-4MY=-O[2]TU5>>TE1&D9
M7!*%-C,K9VD<'J* -^BN>B\6(]WJ%C+I&HPW]E;BZ^RL(F>:(D@,A5RIY4C!
M(.:=9^++;4--T6_M;*\EBU<X@"^7N0;2V7^?@84YQG&,=>* -^BN<'C.P:.R
MNA!<'3;VZ%I!? +Y;2%BJ\;MVTL, X].QS5+XCR-;Z%8W2RW$9BU2SSY+N"R
MF= P*K][()XP: .PHKEO^$[T^UO+VUU>ROM)DM;4WG^EJA$L((!9#&S D$@;
M>O(XJQ/XPL=/NF@U:"XTW_1)+U'N-I5HX\;_ +K'YEW#(]^,\T =#17/GQ7%
M'>V]I/IM[#-=V[W%JK"/,P0 LHPW# ,#@XX[\$52LOB!97D6CW0TO4X=/U9T
MBMKR6- GF/G:K .6&<8SMQGO0!UM%9?B+7(?#>A76KW%M<3P6R;Y%@"E@OK\
MS ?K5!?%\*:Y9Z9>:7J-D+\E;.ZG1/*F8#=MX8LI(!(#!2<4 ='16!+XJBMM
M6LK*ZTV_MXKV=K>WNY%3RWD 8[<!MZY"G!*C.*J:7X@T^WA\0WEQ<:C''::A
MY4ZWI5_+<I'A(@A/RG<N!U)8T =517!W=_=3_%'PY&]EJ-BC6UV66:93%-A4
MVD*CL PR>H!^8=>VOXXUV[\/Z#'=6,;//)>6\ Q'NPKRJK=\9P2![D4 =+16
M*?$:273V=KI]W<7L4"SS6Z[%:%6)"ABS ;FVM@ GISBK.AZU9^(-*CU&Q9_*
M<LI61=KQNI*LK#L000: -&BL"\\51:?J%K;W6FW\5M=70LXKQE3RS*20H(W;
MP"00&VX/'8@UOT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% #9"XC8QJK. =H8X!/;)P<?E7+Z=X3@FL[R;Q!I&DWFJ7,TDDDA42
MA@?N+N9 0%7:O0\+GO7544 >=VW@OQ#'X.TS2VNK$7VB7Z76FR>:[HZ(6"Q2
MG:",(Y7(!Z XK6UO1]?UJ#3+]8]/LM5TN\%S!%]H>6*4;61T9O+4KD,<$*<8
MKKJ* .4U/1]:U.\T;6A#96^I:7/(RVPN6>*:*1-CJ7V JW<':1Q[\5M4\&W.
MMP^);BXDAM[W5]/6PB1&+I"BAB"QP"26<YXX &,UVE% '&C1_$MYKWA[5;V+
M2X?[-2>.:"&YD??O15W*QC'H?EQQZG/%5O!^L3^!_$VB2O8I<ZI<W,\#K*[(
MHE<MAOD!XSV!S7>44 <RND:O'XWBUM5LC;S:<EG<H9FWQLLC/N3Y,.#OQSMZ
M9]J?XGTG5-2N]*EL?LL]M;3.UU8W4K1QW"E2%R55L[3SM(P?P%='10!P-KX+
MO(=*N]-OM,T74;*XU2:\:!F9%".#MVC8=K*<=#TSS71>%-#D\/:0]F\K,C7$
MDL47G-*MNA/$:LW) ]_4UN44 <(G@=Y];M]2>QLM-NA,[WEU87#@WB%6!5D"
MJOS9!).2,<9SFDB\':I+X*A\&WKVK:?"T<7VQ)&\R2W1PRCR]N Y"A2=Q Z^
MU=Y10!R-KH&KZ1/K\&G_ &2>SU6XDNXWGD96MY)% <%0IW+D;AR#R1[U%H_A
M"[T/7]%DM6MWTS3=);3LO*PE<ED;?MVXZITSWKLZ* ,#POH][HQUA+HP,EWJ
M4]Y"T3DG9(V0&! P1[$US6M^"]=U:/78)#I<YN[I)[.[N9',D,8*'R0NPA -
MI^92<YY'.:]$HH X;6_!D^N:E+>/8V-IJ'FQM!JMK<ND\:#;D$!!O(PP&3C!
M'3I6]XKTW4M5T,VVE7$<5QYT4C+)(T:S(K@M&64$J& (R >M;=% 'G=QX!O[
MZ/Q)&W]FZ>FJV]KY L]Q%O-"Q89&T!EW$<\$XZ5I/I'B?4->\/:KJ":3$=,>
M;SH;>>1A('CV;U8H,'G[N/\ @1[=E10!PUQX6UN?3_&EN!IX;7BWD'[0^(\P
M+%\W[O\ V<\?3WJ\^@ZJVK^%[\"SSI=O/#<Q^<WS;U104.SG[A/('6NKHH \
M]D\(:^_AB]TS_B6B:XUK^TE?[0^T)]H$VW_5]>,?K6_<Z1J9\:0:[ MHT2Z8
M]F\3S,I#M(K@@A#D?+CMUZ5T=% ' 6/@N\3PCHNA:OI>D:I%91NDH>=UPV1L
M>-O+R#C<"..HY/2I8/".L:<GAJ2TN+>ZETJ>Y9X[NXDP(Y@P"K)M9FV @#(Y
M [5W5% '-Z1H^IV7BGQ!J,_V06VI-$T/ERLSIY<83Y@5 YQGKQ[US^F^#->A
ME\/7%Z-*DN]+NVEN;L32-->!HW3>6*9!^<'9R..",8KT2B@#AI/"^N#0_%VD
M1_V>T6KRW,EM,T[JR^<N"'78<;>>A.?:M#6O#M_J?A.QMH7MH-9T]X;BUE+,
MT2S1XZG .UEW*>.C&NIHH X[Q#X-DO\ 3M%^Q&UFN])N/M 2]7,5T64B0/@'
M!;<6W8.#VIFL^&=0U/PG=Z?9:7HVFW=U-"["&4[,1NKY9A$"Q^7 &.,]:[2B
M@#D/%ND7.HZAX?N+69;;4/.>VE*DG-O)&?. /'(VJRD]P/7%=;'&D,211HJ(
MBA551@ #H!52+2;"#59]3CMU%[.H628DDD  8&>GW5Z8S@9J[0!Y_/X'U/4O
M#?B/2KR2RA?4=1.H6TD;M*J-N1E5U*KD93GV-79_#VK77A_4(+73]%T/59K4
MPQ7=A(Q.203\PC5D4X[9(SGJ*[.B@#A(/"NKPZS<:G%8:';^=I+61M4=F3S-
MVX%F,?SJ>A) //0]X5\!SVUKK:Z3:VFEIJ&FR68L8[N1H/,?(\TC;A< X 5>
M<G.*]!HH XK^P/$%KJ7A[4K6+39I=.TY[&>"2Y= VXQ_,KB,]/+'!7N:;JG@
M_4)[)FM&M&OKK6(-4NVED9$'E,F$3"DGY8P,G'.3WP.WHH X5/!]U9>(=7NX
M]*T74[/5)1<,+UBLEO)M"LH/EMO0[<@?+CFNMOK:5]%GM+2.$2M 8HU)*(,C
M'8' 'TJ[10!PUOX2U:UTCPDZ/9G5/#J"$)YK>5<1F(1N-VW*D@ C@X(]Z-<\
M'ZEK-MXCN0;2+4-7L4T^.-I6\N&)=QW%@N68ESQCL!GO7<T4 <H^@ZK<>*M-
MU*>.R%K!ILME,BW#ER9"A)7Y ,#9ZCK6=%X-U.3P3%X-O'M6TZ)DB^V+(WF/
M;HX8#R]N ^%"D[B._M7>44 <S?\ AB6[\;V>M).BV@MO*O(#G,S1N'A/_ 6+
M$_0#G/">%?#,_AM+^-IHYHA*ZZ?&"0(;<L7"$XX.YV'&?E5?2NGHH \]C\(:
M^GABQTS_ (EIFM]9_M)G^T/M*?:#-M'[OKSC\,U:\56#V>H:KXAO4M)-+?0S
M8S0R%F8OO8CY0!N4E@/O ]:[BHKFV@O+:6VN84F@E4I)'(H974\$$'J* //M
M'&M>&+K05UC1K69[G9IHNXM3DN)HLJ6^X\8 7Y,G:QZ#).!73^+M'OM8TVT7
M3C;_ &JTO[>\1+ABJ2>6X8J6 )&?7!K0M=%L+.6.6*%C)$I6-I97D,8/4+N)
MVCZ8J_0!S5EI&K)XXN=;N4LEMI]/AM"D<S,ZLC.Y."@!!+XZ]L^U<S!\/]4M
MK;1)VBTJ\NM+FN\VUP[&&XAGD+]2A*.IQCY2.M>ET4 9^CV?V*S9#I]C8L[E
MVALN4SP,D[5R>.N!6"F@ZS;:AXI,(L)+75SYL+O,ZNC^2D15E"$8^7.03Z8[
MUUU% '#V_A?6X;3P5"1IY.@A1.?/?]YB!H?E_=_[6[GZ>].D\+:O/9>-;>0V
M2'7@_P!G*S.WEDP+$ _R#^[G(SUKMJ* .!'@W4+;7HM76PT?43/8PVMW;7;D
M"-XLA7C?RVX(.""H[<UV,%J]MI MK:"UMI%B(2*%<1(V.@&!QGV_"KM% '#:
M5X'^R:L+V"RM-&5[66*Z@L+AWBN'< !MA55 7D@@9.>V*JVWA;Q0-!\,:9.-
M)4:#=0/N2XD/VE(D9 ?]7\AP1Q\V?48Y]#HH Y/2M&UWP_J^JK9I8W>F:A>M
M>J9KAXI8'?&]<!&#KD9'(ZX]ZAMO#.K#2O&%I.;)6UN6>6W*2LP0O"L0#Y0?
MW <C/6NRHH R;*POH/"<.G&:."^CLQ;B6(EU1PFT,,@9YP>E<MI'A'6K74_#
MNH7,&DK-IL,L5T\4\CR7)=%7S#(R DD@G!Z9^\>W?T4 >?3>#]>E\'ZOH_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?HJI>ZE9Z=I[W]W,(K5%WO(RG"KZGC@5EV7C7PWJ,UO%9ZM!,UPVR'8&PY]
M<8[&@#?HH)P,FJFGZG8:M;&XTZ\@NX Y3S8) Z[AU&1Q0!;HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#F_&^H&UT#['%YYGU*5;-!;QM)(%;)D954$DK&'/'<"N'^%-\FA>*?
M$'@HI<0VJR&_TM;F)XG\ECAEPX!XX^N&->DW6A6UYK=GJTDUR+BT5EB592$
M;[V5Z'.!^54;[P9I6H>*K;Q),UTNIVR[(9(YRH5.<K@<$')SGU- 'E>HZI?Z
M-XR^*=[I^GI>NEO:B5&;&R,Q89\8^;;G)7(XSS7I7P_TC1M/\$:(FD3?;+6*
M!F@N7 W'S#N?C^'YB<CMC':K.G>"]*TS7;_683=/>7XVW1EF+K, , %3QP.E
M2^'_  EIOA?3;C3M)-S!:S,SB,S%A$3U*9^[0!Q?P9@BN/#WB-)HU=!XCN'
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (+R\@T^QN+VZD$
M=O;QM+*YZ*JC)/Y"H]+U.SUK2[;4K"836ES&)(I ",J?8\@^U<[XVG-R-/T%
M+&>^%[+YMW;P;-QMHR"WWF489C&AYZ,:Y7X07T^D76N^!KV*:";3)C<64=P5
MW_9Y#D [21P2"<$_?H [FZ\8Z1;ZG-IL3W-[?0 &:&QMI)S%GIO* A3[$YJ2
M'Q;HDVC76K/>?9[.T<QW#W4;0&)QC*LK@$'D<8YSQ7#? N9!X8U6TN3C68=3
MF.H*_P#K-YQ\S=^Q'U!IGQDCCL_^$7O)XP-'&N0S:G@?*WW0&?U&U2/RH [)
M/'.CL+=WCU*&WN'6.&XFTZ=(W9B OS%.,DC!. <U9O\ Q7I5AJ9TS?/=:@J"
M1[6SMWG=%/0L$!VCZXS6L\<%Y H=4FB8K(O<$@AE(_$ BO,_A1(1XG\>Q7G&
MIC5V:0-]XQ9;R_\ @/7'L10!V^E^+-'UF"\DL;B262S.VYMC ZSQ'T,1&_/7
MMSVIN@>+='\4:?/?Z/-/<6L)*M)]FD3)'4+N4;C[#/:N+M8F?]HZ^EL1^ZCT
M5!?E>F\L-H;WP$Q["G? AU_X5_-%D;XM1G5U[J<@\_G0!T]SX_\ #UGH+:Y<
M3W<6FK,T#3O8S !PVT@C9D?-\N<8R"*U+OQ!IMEH)UR2=I--$0F\^"-I1Y>,
M[L*"<8YS7%&VMM0^&UG!<1)-:7>N+N1AE9(WU'/X@J?UKCM8GO?A;IVN>$[\
MRW'AG5;.Y&D71RQMY61OW+?4G]<]S@ ]3O\ Q[H6F).]XVH11VZ*\\G]FW#+
M$& (WL$(4X(X//-6M(\6Z5KEQ%!8F\W30&YB:>QFA22,;?F5G4!A\Z]/6LCX
MI(B?"_Q&RHJL]KEB!@L<@<_ABM3P4B'P/X<D**772[=0V.0#&F1G\!^0H V+
MR\@T^QN+VZD$=O;QM+*YZ*JC)/Y"HM,U2SUC2K;4["836ES&)8G (RI]NH/M
M7/>-IS<C3]!2QGOUO9?-N[>#9N-M&06^\RC#,8T//(9JY;X/7TVD7>N>!KZ*
M:"73)S<6<5P5W_9I#D [21P2"<$_?H [G1/&&C>(=0O;#39;B2YLFV7*R6LL
M8B;.-I+*!G@\>U)J'C#1M+U^UT.ZEN%U&[Y@B6TE?S !DD,%(.!UYX[UR'PR
M_P"1W^(G_857_P!GIGB::*Y^-OP_GAD62*2VNW1U.0RF(D$'TH ])O+RVT^S
MEO+R>."VA4O)+(P55 [DFN=?XA>'X;>&[N)+VWL)B!'>SV,T<#9Z'>5P >Q.
M ?6N7^.DY;P+&D;;[>'4K<Z@B'.(3N/S#T+;/TKJ?'LE@_PSUZ29HFM&TV4H
M>-I)0[,?CMQ^% &MJVOZ5H>GK?:E>Q06[D+&W+&1CT" 9+$^@!JG;>+]-N+^
MULGAU&UFNR5M_M5A-$LA +$!F7 . 3@X/%>/:9]JTW6_A-+XA++8+92)&9ON
MI,P;R\YZ'!BQGT]J][D@BF>)Y(U9HGWQDC[K8*Y'X,1^- %'4M?TS2+[3K*^
MNEAN-1E,-JA!_>.!G'MVZ]R!WI=6UNST5;<W8N6-Q(8XDM[:2=V8*6/RHI/0
M$YQ7D_Q(M+WQ1#K&IV&F7\LVC2(-,O(3'Y<;0L6G;EPV=V5X4\Q+7IOA/7;;
MQ9X6TO7(T0M/$&(QGRY/NN!]#N'TH S[7XC^&[TS"VEU"003?9YF&F7.V&3(
M&UR8\*<D=<5>LO&&C:CXBN= MI;AM2MAF>%K251&,9!+%0H!&,'/.1BN.^$J
M)+<^.4D574^(KC*L,@\U6T_[0?C+\0A9Y^U?V7!Y..N_R5V_KB@#MIO&VC)<
MW5O;F\OGM&*7#6-G+.L3#JI9%(W#N 21Z5/#XNT2Y\.2>(+6]^TZ;$I:26"-
MW* ?>RH&X8ZD$<5RGP-D@?X6V"1X\^.:=;D?Q"3S&/S>^TK^E<YX;B(7XO36
MPQI;O.L.W[AE$<OF8[=U_2@#U32?$>EZ]H:ZSI5R;NR8,0T4;%OEZC9C=GVQ
MFI](U>TUW3H[^Q,K6TGW&DA>,M[@, <>]>475O<?"+6X]?T^)Y?"&J%/[1M8
MQG['*0,2J.P/_P!;^[7HG@21)? NC21G<CVRLI'<&@"_K.OZ9X?AMI=4NEMT
MN;A+6(L"=TC]!QTZ'GH*GU+4;?2=.GO[LR"W@0O(T<32%5'4[5!.!]*\T^(^
MFS^-9-7TVVTJ]O5TZV\JUEMS&%2\;;(<[G4\*(UR >)'K3\/^)_^$L^"UWJ$
MK9NX].GM[L'J)4C()/UX;_@5 '7:/XCTK7]#&L:5<_:[(AB&BC8ME>HV8W9]
ML9Z>M9EY\0O#EAHEOK-U<746GW$GEQ3-8S8+>F-F1GMGK@XZ5P%Q;W/PDU:'
MQ'IL+R^$M3$?]IVD8S]DE(&)4'8'_P"M_=Q7\=2QS_ G098V#1O>6[*?4%F-
M 'I4WCW0+2YMX+^:[T]KA]D3WUC-;H[>F]T"Y^IKH+FX2TMI+B19&2-=Q$<9
M=L>R@$G\*X/XTFW?X8ZA;2H)+BYDABM(@,N\QD7 4=S@'IVS77Z-;W%IX:T^
MVO&W74-G'',2<Y<( W/US0!B6OQ)\.7VF'4[1]1GL%SNN8M+N6C7'7)"=N]7
MKCQKX?M_#*^(_M_FZ0>MS;Q/*%YQ\P4$CG@Y'!KD?@2Z1_"BU=V546><LS'
M W'DUQ.GVK1_!+Q_>0H8]+O-0EEL%Q@&+>H#*/3C'_ : /9I/%^C1:38ZDT\
MWDWY M(Q;2>;.2,C9'MW'CG..G--7QCI)L[RY<7T7V.2*.:&2QE$H:1@J )M
MRV21C:#7'WGAN^US0_ MYHFLQ:=KFFZ<)K431;TD1HHTDR.WWE'_  +\1?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVLMGY68D$A 2>>"W- '0:5XXU#6OA_8>)M.\.RW4]W,4^PQ7 RB"5D+;B!G
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M0!B<@\<'/2JNLOHFCZYX4T1KR/\ X0JZ:[9V%QF!YBQ98W<'&U2< $XZ9Z4
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M0!TXW')QQGDUP&AZSI]OX!\/VER(98[[4KN$&>X\NW7$D[?O3W&!PIZG'UH
M]7HKQ62:%/!FJVXU B*T\40PVQAF9!'$TD!*IEB=F&<CDC'2NRTZUM-%^*C6
M5@QAM[S1S<20^:2LDJS !\$GYL$Y/>@#N*P_$'BBR\.W6E07:N3J%R( R](@
M<#>WHNYD7ZN*VV8*I9B  ,DGM7GM]IUQX[L=>FMY[ Z?=H;&WED+%HUB8_O!
M@X!\S+#U"H: /0ZQ!KLH\:_\(^]FHC:P:]2Y$N2<.J;2NWCECSD]*XI_&LU]
M\/='U":Y,+1:C#9:[)$_,"JQ60DCE59@O(_A:K.FKX?7XLXTAK46\^A2[VMG
M_=LWG)G:0<9QUQSTS0!Z/39&*1.ZH795)"+C+'T&:\5C@L$\ V>L)>2IJ$6O
MF&.Z%V^]8VO2A4'=]TQD\?C75VUK8:5XXU_2H)#!I\^C0W;0^>P7S-\JLXYX
M)"KDCKB@#N-/N9;S3[>YGM)+266,,]O*06C)_A)!(R*-0N9;/3[BY@M)+N6*
M,LEO$0&D('W020,FO*;![>]T#X8?:+R0M<'RY\7+*7'V:0D-@\_-CWJ75(K7
M2M-^)6EVTSV]K:6:7%K L[ 0R- Q)3G(RP!P.,T >L1LSQ([(8V902C8RI]#
MCBJO]J6?]M#2/-/VTVYN?+VGB/=MSGIU[=:X'6UGN#;7EJ^CZE;V^CQO/INH
MRE $)8^;&X! 8[2I)'&T<BFV']G77Q%TNYO3<6;W/AZ"2&"XNW1]_F?<QN&X
MCC*XY/..: /3**\J\/II5CX?\2^))I+RZFTR\U)8_*NG+)"'8!5&<#@##=>G
M.!5CP^]H_P 0H8K.XM([74-%EDF@T^X9D,@DCP3("-T@#M\P .#SVH ]!TK5
M+/6M,AU&PE,MK,"8W*E=P!(S@\]JN5XSH%U;6/PW\*M;W3&TDOX(M9(N6;RH
M\R85P2?+4OL#= 0<'@FNCN[:.T\6ZU;V#"'1&T,RW<<+[(HKG?\ (1CA6*;L
MXQD $T >AT5QOPUTRRA\(Z5JL4DLMY>Z;:BYEDG:3<53@8)(&-Q'&.U:WC"-
MYO"]U#%J$=A)*T4:3R@[-QD4!6P0=K$[3[,: %\4Z[+X<T?^T8[-+I!/%$ZF
M7RR!)(L8(^4YP6''%;=>/:[<M%X3\0Z?>Z=8Z;/#>:=ODTZ?-O*6G0Y0%04<
M 9(]U/>MZ<V'A7Q_)):>;':SZ#<7=Q#'*S><\<B$, 3R^TMSU- 'H+E@C% &
M?'RAC@$^Y[5QH\=7!\)P:Y_9,8WZC]@DA^U'Y#]H\C<#L^;GG&!7/:#?6A\:
M>&;RPGM(8]2T^X-S%;W#2[L+&R^:Y.'D&3S@'KR<U4^V6W_"IP?/CQ_PD?\
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M.:1 SV\I!:,^A()%<;8/&_Q$UFWOYXS+_85FLY5]OS!YMW(Z=?UK"T1;O5?
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MC:]N'95#R-Q$F<O)G/.00,8SF@#JM3UV73O$FB:7]C22'4WE3S_-P8RD;/\
M=V\@[0.HZUMUY5HNIF[@^%<]W>"6YD24N\CY9C]E<9)[G/'UKU6@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***YWQ+XL@\-WN
ME0S0-)'>7 CFD!P+>,D(';VWLB_B3VH Z*BBHH;JWN$9X)XI44X+(X8 _A0!
M+14,=W;2P-/'<1/"N<R*X*C'7FG1SPRPB:.5'B(SO5@5Q]: )**3>H*@L,MT
MYZTQKB!75&FC#L=JJ6&2?04 2$ @@C(/:H5L[5-VVVA7<I4X0#(]/I54:Q;'
MQ"VB 2?:UM1=D[?E"%R@Y]<@_E6A0!%);6\NWS((GVC W(#@5(JJB!44*H&
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M32TU>Y^SQ6-W#'<VJC(=(V7=^\)XS@CIP.G.,G6CFBFB$L4J/&1D.K @_C0
MPVELS,S6\19NI*#)IDFG6,T8CELK=T!W!6B4@'UQBIDECD+!)$8KC<%.<9Y&
M:1KB%)DA::-97&50L S?0=Z $-M SJ[01EUQM8H,C'3%.6&-)&D6-%=OO,%
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MNQQ4]-CD26-9(W5T89#*<@CZTZ@ HHHH **** "BBB@ HHHH **** "BBB@
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M-*FA@MVC8VK8PW+L6",%;@=":],HH \\:]TH^--?M?%/V<VMW% =,DNP##)
M8\.L;'C._<2!R<CK@5#;/HJZ]XBTCQ5'"J3-&NG_ &Q?EDM#$JA(B>X8/D#G
M)S7I-% 'FL9L6A\9Z;XC1/ML]S*UNDJY>:V* 0^3W;'0!>0V>YJ#3R?#OB7P
MK>>)62"ZF\/O:7-U(N?,N T)".W=L!NO7!Q7J-% 'BMU'IK^ =<@-ND+)XHW
MP0E/+DC0W49)5>"HV!NF. ?2NL73=+L?B;%%9V=K!::AH<HD2&-5CN&$J;<@
M<,VTOCOC/:N^HH \Z^'6HZ)HO@+1$$*PWEP\=E,D5N1(USS\KX'4 ,23T S7
M0^-]2CTWP^CSVD=Q!+=P12-,I:*%2X_>2 <E5QDC@'H>#6Y+8VT][;WDL>^>
MV#"%B3A-P ) Z9P,9ZX)'<U8H \1UB*R&@_$2V"V[1316\]I'';^4CR&+!>*
M,YY)QR.O7O76WEGIVF^.O"UYI,%M!]LMKN)YX@ )_E0H'8?>.[IG)))KT&B@
M#Q2\N]-O?AA'!>VC2>)K2XMVOO.MR9XIA<)YDC,1D C.#G&" /2O6=9NK"/0
M+FXO8UN=/:+$RA=ZO&W!..XP<_2M*B@#S&VTJQLM;TAO 6K7$L7FL+RUCOGN
M+1(/+;E@Q8(V[8% (/)XP#BSX)N] N-%TM=7%O%XEL2S78N@%N4G 82.Q/)!
M!8[NF"*]%HH \7L-/TZ+X6^&]5CM8EU&UU.U+W.S]]$/M(#!FZ@;"<@\8/I5
M[8NI7/BG1==U6WL;F[U!WMFEMBTSP?*8'@?< VT 8"@X8'UKUJB@#SJ.ZL%\
M2^(],\46YNKF9T_L]+BW,@GM_*4;8N,9WARP'<Y-8=DUI:^ ?ASJEPB*NGWD
M*7,Y3)MU,4BD.>JC<5SGVKV&B@#S6RO=.'B7QY<P>7%!<:?;.DA78)SLERRY
MQNY9>>^1ZBLNPO9K-/ UQ=74%OI":&(#-<PF6&&[VQ@B3#*$;:&4%CQ\P[UZ
M]10!Y=+';>'9?#S37C7?A>2ZO)9Y%A/V>*1\-$-HS^Z!,@4G(!(.> :U?!9T
M]/''BT:? EO;SFUEB58_+$H\L[G5>,C)Z^^>]=Y10!Q7Q&2\M;;1-;TVV-Q>
MZ=J4>R,?QK*#"5^A+K^59?BO1[[P\WA_4-'#S7A1]'N9%'S/]H'RRM])L,?]
MXUZ310!POC.#3["Z\&($AC-KJT2H2!NCA$4@//9<[,]LXK-$6D6/B_QT]Q;6
M\-ZT22V\CP@,4-L%9E;'0L2#@\DX[UZ910!Y+:V&FV/A;X=:K;V\,-XES:17
M-TJ@2 &W<2*[=<9 !!Z8 [5%J-S8W7A#QEIFN69N/$:F^=(Y;<O(R?,8'C)'
MW%7;@CI@]^OK]% 'F&JV^BZGKO@(7B6L\3VTR3%\$%/(PJN?[I;(P>"<BJGC
M,Z?):^)M"CTZUMWT[2U2S5[5YIIE6(LIB.?D5#@9&>02<5ZU10!YSJZ36>L^
M%O$FG6ZW-U>VS:9+*%#_ #2('C=CZ*R')]&-+H&C2QZW-X5OH9+JRTF[.I6]
MS<+O\R.0$HI)ZD2&4Y_Z9CUKT6B@#Q_6]0MM1E^UK;6]G>V/B.$.JVS&XC07
M"J99)2?E5DR0,8VG&2!77>'KF&3XC^+E25&+)9[<-][:C!L>N"0#Z9KLJ* .
M6\2W?]H:KI_AVUN[>&>5_M4YE7>-D9#*A4,,EF*G&>55NU8VF32^&/B;=V-Y
M>6\L&OPBXS#&8UBNDPI!4LVW>NWDGDKQ7H5% 'G'A&;2KRP6PUY+<>*K>^D>
M5;E<3M*)2R.A/)3;MP1P%XZ5'X2ETZ_\.6MK>I GC*U,AD2Z4"X%T-PWG/)4
MYSGI@CTKTNB@#R94CU'X>Z%9V"[/%EK<VVY#Q<17 D7SWD_B *^823P0>^14
M\TNE:=??$'2+FWC62[(N+:T$.?/!ME^9%Q@_.K9(Z$9.*]2HH \FM;?2;R_^
M&J7,5M*1I;Q3AP#_ ,L$"H__  +< I[@]ZK:QI]I#X7^(&EPV:"WM]2BN(+5
M(^$0I 79%[#._IQUKV*B@#S#75L([PW?A^_T6*(:8%&F7UK^XN8F>1OW6T@A
MF.0< Y^7CI787CI)X"D:_M5M0^G?O;:0Y$;&/[A)ZX/'O6_10!Y-I<5IIOA[
MX?W*V\$6C*BG5C&@"K<&W 1Y@/1^I;H=I/04[7K."2T^(%S:I"^BW6ECR0 #
M'+>^6^6B'0M_JP2.K>X->KT4 8/A'3-*L=$@N-,@A0W4,;3R1G)E<+@ECW;K
MD]?6N#M8/[377=#UW58=/U.35I)H]]J3<LHD#0O"Y;Y@%"@84XQBO6J* /(/
M&%];ZE!KY6T@MM0L-2@V 6S/=$(\0$_F9^1",@8&,#KDD5M?:M(D\6>)+'Q8
M+<Q7?E'3I+L QRVQB *Q,>,[]Q('.2#7HM% 'FUIIFBZQXL\;0W=I;7:".W6
M))5#@ 0;6*@]"#P2.0<"NC\ W7F_#O0I9YLO'81+,SMRK*@!W9Z$8YS7344
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH Q=+T*73O$&L:HUXLO\ :;1L\0BV^640(N#N/8<^_ITK:HHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$\8(H V**** "BBB@ HHKFK3Q=)?WNI6EIH&I2RZ=,()_G@4;BH88S(,\,*
M.EHK)T3Q%9Z[]JCA2:"[LY!'=6EPFV6%B,C< 2"".002#V-:<TT=O!)-,X2*
M-2[LQP% &230 ^BL[1]3EU:U-V;-[>VDVO;.[@F:-E!#X'W>O0\UHT %%%%
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M+A+2%YGCC(#%5!)QD@=!4]A=B_TZUO%0H+B%)0I.2NX X_6@"Q1110 4444
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MGC'5UKU>ZTK3KVYBN;NPM9YX?]5++"KLG.?E)&1SZ5%>:%I&HW N+W2K&YF
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MNDV+WP(;[2UNADR.AW8SD=C4UUI&FWUU;W5YI]I<7%N<P2RPJ[Q'U4D9'X4
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MYG@79%)Y2[HU]%.,@>PH YSQ1++!XL\(>5<W$:SWTD4L:3,$D402L R@X/S
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M.=I+-\O3F@#V*BO./&2W0OM6U*)--U:PMK-!/93SM#/:X#-O@?! 9@PYX.5
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MI# .%ST8FF:'+8:CX'MX+*%8O&%G82JJ3(5N8[SR61F8D9Y8D[CP<CO7I=%
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M94]A5GQ!I9OH/'USID N-*NM)4HL2[DFO%5\O&!P2%V D=_<<>JT4 8_AO\
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MTP:;=[(EA"Q;FDB*C;@#)PQ (YQD>M>BT4 >-2+<:;:S0VB&#2[#Q9+)<PK
M9%AMRN48QC!,0D.>.,C/:O0/"MI:"\U;5+/4X[U=0DC>3[/%L@5U7:2O)R2,
M;N3T%=+10!R=Y<2ZYXP2ST^^MX?[)C,K>9%YH>9\IP R_<7()YYD ZBN<T-[
M_1K?Q=X0LKE)+R*.:ZTF6)=B[I49C$O)"E),\9SA@:]/HH \R673]5^'[_\
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M&%],:>"[4;RL;*5^5@68'# X;TKJM4M-4U'P+=V<0CM=6N-.:,"-L+',T>,
M]@&/6@"]!K6EW-V+2#4;66X()$23*6('7 SSCOZ4R/Q!HTUU';1:M8R3R2-$
MD27"%F=1N90 <D@$$CL#7&RV\NNZ1X0M+.PNK.]TV]MIIUEMVC%JD2D2+N(
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MDZ?:Z?#,L5Q:&,P2,T@;Y2BN1A5/.>O6@#MZ*XN7QI#I6A^&9YK^WU(ZI<)
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M4LB[I(5);R\DX&2!G@5T% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 2CXROL<$BO._%^G>)=:M_%>F?V==SQ3V^W3##<)% 08P&W_ #!F?=NX8%<
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MWG!R-G7'/7CI45[HFH3>-KV[6!'TW4=*2QDF$VUX65I23MQSD2#&.XH N_\
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M2TZPUI_'CZY?6,4%K/IB6H1)@[1.LCO\W3.<]O\ Z]<_!X;\3Q^#M*T Z=;
MZ7J$$YG%R"+B..?S/D&."0/XL<\=\@ W;2_:Q\?^)1>7\JZ=;:=;716:4F.'
M)FWL >%&$'Y5KP>);&6_@LY4GM9+F%KBV:X38LT:X+$<\$!@2&P<'IUKF]9\
M*ZEKVJ>*$>+[-:ZMI45E#,74E'0R'+*#T)<=/0U-9^&Y]2TIK35-%CLKS[%+
M:_;1=F<(SIL9H@>0#[[3VYH K^*O$?GR>&Y--;4HH+G5K5%NH@R07$3.-RD@
M\@CID8(Z$YKI/%\5])X2U1M,N9;>_BMGEMY(C@[U4D#W!QBN6DTCQ9=Z!H&G
M7.FV:2:/>VDLLD=T&%RD)Y* @;<@9PW?CW'H?WEY'4<@T ><:UXOO;7PGH&K
M:6[20)#;ZEJ19B[?9255E^IWL?I$U=,TSR^)[FXCNKG[%:6*LT<)+J\DA."%
M&<E57.!UW@^E9W@[P8VC^&+[2=599UN&EMU&<XM,L(T_[Y8GZN:L^"M$U+PY
MX3%MJ+_:]1!.XHP^=4 CCY/_ $S1,^^: ,U_&/\ 9WAGPK<VUS<ZG'J=W' U
MU-9N9)(R'+-MC'#?*,#'KP<&FVGB)M.\:>)A+_:M[;"WLYX+6.*25H@RR%R$
M/W.@R.#P!CC%06OAG7;3P1X4LQ9PR7^B7T<TT/G@+*BK(IVM_P #!YQT-;VC
MZ=J4'C77=2N;18[6^@MHXF64-AH@X;(ZX._CZ<XH T(_$VEW&GV%Y:S-<KJ$
M?F6D<2DO,,9.%.,8[DX [XKFO#?B'RK_ ,9WE[)J0LK&YC*PW*.\D"^2K, G
M)QN+'CC'/2J&C>&/$>A6GA>\ALX+B[TNUFL;JT:X"B2.1E8/&^",@J.#C-:4
M6BZZI\9O/9Q&36$4VPBF!4'R%BVL3@\$=<<X/L* -G3_ !CINIVLES:P7[1*
MD+QL;1QYWF@E?+R/FZ$$]!ZXYJ*3QQI,.C7^IS)>1QZ=+Y-[$\!$ENV <LOI
MAE.1D8.?6J,^F^(8_!6@V-E$4N+)K>.^@2Y$331(FUU20=,G:>Q(!'&:;I'A
M6XW>*[74K2*&SUDKL$4N\!3 L; DX.<@G..>M '1C7++^U8]*+D:A):F[6W.
M-WE@A?7&<G'7UJO'XEMIM-AO8+2^F$^[RHD@)=PO5L= /<D9XQG(KE$\&Z__
M &#HEV;J%?$UI*JSW .5\ED$+@>N$"OCNZGUK<UK2]574-%BTR 2Z-;Q/%/:
M+=&#G"B-B1RR* P*^X.#B@#/UW78]5T[PQJVCWUS'!<:S! X5FC++O*O&Z\=
M"N"#Z&NYKS>W\+ZY:>'-(TX6$32V6O-J$GERJ$,7G/( N3G.'  /H>:[;7FU
M,:+<KI$0>_D0I"6<*(V(^\<^G7'>@#F(?$M_'X_@%Q(/[ U02V5EQ]VXA))8
MG_;_ '@'J(U]:ZC4-9M["=;81S7-X\9E6VMUW2% 0"W)  R0,DCT%<IXA\#1
M2^$H8-#M)8M5M3#-8M)<DB"5"""<L5[$'&>IQ5J>QUZ#Q9:>)8-/CG\_3A8W
MMB+A5>)E<NKHQ^5AEF!!(XQ]* -9?%5E);PM;V]Y/<RP^=]CCA_?(FXJ2P)
M7D$<GG!QG%+%XHL[F.,V=O=W4S6R73P11@211OG:6#$8)P<+U.#@5DO8:Y8>
M,7\06NGI=6]_91V]U:"X59('C9BK*6PK##D$9'//-2VNG:KI/BW4M82R^U6^
MK00>;#%,N^WFB4KCYBH9"".1R".G- %ZW\8Z-=G2/LT\DJZLS+:NL+;2RJQ8
M,2,*1L;(//'2B?QAI-NFLM(;D#1PK7G^C/E05+9 QDC SGI[US:^$-5T?3M
MGLH8;V\L=4GO[FW67RU(F64,J,1CY?,&,XSCM2W6@Z_<IXW+V,(?7;1(K4).
M"$/D&,AR<'@G.0.Q]L@'0V?C'3+S4[2Q$=Y$][&9+22:V9([@!=Q"-W('/N.
MF:A\)>*&\1-JB2PR1M:W\\$9^RRQJ8T?:,LPQO\ 49R/08JM<:/J<MSX.NEM
M1G2W8W4?F+D P-%E>QY;/T]^*IVAUOPK8ZQ"NG03W%[J\LFG_O\ B8SREOF
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M(Y%NCL0"[-\H)X')-<[IGB_3+'PSI%U=:C?WR7T[6\-U):$/*^]@ RHN%/!
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MHQP2,@]L4W5/!FJWL^I:Y:^3%JDVIVE_!:2O\A6W7:$=AG#,"QR,@?+R<9H
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M+;&>\21625(&!!C&=P9MH'(&,GDX&>[H **** "BBB@ HHHH **** "BBB@
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M3M)"CM&\3,H)C?&Y3Z'!(R/8D4 /HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHK'UOQ3I'AV6VBU.XDB>Y#F)4MY)2P7;
MN^XIQC<O7UH V**RM$\1Z7XBCG?2YY)5MW$<A>"2+:Q&<?.HSP0?Q%:M !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5DZ]J-MHMD=3>'SKI1]GM
MHP<-+)(RA8Q_O,%^F,]JUJIW>EV5]=V=S=0"66RD,MN2QPCE2N[&<$X)Z],\
M4 ,T;3WTW3DBFD$MTY,MS*!CS)6Y8_3/ '8 #M5^BB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
K **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ameh-nonqualifieddeferre008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@;(3(SC)H V**0$, 000>012+(C@E'5@#@D'.* '450UC6+/1-&N-5NV;[+
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MK12*RLH96!4\@@\4!@<X(..N* %HI-R[MN1NQG&><4M !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9
M'B2VU"\TDV^G?927=?/%U(R*T75ERJD\]#QT)KB?!6NR6VK>,[S4IM,2SBNF
MN9VM9GE8;88@2B[?F3 //7(QBO3:* .6U;5O#NLP2Z=?:L]H'@$H07!@>:*1
M>&49!8=1C'48(Z9N>#/[6_X0[3/[<!&H^3^]!0(<9.W<HX#;=N1ZYK<(!()
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MS7;[3I]?^(&F^*[;[1J)MR=&2:W:7$0B8@PX!VX.&8C'/)/!Q[AL4N'*C<.
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MA>TOF6>YFC.Z*$LQB#G&0-N,#M5JSFT9],^+$86WB@F1I;6&5!&6/E-L9$8
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M%]F$FG.7AD;!1C']PGN<\>]<98_8K'3? 4FR!- DA)OVX,0NC @C,O;J&'/
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M7_\ PL.'2[>Y:XG:S:(+&1]HC1$$JH2,-P&7 ZYQ0!Z;:ZA97QD%G>6]P8R
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MN/S8&2<$C/&10!Z4=9TM9(HSJ5F))7*1J9UR[#J ,\GGI5QF5$+NP55&22<
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MHX'DUFQ43QF6',RYD3^\HZD>],7QCX;=+1UURQ*W;;8#YPPYSC'L<@CGN,4
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MMKI&T[4(;EY$" [BBJ5(;T.[]!0!TU%%<EX8\63:SX@U73KJ!8554N]-8?\
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M9V*L =P!RHR >];N@V'FWT-_>Z!?65]!"T8FO+_[3MW$;EC/F-P<#DA>@X]
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M;=9)S(06"(L<;2.[8Z!5!)/!/X&H='UNQUVVEGL9'80RM!,DD;1O%(N,JRL
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M9<[=C +E6R",-CD5=DU[38IM1A-R&ETZ-);M$4LT2L"5) &>@)KC(?">JO\
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ML#@C.0?P[4 =C17 3)=OXFN(=(O]0ET3^S9C>,]S(RQS@CR_+E)W!_O9 ;
M&>HK2\*ZO/#\/O#D\EO?:E>7&G0N1%AG<[%+,S.P'?NV3GO0!UM%<Q_PGFD_
MV9IE^L-\T.HW)M(PL!+),"P*.N<@@HP[]*O:+XCM]9O+ZR%I=V=[9;/.M[M
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MO,\B7<-LJ;71E8JRL.Q# @_2M"@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *Y;2M*U>V\<ZUJ]Q!:K9W\%O#'LG+.GE"3DC:!S
MO]:ZFB@#EK[2]6\1V$&F:O:VUO#'<0S3S13%_.\IPXV+M&W<5&<G@$CGK6^N
MF6"7'VA;&V$V\R>8(EW;B,%LXSDCC-6J* *=QIMM/I$VF)&L%M+ T&V)0H12
M". .!UKD8_"^K7OA+3/"VI);K!8R6XDO(Y,^=% RLNU<9#-L4'/ R<$UW5%
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ML]/CBT\O;Z^=3)29D0Q>>90JC:<'!QCH,=:[Z[@-W83V^=AFB9,]<9&*GHH
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M@Q_PJV#C(Z;N^.E9\O@&\NM+O89K^V6Z;6?[9M)1$62.3/W'4GYEQD=1U]J
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M6:&\@+-#*%"ED8'D$ 94XY'!% &=<ZLFN^.["VDTUK[1_P"RX]0A,GE[$9I
M1/AFS\H  XR.<#FM&#Q]9W"Z5=+"AT_5+A;:WE$X,H9L["T>.%8CU)&1D#G%
ML^'[Q_&+:Q)-;-:OIPL'@"L"1N+%@>W7&/3O57PMX7U'PU;6^F";3KBPM25A
MG:W(N#'GA6P<9'3=[=* ':9XOO=6U&YMK;P[=^5:7<MI<3-/& CH@8<9YR2!
MZ#(Y]#0/&-WX@L%U"'P[>1V<D#/%(TL9,CA]FP+GCUR<#@]>M6?#VBZAHIUE
MI9K:9K^]DO4"AE",P4;3Z@;>OOTK+B\%ZC'\-_\ A%_[1@6="-EPL;;) )?,
M*NN<[3RI /0_A0 MWX@BUW3O$^B7MC'%=65B965)EGC=65]I# #!!0Y! ((%
M;7@S_D1O#_\ V#;;_P!%+60OA/4Q>ZK=FZL%?4-,2Q\J*%D2 J9.5&3D?O#^
M([=!T'A_3YM(\.Z=IMQ)'+)9VT=N9$! ?8H4'!Z9QTH Q?'3O?Z>OAZVU%;"
MZU".1OM'F!#$B#.0?=S&OT+>E2>'/%3:OX#AUTP&6ZBA874$; $31Y$BC)P.
M02/;%6[70Y7UW4-0U1;.Z6<)';KY9)AC7.%YXY+,21CJ!V%9ECX4U'3;OQ']
MDN+..QU8F2*V$; 6\A0(S9[[@ 2,#D4 16WCVXG71)6\/7*P:W"&LG$Z$F0Q
M^9M<?PC:"=V3TZ#I5N#QO NFZC-J%A-:7EA>)8R6@=9"\K[/+"-P"&\Q>3C'
M.<8JM!X1U*"R\(V_VRU/_"/[=S;&_?XA:+_@/#9[\TFH>!IM0DU\M?)%_:%Y
M!?6LBH2UO-"L84D9PPS'STX./>@#3;Q+-:Z[%HU_IWE7=S;O/9F&<.D^S&],
MD+M89!Y&,=ZJ1^.(Y?#>A:TFFSF'5KF&W5=ZYA,KA%+>O7M5V/1+J^U[3]8U
M9K<3Z?#+'!%;%BNZ3:'<D@'HN O;)Y/&.=M_ VN1>'M*T1M5L3;:3>PW-NRP
M,&F6*3>%?YL#TX^OL0#7F\6WS:KK&FV'A^>ZN-,$;/NN$C617#$;3SS@<#\\
M=\Z[\97=Y?\ @RYT>UNI;'5EEGDA7R@TBB$L$)9A@@X)P<<=3TK:TW0[ZS\3
M:WJLT]NT6I)"JQH#F/RU*CD]<YSVQ[UCV/@K5-.TSPK%;ZA:&YT'?'NDA8I,
MC(4)P&!##.>N* -:R\5?VEJ=Q;65M#*EM=FTN!]I GC(."_E8^[GOGD<XJQX
MPNHK/PAJUS<07$]O':R/,EM+Y4FP*2Q5LC!QZ5E7G@UM4UBVO;Z#3EN+6^%U
M'J$$96Y**Y98B<=,84G)R >,G(V_$VESZYX9U+2;>6.%[VW>W\R0$A ZE2<#
MKUH S)O%$MIJ6F:1:Z1<7$UY9-<0,9U"X0)D,QY_C'/\ZQ];\:W\O@RYO;"R
MN+/4;?5(M/N(MT;^4_G1JP!)P0RM@$?WATQD;$7A[41XBT74Y+BUV:=926CQ
MJK9DW[,L#V_U8X]ZHW?@J^FTG7+.._MU>^U5-4MW:,D(RO&P1QGD?NQR#W]J
M -@>(9[G49=-LM.W7\$"3W,5Q.$6$.6"*64/ECM8X'&!R>E6?#VO6_B/2A>V
M\<D++*\$T$N-\4J,59#CC@BLY-!U.S\1R:[:3VCW%Y:QP7T#ADC=D)V.A^8C
M 8C!SD8Y%:'A[0X]!TZ2 2^;-/<2W5Q+MVAY9&+,0.PYP!Z =: ,_P 3^+6\
M,6\U[<:<7L+=E$TIG5'(.,F-#]_&>>0>#C-='-YA@D$)42E3L+= <<9KAM:\
M":EJO_"2PKJ5HL.LJ-LTMN7G@ 15\L-NQL^4GI_$>YS7:R1S2V+Q^8(IWC*[
MTY"L1U'T- 'F&C7^EZ;;Z3;>*='U/2]=2>(2ZM-;EDGN-PS_ *0N05<\8) P
M<=J[7_A)+F[>632-+-]:6]V;2>7SMC;E8*Y1<'<%.<Y*_=.,U!<Z'J^N:=#I
MNN3V)M%DBDG:V5]UQY;!P/F^X"RC/WN,CCK2:-X?U;P_?WT5C>6DFE7=X]V(
MYXV\V!I#N=5(.&4G)&<8SWH YK1M9F\+6GC"YM-$>YL;/6;B:X,4J1^7&(XR
M=BG[Q !..![]JZRX\66YU V%@L,]TMJEVPGG$*A'SL&<'YC@\8P .2.,T8?"
M5]_8?BO3I[NWSKDEQ*CHC?N3+&$P0>H& <\9J)/!VH6>L0:M:3:?+.UC%9WD
M%U"S1R>7G9(A'*M@D$8(/ZT 7M.\9VVN6M@=(MVGN[VT-VL$S^6(D#;#O8 X
M^;*C .2#VYKE_#NN'POX5\7:M+I+J+;6YVDM(I$_=C9&.#TQTZ?E72WOAS55
MU^SUW2[ZRBO4M/L5U%+;MY,L>[>"H#94@D]SG-4SX'O)O#?B?1[G4HW.LW$E
MREPL6#$SA>"N>0"H[]./>@#>N]<6W\3V&A26;M]N@FE2?<-F(]NX8Z_QBN3\
M,:O9>&M%U)755\_Q)=V=K$"%!<RMM&3PJA5))[ < \"MA=!UVY\1Z/K>H7M@
MTMC#/"\$$3*C"39\P)).?D^G0>YSG\ WL^ERQ27]LMY'K+ZQ:2>26C5V9B8W
M4GYEPQ&00><]J -./QS91S:C;7D6R[LI8(O+MY!,)S.<1"-N,DD$$$#&.>.:
MRP;M_C!IKW>FQ6CG2;K$D<PD$H$D.,\ @CW&.>":T]4\,7VM:";6>>RL+V*X
MBNK66S@)6*6-MRE@3\P)[<<'O2P:!K<GBG3M>U"^LGDM[66UDMX(65,.R-N4
MDDY^3OQT],D G\>:6VK^!]7MH=PN1;/);LAPRR*I*X(Y'(Q]":Y'7M?NKCPY
MHFNZ,?+LM)@MM6O(81@/&_RF,8](S*Q'LM>HD C!Y%<QX5\&VWAWPM-H<LGV
MJ*=I?-+#AD;Y57Z! J_A0 S9;W>NZQJ\,'VA+>TCMT\E@K.[*9'(;(YV/$ <
M\<UB'Q'=6^@^!&T6UO3:ZC-&K1O*DDCQ>0[A&=VSN^4'/^R>>QZ'PUX9F\-^
M#(]$CNQ<W*(R_:)0?F)R%S]%VC_@(K-B\&ZG;>'/"]C!?VOVS09D=))(F,<R
MB)HSD @@X?/7M0!GV%Y=Z5XR\92Z;HC73_Z)-)"LJ1!?W)+#/(+$YX'!.<D=
M^DMO%UMJ5MI1TR!I[K4[/[;!!(VP)$-N6D;G;RRC@$DG@8!(33=!OK3Q!KVH
MSW%N\>J+$%1%(,9C38.O7/7V]ZQM/\$:OH\&@3Z=J5H-0TJR.GR>="S17,!*
MGD @JP*@C!- %/PSJ3Z':>.]3ETIHS::@TTEG#(IPJV\;':> 0>3^/3-=-I_
MB/4-0T]KL>'[B%)%C>V\V= )%=2VYB,[ ,=^>1QSBLY?"&J+IOBNT;4+:5]>
M+MYIB*^27A6(_+DY "Y'/H"3UJ?4_#&I7VA:':)=6GGZ9-'(\<L;-!<A$*X9
M<@]PPZX(% %=OB J^&=4UC^S"S:3=&WO84N%8+C:=Z.!AEPZGL<9XXQ6Q_PD
M]M_PD1T(J!>_8C=!BW[HD$93?CJ RD\=&!Q5/3?"<D%OXCM=1N(;FWUJ5I'$
M<>S:&B6)EQD\87CGO^-9Y\ /)X?T2SEU)FU"QE#7%X%^:X1D\N5/8,F%'IM7
MTH V$\07TNAVNH1Z0 ]Q$9@DUTL:1IQC<Y'#$'@8]<D5S6K:M9^)['P/KMO;
MF,S:W&H$@&],+,K+D=1N3MP< UT.L^'[V]\2:9JMI<VHCM(9(3;W4)D12Q4^
M8@!&' 7'T)Z5DV_@G4[;1="TY;^U<Z5J;7_F,C S M(=N!]W_6GGV''- '=5
MYKXL\0R6/B*#7XM05=/T6[2SN[82#]ZDH FDQU.PM%CT*/7HMR)S;2"U,8GQ
M\AE!*@^^.:YZW\)0#PFVE7MO975U+ \<\[1X\YGSO<GJ"Q)/U- &GJ>M1:?/
M96D<9N+V_9EMH0VT-M4LS%NR@#D\]1@'-4!XDNHYH;"YTKRM7N))%@MA/NC=
M$56,GF;1A/F4?=SDXQ61'X-UJ/2?#K?VO;OK.@DI!</"WESQ,FQDD7.02N.0
M>HS5_5/#^L7]_I.M17EG!J^G-*H3RV:"6*0 ,C<[L_*"&'<=* )X?$MU)>6^
MER:6(M8F663[.T_[M8HV"F0R;<[264#Y<G/08-4I?'L4%A=RRZ9.+JQOXK"\
MMQ(O[II&54<-_$AWJ0<9]A5FYT'4Y-<T_P 01SV@U.WADMIX<,(IH7(;;NY(
M8%00V.>>/2IJ/@B6^TC60MY''JNIW<-XTWEDQHT)0QIC()4", GJ<D\=  ;$
MGB!D\4OH2V$K2BQ:]27>H$@#JNT#/!RW?'2L.U^(,EQI>EZN^@W,6E7UPEL9
MVG0M$[R>6I*=UW8!.<\]".:N6^@ZV/%<?B"ZO+&24:>UD;>.-E127#A@Q))Y
M&#G^G-*'P3?Q^ ;'PZU];F>SNHIUG$9VN$F$N"N>,XQU]Z +>CZYJ=WX]\0Z
M;-;3M8VIMUB8F(+#F-F).&W'<<8ZXXSBNLKDKC3-8T?5]=URQ:&Y%_!&5M!$
MQD\]$V( V<;22"21P,_6NDTZ.[ATVVCOYUN+Q8U$\JJ%5WQR0.PSTH \_OM5
MO]9T_P"(%C?V4SV=HLL<#2>5MAVVRN!P=Q)8[@><9'(Q@:?A_P 2SV=MX8TV
M[TF:"UU"UCAM;OS5;+K#OPR#E00K8//3D"II_"NI[_%45O?6GV77 S*)(FWP
MNT*Q'D'! "Y''M4TOAB]DL_"R?:K?SM$E5W^4[9@(FBX].&SWH B'Q L6M[2
M_CB1]+N;P6:3"<>:&+^6KF/'W"W?.<$'%=?7(>&O"=]X91-.MY=.FTR&9G@D
MEMS]H2-F+;"0<$C) ;Z<&NOH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "C SG'-175S%96<UU.VV&&-I';T4#)/Y"N1T[QVM_+
MHDL<=K+;:LP4103^9/:[D+J9%'8@8/3:2!S0!V=(S*BEF(50,DDX KDO^$QG
MA\3:=IEQ;V+17\TEN!;WGF2V\BHS@2*%QR%/0\'UI=(\1:QKNK7ED^B6B6-G
M?2V5W,;O?P(@RE5*#=DL <XQD=>< '4PSPW$2RP2QRQM]UT8,#SC@BI*\KT&
M>&S^'7@I9M,AO(7U2.-"\Q0P2&9PLB@ [L<\$C\:WM1\?Q0+K,ED+.7^R)FA
MDMI;@+/<LJAG$:^V<#KN((XZT =M17'/XXCE\03:5 ]C!<1/"%MKZ?R9;E)%
M5B\8/' 8C'))4CBE\.ZCK%UXV\4V]PB-8V]S#''FY),(\A&PJ;<<ELGD8SWQ
M0!V%10W,%P7$$\<IC;:^QPVT^AQT-9FH:T\6M0:+8Q)+J$UN]S^]8K''&K*N
M20"22S  #T/(Q7,>"Y;JQ/C2:6TM8[F/5R6ACFVQ ^1#SO(&!W/''/6@#MK[
M3[/4[5K6_M8;JW;[T4R!U/U!XJ:&&.WA2&&-8XT&%11@ >@%<2?&-Y=VWB2R
M2.S-Y86 NX+BSNB\4BL' .XKPRE#ZYXIFD^+Y[+1?#5AJ;VD6H:A8K*MQ<79
M9"B1IF1R54[V9A\H]SNXH [RFR2QPQM)*ZHBC)9C@#\:Q_#.NMKUC<RO L4E
MM=26S&-M\<FW&'1L#*D$'\QVKE)+S5-0OOB!9WD44NGP((T5[@MY0^RJXVIL
MP<EMQY&">^* /0XY(YHDEB=7C=0RNIR&!Z$'N*=7G_ASQ!J>EZ/X-MKO3;<:
M;J-M!:13)<$RH_D;E+)MQ@[#T8XX^E3K\1(+BTAU&T6UGM'O?LOV99\W6SS?
M+\T(.V?FV_W><CI0!W-%<AI_C6/4M<FL(I=/C>WNY;>>SFN-ETB)N'FA3U!P
M" /X2#GM5:R^(46H1:3>VR6LUIJ5RMNL$<^ZYA5B0LC*.W R/X0<Y.* .V>1
M(P"[JH/3<<4V.>*4D1RHY'4*P.*XWXLP13?#J_\ -C1]LUL5W*#C,\8./P)I
MWCGP[I47A#4]2M;6"PO]/M9+JUO+:,1R1.BEAAAS@XP1T(- ':5%<W5O9PF:
MZGB@B! +RN%7).!R?>N(L_'[W-F8<V$.HVNGV]S<QWD_E>9+)%O\M!UZ8RW;
M(&#4#ZQ>:_XR\.>7IL4EA=:/+>&UO9"FQB\(+%=C9=0Q ]=S<CN >AT5PT/Q
M$@N[:SU"T6UGL[B\%M]G2?-RJ&0QB78.V>=O]WG/:KECXEUW4M?U#3[?1+00
MZ==BWN)FO3R#$'4J-G)^8 ^G;=V .L(# @C(/!%4[/3=-T>*8V=I:V4;L9)?
M*18PQ[L<=_>N<\/^*M;UNREU!M#MH;*-+I<_;<LTT4A0*,J %.T_,>A!XQ@E
M=.\3'6-8U#0;R&PF460NHYK.X\^)T+%2K94?,"!Z@Y[4 =9#-%<1++#(DD;C
M*NC @CV(IQ8*,L0!TYKE_AK_ ,DT\.?]>$7_ *#6=\0Y;;5(?^$<;5X--D>W
M:\,LDZQX=?\ 4CD]Y!NX_P">9'>@#NJ*Y'3/&+ZA\-1XH@MXI[B&T>6>W:78
M!)&#YBY ;'*G''I5>+Q=KK7VC6\FBV8&M6S2VC"\;]VRH'(E^3@8)^[GD8]Z
M .VHKC;;QQ)_94C7E@D>IIJPT<01S9C><XPP<KD)M;<>,C!X-6+GQ1?:=K4^
MCW=C;R71L7OK21)62.8(0'1LJ2K#(/<$'M0!U5%<D/&%RVB^$]2&GQ>7KLEO
M&X\\Y@,L9?@;?FP 1U':H)_%FO/<>(8;/1;%FT20"0RWK 3*8A+A<1\-AN_
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M#<FV$\9G"[S%O&X+ZXZXY'YUR<'CE=UQ;2V\<UTM_%8VSVTF8;II%W*P?'
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M*J$J6((&.0<=>!GO0!ID@8R>M&1ZUQ'B6RAC^('@ZY'F&66]N-VZ1F  M9,
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M>N%4 #)Y+$]@2>)="U#7/LBVFLG3XH)/,=/LJS"5A]W=N., \@8ZX/85OT4
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MU\2:#=:1=M(D-PH&^,X9&!#*P]PP!_"J9T?6;G1KO3[_ %N"=I[=H!*EEY>
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M1.X;$FU5)!QGD*."3TXQ27>B2SZJ]_;:Q?63R1+%)'"(F1@I8@X=&P?F/0T
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M<-Y?/9RS>=O9D\Q6,OFG!"8^_P \@]:Z&6V2>S>UG+2))&8W)X+ C!Z8Z^U
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M^+]:T5?$UDXLY;S2M/74K:<PMLFB.X%74-PP9",@X(["MM/!5C'HFEZ:EW>
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MCH0G?)YXJO:>(]1A\206FM/J5B9K^6&$BVC>RN8R7\I5D4%E8C:?F(Y!'3@
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M^%A!>"#%I?,I$08C_4YZ^N1],4 =-I&MV.N)=/8M(PM;AK:421-&5D4 D88
M_P 0K1KRM&U:ST7QWJVF:NUF^GZI=W*1+!&ZS%(D8J^X$X.,?+M(ZY/;HM7U
MB[O(U@T[4;NWO_[/6\,-E!$Y3=G#2-*"NW(P%&&.#^ !V#2(CHC.H9SA03RQ
MQGCUXIU>8B[U'Q#J_P .M3:[2VN+O3I[AO+A#;7:&,MC)Z'=T[5Z=0 4444
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MG6KF2WGAE:*6)B,$JZD$9'!&<'O6G45S<):VLUQ('*1(SL$4LV ,G ')/L*
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MS*^Y%SM!#,1QD]NYK4HH YW_ (0?0%L+2TBM9HDLY7EM9([J59(&;[VQ]VX
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M813RVV?)=@04!ZC([' R.AJ%O">A/;R6YTV+R))_M+1 D(9<YW[0<9SSGUH
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M[""S6.TN"3+$K,%8DY/?N2<^N>: .-T:\N[:/X9P0WDJ6UWI^R:W&-DFVTW
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M%P]JN3^Y(! *G.1P2/IQ5:;P?X=N+J[N9='M'ENP1<,4_P!9D8)(Z9(XSUH
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M:7%\8-)TZY@>/[3.66 20HS#<Q) +$G&>]=P"&4,I!!&01WH 6BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!6?3K*62:22SMW>9=LK-$I+CCACCD<#KZ59HHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHJ""]M;J6XBM[B*62W?RYE1@3&V =K8Z'!!Q[T 3T5#=75O8V
MLMU=SQP6\2EY)9&"J@'4DGH*D1UD170AE8 @CN* '4444 %%%% !14%Y>VNG
M6DEW>W,5M;QC+RS.$51[D\"LNR\7^']0O8[.VU:V:YE&8HF;:T@]5!QN_#-
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M **** "BBB@ HJC=:Q866I6>GW%P$NKPE;>,J3YA +$ XQT!//I5Z@ HHHH
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M(M($A0GJ0H R?<USS?#G1&T^YTT2WZZ=-)YJV:W)\J%]X?*+V^89QR!G@"@
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M]P#HR30F:6)XP\C$#:-P&\#:6R,C)4@UT[ LA 8J2,;AU% '&_"M5?X9:2K
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MTG"AF4'&?3)KBM*\2ZG.QL]2NM3T[6#I\LC6MY91B)I4VDM ZKAE'S#!8G#
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MVH2P2Q&$K-?2N5C_ +H);CTSUQWJU8ZO'>RW$+6US;2VR1O,)XRJKO7=@/\
M=8CH=I(!J"R\16EW"MRZM;6D\D:6=Q.Z!;O>,J8P&)Y[ @'OB@!A\*:2=,TS
M3O*F^S:9(DMF/M$FZ)D4JOS9R0 2,$D5/9:#8:?JU[J5JLT<]ZV^=1.YC9\
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M2&46T=U((%<G)(CW;1R<XZ9[5JQWEM-=3VL4\;W%N%,T:L"T>[)7<.V0#4]
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M-A<GDXQFK\^@V%S>Z?>3)*]QIZNMO(9GR X 8-S\V0HZYK3HH Q-+\*:9HK
M:>;N&!6+1VHNY##&3G.U-V .3QT'8"K.D:#8:&MRM@LRBYF:>423O)ND8Y9O
MF)P2?2IX=1BGU.ZL%CG$MLB.[M$PC8/G&UCPQXYQTJW0!F:IH-AK%S97-TLP
MGLG9X)89WB9=PPPRI!((X(JO+X4TJ6>]D\N5([\[KRWCE98IVQ@EE!QD@ '&
M-PZYK;HH CD@CEMGMV7$3(4*KQ\I&,#'2LC2?">DZ*L*6B7!BM_^/>*>YDE2
MWXQ\@8D+P2..@)'2MNB@#$M/"FEV%]+=6?VJW$LQGDMXKJ186D)R6\L';R>H
MZ'N*SOB5!-=^ -3M+>UN+F:=41(K>)G9OG4GA1D< \UU,KF.)W6-I&4$A$QE
MO89(&?J:S_#^MV_B/1+?5;6*:*&?=M28 .-K%>0"1U'K0 S3=#T^VA61%N9R
M\917O99)9%C.,K^\)*@X&1QG STJE9>!M"L&T]H(KG=ISEK,O=ROY *E2JY;
MA=I(V]*Z.LK0M>AUZ*]>&WN+<V=V]I*DX7.],9QM)&.?6@"I_P (7H1TN_TV
M2UDEM+^<W$Z2SR,3*3N+@DY5LX.01TJ2S\):58ZE;ZE&+I[Z")H5N9KN61VC
M)!*L68[AD#@].U;E9-SKT-KXCLM$DMKCS[R&6:&4!?+(CV[A][(/S+V[T 2:
MOH5CKB6RWZRLMM,MQ$(YGCVR*<JWRD9P?6FVF@6%EJM[J<*S"[O@JW#M.[!P
MHPORDX& 2!@=Z30M=@U^"[EAM[B VMU):2).%#!T.&^Z2,9]ZU: *.CZ/9:#
MI<&FZ>CQVD"[8D>1GVCTRQ)Q63;>!- M$M$A@N EE<?:+13=RD6[8880%OE7
MYC\HX/X"NDHH S]:T2Q\0:<UAJ*226S,K,B2M'DJ01DJ0>" ?PJK>^%]-O\
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MEU08,IMTM(%"X$$*\[5^K')/LH[5-?:/IVI3P37MI'/+;G="[CF,^J^AYZT
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M^/78V6BVI_U%UK5I#..S)OW8/L651^-:.O7@A1["Q$/]J7L952^,1KT\Q_\
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M[>[EOO&/@B[N"#/<:)<RR$# +,+<GCZYKII/"V@RW"SR:19M*L/D!C$/]7C
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MGOI5J;/S?.$/EC:LF<[U]&R2<CGDTY_#.BR6\,#Z;;M%#)YT:E<[9/[^?[W
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M=66#3(8KBS87'[R-WB9CE\9905X4G')Z\8[+P]?OJ?@S2M0OF5GNM/AGG;&
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M=R.)'D"8WN.C$="P]3S6K0 4444 %%%% !1110 4444 %%%% !1110 4444
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MD95W%!D!F [[1D_A7+WR:(?'?@FYTR]-R\\UPQ<7;RAU^S288@L1GT/7KZ4
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ML,<\3131I)&XPR.H((]P:4.I7<&! [YJE::O:WNJZCIT.\SZ>8UGRN%RZ[P
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MH;B&.:)_O)(H93]0:J-HFDO%'$VEV1CC)*(;=,*3UP,<5=WKLW[ALQG=GC%
M="H8.I4\@YX- #7@BDDBD>)&>(EHV902A(()![<$C\:@OM+T_5$1-0L+6[5#
MN1;B%9 I]1D'%6MPSC(S2"2,L5#J6 S@'MZT "(D<:QQJJ(HPJJ, #T%9K:0
M$\0G58'5?/@%O=Q,,B55R4;_ '@68>X;V%::NKJ&1@RGH0<BFI+'(A=)%91U
M*G(H K6.DZ=I:NNGZ?:V@?[PMX5CW?7 J#1=)_LR*YDED$U[>3FXNI0,!G(
M '^RJJJCV'J36BLB,Q574LO4 \BJ6DZO:ZU;37%IO,<5Q+;,77&7C8HV/;(-
M $]Y86>H(B7MI!<HC!U6:,.%8=",C@^]0R:)I,S,TNF63LSEV+6Z$ECU)XZ^
M]6WEC1E5Y%5F.%!."?I3F94&68*/4G% %6?2]/N9/,N+&UE?9Y>Z2%6.W^[D
MCI[4ATG33:I:G3[3[.C;UB\E=BMZ@8P#[U;W#;NR-N,Y[4U)8Y(Q)'(C(>C*
MP(_.@"K+H^F37CWDNG6DETZ&-IF@4NR$8*EL9(QQBE.D::?LV=.M#]E.;?\
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M:@ RN2S#CJ!G ]@*6]LK^^U2%9);9=*C*2M&$8RR2*20"<X"@[#TSE?0UJT
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MQ&>6YRKMF  C;M/5QGG&<!17J5% 'ER?V9<>*O!-[JODS"XT62-9IOF$EQF
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M9_*XY_O;OUKFL6.H:?X,E\/>6NJP7EOYXBXFCAVG[0LW<#&0=W5L=R*].I,
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M,' '4=JXRUN+G3->\4V6I:5?74NHS>;931VK2Q3P^4JB(N 53:0W#$#YL]Z
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M%3=70$A#*I&3@,BAO4\=*['PO)!)X;L3;VTMLHA56CEMV@8,% .58 ]>^.:
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MSCB@#J/$'B14\$:OK?A[4+"Z>RMY91(I$\>Y%)*G:PY_'CTJ.36]2C\5^'+
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MV]C;-<74JQ1*0"S>I. !ZDD@ #DDU!I>LZ?K44LFGW*S"&0Q2KM*M&X_A92
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MT\2:-?:HVFVNH0R7BH9/+&?F4'!*GHP!ZXSB@#5HHHH **** "BBB@ HHHH
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M)HH \]T"^DA\1>-+.+1[F[>;4_ED"KY+'[/$-CL3QCJ<CHW&3Q70:1H3>'_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@!"0 23@#J35/2M6L-<TV+4=,NDN;27.R5.C8)
M!_4&L?QQ?-;Z$MA"L[W&IRBT5;="T@0Y,K*!SD1AR/?%<1\++T>'_%^O^"WA
MN+:U:0ZCI<=S&481,<,N#Z<?DQH [:;X@^&+>>[@EU)EEL^;E/LTN81ZO\OR
MCW-6Y/%V@QV%G??VBDEK>@FWDA1I!)CKC:#T[UY+J.HZEI/C/XIWFEV4=W*E
MO:B1'/W8S%AG _B*CG'' ->E_#[3=$L_ ^B#19/M-FD!:"XD WG>=SY]#NSD
M=L8[4 2VGQ \+W[JEKJ@E+3+;@K!)@2$@!2=N <D#GUJYIGBO1=9U*XT^PNV
MFN[;_7Q>3(IB/HV5&T\'@^E<1\&(8I_#WB-)8UD4>([AP&&1E1$P/U! (^E4
M/#S7<?BOXNOI^[[:JQ&WV]?,\J7;C\<4 >@W/C+0;:]GLS>M/<0'$R6MO)<>
M4?1_+5MI^N*CF\=^&;>VLKB35$\F^.VVD6)V$K;BNU2%/S9!&WK[5@?!1K)_
MA;IC6A4R%I3=$?>,N\YW>^,=>V*S?BE:P6E]X%B@C$:'Q+%(5']YY-S'\68G
M\: /2+[4[33=-DU"[D:.UC3>[^6QVKZD 9 '?CCO638^./#NIO;+9Z@9?M3;
M('$$@20^@8KCL>]3>+I$_P"$0UV,NN_^S;AMN><>6W./2N+^%W]K?\(-X5,R
M:?\ V0$8EB?W@;+!,[N,[B!QSDB@#T+5-8TW1+476JWUO96Y<();B0(NXY(&
M3WX/Y4W2M;TK78'GTG4;:^AC;8[V\H=5;&<$CO@BLGQII%]K-E80Z=#ID]Q#
M=B?RM2!:%E$;J25 );!=>/I67\.-5N;D:WI5_HVFZ;?:7>"&<Z;'L@F)7(8#
MKG&.O;'TH [FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HK&UOQ/IF@S6MO=R227EV2MM:6\9EFF(ZX4=AW)P!ZTRQ\3V]WJBZ;/
M8:C8W31-,BW<&U712 Q#J2O&X<9SS0!N45RJ^/=-N+>>[TZRU/4;&!F5[RSM
M2\65^]M)(+@>J@BIKGQUH4'A(>*(IY+O2>-TUNFXH,X^9>",'@CJ,T =)15#
M1=9LO$&C6NK:=+YEI<IOC8C!QT(([$$$'Z5@Z9\1-$UJQU2^TU+RZM=,+">6
M.'CCKMR?FXYX[4 =;17&6OQ/\/7$6F7#"^M[35)?)M+J:V98I'SC;N&<<@]<
M=*W/$7B72_"NG1W^K3^3;O,D"MC/S,>/P')/L#0!KT56O[U-/T^>]>.66.%"
M[+$NYB!UP._'-9GASQ9I/BS1&U;1IFN8%+*R;<2*P_A*GH3QCZB@"S=:%9W>
MM6FK2FX^U6BLL.V=U10WWOD!P<X&<CM5.]\&Z-J'B:W\13QW']J6RA(9DN9%
MV+S\H4'&#DY&.<FJ-]\1-&TWP^FN7EOJ,5@\Y@\PVI.TAMI+8S@;LC)ZD<9K
M<NM<L;:+3Y/,,PU"5(K40C>9"PW9&/X0H+$] !0!1T_P9HVF:Y>:Q;1W'VV]
M&+EY+F1Q*,8 922#@=..*DT+PGI/AK3[BPTB.>VM9V+F,7#L$)ZE,D[/PQ5W
M5]8T_0=,FU'5+J.UM(1EY'/'L .I)]!R:QQXVM52":?2=9M[2>1(TN9;,A<N
M0%R 2R@D@9*CK0!:\.^$M)\*I<II,<\27,AFE1[AY SG&6PQ/)P.?:FZ/X/T
MC0M7O=4L4N5O+X@W+R74CB4C."0Q(R,G'UHO?%VGVVL2:1;17>H:C$@DFM[*
M+>85/0NQ(5<]@3D^E+HWBW2]=:^@M#.M]8\7-C-$8YXSC(^4]<]B#CWH I?\
M*^T2'4KB_P!.:_TN6Y;?<+I]V\*2MZE <9]P!4^I^!]$UBVTZ"]CNY%T^7SK
M9OMDH=9,YWE]VXMGN2:?X9\::+XL:]CTR=S/92^5<02IL=#]/3((S[&HV\:6
M:F51I^IM)%=_8S&EON8R[#(0 #R HSGIR* )H_"&F+#?1/)J$XOH/LTQN+Z6
M5O+YRJEF)7.X],56L/ .B:9#:06K:BEM:2))#;'49VB5E;<OR%MIPP!P1UJI
M#\2]'N&U 0V.K.=.8I>8LS^X(SG=SQT/Y5//X_TV'7;[15L=4FU"RC\V:&&U
MWD1\888/(.1TYYH V-7T.VUG[,TLUU;S6SEXIK68Q.N1@C(Z@CJ#4NEZ19:-
M;/!91%!)(9979B[RN>K,QR6)]36-%X]T.Y\'MXIM9)[C2X]WFM'$=\>W[VY3
M@\?UJ"]^(NC:?H&G:W<P7ZV&H,J6\GD9+%AE>,Y&1DCZ4 ==17.:?XUTS4=8
MO-'2&\AU6T@^T/9SP%)'3CE>QZ@=>]/\->,-.\66MU<Z7%=M%;2-"[2Q;,R
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MZ1KD.L/=1+:WEK/:LJRPW46QAD9!!!((([@F@#4HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /*IIUTO]HQ9M58)#?Z1Y&G22?=WAE)0'H#P_P#WT/6NT\;VLUSX,UM;
M*,-?MI]Q' 5'SG*<JIZ\X'Y"M'6-"TKQ!:"UU;3[>\A!W*LR!MI]0>H/N*AT
MKPSHVB2F;3[".*8KL\TDNX7^Z&8D@<#CIQ0!@?">[M)_A;H;6SH$AM_+EP?N
MNI._/ISD_C7">#+;=\/O%-RJ?\2F]\0![-6'RO%Y\8R!Z'I^!KU";P1X:GN)
MYWTF -<'=.L99$F/<NBD*WX@UH7FA:7?Z=%I]S80/9Q%2D&W"+MZ8 XX[4 >
M2Z!'?^&O$.M?#")9A;7LHN=/N%S^YM),^=SV( *@_P!\U-X!BBM_#_Q-AA14
MBCU*]5$48"J$8 #VKUD:78B=9_LT?G+ ;99,?,(B0=N>N,@5G0>#?#MK#=0P
M:1;11W8Q<*BX$O.?F]: //?A[X27Q/\ #GP?)J-YG3M/D:[CM(XL%YED< N^
M3E1D\ #KR36EX[TZ?QI>:EH\.ES7UM96;0H\<L:K%>2!7#'>PR54)T[2,*[W
M2M%TW0[7[+I=G%:6^<^5$,*#[#M26.B:;IC7+65G' ;IM\Y3/[QO4^_O0!Q/
M@#Q')K_PJG2\)&HZ;!+8W:M]X.BD GZKC/OFN:NM-O?AP-.\<^'X&FTBZM(1
MK>GQ^FT?OE'J,Y/N3V)QZ?;>#O#MFEVEMI%M$MX,7(1<><,Y^;UYK2MM.L[/
M3UT^"VC2S52@AQE=IZC![<]* .9\)P:?XF^&\<,T8GT_4!<95AC<CRN1]#@_
MA7,?!NVFDBU**]NFNO[ NIM)L2P^Y&&W,WU/RCV" >M>EV.E6.FZ8FFV5LD%
MDBE4A3A5!)) _,U7TKPYHVAR32:7IT%H\QS*8EQO/J?4^] '!?&G?;V_A;4I
MT9])L=9AEOE R F1@D>GWA_P(>M>E![6]M$E#0SVSA9$?(9&'!5@>GH0:=<6
MT%Y;26]S#'-!(I5XY%#*P/8@\$5A67@3PQITR2VFC6\91]Z)\Q1&!R"$)V@@
M\Y H X_X5N;?Q?X]L;WY=3_M4SL'^\\+%MA'JN#_ ./#UIUO$UU^T9=W-B/W
M-KHRQ7[KT\QFRJGWQM/_  &NYU/PQHNKWD=Y>Z?&]W&NU+A"8Y0OIO4AL>V:
ML6&B:9I=E)9V-E#;P2DF18UP7)ZECU)/J>: /)+KPSJ.FZ;:>/?"<>=7M);@
M7MJO2^@$SY! ZL /KP,<@5VOPWUVT\4:;JNM6B,L-SJ)D59!\R'R(@1]0<C-
M=3INE6&CVIMM.M8[: L7\N/@9/4TFGZ3I^E13Q6%I%;1SRM/(D2[0SMC+8]3
M@4 >??#,*_C3XBJ0"#JH!!_X'6-J<FMQ?%_QI)X=,)U5-#B:%94+!L;,@#(^
M;'3.1G&17J6F>&=%T:[FNM-TV"UGG_ULD:X,G.?F]3]:2'PQHEMK#ZO#IL":
MBY)>Y ^=L]<GN/:@#S:SFT.7]G+4CH2-'"+"83QR/ND6?'SASZY]AQC@5F>,
MP6^!?@0*VUC/IP# 9P?*->K'P;X<:.\C_L:T$=[)YER@3"S-DG+#H>II9O!_
MAZXTR#3)M(M9+&W??#;LN4C;&,@=J .'T7S]+^.M]87;)JMS=Z6LQU ILEMD
M#8$1"G8%) / !.1G-/\ @E+&FA^(K5G43P:Y<F2,GE00N"1Z<'\C7H&F:%I6
MC&4Z=I]O;-,097C0!I".FX]3^-9FH^ ?"FJZB^H7NA6DMU)S))M*F3_>Q@-^
M.: $\%%)M$GN4VM'-J5])$XY#(US(00?0C!KE?@F%?PWKP(!']O7)Y^D9KT@
M6ENME]C2%$MA'Y0B0;5"8Q@ =!CTJEI'AW1]!\T:3I\%F)3ND$*[0Q]2/7WH
M \PTR*ZN/&GQ=AL-QO)+2)8-O7>8'"X]\XKI?@U<VLWPKT=+<J# )(ID'5)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BL_6M0ETO2I+NWM?M<P>...#S
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M)/84 =712%E#!2P!/09ZUC^)O$UAX5T&XUB_\U[>!E1E@4,Y9B  !D=R.IH
MV:*R;V_U6#Q#IEI;Z8DVFW"R?:KMIU4P,%RH"=6R?2M%KB!)EA>:-97^ZA8!
MC]!0!+137D2/[[JO!/)QP.](98UB\UG41XSO)XQZYH ?138Y$E0/&ZNAZ,IR
M#6;XDU670O#FH:M#;)<FR@>X:)Y3'N5%+$ [3S@>E &I16!INKZU?)I=Q)I%
MHEI>J'=X[UG>%3&7!*F( \@+UZL*WMPW;<C=C.,\T +137=5(7<N]ONJ3C-8
MGAC79]<M+V2[MXK>6VOY[/9'(6#>6VW() SG!/2@#=HILAD$3F)5:3!VAFV@
MGMDX./R-<+'X_P!2;P?<^)WT&W^PVDLJSQI?DRA8Y"C,H,8!Z$X)'% '>45S
M^C^(9]4\2ZMICVT<<%G;VT\,JN2TBS;R-P(&TC9TYZ]:WPP;."#C@X/2@!:*
M3<N[;N&3VS574IKVWTZ:;3[2.[ND4F."2;R@Y]-VTX/X?E0!;HKF;/QE;ZAX
M1AUJUM9'N9F\A+!FVR"YSM,)XX(8')QP 6Z5T:N0D?F[$D8<J&R,]P#QF@!]
M%(6"XR0,\#)ZT$A1DD >] "T450GU>V@UJVT@EC>7,$D\:[?EV(5!)/;EUH
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M*6C7<0<_("5/)QWJUX4U"6WCL8]62&;4+FQ4:%?KS 1Y8_< '(CE!'S=V]>
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MVJZW8V7B.TU,RW$;6Y%[YHE)V[C)ED9>,A=NPXZ"O7*3 W;L#/3-+0 4444
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MF"0=HSS@@CCTJZ3@9/2O'K;2HD^#UK)%I3IJ-MJ<4V!:L)DQ>@[L8W?ZL_\
M?-=UX]M[[4/ NH1Z5&\T[K&_E1_>EC#JSH/=D##'?.* -RVU33[PR"UOK6<Q
M#,@BF5M@]\'BFKJ^F//# FHVC33 F*,3J6D )!VC.3@@CCTKD[X6VM^+?#FJ
M:8,VUG#<_;Y/**J(&CP(G!'7=M.P\C:3BN7M=*B3X064D6E.FH6VIQ38%JPF
MCQ> [L8W?ZL_E[4 >B^,-4O=#\(ZIJUAY!N+.W>=5G0LK;03C 8'\<U>L=5L
M[QA;I>6TEXD:M+!'*"Z9 ZKG(_&LGQW%+>_#S7HK6*2>6>PE6*.-2S.64@
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MRW*&>0QYR 2-I&/:BVF73?&WB8:Y&WV>_C@-E*\9=)85CVM$, \A]QV=3OR
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M&>G(Q7IFMWCQ^&-0O+2S-^ZVDDD=L <S':2%QUYZ>M %JVU/3[QIEM;ZVG:
MXE$4JL8_][!X_&FIJ^F2W$=O'J-H\TH)CC6=2S@$@D#.3@@C\#7G^D2)/XXT
MG4VCE:VFT6>&>0:>T$ 8/$1& 1G  ?AB>^.]8D&F68^'.B(^DL+I-?621/LC
M>8L?VMBQ(VYV^4?I@T >OVE_9ZA&TEE=P7*(VUFAD#@-Z''>FP:GI]U/)!;W
MUM--&,O''*K,HZ<@'BO.M=TN].L^,[70;=[>?4-#@^SM%&4664&4, V -VTJ
M/7D5HWBP>(+OP?+HMN\4UC<A[A3$4-K;>4RR1."/E).Q=IZXST&: .U.HV(M
MFN3>6X@4E6E,J[01U!.<4ESJ>GV?F?:KZV@\M=[^;*J[5R!DY/ R1^=>2ZD%
MC^'GBWP^NF7<FH+J-U+%;)9N?D:?<CJ=NW&T\8/L*ZK[/8WOQ:%RUDLL3Z,$
M$SVY*&3S<XW$8W;/QQ0!TFJ>(;+2[;3[AB9XKZZBM87A*E<R'ALYQMZG(K5#
M!E# @@\@BO'_ .SH8O"6G1W.ER-;Z=XID9XC:,_DVQGD((7:3L(*]!C&*])U
MN<V?@^^GL---WY=DYALEC*^8-G";<9'IC&>U %ZTU*QOWE2SO;:X:(XD$,JN
M4/H<'BBUU/3[V:2*TOK:XECY=(I5<K]0#Q7FL3)<^)TU%H[V2UN/#ES#+);6
M#6ZE@R$1Q@C=N WXR3['K6SX274K;7+>R-];:QI<-@R17PM/(EM\,@6)B#M;
M(!., C9SC(R =/>Z[:V.O:=I$JOY]]'-(C\!%6/;G)SG)WC'XUE:#XH,\VKP
M:U=Z?;R6NJ/8VY!\H2@1QL.&8Y;Y^Q]*H>)K.S'Q%\-7M[IWGP&VNH&E%H9@
M)"8C&&PIQT?!/O6*--MM1\/_ !',FFF:XGGN7M_,MB6D7[.@0ID<_,#C'<4
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M&GF!:.-9E+.!D$@9R>A_*O.]*DCN/&.AZG)%(;:31[B&X<:>T$"G,1$0!&[
MPWWB>G'>LZQTJ*+X3:#+'I;QW]IJ=M*_^C,)H\7(+$C&X?(?R]J /5AJ>GL\
MR+?6Q> $RJ)ES&!U+<\8]ZG@N(;J%9K>:.:)ONO&P93VX(KAM:MKK3/&PFTV
M-_*\36OV.62,?ZF>,$K*?^V1D^OE@5V/V:WT_1S;6\+);6\&Q(H>H55P OO@
M<4 12ZK;7$=U!IVH64E]%&S>7O$A0C^\JL#C/'45G>$_$T6N>'](N+RYLTU.
M]M$N6M8Y &^89X0DMBN7\/?;=*N+*UBOXM7T:#3I46=[(Q7%DH";8V9>&+8
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M65[4PQA-X8;@4'S@YXSP">*KZX(5^)OA^=K=C&EC>1W$HA)4;O*V!FQCG:V
M?>@#IQK&F&:&$:C:&68D1()UW2$'!VC/.",<5+?326]A<31>3YJ1L8_.?8A;
M' 9NPSCFO)ETF$_"&_,.E.+^+4GF11:D3+_IFY&48W?<((QVKTGQ*89_".IE
MD\Z.2SDVKL+;B5.W QR<XH C;Q'%:/H-M>HGVK5@0&MW#PHRQ&1CN.,KQ@''
M.16BVJ:>EZMD]];+=-]V S*'/&>%SGI7F[VEH;/X<7=_ICS6]O;FWN=UDTIC
M;[-M574*2/GXZ=:M(E]9ZZ1I%XE[;7&L[[C2;RS(E@_>8>9) 00H"[EW C&
M#R!0!Z)<7,%I"TUS-'#$OWGD8*H^I-1+J=@]E]M2^MFM/^>XE4Q]<?>SCK6%
MXTMTN+;3/^)E-IL\5Z)8+M(1+'&XC<?O%/&T@D<XY(YKE[>768]3T'4]7MHF
MTVUU"[6>XM;=T20L@$5RT9)*@GS 3T&[=T.: .L\5>(9-/\ !.I:[HMQ97#6
MD+2JS?O8WV]1\K#^=;$VHVEE:Q37UW;VRN!\TL@0$X[9->:^(K&=]-^(5]90
MRM8:G9Q16T<4;'[1<"-@[HH'.04&X=2I]*O7%Q/:^.WO;RXN8-,O=+AAM+@6
MAEC5E9C)&WRG8QRIYQG&.U 'HRLKJ&4@J1D$'@BN6\9^*3H-@IL;S3S?"X@1
M[6<[G9))50D*&!& V<X(XK0T#2X]'\)VNFZ=/<.D,!2WDNUPXZ[=P(&,9 Q@
M< 5YO/<"Y^%]CI4VD7[:Y8W-HUZLEFY=)%N$,DN_&&W?,<J22&],X /4EO+A
MO$#6?^B&U%L),B;]_P"9NP04Q]W&.<]34UMJ>GWD\D%K?6T\T8R\<4JLR\XY
M .1S7%WS0?\ "Q[ZY%O<-!)X>9'E@B8%VWEMH;&-^WD#KTK$>S\1#1[O2=%U
M"'5X5T6>&TO%M3;W%J1L"1%@=I+ >@(*Y..X!Z6FLZ5)<S6Z:E9M/ ,S1+.I
M:,=,L,Y'XU)'J=A*LK1WULXA17D*RJ=BL,J3SP".0>]<?)>Z#J_A"Y:WTZ2.
MYATJ2'[/)92*\.57,1!7KN5<#OC(K FTG[#X$\)7VF6$D/D363ZO]GM2TQ5(
MV&YTQE]CMN(P3QGM0!Z!JWB;3M+\.W>MK*MY:VW#?975\G(7 .<9R1WJPU_,
M=<M[6)K)K1X'=R9_WV\$8VICE<$Y.:\_\2Z-9W_A'Q-J=F]WJL][]FDD5K0A
M<Q,!NC78,MLR"1GH!6EBQ/Q"T&XTJS,%LVEW48D2S:)%9WB* _*,9PQ /]:
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ML\E';!&0.!D]0:JS:3;M\/\ QBMKI3_:$U>6:T5;5@^SS59&C&,[?O$;>.M
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M,$@/(SAA\V,[0!@8Y-:]K=W&EV6W7;R&69IVC@>*(JTR]5 0$DM@'(7TS@4
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MKU<7J/BM9/''AK3=-U,-#>2S+<0>4,2(L+NKJQ7D;@.5.*[2@ HHHH ****
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MB:15"H1GA 5.<XY(QZUN>(M!3Q%I\=G+=S6\:3QSYA"Y+1N'7[P/&5%:R@A
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MIEWXOT>SU"33VDN9;V.$7'D06DLK-&3@,NU3N&<\C(XKGH-"UBQ\-^(?#7V
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M'0\D8XK;KB?#&BW%EXCU2S<(=(T^\>XL #]V2= S+CMLW/CVE]J[:@ HHHH
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M:;<7'V8WCQ($AD,AC 8;]V"P^\ 1R.<Y GT_Q'=W7CW6=&>VF:TM(K?RG6+
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MRDMC//!O 'F6\FQUYSP>U<1H>LBV\9^,[S4EO;"TM+.TF>.]EWB(8F+,NUF
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MD-\ OEM(6*+QNW;2PVAL8Z=CFH/&^M7FF6VE6.G2B&\U?4([%+@J&\A6R6<
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M91C[VW../[M:-% ''VW@JTN/#<T&M:3IEUJMRDAN9ASYDCY)(D*;E&3QP=H
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M;9MS^5,'=R4?Y<IE9".-V#ZUZ'10!R6N:;XAUR'2&-GIUO)9:E%>2(;QW!1
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MK!96L=M;1+%#$H5$48 %2T %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$EM>21JC-O3>R': "5RO;O\ 2@#N**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP5 1_P!T-N0Q.1G[IXK \->.]>\6>&SKFE^&+1H-[H(9-4*RL5ZX'D[?S84
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:I:Z?#-)IVI3B./<(\0H68HK8.T8' QC@5NZ9\3;Z[O?#'VWPX;6P\0*1;W
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M>HVDXYSZB@#JZ**YZ?Q,UGXJETB[M8X;9+!K];LSD[HU.UQMV]02">>A'TH
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MSG)4,"ISSP?3TY[6B@#C]:\(:GK6I^';^76K9)M'E,Y L21,YX/_ "T&U<<
M<GW-94_PRN[G2/%>GS:[#M\0W N&=+$@P-N!P,R'<,#';U]J[V\O[/3H//OK
MJ"VAW!/,FD"+N)P!D]R:L4 <)?>!-3&O:9X@TK6+6#5;6R%A<">S+P7,0.1\
MN_*D'GACT%3>(/!6I:O?Z'K-IKD=GKNE;U^TBTW12JXPRF,MP/3D_GR.UHH
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M<@A]W7YS_#V%7] TS6M+M;>SOM5M;RVMHQ&C+:&.5P!A=YWD9QUP.?:MRB@
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MES&Q'RACR001R<8I]YX9?4B(-0OA<V*7@O(XVA'F*RR>8JB3/W00.@!QQG%
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MAE@M4B$$V_A 4^4Y7<2.HP/49 -)M:O-0U[4](TK[/')IL<332W*LP9Y 65
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M<E4&U2.6"EB<\9'!SQ?LO'SZC)8V30)I=]-8F\F%XCL(OWAC"A1M)R58@G'
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MAF@9\A)8V*,-V.1D<''3M7G5S=ZM??"+4[C442;_ (FA\M_M+2.2NH!=OS*
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M8*NY4KDGKD*Q ],YYJMK/AMM5UW2=6COGM9],9S%LC#;PXPRL3U4C''J <T
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M*P*PYV@]/G?![JAJ+2O'$L/PNDUR^A+ZEIJFTO(')0_:581X;(^4$E6Z<!J
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MUN$N8_)91^\0Y4G(.<'MT]<U6N?"EC=:I>:@9[R.6]M1:W*Q3;4D4!@&(_O
M.V#^E7]*UG3];MFN-/N5F1',<@P5:-QU5E8!E8>A -7J ,RTT6*WOTOY[JXO
M;N.$P1S7&S*(2"P 55')5<G&>!5C4;!=1MTB-Q/;LDBR)+ 0&5ATZ@@_0@T7
MNJ6.GV%U?75RB6UHI:=Q\WE@#)R!DYQVJS'(LL:R(<HX#*?4&@#"N/"&F7D$
MRW33RW,L\=R;PN%F66,81E*@!=H&  ,<G(.3F9O#=M(EXT]S<S75Y +:6[<I
MYGE#/R+A0JCYFZ#OGKC&S10!S7_"$Z<D6E_9[J^MKG3(/LUM=0RJ)!#P/+;Y
M=KKP/O ],]:W[6W%K;I#YLLNWJ\K[F8]<D_Y [5-10!B:KX7LM5U6WU0S7=I
M?P1F$7%I,8V>,G)1NQ7//L>F*IOX$TIM'U#25FO$L;^Y-U-$L@)+E@QPQ!;D
MA3U[>YSKOK5@EW>6GG,]S9Q+-/%'&S,J-G:0 .<[3P,]*HP>,-(N8-&FBDG,
M>LG;9MY#8<[2W)QA>%)P>: 'W7AN*\%U'/J%\UO>($NH-R!)AM"'/RY7*C!V
MD5&_A*R76)M3LKF\T^>X1$N5M) J3!1A=RD$ @<9&#CO6\[K&C.[!549+$X
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M D"1L"453NDWJQ()8\#'&._-5!K.K:OX<\1ZQ::D]E/IMS=16\ C0Q@09&)
M02=VW)P1@,,8QD]'+X5TF35Y=46*X@NY]OGM;74L(FV\#>J, Q XR1TXHF\+
M:1-<7<S6[J+TYNHDF=8ISC&70':20,'CD<'- ',6.JZUXA\16=LFJW&G6E]H
M$.HM%%#$9(9'8 A69#Q_O ]^G&,B]O=4UOPOX<-Y?J;N#Q,+1[A85!D,4[HK
M[>@.%R1C&:]%70=.77/[96*07_D_9_,$S[?+SG;LSMQGGIUYJI)X.T.33I+
MVL@MWNOMN%N959)MQ;>C!LH=Q)^4CK0!G17>J#QO?Z,^JRO FCQ7*-Y489)3
M(ZEA\O\ L#@Y')KG].UOQ%_PC'A#Q%<:V\[ZC=6MO=6AMXEA9)6VDC"[@PR#
MG=CCI7;CPSI8U&34!'<"[DMQ:M*+N7)B&<+][W)]<G-1IX2T5-%M-(6UD%C:
M2I-;Q_:),Q.ARI#;MPP>@SB@#$AU752/'$+ZG)G2Y!]DE,4>8Q]G27!^7!&6
M(Y'2B#6;O4M$\.VXU.]75+[2TNY4L88C*_RQYD)D&Q%!8\8&21CH16S=>#]$
MO=0N[Z>VE,MY&([E5N95CG 7:-Z!@K$#@$C/Y4@\&Z&#IY6UF0V$/V>W*W4H
M(BX_=L0WSIP/E;(XH Y&P\1>(-3TWP5*=3^SS:G<7%K>%8(R'\M)3O (.&_=
M@\'&>Q'!EN/%.K>'(?$UK<WWV]M/NK.*VNKJ-%9%N-HS)L"@A2Q/ &>E=1!X
M+T&V6P6"TEC73Y&EM%6ZE A9L[B!N[[CQ[FK%QX8T:[FU*6XLA*=3C6.\5W8
MI*JC"Y7. 0.A !H Y_Q+>ZOX52WFBU2[OUU*]MK%$FCAW0,['<R$*HR5& &.
M <?2M;0VUU=8OTOX[C^RS'&]J]TT/FJ_S!U_=D@KPI!//)]L2?\ "(:,VE2Z
M9/#<75G*%4QW5W+-M"G*[2[$J0>A&#P/2H;_ ,(6MWI!TI9[DVD\L9NOM-S)
M.\D2'=Y89V) ) !]B>_- &SJ4ES%I5W+9"(W2P.T/FG"%PIV[CZ9QFN#MO$>
MHO::E;7%UK.G:Q#I4EU]GO[6'!=,9DB=5*LN2 1GH1@"N_NK2"]L9K.=-UO-
M&T3JK%<J1@C(P1P>U5(-!L('D=DEGDDA,#/<S/,WEGJN6)P#W]<#.<4 <R^M
MZHMIX#N!?MG5'BCO$\M,2[K=Y">F0=RCI@<UE6=MJKIXXN].UR336MM5FE0)
M#&ZNZP1']YO4Y7@<+M/7D]NJMO GA^T2S6.VN"+&026ADO9G,! *@(2YVK@D
M;1Q[<5./"&BC4+F]%O,)+IS)<Q_:9?*F;U>/=L;TY'3'I0!Q]WXLUQ=/AU/4
M8=3L;&73;>X%UIT$<Z6LQ3=)YZ,"X RO08V^_-:&DV]S=_$SQ+/!J;QQ&SLB
M/*B0[E83;>6!Z=??-=/=>'=.O9[F2=9V6Z %Q"+F012@ +AD#;3P #QR.#FA
M_#NF/K#ZL(I8[UX1 [Q7$D8=!G&55@"1N."1D9XH \]N+S4]?\#^"KRZO_\
M2IM:A\R40KDL)) I Q@8V],5UFG7>IMXVUC1I]3EE@ATZVFB8Q1JR.[2JS#"
M\_<!P<BKH\&:$-"AT9;25;&"83PHMS*&BD!R&1]VY3DD\'N?6I+KPKI%WJ4.
MHRPSBZBA%OOCNI4\R,'(20*P#C)/#9ZF@#@I[W4_$'@OP5>W.H9NIM<0/,(4
MR2'E"D#&. O3'-;U[X@U+0]>\0I-=/?6^G:"FH1PM&BDR9E!Y4 X/ECUQDUM
M?\(9H(T.'1EM)$L8)A/ B7,JM%("2&1PVY>2>A'4U:B\.:7#JLFI+!(;N2 6
M[N\\CAHQG"E2Q!')[=S0!S-YJVKZ9IOAC6%U)[Q=1NK:"ZMVC01LLX^]'A<K
MM)!')R,YSUK,GU+Q(?#7BW5(_$4R2Z'>7(MT%M"5E2)%;;)\G(/(^7:>3R>,
M=M8^%])T[[.+>"3R[5BUM%),[QP$@CY%8D+P2!CH"0,"FQ>%-&AL-3L5MI#;
M:F7:\1[B1O-+C#')8D$CN,4 :=I/]IL[>8@!I8U? ]P#_6L+6-6N1XOT?0()
MFMH[R">XDG4 LWE[ $7<"!G?DG&<#CK5G3/#D&GZW/J98N_V>.SME9F;R8%Y
MVY8DDEB23Z!1VYN:GHUCJQMWNHF\ZV?S()HY&CDB;&#M92",C@CH1UH X'6O
M$>OZ;H_C6VCU%_M.AM#):7IBCW2)*H;8XV[25R>0 <;??/>Z39ZA9Q7 U'4S
M?R23&1&,*QB)2!\@ Z@$$@G)YY)QFJUUX6T>]TJYTRYMGDM;I_,N 9W#3-QR
M[AMS= .3T '85K0Q+!"L2%RJC +N7/XDDD_C0!P'B7Q'J%JMSJ>DZC=S16.H
MPVLT0@B%MS(D;QL6_>,PW_>4X!X[&M6&_O/$6H^(;6'4Y=,CTJX%LGDI&S,?
M*5R[[U;Y<M@ 8X4\\\7)_ _AZY:\,MD[+>3BXFC%S*$\T,&\Q5#85LJ,LH!/
MXFIKCPEHMSJQU.2U?[6Z+'*R3R()U48 E4,%DP/[P- ''>$-8GMO"'@#1;>3
MR&U2T?=<8!9%CCW84'(W$D=0> >*MZ+;W5IXQ\<1_P!JSS3I:V3)<2)'O3Y)
M2 0%"G'TZ?G71-X*T!]$M-(-DXL[-Q):@7$@>!AT*2;MR_@:DM_">C6DMW-!
M;S1RWD2PW#BZEW2JN<;CNR6Y/S=>3S0!Q,UQJ.NZ3\,[V:_V75U.DTDJPKGS
M#:RL6QC'J,8[UHZCXHU30;GQM+).U]'I-A;W%K%)&J[7=9"<E0"1E1U["NC;
MP?HC:38:9]FF6UL)!):!+J57A(!4;7#;@,$C&<8-6(O#>E17]]>BV9IKZ,17
M7F3.ZRH 0%*L2N "1T[F@# U.^U71+SPW,FJ2WT&IW:V5S&\<8&7C9A+'M48
MP5Z'((/XU@7&L^)(O!>M^(!X@E,VDZA<Q1P_9H?+FCBF*;9/ESDJ.JE?QKO+
M'PUIFG_9_)CF86RE+82W#R" $8PFXG;QQD<@<#BHD\(:(FCWVD_9)&L;YVDN
M(GN)&WLQW,<EL@D\G!% %O7M3;1O#NI:HD7G-9VLMP(_[Y12V/QQ7*W>KZOI
MFF^&-8747O%U&ZM8+JW:-!&RSC&Z/ ##:2".3D9SGK7;K!&MN(""\8781(Q?
M(]R<D_C678^%])T[[.+>"3R[5BUM%),[QP$@CY%8D+P2!CH"0,"@#!\$07?_
M  D'BZ:2^9XAK+J8?+4 GR(<-GKP.,9[5J:_>R2:E;Z39ZA>PWDD#S>38Q1-
M)M!4!RTH**H)(QU)/'0UH:;H6GZ1<7<]E'*DEW(99RT\CAW( W89B,X ''I3
M+_PYI>IZG!J-S YNX(S$LD<SQ[HR<E'"D!UR,[6R* *G@?5KO7/!FF:C?E3=
MS1'S61=H9@Q7.!TSC-9O@W'_  E7C;_L*1_^D\==+I.D6.AZ='I^G0F&UCSL
MC,C.%R<D#<20,]JSQX0T=;R\NXUO89KR3S;@PZA<1B1L8R0K@=,#Z"@#@];U
MBY\/>,?%NL:3&&A,5A9S, "GVIY-N[D@%EC9<Y/4KFM;Q!K_ (E\,6.J:G]G
MN)-.2UC\IK\P%X[AIECX$3<IM?<<XY7J :[%O#^D-HLNCG3X#ITJE9+?;\K9
M.23ZG/.>N>>M0P^&-*BT^>P>.>ZM9X_)>.\NI;@%/[H\QC@?3T'I0!BR2>)H
M;F]<->Q:=_9TD@FN_LQDBN%(*[0F059<Y!'&!C&:Q;+4O$CV_@FZ?Q#(_P#;
M\*QW4;6T.V,FW,N^/"Y#?*?O%ER?NXXKL[7POIEI8RV<9O6@DB\DK+?32;4_
MNJ6<E1],4Q/".BI%I<:V\X32_P#CR NY?W/R[>/FY^4D<YXXH Y"?Q9K.B6>
MK6$MT]_<6^N6VFP73QQK((YEC;+ ;4+ .P!.!G&>]7=5U[Q%X;M=5OYX)6TX
M1VZVLE^8=T4[RB-L^4>8P&5N<'@C/3'2W'A31+L:F+BQ$JZF5:[1Y'*R,H 5
ML9PI 5<$8/ IR>&=+&FW&GS1SW=K<1^7*EY<R7&Y?3+L2/PH YK4K*XM/B;X
M3:?5;B[62.]Q%,D8V$1KDKL53@Y'!S6M\1?^2;^)/^P=-_Z :GM/!FAV5Q97
M$5O<&>R+?9Y9+R:1T!&"NYG)*X'W3QUXY-:6K:39ZYITNGZA&\EK,-LD:RM'
MO'0@E2"1[4 <E/<ZJ-;\*:79ZM+:6E_ILS3*D,;,IC2+:4+*<'YSUR..E5X[
M[Q/<^%/$\%EJCRZOH]])%;7!@BW7"*B2!'7;MW$.5R .<'UKJH_"^DQWEA=K
M%<&?3XVCMG:[E;RU;&1RW(.!UST'I5JQT>QTVZO;FTB:.2]E\ZX_>,0[X W8
M)P#@ < =* .1O?%=Q_8-WXGTR[DN-.LM(^T>0R(5FG9-RAB%W#:N"P!'WQTP
M15BTN_$YN+&ZA2>2RELY&N6OFMUC638&C=/+;< 3D$'(P0>HKH[#0M+TS2Y-
M,M+**.RE:1GAQN5MY);.>H.3QTQQTJK8^$M(TZT>TMX[K[*T30B"2\F>-$88
M*JK,0O''&,=J .2M-=U&YMKO3M4EU:PU5]*F=[:^M8S%(ZA=SPR(,$#)&,]&
M!QQS!8S:QI/@/P*MGK+Q_;9+*V8&WC(6)XL[1D9R-O!SWYS7>6^@:?;N9"DT
M[^2T :YG>8K&V-R@N3@' SZX&<X%4H_!.A1V%C8K;W/V>QF$UJAO9SY3@84@
M[\X X Z#M0!S1E\1F[\5Z8OB:Y']D11W%K<&V@,K%XV;9)\FTJ"O95//6I+/
MQ;J>L:EHVGI#<K]JT&+5)FLO*#EY"%P#*<!1STR>5[=>LC\-Z7'>ZC>+#+Y^
MHH([IC<2$2* 0!@M@8!(& ,9JJ_@S0V@T^);>:(Z<GE6DL-U*DL28 V!PV[;
M@#@G'% '.O?>+(KGPI97]^;*ZOKFYM[H+%"^]$CD9'X!"N0JDX.W/;'!RO$M
MYJA\&_$+1KS4VO!IL2^5<S1()&CDB#E6V!5R"2,@"O0)?#6ESW&GSRQSM-I[
M,ULYNI<HQ!!)^;YB02"3G.:2X\,:/=2:J\]H7.JQB*]4ROME4+M'RYP" ,9&
M#0!=L+>>VL4BFN3<R*/]8R!?H,#BN3^$\_G> +83'_3X[BX2^#??%QYK%]WO
MR#]"*ZVPL8=-LH[2W,IBC&%,LSRM^+.23^)K/E\+:4^I3:A%'<6MU<8\][2Y
MD@\XCH7", Q]R,^] 'G_ (BFOM*\2^/=6T2Z>U-MH\$LTD:*P-TH<J"&!!/E
M[<]^171WTVO:-KOAZ8:Q)?0:G=?9;FQD@C"H#$[^9&54, NSD,6X/6K'C+2$
MM_ASKFFZ38R/-=6TB)%"C2/+(XZL>22>[$_4UJZ#HFGV%K;S6\5SO\L!#=RR
MR/$"!E5\TDH.!P,=!Z4 <'8OJNE>#O'6JVNK/'/:WVH3(%@C*^8G.3N!ZXQB
MNGBU>\U+Q5#H0NY+:--(COI)8E7?,[N5XW @ ;23@=6'88.C)X.T.6/4XVMI
MO*U1F:[B6ZE5)"WWCM#87/?&,]ZFE\-:9*UG)Y<R3V:&*">.X=9%0]5+YRR\
M#@DC@>E '$'Q)XB:UAMQJ/EW-MXF&CR3F!"+F$X8,RXX;! .W R#^'1Z%=:G
M:^--6T*]U.74;>.S@O()9XXUD3>TBLI**H(^0$<9YK2N/"FC7-M:6\EJXBM)
M_M,02>1")LY\PD,"S9).3DY)]:MKH]BNM/K"Q,+YX5@:02-AD4D@%<[3@L><
M9YH PO%>IWNB:SH%[_:+P:1-=_9;V/9'M&Y6,;;BI(&X!3S_ !#I65:^(M:U
M"YU#1IIFL-4DNH)K$I&I(LY1NY#*0654E!X^\ .]=IJFE6.M6)LM1MUN+9G1
MS&V<%E8,O3W H?2K%]8BU9K=3?Q0-;I-SD1L0Q'IU _7U- &%87U\?'.N:5/
M>O/9P6%M/$CH@*,YE#<JH)^X.M<CHN/^$/\ A7_U^1_^DTU>A?\ ".:;_:=W
MJ0CG6[NXA#-(MS*-R#.!@-@8R<8QC)JK%X,T*&UTZVCMIEATU_,LT%W-B%L$
M9'S>A(Y]30!!\1 Y^''B/RY A_LZ<DE<Y&PY'X]*J--<VUII6C)K%\U[-:M*
MJ65O#YI10@SEQL55SCGDDC!X(/57ME;ZC87%E=Q"6VN(VBEC;HRL,$?D:QQX
M,T0&Q;R+GS+)&CAD-[-OV,02C-ORZ\#Y6)''2@#A;[Q#J-WX,\%ZS=VTE]J$
M>LN&BMU57G:-+E.!G )VC@=SQ6S=^+KJ'PG9:Q:7XOI-6U"WM%$4:*MIO?:R
MJ&P=P&1^\/WNH XKH4\%Z#%;65M':2I!93M<VT:74H$4ASE@ W^TW'3D^M27
M'A#0;K^TA-IR,NI%6NTWL%D9>C[0<!^!\PP>!S0!#HC:ZNMWJ7L5Q_930QO;
MO=M#YJRY8.O[LD%<;2"><DCTK.OM<U&\\:7^@VJ7L<5G913;[/R=[/(6Y/FG
M&T;1@ =2<]JZ33=)MM*1E@>ZDW  M<W4D[8'0 NQ(_"J^I>&],U34(=0GBFC
MO84,:7%M<202;"<E2R,"5SS@\4 <9,GB"Z\3^!QJMRMCJ9M+S[0L*(XWJ(\G
MN/F&.G3FJT^JZAX;NOB-KL=SYYLIXV6V,8V,QMHMI)ZX7(S@\XKO)/#>F2W]
MC?/%,;FQ1DMY/M,OR!L;OXL'.!DG.<<TD/AG28)M1E6V9SJ61>++,\BS?*%Y
M5B1]T =.G% '.7FK^(M%BFU8V]W<Z9;Z9<7%PMVUN#YJ*&C,?E$G#?,"#D#@
MCOF>XMM5NO##ZM_;\LB7&EO)+ 88S#EH]P*84, .<98\'G-;FF>&=,TF$P6R
M7#0>68EAGNI9HT0_PJKL0!VX'3CI3-,\*:3I$+6]G%<+;%&C%L]W+)"BGJ%C
M9BJCZ#CM0!5\ 6\UOX#T)9;EIPVGVY0%%7RU\I<*,=<>IYK!\3^(]0M4O-3T
MC4;N6.PU"&VFB6"(6PS)&CQL6_>,WSGYD. <#L:[/1]&LM!TZ.PT])4MH^$2
M2=Y=HZ  N20 !@#H*S;CP/X>NGO3-9.RWDPN)HQ<RA#*"&\P*&PK94990"?Q
M- &'JWB'4M,U^Y_M,ZG9Z:MY"MK>VD$<UKY1V!EFX+JQ8NN> ,KCW[VL@^&M
M-:5W=;B1'E69X9+F1HV<$$,4+8Z@'&,9&>M:] !1110 4444 %%%% !1110
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MRV1D^Z?E8\D9Z<\ 5O23ZH^N>.;&QU1XIDM[7[$;B0F."619.G7;EL=O3TH
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M::9P50*.YR0?8 GM7-:;_;E]J.K^&GG/G:58VD$#+?R6Y#&$%IOD4[\OD<Y
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M R;3PQH-A]G-IH]C";<EH62!08R<9(.,C.!^0]*FL=#TO375K*PMX"JE$\M
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M:2/3[*%HFBM+=&B7;&5C *#T'' Y/YT <?XZ@LW\3>#WO;B6W@^W3*TBW3P
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M;;6$<OQ!S>W,=VEW,RH-0E5@GV:(AMN_US\V.@QG'%>BKIE@EX;Q;&V6Z/\
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M@ALX)KTY]/LI'C=[2W9HP C&,$J!T XXQ2'3K)KT7IL[<W8&!.8EW@?[V,T
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M12%#HG@O5M"G=]1NKNV2:19"7NHF7]^)?[V!N8YY4KVKT1;&T2X^T+:P+/\
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M?]V\(0&.4X/WMY #]3N/-)\*K2WA\&1W$,L[M+<7(8/<R2*-MQ*!A68A>.N
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M"@($& 7;)QGL#C.:XS2+HZ9X?\-_;4F.A6FK7T5]'Y1(A&^7R/,0<A 2#@C
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MC@U#?7/V:V9EE@CE88B\YL*S=A_^JF:9I]AI>GQVNF6\-O9J6>..  (-Q+'
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M..N.>QKGH-&URV\&Z!$VAW+W.G:\][-;*\6XQ&2=PR_-M)PZ\9SFM37=$O\
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M3N+#Q-J:Z;)J&E7KWEEKB7,Q$\:P"!9&(,2!OF^4KDL-V2>3TK2M=*U-]/\
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MTJPN/(GGD+"18G:*"25(W;&%=E4JA.1]XCJ*KZ5K<$L6KW,VKPW-O;7C1?+
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M;9AI ZDY&[=@@=<=:U?%KZQ'9V+:1!-,OVQ/M@M]GG"##;MF\@9SM'K@G'-
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M444 %%%% !1110 445Y]XW\2"?0+6XTK^TEBDO[9(M0MF*0N#.BL"0P)4J6
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M),T,R@LZ.VQ2NTD'+?+UR#C.,UHV.HF\EGBDLKFTEAVDI.%Y!S@@JS C@]Z
M+M%9=UKD,%[-96]O<7MU!$LLT5L%)C5L[<EB!D[3@ Y..E<UK_C&TN=-\/OI
MTEU-8ZS=F"22UBE\T1A'+*NT;E?<@4CAA\V.F0 =S156)H;#2D8M-Y%O #F3
M<\FU5[YRQ; ^I/O67#XKLY+^YL)K2^MKN"W^U"&6#YI8LXW)M)SS@$=1D<4
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MJ6G&9K6491Y86CW#&<@,!D>_2L=/$EE8W7B>[GN]1FBTTH]Q ]OQ;+Y>X^6
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M$# 4*!^.1GC%6-%\16,?AY;Q[^]O!+?2VT1N(@LTDOF,OE*H Z$$<]ER< 4
M=117/R>,-.MO[2CNX;NVN=.@%S/;/%ND\DY_>+M)#+P>0>,<XIMEXTTV]O\
M3[46]]"-23?9SS6Y6.8[-Y4'UVY/. <'!- '0D!E*L 01@@]Z%540(BA548
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M HM+J6W*Q.[+N"9[,0#VP<<&@#IZ*P]0\566F7<<5U;WBV[W"VQN_)_<K*Q
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M&:2+."R;"P;!X(!R.XH T=-TZ/3+7R4EFG=F+R3SL&DE8]68@ 9X X
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M8 21]Y62,@Y*DG!&<\=*EN?"D\VO?VG:VCZ3?B_$T]];7A6&X@5\D/$#AF9
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M2;S?* 78VU5" >9D8&.3W-2+X:UA/!WA#3_(A-WHUS:O<+YO#+$A4E3CJ<C
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M=F<02-M69&1D=<]FPV03QD>^:Z.B@#C-1\/7^I7FN:P+=8KJ\TG^S+:V>09
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M^[N3;@-C W!_PH R_B)KO]I_#S5+C3K*ZGLAE5OHI50!E?:6 W!F7((SCGJ
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M6TNK>Y34!IC6;A3)]I) " @[2.0=V<8JSI7B1M1UR_T>32[JWN;'89Y"T;1
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M.-V3QV!.0ZQ\&7.E:MJ9AL=%OK*_O'O%EO$(FMVD.77&TAUSDCE>N* .X!!
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M337I1&5V9<'$9(.4/0$>XJ+3O&ZZK9:']GL=FH:MY^VWEE^6'R25E+, <@,
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M-3N?LXD)8KY2G:<L"IR>V5.#G@ [FBN,75]:D^)9L8[<&S&D13-"]P JLTK
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MWGRONAN,$>O J6Q\*-I5]=R:;J]W;6=W<-<RV82-E61CEBA925#'DCGJ<8H
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M+J%9II\D[G)'.23D#'8#  % &6?$(T>_\<7KZ3;&33(HIW:U4B2Z'E%EWGU
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MXHFU"T=5OA!/:+:X66,W7DYW9RK $$8XXYS5^?Q/K.IMXB_L>*<7.E73VMK
MEN'CN)$16(D8] Q; P5P,')S0!V-[JMII\UM#<._FW#B.-(XFD.20,G:#M7)
M&6. ,C)I]CJ%GJ=M]HL;F*XAWLGF1,&&Y20PS[$$5QMJ=6N/BI=L+B"V']BV
MKO!) 9"H,DN5R' R&SSCD8&.,F'2_%E^OA_2DD^S"]U'6KC3EE6+9'&$DE^;
M:#R2(^F>2V3F@#N+S4+/3UA:\N8H%FE6",R,!OD8X51ZD^E6:XK79M=T.&P:
M74H+V*?6+6!3/:KO$;NJD97"@@YP<=Q4'C+Q/J&E6NK7FDWRRR:2%>6U2UWQ
MXPK%99#C#$'("G(!!(.: .\HKB]4O_$ESXW?0],U&SM(&TP7B/):^8RMY@7;
M][G/KVST-1/KNL6NI>)-)N+M6OH5ADTG$2@2)*=J9XYQ("K'TP>* .YHJ*W2
M6.VC2>;SI54!Y-H7<>YP.E<%/XFU^SC\3:?&4O=;L[@"PA,857A,7FJQQWPL
MB^A90.,T >@22)%&TDC!40%F9C@ #J345G>VM_90WEI/'-;3*'BE1LJX/0@U
MSMEK%UKYEU#2KY!IIL(Y4#PAQYKKNP>A^5=I(SU<>F*Y:>\U+6M!^&UXD]I!
M-=7<<K#[,2@?[-*PPH9?E'/'TYXP0#T.RUFPU"_OK&VF+W-BRK<1F-E*%@2O
M4#.0">,U?KSRVMM7F\:^,%T_4H;.=([)FE^S"3>XA;C:3POYGW'?J_">KRZ_
MX2TG5IT1)KNUCED5/NAB.<>V: -BBN,6^\1WWCC5M+M]1M(+*P%G<<VNYWC<
MOOCSNZD)][Z<51T;Q5KNO:5I.M:?;7$BW=T!+:&!1"EL7*EA(>=ZC#$YP2"-
MM 'H-%<)8>*+U_$,-AJL]WIEW+=30I;SV7^C3H _E^5,!RV C'+<_,,#BJ*Z
MSXLG\%:IK\>KV:3:9->?N6M!LG2"1QACG*Y"8&/U[ 'I-& >U>?IXMU76[C6
M+?3X;JUGL(8?)CCMQ+OF>$28D)Z+\P7 VG@G/3%^QUG5_$&I76DB3^QKJRLK
M6:YVHLKB:96)0;LKM7;CN23U&.0#L<C.,\^E!.!D]*X&P@UC_A:C_:;VT:6/
M0K7[1MMFP^99=P7YQ@E@3G'3 QQDW_BCYW_"L]?\F14/V5MQ92<KW P1@^_/
MTH Z^BN4&I:D_BJ'PP][''(FGF^FNK>W"%@9-B*BN7 Q@DDY[8Q5CPEK-[J?
M]KV6H['N=+OWM#/&NU9EVJZMCLVUAD#C(]Z .CHKEO$^JWD4T]GIFH^5>PVA
MN%ABM?.;JV#(3\JH<8Z@G!P>*U?#>IR:UX7TG59D6.6]LXKAT3HI= Q ]N:
M-2JUGJ%GJ*2O9W,4ZQ2M#(8V#!74X93[@URD%[XEU'QKK&FP:E9P66G2VD@!
MM=S21N&+)G=P<#[WTX'-4H/%&J6GA?4[UT@:2WUV2REGB@PD, F"/,R \X7+
M'GKR>!0!W5[>0:?9RWERQ2"%2SL$+$#N< $T6-[;ZC86]]:2>9;7,2RQ/@C<
MC#(.#R.#WKC4O-9O/^$EB:_AO-"@M#]GN3 -\S-&Q90ZD*0IQR%_BQG(-9VA
MZAK6C:#X$F-[!+8:A':V3VGD8,8:W+*ZOG)(V<YX.>U 'I6021GI02!U.*XC
MP/%?_P!N>+99KJW>#^V9%9%@8,6$,."&+G QQC'7G/:G_$)+N1O#"6L\,1.M
MP?ZR(O\ -M<J>&7@8Z=^.1B@#M**Y.SU'5-=U/7+"WOULWTIH[=7C@4B68QJ
MY=E;.$RP 4$'@_-TQ?\ !NNS>)?"6GZM<0+!/.C"6-?NAU8HV/8E21[&@#=H
MKC([KQ%JGBKQ%I-OJ\%I#9"W:"06@=E\Q6.""<$<#^F*K:5XHU'5O#^FK<WB
M6>JSM<Q,MI;&9YC#(8]\:G(5#C)+<<@9YH [RBO.(_%FN-X-T3Q#<310Q+J!
MM-5"1# C$[0^:,YVX8*2.1@GTK4UO5]9L_#WBC6K2\B$5BDILEE@# ^4OSDX
M()^<,H_W<\YH [.BN$.H>)HO$>D::^K6K1:O92S;Q: &V>,(3LY^8$/CYNF,
M^U58O&VJ0:;:VEUMFU"37)M(:YAAZK'N)D"9QN*J!CIDYY Q0!Z+17GNLZ_X
MITK1M7N4&V*VNK5;.YO+<!YTE=4=652,%2WWMO((X[UJV]]KEIXV.B76H6]U
M%=:=)>02&UV&"1)$7;@-\R_.#R<\=: .M!!Z'-%<7\*H[M?A[I37,\,D;P[H
ME2(JRY9B=Q+'=DGT%.\6>(+[1]4"2_;[32OLOF#4+.S^TJDNXY$HVL50 *<@
M<Y/(Q0!T<.LV$^L3Z3',3?01+-)$8V&$)(#9(P02#T/8U?KSR+[;JOQ#FETS
M4X8#/X>M)/M:0B0,#+*05!.,'.>>WYBYI7BB\U#PAI,]W>Q6NHW=S-:M]GMC
M(\IB:1"8TYP3Y88DY &?:@#J-5UFPT6".;4)C#%)*L2MY;,-[$!0=H.,D@<T
M1:S83:S-I"3'[=#$)I(C&PPA. V2,$9!'![&O/-2U>_U?P!=C4]K7-EX@M[0
MR! AD"7<6&*@D X/(!QQ72PX_P"%NWGK_84'_H^6@#>U/6;#1UMVOYC$MQ,D
M$1\MF!D8A57(!QDD#FK]<?\ $<2'0=.\K9YO]L6&S?\ =W?:$QG':LCQ!XMU
MWP5>:@M]/!JL']F/>V["#RC%(LJ1[6P3E"9 <]>#]: /1ZH:AK-AI4UG#>S&
M)[R800?NV8/(>BY (!^N.AK(TV\UL^(H87CN;C3);9VFFN(%A,$P*[0N,95@
M6XY(V]:J?$(3-%X<%N46;^W;;8T@)4'#\D#&?ID?44 =C17#_P!NZOH>N:MI
MNK:G:36T6FB_@OI;?RQ"2Y38ZJ?F&0",8)Y%10^(?$$.KZSIT*MJ$B:3]OL!
M<VXMW:3<RA",CY20,9"GJ/>@#O:*\TG^(+:?IU](MQ>R7ZBW1;#4[$P2PO)*
M(R^ JAT^8=">1C=S6AJ7B?6/#L6JW\]K<W>EV]B)HIKJ-86%QO"^6=H&5.X'
M..,'D\4 =9=:S866J66FW$Q2[O2PMT\MB)"JEB-P&!@*3R:OUP6M6NH0^/O!
M4EWJ2W*/=7/[H0*@1OLLO*D<[?8Y/3FN]H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "N>/@[3XM0N+[3KB]TR6Y?S+A;*;;'*_
M=BA!7<>Y !-=#10!BW'ABQN5LW:6[%W9R-);WGGEID9AAN6R""."I&WIQP*C
MO?"&F:AI5YI]R9V2^D$MW*),23L,8W,!T&U< 8 P .*WJS=&URTUQ+QK03#[
M)<M:RB6,H1(H!/![?,* (U\/VPUZ+6FGN7O8K?[*&9QM,9()!&,<D YZ_AQ7
M(^+_  ];:;H&EZ78KJ!MY-<AN7\C>[PJ92\CAE&5 +$Y[=J[/7=;M/#NCW&J
M7PF-M;KND,49<@>N!6@K!T##H1F@#'/AC39].N[2[66\%[ ;>XFN)"TCQG/R
M[N,#D\#'//6J]MX/L+2[M[R.ZU!KR"W>U6XDN"[F-B"5.[(ZJN..WN<]#10!
MST?@S2HO#UGH:&Y%E931SVP\WYHV1MR8/< C/.:ADM+3Q!XKL;HVESG1#,//
MGA>,-(V%"KN #K\N[(R,A,'TZ>B@ K$/A32FOM4N9(Y775%VW=N\K&&3Y0A.
MSIG: ,^U;=% &/8^&[2SDLW>>YNOL2E;07,@?R 1MXX!)QQN;)QGGDYLZUH]
MGK^DSZ;?J[6\VTG8Y5@58,I!'((8 _A5^B@#G&\%Z:\EW*T]\TMY9BRN9&N"
MS2Q@L<$G.#\S#(QP:LMX7L&L](MB]QMTF026C^9\R$*4&>.1M8CFMJB@#F+*
MUL];\6IXA2SN(C96S6D<EQ"\1D9FR<*P!(4 @-C!\QL=*Z<\BHXIX9S((I4D
M,;E'V,#M8=0?0\CBI* ,C1_#MIH=S?3VLMRSWTIGN!+)N#R$ %NG!P ..*BO
MO"FFZAJTVI2FY2:>W%M<+%.R).@SM#J.N-S?G@Y%;E1S3PV\?F3RI$F0-SL%
M&2< 9/J: ,.'P?IUNVC-%-=J='B,5E^]_P!6I7:0>/F^4 <YX'KS5J?P]9SZ
M^NMB2YAO1;BW8Q3%5= 25W+T."Q(^O>M:B@#FO\ A!M&_L-=(87+6T=R;N%O
M.(D@F+%MZ..0=S$_B>W%3W7A2UOK6U@N[[4)_LUREU'(\_S>8F"AZ8XQTQCU
MS5S7=<M/#NF-J%\)C;JRHQBC+D%B%&<=!D@9]ZTJ .!M],^W_%#6YGEU6VC%
MG:QI)"9(HYRIDWJ6QAL97D'(SP>3717?A/2[J73I8UFM'TX.MNUI*8B$?&]3
MCJ#@9[Y&<UM.VQ&8@D*,X49)^@JAHFM6FOZ:+^R\WR3+)%^]3:VY&*-P?=30
M!ECP-I*6]O;Q27<<-M?-J$*+-PDY).[D9/+-P<CFK\_AS3[C4[Z_E61I+ZU%
MG<IO^22(;L#';[[<CUI8/$-C<:GJFGKYRS:9&DEQOB( 5]Q!7^]]P]*NV%];
MZGI]O?6CE[>XC66)RI7<I&0<$ C\: ,*T\)K9WNDJEW</IVEQL88IIV=GD("
MKNSQM11P/5L]N=O4;"+5--N+"=I%AN(S')Y9P2I&",]LCBK5-DECAB>65UCC
M0%F=C@*!U)/:@#%?PII[V&FVH>X5],(-E<+)B6#"[<!L<C;P0P((ZYI+KPGI
MM]I>H6%R9Y%U$_Z;+OQ).,;<$@<#  PN .W>M&;5;*WO+&TDF_?7V[[.%4L'
MVKN/S 8''/)&>U7* ,;4/#=KJEK86]U<73+8S)<0L) &\Q#E6)QSC\O7-.B\
M.6<6JZAJ(DN&GU")8KC=)\K*H(4 8XQN/3UYS6O10!S0\#Z5';:9%;R7EO+I
M<9AM+F&<K+'&0!L)Z,O X8'I5N\\,6E]_9YGN;UGT^;SX',Y+"3!&XDYSPS#
M'3!Z5M44 %9&F>'+32M5O]2@FN6N+]E:Y\R3<'90%4XQQ@#'&*UZ* ,:^\,:
M??ZT-5D:YCN3!]FE$,[(LT8)(5P.H!)_,]JJP>"]-MHM'CAFNT71P19 2_ZO
M*E3V^;Y21SFNCZ5'#/%<PK-!*DL3#*NC!E/T(H SKGP_9W.O0ZUON8KV*'R-
MT,Q573.X!AT."<_XBJ'_  @^C-H\^ER"XDMY;HW@+3$/'.6+^8C#!5MQSQ_*
MNDK-AURTF\0SZ(HF%Y! MPVZ,A2C,5!![\@]/2@"E=>$[6_L(K2]OM1N%CG2
MX5Y)_FWH04/ [$ ^_?-8)TPZA\5KZ5IM4MXTTNWA6: O$DK+)*74MC:3@J>.
M1GC%=7<:Y:6NO66C2B875XDDD)$9V$( 6^;ID9''O6E0!AWGA/2[O^SBB36K
MZ>SM;O:RF-EW_?!(Z[N^><\YS58^!M)$"P(]W'"E_P#VBJ+-]V?=NW9(SUYP
M>*Z6HWGACFCA>5%EDSL0L S8ZX'?% &=+X?L9]8FU202M<36@LI1O^5X@6."
M/JQY%9MIX/CLI]'MX;JY.EZ7NDCAEG9V:3:$C!S_  (N<#UP>W.KHVN6FNQW
M;V@F M+E[642QE")% )&#_O"ISJ=HNKII1D/VQX#<+'L;!C#!2=V,=2.,YH
MDO+.WU"RGL[N%)K:=#'+&XR&4C!!K-LO#=I9O:,T]U=&R4K:?:9 _D C;QQD
MG'&YLG&>>3G9K)U7Q)IVBWMG:7AN!->-LMUBMI)/,;!.T%0>< F@!VC:#:Z$
M+L6DD["ZG>YE$K[LR.<LPXXR>W2EU[0;/Q'IPL;_ ,WR!*DN(GV'<ARO(]"
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M&W +L"A<-SD#.0.>!B2/PS9G3;C3[VXO-1MKB(PR)>SF3*'MVY_VOO>];-%
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M0!BWEUJ\_B3PO90ZS<6]OJ.G7$EP$CC)W(L6&4E3@_.>N1[5E2>(==T2]O\
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M;(Z;=K$9P"-B]/2@#9HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M R<'  !/3M76_P#"P)-'\0:QH_B.VAB?3]._M-;BT)9980<$;6Y# \#GGVH
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M"HIX7.[G'7%5]&N+CPE\4_%&@Z/$KZ4-,&IQ6#2E(H905R%(!V [F. /3TH
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M%DE&T#H3R">01[UQUS:P#X5ZTHAC B\1R>6-H^3_ (F"CCTXXH ]>)"J68@
M<DGM3(9XKB(2P2I+&<@.C!@<'!Y'O3G1)$9'4,C##*PR"/0UY=X2U[4?#O@'
M1K@:7;OI NS;2O\ :"LR^9<L@94VX*@L.-P/TH ]3HKD?%7C"?PT)KAK:QDM
MK=D,D37FVXD1BH+I&%/0D\$C.T].,W9/$-S!XT&A7%I!%!+9M=V]TTQ_>;2
MR;=O!&5)Y/!H Z&BN.7QN1)IMI=QV5C>ZA;R7:>?<XCCA4@*22 2S;A\O;GG
MCG9\-:X?$&EO<M;B&2*XDMY K;T8HQ&Y&P-RD8(..] &NS*BEF("CDDG@4V&
M:*XB66&1)(VZ.C @_B*Y#3[W5;SXB^(=/FACFTR&WM1Y<DYQ&&$I)";2"6P,
M@D=!UKG_  ;K^HZ#X"\+NVF0/I,TL=FT@N")D:24HK[-NW;N(_BS@Y]J /4J
M*X>_^(<$$.JW-HMK,FEW+6\ELUP%N)RA <QI[$D '[Q!Z=:[1W<P%X55W*Y1
M78J">V3@D?D: )**\[;Q7J>O>!-1U>\\,VK:.=.N))(GOR&DV,0R<)D J&P?
M4=N#6\FOO]KTO1=.M84NKC3?MB^=(1'&B[%"C RQRP], 9]J .BEN(8"@FFC
MCWL%3>P&YCP ,]34E>7ZQK5SXC\,>&]9N-(BMY?[>M1!&L_F,2)BIPQ5< E>
M#SD8-;\GB;5TFUW2KS3[:#4+33_MMN]M<ET=&WJ,ED!# H>QS0!V-%<]X'NM
M1O?!>CW&I*IGDLH&\WSC(TN8U.]LJ,,23D<_6LI=<U*V^('B!;@)_9%AI]O,
M^ZX(\I3YQ9U0*<D[>1D?='- ';45R$WC&ZL]+TC6KO3XUTK4I(4^24F6W$V/
M+9AC!&2H8 \9XW8KKZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHJK?:G8:8D;W]Y!;+(XC0S2!=['@*,]3[4 6J*C\^(SF#S
M4\X+O,>X;MN<9QUQGO4E !1110 445'<7$-K \]Q-'##&,O)(P55'J2>E &?
MK^BQ:]I9LY)6A=98YX9E&3%+&P=&QWP0..XS51O#]U+=W>I2:DJ:M+9&S@N8
M+?:MNI);<$9FW'=@G)Q\H''.=FTN[>^M(KJTGCGMY5#QRQL&5U/0@CJ*FH Y
M34O#.NWNI6EY!XI\@VT(C13I\<@WXPTG)QN//0< D#J<]!IEO>6NG10W]]]N
MNESON/)$6_))'RC@8&!^%6)98X(FEFD6.-!EG<X"CU)-9\7B/0[B5(H=9TZ2
M1SM1$ND)8^@ /)H TZ*JVVIV-Y=W-K;7D$UQ:D">*.0,T1.<!@.AX/7TJU0
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M_P *CCC))[DUT]IJ=A?RW$5G>07#V[;)EBD#&-O1L=#[599%=2KJ&4]01D4
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M4W$G]B6P\M652?WLO<\4NDV%YX-T)+!+S3[>ZOKRXN1&R/,D1=MPBAB4JS@
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MP2R_+GD[N< <8;HWBO6]=TS1]:L+:>1+VY436AM\11VS,5+"0\EU&"><'!
MH ] HKS._P#$WBFWT'Q/K"W]CC0K^2-8!:$"XC18V*DER5X8\CO^5;$^OZOH
M/B62VU.X@O+.32KC4%6*#RVB:$IE <G<"'[\Y% ':51U;6+#0[/[7J,_D6^]
M4W[&8 DX X!ZD@?C7*:1XBUR_AT#4HX)I[:_027T)MMD=O&T9=7C<X+8.T')
M.[.0!6+XGU#4?$?PN37Q>1P6EW);R_8A$&'EFX3:"^<[^A)Z=1CO0!ZDS!%+
M'. ,G S5#3-;TW6#.-/NEN/(<QR[0?D<=5.1PP[CJ*T*\IM-5U#0O!?C74],
M>!+F#Q%=D>=&7!!E52.",'GKS]* /5J*Y-;_ %NQ\;6ND7M]!<VVI6<\T9CM
M_+:W>,H,#D[E(D[\Y%4=*UW6[VQGTV:[B37[?5C9RD0C8(A\^\+UP8?F!S][
M ]J .ZHKSYO%>MZE::Q<Z/;SR7.GW\EI;VBVVZ.X\I@K;W[%OFQ@@#C.:GO?
M%=W9>(Y+34Y;K2HOML45J\EF7M;B)MF0TH!VR$EP.5 ..#0!W5%>=Z&^L6UQ
MX[O8;VRS#J$A"O:.3N6WB(Y\SICC&.O.>U)::[XI=?"$SZC8LOB"W D3[(0+
M=_(\W>IW?-]TC!XYH ]%HKSM_&FJZ38:C:WIAN[ZVUN'2H;A(2H995C8.R \
MD!SP",D#IFI]7U[Q)I>E^(KJ!6>ULM/^V6MW>VNUC(H;?$5!7/ 4AL=R#F@#
MO:*XR/5=>LO$N@6]Y>VMS:ZQ%*&B6WV&!TB\P%6W?,#@@Y^HQTIGPY2_%IK$
MES<V\D3:O>_*D#*V\3,"=Q<\<<#''')H ZV]U"TTV)9;RX2%6;8FX\NW]U1U
M)]AS5:R\0:7?WC64%V!=JN\V\J-%+M_O;' 8CWQBN;2<R?&B2VNSQ#HBR6*M
MT^:4B5A_M<(#["F_$F$^7X;N[48U*'6[9;9E^\0Q(D7_ '2F[(]![4 =Q17!
M6E_XLU6U\1-;ZO8V\NF7\T$):SRL@2-& ;+<#YCR.>?PJC8:CJGB'QCX2U1'
MMK1KK0);EH9(&DV[G@W ?.O7(P>PZ@YX /0[2_M+_P _[)<Q3_9Y6@F\MPWE
MR+U4XZ$9'%6*\]A\67]CIFIF5;-KQO$0TJ"2.$I&-YC&]UR22-Q/7G@9%:5Y
MJVKZ3XJ@T4W27,.H64\]M/-"-T,L6W<&";0R$,,="".IH ["BO.=/\2^(SH?
MA+7KJ\M)(=6FM[>XM%MMH42@_.K[LY!QQC&./<W5\5747B?[!JDUSIDCZ@;>
MVBFLR;6ZBSA-DP!_>,,'!8<\8[T =S16%XKUR30=*@E@1&N+J\@LXC("41I7
M"[FQU !)QWQCBJ,NJ:II?C*QT26Y6ZM]3M9Y()I8AO@EBVD[@NT,A##T.1UY
MH W$UK3Y)[R%;C!LUW3NR,(U'.?G(VG&#D G&.<5-87\&IV:7=L9#$Y8#S(F
MC;@D'*L 1R#U%>2PG5S\$-/D:_M2);NUV_Z,VX W:YW'S/FRQ!Z#C([Y'7/X
MAU*?Q%?Z#Y\D<VGVL,DES9V1?S)9-Y'R$MM0!1QG))ZC'(!VM%<!+K?B^XN_
M#-@?L6EWFJV=PUTDMN93;RQJO(^?D$MP.W&2>E)_PDVN7PUVWLO--_I#"WB6
M*TWQW4XB5VWG^%69L  J0.<\X !WTDBQ1/(^=J L< DX'L.3572]4LM:TZ+4
M-/G$]K*6"2!2N=K%3P0#U!%8%GK&IZ_J>HZ=;R#2I=/BMS-F,2OYLL>\KSQM
M4$#U)S@C',?PO##X>::'96</<;BHP"?/DZ"@#KZ*YJPU35+KQAXATEY[<16E
MO;2VK" _(9/,SN^;YON#N*YZT\5^(+WPYX-O8Y[))]8NOL]SNMR0,I*V5^;H
M-@X[^HH ]&JC<:Q86NK6FES3[+R\#&",HWS[02V#C' ![_SKCI?%VJ>'D\40
MZG)#J#Z4+5K>41^3O^T$JJN 2  PZCM3]5MM0@^(_A![O44N8W:[Q&( FQO(
M.=I!^[[')]Z .\HKSZQ\6ZUK6E1:QI5M/*S7QB%C]G_=M LQC8F0]'"@MG.,
MC&#UJ_IM_P")-2\7ZQ9?;[&.QTN\A5E%J=\T;Q*Y7)8[2-W7G/MW .RZ#)JB
MFL6$FM2:.L_^GQP^>T)1AB/.-V<8(SQU_E7.?$];AO \RV\L<9:ZM5;>A;(-
MQ&,<,.Y'U&1WR*4]MJTOQ-$,6H6T-V=!'F7*6Q(_X^#C:C,<?B3^O !WU%>=
M6/CC49K?0]/NE'V^]O+VUGN+6 M\MLS*61.<,V%ZY YX-=3X;N]6N8[Y-4@=
M5AN2EK/)'Y;3P[00S+V()*G@9QG H GN?$FD6>HG3Y[P)>!/,\C8Q<K_ '@
M.1[BH_\ A+-",%I.FI1217=P+6%X@7#3$@!"5!VG)Z'%8%Z9E^,=LUM'')-_
MPCTVU9'**?\ 2(^I ./R-9FK^'VT2TLIYY$>ZU+Q7:WLPB!"(S.H"KGK@*.3
MC)R<#I0!Z717!^,/%.H:3;ZI>Z7>Q3'2V0RVJVI=-I"EEDER K88D!3D KD'
M-7)K[Q!?>-=4T.UU*UM+>"R@N8I1:;W4NTBX(+8/W.OZ=P =A16%X-UBZU_P
MG8ZE>K$MU('67R@0I9'9"0#T!VYQ[U-XFOM0T[0I;K3+22ZN$>,&.)-[B,N
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MGE''R-E2K+P.H/(SUYIESX/TVYM+>WWW$8AO!?[T<;I+@'<)&)!R<]NG;&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4454O=2M
M=/\ *%P[;YF*QQQQM([D#)PJ@DX')XXH MT55T_4;35+;[19R^9&':-LJ596
M4X964@%2#V(S5J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
)BB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ameh-nonqualifieddeferre009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9,0X5\$<Y+<>N:]4%I!]C%H8U: )Y>QN05QC!]>*EVJ3D@9^E)(9!$QB56D
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M**58E&=H_B'/7.#TP:P+7Q!I]CHOBR9_)NH9/$OE,#/LC4.85#R,,XCZY[$
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MRL^:'.&+,03\HZ8[\5#X 8FTUL-'+&6UJ\E421LFY'E)5AD<@CH:S#_9MO\
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MAE1)%8F2-AM.PGY3SC.W':HETS2_#_B'PJDT5[<Z1:Z==11SW-H[['>2-D#
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M,8O+<R3+NB7S5S(/51GD?2N+3PK8Z_K.O7,-M]GT75-+CLW B\OSY0SGS0I
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M!M<9& P!X(Y%6];G2#Q+:Z+_ &=Y%@VG,L<\-B9BY+8\A."B   G<,8(Z8H
MZV6^M(-GG74$>\%DWR ;@!DD9Z\ FL]/$FGRZ_#I,3B1IK(WJ3JRF)DWA  <
M\DDY],"O-M.LH9M"^&T&HZ?+(;5F6[6:V8F)!!(H#Y'"[BHP>*Z.;2M+TWXH
M6+/I"+:-I AMG2S+HLB2@@9"D*0N.3C % '6Z5?3W5I/-=FS7RYY%4VT_F+Y
M8/REC@8;&,CM5:YU^":S6;1K[2KMA<1Q2%[Q0B@L W*Y^;&<#N:\]CCNH?"M
MP]MI]R]I;>*I+N[M4@8-)9F9FRJ8RZ_=; '(6MGQE+I.IZ#'>Z9://.^HV+-
M)':2;BJ3*Q/W>R[LGL.M ';W&KZ;:&47.H6D)A :3S)E78"< G)XY]:>^HV,
M=B+Y[RW6S(W?:#*HCQZ[LXQ7"7MUH]K\7)Y+^W#B?1(#&PM6E!8S2]=JG!(X
M&>O(JK:VUSX6MK*W;3S!87VLW5S$WV5I_P"SHF5O+4(F=K/DX[+O((S0!Z*N
MHV+6\,ZWEN89B!%()5VR$G "G.#SZ4R+5K"XM[B>UO(+E+?/F^1(K[2!D@X/
M!^M>2M8HOAR2SFT^Y?9XM698Y+0[A!YZLS[57 4C<3@ =:ZB[TR!?'^I1P:<
MHMKWP^$PD&(Y9!(^ >-I;;Z\XH Z[0]8M]>T2RU6V5DBNX4F5'QN4,,@'!/.
M#6A7#>!;^PTKP1X<MDTZZBN)HX;.<)8.A6<1_,9/E' *D%NF>]=S0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%-<,48*VUB.&
MQG!]:X"T\;7MCX0\2:YJTMO*=-OKFS@C5/*#F-]BY))Y)QG]* /0:*S=%F$N
ME_:#K$.J1NS,MU&$"8ST&WC P1Z^M%AK^D:I=R6ECJ-O<7$:AVCC<$[3QN [
MK[CB@#2HKE-?U35[;QGH&D6-W!#;:E'<M(7@WLAB52-IW#KN[^E,O=<U;PWK
MNE6^K2VUYIFJ7 LX[B*$Q203L"4##<0RM@C(Q@^M '745GG7-,6]2T-[")GD
M,2C/!D'\ /3=_LYS[42:YID5XMK)>PK,T@A )X\P]$STW?[.<^U &A16'<>,
MO#5H[I/KNGHT<GE/F=?D;CAN>.HZ],BK=KK^D7VIRZ;:ZE;37L2[G@20%@ <
M$X[X/!]#0!HT5GKKFF->I9B]A,\CM&BYX=USN53T+#!R <C!KG?B#XMCT#PO
MJ4UCJMO;ZG!'NC5P'RW92#P">P/- '945!<"9K)_)E$<NS*N5W 'Z5ROA'Q?
M'=^#M(U7Q#J=C;W>I+O1"1$"<GA022<8SF@#L:*R+?Q1H5W8W5[!JMK);6AQ
M<2"08A_WO3\:G&N:68[)Q?0E+YMMJV[B8]<+Z\<_3F@#0HK/77-,>]2S6]A,
M\C,B+GAW7.Y5/0L,'(!R,&DCUW2Y;L6R7L1E)<+S\K%<[@&Z$C!R >,'- &C
M17+:/X_T+4](EU"?4;&S2*XDA9)+M"0%D9%)_P![;D#W[U=_X3'PWMN6&MV1
M%L0)L2C*YSCCOG!Z>AH W**I+K&FOIT.H)>P/:3X\F5'#"3/0+C[Q/H.:@/B
M71%MH[A]5M$BEF\A"\H4F7.-F#SNR<8ZB@#4HK(M_%&B7L%[+9ZI:3BR7=.$
ME'[L8R"?0''!Z&F>%_$MGXH\/VNJ6SP@RQ+))"DPD,)(SM8CH?KB@#:HKEM%
MU+4O%NF?VO9WJ6&GS.XLU6$22.BL5#N6X^;&0H P,<^E;3O&BV-_K&E>*;BS
MM+G2_+D^U@^7%<0R [7 8DJW!!7)Y'% '945E6WB71+S5'TRWU2UDOD!8P+(
M-V!UP.^.^.E82>/+#4=&UJ:SU/2;&ZLIYH(VO;E6C.QMHD8 @[2>F/:@#LJ*
MI3ZI9V4<)NKA \J;E5 2S@ 9*J,D@9'TS4#^)-#CMK6Y?5[%8;LXMW,ZXE/?
M;SSCOZ4 :E%9^EZYI>MK,VF7\%UY+;)1$X)0]LCJ/ZT7>MZ;8S^1<WD<<@V[
M@<D)N.%W$<+GMG&: -"BL^ZUS3+*?R;F]AB<,J-N/",WW0QZ*3D8SC.>*RM,
MU2^?QOX@TVZN4:RM+>VF@&P+L\SS-V3W^X.M '2T50M-:TV_N3;6UY%)-Y?F
MA <%DSC>N?O+_M#(JI-XLT2)IXQJ5NTL43R[=^ RJ/FPW0X[X/% &U16!H?B
M[3-:\.66KBYMXQ<1H6A282-'(R[O+XY+X[8SQTK2AUC39[!KZ.]@-JK%6E+@
M!6!P5.>A!XP><T 7:PM3T*YO_$^C:O'>Q11Z:)1Y#0%C)YBA3\VX8P!QP:SM
M"\2/JWCO5]/@OXKG3[:S@E1%0!HI&>0,K=\X53@^M-N_$YT?QW=V6JZE!!I2
MZ9'<QB10I$C2.I&>K<)G'UH ["BLJ/Q-HDOV'RM5M'^W@FTV2 ^?CKLQUQWQ
MTJW;ZE9W=U<6MO<QR3VQ"S1J<F,GH".U %JBLVX\0Z/::A'87&I6T5U(XC6-
MI "7/1?9CV'4U2\:ZG>Z)X.U/5=/DC6XLH&G42IO5MHS@C(H WZ*XR?6]<TS
M5?#,4L]M?0ZNYBFA6 QR1?NRYD4AC\HQ@@CN.:Z&'Q#H]QJ8TV'4K9[PABL(
MD&6V_>QZX[XZ=Z -*BL9/%OAZ6Z6VCUNP>9G= BSJ?F1=SC@]E.3Z5BV7CNT
MUOPU9ZE8ZEI-C<3W$:-#=W <JIDV[<*0=[*.!ZGO0!V=%9^IZ[I>CKG4+V*#
MY=V&.2%_O$#D#WZ53MM=MY-5U/?J^E/86L,3[8Y/WD&=V3*<X .!CIT- &Y1
M6)%XP\.3W5K;1:U9--=@&!1*/WF1D >Y'('4YJS<>(='M-0CL+C4K:*ZD<1K
M&T@!+GHOLQ[#J: -*BL:[\6^'K![A+G6K&-[9@LRF8$QDYX8#IT/TQ5?6O&.
MF:-<Z*DMQ;&'5)2J3M<*J(@C9_,R>JG  ]V'- '0T57N;^UM+9;F>=$A8@*V
M<[B>@7'4GL!UJHGB/1G-NHU*V#W$I@BC=PKO(.JA3SD=QB@#3HJBFLZ8\]Y
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MR <\&@#2HK/?6]-2]%FUY&)S((L<XWD9"%N@;'\.<T1:WILUZMG'>1M.S,B
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M-JMS!%YTT1E4-&G'S,,_*.1R:J0>+O#UU=VUK!K5E)-=#]PJ3 ^9[+ZGV[T
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MGD@@U9\/Z=J-CJNE+I<VI_V69))+O3M3M/ELP4<_NI2BDD.0H +9#'M7H=%
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M3--:3:?)-;QP%9=L,J%P%(!. &^O:N_HH XFXCN[WX@I=06MY;Q2Z%+;+<O
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M P2#@9J/5=&E\3:+JMS8+K2ZS)I4MG$VH0BW"AB&,?"J"25QN&0.>>:]&HH
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M@YQ@U7M]+NK_ ,;P^(I[62RBMM/>T2*5D,DC.ZL2=I("C:,<\DGTY1['4/\
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M74//@#!"A:(>82-P/0JN 3Z<@$GBN^O[7Q?X8M+?5I[.ROY+A;I46/&V.%I
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MN=]LI1$ 4<GCH!6=X4\-W.GZ9I>DZQH5W--I;J8KO^T-]LQCSLD1#)E6QVV
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M.;;[0]I*L22ABNQW*@*<@C!Q^HJ_8^*M(OY;Z)9Y()+%!+<)=P/;E(R"0^'
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M:-(C.T<K.D<X@?RG9 Q8!L8_A;V..,UR7A+PO<:;INFZ+K&B7<[Z;,K17O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!#=VR7EG/:R$A)HVC8J><$8./SKB8_"FK77@NQ\
M(:@MN+:T:"-[V.3_ %L,+JR[4QD.0B@YX&203TKO** .1L]!U5+OQ?)/';*F
ML-NMMLQ8KB!8@'^48^[GC/6M+1--U"P\$V.E.\4.H6U@EL)$;>@=4"AAD#(R
M,]*W** //=+\+:]!J7AO4;NTL/M.FQS1WDOVMY9;EFC"^879,\G)VGIGKVIP
M\(ZV_P -;_P^XLEOI;N2>-A,QC(:Y\[!.W((!QT/->@44 9/B"TO-3\+:C8V
MT<0N[NTDA59)"$5G4KRP!X&?2L*#0=:35_"5R\-H(M)LY;>YQ.22SJBY3Y>0
M-F><=:[.B@#F-*\.S1W'BB#4HH);#5[MIE"N23&T*1E6&!@_(>A/6J%AX,O9
M? VH:'K%ZDEW<VK6"W,8)VP("L1/J<$L?=B*[:B@#B])T&_@TY([GP[H4>HV
MUJ\4=VK[U>0IMR 8\JK?Q<]#CFJ^G^"'M;B\;3K?^QK.XT^:VDL4NFEB>5\;
M7"?=4* PXP3NZ#'/>44 <&WA_P 13>&?"U@]K8)<:1=VTDV+MBKI"NWY3Y?5
MNN.WK6A#H>JCQ%XHO)([86VJ6T4-N1,2P,:.OS#;P#O[$]*ZRB@#S:T\$ZK8
M2>'K]['3M0FL=(32KNUEF(4A,%9(V*=<YR"!P>M;$OAZ^76_#5W9:;IMG:Z=
M+<2W$$$I49E1E^4! ">=Q)QDY^M=C10!P>L>$-5U"#QO!$UJJZV(FM':0\,D
M2(0XV\9*GD9KLK9KV;3E:ZBBM;QD.4CD,JHW;DA<_E5JB@#SK2_"?B!+SPS>
M:A!8/=Z9/(UY=&Z>66ZW1.F\,4&.6SLZ>F,<V](\'S6FO6&J0V4>D3(SOJ(M
M+MC#>%D(P(N%'S$-D@$8QSG([JB@#G/%.E:CJEYH,EC';LFGZBMY-YLI0E1&
MZ;5PIY^?/..E4/\ A'M6DOO&<CI:K%K,"I:D3$E2L/E_.-O&3SQFNRHH X6#
MP[X@2;1HKB*QNK&WTM+.6VEN7\N.=>#+MVXD!4  '!'MDFJT_AF_T[X26>FS
M- FKZ0L4UI)$Y93<1ME ,@'YC\F,?Q5Z'5&YTBRO-0MKZXB:2>VSY69&VCOD
MIG:2#T)!([4 +I5DUAIT4$C!YCF29QT>1B6<_0L37/P:;K^G>+M=OK6UL9K3
M5#"T<LEPRM"4B"'<FP[AG/0]NV>.MHH \[C^'\FA:KIMWIUI::K;0Z<MA/!=
MOY;9#LXE0[2,DNV5XZC!KLK72X4T)M.%G;6,<D;HT%G]Q-^<[?E'/).<#DFM
M*B@#AO"?A6ZT:ST_3=0T/1YSI^%CU%7^9@HPCA"F5?&,_-ZD'M2:'X/FL==L
M-3ALH]'= [:A%:7;-!=LRD8$?"@;CNS@$8 P<Y'=44 >>6GAOQ39>$=+TA%L
MS_9][NE2.]=!>V^7."P3*<LIV\@[2#QUCN/!6LOHGB6SMX=,ADU'4+>]M4CD
M98D$?DY1L)D?ZH\@<YS@=*]'HH YK^R]1U'5+76[^TMX+JRMIHK:UCG+C=)M
MW,S[1V0  #N3[#"M/"FO6WA;P?IABL6GT6[BFN&%PVUU1'7Y?DZG?WQTKT*B
M@#A;KP?/=:\-3@LH]-U%;]9GU"TNV43P*^=KQC 9F0!3N&.2<GH6CPKK,W@_
MQ=I,JV<=QJ\]U+;%9F90)1P&.T8([X!KO** .!7PGJ%KXEN]5;2M-U*+4;>!
M)X9YMK6\L:[,J2A#(PQGH<CH:N+H&KZ+XF35-$LM-:TN;&&SN+$S&%8#&6*M
M&0A!7YV&,#L?:NRHH YSP=H^HZ)9:A;ZD;=WFU"XNDD@8X99)"_((^4\],GZ
MU4M],\0:=XKU^[M;:QEM-5>)XIGN&5H2D2H=R;/FY&1@_EG-==10!P>L>%7T
M?PUX;MM#N%34=)N8HK2649\P/\DN0.Q5F<C_ &?:NULK2*PLH+2 $10H(UR<
MG &.?4U =(LFU<:JT3->!/+5VD8A1ST4G:#R1D#."1FKU '%'P_K<*>,+2&&
MRD@UAY)K:9KAE96>%(MK+L. -I.03]*?+X>U9]-\'($M?/T:>-[E?..UE6!X
MCL.WDY8'D"NRHH X'PUX-GT.!-)NM$TB_M(+EI(+^1_WFPR%QN0H?G7/!!P<
M#D5M>/-&O_$/@W4-'TU8/M%Y'Y8:>0HJ#(.> 2>E=)10!!"UQ]B5I(46X"<Q
MK)E<^F['ZXK@[/PSXFL?#.CZ>!9R&TOYIKNU2\>-+F)VD91O"9^4NI*D8.VO
M0Z* /-Y/!FN)HVJ6$$&F(;K7(=2C$<K(B1HT3%,;.O[K'ISGCI73MI-^?'MM
MK82#[(-,:TD7S#O5S('R!C!'&.HZUT-% &!KVF7FL:AIML]M;3:/'+YUTLDI
M#2, =@V[2" 2&ZCE5K+NO"MSI_C32]:\/65E!#'#);WZF4QF:-L%0 %/*L 0
M3ZD5V=% '!CPYXCLK7Q)H]F+"6PU66YN(+J69ED@:8$LC(%.[#$X.X<'GIBI
MT\/ZTLO@MC#9XT5"MU_I!^8F Q?)\G/7/./2NUHH X27PMK-SHOC>R=+-'UQ
MY7M2)F(7="L0#_+Q]W/&>M7DT?61XLTK5FM[3R+33)+.11<'<7=HVR/EQC]W
MC\:ZVB@#S\>$=;;X9W7A]Q9+?O=M/&PF8QD-=>=@G;D$ XZ'FM"71=9?Q'KN
MI?8["2&^TR*TBAFF+ NGF'#C9C:?,QWZ=*["B@#S^'P)+%::W;Z;&=*L[_2Y
M;-; W3S1"9P1YFWD( ./EZY/ QS:N-&\07EKX4+V=C'+I-RLTZ"[9@P6)X\*
M?+ZG?GGTZUVU% '&Z]H&MZEKE^P2SN]-N; 06Z7,[!;67Y]S>6%(<MN7G((V
MU#9^'-;L)?!T\<-E*^DV#V%W&;AE&&6(;T.PY_U?0@=:[BB@#A8/"^KV?AC6
M?"L2V\EE>O<BWO&DYBBG+%@Z8R64NV,'#<9*U>LO#]]I_C2VO88X#I=OI*:<
MA:8^;E7#;L;<8P,=:ZRB@"E8MJ33WHOX[5(A-BU,+,2T6!R^1PV<].*NT44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY@C\3UKF-'\9Z]J7@[Q'?23Z+!J=AJDUC;/<DP6Q$>SELL3D@L>OI2>6]O\
M'5;TV=X;1=!^RO=BTD*--YN[!<+@G:/Z5R/V2[D^%/CJQ;2=1-W>:S//:PM8
M2[Y%=D*LHV],*W/;'O0!Z;?>-+;2];\.Z1=K$TVKQ22&Y24"&,(FXD$\D$X
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MPTV[;/B!+PVPMV0W=L!!O"9 W!@CC ZX([UJ^-KG3]=\":Q-IEA=W%W-##&
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M6C)?2V>^Z%F5$3Q/NCD">6-P!QNR", 9QB@#O+/4++48VDLKNWN41MC-!('
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M91&5=58J/,P4W,!A=V1@'&<BM6@ HHHH **** "BBB@ HHHH **** "BBB@
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M54.>>3P.<DY]\UYBNCZ@_P (+K3ETJX74!J!G^SF+#L#>^8&'K\F#^E>I44
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M&$;FL_1-,U&RUC33I,VJ1V+7$DE[INHVX,5J&5R3%*R@YWD  %LACT%>A44
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M&X,R%=VW&3G&, ^E+XJ76CH!&B R7@EB\Q8V5'>+>/,"%OE#%<X)/'UKDY=
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MM)&FTJP=U!4CG*DX.?K0!H66OVUUKM]Y6J2SP1V4,XLA8N&C5BV) VW+[NF
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MK+CQOX>MH;&9[\M'?QM+:M'!(XE"@D@84_-Q]WKGC&:T)-<L(M &N/)(-/,
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MVGRO*MO)Y;L8F0$X#?*6 W#!'(R#7&:YX9U74+#QI>V]B_VK7+6*TM[4R(&
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M9+?2Y_M6H/?W[&V%[.K36UFJ+O>1U!#8;@#.?G4$UVM !1110 4444 %%%%
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M^S1NQC+DXQECC]*U+[Q3/8^(?#.G6\-S<6M]:333'R=TK;539R,#/S$MCVH
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M@=: /1IHS+"\:R/$6& Z8RON,@C]*H:#HEOX=T:WTJSDF>UMUVQ>:065?3(
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M+8E] _S2$+M# &/*$]^3C)ZU3C\(:T/AI#X><V(OX;R.<,)F,;*MT)NNS(.
M1TZUW]% '"ZQX.N-8U66^%C;6.IF>-HM5M+ITD$:E<AU &\X!7!R",<CI3-)
M\&3Z3<W]G+HVC:G87%Y)<Q7-RV)45VWE'4QMN*DG!SSQTKO"0.I S2T <-=>
M#IKS7EU..RM].U!;Y9FU*TNG5IH%?.UXP &9D 0[LCDG)Z5V5[:QWUA<6<I(
MCGB:)BIYPP(./SJ>B@#A8_"NK7?A'3O"NI?9OLMD]NKWD4A)FBA963"8^5CL
M4'G Y()K7T/2=2L?%/B'4+I+86NI2Q20^7,S.NR)8\,"H'.W/!KHZ* ,7Q78
M:GJ7AVXM=(N%@O&:,@M(T8=0X+)O4$KN4%<CIFN<3PGJZ77B&XAL]*MAJNEQ
MVD<$,S 12+Y@)8[/F_UF=V >,8[UWM% '&R>'-6?2O!\0%G]HT6>)[A?.;:Z
MK \1V';U^8'D"E_L.0_$>YGAE3^SY[>&[O(,<FXC+)$WT(&?K"M=C5+3-(L=
M'@>&Q@\I'?>Y+L[,>G+,23P .O H NUY[=^!M5NO%FL>((9[>QU!WBDTVZCE
M9RNR,(T<J;0&1\<C)QQCFO0J* .3.EZ_<>*](UNXM]/7[+836\\<=RYS)(8S
ME<Q]!Y??UK,'A#6G^&]_X?<V*WTUW)/$PF8QX:Y\[!.S((!(Z&N_HH Y"VTC
MQ!I7B?5+VQ2PFLM7:.:433.KVLJQA"0 I\Q2%!QE?PJ_X(T>^\/^$+#2=0,#
M7%JA0O Y97&2<\@8Z]*Z"B@#F-<TC5KWQ)8W4*6EWI:6[Q2VEU,R*LA92)=H
M4B3 !&TXQG@C-8=GX0UZS\/>%M.":<TFCZB;N5A.ZJZXE "_)P?WO?ICO7H=
M% '-WNDZI-XZT_684M?L=M8S6S!I6#EI&C;(&W&!L]>]9.C>#[C3=9M=4M-/
MMM*ECBD^V6]I=OY%Y(RX'R;0J@-EMV,]!BNZHH \\LO"/B"U\->%=-9-/:;1
M]0%U,PN7VR*!(,+^[Z_O._I[U+XITN2RE\5ZK>Q6<^G:CIL%I''(SDF8%U4,
MH X9I5&0P(]NM=]4%Y9VVH6<MI>0)/;RKMDCD&0PH X;1YM6T'6-&BUO18WN
M+]18"_34S<R)M1I,%3&N%.PDD$\XSG KN;Q9GLIEMU1IF0A [;021W.#C\JK
MVNCV-I.D\<<CS(I1))YGE9 >H4N21G SCK@5?H X#3_"FNV>F^"K5DL&;06S
M<,+A\2#R7B^7Y/\ :SSCI6_I>D7MEXPU[4I/(-GJ"V_E;7.]3&A4AEQCG/KV
MKH** .=\7:'?:O;Z;<:9+"E_IE\EY"LY(CEP&5D8@$@%7/(!P:JZKI.M:M-H
M^KBVM+;4=*NC+';_ &EG2:-T*.I;8-IPQP<'I[\=910!PVN^$]2UM/$-\%MH
M;_4M*&EP1/*=L<?SDN[!3DY?H!T7KSQ?O=$U6?4O"U]&EINTOS?M,9F89W1&
M,;#LYY.>0*ZJB@#@#X0UJ7X=:OH#FQ6]NKJ:>)A,QCP\YEPQV C ..AJ0>$K
MRU\2:M?_ -CZ1J=KJK),Z7<FU[>0($9<F-MZ' /8CGBN[HH X^'0]8T/Q3>Z
MEI-M87%CJ,$"2VKS&#[.\2[%*81@4*X&,#&.*M-I>KP^.CK<,-G);7&FQVDR
MM.RM$Z.[Y7Y#N!WXYQTKIJ* //;7P;K5OHNFDM9#4M+U:;48569C',DKR%HV
M.T%3MD(S@\BKNL>&-2UB;6M2\NWAO;S1VTJVA:8E45BQ9W8*><D8 !X7KSQV
MM% '(S>']5D7PA(%M/-T>7=<IYS88>0T7R';S][/(%==110!P3?#^6:S\2V<
MUS']GO)99-+"YS:M(5E9OKYR@C'91ZU=UCPWJNH?#B\T57M7U:_A;[1,[E(_
M-?ER,*3@'@#'0"NPHH Y>ZTK6#XNTG6[>&S=8K&6SNHGN&4IO>-MR$(=WW,8
M.WK64?"6LS^"?%.C2_8DN=5N;J>W99F9%$S$@,=@(Q[ UWM% $5L)1;1"956
M4* RHVX ^QP,_E7G^N>#_$&KQ:Y;RC3;@W-VD]E=W$[EHH@R$0A-A"8VM\P)
MSGD<Y'HM% '-Z?I.J0^.-2UF>.U6TN[."W54F9G5HS(<D;0,'S/7M6!/X8O[
M#X4-IER]NFIZ>[75E+"Y8><LIDBQD Y)(3'O[UZ'5*ZTBQO;^UO;F#S)[7/D
MDNVU22#G;G!.0""1QCB@ TFR>PTV*&5E:X;,D[KT:5CN<CVW$X]!@5E>,=(U
M#6M-M+;3EMR\5];W3F>0H-L4BO@84\G;BNBHH YO3-)U.W\;:QJ]Q':BTO;:
MWAC"3,SJ8M^21M YW^O:L>W\&:E_PK*#09I+:/5K%A/9SQNS(LR/YD;9*@@9
MX/'0FN\HH XWQ!X/N=5\-Z=;Q/:R:C97J:BRW /DW$N6,BMP2%;>V.#CCTI\
MWA]KK2IHI?"NAH+AXUN+42 B:-<GE_+'()!7\>1FNOHH \]D\#ZC!X?N[73F
M2,?VE;7UG87%U))'"L3(Q3S""1N*DX (&:VFTO69/&]GKCP62P1:;):21BY8
MMO=T?(^3D#9C/'7..U=110!Y^OA#6SX%FT9OL(O#JHOD(G8H5^UB<@G9D'''
M0U)#X0NK'7=8G_L?1]4L]5G^TG[6^V2!RH5T/[MMZ'&1TZGBN\HH YK3-%U"
MS\:ZCJC16B:?<6=O;1+%(=R>47/W=H !W] >,5AV_A'7;/PKX=LT6PDOM'U,
MW90W#+',A\T8W;,J<2^AZ5Z#10 B;BB[P V.0#D UY^_A;Q);Z#XB\.6C:<^
MGZC]K>UNY97$D7G[F*,@4@_,Q&[=T.<'&#Z#10!R#:%K+ZOX3NS%9"/289$N
M1]H;+%XPGR?)SC&><=<4VP\+W\EAXMT_4_L\=OKEQ-(CV\I=HUDA2+!!4<C:
M3U[UV-% '$Z!X6N+?3K?3]4T/14>W@,!U"U;,C_(4WJIC!5B#S\W<]:O>$+'
M7]$TJRT34(+&:VL8Q E[%<,&DC480F,IPV  ?FQWSVKJ** /.XO"7B)/A[8>
M&S'IOGV5U ZS"Y?;)'%,LF2/+^4G;C'/UK;M=(U71_$VKZE9PV]S;ZL(I7B>
M<HT$R($/.T[D("\]01T.>.IHH X33?!>H:->>%5M7M9K;2OM373O(R,[SY+;
M%VD8!)(R>G%;>AZ1>Z;X@\0W<_D&VU&Z2XA*.2P B2,A@1@<IG@FN@HH YWQ
M=I&HZQ#I2:>ML3:ZE!>2>?*4RL;;MHPIY-0VVBZHGBS7]2D2U%KJ%I#!$%F8
MNIC$G+#;C!W]CVKJ** //M/\*^(;*R\-6<Z:?=VFGV!M+FT>Y<1&0; LV-GS
MX"L-K 8SP>]1:?X,U_1]/\/3VATZ34-&FNP8#*Z0W$,[EB VTE&'RXX(XZUZ
M-10!P5SX-U;6&\6QZG):0PZ]:PQQM;R,YMW1",$%1N&3G/&<=!6MX<T>YM7M
MWU#0-%M;F",I]JLVW,QP 2H,:E0>_/MSUKIZ* ,3QAH]QX@\(:II%J\:3W<!
MB1Y20JY[G )JO#I>HZKJ>EZCK5O:VKZ87>*&VG,P>1D*;BQ5< *6P,'.<Y&.
M>CIDT23PR0R E)%*L 2,@C!Y% '(Z+H<EMXVUJ1)4;2TG%W#"!S'=RQXD_\
M'?F_[;&NQJKIVFVFE6:VEE#Y4*DD#<6))ZDDDDGW)JU0!YS;^#_$3#1I+Y-,
MFO=.U3[5->M<.TMTF)!U*?)C>OR<CCJ,<^C444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% ".BR(R.H9&&&5AD$>AKR#3='@OO"
M?BBUM-,DFU5]7OX+":%"K0,LA$>)>/+5>#C(X!P#TKUY]VQMF-^/EW=,^]8'
MA/P_>>'H=1BN;N"Y%Y?37H,<138TK;BO+'('8T 4M8\27OA'08Y[ZU2\2RMD
M-W</=+$\Q"C>T2$?.>IP2OMFGZKXON[/6H]*T[0IM1N)K!KV#;.L8=59 0=W
MW?O_ ,O7BIK/@F_U.[\2&+5+>.WUNV$!:2V+RP8CV;5;<!L)^8C'4GN<UHP^
M'M0C\56&LM>6Q2VT]K%H1$V6#,C%@=W'*#C!ZT 9]AKFKW7BWQ38R6,\UG:B
M%(D\V-!'F(L<$'/S$]>HXZ5)H/B.T7PQX;ATVSE,^I6I>SM9[@L51%!)DD.3
M@ J,X)RPXJ]%H&HVGB36=2M;ZV^SZG'&6BE@8LDB)L&&# ;<<]*R+7P+?V&E
M>&A::I -3T!&ABE> F*>)E"LKKNR,X!R#P10!9N]5F?7/#L>KZ-+;W4E]-#"
MT-Z3&K")SN/"[U*@XR.#4@\6:M<W>LVFG^'#<SZ7.(I UZJ"0&-7&T[3\V&'
M!X]ZL:AH6K:GJ&A7LU[9))IER]PR) V)-T;)M&6XP'//KVK%T.+5YO&WC(6-
M[:0VK7T*R>9 SR*WV:+YE.X#\"#@C//2@#8C\7F_\-V6M:78I)!=0F7_ $RY
M6V5"#@H6(;Y\Y'3'!Y%58O'@O(?#LMAI$\ZZ[&[0[I50QLB%BK?EU'X9Z%T?
M@J33M7TJXTB[ABM+&Q-D(;F$RL@+;C*AW#$AZ$D'/Z56TKP1J&F+X6C_ +2M
MI$T+S1_J&!G$BLI_B^7 ;WYH K:_XTU(>"?%$L%E)I^LZ3^Y=4D258RRJRR*
MQ ##:P[9]J[>UGN9;'S9;1H9\'$+R*3D=,E<CFN8U/P3/J,?BV'^T$CBUY8R
MA$1+0,D:H,\_,#MSVKJ;%;M+.-;^2"2Z _>-!&40GV!)/ZT <9_PL&^_X1@^
M(QX;E;387E%T5NE,D:QR,C.JX^<#:2>5[]>M;MCXD.H:WJ>F0V3;K.VAN(Y/
M-&)UEW[<>GW#U]:Y/P3I%_KG@633[N\MO[%NKF\1HXHF$Q0W,FY"^[&#SR!G
M!QUYKI)?#VI6_BR?5]+OK6""[M8K:XAEMR[+Y9<JR$, .'(P01T//2@"G_PG
MI/AK1-:CT>>1-5NEMEA65=T;,Y5>O!Z'T'OWJ1O&5S'=P:;<:;;6>KR6[7!M
M+N_5 1YC(JHX4[V.W.,# (]:IV_@;4;;POH&C+JELS:3?)=^<UNW[W8Q8+C=
MQG<<GV'%:WB'P[-KYE@NH=+NK.6W$:I=VY<P2?-F13WR"O''W>M $\'B*27Q
M,=$?3GBE_L\7P=I!SE@NS'8YSS[5%IGB:;5M"DU"#32LJ74UJ8I)P%4QNR,S
M/CA<J>@/;BJ@\)W^G:MI=]I&I0C[)IJZ9*+V%I2\:D$."K+\V1SG@YJ@O@/4
M8=&M;)-5MYGM=6DU)?M%L3'-O9V*2*&&<%\@CNHXH F;XAJGAC5=6_LLR2Z7
M=BUN88;E74D[<,CX^92'7L#UXXK3M_$MW_PDG]C7^CO;236TEU:.EPLGFJA4
M,I' 5_G7C)'/6LB]\"ZC=:3XAL?[6M]VL7D=TTIMB/*VK&"H4-R/W8QSP#SG
MK6[=:'=7/BG2=;^TQ*;.VFMY8?+)W^84)*G/&-G?/6@"C\/=8U/6_"T-WJ<4
MGFM)*1.[)^\'FN  %Z;0 .E5+?Q1>6OBWQ6-0CF72-,BA?S&,>V!1$SLV =S
M;OQ/3I6QX2T.\\.:0=,N+R"Y@BD<V[)"48*SLWSY8@GYL< =*IW/A&2[UC7W
MFNXFTO7+98;F#RCYJE8S'E7W8 P<\@\B@!\GBR6S?1Y=1TW[/9:M*D$$JS[V
MCD<919%VC&>F06 /'O3?'NK:AI&AVLNFK)YTNH6L!9-GW7F56'S?W@2N>V>W
M6DB\,7UU::-9:O>07%OI,\<Z/%&5>X>,8C+@G"XX)QG)'8<5H>*=$FU_1UM;
M:Y2WN(KF"ZBDDC+INBD5P& ()!VXX- '+O+=V_Q2GN+'1E>^GT*-GA:98P#Y
M[#+N >< #@'H.W2S<^*+76-'\/:A/I=THFUA+8QBYV&WN%D:/YMI^=00W'0\
M9%:]MH6HIXQ_MZYO;9PVGK9/#'"RY(<OO!+'')QCT[UD#P1J,>EV=C'J=MMM
M=9;50[0-ELRM)Y9^;U<C/MTH U(_%@NM<N],LH+:62SNDMYXWNPDX!"DR+'M
M.4 ?.21G:V.V>D)"@DD #DDUR6K>#FUR[5M073V,5VEQ#>I!BZB57#B,-VZ;
M=V>G:MKQ%IUYJVBSZ?9W4=LUP/+DD="W[L_> P1@D9&<\9S0!PNE^(_+\?V6
MIMJ<<VG^)$:VC@$H/V=HR3 <=1O0N2/[S8KJ-=\4WFE:Y:Z19Z)+J%S=VTL\
M&R=8PQCVY!)Z??'-)XH\)C7O#JZ?9M:V%VLD4L5TD&?)=&#!D ([CUZ9J2;0
MM2N/%&DZU+>VN;*VE@DB6%AYGF%"Q!W<8V# YZT 9VFZ]K-UXXURQ>PG>UM[
M6U,<1EC40LRR%CG.3N( ]L=!2^'/$=E%X4\/QZ?9SB74O,CLK2>X+M\FYF+R
M-DX 7)//4  UI1Z'J%IXNU'6+2\MO(O[>*.2"6%BRO&&"E6##@[^<@]*Q;7P
M%?V.AZ!#;ZK"-4T.:1[:X-N?+E1P0Z.F[."#C(/& : (M;>YN_$?A&XU+3(K
M.]AUEX 8Y?-#I]FD;*N54[2>V!R#5V\^(EA;6MU?HD,MA:79M9F^TA9LAPC.
MD>/F4,?4$@$@=,W-1T+6-5O-$N[B]L4DTV[-T4C@?#YC9-N2WHY.?IQ46C^%
M]1T"[NXK"\LFTRXNGND2XMF:6 NVYU5@P##))&>1GO0!;\:Z]+X>\.M<VH!O
M)YXK2VRA<"21PH.T<MC).!UQCO4'AG4]/_M&ZT;[/J%OJL42SS'4%'FW*$D"
M0,"01G(P,;>F!TK1\1Z(->TQ+=9O(N(+B*ZMYBNX)+&X=21D9&1@C/0FJ;Z#
MJ$U_>ZQ]KM[?5Y+'[%:LD9>. ;BVX@X+DM@]AA0/4D Z.BF0K(D$:S.))0H#
MNJ[0S8Y(';Z4^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JEKI6G6,\T]I86MO-,
M<RR10JC2'_:(&3^-6Z* "BBB@ IKHLB,CJ&1@0RL,@CT-.HH JV.FV.F0F'3
M[*VM(B=Q2WB6-2?7  YJU110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 45GZYK%OH.CW&I7(=DB  C09:1V(547W+$ ?6HM#O)KV&26XOK.>;(#P6CA
MTMS_ '"W5CZDXSC@"@#5HKFO''B&Y\.^&;ZZT^..6_CMI9XEDSM547+.V.PX
M'N6 ]ZW[61I;."1_OM&K-CU(H FHHHH **** "BN+^(^K>)-%TNRN?#(CFO)
M+GRC:R1!A*HC>0X[YQ&0 .N:@3QN/$O@&'7M NQ;3B>&*>)T#F)VD5&1@?3=
MD'OQ0!W=%8>I>*M&T*46FHWY-S'!YTJQPO(RQC@R.$4[%SW.!6K9WMMJ-E#>
M6<\<]M,H>.6-LJRGN#0!/17FLFO^(KCXEZYX<36[>RL;*P%['/):JQ3.WALD
M#:-QYX/%:_@/Q9>ZK\/XM?\ $XM[$@N6F(\N-XP<*^&Z9_7MUH [.BLO3/$>
MD:N;L65ZCO:$"X1U:-XLC(+*P! (Y!Q@U5M?&OAR]U.+3K?587NYO]3'AAYP
MP3E"1AQ@'E<B@#>HK /C;PT+:^N3K%OY%BXCN9,G;&QS@$XZ\'I5+4]>#^)/
M#45EX@M+>WO0TCV<D):2\1DRFPXRN.3V_I0!UE%<\?'/AG^U?[+_ +8MS?>>
MEMY R6\Q\[5Z>Q^G?&14\'BW0;C58]-AU.%[J5G6)0#MD9?O*KXVL1W )(H
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M^4JV?O8&>>N >IKV2B@#R;4/#,OB'PIXGN=,TO7+77-1LHX7?575&EVD'RU
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MW#\GJ,8P<4PZ5XLMW^'6J:GIDU_>::]TM^EH(PZ>:NU"1D+P,;CG&0:]<HH
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MNVMP.AP, 5U4NGWS?$.PUA;1OL0TJ6UD;>F8Y&DC< C/(PAZ9YH ?X*\3?\
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M9%7DD.1C&.><9'(R*YBU\.:A!KT%]IEMJ.DLU\\U]$;M7LYT)8L5CWMAFX/
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M/D%ZL< A&P[-@89?(8DL,>C< 5J>*-+O9O$FBZAIW[F:^CDTR^4L RP,IDW
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M*J73EY(U$I 1B2>0,#J>E:L?BFWD_MM197GF:.P6XC*IN;*!\I\V"-I!Y(H
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M1%I822-R%7*G!4Y!(- '1T5RMGXZM+N31V;3-2M[/6 HM+N:-!&SLA<(0&+
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M2]2@LM7V+:7DT:",NREE0@.6!(!YVX.."1S75T %%%% !1110 4444 %%%%
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M.I1Z;%%%8SV<UM!<.Y7S&0[E8H-WW.A QZFJWA3PA<^'[6STRYTC0[F&R?\
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M#M.S.3D'!'XUO^'[S4=0LY[N_A2&.6X<VD80JP@!PA?)^\P&[M@$#&<UK44
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MN6W'.-H?(4A1@!0>>@V?$6F>(O$OA"\TR2TTRTNYS&%(O'D0!7#,2?*!_A
MQWZUUU% '(>)/#-YJNL:/KD-KIUQ=622Q365XQ,4J/C.U]APP*@@[><GI2:K
MX<O[C2],;3;#2;.[LM32_:UCD*0R85E(+K'G<0V<[.V/>NPHH XV]\*W^K:[
MK<U\;6.PU32%TUO)F9I$(\PEL% /^6GKVI1X<U;4M-T+3M7^R+'I5Q#<//!*
MS&X:$?)A2HV9.">3C! SG([&B@#AT\)ZQ)X4\7:5.UBDVLS74MNR3.RIYJX
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M[5TOXBLCQHB*\;[=H0X/[K'&>M=!%I&J?\)\=<D6T6S;35LRBS,9 P<OG&P
MCG'7W]JZ2B@#G-7TC4KOQAH6JVRVAM=/2=91),RNWFA1\H"$<;?7G/:LH^$+
MFR\3:O>Q:7HVJ66J2+.POCLD@DVA6 /EON0[0<<8.:[BB@#F(M$U.W\;/K$4
M-@+(:6EC'$LK(P979P<;" O.,9. ,^U8]KX.UJ#P7H>DNU@;S3=3CO&(F?RY
M$64R$ [,@\XZ5W]% 'G6L^"]>U:+6H)?[+G:ZO$N;2\N)7:2*-71A"%V$( %
M/S*3G/*\DC8;0]:/B76]36.P\N_T^*TB0W#Y5D\PY/[OH?,_2NMHH XA?"FK
MKX1\*:8&L3=Z+<6TDO[Y]DB1(5.T[,@G(X(_&NWHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** $<E49@I8@9"C&3[<UY'J&JWN
MO?"LZAJMG*\\6JQF*=Q'D@7X3:H4Y!"C:>!GU/6O7:X,^"-7_P"$1E\.C4K(
MP"^%S!*8&#!1<>?AOFP3GY>,<<\T :@\8BTU2^LM:TZ33A;6+ZBLOFK*KP(<
M,3MZ,,CCGKP32V7C*&XU32;.6WCC75HW>U:.X$C JF\K(H'RG;D\%AD$9Z99
MK?A)]=UDW5S/&+:?29],N(5!W8E96+*WMM[CO5CPWH^JZ3;V]K>RZ9-';1B(
M3P6S)+, , MSA3ZXSGVH M^)]</AOPY>ZQ]D:Z2TC,CQJX4E1UY-9TGBVYM-
M;T^RU'1)[6VU)S%:77G*^9-I8(ZC[A(!QR?PIGQ,./AIXBYQ_H4G\JLV^C7]
M_+IUUKD]K,]@YFMX[6-D1I"A4.VXD\!FP!TSG)XP 9]IX],R7]U<:+<VNF:=
M+<Q7EY)*A$30YR HY;.#TXZ<D\"])XJDL[G25U+33;6VJR"&WE68.4E92RI(
MN!M) (X+#(QGO5:Q\'2'P_K^C:K<12V^KW%S,S0 JT?G$DCGKMSP?TJ1/#FH
M7T6BV^M7-O+'I,Z7"O K!KF1%*HS _<QG) )R<<@<$ JCQMJ,UEJEU:>&9YU
MTNYE@N5%TBL?+ )*?WC@]./KG@68O'-EJ)5=(6*XD^Q17I%Q.( $E!**"0<N
M0#QC [GFL7PO::M?S^+;:&\M8=/FUBZC=A&QG0E5#;3G;T(P2.#V/2M%?!+Z
M3K@O]!-B+>2SALYK2\B+J!$"(W1@<@A3@C'- "'X@K<IHK:5HMW?'6;22YM%
M$B1\H%+(V3A2-PYZ>F>Z6'B+6[GQOJMC_9L[006%K(D#21*L4C^86);.XYV@
M=#C:>!WT;K0=0N/$VB:L+FT":=!-$\:Q,OF&79N(Y.W&S@<]>M21Z+>6?C.]
MUR*\MQ97EK%%<121G>IBWD%6R  ?,.<@]* *VG>,)-4T/3-1MM-_>7]TUJ+9
MY\/$RE@V[Y>J[')'H.,]*Z*^O(-.L+B^NI!';V\32RN?X549)_(5S/AS14M_
M%.O:A!/YEB]R6MX@/ECF=4\\@]\LJ_0[QW-=%JFG0:OI-YIMT";>[@>"3:<'
M:RD''OS0!AOXN>U_LBXO].:WL-6E2&"82AVC>09C$JX&W=TR"V#P?6L_PQ<R
M:QXOU^YOM*9I;"_>VM;N3RR8(Q#%^[7#%AN+,QQP=W/(P+<7A>_NM/T;3=7N
MK>:VTJ>*998E(>Y,7^KW \)S@G!.2.PJ[X=T2]TB^UF>YG@E34;TW@$:D&,E
M$3;SUX0'/'6@"KXXUC4-'LM*;3HY6>XU6U@D\O9RC2#<GSD8W#C/;U%8RSW=
MI\3=3FT_13+=SZ+:RO;F5(P&\V4'<XR,\ <9SCTYKIO%.B7.N:?:QV=Q%!<V
ME[#>1-*A9&:-MVU@"#@^U166AZA#XQN-<N+FV=)[&*T:*-&4@HSMN&2>I<\=
MO4T 5+3QY8WUAH\D,)CNM4$WEP7,@C$?E';)O;G #<# .21QC)&IX=\00^(+
M6ZD2/RIK2Z>TG0.'42+@_*P^\I!!!P.O05R]O\/[ZR@TB:"]LWOM+FNBGG0%
MHIXIW+LC#.002,,,].G-=MI\-Q#:A;G[,),D[;:,JBCTY//UX^E ')W$S>(O
MB3=Z%=2.-+TRQCG>V5BHN99&."^/O(H7[O3)YS@5J7.EZ#X8\[Q D,>GP6=M
M(TZVR[$=>#DHO!(V\<9YIFM>%Y[G7[?Q%HU\MCJ\,)MY#+'YD-S#G.R100>#
MR&!R/>GWFCZGX@TB]TO7)+%+2ZMWA=;17+_,,;@S$8QUQ@_6@!LGBF6RN])3
M4]--K;ZK((;>59@Y24J65)%P-I(!'!89&,]ZRKCXAS6^GZCJ3^'[G[#IEZUI
M>2>>FY-I4%E4?>QNY&1QZ]M%?#FH7\>C0ZU<VTJ:3.EPKP*P:YD12J,P/W,9
MR0"<G'('!S;GP3JESX8\1:0;^T5M8O7NA*(V(A#D$KC/S8VCGCJ: -BT\2W,
MOB&;1;O2);6Y^R->6V9E<3(&"D$C[K LO'(YZUC_ /"P[D>&5\1GPY<_V4C.
M+J07"%XE20HS!/X@,9/(]L]:W'T2[D\7V.O&>$"&PDLY80IY+NC[E/MLQ@CO
M7)>"=(O]=\ #3KVYM1HUS-<JRQ1L)F3[0^Y"2<8/(R!G!QP>: .D\2>+SX<L
MI-1?3_.TZ$*TDQN%1V4X),:'[^ >>1[9IUYXHNH_$DFAV6C2W5R+,7D;F=8X
MV4MMY)R1SGMGV[C)UGP)J&IMXDBCU&T2WUB((DDEL6FMP$">6IW8V<9QC^(]
MSFMFWT._3QFNNRSVWE?V<MDT**V>'+[@?J<8QT[T 41X[#Z+I6IKI<BQ7E]_
M9\RRRA3:S>88_F(!!7>I&1ZCCGC?L]2FN]7O[/[*%ALRJF<29WNRAMN,<$ @
MGG^(=><<Q<^&H[#P#K>C:E=QO'<R7-Q"\8*NK22&1, GEE=EQCJ<5I26VM:7
MX1AM+%UEURX9%DN3'E%E<YDE8?W0-Q ]E7TH Z:N3N?&RPZ'<>((=/:?1+>5
MTDG67]X41RCR+'C!4$'^($@$XZ9ZM05106+$#!8]3[UQD7@N[@\.7_A:.[A_
ML6Z>4)(0?.ABD8L\8'1OO, V1C(X..0"S>^,;B+7WTC3]#N+^86D=XDD<R*C
M1,Y7=DGM@\=3V'<=//(\5O))'$97520@(!;VR>*P;;P_<VOC,ZQ'+;K9_P!G
MQV"VX4[E5&9@V?\ @6,>W6MZ<2F!Q#L\PJ0N_IGWQ0!Q5K\0YKFRT74#X>NE
ML=8<0VT@G0OYI#%59>P.T_-GZBMC2O$TU^VKVT^DS0:CICJLMJDBR>8'7<A1
MN <CUQC%8]MX*U.V\.>&=*6^M&;1+J.X,IC8><$5@%QGY<[SSSTJ;6/!E]J,
MOB=H-2C@764MPA\LDQF( %6P?F5QD'IP>] %JT\7375_JVF?V8IU*PMUN5AA
MNED2=&+  .!PV5(VD#MS@YJ33O%;:KIV@WEI8K(-6!;9Y_,"!=Q+?+SC&T^C
M$#G.:9I?A^\T_P 2R:U=7-D(WT^.S:"WA,:1;'=AMR3Q\_?_ .M47@[1$L+W
M6+J*?S;%[R46"8XA1F#2A?8R[OP04 :'C6&*X\#:\DL:NHT^=@&&<$1L01[@
MX(K#T?Q7-IEAX;M=0T>:VT^^AAMK>],RG]YY>5#H.5#!3@Y/N!75ZU8-JN@Z
MCIR2")KNVD@$A&0I=2N<=\9K#LO"]Y/9Z7::[<6MQ!I94P);1,GFLJ%%=\DX
MP"3M'?!SQB@"*#Q_97":5=I$AT[5+E;:WE6<&4,Q(1FCQPK$>I(R,@<XU/&,
M$5QX*UM)8U=?L,S ,,X(0D'Z@@&LWPOX7U'PU;6^F+/IT^GVI(@G:W(N/+R2
M$8@XR,XW>W2MW7;&;4]!O]/MY$CDNK=X [@D+N4J3@=<9H YCP]XEGLK/PMI
MUWI,L-IJ%K'!;7?FJ<R+#OPR#E00K8.3[@5/_P + L6M[;4(XXWTNXO!9K,)
MQYH)D\L/Y>/N%N^<X(.*FD\+WKV'A:+[5!YVB3)(QV';,%B:+C^[D-GO47AO
MPI?^&E&GVTVG3:7%,TD#RVY^T1HS%C&2#AL9(#?3@T 4/#]]8>')O&UW,OEV
MT.L* D2<EFA@"JH]2S #W-)?M=R_%7PQ)=Z7%:DV]YMF282&0;%PK< @C)XY
M'S'!ZU8N/ UU?V/B.VN=0CB.JWB7T$L*$M;2H(]G!/S &)3VZD5:7P_KUUX@
MT36=2U"Q>73EFC>&W@9$=9 H+ EB=WRY].WO0!T6JR>5I-W)Y,DP6%B4B?8Q
M&.<-D8..]<K8>*TLM'\)P66DWD\>KVRBVWW 9DQ"9 '9CDG Y/\ ^JNLU"&6
MYTZX@@9%EEC9%9\X&1C)Q7*6?A#4K2'PC%]MM6'A]2A.QAYX\HQ>OR\'/?F@
M#9\/^('UBXU*SNK![&_TZ98IX3()%^90ZLK#J"#Z U<U2^N+& -;6BW#G))D
MF$4: =V8@X]!@&J>F:)/I_B?7-3:>-X-2,++&%(:,QQA.O0YQFH/$&@7NJ:S
MI&H6ES; 6)EWV]W"9(WW@ . "/G7!Q_O'I0!;\,Z_#XET2/4H87AS))%)$S!
MMCHQ1AD<$9!P1U%9-]KFIP?$FRTF"VN)K%M-DF=$,0!?S8U#Y9@<*"1CWX!K
M1\*Z'<>']-N+.>Y2Y,EY/<K(J;21)(SX(]1NQQ3+[0[V3QC8Z[9W4"+%:O:3
MPS1%BR,ZOE2",'*XYR.: *6F>,+[5KZY@MO#EUY5K=36D\S3Q@(Z+N&!GG)X
MST&1SV!'XXCE\-Z%K2:;,8=6N8;=5\Q<PF60(I;UZ]JN^&=$O=%;5?M4\$RW
MU])>CRU(*%\?+SUQCK^E<[;^!M<B\/:7HC:K9&VTF^AN;=EMV#RK')O"O\V!
MZ<?7V(!O+XJ%SK=WIMC;PSO9W,=O<(UR$F&X(2ZQX.Y '!R2,[6QTYJ^&-<U
M/4O$?B2VNK:?[+:W_DPNQB"Q*(8VVX4Y))8G//4<CH&:QX.?7KL/?P::72Y2
M:'4(XR+J%%8-L4X]B-V>AZ&DFTK7="E\1W>E2V]PVJ3":UB:%M\4[(D66;./
M+78&/&<9_$ [&N9UKQ:VAWML+K3B+*:Z2U\XW"B3<[!0XCZE-Q SG/?%=%;I
M)';11S2^=*J /*5"[V Y.!P,]<5PMQX$U2:+48/[2LREQJB:BDS6Y,S!9ED$
M;MN^ZNW:,=L=,8(!MCQ4+C6[O3;&WAGDLKF.WN$:Y"3#<%)=8\'<@#@Y)&=K
M8Z<[\TC1022+&\K*I(1",M[#) _,UR>L>#GU^ZW7\.FETN4FAU!(R+J%%8-L
M4X]B,YZ'H:Z\C((]: /(WU6]UOP)X-U?5+.66^&K64BSD1[IMTA)V!3\HX P
M=O0>E=BWCB/3Y-8CUW3Y-.DTRU6\;;*LPEA8LH*D8^;<I&#WQS6?;^"=8@\,
M:'HIU&Q==(O8;B.00.ID2)LJK?,>3W(Z>]7/$/@@^(M3U.6XNE2TU#2DL'15
M.^-ED=U<'H>6''M0!>L_%23:_;:1<P11S7=N]Q;M#<"8$(5W*V -K#<#W!YY
MXK2U?6(-'@@>97DDN9TMK>),9DD;H.>!T))/0 U4T*PU:S55U)M,<HFTR6EN
MT;2G^\<G"_09Z]13?%7A^3Q!86JVUV+2^LKN.\M9F3>HD3/#+D94@D'GO0 ^
M/5=66.Y%SH@2>-U$7EW(>*0$'YBY5=H&.>"?3.:R(OB#9_V5>75S;I;SVE^F
MGRJ;A6A$C[=K>:.-F'!)(R.1C-3:UH6N:YIUDMQ=:<EQ:WD=R81$[03*H(V/
MDY(R0P]"HZU%;^%=3M)=6D-QI]VFHWB7,L$]N1&ZB)8S&1S@?*"#SC'.: +D
MWBP6<=JEY;PQW5Y=&WM%2Y#13 )O,GF$#"@9!XSD8 .15K0?$,6MSZC:^6L5
MUI\PAG5)!(AW*'5E; R"#W (((Q7,'X:I 8[W37L[&]AU WL%LL):TC#1B-X
M]F1PP&21CGH.*[33(+J"V(NUM%D)R$M8RJJ/J3R?? ^E &;K?B.;2=:TS2X=
M+ENYM1$HB=9510R*6(.>1VY_F>*Q9/B'/#H]_J4OAZY6+2KAK?4Q]H0F$KC)
M3_GH K!OX>#ZUM:MHEY?^)]#U6&>!(=-,I:-U):3S$V'![8'/?-9$O@N_N?#
MWBO2YKZW4ZY/).DB1M^Y+HJX(S\V @YXZT ;'B/Q%/H-G-=QZ<+BW@A\Z1WN
M%BW#G*IG[SX7.#CJ.>:B'BQ7UC0[2.S)MM9MS/;7+28'"!RA7'WMIR!GG!YX
MK/O_  CJM[JNH7?V^S"W^GK9MYD#.]L0K F(Y  ;=DY'8=:CUS0I1X/T/28[
MZ.+6;":U%E/&N2'0[2VT]C&)"1Z9ZXH Z;1]2FU2&XFDM1!''/)#&PDW^9L8
MJ6' P,@X]<?2N4U5I;+XLVMQ8:=]JNYM$F!166,,1-%@NQ[ <9Y/3BNVM+6*
MRLX;6!=L4*"-!G/ &!6#JFAZI)XLM->TRZLU:&T>S>"YC8AE9PQ8,I&""J]C
MGGI0!2L_B!:W20VTMHUIJSWDMD]G<2JJQR1*'<F09&W:RD$ YW#BMCP_XABU
MY;Y!&(KBPN3;3HL@D7=M# JPQE2&!Z ]>*P[[P&6GL]3L;J'^U[>\FO)'N8=
MT5P95"NI4'*C:J!3DD;1UY-:<JZ[')IEG;BUA,ESYMW+;P8CC@4<H-W5V8J
M>.,G'% &W>W<=A87%Y-N,5O$TK[1DX49.!W/%<Y#XPDET.?6(]/BN;*.S:[5
M[2\64X !*-P K8.<9/0\UT=['/-87$5K*L-P\3+%(R[@CD'!([X/.*Y.+P)
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M5?#!\2:CI5I#II5HHTCN&,C3^>(E!RN ASG/)X)QVJ]/XZ&ES:@;^-+JSM;
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MS3+>"1=>LTA6*<OYI2Z"%@2HVJQ7(Y/!H ]0HKDD\0:RFKZIHM]9V0NHM/\
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MTG7M4;4+>Y@,+;(%A.#_ !<9^;OD8'M7044 <FO@^]>YT>ZO?$-S>7&E3-)
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M1(;F^^(7C+['K7V>$7%NLL,<:.Q_T=!N5C]T]NXXZ9KT*F)#%&Q9(T5CU(4
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M&P1@KD':2,@'Z=ZYNQ\)/8^#;KPVNHEX9TF03M"-ZB5F9^^"?G./3CK7344
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MD>87:7/F^8#C<'SD\CG&",4R_P#!R:CIVMPSWA%WK,0@NKE8L8C"E0B+GY0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+>6NK2110%90C!I%W)D$=,#UK0_X22XLK?4KG7-*?3K6QMOM+3B82JZ_-D#
M^\-O3W'K7GWQ6UG2]:\$^$;[3KN-;*?6;9XW1@IC4*^?]TKGGTKHY[OPW#I?
MB&TO=>;6K.YM6GN0)TD:*$*L9!9< 9SD<#OZ4 :^G>*-3O?[+N)/#LD.GZD1
MY4WVI6DC5E+*TB < @=F.,UT5W=165G/=W#A(8(VDD8]E49)_(5XXFF7G@_7
M_"]MX2\97NK65Y>)"^F3SK<*MKC+NI'W54#J .HKT#QVQNM'MM#C)\S6;N.R
M..OE'+S'_OVCC\10!;MM<OI/!UKK+Z6SWEQ#'*+*)^07(PN2.,!AD^QK%A\>
MZC/XKN/#2>&9#J5O;"Z=3>Q[=A('#8Z_,*[=5"J%4  #  [5Y;I=Y;']H_65
M%Q$2=%2,#>.7#QY7Z^U ';:AXFBTKP4_B2^M9852T6X:U8_.&8#$?^]N(7ZU
M9T/7;?Q!X:M-:L$9XKJ 2I'D;LXY3/3(.1]16!XDNY-7\4Z=H.GFPN)+13?W
M<%S,55NJQJ0 2>2SXQ_ OK7*?"G41X8USQ#X$U*YMT-C,;JTVS;D$;#+(&./
MNY!]>6]* .HTGXE:??1ZZE]97.G7VC2;)K*4AI'SPFS'WBS< #N1ZBEUGQU>
MZ'?Z#87/A]S=ZR2D,:W:_NW&,JQQCHPY&>_I7!^,9FM_%%E\4M/L8YM(LKA;
M2<A<M=1 E3..V QVJ>^U3TQ6E\2M1T_4/%?PYNX=42*TFN9I5NXI57:A$?S
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=.EN+D$P1I<*6D )'RC//(/Y52L/&UE>^.=7\,-Y,,NGI$1(\ZYG9U+D*O\
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M:TJWO[:2-EEC5F5) ^QBH)4D=QFJEUKMI<6MW%IFI6;WT<#RQKD2<+U.T$9
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M02Z)X;BU&]4ZIJ=C%*JE<-,_E;W( &!T8]J .CHKF?$&OQ2^&?$<FC:ELO\
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MQ7I=_P#8-/;4$DU*6V63:5*^:0H+E3@*Q'<*3BLGXA^+$TCPIJ4NFZG);ZA
M,1RQ0>8@DSC8S%&0'GH2#TH [>BL;5/%>AZ'+Y.IZE%;R^49MC DE1C)  YZ
MC\Z+OQ5HEBT8N;Y8U<H/,,;%$+XVAW VH3D8W$=10!LT50CUJPEU>72DF8WT
M2"22+RV&U#G#9QC!P<'/8U&/$&EM!83I=>9#J#!;62-&=921G (!QP">>P/H
M: *^GZ%+8^)M5UAKQ9!J*Q(T/DXV",,%P=Q[,<\<^U;=9/\ PDVCC5(M.-Z!
M<RNT4>48([KG<BOC:6&#E0<\&L_PS?W]SK_B>SO+M[B*QO8XK?>B*41H4?'R
M@9Y<]>: .FHJAK5^VFZ5-<1*'N#B.",]'E8A47Z%B/PK-\%:Y<:[X;CEOPJZ
MG:R/:7Z*,;9XSM;CT/##V84 =#164/$FE'48K%;EFFF<QQLL+M&SC.5\P#9N
M&#QG/!HC\2:3-J$5E'<LTLQ81.(7\J0J"6"R8V$@ Y /8T :M%9,/B72)[FV
M@2\&ZZS]F9HV5)\#/[MR-K\<_*3QS2#Q1HITV\U :A%]DLI&BN)<'$;* 2#Q
MV!% &O16-=>*]$LYXX)[]%FEA\^.((S.Z<<@ 9/4<#GFL[6/'>E6/AB/6[*X
M@NX9;J.V7,GE_,T@1L@C(*Y)((SQVH ZJBL!]>%]K]AI>F3(Z/ ;VXG7Y@(0
MVU5'N[9Y]$;O@U;CUW3KRX6TM[F3S)2Z12K"^QF7.[:Y78Q&#QD]#Z4 :E%8
M_AW5Y-3MKJ&Z"B^L+EK2Z"#"EE (8#L&5E;';=CM6Q0 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG(1]YLY#;CG#X[T >@T45Y*[+?\ PWUB[NVV^+[:YN '4XN8[D2MY*)W (V
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MU) R0#VHCDCE3?&ZNOJIR* '44R.6.5=T<BNH.,J<B@2QG=B1#M&6^8<#WH
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M1 %_,(V#[W][Z^]8M[KUQ;>+=%TN*&"2SU**=_/#DLIC4' &,8.X<Y[5O;U
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MKP* ,+3M5\10^*DT?6(-/FBGLWN8YK$.ODE65=CAB<YW<-QG:>*ET37M1O\
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MF*1Q.9$E681'Y3D$DOGJ.*Z?XEVTEY\/=8M8+.:[N)8=D,4,+2L7SQ@ '\Z
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M56NH[.9+:XT5(S.L#",R+*Q"LV,!@O8\UT]YY!LIA<Q&6!D*R1B,R;E/!&T
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M:-H>,C<K $9'/(YH V**P(_&WAN24Q)JT)<1><JX8;UXY3CY^2!A<G/%2_\
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M:/ELKR?F[8Z58T7Q/<1:MK.B^(9;6.YTM(Y_MB#RXYX'SM<@D[6!!!&<9Z4
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M"[FU#PYI=[<E3/<6D4LA48!9D!.!]36C0 4444 %%%% !1110 4444 %%%%
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M%_=0>>+IU\QMN%$FUFX"#V!X_&N@U33XM6TF\TZ<D0W<#P.1UVLI4X_.K=%
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M+7M)U:PTF.V6ZL 'RP^]$ZD,I&54@GCD\BO0-!34(O#^GQZMY7]H+;H+CR@
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MYA@DD" MV#-V'K]*XRWTOQ%JFE:EHVJZ!;VJZK;RQW>I#4A,Y=HRH.P1C@<
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M8!R,E1G=C R!GK47A[PC<Z3:G1-1T==0M([MI8;LWI\ID,ID4O$3PZD]E()
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MJ <XH Z)/%-@;RSMIH[JV-\I:S>:(JL^!NP.X;'.U@"?2L]OB'H2VTEV1?\
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M\ME1[)D?>K7KA;OPG?"ZO(;2-%62ZLWL;O>,V4$7E[HQ_%_ ^ .#YG/>NZH
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M,@W?*0<#)]AQ0!UE%065W#J%C;WMLV^"XB66-L8RK#(/Y&IZ "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH2 -I ).1G.*Z"BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""[O+6PMS<7ES#;P@@&
M29PB@GIR>*@M=:TJ^G$%IJ=E<3$%A'#.KMCUP#3M3TRSU:V6WOX4FMUD60QR
M*&5BIR,@\$9K!\*Z=ID][<^(+'3[2V@F4V]D8(53="#S)P.=[#(_V50]S0!O
M7VK:;I?E_P!H:A:6GFG$?VB98]Y]!DC-7 01D'(-<[XFT=;NSO9;?1;74KVX
MMC;G[0R@!0&('(/=CQQGU%.\#7=G>>!M&DL&N#:I:I"AN1B3]W\AW8XSE3TX
MH Z"BBB@ HHHH *AMKNVO(VDM;B*=%=HV:)PP#*<,I([@\$=JR_%>L'0O#=W
M>QD?:-HBMQM+9E<[4X') )!..P->;_"^^@\.>.M;\&QW4T]C<XU#3Y9U96<X
M D'S $G_ .()H ]BHKAH_$NO^(-8U>#PZMA%;Z/>+:3+=QL[W#<;]I#*$ !.
M,[LD=J+'Q+K_ (EU+4)-!6PBT_2]4_L^>.YC9Y9]K+YKJP90@ 8D##9Q^% '
M<U0M=;TJ^U*YTZTU"VGO+4?OX8I S1<XPP'0Y[&O.A\2M;U"66\T;33=6L&J
MFQ>RCL)Y)'A4X:7SE^13WVD<#J:EM-0BTCXL>/M3F4M'::5;3N%ZD+&6('Y4
M >GT5YKX=\<^(M:U+0V6P6;3M6MY))7CT^=%T]@NY-TK';(#TR,<]*/"_B_Q
M5K5KJ>IW@T*WTW3KBZMI'=WBW/&!L))R%3/4Y)YZ<<@'I5%>:Z)XSUG4];U_
M0YY;"[$.F_;;.\MX);=6#<8(8L2,GAAUQ^7/^$/%VH^&?A7X8,H@FEU6\^S6
MLGER2M'ND<O)(HY<YZ*N"<]: /:JH?VWI9UG^QQJ%L=2V%S:K(#(%QG)7J!R
M.M<&WQ%U;2/#^LWFKZ4[R6MY':V$QMI;2.\$G"MMDR5QSNZU7@AU:+X]:<-7
MNK.YD_L.0QO:V[0@+YG0AG;H<\YZ=J /3KBY@M+=[BYFCAAC&YY)&"JH]23P
M*JV>N:3J$,TUEJEE<Q0#,SPW".L8Y.6(/'0]?2KQ (((!!Z@UXUX;U)OAUX@
M\7>$@@*L1J&BQ'@2&4A%C'_ RB_@QH ]<L-3L-4A:;3[ZVNXE;:SV\JR*&]"
M03SR*M5P6KZN/A[HWAO0;11)<WLWV?[0\+R@'&Z24QI\SL6.=HQRW7BLRX^(
M'B/3_#-W>7VD2(UOJJVGV[^SYE0VIR?M/DL0W &,9QDCGM0!ZA51M3L$U1-+
M:\@%^\1F6V+CS"@.-P7KC->0^,?$T_B/X>6=SI^K6-_$VN0P&X@22#<N055X
MR20<GD9Z $#FNJ_M&_C^+6G:9>V>D/<2Z.\WVR*W;S4PV"@8M]S=D_C^8!W]
M%>.7GQ&\96_AOQ%KB0:(UOH6K/92QF.4-,BLB?+\WRG+9R2>O08YZ3Q%XUOK
M3Q*FD03V6EPG2'U(7=\A=97!P(E^91P.3U..PZT =_39)$BC:21U1%!9F8X
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MA5WMUM9+>>%R>0R.Q.WISCKZU3^)UU)%HFDVAD:.RU#5[6SOG4[<6[L=P)[
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M+T3Q-K&LZ3I!4646IS74L-_"87*P"(D28&_/!"@$YSO7BNTH **** "BBB@
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M*D(,9*C(P1Z8K!\2:7YWC:WBU#6M8TJVL=-2.UO8T5UNF+$O_P LRBN-JY
M)XQC'/JE% 'G?A'0-:U2VM[W7M9U=AI^J33:>7(A>XML!4\], G)#'! .#[X
MKT)U+1LJN4)! 9<9'N,\4ZB@#.TO1XM,TG^SFGENX?FR;D(20Q)(.U0".3V[
MUBV?P]T6R\.7^@QFZ:QN[G[2H:7YK=AMVB-L9 78NW.<8[UU=4;[5[#3)[2&
M\N!%)>2B& %2=[GHO ZT 5[70ECU&#4;V[FOKRWA:&&2547RU;&X@* -S;5R
M?;C'-4;+P996?A2[\-/>7=SIMQ%)"J3%,PQMGY5(4=,\%LGI7244 8,OA#2Y
M?["W"7.BMNMVW\O\N,.?XLD*Q]64&I[KP_%=^)+'7&O+I)[.*2*.)=GEE7V[
MLY7/.U>_:M>D9@JECT R: .4N/ -I<:5JVEG5=22QU*X:XDA4Q?NV9][!"4)
MP6YY)]L5HZCX:AU+4+"_FOKQ+BS@F@5HR@WK*%#%OEZ_(,8QBKVF:M8ZS;-<
MZ?<">%)&B9@I&'4X8<CL>*NT 8D7AN-KN"ZO[R>_FMX'MX6E5%VJ^ Y^11EB
M% S^0%9L7@."#2])LHM:U-7TB7?8W&82\2["FS'E[67:2.03[UUM4;75["\U
M*[TZWN ]W9A3/%M(*!L[>HQSM/3TH P9? -E+9WEK_:>I+%=WZ:A)\\9/G*5
M(P2A.,HIQ[>E:-WX8L[_ %D:E<S3R.U@^GRPG;Y<T3G+;AMSDD=B*VZ* .0C
M^']NME86<FN:O+!IMQ'<6*R21GR"F=JYV?,,''S9.!P1SF])X3ADU'5[[^TK
MY9=5MTMYP/*VJBA@NWY.#AVZYZUT-% '.GP?:G1]$TW[=>A-&FCEM9<Q[R8T
M9%#?)@C:Q[ UQRI>-%KFJ0^(K_3=<EN)BFEK##,X93LC4!XR[*P56^4A<-QW
M->IT4 5M/-V=,M3?A!>&%//"?=$F!NQ[9S64?"\:ZSJ>I0:E>P-J4:K<0IY9
M0LJ; XW(2#MXZX]JWJ* .:7P59IX>TC1EOKX0Z5/%-;2YC\P&/[@/R8(_"I+
M+PFFF7]U-IVJW]K:W4YN9;-/+:/S&.6*ED+*&/) /TQ6X]S#'<16[2J)I0Q1
M,\L!C)QZ#(Y]QZU%;:C97L]Q!:W<$\MN0LR12!C&3T#8Z'VH M5S,?@C3O[*
MU?3+JYN[NUU6=[B=9F0%9&(.Y2J@C!4$>A%;$>LZ9-?_ &&._MFNLL!$)!N)
M7[P [D=QV[T-K.F+?K8M?VXNF;8(C(-Q;&=O^]CG'7'- %.#P\!>6UY>W]S>
MW5I&\=M+*J Q[@ SX50"Y QDCUP!DYJVW@G3H?#%[X>N)[J\T^[:1W6=EW*7
M<NQ!51CYCD>F!6O_ &OIXO?L?VN/S_,\K;G_ ):;=VS/3=MYV]<<XJ:.\@E:
MX5)-QMFV2X!^5MH;'OP1T]: .>O[/4]!\+ZC-#J.IZQ<0VCK!#)Y8<\<$&-
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M9HT_AWL-NX^X!8#_ 'C[8SK7PSIVG3P3Q"9DLWFEM8"05A:3)<J,9YW,!DG
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M2'WVLFY=P^0IAN,'Y21T_7FK6N:+:^(-)ETV\,HAD*-NB?:ZLK!E8'L0R@T
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MJ1\RG(.&ST...D7AO6=1UVPT8F]N4NK**1M8C54R\J$Q^61MXRZN1C'"8[T
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MF\@U"'[#&)IXGM'#!"2 P.-I&01D'CO6/X1F$?Q&\:6MZ<:C)-!-"'ZO:^6
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MLT,=O(;F0E%.,C[W(.!G/7 S4NK:U9:+!%)=NV^:0100QH7DF<]%51R3U]@
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M#'NV(,+N<L<?4DDUDZ;X2T32)0]C9&(*V]8S-(T:-W949BJMU^8 'D^M;5%
M'/1VJZSXG@U*YTN6W&DB:*WEN%4-([D*63!/R[5ZG&=_M70T44 8+>"_#[65
MU9FP(M;J;SYH5GD",^[=G ; &[G P,\XS5Z71=/FOK6]EA9[FUC:**5I7)"-
MC<#S\P.T9SG.*T** ,?2_"^D:-(&T^VD@522D(N)#%&3UV1EBB]3]T#K6E=6
MEO?6LMK=P1SV\JE9(I5#*P]"#UJ:B@#"M/!^C6(1;>&Z$*$%;=KZ=X5QTQ$7
M*8]L5-+X8T>:YN9WM#FZ8-<1K*ZQS$<9>,':QP "2#G'-:]% &:^@Z=)J[:J
M8I!?&$P>:L\BD1_W0 V ,\\=^>M5T\):)'I*:6EFPLHYQ<)%Y\GR2!MX93NR
M#N^;@]>:VJ* .%M/#\-]\1M>OKZQO5A:"VCMIM\L:2[ XD4[2 PR5X;(/;-=
M+?>&](U&6SEN;)2]D"MNT;-'L4XRORD94X&5/!QTK5HH PO^$.T(6T%LMDR0
M6]R;J&-+B15CE))+J W!R2>.F3ZU/>VEGI]W/KT>GW%Q?^4D+"V)+R(&X&TL
M%.-Q//O6M10!C^'=*33K6ZN#:K;7.H7+WEQ&,$AVZ D<9"A0<<9R1UJYIFE6
M.C6?V33[=8+?>\FQ22-S,68\^I)JY10!@_V"$US4Y#%'-INKP@7D+]I%79G'
M<,F%/IL'J<.M/"FBZ7);7-E8L+BSC9(&\]V<*<93<S<K\HP#P,<8K<HH R/#
MND2:59W#W+(]]>W#W=TR?=\QL#:/95"J#W"Y[T7GAG2K_5?[3FAF%]Y0@\^*
MZEB;R\YV_(PXSSCUK7HH HV6CV&G0316=N(1.<RNK'S)#C&6?.XG'<G-4X/"
M>CVMK!;6T$\$4$C2Q"*[F0HS9W8(;."221T).:VJ* ,6?PGHEREHLMES:2/)
M"ZRNKJS_ 'R7!#'=_%DG/?-1R>#/#\M@UBVG*+5KDW8B61U"S'/SK@_*?F)X
MQ6]10!F'P]IATNXTUH':VN%*S[IG+R@C!#N3N;CCD]..E1CPQI(FT^802^9I
MRE+1OM,G[H$8('S=QQSVXZ5KT4 8J^$]$73M0L#9%[74',EU'),[B1CU8Y8X
M8\<CG@>E4M4TJ#4(K?PQ_9,\FG*T4TMQ,=\85'W[=S,69R5 /LQ.>U=/10!E
M:OHL>LW6FM<N#;65Q]J,.W_62J/W>3Z*26QW(7TYGUG2K?7-&O-+NL^1=1-$
MQ7JN1U'N.H^E7J* ,!O#D&M6FGR^(+<2:G9*RI<6\[Q$$X#.C(05W!0<9XSB
MG:UH9N_#[Z'8(EO;79\FY<'E8FSYA'<NPR,GNV3G'.[10 V.-(8DBC4+&BA5
M4= !T%<]_P ()X9\N>,:6BQ3R"5HUE<(KA@VY%#80Y .5 KHZ* ,>[\+Z1>W
M\=]+!*MXD8B^T0W,L4CH.BNR,"X]FS3;GPEH5Y>-=3Z>C2O +=\.RJ\8! #*
M#M;&3@D$CM6U10!CMX6T9AIN;,YTP%;1O.?,:G&5SG)7@?*<C@<4Z'PSI$%M
MJ-LEJWDZEN-VCS.PF+#:Q.6/)'&1SP/2M:B@#$L?#5K9:V-2!+>1:+9V<9);
MR(\[FY))))Q] H'K3_$&DRZA'9W5H5&H:=<"YMBYP&."K(3V#(S+GL2#SBMB
MB@#'N_#.DW^I?VG-;21WK1B-YH+B2%G4=%?RV&\#T.:;:Z3*WB>YUFZ"J4@%
MG9QJ<[(L[G8^[,!QV"+W)K:HH SM4T'3=:DM9+^W,DEJY>"19&C9"1@X92#@
MC@CH>]/TS1[#1DFCT^W%O'-*TSHK';O8Y) )P,^V*O44 9>K>'=)UN2&6_M
M\\&?)G1VCECSUVR(0P_ U!+X2T:XL)[*Y@N+B"==DOVB\FE9U_NEF<MM]LXK
M;HH SIM"TZXGL9YH&>:P#"WD:5RR!@ P)S\P( !SFJ-IX*\/6)M3;:?Y9M)#
M);D329A)!!"'=\JX)&T<<GBM^B@#'B\+:-%I^H6"VC&UU!F:ZC>9V$I;[Q.6
M/)[D=:YN^\-6TOBF>75--OI[.*TB@TZ6SGE#!1DNCLC!R=V"-WRXZ$'-=Y10
M!R&C>#HI=!AM=<CGFD@NYI[,R73F>T1F.Q!,K;LA< D-[9(&:ZBSLX;&W$$
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M<J$N/+F=%G & )%4A7XX^8'CCI6M10!FS:#IL^IVNHO WVJU0I ZS.HC4XR
MH(&#@9&.<#-7;FWBO+6:VG0/#,C1R(>C*1@C\JEHH YNU\+P7?AJWT/7H([R
M.Q94@EW$,RIQ'(",%7QP2".0<<&K47AZPTAY[_2;$?V@T B!:=QYVW.T.23G
MDGYB">36U10!E^']'70]&BLO,\Z7<\L\V,>;*[%W;';+,>.PP*JW7@SP_>SW
MLMQIRNU\0UPOF.%=A@;MH. V /F S[UO44 9IT#3&U>#53;DWT,(@6;S7R4&
M2 W.&P23\V>3FI-5T>PUNR^R:C!YT(=9 -S*593E6#*000>X-7J* ,RUT#3;
M/4VU*"!UNVB6%I#,YRB]%()Q@9...YJJW@W0&T^&Q^P$003-/!MFD5H9&))9
M'#;DR2<[2.IK=HH KV=E!86X@@#[<Y)DD:1F/J68DD^Y-9MSX2T*\U274I]/
M1KJ90DS!V42@# WJ#M<@="02*VJ* ,4>$]&6#3X!;2"+3B#9J+F7$) P-OS=
M@2/IQTJ:+P[ID-R)UAE9A,UPJ27$CQK(226",Q4'))X'!-:E% &/!X6T>UU&
M:^MK:2"::0RRK#<2)&[GJYC#;"WOC-2V/A[2].MKNVM[7]Q=L[W$4DC2+(6S
MN)#$C+9.?7O6G10!E:5X<TO10%L(9415V)&]S)(D:^B*[$(/90*JQ^"O#\6G
M1:?'8LEI#,)XHEN)0$<'*D?-Q@\@=!VQ6_10!E7/AS2[J]>\D@D6XDB$4LD4
M\D9E0= ^UAOQD_>SU-.?P]I;W]E>_9ML]BACM3'(R+$IP"JJ"% ( !&.<"M.
MB@"E9Z39:?=7ES:PF.6\D\V<AV(=\ ;L$X!P .!V%17>@Z=>WXOY89$N_+\H
MS03O"S)G.UBC#<,] <XS6E10!E2^&])EEL)#:;&T\8M!%*\8A!&#M"D <$CZ
M<5JT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQI>HQ22V.I6=U'%_K'@G5PGU(/%5K_Q+I-AI5YJ!O89X[2V>Z=()%=C&F02
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M.^TI[6>*YG@C#OEE9)750RD'G&[/O[5H7%_9V;QQW5W;PR2<(LD@4L?8$\T
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MN542*44M$ ,[BH^8@GIVKTC2K#3+"T(TJVMX+>9O-(MU"JS$ ;L#C) %7J*
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M7#F)>5W.IP#@+O!(!XK'N[2 >%/$5I);2,W_  DL$UO&]L4?RR]NSNJ  JI
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M>Y0%"V< \\9P>OH:GAU_1[C4_P"S8=4LY+[9O^SI,I<KC.<9ST(/XUR@@/\
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MWN (I2 2QCW')48)S[5C>''U#0KB[TW4K2ZO(9P]U!J\=LQ>X!_@G4#*R@8
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MTZ\5M Y /KZB@!:*Y#1]2U#Q?>:G<07\MAI5G=R6<"VZ(9)VCX=V9U;"YR
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M'RNK@%3R.".XK!3Q#+=_$ZPTZWNKY;1]/N)9;6XM6A7<K1A67>@)^\W<CZ4
M;OAC0F\-Z)'IGVK[2D<DCK(8]A^=RY!Y.>6/X8^M;%%8UMXHTF^U&/3H;F5;
MBXC:2W+V\D:S*.K1LRA7P"#P3QSTH G&F3/K1O[B^DFACYMK7RU5(6*[2V0,
ML<;NIXW'\-*O,+G6=;C^'NN7JZO<_;++6I;=)ML>6C6Y$84_+C[I[ <UZ?0
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M/ZEXW\/:3.T%Y?E9! +D*D$C[XB0-RE5(8<]L]_0UT% !1110 4444 %%%%
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M%7&<=178T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7=)NA&L=LEE>6MT/,&^/SE0 KV.-IH OP>+-/GFT\;+A+?4B1973H/+G.TL
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M>]N[=((Y9W-J@!W& '",V>[ ;L=@10!9U#5;;3FMHI=SW%U(8[>",9>5@"Q
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MV@XY]#C>KA[?P]J^G:3X@T&&"*XM]2FN9;6[:0 1"?)82*>25+-C;G<,?=H
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MUFF=K:, AO(SB-GS_$P&[';(':J/B71KV[U70]9TX))<Z5/(QMW;:)HY$*.
M>S#@C/'&.,YH <_C'38;75I;B.ZAETE/,O+9HMTD:%2P?"DAE(!.02.#Z5;T
M3Q!;:\DLEK;WD<:!&62X@,:RJPR&3/WA[]*YW5?#.HZF/$^HI D=YJNE_P!F
MVUN\@^1=K_/(1D9W2=!G 4<G.!U6C13V^BV5O<Q".:&%(W56W#*@#@^G% #]
M0U!;")&^SW%Q)(VU(K=-S,<$]R . >20/QK$/CO1ETRUOV%X([B\^P[/LS%X
MI]VPHX'0@_GVS3_$]CK-W>Z3)IZK/912N;VT-RT'F@KA"6 .54Y)7OQUQ7-)
MX2URWTR.TCL[3,?B/^U?W<VU/)$N_:HQ]['&.GO0!TT7C*QD&IH]EJ$-SIT(
MN)K:6#;(T1SAT&<,/E;H<\8QGBK$'B:TN;;1YX;>YDCU89MBJJ<*5W[F^;@;
M1G/X=2!5=-*O5^(,^L&.,V,VEQVA._YE=9)'.1Z885G^"-$FTR6^BED22RL+
MB:UTO;_!"SAV&?9L1^WE4 =E7/-XRTQ+>VO'2X73+F80Q:@4'DLQ.U>^X*3P
M&*A3QS@@UNSPK<6\D+DA9$*$@\X(Q7!Q^$]6N/ =OX*O8HQ# 8H6OTD&UX(Y
M%8$+]X2$*!@\ Y.3T(!;D\2RZEK7BG0V2YBCLH4%O-##+&58Q,[%I!P.0,=,
M]LYJ/PCXP@_X1[PM:Z@NH&>_LX(TOIHF,<TYB#%2YY+'#<D8.#R:M-I&LVWB
M+Q-<0VEO-::K!%Y4GG[61UB\O:5V^O.<]/?BJ@\-ZNOA#P?8>1";O1;FU>X7
MS>&6*,JQ4X[Y& <4 ;EQXNTVV1YV6=K&.Y%I+>JH,4<NX)@\[L!B%+ $ ]3P
M<1_\)IIS:[-H\=MJ$MW!/'!-LM6*Q>8,JS-T"].??C/.,#1?!]QI1NM+O-%L
MM3L9+R2XANI;C V/(7VR1E3EE).",@X'2MS1=,U&T\8>(=0N+>-;34&@,#+(
M"P\N/8=P[9/(ZT =&[;(V?:S;03A1DGZ5R1^(VD+I2ZJ;34QIPD:.:Z^RDI
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M279F0R[@0Z+N(0  C@C.[H,<[GB?3)M:\*:OI=NR+/>6<L$;/]T,R$#/MDT
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MCE?R@H1)2BQX1B<@#DD8//)J]XB\13:!:7%V-+FN;:UA\^:02H@V\Y";C\S
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MALG'!;''6LS6O".I:EK&LW$=W9-;ZC8BVC-S$SR6A"LI\OG #%LD^H[UV=%
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M,<)1H@BE5*MN.3SGIU ^E #M4\4:CX?M)M1UC3+>+3UA#(T-T6<2ET18V!4
M9+_>!(&T_6IM)\5+J'B)]'86DK?9?M4=Q97'G1X#!61C@889!'J#VQ5>Y\)Z
MCJWAJ;0];UJ.ZB,:+%<06ABF5T8,DC$NP)!4=  :TX;'7SIUQ!=:W;&Y:%HX
M;BWL=GEN1Q(RL[!B.N.!U_  V:*BMHY8K6&.>;SYD15>7:%WL!RV!P,GG%2T
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3YKJ2ZB@EMYW)=5<X#!00?SH [2BN;\=>(;[PKX4N];L;.&[-IM:2&1RN4)
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M/8"@#I**@GO;2VS]HNH8MN,^9(%QGIU]:<+JW-S]G$\1G"[_ "@XW;?7'7%
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M&H-9RWU^[PEK1GDE@(7RFA?N5Q@  E2.G->K44 >=_V=HLOQ-U?[?:VLT/\
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MY;(W]M]J9BBQ>:-Q8#)4#UQSCK6%\.()[7P!I5I<VT]M/!&8WBGB9&7#''#
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M.8D,R*460J-P4D$@'T) X]AZ4^LK5M?M-+\-W&M[O/MXHO,01G_6D\*H]V)
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M-KCS3+R&WHJIM]]Q/7M3==UV[3Q%IOAO2C$E]>QR7$MQ*NX6\"8!8+D;F)(
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MG4)I;:WE5)'AN&?9)&=P!P"/ER#@D5W>AZ9;06]_/;6E[9S7TF^5[J3=([;
MH?&XXX &..G2MRB@#S?PEX=DMM(TG1-<TC5'N=*F1TE%SFV+1L2DJD...AVD
M9R2,5:N])U6'Q?#XNL]*+*\@MKG3\J)'B *K<_>V^8N2 .OEG&<\#OJ* /.=
M9\/ZOJ5UXYTV&SFC76K:(VEYN7RLK"$*-SN!+#'0\'-:&F6@NA;7]YH6LQZG
M8VTB(+F<.L;.H5E3Y\-G P<8P.U=M10!YM;Z)JL7P\\'61TN87FEWMF]S "N
MY%C/SL.<'CT/-;^@VU]9>,_$QGT^=;:^GBN(+H%3&5$$:%3\VX-N4\8KJJ*
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MPO(3$&A!P9 3_"#US@CN*=!XIL)KNSMVCN8?MT336;R1<7"J-QV@9(.TYVL
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M#?:(XLC*# QD8/S8]/>M_3M)U*/7O%=U-;*D&IB,VQ\P$_)"(R& Z9(R.O%
M&L?$6GO;64MJ[WCWT'VBUAMUR\L> =P!Q@?,O+$#D#J<5S/@_P 01PV'B:]U
M*YO5MK?66AB6]+M)&"D06, Y.=S8 '4GC.:JZ/X=\1Z WAV_M[*WNIK/2%TF
M\M6N GW2K"2-L$'D'(..,4RZ\&:YJ&CZ_;S+:QW=QK*:M:$2GRGVB/$;$?,/
MN$9QZ'VH ZN;Q;I]K_:"7D5U;3V%N+J:%XMS^2<_.NPL&&5(.#QCG%3Z'XCL
M_$"R/90W:Q(D<BR3P-&LJN,@H3]X<'D<5AS:+<7>A:OY7AZ.SU*ZL'LT9[L2
MN=P(QN[("<]<^U=#X?@N+3P]I]I=1>5/;V\<+J&##*J 2".W% &5J/B=[3QS
M9: 896MY[&6>1X[:5V#!T5<%1@+\QR>W&2.^#X?\80:+IFJMJTFI7$%MK%U
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M05VS2%E!(Z$ \_IF@#T*L-_%5A%JMM8S17<0NIFM[>XD@*Q22KG*!NQ^5L9
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MP;F#9()/,VB%4 !.#\HXR<5<B\2PN)UDT[48;B%U00/ "\A8$J5VD@CY6YR
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MD\O< 'R5W9'KQTJ,>-Y&N=0L1X;U4ZC8HLLEJ##DQ,#APWF;3G:1@'.1T[T
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M;O/#NHS7?AZ>UM-+M$TZ\>ZF@A=E4[HWCPN$Y.'SD@9QT[UUU% '&:GX1O\
M4)_&*K/;I!KMDEO"Y+%HF6-D^88P02V>#VK9?2;C5O"$^CZQY,<EU:O;3?97
M+*H92N5+ $^O2MAY$B0O(ZHH[L<"G4 <>OAO5=0T_0].UA[/R=*N(;AI[>1B
MUPT/W/E*@)DX)Y;I@=<B]X;T?4=+U+79[P6IBU&]-VGDRLS)^[1-I!4?W,YS
MWKHJ* .;NM$O[;QB?$&F&WE^T6:VEU;7$C1@A6+(ZL%;D;F!!'.>O'.5<>"K
MZ/2E:RFM6U)M<&LRK*66)GSS&" 2 %P,XY(S@9X[=I$5U1G4,YPH)Y/?BG4
M<WIVCZG!XSU'6;G[)Y%W:06^V.1BRF,N<X*@8/F'OQCO7,VOP]U*SMM"G*:3
M>7FEBXA>WN2QAN(I7WYW;"4=3C^$]Z]*IK2(C*K.H9SA03RQZ\4 <EJOAS4;
MRQTB.SL]*LVM-2COY88G94PG\((CY)S]X@=.AKI;^U:_TJZM"PC:>!XMW4*6
M4C/OUJU10!P:>%_$7]E>&K:<Z5,NE(8;BS>63R+A1&J(Y^3EEP3M*XYZ\9JS
MI/A34K+1[W1YWL?L=]?W$T[P[E)@D8L8U3&%)SMZG )QSBNSHH \]N? 6I2^
M'8-&^UV<\.DWZ7>DFY5G!C7($$RXY #,H8$G&...=EM#NI='G@;0?#\33M&)
M;126BFC!^8,WE#\/D./7TZ=)$DW;'5MIP=IS@^E.H YOPGX87PV=0\I([:VN
MI5>*Q@E:2*WPN#M+ ?>/)  '2N?/@G7)!;F=]+GN+75UOQ>.SF:XC$I<(QV_
M)@$* -PX'3'/H7F)Y@CWKYA&[;GG'KC\:=0!Q,W@N2\\0P:K)9:?97L-]Y[:
MA9RNLT\08D1NH10<KA6R3W-:OB71]0U6_P!"FL_LP33KX7<GG2,I?$;IM&%/
M]_.?:M\2(TC('4NH!90>1GIG\C3J .//AK5)+CQBTC6:IKD(2#;(Q,9$ B&[
MY1P<9XZ=.>M0KX7UH7.B-*=-N;:STX6<MM<,[QQR C]^B[<.V%Q@[<=CUKMJ
M* //;GPO>:;\*H-(DFMQJFG.DMC-$25-PLFZ+&0"-S$+CT8UV^F67]GZ=#;%
MM[J"TDF,;Y&)9V_%B3^-)/I-A<ZE;ZA/:QR7=N"L,K#)3/7'^-7* .,M?#NO
M6TOB"S633Q8:Q=2S_: [^= '4(0$V[6.%!SN&">AQS5B\!MH^OSW>F:=I-_8
M7-O!"UOJ)*O 84$:E'"/D%0N00.1UKO::)$9V174NN-R@\C/3- &5J^FW%WX
M3O-*M$MHYI[-K91RD2%E*Y  . ,\#\*P-5\'7NI>'?#\)^P'4=%>-TCFS);S
MA4V,K97(!!SG!P<=:[:B@#C-3\*7NHZ1 ;6UTG2=3M+V&]MUMLO$SQY&)&"(
M2"&8<+QGO51(+Z_^(UY;:E]FAGG\.>65MF9U3,S#[S %O7H/3WKOJH#1K :R
M=7$)^WF/RC-YC9V?W<9QMSSC&,\]: ./M_"WB8Z5X7LKE]* T&YA?]U+(?M"
M1Q-&#DI\APW3!'O6DN@:NFK>*;L"R*:O#'' #,^4*(4RWR=\YXSC&/>NMHH
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M&?0XH YW6/"NJ:K::I>I=PVFMWEK%:QF)V\N&-'+E-X 8[LL"V!P1@<<U/\
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MT"V;5&#ZI<*LUZX&,RE0"/P "_\  :NWVDV&IR6SWMK'.UL_F0[QD*WKBKE
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M=;WULEP+Z_%XSW#R1$0B/RHR?ECX^]C^\>35V@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHJG?:I::<T*7$C>;.2(HHXVD=\#)PJ@D@=SC H N455
MT_4;35+07-G,)8BS(3@@JRG#*0>000001D5:H **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "N7UW2]67Q1IGB#2DMKG[-;S6L]M<3&+*2%&WJVUL
M$%!D$<BNHJI?Z;:ZG"(;Q&DA!YC\Q@C^S*#AA['(H YCX<I=2:=K.I7.S9J.
MKSW-OY9)0QX5 5)P2"4)!P,@@X&:[*D551%1%"JHP !@ 4M !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ameh-nonqualifieddeferre010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 4]3U*'2[432AG9Y%BBB3[TLC'"JON?R !)P
M :N5R>O,S?$+PC"_^HVWLH';S1&H7\=KR?K7,>-]9$EAX@O]-N;B"ZTBYCB6
M=]0>+;*!&Q2.%?E=2#SNZDMU & #T:+4H9=5N--(:.YA190K8_>1GC<OJ 00
M>X(]",W:Y/7V:/X@^$&BX>3[9%)CO%Y08Y]MRQUUE !1110 4444 <GJ'CJ.
MQ\7CPPFB:E=:B]N;J/R3"$>,$C(+2#'((P<&K_A3Q9I_C#2I;_3TN(A#.UO-
M#<(%DCD7&5(!([CH:X?6HWN/VA=.AANWM96\/L%EC"LRGS7/ 8$?F*N:S9>'
M_ ^BZ7X=3[:_]K7SL7:^-M]HD*_.T\RX*KRO"CD@#&,B@#TFBO$M$M=7\0_!
MG78K75KYM0TV_N18SPWCE]L9#!-X(+@C(&?4=*WO#]XOB[P[>^)HYKZVMDTE
M;:%([N5!YRH6E<8;G#%4!Z_(W7- 'I]%> :4ERVF_#;4/[:U;[3JT\EM>/\
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M^TN\BN[5F91+$<@D'!%7J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXD\'WVCZ;]F$]TJKON)&14 8-GA6)Z5M3I>W&DS1HT=K>R0LJ.K;UC<@@')
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MSJ7VB9[2."1G622:9F0-E5( +C)] 3Q780"86\0N&1IP@\QHP0I;'. <X&:
M,)]2B7QQ+9[]3:X33#,+8;/L[J)!\Z\Y\S)V\X&!5*V^(>G7-II]\-.U1-.O
MIA;I>20J(TD+E%5OFW#+<9 (Y'.<U9ETG51X^_MR*.S:S73&LU5IV60N7#YQ
ML( XQU]_:L6'P?K:_#>RT!S8?;[6\BGW"9_*94N!,>=F0<#'2@#OZX.Y\17>
MJ7/C32GCNXH;",);3PJ\1C/V<2$LX(()8\8ZC'K7=KN*@L &QR <X-<?+H.M
MQ:IXL:WCL9+;645H9)+AD:-Q L6UE"'CY<Y!]L4 1>%_%L4>C^%[&]M-10WU
MG#'#?S(#%-*(0Q7.[?DX8Y90#C@FM67QEIT4*7?DW+:<UW]C-\JKY0DW^7_>
MW;=_R[MN,^W-9C>&=7/A_P 'V@%E]IT2X@DN!YS;'6.%XSM.S.3N!P0/K5;P
M]X,GT-6TR?1=%U"R2Z>:"^F.)@C2%P'4QG+J3P=V#@=* .]KGI/&6G1PQW?D
MW+:<]V+,7ZJOE"3?Y?\ >W;=_P N[;C/MS70UP7AWP9/H4?]ESZ+HM_9QW+2
MP7TIQ,$:0N RF,Y=<\'=@X'2@#<B\7VDL6N.;*]C;1F*W4;B,,?E#Y4;^1M(
M(/&>W-23>*(8_M*1Z??3SVD"SW4$8CWP*P) ;+@%B 3A23^8S3O_  O//XTB
MU6WFB2PN8%CU* YW2M$V^$C\2P.>V!5*Z\)W4'C+4]8ATS2]5M=42+S8KUMC
MP21KLRIV,"I&,C@Y'>@#0_X3BPEO+6ULK*_OI+RQ^WVOV>-=LT65'!9@ ?G'
MWL#WS@'.U?QW_P 4Q:ZGI5O<++)JD5A+!/;DR1-YP21& . W4#DC)'6KT.@W
M]OXTT_4X;;3X-.MM+>Q,,4A4H6='^50F-HV8QD=:R9_"&M_V-J-O%]A:=O$
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M4$@$@=,]+K$$5SHUY%-&LD9A;*N,C@9'ZT 7:*\BT31Y-2\ ^$CHUM-#K?\
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MS(%9 . 0#@Y^H%=?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPR) P60LC)M'S<8#]><D=!7357MK^SO);B*UNH)Y+=_+F6.0,8WZ[6 Z'V-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDB0LB]D\S&2HSQQGIS6?9^ !9V>EVBZU=R0:5>_:[1'C3"\/\K8 +?ZP\_\
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MY0"[%9F!'.<[F/X<5+KV@PZ[!:[II+>YL[A;FUN(P"T4BY&<'@@@D$'J#^-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!0 '><@#&:M3:GI]N&,U];1A6",7E488] <GK[4 6J*AN+RULX1-<W,,$1(
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M4?4F@":BN<\+>(9M7TW4;G4'M(Q::A/:B2(E49(VP&Y)Z]>M;;7]FD4TK7<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MECYP$+%@<'[PQZ"NY\-:;%I'AK3]/M[BXN(;>$)')<*5<KVR"!CCCIVK5HH
MXB">&Q\;^)D\0!%M[V.#[$\ZYCE@$>'B7/!(?<2O4[@<&N6L]&2WM_A]9:_9
MI,89KKS$NX@YBMVCE\E9,@XQF,8/<8ZBO8** $ "@   #@ 5Y&MZ-3NO#.I_
M8OL5S#KC?:(([-D-JK"8,)93U+<$] <].AKUVB@!KNL4;2.P5%!9F/0 =Z\^
M\!:;8:KHVHQ7T+RA=7NYOL\K.J,C3,R,T>0K ]02#7H=% 'EOCJX&I+XOTM]
M/"30Z>#;%;)I9;L^46#*_155CCCG(/()%3SZ?H^L^/M&&HVD%W#+H3QS-+'N
M5Y"\6U7/=L!B >>,BO2Z* //+&QT6U^(7BK[?IMNKRI!+!)):9#)Y)$A#;<=
M<@\\D^]8NBSR:?X8^'MQ>P3'2+2*2+44\IF$$Q0")I$QD '=R1P6!KUVB@#S
MS6%T4>(_"5[ID$(1M4EEEFBB( #02*6SCA2VT9Z$^]5+ >&D\;>-+#4K"&>2
M6ZA\NW-J9-ZFVCW!!@C)/) YZ$UZ=6#HFAW>F:YKFH3W4,J:G.DPC2,J8RL:
MQ@9).>%![4 <9IL-QHUMX=\-:S:)N73),W,MLUT<LX_T9,97<%QDG.0HP,<U
MF:':VDMI\-HK^V#R6[7$=P)H\F)/*D"*^>@W%0 >.E>R44 >1Z_I,8TWXEZ9
M:Z<-C"&XMK:.'@MY";G1<<G/4CO7IFC'33I$+Z3!'#9,"T:Q0^4ON0N!_*M"
MB@#S7PF+NTU31+2TO;76-*V2L&DMC'=Z>"I($C D$DD*00"3SS@UVOB.73XM
M"G_M6U%S82%(IXS&7&QF"DD '@9R?3&:U:* /+1H:6NJ(WP^O+H6YL;H7*+=
M22VH<QD0[2Y(#^9@X4\ '..^KX;OM!N/#.G^9;_9]5L+,B:.:%DFAD\O;)N)
M&>23R?O$@\FN]HH \AL=.M+7X?\ @.]CL5BO;:^LA<3"+$L?!$F\XR!C@YXQ
MBIK*T-_#KF@:]J,UG>S:K).H6T+2RKY@:*2%^<@*% P#MVXXKUBB@#S5KJ!)
M_&&EZ[837&HW,TKV:/:M*MQ;F,>6J-@K@$'(R #DGJ352!K>PT?X9:O<PE8K
M"-8+N<0DM!FT= KX&0-Y .>AKU6B@#R[SK?_ (N6\-N\$=U;(T"F$QF?-KMR
MJXR<L<>N3[TV*[N;+7?#E]<W)MM)?0$MHYY+<RQQ7(8>8K?W&*A1D_W2*]3H
MH \QCAM_"VH^&_/DN[KPTL5V$F>W8I#</(&0L@'"[=ZH<8 /7G-:_@86\?B+
MQ<MO:&TBFOXYH8FA\K<I@C!<+@<%LGZGGFNWHH R_$NE#7/#&J:60#]KM9(E
M]F*D _@<5PT&D:GXE^%<NHW43PZ]<00W=L&'SQ20 &(#TRRLW_;4UZ;10!P4
MP-_\)M7U#4+39<ZK:3W9@D7<P9T/E+C^\%$:COD5FWEMILMY\/[S4+".XM5M
M);>5WM?-"OY2!$88.#N#  ]P:]/HH \M&FZ?JFG_ !&::QBN9I)IG@+Q;F91
M;( R9']Y3R.X]JFT[5%M-=T>YUM)Y-.GT*"*UF,+RHER"?-5@ =LA&T<]=I'
MM7IE% 'C5W;6Q^%'C&R&GF)_[4N6MK0P8==TF4V)CC@'&/0^E=7K+:5HDFC0
M:=IMG%87]U)-)>"U::..01[0=J]7<?*"?0]37=44 >3V>BR7OPU\1V5O"ZW=
MCJES=V,4D6QD:.7S(]JX^4-C&!QR:N3_ -L#5K#Q!;P7*_\ "20-8RP,,_8P
M1NMW*]MH\PM[N17IE% '"ZO]BL=>T[PZ-.BAL%TTI#,UFUQO^8+Y$8^Z#A02
M3G(QQU-<]H$QBT?X9QSF026TL@G#@YA'D2H-_P#=Y*@9]J];HH :[K%&TCL%
M1069CT %<"VE2>--,UZZDU".WLM1#6IBDMMSQPQY"G)(P22T@XXWBO0** /*
MCKFHZG\/]$GNK>XFDT[488];B2-F:6&,LIDVXRZ$A'X!R,^AK1\1W&G,-+UC
M2K?[1I0U*)M6-K"Q#QA'",R@?,$9E) !(P,]*]$HH \^U:33UUG0=9TZ-7T,
M7\DFI20QG9YIAV12L,8*J< GH#@GD5E>(]&DU2W\>W6FVWVC3KO38S$J)N6>
M[57W/&.Y"[!N'4\<D5ZM10!YS/J>F:KXV\'ZA:1,\ ANHY;IH&15S&H5&9@.
M<D\>I]ZP)M'L9_AEXS:VTV-KQ-0O);8I!^\4>:6B:/C('<8XZXKV6B@#@6@T
MM_BW%>SV44@NM)B-K<?9MX:997)(8 X8+MY[#%==KLBQ:!J#N<#[/(/J2I '
MYUH44 >46^GV=GX2^'5_!9)%=075HES.L6)(P8&60.V,@9X.>.!4.OWG]II=
M/]A^RW=CX@@(CCLF\U46X0><\I[,F2-N.#CD UZ[10!YIJ)NK;7+ZXTB]M+_
M .T:E!)-HUY;YE+J8U$D4BG(4!58$@J,'IS7I=%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% '*^(-=GT7Q?H44U]%!I5U%<FY$BJ #&H*G<>1RW3Z5K
MV?B+1K_36U&TU*VFM%?RVE6085\XVGT;)''7D>M8/BM)H?%_A?5/[.NKNTL_
MM7G/;0F4Q%T55.T<]<] 3UKGM;\,ZL=2E\2V5M<K')K%O>265N%\XPQPF(R!
M3D;\MNV]< =^  >AQ:WIDUM/<+>Q".W?9,7.TQ-Q\K X*GD<'U'K4#^)]#AM
M9[F?5+:"*!Q'+Y[^68W(R%(;!!(Y QSVKB->T&>\MEUO1X=8FNEU*TNKP3QK
M%-/'"&&(XV51N7?GE1G:.N*=XETE-1\*>(+JPLM9N]1U&*WMR+JV*-($<L!L
MVKC +98@#D#)H [FQ\0Z/J=_-8V6I6T]U -TD4<@+ 9QG'<9XR.*=?:[I6F7
M,5M?:C;6\\JLT<<L@5F5023CT !Y]JP]0MI7\?\ AO48+2;[(ME=0R2K"P\L
MN8BBL,97[K=>E5/&MREGXN\&W$EK/<JEU<GRX(O,?_4-R%ZG'7CGB@#I+#Q'
MHVJ6<]W9:G:S6]N2)W$@ B(_O9^[^-0_\))I5WIVH36.K6(:T4B1YGPD+$?*
M9 2"%/X9[5S&IV.K02>(O$^E::QN+V"UAAM7B!D=4<[Y60_Q!7.U3S\@R.<5
M!%;7O_"0Z_?O9:K)#>:''##)<6_SRR!I<@JBX4_,O! H [2TU6&/0+*^O[ZT
M;SH8V,\.1'*Q7.8P<D@]0.3BL;PAX@FUS5_$<?VZ.\L[.[CBMGC0+A3$K,#C
MN&)'/I6!80ZII$?@C4I=*OKBVL=*:QN[>*(F6VE*1C?L/+#Y&4D9X/&0:W/"
MD=VOBCQ5<76GW%HE[<PS0>8G#H($4G(XSD<C.: .@OM:TW3"PO+R.$HGF/GG
MRT_O-C[J\'DX'%1ZCXAT?255K_4K:W#*'!=Q@*> Q]%]SQ7'3Z?>6?C'Q(-0
M35FTW6%B,,MC )D91$(VC?Y69#P2#P,-US4>J6FJ1P:EH%OINHKIRZ+';6 @
MC1_/Q&X*32G."O  !&<G&<T =GJ/B;0]);;J&K65LWE&;;),H.P?Q8].1^=8
MMMX@N3XIUV"74;8:;!IUM=VTDJA4C\PR#+-QE?D7O65;64S:UX#>?3;IH[#3
M)H;AWMG(AD=(E4'CU1QGMU/!JZ(IK?QKXBN!870M)-*M[>!TMG*NZ&7*K@?[
M:^WI0!T%AK$0T'3[N^OK2:6XB4B2T!*3L5R3$O+$=2.O%.?Q-H4=K;W,FKV2
M0W+%(7>91O8'! R>HP<^F.:\\T[3-8TZV\$W\EKJB06&E-I]Y';0!IK>0B/Y
MMC*2RG9@E0>U:6KZ+#%8:,+'3M2GCD\0)J5UY\#,V/F+R%0/E&2#MP#STZT
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M\IW;,#!(.!FMC0K>VO\ 68]9>+6A>QVK6^[4(!"(U9E8I@*H8Y4'(R.#SSR
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M=*$D*C DC<;HY .V1D$?WE;MBLK75EN/&OA.[M[>>>U@-P\L\43,B"2+:A)
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M7FM*CJIXP1A<YZ#UJ_XC:]TPZ+!I5A(NGBX9;A[&V622W78VW8A! !8X)P<
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M6?G).5@8& - 4 88R!NP.F._2@#7\->+;#Q,;Y+:6 2VMU+!Y23J[,B-M\S
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MKX>N-6G5'$155C:0)O9F  R?KGZ U9;7M*%O%.E_!-',&:(P-YN\*<,5"Y)
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MW<HDF%U/YLDC!0H8G>W8 8SVK8HH \TU[2O$^L6FK6UQIEU/,NJ136CK=QI
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0\N06R3^% 'I^1C.>/6@$'."#CK7C-X-/A^&VIV\CHMOI/B;RHOF^:UA%ZH
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M?!,[7'A:W=M/AL,23*(8'+1$"1AOC) ^1OO+QT(QQ0!T!8+C) SQS02%!)(
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MO>7$TY,(8+]^8YQM7D$< \*<#H =GXMUN?P]X5O]9M;:*Z:TB,IC>4H"!UY
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MFYC&=A'?D$CK6KXWU2RT^UTR&_AMFM[R]$+2WC8MH?D8[I!T8<8"G )(Y&*
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M=VV-95+,5&6 &><#K63;>)3JN@Z3JVEQP"*_DB)2\F$3+$YY(QG+XQA>^>M
M'0T55O=3L--"&^OK:U$APGGRJFX^@R>:KP:C*=0U%+EK*.SM_+,4BW&7P0=W
MF+CY.1@<G- &@T:.NUD4KUP1Q3JIQZMILUS';1:A:R3R()$B692S*1D,!G)&
M.<T]M1LDOELFO+=;MAE8#*HD(]0N<T 8ZZ1J%IX@U/4+?[)=QWXCPMR[*UOL
M7;M4A6RI^]CCDMUS5OP_H4.@Z,NGJ5D!DDFD(3:I>1R[87^%<L<#L,5:GU;3
M;7/VC4+2+:X0^9,JX8]!R>OM4%]KEK8:SIFF2JYEU 2F-QC:HC4,=QS[C&*
M-/ ]**Q]+U:>[74KJ\BBM;""X:.VD=L&2-.&D;/ !;=CV&>]:-I>VE_"9;.Z
MAN(@2I>&0.,^F1WH F5%0850!UP!00",$ @]JY_QEXE?POH37T%HUY.&R(%/
M)107D;_@**Q^N!WK<MKF&\M8;JWD$D,R+)&Z]&4C(/Y4 2XHJI;:II]Y<2V]
MK?6T\T/^MCBF5F3_ '@#D?C26VJZ=>F86NH6LY@_UHBF5O+_ -[!X_&@"W@9
MS@9]:38F\/L7<!@-CFJ]MJ5C>I(]K>VTZ1\.T4JL%^N#Q3_MUIY4<OVJ#RY6
M"QOY@PY)P #W.>* )=B;]^U=^,;L<TNU=V[:-V,9QS52XU73K0.;G4+6$(P5
M_,F5=I.< Y/!.#^507^NVNGZII5A*':34GD6)UQM79&7)8YZ8&!C/)H TMH.
M>!SP:JW>F6EZEND\0:."99TC'"EUY4D=\'D>X![5;JM-J%E;7,5M/>6\5Q-_
MJXGE56?Z G)H LTF!G.!FJMQJFGV8D-S?6T C +^;,J[<],Y/&:F:Y@2V-R\
MT:P!=YE+ +M]<],4 2XI-J[]VT;L8SCFN;\.^(IM9\0Z]9>=97%G8M!]FFM<
M_.LBECD[B"1@#C'2MR[U"RT\(;V\M[8.=J&:54W'T&3S0!/(7$;&-5:0 [59
MMH)]S@X_(UA>#-%N_#_ABUTR^-N\\!<>9 Q(8%RPZ@$?>QCVI-2UB^L_&6AZ
M7&+=K+4([AI"4/F*8U!&#NQ@[O3M[T>%=8OM735UOQ;^98ZE+9H8$*AD0*02
M"QY^8]Z -YD1F5F125Y4D=/I3L54O-4T_3C&+Z^MK4RG$8GF5-Y]!D\TL^I6
M-K<1V]Q>VT4TF-D<DJJS9Z8!.30!9P"<X&:" 000"#U%5KO4K"P*"\O;:V+_
M '!-*J;OID\U6CURVE\1W&B!7%Q;VT=RSG&TJ[,J@<Y)^0]O2@#25%10J*%4
M= !@"EQ56WU*PN[B2"VO;:::/[\<<JLR\XY .1S5J@ IJHB,Q5%!8Y8@=?K6
M-K.O06VG:F-/O[!]3L[=Y_L[N'(VC.&0,&'3'XT_0-<@U72]/:6YM?[1GLXK
MB6WC<;EW(&)VY) Y[T ;&*0@,,$ CWJO_:-E]N^P_;+?[7C=]G\U?,QZ[<YH
M;4;%)A"UY;K*7$80RJ&+'HN,]3@\>U %G%0W7VC[)-]D$1N=A\KSL[-V.-V.
M<9]*C_M.P^V&S^W6WVH#)A\U=X'^[G-+-J%E;W$=O->6\4TN/+C>559\], G
M)H @TFRGM899;QXWO;F3S9VB!"9P%"KGG 4 >^">,UH55FU*PM[N.TFO;:.Y
MDP$A>50[9Z84G)JU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0?+$\>$N,^F^,I@_WJ=XGG636;_17T[RK=M*"PR1V)F:Y^_F)&P40+QD$?Q
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MW!7..""*TO%<Z7\7B32(]+:")=(46:Q:<S/=#RW8 $KM14)QMP"#W!Q7J%%
M'F2R64?C#0KS6+:66V/A]81++:O(@G+@[3\IP^%;KSUJM+I3Z)IVF(+:6&VF
M\5B^@MEC/^C6Q)Y*@?(N?FQQC?@X->K44 >5BS-S<>+-"\07E[:G4;^26(QV
M9D,\#!?+,3A3EE  P.5*]*Z?XCZ>U[\-]7MDMWO)5MLHNS>Y((Y QUQGI76T
M4 <#%/:6/C?3M3C@%OX=FTMX;206YBB@G,NY]P(&S>N,$@9V^]:?@;3Y[&/7
M'\MXK"ZU26>QB92NV(A<D*?NAG#L!Z'/>NKHH \DU*[EU0V<[V$MK<67B2-Y
M+>&Q8&&,3D&624CYMR_-E2!ANA )KJ?BH&E^&^L6\4<DL\\02**)"[.VX'
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M8D=-P7<,9QD9Z^M 'F.DZ?IOB/P/X2MM'M-NIVAL9I+K[,T;6^P*9&+L!G<
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M1MZ]0.M.\3366LZ&FH:#:R7 AN;1[^.*V=7EM4EW-'M(&2!DE.N,C'->A44
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M-!?W5A(;59/DD21HSM!_NMDCZ&M.[L[>_MS;W40EA+*Q1NA*D$9]1D#CI4]
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MA0,#E2O2NKA\(3?\(Q!X:NM0BFTF*-("JVVV62),85FW$9( !(49YQ@\UU5
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M(WECOI([(R3VQPVS:K*<!BV"V" ,CC/%?^RM1A\*7RMI5^TL/BA;\PF'=(T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M''!Z"@#S?X;RW/B.'3]/U!KQ+KPVT\6HOY\@,LY<K&"<_-A0S'W"UQ]\9D\
M>(];36-3%_IOB=X;24W\K;$WQKC!;#<'J<GCZU[GX>T5M-L+HWJ6[7M_.]U>
M>2O[LNV!M&1R H5<GKC/>I_^$<T,(4&C:=L)!*_94P2,X/3W/YT >=6QNO#W
MQ+\4V.D7-W.AT W\5O/<//NN0< C<2<G^OTJEX 74-?/AO7DURVC8QS1ZDAU
M*22:]8@\-&0 C*02,'@=. *]:CTK3HKB*XCL+5)XD"1R+"H9% P #C(&.,5!
M#X?T6VO);R#2+"*ZF!$DR6R*[@]<L!DYH \$OEN$^&OBK7X]9U7^T-*\0R1V
M<GV^0A%\R-<$%OFX/4Y/'USW-Q#9G]H6%[J^EA+Z#')#BZ:(22>> $&"-RG&
M=G(/)Q7HB:#H\<$L":58K#+CS(UMT"OCD9&.<=JD_LG3A-;3?V?:^;:KLMW\
ME=T2],*<?*/I0!Y+X3O=4TCQ/H,6MV\=Z-3^T36^N6M\Q^TIL+YEB;HH!&.F
MW ]Z]8TC6-.U[38]1TN[CNK20D)*F<$@D'K[BFV6A:/IL\D]AI5C:RR##O!;
MHC,/0D#FK5K:6UC;+;6=O%;P)G;%"@15R<G ''6@#C]/59?BUXDB+$;M*M 2
MK8(^:7H1R#S1\*+2*#X>:5-').YGBRPDG=U&&8?*&)"_ABNH.BZ4;B2<Z99>
M=)G?)Y"[FSUR<9.<\U/:6-I81&*SM8+>,G)2&,("?7 H XR>UM6^,N^:YGC?
M^QHWC473H&83D8P& (X'R\@YZ5RL5LMK\+Y?$%M>7D5]::I,T+QW+JB W[*5
MV [2""<Y!SGV&/6[C3K&[GCGN;.WFFB!$<DD2LR \$ D9&:C31],CM)+1-.M
M%MI#EX1 H1CZD8P: //S+JGB*_\ %]@]S!;7UG=&.TFDO7A>SB\M3'*J*N""
M<L3GYN0> *]%6%IM/6&Z?S&>(+(\9*[CCD@CD?A4$^AZ3<S0S3Z792RP +"\
MENC-&!T"DC@?2K] 'G'AJ.>Y(\)WEU>/>:/?O)=7#7$F^: ?-"2V<_.'0$=#
MY;BJND2:QXETN\N#>6UGJ]KJLBO<27CA[8)/Q$8MN-IC 7&<'=GK7IJP0I-)
M,L2++( '<* S 9QD]\9/YU6?1]+DU!=0DTVS:]7&+EH%,@Q_M8S0!PSS:EI_
MB&.ZOK8:A8W.L&&WU"TO66:#,A01/$1@HI!4[3C +8SS6";I]!\,^)[W3[R=
M;A?$,D%PS7DG[JW,Z!W(R=IVG&\#(!SFO6(=(TRWO&NX=.M([EF+-,D*AR3U
M)8#.33ETVQ2:XF6RMEEN1B=Q$H:4=,,<?-^- ' Z])K'A[2M:US3KJWAMS81
ME;6VN&N=C>8 UPNY0!B-CG ()4$YI;R+1E^(G@R?3+QKAYS=,S"[>977[.V&
M.6(R?7J>?2N[LM(TW38I(K#3[2UCD^^D$*H&^H YJ.'0M(MT1(=*L8U20RHJ
M6Z *Y_B&!P>!S0!:O+N"PLI[RZD$=O!&TDCMT50,D_D*\QUVRU^#0(/%9TZU
M6]L+LZPY6Y8S&(KAX2NS'$.%/S?P9KTZYM+:]@,%U;Q3Q'DQRH&4_@:8^GV4
MED+)[.W:U  $#1*4Q_NXQ0!R6I:U;ZEXMT"PENBNAZGI\MQ R2%%N9LH54L"
M#]PL=N><]\57VVMMXRLO"MQ=3G1Y-/FGMEDN6_?3>>=T9?.6V*0 N> ?88["
M71-)FL18RZ9926:G<+=[=3&#Z[<8S1/HFDW-E'97&F64MI$<QP26ZLB?12,"
M@#DK*&,>-SX<N9YY=,@TP364<L[-YK&5Q(2V<N4&Q1DD@<]ZP8KV_M['2GN=
M1N_LMMXL:RM[A[EP)K0%PH<YPX##;EL_=%>F3:1IES!#!/IUI+#!_JHWA5EC
MXQ\H(XX]*DN-.L;NQ^Q7-G;S6F OD21*T>!T&TC'% '"272S^)O',,.HW30P
MZ5;RKY=W)B&3$Q8H0WR?=7(7'2J5I$]AIGP]UF*_OFO+^2VM[IY;N1UG1[9V
M(9"=O500<9SSUKT+^Q-)V[?[+LMOEB+'V=,;!T7IT]J>=)TTVT=L=/M3;Q-O
MCB\E=J-Z@8P#R>?>@#D? MK:Q:]XL<7,S7*ZS*OEO=.1M\J'DH6P3_M8SVS3
MO&,5O<>./!]O<W#PQRM>*2DIB9OW0^4,"",^Q!KL([&SBO);R.U@2ZE 62=8
MP'<#H"W4TV^TS3]3C$>H6-M=H.BW$2R =.Q!]!^5 'GD=T/#_P#;=F;B^GT:
M;5+6TTW=>,-LK@&1/.8EA&&X)!./F YK/NIY(_"WQ,T_[0'M+:US#$MRTZ0E
M[<EE5VYQN'3H#FO5)M.L;BQ^PSV=O+:8"_9WB5H\#H-I&,"HGT72I P?3+)@
MRJC P*<JO"@\=!CCTH Y#6KVROKJ/1G>02QZ4MTSO?O;1QJQ*JR[.6?*GV''
M/-8^F3W.L_\ "N6O=2OBVH:=.;L1W3H)RL*D%@".>3R,'GK7I']D:89+>0Z=
M:;[8$0-Y"YB!ZA3CY?PIJ:'I,3Q/'I=DCP_ZIEMT!3G/R\<<^E 'F\NK77AZ
MQURRBO;I=-M/$5M:R323,[VMI(D3/AV)(&6(SG(#<=JTO%0C\-OILFE7#)9Z
MEJ,$5[YEZXC5-LA4[_F*!VV@D=< =S7>'3K$O.YLK<M<#;.WE+F4=,-QS^-0
MP:'I-K92V5OI=E%:R_ZR".W14?ZJ!@T 9OAS3[VPU'53-<P?9)FB>"RBG:46
MQVD-@L!@,0"!C Y]:P_%]]:WNH:GI?F2I/9Z<MPTCW[VR1%B^UHPG+OE>_ ^
M4=S7:66GV6F6_P!GL+.WM8<Y\N")47/T Q23:;87-W'=SV5M+<QJ42:2)6=5
M/4 D9 .30!YLQ35KKX:WFJ7LZR7.GRO+*MT\.YS;JQ.5(P22<XZUW/C",2>"
MM<4LZ_Z!,<HQ4\(3U'-76TC3'MX+=M.M## ^^&,P+MC;U48P#[BKC*&4JP!!
M&"#WH \M6SLWMOAS;07<[1S3$NZW;NPS9/E58DE!C PI&,\8/-5]6U&^\,Q>
M+++3KNY%E:7VG\S7#N;:&8+YI#G<RKUYYVY)%>EIH.CQK$J:38*(3F(+;(-A
MSGY>..>>*G.GV1GFG-I;F:9-DLAC&Z1>F&..1P.#0!@Z'I]W;^()[L7-K'I]
MQ:)BR@NFG'F!C^]!8# *G!P.< U7U[4U'CC2=&U"X-MI=U9SR#]X8Q<3JR (
M6!!X4L=N>??%=)8:5IVE(Z:=86MFCG++;PK&&/J=H%.O=/LM2@$%_9V]U"#N
M\N>)77/K@B@#RM$AM_"GQ-.E7=T%MIY)8)HKJ3>K+:QD8?=N(!!QSC ]*Z&Y
MU**7QGX(6UU&1Q<0SF6*.Y8I(H@)4LH.TG)."1G\J[./3K&*262.SMT>9=LC
M+$H+C&,$XY&.*@@T'1[5(TM])L85B<R1B.W10C'JPP.#P.?:@#S[PU)K'B70
M[+4GO+:TU6'4C]JF>\?S%VS$-;M%M  *_*%SW#=>:]1JE_8VE_VC_:/]FV?V
M[_GY\A?,_P"^L9J[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&=O-ZY@._.3TR%R.@(% 'H)UB:Y\0R:7810.MF(VOGE<J4$@8J$ !W'Y<G)
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MF?P^9MQSNV[\8YS67<1:9)XI\,7?A@VHAD67[<;3 1[0QG!DQ_M[=N><D^]
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MG[O;:>!CM4T$?]MG7;#5M<T_3-:CU60Q27$&;J)!(#"8F,@RI4 # P<GJ2:
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M17-:_P")7TW6-%L[*>QF^UZ@MG<PL=TL89'?<,-Q]S'([UTI(4$D@ =2: #
M]!36BC=D9XT9D.5)4$K]/2H4U"REG2".\MWF==ZQK*"S+Z@9Z>]+-?V=O<1V
M\]W!%/)]R-Y K-] 3DT 3.B2 !U5@#D C/-#1HZE7164]01D&G5G6.H3/'>R
M7XM+=(;EXXVCN X,8QM9C@;6.>5[<<T 7_*C$8C"+L'1<<#\*7 ]!44-Y;7$
MLL4%S#+)"=LB(X8H?0@=*@_M:P9;GRKN"9[92\L<4BLR =<@'B@"Y@>@I B
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ME6 *D8(/0U!:7UI?HSV=U!<(IP6AD#@'TXHN[^SL$5[R[@MU8X4S2! 3Z#-
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M!!<V]W-(Z[AL\EU"G<3C#*X/(XH ZZD  & ,"L[4=1ECTC[;I?V2Z8LFPR7
MCC92P#'> >@R??%6;C4+*SDCCN;RW@DDX19954O] 3S0!.L:(6*HJECEB!C)
M]Z2.*.($1QJ@)R0HQDTLHD,3B)E63!VEAD ]LC(R*P?".ORZWX5L=4U#[/!<
M7+.A6,E5R)&4 9).>!0!O&.,QF,HI0]5QP?PHV+LV;1MQC;CC%-\^+S&C\U-
MZ#<R[AD#U(J)-1L9)?*CO+=I-GF;%E4G;_>QGI[T 6 H&, #'2C SG%0)?V<
MEJ;J.[@>W&?WRR IQ[]*([^SFN6MHKN!YU4,8ED!8 ]#C.<4 3X&<X&:3RT\
MSS-B[\8W8YQ]:5F5$+NP55&22< "JT.IV%Q T\%];2PJ=K2)*K*#Z$@XH L>
M6@D,FQ=Y&-V.<?6D$4:R-((U$C#!8#D_C09HQ,(3(GFE2P3<,D#OCTYJ$:C9
M&=(1>6YED)")YJ[F(ZX&><4 3E$+ARBEP,;L<XI=H]!44%W;76_[/<13>6VU
M_+<-M;T..AI\DL<*AI9$0$@ LP&2>@H <5!SD#GK0  ,   <8JK_ &KIWV=[
MC[?:^2C['D\Y=JMZ$YP#[5'>W=S#=6"6T=O)#/+MF:2?857:2"@P=QSCB@"X
MD,<2E8XT12<D*H'-.P/057EU&Q@.)KRWC._R\/*H^;^[R>OM44UU=1ZS:VR1
M6YM9(Y&DD:;$BL,;0J8^8'G)SQB@"Z$4$D*,GD\=:-H]!5<ZC9"9(3>6XED8
MJB>:NYB.H SR:?#>6MP91#<PR&)ML@1PVP^AQT- $V!C&.*:J(I8JJ@MR2!U
MIGVJW\M)//B\MR%1MXPQ)P #WYJ.XU"RM=WVB\MX=N-WF2A<9Z9R>] $_EIY
MGF;%WXQNQSCZTZH1>6S77V47$)N-N_R@XW[?7'7'O4U !1110 4444 %%%%
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M5R=CINF)X \&E]/C2Z36(_M&8,2+'YC!]_&=FQAG/&".U>UT4 <9X=MH-/\
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M@:]EHH \]U>UT_3?&^G7EG:>1:W&BWD<LEE&%,@S$R $<%OO;<U3TNTO-O\
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M=7SET@)F6 S.RJH SM*@$ <'M7H%K<)=VD-S&'"3(LBAU*L 1D9!Y!]C4M%
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M="3G% ';6>OZ1?Z9)J5KJ-M)91$K),)!M0CJ&ST(]#21:K9ZG]IM;&]5;N-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 8VCZ"=)U/5;[[8\[:E,)Y$9  C!%0;<=MJCK1J&@F_\1Z7K'VQX
MVTX2+'"$!5Q( &W'KT QCI[ULT4 %9SZ6\VLI?37T\D,7,-H501H^"I?(&XG
M!/!.!GIG&-&B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPV5M'(BA%=(E!50,  @<#'&*BAT/2;>XFN(-+LHIIP1+(ENBM(#U#$#)S[T
M?/LB,GPRO/$46JZA_:=CX@:.WF-[(0B>8HQC=@Y'.3D\=<5WUU#IX_:(C>[N
MY(3)H<<D'^F/&))?/P$ # ,"!G9R#R<&O1ET?3%A>%=.LQ$Y!9! NUB.F1CG
M%2?V=9>=!-]CM_-MUV0OY2[HEQC"G' QZ4 ><_&&5(KSP0TCJJKX@MV)8X
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MGI<>M>//$%CJDUVT8L+*5K9;R4(DC>;N*X;CH.!Q[=*[@Z98&^^W&RMC=_\
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M-<3:? \LC')9B@R3[URG@'1+;Q!\-[&WO+B9[$W%SYMHA41RXNI& 8XW8Z9
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M4JHVEZ>U^+]K&U-X!@7!A7S!_P "QFK= !1110 4444 %%%% !1110 4444
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M092!I5#L/9<Y-9_BC7?^$=T;[8(UDE>>*WB$C;4#R.$!9NRC.2?04 :YC0@
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MT#7%G<6[DQ7"J0'&#RKKD''(P<YK<AU"RN+F2V@O+>6>/[\22JS+SCD Y'-
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M^/?#$TED)8UTF9))'MR560F+8K$C /RO@'TKT2B@#R*YB&E>'-<98Y;9-/\
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M@:IID=K;0.NQYW17RY4X(^\%&<'@]L5WNF7)O-.@G:VGMBRC]U<*%=?J,G%
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M6U]X=U_28&^W,ATR>.1=I\N495F![)(JL?8M79V%E#INGV]E;@B*",(N3DG
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M*""7\[^(+S]TDGCBK[)J&G>*/%BC2+RY75(H7M9HD!C8K#L8,V?E(([]NF:
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MTM[:PL)2JHI4J IV[BV3QQC'>NON[R#3K0SW#N$4JORH79B2   H)))(X H
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M 16T306T<3R&5D4*7( +>_%2T44 9VEZ4VGF:6>^N+ZYFP&GN @8(N=J (H
M R>V<DY-:-%% !1110 4444 %%%% !1110 4444 %,FACN()()5#1R*4=3W!
M&"*?10!S\/A2%-+MM*GO[NYTVVV".WEV?,J$%%=@H+ 8'UQSGG/0444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(^0YVD_C76T4 ><^&_"MQIVGQZ!K&BWM[%;W9DBO%U#-M(OFF1':,R JPR.
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M+T%=510!QWA)->T3P=H6ES:$?M%LT5G<[KJ,!8P"&F7!.X<#"\$Y[8KL:**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8?+C.W<<9"^@KT;P?I\-A:7YM=4MKZUGNVFC2U3;#;Y5=T:?,W&06QGJQXH
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MUFM)]!/F2"0&*0B;G#=&P!SCT]J /0JSX=8MKJ_U*PMM\MUIX3SDQM&YUW*
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M\P8/$&=L;B0>5 R< C.,9'6K4>HP:?96RZMJMC]H=1^]W"%93ZJI8]<CC)H
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MOO[1N;.&-6\KS1%(4!568DDX]3UK?N]2L; H+R]MK<O]T32JF[Z9/- %D *
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M\WA?Q$;*W^RRS:D=5TB IM,,D80H=O\ #O=&..P?D Y%>D5G:M8WM_"D%KJ
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M0R,8PS$+Z=3Q6#"NK:;_ ,)=I4VC7MU-J-Q<7-I<QJ&BE1XP%5FS\I7&W![
M8S4<5I=C3_AS&^FWA;3?+-X#;/\ N"MLT?/']\CI]>G- '4_\)MX8%K'='7+
M$0O(8@YE PP(!!_NX)'7'45-/JHC\2V]D-2TY(OLTDLMJY_?G!7#CG 0#.<C
MN*X^;2[JXLOB3%'IEP'U)7:T#0%?/_T94XR.N\'\\U=A2Y_X2SPM=M8WHAMM
M)G@N)#;/^[D;RL*>/]AO\F@#?'C+PTTD"+KEBQN',<168$,V2N,],Y! ]2*E
MAU0/XCO;3^TM.>"WMD=K=#^_A;)RSG. I&,< \&N#;1[^;X3Z[IZ:5<B^EU"
M>=(#"5=PUUYB,,]?EP?;%:]]#)=>,-=NGTJ]N+"Y\/I; "%T\YPTK-&"1P2K
M@9]3ZT =!=>+-)M]-OKQ+I'%I;-<E6)3>@'!4L ""< $9'(J*P\:Z#=Z-8:A
M/JNGVYNXU/EFZ1MC[ S)GU4'GIZ\5S-OI&M"TU33[2]U#4M*?1YX8/[3M1%/
M%,P 2-7*JS*1G.1QA>:+R.XO?#W@B-M'U &POK>2YBDM6+1K'"REB!GHQ&.Y
MZ@8YH ZZ3Q;H$6G0:@^K6PM)T\R.7?PR9P6_W<]^E5M6\9:7I&MZ/I\]S:JF
MI))(+A[E46-%4%3SU#$X'XUEZZ=4;7;O3X=/NUTV;3OW+V4"8FE)?<DKD?(
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* (X8(K>/RX(DC3);:B@#)))/'<DDGW-2444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRSNI%&U7G@5R!Z D=* .4\5C^V_%WANRTTK-<Z9=M?W3QG(AC6-E",>Q=F
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M $;2]4*G4--L[LKC:;B!9,8Z8R#ZG\ZDO-,L-1MEMKVQMKF!2&6*:)74$="
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M'F\/1^(/ $^F367EO+/^\B<$$&W<=?\ >X^O'6@#TTLH8*6&X\@9YH+!1DD
M>]>2.(;WX>ZU!?A?^$QBN+C:.!=?:?,8P&/^+&WRPI'&WVS6E8:7I&J_$C5[
M/5[>RNY6TJT\Z%PK(\VZ7S#MZ%AQSC(SVS0!Z51G%<C\,;@3_#_35\XRM"98
M3E]S*%D8*I[\*%Z]L51\;0Z7/XV\&Q7PMVWW-PLBR$#=&;>0 -ZJ6(&#P<X[
MT =WN4@'<,'ISUI:\6N-)T*3PS\0X[:"V8Z;---IRH0?LN($?="!]S]YN^[C
MD8[5T;:GI5C\0M)U2_NK6"#4-!DB%S*ZJDTOF1';N/!; Z=: /120 22 !U)
M[51U'6+/2ULFN'8B\N4M8=B[MSOG'T'!.?:O,=,^RW/A>>VMM2M--D3Q-<M#
M'>QYA?#R,L4J$J0I4<#@@JN.E,U%K6;0M)N-7T_3[*VMO$RI--:R'[)(A0[I
M5)P%4L0#GHP//- 'L%(2!U(%1VRPK:PK;A1 $ C"]-N.,?A7GMKI6@ZK\5_$
M$=S'!+)#%8SPQ^9@>>C2L6P#RPPN?3)]: /1MR[MNX;L9QGG%)O7?LW#=C.W
M/.*\E\+1+K&GZ;#JFMV-GXCM-1\VYB:WQ>F59"2I)DR59>,A<;3Z"K6E@P^(
M-/$9T?7;2ZOYRLJKMOK;S!)O\W!(95!*'./X1CI0!ZED5A1ZY<MXXFT"2UB6
M!; 7B3K(2S9?9@C  Z'N>U>7W%_I,7PFO=(>6'^T;'59-UKUE@'V_(8KU5=C
M#D\8..]=L+JRNOBY) +B*02Z"J860?-F9C@8/7:<_3F@#J='U>UUW2XM1LB[
M6TI8(77:3M8J3CZ@T_4+F[MHX&M+$W;/.D<BB58_+0G#/SUVCG Y-<?\)DTU
M/!<"6?E"\C+1WBJ?G1P[X5QV..Q]:F^)+V<5EH4MRT22)K=DR,Y (43*7(]L
M=: .T+!1DD#ZFEKSBQTKP]K?Q'\6VMW;65Y&]O9MY+X92V)=[!>FX9'/49[9
MK;^&5V;SX<Z([SF:1+<1NQ;<P*\8/OC% '5D@8R>M 8,,J01ZBN \=#1H/&G
MA*YU@VT-L[744LLY"JRF+A7)_AR>AXY]ZRY5L?#,7B34K"RC/AF[DLDAA5BE
MKYA?$LHQP(L,F[ PVTCI0!ZF&##(((]12YKRS0M(TK6=9\8:"LEDVGWME:R1
MK9P^5#N99 TL2Y(SPAW*<$@5I>#HHM<M;.ZU:Q@CET&WDT^;?$ OVA3ME89'
MW0J@@CC]XWI0!Z!N&<9&3VH!!Z$'MQ7AL=KH*?#ZRU%/L\>H1:^5CN$DVRQQ
MF]8%58'*KY;$X'&#GWK;UJ!M%UKQ98^%(TM9[KP_%=006F%WS;Y0SQJ/X]@'
M(YZ4 >KAE8D!@2." >E&X9QD9],UYUH<&@ZG=6.J0:WI#0PV,D=S:6UN(_,C
M8+Q.#(Q&TC^(=2?6N;TJSTJV^&_@K7(DA34(=1LXY;W/[U%:7$B,_4+M)RIX
MQVH ]<M-7M;W5-0TZ$N;BP,8GRN "Z[E /?C'YU7\3ZM/H7AC4=6MK>.X>SM
MWG,4DA0,%4D\@'GBN7\.Q:5%\4/%2OY(U!I+>:W#-\[1F!0S+GJN<@D<#I6Y
MX]!;X>^(U4$LVFW   R23&<"@#;L[C[39P3-M#R1J[*#TR,U-N4L5##<.2,\
MUY8NG:=?3>']2\$FU?584<WEU;N&W1^0PVSMW8R>7@-SP3V--\(16>KV'AR6
M?6["#6+%@UY +<I>2/L*S1S%I"Q!)))*X. >* /2]/N;NYAE:\L39NDSHB&5
M9-Z X5\CIN'..HJT"#G!!QP<5XK=2:2WP[UB)9;<"/Q0WD;' *(;U>4P<@>7
MGD=AZ5U'V"PTOXD&VT<P:<NI:%,VZW 59)1(NR3 X9P&8YZD9H ]"#*6*A@6
M'49Y%+7CWA:7PWKEWX7>YU#1(KVQB>&2-+H>??2$!1O0@-R1OPV6W'IUKV&@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@!&17&'4,.N",TM1SSPVL#SW$
ML<4*#+22,%51ZDGI7/>&O$,^LZQK]L\UG/:V$\26\]J#B17B#Y)W,"1NQD>E
M '2 !0   !V%+5--6T^:"XF@O()TMU+2^3('V<9YP>.E9GA_6I-1T9-;O;JT
MBL;N*.X@3;L,",N=LC%B&;D<@+Z8[T ;](5##! /UJNNHV+VT=PMY;M!(<1R
MB52KG., YP>::-5TYD#K?VI1BP#"9<$KG=W[8.?3!H M%0<9 ..1FEJG+JVF
MPPPS2ZA:1Q3@&)VF4+(#T*G//4=/6GWM[;6%L9KJ[M[6/[HDG<*H)Z=2/RS0
M!895;&Y0<'(R.AI:Y[P;K=UK^BS7=Y]G,D=[<6X:W4A&6.1D##)/4+GKWI\V
ML3W'BEM%L9K>%K2.&XNC/&6,B2,X")AAAL(3DYZCCT -ZC'.>]54U*PDO#9I
M>VS70SF!95+C'7Y<YH;4K%9A"U[;B4N(PAE7<6/1<9Z\'B@"U145Q<P6<#3W
M,\<$*<M)*X55^I/%+!<0W4"3V\T<T+C*R1L&5A[$=: ),8HJE/J^F6OF_:-1
MM(?)($OF3JNS.<;LGC.#C/I4TE[:16HNI+J%+8@$3-( A!Z'/2@"4(JL6"@$
M]2!UK T?1KZR\5:]J=Q]F-OJ+0M$L;L73RTV<Y4#GKUXZ<]:V1J%D889A=P&
M*8@1.)!MD)Z;3GG\*IIJIN=5M8[.6PGL)89':5+D&3<I  51PP^]DYXQ0!ID
M!AA@"/0T$ C! (/8U6.I6 O19&]MA=GI!YJ[^F?NYSTJ'5]2@TZR9GOK2UG=
M2(#=, K,.V-P)^@- &ATHK&\):M<:]X1TG5KI(TGO+5)G6($*"PS@9)./QJ_
M)J5A#=I:2WMLERY 6%I5#MGIA<Y- %DJ&&" 1Z&E(!ZU@WFL3R>*(]#L9K>&
M6*&.[N'GC+[XF<KL3###':W)SCC@YXV9;F" H)IHXR[;4#L!N/H,]30!+15>
MTO[/4(VDLKN"YC5MK-#(' /H2.]-MM2L+R5XK6]MIY(^72*56*_4 \4 6J*S
M-$URVUVWN)K9718+F6V(DQDM&Y1C@$\9!Q5*#6+X^/KK0Y1;FS33H[R-E0AP
M6D9"I.X@CY<\ =?:@#H*" 001D'M5:'4+*XN9+:"\MY9X_OQ)*K,O..0#D<T
MV#5-/NIY(+>^MIIHAF2..969!G'(!XH 673K:>_MKV2/=-:JXAR>$W  D#UP
M,9[ D=S5JJMIJ5AJ!D%E>VUR8\;Q#*K[<],X/%5;C7+>W\0VVB,KBYN;:2Y2
M0@;%5&52#SG.7''L: -2BN7\->)S?072:Q=6$%W'J5Q90JA\OSA&^T%59B23
MUP">M;]UJ-C8O$EW>6]NTIVQB654+GT&3S0!8VC=NP,],TM5KC4;*T+BYO+>
M$HGF-YDJKM7(&XY/ R1S[BI89XKF%)H)4EB<95T8,K#U!'6@!P158L% )ZD#
MK2X&<X&?6L%]:FNO%$^E6<]M NGI%+=F="QE$F_"H0PVD!,DD'J!CO5G3]97
M^RK6?5[G3K6ZF#96*Z#QD@X^5CC=VSQP: -4@,,$ CWH959<, 0>Q%0K>VC7
M$ENMU"9XQN>(2#<H]2.H'(_.DM+^SOU=K.[@N AVL89 ^T^AQTH G(!&" 1Z
M4N!C&.*R]2U8VNIZ?IENBR7EXS-AND<*8WN?S51[L.V:QX]8\3W>IR1VEEHG
MV-;EXE,U[(L[(CE6;8(R,\'O0!;TS1[^S\8ZWJTQMC:ZA' D:H[%T\H,,D;0
M.=WKQCO70 !1@  >U9EEJQFUJ^TFY18[JW59H]O26!R0K#W!5E(]0#W JY-?
MV=O<);S7<$<TF-D;R ,V3@8!Y/- $^T;MV!G&,TM5UU"R<SA+NW8P9\X"0'R
M\==W/'0]?2B#4+*ZMWN+>[MYH$)#21R!E7'7)!P,4 6**JP:G87-HUW;WUM+
M;*2&FCE5D!'J0<4G]JZ=Y<LGV^UV0[?-;SEPF[E=QSQGMGK0!;HJ&VNK>]@6
M>UGBGA;[LD3AE/T(XK%@UN6^\2WMG;W%M#::7((KM9D)>5FB#C8VX!0NY<Y!
MSSTQR ;X 48   ["@J&&& (]#5>+4;&<N(;RWD*()&"2J=J'HQP> <'FDM]3
ML+R.22VOK:=(^)&BE5@GU(/% %JBJ<>K:;+,88]0M'E$?FE%F4G9_>QGI[U-
M:WEK?0">SN8;B$D@20N'4_B.* )L#.>]%9<^N6\/B*#0R&%U/:272R$#8%5E
M7!YSG+CCV-9?ACQ0=0M9UU>ZL8;Q=1N;.)$;R_-$4A0%59B23C/!/6@#J**K
M76H65B4%W>6]N9#A!+*J;C[9//6K- !2!0HP !]*Y?Q1XH.DW>EVUA=Z>]Q-
MJ-O:W-M(=TJQR.%+ !@5(![@CFN@GU&QM;B*WN+RWAGF.(HY)55G_P!T$Y/X
M4 6 H&< #/)Q2]*S#KEL/$W]A%7%S]D%WO. FTOL ZYSD'M5I-0LI+QK-+RW
M:Z49:$2J7 ]USF@"QM7?OVC=C&<<XI:S==UNWT#3EO;E)'1IXH L>,[I'"+U
M(XRPS[5E/XDEM/&UQIM[<646EIIJWJSM\A5C(4PS%MI''H.M '3T5 UY:I:"
M[:YA%L0&$Q<;,'H=W3%.M[F"[@6>VFCFA?[LD;AE/T(H EI" <9 ..16"^M3
M77B>XTJSGMH$T]8I;OST+&42!R%0AAMP%R20W7&!UJYIFI/+I-I<:G)8P7,Q
MVE8+@/&7W8 5CC=V[=>* -)E# A@"#U!HP,8QQZ52?6M*BMH[F34[)+>0D)*
MTZA6(." <X.#4)UZT_X2.+1 &,\EF;Q9,C84WA ,YR22?3M0!J45'//#;0O-
M<2I%$@RSR,%51[D]*A74K%[-;Q;VV:U;[LPE4H?HV<4 6=HW;L#.,9H"J&+!
M0">IQUJD=9TL17$IU*S$=NVV=_/7$3>C'/!^M6'N[:.U^U/<1+;[0WFEP$P>
MASTQ0!+@ D@#)ZFEJJFIV$EF;Q+VV:U&09EE4H,=?FSBI6N8$F2%IXQ*X)1"
MXW,!Z#O0!+15,ZOIHEBB.HV@DE8I&GG+EV'4 9Y/M4']N6W_  DS:%M<7*VB
MW9<X";6<H .<YRI[4 :=%5[J^L[+9]KNH(-_W?-D";OIFGR75O$KM)/$BQJ'
M<LX 53T)]!P?RH P]8T:_OO%.A:E!]F^S:<9C*LCL&?S$V< *1QUZ\]..M=#
MC(QVJG+J^FP6T=S-J-I';RG$<KS*%<^@).#3[O4;*PB66\O+>WC;[KS2J@/T
M)- ":A]N^Q/_ &;]F^U979]IW;,9&<[>>F<>^*33+(V%BD#2"24EI)9 N-\C
M$LS8[ DG [# JRCK(BNC!D8 JRG((]15>VU.PO)Y(+6^MIYH_OQQ2JS+SCD
M\4 6J*YWQ%XDBL="UF?2K_3YM2TVUEN6MW<2$;%+$,JL",XQGMFM#2M7MM0M
MX(_M=LU\8$EF@CD&Y-R@\KG('/>@#1"@9P ,\GWI:K?VA9?;?L7VRW^UXSY'
MFKOZ9^[G/2L3QIXD'ASPY?W=M=V":A!;/<0V]T<^:%!. H92>G44 =)WHJK;
M7D<D=NDDT0N98A)Y88 G@9('7%8OC#Q!<:1X1U'5](ELYI[/&Y9 9%SD J=K
M#!^8'^G- '1@ = !WXHV@$G R>IJ"[O[.P16O+N"V5CA3-($!/MDTMW>VME;
M&XNKJ"WA'_+69PJC/3DD4 3U4U2R.I:3>6*W$ENUS \(FC.&CW*1N'N,YK(\
M'ZY=:]8:A-=M;.UMJ,]K');*0CHC8#<LW7KUJ_\ VY;?\),VA%7%RMHMV7.
MFTN4 '.<Y4]J ,AO#5UJ&F:9IFHQV$5K8RPREK8$M*8B&7:"!Y8)49Y;C([Y
MKJJJKJ5@]Z;-+VV:Z&<P"52XQU^7.:M4 %%%% !1110 4444 %%%% !1110
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M42?-T;=QG-:GA[2],N/B%XIN9=.C+BYMY;262# !6%0S1DCKN!!(ZXYKOJ*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %8]IH"VOB>^UP7DSRWD4<,D+
M*NP+&6*XXSGYV[UL44 %%%% !3##$TRS&-#*BE5<J-R@XR ?0X'Y"GT4 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MYG4866:W1V ]B1FL3Q7H=QK&J>'RFGPW5C97337,<I7:R&)XP IX/+@\\<4
M<;XAEU#PO_PDLGAZZNCHZ06AE+W#R+;2M,5F\MSN*XBP6QG;D&M+76U?1-)U
MG7=(N;6*(Z5N2TM+AKG+AQ_I"[E R$+9.#GC/2O18K6W@M5M88(H[=5VK$B
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M Y"EE!Q^M6\C..]>5^%M3DACLX]66"34Y[ #0;T'-NZ^6/W2YX24$?-GEO7
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M74Q/N903R.W' ]JP].M=)L/!/P^URW\F*^%U96\UX'^?8RD/&S9^[VVG@8H
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M!JHJ($10J@8  P!2@!5    ["EHH 3:,$8&#U%-\F+RO*\M/+Z;-HQ^5/HH
M8T,3QB-HT9!T4J"/RI_08%%% ";5R3M&3UXZTN!Z444 ($4# 4#G/ HP/04M
M% !2!5"[0HV^F.*6B@ P,YQS36C1RI=%8J<C(S@TZB@ P,YQS1@9SCGUHHH
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MFVD5]_&0-^,Y[U4\.Z:UUI$6@>(+K5H-2MM3-PZ1VG$D@G,B2K+Y9RIXRV>
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M8^5MQ+;" 3NZ<5I?#_3+O2/!UK9WB/$1),\4+_>BB:1FC0^A"D<=NG:NGHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\R2$MYK=,N2<L>!UST'I6G6/XDUX>'=/BO&M)+B-[B* [& V&1U0$Y[98=*
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MH)Q >GR<_+QQQVK7HH R6\,Z,PO0UA&1??\ 'V"3^_XQ\_//''/;CI4HT+3
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MM,@:;;D1;CNRPD5@_/'R$=ZUO'^JWFEV^B+ ZQVUUJ<4%U(TIB41E6(!< E
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M5DAU"7+,)E4-G<>?IU[YYS&DS:QHGC*YU"]N+;4-.O+F.%TG:,VL<:YA90"
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MV,UT;>']%:S:S;2+ VKL':$VR;"PZ$KC&?>K4%C:6LLDMO:P122X\QXXPI?
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M)-IB(='?KM[;3P,#IBO8J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW^8AD*^6@W##':W/...#FEU_79[#6=&T>T:WBN=3:7;/<J61%C4$@*"NYCN
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M10 4444 %%%% !2%5+!B 2.AQTI:* #'.:*** #H,"D*@J5(!!ZBEHH 0 *
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M$([8VHF,>:Y[J,\#N>!W(NZ%IMKHV@V.F63[[:T@6%&)R6"C&3[\4 :%%%%
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MS#YL'=USQC)-6+R>Y\*^*YS_ &S?SZ2=)N+R]%R_G&U9"NR1,C(W9?Y>AVG
MXH [^BO/M*N[]/'-C9BZODLM3TF:X:"ZNA-(K*T863'(C)#GA25XZ#%5/#][
M<6G@B;Q3J_B+5) BW5ML!5@/])9$95(P9.  3Q\W8"@#TPD $DX ZFLZ37+%
M;*SO(7>ZM[R9(H9+5#*I+' ;*YPOJW2N1TV;48?%VLZ.]Y=Q6KZ2EVD4UT+B
M2"0NZDAF!QD ?+EAZ=:QM'-YI?PU\#3VVJWBBXN].C>/<H7RW90R<*#C'J:
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M+P!?W>I>#+.>^N&N;E9)X6F<#<XCF= 3COA1F@#4U;5TTM8D2VFO+R;=Y%I
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M"P* S9YVJ6("@D#C(' KG?A7X)7PQX;M4U318K?6H#()+G<C[PS$@J03CY2
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MX*\,B"" :'8B&W<R0H(1B-CU*CL>.HK>HH HVNBZ99:A<ZA:V,$-Y=?Z^9$
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ME=6=KHMI';W2&.9-F0Z?W>>WM6S;6T%G:PVMM$D,$*"..-!A44#  'H!6?\
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M44?B.RF\5R^'8A*UW#:_:9'"_(HW ;<_WOF!QZ5IW$\5K;R7$[A(HE+NYZ*
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M#IE@8H8C8VWEP'=$GE+B,^JC''X4^*RM8+B:XAMH8YYL>;(D8#28Z;B.3^-
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MD Z!CCG&!U]* ./1K;Q'XG\4:/K=S)$]FT8M(EG:+RX&B!\U,$9.\O\ -SC
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ML4B9FNT9B&GRTIP.26SP/6NGU2_N=5^PS:);0:MIR2N\YBNT0&2-L*N3G(#
MD^ZCMFMP:5IPN_M8L+7[3G=YWDKOSZYQG-/%C:"U:U%K!]G8DM%Y8V$DY.1T
MZ\_6@#AOACK"6_@#3CJ0@LH9+B2&VDDN%(G=YI/E ['.1CO7H-4XM)TV! D6
MGVD:!Q(%2%0 PZ-TZCUJY0 4444 %%%% !1110 4444 %%%% !1110 4444
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M9N&[&=N><4ZO'-(AL+;PO\.];58TU$WL-O=WA/[TJ89 R2/UQPHP3Q@5['0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6
M5+97]WK*27,MM_9MNPEAB1&\QI-N,N2<8!)( '7:>W.K10 4444 %%%% !11
M10 8YS1110 4444 %%%% !1110 4444 %%%% !1110 =:.E%% !1110 $ ]1
MFBBB@ HHHH **** "BBB@ HHHH " >HS1110 5G7FCQ7^I6UW<SS/';$21VI
MV^5Y@SB0\;BPSQSCH<9 -:-% !1110 4444 %5[[[;]BD_L\P"ZX\O[0"4Z\
MYQSTS5BB@"GIEDUC9B.602W#LTL\H7:'=CDD#G [ 9.  ,\5<HHH *  !@#%
M%% !1110 8 )..M%%% !1110 4444 %%%% !1110 4444 %%%% !64;*_N=;
M$]W+;?8+9M]K%&C>87*[2SDG'&7P /XAW%:M% !1110 4444 %&!G..3110
M4$ ]1FBB@ HHHH **** .=M=&U/3;G5OLLUI-%J%PUP);@,7A+*!M*CB11C@
M97 X]ZTM#TBWT#0[+2;4L8;6(1JS=6QU)^IR:T** "BBB@ HHHH **** "BB
MB@ H  Z"BB@ H(!ZC-%% !6#XPT:[\0>'9-,LG@C>26)R\I("A)%?H <YVX_
M'/M6]10 U"YC4R*JO@;@IR >^#@9_*G444 %%%% !00#U%%% !1110 4444
M&!G..?6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BCH,FLS3O$.DZO?7-GI]['<S6
MR(\OE9*@/G:0W0YVGH3TH TZ*R3XETD7D=L;DAI)S;)(8G\II1G*"3&W=D$8
MSU!'48K6H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N/T/ ^)W
MBT#'%IIX_2:NPK+M/#NFV6K3ZI!%,M[< ":1KF5O, !"@@L00,G''&>* /.X
M ]Q\#]#QDWC7EIM_O>=]L7=^.=WZUZQ65!X<TJWNOM$5LRD3-<"/S7,:RMG+
MB/.T,<DY ZDGJ36K0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
80 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>ameh-nonqualifieddeferre011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN6M9LJ1B0*K$#/7AAS5V@ HJKJ-S<6EC)-:VOVJ<%52'=MW$L!R<' &<DX/
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M9>I XR*U=<?P9/X#US5M%FTX74VA7,9:*11+(KH/]9_$S;@!\W.2?6O30BJ
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MGK4GPLCTV/P]/';2(;Z*\NDNH_-+/'_I$NT,I/R\8^M=WM7C@<=.* JJ254
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MPP07)CBDCN0PV;01YF<!6Y/'IBN0GO[#5/&W@_4-.T^Y6VB%S%)<-8O$(LQ
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M>:?,+N]^RW<&=TL0\MWSPWR_<QR.]<_J5F^NZ9J>JZ#J.H2ZT-'FM($^RFW
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MK6JJ=CA<<ON!&<DTQ-/@M=!^'5Y;Z>T4]M<P+<2);D21 VTBR;^,@;L Y[T
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M4D]TH:!$F4^8",C;ZY'./2I;KQ#H]C?1V5UJ5M#<R.(UC>0 [C]U3Z$]@>M
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MY.*]'U"U:]T^XM5E\HS1F/>%SM!&#Q]*KZ%I7]AZ%8Z4L[3QV<*01R,H#%%
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M8X26:W^U;]R#^(;><"NS\5V5[KG@;5;/3@\-Y=V;I$KG:<E?NGTST]LUOT4
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M,K[MFX Y.W'(SD\<GBNXHH \JL-(O8?AUX<M1I-U'<6.N17$T MV#QH+AG+
M8Y&P]L]<=>*D\4IKNLZ;XCL7TS4-XO(FM8K>W40RPJT1$A?&YWX/ .1@<<9K
MU&B@#B&\X>.==OOL-Z;6?1X((I/LLF'D5I25''7#K_D5DV^EWD/P]\#0?V9<
MK<:;>V;W40@;?%L!$C8QD]3R,YSWKTVB@#S+5+2]GLOB1%%IMZS:F@6R'V9_
MWQ^RI%QQ_>!Z_7IS6O=VDQUKP-=PV$X@M!,DQ6!@8 T&P!AC(&[ Z8[]*[:D
M(# @\@\&@#R#3[^PL=+@BU5-3_L+2-5ENK:X73VD4A9'VN\Z$JR L3D =!D]
M<^@^-K*XU3P)KEG91&>XN+&5(8UZNQ0X J*#PA#%H::"]_<2:,BB,6S*N3$#
MQ$SXR4QQV)'4GFNDQ@8% '"AKQ/%.A^(6TZ__LTZ;)8R1&W8RVTA=&#F,9;#
M;-I('&!GCFM/PGI=Q::GXBU%XW@MM3OA/;P.-I"B-4+E>Q9E)P><8SSQ73T4
M <!9I/9Z]XQMY]#O)VU6X#6[_9\Q3IY")M:3HHW!OO8X/&<UEZ-X?U/P?K2P
M7DNJ36,NE6EJEUI\ G"O"K*R,I1F );(.,<G->IT4 9V@:;;:/H-CI]G%-%;
M6\02..=LNH]"?6O-/#]K_P )-\(U\,VVFW$<TY=3<2P%84'G$F4/T8CJ .<C
MH!S7K4@=HV$;!'(.UB,X/KCO65X9T(>&]"@TE+I[F* MLDD4!L%BV#C@\DT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUP>#[B@#C]5^&\NOZ-XH:^N(H-6\0"'=Y1+Q6XAQY: D L,K\S8&<].*CMO
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MUO\ R#8/=O(7M C*615 *IG!RPR3WZ\>KT4 1V_FBVB$RHDNP;U1BR@XY )
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MW5E':WMG-<,@!1F*NCA#G[S @J*L1Z3JS>.X-<FCLEM1IALW1)V9PY=7)&4
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ME93AE"C<< K@DC'/M7<T44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'RAACH2>F0*W=3\<6UDFL2V\*7$.CDB\S.(W)"!V$:D?.0I'4KSP":SSX/\
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M]F]J+F.)P6++M\Q@3P<$G ZGN*CC\,ZFNI>&;LW-J1HUM);NNUOWV]57(/\
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M6V8YF^9<Y[D<'W]JZNX\.75XFH7MS/;G5KNQ-BC*I$4$9))P.I))R2>NU>E
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MPAWJTHRLF/O9)SD9K9MO'=I<-H\WD(+'5Y1%:RB<-(K,I9/,CQ\H8*>YQD9
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M]SFU<HX551Q@$L#NY(P.Q-7M3\07]GIEK/'#IB3RVPF*7-]M5GQDQQD*2_\
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MNC@AE89!'>J^GV%AI=N+/3K6WM85.X0P($49[X%>>V6K1Q_$6_U"6]@DN)-
M\U81.K+&?-<B)<'J%49QU.3WJ-(5M_"'@378@!JEQ>6+W%T!B2;[0 )0QZD'
M>3@^@]!0!ZAN&[;D9QG%#,%&6( ]37C=S?2V7A&(7&FWD7C"#5HM]RUJX+NU
MR!D3$;61D;:%!/!QC XZ[X@RVFIVZ^&9M6ATTW,#W$DTDXC*[>(@"3WDVM](
MV'>@#K9]-L;J\M[RXL[>6YMMWD321AGBSUVD\C.!TJU7/^"?$'_"3^$;'4G*
M_:2ABN54@[9D.UQQVR"1[$5J:M=S:?I%W>6\*32P1-*(WD*!MHR1N ..!Z4
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M$1AWW$,%#<84<A<].>HHH R9-%-YJL-[J-S]H6U<R6ENL>R.-L$!V&26< D
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MZ?\ 89D6W$:[=S-E,$[?O=#N^OI2C\$WJ>']#TEM;5UTBXAFAD-I@L(AB-2
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M&ZM=5BO))KF75;?[-=7#D!S'M("KM "@;F(P.I).: +6@I=QZ):+>/"\@B4
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M()&=J\CI572_&>JZS8Z-JEC922V^H7"I+;"QF'D0N2!)YQ^4E>">Q&0.F:Z
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MVTJK$Z1LX*3$[91\I!P!Z^U;>D>&1I%JEDNK:C<V$<9BBM;AXRJ)C 7<$#D
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MOER?<$Y]ZYOP_=:OHOP[\-ZM:ZJ1;_;(K:2Q,"&)XY+GRS\Q&\,-V<AL<=*
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M4/;Q,KQ!&*-$R_=9&4@J1V((JM<^%-*OM)?3+T7EU;2.KN)KV9F8J01EMV<
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M-W*Q=G^\V2V5)]1BI%\/:=MN!/')=&X@-M*US*TA:(YRF2> <\XZ]\XK5HH
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M_!;>(K;1'MKDW%S!)/$X"[&5-NX9W9S\R]N]/T+7+?Q!827=M%/$L<\MNR3
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M[N-AE9F/5B.F>!SUX'I3+7PMHEE+%-;:?'%-%&T:RHS!]K8R"V<GH.I[#T%
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M8IF!3;K(<<8QN)ZBJ$=]JE];?#D?VS>0_P!JVO\ IAC*YE/V1I"V2"<[N_\
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M=!$;[2/%/A5$U:[N(-4BFCN8)F4QY2'>I08^7!&..H/.>M=')X5T*5KYGTR
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M41G.$5F +'V]: )***Y^7Q#<7>O76C:-:Q3S62H;RXGD*10EAE4& 2[XYQP
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ME*;5!"X"G':O6Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR[XH4N$+NOJH!R1P>GI7#:;(\WCC3]6EAU"6VDT2:&69]->&,/YD3",+LW
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MTV\MI)D>!HS:)&I$JL2 ,$94 ?>R",CF@#N$UK2I+A+=-3LVGDD,21K.I9G
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M%XW4QL4)W ] #C'84VQM$\(>(]%;R=3G\/II+6EM/);O(]O*9=YWJJY0,NT
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MWQ&18@".>1\AZ9[5EQ^%]7NOA[;^";RT""$Q0-J"R(8FACD5@ZKG?O*J!@@
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MAEH2X<I[9'!_"@"C>^(;*SFNH@EQ</:('N1;1&3R5(R,XZG'.T9..<<BN?\
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M9VM4N_*,\-P[G*.IX8!AP< \C- '73>-]$MK<RW,T\)6\6QDC:W<M%,V,*^
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M":1Y'11N4$[0I()P,=>@H M>&/$B:;X;>?6KRZF+:Q<V44KHTAS]H:.-20,
M?=&3@5TYU[3UUN;2&E=+N&V^U.'C94$60-V\C:>3V/8UQ1\-:ZW@>\LEL%%^
MNM'4H87F0"5/M7GA=P) .WCGC/YU;O=#UG7_ !#>W-U8FQL[_09=-R)D>2%V
M8G+ ''3^[GM[X .CMO$^G75W96ZF9/MZL]E+)&52X &X[3].<'&1R,BM*]O;
M;3K*:\O)DAMX4+R2.<!0.]<CX6T2YMX=*@U?0I%N]-0*+M[\S0[@A3?$I8D$
MCL57 )YK8\9:'/XC\)W^EVLRPW$JJT3O]W>CJZ@X[$J ?8T 30^([%]3ATZ9
M+BUNKB-I;=+B(IYRK][;[@$$J<,/2L;P9K(\1SWNIO+?K*L\]NL#QR);K&DK
M*A&Y0I?"Y)R2"2#C@"2YT_4->UK0=2N].DL1I+2W#HTL;M)(T90(A5B-OS$D
MG'0<<G$_@C3[_2M%GM-0M3!*;VYG7YU8,LLSN/ND\@,,_P!: '>*_$S>'9-&
M1(6D^W7Z6TF())"J%69B @.6^48'UX.*Q;7Q+_9OC'Q*MS+J=W:I#:3P6T<$
MDK1*ZR%SL RHZ9SST%;'C#3M0O1HESIULMU)I^IQW4D)D"%T".AP3QGYP>?2
MF:-8:C!XUU_4;FR,5K?0VR0N)$;F(.&R <X.X8X^N* -%/$NF7%M8S6<S79O
MX3/:QP+EY(P 2V#C &1DG') ZG%6M*U6SUFQ%Y92%XB[1L&4JR.I*LK \@@@
M@BO-]'\'ZYI$/AJ]DT^6XDL-.?3KRT@O1"^"X=9(V# -R,$,1^E>B:)8PV&G
ME8; 67FRO,\1D\QB[')9FR<L>IY//<T <UXBO+JW\?Z'9_VO<6>G7=K=2W*J
MZJN8Q'M.2/E^\<\T[PWK=[%)KAO;J?4-*BO%BTNZ$.Z2X!0%U&P#>%;(#8['
M)XJQJVG:E<?$/0M4AL'>QL8+B&63S$&3+LP0"V2!M.?TS5SQ9#K,UK8_V0KR
M(EVC7D,4XADE@PV55R1@[MIZC(!&: &/XWT2+0[W5YI+F*WL93#=(UM)YD+C
M!PR@9'!!STY'-9^K>/K>V33WL;>Y=)]66PE,ME-G;LWLR +ELC;M/?)(SBL6
M^\*ZW)X:\9:?%IJ^=J]RDEL!<JRA?+C4[F8@Y!0YX[BNE\5V.I:E:Z'=V-@9
M)K'4HKN2U>5$8H%=2 <E<_.#U[4 6+'6K:X\2:E'_:=QL@M(9GM+BU,*P*=_
MS[F4$[L<^FVFS^*[&2*14&H0QR6SS0WBV3NC*!]Y>#G&00".1SR*R-0\.ZGK
M&N>)1+;FVM=5T9-/CG$BML<>;DD YQ^\&..<'I5[3I->;PR=.O\ 0VCO(;,P
M&2.XB:.5PNT%/FR >OS 8]Z )+;Q;IECH^@-=WUU=MJ<*?9[G[(P-P?+W9(4
M8#, 3MZ]@*LV'B_2;\W\8-S;W%@H>XM[FV>.55/W6"D98''&,UQUY!J6B:/\
M.+-].,NH6-RL#VXF0;REI(K%6SCL2,X_"MG5]$UV[_M77M.5;36;BRAL[6 R
M+N2-9"[[GY4.P8@8R%P.>> #83QAI1&HB47<$NGQ":XAEM9!((SG#A0"67@\
MC.,'.*CLO&NCWUYI]O&UT@U%-]I-+;.D4QV[]JN1C.W)Q[&N>;0-8_M36;U-
M)D1+[1!9Q(]X)I!+ND^^S-_MCH2.*MR:'JIT+P3$+(^?I%Q"UW'YB9"I \9*
MG.#RP(YZ4 .M?%&I>(+7Q'8Z7$T.HVUW)9V<IMI%1%"H/,=G&TLI=FV]2%'!
MK=GUJWTD"QD-U>W-M;+-/Y4>]Q'R!(P&.I5N!R<' XJEX8T_4M+U;7XKJT46
MMWJ#WD%RLH(<.J#;MZ@C:<Y]L9JCXJ\.R:MJLMS!I]]'?):B.TU.PO1;LK98
M[9/G&5!(/W6ZMQ0!V4;K+&LB'*L P..QKF/'&I:O:Z5]F\/;3JK(]TH(S^ZB
MPS#'^T=J?\#SVKH;"*X@TZUBNYA/<I$BS2@8\QP &;';)R:Y^UT675=<U'4-
M7M+NV;*0VGEWA0>0HSSY3_>+ER<]MH[4 :NGZ]8:AX;@UY9TCL);87)DD8 (
MF,G<>V.<_2JZ^*M.$TJW"75I'' USY]U T4;1J0"03[LO!P>>E<A;>#M6?PC
MXF\)I"UGI]Q)))I,TLJOY:L0_EN 20-^<'G@G//!UM:LM>\6>#KO3)],&EZB
M4CD222=)(FE1U< ;23L)7J0#ST- &P?%>G1-<"[CO+-8(Q)ON;9D$BE@HV\9
M))(&W[V2..:DC\2V!OY+"9+FWO$@-P()(6+R1@X+(%SNP<9 Y&1D5B:Y9:WX
MH\/)&=*_LW4;2X@O(DGN$>.62*0/LRA)VG&,D#MQ5PZ7=ZSXLTC6[FSDL(]-
MMYT6.5T9Y'E"@_<8C: I[Y)/3B@"TOC#1FTK2]26:8VNJ2I#:N('.YG;:N>/
MER3_ !8J*Z\;:1:W>H6@2_GN-/VFYB@LI79 P)#?=Y7 )R.#VS7)6GA_Q-'X
M/T#0WTB-7T?4+:6247*$3QQ2[LQC/&0/XL>GN.FTG3]1A\7^)+Z>R:.UOT@%
MNYD0DF-"IR 21DGCVZXH CU+QO;VVI>&ELPUS8:N))3-%;2RMY8B+J5" \DX
MR,9 SQWKK0<@&O.=*\.Z]IFE^!S_ &<LL^BK)#=0^>B\-$4#J<X(!_'VKT:@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **9-$D
M\+Q29V.-IVL5./J.17FO@SQ@=(\!>'Y-1T[4GLI L$NIML9%D=RH+ MOQN(&
M[;C)H ]-HKG]8\5)HDH>ZTN^^P"XCMY+T!-B,Y"J=I;<5RP!('YUG:6_V7XC
M>*SNG>)+&SF\L,SX),^=J\]<#@4 =C17/P>*?,UF329](OK:]^RF[@C<Q'SX
MPP4X(<@,"PX)'6L^S^(5K>6ND7_]CZE%INJ2I!#=R+&%61VVJK*'+ $\9QC)
M'/>@#L**P;GQ/M>[_L_3+O48[*7R;I[<H C  L &8%B 1G'TZY%077C2RMK2
M;4!;SR:7!=?9)KQ=NU'WB,D+G)4.<$@=C@$<T =+5#2](MM(A=('N)&D;<\M
MQ,TLC<8&68DX Z#I5B\N3:6K3+;S7# @"*$ LQ) &,D#OR20 ,DUSP\<645M
MJK7UI<V=QI<L,4\$A0DF4@1E6#%<,2!DD8YSC% '4452T^^FNVF6>QEM6C(P
M69660$9RK \^G.*S;KQ3'$FI2VEA<WT.F,4NW@*\,%#,J@D;BH()'X#)R* -
M^BN!UO78=<USP]IT-K<ZAHNIV4UVPMR$\T#R]A)+*<+O)(]2O&1QL>-]<O=!
MTBTGL(G>::_MK<[45OE>558?,0,D$@>YH Z:BN ?4;FT^)EQ+;Z;J%Q+-HD4
MOV$2KE6\YP2=S[%X Z'GWK<LO&=AJ-AID]K!<&XU%Y8X+1U"R!HB1(&YP I4
M@G)[8SD4 ='167HNN0:TEV$BD@GL[AK:YADQE)  >H)!!# @^A]>*Y70--CU
M'Q=XOM[NZU&2&UO(4@C_ +0G41*T",0H#C'))H [ZBO-Y-5N= U;Q/X>N[K5
M+S38=*&HV\T4P-W;QG<CJ)'(+$;=RDG(]ZZ6#Q)"B:986<%Q=W<]@MVD<LJ*
MYCP!EF8\L2>WODB@#HZ*PM2\1R:?IOVU=$U&>-+874RJ(T:)""2IW,,N,'*C
M/ZC/.7FK*WC[0=3TZ&\OHK_19YHK>%\>9EH2K8=@J_*QY./3DD"@#T"BN'NO
M&%EJ=A:/);ZU92PZS#8W$,+I&\,^]=J28;YHVW#.W.14EJ7M_B-XF"?:95_L
MRTE$*2Y.XM,#LW$!3\H[@<4 =I17GI\536GAKP9-I":E=0:E=1Q,UULDN)(O
M+=L,Q8#>=HYST!YKHK;Q7#/JNJ:=)I]Y;3Z=;I<R>>8P'1@2"I#G^ZP). ".
MM '045GVFJI<Z$FK36T]G$T'GM%< "1%QGY@I(!QVS61X=U*[E\+6VMW%O<W
M5WJFVY6WB(/EJXRB#<0JA4QDY&3D]30!T]%<E-X_L[;1-0U&XTS4$;3KM;2\
MMP(V>)VV[3PV&4[UY4D\]*NVGBJ.779=)O=.N].F%LUW$]R8RDL2L%9@58X(
M)&0<'!H Z"BO.O&&MOJ=CX>N[.QOULI]6LFAO1($1T:9?O)NW;6'3*_@,UW&
MK:K:Z+ILM_>,PA0JN%&69F8*J@=R6( ^M $&E:#:Z1=7UQ;23L]]-Y\_F/N#
M28"[AZ<*!QQQ6I6&GB6,:G=:;<V-U#>PVGVU(5VR&:+.T[-I^\#@$'U'6H8?
M%]JM]J-GJ=K<:9+8VOVV0W!1E,&2"X*,PX*G(Z_6@#3NM(MKW4+:\G>X9K?E
M(A,PB+ Y#,@.&(/()'%7ZY+6=7GU'0]1MVTG4+6WFTV:XANS(J_=4$ [6W(>
M00#Z'..E5?#/BH6^D^%K"\TV_BCO[2&&WOI-ACEE$.X@C=O&0K8)49Q0!V]%
M5KZZ>T@#QVL]U(S!5BA R3[DD #W)KFY?']G;:'J&I7&F:@C:==BTO+<"-GB
M<[=IX;#*=Z\J2>>E '6T5S]KXI\[7)=(GTB_M;O[,UU;K*8B+B-6"G:0Y .6
M7AL=16=;?$.VN;#3M2_L;4XM,O9UMQ=R+&%BD:0QJ&4/NP6P,@$<CF@#L:*Y
M:#68X=?\3>7;ZQ/<64,$DEJTB-&RE7VF!=V 2%).<$G%6;/Q9;ZAI^B7MK8W
M4D>K\Q &/,2[2VY_FX  .<9P<#J: .@HKFD\9V3Q:?>"WG_LS4+D6MO>?+M9
MV)525SN"L1@''<< '-0V_CNWGO+R'^Q]4CAL9Y8+RX>-#';F.+S"6*L<@C@8
MSSC.,C(!U=%8NG^(&OX%N?[-NEM9+4W4,J%90Z\?+A2?GY&!SGG!XJ*U\3^=
MK<VCSZ5>VM\MJ;N*.1HCYT88*=I5R P) P2.HH WZ*XJ#XC0W.AS:U#X?UE]
M.AMI+AI1''R$?:R@;^2.3Z8!P3@UO1:^DU[IMM%9W$GV^W-RLBE"D:#;RWS9
M_C7&,YS[&@#7HK-O]9BL]0M=-CB>XO[E'DCA0@81,;G8GHH+*/7)X'7'+>(_
M&S#P=K-QI\%S!J5C<1V=Q P7S(&=E&[.<$%6RK ]Q[X .[HK,TNPM4T1;:*R
MN+*&3<3!)*?,4EB3EE8\D\\-WKC_  #H\>N_#K2KR^U#5FO9XF9[E=2G$F[<
MP!^_CL.,8]J /0Z*\TTGQ-<7&E6=KK4VHR75CXC.E&\LG6,3NC80RC(RC!OF
M !R5[5UZ>)4N-0N;:SL9[I+2Z2TN9(V3,;MMYVDY*C>,GV.,XH W**Y_4/%2
M:7?6L=UI=\EI<7:V:7A";/-9MJY7=OVEN-V/3MS7-:;K%QH?B#QF(-+U/5(X
M+V.0K ZMY2?9XV./,<9.2QVKD_3(R >BT5R5IX@T[6?$ND/;2:F4OM+DN+<K
M(%MI(\QY++G=Y@W #(&,FN>L+Z/3? NK274FK&"+7[B'S;*<":,"[VH-S-G;
M]U3C)P30!Z=17)S^(M0B^(K:+'97$]FNFK/B-4'[QI"NXLS#Y0!CZYXJ:T\:
M07NA#5(=+OR?MOV$VI\H3"42>601OP,-UYZ<]* .FHKG/'>L76A>!]5U*R5A
M=16Y,9 !V,>-W/'&<TS3]0L]-,&E6&EW:7URDEVUI-(I=%#!3([%V R2,8))
M)Z=< &]>VBWUG+:O+-$L@P7@D,;K]&'(I;.S@L+2.UMU*Q1C W,6)[DDGDDG
M))/))S7-3^/]/M]$N-3DLK[%K>BQNX%1#);REE4!ANY!+*05W9!K=TS4I-0L
M7N;C3[K3RCLIBN@H? _B^4D8(YZT 7Z*YZP\5#4K&+4+72[N:QGMFN8)HVC.
M]1CY2-PVL0<@'T.<'BF+XSLWTC0=36RO#;ZU+%% <)F(R<KO&[CC/3/2@#I*
M*\YTO6I]"UKQD(=+U/5(K?4%=A ZMY4?V>-CCS'&3DL=JY/TR,[\?C:SOESI
M%K/J)%C'?E(BJN8I-VT*K$%F^4\=NYYH Z>BN?O_ !7;V@U1H+.XNX]*4-?-
M$5'E_)O*C)&Y@I#$#UZYXJ7_ (26WNG:/2;>74I5@CN'6$JH5)!E,ER!E@"0
M/SQD4 ;=0WEI;ZA93V=W"LUM.ACEC<9#*1@@_A7.V'CBRU%-!DBL+Y(]:>2.
MW>0( A0.2'PQ(R(R1@'J*F?QEI]N^N"[AN;8:.T2SF15/F&0939M8YSE0,X.
M30!>@T"SA>V9WN;G[*<VXN)VD$9Q@$9ZG!/)R>>M:E<U>>,(M.GN[>]TV\CN
M+>R;4!$AC8R0J<.5.X#<N1D$]QC--L_&D5S?:3#-I.H6MOJR9L[J8)L=O+\S
M:0&+*=H.,@9P: .GHKE?"/B&_P!:O=<BN[2=8[7498(92B*JHH0!#ALELDG.
M._7M4W]I1KXYN[18]5>ZCTU91!YJ?9Y$\P@,BEN)"<@EL< 4 =)17'6?Q"M;
MRSTG4!H^IQ:9J<R017<BQA4D=MJAE#E@">,X(R1SWK5@\2I=WL\-G8SW,-M=
M_8YY8V3,<G )*YSM!/)^IP1S0!N45R'AOQ/?:C-XB-W87;16-]-'"4B3[B*F
M(\!MQ<DD]._7M5K^WH]5N-3T*[L+RPO(K3[0$D=?GB;(#*T;'!!&",@_6@#I
M:*\ML&D?PM\+[EIYC++<0)(?-;]X#;2,=PS@\J#SZ5TE[X\2SFUF-="U6?\
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MFX,-]*!%B$!58MC?EAA@?ER< Y XSHVOBR";7%TRYL+RR,UL]U;37&S9/&I
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M,H/0YY''6L?5_!>H7^E:\89+1=2UJZ@FEW2,(X4AV;5!VY8X3DX'+'TKNJ*
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MH>!=3UJ+Q1%?W5G&-9^S2PM%N;R)(0N 5(^9<KR<\CL,X'::7I5EHMBEEIT
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M21F5/.&,-E1T]1U]JOQZ)J\7BS3]80V1B&G"QNHVD;*X<-N0[?F],';74T4
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M\CL2B*<=LU5M= U^SOO$$43Z?]AUBY><3F1_-M]T:QXV;=K\(#]X8)[UV-%
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MPN(Y[=(2QE#;&.SYN#^[X!SUH I1^-[F;^P9H=%,MIK@)LV2Y'F+\AD'F*0
MN4!/#'!&*L_$+5+_ $?P9>7>FF1;H/$BR)MR@:15)^;V./Q_&N1T>'6_#7A_
M2=7MQH5[%<RQB*%+=TF*3R E8R'**0&R0JA<+Z"N^\4Z(_B+PY=:7'<BVDEV
M,DI3>%9'5QD9&1E0.M $ \07,VJ?V3;:>O\ :*6PN9XIKC:D2%BJ LJMEFVD
MX X Y/3,_AW7H?$>G33"!X)K>XDM+JWD()BE0X9<C@CH0>X(JC_PC^I0^((]
M?@N[4W\MH+2]B,3+%,%8LK+\Q*E2Q'.<@]JT= T2/0[6Y02>;/=W4EW<R[=H
M>5SDX'.    ,G@#DT <'H.L7GAC1O$MQ8Z!]JTZRUF]DG\N=8BD8?)\M,'=M
M4=,KZ#-=%<^/K+=?#3Q;3FRMX[B03W0@+AT\Q50$'<VW!YP/F SUPVV\(:E%
M%K6G2:I;MI.K7,]Q*J6[+.BRD[D#[L=.-V,]?;$L?A2[TOQ#>:CH=U9Q6]\D
M2SVMU;F14:-=BLA5ACY0 5/IU% &W;:LM_X>AU>PB,J7%LMS#'(=A*LH8 GG
M!P:Y9/B#=C0-+\0W'A]XM%O!#YLXN@TD'F$*&*;>5RPYSGGI793[DT^02,&8
M1'<P& 3CDX[5P7@71;W6/AQX?MM5N[:72Q;V\R0PP%'<)AU1V+$$ @9P!G';
MD$ W?$'B^3P]<(US81&R-Q' SF[59CO95#I%CYE!8 _,#P>*CBUFPL?%7B:6
M[MY;8V-C!<7-RUPSH\7[T@A.BD!6SCDYJA>^ ]1NH-:M5U>W6#4+]+Y7:T+2
M@K(CB-FW\H-F!@ CCGC!OW'@^74-5UZ>_O(GM-9L$L9(8XBK1JH<;@Q8\_O#
MV["@#&\4W%WJ&J>#;N;2(8;=]7A>&X,X:9 8W.QUV_+G@\,PRM>BUQ+>$=?N
M;718;[7K68Z1=QW$++9%3.$5E_>?.?FPW5<#KP>,=3:07\=_?275ZDUM*RFV
MA6':80%PP+9^;)Y[8H NT444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4,K#T(/6F6=E::?;K;V5K#;0+TCAC"*/P'%3T4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4 %%%% !1110 4444 %%5-2U&#2[3SY]S;G6..-!EY'8X55'J3^'<X )JW0
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MZMAF&0/;FLS2/&<6L_V9)%HNJPVNI#-O=3)%Y9&QG&=LA89"GJ/2@#IJ***
M"BBN?M_%D%QXXN/"OV*YBN8+/[89GV>6Z;@HVX8GJ3U Z4 =!1110 444=J
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M/EY)/%-O_"GA_5-134+_ $6PN;Q,8FE@5FXZ9)'./>@#-^(>\?##Q!YI7?\
MV=+NV],[>U8O@&"ZM/"_A:ZN]<=[";2TMTM"@7$CB,IM*C)P%89/3/UKO;RR
MM=1M)+2]MH;FVD&'BF0.C<YY!X-9EOX/\,VEPEQ;>'M*AF3.V2.SC5ER,'!
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M0.I[F@#@EUJ2XU7POK.FWEXMKJFI/ 1<7S-]HB*R9/D?<0 J,$8(XR,FHUM
MFE?$^X:\N'99+I2C2#:1]CC.2H'7M]!7?1>&-!@),6BZ>A,PN"5MD'[P9P_3
M[W)Y]SZT^;P[HMS<W-S/I%C+/=(([B1[=2TJCLQ(Y' Z^@H XNUBGTC4? T]
MOJ5\XU%?L]U#+<,T4B_96=2(S\J$%!C:![YK9^(#SV.C6VLPW5S#'I]Y#+=)
M#.Z"2W+A9 0I&< [O^ _6M\Z+I9AM83IUH8K1MUNAA7$)]4&/E//:K-S;07E
MM+;7,*302H4DCD4,KJ1@@@]0: //)]:U636+RPGN94A\16JR:*8V9# RML."
M#G.QHYB/]\=JMW.DQ77Q.2P:[O4B7P^ QCN725P)^,R [_R(S].*[=[2VDF@
MF>")I+?)A<J"8\C!VGMD<<5#_96G?VE_:7V&V^W[=GVGRE\S;Z;L9Q[4 ><0
M:EJ(\+Z(SZI>/-;^*!IQE,Q#30BZ9 LA'WOE4 YZ_B:L:]JEYHVM_$#4=.7=
M>6VC6<D7R[MI'G_-COCK^%=N_AO0I%VOHU@P\TSX-LA'F$Y+]/O9[]:GCT?3
M(;V6\BT^U2ZE7;),L*AW'H6QDB@#G=%L]6?5-+U.&\B_LR6U87"'4)+G[22%
M,;J&4!2/FR1C(;IP*JWM_J.I?$+4-"(Q;0:?#-!$+Z2U9R[.'D!126QA1UP/
MQKJ-.\/Z/I$K2Z=I=G:.V06@A5#@G)' Z9[4[4=#TK5WB?4=.M;MX23&TT08
MIGK@GIF@#B#::NNO>$=)U?6KEYI[*[6^-E=/&DYC";3D8(/S')&#FL>>34+7
MP3KNIKKFJ-=:'JTMO:.UVQ'E),HVR#I+D,02^3]*]/.B:2;BWN#IEGYULNR"
M3R%W1+Z*<?*/I3$\/:+':7-HFDV*VURVZ>(6Z[)3G.6&,,<^M ',WELU_P#$
MZXTR74M0BLY-'2<V\-Y)&"_G,I9=I!7@#[I'OU.<"1[X>'K2&\O)KRWM_%]O
M#8W-PVYY8%F3&6_BPV]=W?;7177A>/4/B(MY?:#!<:5%IB6L,DJQ,J2+(S<*
M3D#:<=/TKJ;S2=-U".&.]L+6YCA(:)9HE<(1T*@C@\=J .6LI)/$6K>*[74+
MV[M'L+E8+=8+AX?)B,2LLORD9)8L<G(^7'3-85GK6J0Z+X+\7:S>7$5O,HM]
M43S62+]X"(IV7(4?,%SQC]Y[5Z'=:'I5[<"XN=/MI9@GE[WC!)3^Z?5?8\52
MUFTN=5GCTA].1M+?RY9[EW4J=K;O+"=2257GI@GN* .5U*\U32CX=A\ZX":W
MJ,C7 N;R1/+4H[Q0!SN*?P@XZE2.AIVHW6M^&A%%>WZ1:=J.LP0(PN6F>TA=
M#O4R. 1N=< _PA^",#'=W^GV6J6CVE_:075N_P!Z*:,.I_ U N@Z0FFR::-,
ML_L,O^LMS"I1_P#>&,'H.OI0!R>FVEK8_&&YAMKFXE_XD@9TGN7F,9,W0%R2
M,]<9[^]2:_:)?_$_1+:2YG@1]*O-WD2F)W'F0_*&&&'K\I!X^M=/:>']&T^2
M"2STJRMW@0QQ/% JE%)R0"!P"232ZCH6DZP\;ZEIEI=O%_JVGA5RGT)'% 'G
M5Q'K5IX:UF[AU/4[FVT+5S+;L;I]]S:($,T3,#EPN9 "<G*8S7;Z"RZE>WNN
M0W4TMG<E8[1/.8Q%%&#(%)P"S9&0.B@]SFQJRWL=E'8:5I\;I,C0F0LJQVRX
MP&*G[PZ_*!VQQG-7[&S@TZPM[*UC$=O;QK%$@_A51@#\A0!QVG68?XMZ],UW
M< QV%DPC$@"D%IN" .0,?K7+:+%-IOPX\)ZW:ZE?)<?;;:!HQ<,(6BDN-C(8
M_NGACSC=GO7J=QHFE7E^M]<Z;:37:QF)9Y(59PASE=Q&<<GCW-,70-&33AIR
MZ59+9!Q(+86ZB,,#D';C&<T <+#<>(?$R^)DL[F.UU"QU.6WM97OI(A;*F-A
M:)5(96'S$MG=N/8#&G\4([D>%K&]$330:?J=K>7T48+;H$?+\=P.#]!72S^'
M-$NKY;VXTFRENE 43/ I; Z#..<=O2M,C(P: *]M>VE]8QWMM<136DJ;UF1@
M49?7/I7'6<LGB*Z\6QWU_=6DMA=F"W$%PT7D1")627"D [B6;+9! QT&*WU\
M(>&TG:9-"TY79MS8MU +>N,8S[U;NM$TN]NOM-UI]M-/LV&1XP2R]=I]1['B
M@#SZQO=5UR3P"VI7U]:RZI97#7L5O.T(FVQ@J<+C:3G.1@\]L"J-VU_:^"O%
M.H1Z[JIN= U*:.Q=KMSM1"C!9!G][]XCY]W'I7J4^DZ==7L%[/86TMU!_J9G
MB4O'_NL1D?A4*>']&CMKFV32;%8+HYN(Q;J%F/JXQAOQH YJ_MVOOB=_9TFI
M7\5G/HQF:WAO'C#.)57(P05X_NX_4YS-,U"XM+271[N^U&^BGUN6STN3[24D
MGB6/<0\WWMJL'&X'<=@'/2M6]\+1:A\0;>ZO-!@N-(@TS[-$\JQ,J2^9N!"D
MY VY&<=_3FNHOM'TS4[2.TO]/M;FVC8,D4T*LJD=" 1@8H \PGU'4H_ /B;;
MJUTDNFZXEM;3QWC2M'&S090R'!<#S''S<_E73+:R:?\ $2+2TU+49+/4=*GF
MFBFNW?;(DD8#H2<H<.W"X'3 &*Z.3PYH<T<L<FCV#QS.'D1K9"'8# )&.2!T
M-276GVJ!;V+3(+B]M(66U^55<<?<5C]T' 'I0!Q/AJ2\OTA\-7>H7S:CI%_+
M]OG^U2!Y8EYB)(.<2!X^.F%?'2N_@N[:YDFC@N(I7@?RY5C<,8VQG:V.AP0<
M'UK/T6RE26\U.[M8[:^OG4R1JP8HB+M12PX8CD_5B 2!FIM'TB#1K-X(F+R2
MRO<3RL/FEE<Y9C_(#L !VH X6PM MQ\1KAKRX=DGD4HT@VD&TC.2 .V<#Z5%
MIT4^D:7\/=0MM2OR]\;:TN(7N&:%XVMF8 1_=4@HN" #ZDUWTWA_1KB[N+N;
M2K*2XN4$<\KP*6E48PK''(X'!]!3CH>DFTM[0Z99FVMG#P1>0NR)AD J,84\
MGIZT <#H5QXC\4:(-3@N8K;4HM3<2M)?R!8E2<AH6@"[?]6,<\DD-G->FUFG
MP]HS:F=2.E61OB0QN/(7>2.A)QU'KUK2H **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"GJFJ6>BZ7<:
MEJ$PAM;=-\CGG ^G<D\ =R:RGUS6_P"SVU"/PX?LX0R>3+=A;DKC/W-I4'V+
MU0^)NFWVI>"YAI\#7,]K<0W?V9>LRQR!F4#N< \=\5KZ=XKT+5=,74+;5+7[
M.5RQ>55,?J'!.5([@T :T,GFPQR;&3>H;:W49'0T^N$M'L]:\4^*+37C&\<"
MPO9B5L*EJT0)EC/8[]^7'(( SP*Y[35NM0_X5W%KUS=-<727:3*\[H9XA&_E
MEP",DKM)[G/- 'KE%>,W=C:Q^"_'$T%U<^;H=_/_ &:PNG)M J1N G/ W,WX
M<5T>JC2[CXEV":E=A+6\T65C&]R4CF821X&,@'C)P.N* /0Z*\MMKB+0;"YL
MIC+-HM]K@M]*%S=LD0C,6YMTAR3%O5]HYW8'8YK(NYEB\$^+((M198;/7+=;
M0V\[JL:.;<L$RQRGSO@<CDD4 >TT5PD>GV>F?$V"QMBZVFI:1/)<0O,SK,ZR
MQ@,0Q.6P[<]35#PW9>=,W@Z[5Y'T74'GFF<DM-;GYX"6[EMX4^HB<&@#TJBB
MO-?$;7EEK.J:K]GL=9T^.Z@4Q^<T5Y9.!& D7!!!)#;1M)+D<T =AHFNR:MJ
M6LV4MF+=],N5MR5EWB3,:N#T&.&'%;5>7OI>GZM?_$22X9W>WG5XO+G9?*86
MD>'&TCY@1U]OK4JZS8ZS8>&]-U-H99[G0X[R2>\N62(E@@)"C[\F<]P1D\\T
M =CJ^NR:5K6BV'V,2Q:G<-!YWF[3&PC9_NXY&$/<4:+KLFJZIK5A+9BW?3+A
M("RR[Q)NC5P>@QPPXK@='U![K0_AC-=W9FG:]D#22MEFQ!.HR3SGH.:ZGPI+
M&_C/QL$=6(O[?@'_ *=8A_,&@#KZ*BN84N+:2*0$HZD$ D''U'->.:5:6FI?
M#'0;W2;^2;Q4H@%O+'=L\H?S '5E!^X%+;@1C&2>>: /:**\C\8ZQ:7<.LWU
MI*EKJ&EZE%#'*]RQN-RO$&V(,!(R">N0V6)'-;>M$^'O'#SQ1":'Q#9M;0(^
M61;Q3P/]E75B6Q_SS)- 'H-4[_5+/3/LHNY?+-U<+;0C:3OD;.!QTZ'D\<4F
MDZ;#H^E6VGP,[)!&$WN<LY'5B>Y)YKE?B/#:N?#$EY,\,"ZU$KN+AH@H,<G)
M*D8.0,'J.W6@#=TW79+[Q-K&C268B_LY('642[O-$N_'&!MQL]3UK:KSNRTC
M2=;\?^)K.Y9KBV2QL J"X;GY9<,2#EB!CDD]<U@:'KE[=V_@J#4KN";3[G3)
M@7OW)CGN5=0%<_Q,$!(#=3D]0* /8ZQ/%GB$^%O#\^L-:&ZAM]OF(L@5L%@H
MQD8/)'I3?"=C)I^CO VI17T?VF5H6B;<L,98D1 DDD)T^@QVK'^+<B1_#'6-
M[JN1$!DXS^]2@#4/B:6T\1:=HVIZ:UM+J2R?99HY1+&S(NYD;@%3CGI@XZUT
M-85[86-K)+XDNY;B]DLK>:2#)4^2A&6$84 9(&,G)QQGDUP^AWEM+XP\,W-E
M/##%JEA<&YA@NVF9P$1D,KY ,@R><9'/)H ]1GFCMK>2>9ML4:EW;T &2:H#
M65N++2[W3[2>]M=0:,K)& OEQNI82,&(.WIQUYZ5Y]X>T>RO?".O:FUQ>3W4
M,NIV\;?;)#MC\Q\*!N_V1SU/KCBH[9M/MO"7P]ELM0D8O?V4<N+UY%R8"60@
ML0!D+\O0>@H ]8JI:7DUQ=7D,EC/;I;R!(Y9"NV<%0=RX). 3CG'2N'LFTOQ
M!JGB6Q\2SHE]:7[+;K++Y;06^U?*>+)XSR=PZGKV%5+@HUI\4($N9F%NN^+]
M^Q,9^R*W!SD?-D_6@#TZBO,(;&RGC\(:AX>O7FU9IK<W4L-TTGF6VS][YHR1
MMP,#(&&V@8Z52N=9M+_4=$UG3Y8[6=]?%LX-TSW+Q&1T99%X")QPIS@;<$&@
M#URJ<NJ6<&JVVF22XO+F-Y8H]I.43 8YZ#&Y?SKS4Z98ZA9?$%YI[B5[&ZE>
MU/VN3,#"VC8,OS<'=GGVQ4\;VE]XN\%WNI7LBO<Z%(_F&\>(22Y@.!A@"3DY
M'?OG H [W1M7&LQW<T=O)%!!=26T<CD?OMAVLZX_AW!@/I6E7->+K2:32+*R
MTZYL[65KN,107((@N-H9O);;R%(4G\,8.<4SP1<O-9:E!)I<>G2VU\T,D5O-
MYL!;8A)B.!A>>F.&W"@#J**QO%>B'Q#X9OM.CE:&XDC)MYE8J8Y0/E.1[]?8
MD5QT6H76N^$[OQ-IMFT.HZ?I,EM;P*F"EV%/F +_ !;" J^Y<=Z /2J9--';
MP232MMCC4NS>@ R37F^DK#=6>EZY::]86D::?*;E[9S)+<@Q?>D!.2Z,-V3D
MY!'&34%K!>6*W.DZE86;3RZ).ZZEI5T_^D*NSYI5P&#DD$-N.<L/6@#TK3[Z
MWU33K74+1R]M=1+-$Y4C<C $'!Y'!%6*\>T^^AM-*\ VUO>0/I-W:%;PW5T\
MD!N1!'LC<DD+_'A.!D#C(%:EQ,_AUM+M[O6(6T"\UF47#P2$16J&(F.W+YX0
MR<]A@A>E '9V6NR77BO4]#DLUC^Q00SK,)=WF+(7 ^7 P1L/<]:VJ\_\*)I,
M'Q,\1QZ08A;M86; 1/E"VZ;.SG&.GW>,Y[YKT D 9)P!0!B>(?%%CX;;3A>!
MR+VZ6W!4<1AB!O;T4,4!/JPK;K@+_3Y_'$6NM UC)IT\;Z;!)*[$H$)WR+C@
M'S!^/E*:S6\8W5S\.-.NY[AHY[348+#79(G^:%4DV2MD<@-@'([-Q0!ZC17G
M7B-])\/P6EYI%Q'!IMYJ-K'JK6LWR1P'S,.2I^0,Q4,W&13M9BTO1]1T9--D
MBBT2^U)5U(02CR@?*;RE;'"JS[<]CP#UY /0Z*\N\06L]K<>-K32VFCTN/0O
MM'EP2,JP7F),!-I^4E0K%1[$CFK3ZM87?B?P ;/41,9$F$@BN"R$?96(W '&
M<],\_E0!Z/5-]4LX]7ATII?]-E@>X2/:>8U*J3GIU91^->53V%I/X)\=:@+F
MY>[TR_O7LYOM<A:W9%4KM.[CD?CTZ5NW L;CXG:'<WMV\9GT1VC;[6\2R2>;
M#A1A@#GNO0]P<4 >B5B^']=DUJ75HI;,6SZ=?-9MME\P/A$?=T&/O]/:MJO)
MTL]#U"?QVFH7;"[CU)V@CCN621&\B(*Z(I!+%A@<')&* /6*Q;[79++Q5I.C
M&S#QZC',ZW EP4,8!(*XYSN'?UKA-1O1=Z9_8VNF-=8M-"@FN)KJY92)F5N8
M47&Z3<IRP(YV@9JYI]^;S5?AG<7-R);F?2YW=V;+.Q@B))]R<T >DT5Y&^LV
MFH:GX>UO3Y8[6:?7#;N#=-)</$6D5EE'15R!A3G'RX(I7TVRO?#OQ!N'N+F2
M?3KRZ>T?[7)FW9+=&5E.[@[OY8H ];HKSFVU.VU;Q-:Z=XCFC>QN-$M[BSCG
M;$4\I)\UO1G'R<=0,D=35*(1S>)=7\/SW5F;&"PMETLWTYR83&0TL3=VWYRP
MYX7F@#U.JES>307UE;I8SS1W#,))T*[8 %R"V3GD\# /-1Z'#-;Z#I\-Q?"_
MF2WC5[L=)R%'S]3UZ]>]<[XFD6'Q[X,/GNAEN;E&3S2%91;2$97.#SCG% '8
MT5Y$^G6=WX7^(-TUQ<R7&FWMW):2?:Y"UNR0(RE3NXY'Z8KU#2+AKO1;&X=]
M[2V\;LP[DJ"30 MUJEG97UC93R[;B^=H[=-I.\JI=N1TP 3S5'1-=DU;4M9L
MI;,6[Z9<K;DK+O$F8U<'H,<,.*Y[QO#8MXQ\'R7]S);P&:Y1I!=/ H_<-CYE
M88)/?J>E9+:7IVJWOQ#>=Y'>WG5X2D[+Y;+:1X<;3]X$=?;ZT >HT5Y1I^L7
M.IZQH=MJT]G+:77AVWG@6_<B.><_ZUAV,@&WW )QU-=_X5M)K#PU96L^IKJ3
MQ*RBZ4Y#KN.T9R<X&%SGG% %C6-5BTFUBD90\T\R6]O&6V^9*YPHSS@=R>P!
MX/2K5F]S)9Q/>0QPW)4&2..3>JMW ; R/? KCOB/!;3CPRES)(BMKENGR3M'
MD$-G[I'/OU':H[..TOO%WB/2M< >"T@M_L,=Q(2%MO+^:123G=OW OG/ R>E
M '=T5Y#:K=7^F_#^+6KV\$MS<W,,C&X>-Y[<1S>66P1RRA/FZ\]<UL-H6E#X
MC0Z'(\[V$>@?\>TEW(5.V55!(W<G _KUYH ]&HKQO3UCC\#^&M=6]N7OX=;B
MM?M+W+L?(^UM%Y9R<;?+XQ^/7FO9* "LW6-672H;<*BRW5W,+>UA9]@DD(+8
M+8.!A6).#P.A/%<ZK1:E\0=<TS7$22WCL[>33X9ON-&0WFNHZ;@V 3U  Z9K
MDDCDO='\$QZM=7,B_P!O3Q6TK7+H\ML$G$;DA@22H3#=<'KR<@'KELTSVL+W
M,2Q3LBF2-'WJC8Y ; R >^!FI::B".-47.U0 ,DD_F>37G^JP:3+\59K35;H
M);7&BK)Y$MT421Q,P)QD9P ./;/:@#T*BO++*YCT?3(=*OC)-IU]K5Q'I9OK
MIHXA;+&2!(YR63(?8I^]\O..:@LM.N-6\">(H+&X,]SI.KS2Z<$=BNU-D@B&
M228V^9<$D8;Z4 >M45Q-BUCXATO4?%,>^.UNK$1VQ#F,A%4EFX(PVXE?I&.Q
MKE-.LK-=)^'%Z+NX6YU)8[>]D%V^9XS;,Q5OFZ;E7Z4 >PT5Y!J5[<^'K#Q=
M8:9/+%8V6KV>X>8S?9K:1(FFP<EE7ELXZ G&*N^)+)+?PWXHU.TU:RBMGT<L
MEGILY"B5=Q68$$8)!V\#G SG% 'J54]/U2SU6.>2RE\U()Y+>0[2,2(=K#GK
M@@C-<0;.UTKQAX/GLIID.IQ3Q73&X9A< 0[E+9."01P1TJQ\-(;&*WUA8;EW
MNTU6]62)[IW*+]H?!*,QP2,?-C)]30!W=07LTEM8SSPQ++)&A8(S[0V.V<''
MY5@_$"\U'3_ 6L76E&07D4&5:,?,J[AO8>X7<?PK)TZWMVOO[6L=5TQ+-]-D
M$EM9R%A<#Y2LK9/5>1NP2=V": .H\.ZO_;_AS3M7\CR!>VZ3B+=NV;AG&<#/
MY5IUX]I&I2QZ5\/+*:2U72;C265A=,1#+<!$VH_8G&\@'@GW K3E=M#NM"T_
M4-6BG\/WNHW8E>.0^3#E,PV[/G[H8N #@<*,8&* /0KW5+/3Y[*"YEV2WLWD
M6Z[2=[[2V..G"D\^E7*\S\2:5H%AJ7A8077D:<VL2ES%>M''$QMI. 58;>0.
M^>2.AQ51#-KDOBJPO-3LK&_MKYDM+FYF836D 53#)'DCY2.<@_,2V2: /4YV
ME2!VAC624*2J,VT$^A.#C\JS?#&M_P#"2>&=/UD6YMQ>1"41%]VS/;.!G\JY
M..^TZ_\ $GB+3/%5S&9K5HA9P2N8\PF)3YD0!R6+[^5R0<#TK4^%[*WPR\/[
M3D"U4=>AR: -3Q'KLF@0V$RV8N$N;Z"S;][L,?FN$#=#G&>G%;5<9\37AC\.
MV#7$_D0C6+$O+OV;%\]26W=L#)SVQ6?'X<L[KQ7?6>DSR_V-=Z4Z7IBN&=%N
M"X\MU))Q)MWDX.?ND]10!Z'17GW@L'6XM,AO8=MSX=62UN\ @/=*=@.>XVJ9
M/K(A[5Z#0!AZCXEM[;3=;N+)!=SZ.A:YA+&/!""3;N*GG:0>,]:TM,O/[1TJ
MSOC'Y?VF!)MF<[=R@XSWZUYGY>GV_P#PLPO=.MXIG*PR7;DE#9Q_-L+8/)(!
M(XZ#I5BWM+72I_A_J5G-*D]Z5M[F0SL1.AM7;# G!PRKCCC'% 'IU%>4>&3=
M^(-(L;JZU2QLM=M]3)NI7<_:5<3$- RDCY67Y0O3!! KU>@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "JC:5ISW8NWL+5KD'/G&%2_P#WUC-5?$NIW&B^&]1U6VBCE>RMY+@QR$@.
M$4L1D=#Q6$WBW4[)/#ES?Z?:O::U-%;@V\K;X'D0LN01AEX.3D8Z\T =5<6-
MG=O&]S:P3/$<QM)&&*'U&>E.DM+::599;>)Y%QM=D!(QR,&E6Y@:X:W6>,SJ
M,M&'&X#U(ZT&Y@$@C,T8D+;0N\9)QG&/7'- #$L;.-75+6!5<8<", ,/?UKG
M;GPY/<>.[74GLK&32H=/>T\MSE@[2(X8)MQ@;<=>]78/$3:IX<@UC1[03+-*
M$"74HA^02;&;//8$@=^*U[F[MK.,275Q% A.T-*X4$^F30 L]O!<Q&*>&.6,
MXRDBAA^1ICV%E*Q:2T@=FY):,$G]*ABN[E]6N8)((5LTA1XIQ."SDYW ICY0
M,#G/.:G6^M'E2);J!I)!N1!("6'J!W% #;BV40E[>UMWN(HR+<2#: <<#(!*
MCZ"JND6=S%]HO=02!+^[8&18&+K&JC"H&(!8#DY('+'BKSW,$<Z0//&LS\I&
M7 9OH.])-=VUN&,UQ%$%QN+N%QGIG/KB@":JQT^R-X+PV=N;H=)O*7?_ -]8
MS5>_UFVT_4-,LI5D:749FAAV $ JC.23G@84UHT 0)96L1<QVT*%P0Q6,#</
M?UI!8V@,1%K #"28\1CY">I'I4&F7EQ<:='/J,,%K<,[(8XYQ*H.XJN&P,D@
M#C'4XJU#<07*LT$T<JJ=I*,& /IQWH C_LZQX_T*WXY'[I>/TI\5I;02-)#;
MQ1NW5D0 G\14KNL:,[L%51DL3@ 4V&:*XB66&5)8VZ.C!@?Q% "3F06\GDHK
MR;3M5FV@GZX.*Y_P-X?E\.^%K"PO+>T2^@A6&66WY$F.AW$ G\:W;>\M;L.;
M:YAF"'#^7(&VGT..E)#?6EQ$\L%U!+''D.Z2!@N.N2.E "M96CR22/:PL\H
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MA77;G6X]7-VMLIL=1DM$: G:Z*B,&Y/?<:W+>ZM[N,R6T\4R X+1N&&?3(H
M6:"&X"B:*.0*P90Z@X(Z$9[TQ+*UB+F.VA0N"&*Q@;A[^M22RQP1-++(L<:C
M+,YP /<TV.Y@EMQ<1SQO"1D2*X*X^O2@".33;&:W6WELK=X5.Y8VB4J#Z@8Q
M5A5"J%4  #  [4R.>*8N(I4<H<,%8':<9Y]*2XN8+2$RW,\<,8X+R.% _$T
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M3I;B&" SS31QQ 9,CL H'U-4=1URSTU=/:0O*M_=):P&'# LX)!)S]W"DYH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV?:CPF20H!E=Q1VY Z>]:&NV>HZKXH\0QZ=!>0O>>'%M;:Y>WDC3SMTK;=Y
M .'7Z9]: .W@UK2[JZ%K;ZC:RW!!81I,I8@=2!GD#OZ40:UI5U!--;ZG9S10
M';*\<ZLL9]&(/!^M<9/!+K]AX/@LK"ZL[O3;VWGG$MNT7V:.-")$W$ '/W
M3G.>@S4=WX5NM1U_Q+X>DAEBT'4PNHFX7(7SF0QE ?7>BR_@,]: .UO-8L;5
MIK=M0L8KQ(C((IYU7:.S,,Y"YQS5:SUZS33+!]4U72DNKB 2DPW \J3"[F:,
ML<E, G/H*Q?#XU*X\-76JZ[931ZFUJ+-XA&6=A$"I(4 GYY"[#'52M<_IUG-
M_9OPTAN=)OBVGC%VKV,A\@BV9!N^7CYRO\_>@#T6RUG2]2L7OK'4;2YM$)#S
MPS*Z+CKE@<#%-MM>TB\N#;VVJ6<TX./*2=2V<9Z9STYKS[Q#8-$/B'YL%W;0
M3+:W,$L<!VS.B*3M)PK$L%4C.3R*U- U/2[[QI'?7[3Q:Y=V0M[>&73)[5"D
M99VVM*OS-\Q[\ =.I(!TFN>)+/0+G2X+HJ/[0N?LZLT@41X1G+'/;Y<?4BLB
MS\7Q6GB'Q!;:YJNG6UC:26ZVDKL(0PDCWX)9CN/T].E'C:W_ .)GX8OVL)[J
M"TU$M<&"V:9D1H9%!*J"2-S+VJMI=H)_%_C*2;3)Q%=0P)#)-:.JRJL6UE4D
M8(SQCO[T =?<:E8VD"3W%W!%%)RCM( 'XSQZ\<\5-;W$%W;QW%M-'-!(H9)(
MV#*P/<$<$5Y+H%MJNER^%;Z]CUFULX] 73Y#;V1DDMYU8$AXVC9@K *-P'51
MS7HWAC3+32=#CM[(W9@:228?:DV/EW+'Y<#:,DD# P#0!D>/O%J>'/#E]+9:
MGI\.JPH&C@N"&9_8+N!SCD=>G2NAU#6-,TB))-3U&ULU;[K7$RQ@^N,FO+KM
M=2/PKUCPQ<:'J<^N(9C(5M'=+@F8OYJR8VMD$' .[/;BNLUF_O)O$:VBV-\E
MA<:;E+BWL"[S2%B#"[.I6-0,'# 9W=1B@#7U3Q3I^E:IH]E-)'MU,R;)S*JH
MBHA?<23R#P!]:OS:QIMO=):S7]M'.[!%C>50Q8]!C/4]AWKS;2K&>STSX<W%
M[I%ZXLK>2VNU^Q.[PL8=JAEV[@-W&<8'K4ECH\DT.N^'O$#ZZGVK4Y9T^S6F
M^*X1I \;K*(VVD84'+#;M["@#U"21(HVDD=41069F.  .I)JI::OIM_))':7
M]M/)&H9UCE#%5/0D#L?6L;Q]8W^H>$IXM.B:>9)H9GMUZSQI(K.@^J@\=^G>
MJ-W%_;?C30M9L[>Y6UL;6Z^V/+;21ETD50L6UE!8[@6P <;?4C(!H>%->/B5
M)M3BOH&M&9TCLD4%X=LC*&=@<Y8+G&!CWQDS?\));W'B2_\ #T,L4-[;012+
M)*P8,TF_ "9!.-F3R.HK.^&MLUIX,MH)K&:TN5DF\U)K=HFYE<K]X#/!'YU%
M;1KIOQ,UNYN--N?*N[*U:WN(K-Y$)C\[S!N52 WS+P>3GC- $_@WQC:ZSH&C
MG4M2L$UJ^@\TVJRJKMDG[J$YQ@5T%QJ^FVERMM<7]M%.S*HC>4 Y/W1@]SV]
M:\TL=*N8?A5X5A_LB[2\LM2M)9X?LCB6/;,"[;=N?NYR1VJ:VTIYCXET'7VU
MU(]1U&:XC^RV>^.>%R"A$@B;:R@!2&8;=H[4 >C:K+<6^E74]H\2SQ1,Z&5"
MZY SR 0>WK7$1^,/$$7A'P]XCG73KB/4Y;9);.&W>.0><0!Y;&1LD9S@CD ]
M*[366\K0KW"2R'R&4+'&TCL2,#"J"3UKGO &DVZ>#]!DO--:+4K.TCA;[3;L
MDD3A #@,!CTR.OK0!T+ZYI,>I)IKZG9K?.<+;&=1(3C. N<YQ37\0:-%<_9G
MU:Q6X$RP&(W";O,;(5,9SN.#@=3@UYWK$FJZK 4ETS48IK/Q##+]FM]//E+"
MMP#YV_:3(Q7+$H>_( K>TJP@N/B1XDNKO2I622.S^S3SV;;&:,.6*LRXR#MY
MSV&.E %L>-+6_P!(UB:QN]-M+JQN)K:,ZC<A8BR-MWM@Y"DYQ6_=ZK8Z;:)<
MZA>VUM&P'SR2!5)QVSUKS6XL98_ 7CC24T:]%_-=7IA1+%R)5D<F/8P7##&.
MAX[XK=:ZN-,\<V^JW5C?RZ7=:2EM%+%:22-;2JY9E9%4LNX%><?P@=J .@AU
MV&[UF-+74](FT]K(W!"7 :<G*X< ''E[3R?4BG'Q9X<#6ZG7M,S<,5A_TM/W
MA!VD+SSR".._%84,:K\2M-N+73[N*Q71I8!)]CD1$9I8V522O!PK'!Z=#S7-
M:-%;:U\/]?\ #EOI<TM]=WE_&K/:.L)8SR!9#*5V?+P>N[Y< 9Q0!Z7?:YI.
MES1PW^IV=K+*0$2>=4+9.!@$^M-O/$&C:>\T=YJUC;O"@>59;A%**2 "03P,
MD?F*X#Q-'JL^G>)M -EJ$FS2UBM'MK'?]O(A.6>4J1D-P%!#>F216GID+2_$
M2PNY=/N_+30%@^T2V<BJLN\$J6*X!VY_E0!T&K^+--TK3M.OQ-%<6U_=PVT4
ML4R[/G;&_=G!4#)./2I;/4[N[UN]PL*Z+;P)LN2#F:4_,Q5LX**NWG'))YX-
M>?#3)[?PM:I)H]X4T_Q2]PT*V;LRVQN7;<BA<LNT@_*#Q7H6NQ6UYX2OX);:
MY>UGLW1H8(R)=C+@A5 R&P>F/PH MV6K:=J,DD=E?6]P\8#.L4@8@'H<#L<'
M![XIU]J%GIMOYU[=P6L9X#S.%&?Q-<OX436(=;GBN+Z74],6T41WEU8_9YU?
M<<1DX7>,9).!@_6DU"XN='^(XU&[L;ZYTVYTU;:":UMWG\B42,SJRH"5W I\
MV,?* >E %KP?XCDU?1M1O]0O+-XK;4+B!+F'"1-$C85LY(P1SG/>MR'5]-N+
M>>XAO[9X8#B9Q*,1G&?F/;CGFO+WTW6#X<N&@TS4+9K7Q6^H36T<'[Q[;S&(
M,8(*R$95L#(^7Z5MWW^BV>HZ_I,&JZC=W3V<5PUYI[ I&DG^L2'RT+L@8G@'
MD#TQ0!U-QXITF/P_J.LVM[;WMM81222_9IE?E%W;<YP&/H?45C7OBV3[=X7N
M+6[LUTS47D6[W$,8ML#R_?W8&-HSQ7/RZ9>7S?$ )9:C/_:6D1?9)+JT\LW#
MB*4< *H# L@P0&Z<<5<G5+R7P(\6D7P@MK@R7"OITJ^41;N@+ KQ\Y')^O3F
M@#N].U73]8MC<Z9?6UY &*F2WE6101U&0>M&I&^^PN--\D719 IF4LB@L Q(
M!!.%R<9&<5R5I-+H/BKQG?MI.H30/]EFB2UM68W!$85MG0,V2,C.>#Z5VX.5
M!P1D=#0!Q,&K^++KQ%KVCP76D&73+>"6)S8R#SFD5R%(\[Y>4QGGK4VG^+EL
M]<U^T\1:IIUI#974,-L[L( V^%9"/F8Y/S8Z]J;H7FCXF^)YWM+R.WN8+1(9
MI+618Y#&)-^&*XXW#OSGC-5;*R-QKOCYY=,N"MZ(UA>6T<"=%ME0A25^;Y@1
MCO0!V=UJ5C91)+=7<$,;C*,[@!N,\>O%303PW4$<]O*DL,BADDC8,K ]"".H
MKRK18-4TR^\-W]ZFLVUG_P ([!8.UO9&1[>X0@NKH8V8!N/F P2HYKT+PSIE
MII&@6]G9?:OLZL[I]J7;)\SLQRN!CEC@8&!CB@"PNN:2^I_V8FIV;7_/^C"=
M3)QU^7.>*@G\4^'K9]D^N:;&WF>5A[I =_\ =Z]>1Q[UP#RZKJI\/7-UIFI0
M7%IKOF7-K%IQ2&U3]Z-P;;N?(()925.[G&0*FO;)Y[3XEC^R+QWU!,6N;&3,
MY%LJ+M^7G$@/\_>@#T&WUG2[S4)]/MM1M)KV 9FMXYE:2/M\R@Y%#:UI:7JV
M;:C:BY9_+6(S+N+_ -W&?O>W6N.6SE37/ ES!I]S&D-E<6\SBU<>23&@4.,?
M*-P/7 XS62-,U"\^%)\(RV5TGB".01;VA?;YHFW_ &@2XVX_CW9SU'7B@#TE
M=6TUFN@NH6I-IC[2!,O[G.?O\_+T/7TJ)M?T9$@=M6L52X0R0L;A )% )++S
MR  3D>AKEHY9=(\=>)//TZ^F74K>V-J\-J\D<K(CJREP-J')'WB.M86DV5PN
MC_#6WNM)OM^GN3=J]C(?(Q Z@M\O'SE?YT =S?\ B[2+7PM?^(+6\@U"SLXW
M=C:S*X8J,[00<9Z?G6M97L%_:1W-O+'(C@',;A@#W&17F_B#1[NY7XD6MOI=
MP[7MK#):[;=MLSB##;#C!;.!QSFO0=+FBN]'BDM(9;9'3Y5FMVA93[HP!'/J
M* %.M:6MZMF=1M1<L_EK$9EW%_[H&>OMUK(;7_MOC*;0[:_M[5K%899D=0SW
M/F;SL7D8VA 2<$_,.F.>/&F7][\*H_";V5U'X@AD2+>T+[5E68-]H$N-I&,O
MN!R<D=>*Z/1;<)\2O$EP^GSI'-#:+!</:NJ.R"3S-KE<?Q#G/.>] '5W5[:V
M,8DNKB*%"=H,C 9/H/4U7DUO2HM.349-2M%LG^[<&91&WT;.#T-<MXKAO[;Q
MMHFKYU#^S([:>WDDL8!.\$CE"&*;&.TA2,@<>P-5F1M"DTQ--M]5>PO[VZN;
MJ^:P:2>"1P" L83]V'8MR4P,'US0!VT>J:?+IPU&.^MGL67<+E95,9'KNSC%
M<WK7BQ5_L6YT74K"XLKC54L;MEQ)M!5F/S!L*1@=1T/:N3L+/5=,L]/NWTO4
M9+33_$EY<75K]G)D,4AD$<JHHPX4L&^3/J*WO%36VJ)H4UGIE]-$=<AN+G_B
M73 [5C*EV4IG &P9(YQ[4 =AINL:9K,3RZ9J%K>QQML=K:99 I]#@\4V[US2
M;"=H+S4[.WE6,RM'+.JL$'5B">![UA:=;26WQ.UN?[)-';W>GVNV80MY<DB-
M+N^;&-P#+U.>E4/%5W:V'Q)\*W%U;3S(MI? >1;/.R',.&VH"V.V0.,T =;:
MZUI5[IK:C:ZE:36*YW7,<RM&,=<L#@5$GB30Y-/?4$UG3S9QOY;W'VE/+5O[
MI;. ?:N,NK._T9==UNPTMS#JFI6CBW%L97AB7:'N/)'._(+!<9^521G(J31]
M%&K:SXRM-0M]0-CJUO;JL]W;>491Y;*S#"J PRO! 88&1Q0!VKZQID<D,;ZC
M:*\Z&2)6F4&11R649Y'N*KQ^)] FN8+:+6].>>?/DQK=(6DP2#M&><$$<>A]
M*P?!/V^\L([_ %J%UN]-B?3 2N[S&C;;+*N.H<HG_?!]:Y0:8[?#:VM'T2]-
MT-?^TO"=/DW;/MA<N1MZ>4>OIQ[4 >HZ=K.EZNDKZ;J-I>+"VV0V\RR!#Z'!
MXID>O:1*91'JEFWE)YDF)U^5,XW'GIGC/2N#\5:/J6H:UXIATJUN(WU+P]%%
M#,(F1))5>7*%\8#;2!R1U%7["*SU+[)JDPU\WMA92QK;W.GF(1AU4,AVQ*'Y
M5<!2>F10!U4'B/0[J]BLK?6+"6ZF3S(H8[E&=UQG( .2,<_2H--\366IZ]JN
MD1LBSZ?*D1!D7,I,8<E1UP-P!]P:X:UTR>#X=>!4&DW27.GW]F]S&+1_,BVY
M$C%=N<<G)[YKH?#=N++QOXICETZ>)KFZCN+>?[,PB>/R(U.),;<[@V5SGVH
MZ>^U2PTT*;Z\@MPP)7S9 N0.IY[#(R>U<[=>*#8^-([>[U"QBT*326O5F?"@
M,)(U!,A;!!#<<#J.M0>*;69O$$=Y8:CJ6F:A%9[$FAL#=03H6),;+M/S J#P
M0<-5+28;Z3QOH%QJ>DO#+#H!AE:*V8P03L\9V*V"H^4,.O'3- ':#6-,.F+J
M8U&T-@PRMR)E\LCIPV<=:P?%7B5[;P7-KGAZ^LKA4DC42C$R,&D5& (; (W>
M_3I7-6,NHZ):RV\>DWD5N?$MVSS)I[RO;P.9"DD2!3G=G;N ( 8\<U3NK&_3
MP9XRM!INJ/<76MI/ C6;%Y4/D$N-B[?X')QZ<\F@#NAJNH+\13HSO";!M+-V
MBB,APXD5.6SR,$]AUJ/Q#KEUI'B7P_ ;BVBTV\DG6Z,JX*A(7<'>3@#Y1V_&
MJP:23XJ0W2VEY]E.C-#Y[6L@C#F57"EBN =HSS].O%1^-$V>(/"M]+87-U9V
M=W-)<&"V:?RP8F56*J"?O,O0>_:@#I+/7-)U"P>_L]3L[BSC)#SQ3JR*1U!8
M' J:SU&RU%9&L[J&X$;;'\IPVQNN#CH<5YGX@\/ZE+?7OB/3+6[CM)M2L+F2
MU@B GECA#[Y!$P^]EU(5AD^7TZ5V/AVTLI-4O]9MY]4FGNXHHI7O;8P!@F[;
MA3&F2-QR<>@H U]3U2RTRV+WFH6MEN!V/<N%7/KR1D#OS6+X.\12:KX+MM9U
M6YM5=Y9E:9,)&0LSHN,D]0H[FJ*W-UHWQ"U>:^TZ_N;748+=;&XM[9IE38&#
M1,5!V98[LMA>>3Q7*V6GZO:^%/"LWV#4K:/2]5NI;VV@MLS1J[S!'1&4APN\
M'Y0>#QR. #T#6/%VF:5H$FL)/%=P)/';_N95^^\BI@GMC=DCJ #6A/K>E6L"
M3SZE:1PNI97:90I4=2#GH.Y[5P?B#1;>?PQJVHZ?!JNH3W6H65S.+BT*R,(I
M(MQ2+8I^XO.%YQWJ5EGM/'&H7TXU>WTG4[&W2TDM-/,H39OW12(8F:,DMN (
M .3GGB@#M;K7]'L?^/O5K&#]UYV);A%^3^]R>GO45QXI\/VBLUQKFFQ*@4L7
MND&T-]W//?M7'MH-G9^)/!=E%IM]<Z986-S#YES:O((]XC$8<[< \-UZ8YQ5
M^*VAB^)6J7$FES_8AHT%LD@LG,9*O*612%P?E*\#KTH Z>/7M'FU"/3XM5LG
MO9$$B6ZW"F1E(R&"YR1CG/I56WUV%;C59+W4](6QM956-X[@;H@5&1,2<*V[
M.!Z5P.EZ9<VW@'P&ITB\CN=/U.%KF,6CB2%=L@=B-N<<C)Z5:U."YE@^)<<>
MF7[&_A"V@%E+^_;[*(_E^7GY^/UZ<T =]:Z]H]]?O8VFJ64]XB[V@BG5G4>I
M4'..13QJ^FF^%D+^V-TQ*B'S1N)') 'J!VKCKNRD74/ =S:Z?<1I;":.5DM'
M!MPUNR@.,94;]O7BLWPEI+2:+HVBZZVNQZCI=VLQA^R?N3*CDB03"/#(V22=
M^3D@\T =)X\\5Q^'/#6HSVFIZ?!JD$#210W#!BY S@+N!R>W\C739FDLP8W5
M)F3AF7< <=2,C/TR*\JNUU(?#7Q)X9N=$U*XUMC=L76T=X[K?(S+*LF-I."O
MRYW?+@#BO5+.02V4,@5U!0<2(48<=P0"* .7\'^,[35=!TG^U=4T^/6;V,M]
ME$JHS'<0-J$YZ"M]-=TB6.YDCU2R=+4XN&6X0B$_[9S\OXUYKHVD-JWPUL/#
M*Z3>6FJQ7$4LKW%D\0MRLP<RB1E )VCC:23G' SC=U'3+FW\<W>G6\+'3?$M
MN)+IUZ1/%A92?3S(V5<^O- '<P3PW4"3V\J30R#<DD;!E8>H(ZBN4\3^+4T_
M4='LM-U/3VN+C4X;6YMB0\OELV&( ;@COP>O:M_6K:ZN/#VHVNG.(;N2TDCM
MV!QL<H0I]L'%>>SW,U[X9\)6D7A[589]+U&R-W&]C(/LX3ABIQ\XXZIGCKC/
M(!W46L*-6U1)[_2Q96D<;82?]]"3NW&8'A1P,?0U9&N:0;:"Y&J61@G;9#+]
MH7;(WHIS@GV%<_I4;GXD^(I7L[E;:XL[2-)9+9UCD9#+O 8C!QO6JGA/1[VR
MO'T.[MI!IFAW3R6$SCY9DD&8@#W\M7D4^^WTH Z;1]2>_&H227>FSPPW3)$U
ME+OV(%4@2'L_)) XP16(WBQ;CQ]IFDZ?J>GW5E/;7$DZ0D/)&R;-N6#' .X]
MATZUS5Q9:I/H/BU;/3+UF?7DO1;-;O&;NV7R2ZKN !W!'&._3O6Q)>MJOQ \
M-ZI;Z5J4=FEI=PR3S6,D95V\K:K KE1P>2,=<$\T =!8^(+?[)=76HZKHX@6
M\>&&6WN1LV\;5<DX\S!Y J]9:WI6I7,]M8ZE:74]N<31PS*[1G_: /%>97]I
M<S^!?%MH-(U!Y;K73-##]AES+&9HVW ;>F%8_A[BNHU"SS\0=)NXK2XBLY='
MN;:2XB@91'N>(HK''R<!B,XQ0!T!\1:(MS]G;5[$3<_(;A03@X/?L>#Z5IUY
M!X<U'2C9>%AKCW<,&DL8+)Y=)F1'9@88R\V#'RI'0X+$'/%>OT %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%;R21I(Q "NZJ50Y(X8CJ/6@#6HKF+7Q386FDZKJFH:RMQ96U[)&TJ6;I]F
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MIMW)#O\ ,RK1H$_>$XP,EB,?2@#J**S[/6K"_O9;.&5UNHD61X9H7B?820&
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MND896=(P5"_+O)RV, G/'% '=T5D6?BC1K[3)=1@OE-M#+Y$A=&1TDR!L*,
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M[N?KQZ\5LT4 <%I5AJB>-;76I=)U(6_]D2V\CW5S&\OFF1&P5#E5!"G&WCU
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M110 4444 %%%% !1110 4444 %%%% %>]OK;3K.2[O)EA@C W.WN< >Y)(
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M97QMI#V6EWD7VEX-3G^S6["$C$V2#&V<;6RK#GT-3:CXLT[2TU22[CNUBTQ
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M^([C@ 8R 3QC!W/#6N_\)!I;W30>3)%/);R*K[T+(Q7<C8&Y3P0<=#7/Z?X
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MEQ&X<  G)P5;&:H:AX"N+Z'7[5=;,5GK%P+EU^RAI$<!!C?NY3"#"X!'KVH
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M.,J2 >O2NFH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HK)\1:VF@:6MT8O.DEGBMH8]VT-)(X1<G
ML,G)/H#65J6MZWH#*M^;"Z^VW5O9V#0Q/$!+(S!O,!=LA0 V1C/3CK0!U=%<
MK+K^J6/B5M"NDM)9;BQ>[L[B.-HU)0@.CJ68_P 0((/X5BV7C+Q+/IWAC4I+
M32C;Z\RPK$ID#P2-&SJQ;)#+A#E< ^] 'HE%</)XLUJST?Q8;F"PDU'P^OF;
MHPZQ3H8A*/E))4XX/)YI1XA\3KK6E:?)#I.-7M))K=U$G^C,@0L'&?W@P_&-
MO]: .WHK@XO'MS#I<*7UM"NIOK$FDDPJ[Q;DR3*%'S$;1G;G.3C/>FZEXSUS
M3]+UBX73XI?L$]LL-Q+;RP1W*3,J_*&Y#*3SR1TZ9Q0!WU%<BWB;4M(\17-A
MKB6;6HTV;4HY;0.&18F4.C!B=QPP(88SCH*CN/$VKV/AU/%5TED=(-D;N2TC
M1O/C!CW(!(6VL2=H/R#&?:@#LJJWFI6.GO EY>6]N]Q((H5ED"F5R0 J@]3D
MC@5RR>,+VVN;>6\MC-ITEG-<W$T%G-']D,:!\,S\,"-P!^7D=.>,KQ-=:MJ>
MF^%-2E^Q1V-UJ^GS?9@C&6+<X*_O-V&Z\C:/J>X!Z1116/KNI7%E]GAM;JRM
MYI]VPW$;RLQ&/E2)"&?J<D'C'0YH V**\_3XA3GPSHVJ7<,=A'>2SPW5TT$D
MT-N\3,G*KA@&*G!)&,<UV&AW_P#:FC6]Y]IM+GS02)[-LQ2 ,0"O)QTZ9.#D
M=J -"BN+U_Q=>Z1>+)"]A<6L=]#:7%M&DCRH)'5 QD!V(V6!V,.1WYJ;^V/$
ME[XFUW1[ :7']@2"2*>>.1LB0.=K*&&?NCD$8]#G@ ZZH+R]M=/M7NKVYAMK
M>,9>69PBK]2>!7#6_C?6KRR\/R16%E'<7^H3:==12,Q"2Q"7<R,.JYB].^*3
M5]:U=K+Q9X=UN&S>6/1);R"YLU94DC970AE8DJP(]3D4 =W'>6TJP,EQ$PN%
MWPX8?O%QG*^O!S4U<-:79@U'P';M8V<RW%DXCN)$S- 5MP3L/8,, _2M'3=:
MUCQ!;0ZKI/V%-.-XT)AGC9I9(DE,;N'#@*?E8A2K=!SSP =))#"[+)+'&S)R
M&902OX]JBL=1LM3A::PNX+J)7,9D@D#J&'49'&17*3^+KVVU_3(=]A=6-]?-
M8LMLDA:!L.5)ESL8_)RN 1GOBL+3-1U_1]"\5:GI<&GR6UCK&H7$L-P7WS*L
MA9@I'"' .,ALGTH ]'BU*QGOYK"&\MY+R%0TL"2 O&#T+*.1^-6J\]DUVVL?
M&6K>(9(W^SQ^%[>\*8^8J))FQ]>U:>E^)]3O-4TB-K3SK74(F:5H;29!9L$W
MC<[?*RGE<X7G'K@ '7U5L]2L=1,PLKRWN3 _ER^3('V-C.TXZ'VJU7G-A)K\
M.N>-Y-#33RT>HK(1=ASYA^S1'8-I&W_>.>O2@#T:BN-\/^,;O7M7T^%;6&*T
MO]%&I1Y)+HY9%VD]"/F/..>*QM?\1:OJ?PWU2Z00V]U#JWV%F@E=/E2Z6+(/
M)^;H1QP3]" >E,RHA=V"JHR23@ 57L=0LM3M_M%A=P74&XKYL$@=20<$9''!
MI]J;@VR&[$0G_C$1)7KV)YZ5YAI.K:]H'@W6=6T^WT^6QL-3U"::"8OYLT:W
M#E]K X0@9QD-G':@#U6JMYJ5EI[6ZWEW# UQ*L,(D<*9')P%7U)KC9_'=U=P
MZS-HUKYITR0Q);/:2R/=.J*[*&3A#\VT9#<C)&*$U+4&^)=S,\<4=C%HD$[Q
MS,V^-&DD+$+CA\J 1_LCGL #O**X:?QEJ5MX2L/%SP6K:5<-"\MJJMYT4,K!
M58/NPS#<I*[1W&>,FPNO^(;CQ9JNF6]OIBV>F26SS32,^]H9 6; '&\ ?3CO
MG@ [&BN$TSQQ?ZK;:-J5I8M-::C<+&]LEI-YD$3DA93+]P@<%A@  GGCGHO%
M>JW6A^%=3U:SCADFL[=YPDV=K!5)(X^E &S17$S>+-7T^;3;;4X+*.?5I3]D
M-NDDHAB6+>Y=1RS9P,+@<YSQ3HO&5^KK8W-AB\GU(6-G.T,D,,RF/S/-VO\
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MG,6/$Q&Q<8#,0 ?PZU;\)>+E\177E#4=/ED%OYDUFD+PW%L^5^5E=B6')&[
MY ]: .NHK#U76Y8/$&FZ%9B(7=['+.995++'''MS\H(+$EE &1W/;!Y^_P#&
M.LV>G>*(UM;234_#_ES281O+N('7>&4;LJP4-D9/*^_ !WE07-E:7JJMU;0S
MA>5$L8;'TS7-GQBB^)+?2V\H6L]D\B:AC$;3JJR%,9Z>6P?KTR,\&JR^+K^.
M[TO2[M(8-1O+)[Z5EM9)%A0,JJFQ3DL2W)R ,'KQ0!V:J%4*H 4#  ' %5K7
M4K&]N+BWM+RWGFMF"SI%(&,1.<!@.AX/!KE[#Q=J%XVGZ;+8?9=6O);I TT3
MK%Y<! ,P1L,5;<F%R/O'GCF/P@MZGCCQB-0>W>XWVF7MT9%8>4<':22#CMD_
M6@#MJK7VH66EVC75_=P6MNGWI9Y BC\3Q5FO);F?5;KX<_$)K]HGA$^H*O[Y
MW92O 49 &P <?R% 'K*LKH&4@JPR".XI:XZ/7]6TK6])LM3BL38:A;RM&8-_
MF0&*,.0Q)PX(SR O-5],\;:AJD&B:A;6+36FI3*DEO':2[[:-P=LAE^X0,+N
MX ^;@\<@'<UER^)-"AN3;2ZUIT<X;:8GND# ^F,YS6#\4-0N-/\ !;^1.]NE
MQ=06T]PAVF*)Y KL#VX.,^]=(-'TX:,=(2SA33S$8?(50%V$8QB@"\"" 0<@
MT5S$.KZAJ5YK%CH8LX5TEUMA]IC9_-E\L/@89=J@,HSSSGCCG)M?'&IZROA>
M32[2TB37(I]XNBS&"2)3N^[C<,CVSCMG@ [VBO.9_&GB6V\.ZSJLEII9_L*[
MD@O$7S/])5-I+1\_N_E8==W.>E;M_K.M_P#":#0;!=/$4NG-=I/.CDQD2*G(
M##<.3QQ]>.0#J:*XW3?%>HS:;J<6I#3K+4=.OQ92S,[>0^55E=5)W$D./DSG
M/>LZ?QUK%OX<UZZ^RV<E[H][';L3')$DR2",JP1CN0XD'!)Z=>: /0Z*Y:'6
M=;@\7)HFH+I^V\LI;JUF@5_W3(R*4<$_./G!R-N<'@54TKQ/K&IZ-"-EE%K/
M]IO87$'E.4BV$[S]_/W!O!Z'*CC.: .TJM?ZC9:7:-=:A>06ENOWI9Y BC\3
M5?7=0GTK0;Z_MK1[N>WA:1($!)<@=,#G\N:X+Q#XDA\1?#CQ=Y.JZ=?Q0Z>2
M!;1/#)&Q#9$D;L2.@P>._'% 'IH(90P.01D&EKE(=:UFR\4:5I>HPV+6FIPR
MM";?>)(&C4-AB3AP0>H"\]JK+XNO4\2:3:L]A=6.I3R6V;5)";=U1G'[W)23
M[A! "D'UQ0!T#>)-#6PFOVUBP%G#(8I+C[0GEJX&=I;.,X/2M2O)-64?\*W^
M)(QQ_:=T?_'8Z];H **Y/3/$&JZUI5GXALS8QZ/,6=X)(F:;R02-X<, #@9V
M[3Z9JE/XSU*V\(V/BYX+5M*N&B>6U"MYT<,K!58/NPS#<I*[1W&>,D [FBN(
ME\0^)I[WQ+;6,.E)_8SIM:82-YP,0DVX!&T\XW<_0U4GUO5=7\1>!KVP6.*#
M4-.GNS!).X4DQQ'# #!VA^#[GI0!WZ312M(L<B.T;;7"L"5.,X/H<$?G3Z\^
MF\17>D:5XWU&UTW38[K2KHLY1&47.(4?<Y');# ?A6JNN:[:^)M,TZ_AT]H-
M5AF: P;PT$D:AL.2<."#U 7Z4 =917"/XSU5?AY)XB%M9_:HKQ[=XCNV%5N3
M!D<YST-6M0\7W+:MK6G:8B"?2D3(DM99O/D9-X0;,;!@J,G/)Z<<@'8T53TR
M\EU#1[2]DM)+6:>!)6MI@5:)F4$HW&00>#Q7 >'O$FJ:;X:>XO%AGEOM<FL;
M7=,[$2/<N@W$C[B@'&.H4#B@#TNBN;BUR_L_&,&@:DMO*MY:O<6MS;QM'S&0
M'1E+-V8$$'U&*=XLUK4=$726L(;:;[7J$5FZ3[APYZ@CIT]#].U '145R$/B
M'6K#Q+<:-K$6G2!M/DO[6Y@+0IA&"LDFXMM^\IW9QCM4>F^)]3O/$DNC"2PN
M!-I[7MI=Q6\J1Y5U4J0S'>/G!#*1WXH [.BN-T7Q/JNLZ1I$B)9QZC<7,L-[
M 8F(MQ$6$G\>>" ,]RZ],UV5 !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 9FOZ%9^(]&FTR^\P12[6
M#Q-M>-E(964]B" :H77A5M3TG[%JNKW=VZ21S07&R.-X)(SE9%VKC=GKG(]N
MM=%10!B+X>\R[DO[J]DFU VQM8YQ&JB*,D%MJX(R2!DG/0=*SXO T$.EZ#IZ
M:I>^3HDJRVQ(CRQ560;_ )>1M9AQCK75T4 <U?>#;>^;Q#G4+N)-=B6*Y5 G
MR@1^7\F5XROKGK4O_"+*=4T:_;4KII-)A>&)=J;75PH;=\O7"KTQ7044 <G-
MX"LIH+I/MUY'++J9U6"9"@>VG/=/EP5QQA@>":M:IX6EUK0I-+U'6KR19)(Y
M&E2.)"-C!P  N -R@GK7144 8EYX:M[_ %JWU.XGE>2*RDLI(B%V31R%2VX8
MSD[1T(JG8^#([319-"GU2\O-%,#6Z6DZQG;$1@+O"AB .G.1@<FNGJM?:C9Z
M9 L]]<QV\32+$'D; +,<*/J2: ,O3?#LMG8'3[S5[O4;$0F 0W*1\QD8PS*H
M+''&>/?)K*3X?1KIUCI[Z]JDMKIUS%<6*.8_W)C.54G9EP.GS9X_.NRJM=:C
M9V,MM%=7,<,EU+Y,"NV#(^"=H]\ T 4=*LM0CU/4[Z^N9&6XD5+:VWY2*)!C
M..FYSEC[%1VJ/5/#BZAKECJ\.H75G=6L4D&80A$D;E2RD,IQR@Y&#6W10!S>
MF>$WT2SMK73=8NTCMWG(694D#B5_,(;@$D-G!SGDYS6KHVD6VAZ8EA:;O+5G
MD);&6=V+L3@ <LQ.  !VJ_5:VU&SO+BZM[:YCEFM'$<Z(V3&Q (!]."* .9F
M\ 6\T%];?VOJ"6ES?C41 OEXCF\P2$@[<L-PZ$D<_0C,T^-[[XI^)EM==EM6
MCM[-)(X1$WFX$F[[RD@J>..F[GM7H5% 'G?C*RL].N?!FE6-[_9@35&=)$92
MZ?N9<L=^<Y9L$G.2Q[FNFN/"\-UIVHP3WEP]UJ-O]FN;W"^88\,-JC&U0-S8
M '4D\GFMT$,,@@CIQ5'6=9L= TR74M2E:&TA&9)%B9]H]2%!./>@#+7PDBW6
M@W']I79;18VC@&U,2!EV'?\ +S\N!QCUI=*\*_V)>3G3M5NX-/FN&N6L=L;(
MKL<L%)7<JD\D9[G&*TSK5@-;31C*XOWA:=8S$P#(" 2&QM."P[]ZOT <?:?#
M^"TM=-M5UC4'M],O/M=G&WEXC/S_ "GY<L/G/)Y]".<V+?P5% VI0-JEY+IF
MHW$MS<6+B/8S2,2R[@N[8>F,_CR:ZBB@#G[CPC9W>M7VH7,\TL=[8C3YK0A1
M$8<L<# R#\[<YIECH>I:%I1M[/5KN_%M 8[.WNA&!P,('<*"0..>N/4UT=)D
M9(R,CDB@"EHUA-IFC6EE<7DU[/%&!+<S,2TK]68Y]\X'8<5D#PCLU74[N'6+
MZ*#5'\R[M5$>UCL"?*VW<ORJ <'/I@UTM)D9 R,GH* .?N_"<3ZK8:AIM_<:
M7+9VILE6V2,HT!*G9AU(&"HP154>!+,>&=0T(7][]GO+IKL2EE,D4AE$N02.
M1N ^]FNKHH BMHI(+:.*6X>XD5<-+(%#.?4A0!^0KF[/P3#:Q7=G)J=Y<:7=
M7$EQ+8RK'L+NY=AN"AMA8_=S['(R*V9]:L+;5K/2Y9F6[O59K=?+8K(%&6PV
M-O ]_3UK0H YU?"OV76;W4-,U6[L%OW$EU;QK&Z/( %WKN4[6( SV..E3IX<
MC7Q//KC7D[R3VJVCP,J&,QJ6('3.<N><UMUDW7B72K/4_P"S9IY!>[/,$"V\
MCLR=V "G(YQD4 9UKX*MK?3(=&:\GFT6"998;.0*<!6WJA?&616 ('7@ DCB
MKUCX>2Q\0:GJXO9Y7U$1B:%U38 @(7;@9Z$]2<U=TS5K#6;4W.G74=Q$KF-F
M0_=<=58=01Z'FKE '.Z%X5;P\B6ECJ]X-+B<M#9.L;",$D[ Y7=LR>!G/OBM
M#7M'CU_0KS29IY8(;N)H9'BQNVL,$#((Z>U:)(&,D#/ S5>'4;.YOKJRAN8Y
M+JTV?:(E;+1[QE=P[9 R* ,C4O"L6I6>F*U_=0WVF/YEI?1!!(AP5(((VD%3
M@C'-)J?A4:SID%O?:G=O=V]RMU;7L81'@E48!4!=N.2""#G)_#;NKJ"QM)KN
MZE6&W@1I)9'. B@9)/L!3H)XKFWCG@D62&50Z.IR&4C((_"@#G[_ ,*/J<5E
M+=:Q>'4K&8S6M]&D:-$2NUEVA=I4CJ"#GVJ35/#$FLZ5%8WVL7CE+F.Y,JI$
MI+1LK*,;<!<J#Z^]=!10!C:UX:L]=ETR6[>42Z?/YR/&0"X*E61O5&!Y'?%+
MJ?A]=3US2M4:]GADTUG>*.,+M8NI1MV03]T]B*V*KWM_::=93WEY<1PVT"EI
M9'. @'K0!A1>#;=-'U_3)-0NY8=;>9[AF"!D:5=K;,+QP!C.:YW4; /XLBM;
MK7I=*33+"..UFG2!ENMQ)9U$B%0R[%!V\\CH.OHJ.LD:NN=K $9&.*KZAJ%K
MI5C+>WLABMH5+22;2P11U)P#@#N>U &5X0GU:XT5WU>8W$@N95@N&A$330AB
M$=D& "1[#(P>]4+WP!;7L6L6YU;4(K/5+@74MO&8\++\N6#%=V/D7Y22*UK3
MQ3HM[=VUI#>@3W2%[=)(WC\Y0,DIN W<<\9XK8H PX_#AC\17&MC4KG[5/:)
M:,I1-@52S @;>N6)ZU-X;T*+PUH-MI$%S-<06P*QO/MW8SG!V@ ]3VK6HH Y
MZ7PHLFJZOJ U*Z235+=+:50J;41=VW;\N<_.W7/6F?\ "'0?V'H6EB_N@FBS
M12VTN$W-Y:%%#?+@C!YP!TK8U+5+72;0W-TTFW.%2*)I7<XSA44%F. 3P.@)
M[4ZTU*ROIKF&UN8Y9;5Q'.BGF-B P!'8X(H RQX9\Z:S-]?S7D-E<_:K=)$4
M,K\[<L!DA=W'3H,YK/D\!0-87=DFK7Z0R:A_:-N (S]FF\WS<KE?F&[LV>/S
MKI=0U"STJQEOK^XCMK6$9DED;"J,XY/U-6001D=* .5E\$13+K?F:M?N^M6J
MVMV[>7G"JRY7Y<*<,W;'M5@>%$^WZ'>'4KHOH\310KM3$@90IW_+UP .,5T5
M% ')3> K>XT/6M)DU6^,&KW+7-PP$896;&X+\N /E'KTK1NO#,%]K%MJ5S<S
M2R164ME)&0NR:.0J6W#'7Y1TQ6Y5:QU&SU.!I[&YCN(ED:(O&V0&4X8?4$4
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M,,I7;L*D8&,=ASFJ<OA2\L$UNZTG4[I]2U>..*2:=DQ$P79YPP!@JI)VCC(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS?[8+34IFGN8%NG"%F.YMHS\N6Y.* (%OM9TWQSIVFWE_%>6>IVUQ($%N(S
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M-W;FVDG;!9;EHQ*K$@=  4_WB1VH ]$HKATOM6M]4\-Z#?7TXEU**XNKF8A
MX*!2(%(  QOY(&?DZ\UD:WKVNZ99>+K.+5)@=(EM)+6[*(7*3$;HGRN#MYP>
M&P1DT >G,VU"V"<#. ,FL_1-;M-?L'O+,2B-9I(")4VL'1BK<?4&LF[U"\A^
M)6F:<MZYLKC3KB9[8JF Z/$%8'&[^)NIQ7,:/K4VD^'H(+=UB;4O%-W9&<@'
MR@T\S$C/&X[<#.1EAP>E '=IKMH_B.30@LPO$MOM1+1X0Q[MN0>_/\J+W7;3
M3]8TW2YUF\_46=(&6/*95&<@MVX4US&GVC67Q?GC;4+B[W:&& N"I:,>?T!
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M?A01R[<9QTXH ["BO,T\5:KI!$NM0:G'?>5<RQ%?+EL;[;&\B+&RG*':H(R
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K*7PWHRZ-#I T^$:?!(LL<&/E5E?>#_WUS6K10!2U+2+
M'5DA%[!O:"3S(9%=D>-NF592&4X)'!Z&H9/#^E2Z7=:;+9I+:W>?M"R,6,I(
M RS$[B< <DY&!Z"M.B@#$M?"6BV=S!<P6LBW,"-''.;F5I K8RI8L21P."3C
M%'_"(:"=)N-+?3UDL;B0S20R2.X,A.XL"22&SSD8.>:VZ* ,BQ\,:/IU]'>V
MMJT=U'$81,9G9F3.<,2QW\_WL]!Z"I[[1;#4;ZTO;J)WN+-BUNXE=?+)!!(
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M1M+6"PLH+.UC$=O!&L42#HJJ, ?D*FHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKVQ:QG)8- TBR%0&(!W+QR #^-)>W5S!]E-I9->"6=8Y2LJIY,9SF0YZ@8'
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MOF.,_-0!ZY1D9QGFN5^'VGZ=I_A6"+3]1M=0^9O-N+6?S4W;B0@;/100HZ<
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M3>I..><F@!_A;66\0^%]-UAX%@:\@68Q!MP3/;/>M>O%?#VFZ1J7@7PN^B-
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MMV.U9A,NPGT!SC- $5CI26FH7VH/(9KN\90SD8VQKG9&!Z#)/N68]\#0JO\
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MB.^%1;2*P;C*C<5'/?%:VB3V::CK^D^);9S?3ZI)+"98&87$!(,)1@.0H &
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M7P#X"NX[ 1WEK?60N)1"1+%\I$F\XR!CKGC%2V%F;ZVUCP_K]_=VE[+JTEP
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML?FA=-R8?!7+=\'VK8\=:9>:OX-O[+3X1-=-Y;QQ%@N_;(KD9/ )"GK7144
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MG(//(Z5CVWABXAUW4_%6KW%O)J,M@;...V0K'#""6/).68GG/'IBNN)"@DD
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M'2T4 <<O@^]3PKX;TD7T!FT2XMY1+Y1VS+$I4#&>"<^]=C110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 (0&4JP!!&"#WKS[P,
MZ:5X=\17-O#:JR:]>J3+((4"^?C+-C@*.?PP*[R[N5L[26X:.618UW%(8R[G
MZ*.2?85Q5AX+N+OPO+;SW+V-U-K,FL1?('\LF<R(KKG!XVY&>O?B@!DWQ O+
M?1?$MS]@LKFXT-4D)AN6$,\;IN#*VTG(P1CIQUK57Q#J]OXEL=+O]-M$CU*"
M62T>*Y9F5XP"5D!7 R&ZKG&#UZU5OO DU_;Z_%+K+,=<ACBN7:W&4V*5^3#
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M6B<;MI1FV\$''(!R#T%6+[PUJ&L^'+[1]7UOSEN8/)$MO:B(C_:8;FW'CH,
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M[I))/H!UR #=FU2PM]1M].FO($O;D$PVY<;W !)(7K@ 'GVJW7GHU"]U77?
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MYI0X<;3CC=S]*M6/B766UOP\MY'8FPUV!Y(HXD<2VS+&) &<MAP1D<*N#ZT
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M/;#-YGF\?)E@6YPQ;VK1M?"\%K=ZU<?;KR5M7Q]H5RF%(0("N%&,* .<UN9
M&3P/>L^XUS3[;5K#3)97^U7X8VP$3%'"J6/S@;>@SC.>E &5'X*MH(M 6#4]
M0BDT2)H+:53&6>(JJE'RF",(O( /'6NFHHH YN?P=;SSZ]*VI7X.MQ"&Y \O
M"J%*#9\G'RDCG/7UJ9_"MO);Z'$;V\W:-('MY,IN;"&/#_+@C:Q' %6M3\0Z
M9I%W;6M[-*D]T=L");R2>8>3A=JG)P"<=<4_3=<TW5IKF"SN=\]J0)X71HY(
M\\C<C ,,]CCF@#1KD6^']DT,UN-4U-;5[\:C' KQ[89O,\TD?)D@MV8L/2NN
MI&=44L[!5'4DX% '/Q^%$M-9O-1T[5;ZQ^W.);JWB\MHY9  -^'0E6( !P1G
MZT6GA1-.U6\O--U2^LX;V?[3<6<?EM$TIQN8;D++NQS@C\*USJ5FNJKI9N$%
M\T)N%@S\QC!"EOID@5:H YK_ (0RS6WU"QBN[J/2]0D>6XL5*["7_P!8%.-R
MJW.0#W.,9JXOAR"/Q.NNQW=RDJVHLQ;J$$0B#;L8VYZ^]7].U*SU>PBOM/N$
MN+67.R5#PV"0?U!%6J .5F\"V<DVK"+4M1M[+5=[7=E#(@B=W7#.,J64GJ0&
M )Z@CBI$\&00W.EW,&JZC#/I]H;$2(T>9H,J=CY3'\*\KM/O7344 <I:^ [.
MS@TB"'4M1$>DW$ES; M&?F?=G<2F2/G;\ZGU#P3IFJ3ZT]W)<R1ZQ'$EQ#N4
M*IC^XR$#<&!YZGGM70M+&N_<ZC8NYN?NCU/Y'\JAT_4+75;""^LI1-:SKOBD
M (#+V(SVH Q+GP@FHZ.VFZKK&HWRAD>&9S$DL#H<JZLB#Y@<<G/TY-:VFV-S
M9(PN=4NK]R  TZQKC'H$51^=7JQ9/%>CQ2R(;B5ECE\F2:.VE>)'S@J9 I0$
M'@\\'@T ;5<Q_P ('HX\,WV@H;A+6[N6NBZOB2-R^\%#CY=I  ] *Z>L_3M:
ML=4NKZVM))&FL9!%<*\3(48J& ^8#/!!R..: *VM>&[;6;&RLVN+BTALYXIX
MEMM@^:,AD^\IX! XIK>&T'B*;6H-2O;>XGMTMYXX_+*2!-VQB&0D$;VZ$#U%
M;=% '+Q>!K&'PK9>'EOKXVUE/'/!*6C\Q6C<.HSLP1N'<5TZ@A0"22!U/>J&
MF:W8ZQ)>QV4DC-93_9YP\31E'VAL88 ]&!STYK0H PV\/W N;MX-<U""WNI#
M(\""+"D@ [&*%E!QZ_3%5CX*L;>^M;W1[JYTF>WM5L_]%V%9(5.55E=6!().
M&Z\GDUJZ3K5CK<=S)8R2.MM<-;2^9$T9610"1A@#QD5H4 <_?^%(KS4;+5(M
M2OK75+2(P?;(C&6FC)R5=64J1GGH,'IBI+CPTMQJVFZH=4ODO;*)X3*OE_OX
MW*EE<;,=47[H4U<FUJQ@UNVT>221;VYC>2)/*;:RIC<=V-O&1QG/(IVK:O8Z
M%ITFH:E,8+2/&^78S!/<[0<#WZ4 8J^!=/.F7UE+>7LPNK[^T!*S()(+C=NW
MQE5&""!P<C\":N-X:CFEFN;J^N9[V2U-HMR516BC)RP4!=H)(&20>@]*T)-5
MLH4LWFG\H7D@BMQ(I0NY!8+@C(.%/7TILFL6,6I'3Y)76Y$1F(,3[0@ZMNQM
MQSZ^U &2/!EH-!T;21?7HBTB:*:UES'OS&I50WR8(P?3-=)56RU&SU&PM[ZT
MN(Y;6X4-%*#PX/3%0V6M6.H:E?Z?;22&YL"@N$>)DVE@2N"P&00"<C(H K:[
MX=CU]K(S7UW;BSN8[J-8-F#(A)4G<IR.>E)=>'FNGO)#K&I(]QY+(5D4BW:(
MY#1J5P-W\0((/I6U6?INM6.K3WL%G)(TEE+Y-PKQ-&4?:&QA@,\$'(XYH KQ
M^'XQ-/=3WES/?S6QMA=G:CQ1GG";0 O/.<9) SG QH6-J;'3[>T-Q/<&&-8_
M.G;=))@8W,>Y/4FK%% %'6=+36M'NM-EN)H(KJ)H9'AV[MC @@;@0.#Z5G77
MA2WO/!Q\,S7UX;,VXMC*#&)3&!C&=F.G?&:WZ* ,6Y\-P7=]I%Y-=W+3:6)!
M&?DQ*'4*P<;<'@=L5#H?A5?#Z);66K:A_9L3$PV+F-DC!.=H;9OVC/ W?IQ6
MAJ6M6.DW%C!>22(]].+>#$3,K2'HI8# Z'J1T-:% !7(CX?V:P"V75=36UCO
MQJ%O"'CVPR^89#CY,L-Q/#%O:NDEU*S@U&WT^6X1;NY1Y(8B>75,;B/IN%6J
M .<?P? \NO2'4K_.MH$N<>7\H";!L^3CY>.<^O6GIX3MD.@,+V\+Z(&6W<E,
MNI39A_EP?EXXP:Z"B@#F8_!-C%83Z6MU<_V--,96T\[?+&6WL@.-P0MD[<]R
M.G%3W'A:.7Q#-K%OJ5]:/<PI!=0P%-DZH6VYRI92-Q&5(-;]% '*6O@.SL[#
M0[*+4]1$.BR^=:Y,1.=K+\WR<C#,/QJY=^$;&]NM=FFGNMNM6JVMU$&4*%56
M4%?ER#AF[D>U;]('4N4# L "1GD9Z?RH J:58/IFFPV;WEQ>&)=HFN-F\@=,
M[54?I576-!@U>XL;OSI;:^L)&DMKF'&Y-PPRD$$%6'!!'IT(S4UYK=C8:I8:
M;<22+<W[,ENHB8JY52Q&X#:#A2<$UH4 <W?^#++4M+U6SN;JZ\S5@JWERA02
M.JC 4?*0J@= !W)ZDFM^WB:"W2)IGF*C'F.!N;ZX 'Z5%J6HVVDZ=/?WC.EM
M;H9)62-G*J.IPH)P/I4EI=17UE!=P,6AGC66,D8RK#(X^AH R]:\-P:O?6.H
M)=W-CJ-EN$%U;%=P5L;D8,"K*<#@CMQBH;WPL+ZXTR\?6-02_P!/:0QW2>5N
M82 !U92A3! '101BN@HH Y-OA_IIT]K5+W4$==0?4K>Y$BF6WG8DDJQ7D'<1
MAMV0>:MWGA5M1&G->ZWJ,TMA="[B?;"N7"E1D"/&,,W'O]*Z&B@#+@T."V\1
MWFMQSS^=>0QPRQ$KY>(]VTCC(/S-WJQJTT<&D7DLKJB+"^68X XJY10!P7P\
MT2.Y\#>'Y+S4;J^BAMH)$M)O+V6\JJ#CY5#':>@8G&!W -:$_@"RGAOK<ZIJ
M26EW>B_^SH\86.;S!(64[,D%E^ZQ(YX'3'6T4 <E=6FF^(_%VFS1/)++HC2_
M:) "J[CM C;@!CN4/QT\L>HK6O\ P_%J&OZ;K#WEU'-IPD$44>S8=X ;=E23
MD =Q5J]U6VL+BVMY!,\UPX5$AB:0@$@;FV@[5!(RQP!3-8UK3]!LOMFI3-!;
M!@ID$3N 2<#.T'&20.>YH QV\#64FBZWI4M_?R0:Q,\]PS-&&5VQN*$(,?='
M!S4TGA-5UE]6LM6O[*\GB2&Z>$1$7(3[K,K(1N .,@#BK(\5:.+J&WFN9;66
M=@D0N[:6 2,>BJ9% )]AS6S0!BIX<B3Q+'KIO[Q[A+3['Y;%-C1Y#'/RYR6&
M<Y_3BJ$G@:R?3)K)-0OXP^I'5(I5:/?#.9#)E<I@C)Z,#Q74T4 ,B0QPHC2-
M(RJ 7?&6]S@ 9^@K)U'P^=2:]1]2NTM+V+RI[91&5*XVG:2I(R.#S],'FMFB
M@#$L?#-MI^OS:O!<W(>6VCM?LYV>4L<>=@'RYXW'O6;;> +2R32_LFJZE!)I
MKSF"53$6V3,&D0Y0@@D<'&1ZUNV.M6.HZC?V%M)(;FP9%N$>)DVE@2N-P&<@
M9R,BM"@#E/\ A K(:=%8QZEJ*01:D=33YXV82^9YG)9"2 Q)YY]2:T[3P_%:
M>([W6Q>W4D]Y%'#)&^SR]J;MN %!XW-W[UL44 ,FB$\$D1) =2I(ZC(Q7/:/
MX.MM)M+.R?4+V^LK JUG;W1C*PE?NG*J"V.VXG'!Z@&K.G^+M U74_[.LM4@
MFNBI94&1Y@'4H2,.!_LDU<AUO2[G57TN"_@EOHXS*\$;AF100"3CIR1UH S=
M-\)IHUS+_9VJW]O82SM<&P7RS$KL=S!24+*I.3@-W.,5T--9U0 NP7) &3C)
M/04Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH C
MN)EMK:6=@2L:%R%ZD 9XKS'Q%=:AKOPZTKQ!+J1CCO+FPG:Q2-#$%:XC(4-C
M?N&1D[L'!X&>/4NM<L/A[X<%I)9BVN!9M*LR6PNY?*A<.'#1KNPAW#^''4CH
M2* ,^[U_6-3UWQ'IFF+=Q/I8CC@-ND+!Y7CWYD\P_=R0,#'0\\C%.)M7E^(]
MA>7KQ6ETOAP2W-ND0DVGS4,D8;=@_,#@C]>M=5<^%=-N-4_M(&[M[UHUBEFM
MKJ2(S(O0/M(W8[$\CUJ:;P[I\^KV>J%9TO+2+R4DCN'7='D':X!^<9 .&S0!
MRFA>(/$NO:9H.M6EO</'>S*UW PA$$=NQ()1L[]R\'DG.#QR,6?#TWB36-3U
M4RZZB6NGZG/:");1-TJ"-=I+=L,P/'7G/4 ;FF^%-,TB<O8?:X(?,,HM4NI!
M K$Y)$>< 9)..F>U2Z=X=L-*%]]C^TI]ME::<FX=BTC  L,G@X Z8Z4 <'8:
M_P"*9?#GA76WUJ)WU6\2SGMVM$\L!RX#C&&W#:.^#Z5J_P!K:W:1>,]/EU,7
M,NDVR75K=26Z!L/&[;750%(!3&<#@UMIX(T2+3-/TU(KE;33YQ<6J"ZD_=N.
MASNR<9/!XY-6;GPOI=W<:G/)',)-3A6"[V3NHD100!@'C@D9&#R: .<;5M<N
M+_P=:P:FL":MI\DER1;HQ#+$C;ESP#ESQTX'!Z51;Q?K.EV]SIUQ-]NNT\01
MZ3%=+$BN8WC67<5X3> 2HZ#.#CL>OB\)Z5#<Z7<(MSYFEQF*S)N9#Y:$ $8S
MSD #G/ %,NO!VAWBZBMQ:NZZA,MQ./.<?O5 "NN#\C *O*XZ4 85[XA\0:"E
M\]U;R/:2W%I;Z?<7HB#*\K['WB(C*KD,.!G.,]Z)[2ZM?BOH!N-4FO5?3[TH
MLT<:F,YAS@HJY!XZ@D8ZUT4GA?3;G2+G2[X7-]:W*A91=W+RD@<C!)^4@\Y&
M#GGK45KX/TFTO[._7[9)>VBLD5Q/>2R/L;&5)9CE?E'!X'/J: ,[XFACX%N=
MFW?]KL]N[IG[5%C-03R^(['Q;!HYUHW,.IV5Q+'*;6-6LY8RF",##(=X&&R?
M>NGUG1K'7]+ETW48FEM92K,JR,ARK!E.5((P0#P>U5XK"S\/VD]XJ7MW*D>&
MD9GN9W4<A1G+'Z#O[T <]X<UK5==L-$B:^DBU")YAJX$<?#1$HR8V_+E\;<?
MP[NIYK=\6:Y)X?T%KV%$:9YX;>/S,[%:214#-CL-V??&.*9X;TN&VFU/5ELV
MM9]6N!.\;C#!54(N1V) +$=BY!YK3U33++6=-GT[4;=+BTG7;)$W0CKVY!S@
M@CH10!Q][9W5K\4O#1N-4FO%>TOBB2QQJ8SB+."BC(/'!R1CK44>I>)+SPIX
MHEL+T-JFFZC<1VQ6!/WJ1A3L(P1DC//7)';BNAM?!VDVM[97J_;)+NR#+#<3
MWDLCA6QE268Y7@<'CKZFKND:%8Z(;LV2S+]KG:XF\R9I-TAZM\Q.">.GI0!D
MZ9J-QXBFMKO2]4E73O[/21F,<;;Y9 "N?EX*KRPX^\O3D'&T'Q7J.HZ'X,MI
M)4CO=<@EDEN5C4;!&FXA%QMW'(QD$  \&NNTW0-.TC3)-.T^$VUM([R$1N0=
MSDDX/4=<#T  '2L\^!M!_L2RTE;>=+:P?S+-DN9%EMV]4D#;AU/>@#!T6"]M
M/%WCA#J;W%PEM9LEQ)$FY?DE(#!0%/Y"H[77M=N],\ O%J$<+ZU%B[/V=2,_
M9VDRH[<C@=/KTKJ;;PCI-I/>SP)<I-?1+%=2?:I"TH4$ L2V2V"?FZ\TR'P;
MHT":2D4=RJ:3_P >0^U2?NOE*^O/RDCG/% '.OX@\0:59>+;7S3JMUI#P&WF
M-N!(8Y%5F+(F Q0%CP!G%:>C76KWGBF7[/JKWOA];:.43RVZ M*Q8&-64*"
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MZ]>?#^SO=0UB&?[=<:7(L0M HA+31Y (/S9)4\^AP #QV8\&Z,!J'[NYW:C
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MQI5_%/<Q16MGB\A\YB&N2<&-LGDH5?.>3N7M0!UTUW;6TL$4\\<<EP_EPH[
M&1L$X4=S@$_050TO7H-4U/5-/2WN(9]-E2*;S0N"64."I5CD;2#VZUSWC.UD
MNO%W@Q$OKBVW7LX!B"9!%M(<C<IY[>G/3/-9JZ;+>>(_'ACU6^M&@>W9&M9
MC;Q:H0S''/TZ>WH >D45YGI/B75M>U#0M/N%DD6Y\.P:C((;C[.TLSG#-N7!
MPN.@(^_SVKM?#UOJ\/AV&VUNY634%WHTT39)7<=A)P!NV[<\=<T :]%>3)>:
MO'\.4\3'7]1>^M=1>-0T@\MXQ>F(JZXPV5[]1QC%=7I]S<OXW\56$^I3BUAM
M;26$,RCR-_F[BO&!]T<G/2@#KJ*\LM-5U:]\$^ [LZU>1W&H7\<%S*A7,JLL
MA.<CK\HJ9X-2\WQGIZ^(M5$6D1I<63^<#(C-#OPS8RZ@C@'C!/7C !W$VO00
M>);70GM[@3W,$D\4N%\LJA4,,[LY^9>U:M>;L\^O^)/!$\UY+;RW>AW$TTEN
M0K$L+=B%/\.2>W/IBJ*ZYKNF:O%H!N[B]T^37'LXKV:4+*\8MQ)Y7F8Z^82N
M[K\I&<] #U:BO-_$?_"2Z-X3UJY.HRVJ+>6S:>?/\V6-'>-'1V(R1DL1SG!Z
M\5W.E:=)IEM+%)J%W?L\K2"2Z8%QG'RC  QG.!CC- %^LZZU=(-3AT^&VFNK
MAMK2K"5_<1L2!(^XCY<@],G@\<&O/Y-:U2Y^%;>,H+ZX368V:;R1(?*R)BI@
M,7W<8&SINSSG-;&F6TLOQ9UR8WMS'LT^R=H!LVG)F^4_+G Z\'.2>: .YHKD
M/%;W@\4^%K>VU*ZM(KRYFAG6)@ ZB"1AP1UR!62VHW7AG5/$5I<:OJ%SI,,%
MJ\4KE99X)Y7*>2K-U)^0C=]W<#TH ]%HKS[34U6Y\0>)?#PU*\MT^P07%L7N
MC-+:RN9!G?U_@4[22/P-3>%+^Y\26VCAKJZAGT^!UU1!.V3<AC'L;)Y^9)&^
M@4=#B@#NZ*\DFN]8B\(:CKB>(=1^V6&N26T(9U,9B%V(MKIC#?*>_3MBM75=
M4U/PIK'B&*UOKJ_CBT%M2BBNV\S9,KLN1P,*0 2O3CC% 'HU%<3I%OKM]+H]
M_#=RI87%JQOI'O/-,VY 4DC7!5#N],#!/' KG=-O=77P3X3\22:[?RWEQ>VL
M,Z.X,4L<DVQ@4QC.#G/7/MQ0!ZE'=VTUU/;13QO/!M,T:L"T>X97<.V0*FKS
MRRMKQ/%_CVYM=5DBN(EA,?G"/R@QMLJ7^7.U21WZ#G-7O"NHWBZ]_9FJV.J6
M.HFR\UH[B[%S!,%95:1'W':<L,KA>HXH [6BN&UR#4=2^(,>C0:[J%A:7&CR
MSLMLR@JZRQJ"I(..O\^F:SX+[Q'XE@\0-IKM#J-CJ<MK:.UT4BA$;#:'C .X
M,.22"3NXQ@8 /2:*\]N8M0U'Q-XOLVUW4K>&SL[:>W2WE">4[+*3@@9(RHX/
M7OGBJ^F:AJH7P'K,NKW<TFMA8[V!R/);=;-("J 84AE'(Z]\T >E54MM1AN[
MV]M(TG62T94D+Q,JL64,-K$8;@\XZ5P&I:Y<R7>EZOI=]??9Y-=2P=YI@L4Z
M&8QNB0C/ P0&.&^7/-2ZCJ.I0P_$98]5NE;38%EM&W+F$_9O,P.,8W4 >BU4
ML-1AU%;AH4G403O WFQ-'EE."1D<KZ$<&N+B?4-.U[P?+_;%]<+JZO%=Q3.&
MC;%NTBLJX^4AE'3KGG-9=]JNK1^!?$MS'K-VMS9:ZUM#.67<(_.C3:>.F&/3
M% 'J=%<4O]HZ1X_CT^WU.ZNX;[2KBX\F\D#*LT;QA2N -H.\Y X]JS="_MS7
M5\.WD&H:I;R;'_MIV8&)V"D8C# H?W@X,8QMSD]* /0;J[MK&W,]W/'!""%+
MR,%&20 ,GN20![FIJXWXG0M-X2C5;B2$'4;('8%YS<QCN#TZ_4=QQ2VDL^H^
M,M4T"]OKP0:?96\D!68Q23F0OND+1[<XVJH XZ\4 =>[%49@A<@$A5QD^PSQ
M6=H&N6_B+2AJ%M#-#&998MDX 8-&Y1LX)'53WK,\":CJ&H^'Y?[2E,\MK>W%
MHER5 -PD<C(KG'&2!V[BN&M;?4+7X;7^M:;K%[!?6E_>/:V\3#RG;[6X$;)C
MY]Y..>>1B@#U^BO.5O\ 7_$=UXIM;0R6]]87'V>RV7?E+ ?*5E=TQ\X9B3\P
M((& .M=/XEDO8? >IW!N&M[^#3I)O-MFQME6,M\I/;(_*@#?HKSN5-6L8?".
MJ6FM7]S=7UQ;0W-M+(&BFB=,R$)CY2J@MN'/'.<U#>:Y<RWVBZQI=]?&UNM;
M%BS3S 13QF1T94A&1A=N QVM\N><T =_::C#>75Y;QI.KVD@CD,D3*K$J&^4
MD888/455O=>@L-?TS2);>X,NH^9Y,RA3&"BEF#?-D' ]._UKC+_Q)J6AVWCR
MY6[DN#IUU;I;F?#"!9(XBQP,<*9&;\*LZG90VGQ(\&R)J-U<-,;MBDUQYBM^
MX/SJ/X>O\.%]J ._K-U[6[?P]I$VIW<4\EM#S*85#,H]<9&><=,GFK\<T4N_
MRY$?8Q1MK [6'4'T-9/BD@>'Y2>GFP_^C4H N6VJVM]H\>J6#&\MI8A+$8<9
M=3Z9(Y]C3M+U"/5=,MM0ACECAN(UEC$H 8J1D' )QD8-<1)_Q;?6G;[OA+4Y
M>?[NFW+'K[1.?P5O0&G:3J$T]YX2T!Y98+&;0?M1:)S&T\BB)0@88( #%C@C
M/';J =U=W=M86S7%W/'! I :21@J@DX')]20/J:FKR3Q%-J,_A[Q/I%Q?W$E
MKIVM6,5M<-M9F222!S&S,#N*%^O7IDGG/0ZY>7/A;Q1HUS<7]]=V%W#/;&*2
M7&^Z"[XN% 7<P5T QC..,\T =U6?'K-FZZ@\CO;Q6#E)Y;A#$@PH8L&; *X/
M4<5QVC7VJZC>'PWJE[*-7L-0>6YEMW:/S+4CS$(P>A+K'Z@ XY%9VN7%Y<^#
M/B7;SZC<2K:22QPERI*I]FC;9TQ@EF]^>M '=W'B&VM]=TS2C#.SZE'));SJ
M%,9"+N;)W9Z$=N_UK7KSS4].D'B?P39G4KMBT5YF?*"3;Y2<*0H ^N,^^>:C
MM[G7TM-?TFPO9;^:PUB.*!;FY$<TT!BCE>(2X^]@OACSCOWH ]!N;NVLHUDN
MIXX49UC5I&"@LQPJC/<D@ 5-7D^KW;:KHMO:EM7TZXMO$MC%-;7DB2O"S-$0
M%D._<O.X'/?D8XK6\67\XM-<@T_5-2-[HNGB9YQ.D,<4FUG4M@?O&8 97;MQ
MCH30!Z%17 ?:-1U;Q9H=K)JUY;V]_H;W4\5NX0;PT(RIQE?OGG.?2J5GXCU*
MRT^#3I]1E=6\32:0;Z;!D6$!F4$XP7. FXCOZT =O%KT$GB>;03;W"7,5J+O
MS&"^6\9;:,$,3G(/! Z5:TS48=6T^.]MTG2*0L L\31N,,0<JP!'(KC=/L8K
M7XM:A;0WUU)NT.,GS9S*\.9FX#-D^^#GKZ5DV^JZO<>!_"EU_;5VES<ZV+6:
M8%294,\BX.1Z* .WL: /4Z*\^>?6M'UGQ3I6FZC-=O%H\=]9"_E#^5,QE4C<
M<?+\BG!.!["K&B1:EJ>M:9J-C?ZM%I#6(DNTNCD33Y4H%#@D C?N*87[N#0!
MW-%<_P")+Z-;K3=*$MY]IOGD\N&TD$9D5%RQ:3(*J,J?EY/ YYKB4U?6G\(6
MI_MFX2X@\3+IOGHZN9(?M(3#,5^;"\9P,]Z /5J*X>"VO8?&FI^'EUG4'M;G
M25NXWEFW26\ID9"R-P0. =O3CT.*A\*7UYKMKI%G/=W*7^E-*FKE9VR\J$H%
M;GD.P,@] N!@'% '3:MXDL=*T74-5^:\@T_<+E;5D9HRHRP.6 R!U&<UJPRB
M>".500'4, >HR,UY-]DDB^'?Q%F>_N)A]HU-#&X3;D?Q<*#NX]<>U="JWND^
M*O"\<>KWLT.JPS1W,,SAH\I#O5D7'R$$=NHZYH [#3]1AU*&66%)T6*9X6$T
M31DLIP2 1R/0]#5NO++G5=77P+JERFLW:W5MXC:SCFRI8Q?;%B"GCIM/;%;B
M-J>D^.KC3+34KF\CN='EO(XKV0.%G215!!P-JG=R!QQQB@#MZ*\[T$:SK;^'
M;ZVU#58$-NQUEY&!CE<*,",,"G+YYC&-O?I7HE !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 CL51F"EB!G:O4^PKBO /A:/3=.>
MXU'15M=4-W<2L[E'+!Y79&^5B,[2HSU[5VU% %$:-IXU8ZH+5!?E=AGYW%?[
MN?3GITID6@:3 ;S980_Z;G[4"NX39&#O!^]QQSVK1HH S[/0].L%(MK8(3'Y
M08NS,J?W 2257V&!3]-TFPT>!H-/M8[:%F+%(^%R223CW))I[ZC:1ZG#IKS@
M7DT3S1Q8.2BD!CZ<%A^=6J *-QHVFW6J6^ISV4,E[;J5BG9?F49SC/UY^M10
M^'])M[HW$5C&CF4S;1G8)#U<)]T-_M 9JQ9WS7=Q>1&SN8!;2^6'F0!9OE!W
M)@G*\XSQR#5N@""]LK74;*:SO8([BVF4I)%(N58'L15*#PWH]K<6UQ!I\,<U
MJAC@=0<QJ>H'L>_KWK4K'\4Z]_PC/AZZU<VCW26P#/&CA3C.,Y/U% #Y?#>B
MSP7D$VF6TD-[)YMS&R961_[Y'][ISUX'I5K3]+LM+B,5E;K$K'+$9);ZD\G\
M:MUCZ3KW]J:QK&G-:/!)IDL<;,SAA)O0.",=."* (M.T%DU+4M3U/[//=W\2
M6\B1H?+$*;MJX;.2=[9_ 8XYDMO">@60@%KI5O"8 PB:-=K(& # $<X( 'X5
MLT4 92>&M%327TI=-@&GNX<VVWY-P;=G'^\,_7FBX\-:+=:C'J%QIL$MW&@C
M69URVT= ?7';.<5JU4:^9=6CL/L=R5>%I?M(0>4I! V$YSN.<@8Z T 46\)>
M'VMK2V;2;4PV;%K9"G$6>H7T!QR.AIS^%M#>$0MID'E"<W(C PHE)SO Z!L\
MY]:UZ* ,#7+.35C'H3Z6TNF2B-Y[J1T,>U7W&/:3N+':O.,8;.<C%;]5;+4;
M343<BTG64VL[6\V ?DD4 E?PR.E6J ,Z;0=+N-334I;.-[V/A)SG>H] >PX'
M%(= THW[WILT,[N)&))*EQC#%<[=PP.<9XJY=W4%C9SW=U((K>"-I99&Z*JC
M))^@%9%QXECAUO0[".V>6'5UD:*Y# !0L9?E3SR,?G0!NTC$JA8*6(&<#J:6
MB@#B/ GA>/3[6XNM2T46NIO?7$^^0HQ97E9D;Y6(R%(&>HZ5T-WX8T.^O9[R
MZTJUFN+B+R9I'C!,B8(PWKP2/IQ6M10!SM_IQU">UT0Z05TFVDBN#<2,A0^6
M=RHBY+9W*N<@#;GGFM74-(T_5?(^WVJ3^0XDBWY^1QT8>A'KU%7:* ,^/0],
MBO+N[2SC%Q=KLN).<RKZ-Z@9./3-5Y?"NA3V=I:R:9 8;/\ X]@ 08.V$(Y4
M8[ U>T_4;35;3[58SB:#>\>]00"R,58<^A!'X5:H S#X>T@S6DWV"$26>?LS
M 8,6<Y*^A.3D]\\T]]"TN62_>2P@9M079=[ER)QM"X8=#P /I6A10!6L;"TT
MRSCL[*!(+>,82-!@"LP>#?#:F<KHMDOGN)) (@ 6#!L^QW 'CN!6Y10!D7'A
M;0KRZFNKG2K6:>:'R)7=,F1,;<-Z\$C)YQ4K^'M(DN+*X?3X&FL5VVTC+EHA
MQP#Z<#\JO3N\4#O'$975250$#<?3)K.\-ZVGB/PY8ZQ' T"7<0D6-CDJ#ZF@
M @\,Z+;:@]]!IMO'</)YK,JX!?\ O[>F[WQFK&J:/IVMVJVVIV<-W KAU25<
M@, 0&'H1D\U=HH S'ACT'2F&E:2]P58?Z/;LBN^2 6+.P!('.2<\4:#I:Z7I
MS*88HKBYFDNK@1]/-D8LW/?&<9[@"HO$VO?\(WHYU$VCW,:RQQLJ.%*[W5 >
M?=A6M(S+&S(F]@"0N<9/I0!3U/1].UF.*/4K*&Z6&02QB5<[&'&1^!(_&FV^
MAZ9:W%W/!9Q)+=C%PPZRC&/F]>./IQ4/AG7%\2:##JBVS6PE>5/*=@Q4I(R'
MD?[N?QK6H QI?">@S6MI;/I<'E6?_'L%!!A'HA'*CV!Q6G#:6]O:"U@A6* *
M5"(-H /7I4U% &4GAK14TJ72UTV 6$K;WM]OR%MV[./7=S]:+CPUHUWJ$%_<
M:=!+=PH(TF=<MM!R 3W //.>:U:* ,=?"NAK;6MLNFPK!:/YEO&,A86_O*,_
M*?<>I]:G30=+CN+V=;*(2WR[+I^\PQC#>O''L*T:* ,:?PGH-S!:0S:7;LEF
MNVVX(,(]$/51TX'I5J[T32[[3!IMUI]O+9+@K T8VJ1T('8CU%7ZJV>HVE_+
M=QVLZRO:3>1. #\DFT-M_)AT]: *;^&=%ET\V$FG0R6I<2-&^6#L,8+9Y8C
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MT#S3"=V$>#Y@.[</0YYR._-2/X9T60WI?3XF-\,76<_OQTP_/S<<<]N*UJ*
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MZM-/LH[B>XCL[=9K@ 32+$ TH'3<<9/XTEEIEAIJLMC8VUJ&QN$$2IG'K@4
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MD1Z<VGII=BMBQRUL+=!&3[KC% &/H@;P_%>KJFIVP@N+\)9P"<R>075<0AF
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M$5YX5D6\"W$B8M4F9PT2MDD;%7>J9)'Z5)K%AX5MO$?A"6*.R&C227RJZD&
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M5F_A:W) E'H3*H_[]K6OX=O#K?@+4-=UNW2&2^A(ECG PHC3RR#GMYBR,/\
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M620.21M"G Y/ % &YO7<%W#)Z#/6D9T0J&=5+' !.,FO%;2PTB+X1V6M6\$
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MF2!,27,IFF<G)=B .3[   =@!5@@'&0#CGFJ]EJ-CJ4;26%[;W4:MM9H)5<
M^A(/6F:MJ4.CZ/>ZG<*[0V<#SR*F-Q55+$#..>* +E%48=7LI-*@U"6XA@@E
M16W2R* I89P3G&>:LVUU;WENMQ:SQ3PO]V2)PRM]".* ):,#.<5SWBO6+[1H
M])EL_LY2YU.VM)UEC+'9)(%)4AA@@9Z@UKV>IZ?J(D-C?6UT(CMD,$JOL/H<
M'@T 6J*K6NHV-\TBV=[;W#1XWB&57*YZ9P>*EGGAM86FN)8XHEY9Y&"J/J30
M!)5:ST^VL//^SIM:XF:>5B<EW;N3]  /0 #M4<6LZ7<7BVD.I6<ERR"184G4
MN5(R&"@YQCG-.;5-/34%L'OK5;UAE;<S*)"/4+G- %NBL^RO;BXU;4;=VLC;
MP&,0^3-NEY!W>8N/EY''7/-8FK^*OLWBC0],T^]TZ=;N[:WNX0=\T6(W<'AO
MEY3'(H VM6AU2XA2'39[>W$A*SRR*Q=$(ZQ@<;OKQ5VW@BM;:*W@0)%$@1%'
M15 P!^5252?5+$W9L(]0M!?$$+ 95+YQG[F03ZT 7:*Y;PIXJ74]*A;5[RPA
MU&:ZN((X4<1^8(YGC!5&8D_=]ZWKO5-/L)HH;R^M;>68XB2:94+GT4$\_A0!
M;P,Y[T8&<XYKG9M7U%/'T.B!K;['-IDMTC&)MZR*\:<G=@CYR<8'UI_@[6+W
M7-#>[OQ +A+RYMSY"%5(CE9 <$D]%]: -X  D@#)ZFEQSFH9KNWMFC6>XBB,
MC;4$CA=Q]!GJ:99:E8ZE&\EC>V]TB-M9H)5<*?0D'K0!9HJI;:II][.\%K?6
ML\J#+1Q3*S*.F2 >*JZ)KUKKT=V]L&3[-=36K*Y&28W*%@ 3P2#B@#5HQ7/>
M+M8O]$LK"YLOLY$NH6UK*LT9;*2RJA*D,,$9[YK7L]3L-0,HLKZVN3"VV00R
MJ^P^AP>#0!:HJK:ZE8WTDD=I>V]P\>-ZQ2JY7/3(!XJ>::*WA::>5(HE&6=V
M"@?4F@!]%48M:TJ>[CM8=3LY+F1!(D*3J79",A@ <D$<YI\FJ:?%?I827]JE
MY(,I;M,HD8>RYR: +>!G/>C SG'-9UI>W$^L:A;.UD;>!8_*\J;=+D@[O,7'
MR\CCGGFL77?%7V+7]$T_3[W3YC=7XM+NWSOFC!1WW##?+]S'(/6@#JL $G R
M:" 1@@'ZTM5AJ%D8I91>6YCA;;*PE7"'T8YX/(ZT 6<9ZT54EU73H5#2W]K&
MK1^:"TR@%,9W=>F.]26]Y:WEJMU:W,,]NPRLT4@9"/4$<4 -OH[B2PFCM#&L
M[J51I,[5)XR<=<=<=^F1UJ'1M*@T30['2;<EH;.!($+=6"@#)]SC-8EEXH-_
MX^.D6EYI]WIO]G-<[[<[G202(FUF#$="3T!Y%= FI6$EXUHE[;-<J"6A652X
M ZY7.: +1&1@T54BU33IIT@BO[629]VR-)E+-M^]@9YQGGTI]]=QZ?I]S>S!
MC%;Q-*X7J0H)./RH L4A4,,$ CWKD;WQ9.8?"M]8FW6RUBYCBG29<O$KPO+]
MX-@$;<'(/6NFL]1L=1@,]C>V]S"I*F2"574$=1D'% %FBJUIJ-C?F06=Y;W'
MED!_)E5]N>F<'BK!(4$D@ <DF@!:*R[K5H9])OI](OK.>>WB9LAA*JL!D!@K
M \X]14&@ZZMYX.TC6=4FMK9[NSAGE8L$0,Z!B!D].3WH VZ*KF_LUL?MQNX!
M:;=_V@R#R]OKNSC%9<_BS2H[G28H+F.ZCU.9X89[>5'C4HC.26!]%QQGDT ;
ME& :SK*^GN=4U&%VLC;0&/R3#/ODY4[O,7'R\@XY.14UOJNG7CR);7]K.T:[
MI%BF5B@]3@\"@!=3AFN=+NH+<1^=+$R+YC$*"1C)(!_E5/PQIMQHWA?3-+NF
MB:6RMH[8O$25<(H4-R!C..E6%UK2GGA@74[(S3Y\F,3KNDP2#M&><$$<>E7J
M "BJDVJ:?;WL5E-?6L=W+_JX'F4._P!%)R:+C5-/M;E+:XO[6&>0@)%),JLV
M>!@$Y.: +=%%96F:_:ZK?ZI9PADDTZY^S2;R/G;8KDJ >F' _.@#5  & ,"D
MVC=NP,^M5;75-/OI7BM+ZUN)$&72*97*CU(!XJW0 $ ]:*YJ#Q6FJ^&DU72O
MLL;O.8UCU"<1 *LI1B2,X)"L0/I6Q=:OIEB7%WJ-I;F,!G\V=4V@G )R>.2*
M +O7K151=5TYKJ*U6_M3<S)YD<(F7>Z?W@,Y(]Z6?4K&VN8[:>]MHIY" D4D
MJJS$], G)H M48HJI/JFGVUY%9SWUK%=3?ZN&295=_HI.3^% %N@ #H*I7.L
MZ79B0W6I6<'E$"3S9U79GIG)XS@_E4\EW;16INI+B)+<+O,K. FWUSTQ0!-1
M7,>&O$4VMZ]K]K]HLKFSL9(1;3VHX=7CWG)W,"03C(QTZ5N:GJ$.DZ3>:C<!
MC#:0//(%ZE54L<>_% %NBL71]4=]'&I:IJ%B(IRLD90>6L*LH(C9BQW,"3SQ
MGT%7QJFGFQ%\+^U-H>D_G+Y?_?6<4 6Z*I_VOIA+#^T;3*RF%AYZ\2#JIY^]
MR..O-1?\)!HIM%N_[7L/LSR>6LWVE-A?^Z#G&?:@#1HHJO=WUI81B2\NH+:,
MG ::0("?J: +%%8NN^(8-*TFVO(9(I/MEQ#;6\FX-'NE<*&)!Y49W'!Y ZUH
MZ>+@6$/VNXAN9]OSS0Q[$?W"Y./S- %FBLAM=AD\0W.@Q'R[V*T2Y$L@!3YV
M95&,@DY0DCCMS6=X0\51ZUH&FS:E=V,6JWBNWV:-PA8!V7*H26QA?>@#J**J
MSZE8VMQ';W%[;0S2$!(Y)55FSP, G)JU0 4$ ]:Y)=:URY\:ZGH-O)IT<=I:
MQ7*2R6[L6$C, I D'3;U[^@J?PYXMCU/PVVJ:M]FTTPW,MK,SS 0EXW*%E9L
M94D<4 =,0#UI" <9 ..1FJYU&R$,$QO+<13D"%_-7$A/3:<\YR.E9TWBG3(]
M3TJSCF2<:EYQBN(I%:("(#=EL^IQQWSZ4 ;6,]:*SM-O9[NYU!9FLC%#/LA-
MO-O;9M!_>#'RMG/'IBJE]XBM&TV^?2-2TFXO;9?N2WBK&C>CE<E>_:@#<J&[
MM(+ZSGM+J)9;>>-HY8V'#*1@@_A4,VJZ?:L4NKZTAD6/S65YE&%'5N3TYZTZ
M+4[">P-_#?6TEF 3]H253'@=3N!Q0 :?:-96$%K).]R85V"60?,P'3/J<8R>
MYYJ)M*CDUQ-4F<R20PF&W0CY8@Q!=AZLV%&>P&!U.7)K&F2V/VZ/4;1[3.//
M6=3'G_>SBGV^I6%W<36]M>VTT\!Q-%'*K-&?1@#D?C0!:HKEAXN?5/#L%]H5
MKYMW=79M889_X=LK([OM/"A4=NO. .IK>N=4T^RF2&[O[6"63&Q)9E5FR<#
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M2W$JQ[-P10H.,G!P/6M&@#S2^M[^XUCX@IHL,T-Y=Z9;K:2K$T8EE5)=VUR
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M5E0 C\P:S;VUN-:\61QRK?VEGI\)>">,!1+,^58@\_=3@>OF-Z4 7?"6N_\
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M/J/V"TL[:46\]LX:)F:7=M0+D@A5Y&?K0!W-%8H\5Z.;'2;T7$AM]6=([-Q
MY$C/]T$X^7/^UBLK3-4DL_%WB\:CJ+_V=91VLR>>P"0*R.S8Z8''Z4 =<Z+(
MC(ZAE88*D9!'I0B+&BHBA44855& !Z"LN#Q%I\U\UF[RV\X@-RJW,31;H@<%
MQN[#(R.HR,@9KF?$7B7S=:\+QZ;<W\4=UJ2(S"!E@N(BCDX<K@\A<<\CD9%
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MS#S1/'^]+^7MPP!^]P?3!H W**S7UVPCO+VUD>5'LH1/.QA?:J'.#NQ@_=/
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M$J5)&2IQD>W%<]>SW]R][87OA@ZA;ER+>0O"870@??#-N'.0?E/'3/2NBHH
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M7/(.<$]*U]?_ .1<U3_KTE_] -:-5K^S34=/GLY'D2.=#&YC(#;3P0,@]N*
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M'W<<UU6IZ<;[P]>:9$8X3/:O;H0N%3<A4<>@STH QM'\5F?1=$^U6MRVJ:A
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M-I)>6PBU&"4)$09T4Y <,5(R 2I!R.Q!KNM3E\C2KJ4K.P6)B?LY D QU7)
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MXIM^;[VS.WG&<50T+Q+X5B_M:_L=;N#;V\,;7%I=-/N@(+?,$E^8;MRC ')
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **.@R:S-.\0Z3J]]<V>
MGWL=S-;(CR^5DJ ^=I#=#G:>A/2@#3HK,MO$.DWNKOI5K?13WL<1F>./+!5#
M;3\PXSGC&<UIT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7'Z'
MM_X6?XM QQ::>/TFKL*R[3P[IMEJT^J013+>W  FD:YE;S  0H(+$$#)QQQG
MB@##7:/C$X  QX?7C_MX-=A66/#NFKKAUD13?V@4\LS?:9?N9W;,;L;<\[<8
MK4H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
-HHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>ameh-nonqualifieddeferre012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9QGFEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]E\ZYEBC*)D*%55!)(554 9)[GO0!X/JUCX?N-(^)D@CLVFBO4?3]K#CD<Q
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M*>XM&>Z\D,/)\B3>/EP,!0IZD]^/?::44L&*@L.AQR* %+!$+.P"J,DG@"O
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M20.@X!KBKK^SXO#GQ)LT>S-MY"36L4,7E1>8UO\ ?B0DXRV.1U/(ZU[1UHH
M\L\1Z+X>L?">BZA##"+275K&>]N/,+(PW!7=SG';!)J^7L8/B85T8VJSOX<<
M0!"H#/YBE![G: ?H/2O1** /-_"<GA+5= TJ74_L!U^U@/VU;O:+D3>6R3>8
M&^8@Y8\\=/:N>C?2A\,OA[=WSPK%;ZC!'-,S8,0VR;@S#E1TS^M>T8&<XYK
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M-5O!T5GJUOX9F_MJRAU>P -S;1VY2\=_+*RQS9<L<M\Q)7D@&O4J3 SG')H
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MO7$.NG7UMX-N/#?DC48[N'[1Y6!(MOL/VA9N^/7=_%CO7IM(% )( !/4XZT
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MNKO4[>*.>.&ZLS>+$9(XI9PN>,C=W"].<4MM?JNC6]]J$UK#NA22:1)@85)
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M>0ZE8W$RPP7MM+*REU1)59BH.TD 'H#P3ZTZ:_L[:>.">[@BFD^Y&\@5F[<
MG)KC/AEI5A;Z#]I_LY;?45N;M6>2 I((WN'91R =I4(0.E:'CNQG.FVFNV,+
M2ZAHEP+R)$&6DCQMEC'^]&6X]0* .B74+)FG5;RW)M_]<!*O[O\ WN>.G>DC
MU.PFM'NXKZV>VC)#S+*I1<=<MG KA/%%AJ":%IVK0P7 :76(=0U)(8?,D6$
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MO#MBUPESK5C&ULP693,"8R<\,!TZ'Z5K0S17$$<\$B2Q2*'1T8%64\@@CJ*
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MT5FZ?X@T?5KF>VT_4K:YG@YECCD!*CUQZ>_2G6VN:9>7:VMO>Q23.I>-0?\
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MY&T[,R(!G#LN=RANA(P<@'(P?2@#0HK*?Q+HL=\+)]3MUG.["E^,J"6&[ID
M$D9R,&FVGBK0+Z1H[36;&9D@:X;RYE(6(-M+D] N>,T :]%8UUXHTJWT_4+M
M;J-S8P&>6)FV-MP2IPV.&Q@'H:S[7Q;;:M::#<V.J:3$U\Z>?;23B20YCW&-
M-I'S@E<Y'3/% '16]G;VKSO#$J-/)YLK#J[8 R3] !] !4]9UYKVE:?(Z7=]
M#"8R!(6/RQYZ;ST7/;.,U'>>)=$T^XDM[O5;.*>./S7B:4;U7( )7KSD8]<T
M :M%5K#4+/5+**]L+F*YM91E)8G#*W;@CWK)?Q;I\7C/_A&Y9K>.;[*LX=YU
M!9V<J(PO4M@9_$<4 ;]%9O\ ;^D_:X[7[?#YLDABCRWRO(.J!NA88/R@YX-:
M5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 CL$1
MG.<*,G )/Y#K7EL>GZDOP\M5_LN]:YLM?%]);>21(T7VQI<J#C<=AS@?3K7J
M=% '$V<]Q-\1I]8?3+^"PDT9(8Y9+9LLRRNQ!4 E3@]" ?S%<[9:7=P^ O!-
ME+H]V+FPU6*>YA^R.3"JLY9CQ_M#IUSQG!KUBB@#S[4[2>WU#XA3R6LJ6]YI
M4;13&,[)"D$@;GID94<_TJ+3[3_A*?"WA.TMM.N;0:=+9W4DUQ 8A&(E!Q&?
MXBV,97(P3D]CW.L:>=6T>\T[SC"+J%H6D5<E588./?!-+I-B=+TBTL#,9A;1
M+"LA7!95&!D>N * *7BNTAOO#=U:W$-W+#(8PPL\^<@\Q?G7 )ROWL8/W:XG
M5-+\17?A7Q':F6[U>#9;-927-HL%U+LDWNA&%W  #!(&23UKT^B@#B!=7%_\
M0M*U==*U&'3TTRYA,LULRL'9XF *XW#A#U'/Y9YY]+NW^'$U@VCW9NVUXW7D
MFT?)C^V>;NZ?\\_\.O%>L44 <I!;S+\4+B_%K,MI<Z/#$)_*8*9%ED8J3C@A
M2.N*K?$J18=)T:5[=[A4UNS8PQIN9\/T [GVKM*QO$.@G7DL$^V-;"SNX[Q=
MJ!MSQG*@Y[9Z_P Q0!SNK6=_J&IW7BC2M,8S6^C3VMO!=Q&-[N1R&"LC8.P;
M>C8R6].3%HT5_<>/-*U6XMM5,+:1-;R3WEN(\2F2)@NU0-H^5L9'XGC/H S@
M9ZU'/&\MO+''*T,CH5610"4)'! /''7F@#A_#6DW-GX@OM"DAQI&EWC7UFW\
M)\X%ECQZ(S2G_OV:I7=E<2Q?$@#3+MFU./;:?Z*_[_%JL8 X_O@]?KTYKO-+
MTXZ=;,CW,MU<2OYDUQ*%#2-@#)"@ 8    Z 5=H X$V%T=1\"SQ65Q&EK:3V
M\[B!@;<M"B@,,9 W#Z<9Z<U0\):+*NC:/H>O0:T+S2KE9 @B7[.7C8E95E"C
M*GK@MGD@@UZ;10!YF-+N[KP1X_M5TNX%S?W-Y+;1O;LK3JZ 1D9')R.G4>U:
MMNEU#X[TC4&TZ\>VFT;[(95A/[N7S%8A\X*\ \GTKMZ* .9\>6.H7_A=ETV
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M:U9HFE65W(R1CHPYZ>]=Q10!R/BRU=;SPK'96,S06>J)-(+>!BL40BD3/RC
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M>F44 <7?13>)-:\,7UM97EG_ &;.]S<M<6[1F-3$RF(9'S$L1]W(PI.>F9/
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M'Z]"#573-*U6WN[*+1+K4XK*629KFQU*T^2Q+(YW13%%8D.P  +9#'M7I%%
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MC.LN-I!52PP<DG&.M>GT44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]NDQ91%'NP"$P#N"G/<YK6L](U0OXV$NGO$-5=GM"TD9W_Z.L6#AC@Y7OV-
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M110 4444 %%%% !1110 4444 ( %&%  ]!2T44 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;@2(J8,?W&*,"<@8'/)[5Z_I5JEEH]E:1M,T<%O'&K3_ .L(50 6Z?-QS[T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:_\ %F@:9/-!>:M:Q30*&EC,F60'N0.>Q_*G0^*=!N+^WLH-6M)+BY7? B2
M^8,;OE/0G'..N.: ->BLZYUW2[2X\B>\C1PZQ,3G:CMC:K-T4G(P"03D>M03
M>*] M[_[!+J]FMV)H[<P^:"WF.2%7 [G!XH V**R+KQ3H5C,([O5+:#]X8O,
ME?;'O'5-Y^7<,?=SGVJ6Z\0:39#-Q?PJ@579P<JBM]UF8<*#V)(!H TJ*QKS
MQ9H%A+<17.KVB2VX!FC\S+)G.,@<]C^1JVVLZ:NG1:A]M@:TF ,4J/N$F1D;
M<?>)]!0!>HK'M_%>AW4EK%#J,32W3,D$>"&D9?O  C.1W';O5ZVU*SO+FYMK
M>=9)K5@DZ#K&Q&0#^'/TH M45E7OB71=.NY+2[U*WBN8XO-:(M\P3(&<=>I'
MYTZU\0Z/>Z6NI6NHV\UFS;%E1\@OG&W'7=GC;U]J -.BLE_$VB1V4EY+J=O%
M!'+Y,AE;84D_N%3@AN1P1GFH5\9>&FC#C7+':TS0*?.'S.HRP'K@>E &Y16
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M6SNY8!&EPKLZ(0/,P.BDG_Z] '045DR:D1XIM].34;$*;9Y)+,Y-P2"N&'.
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M;60#< P?.<=5P<<5SMQX>OK;18E?3YY5N_%2ZK]E2,OY%OYH8[@,@' W;?\
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M\9 QGG&IXDT%?$FD'3I+J6VB:6.5FB4%B4=74<_[2BM5 P10S;F &6QC)]:
M.9\7:?'?7.F,TFJVDT!D>&_TU#(T+8 VL@5LJP)ZC^'WK \C7[27PIJNJ6=Q
M?/975X+AK6V E\N0,(Y&C7H2-I8#H37H]% 'F[VNI2Z=\0P^DWD<NJ*QLXC'
MN,N;58QR,C.X8//'ZU96SG.N^!)AIER(["UFCN'-NP$!:)44'CCE2..@YZ<U
MW]% '+>#;2XL;GQ)'<6LL FUB:XB+(0LD;*F&!Z')#?Y-9M_?II_Q?61K&ZN
M2^AJ@:VA\PI^_;KCD ^O3UKNZQAH&/%S>(/MDAD:T%IY&U=FP,6'/7.X]: .
M4&FZSX?"S6UE,L&IZU->W:V<2336D;1E4"@Y&25&X@'&YL>M+I/A>;4O#7B[
M1K^VN;1K_49IX'GY8;E0QR;AP2'7/!ZCZ5Z'5'5;";4;9(8=1N;$;\R/;A-S
MK@@KE@<9SU&",#!H YSP]+?:CX5FU[4[1TU&]LUB,*+O(55(  '4,Y=A[,/2
ML*STV[B\/_#JWDTJZ$VES1M>+]G8^3M@="3QS\Y7IGUKTN&*.WACAB0)'&H5
M%4<* , "GT >6^(- UFZNO%OV&SN,OJ=A?P*H"BZ2)(MZJQ^7=E3P>I%7-<T
MU-5\-^(+VULM;GU6[TE["/[9!L8YW%4"@#HQ)W8QSUKT:B@#B[RSG?7/!%Y#
M83B"T$R3D0D& -!L (QD#=@?AGI5GP9#=V5QK]G=V%S 6U6YN8Y74>7)'(^5
M*G//'Y8YKJZ* .3U&*X/Q*TF\2SN'M8=/N89)EB)57=HBHS]$;GH.]97A72]
M1T[4M*BTZ?4_[&2%_M%AJEN/]"^7Y4BE*JQPW&,L-H//3/H-% '*^-X+IQX?
MN[:SGNULM7CN)T@7<XC\N12P'?!9:JZ8MWHVO^)/[0TZ[N(-3F2ZMI(H3+O'
ME*AA;&0I4KCYL*0>O6NTHH P/!&C77A[P5I6E7KAKFV@"R8;(4DD[0>X&<?A
M7&V6CWFH>!=8\)2Z/=6]Y>W5RWG30@0A))V=9=_0D*5X^]D 8'6O4:* /,H-
M#N;:]\3:-K$&LW%CJMV\T3VB*\=Q$Z*NQFQE&&W;DE1C&#79^(]+N;_P9J>E
M:=(8[F:QD@@9FZ,4(&3_ %K:HH \YO+C4=4M?">WPYJ%H--U&%[M'B'[H+$Z
MG8%)WKDCD<8Q4$&AW"3^)=$UNVUF>TU._FN(C:(K0W$4F"%+XRC+C:=Q4<#!
MKTVB@#S[4M(U*;7?&%C;VMP@UC2HH+2\ S&K+'*I#-G(.67WYS4OANS6X719
MM3L=;CU#282!'<1 1P-Y>QMK* ) 1D#!;MP*[RB@#SO0].GMOA=JMG)I5Q'J
M+K?A8C;G>YFDD*8XYR"F?3 SC%+%97 O_AZYTRY"Z=;R)<L;=O\ 1R8/+ /'
M]X8X^O3FO0Z* /+M7TK4O^$6\=6$6F73SW^JF:U1(B1*I6+Y@>G5'Z_U%=$D
M<LWQ2CU$65R+0Z/]G6X>!E D,N_;R./E_#MUXKKZ* /)(M%UFS;3+U++4$AT
M[6]1EFAMD'F^5.S^7+&&!#  \@9.&/%:NIZ/- EEKNDZ?J=WLUA+Z^MYP$FN
M%$)BWJAQRN5(4@$E<^AKT:B@#C---Y=?$F;59-+N[:RGTB*"*2:/!+K+(Q#
M?=.#T/\ 7%2^-(+@ZEX9OHM.N+V"PU!I[A;>/>R+Y3H&"]\,RGCGCCI7744
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MP:''I-[:1S1"2)T((D7+A64G(/S ]#[4 =?'XITN:"*2%[B5I(C-Y*6TAE5
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M,;QO*T@9P6#AANY 4].#6,=(\47XT:;4M-N9+ZRUD7-S*;U/*>(&3:88P^W
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MCC$DS2 GSV&XQ@#CY5*Y()Y8"LZ]L]1_X6+8:I%ITLMC!IL]N\JR1CYW>-@
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MN+-)8EFMV$A=7Y<(P.X@@-Z'FI8;/4].\:7.N)ID\UGJ5E##)"CQ^;:R1LY
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M ,@@4,P'3."156V\56TVNC2;BQOK*:2%Y[>2ZC54GC0@,5(8D8W D,%.#TH
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MK+N# EP",<X'S<].N*NH>-"-8\++IL4MSI^K0RW#&. LS((PR;>F.3DCK]*
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M+N.4#Y7YN1M(/:EC\4V=Q;:4]M!<3SZI:_:[:V4*)/+VJQ+98*,;U'7J>,T
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M0F6"*\DA41K(S%%5ANW#)XS@KR.: .NHKE]*\2W-[XXUS1Y+>4VUGY"PNL)
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MCJ8VW8).#GGOBN\!!S@@XZTM '('0M976O%5XL=D8M5MHH;8&=@5*(RY?Y.
M=V>,]*JV_AG7(;;P3$4L2=! %R1<-\^(&A^3Y/\ :SSCTKN:* ."U;P?K%]8
M^,+6%[)?[8NH9[9WD;Y=JQ*0X"\?ZLGC/6MR#2K[5-8T[5]8@M[673TE$,%O
M,907D 5F+%5Z $ 8[Y)[5T-% 'FUIX2\41>%M!T-X]+5=%OK>83"Y<_:8XGW
M=-GR'&/[W/I72V>DZG#X]U#698[465S9PVR[9F,BF-I&R1MQSOQU[5TE% '
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% '.^/-2N]'\":W?V.\74-I(T;IC,9Q][GTZ_A69_;1\,I
MI-A:>%C')JLL@6&&6-<RB,MEB."6"#+9]SS6YXKT:;Q%X8U#1X+A+=KR%H3*
MZ%]H(P3@$9/XU3U'0-2O]2\/WOVRU1]*D>1E\IB)2T;1\?-\HPV>_- #K7Q)
M>W\\ME:Z4G]HVMM%->P376Q8'D4D1!PK;FP#DX Z<\U03Q^ES9Z)<6.DSS_V
MK<26@C:54:"9 Y9&^AC;D?7FM Z!>6/BB^UK2[B ?VC%&EW!<*<;XP0DBD?[
M)P5[X'(K/3P1+:)H*65]$!IM[)?3-+$2;B602!^A^4?O&(ZXP!0!#)X\U"*Q
MUB9_#;^=HCG^T(Q>+A4""3=&V/G.PYP0M=E!<+<V<=S""R2QB1 >,@C(KF&\
M)7DJ>+DEOX-NOH57;"?W!\D0C^+YN #VKH=,M9K'1[6SDD22:"%8MZJ0K%1@
M'&>.E ''67BJ'1_"LFH6VCW31_VO)9RPM=^8ZR-<>62"W;>> .U:?_"8RV>H
M:E9ZOI,EI)9V#:DAAF$PEA4D-T PX('R\CGK6>W@?4V\.RZ5_:EKF35O[3\W
M[.W!\_SMF-WJ,9ST[5K:AX?U"X\1-K-I?PP3'2I+ *T);:[-N$@Y&0"!Q^M
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M18VN89T8A)D7:)$(/(( RIQTZBJ5GX(?3+SPVUC>QBVT=9]RRQDO.TWWVR"
MO.3T/6@#6\.:^^MK?Q7-BUE>Z?<FVN(?,$BAMJN"K #(*L#T!]J=/KDCZU<:
M1IMK'<W=K D\_FS&)$#E@BY"L2QVL>G '7D4W1]$FTO6M<O6N8Y8M3N5N%0(
M0T9$:1XSGG[F>@ZU#-H-U;>*I]>TN>$/=VZ6]W;S@[7V$E'5AR"-Q!&""/3%
M ',ZUXL;7-.\/K::;-)'=ZNUEJ%E*4^]&DFZ%LG!&Y0?0@<]<5W+8T_1#]EM
M/+%O;XCMHMHV87A1R%XZ>G%<TW@B>%=*^R7T(DM=4DU6X>2$G[1-('#  -\J
M_O#CK@ =>M=A-&)H)(B2 ZE21VR* /*)-0O=6\'^ M7U*R>;4#J5HZS'R]\^
M]&)VX.%!..#CH/2NK;QTFGKK2Z[IS6,VE0Q3LL4PF6:.0E4VMA>2RE<$#G'.
M*JP>"]8B\/>'M*?5;)AHEU%-'(MJP\U(E*JI&\X)!Y(_*K&O^!O^$@U#69)[
MT1VVIV,-J52/YXGB=I$<'.#\S#C';K0!>T_Q7'=>(DT6:.W$\MJUU"]M="="
MJL%96X&UAN![@COQ63\2+:"9_"S20HQ?7;:%R5R6C(?*'U4X&1T-='H]KJ]N
MH&ISZ?*0FW-K;-&7/]XY8X^@_.J?BGP_>Z_)I!MKN"W73[^.^_>1%S(R9PO#
M# .[K0!EZ9IUQ8^+]1U?2["XM]&_L\1_8@OE"XN0^=Z1G&W"_*20,Y[XS5VQ
M\8276I:IIDEA%]NL;=;D+;78FCE0EAC=@;6!4Y!'IUK1\3Z--X@\,WFE1W8M
M9;A /-"[@,,"01D94XP1GH367;^&-3BUFXU1[ZR\V?3%L?)BM2D<6UF8%1N)
MQ\_0_ITH PM7\<ZS>_#N]US3]'N-/22SAFM+HS1N<NV#\IZ8]>^1@5OS:B&\
M9Z##>Z7<P7<]O=&%S=Y5 NS<&13M8G*X)Z9J+_A#;E_AH/"4FH1^9':I;QW2
M0G'R8VDJ3ZKSS5J70=5N_$6AZQ=7UGOTZ*:.6.*!E$GF[<D98[<!!CKGVH =
M:^)+S4XK>^TK2ENM*EF,7GFXV2$!RA<1[2"F1U+ XYQ6+:^*8=%\&7FK6ND7
M#1PZI+;S0279=PYN/+9@QSQO;@>E:GASP[JWAF#^R[74+2;2(Y7>W6:!O.B1
MF+>7N#8(!)PV.G8US?B?0[S0?AEK%M+>P2R7&J1W4<BPD!&EO$?!!;D GU&:
M .HB\47</B>TT75-':S^WI(UE.MPLJR%!N9'  V-MY[CKS4</B^7_A([71KK
M34AFO89)+<)=K(ZE%#%)5P-C8/8L.#S4[>'[S498[S5[V+[;!!+#;-9QF-83
M(NUI!N)); XYP 3UZUDZ5X+U33Y/#TCZC8L=%CEB5(K0HLP= F]CN)WG&2>F
M3^- ")\0;DZ)'K;^'Y4TQ;IK6XD-TI>,B8P[E3'S#=C/(/L:L1ZSK,WQ"UC2
MX(':U@L+=HM[($C=S+\YP=Q!V@8Z_*>!FHE\$7A\ W?AJ34H#)-<M.ERL!PN
MZX\X@KNYYR.M:T&AW]OXQGUN.\M_(N[2&"Y@:%BVZ,N04;<, ^8>H/2@"D;V
MU\#:?HNA>='+/<;U6XOKCR4D<#<[,^&^9BW P>I]*Z33[B:ZL8YKBW%O*V=T
M8?>!@D9#8&0<9!P.#5#7-+GU1H$\G3[JS"N)K2^AWHY.W:P/.",-V.=W:G>&
MM"B\-Z#;Z5"^](B[# VJ-SE]JC)PHW8 R< "@#-U+Q<^DZQ8VMWIZ);7EXMG
M&_VI?.#,2JN8L?<)'4-G!&0*?8^+!J>K7%G906TJVUXUI.INP+B,J<%_*V_=
MST.[D<UD)X$U-+>.W.K6K)#JXU-)#:GS9B)3)ME;=SC.T$ < ?2KUUX.;4]6
MM;W4$T\S6E\+N*]A@VW)57+)$6],84G)R!T&<@ DTOQI#JD;7D,=M_9T9F\^
M078::W$>[F2+;\H.WU)Y'%16GCVVN9]'_P!'B^SZN=ML8[E7E5BA=1(F!MR
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MNU>V\RWM74 LI4N07]#]W]:9+X8O)(/#'^FPB;1) ['RCMF B:+@9^7AL]Z
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MQ@XX- '55#]KMOM8M?M$7VDKN$.\;]OKCKCD5R$WC:^A\&Z_KATNW,^D7-Q
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MFO?6TEQ<F/;MV?*X"G'WQT)Y]!S0!VS,%4LQ 4#))Z"H[>YM[N$36T\4T1)
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M!![@'@8K,\/>)3H_AKPM:WL-A;7VK6B.ERTY961(59I9254ER6'RY/+?>ZT
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M-@8);9VS794 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCP5.U9-V ,KUVYY.#W"W'A>34+JV;4[R*ZAM+W[;;_Z-B9&#EU7S"Q^4$@<
M9  ]<]"[K&C.Y"JH))/856TW4[+5[(7FGW"7%NS,@D3H2I*D?@010!RL/@&6
M"SM;-=;E:VLM2_M"V1K=3AM[.1(0<ORQYX_'MH?\(M/%?:]-;ZH4AUCYGA>
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M:-/I=ZTJV\Q0L87VL"K!A@]N5%5HO#-FT$J:C-/JKRV[6KRWNTMY+?>0!%4
M' R0,G R3@8 ,-/%.J6SVMY/;RW6G/937%XRV,D MF2/>-K/]Y6P5QR<X.<<
M5HZ7>ZU>V6G:W+>6"6%S;"XFMC$1Y2M'N4B7=S@X!)&",GBK.E>&H]+M5LSJ
M>H7EBD9BCM;MT9$3&-N0@9ACCYBU5[#P9:6&E2Z0NHZC-I#PO MC-(C)'&P*
ME5;;OP 2 "QQ^% &7I_B?5)O$VGZ>;JUNK74[.::&9+&6)8GCV'*EF_>H0_4
M8^O-0#Q?K1^'-CX@_P!!%W)>K;S)Y+;"K77D_*-^00#GG-;=AX-M+"\TN[_M
M'4;B?38G@@:>56_=L%!4@*!T4<@ ^I-53\/--.G2:<=0U3[ ;D74-MYR[('\
MSS/D^7)&[LQ8<T 5=;\7SZ7XAN;*]N!I4"/$+.XN;-WM[H, 6W2CA#DE0#C&
M,\YQ4$OC/5;ZUU:[T>UEFET^^DM8;);*5Q<B-@KYE VJ3\V/3C.:Z.[\,0WW
MVN*[U"]FM+ME:>T;R_+?"J,9V;@#M&0"._3-,A\)V]IJ=W>6&HZA9)>R^?<V
ML#IY4LAQEOF4LI..2I7- %GQ+KB>'/#&H:S)"THM(&E\H'!8]AGMSCFLF_UG
M5]"U+0/MLMO=VNJ7(LY1%$4,,K(65D.3E?E((//0Y[5TE]8VVI6%Q8WD*S6U
MQ&T4L;=&4C!%9=GX8M[9K$SWMY>C3\_9%NF0^2=I4-PH+,%) +9/)[G- &-X
M .I23>(9+NXMY(?[8NEVK$P?<& ^\6(VX& ,>G-:OB#4KN"YCLK"_M[>Z>%I
M%C-I)<R-@@ [$(VIG@L?85:T/0(=!%X(+JYF%W</=2"<H?WCG+$;5&,^G2H[
MWPU:WNOQZR+J\M[E;?[+(()0JS1;BP5N"1@D\J0>>M ',67B_7=7A\'26HL+
M<:[;RM,)(7?RG2,ME<,,C/\ ">?>M[PMJVI7EWK6FZJ]O+<Z7=K!Y\$9C65&
MC2125).#A\'GM4=CX'L=..B>1?7^W15=;16:,@!AA@WR<Y''_P!?FM2PT2WT
M[5M3U&&68R:C(DD\;$%-RHJ CC(^51WH Y[6L?\ "V?"A_Z<;_\ ]I5M:D"?
M$VC!2 _EW)!(SCY5Y_44NN^&K37I;.XDGNK2]LF9K:[M) DD6X88#((((QD$
M$<4[3M 6RN6NY]1OK^\,9B6XNF3,:D@D*J*JC) ).W)P,]* .,F\6>*(O"FI
M^(3-I9CTN^G@DMA;/_I$<<WEDAM_R' R.&Y^N!I3S:A'\6KAEN8%M(=%CD='
MB9CL\Y]VW# !CMZX/ ''%:8\$Z<?#FI:%)<WDEGJ$LDLQ9T#AG;>Q4A1C)Y_
ME5R'PY%%XB.MM?7DMVULMHX?R]C1@E@" @YW,3D>OIQ0!S-QXPU:'P+:>- +
M=K.0QS2V'EG<('<+\KY_U@# GC!P1@=:NKJWB2[\9ZMI5O/ID=EIS6DS.\#[
MVBD+ET^\1NPO#=..G.1?MO!>G6UFNG+/=-I*3":/3W93"A#;PH^7=M#<A2Q'
M;IQ5VST"&R\07^LQW=TT]\J+-&Y380@(0 !<C&X]^>^: .7TGQEJVM:?H^KV
M%I++#?7*K+:"RD BMV8KO$Q&TLHPQ['D =Z2U\<R)JAAU6?^S[F.2X\S3KBS
M=#)$@<J893\KL0JD\X()P!70:3X3M]#?R]/U'4(=/$IE73]Z&%"3DA25WA<G
M.W=CVIT7A>V_T1;N\N[Z"S<O;PW/EE4;:5!^5 6PK,!N)Z^N#0!@:;XNU:]L
M]#U:.UDFM;\"2[@6RE06L31EPZRL &VD*#_>SD8HTCQ=J^L6>AZI:6DDL.H3
M*+BU%E(JP0OG#B8@*2ORY['G %;VB^%8=!1+:SU+4#IT1/DV,DB-%&#GY0=N
M\J,\ L12:-X4@T';#8:CJ":>CEX[ NAACR<X4[=X7)^[NQ[4 8MSXLO[?6]+
M,-U:7EA>:D;"1(;60*F=^&6<G:S IA@!ZCC%9>GR:_:VOC2]T:YL(A::O<S>
M5<P-)YY6.,E<AEV# ZX/7MCGHK?P!IMM!9V\=]J7D6-W]KM(C,I6!LL< ;>1
M\Q^]DCL14\?@RSCNM0<7VH&UU&5IKNQ,BF&5FX.?EW 8 & P! YSS0!ST>O1
M_P#"6+XCE@=(_P#A$1?/#_$!YF\K]>U:.D>)-8U";0;E+:2>UU%-UV@LI8UM
M0T>]661@ PSA3ZY!&.E;4GABSEUY]6DEF9WLS8M;G9Y)A)R5V[<]>>OMTXIN
MB>&8]!CBM[75-1DL8!M@LYI$9(EQ@*#M#D = S$#CT% &-\6AN^&.L@ $D0@
M _\ 79*V[9M6N-3F^W6%E;&.W'V6:.9IQO8G<#E4Z;4.!U]14WB'0;7Q+HLV
MDWLDR6TQ4N86 8[6##D@]P*B7093=P7$^MZE<- 6:)9/)"JQ1DW86,9(#'&<
MCVH XVV\6^*G\/:-KCR:4Z7FHBPDM1;NOWIVB5P^\XP0IVX/&>:N7OC/4_#:
M^*$U?[+?-I5K!=6\EO$T/F"8LH1E+-C#+U!Z&M9/ EA'H=EI"7^H"UL[L7D/
MS1[A('\P9.SD!B3CW].*MWOA'3-1O=1N;SSIEU&T2SNH68;)$7=M/ R""S'(
M(H HV^K:X^KK:QJ9K66T>0W4VG2PK;S*5PI#$;E8$X&<C;R>:QK'Q;XE'@-/
M%E\FGO#<6L#I!!"_[EGD"M(YW'*!6W$#& N,]ZZRPT"2PM6MSK>J7*"+RHS<
M/&QC'L0@W'CJ^XUA:WH7]A_#P:#I[7TUENBM7D!W2V]NS .R[ "VT9/?OG(X
MH B?Q5JEA=ZW=-<V6HZ'IEA]M-Q!"0TC[7)A#A]N1M4YP>'&?6K.GZ]KM[>:
M3Y,1E@OX':X=]/EC2S?9N0@L1O4GY<9R20<CI5:STZYFURWL[;6K[6="GM9H
M]1CO5C:+!4!%5E1?F))R 3QG..,[^D^&O[&MDM;?6=4>UB3R[>&9XV$(Q@8.
MS<V!TWEJ .3LO%GB9_#&A>)+F333;WEW#;7%I';N#MDF\O>KE^",@X(/?FMV
M+5=8\0/K']BW-K:?V;>/9HL\)D\^1%5FW$,-JDMCC)XSWQ4T7@G3XO"]MX?6
MZO#:6TZ3PN77S$9'$B\[<$;AGD&I5\)P6^L76I6.I:A927A5KN*!H_+G8#&X
MAD.UB  2FW- &2?$FM6]]XETRX:S-_9B)],"P,!.DORQ[LOS^\!0D8QUKL(E
MN19JLLL37.S#2+&0A;'7;G.,]L_C7-QVNG^(/&EMK,$<Q.E0S6S2M&T:R2,P
M&WY@-P7:QSTRX(KJ7!9&4,5)& PQD>_- 'FJ>+?%0\.6NO-)I3Q_VH;"2U%N
MZ[U-R8 X?>=I!P<8/?GGC9CUK7K76-<TB[N+">>UT]+^UN$MF1<,7!1TWG."
MG!##K5D>!+ :$NC_ &_4/LJW?VP?-'N\SS/-Z[.F_G'X=.*TSX>M6UV75GEG
M:>:S6RE0E=DD8+$9&,@Y<]"* .?'BC53H'@G4A]DSK4EK'=H8FX\V(R$H=W&
M"N,$'K39_%\]OXG?3;^X&EM]N2&VCNK-_)NXCMY68?+O.6P,C! !!ZU;M_A_
M8P6>F6O]J:K)%I<Z36(DF0^1M4JJCY,,,-CYLG@<UI2>&H;AF2YOKR>S-T+K
M[)(8_+#A_,'(0-@/AL%NV.G% &+X&_M)]7\527%S \ UB5-@C;>"(HL88M@+
MCMCKW[4WQ E[)\3-!73Y8(9VTR]'FS1F0(-\'.T$;C^(ZY[8/0Z;X?M]*U74
M;ZVN+K%_*9Y;=G!B$A"@LHQD$A1W(],5%JWAJ'5=5L]46_OK*]M(WCBEM63[
MKD%@5=64@[1U':@#E(/'6J6VHKH&HQQ-J7]IR61N[:V=T:-8!-O$8)._#*,9
M(!.>@Q74^'-0U.]DU&'4+=Q';SA;6Y:!H?M$94')1N0025/0'&13;[P?I=[9
MP0YN()X+G[7%>0R8G68\%]Q!R2#@@@C'&, 5JV%I)9P%);VYO)"<F6XV;C^"
M*JC\ * .9*N?BS=^4RK*= B"LZ[@#Y\F,C(R/Q%9%GXFU>/P-X9OK&'2[>2^
MU%+.6%;9EB57F9<H WRXQ[YSVKKV\/1'Q'+KBWMVEW):BTPI38L8)88!7J&8
MG)_EQ6='X$L(M%T[2DO]0%MIUT+NW^:,L) VX9.SD!B3CWYSQ@ S%U7Q:^H^
M(-(6^TK[1I<,5S'=&S?$JR*Y"%/,^7!0_-D\$<4^#Q'<ZE=> [TVMD(]8B:1
MP\):2!C;-(?+?/ XQTSCO6_#X;MX=8U+4_M=TTVHQ)#.K%-NU P7&%R,;F[]
M^<U4M_!5E:IH217U]MT0%;,%H^ 4*8;Y.?E)'_U^: .3@U_4O#D?C+5II+>X
MC36EMTA\IRV]T@13G<?E&[)4#)P<$9K9O_%^HZ$-3N[JUFO-,MK#[2D[6CVI
M$^\+Y1WCD'<"#C@ YS6I<>!]*NSK*7#W4EKJ["2XM3+B,2 */,7 W!OD4]<9
M'2K*^&89M*N=-U/4+[5;6XA,#I>,GW#[HJY/^T<GWH YS7(=53QOX+DOKRUF
MB:]G_=16Y0H_V:7HQ8Y'U&?Y5N^.Y)XOA_XADMI!'*FG7#!CG( C8G&",'T/
M8U!#X'M8IM,GDU75;B?3)"]K+/,KE 4*%?NX(P3R06]ZWM2T^WU;2[O3KI2U
MO=PO!*%."58%3@]N#0!RNG:KJ4-SH7AOS[87,^GM=O<) 0$B0(H55+'+$OU)
MQ@=.:T?#6MWE]JFN:/J*Q&[TFX2/SHE*K-'(@=&P2<-@X(SC(]\4X>$+41:8
MPU"_^VZ:&6WOBZ&78P *-E=K*0!P5[ ]>:T]-TFWTS[2\1>2>ZE\ZXGD(+RO
M@*"< #@      4 <Q/\ VD_Q?18;F!($T8,4>-FRIG&[&& #''7!^AKG=(U3
M6] \!RZQ9RV1LK75;D26LD+,\R->NK$.&&TC=P-IZ<]<#O[OP[;W7B"#6TNK
MNWNXH#;GR74+)'NW ,"#T;GC'OD<527P1IX\+W7AYKJ]>RN96F8LZ[U9I/,.
M"%[MSR#UH S+SQ;J%W=^(;?28W$VDOY,,8L99Q<RB,.0S*,*"6"CG/?IQ77V
MMR\NFPW5Q%]F=X5DDCD/^J)&2"?;^E9!\)PQZO/J=GJ>H65S=*@N_(:/;<E1
M@,RLA ;'&5VFMFYM(;NPFLIU+P31&)P6.2I&#SUZ4 <;8>*=3E\2Z39&ZM;N
MSU6WF=)8K.6-(G158%'8XE0@GD8['/-9O_"6^*D\.#7FDTIXH=5:PDM1;NOF
MK]I\@,'WG:<D'&#W]<#I++P1:6,NE3+J6IRRZ7&\5J\LJ-MC90NW&W!  '.,
M^I--/@2P.A/HYO\ 4/LKW?VP_-'N\SS/-Z[.F_G'X=.* *$_BO4_#VHZ_;ZR
MUM>Q6&E#5(7MH3"2N74QD%F[H,'/?FIKW7M8T@>'KRZDMKFVU6YAM)XHXBIA
M>4?(R'/*@\$'KG/'2MFX\,V-WJ\NHW+S3//8?V?/$^TQS198X88ZY8]"*BLO
M"EK:)812W=Y>6^G,&LX;EE982 54Y"@L54D#<3Z]>: ,";Q9K<7@CQ3JVZP-
M[H]U<Q1_N'\MTBQC*[\@GZU>N]6UZ7QA;:)9W%A#!<:6]YYTELSO&RO&O3>
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MN4EB0S9R><D]>:I+:Z?X@\:6NK0QS%M(CFMWE:-HU>1F V<@;PNQCGH"RD4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI!.9(#;HGDO&@<&,J,X.2,,3]:=X>N=6\5:)I?B"+6I;2.[4R/9Q11-&J'<
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MAGC66,D8RK#(X^AI#=P"]6R\P?:#&9?+ R0H.,GTY/&>N#CH:I>&O^15T?\
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MTN[\0:7J^KB5+.6T6UU VH,K^>2/*V(-K2#'&!_$"1CB@#O:*\_M=0\3W?\
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M4)7S,@H.,<9QV.9+?7/A?Q7XSU*:[DU.2ST.WN$\U$1N&G(1M@ ZCK@<'VH
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MNN&TBTVV@N+;;:QL0SI(VUMP.5^49[^A'.8]-U[76F\&:E<ZA'+;>($ GLA
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M?)(UU%9LR3+:J97#K]Y=JY)8=QVH I+X/T4:?JE@UO+);:H[27B27$C>8[
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MSOD(VW<#S\V=J]<]*7Q!K</AS0KK5[BWGG@M4,DBP!2P4=3AB!^M:,;B2-'
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MN">&YB$MO+'+&<@/&P8'!P>1[@U)7D?PAU*WTG6]?\$1W?VFVM)C=Z;*3G?
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MM6CF5A,Y.,*1UYK3H YRP\(Q:;XSU/Q%;:C=+_:2Q_:;/"&-F1=JMG&X8&>
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MLR]0&4@D>_-8^E^%%L8+&"\U&XU&#3L?8TG1%$>%*J3M W,%) )^N,\UT-%
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M#4WN4L;N*X-M)Y4WEMG8^,X/O@B@#-D\*VE_]KDU>0WT]U:-92.5"!86^\J
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M3]7NH]+$S31V12-A'N8L45RN0F2>.HSP171T44 %%%% !1110 4444 %%%%
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MAOKTEM($F6R?+@E2!CDC!R#Z4NA6>GZGXHOO%5DLOEW%O%;(SJR"4KDM(%8
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M@CI(B\+Y@R#OZ9&/4XP=B_\ #$>HG3'N-3OS+IT_VB*0&/+289=S?)CHS#
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M(R"BNK(V!P58<$ BM^L0>&;=("L=[?1327JWL]Q%*$DN'7'#D#!0A57: !@
M5MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M( R5)\S@]CG 'K6;!\7=.FTZPU%M$U6.QN+O[#-.Z)MMILXVL-V3ZY Q^/%
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M=>,(+%]3AN]/O([G3[/[<\"F-C)!R"Z'=@X*D$$@^F<B@#I**Y!_']O#I/\
M:LVAZO'9,UNL<IB3]X)B I4;\D9(!XSR.,&I1XT=K^\TT>'-6.IVT2S_ &3]
MSF2%B0'#>9LZJ1C.<]CS@ ZJBN0N?$VGZG;^%=1A;54MM2NT%NUNRHI<HY\N
M8$Y*X#$@ \J.:CM_%>H-XA\56CV5S);Z;Y8MRD2X4^3O.[YLG)/'MCI0!V=%
M<=X;\82WGAK0);^UN&U34X$:.,*B^>WEAW=?FP$ [G!Z#!)Q6A!XQT^:*17B
MGCO8[TV!LR%,C3[=^U<':05^;=D#'7&#0!T-%<-H-U<S_%'6EGM;RS TRW;R
M+B8.I8R2Y=-K, " !VY!XJ?QY*UK=^%KI#<EO[9CC:.%V_>*8Y#M*@X/*KUZ
M8[4 =E17,P^-[%8M7.I6=YIDVE+&]Q#<!&8K)GRRI1F#;B", YSQ4TGBJ.WO
MY["YTV[BNTM&O8X<QL98E(#;3NQN4D9!(ZC!- '045R=AX^LKZPAOO[-U*"V
MNEM_L;S1*/M3S9VHGS=1CG.!WSCFJWB/Q9:+HVMVMY#J]G/8)$]Q]ADC698W
M/RR1ONP02I4]QSQWH [6BN?OO%(L]?;0X=(U"[OOLOVJ,1>6$D3<%.&9P!@G
M^+'3C/&;N@:Y;^(=*6_MHIH1YCQ20SJ%>*1&*LK $C((/0F@#3HK$N?$B)<:
MA#96%S?MI^/M7D%!M8KNV+N8;FVD' ]1SGBL^?Q]IRIH\EG97^H)K$3RV;6J
M(?,*J6*$%@0W'<8'<\' !U=%4&O&FT+[:;6[C:2W$AMQM69,KG;R0 PSZ]17
M.:?XOL[+0?#/E6VL7T>JQ*EI+*4DE=O++@2'</F(4\]/4@<T =E16-H7B*/6
MI[^U>RNK&]L)%2XMKG867<NY6!1F4@CT/8U+>:U';ZHFEV\$EU?M";@Q1E5V
M1@[=S%B ,G@=2<'L": -2BN%UCQVS:+9W>DV]P+@ZS#IUU;O$IDA;S )(SSM
MW$'@@D<@Y[U$NI7-E\2-2>WT[4KMYM'MIA9+(N48RRAC\[A%X"C /..,\T =
M_17.V?C+3]1L=+GLXKB2;4Q)]GMF4+(/+.)-V3A=I&#R>2,9JM/X^L+>Q6YD
ML;\D:B-,GB1$9H)RP # -R#N!!7.0?PH ZNBJ6E7\FIZ='=2V-U8NS.IM[H
M2+M8KSM)'.,C!/!%9UAXI@U$)<06DYTYY)8_MNY-B&/=DN-V57Y#@D>F0,T
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MLK5_ <FJWNMSG4EA-]<6MW;,L.6MIH%4*3DX<''(XZUTFE0:G$C?VE)8LV
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M:G?:5J=G<+!J.ERM)"TBED=77:Z, 0<$=QT(!YZ4 9]SXV:Q@U]+K3&%_HL
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MVCR?[QRQ_+]3577] DU._P!*U2SN%@U#2Y7>$R*61U==KHP!!P1CD=" >>E
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M<<U;L?%#ZKX7LM9L;#_CY!W1W4XB2 KN#;WP< ,I&0#DD?@Z/0[T>-1K\EW
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M&EDDR[YW J-N. ,$\>E '7T5R/B[Q=<^&H+NZCBT^6.SC$TEO)<D3S1_Q%5
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M?&"20.>H/':N,/B631-"\9:K::'9QW&G:@WVB-+EL3MY49,A;9UPP&,#IUH
M]"J&YO+:RC#W5S# A.T-*X4$^G-<ZOB+4[3Q1::9JUE:16U_!--;RP3LS1F+
M:660%0.C9R#V(]ZYKQEJM]X@^'\&K06EJNE7-S9R1^:Y\]4-Q'M<<8R>/E[
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MF0_,@D!R%(X/&>N"*G/A6:SU^ZU71=2%B;U(TNK=[<2QN8UVJRC(*L%XZD'
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MO&#E 01^1K.E\!.^AZII(UAS#J&H"_>5X TBOO5\9! QE%[>OMCLZ* ,&_\
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MG-N(R\J/$N[& 5^\V5[&@#MZ*\W_ .$QU>TTZ2.24W5S-XF;2(I4C162,<\
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M'&1GO0!Z117,Z9+XA'B&))HKN329+9C+)=_9U:*8%=NWRSDA@6SD'&!S734
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M.:Y-S*NNW :8J%+G;'R0. ?I75:G;PW>DWEM<R^5!- \<DF[;L4J03GM@=Z
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M&D;$@0*F\%>Y))![=* .EHKCH;S59?$?_"*2ZO*DT&G_ &R2^CBB$TVZ5D0
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MB/X?_P"P;;_^BUH VZJ1:E9S:G<:;'<(UY;HDDL(ZHK9VD_7!JW7'OJ6I_\
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M"TT50MK+>NBIY:+<7<DH1?0!F/IUZUJ454CU&*359M.$<XEAB25G:)A&0Q(
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MO'@[ES)C.WH#P!U#M.\--=:EJ=N]UK,OAVZLA \&H7<Q:24L=Q3>?,5=O!Z
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MDY/>H!I^F>%3=ZE:6%]-->-&LZVYDG>1@-JL02><#EOQ)K?HH Q?#>A0Z-H
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M=1N(9OM#P"WEV7$B+-&,D*ZJ0' W'J#UK6BD$T*2J&"NH8!E*D9]0>0?:GT
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M=;F0;HQG"X#8&-QZ8ZFM&WO+:[:=;>XCE,$AAE",#L< $J?0X(X]ZGH Q/\
MA$M'&D:?I8@F%IITJ2VBBXDS$R A<-NS@ ]"<5MUE:AKT.G:WI6ERVUPSZD[
MQPS(%\M65&<AOFR.%/8UJT %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC/4<#DUIRZ'I<T]Y-+I]O))>H([DO&#YR@8 <'[P XYHTS1-,T="NGV45N"
MIV#G Z#)[#TZ4 <OJ]H]Q\6M%Q?7,(&E7+;8BHZ2PY'*G@]_H,8K)?5=0U#X
M:ZMXH&HW-MK%I)=2)&LI$<1AD8+"8L[3E5 .022V<]*[^71].FU./4I+.)KV
M-=J3D?.H] ?3@<5&= TEKV2[-C%YTCB20X^5W'1V7H6&!@D9X% '.Z;-)/\
M%":6:/RIG\.VK/'_ '6,TI(_"N>\)ZE.NA^ ]&65X;+45NS-)&Q1G,>2L88<
MC.2>,$[,=,UZ,VB:8^H27YLHOMDL?E//CYV3^Z3Z<GBH5\-:*FF)IR:;;I9Q
MR"6.%$VB-QT9<?=/N,4 <5J']N-_PFNCZ?J%X?[.@AN].F\YC(DC(S-"7SE@
M=H^]D@/]*=_PF<BWFDZV))#X6O[9K- &)?S_ "Q(K[LY))5XO7<O7FO0+2QM
MK&)H[:%8U9BS8Y+L>I8GDGW/-0KHVFI86]@MC;BTMF1X80@VQLAW*0.Q!&:
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M9<V$$UB,8@D3<HP<C&>F.WI4,OAC1)]+_LV;3+>2T\P2^6ZY^<=&R>=WOUH
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MTZ*R_LQ4LKAI[5@VV7[4TQ.3S^\+$_KQ0 [3;R6^M/.FLI[-_,=/*GV[L*Q
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M-OS0G.4W;3[9'';%-\;P63^,/!\E_<R6\!N+E6D%T\ '[A\?,K#!SWZGITH
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M;+BWN1*BD#.&RJD9 /0$5S&K7*^'/BS!K6IMY6E:AI8L$NWXC@F64N%<]%#
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MJX55 /9>>];/BN^AM/&.FPZFT-SIES8S(ME).D>)0RGS"'*J1@[1SD$\#J0
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M:8Y&CZX'7;GIWKE+:^M9_$]_HOBO4894M["T:T,TGE1W *'S9E&>6W\9R2H
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M]: (5LK5;@W"VT(G/601C=^?6FMIUB]O);M96Y@D.9(S$NUS[C&#5@NH#$L
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M4+C6+6VUBPTMRYN;Y)9(=JY7;&%+$GM]X?G5^@ HHHH **** "BBB@ HHHH
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MA1@], <5H3Z/%8>+=8\,162BQ\3*MVK+&-L>W"W()[?+L*^C/7I596GV-_\
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M(VD65SM9L8#!2.#SC%,UVW\_XD^%YC83S0V\%V))Q:N\<3.(]F6 P#\K=^*
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M ""I /4&@"R-=TAIW@&J6?FH&9D\]<@+]X]>W?TI_P#;.EB"VG_M*S\JY8)
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MU=8U# A@#U!K@M'BM-9\ ^(/#L&ES37]W>:A&A>T<1%C/(%D\TKLPO!ZY&W
M&<"@#TV^UK2M,FBAO]3L[664@1I/.J%\\# )YYI_]J:?_:#:?]OM?MJKN-OY
MR^8!C.=N<XQ7G/B9-3FT[Q-H#65_(4TI8K1[:P,AU!A"<L\A4C(;@*"&],DB
MM'68[W3)O#7B73K266[\E=+N870HS)*!Y98'!&V4+G/9FH ZX>(=%,:2#6+
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MAXYDO/!<>O:(]O&WVR*"2&8"1@C7(AS\K#:2,L,YKK;'6=+U26>+3]2M+N2
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M-GI<T'PV\$(-(NTNK#4+)[B,6;B6+:W[QBNW=C!.3BO5@<C- !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44CNL:,[L%51DL3@
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M0!V%%8WB'59=#CM=18@V"SI#=J1RJR,%60'_ &6(R/0D]A6S0 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO[278]Q%*6)+9X>)=HX]6)R.*ZCP5/>7/@W3)+^&**X\K;MAC\M"JDJC*O\
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M=,K,H4?>(.<YXSUSWHANKWPQIGQ2L?#D\J-I\L,EG")"[0*P_>LN<G@$G/;
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M/110 4444 %%%% $4MM!.0988Y". 74'%#6T#[-T$;;/N90';]/2I:* .?\
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MHPRK*<@B@!U%%% !1110 44A('4XI: "BDR,XSR.U+0 4444 %%%% !1110
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MUVC) SUQT5<O!X=U32O$&IWVD:A:K::G*L\]M=0,_ES!0I="K#((49![CK0
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MOA9+Y:^8MW&H?'./L\QQGTXKUN@ HHHH **** "BBB@ HHHH **** "BBB@
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M?!/]KW.ON=2>&/6;**TD58LM'Y>[# YY!WG((Y'>I;?PQJ,6MKK$NL12W?V
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M3RC$-V%&%##[[<Y[T_2O#LNE6BVJ:[J<]O%'Y<"3&(F(8P/F$8+$#IN)]\T
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MYI4\(6]IJMQ?:5J-]IGVH)]H@MO+,<A50H;#HVUL #*XSB@#'L[K5KKXH3N
MD, T6UE:VEW%D#22Y&,@!\K@GV'I4GA;QC)K>IP6EW=6]M?- SW&E3VDD,\+
MC'"LQQ(HY!('/!XZ5N3>&X9?$0UJ.]O()VM1:2QQLNR9%+%=V5)R"Q.01[YH
ML_#D<%W8W-U?75]+8QM';-<",%-P"D_(JY8@8R?RH D\3ZY'X:\,ZAK,L1E6
MTB+B,'&]N@&>V21S67?:UJVAZSH<&H-:7-KJDYM&,$31M#-L+*1ECN4[6'8C
MK[5T&I:=:ZOIMSIU]")K6YC,4L9_B4C!^GUK-M?#4<4EB]W?W=\VG@_9#<;/
MW9*[=YVJ-S;21DYZGN<T 8_P^DU*9-<DO);=XO[7O%&T-O#"4CJ3]T  #CL*
MF^)LEW%X#O39R"-S+ C-N((4S(#C'KG'TS6OH/A^'P_'=QP7=U.MU<R73B<H
M<2.Q9B-JC@D]*EU[1;;Q#HMQI=V\L<,^W+PL ZE6#*02",@J#TH Y2]CU=OB
M7IJ0S627[:'<AIFB9HT'GP\A-P+=AC<.I/L66_CR^6UL[.\@A_M2;5KC3'EM
MX))(\0AF:18QECD ?+G@G.<"NDA\,I'KUKK,NJ7\]W;VK6N9/*VNC,&;<%0<
MDJ#QCIQQ5&;P%ITL<P6\OHYFU%]3AG1T#VT[9W%#M^Z0<%6W#% %WP[JFI7\
M^I07]JZQVTRBWNC;/ +A&4'.Q^05.5/8XS6'\1IBTOAC39VVZ9J&KQP7F3\L
MB[698V_V68#([XQ77V%I-:0E)[^XO9"<F2<(#] $50/RJ+6=&T_Q!I<NG:G;
MB>VEQE22"".001R"#R"* )[BRMKNT^RSPH\'R_N\8'RD$?D0*Y-_$^K7WA_6
MM=TL6@@TZ:X2.VFC8M.L!(?+!AM+%6QP<<9S6M9^'KRU5(F\3:O/;IC$<ODE
MB/0N(PY^N<^]1MX/M!_:<,-Y=P6.INTEW9QLNQV<8<@E=R[N^#ZD8/- &5'X
MEUK6->LK+27L+>UO]&74XI;FW>1XLL@"D!P&^][8]\<T;3QCXBDT+1]=N(],
M6VGU!-/NK:.-RY)G,!D1RV!\PSM*GC^*NJ'ABV3Q!'K$%W=02Q6?V&.&/R_*
M2+(. "A/4 ]>WIQ5*/P-8Q^'(]$%_?FWBO!>QR%H]ZR"7S>NS!&_G!% $']J
M>)+[Q5KNBV5QID"64-O-#/+;.Y_>>9\K*)!G[@^;(QZ'/$&F^+-1U+0+9YI+
M'3]3:YN+25?)DN \D+E&,4:D,PXSG/ ]>M5+*V-]\4_$/D:U=VA2TLT*VYB(
MGQYN\'<AY7(^[@C=[UT%QX.L'N-+GLKBZTZ335D2(VK*=R2$%U;>K9R5!)^]
MGG.: .>C\::W/X;T6_B@L1=7.KG2[E'CD521*T9=><K]S.""1GVK1AU?Q*-5
MUS0W?3)]1MK*.\LITMW2-]Y==CH9"1S'C(;H<XJ8> K%+"ULH]1U)(;746U*
M(;XV(E+E^2R$D L>O//)-7[NQT_2=9N?%-S>3Q$VL=M,#@Q[%9BIP%W9RYZ&
M@#.T+Q'J.OVGAZ>V>T'VN!I]04P-^Z"_*47Y_E;?E><_=8]L5UM<YX2T>VT^
M+4=0MXI8AJ=V]RL<F040DD  _=!)9\8&#(0:UM+T_P#LRT-O]LN[O,CR>9=2
M;W&YB=N<=!G '8 4 0ZU;PC2M4N=@\Y[)XV?U4*Q _-C^=<II5M#)\$["9HP
M9(_#A5&] T S^>!7:ZC9C4=/GLS/+ LR%&DBV[@#P<;@1T]JS+;PQ!:^$?\
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M2@&5(;ODC'4U+HVH>)[]]!OECN)+.\AWWWGBW$48:/<KQ;&WXW8&"3P>>>:
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MI^G:I>ZE;),MU?,&N&:XD<2$ *#M)(&  !@=*TZ* ,2W\)Z1:[8XH)!:K/\
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M#R\<D#:>!G)?H?@VU71KRQU6T\RSFOVNK2TGE,IM%PH4*^20<AF^4\;R >Y
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M-N-0OYU@M;="\DC=%']?IWK(?Q!J@T]M03PW=&U5#)Y;SQI.5QG/EDX!QV+
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M""." ,9QTKE=6O\ 3]<^$W]JZC>E]>\Y!.GVAE>*43J&C,8/"J/X2,8&>O-
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MWET;;=>OYR?N$,84[MV,]!TZUI26R:AXS\-VDUW>&VN=#FDFA2[D5)"IA )
M;C[QY&,]\T >AUC1Z\6\82^'VLV4I9"\6X\P$,I?9C&.#D&N!AUBXT;27LVO
M[B/2X?%3Z=-<23,6@M<;@ID)RJ[BJ[LY /6K0^RZ?\0=:D\/'SKA/#C2QQK*
MTJF42-@#)(&3MR!Z^] 'IM%><>%8[G6K#PSJ\.I6L;M'_IDB7CO+>YB.]'7
MPP;YNIV[2!@5:^'VF1W"W>K37U_<7%OJ5];1>==NZK$)F 4J203@#D\^^,"@
M#LIM2M(-2M].DF O+E'DABP<LJ8W'/08W#KZU1\.Z\=>AOW:T:U>SO9;-D,@
M?)3&3D#IS7/>(+:SD^*?A]KNYFA#:==[=MV\(+!X< ;6'J<COCG.!7-7-A%)
MX.\>:LES=1WMAJ=]-;20W+Q^4Z ," I /(YSGTH ]?IDK.D3-&GF.!E4SC)]
M,UYR;Z\UOQ?K&E7IMB@L+:2R2>Z:#"NA+RQ[5.6#\;NHP,8S7<Z%%<P:!I\5
MY?)?7*6Z+)=)TF( ^?\ 'K0!S4?Q$C/A;_A)I-%O4TE9&260/&SQA9#&S% V
M2H8'IDXYQ6WI7B#^T]?U?2_LIB_L]86$OF!A*LH8@@8XX7]:Y#P#HEMX@^&U
MC;WEQ.]BUS<^;:(5$<N+J5@&.-V.F0" 0/KF:XU6VT;Q%\0;^X,PBMK"S=_L
MYQ(!Y<OW3V/H>U 'H=%><:&1_P +!FL8[@1VEWHS3S6]MJ$DRB02H ^\X(;:
MQR1CM]:Q=+C:+P#X+\0C4+Y]2EO[.*6=[N1O,CDFV.C*3M(()[=>>M 'L-%5
MK?4+.[N+F"VNHI9K5Q'.B."8V(R P['!JS0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-->6>5]/M&DG $SF%29 .<,<<]!UJY10!$UK;M;?9F@B-OMV^44&W;Z8Z8J
MZ3IK6GV0Z?:&VW;_ "3"NS=Z[<8S[U<HH IC2M.6]-ZNGVHNR<F<0KOSC'WL
M9K/\4Z3=:O86T-MY,B174<T]K,Q$=U$,YC8X/&2#R""5 /!-;E% '+:;X5@@
M\4Q:W%IEGI8AM)+80VJJ&FWLI)DV@#"[.!S]XGCI6U#HFDVZS+#I=E$)_P#7
M!+=%\S_>P.?QJ_10!4_LK3C:BU^P6OV<-O$7DKL#>N,8S1)I6G2WR7TEA:O>
M)PMPT*F1?HV,BK=% %:+3K&"Y:YALK>.X?):5(E#-GKD@9J-='TQ 0NG6B[I
M?..(%&9/[W3[WOUJ[10!6MM/LK)G:UL[>!G^\8HE4M]<#FDETVPGN&N);*VD
MG>,Q-(\2EBAZJ3C./:K5% %%M$TII8Y6TRR,D0"QN;=<H!T ..,4\Z5IS7WV
MTV%J;O(/GF%?,R.!\V,U;HH J3:5IUQ>QWLUA:R7<?W)WA4NOT8C(ITNG64\
M[3S6=O),T9B:1XE+%#U4DCI[=*LT4 5K/3K'3D9+*SM[96^\L$2H#]<"A].L
M9+L7;V=NURN")FB4N,=/FQFK-% %4Z9IYOOMQL;8W?'[\Q+YG' ^;&:4:=8B
M\^V"SMQ==?.\I=_3'WL9Z59HH YSQSI5[KGA6?3;"&.6::6%L2N%4*DJ.<_4
M*1^-;5C96MC:K%:V4-I&WS-#$BJ QZ\+QFK-% %%-(TZWC46^FV:&-C+&JPJ
MH#GN,#@G YJMH]I>-<3ZIJEM;P7]PB1>5#)Y@CC3)"[RHR=S.>@Z@=LG7HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9()T5B)1"(E)3. 3MQD@YXK*UG3?$^I_#O4SJ-I-JTL&LPS6]PFG^3<74"[
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MQG'H,9K@AH_B!]'GT;1-0N;VQ?1[BWMVO[$V\]D=JB.,2;5W;L8.1D;02>E
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M^G:C;1KIS0W%RFGO)/%*NP"+!4[%;!)9ACY1R.M 'H#ZYI$4=K))JEDB7?\
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MU*SN+JW.)H89U=X^<?, <CGCFO,]4M;J?P5X]M8])U!Y;W56DMHA8RYF4K$
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MNY !H Z^?7-)MHHI9]3LXXY4$D;O.H#(>C YZ'UZ5<DECAA::214B12S.QP
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M[/N98FS=*Q,<> 93Z*2>O3WK5L]:T^^NWM(+D&Y1!(874H^P\!@K $KGN.*
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MZ@>H^7WIVL3ZO=ZO-:II]_\ V=/I@$+6\*J99<ON25FY0 ;<#C.YNO2NXHH
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MDW,?ER2M(%4)MZ[1@DD]\8SR:U/$F@KXCTK^SY+N6VB,L<K-$H+$QNKJ.?\
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M** "BBB@ HHHH **** "BBB@ HHHH YGXA7%U9^ =:O+*ZFM;FWM7ECEA;#
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M&02/D()P#GM5,:/XGL(KQ+2TD,,WB"6\GC@N4C>>U<' 1\@J=VTD94XX!ZT
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MEX+,"3M.!D#GKBNDTVPU"+Q]K.IS63QV5W:6T,4A=#\T9D)R V0#Y@Q]#TH
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MW [NQ!R#@\< T =+17-W'C.QM[5[_P"SW$FEQW?V22]7;L5]_EDXSN*A_E)
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MEM^[9PC*65U(?:P(![YX/% '545SMMXMCEUFTTV?2M0M6OHGELYI@FR?: S
M88E3@YPP%1VWC2WNM&N]1CTS4,VM[]ADMB(A+YN\)@#?CJR]^<@T =-12*2R
M E2I(R5/4>W%8/BUKNYTP:-IMRUMJ&I;H8YTZPH%R\G'(P. >S,M &_17/\
M@O7)-?\ "UK=W*[+^/=;WL?=)XSM<>W(S]"*Q/$>%^)6A0RW=_'9SV-W)/#!
M=3*KE/+"G:C=MQZ"@#NZ*XOPU+JNG'6I'AU2\TV2]"Z5#.2T^S8-Y)E((3<&
MQO(X'N,V)O'ME;>'=4U>?3K]/[*G-O>VV(S)$P .?O[67#*<@GK]: .LHKB-
M;\97]O\ V4;72-0M_M&L+9NL\"AIHO++Y3+8&[C&<'ALX(J_::W9IXEUIKI]
M2M6M+&&XN([N1/L\4?[P[D"DX/RMNS_=% '445S5QXCEFM9"=&U5+2:T>:*Z
MB:(,5 !X!?*-@Y&X#IV/%5K;Q;:Z?HOA<):ZM>1ZM!&MK+)L>5CY1<"0[A\Y
M"\GIGJ0* .NHKG-/\717EWJ%A<:7J%GJ5C$LSV<J(SR1MD*T91BK D$=>#UI
MG_"90Q/JT-UI5_;W>FVRW<ENWE,TD)W?.A#[3]UL@D'B@#IJ*Y>S\;075WI$
M<NE:C:V^KJ#9W4RIL=O+\S80&+*=H.,@ X.*;X3\17NM:AKL%U:SK':ZC+!!
M(8U55153"GG);))Z=_PH ZJBL#7?%4?A^.:YN=,OGL+=E6XNXU39&&Q\V"P9
M@-PR5!QSZ'$=UXM\G6[S1[;1-2O+ZUA2X*1>4%>-BP!#,X'53P<'T!YP ='1
M7/VGB_3K_2],O;1+B634PWV6UVA96*9W@@G"[<'))Q[G(SD>#KF>X\:^+Q/;
MWEMM>UQ;W,H?82C$E<,PP3SP?P'2@#MZ*X-K^XTSXF:VMM97^HEM,M95MH90
M0I,DP8CS&"KT7@'GL.M7)O$^GZK!X7U"$ZM%!J%Z$A,++&IDVN#'.I.2!M;@
M9&5'- '845AP>)$O+R:*SL;BX@@NS9S3QE/W<@(!)7=NV@G!./?&.:MZCK$.
MGWEG9"-Y[V\W^1!'@$A!EF)) "C(Y]QC- &C17*77CRQLM)UB]N+&]$VC,%O
MK10ADC!&Y7'S892.00?PX-;.F:B=9M[K?I][9QI(85^TKY;2KM!WK@Y .[V(
M(/ (H TJ*\U\(^*O[$\'637UCJ4]G]NGMY=0)5TB9KIT3=N;>PY49 (&>O!Q
MU&H>,+.QM]3NDMKBYL]+<I?3PA<1$ ,V 2"VT,"<?AD@B@#HJ*YBY\:P0ZW)
MI,&D:G=W*113YMXT9&BD8J) =W08.<X/H#6QJ.K6^G26T#*\MU=L4M[>+&^0
M@%FZD   9)) _$@4 7Z*\]T+6DL/%'C?4-42[L+6TBM99([J7S/+&R0DKM9A
M@]@/IC/%=!<>,+33K@Q:K:W-CFSEOHVE"L'CB ,@^4G#*"#CWX)YH Z*BN8U
M#7S+X>U&>;3M3M[86+7 N+26(OY94Y*,'P'4<_RS4]OX@MX[?2;.UBNKR\N[
M$7,43LOF&)0N7D8D#.74>Y/ID@ Z"BN/3XAV3Z-;ZJ=)U5;::\6RR8XRRRF3
MRR" ^3AP0< ].,UHV'BF.ZU.]TVZTR_L;VU@%UY,RHYEB)(#)Y;,#RI&.N:
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M&PD'GYC5 ^%?%4OAC2]#GGTEDTJYM9(9U>0&YC@=2 R[?W9PHY!;)]*]"HH
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M/,LL)/SB25I.00-I^;&,GZUS8\%:\XLS<MI4]U9ZN+XWKNYFN8Q(S!22G[O
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M>W^0E@CA0=R%@Q4M@@YZ  &A))=VWQ2EN;'1T>^N-!1I(6F6,!O/;[[@'G
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M+0W,!E4;RI\Q,,,.-N,\\$UG6'@Z\L-!L](FDTW5+2%K@RQ7MM\LOF2;U;N
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M4PG2>+<$^4X7#;BHP0.HYQ4K^/+*ROY+?4Q;1(MC)?":VN1.NR/&]6P 0PW
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M \]GC4;8>2VT,?IC\>] '?T5PJ^/9[2QEBU.UMX]2CU@:1F)F,+,4$@DZ;@
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M25&?F'TH HKX8ECU"XU6'4!%JEPT1EECMP(W2,. A3.2/WC$DMG..1@53N/
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M+>V$8*^6VS<"2<Y^1<'^=='15*YU:PL]0M+"XNDCN[LD01'[TA )./P!/X4
M<U'X $5K#:+K5W]EMM2_M&VB:-,(_F&0ACC+C<QZGI^!KLJ** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRQM5LDN87CWR0+]U'#(58#L=N?>@#3\.7VH:CX?L[K5+(V=\ZGSH,$;6!(R
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M$GF!5+I]U>",@<'G:..M9LFK>)=2,T=G=7=MJ\.KFV>T%JK0I;;_ +Q8J?\
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MM-LJXD\N-<*6&3@DD\>FW/(JUK&O0Z+<:;%/;7$@U"Z6TCDC"E4=LD;LD'&
M>@/2M6@""]LX-0LIK2Y5FAF4JX5RAQ[%2"/J#69<>$](O+6YM[N&>X2ZB$,S
M2W4K.\8S\F[=G;R>,X/>MJB@#,E\/Z;-+ITLD,C2Z=N^RN9Y-R;A@Y.[YLCC
MYLU0M? _AZR^R?9[*119S&:US=2GR&(((3+?*N&/RCY?:NBHH P6\&:$]AJ%
MB]K,UMJ,AENXS=S$2N0 2?F[@#/K@>E;4,*6\"0IOV(-HWN6./<DDG\:DHH
MQ8O"FC0Z?J5@MM(;;4R[7D;W$C^:7&&.2Q()'4C%12>"]!EG::2TD9GMQ;2
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MU+&(-L)/?CGO6U110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&4$,0<C=SGN,TR3PWI$I0M8Q_+$(, D Q@DA& /S+R>#D<FM-55$"(H55&
M, "@#QNQM'C^$OAUQ?SL9M8L]F_81$?MG51M]\\YZ5M:YJNJ>$-3\11V-]=W
MJ1Z"=1BBO'\WRYA(RE@3SMQ@E>G':NQ'A'P\L+1+HUFL;3>>4$0 \S.0V/4'
MD>E7GTG3Y+Y;Y[2)KI8?($I7+>7S\F>XY/% '-:79ZW<WNFWL-VZZ;/:.+MG
MOC,9BR@QR1@KA3G.<8&#TX%<E;:IK6G?#2U\4OKE]<W5R4M9/.=?*A1KD*9
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M75K!?6LMK=1)-!*I5XW&0P]#5%_#>CR6LUM-8130S@+*LV9/,49PK%B20,G
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M''=PB18W$D9R048 C<".0<$C(]: //&UNY:+3/(EU?3Y8O$<-E=VEY,)"H=
MQ3?EMZG*D'/\6*N:IX@O])U_QI);7,EV-.T:*[AMG;<L<I\XG@=L*A]<5UUQ
MX>TBZTQM-N-/@ELW?S&B=<AGSG<3U+9YSUI;3P_I%A/YUIIUO#+Y?E%T0 LG
M)P?49)//J: .7U/3UE\#ZAK4>KWMRL^ASM('N&:*8M%D.$SM3'/W0!S5.R6\
MTBY\#3PZK>R1ZDJVUS;RR9B9?LS.I5,84@H.1U[YKK(?"'AZW@F@ATBU2&92
MKQ*F$*DY*[>@![@<&K1T+2V@LX#8PF.R;?;+M_U)P1E?3@D<=J ,;XBW5U8^
M!M0O+.\FM;B#8RR1-@\NH(_(FJ=]%=7_ ,2I=*;5K^&Q?2!<&&";9A_-VY!
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M$LXDB6103*8RQ5#QL!&2S9S\O7)KK%\-:)&MPL>EVR+<QK%.J(%$J   ,!U
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M<%B9(B(G<' /'W.] &[/:6URR-/;Q2E/NF1 VWZ9Z4^:&*XB,4\22QMU1U#
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MS(>4'!PJ*0S'GC/H: -^;3;"XMDMI[*VE@CQLB>)65<>@(P*LJJHH55"J!@
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M&>[%" ![DD "N(CL=-L8/AWJ=I;0PS><D5Q<HH#%6MG#"1NI^<*#GN*]0HH
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MTH TZ*Y^V\;^';O5X]+AU'-U*S)%NAD5)67J$D*A7(QV)KH* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
,B@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>ameh-nonqualifieddeferre013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)\2ZT?#WA
MZ[U46WVDVX4B+?LW$L%ZX..OI6M7/>.-/O-5\&ZC96$!N+J14\N(,JEB'4XR
MQ ' /4T 1P>)=1M]6LK#7-%6P%\[16UQ#=B>-I I;8WRJ5)"L1P0<5IVGB'1
MK[4)-/M-4LY[R/.Z&.9688X/ /8]?2N>O+?6_%6IZ4MSHT^CV-A<&[>6XGB>
M21PC*BH(V8 9?))(Z8[UDV?A[6KG2?#>@OI;Z<^C9$NI>;&4?$+Q9BVL7.\N
M&.X+CG.30!V4?BKP_,UTL>M6#FU0O/BX4^6H."3ST!X)[&EUSQ#8Z#IU]=7#
MB1[2V-R]NC#S"F< X/0$\9/%<5/H>M:EX*7PZ/#<-K<6FD268NYY(R&DV*H$
M)4DA7*Y)8+QCOTORP>(]3UK4-5@T-;,MI2VT,.HR1N)7$I9D8(S84J2 ?Q([
M$ V+/7]8^T+'J>A1V\4L#S0W-M>>?$-H!VR-L782#P>0<'FK+>*]&M;:R?4M
M4L+.:Z@6=8WNE(VD=0W&5SP&Z&N/L?#MW_:8ET;PS=>';;[/.M[ ]U'Y-RS1
MD(J1H[*"&(._"\ CO65=)<^'/#NOVES8PW<DV@VT=P#<Q VC);E"L@9LE<@E
M2@;))'O0!Z3<^*O#]G.D%SK5A#*^W:CW"@G< 5[]"".?<4>)M;?P]H4FH1VH
MNI!+#"D)D\L,TDBQC+8.,%L].U<>?#&I3^&_%D:V(,^IZ5!!:AF4&1UMMNWD
M_+ASWQ6]XYTF[U?P3+86UFUY.9;9VMU=5,BI-&S@%B!]U6ZD4 7;35=7C,\V
MN:79:;8PQ-(]RNH>:%QR<@QK@8R<Y[5-;^*- NA<&#6;&06[*LQ6=2$+-M7/
M/<\#WKCI-#:70->L=,\$7FEW-YID\"2RW4#*[,A"I\LK8R<<XQZFM:_\*-J6
MKK#-;B/3I-!DT^1T*C8Y="H SG@ D'H,4 =)=ZOIMAY_VN_MH/(C6:7S90OE
MH20&.>@)! ]2*SYO%5@8],FT^6&^AOKX67F0R@B-BK,2>O(V]..M<;+X5\27
M_A\:CJ,;#76U&WN9X+::/<T4"[%5&;*9SNE ;C+8..UBU\-:K->PWYM+^-I-
M8AN)&OKF%IO+2!T\QECPH.6 P"Q( SB@#M;;Q#HUYJ,FG6VJV<UY'NW0),I<
M;?O<9[=_3O3=/\2:)JUQ]GT[5K*ZFV>8$AF5R5XY&#R.1^=<;I>B:PMAX7T:
M;2&M?[#F$D^H&6,QS!8W3,>&+DR%LG<!C)SGBLKPWI6I^(_!?A*UM]-?3(K/
M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@GD@<]: -JBBB@ HK&77UOM"GU+1K2743'*\*0*1$TC))L?!? &"&Z]<5LT
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ML9K@Y[.]T;4K2+P9XAOM3#P3^=93W8NXHD$+&-@QR4_>; !GG/H#7J! 8$$
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M3C^$?7%>B;5'11^5)L7*G:,KT..E  L:(<JB@X"\#L.@IU%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !6%;:%<P>,KW76O8FBNK6*V^SB @J$9V!W;N3ESVK=HH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEE:6+(@AC5BH+$J2S$@YSQ[5S]QXMU\^&/'>BWNI2C5_#@WP:A !&\T9R5+
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ML[!?8%B!["N3\3>'O$VMVOB.RDMA<BXE5M/E:]V1)$-GR>5_?R&.XCOUX H
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M!=(L\'VB"62+:DL?R\@]OO+P<'GI6#/I^KR^,)=472P8&T5K-5FD0@S;BX#
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M6-4$:B*UU#0OL"SEQ^[F\QG&X9SMY XSUJ_HEA<JUM=ZAX=ECU"SA95E>_\
M/&X@!A#N8X#8_BV]NM &%I/B>._\*P:_<ZKJUA<W]Q;K(1:2/"F9<+'&&38
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M_,4LKHZR2N^.#Z-@YJMX!TJ[L;!UOI%F%BTFG6,F<DVT<A 8^C'"J?\ KFM
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M8E6*Y(# 9QCKQ6<_Q$TR.RGOFT_5?L5K<O;7=Q]G&VW=6VDM\V2 >Z@X[XH
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M$*7  W;@2H)&X#./6J,?Q#TR2QM]0^P:FNGRW!MGNVMP(X9/,,>'^;."PQD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 1SSQ6UO+<3.$BB0N[MT50,DG\*R/"?BG3_&.@
M0ZQIOF""1F0I* '1E."& )]C]"*H^-IY[BVL]!LXHY[K4YMKQ22^6#;I\TN6
MP< @!.A_UE<7X*GNO"'Q6UCPUJ$$-I;:XIU*RABF,B))SO5257J W&. @H Z
M=OB/&=5UG38/#NL3W.CJ'NUC\CY5(W KF4;LCG YJY8^.;;5]%TO5-&TO4-1
MBU$2&..(1H\>PX;?O=0.>.":\TOH=:NO&WQ13P]<^7J @M6"!0QF018=!Z$C
M.".<XKTOX<ZEHNI^!=,ET&!+:RCC\LVP.3 X^\ISR3DDY/7.>] %/1OB/#KL
M3SV?A[6#;17RV$TS>0!%*65>0)=Q +KD@&K^@^-K?7]?U71XM,OK>?2F5;MY
MS%L0MG: 5<DYVGM7,?!%E;0?$>"#_P 5!='_ ,=CK-\.VTVH^+?BY8V;A;FY
M6.*$YQAS%*H/YD4 =K9^.$UDSOX?T:_U:T@<QM=Q-%'$[#J$,CJ7QZ@8]ZJW
M_P 2+/3K72)YM%U7_B:71LH8]L09)Q(8RC R<'*GGD>]9OP9UBQD\!6FC,Z6
M^I:8TD%W:2';)&V]CDJ><'/7UR.U4_BI<6LMYX$E@FB>'_A(H3OC8%<A_FY'
M'7.?>@#T/5M4_LC1+G5)+2>9;:$S20Q%-X4#+=6 .!GO]*P]$\<_V]9Z=?6W
MA[5DT^_<+%=2&#:.2,LHD+ 9![59\4ZG93>&/$%I%<1R3II4\K*ASM4HP!)^
MH/Y5QGPR!L_!/A6^G\0R_9@#$;!Q'MW2.8T"[5#GYF'WB1SGM0!Z)K.N6>A0
M0279D9[B9;>WAB7<\TC=%4?@3DX  Y-,T/Q#8^((KDVGFI-:3&WN;>9-LD,@
M[,/U!!(/K61XW\,WVO#2+[2[Z"TU#2;L741N4+1.,896QSC'?Z_48GPMM;Z;
M4O%>OW4B2Q:G?@02Q(4CF$0*ET!)^0DX!R<[: /1Z*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BN"F^(6H+X@U[1X/#R33Z+ +B=
MOMP4.A4,-N4ZX/0X^M1ZC\4X;7P!IOC"VTF6>RO)/*,3S".2-MQ7T((RK<Y'
M;UX /0:*PH-5UUIYH;G08H2L!EBD%[O1V! V$[/E/.>AZ5E>!/B)8>.[&Y:V
MMWL[^V/[RSG?Y@I&5<''*GUQQ^60#LJ*X?5/'MYI'@V_\27.B1F"RNGMI(DO
M,L=DQA+#Y,??'Y<^U:VFZYK=\UN9= C@AN;9IXI1>;U!P"JOA/ESGKST/6@#
MHJ*X+0/B!JGB.SO+NQ\,[H;.]:RF'VT;]Z[=Q5=G( 8'MWK0T_QE<7WC^_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M91\O)W.4(]0K=JY+P'??\(=\3]>\(7]Q9QPZDPU"T6&3]VDK?>C&>02.@/\
M<'K7KXBC!!$:@CH<=*#%&6W&-=V<YQS0!\^K#=Z[>?$Z+0-11KK[;'.MM&X(
MOH5W[X^.2"./E/H.]>N^$-=T+Q5X(M[BRBMXK V_DSVG 6WPN&C8=@!GZCFN
MF6*-#E44'U Q0(T4$*B@'J .M 'DGP06Q4>(8(;H3FQOY+2S5I0YCM0Q9=O^
MR68DGN<>@J]\?)$3X9R!F +7D(4$]>2>/P%>FK&B'*HJGV&*5D5QAE##W&:
M/.?B-KUAX@\'W?A[0+FWU?5=2V0PP6<JR[ 6!+N5)"* "<G%<YXXL[71/$/P
MLTJ[U(6Z6,<L,MR)A&4"QQ+NW'[H)4\FO:$C2,81%4>PQ0T:.<LBL?<9H \U
MU*3P;?\ A>_T34M:_M/39+R,RWRW*MY#RLQ3,H)&5*]^Q&>M9_AR"_T#XDV&
ME:1XMO==T)K.66^2[G$XM !^[^<< EL8'' /:O6/(B*,GE)L;AEVC!^M)!:V
M]K&8[>"*%"<[8T"C\A0!XEX8MU\2:9\5M)TVZA>[O=1N6MU60?O 2V"/]DG
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF!DCW+)@<@C(QF@#I**\LT7QKXCN]9\(PQW-EJL.L68N-0A@@VM8 HK9+!B
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"-QY  R.I/;!S_[5UFUUZQ\.7%S:R75TL]P+Q8"N($V #9N(WEGQG.,+G'-
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M5KGP3?>+K#[-]FM6GD2RDC.9(8796W/GAR$8C P,@$'K0!W=%<1/KWB/4/%
MTS1Y--BMY=+BU&*2Y@<LNY]NPX;G('7 QGH:[>@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[K^GZR]U<I/8+(D,:%-F'QOR"I)SM'?MQBM:F22QQ!3)(J!F"@L<9)X ^IH
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M0!SUA>:GX@N_$-M%JLUC)I=P+. QQQDLPB5_-<,ISDL>!@8'KS5C0]<O=?\
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MU'<SP+*LW[R\F+%U(*L6W;C@@$9/&* !;/4+/P[>076JO>7)65EN9(44@')
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MOC#,+JSB\F&5;F56\O(.UL-\XR <-GF@#CX/%6JPZ0L4MX9;BY\3R:.MTT:
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M6\\9*ER3SD'!XXH ]!HKA%OI/#7BS6;6YU>\ETR/1AJ3-=-YS0,'=6*\9Q@
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M+B?3K^QGEFAGE:7R'C9 KAF)(#;]N,XXH ZB[O+:PM7NKR>."!,;I)6"J,G
MY/N0*BDU&&/58-.,<YFFB>57$3&,!2 07Q@'D8%<S\48FE\!78$[Q#S[;.S;
MR#/&,'(/KGCT_"EE:]LOB!HNG?VK>36\^G7;R)*R_,Z-%M;Y5 R [4 =A17D
MEQ=:O%X1U;6T\0ZC]KT[79;:#=(#&8A="+:Z8PWRGO\ ABM;5-3U/PKK>OQV
MM]=W\<>@/J44-V_F;9T9ERO PIXRHXXXQ0!Z+65X@UZ#PYIG]H7-O<30"6.)
MO("DJ7<(I.2.-S <9ZU@:#'KEU<Z%JD5P3836Q:_,UX91<;HP4=%QA3N_N[1
M@GC@5+\3LGP#>8<(?M%IAB,X/VF+F@#KZ*X:?3]1M/&EMIEMK6ISVFHV%P]T
M)9MS6SH4"2H0!L)+$;1\IQTXJ#PK>7NM6VEZ=<WMR-0TF:5-799VR[H2BJW/
M20XD'LI P#0!W[NL:,[L%11EF)P /6L:^\3V5D-(=4EN;?59T@M[BW*M'N<%
ME).X'! )R >E6/$*L_AO4U65XC]ED^=,9'RGU!'Z5YV+.2+P'\.HQ?W!,U[8
M%78(3$#;MPGRXP.V<_C0!ZM17ENMZYJOA'_A+X+34+JZCM+2SN;=KM_-:W,L
MCQR$,1R %#8.0,>E=9I-GK,7B%;C>RZ1):$20S7C7#&;<"KH2.!MW C('3B@
M#1\0Z_:^&=)?4[Z*=[6,J)&A4,4W$*,@D$Y) XS4,7B>T_MNVT>[MKNQO;M'
M>V2X08F"C+!64L,@<D$@XK'^*_\ R375?]Z#_P!'QUJ7FDQ#5H_$6K78<:7%
M,ULJ1;$A5E^=SR2S;1C/ QGCF@#?I&940N[!549))P *\ZTS4[X^*O#3PWE_
M]BUFTG>1+NX5VE"QJZ2B,96(\]%..<$#%-T2VU+4M$UW4+KQ#J3FUN=1M(XM
MR;-BNRJ2"O+ #KTQV[T =Q+K5DEM87,;27,%]*D<$MM&95.X$AB5SA<#[QXZ
M5H5Y?IQO-*\#_#^2WU:\VW-Q8121ED"F-X\E.%!QP.IS[FMJQ>?Q;?>)+:;4
MKRQGTZ^-K;):S-$8E$:E9& (W[B2?FR,# '4D ZNUU&&[O;RUCCG62T=4D:2
M)E5BRAAM8C##!YQT-6Z\_FO=0$GQ"@&IW7^@1I):L' ,)-MYF%XZ;C5=UU:T
MTSPAK%IK>H7%[>S6D5Q;2R[HIXW4&3Y,<%5RVX<_*<YH ](HKS34=<N9+O2M
M8TN^OOL\VNI8,\TX$4Z&4QLB0C(P,$!CAOESS3GCU&^/C?=K^J1_V7.39^5,
M%\LBW23G ^8;B>#Q0!Z'+>6T-S!;2SQI/<;O)B9@&DVC+8'? ZU'J-ZNFZ;<
M7KPRS)!&9&2+&X@<G&2!T]ZX"4W.M^(?A]>RZA<0376F3S.8 @PQBB+$94]=
MWZ<8KN=>_P"1=U/_ *])?_0#0!+I6H1:OI%EJ4"ND-W DZ*X 8*ZA@#CO@U;
MKR[3;?4M-\-^!-0L-7OI9KK[%;S6;.##) T8W@)C@HH+;AS\ISFKL4]_!JFN
M^%)=1O#?W%S%+IUPT[;UM9!DE>?^6>R7KUPH.<T >B5C7'B."&>]"6EW<6]D
MCFXN(%#JCJH8QA0=[/@@\*1VSGBM>-!%$D8+$*  68L3CU)Y)KRZPBN[+PI\
M0-0M]8ODGMKS4'CP8P%=%#!N%Z\8],=J .[E\1V\.M:5IC6UT'U.)Y()2@"
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M2T273X"EF=ULH7 A/JH'0]>15?2]=?4/$.M:3)9B%M-,.)!+N$HD4L#C Q@
M>O6MJ@#-NM TF]ENY;G3X)7O(A#<%DSYJ#HK>H&3CTK0CC2*-8XU"(@"JJC
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MQ>']'@6Z2+3;58[M0EQ&(QME4*% 9>AX 'T%0P>%=#MK.2TBTR!8) %9,$\
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MX)8XS$KHN#L)R03W&?6H(_"'AZ*TCM8](M4MXI?/CC5,*LG9@.Q'8]NU;5%
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M@.1MYVYZ\XQZO;Z;8VBRK;65M")?]8(XE7?]<#GK3DT^RCB>)+2W6-\;D6,
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M;PP3F2[@MY%DD*E5DD5-P '.-WM7-7]I9:/X_P!)GT&&UMY=0TJ]!>+"K<R
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M17#X'WOW95@?4-6IXITS3],\&V=Q/:VUO>W6L6MY)E%5E9KA&8?\!3Y2?1:
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M^2JFZ0%I./E'/7D<>XH U<8HP,YQS5*UUC3+Z\N+2TU&TN+FW.)H8IE9X_\
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MH   .@KGSHU\?'HUS-O]C%@;+R][;\[P^_[N.HQC/OGM7044 %%%% !1110
MF!G..?6EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#F/B)%-<?#[7+:VMY[BXGM'BBB@B:1F8C
M&%!-9]R[2^/_  Y>+8WIMX]-N8Y9?L<NU&<Q%58[>#\K<&NWHH \A&DW[>"+
MG[#I=[#-;^(FO9H$LS'--:BZ9QL#KA_EPP7!Z8QVK6US1K?6O#7BC4+#^UM0
MU"[TDVP2[LS#O*AR@5#&F7!8\\GG%>D44 <!</'<>(?!%U9:9?);0O<-*W]G
MRIY(:!D&\%1MRW'/UZ<UBZAI[W'A7XC1+HUZUQ?7<C6J_8)-TP\F,(5^7D!U
M;Z=:]9HH X'4+&=O%/A^XTVRN+</H]W:^>MJZB%SY7EJ_P OR\AB,XZ&J7A'
M38[G2?#FGZJVNP:EHSHWV:2S"1)*B,A/FB+#(P+'.\YSW->ET4 4M+U$:I9F
MY%I=VO[QX_+NHO+?Y6*YQZ'&0>X(J[110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME?E)P3G./2@#TF.[MI;F:VCN(GGA"F6)7!:/=RNX=1G!QGK4U<'<^*)= O\
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MM@=B "#UKMZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"L%MJXU274+^[NS:&SD>X=")8]V[D*H .?[N/QYJSX>T*+PYI$6F6]W=7%O
M D/VEE8QH. @*J.![Y/O4NFZWIVKO<1V5R));9@D\3*R21$C(#(P##(Z9'-:
M% &-<>'89O$8UR*]O+:Z-L+618639(@+,N0RGD%B1C'OD<52C\#Z>GA,>&_M
M=ZUFLRS(Y=/,5A*)1@[<8WC/(-=*S*BEF8*HZDG JL=2LQJJZ8;B,7S0FX$&
M?F,8(4M],D"@#(3PE%;ZK=7]CJFH637A#W<4#1^7.X &\AD.UB ,E=N:Z$#
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M75W'"9&;#;T94XP"%(.!][OBNBN?!NB7B:BD]M(RZA.MS,/.<8F4 +(A!RC
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M %2^Q_PM30?^P3>?^C(*G\9:AJ>G?V(=,NT@:ZU.&UE#Q!U9'SGW[=B*T?\
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M"LZ?7[:#Q!I^CM!.9;^*26"90IC(0 MSG.?F7MWK(^)ZLWPS\0[97CQ9N25
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M@G"@Y&<<'''<\U;LOMVCW'@:>+5KR6/4E6VN;:1@8BOV9G4JN/E(*#D=>^:
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M(HX K,\0Z]_8$-E*UI)<)<WD-H2C@>69'" G/49/:MB@#*G\-:+<W=W=S:;
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MA*JT4[;=L@W$?+CS 0#U8'![=99ZC::@]TMK.LIM9S;S;0?DD !*_DP_.K5
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M'L*[2/3-/AD>2*QMHY'C$3,L2@L@& I..1@ 8]JKP>'M%M;>>WM]'T^&"?\
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M5U6O+N\/:C^\EC(MI&#Q2-&RD*2"&4@CI5B#3K&UG,]O96\4Q01F2.)58J
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MA&T7Q-INL6NB66C+8I*"MNB+).77;M;8,;!R>23G' QSU] 'D.H7.FZKX/\
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M;KH4/P?M=GV5=0AU&V2<$CS(W6[&0<\@A-V?;VKK+B]T:?QOKECXL:R-G-!
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M&@#\;"QVD$X!;BJC?V;/=>!KO6--M=/MF>^A,>\FWSSLV$X^5S\RC R" .U
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MEX/BAU>PT#[7K=E;:]8W(DNH/LY6^>49$B2$R;B&R<G;C&#VH ]9IH=68JK
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ME%(S!5+,0 !DD]JIQZOIDMQ';QZC:/-*I:.-9U+. 2"0,Y(!!_(T 7  HP
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MMX%^]),X11]2>*A?6-,CLX[Q]1M%M9?]7.9U"/\ 1LX- %VC%5VOK-4B=KJ
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MLO(DG^V6_DQMM>3S5VJ?0G/!H S;;19)/$BZ]>K!'<Q6K6L44!+!59E9BSD
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M"4*B,,!F.6RYZ'TKH;O4++3T5[V[@ME;@--($!_,T 3[5W!L#<.,XYI:0$,
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M I:I#6-,::&%=2LS+/D1()UW28.#M&><$$<>E00Z[:S^([S1%5UN+6"*9V;
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MRQ1M:M(+*/R@&G,2\@LZG .,;@2.U8^IV7_%,^-;4V5Y*9]6MI[9'LRKR B
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M ^:R ' 8F0;L?+N[ UZ+10!R6C3Z9X>CCCMY[Z\;6]3=XPT&W$C+N<JI"XC
M0L3SR3US76U UG;O>QWC1*UQ&C1HYZJK$$@>F<#\A4] !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@!DL,4Z;)HTD3(;:Z@C(.0?J" ?PI]%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCG16R8V(# '\"*LT %%%% !12$@$ D9/0>M5K/4;2_:Y6TG64VTQ@FV_P2
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MLP:XV@F-(XRY"@\;CP.<C&>#6!J?B/6]*_X2[3Q=)+-I6G+J-G=R0J25*O\
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MNUIJUU8%/LKHUL$R6^S@@MN4Y'3CBNK\):E<:UX,T;4KIA]IN[**65E&!O9
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M_<F9+A='>V4HEY*CRI.&.[:5)^4KCJ>".,9J&;4)]5\:WOAX7<MG!:6,5R#
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M(W5T<!E93D$'H0:\MU.]U23P[\1=)NKRZ,-EIHF@^TF-Y4$D,A9&91@@[?J
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MFLBR;4]+\!^-]3M-;NTGM;[4GC'EPE0Z2,=W*9R<<C./3% 'JL;K)&LBYVL
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M@*&'.,[NG'/:54>^V:K#8?9+IO,B:7[0L>84VD#:S9X8YR![&@"OI7A_3-%
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M-F5"[ $A00"Q].>*P-+\5IJ?ARUUF/3+XK<7)M_(B022)B4QEFP<;05R3V%
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MSR/6FVOB9;B[U^W_ +.NQ)HVW?&FUWGW1^8-@!Y)&,#/4T 3P^%]%@%X([!
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M&&.0S.<(<97!.""0"<]2,GFF>']>77H;YQ:2VS6=Y)9NDC*263&3P2,<UKT
M8-IX,\/6)MC:Z<L1M93+;E9'S$Q!!"\_*N"1M'')XJQ;Z78^'X+ZZT^SN'DE
M+7$L4<K.T\F.2 [8+G &3CMS5O4K[^SK,W'V2ZNOG1/*M8][_,P7.,]!G)]
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M/HVEW20I<:;9S+!_JA) K"/_ '<CC\*<^EZ?)>I>O8VS7:#"3M"ID4>S8R*
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MEOKN2UT[6(8X#-<,[)&WD-L+DDE07;&3Z>E>GQZ#HT,D$D6DV"/;_P"I9;9
M8^_RG''X5(^D:;)]JWZ=:-]K&+C="I\X?[?'S?C0 T6$,FDM8K<7+1,K+YPN
M',@R3R),[L@^]>8V6O:S:^%["\-S</\ \(S=&+6][,[7!#M$^222=L?[W'3Y
ME]*]7M[:"SMX[>VACA@C7:D<:A54>@ X IOV&T,,\)M8/*N"QF3RQME+##;A
MWR.#GK0!P'B-9K;P#?:U#?W\4MW>P7$++>2@)$TZ(J@;N 4.2OJQ]!6SD?\
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M'1+Q?$_B#6+6_DO([>&TM)+*%IFA<121;FD.TC+[LJ3VVX&.<Z/@B]U"_P#
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MYVC^RI&N8F ! P1AB2/FR<Y'%1:8M[KGBK28-8NM0A:[\-)=7EI%=21+YV]
M3A2-A_W<>_?/>S:/IES>"\GT^UEN0 /.>%2^ <CDC/!Z>E/.F6!U#^T#8VQO
M<8^T>4OF8Z8W8S0!S'@C5$@T&2WU'4]YAU:ZT^VDNY\R2;96$:;F.6; ^IQ7
M8U271]+5MRZ;9AO.^T9$"Y\WGY^GWN3SUY-7: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*[8+LD8J67(SN4,%)!(^N.* .BHK.U#68;&]M+!8WGOKL.T,$> 2J ;F))
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M?484L;I1<K>,KK$3&A"PA"?E(*G'4LQK,U&_NI_B9X662PU"R1ENL^;,IBE
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M'B%9C'IWDM.[RK@QJN=VX>H((/TH UJ*Y\>*XA>6=K+IM[%)?P/-9AO+S-L
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M11W]Y\2GAU);:">;P\Z%+9VD5,S 9W,%)_[Y'XU%;>%?% T/PQILYTE1H-U
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M"K+<JKMYPC_@P,#. 2>?<]:^JW6E>'--:UM;23_1$):[O!;1Y"KA0VULL>W
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M!H>J+?0Q#3#(S1&W+>:70HW.\;1@\<&J$W@H:E?V5UJQL9I;21G^TP6OESS
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M AD"%R#OW')^<]JQK?P1JD/A_0-);6K1ET6ZBGAD%BP,BQ@A5;]YUP3DC\J
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M*5@-Y1@Z\'&<$<'\J9K/A!M?E=-1>QEA%PDT,_V7_2855@VQ7W<<@C<.QZ4
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M#.MI"D*2,H4E5  SCO@5?JC:ZO87NHWFGV]P'N[,(;B/:08]V=O48YVGIZ4
M<U#X \BTM;1=:NC;66H?;[6-HTPC;V<AB!EQECU/^-;.E: ^F:YJVI_;6F.I
MR))+$8P A5 B[3G^ZHSGO6U5'5M7L-#L'OM2N!;VR$!I"I(&>G0&@#G)/ 6_
MPUJ&@#6+D6%W<-,H,2%H0TAE90<<_,>ISQQ[U>N/"\QU\:Y8:H]G?RVZV]WB
M%7BN%4DJ2IZ,,G!!Z''-='10!@IH1M?$Q\0SZDS%;$6;K(BJI126W$C&&W$G
M/3'&*Y3X;:/_ &O\/-)6]U1KS32 XLPB *RON"LPY8 @'!_'(XKT6XEA@MY)
M;F2..!%+.\C *H[DD\ 5DQ>*= WQ1I?PQB=PD3LI2.5CP KD!6)[8/- &1?>
M 4O8M;MO[8NXK+5IQ=2P*B';+\F2&(R5^1?E_P#U5K66@26GB:\UM[XRRW<$
M4$D7E!5 CW%2.<@Y=LUMT4 <A#X$%MH^CV-OJUQ')I-V]S;7 B0M\P<,K \'
MB1N?I^/2W]K-=V#00W<EO-E2LZ@$@JP/(Z$'&"/0FK5% &1IVA+::O=ZO/)'
M+J%U%'#(\47EKL0L1\N2<Y8Y))[=,4OB+0+?Q'I@LYY98'CF2X@N(2 \,J'*
MNN01D'U'<UK44 8W]E:LUD8Y===KD.C+*MLJJ-IR05')W=#S],5FWO@>WO[#
M54ENS%>ZE-!/+<V\00*\+*T>$.> 5YR23D\],=710!S,WA*6763J?]M72336
M2V5UMCC_ 'JJ6((X^0Y<].WOS44'@D6MKX<CM]5N(I="C:"&41H3)$RA2K @
MC.%'(_*NKJC::O87]_>V-M<"2YLBHN(]I!C+9VYR.^#TH R=.\+3:->77]F:
MO/!I]S<-<O:&)'V.QRVQB/E4GG!!ZG&*Z2BB@#&F\-VDWBVW\1,S_:8+8VX0
M'Y6Y)#'W 9P/]\TW0O#5MX=M+V"PE?\ TFXDG7S!N$6XDA%']P$D@>Y]:VZ*
M .0C\"K%X6LM$CU6=6L+Q;RVN?+4LKAR_P PZ,,L?3C%:=EX>DM/$MSK;Z@\
MTMQ;1VSQM&H!6,L5/'?+MGM["MRB@#D+3P)'86>EK:ZC*MYI4TTEI<M&#\LI
M)DC=>C*<]L$8'/'-F]\&6FI:9K5O=W,ANM7"?:+J-0I78!Y80<X"XR <]3D\
MUTU4=4U>PT6V6XU"X$$+.L8<J2-S' ' [D@4 9%OX6N5UZPUJ\UJ:[O+2"2W
M.Z%41T<J3\J]#\@YY_D!;\/^'SX?6\ACOYI[6:YDN(X9$4>29'+L 0,GYF/6
MMJB@#(\3:$/$N@SZ2]T]M%.5WR(H+8!#8&>!R!5>7PT]QXC369K]BXL6L6B2
M,*I1B&8YSD-E1CT_6M^B@#D--\"G3O[!SK-S.NB%EM4>) OEF,Q[6V@9.T_>
M_3KE^G>"196,FESZI/=Z0\S3_9)(D&69S(5+ 9*;B3C\"2.*ZRB@# B\.2P:
MUK.IQZ@WF:I%'$R&($1A P4KSUPQSGK[51A\$>1I/A[3DU23RM#F6:W8PC+E
M49%#\],,W3%=;10!SPTNWT'6M6\13ZL;>RNPDEU%-L$:,B! V\C(& .,]:@\
M'Z1:VLNK:K:.[6VI7;36X)^58SR2OLSEW'J&6NG(# @@$'J#2T !S@XX-<FO
M@6W?1M3TRZOII8[Z]:_$J($>"<N'W(>>C $ @^^:Z3[=:?VA]@^TQ?;/*\[R
M-XW^7G&[;UQGC-6* ,2+0I7U&#4[^]6YO[6!X+9Q!L2/?C<VW)RQVKGD# P
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MAC957!"XY 4<YJ=_!T'V^QU.*]GCU:VE=Y+P*-URK\-&XZ%.%P/X=HQ72T4
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M8P&4%\3<*N1QG/7M^==)<^%+6;6/[7@O;ZSOWA6&>:VD5?M"KTWJ5*DC)P0
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M:G<BX22."V>X9VBD\LM&G9"1DENF5&><U4M?%WB"^T7PI=1FQAGU2^EL;D/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2%YZ#@'DT =A17._\)UX:&@RZVVJ(NGPRF&:1HW!BD'5&3&Y6]B/2JX^)/A
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MU5%0VUW;WEG%=V\R2V\T8DCE4Y5E(R"#Z8KC?"GQ(T_7K?7KB]GM+2+3+N9
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MPR#[4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS1NB6,NGS8;&#W]/?'KE% 'G'B>RU+5=8\'7^G^';V."ROWO+J,B)&C#$Y)
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M V2P*L0J[> -V3WQQ0!Z?7&>.]>U3284ET@;_P"S@NH:B@&2UL&VE!Z%AYC
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M'^WXO;%2J!!YN]<_\M,_,>JCG% '5KXCLW6W6..X>ZN!(T=H(\2XC;:Y(.
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MNS"D4V6W-(HY?(*8Z@8[9S0!)J/C6"VUSP[;6JO<6.JP2W!FBMI924"*4*;
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M<I*AE(*D@@J00<_D:Y[2;B;QAXAUXW-S<1:9I5X;""UMYFBWR*H+R.RD,W+
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MCY[XE!MY&.X9PW*@Y/->HT %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK.MO SV(U V.F:?#97<443Z/)<O);28DW.QRA"$KP,+[G';OJ* .9\)^&?\
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M%A$,L<8Z<<=:;XF\&7?B/5M0=YH(K*^T7^SV8.QDCD\PN&"[<,N2.X[UVU%
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M@'V/4]O1UH X*V\)Z[;Z#X.L/^)>TFA31R3-]H?$@2)X_E_=]]^>?2N]HHH
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MM/MB)!<I*LD>[:03QM8''!]>":9JOA*[UJRU*:YU!8-6O+$V,<UNA"6Z%MQ
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MVADMB)+&_(WAI<#Y\*00P7<!GAN]12>!;VYTG5+:748HKJXU8:O:7$49/D3
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MEO<P7ENEQ;3QSPORLD3AE;Z$<&L-]9O=3O\ 5+#1X;5FTYUBF>[+;9)&0/L
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M.10RL/0@]:;:6=M86L=K9V\5O;QC"11(%51Z #@5/10 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1G<H9=O+AN .HR>*Q;_1=-B^"EL(-*7^T)K6PCG5+8^<\B,A8,,;LJ"_T&:
M/3CK.EB*>4ZE9^7;MMF?SUQ$WHQSP?K4>H7\T2V#V1LY$N+A$=II]@\H]63
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M-FN8[:+4+1YY$$B1+,I9D(R& SDC'.:S&TZ"Q\ -IRO-<00::8E:Z7YV58\
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MO6;&)[? F1IUW1DYP&&<CH?R-6WU;3TLH;PWD)MY\>3(KAA+D9&S'WLCGC-
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MU2VUC38;VUFAE2106\J02!6P"5R.XS0!=HHK.AU[2KB[CM8M0@>:7=Y2A_\
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MJP#!1M;D@<OQ75^(M";7[>SA%V;86UW%=@B/<6>-@R@\],CG^E; SM&2">Y
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MO<Q@&51!&I.5 7.0>.H[BO7JR?$VB#Q)X>N]':Y:WBND\N21%W,%[XST/YT
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M);K.A+1LF\$*22,9Z=:X_P 5:#-J6L275K9ZK#>I9B.VU'3KQ823N<^7(&<
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M:T@O%B>6&XD+*\;JX&5^7Y6(SDB@#T?3-6L]7@DELY"PBE:&5&0HT<B]592
M0>GX$'H:Y?5+Z_3XDV^EG7+BSTR72Y+MU580%=9$0?,R$@?-Z]:W] L+>RM[
MB6'39[%[J8S2I<3>;([;0-S-N;G  ZG@"L:ZT[4)?B?:ZI_9DDFFQZ9)9O,7
MCQO:1'!VEMVT!3GC/M0!SHUSQ ]C!*VJ2RVT?B>WLK>[1$3[;:M(@.["X(!+
M+N7 .#7<:IXITG1I&6^FFC2-U269;>1HH2V,;W"E5ZCJ>XSUJCXTL+^_M=)C
MT^R>Y-OJEM=2!71=L<<@9OO,.<#@?RKG?%>C>)]=L_$^GM83SK<*!IKK>K%
ML>U<JRA@2^[<?F!'3!% '67GB_2+'4+C3Y'NI+VWC65[>&SFD?820& 53N&0
M>1D5I:9J=GK.FP:CI\ZSVDZ[HY%!&1]#R/3!K L+/4?^%AWNJRZ;+#93Z;!;
M)(\D9(='D8@@,3_&!]14W@33K[2/"L.GZA;&WN(IISC>K JTKNI!4GLPZT 3
M^++S4;?1FM=%9%UB\S#9EP"%?:6+'/HJD\\9P.]2>&-?B\0^%[+6,"+SHLS(
M>/*D7AU.>F&##\*HOI=QK/BJ>XU&TO;>TM8/*LI(KSRMY8YD8^5(&YP@ (Z*
M>YQ6#:^%=4@3QAX>MK:>WT;5HY'LKJ6=7,4TD963/SERK-A@>O)S0!;\2>*
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M! 2\4N_85=>Q#9'?IQF@#IZ*P;;Q7;W8ACAT_4/MLJ22BRDB6.941]A9@S
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M)^;<%W<;MN.^<<T =%17&C51JGQ&N])GCOQ#IL5O+ 81*B>8_F%FD(P&7"J
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M^]'0G@G)8$$C@Y[8K%O_  =JCZ/?K;+;->ZCK,6IS(TI5(EC>,A =O)VQCG
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M':L9D1\,=O7"8XSUK9UOP]>ZQXCL[PK&EHVEW5C<8D^=#,4Y7C!QL/<5UE%
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MVU.V>!;"WTU=.2 [MX4,&#9Z=L8_'-=-0 4444 %%%% !1110 4444 %%%%
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M*B>:WN;*2XQ=0JFX;FC(Y#%1QV#9R<&N:\+:]J'AOP%8W2Z7;R:/'?RP3/\
M:"LJA[MT#(FT@@%AP6!//X@'J=1?:8/.:'SH_-5=Y3<-P7UQZ5RWBWQA/X7A
MN+IK:QDM[4*\D4EZ$N)8^-S1IM.<9/4C.#TX)C%M ?B]<YAC/G:"HD&T?/\
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M_A/;O4/[!.AZ1'=KK=G-<VYFNO*V-&%W*XVG RV,@GD=.] ';QHL4:QHH5%
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M!YV89<Q-SP<8X/2K$?C:6P37DUVP2"XT@0LPM)C*LZS9$84L%(8L-N#W[XH
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ML;9[F[N(K>",9>65PBJ/<G@5GQ:YX>U=ULHM4TN]>8;E@2XCD+@<Y"Y.<=:
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M/["L+>58UDGNKN&S@5CA=\KA06/H,D^^,58TS3;BP4BXU:]U [0JFY$8P/\
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M-VNI+<);6\OSN[2$EEW!> &DSN;H.<\4 ;NFW=_>:MJ6]K<Z=!((8"L3!V<
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M-C-<"XE,8?:2G"#D+ZYR>G61?AU8+I<>EC5M6.GV\\<]I;F9"+9D<.H4E,D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>E6EA>7MW;HXFO75YRTC,&*J%& 3@< =,5=HHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BCH,FLS3O$.DZO?7-GI]['<S6R(
M\OE9*@/G:0W0YVGH3TH TZ*P8O&>@S:Q'I:WCBYE=HHB]O(L4KKG<J2%=C$8
M/ )K>H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>ameh-nonqualifieddeferre014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)\2ZT?#WA
MZ[U46WVDVX4B+?LW$L%ZX..OI6M7/>.-/O-5\&ZC96$!N+J14\N(,JEB'4XR
MQ ' /4T 1P>)=1M]6LK#7-%6P%\[16UQ#=B>-I I;8WRJ5)"L1P0<5IVGB'1
MK[4)-/M-4LY[R/.Z&.9688X/ /8]?2N>O+?6_%6IZ4MSHT^CV-A<&[>6XGB>
M21PC*BH(V8 9?))(Z8[UDV?A[6KG2?#>@OI;Z<^C9$NI>;&4?$+Q9BVL7.\N
M&.X+CG.30!V4?BKP_,UTL>M6#FU0O/BX4^6H."3ST!X)[&EUSQ#8Z#IU]=7#
MB1[2V-R]NC#S"F< X/0$\9/%<5/H>M:EX*7PZ/#<-K<6FD268NYY(R&DV*H$
M)4DA7*Y)8+QCOTORP>(]3UK4-5@T-;,MI2VT,.HR1N)7$I9D8(S84J2 ?Q([
M$ V+/7]8^T+'J>A1V\4L#S0W-M>>?$-H!VR-L782#P>0<'FK+>*]&M;:R?4M
M4L+.:Z@6=8WNE(VD=0W&5SP&Z&N/L?#MW_:8ET;PS=>';;[/.M[ ]U'Y-RS1
MD(J1H[*"&(._"\ CO65=)<^'/#NOVES8PW<DV@VT=P#<Q VC);E"L@9LE<@E
M2@;))'O0!Z3<^*O#]G.D%SK5A#*^W:CW"@G< 5[]"".?<4>)M;?P]H4FH1VH
MNI!+#"D)D\L,TDBQC+8.,%L].U<>?#&I3^&_%D:V(,^IZ5!!:AF4&1UMMNWD
M_+ASWQ6]XYTF[U?P3+86UFUY.9;9VMU=5,BI-&S@%B!]U6ZD4 7;35=7C,\V
MN:79:;8PQ-(]RNH>:%QR<@QK@8R<Y[5-;^*- NA<&#6;&06[*LQ6=2$+-M7/
M/<\#WKCI-#:70->L=,\$7FEW-YID\"2RW4#*[,A"I\LK8R<<XQZFM:_\*-J6
MKK#-;B/3I-!DT^1T*C8Y="H SG@ D'H,4 =)=ZOIMAY_VN_MH/(C6:7S90OE
MH20&.>@)! ]2*SYO%5@8],FT^6&^AOKX67F0R@B-BK,2>O(V]..M<;+X5\27
M_A\:CJ,;#76U&WN9X+::/<T4"[%5&;*9SNE ;C+8..UBU\-:K->PWYM+^-I-
M8AN)&OKF%IO+2!T\QECPH.6 P"Q( SB@#M;;Q#HUYJ,FG6VJV<UY'NW0),I<
M;?O<9[=_3O3=/\2:)JUQ]GT[5K*ZFV>8$AF5R5XY&#R.1^=<;I>B:PMAX7T:
M;2&M?[#F$D^H&6,QS!8W3,>&+DR%LG<!C)SGBLKPWI6I^(_!?A*UM]-?3(K/
M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7)E9F7&XGY%P.1CKWZ4 =917$WOC75HOB ?"5GH=G-.;/[;'<2ZBT:F/<5Y
MA8ALCIR/>NHTBZO;S3UFU&R2RN=[HT*3&5<*Q4,&*KD$ $<#K0!>HKD[7QU!
M=^-+?PVNE7\$L]J]TLUR@C!0$KD+G=R0>H%5=5^)%II@U&[&G7$^DZ9>+8WU
M\CJ!%*2H.$ZL%+*">.3P#0!VU%("& (.0>0:6@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHJY]<#%2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ"[LM&UNVOK"]LYI-6FN46ZM9(MT;!=K L #T/'6O2J "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM-0T?[%%NG0LL@&?F /3/'&: .E_X3+1FTC3=1AG>=-4P+***,M+.<9("]>
M#G. ,<FL^?XE^&[?0#K,LUTMLMRUI*OV9]\,P."CC&%/(ZFN*?P#XCA\,>"W
MCL4FU#PZ\R3V2WGE?:(Y,9*2J1M.!WQW_'3\1>#[_4/ YT[1O#<>GW-QJ27L
MT3WBN25()9W).6;'8GIR: .NT;QMH^MZO?:5 ;J"\LD$LD5W;M 3&?XP& ^7
MD=<=17%^-/&AO+_PH="N]4BMKG6H(&N8XV2VNHBV& ?^+D >A&<9%:M]X4U7
M4?'^K:DT'DV&IZ =-\T2*7AD;DDKGD#IQGGVYKG(O"GC>7PSX6T>ZTBR5?#V
MJP7!ECO 3<Q1[N54@!>#CDY)["@#V6O.[[Q-91^+=7T[Q)KT^B")XUTY?,\B
M.2,HI,H<C#G<6&"2!M''6NNTVXUR76M4CU&RMH=-C,?V"6.3=)("OS[QVP<?
M_7ZU4NKC59FOK&Y\/+>P.Y$$AEB\ET(X$@8[ASD'"M0!-I^N6JW5CHLUXUUJ
M3V(N#,L)$<RJ%#.K ;3DL#@>M<[XJ\30W?AZ+4M+O[JW6TUJWM+AMKPG_7(L
MBLI .,,14=CX6U7PM=^&9-/MAJD6GZ=-87 $RQ,I=HW#KNZJ"A&,Y QUJO+X
M9\0MX>U.W^PP->/XA75(E%P!')&)EDVANH.$QR!U'O@ W+WQKI4MIJUJ;C4-
M,N[:S>X+RV$@D2+!'G(A7YE4]>..^*T8O$-I%:01H]SJ%P+..YD$,0,GED<.
MRC !.#A1R<' .*Y[Q1IMS?Z3K/B&_MC9-;:#>6T-LSJ[_.NYV8J2/X   3U)
M]JJ:?X>U&QUB+6([&>_M-0TRTBECM[TV\L$D2$#C<H92&]<@CIS0!U__  E&
MF2VMK/9227QNH/M,$5JA=WBX^;'8<XYQSQUXK)C\<13^+-.TV*WN/LEWI[W1
M8V<QD5_,1%! &%'S-DG@$#)'>M%H6H>'O$MIJFD:1%+I[Z:EC-I\$RJUN5=G
M5D+X5A\[ C(]>:O36.K?\)SIFMQZ>C6[:=)9W"^>H:!FD1\G^\,*1QW_ #H
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MQ@S8S:7%;"0.N5D621B",YQAAR,T 4OB)KU_H_A74FT>417\-JUP9BH;R4'
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M;9$_>.<$@@C ZJ,UT.E:M<ZGJFI1_95BL+1UACF+9:67&9!CIA20N03R&]*
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M+D% 0"1D9Y!I=;\+ZGJ5GXOO8;7;>:W91V5O;-(H**JL-\ASC)+G@$X 'J0
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M\J"TDD+1Y )4@8(&><=,'.*Z&N4CL-2/Q MM6;3W6R72C9LQDCW+(9%?H&Z
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M=N+D16\2G?&6VY#%@.H/4CI]*+7QAIE[I>G7ML+B1M0E>"WMMFV5I$W;U()
M4KL;.3CCKR,@&_16-H?B6VUV>\@@M;R":RE:"X2XB \N08.W<"5)P0>">#7/
MWVIS:7\4)51-2O8Y=&$BV5NY<%_.P6"LP1> .<C\SR =S17.V/C32]1L[66U
M2Y>YN9I+=+(QA9UDC_UBL&("[<<DG'(YY&9(?%VEO#J#7#2V<VG2I%=6\Z?O
M$9\>6 %)#;LC;M)SG'6@#>HKA)-3NYOBGI4)M=4M(VTZZ=X)Y1Y4Q4Q;655=
MDR,L.<'D9ZUL6_C*SN=&N=3CL;XI;W?V-X2J"7S=X3;MW_WB![Y&* .CHI%)
M902I4D9VGJ/RK(O_ !##9WMQ9PV=W>W-M;K<SQVP3,<;%@I^9ER3L;@9/'N,
M@%S5-*L=:T^6PU&W6XMI,;D8D<@Y!!'(((!!'(JK8^&],T^]6\1+B:Z1#''-
M=W,EP\:GJ%,C';G SC&<<US4FJS:;\2M26.'4[Z-](MYTLH6+X8RR!F578*G
M"KW&<=S706OB>UU'0[35-.M;R\2[W".&.,+)E<A@VXA5(*D')'(P,T ;=%<#
MXBUV+6O#ND:GIL][;%=<M;:6/>T3J?M"I)'(H.#W!!R*TM.>9/BAK=O]HN'M
M_P"S;698GF9D1F>8,54G"YVCICI0!UE%<9XKNY-/\:^$YDDO6262Y22V@=B)
ML0,5&S.TG/<].Y %:VG>*K34K2^D6TOH;BQF$%Q9RPCSD<A2HP"000RD$'&#
MG(YH W:*YQ/&-J;;5WDT_4(KG2462ZM'C0RA""P9<,58$!NC$\$8SQ5F'Q+;
M3Q:1+%:W+QZHGF0L-A")MW;G^;@8P<C/4#J0* -JBN?A\7Z?,VG.(KE;/4I/
M*L[QE7RIF()4#YMPW!3@E0#^(RSQOKUQX<\-27]I'ON#/!$@,3.!OE53D#V)
MQGOCZ4 ='17!SZQ+;?$B*:*'59XY]%>0:>I;)<3(-P1V"(<#J<?F>=RT\8Z9
M?:=:74"W!EN[A[6*T:/;-YR;MZ%2< KM8DDXXZ]* .@HK-TG6[;5VO(HXY8;
MFRF\BXMY@ \;;0PS@D$%6!!!(YK.N_&=E:Z[-HPL-3GO(?*+K!;[@$D8J'SG
M[H(.3_.@#HZ*Y73/$>GVVGZY?SWFH/%;:DT$BW:#='(1&!%&%ZKEU SSEC4_
M_"1VVHZI=>'I;+4K2^6#S6!&W$;9PXDC8@#*D=0<B@#HZ*\\\$^,4A\(^%HM
M2AU)VOHHH!J,J;HWG8<*S$[LD\9Q@GO6WHGB:?4O%VOZ5);RB"QFCB@<6[*!
MF)7;>Q[DMQZC'UH WM0T^WU2S:TNU9[=_P#61AB!(/[K8ZJ>X[]#5KI7+^(O
M$T^C^)] TZ*WEEAO3.9Q';L[$)&2H4CC.>O4X':K-YXNLK2WO[I;6\N;/3W9
M+NX@166$J,OP6#-M!YV@XY'4$  WZ*B@N(;FUCN8)%D@E02(Z\AE(R"/PK&M
MO%5M/J\&FRV-_:S74+SVC7$2A;A5P6VX8D$!@=K!3STH WJ*Y!OB-I26[7<E
MAJB645VUE/=&V&R"4/LPWS;L;N,J#[XK0M?%UA+>W]I=P7>G2V5O]KD%Y&$#
M0<_O 03\O!SG!'<4 ;]%8*>*[1KJSMWL[V)KZ%YK,NB_Z0%4,0H#$AMISA@I
MQGT-4+3XA:7=V^F7:66I)8:C*L$-Y) !$)&8JJM\VX9/&<8YZT =;17,^(M=
MB.EZM;V=OJ%V]K&R7$E@P4V[[-P^;<I) ()"9(!Y'-6?!,TMQX$\/S3RO++)
MIUN[R2,69F,:DDD\DT ;M%>=W7B:[UKP]XXA9;NW?3C=):3P))!L$<"LI+@@
M[MQ)QZ8XQ6OH/BRW*:%IEU:ZA%+>VJBWNIX_W=PZQAF .=V< GY@,X.,T =;
M17/_ /"8:=MM9Q'<&PNKH6D5\%7RFD+% /O;L%@5#;<9[X(-0?$2:>U\ :U>
M6MQ/;W-M;/-%+#*R,K <=#R/8\4 =/17 %+S^W/#L6BW^H3[\C5DDN9)8EA\
MLY+%B=C[MNW:03D]A5OP3J,UOX/:6?[;?S#4;R&,;C+*^VXD"C<YZ +U8@#'
M6@#M**Y>7QYIEOH5_JL]K?Q+I]Q]FO+=H@987XQD!B"#N4Y!(YJY9>*+:[UX
MZ/)97UG=-"T\!N8@JSQJ0"R$$]"PR&P>>E &Y116%=>*K:RU&VMKFROHX+FY
M^R17C1KY1FR0%^]O&2" 2NT]CS0!NT5R^B>)I]2\7:_I4EO*(+&:.*!Q;LH&
M8E=M['N2>/48^M;6HZDU@$$=C=WLKAF$5LJYP,9.695'4<$Y/8'!H O45S'_
M  G>DM8Z1>1PWTL6JR-#;[("2)%W91AG(8%&'X4J^-K(Z?J]S)I^HPS:0 UY
M:/$OFHA7<& #%6& 3P3T- '345D1>((9IM+CBM+E_P"THC-$R["$0 $LWS<#
MYEY&>H'6J7C'Q#<>'[?2FMHFD:[U*"V<"%I#Y;-\V,=&QP,T =)17-6^L0S>
M+;F$/JHG734G^Q21J(MI<X91UWDY4@G^&JD'Q&TJ>WT^[^PZJEE?R&&"Z:V^
M0RY("8!+9)4@<8[9S0!NW&@VESKUKK,CS_:[6-HXMLF%"MC<-O0YVC\JTZYV
MW\9Z8\&JR7D=UISZ5M-W%=Q@.JL,HPVE@P;! P2<\=:N6NOP3ZS_ &3-:W-I
M>- ;F-)PO[R,$*2I5F'!(R#@\CB@#6IDT0FADB8LH=2I*,5(R.Q'0^]4M3U1
MM.""/3[R^E=6<1VJ*3M7&3EF5?XAQG)[ X-9+>.M)^PZ/>11WDT&KMLM3% 2
M=^&.UAU!^5A^% &UINFV^E6@M[<RL-Q9I)I6DD=CW9F))/ '/8 =!5RN?L_&
M.FW$&IR74=SISZ85^UPWB /&&&5(VE@P;M@G/3K6)?ZI=3_$KPQ#]EU6RBD2
MZWK-)B&<"/*G:KD9!)^\ W- '=U0ETBVFU>+4Y6G>:)-L<9F;RE//S>7G;NP
MQ&[&<&HO$&NV_AS29-3NX9Y+:(J)#"%)0$@ D$CC)'TZ]*!K]D=:.C O_:0L
M_MAM^,[,[<9SC.??'(YH U**Y0^(K;4-3\,R!M5M!?O*UO%L01SCRF;]YR>-
MH+#!]*Q=1\37>KZ'X[M]MW;G35N$M+B!)(2FRW5P2X(.[<V<=QCB@#T6BN3T
M+Q9;M_8FEW-KJ$4M[:K]FNIXOW=PRQAF .=V< GY@,X.,UK^(=?M/#6DOJ=\
MD[6T;*KF%-Q7<P4$\CC)% &K16!!XLMKB2.!;#44O)9)%AM)81'+(J!2T@#$
M )\R\DCJ!C--@\8Z?=K EM!<RWDTTT'V,!%E1X?]8&W,%^7(_BYR,9H Z&BN
M>NO%]K9RZ9#/I^HK+J+2)#&(06#H&)1L-U^4],CH<XYJ*W\=:4ZZBMY#>:?<
MZ>8Q-:W<0$A\PXC*[2P<,>!@GF@#IJ*PF\6:=;7-[;ZBLVG2VEL+N1;D*<PD
ME=ZE"P/S#&.N<<<BLSQ'XRN-*T#6+J/2+ZVN;6QDN;=[F)6CE(X'W')')&0V
MT@4 =A15+2[UK_38;AXIHV91N$L90DXY.#VKF=#\<)<6>M7>J1RPP66H36\3
MBV=0RJX1$YY,A)Z=<GH* .SHK'M_$5O)K::/<VUS97LL)F@2X"8F52 VUD9A
MD9&02#SG&*N:A?FQC0I9W-W*Y(2&W5=QP,GEB%'XD4 7**Y<^/-)&F6-_P"3
M?>7=WAL0@@R\4X8J4=0<@@@],].,T^/QI:-'JPETW4H+G2XEGN+22)?-,1R0
MZ88JP^5NASQC&>* .EHK%@\26]S'H\D%I=2+JJ>9 5V':FW=N;YN!@@Y&>H'
M4@5)K_B"U\.6<-U>0W#PR3QP;H$#;6=@JY&<XR1TS0!K45SUMXOM9M9?29]/
MU&SO?):>".XA4?:44\F,AB"1D<'!YZ55L/B%I%_8-J"V^H0V A,HNIK8K&QW
MB/RU.3N?<0,#UQUR* .KHK%3Q+!_:R:5<V5W:WTT+36\4P3_ $@+]X(RL5W#
M(R"1USTYJO:>,;.]T%-7M[&^>%[K[((MJ"7S-_EX*E^/FXYY[XQS0!T5%<K!
MXCL+*^\37-S=Z@$L'A\^&X5=D)*#:(L<G=P>3U-)XD\0);^&M6EO8-9TM;:)
M7>>W6)I54Y^9"&9?X2#GD9]P: .KHK+N=;BM[_\ LZ"WN+V]6$3O#!LW(A)
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M)I?/ ER'$;.L>/F4,>N0< D \9@L_!VJ6%KX3$%_:>?H4+VS&2%BDT;(J$@
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MGPQG$:B7[+(A?')7[(2!GTZ_G6CX_58M0\)7:6IGN$UE$41@;V!AE.T$XXR
M>3CC/:K$?A?4DN/"DANK4C0XV1QM;]_F(Q9']WCGOSQ[U>\4Z'>ZRNE2Z?=0
M07.G7RWB^?&723".NTX((SOZ^W2@#.?Q_#837]IK>FRZ??6HA:.$2K(+A97V
M(4;@?>!!SC'TK4TSQ*E[K]QHLT44=W%;K=*T$_G1R1EBO#8!!!'(([CK65K7
M@8^(+:[N+Z[CCUB80>5/%%F.W\ES(@"D_,-S-G)YSVP*WM'M=0MT8WZ::C$
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MNMYC)Y7W1]Y0_!((^E6]3\<6UDNL2V\*7$6CDB\S<"-R0@=A&I'SD*1U*\\
MFJ0\$Z@?!L^AO?6WG/J0OTF$;;1_I(G*D9]>,U8M_"E_INNZE>V$FFR6^IS"
MYEBNX&=H)MH5F1@1N4[0=IQSWH E'C&YN]5NM.TK1)KR6&UANT=KA(TDCDW;
M3DYP?E/!'Y5FW_C2[O;/PA?Z/:77DZI?%)H?W08JL<A:,EFX.Y,Y'&%//.#N
MV6B7MMXRU#6I)X&@N[6&V$2J0R^67(.>G.\\=L5BVW@G4[/0=!M(-0M/M>CW
M[W4<DD3%)5<2 @@$$$"4]^WO0!UEI?7%QJ-U;2Z;<6\4*1LD\C*4E+ DJN"3
ME<8/UXK'N/%%\/$-_HEEH<ES=6MO'<!C<+&CJY8#DYQ]P^O]:OZ5)JMQJFIS
M7I$=BLBPV<7E[6;:/GD/?!;( ]%SWKFR-4;XM:M_9LMFJ_V5:"87,;,<>9-@
MKM(Z<\'KGJ* )Q\0XVTBPO4T:]:6XU$Z9-;;D#P7 )!4\X/(."..F2*T;7Q+
M=W5S%IPTGR=7^SFYGM9K@!8$WE%RZALEBI(P#P#DCC-.]\&S?8],@T^YB5K;
M5?[5N)9U),\I9F8<=,EC]  .:O76A7<?BI/$6G2P>?):"SNK:8D)(H8LK*P!
M*L"6[$$'MUH SI/'\8TF*^339 %U+^R[U)90OV2;<%RQ (*9(^8=F7CDXL>)
M-:*:;XBAFTZ>:QL;(O/+;7/ENV4+,JGC:P49Z]&7KGB2/P;:OX;UG2KN3S7U
MB6:>ZE5< 22="H[;<+CG^'-$OAN]E\"7>AR7T<NH7UM)%<WKH<,[J59\#T!P
M!Z "@">/7446&G6%NT]_-9+=+#+,0(XA@9>0@GDG X))!]S7*^$M9M_#ND>)
M;N]M/LA;Q$\"6B,I_>.L*J@/ QD]>,#GBME_"^KV^IZ7J^FW]I'?V]B-/N8Y
MXF>*>('((P058')[]2*IR_#^ZN=)U:SN-3B:>ZU4:M;7(@_U4PV8#)G#+\F,
M9Z'\: -)O'-E9W6HVVI(D4MG;QW.;:7SUE1W**%. =V\;<$#J.>:RM1>\E^*
M/A22[TJ.U)CN]DR3"0N/+'RMP,$9/J.3@UJ:AX8O==\-7FEZA+86<DP0Q2V$
M)'ER(P=7.X\C<J_+]>>:9_8&OW.N:)K&I:A8O+IGG*\-O ZK(LBA2PR2=W&<
M=.WO0!UU>9:/J\WAA/&=Q9Z*]U9VFKS3S^5*D?EQB"(ML!^\0 3CCZUV_AY]
M4FT^2YU;Y)9YWDB@V!3!"3^[1O5MN"?<D=JQ[?PI?+I7BNRFN[?.N232HR(?
MW)DB6/!S]X#:#VH T1XD6\OQ8Z3;K=7 M$O'\V7RD2-\[ 2%8[FP>,= <D<9
MS!X]CDTZQO(=.DQ/J/\ 9=PDLH5K6XW%</@$$;AC(]5]>'6'A?4=(U2WU.SG
MM9)VL(K&\ADW*DOE9V2*P!*D9((((.>HQDEQX(67P=JFCI= 7M_<27K76S 6
MY9Q(K!<\!6"X&<X'6@"U)XRM/.U^W@A:2?1XUD=&.T3*0<[#@YPRLG^\,4D_
MBWR[NYL8K6!K^SMTGNH9;H1A"X)5%;!W-A3V Z<\U%+X,C;6-%OHKID%E$8;
MH%>;M=PD4L?42J'SWRWK3;KPM=P^++O7=-DL9!?Q1QW5O>PEANC!"NC#H<'!
M&.<#D4 .T_QM#J>IZ)!!9L+76+-KNUN9),9V@%HRN/OC=G&<8!YXQ3O^$Q13
M:136L<5S?7$T-HKW "2+%G?(6QPO''!)RO'-3^(O#D^MZ78)#>I9ZE8SQSPW
M<46 C#Y7PN3PR%AC)ZCKBH->\)&]FT2\TN2W@N='WI!%<1&2&2)U"LC#.1PJ
MD$=".AH J3?$&&'3)KK^S9I9+;4DTVXC@E5PLC% K*>-RD.I' /8@5TNDW=W
M?6(FOM.?3Y][*;=Y%<@ D Y7CD8/XUB:SX>U/5]%M;3SM/MY8KZ&[/E1,$ B
M=7"]><E>O'TK1:35IO$EK$F(=.@MFDNFV9$TK<(B$]EPS$^ZCUH S/%6MZEI
MGB+PS:6-O/-%>74JSI%Y8\U5A=@N7(QR W;IU[5A:??W6B>)O&\NG:(UTL<]
MO-)$DJ1!1]F1F SU8G)QT]QGGJ?$.B7NIZAHU_I]U!#<:;<O*%GC+HZO&T;#
M@@YPV1]*@L?#M]!J?B2ZFN;=DUC:55%.8BL0C&<]<@9[4 3R^)'ET.RU73+#
M[1!=VJW2M/.L"JI (4L<_,=W Z<')%86H>-+J]MO!U_HMM=-;:O=9DB B#,@
MBD;RR6;@Y4'(X^4\\X+]-\%ZKIT^A.-0LI5TW3%T\K- SA=I'[V,9X<@ '/H
M/I1;>"M2LO#WAFRM]0M3>:'<F59)(F,<RE'0@@$$'$A/7M0!O^)?$/\ PC>@
M/JTEA-<*C1AXHV4,NY@H[\\L.F:J1^+&AUR;3=7TV33@MG)?13M,LBO$A ?=
MM^ZPW XY'O4_BW1+KQ%X;ETNWN(8))7C9I70D#8ZOP >Y7'7O4&K>&)=8UVU
MOKB6+[/_ &=<6%S  <LLVS<5;VV=QWH C?QE]GM-*U&[TYH=*U.2.*&?S=SQ
MF3_5F1,?*#P.&."1FNIKCX/"5]-HFEZ%J=W!-8:;+"ZRQJ1)<+"08U9>B\JN
M2"<X/ SQV% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 44V1_+B>3:S;5)VJ,DX["N-T/QP^O63W=B=+N,6;7#VJWA6:W<;?W<@
MVDC@M\VT8*XP<YH [2H;JUM[VVDMKJ&.>"08>.10RL/0@]:Y=?&-RVA^%-3&
MG1;-<EMXW4SG,!E3=P-OS8P1U':K)U_4M1;4&T*RMKB/3[EK:7[1,4:9T +A
M, @8SC)ZD'@#D@&UIR:?!:_9=,%LEO;GR_*M]NV,]=N!P.HXJW7F6G:CJ6@)
MXWO-*TNTGMK/59;B999S$65;>)F5 %/. 3S@<CKSCT.WO1=Z7%?01LRRP"9$
M) )!7('H* +5%<CIWB^YNO$HT9X-.E>>SDN;>2TO#(H9"H:.0[>#\XY&>_%9
MMOX]UF72-)UA]"MA97][]A\M+TF5)#*T:MR@&W<!GG/.<=J /0**XN7QS+I"
M>(1KUA%#+H\,-Q_HDQD69)2P0 LJX;<I4YXZ&IXO%UPVJ&PCBL+UI+.2YBDM
M+HM&C(1F.1@IQD-D-CG!X&* .MIDLL<$32S2)'&O)9V  _$UQ-CXWU6>Q\.:
MK<Z/;1:;K3PPC9=%IHGD4E25V %<C'7/(/L&^*-7NM=\'>)?[-LK6:RM8[JU
ME:YE*F1HU(<H I'RG.,]2O88- '<QR)+&LD;JZ. RLIR"#T(-.KB;?7]0TRR
M\'Z79:=;W']I6819);DQ^6R0;^0$/' Y!S[56F\=:W;Z)J^HR:':?\2.X>'4
M%%X?G"A6)A^3GY6!^;'I[T =_17*W_C*%-8O=*M)K&.XL[>.9S?7 B#EP2J+
MWZ#);MD<'/%6#QIJ6HWFC6UAHT:G5=/>\C-U<,AA*% RNNPG@OU&<^@Z@ [2
MBO.-<\5ZQ>>"+N:"W6RU*UUB'3KCRKD[01/&I*-MR58,!T! 8^G/9:IJT^C^
M&;O5KJS#S6L#2O;P2%P<=@VT''OM]>* -&>XAM86FN)HX8EZO(P4#\33P00"
M#D'H17F_BG6HO$?PS\4NEQI5]:Q6!DBGLIQ)AR&RK*>5*X'/?/08KH+;Q!J=
MMXCTS2=1TVWBM]1AD:UEAN"[H8U!*R*5 &0?X21D8YZT =358ZC9"*64WEOY
M<3;9'\U<(<9P3G@X(KFIO&,]KXCT_3Y[>Q:"]NFM,07GF30.%9E+J%Q@A#QG
MC/>N4U&U@'@;XHQB&,(E[<,J[1A3]FB.1^- 'K (90RD$$9!'>HY;F"!XTFG
MCC:1MJ!W +'T&>IJG<:A;Z1X=DU&[8K;6EJ9I2!DA57)P/PKC/$\VI7NH>#;
MNYL+2&VDU>!T(E+31DQR$*PVXY'7!X([]: /1**XC4/B#%#%J\]FMI,NE7#6
M\EJ\X6XN"F-_EK[9(&<[B#TZU;/B/6[OQ%J>CZ=I=D7M;>"XCFN+IE5EDWX#
M (2&^3H,CKST! .K90RE6 ((P0>]4K31]+L) ]GI]I;N 0#%"JD#N!@<"N2'
MC^^DTC3+F+0T-U<ZHVE7%N]U@PSJ6!P=N&7Y#SQUZ&K%I?7<GC>PAU31+.#5
MGTJ=UN8KII JK*@*8VC@EE.>OL* .SHKC]/\7:C?Z//*--MTU2'4SISV1N&(
M#!L$[MO39^\Z?=JO??$**&#5;BU6TF&EW+6\MJT^+B<H0)/+7V)( /WB.W6@
M#LKNTMK^TEM;R"*XMY5VR12H&5QZ$'@TZ&&*V@C@@B2*&-0J1HH55 Z  =!5
M?4+QK737NXDB8J%(\Z41( 2,EF(X !R>.U8_AGQ-)K>H:KI\\5L)M/:+]]:3
M&2*9)%)4J2 0>""/;K0!OM<0(2&FC4CJ"P&*D!# $$$'H17G^H6=HWQD$CZ8
MEXW_  C[,8Q&A9C]H49^8@9P>YZ5:T"PO?"&A7S-'9VT=YJ<L\%M<W(CAL8G
M'RJ2,CJOW5XR_' )H [>BN$?X@72>#[[6ETN&:>PO_L,\4=R=K'S$0/&VWY@
M=ZG!V]^:;K6K>*8]7\-0O96UM)<:E,C0QWS;)HU@=E#,$SVR>.JCUS0!WN:*
MXA/$-EHVK^,;^_TR*U?3X+::YG@F,K7(V-L&"% ( P![]:MZW>ZU'HVJ/J.B
MZ?<:<=.FEDA%VZG@#,3'9W4MR.ZX[YH ZRBN-_X22\LQX5L-.TBV:+5;4^6&
MN2HA*0[PI^4_*!@9Y/M4VG^*=1:[UG3-2TZU@U'34BEREU^XEBD)P^]E!4#:
MV00>G&: .LHKA?\ A/;I+#Q,_P!AL;F?1+9;O=;79,,\3*[<-L)##RV&,$=.
M:O6_B?55US1K34-+MHK;6(W-M)%<EWC=8_,VR*5 Y /0G!'?K0!UE%<?X$U#
M5]0766U%4:)-5NXXW^TEV3;)M$87: % '!S^'-73X@OK^XUB/1;2"?\ LJ3R
M'\^0KY\P0.47 .T ,HW'/)/'&2 ='17#_P#">W>H1^'9-%TF*Y37()9(3/<F
M,Q/&N2K@*>,\9!/0\5U+W=W!HBW<]M$MV(5>2%I@J(^!N!<_P@YYQT'2@"_4
M;W$$9(>:-2.H9@,5SOASQ1)J^M:EI4\=H9+2.*=)[.<RQ2I)N Y(&""A!ZU@
M:[:QM\7[)ETB'4)&T.8M$X09(F0 DMQ[?C0!Z("&4%2"#T(I:\O\+^(M/\+:
M#-9G$-Y-KLML;*=A%%8R/F38&Y'EJ@R"."3QC/&K?>/[JRT[6)XM/MKYM-FM
MT,L%P1%.DS!04.TC<"<%2>W7F@#NZ*Y*3Q==Z3K-W9Z]8V]O!'ITVI1SVLYE
M_=Q$!U8%5^;Y@>.#3-/\;->W^D1)%9SQZI&S*MM<>8]JP3>!+@=" 1GC!P.<
MYH ZH75N;IK47$1N%0.T6\;PIX!(ZX]ZFKR2WO[A_A?J>KZQH5AJ"O=3^:SW
M;"28"[<8)$>0$*H ,\A1TQBN]N=;NKC6;S1]'AMY+NSACFGDN7*QKYF[8HV@
MDD["3Z#'7I0!O9YQ17(Z9?/-X[\J]T:"UU)M%BFDN$N#(P4R',1&T#AMW/.>
M*2S\8W,OB6RTF>WL&^W0RO&;6\\TPR1@$I)A<=#U&>0>.] '7T5Q>F>*O$FK
MPWL]IX?M/+M)KJV(:^.9)8F*@+\GW6P>3SD],<U<TGQ3<ZS8^';FTM(&.J1M
M-.AF8?9T4#=_#\Q#%4(XY/M0!U%%8^K:V;+5M-TFWC62^U#S&C\QL(B1@%V.
M.3]Y0!W)ZBN2\4^+=0'A7QE8+"MKJ^DVH)EBE.UHY%)65#C(/##'8CKWH ]
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MS#N0;,$ X/.">>G!(!WU%<?9:CK$OQ/UBRV(^GP65J0C7)'E[FERZKM(+':
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MI#E %(^4Y )ZE3T'-)IGBFWT[3/#>B":U@NIM'BN3+=RA(T1510/]IB3P..
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M>9U)16R/F!P1D8P<<&HO'-_JEBWAY=,QFXU>**0&<QAUVN=A(4_*<<_3H<T
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MV99\W6SS?+\T(.V?FV_W><CI7<T %%%% !1110 4444 %%%% !1110 4444
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MG'0YXYZYK;=TCC:21E1%!+,QP !W)IL$\5S!'/;RI+#(H=)(V#*RGD$$<$4
M<@_@2<Z;)9)K'R/J_P#:OF26VY]XD$@4X8 C<!T X]*UK?0)X?%5YKCWR/\
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M>&-&2\;$H9E+!%'(!&>#Q]36[I_A^'3M<U+58[RZDFU$HT\<A39E%VKC"@C
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M60NHC&6E@!R$=60JV.QV@^] &3#XF\3W5YX<LVM+.PGU2"Y,Z7-O(6@>' W
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M&.4VKGH/4C:#ZA5]* ,^36=1N?[5N]-GL7T^VLTEMW>!F+RE/,()#C*["AX
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M#K#54F&LS3ZD9;5K3=.$4K&Q5FQL5>254Y[;1C%20^')4TR>PN->U2ZBEA,
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M9I;U8UGO"RB9MC;DP0 HVGD *!DGCDY ,./Q7K*7NNV+/:S26FF+J-K.UC+
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW!25(!([>G-/U7XA6.G0ZC=0:?>W]AI<IAO[JV\O; XQN4!F!<C(SM!QGZT
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M;K0+233H+P22ZQ%IEY %"S0G>!)'D-@,1P"#T;(/>@#O:*S[:#[)H"Q:=;-
MR0'R()VR4;&0K')[^YKS[P]K>D$:/:ZU>ZSI?B<R1B?[?Y\8N)OXT!/[IE8Y
M"@<8(P* /4:*YN;QG8Q6POQ;W#Z7]K^QM?+MV*_F>7G&=Q7?\N['7GIS4TWB
M=?,F^P:;>:A!;W'V:XF@*!8W! 8 ,P+;<\X'KU((H WJ*\^_X2VYN]+\9&_M
MM42ST^XGB6XL1'')#"L2$E2S [QEF_+Z5TJ:]"C6-A:PW%W>S68N1$64,L7
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M 0&WC(4X)7F@#?HKCYOB#!%9:E>#0M6>WTNX>&^=5B_<[ "S?ZSY@ V?ER<
MYQQGK$F66!9HOG1E#KC^($9'6@"2BN,;XC6<=F]])HVK)80WK6-S<F.,B"42
M>7RH<LPW8&5!Z_A6OIGB6._UJZTB?3KVPO8(5N%2X"'S8B2H92C,.HP0<&@#
M<HKGH?%:OK%OIEQI-_:S7<#SVAF$>)P@!9>')5L,#AL5%:>-+:^T&/58-,U
MA[S[$+8B(3"0/Y9R-^!A@<\YP,]* .FHK'\4H9/".K_-)&PLY65HW*,I"$@@
MJ<]17/\ A[Q>EII/AFSO]-U&&&^MX+>#4)0ABEF,8(4_,7&<'!91G]: .XHK
MF_\ A,['R;2\%O<-IEU="TBO1MV&0N4!QG=M+#:&QZ'IS724 %%%% !1110
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MHM&KW<QZO*0,_E@*/914%[H=Y<^,=/UR.Z@6*SMIK?R&C)+^84).[/&-@[4
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MV\>W:4G.+>,HBCTY)S]>/I7.Q>%;ZQCUNQL+V%-/U::6<^9&3);/*/WFWG#
MG)&<8)[CB@!3XRDNM6LK'2M+^VK?Z:=1M9S<"-63*#YL@E?OCGGZ>F5J7BZ'
M4/#]W_:6C74-QI^IV]K>6L=WL,;M)'Y;AUQN0[U/;C/%,GTZYTSXB:#IN@RV
MT"V?A^:%5NHVD!B66%0/E((/ .>>AXYR-75O!DM]HUY:6][&EY?WT-[=W4D1
M;>T;1LJJH(PH$:J!DX'J>: +%UXGU >([W0['0S<W-M;1W*N]TL:.CLRCG!(
M.4/8_A6;+XGL]9L?">IOIUT$O=1$48%SY9@F D4API^<#8_'0\5LVFAWL/C*
M[UV6Z@:.YLXK4P+&05V,[!MV>Y<\8K%M_!&HVVD:'8+J=L1I6I/?AS W[W)D
M.PC=Q_K3S[#B@#1N?%T@T_5-2L--^V6&F2R13L)]DCF/_6>6NTAMO(Y9<E3[
M$Q_\)E->:O%I^DZ2;PW&G)J-O.UP(XWC8@#/!*]?0]N.I"1^%+VRM]:TZQO8
M4TW5999B9(R9+9I?]8%YPP))(SC!/\0XJ;3_  K)I?B>UU"UN(ET^VTM-,BM
MC&2X13N#;L]>,=* -'PWKJ^(M&2_%M):R"62&6"1@QCDC<HPR.#RIYK.N?%T
M@L-5U*PTW[98Z7+)%.PGV2.8_P#6>6NTAMO(Y9<D'V)N>&=$FT"RN[:6Y2=9
MKV>Z1E0J5$LC/M/)SC=C-9L?A2]LK?6M.L;V%=.U6:68^9&3);-+_K O.&!.
M2,XP3_$.* ,V^U5?$'C;1;--.&I:-<Z2U^B2;-A+21!9<,>JJQQQGYCBM;QU
MJVH:1IVF-IRRF2?5+6!RA3E&D 9?FZ;AQD>O:EM/"LNG>)=.O[*XA2PL-,_L
MR.V:,EO+W(<[L]1Y8'2KOBC1)]=TVWBM;F.WN;:\AO(GEC+H6C<, P!!P<=C
M0!S EO+7XGZA/I^C+)>SZ);R20M,L2AO.E!W. <G  X!SCTYK4M?']E=Z?H\
MJPB"[U,S!(+J81K$86*R;GYX## P#G(XZXNVFA:A%XQEUVXO+:19;".S>&.%
ME^XS-N!+'J7/'IWK#M_ %[8PZ5-:ZE;&_P!,N+IXFEMR8I8KAR[QNN[(()&&
M![=.: .D\.>(8O$-K=ND8CEL[I[2=5D$B;U .588W*0RD' Z]*YSPQ'#XRU#
M7M2UF-;N.UU.;3[6SF&Z*%(L#=L/!=B222">@&!79V$=U%;!;Q[=I<Y_T>,H
M@'I@DY^OZ5SI\+7^E:]>ZKX=OX($U!Q+>6-U$7B>3&/,0J048CKU!]* )IX]
M*\&YFLK;RVU*XAM8+.'Y(S,=V"!T7C)8@=%Z$]6S^+9;+4K[3+W3=E]!9&_A
M2*?>EQ$IPV&*KA@<9!'<8)I=6\.ZEKMC!]LO[6&^L[N*\LG@@;9%(F>&RV7!
M!(/W>#277AJ[U&\NM3NI[=-0?3WL( BLT<*N<NQS@L20/3&,=R: *-OX[O9C
MH;-X=E6+6X-]DPND)W^7YFUQCY1MR=P)X'0'BG3^.Y;;PQKNJ3Z.R7>B3-%=
MVGV@$<*KAE?'(*LIZ ]>*=#X1U&&'PE'_:%L?^$?4*3Y#?O\0F+^]\ORG/?F
MLGQKHDVE>"_'UZ]S')#J<9N%0(0T9$:1XSGG[@/0=: .@D\57=EKVG6.IZ*]
MK::E(8;6Z%PK_O I8)(@'RDA3C!;I22>+GM?$>GZ5>:>D*:A(\4#+=*\J,%+
M#S(\?*"%.""W;.*L0:)?7UQ876N7=M/)8N9;=;2$QIYA0IYC!F;D!FP.@R>O
M&,/3/ FIV-OH4,FJVDBZ1>M<JRVI5KG*.I:0[SESOSD>^<YX )9O'E]'INL:
MA'X=D>VT>YEAO";M VV-59F08^8@$G!QTZD\#77Q*S>*K71OL86&[LFO+>Z:
M7 D"X#*%V_>&X'&>AS[50B\'WO\ 8'BG3)[^ G7)+B59$A(\DRH$Q@M\P& >
MU0^(=$-]:>'M/2_6/5[2X1%E@X;RO+*S<9)4&,G_ (%M]J .DT/4IM6TM+V:
MU6W65F,2K+OWH#A7S@<,.1[$?0:-8]\NHC4])LM, M[*-C)=R",$>4HPL2YZ
M%B1TZ!3TR*V* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ I 01D$$>U(Y8(Q0!GP=H8X!/N<''Y5Y]IOB>32O!NFW>FZ!:PQW.K
MO8O:I<D"-FN6C+*2OS9.3SMZT >AT5SFDZ[J4OB>\T+5K.VBGCM4O(9;69G1
MXV9EP=R@A@5_'/:I[C6YYO$<NA:<D/VF"U6ZGEGR50,Q5% &"2=K$G(P .N:
M -RBN%?Q_>?V1!<Q:/&]VNLC1[RW-R1Y<N\+E#M^8$$$$[>HK4@U[57NX-&G
MLK.+7'MY+J95F9X(HA)L0YP&8MP<8'0YQ@ @'06]W;78<VUQ%,(VV.8W#;6P
M#@XZ'!''O4U>8^'M>'A?1_$]YJ%O EP_B0VZPPR8B\R1(5'S$#"\Y)QP >M;
M<WC2ZMUUI8[:TOSI^G_;XYX)66&11NW1DX;:XVYQSD$=* .SHK$\-ZEJVJVG
MVS4;"WM()HHI;813&1B&7)#\#!'' R.>IKE[+Q3J.D2>--3U6-9=/T^^V(JW
M3,ZGRHML:*4 PQ<<Y&"QX.,D ]#JO=V%G?\ D_;+2"X\F02Q>=&'\MQT9<C@
M\]16%<>(+_2=<TBQU6VM_)U5VACEMV;]S,%+!&S]X$!L,,<CIS4NN^)X-(U;
M3]*,L$5S?))();AL1Q(F,D^I)8 #([\\<@'045PI\=:B;>Q:+2()9)]7.E,W
MV@JC':665#M.Y"!U[<CYL5,_C/4-.C\11:IID)N]'AAN!]DE9TECEW 'E=R[
M=K;N#P,B@#M**X>Z\<S0^&K_ %FQ?2-7M[8Q;9+2Z*C#MM(9<,0RD@X)&0>V
M,5MW.N7,'C&ST,6D1ANK.:Y2?SCNS&4&TKMX'SCG)Z=* -VBN!C\?:G%I6IZ
MU?Z/;PZ5ILMS!.T=T7D:2)]BA 5 *L>,G!R>F!DZ^G>*);GQ#;:8ZVES'=6[
MS">R<NL#H5S&Y]PW#<9VG@4 =/4-O=VUXKM;7$4ZHVQC$X8*W7!QT/(X]ZY3
MQ!?ZQ#\0?#EG8+$UM+;7DDD3W31K(5\H98!&^[NX]<GICG T[5=4\.Z;XRU#
M3=-M)K.QUBZN)TEF,;,BHA8( I&< ]: /4*J7NEZ?J?E?;["UN_*;='Y\*OL
M/J,C@UA:_P")KG3K'[59)IY'V7[4D=W<E'FX)*(H!.< <].1[XRKC7]5U'Q3
MX/FTR)!9ZAIL]XT$MTT8;*Q$;@$;)4/QZDGICD [VH5N[9[IK5;B)KA%W-$'
M!<#U(ZXKF?B#>ZE8Z)9-IC!)9=3M(6;SC$2K3*"N0IX/0^Q/7I67(=53XH3M
M965B-0DT&(R"2=O*4^>_\03<W_?(_P 0#T"J]M86=G)/):VD$$EP_F3-%&%,
MK?WF(')]S7'VOQ"CN+#1A/#!97^HRW,+":7,4!MV*R-NXW#<!@<9W=1BMWPU
MKLFN6]Z9H%CDM+IK<R1DF.<  B1">Q##UP01DXS0!IF_LP<&[@SG'^L%.>[M
MH[F.V>XB6XD!*1%P&8#DX'4]#7GFG6-JWC;QZG]A1ZEOEM$\D)$!@VP)SO(
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MXECAAC4L\DC!54#N2> *X^#Q3!8C1]"2>UM[EM*CNVFNWPBKPJ@#(+$D'N,
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M&^7Y<%6/&[J*H6/C?5Y],\.:Q<Z3:1Z;K$L,!5+EFFB:7[K8V[2N>.N<'/L
M#NZ9++'!$TLLBQQJ,LSG 'U-<1<_$-/LU[?626\\-E>-:M:;R;F8*X1W11Z'
M)"X.0.HS5S5=8N]:TS7X=)M;66"Q,EK,;MRHED5 6"X!P!N R>X/'>@#JX9H
MKB%)H9$EBD4,CHP96!Z$$=13/M=M]L%G]HB^U&/S?(WC?LSC=MZXSQFL3P'Q
M\._#6/\ H%VW_HI:Y;0O$5WIFG:WJ^I6%K+,VLSV<#I<%I7D:<1)$<QC"#"C
M=D\+]WM0!Z517-2>(+^P\36>B7]M;N^H02R64T3LJF2, M&X()'!!##.>>*B
M\(>(M9\2V\-_<:5;6FG2I* RW)DD\U)2F,;1\I )SUR.@XH ZJJ][86>I6QM
MK^T@NH&.3%/&'4_@>*YSQ;XJNO#MO=7$,6GR+:0?:&@FNBLTR#);8H!Q@#J>
M"?3K6QJ6L"P\-7.LQVTMP(;5KE8$'SOA=P7OS^= &A##%;PI##&D<2#"HB@!
M1Z #I233PVT+33RI%$O+/(P4#ZDUQ8^(5I%HUUJGVS2]0ME,$<+64^#YLKE=
MD@.2@'RG<>V>.,5%K.OG4]*\2Z/,EM=1+HTUS'=VN6B/RLI1LYPX.".>0<X&
M* .[CD2:))8G5XW 964Y# ]"#W%0I86<=])?):0+>2J$DN%C D=1T!;&2!Z5
MQ]AXI@L;70M"2>UM[EM'BNVFNVPBIA54 9!8DY[C &>>E6--\9SZPFGV=M8K
M#JMW'/(R3.?*B2%Q&7SC+!F*[< 9!SD8H ["BN"U#4_%">*_"UL]O:1R2B],
MT"7KI%-LP%)PC'&TA@#GEL<8S7>T %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% ".&*,$(#8X)&0#]*XU/ LT>A6FE#5QLMM2_M%9
M#;<L_FF7:?G^[N)]\?G79T4 8XT-AXM_M\77S-8K9R0^7P0'9PP.>#EO?BH[
MSP^[>(UU[3KQ;6]-O]EG62+S(YHPVY<J&4A@2<$'H2"#6Y10!R=SX)233[:V
MM[XQ2)J8U6>9X=QGG#[^0" %SQ@=@!GC-6M5\,SWNMV>MV&J-8:E! ;:1UA$
MD<T1(;:R$]F&00>,GK7144 <:?A_#)IFK6,VIW#B^OQJ4=QL E@N!LPP/0@%
M <8'4CITU+C1-4U#0+_3+_6(Y6N[=K<RQV@0*K JS;=QRV#USCVK>HH IZ59
M2:=I5K923+,;>)8A($V[@HP,C)YP*P9_!$%V?$-O=7LLFFZVWFRVP0!HY-B+
MN5^O\"D#'!'>NHDD2*-I)'5$0%F9C@ #J2:@T_4+75+-;NSE\R!BRAMI7)!(
M/! /4&@#*A\/3S7>FW.KZ@M\^FEFM]L'E9D*E/,?YCN;:3TP/F)QTPNN^'&U
M34M.U6SOFL=3L-XBF\L2(R. &1T)&0< \$$$=:W:* .=U/P[>ZJ-*:XU5/.T
M^]6]#"UPKN%90N-W"X8\9)]Z+CPU<G7=1U:RU0VTU[#;QD&'<$\ERP_B&0=S
M CN#U%=%10!R5[X$MM2M-;%S<)'=ZM#%%+-:0")5\LED8*2<MN8DDDY&!QBI
MX?#%_P#\)!8ZW=ZU]IO+6WEMBOV4)&RN5)(4-D'*#N:Z:B@#E;?P3"?#FKZ%
MJ-V;JTU.:::0K'Y;(TK%VP<GHQR/3'.:U-'T_5;%$CU#6!?I&FQ#]F$;-[N<
MG)^@4<]*UJ* ,35M DU#7M)U>WOWM9[ 2QE1&'$D<FS<.>A^08/Z&J,7@YQH
MGB/3)M1WIK;S22.L&TQ-*FQL?,<@ # /YFNIHH Y$^"IQ>7$Z:U)&+O3X["Y
M5;=265 P4H23L^^<CG/M4D/@Z6W;PY)!JK1S:+;-9AA ")H6" @@GAL1KSZY
MX[5U5% &1XDT/_A(-*6T6Z:UECN(KF*94#[7C<.N5/49'2H+;P_<P^*O[=FU
M$32&R6R>/R-H*JQ?=D-P=S'MC''O6]10!Q<?@ VT5E)::L\-]87EQ=6ESY ;
M G8M)&ZDX93GM@C YKJ[**ZAM\7ETMS,3DND7EJ/8+DD#ZDGGK5FJU_?VNF6
M4M[>SI!;1+NDD<X"CU- &3H_AV?2_$.L:L]^DQU1HWEB$&T(40(NT[CV'.<\
M^E2:EH,NH>(](U9;Q8AIOF;8?*W>9YB[6R=P[=..#Z]*U[>>*ZMHKB%P\4J!
MT8=U(R#^5-M[RVNVF6WN(IF@D,4HC<-Y;@ E6QT.".#ZT <A!X!E@L[2S76Y
M6M[+4O[0MD:W7AM[.0Y!R_+'GC\:OV_A-XK3Q';RZAO77&DDD*P[3$SQB/Y?
MF.0 HX/?O713SQ6T#S3.$B0;F8] *BT_4+35+"&^L9UGM9EW1RIT8>HH @L-
M/FT_0;?3DN4:6W@6%)C%P=HP"5W>@'?\JQ]*\+7NC:)INEVNJQ2064+P%;BT
M+K,A*D%E#CYAM//3#'BMNSU:PU"[N[6TNHYI[-@EPB]8R1D _E5V@#*T?P_9
M:-H"Z/$H>V_>;U( #&1F9\ < 98X Z#BL[0_#6I:#IR:7;ZV)=/@0QVR3VH:
M2-<856<,-P7MP#P.:Z:B@#DHO!!A\)Z/H2ZD2-*N8)X)S#RWE-N4,-W/(YP1
M4%QX!EGM=3M!K<JVM[J U$1^0I*R^8LA!;.67*# X('<XKM** ,.ST&>U\57
MNN-?(YO((H)(1 0 L>XJ0=QYRYSU_"L:#P#+!9VEFNMRM;V6I?VA;(UNOWM[
M.0Y!R_+GGC\:[6B@#FM.\,76BZG>R:9JWE:?>W37<MG+;B0I(QR_EOD;0QYP
M0V,G%5;GP'#>6^O6<^HSFQU:X^UB)$57MY_D.]7[X,:D#'KUKKZ* ,1=*U>7
M2KFSOM9CN'EA,*R+9B/ (P68;CEL>A ]JH77@^2Z\!P>%6U(+%#%# +@0?,4
MCV[>-V-WRC)^O KJJ* .:N?#-[=>)8=;DU2)YK>#RK:&2U+1P$CYW4;Q\S=,
MG.!QZYC_ .$3O(-836;+6C%J3P>1=M+;^9%<*'++E-P*E=Q (;IQS74T4 <W
MJ'A>YN-7LM9L]8EM=4@MS:RS&!72XB)W;63C&&Y!!X]ZL>'?#S>'Y-3Q?/=)
M?W;7C&5 '5V"@\@X(^4<8&/IP+^I:M8:1#'+J%U';QR2+&A?^)B< #W)(J[0
M!QVJ>!7U*3Q"BZS-!::X@$\0A5F5A&(^'/.W 'R^O>KNI^&;K5K&ZT^[U""6
MQNXA')&]IN9/EVDQDOA2>HR&P>:Z2B@#%U[P[%K?AIM%2X>U0>48Y% 8J8V5
MER#]X949!ZBHM,\.SV/B*YUFXU)KJ>ZM8K>93"$'R,Y!7!X'SG@Y^M;]% !6
M)K&@2:EK6DZI;W[VD^GF50!&'$B2!0PYZ'Y1@]O0U>M=6L+V_N[&VNHY;FSV
M_:(UZQ[LXS]=I_*KM '++X.:&UU73;743#I.IR2236_DY>,R?ZP1OG"ALD\J
M<$G';&/=6DT?Q5LK+2+^&P^SZ#M$;0B53&)@ N,@C Q@Y[=Z]!J+[+;^?Y_D
M1>=_STV#=TQUZ]* *VF:5;Z5#*D.YWGF:>>5^6ED;JQ[=@,#@  #I5(:#*/&
M)\0?;%P;,6?V?RN-@8OG=N^]N/IC'&.];=% '&1^ Y;9K*2UUAHYK+4+F]A9
MK<,/WY;>K*3SC><'C'O3Y/ I?1=1T\:M+NNM274X[AHE+1RAU?D9PPR@XP.]
M=A10!' DD=O&DTOFRA0&DVA=Q[G Z4\D*"20 .232TCHLB,CJ&5A@J1D$4 >
M;_#W1Y-:\ 6<-[J2W.DRO(WV180IXF8[&<'E<C., GH21Q707W@TZC?:_--J
M++%K-DME(D<6TQHH<*5;/7]XV<C!]JV-.O\ 2KBYO++3I8#+:.!<QQ+CRV(X
MS[X%:- '+6GA.]MM4L=3?61-=VME)9 -:!8]C%#D*K#!!1>YSSTXQ%#X',/A
M#3- &I$C3;F&XAG,/)\IPZAANYY'.,<5UU% &3X@T&+Q!IL=M-,\,\$T=S;W
M$0&Z*9#E6 /!Y['J"14"Z!/)J)U2[O(I=26U:U@D2W*1Q*Q!8A-Y))(7)W=
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M/\+Z$_AO1(]+-W]JCB=V1S'L;YG9SGDYY8^G%;-1P7$-U LT$J2Q/RKH<@T
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M&^7!&UB.GZUA^(/#QTGPWK2V4NH7 U>Z1[UE(+Q*Y1))4"*&.U /E'''3KD
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M6VVX3&V/Y_O*^3CN-O4YJ\O@?23_ &NMP]U=1ZO$D=['/(&$A5=H;.,AL>A
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M3[MD\?6@"C<W6HV/BSPO8W8TVX%R+E3*EHRR1[(\_(Q=L \ ^N*H2^+=6N/
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MO+>WN;3[,BQNDLOED@@;@PR#P<<=.] 'H%QJMM;ZC!8$327$W:*)G$8.<,Y
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M,&90A*X!0G;UY'K5CPIX@DU#59K&[N-5BO%MEE:QU.S2)UYP71D4*RY('4T
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MK+*C1.H"L2%() # [3TSTKCM+\6ZI-9Z3IMS/$VH7>K7>FR7HC"C; 9/G"]
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MAD9QM(Q[T >M45PMSX@UG5-<\1:9I:7<3Z6L4<!MTA8/*\7F9D\P_=R0,#'
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M1F67R@"RH!DM@D9P/QH IZ3X5TS1'4:>;N*!&+1VOVN0PQDYSM0M@#D\=!V
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MTDYXZX"YY%=!65J>O0Z7JNEV$UM<,VI3&&*5 I17",^&R<CA3T!K5H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (+R:2WL;B>*(
MRR1QLZQCJY R!^->=2ZIJ(^'6A^+;/4;B;59WM'EB\TF*<RR*CPB/.T8W$#
M!&WKUSZ96;;^']*M;G[1!8Q1OYAE  .U9#U<+T#')R0,G)H XJVM''B'XASM
M?7#! @,1V;6!M%(SA<\9XY[<YJMI:WFCZ'\/;^WU6];[=]ELY[=Y,PM&]LQ
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MBB]F\2ZI!+IFH7JVLJ7&!&(S\H88^<<#@\8Z8)R>W\/Z+8:1IT1M-+CL96C
M>-57<,?PY!(QGL#BL#P?X7CM[[6-0U30UM[V;5)[F&678Q>-FRA^5CR/?D9H
M @TR6\O/'FAR:BIAOYO"SM<*HP4D,L.[ [8.:H:?XCU"+PSH<=Q?S-_:&OW&
MGSWCD%UC$LP50>@)V*H/;/'.*[^31M.FU+^T9+.-KWRS$)\?.$/5<^GM4 \,
MZ&-+FTS^RK4V,S;Y+<Q@HS9SG'KGG/KS0!C:C#%HCVVF+J&KW#ZI=D6]N+IB
M^%B)9?-=MRH-NXD'/8=<5Q\MW?WOA^*TNK]W>S\8PVD,YD$KH@=2!O(^8C<1
MDCMSFO17\*:#+9QVDNE6TD,<@E177<0X&-V3SG''TXITOA709[6:VETBS:WG
MD$LD1B&UG P&QTSCO]/2@#D=1BOM+U3Q%IJ:C>7NER:!+<R+=R>:;>;YE4!C
MR RACM_V>*ATW5;Z6]\,:!&KFS?P['=[8[DV[2R?(N XY^4<X!'WLGI7=IH>
MEQZ9)IR64(LY1B2+'#_[WK^-0S^&-$N;.UM)M,MV@M#FV7;@P_[AZKZ<4 )X
M:M]6M-%2#6ITGNDDD"R*^XF/<=FXX&6"X!..2*Y7^U+?1];^(5]<7$L$<36F
M9(5#.I-NH7:#P3DC&>/6N[M;6WLK=+>UA2&%/NH@P!W/Z\U1?PWHLAOB^F6S
MF_7;=[DSYX_V\]?;/2@#E=+^WGQIJ>A27E[#:SZ4ETL<EZ9I;>0R,N0_5> #
MMR1QZ'%8UCXKU>#PWI5\]P[+HESY/B R,69VWM"W)Z;?]:1Z%>U>BV7A_2-.
MGCGL].MX)HX_*62-,-LSG&>XR<\U,=)T\VMY:FSA\B]9VN8]@Q,7&&+#OD=:
M *7AV.1[6>_>XGE2]F::!9)6<)#T3;D\9'S?\"QV%9B.TWQ:FCE^Y;:(C0 ]
MC),V\C_OV@_"NJ1%CC5$4*B@!5 P /2LJ^TF237K#6+1D6X@5K>97X$L#D$C
M/]Y64,/Q'&[( .#U+5-5A\#^-)X]8O%N-/U=XK>?>-R(!"-O3I\Q_.MJ\FOO
M#OC:UC@U"^OH;W3;N>2VN)-X,L7EE2@Q\N=Y&!Q[5T+>%=!>VN+9M*MF@N9/
M-GC*965_[S#N?<^@JV^DV$ES:7+VL;3VBE;>4C+1@XR >O.!GZ4 <[X2C?7=
M&T+Q*VK7<ES/ )KE$G;R)"R$,GEYVKM8\$#/R<D\UR^A7=S9^!? ,EM>30I/
MJBV\R(V%D1C*<'\5%>@6_A?0[2XEGMM,MX9)2S.8UVC+##$ < G)R1SS0WA;
M0GT?^R#I5K_9X<2+;[/D5@<@@=CGTH X_6?$NH:)JOCJ>VN7NO[-TRVN(()#
MN2&1O-W' [8"DCT%/UJTMXO%?@:ZCU6ZNWN+UV_>7!=)1]FD/F*O1>H^[@?-
MTZ5V-KX>T>RD>2VTVVB=XA"Y6,#>G/RMZCD]?4^M5[;P?X=LUC6VT:SA$<OG
M1[(@-CX(!'IP3T]3ZT <EJ6H:E#9_$<1ZK=JVFQK+:/O&83]F$F!QTW$U;C:
M^TSQ+X1D&KWUPFK)+'=Q3R;HVVP&165<84@KVZ@\YKJ'\,Z+)]LWZ;;M]M_X
M^LK_ *__ '_[W''/:IFT33&6S4V4)^Q'=:Y7F$XQ\OIQQ]* .%M3X@UR.V$5
M[J-MJ\&KR17\T,G^C+;J[95<YC)V; , N&Z]&KOKY=FD7*EBVV!@6;J?E/)K
MSD^ C>>'KBUN=!6/Q'<,YDU>.5$3SF8GSUVL&']X+M'/!]:]-\E6M_)E_>*4
MV-N_B&,'- 'E>CV^HZ=X'\#ZIIVKWSW4WV&W:S,@,,L3@!UV8P"J;FW=?E)-
M7)]5U"#P%X[N&U>Z6XTV]NTMIVD&]-L:E%SCIDCCWKN-,\.:-HTC/INF6UJS
M9_U484+GJ /X0?08J.?PIH%S>7-W/I%G)/=*5G=H@?,!&TY'0G'&>N* .8N[
M:6]^(GA=SJ%S&3H]R_[LIUW09Y*D\YY^G&*W?'MQ<V?@/6[RSNI;6YMK.2:.
M6(X(95)%:$WA_2+AK)IM.MY&L23:ETR8LX^Z3TZ#\AZ59O\ 3[35+-[2^MX[
MBVD&'BD&58>A'<4 <:S7VD>+/#1CU6^NDU2&=;F">0,CLD6]2BXPAR,<=<\U
MDR:SJDWPJM_&5M?7)UG<DQA$C>4[&8(8/*^[CG8.-V0#G.:]#;1=-<V3-9Q%
MK$DVK$<PY&#M/;CCZ5''X?TF&[:ZCL8EE:7SC@?+YG]_;]W?_M8S[T <UH5F
MY^*'BN?[=<X1;,F(;-K QO@'Y<X';GZYJU\0R!HNFY_Z#.G_ /I0E;YT;33J
M_P#:WV&#^T-GE_:=@W[?3/XG\Z=J.DV&K1QQZA:17*1N)$609"L.01[CUH Y
MV&:[D^(6N::VH7/V8:7;S1H&'[IV>4,5XXX5:Y+3;C5W\,>"-8;Q#J1NM5NH
M[6ZW2@HZ.DA.%(P&!48;K7I7]@Z5]LEO/L47VF:/RI)>=SI_=)ZD>U0CPMH0
MM;6V&EVP@M7\RWC"X6)O51_"?<4 <5>W>I:9I?Q!L8=8OF&DVRW5E-++OEB+
M0%]N\C)&Y>_K5O4+>6^\<^#'.HW43/IET^8RF<@0Y.2IZYY^G&.:ZZY\/:1>
M2W<EQI\$CWB!+DLO^N4# #_W@!QS1-X>T>Y6R6?3K>46)S:[TSY7^[Z#@<>P
MH XC1;WQ)XHT4:I9R>3J*:E(K>9=LL4<<<Y5H6B (_U8QDC=D@Y%&I7G_"1^
M#O&5Y>ZA<6SZ?+>VJ103F-8EC4A0RCA]XP?FS][C%=K_ ,(UHO\ :;ZC_9EL
M+N1@[R!,;V'1B.A8>IYI+CPOH5UJ$NH3Z39R7<R>7+*T0+.N,<^O'&3VH 7P
MS_R*FC_]>,'_ * *\^O;N_T"?XCZW97EQ)<VDT16-E0IS;Q_,P"Y.P,2.>B\
MYYKU"TM+>PM8[6UB6*"(;4C7HH]![55_L/2O[3GU+^S[;[;/'Y<LQC&Z1<8P
M?7CCZ<4 <WJ3W6B^(?"[:;?75U!J,[6UU%-.TJRIY3.)1DG:05S\N 0V,=*T
M/B"0/ASXDS_T#+C_ -%FM2PT/3-+96L[..(HI2/&3Y:'JJ9^ZO X&!P*LWME
M:ZE9RV=[ D]M*NV2*095QZ$=Q0!SV@1:C96ND3WNJ0R6)L4A6)8?+/F-Y>SN
M=W 8=NOY<*;C4K33O%UQ"S'1QXBN4U98$_TA;=HX@SQDY'R]2,9QG!!%>EP^
M%M"MYH98=+MDDA.8F5/N'&./3BI[#0M+TMIVL;&& W!+3;%QYA/4MZD^IH X
M_P 1QV$+_#V+2_+_ +/35(EMO+.5\L6\FW![C&*=?:'J>E1:SK7A?Q+';VTD
ML]W/97MLLL!F7(DPV0R E#GD@'-=(/"/A\16T0TBU$=JVZ! F!$?51_">3TI
M_P#PBVA_:I+C^S8-\LAED&#L=R<[BGW2V><D9S0!A76K7VNZ/X?MDT__ $K4
M((KZ]M3)L\N)0K,I)]7*+@]1N]*K^!I9]&\0:UX6O(!;+O.IZ?%O#@02L=Z@
MCLLF?^^Q78#2;!=4;4Q:QB^9=AGQ\Q7TSZ>U,DT33)=6359+*%K]!M2X*_.H
M] >P]J *OB;4H=-TN/S9;E'N;F*VB%MM\R1W< ("V N>1G(P,D'.*\_U'4]8
ML- \?V\>J743:5'%/:-]I\Z2$O'N*&1ADC(S@\C/6O3M2TRQU>S:SU&UBN;=
MB&,<JY&0<@^Q![U2?PIH#Q31-I-IY<Z*DR>6 LBKT##H<>] &!,;W1/&^AI'
MJ=]=PZE;W7VB">3<K-&BLK(,?(>2,#CFN9UNZ&O_  FLO$=WJ<_VNZGMF>*.
M<K#N-PF8O+^[\O/.-WRY)ZUZ>^CZ=)+9RO:1-)99^S.1\T6<9VGMG JDW@_P
MXTETYT2QW7;;I_W(^<Y#9/OD Y[D4 ;1&5(!()[CM7CDEH\7PC\23&_GEWZI
M<+MDV;01?8W8"CDXR><>@%>Q(BQQJB#"J  /:LB3PGX?E6[5]'LV6\D\VX4Q
M#$KYSEAW.>?KSUH YG5;K4?"_BH_9;^]OH[C1[V[:VN9-ZF:'85*#'RYWD$#
M ]J?X;.OZI;>&M:AN<PSPB34&EO"Z7"O'GY(\;48/@@#&!D'-=@^DV$EU:W3
MVL;7%HA2"4C+1J<9 /7!P,_2JUCX:T73+HW-CIEM;REBP,:8"D]2HZ*3DYQC
M.: .<^*@E3PS8WGEO)966JVMU?HHSNMT?+Y'<#@GZ5V4,]O>VB3PRQS6TJ;E
M=2&5U(Z@]"*E90RE6 ((P0>]8<7@SPY"[&+1[5%8[FB5,1D^I3[OZ4 8UE/<
M>)+GQ5'<:A=64NGW9MK403-'Y*")&64@'#;BQ/S9&!C'7.=X9\1ZCXHN=%T[
M5I)+0W.A)J$@@<PO<2%RI(9<$  !L*1]\=A7;76@Z5>W;75Q91/,Z".1N1YJ
M#HK@<.O)X;(YI-3\/Z1K(@_M+3K:Z^SG,)DC!,?K@]OI0!YG9ZM<>'_#.K_V
M?=/,LWBTV<EW)("RQNR*S%\8!_AW$<9SUKN])T[5HM6U 7I!T:X@01VTUTUP
MZ2Y8/\S#.PJ5X)/(/3-:"^'M&6VO+8:9:_9[PYN8?*&R4^K+T/;\A4#Z#%8:
M1<VN@0P65Q.@C$QR2@Z;NY.T$D+TSZ9H S/AS>^9X"T-+B<&4Q/%$';YI$C9
ME4CU^50:U/%1 \-W1/3,?_H:U-9^'M*L8-+BBLHB=+B\JSD=07B4J%.#V) Y
M]:M7VGVFIVQMKZW2> D,8W&02.G% '$3C_A7&NO<J,>$]3FS,H^[IUPQ^^/2
M)SU[*W/ -)I.H32W'@W0GED@L;C0_M):)RC3R(L0"!A@@ ,S'!YX[=>ZGLK:
MYL7LKB".6U>/RWBD&Y67&,$'J,56FT+3)[*TLY+.,PV>W[,!D&':,#8PY4@<
M9!Z4 8OA.[OO[9\2:3<3RW-IIUY&EK/*=S[7B60QENK;2V,G)P1DUE^+[S5[
M*_U&[:WOKK1H;5<R:9>B*:Q=0S.[1EE\S@H<$G@=.3GM[6SM[&#R;:%(H\EB
M%'4GDD^I)Y)/)JK<Z#I=W=27,]FCR2@"7).V0#H'7.&Q[@T <]H]_+=^,?$U
MO)J5Q]B%E9W$ =@OD"02EBN1QT7KZ5AZ!XCOKW1? EE>7\VW6HK@W-WOVR2,
MBY5 X^Z6R3D8/RX&*[R[\/:/?:G%J5UIUO+>Q*$29T!8*#D#W /(ST-1-X7T
M)])32FTJU-A&X>.#RQMC8="H_A/N,4 <KK>CM:>*/"%BNIWK+)?7;)+)*9)8
MU-L^5#MDGO@GD9_&M7PC+=0:[XET>:^N;RWL+F'[.]R^^15DA5RI;J0"3C/-
M:Z^&M%62VD&G0>9:DM Y&6C)ZD'KD]SWJW#IME;W]Q?0VT<=U<[?/E48:3
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MQ7>G0=)-U:W/]GP":T7;;N$P8AW"^@/?'6DD\/Z1,E\DNFVTB7YS=*\8(F/
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M@9VJ.,4 =O*YBA>0(SE5+;$&6;'8>]16%TU]I]O=-;3VS31AS!<*%DCR,[6
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MPW6E6"R><VH/!Y4C([H8D7[S<#)..PYYKNM%GDNM!TZXF;?++;1N[>K%02:
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MA%?:KJ=ZYUP.Z31"Y96AD$V/*\L'&T+V(Y W'UH ]HHK@+V[N]1^(>JZ)=+
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ME9U!Z@$C(!S5FB@"C'HNE0R121:99H\7^K98%!3OP<<4]M+T]Q<![&U87/\
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MU>:( 1R-"I9 .F#CC%6Z* (TMX(YY)TAC6:4 22!0&<#ID]\9-2444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,5VG&/XL@CL>>B^G+O%WA#4?$7B/0-4M;^UMTT:8SI')"SF5CC()## POZT
M<C\6-"M- \(V9TXS0^;K4.-LK9177#(#G.T[ <>M:6O7$NK_ !4TGP0)I;31
M+?3S>3P6[F,W!!*K&2N#L& <#KSFM_X@^$+WQGI5G86U]!9I!=)=,\D1<LRY
MP!@C Y-1^)O!-SK6IZ5X@T_44T[Q%IR;%N!%OBE0_>C92<[>6QSD9/X &A'X
M)T6VU&&ZLK86JJCQS01%A'.K+C#KG!QUR037)_ Y=_A'4+B1GDG.I31&21BS
M;%V[5R>PR?SKM=-C\3&4-JEQI(15/[NTADR[8X.YFX'M@_6N4\-^!_$_A;P[
M>:/I^N:;MN9I9O/>SD\R-G !*XDQQC(H PM>BLT^/"VUU9W5U92Z-Y[VULKO
MNE\PC>54]<#K7I'A**TC\,63V,4T-M.IN$BF8LT?F,7VG/INQCL!6'J'@_5Y
M/B*/%NGZC91LM@+%;>XMW<;=VXL2&'.373:/;:E;VTO]J7<-Q<R2E\P1E(T7
M  5023V]>I- '!QG4['XX:=IL^M7][;/H\ERT<SA4\PR,N0B *,  #C/O1KI
MU.P^,'@ZU.M7\]K?/>R26[.%B 6,E%VJ "!GJV3[UL3^$]8F^(\'BO[?9!8+
M0V2VWDOS&7+9+;OO<^F*77/">KZKXXT;Q%#?V42Z0)A# \+L9!(NT[F#<?@*
M .SHH[<T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!7GO[.U?9<7<$3XSMDD"G'KS2#4+(V_V@7EN8<[?,\P;<^F<XKS7
MXL00R>*O +/;),QU8*5*@EURIV\\?GQ5.[\'W&G:/\2-<N;&+3[/4K"0VVG
MJWEE(6_>,%RH8GG@G&3S0!ZW!<07*%[>:.5 <;HV##/IQ2R2QQ;/,D5-[;5W
M'&X^@]37*?"^*.+X9>'O+15W6:,VT8R3U/UKB/C#J2WDDJ6FKP6EYX=$5_#
MTH#3W!;. #R2L8)]_, H ]AFGAMH_,GECB3.-SL%'YF@W$(M_M!FC$.W=YFX
M;<>N>F*XW6M6L_%?P;U'5HD5H;O2)90IYV-Y9R/JK CZBN7\/7DWPT\1#P3X
M@D,_AR_8G1[V;E4R>87[=3^9]#P >M17$$\7FPS1R1_WT8$?F*K_ -KZ:?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9.[J,J5)[\X]NE7=%\)0Z)_:5U#>2S:OJ3;[G4)U4LQ PH"C "J.B_SKHJ*
M,&S\*VD?@Y/#.HO_ &C8K;BV/FH%+1@ #..XP.1WYH\'>%[?P=X;AT2UN))X
M(7D9'E #89BV#CTS6]10 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!%<7,%G \]S-'#"@RTDC!57ZDU5L=;TW4M-;
M4;2\BDLE9U:?.U 4)#<G' (//2KS*KC#*",@X([CI7(?#54?P9@@,IU"^R",
M@_Z3+0!T6EZSIVM1SR:;=QW4<$Q@D>/E0X )&>_##D<<TS5]>TK0+4W.JW\%
MK& 2/,;E@.N%ZGKV%8/@+'F>*L?]!^Y_]!CI/BDJ?\*WUIB!GRD&<<X\Q: .
MPHHHH **** *FIZI8:-827VI7<5K:Q_>EE;:!Z#W/M65!XTT2>YMH-]["UTX
MCMVN=/N(4E8] K.@4D_6N,^*4HA\;^ 9-0(&C#4',Q?_ %8F^7RRW;CG&?>O
M3I[>&Y5!-&'".LB@]F4Y!_ T 2T5XC-XU\22_#:_\>1:M)%<6VI;$T[RT\@0
M^8J>6PV[B?FSNSGZ5N:GJOB6\\>:UH]IX@FL;2'1!J$2BVB9HW+#C)7IQCG)
MP3TZT >I45XSH_BOQ5)#X UBZUKSXM;G-I=6?V:-4(&0'! SNXR><9Z #BM+
M[9XJU7Q7XXTFV\4R6<.D);R6K?9(6(WQL^"2OW<\'C/ Y'.0#U2BO+++Q;J>
MN^"?#JS:K=6.O:G:RRK#86L;RS;#@2?/\B)@;CG&<C!&*S7\:>)[KX6>#]=A
MU06^HZAJ4=E<MY",DJF1UR1C@X0?=(ZGVP >RT5YQH-[XDD\:^*O"UUX@DN!
M;VT,]I>&VB62%G&<8"[2,^H/ JEX)\3:]XDM]-TVYU>>/6K.^N5UG$,/$<1P
M%QLXRS1@$8/W^3C@ ]$T[6]/U:XOH+&X\Y[&8V]QA& 20=5R1@D=\9Q6A7"^
M)+34/"'A*"#PK;W$\LE^'NS$4:ZE1RSRNFX8:0X]#@9P..+O@#Q!'K^E7KK<
MZC*]M>-"\6I0+%<0':IV.% !P2>>O.#TH ?)\1O"\4M[$][=;[#_ (^P-/N#
M]G]WQ'\HX/)JY>^,M!L/#D'B"6_5]+G9%BGB1G#%C@< 9Z]?3%>1WM]JNFZ_
M\6;G2;6.X=?LJSJV=RPF.0.ZCN0#G!XX/T/0:W?1>&/@II-WX,U*2.RC:%8I
M'1)#(LDGS;MRG#;B3QC!S0!ZU6/K7B?3/#]SI]OJ#S))J%PEM;[('96D8X +
M ;1^)Z UR7B[7-8M_&3Z6+J^L=/.D27%I)8V_FO/=!@-I^1C@ CC SGKT%<[
MXG'B.;PIX DUZX5=:G\0VCMOA4"$D-@%5QG'4CCDD4 >S,RHC.[!549))P *
MCM[F"\MTN+::.:%QE)(V#*P]B.#7E2ZGK[+\2O#FI:Q]O33;!9+>YEMT5PLL
M+.RD* #QP/\ (KJ/A;;W$/PVT3S;OSA):1O$#&%$2E1A>.O.>3SS0!UEO=VU
MV91;7$4WDR&*3RW#;' !*G'0X(X]ZFKP;1];U;PA\-O&FNV=VLLL>M7$,<;0
M+L65I$4RGOT/W>G2NT@U76=$^)>AZ%+JT^IV&JZ?)+)]H1-T<J G>I51A3@#
M'3F@#L]6U_3=%:W2]G837+%8((HGEEE(&3M1 6..Y X[T[2-;L=<AFEL7E/D
M2F&5)H'A>-P =I5P"#A@>G>N2\9>'-;U#Q7INM>&-5LK?6+"V=&MKU"T<D3G
MKP"1R"/RZ8KG&\:^)#X.\:O<P6NE>(-#D1I;BR0/%.Q4 '#AOX5'OC;TZ4 >
MP45YQ;>(-8_X3SP?8-J3R66I:2US<0F-/FD$8^;<%SR3G&:SO#OB[67\3V&G
M>(Y=8L+Z]FG6,?9XFL+A-K%!"X&<@;#DDYYSU% 'K%%>)'Q!XSF\"^)/$">*
M62;1=4GACB-G#MF1"@VL=OH>,8Y)Z\8V-1\6^)=7\1SZ#IT=Y:7<.C1WBI9K
M!O-PX!^?SCCRU) PO/7)H ]5HKR[5M8\8PZGX$L)]0&F7NK++%J,*0Q2JKH@
M.Y3@\G.<9QG'!Y!I6WCO7O#_ (0\;W.H7*ZM=:#?_9K::6)4+AF55WA,#@MG
M],T >C77B?3+3Q+9>'II)AJ-ZKO"GD/L954L3OQMX ['THU_Q1H_A>"*?6+E
M[:&5]B2""1U+=@2JD GL#UP?2O/)[2[@^,/@::ZUN?4_M%G=R*94C4(3%SLV
M*/E.1@'.,=:O?'/_ )$>R_["MO\ ^S4 =9!XX\/W$]Y;QW<PNK.+SY[9[29)
ME3^\(V0,1R.@/6M#0M<L?$>BV^K::[/9W&XQLR%20&*YP>1R#7-2^$9AXDU7
MQ;J=W%+=G37LK>&",JD<?+$L2268GZ #UKFO!NJI8?!WPI:+JEQ8W5\[PPBT
M@66>4[Y#M0,"JG."688 ST)! !ZW17BLOC/Q3'\&M=U=M4DCU;2=2>S6<P1;
MI$$B)\ZX*Y^<\KZ#D]^ETK5/$.G_ !7CT'4-8_M&QO-)-\$:W2/R7#[<+MYV
M\=R>OXT >@7-S%9VLUU.^R&%&DD;!.% R3@<]!6)_P )IHOVU;+.H?:VB,RP
M?V7<[S&" 6V^7G&2!GWK<!@N[<X,<T,@*G&&5AT(]#7(S?\ ):+3_L7YO_2B
M.@#:TWQ/I>KZ@;&REF>86J7?SP/&#$Y(5AN SG!_(UL5P=Q87%Q\4;RVL;]]
M-4:%;CS+>)"Z@3RX"AP5 _X"?;%4-,\9:S>6_AFPE\R:[OVOEN)[5(U=Q;2&
M,;0Y" MPQ^AP/0 ]+K*N?$>FV][)9!YKBZB ,L5K;R3F//(W[ 0I(Y .":A\
M--K9M+M-:C8.ETZVKR&/S)(, J7$9VALEAQCH#WKG_A),)/!;+.?^)JE]<C4
M@WWQ<>:Q.[WV[?PQ0!UVF:M9ZO#++9O(1%(8I%EA>)T< '!5P"#@@].]7:YK
M7M3ELO$.AZ1:$6S:Q/*9[E$4L!%%NP,@C<<*,D'@'VQS^L:_KFE+XQL$U!W?
M2]-74K.[:*,NN5?]VXV[3S'P<9P?QH ]%HK@3/XAB\2:'I[>(IG@UFQFEE/V
M:$-;O&(SF+Y>^_&'W]*I7'B#7XO FI7"ZJ?[1TW6O[/%SY$?[]/M"1Y=<8!V
MO_#CD4 >ET5Q=Q>:QX?\9:=!=:R]]I=_!<R3I<0QI]D\I0V]2B@[.0N&SC(Y
M-4]/US57\3:%$NHWMQIVLVL[![BWAC4,J*RR0@#>H.>DF>"* /0**\M36_$B
M> U\3OKSO-;7[PM;?9HA%/&+LPX?Y=P;;T*D=!P>2=_4-9OM$\:7%O?W\S:9
M=Z<\]C&L<8*S1GYXP=N6)5E*@D]^M '9T5G:7;:A%H<$.HWSS:@8OWLX1!AR
M.=H"@8!Z9';FO/+;Q-XEL_ ,?BF[U47;S'[(EM]FC54=KH1K*6&,D+GC(7I[
MD@'JE%<3=W'C&U;4FL;>XE@-B&MOMSVXD%SO VKL.""IR-W&X =#BLBY\=7-
MG$]O"VK"_FO+.U-IJ=K''-;"5V4R*0 C@A2!DD!ASQQ0!Z;17#W]WXGL--\2
M7)>Y@M+?3C=65Q<BW:5)E5RR$)D%.%.2,\D9Z8JWTGBRS\#/K\>O27%PL$%Z
MUO':1*!& #,BY4Y)7)!]1Z'  /0J*X/Q!XIO-.T75_$FG7AN=/MK>".VB9$,
M;RR%<R9P"5 D0XW 9W#C%3W,_C"VEO7L8)YH#ITAB_M%K=2MV"/+"^6?NL"<
M@\9 Y&30!VM12W,4(?<Q+(F]D12[[?4*,D_@*Y?PIKK:AJMY97,NKPW:01RF
MRU2V2-T&6!=&0!74G X)P1VS56PMKI_BYKDHO-D::?9[HUB'S*6FPI)YZC.1
MZT =3H^KV>NZ3;ZG8.SVMPI:-F4J2,D=#R.E7J\C\.W.KZ-\//"NJVVK-]G:
M[@M9+$PQF)XI)]A.[&\.-V<AL<=*V?[?\2ZY#K\NBP7(NM/U"6TM(E\@0.8M
MN1)O;?\ -SR,8!&.>2 >AU4O=3L].>U2[G6)KN<6\ ()WR$$A>/8&L/Q[J6H
MZ3X%U'4].N#:7MO$)%;:KC.0,'<",<U1U:77M#FT8RZZ;K[=K<<+K]EC15A=
M"3&.">"AP<YPW)/6@#M:SO[;LO\ A(1H6Z7[>;=KH*8F"F,,JDAB,'EAT-<?
MK6M>(99_$%I83W-KJMG+&-,M8[97CN(V5<,[%3D%O,!.1M"^V3)>65]+\2M,
MMAJDD-P="N?,NHXDWX\^'[H(*@YQU4\9XSR #NY)(XDWR.J+D#+' YX%*2%!
M)( '))KRG5;W5=6\&I;WM^LEQ9^*(;$W/DJ&E"72!6('R@\@G P<5VWBN.XC
M^'^M(;G?,NG3[IFC'S?(<\#@9% &^CI)&LD;*R, 593D$'N#3JX#2;^_M3X2
M\._;W5;W3VN&N!$@8)''&!$F01_%DD@G ]\C8\-:GJ$GB'Q#HE],;I=-DA:"
MZ9%5G25-VU@H RI!&0!D$4 =/17!2^(M2M/$9M]7?4[&&341!:3PV\<ME+&S
M!41F +(Y/'.,-[<55N?$.MP_#WQ;J(U1OMVE7MW';SF&/[L9PJD;<'\J /1Z
M*X3Q/KFKZ9>2NXU.+2A9(Z7NFV\<_DS?,7:9&!;:!L(P,?>S[/2[U75_&=WI
MUGX@G@TU]*M[V&2&"(NID>0?*60\$(/O GTQ0!W%%>8Z?XOU]KS3="NC)<W$
MM_?VSWMM'&CW$=MC#*'(0$EL'_<; [BWJ.I>+=.TRV,]RUK(^O06D#S1PNTU
MM(Z#]X$X##+#Y2"0/7F@#T.L[4=;LM+O+"TNFE66_F\B#;$S*SX)P6 P. 3R
M>U<??>(M5\)ZEXAAN[Z75X+/1QJD GCC1U;<ZE,QJH*_*#G&1[TWQ!;WG]J^
M";RXUB2Z6;58R8/+C$6XP2G<A"[@.HP6;@B@#T&22.%"\KJB#JS' %4!K=D?
M$/\ 8>Z7[?\ 9S<[3$P4QAE7(8C!Y8=":Y[XG12S>$42*81;M1L@3L#9S<1@
M=?0X/X55O+*]F^)EC;)JDD,_]@SB2ZCB3S"//C^Z&!4'IU!XS]0 =Y17FD'C
M#68;'3].FD>ZO9M=N=+>[BCC5VCBWD,%;"!V"@>G7C-=;X>;7/M6IQZK'+]C
M61#8RW!B\UE*_,K",XX;.#U(- &]17!?VWJ^K>&/$.N6>HM9SZ=<726]MY:-
M'B D8DR"Q+;23@C 88Z9*6NJZSKOB73K>+5)]/M-0T%=0:%(8F>&0L@PA93Z
M_P 0;OQTP =]17F,'BW7[2]AT&YE>]G;6I;!=0BBC222)(!+P&Q'OR0I/3@X
M&:M:[J?BS2/#&MW;32VQM[NW_L^:X6!Y)(W9%=9 F5X+-@C!QC\0#T2FO)'$
M 9'5 6"@L<9)X ^M<I=OJ.GM;Z5<^(;NXO[R266$6EI"LQC4+D#<"BJI/5N3
ME1G/7E+F_P!6U_POX5EO+L)=IXD^S/+Y*[F:.25%<@':#A.0.,].* /34U.S
MDU6;3$G4WL,2S218.51B0#GIR5-6ZX>]\0:EH>O^($FN6OK?3M!344A,:*6D
M!E!Y49P?+'TR:9=ZQK&F:9X8UE=1:\74;JU@NK8QH(RL^!NCPNX;201DG(SG
M/6@#NZ*\RGU/Q*WAOQ;JD?B&5)=#O+D6Z"UA*RI$BMMD^7D'D?+M/)Y/ '4^
M)_$<VB^!+C788T,ZP1L@;)56<JH)]0-V3["@#I*HP:M;W.IRV,*S.T2DO,(C
MY08$ IOZ%AGI]?0US^H7NJZ%XI\/VHU"6^M-4>6VF2>-,QNL9=9%**O'RD$'
M(Y&,=Z_PTANET6^EGO3,C:G>@1^6% 87,F6SUY]* .MN[^VLK>XGF<E;=/,E
M6-3(ZKZ[5!/8]NU)IFH6^K:7::C:,6MKJ%9HF9<$JPR#CMP:X>RMKH^,O'<S
M7G[I4A#Q"( ./LYV@GJ,9_&J.@W.KZ-X6\ 7D>K/):WJV=E+8M#&(PCP\,K8
MWAAM&<L0>>!TH ]0HKSNQ\0>)M?TJ75-)M[GSTU%XH[<_9Q;F*.;8RN6/F;M
M@)SQ\V,#'7T2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **:[;$9MI; SA>I^E<R/'NCFPN[\QWXL[*9X+J?[(Y6%T.'W8&< ]
M2 0* .HHK(LO$=C?ZY+I4 E,T=JEV)-H\MXG)"LK9YS@_E6O0 445#=W<%C:
M2W=U*L4$*EY';HH% $U%5=/O&O[7SFM+FU.XKY=RH5^#UP">#U']*M4 ,EB6
M:)HV+A6&"4<J?P(Y'X5G:1X>T[0K*2STZ.:&WD+,4-S(^"Q)8@LQ()))R.]:
ME% &1IWAG2])6]6SBG1;UWDN ]S*XD=OO-\S'!.!R*CN?"6BW?AZ'0)K:4Z7
M"BQK;BYE4%1C )#9;H.I-7=4U2'2X$9XY9YI6*0V\ !DF8 L0H) S@$\D#BE
MLM5MK^YNK:(3+-:E!,DD3+M+*& !(PW!YP3B@"S!"MO"L2&0JO ,CL[?B6))
M_&I*** "BLS6==MM#%D;J*=EN[J.T1HD!"O(P5=W(P,FM.@"CJ^C:=K^FR:?
MJMG%=VDGWHY!D9[$=P?<<UFZ9X,TK2I(6@DU*1("###<:C/+''CIA&<KQVR#
MBN@HH YD^ ?#AN99/L3^5-<B[DM?/?[.\W]\Q9VD\#MC@<58F\&Z)<:O=:M)
M!<?;KJ$V\TRWDREHS_!@/@#V'2M./4K:759]-0R?:8(TE<&-@NUB0,-C!/RG
M@&K= '-1^ ?#<5CIUG'8RK!ILQGLU%W-F!SU*G?D?3IU]:Y/2O"O]I?%#Q;J
M&K:=J4=C>_9UM6$LD44ZI'MD6158!E) X88/XFO1=5U&+2-*NM1GCE>&VC:6
M01+N;:!DD#V%26-W'J&GVU["&$5Q$LJ!A@@, 1GWYH RM4\':#K-[87E[8!I
MK%2EN4=HPJ$8*D*0"OL>*J?\*[\,?V19Z2+&<6%E-]HMX!>SA8I,YW#Y^N22
M/0DXZFNCEN8()(HYIHXWF;9$KL 7;!.%'<X!/'I4M &#/HNFZ1J%]XEMM.NI
M]4> +(()G9YU485=I;:3@<9[U5\(Z*MK>:SKTNG&PN]9N5E:!\;TC10JAL$@
M,3N<@'C?CM7444 4-5TBUUB&&.Y,ZF"431203/$Z. 5R"I!Z,PQTYHTG1K'1
M+>6&QB*":5IIG=V=Y9&ZLS,22>!U]*OU4T[4K;5;4W-J9#$)'C_>1LAW*Q4\
M, >H/- &;IO@[0])U2\U*SMIEN[T8N7>ZED$W^\&8@XR<9'%41\-O"HT9M'7
M3I5TTS>?]F%Y.$W^H&_CUKJZ* /,_$/A6*^\:O=:OI.JW-A%816UC<:=<R;S
M@L764APQ.2,$\<G)S5CPO\/(GT18_$BWLQAU*2]TZ":_D+V:9'E@LCX+@#.<
MG!8X-=_;W,%W )K::.:(D@/&P9202#R/0@C\*EH Q4\)Z*FJ:CJ(M&-UJ40A
MO&::0K.@78 REMOW>,X]?6IM!\/:;X9TQ=.TJ!X;56+*C2O)C/NQ)Q[5J44
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MVUDMM+=?:)"#T+#&=I&0,G')&:Z6H+R\M]/M)+JZD$<,8RS'\@!ZDG  [DT
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M9N=#\._:;5A')+=06QG(!$"R2JC/@\< G&>,XS3H_ _AJ%&2+2(8T,HF54+
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MJV$MC?VT5S:RC#Q2+E3W'Z\U'IND66DQLEG&Z[@ 6DE>1B!T&YB3@9.!G'-
M'':?XBN=4T&#6[2:Y(T[2I)[RU+9\RY (\IN,Y5DDST/*]C3]!G\1:O:>'M4
MMY;E8[N$/J,DLT1C=7C)#1("VUE?;@8'&=V378V6F66G+<+9VT<(N)GN)@@Q
MOD;[S'W-4;'PKHNF.S6-E]G!+$)'*X2,MG)1,[4/)Y4 \T <%%J6NQ_#ZV\4
M/X@O)+N#4/*,;+&(I8_MAB*NH7D[3U!&,#&*W[*TFD^+NLRC4+A%CTVS)B58
M]K O-\IRF<<9X(//7ICH$\+Z*FC/HZV*_P!GN_F& NQ7=NWY'/'S#=QWYJ8Z
M#IC:M#JIM5-_%$(5G+,6V#. >?FQD\G/6@#(U#49[GQ[9^'C-);VC:=)>LT3
M;&F<2*@0,.0 "6.,$Y';.>-\07FIW?A7Q%IEU?SNNF:[9P0785-TD;2P.%8E
M2"R;^N.<#.><^F:AI%CJCP27<&Z6W8M#*CM')&2,':ZD,,C@X//>H+CPWI%U
MIPT^:S#6HD\TQ[V&Y\[MS$'+-NYR<G//6@!-5O$T'PO=W5[J4P6V@8M>21JS
M@]FVJH4G)&   :Y_0K[4X/'TVE3S7ILYM,%XL-\\;R1R"382"G !!Z9/(XQ7
M676G6E]ILFG7<"W%I+'Y<D<I+[U]R>3]>M5+'PUI&FW45U9V:Q7$<1A$H=BQ
M0G.&)/S=NN>@]!0!S/B[4=7L-1O9S!J,NCQ6BE9]*E3S+.4;B[R1D@N,;"!R
M, \<U;T?4KJ_\8ZY:_VI.]C_ &?:7-KE4!A\SS<E?E_V5^]FMZ[T#3;VYEGN
M('9IE"3*)G5)5'0.@.UAVY!IEYX:T>_U.+4;FQC>[CC$0D!*Y0'(5@#AER3P
M010!Q.EZQXAU#P3X:OXQ<:KYPFDOX[:=(;F90Q"LA)48!(R 1U7Z%\>KWFIW
MGA%-/UG4X+>]GO;>Y2XB1908TD^5@0?G4KMSDCY<XKKX?"NCVUO;06UM);QV
MV_R1!<21F,-C< 58'!(!QTS7/^)O#D-WKOA6UBTF632[*::2<PY41;HV"MD$
M-G>021SW- &+JVOZ[X4N]:L(M0N-0M$FL$ANK@(9+4SR%9%+8"L0H##=TW+G
M(K6UEO$>FZ7XCO8+B[L["'2GN+<SRQRS1W*!B<'YOD(V\$\$<8S77-HFF/I4
MNF264,EE*")89%W"3/4MGDGW/-5D\+:.FG3V'V5VMIT\N1))Y'W)_<R6)V_[
M.<>U '-0SZIIVN^$)7UFZNH]75XKN"8)Y>1;M(&0!05(*^IR#SGK46D:OJB:
MS86>N+J=K=WLDR0WD$D<UE=C8[+LP3Y9"@,,KSM.<YKL&T'3'2P5K8G^SVW6
MI\QMT1QC@YST)'TXZ4RU\.:79>7Y$$@\I2D0:XD;R01@^7ECLXX^7'% '%:1
MXDU2?0?"EM<WTC/JNIW5M<WQ"AMD;3%5&!@%MBKD#IG'/(/$6JZSHL_BW3K3
M4KGR+31/[4M9VVN]O)^\7RRS [E.S(SSUYKLD\+:+'I/]EK8J+(2><L6]CL?
M.[<ISE6W9.00<DFI)/#NE36-S9RVQDANN+CS)79IAC&'8G<PQQ@G&* .:CFU
M/3/%'A;=K-U=0ZO'*EU!,$V!EA\Q60  KR,=3D'GGFM+6=3G;QGHV@"5[>UN
M[>XN))(SM:4Q[ (PW4?>+''/ YZUK-H6FN; M;DMIY)M7,C;HLC!P<YZ<<]N
M*DU'2;'55A%Y!O:!_,AD5BCQMTRK*0RG!(X/2@#S+Q5=ZB_AGQSHUQ>S26^F
M36IM[E@I<I)L<QL2.=I/7K@C)KTBXMIH= N('U"XEE$+_P"E2+&).A.<!0O'
M3[M,N/#>D7>F2:;/9B2TE?S)8V=OWK>KG.6/ ZD]!Z"M&.%(X!"-S(!M^=BY
M(]R<D_C0!Y-:6<\?P]^'2C49V::^L6C+I'^Y!@?A,*,^V[=[YJ]K/B'5_"(\
M701ZA/?I96EG<6KW85GA,TCQOR ,J-H89Z?2NQB\&>'X+6VMHM/$<-M+Y\")
M*X$;]F7YN".<>F3C&:NS:%IEQ>7-W-9QR37,(MYRV2)8QG"LO0CD]1W- &7I
M<.MQ^(5D(N5TA[4B5+R=)'\\,-K)M)P"N[(X'3 %9OB 2M\4_"PA=$E-A?[6
M="P!_==0",_F*Z32M TS11BPMVC 78H:5WV+_=7<3M' X&!P*6XT'3;K5H=4
MF@9KZ $13>:X* XR  < ' R._>@#C/%V@QZ3X:U*_EG^T7^I:MI\MS-LV*=M
MQ"B*JY.%"CN2>O-2^-=9NDM?$,FDZA?QW6BVGGMY/EI#"X0R!7W<R%AC@ C!
M'0FNRU32+'6;9;?4(//A5PX0NRC<#D'@C." 1Z$53NO".@WMS<7-SIL4TMS"
M()V<L?-4+M&X9P2!QN//O0!SYFU/5?'$.G'6;NVL[C1%NVBMPBE)#(%^5BI(
M'UR?<5I>"=4N;KPZ_P#:=Z)Y[:_N;$7$NU6E\N9D3.,#<0!TZUJV_A[3+748
M]0BMV%W'"($E,SDB,?P<G[O?'KSUJF?".G#4K.XCC$=O;7,EZ+<9*M<MD>:<
MGC&YS@#JV>U #/%.L3Z;<:'90R" :GJ"VCW! )C78[87/&YBH49SUK$TZQ-O
M\5=6MDU.[E9M$@(>1U=X<S2< D?C\V>OIBNPU32;#6[%K+4K2.YMF()CD&<$
M=".X(]1S5>R\-Z1IUZEY9V8BN5B\GS%=MS)DG#<_-R2><T </!K^K2?#GPEJ
MCZM*+R[U"UAN'VI^_#SA64_+QQG[N*U735]2^(FIZ8GB"\MK*VM;2[2*)(_O
M-))N3.W.PA.>_3GL=A/ _AN-61-*C53,)U4.V(W#;MR#/R?-S\N.:T(=$T^W
MU635(X6%[(H1Y3*Y+*,X!!."!DX';- 'G^HZUK4'@KQI<QZU<"ZTW57AMYRD
M>1&%BPA&W&/G/0 ^];Q?4M'\?Z=9#5;F]MM2L[F22&YV;4DB,>TIM4%0=Y!'
M(K7?PAH<EI=VKV1:WO)?.N8VFD(F?^\WS<G@=?0>@JQ>Z-;SF"ZBC!U"SB=+
M.>1V)C+ =3G)!*KG.<XH XK2)_$6NQ:%/#J&I6MZTLB:R?*7R4"A@1'O5D)#
MA5!3)QG)[UZ17F%MX)#:%8P6>E7VFZZLD3SW@N2D<3APTK@*^U@WS855Q\P!
M"]O3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"J[75N<@Y'(K)T*P>;X;ZEKTNKZM)>1VVHQ(YOY<($FD*D<YW#8/FZX)!R,
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M3@;FW'('*[:R_%<6K2:S'+806^IVL%H3<::]XULX+,=LJL!M)PC#G&,<$9H
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MH+!06XQGJ,UFZQ!'H.LZ'8VMS<Q:5JFI%;S-R[!#Y+&.,,22H=P,@$9Z=SD
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M3@QV_EAUC:7#,%WD#/)QQGFN\\.Z=?V&HZJ;BXA^R3-$]O91W#3?9CM(?#,
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M;:CIUW=)$Z3M&;1(US"5 ( !7#9_BR<Y'% '9:IK!LKN"PM+;[9J$Z-*EN)
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M5&DR@(PSAQAB#OR<<9X% 'L5%<)?VL%Y\4I=/N[^[2TFT993;+>R1J[^<02
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MFNERC:?:,ET<W"F%2)C_ +?'S?C5RB@"M8Z=9:9;_9["SM[2#.?+MXEC7/T
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M2HSZXIOE1^;YOEKYF,;\<X],T ><^'-*T+4?&OBF:9HY7L=122W7SSMB'V=
M[!<XZE@367X=_L33/ .K^)O)DO+NT:_A/E7+!EA:X?"@@_(, '<!D<D5ZV$0
M9PJC/M0$4 @* #UXZT >;>&KG3K/XBW LKO3([*YT<3NNG_);M(LI&X'.UV
MR"PQQU%;?PMFBG^&VBF*17"Q%6VG.#N/!]ZZX11A0H10 ,  =!2A0HP !]*
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M]35S17\/1_%LMH?V)(+C1"=UIM$4KB89V[?E) './QZ5Z(L:)&(U150#&T#
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M2O7MB[MVT9]<4WR8O.\[RD\W&-^T;L>F: .(L;^VC^)GB$3W4"R)I%GYGS@
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M./3-/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"N5\8^*3H5G']AO-/-]]IMXWM9CN<I)*B$A0P(QNSG!'%=+<B5K640,%F*$1
MD] V./UKR*>X6Y^&6G:7+I%^=;L+JS:]62S<O'(LZ>;+O(PV[YCE220Q[9P
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M0#C.>U 'KUM=6]Y L]K/%/"V<21.&4X]Q7,#6M;N/&NI:!;MIZ1VMI'=)+)
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M#@DL=I##)SGG!-;7B4SVGC+PYJ4Z.VD0+<1S.JEE@F=5$<C =!@.N[H-W;-
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M,#<Q;'OFN:M]+L]5\&^(=!_LJ0Z]=7UVT/FVCH5+SLT4OF%<!0"&R#Z@<G!
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M17$1) DB<.IQ[BO+]&6.STSP%?16$L.FV49BU-?LC1F.Y,"HLCJ5!.&#J7Y
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M!D4;=BG=G<Q*';R!SSQV7A!-&3PI81Z#-'/I\<0B25%QO*_*2PP/FR.<C.:
M,?7_ !K)#X0\0:KHRQ"YT>:6%DNTW"0QD!B K @9/!]NE=7!J%E<W,MM!>6\
MMQ!Q+%'(&:/_ '@#D?C7DE[8VUMX'\>Z?!I,D>IR7ETL21V+!I(W<&,*P7!!
M'( /;VKI=;L8XO%WANZT:U%N9;*]@%Q%"552R)Y8<@<?-TSWS0!VR:C927C6
M:7ENUTH):%95+@#KE<YI\]W;6IC%Q<10F1@B>8X7<Q. !GJ<D<5YMX0LHK_2
MO#=EJ5UJ5OJFCR+(UJ;,HR3*K*^Y]IRC;F.[/S9'.:V?B?\ 9DT#39KJ(R11
MZO9LP6,NVWS5W   DY'8=: .LM-2L-0:5;*]MKEHCMD$,JN4/H<'@T0ZE87$
MLL4%[;2R0C,B)*K%![@'BO._$.AS:W<7NK>$K<VS?V)<VIFCB,!N9'*^6@!
M)VA6^;H"P&>N+^@PZ9JDVD:A-=7PFTVSDB-I)8F%8D9 'CE&SMM&!GDC(S0!
MU=[K-N+&Y;3[S3YKQ8&EBCEN556QD L1DA=W!-6#J%O;6$-S?W-K;JZJ2YF
MCW$9X8XR/2O,=(T;3XO@OJ+?V0%U1K"\@(:U(G9F9RBX(W'^# ^F*V;*>2Q\
M4:%J-\LBZ4^ABUBE=#MM[@,"X?CY"R@#)Q]S% '>)<P2VPN8YXWMRN\2JX*E
M?7/3%<YI?B9]2\;WNE075A=:=%81W44MM\S!FD="K,&(.-F> .M<<UEJ&E1G
M4/L=T_AYO$KWCVD4+,PMC&0)/+ SL\[Y]N/1L5OZ//!<_%.]O[:SFAM;O1X
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M00"2JJPW>K@ \'%^RBTK5A:ZF]S?/+8V$L'V1[ Q*B.%!CD&SJ"HPN>HR,T
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M$_#VYBTYHKJTN[,7+K;D21?NF67?QD#/7/%>K4 %%%% !1110 4444 %%%%
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MR%20P50,M@@]!VK$\&^)3J5EK]Y>ZHEQ9V>J200W#JL8$02,@' '.6/7G/%
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M0O#+@'OUK=HH !G'/6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/8J_+\PX;/ ZUS=SXU\;0>"M7\2KK=LPTK6GLS;&R3$\8=$P6[?>SQSUYZ8
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MR,N<=LA<UYGK_B?3KKQUX9U:YCOEG74Y=Z/83@QP(I6-5^3YR<ER%SRY[ 4
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M86XL"T^]+^01VSQ*9%D)4L.5! ! )R>* (M6T&SUJ2R>[,VZRG%Q!Y<I3;(
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M#""ZA2>/>,':RAAD>N#5J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNTC,?4LQ))^IKC/!_ANW-[KE[J.F7$4\^JSW$8G9PDL;-E&*9VD\=QD<=.*
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M8IYI/-E$<SK'(_\ >:,'8S>Y&:GM="T^RO;R\MXI$N+SFX?SY"9#C )RW4
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M*K CH1@]#65+]OL/&MGX6CN[FZLFTZ6\1KW49(I)I3-R/,52S;%/"\<-GL*
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M %%%% !1110 4444 %9)\+>'V$X;0]-83R^=*&M4(D?KN;CDY[UJLP52S$
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M-+6W1IIM2(-O']T[,!F<^@53^9 [U#/K\ME$]QJ&G2VEJE[]F,SR*?D) 2;
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MSK3[:%""Y\E?,"^F[&<>U7:I0:K:7.K7FEQ2%KNSCCDF7:0%$F[;ST.=IZ4
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M[;:9!++)9M>)-)=E%V*RH00(R0<L/7CO5GPYXB77TOXWM)+2[T^Z:TN868,
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M'9,ZRJ YR>6VLWS=2*[K[/#C'DQX]-HI3#$<9C0X&!\HX'I0!XW:3V,_P_\
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MJS!?$5K=70C?.+B%@2;;ROX@"-FW;]XD]237J4<4<,:QQ(J(O 51@#\*8UM
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M699HS$^-KAA@YZ8->5:-JT-IX/\ #UK/;0&.74[P27%U"TJ6I\R9D+(,<L&
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M=@KLQTQ@[L]\8KSM;?0+CQ!XUL]9L$N;NZNLVL,MN6>9/L\:_NLCKN4@E>A
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 5[VQM]1LY+2[C$MO)C?&20& .<''4<<CH1P>*L444 %%%% !65;Z/L\1
MW>M3R*\TMNEK$BK@)$K,W/JQ+<_0>Y.K10 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ "BBB@ HHHH **** "BJ=YJMG87=E:W$A$][(8K=%0L78*6/0<  $DGBKE
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M7E#M"GD DJ<DYKOJR[7P[IEG-#)%%*3"Q>%9;B218F(()568A3@D<#@$@=:
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M1O,95D3G =0=K8R<9!QVIL/A;1X)M/FCMY5?3HS%:'[3*?*0X!4?-TP ,>@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD;1RY[GU/?K7%>!="B\0_#2RL[RYE_L^2XN?.MHPH$P%U(<,V,X/&0",X^M
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M4C:?G;E<'WK&U3S9? >M6-QJ%W+!I_B:&UB>6<LXB^T0$*SGD[=YP2<\#TH
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M8P<9./K6%>>%X]0^($-W>Z%;7.D0Z:+6(S)$ZI()-P(0G(&.,XSGMCFNSHH
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M& W$V/,7=\BD[-QXR"<YR:]F2TMHP@2WB4(25"H!M)ZD>E.%O"HD AC E.9
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M"S:[@%TPR(3(-Y_X#G-*EY:R3M ES"TRYW1JX+#'7(KRSR)KSX67?A^XC?\
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MZYU""XOM)TR>S3[--I *W+V;3M*Q(5H$'W5(VY.0>W'% '1:QK5Y8>)O#MC
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MADS]WY R@GIG'?GKO!]E)!K?B>[@4II%Y>I)9KC"LWEJ)74?W6?//<@D<'-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M80\:>&3!;S?VY8^7</LC;SA@MG&#Z<\<XYK1O=5L=/8+=7"HY4N$ +-M'5L
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M/V35+FU$S*(QL238HX[GCZDUK+XATAK>[F-]$B68!N1)E&A!Y!=3@J,<Y(H
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MRWL2RM((>3P)#T0MT#'C"DY.:T* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YOQ_I]UJO@'6[&R@:
M>YFM76.)>K'T'O6?XHBU#4+30O$&C:=/_:-C> I;W";'\J4&)PP[#YE8^RUV
ME% '!:9X8O-*\53:;'&\NA71AU*6=SUNH_E8'W=Q%+]5;UJBFCW,6H^*=)UF
M+69;+5[MYXFLH5DBGBD15V,VTF-AMV\E1@ @UZ710!R&F6LL'Q&U&3[)<BR;
M2K:UCFDB;:S1O*6&XCGAUY[U7\*:'?:=?RZ1=6[+I6CW,DNFRMTD6490#_KF
M&D3\5]*[>B@#S#PYH4Z:3'X<\00ZT\MM?M,/+B4V\Q$YE242A>.2"06#9R,'
MI7I]%% '(?#P_8/ -K;3A_.L'FM[A%0LP=)6!X&2<]?H15/PA=7NA?#^<S:/
MJ$E];SW,HLQ P>3S)Y&0 D8Y# GT[UV4%A;VUY=74*%)+HJ9@#\K,HP&QZXP
M">X4>@JS0!QWA74I)]2E-UH&M0:A>#?<7MW;(D7RCY8UPY(49.![DGDDU+X$
MC9H->O!_J+S6KF: ]F0$1Y'L2C'\:ZBXA%Q;RP,SJLB%"R,58 C'!'0^]):V
MT%E:Q6MM$D4$*!(XT& J@8 % '+^+H)I]>\*O'9SSQVNHF>=HX6<1IY,B@G
M_O,OOWK&ETNYN(OB3''IEP#J41-KN@*^?BU"<9'7>#^>?>O1J* .!TJ*^TOQ
M+8ZK=V=Y)97&B0V9*0.[VTT;$LK( 6 ;=][&,KSVK*DT&^M+:R=M/N)([CQ6
M=6\A(2_V>W.>6 ! .<-MZ_-TX->IT4 <)JFEWLWB;Q;Y-E*4U'0XX() GR22
MJ)AMW= ?G7K514N;J+P"6TB_1=/E!NEEM6S%BW:,,1@_QD8^F>G->C44 >=:
MEI)EUSQ<EY8:D+2]EL)(I[)&W@QA<R(0#ED8*<8R<=#6]X1AUB&;4EU"[FO;
M/?&+.ZNK403N-OS!P N0#@ E03SVP:Z>B@#FO%%UJEOJ6C+:6UR]D\D@NKBT
M@66:([?D # X#$D%L<8[9S7%II5_%HUO:S:3?%T\6&^>-H"^(/.+;R0"#P0>
M.O:O6:* /._%.B:IJ6O>)8].@EC;4?#R6T%P%(1Y0\I*%NQVL!D^M+>W=[J\
M_A&>/P[J-I'8:@'NED@P8!Y$B84#)9<L/F''3\/0Z* $8A5+'. ,\#)KRV31
M[ZX^%OBJPCTJY%[<W]U<10M 5:0//O1AD<G;CW&.U>IT4 <;9FYTKQQK6HW5
MI>2V&JP6S6LT5N\AC,:LK1.H!9>3N&1CYCSFKW@31KG0O"L-E=)Y<AFFF6#(
M/DJ\C.J<<<!@..,YKI** .2O8[H?$VQNX[.X>WCTJ> S")O+$K21LJEL8Y"'
MGH*YRP36]0U#P=?ZAINHQS6=U+]L0VRQPVQ:"1-L:J,E-Q4;N1C'/7'J%% '
ME5]H^M3Z!XBT^UTZ\6ZCUXZD@"JJW,(F60*C'@L0,X/<8-;%W90W^E:WJD-M
MK<^HSZ3)8K]LMO+8A@Q6,(%7)W'[V"!GKBN]HH Q?"ELEMX8TN/[*;::.SAA
MD1XBC JN"#D=CGVY-9WC2"Y-UX;O8+*XNX[+5!-.MNF]U0PRINV]QEEKJZ*
M.-T>VE;QOXKN9M/G2&[AMDADE@(60(C!U!QC@D?7MD5A^'&UW3M'\*:;-INH
MP6\6FM#<26]LIF6<% (V+CY$(!.[H2!R,5Z=10!Y3H^EWUMI'@BUN-*O ^G:
MI<37*FW9A"I$P4YQ@\NG3^E=;HMI/;>/_%$\EK+'!=K:-#+L.R0I&5;GID9
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M,K!'^]3"MNPZ8(P>I.*](HH YOPC%J\46H+J=S)=P_:1]DN9[8032IL4$R*
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MT34K:TMOM23O<0%6C9XP%!49.,_Q=/?KCN9%+Q.@;:64@'TIU% 'EBVMU<?
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M,P/'X5Z?110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)LHA/<)):RJZ1'/S[=N2O!Y (&#G%6X=<TZ>6QB2Y DOXVEM4=65I44 L0"
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M:>,=8U&?3KJVM+VTM5A:XNEF<,ADW*_SL0?G'0D>] #_ !GXA.BW^B6\]_\
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MZ8KT*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_,(B8E.9&)ZG.<<L>N,<T =717/KXQTYQ8S"*X^P7UP+:WOMJ^4\A)"C[VX
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M,\8P>IB\+>#=9\*VVFQ64EJ+>2".#5;)IF,9=4"FXA;;D,<<J0 ?8C->@44
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% %34=+L=7MA;ZA:Q7,(8-Y<J[ER.0<>QJRB+&BHHPJ@
M #VIU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%9&N:M)8-8V5J%:_U&?R8 XRJ *6=R.X503CN<#C.:PK3QC#I
MNO\ B*T\0ZO9V]O9W44=JTNV+Y6B5SWYP7Z_2@#M**Q;G6OL>M:;$[Q2:?J8
M,=O,G.)@I<#/0JZ!L'U7ON&-J@ HHHH **** "BN6AU?56^)5QH33VYL(].2
M^&(2)"6D9-N[=C VYZ5>EOKN#Q.T$MW;QZ:EF;AP\>&4@[>7W8 []* -NBL1
M/&/AIY;6)=<L"]T<0 3K^\.2!@^Y!QZ]JMWVN:7IKLM[?0PE%#OO;_5J>C-_
M='!Y.!Q0!H45F7?B+1;"7RKK5;*&3R_.V/,H;9Q\V,YQR.?<59T[4K'5[)+S
M3KN&ZMGSMEA<,I(X(R.] %JBL7Q-XDM?#%A;W5UL(GNH;90\H0#>X4MD]E!R
M?85C-XNBLO&5W#?:M9KHG]F17<$GR@;GD=>&S\W"9X]Z .SHJD-8TYK"&^2]
M@>UGQY,J.&67/0+C[QX/ J6ROK74;87%G<1SPDE=T;9 (."#Z$'@CM0!8HK
M\2>()=+N=+TNPACFU759FBMEE)"(JKN>1L<D*.PY)(''6GM:^(H)+>6/5+:Z
M'FH+B%[38#&6 <H0^5(&2,[NF* -RBLZ77M*@NA;2ZA DID$.&? \P]$STW?
M[/6H;WQ5X?TV6:*\UFQAD@QYJ-.NY,YQD9R.A_(T :]%9</B31+C48M/AU:R
MDNYD\R*%)E+.N-V1SSP<_3FH+GQAX;LQ,;C7+",0R>7)F=?D;&<'T(!&?3-
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MT5F>(M6.A>&]2U98#.;.VDG$0_C*J3CVK/T:XU2]&GWL>LV&HVDPS<K!$ J
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MD@+$CO(1_L@?+^(]:]%JK_9]N=3_ +192UR(O)1F.0B9R0H[9.,^NT>@JU0
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M&4%2!@C9SGIVZUTUJUSI7CO6-0N[6\EL-4MK8VLT5M)(8S&&#1LJ@LG+;AD
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3(DLC9<,P.TA^JY/'2N4NK+5=#^'>@6E[IQ_M"#Q#!((%E0B4M=LZA6S@9#
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M0\ZVUN\QA4C.7V [> 3SSBDO/$^EV2W+22S.EH UR\,#R+ "-WSE0<<$$CJ
M03@5BVEKK&@^*M>D_LF;4M.U65+F.6"6(-$PC6-D=9&7CY 01FF6&FZMHLWB
M2T&FO?0:G=27EM,DB!09$"F.0,P(P5Z@'*GU&* .BB\0:9-JD&G17)>YN+8W
M4(6-BDD0V_,KXVD?,O0]ZJ2>,]"AT>[U:2ZE6RLYVM[B0VLN8Y!C(*[<C!(&
M<8S7.6?AS5?"UYX4DM;*75H=.TN73KGR)(T=68Q,' D905RA'7(&*IW?A[Q!
M/X'\6:8VD[KW4M2EG@1)XRC([J0=Q8= IZ@'D<=< &YJ?Q!T^W.G&QW3I<:H
M+"9F@D!4",NS*-N6XVX(X.[(SBNOCD66))$SM=0PR"#@^QY%<QXKM-1O4\/W
MUCILL[V.I)=36OF1K)L\N1#@EMI(+@XW5IZ3J\^J:CJ<7V,1VEG(L"7'F9\Z
M3;F0 8X"DA<Y.2&]* (KWQ9I-AJDNF2O=/?1PB<V\-G+([(3C*A5.X9STSC!
MSBH!XY\.G2;?5/MY%G/<"U$A@D&R7<%V.-N4.3_%BL>^O+JS^+FZVTNXOP^A
MHKB!XU9!Y[X/SLH(^AS[57U+PKJ4.E8MK,75U>>(8M7N8XI$"1JLB$J"Y7)V
MH/J<]* .HMO%>E7EM;S6TD\C7!D$4(MY!*WEMM<[" P /&2 .1ZBHG\9Z%'I
MT=^UW)]G>Y^R$BWD+)-G;Y;J%RC9(&& ZBJE_8:C;>.++Q';6<EU;/I[6-Q;
MHZ"2$EQ(KC+ $9R" ?0C-4XO!C:AH_BF&^'V=M=N6G2,$$VY"*L;$CC?E YP
M3SQDXH V]6U^SM8[^T^U7%M=0VAN&E6RDE$*G($G"D'!!./]D^AI]KK5I#HN
MF3S7K7<EU;H\3QP$27/R EUB49&<Y(QQGFLJVL-:E\%:A+J5HKZ_?VACEABD
M4@-LV*H8D#&<MUX+-65:Z3K^DS>%M5BTE[MK+23IE[8K/&LD9/EGS$);8>8\
M'YAP10!;\*>(Q--XKN[_ %&<V%E?JD;7D9B:%/*C)4J54CYF(Z9/'6NCA\1:
M;+=7%L\S6\UO#]HD2ZC:$B+G]Y\P'R\')[=\5PVH>%?$&K:;XN@:T6VN-0O[
M>^M#]H&R01+#^[8J=RG,9&<8!Y!J]J?AB3Q'X?U1(]'O=,U6>Q:VCGU"]\_J
MP;RP1(_R$J,GCZ4 3ZKXD:;QKX5M+&ZOXH+JXE$L;VSQQ3H()&!#,HSA@O0^
MG'>MGQ?XC_X1C2(KQ8UDDENX+=58,>'D52<*,\ DX[]*Q;I?$>L:OX7OY_#T
MEHNG7<CW<9N8G;YH73<F&P5RW?#>U:WC?3K[4M C33K;[3<07UK=>0'5#(L<
MR.P!8@9PIZD4 9,GB4V?Q D62[OIM.ET=+F*TCMG=]YE*DK&J;^@'4<5T4/B
M?2;G1[;5;:>2XM;EBD/DP.[NPSE0@&[(VMD8XP<UEVUIJ<OQ%_M>72YH+)])
M6U,CRQDK)YA<@@,3C! R,\^W-8=CI?B?2]/L[5-.N3:#5KR:\BM;F))98I'D
M>(JV\8 + L,JWZT ;.L^.[&T\,Q:QIQ%P)+V*S*21NK(QE".&3&X,N3P0.@]
M:WKS5H;;0;C55W&**!I0'1E)P.A!&1^5<&?#.N1>%]4METPM<_\ "0)J<4/V
ME7\Z)9HWP'8_>PA^]BN]O8I]1T&YA$)AGN+9T$<C [&92 "1D=^V: .(N?%\
MU[IW@K64NYK6.]NXH[ZW2)@C;[=Y"HRNYOF  VDY]ZZNS\6Z->6M]<"Z>!;
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MCF-RN5]CM)'Y&O.K_0M>?PQXUT6+2'DDU*YN);299X@D@E QU8$$8.<CZ9H
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M-YTD;M*ZQLJA-C'Y<MDDX.!C'/&*ND>*+[^PI]3TVYDOK'5Q<7<IO4,;QXD
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M22>5+I#97,8<;G>(L?F,8QPH.[';FN^H **** "BBB@ HHHH **** "BBB@
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M6Y9UG7=NC8#HV488&<XXH ZBBN8'CBT-S;6BZ5JYO;FU:ZCM3; .55@I!RV
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MM-2T+2O/T] B:A'+O+%5VB14*95B.O(QDX)KLH88[>&.&%%CBC4(B*,!0!@
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M72T&H6EY#.<3'RW5+@2G!VYS@8Z=:ZKQ/ID^N>$=5TN I'<7EG+ A<_*K,A
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MS"0X.W.2!CIUKT&B@#@++PA=:?J.L0SZ+IFJV.I7DEXDEQ-M,?F8+QR*4(8
MYP1G(/(%='XNT&3Q%X3O=(MIUMII54PR$?*KHP=<CTRHS[5N44 <EJB>+=6\
M,S6\=K;:?J&8B3%?-B4!U,BJP3*!E# -U&?QK-3POJ\=SXDN(K"P@&K:7':Q
M11SD^7(HE!+MM^;_ %@.[';'/4]_10!YX/"&J6]]H6J&QLKZ6TTI=,N[.2<J
M/E((DC;;@G.>"!P:T9O#UZNL^&;JQTNPL[;3Y[B>YAAEP,RQNGR_(-Q^;<2<
M=^O6NRHH X#6/!VKZA>>)9;:2VB:[N[.^L)'<D>9;K'\LB@< E#R,^OM5\:=
MXBO_ !;H>MWME96T5I!<0301W)D93)Y?S!MH!^YTXQZG.!V%% 'G$/A3Q)*-
M&EU"&QGOM/U7[5/>-=,\EQ'^\'RY7]V &7Y.G';'/1^'-+U+3]=\0W5Y#"L&
MHW:W$)CEW$ 1)'AA@<_)GC-=)10!SGCK3SJ'@^^\J017=L!=VDG=)XR'CQ]6
M 'XUGZ]X1O-6\)6MLCVW]JP7D>I.)<^3+.&W,C$9.PY*CK@ >E=+>:197][:
MW=S&\DMJ2T0\UP@.0<E =K$%01D'!&1BKU '&7FAZI<>']1.EZ58Z-J\T<<:
M2Q7&7=0^60R*@*@C< 1G!;.!BH;3PYJUOKNI:DFG6,"7FE):K#'<%F64,YR[
M%?FR''S>V.<9/<T4 8OA#3KS2/"6E:7?)&MQ96L=NQB?<K;% R#@=<5GOI6K
M+XVU+5X[>!K6?3([.(&;#%T>1LD;> =^.O:NJHH X&#PKK,7@7POI)CM3>:1
M=VLLH$QV.D1R=IV]3VR*[34;&'5-+NK"Y7,-U"\,@_V6!!_G5JB@#SQ/!&MC
MP[HLAOH5\264R^;=KG:8BGDNH_[9X;W=<\9K;U?1+R37?#$VG6\ L=)E=G5I
M-I"M"T0"C!Z;@><=*ZBB@#@]:\+ZS>#QM%;1VK)KL$<5L[S%=A$(C.\;>.>>
M,U:;1]=L/$]IK]E;V]QYFG)87EF\^PJ48LKHVT@_>8$'':NRHH Y>'3-7?Q]
M%K<]M;1VG]F?8W"3EF#F0/D?*,CMV^E3^$=)O=&L]0M[U8LRZC<W431ON!26
M5G&>!@@&NAHH XR70]:BU3Q:8+>TEMM9C5H)&N"K(X@6+:R[3QE<YSTIK^'-
M7/A_P;;".V^TZ+<027*^<=K+'"\9VG'))8$9 KM:* . \/\ @ZXT:)M)N]%T
MS4;)+IYH+V67YMC2&0;T*'+J3QC@X'(KOZ** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH @NYWMK9Y
M8[>2X<8"Q1XRQ) [\ <Y)],US,?CA?LWB#SM-?[5H<2SSPP3I(KQLK,"K\=D
M;((!&*TO%>C7.O:"]C:7*02F6*3]ZI:.0(X8QN 02K 8/L:Q'\'ZFW_"1M]J
ML%;6M.CL]L<3(EN561<@<Y&)">W([9X )H_&]T]YIML_AZZ1M5MS-8'SXSYA
M50S*_/R<'.>>!TSQ4]KXWMY=)>XN+*:WO4U'^RS9EE9C<Y&%##@K@AMWIFF+
MX:U(:AX6N6N+7;HL+Q2*-W[[<@CR/3  /?DX]ZJ3^!KJ:/4<7T23OK2ZS8R[
M"1'( H".N>5(4@X(^\?2@#2E\6-9ZG=Z7?:<Z7T5F;V%(90Z7$2G#;68+AE.
M,@@=1C-)_P )C&=,\-7XL)C%KKPI&=Z_N3(A<;NYX!Z#M4A\/3:CK+:MJC1)
M.MB]E%%;L65%<@NVX@9)VJ ,#&#USQB6_@[7UTCPYI]QJ.GLF@W,,D7EPNOG
MI&C(-Q).TX(Z9'6@#0G\97@O-:M;/P]<W$ND,OGYGC0,K)O!7DY."./SQWJ7
MOBZ\GUOPB^E6MU/I^JVLUTT:"(&1?+5D&788*[LGD=NM:=EX?OH-7\27DL]N
M8]7V%%4',16(1C/KD#/;'2L^T\(:I8V_A+R+ZS\_0K=K5R\;%9HV14W  @AA
ML!QTYZT =C.S);R,D;2L%.$1@"WL"2,5QFB^+-/M/"_AQ;6-T_M-'%JNHWF,
M!<D[Y3N)/H #U]!7:2^9Y3^2%,F/E#G S[UQFG>$+VR\+:5H5Y#I.JVMI&\<
ML-U&=DN2"CC*MM(^88P<YZT =;87$UU9)-<6QMI3D-$6W8()'![@XR#Z$5S\
MWBR];6-6TNP\/W%U<Z:L3MF>.-9%<,1@DGGY>!^>*TO#&A)X;T&#2XY-Z1M(
MP SM3<Y;8H))"KNP.>@%5]-T6]L_%NM:O)- T&HI"B1KG='Y08 D]#G=^&.]
M $-EXRM=6@TC^RX&FN=4M#>10RMY8CB7:&9R <?,P7@')/IDU=T+Q!'K3W]L
MT#VU]I\_D75NY#;6P&5E(ZJRD$'CZ"N<T7P/J&@PZ!<6UW;27^E6CV,@8,L=
MS Q#8SR48,H(.#W]>.CT31/[-O-4U&=U>^U.=9IR@PJA4"(B^H"KU[DD\=
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M7)?W0=D5E1409:1V8*JC/<L0/QJA_P ))):Z];Z/J.GF&YNX))K,PS"1)C&
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MJ[QM P0I'!XH [($'."#@X..U5[S3K+4!&+RT@N/+;='YL8;8?49Z'Z5PO\
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M"6)".P P <#Y3R,]^E '84@((!!!!Z$5P5EJ.LSZQXWCGM;:[LK>58UAFO7
M5?LR-L4>61AMQ)]SCGK4MGXEET[0/!<MMIMM;Z5JL=O P$C?Z(7CW1J..03A
M,G')'K0!VDMK;SR1230QR/"VZ-G4$H>F1Z&DNKNVLH#/=W$5O".LDKA%'XFN
M8U'QC)I1E>ZAMQ!+J2Z=92F0J';&7=R1PJX<<9R4/3-<_P",=<;6/ WC"PGB
M@E%E;))'=V^3%,'YXSG#*5((R>H/?% 'IO6BN>N-=N[3QI8Z+-;PK97MM)+!
M<[SN:2/&Z/&,9P=V<] ?2KV@7]WJ>E)>W<,47G,S0B-B0T6?D8Y'&X8;';-
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MKA8<+'" P"HN[C[['))Y/H !N:9:R6.F6UI+,LS01B/S%3;N &!QD\XJU10
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0R75V85<J#%N8JI^7); Z8 )XJ*XN)M9^&K-IMK)<S7VF&..)&12KM&1AMQ
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M/,7^C&+(^;##<1T)..U '1W'BO1K7<\UTRP)-]G>Y\ES"DF=NUI -H^;@DG
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M</ND(7[P/!*_CD5;?1M7/A[P+$--D^T:3<V[7<7FQY14MY(V(.[!&YAT.<4
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M9'9BS'CG V]C[T_0O$=BOAG0WBN-0U"2_4K:BX"_:+C:"2S=%& ,DD@=.Y%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK":_XIOEAM##JEM##; SL&!177+_ "< [\\9Z55MO#&L0Z3X)@9;,SZ$Z"Y
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MPRV$!'ER(P=7.X\C<J_+QWY.> #*OVO)?BIX7DO-+BM28+S9-'.)#(-B_*W
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M=0C;>"">HR!3;3Q9>7WB*\TJWT"X9;*Z2WNK@SH%C5HPX;'5N".!T[XK)MO
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M<XI)\08Y=%T[48M)N)3=:C_9KQ)*A,4V\IP<X89!P1QTZ4MSX)FBGTF;3KR
MM:7-Q<W"7L)D2XEF.6D(4C#*<[?0''%5AX(U..Q@MDU*V?R=<;5_,>(@OF0O
ML(!P/O'G]* +DOBV]$.OV<^E26>J:=9?:XU29)5D1@X5@3@<%#D'T[UI^#M0
MO=3\)Z7=ZA#*ES):Q,[R%"9B44EQM) !)/'!]JK7GAF>[\1:EJ'VJ-8+_2ET
M]DV'<A!D.\'.#_K.GM5_PUI]]I/A^RTZ_N+>>6UB2%7@C* JJA1D$GGC)^M
M$7B'7+G1;66XAT];B.&+S7:6Y6%2.?E4D'+\=#@<CFLX^-C/<Z+#I^DSW/\
M;%BUY:NTJQC:%0D-G./]8O//MFG:IX7O[SQ-<:G;WULL-Q8BT*SP&1[?!8EH
MCD ;MPSD?PCKTJOI?A'4=/O/#$KWML\>B:>]B5$; S!A&"W7@XC''/4T 6;+
MQK!-IDLUW8S6U[%J/]F-9AE<M<<856X!!!!R<<9]*R[#[4WQC>2\TZ&TE;0W
M^>&82"4><G.=JG(Z<CTY-2W?@6\GCU%H=3CAN9-876+*7R2PBE"JNUUS\RD
M@X(^][5H66@:NOBZ#Q!?W]I(XL&LI((8615!</N4DDYXYS^F.0#H[F5H+669
M(9)F1"PBCQN<@=!D@9/N:YB+Q#'K-]JWAW4+"%+B*S\\A)UGCDC)*\G PP(Y
M!'IUK6\3Z1-KWAJ_TNWNS:2W,>Q9@,[>0<$9&0<8//0FL:V\+ZI!K+ZH;G3U
M=],^P"W@MVCCBPY8%>2<<]/Y4 <OI\$1\)?"N<QKYPN;==^/FP;:4D9],@'\
M*]7KB;?P;J5OHGA73A?6I_L&9)=YC;]^$C:,#&?EX<GOTKMJ "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** *<6E:=!J$E_%8VR7DHQ)<+$!(X]"W4U<HHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHZ#)K,T[Q#I.KWUS9Z?>QW,ULB/+Y62H#YVD-T.=IZ$]* -.B
MJ-SJ]A::I9:9/<JM[>[S;PX)9P@W,>.@ [FKU !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
..*** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>ameh-nonqualifieddeferre015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV"7D,IG/[S<[(%8;/EY4]-U3>%-<?Q)X9LM7DMA;/<JQ,*OO"88KC.!GIZ4
M;-%%% !1110 4444 %%4M6U:TT33GOKYV2!72,E5+'<[A%&!ZLP%7: "BB@D
M 9/2@ HK'\/ZO/KMJ=26*%=,N%5[)UD)DD4YR74@!>Q !/7G%;% !1110 44
M44 %%%% !1110 452U35K31[6.XO'98Y)X[=-JEB7D8*HX]R*=]IN?[7^R?8
M7^R>1YGVSS%V[]V/+V_>SCG/2@"W1110 445AZSKL^E:WH=BMI'+#J=PUNTQ
ME(:,B-W^[MYX3U% &Y116.=8FN/$,FEV$4$@LQ&U\\LA4H) Q4( #N/RY.2
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M^E=-XOU5;/38].AO8;;4-3D%I;,[@%-V=TF,C[JAC[D =ZZ':H.0H_*@J#U
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M8I!,GF^<?O*,AA\W'3':M>^>/5/$_BK3-;U33;,R"/\ L]KZ+)6 Q#$D#%U
M(?<21R&QSTKU$1H"Q"+EOO''6D:*-RI>-6*'*DC.#[4 >97&C:1J?Q%M='U:
M[6^W>'E6?,IC-Q()$ =E!^\0-V/H>P->H4FU<YP,^N*6@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 <EJ?C@Z=XQ@\,1Z+>7-]<6YN
M(6CDB5'09SRS#!^4\&LN7XM:9%X3O/$']EZ@8;&[-G>P$()(),@8QNP1EAR#
M65XCQ-^T!H4$=ZUK(VCRJ)8MA=#F3H&!&?J#5;XI>'-.\+?!?5K.P$A\Z[BG
MFEF?=)-*TJEG8]R<=@.E 'K%E</=64-Q) T#2*&,3,"5SV)'%8FH^,]+TOQC
MI?ABX9A>ZC&\D;#&U<9P#[MA@/I5NUU[2@EG;"_MWEDBW!4D!P%7))P> /4U
MY)XRT_6M>\)W7C*RM;%6@O!JUE>"[;SE@C&U%\OR\8*KOQOZD_2@#U'QEXKB
M\&:&VKW-C<75LC!9/(*[ER0 <$C/)I9_%UB?!A\4:?&]_8" W&(64-L RW4C
MD8((ZY%8U]X@L/$G@G0-61XO)O;^Q+(Q! ;SDW(?H<@_2N \76%_\+8]8M["
M)[CPAKT,L0B7G[!<NI Q_LG^7N!D ]T@>22!'EB,,C#+1E@2I],CBL'4_&>E
MZ5XPTGPU<,PO=21WC88VICH&_P!XA@/<5T#NL:%W8*BC)9C@ 5XAXRT[6?$/
MA2]\865M8@PW@U6QO!=MYZ01#:BB/R\8*@OC?U;\* /3O&GB^#P3H@U:[L;B
MYM0X1S 5RA)P.&(SGVJCJ_CQO#EM'>Z[X>U*STYG5'NT:*9(23@%PKE@/< U
MQOQ1\06WB;X#Q:Q;LNR[>W8J#G8^[YE^H((_"NA^)^KV5WX$N]%L98K[5-35
M+>TLX'#R.Q8?-@=  "23P,4 :'B;XCZ9X5U'2(+ZVG>TU0CR;Z)D:)5RH+-S
MD ;U.<5K^+/%%CX/\.W&LWZR/#$5 CBP7D8G "Y_$_0&N)U?PA!J5CH/@Z^F
MC,Z^&[BW#D_=E1K7:P[_ 'ES] :Y1[_4_$7PEU6;7H&AD\/V4VGCS3_KKH?(
MS_58\+GN9'H ]%U3XD0:3X4TKQ%<:->FTU)HUB1'C+KY@W)D;NX_*IO$WQ#L
M?"%_I-OK=E<V\6H\"X5D9(2-N[?@YP"R\@&N \;SQ?\ "C?!/[Q/];I_\0[1
M'/Y5W_B;3M,U_P 4Z9I.I+'-;7>EWJ-&6&3E[8@CWXR#[4 ;6K:XVF3::D5C
M+>+?S^1&\4B *Q4L"<D<85CD>E9MEXT2\\<WGA4:7=1W5G$)I9V=/+\LXVD8
M.3G(XQ7GNB3:WX4\8Z#X"UD275I%?&XTG4#_ !P"&4&-O==PX[?3%;6C30G]
MH;Q,ID3_ )!,((R.WEY% '00>/#?:<VKZ;H5[>:,)3&+Q)(U,@#;"Z(6R5!!
MZX/'2G>)/';>&;?4[VXT#4)M/TYT26ZC>(*Q8(1M5G#$9D SCKGTKS>_TNX\
M(>#8O$?@/QE>"QF>.2UT>?9.KM(P_=*.<-\QR ">#SGFNU^,<K?\*=U<SA8Y
M7C@RF?XO-CR!ZT :4WCF>VTJXU*Y\-ZA#;PV1O@3+"V^(8)QASR 0<'%4X?B
MA:[-!N+S1-1M;'7)$BL[IFC==[?=#!6)7/TJ?Q#-&?@MJ#^8NUM!< YX),!%
M><:7>'1K?X=ZQKCK>>&?LR0Q[@ NGW>/ED./O=/XL[?F(Q@4 >T>(]>M/#/A
MZ]UF]W&"TCWE5^\QZ!1GN20/QIMMX@M;WPHOB&T22>V>T-VD:#YV&W=MQ_>[
M8]:P?$LLVN>(K'1=/M[&_CM8S?7D%S<F)&#!DB4E4?/)=L8_A4YKG/@_>SZ)
M=ZWX!U)XUNM)G,MLJR;P87^;"D@$X)!S@??Z4 =!-\0;BW\1V>@2^%M274KN
M%IX8O/MR"BYR=WF8'0T[4/B&-,FT6"YT"_6?5KA[6&/?%E)5<H5;YL8Z'(R"
M#6)KLT8_:&\,*9%!&ESC&>Y\S%'Q0EC3QM\/ \BJ1JI)R>@^3F@#K=0\706V
MOKH%A97&I:OY/GRP0LJK!'V:1V( SG@#)]J9I?C.WO/$<GAS4+&XTS6%B\Z.
M"<JRSQ_WHW4D-T.1P>#QP:Y'P]*-"^.?BF#5&$+:Q##-82R'"S*@P54GJ1GI
M_LU+K<?]N_'/PW_9I$HT:VFEOYHSD1!P0B,?[Q/;K@YH Z#0/B'IFN>*=0\-
M/!/8ZK9$YBG*D2X^]L()SC_/0XV;'6I+W7=0TPZ?-#]B"EIV="K[N5P <\@$
M\CBO/M5\'CQ78:EJ6BW*VWB/2]7N)+&Z1AG((/EL?[I]^A]B0=/X8>)+GQ1=
M:[>7]D]EJ$+06UW PQME16#8'8>QZ=/>@#T2BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@"G)I&FRW/VF33K1[C<&\UH5+9'0YQG/%2W5G:WT0CN[:&XC!
MW!94#@'UP:GHH STT+2(MWEZ58IO4JVVW09!['CI4PTS3Q9FS%C;?92<F'RE
MV9SG.W&.M6J* *!T/2#"(3I5CY08L$^SI@$@ G&.O _*K5Q:V]W;-;7$$4T#
M##12(&4CW!XJ6B@!DT,5Q"T,T:21.,,CJ"&'N#4 TS3Q9FS%C;"U)R8?*783
MG.=N,=:M44 4?[%TK[/]G_LRR\G?O\OR%V[L8SC&,XXS4EIIEA8,S6=C;6Y;
M[QAB5,_7 JU10!6?3[*2[6[>SMVN5^[,T2EQ]&QFB;3K&XA,,]G;RQ%S(4>)
M64L>K8(Z\GGWJS10!0;0])>-(VTNR,:9V*;=,+GK@8XS4@TK3A-%,+"U$L0"
MQN(5W(!T .. *MT4 12VT$\D4DL$<CPMNC9T!*'&,@]CCTJ!-)TV*Z^U1Z?:
M)<;BWFK"H?)ZG.,Y.35RB@#.@\/Z+:WIO;?2+"&[)SY\=LBR?]] 9JS=6-I?
M(J7=K!<*IRJS1AP#ZC-6** *ITRP:S6S:QMC:J<K"8EV YS]W&.I--&E:<+0
MV@T^U%L6W&$0KL)]=N,9JY10!4@TO3[6<3V]A:Q3!=OF1PJK8Z8R!TX%)'I.
MFQ77VJ/3[1+C<6\U85#Y/4YQG)R?SJY10!3DTG39;K[5)I]H]QN#>:T*E\CH
M<XSD8%%UI6G7LHEN]/M;B0#;OEA5SCTR15RB@"I?:7I^IP""_L;:[A!R([B%
M9%'X$4^RT^RTVW^SV-I;VL.<^7!&$7/T Q5BB@"M::?96&_['9V]OOQN\F)4
MW8Z9P.>M21VT$,TLT4$:2S$&5U0!G(&!D]\#UJ6B@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** (;J2>.W9K:!9YN L;2;
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M+J=DEO,N^*5IU"R+ZJ<X(Y'2N7\;6L%WXE\)^?8274$-[(\Y6V:543R9 -Q
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M&R66JSVJ3.JQ@(I4*#CN2?Q)H ZJBL<>*] .FSZ@=6M4M+=_+FD>3;Y;]=K
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MQ)HNNOX?9TT^\BN+/Q1+J<MM%@/+ TCG,9;Y6(#!@/\ 9^E>LT4 >=:[H?\
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MM/IT5K.%M;>)YIW&T+(_(CP>=P4;CZ!E]:V*9'#%"7,42(9&+OM4#<Q[GU/
MYH Y6[CNK/XF0Z@;"ZFLYM*^S>?"FY4<2[R&[CY>??H.:YK^Q]0D^$>J:<NE
M7 U!M0DG$!B(=PUWYBL,]?DP?;%>I44 >;#3+J+7_$L&I0:S)IVMNLL+VD(9
M9(VB6-HG!4M&PVXYP,'J*ZG7[3R/ 5]IUG;3R,=.>U@A4&1R3&54'&?;GI[U
MT%% '.^$-.M[;PYI4LNG+;ZC%8PP3N\&R4,J*I!.,D9'TXKF+9M<L-%UE[32
M[L//XA:X/^C;I!:NZDRQJPP6 &0""1UQ7I-% 'DVK:3J<^F^/8X],U*275K>
MW6T\V/<\Q$>TY*_*I'H<8_2NKU&UFE\8>$;^"RF^RP0W4<KB$CR=Z(%##&0"
M1^&*ZZB@#G/%"SZA)8:,D5VMM=3*UW<PQ%A'&O(7."/F<*#D$;=V>M8MWIE[
MH'Q!TW5[3^TM1AO+=K34BT8;8@.Z)_E4 D-N!')PU=[10!YN(M8L=*\7Z')H
MMY<W-_->3VES& 89DE4[ S9^5E&%P1GY1C-3I:W9O/A\S:==E=/B<79,#?N"
M;<QC/']_CCZ].:]!HH \QN=(O;KPO\1;6+2[@3ZE<32VB-"5,X,,:J1GOO5N
M#SWK:7[0?'^E:B;&\^RQ:--!)*;=_ED9XF"GC.<(U=I10!Y:FCZ@WP?GTY=*
MN%U!=0,_V<Q8<@WOFAAZ_)@_ABM2[M7N_$GBN6?2;VXT^^T>&W55B9#.5\[>
M@.,@XD&*[ZB@#S9M'UV72/$.GVUYJ&IZ=/HTL-J=3MQ%<"=E8+&&*JS+CJ6'
M4CD\U8OUN+^+P1*='OPEC=K+<));$M$JP.F2!G^,C'?OTYKT&B@#A/$2ZO-J
M>KZ9'IUW_9\NFA+0V42!)W(DWK*YY4#(P!C.6ZYQ5>UM-0LI? %TVF7DB66G
MR6ETJ1_-#(T<2C<"1@91AGI^!KT.B@#SF+3M0MO"7B?PS=Z=<W%[>37AMI1$
M6BN5G+,C&3[J$;L'<01MXSQ5JQTB:T\<Z4MW:S74%KH']GR7;0%D:7>F1G'=
M0<GIV)KO** .;\86$6H6^GI+_:<3177FQ7>F@M+;.$<!MH5L@ABI&"/FKF&L
M]=D?PY_:<%Q??9-<DN?M'V,(YM_*D5))%48#[F'& <8) .:]+HH \^U.'6K#
M6?&MYIFEO//=6MH;3=%N28H&63&>"P## /7&.:2T@O1XOOM4DLM5>WGT-8$F
MN81O>02.=I5!\O!'&!7H5% 'F=G9:A#X;^'EL^FW@FTR>)KQ?(;]R%MWC)/'
M/S,.F:],HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU(6^O17D?VF>(SQ6J8X=MP#-G<1C/!&30!V%]XDTS3VNA-)*XM &N6A@>40
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MP&K^'M1NM9O+_2+?5-*U26>(BYBNT^RSJ @W2Q%SD@ KPN3@8]:[^@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **1U#HR'(##!
MVD@_@1R*\FM9;F?PKXE:/5-9?68=3OK?3%BO)I'S&Y6)=NXJ5!P#N&,9)/>@
M#UJBN(T5[^#X@W$6H7$KR_V#:S3Q"5GC68R2!RBY(&=HX [5L0>*X9=6CTV;
M3=0M;B>W>YM1.B 7"+C<%PQPPW#Y6VGF@#?HKD(/B'IT]E9:@--U1-.NIQ;?
M;'A41Q2&0Q@/\V[!88R 1R,D'('0ZMJMMHUC]JNMQ4R1PHJXR[NP15&2!RQ
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M-K9[C:<BNBH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJV0IR=I&#^ KHZ* //K;P7=1:5<:;J6DZ3J-E-JD]YY*R-'L5R2A3Y?E9>F
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MF:A;Z8HFOKIK;[*]QAHF4L'W';U78Q(]N,YIWQ#U*\TKP1?W-B)//)CC#1L
M4#NJDY)&."1QSDCZU%X;T:*#Q/KVI6]QYEC+<DV\8QM25E3SV4]\LJ_0AQW-
M:/B[0[CQ'X=GTJWNH[9IGC)E>,O@*X?@ CJ5 ZT 9-J;+3_%>A6"Z"VG236U
MT\*PSA8HP"A<&-/E).5.?<UB?$+5W\0?#74;RRTR*YTL\)<R3!9 5DV^8B%3
M\N0>=P.#TKK+O0[^[\5:/K375NJV$$T3PB)CYGF[-Q!SQC8,<&N?D^'^K?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH KQ6%G;WD]W#:01W-QCSIDC >7 P-S 9.!ZU8HHH *
M*** "BBB@ HHHH **** "BBB@ IDT,5S!)!/&DL,BE'C=0RLI&""#U!%/HH
MBMK:"SMH[:U@C@@C&U(HD"JH] !P!4M%% !1110 4444 %%%% !5>TL+.P61
M;.T@MA+(99!#&$WN>K' Y)]:L44 %%%% !1110!7M;"SLFG:TM(+=IY#+,8H
MPAD<]6; Y/N:L444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3DJO<GM73/(D:[G=5'3+'% #J*3( R3Q65=:CJ4?B+3[*WTKS]-G20W%^)U
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ME6O@K3]4LOGO;RSA2\D\]I"60'"X)(7&XC QVKO(X8H8A%'$B1CHJJ !^%.
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MI12P8J"P& 2.11L0XRHX.1QT- 'EKFTOO"OBU=9*CQ%!=77E$\7"')-MY/\
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M\>^'D73+5M-?3KE&0VNV(EFB,:LI '/S%0?J* /09+^SBFAADNX$EF_U2-(
MS_[H[_A55=:MF\1RZ&%D^TQVB7;.0-FQG9 ,YSG*-VKS3QI-]OTWQ581Z<;>
MYM)(OLT45D[S3!%CVS>9@@*.@ P1MZY.*WI+;2/^%KSW=Y80R1W6D0-;W#6N
M]&=9)2YWX(!"E,DGIB@#K],OIY],-UJ*VMNZO('\F?S(U56(!W8'8 GT-6(;
M^SN;=KB"[@E@4D&1) RC'7D<5Y5I:RV_A+0)%MY/[-LO$%Q+?P+$<I"TLQC<
MKC)12T;].@![5<\36<5]>>+M3LD2;2[GP\87*+N2YO/G\LI_><+@9'J!U' !
MZ3%?6<]PT$-U!),JAVC20%@IZ$@<XJQ7FWV&QL[SX?7]G9QPE6>*>>.+! :V
M<$.V/[^WKW]Z[S68[R;0]0BT]]EZ]M(MNV<;9"IVG\\4 2QW]G+=O:QW<#W*
M<M"L@+K]1G-9=IJ]QJ7B.\L[1[=+3391!=B1"9)':,.-A! 4#<N<@YYZ8YXS
MRTU7PCX2L=,B:'7+"ZM3)$5*RVA3 G,G< C>"3PV1UR*U?!MGIH\8^++F.SM
MTN&OPT$WD@,T?DQABK8Y7>&SCC.: .IU[6;?P]HEUJMTDKPVZAF6( L<D  9
M('4BLV\U^XLO&UKI<S6B:;/83732ME60QM&O+$XQ\_IVJK\3;,7OP^U./[*;
MED"2!!'O88=22![+GIVS62\.BWGQ \/+:V4/]FKIEUL06VR)7>2(J-I  )PQ
M&1SUH ['4-1ECTV.[TW[)<[Y(P#)<!(RA8!B& .2!D@=ZLSZA96LT<-Q>6\,
MLO\ JTDE56?Z GFO)KVUM[;PGKMBMIM:W\4+):P"$Y2/SXF+(,<+@.<CC@UK
M^(FN8=7UJ\T6_M;R:<P++HM[;;_M9"+M,+J0P&".<$!@Q..: /2ZXNS\1>(+
M^X\0PP0:9OT>?R0'WJ)SY8?KD[.&QWKM*\]\,6ECJ_B'QC#=+*\%QJ"RQIO>
M-)X_)C4G@@.N01SD4 7M!\9W>NZOH2K:Q0V.JZ5)?!'!\V-D:-=N[."/G/.!
MVKK4O;22Z>U2ZA:X09>%9 74>I'45R=ZT5M\4-%2*/;%#I-S" BX5&+PE$]
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MS;DX$HE783Z9SBO,[32+OPY<:+<SVTD/AY=:O+DVVTE;2.12(&91]U0VYO\
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M8.3_ *Q:[B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M821"$17<JG8H((PRJ&)&!AB21CK5F#P]''<174]]>7=W!$T-O/<%"T(;&XJ
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M?WA+.IW(006)/(R.QKH:* .>?P=8,UBZW%W&]G=O>JRLN7G?=N=LKR2&88X
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MKJJ$8V\*"PQQ\Q:MNB@#GM.\(6>G:<^E_;+ZYTHQ- MC<R*\:1D8V@[=Q&.
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M%QD9[#I717U]JFA^+/#]H;^6_L]4>6WF2:- T;K&75U**O'RD$'/48QWU_\
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M5SM!!8CC)QQW- '):#XMU'7+7PM92S+;76J6,]S<7,2#.8BJXC# J"2V3D'
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(7X("\8"CZDX[59T37K0^&+;4+G6#?I+*\:7/V4Q-,PD8!%B SD8*X R=N:
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M0#N('7@\'%5M&UVV;19[V;59+^-;R6$2"R:-PP<@1",#<2OW<XR<9H Z*BL
M^--#71[W5)+F:.VL9#'=A[6420,!G#IMW#@@YQCFJ=WXMTV\-F+'5YK0?VG%
M:LYL'=9V.#Y0)7 #!EP_3T)H ZNBLB_\3Z5IIN3<3OY=H0+J2.)G2WR 1O8
MA>""?0$$X'-.G\1Z=!<R0%YI#%(D4KPP/(D3/@J&900,AE/L""< T :M%4[7
M5;*]O[ZRMYM]Q8LJ7";2-A9=R\D8/!SQFL=_%<<?CQO#K)\BV23^8L;L?,9R
MH4X& ,#.3Z^U '245BKXLT=GM/\ 2'$-Y)Y-M<-"XAE<]%5\;3G''.#VS6U0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!RGB*)H/&OA75'XMT>XLW;LK
M3(I0GZM'M^K#UJO:6^M:9XN\2S)HCW-OJDD+VUP)XA&I6%4(D!;<!D=E8X[5
MUMU:07UK);7,2RPR##*W^>#GG/:IJ //[K0!I>F^!_"UO*9I;2]CN'?&/W<"
MLSOCL"S*O_ P*] J$6D"WCW@B7[0Z",R=]H)('L,DU-0 4444 %%%% '*>.]
M/U'4[+2X=.L)+IH-3MKN3;)&H5(Y Q^\PR2!Q_2G^(]-U"?6/#VNV-LT[:;+
M*9[/>JNZ2Q["5).W<O!QG!&>:ZBB@#F](TBX_P"$NU;Q#/"ULMW;P6T4#%2Q
M$>XEVVDC)+X ST'O@5+BTU?2/'EUK-MITNI:?J%G%!(L$D:RP/$SD'$C*"I#
MGH<Y[5U]% '(65EJ>C^+M5U-=,FN;/5H+=@D,D8>VDC0J48,P!!&""I(SGZU
MD6OA75=*M_"T$=D;C['JD^H79BD0+")1+\B[F!.#*.@[$^U>C44 <%+HFKW$
M7Q C_LUT_MB-A9%I8\2'[,L6#ACC+#OVJK=S7^F^*_!(_LBXN;F/2KJ*6VBD
MB#KCR 2"SA3R/[W0_A7H]95SH,%UX@L]:>XN%N;2-XHE4KL"OC<"-N3G:O?M
MQB@#E=<\)ZE>Z-XDO;>W0ZGJMQ:7"6GF 86W:,JA;IO(1LGH"0,D#)O6T&LW
MGC^RUN?1IK2Q&ERVI$LT32)(TB-\P5B,80]"?PKL:* /+?\ A%O$#>$].L?[
M-=;K1M8>]6-;M4%[&TDI(C=6RAVR<;MO(KMM L((I[N_&D7EA<W*HDK7ER)I
M9 N< D2. !N..>YXK<HH X+Q1IOB/5;CQ%8BSGN+*YT\Q::T5XL,2.8V#B0!
M@S,6(QD%<8^[R:GTC3-5@\8:5>S:9+%:P:&+&20RQ';+O1N@<DC"GD=Z[:B@
M#S-?#GB&S6*]M].\V>P\17>H):M.BBY@F,BY4YP' ?(#8K>TJUUB3Q]=ZS=Z
M4]K9W.FPV\>9HV:-D>1B'"L>?F'W=P]ZZZB@#E?$NGZJGB;0M?TVT-\EBL\%
MQ:)(J.R2A?G0N0N04'!(R#6;JVE:G/XLT[Q)%I%])!]CDL[BQAO%@N(\N'60
M%9 K9Q@C?Z'DBN\HH X34=!N$3P[_96@SQQ6VKG4;J)KB-G7*2!B2S_,Y+@\
M$]^:T[^RU&+X@Z;J]O8-<V9L);.5TD13"S21N&(8@E<*?NY/M7444 >9WF@:
M]<>"?%^FII$HN]3U&:>U1IHL,CE2"3OP,;3D>XZUO>-+:\ETS3-:T^VVZMIM
MY'+!#*P!<.WE/$6!(&Y7[9Y KKJH3Z1#<:M#J$LURQA4!(/-/DAAGY]G0M\Q
MY/MZ"@"33+$:;IT-J&WLH)DDQCS')+.Q]RQ)_&N<2RU6Q\9>(;M=+DN+34;6
M#R9HI8QAHU=2C!F!R2PP<8]Q7744 >=P>']9B\ >$=..FM]MTJ\LY+B$2QYV
MQ'YBIW8/MSFF:;X5N+0ZKH^K:)>ZE97=_+<Q3Q:AM@9)'WXEC,BD%2><*V<9
MKT>B@#(\3KJ[^&KY=!*C5#'B#<0.<C."W .,XSQG&:YBUTG5H_$UWJHT>]6"
M?1OLJ+/>I-*)?,8X;,A ZC[I(^AXKOJ* /.K30];@T+P%:/I$OFZ-+&UYB:+
MY0L#QG'S\\L#]*-9\*ZSJ%SXL^SP*ANKVROK%WD7RYC D64;!RN6C(Y&.]>B
MT4 <K)IUYKGBS0M9FL9K"+2XK@E9W0O(\JJNT;&88 !).>NW&><<O;Z)XE3P
M5H^@'0G$VEZC;S23&YAV31QS[]T?S9S@=&"_C7J5% '+Z-9:A#XY\0ZA<:?)
M#9WL-JD$K/&=QC#AL@,2/O#''KTKG-,T#7M-\,^"%;2));K1;AOM5LD\0;:8
MI$W*2VT@%QQG/M7I=% &)XOR? ^O9&#_ &;<9'_;-JY_3K&]\3^'O#,%UIDN
MGP6#VMVTDTD;^:8UR@CV,3@G&2VTXXQSQU^JZ='J^E76G3R2)#<Q-%(8B Q1
MAA@"0<9!(I^G62:;IUO91R221P1B-&DP6VC@ X Z#B@#SVXTCQ3J"V+ZAIMS
M->6>MI=22_;4$+P+*Q7RH]^.$V@[@K9]<UJZSHMR_CR$VH3[#K-F8M40G!VP
MLI5L=]RN8S[,/2NVJA8Z1#8W=U=":YGGN&)+7$I?8N2=B#HJ@D\#V]!0!SNO
MVFOW>O74"6EQ<:5+8;+;R+L0)'/EMQEPP=@1M P&'7([UE:?I&NZ0?!5S_8D
M]S_96DR6-W#%/"'1V6( KN<*P_=GOT/X5Z-10!Y[K'AC4WL[RZMK$S7NI:U:
M:A+!'(@$,<+1<$LP!8K&2<=SCH,E1X>O;3Q%KYN](O\ 4M-UB19U-K?B+9F-
M4>.5#*@(^7@C=P<5Z#10!6BM$@TM+."-8DCA$4: Y" +@#/H*\^TO0-?M-"\
M'3/I;K>>'6,4UH9XR;A&B,3/&0VW(SD!BO<<=_2J* .:TO2;A_&>H^(YX&M4
MGLX;.*!RI=@C,Q=MI('W@ ,YP#ZU5UZUU^Z\03PI:7%QI,MAL@\B[$"QSY;<
M9<,'((V@8##KD=ZZ^B@##\'65UI?@K1K"]MVANK2RB@ECW*WS(H4X()!&1ZU
MF^"]-U"QO/$#ZCIDEN+S59;VW=WC?Y&5% ^5B0WRG_&NNHH X;Q+I_B+4M0U
MNT6SGN-/N-/\NP:&\6&..0JX?S0&#,22N.&7Z<FDL])U:+7/!T[Z5*(=-TV6
MUN7\V(^6[K$HP-^2!Y;9QV(ZUW5% '++9ZE9?$.^U)-.DN+&\T^"$31RQCRW
MC:4E2K,#SO&" 1ZXKF[+P[XBLO#GAV=--)O]&U.XN9+)IXQY\4K2@[&#%=P6
M7C<1R#7IM% '&^(X=5UFWT66VT*ZC>WU:"ZFCEE@#B-.IXD().< 9[<XXJK9
MWUY:?%#Q,EMI-Q>K+;6(:2*6-1$=LF-V]@<')Y7)XZ5WE95GH,%EKU_K$=Q<
M-<7RHLRN5V$)G9@!<C 8]^<\YH Y:'0-<T(:39VT,UWI\DMU/J"6-PL!$TK[
MTPQ96\M=S#"G)P#@]*H67AW7;31_#]HVD2-)8>()K^?;<1L/*9IB""S@L?WJ
M]0#P<UZ;10!P^J:!JEUJ_C(Q6O[G5M'CM;:8R*%,BI,"&&<C_6+SCUKI/#GV
ML>'[&.]L9+*XBA2)X9'1R"J@9RA(QQQST].E:E% 'FESI'BG45LGO]-N9KRS
MUR.ZDE^VH(7@64LOE1[\<)M!W!6SW.:V;'2]3&J>,Y9=/>*/4RK6K-)&=^VW
M6/!PQ(R5[]J[*B@#SC2-(\1:#<>'=171Y+OR-$CTJ\M$N(EDA="#YBEF"LI(
M(/S \ ^U;_@ZPU/3Y]?.IV8@-YJDEW"R2*ZLC(@ X.<C:<Y KJ** .86QU#_
M (68^IFQD_L\Z6+07&],>8)"_P!W=NQ@XSCK^=<VN@:[#H5C9#2)7EM_$C:B
MVV:+'D?:&DR,OUVL./6O2Z* .!U#P[J$VMW%_I$&IZ5J,EY&\DT=VAL[A 5!
M>2(N<G8,<*#D#MS6YXTT>]UC18!IVQKNSO8+V*)VVK,8G#;">V0.#ZXKHJ*
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MAVN/EP<$9%:VL>&K^_\ #Z6FGZ5I&GSMJ%O=RI'*0A$4B/RRQC+'9CIQQR:
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M(-UY^"=F0<9'0\U:O?"FHZOJ_B-[S[-#9:QI<=@&BF9Y(RHD^;!4 C]YZ]J
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M%L\PNR Y)).T]/7M0?!NNMHMP@EL(=1BUY]9L_WCO$Q,C-Y<GR@@88C(SZT
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M)AY@9G**YCQ]PMWSG!!Q6_JVKV^D0P/,'>2XG6W@B0#=)(V<*,\= 22>@!H
MOT5Y]:W,EO\ %>^N]2L8[ 1Z$9)'282(ZB7E\@ \ 8.1V[UL6OC:WN+C1B]N
M$M=8.VTD$P9PQ0NHD3'RY4'&">>#B@#J:*\S^(.L'7?AY=WEEIOVC3&=/+NV
ME"L,2A=ZH1RIY&<@D'IBNT_M\?\ "5OH/V*42+9&\6;<NUUW!=H&<YR>^.E
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MQX]2>3]33J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2?L&L2LTCZ%#+/;QW+*IG\TY. >HP..G0XZ5L_%.**3P!>-,S+''/;,Q60J
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M)OV[79>N!G[OI7,2ZCI5YXVUW3/$\UOY*1V[:;!=, CQ,GS/&#]Y]^1D?,,
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M[MHS^=244 1M;P-*9&AC,A786*C)7TSZ5&]A9R&,R6D#F,Y0M&#M^GI5BB@
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M%% !1110 4444 %%%&: "BBD+!1EB />@!:*** "BBC/..] !1110 44=**
M"BBB@ HH!STHH **** "BBB@ HHH) &3P* "B@$$ @Y!Z&B@ HI,CCD<]*6@
M HHH) !). .I- !10#D9'2B@ HHHH **** "BBB@ HHHH **** "BC-% !11
MGG'>B@ HHI"P! ) )Z#UH 6BC.** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **3< 0"1D]!2T %%&:,YH **** "BBB@ HHHH **** "BBB@
M HHSBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#FO$MV\VLZ'X?1BB:
MC)+)<LIP3!$H9E_X$S(I]BU+J>KMJ,.K6&G:9'J2V?[F[6641J7*!MBY!#,
MRDYP.1SUPSQ/;FUUS0?$)!,&GR2PW1'\$,RA2_T5E0GT&3VJ-/#.JV.M:M/I
M>J6\6G:M)Y\\,L!:2&78$9HV# <A5X8'!'?I0!SNFW;Z-\'/#?B&%B)-,M()
M9!GB2%MHE4_\!.X?[2J:]-KS^_\ #]Q:?#K3O [3)<75RL=D)(U*CR%*F20@
MYP @/XLH[UZ!0 4444 %%%% 'G7CW0;"SLM.N(XB;BZUZU$TI/S.LDPW(3_=
MP<8]!71,=/\ "UY!8Z?;9NM7G/D6P;:@*1Y=LX.U0JY/!Y(XYIWBW0;SQ#;6
M$%K<P6XMKV&\+2H6W&-@P7@C&<=:=KF@W&IW>D:I;3QPZGI<C/'O4M'(KKMD
M0]P".A[$#@]* )=(\0#4-7U'1[FV-KJ-@$>2,/O1XW!VNC8&1P0<@$$54N_$
M]['XFN="L]%:YN8K1+M'-RL:,C.R\G!QRI['M[D6],T1K?7+_6[MT:^O(XX=
ML>=D4:9(4$\L268DX';CCGGKH:FWQ?G_ +,FLT(T.#S1<QLV1Y\V"-K#D>G?
MVH F_P"%AK_8]O>G1;OSSJ8TJYM=Z;X)RP7&<X8<@@C@Y'2M*V\2WES=0::=
M(\C6'@>YEM9KD;88ED**S.H.2Q&0 #WSTYIZAX,EDL+2WL;N-)4U9=5N9ID)
M,TH?>1@$8!Z>P ZU>O=!NQXHMO$5A+"+L6AL[F";(26/=O!##E65L\X.02/>
M@#-G\?K%HTE__9CAK341IU_'),%^RR%E4.2 =T?S*=P[$<=<7=>UATM==M9-
M.DGL[2P,L\D%SL<AE;**<#:P4$Y!X!4]Z?;^$;4Z+K5C?,)VUJ666\95P,NH
M7"CG 50H'N,TV'PW>Q^![G19;]+C4;JV:*XO9$/SNR;-Y /9< #/\(H =9Z]
M$+/1[#3[9IKVZL%N8H)9CB.(!1F20@GJRC."2>W4CF/#&LV_ARU\87^H68L]
MNMB,6L3JWSO%"JJIX&"6!R<8!R<<UL?\(EJMI/HFHZ=J-K'J6GV/]GS":%FA
MN(?E(X# JP*@]3U(JO/X N;S3M=M+K5$9]1OTU&&X2#!@F01X^4G#+F,<9S@
MXSGF@#;TSQ-'?>()]$FCA2ZCMEND:WN/.C>,L5/. 0P.,C'<<UCZQ<R7WQ)L
MM&N=+-]IZ:>;G8YCV))YR#SL,<Y4<#C(R<5T>CVVI0(3J']G!MH&+*%D!/J2
M2?R[>IJH^B7A\<KKPN(/LXL39>05.[!<.6W9QU&,8_&@"A<>.4AT >)%L#)H
M(DVM<K+^]$>_9YOEXY3//WLXYQVJ5O%MW)XFN]%L]!N+A[5K8RSB= @BE+#S
M/7@+G'4\],52A\$7,?A67PBUW"VALY5)-I$ZP%]QBQT)ZKOST_ASS6MIVA7=
MCXNU75VG@:WOXH(A"J$-&(@^TYS@YW^G&* *OC?6-1TB+1?[.CE=KG58()?+
MV?,A))3YB,;L8R/?D5C6\]Y9?$?7Y=.T7SKJ?3+*5X#,D05MTV=S<C=T'&<X
MZXYKI_%&B7.MVEB+*YB@N;*]BO(S,A=&*$_*P!!P03TJ+3]#O[;Q=?:W<75O
M(EW:PV[11QLI4QESN&2>I<\=O4T 5+7QY8W]GH[V\02ZU2*26.&ZE$0C$9VO
MO;G&&(48!R?;)&KX=U^'Q#8SSQQ^5);7,EK.@<.%D0X.UA]Y2""#QP>@KEK/
MX?WVG0:--;7]G)?Z7Y\0\Z M%<0ROO*L,Y5@<8(STZ<UV]A%<0VJK=&W\W))
M%O&40>P!)S]?T% 'GWQ#U=M<^&NMW%CIB76FK'*@N7E"L&1BID1".5!!&<@G
M!P",9Z2XO((_'6CV<EK<^?)8SM#,MP1%M4Q[@8P>3\RX)'K6+-X"U?\ X1;5
M/"UOK5LFCW/F_9F:V)GA#L7V$[L%02><9QQQU&[-H6HW'BG2-8>YME6QMIK=
MX@C9?S-F2#GC&P8'O0!%H_C*'6+9=0ABM_[+*2.\RW0:2 +D_O8]OR< ]SBI
MK?5;K6X[0OHBMHVHQ%EFDF#.%*%E,D6W !'^T>HR!66O@*.^O[:]U.#3X[F.
M"6&XN+&,QR7OF1E&,G P.2<?-SCD8YT?#^D^(-%TF#2IK^PNK>TA\F"8PNLC
MJ!A-_P V 0,9(ZXZ"@##\!ZTMEX%\(:9#%Y^H7MD7CC9]BA$ +NS8.!\RC@$
MDL/<C2E\>VMI%J$5_;"UO["[AM)HI)AY0,V/+D\S'$9!SD@$8(QFJNE^!K[2
M+'PX]O?6[ZCH<3VRLR,L=S"X&Y6&25.0"",X(Z'-:!\,7(GU'4-UE->:E-$U
MW!/&6@>&-"BQ>O&=V[')[8XH ?=>*[BPM[*6YTQ66ZU&*Q22WN1)'B0J%D#$
M D?,1TZJ?K5M?$#MXFO=#6PD,UO9I=H_F+B4,S* /3E3UKGV^'QATBXBTR6T
ML+E]4AU.&".(FVA>/;A H(.#MR2,<GH*T[/0=8A\4SZ]<7MG++/8):&%(F1$
M*N[ @Y)(^;G//7ITH S[+XBBXT2+6[G1;FTTV=%$$SS(3+,T@C$87/')SN.!
MP>PS6UI?B:._U^YT6:.%+N*W6Z5K>?SHWC9BOWL @@CD$=QR:QHO 4[_  ]M
MO#-SJ$?VBSD26VO(XN%D1]ZL4)Y&>",\BNDTBVU&!&.H?V<&( Q9PL@)[DDG
M],<>IH @FUV675KW3-+M$N[FQC1[CS9O*52X)5 =K98@9Z  $<\URFM>*QKV
MG>%WL=.GN;/4]0>"[M)/+!;9'+NA<,V/OID]B%Z\X/1_V#>V'BB_UK2YH"-2
MBC2Z@N-P >,%5D5A_LG!7'.!R*SE\$3V<6@QV-Y#_P 2R]EOY6EC.;B602!^
MA^49D8CKC % '3D_V?I4:VMB2(D2.*UBVC:. %] !^@%<?J?B"'Q%X;\8:3=
M644=UIUBS2!)EGB8/&Y1E; Y!0\$ @BNA\5Z)/X@T&2PMKI+>0RQ29D0O'($
M<,4< @E6Q@C/0UCMX0U-G\02-?68?6-/CL]J0%$MRJNN5&3D8D/!/4>^  9M
MK;Q+XB^'4ZQJ)6TN=6<#D@0QX!/MD_F:Z+Q=>06BZ-]IM;F9)=4MXT:"X,7E
MR%P%+8.67DY7D''-58?"^HQZAX8N6O+4KHML]NZB-LS;E5"1S\N H..>35_Q
M1HEWKD.G1VMQ#!]DOH;QC(A;?Y;!@O!&,^M %.;Q9J#:OK&F6'A^6YN-,$;L
M6N4C617#$8//.%X'YD=\;6_$G]NQ>#C::9+>:9K3O+-:/Y8\U1 ["-@S8X.&
M/8[>O:NCTW0[VS\3ZWJTMQ \6I)"JQ*A!C\M2HYSSG=[5C:;X*U/3K7PI +^
MT<:!OY\IAY^Z-H_7Y<!L]Z -!O$Y@TW4;C2M*%Q8:.S03!9@CDQ@;UB7!#;>
MG)7)! ]:AO/'+?:M/@TG1KC4SJ-@U]9M'*D8D4;#@[ON\..OTI\7A>_T\:W9
MZ?=P"PU::6X)E4F2VDE'[S:!PX)Y .,$]Z=;^$Y=/U[1+JPGA2PTK3VL(X'4
MEV1O+^;=ZCRQVYS0!#<>,[]+W6+.V\.S3S:7#%/,&ND0,CJS?+UYPIP/S([R
M6/C8WE[H@?29X=/UM,V5TTJDEO+,@#H/NY4'!R>G.*D'AS45UKQ%?K=6VW5K
M>*!$*-F+8K*"3GG(<G''2J\'A"]@TOPE;?;8#)H#KEO+.)U6%HO7Y3AL]Z +
M.I>+GTG5[&VN].V6UY>+9QR?:%\W>S%58Q?W"1U!SR"0*SK37]4N==\7VEQ8
MW<]E9ND<2K)%'Y:^0K$ AMV6+$@]LCIC%0KX$U18%@.IV;K%JZZFLIMCYL^)
M3(%E;=SC.T$#H!Z8K73P[J5MK/B&ZM[VU-MJX5_+DA;?'((EC^\&P5PN>F>U
M $.B^([8:)X:M-.M97N-1L1/;07$Y)CB5%):20@GC<HS@DD^F2(;SQ^MAI^K
M23Z5,;W2;F*"[MHY0<"4J(W5CC<IW#L#UXXI++P9>Z;;>&YK>]MVU'1+4V66
M0B.YA*J"&ZE3E5((S@CH<TFK>";G4[#6"MY!%J&KW%O+/)L+)&D)4HBC()^[
MR3C)8G X% &K8^)+B;Q,VAW^E/93/;-=V\GG+(LD:LJL#C[K LO'(YZU=UG4
MKK3H0UM91SG:S,\UP((U QP6(/)SQQC@Y(JK-HEU+XNT[7?/A M[*6UEAVGY
MM[(Q*GV*=QWJ'5O#]]>>*;#6+6[M@EO;O T%U 9 A9E/F)AAA_EQSV- %&'Q
M\EW9^'KFSTFYF76RZ1#S$4QR(KL5//\ L'GIW]JGM_&T4=MJYU:QEL;K2YHH
M9H$<2^89=OE;&&,[BP'.,'K5#3O!.I:?!X:A&H6TBZ+<S3[C$P,WF!UQU^7
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M^'/$-YJ6@ZAJ6K6,L^DS.^V&V9%G#1-&2V6.&^;/' YZYX["@ HHHH ****
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M<D9R.F?:M6@"G8Z5IVF>;]@L;:U\YM\GD1*F]O4X')]ZN444 %%%% !1110
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M6QA@M#"H0LI D!SAE(X4X(RW'6M7QE?-IWA'4;I;'[=MC -N5+!@6"DD+R5
M)) [ T :\%Y;7,;26]S#*B'#-&X8 ^A(I([VTEF$,=U"\I0.$60%BI[X]/>O
M,85LCXC\02-Y$EE>:!&Q9;3R(9Y \H&U3]X@;<')/2H[;3[&S\)?#O4(+2*&
MZ@NK1+FX6/$B P,L@=NH&< YZ8% '?>*];.A>'K^]@EM!=V]M)<10W#8\W8I
M8@ $$].U:.FW+WFE6=U(%$DT"2,%Z E03C\Z\OOKB"7PIXTTG6=/FN-?9KUX
MTDM6D,J88P/&V,;57;C!X*^O7TCP_(DOAS361@P^S1CCL0H!'U!XH N2W5O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3X-3M9+P MY*R@L0.N/7'?'2L!/'=AJ&E:V]GJ6E65W83S01->W*F,[" )&
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MZOINEM"M_?VUJTS;8A-*J%S[9/- %VBLNP\1Z)JDD4=AJMG<R2Q&9$BF5F9
M<%L=<9XS6+XM\2F'P7?ZOX=U*UEDM94C:2/;,N=ZJR]<9 :@#KJ*I7VKZ?IG
M_'[=Q0X4N0Q^Z@ZL?11ZGBH[S7M*L%5KF_AC4Q^;G=D"/^^2.B_[1XH T:*:
MTB)&9&=50#<6)P /7-4;;7=*O)S!!?P/*(_-V;L$Q_WQGJO^T.* -"BLJT\2
MZ'J%Y'9V6K65S<2*[)'#,KE@IPQ&#T!XJ2]U_2--N?LU[J=I;S^69?+DE ;8
M.K8ZXY'YT :-%9$?BKP_+I1U1-:L?L"OY9N#.H0/_=))^][=:EB\0Z//;RSP
MZE;2113FV=DD# 2CJG'5N>@YH TJ*I6VKZ=>6DMU!>P/!"2LK[P!&1U#9^Z1
MW!Q4%OXDT:[2Y>'4K=A;%1-\^-F[[N<^N./7M0!J453MM6T^[@GF@NXFCMR5
MF);'E$#)#@\KP0>>U<U#XK6Z^(D6EVFIVTVG?V;-<S1J!NC='C );K@AF/I0
M!V-%9A\1Z(NFC4CJ]B+$N8UN//7RV8'!4-G!.01@4S4/$^A:3++#?ZQ8VTL2
M"22.6=0R*2 "1G(R6&/K0!HW5NMW:36SLZK+&T99#A@",9![&N;3PK<S>'K/
MP_?WEM+IUL(4;RK<H\R1%2H/S$+G:,D#GG&WMM7&MZ9:7(M[B^ACEWK&0S<*
MS?=4GH"<C /)SQ1+K>F0WHLY+V)9S(L6TGH[8VJ3T#'(P#R<B@"_14-W>6UC
M;M<7<\<$*]7D8*.>E4!XGT(Z4^J?VO9"Q1S&T[3*$5QU4DGAO;K0!JT5FQ>(
M='GAFEAU*VE2&<VTACD#8E R4XZMST'-6K*_M-1M_M%G<1SQ;BI9&SA@<$'T
M(/!!Y% %BBL2?QCX:M@3-KVG(JR^2Q-PN%<8R"<\8R,^F16A=ZI8V(3[3<HA
MD!9%ZLP'4@#D@9&3VS0!;HKG=:\9:7I%CI=Z+FVGMM1NX[>.87"J@5CS)NZ$
M*!S_ $K2U+48H-"N+^&^LH4\@O#<W,@\@$CY69@?NYQT/2@#0HK&7Q'I=K:V
M@U'5].2YFMA/A9@H<;<ET!.=OH?I5JRUO2]1TUM1L]0MIK)<[ITE!1<=<GMC
MOF@"_167;^(]&NHKF2'4K=DM2HG)?'E[ONYSZ]O7M3E\0Z.UO<SG4K9([3'V
M@RR!/)STWAL;<]L]: -*BLJT\3:'?:@EA:ZM9S7;IYB0I,"S+C.0._'-2#7M
M*-W]E^WP>;EU +<$J"6 /0D '(SD8.>E &C16)I6N12:(M]?:GILZM/)&DUB
MQ,3X<A57DEFP,$#N#BJVK>-M)TN'2YOM-O)%?WHM-[3",1<,69L_W=N"/4CI
M0!TE%9USK^DV@4SZC;HK*K[BXVA6^ZQ/0 ]B>#4-YXJT#3WG2[UFQB>WQYR-
M.NZ/.<9&<CH?R- &O17/:WXQTS1H-(N&N+:6WU.Y2".;[0JH$92QDST*@#]1
M6M=:I866G_VA=7D$-EM#?:'D CVGH=W3'O0!;HJM'J%G,T"QW,3-/&TD0##,
MBKC)'J!N7\Q63>>([20V TW6-)!EOEMY!<29,@!P\<8!'[S)'KCG(H WZ*YE
MO%EK=:]K&@6]S;V]]911F)WE5C*[*S$*G4[0O/UJ#P?XRL=6T/1(]0U6S_MJ
M]M$F> .JLS%=Q 7Z<XZXH W-?T^;5O#^H:;!*D4EW;R0>8ZE@@=2I.!UQFI-
M(M)M/T:SLIY$DDMX5B+H" VT8S@].E4_%/B&#PMX>N=6G19%AVA8S($WL6
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M"67]I07E[#!&\Q1EW,&'#E1T#8)';TJ]0 4444 %%%% !1110 4444 %%%%
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MC@U/0]8U-)K^UL;ZZ5WBM/+G>*2-5CG>%1G<"&!P,[6SCK7I=% '+:!IT_\
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MCMV[3QD!NF*[.B@#R[7-!U>ZU#6]?TVRFDMY+W3K@63+Y;W:V[9D.UL8)RH
M."=GTSH^+#<ZY;:5JVDV&IJ;#4(9[M/LABG>(+(/D61?G*%]V,$<G'->@44
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M7&YCU)]2:DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME;4!XQN#')SQCCG(E77]5&O3>'+FZD^T6=FL\MY:61D,K.[A/DP0H"J"?4G
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MYBH/(&<XJ>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH PO$.F3S7>EZO9Q^
M;=Z9,S^4#@RQ.I21!GO@AA[H!WJ6'1(+#6K_ %R.6[DN;J-5FC!4AU0-L4#'
M&-QQSSGG-;%% &)X8TF;3;*ZGO HOM0NGO+E5.0C-@*@/?:BJN>^">];=%%
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MO;%'CBGGG#L4? *D$8Q\H[ ^^:GL?"UA96>I6;--=6VI222W45P597:3[YX
MQGTZ>@%;=% &#9^%+>STV33AJ.IS6;0-;QQ2W&?*0C;A3C)P.A8G%1W_ (;G
MEM+A[?4)Y-3DMFLX;RY*AK>-R-Y0(H&[@'IDE5Y KHJ* (+*TBL+&"SAW>5!
M&L:;VW,0!CDGJ?>IZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'UW5I+%["PM-IO
M]1G\F#<,A %+/(1W"J#QW)4=ZFO_ !!I.E,RWU_#!LVF0N>(PW"EST0'L6P*
MQ?$$;1>/?"5Z_%OF[M2QZ"22-67\_+8?C7,ZQ@^(?%NEB#4Y],U%8OMC6ED;
MDAS$$=496^0[%3A@3SD#&,@':3^(8H=2TJ2*XM[G2=3<VT4\+!@LX#%?F!P5
M8*R^S*/7C>KA-=O;/Q!H_A%M'<R0W6K6LL'!!$<1+N2#R,*A!SWXKNZ "BBB
M@ HHHH XGQ1J7B71(+:YBOK,+=:K#9I$UKNV122[ =VX9;&#706]Q=:7%</K
M=_;R1F55MY%C\LL"H^7;DY;=G ')K%^(4-S=6&D16EI<W+QZM:W+B&)GVQQR
M!F)P.P[=3VJ3Q/;WAUSPSKEO;SW%G83RFY@C0F0+)$460)U)4GD 9PQXH Z&
MPU.RU-)&L[E)?*?RY5'#1M_=93RI]C4&I>(=(T=PFHZC;VQ(!_>/C:"< G^Z
M,\9.!61HFG3-XVUO7UBD@L[RWMX$21"C2O'NS(5.".&"C(!.#VQG&\6C6]0E
M\3Z6-/OFMY=-*6/V6%-ER3&V[S)#R"&. N1QV.: .NO/$>BZ?=-;7>IVL4ZQ
M><8VD&[9D#./JP^N:C3Q9X?DTM-236+-K-Y/)642C!?.-G^]DCCK7'/>+IOC
M3PE)<6%Y,R:%/&R16S/)$VZ $E?O8ZC('?TJKXLT=[#PCXKU6:U*+JFI6<ZV
M2@$A5DA3D=-[D$D9[C/>@#O;/Q1H5_=W%K:ZM:2SVZ&25!*,J@ZM[K[CBDL_
M%6@:A.8;/6+*>00/<$1S XB5MK.3T #<9K(>U.N^)]&UY+*YM+?2HK@L9X"D
MLA=0NP)]X@<D^X7&><<[:>'-0O/A#>Z5;Z>]MJYEGD$<\?EF0-<F79N(QAT5
M1UQT!Z4 =_;Z]I=U.T$-XC3"+SA&059H_P"^H(^9?<9%1Q^)=%ETS^TX]2MW
ML?,\L7"ME-V<8S]>/KQ6'=P3>(_$_AG4K:TN[5=->::X>Y@:)E#QE/*&X#<2
M2"<9&%Z],PZ5H5[9>)]0TIK8_P!@?:QJT$G\/F-R8<>TH,H].* .FN==TNTF
M\JXO8HVW*C%C\J,V-H9NBDY& 2,YIGB37(/#?AR_UBX572TA:41EPGF$#(4$
M]STKA;;0YQ)XCT+78-9EM=1U":XB-I$KPW$4A! +[<HPQ@[F7H,&NN\;6%SJ
M/@/7+"RB::YFL98XHP>78J0!SWH R;SQ>J>(?#TT.JVG]C7L%RUSL9'57C12
M!O'?+8Q["NEM-?TB^TQM2M=1MI;)&*M,L@VJP.-I]#DC@\\UR]PTVH^+/!U\
M-*OT@MHKD2F:V8&%G153=Z9(/TZG -86KZ'K+7.M2V=E=@0^([?5!'"H#7$*
MQ(K&,M\I8,"V#U*T >EV.IV6HF9;6=7>!@LL9!5XR1D!E.",CD9'-<_J'B2*
M3QM#X;BU:"PECBCN7):,O.6<@0@-T)"DG'S?,N,=[/AZSM7U&]U>--4^TW,4
M44LM_%Y18)N*@)M7IN/.._!-43!=2?$N_G6"YBMYM'CM8[KR6V"422,1G&.
MP.>G;.: -[_A(-)^UQVQOHA))(88R3A7D'5 WW2W!^4'/'2H9O%?A^WOC92Z
MQ9+="9+<P^<"PD;.U,>IP>*XA='U&_\ AC9>#Y+"YM]7MW@A:4Q-Y2&.56,Z
MRXVD%5+#!W9.,=:WM)M"/B'XEN[C3YA#<1VBV\\ENVUS$&W8..S;<>O&,XH
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MPW/>@#MK36]-OKH6UM>1R3&/S47D;TZ;US]Y>1R,CD5S7BGQ;'9WVB6NEZK
M)[C5(+::(*&\R-G <*3QD=\<C-4H-,DU_3HV,6MVVLVVGSP0&\B$4=K))'L.
M&50'&0,$%N@/%497U.\\+^%K >&]1MIM*O[$WBM"-L:Q'#-'@G>.,_+V]^"
M>@IK6ER37L2:C:L]B ;H"4?N,YQO_N_=/7TJ!_$VA16EK=R:O9);W?\ Q[R-
M,H$ONO/(XZU@1/=Z3\0=;N&TJ]N(=2M;7[-+#%E"T8D#*[?P'YAUKG;/3+V/
MP'X$L+G2KPSZ?J$$MW";9CY2HKY8\<X++TSGMT- 'H*>)=&DL(;V+4(I;>=&
MDB>++[D4X9@ ,[0>IZ"GSZ_I5O!%,][$T<T7G1M%F3='_?\ ES\O(^;ISUKD
M[ZRO=+^(-QJ?EZDNEWUC%$DNG0+*89$=V*NFUF ;?NR!USFJMQX=BTS[*FB2
M:_I%S;:>([:6&#[2DP+NWE2J59<@G/)7A^HQ0!Z!+?6T.GM?/,@M5C\TR[AM
MVXSG/3&*YOPKXGM]6T(:]<:S;O%=K$PM4*'[([#(BROS,QR.#SD< 9Q6K!]M
MA\(0C4(%%^+)5GBMD)42[ "J =L],5Q6GZ=JEIX=\ W;6%TPT,"._L_*/F+F
M Q;U7^/86S\N<@G&: .Y7Q%HYLKF[;4K>."U;;<-*_E^2>N'#8*GV-/TW7-+
MUAYTTV_@NFMRHE\I]VPL,@'WQ7&:QI5W>7'C#6+6TN1#?Z*+""#R6$ES,%D^
M;81D ;U4%@._;D];X9@C@\.Z<@M3;R):Q1.C1%&!5<8((['- $JZ]I#1WDJZ
MG:&.R;;=/YR[83Z,<X!HDUW3([6VN#=H\5S'YT!C!<R)@'< H)*X(YZ#(KD)
MEO[#7?&EN-(OISJB))9RQ19BDQ;+&07Z*0RG@\GMFJEOI4QT;PV3)KFCZK8Z
M/';BYM+4RC<%4/%)&48$ H"#QGL: .ZFUW2X+:&X>]C,4T7GQLF7W1X!WX&3
MMY'S=.:M"\M6LA>BYB-J4\P3AQL*8SNW=,8[UYOIEGXATKQ"FH:W'?HM]I=M
M"\FE6ZR+!+'OS&R!6*@[\Y4;<Y]J[WP_IEKH^@66GV4,T-M!'MCCF;+J.N#^
M= "?\)%HWV*UO/[4M/LUVXCMI/-&)F)V@)_>.>.*AO/%OAZP>YCN=8LXWMB%
MG3S03&3G 8#IT/Y5Y];VVJIX T;0CH6HB[TW4[=[DF'Y B7.\LA_C&T9^7/^
M/5Z-;R'XA>)+N6QG6WNK:UCAFD@95DV!]XR1_M+UZ]LT =')JMA%8Q7K7D/V
M:4 Q2JX(D!&1MQ][(Z8ZUSGA7Q*=5U'Q,TVI0W&G:?<HD$VU45$,2NVX^S$@
MYZ8KE_#UIK&A67@V^N=(OYX+"QGLKJVCB)EMI'*%9 G5AA=N1G -/U71M;U>
MR\<QVVG7%M<WUU:75K&X"B=(TAW+NY4,=A&">IYXS0!Z"GB'2&6X)U"",6Z"
M2;SF\O8AZ.=V/E/9NAI=,\0:1K,LL6FZC;W;Q)')((7#;5<90G'J.:YJ.W@O
MDO-8^S:[)J TV2U O;;RR Y!\L*JC<=P'(! YYK5\#6?V'P7HUO)9M:W4%C#
M!.CQ%&#JHW Y'/S%N>G)H @F\76D^OZOX>@N[>WO;2WC>*1ID9I'8.2JH>I4
M(,_[W:HO"'C*QU30]#BU#5;4ZS>V<<KP[@I=R@8@ <9YSCKBH=MUI_CCQ'-)
MIUY);W]A;"">&(NA,8E#*2.ARR\>]8UOI5[#\//!%M_9ERMQIM]9O=0B [XM
MF?,;&,GJ>1G.>] '96.M123ZQ)/JNFRVEI* # W-NNT9$I)(W9STQQBM"RU.
MSU$RK;3;GA($B,I1DR,C*L 1FN%ET\W=SXU2]T[4_LE_>6KQ/;Q.DC*J1(9$
M.,Y1E+8QD[>A%;GA*#5X+W4EOKVXOK "(6=S>6H@N&/S;U8!5+*,K@E1R6H
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M#L&8 98#&3ZXIU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M89A&P/EN "5/H<$<59H **** "BBDR..1ST]Z %HHHH **** "BBB@ HHHH
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MW(3Z9XS^-<=:^+[Z6PU ?;KBVUBWTN2[>PU/3C$4= "3'@*&CZC[S$9!R:]
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M\C=$4#))^@K@[+7M3M_$VCDW>H76G:G87$Y6[BA7<8U1E>)4^9<AC\K>H[T
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M\P@  X+8!   (Z <53O?%=G;+HDL$4EW:ZQ<)!;W,)78"RE@3DYP0I/ -;U
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MF'9L4C. ,\$#GKFYX3TZ?4=5UNYGUO5F&GZQ<V\$/VMB@0Q*,,#G=C=D9Z$
MCOGK8O#^C0:B^HQ:591WKMN:X6!0Y;N=V,Y]Z?;Z+I5HLZVVF64*W&?.$4"K
MYF>N[ Y_&@#R_P .7$VE^ /!RQ7ETMKJE^EO=RF8_NTS(0JG^#<P521CKZD5
MT%X;RP\4ZWI=M>7ATQM#-Z<W#LUM.'95VN3N4, 3C./E/J:Z]-#TB+3I-.CT
MNR2QD^_;);J(V^J@8-.31]-CM);1;"V^SS?ZV(Q K)_O ]>@Z^E 'FEU;WMI
M\'TU\:_K#:A=6%A(TK7C81B5!*CMD.0?7 )YYK9;2B/B))HG]K:N=/NM*-W+
M#_:$N?-64+N5]VY!AN54@<#CM77MH.COIZZ>^DV+62D,ML;9#&".A"XQ3TT;
M2X[U+U--LUNT01I.L"AU4# 4-C(&.U &+\/;RZOO!5G)>7,ES.DMQ 9I3EW$
M<SHI8]SA1SWKGEO]7TO6;>;4K2YO(KB_F6SU"RU!C')N\SRXI(#@  8&0",K
MGU)] L["ST^-H[*T@MD9B[+#&$!8]20!U]Z@MM$TJSN?M%MIUK#-N9M\<2J0
M6^\1@<$YY]: .$\*/K_B'0O#VNQWT,<S3K)?2-?R,)5)(DB,.S8I!. ,_*5'
M/7-KPMI4NK7VMS76MZPZ66KW5M#"M\X41^6HP><G&[(YX(&.^>OA\/Z-;ZB^
MH0Z591WKL6:X2!0Y8]3NQG/O4MEI.FZ:TC6&GVMJTIW2&"%4+GU.!S0!P_A>
M2\U&.W\/7M]>MJ.BWDHU&;[5('F1?]42=V<2!T;!XPKBJ=QK]_HVA>+9TOKA
MDMM?CMO/ED,IM;=A '(W9P '8CL"<UZ7':V\5Q-<1P1I-/M\V14 :3:,#<>^
M!TS5:'1=*MEN%@TRRB6YSYX2!5$N>N[ ^;\: .-\6B3PQ:VEYI=]=>1J6H6M
MM<FXOY6CCC)8EP[%C'N^52P[$8YYJ2]TSQ-:Q:F+2_MHEN7MFM;-[^60[@Y,
MJ"4J&02*,#&<')&,UU%MX;T.TLYK.WT>PBMIQMEA2W0)(.P88P1[&B/PWH<-
MBUE'H]BEJS*YB6W4*6'0XQU'8]J ,KP;?23OJUG<V%[8W=M<)YUO<7?VE$W1
MJ1Y<F3\I SCC!/3FL:]EU"Q\;:OH4%_=B76;2.337DF=UMN66<J"<#: ''N0
M.]=W:65K8Q&*TMXH(R=Q6-0H)[D^I]Z<UM ]U'=-#&;B-&1)2HW*K8+ 'J =
MJY^@H XKPG>7/B?[)->3W45QI=N]GJ$<=PZ*]V&V-D @9 0M])5/:N=E>;4O
MAKH3W>H74C?\))'&TKS$L5%^RC+'G@ 8],"O5DL[:-9U2WB59V+S ( )&(P2
MWJ2 !S5/_A'M%_LZ73AI%@+&4[I+86R"-SG.2N,$YYH Y*328;[XGW-C)>7H
MB70( QBNGCD?]_+@F12&_(\]ZU_A]>75[X-MGO+F2ZFBGN(/.E.7=8YW12Q[
MG:HY[UM0:+I5K=K=6^F64-RJ"-9HX%5PH& N0,XQVJ:SL+/3T=+*T@MD=B[+
M#&$#,>I.!R3ZT >>V<=^;CQ?J46J:I/+HM[,;*S-RS1L1:HP1E/WAN;@'H1Q
MU-3^'QK.H:=X>U^+4H(X7M_,O96OY)A<AHB3^[*!597P<#&,$=*[>TTG3;":
M6:ST^TMI93F1X851G/N0.:@MO#NB6=S+<VVD6$,\N=\D=NBEL]<D#OW]: .,
MT&34[?4[+2]?MKU+NZL956_M=3>6"[*A"TA7(:)NXP,#<0#VK(M(]0E^&'A_
MQ!9ZWJDWB!_LPBS>NZ7#-( T;QYVL,%LDC(P23Q7I<6D:?I5O*^FZ7!'((RB
MI;QHA([*"< #VR!6'\/O"\/A[PQI\=QH]K9ZM' (KF6-(]TA'4[UZ@\=?2@#
M"2;7O$TOBN"WNH[6_L;]X+61K^2'[*BJIC8Q*A#*W+$L3NR1T%:-F7\4ZUXE
MTK4[ZZM[C3Y(H[=+2YD@,:-$K"4;""V7+=<@;0/7/4W7A_1KZ^6^N]*LI[M0
M )I8%9\#H,D9HOM T?4[J.YO]*LKJXC7:DLT"NP'IDCI[4 <OX=LD'Q+\5RF
M\N6>/[)A#+\K PMU'?':E\56:W7Q"\)*]W<0AH[W'E2[,$1J>".<\\^PKK?[
M*T[^TQJ?V"U^WA/+%UY2^;M_N[L9Q[47VE:=J?D_;[&VN_(?S(O/B5_+;^\N
M1P?>@#@OM=SJWA'Q7JMQJ-W::IIUS>+$8[AD%MY.3$-@.T@J%)R#NW'VKK!+
M=W_@99KT/;7DVG!YU3Y2CF/+ >F#D5=ET72Y[TWLNG6KW1V[I6B!9MOW<GOC
MMZ5?(!&",B@#R.WLD3P#\-T2\N,SWMB2WF[C&3;29"Y^[W^E3:YJFI>$U\9V
M^F7UY+%:VUC<0?:KAYVM_-D=)6#/N; 5=W.0",XKT"/PMX>BBCBCT+3%CCD,
MJ(+2,!7/5@,<'WJXVF6#W4ET]C;-<RQ^5),8E+NG]TG&2.3Q0!@Z/I^JP^(%
MO?M,*Z7-9D&W%_+=;Y-RE9%+J,#:2#@\Y%4/%%M/>^.]!TU-5U&SMKVSO//2
MUN6CW;!'M(Q]TC<>1S74:=H>DZ/O_LS3+.SW\-]GA5,CTX'3VI\VDZ;<WL=[
M/I]I+=Q?ZN=X5:1/HQ&10!Y_ =<UVY\4Z5!=^5=Z=,+:SEEU&2%X%$2F.5D5
M"'W,2Q+'GD=!3M<N]:TRYO=1U"*;4=-A$&^?3+]H9+-@B%QY7 D!8[NN2&P1
M7<WN@:-J-XEW>Z597-R@VK+- KL!Z9(SCVIS:)I3WK7K:;:FY9E=I3"NYF7
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MEV4MM&VY(9(%9%;.<@$8!SSFG7&C:7=R"2YTVSF<0F -) K$1GJF2/NGTZ4
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MT_4Q&+^PM;L1-NC\^%9-A]1D<&@#SKQMK+MI^OZEI=W>0W&CW,<(G:_:)%E
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"V7(R,XSC/4\U;U;QS;V=Q<V^F:==ZQ/9VZW5VMH4 @B8%E)+L,L0"0HR<4
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M]5E$-G=G;M=B"4RN=P#!3@X],XS0!TE%5-2U*UTC3IK^]E\NWB +-@D\G
MY))(  ZDUQM_>W4_Q/\ #"RZ??62-%=\R3*T<H$8Q\JN0&&3U'?J>P!WM%<T
M_C2R6V@OQ;SMI4UV+-;T;=N\OY8.,YV;_EW8]\8YJ9O$_FRDZ?IEW?VL=U]D
MFN(2@5'#A&P&8%@K'!('8XSB@#?HKCM.\3V%EI^K7DAU/*ZP;1HKV5&99G*
M(A#;5CRPQD\<U+K^M^7I*27]EJ]DJ:C;P;[25 6+.FT[MWS1L7"G SPPQ0!U
ME%8EQXB475_;V%A<7\FGA?M(A*C:Q7<$7<1N?:0<=.1SFJ \>6%Q)I"Z?8WU
M\-6MY+BS>%4"N$ W*=S#:1N .[ ]Z .JHK(\/Z_%K]K<NMK<6D]I<-:W-O<!
M=T<B@$C*D@C#*00>AI]WK:0:JNE6T$EU?F#[0T2,%"1YV@L2>,G( YZ'L,T
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MW6HQ)_RW1^'3_@$99\?[2GM76WNM65C96UT\AD6Z=([98N3,[\J%[<CG)P
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M3M*L0&!(&#CJ*Q_"OC6:\\(:3?:K;7!O]0<10JJ(HN7;<?D ;@*JDDMC@=Z
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M.&YV@!?FW9Q@C&20* .HHKG(O&5@PGBEAGBOX;T6)L\*9'F*[U"G.""GS9)
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MT\5TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*#@DX/'K0!YKJNI7VN_"O5KK5K-Y&AU,^1-)Y9(VWH0*H7H0HVY[\\G-=O\
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MHLB2"-O-C!(8X!#*X .,_-T&,UM3^, FH3::EM;QZA;VZSSPW=XL2KN+!%#
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M8NT<NP(SQ-N &0HX8'!'?I6EX4T:;P[X8T_1YKA+@V<0A65$*;@!P2"3S^-
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M":U#,T[1N5!;*\1D;C@,.<=1FI9-<\0W7B?6-$TZVTU#9003QS7#N0PD+\$
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M:RO+>Y6)_+D,,@<(V =IQT."./>N=L/%LFMC2+;388X;S4-+74V:?+I!&=H
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M7_",WF@)JERMI<WANRY56D4F7S<;CU&X#D\XK5@\/O%XJ?7GOG>9[-+-XO+
M0HK%@1W!W,?Y5MT4 >;:YH*:59:/X=.J26^GSZA-=M>SQQM&C;FD$3AAM;<S
MDC./N=SBMSPI+JBZOJ%E)J,6IZ1!#%]GNH[=(@LA+;XQL^5@ $.1TW8KK2 1
M@C(HH YZ?PP[>)+G5[35KFT^V0QPW<$:(1($W;2&(RIPQ&1^AYKD?$>CQ>&]
M#\%:!!K+0FWU>)8+EPF]5$4O)!X/)QT[UZ?2%0>H!^HH P+GPC8ZE8W\&KN]
M]-?VXMIYV 0^6"2 @'"X))]<]2<"G1>'97N+"XU'46O9M/#?96:(+ARNWS'
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M!5$DB>H;:BY[F//>NKHZ44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6DEU:-I<;Q0^1)C>CE2ZOD'()4$G@Y[T 1>.;ZXTW0H;J"*SE O;:-X[J'S
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **ANOM/V=OL@B\_@+YQ.T<\DXY/&>._J.M<SX;UG6]:\
M&2WP%J^J&ZN((SL*Q#9.T88KNS@!<D9R<=: .LHKD=&U+7K7QG-X>UBZM=0C
M:P^VQ7<%N8&3]YL*,NYASG(.>QK8\1ZM)I&D336T:RWI1_(C?[I8*6);_9 !
M)^F.I% &M167X9OY]4\*Z/J%T5-Q=64,\NT8&YD#' [#)K4H **** "BN/\
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MF\A6VMY9E_YY[\;=_!&W.<\8JM_PF/AXWXL5U2![LRM"(8\LQ<+N*X ZXYH
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M4\<:7IUSH"BXMFM=89F6X>8($B$;.'P>H) ';K0!T]%5[F^M;.V^T7$Z1Q'
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M4QJ3 1B0L1M!SUYZ'VSZ[7/Z5X2MM)\2:IKD-]>R7.IE#=)*8RC; 0F $!&
M<<'ZYH \YNO ^M>%(O!$UK'>ZC!H\,\%ZNG.!,IEY+1ANHR2/7 '3/%G7_"S
M#PEHMGH'A[5 @UV/4KB&Y*M)M4G>S98@9R,+^@KUVB@#R^]T&^D\;>-;R;0[
MFYT_5-(C@B\ME7SV$>&3.<ANP)[BJ&G:3XNT2+6O[!DU/4-.CTKR[*'7(U\T
M3[A\BYP2H0'@X4D@<UZ_10!Y7X4TK7F^(4NM:EIVI1I>:&MNUQ>&+=Y^X,0P
MC.%'' QZ=#6&/#_B*3]G^7PD?#U\NJQ2B)4)CVR?Z1YI93N^Z%[G&3TS7N%%
M 'G$]GJ6G?%*U\5MIE[<:;<Z-]B=8H]\MM('#X9 <X.,9&>3S7*GP7KUGX"T
MBQ.D3S7+^(QJLMM&5;[/ "?E)SC.,<#/4U[C10!P>C:5?VWQ?\0:M)I\T=A?
M65ND5Q@;695&X'G(/;IVK!^(5EXNUVY\2Z/#I=W-ILMG#_9YMO*6.5^"_FLQ
MW$@_=4<<9([UZU10!YG)IFIR^/? ]^-'N_LFG6,D-S*RK^Z=XPH[Y.#U(KGI
MO!OB*;X?^+M,M],DBNY?$#ZC;P.5"W,.]2%!SC^$G!QT'K7MM% 'F=F-<U?X
MHZ-XCN/#E]I]B-,DM7\YD+(Y<GY@#P/3\R!4WQ.T;4-6UGPE-::3-J-K8ZA]
MHNT15($8VY&&(!S@\5Z-10!Q*%CINL6%AX-G@M;I546\ZI&DTD@*.2%8A8PJ
MH6(YY. 37-Z'H>J^$O 7C'PWJ%H9+:"TN9+34U "W,9A("L,DAEP!SV&!P*]
M:JEK&F1ZSH]WILLTT,5U$T,CP[0VQAA@-P(&1D=._% 'E7AO2;CQAX0\!6R:
M=<6<.CRP7LMY.JJ) BG"Q8)+;S@YXP!SS@5%:^$[J/5?$6A^(=&UR_T_4-5>
M_MI;&51!*&8$;SN!5A@=^WL,^JZ!HL/A[1;;2K:XGFM[9!'$9RI94 P%RJC.
M/?GWK2H \T.CZE)\1O%M^VD7!L[W21:6\S*NV1U7!'7.#VSUK$L?"EU_PA7A
M*SU&RU_3=0TR*Y O-,P9;>1F7"E1G<CJ3R/[N.,FO9J* /%9-!\96C^$-=U2
MWO[V6SCN8;Z/3RBW,:R,2CX'!;&-V/3KWK4OO!VG#2='2QTWQ-I:Q3W-S'=6
MK[KJWE?:#N4%OE<9X'3 SC)KU:B@#A/"EUXMTK2M!T_5]*EOI;J6?[7>;T1K
M5,ED,BCAF;/.#UZDFNB\6QS7'A#5[:VMY)[BXLYH8HXQDL[(0/IR>M;-% '#
M:I97]U\&I-)BT^X.HOI2V8MBH#>9Y84CKC&>^<5+K&GWEYK?A.YMK2>.*"*Y
MBFD5,&WWQ!%R.OWL=/2NTHH \X\(Z#)'I.BZ/KFEZM]KTB1&5O-!M@\>0LJL
M",@@_=Z\X(K5\;6MW>:MX9-OI]Q=0V>HBYN3&@*K'Y<B'J>>6' KLJ* .9\7
M:7GP#K6F:3IX\VZLY88;>WC"@NZD#C@#D]:SKB36Y-4LK;^SK[^S'TQ5_P!'
MV(QN,D,LK$[E4#!&WKD]>!7;T4 >8^'])U.T'P]CN-*NE.EVLT5XQ0$0LT81
M>_/(/(S@5T_AJRNK+Q+XJ>>UDBAN[Y)X)"/ED7R(T)'_  )373T4 <K%8W.M
M>)KZ]NAJ-A';(+:SVD)O0X:1^_WFP,>D8/>N7M_#NLKX/\6>#K2UN([4M(VD
M7$^%62-\,T1YR/FW+DXR&KU*B@#@KRXU76=8\)WW_".W]G#8WCO=K+LS&6@=
M!M"L=R@MU^F,\XK7>G:A-:?$5%TJY+:JI6R&P?OO]&6(=^/G!ZX]:]&HH X?
M[#>C6?!%X-/G$5E:SPW.$YA+1HH!'IE>WIFL2YTO59O!6MV T>[:XN?$!O(H
MB@^>$W:R[NN/NJ>#SVKU.B@#E+J"YC^(UGJXLKA[+^QY8&E1,D.98W52.N<*
MU<WI.@S?\(=X:L]2M-:TZ]L5FQ=6',MLY/0@!@RLK'L1\M>GT4 >=K9>(K>3
MPE?ZC:3ZA+97EWY[0I&LOER*ZQ.Z@A=Q!7=CH2:UM$L[A/'?BB[GTZ5(+O[+
M]GFD0;9/+0@\]L-TS]17744 >86UKXAU"?PK>:GI=^MW9:BSWN=BQ0@Q2K^Z
M13R@++\W7W/.'7>@ZU=Z%XMTF#3YDN9=6.H6SNRB*Y0/&X0-G.6"$<C [UZ;
M10!R%U;3Z]XJ\/:Q'9W5K#I27$DYGB*.3)'L$0'\7/)(R/E&"<T_X?6,]AX>
M>"\L)+6Y%Y=2D2( 2LDSNI!'7Y2OY5UE% 'GVMZ1J)UO4KS09-5L=3FGBS$4
M62RO %0;W# A<*-IP0WR< G%3V>G7KS>/-^G3(-28M:ET \Y1;+'C_OH'@^M
M=U10!YWIRZ_##H6G3Z9?K8IHL4,@M]B-]I4;621R=RH  05ZY/7@55T/2]4L
M[/X=PS:7=*VE"47OR@^3N@>,=^?F8=,\<UZ=10!ROA.WNX-:\3R7-G/!'=ZB
M+BW>1<"1/)C3/MRAX-9#:1J,.O-<Z))JMG)-JGF7EC<(LEE)%YGSRJ6'REE&
MX;6SN(XZFO0:* /,_#/AV:WTFW\.Z_I^KSR6EZ95ECE'V:7$QD24,&&.Q*GG
M(/!K?\+V<\/B;Q1<7.GRPI>7R3V\LB#$B+#&F<]OF#<'UKK:* .*TKP_?6/B
MG4+ P?\ %/M=#58'R,><WWHL>@D!E]B163:^'IXY?$.BZWI^KW=GJ.H37,;6
ML@\F>*0A@K'(*,O0YQT&#7I=% &#XQT>36_!^HZ?;9^U&+S+8]Q,A#QG_OI5
MKF+CP]K<E_IFM16_EWVKQO::RBO_ *B*0!E(/K$%V#'4MGO7HM% ')ZK9W \
M=^&)K:PE-E90W,<LL:?)%O5 @^GRGITKF]0TS5V\&^-M%31KQ[J]O;J6V90I
M2996RN#N].N<8Q7J%% '':S87=YXF\+WEM:SI!%!=Q2RJF#;F1$5<CKU'Z5B
M+H>IWWPSL_!LUA-!J5NT$#W&W]TJQRJWG+)T.57( ^;)P0.37IE% '"21:G8
M>)O%JIH]W<IJL<3VDT>WRR5@$9#L3\N"/3H>,U3M=/U2RTCX>S-I-W*^DIY-
MY!&%\R,FV:+."0"-QZ@UZ/10!RGC"TU(WWA_5["TDO4TR\:6XM(R-[H\;1EE
M!(!9=V<9YYJKJT=W<Z]X?\1VFEW?V:RFG6[MVB"S,)(U02A,Y.W:!C[V"< U
MVM% 'G.M:'?WEOXYU*ULIR=9TY+*UMMNUY76-UWL#]WEP!G!PO/:K[VEW)XL
M\(7:Z9<""SLKB*XD,>!"SK&%!_[X;ITKMZ* /)]>M+K3O 'BJ.ZL)1YGB%+F
M*,@?OHWO(BI7G'.#UQUYK?UW1+OQG<07D-O/IAMK&\@C>Z4)(TDT?E@8!.%7
MDD^H&,]:Z/Q'H,7B32CIT]U<6\)ECE9H-NXE'#K]X'C<HK40%4568L0,%CU/
MOQ0!P?AG3MUKHHU;2-9CU#1XN!*X:&)UC*$H5;YP1D #/49 K.AT35/^%10:
M9_94ZZA#?QS-;D -@7@E+#G!^3GK[5Z?10!YYJ>E:@^LWM]H+ZM8:C/=1.]O
M(@>RN@ @,CA@0IVC!P0WRC )Q5/7K3Q%J]GJ5M<:7?/+#K$,MNL118/LR3HP
M9<'+N5!)W=#GIP*]/HH Y&P2\T_Q[K]U+IMV]I?06SPW$:@K^[1@RD9R&R1@
M8[USFAZ-K.FZ-X(O9M.N-VC>?#?68 ,BB12HD49^;;QTR<,<>E>HT4 >8^)_
M#^HZE:>,M0L["=CJ]G;VEM;;=KRM'NS(P/W1\V!NP?E]Q71ZE:W,_C3PKJ4-
ME,;6""[CF<)@Q;UC"AAUZJ?IBNKHH Y36(+M_B#X=O(K.>2TM8+J.>9%RJ&3
MR]ON?NGITK&ATO4K7PIXE\,W&G3W-U>S7AM9PN8IUG+,K,_1"I;!!P?EXSQ7
MHE% '#6&C75CXXTOS[2:YM;30!ISWA3*M+O0_7D*<GIVK2\6Z;%J,NG>8-4A
M:%W>*^TPGS;=\ 8*@'*L"P/!'%=/10!Y=%I'B:SUG2-9U,7][%'!=6DK6:HE
MQ&CS!XY'1>"651N"\YQ[U?U31!#;^'QINCWYC37?[3NEEP[KE9-TAY/)9@=H
MY]A7H5% ')^+M,OA/I.NZ':"?4=.N"OD9"^=#+\LBD^QVO\ \ JMXDTFXM]-
M\-VEE:SWAM=5@NKF2-><*2TDA]RS$X')R:[6B@#B=+6_T37O$5K?Z1=7MIJ=
MY]KM[F%%D5U:-$,3@D;=NS'/!!ZUDV7AV:-M>T/7-/U>[M;[4)KF-[60>3/%
M(^\!CN!1AT.<=!@FO3** //;G1]0CUN:ZT.35;*[EU%'N+.91)93('4-+EA\
MI*+GY6!W8X[UZ%110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?-B_>E83&<_/QR<\XX]^* .@M/%FBWNJ1:=;W;-<3QF2 F%UCG4#),<A&U\
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M%1:KXON;76_#EM%I]VL5^]Q]I@:WW2J(T;"@@E<[ADX)X&>AH [!%*HJEBQ
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M0<C<, 'AOO=".-F#6K6RA;3M-T_4+MK"",S0QD,\(9<JC&1P6?'.,D],]1D
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M\JR!@@"G@-(2,GH,5KR:5J@\?MK<<=JUD-,-FJF=A(7W[\XV8 [=??VKI:*
M//[?PAKD7@C2])?[!]ML=6COB1.WENBW!FQG9D'!QTJ+7O!_B#68-?MI5TVX
M-Y.LME=7,[EH(QL_=!-A"8VM\P/.>1Z>BT4 <WIFE:I!XVU76+F.U6TO;6WA
M58YF9U,9<G(* 8._U[5SNE^#O$.BVWAR[M_L$M_I*W-O-;F=A'<0RL&RK[,J
MP('&,'UKT:B@#B-6\-ZG>^);#Q&=-TRZF2T>SN;"XF+*$+[U='*?>!SD%<8/
M6NJTFS6QT](EL;2R)9F:"T_U8).2<[5R3U)P.:NT4 <O;Z1JFC>)]9U"QB@N
M[75C',4DF,;0S(@3^Z<H0%/J"#P:R[+P9J.COX2BLFM9X-'DN)KEI)&C:1YE
M<-L4*> TA/)Z<5WE% #7+"-BBAG .T$X!/U[5P$/A'78? UAIF+!M0L-574$
M43MY<H%R9MI;9E3@XS@\BO0:* .$\0^$+KQ!<W-Q)IUI:ZFR(MIJMK>.DMO\
MHSNVJI?:VX@'@C .VNVEA$UJ\$C,0Z%&;H>1BI:* /-SX4\5MX'@\+'^RFCL
M)+?R+OSW!N(HI590R;/D;:HR<MR.G.1O7>EZW#XV37+&WLIHI].2RGCFN&C,
M3+(SAAA#N'SD8XZ"NJHH \]A\(:];^"K#3<V$NH6&K#4%_>LL<RBX:7;G:2A
MPV.AZ5?U#PQJ>L^(K^XNUM8;&^T0Z9)Y4[-(C,6)8 H 1\V.HZ9]J[.B@#BO
M#WAR_P!.T^UMKK0M!6\LH#'%J$39+L$*JX4QY4G^+GN>M+X?\'G2M?@U&TLH
MM'@$#K=6EK=,\-Q(VW!"8"J%PQ! !.>E=I10!SOC+2-0UO2(+33A;^8EY;W#
M&>0H-L4JR8&%/)VXK-\2>$+SQ#K5U(SP165YHDNFR,')DCD9PP8#;A@,>HKM
M** .2\.Z+>6$=L;WP]H<5Y:1%%N[:3F1MN,K^[!0-WY..G-9B>!]3NOA@?#-
MY)9Q7L4OG0RHS21,PF,JA@5!QT!KT"B@#EK309+C3[V.XT+2=+N;BS>V\ZT?
MS&.X8(SL4[<X.,_AQ63;^'O%$MEX3@N8-+B_L*>-I ET[>>JPM%N!\L;?O9P
M<]>HQSW]% '&VWAS5Q9>,8)Q9J=:DEDMBDS-M+0+$ _R#'W<Y&>M5['P[XBT
M75-/U.RCT^X<Z7#IU[;2W+H 8B2LB.$.1\S94J*[JB@#S>;P'K%SH5S;7$FG
M27D>O-K%MN+&&;+$^7(NW*@AB.-W;KBM/4_#=YJ7A'6K&UT31],OM0M3;!HI
ML@@@C+L(P<#/ P>IZ5VM% &61K,=GIJ6\-B)!*BW@DD8A8@#N,9 &6Z8R .M
M:E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 C
M*'4JP!4C!![BO)/#J:5<:?KEE?V^HRRR:]<V4,T<<Q$*--Y:8D VJ%SZ]J]<
MKC=%T#Q#H5GJ$$$VERF[OI[T-()/D:1RV,=\'OQ0!H7_ (LM](UW^R]0M9H%
ME@,MG."&6Z8<-$H'/F<C"]\\4R\\4W5IK%AI)T.X>\O;62XC59DV@IMW*6SQ
MC>,GIZ9XJ#6?"=YK]FL5YJ1CGM(XVT^>'.Z*Y7GSF]3D8QTVEO[W&9K']MCQ
M]X5$3:>VHKIM[Y^\.(G&Z#.W'*YX/.?3GK0!H6_CZU*7$%]8SV6J07L=BUE(
MZDF21=R$.#@H5RV?13QTRV_\?PZ9;:NUQITLEQI;0^?';2JZE)3A'5C@D9R"
M,9!'3O4>L> CJ<+W@NH?[9-_%J'G2P[H2\:>6L93.=FS(ZYR2?:I=8\-:IK'
MA2[TL)I-E-<M%S;HVU0CAB2<#<3C&,#&>IH O6_BE_\ A(&TG4=*N+%VM7N[
M>1G202QH0&SM)VL-R\<]>M067C6WN='.MRP)'HWV-KS[5'.)"BJ =CJ!\KD'
MH">A%3ZCHFH7?B33M9@GMXI+:RGMG0Y.&D*$,IQS@IT(&<]JPKGX;6VJR7$E
MU:6&F/<6,UK<-IF1]H:3'SN-JCY2,@8/)Z\<@&]:^*DDUG3].N;7R'U&%YK5
MEF$F=@!9' ^ZV&SQD<'GBM#5=0N;"-3:V#73E6<DRK$B@8ZL>A.>..QZ5G^'
M=)U+3DBCOXM()ACV&XM("CS8&-Q!X3W&6_"F:UH%_?\ B;3M4MY[-X+>"2%K
M:\B+JC,RGS4 (^<!<<]B>10!47Q];3:3H.H6VEWL\>LSFWB52@,<@#DJV6_Z
M9MSTXZU/;^-;=(]9&KV4VG3Z2(VN(V82AED!\LH5^]D@C'7/%9EGX+U6STGP
M[8BYM'_L?4'O#(2P\X-YGRXQ\O\ K3SST]^+&M>")M9O/$9>\2*#5[>V2-T!
M+P20$LK8Z,-Q!QD=/?@ IZI-=S?$WPB]SI9M ?M>V7SE?>/);Y6 Z$9SW')Y
MK7^(.J7FD>#[BYL4E:9IH(<Q%055Y41N21@D,0".A(/'40'0?$5YK>@ZKJ5[
MIS2Z8TN^&WC=%E$D>PMDY(/?'3MGG(T?%^BW?B#0&TVTEAB9YX93)+G $<JR
M8P.N2F/QH IV>L6FFDZ'I.D);7%M!]JELI)DB6$2.Q"Y4L"S$,<#CU(R*+#Q
MS9:S':#2(A-/<68O?+GD$(C0L5 8X/S%E88 (^4\CC,-[X5O#XI?Q!:)ILTE
MW;1P7EI>(67*$[7C<#(/S$$%>>.E-O?"-V/$<&NV8TN:9K-;2ZM;F B)@K%E
M>,C)0C<1C!!'I0!+9^/+/55TY--A5KF]MWN$ANIQ#@(^QDS@[GW9&!QQG(XS
MT1N))=(%P;2<2/"'-N&"R*2,[<Y !'3K6!J_AJ75H8[:^TS0]0M1!M$4\100
M29.63"L<$%1C(/R]1FM?3-,ET?PU::7#.;F6UME@66=B-Y5<9/4_SH YK2_%
MUM8^&O"QM--U*Y@U4"&V,DRR2 [&8!V9LDD*>>GO6YH7B%M7O=1L+G3Y;&_T
M]D$T3NK@JXW(RLO4$ _3%8-CX-U6RTCPG8?:+-_[!F$C/EAYX$;Q@8Q\O#D]
M^E;VGZ+<V7B[6=6,L3V^HQP*$&0\9B##Z$'=^&.^: '7FNR#4;G3=+LC?7UK
M&DLZ&41(@?.T;B#\QVD@8^I&1FO#XFFOGGAT_2Y);JT@BDNH)91$8GD3>(AP
M<N!C(.!R.:AFT'5;'Q;=Z[H]Q:LFH0QQ7=K=;@-T>0CHRYP<,001SZTMOH6I
MZ7X@U+5+"6TF75$B:YAF+((YD39O0@'(( RIQT^]0!7B\?VUZ-#.FZ9>7:ZQ
M'*UN043:\8.]'RW!!&#V]":9-X_2TT+5-0NM&NX[C2[I;6[M5=&*,VTJP;/S
M*0Z].>>E-LO!5QI5YX:^Q7$+V^D?:&E,F0\[SYWL  0N"20.>N.,9J'6/!>I
MW\/B6"WNK54UF[@N%=]V8?+6,8( YSY?J.M &JGBX0:U-IVK:;-IP6SDO8II
M)$=7BC(#YVD[6&X''/7K3+?QI;R7&D>?;^3:ZNI-I-YH8@A#(!(O\&5!(P3T
MP<4:WX7FUS6;6[GDB6W.FW-A=0ACDB;9DJV.VSN!UJ+P[X9OM+L(--ODTF:W
M@A\C[5# 4FF3;M&1T5L8R03GG@9H N6?B6ZU%;*[L=&GN-+O 6BN5E4.1M9E
M8H<85L  DC[PR!7*67BBZU#X;V.I:Y9:FQDNH0UQ;S1P[RUQM3&Q\A0=JD8Y
M'KUKIO"FC:WX=L+71I[JRNM-LU\N"?:RS&(?<5E^[D<#(/('2L=/!>LIX%B\
M-&]L6%O<QR13['!*1S"4;AS\QP!QP.O/2@#I)M>DDU*^T_3++[9<6"(UR&E$
M8!<;E13@Y8CGG Y'/-947C^VO%T-M/TR\NAK E$/*)L>,,71P6X(*D'M[FK4
M6AZEIOB34=7TYK5UU1(C=6\[LHCEC7:'1@IR"N 5('0'(Z50L_!5QI=WX;-G
M<0O!I+W$LQDRK3R3AMY  (4 L2!SZ>] &UX?\0?VVU_!-8RV-[I\_D7$$CJ^
M"5#J59>""K ]JB;Q/'!XAO\ 2KJV:!;.S%ZT[."KQ$L,J ,\%3D=N.N:?I&B
MW.G>(]>U!Y8G@U.:*9%&0T92)(\'L<[<YJ'6O#']K>)-(U5;CREM%DCN8P/^
M/B,E75"?0/&I^F1WH 2P\6)JMEHEU8V4DJ:H&)4N%:WV@[]X_P!DC:?]H@=\
MUS>H>))[#P%XAU'1H=0ANX=4D@;[3*DS1R&558C<Q4)R0 ,XR.*Z70O#']B:
MQJ]VMQYEO=3M+:P$8^S[\-* ?]IQN_ 5D/X+U*?PMX@TF2[M4FU*_>^AD4,R
MQEI%DV,.,@%0,CKGH* (+VZN(OB9IEY#I%Q]LGT:Z!M6DC#9$T(!9@Q4#'?)
MZ@=>*ZGP[KR>(-/EN/LLMI/;W$EK<6\I!,<J'##(X([@CUJ@FBZM)XNT_7+F
M6RQ;V,EI+'%N&2[(Q9<^FP#!Z]>.E6O#FBW.BR:N)I8I([W4);R,ID%0Y'RD
M'TQU]Z .=EU>_P!4U7QKI-W93O86L2I"Q\H)#^XWY.&W'<2".#CC.*3PIXGE
ML/#G@^SN]*N8[2^M+>UAO3(A!E\G< 4SN .UL']!6I)X<U2/6?$=S;7-FUMK
M$2?)(K!XW6(1=1P1@;NF>WO41\*:A_PC?A;3Q<6WGZ'/;R,WS;9EBC9/3*DY
MSWQ[T 23^.[**S.I)#YFE)>?8WN!*-X;S/*+A.Z!^,YSU(!%=)>W$EK:M+%;
M27,F558H\ DD@=3P ,Y)] :Y30O"%YX>FEM+==*N-.-R\\,L\!^T0J[ERG'#
M8).&R,>AQ6MXLT6[UW28K:SN(HWCNHIVCG4F*=4;)C<#G:?Z=* *=KXXLFMM
M7>_@>TFTJ:.&>-7$H=I,>7L9?O;BP&."#UK*OI;N7XJ>&7N=+-IFVO-L@F5_
M-&U, @="N3ZCYN">:=<^ ;R^BUY);ZV@;4C:S026T)46TL&TKA#U7*CO_/B^
M-"\077B+1-9U&[T]I-/2>.2"W1U5A(%!8$Y.?ESCIV]Z *MQ\1#;V.HZ@^@7
MPL=,O&M;V4R1[H\;06"ACN W<X[>O0:UIXGEF\02Z-=:1<VMR;1KRVW2(WG1
MJP4C@X5@67@G'/6L2Y\&:M=>&/$ND&YLU?6;R2Y64%B(0^W*XQ\V-HYXSGMC
MG;GT;4)/%ECKRM;;H-/EM)("S8+.R-D-CIE .G>@#&TOQ;:Z9X1T>ZM].U2>
M"]OVLT6:=994<SNGS,S9/(.,9 &!D5H#Q0]RVLZ9?:1>6MY9V@N#%'.A,L+[
M@&1P0 05;KC!'&:S(/!FKP>&]'TK[39,^GZK_:!ERP$@$K2[,8X^^1GGIG'.
M!K7_ (?OYO$FH:K;RV^V[TI;#RY"P*,KR-NR <C]YTXZ4 5].\4VD&D>&[2S
MC)FU+3Q<6RW]UM)153AI""6?YUX .>3QBH[[Q)JT?B_PY91Z;=K!>65Q/<6P
M,.[<OE@#+,/N[CG'7(QGLD7A&Z_X1S2-%U"QT?5;6RLUMGCN@<%E 59%.QB#
M@'(]^M+9^#;[2KCPU)8W\,G]DVTUK-]I1CO20H25YR-NS !)X[\4 7-.\73Z
MGKEQIT&@WH2UO#:W5P[Q[(3Y8<-PQ)SD#C..^,BG0^+6_P"$AL](O-+FM9+Z
M%Y;4M*C,=@!*NH/R-@^XX/-)I.@:C92^(C+<PQ_VM<-<1R0$EH&,:1CJ!G&P
M'/'/:LO1O!>IZ?=^'+B>?3<Z2LD<@@B93<;T"&1F.27.,GWSSSD &8/%5W=_
M#_7;[6K#57MX;NY0RVLT4+K&D[*JJR/N!4* 3CGGK7:SZXQU>72=/MA=7MO
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MAO8RSI*)X@P0[2I^_N91M/\ >'-:/BW1+O7M*@M[*XA@N(+N&[1ID+(3$X<
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M#YFEVUW]DFG$H#AA((RRI_$@8X)R#P2 1C,"^$=03PIX9TH7%L9]$N+>0O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5*72-/GU*+49;.%[V
M(;8YROSH.X!["KM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7'Z)M'Q.\6] %M-/\ PXFKL*R[3P[IMEJT^J013+>W
M  FD:YE;S  0H(+$$#)QQQGB@#EM377_  O#::C9ZQ'>V<VI(CZ?]E4*\=Q/
M_ X^;</,SG)!P>!7>UE67AS3-/DC>"*8^4284EN9)4B.,?(KL0G!(& , X'%
M:M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
-%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>ameh-nonqualifieddeferre016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%4M7U:TT/2;G4[YV2UMUWR,JECC.. /<T 7:*** "BBB@
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M6'I]Y8)X ^&<K7,"R)?6T9;S " $?<#STSMS[XKV$QH65BBDK]TXZ?2C8O\
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M@D=S784C(KXW*&P<C(S@T >*6\U@_ACPS;W-ZO[CQ3+:KF5HV2$2383!.Y5
M"<$\<5J:H)/#6H^-['PRGV:3^RK:[@M;;C:Y,HD>-.S;0#P.H%>K;%_NC\J7
M SG SZT >6W-WX1F\8>"=1T.2Q8R74RRW,)&2#;28$K?WR2.&^;K[UZG31&B
MC"HH!.>!WIU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5#8S_6N>_L;4?#NIZ5J CN;/0SJE]<>7#;^9]C655$3-& =H.)#T^7S.<<T
M>L6]S!=VZW%M/'-"PRLD;AE(]B.*KC6-,,\4 U*S,TK%8X_/7<Y'4 9Y-9GA
M?3[*RL]0GM;JXN8KV[>ZD:>+RUW,JAMB[1\IQGODD\UYS=:;:/\ #WQ"J:4_
MVMM?>:!5M&$A3[4&5D^7.-F3D=LT >O6M_9WK2K:7<%PT+;)!%('*-Z'!X/U
MIMOJ5A=W,MM;7MM-/#_K8HY59D_W@#D?C7&R1II?Q#FO=.TUC%+X?)18(2B3
MR+(2B9 QNVYQGG%8VDR2WGB/P?J,5O+"PL[B"8)I[00VS&--L7S#<<-QR2,C
MC% '5^-?%)\/Z4\EC>:?_:"21 VLYW.R/(J$A0P(QNSGGI70W>H65@%-Y>6]
ML'X7SI53=],FO)+B=KCX5+H]SI%_)K]G/ UXCV;LPE%PI>8/C#;ADY4DD'TS
MC<NC)'XXU\:I<W4&G:K:VZV<JVAFCDB"$/'G:=K;F)VGKNH [[4KB6VTRYGM
M_(,R1,T7VB39&6Q\H9NPSCFHTU.VCM('O;NSAE>$2L!.-N,98J3C*CU]*P=9
MTZ"Q^%5YID8N+N.+27@@$\9:60^453*XSNSCL#FL!+>UNO$?@)Y;%I%ATV9)
MF>V8B-RD017)'!RK8![B@#T6UNK>]MTN+2XBG@?[LD3AU;Z$<5&VI6"WZV#7
MML+QAD6YE7S"/7;G-<UX)MQ8ZGXJM%MFMXCJ[30IY912C1199>,$%@W3OFN4
MU>ZGU18G?3[BVN+'Q)#(UO#8,/+C6X ,SR$'=N3+94C@]" 30!ZK/<P6P4SS
M1Q!F"J9'"Y)Z 9[U4_MW2/LTES_:MC]GC?RWE^T)M5O[I.< ^U<Y\2H(KKP]
M91M:M<M_:5H^U83(0@F0N< ' V@Y]JJ6>EZ9-\4-5_XED1M)]*@3+6W[IY \
MFX9Q@G85S[4 =O<7UI9VINKFZ@@MP ?-ED"ISTY/%-&H61BAE%Y;^7.0(G\P
M8D)Z;3GG\*\ST#4;FP\(>";*XL9HU,4D4]S+923/:LJX5 F,AF!P"01@$8.:
MSX[&-/#NF65SI]PP@\6R2>5+:G,=OY[DL0%P$P03CY>: /6K?5-/N[>2>VO[
M6:&,[7DCF5E4^A(.!1#JNG7%T+:"_M9;@H)!$DRLY0C(; .<$'K7":K96]GX
MJ\4JE@4M;S0(L".W)2:8-,,<#!?!3WZ55CT^"U\-_#F[@TYHKBVNK=;ETMR)
M(@;:19-_&0-V <]\4 >CMJ-BEXMF]Y;K=-]V RJ'/&>%SGI2'4[ 3"$WUL)6
M?RPAE7<7QG;C/7':O,]"T]KS2W\/^(+W4;;4HM5:Y9([,EI'%P9$E278<J1M
M!.>!D' %;/AS2]-G\?\ BJYETU-XNX);2:2W('RP(K-&Q']\$$CKWH [2\U"
MRTZ(2WUY;VL9.T//*$!/IDFEDOK2'R_,NH$\P93=(!N&,Y'KP,US'B&^8>++
M33IK-EM9K*3%VMD;AI&+@&%3@JN0 QW @\=,&N-TBSC;1?AQ!>Z?,[VD\BW*
MS6S$PIY4JJ'XX&XKUXZ4 >M6=]::A!Y]E=07,))'F0R!USZ9'%<Y/XI+>-](
MTBQO-/N;2ZCN/M C.^6)XU4@$AL#.[H1VKD];L+VVN?'-OI.GS@2R6%P(+>(
MK]HC 7SPF."2H((')SCO6I+?66I^/O"FI:?87"VJ07<+W+63Q!2538AW*".<
M]>,\=<T =Y=7=M8V[7%W<16\*_>DE<(H^I/%9VJ>(K'2]/L[TM]H@N[J&VB>
M!E929'"ALYQM&<DUF^+-1DLM3T2'[*3;S2R^9>BT>X-N0GRA54'#-D@$@C@\
M'-<+_9J1^#E2YTRX>&Q\5F9XY;0LT=N;G)8(%^Z5Y.T8H ]?>>&*!IY)42%1
MN:1F 4#USZ56BU?3)X1-%J-I)$7\L.DZE=_]W.>O(X]ZQO%%M9W7A2&!)I]/
MMS+ \$T%O_Q[E75T9HR/N@J,@CIUQ7'ZJFJW'AV_N+^"#45LM7L;F/4+*S9&
MN8U>(R/LRQ)51@E>"![&@#U$7,!N3;":,SA=QB#C<!ZXZXY%4[C5K1IIK"TU
M*Q&J*A98'D#L,#.2@8-C\JXN6:34_'M]=Z/!/$UUX=>&VO'MVC5Y_,)7E@.1
MP>>PJYX3U#2G\-:5!<V4]OJFFVV)8I;60/#*$*R$G;SNRW.?FSW- &KX1\41
M:[X>TBXO+FSCU.^M5N&M8Y &Y&?E0DMBM'6];M]"M[6:Y21Q<W<-H@3'#2.%
M!.2.!G)KS6PTN.V^&W@B9=,>.]L]1LFN"+9A+%A\2%N-P&W.?:NK^(UK#<:1
MI5Q-9&ZAMM6M9IL0&4I$)!O.T G&.N!TH Z!=0E;7'MMUD;);42[Q/\ OM^[
MG*8QLQCYL]34L>KZ9+<1V\>HVCS2*62-9U+, 2"0,Y(!!_(UR-NMC%\39)8K
M(Q6+Z"L9;[*R1Y$A;8?E SLP=IYQ7)VNF6:_#SPNDFDN+F/7$>=#:-YBQ^>V
M\L-N=OEL,YXP: /7[2_L]0B:6RNX+F-6*L\,@< CJ"0>M);:E8WAD%K>V\YB
M_P!8(I5;9]<'BO,O$NE7QO/'5KHEG)'+>Z;9/"L,959RK2>:JG&"Q3 QUY%7
M[BTTC7[2ZU&2_P!6D(TJ:RDCAL3"T<4FW(8;/OJ1D+]>#0!WMGJ=AJ!D%E>V
MUR8\;Q#*K[<],X/%%QJ5A:W,5M<7MM#/,<1122JK/_N@G)_"N7\)OJPUVZBN
MKRUU:S6TCV:G%:^0Y8,V(FP2K8!)^7&,\CD5S7CF>YU2P\8::-.GCGB"-;1P
M6+.]UA$(E,I!7 .0 N"-O7)Q0!Z9<ZGI]E,D-W?6T$LF-B2S*I;)QP">>:KZ
M]K=OX?TO[?<I(\?G10A8\9W2.J+U(XRPS[5P_B#[8FHZQ>Z'?"6YGCA631[V
MR,B7V(QM\MAAE!#8)Y ()..:VOB3:+=^$D>2R-R(+VTF=5B\UE19T+D  DC;
MNS@=,T =/=:E8642RW=[;6\;?=>654!^A)JPCK(BNC!D895E.01ZBN'L)H-+
M\<7US=0F'2;W3K==-E,!2.,*7,D6,#8Q+*V"!N]\5;\&:7J&G>#+NU56MVDN
M+J33XI1@P1,[&)2#TP"#CMG':@#I/[5T[^T?[.^WVOV[&?LWG+YF,9^[G/2E
MCU.PFNVM(KZV>Y7.Z%95+C'7*YS7!: Z7W@.VTA+6>T\4V=E+&@G@=7BN_*9
M#*7QCYBQ.[.#NZYJ(P_VOX6\(6&G6TL&KZ?=VC2QM&4>T$?$V_(X!7</1\C&
M<T =_)K.EQ2+')J5FCM)Y2JTZ@E_[H&>O(X]ZDBU&RGN)[>&\MY)H/\ 71I*
MI:/_ '@#D?C7E=_IUG-X?^)(&EEI[B=S9C[(=TG[B,(8^.?W@/3O6\MI;V_C
M+PA=VMD8XI=.NH)Y$@('(B*K(<>H;&>^: .P.N:0&A4ZK8AIF*1 W"9=@<$+
MSR<^E9?]NW4/CNYTBY>U73H],%ZLA4JRDR%"&8MC'!/0=?:N"TNUTG5O!?B7
M08M,^TZK/?:A'"AM6 W&:3RV$A&T*IP<YXP>_%=/IT,EO\28K>X\V<1^'X[5
M[AHVV22K(2P+8QDCG'O0!UO]K:;Y"3_VA:>2[;%D\Y=K-Z YY-7*\^\*Z9-!
MJ,WA>>W;^S] O6N;:1A\LD<F6@7WV%I,^AC2O0: "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **JZC
MJ=CI%FUWJ-U%:VRD!I96VJN?4]J<+^T:2.(7">9)$9D3/S% 0"V.N 6'YT 6
M**P+CQ%:SW&EC3M8TO9<71B=)GR\P (98@"/F#8SU P:S[KQG;W5QXDTJQN[
M:#4-+CS"QE5VE;RO,;">B]#^/3% '7T5S/ACQ;I^IZ;H]M<ZI:OK-U8Q320A
MP&9S&&; ]><X'05O7E]:Z=;F>\N(X(LXW.V,GT'J?:@"Q17(^*?$K+X,?6_#
MVI02!+B&/S$42*0TR1LIST(W'Z$5:CU*_'Q'ETEYU:P.EBZ2/RP"K^;L^]U(
MP/UH Z2BJ&IZUINC1B34;V&V4@D>8V"0.IQZ#(R>U1S^(M%M3:B?5;-/M2&2
M#,R_O$"EBR\\K@$YZ4 :=%8T'BWP]<:=<W\6LV1M;5ML\IE $1]&ST/UIUOX
MHT*\U-=-M]6M)+UU+)")!N8 9.!WQW Z4 :]%<-9^)-03P_XBGO=6TVWN++5
M);2VN;Y=D(5=N P4@DX+=#G-=9J&KV&E1J]]=1PA@2 >2P'4@#D@?I0!=HK(
MN/%.@VEO!<7&K6D<,\:RQR-*-I1ONMGLI]3Q6/>>)CI/CN6TU'4H(=(.EBZ0
M2*%Q(9-O#=3P#Q[F@#KZ*Y+6O$;M_P (S>Z)J,$UAJ.IQVLC1A9%D0JY.&['
M*8_.MVYUS3+.X\BYO88W#*C;CPC-]T,>BDY& <9SQ0!H454U+5+#1[-KS4KR
M&TMU.#),X49].>_M56W\3:'=ZE+IUOJMI)>1*6>$2C< .I]P.^.E &FX<QL(
MRH?!VEAD ]LBL;PGH4_AO0(M+FO$N_+DD=95A,>=[LY!&X]"Q%2VOBC0;Z\2
MTM-7LKB=U=U2*96)5#ACQV!XS[&I;?7]*N[E;>"^A>5T,D:YQYJ#JR?WQ[KD
M4 :-%9<?B319=/FOX]3MFLX&*2SAQL1AP03V(J&SUF.XUG4H_P"T]-DM+:&.
M3RHV_>P9W;C*<X .!C@=#F@#:HK"O?$E@=+OY+35+&WG@@\Q9+TE(DR#L=LX
M)0D=1U[5<&KVMO8VDEW=PF2>(.OD@GS> 2R*,L5YSWP",T :-%9;>)="2WM;
MAM8L5ANB1 YG4"0CKMYYQ@Y],<T67B/1=1M+FZM-4M98+4XN'$@Q%QGYO3CG
MF@#4HJG9:I9:BTJ6LX=X<>8A4JRYZ9! .#@X/>HK[7=+TUW6\O8H3& TA8\1
M ]"YZ*#ZG H T:*Y3Q-XFAL]4TS1(]7M].FU&.647CLA\M4VX #<$L6XSV5L
M<])_%OB"31'TBV2>"T_M&\^S->7 S' -C-Z@;CMVC)QD]\8(!TE%9%A-=VBW
M<VHZG;7&GJBO#=%5C*CG>'(.T@84@X'4U:M=8T^\-PL%U&6MP#,C?*T8(R"P
M." 0#@]#B@"[17,:SX\T32]%U._ANX;J2P@\XP+)L,@Z+M)Z@G@$9JQ'X@M[
M[6=,AL-8TF6&>*5I(%E$DTA &#&5., [MV1Z4 ;]%9LNOZ3!<BWEOX4D,HAR
M6^7S#T0MT#?[.<U!>>+/#]@]REUK-E&]L0)T,P+1DYP& Y'W3^5 &S14=O<0
MW5O'<6\J30RJ'CDC8,K*>001U%<U;^)KF[^( T6*&(::+":<3'.^21)40X[!
M068>I(/;&0#J:*X8>+]1.AZ7XF MCI5]>1PFW\LAXX9)/+23?NY;)4D8Q@D=
MLEK>-+X>%!XM'V7^S!=^6UJ8SYGD^?Y.[?NQO_BQC'\/7F@#NZ*PO%NJWVDZ
M#*^DP)<:K-F.S@?H[[2QS]%5C^&.]7="U>WU_0;'5K4_N;N%95'=<CE3[@Y!
M^E &A16?J>NZ5HP!U*_@M01N_>/C"^I]![]*CNO$>B6,BQW.K6<4C1><J-,N
MXIQ\P&<XY'/?(H U**HV>M:7J&F?VE::A;2V0SF=9!L7'7)[8[YKG=/\3G4?
MB/+I5IJ$5QIZZ8;AH50!HY1(J\GKC!)'UH ["BL#7?%EAX?U;2+&\E@C&H22
M*999UC$*JC-N.>H) 7MR:R;#QC!8:SXAM]?UBUBM[2\CBM7DVQ_(T*.?J 7Z
MGVH [6BJ=UJUA9I&\]R@$BET"_,64=6 &20,C)Z#-2Q7MI/8K?17,+VC1^8L
MZN"A3&=V[IC'>@">BL>U\5^'[V1DM=9L9BL#7#;)U(6)6VER<X SQFK-OK6F
MW7V@17D6;90\ZN=AC4@D,P."%(!P>AP: +]%9">*M!>Y-L=7LTGVAA'+*$9E
M/1E#8W+P>1D<5(?$>B#3HM1.K6?V*9S'%/YR[)&W;<*<\G((XH TZ*YN'4[\
M?$:[TF2X5K!=+CNXT\L J[2NAYZD87]:T;3Q%HU_=R6MKJ=K+/''YK(L@SL_
MO#U7W'% &G17%P^/;+5O"]QJ%CJFD6%TEPT*B]N ZJ%E* L%(/S*I*CW'6NG
MO=6L=.8+=7*HY4OL +-M'5L#)VCN>E %VBLN7Q)H<"6SRZO8JMTADMR9U_>J
M 267GD8!.?:EM/$6C7^GS7]KJ=K+:P,4EE608C;T;T/(X/J* -.BJECJ5GJ(
ME^RS!S$VR12I5D.,X((!'!!J"?Q#H]MJ,>GSZE;1W<CB-8FD )<\A?\ >/8=
M30!I45BW?B[P[8M<+<ZU8QM;L$F4S F-CGA@.G0_2K\VJ6-O9QW<EW"+>4 Q
MR!P1)D9&W'WLCGB@"W17*>#-?FUZZ\0;KZ*\MK2_$%M)&@4;/*1B#CN&8CGT
MK;U#7=+THL+Z^A@VJ'?<?N*3@,W]U<@\G XH T**S;?Q#HMW<V]M;:M8SSW
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M#&XD$1+-\JN>B%N@8Y& 3GD4 2:582V-O(;FX%S=SOYD\RQ[ S8 &%R=H
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MEKHP6 MNG7/S"FSVO_"1ZSX?U&#3[JRATB629VN+<Q2<Q%/*5>I!W DCCY0
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ME6&#7=)LM4O6&L07U_#<1B.6Y1(S'E(R%Y7*'! R4^E>CT4 <7I\EU>?$O\
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M*W#8'+!>@JII'A_5]%\3S:A';1/:ZVI?4(H65393=F0G&Y2#ANY8;L<XH Z
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M4]*67R6O+62 2?W2RD9_6@""'Q3I4US90^;+&+[_ (]))872.<XSA6(QDCD
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MD26-1$WEMC?N8''7E0QXZ4S3_".H>&-4T74K2/[>(8KJ&]@A95*F>43%XPQ
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MCJX!]B5P?8U0NK#4-?UOP_J5QILU@-*>6XD622-F=VC*"-"K$8^8DDXZ#U.
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MNZ0.BC)82$;<8.<YY'(S7(S>%M5U;5+QVLKJRM[_ $"?3O-NKT3R12NV<O\
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MYJ0\,ZGX?O=,58]2U&Z:65IEE1()'+;@2=S-@X&1G=@GI5*Z\+>(W\-6.EM
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MR EDQG(88(QZ]>,FG-XXMOM8LXM'UB6]-E'??9DMU#^6_'.6 !!!!&>H(&:
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M.JZMIMM<0WUC.+62WNK<EH925X8*2,;6!!!P<CGM0!V]%06US]JM%N%AFCW
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MK=W6G!&GCMX%/RL"0P)8 C"].ISP#SBW%XHTZZL=.N;(RW;:C#Y]I!"H$DB
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M=P%!*LR[&)P><]: .OHKBK[5_MGQ#?1Y[?4)+>PM(+R(6PD0&8N_+D$!EP@
M!RI);\+F@^(;!/"MA="[U"\^U3RP6_VI5^T3R!W^7 P.-K>@"KDD<T =316)
M%XB:6WE8Z+JB7,=P;?[*R1[V;8'R&#E-NT]2P&>.O%<YXEUZ+6?"=IJ6G37M
MI)#K%M;2QEVB=&^TI')&X4X/4C'(YH [ZBN.2YGL_B7K 5KRX@71X+@6JREQ
MO,LH)16; )"CICI6C:>+K._TG2M2M;2\EAU23R[<*$W9P3EANX&%8GTP<XH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'\GR=3OSSCI7?444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M ':<<]ZZ+4;'^T-'N[!I GVBW>$NJ_=W*1D#\>E 'G=_>W5]I/P_U6]L)FU
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)S\V<# /3FK= !15.\U2SL+FRM[F79+>RF&W7:3O<*6(XZ<*3SZ5<H ****
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M10 4453N-4L[74[/3I9=MU>"1H(]I.X( 6.>@QD=?6@"Y1110 4444 %%%%
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M6O'M6MH)5<J%F,3/N;;P-I;Z5L+JEFVL/I*RYO8X%N7CVGB-F*@YZ<E6X]J
M+E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]!Y8PC>H]#0!YY9->6'B+3[FX@L-6M;W4YEMM2MYF2[CW>8=DB$?,B#*X!
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MM#!9F_<XRH..[?6O1GM;>283201-*%*;V0%MIZC/I[4Q;"S1U=+2!67[K",
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MURSW+IY_ER!UR D9&<*<C&WH37JG]GV0V_Z);_)]W]V/EYSQQZT&QM&,I-K
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MKS;4=,BB\-74=S;(VF3>*89]/@ECR%MO-C\PJIZ1D^8?3:<]#79^./#TFL>
MGL= B@66!H;FS@CPL;^6X<(,< $# [=* +QN?%3V!O%LM,BDV;Q8R2.S],[3
M(!@-]%(SW/6M?[?##;027LD5I)*H^260##$<J"<9Q6+I_CK0[RW0SW#6-YC]
MY8W2-'.C=UV$9;_@.0>U9%K<VL/C#Q(OB((MO>Q0&Q:[3"2V_EX:-0PZA]Q*
M=?F!Q0!W$LL<,32RR+'&HRSN< #W-8/AK7KG6;[7()Q;%-/O%@BDMR2)%,2.
M"22?[_;TKAM%-[X>C\)#Q2EQ_9*65S&IFC9U@F,H,/FC!P1#\H)Z'(JM<Q3C
M0O'<.AV4D&_5(+@6L<!1Y+?;#YI6/@D, ^1WR1U- 'KMO=VUVK-;7$4P4[6,
M;AL'T.*Y^+7-3U;4=7M]'BLECTR86SFZ+%II=BN0 OW%^8#<<Y.>..:_AR*P
MU#Q"^N6>K174C60MGCM;8Q1[0VY2^2?G'( ." 3Q65K=CX,U74]0N+B6XT[7
MHV,3/97$D%U(5X5E1"/,XQCAO2@#MTOTCT^WN-0,5D\J*6260 (Y&2N3C)!X
MJ>>Y@M83-<31PQ#J\C!5'XFO*=+EUK3=<B7QA>0PM<Z-;PQSWEN98BXW>=&6
M#!5<DKG^]@>E7K..U\,^(='M-6GFN- 71Q!97=[&?+682$L'R,(Q38 3CA<4
M =U_;MF==MM)0M)/<6KW:2)@Q^6K*IYSU)<8_&I=/NKJX6[-Y;PP>5</''Y<
M_F;HQ]UFX&TD?P]O6N&ETWP_;?$70I/[-M_L$NE2QVCM:[D,OG1LH''! W$>
M@Z<5CQ*4\-:PNGP%K&'Q5]HO+>!,[[+S%+%5'WD(&>." : /6;>\MKN-I+:X
MAF13@M&X8 _44)>6TDPA2XA:5EWA%<$E?7'I[UP6J166H^+6U.P:WFTK^QIH
MM2E3#0RG<IA4]F<?.?4#ZC.+9:?86?@CX?ZC#:117D%Y9I<W"QXDC!C*R!VZ
M@=B#P,#TH ]6O+N*QM)+F8D1QC)"C))[ #N2< #N37,:=XU;4/#>E:A]@$5[
MJEY)9V]JTN0&5Y 2S = L;,<#VJ_XCM]3DDL[FSN=.BMK5FEE6]#;2_ 0Y4C
MIENO<@]0*\W\,&_A\/>%=2O&MS:Z;J\[3K$K!X$E\]-\@/1=SJ0>,*<GUH [
MB3QLUG<WNFW=DG]JP7=O:Q1QRGRYS/S&VXC*CA]W!QL.,\5JZ?K<LOB"ZT.^
M@CBO(;=+J-HG+)+$S%<\@$$,I!'N#GG Y>YT33O$&L^(M5O;IK?3C]B6UOX9
M0A66#>WF1L<@X:0+GD$@BI-'M3I>JZQXQU2YO98!9I:V[W:!9ID0L[-Y:JH7
M<Q 50H)QDC+4 ;=QXMBM_'%IX=:!O+N(7Q=9^43@!Q%]?+RWY5H:SJPTQ+6*
M)!+>WLP@MHB<!FP22?154,Q]AZD5P.MZ-JL_@3^VEU2R^VPSC68@(>?M .X1
MB3?SQ^Z''(P*UI-3CUGQ=X(U6(,MM<6]XH1Q@QS-&C!6'9@JR#\#0!VSW5O%
M-'#)/$DLGW$9P&;Z#O5%-6V^(9-(N$$<CP_:+5P>)4!"N/9E8C(]&4^N/-?&
MUXFIVGBB$626]]9W41A5;1WN)=OE%9Q)T5>PP/X>N3BNOUMOM'C_ ,'-;L'P
MMY,S*<CRO*49^FYH_P!* -2TUR;4$OI[&R-S;P3FVA99 IE=25D;)X"*WRYY
M)*M@'C-71?$EWK7@I->ATY1<-YC"T67<6"2,I4-@98A>. ,D53^'4R6?PVTP
MW<BQ- LD=PTAP%D65E?.>^[-,^%LZ-X L(B=LL1E\R-N&3,KD9!Y&1S0!U5A
M?6VJ:=;7]G*);:YC66)Q_$I&14D=U;RS211SQ/+']]%<$K]1VKD/ 4LMG\,+
M:Y6!YBL=S/#"GWI$,DCQJ/JI7'U%<SH]S;3>)/".IP10P*]G<Q3K:6C0K%F-
M"(6=N78-QSW'09H ]3CO;6:XDMXKF%YX_OQK("R_4=13I[JWM@IGGBB#G:OF
M.%R?09KSOP>+JSU;1K*WN[#6M-6UD$=TL'EW5DN 0LI#%26. <@$D$]C4GC&
MZM[W5]8TBYL85/\ 90,4DEHT\EUGS"5B[+M(&3R?F!XQF@#T4G R>E1)=6\A
M8)/$Q50[!7!PIZ$^W%<UI3P7'PML3?E)4.DQK-YWS9<1@$-GON&.>]<-%I4=
ME\+?#>H:79JLRO8?VTT<!DD:*,982(/F<*Q!*_W1CH* /7(KRUGMVN(;F&2%
M<YD1P5&.O(XHBO;2> 3PW4,D1.T2)("N?3([UYY?V&F7]MJ6IQ>)%0WTEF&N
M+>V'V:.2)RR,ZL2&S@*V3T"YQQ6=JOVN?P]>WFHV=A<_8-;LKG^TM.MVVW"!
MXO,D"Y8Y55 8J2.#Z&@#U>5SAHXGC$Y0E%?^9'7&:Y;1?&7VCPEH^KZI!LGU
M&[%HL=LN5#M*R+U/3Y<D_P#ZJSK'4--G^*LNHVVQ;:;0QF[*;$F83$G#$#=A
M1U]![5S,<%E/\,?"DM]:)+#::TANA)#O\F,S/NW#!(!!7/L10![(2 ,DX J&
MWN[:\1GMKB*=5."8G# 'TXKE?&T4@\(V9TVV9M/ANK62ZMH(B"UFKJ74(!G&
MWJN.@(Q565+*_P#'EKJNG26\FEC2YHM4F0@PR*2OE(QZ%A\YQU Z]1D W_#>
MKW.OV?\ :P\@:9<J&LT56$H7+ ER3@YP"  ,<CGK6M]JMS<FV\^+SP-WE;QN
MQZXZUQWPIL[*U^'^F&WM88+EH@+K9&$<N"?O\9S@]_6N6FOXM2N=#U(6D5E=
M0>(?W\,=HRR6ZEI QEE/7<.<<#![@9H ]8DO+6)@LES"C%]@#. 2WI]?:G_:
M(!-Y/G1^;_<W#=Z]*\IBT;1[WP_\1@-.M99!<W4EL!""0OV=-K1\<?.#RO<>
MU:.H.=,3PIXSM[=KN9;=-.O1&,R2+*JA.?43!1_P(T >BQ3Q3J6AE20 X)1@
M?Y5CZ-K%QK-S=7<1MTTJ&6:V4,I\TRQ/L9B<X"Y5N,9X!SS@6=%TN'1=&6V(
MB#'=+<NJA5>1B6=OH23]!Q7FVC2:9HW@74;NWTBSDEDUB2.<FWXCA:[)220*
M-S1JN& Z$#'2@#T^XOBVE7%UIGD7DJ1L8E\X*CN!PI?D#GOVK)NM=O[;Q-X=
MT\PVWV?4XIFE(8LT;)&&PK< C)'..WO7!S16GV;XBQ%(G@NM,BFMU%KY232^
M5(-T:'J<[!D9).WGI6W]JMWU[X>XD4JMI.K^B$PJH#>F6!49[@B@#T'SHMCO
MYJ;4.'.X87Z^E-DN8(5W2S1QKM+99@!@=3]*\?U$V%MX&\>>'S9G[=]MNYK>
MS6V)(5@"DBC& .>"*W=8L=#UCQ]X:%W;VMS;RZ;<)-O4,CDF+RU?L>C;0>XX
MY% 'H4EY:Q211R7,*/-_JU9P"_T'>JNN:S;>']%N=4NUE:"W ++$H+')   )
M'<BO./LR27GBSP_KEZEB+VY(M?,M&=Y+;RU$7D/G!*X.% )#9..:Z3XCV*S_
M  VOH7A:\,*0MEH][G:Z[FQCKMW$_C0!UUQ=6]I%YMS/%#'G&^1PHS]34BLK
MJ&1@RD9!!R"*X&WGTZP\<6]PT=O;>'I]*V:;)Y8BMXY?-8RKR %9P5/;<!QF
MM/P#8W%CI6IH4:.QDU.XETZ-@0$MR1M '92VX@>A% '2M>6J72VK7,*W##*Q
M&0!R/4#K2B\M6NC:K<PFX49,0<;P/IUKSOPE+9WGAJ#3]0CCC\86SREUN8SY
MWVH%L2YQEE.0=PXP<516,:C\.M"TZR0Q^*K2XMBT;#$\%PLB^?(_< CS"6/#
M!N^10!ZE+>6L#;9;F&,[@N'<#D]!]33EN('G>!9HVF0 O&&!90>F1VKRJ]TW
M1+B^^))FLK1]T*& M$IRWV< F/\ VO,P"1SNQWJW8VME:ZG\/=0@@CCDGMY8
MKNX5<,Y-OR)6[GS /O<[O>@#T9[^SC(#W<"EG\L R 9;^[UZ\CBL<ZY=1>.S
MHLJ6XL3IK7HEY#@B14()SC')/Y5P6F6GAFZL_&.CW&G6]S?OJ=VL%J+?+D$#
M:(^,+SW! 7J<=:V=$@EL?'.C:=J,ZW%U!X9%K<2,=P>8/&2I)ZD@$XZD<T =
M[]LM?+\S[3#LSMW>8,9],U/7G'AS2!%J5QX-FLP=.TB^.H0LR91X7)>%/<B0
MO_WY'K7H] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%5=0U*QTFT:[U"[AM;92 TLSA%&>F2>*<M
M]:,Z(+B,O)$9D7=RR# + >@W#GW% %BBL&X\0VL]QI@TW6-)*7%T8I%EER\J
M@'*Q8/+AL9Z@8-9]UXR@N9_$FF6-S;P:AI<>8F>17,K>5YAPF<X'0^^?2@#K
MJ*YKPQXLT_5--T>WN-4M'UFYL89Y+<2*'9C&&;"_CG Z"NCDD2*-I)'5$0%F
M9C@ #J2: '45EV^M:?K$=W#I.J6TMS"OS>6P<QYZ$KGH>W8UR-EXHUJX\+>"
M-3:YB\W5;N&&\40CY@ZNQV_W?N@?C0!Z%13)98X(GEE=4C0%F9C@ #N37!2^
M/&U30/#NLZ5=6T$=YJ-O!>6[,LK1QR,>&/\ "<#T[^U '5^)=,FUOPUJ6E6\
ML<+WMO);^8X)"!U*DX'7K5O38);73+:WG9&EBB6-F0$ X&,C-0:=K^D:ND[Z
M=J5K=+;G$QBE#>7W^;T^M/L]8TZ_N&M[6\AEF5!)L5N2AX##U7W'% %ZBJE]
MJEAIBQ-?WMO:B5Q''YT@3>Q. HSU//056B\1Z-<627D&I6\UO(S)&\3[P[+]
MX+C[V,'.* -2BJ:ZKI[:>FH+>V[6<@!2<2 HV>F#WJF/%?AYK:6X_MJP$43B
M.1FG4;'.<*<GAC@\=: +NI)J$EIMTR>V@N-P^>XB,BA>_P H93G\:C72+4Z+
M_94P::W:,QR[F(,N?O%B,<L22?7)J1]5T^/4/L#WULMYY9E,!E&\(.K%>H'(
MYK,T[Q%:+H_V[4]9TAHVN9(HY[:;$3?.0J@L3E\8! [YQ0!NJJHH50%4#  &
M !2UF0^(M'N+7[5!J5M-#YK0AXG#[G7JJXZD>@I'\2Z'';V]Q)K%BD5SD0NU
MPH$F.N.><8.?3!S0 :987L5U->:G<P7%RP\N/R(C&D<8).,%F.X]SD9PO'%:
ME81\:>&19B[.O:>+<R&+S#.H <8R#SQC(Z^H]:TKO4[*Q1&N;F- X+(,Y+ =
M2 .2!GD]J +=%94OB;0H5A,FLV"B:(S19N%^>/&=PYY'O5#5_&NDZ?X1N?$5
MI<V]_:PD(OE3J [Y VY['GD=: .DHK+E\1Z-# D[:G:M"ZEU>.0.-H."V5S\
MH/!/05IHZR(KHP96&0P.01ZT +16=-KVE6]R+>;4+=)?,$6&? $AZ(3T#'(P
M.O-8]]XCCE\:Q>'(=4M[*6&**ZDW%&:XW.1Y*@G@X4DXY^9<>X!U-%8'C#7W
M\.Z-'=1F%'FNH;433Y\J#S'"F1^1\H!SU';D5/IQU&.Y>2XU*VO=.,.Y9EC"
M,K@\\@X*X]N,=30!L451L]9TZ_N&@M;R&694$FQ6Y*'@,/5?<<52N/%NAP+=
M :E;22V\#SF,2@;E7K@]#S@>V: -NBN5M/%]OJ^F:#>6.I:3 ]_)$9K:><.^
M&3<T2;2/W@)7J/7BMF\UW2K"5H[N_@A9"H?>^!&6Z;CT7/;.,T :-8/]B7G_
M  G7]O>?!]F^P?8O(VG?]_?NSTZ\8QT[U:O?$FB:=/+!>:M90S1())(GF4.J
MG !(SGG(^N:N65]::E917EC<Q7-M*-T<L3AE8>Q% &3XIT2[UVTL8;6XAA-M
M?07A:12V[RG#A>/4CK6Z,[1NQG'.*YCQUXGN/#/AZXN;"&*>^5-ZK+G8B!@"
M[8YZL !W)'8'%J[U6\N/$KZ'ILD$,L%FMW---$9 -[,J*%#+_<<DYZ >N0 ;
MU%</HGC2]\13Z=I\$=O9WTMM<3W;.ID5##-Y)5!D9RV3DG@#OGC<\,:Y)K5E
M>?:5C6ZL+V:RG,6=C/&?O*#D@$$'!)QG&3C- &Y17)^%_%LVMZYJNGW4"P!
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MO:@#0HK-U?6+#3+=A=:E;V4C(2KRD?*/[Q'I[GBJ/@?5KO7?!.DZI?,K75U
M))"B[1DD]!0!T%%8[:NJ>(Y[1]2TP6L%GYLL!D_TB-MW+MS@1[2.HSFDA\6>
M'KBZMK:'6["2:Z_U").I\S_=YYZ'ZT ;-%,E5WA=8G$;D$*Y7.T^N.]<9H'B
M>^O?"/AN]N]1TR&_U"X"RBY^3SEWL"L2@CY_NXZCUH [:BLZ_P!>TG2W*7VH
M6]N5V[_,< )N.%+'^$$]"<9KG[SQ6EKXQL%.K69T&XTZ>X,@*E=Z21H,/GG[
MY&!WH [&LNXL+V[U>*2>Y@_LR$K*ENL1\QI!G!9MV"H.& "YR!SQS0UCQII.
MF>&H]=M[FWO+26:.&-HYU"L7D"'YO]G))],&MZWN(+N!)[::.:%QE)(V#*P]
MB.#0!+16=+KVE070MI=0MTE,@APSX'F'HF>F[_9ZUCWGB..;QJGAV#5+>RD@
MBBN9 Q1FN-SL/)4$\?*I)QS\R].X!U-%%9M]X@T?3+E+>^U*UMYG("I+*%.3
MP,^F>V>M &E163>^)]"TZ6:*\U>RAE@ ,L;3+N0'ID9R,\_E5M=5T]M.345O
M;=K)U#)<"0%&!Z8/0YH MT5R7ACQ')K?BSQ':1W\%W86:VQMS$H!0N)-RL>N
M1M'6NHN;JWLX&GN9HX8EZO(P4#\30!+169!XBT>ZLWNX=1@>!)?(9@W(DP#L
MQUW8(XZ\TC>)-$33Y+^35;..UB<Q22R3*H1Q_"<]&]CS0!J45G6>OZ1J-_/8
M6>I6L]W ,RPQR@LHSC./3/&?6H_^$BTF595AU.T#K"TH:1\)M& 7ST*@D D'
M'(H U:*QK#6X5T&PN]1U"QEEN(P?,LR3%,V,DQ#DD=^_%5+_ ,;:18ZIHUJ;
MNU:'4UE=;DW"JB*BY!YZY/ _&@";PQHEYHO]J_:IX9OMM_)>KY2D;-^,KSUQ
M@<_I6W,)3!((&59BIV,XRH;'!([C-4YM;TR"[6UEOH$F:01!2W\9Z(3T#'C
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M[E"':(HS$$(%.%R,"JVI:1#;P^'_ +!8ZG<1'Q!_:5R9K9BRY63=(5"C:-S
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MZ%LC&.M6;TWX\:6'B!(-9M]*N-+-I_HUF'FMY!)N^>(HS!6&.0.JC/%>B44
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M-N!F&[@>%_HP(_K7G\7AOQ.NC:'K9BB_X2JS=()%+@K]G*^4P)[C_EMCUR*
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M7<,$UVR;A:QNX#2D=.!Z\9(SGI1H]_ 6N;Z/Q5!JFDQP;GD>6%O)8<EBT:J
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MD6*UE$;XD=FVJ.G&3QSBLY;*Y\0>(-$U>?3KC38]+\YPER4\QWD39M&QF&T
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MN@:T_P ))]'.E2KJ0OC,MN9(\NIO?.R&W;?N'N1R* .VO_$>E:8TXNKDJ+<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%9^MZQ;:!H]SJEXDS6ULADD\I-S!0,DXK.M_&%C<[52UOTEF
MF\FUBE@V-<G9OW1[B,J%R=QP./I0!T-%8</BS3)89VD,L%Q!=BR>UD4>;YQ
M*H "0<@@@@D8YSP<5IO&ME:OJ<5W8:C;S:;;"[N(VB5B(CG# JQ!'RMT/\)S
MB@#I2,C!Z4B(L:*B*%11A5 P /2L=_$MDEWHULT=QOU<$VS>7\O$9DPQSP=H
M-9=KXFLK&Q\2:G-<:G<0:?=O]HCFA&;?$:L50#!V $'GU- '6T5SMMXRL+I4
MV6M^CS2K%:QRP;&NB4+YCR>5"@DL<#@\U-%XLTQXKGS?.M[BVN5M)+651YHF
M8 HH"DAMP((()&/H< &Y17#Z7J-S=?%:[@>'4K2(:0LAM;J3*;_-QO0!F3D
M#CT.:VM;U"&UUO0;:2ZOH&N+IDC6! 8YCY;'9(2.!@$\>E &]17*W'C[3X$U
M)UT_59ETR4QWABML^2 H8L<D9&"#QD^U=$+ZU.G#4//06AB\_P XG"^7C=N^
MF.: +%%8*>+;'S=.$]O=VT&IL$L[F9%$<K$;E7@EE+ 9 8#/3KQ4-KXUT^\U
M>338;343+#<M;3R&V(CA8)OR[9P 1T]Z +UGH$-EX@U#64N[IY[]8TEC<IL
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MC:/I^JV&K3_:1]HGV-"S(%='!4AD.W(QZD8KO:* ."U7P9+?:E+<6>GQZ9J
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MKA9C*% V\$YQGVSSG Z7Q1I=[K?AF[T^QNEM+J8)MD).WA@S*2.<, 5..QH
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M6UU]DGNE895@XC9@O5D5C@GKP2 1S47B36Q>Z'KEOI^GSWZ6B20W,D4BQ[)
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M+Q<^CZ+>ZI>:1</;VR)('M98Y%D5B1D,2O0@9'^T,9K9U:WN+K3)H+5;=Y7
M&RY&8W7(W*W!X*Y'0]:XR7X<K)I7B"VLH[32!JELD26EHS/!'(I+>800O)R
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M@"/RKEV4",3 #:5!Y&!U'/M5W4_!MU+IAALYK=KNXU:+5+N:8E SHZ,%4 '
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M-W)=1S749\^#>VYEQM(< DX^93S4J>&-;L;O7;?3KVR_LS5Y9+@F9&\ZWE=
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MS5RBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME@)6_0AKK.%CD/\ JT]RV/U7UIWQ#\7W?@GP^FKV]C#>1B98I(Y)3&1NZ$$
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6;YCM# ?Q;<< 9.1QF@#TJBN0'Q$T^5EBM=,U6YNUL_ML]K'"BRVT7_30,X
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MP48)*L0"0&"D_7BL^7XAZ1%:7-X;;4C:6=P]O=SBT;;;LI )?O@$]@2.I&*
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MT0Y8@X&UCTP<]Z .NHHKG/'LT]KX$UJ\M;B:WN;6SEGAEB<J5=5)'3J/8\4
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M[\N6*0!0K1N"IVD;L\@\#@UUOAK3[W2O#UI9:C>/=W40;=+)(7;!8E5+'EL
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M08D9/,R'&/NMYF.]=C10!R/A?PR^B:Q/<6<=UI^E/;",:=-=F=1+NSO4%F"
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M("P\M64[AVSGCK[TGCW1K_7_  K+IVFI$UP\\$G[U]B@)*KGG!_NX_&NFHH
MP+J;Q+=CR;>RMK#*29G:X$F&\M@GR[?[Y4GV!]:Y[2?#>N1ZUX:U*^LX%EL8
M9HKV4WC32RLZ*N_<PZ9!.WMG\*] HH \]TCPKK,W@JW\):O:6T%M&ZF:ZBN/
M,\U!+YFU5V@@G[I)Z=1FKEMH.KZ79^(M(@MXKFWU2XN+BVN6E"B(S<LLBGGY
M6)(*YR,#BNVHH XRP\,WND>)/#[6T2S:=I>D-IIE:0!V),6&V^F(^>>]=A,S
MI"S1Q^8X'RIG&3]33Z* /--,\#:S:>#M+6,6]IXET:662TG63=%*KR,S1.0
M=C!L'C@@$=*NGPWJ47BO4-9ETBVOH=6BA\Z W>QK:6--A .,.A&.>OM7?44
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M'(]JJ^(O$,?ARUMKB:SN;B.>YBMLP!3L:1@H)!()Y/8$UL(BQHJ(H55& H&
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M(!QU'&,YK+\)7CZWXAUJ]O=.N5GL[Z>UM[EV79'$H0>6 ')R>6/RX]^U6O\
MA']4U2/0X=:>TV:5<)=&2V=F-Q)&I5"05&P9.XC+=,9[U:\+:/J&CMJ_VW[,
M1>ZA+>H89&;;OQ\IRHZ8Z]_2@#<N93!:RRK&\C(I8(F,M[#) _6O+)-<O]9\
M&>"M9U"WNUO'U2T9G3:!<!\DA51NG ^\!7JTB[XV3.-P(S7!6WA#7X?"_AS1
MWETUVT:\@F$BR.HECBZ#[IPS9Y[#'?/ !JGQ4+N+6["[TK4K*\L;4320I)'Y
MCPN& >-P^W(VMW&"*-.\36R:9X>M+-+BXN=0TY;JW2[G42-&JI]]S]Y_G7IG
M)R>G-&H>'M2F\1:KJ5LUJT=]I26(221E*.K2'=PIR/WGZ52_X1"XF\.Z/H^J
M:5HVJ06-BEL1<2,I61%"B1&\LD9 Y'&/4T =A9W#7=E!</!+;M+&KF&4 /&2
M,[6QQD=*9J5_#I>FW-]/GRH(S(P7J<#H/4GH!ZFJWA[2WT3P_8Z9)<O<O;1"
M,RN22WYDG'89/0"JWB#2[S5Y;"V$5I+IJ3K-=Q3N09@N2JXVD$!MK<]=N.^:
M ,/P9?:G9>(=6\/:Y<^?=NJZG;/G(\N3B2-?]E) 0/9A6B?&);Q%=:+;Z'J4
MT]I+ D\BB/8B2YQ)G=]T8SCKUXX-5M6\(-'K^C:MX<L],L9K&1S,0/*\^)UP
MT9"(?8@GH1TJ_I6CZA9^+M;U6;[,;;41 J*DC%T\I67D%0#G.>O'O0!S \67
M5WX,\37FKV>KI;6MU=1^?8O#%)'%'(5"J0^=P Y/UQFNNN-=$5U_9UA:2WU^
MENMP\*R*NQ&)"EF8XR2K8'/0]!S7.S^#]:?PMXFT%)[ Q:I<7,MO,6<,@F<L
M=XVGE<XXZ^U7FT+6[+Q,->TYK%WN;..UOK.>5U4F,DHZ2!"<_,1@K0!2M;Y/
M^%C+J4Z36<4OAS[3-#.W^J_>C.X9(! &#CTK9M_%UO-/I'F6D\-KK'%E.Q7Y
MCL+@,N<J64$CKTP<'BJEYX9O]4\2SWMZ;465SH[Z9,D4C;QO.YF7*X]1C/O[
M4WPKX:O=#@LK.[L=$=;-!&M_!&5FE4#"DKM^5NF3N.>>.: .OK 'B9KB0/IV
MF7-]9K=_9);F-D 5@^QB%)RRJV<GV.,UOURGA[0]:\-S7-A;O8W.CR7<EQ"\
MDCI- LCEV3:%(?!)P=PZT /N?&]K;Z1)K8LYY-$BE,<EXA4X ?89 F<E P//
M7 R 1S2S>+W.K:CI=CH6H7EU8QQ2L$>)5D1]V&5B^/X>AP>>G4UFP^#-1A\(
MW?@\3VQTB5I$CNM[><D#N6*%-N"PR5#;O0XXP=;2M#O=/\7:KJ;"V%E=V]O!
M$B2,701;\$@KCG?Z\8[T 8>N^*EU;3?"LFGV5W<Z=K=R5FA38CO&(I&,9W,
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M%\^G_8N"[3*N\@'.-NSYMQ(&/0\55\2>&+O6KW1=6CBT]K_33(&M;K,D$R2
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M;258,H/0@]*NR^$IG_M&YGM--OYM5O4GOK2ZSY)B2+RT1248Y!"MNVC)STH
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M^#P&&!@<Y'3G&3KOC"?5?#\:V=HK2#7K?3;N..=7BE4R(2JN0-RNK =.Y!H
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M =8'4L5# LO4 \BEKS:PN[[1O%'CB72=$AN-DUM/+$;@0*/]&0L%(4Y8G)Y
M'/)K<'CRPN&TZ&U-ND]]IR:DHO;@0*D3X"@G!RQ.> /X3STR =)>Z?9ZE$L=
MY;QS*CATW#E&'1E/4'W'-+:6%K8JXMH$C,AW.P'S.>F6/4GW-4?#>NQ>)-!@
MU.*)HA(71HRP;:R,48 CJ,J<'N,&O/\ 3-'TR:Y\<6YT%;V4ZDT-LD4*@Q_N
M(R K''EC+$YR,'F@#U4NH<(6&XC(&>32UYSH.DW.D^.?#<&HRK<:FGAR:.ZN
M1R9662 <MU;'3)K;/C":'Q+I^D75A;Q_;VD2$QWHDEC=4+XECV_+D*>06YH
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MQ5;:T^HPJ(;"2R:*.W()#LK%@V_@Y08X-;-[J5CIJ(]]>6]LLCA$,T@3<QZ
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MVL0#^UKU[LS"S/[K>P8J!YG/W1@Y]:ZB*WU(:J+B;4(VL_LPC-JEOC]]NR9
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MJ5(!(QR"*;#X9U/3M?O]3TO4K1%U+RWNX+BT9U$JJ%\R/#@C( RISTZUU-%
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M(-K%=R_*HS@_3%))X.M[?5+?4=&O)=*FBM5LV2!%:.2%?N*RL#RN3@C!Y[T
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MH8G<P (P1R.* +]%0&\M5>W1KB(/<Y\A2XS+@;CM]> 3QVJ>@ HHHH ****
M"BBB@ HHHH **B>Y@BN(K>2>-9IL^7&S ,^.3@=3CO4M !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% ')^()&E\?>$K-^;?_2[DKV,B1JJ_D)'-8GC+7[R
M&QUO4M'U"^$FCSQHQ'EK;(^$+1,#\TA(;DXXW  C%=?KNDRWS6-]:%!?Z=/Y
M\&\X5P5*O&3V#*Q&>QP>U,NO"'A^]N+R>YTN"22\Q]HSG$A  R1G&[  SU]Z
M ,[77:V^(7A.2+AKE;NVFQ_%'Y8D&?HR+^9]:ZRL6/1GD\3)J=R08;*W-M9)
MN+'Y]IDD8GN=JJ.O )S\W&U0 4444 %%%% 'F6K?\G%:#_V!9?\ T*2N:U'4
M?$CZ3X^OD\5ZG&^@WV+15\L!@,</A>1@]!CGKFO6IO"VBW&N)K4MBK:E'C9<
MEVWJ!V'/ ]NG)]:B3P9X>C@OX%TR/RM0_P"/M69B)SG.6R>3[]: .3OM<U;_
M (3+X=*-1F2WU>WF>[ME"B-V6 ,#TSU8\9QP*S/"MI=KXC^(]Q#K-Y"\-TW"
M+%@MY9(8Y0\C&!CCU!/->@MX0T)I[&=K &6P7;:.97S /1>>/3Z<4/X1T!]2
MO=1.F0B\OD\NYF4E6D7T.#[<XZ]Z .&T7Q-+=_#3PL-1U74SJFL2.BFRV?:+
M@AGR [X5 /E.>.!@=:Y/6M2U76/@5JW]J:A//+9:U]E$DFPO(BRH '..2"<Y
M'H.U>O/X$\,2Z=:Z?)H\#6=K-YT$+%BL3]]O/ /<=#Z5*/!GAP:3>:4-)MQ8
M7K^9/;C.QVSG=C/!R!R,=!Z4 <UJEUJND_$SP5I(UR]N;2\CN_M*3",>:8XR
MRD[$7NWTX%<I=>(=<U#P7XR\4C6;RTU'2=5>"U@CDVQ11QL@"-'T8G<<ELG-
M>HKX/T!;BQG738UEL%V6K*[ PC_9YXSW]>^:;<>"_#MU?3WDVF1M+<2++.N]
MA',Z\AGC!V.1ZD&@#B)+O7=<^(]CI)U[4-.M;WPZM_)#;[ 8I2X4A25./QR>
MN",\;_PGUG4=<\ 6MUJMT;JZ6::$S, &<*Y )QWQ71'P[I)UT:V;-3J078+C
M>VX+_=Z_=]NE/T?0M,T"U:UTJT2U@9BYC0G;D]2 3Q0!G#7=<;Q3_9@\+7 T
MW?M_M1KJ,)C;G.S[W7BG>.M*_MOP)KFGA=SRV<GEC_; W+_X\!704'D8- 'S
MR+#4/&_PB@\0Q^;'=>';2)-..>6>'F:0>N0% ]XSZUW>BZM=:W\.O$/C*"26
MQN[^!YX'0+NC6"(* -P(QO60_1J[_3]*L-*TR/3;&UB@LHU*I H^4 DDC'N2
M?SJ%?#^E)H(T-+-$TP1^5]G4D+L_N\'.#W]: /(M3O?$VG?!4^+/^$KU![VZ
MMK1E3:@6/+[6QP3DA^3P<KZ<#H-;LYKCX\:&$U&YM_\ B4R./*6,\!^5^93P
MW?OZ$5V<O@[P_/HJ:-+IJ/IL;;EM6=C&/3C/08Z=!4EUX5T.]N]/N[K3HI[C
M3QBUED)9H_Q)Y_'- 'D^CZAJ/AC0_B9KUG?3SW%IJURBP2)&8V<L@\U@%!R,
MG@$+CM73^'D\57-R+\7UXNAW>DAVEN+B&607'421!00JD=NGM78P^%-!@O\
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MN=(1-,D$>X_?D8X51[DUPD5WJFG>(K:35+>XNK2ZU1X[74K*_8KAV<)%) <
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MY4$8=)&C/R1MG^YQR1VK-TVYFT7P8US;WUTJ7/B.2TO)3,?W$+7C*[C^Z2,
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M9;G4G@M[P37;O',KVSMRA.T$%000 >N<DT >F45R_P 08KP>#[R^L)[J*ZL
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M>AO#^C-!!"=*LO*MR3"H@4",GKMXXSWQUJMX>UV;6I=7BGLTMGTZ^:S.R;S
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MOMCDR[HF#9);."47\:]#^S0&%8?(C\I/NIL&U?H*1K2V955K>(A1A04''TH
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MXWV4_*"SHPVX7)QT^5MPX.:]8EL;2=76:U@D#G+!XP=WUSUIQMK<VXMS!$8
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MJ&M+9R2UO$23DY0<GUH X3Q1H-AX;TJPU_3(7,.E7HO+A3(TOF0.<2DEB2V
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M@#&C 'D-N)4<DMFDTZQT2U^(WB7[?IMNAEAMY;>2:TR"GE,)"&*X'/!YYZ4
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MQ'H=GJ=J\>)X4D>)9 YB+*&V,1W&: -2BL&Y\46<'BM/#KRPPW,EF;A)9)%
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M!/&3O22,QLP!R/F P<=>E>@>&],M='\/VMC9+<K;1AB@N1B3#,6Y&!CD],#
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MY',XF8, S<J,' &.*U_'.B:%X;\$ZW>MIMU<6$\,*75M!=&,@*Y(8,22#N8
M^H XK9^(GA&[\;>'!HUO>PV:-*LDDDD1<_*<@  BI_%_AR_\5>";C0OM=M;S
MW2JLTWELR@!@QVKG/4#J: *6I>-)=%U3P[HMMH4UU)JUN[6Q6Y48,<>XJ2WI
ME>3[GD\'#;XO3Q:%-J\_A6YCM;&_-AJ3?:XS]GD# ?+QF3[P[ <]36U>>#]6
MO/$?A;5S?V:G0HY4,8A;]]YB!&.=W' &.O-8TWPOU*Y\(>(="EU>U!U?5#J0
ME6W;]VQ=69<;N1\@P: -:\N[$?&.PMY--N#J1TN0PW0N<1F+=DCR_7=D9/Z\
M8RKKXMW%MIFKZE_PBET]GI&H-97L@NX_D(*J2!U8Y;H..ASSQOS^%M5N/']A
MXG:]LP+6R-HUN(F^;<<LV[/'/3CI6(_PTU&?PIXKT675K4'7K\WPE2!OW+,Z
MLRXW<C"X'2@#>U3QHT.O)HNE:>M[>G36U-_.N/(00AMH .UB6)[8 ]ZO>#O$
MP\7^'+?6H[":SAGSY:S,K%@#@D8/3((YP>,XK@_$6DZAK7CFSTVUN=)2\TS2
M L_VR%U642-C*%'#LN%(()VC/<GCJ/AOJFHZEH5W%?VVGQ)87LEE;2:<A2":
M-,#<@)/&<CCCB@"WJGBV6#Q7%X9TK3TO=3:T:]D\ZX\F.*(-M&6"L22>,8_&
MN*\5_$2XUCX6_P!J:/;75I/-?+872AU#0-O =-V1]X' (]>U==JGA2^'CJ#Q
M;H]S;K=?8C8W%O<AMDD>[<&#+R"#CL<@=JPKCX6W!\#1^'K75(5FDU#^T;NZ
MD@)#R[@V%4-P. .IZ4 =OX>LH-.T.WMK;2AI42EB+,,K>7EB3RI(Y)SP>]<)
M9ROXW^*OB'3-4EE.D:$D4<-@LA1)I'&3)( 1OQ@@ \<BO3(?-\E//V&7 W[,
M[<]\9[5QFK>";Z/QB?%GAK48;+49HA#>6]S$9(+I1C!.""K# Y'H/?(!+J<.
MB?#JQU/Q,B2P64=NJ/9P,=C/OPI52=H8E@. *2U\;W:^)+'0M5T5;2[U&S:Z
MLC#=>:KE028V)5=K #W'O3]<\+ZKXO\ "VHZ-KUY91+=1J(OL4+_ +IU8,&)
M9OFY XP.,\^D%IX0U6X\1:7KNL7=G)=Z39/;VB6Z-M>1EVM(Y/(X_A'KUH Q
ME^+TQTNVU9O"UT-.DU$Z?)*+J,LCYP,+_%SGN![FMS3/'5S>:GK^EW>@S6FH
M:1$L_D?:4D$T;#((8< X[<_6L ?"[5AX1CT+^V+/":K_ &EYWV=NN[=LQN]>
M];K^&+RP\3>(/$LEY \5_IRPR0",@H8TZAL]"<]J ,F'XLRG1]&URY\,74&B
MZE,(#>?:48Q,7*@E!R5XZ\=QSQG9\6^.YO"5S#)<Z)))IC7$<#W7VE%8%L?,
MD?5E&<$Y'(/UKD_AMX<N_$?PV\-PZK<6K:-;2_:HH(8V$LC)(Y59&)QM#9/
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M"F4."5!>+&55B.#DGU KT"N!\&^!]7\(%-.BO-*N=(AF9X99;0_:U0DG9N#
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M.<D#)(QG@8 K%M_ VK0>%]&T\:Q"=1T.X$UA=&$E2@#+Y<B[LD;&VY!!X!H
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MM[A77+?==20-P(SZ>^.M0-XZ33;[4+3Q#ILFF/:V37ZNLHF2:%2%;:0!\P)
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MPL5FC98UW## AOW8]1S78T %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;SKK,*J9&6,*2 6+!<G@8].U.TSQG-KD6GVUC8+%J5W:R73QW+D1PJDGEDY
MRV6^[@#(&>. 0#KZK75A97LD#W=I;SO _F0F6-6,;?WEST/N*Y@^,9XM1&C7
MO]FV.JQVQN)S/<XAP9&1 A."VX*6[;01UJI8^(H];U[PI>3:&D4]Y;79AFDG
M;?;LF!(H7: 58@8;/(YP* .[HSSCO7'VWB[4)[+6@^FVZ:GIU\MDMI]H;$I;
M;Y;;MO 8."#@XYSTHAU!X?%^O*NCV@U&#3;>9IUNFQ<*3)M4_)\N"K= >HH
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M&#[XB!"AEW=\\D$5S BNIKKQ#XEMM6TVRN(KN1%@O;!)IHVB&Q1N#*PW[=P
M!.'')S7J=9\ESI2ZU#:R/:_VG)&7C0@>:4'4COC_ .O0!)I$]W=:+8W&H0"W
MO9;>-YX1TCD*@LOX'(JCXCT&37(M/,%Z;.YL+Q+R&3RA(I959<,N1D$.>X[5
MM44 86FZ!/8>)-3U=[]9OM\<,;1>1MV^6&"D'=U^8YX^F*Q=/\ 3:1!H\FG:
MSY6H:7;O:).]KN2>!B&V2)N!.& ((85V]% $-I'/%;JMU.)YN2SK'L!^BY.!
M^)/O6?XDT"#Q+HLFG3S2P$NDL4\6-\4B,&5QGT(%:U% '+ZMX:U77?#5UH^H
MZU QGV SPV)0@*V[H9#\Q('/3VIE[X0N;O5-3O%U@PC5+)+2[1;<$_*& ,9)
M.P?.<CGZ@\UU=% '+6OA*XMK_0+K^TXV_L>S>SC3[,1YBL$!)^?@XC7]?PJR
M^!;B;PWJNC-JZ!-1OFO7E%KRC-()"H&_IN Q[9Z]1V=% &&^@S/XGAUP7RK,
MM@UDZ"'@Y8/O7+<'('!SQ6CIEM<V>F6]O>7KWUQ&@62Y=%0R'U*KP*G@GAN8
M5FMY4EB<95XV#*P]B*DH Q_%.AOXD\.WFCBZ%M'=H8I9/*WD*>N!D8/OS]*J
M#PW>-KVDZK)J4+/I]M);>6MJ0)%<KN/WS@_(N/QZUT=% !6%=Z!/+XK@UZUU
M#R'6T-I+"T(=9$W[Q@Y!4YZ]<CTZUI7^IV&EQI)?WD%LLCB-#-(%WL> HSU/
ML*MT <>/ ['P7?>&Y-3W)<SO.)U@P4+3>:1C<<_,2!TX]:M0^&+ZPUN]U+2]
M6CM_[1*/>026GF(TJJ%\R/YP4) '!+#BNFHH 1054 L6(&"3U-8/B;P]/X@.
MF^7?):K87L=ZH,'F%Y(R=H/S#Y>>1U]Q6W//#;0///*D42#<\DC!54>I)Z4R
MSO+;4+.*[LYXY[:5=T<L;;E<>H/<4 5]7L)-4T.[TX3K$]U T+2^7N"AA@D+
MD=B<<_G6%!X/NK:]T>[@UDQS6%@=/<_9@PDBRIRH+'8_R#GD'TKJ)IX;<*9I
M8XP[!%+L!ECP ,]SZ5)0!QMAX&GT^+0(H]65DT6>6:+=;<R>8'!#'?Z2-T]J
MVK#0VL/$FKZLMUO34O*+0F/!0QIM&&SR",]JV** &R!S&PC95<@[69<@'MD9
M&?S%9>BZ3/I6E2VDMW'<SR2RRF<PE=S.Q8EEW'/)/0CC XQ6M51=3L'U-],2
M\@:^2/S7MED!D5,@;BO4#D?G0!R=O\/6@\+VVB_VQ(K6%X+S3KF. *UJX9B%
MP6(9!N(P>QQFM*T\,W\'B0:]/K"W%X;$V<BM:[8\;MP*J&XYQG).>>>F.EHH
M XQ/ MQ'X9LM%&KILM+\7RRFUY9A-YP4C?TW$_A^=:4_AN>37-0U2*_1)+ZP
M2S=&@+!=I<AA\P_OGCZ5KWVI6&F1K)?WMM:(QPK3RK&"?J34,.O:/<K,T&K6
M,HA7?*4N$;8OJV#P/<T 8-KX+N+2+PQ&NJHRZ I6+-L<RCRS%\WS_P!T]N_/
MM2:QX'?5/^$D1=3$,6NK$LP-ON:+8@3Y3N'4#N*ZBRO;74;..[LKB.XMI1F.
M6)@RL/4$=:GH YW5?#EYK%M<V=W?VDMG=0"*2*2RWE#@@M&2^%)SW#8([TD'
MA9['Q"FIZ?J!AB^P16+V\D7F!EC+%#NR"/OG/K[=:Z.B@#D8_ [?\(1?^&)M
M39H;II76>.':R&20R'(+$,-S8QQQQ[U9M?"]RFNG5KW5?M,TEA]AE1;<1KMW
M%LI@G;U[[O\ #H3/$LZ0&5!,ZEUC+#<R@@$@=2!N&?J/6I* .-M/ LMKH^BV
MPU<M>Z&X^P71MP L>S84=-WS KP2"#T(Q5N]\(G4+76S/>I]OU>T^Q2W"P86
M.':PVHF[C[['))Y/H *W+74["^N;FWM+R">:U8+.D4@8Q$YP&QT/!XJW0!4T
MRUDL=,MK2699F@C6/S%39N &!QD\X]ZCUK2+77M%O-)O0QMKN)HI-IP0".H/
MJ.M6YYX;:%YIY4BB099Y&"JH]R>E24 <@/"&IS2Z-/?>(FNY])N/-A9K0*)!
ML9#O ;EL,?FR/IUJSIWAB\T6^O?[+U98M.O+EKI[66V$C1NYR_EON&T$\X*M
MC/%=%+/#;A#-+'&'<(N]@-S'H!GJ3Z5)0!R]WX,BOM3UV2>]=M/UJ!8KJT\L
M9RJ; ROGCCG&.H'/:KND:7K.G6B6USK45XD,7EPLUGL<X& 9"'PV/]D+FMNB
M@#E+;P;-;^ ;GPI_::M%-#+!]H^SX8))NW<;L$_,<'Z<&I_^$9N3JV@W[ZE&
M3I,$D(06Q E#A58D[^#A1CWSUZ5TE% ''7?@:6YT?6-,350D.I:C]O+&WRT9
MWJ^T?, 1E%YQZ^O&I!H-S'XN?7Y;Z-VDLDLV@6 J-JLS@@[C@[F/X<>];M%
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M(8_E0(, *#C: .IH P=+\8ZGJ4>A7\5@TMGJ;+YT*64P:UC="RN93\C 8 /
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M@@ $'Z5VI&1BN0L?A_:V-OI5NNKZD\.DW/GV2,T>(QM9=APGS##GDY/H1SD
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M#J >0:U+O6O$DWB;6='TW^RD%E:0W44MQ%(V[>9!L(##^Y][/'H>TI\ V?V
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M+12,H8LQ*-R!D@ D9X;L172UF:QKMKH9L?M4<["\NH[2-HTW .[!5W<\#)H
MAD\,:?)J=[J)-R+F]A%O.RSL T8SA0,X&-QZ>II@\):2-'T[2A'.+73I4EM
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M&Z=I;?C;A&).%V\;>A'4&NAHH IV&F6VG>>T*L9KA_,GFD;<\K8 R3[   =
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM[A$@$:LCM)*IVMM.!\@ZY/OC@]-8:+8:;=75S:0M'-=/OG8RNWF-C&3DGG
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M?N[J]N)]-C=[T$7(+-LER-N2F=N['&[&?>@#,;4-07QEX9M?M\IM;W3;B6:
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MW$:R2PF42 C@#?\ ,@(!'?%-L[S54\5ZCI$MW?I:S:.;Q%O&A>6&3>5)!4$
M$=CD9';I75W?AO2+^>\FNK%)7O81!<[B<2H,X##.#C)QW&:;9>&='T^Z2ZM;
M,1SI$8?,\QF9D)SM8D_-^.>@]* ,?X96TEO\.]"9[N:=9+&%U20(!$"@^5=J
M@X_WLGWKCI[2:+P!\2)GU"XE3[5?H876,(6VK\_"!MW&.N/:O4-(T73M"L_L
MFF6RV]OG(C5B0/89)P/;H*IS>$="N#J!DT]2-0.;M1(ZK,>^0#CG SZX&<T
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MA;1DCL(UM6":=_QZ*)Y,0<8^7YN../IQTJY;:596=_=WMO#Y=Q=L&G8,<2$
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MN!8@XW#&,5W]92^'-+6<RF&5B9!,4>XD:,N,$,4+;2V0#G&<@'K6K0 4444
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M.>.HH ZN'589-4;3G22&X\D3QK(!^\3H2,'JI(!';(]15ZN(U:6\.L^ 9[A
MFI23NEPB] &M7,@^@95_(5TOB&\NM/\ #>J7MC%YMW;VDLL*8SN=4)48[\@4
M 0Z[KPT.;2T:TDF6_O8[,.K "-GS@G/)'!Z5L5Y5J3Z5>6?@;5(-3DN[RYU.
MT9W^ULWFY4EBR9VC!]AM)P,=*/&VLK+8^(+_ $ZYG@N])NHX4G?4'C*R@1DK
M'"ORLI!YW=<MV H ]5HK@M<N9?#?CA;EY;J>SUFS>WM[=KA]BWB\JJC.%\Q2
M1QW2DU+2-8L#IUK8,NMQVEDPN[.[OY(9)78C$P<Y!.58 $@#/&* .^K(\4:Z
M/#/AV\UAK22ZCM4WO'&P4X]<FH/#.MV%_HND1Q32+/<6*3QV]U(&N#& %WMZ
M\X^;N35'XG$#X9>(<_\ /F] '5@Y4'ID4M<'-IGV?QCH3:3J-_/'>QS?VDIO
M9)$DA\L[9/O80[]H!3;U(' XY^+5W;X6^')WU:Y-^=4@B9_M;^9)F["NK\Y;
MY<@ALT >I)J-I)J<NG).K7D,2S21#.51B0I/U*G\JM5PUA:VQ^+NN227,ZRK
M8V3QI]I90V6FR-H.& P.""!GWK7\=ZI>:+X(U34; LMQ!&"'5=Q12P#.!ZJI
M9OPH Z*BN,U8Z)X?T2Z\007MZ\$UND9,%\S^=O=%1P68@'+ ;QT#'VK%MWFM
M];\6::EW)';)H\=V(H-1EF\B;,H)60X920BD@<?G0!Z;17E]G'+8:7\/=9CU
M&_>\U"2VM[MI;N1TG1[9V(*$[>J@@@9SSU->H4 %%%% !1110 4444 %%%%
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MWJY110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M93-X6ED@F=H\>9*/EB8'OF,^8?\ :*&N\N4G@T^1=,AM_/5?W4<I*1Y]RH)
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M^90>:6'6K%;"QTG4](TNRCN-2N8BSS[M.)1,EU! #@EB AQ\RMSD5Z>;6W:
M0&"(PCI&4&T?A3C#$45#&A5<;5VC QTQ0!XO)-:CX>RVTE\%%IXG%O;E9&C,
M47VI?E4$Y50I. 3P*Z?Q)H>E>%(-&\2:;;*MII=YYET 3(&MYCAWYR3M9@X]
M,''6O0C'&3RB_E67J=E?W]Q%9J+1=)8*;@DL96P<[ N-NTX ))Z9&.<@ H:8
M;#P[ICZE?JMI-JET'=1&=V^1L1QX49R 0..^X]S1X_O;W3_!=_=6!F62,QF1
MH ?,6'S%\UEQSD)N.1TZUM76G6U[=6=Q<*7:TD,L2D_*'(*[B.Y +8],GVJW
M0!YDTWA9_B1X4NM">P*SQ7:R36I&QSY:[0Q'!?D]?F]>U9.H7VF6?@3X@:7+
M=)'>Q7MX\%MYA\U1L4HRKG=MQSGI@>U>P+#$B@+&B@'( 4#!H\F+S#)Y:;V&
M"VT9(],T >:7-['<^,_L>J7>FII<VDP-IXU!-\$ARWFE#N"[_NYZG&.G-=MX
M:L6LO"UC8R:F=3$<.P7@)!E7L002>F!G)Z9S6H\$,J!)(D=0<@,H(!J2@#QC
M2IK2P\"V)MIL)'KIBUQ1,6:&V^TR_P"L&<JI.S=TRN<Y&:[+3[>.W^);?V((
MTTN32RU[';X\D3>8/*; X#E=_P!0!GM79B-!NPBC><MQU^M)%#%;QB.&)(T'
M144 ?D* .*\17MHGC[3[#Q 81H5SI\GDK=8^SR70=<J^?E+;/N@^^.:I6L>A
MZ=\1]#M=+N+<6CZ5>;4CF!3F6,@#!Q@9<#V'M7H4L4<R%)8TD0]589%+Y<?'
MR+Q[4 >2:/8PMX7\6:SHA:XURQO-32Q9)BYB4NP4*N<= "..<"M2>U\)ZQX-
MOM2T4VDNIOHL_,,@^T.=@.9,?,SAE'+<@D^M>CJBI]U0/H*1(8HF=HXD1G.6
M*J 6/OZT >8+K6D7FH?#F2TU""9PQCE:.7<%'V1\*^#@'=C@\Y'M61J=KHLV
M@?$:[,D9N;"\DDLI!.=T#B",J8^?E.\'D=<8KV5((8UVI$BKG. H SZTOE1_
M\\U_*@#SR)-.TGQUX;NK*581JFF71NI%ES]I9/*96;)^9AN;GKR:J^%X9;;5
M=+LIX]+U2*[LY1'J^GR-'<M'@$M..22W'S!OO'WKT[RTX^1>.G'2FQ6\,!8Q
M0QQESEMB@9/O0!Y#X:U/0M/^&_A>V?[),;V1+>Z-U<GR()!&[$3 DCL<(<9.
M.F,U4NI;.'X>>*K4WD0BM->C2U$3&(1(S0$B-2Q*J=TA SC!..*]J,,10H8D
M*D[B-HP3ZTIC0G)123[4 ><W]O#H/CK'A]8X9]0T&[E6-'RMS<(T9C8@G#-\
MS<]2":I0RZ5?_#]=7T.2!_%\6F2'>K#[:T_E%9%<??9@23@]P,5ZGL7CY1QT
MXZ4BPQ)(TBQ(LC_>8* 3]30!YGIT>FW=I:ZU9>)=.M1%ID_V@6,6)I$,?WI<
MR$EHV&[)&<YZ9J]X.2XT_P 1Q:=<6>CSO_9Q8:GI3$"10R ><A_B;D@[CG#8
M[UWJ011L[)$BESER% W?7UHB@AMU*PQ)&"<D(H&3^% '!^*?['?XEZ-%K<T$
M=G)I5TFVXE"1R,9(B%;) /"L<'^[[5S;)=:%<6$0G2W\(S:W<>2;L,\"1&$>
M4&Y'[HR^85R=OW3TQ7L,D,4HQ)&CC@X90>E.=%D0HZAE(P01D&@#S34/"RS^
M$]8N-,O[/49;>\&HV,%K&!# Z!6>!1N;Y7VG*\#+]*?JLTVI>#-<\8Z%!(MW
M>VD:VC1)ME%NN-[#OO(,F".<*GH*[?4X=2-M%;Z/]D@5B4DDDR#$A'WD4#!8
M>AP*NVMM#96D-K;H$AA18XU'\*@8 _*@#@[N'3&\2^&+KPTUL()Q+]N^S$!)
M+/RC\TF.N&VX)YR3[URD5KIB_"=]>A=3J-CJ;F&[$Q+PC[<1@'/"E3TZ'.:]
MHCMX8=_E0QIO.7VJ!N/J?6G>6@!&Q<'J,4 >??VCHU_XM\0:=XI>VD(:%M,@
MN,$/ 8U^: ?Q.7WY*_-G ["M/X5RQR_#+0O+=6"V^UL'.T@G@^]=<8HRR,44
ME/NG'W?I2JJH,*H ]A0!Y.XTFS'Q,$MRD=^IG9(Y;@[S&UI'\VTGD%B0#CVJ
M>"UTS2Y_A]JUDR13WC"WN+D2_P"O0VKG:YS\V&5< ]",#%>H&*,L6**6(P3C
MDT>6F -BX'08H \F\,HVN:=8-J&MZ?8^(K74MUSOB_TSS!*<Q$EP2K+\H&,;
M2,#BO6Z9Y,7G>=Y:>;C&_:-V/3-/H **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#)\3ZC=:/X9U+5+0
M0M+96TESLE4E7"*6*\$8SCK^E8$GBC6;"+PW=7<-E/;ZW-%;E8$='MWD0LIY
M8AU&#G[OK6KXZ)_X0/7HE1WEFT^>&)(T+,[M&P  '.2:9X9TZP?1=)U%X&:Z
MALXT#3ER83L"L%5ON'C!P!F@!?"^NW.I:9J5QJKVL9LM0N;4R1@QILB<J&.Y
MCC.,]:UX]5TZ6R^VQW]J]IG'GK,I3_OK.*\XL]2FT_PYJ+C3GD67Q-,SM/:2
M2"&%YBRS[  6' QCC)![5E:S9EM!^($ L[N;[7+;RVJO9E6F8Q)N=$"CG(/;
M/'/- 'KT&H65U<36]O>6\T\!Q+''*K-&?]H Y'XU9KB+NSM;7XA>%[RPLA%;
MRV5W#)+# 57!\HHK$#CG.,^]:_BZ_DM])%E;O+'<W[BV26.-F\E6.'D.!QM4
MDC/? [T 0^&O%JZ_J^KV#6_D-:.DEL2?^/BV8864>Q97_#%;6HW]O86^9[ZT
MLWD^6)[E@%+=N"1GZ UPFN6%UX5\2>'=<BGFNTC/]FW$$%IR+5APV$!X1@I^
MA-6[:^2S\:>((=9L;JX74!"=.<6K2QS0>6 8@0"%(?<2&Q][/2@#:\)>(VUC
MPAI6K:G):V]Q>IDJK;%+;B %W$GT[UI?V[I'V7[5_:MC]FW^7YWVA-F_^[G.
M,^U>6VUK&_PV\#VMWITAEMM4@\^%[9BT2*Y+[ACA<$9[8(K;@TG3I_%_C:-M
M+1H9[& 19MODD8)()-O&"?N X]!0!V]W>W$6JZ=;P_8S#.7\[S9]L@ 4E?+7
M'S<CGI@<T]]9TN-D634K-&>3RE#3J"S\?*.>3R./<5YUI6=WPQDFMI_M%M:M
M'=.T#;H?]%* .<?+\_'/>H%TBSN_!GQ$1-)#3RW-Y);*;4AG7RE\LQY&2-P.
M,=Z /26O+C^WTLU^R&U-LTC$S?O@X8 83'W<'KGKBI8M5T^>XEMX;ZVEGB!+
MQ1RJSJ!P<@'(KA[:6,^/=*O3!.0WAZ6*:586!,A>(A"V/O85N#SQ4'AJTO(;
MG3M+BN8-;T46$L0-Q9>7/9)M7;&[?=8M@ @@-\N>QH [/1O$FGZUH5EJT<@M
MX+Q5:))W56^8_*#SC)]*M/K.EQ68O)-2LTM2Q03-.H0L#@C=G&<@C%>306-@
MWPI\-V@TF1;R&]L5O$^PND@*2KYI/RY.!G)KKM3>TT[7M-TJTTN.UTR:TF=+
MFWT\RY=W4F)  50M]XE@0<4 ='JNOVFD_P!F>:&D74;I+6%HR"H+*S;B<_=P
MIZ9[5;N=3T^R*"[OK: R?<$LRKN^F3S7E%K81)X$\#/J.F32)8:H4NDEM#(\
M,9$P 90I.W)C[8Z>U=)IK6^GZOXJL]<MF\F^D5[3= Q6>U\E5$*#')4AALZY
M;..: .UGOK.U(%Q=00DJ6 DD"\ 9)Y[  G\*S['5KB_UR\CABB.DV\,96[#9
M\Z5AN(4]"H7;SW+>QKSVST-[>3X>6/B"S-S/;6UPMWYD1E6,&/$:2'!'!P!G
MC(KT#7[&R'@Z_P!/=)HK$V;6Y6T7YTC*[?D ]!V]J -"TU*PU R"RO;:Y,>-
MXAE5]N>F<'BG7M_9Z;;_ &B^NX+6$''F3R!%S]2<5RGA-]5&NW,-U>6FK6:V
MD>S4XK7R'W!CB)L$JV 2?EQC/(Y%,O[PZ5\2'NM6AF;2[C34AM+@0M)'%*'8
MR(< [2P*')Z[<=J .JFU;3;>VBN9]0M(H)1NCE>955QZ@DX-2R7UI%Y?F74"
M>8,IND W#&<CUXYKBM,:WT7QGJ#7<+0:3=:?;1Z7(\3"-$0-OAY'RL2P.TX)
M]\5SMGHALQX/M[^P=H8]7NYHXI("QM[1UF\I7X^4?,G!Z9 [4 >D7_B/3;+P
MY>Z['<)=V5I"\KM:NLFX*,D YQG\:M+JEEY$,LMS##YJ;U6210<;=Q[]@"3]
M*\VU[2-T7Q*L+;3&(N+.*:VA2W.V200$,R#&"V=O3G.*M:I:Z)?:KX(>WTM3
M8+-,TP^PLBJI@=1O!48!?'7@F@#OY=6TVWMHKF;4+2.WE&Z.5YE"N,9R"3@C
M%9/B'6[S3;[P^+-K:2UU&_6UEW(6;:R.X96#8_@]#UK*M4B\/^/-16^A$&ES
MZ?;0:9)L_<Q+'O#PCLI)*G'<8ZXKGK:PNM)T?PM;SV]PD2>(Y+J&'RF)MK0^
M=LW#'R@!EX/3<!VH ]8JEJU^-+TNXO-AD:-?W<8.#(Y.$0>[,0!]:+/4HKZ[
MO;>.&X1K.41.TL117)4-E"?O#GJ*P]9DEU?Q/8Z1;SRVR6@-Y+-Y!97D'$:
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ME:9XXU2?3-+E>*/PY$D$2PL@ED1I6$62/O;=@P>>15'1YO/\5^%-4$,L<?\
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M;)0@?C@9*8[=*M:W87MM<>-[?2M.F,;7-A=&V@B*BYB4(9PG&&) (('7IWH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVQ-K'=N(0+QT8YW8QSUKT6B@#B[RRN7UKP3>16,XAL_.2<B/!@#0; ".H&[
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9BX)"@GUY8'!QQI>-M<O="T[3Y+"*226XU*VMFV(K'8\BA@-Q R02![GMUH
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M)6"[8\!068GN<@>N#VYH Z"BN2B\?V5R=)6TTS4;A]46;R%18QAXLB2-LO\
M*P(QD_+[U4U?Q=:7G@W6;FYM-9L6T^?[/>Q6LD:7,##:P*L&VE2&7D$\-TH
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MGF/YZP[P^SR]NW=D?>W8YZ5TD'AC5].^(VH^(+*6P>POK..%X92ZR*\8PH!
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MW^F<BM5]#U&7Q7I6LR3VP2RM);9XE#9?S"A+ ]L;!Q[UE3>"M2;1+K38[ZU
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M@5BC X(. >1P?6J<?@6^M;7PW-;W5D^H:+:?86$\):&YA*J.1U5LJ"",]^M
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M,9.#TQ@9_I6[<^'=<_MG3]>M-1LEU2*S-E>++"QAG3=N#  @JP;)[]2*K?\
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M;<_*#P?D'.3_ $JH? <G]G-;C5W69=6.KQ3" 868LS%2I)#)\QP."/4UV5%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%%% &5+X=TV;7XM<=)_[0BC,22"YD "$@E=@;;@D D8YQ3UT+3UU]M<$<O\
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M@;&:O:!KL'B"QENX()X!%<2VSQSA=P>-BK?=)'4'O0!J4444 %%%% !1110
M445E6.O0WVOZGHXMKB*?3TB>1Y-NUUDW;2N&)_@/4"@#5HJI=ZA%9W-G \5P
M[7<AC1HHF=5(4MER/NCCJ>]6Z "BLK0M>AUZ.^:*VN+=K*[>SE2?;G>H!.-K
M$8^;UK4)"@DD #DDT +16'?>*;&T32)HUDN[;5+E+:"YMBC1AFS@D[@<$ \@
M'I6Y0 4444 %%96A:]#KT5Z\5M<6[6=V]I*DX7=O3&<;21CGUK5H ***J:=J
M$6IVIN(HKB)1(\>V>)HVRK%2<'G''![B@"W165XCUZ'PUH=QJUQ;7%Q!;@&1
M8-I8#IGYF'&<>]:C,%0L02 ,X R?RH 6BJNG7T>IZ=;WL4<\<<Z!U2>,QNH/
MJIY!J>5VCA=UB>5E!(C0C+>PR0/S(H ?16;X?UNW\1Z%:ZO:QRQP7*ED28 .
M "1R 2.WK6E0 4444 %%4]5U!=)TFZU"2":>.VB:5TAV[RJC)QN('3)ZT_3K
MV/4]+M+^)62.YA295?J R@@''?F@"S1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1L+B6:&ZEWJ)(WCPR#^'AV! P/:MN3PKH$L4T4FCV313E#*GDC:^T +D=#@
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MU[=M!=;2%6<+%,<L!WRBFM?16E\7-J\UQJ-[:W5AJTUM'';7#1K$D;#:&12
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M  ?@*T#:P&T^RF,&#;LV=L>E 'G.EW_B'4?!'A.\M_-U1Y;9Y;ZV6^^S3S\
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M"V]R1)\JX/RAD4,5''MSSV'@^TBM/".EB%YG62UBD)EG>4Y*+T+$X'L.!Z4
M;E%>3ZMK,-Y=V6JZ?.\$\?B&.SWO?.9I%^T"*1#$/E6/!. <\8/!-7#I<&IZ
MGX]BN;R_=+.1&M@+Z4>0QME?<N&_O$GT'8#F@#TRBO,9+^6QT?P/XTO;J9K=
MK6"+5"9&V$31+MF9>F5DQSCHYKM_#FGO9::99A(+B[D:XD21RWE[B2(QD\!0
M0O'H3WH UZ9*SI"[1IYC@$JF[&X^F>U>5>--9AN+77;ZQG:VO=*OHH8YGOG6
M02+Y>Y8X1QL()SGK\QQC%;IO['4_%_B/2_$%V(H[,0&S@:<PCRFC!,JX();>
M6&1R, #'< Z7PSKB^)/#EGJZV[6ZW*EA$S;BN&(Z_A4=IK[7/B?4]%:R9&LK
M>*X$HD!\U9"X&!V^X>]>>^']6_L_P)X#@FN7MM)O+B6&\N"Y3M*8T9NJAG !
M/'3'<UM>';72Q\1O$]MI\K&V?3K3=Y=PY"G=-D(V<J.GW3P<]\T =;'KULNG
M:==7\4^GO?RI#%;W*?O!(V<(0N0#P3UJU%>O)JEQ9&RN42&-'%RP'E2%L_*I
MSG(QSQW%>4Q&/4/A]\.;G4+VX._4HA+.;IT)RDO)8,#G('.<_G6IJM[?Z7J_
MC(Z)<7,\\&@V\]JCSO/M<F;+*&)YP%/O@=: /3:*\^O4C@F\'7WAZXE=[ZY2
M.<K,S?:K9HF:1WY^8KA3N/()QGFN=NK?;\/?%6LKJ&H&_P!+U2]-G.;V4F$1
MS$*!\W(P,<YR/PH ]CK&DUYH_&$&@-9G$UG)=I<>8,81D4KMQZN/RKB_'.J6
MMY'XEABE:&\TJP619WOGB,<IC:1##&OWCTR21V'.*T[:X:X^(?AJ65PTLOAZ
M=V/J2\!)_G0!U^H7KV,<#)97-T99TB*P $H&.-[9(^4=35NN1\?NT-EHLR7$
MT+?VU91GRYF0,K3*&5@#A@1V.:SH-)MM9\?>++"]N;V2VCM[-UA%Y*JHSB7)
M7#<=!P.!Z4 ==J^K+I<=NB1B:\NY?)M8"^SS9-K-@M@X 56)..W<X%78'EDM
MXGFB$4K("\8;<$;'(SWP>]>36C'7=%^&4VHWEU+--/(CRK=21NV+>49+*0=W
M YZ]?4UNV@AUB;QA!K=Q)#/87+1P,9F5K6V$2F.5#G().]BW4D8)XQ0!Z!17
MD]G!?:_?^#+;7;O4(9M0T2X>^ACN9(O,9?*VDA2-K?,2<8/4'C(J^VCVU[XL
M\6Z?<WE^]O:Z=:/$GVZ4>6Y6;+##<'Y0?3VH ])HKRK2FEBLOAWKOVZ\>_U-
MXX+V22Y=EG5[9V(92=O#*I&!3-5UF&\O+#5=.G:"9/$,=GN>^<S2)Y_ER(8A
M\JQX)P#GC!X)H ]+35;2:ZO[2W<S75B%,\**<J67<HYX)(]ZDT^Z:^T^WNGM
M9[5IHPY@G $D>1]U@"1D5PFFV=B?''C<27ERDX>$JBWTJ$@VRDG:&&<<X/;'
M&,52T'4KBYT[X=VE_/(^GW]@YG=W)$]P(U*([=\YD.#U([XH ]1HKR+Q&;NR
MTKQO;6][=PZ997-D;*2.X=?)D<KYT:G/*C<IVG(&[I73QVB:+\3]/M[.>Y$.
MH:=<R7$4MP\BO(CQ;7PQ.&P[#([4 =M17)^*+R5/%/AC3YV9-*O99UN#G:LD
MHCS%&Q]#\QQW*@<URVO?:['3OB';6EU=1Z99V<<]H8YW7[/<&-BZ(P.0/N-M
MS@;NG- 'JM%8_A[2+?2[)I(9[F9[O9-*\\[29;: 2,GY0<=!@#L!7#W^GPWV
MK?$!9[V_(L8(9K<+>R@6[F ON7#<<\XZ#L* /4**\TTW?;ZOX U);RZ:XUBW
M<7S27#LMQFU,@)4G:,,,C &,XJE+K,-]J6@:SIL[0-<ZX;<[[YWFEB+R*RO%
M]U4R!@<X^7H: /3;74K.]NKRVMIA)+9R"*X4 _(Y4,![\,#QZU;KQ^^GDT:S
M^(M_IEU<C58+X%$%U(Q6,PP;WV$D'"ER&P<8XZ5U-GIYFOOM]MJ%K!I\^G2!
MX+*^DD-P<J5F#?*01R"PR3NY- '6:G>OI^G3W<=G<7CQ+D6]L 9'YZ*"0/UJ
MV.1TQ7CIL?)^!DGB'^TM2;4I](B9YS?2?>'3 #8'4@^O?)YK>\9:C97USK.G
M!S'/8::LWFR7SPB-F$A1HD7EG^7DY'\(YYH ZNZUYK7Q7I^AM9DB^@FF2X$@
MP/+V[AMQ_MBMFO/+&[DO/$GP\N;F7S+B?1+F21SU9F2W)/XG-:?Q%W+I&F/'
M=7%LYU>SCWP3-'E6F4," <'C/7- '845Y;X@DO?"VL>)(?#TMUO;P\;U(7F>
M;;,)&4R*')YV_G@5<47RV$6OZ%=V>5TJX98(+I[@W[^6&C8A@,LK#D\D[B#0
M!Z-17F-W- ?AP?%>@WDL^MC2V=9EG+O(YC^?<I)!93DXQ\I7& .*M);RS6T>
MKZ=K=EIUJ^E3AY8;I[@SY0%)B"!\R$$EN2<D&@#T2BO+E&K6POM$N8;;2-5E
MT]/*U&UO'EMIB950%P0'1V9L;N3@L<\4_P#MS^QDU2QU71SI]T9+*(BQU _9
MI#+(RJ0^ 8L[3OXSMQUS0!Z=17DZRO#IOQ&M(+UTMK.Q2YMUM;V1EMY##(6V
M/D'&Y 2.F<\=:OZAX:>/X?KJVFW-_-J:0V^H'?=R-YYC4,R8ST=<KM''3B@#
MTFLK6-8;3GM[6UMUNM1N]_V:V:7RP^P98EL'  QV/)%4/#;V^M75QXFMWD:U
MNXTCM 7;:8U'+[<X#%B1GT1?6LOQ18P7GQ)\))-+<(7@O>(;F2(_*L9XV,/7
MGU[]* .W&2H)&#W%+7F1E_M3PEXNOM0N98-9L+J[6.19"KVNS)@"8/ *[#Q]
M[)ZYI3I\^O\ B_2[#6;J_@DN_#1GO;>"[DB F\R($@ _+@D],9QSD9R >BWM
M[;Z=87%]=RB*VMXVEED(.%51DGCV%95SXC6#7]%TU+5I(=5CD>.YWXV[$W\J
M1GD$?G53XB1"3X;^(E)<;=.G8;&*GA#Z=1ZCH>]<[=V6GSZ]X%M(+N:6VE2[
MRPO'D9OW"Y <L6 ]@10!Z317D-_J5YX>M]<T^RNIETVU\0VD,C37#G[/;2QQ
MLX\PY9$W'&>P8XKN?#VGW%IK>H3K=6BV4\,16PMIC*L3C=F09 VAAC@#!*Y]
M: +NI^((;#4K?2X+>6]U.=#*EM#@%8P<&1V) 5<\9ZD\ &H'UW4;>9X+K0Y%
M?[/)/&\=PKQMLQE2>"I^88^7'7FN>ENH_#GQ=N[O5G$-CK%A##:7<AQ&LL9;
M,18\*3NW#/7ZUV5_>6HM)XOM,/F/ [*F\990.2!W% #/#^K+KWA[3M76$PK>
MVZ3B,MN*AAG&>_6IK^]>R%N4LKFZ\Z=(3Y"@^6&_C;)'RCOC)]J\ZT?4;(>"
M_ ^D7"AWO-+$@$MV;>';'&FXN1RQ&X87ZGC%4[*\N&\&^')'U&Y=H?% LTD%
MR_SPBZ90K<_.-J@?-G@4 >N45YS<Z9;ZIXQ\96MW=WQ@@L;6:.-;V51$[+,2
MR@-QT!QT'I5'2FEBM/AWKGVZ\>_U-HX;V22Y=EG5[9V(92=O#*","@#U2BO)
M]2UF&]O=-U;3IV@F'B&.S+/?.TTB>?Y<B-%]U8^N <\;3P35LZ7!J5[X^2XO
M+]ULIE:U OI1Y#?94?*X;^\2>>!V[T >A3ZE9V^HVFGRS!;J[5V@CP27" %C
MZ#&1U]:MUY;$T.IZU\/+[4[V=9+K19I'E%V\.^39 >JL.3DY]>^<5ZE0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9<VC*V
MO)JD3*ID@-M=Q,N5GC&2GXJ2?P9AZ8E_L32?+$?]EV6P'<%^SIC/KC%7Z* *
M$VF0HLTUA;VEO?NA5+@P E21C)Q@GZ9YIVD:7;Z+I5OI]KN,4*XW.<LY)RS,
M>Y)))]S5VB@ HHHH *1E5T9'4,K#!!&012T4 5[>PL[2)XK:T@AC?[R1QA0W
M;D#K26NGV5CN^QV=O;[\;O)B5,XZ9P/<U#I&L6NM6LMS:>9Y<5Q+;DNN,M&Y
M1L>V0:N1313*6BD210<$HP(S0!%/86=U/#/<6D$TL)W1221AFC/JI/3\*9_9
M>G_99;7[!:_9Y3F2+R5V.?4C&#5IG5<;F STR>M)'(DJ!XW5T/1E.10!3.BZ
M4UFEF=,LC:QMN2 P+L4^H7& :EDTZQEL?L,EG;O:8QY#1*8\>FW&*FCFCF3?
M%(CKG&58$5GZUK=OHVF/=MB5O,BA1%;K)(ZH@)[ EASZ<\T 2_V)I/E1Q?V9
M9>7$,1I]G3"#V&.*DDL+,W/VPV4#W2C*RF-=_ X^;K26LMQ#8Q'59+5+DDAC
M"2(R<G&-W/3'XYJQ++'#&9)9%C0=68X _&@#E_!?AQ]'M;F34-.M(]0>\N)E
MN(PK.4EE9PN[&> V"*Z.:PL[F9)I[2"65%*J[QAF4'@@$] >]5_[9M#KT>C
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEUN;9@C@OLX./5<]JZ?P!;V-OX&T?[#%!&'M(6F$0 S+Y:AMV/XN.<\UTM%
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M)D5B!@' ; /O4GQ$MM0GT2PEL8[B5+74K>YNH[9 \C0HV6VH0=Q!VMC!SMH
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MF@O9#"V)]S*8X]I&6(PY/!QG'>I_AC:+9_#_ $F%[)[2Z2!4N$D@,3[Q_>!
M)^M &Q?>(;2P\06&C396:]AEF21F 11'M!!R<Y)<8^AK*\/>+%F_M"'7=0TZ
MWN8M4GLK<;A#YJIM PK,23SV)ZU6\06L$?Q(\/W]SISS6[6=S TR6C3!92T1
M0-M4[> V">.M<\^EB^\#?$)/[)G>[N;N\E@62T</*"O[MDRN6Y'&.] 'IEYJ
M5AIP4WU[;6P;H9I53/YFK((8 @@@\@BO,XC<P^+-3FU275(+#5+"U2VEBLC,
MI"HRR1/F-BC;F)P<9W&N]T'3X-*T#3]/MGN'@MK=(XVN?]9M P-W YQ["@#
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M &YIGVV[L_MD?VBTC$MQ'SF-3G!/Y'\JI6?C/PYJ E-KJ]M*L4*SNP)VJA.
M<D8Y/;KR/6@#=HK+3Q%I3+=%KORC:!3.DT;1N@;[IVL <$\#CD\"FOXETB&R
MN;RXN_LT%JRI.US&\/EEB N0X!YR,&@#6HJ*XN(;2W>XN)5BAC&6=S@ 5F0^
M*M$GM[V=;]42QQ]J$J-&T(/0LK $ ]CCF@#8HK%L_%V@W]_;V5KJ44D]RGF0
M+A@)1C<=K$88@<D Y'<5D^/?%,6C>%M6ELM2>WU"V@=HY(H?-5)0N51R595)
MXX.#R,4 =A14%F[26-N[MN=HU+'U.*GH **** "BBB@ HHHH **** "BBB@
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M5N]PTC(K 9C;:V,Y]>>] &KJGCBWM_#'B"_M()TO](A9I+2Y@8,C[-R;@O\
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M2&2+.&4Y"LI#'C(/?VK2.@W5OXC\,3V.E06NGZ=#<I-'#*N$,VW&T<9P5)/
MZ\9H 9K7CV&#P7J.M:7%*;FTG6U>WN;9]T4I905=1R.&!SG!R.>:Z:36+*#2
M)-5N)'M[.-"[M<1/&R@''*L WT&.>,=:XS4_"NL7.D^,;2&&$R:E?QWEH6E
M5PHARK=U)\H]L<BM_P 3:->>*?!5UIQV6-[.B.@+[U21'#J"0.1E0#CU/6@"
MU%XDM#JD&FW,-S9W5S&TMLEQ&!YZJ,MMP3R 02IPV.U8W@K5QXBEO=5E:_6X
M$\]N(G25+=8DF94VA@%+X7DCY@20<=!//INH:YK.A:E>V!LO[):2=H_-5S+*
MT90*A!^[\Q.3@\#CKB;P3IM_I&BS6>H6XBE-Y<3J5<,"LLKR <=P& /]: ,*
M_P#%4^J:9XWM$^U6TFEK,MI/#!-$04@63+/C .X].,@#@@Y.MX?\6V<L6B:;
M<B]6YO+5#!<3PL([EUC#,%<]3C)YZX)&:H3Z%K<<7C:SBLH98M9,DEK.)P/F
M>!(MK*1Q@J23GITS5B;1-4D@\&.+9?,TF8-=1^8N<>0\1*GH>6!^GY4 :I\6
MZ8&MW_?&SN;G[)%>A!Y+2[BH7.<\L" V-I/>J?B;6;Q-?T3PWITWV:XU0RR2
MW04,T,,2@MM!R-S$@ D$#DX-8WA;PA<Z+8VVB:CHT-]#9S[H;YKLE&0.61C&
M>D@XX QD=16WXK\.7NI7VE:UH\T,6L:3([0K/GRIHW&'C<CD9 &#@X(Z4 6V
M\/2136\UGJVI(Z2*95ENFE69/XE*MD#([KC%9/A'4I+;2-:EO;B[NA;ZU=6\
M6XM-)M$FQ$'4^@_4]S6S9ZEK=PT:7&@?93D>8[WB,H'?;MR6/ID+^%<M%HGB
M>VT34(K6'RI9]=>_>-+H1M-:O(6:,./N/C&>GL: -74O%NGW'AK6YA<ZAIDN
MG@QW1%KNGM25W!MN""-IR#R,=ZO7GBNPTV\L].E2^GO+J!IH4BMF8RA0,X(&
MW/S#/IGM7+77A367T[QI;PZ?!&VMV\<=LJ7 94/D[#O8X.<\YP<UMR:;JLOB
MSP]J7V'%O8V4\$^94W!I/+Q@9Y \LY^HH <GQ"T22TANPM\MJT_V::9K1PMM
M+NV;)3CY3NP.^,C/45HZUXGLM"266[AO'@MU#W$T,!=(%/\ $Q].YQD@<FN5
ME\+ZW<>"?$6E_98TN[[5)+VW#3+M*/.LF"1T( .?T)I_B30?$>N'Q';-;1S6
MU]9>7I_FW95+8F(AE:,9!?>2=W/'?C% '17?B_3K756TM8KVYO1;"Z6*WMF?
MS(R0,J>AZ]<XK,U7QY;QZ)HVIZ6DDT5_J4=HX>UE9XQO*R JHR'&" #WZ U)
MIVE:I%XTM=2ELO+M$T=;%F\U2PD#A\X!^[QC/7/;'-9)\,:Y#H20QVD,ES:^
M(GU1(S.%$T1F=\!NS8;OZ4 =,L]S'J5[KE]=/;:)!9+Y4,B[>@+R2NI&X$#"
M@'D;6XYJ[8:NE_/Y7V.[MR8A,C3( )$/<$$_D<'GI3]1CGN="NHQ:037$MLR
M_9I6S&[%?N$XY4],XZ5SOA?PU+HVLR3V:7MAI!M?+_LZYO#.HEW [T&Y@@"@
MC@\YZ#'(!>N?&FEVVM2Z1Y5_+>Q-$KI%:.P42,55R<8V9'+=*BTOQ%81:=K%
M_<:G=3P6^HO"WVFWV-"YV 0HH4%AE@!D9)-+I^G:A!X^UC5);4"RO+6W@BD$
MBD@Q&0DD9Z'>,?3G%<OJNF7MGX4\307UD@N=4U<7&FH9\%I7,?E#*YVN&3/]
MWU.,T =6_B2SU"\O=",>HVFHI!YC(8F!5""5?S$RH!VD#YNHQUK%\&>,[<^%
M_#$.IM?O<7]O%&+Z:%C'+.5SM,A_B.#[9XS26-]?6.NM:ZCH-T-4U6U=8KM[
MN*7S!$,B,[0H0#>3TY)/>DA\,ZQ%X$\*:8;:,WFD7=I).@E&&2(_,5/?/;./
MPH V=#\4OJGBC7=*D@E5+&X2&!Q:R@$>4KL7<C:#ECCID8(SG-)'XJ)\>WN@
MR0R"WM[2&42+;2GYW9\[GQM"@(,$X&<\\<.T33=3T[Q9X@FEMHC8:C/'<Q3B
M;Y@1"D90ICKE"<YQ@U6N]"U";QCJL_DQMINJZ7'9R3B;:\#*9<_+CG(D&.>U
M %\>+],Q8S.+B.ROY%BM;UTQ#*S?= .<@-V) !XP>16=XROY-+U[PM<+<W4<
M,M^\,\4+,1*OD2,%*+]X[@,<527PWJ^H>#M*\*ZA;)$MC);++>I(I22*!E92
M@^\&8(H(( &3R<#.MXMT[4[N]T&^TRUCNFTV]-Q)"\PC+J8GCPI((S\^><#C
MK0 G_">Z,EAJEU<)?6[:6 UY;RVK"6-2"5;:,Y4@'GIQ4%[XLL;Q+(Q7.J6"
MMJ<%NLGV(A;DMC"Y9<>6VX?-QT.#5/7_  OJ.K:5XDNDMXUU/6+!+&*#S!MA
M10^"S=SESG&<8 &>M7_$>FZIJ>E:'':V/[ZUU"VNIT:51M6)@2 <X)../UQ0
M!9N?&NFV][J-DEMJ5S<Z>$-Q%!9NQ56!(8>HPI^O;-6E\3Z;/;:=+9N]XVHP
MF>TB@7YY8P 2WS8"@;A]XCD@=:HZ3INHP>,?$6H3VH2UOX[=8&\Q2<QJRG<
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MD\<<@'.Z?J_]JZCHFCV&MSWEE-ITU_+J *K+.%=$5<A0%Y=LX /R >M1Z/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRWL7F1;U<88JRLIRK*P(*D$9!!S5NB@"C:Z1:6MU]J EEN=GEB:>5I&5202
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5Q^AX'Q/\6@8XM-/&/PFKL*R[3P[IMEJT^J013+>W  FD:YE;S
M0H(+$$#)QQQGB@#SK0=7\0:7X,M/%.^RF6_U'=?6S0L9I/-N/*&)-WWE!50N
MW "XKUFLJ+PWI4-SYT=L1^_-P(_-<Q+*3DN(\[0V23D#J<]>:U: "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
%HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>ameh-nonqualifieddeferre017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
M5=5C)P,':P.<\@'3^%_$L7BBRN[N&UEMXH+I[=/-X:10%(?&/ER&!P>:9XC\
M56_AZYTRU:![BYO[N*W$:''EH\BQF1CV4%U'N2!ZD8^@^%]?AAUJ*^URYM6N
M=2-Q#-:0PJSKL +?,' #<<8!&WWJEKW@C7I)?M-CKCW4TM]8R.9[:/>D<,B'
M.[(&%PS[0!DEN.: -N3Q)K4^OZKINE:%;72:<\<;S3:AY)8O&LG"^6W9L=:=
M>^)M2M[H6-KHBW5_#9K>7D*W858E8L%56*_.Q*/@$*/EY(S7-WWAR3_A+]<O
M=0\'76M1W3P-!<P7$"#"PHK JTJD?,#VK3\C5M)U274]/\.W,L=]I<-JMH)X
M0]K+"9-@<E\;2).JEL;>AS0!97QE>ZEJ45MH&D0WT4FG0:@)I[WR/DE+A1C8
MW/R?K73:?+>364<E_:QVMR<[X8YO-5>>,-M7/&#TKS(>"YM,U*P2\\,3Z];6
MVAVEBLMO<1(%EC:3?P\B'!W+BNQT_2+B>SL'MY-4\/PVQ(_LU6MW#@-GYCB3
M@_[+#@]C0!7L?&K7>I6:-IGEZ??7D]C;7 N TAEBW[M\6/E4^6^#DGID#-/M
MO%UY]LTY=0T.:RM-2D>.T=I=TVY49P)(MH*95&(P6QP#BN<TGPQJ5KJFG3?V
M)+%K%O?237^M>=&5NXCNRH^;<=PV *R@+CV&;VB'Q!<:Z=6U_P +Z@;T"1+;
M%S;&"SC(/RH!*6+M@ N1GG'"T :MIXMO#>V$6I:%-91:E')):?O?,F^1-^V2
M/:-C%0> 6YX.#4^D^);N[UB#3=2TAM/FNK1KRW7SQ(VQ64$2# V/\Z\<CKSQ
M6)X?3Q%<:M)J>M^'KN/5Y8I(X9YIX&M;)<9"(J2%R"0H9L9/L!@%II&JZEXE
MBU(:5<>'IWM)(M2NHY8F-Q(0H3RP"X;:02&<#@XQR0 #J/$NOV_AK0Y]2GC>
M8H"(H(_OS/@D*/R))[ $]!5'7/&%MH7@Y=?FMWD>2W$T5HC?-(=F\J#CH%!)
M.. I-9.N^"M8NK:26W\1W-W/%8SP1)>6\3EFD!R05"*I(PN<<#//)JAJO@?Q
M!=^%6VZL)-030Y+!;1K9,%F0[E5MV%+?*I;_ &0?6@#I-3\53V]XEEIVG)=W
M(M5NIA+="!45R0BAB#N=BK8& /E.2*/$'C&W\/Z)9W\ME.]Q=[/+LV^6102N
MXOUVA=W)]<#N*YV^\*W$&K_;]1T%?$@N-*CLV4")3%*A<Y*NP 5@X&Y22-I]
M:JZAX \2'PT FM"ZU V-I:M"\"M@1E"P61F'!8%B3R<#/04 =3>>)-6_X2&_
MTK2M#AO/L,4,LLDM]Y)/F;L #8?[AZD4ESXTB7P79>(+.PFN9;[RUM;(L%>2
M1SC;GD<#<<\\*37.ZMX9FF\6:C=ZIX4F\0PW%G;11W$4T,0WH'$F5:12,EAT
MS4FF>$O$5Q_8%KJ%[<6$.D6TDL<]O)%*WG.S*D?[Q6SY</R[BO);@]: .BU'
MQA!;>'=+U>Q@6[&IO&MLCS"('>I?+,00,*K$_2H;[Q;>:?I.GW$VEV_VN^N3
M#%"NH+Y>T(SES+MQC"'MW%8MKX=U+1K7^S;G0TU_3+'4C<6K3F'S3%(C$E%)
M5-R2,PP0HVM\O2BS\/W5C;K<S^$X+NSDU.:ZCTS,32V4;H%!0%A'DL&9@&XW
M\9Q0!T&I>+&T7PJVL:CILGG['9+2S?[1OP"V=X  &T9+'@"K%UKFHE=/33-&
M:[FNX#<,TDQBAB4!>#)M;YB6X '."> *Q]/\/W\'P^UW3A9K;S7PO'M+!77%
MNL@;9%D':.3DX. 6.#@9IOB%?$BZ=I.DZ=I=[)9M;@:A/93PI,N% \M"[KC/
M.7&<#IR<@ FC\=&^M;$Z7IHENKB!YY8KFZ6!(%5S&07PV27#!<#!P3D"I;[Q
MC=0-!%;:([7)T\ZC<0W=P(##&#@KG#;GSGC@<<D9%8MSX;1=3T_56\&-=62Z
M8; :4S6[/:E7)1L,^P@AF&0Q(S[FJ7_"'WT-OIT6NZ%)XAMXM*6VA@BN$_T2
M;<Q;F1EX*F-0XR1Y?3F@#TK3KZ+4],M+^ .(;J%)D#C#!64$9'8X-6:S?#UK
M?67AS3;74YQ/?PVT:3R@YW.% )SWY[]ZTJ "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *I76D:9?74-U=Z=:7%Q#_JI9H%=T[_ "DC(_"KM% !1110
M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC<!GK@G&:NT %%%% !152]N;FWEM%M[%[I9IA',ZR*OD)@G><]1D 8'/-6Z
M"BBJ5YJUI8W^GV4[L)[^1H[=0I.XJA<Y/;A30!=HJI;7-S-?WL$UB\$$+((9
MVD4B<%<D@#E<'CGK5N@ HHHH **** "BBB@ HHJ.X>2*WEDBB,TBH66,$ N0
M.!D\#/3F@"2BH+*::XL;>>YMFM9I(U:2!F#&)B,E21P<'C(J>@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!"20=L>_[F\@83/;=C- &[117)C5=17XF3:/)? :;'I:W^TQJ"&,K(5+8^Z
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MV'+'V4T :U%8WA375\2>&+'50GER31XFC[QRJ=KK^# BL+Q7XM2TN=%@TO5
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M$,,O(61R<!5)Z\\<>AK"\<>(Y+'PMK<NCWY@U/38Q(W[D-MR< '<I&".1]*
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M>[B"?-$H20,WN/F'3/6C6[;Q#JUK>07.EW[2V^M0S0I$$6#[.EPC!UP=TC%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWABUM,8F8?W21S@YJS%%'!"D,2*D<:A451@*!P *?10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% "$!A@@$9SS2T44 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG(PAR<Y]C0!Z-1GG%<+)XQ\0QP:\G]B6+7>A'?=#[:P2:,QB0>6=F=VW/W@
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MMM4T+P.VG:8EE)9+9W<NH@1INC$0+QC:=S;\X(( ZD]LZ?A.;^R]+\42V\4
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MSVQ7=4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVX8.K*RLK+NZX<\Y_"NRHH YE/"L]G<:M_9NI_9K359&FN(G@WLDK*%=XVW
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M:-:0.EN4CB5B"QV%R220/XN@'OG>HH R?#.BOX=\.V6D-<BY2SC$4<GE["5
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M*G.\9.7.>G;I6?;^"'MO#GA_25U,$Z+=1W$,QM_]8$5E"L-W^V>01TZ5U]%
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M:Y_:!@674;J)_P#A'A,?(=5'$^"@^7[AY/K[UW%_X/\ #FJ:DNHWVBV5Q>*
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M'F%1T&[K[47FCZ?J$Z3W5JDDR(4#\AMIZKD=1[=* ,-=1&H?#!M1L[J]C/\
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M7*G=G[_.#G'..ISM7VJV>KR:5I=\RM/-I"WLDD]XT$0#;5W +R[YSCI@=^:
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M,$E6.[;G[P"]C5WQ%87>F>%;TC5RBMK5H;>.SNG(M%>6)7CSQD<LP4C W=*
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MWAN(;[4(;.1VE(*"1L;@ #N[]Q^- &HFF6$;2M'8VRF92LI6)1O!Z@\<@^]
MTRP!@(L;8&W),!\I?W6>NWCC\*L@@]"#]*9*TGDR&!4>4 [5=]JD^A(!Q^1H
M KMI.G/:?9'T^U:VW;O),*E,^NW&,U*EC:1S/-':PI*Z[7=8P&8=,$]QP/RK
MD+7QO>W/ASPOJW]G0*-9NX[:5/..8-Y;!'R_-PI[BNVH JV>FV&G!Q8V5M:B
M0Y?R(E3<?4X'-.N["SU"/R[VT@N4Z;9HPX[=B/8?E4X()(!&1UHW+NV[ANQG
M&>: *&H_VC;6<46C6EJ[[A'B:0QI"F#\P 4[L''R\9'<5-IUC%IFG6]E /W<
M$80'&,X[GW/7\:CM=7M+W5=0TZ%G-Q8&,3Y7 !==R@'OQ_.J#Z[<1^.(=!>U
MB%M+827BW D);*.BE2N,#[_J>E &K<V%G>,K75I!.R?=,L88K],BFIIMA')+
M(EE;*\H(D98E!<'J"<<YJSD;=V1C&<T A@"""#T(H IS:/IEQ:):S:=:26R'
M<D+P*44^H!&!3WTRPDDBD>RMF>( 1LT2DH!T ..,59R,@9&3VI: *D>E:=$D
MJ1V%JBRC$@6%0''H>.:;+H^ESK$LVFV<BQ8\L/ I"8SC&1QC)_.KBNKKN5@5
M]0>*;*7$3F)5:3!VJS;03VR<' _ T -N+:WO+=H+F"*>%^&CE0,I^H/%0?V1
MIGV6.V_LZT^SQ\I%Y"[$^@Q@50\)Z[)XB\-6FJ3P);RSF0&)'W!=LC+P2!G[
MOI6T652 6 )Z9/6@"I/I&F70B%QIUI,(5VQ^9 K;!Z#(X'TJX  , 8 H) &2
M<5%</(EN[0K&\N/D61]JL>P) ./R- $2Z;8+>M>K96PNVZSB)?,/&/O8STI4
MTZRBNFNH[.W2X8DF58E#G/7G&:Q-"\1WVM^%M%UB'2@[Z@R>?&DX MXR3E\M
M][&!P.3FNC) ZD#ZT 1W-K;WD#074$4\+?>CE0,I^H-1QZ=90W)N8[.W2<]9
M5B4-^>,U8)"C)( ]35+4-7M-,N+""X9Q)?W'V> *N<OM9N?084T .?2-->U>
MU?3[1K=VW/"85*,WJ1C!-6(((;:%(;>)(HD&%2-0JJ/8#I3RR@@$@$]!GK2T
M 54TRPCNOM26-LMQDMYRQ*'R>ISC.3DTZXL+.[D22YM()G3[K21ABOT)'%3A
ME;.U@<'!P>E8^BZO/K<LUW!' -)#RPQ/N;S7DCD*,2,8"Y5L<YX![X !>?2M
M.D>9WL+5FGP9B85)DQTW<<X]Z=#IUC;SM-#9V\<K@AG2)0QSUR0*K'6(9=3O
M=*M1YE_:0).R/E$PY8+\V#UV-T!JOX4UQ_$?A?3M7EA2"2[B\TPJVX+R1C/>
M@#5M[6WLXO*MH(H(\YV1(%&?H*9;6%G9L[6MI! 7^\8HPN[ZXZ]:G+*&"D@$
M]!GK2T 58--L+61I+>RMH9'!#-'$JE@>H) ID>CZ9$BI'IUHB(_F*JP* K_W
MAQUX'-7%96SM8'!P<&J]]//;V%Q+:6WVNY2-FBMQ($,K <+N/ R>,F@"/^QM
M+VNO]FV>'.7'D+\WUXYIYTVP98E-E;%801$#$N$SUV\<?A4T<I-NDLRB%BH+
MJ6!VGN,]#4%_<W=LMN;2Q-V9)TCD E5/*C)^:3GKCT')H C_ +$TG9L_LNRV
M9SM^SIC/KTJ673;&X96FLK:1E38I>)20OH,CISTJR6 ZD#ZT$A1DD >IH HO
MH>D2Q)%)I=D\:$LB-;H0I/4@8XS@58ELK2=85FM89%A8-$'C!$9'0KGH1[5D
M^(-<N=&O=%BBM8I8=1OULW=I"&CW*S9"XYX0]Q6[0!6ATZRMIVG@L[>*9L[I
M$B56.>3D@4Q-)TV, 1Z?:J!)YH"PJ,/_ 'NG7WZUG7&NW$'C2PT/[-$;>[M9
MIQ.)26!C* J5Q@??'<]*W-R[MN1NQG&>: (8[.UBFFFCMH4EGQYKJ@#28Z;C
MW_&H[;2]/LHI(K6QM8(Y!B1(H54/]0!SU-6BZA@I8!CT&>352PNKJXBG>]LC
M9M',Z(K2J^^,'Y7R.F1S@\B@"6UL;2R#"TM8( WWA%&%S]<47=E:W\/DWEM#
M<19#;)HPZY'0X-17MU=0_9#9V7VM99UCE*RJGE1G.9.?O8XX')S5LLJD L 3
MTR>M $)LK5K/[&UM";7;M\DQC9CTV],4Q-,T^*=)X[&V29  LBQ*&4 8 !QG
MIQ]*M$@#).* <C(Z4 56TS3WBGB:QMC'.<S(8EQ(?5ACG\:9_9&F?98[7^SK
M3[/&<I%Y"[%/L,8%7"0.I HR,XR,CM0 D<:11K'&BHB@*JJ,  =@*KRZ983R
MR2S6-M))* LCO$I+@= 21R!5G(SC(SUQ6'X?URYU>^UNVN;6*!M-O/LP\N0N
M''EH^[) _O\ 3% &F=-L3#%";*W\J)MT:>4NU#Z@8X--_LG33YF=/M?WK^9)
M^Y7YW_O'CD\GFK995QN(&3@9/>@D 9) 'O0!6BTVP@,ABLK:,R@K(4B4;P>H
M/'-306\-K"L-O#'%$O1(U"J/P%4O[5637CI4$?F/%")KE]V!"&)"#W9B&X[!
M2?3-F[N)8K.>6UA%S-$I(A#A2Q'\.>Q],_I0 Q]*TZ5I6DL+5S,P:4M"IWD=
M"W')'O3CI]D1 #9V^+<YA'E#]V?]GCCH.E)IVH6VJZ;;W]G)OM[B,2(V,'!]
M1V/8CM5J@"K'IFGQ7KWL=C;)=O\ >G6)1(WU;&35B2-)HVCD17C<%65AD$'L
M13J* *D.EZ?;6KVL%C;16[_>B2%51OJ ,&@:5IPMC;"PM?(+;S%Y*[2WKC&,
M^]6Z* .5O?#C-XB-VVFV.HZ=]E2""UGP!:,&8L44J5PX*Y/!^0=>TOA_PA8:
M78W,5S8V3FXNY+OR$B#10%\#8F1TPHSP,G)P.E=+10!6BTZQ@F>:&SMXY9 0
M[I$H9L\G) YIBZ3IJ^3MT^U'D-OBQ"O[MO5>.#[BKE% %(Z-I9QG3;,[26'[
MA>">IZ5=HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#F/B!=7EEX2FN+3SPJ3P&Z-OGS!;^8OFE<
M<YV;NG.,US4=QX9?XF>&[S0!IXCGLKQ&GM558Y6_=;5R."PYXZC(KTRD  &
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MK&40WWPZTAK$J/&45Q;ACP+H70E43^9_%C;O+9XV^V*]=IH10Y<*-QX)QR:
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M3YBV]& ;!.<$8YPO/%2Z%H:Z3)J-R[1M<ZC<_:9_*7:BG:J */8*,GN<GC.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&0IG<%E*[&Q@]">A]* -JBL;3?%6CZM=I;6-S)*TBNT4GV:18I0IPQ20J$<
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MQ:S+NCEC.0PZ?SXJRP)4@$@D=1VH 6BN$\.^-;6UM+V+Q!K :>/5;FT262,
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MMK]@E\X(<D.%VYV\'G\.O%8%]X4U7^S;V2"T\RZU'7H-4DA61 (8XWC.TDD
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M3/;&ZC2WM9)?-C&,E"H(;[P/&<#). *R+;1-8TW2_$>B)9"ZBU*XN9K6Z\U
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MT$SF-$2!S(9 2"A3&005;.>F#6;)8ZE/X\TG5O[/D2T@T^:VE9I(\J\C1L.
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M,9VE!L)[_,U6?$^CZAJ5QHMYIK6WGZ;>_:3'<LRK(IC>,C<H)!^?/3M70T4
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M/F=XIG?&'*E54;<'&!D[NHQSO^%+#4-)\,Z?INI?9?.LX$MPUL[,K*BA0WS
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M,005'UJ9=%UW3?%5YK6G?8+A-3AA6\M;B9X_+EC4J&C<(V00<$$#H#FNMHH
MX9?!]W9^)-3U&/3]%U*WU1DFE2]RKV\H0*VP[&W(< X.W%'B'P0^O2SA]/TR
M*8*B66IPR/%<6BA5' 5>=K!B!OQR!7<YQ10!Q&K^"I-8U0W<EGI]O>)<H\.K
MP3,ETL:L#M(5 &. 5Y8C!SVQ7;T44 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S7Q U2]T7P'K&H:
M<72[AMV:.1-N8S_>^;CC\:E'B"Y.HV^CIIX_M1[9KEXIIP%CB#!0S,H;EB>
M >ASC'-KQ/HO_"1^&-1T?SS!]L@:(2[=VPGH<=ZSG\/:G_;=CKZWMH=5BM6L
M[I1"RPSQ%MP &XE2K<@Y.<GCG@ O>'O$":[%>JUNUM>6%RUK=0,V[8X .0W&
MY2""#@=>@K9KDTT74M+ND33I_P#2=3U$WNIW8B&U8U4#8H.<$@(@ZG[S5TM[
M;M=V%Q;+,\+31-&)4^\A(QN'N.M '.0>,)CXCMM&NM.BBFO(9);<1WBR.K(
M2DJ@#RVP>Q8<'FJ$?Q NVT.'77\/NFE_:C:W$GVM3)&1.8=RIM^9=V,\@^QQ
MFGZ7X+U.PD\/2OJ=BQT6*6%(XK,HLH= NYOG)W<9)Z'/3O2KX'N_^$!G\,OJ
M<)D>Y,Z7(MR ,W'GD%=W/.1UH U;W5WU";4M-TW38=1-GMCNTN)O+0LRAMB_
M*VYMI!.<#YASUQ1^%XQ\,] &,?Z,./Q-21>&M5L?$-_J&G:M!#;:IL>\@DMB
MY254"%XFW#!( X8,,C//2K_A+0YO#7ABRT>:Z2Y-HGEK*L93<,Y&1D\\^M !
M=ZY.VJW.E:19Q7E]:PI-.)IS#&@<ML&X*QW':QQC&!R1Q5>V\27FH33VECI:
M-?6EO#+=PW%SY8BDD7<(@P5LL!U. .1[X;=>'=0@\5S:]HU]!"]W;I!>6]S"
M72383L=2K A@&([@CTI8O#^H6'B"]U>PN[8R:C%$MY%-$VSS8UVK(F&R.."I
MSG Y'< H1^/UN[;0+BPTJ6=-7EDMPC2A'AEC5RRL,8X,9&<^_-0:EXLDETWQ
M)I>M:')!<V.GM=2P07N5GMB&!:.4!2#\K#& <U0UG0Y= G\$:9I-S$MRNISR
M>?<Q%U=V@F=R5!'4LW0\9'7%=#J'A2?4=.UDS7D7]J:K9?89+@0GRX8L, J)
MNSU=CRW)/I@  ;_PEEI;26&E6ZVZ73Z>EYLO+ORT2,_*H+D$LQ.>W\))[9J6
MOQ$L[^'3!;1V\-Q?PS2*M]=B% T<GEL@<*VYMV<8'09]JE_X1'4+75-/U:QO
M[07T%@NGW*3VY:*>-3E6 #91@2>YZXJ]J>A7FIQK#>KI%_;M#LD@NK,E%?)^
M=1N/8@8]AR* -RSFDN+*"::$P2R1J[Q%MQ0D9*Y[XZ5SESXOE&F:GJMAIOVO
M3M-EECF<3[)'\K_6&-=I#8P1RPSM/MG9T+28]"T&QTJ*5Y8[2%85=^K8&,__
M %JP8_"-Y:6>LZ597\2:7JDLLIWQDRVQE_U@3G# DDC/W2?XNE &?-J8U[X@
M:=;#3UU#2&TJ.^@\W9M5GD&)@#SD  #N.<=:[ZN6M_#4FD^(HM6M9X_L%II:
MZ?'9K"S/Y:'<"&W<GC&,5K>'UU4:-"^M2J]_*6DD154"(,<B,8Z[1@9[D$T
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M,O8C+%*UUME"E"ZETV84-@#[Q(W#(JO'XV\WP]X=UA--?R=9G@AV^<,P^:<
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M$W$("I#%<CKM&1P>*HZ'XF@T7PGX-TT_95N+W2(GB:[N/(B.R*/*[MIRQWC
M Z GMS=_X1'4[:YUN'3]8AATO5WDGEBDMB\L,KKM<QON P>#@J<4^'PK>1:#
MI>CW#:7J-I9V:VKQ7=H2CE0%60 DX. <COGJ* .EL9Y;FP@GG@\B61 SQ;]V
MPD<C/?ZUS_B'Q?)X=G1[FPB-EY\<+.;M5F(=E7>D6/F4%@#\P/!XK5\/:-%X
M>T"STF&1I([:/8&(QGDG@<X'/ SP,"N7OO >HW<&MVJZO;K!J5\EZ':T+3*5
M=&$;-OY0;,# !''/'(!HR^*=3DUK5])T_0/M-QIR12%GO%C619 Q&#M)#?+P
M,8]2.\ECXRM]6LM'?3K9I+S5;5KJ&WE?8(T7;N+L < %@O .2>F,D3Z9H5Y9
M>*-7UB:\@D348X4\E(2IC\H, =VXYSN/:L*P\!ZEI%GH+Z?K%NNI:1!):^9)
M:DQ7$#D$JRAP005!!#=J '^ DD3Q%XR$UC%92_VC$6@A<.BG[/&<@@#.<[N@
M//(S72:MK2:;=Z?8QQ>=?:A(T=O$6VK\JEF9FP<  >A.2!CFJF@>'[S2-8UF
M^N=0CNO[3F2=@(=A1EC5,#YC\OR\#J!C)/6I-?T"35+S2]2M+A;?4=,F:2!W
M3<CJZE71AD'!!ZCH0#STH P/$/C.\MM!\5VR6K6FMZ59&X0QR+(A1E;9*I8#
M(!!R",Y'>JFI2W9\7^"[XZ5G4FM[R/:TB!GQ$F"SC.!R3WQDX&>*V[_P:=6M
MO$#WETJ7VL60L?,B3*01@-M !.6^9V)/&>!QBG?\(YJ\^L>']2N]2LFDTM)4
MD2*U91+YBA3C+G;@ >O- $">/88=/NGU.R^Q7UOJ*:8UN9PR&9PK*1)@#9M;
M<20" #QZQW/C]+6UUYC913SZ/;+=NMM=B2.6)@QRK[1@@H001Z=<TW4? 4U]
M/JDZZFD4MQJ4.J6C^1N^SS1HJ ,-V'4A3D<=:T=4T+5];\*ZGI%W>V$,M] 8
M/,M[5ML88$,<%\D\\=,>] &CHFI7VIPS2WFE/8)N4P;YE<RH5!W$#[O)QCVK
M.NKR)/B#:6IL96NVTV>2&<7)"%5>/<ICZ9RR_,:W;&*:"QAAN'1Y40*S(I4'
M'?!)Q^=9%YH5[/XQM-=BO($2VM);40-"26WLC%MV[L4'&* ,5?B!=G0TUQ_#
M[IIBW36MS)]K4R1D3&'<J;?F&[KR#['K275Z]U\3;FUOM.2XT_3K"WNHGF*%
M;=R\A,P!YS\@''(V^_,J^![L^ KOPU)J<)>:Y:=+E;<@+NG\X@KNYYR.HK1C
M\-W3^*+[5KNZMY;>]L8[*6V6%@0JESD-N[F0]NE %:3QL8-&T_7I]-V:)>R1
M*MP)LRQI*0(Y'CVX"DE<X8D;AQUP]?%>HS^)+_1[3P_),;&:%)Y_M2JJQR#(
M< C)('\(]^1QF"#P9<GPY:>&;V^BGT>TDBVL(R)I8HG#QQMS@8*J"PZ@=!G-
M:6F:%>V'B;6]6>\@DCU+RB(1"08O+3:/FW'.>_ H PW^(5W%IDVJR>'9/[/M
MM0:PN76Z4R*PE\K<J8^8;B.I'XUM:=XDNI_$%YHVH:4;2ZAM5O(?+G$HFB+%
M>N!M8$8QR.>M8\G@;49?"NH:(=5M@;S43?F;[*WR9G$Q7;OYY&,YZ5HZIX6N
M]2UJYU!=2%N;G1WTQ_+B.Y&8EO,1MW&">GMUH +/Q=))XE71+O3XHYYK:2XA
M^SW:S'Y"NY)!A=C_ ##N1UYKE[;Q%>7GPQ.HZ]IUS=Q?;,-(MV(6;_2RJ8V<
M@*0@([@=ZZ#2O"&H66I:#>3ZA9$:5:RV@@M[0QHROY?S#YR0W[OGMST'4U3X
M&U,^"[CPR-7M?(-UYL$WV1MZIY_G8;Y\,<\9&.* -^779IM7OM+TJTCNKFQC
MC>X,TYB56<$J@(5B3@9/  R.>>,>'X@"]30VL-(FF.K230!'E5&@FB5RZ..>
MA0C([<C/0Z"Z!?67B.\UK3KFW$FHPQ)>0S1L5,D8(61"#D<'!4]<#D51@\$2
M6-QH#V=_&$TNXGNI?,A):XEF#ASD,-H_>$@<XX% &KX?U^;5[C4[*\L/L5_I
MTRQ3Q+,)4(9 ZLK8&00>X!%-\2^(Y?#[Z8J:;)>_;[M;1!'*%*NRLPZ]OE/.
M13]-T.;3_$VMZH;E)(=3:%A%Y9#1F.,)][/(.,]!3/$FA7>M3Z1);7<-N-/O
M5O,21%_,*JRA>&&!ASZ]* * \:2?:&T^6RM;75H;99[FVNK]42/<S!4#A3N)
MVD], $<\UDPZG8Z_XS\$Z_:0>6+W3[UB74!P (OE8CK@[A^?K6Y=^&KV/Q5+
MK^DWEM')=6Z6]W;W4!D2383L=2&!5AN([@CTZU+=^'[Z[\2:+JTE];;=/AFB
MDB%N1YOFA0Q!W?+C8,#GKUH S8?B+8W$>FW<*0/8:A=K:1,MT#.I9BJ.T6.%
M) _BR 02.H%F#QA<2V>NL^EHEYI-R+;[+]I):9F"E-IV<!]R[?4GG%+X9\,Z
MEX9MHM+@O[.;2;=R8/,MF\]8R2?++!L'&<!L=.U6IO"Z2>,H]>2Y*1F!4N+4
M+\L\B$^4Y/\ L[W_ /'?2@"OXE\5W7AK3Y+Z?38'@MXA)/NO0C-QEA""O[P@
M>NW/:EN/%5X?$)T;3]'^TS/8B^BEDN1$C(6VX;Y25[]CV]R*.L>";_4KOQ(8
MM5@BM];M1 QDM2\L&(]FU6W ;#]XC'4GH3D:%EX<OK;Q5!K,M];O''IJV!A6
M @G#;MX;<>_;'2@#$U;QE?WGA72=1TVTGMKB?68;*YAWH2A6?RY(]QX.2I (
M['M7>0/)) CRQ&*1E!:,L#M/ID<&N.;P1>KH#6$.IP">/6#JMO*UN2H;SS+L
M==W(R<9!%=E")1"@F9'E"C>R*54GN0"3@>V30!R_AW4)=376M?,4EPPNIK6T
MA0@8BA8IA<G +.K,3_NC^$5"OCV.WEUN'4+.-9=*LOMS?8KD7"R1_," =JE6
M!7!!'?.:I1>'9;C0_$?@[[2UF\US+=6LVS<KPRR>9TR,@,71AGIC^\*T$\+:
MNFKS:J-4LDN9=.2R$<=F5BC*NS@J-^=OS8()_$=* -;0]:DUCS) ED]L$1HK
MBSO/M".3G*YVK@C ]>M2ZIK*:?=V5C''YU]?,ZV\.[:#M7<S,W.% QS@GD8!
MK.T3PK!I6NW>L+!9VL]S L#PV,7EQMAB=[?WF.<9QP!WJ3Q'X>NM4OM+U33;
MY+/4M-D=H6EB\R.1'7:Z.H(.#@<@\8H Y;2-5C\/^)O'NKZO916*6\-I-,EL
MXE#_ "2<J<+DL?4 Y/XUT-IXP2;6[?2Y+>!IKJVDN+?[)=K-DIMW(W "M\PQ
MR0>>>*I3>!)M2?Q&-5U))XM=MH89EA@,9A:-2 4RQXR<X.>G4UMZ39Z[:V_E
MW]]I]PZ1[%DBM&C,C=F;YR![@?F.E ' Z9J*R?#R+7M6T)I9KNZ@^T745R(I
M9R;G"$LGS;58J-I[<#BNRNO$VHCQ)>Z'8Z(+FYM[6.Z5Y+L1QNK,R@$[20<H
M>Q_"LU? VH+X MO"_P#:MOF":.3[3]F;Y@DHE V[^N1CKTK9M="O8?&5SKTM
MY R7%G%:&!82"NQG8-NW=RYXQ0!GVWQ L;NPT:1(E@NM468I#=3B-8O*.V3<
M_/1N!@'.?3.'Z?XYMM1BCABM]VI27TM@ENDH9&DC7>S"3'^KVX.[&>0,9XK.
MM/ %[IT.DS6FJ6YU#2Y;GRWEMB8YHIW+LCKNR""1A@>W2M75_#>I:F-+OHM1
MMK;6--G:6"1+8F$JZ[6C9-V2".X(.>: ,SPHLX^)7BQKK3X+*=K:R9E@E\Q7
M_P!=\^[:I.?< \5K^-KN"RT.*6ZLY;JW^V6ZL(K@PE6,JJAR.2-Q&12Z/X?U
M"P\3:CK5WJ,-PU_;P12Q) 4$9CWXV?,>#O/!R??M4_BO0[CQ%HZV%O=QVO\
MI$,[.\1?_5R+(!@$=2H% %2Y\3ZC_P )%?Z)8:&+FYM;:.Y5Y+L1HZNS <[2
M0?D/8_A6GX<UN+Q'H%IJL4,D"SJ<Q2$%D96*L"1UP0>:J6>A7D'C"\UV6\@=
M+FTBMC L)!7RR[ [MW<N>,5)X4T.;PYH$6ES7*7/E22,LBQE,AW9\$9/3<10
M!7\4^)Y_#=I/>"PAFMK>+SI&EO%A9P,DB)2#O8 9P2O48)J*X\67/]N6>F6&
MD_:C>V#7MO*UP(UP"@PXVDK]\<C/TJMJW@V_U#4M?FAU2"*#6+(6K>9;&26#
M",F$;< %.[)&.N?7(S+JSU2T^('ARSL;NS%U;Z'.DCS0,R2*)(1P P*GH>IZ
M8[T 7)?B#-;:/J-S<:')'?:9>Q6EY9_: =ID*!'1L88'>IZ ]:T%\1W)\1V^
M@:UH@MH]1BE-I*)UG278,LCKM&UMISCY@>>36+XZT<:9X%U69)PU_?:A9S3W
M+)P9//A5<+GA5"J ,]!U))-=+#HUY/?6^IZK<6TU_:12);""%DBC+@!F(+$D
MG '7@$COF@#BM N+:P^''A9)K&2>%M7$2>5<&'RG-TZHQQ]Y03RO0UV-WXBO
M))M2AT33$U"336"7(DN##ER@?8F%;<VUEZX'(&>N,>'P-J,/A;2M%&JVQ;3]
M06^\XVK?O-LIE"[=_')(SGI6C#X<U33/$.I:CI.HVJ6^ILDMS;7-NSA)0H4N
MA5AP0!E3Z=: $\1>+Y/#A$]SI\1LEECC=C=JLQ#E1OCCQ\Z@M@_,#P>/7%LI
M;W3/'OC+^Q=%CO)6%G*Z>>MNI/EMGG!RQ/MCKDCO8U#P'J%[#K]LNKVZ0:K=
M+=>8UH6F0@H1&6WX*#9P, C/7UTT\/ZS:^)M2U6SU.S2/4DA6:.2U9FC,:;0
M4.\ YRW!'I^(!AQ:I9>(O%_@;7[6W,1NK:^#>8H$B[54%&/^RVX?GZUH1_$6
MPFAL;V%()-/O+Q;1&6Z!G!9RBN8L?=+8_BS@@X["S'X.-GJGAV;3[J.*RT:.
M:,0R1EWF\T ,Q;( /&>G4FE\-^&=2\,P)IEM?V<NDPRLT DMF\](RQ;R]P;!
MQD@-CIVH Z>:&*XA>&:-)(G&&1U!##T(/6O)?A[;:1=^#?#4-WHDKWD\['[>
M;<##([R ^9C)^X%_2O7'W;&V$!\?*6&1GWKC=#\*^(-!\*6^@6VMV)CAC:,7
M'V)Q( Q))'[W /)P: .=U.;0-(^(/B:ZUG3XY[);2R^7[.'5'D:0%CGA<D %
MB0.F33/$6B7>E?!6:#4W$MU%<QO"3)YC6\;W*;8PYY.$.TG\.E=A'X4F?Q5K
M&J7MQ:W-EJELEK+9FW/^K3?CYMV#G><\5F7?@75)_!4WA8:Y&]H)4-M-/;,\
ML4*2!TC8[QNQM"[N..U %?6X&TSQ7<3ZEX6N=:T-K2*.R2SMTG6T8%O,!A)&
M"V5^8 \ "MG3?$&BV/@ :MI<K2Z= CB%9<HP?>5$1W8VG>0O/3BKQM?$<=Y-
M)#?Z>\,P4[)H')A8* =N'Y4XSCCDGFJ,7A"6U33+:"\A>SM[M[VZ2:$EKJ9R
MS%B0P"@,Y8#!P0OI0!D> =1:RU[6/#-SJL>HR#;J5O<)('WK+_K1QTVR[CCT
M<5Z#7,ZUX8N+WQ#HVKZ;=6UE-IS2;LVY;SD<89#AAQP#WP1734 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M80M( Y0=6QUP/6N/T[QU<ZG;Z/J-K:":TU*X6)K:."0RP1N2%E9_ND# +#
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M%& .!T%7:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=@!;+ 87@]R,]JX75KGQ5INB6QEU"6TD?7H+>W9Q%([VLDB "7 (R,L/E()
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M*;-JOB&"Z\4>'K._>XUM9%ETQIU7"6[1[P< #.&5TR<\E<T >D4C,J*68A5
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MBI?#^MP>(]$M]5MHIHH9RX5)@ XVN5.<$CJI[UIT 8]SX6T2\U4:G/81M>;
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M?;FA%N9\?-Y88L%^F235JJ&MZK'H>BWFJS033PVD+32I#MW;%!+$;B!P >]
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M]5^RYODA$(F+L2R#. W.&QD\G)YHOM;M+*UU&9";J33H_,N8+=E,B#;NY!(
M.WG!(X_"I]+OX]5TFSU&%'2*[@2=%?&X!E# ''?F@"I9^&M(L)(VMK38L4AD
MBB\QS%$QSDI&3M0\G[H'4^M:U%% !1110 4444 %%%% !1110 4444 %%%%
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MVW-J[!FC9,Y(Z')YR,#![8XJ3^P],-C/9M91/;W'^O20;O-XQ\Y/+<<<YXH
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MVP>(3XM2_P!0N;,:5</!%';W!A,48B5A(V#\VXEC\V5P.G7.M\//^2<>&_\
ML&P?^@"M&?PWHEUJ,>H3Z5:27D:A%G>(%\#H,]\=O2K=C86FF6B6EC;QV]O&
M,)%&NU5'H!VH \[?5-0U#X;:QXG&HW5KK%G)=2)&LK!(6AD8+"8L[3E5 .02
M=V?3%_38+B\^*EQ=3W-S!+_8=G*\"E0 3)+E#\N< CUSR>:ZUM TIKU[PV$/
MGR.))#CAW'1F7H6&!@D9&!3KK0]+O=0CU"YL+>6\CC,23L@+JASP#UQR?S-
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M.M 'FNM72Z_\)K/Q'=ZE<&]N9[9GBCN"L.XW"9B\K.WY>>V[Y<D]:]*\2_\
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M3S846( 1O_>7T/;- '":SK>J>$T\8VUGJ%U<16<=A+;O=R>:UOY[LDAW-DX
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M(@9A'&P'R!V Z<G'7)S2>*;35['P9KJZE,K6;W]D]E&UPTTD2F>'<K.P!(W
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-D*\[L;@2,<=:MV^HV\^L^&]+UJ5/['NM!62!9GQ%<7(*[@QZ,P3! /J3UH
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M=5BE9$M[S#_*F",94(Q4<<@XYH ]8HKSTVMKI'C'P?<64TJ'4HIX[IC.S"X
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MYYSMV\ "O36 *D'H1SSB@"KI]Y->PRO-8SV;),\828KEU4X#C!/!ZBK1.%)
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MW"V[3QB=AE8RXW$>H'6L72-:O+WQ5KVDW,<"Q:>+=H7CSN82!C\V3VVCI[T
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MQF'#;FD<(O?&,L.: +;V-I)<&X>U@:8IL,AC!8KZ9ZX]J;)I]E-;"VEL[=X
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MC1*0P.1TJU10!XOH>DZ;J_P[TK3]/M$7Q1#<0OYIA*SVK+,&+LQ&54)G'8C
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M62,NF'$ &(P?J,OCL7([5SNN'1X_BI')KD436CZ,L<37,1>(R><QV\@KNQG
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M+CR_M,@3:9F928MVW##D''OUJ$B"3PUXPTC6X]VM3W5TT43+F6X#9^SM%W;
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MDC'.?2N8ABLM2:;6LZ_->PZ;+;^5=Z>T6U7VDIM$2[VW =,XYK*@TV:#P)X
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M1L+6]U:)F^V@AX(PL>XLH8C<"2 N3WS['JD#"-0[!F &6 QD^N*\W@MF>_\
MA\TVE7C+:V,D=T7L9"(3Y*JH?Y>/F!_GT.:]*H **** "BBB@ HHHH ****
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MXY#@!6<#:IR1U(ZCUJKXDU^TT[3+]%O9X;F*$L9+:W:8P'&5+X1E0'_:&,4
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M4^H/X=CD4 <GHVK1P>*&;4M(UB'6=1M=D4ES%"J2)#EO+39(P!^=F^8\YZ\
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ME78'=@\GL<\UZ)110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH>>&#S/+1L@,,9R<JW&/X3VKG+B_FED\ 75KJEY-#?3!9)';R_M*&VD<,Z#
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MINK1@8R9PC(50 X4$@9QD@#N!6CX6\-W6@WFH+,R/8PRR#2D4\QPR,)'4_\
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MJ,6G:?;/+?75D)+N&,2V\'F$DR* C9!"AB<9..M9'A;0KJTATR#5="@6ZTY
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M]@02!R.M>A4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 45S_CC5KK0_!&LZE8JQNK>U=XF !V-CAN
M>,#K^'0UD6LEEI^L>'+4:9J^GRWLT\BJ;A/+DD\HEC,%D;>2%R.O)SUS0!V]
M%<Q-XVLXK,:DMO(^D_:_L;7:L.'\SRMVWJ4W_+GKWP1S67X?O[30;KQK=7<K
MI:V^JJ!DER-T$.%4=<EFP!ZF@#NZ*X*^N;J;XH^&//TVXLPT-WAVF5EE 1<
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M1C/'KTYH Z&BN'TWQ=9Z9X4TZ]CL]9N8+O47LU^T2)+,DC3LGS$MR-V0 N<
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M5U&UB3@CJ0,]JS)=;OY/B-/H)LKB73?[,CD;9Y0 9Y&4N26#;<+C YX/'0T
M=;17F7@_Q0VA>"=-:ZTV]EL/MDMO+?!U(C9[IT4D%MS#)4$@=^]=3J'C"WLX
M=6N(+66ZMM()%])&R@H0H=@@/WBJD$]/0$G(H Z2BJD^H1Q:2^HPQR7,0B\Y
M5BQN=<9XW$#IZD5R]M\05G31Y3H.I);ZQ&&L9,QGS'*;PA&[Y<@'DX'![<T
M=G17+P>-[/[!?S7UG<V=U8W:64MH^UG:5]OEA2#M.[>N#D=><8J63QC96%W?
MVNK1M9S6=LEV<-YBR1,Q0%2.2VX;=N,Y(QG- '1T5P.IW5W/\3/"9GTRYLU8
M76':9660"$X4JK'##.>XYZUH:9XBT^SM_$-[-_:42VVI^1+'=R"5O-98PJ1
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M2"Y9DP9!NQE,[@K;3@X],XS0!T-9CZ%9/X@37#YWVY(3;JPE;:(R02NW..2
M>G:LB/QJLNLWNGKHVH!;"X$-Y</Y8C@4QB0.2&.001TR1WQWFM_&-O-)H\CV
MDL5EK#;+*X9A\S%"ZAUZKN4$CK[X/% &GK6AV6OV:6E^)6A61)0L<K)\RL&4
MY!'0@'\*T%7:BKDG QDG)-8_B/Q#'X<M;6XEL[FX2>ZBMLP;3L:1@H)!.3R>
MP-4[?Q:YUUM&O=%OK.\>![BU5WB87**0&"L'P&&1D$CKUH Z6FNN]&7)&X$9
M4X(^E<AI_P 0K6^T<:P^DZA;::\2M#/*J?OI&D$8B50V=Q8@<X'O@9K47Q)Y
M.NPZ/?V,MM=W,#SVN'5UG"8W(#QAP"#@\<\$T 7-%T2R\/V'V'3UE6W#M($D
ME9\%F+-@L2>22?QK1KSKPEXCA_L:'7=2TZY35-3N3:QRLR?Z4QEDVHN'.U45
M3G<!@ XS6Y-XXL[22]MKR!H+ZTN(+=HC(I1C-_JV#\#:<-DG!&T\=,@'4T5S
MUQXH^Q+;17EB8+NZNS:VZ/,HCD/E^9N$G]W (Z9R,8JKJ.L!K_PZ+ZRU2TFN
M+]X8UBG58]X63B3#9="JEAQZ=.E '5T5SEWXNCBM-2OK6PGO+'3)'CNI8F4-
ME/\ 6;%/WMO.>G((&:B;QI'-JL>GZ;I5Y?RSV"ZA;R1M&L<L3$ $,S<=>X'M
MF@#J**P-.\3C5M"BU&RTR[>5YI+=[5MJO%(A97#G.T %",Y/4>M<QXIUR#Q%
MX#N+R*&>UN;+5;>UEB=QNCD%Q$K#*DA@5;KW!H ]&HJ*ZED@M998H'G=%+")
M" S^PSQFN<M/'>F7-AH%VZ2PKKDOEVR/@E.#]_!P/FPO^\P% '445Y]XZU/[
M=X9O)?LEQ#_9^K6D*RAL^:?/B#[0IR1ABIR.N1VK>@\7Q)JMYI^J:?<Z9);6
M;7X>=D='@4X9LHQP0>H/KWH UM1TFSU58/M4;%[>3S89(W9'C?!&592"."0?
M4$@TMGI=K932SQ*[3R@+)-+(SNP&<#))P!D\#CD^M8Y\7QP_V5->6$]M9:K(
MD5K<,RG#N,H)%'*[NW7G .*?XWOH-.\)7MS<IJ!@7;YC:?*(ID&X<AB1@9P#
MC)P>E '0T5@WWB5;?5+K3;.S>\N[2W6XFA615<JV[ 0'[[?*?0=.<FM34=0M
M=*TVYU"]E$5K;1F65R,[5 R>!U^E %JBN<N?%3:='-=:II-U9V"6YG6X9D?.
M&51&54DAR7&!SGGFI'\3&UUBTTS4-.GMY[Z.1[/$B.)60;FC)R KXYY^4\_-
MQ0!OT5QD/Q#BETNTU<Z'J,>ES7/V:2Y<Q_N7,IB&5#9(W8R1G&>]:H\3+/JM
MW965F]U]BN8[:ZVR*'0N%.X(>2H#@D\=#C.* -J>%;BWDA9G574J2C;3CV/:
MJFC:1::#I4&F6"NEI NV)'D+[5],GG%9:^,(6T[7KS^S;T?V+*\4\/[O>VV-
M9"5^?;C:P[YK*OKA+[QMX'U&(21B[M[F0H6/0PAE!'3(W'\Z .XHKAM'\;3I
M!X@NM9M;I+:TU.2V@<+%CK&B0@!\ERS=2,<_>%:TOC&SL+R]M=7C:RDM;07Q
M;<)%>'=MR".=P; *XZD8SF@#HZ*X#5[N[G^(W@XS:9<VB-+<XD>92''V>0[6
M56.&!Y[_ %KL-7U>VT6Q^U7.]@TB0QQQC+RR.P5$4'N20/3UXH OT5S[>*/L
MVKMI5[IT\5ZULUU;I&Z.MPBD!@K$@;AD9!QUX)K/LO'T5W!HMZVC7\&FZN\<
M4%W(8\+(X.T,H;< <8SC&?;!H ["BH;NX-K;/,L$L[+@"*( LQ)QQD@=^I(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%9P9-N"P7 )QUQG^M<CHG@NZL="L-"U/4X+W3-/:-H4CM3$\GEL&02'>P(#
M'  S@9[@@$,_Q(L4MI+Z!;::RBO?LCJ+H"X.)/++K%CD!N<9!*C/M75:Q<36
MFBWUQ;J6FB@=T ('(!QUXK%T7PUJ7A^6>UT_5+?^R);E[A()K4M+#O;<Z*X<
M#&22,J2,]ZZ&[MUN[*>V9BJS1M&2.H!&* /+I;J^OO#WPYU6^LA-J+7MMME,
MBEYM]K(Q); V@G!(]JZ5_'G]FP:Y_;NGK9W&D^066"X\U)A,<1[6*KC+ @Y
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M=BIQ@N=P!4>G>K\GA_4[KQ!HNL76J6IETZ*:.2..S95E\W;N(S(=N-HQU[T
M077C"6P\0V&G75E;+#>W1M4,=Z'GC;#%6>+;PK;>H8XR,U#X)MX;;6O&,4$2
M1QC6 0J* !FWA)X'N35:S\!7]K9:7:-KD+PZ9J1OH3]B^>7._(E._P"9OWA^
M88Z<@]MW0=!N=(U+6;N:^BN%U*Z%SL6 Q^6=BIC.XY&$'84 3ZAK1M]6@TBS
M@6XU&>![A4>38B1J54LS $CE@  #G\,UQ/A[6H?"]MXTU'4;.&T*:RB&WMY
M4WO%"J@,0HP2P.2!@$D]*ZK6O#EW>:[8Z[I.HQV6HVT3V[>=!YT4T+$$JRAE
M/!4$$$5ER_#][JQUZUN]7:3^U+N.^29( KV\Z!-I'S$%08QQ@<<9/6@!FI>-
MY3:Z[9VR6SWMMI,E];SV-TLT>!E3DE1AE.#C!R/RI]AXR>ST[0K'41;Q:E>V
M8F#W5V$0HJ)EV;'5F;A0#W]*VFTK5=0T6^T[6-1M91=6SV^^UM6BQN4J6.YV
MR>>G%9*>#]4B.BWT6L6RZOI<#6@F^QGR9X"%&QT\S.?E!W!NO;'% $1^(,C:
M99W<&D_:'FU4Z5(D5R,"7) 9&VX="!D'Y>H]\69/%.N0ZEI>ER^'8$O]0@GE
M5#J&4C,3 '<P0\$,I! )YZ5:UGP]J>LP:4)=4MHY[&^2]9ELV*R%,X4#S,@<
M\G)_"IK[0;N[\5Z7K:W\,:V,$T/D&W)\SS-FX[MXQ]P8X- &$/B!?KHTFK3>
M'Q':V=Z;+4!]L!>)Q((R8QMQ(H)!R2I]JTA>*OQ U"VCTQ3?KI4<J7!NVVRQ
M^8P5"F,*=P8Y )Z54?P-=2^%];T:75XBVIWS7HF6T(\IFE$A7;O.X9&!R*TA
MX?U >*YM>&I6V^33ULO)^R-@;69]^?,]6/'IW[T 9%CX]OKK3-"U>;0EATO5
MIHK<.+P-+$\C;5)39@KG SNSSTJ]XA\82^'KE6GLK9K/SXH6S>A;@AV5=Z1;
M3N4%O[P/!XJ"#P/<0>#=&T :M&SZ5=07$=Q]E.'$3API3?WQC(-07?@*^NK7
M6;,:W$EOJ-^E_DV6Z17#H^QFW_,@V8  !''.!@@%BRU?69OB%X@L$M_.L[:V
MM3$DDX18RPE);@$_,0![8J#PWXDLX?"_AVWTW33#+J;RQVEG)<LX0(79V:0@
MG "D]"<L![UL1:!?VWBJ^UFVU& )?6T44\$EL6.^,/M96#C ^<Y!!Z=1639>
M Y[#1M#@CU6-M1T6>26UNOLQ"LLFX.CIO.00Q&01C /;D =J7CN;2;?7TN=*
M0W^C6ZW;PK<_)/ P.'1RF<Y4@@C@]S5^#Q+?IXDL-+U'2$MHM1BDDM)H[KS&
MR@!99%VC:<'/!8<=:JZOX*EUJSULSW\4=_J]JEF\RVY9(85W855W DY9B23^
M'%:%WX?N;O6- U)K^)9=+$H=1;G;,)%"G'S_ "XQ_M4 7-=UJ'0[**:2,RRW
M%Q':V\0./,ED8*HSV'<GL >O2J \1W4/B+^PKS3XH[R>U:YLWCN"T<P4@,A)
M0%6&0>A&#^%6O$F@IXATQ+8SM;7$$\=U;7"KN,4T;;E;'<=B.X)Z5"FA74^L
M1:S?7-N]_;VKV]L(X6$<>\@NQ!;+$[5[C 'OF@"MX1\3ZAXHL[?4'T0V6GW%
MOYL4S7(=B^[!7: ,#'.>_I4'B75M6L_&?AJRL(FD@N!<M-'YJHLNV/@$D$\9
MS^5:GA/0IO#7ANST>6\2[%JNQ)5A,>1G/(W-SS3-;T*ZU'6='U2ROH[:?3GE
M^66 RK(DBA6& RD'@8.?P- '(:7J%[X=G\<7&E:+!<VUIJC3S*;@0846\3,$
M 5LMU.#M'(Y].@E\<V4EY'9V;6@G>QCO3]NNA;J%DSL7.&)8X.>.!CUJ2V\)
MW,5OXFAFU**0:X\DF5MBOD,T2Q_WSN "@]JJV?@W4=(OK._TS5[=;I+"*PNQ
M-:%HKA(\['"B0%6&3W(.>E &_P"'=:B\1>'[+5H8GB2YCW>6_5#D@CWP0>>]
M9&F>,?[8U.6UL8K)S#=36TT+WNVYB\LL-[1;>%)48YZ,#[5TT"RI BSR+)*!
M\[JFT$^PR<#\37,R>$7OM4L+W4I;*6:QNOM$5S%:;)WQNVHS[CP,C/KCM0!7
MD\<S1^"KOQ%_9*DVMU);R6_VG^Y*8BP;;SR,XQTJBQO+'XI:X=&TNWN+F;2K
M21Q)-Y"$^9,"68*Q+' [=N2*DN? .I7&AZMH2:]#%IM[=2746+(M+&7E\TJS
M;\,N<] #SU['6E\/:LGBF37++5;2-[BTBM9X9;-G4A"S!E(D!!R[<'- %;2/
M'2ZY]AM;/3RFJ7"SM/:SR[1;>2XCDW, <_.0!@<]>,5!>^/Y+'1M:N9-)S?:
M-<I!>6@N."'V['1MOS A@<$ ]?QMCP7'87NFZAH]UY%[9K,DC3IO%TLS;Y-^
M",,7^8$=#VQQ4.J>!Y-2TC6;<:C'%?:Q<1375U]G+ "/:$14WC  0#DGJ3WX
M +J^)+Y+BWL;O2%M]3O)I1:6YN0RM$BJQD=P/E'S 8 8Y(ZCFN:T7SX-<^(,
MESI5M'+LMVEMH+@A)!Y+9(<*""1DYP#G\ZZ;7/#EYJ=WI.J6>I1VFK::7V2F
MW+Q2*X =&3<#@[5/#9&*KVWA34(+O7[I]8BEEUF&-'S:$")E39E0'^[@G //
M3)/.0"I9>*)+/3?"%IINB!H=7LQ]G1KP_N-L'F!69E)8  #=UZG!/!T=+\37
ME[%J\%QI:0:EI<ZPRP+=!HFW*K*XD*CY=K9.5R,'@GBJMIX-O;7_ (14?VM
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MDN9T&75@",!<%?4G)Z ;@#KZ*X,^*_$=KI7A_7+NUTU]-U)K6.>"$.)H3-M
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<]ZZ&[U&SL9+:.ZN8X7NI1# KM@R.03M'O@&II)8XD=Y'551=SDG&T>I_(T
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MT.STJ.YEN(;2)88GE"[MB@  [0 >!UQ6C10!R4G@.WEL=1MSJEZ&O-034_-
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M!@\;8W(ZGJN0#V((X-4+_P $VFH:/?6#WERCZA<I<W=R@3S)74J5'*D #8H
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M#.;!/+:SN;A$21\@[U8+Q\I P<#(;OC-)<^"]%NX[^.:*8K?72WDF)F4I.H
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MW-<U-X$T2<7BNMWY5W<B\>$7+A%FWARZKG )8 G\?4T 0?VC?^(I/$$-G?\
M]G1Z9<&T4B)9#(XC5V9PW\/SX &#P3GGCG=,U+4-$^%?@[5+:Y,5A%%:IJ*^
M6K$0. I<$@XVDJ3[9KL)_!VDSZM/J1%S'-<HJ7217#I'<@# \Q <,<<>XX.1
M5BU\-:;:^&3X=6-Y-,,!M_*E<L1&1C;D\]* .?USQ)J.DQSWD4IF@NM3@TRR
M0QJ=A9@LC\8+8.]0">J]\TS4]6\2Z=IGB2YC$HM+/3C=V=W>0QA_-57+QE5(
MR,*I!P.I'-=)<^&=)N_#J:#/;;]/CC1$3>0R[<;6# Y# @'=G.:B?PQ:SZ/=
MZ9=7FH7,%W$89C-=,S,A!!7/;()R1R>YH P+C4?%.GZ/97\\LNH0W<D;SKIM
MFIFM8C$2=BG/F?/LR<'@G"],5K3QL]]>:3I=C>7-W]J%U)-=):A)T$3@",QL
MH"N-XW$K_#P.<CKFT&'[+90Q7=Y";+(AE27Y@,8P<@AACU!Z54N/!ND7$=M\
MD\5S;3/<17D,S),)'^^VX==W<'C&!C@4 3^&;C5Y]/G&LP-'-%<R1PR,%5IH
M0?D=E4X4D'!''(Z#-8GBV.YE\;^$$M)D@F9KP"5DW[!Y/) [GZ\?7I76V=JM
MG;B%99I><EYI"[$_4_R'%9^L^'++6[BSN;A[F*YLBS6\UM.T;1E@ W3KD#&#
MD8)H XN?QAKFBZG<Z%>R+?3_ -J6UI!?1P!6,<T;2'* [2ZA"!V^93CL;&N:
MYXJTG1-<NDW)#;/;-97-Y"F^4.X21&52!\I((; Z]\9KJ;OPII%]I3:?<6[L
MC3+<&7S6$WG+C$GF [MXP,'/08Z<5'=^$['4-'ETR^NM0N8)61I#+=,6;:<J
M,]N0#QC..<T 8M_KVK^&?$,\6H7B:C9/I-UJ*QK (FC>$IE5()RI#]\D8ZT[
M1]8\1:@V@WL<4TUM?Q;[Y9(42* -'N5XR#N(#8&"6)!SQ717'A^QN]2M+^X$
MDEQ;0/;JS/P\;XWAAT.=HJOI/A:RT1%AL;F_2VC!$-NUT[1P@C&%!/09X!R!
MVH X&QOM:TGX3ZUJL5_:N\-W>.J/:9^;[5(&SECG).1QQ[UT=]#?2?%^P,%U
M!&BZ-,</ 7.WSHMPSN')XP<<>AK4_P"$(T@^'KG0B;HZ=<R-)+$9SDEF+-\W
M498Y/-7)_#EE<:K8ZF\ET+RSC,*2I.R&1"02KXQN&5!P?2@#F]#\47L^O6=A
MK,M]I^H3R2J;.XLP+>8 ,1Y$P7YL  \MR,\5U^KZ@FD:+?:E(C.EI;R7#(O5
M@BEB!^54[+PW9V;V;&:YN%L01:)<2;A!E2N1QDG:2,MD@$XZFM66*.:)XI45
MXW4JRL,A@>""* /.?$)U*^T_P?JMSJ2LEUJUC*]HD2^6I8Y&QOO<9ZDG/H*N
M3^)=;U5_$:Z-%<"XTNY:UM(4A1HYY$16(E+<@,6QP5P.<FM.+X?:'#;6ULIO
MC!:3I/:1O>2,MLRG*^6"3@#T]..E7I/"FGMJT^I0RWEK<70477V:Y:-9]HP"
MP'\6.-PP?>@#E7O-1L_'^N:M,T4:VF@6UQ-;>46;:&F8QAMV,Y4_-@CIQQS>
MT;6?$>I1^']0ABFE@U",/>H\*+% KQEE>,YW$!MHP2<@YXKHI?#FGS:Z-883
M"Z-N+:0+,PCEC!) =<X;&YNOK4.D^%;'1%6*QN+Z.UCSY-L;IVBBSGA03TYX
M!R!V% '.Z)J/BG4M.U34I=7M%BLKB^MEA6S'SF)V57)W<?=Z>^<GI52RUSQ1
M):^#;R35K9U\00JDT1M !"S6YE#H0<D_*1@\<]!77V/ABPT[3;W3[>2Y6WO'
M>24&8D[G)+D$\C))S^F*A3P=I<<&D0HUT(]'(-D///[O"E!]?E)'.>* .8OO
M$&N6?A7QK'->6]Q>:$Y$5Q);#$T9A24!D!QGYL9'''2M:]U#6YO&ECHUKJ,5
MM;76ERW3-]G#.CJ\:Y!)Q_&>HQ[&M*\\'Z5?+JZ3"X$>KE3>HLQ DPH3\/E4
M#C%3Q^&[*/6+75?-N6N[:W-M&S2DCRR02I'0Y*@YZ\4 <]IGB6^?0YX=2U*.
M.^AU:;3%N(;8L]QL)P4C&1O('/4#!/2N?U[5-7U3X>^*+.]F4S:?J<-KYLL
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M*SB$<$2[47)/XDGDDGDD\DU3ET&TF\01:VSSB]BA,"$2$*(R02NWI@E0?PH
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MG8#G@ %B21SC/7I6;IG@\V*:%!+=>9;Z8))W"Y!N+IR278=-H+.P'/+#^[R
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M:+,OV.Z:UE$T>PB10">/3YA67>ZI/>^-8_#D=T]K!_9IOFEAQYDI,FP*I(.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD\S W,JJ21ST^;'/H: -+%8&NZ1J6M7,5G]IM(]#<*;N(Q,TTNUMQ0'.T*P
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M )L45'!<0W4"S6\T<T3C*O&P93]"*C>_LXY1$]W LA<($:0 [CT&/4X.![4
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M_P!WGYOPJ+[9<#76M2EJ+,6WF>9Y_P"]W[L$;,?=Q@[L]3C% %X*%    '
MI B*S,%4,W4@<FJZZG8//' E[;--*"T<8E4LX'!(&>>A_*G37UG;W$=O-=P1
MS2\1QO( S_0'DT 6,456EU&Q@NH[6:\MX[B3&R)Y5#MGI@$Y-6: "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH Y;XA:'>Z_X2FM],"M?V\T5W;QN<+(\;AMI/O@CZXJ6P\;Z1=VZ>?]
MILKS'[RQN+:03(W==NW+?5<@UTE% ' W-^T/CW7KR"SFN2OA^/RH0C+YTB-,
MYB!Q][#+QU&:RM(D@N/%OAO43$J6\NE7,-R8[%H($XB(B.X9./FZD]..XKU.
MB@#QM;>UD^&&CVLMD2\6OAC"T!W)%]N9R<8R%\L@YZ8-=%::3HTWQ*UN+^S;
M9K2?2[< >0/*>0&4/CC!;:4SWQ7H5% 'E.@:G);>&/!5A=VC*K6<D4MU/9O.
MT#J% B" ?*[ \%AT7 !S6=9V5L/#GA6TNK-BUKXDGWQS0?-%!OGQN &%3YD_
MV>17L]% 'F6J:3$NI_$"PMM. 2\T:)X(4@^668),"5&,%A^[Z<]*Z_P8-/\
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MJZLC,/E0C(^\0*P=/L;N/PA\/+2XTJ^\[3[V*2[C-I(3"%BD7)^7LS+_ )%
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M*Y&6('(SWZ<UAZN=9U6 )<:9J,<MGX@AF^SP60$*P)< B4-MW2,4RQ*D\DY
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M/MJSBW>+[/("CE=PW97 !&,$\'/6@#?HK(A\3Z3<7-I#'<L?MA9;64Q,(YR
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M\BS *6PI4$$X!XZGIC)J34/$5M;>#KCQ%;_O;=;-KN$.K)O&W<H((R,\=N*
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M-W>,@L%<C&$.-I)]0*Y]]$\4I\-)_!XT0RW-MM2.\%S$(KE%F# @%MP<CJ&
M'4Y['U.B@#E7M-1E^(UCJO\ 9LRV*:7+;/*TD?RR/)&X! ;/ 4@D \_G7.2Z
M%KY^&FJ^'5T65KPWDK0L)X=DRO<M*&!+Y VGN <]J]-HH Y*"TU+2O&NI:NN
MGSW5EJUK;@K&\?F6TD08;2"P!4A^H)P0>W-8EIX6U;3)?#I2Q:80ZQ=:E=".
M2,+;K,LH"#<PSM\Q<X'8UZ110!P.J:;XFMM5\6WFCV;>;?"R-K*LD8+B,!90
M-Q^5]I."PQGO42:-JZZKXAO4T>\$6H:/';6ZS7B2R>8#+E7+2'!^<="5QWSQ
M7H=% &#H=K>6O@.QL;BQQ>P:<D#VTCJ0SK&%VY!(P2/7H:YW2- U+2;G.EQ:
MQ#I0L98WTR^NHY@LAVB-827)4#YLY;&,8SV] HH X&T\-:AJ'PZT;PIJ%A):
M%+6**ZN3)&QMVC P8]K'+E@,'H.2>< LNM-\1S^#=*M;C25>_P!(U*VD:.WD
MC5;J*&0'?'E@%)49VMMP<BO0:* .*\46&HOK>@ZMIB?9[VY#Z;<JS#<L,B%]
MV1D%HV3< .O//-=?!:PVMG%:0((X8HQ'&J]%4#  _"JL>D1)K$NIO/<RRN-J
M1R2YCA& #L7H,[1D_7U-:% 'F.G:#<:A\,]$TY(%GO= U"/SK1R!YK6\I#)S
MQEE^89X.5['-6O$/A+4/$-[JVK6MK]CG>TM8[>&9E#3RPS^=E]I( X5 3SR>
MP&>^CM((;F>YCB"2S[?-8?Q[1@$^^.,]< #L*FH YN"SN=2\6VVN7-G+9P6=
MC);QQSLF]GD9&8_*2, 1@=>=Q],U!X!B8Z1J.H<B+4M4N;R#/>)GPC?\"50W
M_ JZ:YMXKNVEMITWPRJ4=<D;E/!'%2(BQHJ(H5%&%51@ >@H \SDT7Q-!X'\
M0^$H]'-Q).+PVM_]HC$<RS.SC<"VX/\ .1TQQUQ6U=1>()=7L8SI]VVE'3PA
MCANTA,5SNY,K*VXKMQC;N[\'BNSHH \T.A:GIGPKT)C:>5KF@&&>&%I%/F.I
MVM&&4D8=69?J16]JWA]9O#UC97-A<WK_ &K[1<2V4_E2PRD.QE1MRGASC /W
M3T.*W;K2(KS4K>\FGN2L&"MN)<0LP.0S+W(/3Z ]0*T* ,#PE8ZII^G7,.IW
M5S< W+-:F[=7G2'"@+(R\,<ACGG@C-<S::)K,WAWQ#X9N-(D@&IW=XR7S2Q-
M"(IY&.[ ;?N"MP-O4#D=1Z+10!P_B/1+JVU_0KC2&VM<POH]T2V&%N4+B0'^
M\FQL>[UV:QI:6BQV\/R1)MCBCP. .%&<#VJI!I$,.K3:DT]S--(-J+++N2%3
MC(1>@SM!/TK0H \VB\.ZW_PJ>#1FTMUU*&^CF\@S1_,HO!,2&#;?NYZD<UK:
M;9:KHE_XBC.ERWMOJER;VW=9(QAGC56BDRPQ@KP1D8/KQ79T4 >?:=X7U3PW
M<>"TAMFU&+3+&>SNI(I$78TGED-AR,H"C#C)QCBHKO1-<G\.^/+-=(F\[6)Y
M6LP9H<.'@2,$G?QRI//:O1J* .-\66=Y+X1L=2M[9HM6TB6*[MX9&7+,ORM'
ME21\ZEEX/\0I/$^A:C+X DTNQM#>:A/-%--L=%!?SEED;+$<<-@?05T=UI$5
MYJ-O>33W)6#!6W$N(68'(9E[D'D?0>@K0H Y6VL]1;XDSZJ^FS16$FDQ6HF:
M2,XD61W((#$XPX&<=?;FN2?3]2T?1O#]M_9UR-<M]8NI[:*WFB+M [RL[*&.
MTC9(H(8K@L.>@/J]9VHZ-;ZE<VETSRPW=H6,%Q"P#)N&&'(((( R"".!Z4 8
M?A"^MEU#5-+;3-1L=3WB_N?MWE%I_,RH<&)BN/W>W'&-H]Z6*UU/3_'FLWZZ
M7+<V=_9VRQS12QC:\7F95@S Y.\8P,>I%;]CI<%C//<*9);JXV^=/*<NX7.T
M<8  R<  #DGJ35V@#S>U\.ZW%\-O#&F-ICB_TR]M)9X/-CSMBD#,5.[:>/?-
M+8^%[BWFUO2M6T2_U*QU"_FNHYH;_9"R2MN*2IYJX*DD$A3D"O1Z* .>\9^&
MY/$WA_[):W"VU];S1W5G,PRJ31G*Y'IU!^M)9:[KC0+'?>%;V.\ PYAN(&@)
M]58R!MOU7/L:Z*B@#A[FQ\1Q^(/%E_IUAY4UWIL,-A/))&4,T8EZC=G&7&,C
M'KBH=*TW6$\7Z=K4^D:@L2:5-;S?:;V.67S2\;=-Y4 [#C:<<\A:[ZB@#S*T
MT'7H/!'A?3GT:;[7I^JQW-P@FAPL:2LY(._!X88'L>E;MMINI?\ "6^*KM].
MD2UU"SMX;>4R1D.T:R@@@-D9WC&1Z]*["B@#SW3;#Q-8:1X3T^33KLV=KI_V
M>^AMKJ..19E5%1BX<'R^'^Z<],@]*IV'A[7;31?#%F^CRF33M=FO;C;<1,!$
MQGP02X+?ZU>O/!KTZB@#A=5T#5;O4_&PAM/W6KZ3';6LQD0*TBQRJ01G(Y=>
M<8ZUTV@O=?\ "/V8N[":TN(H51K>1T9LJ .JL5YQQS]<5J44 >9'0M?/A"2P
M_L6;[2WB#[>$\Z''D_:_.SG?C.WC'K73G3[[_A8\.K"S?["VDFV:7>GR2>:'
MP1G/0=0#7344 <MXPT;4[^[T74-&*K?6=RT;.Q V02H4D;GJ5^1P.Y2JND>%
M+C2/%ES%;Q(GATE+Z! W*76PQ,N/[N 'S_>-=G10!RNBV6H6WC;Q-?7&FRQV
MM[]G^SS;XSO\N,J> V1R>,C\JP)/#^NR^!-=L?[*=;R;67OX(6FC_>QFZ68
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M$.2,\UZ/110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% %/5-4M=(LOM5VY"%TB15&6=W8*JJ.Y)(%8
MM_XWL-+CU,WUE?0S:=;K=30%$9S"V0)%PQ!&5(/.01TJ3QKX=E\2Z$EK;/"M
MU;W,5W +A28G>-L[7 _A(R#]:R=5\,WVJ>$]8LK;0=%TR_OK0VH>.;/!SG<P
MB!VCL.>O:@#9M?%EM<:W;Z5+87]I)=Q-+:2W$2JEPJ@%MN&)! (.&"FN:\?>
M(OM?@V6XTN+4S 9XECU&UD$<6?.56SAPY4_,,[2IS]#6[?Z+J5YKGAK4 ELJ
MZ>LZW2&9LXDC"?(=O.,$\XKG&\(>*5\!/X00Z6T%L8UMKUIW#2QI*KJK)L^0
MX&"06Z=.<@ ]'FFCMX))YG6.*-2[NQP%4#))K!'C"R!TV2>UO+>TU-UCM+N5
M%$<C,,H" Q9=PZ;E'H<'BM/4]/&L:%>:;<_NA>6SP2;#G;O4J<'C.,US"^&]
M6U'0]$T755MDCTR>WEEN892WGB#!3:N!M+$+G)XY SUH =H6I_VYXTUDW$%[
MNTN[-O:L-Z0HGDH6W#(!8EV/(/&W%6]?\2W.D^+-!TR&WEF@O%N'G$<!=B$4
M;0IZ=3D_A4OAO2=3TW5]?N+U+40ZC>_:HO)F9F4>6B88%1S\F>">M&O:3J=Q
MXET'5M.2UE%@9TFBGE:/*RJHW*0K<C;TQSGK0!SFC^)?^$>;Q;)<VVKZA:V>
MKR%Y$)F^S0B&(\EWR5&6.%R1Z5UTOB.U-Q]GL8+C4+@6RW31VP7*QMG82791
M\V#@9SP:P[;PUJXTCQE:3BS5]:EGEMBDS,%WP+$ _P @QRF<C/6J%OX-U*PU
MBWU-M.TK4O-TZ"SNK>XE(\IX@0KQN8SE2#R" >G6@#M=+U:TUG1K?5;!FEMK
MB/S(SC!(],'H>V/6N:L?%VGZ9X;74)6UB[MWU*2T+W$:O+'(9BFTA3]T,=HQ
MDX%=186RV.FQ6\-I;6PC3BWM^(D/7"\#C/? ^E<-_P (CXA_X1?^S-FG>?\
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M4ZC#B=C&P^U"?8QV @\8S@UJSZ+JU]XPL]5N8+..T&F364\<=RS.&D9&)7Y
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MJ*70KDD G SZ4 9B>.[1[RUM3I.K++>P&>Q#0+_I0 !(7YOE(# G?M'O3_\
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M@*1QMSR1UK-M_#>KZ=IVOZ+:K;36>ISW$UO<R2$&#S\EU=,?-M))&#ST..M
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M96*@<L<Y[],\4 >@T5REOXZM7T]Y;JSFM;U-1_LLVCNI/VC 8 .#C;M.[=Z
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M-K^HQ?$O^R%M;B33UTQ9FV^4%5FEQYA)8-M !&!SUX/6EE\<0PZ+;Z^]D_\
M8,TBH+L2#>J,VU96CQ]PDCG.<$''H =917,/XNG;Q+=Z):Z#>SRVCV_G2B2,
M(L<I8>9][.!MSCJ>>!BM/5]<M])FL;9@'N[^4Q6\98*"0I9BS'HH Y//; )-
M &I17(S>.DM[#4;E]-F<Z5<K#J*02!_)0JK>:O\ ?3:P/0'@\<5/JGC*+3_#
MVHZ[;V,EYI]FN5EBD4"<?Q,N>J@\9[G.!@9H Z>BN8D\7O9:Y96.J:1<6-M?
MEDM;QY$92ZJ6VN <H2H)'7I4<'CFTG72+H6^-.U:<06LXE!?<P)0O'_"K;>#
MDGD9 [ '5T5SUOXFGU!;>[TW29;O2YIC$+E955CABN\(>J9'4D>N,<U@Z#XX
MN4\,R:CK-M,I?4I;6&:9H8XR3<-&BDJQVA0 "Q'8XW<9 ._HJEIEY<7D,K7-
MJL#))M4I+YB2+@$,K8&1SCH.0:Y>P\6W,.N>+6U6&XCTK2I5VS,(ML""!7;.
M&W,6))'!Z@<=* .UHKG'\4M:7>E)J6G/:V^JN(K:;S ^V0J65)!CY20#C!89
M&,U9\2^(4\-6$-Y+97%S')<16Y\G;E2[A02"<GDCIF@#:HKF8O%DLES#ITNE
MM::M+')/]ENKA%"1(^T,SKN'S$C &>_IFJD/Q ANCI*6NDWDTNHS3VP4/&/+
MFA#[T)W>J'GI@Y]J .QHKE[7QK;?9-3?4[*>QNM-N([::V++(6>0*8PA7AMV
M]0.G/7%9-Q+=2?%C0'NM,^QDV-X1()E<2@>5@''0KD^WS<$\T =]17)Q^.[.
M6'3[Y(=VEW]VMI#<"4;]S,51C'V0L, YSR"0.TNF>+I]5UJ?3X-!O5CM;Q[2
MZN'DCV0D1AP<!B3G('&<9&<9H Z>BN=UV]@M_$OARWFAO2\]S(L,D,^R(,(G
M)$B@Y;Y5..,9K&M/&EU:7?BZYU2TNSI^E7.V-P(0(U$,;;>&R22Q.3D $9(P
M0 #NZ*S=*U*XU!I?-MHDC"H\4\%P)HI0V>C8'(QSQW'-5;W6?M%U?:78:?\
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M^I22VIBL=-:P=%+9?<4)<<<?ZL<>_6L^;P-J)CN);;4+>*]CUM]7LI60LH+
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MV58G#8]5)QCOBNJL8]22XO6OI[>2%Y0;5(HRIC3:,AB3\QSGGBKM% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% $<\\5K \\\J111J6=W. H'
M<FJM_K&GZ8\*7MTD+3$B,-GG'4\=![GBL/Q',UQXO\+Z.W_'M-)/>3+V<PJI
M0'V#NK?5!532VU*3XJ^(AY]O]ECM+(,C1L6V'SR IW8!SDG@YH [-'22-9(V
M5D8 JRG((/<&G5RO@R9HYM?T?/[G3-2:*W'98G1)54>RER!Z  5U5 !1110
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M-TEO-:QP%#;^9]PHVXDX[YSGVH ]4HKR'4/&WC1+;QE<6T^CJGAVX"X:U?\
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M-LE'GQJL@1FS&PW@\YP16U>ZGXBG\:7>@Z?=:=;Q)IR7D<TMJ\C*6D9-I D
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M&246+QG+P)(5.7SPY"ENF!TP>M364^H77Q6O'AG@%G_9%I)Y<D;%MC22]/F
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MO%Q&VQX20 ROC:PRPZ$T 9_B+P7IWB&;3KHSW6GWVFL3:7=BX1X@1@KR""I
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M?;H(5GDC:)E 1B0"&(PP)!Z$]#0!##X<TZ'7-1U<1%KK4(DAG#'*E5&.![C
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MWV:.ZD$ <G)(CS@9/..GM5R71=/FURWUF2W!O[>%H(Y<GA&()&.G;KVR?4T
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M:)89Y()V0SHO3?CJ1DX;[PSUI#X7TG[;IEU' \3Z8ACLUBE9$B4@ C:#@Y
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MHA=8#(&0@9_A((8GKVK'FU_Q-%X,U3Q%_;2&32]0N(A;_98]D\<<YCPYQD'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(R>,]ZZ? SG'-<9\,,'P:>__ !,;W_THDH Z'0-:M_$6AVNK6D<L<%RI9%F
M#  D<@$CMZUI5X_HGVS2_AQX8UJTU:\207L$#6X<>0\4ESL92F.>&)W=<]^U
M;$=]XB\2CQ*-.=X-0L-2DM;)_M7EQPA-NW?& =X;DDL#D-QC H ](HKF?'ES
M>67P_P!8O;:ZDM+RWLWE62$C(8+GN.F:S)7O]&\7^'Q'JE]=QZG!<"XMYW#(
MS)&'4H,?(<Y''7- '<U M[;/<3VR3QO/;JK31(VYT#9VY Y&<''KBO-I-9U2
M3X6VGC*VOKAM8+1S-")"8I"TP1H/+^[CG:"!NR <YSG5TBPEF^(WB]QJ=W&
MMH"B>6 08FQGY,_+GCGZYH Z8>(+,Z);ZJ$G$=SM6"&2,QRR.QPJ!6QAB?7
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MS&N#)(0 6/J>!5JB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX<<@ X[9Q6;XNUVX\/>&;C5[.WAN3"4RLDA4;68+D8!SU'''UK@='UC3-/\
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ML=Y) H5L9P2>AY%<[:^*?*\4:W9ZI>Z?!IMI#:RVTY/EY\[S.&9F(/W!C&*
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M\E4$*@#JI##9U^;..:V? ^EWNF^ ])TW5P7N8[8)*DAW8!SA#ZX4A?PKHZ*
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ML((8)6N XN%WPB$&5I5QG*JH)88(.0.]4W\6>'TCM';5[4+=JS0?/_K H);
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M#/;1B-H]PW[=H#*=N2,EN0.M4O#&M7#0^(GUB_$D=AJTEM'+(JIMC"1E0=H
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MA&N2V48=4PB-(I5BG' SC;QQSZ5!]D34K2XU)]*US^TXM.FMXQ> ?(9  8P
M<-D@<C(XZB@#H;3Q=H%_>VUG:ZI!)/<IYD"@G$HQN^4]"<<X'(K*B\<V%_'X
MBACU#3[*?399((I9IPZG$:GS2HP=H9\$9_A/-9?]EWZ^%/ ,:Z;.)M+NK4W<
M83YH0D#HYQW&XCIG.:>MIJ-M9>/+!M*NV>_FGGM9$5628201QJ <YSN4YXX[
MT :UWXTLM*NO#MI>W=FW]J1-))=&81(JK'N#A6YPQX&3W[TNB:Q<C7O%<&I7
MZM9:;/%Y3RA$$2-"LC9( XRQY/85D_9-1MV\!WHTJ[E6P@>"ZCC4;XF:$(,@
MD<;@1GIWK/US0=9U>/QS#9V<\<E[<6EQ9F3Y%N!"L6Y0QZ9*$#/KZ4 >@6FM
M:?>W$MO#<8GB02/%*C1L$/1\, 2O!Y''%<SJWBM3XM\-6.F:GF.\NGCGA\D;
M9HQ$[!E<KR-RKRIQS5#5= D\3:'JLMG::O!K$VF26<<FHL$ #$,8N#@Y*@;L
M$>]2WMSJFLZCX3NQX=O[.*PO6>[655S%F"1/E"D[E!;J/;&>< '1>*O$UOX7
MT^VNI_*/GW<-L!),(P [A2V3V4$L?IVJU-X@TN&-'^UK*KQ><OV=6F/E_P!_
M" X7WZ5E^.[2[NM$M'L[26Z>UU*TNGABP79(Y59MH)&3@=*J60O=*\:ZOJ=U
M8WCV6K6]LT+1Q>8T#QJRF)U7)&=VX'[N2>: .J@O[2YL$OX+F*6T>/S%G1P4
M*XSG/3%9EIXP\.W\C1VNL6DI2![AR'X6-6VLQ/0 'UJKX*TBX\.^%1;7:%)#
M-/<^0GS>2KR,XC&.I (''?.*Y.+PUJMW\(+C2(+![;5TG>80R (9!]J\[:&Z
M?,H ^N,T >@VNMZ==SS017&V:&,2O'*C1L$.</A@"5X/S=.*@A\4:+//+$M^
MBF*$SLTBLB&($ N'8!67D<@D<UR.K^'W\3Z%JLEG::M!K$VF/:1R:D0@ 9E8
MQ8!P<E<;L$=>:G\2IJ7B_P %S6]IHMY9ZI$L4OE7"K&"4E1VB5\X.[9P1QP,
MXH Z&^\26']G:CY&I06=U;6YDW7D;((L@A'96VDID=1P<$9J:WUZQ5M,L[B^
MBDOKV!9(A'&P$_ )9!SQSGKP",US%YIZ:CI&L:A#IFMMJDNDS6,?VT -\XR(
MPH.#\V/FP0.>:DU+2M0?P;X>U&QLI3K.B"&5+8C:[@*(YHN?[REO;(% '4C7
MM,Q<_P"E ?9I1!*"K B0]$ QRQR, 9)R/45-8:G9ZFLIM)@YA?RY4*E7C;&=
MK*0"IP0>1T(KC?$GA_4TL- O;6*:XGL=0-[?PVK@22&1'#LF[@E2_ /\(Q5R
M"YM=#,NI6VFZE+?ZQ=P6^V[;8\S!2 V#]T*@8DX'"GK0!TNHZK8:1 LVH7<5
MM&[B-6D.-S$X 'J2336UG3DU-]-:\B%['";AX=WS+&, L1V'(_.LCQ_87FH^
M#;N"PMFN;E9;>984(W.(YTD8#/&<*<50MFOK[XCV>KG2;RVT\Z3+;"2= &$A
ME1L,H)*C"GD_X9 -,^.O"X2"0ZS;".=S&DA)V;@Q7!;&%Y!'.,XK0OM<T[37
MD2YN-K1IYDH2-G\M.?F?:#M7@\G X/I7G7A^&;7_ (::CX:@TN=7NY[V+[5+
M&H@ :XD_>;LY)7TQG*^G-=#I-I=^&O$6O+<VEW>6E^89;6>*,REMD2QF)\?=
M/RY!.%.[J.: -^Y\3Z'9O;I/JMJK7,1FA D#>8F,[EQU'ICKD8JQI6L:?K=F
M;K3;N.YA#F-F3JK#JI!Y!'H:X'0_#>HZ'=^!K2>SEF738KO[3+&NY(#-C8N>
M^.5R.@'I72>&+.ZLM?\ %)GM9(HKK45N('(^61?)C4D'_>4T 7G\6Z FI#3C
MJUM]L,ZVXA#9;S#T7 _SR/6K":_I<EY%:K>*9)G:.([2$E=<[E5\;688.0"3
MP?0USVE:?</XP\7326<T$=_]G%M=/'PWEQ;20>V&Z9QZBLKPCH4B:1HNCZYI
MNK_:](E1E^<?9@\>0LJN",J0?N]><$4 =C?^)]%TLM]MOTB5&V/(58HC?W6<
M#:&]B<\BITUS2Y)[Z!+Z!I+$*;I0W^ISG&[T^Z?RKS'4%U/2?A3>Z!J6EW*W
M%K<*'O/E,,ZM=*PD#9R2V[D8SGK76*+_ $KX@:W<C2;NY@U*UM1;S0A2@>/S
M RN2?E^\#GT_*@#H4U[2Y=/MKZ*\26WNO^/=H@7,W4_(H&6X!/ Z#--7Q#I3
MVD5S'=B5)9&B18T9Y&=<[EV ;MPP<C&1@YKS?2]#UO3M+\%7DMCJ(72[6>TO
MK>VP)H2^TAU!X<?+@XR<'CO6W=>'; K;2P6_B'3Y);J>\^WVY+3QS,J*2R -
M\K@="O\ #T&: -G5/'&EZ=<:(GVBW,&ISO%YTLPB\I41R6(89^\FW!QR?PK?
MN;ZUL[3[5<3HD'&')ZYZ >I/8#K7!M9^(88_"5_J-I/J$UCJ-R\Y@C193$\<
MJ1NR A0QW*6QT)-='XMGU:#3[)]+MII<WD8NC B/-'#SN9 W!;.T=^"<4 3_
M /"6Z!_9,VJ-JENEG!(8I9')7RW'56!Y#>Q&:FLO$>CZCJ4NG6FH0RWD:[VB
M!()7.-RY^\,\9&17GFJ:+JTF@>/+:+2;YIM5DA:T20AVE'E1J26S@'*G//'2
MNHUJRNKOQAX:OK6VG2WCM;R&298\& R+&$W#J.5/TQ0!!XX\6IIFEI_9>J>5
M>_;((1MB#I)NE5'3<5*[@I8X!R,5TGB#6(O#_A[4-7FVE+.W>;:S!=Y )"Y]
M2<#\:\[:TUYOAG:>&6\.W@O]/DM4F<%#'*L<Z,7C;.6+!=V,#OGW[?QC%/?>
M!M9MK2WEFN+NQEAAB5?F9G0@ @].3WZ4 4]*\4Z5:Z5#=:EXFMKAKUC(C,T:
MK&=@+1KM'W5PQ^;)]2:U!XHT9K**\2]$D$L/VA6CC9SY7]\@ E5]R *YS6+:
MZND\%LNF74BV-XD]ROE',06%TR1W.YATSZU%<Z9>Z9X]U6^DM]2DTS4[:!8I
M-/ ;RFC# HZ]0#NR"..3F@#KI]=TRWBBE:Z6198O/3R%,I:/^^ @)V\CYNG-
M6[>[M[JTCN[>>.6VD02)*C JRD9!!],5YW:^'Y_#7B=)K:RU==%GTR"UA%HX
MDDM6C+GRY!DD@[\Y&1G/UKHKKPTK?#>[\.Z/')8^;8RP0).^6C+@\,03W/8G
M&: -6W\0Z5=7<-K%>*9;A2]ON5E6<#DF-B '&.?E)XYK&T#Q'%XB\1ZDD&K1
MJFGW$EL+"-HV\U5"9E)QN^\Q P0/J:HW%G>>(K7PK!_9US8W.F7L-U=F:/:L
M(C1@R*W1]Q.!MR,$DXZ5?\%PW5O/XA^U6=Q;_:=6FN83*F \3*@#?^.G@\T
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MQSFNMH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,[9Z>]0?\(MJX\+^$=/!LC=:)<6TDW[Y]DBQ1,AVG9G)R#@C\: .T9@JECG
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M6LVOB'1K;5+,2+!.#A95VNI#%65AV(((/TK,72-4;Q[%KCI9K:#339LBSL9
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M,=<D=XX/B!I][!I'V80QSZG9&^5+R<0I'&"!AFP<MN.  #T)XQ0!US,%4LQ
M4#))Z"A65T5T8,K#((.017F^K^*Y=>T_P]]DT[S8KO6)+.]M6E1HY#&DN8]Q
MX92R!@<8('/7%:]C>0VFO^(+:UT=K:[L].MF'EW&Y&3$@C54.%3;M/3K0!V5
M%>?:'XVN;3P=X9GUE8DNM3B0+=7ERL43MY>\LS ':3T"XY-=3!JFHRIIK'2=
MPN9)%N)(;E72!5W;7!(!=6P,8&?FYH V" 1@C(--CC2*-8XT5$0!551@ #H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP?FZ$'I5-O".O7,&BQWWB"VF;2+M+B%EL2OG!49/WG[P_-ANHP.O!R,=I10
M4444 %%0+?6CWSV*W4+7:()'@$@,BJ> Q7J![U/0 45!'?6DMW):1W4#W,0S
M)"L@+H/4CJ*GH ***1F"J68@ #))[4 +15*WUC2[N1X[;4K.9T!++'.K%0/4
M \5/:WEK?0^=:7,-Q%DKOA<.N1P1D4 344C,J*69@JCN3BEH **** "BBB@
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M)9:K:-F"[A65/49&<'W'0_2H=%TF72+.XA>\^TRS3R3M,T6TEG)/.#SCH.F
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M P""+:"+93@AF!.3SP#^=>H5S-OX7O+'6=7U*RUDQ/J<RS2HULKA2J!% Y]
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M9EL?#.JW>FV2:=K;PP[8YF,L3RH65N1@KD8QUY!]J[JN67P8$\.:'I"Z@_\
MQ)IX9H)3$,OY0(4,,\]><8_"NIH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH :(T5RX10S=2!R:=110 4444 %%%% !1110 4444 %-1$C7:B
MJJ^BC IU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 44=!DUF:=XATG5[ZYL]/O8[F:V1'E\K)4!\[2&Z'.T]">E &G17)?\++
M\*8S]ON"-VW(L+@@G..#LYYKK: "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KC]#V_\+/\ %H&.+33Q^DU=A67:>'=-LM6GU2"*9;VX $TC7,K>
M8 "%!!8@@9...,\4 9RF'4]>CT>U4#3=%$;SA?NF; ,47_ !AS[^7[UTM4]/
MTNRTJ.:.R@$2S3//+\Q8O(QRS$DDDFKE !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
D !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>ameh-nonqualifieddeferre018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%0W1N1;M]D$1GX"^<2%'/).!G@9X[],CK7-
M^&-9UC6_!\M\RVKZD;BY@CPA6(;)FC4D9)P N2,Y- '545R^B7FOQ>*;S2=3
MNK74;5+5+A;N"W,)BD9B/*8;F!R!N'.<=>HJ_KB:W*0NF:A::= D9>2YN(/.
M);LH&Y0 .22?;'>@#9HK(\+:A?ZKX8L+[4[=+>\FCW2(@(7J0& /(!&& /K6
MO0 4444 %%<AXV\6W6@W.CZ/I4$,VL:S.8;;S\^7$HQND8#D@9' QG\*M?8/
M%-I/9RKKD-\GG(+J&6S2,&,GYBA5@5(Z\EJ .EHK#3QCX>DUY=#758#J+%E6
M'GYF7[RAL;21@Y .1BL3PKK>JWGQ \9Z3?WOGV>EFU^S QJFP2(SMD@<]ASZ
M4 =O17/1^.O#$LMU&FLVY^RQ&:5^=@0,%+!L;6&2!D$]:FC\7Z!+)IL::G"7
MU,!K-.<S#U QTXZT ;=%</X8U[4[CQWXTTW4[]9;'2C;&WW1H@C5T9V)( SV
MY/I6WIOC/P[J\]Y!9:K!)+9Q^;.K938G]_Y@,K_M#B@#=HKRZ'XEIXB^',^K
MVVM:;H&HB;:?./GB!?,( 88Y+*IQQ7=:EXETK1W@@OKO_29D,B0PPO+(RCJP
M1 6VCUQ@4 :]%8$OC?PS#IEEJ,FM6BV=ZVRWFW\2-G&![@]<].]3Z)XJT/Q(
M]RFCZE#=O:L%F6/.4SG'!'0X//2@#8HJAJNMZ=HD,4NH7(A$T@BB4*7>5ST5
M%4%F/L :Q=1\>Z+:^$M4UZTNHKE+!75X6)B?S@.(V5@&5B>,$9]J .IHKE_
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M0MHM9M))B9!L1\G*#+=/04V+QOX:FEM(X]8MB;P@0')"N3T&[&,GL"<GCUH
MWZ*S+[Q!I6FO*MW=K'Y(!F8*S+"#T,C $(._S$4Z]UW3=/\ ^/BY_P"67G'R
MT:3;'_?;:#M7@_,<#@^E &C16;>Z_I>GAC<W:J$C$LA5681H>CN0#L7@\M@<
M'TI+OQ!I=BQ$]T/E19':-&D6-&Z,Y4$*#@X)P.#0!IT4UW6-&=V"HH)9F. !
MZFLZV\0:7>7<=K#=CSID,D*NC)YR#JT98 ..1RN>M &G17)^&O$<7B36]1D@
MU:,QV<TUJNGQM&P948#SB<;N3G'.W!'&>:MZMXNL='\3Z9HMS-;QF]BEE:66
MX5/+V;=HP>NXMQ_NGK0!T-%<-HGC.VLCK$/B+68@UOJTMK"\JJFV(!-N[:
M,D_,<<UU5]K.GZ<2+FXVL(_-941G*I_?(4$A?]H\4 7Z*CBGAGMTN(94D@D0
M.DBL"K*1D$'N,5QJ^/K'4O#VKW5MJNEZ=<6EQ-!')<3"90J/M$C*I!PV"1CU
M'6@#MJ*R;[Q-HVF7(M;W4H([KRO-\G)+E>.0HR>XXJ"+QGX;F:S$6LVK_;2%
M@*OD.Q. N>@8D$8.#F@#=HK-OM?TO3G=+N[6/RMOFMM)6'=T,C 80'U8BK\L
MT<$+S2N%C0;F8] * 'T5S\?CCPS*]HJ:S;'[60L#9(5R>@W8P">P)R:O7FOZ
M7I\KQW5XD?EE5E;!*1%ON[V PF<C&XCK0!I45C7GBW0+"]:SNM6M8[E72,Q%
M\L&<X48'<D'\J9I>MP36^JW=QJ]A<6MM=M&)(1M6!0JG8Y)(+#/4>HH W**H
M6>LV%_=2VD$Y^TQ*'>"1&CD"GHVU@#M/KC%<QXF\6I!J6@6^E:H%>YU2&WE1
M8@R3Q,?FVN5P2,8^4\9- ';45G3:[IMO>?99+@^:)4A8K&S*DC8VJS ;58[E
MP"0>1ZBK=U=065L]S<RK%"@RSL< =OY\4 345CS>*=&MK2:YN;T6\4,BQR>?
M&\;*S?=!5@#SGCCFG67B?1-1U-]-M-2@EO$4OY0)!91P67/WA[C(H UJ*S8-
M?TNYO(K6*\1I9MWD_*0LVW[VQB-KX[[2<5')XFT:*]6T>^02LS(&VL4W*"67
M?C;D '(SD8H UJ*XN\\8+IG@JTU.?5-/NI;J[6U2[A'EP_-/Y98!B<[%R3SS
MM/05H:-J?FZPEBGB.TU.);'SBNQ?/8E^)"R83;M*C 4<\T =)16;;Z_I=U>1
M6L-VK2S!FA^4A9@OWO+8C#X[[2:YOQSXM33-+7^S-4$5]]L@A&V(.C[I51TW
M%2NX*6. <C% ';44R65((7EE=4C0%F9C@ #N:Y_3O$^GP:%IMSJNNZ;++=DH
MEQ#^[BF8$CY 23@8]>Q- '1T5G:5KVEZYY_]FWD=PUNP29!D-&3R,J<$9[>M
M9^N^+;'0-<T?3KN6WB&H-+OEFN%C$*HA8,0>N2 O;K0!T-%</IWC&#3=4\10
M>(-8C$-G?K%;M(@&V,PQOSM'3+GYC^=;\VJJ?$FGV4.J6(2:"21K4C=+*/E*
MNA!P%'.>.<B@#9HK.M]=TVZO$M8;@O(Y81MY;;)"OW@KXVL1@YP3TK1) !).
M .] !17(^%O%=SK&OZII]]"L(V)>Z:1_RVLW^4-]=RDGTW@5JWWBW0--O&M+
MS5K:*Y5D5HB^6!<X48'<G/Y&@#9HKD(?'.GW\7B*&/4=/LI]-ED@BEFG5U.(
MU/FLH(.T,^",_P /6MM-8M;;1[*ZO;R)S/"K*\*,?.)4$E$&6([X&2!0!J45
MR"^();SQKH<>GZAYVD7]G=2-'Y8'SQ-&O4C<.68$'N*W5U_2VO(K47B>9+(T
M41P=DCKG**^-K,,'*@YX/H: -*BBN;/BNSG\77OAD74%O<16T;I*)T+M(Y<;
M%0CJH4'O]X<4 =)17$^#/&UI?>'M&36=6@.KWH*D$!-[[FPO VAL 87J:Z2[
MU_2[&5H[F\2,HRI(V"4B9L;0[ ;4)R,;B.H]: -*BHKFYAM+>2XN)%CAC&YW
M;H!6-#XU\-SW%G!'J]N7O-OV?DA9"PR &(QN([9SSTH WJ*S;G7]+LYS#/>(
MA618G;!*1NV-JLX&U2<C )!Y'J*KW'B[P]:W[6,^KVJ72S) 8M^6$CDA5P.Y
MP?IWH VJ*P](UN&72;J^N]6L;F".ZDC$]N"J*-V%0Y)RPR!QU/ J[9ZSI]_-
M/#!<?O[< S0R(T<D8/0E6 (!P<'&#B@"_17%:QXK7_A*_#5CI>IY2\NVCGA$
M0*RQB)VW*Y7D;E494XYKM: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH 9+((8FD*NP49PBEB?H!UKB
MO!SZEHO@J5)M(N_MD-Y/,UL4PSQR7#OE><$[&SC/48KN** .*M-&0^+X->TG
M2WT^SM[&6*>)8! UX[%2B[#C[NUN6QRPQQG&A-J0OXK6/6/#-TUO<0+,(Y+<
M7'E2\@HX&0I (P>G)Y%=+10!SO@K1;C0?#YM+CY-US--%;[MPMHG<LD0/3Y0
M0..,YQQ71444 %%%% ' _$;PSJVH7N@^)- B2XU/0[@R"U=PGVB-L;E!/ /R
M_J:W=,\43:E)#%_PCNM6TCD"3[3 L:Q>I+%L$?[N3[5T-% 'BJ67C#6-:\-Z
MAK.BWZS:=K$DEPJ)$L$41S@Q!3N8="6;.3TS6H= UJ_UWXEK%8W-JNN6L,5A
M<2 *KLD+(P)S\N20.>U>K44 >=Z$M]JW@!]$N?#E[8:M:Z-)IX>XC58RQC"8
M1\\ABJGCCCGMGF-*T_Q%(GP\2?PSJ-NF@2/%>/)L_N!0R@-DK[\>V:]KHH \
MNM[7Q#9>)?B+J=EHTS2:A!"=.^T(-DS1Q%2",^IX!QFHO"6GZ_)\2;/7M5T[
M4T6?0!:S3W:Q BX\T,1MCX5< XXSTSUKU:B@#PL:!XB/P&O/")\/7XU2.YVH
M"$V2_P"D>:64[N@7N<<],UUL]IJ&F_%2V\5/IM[<:9=:-]B/DPEY+>0.'PR#
MG!QU'<\UZ/10!X:?!NNV7@'1;!M(GFN&\1KJLMK&%;[/ "?E/.,XQP/4UVVB
MZ7?6WQ?\1:I)I\T=C?6=NL-QM&UF51N![@]N?2N\HH X+QWI6HOXL\(>(+2T
MFO+32KB874,(W.JR*%#A>K8QT'-<[/X;UB;2?B-J$6FW(/B$K'8VA7$C!49=
M[*3\H8MWP>.17K]% &-X32:+PEI%O<V\MO/!:10RQRK@JRH ?U'6N4^+>FZG
MK&G:%;:7IMS>26VK0WDOE 86- X/)(Y^8<5Z)10!P7Q5L=0UWP*+/3-.N;FZ
MFGAE$2J 5"L&.[)X.*AU&WOYOBYH^N)I-ZVGV^F20R3>5]UW^8#&<]#CZUZ'
M10!X7;^%M>3X:Z=IQT*Z6\M?$27KP[5SY6YFW#G!XP*U=4T"^C\=^)7U/3-;
MO=#\00P;6TW:?N)M,<H/*]3@Y'Z\>OT4 4]/MXM-T:UMH()8X;:W2-(F.]U5
M5 "DY.3@8ZFO/?AKX>FMK_Q!)K>@-%+/JTU_9374*-M1R,;3SM;@<>U>G44
M>3^(=#U&W^(^KWEW8:Q>Z%K5A';,VEE69"J[2CJ>0I!)R/7ZXL7GAZ2#QKX$
M:ST*].D:1:S1RB55D,.^,*BDY.2#U(SBO4** /,VT+4KGXC>)GBL+BUL;_1O
M[/MKK8!&L@!';D#T..U85KX<UK4O"7@KPT^D75G?:-JD=Q>3R)B*..,OEE?H
MY;<,!<\]<5[310!XQ<Z3XFL;3X@:!_PC]W?'6IY[NSOHV3RRKK@*Q)R"
M#SZ#FK6H^'[N;2_#\Z1>(M+UBQT5+:*YTY-^9  &AD7GC*@@Y .>3P*]=HH
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M[R6U1X\&8/$%0C/?(Z'D4RTT_4M/\37-]=VNK-8ZE86L:M9J"T+Q*RM'(AY
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M&XMB[)YT;1[UZKD8R*X-?#FL7_@'3O"%Y8F"2T:VADOED0Q&.%U8.F#NW,J
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M*:[%(V949R 2%7&6]AG _.N<@\<:1+HMMJLOGVUO<WHL8Q.JAC*7,>" 3C#
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M4&2O48/3KQSR0,D9Y^(&EQZ7JUY<6>HV\FD8^VVDL(\Z)2,JV Q!4@'!!(H
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MF%O;R3,&8(I8A%+$X] .37(^&/&W]H^$M)U#4H)1?W^U(XHX2HGD8%L1[CR
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M)&[D&-G!_P!\CM6WXA\/7MQH^BV&E+"XL+ZVN9&N)2A98G#'HIRS8/XUU=%
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MK?>!P(R@PI*#)W,V ,DXI\/A+Q'*-(DOXM/GO=/U7[7->O<N\ES'^\Z93]V
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M>>@(!H$V.J6TT),%W 28Y4R'7/=2/RXIUG8VFG6J6ME;16UN@PD4*!54>P'
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MD<2B)&0!EW=PW)![5U-% ',Z/X8O- EFM].U=4TF2X>X6UDM@[PEVW,J2;@
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MQ"L<@$]AUJ_ING?V;!+%]KN[KS)GEWW4OF,NXYV@]E'0#L* +M%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX=LUU5 !1110 445A:CXKL+&PL;Z)9+VTO+N.S2:U9&17>3RP22PXW<9&>E
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MV@CN&2.(K*56%HP=I. ,[@6.<Y'&.SEN;B/XG6-I]LG%K<://*;<O\GF+)$
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M7S;"\,ACN&D4_P"JP>I&XC.2.3QGM7/W]N(_!?BO5TU"_6^TS6YEM+@WLC&
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MC8 -NSC<3QG%6GTBUB\9^'+5+J]\C5=-N&O8S>2$7!01%2?FX/S-TQQQTXH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.\L#<P4@\XSS77>"M-NCX^\8^(%MY[?2]1>W6U$T31-*R1X=]C $#.<$CG-
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M!HUM;RW$^JV44,4YMI)))U55E'5"2?O>U3ZC+.FE7$UE)$LRQ%XVD0NG SR
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M.)HH9E=H_P#> /%>93V4Z_#/7-&&BW_V_P#M.0F);&0B1&O#("K!<,NSG()
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MLUN]7\<Q7EAJ@LKY;1%EM[60,X50CM&=IW%2<X .<="* -CQ;XI-IX1U/4=
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ML9I?$WA>XTVTGA06=Y;^>ELX$&^-!&'P,J-PXSCI0!UB:OILMZ+*._MFNCN
MB$H+$K]X =R._I5J6:*WA>::1(XD&6=V "CU)/2O-_".EB?2/#VF:N-=AU'1
MY$?[.]H%A25%92PF$8#(06_C.<\Y-=!X[AOVL=)N[.UFO(K'4X;J[MH5W/)"
MN[.U?XBI*MC_ &: (_$'BU5TZUN_#^I6-R!J=M:7(7$I"R2JI'!^4X;/(-=!
M>ZYI.FW,=O?:G9VT\I 2.:=49L\# )[FN3\6W$.JZ+:W&FZ=J$LC:I922_\
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MF*/)M20'"(<,Q/0 '//L:MV>MZ=?W1MK>Y5IQ&)0C*5+1YQO7(&Y<_Q#(]Z
M+]%<5XB\6I#K'AZUTK54W7>I1P31",,LT1#%BK$8." ,J>,UH>/=1O\ 2/"-
MSJ&FW7V>XADBPVQ6!#2*I!# ]F- '2T5BP>+O#]U-=0P:K;R2VL9EE13DB,=
M7'JON,BIU\0Z2]G:7:7J-;WCA+>0 E92>@4XYSV]: -.BL/Q5XEM_"VD+?W
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M+)*<+"Q'REP<''Y9[5';^)],MM-TLZEK-@;J\MEE1XVV+/\ )N+HI).TX)%
M&]17.7_BK3I_"][J6EZYIT(B)C%S=9,<4@_A=<@YQVZUI7FN:?IH N[D!Q%Y
MK[(V?8G]]@H.U>#R>.#SQ0!HT5SC>,M,3QA)H$MS:1E;-+D2O<J-S,Q 0*>^
M%W=>A'%6;7Q=X>O;CR+76+.63RI)B$E! 1#M9B>@ /&?:@#:HK)M_$VC7?VL
M0:A 6M$\R=7;847LQW8^4XZ]*PK#QQ:ZYX>T;4;34]+L9[VX@62VGE$K .W,
M0VD$2$$ 9'![4 =G15!-:TZ74;C3X[E6O+9=\T*J2R*>A(QW[>O:HU\0:7):
MQ7,5V)8YMWE")&=I-OWMJ@9('<@<4 :=%5[.^M=0LH[RTN(Y[:1=R2HV5(^M
M9UMXM\/WE\EE;:Q:37#^9B..0,?D^]T[#U]CZ4 ;-%9D7B+2)I3&M]$&$1G!
M?*!XQU=2<!EY'S#(Y'K52+QMX9GEACCUNR8S*SQGS,*P ).&Z9P,XSG'- &]
M1698>(=(U.TN;JSU&"2"U)6=]VWRB!D[LXV\<\]JDM-9T^]N)+>"X'GQH)&C
M=2C;#T<!@"5.#\PXH OT5Q>L>+$_X2KPW8Z7JBLEY=M'/"(P1+&(G;<K$<C<
MJC*G'-;5AK$<U]K)EU;3YK6S=>(C@VPV982L3C.03VP.M &U16;%K^E2FX'V
MQ(S;Q>=*)@8BL?/SX8#Y.#\W3CK4MCJMGJ,LT5O(YEA"M)')$T;*&SM.& .#
MM.#TX- %VBLS4_$6D:.X34=0AMSP3O/" G +'HH)[G J5M9T]=632C=)]N>/
MS5@P=Q3^]].V>E %ZBLP>(=*-K)<_;4\J.4PL<'/F#J@&,EN#P.>*H:CXFLI
M= 34-,UO384DG2))[G+(3O 9-H(._&1CJ#0!/?:%->>*=,UH7JQBPCEC6#R<
M[Q)MW9;=U^08XXYZUMUS4>HWZ_$F;2GN=VGG2ENEB**-LGFE#\V,D8'?U-7X
M/$&DZG=/IUEJD1O#$70)R2O3>F1AP"1R,B@#6HKA_!_CFRNM TI-;UBV_M:[
M=T(;";F\Q@J\# ) &!U/O6AHVK7?_"3>*K74+U6LM.>!H6D54$2-%O;) ' )
MZGL* .HHJC9ZS87]R]M;W ,Z()#$ZLC%#P' 8 E3_>'%..JZ>-4&F&\A^W&,
MR_9]XW[!C+$=AR/SH N45D-XJT%;)[TZO9_9DG^SF7S1M\SCY0>YY'2I-.\1
M:/JUY/:6&H03W$ #21HWS!3P& [K[CB@#3HKBO%7BU+2[T2WTO546:XU6WMI
M4$899HVD"N Q&,@9^Z<CFNDOM>TS37=;N[2+RP#*2"5B!Z%R!A ?5L"@#1HK
M&O\ Q9X?TNY>WO=7M(9T"EHVD&X;CA>!SS6S0 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 (S!$+$$@#/ R?RKS"/PWJ6H?"S7=)
M@L7M=5FNKF>-9DV&0/<&11N/'S( OMQFO4** //+[19/$^D7\MO!K-OK+:7/
M:0R:@!&(C(!F/(P&R0/F&0,=?6.YU">]U'P)%/H]WISPW[))'.JJ%=;64;5P
M3N'H1Q7H]8VL: -7U+2KUKR:!M-F,\21JI#,59#NR.FUCTQ0!P6I6.L?\(;X
MR\/PZ%?2WEW?7<]NX4>5)'+)O4AL\G!Z=<_G73R"X?XD:?J*V5W]C32)H'F\
MA@%D:2-@I&,]$/\ *NOHH \PC\-ZCJ7PU\3:3#9/::G=WEY/")DV>8LDQ=1N
M/'S( I],\U>N-(D\2Z7=21V^LVVLC3+BU@DOP(U@:50"N5P&R0.1D#&<BO0:
M* /-[J75-2TSPI'_ ,(WJ%H=,U&W>\1T4B-4C=3LVD[UR>H[8[\5T/Q"L+K4
M_ VH6=E:/=W$ABVP)C+@2H2.2!T!ZUT]% '*)9/X@\4Z/K8LKBSM].@G0BZC
M\N21I HV;>NT $DGC.,9YJAX/TFZL]2NM(N(O^);H-W)_9[YR&$JAT'UC21D
M^CCTKM+N&2XLYH8KB2VDD0JLT8!:,D?>&X$9'N#46FV"Z=:"$32SR%B\L\N-
M\KGJQP /P       H P_'MG=WGAE19VLMU)#>VMPT,0!=DCG1VV@]3@'BJR)
M<7'Q-M-3;3KJ.U_L=X/-DBX21I$<*3V.T'GIVZ\5V%% 'ELNF:E%H$]F-*NS
M*OBO[<J)$2/LXNA)O!Z8VC..OM5_5M,U ZSJ%[H$NJV>HSW,3/:RP"2RNP @
M\QMRX3Y1@X8'Y.A.*]#HH R_$5[>6.B7,FG6TMQ>LI2!8TW8<\!B/0=3],=3
M7&^)/"ESI_AS2[S1)]3O=0TF:*>QMY #OQPZMA01N0L"2>IYKT:B@#C-126_
M\>>&=1_LRZ-K;VETLKO ?W+R^4%!_P"^6!QP/QJ6SBN=+^(>M7#Z=<FRO+*U
M$,\,89!Y7F[E.#D'YEP .<UUU% 'E>E:;K6G>'/!UX=*NI&T>[G-[8!?WFV0
M2*)%!.&*AP>/4UO>)&EU)O#]S9:5? 1:S'=7&;8JPC6-E+L.O=1@\\=,"NVH
MH \RMM!G27Q'HFN6FL7%IJ.H37$1M IAGBD((!;JC+T.2.@P:[G3-6&HZAJ5
MK%;2+!82K!]H9LK*^T,P7_=R 3ZY':M2F10Q0)LAC2-,EMJ* ,DY)X]22?QH
M X'Q9'KNHS>)M,&GWKVLVFE+#[*J".=C&V[S'/S9#' 7(R.QS72)I2ZMX$&C
MW2R0BYT[[+*&7#)F/:>#W%;M% '%^&=4U30M&M=$U[1[XW-C&MNEW9P&>&X1
M1A6!7)4D 9# <U)?_:[SQUX8OQIMY';P07:3L\>?*,GEA,E21SL/0\=\5V%%
M 'E_DZ_J?_"/W&HZ7J"W5EK7G72"-%@@3$HS&%Y<89?F.>IYYQ4M[8:A-X?^
M(=LFF7AEU260V2^2?WP:W2,$>GS*>N*]+HH XA[::3QEX2O$TVX$%I87$,TA
M@($3.(@H/'^RWT_&LV"/7=(L+Y+73;I1)XEGFF:&!7D6U=F(DB#9!).!W(!)
MQ7I-% 'DVI:-J;Z!XSM1I-_)+J.H6TUO'(N]I4"P[B6'R_P-D9[8]*Z^\MIW
M^(FB:G':3&T&FW,$DHC(V,[Q,BL.H^ZW7I7544 <I\.X;NQ\)6^FWUA<6EQ9
MM)&_F@ .2['*D'D8(Y]ZR)=+U&'7);C0Y=4M9IM462ZT^YA$EG*@D&^579?E
M)1=PVMG=@8KT*B@#SN'3+V?PS\0K?^S9UGU&:[DM5>+:9U:W5$QGN64\'D5*
MSZV\UI8OIU^+!]'CC!MXU5GN!N#I*[<HH&,8QG)Y/ KOZ* /--%T_4;6/X<Q
M2Z;>*=,MI([TF(XA8P>6 ?7YO3/'/2N@\'0W,&H>)FN+2>!;K56N(&EC*B2,
MQ1J"/Q0\=:ZNB@#BHS=:7\1-;O9-'OKB"^MK6*WG@B#*6C#[E)S\OWUY.!P>
M>*Y_3O"VJ>$M8TJY=+Z2Q_L^6VE_LP"0VLKW#38VD9*8?;D#^ 9 KU6B@#*\
M/:;;:7HJ6UG!<6\3/)+LN#EPSN6)/)QDDG';/0=*\[DL]>7X63^%'T"]DU.U
M*J\PVF*<"<.9$;/S%ASC&<YSCK7K-% 'G\]G?6?CK5-2FAU9],U6UMQ%)91A
MC&T88&.1""PSNR#C')S52UT&X\,>)TEM[76$T6?3+>U@^RXFDMFC+_NY!\QP
M=^<C(SFO2Z* .!BT5=+\3>#X]/TN\33M/M;M&:12Y@,NS:"1GDX;IG'?%9<^
MC:A<> ?&-G#I-P+J[U:6ZMXC%M,J-*C*PSWPI..HQS7J5% 'G;Z?>6_C#7YK
MR#5Y-,UF.%X'LXPPP(MC12*1N0]P>!\QY!J?3[.[\*>*W:'1K^ZTJYTVTM+5
MH2LCVIAW#RWRW .X'=G&1R:[VB@#E?A_:WECX?GMK^SDM;D7]U*8V'&UYG=2
MIZ$8(K)U'1]4N]8\;Z?#:W$7]LV4:VEZ /*!$+(0S9R#N.,8SSFO0** ."GL
MKSQ#I_A2U&G7-C=:9>V]S=>=$46 1*0RJW1]Q^4;21@Y.*TO'EM<7EEI$5O9
MS77EZM:7$JQQEML4<@9R?P[=3VKJZ* .$UVWU>#Q=JVI:7IAN))?#PAMC(F8
MY)UDD8(WX$=<#G&:CT:VU&;QWINK7%IJGDMI,UO)<7J*K>:9(VVE$X0?*W8?
MRSW]% '$Z!H-]I^O7FE26Y&A6EVVH6,F>"TH)\H#T1S*WXI61I>@3K;ZIX>U
MZTUF>*?49;A&M]I@N$>7S%8N.4(.,@D=.,UZ;10!RGQ TS4=2T.T?3$DEFLM
M0M[QX(F"O*D;9*J6XW=QGNHIEE!:@ZAK*:7J]W>7%LEJR7L80S*"Q";3@  L
M<L1C!ZFNNHH \^\/:3J7A6VU;1+BRDNK9[?S+*\@5G&-N/LY!)8!#G;VVGUS
MFO%I5]%X#\"V_P#9MP+C3+RS:ZB$7S1!$82-COR>V<YKTFB@#R_5X?$&JV\L
M=UI>H>;:Z[#.D<4:+ MNEPK!UQ\TC% 2<YY)X' K97[?IGC;Q%*-(O+B+5+>
MW-K+$@,99$965V)^7DCKV_*NWHH \OTW1)E\+^%(+I=<TK4M/L&A%W8Q%VB?
MY T;IM8,K;0<XQ\G6K\%MK]OJG@W4-4L);J>""\@NWM8T'EM(8_++*#A<A><
M< YKT&B@#S+0_#\\>GS^'-?M-9FVZ@\ZM#M^SSJ9S*DF\<J02"02#D=^E3+#
MK5AIGB_0Y-%N[FXOYKRXM+J/:89DE4[0S9RK+PN".PQFO1Z* ,KPPDD7A;28
M9HI(9HK2*.2.12K*RJ 1^8K@+K3M5/PS\1Z#_8UZUZ]]<F)1&"LPDN&D4J<]
M-IZG'IUKU2B@#B?$NF7FI>)-&GL8)HXGTV^MC<",CR&E6,1[AU'(/TQ5+PGI
M+2:?H%CK&GZS'?:.$VK)M$$4B1E-ZNN RD$X&2>>1QFO0Z* .:\47&JP:AHZ
MV5M<R6+RR"[EM(T>:/Y?D W= 22"P''J,YKCK?1];L+&"[32;N7[!XEN+^6R
MR#)+ ^\*ZDG#L-X;&><5ZM10!Q>GO>2_$2[UB;2KRVL9M'BAB>2++%DEE8A@
MN=IPPP#[=SBN>@TJ_3X?>'["31[K[5;:XEU-#Y!)2,732%O0_(W;DYQZUZK1
M0!Q%S:7</BSQ1=BQN&@OM)MXX72(D22+YH*\=_G7K_2LW3["^CC^'"3:9=@Z
M7 4O,PG]PWV8Q#/K\_IGUZ5Z310!YCXBTG4I+7XB6T&FW,CZHL7V/RXR1,?(
M1#@]!AAWQ5[Q!87%W?S:AICZWIVJ&P2.)X+?S(;K&\K'*CJ5&TL>25X?K7H%
M% '%V<.IV7CU+V^T^61;G1+>WDGM4!B29'D9QUR!\PQZU0T:UU;3OA]K8LM'
M/]L_:+V>"&XA \SS)793SPV4QQGL :]#HH X'2[._F\<KJ<EIJ?D3:,]L+B^
M158R>8&P57A. >P_EG+M[/4Q\.O">FOHU^EWIM]8_:(VBR0L,BF1A@G(P./7
MMFO4J* ..\2:9J<?B;3=:T2)FENH6TV\(X,<3?-',0?^>; \=?F(JEJVCW>D
M>,M+U&T@U Z/'I9T[&G@/);L'# E2"2I  ) )RHS7?44 9/AW3K72]'$5I;W
M,$3RR3E+@Y?<[EF)&3C))..V>@Z5QEOX?OM2\'>---CLY+2^U&]O)K9YHRF]
M9.$.>V1D'N >:])HH XK0H([J?3M0O\ 3]<CO]-@<!;E!MA+*%=5VX$F<<8W
M=!TKG[+2K^'P)X+L9='NA<Z?JD4]S%Y!)B56<LWH?O#IG.3Z&O5:* /,O$_A
MW6-3NO&T-A:R*]_#826KGY5G,)W.F[H"0 O/KZ U8U30Y/$VB:I-9V^L1:S+
MI<MG$^H@1!0Y!,7& <E1\PR!SS7HM% 'G][=:EK%YX3N5\.ZA9Q6%_ONUEC&
M8OW$B?*%)W*"PY''3WQGZ[H6L:NOCN"QLYTDO9;2:T:1=BW A6/>H8\#)0J,
M]<YZ5ZA10!P-QIEEK5G=WMWI6OSSM8M:2+<CRG6-W4LJ@8W,,;@0"/EZ\UH^
M%+75K75KU9=0OK_2?(C$$VI6XCN!)EMRYVJS* 0<L.IX)YKK:* /._%T6NZF
M?%6EC3KU[>;3RFG_ &94$<Y,1W&1S\VX,<!<CC'!S5W6M.U&/3_#>NZ39/-J
MFF;(GMF^1I89%"2(<^AVO_P"NWHH Y#5X=3T:ST.VT^"XGMQ<L=0N+6)7G!9
M')=5;(&Z1OF.. QKF+C2-43P?XDL1I5\;JZUZ.[AB9=[/'YL+EBPXZ1L3SU'
MN,^K44 <9<#4/^%@W.HV>GSO&=#\B&22,K&TX<N$)/3C'/3MUK)TNWUB[U_P
MAJ5]I^I*]M#/'>-/$B)#(\:C:B)T3<" <= .3UKTFB@#RW2M$OM3^'$?A&XT
MB[LKOS]TTT\86.-?/\SS%8$[FV] .<]<#)I^O:%J^L?\)Y;V5I/')?&TDLWD
M78MQY*IO4,>!DJ5YZYSTKT^B@#EM"MK>^U>+5Y;364OHK5H-^H*$\M6924P,
M!CE0<C(XZ\U#KRW=CX\T;6$TZ[N[1;*YM)&M4WM&[M$RDC/0[",]N]=?10!Y
M5>:9JLW@WQ)8R:-=?:KO7OM44'E[M\7GQONR/E^ZC=_YC.]KVF7]_P"+X[BS
MBFBCN= NK);H(0(I7:,IN[C&TGVKMZ* /,)/[7N_"OAC3CX;O[>?2;^Q-V"J
ME52%AN:,@G>.,\=O?@SC2+J#6O$]EJMMJ\^GZS.9HGLU5HY8WB5#&_&4(VXR
M2!C'(KTBB@#B[;3/)^(XE_LV?^STT2.P2:2,LH82,Q0GG/RXYZ'US7:444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ".P1&<YP
MHR< D_D*\QU#QE<ZQ\/&UF*:YT^Y@U&-&:**2)#%]L$6-S##93.<'@^G2O3Z
M\T/A[Q OP_D\/?V6K7$6I":.5;A-LL8N_/+<D$?+Q@\Y]N: .PL_%>EW=_=6
M+-<6MQ;0FY=;RW>#,(.#(-P&5!ZGMWI]KXET^ZO;2U'G1M>QM+9M+$56X50"
M=I]<'.#@XYQBL'Q-X:O]>UV5TC,5I>:#<Z:\NY=T,DK(02,\@!3G&:D\,Z/<
M1C3!JVA217NGQ[1=27YGB#;-A:(%B1N&>"JX![T /^(-W?6.G:7-87\]I)+J
MEM:N8MOS1R2!6&"#SCH:S;B]U)O$&H6FEZU<7NDKI4LTTP9&^RW /R!9%'4C
M.5.< 9XS6OXZTW4=6L--@TZS:X>#4K>[D/F(H"12!B/F(Y../U(K<U19Y]#N
MTAMW:>6W95BW*#N88P3G'&>>?SH Q?#^N^3X'\/W-Y]KO+RYTZ&5A%$TLDA\
MM2S''N>I]:F/CC018Z9>"YF:#4I#%;,MM(=SC=E#A>&^5AM/.1C%85GI7B6T
MTWPK9-9R/9V=@+6]MHKP0GSE5%5RRG+1\/P.><D'I533_#6N66D^&K-M-R^F
M:U/>SE)D*F-S-C;ELD_O5ZXZ'VR =KHWB&QUR2[AMA<1W%FZI<6]S"T4D>X9
M4E6'0CD&EU;7K71U8SQ7<Q2,RNMM;M*40?Q' X'!]S@X'%4--TR]M/'6O:A)
M!_H=];VJPRAU^]&'# C.1]\8X[&JNN6&O7?B-Q' USI$ECY<2+=F%8I\MN:0
M#EP5V@=0,'@9S0!>G\9Z+#)I\:S3S-J,!N+,06TC^>@4-\I"X)P1QU&><5+8
M^*](OM+GU!9WABMY_LTR3Q-')'+D#RRA&=Q++@#.<C&<UR^B:!K-C-X'6;3F
M5-'L);6[82QG#,D:@K\W(RA)]B._%1W_ (6UV2369[2"+SQKT.KV:R2@)<*D
M<:F-B,E2=K<D8Z4 :%IK4]Y\5DLD?48;;^QY97M;F-D0N)8E5U!X/!/TR>E=
M3J&J6^G&W24.\URYC@AC7+R,%+$#MP%)R2!Q7.6MIKEUX\LM=N]+%K:#3);1
MHQ.CO&[2(^6P<$80_=SV]>+WBO2(]8CLH9]*FOH8Y#)OM;CR9X'QA71MZ^I!
MY[T 9&MZ^4\0>$[V&XOH+.XNKJ"XM=C R%(I<*4 R3O7C&<\8SQ6_I_BG3-1
MM+VXC:XB-C)Y=S!-;NDL3$ @%",G(((QG.>*YBUT#Q!;W_AF2X%S?1Z??74[
MR3W"/+'#)')'&C,2-[ ,"3^1.*EU+1_$D-]XNN-(C"2Z@]H]K*)E4LJ*BRKD
M\JQ 8 XQWR* -:[\0VVJZ5KEI:2WEGJ%E;&1TDC:*5,J2CC(Y!VGD>A%8=KJ
M&H.GPVF;4+D_;X@+M3)Q.?L;/EO4[AFGQ:%JT>K:[?+I4B1ZAI$=K"C7@E<2
M RY#LS=?G'()''6G6^BZS%;^ T;3GSHJ@7F)8^,6[0_+\W/)S]/?B@#2^(MW
M<:=X2>^MKV:T>&ZMLR1OM^5ID5@?;:QJY;^,M'FO[BREDN+.:"!KHB]MW@#0
MK]Z12X&5'?TIGCG2[[6/"D]GIL22W1F@E1'?8&V3(Y&>W"FL;Q'X4O?'%O)+
M=PG2Y4TZYM+>*1U=O,FVY9RA(VC8!@$D[CTQ0!TMKXBL;K4+>QQ/#-=0F>V\
MZ(H)T&,E<]QN&0<'!Z59OM5MK":"W??)=7&[R;>,9>3:,L1V &1DD@<CU%8'
MAW3)S-93ZIH,MO?6<147$U_]H16( ;RLLQ /N%X]:B\4:#?S^*=)UZRMY+R.
MV@EM;BUBNC;R%'*L'1MR@D%>02 1]* +S^.-"CAM)'GG'VJY>T1!;2%A,N=T
M; +PXVGCJ>V:@O?'%DOAS7M0M([@7FD0,\MK<VTB.K;"R;EQG:V/O#C&>>*H
M7V@W7FZ!)INB- EOJQU"[0W",YS&Z$L2WS.=P)Y(XZTNJ^'-4O;[QLL4""/6
M=*CMK64N,>8L<JD,.HYD'..QH N1>)(KZ?PUNOKNSFO&(:W_ +/D5+EO*+%=
MSK\H&"P(/..]9]WXLFU.S\9641N;673%D6UGA@E4Y6!9,LY&T'<>!QD>N<U+
M/8:W=S>#YWTAHCIDS272?:(V*CR7BX.>3EL_3WXILFCZU"?&MM'IPFBU<M+:
MS+.HR6@2+:5)!&"I)/ITR>* -?2==CCT+1HIFGN]1GTZ*X:*,;Y&7:NYSGW/
M4GD],U:B\4:5<V%I=VL[7 O%8V\449,DFWAOEZC:>#G&#P<5R$/AG5[+5M(U
M9M.N+E%T>+3;NUM[T0RQ/&20ZD.JNIR>"P['VJZ^@ZCHNMZ3K.B:/$T$5K/:
MW.G"Y"N@DD$GF*S<%MP^;)[\$T 6? NISZE?>)O-GO)(H-3\J%+M65XE\F,E
M=I Q\Q:KFH^*?L'C?3]",$C0W%I+/(Z6TLC!E9%4#:",?,<GM@9QFF>%=.U2
MPU?Q%/J5JD8O[U;F%HY R[?*C3;ZY&P]L&G:GI^I+X\TG6+6T6XM4LI[.8^:
M$,1=XV#X/4?(1QS0!9N?%^DVD+W4KR_8(YOL\EZ(R84?=M(+>@;@MC:#P3Q5
MS7;M+'0+^Y>ZEM5C@<_:8H3,T/!^<( <XZ],<<UQD/A?6(_ 5]X)>U#I(988
M=1,B&/R9'+;V7._>H8\8() YYR.LURQFD\(7^FV4333263VT2E@,DH5!)) [
MY- %0^+--T^WT>"YN+NYN-0MQ);LEFY:XPFXG"K@,1SM[9Z8JO\ \+#T 637
MC->K!#*8;IFLY/\ 1'!P1+Q\G)'7L<]*I1:1JXOO!,C:<X328'CO#YL?REH?
M+&WYN>1GZ'UXJG<>&]9N_"OCC3OL/ESZO<S3V@>5,$/&B ,03@Y0G\1S0!U&
MH>+-,T[5CI;K>37_ )!N%@@M))"Z @94@8/)'0\55M_'V@72V$D,URUO?2+#
M%<&UD$0E)P(V8C"MGC![\5 EEJ?_  GEKK#:;*+2/2'M&/F1[O,+J_3=T^4C
M/K[<UBQ>&M;'@"WTMK +>P:PM[Y?FIAH_MAGX.<9VG&#CG\Z .MO_%&F:<+Q
MY6E>&Q(%Y-%&72VR ?G(]B"<9P""<"G:CKEE$LUNC75Q*L8>1;&-I7B1@<,=
MN<9P2!U/8&N5@\,7MEJVO0W6D3ZGIVKW+72,E_Y2IO15>*:/> 5XZJ&R#C%:
M%EIFM:!XJU:2QTZ"[TW4S#)&_P!H$9M72-8RK C)3"@C;D]>* ,[P[K\K^ O
M"=S?ZS>175[=QH9OLYF-R3(1Y;D@A V1SP1CBNHU7Q5IFBN_VW[2L,3K'-<+
M;NT4);&W>P&!]Y?ID9Q7(VOAS7;?P/X8TI].+W>FZE#<7&V6/:4CD+DJ2W)(
M/ ]CG'&5\3^'_$VN6OB2Q>U-PMR5.GR->[(HXL)\GE@_?W!CDC'/7@"@#HF\
M5A/'LOA]X7$$=C'/YJVTK'S&=EY8#:$ 7[QXR3SP:MQ>*-,NI;*)9)EBU#*V
M=R4(CG(4G"-] 2,XR!D9K)OM&U.[\7W=TMH18:EHRV,DOFJ'MG#2$Y7OQ(,8
MSR/3FJGA7P_=V.GZ5I^KZ%))/I041W9OS) 2BE5DC1FRK$=BH R>: %\/>)D
MTCP[>76MW=W/&FM7-DDS*TI4"<QQJ2!P.@STKK4U:W?5SI86;[2L(G;]T=H0
MD@9;IG((QUX/I7+:5X8N+OPAK^BZS;&V74+N[F1MZMM661G1N"<,N0?J.]:G
M@J._D\/V^I:OL.IWL4;S%#D !0% ]B,MCL7:@"YJOB73M&U&SL+LW'VB\#F!
M8[=WW[5)(! P3@=.O3BL_P#X3_04TW4;V=[N ::RK>0RVD@EAW#*EDQG:1T;
MI[U0\8W%S;>,_!TMI9->2B:Z_<K(J%AY)S@MQD#G!(^M1:[X1OM:TKQ1=!(X
M=2U>RCMH;=GR(UCW%0S#@L2QSC@<#)QF@#JI]<L;?6[72)6E%Y<QO+$ODMM9
M4QN^;&W(R.,YY%947C[0)IID6:Y"6[3+/*]K(D<)B4LX=BHVG /!Y..E4FM]
M>U+Q=X?UFXT;[);VD%S%/$;F-Y%:01X/!P5^4]#GVI-'TG4K?0O$]M=Z0LC7
M][=7,5O+(A29)>B,0W!QP>WO0!KW'BS3[*SN[J]AOK:&U@%P[/:N<Q\_,-H/
MH<@\CN!5E_$.GQZCIE@[RBXU)6>V'DMM8!"YRV-H.!TSFN/7P;J!TO7=/T][
M^STV]TJ2U@L=1O//"3L" RG<^Q #C&[G/3CFS'8^(;W5O"5[<Z,+6+2S*MRG
MVF-WRT)C#+@XVY/KG'8=P#H'\5Z6CQ$R2&VDN?LBW80F'SMVW9N_WAMSTSQG
M-:EY=PV-LUQ.7V*0,(A=B20   "222!7!>&_"=SI5DFA:IH\M_;P7320WGV\
M^0Z>:9%9HBV0ZY' 4C(SGO74>+(=8GT4+HF3<"XB:5$E$;R0AP9%1S]UBN1G
MCZB@"%O&VC1:?J=Y<-=0+IA O(I+63S(01N!*@$[2.0W3WJ6V\7:7=:I'IR"
M[2>:)IK?S;9T6X50"WEL1AL9'YYZ5R%]X7UN:S\9Q0Z65;6[*&&V!NQ(58(R
MGS&9LY^;MGOR>_17VFZC<Z_X3U%+-O+L1.+I3(FZ/?&$'?!Y]#TH MP>,-*N
M=$.KPFY>T^T?9LBW??YF_P O;LQN^_\ +TZULW%S%:VDEU.2D4:%W.TD@ 9Z
M#D_05R&F:)<6_CS585*'1S)'JBH#RMTZLC+CT^7S/]Y@:WO%$6KS^&KZ+0I%
MCU)D A8L%[C(!/ )7(!['% $5OXKTZXEOH/+O([FRB$\MO+;.LAC.<.JX^8<
M'IW&*=;^*=-NM.TR_@^T26^IN$M66%B7)!(XZ@8!//8'-8VAZ-J-OXVDU>;3
MI+>UGTQ+;]Y=^?(KK(S'>22>A'0D>]2^%_#5YHVI7D$_EG2K2>1]*53DJLV&
M<$=MIW*OLQH TY_%6F6VHP6<WVE//N/LL<[6[B%ILD;-^,9R"/3(QG-9&H:H
MUSI_C);36+PSV,)98_(\DV;"'< K%07!(W9.>O%9%UH/B>_6W:_LFN+JTUN.
M\,YO04D@2;<HBCR%4A,#G!R.ISD:$ND:NUQXX<:<^W5XE2S_ 'L?S$0"+YOF
MXYY^GOQ0!KZ=KBV?A;1IKI;R[NI[".4K!"TLCX1=S''NPZ]<UBZKXG@DU_P?
MJMAJ-S)I5^+G=%"K$38B)4>6!N+!NV,Y'M3X=.\1Q?\ "/6[V<DFGV^FBWN;
M>.]$.RX&T!W*G+)@-P,]>5],S3/#GB#1[#PBZZ4+B71Y;LW,*7"*667<%*$G
M!^_G!(Z'VR 7?%7BJ+4_!.K76CWE[97VGSPQS1LC031%I$&&5AG!5C@]ZZJ_
M\065A-<0D33RVT0FN$MXRYAC.<,V/7!P!DG!P*Y3Q#X6U._TCQ#<V]H&U+67
MM0+<2*!#'"01N8G!;[V<9Z@<@9J2;0-0MO&6J:M_9EU?6.KQ0%HX+[R)+:1$
MV%67>JLI&#D$X.>#F@#M+>^MKO3X[^VE\ZUEB$T<D8+;T(R" .3D5@V?C_P_
M?(\L5Q.MO'%)*]Q+;2)&HC?8REB!\V2/EZ\CCD5MV%K'INDP6UM:+#'!"%2V
MA.0N!]U2<?3G%<(GA#5[[X5W?AR6);/4#<27$3/(#&Q^TF=02A) Z ^F>,T
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MRL%::%XP3T!((KS^WTCQ+)H?@^RFT983H=U ;C%TC&58XGCW)SC'(."0>>E
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MYS[YKT"[BDO=*GA53%)- RA7(^4E<8.,COVS7"P:-K__  CO@RRET@I-HMU
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MFOI/KKZ+<VDUK>BV^U1J[*RR1;MI(*D\@X!'N,9J?4M8ATZ>UM1')<7MWO\
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M"VP2%<[O++=\9YSC'-%QXS*:AJUC:Z#JEW<:7L,ZQ^4 592P927 / Z=>>E
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M"  1NQP3GVI-8T?4;CQ7HNLV#6I6SBG@GCG9E)24QG<I .2/+Z'&<]17144
M<5'X4U5_#/B[2YWLTEUJ6YD@=)&98_-C"@-E1TQU'7/2J\?@R_M->?5EL-&U
M#[7:P0W5O>L1Y;Q+M#QOY;<%<94J.@YKO:* (;2$6UG#"(X8]B ;(5VHOLH[
M"N>\-:)J>EZWKUY>BS\K4[D7*"&9F:,A%3:<H,_=SG]*Z9F"J68@ <DGM2T
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MG(.TX([TNI^%;Z_TJUDLK;2M*U.ROX[Z". %X79%*[9&"J2"K,,A>..M=B6
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MHZY;):!3(QC@B16 ^;;ECEF)X'8=LGLK03+:1+<+&LP4!A&Y9<^Q('\JFHH
MX^;P[K*:EXJ>V:Q>UUJ-3&9)'5XW$*Q8("D8^7=G.>V.X1_#&J-H?A*U#V?V
MC1+B&2;]XVR54A>/Y3MR"=P/(KL:0L 0"0">![T <-X>\%W'A]FL/[-T2\L5
MN7F@O)E(N41G+[6780Q&2 V\=N.*[JBB@ HHHH **** "BBB@ HHHH ****
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MYA6 @L P;?G<<<CIBLU_ M^EM''#JELS0ZS-JJ)-:EHW\QG.QU#C.TOD'(Y
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M]Z /09)$B0O(ZH@ZLQP!3J\YUCQ+>3^"O$JZMI&FW<^DW:V]Q Q8P3KB-U8
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M&PNFM5N8'8"=@%.0A!P!NP?F.&4BM+6K]]/LEE2:TA+R"/S;M]J+G...K'.
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MN[P0&U2"0S)$7*"7>/EXX8KC@9^;BN[H **** "BBB@ HHHH **** "BBB@
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M8T=#)@*73</E8@#/4''2I-9\)V>OQW::E--+YT8C@884VN"&#QD='W!3G_9
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M7<$5S)-'<7<MU^\ !1I'+L..HR>*9K'A_P#M75-+U&*_GL[G3VD*-$JL'5P
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MJ"6)5;#!64@A@005=JFMO$.D7E]#96NH03SSPFXB6)MP>,8^8$<$<COWK2H
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MPB+R['L!_2LGQ#KFK:GX \865Q+&)].N$MQ.+=X3+$ZQN,H6RK8?'I[5UO\
MP@>GC3DM%OM04Q7[:C#,LB"2*=BQ9@=N,'>V001S4DG@?2YK+6;26:\>+5RK
M7.Z;+;U55#JV,@_*O?''2@""XO-2M/&OAZQO#IUP+J"[9IH[1DD0H$.%)=L
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M8] ![55'@+2TT72]-BN;Z(Z4VZQNHY0LT&1@@,%P01P0P.>] %'PG%>0^/\
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M'R;F[M[;4F+WEK$ZB.5F&&;E2REAP=I&>O7FMR&&.W@CAA18XHU"(BC 4 8
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M?6@".VU/7;?Q=<Z%>W5E<B73FO;:9+9H_*8.$*,N\[A\P(.0>M9WP]TF34O
MOAFYU2X2X2W1;JWC6,KAR&PTA+'>1N)!XYYP2!CJGT*W?7X-:::?[7%:FT/*
M[7C+!CN&.N0#D8Z4GA[0+?PWI::=:7%U+;1\1+<2!O*7LJ\#@>^3[T <Y?\
MBZXLO$TMAJ$YTI!>116K7%F[6]U$VS<?.' <DN ,C! SFNXK$G\-0732QW-[
M>36<MP+AK-RGE[@P8#.W=C< <;L?AQ6W0 4444 %%%% !1110 4444 %%%%
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MQW=I'B.\U+PEH0N]0N%U6^EGA_T*&/S;CRF=6(W_ ")]T,2>.PQD4 =U+-%
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M#,,\X8FMFJB:A&^K2Z<(K@2QPK,9#$PC(8D8#]">.E %2?PWIEP[,Z7 WPK
MZI=RJKH,X#*&P>IY/)SS3V\/:6VL6^JBVV7EO"((WCD=!Y8)(4JI"L 22 0<
M=J;K>O0Z$VGB>VN)5O;N.S5XMN$=V 4ME@<?0'I6K0!!>6D-_9RVEP&:&52C
MA79"0>HRI!K./A;1SI-KIGV9_LMFRM;#SY-\!484H^[<N!QP>G%;%% &3+X;
MTJ?3KRQFMWD@O>+HM,^^88QAGSN(QQC.,<5H6EI%8VD=K '$42[4#R,Y ],L
M2:BU2_72M+NK]X)9DMXVE>.';N*@9.-Q Z<]:73+^/5-*L]0B1TCNH$G17QN
M 90P!QWYH @O=#T_4-2L]0N8I&NK(DV[K,Z^62""0 0.02#D<CBJ;>#]#>TU
M&U:UE:#47,EVANI<3,0 2?F[@ ?0"MVB@#,?P_ILES97+12F>QC>*WE^T2!D
M1L;AG=DYVCKGI5/_ (0O0?[,.F_9)?L9G^T^5]KFQYF[?N^]G.[YOKS6_10!
MFR^'],FU%[^:V\RX>U^QR,\C,)(<D[&4G##+-U!ZU%I?AG2]'01V44XA"E$A
MENI98T4]E1V*J/H!Z5KUFW^L+9WL%C#;2W=W+AS#"R QQ;@ID;<1\H)Z#)/8
M'!P 9L7@'PU!"D,6GNL44RSPH+J7$#J<@QC=^[YYPN!5R7POH\]U?7,UJTLM
M_!]GNO,GD998\$;2I;&!N...,FJVH>+K73]).I/8Z@T"W@LVS"$97,@C#8<@
ME2Q'(SQ70T 8MCX3T73;NUN[6VE6YMHFABF>YED<1G&5)9B67@8!R!CC%0KX
M)\/+I4FF#3S]C>;SQ$9Y#Y;@DAHSNS'@DD;,8R?6MYV*HS!"Y )"KC)]AGBL
MWP_KD'B+25U"W@FAC,LL7ESA0P:-V1L[21U4]Z +-AIMOIL)C@,[!CDM/<23
M.?\ @3DG]:AU30]/UE[5KZ*21K6430;)WCV. 0&&UAS@GGW-:-% &3J/AO2]
M4OH+ZXAE6\@0QI<6]Q)!($)R5+(P)7/8DBIK[0]-U+1GTB]M1/8NH5HG9CNP
M01DYSG(!SG-:%% &?JNB:?K4$,-_"\D<,BRQJDKQA74Y4_*1R" 1Z56N/"ND
M7.IMJ)AGBO)$5)9;>[EA,JKP!)L8;\?[6:V:* *5SI-A>7-C<W%LDDU@YDMF
M.?W;%2I(_ GK_2EM]+L;34+R_@MDCN[W9]HE&<R;!M7/T'%7** $90RE6 *D
M8((X(K(L?#&D:<8/LULXCMV+V\3S.\<).1E$8E5X) P. 2!@5L'ITS65H6O0
MZ]#>20VUQ;FTNY+21)PN[>F-WW21CGUH 9#X6T>"SU*T2V<V^IES>(]Q(WFE
MUVL3EC@D<9&.@K2M+6*RM(K6 ,(8E"(&<L0!T&2234U% &3/X:TJXU2XU)X)
M%N[B(0S/'<21B10"!D*P!(!(!QD ]:8/"FC#2;/2Q:N+.RE26VC$\F8F3[I5
MMV1CL,XK9HH QAX5T=-3FU"*":&>=Q).(;J6..5O[SQJP1CZD@Y[ULT44 8>
MG^$=$TN;S+.UD0;_ #1$US*\2OG.\1LQ4-GG<!G-,N_!7AZ_FOI;FP+_ &\@
MW*>?($D8 #=L#;0V /F !]Z?J?BJPT_3;74(UDO;2XNDM%FM61E5VD\L9)8<
M;N#C/2MR@#(D\,Z7-+*\L=Q()BK2QO=RM'(5 4%D+;3PJ@Y'..<TU_"VD/<W
M]R8)O.U#9]I<74H+[3E2,-\I7L1C':MFLCQ#XAMO#=E'>7=O<RPO*L.Z!5.U
MF8*H(+#J2!Q^.* +5EI5I832S0I(TTJJKRS2M*[*N<#<Q)P,GCIR?6DU;1K#
M7+(6FHPF6$2+*NV1HV5U.5964AE(/<&LU_%UM#J+:;<V%];W_P!G:YBMY%3,
MZ+][8P<H2,C(+ UHZ)JT.O:'9:M;)(D%Y"LT:R !@K#(S@D9H CM?#^FV>JM
MJ<$4HO'B6!I&N)&RBYPI!8C R>W<U2_X0K0!;6L"V<J):3/-;F.ZE1HF?._:
MP8$!LG(S@YZ5T%5M0OK?3--NK^Z?9;VT332MC.%4$G]!0!EMX.T%M-N=.^P;
M;2XN/M3QI-(N)=V[>I#90Y /RXK:AA2W@2&/=L10J[F+' ]2>3]33+.Y%Y90
M72QR1":-9 DJ[74$9PP['VJ:@#'G\+:1<7][>O;2"XOHQ%<M'<2()5 VC*JP
M&<<9QG'&<4I\,:0=.T_3S;/]FTZ1);1?/DS"RJ57#;L\ D 9Q6O10!C1>%='
MM]1FOH()H99Y?.E2*YE2*23^\T0;82>Y(Y[UL,H=2IS@C!P<'\Q2U'<3+;VT
ML[*[+&A<JBEF( S@ <D^U %#2= T[0S<G3XI8OM,K33;IY) \C?>;YF/)[GO
M1+X?TR?6&U66!GO&@-NSF9]IB/5-F=N.^,=>:N65TE]8V]W&DJ)/&LBI*A1U
M!&<,IY!]J?<7$-K;RW%Q*D4$2%Y))&"JB@9))/0 4 8=IX)T"Q-FUM9RHUEN
M^S/]JF+0@C:54ELA<<;>@]*E7PCHB:)<Z,+-CI]RYDEA:>1MS%MY.2V1EN>#
MUK8BECGA2:)P\<BAE8="#R#3Z &QH(XU12Q"@ %F+'\2>3^-8K>$-$>WU&!K
M:8Q:DQ:\4W4N)B0 <_-Z #Z#%6K[6%M+^"QAMI;N[EP[10L@,46X*9&W$?*"
M>@R3S@'!Q;N[VVL(//N[B."+<J;Y&"C<Q 4?4D@ >IH I_\ "/Z:;G3K@PR&
M;3D9+5S/(2BMC<"=WS [5ZYZ5#IWA72-)G,MA!- N\R"!+J7R%8]2(MVP=>R
MU)'KT,GBF70#;7"7$=J+OS6V^6Z%MHQAB<Y!Z@=*U: ,[3M"T[2KN\N;*!HI
M+R4S3CS7*LY.68*254D\G &>].U?1K#7;(6FHPF6%9%E7;(T;(ZG*LK*0RD'
MN#5^HKB8P6TDRPR3%%+>7'C<WL,D#\S0!1M?#^FV>JOJ<$4HO'B6%I&N)&RB
MYVJ06(P,GMW-4V\%: ;""R%DZ16TS3VY2XE5X78DL4<-N7))R 0#FKV@ZQ!X
M@T*RU>UCDC@NXA+&LH 8 ],X)&?QK1H KV=G#86X@@\PJ#DF65I&)]2S$D_B
M:JWFAV-_=M=3?:1*\0A?RKJ6,.@)(!"L >6;G&>:GO=0CL9+1)(KAS=3"!##
M$SA203EB/NKQU/'2K= &4_AS26U&ROQ:>7<V47D0-#(T86/@A"JD!E! (!!
MJG!X'\.VPA$-@R""X^TP 7,N(9.>8QN^0?,<JN ?2M:QU"._>[6.*XC-M.8&
M\Z)D#$ '*Y^\O/4<=:MT 8\/A;1X++4K-+9S;ZF7-XCW$C>:7&UB<L<$CC(Q
M45QX/T.YELYI+2036<?DPS)<RI((\YV,RL"R_P"RQ(K=HH P3X,T Z;)IPL"
MEH]S]J\M)Y%V2[MV]"&RAR2?EQ2GP;H30W\1LWV:A&L=V!<2CSU Q\WS<G'4
M]3DYSFMVLVQUA=1OIHK:VE>UB+)]M#)Y;R*VUT SNR"""2,<'F@".\\-:3J&
MC1Z3>6IGLXBK1J\KET9?NE7SN!'8@Y%0Q^#]#BEFE2TD\V>U-I-(US*S2Q<\
M.2V6/S'YCD^_ K4DOK9+O[&)4:\\DSK;JPWL@(&0">F2!D\9JGX?UR#Q%I0U
M"W@GA3SI83'.%#!HW*-G:2.JGO0!)9Z-96-Q]HB69YQ'Y0EN)Y)F5,YV@N20
M"0,XZX&>E.U?1['7=/>PU*%IK5R"T8D9 V#D9VD$\X/X5>HH S+KP_IUY-:S
MRQR_:+52L-PEQ(LJJ>JEPVX@X&021P*BN?"^CW>GPV,MJWV>&87"JDTB'S=V
M[>2&!9MW.22<\UL44 -1 B*@)(4 #<23^)/)K.NO#^FWFKQ:K-#(+Z*(PK-'
M.\9*9SM(5@&&3D9S@\BM.B@#$3PCHB:%+H@LV_LZ63S&@,\A^;?OR"6R/F^;
M@]:6;PIH\VHMJ'DW$=VZ+'++!=S1&95&!YFUAOP.,MDUIQ7MM-=SVL5Q&]Q;
MA3-&K M'N&5W#MD#-3,2%) )('0=Z   *H4#  P!6.GA71X]2GOX8)H9IY/-
MF6&ZECCE?^\\:L$8^I(Y[TS3/%5CJ>G:E?B*XMK?3I98KEK@*-K1YWC 8],?
MX9IS^)[/_A'['6H(;BYM+WR?*\H+N_>E0@(+#NP'M]!0!+=>&](O;&YL[FS$
ML-U,)YM\C%FD&,-NSN!&U<8/& !45SX4TBZU$:BT-Q'>>6L3SV]W-"\B#H'*
M,-^/]K-7(M5@DN[ZW=)H?L2HTLLT92,AEW95SPV .<'CO5.Z\36=M=Z+$D<U
MQ#K#[+:YAVF/[AD!)W9P54D$ T $OA31Y=3EU$6\T5S,%$S6]U+"LV!@;U1@
MK\<?,#QQ7/C0X]1^)VJ7MW:Z@D'V&WAMYXI)H$=E:0NI*$!A\R<'(/:NRO[Q
M-/T^XO)(Y9$@C:1DAC+NP SA5')/M4L,@FACE4,H=0P#J5(SZ@]#[4 9VH>'
M=*U2QMK*YM (+619;=87:$Q.H(!4H05X)'![T1>'=+AU*YU!;=C<W40AG+S.
MRR(,X4J25P,GC'<UJ44 9%CX9TK3C;_9X)-ML"+=))Y)%@R,?(&8A>"0,= <
M#CBF1^$]%CTS4--%H[6>HL[W43SR,)&;[QR6)!/?&,UM44 8VE^'H=/UB]U-
MG,L\\<=O$6)8Q0(.$R2226+,3WR!VJ]J>FV>L:;/I^H0+/:7"[)(R2-P^HY'
MU%6Z* ,B'PQI4%_:7R13FZM(S%#*]W*Y5"02#ECG) SG.<"HI_"&A7-O>036
M.^.\N?M<P,K_ .N_YZ*=WR-P.5P:W** *FGZ;;Z;$8X#.VXY+7%Q),Y_X$[$
M_AFH=7T+3==@BBU&W,HAD$L+I(T;Q..C*ZD,I^AK1HH QY/"^E2O9/*EU+)9
M2&6W>2]F9D<@@MDODG!(YSP<=*KR>"/#TKW#/8,?M%P+IU%Q*%$P8-YBKNPC
M;ADE0,]ZMKKT+>*F\/FVN%N!:?:Q,P7RW3<%XPV<Y/<#I1K.O0Z+<:;%/;7$
M@U"[6TCDBV[4=LD;LL#C /0'I0 S_A%])-SJ%QY,_FZ@@CNF^U2_O5' !^;C
M )'&."1WIB^$M&1-,1;>8+IG_'D/M4O[GC;Q\WH2.>W'2MNFNZ1QM)(RJB@E
MF8X  [F@"G::18V-_>WMM"T=Q>N'N&\QB'8 *#M)P#@ <#M2WVE6NHRP2S^>
MLD&[RWAN'B(SC()0C(.!P?2F2:U:+;Z?<1>;<P7\B)!+;1F1<,"0Y(Z)@?>/
M'(K0H QO^$5T?[18SBU=9;%W>W9;B0;6?.]CAOF9LG).2<\TEYX2T34&U%KJ
MR,AU$QFZ_?. Y3&QN&^5AM7!&#Q6U10!AKX/T13=$6LH>[MQ;7#_ &J7=-&,
MX#MNRQY/)YY(S3E\*:.ATPK;S Z6-MG_ *5+^Y&-O'S<\''.>..E;5-DD2&)
MY975(T4LS,<!0.I- "D!E(/0C!K%TGPEHNA^6+"UDCCB.8HGN))(XCZHCL50
M\GE0.I]:ELO$%O=0QS3QO9PW,JQV37#H/M89=RL@#$\C)P<-P<@5K4 8R>%=
M'BU*>_A@FAFGD\V98;F6.*5_[S1JP1CZDCGO6S110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 174KP6DTT<9D>.-F5!U8@9 KA
MM(N+G4? ]EXRBU"\N=26QDNY+=)W\B:3RF_<^4#M 5\ 8&[Y>2<FN^K+M/#F
MC6-^]]::9;07+L79XXP/F/5L=,GG)ZG- '&SWU];^%O"OB&PU*ZN;V]N+-;A
M&F9H[E9L"0"/.U<9)&T#&WTS525=1N-"\<7G]OZJDVD7EP;(QW&T1[($< @#
MYADG@Y'7C)S7H%IH&E6,XFM;"&)U9G0*/E1F^\57HI.3D@#.:(= TFWBO(HM
M.MTCO<_:E"#$V1@[_7(XYH XG6M2UMH%U-K>[O=,.E12R_V9??9Y[24JS/)L
MRHD!!4@$\;3QR<V6UZZM_$NKW-K/<75LGAN/4K>TE/!<M+_#V)"**ZC_ (1G
M1>,:; %$8B*@85D&<*R]&49. <BK*:/IT>IMJ264*WS)L:X"_.5_NY]/:@#S
MK5_)OM#\$:U)JUQ<7-[JFGNW^D'RI69@3B/.U<<_= (QSFKOVO7O$E[XLM+.
M5K>]L+HVUB1>-"(,1*R.R '>&8DG=D$< <5U4?@[PW")!%H=@@DD$K!8%'S@
MY##T(//'>I[OPWHM_>B]NM,M9;D($,K1C<RCHK'^(>QS0!RDUKJFI>/Y-*GU
MV^M8AH\%W)'9R[5\[S74[21G:=O3J?7K532;OQ)XGTBXU"RF6#4H=4DCR]XR
MQ1)'-M,3PA2#F,=3SELY'&.\71M-74SJ:V4(OBNPW 7Y]O\ =SZ>U0MX;T5]
M3?46TNU-X[!GE\L9=AT+>I'8GF@#C;R\'B+P[XRGO]0N;5]-GNK:.*"X,0B1
M$^4L </OZ_,".<"NM\(?\B5H/_8.M_\ T6M27'AG0[O4GU&XTFSEO'38\[0@
MLRXQ@GOQQ5ZSL[;3[2.UM(4@MXAM2-!A5'H!V% 'G6H:W/+=Z1K.EWMZ()M>
M2P9Y[K$<\9E:-T6 97 P0&.&^7/-6I-1U33_ !"LFJV]])9SZJ(;74;&]W0J
M&?8D4L&1C!^4M@\\YKJO^$4\/B2:0:-9!YI1/(PA&3(#G=]<\Y]>:GAT+2X+
MLW,5E$LOFM-GG D;.YP.@8Y.2!GDT 8WQ(N;NR\!:G>6-Y-:7,"JT<L38(.X
M#\N:RM3?4=&\4:-H27][>P:H]U<R/<W7ELS(B8B1U'RKRS[5Q^60>UU#3+'5
MK0VFH6L5U;L06BF4,IQZ@]:AO=#TO4K&.RO;""XMXF#1I(N=C#H5/4'W% &%
M8MXKT:QEA?3TU9FNY6@!OP&A@(4HKNZY=LEAGG@#)-4!:SW7Q<$DMW<VTG]A
M12-#$ZE1^^.4SMY7/?K_ "KM+.QM=/MQ!:01PQ YVH,9/<GU/O4+:-IK:F=2
M-E#]N*>6;C;\Y7^[GKCVH \WOKNXNOASJGVN[EN6@\2K CS-N8(E^BJ,^P K
M5FO=9U_Q'XJTJW=XI+#RHK/9>- 8B\082D*#ORQ/7(PN,=<]5_PBN@FU>U.D
M6AMWE\YHO*&UI,YW$=VSSGKFGWGAO1;^YBN;O3+::>)/+65D^;9_=)[K['B@
M#G-.N[[6/$5[H.MWK0RV&G6DK+93M#YTKAO,E#+ABH8  <#U'(Q)\+=G_"#1
M>7,TZ?;;S;*Q!+C[3)\Q(ZYZUT%]X=T74I[::]TJTGEMAB%Y(02@]![>W2K-
MCIMEIJ2)8VL5NDCF1UB7:"Q.2<>I)S0!S%G--XA\2>)]/N[R[M1I\D4-LEO.
MT116B#^;\I&XEB>N1\N,=<\YH^J:UKK^"#?:I=P-J5K>"[6W?RQ.(\!'&!P6
M!W9'KQCBO1+S0],O[H75U9123[/*,F,%D_N-C[R^QR*=+HNF37MM>26,#7-J
M-L$I0;HAZ*>P^E &%X)GNA-XATVXO;B[CT[4S!;R7#[Y!&8HW"ENK8+GD\UE
M^,]2>=/$$>GWE]%=:18"=I([KR(K=RKNO3F1B /E8%< <@DUVMOIME:75Q=6
M]K%%/<MNGD1<&0XQEO4X %5KKP[HM]?/?76EVDUT\7DO+)$"S)@C!/<8)'XT
M <D9KW5/%7AR&75;R"'4-$EN+B*WF*!W'D\KC[I^=N1S61JEQK.F^&_%,,6M
M7[V^G:G;16-\\N9,.T7FQLW\84NRY//49XK?U7PM%>^-M%+Z$LVBV-C-"&S&
M$B=FC*[5W;A@*PX'?%7/'>C3ZAX(FT?2M,6X,DD 6W38B!%E1V!W$#&U3Q0!
MDZZVJ^&/$5O<:5J%_J"S6-Y/=6=S*95_=Q[D=1_!ERJX7 .[@<4_P])KE_8^
M'=?2\7[-) )M2>6]:1)T:,DE8]NU&#X.%Q@ CFNPTK2K#2K4)86$=FK@%D50
M#]"1GITZX]*ALO#6B:;<M<66EVL$I);,<8 !/4@= 3DYQUH XJQUBZE\2>$K
MZSO+[[#K1F#K=W6XW""%I%D$(RL?*C&TC@X(K=\!D%?$F/\ H/7?\UK5M?"G
MA^R\HVNCV4)BD\V,QP@%'P1D>G!(X]35O3])T_2O.^P6<-MY[^9+Y2[=[=V/
MJ?>@# 2XN1\3[O3VOI_LCZ,DZPE_E1S*REE';@"N535=1N/AQIE^FM78N#KP
MM_M2R\O$;XQX/8C9CVKT34/#^D:M=P76H:=;7,\ (BDEC!*@]1]/;I7.>,?#
M"3^'H-,TC0XYH9-2@N+FWC\M$9%E5Y,AB <C/'?- &=KD^K^$]=N9=)OK[48
MCHUW>3VEW*9A%)&%,3+GE=Q+#:.#@X'%2W=U>6.G>$-7T[4KJZFU"[M8+E9)
MF=+F.5<NP0G:I7[XV@8 (Z5VNG:98Z9:^38V<=M&W+(J@9/OZ^E166@:5ITJ
MR6EC#"REB@4<1[OO;!T7/?&,T >=7#:F_A+QEJ@\0:HMUH]]=FS*SX5!$JL%
M88PX[8;(],')/IUN[W6G12;RCRQ!MR8RI(ZC.1^=58O#VCP6MY:Q:;;+;WF?
MM,8C&V;/!+#N3WSUJ];V\5K;I!!&L<48VHB]%'H* /'K2T>+X0:6XOIV,VKV
M^W?M(B/V_JHQU[G.:W-:U+4_"6L:\EA?7EZBZ!)J,<-W(9MDR/MW+GD+@Y*C
MCCC%=A_PB7A[RY(QHUD(Y)O/=1",-)G.['KGGZU=;2K![Z.]:TA:ZCB\E9BN
M6$?]W/I[4 <SH<&MSWNBZG#= Z=+:L;SS;YI_M&Y 4=%*[5.[.=N!@GC@4GQ
M0_Y%*'_L)V7_ *4)70:=X<T;2)3+I^F6UL_.#%&!MSUVC^$'VQ4VI:/IVL1I
M'J5E!=QHVY4F0, ?7![\4 9MQH*OJ;ZW?W'VBZM[66"V58]B0HW+$#))8[0"
M2>@X YKE?#EY$_@?P5HZR7AN;S30Z16T_D;E1%W,T@(90"PX7DD]" :]#>TM
MY+,VCQ*UN4V&,]"OI6:_A70)+:TMWT>R:&T8M;QF$;8L]=H[ XZ=* . M=5U
M>Z\,^&V;6KI9F\12:<\\4H8S0K)*!DXPQPB\XYZD<UT6C6S+XOU_P]=W5S?Z
M:EM:7445[*92C,TFX;CR5S&IP<C\*WV\+Z$X4-I-IA)C<*/+&%E)R7'HV2>>
MO-7!IMDNI/J*VL0O701M.%^=E&< GN!D_G0!S/BJ364U>-[.SN-1TZ.U)GM+
M&^^S7$;EN)!RN\85@!N'(/6MW0KN+5?#&G7<$UP\5S:1NDLHVRD%1\Q]&[_6
MI+S1=.O[G[1=6B23>7Y1?D%DR3M..J\G@\<U<\F,0>2$41;=@0#  QC% 'DT
M>HZSIOPYO_%8UN_N;N"2YM4CE<-$B?:_+$A7'+*H)R<C';%;>M7'B/P[I^JZ
M]9%6L8=*D<6\UX]T3.""DB[APH7=D @'CBNRM-$TNPLY;.UT^WAM9L^9"D8"
M/G.<KT.<G/KFH].\/:/I*,MAIUO;JR["$0?=_N^R^W2@#DO$\T_A[P?<^*-)
MU:]N)&M8U+2W#21-YDD8\\(<JI52Q^50.>F!5N6RUR"2^NTNWM]+;3)"5^WO
M/()UP4D0L/E&W<#@X/'%;]EX8T/3HY8[/2K2&.5&C=%B&THW5<= I[@<46OA
MC0[*VEMK;2[:.&5/+=%3@I_=_P!WVZ4 <6MYJ%WI7PWD.KWL3ZBD:7;I+_KL
MVCN2<\$E@.:J^((-0L;'QWI46J7UUI4>A-<!KB7S7@F99,Q!V!)#*H)!Y (Q
MC-;OB;PO'=7?ABQM-"2?2+&[:6>)/+6.-/*=%PK,.C,IX'&*ZR+3+&'3VT^.
MTA6S=2C0[!M8'@@COGOGK0!7\/6QM-!LHS<S7&84(>4@D#:.!@#BN&;4[_4?
MAUKGB7^T;JUU>RENW1$E8) 878)$8\[6RJJ#N!)W9],>A:?IMEI-DEGI]K%;
M6R?=CB7:HJ!M TI[V2\:PA,\CJ\AQP[+]UF'1F&!@D9&!0!R-E%<7WQ4BNKB
MYN;:9M MYY+="H4$RME#QG&<]\^]7?B9"9_#5H@N)(0=4L0=FWG-Q&.X/3K]
M172_V/IPU0ZI]CA^WE=AN-OSE?[N?3VJ34-.L]5LI++4+6*YMI,;XI5#*<'(
MX]B : .*GTO[5\3C9/J-\JC0$WRQ2^7*_P#I#8RZ@$?AC\N*R-/\2:PT'AK2
MI;F2Y6YU#4+2:XDF\J280.XC0R <,0 <C!.SW->B6^@Z3:7J7MOIUO%<I&(5
ME1 &"#HN?3VJ.7PSH<UE)9R:5:-;22F=HC$-IDSG?[-DDY'/- $'ANTU>RCO
MXM4F62(W)>S4SM,\<14?([L 20V[&<G!'-8T5X/$&J>*;6_U"XLDTF98HH[>
MX,+1QF)7\UB#\V26QNRN%Z=<]996%IIMOY%G;QP1YW%4&,GU/J>.IJM=>'M'
MO=3BU*YTRTEOH@ EP\0+@#H,^W;TH \W\.ZM>P>'OAWHUN"+;4+&5I<3F$R-
M&BE4#@9'WBV!@G;Z9SL27>N:->Z1HVJWOEV>J:M-%'.D[/)'!Y1>.$R$ [BX
M(W=<8P<\UUC^&-#DTN/3&TJT-C$P>.#RAMC8="H_A/N*?+X>T>?2SIDNF6LE
MD6WF%XP5+?WO][WZT <SK=K<^'KK0$M-7U%H;K78XVCFN6D_=M$Q,99B6(W)
MGD]R*K7FHZIIVO-<:G;WTVG2ZI'%:ZA87N8XU+K&(I8,C^+*DX;DY]*ZP^&-
M#,4$3:7;,D$GFQ!DSM?IN!/\6.,]:ECT+2XKLW2640E,IFSSCS#U?;T#<GG&
M>: ."F\0:GINB^(V%_.XB\21V/VF5@QM;=_(#$9X& [8]"<UM7PO-,\<Z9IM
MG>WC6&I65R;F.2=I3 8MFV568DKDOM(SCIQFNCAT#2((KN*+3;58[S)N4\L$
M3$C!+C^+(]:6WT/3+2*2*&T0+(@C;.6)0=%R>=HR<#H* /-],NM43P;X,\1/
MKFHRWMW>6D%PLDV8I8Y7VL"G3//WNN1UKM?'>KW6A>#;_4;)MDT?EKYFW/E*
MTBJSX/'RJQ;GCCFM >'=&738M.73+4643B2. 1C8C#D$#L0?2M"2&*:!X)8U
MDB=2C(XRK*>""#U% '(7QN]'\:>';;3[R[EM-26XBNHIIVF "1[UE4N3M(.
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MT DA2NW.5P.<>E=3::-IUCN^SVB*63RR6RQV?W<G/R^W2F66@Z5IV/LEC%$
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MM7S3+(" 2,[#L&1U/K7>U131].CU-M32RA6^9=K7 7YROH3Z<GBKU !1110
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MX[.XN"_SJ81'G)P3C/S8&<YJIYCW/PUT76M/E<^*3<6ZM+G]]+<F55GB?N5
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MQSBWF:WE,;9V2+]Y3[BK5 !1110 4444 %%%% !1110 4444 %%%% !1110
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MTSGD_G1HNE";XQ>)M2O='F:VN([9;.ZGLVV%XE&XJQ7Y<%1@\9P,9XKE=/\
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MK<2P*&D2.4$JIZ-]/?I7)ZQ;WFIZA)XFT?2I&DL](N;>*"[MVB:[D?:5C9&
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M0?3.>,]:TJX;PP\^ERZIHNLZ9>O-+JDUS#<+:O+#<(\F]&+J"JE> 0Q&-HH
MZB;7M*MKD6\VH6\<OF"+#.  YZ(3T#'(P#R<U#?>*= TV6:*]UFQ@EA ,J/.
MH9,],C.1T/Y&N'72]0;X;ZQX0N].NI=6E>YCCE,+&*=I)6=)O-QM &X$Y.05
M/&<9V+.VDM?B'=W-U:W4T":'!:&Z-J["21'D9P#CG(93[].30!T<7B31)]0A
ML(=6LI+N=/,BB2=2TBXW9'//'/TYJ&Z\7^'+(3?:=;L(_(?RY<SK\C8S@\\'
M'Y5PFF:5>6WP^\$PG2KN.XT[589+F(6S;XE'F;FQC)&&'(SUK4TO4(+3XA^,
MX'TV[N9)Y;4!H;4R(_\ HR?(S]%Z_P 1 YZT ;6I:U=)XK\+PV-W#)IFI^?Y
MFQ0V\+"75E?/3IT]*V'UK3([Q;1[Z!9VD\H(7ZOC.S/3=CG;UKA=.T"\\/W7
M@.P>WGE6P:Z>YD@B=XX/-1]J[@.@9MH]@"<"H/#VBS?V2/#?B%=;,T.H-./*
MM@8)CYYE243!..2"0S@]1CM0!V.E^+M-U36-7TY9[>.33IO*.9U)D 179@.P
M&[!]P:TK/6-.OYW@M;R&65$$A16YV'HP'=3ZCBO.]7T75KRP\?:19V%REW?W
M*75K*8]L4T8CA!0.?ER=C+CWYXJSJVDS>*-%U"XL3KBZW_9<UK"+^W%L$W[2
MT>0B!B=H&02!ZB@#6UCQ:B>*?#VG:9JMI(MY=M#<P* S%!$[;E.>F5 ./6NR
MKSR]O;G6+WPA<P^']3M8K&_W7*RVK*;<>1(F  ,LN6'S#CISZ>AT %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !137<1QL[9PH).
M 2?R'6N;/Q!\,+;QW+:F1;O(8O/-O*(T<,5(=MN$.1_$1^5 '345EW_B+2]-
M,PN;DC[.@DG,<3R"%3T9RH.P8!.3C@$]*J:EXU\.Z1.T%[J21RK")]HC=]T9
M( 9=H.X<]L]SV- &_17(6WB.'4_'&H:>=3>VCTAE AC*[+@F(LYD)4X"Y' (
MY4YST&S!XETFYN[:V2Y827:EK8R0NBS@#)V,P"OQSP3QSTH UJ*Y^+QMX>GO
MOL46H;[KS9(3$L,A8.B;V!^7CY>>>N"!DBHX?'WAB<VQ355\NZR(96BD6-R,
MY4.5V[N#\N<^U '245DV'B;1]2M[V>WO,)8G%T)HWA:'C.65P"!CG..:CA\5
MZ--]M N9(WLD$MQ'-;2Q2(AZ-L90Q7@\@$4 ;5%8-GXS\/W]W96UMJ&][U ]
MJQAD5)OEW85RH4MCJN<CN*L77B72K.Z%O+-*SF98&:*WDD2.1B %=U4JAR1P
MQ'4>M &M164?$FDK<Q0&[_ULYMXY/+?RFER1L$F-F[((QGJ".O%6[W4;73Q%
M]IE*M,VR*-4+O(V,D*J@D\ G@< 9H M45RVN^-K#3_"&KZU8RI-+8*R&&56C
M99NR.K ,.H.,#BKEM?P:=X9NM3.IS:A#&LDWG7)5"<?PC"@ 9&!Q^= &[17G
MEQXSDO+#P;K$%_\ 98+ZZCCO[=5!0;K=Y"N2N[(( X/-=79>*=%O[6]N8;Y4
MCL3BZ$\;0M#QD;E< C(Z9'/:@#8HK/L]:L+Z]ELH976ZB02-#-"\3["<!@'
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MPYY7(7=QDT =/163I_B;2-4OY[&UNR;J!/,>*2)XCLSC>N\#<N?XAD>]0?\
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M8 !:6-71MZ\?*^<C'UK;M/%VAWUW<VD%XQN+>+SGB>"1&,><;U#*-ZY[KD4
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MU2=[B.*RF^SW49A8R02<<.!T'(^;H<CFM/2]8@U:WGFAANHDAE:(BX@:-FP
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M@LSMTZA>!G !/).  1W'B\Z<_A""-KB\M]5B+RW!LY'E=! 7#!8Q@,3@D '
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MI((SRK@8XQC/>J=UX.UJ^TG4%^SQ172^(/[9M8I)\),G'[MF7)4XSR,@''-
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M5=S*6&6*G &>ASBLV3X@6":3;7ZZ??R>;J TV:%53?;W&_84<;N>?[N<\>M
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MTA5H;2:ZE9MJQQ8'."<DD@ <=?YFN:?X@6L.@WFIRZ9? V-\+"Z@38S12%D
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MM'L9&.T$$]00#C X-3:GX6O[[3K&6S33-,U2POEO;=($+0$A2A1SA200S<@
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MEW, 20!P,#&3R<\:]_IFG:Y:+#>PQW5ON#A2<J2#D'CK@C(]Q5Q%"(J+G"C
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MM\LN00V\]=Y[>E8=KX!O=.L-%^PZW&FI:0TXAN'M"8Y8I3EXY$WY/.,$,.E
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M&<X*_+G(Z@BJ&F^-+N\T;2&DM[==2U34+FRB5<^4GE/*"YYR?EBSC(R2!QU
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M#3_[7;20-2-DFI?.";=6:$?,=AP2"?EVY&1SF@"_3)IHK>)I9I$CC499W8
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MQJFH0I;:5'::?J$MG-(3(7<")60J.GWF&<]CQTY .RIKND4;22,J(H)9F.
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M2Z??;?/MFC3H%52%;&5!VY/?)."*C@\*?8-4OKO2]6O+*"^F\^XM8UC9#*0
M77<I*DX&>WTKHZ* ,&]\,_VDLUM>W\T^GRW"W!MG1>"K!@H;&=N1]?>MZBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1F5%+,
M0J@9))X K@[+Q+J3^)O#ZQWIO=,U@3*S-:B*,,L1D5H2<.5.TCYL@@Y!KNY8
MTFB>*10R.I5E/0@]17.V/@?1].?37@-X6TQB;,R73OY*E=I09/W=IQC_  %
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MV([6Z^UVL9NG*P/EC\@)P!ECQ[T 9J^(-9'A[QK<&[@-SH]Q.ML_D?+M2!)
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M=.1$C$4<A4E4QM&1SV'Y4 <[XI\27^CZI=K<O?V&F);H]O?VUF+B$/\ -O\
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M7DJ!\O7G/=UC-X:M)7=9I[J6VDF%P]K))F-I 0P.,9QN .W.,]JV: "BBB@
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M\C 88P>: /1;6Y2\LX+J+/ES1K(NX8.",C/YU-6;HKK%X:T^1V"HMG&S,>@
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M<!09)'^4LF"3MV@\G&=P]#70T4 %8">"?#\=HEI'8,EO'.+F.-;B0*D@.05
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M:S>X<&7S"-VR(Y' ],5Z+X32V7PS9R69N?LTX:XC%T[/(JNQ<*2Q)XW8Y]*
M-JBO-H[C6;/XUZ?I-UKEW>6DFD2731,%CCW[RO"J ,  8SD^]0^,]:U*7Q1X
M::QOY[?31KT-@Z0N5%RPR9=V.J@@)CU#YSQ0!Z?1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;?$H>+=/N-/VIIXL5@N-^2-VXL2!QR<8KJ-&@U*"TD_M66W>=Y2RK; B.-,
M!1GGMGZFM&B@#B;CPOK<WQ+M_%8DT\0P6;6*V^]]S(7+;BVWKSTQCWK'\4_"
M6SU75;"XTNRT^WB@NQ=7 EFEW7/)+(<9"@YZCFO3J1G5<;F STR>M #8D$<*
M(%"A5 P#D"GT44 %%(2%!)( '<T A@"""#W% "T444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BF3316\+332)%$@RSNP4*/<FJ^G:G8ZO:"
M[T^ZBNK<LR"6)MRDJ2#@]^0: +=%58=1L[B_N;&&YCDNK4(9XE.6C#Y*[O3(
M!-1ZIK.FZ):FYU.^M[2$?Q32!<^P]3["@"]1110 4444 %%9&M^*-%\.-"-7
MOEM?/.V(NC$.?0$ C/MUJ34?$&F:5;VT]].\,=TP6$F%R68XPN ,@G/ /- &
MG1163'XDTJ7Q*_AY+A_[4C@-PT)A=<1Y W;B,$9('!]?2@#6HK-T;7],\06]
MQ/I=T+B*WG>VE8*1MD7&X<@>HYZ5')XDTJ+Q)#X?>X<:G-&98X3"^&0#)(;&
MW'XT :U%9>F>(M)UA;]K&]25;"X>VN6(*B.1?O D@=/4<5I(Z21K)&RLC %6
M4Y!![@T .HHJEJNKV.B6#WVHS&"U3[\NQF5/<X!P/<\4 7:*BMKB.[MTGBW^
M6XRN]&0X^C $5+0 4444 %%%% !1110 4444 %%%% !1110 4455M]1L[N[N
M[2WN8Y+BT94N(U.3&6&X _4'- %JBJU_?VFEV$U]?3I;VL*[I)9#A5'J:L*R
MNH92"I&01W% "T444 %%%5KZ^M].M6N;EF"+P B%V8]@JJ"6)] ,T 6:*B@N
M(Y[2.Y7<L<D8D'F*4(!&>0>0?8]*J/K5C'KD6C-*XOI8FFCC,3X9%P&(;&TX
MW#C.>: -"BJM_J-GI5K]IO[F.W@WJGF2' W,0JC\20*M4 %%4M4U6RT6P>^U
M"8PVL?WY=C,$'J< X'N>*J0^*-'FNH;473I<3H9((I8)(VF4#)*!E&_CGY<T
M ;%%4=)U>RURP%]I\K2VY=XPS1LAW(Q5AA@",$$=.U7J "BBB@ HJA'K5C+K
MDNC+*_V^*$7#QM$ZCRR<!@Q&",Y'!/0U?H **H:OK5CH5F+O497B@+K'O6)W
M 9B%4':#C)(&3QDT)K5C)KDFBK*_V^. 7#1M$X'EDXW!B,'GC@GH: +]%4&U
MJQ37(]&:5Q?RPM.D9B<!D4@$AL;3@L.,YYJ_0 445E77B32+2UU&YEO 8M-.
M+PQ(TAA.T,=P4$]#F@#5HK+'B'33J&GV/G.+C4(C-;*87 D0+N)W8P, CC.>
M16I0 4444 %%4%UJQ;7FT42O]O6#[28S$X!CR!N#$;3RP'!J_0 4444 %%5;
M#4;/5+<W%C<QW$(D:,O&<@,I*L/P(-6J "BBB@ HK*B\1Z5*VJ*+DI_97-Z9
M8VC$(V[LG<!D;><C(Q6C;W$-W;17-O(LD,R"2-U.0RD9!'L10!)15#3=:L=7
MDO([*5W>SF\B=7B>,H^ V,,!V8'\:=>ZK:V$]M!,96EN'"(D4+2$9(&YMH.U
M02,L< 9ZT 7:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBHYYXK:WDG
MGD6.*)2[NQP%4#))_"@"2BH;2[@O[."[M95FMYXUDBD0Y#J1D$?456T_6K'5
M+J^M;25VFL9!%<(\3H48C<!\P&>"#D<<B@"_15*75K&*^EL6N ;R*#[2UN@+
M2>7DC<% )/((XJA'XOT26QTR]2Z=K;5)A!:2""3$CDX /R_+D@_>QT- &Y11
M10 4450O=:L=/U"QL+F5TN+YS';CRG*NP!8C<!M!P">3VH OT55M=2LKV6ZC
MMKF.5[27R9U5L^6^ <'WP15D$$ @Y!Z$4 +1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$(!;^:48[R=^]5&[.<$@C;75#PW9>=NDEN981<F[6WDEW1K*6+[@.O#'(!.
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M)6>8(><!FY4=\<<]>: .%LO%/B2V\"#Q7?7]K<"13;1VHM@JI*UR(DE9@<D
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M:*LA\M85^Z@7I@'GUJFW@?1O(AB07<7D7<EY#)%<NKQR2;MY5@<@-N;(Z<T
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MV87?VW9]I?\ UV_?NSG/WN<=,UIG1+,ZY'K/[W[;';?9=_F'#1YW8(Z'GG-
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MGWXZ8]!K*'AZQ&OKK2^<MXD'V9=LA""+(.S;TQD9K5H **** "BBB@ HHHH
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M]F,F\97AL_ATX/0U]2UO7=+\.^.(%UF:6YT-E>UO)(8O,*M"LFUQMVG!8C(
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M.L \B(OL+9^9\?=48Y/;B@#)3P/X=CQLL7 6Y^UQJ+F7;%+DMNC&["9))(7
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M@9?+V[,^:V['^]G=GWSFIJJ27ZQZK!8?9KEFFB>03+$3$NT@89N@8YX'?!H
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MTO6-)TZ2UG<ZE,T,<RE=B,J,Y#<YZ*>@H F@T+3K;6KG5X(&2]N@!.PE?:^
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M?<H;&X$Y^;.T?>STK,/@'PSY4\/]FD032"5H5N)1&CA@VY$#;4.1U4"NDHH
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MN@5USG!&.F>W2@#AK,WEEI7@#65U?4I;K49+:WO!-=.\<R26[,<QD[005'S
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA]Y<,QWH,CD<_F*+#QV?$'A;Q))#J6E:F]GIWGO:3Z?)"5(5S)')&S_,I 4
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M7T5S.FZUJLOB**QFMGGLIK9I#=+836XAE4K\A\S@A@21CD;3Z\:.NZA)86\
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M[Q, L2J2Q:3 4[P=N >IZ8%=9J6@QZEJVDZ@;V]MSIKNZPV\NR.;<,8D7'S
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MYC1$ %'!3:PX';J,]:Z>B@#"D\-+-K&EZK/JE]+<Z<DB1[O*"N),;]P"#J%
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MHH ;(SK$[1IO<*2JYQD^F:\UB^(DMAIUU=ZG)/%J-MILMS/I%W9-;MYJ[?\
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M),@PPSM(J/Q%X:BT[1Y+2R_M V6IZI'/J$D3M)+ ,9,BX^8Y9(P<[@ 22.M
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M#X5MX=3T_4&O[^:YL(GAB>:56RKXW!OEYSM7\N,4 <S'XWU.TM!8WOE37_\
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MQ9Q74OF+; #:-G'8' +9(' /)I-,\)V>CSM_9]W?06;2F86*S?N%<G<=HQN
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M4"<+PI8,IY ) 88.._2HKCPCI<L6DQP">S&E$_93:RE"H*[64GG((Z]^^<T
M<E"^M6UWX]O=)O;6V-I?>?MEMS+YK+:Q':?F&T<=1D\^W.C!XRN-7U*"PA$U
MINTF"_DD@MFG;?+G"@8("C!R2,G(P1CG>M_"UG;C6!Y]U(-7+&Z#LO)*!,C
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MSVEL=L:1/+EEC&26(0>O)).<8/6)X:@CUJ+5A>WGVN*T-FK$ICRR0<8VXSN
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M@L\FZ/.W.TA,'OTYZ@]!XCU%+"QMU-U/!+=7*6\(MXU:61SD[%W?*"0#R>
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M[Q# APQ"CHSY&/0YSQB3X5VTL/@2QDDO)9TD\PK&ZH%C_>OG&U03G.>2?;%
M'16>N6E[K=_I$2S"ZL4C>;?&57#[MI![_<-:=<&+"XU'XE>)8;?4[G3Q_9]B
M6DM@F\G,^.75AC\.>.>N<W1O&.KZJGA:PN!/+)?6-Q<7,MIY<;S-$X0 ;B O
M4L=O/3&!F@#TZBO.]2NO%EAIFD1W&HR6EQ/KJV:LR12-):N6*&3 (W@#'RD
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M<E[:[>5BZS@;FL_-)SCHP.<XRG7I-:V#:KXH\7V-WKFJPVMI+ T*PW[QF#=
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M)E0M+($.T2 @JPR>@QCFI-6U34K/4;G5;JWO;K1#<P/#=6%\8WM%Q&#') 2
MV6R2?F.'Z<#';2Z!I$UP9Y-.MFD*JI/ECY@OW01T(';/2E.AZ6;UKPV%O]H=
MQ*S[!\SC&&/8L,#GKQ0!R-M83:IK?Q!L[2\FM+J2:W$-Q#(4:-_LJ;3D=L]N
M]3>$;^3Q,FE7?G741T^U,=]#]H?!N\[61QGG:4<G//SIVKHIK&WTA;K4-*T2
M*:_F*^8L 2)YN0"2QP#@<\GM4FAZ;_9M@P>.)+FXF>YN1%]WS7.YN>^.!GN
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MIO+B ,+S'DL%((C'(.,Y.?RKJK31]-T^=Y[/3[:WE=%C9XHE4LJ@!02!T
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MTMH;&5;=(5D6[++L=B2"@&<Y& >F.:\@:UL1\+M5UR*:0ZAI^IW#6UT+AB\
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MD,DKSL_R^:2%P3@8P.W<^M '?T5Q_C*VNKO5-+6RN-+EECBGD;3=4SY-POR
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M?4#I56;6K:'Q#;:*R2&YN+:2Y5@!L"(RJ<G.<Y<=O6@"^B)&BI&JHBC 51@
M5S<N@WD_Q _MF:"QDTX:>+0*[DR!Q)OW;2F/;[WO[5OB]M3,L(N83*S%53S!
MN) R0!Z@<T0WMI<2RQ0W4,LD1Q(B2!BA]P.E $DL,4Z;)HTD7.=KJ",_C5'4
MX]26$?V-%9+/*^)9;ABNQ<'Y@%4[V!Q\I(!YY%6!J-D98XA>6YDER(T\U<O@
MX.!GG!%+-J%E;W,=M-=V\<\GW(GD 9OH"<F@!+2PM[/3H+&- 8(8UC56&<@#
M'-/^R6V /L\6!T^05DPZO<:AXGNM/LW@2WTUT2\$J$O(SQ[U"$$!<90DD'.2
M.,9.I#?6EQ)+'!=02O%Q(J2!BGU Z4 2B*,2-((TWL,%MO)_&HX[*TBB,4=K
M"D9.XHL8 )]<41WMI*^R.ZA=PF_:L@)VYQGZ9XS65KVN&T\)ZKJ^D3VES)8V
M\LPRWF(2BEBIVGKQZT ;'V>':J^3'M0Y4;1@?2E6*-)'D6-5=\;F P6QTR>]
M4=-U2*_LX +FV^W/;I+)"K@E"R@Y*YR!DU0\*Z[<ZOH]W=ZB+>)[:]N;9FC!
M5-L4C)NY)Q]W/6@#<F@BN8FBGB26-OO(ZA@?J#2?9H/)6'R8_*3[J;!@?046
M]U;WD/G6L\4T9) >-PRY^HKGO#GB5[Y=235IK*":VU.6QAV-L$H0+@@,Q))W
M=J .E1%C4*BA5'0 8 J,VT#.[F",M( ')09;'3/K3?MEKY[0?:8?.7K'Y@W#
MC/3Z4^"XAN4WP31RIG&Z-@PS^%  EO!&^Y(8U;U50#65JNGWEX$TZWALH]*G
M4K>,S$2%<C**@7!#+E221C/>M%+^SDNVM$NX&N5&6A60%Q]5ZTR;5-/MPQFO
MK6,*P1B\RC#'H#D]?:@"W3)88IXS'-&DB'^%U!'Y&F7%Y;6</G7-Q#!%TWRN
M%7\S2O=6Z*C//$JN,H2X 88SQZ\<T .$,:N76- [#!8*,FF0VEM;HR0V\4:L
M<LJ( "?4XJ-]2L8XX9'O;94GQY+-*H$F>FTYY_"H)]:MK?7[/1F60W-U!+<(
MP V!8RH.3GKEQCCUH NPV\-NK+!#'$&.XA%"Y/KQ37L[61)$>VA9)#N=60$,
M?4^M5M.N[FX^VF[BMXEAN&CB,,_F;HP 0S<#:W/*\XXYJ>VO[.\1WM;N"=4.
M':*0,%/OCI0!#)I%E+=6,YB ^PEFMXE "(S#;NQZ@%@/3<:O5734+*2=(([N
MW:9UWK&L@+,OJ!GD>]6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@!LD<<T312HKQN,,K#((]"*\?T,6VG>'_AUK$\&RVM;BYCF
MN$B+>4KI,JY(&0NXCVYKUVX$[6[K;/&DQ'R-(I90?4@$9_,55T328-!T2STJ
MV9FBM8A&&;JV.I/N3D_C0!YK=_:Y8OB&=#M+B.>X>UF@CCB,4D\8CC\TH.#D
MC<..<GU-:,]]H^H>-/!FH:59%+>)KF*2X^R-$(@82%C8D#')QCL?J*](HH \
M=OY]&D?7M UV^@BM$US[9)=7,$GFXW)+MQM*XQ^[#EON_P .,9WA8Z!+\3Y'
M-E8M8?V"BJWDJ8<B1C@<;<B/'_ ?:MRW\+WEKHUYHL6I1?8+EYSO:W)F5969
MG&[=M)^<X8CTR#WZ*TM8;&R@M+=-D$$:Q1KZ*HP!^0H \ATO3[6W\ >$;R.R
M\N\M-;A$LOE$2Q1^<P.XXW!?+QUXVX[5=CM3?/XHT'7]0FLYKW4I)8L6C/)+
M"2IA>%^<E0   "5*]*]7HH \\TS2=(O?''C..YL+>=)([<*9(05D(C82%>,$
MY(#$=^M8.GVUG+I/PVN=8L/M$4$$EM<F:U,I1O)PB.,$CYN@/>O8:* /-)!=
MVFNRG2KRUU&&XUE7GTF[MB+B%A(JM+'(IR%4+O!88VC&>U=YI6KVVL1W,MH)
M#'!<R6Q=UP'9#M8KZ@,",^H-7B,@@YY]#BH;.SM]/LXK2UB6*")0J(O8?U^M
M 'E,UZ-3GT/4#9?8KFW\0[IX([-E:V4O(&,LIZ[AR<8'S=,#-6]0-O<Z=\3H
MY(Q+Y^3;JR9\UA:(@*?WCO&!CO7J5% 'FL\&FWOB;P&\UM#,JV4RRL\08*?+
M0(K\<?,& ![@XYK"N-)L7\ ^-C9Z<AN(-4EELO+A^=$WHR&+C(7=N(V\=?>O
M9Z* .'M[R"U\>:W-K#Q_8;^TM_[.GE&8GB"MYD8)XSN.2O4@CKBN7T[1EM9/
M UMJMID1WMZ52>/+0VK++Y*29Z#E0 >_':O8** /.8/#=EJFI>/O#C6ZVUI>
M-"\*+'M0,8%S(@Z9#@$D=Q6EX0NI=8M(O$.L6WV>YL;9K%O,7&V1#BX<>Q9
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MMX!\SPK(ID10/5 PQWZ=ZU;#3[V._GO=1NX;B4AH[<0PF-8HBV<<LV6.%R>
M=HX'?4H X>XCM=<\;^'=0T7RY;:&WN4U!XU^0P,@"1/[[\$(>1AN!7'06VG0
M?"^*Q33_ "+]=7A2\C6U,<A"WN[DX&0J<]\#TKVFB@#S'Q'ILMOXGU./PY;I
M:W%]X8F2!K9!&LDP?Y ",#?M+8[U:\.Q:7JK:+>RW[++IEG)$]F;(P^6C1A7
MCFR. , X. 2.]>B44 <%\+-)TVW\,6UW'8Q0ZDK7$4CF/;*$:=F"G/.W 4@=
M/2JK/H%K\5=?BU6VA8W%C9F-7MC(KMF8-P 1N.1[GG'>O1ZP;'0[NU\8:IK;
MW4+PWT$,(@$9#((B^#NSSG><\=J //K;3-3\+7GAZ6Y,MGHJ3W[1J83,ECYK
MY@#@'Y?DR,]%+$=ZM:YHVDP:1I 21KZ&Y\21WC,T!58T9LR[!CB+/)/3YCS7
MJM% 'G.O:?;Z5JA;0+^QTUXM.VKI]S9^9:W,;R.^V,*00Q;.0N<@KQTI^A7+
MV7B2]D\2VJ6,=[I=F+1)OFBC54/G0!CQD.?N]6&.N*]#HH \?T_1EM7\#VVJ
MVF5CO[QE2>/+0VK)-Y*29Z#E  >G3MBN@TV]L/"?B+QI+) UM8K-:RQPP0\2
M,\:(?+4<$ERH..Y&:] J"YLK>\,!N(A)Y$HFC!)P'&<''?&<C/0X/4"@#F/B
M7&\_P_OE6&:0F6V)CB0L^!/&3@+SP 3QZ5S?B#1O[6DDU3P/ EN\>CW<#SVT
M7DB=G"^5&.!E@0QS_"<>M>I44 <#X8BL-6OM#OX[^476G6KPBT2R,!C5E :.
M7(XP5! ..1QFI-;L]/7XJZ/=:AI\<L<NG30QRM:^8#.)8B@R <,%#$$].:[J
MB@#S/PQ8Z7;#Q9JL&D17%_::C=7%DB1[7=/)4 1''W6^8<<$FJVD2VUQXK\,
M:CY44=O+IEU#<^59-! G$1$1+<MCYNI[=N:]5HH \:BTJR'P?EG@TU1J-MJ9
ME1E@_?1_Z=E2.-P&P@\=C6SJKW,.M:E=Z-?VE_\ :;VW>71KRWW/(RB,!X9%
M.0H"JP)!4$$\<UZ910!Y->Z9]JNOB.VBVD2ZO*%^Q2QQ!9&'V=!)Y;8SDMN!
M(/WCZUMZ)'I&KW>G:F]_DV-E) ]I]B,*I&P7,<P(.-I48!QSG&:[ZB@#R7P]
M;V.B?".'4X-#BGU%8Q!<J\#%PK3#/F*/F95&&V^@P, TD\6^?QW]E221+_PZ
MK1&.T,*W$FR=3L3&3P5'<\CJ,5ZW10!YI8Z=I>J-X2NM"MD@N=-E$E]=" Q-
M'&(6$D<A(!+,Q7(//4FL@O>#P]!<VXF%I;^*KFYO0D#2$0-+*4D*=60$HW'H
M#VKV*B@#FO"]I9_;]5U:TU%KPZ@T32E(?+A#(NW*^I(QDY/0=*XN.QTF^M/&
MNEWFE_:-6O+^Z-K%);$O("H",C$8"A@?F!P""3BO6:* /.]3LK[PKJ?AW68H
MC>WLMFNC7I49\V0J#%(?;S%()]']JZQ-)DTOPG+INE,%NDMG6*7 &Z8J?G/N
M6.3]:D;3[V?6EN;F[A:Q@.^VMDA*N'V[2SON(8#+8  Z]\"M2@#RT1+JG@CP
MOI^GQ/%X@L;FT+QE2);:1&'GO)W (\S)/#;AUR*DT\>&D\9^-+#4K"&>26ZB
M\NW-H9-ZFVCR$XQDGJ!ST)KTZL'1-#N],UO6[^>ZAE34YTG$:1E3$5C6,#))
MSPH/:@#@-)LM6\*:KH$.M7;6]FFB_9HYY83/'#-YI9HV8'"G844-T.S%6;W0
M=&LI_!%BP-[9Q7ERSR7$&-L+QRD*P(&(]S!0#P1CK7JE% 'F'BD6I;7?#T>E
M1V\,&CK':!+%I7N5V2$+&?NHJ' Z9R<Y&!1#;6$GB?P9>ZG8K.LNBO!YTEL9
M<W ,)4,<'###]>G/O7I]% 'D7DR_\([XE33;9VMD\3)=3VT$9S/9@Q%]B@?,
MI"MTZ@$<UT&H1V>J>-+/5K PRZ;'IEQ'J<R@&*124\J-NQ8'><=0/3(SWM%
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M;03D@<G'<UT5W&VK>,]&UVTM[R*UT^SN1=/+:R1M() H2,(5#,006X!QCU-
M&[!XIT"YO+>T@UK3Y;BX7=#&EPI:0?[(!Y_"F66I7AN-7NM2$-II=O,([5Y
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MBS\TR0,B6Y@(WN),;6!"L!M)SN'O@ [8>)-#-XMH-7L6N7E\A8EN%+&3&=N
M<YQVK.\6ZQ>Z-/H4EO<0Q6USJ4=M=>8F?W95F)#$_+]WT[U0\/6,;^.?%5W<
M:;*OGW-O);3SVK*'"0HI*LPQPP/\Q4OQ @DEMM"F6PN+V*UUB&XGC@A,K"-5
M?+;1R<9'2@#=L/$.C:K;W%Q8:K97,-N?WSQ3JPC[_,0>./6I[/5+#4))8[2[
MAFDBQYB(V64'H2.N#V/>O.?%OA[4M>DU37]'M;B,/;6D8MS'Y4UYY4_FN=C@
M8(7"C>,GD8QC/4Z#;VE[K;:VKZS)>?9!;,VH6AMPJ;MVW:8TW$'/(R.O/- %
MO5_%-AHVO:7I=W)%&U^LK>;),J+&$ /.?4G _&K(\2:&UXEHNKV+7+R^0L2W
M"EC(!DK@'KCG%8GB6"2/QOX8U'^S[BYMHENH97@@,GELZILW8' R&Y/ [XJO
MH-GCQ=XNO9-*E,LUS%-:23VS() D"+\KL,#YPW\^E '2P^(-&N;Z2R@U2SDN
MHU+M$LRE@HZG&>@[^E0?\);X<,L$8UW32]PY2("Y0[VSC YY.>/KQ7#Z<VJ7
MVK>"]2O=/U.-K1YUO(O[/\J*T9K=EV(H7<4W%0&RPX'/I%)I-W/\*_%-G%I-
MT+V?4+FXBA:U97DW7!>-@",D[<'VQ0!Z1=ZUIEC.(+J^@AE^7*NX&-QPN?3)
MX&>M8R^(EU#QK<:);ZE;VQT_RVEA;:SW1=68JN3D!0 20,\]@.<#7;;46U75
M;_P]-J<-]<&(-8W.G-):7N(T )9D'E\':3N&-O(HN]+OM0U7Q_;V=K/!/J%E
M'%97#P.B.XA=6PY&!R0,Y[Y&: .VBUW29Y7BBU&U9UC,I E'W!U8>JCN1P*C
MMO$NAWDICM=8L)G$+3D1W"MB-6VL_!^Z&XSTS7+^'+>"\.BW=]'KR7^DP,!!
M<V7EI"3'L=0RQJ)!QP%+9X-9^AVUYI/PNNY;/0&?6HVN?W%Q9G>ZR7#-T(!?
MY-K;0>=H% '67_B*UN_#^KW.A:G9SW5E \AV,)0C!2PW*".N.*9X=\5Z;JEC
MIEK+JUD^LW%E%-);+*N_<4#-\F<]\X]*Y9[6^N?$.N7B6VK317?APPQ37-IY
M;2R!I#MVJJ[3R,!@#S]*FT[3#K.@^$+"+3+NRGT6>WGN7N+1H?*,:$,J$@;]
MYX^7(P22>F0#?\+:Y<W5AK,VL75N!8ZG<6HEVB)!&A &<G^O>MVRU*RU$2FS
MN8IC$VR0(V2C8SAAU!QSS7E]QIVL3Z+>S6MEJ*&V\5G4GB6W*RS6VXX:-9%P
MQ'# 8_AZ9Q7;^';2S?4K[6(7U62XNHXHI9+^V-ON";MH"%$.1N/..XYH FNO
M%-A9^+;?P_/)%'+/:M<"2295&0ZJ$P>2QW$CZ5=DUS2HKQ;234+99VD\H(9
M,O\ W/\ >]NM8%_!);_%#3[]K"XEMIM,DM1/% 75)3*C#>0/EX!Y.!Q7-KI6
MHW'PKN?!UQ871UL.\0D,+^4[F8NLXEQMQSO)SG((QGB@#U)F5%+,P50,DDX
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MUK3(+T6<M] EP7$8C+C.\]%]F.1@=3FO,[/[>W@KP9IAT355N=)O[/[:'LW
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MU8SV\<@B>5"@<KNVYXSC(_G63<>,=#M+*\N[F[>&*RD6.Y$EO(&A+#*[EVY
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M;LT)DCD\O:Z\9'RNO'T(KSVU\1:__P (9X9UB'6WO=7OY+?S-.DAAVS*Y&\
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M*Z*FU%SM4*HQ@;B<]23] *<OC+08+?SY[TPH+H6;^9#(ICF)&$<%?DSN!R<
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M]U&8I3$0&*$8(R0<9%6;2W^R6<-N)7E$2A \F-Q ]< #]* .*TSP]J5WX?\
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MKJEK+%>VD4C*#YL3A@I(.!D KUQ\U=-10!P;>$=0M_$5G/"(WM=2M_+UQMV
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MKG_@57:* /--.\,W8\(^&-/U32=4M[S3K9XS=:==HDUO)\HX(?#*PSGK]T9
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M!N5U4Y1L,/4=>>*Y/2[NWTSX>2M<17[VZZ]-%NLY_+9/]-*IDY!VYV@@9XH
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MW@<;E5FVK(R=D)(YR3@@D"KL/B=9KK7;==.NA+HY3S$W)F7<F\%?FQC&.I%
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MVEZA=+:07 D&XNS%48IV1F& <YY&0*'\;PIX:UK6FTN\V:3/-#/!NCW_ +L
MLWWL8Y[$T =517.7WBI[76K/28-(NKFYO+5[F$JZ*A"[<@DGC&\<D?3-,LO&
MEI<Z7]IGM+BWNQ?G339-M9S<C^ $':1CG=G&.: .FHKS^TNY(?BK?W6H6?\
M9ZQZ%YDC><)$=1+R^1[#!R >.];,'C."672&>S=+76,BRD$BEBVPNJNO\!90
M<<GT.* .GHKF=!\72^(+QHX=#O8;6.:>WEN96CVI+$VTK@,2<X/(X]\].FH
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MCT19/B/<ZA!.#:-;0S74 &0URN]8FS_N$Y'^S&?2NNJIIVEV&D6QMM.LX+2
ML7,<*!06/4\=Z +9S@XZUP4_@S6)O#6KZ5]HLE>_U7^T1)N<B,&99=F-O/W
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MUM:F!N?XSEV&X8SP ,]J &S^)+S3-5TFUU;3XH8=4D,$4L$Y?RIMI8(X*CJ
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M1HK=;E+BSG\Z)E+%2I.!A@0..X(/M5'5? BZM>ZU.^I-%_:+VT\1CA^>VF@
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MS]UX':738[>WU%8IVU5=6N9GM]_G3*X<  ,-J_*%QDG '.>:ZY-P10Y!;')
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MX66:]*(ZN7 !Q&2&^0\8(]QWHWO@*[N[?6[1=;6.TU2]6]P;0-(CAD.TOO\
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M** "BBB@ HHHH B-M URMR88S.J[!*4&X+Z9ZXJ6BB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BCH,FLS3O$.
MDZO?7-GI]['<S6R(\OE9*@/G:0W0YVGH3TH TZ*RO^$CTK[2D'VAOWDYMTE\
ME_*:4$C8),;<Y!&,]1CKQ6K0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %<?H>T?$_Q:!CBTT\?3B:NPK+M/#NFV6K3ZI!%,M[< ":1KF5O, !"
M@@L00,G''&>* /,[1=4T[2=,U5&2_P#!\VIQW,%E(=MS ))AY3;@,.HD</LZ
MC@9.#7L%95OX<TJUD1H;9E1)3,D)F<Q(Y.=RQD[5.23P.#R*U: "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
$H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>ameh-nonqualifieddeferre019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ameh-nonqualifieddeferre019.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MPHJM'%\VY26F^?&&4 8STJV_@G6/M^JZ:NK7,FEZBT5])=SQQ,3.IVO$T:A
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M 4444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBL?1]8FUJ>>XMXH/[*1Y(8Y?,/FO)'(4;Y<8"Y5L'))Q[T ;%%%% !167)K<
M+W6IV-DHFO\ 3X4EEBD)1?G#%1NP>H4] :3PSK#>(/#&FZN\(@:]MTG,0;=L
MW#.,\9H U:**P_$FNSZ%_9;16D<\=YJ$-G(S2E#'YC!=P&T[N_&10!N4444
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ME !151;FY.K26IL7%JL*R+=^8NUG)(*;?O9  .>G-6Z "BBB@ HHHH ****
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M$VFZ9_PAVEZQ ?-U"6T\F>8S%S@,3M(S@8_SUKO8X8H8_+BB1$_NJH _*G
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MW=_:AQ,6,4+3-M"C.!P P/J,BKO@JW&JQZ=:W]H@N/#!DM)F,> ]P#M5@?\
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MDDU12\%Q<12O(Z6IN\R *#P-BD\8.,G.3FO:EBC1G98T4ORQ"@;OKZTX #H
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M!O ?V>]@"R7]FD[QW7(/E?O%)W97HN1QCCH:]@BABA!$4:1@G)"J!DTHC0#
M10/0"@#S?6X/#MK?KX2^QV$-O%IS7%N;TM*IWR/\L$>02^03N!R,J!GMD6DV
MGWUG\,K[6;P/')9RQRSS7!53)Y P"V<;B<^YQBO7RB%E8J"R]#CI040@ JI
M.1QT- 'E[?8K[0/&":YL77+>ZN?)+\3QK_R[&'^(#&W;MZMGN33;NPM=5\6>
M%=.\2NC7ESH4JZA#YVSS9?W/# $9YWX'M7J+0Q-*LK1H9%X5RHR/H:=M4G.!
MGZ4 <QXRM0VAV5E#J%K8N;J)81>+N@F*@L(I!D94A3WZ@5P]]>0-INF6E]:V
M&FE/%,*.;"X(MY_W>6>(_*5'.&QT8'G->O21I*A21%=#U5AD&@1HJA0BA0,
M < 4 >87ESIG@S7_ !?%:6Q2Q&C079L;60Q;G+2J[)C[AP%RRCC&:=X?NM-L
M?B!<FSN]+BLKG13/(NG_ "6[2++C=G.UV )!88XZBO3BJGJ ?PI!&BJ%"* !
M@ #I0!Y#H^HV2^#_ (7 W4(*WJ!@9!QBWF!SZ<D#\17L%-V+_='Y4Z@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y7QEXI.A6<
M?V&\T\WWVFWC>UF.YRDDJ(2%# C&[.<$5TMR)6M91 P68H1&3T#8X_6O(Y[A
M;GX9:=I<ND7YUJPNK-KU9+)R\<BSH99=Y&&W?,<J22&/;. #U 7T_P#;TEJ3
M9BS2V$F[S_WP?=SE,<)C'S9ZFIX=2L+B4107MM+(4,@1)58E0=I; /0'C/KQ
M7)AK?_A:MS<&!OL\NAJCS>2=CL)68J6Q@G;@X]*Y.TT!W^#UTVEZ4Z:T'E$J
MBWV7#P&[WM&,@$AHU&%Z'@=Z /6;74+*^W_8[RWN/+(#^3*K[3[X/%4;WQ/I
M%G9:E<"^@N&TVWDN+B"WE1Y55 2?ESP>,<XYKBM7L7UW2-7U70=1U"YUAM(>
MTCC^S&W!4L&VGY1^\X( SD;CQ5[6'T?Q-X$U9=-TN1KY=&N(8K=[)T>(E.(\
M%0 P95P.N1D4 =M8WD=_8P7<?"S1J^,@E<@'!QWYJQ7,^'M3TRVTS1+.RL;B
M);V,A3'8O&B,B L7RHVYQ@$]3734 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)'+(D*%V6)<L0.N!0!9HK+\.:]:>)] M-9L4E2VN@S1B90&P&*\@$^GK6I0
M4444 %%%% !1150ZG8C51I?VN'[>83/]G#C?Y8(&XCL,G&: +=%%8VK>);31
MY;A)[>\D6VMA=3/#"76./YN2?^ -Q[4 ;-%<K<>/M-MM);4GL=3^S"S:^5OL
M^-\(VY89(_OJ<>]=/%()84D4$!U# 'KS0 ^BBB@ HJ&VNK>\@$UK/'/$690\
M;!ERI((R/0@CZBIJ "BBB@ HHHH **** "BBLNVUVWN?$5YH@AG2ZM84G9G4
M;&1RP4J0<]5/8=* -2BBB@ HHHH **CN)3!;R2B-Y=BEMD>-S>PR0*R+'Q3I
M]_HNE:K&ER+?5'2.W!A+,"V<;@N=HX/)X'K0!MT5 +RV:>>!9XWF@56EB1MS
MH#G&5'(S@X]<4S3=0@U73H+ZV$@AG0.GFQM&V/=6 (H M4444 %%%% !116=
M8ZO%J-W/%;03M;Q947>%\J1E8JRJ<Y)4@@\ >A- &C14-Q=6]HL9N)XX1)(L
M2&1@NYV.%49ZDGH*HVFNV]WK]_HRPSI<V44<LC.H",KE@I4@G/W#V% &I152
M\U*WL9[.&82[[N7R8MD3.-VTM\Q ^48!Y-6Z "BFNQ1&8*6(!.U>I]A7,+X^
MTHZ==ZB;;4%L;*9X;J?[,2(60X?(&3@'J0"* .IHK(LO$=EJ&N3:5 DQECM8
M[L2D#RY(G)"LI!YSM/;M6O0 4444 %%(QVJ3@G S@=36;H6N6VOV4MU;13Q+
M%<26SI,H#!XV*MT)[@T :=%%94FOV\?B1="-O<FZ>T>[1@J[&1652 <YSEQV
MH U:*S-"URV\0:<U[:Q31HLTD!690&#1L4;H3W!K3H **** "BH;:ZM[R(RV
MT\<T89DWQL&&Y201D=P00?<51U/7;?2=0TRTN(9V;49_L\,B*"H?:S8;G(X4
M]CTH U**** "BBLLZ[;CQ.N@-#.+I[5KM9"H\MD5E4X.<YRP[4 :E%%% !11
M10 445E^(-=M_#>DR:E=PSRV\;*K^0H)7<0H."1QD@?C0!J445"MU;O=O:K/
M&;B- [Q!AN53D D=0#@_D: )J*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\_\(7EU9_#6>XT^
MUENKK[?>B..)0QR;J0;L$@'&<XR,XKO98EGB:)]VUA@[6*G\QR*IZ5HNG:)"
MT.FVPMX6)8QJQVY))) )P"223ZT <-X*O!'\0/$5JFE:E;HUO9AGN53*$+(2
MTA#'EB2<\Y.<XKN+IGNU=-+O;2&[,:L97A\[]V=VTX#+W!P<D<'BF0^'M*@O
M+F[2U_?W2[+AVD9C,N" 'R?F !(&>F>*B'A7142U2*R$(M8O(A\B1XML?78=
MI&5]CF@#-^'<[R>$DMWM8X#9W,]INBSLF,<C*95SSAB">IYS755'#!%;0)!!
M$D44:A41%"JH'0 #H*DH **** .5\;:=9ZO_ &#I]_ D]K<:D8Y(WZ,#;3_K
M[UYK)=:E\/IAX$U8RW6DW=U ^B7Q&2 )T8PO]/T^A&/9=0T73]4FMY;VV6:2
MV;?"Q8C8WJ,'K[T[4M(T_6(HHM1M(KE(95FC$@SL=3D,#V(H X"YO=0U_P"(
MGBK1IM3O+&UTK3XGLUM9S#EW3<96*X+8/&#E?:N1AO\ 5/%D/PLU#4M1N;>\
MN9[N-IH5C#97*B0;E(W$ =01Z"O8M3\+:+K%X+R^L5>Y\HPF5':-FC/5&*D;
ME_V3D4:AX5T'5;.SM+[2;6:VLF#6T1C 6+ P-H'08[=* -=1A0,DX'4]Z\=U
MCQ5=R>)]%U/1-7U62TE\0KI5P)6C6UD4D[D2,?-\HXWD<]?I[$    , = *Y
MT^ O"GGRS_V%9B:2X^U-($PWF\_,#V/)Z4 ='7E7PDG6U\0^-=*U!@NM_P!K
M27$@?AI(C]UAZKU/_ AZUZK6+J_A'0-=NXKO4=,AFNHAA+A24E4>F]2&Q[9H
M YWXG:O=Z'I>FKILOV.35-5M[.ZNXP Z1-G)!['"X![5BSW^K:5XR\5^'[75
M;YK"'0_[1@DEE\V2VE'& [Y.#R<'/MBN]/A+0#I,^EMI=N]G.0TL;@L9&'1B
MQY)&!@YR*6'PKHEO:7=LEBI2\ %RTDC.\P' #.Q+$ <8)QB@#RK2-5\06R?#
MK5I/$>H71UF7R+RVF93$RD$Y  SGW))^@XK4\,6-PWCWXC2QZO>PM%+%Q&(A
MN)B8@G*?P]!C'OFN]'@_P^+6RM1I< AL9#):H,CR6/=>>/PI\GA/09=5NM4?
M2X/MUU'Y4\X!#.N ,$CV &>N.* /-?"^LWMO\-++Q3KWBG59'U!?LJ0Q*C,'
M-P0-F>-Y 9=S= >,8%16GB_7_#F@_$%FGN;R3198?L:W\BS21>;P0[+PVW(/
M7L:]+;P7X<;0FT1M)MSIC,'^S<[ P.<@9XY],=ZDM/"?A^Q%V+72+2)+R,17
M"+'\LJ 8PR]#QQ0!Y_XSTBYB^%FNZD/$FH7]O=Z=%)B9U=2V[)9?EPJL".!C
M&.*] \)VSVOA73(WO)[HFVC823;<@%00!M4# Z#C\ZAL/!7AS3-/NM/M-*A2
MTND,<T+%G5E/;#$X'/05IZ7I5AHFG16&FVL=M:1#"11C % '$ZI?WNK?%V+P
MO+>W=GID>CM>A;69H7FE,FWEUP< 9X!ZCG-<!J^JZMKOP;634]0GDEM-?6T6
M?"YN$60!68D<D9/(ZXYS7MNJ>'=*UFX@N+ZT#W%N"(IT=HY$!Z@.I!P>XSBH
M;CPEH%UI5MI<VE6S6%L<PVX7"(?7 [YYS0!I6-M):6<<$MW/=NF<SS[=[\YY
MVJH]N .E>9^-$N9/C=X)2SGC@N#;7>V22+S%'R-G*Y&>,]Z]1AA2"%(8P0B
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M 4444 %%%% !1110 4444 %%%% !1110 45%=2216DTD,?F2I&S(G]Y@.!7
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ML<C+*"%+X#<=<UN>#?,M-:\4:0+FXFM+"]B%L+B9I6C5X(W*[F))&YCC)XH
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M?N=42:.\6:Z>1)L6YD4["=JD,O\ "!U- '4>)]>7PSH%SJSVDMU'!@ND;*"
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MUC,DA52QP/0#K6?<Z]<6_C#3=%-K']GO;6:<3^:=RF/9D%<8_C'.3TH N?\
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MC6BZ79+;,P<PBW0(6'0[<8S[TMWJUI9:EI^GS,PN+]G6!0I(.Q"[9/;@5>H
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M&@Z/=W<5W<:38S7,0"QS26Z,Z = &(R*T*J/<W2ZM%;+8LUHT+.UWYJ@(X(
M3;U.02<].*M9&<9YH RI?"WA^:\:\ET+3'N6.YIFM(RY/J3C.:LW>D:9?R1R
M7FGVEQ)&I5&EA5RH/4 D<#VJ[7,:WXP2R\,Z[JVF6ZW;Z.\D4\<K&(%D4,P!
MP<XW#Z\\T ;D^EZ?=3PSW%A:S30_ZJ22%6:/_=)&1^%,31=*B2X2/3+)%N01
M.%@4"4'J&X^;\:MPR>9$C' )4$@=LBG9&<9&?2@#C=1\+QW_ (WTZ>?0K6XT
M6UL);;9)'$R*[/&RD(>P"$9QGGBNINM-L;ZR^Q7=E;7%I@#R)8E=,#I\I&.*
MM4@8-G!!QP<4 9\F@:-*KK)I%@X<*&#6R'<%&%!X[#@>E2RZ=98@D&GVTDMH
MI^S9C7,?LIQ\N<#IZ5;!!S@@XXI<C/6@#'T>TNGNKC5M2M(;:^N42+RHW$GE
MQ)DJI? R=SN?Q [5HWEE::C:O:WMM#<V[_?BFC#HWU!X-2N66-F5=[ $A<XR
M?2J^GW%Q<Z=;W%Y:&RN'0-+;M(KF)NZ[AP<>HH A.@Z.R,C:38%618V!MDP4
M7[JGCH.P[5*=*TXI;H;"U*VQS ODKB(^J\?+^%6MR[=VX;?7/%+0!G/H&C2W
M%Q<2:38//<KLGD:V0M*OHQQEAP.OI5Z.*.&)8HHU2-1M5%& !Z 4XD*,D@?6
MLS6]7&E16J(BO=WLXM;5'8JK2%6;YB < !6/3M0 J^&]"2)(UT73EC1S(JBU
M0!6/5@,<'WJTVGV373W36=N;AT\MIC$N]E_NDXR1[5);&X-K";I8UN-@\T1$
ME ^.=I."1GIFN:UWQFMCX5U;6M+MUO/[-N'MY4F8Q#<C;6Q\IS@GVS@\T ;F
MGZ+I6DESINF6=F9/O_9H%CW?7:!FEO=&TO4Y$DO]-L[MT&U6G@60J/0$CBKN
M02>>E)D9(R,CM0!G+X=T1+5[5=&T];>1@[Q"U0(S#H2,8)J5-'TQ+J.Y33K1
M;B-0J2B!0Z@= #C(%27]_:Z7I]Q?WLRPVMO&TLLC=%4#)-8]KJ^OZE8I?V>B
M6L<$JAX8KR]:.5E/(+*L;!"1VR??% %'Q?X;%[IEI::7H]O(AU."[NHU6-%D
M1) S[@<;BPR.>O?%=';:5IUKI_V&WTZU@LV!S;1PJJ<]<J!BGV%T]WIMK=3P
M-:R31)(T,A^:,L =I]QG%6: *)T32C8?8/[,L_L>[=]G\A?+SZ[<8S[U'=)-
MI>GK'HNEV\K;\" 2"!%!ZMD ]^N!FM'(QG(Q2YQ0!2TC3DTK2X;1=FY<O(R+
MM#R,2SMCMEB3^--L]#TC3KF2YL=+LK:>3.^6"W1&;/7) R:O@@C(.10"",@Y
MH H6NAZ18WDEY::796]U)DO-%;HCMGKE@,FK-M:6UG;K;VMO%! N=L<2!5&3
MDX XZDU-D$XS10!6L]/LM/5ULK.WME<[F$,2H&/J<#FG1V=K#///%;0I+<8,
MSJ@#28&!N/? XYJ>C(SC/- %.RTC3=-9FL=/M;4L,$P0JF1G..!ZU%)X?T64
MSF32+!S<.))BULA\UQT9N.3R>3ZUH;ANVY&>N*6@"I+I6G3&$RV%K(8$*1%X
M5/EJ>"%XX''05!_PCNB>2D/]C:?Y2-O1/LJ;5;U QP?>M($'H>E)D9QGF@#%
M\1:&=2TJ^_LY;>WU:6V,$-VT8#*/[NX#(!R1QTSFL*/P58S:CH]S9^&['1'T
M^X$\DT*QB5\*1Y:E.64D\EB.!TYR.W;<%.T MC@$X!/UKC],\6ZYJ^FZG>6?
MA^S<V%U/:M$=1;=*\1P=O[GN>F?TH Z>\TRPU$QF]L;:Y,9RGGQ*^P^HR.*2
M'2M.MYYIX;"UCFG!$TB0J&D!Z[B!S^-6LX&3@>O-+D9QGF@"&UL[:QMUM[2W
MAMX5^['"@11] .*IGP[H;+(IT;3R))/-<&U3YG_O'CEO?K6B2!U(%8FMZY<:
M3K&AV:6L4L&I71MFE,I#1D1N^0N,'A/44 :$VE:=<2K+/I]K+(L?E*[PJQ"?
MW02.GM4)\.Z(T441T?3S'"28D^S)A"<9P,<9P,X]*T20" 2,GH*6@"-;>!;8
M6RPQB )L$04;=N,8QTQCM4%EI>GZ9O\ L%A:VOF'+^1"J;OK@<U;) &2<"DR
M,9R,>M %3^R=.^UR7?\ 9]K]ID4J\WDKO8'@@MC)%0Q>'M$@BCBAT?3XXXMW
MEJEL@";OO8 '&<#/K6D"",CD4A(49) 'J: *2Z)I26)L5TRR6T+;S +=1&6Z
MYVXQG@<^U37-A9WMK]ENK2">WX_=2QADXZ<'CBK% .>E &>VA:0]LML^E6+0
M*V]8VMT*AO4#&,^]3/IMC)<)</96S3QQ^4DAB4LJ?W0<9 ]JLD@8R0,]*I76
MK6EGJMAILK-]IOO,\E0I((1=S$GMU'YT ,A\/Z+;1QI!I%A$D18QJELBA"WW
MB,#C.!GUQ2?\(]HGV?[/_8^G^3NW^7]F3;N]<8QGWJIX<UVXUF35X[JUBMGT
M_4&LP(Y2X?"(V[) _O\ 3':MPD 9) ^M $<EM;S6YMY8(W@( \MD!7 Z#'2H
M-/TK3M)B:+3=/M;.-VW,EM"L8)]2% YJYG%% %"VT/2+*]DO;32[*"ZD)+SQ
M6Z*[9ZY8#)J:^TZQU2V-MJ%G;W<!(/E7$2R+GUP015FJEA<W5S'.UW8M9F.=
MXT5I5?S$!^63CIN'.#R* "'2M.MY7E@L+6*1T$;ND*J60  *2!R  !CVJ.PT
M32=*\S^SM+LK/S?]9]GMTCW_ %P!FKP8%=P((]:4$$9!R* ,VV\/:)9"86NC
MZ? )P1*(K9%\P>C8'/XTO_"/Z+Y447]D6'EPMNC3[,F$/J!C@UH$A1DD >II
M: *QTZQ-Q/<&RM_/G39-)Y2[I%QC#'&2,=C45AHNE:5')'IVF6=FDGWUMX%C
M#?7 &:O9STJBNK6CZ[)HZLQO(K9;EUVG 1F91SZDJW'M0!%#X=T.V14@T;3X
ME63SE5+5% ?IN&!][WZUITF1G&1GTI: "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@!'4.C(V<,,'!Q^M>,:4]I9> [+[*RA8==*:
MZBN2\5M]IEXD&<A?N9SU7.>,U[12;0,\#GK[T <5IUO"GQ+,NA>4-+?2S]N%
MMCR3-O'E'Y>-^W?[[<9[5;^(LS6GA,WGVB.*&VNK>6=)"0D\8D7,3$ X#9P2
M>/7C-=2D:1J%C144=E&!61XBTBXU:WLOLTR+):7:7/E2Y\N<*"-CX[<Y!P<%
M0<'% '&:3#X7N9O$VJ0:AHLBW%N&%G9W:2);JJ;6<A3@%B1G [#DDU3%K"_P
MJ\(^)K>*.XN=!MK:YE  8O$J 3(?<*6;V*BNZM]">7Q+%KM[';13P6KVT45N
M2PP[*S%G(!;[@P,#'/7/&]@8QCB@#S+Q-')9Z!%K]M&D$6IZM!<:C*820EET
M7>H()7A&<9_B;/&:Z+PI96<>J:GJ&GZQ87D%TL6ZWT^,+#&ZAOG&'8;F!&>G
MW175]L4BHJ+M10JCL!B@#AOB/'IXN/"MQJ;(EI'K"K-)+(5C13#+]XYP/FVC
M-4+'3/#^O>.?%UG>0VM["EO9B.%V#JN(V!*C^\.!NZC/49KT@@$8(!'O2X'I
M0!XOH>L33P>#&U74;1=+DT5HQ-J">;";L,H*O\R@/L'!8_W@.37I?A#3X]-\
M/I;P:E'J%OYTKPRQ+A$1G)")\S?*N=HY/ K;9%=2K*&4]01D4[I0!YWXLFT]
M?BEX>6^U$6,::==DR?:?)():, ;LCK@_7%4/%MWH;^ +BTMM4COA:ZE;XNA.
M&.Z2Z5V <')8(QR?2O4\"DP/04 >:P:)X9F^)U]I"6MB]A<Z1%.]DI!BDF\Q
MQOV="^S'.,XY]ZPDN=/D^'G@2\U*Z3R[;6$MY;F27#1H/.&UGSD# 3.3T KV
MC ]*YWQ1HU_J\VBM9"U"V&H)>2":1EWA59=HPIZ[^OM0!RO]GZ9I^J:_J>@_
M9[;P_)HCI<&V(6VDN<G:4Q\I8+D$C^\!UJ'1[R%E\!KJ+Q/H4FB"-3(08?M@
M2/ ?/&[:'"@]\XYKU$*     .@I'1)$*.BLIZ@C(- 'ES>&9-:T?Q?9Z>B&P
MBO%N-#X!19E16<1]O+,@*X''+"IKZ:XU[P1K'C#0[-X=1N--6&Q"1XE15&9"
MO?=DNH_ZYKCK7?:HFJ-;1QZ0UI%(6VN]P&(1,'E0.K XX.!UJQ9VD5C906D
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MD7A3Q'JFD1QBXT626)DNTRLC1@%L!6!QSU]NE=-:ZA:W4C01W4$ES&H,L22
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ME!Q@ @KSC(SJZ_?:'J_P_P!6DTNR>.^_L>>VC@%HZ21;U'[HC;UW!>/;CC-
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M+B:*6TB\E3;_ "LWE,)-G&,Y"YQW H ]&FO;6WD6.:YAB=E+!7D"D@#).#V
M!/X5A>*/$;Z?X)U+7=$N+*Z:TA:523YL;;1R,JPY_&N)DGT^$?#.ZUB$L%LI
M(KCS8&=E<6ZC#C!/#=<C@\U)X@T<0Z!X\U#3K-X;'5;..*UMHX2IGF",&D6,
M#(W;E'0$[2>F"0#TR:_M;.UCFO;J"W5@/FED"+G&>I-+)J-C"(C+>VZ"49C+
M2J-X]1SS7()>"S\?C4-0;&EW6DQQ65RX/EQR!V,B$]%9@4/.,[<=JQ/^$=O8
M? FH7EO;LDVG:Q-J^C0.I4I"K[A&%/*AU\S"^CB@#TQ;RU>>2!;F%I8QEXPX
M+*/<=J2UO[.]1WM+N"X5#AFBD#A3Z''2N \1VE]J7@>\UNPM9VN-1N;:ZF@2
M/=*UFCKB/;W.P%BOJS#O5+Q+8-K.C:MK.AWUYJ%[):P030PVIC$L*3!V7:5&
MZ3;O&W.<$C'- 'IEK?V=\'-I=P7 0X?RI ^T^AQTHN[^SL%1KR[@ME<[5,T@
M0,?09/-<UX?BL-1\0G7;?4KBYG^Q?967[*88]F\,-V5'S@Y !.0">*S_ !5=
M_:=?O](GL2L4FE_NYELFG>Z)+YC5L%5"\$Y'\0/ &: .JO\ 7+;3]6TO3I5D
M,NHM(L3+C:NQ"Y+'/H,#&>M:,DB11M)(ZHBC+,QP /4FO*8K2U>R^&MUJNG-
M<10V1M[II;1I2C_9P%1QM)SO!ZCK7:^-+]].T.&1+)+F-[R!)6>%I4@3>#YK
M(O+!< X]<4 ;,>IV$UF;R*^MGM1G,RRJ4&/]K.*6/4;&6::&.\MWE@&9D652
M8Q_M#/'XUY#K%JKZ+\0X5MKB;[7';RVBM:%#-(8@"T:!1SGVSZUUMW9V5IXZ
M\(WMA9I%#);W<,DT,.T$%4**Y _O=,]Z .O&JZ<8#.+^U\D-M,GG+M!],YZU
M'K.KV^B:%>:O<!WMK2!IW$6"S*!GC) _6N+TK2GMO$>I>$&M3_9*W:ZQ$VWY
M/*=BWE>V)U)QW7(K<^(EBVH?#S7K:.U-S*UG(8XU3>Q8+QM'KZ8YH U)-1G:
M^TQ+=+4V]R',QEGVR)A,KL7!W'/7D8 S5A]5TZ.18WO[57>3RE5IE!9^/E S
MUY''N*X6;^R?^$H\#W6EV2PVZM<EGCM#$$5H64;OE& 6.!GJ:P=0TVPE\)?$
M41Z:IN9;Z5K,+;'>_P"ZCV&/C)^<-@CN#0!ZY#>VEQ/-!!=0RS0G$L:2!F0_
M[0'3\:1+^SDNWM([N![E!EH5D!=1[KG(K@[ZR6#Q;HEQHUNML]SHMY )XXMJ
M^9^Z,8<@==VXC/O57PA:0:CIGAFUOKR^M]4T=E=[0V921)0C(X=]IRC98ELX
M;(YS0!Z=15+2]3AU:S^U01W$:>8\>V>)HVRK%3P><9'!J[0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5CZOHLFH:CIFHVUTL%UI[R%!)'YD;JZ[
M6!4$'..A!X]\D5L44 95CHQ@UBYU>[F6>^GA2WW)'L1(E+,% R3U8DDGTZ8K
M5HHH **** "BBB@ HHHH **** "BBB@ K.U[3I=7T#4--AG2![NW>#S70N$#
MJ5)QD9X/K6C10!2TBSET[1[.RFE2:2WA6(R(A4-M& <9..GK5VBB@ K,O-.O
M+W5(7DO(AID6R0VH@^=Y5)()DW?=!VG;MSE1SC(K3HH **** "BBB@ HHHH
M*#TXHHH PO#.A76A+J8N+R*Y^VWTMX/+A,>PN<E>6.0,#GBMVBB@ HHHH **
M** "BBB@ HHHH **** "BBB@""]M$O["XLY6=8YXFB8H<, P(.#V/-8"^%[F
M?1;+1=0OH)]/MC#E8K4QO*(BK(&.\@#*KG &<<8KIJ* "BBB@ HHHH ****
M"BBB@#"U70KK4/$^BZM%>111:;YN86A+&7S%VGYMPQ@=.#6[110 5F:OI]YJ
M2Q6\-[';V;AENT,)9Y4..%;<-G&03@\'C!&:TZ* $    & .@%+110 4444
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M6+ZXCU:.:.ZBG<,A*P[U9%Q\I!';KGG-=,_AC19!>!].A87W_'T#G]_V^?\
MO<<<]JF?0],D%F'LXS]B)-L3G,.1@[3U'''TH XFRO=?NO#E\ME<O?74/B"X
MM_+EN!#)/!&[9C1\85MJYSQP#R.M9VJ71U?3=+A$FKZ?-;>)[:":WO'222%R
M%8 .=^X#(93D_>YSQ7H"^%]%C@:&.P2-#/\ :/W;,I$O.7!!R&.XY(Y.:DG\
M.Z1=::=/N-/AEM3()2CC.7SG>2>2V>^<T <=]KUK6=9\3:/;S7/G:8(H+.07
M0A9&:(,)7"@!\L>X*X7 '7+KFWUS4?&%IHUUK]W9--H)GN18LH43K)&I9"5R
M!DGWQZ9KK+GPQHEY<Q7$^F6YFBC$2.J[3Y8Z(<8ROL>*F_L33!J2:B+.,7D<
M8B28##*@Q\H]%X''2@#AK:^\2>);37)=-=H=2L]4EMK9FNBD4*Q. %DC .X,
MHR203\W&,#%[[8WB)/%BWNHW%D-*N'MXX[>;RC$@B5O,;^]N);[V5P.G4GII
MO#.BSZD^HRZ;;M=R8\R3;CS,=-XZ-CMG-%SX:T2\U0:G<:7:R7H4+Y[1C<0.
MF?7';/2@#,\!7$,/P[\+K+-'&TFGVZ('8 NWEC@>II_B_6)]+.B6\4IMX]1U
M*.SFN!C,:LK' )Z%BH7/;/'.*M0^%]/M]1TZXAB6.WTV)TM+9%PD3/PS#_@(
MV@=@6]>-'4--LM6LI++4+6*ZMI/OQ2J&4XY'!H Y+5!<Z%K6B:5%J-\;'6+]
MUEDFG9WB"PLPB61B6&]E]<]0,5D>)-1U?1SXRL+/4KL6UGHZ:C;3&3>]O*?,
M'E[VR2#LW8)R.<'%=T/#>C_V<U@;")K8N)"K98[AT;<><C P<Y':G/X?TJ6P
MGLI;));>X.9UD)<S'&/G).6XP.2>!0!S -]I7B_PR!J][<Q:K%.MU%<.&0E(
M@ZLHQ\AR.W4'FJF@:AJL>JZ=8ZY'J5O?WL4JQW]O=+/:79"EMRJ21&<#<HV
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MBMHY-/A*6K;X!C'EOS\P_P!KD\]>34QT?3SJJZH;5#?JGEB?G<$_NY]/;UH
M\YM/$NL11Z1H\EU-<K+KE[I\ER\@CEDCAW^6A<#AFP!D8)V^IS6I>7VO>'VM
M[6\N1%9:GK,5M;2O-YTMM"T9+*78<DNA52<D!_85U4OAC0Y[2XM9=+MG@N)C
M<2QLF0TI.=_LV3G(YIS>'-&DTJ73)-.MY;*8YDBD7>'/&"2<DG@<GG@4 <QI
MEG%8_%^[ABO+F?.B(Q6XG,ICS,> 3DX[X)/6M+Q==W=GJ?A<VUY-"EQJR6TT
M:D!9$,4C8/&>J#O6K9>'-'TZXBN+/3X()HHS$DB+AMA.2">XR<\U/?Z/I^J2
M6\E[:I.]N_F0EL_NV_O#T/7F@#AGBU&_O/&\;>(-3B73)5-IY,H3RS]F23G
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M'>:C+J%QI=M+=S)LED9,EP!@;NQP. 3R* .1%WJ5Y-\/X_[8O(DU.Q<W8C8
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MH]O8RV,.E6,=G+_K+=+=!&_U4#!K0HH H?V%I'GI/_95CYT854D^SIN4+]T
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MXC!..32A%!R% /TH XWQ/=V\/Q!\%QR3QHYFNSM9@#S P'YGBN0O]8TV_O\
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M-9FT>R@N(]*F>!UFE*-/(BAG5< [<9 !.<G/ ')QD\47^M>+/#%QHZ!M-O\
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MVKEP\:RR$L<@$-P1CGH.>P /1**XVP\<-?7>D)%#9S)JJ,42"YWO;-L+J)<
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MWNN>&-$U5-/METVYU&PFB>24^>B-/&5;;MQR",C=QGJ>E 'IE%-D+"-BBAG
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MUY'-;><K;1A77#KM8#CG(]JI2?#*WM]-\,6ND:I-8/X?E:2&5HEE,F_[^X'
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M@.^XAL#N%4FL8> +T:!;:(WB.5[&QGAELE>U7>@B<,J2,&&\#:!QM_&NYHH
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MS'IU [54T[POJ.F6]TEOJ\)>XU&2_??:$H?,W;XROF<KR".>,=ZZBB@#C)?
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M;:(DB1120ES*9%VL6;<.3UX'4GZ5U=%% !1110 4444 %%%% !1110 4444
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M_M(\:^#FLXXGN?-NPGFL0HS >3CG ]!U]NM;=KH!M_%%UKIO9'EN;>.V>$H
M@5"Q7'?.7:FZ[X=;6+[3;^#49[&[TYW>!XT5P2Z[6#*P.1MR.,=>M '.2>/K
MW2[NZTG6+2V74X[ZWM8I;<N89%F5G5\'+#:(WRO<@<\Y'0:!K=WJ.IZE97,
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MG/''!SQS[>/-2?2+6>#3+8WHUK^QKR%YF"K+OV[D;'*D<\],]#BNCN_#^_Q
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M)$,Q(!*)-N\L !C[HQCICO0!2L/$6IZOI=OX@LELTT9W9GBE5C,858@R!@P
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MB_M+2>VAN;F**6Z?RX$=P#(V"<+ZG -0V.L6&I75Y;6DYDFLG$=PA1E,;$9
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M+;;=OFH2'5]V<@@<8Q@_C0!Z+GG%41K%@=;.C"<_V@(#<>248?NP0"V<8/+
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M+@Q'+;LJ<#C&??.>.ECO[]OB#J.EA[01KI<5Q#)]G^96:1UPQW98#;G QU-
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M9HKS6:^O-;\2^"+S3M7LKA)(;YDN&M'*N5"J25WJ0<'&.,$'KTKTJ@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH " 001D'J#7)#
MX=:&NGMIZO?K8B59H+;[4QCMW5PX,8/3D=.>X&,UU;MLC9]K-M!.U1DGZ50T
M+6K7Q#I,>I6:RK [R(!*NULHY0Y'U4T 4Y_"MG)J[ZK#=7MI>RQK%<26TNS[
M0J_=WKC!(YY !'K4I\.VW]NIK"W%VMVEJ;13Y@8"(D''(.3D Y.3GVXK8HH
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MTBVTRT:4VUL@CB$C;BJC@#..<>]8S^/=(32SJ/DZB;7[&U\K_9'4/"H4EE)
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M%BH=>AP6;\ZK6?A#3;*&WM4>X?3[:836]E(X:*%@<KCC<0#R 20.,#@8WZ*
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M2*W8-?C%T6E=O-XV\Y/7'&?3BHO^$7T<06426K1BQ4I:O'/(CPH1C:KA@P7
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M*ZTRTTZ:P5[:R(-J#(^Z# P-C9W+QQ@'IQ3H_"VBPK>I#9>4MZ@2Y6.5U$H
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M :6C6]U9:3:V^HWC7-\4S+(Y'S/U(& .!T'M47B55'A?66P-QL9@3CG&QO\
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M@.+6([GW*<KP..._MANA>)=<\2W,ME>6]]!-#I5G.5LGCB82S(S-(=[ D @
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M8V^FV4-G:(4MX5"1H7+;5'0 DDX'8=JR1X,\/K9-9+IX2V:83F)975=X.X$
M-Q@\@#@'D4 <SJVLZKX2UG6434+G4X8]!FU..*["$I-&X7@JJ_*01D>W%:6B
M/KUS>Z+?1FZ:PGMBU^UU+$RR$H"CQ!"=IW<8&!@],BNCDT73Y=0COY+??=1P
M&V$C.Q)B/)1N?F!//.:@TOPUI&BL#I]J857.R/SG:.//78A)5/\ @(% &=>Z
ME/>^.!X;%S):P+IOVUGA(625C(4P"<X"XR<<Y8<XZ\YX;OH]&\/^)/,U.Y9S
MXCDMH[A$1YI79HU"@8"[CTR1@=3TKMM5\.Z3K<MO-J%FDTUL2890S(Z9Z@,I
M!P>XS@U WA#0'LKJR.FQBUNI1/+$K,%\P$$.H!^5N!RN#P* .'U&\U.30?B+
MI-U>7?DV6F":#[28WE020R%D9E!!!V>Y 8\]*T(-2U"TU?0O#?G7]W;S:4UX
MSQM#'*Y!150-\@"J"3Q\QR.<9KK(?#&BV_VOR[! +R 6]R"S$3)@C#@G#'!/
M)YY//)J)_!^@O8VEH; ".S8M;.LKK)$3P=L@;>.,#KT ':@!?#_]LVVARC60
M9;F*67RCE3(\(8F/?M^7?MP#CC(KCI=?U8_#*S\:V]_*^H,8IWM1@PR*\H4P
M;<<8#8!'S9')KT:TM(;*W6"W0K&N>K%B2>I)/)/N:SX?#6D6\YEBLPH\[[1Y
M7F/Y0DSG>(\[ V><@9SSUH Y[1+:=OBEXIE_M&X$<<=F6@"Q['!23 )V[N.H
MP1[YJ;5GU*X^(=EI,6L75K8W.F3SR1PK'D,DD2@JQ4D'YCUSWQBNAM]$L+35
M+G4H(76\N<>?)YKGS,9VY!.#C)QQQGBEDT6PEUB/5GA8WT:&-)?-<;4.,KC.
M,' )&.<"@#@[+Q)JT5O9Z3/?R2-)XCFTEK]U42>2BLZ@X&-[8"YQZGK4OB"Z
MU&TO/%&@"]GEL&\/R7\4DF'>W;+H4W$'*L!GG)&#@^G7OX8T:2WNX'L5,5W/
M]IF4NV#+G/F#GY6SSE<'@>E6(=&T^"&YB%OY@N5V3M,[2M*N,89F))&">">Y
MH XN"34='TCP&D.L74D5Y<P031.D0!C-LS!?E0' *#'.>3G-:&F3WOBQ]9==
M5N;"73]3ELX8[<J%41D8+@@[MW7GC!&,=:UX_"&AQ6UE;QV;+%8OYELHGD_=
M-C 8?-U X![#CI4LOAC1Y=5DU/[(4O)=OFO%*\8EV]-ZJ0'Q_M T <?IFL>)
M/$FD2:EIT=RE_'J4D:*TL2VRQ1S%&C==V[)0$YVYW'@@8KT>L=?"^C)J<NH1
MV?EW$SB2;RY75)7_ +SH#M8^Y!-;% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 45%=220VDTL49DD2-F5!_$0.!7!Z-++J?@:R
M\807UY=:NEC)</$MS)Y4TWE-F$Q!M@ ?& !GY1[T >@T5YM-=W<7A7PGK^FZ
MC=W%_>7%FLP:=G2Z$N!*I0G:,99N -NWC S566WNKG0?'=V=;U=9M)O+DV)2
M^D7R=ENC@<'YAG^%LCKP,F@#U.BO-M9O=;DMAJGDS:AIO]DQ23QV6H&UGM)-
MK.\H7A7R",9/&W@<G+;;4-6\6ZEXDM+65H'MXX18[[Z2V>!7A5UE*(IW98DG
M.>FW'7(!Z75>[O[6Q\@74Z1&XE6"(,<;Y#G"CU/!_(UPT%E>:AXYETK4M7OC
M'_85M<3QV=Y)$C3F1U9T*D%0=HX&/>L3?<ZOX6\$M?:E=22KXADMC-YF'<(U
MPBL6QDMA ,^YH ]<HKE_'&I76A>#);FSF=2CP1/<D[FBB:15>3)[A23G\:J7
MD=QIOCO0K*PNKM[+4K>Y6\ADN7D"JBJ4E4L25.Y@I(/.X=Q0!V=-=BJ,P0N0
M"0JXR?89XKB/AQ:7-UI$&MW>L:E=S%KNW$4UP6BVBY8*=IZL F QYP2.F,66
MO1J_CC6-#U"[FMK>SLX)K>*&X>!I0^_?)N0AB 0J]<#ZF@#;\.Z[%XCTA=1A
MMYK=#-+%Y<V-P,;LAS@D=5/>M6O'M&U:YTWP5X:MK&<FUOM>NK>:XDG,9=/.
MG*@R $J68+R!D].,UK>)[;7=&\*>(+E]4DMH_M%K)8K;WTDDEON=$D!=@"5.
M20#D#)]J /2Z*X Z4W_"PY]#_M?5SI]SI7VR2'[?+N$HEV;E?.Y!@_=4@<#C
M'%5]$UR2[\'>';*^NKVZO[Z[N+6,I<&%IA"THS)*,, %0$E?F) ZY- 'H]%>
M1_VAJ7_"(7:KK%VDEGXGCLH)HKQI&$+31 H7/,@ =AE@?>M?4+N]\*^(];CT
MZYO;N-?#\NHQVUW</.//1R 5W$D ]U!QZ"@#KM:UZ/1+C3(I;6>4:A=I:))&
M5VQNV2-V3G& >@/2M>O+]76RN(/ NJ)JMS=7-WJ=JY9KMF2;*,6;R\[%P?[H
M&,XKTJ.ZMYIYH(IXGF@($L:N"T9(R-PZC(YYH FK*;Q%IR^*$\.F4C4'M3=*
MN/E*!MN,^O.<>G-:%S<0V=K-<W$BQPPH9)';HJ@9)/X5Y=KEOKL&CV_C$Z9;
MK=6-X=6<BY8S&V9=KPE-F 1"%!^;JF: /5J*XC79_P"T?%GA$6>J7D=CJ45R
MSBVN&19D$6Y3P>/O=1@^A&!C/M[#4[_2_&F@6&KZBL]A=@:;.UVYEC)@CD"&
M3.YEW,1\Q/!]A0!Z/17'^%M07Q3-9ZW;S74=K!9)$T'VA]IN& +AU)PQ08&3
MGECGD##/%*R/XV\+6RZA>6L-V;J.=(+EHQ*%BR!@' .2>1SZ'@8 .SHKR?5]
M1U?PLGB.'3]0NI])BN;&-+B[N&D-H97Q.HE;<V I0Y.=N^MW4K#6;&QU^]-\
M;:P.DO)%#%J$LTB7"!F$BNP!4$8! ."1TY- '=T5YW%INLQ^%=(O=/U2[O[V
M_%K+<6UY?M&)U6%BR1N!F,G(8^NSGJ<U[+7I[G5-$T=XM2TZVGU&[M[V.XNB
M[K+'$'2)9@Q)0[B1@Y^7;TR* /3**\G\3W>IZ99>.;.UU*^2TL+>VN;2<7#[
M[>5\[XP^=Q& &P2<;A[5TCPS:+\1=%@@U&_F@U.UNC<Q7-RTJ,\?EE752<(?
MF/"@#':@#M**X_QEYYU[PK!%?WEK'=W[P3K;SM&)$\B1L''NHYZCL17,W-K=
M1Z7X[A37-8 T)FETYOMTFZ(_9EEPS9S(-Q(PY88H ]6HK@M3U-=86.Q^T7:W
M:Z0E_,\=^UG%"'R ^Y.6;*G@@J .>O.>-3OT\)^"?%]WJ%T8D2W&JJL[)')'
M*H7S74'!VNRL>.A.>* /3:*Q?#D$AMKC49)KA_M\QGBCEF=UBB/W H8G;E<,
M0.[$= ,8.EY\6W?B*&]O[VVN].U)[>".VNGA\B-54QN54@-NY;+9SDCH* .A
MT/7H]<DU.-+6>V?3[LVDBS%<E@BMD;21C#CO6O7EC6!N+'XAWT>H7]M/9W\\
MT!M;EH@DBVL3!B%(W\@##9''3DUK76J+K<-E8O<78O#HR:A,\=\UG%$K<;RR
M?,6R#@8*C'/44 =[17ENGW^HZQ:_#B2YU6]234X)5O#!.8_/ MV;) XSGN.>
MX((&)+B]U31]-\;65CJ-Q)'I=U;/ ]W=;I(X72-Y4620YS@N%R>"1S0!Z=17
MGMU'JVG#Q!X@T^74EL[?3#+9V-U<-(7N0CEF*EF(7&S@GD@G'<VO#L&L7LGA
M[68;Z+[%+;DWA.H23_:PT>5(0J%5@XSQC R.E '83W]K:W-K;3SI'/=.R01L
M>9"%+$ >P!-4-+UZ/5-7U?3A:SP2Z9)''(92N'WIO!7:3Q@CKSSTKG_&%H+K
MQOX.1KNX@5IKH#RI-A!$#'(/7/;Z5GKI2:EXH\=@W]_;F$VS(;2Z>$JXMEPQ
M*D%OH<CVH ]'HKR[1O$&KZYJ'ARPN7$J77AR*^8-=O:^?.Q <[D4DE1@[>!\
MQ/88[CP]#J&F>'(X]:O$N;B#S-\Z.7R@9MN6(!9@N 3CD@T ;-9/B;7H_#.@
M7.KS6L]S%;C<Z0E=P'3/S$<?K[5Q&GZM--XE\(7]G=7BVFL^=OCN;]I6N(_)
M9U<P\I&<J#\A&,X([5E:_>Q>(?@[J>N:AJ%PFH[I8WA2Z>-(G$Q40F(':< #
MJ"3USWH ]A)PI(!)QG [UE>']>C\06ES/';36WV>[EM'CFV[@\;;6^Z2.H/>
ML>YOO[1\?3^'KVYEM[2/38[F&.&=H6G9G97;>A#84*HP#_$2>V.,25[/X1^*
M;C3M2ND>WU>[,%VEPV]OW^ Q8'+9![]<YH ]AHKS_6?MV@Z_H.D07]W=6VK7
M=Q+.][>LA+K$NR)9%4E%)W,%7&2,=#BBXT_Q59VXMXKB"] U%YTT_P#M&19'
MMO+_ -5YY4-E78-@]1@$XH ] HKS6*]U?4;&P.EV5Y.EK+>17NE76IM%<%Q(
M "LP)#JAW*,M@@CN..N\,7D>K>$;*>%KV)9(B@-RVZ=2"5.YCG)R#SSGK0!J
M6-_:ZG9QWEE.D]M)G9+&<JV"0<'OR#5BO(O#5S-IG@;P5#%>W*VNJWBP7<GG
M']VN)"J*1RFYP 2.>U=?ICW=A\1K_289YYM*;38[LI-*TOV>8R,F S$D!E4G
M;G^$XQ0!UU%</XDOKCP_XWTN^$UU+:ZC;36D=J9W\HW8PT7RYV@L-Z],< ]:
MJZ#/J5_?+X:U._N7U'2+Z26ZN(I7B\^W(W1$[3T8R*,'M&XH ZO0=>CUX:CL
MM9[9K&\>SD28KDLJJQ(VDC'S#O5QK]4U:/3_ +-<EI(6F\\1$Q+@@;2_0,<Y
M ] :\SDLG?0?B#J<.HW]M<V&HW<]N;6Y:)4D2"-LL%(#Y( (;(QT YK?@U"[
M?QSHK?:9W2[T&:YDMA*?+>0-#@A>@/S-^= ':RNT<3NL;2LH)"(1EO89('YD
M5G>'=;A\1Z!::O!#+#%<J66.7&Y0&(YP2.U<[X+ \3:!HWB2?4;PZ@Q+W"I<
MNL6_YE:(Q!M@"GCIGY0>O-<GI$4VG?#;PUKEIJ5]'<K?P1;%N6$+1/=;&0Q9
MV$88\D;L]Z /8J*Y3XDSSVGP]UF[M;J>UN((#)'+!*496^H^M4+Y;K0/'&E"
MROK^Z&H6=XT]O<7+2)+)&J,A52<(<DC"@#GI0!W55%U*T>>\MXIA+<6:JT\,
M?S,FX94$>I R!7G+ZA?O\--&\566H74NMR26S.GG,4GDDE5)(3%G:!\S  #(
MV_6M'2[!9/&_CB1K^\5D>#A)RG6W!'3'3M]* .WT^\&H:?;WBP3P":,.(KB,
MI(F>S*>A]JLUYEHVN7=UI?P_T^_OK@0:O8R/<W'G,LDTJQJ53S =P)W,>""=
MH'3(-N[-YIOC33?#,%Q/-I\]I<74:W6H2HTDF]1Y8E^9VVJ20N>AR>@H ]"J
MII]^NH132+;7,'E3/#BXB,9;:<;E!ZJ>H/<51\-66IV6CM:ZK=I<RK/+Y;K*
MTC+$6)16<@%F52 3U.*X^QFUJ[\.ZA#87KW-U%XBN8$BN;MT:>&-V_<K+R5.
MU>OL?4T >DU7MK^UO9+F.VG25K:7R9@ASL? ;:??# _C6%X-OS>6FH0R6E]9
MW%K>&*:VN[C[1Y3;$;"29.Y,,".>,D8%<3]INM!\/^/=7L;RY:ZAUB1.6#!%
M(@#2[<8W*I)SC'% 'K=9%[KT=CXCTO1GM9V?45E,<X*^6OEKN(/.[/3MCGK6
M'?"?2?&?AE-+N[J:UU#SX[N&6X>96C6/<LHW$[2&P,CKN /:F>+K=;KQQX/M
MWN)8%D-X"T,FQR/*' 8<C/J.?0B@#MJ*\EO=2UCP_J%SIEM?W,^C2:Y:VD=S
M=W3%HU>)FDB\X@L!O"+NY(W$9S7=>']/U:QU+5#>W$9L9O*>UMA=/<-"<$/\
MSJ#M)"D#G'- '045YWJM[JFFZW<7]];W5YI)U&$0WEAJ#(UL-R)Y3P9 8;\@
MD9)#=.!BMI,_B+Q1I-W?6]U%;:G;ZK(A=[^15@6.;'E-"%VX,8QSUW;LYZ '
MIM5Y;^UAOK>RDG1;JX5VAB)^9PN-Q ]!D?F*\[>TN+[_ (3K?K.K)_9MP39^
M5?2)Y)%LC]CR-Q/RMD>U*GF:SXI\"7MW?7"37.ASSN8G"98K;DXP.^3GZ4 =
MIKFO1Z&^FK+:SS+?7D=FKQE=L;.< MD@XZ] >E:]<;\11NL=!7SC!NURS'F*
M1E?G/(SQFJ+Z+?\ _"3:QH>G:SJBV,^E"7S)+V21[2[+D(5<DL 0"2N<?+TP
M: /0**X7PA?2^)(])N'GNXGTRW:+4(OM,F&NPVPH_/S;2CM@]G3M6CXOO+JS
MO=! >3^SY[QH;N*WEV329C;8%Y!(##)"G.!GH#0!OZE?+IFG3WK6]S<"%=QB
MMHC)(_LJCJ:L@Y4'!&1WKS+6++5]&^''BG4)=4U.*93--8*UZS/;Q#[BE@3D
M]>YX(':MGQ+=OX?\1Z'KT][<KI$NZSO8S._E1LRYBE*YQ]X%3_OCO0!U5]?K
M8&UW6US/]HG6 >1$7\LMGYGQ]U1CD]LBK=>?ZK%?:5I_AN=K_4([F\UR'SHV
MNY& 21F/DD$G(4!5_ ^IIJ6$NK>)_&5G-J^K1P6GV=[=(+Z2/R6:$L2"ISU.
M=I^7VX& #T*BO-+#6]1O].\$RZC-//:ZCIC&X2UF\N:6XV(P<[2K%<;\XX!8
M9[5U7@W3-1TW0PNJWES<W4CN<3S^:8X][;%)YRP4J"<G)'4]: .AHKS@V4VI
M:OXX@EUC5DCL'B:T6&^D3R6-LKD@@\C<3\IROM3] UF\U[5/#UCJ=Q,(+GPY
M%J&8Y&B^T7#%0^2I!.T8.!Q\^<<# !WEY?VNGPK+>3I#&\B1*SG&78A54>Y)
M IGV]?[7_L[[-<[O(\_S_*/DXW;=N_IN[X].:\MU)KV[T26QO+ZZDM;'Q=;6
MMK<-)\[Q>;&<%SRQ0LR[LYRO.2*Z66XN],\>W%O;75W=)'X?>X2VEG9U>59
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M;J.VAN("I0%SP3D@D<'H#TK1>T\C2)+9;FX.(V'G.^Z3OSD]Z\KL+-4^&?@
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M?, %4'*_,2!UR:S'U'4AX#U8KJ]VDMAXBCL[>>*\:1EB::$%3(>9  [#+9H
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MI1(XTS\R",#.2. 1P,Y[<]%10     # %9MUX?T:]OUO[K2K*:\4 ">2!6?
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MCN$7?P+H7GG .C=]N-V5/&SV%>N"*,$$1J".AQ2"WA$YG$,8F(P9-HW$>F:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF,NF?E8=5(/(/(X/K6C7A&A^+&\&^ _%)M;,#6;76S;W=R[^9%+,[[6E487
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MGP,D]CDY[YK#O;[4]<^'_ANYN+N+[3)XAAC>3R!@[;QE4@ @# 4?6@#U:BN
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M'M*GDFNIKN^U"VGN(1&DLJVS,J@;B%5F&"2.<*<8S2^)8==/AZ.'4KB>!/\
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M;Z^TOPL]]I]Y):S17-LI*JC!E>9$8'<#V8],&FS7U\/B7%I2ZA*+.;1Y;CR
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MQ&DDM] M+B*^N+-UU*T0RPS&/"-.BMNYP1@GA@10!U]%<0NF2V'C^UM-.O\
M49;"[L9WU&&6]EE6,@J(W5F8E&8EAP1D*<#BN7L+C4-/^%4'B@:QJ<]Y,B03
MRRW#.L4+7(5Y IZ,JY^;KSD]. #U^BN*O4NM*\=:%;Z/<3-;W]M<_:H99GE0
M!%4QR_,3@[B%)'7=6-X?@U#Q##X=NOMU]%-$9!JMPFH9CNR RD(%<Y!D 8$
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MF-3C/KZU52UN4T'P;J^F:OJ$VK7+V:RJUX\D=Q$57S@T9.W"KN.X $$<G)H
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M!#-J%M;W=PAP88'D =L_P\<9[;L]:IR17&G_ !"M=.L;FZ.GWNFS27<1F9Q
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MP-D$Y)'S <BLK4KV^M/#'C^WBU.ZB73)(7M6AU"25H&:-2RB4X8C)/RG@'-
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MT+VPMKM5*">)9 I/(W ''ZUYW>,OV'XK\CB-L_\ @"E=WH)!\.Z8>WV2+_T
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MT[4S%Y1O+6*X,8;=LWJ&QGC.,]: *NNZ3%-I6IR6>G0R:E<VCVZR*B*[94J
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M!4M% %&RT;2]-?=8Z=:6K;=N8853 ZXX'3VJ!/#&@1M,R:)IJF=Q)*1:I\[
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MSC;@GY>G>O9'@AD?>\2,VW;N*@G'I]*/L\'E^7Y,>S.=NT8S]* /*81+K_\
MPD5IJ&LZ?INL0:I((;BX4_:+:,.#"8\L/D*XQC@Y;.<FM:QTO3-5^*/B..YE
M>0V@L+F&$7+ +*#(Q;:#S@@<=.3ZUW[6MN\R3-!$TJ#".4!91['M2B"%9/,6
M) Y_B"C/YT <SXSM[B[;2X+.\L$N!.\JVFH@F"[ 0@HV.<C<&'!Y&<<5R4&H
M6\%QX-O[FVCTB"'5;VUEVW.ZVSLFQM8X!0O]W@8Z=J]2N+6WNDV7$$4R9SMD
M0,/UHDMH)H?)EAC>+CY&4%>.G% 'E5YJ\L$?Q%N=!N)97B>TDC,+EF$9C0R-
M'^!<@CC/(JSXSC\*#X?Z]J>B3V(DN-.VLUM*O[U2RD,P');/<\\FO3EBC5RZ
MQH&(QN"C.*C2QM(U94M8%5FW,%C R?4^] '$RVEAHWQ'\.2:>YB&IVMVMR?.
M+"Y*B-D+9/S-DGGKS4OQ'^QPMX8N;RX^S0C6HHY)C,8P$,<F06R, D"NT\B+
MY/W2?)]WY1\OT]*Y_P 6:+J&LS:+]C2S:*RU!+N87,K+O4(Z[0 C9SO[^E '
M,G3[/3=5\176B2+'H#Z(_P!H$<F;<W66P4YQNV [L>JYY-16NJ:5/H'@W1KU
M;-TN=%642WTN+<;4B4C9TDDR>!D$#=S7I8@A$(A$2"(# 0*-H_"D^S080>1'
M\AW)\@^4^H]#0!X_9SPW7@[P*+N_E:3^W'M68SLC&)6G 4\YQA4'/(XKK_"]
MO:Z3X_\ $VD67[FT%O9W$=J'.U';S0Y52>,[4SBNP-I;GK;Q'G/W!4GEQ^9Y
MFQ=^,;L<_G0!QDCP7GQ&U/3M>2)[3^SX7TZ*X ,;C+^<P!X+ [ >X&.QKDI%
M<^&_#<6H7LX@/B9H+.9KAE>2RW2;,MG)!4+@]<;2#TKUV>UM[I56X@BF53N
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M@Y*J>_2N@\J/S?-\M?,QMWXYQZ9]* .1\6ZAIKZ]IVB:A':8N+::827\I$
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M,2JT@'RJS;03[G!Q^1H \4TRQTW5?A=82:7=^;XLB;;:217):>*43'@@'(0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[J)I$_UK=E8'T[U@^&/%P\+?#R*STNRDAOY?$7]EW<S,)OWK<O*G"@\ !5(
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M(Y'/R5U?AN_U0>)==T34;T7RV*V\T%P8EC<K*'RK!< X*<$ =: .G9@JEF(
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MH9$-K+PP0*"0=W8=JV?#5_J?_"1:]HFI7HO18?9Y(;@Q+&Y656.U@N <%>H
MZT ;FIZI9Z/827U_*8K:(9DD",P0>IV@X'N>*IVWBC1[J[MK5+LI/=*6MTFA
M>+S@!D[-X&[CGC-4OB)_R3CQ)_V#9_\ T U5309M;C\-W%X\,5EI?EW<2QDL
M\L@CVKN) "J-Q) SGCD4 =?17 P>)=1;Q#X?DM[][W2]6FE@<M;+'#D1.ZM"
M>'(^3&6R"#D&K'AVZ\2ZOJNJ-+K%LMKIVISVGE?8P3*HB4KDYR,,P/')YYZ8
M .KOM3L=-M?M5[=100>8L7F.V!N9MH'UR<5;KR71+O5]&^$.GW\%[;D?:HE6
M,VH.!)=[6Y).3\^0<<8KL#J-_KOB+7-'LM0?3?[*6 "2*-'>1Y$+Y.\$; ,#
M &20>: .@CU&SFU&?3H[F-KR!%DEA!^9%;.TD>^#5JN1TZ\U>3Q=J^D7-[$3
M#IMK,DL<"@K(YD#?493C/K7.Q:_XJ7X=Z3XP_M2*:5D@>?3_ +*H2=7<*0&'
MS!_FXQQT&.] 'J%%<!XI\3:A8+>ZAI-^\Z:=>0PS6ZVR^0 S(K(\C?,7^<GY
M#QP".M7!<>(-3\7^(-'M]:2S@M(+:6!TM4=U,GF9!W<$?*,]_3% '9%E7&2!
MDX&3U-+7EG]IZIXF3X<:BT]M;W5S-,[D0%U$@MY<L!N''!X]^O%>I*"% 8Y;
M')QC- %;4-1L]*M#=W]S';VX94,DAP 68*H_$D"F7^JVNFM"LYE:29@J1PPM
M*QY +$*"0HR,L>!D9/-8_CO4+W2?"TM]8RQQRQ3P*1)&'#!I40\'H?FSGU%9
MTZ7\GQAC$5Y''"NC!BAAW$KY_P PSNX)QUQ^% ';5G:IKFGZ-!%-?3,D<LRP
M(R1,X\QF"@$J#C)('.*ON',;"-E5\':6&0#VR,C/YUX[;0WJ?!VP=[F&0/J\
M!A7R2NQO[0Y).X[@2?;% 'LE%<!J?B75_"FJZS%>W:ZI;P:+)JD(:%8F1T?:
M4RO53D<G)'J:T=)O_$,^J:3(8KF?3[J!FO7GCBC6%]H9&CVG<5)RN#NX(.>#
MD ZJ>9+>%Y7#E4&3L0N?P !)_"L2#QMX>N+>VN4U$"VN7$<-P\,B12,3@ 2,
MH7.>.M;]>5^$= G\4?!W1-&D:&+39D#7$@),K!9RVU1C R5'S9..>* /1+#6
MK'4KV^L[65VN+%UCN$>)T*,PR/O 9R.<C(Y%:%<):WT>E^(O'][)<Q6JQ/:M
MYTJEE0_9E )4<GG' Y/2BSUK6TU_5M*DNIGB72UO[6:[MHTD0[V4@JN,K\O&
MX!ASF@#NZ*\YL=>\1)I'@W6[G4XIX]8DMH+FT^S*JCS8R=ZL/F# @>WL*]&H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJ&H
M:S8:7<V%O>7"Q2W\_P!GMU/\;[2V/T_,@=Z +]%%9BZ[:MXE;0?+G%VMK]JW
M%,(8]P7@YY.3^AH TZ**9+*L,+RN2$12S8!)P.>@Y- #Z*KV%]!J6GV]]:LS
M07$8DC+(4)4C(R" 1^-)J-_;Z7IUQ?W;,MO;H9)"B%R .N H)/X4 32Q^=$T
M>]TW#&Y#@CZ&L[0] L?#MFUII_GK SM)LDF:3#,Q9B-Q)Y))-:4;K)&KKG:P
M!&1C@^U,^T0?:A:^=']H*>9Y6X;MN<;L=<9XS0!F6_AFPMM2OM01[HW-^BI<
MLUPQ#A00O&>, G&,40>&-,MVTDK',YTE&2T\R9GV;EVDG)^9L9&3TR<=:V**
M "BHK>Y@NX%GMIHYHFSMDC8,IP<'!'O4M !1152XU*UMM1L["5G%Q=AS"!&Q
M!V %LL!A>#W(SVH KZ_X>TOQ/I,FF:O:K<VKD-M)*E6'1@1R#[BL_2/!6F:1
M>0W8N-1O9X 1;M?WLDX@!&#L#' ..,XSCBNCHH YX>"M&&HZM?[+EKC5H3!>
M,URY$B;=H&,X&!P,=*JW/PZ\/7.C:=IABN8X],??8S1W+B:W/^P^<@<#CV'I
M75T4 <Y=>"=)OFTV2[DU">;36,EM+)>R%U<G)8G/)^O;CI5.[^&?AB]N;^>>
MUN2;ZX6ZF1;N14\X'.\*&P&SWKKZS(M=M9?$<^A".=;N&W6Y)9,(4+%00<\\
M@_E0!4_X1#2_^$B_M[==_P!I?9_LOG?:7_U77;C.,9YZ=>:SC\,_#3:3-I9A
MNS9377VN2+[9+AIO[V=V<_X5N:GKMKI-]IUI<1SE]0G^SPLB97?M+8)SQPI/
MX5IT 8:>$M)36YM8,4KWD]L+29I)F998@,892<'\JKZ!X'TGPS,#IDNH);H6
M,5H][(T$1;.=J$X[GKFNDJ*"Y@NHO-MYHYH]Q7=&P89!((R.X((/N* ..?X3
M>$72[B-E.+>YF$YMUNI!'&^<[D4'"GW';CIQ7:1)Y421AF8*H7<QR3CU/<TZ
MLS6M=M=!AMI;N.=DN+B.V4Q)NP[L%7// R10!0U#P3H^I:^VN2F]CU(P?9_/
MM[R2(B/^Z-I&!GFFW'@/PU<>%_\ A'#IB)I@?S%C1F#*_7?OSNW>Y.:Z2B@#
MFW\$:7<:#/HUY<ZG>6MQM\TW-_*[N!T7.>![#&>]2KX-TA=0TJ_"7'VK2HC!
M:R&X?*H>JGGYACCG/%;]127$$4T4,DT:2S$B)&8!G(&3@=\#GB@#G;#P%HVE
MZO-J&GM?VHFG^T2VL%Y(EN\F<[C&#C\.GMBK-IX1TNQUK4-7MC=I?:@ +F3[
M2YWX&U>"<# /&.E;U% '+1_#SP['X:OO#PMIVTR]?S)8GN';Y]P;<"3D'(!X
M]*EF\%:;-$(OM6IHAM19S!;UR9X@6.')))/SMR"#SC-7-2\2Z=IEK:73,]Q;
MW5TEK'+; 2*)&?8 2#@?-Q^!K8H Q+3PEHUAKD.KVEJ8;J"R6PCVNVQ80<A0
MN<?C6K=VJ7MI+;2-(J2+M8QL5;'L1TJ:L_6M9M- TJ;4K[S1:P#=*\<9?8O<
MD#G% &9%X(T>"RTRSC^UK;Z7*);-/M+_ +I@"H/7G )&#GJ:TX=&L[?6[K5X
MED6[NXTCF/F':ZIG;\O3C<?SJG%XLTQ[^QLY?M-M-?@FU^T6[HLV!G 8C&<<
MX.#6Y0!3U72[36]*N=-OXO-M;E#'(@8J2/8CD&J,?A>PCU&PU RWLMU8QM%#
M)+=.YVL06!R><X'7T'2MJL^XUK3[:TMKIK@26]S,D$4D"F56=CM'*@\9[]!0
M!0G\&:)<V^H036\C1W]R+R4><P*SC&)$(.48;5Y&.E:6G::FG1LJW-W<,V,O
M<SM(>.G7@?@.>]7:J6^I6MSJ-Y81,YN+,(9@8V &\$KAB,-P.Q..] $6LZ)8
M:_IYLM1A,D.]9%*N4:-U.596!!5@>A%4+CPAI]Y!;)<W&HRS6LWGPW+7D@EC
M;:5.&!X!4D$=\UOT4 8$/A#3+7S39M=VSR7?VTM'<-GSMA0MSG.5."#D'KUH
MN?!VCW=NJ2QS>>MS]K6[29EG$V-I<."#G: ,=, #&!6_44ES!%-%#)-&DLQ(
MB1F 9R!D[1WP.>* ([&R2Q@\I9KB7)W,\\K2,3]3TZ=!@57U71;/6/LS7*NL
M]K)YMO/$Y22)L8)4CU!((.01U%:-% &)=>$]+OM+OK"Z2:6/4"#>2&4B2?C&
M&88., # P!VK6MX1;6Z0J[N$& SMN8_4U+6?K6LVF@:5/J=^9%M8!NE>.,N4
M7U('.* *U]X7TS4-7.IS+.MRT'V:7RIW19HP20KJ#A@"QZ^OI5S2=+MM%TJV
MTVR#K:VR".)7<L54=!D\\51MO%>FW&J6NFL+JWNKR-I+9;BW>,3*HRVTD8)
M.<9SBMN@#'U3PU8:MJ5MJ,KW<-[;(8XIK:X>(A&.64X."#@=?04V^\*:1?V-
MO:26[QBVF^T02PRLDL<O.7#@[MQR<DDYSSFMJB@##NO"MA?6=O;7<U].L%PM
MTCO=.6\U2"K9SV(! ''M4MWX:TN_U&6^NH&EEFL_L,JNY*20Y)VLO0\L>>M3
MZEJ\.FO%$89[FYFR4M[=0TA4$!FP2/E&X9/N.Y J6PU*UU(7/V9G;[-.]O)O
MC9,.O4#(&1SU'!H HZ=X:M-+MOL]O=:B85C\J-);R1Q$GHN3V[$Y([&JP\$Z
M.- M=#"W(T^UD22&(7#_ "%2&7G.< @'K6OJ6I6ND6+7EXSK K*I*1LYRS!1
MPH)ZD5;H RCX?L3KT>M W"WJP"!F2=E61%)*AU!PV"S=1WK1GD$-O)(P<A5)
M(1"Q/T R3^%244 <%\-O#<-OX,TAKZ'45N(4#-:7S2A890<Y6-^!SR#C [8K
M9NO NAWAU 317)BOY1//"MU((S+D'>%!P&^4<^U=)427$$EQ+;I-&TT04R1J
MP+(&SC(ZC.#CZ4 <[=V=MK_B+3HY+&ZQHDYG^TSPLBL^S:JHQ W@[MQ(R 4%
M:.H^'-/U/5+;4IOM$=W;QM$LD%P\1:-B"4;:1E<@''M6M10!S1\"Z(--LK&)
M;J"*QF>>T,-RZ- [9R5(.<?,W!R/F/%6[SPKI5_HMSI5S',]O=_\?+&9O,GX
MQ\[YW'@ =>@ Z5M5F:QKMKHC6(NHYV%[=1VD;1IN =R N[G@<_I0!6NO"FGW
M5_!J'F7<%]%#Y'VF"X9'DCSG:Y'##///3M6S#$L$*1(7*H, NY=C]2223[FG
MT4 95WH%G=:J-41Y[:^\KR7FMY-IDCSD*PZ'!)P<9&3@C-0OX3TECIA2*6(:
M8YDM5CE90CD$,QY^8D,V2<YR:VZ* ,^VT:SM-9O=5A61;J]5%G_>$JVP87Y>
M@('IZT:UHECX@TXV&H)(\!=9/W<C1L&4Y4AE((((!_"M"B@#)C\-Z:+.XMKB
M-[T7,7D3O=R&5Y(^?E)/;D\#'4GK4=AX9M-.M6MH;O46A\ORD66\D?RT]%R?
M;&3DCUK:JKJ-]'IFG7%],DCQ0(9'$:[FVCDX% &6O@_2$T.QT=4G%G831S6J
M^>VZ-D.4PV<X![&H+CP)H=U]N66.Y,5[.+F:$74@C\T$-O"@X#$J.1_6MO3;
M^'5-+M-0MPPANH4GC#C#;64,,CUP:34]0BTK3+G4)TD>&WC,D@B7<VT#)('T
MH I+X:L4U2ZU)9+H7=U"L$LGGM\R+G:,=!C<>1ZU8T71K30-*ATVP$BVD VQ
M(\A?8OH"><58L+V+4M-M;Z ,(;F%)D##!VL 1GWP:L4 9VJZ+9ZP+9KE76:U
MD\VWGB<I)$^,94CU!((/!'4&JMUX4TN]TR^L+E9I4U _Z9(92))^,89ACC Q
M@8 [5MT4 16T"VUND*N[J@P"[;FQ[FJ%[H-O?74T[W%W']HB$,\<4Q59$&>"
M.WWCRN#[U)JFKPZ4D8:&>YN)<^5;6RAI9 /O$ D< 'DY[CN0"L&LV$Z7SB?R
MX["5HKAYE,:HP 8\L ",$<CCWH I7/A+2KC4[>_1;BVG@MUM1]EN'B5X5.51
M@I&0"3CZU / VA+H<&CI!,EK;3FXMMD[*]O)DMNC<'*\L>_?'2NB5E=0RD%2
M,@@\$55M]2M;K4;RPB9S<6>SS@8V &\97#$8;@=B<=Z ,Z;PK87+6+W$]]/)
M93?:(9)+IR5DVE=W7'0D8Z<GCFKD&C6=MK5WJT2R+=WB)'.?,)5PF0OR]!C)
MZ>M:%% %'6-(M==TN?3;WS#:SJ4E2.0H74C!!(YP:EL[&&RT^.RC+O#&FQ?-
M8N=OH2>O'%6:* .:LO NB6']G^0MW_Q+I3)9[[J1Q!E2NU03PN&(Q_@*T=)T
M&RT66\DLS/F\F-Q/YDI<-(0 6YZ' '3TK4HH YH>!=%&C-I %Y]@,XG$'VN3
M:C!]X"\_* W.!5FZ\*Z=<ZJNJ+)=V]]Y0ADGMKAHS,@Z!\'#8YYZCUJSHVNV
MNN"^-M'.ALKIK299DVGS%56..>F&%"Z[:MXE;0?+G%VMK]JW%,(8]P7@YY.3
M^AH A71+#3=3NM<07;74D"Q2D.\NY$SM&WG.,GH,\US?PU\-PVO@O1C?0Z@+
MF&)2UI?-(%AE'=8WX'/(.,#MBN]HH YNY\"Z'=F_$L5R8KZ87$T*W4@C\W(.
M\*#@,2HYK0L] LK'6+O58FG-W=HD<[/,6#A,[>.@QD]/6M,D $DX ZDUF66O
M6=]&9AOAMG=$MYY\(ESO'RF,Y^8'MTSVXH H)X(T6/3-.L(ENHX=-E,MHT=T
MZO$2"" X.<$,P(SWJYHNC-IL^HWD\OFWE_<&61@20J@;8T7/95 ^I+'O6O10
M!G:WHEEX@TXV&H"5K9G5V2.0IDJP9<D<\$ _A4:^'K)=>76M]P;Y;<6V\S'!
MC!SM*].O.>N:U:* "N:'@311IK:<!>"S^TBY6#[7)M1P^\;1GY0&YP.]=+10
M!E7/AW3;S4QJ%Q$TL_V1K)]SDK)"QRRLO0Y-,T?PW9Z&J1VD]\8(EV0PS7;R
M)$OH 3T';.<=JV** (YXA/"\1=T##&Z-MK#Z'M5#0=!L?#>EQZ;IHE2TBSY<
M<DK/L!.< GG&2:TZ* .?N/!FC7?]KBXCGE&K;?M8:=OG*X"$<_*5VC&,=*6/
MP?ID=S)=![QKJ6U^R2SO=.SR1Y)P23UR3S5RRUVUOM;U'28XYUN;!8VE\Q,*
M1)NVE3GG[AHO-=M;'7--TF:.?S]0WB!U3*912S G/' _44 51X1TH:/IVE!9
MQ:Z;+'+:#SVW1,@(3YLY( /0YK=HHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "O-_%-E>^+%UAK+3KF9[4"#2[N)X@L5Q$X=W
M&YP?]8JH<#I&?6O1G021LC;L,"#M8@_@1R*J6&DV6EV)LK.-XK<ECL$KG&>N
M"3D>O'<YH Y23QL][X2\-ZE:%;=]8O8+*9V&?LS-N\P8/&X,A09XR1P>E1VE
MBUI\79(1J5U.SZ"S#SF5FAS.!P=O3C/.?RXKH$\'Z FE76F?V;&]E=/YDT,C
MLZL^<[N2<-GG(YS4EKX5T:QN4N;6T,5PD1A$RS/O*$Y(9MV6[=<]!Z"@#S^+
M4O$ \'Z?KW_"1W;71UDV3(\<1B>)KQH?F4*,D#!R".E=#:S:G9>)]?T1M9NY
MX4TV&^MYIEC,D+LTBL =F"/D!P0<5MCPAH0TY-/%DPM$F^T+#Y\FT2;MV[[W
M7=\WUYZU:FT#39[R2\D@?[3);BVDE69U9X@20I(//)/YT </:ZMK5]I?P\D_
MMFXB?5X]MX5CC/F'[,\A;E>&R/I[&DOM3UG2]&\>6D>M74DFC0K<6=S*L;2K
MNAW[&.W!&X'G&<'K78Q^%-%A6P6.T95T\YM )Y,0<8^7YN."1]..E/N_#&CW
MTE_)<6FXZ@JI=@2NHF51@!@#@\<4 <WX@U+6;::&;[/J-UI0TY'D?2Y4$\$Q
M)S(R$@NN , 9&0V0>*KZ<KZK\2X+^VUBZ\F7P[;SHR11#S$:5C@AD) .,^N3
MU[5UK^&M+D(+13_ZD6[ 74H#QC.%8!L,/F;KGJ:?-X?TJ?4K;47LT%W;1>3%
M(A*%4ZA< @$ \C/0\B@#C=$O]132=9U_5_$]R+73;J_M]K01E D<C*KL%4%F
M&!P, ],9.:M:3>ZJ/'+:5)>:BEI=Z2]VJWAA:6*19$7<NT$ $.?E.1D=!TKI
M8/#.CV^GWE@EF#:7I8W$,CLZR%L[B0Q/)R<GO26/A?1M,NH+JSL_+N(8C"DO
MF.6*$@E6).6' ZYQ@>@H \]\)7U[I?@GP/91ZA.(M8F$+R,L8$"A)'V(0HY<
MJ!ELGKC!K;O]0U;3-:\1:/!J-P;:+1O[2MKA@KR6TF779E@=P.S(W9/7GTZ.
M+PAH,&F/IL6FQI:-*)A&&;Y'!R"ASE"#R-N,=JL_V#IOV.ZM3 [1W8"W#/,[
M/*,8PSD[B,<8ST)'>@#-\%PZB^B6FIZCJ]Q?27]E;2F.1%58FV9;9M X.1G.
M>1[X#-9O;VV\=^&;6*]D6TO!<B:VVKM<I'E3G&[.3ZXX'%;UA86^F645G:(8
M[>)0L:%V;:HX &2< >E0W6BV%[J5KJ-Q"SW=IGR)!*X\O/7 !QR.#ZC@T <?
MIFM:G;^(+"#78]2@ENKJ5(;J%TEL;M"',:C:<QG: 1D G:<DYK8^(=[>Z9X$
MU6_TZ\DM+JVB\Q)(U4]P,'<#QSVY]ZU+3P]IEC+%)#!)F$DPK)/)(L1(()16
M8A>"1P!P2.]7+VRMM2L9[*\A2>VG0QRQ.,AE/4&@#G=5OKR'XA:%I\6H2I:W
MEG=O+;A4P&3R]K [<_QMU)''2N1DU+7H_ >H>(SXAO&N].U&>..,I$(Y(TN3
M'MD 7G*CJ,8XQWSW=MX0T.SEMIH+-DFM5989O/D,BJV 1N+9(X'!..*D3PMH
MJ:3<Z4+(&QN6+S0-([*S%MQ/)ZD\G'4T <MXUUN[BL_$$^D:C?I=:+ )6\H1
M+!"X3>%?=S(6&.!P 1T-.EM9]6^)C*E_<6/F>'H7=[7:'.9GX!8' _#/3GKG
MH[CP=H%W/<S7.G)-)=1"&X,CLWFJ%VC<">6 XW'GWIUQX3T6ZNX+N6T8W,$0
M@CF6>17$8)(0L&!*\G@Y!H X>.]U&[M_"ZZG<&ZEM?%4UK'=E0IN(XX[A5<@
M<9XP<>E6[?5_$GB*SUBYTJ.X34+/4Y;:V'FQK;HL3@;)%)W'<H))QD;N,5VM
MWH&EWOV/SK48LF#VRQNT8B8# *A2 #@D9]":A?POHSZG+J/V/9<S$&8QRNBS
M$="Z*0K_ / @: -9@61E#%"1@,,9'OS7E'AZ^OM$\"Z+Y.HSD:IK;V3.Z1XM
MU:YFW,N$'S-C'S9 +<#M7K-8T?A/0H[*\LUTV+[->2&2:(DE2V=V0"?E^8Y^
M7&#SUH S+:ZOM.^(BZ*+F:YTVZTUKL+,=[6\B2*IPW4JP;H<\CCTI/B'C^P=
M/S_T&+#_ -*8ZZ&RTJST]WD@C<RR*%>665I9&49P"SDG R>,XY/K3=4T>QUF
M&.&_A,T<<@E1?,90'!R&X(Y!&1Z4 <Y975[XDU'Q-;G4+BP?3;K[):K"0/+_
M '2N)6!'S9+'@Y&%''4UD^&O%.H^+9=%T^]F>P:ZT0:A*UOA'F?S/+^4G.%P
M-W'/SCG'7LKCPYI5U=O=2VS>?+&(I729T\Y!T$FTC>.3][/4T:CX<TC5/LAN
MK-=]GQ;20NT3PC&,*R$%1@#@''% '.:I+=PK+HD&M:I/?V=D;AI8!$A0%GV/
M*S#!^[C:!SM)(Y%9"37WB'4_AQJ,VHS6US=Z=//(T"1\.84+$!D;KN_PQ7;2
M^$]#GNHKJ73T>>.'R [.Q+)DG:W/S\DGYL\G-#>%-#:VT^V:P4Q:<<V@WMF$
M8Q@'.=N.-O3'&* .1L=7\2>(],O;[3([A-0@U.2&%3+&MNL<<NTQNI.XDH"2
M<9R>,#%>BR*7C95=HV8$!UQE?<9!'YUD_P#"+Z-_:<NH+9[+B9@\WERNB2L.
MC.@(5C[D&MB@#QNRM9XOA'H#_;YI#+JUF8UD1-L)^V=1M4$Y)R<D^V*W-:US
M5O!^I>((X[^XU.*'0VU*%+L*3'*'*'!55^3H2/8XQ75+X+\/I:_94T\);^>+
M@1I*ZJ) =P8 -Q@\@#@'D5>ET33I]0%_+;![D6YM2[,3NB.2489PPR<\YH P
MM(_MV75=+NHS=-ILULQO3=S1,'<J#')&$)QSG(&%P1QQ3_B5_P DT\1_]>$O
M\JU=*\-Z5HI']GVS1*H*HAF=TC![(K$A!_N@59U32K+6;%['4(3-:R??BWLH
M<>AP1D>QXH Q!H7]H/HVHZE>1M:Z8HN;>!(MF'\O:&=BQW8!.,!>3DYK!LM<
MOY/$?A>YMK^_FT[63,C_ &I8E291"TB21HOS(,J.O8\Y/-=];6<%I9I:1*?(
M1=H5W+\>F6))%9-IX-\/V#6K6NG+$UK(9+=ED?,1(((4YX7!(VCCD\<T <_X
M<CUK5;C6;BY\27ICL-3N[6.)8H@&0* I;Y/O D$=N.0<UB:'+J.C_"[P=<VN
ML72BXN;")XBD6WRY)%5D!";L8)YSGWKTC3=$T_2#<&RA:/[3(99@97<.YZL0
MQ/)[GJ:HIX,\/Q6$5C'IX2UBF$\<2S2 (X.01AN,'D>G;% &7'<7GB?6O$FF
MIJ=SIQTN:." 6Q 8%HE<2MD'<"6( Z86HX;W5#KGC*Q;5KADL[6WDMFV1YA+
M)(QQ\N#DJ.H)K?N_#&CWNHC4)K5A>>6(FFBFDC9T'17*L-X]FS4-]HEE9P:M
MJ%G:2M?7EN4D*.[&4X(48)QQG ] 3T% ''K<Z_!X-\+^)(M=N[B_N?L*RV;J
MGE7(E**RXVY#88MNSV/;@3Z]X@O4<:II6H7SQ6^L0V,FX1+;,#,L4D87[[$;
MC\WJ#@XXK8\!>&[72/"VD>9I\EOJ$5K&DR3.S>7*% ?:"2%R<\KC-:,G@SP]
M+)<R/ID>ZXF%Q)AV \T,&W@ _*V0"2,$XYH Y[;J^J>(?%UC_P )%?V\-AY#
M6ODK$#&6BWX)V<KGM^9-9D5Q?>([_P"'&HS:C/;75W83S2/ D7#F%2Q 9&'.
M<8Z>F*[^VT'3;2\O+N&!A/>@"Y=I7;S<# SDGH.!Z#@57/A+0C:V%L;!?)T]
MMUHOF/\ N>,$*<YVXXV]/:@"UKNH2:3X>U+488O.EM+66=(_[Y52P'XXKD+K
M4M3T_1?"VN6VI37<NH7-I%=Q/@QSI/@$JN/D*YR,8X'.:[X@$$$ @]0:R[+P
MWI.G/$UK:;%A8M#&9':.$G.3&A)5."1\H'!/K0!SF@+K&I>*M;\_Q!=FUTO4
MQ'';B.,"1# C%7(4' +Y&,=\YXQ=^)G'PS\1?]>,G\JV[#1-/TR[N;JTA>.:
MZ;?.QE=O,;@;B"2,X &?08J;4M-L]7T^:POX1/:S#;)$20&'7!QVH X'4&N]
M'\3>$+V[D351,)+:WA\K9);%H=S2)@X;A=IR. >",FG^'-4\2>(]%T'7+47"
MR7,RO>%Y8OLY@)(=43)(9>,' )*\GFNSL?#^EZ=<BYM[7]^J>6LLKM(Z)_=5
MF)(' X''%0VOA;1K&\DN;6S,+O(962.5Q%O/5O+SL#>^,T <%=:AKZ>#/$VN
M#Q'>_:M&U"[6W7RX@CI$^ L@"?-D#'&/SK8FUG5M:\1^(]*M4O(SIT<"VK6L
MD:;7DBW^8^\@L,G&,%<*>,UTT?A?1H]-O=/%GFTOF9KF)Y'82LW+$Y/4]SW[
MTVX\*Z-=745U):N+F*,0B>.XD21D'\+,K L/9B: .5BMM5N/B1H9U#4);:^'
MA]WN4MA&4+B6'>HW(?E)].>!@BHE\4:GI^BZFTU^TT@\2C2TNID3_1X6>-=V
M  O )QD8R1G/2NV_L#31JD6I+;E;N&+R8Y%E==L?'R  XV\#C&.*A3PKHB6-
M]9&P62UOW,EU%*[2+*YZL0Q/S<#GKP/04 <]XNAU3PYX:U+4;+7[_/F6VQ9=
MC["90KX)7HP<<#&"O'7%'C#5;DKK<>E:CJ$=WI5B+AA;B)8H'VNZF0OR^X*/
ME / [9K>;PCHLFFOITMM-+:.5+1RW4KYVG*C+,3@'D#H#2W/A/0[R[DNKG3T
MEFEA$$K.['S4 (&\9^8@$X)R1ZT <Q>7FM:OK?AJT@UNXT^+5=)FN)Q;QQDH
MZB(@H64D'+GKGCI@\U)<ZEJ.@>*+_3[W4;FZBOM.$NEJQ5?WZD(\8('4L\9&
M<XW'TKIX_#6DQ75G<I;N)K*/RK=_/DS&G&5'S=#@9'? ]*JRVO\ ;7B.UFNM
M+EBATB1Y(9YPO[V1EV I@D[=I8G('.W'0T :NF6T]GIEM;W5W)=W$<8$MQ(
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MQ(A21HV5AT(92".I[U3N/#.CW>F3Z=<62S6T\@EE$CLSNXQABY.[<-JX.<C
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M*^PC>!Z-FIQH6G+JXU58&6]$0A$HE<8C'(3&<;<\XQC/- %Z5&DB=%D:)F!
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MC9<[L[ ><;MW?'%>CUCQ^%]&AU*6_BL_*GFD\Z41RNL<DG]]HP=A;W(S6Q0
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M:E=-<W&II;7#B4KYZ 2C#@<-G8O7^M 'J%5)[\0:E:61MKIS<J[":.(F*/:
M<.W\).>/7!K@C92ZEJ?CB&76-62.PDC:T6&^D3R6-LKY&#R-Q)VG*^U2Z9JE
M[>:G\/+J6^N"^I:7++=1B0B.5Q!&VXITSEF/3O[4 >AU7L;^UU*V^TV4Z3P%
MV02(<@LK%6'X$$?A7!:5=:K::WI<6L0W4@OYY5M=5L]0:2&<,DCJ'@;&S"#(
MP" 5'/)K!MHY=/\ @E=7]GJE]#=+<R;72Y8>6?MC*< $=03GUH ]CJO>7]KI
MZQ-=SI")ID@CW'[\C'"J/<FN4U"W@TN[LM"^W:M>W.IRSW*"74&B "JN_,J_
M,JC((5>['C XY+S;C5?!_A\7FI7$OD^*?LJ3"?<S(L[JA,F,L0 ,-WZT >P4
M5Q=D6U7QCKFBWUU>+;V%K:BT5+EXVD1U8M*64@L=PVY[;>V3GFX+W6-1T+P?
M]JU:^BFN-8FL7N(9BAN;=1/M8@<$D(IW8]QUH ]8) !). *KV-]:ZE917ME.
MD]M,NZ.5#E7'J/:JT6GBQT#[ MW=R".$H+B:7?*>#R6/4^]>;^&9Y;#PG\/K
M)+RY2QU7:EU)YQ&TB%F2)2.4#.,<8)QCO0!ZS61'KT;^+)?#YM)TECM!=B9B
MNQT+[>,$G.<]0.E9&BO=V?C_ %G28YYY]*2S@N5$TC2&WF=G!0,Q)P0H;!/'
M;&:J:I<SVGQ&U&XM(O.NH?#+2118SO83,0/Q/% '<T5YI+>7:>#/"OB+3M1N
MY]2NI[,3 SLR77FD"5#'G:,98\ ;=O&,&M+0?^*L_M6>]O[R"^L-6E@6."Z>
M(0)&_P BE%(#!E )+ YW'M@  [FJ\%_:W-W=6L,Z23VI59T4Y,98;@#[D$'Z
M$5YO>:T]Q>Z)K6F7=Y'#<ZZ+/=-?M^_C\UD=1;_<"C'!X;@$\GFMJ-Q=Z&_Q
M)UG3KJX:_M9HC&I?*C-M%\Q7&#M!)&1_#0!ZS17)Z/8ZH-;LM1ANX1I<MHPE
MB_M"6Z\]CM,<B[U ! W9(ZAAZ"H/%G]L_P!L++96S:E80V?[^R@U!K2:-F8X
ME4C ;(4@ D8(XZT =G17 :#J?VWQA9%+Z_\ L-[X;CNDBNIF!W%P"Y&<!]N,
MD?UK*T[Q'=1^&=&$FI3M:7WB&XLI[UYBS"$23>6H<G(SM1=V> >"#S0!WNM:
M]'HMSI<,MI/*-0NUM$D0KMC=@2-V3GHIZ ]*UZ\]\6:-%IW]@P07M[LN/$-N
MR^;<O*T7[MP0C.6(S@GZDUH^'5ETWQUKVC)>WD]DEI:W44=U</.8G<RJVUG)
M;!V*<$T =C17%:U"US\2M+L&U&^@M;K3+EI8(;MXUD97B Q@C:<%N5P>O/6L
MNTOYM&@UC3[B^U*\TY]8AL=+E-R?.=G52\7G$YV*VY2V=PPP!R* /2:KWE_:
MZ?'')=SI"LDJ0H7/WG<[54>Y)KS&:\O[7P]\1+5=1N4&EQ^;:-'?R3/ Y@WE
M1*V&(W#H>G(JSXDT7R-"T*675]2G:[UG3Y)&FN2=K%E&4_NCN .,T >FU3U+
M4H-+M1-,&8NZQ11H,O*['"JH]3^0&2< $UQNJW$GA7Q?:SS7=_<Z;J5D]M%#
M)=NP%V@W*!DX#2+D#_:7CK3FL9]/\6^"M.N[J:Z*07D\DLTK2;[@(BY!8DXP
M\F!V% '8P7XGU*[LA;72&V"$S21%8Y-P)^1OXL8Y],BK=>9Z[K>J:+<?$*?3
M[FXEDLK&TFMXY',BP,XDWLJG(&,;L=/E%:,EEK8C.HZ=JUM:6<NF3+YDFH2W
M:O(5!BF&] !M.22.H(XX% '9:A>IIUA->21R/'"N]Q&NY@HZG'? R<#GC@$\
M5-%+'/"DT3J\<BAD=3D,#R"#Z5QOA6[O(O$$VEZKIMY97WV(2G.H-=V\RJVT
MNI8Y5LGH0,CUQ3OAY?P6_@K3(+FYCC+7%Q;6BR. 9$2:0(J@]<(HZ=A0!V=%
M<WXN35I(]/72?+F=9S)-9-<M;FZC","JR*"00Q5L=#C!KE[35I)-0\)E'U2Q
M!U:[LKNVNKPR LL<K;"VXAP&P%//0#M0!Z963XEUU/#7A^[U>6UGN8K5-[I"
M5W8]?F(X_7VKAM3\17VDCXAW-A>SS_V>UKY(:0S"WW(/,*@Y VY9L=/E]JN>
M.=*L[;X?:_J5G?W<T<^EN");R2:.3."' 9B ?=<<&@#T)3N4-TR,UC^(O$</
MAN&TEN+*[N%NKA+5/L^PXD<X4'<R]3W_ #K!>&;1O'WA^.#4;^6+4X+D745Q
M<M(CLBHRLJDX0\G[H P>E2?$D@:;H.?^@_8?^CA0!>G\9V]K>W5A<Z9J$-]!
M:->I;N(\SQ*<,48.5R.X)!]JV-(U%-8T6PU.*-HX[RWCN%1NJAU# 'WYK%U/
M08HH]4UJ[N)+J^&G2V\;NH58HR"Q"@#J2!DG)X'05@Z7>07'AGP?HH:Z:XGT
M..XV17K6D81(X@6>1/GR-V !GJ2>@- 'HM%>3V>H:C?>#O!D\FL7HGGUMK*6
M>*X.9H@\Z@,>C<1KR1GC/>NH\-K+I_C?Q#HR7MY/916UI<PQW5P\[1,_FAP&
M<EL'8IP30!LIKT;>+'\/FTG25;/[8)V*['7>%P,'.<YZ@=*UZX74[&+4OBPE
MK-=7$*-H1)6WG:%W_?\ 3<I# =^"/RKG]/U;7(=4TC0Y;N2ZTVXO]0CMKBZN
MVB>ZCBV^4IE4%FZR8_O;1SCJ >M45YKJEIK>EPZ/;W6L3QF?Q&L,7V:\=REL
MZ,WE.S %R"."03C%4]=U34O"7_"9P:9?7DL=K96=S +J=YVMS+(Z2LK/N; 5
M=V#D CI0!ZJS!5+,0 !DD]JPK;Q-]J@@NX],O7L;J:*.TN(5$@E23.)2 <H@
MX)+8X(K';3=462ZNUO8XM*GTN57BCU"2Y9WX*RH748^4L"1UR/2L"P273?AW
MX"GMM1OD:XNM-1Q]I;:4<*&3&<;>.E 'IL=_:S7\]C'.C75NB/-$#RBOG:3]
M=I_*K%</HUFK?%3Q1,UW<;DALB(Q+A6RLO! Z@=JF\5I++XQ\*6B7][;PWDM
MS'/';W#QB15@9@#@]<]QSZ$8% '945Y'=QWD'A/QK/'KFK^=H%Y,-/<WLA,8
M6*.4*_/[T98CY]W%='XBU"+4KFXT^.>[2YM],6\D>/4'LXX Q8*VY.6;*G@@
MJ !Z\@'<T5YDNJWMMH7@;Q=?ZC<_99(((M5'GLL1\V,!9F4';Q)C/'1O:NU\
M.6LT6GO=7$MRTE[*UP(YYG?R48Y1 &)VX7&0.^: %T;7DUB\U6U6TGMY--N1
M;R"4J=Q**^1M)XPPK7KS2'3+;4-7\>R3ZM?6(M[Q'#VMVT'E'[+%\YVD;NG1
MLCCIUJOX?U/Q%KNI?V3K(V74>C6DPB-[):.SN&\R3Y%))!"@] I' Y- 'J=9
MFEZQ_:TTSVULYL%RL5YO4K,RL58*H.< CJ0,]N*30K?48?#EG;:K>)<:@D C
MGN8#P[ 8W#(Z_AUKS;P_<3Z1\//#+07ETMOJ6JK:W<IF.(8C++]T_P &Y@JD
MCGYNQQ0!Z[5>^O;;3;"XOKR58;:WC:661NBJ!DFN2"7-IX^NM(@NKMM*N-(-
MS*C7#L;>82;5*N3N7<-W /\  3ZUR,UE<7/P'O-;O-9U.ZNKS1091-<%DR.>
M%/0]B>IH ]7TZ[N+RW:6YL);,[R$CD=6++V;Y20,^GM2W5^+6[L[<VUU*;IV
M0211%DBPI;+G^$'& ?4BN+NY[Z'QOI_AR.:2:R?2WND^TW\D+3R^8 1O52S;
M5_AX&&SV%1^7K.DZAX-M=0U62::34;F"7RKEV66$13,BOG&]EPH)(R2* .[M
M[^UN[BYM[>=));5Q'.JG)C8@, ??!!_&K%>27ES=Z%9?$76=/N[EKZVOU"@O
ME5!A@RY7&"5!8@X_A]JUM9EU_0=+O_$6FSP-:QZ3*X@^WRWGF2#:4F7>HX W
M9P>010!UVJZ\FE:II-C):3R?VE.8(YD*[$8(S_-DYZ*>@K7KS?5X-/'B+P+>
M6NIW-W)<WQ<%[QY$E7[/+^\"$[0<D?= '.*](H **** "BBB@ HHHH ****
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M=,_LR?3K22PX_P!%>%3%US]W&.O-3V5W%J%A;WL!)AN(EEC)&#M8 CCZ&IZ
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M@(?R(%3(].!T]JT:* ,F#PMX>MDV0:%ID2B7S@J6B "3! ;I][!//O6M110
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MDCJ.OO6G/>)JWBW6++6+_3(K6:QMVTXWZ;D:,H?,>([E 8.3DCGA?2O41%&
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M=6"6,F@I=)'8GRX/._?#<GS8)^5067&2!QD5[!Y:>7Y>Q=F,;<<8],4GDQ8
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M/'<QVTI>1@8"RI<2Y^>3<!P1D'.":]<\M/E^1?EZ<=*188E&%C0#.[A1U]:
M/%YX](M_AIXY"W*KJ$%Y?@HURQD3]\VS*ELY(Q@]_>NQ>XM;SQ\+75_(FTN7
M28WTY9\-#(^]O-(SP7QL]POU-=OY,>6/EIECDG:.339;:":,1RPQR(#D*Z@@
M'Z4 >/NBQZ?H45[=.+/_ (2N2+3W><JS66)-H#9R4R.#Z;<=JZ72)M)\)^-/
M%=N)8['2X;&UO3""=D9_>B1U7MD*N<#TKOFC1L;D4XZ9%!C1B2R*21@Y'44
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M$='DMXEPH5N8#@=%60!2>P<^E=?I>F0Z7I,&GQ@.D:8=B!^\8\LQ]V))/UH
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M2G+*2<@]%+9%;7A&;59-5U-;^>SU&!8H1%JMM;F'SS\^489*L5XY7CYL=>
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ML#AB20I# $]><&L6TFC/P^\)Z8=/NS?Z7JMF+I#:.#;!)P7))&,8';MST!H
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M,<LUY$$E3S$*MNW)P2PQU7D<].:L)=V\MFMW'<1-;,GF"97!0IC.[=TQCG-
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MJ<C'S5S%S!K\>G:'?ZC;7&H?8->:=I+>SV3R6QBD02M$O.[<_( SC!Q7I=%
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M-&?+P5W 9)VMQU_.M"]-^GCF#7_)UF#2KS3%ME:UM!)+!(LC-B2(HS*&# Y
MZCFO0J* /.H=.?PKKNAWMGIFIW6B)97%ML6,R36TLDJR;R@YPV".!QP"!6OX
M,BNHM6\4/=V%Q9_:M3^TPB2/ >,PQKG<.,Y4Y&:ZZB@#B-5M3=?%'399M/N)
M[!--FMII#:NT0=WC903C'13ST'<BI_&MCY6AZ7::9ISE(=4M)O)M+<D)&DRN
MYPHP, $^]=A10!YAXR76]8L/%VEKINH;9(!]ACMK5?+N5\M?G>0C)<-QM!!
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M8X&"-A!XZYXKJ=<MGMO&7A?4+;3)Y;.-+N.4VT&?+>4(5+#L"0V2>AZUV-%
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MT^ZGN9XO/C8Q^9'(O5G^9MS[C@D<GDU<\4^'[_4-?T>_TW:HVS6-^V[:1:R
M,2/<,@ QT+9]: -9/$^DRV5A>0W+36]_)Y5M)#"\@=N>/E!Q]UNN.A]*IZ;X
MALQ#J]U<:N]S#!J'V<*UFT30,P0+"%QN<Y88.,G=BJ?A[PU=Z1XBU!&2-=$B
MG>ZTU%(^228#S!M_A"D/CVE/I6;'H5[-9^);?4M N)[;4-76[CC2XC5S'MB
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %! (((R#110     #
M '0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LJ/0
M8(O$DVNBXN#=2P+;LA*[/+4EE&-N>"Q.<YYK5HH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#EBP7<P&!QG)Q@<=JK6L?B.76/*\R_ATR:S<23W)MC)#."-K1A-P((+9!!'
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT4L1&594+#J#QD5R'PW\7WTEAK>D^*[L'5M#D9YYW 7S+<C<LG&.,9_#;ZT
M>D45Y5X"UK7_ !'XX\56NKWUU!!;)"]M:)M7[.LRE@#QG<J[?QS67X%\0W&N
MZ(W]J>-KN+66U)K:WMU>++*&4+F/;D@\Y/I0![317F;W.K7GQJO/#O\ ;FH0
MZ8-*^VK%$R K(75< E2<<GBGQZSK7AGXJ:?X8O-3FU/2=8MI)+=[A$$UO(@8
MD;E W#Y>X[CTY /2:*\F\.^*]0TV?X@W^JZC=W]KH$[QVT$A4#:-Q ) &2<
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M9^;=UR<8YH UJ*R]*\1:9K5]J5G8SM)/ILWD72E&78_H"1ST/3TK4H ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_4W_ ,56EI@U<))_:SV3-D>7]D5U&.^=Q-7Z* "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]BC[!9_\^D'_ '[%6** *_V"S_Y](/\ OV*/L%G_ ,^D'_?L58HH K_8+/\
MY](/^_8H^P6?_/I!_P!^Q5BB@"O]@L_^?2#_ +]BC[!9_P#/I!_W[%6** *_
MV"S_ .?2#_OV*/L%G_SZ0?\ ?L58HH K_8+/_GT@_P"_8H^P6?\ SZ0?]^Q5
MBB@"O]@L_P#GT@_[]BC[!9_\^D'_ '[%6** *_V"S_Y](/\ OV*/L%G_ ,^D
M'_?L58HH K_8+/\ Y](/^_8H^P6?_/I!_P!^Q5BB@"O]@L_^?2#_ +]BC[!9
M_P#/I!_W[%6** *_V"S_ .?2#_OV*DB@BA!$421@]=B@9J2B@ HHHH ****
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M="NM3A$MQ87[SW=_)J4DOVA2DB@QQ'Y4'S#CC'0=S77?9?&7_08T'_P53?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **.@R:S-.\0Z3J]]<V>GWL=S-;(CR^5DJ ^=I#=#
MG:>A/2@#3HK)3Q+I,ES'"MT?WLQ@CE,3B)Y!D%%DQM)R", ]01U%:U !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5Q^B!?^%G>+0.,6FGCCMQ-7
M85EVGAW3;+5I]4@BF6]N !-(US*WF  A006((&3CCC/% 'G-YI/B#3/#6@^#
MI8[)RNIP+;W<4S-)+%'*)2YCVC855?F.X\\#.[CUJJ=OI=G:WDMY'$3<RC#3
M2.SOMSG:"Q)"Y_A&![5<H **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
; HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699778482704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Aug. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Apollo Medical Holdings, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4472349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1668 S. Garfield Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">2nd Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alhambra<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">91801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">282-0288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMEH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,562,198<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001083446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699774416496">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 293,921<span></span>
</td>
<td class="nump">$ 288,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">345<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investments in marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,789<span></span>
</td>
<td class="nump">5,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,201<span></span>
</td>
<td class="nump">1,834<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,087<span></span>
</td>
<td class="nump">14,798<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">465,063<span></span>
</td>
<td class="nump">428,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Land, property, and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">123,859<span></span>
</td>
<td class="nump">108,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">74,421<span></span>
</td>
<td class="nump">76,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">274,029<span></span>
</td>
<td class="nump">269,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivableNoncurrent', window );">Income taxes receivable, non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,943<span></span>
</td>
<td class="nump">15,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in other entities &#8211; equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">45,831<span></span>
</td>
<td class="nump">40,299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue', window );">Investments in privately held entities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,896<span></span>
</td>
<td class="nump">896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,905<span></span>
</td>
<td class="nump">20,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,229<span></span>
</td>
<td class="nump">6,056<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">562,113<span></span>
</td>
<td class="nump">538,088<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,027,176<span></span>
</td>
<td class="nump">966,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">49,904<span></span>
</td>
<td class="nump">49,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_FiduciaryAccountsPayableCurrent', window );">Fiduciary accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,603<span></span>
</td>
<td class="nump">8,065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100,047<span></span>
</td>
<td class="nump">81,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,354<span></span>
</td>
<td class="nump">4,279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividend payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">638<span></span>
</td>
<td class="nump">664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">591<span></span>
</td>
<td class="nump">594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,027<span></span>
</td>
<td class="nump">3,572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,630<span></span>
</td>
<td class="nump">619<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">185,794<span></span>
</td>
<td class="nump">148,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,335<span></span>
</td>
<td class="nump">14,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,078<span></span>
</td>
<td class="nump">1,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,852<span></span>
</td>
<td class="nump">19,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion and deferred financing costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">205,136<span></span>
</td>
<td class="nump">203,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21,383<span></span>
</td>
<td class="nump">20,260<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">257,784<span></span>
</td>
<td class="nump">259,056<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">443,578<span></span>
</td>
<td class="nump">407,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 12)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_MezzanineEquityAbstract', window );"><strong>Mezzanine equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,845<span></span>
</td>
<td class="nump">14,237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value per share; 100,000,000 shares authorized, 46,553,517 and 46,575,699 shares issued and outstanding, excluding 10,569,340 and 10,299,259 treasury shares, as of June&#160;30, 2023 and December&#160;31, 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">47<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">357,246<span></span>
</td>
<td class="nump">360,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">208,719<span></span>
</td>
<td class="nump">182,417<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">566,012<span></span>
</td>
<td class="nump">542,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,741<span></span>
</td>
<td class="nump">1,749<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">569,753<span></span>
</td>
<td class="nump">544,310<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, mezzanine equity and equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,027,176<span></span>
</td>
<td class="nump">966,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">66,927<span></span>
</td>
<td class="nump">49,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Loans receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">973<span></span>
</td>
<td class="nump">996<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">82,820<span></span>
</td>
<td class="nump">65,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Loans receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,125<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Company&#8217;s consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The consolidated balance sheets include total assets that can be used only to settle obligations of the Company&#8217;s consolidated VIEs totaling $520.8&#160;million and $523.7&#160;million as of June&#160;30, 2023 and December&#160;31, 2022, respectively, and total liabilities of the Company&#8217;s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $136.2&#160;million and $131.8&#160;million as of June&#160;30, 2023 and December&#160;31, 2022, respectively. The VIE balances do not include $325.5&#160;million of investment in affiliates and $5.4&#160;million of amounts due to affiliates as of June&#160;30, 2023 and $304.8&#160;million of investment in affiliates and $30.3&#160;million of amounts due from affiliates as of December&#160;31, 2022 as these are eliminated upon consolidation and not presented within the consolidated balance sheets. See Note 16 &#8212; &#8220;Variable Interest Entities (VIEs)&#8221; for further detail.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_FiduciaryAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fiduciary accounts payable, due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_FiduciaryAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of Investment in privately held entity that does not report net asset value per share .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_MezzanineEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_MezzanineEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699778571360">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,553,517<span></span>
</td>
<td class="nump">46,575,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,553,517<span></span>
</td>
<td class="nump">46,575,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,569,340<span></span>
</td>
<td class="nump">10,299,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,027,176<span></span>
</td>
<td class="nump">$ 966,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">443,578<span></span>
</td>
<td class="nump">407,666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">520,800<span></span>
</td>
<td class="nump">523,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">136,200<span></span>
</td>
<td class="nump">131,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">325,500<span></span>
</td>
<td class="nump">304,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due to affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Due from affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,111,111<span></span>
</td>
<td class="nump">1,111,111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">555,555<span></span>
</td>
<td class="nump">555,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Company&#8217;s consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The consolidated balance sheets include total assets that can be used only to settle obligations of the Company&#8217;s consolidated VIEs totaling $520.8&#160;million and $523.7&#160;million as of June&#160;30, 2023 and December&#160;31, 2022, respectively, and total liabilities of the Company&#8217;s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $136.2&#160;million and $131.8&#160;million as of June&#160;30, 2023 and December&#160;31, 2022, respectively. The VIE balances do not include $325.5&#160;million of investment in affiliates and $5.4&#160;million of amounts due to affiliates as of June&#160;30, 2023 and $304.8&#160;million of investment in affiliates and $30.3&#160;million of amounts due from affiliates as of December&#160;31, 2022 as these are eliminated upon consolidation and not presented within the consolidated balance sheets. See Note 16 &#8212; &#8220;Variable Interest Entities (VIEs)&#8221; for further detail.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699773052800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 348,209<span></span>
</td>
<td class="nump">$ 269,697<span></span>
</td>
<td class="nump">$ 685,453<span></span>
</td>
<td class="nump">$ 532,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services, excluding depreciation and amortization</a></td>
<td class="nump">292,876<span></span>
</td>
<td class="nump">230,070<span></span>
</td>
<td class="nump">582,273<span></span>
</td>
<td class="nump">450,798<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">24,056<span></span>
</td>
<td class="nump">19,894<span></span>
</td>
<td class="nump">45,236<span></span>
</td>
<td class="nump">31,837<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,248<span></span>
</td>
<td class="nump">4,351<span></span>
</td>
<td class="nump">8,541<span></span>
</td>
<td class="nump">8,725<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">321,180<span></span>
</td>
<td class="nump">254,315<span></span>
</td>
<td class="nump">636,050<span></span>
</td>
<td class="nump">491,360<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">27,029<span></span>
</td>
<td class="nump">15,382<span></span>
</td>
<td class="nump">49,403<span></span>
</td>
<td class="nump">41,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income from equity method investments</a></td>
<td class="nump">2,723<span></span>
</td>
<td class="nump">1,512<span></span>
</td>
<td class="nump">5,207<span></span>
</td>
<td class="nump">2,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(3,632)<span></span>
</td>
<td class="num">(1,854)<span></span>
</td>
<td class="num">(6,901)<span></span>
</td>
<td class="num">(2,927)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">3,327<span></span>
</td>
<td class="nump">421<span></span>
</td>
<td class="nump">6,335<span></span>
</td>
<td class="nump">467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized gain (loss) on investments</a></td>
<td class="nump">859<span></span>
</td>
<td class="num">(1,866)<span></span>
</td>
<td class="num">(5,533)<span></span>
</td>
<td class="num">(10,829)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="nump">1,185<span></span>
</td>
<td class="nump">3,034<span></span>
</td>
<td class="nump">2,389<span></span>
</td>
<td class="nump">3,647<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="nump">4,462<span></span>
</td>
<td class="nump">1,247<span></span>
</td>
<td class="nump">1,497<span></span>
</td>
<td class="num">(6,697)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">31,491<span></span>
</td>
<td class="nump">16,629<span></span>
</td>
<td class="nump">50,900<span></span>
</td>
<td class="nump">34,897<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">14,009<span></span>
</td>
<td class="nump">5,352<span></span>
</td>
<td class="nump">20,930<span></span>
</td>
<td class="nump">12,170<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">17,482<span></span>
</td>
<td class="nump">11,277<span></span>
</td>
<td class="nump">29,970<span></span>
</td>
<td class="nump">22,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income (loss) attributable to non-controlling interest</a></td>
<td class="nump">4,312<span></span>
</td>
<td class="num">(673)<span></span>
</td>
<td class="nump">3,668<span></span>
</td>
<td class="num">(2,987)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Apollo Medical Holdings, Inc.</a></td>
<td class="nump">$ 13,170<span></span>
</td>
<td class="nump">$ 11,950<span></span>
</td>
<td class="nump">$ 26,302<span></span>
</td>
<td class="nump">$ 25,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share &#8211; basic (in dollars per share)</a></td>
<td class="nump">$ 0.28<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
<td class="nump">$ 0.57<span></span>
</td>
<td class="nump">$ 0.57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share &#8211; diluted (in dollars per share)</a></td>
<td class="nump">$ 0.28<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ameh_HealthCareCapitationRevenueMember', window );">Capitation, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 300,549<span></span>
</td>
<td class="nump">$ 227,623<span></span>
</td>
<td class="nump">$ 600,753<span></span>
</td>
<td class="nump">$ 449,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember', window );">Risk pool settlements and incentives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">20,121<span></span>
</td>
<td class="nump">18,793<span></span>
</td>
<td class="nump">33,583<span></span>
</td>
<td class="nump">36,868<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ManagementServiceMember', window );">Management fee income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">12,493<span></span>
</td>
<td class="nump">9,984<span></span>
</td>
<td class="nump">22,389<span></span>
</td>
<td class="nump">20,457<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember', window );">Fee-for-service, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">13,262<span></span>
</td>
<td class="nump">11,740<span></span>
</td>
<td class="nump">25,324<span></span>
</td>
<td class="nump">22,835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,784<span></span>
</td>
<td class="nump">$ 1,557<span></span>
</td>
<td class="nump">$ 3,404<span></span>
</td>
<td class="nump">$ 3,112<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ameh_HealthCareCapitationRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ameh_HealthCareCapitationRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ManagementServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ManagementServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699773681344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common&#160;Stock&#160;Outstanding</div></th>
<th class="th"><div>Additional Paid-in&#160;Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Non-controlling Interest</div></th>
<th class="th">
<div>Non-controlling Interest </div>
<div>Mezzanine</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, beginning balance at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net (loss) income (restated)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,252)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Share buy back</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(230)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionOfDividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, ending balance at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,053<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,630,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 454,107<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 310,876<span></span>
</td>
<td class="nump">$ 137,246<span></span>
</td>
<td class="nump">$ 5,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity', window );">Net (loss) income (restated)</a></td>
<td class="nump">14,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,764<span></span>
</td>
<td class="nump">938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of non-controlling interest</a></td>
<td class="num">(200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale of non-controlling interest</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Shares issued for vesting of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants', window );">Shares issued for exercise of options and warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants', window );">Shares issued for exercise of options and warrants</a></td>
<td class="nump">1,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">3,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of shares for business acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of shares for business acquisition</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Cancellation of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,084)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Cancellation of restricted stock awards</a></td>
<td class="num">(457)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(457)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares', window );">Dividends</a></td>
<td class="num">(1,178)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,178)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,845,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance at Mar. 31, 2022</a></td>
<td class="nump">472,638<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">316,047<span></span>
</td>
<td class="nump">151,010<span></span>
</td>
<td class="nump">5,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, beginning balance at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_TemporaryEquityDividendsImpact', window );">Tax impact from dividends</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, ending balance at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,034<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,630,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance at Dec. 31, 2021</a></td>
<td class="nump">454,107<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">310,876<span></span>
</td>
<td class="nump">137,246<span></span>
</td>
<td class="nump">5,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,719,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance at Jun. 30, 2022</a></td>
<td class="nump">479,513<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">310,629<span></span>
</td>
<td class="nump">162,960<span></span>
</td>
<td class="nump">5,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, beginning balance at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net (loss) income (restated)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,019)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionOfDividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, ending balance at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,034<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,845,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance at Mar. 31, 2022</a></td>
<td class="nump">472,638<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">316,047<span></span>
</td>
<td class="nump">151,010<span></span>
</td>
<td class="nump">5,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity', window );">Net (loss) income (restated)</a></td>
<td class="nump">13,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,950<span></span>
</td>
<td class="nump">1,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Shares issued for vesting of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Shares issued for vesting of restricted stock awards</a></td>
<td class="num">(253)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(253)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants', window );">Shares issued for exercise of options and warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants', window );">Shares issued for exercise of options and warrants</a></td>
<td class="nump">165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(250,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Purchase of treasury shares</a></td>
<td class="num">(9,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">3,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Investment in non-controlling interest</a></td>
<td class="nump">371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares', window );">Dividends</a></td>
<td class="num">(1,374)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,374)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,719,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance at Jun. 30, 2022</a></td>
<td class="nump">479,513<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">310,629<span></span>
</td>
<td class="nump">162,960<span></span>
</td>
<td class="nump">5,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, beginning balance at Dec. 31, 2022</a></td>
<td class="nump">14,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net (loss) income (restated)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,729)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_TemporaryEquityTransferOfCommonControlEntities', window );">Transfer of common control entities (restated)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,769<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, ending balance at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,277<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,575,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance at Dec. 31, 2022</a></td>
<td class="nump">544,310<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">360,097<span></span>
</td>
<td class="nump">182,417<span></span>
</td>
<td class="nump">1,749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity', window );">Net (loss) income (restated)</a></td>
<td class="nump">14,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,132<span></span>
</td>
<td class="nump">1,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Shares issued for vesting of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Shares issued for vesting of restricted stock awards</a></td>
<td class="num">(109)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(109)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants', window );">Shares issued for exercise of options and warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants', window );">Shares issued for exercise of options and warrants</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(270,081)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Purchase of treasury shares</a></td>
<td class="num">(9,539)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,539)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">3,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares', window );">Dividends</a></td>
<td class="num">(120)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(120)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_TransferOfCommonControlEntities', window );">Transfer of common control entities (restated)</a></td>
<td class="num">(2,447)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,447)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,488,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance at Mar. 31, 2023</a></td>
<td class="nump">551,007<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">352,697<span></span>
</td>
<td class="nump">195,549<span></span>
</td>
<td class="nump">2,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, beginning balance at Dec. 31, 2022</a></td>
<td class="nump">14,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_TemporaryEquityDividendsImpact', window );">Tax impact from dividends</a></td>
<td class="nump">3,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, ending balance at Jun. 30, 2023</a></td>
<td class="nump">13,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,845<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,575,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 544,310<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">360,097<span></span>
</td>
<td class="nump">182,417<span></span>
</td>
<td class="nump">1,749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury shares (in shares)</a></td>
<td class="num">(270,081)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,553,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance at Jun. 30, 2023</a></td>
<td class="nump">$ 569,753<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">357,246<span></span>
</td>
<td class="nump">208,719<span></span>
</td>
<td class="nump">3,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, beginning balance at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net (loss) income (restated)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionOfDividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(601)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_TemporaryEquityDividendsImpact', window );">Tax impact from dividends</a></td>
<td class="num">(3,076)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, ending balance at Jun. 30, 2023</a></td>
<td class="nump">13,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,845<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, beginning balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,488,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance at Mar. 31, 2023</a></td>
<td class="nump">551,007<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">352,697<span></span>
</td>
<td class="nump">195,549<span></span>
</td>
<td class="nump">2,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity', window );">Net (loss) income (restated)</a></td>
<td class="nump">14,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,170<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of non-controlling interest</a></td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale of non-controlling interest</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Shares issued for vesting of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Shares issued for vesting of restricted stock awards</a></td>
<td class="num">(464)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(464)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">4,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of shares for business acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of shares for business acquisition</a></td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares', window );">Dividends</a></td>
<td class="num">(96)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(96)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,553,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance at Jun. 30, 2023</a></td>
<td class="nump">$ 569,753<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 357,246<span></span>
</td>
<td class="nump">$ 208,719<span></span>
</td>
<td class="nump">$ 3,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Including Portion Attributable To Noncontrolling Interest And Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Value, Release Of Hold Back Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents number of share issued exercise of option and warrants during the period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents value of stock issued during the period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_TemporaryEquityDividendsImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Dividends Impact</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_TemporaryEquityDividendsImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_TemporaryEquityTransferOfCommonControlEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Transfer Of Common Control Entities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_TemporaryEquityTransferOfCommonControlEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_TransferOfCommonControlEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfer of Common Control Entities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_TransferOfCommonControlEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-23<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-23<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-23<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares related to Restricted Stock Award forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity during the period due to unpaid dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699774263840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 29,970<span></span>
</td>
<td class="nump">$ 22,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">8,541<span></span>
</td>
<td class="nump">8,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance cost</a></td>
<td class="nump">474<span></span>
</td>
<td class="nump">474<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">7,658<span></span>
</td>
<td class="nump">6,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Gain on sale of equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,272)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_UnrealizedGainLossFromInvestmentInEquitySecurities', window );">Unrealized loss on investments</a></td>
<td class="nump">5,485<span></span>
</td>
<td class="nump">13,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income from equity method investments</a></td>
<td class="num">(5,207)<span></span>
</td>
<td class="num">(2,945)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized loss (gain) on interest rate swaps</a></td>
<td class="nump">49<span></span>
</td>
<td class="num">(2,830)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred tax</a></td>
<td class="num">(3,746)<span></span>
</td>
<td class="nump">3,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of business combinations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Receivables, net</a></td>
<td class="num">(17,296)<span></span>
</td>
<td class="num">(56,202)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueFromRelatedParties', window );">Receivables, net &#8211; related parties</a></td>
<td class="num">(17,673)<span></span>
</td>
<td class="num">(12,151)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="nump">1,229<span></span>
</td>
<td class="num">(3,580)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(2,277)<span></span>
</td>
<td class="nump">4,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_IncreaseDecreaseInOperatingLeaseAssets', window );">Right-of-use assets</a></td>
<td class="nump">3,240<span></span>
</td>
<td class="nump">2,290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(21)<span></span>
</td>
<td class="nump">1,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(2,864)<span></span>
</td>
<td class="nump">14,181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable', window );">Fiduciary accounts payable</a></td>
<td class="nump">538<span></span>
</td>
<td class="num">(4,464)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_IncreaseDecreaseInMedicalLiabilities', window );">Medical liabilities</a></td>
<td class="nump">13,335<span></span>
</td>
<td class="nump">55,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable/receivable</a></td>
<td class="nump">15,396<span></span>
</td>
<td class="num">(14,010)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(3,309)<span></span>
</td>
<td class="num">(2,254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">370<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">33,522<span></span>
</td>
<td class="nump">33,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for business and asset acquisitions, net of cash acquired</a></td>
<td class="nump">350<span></span>
</td>
<td class="num">(858)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties', window );">Proceeds from repayment of loans receivable &#8211; related parties</a></td>
<td class="nump">2,143<span></span>
</td>
<td class="nump">4,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="num">(2,022)<span></span>
</td>
<td class="num">(1,750)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment', window );">Purchase of investments - privately held</a></td>
<td class="num">(2,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of investments - equity method</a></td>
<td class="num">(325)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(17,367)<span></span>
</td>
<td class="num">(18,845)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sale of marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital', window );">Distribution from investment - equity method</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_PaymentsToEquityMethodInvestments', window );">Contribution to investment - equity method</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,685)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(19,221)<span></span>
</td>
<td class="num">(12,228)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(842)<span></span>
</td>
<td class="num">(12,556)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(312)<span></span>
</td>
<td class="num">(200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations', window );">Payment of finance lease obligations</a></td>
<td class="num">(303)<span></span>
</td>
<td class="num">(283)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from the exercise of stock options and warrants</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">1,738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of shares</a></td>
<td class="num">(9,539)<span></span>
</td>
<td class="num">(9,480)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders', window );">Proceeds from sale of non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_PurchaseOfNonControllingInterest', window );">Purchase of non-controlling interest</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(199)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt', window );">Borrowings on loans</a></td>
<td class="nump">1,734<span></span>
</td>
<td class="nump">1,237<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(8,062)<span></span>
</td>
<td class="num">(19,705)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">6,239<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents beginning of period</a></td>
<td class="nump">288,027<span></span>
</td>
<td class="nump">233,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents end of period</a></td>
<td class="nump">294,266<span></span>
</td>
<td class="nump">234,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplementary disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="nump">7,881<span></span>
</td>
<td class="nump">22,311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">6,264<span></span>
</td>
<td class="nump">2,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosures of non-cash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">701<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Fixed asset obtained in exchange for finance lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common stock issued in business combination</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoanRelatedToPropertySales1', window );">Mortgage loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract', window );"><strong>Reconciliation of cash, cash equivalents, and restricted cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">293,921<span></span>
</td>
<td class="nump">234,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsCurrent', window );">Restricted cash &#8211; current</a></td>
<td class="nump">345<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</a></td>
<td class="nump">$ 294,266<span></span>
</td>
<td class="nump">$ 234,223<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_IncreaseDecreaseInMedicalLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of medical liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_IncreaseDecreaseInMedicalLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_IncreaseDecreaseInOperatingLeaseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents increase in operating lease assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_IncreaseDecreaseInOperatingLeaseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the value of prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_PaymentsToEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_PaymentsToEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_PurchaseOfNonControllingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase of Non-Controlling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_PurchaseOfNonControllingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reconciliation Of Cash Cash Equivalents And Restricted Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_UnrealizedGainLossFromInvestmentInEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrealized (Gain) Loss from Investment in Equity Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_UnrealizedGainLossFromInvestmentInEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoanRelatedToPropertySales1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mortgage loan related to property sales in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoanRelatedToPropertySales1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire securities classified as trading securities and held for investment purposes. Excludes payments for trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with collection, whether partial or full, of long-term loans to a related party. Alternate caption: Proceeds from Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-21D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as current. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480602/954-210-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776253248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of Business</a></td>
<td class="text">Description of Business<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Apollo Medical Holdings, Inc. (&#8220;ApolloMed&#8221;) is a leading physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to participate successfully in value-based care arrangements, thus empowering them to deliver high-quality care to patients in a cost-effective manner. ApolloMed was merged with Network Medical Management (&#8220;NMM&#8221;) in December 2017 (the &#8220;2017 Merger&#8221;). As a result of the 2017 Merger, NMM became a wholly owned subsidiary of ApolloMed, and the former NMM shareholders own a majority of the issued and outstanding common stock of ApolloMed and maintain control of the board of directors. Unless the context dictates otherwise, references in these notes to the financial statements, the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and similar words are references to ApolloMed and its consolidated subsidiaries and affiliated entities, as appropriate, including its consolidated variable interest entities (&#8220;VIEs&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Headquartered in Alhambra, California, ApolloMed&#8217;s subsidiaries and VIEs include management services organizations (&#8220;MSOs&#8221;), affiliated independent practice associations (&#8220;IPAs&#8221;), an accountable care organization (&#8220;ACO&#8221;) participating in the ACO Realizing Equity, Access, and Community Health (&#8220;ACO REACH&#8221;) model, and clinical operations. Together, ApolloMed provides value-based care enablement services and care delivery with our consolidated care partners. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company&#8217;s physician network consists of primary care physicians, specialist physicians, and hospitalists. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable segments changed from one to three in the first quarter of 2023 as a result of certain changes to the information regularly provided to the Company&#8217;s chief operating decision makers (&#8220;CODMs&#8221;) when reviewing the Company&#8217;s performance as well as an effort to provide additional transparency to investors and other financial statement users. The three segments identified by the Company are Care Enablement, Care Partners and Care Delivery, which are described as follows:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Care Enablement</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Enablement segment is an integrated, end-to-end clinical and administrative platform, powered by our proprietary technology suite, which provides operational, clinical, financial, technology, management, and strategic services in order to enable success in the delivery of high-quality, value-based care for providers and payers. We provide solutions to providers, including independent physicians, provider and medical groups, and accountable care organizations, and payers, including health plans and other risk-bearing organizations. Our platform meets providers and payers where they are, with a wide spectrum of solutions across the total cost of care risk spectrum, ranging from solutions for fee-for-service entities to global risk-bearing entities, and across patient types, including Medicare, Medicaid, commercial, and exchange-insured patients. This segment includes our wholly owned subsidiaries which operate as management services organizations, NMM and Apollo Medical Management (&#8220;AMM&#8221;), which enter into long-term management and/or administrative services agreements with providers and payers. By leveraging our care enablement platform, providers and payers can improve their ability to deliver high-quality care to their patients and achieve better patient outcomes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Care Partners</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners with a shared vision for coordinated care delivery. By leveraging our unique care enablement platform and ability to recruit, empower, and incentivize physicians to effectively manage total cost of care, we are able to organize partnered providers into successful multi-payer risk-bearing organizations which take on varying levels of risk based on total cost of care across membership in all lines of business, including Medicare, Medicaid, commercial, and exchange. Through our network of IPAs, ACOs, and Restricted Knox-Keene licensed health plan, our healthcare delivery entities are responsible for coordinating and delivering high-quality care to our patients.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated IPAs consist of the following: (i) Allied Physicians of California, a Professional Medical Corporation d.b.a. Allied Pacific of California IPA (&#8220;APC&#8221;), (ii) Alpha Care Medical Group, Inc. (&#8220;Alpha Care&#8221;), (iii) Accountable Health Care IPA, a Professional Medical Corporation (&#8220;Accountable Health Care&#8221;), (iv) Jade Health Care Medical Group, Inc. (&#8220;Jade&#8221;), (v) Access Primary Care Medical Group (&#8220;APCMG&#8221;), and (vi) All American Medical Group (&#8220;AAMG&#8221;).  The Company&#8217;s ACO operates under the APA ACO, Inc. (&#8220;APAACO&#8221;) brand and participates in the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) program that allows provider groups to assume higher levels of financial risk and potentially achieve a higher reward from participation in the program&#8217;s attribution-based risk-sharing model. The Company&#8217;s Restricted Knox-Keene licensed health plan is held by For Your Benefit Inc. (&#8220;FYB&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Care Delivery</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients. Our care delivery organization includes primary care, multi-specialty care, and ancillary care services. This segment includes our primary care clinics, operating under the AMG, a Professional Medical Corporation (&#8220;AMG&#8221;) and Valley Oaks Medical Group (&#8220;VOMG&#8221;) brands, our multi-specialty care clinics and medical groups, operating under the ApolloMed Hospitalists, a Medical Corporation (&#8220;AMH&#8221;), Southern California Heart Centers, a Medical Corporation (&#8220;SCHC&#8221;), and AllCare Women&#8217;s Health brands, and our ancillary service providers, operating under the 1 World Medicine Urgent Care Corporation (&#8220;1 World&#8221;), DMG, Concourse Diagnostic Surgery Center, LLC (&#8220;CDSC&#8221;), and Sun Clinical Laboratories (&#8220;Sun Labs&#8221;) brands.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2023, AP-AMH 2 purchased 100% of the shares of capital stock of AMG,1 World, and Eleanor Leung M.D., a Professional Medical Corporation from APC-LSMA. As a result of these purchases, these entities are consolidated entities of AP-AMH 2. AMG provides professional and post-acute care services to patients through its network of doctors and nurse practitioners, 1 World is an urgent care center, and Eleanor Leung M.D. provides specialized care for women&#8217;s health operating as AllCare Women&#8217;s Health.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a financing obligation to purchase the remaining equity interest in DMG and Sun Labs within three years from the date the Company consolidated DMG and Sun Labs. The purchase of the remaining DMG equity value is considered a financing obligation with a carrying value of $8.5&#160;million as of June&#160;30, 2023 and December&#160;31, 2022. The purchase of the remaining Sun Labs equity value is considered a financing obligation with a carrying value of $7.6 million and $5.8 million as of June&#160;30, 2023 and December&#160;31, 2022, respectively. For the six months ended June&#160;30, 2023, the change in the fair value of  Sun Labs equity value obligation is $1.8 million and is presented in unrealized loss on investments in the accompanying consolidated statement of income. As the financing obligations are embedded in the non-controlling interest, the non-controlling interests are recognized in other long-term liabilities in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Affiliates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our other affiliates are not included as a reportable segment and primarily consist of real estate operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APC owns a 100% equity interest in each of Medical Property Partners, LLC (&#8220;MPP&#8221;), AMG Properties, LLC (&#8220;AMG Properties&#8221;), ZLL Partners, LLC (&#8220;ZLL&#8221;)&#8221;), Tag-8 Medical Investment Group, LLC (&#8220;Tag 8&#8221;), and Tag-6 Medical Investment Group, LLC (&#8220;Tag 6&#8221;), and a 50% interest in each of One MSO, LLC (&#8220;One MSO&#8221;). These entities are deemed Excluded Assets that are solely for the benefit of APC and its shareholders. As such, any income pertaining to APC&#8217;s interests in these properties has no impact on the Series A Dividend payable by APC to AP-AMH Medical Corporation, and consequently will not affect net income attributable to ApolloMed.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699781507328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated balance sheet at December&#160;31, 2022 has been derived from the Company&#8217;s audited consolidated financial statements, but does not include all annual disclosures required by generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;). The accompanying unaudited consolidated financial statements as of June&#160;30, 2023, and for the three and six months ended June&#160;30, 2023 and 2022, have been prepared in accordance with U.S. GAAP for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, these unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes to the financial statements included in the Company&#8217;s Annual Report on Form 10-K/A for the year ended December&#160;31, 2022, as filed with the SEC on August&#160;9, 2023. In the opinion of management, all material adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been made to make the consolidated financial statements not misleading, as required by Regulation S-X, Rule 10-01. Operating results for the three and six months ended June&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023, or any future periods.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated balance sheets as of June&#160;30, 2023 and December&#160;31, 2022, and the consolidated statements of income for the three and six months ended June&#160;30, 2023 and 2022, include (i) ApolloMed, ApolloMed&#8217;s consolidated subsidiaries, NMM, AMM, APAACO, Orma Health Inc, Provider Growth Solutions, LLC, and FYB and its VIEs, AP-AMH, AP-AMH 2, Sun Labs, DMG, and Valley Oaks Medical Group (&#8220;VOMG&#8221;); (ii) AP-AMH 2&#8217;s consolidated subsidiaries, APCMG, Jade, AAMG, AMG, 1 World, and Eleanor Leung M.D., a Professional Medical Corporation; (iii) AMM&#8217;s consolidated VIEs, SCHC and AMH; (iv) NMM&#8217;s VIE, APC;(v) APC&#8217;s consolidated subsidiaries, Universal Care Acquisition Partners, LLC (&#8220;UCAP&#8221;), MPP, AMG Properties, ZLL, ICC, 120 Hellman LLC (&#8220;120 Hellman&#8221;) and its VIEs, CDSC, APC-LSMA, Tag 8, and Tag 6; and (vi) APC-LSMA&#8217;s consolidated subsidiaries, Alpha Care and Accountable Health Care.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited consolidated interim financial statements have been prepared under the assumption that users of the interim financial data have either read or have access to our audited consolidated financial statements for the fiscal year ended December&#160;31, 2022. Accordingly, certain disclosures that would substantially duplicate the disclosures contained in our December&#160;31, 2022, audited consolidated financial statements have been omitted. These unaudited consolidated interim financial statements should be read in conjunction with our audited consolidated financial statements for the fiscal year ended December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restatement of Previously Issued Financial Statements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed Amendment No. 1 on Form 10-K (&#8220;Form 10-K/A&#8221;)  and Amendment No. 1 on Form 10-Q (&#8220;Form 10-Q/A&#8221;) with the SEC on August&#160;9, 2023 to restate previously issued consolidated financial statements and financial information as of December 31, 2022 and 2021 and for the fiscal years ended December 31, 2022, 2021 and 2020 in the Form 10-K/A and unaudited consolidated financial statements and financial information as of March 31, 2023 and for each of the three months ended March 31, 2023 and 2022 in the Form 10-Q/A. The Form 10-K/A also provided restated interim financial information for the quarterly fiscal 2022 periods.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combination and goodwill valuation and impairment, accrual of medical liabilities (incurred but not reported (&#8220;IBNR&#8221;) claims), determination of full-risk and shared-risk revenue and receivables (including constraints, completion factors and historical margins), income tax-valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, as circumstances indicate the need for reconsideration, the Company evaluates each legal entity that is not wholly owned by the Company in accordance with the consolidation guidance. The evaluation considers all of the Company&#8217;s variable interests, including equity ownership, as well as management services agreements. To fall within the scope of the consolidation guidance, an entity must meet both of the following criteria:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity has a legal structure that has been established to conduct business activities and to hold assets; such entity can be in the form of a partnership, limited liability company, or corporation, among others; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company has a variable interest in the legal entity; i.e., variable interests that are contractual, such as equity ownership, or other financial interests that change with changes in the fair value of the entity&#8217;s net assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity does not meet both criteria above, the Company applies other accounting guidance, such as the cost or equity method of accounting. If an entity does meet both criteria above, the Company evaluates such entity for consolidation under either the variable interest model if the legal entity meets any of the following characteristics to qualify as a VIE, or under the voting model for all other legal entities that are not VIEs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A legal entity is determined to be a VIE if it has any of the following three characteristics:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity does not have sufficient equity to finance its activities without additional subordinated financial support;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity is established with non-substantive voting rights (i.e., where the entity deprives the majority economic interest holder(s) of voting rights); or</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The equity holders, as a group, lack the characteristics of a controlling financial interest. Equity holders meet this criterion if they lack any of the following:</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The power, through voting rights or similar rights, to direct the activities of the entity that most significantly influence the entity&#8217;s economic performance, as evidenced by:</span></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Substantive participating rights in the day-to-day management of the entity&#8217;s activities; or</span></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Substantive kick-out rights over the party responsible for significant decisions;</span></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The obligation to absorb the entity&#8217;s expected losses; or</span></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The right to receive the entity&#8217;s expected residual returns.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company determines that any of the three characteristics of a VIE are met under Accounting Standards Codification (&#8220;ASC&#8221;) 810, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company will conclude that the entity is a VIE and evaluate it for consolidation under the variable interest model.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Model</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company consolidates a VIE if both power and benefits belong to the Company; that is, the Company (i) has the power to direct the activities of a VIE that most significantly influence the VIE&#8217;s economic performance (power), and (ii) has the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE (economics). The Company consolidates VIEs whenever it is determined that the Company is the primary beneficiary. Refer to Note 16 &#8212; &#8220;Variable Interest Entities (VIEs)&#8221; to the consolidated financial statements for information on the Company&#8217;s consolidated VIEs. If there are variable interests in a VIE, but the Company is not the primary beneficiary, the Company may account for the investment using the equity method of accounting.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reportable Segments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the Company operates in three reportable segments: Care Enablement, Care Partners, and Care Delivery. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; and Note 18 &#8212; &#8220;Segments&#8221; to the consolidated financial statements for information on the Company&#8217;s segments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cash and cash equivalents primarily consist of money market funds and certificates of deposit. The Company considers all highly liquid investments that are both readily convertible into known amounts of cash and mature within ninety days from their date of purchase to be cash equivalents.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains its cash in deposit accounts with several banks, which at times may&#160;exceed the insured limits of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). The Company believes it is not exposed to any significant credit risk with respect to its cash and cash equivalents. As of June&#160;30, 2023 and December&#160;31, 2022, the Company&#8217;s deposit accounts with banks exceeded the FDIC&#8217;s insured limit by approximately $326.8 million and $324.7 million, respectively. The Company has not experienced any losses to date and performs ongoing evaluations of these financial institutions to limit the Company&#8217;s concentration of risk exposure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Marketable Securities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in marketable securities consist of equity securities and certificates of deposit with various financial institutions. The appropriate classification of investments is determined at the time of purchase, and such designation is reevaluated at each balance sheet date.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certificates of deposit are reported at par value, plus accrued interest, with maturity dates greater than ninety days. As of June&#160;30, 2023 and December&#160;31, 2022, certificates of deposit amounted to approximately $2.0 million and $0, respectively. Investments in certificates of deposit are classified as Level 1 investments in the fair value hierarchy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities are reported at fair value. These securities are classified as Level 1 in the valuation hierarchy, where quoted market prices from reputable third-party brokers are available in an active market and unadjusted. Equity securities with low trading volume are determined to not have an active market with buyers and sellers ready to trade. Accordingly, we classify such equity securities as Level 2 in the valuation hierarchy, and their valuation is based on weighted average share prices from observable market data.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company are primarily comprised of common stock of a payor partner that completed its initial public offering (&#8220;IPO&#8221;) in June 2021 and Nutex Health Inc. (formerly known as Clinigence Holdings, Inc.) (&#8220;Nutex&#8221;). In May 2022, the Company exercised warrants from Nutex and subsequently recognized the shares within investments in marketable securities in the accompanying consolidated balance sheet. In March 2023, the contingent equity securities were settled and the Company received additional Nutex common stock. The additional common stock received from the contingent equity securities is included in investments in marketable securities in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023 and December&#160;31, 2022, the equity securities were approximately $1.8 million and $5.6&#160;million, respectively, in the accompanying consolidated balance sheets. Gains and losses recognized on equity securities sold are recognized in the accompanying consolidated statements of income under other income. The components comprising total gains and losses on equity securities are as follows (in thousands) for the periods listed below:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Total losses recognized on equity securities  </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,348)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,701)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,886)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Gains recognized on equity securities sold  </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Unrealized losses recognized on equity securities held at end of period  </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,348)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,059)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,701)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,614)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables,  Receivables &#8211; Related Parties, Other Receivables and Loan Receivable - Related Party</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables are comprised of accounts receivable, capitation and claims receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivable are recorded and stated at the amount expected to be collected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables &#8211; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#8211; related parties are recorded and stated at the amount expected to be collected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s loan receivable and loan receivable &#8211; related party consists of promissory notes that accrue interest per annum. As of June&#160;30, 2023, promissory notes are expected to be collected within 12 months.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitation and claims receivables relate to each health plan&#8217;s capitation and are received by the Company in the month following the month of service. Risk pool settlements and incentive receivables mainly consist of the Company&#8217;s full risk pool receivable, which is recorded quarterly based on reports received from the Company&#8217;s hospital partners and management&#8217;s estimate of the Company&#8217;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately 18 months after the risk pool performance year is completed. Other receivables consist of receivables from fee-for-services (&#8220;FFS&#8221;) reimbursement for patient care, certain expense reimbursements, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains reserves for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer creditworthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected and adjustments are recorded when necessary. Reserves are recorded primarily on a specific identification basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided and collection is reasonably likely to occur. In regard to the credit loss standard, the Company continuously monitors its collections of receivables and our expectation is that the historical credit loss experienced across our receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#8220;CECL&#8221;) model. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risks</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disaggregates revenue from contracts by service type and payor type. This level of detail provides useful information pertaining to how the Company generates revenue by significant revenue stream and by type of direct contracts. The consolidated statements of income present disaggregated revenue by service type. The following table presents disaggregated revenue generated by payor type for the three and six months ended June&#160;30, 2023 and 2022 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other third parties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,697&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532,954&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had major payors that contributed the following percentages of net revenue:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payor A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payor B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> *Less than 10% of total net revenues</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had major payors that contributed to the following percentages of receivables and receivables &#8211; related parties:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payor B</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payor C</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements of Financial Instruments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments consist of cash and cash equivalents, fiduciary cash, investment in marketable securities, receivables, loans receivable, accounts payable, certain accrued expenses, finance lease obligations, and long-term debt. The carrying values of the financial instruments classified as current in the accompanying consolidated balance sheets are considered to be at their fair values, due to the short maturity of these instruments. The carrying amounts of finance lease obligations and long-term debt approximate fair value as they bear interest at rates that approximate current market rates for debt with similar maturities and credit quality.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 820&#8221;), applies to all financial assets and financial liabilities that are measured and reported on a fair value basis and requires disclosure that establishes a framework for measuring fair value and expands disclosure about fair value measurements. ASC&#160;820 establishes a fair value hierarchy for disclosure of the inputs to valuations used to measure fair value.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in Level 1, Level 2, or Level 3 classification and no changes in valuation techniques for the six months ended June&#160;30, 2023. This hierarchy prioritizes the inputs into three broad levels as follows:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that can be accessed at the measurement date.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates and yield curves), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Unobservable inputs that reflect assumptions about what market participants would use in pricing the asset or liability. These inputs would be based on the best information available, including the Company&#8217;s own data.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company&#8217;s financial instruments as of June&#160;30, 2023, are presented below (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market accounts*</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate collar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APCMG contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AAMG contingent consideration (see Note 3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VOMG contingent consideration (see Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DMG remaining equity interest purchase (see Note 1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sun labs remaining equity interest purchase (see Note 1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,246&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,246&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Included in cash and cash equivalents</span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company&#8217;s financial instruments as of December&#160;31, 2022, are presented below (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market accounts*</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,164&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,866&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APCMG contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AAMG contingent consideration (see Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VOMG contingent consideration (see Note 3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DMG remaining equity interest purchase (see Note 1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun labs remaining equity interest purchase (see Note 1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,259&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,259&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Included in cash and cash equivalents</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of Level 3 liabilities for the six months ended June&#160;30, 2023 was as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain recognized from change in fair value of existing Level 3 liabilities*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,246&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* The change in the fair value of existing Level 3 liabilities is presented in unrealized loss on investments in the accompanying consolidated statement of income.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Swap and Collar Agreements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to interest rate risk on its floating-rate debt. The Company has entered into interest rate swap and collar agreements to effectively convert its floating-rate debt to a fixed-rate basis or to a rate within the agreed-upon range. The principal objective of these contracts is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#8217;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit&#8221; for further information on our debt. Interest rate swap and collar agreements are not designated as hedging instruments. Changes in the fair value on these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and reflected in the accompanying consolidated statements of cash flows as unrealized gain or loss on interest rate swaps.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the interest rate swap was determined using Level 2 inputs. As of June&#160;30, 2023 and December&#160;31, 2022, the fair value of the interest rate swap was $3.1 million and $3.2&#160;million, respectively, and are presented within other assets in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s collar agreement is designed to limit the interest rate risk associated with the Company&#8217;s Revolver Loan.  Under the terms of the agreement, the ceiling is 5.0% and the floor is 2.34%.  The estimated fair value of the collar is determined using Level 2.  As of June&#160;30, 2023 the fair value of the collar is  $1.2&#160;million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Contingent Equity Securities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the common stock and warrants purchased under the stock purchase agreement between ApolloMed and Nutex, ApolloMed is entitled to additional common stock if Nutex did not pay NMM management fees exceeding a threshold by the end of December 31, 2022. The contingent equity securities are considered to be derivatives but are not designated as hedging instruments. Changes in the fair value of these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and the accompanying consolidated statements of cash flows. The Company determined the fair value of the contingent equity security using a probability-weighted model, which includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of recognizing management fees and assigned probabilities to each such scenario in determining fair value. Based on the outcome, the metric was not achieved and the Company received additional common stock during the six months ended June&#160;30, 2023. As of June&#160;30, 2023, the common stock from the contingent equity securities is recognized within investments in marketable securities in the accompanying consolidated balance sheet. See Note 2 &#8212; &#8220;Basis of Presentation and Summary of Significant Accounting Policies - Investment in Marketable Securities&#8221; in the accompanying consolidated financial statements for information on the treatment of the marketable securities. As of December&#160;31, 2022, the contingent equity securities were valued at $1.9 million, and were presented within prepaid and other current assets in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company receives payments from the following sources for services rendered: (i) commercial insurers; (ii) the federal government under the Medicare program administered by CMS; (iii) state governments under the Medicaid and other programs; (iv) other third-party payors (e.g., hospitals and IPAs); and (v) individual patients and clients.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue primarily consists of capitation revenue, risk pool settlements and incentives, GPDC/ACO REACH revenue, management fee income, and FFS revenue. Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GPDC/ACO REACH Capitation Revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS contracts with Direct Contracting Entities (&#8220;DCEs&#8221;), which are composed of healthcare providers operating under a common legal structure and accept financial accountability for the overall quality and cost of medical care furnished to Medicare FFS beneficiaries aligned to the entity. The combination of the FFS model and the GPDC and ACO REACH model changes the distribution of responsibilities, risks, costs, and rewards among CMS, DCEs, and providers. By entering into a contract with CMS, a DCE voluntarily takes on operational, financial, and legal responsibilities and risks that no party has, individually or collectively, under the existing FFS model. Each DCE bears the economic costs, and reaps the economic rewards of fulfilling its responsibilities and managing its risks as a DCE. APAACO participated in the GPDC Model for Performance Year 2022 and is currently participating in the ACO REACH model for Performance Year 2023, beginning January 1, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each performance year, CMS will pay a total benchmark amount, determined unilaterally by CMS in advance but subject to prospective adjustments throughout the year, for the totality of care provided to the DCE&#8217;s population of aligned beneficiaries over the course of that year. The benchmark is net of a quality withholding applied by CMS. At the end of each performance year, a portion, or all, of the quality withholding can be earned based on APAACO&#8217;s performance. GPDC/ACO REACH capitation revenue is recognized based on the estimated transaction price to transfer the service for a distinct increment of the series (i.e., month) and is recognized net of quality incentives/penalties.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted for both items that do not have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the consolidated financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699778467872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations, Asset Acquisitions, and Goodwill<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations, Asset Acquisitions, and Goodwill</a></td>
<td class="text">Business Combinations, Asset Acquisitions, and Goodwill<div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FYB</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;1, 2023, the Company acquired 100% equity interest in FYB. FYB is licensed by the California Department of Managed Health Care as a full-service Restricted Knox-Keene licensed health plan, which enables FYB to assume full financial responsibility, including both professional and institutional risk, for the medical costs of its members under the Knox-Keene Health Care Service Plan Act of 1975.</span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Chinese Community Health Care Association (&#8220;CCHCA&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;1, 2023, the Company acquired certain healthcare assets from CCHCA. CCHCA is a non-profit independent physician association in the San Francisco Community. The purchase price consists of cash funded on May&#160;1, 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Orma Health</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 27, 2022, the Company acquired 100% of the capital stock of Orma Health, Inc., and Provider Growth Solutions, LLC (together, &#8220;Orma Health&#8221;). The purchase was paid in cash and the Company&#8217;s capital stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Jade Health Care Medical Group, Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(&#8220;Jade&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 19, 2022, the Company acquired 100% of the capital stock of Jade. The purchase was paid in cash. Jade is a primary and specialty care physicians&#8217; group focused on providing high-quality care to its patients in the San Francisco Bay Area in Northern California. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">VOMG</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 14, 2022, VOMG was determined to be a VIE of ApolloMed and is consolidated by the Company. VOMG owns nine primary care clinics in Nevada and Texas. The purchase price consists of cash funded upon the close of transaction and additional cash consideration (&#8220;VOMG contingent consideration&#8221;) contingent on VOMG meeting financial metrics for fiscal years 2023 and 2024. The Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). The contingent consideration is included within other long-term liabilities in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AAMG </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2022, AP-AMH 2, a VIE of the Company, acquired 100% of the equity interest in AAMG. AAMG is an IPA operating in Northern California. The purchase price consists of cash funded upon close of the transaction and additional  consideration (&#8220;AAMG contingent consideration&#8221;) and stock consideration (&#8220;AAMG stock contingent consideration&#8221;) contingent on AAMG meeting revenue and capitated member metrics for fiscal years 2023 and 2024. The Company determined the fair value of the contingent considerations using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of revenue and assigned probabilities to each such scenario in determining fair value. As of June&#160;30, 2023, the contingent consideration is valued at $5.1 million and was included within other long-term liabilities in the accompanying consolidated balance sheets. The stock contingent consideration is valued at $5.6 million and is included in additional paid-in capital in the accompanying consolidated balance sheets. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisitions were accounted for under the acquisition method of accounting. The fair value of the consideration for the acquired companies was allocated to acquired tangible and intangible assets and liabilities based on their fair values. The excess of the purchase consideration over the fair value of the net tangible and identifiable intangible assets acquired was recorded as goodwill. Determining the fair value of assets and liabilities acquired requires the Company to make estimates and use valuation techniques when market value is not readily available. The results of operations from the acquisitions have been included in the Company&#8217;s financial statements from the date of acquisition. Transaction costs associated with business acquisitions are expensed as they are incurred.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time of acquisition, the Company estimates the amount of the identifiable intangible assets based on a valuation and the facts and circumstances available at the time. The Company determines the final value of the identifiable intangible assets as soon as information is available, but not more than one year from the date of acquisition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is not deductible for tax purposes. The Company had no impairment of its goodwill or indefinite-lived intangible assets during the six months ended June&#160;30, 2023 and 2022. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the carrying value of goodwill for the six months ended June&#160;30, 2023 was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2023  (restated)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,029&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699782419504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text">Intangible Assets, Net<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2023, the Company&#8217;s intangible assets, net, consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Useful</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Life</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net June 30,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite lived assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortized intangible assets:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Network relationships</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11-21</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100,244)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,982)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Member relationships</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-14</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient management platform</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tradename/trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,316&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124,895)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,421&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the Company&#8217;s intangible assets, net, consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Useful</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Life</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite lived assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Network relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11-21</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,208)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient management platform</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tradename/trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,472&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,611)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,861&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2023 and 2022, the Company recognized amortization expense of $3.3 million and $3.5 million, respectively, in depreciation and amortization on the accompanying consolidated statements of operations.  For the six months ended June&#160;30, 2023 and 2022, the Company recognized amortization expense of  $6.3 million and $7.2 million, respectively, in depreciation and amortization on the accompanying consolidated statements of operations. The Company determined that there was no impairment of its finite-lived intangible or long-lived assets during the during the six months ended June&#160;30, 2023 and 2022. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future amortization expense is estimated to be as follows for the following years ending December&#160;31 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (excluding the six months ended June 30, 2023)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,271&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776397728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Other Entities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodAndOtherEquityInvestmentsTextBlock', window );">Investments in Other Entities</a></td>
<td class="text">Investments in Other Entities<div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Equity Method</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2023 and 2022, the Company&#8217;s equity method investment balance consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:19.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.745%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Initial Investment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allocation of Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distribution </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James Song, M.D., A Professional Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,207&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,831&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:20.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.421%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.910%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allocation of Net Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding Reclassified To Loan Receivable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distribution</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tag-6 Medical Investment Group, LLC*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,685&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,820&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Investment is deemed Excluded Assets that are solely for the benefit of APC and its shareholders. </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2023 and 2022, the Company&#8217;s equity method investment balance consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:19.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Initial Investment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allocation of Net Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distribution</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James Song, M.D., A Professional Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,108&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,723&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,831&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:19.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.503%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.945%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.240%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allocation of Net Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding Reclassified To Loan Receivable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distribution</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tag-6 Medical Investment Group, LLC*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,383&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,820&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Investment is deemed Excluded Assets that are solely for the benefit of APC and its shareholders. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">James Song, M.D., A Professional Corporation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, AP-AMH 2 purchased a 25% interest in James Song, M.D., a Professional Corporation (&#8220;Song PC&#8221;), a medical corporation located in Hacienda Heights, California. AP-AMH 2 accounts for its investment in Song PC under the equity method of accounting as AP-AMH 2 has the ability to exercise significant influence, but not control over Song PC&#8217;s operations. For the three months ended June&#160;30, 2023, AP-AMH 2 recognized income of $58,000 in the accompanying consolidated statements of income. For the six months ended June&#160;30, 2023, AP-AMH 2 recognized income of $95,000 in the accompanying consolidated statements of operations. The accompanying consolidated balance sheets include the related investment balances of $0.4 million as of June&#160;30, 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There was no impairment loss recorded related to equity method investments for the six months ended June&#160;30, 2023 and 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_EquityMethodAndOtherEquityInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method And Other Equity Investments [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_EquityMethodAndOtherEquityInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699782419504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loan Receivable and Loan Receivable &#8211; Related Parties<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_LoanReceivableTextBlock', window );">Loan Receivable and Loan Receivable &#8211; Related Parties</a></td>
<td class="text">Loan Receivable and Loan Receivable &#8211; Related Parties<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan receivable</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pacific6</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, NMM received a promissory note from 6 Founder LLC, a California limited liability company doing business as Pacific6 Enterprises totaling $0.5&#160;million as a result of the sale of the Company&#8217;s interest in an equity method investment. Interest accrues at a rate of 5% per annum and is payable monthly through the maturity date of December 1, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the outstanding loan receivable under the CECL model by assessing the party&#8217;s ability to pay by reviewing their interest payment history quarterly, financial history annually, and reassessing any identified insolvency risk. If a failure to pay occurs, the Company assesses the terms of the notes and estimates an expected credit loss based on the remittance schedule of the note</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> related party</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LaSalle Medical Associates Loan (&#8220;LMA Loan&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LaSalle Medical Associates (&#8220;LMA&#8221;) issued a promissory note to APC-LSMA for a principal amount of $2.1 million with an August 2023 maturity date. The contractual interest rate on the LMA Loan is 1.0% above the prime rate of interest for commercial customers. In March 2023, LMA paid off the full balance of the promissory note and all interest. APC&#8217;s investment in LMA is accounted for under the equity method based on the 25% equity ownership interest held by APC-LSMA in LMA&#8217;s IPA line of business (see Note 5 &#8212; &#8220;Investments in Other Entities &#8212; Equity Method&#8221;)..</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_LoanReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loan Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_LoanReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776230256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Expenses</a></td>
<td class="text">Accounts Payable and Accrued Expenses<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounts payable and accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other accruals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitation payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subcontractor IPA payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to related parties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other provider payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,904&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,562&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699898538544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock', window );">Medical Liabilities</a></td>
<td class="text">Medical Liabilities<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s medical liabilities consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical liabilities, beginning of period (restated)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,255&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired (see Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of medical care costs related to claims incurred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,066)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(950)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical care costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429,377&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for medical care costs related to claims incurred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(336,231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204,032)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,978)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(417,396)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(258,010)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical liabilities, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,499&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//944-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776280976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Credit Facility, Bank Loans, and Lines of Credit</a></td>
<td class="text">Credit Facility, Bank Loans, and Lines of Credit<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facility</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s debt balance consists of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate Loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promissory Note Payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,611&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,327&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,319)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,136&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,389&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our long-term debt was determined using Level 2 inputs primarily related to comparable market prices. As of June&#160;30, 2023 and December&#160;31, 2022, the carrying value was not materially different from fair value, as the interest rates on the Company&#8217;s debt approximated rates currently available to the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the future commitments of the Company&#8217;s debt for the years ending December 31 (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (excluding the six months ended June 30, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,611&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amended Credit Agreement</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement provides for a five-year revolving credit facility to the Company of $400.0 million, which includes a letter of credit sub-facility of up to $25.0 million and a swingline loan sub-facility of $25.0 million, which expires on June&#160;16, 2026. The Company is required to pay an annual agent fee of $50,000 and an annual facility fee of 0.175% to 0.350% on the available commitments under the Amended Credit Agreement, regardless of usage, with the applicable fee determined on a quarterly basis based on the Company&#8217;s leverage ratio. The Company will pay fees for standby letters of credit at an annual rate equal to 1.25% to 2.50%, as determined on a quarterly basis based on the Company&#8217;s leverage ratio, plus facing fees and standard fees payable to the issuing bank on the respective letter of credit. The Company is also required to pay customary fees between the Company and Truist Bank, the lead arranger of the Amended Credit Agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amended Credit Agreement, the debt bears interest at an annual rate equal to either, at the Company&#8217;s option, (a) the Term SOFR Reference Rate, calculated two U.S. Government Securities Business Days prior to the first day of such interest period, as such rate is published by the Term SOFR Administrator (Federal Reserve Bank of New York), adjusted for any Term SOFR Adjustment, plus a spread of from 1.25% to 2.50%, as determined on a quarterly basis based on the Company&#8217;s leverage ratio, or (b) a base rate, plus a spread of 0.25% to 1.50%, as determined on a quarterly basis based on the Company&#8217;s leverage ratio.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the interest rate on the Credit Agreement was 6.68%. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement requires the Company to comply with two key financial ratios, each calculated on a consolidated basis. The Company must maintain a maximum consolidated total net leverage ratio of not greater than 3.75 to 1.00 as of the last day of each fiscal quarter, provided that for any fiscal quarter during which the Company or certain subsidiaries consummate a permitted acquisition or investment, the aggregate purchase price is greater than $75.0&#160;million, the maximum consolidated total net leverage ratio may temporarily increase by 0.25 to 1.00 to 4.00 to 1.00. The Company must maintain a minimum consolidated interest coverage ratio of not less than 3.25 to 1.00 as of the last day of each fiscal quarter. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Financing Costs</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, the Company recorded deferred financing costs of $6.5 million related to its entry into the Credit Facility. In June 2021, the Company recorded additional deferred financing costs of $0.7&#160;million related to its entry into the Amended Credit Facility. Deferred financing costs are recorded as a direct reduction of the carrying amount of the related debt liability using straight-line amortization. The remaining unamortized deferred financing costs related to the Credit Facility and the new costs related to the Amended Credit Facility are amortized over the life of the Amended Credit Facility. At June&#160;30, 2023 and December&#160;31, 2022, the unamortized deferred financing cost was $2.8&#160;million and $3.3&#160;million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Real Estate Loans</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MPP</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 3, 2020, MPP entered into a loan agreement with East West Bank with a maturity date of August 5, 2030. As of June&#160;30, 2023, the principal on the loan was $5.8 million with a variable interest rate of 0.50% less than the independent index, which is the daily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Prime Rate.&#8221; If the index is unavailable, East West Bank may designate a substitute index after notifying MPP. Monthly payments on the principal and any accrued interest rate not yet paid began in September 2020. MPP must maintain a Debt Coverage Ratio (defined as net operating income divided by current portion of long-term debt, plus interest expense) of not less than 1.25 to 1. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AMG Properties</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 5, 2020, AMG Properties entered into a loan agreement with East West Bank with a maturity date of August 5, 2030. As of June&#160;30, 2023, the principal on the loan was $0.6 million with a variable interest rate of 0.30% less than the independent index, which is the daily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Prime Rate.&#8221; If the index is unavailable, East West Bank may designate a substitute index after notifying AMG Properties. Monthly payments on the principal and any accrued interest rate not yet paid began in September 2020. AMG Properties must maintain a Debt Coverage Ratio (defined as net operating income divided by current portion of long-term debt, plus interest expense) of not less than 1.25 to 1.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ZLL</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 27, 2020, ZLL entered into a loan agreement with East West Bank with a maturity date of August 5, 2030. As of June&#160;30, 2023, the principal on the loan was $0.6 million with a variable interest rate of 0.50% less than the independent index, which is the daily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Prime Rate.&#8221; If the index is unavailable, East West Bank may designate a substitute index after notifying ZLL. Monthly payments on the principal and any accrued interest rate not yet paid began in September 2020. ZLL must maintain a Debt Coverage Ratio (defined as net operating income divided by current portion of long-term debt, plus interest expense) of not less than 1.25 to 1.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">120 Hellman LLC </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;25, 2022, 120 Hellman LLC (&#8220;120 Hellman&#8221;), a subsidiary of APC, entered into a loan agreement with MUFG Union Bank N.A. with the principal on the loan of $16.3 million and a maturity date of March&#160;1, 2032. The loan was used to purchase property in Monterey Park, California. As of June&#160;30, 2023, the principal on the loan was $15.8 million. The variable interest rate is 2.0% in excess of Daily Simple SOFR, which is the daily rate per annum equal to the secured overnight financing rate as administered by the Federal Reserve Bank of New York. If the index is unavailable, MUFG Union Bank N.A. may designate a substitute index after notifying 120 Hellman. Monthly payments on the principal and interest began on April 1, 2022. Should interest not be paid when due, it shall become part of the principal and bear interest. 120 Hellman must maintain a Cash Flow to Debt Service ratio (defined as net profit after taxes, to which depreciation, amortization and other non-cash items are added and divided by the current portion of long-term debt and capital leases) of not less than 1.25 to 1 and 35% or more of the property must also be occupied by APC. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Construction Loans</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, Tag 8 entered into a construction loan agreement with MUFG Union Bank N.A. (&#8220;Construction Loan&#8221;). Tag 8 is a VIE consolidated by the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Construction Loan allows Tag 8 to borrow up to $10.7 million. In December 2022, the Construction loan was amended to extend the maturity date to March&#160;1, 2024 (&#8220;Construction Loan Term&#8221;). If construction is completed and there are no events of default or substantial deterioration in the financial condition of Tag 8 or APC, guarantor on the loan agreement, at the maturity date of the Construction Loan Term, the loan shall convert to an amortizing loan with an amended extended maturity date of March&#160;1, 2034 (&#8220;Permanent Loan Term&#8221;). Under the amended Construction Loan, upon conversion to the Permanent Loan Term, monthly principal and interest payments shall be made beginning April&#160;1, 2024. The principal balance will bear interest at the SOFR reference rate. As of June&#160;30, 2023, the likelihood of the construction being completed by the maturity date is probable. The loan balance as of June&#160;30, 2023 was $5.7 million and was recorded as long-term debt, net of current portion and deferred financing costs in the accompanying consolidated balance sheets. Once the loan converts to the Permanent Loan Term, APC, as Tag 8&#8217;s guarantor, must maintain a Cash Flow Coverage Ratio (defined as consolidated EBITDA minus unfinanced capital expenditures and distributions paid divided by the sum of current portion of long-term debt, plus interest expense) of not less than 1.25 to 1.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Promissory Note Payable</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, FYB entered into a promissory note agreement with CCHCA. The principal on the promissory note is $2.0&#160;million, with a maturity date of May&#160;9, 2024. The interest rate is the prime rate plus 1.0%. The prime rate is updated annually on the effective date of the note and published by the Wall Street Journal.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effective Interest Rate</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s average effective interest rate on its total debt during the six months ended June&#160;30, 2023 and 2022, was 5.93% and 2.16%, respectively. Interest expense in the consolidated statements of operations included amortization of deferred debt issuance costs for the three months ended June&#160;30, 2023 and 2022, of $0.2 million and $0.2 million, respectively, and for the  six months ended June&#160;30, 2023 and 2022, of $0.5 million and $0.5 million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lines of Credit</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">APC Business Loan</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;10, 2019, the APC Business Loan Agreement with Preferred Bank (the &#8220;APC Business Loan Agreement&#8221;) was amended to, among other things, decrease loan availability to $4.1 million, limit the purpose of the indebtedness under the APC Business Loan Agreement to the issuance of standby letters of credit, and include as a permitted lien, the security interest in all of its assets that APC granted to NMM under a Security Agreement dated on or about September 11, 2019, securing APC&#8217;s obligations to NMM under their management services agreement dated as of July 1, 1999, as amended.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standby Letters of Credit</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company established irrevocable standby letters of credit with Truist Bank under the Amended Credit Agreement for a total of $21.1 million for the benefit of CMS. Unless the institution provides notification that the standby letters of credit will be terminated prior to the expiration date, the letters will be automatically extended without amendment for additional one-year periods from the present, or any future expiration date.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APC established irrevocable standby letters of credit with Preferred Bank under the APC Business Loan Agreement for a total of $0.1 million for the benefit of certain health plans. The standby letters of credit are automatically extended without amendment for additional one-year periods from the present or any future expiration date, unless notified by the institution in advance of the expiration date that the letter will be terminated.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alpha Care established irrevocable standby letters of credit with Preferred Bank under the APC Business Loan Agreement for a total of $3.8 million for the benefit of certain health plans. The standby letters of credit are automatically extended without amendment for additional one-year periods from the present or any future expiration date, unless notified by the institution in advance of the expiration date that the letter will be terminated.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699781076048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mezzanine and Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Mezzanine and Stockholders' Equity</a></td>
<td class="text">Mezzanine and Stockholders&#8217; Equity<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Mezzanine Equity</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">APC</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the redemption feature of the APC shares is not solely within the control of APC, the equity of APC does not qualify as permanent equity and has been classified as non-controlling interests in APC as mezzanine or temporary equity. APC&#8217;s shares were not redeemable, and it was not probable that the shares would become redeemable as of June&#160;30, 2023 and December&#160;31, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Stockholders&#8217; Equity</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, 140,954 holdback shares have not been issued to certain former NMM shareholders who were NMM shareholders at the time of closing of the 2017 Merger, as they have yet to submit properly completed letters of transmittal to ApolloMed in order to receive their pro rata portion of ApolloMed common stock and warrants as contemplated under the 2017 merger agreement. Pending such receipt, such former NMM shareholders have the right to receive, without interest, their pro rata share of dividends or distributions with a record date after the effectiveness of the 2017 Merger. The consolidated financial statements have treated such shares of common stock as outstanding, given the receipt of the letter of transmittal is considered perfunctory and the Company is legally obligated to issue these shares in connection with the 2017 Merger.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APC owned 10,299,259 and 10,299,259 shares of ApolloMed&#8217;s common stock, respectively, as of June&#160;30, 2023 and December&#160;31, 2022. While such shares of ApolloMed&#8217;s common stock are legally issued and outstanding, they are treated as treasury shares for accounting purposes and excluded from shares of common stock outstanding in the consolidated financial statements. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023 the Company bought back 270,081 of its common stock. These are included as treasury stock. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023 and December&#160;31, 2022, the total treasury stock was 10,569,340 and 10,299,259, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, APC paid dividends of $0 and $10.0&#160;million, respectively. During the six months ended June&#160;30, 2023 and 2022, APC paid dividends of $0 and $10.0 million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, CDSC paid dividends of $0 and $1.5&#160;million, respectively. During the six months ended June&#160;30, 2023 and 2022, CDSC paid dividends of $0 and $2.9&#160;million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776144000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based CompensationThe following table summarizes the stock-based compensation expense recognized under all of the Company&#8217;s stock plans for the three and six months ended June&#160;30, 2023 and 2022, and associated with the issuance of restricted shares of common stock and vesting of stock options that are included in general and administrative expenses in the accompanying consolidated statements of income (in thousands):<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422000</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,213&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,658&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,975&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized compensation expense related to total share-based payments outstanding as of June&#160;30, 2023 was $37.7 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s outstanding stock options consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.917%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aggregate<br/>Intrinsic<br/>Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options outstanding at January&#160;1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options exercised</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options forfeited</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at June 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at June 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,118&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.77&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023, options were exercised for 125,000 shares of the Company&#8217;s common stock, resulting in proceeds of $1.3 million. During the six months ended June&#160;30, 2022, options were exercised for 38,500 shares of the Company&#8217;s common stock, resulting in proceeds of $0.7 million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants restricted stock to officers and employees, which are earned based on service conditions. The grant date fair value of the restricted stock is that day&#8217;s closing market price of the Company&#8217;s common stock. During the six months ended June&#160;30, 2023, the Company granted 279,501 shares of restricted stock with performance based conditions and 359,527 shares of restricted stock without performance based conditions. During the six months ended June&#160;30, 2023, the weighted average grant date fair value of restricted stock with and without performance based conditions was $32.95 and 33.15, respectively. As of June&#160;30, 2023, unvested restricted stock awards, including performance based restricted stock awards totaled 1.3 million shares. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All warrants issued by the Company have expired as of December 31, 2022. As a result, there are no outstanding warrants as of June&#160;30, 2023 and December&#160;31, 2022. During the six months ended June&#160;30, 2022, common stock warrants were exercised for 101,953 shares of the Company&#8217;s common stock, which resulted in proceeds of approximately $1.1 million. The exercise price ranged from $10.00 to $11.00 per share for the exercises during the six months ended June&#160;30, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699767882064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Matters</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laws and regulations governing the Medicare program and healthcare generally are complex and subject to interpretation. The Company believes it complies with all applicable laws and regulations and is unaware of any pending or threatened investigations involving allegations of potential wrongdoing. While no regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action, including fines, penalties, and exclusion from the Medicare and Medi-Cal programs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a risk-bearing organization, the Company is required to follow regulations of the Department of Managed Health Care (&#8220;DMHC&#8221;). The Company must comply with a minimum working capital requirement, tangible net equity (&#8220;TNE&#8221;) requirement, cash-to-claims ratio, and claims payment requirements prescribed by the DMHC. TNE is defined as net assets less intangibles, less non-allowable assets (which include amounts due from affiliates), plus subordinated obligations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the Company&#8217;s payor and provider contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of medical services. Such differing interpretations may not come to light until a substantial period of time has passed following contract implementation. Liabilities for claims disputes are recorded when the loss is probable and can be estimated. Any adjustments to reserves are reflected in current operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standby Letters of Credit</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company established irrevocable standby letters of credit with Truist Bank for a total of $21.1 million for the benefit of CMS (see Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit &#8212; Standby Letters of Credit&#8221;). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APC and Alpha Care established irrevocable standby letters of credit with a Preferred Bank for a total of $0.1 million and $3.8&#160;million, respectively, for the benefit of certain health plans (see Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit &#8212; Standby Letters of Credit&#8221;). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is involved in various legal proceedings and other matters arising in the normal course of its business. The resolution of any claim or litigation is subject to inherent uncertainty and could have a material adverse effect on the Company&#8217;s financial condition, cash flows, or results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liability Insurance</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that its insurance coverage is appropriate based upon the Company&#8217;s claims experience and the nature and risks of the Company&#8217;s business. In addition to the known incidents that have resulted in the assertion of claims, the Company cannot be certain that its insurance coverage will be adequate to cover liabilities arising out of claims asserted against the Company, the Company&#8217;s affiliated professional organizations or the Company&#8217;s affiliated hospitalists in the future where the outcomes of such claims are unfavorable. The Company believes that the ultimate resolution of all pending claims, including liabilities in excess of the Company&#8217;s insurance coverage, will not have a material adverse effect on the Company&#8217;s financial position, results of operations, or cash flows; however, there can be no assurance that future claims will not have such a material adverse effect on the Company&#8217;s business. Contracted physicians are required to obtain their own insurance coverage.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company currently maintains liability insurance policies on a claims-made basis, which are intended to cover malpractice liability and certain other claims, the coverage must be renewed annually, and may&#160;not continue to be available to the Company in future years at acceptable costs, and on favorable terms.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699781076048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Transactions<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related-Party Transactions</a></td>
<td class="text">Related-Party Transactions<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, NMM recognized approximately $6.9 million and $4.8 million, respectively in management fees from LMA. During the six months ended June&#160;30, 2023 and 2022, NMM recognized approximately $11.9 million and $11.1 million, respectively. LMA is  accounted for under the equity method based on the 25% equity ownership interest held by APC in LMA&#8217;s IPA line of business (see Note 5 &#8212; &#8220;Investments in Other Entities - Equity Method&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, NMM recognized approximately $0.5 million and $0.4 million, respectively in management fees from Arroyo Vista Family Health Center (&#8220;Arroyo Vista&#8221;). During the six months ended June&#160;30, 2023 and 2022, NMM recognized approximately $1.0 million and $0.9 million, respectively. During the three months ended June&#160;30, 2023 and 2022, the Company paid approximately $0.1 million and $0.1 million, respectively, to Arroyo Vista for services as a provider. During the six months ended June&#160;30, 2023 and 2022, the Company paid approximately $0.2 million and $0.1 million, respectively. Arroyo Vista&#8217;s chief executive officer is a member of the Company&#8217;s board of directors. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APC and PMIOC have an Ancillary Service Contract together whereby PMIOC provides covered services on behalf of APC to enrollees of the plans of APC. During the three months ended June&#160;30, 2023 and 2022, APC paid approximately $0.5 million and $0.7 million, respectively, to PMIOC for provider services. During the six months ended June&#160;30, 2023 and 2022, APC paid approximately $1.1 million and $1.4 million, respectively. PMIOC is accounted for under the equity method based on the 40% equity ownership interest held by APC (see Note 5 &#8212; &#8220;Investments in Other Entities &#8212; Equity Method&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2023, the Company paid approximately $0.4 million to Song PC for provider services. As of January 2023, Song PC is accounted for under the equity method accounting as AP-AMH 2 has the ability to exercise significant influence, but not control over Song PC&#8217;s operations (see Note 5 &#8212; &#8220;Investments in Other Entities &#8212; Equity Method&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, APC paid approximately $0.1 million and $0.1 million, respectively, to Advanced Diagnostic Surgery Center for services as a provider. During the six months ended June&#160;30, 2023 and 2022, APC paid approximately $0.1 million and $0.1 million, respectively. During the three months ended June&#160;30, 2023 and 2022, Advanced Diagnostic and Surgical Center paid approximately $0.2 million and $0.1 million, respectively, to MPP for rent. During the six months ended June&#160;30, 2023 and 2022, rent to MPP was approximately $0.3 million and $0.3 million, respectively. Advanced Diagnostic Surgery Center shares common ownership with certain board members of ApolloMed and APC.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, APC paid approximately $1,000 and $0.2 million, respectively, to Fulgent Genetics, Inc. for services as a provider. During the six months ended June&#160;30, 2023 and 2022, APC paid approximately $10,000 and $0.3 million, respectively. One of the Company&#8217;s board members is a board member of Fulgent Genetics, Inc.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, the Company paid approximately $0.6 million and $0.1 million, respectively, to Sunny Village Care Center for services as a provider. During the six months ended June&#160;30, 2023 and 2022, the Company paid approximately $0.8 million and $1.0 million, respectively. During the three and six months ended June&#160;30, 2023, Sunny Village Care Center paid approximately $0.3 million and $0.5 million, respectively, to Tag 6 for rent. Tag 6 was consolidated by APC in August 2022. Sunny Village Care Center shares common ownership with certain ApolloMed officers and board members of ApolloMed and APC.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023, ApolloMed paid $9.5 million to purchase ApolloMed&#8217;s stock from a board member. During the six months ended June&#160;30, 2022, APC paid $9.3 million, respectively, to purchase ApolloMed&#8217;s stock from a board member.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, NMM paid approximately $0.4 million and $0.4 million, respectively, to One MSO for an office lease. During the six months ended June&#160;30, 2023 and 2022, NMM paid approximately $0.7 million and $0.7 million, respectively. One MSO is accounted for under the equity method based on 50% equity ownership interest held by APC (see Note 5 &#8212; &#8220;Investments in Other Entities &#8212; Equity Method&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with Health Source MSO Inc., a California corporation (&#8220;HSMSO&#8221;), Aurion Corporation (&#8220;Aurion&#8221;), and AHMC for services provided to the Company. One of the Company&#8217;s board members is an officer of AHMC, HSMSO, and Aurion. Aurion is also partially owned by one of the Company&#8217;s board members. The following table sets forth fees incurred and income recognized related to AHMC, HSMSO, and Aurion (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:29.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.764%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AHMC &#8211; Risk pool, capitation, claims payment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,658&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HSMSO &#8211; Management fees, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(649)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aurion &#8211; Management fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,695&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,907&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and AHMC have a risk-sharing agreement with certain AHMC hospitals to share the surplus and deficits of each of the hospital pools. Under this agreement, during the three months ended June&#160;30, 2023 and 2022, the Company has recognized risk pool revenue of $15.8 million and $13.3 million, respectfully. During the six months ended June&#160;30, 2023 and 2022, the Company has recognized risk pool revenue of  $28.8 million and $25.3 million, respectfully. The Company has a risk pool receivable balance of $73.2 million and $58.7 million as of June&#160;30, 2023 and December&#160;31, 2022, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, APC paid an aggregate of approximately $9.5 million and $12.3 million, respectively, to board members for provider services which included approximately $1.2 million and $3.3 million, respectively, to APC board members who are also officers of APC. During the six months ended June&#160;30, 2023 and 2022, APC paid an aggregate of approximately $18.8 million and $21.6 million, respectively, to board members for provider services which included approximately $2.6 million and $5.2 million, respectively, to board members who are also officers of APC. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, affiliates wholly owned by the Company&#8217;s officers, including Dr. Thomas Lam, ApolloMed&#8217;s Co-CEO and President, are reported in the accompanying consolidated statements of operations on a consolidated basis, together with the Company&#8217;s subsidiaries, and therefore, the Company does not separately disclose transactions between such affiliates and the Company&#8217;s subsidiaries as related-party transactions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For equity method investments and loans receivable from related parties, see Note 5 &#8212; &#8220;Investment in Other Entities &#8212; Equity Method&#8221; and Note 6 &#8212; &#8220;Loan Receivable and Loan Receivable &#8212; Related Parties,&#8221; respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776144000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the liability method of accounting for income taxes as set forth in ASC 740</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under the liability method, deferred taxes are determined based on differences between the financial statement and tax bases of assets and liabilities using enacted tax rates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an interim basis, the Company estimates what its anticipated annual effective tax rate will be and records a quarterly income tax provision in accordance with the estimated annual rate, plus the tax effect of certain discrete items that arise during the quarter. As the fiscal year progresses, the Company refines its estimates based on actual events and financial results during the quarter. This process can result in significant changes to the Company&#8217;s estimated effective tax rate. When this occurs, the income tax provision is adjusted during the quarter in which the estimates are refined so that the year-to-date provision reflects the estimated annual effective tax rate. These changes, along with adjustments to the Company&#8217;s deferred taxes and related valuation allowance, may create fluctuations in the overall effective tax rate from quarter to quarter.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, due to the overall cumulative losses incurred in recent years, the Company maintained a full valuation allowance against its deferred tax assets related to loss entities the Company cannot consolidate under the federal tax consolidation rules, as realization of these assets is uncertain.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective income tax rate for the six months ended June&#160;30, 2023 and 2022, was 41.1% and 34.9%, respectively. The tax rate for the six months ended June&#160;30, 2023, differed from the U.S. federal statutory rate primarily due to state income taxes, tax on dividend distributions and income from flow-through entities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the Company does not have any unrecognized tax benefits related to various federal and state income tax matters. The Company will recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense.</span></div>The Company is subject to U.S. federal income tax as well as income tax in California. The Company and its subsidiaries&#8217; state and federal income tax returns are open to audit under the statute of limitations for the years ended December 31, 2019 through December&#160;31, 2022, and for the years ended December 31, 2018 through December&#160;31, 2022, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776316288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated using the weighted average number of shares of the Company&#8217;s common stock issued and outstanding during a certain period, and is calculated by dividing net income attributable to ApolloMed by the weighted average number of shares of the Company&#8217;s common stock issued and outstanding during such period. Diluted earnings per share is calculated using the weighted average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period, using the as-if converted method for secured convertible notes, preferred stock, and the treasury stock method for options and common stock warrants.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023 and December&#160;31, 2022, APC held 10,299,259 and 10,299,259 shares of ApolloMed&#8217;s common stock, respectively, which are treated as treasury shares for accounting purposes and not included in the number of shares of common stock outstanding used to calculate earnings per share. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2023 and 2022, restricted stock of  238,096 and 394,606, respectively, were excluded from the computation of diluted weighted average common shares outstanding because the assumed proceeds, as calculated under the treasury stock method, resulted in these awards being antidilutive. For the six months ended June&#160;30, 2023 and 2022, restricted stock of  246,431 and 257,193 were excluded from the computation of diluted weighted average common shares outstanding for being antidilutive.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended June&#160;30, 2023, 838,628 of contingently issuable shares were excluded from the computation of diluted weighted average common shares outstanding because these conditions were not achieved as of June&#160;30, 2023. For the three and six months ended June&#160;30, 2022, 242,899 of contingently issuable shares were excluded from the computation of diluted weighted average common shares outstanding because these conditions were not achieved as of June&#160;30, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the earnings per share computations:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share &#8211; basic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share &#8211; diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding &#8211; basic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,482,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,858,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding &#8211; diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,778,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,023,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share &#8211; basic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share &#8211; diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding &#8211; basic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,517,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,815,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding &#8211; diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,844,044&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,082,643&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the shares included in the diluted earnings per share computations:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding &#8211; basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,482,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,858,657&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding &#8211; diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,778,299&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,023,015&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding &#8211; basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,517,108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,815,307&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding &#8211; diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,844,044&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,082,643&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776292064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities (VIEs)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable Interest Entities (VIEs)</a></td>
<td class="text">Variable Interest Entities (VIEs)<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A VIE is defined as a legal entity whose equity owners do not have sufficient equity at risk, or, as a group, the holders of the equity investment at risk lack any of the following three characteristics: decision-making rights, the obligation to absorb losses, or the right to receive the expected residual returns of the entity. The primary beneficiary is identified as the variable interest holder that has both the power to direct the activities of the VIE that most significantly affect the entity&#8217;s economic performance and the obligation to absorb expected losses or the right to receive benefits from the entity that could potentially be significant to the VIE.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows guidance on the consolidation of VIEs that requires companies to utilize a qualitative approach to determine whether it is the primary beneficiary of a VIE. See Note 2 &#8212; &#8220;Basis of Presentation and Summary of Significant Accounting Policies &#8212; Variable Interest Entities&#8221; to the accompanying consolidated financial statements for information on how the Company determines VIEs and their treatment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes assets that can only be used to settle the liabilities of APC and its consolidated entities and VIEs, including Alpha Care and Accountable Health Care, and to which the creditors of ApolloMed have no recourse, and liabilities to which the creditors of APC, including Alpha Care and Accountable Health Care, have no recourse to the general credit of ApolloMed, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of the investment in a privately held entity that does not report net asset value per share and amounts due to affiliates, which are eliminated upon consolidation with NMM, are included in the accompanying consolidated balance sheets (in thousands). The assets and liabilities of the Company&#8217;s other consolidated VIEs were not considered significant. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net &#8211; related party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan receivable &#8211; related party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount due from affiliates*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current assets</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, property, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in affiliates*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in other entities &#8211; equity method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in privately held entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total assets</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiduciary accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount due to affiliates*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion and deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total liabilities</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,773&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Investment in affiliates includes APC&#8217;s investment in ApolloMed, which is reflected as treasury shares and eliminated upon consolidation. Amount due from affiliates are receivables with ApolloMed&#8217;s subsidiaries and consolidated VIEs. Amount due to affiliates are payables with ApolloMed&#8217;s subsidiaries and consolidated VIEs. As a result, these balances are eliminated upon consolidation and are not reflected on ApolloMed&#8217;s consolidated balance sheets as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2023 and December&#160;31, 2022.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776411056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating and finance leases for corporate offices, physicians&#8217; offices, and certain equipment. These leases have remaining lease terms of two months to fifteen years. Some of the leases may include options to extend the lease terms for up to ten years, and some of the leases may include options to terminate the leases within one year. As of June&#160;30, 2023 and December&#160;31, 2022, assets recorded under finance leases were $1.6 million and $1.8 million, respectively, and accumulated depreciation associated with finance leases were $1.3 million and $1.0 million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, the Company rents or subleases certain real estate to third parties, which are accounted for as operating leases.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases with an initial term of 12 months or less are not recorded on the balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.551%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of lease expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,735&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(499)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.77 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.12 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.11 years</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are future minimum lease payments under non-cancellable leases for the years ending December 31 (in thousands) below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance Leases</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (excluding the six months ended June 30, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease payments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,879&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: current portion</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term lease liabilities</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the Company does not have additional operating and finance leases that have not yet commenced.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating and finance leases for corporate offices, physicians&#8217; offices, and certain equipment. These leases have remaining lease terms of two months to fifteen years. Some of the leases may include options to extend the lease terms for up to ten years, and some of the leases may include options to terminate the leases within one year. As of June&#160;30, 2023 and December&#160;31, 2022, assets recorded under finance leases were $1.6 million and $1.8 million, respectively, and accumulated depreciation associated with finance leases were $1.3 million and $1.0 million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, the Company rents or subleases certain real estate to third parties, which are accounted for as operating leases.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases with an initial term of 12 months or less are not recorded on the balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.551%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of lease expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,735&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(499)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.77 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.12 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.11 years</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are future minimum lease payments under non-cancellable leases for the years ending December 31 (in thousands) below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance Leases</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (excluding the six months ended June 30, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease payments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,879&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: current portion</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term lease liabilities</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the Company does not have additional operating and finance leases that have not yet commenced.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776235744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments</a></td>
<td class="text">Segments<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its operating segments in accordance with ASC 280, &#8220;Segment Reporting&#8221; (&#8220;ASC 280&#8221;). The Company currently has three reportable segments consisting of: 1) Care Enablement; 2) Care Partners; and 3) Care Delivery (See Note 1 &#8211; Description of Business). The Company&#8217;s reportable segments changed from one to three in the first quarter of 2023 as a result of certain changes to the information regularly provided to the Company&#8217;s chief operating decision makers (&#8220;CODMs&#8221;) when reviewing the Company&#8217;s performance as well as an effort to provide additional transparency to investors and other financial statement users which the Company believes will assist in the evaluation of changes in the operating results of the Company&#8217;s segments separate from non-operational factors that affect net income, thus providing insight into both operations and other factors impacting reported results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the performance of its operating segments based on segment revenue growth as well as operating income.  Management uses revenue growth and total segment operating income as a measure of the performance of operating businesses separate from non-operating factors. The Company&#8217;s operations are based in the United States. All revenues of the Company are derived from the United States. Our segments are not evaluated using asset information.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Enablement segment is an integrated, end-to-end clinical and administrative platform powered by our proprietary technology suite, which provides operational, clinical, financial, technology, management, and strategic services to enable success in the delivering of high-quality, value-based care for providers and payers. Revenue for this segment is primarily comprised of management and software fees, charged as a percentage of gross revenue or on a per-member-per-month basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners with a shared vision for coordinated care delivery. Under relevant accounting guidance, while our IPAs and ACO are two operating segments, they share similar economic characteristics and meet other criteria which permit us to aggregate them into a single reportable segment, which we have done. Revenue for this segment is primarily comprised of capitation and risk pool settlements and incentives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients. Our care delivery organization includes primary care, multi-specialty care, and ancillary care services. Revenue is primarily earned based on fee-for-service reimbursements, capitation, and performance-based incentives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other is not a reportable segment and primarily consists of real estate operations and other entities that are individually immaterial. Revenue is primarily comprised of equipment sales and real estate revenue is presented in other income.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, our reportable segments enter into transactions with each other. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues recognized by a segment and expenses incurred by the counterparty are eliminated in consolidation and do not affect consolidated results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate costs are unallocated and primarily include corporate initiatives, corporate infrastructure costs and corporate shared costs, such as finance, human resources, legal, and executives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about our segments and prior periods have been recast to conform to the current presentation (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,603&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,887)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,887)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,998)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,933)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39,931)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321,180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,212)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269,697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,781)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,781)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269,697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,690)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(896)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,967&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,586)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,949&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,805&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,526)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,382&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">636,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">685,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,486)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,541&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">639,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,486)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">685,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">578,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,967)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">589,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(74,693)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,621&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">636,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(397)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,319)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,621)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,912&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,621)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">488,588&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,621)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">532,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,515)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,279&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">463,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,902)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491,360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,669&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,355&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,475&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,203)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,594&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Balance includes general and administrative expenses and depreciation and amortization. </span></div>(2) Income from operations for the intersegment elimination represents rental income from segments renting from other segments. Rental income is presented within other income which is not presented in the table.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776194112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Texas Independent Providers, LLC</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 12, 2023, the Company entered into a definitive agreement to acquire assets relating to Texas Independent Providers, LLC (&#8220;TIP&#8221;). Through its coordinated network of over 120 primary care providers, TIP provides high-quality primary care services to over 4,500 Medicare Advantage patients in communities throughout Harris County, home to Houston, the largest city in Texas and the fourth-largest city in the United States. The Company anticipates closing this transaction in the third quarter of 2023 and will fund the transaction with cash on hand.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IntraCare Convertible Promissory Note Receivable</span></div>On July 27, 2023, the Company entered into a five-year convertible promissory note with IntraCare as the borrower. The principal on the note is $25.0 million with interest on the outstanding principal amount and unpaid interest at a rate per annum equal to 8.81%, compounded annually. In the event that the convertible promissory note remains outstanding on or after maturity date of July 27, 2028, then the outstanding principal balance and any unpaid accrued interest shall, upon the election of the Company, convert into shares.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699775574576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 13,170<span></span>
</td>
<td class="nump">$ 11,950<span></span>
</td>
<td class="nump">$ 26,302<span></span>
</td>
<td class="nump">$ 25,714<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699780995888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699774185936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of PresentationThe accompanying consolidated balance sheet at December&#160;31, 2022 has been derived from the Company&#8217;s audited consolidated financial statements, but does not include all annual disclosures required by generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;). The accompanying unaudited consolidated financial statements as of June&#160;30, 2023, and for the three and six months ended June&#160;30, 2023 and 2022, have been prepared in accordance with U.S. GAAP for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, these unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes to the financial statements included in the Company&#8217;s Annual Report on Form 10-K/A for the year ended December&#160;31, 2022, as filed with the SEC on August&#160;9, 2023. In the opinion of management, all material adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been made to make the consolidated financial statements not misleading, as required by Regulation S-X, Rule 10-01.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated balance sheets as of June&#160;30, 2023 and December&#160;31, 2022, and the consolidated statements of income for the three and six months ended June&#160;30, 2023 and 2022, include (i) ApolloMed, ApolloMed&#8217;s consolidated subsidiaries, NMM, AMM, APAACO, Orma Health Inc, Provider Growth Solutions, LLC, and FYB and its VIEs, AP-AMH, AP-AMH 2, Sun Labs, DMG, and Valley Oaks Medical Group (&#8220;VOMG&#8221;); (ii) AP-AMH 2&#8217;s consolidated subsidiaries, APCMG, Jade, AAMG, AMG, 1 World, and Eleanor Leung M.D., a Professional Medical Corporation; (iii) AMM&#8217;s consolidated VIEs, SCHC and AMH; (iv) NMM&#8217;s VIE, APC;(v) APC&#8217;s consolidated subsidiaries, Universal Care Acquisition Partners, LLC (&#8220;UCAP&#8221;), MPP, AMG Properties, ZLL, ICC, 120 Hellman LLC (&#8220;120 Hellman&#8221;) and its VIEs, CDSC, APC-LSMA, Tag 8, and Tag 6; and (vi) APC-LSMA&#8217;s consolidated subsidiaries, Alpha Care and Accountable Health Care.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited consolidated interim financial statements have been prepared under the assumption that users of the interim financial data have either read or have access to our audited consolidated financial statements for the fiscal year ended December&#160;31, 2022. Accordingly, certain disclosures that would substantially duplicate the disclosures contained in our December&#160;31, 2022, audited consolidated financial statements have been omitted. These unaudited consolidated interim financial statements should be read in conjunction with our audited consolidated financial statements for the fiscal year ended December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of EstimatesThe preparation of the consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combination and goodwill valuation and impairment, accrual of medical liabilities (incurred but not reported (&#8220;IBNR&#8221;) claims), determination of full-risk and shared-risk revenue and receivables (including constraints, completion factors and historical margins), income tax-valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, as circumstances indicate the need for reconsideration, the Company evaluates each legal entity that is not wholly owned by the Company in accordance with the consolidation guidance. The evaluation considers all of the Company&#8217;s variable interests, including equity ownership, as well as management services agreements. To fall within the scope of the consolidation guidance, an entity must meet both of the following criteria:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity has a legal structure that has been established to conduct business activities and to hold assets; such entity can be in the form of a partnership, limited liability company, or corporation, among others; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company has a variable interest in the legal entity; i.e., variable interests that are contractual, such as equity ownership, or other financial interests that change with changes in the fair value of the entity&#8217;s net assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity does not meet both criteria above, the Company applies other accounting guidance, such as the cost or equity method of accounting. If an entity does meet both criteria above, the Company evaluates such entity for consolidation under either the variable interest model if the legal entity meets any of the following characteristics to qualify as a VIE, or under the voting model for all other legal entities that are not VIEs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A legal entity is determined to be a VIE if it has any of the following three characteristics:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity does not have sufficient equity to finance its activities without additional subordinated financial support;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity is established with non-substantive voting rights (i.e., where the entity deprives the majority economic interest holder(s) of voting rights); or</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The equity holders, as a group, lack the characteristics of a controlling financial interest. Equity holders meet this criterion if they lack any of the following:</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The power, through voting rights or similar rights, to direct the activities of the entity that most significantly influence the entity&#8217;s economic performance, as evidenced by:</span></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Substantive participating rights in the day-to-day management of the entity&#8217;s activities; or</span></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Substantive kick-out rights over the party responsible for significant decisions;</span></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The obligation to absorb the entity&#8217;s expected losses; or</span></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The right to receive the entity&#8217;s expected residual returns.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company determines that any of the three characteristics of a VIE are met under Accounting Standards Codification (&#8220;ASC&#8221;) 810, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company will conclude that the entity is a VIE and evaluate it for consolidation under the variable interest model.</span></div>Variable Interest ModelIf an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company consolidates a VIE if both power and benefits belong to the Company; that is, the Company (i) has the power to direct the activities of a VIE that most significantly influence the VIE&#8217;s economic performance (power), and (ii) has the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE (economics). The Company consolidates VIEs whenever it is determined that the Company is the primary beneficiary. Refer to Note 16 &#8212; &#8220;Variable Interest Entities (VIEs)&#8221; to the consolidated financial statements for information on the Company&#8217;s consolidated VIEs. If there are variable interests in a VIE, but the Company is not the primary beneficiary, the Company may account for the investment using the equity method of accounting.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text">Business CombinationsThe Company uses the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Reportable Segments</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reportable Segments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the Company operates in three reportable segments: Care Enablement, Care Partners, and Care Delivery. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; and Note 18 &#8212; &#8220;Segments&#8221; to the consolidated financial statements for information on the Company&#8217;s segments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cash and cash equivalents primarily consist of money market funds and certificates of deposit. The Company considers all highly liquid investments that are both readily convertible into known amounts of cash and mature within ninety days from their date of purchase to be cash equivalents.</span></div>The Company maintains its cash in deposit accounts with several banks, which at times may&#160;exceed the insured limits of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). The Company believes it is not exposed to any significant credit risk with respect to its cash and cash equivalents.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Investments in Marketable Securities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Marketable Securities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in marketable securities consist of equity securities and certificates of deposit with various financial institutions. The appropriate classification of investments is determined at the time of purchase, and such designation is reevaluated at each balance sheet date.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certificates of deposit are reported at par value, plus accrued interest, with maturity dates greater than ninety days. As of June&#160;30, 2023 and December&#160;31, 2022, certificates of deposit amounted to approximately $2.0 million and $0, respectively. Investments in certificates of deposit are classified as Level 1 investments in the fair value hierarchy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities are reported at fair value. These securities are classified as Level 1 in the valuation hierarchy, where quoted market prices from reputable third-party brokers are available in an active market and unadjusted. Equity securities with low trading volume are determined to not have an active market with buyers and sellers ready to trade. Accordingly, we classify such equity securities as Level 2 in the valuation hierarchy, and their valuation is based on weighted average share prices from observable market data.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock', window );">Receivables, Receivables &#8211; Related Parties, Other Receivables and Loan Receivable - Related Party</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables,  Receivables &#8211; Related Parties, Other Receivables and Loan Receivable - Related Party</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables are comprised of accounts receivable, capitation and claims receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivable are recorded and stated at the amount expected to be collected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables &#8211; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#8211; related parties are recorded and stated at the amount expected to be collected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s loan receivable and loan receivable &#8211; related party consists of promissory notes that accrue interest per annum. As of June&#160;30, 2023, promissory notes are expected to be collected within 12 months.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitation and claims receivables relate to each health plan&#8217;s capitation and are received by the Company in the month following the month of service. Risk pool settlements and incentive receivables mainly consist of the Company&#8217;s full risk pool receivable, which is recorded quarterly based on reports received from the Company&#8217;s hospital partners and management&#8217;s estimate of the Company&#8217;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately 18 months after the risk pool performance year is completed. Other receivables consist of receivables from fee-for-services (&#8220;FFS&#8221;) reimbursement for patient care, certain expense reimbursements, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains reserves for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer creditworthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected and adjustments are recorded when necessary. Reserves are recorded primarily on a specific identification basis.</span></div>Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided and collection is reasonably likely to occur. In regard to the credit loss standard, the Company continuously monitors its collections of receivables and our expectation is that the historical credit loss experienced across our receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#8220;CECL&#8221;) model.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risks</a></td>
<td class="text">Concentrations of Credit RisksThe Company disaggregates revenue from contracts by service type and payor type. This level of detail provides useful information pertaining to how the Company generates revenue by significant revenue stream and by type of direct contracts. The consolidated statements of income present disaggregated revenue by service type.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Measurements of Financial Instruments</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements of Financial Instruments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments consist of cash and cash equivalents, fiduciary cash, investment in marketable securities, receivables, loans receivable, accounts payable, certain accrued expenses, finance lease obligations, and long-term debt. The carrying values of the financial instruments classified as current in the accompanying consolidated balance sheets are considered to be at their fair values, due to the short maturity of these instruments. The carrying amounts of finance lease obligations and long-term debt approximate fair value as they bear interest at rates that approximate current market rates for debt with similar maturities and credit quality.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 820&#8221;), applies to all financial assets and financial liabilities that are measured and reported on a fair value basis and requires disclosure that establishes a framework for measuring fair value and expands disclosure about fair value measurements. ASC&#160;820 establishes a fair value hierarchy for disclosure of the inputs to valuations used to measure fair value.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in Level 1, Level 2, or Level 3 classification and no changes in valuation techniques for the six months ended June&#160;30, 2023. This hierarchy prioritizes the inputs into three broad levels as follows:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that can be accessed at the measurement date.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates and yield curves), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Unobservable inputs that reflect assumptions about what market participants would use in pricing the asset or liability. These inputs would be based on the best information available, including the Company&#8217;s own data.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Swap and Collar Agreements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to interest rate risk on its floating-rate debt. The Company has entered into interest rate swap and collar agreements to effectively convert its floating-rate debt to a fixed-rate basis or to a rate within the agreed-upon range. The principal objective of these contracts is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#8217;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit&#8221; for further information on our debt. Interest rate swap and collar agreements are not designated as hedging instruments. Changes in the fair value on these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and reflected in the accompanying consolidated statements of cash flows as unrealized gain or loss on interest rate swaps.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the interest rate swap was determined using Level 2 inputs. As of June&#160;30, 2023 and December&#160;31, 2022, the fair value of the interest rate swap was $3.1 million and $3.2&#160;million, respectively, and are presented within other assets in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s collar agreement is designed to limit the interest rate risk associated with the Company&#8217;s Revolver Loan.  Under the terms of the agreement, the ceiling is 5.0% and the floor is 2.34%.  The estimated fair value of the collar is determined using Level 2.  As of June&#160;30, 2023 the fair value of the collar is  $1.2&#160;million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Contingent Equity Securities</span></div>In addition to the common stock and warrants purchased under the stock purchase agreement between ApolloMed and Nutex, ApolloMed is entitled to additional common stock if Nutex did not pay NMM management fees exceeding a threshold by the end of December 31, 2022. The contingent equity securities are considered to be derivatives but are not designated as hedging instruments. Changes in the fair value of these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and the accompanying consolidated statements of cash flows. The Company determined the fair value of the contingent equity security using a probability-weighted model, which includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of recognizing management fees and assigned probabilities to each such scenario in determining fair value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company receives payments from the following sources for services rendered: (i) commercial insurers; (ii) the federal government under the Medicare program administered by CMS; (iii) state governments under the Medicaid and other programs; (iv) other third-party payors (e.g., hospitals and IPAs); and (v) individual patients and clients.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue primarily consists of capitation revenue, risk pool settlements and incentives, GPDC/ACO REACH revenue, management fee income, and FFS revenue. Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GPDC/ACO REACH Capitation Revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS contracts with Direct Contracting Entities (&#8220;DCEs&#8221;), which are composed of healthcare providers operating under a common legal structure and accept financial accountability for the overall quality and cost of medical care furnished to Medicare FFS beneficiaries aligned to the entity. The combination of the FFS model and the GPDC and ACO REACH model changes the distribution of responsibilities, risks, costs, and rewards among CMS, DCEs, and providers. By entering into a contract with CMS, a DCE voluntarily takes on operational, financial, and legal responsibilities and risks that no party has, individually or collectively, under the existing FFS model. Each DCE bears the economic costs, and reaps the economic rewards of fulfilling its responsibilities and managing its risks as a DCE. APAACO participated in the GPDC Model for Performance Year 2022 and is currently participating in the ACO REACH model for Performance Year 2023, beginning January 1, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each performance year, CMS will pay a total benchmark amount, determined unilaterally by CMS in advance but subject to prospective adjustments throughout the year, for the totality of care provided to the DCE&#8217;s population of aligned beneficiaries over the course of that year. The benchmark is net of a quality withholding applied by CMS. At the end of each performance year, a portion, or all, of the quality withholding can be earned based on APAACO&#8217;s performance. GPDC/ACO REACH capitation revenue is recognized based on the estimated transaction price to transfer the service for a distinct increment of the series (i.e., month) and is recognized net of quality incentives/penalties.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted for both items that do not have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the consolidated financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Receivables and receivables from related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-2AA<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699772473264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Schedule of Gain (Loss) on Securities</a></td>
<td class="text">The components comprising total gains and losses on equity securities are as follows (in thousands) for the periods listed below:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Total losses recognized on equity securities  </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,348)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,701)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,886)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Gains recognized on equity securities sold  </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Unrealized losses recognized on equity securities held at end of period  </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,348)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,059)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,701)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,614)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregated Revenue by Each Payor Type</a></td>
<td class="text">The following table presents disaggregated revenue generated by payor type for the three and six months ended June&#160;30, 2023 and 2022 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other third parties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,697&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532,954&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Schedule of Contributions to Revenue and Receivables by Payor</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had major payors that contributed the following percentages of net revenue:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payor A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payor B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> *Less than 10% of total net revenues</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had major payors that contributed to the following percentages of receivables and receivables &#8211; related parties:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payor B</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payor C</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Carrying Amounts and Fair Values of Financial Instruments</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company&#8217;s financial instruments as of June&#160;30, 2023, are presented below (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market accounts*</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate collar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APCMG contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AAMG contingent consideration (see Note 3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VOMG contingent consideration (see Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DMG remaining equity interest purchase (see Note 1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sun labs remaining equity interest purchase (see Note 1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,246&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,246&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Included in cash and cash equivalents</span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company&#8217;s financial instruments as of December&#160;31, 2022, are presented below (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market accounts*</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,164&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,866&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APCMG contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AAMG contingent consideration (see Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VOMG contingent consideration (see Note 3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DMG remaining equity interest purchase (see Note 1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun labs remaining equity interest purchase (see Note 1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,259&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,259&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Included in cash and cash equivalents</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of Level 3 liabilities for the six months ended June&#160;30, 2023 was as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain recognized from change in fair value of existing Level 3 liabilities*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,246&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* The change in the fair value of existing Level 3 liabilities is presented in unrealized loss on investments in the accompanying consolidated statement of income.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2C<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2C<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized and unrealized gain (loss) on investment in security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776330176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations, Asset Acquisitions, and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Change in Carrying Value of Goodwill</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the carrying value of goodwill for the six months ended June&#160;30, 2023 was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2023  (restated)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,029&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699775600704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets, Net</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2023, the Company&#8217;s intangible assets, net, consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Useful</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Life</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net June 30,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite lived assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortized intangible assets:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Network relationships</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11-21</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100,244)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,982)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Member relationships</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-14</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient management platform</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tradename/trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,316&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124,895)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,421&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the Company&#8217;s intangible assets, net, consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Useful</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Life</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite lived assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Network relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11-21</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,208)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient management platform</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tradename/trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,472&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,611)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,861&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Future Amortization Expense</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future amortization expense is estimated to be as follows for the following years ending December&#160;31 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (excluding the six months ended June 30, 2023)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,271&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699781071056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Other Entities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Equity Method Investments</a></td>
<td class="text">For the six months ended June&#160;30, 2023 and 2022, the Company&#8217;s equity method investment balance consisted of the following (in thousands):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:19.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.745%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Initial Investment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allocation of Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distribution </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James Song, M.D., A Professional Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,207&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,831&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:20.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.421%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.910%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allocation of Net Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding Reclassified To Loan Receivable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distribution</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tag-6 Medical Investment Group, LLC*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,685&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,820&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Investment is deemed Excluded Assets that are solely for the benefit of APC and its shareholders. </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2023 and 2022, the Company&#8217;s equity method investment balance consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:19.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Initial Investment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allocation of Net Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distribution</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James Song, M.D., A Professional Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,108&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,723&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,831&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:19.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.503%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.945%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.240%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allocation of Net Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding Reclassified To Loan Receivable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distribution</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tag-6 Medical Investment Group, LLC*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,383&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,820&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table>* Investment is deemed Excluded Assets that are solely for the benefit of APC and its shareholders.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699775970688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Expenses</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounts payable and accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other accruals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitation payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subcontractor IPA payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to related parties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other provider payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,904&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,562&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776448272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of Medical Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s medical liabilities consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical liabilities, beginning of period (restated)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,255&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired (see Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of medical care costs related to claims incurred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,066)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(950)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical care costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429,377&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for medical care costs related to claims incurred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(336,231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204,032)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,978)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(417,396)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(258,010)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical liabilities, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,499&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699777429328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Credit Facility</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s debt balance consists of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate Loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promissory Note Payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,611&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,327&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,319)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,136&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,389&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Future Commitments of Credit Facility</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the future commitments of the Company&#8217;s debt for the years ending December 31 (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (excluding the six months ended June 30, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,611&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699777445376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-Based Compensation Expense</a></td>
<td class="text">The following table summarizes the stock-based compensation expense recognized under all of the Company&#8217;s stock plans for the three and six months ended June&#160;30, 2023 and 2022, and associated with the issuance of restricted shares of common stock and vesting of stock options that are included in general and administrative expenses in the accompanying consolidated statements of income (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422000</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,213&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,658&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,975&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Transactions Under Stock Option Plans</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s outstanding stock options consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.917%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aggregate<br/>Intrinsic<br/>Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options outstanding at January&#160;1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options exercised</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options forfeited</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at June 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at June 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,118&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.77&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699781517440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Fees Incurred and Revenue Earned from Related Party Transactions</a></td>
<td class="text">The following table sets forth fees incurred and income recognized related to AHMC, HSMSO, and Aurion (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:29.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.764%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AHMC &#8211; Risk pool, capitation, claims payment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,658&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HSMSO &#8211; Management fees, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(649)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aurion &#8211; Management fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,695&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,907&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776285232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share Computations</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the earnings per share computations:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share &#8211; basic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share &#8211; diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding &#8211; basic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,482,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,858,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding &#8211; diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,778,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,023,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share &#8211; basic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share &#8211; diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding &#8211; basic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,517,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,815,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding &#8211; diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,844,044&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,082,643&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Shares Included in the Diluted Earnings Per Share Computations</a></td>
<td class="text">Below is a summary of the shares included in the diluted earnings per share computations:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding &#8211; basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,482,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,858,657&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding &#8211; diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,778,299&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,023,015&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding &#8211; basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,517,108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,815,307&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding &#8211; diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,844,044&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,082,643&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776480400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities (VIEs) (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Assets and Liabilities, Variable Interest Entities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes assets that can only be used to settle the liabilities of APC and its consolidated entities and VIEs, including Alpha Care and Accountable Health Care, and to which the creditors of ApolloMed have no recourse, and liabilities to which the creditors of APC, including Alpha Care and Accountable Health Care, have no recourse to the general credit of ApolloMed, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of the investment in a privately held entity that does not report net asset value per share and amounts due to affiliates, which are eliminated upon consolidation with NMM, are included in the accompanying consolidated balance sheets (in thousands). The assets and liabilities of the Company&#8217;s other consolidated VIEs were not considered significant. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net &#8211; related party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Restated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan receivable &#8211; related party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount due from affiliates*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current assets</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, property, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in affiliates*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in other entities &#8211; equity method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in privately held entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total assets</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiduciary accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount due to affiliates*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion and deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total liabilities</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,773&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Investment in affiliates includes APC&#8217;s investment in ApolloMed, which is reflected as treasury shares and eliminated upon consolidation. Amount due from affiliates are receivables with ApolloMed&#8217;s subsidiaries and consolidated VIEs. Amount due to affiliates are payables with ApolloMed&#8217;s subsidiaries and consolidated VIEs. As a result, these balances are eliminated upon consolidation and are not reflected on ApolloMed&#8217;s consolidated balance sheets as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2023 and December&#160;31, 2022.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-9<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699775571712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Information Related to Lease Costs</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.551%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of lease expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,735&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(499)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.77 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.12 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.11 years</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Operating Lease Payments After Adoption of 842</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are future minimum lease payments under non-cancellable leases for the years ending December 31 (in thousands) below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance Leases</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (excluding the six months ended June 30, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease payments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,879&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: current portion</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term lease liabilities</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Finance Lease Payments After Adoption of 842</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are future minimum lease payments under non-cancellable leases for the years ending December 31 (in thousands) below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance Leases</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (excluding the six months ended June 30, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease payments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,879&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: current portion</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term lease liabilities</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776480400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Information about our Segments</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about our segments and prior periods have been recast to conform to the current presentation (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,603&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,887)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,887)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,998)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,933)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39,931)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321,180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,212)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269,697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,781)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,781)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269,697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,690)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(896)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,967&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,586)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,949&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,805&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,526)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,382&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">636,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">685,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,486)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,541&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">639,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,486)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">685,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">578,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,967)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">589,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(74,693)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,621&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">636,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(397)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,319)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,621)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,912&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,621)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">488,588&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,621)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">532,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,515)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,279&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">463,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,902)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491,360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,669&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,355&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,475&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,203)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,594&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Balance includes general and administrative expenses and depreciation and amortization. </span></div>(2) Income from operations for the intersegment elimination represents rental income from segments renting from other segments. Rental income is presented within other income which is not presented in the table.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699777212352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th"><div>Feb. 23, 2023</div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in other entities &#8211; equity method</a></td>
<td class="nump">$ 43,108<span></span>
</td>
<td class="nump">$ 45,831<span></span>
</td>
<td class="nump">$ 40,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,820<span></span>
</td>
<td class="nump">$ 44,383<span></span>
</td>
<td class="nump">$ 41,715<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_DmgMember', window );">DMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in other entities &#8211; equity method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_DMGAndSunLabsMember', window );">DMG And Sun Labs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase', window );">Equity interest purchase obligation, period to purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember', window );">Allied Pacific Of California IPA | MPP, AMG Properties, and ZLL Asset Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_AssetAcquisitionPercentageOfSharesAcquired', window );">Asset acquisition, percentage of shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember', window );">Allied Pacific Of California IPA | One MSO, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_AssetAcquisitionPercentageOfSharesAcquired', window );">Asset acquisition, percentage of shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ameh_AmgIncMember', window );">AMG, Inc | APC LSMA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ameh_ApolloSunLabsManagementLLCMember', window );">Apollo-Sun Labs Management, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Equity interest purchase obligation, noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,600<span></span>
</td>
<td class="nump">$ 5,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation', window );">Change in fair value of equity interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_AssetAcquisitionPercentageOfSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Percentage Of Shares Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_AssetAcquisitionPercentageOfSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Change in Fair Value Of Equity Interest Purchase Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Equity Interest Purchase Obligation, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Equity Interest Purchase Obligation, Period to Purchase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_DescriptionOfBusinessLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_DescriptionOfBusinessLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_DmgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_DmgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_DMGAndSunLabsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_DMGAndSunLabsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ameh_OneMSOLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ameh_OneMSOLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ameh_AmgIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ameh_AmgIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_ApcLsmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_ApcLsmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ameh_ApolloSunLabsManagementLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ameh_ApolloSunLabsManagementLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699777318288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Amount deposit accounts exceeded FDIC insured limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 326,800<span></span>
</td>
<td class="nump">$ 324,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,767<span></span>
</td>
<td class="nump">5,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod', window );">Promissory notes expected to be collected within period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear', window );">Risk pool surplus or deficits, settlement period after risk pool performance year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ameh_CollarMember', window );">Interest rate collar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DerivativeCeilingInterestRate', window );">Derivative, ceiling interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFloorInterestRate', window );">Derivative, floor interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.34%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ameh_ContingentEquitySecuritiesMember', window );">Contingent equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Contingent equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedges: | Interest rate swap | Other Noncurrent Assets | Derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_MarketableSecuritiesCurrentMaturityPeriod', window );">Short-term marketable securities, maturity period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_DerivativeCeilingInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Ceiling Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_DerivativeCeilingInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_MarketableSecuritiesCurrentMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Current, Maturity Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_MarketableSecuritiesCurrentMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Promissory Notes Expected To Be Collected Within Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risk Pool Surplus Or Deficits, Settlement Period After Performance Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFloorInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Floor rate on an interest rate derivative such as an interest rate floor or collar. If market rates falls below the floor rate, a payment or receipt is triggered on the contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFloorInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ameh_CollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ameh_CollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ameh_ContingentEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ameh_ContingentEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699774187696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Gain (Loss) on Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Total losses recognized on equity securities</a></td>
<td class="num">$ (1,348)<span></span>
</td>
<td class="num">$ (4,331)<span></span>
</td>
<td class="num">$ (5,701)<span></span>
</td>
<td class="num">$ (14,886)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Gains recognized on equity securities sold</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,272<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized losses recognized on equity securities held at end of period</a></td>
<td class="num">$ (1,348)<span></span>
</td>
<td class="num">$ (2,059)<span></span>
</td>
<td class="num">$ (5,701)<span></span>
</td>
<td class="num">$ (12,614)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699773285200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Each Payor Type (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 348,209<span></span>
</td>
<td class="nump">$ 269,697<span></span>
</td>
<td class="nump">$ 685,453<span></span>
</td>
<td class="nump">$ 532,954<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=ameh_CommercialMember', window );">Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">38,907<span></span>
</td>
<td class="nump">42,014<span></span>
</td>
<td class="nump">78,926<span></span>
</td>
<td class="nump">84,167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=ameh_MedicareMember', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">222,159<span></span>
</td>
<td class="nump">142,641<span></span>
</td>
<td class="nump">438,469<span></span>
</td>
<td class="nump">276,299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=ameh_MedicaidMember', window );">Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">69,112<span></span>
</td>
<td class="nump">70,635<span></span>
</td>
<td class="nump">136,451<span></span>
</td>
<td class="nump">142,299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=ameh_OtherThirdPartiesMember', window );">Other third parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 18,031<span></span>
</td>
<td class="nump">$ 14,407<span></span>
</td>
<td class="nump">$ 31,607<span></span>
</td>
<td class="nump">$ 30,189<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ameh_CommercialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ameh_CommercialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ameh_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ameh_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ameh_MedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ameh_MedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ameh_OtherThirdPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ameh_OtherThirdPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699772765760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Contributions to Revenue and Receivables by Payor (Details) - Customer Concentration Risk<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Net Revenue | Payor A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_AccountsReceivableAndNetRevenueLineItems', window );"><strong>Accounts Receivable And Net Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Net Revenue | Payor B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_AccountsReceivableAndNetRevenueLineItems', window );"><strong>Accounts Receivable And Net Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">38.20%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">39.80%<span></span>
</td>
<td class="nump">30.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Receivables and Receivables-Related Parties | Payor B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_AccountsReceivableAndNetRevenueLineItems', window );"><strong>Accounts Receivable And Net Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Receivables and Receivables-Related Parties | Payor C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_AccountsReceivableAndNetRevenueLineItems', window );"><strong>Accounts Receivable And Net Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_AccountsReceivableAndNetRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_AccountsReceivableAndNetRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ameh_PayorAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ameh_PayorAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ameh_PayorBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ameh_PayorBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ameh_PayorCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ameh_PayorCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699766645632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">$ 78,647<span></span>
</td>
<td class="nump">$ 135,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="nump">2,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable securities &#8211; equity securities</a></td>
<td class="nump">1,767<span></span>
</td>
<td class="nump">5,567<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">86,754<span></span>
</td>
<td class="nump">145,866<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">22,246<span></span>
</td>
<td class="nump">21,259<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_APCMGMember', window );">APCMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Cash contingent consideration</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AAMGMember', window );">AAMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Cash contingent consideration</a></td>
<td class="nump">5,056<span></span>
</td>
<td class="nump">5,851<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_VOMGMember', window );">VOMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Cash contingent consideration</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_DmgMember', window );">DMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">8,542<span></span>
</td>
<td class="nump">8,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_ApolloSunLabsManagementLLCMember', window );">Sun Labs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">7,631<span></span>
</td>
<td class="nump">5,849<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">3,116<span></span>
</td>
<td class="nump">3,164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ameh_CollarMember', window );">Interest rate collar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">1,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ameh_ContingentEquitySecuritiesMember', window );">Contingent equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">78,647<span></span>
</td>
<td class="nump">135,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="nump">2,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable securities &#8211; equity securities</a></td>
<td class="nump">1,767<span></span>
</td>
<td class="nump">5,567<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">82,436<span></span>
</td>
<td class="nump">140,802<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | APCMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Cash contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | AAMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Cash contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | VOMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Cash contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | DMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Sun Labs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Interest rate collar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Contingent equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable securities &#8211; equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">4,318<span></span>
</td>
<td class="nump">3,164<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | APCMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Cash contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | AAMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Cash contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | VOMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Cash contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | DMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Sun Labs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">3,116<span></span>
</td>
<td class="nump">3,164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Interest rate collar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">1,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Contingent equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable securities &#8211; equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">22,246<span></span>
</td>
<td class="nump">21,259<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | APCMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Cash contingent consideration</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | AAMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Cash contingent consideration</a></td>
<td class="nump">5,056<span></span>
</td>
<td class="nump">5,851<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | VOMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Cash contingent consideration</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | DMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">8,542<span></span>
</td>
<td class="nump">8,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Sun Labs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">7,631<span></span>
</td>
<td class="nump">5,849<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Interest rate collar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Contingent equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Equity Interest Purchase Obligation, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_APCMGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_APCMGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_AAMGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_AAMGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_VOMGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_VOMGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_DmgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_DmgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_ApolloSunLabsManagementLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_ApolloSunLabsManagementLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ameh_CollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ameh_CollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ameh_ContingentEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ameh_ContingentEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699777404160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 21,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Unrealized gain recognized from change in fair value of existing Level 3 liabilities</a></td>
<td class="nump">987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 22,246<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699774718960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations, Asset Acquisitions, and Goodwill - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>May 01, 2023</div></th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 14, 2022 </div>
<div>clinic</div>
</th>
<th class="th"><div>Apr. 19, 2022</div></th>
<th class="th"><div>Jan. 27, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_NumberOfPrimaryCareClinics', window );">Number of primary care clinics | clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ameh_ForYourBenefitIncMember', window );">For Your Benefit Inc. (FYB)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember', window );">Orma Health, Inc., and Provider Growth Solutions LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ameh_JadeHealthCareMedicalGroupIncMember', window );">Jade Health Care Medical Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ameh_AAMGMember', window );">AAMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="nump">$ 5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_NumberOfPrimaryCareClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Primary Care Clinics</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_NumberOfPrimaryCareClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ameh_ForYourBenefitIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ameh_ForYourBenefitIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ameh_JadeHealthCareMedicalGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ameh_JadeHealthCareMedicalGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ameh_AAMGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ameh_AAMGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699773617584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations, Asset Acquisitions, and Goodwill - Schedule of Goodwill (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 269,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">3,924<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Adjustments</a></td>
<td class="nump">1,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 274,029<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 16<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479405/805-10-25-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699774842624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">$ (124,895)<span></span>
</td>
<td class="num">$ (118,611)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">72,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross</a></td>
<td class="nump">199,316<span></span>
</td>
<td class="nump">195,472<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net</a></td>
<td class="nump">74,421<span></span>
</td>
<td class="nump">76,861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived assets:</a></td>
<td class="nump">2,150<span></span>
</td>
<td class="nump">2,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_NetworkRelationshipsMember', window );">Network relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross</a></td>
<td class="nump">150,679<span></span>
</td>
<td class="nump">150,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(100,244)<span></span>
</td>
<td class="num">(95,451)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 50,435<span></span>
</td>
<td class="nump">$ 55,228<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_NetworkRelationshipsMember', window );">Network relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">11 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_NetworkRelationshipsMember', window );">Network relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">21 years<span></span>
</td>
<td class="text">21 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_ManagementContractsMember', window );">Management contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross</a></td>
<td class="nump">$ 22,832<span></span>
</td>
<td class="nump">$ 22,832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(15,982)<span></span>
</td>
<td class="num">(15,208)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">6,850<span></span>
</td>
<td class="nump">$ 7,624<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_MemberRelationshipsMember', window );">Member relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross</a></td>
<td class="nump">20,477<span></span>
</td>
<td class="nump">$ 16,633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(6,302)<span></span>
</td>
<td class="num">(5,619)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 14,175<span></span>
</td>
<td class="nump">$ 11,014<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_MemberRelationshipsMember', window );">Member relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_MemberRelationshipsMember', window );">Member relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_PatientManagementPlatformMember', window );">Patient management platform</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross</a></td>
<td class="nump">$ 2,060<span></span>
</td>
<td class="nump">$ 2,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,060)<span></span>
</td>
<td class="num">(2,060)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Tradename/trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross</a></td>
<td class="nump">$ 1,011<span></span>
</td>
<td class="nump">$ 1,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(282)<span></span>
</td>
<td class="num">(257)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 729<span></span>
</td>
<td class="nump">$ 754<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross</a></td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 82<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_NetworkRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_NetworkRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_ManagementContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_ManagementContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_MemberRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_MemberRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_PatientManagementPlatformMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ameh_PatientManagementPlatformMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699781318432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="nump">$ 6,300,000<span></span>
</td>
<td class="nump">$ 7,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of finite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699780909584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net - Schedule of Future Amortization Expense (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2023 (excluding the six months ended June 30, 2023</a></td>
<td class="nump">$ 6,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">12,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">11,171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">9,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">8,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">24,453<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 72,271<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699766344656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Other Entities - Schedule of Equity Method Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 43,108<span></span>
</td>
<td class="nump">$ 44,383<span></span>
</td>
<td class="nump">$ 40,299<span></span>
</td>
<td class="nump">$ 41,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Income (Loss)</a></td>
<td class="nump">2,723<span></span>
</td>
<td class="nump">1,512<span></span>
</td>
<td class="nump">5,207<span></span>
</td>
<td class="nump">2,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable', window );">Funding Reclassified To Loan Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,125)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(200)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 45,831<span></span>
</td>
<td class="nump">$ 43,820<span></span>
</td>
<td class="nump">$ 45,831<span></span>
</td>
<td class="nump">$ 43,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_LasalleMedicalAssociatesIpaMember', window );">LaSalle Medical Associates &#8211; IPA Line of Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 7,848<span></span>
</td>
<td class="nump">$ 4,292<span></span>
</td>
<td class="nump">$ 5,684<span></span>
</td>
<td class="nump">$ 3,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Income (Loss)</a></td>
<td class="nump">2,689<span></span>
</td>
<td class="nump">1,277<span></span>
</td>
<td class="nump">4,853<span></span>
</td>
<td class="nump">2,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable', window );">Funding Reclassified To Loan Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,125)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 10,537<span></span>
</td>
<td class="nump">$ 3,444<span></span>
</td>
<td class="nump">$ 10,537<span></span>
</td>
<td class="nump">$ 3,444<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_PacificMedicalImagingAndOncologyCenterIncMember', window );">Pacific Medical Imaging &amp; Oncology Center, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 1,886<span></span>
</td>
<td class="nump">$ 1,726<span></span>
</td>
<td class="nump">$ 1,878<span></span>
</td>
<td class="nump">$ 1,719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Income (Loss)</a></td>
<td class="num">(231)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="num">(223)<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable', window );">Funding Reclassified To Loan Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 1,655<span></span>
</td>
<td class="nump">$ 1,741<span></span>
</td>
<td class="nump">$ 1,655<span></span>
</td>
<td class="nump">$ 1,741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_FiveThreeOneW.CollegeLLCMember', window );">531 W. College, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 17,191<span></span>
</td>
<td class="nump">$ 17,048<span></span>
</td>
<td class="nump">$ 17,281<span></span>
</td>
<td class="nump">$ 17,230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Income (Loss)</a></td>
<td class="num">(121)<span></span>
</td>
<td class="num">(123)<span></span>
</td>
<td class="num">(211)<span></span>
</td>
<td class="num">(305)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable', window );">Funding Reclassified To Loan Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 17,070<span></span>
</td>
<td class="nump">$ 17,175<span></span>
</td>
<td class="nump">$ 17,070<span></span>
</td>
<td class="nump">$ 17,175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_OneMSOLLCMember', window );">One MSO, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 2,833<span></span>
</td>
<td class="nump">$ 2,847<span></span>
</td>
<td class="nump">$ 2,718<span></span>
</td>
<td class="nump">$ 2,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Income (Loss)</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable', window );">Funding Reclassified To Loan Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(200)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 2,960<span></span>
</td>
<td class="nump">$ 2,764<span></span>
</td>
<td class="nump">$ 2,960<span></span>
</td>
<td class="nump">$ 2,764<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_CAIPAMSOLLCMember', window );">CAIPA MSO, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 12,988<span></span>
</td>
<td class="nump">$ 12,140<span></span>
</td>
<td class="nump">$ 12,738<span></span>
</td>
<td class="nump">$ 11,992<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Income (Loss)</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="nump">451<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable', window );">Funding Reclassified To Loan Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 13,189<span></span>
</td>
<td class="nump">$ 12,320<span></span>
</td>
<td class="nump">$ 13,189<span></span>
</td>
<td class="nump">$ 12,320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_JamesSongMDAProfessionalCorporationMember', window );">James Song, M.D., A Professional Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Income (Loss)</a></td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_Tag6MedicalInvestmentGroupLLCMember', window );">Tag-6 Medical Investment Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable', window );">Funding Reclassified To Loan Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,376<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_EquityMethodInvestmentAdditionalInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Additional Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_EquityMethodInvestmentAdditionalInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Funding Reclassified to Loan Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_EquityMethodInvestmentsContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Contribution</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_EquityMethodInvestmentsContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_EquityMethodInvestmentsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_EquityMethodInvestmentsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the entity's equity method investment which has been sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentSoldCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_LasalleMedicalAssociatesIpaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_LasalleMedicalAssociatesIpaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_PacificMedicalImagingAndOncologyCenterIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_PacificMedicalImagingAndOncologyCenterIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_FiveThreeOneW.CollegeLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_FiveThreeOneW.CollegeLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_OneMSOLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_OneMSOLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_CAIPAMSOLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_CAIPAMSOLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_JamesSongMDAProfessionalCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_JamesSongMDAProfessionalCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_Tag6MedicalInvestmentGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_Tag6MedicalInvestmentGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699772713152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Other Entities - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income (loss) from equity method investments</a></td>
<td class="nump">$ 2,723,000<span></span>
</td>
<td class="nump">$ 1,512,000<span></span>
</td>
<td class="nump">$ 5,207,000<span></span>
</td>
<td class="nump">$ 2,945,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in other entities &#8211; equity method</a></td>
<td class="nump">$ 45,831,000<span></span>
</td>
<td class="nump">$ 43,820,000<span></span>
</td>
<td class="nump">45,831,000<span></span>
</td>
<td class="nump">43,820,000<span></span>
</td>
<td class="nump">$ 43,108,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,299,000<span></span>
</td>
<td class="nump">$ 44,383,000<span></span>
</td>
<td class="nump">$ 41,715,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_JamesSongMDAProfessionalCorporationMember', window );">James Song, M.D., A Professional Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income (loss) from equity method investments</a></td>
<td class="nump">$ 58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in other entities &#8211; equity method</a></td>
<td class="nump">$ 420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 362,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_JamesSongMDAProfessionalCorporationMember', window );">James Song, M.D., A Professional Corporation | AP-AMH 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_JamesSongMDAProfessionalCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_JamesSongMDAProfessionalCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_APAMH2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_APAMH2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699773606048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Loan Receivable and Loan Receivable &#8211; Related Parties - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_NetworkMedicalManagementMember', window );">NMM | LMA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember', window );">Convertible Secured Promissory Note | Related Party | NMM | Pacific6 Enterprises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on loan receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember', window );">Convertible Secured Promissory Note | Related Party | LMA | APC LSMA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Amount of loan</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_FinanceReceivableInterestRateStatedPercentage', window );">Note receivable, interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_FinanceReceivableInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Receivable, Interest Rate, Stated Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_FinanceReceivableInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_NetworkMedicalManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_NetworkMedicalManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_LmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_LmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_Pacific6EnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_Pacific6EnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_LmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_LmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_ApcLsmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_ApcLsmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699767902240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other accruals</a></td>
<td class="nump">$ 9,939<span></span>
</td>
<td class="nump">$ 10,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_SpecialtyCapitationPayableCurrent', window );">Capitation payable</a></td>
<td class="nump">4,543<span></span>
</td>
<td class="nump">4,229<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_SubcontractorIPAPayable', window );">Subcontractor IPA payable</a></td>
<td class="nump">3,326<span></span>
</td>
<td class="nump">2,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">2,680<span></span>
</td>
<td class="nump">2,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Due to related parties</a></td>
<td class="nump">3,246<span></span>
</td>
<td class="nump">3,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="nump">647<span></span>
</td>
<td class="nump">531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">13,393<span></span>
</td>
<td class="nump">15,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other provider payable</a></td>
<td class="nump">12,130<span></span>
</td>
<td class="nump">10,600<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued expenses</a></td>
<td class="nump">$ 49,904<span></span>
</td>
<td class="nump">$ 49,562<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_SpecialtyCapitationPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of specialty capitation payable current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_SpecialtyCapitationPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_SubcontractorIPAPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subcontractor IPA Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_SubcontractorIPAPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699780841760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Medical Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical liabilities, beginning of period (restated)</a></td>
<td class="nump">$ 81,255<span></span>
</td>
<td class="nump">$ 55,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquired (see Note 3)</a></td>
<td class="nump">4,757<span></span>
</td>
<td class="nump">1,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_MedicalCareCostsAbstract', window );"><strong>Components of medical care costs related to claims incurred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current period</a></td>
<td class="nump">441,443<span></span>
</td>
<td class="nump">313,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior periods</a></td>
<td class="num">(12,066)<span></span>
</td>
<td class="num">(950)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total medical care costs</a></td>
<td class="nump">429,377<span></span>
</td>
<td class="nump">312,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_PaymentsForMedicalCareCostsAbstract', window );"><strong>Payments for medical care costs related to claims incurred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current period</a></td>
<td class="num">(336,231)<span></span>
</td>
<td class="num">(204,032)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior periods</a></td>
<td class="num">(81,165)<span></span>
</td>
<td class="num">(53,978)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total paid</a></td>
<td class="num">(417,396)<span></span>
</td>
<td class="num">(258,010)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease', window );">Adjustments</a></td>
<td class="nump">2,054<span></span>
</td>
<td class="nump">742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical liabilities, end of period</a></td>
<td class="nump">$ 100,047<span></span>
</td>
<td class="nump">$ 112,499<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_MedicalCareCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Medical Care Costs [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_MedicalCareCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_PaymentsForMedicalCareCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Medical Care Costs [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_PaymentsForMedicalCareCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -SubTopic 40<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -SubTopic 40<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of increase (decrease) in the liability for unpaid claims and claims adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -SubTopic 40<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699780758736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 210,611<span></span>
</td>
<td class="nump">$ 207,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion of debt</a></td>
<td class="num">(2,630)<span></span>
</td>
<td class="num">(619)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: Unamortized financing costs</a></td>
<td class="num">(2,845)<span></span>
</td>
<td class="num">(3,319)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion and deferred financing costs</a></td>
<td class="nump">205,136<span></span>
</td>
<td class="nump">203,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RealEstateLoanMember', window );">Real Estate Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">22,862<span></span>
</td>
<td class="nump">23,168<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ameh_ConstructionLoanMember', window );">Construction Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">5,749<span></span>
</td>
<td class="nump">4,159<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember', window );">Promissory Note Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolver Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RealEstateLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RealEstateLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ameh_ConstructionLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ameh_ConstructionLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699780739184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2023 (excluding the six months ended June 30, 2023)</a></td>
<td class="nump">$ 312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">2,642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">7,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">180,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="nump">472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">19,547<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total</a></td>
<td class="nump">$ 210,611<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_LongTermDebtMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_LongTermDebtMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699763675312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 25, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 16, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Aug. 05, 2020</div></th>
<th class="th"><div>Jul. 27, 2020</div></th>
<th class="th"><div>Jul. 03, 2020</div></th>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>financial_ratio</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>financial_ratio</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 10, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,845,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,845,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,319,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,632,000<span></span>
</td>
<td class="nump">$ 1,854,000<span></span>
</td>
<td class="nump">6,901,000<span></span>
</td>
<td class="nump">$ 2,927,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_MedicalPropertyPartnersLLCMember', window );">Medical Property Partners LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum', window );">Debt instrument, covenant, debt coverage ratio, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_MedicalPropertyPartnersLLCMember', window );">Medical Property Partners LLC | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AMGPropertiesLLCMember', window );">AMG Properties LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum', window );">Debt instrument, covenant, debt coverage ratio, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AMGPropertiesLLCMember', window );">AMG Properties LLC | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_ZLLPartnersLLCMember', window );">ZLL Partners LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum', window );">Debt instrument, covenant, debt coverage ratio, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_ZLLPartnersLLCMember', window );">ZLL Partners LLC | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_A120HellmanLLCMember', window );">120 Hellman LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt, principal sum</a></td>
<td class="nump">$ 16,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum', window );">Debt instrument, covenant, cash flow to debt service ratio, minimum</a></td>
<td class="nump">1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DebtCovenantThresholdPercentageForOccupationOfProperty', window );">Debt covenant, threshold percentage for occupation of property</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_A120HellmanLLCMember', window );">120 Hellman LLC | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ameh_AmendedCreditAgreementMember', window );">Amended Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Annual agent fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ameh_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Truist Bank | Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ameh_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Required annual facility fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.175%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ameh_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Minimum | Secured Overnight Financing Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ameh_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Minimum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ameh_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Required annual facility fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ameh_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Maximum | Secured Overnight Financing Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ameh_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Maximum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ameh_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DebtInstrumentNumberOfKeyFinancialRatios', window );">Number of key financial ratios | financial_ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DebtInstrumentCovenantLeverageRatioMaximum', window );">Maximum consolidated leverage ratio (not greater than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DebtCovenantAggregatePurchasePriceMaximum', window );">Debt covenant, aggregate purchase price, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange', window );">Consolidated leverage ratio, annual decrease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum', window );">Debt instrument, covenant, leverage ratio, adjusted maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum', window );">Minimum consolidated interest coverage ratio (not less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.93%<span></span>
</td>
<td class="nump">2.16%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ameh_ConstructionLoanMember', window );">Construction Loan | Tag-8 Medical Investment Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt, principal sum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConstructionLoansMember', window );">Construction Loans | Tag-8 Medical Investment Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum', window );">Debt instrument, covenant, cash flow coverage ratio, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ameh_SubordinatedLoanAgreementMember', window );">Subordinated Loan Agreement | Subordinated Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt, principal sum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolver Loan | Amended Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Revolving credit facility term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.68%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.68%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolver Loan | Amended Credit Agreement | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolver Loan | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | APC Business Loan Agreement | APC | Preferred Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Amended Credit Agreement | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_BridgeLoanMember', window );">Bridge Loan | Amended Credit Agreement | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit | APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit | Alpha Care Medical Group, Inc. | Preferred Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit | Amended Credit Agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Required annual facility fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit | Amended Credit Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Required annual facility fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_DebtCovenantAggregatePurchasePriceMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Covenant, Aggregate Purchase Price, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_DebtCovenantAggregatePurchasePriceMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_DebtCovenantThresholdPercentageForOccupationOfProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Covenant, Threshold Percentage for Occupation of Property</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_DebtCovenantThresholdPercentageForOccupationOfProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Cash Flow Coverage Ratio, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Cash Flow To Debt Service Ratio, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Debt Coverage Ratio, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Interest Coverage Ratio, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Adjusted Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Incremental Change</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_DebtInstrumentCovenantLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_DebtInstrumentCovenantLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_DebtInstrumentNumberOfKeyFinancialRatios">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Key Financial Ratios</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_DebtInstrumentNumberOfKeyFinancialRatios</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 835<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479359/835-30-S45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_MedicalPropertyPartnersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_MedicalPropertyPartnersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_AMGPropertiesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_AMGPropertiesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_ZLLPartnersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_ZLLPartnersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_A120HellmanLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_A120HellmanLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ameh_AmendedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ameh_AmendedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=ameh_TruistBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=ameh_TruistBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=ameh_SecuredOvernightFinancingRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=ameh_SecuredOvernightFinancingRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ameh_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ameh_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ameh_ConstructionLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ameh_ConstructionLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_Tag8MedicalInvestmentGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_Tag8MedicalInvestmentGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_ConstructionLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_ConstructionLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ameh_SubordinatedLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ameh_SubordinatedLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SubordinatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SubordinatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ameh_ApcBusinessLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ameh_ApcBusinessLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=ameh_PreferredBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=ameh_PreferredBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_BridgeLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_BridgeLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_AlphaCareMedicalGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_AlphaCareMedicalGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699763616912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mezzanine and Stockholders' Equity - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_StockIssuedDuringPeriodSharesMerger', window );">Holdback shares not issued to former shareholders (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares (in shares)</a></td>
<td class="nump">10,569,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,569,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,299,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember', window );">APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares (in shares)</a></td>
<td class="nump">10,299,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,299,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,299,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends paid</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_CDSCMember', window );">CDSC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends paid</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_StockIssuedDuringPeriodSharesMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_StockIssuedDuringPeriodSharesMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481071/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_CDSCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_CDSCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699774764464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Share-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 4,213<span></span>
</td>
<td class="nump">$ 3,920<span></span>
</td>
<td class="nump">$ 7,658<span></span>
</td>
<td class="nump">$ 6,975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">422<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
<td class="nump">988<span></span>
</td>
<td class="nump">1,921<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ameh_StockAwardsAndUnitsMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 3,791<span></span>
</td>
<td class="nump">$ 2,779<span></span>
</td>
<td class="nump">$ 6,670<span></span>
</td>
<td class="nump">$ 5,054<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ameh_StockAwardsAndUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ameh_StockAwardsAndUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699766636976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 37.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares issued for exercise of options and warrants (in shares)</a></td>
<td class="nump">125,000<span></span>
</td>
<td class="nump">38,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Purchase price adjustment from merger</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod', window );">Warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised', window );">Proceeds from warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice', window );">Exercise price of warrants exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice', window );">Exercise price of warrants exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock awards granted (in shares)</a></td>
<td class="nump">279,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance', window );">Contingent on performance (in shares)</a></td>
<td class="nump">359,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 33.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ameh_PerformanceBasedRestrictedStockMember', window );">Performance Based Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 32.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of shares, performance based restricted stock (in shares)</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=ameh_ApcStockOptionMember', window );">APC Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Purchase price adjustment from merger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Contingent on Performance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based Compensation Arrangement By Share based Payment Award Warrants Exercises In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share based Payment Award, Warrant Exercised, Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Issued During Period Value Stock Options Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ameh_PerformanceBasedRestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ameh_PerformanceBasedRestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ameh_ApcStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ameh_ApcStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699773167008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Stock Option Transactions Under Stock Option Plans (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">684,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">859,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="num">(125,000)<span></span>
</td>
<td class="num">(38,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options forfeited (in shares)</a></td>
<td class="num">(50,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, ending balance (in shares)</a></td>
<td class="nump">684,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">859,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable (in shares)</a></td>
<td class="nump">589,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 25.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (in dollars per share)</a></td>
<td class="nump">10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options forfeited (in dollars per share)</a></td>
<td class="nump">0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, ending balance (in dollars per share)</a></td>
<td class="nump">30.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options exercisable (in dollars per share)</a></td>
<td class="nump">$ 21.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted Average Remaining Contractual Term (Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options outstanding</a></td>
<td class="text">2 years 1 month 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 8 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable</a></td>
<td class="text">1 year 8 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value (in millions)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding</a></td>
<td class="nump">$ 7,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Options exercised</a></td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable</a></td>
<td class="nump">$ 7,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699778536496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Amount outstanding</a></td>
<td class="nump">$ 210,611<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit | APC</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Amount outstanding</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit | Alpha Care Medical Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Amount outstanding</a></td>
<td class="nump">3,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ameh_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Truist Bank | Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="nump">$ 21,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_AlphaCareMedicalGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_AlphaCareMedicalGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ameh_AmendedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ameh_AmendedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=ameh_TruistBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=ameh_TruistBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699772506144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Transactions - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 348,209<span></span>
</td>
<td class="nump">$ 269,697<span></span>
</td>
<td class="nump">$ 685,453<span></span>
</td>
<td class="nump">$ 532,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for repurchase of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,539<span></span>
</td>
<td class="nump">9,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember', window );">Risk pool settlements and incentives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">20,121<span></span>
</td>
<td class="nump">18,793<span></span>
</td>
<td class="nump">33,583<span></span>
</td>
<td class="nump">36,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember', window );">Board members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for repurchase of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ameh_SongPCMember', window );">Song PC | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ameh_AHMCMember', window );">AHMC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCreditsAndOtherLiabilities', window );">Amount outstanding under agreement</a></td>
<td class="nump">73,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ameh_AHMCMember', window );">AHMC | Related Party | Risk pool settlements and incentives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">15,800<span></span>
</td>
<td class="nump">13,300<span></span>
</td>
<td class="nump">28,800<span></span>
</td>
<td class="nump">25,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_NetworkMedicalManagementMember', window );">NMM | LMA | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">6,900<span></span>
</td>
<td class="nump">4,800<span></span>
</td>
<td class="nump">11,900<span></span>
</td>
<td class="nump">11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_NetworkMedicalManagementMember', window );">NMM | Arroyo Vista | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_NetworkMedicalManagementMember', window );">NMM | Arroyo Vista | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_NetworkMedicalManagementMember', window );">NMM | One MSO, Inc. | Office Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember', window );">APC | Board members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for repurchase of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember', window );">APC | PMIOC | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember', window );">APC | Advance Diagnostic Surgery Center | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember', window );">APC | Fulgent Genetics, Inc. | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember', window );">APC | Sunny Village Care Center | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember', window );">APC | One MSO, Inc. | Office Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember', window );">APC | APC Shareholders | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,800<span></span>
</td>
<td class="nump">21,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember', window );">APC | APC Shareholders and Officers | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember', window );">APC | Board Members | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">9,500<span></span>
</td>
<td class="nump">12,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember', window );">APC | Board Members Who Are Also Officers | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_MedicalPropertyPartnersLLCMember', window );">Medical Property Partners LLC | Diagnostic and Surgical Center | Rent Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_Tag6MedicalInvestmentGroupLLCMember', window );">Tag-6 Medical Investment Group, LLC | Sunny Village Care Center | Rent Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_LmaMember', window );">LMA | NMM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_PmiocMember', window );">PMIOC | APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_OneMSOInc.Member', window );">One MSO, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCreditsAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total carrying amount as of the balance sheet date of unearned revenue or income, not otherwise specified in the taxonomy, which is expected to be taken into income in future periods and obligations not separately disclosed in the balance sheet (other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCreditsAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_SongPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_SongPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ameh_ProviderServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ameh_ProviderServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_AHMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_AHMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_NetworkMedicalManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_NetworkMedicalManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_LmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_LmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_ArroyoVistaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_ArroyoVistaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_OneMSOInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_OneMSOInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ameh_OfficeLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ameh_OfficeLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_PmiocMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_PmiocMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_AdvanceDiagnosticSurgeryCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_AdvanceDiagnosticSurgeryCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_FulgentGeneticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_FulgentGeneticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_SunnyVillageCareCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_SunnyVillageCareCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_ApcShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_ApcShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_ShareholdersAndOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_ShareholdersAndOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_BoardMembersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_BoardMembersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_BoardMembersWhoAreAlsoOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_BoardMembersWhoAreAlsoOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_MedicalPropertyPartnersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_MedicalPropertyPartnersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_DiagnosticAndSurgicalCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_DiagnosticAndSurgicalCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ameh_RentPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ameh_RentPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_Tag6MedicalInvestmentGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_Tag6MedicalInvestmentGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_LmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_LmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_PmiocMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_PmiocMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_OneMSOInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_OneMSOInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699766193824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Transactions - Schedule of Fees Incurred and Revenue Earned from Related Party Transactions (Details) - Fees Incurred and Income Recognized - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">$ 11,717<span></span>
</td>
<td class="nump">$ 13,695<span></span>
</td>
<td class="nump">$ 19,897<span></span>
</td>
<td class="nump">$ 24,907<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ameh_AHMCMember', window );">AHMC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">11,574<span></span>
</td>
<td class="nump">14,419<span></span>
</td>
<td class="nump">19,658<span></span>
</td>
<td class="nump">25,785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ameh_HSMSOMember', window );">HSMSO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">243<span></span>
</td>
<td class="num">(649)<span></span>
</td>
<td class="nump">389<span></span>
</td>
<td class="num">(728)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ameh_AurionMember', window );">Aurion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="num">$ (100)<span></span>
</td>
<td class="num">$ (75)<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ameh_FeesIncurredAndIncomeRecognizedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ameh_FeesIncurredAndIncomeRecognizedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_AHMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_AHMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_HSMSOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_HSMSOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ameh_AurionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ameh_AurionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699776508752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">41.10%<span></span>
</td>
<td class="nump">34.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699774859216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Additional Information (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities not included in the calculation of earnings per share (in shares)</a></td>
<td class="nump">238,096<span></span>
</td>
<td class="nump">394,606<span></span>
</td>
<td class="nump">246,431<span></span>
</td>
<td class="nump">257,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities not included in the calculation of earnings per share (in shares)</a></td>
<td class="nump">838,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">838,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember', window );">APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities not included in the calculation of earnings per share (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,299,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,299,259<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Earnings Per Share [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699780800944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Schedule of Earnings Per Share Computations (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share &#8211; basic (in dollars per share)</a></td>
<td class="nump">$ 0.28<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
<td class="nump">$ 0.57<span></span>
</td>
<td class="nump">$ 0.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share &#8211; diluted (in dollars per share)</a></td>
<td class="nump">$ 0.28<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares of common stock outstanding &#8211; basic (in shares)</a></td>
<td class="nump">46,482,271<span></span>
</td>
<td class="nump">44,858,657<span></span>
</td>
<td class="nump">46,517,108<span></span>
</td>
<td class="nump">44,815,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares of common stock outstanding &#8211; diluted (in shares)</a></td>
<td class="nump">46,778,299<span></span>
</td>
<td class="nump">46,023,015<span></span>
</td>
<td class="nump">46,844,044<span></span>
</td>
<td class="nump">46,082,643<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699780628256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Schedule of Shares Included in the Diluted Earnings Per Share Computations (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares of common stock outstanding &#8211; basic (in shares)</a></td>
<td class="nump">46,482,271<span></span>
</td>
<td class="nump">44,858,657<span></span>
</td>
<td class="nump">46,517,108<span></span>
</td>
<td class="nump">44,815,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Contingently issuable shares (in shares)</a></td>
<td class="nump">3,690<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,855<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares of common stock outstanding &#8211; diluted (in shares)</a></td>
<td class="nump">46,778,299<span></span>
</td>
<td class="nump">46,023,015<span></span>
</td>
<td class="nump">46,844,044<span></span>
</td>
<td class="nump">46,082,643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Adjustments to weighted average shares of common stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">651,725<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">689,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Adjustments to weighted average shares of common stock (in shares)</a></td>
<td class="nump">252,311<span></span>
</td>
<td class="nump">418,322<span></span>
</td>
<td class="nump">254,718<span></span>
</td>
<td class="nump">455,170<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Adjustments to weighted average shares of common stock (in shares)</a></td>
<td class="nump">40,027<span></span>
</td>
<td class="nump">94,311<span></span>
</td>
<td class="nump">70,363<span></span>
</td>
<td class="nump">122,926<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Earnings Per Share [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-26<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 44<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-44<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 51<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-51<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-52<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-53<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 54<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-54<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-48<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699767812592">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Variable Interest Entities (VIEs) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 293,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 288,027<span></span>
</td>
<td class="nump">$ 234,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investment in marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">465,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">428,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">74,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">274,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">269,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivableNoncurrent', window );">Income taxes receivable, non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in other entities &#8211; equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">45,831<span></span>
</td>
<td class="nump">$ 43,108<span></span>
</td>
<td class="nump">40,299<span></span>
</td>
<td class="nump">43,820<span></span>
</td>
<td class="nump">$ 44,383<span></span>
</td>
<td class="nump">$ 41,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">562,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">538,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,027,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">966,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">49,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_FiduciaryAccountsPayableCurrent', window );">Fiduciary accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,255<span></span>
</td>
<td class="nump">$ 112,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,783<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Amount due to affiliate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">185,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion and deferred financing costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">205,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">257,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">259,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">443,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">407,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">66,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Loans receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">82,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Loans receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">79,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investment in marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Amount due from affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">182,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Land, property, and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">121,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">49,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">110,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivableNoncurrent', window );">Income taxes receivable, non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Investment in affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">325,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">304,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in other entities &#8211; equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">32,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue', window );">Investment in privately held entities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">663,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">631,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">846,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">858,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_FiduciaryAccountsPayableCurrent', window );">Fiduciary accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income taxes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Amount due to affiliate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">95,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion and deferred financing costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">141,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary | Nonrelated Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Loans receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary | Related Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">76,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Loans receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Company&#8217;s consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The consolidated balance sheets include total assets that can be used only to settle obligations of the Company&#8217;s consolidated VIEs totaling $520.8&#160;million and $523.7&#160;million as of June&#160;30, 2023 and December&#160;31, 2022, respectively, and total liabilities of the Company&#8217;s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $136.2&#160;million and $131.8&#160;million as of June&#160;30, 2023 and December&#160;31, 2022, respectively. The VIE balances do not include $325.5&#160;million of investment in affiliates and $5.4&#160;million of amounts due to affiliates as of June&#160;30, 2023 and $304.8&#160;million of investment in affiliates and $30.3&#160;million of amounts due from affiliates as of December&#160;31, 2022 as these are eliminated upon consolidation and not presented within the consolidated balance sheets. See Note 16 &#8212; &#8220;Variable Interest Entities (VIEs)&#8221; for further detail.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_FiduciaryAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fiduciary accounts payable, due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_FiduciaryAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699778522000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease option to extend (up to)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRenewalTerm1', window );">Finance lease option to extend (up to)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable', window );">Operating lease, termination period, if applicable</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable', window );">Finance lease, termination period, if applicable</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Assets recorded under finance leases</a></td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization', window );">Accumulated depreciation associated with finance leases</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term, operating</a></td>
<td class="text">2 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm', window );">Remaining lease term, finance</a></td>
<td class="text">2 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term, operating</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm', window );">Remaining lease term, finance</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Finance Lease, Termination Period, If Applicable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Termination Period, If Applicable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseRenewalTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseRenewalTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699780759808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Components of Lease Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 1,816<span></span>
</td>
<td class="nump">$ 1,547<span></span>
</td>
<td class="nump">$ 3,568<span></span>
</td>
<td class="nump">$ 3,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_FinanceLeaseCostsAbstract', window );"><strong>Finance lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of lease expense</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="nump">303<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(252)<span></span>
</td>
<td class="num">(206)<span></span>
</td>
<td class="num">(499)<span></span>
</td>
<td class="num">(332)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost, net</a></td>
<td class="nump">$ 1,735<span></span>
</td>
<td class="nump">$ 1,501<span></span>
</td>
<td class="nump">$ 3,417<span></span>
</td>
<td class="nump">$ 3,142<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_FinanceLeaseCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_FinanceLeaseCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699777315904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Other Information Related to Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_CashPaidForLeaseLiabilitiesAbstractAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 1,937<span></span>
</td>
<td class="nump">$ 1,495<span></span>
</td>
<td class="nump">$ 3,678<span></span>
</td>
<td class="nump">$ 3,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from finance leases</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">303<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_LeaseWeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted Average Remaining Lease Term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">6 years 9 months 7 days<span></span>
</td>
<td class="text">6 years 6 months 18 days<span></span>
</td>
<td class="text">6 years 9 months 7 days<span></span>
</td>
<td class="text">6 years 6 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases</a></td>
<td class="text">3 years 1 month 13 days<span></span>
</td>
<td class="text">3 years 1 month 9 days<span></span>
</td>
<td class="text">3 years 1 month 13 days<span></span>
</td>
<td class="text">3 years 1 month 9 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_LeaseWeightedAverageDiscountRateAbstract', window );"><strong>Weighted Average Discount Rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">5.71%<span></span>
</td>
<td class="nump">4.92%<span></span>
</td>
<td class="nump">5.71%<span></span>
</td>
<td class="nump">4.92%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">5.08%<span></span>
</td>
<td class="nump">4.32%<span></span>
</td>
<td class="nump">5.08%<span></span>
</td>
<td class="nump">4.32%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_CashPaidForLeaseLiabilitiesAbstractAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_CashPaidForLeaseLiabilitiesAbstractAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_LeaseWeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_LeaseWeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_LeaseWeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_LeaseWeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699773140976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Future Minimum Payments Under Non-cancelable Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023 (excluding the six months ended June 30, 2023)</a></td>
<td class="nump">$ 2,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">3,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">3,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">3,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">3,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">9,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">25,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="nump">4,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">20,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="nump">3,027<span></span>
</td>
<td class="nump">$ 3,572<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">17,852<span></span>
</td>
<td class="nump">19,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023 (excluding the six months ended June 30, 2023)</a></td>
<td class="nump">343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_FinanceLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">1,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">1,669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="nump">591<span></span>
</td>
<td class="nump">594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">$ 1,078<span></span>
</td>
<td class="nump">$ 1,275<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_FinanceLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, To Be Paid, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_FinanceLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, To Be Paid, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699780921696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Narrative (Details) - segment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699774464880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Schedule of Information about our Segments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 348,209<span></span>
</td>
<td class="nump">$ 269,697<span></span>
</td>
<td class="nump">$ 685,453<span></span>
</td>
<td class="nump">$ 532,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">292,876<span></span>
</td>
<td class="nump">230,070<span></span>
</td>
<td class="nump">582,273<span></span>
</td>
<td class="nump">450,798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">28,304<span></span>
</td>
<td class="nump">24,245<span></span>
</td>
<td class="nump">53,777<span></span>
</td>
<td class="nump">40,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">321,180<span></span>
</td>
<td class="nump">254,315<span></span>
</td>
<td class="nump">636,050<span></span>
</td>
<td class="nump">491,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">27,029<span></span>
</td>
<td class="nump">15,382<span></span>
</td>
<td class="nump">49,403<span></span>
</td>
<td class="nump">41,594<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=us-gaap_HealthCarePatientServiceMember', window );">Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">348,209<span></span>
</td>
<td class="nump">269,697<span></span>
</td>
<td class="nump">685,453<span></span>
</td>
<td class="nump">532,954<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=us-gaap_ProductAndServiceOtherMember', window );">Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="num">(38,887)<span></span>
</td>
<td class="num">(30,781)<span></span>
</td>
<td class="num">(72,486)<span></span>
</td>
<td class="num">(58,621)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="num">(36,998)<span></span>
</td>
<td class="num">(31,690)<span></span>
</td>
<td class="num">(70,726)<span></span>
</td>
<td class="num">(59,387)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="num">(2,933)<span></span>
</td>
<td class="num">(896)<span></span>
</td>
<td class="num">(3,967)<span></span>
</td>
<td class="num">(1,515)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="num">(39,931)<span></span>
</td>
<td class="num">(32,586)<span></span>
</td>
<td class="num">(74,693)<span></span>
</td>
<td class="num">(60,902)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">1,044<span></span>
</td>
<td class="nump">1,805<span></span>
</td>
<td class="nump">2,207<span></span>
</td>
<td class="nump">2,281<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="num">(38,887)<span></span>
</td>
<td class="num">(30,781)<span></span>
</td>
<td class="num">(72,486)<span></span>
</td>
<td class="num">(58,621)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">9,212<span></span>
</td>
<td class="nump">4,526<span></span>
</td>
<td class="nump">14,621<span></span>
</td>
<td class="nump">8,203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">9,212<span></span>
</td>
<td class="nump">4,526<span></span>
</td>
<td class="nump">14,621<span></span>
</td>
<td class="nump">8,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="num">(9,212)<span></span>
</td>
<td class="num">(4,526)<span></span>
</td>
<td class="num">(14,621)<span></span>
</td>
<td class="num">(8,203)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate Costs | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate Costs | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ameh_CareEnablementMember', window );">Care Enablement | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">34,975<span></span>
</td>
<td class="nump">29,558<span></span>
</td>
<td class="nump">65,541<span></span>
</td>
<td class="nump">58,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">15,162<span></span>
</td>
<td class="nump">10,921<span></span>
</td>
<td class="nump">30,783<span></span>
</td>
<td class="nump">24,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">12,175<span></span>
</td>
<td class="nump">11,315<span></span>
</td>
<td class="nump">21,375<span></span>
</td>
<td class="nump">15,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">27,337<span></span>
</td>
<td class="nump">22,236<span></span>
</td>
<td class="nump">52,158<span></span>
</td>
<td class="nump">40,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">7,638<span></span>
</td>
<td class="nump">7,322<span></span>
</td>
<td class="nump">13,383<span></span>
</td>
<td class="nump">18,669<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ameh_CareEnablementMember', window );">Care Enablement | Operating Segments | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">12,719<span></span>
</td>
<td class="nump">10,225<span></span>
</td>
<td class="nump">22,858<span></span>
</td>
<td class="nump">20,912<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ameh_CareEnablementMember', window );">Care Enablement | Operating Segments | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">22,256<span></span>
</td>
<td class="nump">19,333<span></span>
</td>
<td class="nump">42,683<span></span>
</td>
<td class="nump">38,036<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ameh_CarePartnersMember', window );">Care Partners | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">325,246<span></span>
</td>
<td class="nump">247,296<span></span>
</td>
<td class="nump">639,899<span></span>
</td>
<td class="nump">488,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">292,119<span></span>
</td>
<td class="nump">233,622<span></span>
</td>
<td class="nump">578,197<span></span>
</td>
<td class="nump">452,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">5,298<span></span>
</td>
<td class="nump">5,725<span></span>
</td>
<td class="nump">11,552<span></span>
</td>
<td class="nump">10,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">297,417<span></span>
</td>
<td class="nump">239,347<span></span>
</td>
<td class="nump">589,749<span></span>
</td>
<td class="nump">463,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">27,829<span></span>
</td>
<td class="nump">7,949<span></span>
</td>
<td class="nump">50,150<span></span>
</td>
<td class="nump">25,355<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ameh_CarePartnersMember', window );">Care Partners | Operating Segments | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">321,776<span></span>
</td>
<td class="nump">247,269<span></span>
</td>
<td class="nump">636,413<span></span>
</td>
<td class="nump">488,561<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ameh_CarePartnersMember', window );">Care Partners | Operating Segments | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,470<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">3,486<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ameh_CareDeliveryMember', window );">Care Delivery | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">26,718<span></span>
</td>
<td class="nump">23,351<span></span>
</td>
<td class="nump">52,101<span></span>
</td>
<td class="nump">43,677<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">22,523<span></span>
</td>
<td class="nump">17,135<span></span>
</td>
<td class="nump">43,886<span></span>
</td>
<td class="nump">33,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">3,626<span></span>
</td>
<td class="nump">2,832<span></span>
</td>
<td class="nump">8,612<span></span>
</td>
<td class="nump">5,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">26,149<span></span>
</td>
<td class="nump">19,967<span></span>
</td>
<td class="nump">52,498<span></span>
</td>
<td class="nump">39,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">569<span></span>
</td>
<td class="nump">3,384<span></span>
</td>
<td class="num">(397)<span></span>
</td>
<td class="nump">4,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ameh_CareDeliveryMember', window );">Care Delivery | Operating Segments | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">13,603<span></span>
</td>
<td class="nump">11,951<span></span>
</td>
<td class="nump">25,866<span></span>
</td>
<td class="nump">23,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ameh_CareDeliveryMember', window );">Care Delivery | Operating Segments | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">13,115<span></span>
</td>
<td class="nump">11,400<span></span>
</td>
<td class="nump">26,235<span></span>
</td>
<td class="nump">20,527<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other Segments | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="nump">398<span></span>
</td>
<td class="nump">362<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">926<span></span>
</td>
<td class="nump">743<span></span>
</td>
<td class="nump">1,584<span></span>
</td>
<td class="nump">1,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">996<span></span>
</td>
<td class="nump">825<span></span>
</td>
<td class="nump">1,717<span></span>
</td>
<td class="nump">1,345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="num">(839)<span></span>
</td>
<td class="num">(552)<span></span>
</td>
<td class="num">(1,319)<span></span>
</td>
<td class="num">(983)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other Segments | Operating Segments | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="nump">331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other Segments | Operating Segments | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>General and Administrative Expenses and Depreciation and Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ameh_CareEnablementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ameh_CareEnablementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ameh_CarePartnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ameh_CarePartnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ameh_CareDeliveryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ameh_CareDeliveryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139699773662752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Details) - Subsequent Event<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jul. 27, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 12, 2023 </div>
<div>careProvider </div>
<div>primary_care_service</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_NumberOfPrimaryCareProvider', window );">Number of primary care provider | careProvider</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ameh_NumberOfPrimaryCareServices', window );">Number of medicare advantage patients | primary_care_service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ameh_IntraCareConvertiblePromissoryNoteReceivableMember', window );">IntraCare Convertible Promissory Note Receivable | Convertible Secured Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Revolving credit facility term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt, principal sum | $</a></td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">8.81%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_NumberOfPrimaryCareProvider">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Primary Care Provider</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_NumberOfPrimaryCareProvider</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ameh_NumberOfPrimaryCareServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Primary Care Services</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ameh_NumberOfPrimaryCareServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ameh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ameh_IntraCareConvertiblePromissoryNoteReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ameh_IntraCareConvertiblePromissoryNoteReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>ameh-20230630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ameh="http://www.apollomed.net/20230630"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ameh-20230630.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2023-08-01</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ameh:HealthCareCapitationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ameh:HealthCareCapitationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ameh:HealthCareCapitationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ameh:HealthCareCapitationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:AmgIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApcLsmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-23</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:DMGAndSunLabsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ameh:MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:CommercialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:CommercialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:CommercialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:CommercialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:OtherThirdPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:OtherThirdPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:OtherThirdPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:OtherThirdPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ameh:PayorCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:CollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:CollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:CollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:CollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:ContingentEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:ContingentEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:ContingentEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ameh:ContingentEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APCMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:ForYourBenefitIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-01</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:OrmaHealthIncAndProviderGrowthSolutionsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-27</instant>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:JadeHealthCareMedicalGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-19</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2022-10-14</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ameh:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:PatientManagementPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ameh:PatientManagementPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:JamesSongMDAProfessionalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:JamesSongMDAProfessionalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:JamesSongMDAProfessionalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:JamesSongMDAProfessionalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:JamesSongMDAProfessionalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:JamesSongMDAProfessionalCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:APAMH2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:Pacific6EnterprisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ApcLsmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:LmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:LmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ameh:ConstructionLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ameh:ConstructionLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-16</instant>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-16</instant>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-16</instant>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ameh:SecuredOvernightFinancingRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ameh:SecuredOvernightFinancingRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-03</startDate>
            <endDate>2020-07-03</endDate>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-03</startDate>
            <endDate>2020-07-03</endDate>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AMGPropertiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AMGPropertiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-05</startDate>
            <endDate>2020-08-05</endDate>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AMGPropertiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-05</startDate>
            <endDate>2020-08-05</endDate>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ZLLPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ZLLPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-27</startDate>
            <endDate>2020-07-27</endDate>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:ZLLPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-27</startDate>
            <endDate>2020-07-27</endDate>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:A120HellmanLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-25</instant>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:A120HellmanLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:A120HellmanLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-25</startDate>
            <endDate>2022-01-25</endDate>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:A120HellmanLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-25</startDate>
            <endDate>2022-01-25</endDate>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:ConstructionLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:Tag8MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:ConstructionLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:Tag8MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:Tag8MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:SubordinatedLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SubordinatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:SubordinatedLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SubordinatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:ApcBusinessLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ameh:PreferredBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-10</instant>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialSupportToNonconsolidatedLegalEntityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ameh:TruistBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialSupportToNonconsolidatedLegalEntityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ameh:TruistBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ameh:PreferredBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlphaCareMedicalGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ameh:PreferredBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlphaCareMedicalGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:CDSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:CDSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:CDSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:CDSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ameh:StockAwardsAndUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ameh:StockAwardsAndUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ameh:StockAwardsAndUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ameh:StockAwardsAndUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ameh:ApcStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ameh:PerformanceBasedRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ameh:PerformanceBasedRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialSupportToNonconsolidatedLegalEntityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialSupportToNonconsolidatedLegalEntityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlphaCareMedicalGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:LmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:LmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:LmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:LmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:PmiocMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:PmiocMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:PmiocMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:PmiocMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PmiocMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:PmiocMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SongPCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SongPCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:DiagnosticAndSurgicalCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:RentPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:DiagnosticAndSurgicalCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:RentPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:DiagnosticAndSurgicalCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:RentPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:DiagnosticAndSurgicalCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:RentPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:FulgentGeneticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:FulgentGeneticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:FulgentGeneticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:FulgentGeneticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SunnyVillageCareCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SunnyVillageCareCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SunnyVillageCareCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SunnyVillageCareCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SunnyVillageCareCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:RentPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:SunnyVillageCareCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:RentPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:OneMSOInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:OfficeLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:OneMSOInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:OfficeLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:OneMSOInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:OfficeLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:OneMSOInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:OfficeLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ameh:OneMSOInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:FeesIncurredAndIncomeRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-434">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:BoardMembersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:BoardMembersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:BoardMembersWhoAreAlsoOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:BoardMembersWhoAreAlsoOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-438">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ApcShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ApcShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ShareholdersAndOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ameh:ShareholdersAndOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ameh:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-442">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ameh:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-450">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-451">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-463">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-465">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-466">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-468">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-469">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-470">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-471">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-476">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-477">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-481">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-482">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-485">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-486">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-487">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-488">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-490">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-491">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-492">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-493">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-494">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-495">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-496">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-499">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-520">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-522">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-524">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-528">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-532">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-533">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-534">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-535">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-536">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-537">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-538">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-539">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareEnablementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-540">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CarePartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-541">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ameh:CareDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-543">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-544">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-545">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-12</startDate>
            <endDate>2023-07-12</endDate>
        </period>
    </context>
    <context id="c-546">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-27</startDate>
            <endDate>2023-07-27</endDate>
        </period>
    </context>
    <context id="c-547">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ameh:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-27</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>ameh:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="clinic">
        <measure>ameh:clinic</measure>
    </unit>
    <unit id="financial_ratio">
        <measure>ameh:financial_ratio</measure>
    </unit>
    <unit id="careprovider">
        <measure>ameh:careProvider</measure>
    </unit>
    <unit id="primary_care_service">
        <measure>ameh:primary_care_service</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-26">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-27">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-28">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-29">0001083446</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-30">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-37392</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">Apollo Medical Holdings, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">95-4472349</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">1668 S. Garfield Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-10">2nd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">Alhambra</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">91801</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">626</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">282-0288</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">AMEH</dei:TradingSymbol>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">57562198</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:TreasuryStockCommonShares contextRef="c-3" decimals="INF" id="f-25" unitRef="shares">10299259</us-gaap:TreasuryStockCommonShares>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-31" unitRef="usd">293921000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-32" unitRef="usd">288027000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash contextRef="c-4" decimals="-3" id="f-33" unitRef="usd">345000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash contextRef="c-5" decimals="-3" id="f-34" unitRef="usd">0</us-gaap:RestrictedCash>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-4" decimals="-3" id="f-35" unitRef="usd">3789000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-5" decimals="-3" id="f-36" unitRef="usd">5567000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-6" decimals="-3" id="f-37" unitRef="usd">66927000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-7" decimals="-3" id="f-38" unitRef="usd">49631000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-8" decimals="-3" id="f-39" unitRef="usd">82820000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-9" decimals="-3" id="f-40" unitRef="usd">65147000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-4" decimals="-3" id="f-41" unitRef="usd">1201000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-5" decimals="-3" id="f-42" unitRef="usd">1834000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-43" unitRef="usd">15087000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-44" unitRef="usd">14798000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-6" decimals="-3" id="f-45" unitRef="usd">973000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-7" decimals="-3" id="f-46" unitRef="usd">996000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-8" decimals="-3" id="f-47" unitRef="usd">0</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-9" decimals="-3" id="f-48" unitRef="usd">2125000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-49" unitRef="usd">465063000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-3" id="f-50" unitRef="usd">428125000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-3" id="f-51" unitRef="usd">123859000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-52" unitRef="usd">108536000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-3" id="f-53" unitRef="usd">74421000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-3" id="f-54" unitRef="usd">76861000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-55" unitRef="usd">274029000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-56" unitRef="usd">269053000</us-gaap:Goodwill>
    <us-gaap:IncomeTaxesReceivableNoncurrent contextRef="c-4" decimals="-3" id="f-57" unitRef="usd">15943000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:IncomeTaxesReceivableNoncurrent contextRef="c-5" decimals="-3" id="f-58" unitRef="usd">15943000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:EquityMethodInvestments contextRef="c-4" decimals="-3" id="f-59" unitRef="usd">45831000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-5" decimals="-3" id="f-60" unitRef="usd">40299000</us-gaap:EquityMethodInvestments>
    <ameh:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue contextRef="c-4" decimals="-3" id="f-61" unitRef="usd">2896000</ameh:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue>
    <ameh:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue contextRef="c-5" decimals="-3" id="f-62" unitRef="usd">896000</ameh:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-63" unitRef="usd">17905000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-64" unitRef="usd">20444000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-65" unitRef="usd">7229000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-5" decimals="-3" id="f-66" unitRef="usd">6056000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c-4" decimals="-3" id="f-67" unitRef="usd">562113000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c-5" decimals="-3" id="f-68" unitRef="usd">538088000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-69" unitRef="usd">1027176000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-70" unitRef="usd">966213000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-71" unitRef="usd">49904000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-72" unitRef="usd">49562000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <ameh:FiduciaryAccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-73" unitRef="usd">8603000</ameh:FiduciaryAccountsPayableCurrent>
    <ameh:FiduciaryAccountsPayableCurrent contextRef="c-5" decimals="-3" id="f-74" unitRef="usd">8065000</ameh:FiduciaryAccountsPayableCurrent>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-4" decimals="-3" id="f-75" unitRef="usd">100047000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-5" decimals="-3" id="f-76" unitRef="usd">81255000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-4" decimals="-3" id="f-77" unitRef="usd">20354000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-5" decimals="-3" id="f-78" unitRef="usd">4279000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="c-4" decimals="-3" id="f-79" unitRef="usd">638000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="c-5" decimals="-3" id="f-80" unitRef="usd">664000</us-gaap:DividendsPayableCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-81" unitRef="usd">591000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-82" unitRef="usd">594000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-83" unitRef="usd">3027000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-84" unitRef="usd">3572000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-4" decimals="-3" id="f-85" unitRef="usd">2630000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-5" decimals="-3" id="f-86" unitRef="usd">619000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-87" unitRef="usd">185794000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-88" unitRef="usd">148610000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-4" decimals="-3" id="f-89" unitRef="usd">12335000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-5" decimals="-3" id="f-90" unitRef="usd">14217000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-91" unitRef="usd">1078000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-92" unitRef="usd">1275000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-93" unitRef="usd">17852000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-94" unitRef="usd">19915000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-3" id="f-95" unitRef="usd">205136000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-5" decimals="-3" id="f-96" unitRef="usd">203389000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-97" unitRef="usd">21383000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-5" decimals="-3" id="f-98" unitRef="usd">20260000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-99" unitRef="usd">257784000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-5" decimals="-3" id="f-100" unitRef="usd">259056000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-101" unitRef="usd">443578000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-102" unitRef="usd">407666000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-103" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-104" unitRef="usd" xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-4" decimals="-3" id="f-105" unitRef="usd">13845000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-5" decimals="-3" id="f-106" unitRef="usd">14237000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-10"
      decimals="INF"
      id="f-107"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-11"
      decimals="INF"
      id="f-108"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-10"
      decimals="INF"
      id="f-109"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-11"
      decimals="INF"
      id="f-110"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-11"
      decimals="INF"
      id="f-111"
      unitRef="shares">1111111</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-10"
      decimals="INF"
      id="f-112"
      unitRef="shares">1111111</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-11"
      decimals="INF"
      id="f-113"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-10"
      decimals="INF"
      id="f-114"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-10" decimals="-3" id="f-115" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-11" decimals="-3" id="f-116" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-12"
      decimals="INF"
      id="f-117"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-13"
      decimals="INF"
      id="f-118"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-13"
      decimals="INF"
      id="f-119"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-12"
      decimals="INF"
      id="f-120"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-12"
      decimals="INF"
      id="f-121"
      unitRef="shares">555555</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-13"
      decimals="INF"
      id="f-122"
      unitRef="shares">555555</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-12"
      decimals="INF"
      id="f-123"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-13"
      decimals="INF"
      id="f-124"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-12" decimals="-3" id="f-125" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-13" decimals="-3" id="f-126" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-127"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-128"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-129" unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-130" unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-131" unitRef="shares">46553517</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-132" unitRef="shares">46553517</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-133" unitRef="shares">46575699</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="INF" id="f-134" unitRef="shares">46575699</us-gaap:CommonStockSharesIssued>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="INF" id="f-135" unitRef="shares">10569340</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-5" decimals="INF" id="f-136" unitRef="shares">10299259</us-gaap:TreasuryStockCommonShares>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-137" unitRef="usd">47000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-138" unitRef="usd">47000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-139" unitRef="usd">357246000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-5" decimals="-3" id="f-140" unitRef="usd">360097000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-141" unitRef="usd">208719000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-142" unitRef="usd">182417000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-143" unitRef="usd">566012000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-144" unitRef="usd">542561000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-4" decimals="-3" id="f-145" unitRef="usd">3741000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-5" decimals="-3" id="f-146" unitRef="usd">1749000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-147" unitRef="usd">569753000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-148" unitRef="usd">544310000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-149" unitRef="usd">1027176000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-150" unitRef="usd">966213000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Assets contextRef="c-14" decimals="-5" id="f-151" unitRef="usd">520800000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-15" decimals="-5" id="f-152" unitRef="usd">523700000</us-gaap:Assets>
    <us-gaap:Liabilities contextRef="c-14" decimals="-5" id="f-153" unitRef="usd">136200000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-15" decimals="-5" id="f-154" unitRef="usd">131800000</us-gaap:Liabilities>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-14" decimals="-5" id="f-155" unitRef="usd">325500000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:OtherLiabilities contextRef="c-14" decimals="-5" id="f-156" unitRef="usd">5400000</us-gaap:OtherLiabilities>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-15" decimals="-5" id="f-157" unitRef="usd">304800000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:OtherReceivables contextRef="c-15" decimals="-5" id="f-158" unitRef="usd">30300000</us-gaap:OtherReceivables>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-16" decimals="-3" id="f-159" unitRef="usd">300549000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-17" decimals="-3" id="f-160" unitRef="usd">227623000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-18" decimals="-3" id="f-161" unitRef="usd">600753000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-19" decimals="-3" id="f-162" unitRef="usd">449682000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-20" decimals="-3" id="f-163" unitRef="usd">20121000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-21" decimals="-3" id="f-164" unitRef="usd">18793000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-22" decimals="-3" id="f-165" unitRef="usd">33583000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-23" decimals="-3" id="f-166" unitRef="usd">36868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-24" decimals="-3" id="f-167" unitRef="usd">12493000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-25" decimals="-3" id="f-168" unitRef="usd">9984000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-26" decimals="-3" id="f-169" unitRef="usd">22389000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-27" decimals="-3" id="f-170" unitRef="usd">20457000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-28" decimals="-3" id="f-171" unitRef="usd">13262000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-29" decimals="-3" id="f-172" unitRef="usd">11740000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-30" decimals="-3" id="f-173" unitRef="usd">25324000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-31" decimals="-3" id="f-174" unitRef="usd">22835000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-32" decimals="-3" id="f-175" unitRef="usd">1784000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-33" decimals="-3" id="f-176" unitRef="usd">1557000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-34" decimals="-3" id="f-177" unitRef="usd">3404000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-35" decimals="-3" id="f-178" unitRef="usd">3112000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-36" decimals="-3" id="f-179" unitRef="usd">348209000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-37" decimals="-3" id="f-180" unitRef="usd">269697000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-181" unitRef="usd">685453000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-38" decimals="-3" id="f-182" unitRef="usd">532954000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-36" decimals="-3" id="f-183" unitRef="usd">292876000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-37" decimals="-3" id="f-184" unitRef="usd">230070000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-185" unitRef="usd">582273000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-38" decimals="-3" id="f-186" unitRef="usd">450798000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-36" decimals="-3" id="f-187" unitRef="usd">24056000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-37" decimals="-3" id="f-188" unitRef="usd">19894000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-189" unitRef="usd">45236000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-38" decimals="-3" id="f-190" unitRef="usd">31837000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-36" decimals="-3" id="f-191" unitRef="usd">4248000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-37" decimals="-3" id="f-192" unitRef="usd">4351000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-193" unitRef="usd">8541000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-38" decimals="-3" id="f-194" unitRef="usd">8725000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostsAndExpenses contextRef="c-36" decimals="-3" id="f-195" unitRef="usd">321180000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-37" decimals="-3" id="f-196" unitRef="usd">254315000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-197" unitRef="usd">636050000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-38" decimals="-3" id="f-198" unitRef="usd">491360000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-36" decimals="-3" id="f-199" unitRef="usd">27029000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-37" decimals="-3" id="f-200" unitRef="usd">15382000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-201" unitRef="usd">49403000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-38" decimals="-3" id="f-202" unitRef="usd">41594000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-36" decimals="-3" id="f-203" unitRef="usd">2723000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-37" decimals="-3" id="f-204" unitRef="usd">1512000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-205" unitRef="usd">5207000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-38" decimals="-3" id="f-206" unitRef="usd">2945000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InterestExpense contextRef="c-36" decimals="-3" id="f-207" unitRef="usd">3632000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-37" decimals="-3" id="f-208" unitRef="usd">1854000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-3" id="f-209" unitRef="usd">6901000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-38" decimals="-3" id="f-210" unitRef="usd">2927000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeInterest contextRef="c-36" decimals="-3" id="f-211" unitRef="usd">3327000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-37" decimals="-3" id="f-212" unitRef="usd">421000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-1" decimals="-3" id="f-213" unitRef="usd">6335000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-38" decimals="-3" id="f-214" unitRef="usd">467000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="c-36" decimals="-3" id="f-215" unitRef="usd">859000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="c-37" decimals="-3" id="f-216" unitRef="usd">-1866000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="c-1" decimals="-3" id="f-217" unitRef="usd">-5533000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="c-38" decimals="-3" id="f-218" unitRef="usd">-10829000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-36" decimals="-3" id="f-219" unitRef="usd">1185000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-37" decimals="-3" id="f-220" unitRef="usd">3034000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-221" unitRef="usd">2389000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-38" decimals="-3" id="f-222" unitRef="usd">3647000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-36" decimals="-3" id="f-223" unitRef="usd">4462000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-37" decimals="-3" id="f-224" unitRef="usd">1247000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-225" unitRef="usd">1497000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-38" decimals="-3" id="f-226" unitRef="usd">-6697000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-36" decimals="-3" id="f-227" unitRef="usd">31491000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-37" decimals="-3" id="f-228" unitRef="usd">16629000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-229" unitRef="usd">50900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-38" decimals="-3" id="f-230" unitRef="usd">34897000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-36" decimals="-3" id="f-231" unitRef="usd">14009000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-37" decimals="-3" id="f-232" unitRef="usd">5352000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-233" unitRef="usd">20930000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-38" decimals="-3" id="f-234" unitRef="usd">12170000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss contextRef="c-36" decimals="-3" id="f-235" unitRef="usd">17482000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-37" decimals="-3" id="f-236" unitRef="usd">11277000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-237" unitRef="usd">29970000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-38" decimals="-3" id="f-238" unitRef="usd">22727000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-36" decimals="-3" id="f-239" unitRef="usd">4312000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-37" decimals="-3" id="f-240" unitRef="usd">-673000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-241" unitRef="usd">3668000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-38" decimals="-3" id="f-242" unitRef="usd">-2987000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-36" decimals="-3" id="f-243" unitRef="usd">13170000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-37" decimals="-3" id="f-244" unitRef="usd">11950000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-245" unitRef="usd">26302000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-38" decimals="-3" id="f-246" unitRef="usd">25714000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-36"
      decimals="2"
      id="f-247"
      unitRef="usdPerShare">0.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-37"
      decimals="2"
      id="f-248"
      unitRef="usdPerShare">0.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-249"
      unitRef="usdPerShare">0.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-38"
      decimals="2"
      id="f-250"
      unitRef="usdPerShare">0.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-36"
      decimals="2"
      id="f-251"
      unitRef="usdPerShare">0.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-37"
      decimals="2"
      id="f-252"
      unitRef="usdPerShare">0.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-253"
      unitRef="usdPerShare">0.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-38"
      decimals="2"
      id="f-254"
      unitRef="usdPerShare">0.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-39" decimals="-3" id="f-255" unitRef="usd">14237000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="c-40"
      decimals="INF"
      id="f-256"
      unitRef="shares">46575699</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-40" decimals="-3" id="f-257" unitRef="usd">47000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-41" decimals="-3" id="f-258" unitRef="usd">360097000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-42" decimals="-3" id="f-259" unitRef="usd">182417000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-43" decimals="-3" id="f-260" unitRef="usd">1749000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-261" unitRef="usd">544310000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome contextRef="c-44" decimals="-3" id="f-262" unitRef="usd">-1729000</us-gaap:TemporaryEquityNetIncome>
    <ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-45" decimals="-3" id="f-263" unitRef="usd">13132000</ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-46" decimals="-3" id="f-264" unitRef="usd">1085000</ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-47" decimals="-3" id="f-265" unitRef="usd">14217000</ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c-48"
      decimals="INF"
      id="f-266"
      unitRef="shares">57825</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c-49" decimals="-3" id="f-267" unitRef="usd">-109000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c-47" decimals="-3" id="f-268" unitRef="usd">-109000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <ameh:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants
      contextRef="c-48"
      decimals="INF"
      id="f-269"
      unitRef="shares">125000</ameh:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants>
    <ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants contextRef="c-49" decimals="-3" id="f-270" unitRef="usd">1250000</ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants>
    <ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants contextRef="c-47" decimals="-3" id="f-271" unitRef="usd">1250000</ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-48"
      decimals="INF"
      id="f-272"
      unitRef="shares">270081</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod contextRef="c-49" decimals="-3" id="f-273" unitRef="usd">9539000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod contextRef="c-47" decimals="-3" id="f-274" unitRef="usd">9539000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-49" decimals="-3" id="f-275" unitRef="usd">3445000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-47" decimals="-3" id="f-276" unitRef="usd">3445000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-46" decimals="-3" id="f-277" unitRef="usd">-120000</ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-47" decimals="-3" id="f-278" unitRef="usd">-120000</ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <ameh:TemporaryEquityTransferOfCommonControlEntities contextRef="c-44" decimals="-3" id="f-279" unitRef="usd">1769000</ameh:TemporaryEquityTransferOfCommonControlEntities>
    <ameh:TransferOfCommonControlEntities contextRef="c-49" decimals="-3" id="f-280" unitRef="usd">-2447000</ameh:TransferOfCommonControlEntities>
    <ameh:TransferOfCommonControlEntities contextRef="c-47" decimals="-3" id="f-281" unitRef="usd">-2447000</ameh:TransferOfCommonControlEntities>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-50" decimals="-3" id="f-282" unitRef="usd">14277000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="c-51"
      decimals="INF"
      id="f-283"
      unitRef="shares">46488443</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-51" decimals="-3" id="f-284" unitRef="usd">47000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-52" decimals="-3" id="f-285" unitRef="usd">352697000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-53" decimals="-3" id="f-286" unitRef="usd">195549000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-54" decimals="-3" id="f-287" unitRef="usd">2714000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-55" decimals="-3" id="f-288" unitRef="usd">551007000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome contextRef="c-56" decimals="-3" id="f-289" unitRef="usd">3245000</us-gaap:TemporaryEquityNetIncome>
    <ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-57" decimals="-3" id="f-290" unitRef="usd">13170000</ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-58" decimals="-3" id="f-291" unitRef="usd">1067000</ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-36" decimals="-3" id="f-292" unitRef="usd">14237000</ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-58" decimals="-3" id="f-293" unitRef="usd">50000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-36" decimals="-3" id="f-294" unitRef="usd">50000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-58" decimals="-3" id="f-295" unitRef="usd">106000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-36" decimals="-3" id="f-296" unitRef="usd">106000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c-59"
      decimals="INF"
      id="f-297"
      unitRef="shares">42734</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c-60" decimals="-3" id="f-298" unitRef="usd">-464000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c-36" decimals="-3" id="f-299" unitRef="usd">-464000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-60" decimals="-3" id="f-300" unitRef="usd">4213000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-36" decimals="-3" id="f-301" unitRef="usd">4213000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-59"
      decimals="INF"
      id="f-302"
      unitRef="shares">22340</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-60" decimals="-3" id="f-303" unitRef="usd">800000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-36" decimals="-3" id="f-304" unitRef="usd">800000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:TemporaryEquityAccretionOfDividends contextRef="c-56" decimals="-3" id="f-305" unitRef="usd">-601000</us-gaap:TemporaryEquityAccretionOfDividends>
    <ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-58" decimals="-3" id="f-306" unitRef="usd">-96000</ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-36" decimals="-3" id="f-307" unitRef="usd">-96000</ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <ameh:TemporaryEquityDividendsImpact contextRef="c-36" decimals="-3" id="f-308" unitRef="usd">-3076000</ameh:TemporaryEquityDividendsImpact>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-61" decimals="-3" id="f-309" unitRef="usd">13845000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="c-62"
      decimals="INF"
      id="f-310"
      unitRef="shares">46553517</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-62" decimals="-3" id="f-311" unitRef="usd">47000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-63" decimals="-3" id="f-312" unitRef="usd">357246000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-64" decimals="-3" id="f-313" unitRef="usd">208719000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-65" decimals="-3" id="f-314" unitRef="usd">3741000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-315" unitRef="usd">569753000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-66" decimals="-3" id="f-316" unitRef="usd">56535000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="c-67"
      decimals="INF"
      id="f-317"
      unitRef="shares">44630873</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-67" decimals="-3" id="f-318" unitRef="usd">45000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-68" decimals="-3" id="f-319" unitRef="usd">310876000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-69" decimals="-3" id="f-320" unitRef="usd">137246000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-70" decimals="-3" id="f-321" unitRef="usd">5940000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-71" decimals="-3" id="f-322" unitRef="usd">454107000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome contextRef="c-72" decimals="-3" id="f-323" unitRef="usd">-3252000</us-gaap:TemporaryEquityNetIncome>
    <ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-73" decimals="-3" id="f-324" unitRef="usd">13764000</ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-74" decimals="-3" id="f-325" unitRef="usd">938000</ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-75" decimals="-3" id="f-326" unitRef="usd">14702000</ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-74" decimals="-3" id="f-327" unitRef="usd">200000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-75" decimals="-3" id="f-328" unitRef="usd">200000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-74" decimals="-3" id="f-329" unitRef="usd">36000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-75" decimals="-3" id="f-330" unitRef="usd">36000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-72" decimals="-3" id="f-331" unitRef="usd">230000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c-76"
      decimals="INF"
      id="f-332"
      unitRef="shares">81779</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <ameh:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants
      contextRef="c-76"
      decimals="INF"
      id="f-333"
      unitRef="shares">124735</ameh:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants>
    <ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants contextRef="c-77" decimals="-3" id="f-334" unitRef="usd">1573000</ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants>
    <ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants contextRef="c-75" decimals="-3" id="f-335" unitRef="usd">1573000</ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-77" decimals="-3" id="f-336" unitRef="usd">3055000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-75" decimals="-3" id="f-337" unitRef="usd">3055000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-76"
      decimals="INF"
      id="f-338"
      unitRef="shares">18756</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-77" decimals="-3" id="f-339" unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-75" decimals="-3" id="f-340" unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="c-76"
      decimals="INF"
      id="f-341"
      unitRef="shares">11084</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures contextRef="c-77" decimals="-3" id="f-342" unitRef="usd">457000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures contextRef="c-75" decimals="-3" id="f-343" unitRef="usd">457000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:TemporaryEquityAccretionOfDividends contextRef="c-72" decimals="-3" id="f-344" unitRef="usd">0</us-gaap:TemporaryEquityAccretionOfDividends>
    <ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-74" decimals="-3" id="f-345" unitRef="usd">-1178000</ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-75" decimals="-3" id="f-346" unitRef="usd">-1178000</ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-78" decimals="-3" id="f-347" unitRef="usd">53053000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="c-79"
      decimals="INF"
      id="f-348"
      unitRef="shares">44845059</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-79" decimals="-3" id="f-349" unitRef="usd">45000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-80" decimals="-3" id="f-350" unitRef="usd">316047000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-81" decimals="-3" id="f-351" unitRef="usd">151010000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-82" decimals="-3" id="f-352" unitRef="usd">5536000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-83" decimals="-3" id="f-353" unitRef="usd">472638000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome contextRef="c-84" decimals="-3" id="f-354" unitRef="usd">-2019000</us-gaap:TemporaryEquityNetIncome>
    <ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-85" decimals="-3" id="f-355" unitRef="usd">11950000</ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-86" decimals="-3" id="f-356" unitRef="usd">1346000</ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-37" decimals="-3" id="f-357" unitRef="usd">13296000</ameh:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c-87"
      decimals="INF"
      id="f-358"
      unitRef="shares">108933</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c-88" decimals="-3" id="f-359" unitRef="usd">-253000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c-37" decimals="-3" id="f-360" unitRef="usd">-253000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <ameh:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants
      contextRef="c-87"
      decimals="INF"
      id="f-361"
      unitRef="shares">15718</ameh:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants>
    <ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants contextRef="c-88" decimals="-3" id="f-362" unitRef="usd">165000</ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants>
    <ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants contextRef="c-37" decimals="-3" id="f-363" unitRef="usd">165000</ameh:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-87"
      decimals="INF"
      id="f-364"
      unitRef="shares">250000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod contextRef="c-88" decimals="-3" id="f-365" unitRef="usd">9250000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod contextRef="c-37" decimals="-3" id="f-366" unitRef="usd">9250000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-88" decimals="-3" id="f-367" unitRef="usd">3920000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-37" decimals="-3" id="f-368" unitRef="usd">3920000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance contextRef="c-86" decimals="-3" id="f-369" unitRef="usd">371000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance contextRef="c-37" decimals="-3" id="f-370" unitRef="usd">371000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:TemporaryEquityAccretionOfDividends contextRef="c-84" decimals="-3" id="f-371" unitRef="usd">-10000000</us-gaap:TemporaryEquityAccretionOfDividends>
    <ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-86" decimals="-3" id="f-372" unitRef="usd">-1374000</ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-37" decimals="-3" id="f-373" unitRef="usd">-1374000</ameh:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-89" decimals="-3" id="f-374" unitRef="usd">41034000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="c-90"
      decimals="INF"
      id="f-375"
      unitRef="shares">44719710</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-90" decimals="-3" id="f-376" unitRef="usd">45000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-91" decimals="-3" id="f-377" unitRef="usd">310629000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-92" decimals="-3" id="f-378" unitRef="usd">162960000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-93" decimals="-3" id="f-379" unitRef="usd">5879000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-94" decimals="-3" id="f-380" unitRef="usd">479513000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-381" unitRef="usd">29970000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-38" decimals="-3" id="f-382" unitRef="usd">22727000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-383" unitRef="usd">8541000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-38" decimals="-3" id="f-384" unitRef="usd">8725000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-3" id="f-385" unitRef="usd">474000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-38" decimals="-3" id="f-386" unitRef="usd">474000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-387" unitRef="usd">7658000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-38" decimals="-3" id="f-388" unitRef="usd">6975000</us-gaap:ShareBasedCompensation>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss contextRef="c-1" decimals="-3" id="f-389" unitRef="usd">0</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss contextRef="c-38" decimals="-3" id="f-390" unitRef="usd">2272000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <ameh:UnrealizedGainLossFromInvestmentInEquitySecurities contextRef="c-1" decimals="-3" id="f-391" unitRef="usd">-5485000</ameh:UnrealizedGainLossFromInvestmentInEquitySecurities>
    <ameh:UnrealizedGainLossFromInvestmentInEquitySecurities contextRef="c-38" decimals="-3" id="f-392" unitRef="usd">-13659000</ameh:UnrealizedGainLossFromInvestmentInEquitySecurities>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-393" unitRef="usd">5207000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-38" decimals="-3" id="f-394" unitRef="usd">2945000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c-1" decimals="-3" id="f-395" unitRef="usd">-49000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c-38" decimals="-3" id="f-396" unitRef="usd">2830000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-1" decimals="-3" id="f-397" unitRef="usd">-3746000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-38" decimals="-3" id="f-398" unitRef="usd">3361000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-399" unitRef="usd">17296000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-38" decimals="-3" id="f-400" unitRef="usd">56202000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInDueFromRelatedParties contextRef="c-1" decimals="-3" id="f-401" unitRef="usd">17673000</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
    <us-gaap:IncreaseDecreaseInDueFromRelatedParties contextRef="c-38" decimals="-3" id="f-402" unitRef="usd">12151000</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c-1" decimals="-3" id="f-403" unitRef="usd">-1229000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c-38" decimals="-3" id="f-404" unitRef="usd">3580000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <ameh:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets contextRef="c-1" decimals="-3" id="f-405" unitRef="usd">2277000</ameh:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets>
    <ameh:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets contextRef="c-38" decimals="-3" id="f-406" unitRef="usd">-4109000</ameh:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets>
    <ameh:IncreaseDecreaseInOperatingLeaseAssets contextRef="c-1" decimals="-3" id="f-407" unitRef="usd">3240000</ameh:IncreaseDecreaseInOperatingLeaseAssets>
    <ameh:IncreaseDecreaseInOperatingLeaseAssets contextRef="c-38" decimals="-3" id="f-408" unitRef="usd">2290000</ameh:IncreaseDecreaseInOperatingLeaseAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-1" decimals="-3" id="f-409" unitRef="usd">21000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-38" decimals="-3" id="f-410" unitRef="usd">-1790000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-3" id="f-411" unitRef="usd">-2864000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-38" decimals="-3" id="f-412" unitRef="usd">14181000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable contextRef="c-1" decimals="-3" id="f-413" unitRef="usd">538000</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable contextRef="c-38" decimals="-3" id="f-414" unitRef="usd">-4464000</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <ameh:IncreaseDecreaseInMedicalLiabilities contextRef="c-1" decimals="-3" id="f-415" unitRef="usd">13335000</ameh:IncreaseDecreaseInMedicalLiabilities>
    <ameh:IncreaseDecreaseInMedicalLiabilities contextRef="c-38" decimals="-3" id="f-416" unitRef="usd">55106000</ameh:IncreaseDecreaseInMedicalLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-1" decimals="-3" id="f-417" unitRef="usd">15396000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-38" decimals="-3" id="f-418" unitRef="usd">-14010000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-419" unitRef="usd">-3309000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-38" decimals="-3" id="f-420" unitRef="usd">-2254000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-1" decimals="-3" id="f-421" unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-38" decimals="-3" id="f-422" unitRef="usd">370000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-423" unitRef="usd">33522000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-38" decimals="-3" id="f-424" unitRef="usd">33059000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-1" decimals="-3" id="f-425" unitRef="usd">-350000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-38" decimals="-3" id="f-426" unitRef="usd">858000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties contextRef="c-1" decimals="-3" id="f-427" unitRef="usd">2143000</us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties>
    <us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties contextRef="c-38" decimals="-3" id="f-428" unitRef="usd">4030000</us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-1" decimals="-3" id="f-429" unitRef="usd">2022000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-38" decimals="-3" id="f-430" unitRef="usd">1750000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment contextRef="c-1" decimals="-3" id="f-431" unitRef="usd">2000000</us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment>
    <us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment contextRef="c-38" decimals="-3" id="f-432" unitRef="usd">0</us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-433" unitRef="usd">325000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-38" decimals="-3" id="f-434" unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-435" unitRef="usd">17367000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-38" decimals="-3" id="f-436" unitRef="usd">18845000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-1" decimals="-3" id="f-437" unitRef="usd">0</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-38" decimals="-3" id="f-438" unitRef="usd">6480000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital contextRef="c-1" decimals="-3" id="f-439" unitRef="usd">0</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital contextRef="c-38" decimals="-3" id="f-440" unitRef="usd">400000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <ameh:PaymentsToEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-441" unitRef="usd">0</ameh:PaymentsToEquityMethodInvestments>
    <ameh:PaymentsToEquityMethodInvestments contextRef="c-38" decimals="-3" id="f-442" unitRef="usd">1685000</ameh:PaymentsToEquityMethodInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-443" unitRef="usd">-19221000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-38" decimals="-3" id="f-444" unitRef="usd">-12228000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDividends contextRef="c-1" decimals="-3" id="f-445" unitRef="usd">842000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends contextRef="c-38" decimals="-3" id="f-446" unitRef="usd">12556000</us-gaap:PaymentsOfDividends>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-1" decimals="-3" id="f-447" unitRef="usd">312000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-38" decimals="-3" id="f-448" unitRef="usd">200000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations contextRef="c-1" decimals="-3" id="f-449" unitRef="usd">303000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations contextRef="c-38" decimals="-3" id="f-450" unitRef="usd">283000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-1" decimals="-3" id="f-451" unitRef="usd">1250000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-38" decimals="-3" id="f-452" unitRef="usd">1738000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-3" id="f-453" unitRef="usd">9539000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-38" decimals="-3" id="f-454" unitRef="usd">9480000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders contextRef="c-1" decimals="-3" id="f-455" unitRef="usd">0</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders contextRef="c-38" decimals="-3" id="f-456" unitRef="usd">38000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <ameh:PurchaseOfNonControllingInterest contextRef="c-1" decimals="-3" id="f-457" unitRef="usd">50000</ameh:PurchaseOfNonControllingInterest>
    <ameh:PurchaseOfNonControllingInterest contextRef="c-38" decimals="-3" id="f-458" unitRef="usd">199000</ameh:PurchaseOfNonControllingInterest>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt contextRef="c-1" decimals="-3" id="f-459" unitRef="usd">1734000</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt contextRef="c-38" decimals="-3" id="f-460" unitRef="usd">1237000</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-461" unitRef="usd">-8062000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-38" decimals="-3" id="f-462" unitRef="usd">-19705000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-463" unitRef="usd">6239000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-38" decimals="-3" id="f-464" unitRef="usd">1126000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-465" unitRef="usd">288027000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-71" decimals="-3" id="f-466" unitRef="usd">233097000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-467" unitRef="usd">294266000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-94" decimals="-3" id="f-468" unitRef="usd">234223000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaid contextRef="c-1" decimals="-3" id="f-469" unitRef="usd">7881000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-38" decimals="-3" id="f-470" unitRef="usd">22311000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-471" unitRef="usd">6264000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-38" decimals="-3" id="f-472" unitRef="usd">2231000</us-gaap:InterestPaidNet>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-473" unitRef="usd">701000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-38" decimals="-3" id="f-474" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <ameh:TemporaryEquityDividendsImpact contextRef="c-1" decimals="-3" id="f-475" unitRef="usd">3076000</ameh:TemporaryEquityDividendsImpact>
    <ameh:TemporaryEquityDividendsImpact contextRef="c-38" decimals="-3" id="f-476" unitRef="usd">0</ameh:TemporaryEquityDividendsImpact>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-1" decimals="-3" id="f-477" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-38" decimals="-3" id="f-478" unitRef="usd">398000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:StockIssued1 contextRef="c-1" decimals="-3" id="f-479" unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-38" decimals="-3" id="f-480" unitRef="usd">1000000</us-gaap:StockIssued1>
    <us-gaap:MortgageLoanRelatedToPropertySales1 contextRef="c-1" decimals="-3" id="f-481" unitRef="usd">0</us-gaap:MortgageLoanRelatedToPropertySales1>
    <us-gaap:MortgageLoanRelatedToPropertySales1 contextRef="c-38" decimals="-3" id="f-482" unitRef="usd">16275000</us-gaap:MortgageLoanRelatedToPropertySales1>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-483" unitRef="usd">293921000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-484" unitRef="usd">293921000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-94" decimals="-3" id="f-485" unitRef="usd">234223000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashEquivalentsCurrent contextRef="c-4" decimals="-3" id="f-486" unitRef="usd">345000</us-gaap:RestrictedCashEquivalentsCurrent>
    <us-gaap:RestrictedCashEquivalentsCurrent contextRef="c-4" decimals="-3" id="f-487" unitRef="usd">345000</us-gaap:RestrictedCashEquivalentsCurrent>
    <us-gaap:RestrictedCashEquivalentsCurrent contextRef="c-94" decimals="-3" id="f-488" unitRef="usd">0</us-gaap:RestrictedCashEquivalentsCurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-489" unitRef="usd">294266000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-94" decimals="-3" id="f-490" unitRef="usd">234223000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NatureOfOperations contextRef="c-1" id="f-491">Description of Business&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Apollo Medical Holdings, Inc. (&#x201c;ApolloMed&#x201d;) is a leading physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to participate successfully in value-based care arrangements, thus empowering them to deliver high-quality care to patients in a cost-effective manner. ApolloMed was merged with Network Medical Management (&#x201c;NMM&#x201d;) in December 2017 (the &#x201c;2017 Merger&#x201d;). As a result of the 2017 Merger, NMM became a wholly owned subsidiary of ApolloMed, and the former NMM shareholders own a majority of the issued and outstanding common stock of ApolloMed and maintain control of the board of directors. Unless the context dictates otherwise, references in these notes to the financial statements, the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; and similar words are references to ApolloMed and its consolidated subsidiaries and affiliated entities, as appropriate, including its consolidated variable interest entities (&#x201c;VIEs&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Headquartered in Alhambra, California, ApolloMed&#x2019;s subsidiaries and VIEs include management services organizations (&#x201c;MSOs&#x201d;), affiliated independent practice associations (&#x201c;IPAs&#x201d;), an accountable care organization (&#x201c;ACO&#x201d;) participating in the ACO Realizing Equity, Access, and Community Health (&#x201c;ACO REACH&#x201d;) model, and clinical operations. Together, ApolloMed provides value-based care enablement services and care delivery with our consolidated care partners. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company&#x2019;s physician network consists of primary care physicians, specialist physicians, and hospitalists. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reportable segments changed from one to three in the first quarter of 2023 as a result of certain changes to the information regularly provided to the Company&#x2019;s chief operating decision makers (&#x201c;CODMs&#x201d;) when reviewing the Company&#x2019;s performance as well as an effort to provide additional transparency to investors and other financial statement users. The three segments identified by the Company are Care Enablement, Care Partners and Care Delivery, which are described as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Care Enablement segment is an integrated, end-to-end clinical and administrative platform, powered by our proprietary technology suite, which provides operational, clinical, financial, technology, management, and strategic services in order to enable success in the delivery of high-quality, value-based care for providers and payers. We provide solutions to providers, including independent physicians, provider and medical groups, and accountable care organizations, and payers, including health plans and other risk-bearing organizations. Our platform meets providers and payers where they are, with a wide spectrum of solutions across the total cost of care risk spectrum, ranging from solutions for fee-for-service entities to global risk-bearing entities, and across patient types, including Medicare, Medicaid, commercial, and exchange-insured patients. This segment includes our wholly owned subsidiaries which operate as management services organizations, NMM and Apollo Medical Management (&#x201c;AMM&#x201d;), which enter into long-term management and/or administrative services agreements with providers and payers. By leveraging our care enablement platform, providers and payers can improve their ability to deliver high-quality care to their patients and achieve better patient outcomes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners with a shared vision for coordinated care delivery. By leveraging our unique care enablement platform and ability to recruit, empower, and incentivize physicians to effectively manage total cost of care, we are able to organize partnered providers into successful multi-payer risk-bearing organizations which take on varying levels of risk based on total cost of care across membership in all lines of business, including Medicare, Medicaid, commercial, and exchange. Through our network of IPAs, ACOs, and Restricted Knox-Keene licensed health plan, our healthcare delivery entities are responsible for coordinating and delivering high-quality care to our patients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated IPAs consist of the following: (i) Allied Physicians of California, a Professional Medical Corporation d.b.a. Allied Pacific of California IPA (&#x201c;APC&#x201d;), (ii) Alpha Care Medical Group, Inc. (&#x201c;Alpha Care&#x201d;), (iii) Accountable Health Care IPA, a Professional Medical Corporation (&#x201c;Accountable Health Care&#x201d;), (iv) Jade Health Care Medical Group, Inc. (&#x201c;Jade&#x201d;), (v) Access Primary Care Medical Group (&#x201c;APCMG&#x201d;), and (vi) All American Medical Group (&#x201c;AAMG&#x201d;).  The Company&#x2019;s ACO operates under the APA ACO, Inc. (&#x201c;APAACO&#x201d;) brand and participates in the Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;) program that allows provider groups to assume higher levels of financial risk and potentially achieve a higher reward from participation in the program&#x2019;s attribution-based risk-sharing model. The Company&#x2019;s Restricted Knox-Keene licensed health plan is held by For Your Benefit Inc. (&#x201c;FYB&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Care Delivery&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients. Our care delivery organization includes primary care, multi-specialty care, and ancillary care services. This segment includes our primary care clinics, operating under the AMG, a Professional Medical Corporation (&#x201c;AMG&#x201d;) and Valley Oaks Medical Group (&#x201c;VOMG&#x201d;) brands, our multi-specialty care clinics and medical groups, operating under the ApolloMed Hospitalists, a Medical Corporation (&#x201c;AMH&#x201d;), Southern California Heart Centers, a Medical Corporation (&#x201c;SCHC&#x201d;), and AllCare Women&#x2019;s Health brands, and our ancillary service providers, operating under the 1 World Medicine Urgent Care Corporation (&#x201c;1 World&#x201d;), DMG, Concourse Diagnostic Surgery Center, LLC (&#x201c;CDSC&#x201d;), and Sun Clinical Laboratories (&#x201c;Sun Labs&#x201d;) brands.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 23, 2023, AP-AMH 2 purchased 100% of the shares of capital stock of AMG,1 World, and Eleanor Leung M.D., a Professional Medical Corporation from APC-LSMA. As a result of these purchases, these entities are consolidated entities of AP-AMH 2. AMG provides professional and post-acute care services to patients through its network of doctors and nurse practitioners, 1 World is an urgent care center, and Eleanor Leung M.D. provides specialized care for women&#x2019;s health operating as AllCare Women&#x2019;s Health.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a financing obligation to purchase the remaining equity interest in DMG and Sun Labs within three years from the date the Company consolidated DMG and Sun Labs. The purchase of the remaining DMG equity value is considered a financing obligation with a carrying value of $8.5&#160;million as of June&#160;30, 2023 and December&#160;31, 2022. The purchase of the remaining Sun Labs equity value is considered a financing obligation with a carrying value of $7.6 million and $5.8 million as of June&#160;30, 2023 and December&#160;31, 2022, respectively. For the six months ended June&#160;30, 2023, the change in the fair value of  Sun Labs equity value obligation is $1.8 million and is presented in unrealized loss on investments in the accompanying consolidated statement of income. As the financing obligations are embedded in the non-controlling interest, the non-controlling interests are recognized in other long-term liabilities in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Affiliates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our other affiliates are not included as a reportable segment and primarily consist of real estate operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;APC owns a 100% equity interest in each of Medical Property Partners, LLC (&#x201c;MPP&#x201d;), AMG Properties, LLC (&#x201c;AMG Properties&#x201d;), ZLL Partners, LLC (&#x201c;ZLL&#x201d;)&#x201d;), Tag-8 Medical Investment Group, LLC (&#x201c;Tag 8&#x201d;), and Tag-6 Medical Investment Group, LLC (&#x201c;Tag 6&#x201d;), and a 50% interest in each of One MSO, LLC (&#x201c;One MSO&#x201d;). These entities are deemed Excluded Assets that are solely for the benefit of APC and its shareholders. As such, any income pertaining to APC&#x2019;s interests in these properties has no impact on the Series A Dividend payable by APC to AP-AMH Medical Corporation, and consequently will not affect net income attributable to ApolloMed.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-95"
      decimals="INF"
      id="f-492"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-47"
      decimals="INF"
      id="f-493"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-494"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-96"
      decimals="INF"
      id="f-495"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase contextRef="c-97" id="f-496">P3Y</ameh:BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase>
    <us-gaap:EquityMethodInvestments contextRef="c-98" decimals="-5" id="f-497" unitRef="usd">8500000</us-gaap:EquityMethodInvestments>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-99" decimals="-5" id="f-498" unitRef="usd">7600000</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-100" decimals="-5" id="f-499" unitRef="usd">5800000</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation contextRef="c-101" decimals="-5" id="f-500" unitRef="usd">1800000</ameh:BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation>
    <ameh:AssetAcquisitionPercentageOfSharesAcquired
      contextRef="c-102"
      decimals="INF"
      id="f-501"
      unitRef="number">1</ameh:AssetAcquisitionPercentageOfSharesAcquired>
    <ameh:AssetAcquisitionPercentageOfSharesAcquired
      contextRef="c-103"
      decimals="INF"
      id="f-502"
      unitRef="number">0.50</ameh:AssetAcquisitionPercentageOfSharesAcquired>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="c-1" id="f-503">Basis of Presentation and Summary of Significant Accounting Policies&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated balance sheet at December&#160;31, 2022 has been derived from the Company&#x2019;s audited consolidated financial statements, but does not include all annual disclosures required by generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;). The accompanying unaudited consolidated financial statements as of June&#160;30, 2023, and for the three and six months ended June&#160;30, 2023 and 2022, have been prepared in accordance with U.S. GAAP for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, these unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes to the financial statements included in the Company&#x2019;s Annual Report on Form 10-K/A for the year ended December&#160;31, 2022, as filed with the SEC on August&#160;9, 2023. In the opinion of management, all material adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been made to make the consolidated financial statements not misleading, as required by Regulation S-X, Rule 10-01. Operating results for the three and six months ended June&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023, or any future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated balance sheets as of June&#160;30, 2023 and December&#160;31, 2022, and the consolidated statements of income for the three and six months ended June&#160;30, 2023 and 2022, include (i) ApolloMed, ApolloMed&#x2019;s consolidated subsidiaries, NMM, AMM, APAACO, Orma Health Inc, Provider Growth Solutions, LLC, and FYB and its VIEs, AP-AMH, AP-AMH 2, Sun Labs, DMG, and Valley Oaks Medical Group (&#x201c;VOMG&#x201d;); (ii) AP-AMH 2&#x2019;s consolidated subsidiaries, APCMG, Jade, AAMG, AMG, 1 World, and Eleanor Leung M.D., a Professional Medical Corporation; (iii) AMM&#x2019;s consolidated VIEs, SCHC and AMH; (iv) NMM&#x2019;s VIE, APC;(v) APC&#x2019;s consolidated subsidiaries, Universal Care Acquisition Partners, LLC (&#x201c;UCAP&#x201d;), MPP, AMG Properties, ZLL, ICC, 120 Hellman LLC (&#x201c;120 Hellman&#x201d;) and its VIEs, CDSC, APC-LSMA, Tag 8, and Tag 6; and (vi) APC-LSMA&#x2019;s consolidated subsidiaries, Alpha Care and Accountable Health Care.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited consolidated interim financial statements have been prepared under the assumption that users of the interim financial data have either read or have access to our audited consolidated financial statements for the fiscal year ended December&#160;31, 2022. Accordingly, certain disclosures that would substantially duplicate the disclosures contained in our December&#160;31, 2022, audited consolidated financial statements have been omitted. These unaudited consolidated interim financial statements should be read in conjunction with our audited consolidated financial statements for the fiscal year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restatement of Previously Issued Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company filed Amendment No. 1 on Form 10-K (&#x201c;Form 10-K/A&#x201d;)  and Amendment No. 1 on Form 10-Q (&#x201c;Form 10-Q/A&#x201d;) with the SEC on August&#160;9, 2023 to restate previously issued consolidated financial statements and financial information as of December 31, 2022 and 2021 and for the fiscal years ended December 31, 2022, 2021 and 2020 in the Form 10-K/A and unaudited consolidated financial statements and financial information as of March 31, 2023 and for each of the three months ended March 31, 2023 and 2022 in the Form 10-Q/A. The Form 10-K/A also provided restated interim financial information for the quarterly fiscal 2022 periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combination and goodwill valuation and impairment, accrual of medical liabilities (incurred but not reported (&#x201c;IBNR&#x201d;) claims), determination of full-risk and shared-risk revenue and receivables (including constraints, completion factors and historical margins), income tax-valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On an ongoing basis, as circumstances indicate the need for reconsideration, the Company evaluates each legal entity that is not wholly owned by the Company in accordance with the consolidation guidance. The evaluation considers all of the Company&#x2019;s variable interests, including equity ownership, as well as management services agreements. To fall within the scope of the consolidation guidance, an entity must meet both of the following criteria:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The entity has a legal structure that has been established to conduct business activities and to hold assets; such entity can be in the form of a partnership, limited liability company, or corporation, among others; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Company has a variable interest in the legal entity; i.e., variable interests that are contractual, such as equity ownership, or other financial interests that change with changes in the fair value of the entity&#x2019;s net assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If an entity does not meet both criteria above, the Company applies other accounting guidance, such as the cost or equity method of accounting. If an entity does meet both criteria above, the Company evaluates such entity for consolidation under either the variable interest model if the legal entity meets any of the following characteristics to qualify as a VIE, or under the voting model for all other legal entities that are not VIEs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A legal entity is determined to be a VIE if it has any of the following three characteristics:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The entity does not have sufficient equity to finance its activities without additional subordinated financial support;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The entity is established with non-substantive voting rights (i.e., where the entity deprives the majority economic interest holder(s) of voting rights); or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The equity holders, as a group, lack the characteristics of a controlling financial interest. Equity holders meet this criterion if they lack any of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The power, through voting rights or similar rights, to direct the activities of the entity that most significantly influence the entity&#x2019;s economic performance, as evidenced by:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Substantive participating rights in the day-to-day management of the entity&#x2019;s activities; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Substantive kick-out rights over the party responsible for significant decisions;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The obligation to absorb the entity&#x2019;s expected losses; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The right to receive the entity&#x2019;s expected residual returns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company determines that any of the three characteristics of a VIE are met under Accounting Standards Codification (&#x201c;ASC&#x201d;) 810, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company will conclude that the entity is a VIE and evaluate it for consolidation under the variable interest model.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Model&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company consolidates a VIE if both power and benefits belong to the Company; that is, the Company (i) has the power to direct the activities of a VIE that most significantly influence the VIE&#x2019;s economic performance (power), and (ii) has the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE (economics). The Company consolidates VIEs whenever it is determined that the Company is the primary beneficiary. Refer to Note 16 &#x2014; &#x201c;Variable Interest Entities (VIEs)&#x201d; to the consolidated financial statements for information on the Company&#x2019;s consolidated VIEs. If there are variable interests in a VIE, but the Company is not the primary beneficiary, the Company may account for the investment using the equity method of accounting.&lt;br/&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reportable Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, the Company operates in three reportable segments: Care Enablement, Care Partners, and Care Delivery. Refer to Note 1 &#x2014; &#x201c;Description of Business&#x201d; and Note 18 &#x2014; &#x201c;Segments&#x201d; to the consolidated financial statements for information on the Company&#x2019;s segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s cash and cash equivalents primarily consist of money market funds and certificates of deposit. The Company considers all highly liquid investments that are both readily convertible into known amounts of cash and mature within ninety days from their date of purchase to be cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains its cash in deposit accounts with several banks, which at times may&#160;exceed the insured limits of the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;). The Company believes it is not exposed to any significant credit risk with respect to its cash and cash equivalents. As of June&#160;30, 2023 and December&#160;31, 2022, the Company&#x2019;s deposit accounts with banks exceeded the FDIC&#x2019;s insured limit by approximately $326.8 million and $324.7 million, respectively. The Company has not experienced any losses to date and performs ongoing evaluations of these financial institutions to limit the Company&#x2019;s concentration of risk exposure.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in marketable securities consist of equity securities and certificates of deposit with various financial institutions. The appropriate classification of investments is determined at the time of purchase, and such designation is reevaluated at each balance sheet date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certificates of deposit are reported at par value, plus accrued interest, with maturity dates greater than ninety days. As of June&#160;30, 2023 and December&#160;31, 2022, certificates of deposit amounted to approximately $2.0 million and $0, respectively. Investments in certificates of deposit are classified as Level 1 investments in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities are reported at fair value. These securities are classified as Level 1 in the valuation hierarchy, where quoted market prices from reputable third-party brokers are available in an active market and unadjusted. Equity securities with low trading volume are determined to not have an active market with buyers and sellers ready to trade. Accordingly, we classify such equity securities as Level 2 in the valuation hierarchy, and their valuation is based on weighted average share prices from observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities held by the Company are primarily comprised of common stock of a payor partner that completed its initial public offering (&#x201c;IPO&#x201d;) in June 2021 and Nutex Health Inc. (formerly known as Clinigence Holdings, Inc.) (&#x201c;Nutex&#x201d;). In May 2022, the Company exercised warrants from Nutex and subsequently recognized the shares within investments in marketable securities in the accompanying consolidated balance sheet. In March 2023, the contingent equity securities were settled and the Company received additional Nutex common stock. The additional common stock received from the contingent equity securities is included in investments in marketable securities in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023 and December&#160;31, 2022, the equity securities were approximately $1.8 million and $5.6&#160;million, respectively, in the accompanying consolidated balance sheets. Gains and losses recognized on equity securities sold are recognized in the accompanying consolidated statements of income under other income. The components comprising total gains and losses on equity securities are as follows (in thousands) for the periods listed below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.456%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.001%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Total losses recognized on equity securities  &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Gains recognized on equity securities sold  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Unrealized losses recognized on equity securities held at end of period  &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,614)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Receivables,  Receivables &#x2013; Related Parties, Other Receivables and Loan Receivable - Related Party&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s receivables are comprised of accounts receivable, capitation and claims receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivable are recorded and stated at the amount expected to be collected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s receivables &#x2013; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#x2013; related parties are recorded and stated at the amount expected to be collected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s loan receivable and loan receivable &#x2013; related party consists of promissory notes that accrue interest per annum. As of June&#160;30, 2023, promissory notes are expected to be collected within 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitation and claims receivables relate to each health plan&#x2019;s capitation and are received by the Company in the month following the month of service. Risk pool settlements and incentive receivables mainly consist of the Company&#x2019;s full risk pool receivable, which is recorded quarterly based on reports received from the Company&#x2019;s hospital partners and management&#x2019;s estimate of the Company&#x2019;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately 18 months after the risk pool performance year is completed. Other receivables consist of receivables from fee-for-services (&#x201c;FFS&#x201d;) reimbursement for patient care, certain expense reimbursements, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains reserves for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer creditworthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected and adjustments are recorded when necessary. Reserves are recorded primarily on a specific identification basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided and collection is reasonably likely to occur. In regard to the credit loss standard, the Company continuously monitors its collections of receivables and our expectation is that the historical credit loss experienced across our receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#x201c;CECL&#x201d;) model. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disaggregates revenue from contracts by service type and payor type. This level of detail provides useful information pertaining to how the Company generates revenue by significant revenue stream and by type of direct contracts. The consolidated statements of income present disaggregated revenue by service type. The following table presents disaggregated revenue generated by payor type for the three and six months ended June&#160;30, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.122%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicaid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other third parties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had major payors that contributed the following percentages of net revenue:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.122%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payor A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payor B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; *Less than 10% of total net revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had major payors that contributed to the following percentages of receivables and receivables &#x2013; related parties:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Restated)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payor B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payor C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial instruments consist of cash and cash equivalents, fiduciary cash, investment in marketable securities, receivables, loans receivable, accounts payable, certain accrued expenses, finance lease obligations, and long-term debt. The carrying values of the financial instruments classified as current in the accompanying consolidated balance sheets are considered to be at their fair values, due to the short maturity of these instruments. The carrying amounts of finance lease obligations and long-term debt approximate fair value as they bear interest at rates that approximate current market rates for debt with similar maturities and credit quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 820&#x201d;), applies to all financial assets and financial liabilities that are measured and reported on a fair value basis and requires disclosure that establishes a framework for measuring fair value and expands disclosure about fair value measurements. ASC&#160;820 establishes a fair value hierarchy for disclosure of the inputs to valuations used to measure fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no changes in Level 1, Level 2, or Level 3 classification and no changes in valuation techniques for the six months ended June&#160;30, 2023. This hierarchy prioritizes the inputs into three broad levels as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that can be accessed at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates and yield curves), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Unobservable inputs that reflect assumptions about what market participants would use in pricing the asset or liability. These inputs would be based on the best information available, including the Company&#x2019;s own data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts and fair values of the Company&#x2019;s financial instruments as of June&#160;30, 2023, are presented below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market accounts*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities &#x2013; certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities &#x2013; equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate collar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APCMG contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;AAMG contingent consideration (see Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;VOMG contingent consideration (see Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DMG remaining equity interest purchase (see Note 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sun labs remaining equity interest purchase (see Note 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&#160;&#160;&#160;&#160;Included in cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts and fair values of the Company&#x2019;s financial instruments as of December&#160;31, 2022, are presented below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market accounts*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities &#x2013; equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APCMG contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AAMG contingent consideration (see Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VOMG contingent consideration (see Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DMG remaining equity interest purchase (see Note 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sun labs remaining equity interest purchase (see Note 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&#160;&#160;&#160;&#160;Included in cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the fair value of Level 3 liabilities for the six months ended June&#160;30, 2023 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gain recognized from change in fair value of existing Level 3 liabilities*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* The change in the fair value of existing Level 3 liabilities is presented in unrealized loss on investments in the accompanying consolidated statement of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Rate Swap and Collar Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to interest rate risk on its floating-rate debt. The Company has entered into interest rate swap and collar agreements to effectively convert its floating-rate debt to a fixed-rate basis or to a rate within the agreed-upon range. The principal objective of these contracts is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#x2019;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 9 &#x2014; &#x201c;Credit Facility, Bank Loans, and Lines of Credit&#x201d; for further information on our debt. Interest rate swap and collar agreements are not designated as hedging instruments. Changes in the fair value on these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and reflected in the accompanying consolidated statements of cash flows as unrealized gain or loss on interest rate swaps.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the interest rate swap was determined using Level 2 inputs. As of June&#160;30, 2023 and December&#160;31, 2022, the fair value of the interest rate swap was $3.1 million and $3.2&#160;million, respectively, and are presented within other assets in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s collar agreement is designed to limit the interest rate risk associated with the Company&#x2019;s Revolver Loan.  Under the terms of the agreement, the ceiling is 5.0% and the floor is 2.34%.  The estimated fair value of the collar is determined using Level 2.  As of June&#160;30, 2023 the fair value of the collar is  $1.2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Contingent Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the common stock and warrants purchased under the stock purchase agreement between ApolloMed and Nutex, ApolloMed is entitled to additional common stock if Nutex did not pay NMM management fees exceeding a threshold by the end of December 31, 2022. The contingent equity securities are considered to be derivatives but are not designated as hedging instruments. Changes in the fair value of these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and the accompanying consolidated statements of cash flows. The Company determined the fair value of the contingent equity security using a probability-weighted model, which includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of recognizing management fees and assigned probabilities to each such scenario in determining fair value. Based on the outcome, the metric was not achieved and the Company received additional common stock during the six months ended June&#160;30, 2023. As of June&#160;30, 2023, the common stock from the contingent equity securities is recognized within investments in marketable securities in the accompanying consolidated balance sheet. See Note 2 &#x2014; &#x201c;Basis of Presentation and Summary of Significant Accounting Policies - Investment in Marketable Securities&#x201d; in the accompanying consolidated financial statements for information on the treatment of the marketable securities. As of December&#160;31, 2022, the contingent equity securities were valued at $1.9 million, and were presented within prepaid and other current assets in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company receives payments from the following sources for services rendered: (i) commercial insurers; (ii) the federal government under the Medicare program administered by CMS; (iii) state governments under the Medicaid and other programs; (iv) other third-party payors (e.g., hospitals and IPAs); and (v) individual patients and clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue primarily consists of capitation revenue, risk pool settlements and incentives, GPDC/ACO REACH revenue, management fee income, and FFS revenue. Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;GPDC/ACO REACH Capitation Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS contracts with Direct Contracting Entities (&#x201c;DCEs&#x201d;), which are composed of healthcare providers operating under a common legal structure and accept financial accountability for the overall quality and cost of medical care furnished to Medicare FFS beneficiaries aligned to the entity. The combination of the FFS model and the GPDC and ACO REACH model changes the distribution of responsibilities, risks, costs, and rewards among CMS, DCEs, and providers. By entering into a contract with CMS, a DCE voluntarily takes on operational, financial, and legal responsibilities and risks that no party has, individually or collectively, under the existing FFS model. Each DCE bears the economic costs, and reaps the economic rewards of fulfilling its responsibilities and managing its risks as a DCE. APAACO participated in the GPDC Model for Performance Year 2022 and is currently participating in the ACO REACH model for Performance Year 2023, beginning January 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each performance year, CMS will pay a total benchmark amount, determined unilaterally by CMS in advance but subject to prospective adjustments throughout the year, for the totality of care provided to the DCE&#x2019;s population of aligned beneficiaries over the course of that year. The benchmark is net of a quality withholding applied by CMS. At the end of each performance year, a portion, or all, of the quality withholding can be earned based on APAACO&#x2019;s performance. GPDC/ACO REACH capitation revenue is recognized based on the estimated transaction price to transfer the service for a distinct increment of the series (i.e., month) and is recognized net of quality incentives/penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted for both items that do not have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the consolidated financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-504">Basis of PresentationThe accompanying consolidated balance sheet at December&#160;31, 2022 has been derived from the Company&#x2019;s audited consolidated financial statements, but does not include all annual disclosures required by generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;). The accompanying unaudited consolidated financial statements as of June&#160;30, 2023, and for the three and six months ended June&#160;30, 2023 and 2022, have been prepared in accordance with U.S. GAAP for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, these unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes to the financial statements included in the Company&#x2019;s Annual Report on Form 10-K/A for the year ended December&#160;31, 2022, as filed with the SEC on August&#160;9, 2023. In the opinion of management, all material adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been made to make the consolidated financial statements not misleading, as required by Regulation S-X, Rule 10-01.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-505">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated balance sheets as of June&#160;30, 2023 and December&#160;31, 2022, and the consolidated statements of income for the three and six months ended June&#160;30, 2023 and 2022, include (i) ApolloMed, ApolloMed&#x2019;s consolidated subsidiaries, NMM, AMM, APAACO, Orma Health Inc, Provider Growth Solutions, LLC, and FYB and its VIEs, AP-AMH, AP-AMH 2, Sun Labs, DMG, and Valley Oaks Medical Group (&#x201c;VOMG&#x201d;); (ii) AP-AMH 2&#x2019;s consolidated subsidiaries, APCMG, Jade, AAMG, AMG, 1 World, and Eleanor Leung M.D., a Professional Medical Corporation; (iii) AMM&#x2019;s consolidated VIEs, SCHC and AMH; (iv) NMM&#x2019;s VIE, APC;(v) APC&#x2019;s consolidated subsidiaries, Universal Care Acquisition Partners, LLC (&#x201c;UCAP&#x201d;), MPP, AMG Properties, ZLL, ICC, 120 Hellman LLC (&#x201c;120 Hellman&#x201d;) and its VIEs, CDSC, APC-LSMA, Tag 8, and Tag 6; and (vi) APC-LSMA&#x2019;s consolidated subsidiaries, Alpha Care and Accountable Health Care.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited consolidated interim financial statements have been prepared under the assumption that users of the interim financial data have either read or have access to our audited consolidated financial statements for the fiscal year ended December&#160;31, 2022. Accordingly, certain disclosures that would substantially duplicate the disclosures contained in our December&#160;31, 2022, audited consolidated financial statements have been omitted. These unaudited consolidated interim financial statements should be read in conjunction with our audited consolidated financial statements for the fiscal year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-506">Use of EstimatesThe preparation of the consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combination and goodwill valuation and impairment, accrual of medical liabilities (incurred but not reported (&#x201c;IBNR&#x201d;) claims), determination of full-risk and shared-risk revenue and receivables (including constraints, completion factors and historical margins), income tax-valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="c-1" id="f-507">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On an ongoing basis, as circumstances indicate the need for reconsideration, the Company evaluates each legal entity that is not wholly owned by the Company in accordance with the consolidation guidance. The evaluation considers all of the Company&#x2019;s variable interests, including equity ownership, as well as management services agreements. To fall within the scope of the consolidation guidance, an entity must meet both of the following criteria:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The entity has a legal structure that has been established to conduct business activities and to hold assets; such entity can be in the form of a partnership, limited liability company, or corporation, among others; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Company has a variable interest in the legal entity; i.e., variable interests that are contractual, such as equity ownership, or other financial interests that change with changes in the fair value of the entity&#x2019;s net assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If an entity does not meet both criteria above, the Company applies other accounting guidance, such as the cost or equity method of accounting. If an entity does meet both criteria above, the Company evaluates such entity for consolidation under either the variable interest model if the legal entity meets any of the following characteristics to qualify as a VIE, or under the voting model for all other legal entities that are not VIEs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A legal entity is determined to be a VIE if it has any of the following three characteristics:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The entity does not have sufficient equity to finance its activities without additional subordinated financial support;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The entity is established with non-substantive voting rights (i.e., where the entity deprives the majority economic interest holder(s) of voting rights); or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The equity holders, as a group, lack the characteristics of a controlling financial interest. Equity holders meet this criterion if they lack any of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The power, through voting rights or similar rights, to direct the activities of the entity that most significantly influence the entity&#x2019;s economic performance, as evidenced by:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Substantive participating rights in the day-to-day management of the entity&#x2019;s activities; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Substantive kick-out rights over the party responsible for significant decisions;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The obligation to absorb the entity&#x2019;s expected losses; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The right to receive the entity&#x2019;s expected residual returns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company determines that any of the three characteristics of a VIE are met under Accounting Standards Codification (&#x201c;ASC&#x201d;) 810, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company will conclude that the entity is a VIE and evaluate it for consolidation under the variable interest model.&lt;/span&gt;&lt;/div&gt;Variable Interest ModelIf an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company consolidates a VIE if both power and benefits belong to the Company; that is, the Company (i) has the power to direct the activities of a VIE that most significantly influence the VIE&#x2019;s economic performance (power), and (ii) has the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE (economics). The Company consolidates VIEs whenever it is determined that the Company is the primary beneficiary. Refer to Note 16 &#x2014; &#x201c;Variable Interest Entities (VIEs)&#x201d; to the consolidated financial statements for information on the Company&#x2019;s consolidated VIEs. If there are variable interests in a VIE, but the Company is not the primary beneficiary, the Company may account for the investment using the equity method of accounting.</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:BusinessCombinationsPolicy contextRef="c-1" id="f-508">Business CombinationsThe Company uses the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-509">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reportable Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, the Company operates in three reportable segments: Care Enablement, Care Partners, and Care Delivery. Refer to Note 1 &#x2014; &#x201c;Description of Business&#x201d; and Note 18 &#x2014; &#x201c;Segments&#x201d; to the consolidated financial statements for information on the Company&#x2019;s segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-510"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-511">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s cash and cash equivalents primarily consist of money market funds and certificates of deposit. The Company considers all highly liquid investments that are both readily convertible into known amounts of cash and mature within ninety days from their date of purchase to be cash equivalents.&lt;/span&gt;&lt;/div&gt;The Company maintains its cash in deposit accounts with several banks, which at times may&#160;exceed the insured limits of the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;). The Company believes it is not exposed to any significant credit risk with respect to its cash and cash equivalents.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashUninsuredAmount contextRef="c-4" decimals="-5" id="f-512" unitRef="usd">326800000</us-gaap:CashUninsuredAmount>
    <us-gaap:CashUninsuredAmount contextRef="c-5" decimals="-5" id="f-513" unitRef="usd">324700000</us-gaap:CashUninsuredAmount>
    <us-gaap:MarketableSecuritiesPolicy contextRef="c-1" id="f-514">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in marketable securities consist of equity securities and certificates of deposit with various financial institutions. The appropriate classification of investments is determined at the time of purchase, and such designation is reevaluated at each balance sheet date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certificates of deposit are reported at par value, plus accrued interest, with maturity dates greater than ninety days. As of June&#160;30, 2023 and December&#160;31, 2022, certificates of deposit amounted to approximately $2.0 million and $0, respectively. Investments in certificates of deposit are classified as Level 1 investments in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities are reported at fair value. These securities are classified as Level 1 in the valuation hierarchy, where quoted market prices from reputable third-party brokers are available in an active market and unadjusted. Equity securities with low trading volume are determined to not have an active market with buyers and sellers ready to trade. Accordingly, we classify such equity securities as Level 2 in the valuation hierarchy, and their valuation is based on weighted average share prices from observable market data.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
    <ameh:MarketableSecuritiesCurrentMaturityPeriod contextRef="c-104" id="f-515">P90D</ameh:MarketableSecuritiesCurrentMaturityPeriod>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-105" decimals="-5" id="f-516" unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-106" decimals="-5" id="f-517" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-4" decimals="-5" id="f-518" unitRef="usd">1800000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-5" decimals="-5" id="f-519" unitRef="usd">5600000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:GainLossOnInvestmentsTextBlock contextRef="c-1" id="f-520">The components comprising total gains and losses on equity securities are as follows (in thousands) for the periods listed below:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.456%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.001%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Total losses recognized on equity securities  &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Gains recognized on equity securities sold  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Unrealized losses recognized on equity securities held at end of period  &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,614)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:GainLossOnInvestmentsTextBlock>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-36" decimals="-3" id="f-521" unitRef="usd">1348000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-37" decimals="-3" id="f-522" unitRef="usd">4331000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-1" decimals="-3" id="f-523" unitRef="usd">5701000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-38" decimals="-3" id="f-524" unitRef="usd">14886000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss contextRef="c-36" decimals="-3" id="f-525" unitRef="usd">0</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss contextRef="c-37" decimals="-3" id="f-526" unitRef="usd">2272000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss contextRef="c-1" decimals="-3" id="f-527" unitRef="usd">0</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss contextRef="c-38" decimals="-3" id="f-528" unitRef="usd">2272000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss contextRef="c-36" decimals="-3" id="f-529" unitRef="usd">1348000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss contextRef="c-37" decimals="-3" id="f-530" unitRef="usd">2059000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss contextRef="c-1" decimals="-3" id="f-531" unitRef="usd">5701000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss contextRef="c-38" decimals="-3" id="f-532" unitRef="usd">12614000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <ameh:ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock contextRef="c-1" id="f-533">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Receivables,  Receivables &#x2013; Related Parties, Other Receivables and Loan Receivable - Related Party&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s receivables are comprised of accounts receivable, capitation and claims receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivable are recorded and stated at the amount expected to be collected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s receivables &#x2013; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#x2013; related parties are recorded and stated at the amount expected to be collected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s loan receivable and loan receivable &#x2013; related party consists of promissory notes that accrue interest per annum. As of June&#160;30, 2023, promissory notes are expected to be collected within 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitation and claims receivables relate to each health plan&#x2019;s capitation and are received by the Company in the month following the month of service. Risk pool settlements and incentive receivables mainly consist of the Company&#x2019;s full risk pool receivable, which is recorded quarterly based on reports received from the Company&#x2019;s hospital partners and management&#x2019;s estimate of the Company&#x2019;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately 18 months after the risk pool performance year is completed. Other receivables consist of receivables from fee-for-services (&#x201c;FFS&#x201d;) reimbursement for patient care, certain expense reimbursements, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains reserves for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer creditworthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected and adjustments are recorded when necessary. Reserves are recorded primarily on a specific identification basis.&lt;/span&gt;&lt;/div&gt;Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided and collection is reasonably likely to occur. In regard to the credit loss standard, the Company continuously monitors its collections of receivables and our expectation is that the historical credit loss experienced across our receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#x201c;CECL&#x201d;) model.</ameh:ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock>
    <ameh:PromissoryNotesExpectedToBeCollectedWithinPeriod contextRef="c-1" id="f-534">P12M</ameh:PromissoryNotesExpectedToBeCollectedWithinPeriod>
    <ameh:RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear contextRef="c-1" id="f-535">P18M</ameh:RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-536">Concentrations of Credit RisksThe Company disaggregates revenue from contracts by service type and payor type. This level of detail provides useful information pertaining to how the Company generates revenue by significant revenue stream and by type of direct contracts. The consolidated statements of income present disaggregated revenue by service type.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-537">The following table presents disaggregated revenue generated by payor type for the three and six months ended June&#160;30, 2023 and 2022 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.122%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicaid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other third parties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-107" decimals="-3" id="f-538" unitRef="usd">38907000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-108" decimals="-3" id="f-539" unitRef="usd">42014000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-109" decimals="-3" id="f-540" unitRef="usd">78926000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-110" decimals="-3" id="f-541" unitRef="usd">84167000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-111" decimals="-3" id="f-542" unitRef="usd">222159000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-112" decimals="-3" id="f-543" unitRef="usd">142641000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-113" decimals="-3" id="f-544" unitRef="usd">438469000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-114" decimals="-3" id="f-545" unitRef="usd">276299000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-115" decimals="-3" id="f-546" unitRef="usd">69112000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-116" decimals="-3" id="f-547" unitRef="usd">70635000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-117" decimals="-3" id="f-548" unitRef="usd">136451000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-118" decimals="-3" id="f-549" unitRef="usd">142299000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-119" decimals="-3" id="f-550" unitRef="usd">18031000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-120" decimals="-3" id="f-551" unitRef="usd">14407000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-121" decimals="-3" id="f-552" unitRef="usd">31607000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-122" decimals="-3" id="f-553" unitRef="usd">30189000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-36" decimals="-3" id="f-554" unitRef="usd">348209000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-37" decimals="-3" id="f-555" unitRef="usd">269697000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-556" unitRef="usd">685453000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-38" decimals="-3" id="f-557" unitRef="usd">532954000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock contextRef="c-1" id="f-558">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had major payors that contributed the following percentages of net revenue:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.122%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payor A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payor B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; *Less than 10% of total net revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had major payors that contributed to the following percentages of receivables and receivables &#x2013; related parties:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Restated)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payor B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payor C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-123" decimals="3" id="f-559" unitRef="number">0.103</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-124" decimals="3" id="f-560" unitRef="number">0.105</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-125" decimals="3" id="f-561" unitRef="number">0.382</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-126" decimals="3" id="f-562" unitRef="number">0.310</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-127" decimals="3" id="f-563" unitRef="number">0.398</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-128" decimals="3" id="f-564" unitRef="number">0.307</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-129" decimals="3" id="f-565" unitRef="number">0.280</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-130" decimals="3" id="f-566" unitRef="number">0.260</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-131" decimals="3" id="f-567" unitRef="number">0.500</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-132" decimals="3" id="f-568" unitRef="number">0.520</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-569">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial instruments consist of cash and cash equivalents, fiduciary cash, investment in marketable securities, receivables, loans receivable, accounts payable, certain accrued expenses, finance lease obligations, and long-term debt. The carrying values of the financial instruments classified as current in the accompanying consolidated balance sheets are considered to be at their fair values, due to the short maturity of these instruments. The carrying amounts of finance lease obligations and long-term debt approximate fair value as they bear interest at rates that approximate current market rates for debt with similar maturities and credit quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 820&#x201d;), applies to all financial assets and financial liabilities that are measured and reported on a fair value basis and requires disclosure that establishes a framework for measuring fair value and expands disclosure about fair value measurements. ASC&#160;820 establishes a fair value hierarchy for disclosure of the inputs to valuations used to measure fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no changes in Level 1, Level 2, or Level 3 classification and no changes in valuation techniques for the six months ended June&#160;30, 2023. This hierarchy prioritizes the inputs into three broad levels as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that can be accessed at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates and yield curves), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Unobservable inputs that reflect assumptions about what market participants would use in pricing the asset or liability. These inputs would be based on the best information available, including the Company&#x2019;s own data.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="c-1" id="f-570">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts and fair values of the Company&#x2019;s financial instruments as of June&#160;30, 2023, are presented below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market accounts*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities &#x2013; certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities &#x2013; equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate collar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APCMG contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;AAMG contingent consideration (see Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;VOMG contingent consideration (see Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DMG remaining equity interest purchase (see Note 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sun labs remaining equity interest purchase (see Note 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&#160;&#160;&#160;&#160;Included in cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts and fair values of the Company&#x2019;s financial instruments as of December&#160;31, 2022, are presented below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market accounts*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities &#x2013; equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APCMG contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AAMG contingent consideration (see Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VOMG contingent consideration (see Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DMG remaining equity interest purchase (see Note 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sun labs remaining equity interest purchase (see Note 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&#160;&#160;&#160;&#160;Included in cash and cash equivalents&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-133" decimals="-3" id="f-571" unitRef="usd">78647000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-134" decimals="-3" id="f-572" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-135" decimals="-3" id="f-573" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-574" unitRef="usd">78647000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-133" decimals="-3" id="f-575" unitRef="usd">2022000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-134" decimals="-3" id="f-576" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-135" decimals="-3" id="f-577" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-4" decimals="-3" id="f-578" unitRef="usd">2022000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-133" decimals="-3" id="f-579" unitRef="usd">1767000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-134" decimals="-3" id="f-580" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-135" decimals="-3" id="f-581" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-4" decimals="-3" id="f-582" unitRef="usd">1767000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets contextRef="c-136" decimals="-3" id="f-583" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-137" decimals="-3" id="f-584" unitRef="usd">3116000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-138" decimals="-3" id="f-585" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-139" decimals="-3" id="f-586" unitRef="usd">3116000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-140" decimals="-3" id="f-587" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-141" decimals="-3" id="f-588" unitRef="usd">1202000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-142" decimals="-3" id="f-589" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-143" decimals="-3" id="f-590" unitRef="usd">1202000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-133" decimals="-3" id="f-591" unitRef="usd">82436000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-134" decimals="-3" id="f-592" unitRef="usd">4318000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-135" decimals="-3" id="f-593" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-594" unitRef="usd">86754000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-144" decimals="-3" id="f-595" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-145" decimals="-3" id="f-596" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-146" decimals="-3" id="f-597" unitRef="usd">1000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-147" decimals="-3" id="f-598" unitRef="usd">1000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-148" decimals="-3" id="f-599" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-149" decimals="-3" id="f-600" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-150" decimals="-3" id="f-601" unitRef="usd">5056000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-151" decimals="-3" id="f-602" unitRef="usd">5056000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-152" decimals="-3" id="f-603" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-153" decimals="-3" id="f-604" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-154" decimals="-3" id="f-605" unitRef="usd">17000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-155" decimals="-3" id="f-606" unitRef="usd">17000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-156" decimals="-3" id="f-607" unitRef="usd">0</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-157" decimals="-3" id="f-608" unitRef="usd">0</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-158" decimals="-3" id="f-609" unitRef="usd">8542000</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-159" decimals="-3" id="f-610" unitRef="usd">8542000</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-160" decimals="-3" id="f-611" unitRef="usd">0</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-161" decimals="-3" id="f-612" unitRef="usd">0</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-162" decimals="-3" id="f-613" unitRef="usd">7631000</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-163" decimals="-3" id="f-614" unitRef="usd">7631000</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-133" decimals="-3" id="f-615" unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-134" decimals="-3" id="f-616" unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-135" decimals="-3" id="f-617" unitRef="usd">22246000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-4" decimals="-3" id="f-618" unitRef="usd">22246000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-164" decimals="-3" id="f-619" unitRef="usd">135235000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-165" decimals="-3" id="f-620" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-166" decimals="-3" id="f-621" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-5" decimals="-3" id="f-622" unitRef="usd">135235000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-164" decimals="-3" id="f-623" unitRef="usd">5567000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-165" decimals="-3" id="f-624" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-166" decimals="-3" id="f-625" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-5" decimals="-3" id="f-626" unitRef="usd">5567000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets contextRef="c-167" decimals="-3" id="f-627" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-168" decimals="-3" id="f-628" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-169" decimals="-3" id="f-629" unitRef="usd">1900000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-170" decimals="-3" id="f-630" unitRef="usd">1900000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-171" decimals="-3" id="f-631" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-172" decimals="-3" id="f-632" unitRef="usd">3164000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-173" decimals="-3" id="f-633" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-174" decimals="-3" id="f-634" unitRef="usd">3164000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-164" decimals="-3" id="f-635" unitRef="usd">140802000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-165" decimals="-3" id="f-636" unitRef="usd">3164000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-166" decimals="-3" id="f-637" unitRef="usd">1900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-5" decimals="-3" id="f-638" unitRef="usd">145866000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-175" decimals="-3" id="f-639" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-176" decimals="-3" id="f-640" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-177" decimals="-3" id="f-641" unitRef="usd">1000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-178" decimals="-3" id="f-642" unitRef="usd">1000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-179" decimals="-3" id="f-643" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-180" decimals="-3" id="f-644" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-181" decimals="-3" id="f-645" unitRef="usd">5851000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-182" decimals="-3" id="f-646" unitRef="usd">5851000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-183" decimals="-3" id="f-647" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-184" decimals="-3" id="f-648" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-185" decimals="-3" id="f-649" unitRef="usd">17000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-186" decimals="-3" id="f-650" unitRef="usd">17000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-187" decimals="-3" id="f-651" unitRef="usd">0</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-188" decimals="-3" id="f-652" unitRef="usd">0</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-189" decimals="-3" id="f-653" unitRef="usd">8542000</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-190" decimals="-3" id="f-654" unitRef="usd">8542000</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-191" decimals="-3" id="f-655" unitRef="usd">0</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-192" decimals="-3" id="f-656" unitRef="usd">0</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-193" decimals="-3" id="f-657" unitRef="usd">5849000</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-194" decimals="-3" id="f-658" unitRef="usd">5849000</ameh:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-164" decimals="-3" id="f-659" unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-165" decimals="-3" id="f-660" unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-166" decimals="-3" id="f-661" unitRef="usd">21259000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-5" decimals="-3" id="f-662" unitRef="usd">21259000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-663">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the fair value of Level 3 liabilities for the six months ended June&#160;30, 2023 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gain recognized from change in fair value of existing Level 3 liabilities*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* The change in the fair value of existing Level 3 liabilities is presented in unrealized loss on investments in the accompanying consolidated statement of income.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-5" decimals="-3" id="f-664" unitRef="usd">21259000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-1" decimals="-3" id="f-665" unitRef="usd">987000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-4" decimals="-3" id="f-666" unitRef="usd">22246000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c-1" id="f-667">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Rate Swap and Collar Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to interest rate risk on its floating-rate debt. The Company has entered into interest rate swap and collar agreements to effectively convert its floating-rate debt to a fixed-rate basis or to a rate within the agreed-upon range. The principal objective of these contracts is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#x2019;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 9 &#x2014; &#x201c;Credit Facility, Bank Loans, and Lines of Credit&#x201d; for further information on our debt. Interest rate swap and collar agreements are not designated as hedging instruments. Changes in the fair value on these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and reflected in the accompanying consolidated statements of cash flows as unrealized gain or loss on interest rate swaps.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the interest rate swap was determined using Level 2 inputs. As of June&#160;30, 2023 and December&#160;31, 2022, the fair value of the interest rate swap was $3.1 million and $3.2&#160;million, respectively, and are presented within other assets in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s collar agreement is designed to limit the interest rate risk associated with the Company&#x2019;s Revolver Loan.  Under the terms of the agreement, the ceiling is 5.0% and the floor is 2.34%.  The estimated fair value of the collar is determined using Level 2.  As of June&#160;30, 2023 the fair value of the collar is  $1.2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Contingent Equity Securities&lt;/span&gt;&lt;/div&gt;In addition to the common stock and warrants purchased under the stock purchase agreement between ApolloMed and Nutex, ApolloMed is entitled to additional common stock if Nutex did not pay NMM management fees exceeding a threshold by the end of December 31, 2022. The contingent equity securities are considered to be derivatives but are not designated as hedging instruments. Changes in the fair value of these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and the accompanying consolidated statements of cash flows. The Company determined the fair value of the contingent equity security using a probability-weighted model, which includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of recognizing management fees and assigned probabilities to each such scenario in determining fair value.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-195" decimals="-5" id="f-668" unitRef="usd">3100000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-196" decimals="-5" id="f-669" unitRef="usd">3200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <ameh:DerivativeCeilingInterestRate contextRef="c-143" decimals="3" id="f-670" unitRef="number">0.050</ameh:DerivativeCeilingInterestRate>
    <us-gaap:DerivativeFloorInterestRate contextRef="c-143" decimals="4" id="f-671" unitRef="number">0.0234</us-gaap:DerivativeFloorInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-143" decimals="-5" id="f-672" unitRef="usd">1200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetsCurrent contextRef="c-170" decimals="-5" id="f-673" unitRef="usd">1900000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-674">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company receives payments from the following sources for services rendered: (i) commercial insurers; (ii) the federal government under the Medicare program administered by CMS; (iii) state governments under the Medicaid and other programs; (iv) other third-party payors (e.g., hospitals and IPAs); and (v) individual patients and clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue primarily consists of capitation revenue, risk pool settlements and incentives, GPDC/ACO REACH revenue, management fee income, and FFS revenue. Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;GPDC/ACO REACH Capitation Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS contracts with Direct Contracting Entities (&#x201c;DCEs&#x201d;), which are composed of healthcare providers operating under a common legal structure and accept financial accountability for the overall quality and cost of medical care furnished to Medicare FFS beneficiaries aligned to the entity. The combination of the FFS model and the GPDC and ACO REACH model changes the distribution of responsibilities, risks, costs, and rewards among CMS, DCEs, and providers. By entering into a contract with CMS, a DCE voluntarily takes on operational, financial, and legal responsibilities and risks that no party has, individually or collectively, under the existing FFS model. Each DCE bears the economic costs, and reaps the economic rewards of fulfilling its responsibilities and managing its risks as a DCE. APAACO participated in the GPDC Model for Performance Year 2022 and is currently participating in the ACO REACH model for Performance Year 2023, beginning January 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each performance year, CMS will pay a total benchmark amount, determined unilaterally by CMS in advance but subject to prospective adjustments throughout the year, for the totality of care provided to the DCE&#x2019;s population of aligned beneficiaries over the course of that year. The benchmark is net of a quality withholding applied by CMS. At the end of each performance year, a portion, or all, of the quality withholding can be earned based on APAACO&#x2019;s performance. GPDC/ACO REACH capitation revenue is recognized based on the estimated transaction price to transfer the service for a distinct increment of the series (i.e., month) and is recognized net of quality incentives/penalties.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-675">Income Taxes&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted for both items that do not have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the consolidated financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-676">Business Combinations, Asset Acquisitions, and Goodwill&lt;div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;FYB&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;1, 2023, the Company acquired 100% equity interest in FYB. FYB is licensed by the California Department of Managed Health Care as a full-service Restricted Knox-Keene licensed health plan, which enables FYB to assume full financial responsibility, including both professional and institutional risk, for the medical costs of its members under the Knox-Keene Health Care Service Plan Act of 1975.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Chinese Community Health Care Association (&#x201c;CCHCA&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;1, 2023, the Company acquired certain healthcare assets from CCHCA. CCHCA is a non-profit independent physician association in the San Francisco Community. The purchase price consists of cash funded on May&#160;1, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Orma Health&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 27, 2022, the Company acquired 100% of the capital stock of Orma Health, Inc., and Provider Growth Solutions, LLC (together, &#x201c;Orma Health&#x201d;). The purchase was paid in cash and the Company&#x2019;s capital stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Jade Health Care Medical Group, Inc. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(&#x201c;Jade&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 19, 2022, the Company acquired 100% of the capital stock of Jade. The purchase was paid in cash. Jade is a primary and specialty care physicians&#x2019; group focused on providing high-quality care to its patients in the San Francisco Bay Area in Northern California. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;VOMG&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 14, 2022, VOMG was determined to be a VIE of ApolloMed and is consolidated by the Company. VOMG owns nine primary care clinics in Nevada and Texas. The purchase price consists of cash funded upon the close of transaction and additional cash consideration (&#x201c;VOMG contingent consideration&#x201d;) contingent on VOMG meeting financial metrics for fiscal years 2023 and 2024. The Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). The contingent consideration is included within other long-term liabilities in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;AAMG &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 31, 2022, AP-AMH 2, a VIE of the Company, acquired 100% of the equity interest in AAMG. AAMG is an IPA operating in Northern California. The purchase price consists of cash funded upon close of the transaction and additional  consideration (&#x201c;AAMG contingent consideration&#x201d;) and stock consideration (&#x201c;AAMG stock contingent consideration&#x201d;) contingent on AAMG meeting revenue and capitated member metrics for fiscal years 2023 and 2024. The Company determined the fair value of the contingent considerations using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of revenue and assigned probabilities to each such scenario in determining fair value. As of June&#160;30, 2023, the contingent consideration is valued at $5.1 million and was included within other long-term liabilities in the accompanying consolidated balance sheets. The stock contingent consideration is valued at $5.6 million and is included in additional paid-in capital in the accompanying consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisitions were accounted for under the acquisition method of accounting. The fair value of the consideration for the acquired companies was allocated to acquired tangible and intangible assets and liabilities based on their fair values. The excess of the purchase consideration over the fair value of the net tangible and identifiable intangible assets acquired was recorded as goodwill. Determining the fair value of assets and liabilities acquired requires the Company to make estimates and use valuation techniques when market value is not readily available. The results of operations from the acquisitions have been included in the Company&#x2019;s financial statements from the date of acquisition. Transaction costs associated with business acquisitions are expensed as they are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the time of acquisition, the Company estimates the amount of the identifiable intangible assets based on a valuation and the facts and circumstances available at the time. The Company determines the final value of the identifiable intangible assets as soon as information is available, but not more than one year from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is not deductible for tax purposes. The Company had no impairment of its goodwill or indefinite-lived intangible assets during the six months ended June&#160;30, 2023 and 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the carrying value of goodwill for the six months ended June&#160;30, 2023 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.398%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, January 1, 2023  (restated)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-197" decimals="2" id="f-677" unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-198" decimals="2" id="f-678" unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-199" decimals="2" id="f-679" unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <ameh:NumberOfPrimaryCareClinics
      contextRef="c-200"
      decimals="INF"
      id="f-680"
      unitRef="clinic">9</ameh:NumberOfPrimaryCareClinics>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-201" decimals="2" id="f-681" unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-202" decimals="-5" id="f-682" unitRef="usd">5100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-201" decimals="-5" id="f-683" unitRef="usd">5600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="INF" id="f-684" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-38" decimals="INF" id="f-685" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c-1" id="f-686">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the carrying value of goodwill for the six months ended June&#160;30, 2023 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.398%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, January 1, 2023  (restated)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-687" unitRef="usd">269053000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-1" decimals="-3" id="f-688" unitRef="usd">3924000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments contextRef="c-1" decimals="-3" id="f-689" unitRef="usd">1052000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-690" unitRef="usd">274029000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-691">Intangible Assets, Net&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2023, the Company&#x2019;s intangible assets, net, consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.935%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Useful&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Life&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortized intangible assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Network relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11-21&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Member relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10-14&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient management platform&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tradename/trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Developed technology &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124,895)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, the Company&#x2019;s intangible assets, net, consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.625%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Useful&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Life&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Network relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11-21&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Member relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patient management platform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tradename/trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended June&#160;30, 2023 and 2022, the Company recognized amortization expense of $3.3 million and $3.5 million, respectively, in depreciation and amortization on the accompanying consolidated statements of operations.  For the six months ended June&#160;30, 2023 and 2022, the Company recognized amortization expense of  $6.3 million and $7.2 million, respectively, in depreciation and amortization on the accompanying consolidated statements of operations. The Company determined that there was no impairment of its finite-lived intangible or long-lived assets during the during the six months ended June&#160;30, 2023 and 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future amortization expense is estimated to be as follows for the following years ending December&#160;31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (excluding the six months ended June 30, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-692">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2023, the Company&#x2019;s intangible assets, net, consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.935%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Useful&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Life&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortized intangible assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Network relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11-21&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Member relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10-14&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient management platform&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tradename/trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Developed technology &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124,895)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, the Company&#x2019;s intangible assets, net, consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.625%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Useful&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Life&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Network relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11-21&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Member relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patient management platform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tradename/trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-203" decimals="-3" id="f-693" unitRef="usd">2150000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-203" decimals="-3" id="f-694" unitRef="usd">2150000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-204" id="f-695">P11Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-205" id="f-696">P21Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-206" decimals="-3" id="f-697" unitRef="usd">150679000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-206" decimals="-3" id="f-698" unitRef="usd">100244000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-206" decimals="-3" id="f-699" unitRef="usd">50435000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-207" id="f-700">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-207" decimals="-3" id="f-701" unitRef="usd">22832000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-207" decimals="-3" id="f-702" unitRef="usd">15982000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-207" decimals="-3" id="f-703" unitRef="usd">6850000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-208" id="f-704">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-209" id="f-705">P14Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-210" decimals="-3" id="f-706" unitRef="usd">20477000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-210" decimals="-3" id="f-707" unitRef="usd">6302000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-210" decimals="-3" id="f-708" unitRef="usd">14175000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-211" id="f-709">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-211" decimals="-3" id="f-710" unitRef="usd">2060000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-211" decimals="-3" id="f-711" unitRef="usd">2060000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-211" decimals="-3" id="f-712" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-212" id="f-713">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-212" decimals="-3" id="f-714" unitRef="usd">1011000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-212" decimals="-3" id="f-715" unitRef="usd">282000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-212" decimals="-3" id="f-716" unitRef="usd">729000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-213" id="f-717">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-213" decimals="-3" id="f-718" unitRef="usd">107000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-213" decimals="-3" id="f-719" unitRef="usd">25000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-213" decimals="-3" id="f-720" unitRef="usd">82000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c-4" decimals="-3" id="f-721" unitRef="usd">199316000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-722" unitRef="usd">124895000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-3" id="f-723" unitRef="usd">74421000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-214" decimals="-3" id="f-724" unitRef="usd">2150000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-214" decimals="-3" id="f-725" unitRef="usd">2150000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-215" id="f-726">P11Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-216" id="f-727">P21Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-217" decimals="-3" id="f-728" unitRef="usd">150679000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-217" decimals="-3" id="f-729" unitRef="usd">95451000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-217" decimals="-3" id="f-730" unitRef="usd">55228000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-218" id="f-731">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-218" decimals="-3" id="f-732" unitRef="usd">22832000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-218" decimals="-3" id="f-733" unitRef="usd">15208000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-218" decimals="-3" id="f-734" unitRef="usd">7624000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-219" id="f-735">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-219" decimals="-3" id="f-736" unitRef="usd">16633000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-219" decimals="-3" id="f-737" unitRef="usd">5619000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-219" decimals="-3" id="f-738" unitRef="usd">11014000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-220" id="f-739">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-220" decimals="-3" id="f-740" unitRef="usd">2060000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-220" decimals="-3" id="f-741" unitRef="usd">2060000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-220" decimals="-3" id="f-742" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-221" id="f-743">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-221" decimals="-3" id="f-744" unitRef="usd">1011000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-221" decimals="-3" id="f-745" unitRef="usd">257000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-221" decimals="-3" id="f-746" unitRef="usd">754000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-222" id="f-747">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-222" decimals="-3" id="f-748" unitRef="usd">107000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-222" decimals="-3" id="f-749" unitRef="usd">16000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-222" decimals="-3" id="f-750" unitRef="usd">91000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c-5" decimals="-3" id="f-751" unitRef="usd">195472000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-5" decimals="-3" id="f-752" unitRef="usd">118611000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-3" id="f-753" unitRef="usd">76861000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-36" decimals="-5" id="f-754" unitRef="usd">3300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-37" decimals="-5" id="f-755" unitRef="usd">3500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-756" unitRef="usd">6300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-38" decimals="-5" id="f-757" unitRef="usd">7200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-1" decimals="INF" id="f-758" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-38" decimals="INF" id="f-759" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c-1" id="f-760">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future amortization expense is estimated to be as follows for the following years ending December&#160;31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (excluding the six months ended June 30, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear contextRef="c-4" decimals="-3" id="f-761" unitRef="usd">6157000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-4" decimals="-3" id="f-762" unitRef="usd">12249000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-4" decimals="-3" id="f-763" unitRef="usd">11171000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-4" decimals="-3" id="f-764" unitRef="usd">9811000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-4" decimals="-3" id="f-765" unitRef="usd">8430000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <ameh:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour contextRef="c-4" decimals="-3" id="f-766" unitRef="usd">24453000</ameh:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-3" id="f-767" unitRef="usd">72271000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <ameh:EquityMethodAndOtherEquityInvestmentsTextBlock contextRef="c-1" id="f-768">Investments in Other Entities&lt;div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; Equity Method&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six months ended June&#160;30, 2023 and 2022, the Company&#x2019;s equity method investment balance consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.898%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.500%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.745%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Ownership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Initial Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allocation of Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Distribution &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LaSalle Medical Associates &#x2013; IPA Line of Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531 W. College, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One MSO, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;James Song, M.D., A Professional Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.750%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.569%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.421%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.569%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Ownership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allocation of Net Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funding Reclassified To Loan Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Distribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LaSalle Medical Associates &#x2013; IPA Line of Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531 W. College, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One MSO, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tag-6 Medical Investment Group, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Investment is deemed Excluded Assets that are solely for the benefit of APC and its shareholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended June&#160;30, 2023 and 2022, the Company&#x2019;s equity method investment balance consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.341%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.929%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.341%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.135%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.341%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.664%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.580%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Ownership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Initial Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allocation of Net Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Distribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LaSalle Medical Associates &#x2013; IPA Line of Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531 W. College, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One MSO, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;James Song, M.D., A Professional Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.503%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.945%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.389%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.682%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.389%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.389%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.472%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.389%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.389%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.919%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Ownership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allocation of Net Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funding Reclassified To Loan Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Distribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LaSalle Medical Associates &#x2013; IPA Line of Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531 W. College, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One MSO, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tag-6 Medical Investment Group, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Investment is deemed Excluded Assets that are solely for the benefit of APC and its shareholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;James Song, M.D., A Professional Corporation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2023, AP-AMH 2 purchased a 25% interest in James Song, M.D., a Professional Corporation (&#x201c;Song PC&#x201d;), a medical corporation located in Hacienda Heights, California. AP-AMH 2 accounts for its investment in Song PC under the equity method of accounting as AP-AMH 2 has the ability to exercise significant influence, but not control over Song PC&#x2019;s operations. For the three months ended June&#160;30, 2023, AP-AMH 2 recognized income of $58,000 in the accompanying consolidated statements of income. For the six months ended June&#160;30, 2023, AP-AMH 2 recognized income of $95,000 in the accompanying consolidated statements of operations. The accompanying consolidated balance sheets include the related investment balances of $0.4 million as of June&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;There was no impairment loss recorded related to equity method investments for the six months ended June&#160;30, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;</ameh:EquityMethodAndOtherEquityInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestmentsTextBlock contextRef="c-1" id="f-769">For the six months ended June&#160;30, 2023 and 2022, the Company&#x2019;s equity method investment balance consisted of the following (in thousands):&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.898%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.500%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.745%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Ownership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Initial Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allocation of Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Distribution &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LaSalle Medical Associates &#x2013; IPA Line of Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531 W. College, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One MSO, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;James Song, M.D., A Professional Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.750%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.569%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.421%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.569%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Ownership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allocation of Net Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funding Reclassified To Loan Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Distribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LaSalle Medical Associates &#x2013; IPA Line of Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531 W. College, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One MSO, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tag-6 Medical Investment Group, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Investment is deemed Excluded Assets that are solely for the benefit of APC and its shareholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended June&#160;30, 2023 and 2022, the Company&#x2019;s equity method investment balance consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.341%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.929%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.341%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.135%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.341%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.664%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.580%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Ownership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Initial Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allocation of Net Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Distribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LaSalle Medical Associates &#x2013; IPA Line of Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531 W. College, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One MSO, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;James Song, M.D., A Professional Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.503%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.945%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.389%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.682%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.389%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.389%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.472%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.389%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.389%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.919%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Ownership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allocation of Net Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funding Reclassified To Loan Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Distribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LaSalle Medical Associates &#x2013; IPA Line of Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531 W. College, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One MSO, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tag-6 Medical Investment Group, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;* Investment is deemed Excluded Assets that are solely for the benefit of APC and its shareholders.</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-223" decimals="2" id="f-770" unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-224" decimals="-3" id="f-771" unitRef="usd">5684000</us-gaap:EquityMethodInvestments>
    <ameh:EquityMethodInvestmentAdditionalInvestment contextRef="c-225" decimals="-3" id="f-772" unitRef="usd">0</ameh:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-225" decimals="-3" id="f-773" unitRef="usd">4853000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-225" decimals="-3" id="f-774" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-225" decimals="-3" id="f-775" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-223" decimals="-3" id="f-776" unitRef="usd">10537000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-226" decimals="2" id="f-777" unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-227" decimals="-3" id="f-778" unitRef="usd">1878000</us-gaap:EquityMethodInvestments>
    <ameh:EquityMethodInvestmentAdditionalInvestment contextRef="c-228" decimals="-3" id="f-779" unitRef="usd">0</ameh:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-228" decimals="-3" id="f-780" unitRef="usd">-223000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-228" decimals="-3" id="f-781" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-228" decimals="-3" id="f-782" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-226" decimals="-3" id="f-783" unitRef="usd">1655000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-229" decimals="2" id="f-784" unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-230" decimals="-3" id="f-785" unitRef="usd">17281000</us-gaap:EquityMethodInvestments>
    <ameh:EquityMethodInvestmentAdditionalInvestment contextRef="c-231" decimals="-3" id="f-786" unitRef="usd">0</ameh:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-231" decimals="-3" id="f-787" unitRef="usd">-211000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-231" decimals="-3" id="f-788" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-231" decimals="-3" id="f-789" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-229" decimals="-3" id="f-790" unitRef="usd">17070000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-232" decimals="2" id="f-791" unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-233" decimals="-3" id="f-792" unitRef="usd">2718000</us-gaap:EquityMethodInvestments>
    <ameh:EquityMethodInvestmentAdditionalInvestment contextRef="c-234" decimals="-3" id="f-793" unitRef="usd">0</ameh:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-234" decimals="-3" id="f-794" unitRef="usd">242000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-234" decimals="-3" id="f-795" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-234" decimals="-3" id="f-796" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-232" decimals="-3" id="f-797" unitRef="usd">2960000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-235" decimals="2" id="f-798" unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-236" decimals="-3" id="f-799" unitRef="usd">12738000</us-gaap:EquityMethodInvestments>
    <ameh:EquityMethodInvestmentAdditionalInvestment contextRef="c-237" decimals="-3" id="f-800" unitRef="usd">0</ameh:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-237" decimals="-3" id="f-801" unitRef="usd">451000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-237" decimals="-3" id="f-802" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-237" decimals="-3" id="f-803" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-235" decimals="-3" id="f-804" unitRef="usd">13189000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-238" decimals="2" id="f-805" unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-239" decimals="-3" id="f-806" unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <ameh:EquityMethodInvestmentAdditionalInvestment contextRef="c-240" decimals="-3" id="f-807" unitRef="usd">325000</ameh:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-240" decimals="-3" id="f-808" unitRef="usd">95000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-240" decimals="-3" id="f-809" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-240" decimals="-3" id="f-810" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-238" decimals="-3" id="f-811" unitRef="usd">420000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-5" decimals="-3" id="f-812" unitRef="usd">40299000</us-gaap:EquityMethodInvestments>
    <ameh:EquityMethodInvestmentAdditionalInvestment contextRef="c-1" decimals="-3" id="f-813" unitRef="usd">325000</ameh:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-814" unitRef="usd">5207000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-1" decimals="-3" id="f-815" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-1" decimals="-3" id="f-816" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-4" decimals="-3" id="f-817" unitRef="usd">45831000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-241" decimals="2" id="f-818" unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-242" decimals="-3" id="f-819" unitRef="usd">3034000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-243" decimals="-3" id="f-820" unitRef="usd">2535000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-243" decimals="-3" id="f-821" unitRef="usd">2125000</ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-243" decimals="-3" id="f-822" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-243" decimals="-3" id="f-823" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-241" decimals="-3" id="f-824" unitRef="usd">3444000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-244" decimals="2" id="f-825" unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-245" decimals="-3" id="f-826" unitRef="usd">1719000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-246" decimals="-3" id="f-827" unitRef="usd">22000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-246" decimals="-3" id="f-828" unitRef="usd">0</ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-246" decimals="-3" id="f-829" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-246" decimals="-3" id="f-830" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-244" decimals="-3" id="f-831" unitRef="usd">1741000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-247" decimals="2" id="f-832" unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-248" decimals="-3" id="f-833" unitRef="usd">17230000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-249" decimals="-3" id="f-834" unitRef="usd">-305000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-249" decimals="-3" id="f-835" unitRef="usd">0</ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-249" decimals="-3" id="f-836" unitRef="usd">250000</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-249" decimals="-3" id="f-837" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-247" decimals="-3" id="f-838" unitRef="usd">17175000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-250" decimals="2" id="f-839" unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-251" decimals="-3" id="f-840" unitRef="usd">2910000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-252" decimals="-3" id="f-841" unitRef="usd">254000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-252" decimals="-3" id="f-842" unitRef="usd">0</ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-252" decimals="-3" id="f-843" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-252" decimals="-3" id="f-844" unitRef="usd">400000</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-250" decimals="-3" id="f-845" unitRef="usd">2764000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-253" decimals="2" id="f-846" unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-254" decimals="-3" id="f-847" unitRef="usd">4830000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-255" decimals="-3" id="f-848" unitRef="usd">111000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-255" decimals="-3" id="f-849" unitRef="usd">0</ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-255" decimals="-3" id="f-850" unitRef="usd">1435000</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-255" decimals="-3" id="f-851" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-253" decimals="-3" id="f-852" unitRef="usd">6376000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-256" decimals="2" id="f-853" unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-257" decimals="-3" id="f-854" unitRef="usd">11992000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-258" decimals="-3" id="f-855" unitRef="usd">328000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-258" decimals="-3" id="f-856" unitRef="usd">0</ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-258" decimals="-3" id="f-857" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-258" decimals="-3" id="f-858" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-256" decimals="-3" id="f-859" unitRef="usd">12320000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-71" decimals="-3" id="f-860" unitRef="usd">41715000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-38" decimals="-3" id="f-861" unitRef="usd">2945000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-38" decimals="-3" id="f-862" unitRef="usd">2125000</ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-38" decimals="-3" id="f-863" unitRef="usd">1685000</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-38" decimals="-3" id="f-864" unitRef="usd">400000</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-94" decimals="-3" id="f-865" unitRef="usd">43820000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-223" decimals="2" id="f-866" unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-259" decimals="-3" id="f-867" unitRef="usd">7848000</us-gaap:EquityMethodInvestments>
    <ameh:EquityMethodInvestmentAdditionalInvestment contextRef="c-260" decimals="-3" id="f-868" unitRef="usd">0</ameh:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-260" decimals="-3" id="f-869" unitRef="usd">2689000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-260" decimals="-3" id="f-870" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-260" decimals="-3" id="f-871" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-223" decimals="-3" id="f-872" unitRef="usd">10537000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-226" decimals="2" id="f-873" unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-261" decimals="-3" id="f-874" unitRef="usd">1886000</us-gaap:EquityMethodInvestments>
    <ameh:EquityMethodInvestmentAdditionalInvestment contextRef="c-262" decimals="-3" id="f-875" unitRef="usd">0</ameh:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-262" decimals="-3" id="f-876" unitRef="usd">-231000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-262" decimals="-3" id="f-877" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-262" decimals="-3" id="f-878" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-226" decimals="-3" id="f-879" unitRef="usd">1655000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-229" decimals="2" id="f-880" unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-263" decimals="-3" id="f-881" unitRef="usd">17191000</us-gaap:EquityMethodInvestments>
    <ameh:EquityMethodInvestmentAdditionalInvestment contextRef="c-264" decimals="-3" id="f-882" unitRef="usd">0</ameh:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-264" decimals="-3" id="f-883" unitRef="usd">-121000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-264" decimals="-3" id="f-884" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-264" decimals="-3" id="f-885" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-229" decimals="-3" id="f-886" unitRef="usd">17070000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-232" decimals="2" id="f-887" unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-265" decimals="-3" id="f-888" unitRef="usd">2833000</us-gaap:EquityMethodInvestments>
    <ameh:EquityMethodInvestmentAdditionalInvestment contextRef="c-266" decimals="-3" id="f-889" unitRef="usd">0</ameh:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-266" decimals="-3" id="f-890" unitRef="usd">127000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-266" decimals="-3" id="f-891" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-266" decimals="-3" id="f-892" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-232" decimals="-3" id="f-893" unitRef="usd">2960000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-235" decimals="2" id="f-894" unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-267" decimals="-3" id="f-895" unitRef="usd">12988000</us-gaap:EquityMethodInvestments>
    <ameh:EquityMethodInvestmentAdditionalInvestment contextRef="c-268" decimals="-3" id="f-896" unitRef="usd">0</ameh:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-268" decimals="-3" id="f-897" unitRef="usd">201000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-268" decimals="-3" id="f-898" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-268" decimals="-3" id="f-899" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-235" decimals="-3" id="f-900" unitRef="usd">13189000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-238" decimals="2" id="f-901" unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-269" decimals="-3" id="f-902" unitRef="usd">362000</us-gaap:EquityMethodInvestments>
    <ameh:EquityMethodInvestmentAdditionalInvestment contextRef="c-270" decimals="-3" id="f-903" unitRef="usd">0</ameh:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-270" decimals="-3" id="f-904" unitRef="usd">58000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-270" decimals="-3" id="f-905" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-270" decimals="-3" id="f-906" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-238" decimals="-3" id="f-907" unitRef="usd">420000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-55" decimals="-3" id="f-908" unitRef="usd">43108000</us-gaap:EquityMethodInvestments>
    <ameh:EquityMethodInvestmentAdditionalInvestment contextRef="c-36" decimals="-3" id="f-909" unitRef="usd">0</ameh:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-36" decimals="-3" id="f-910" unitRef="usd">2723000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-36" decimals="-3" id="f-911" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-36" decimals="-3" id="f-912" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-4" decimals="-3" id="f-913" unitRef="usd">45831000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-241" decimals="2" id="f-914" unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-271" decimals="-3" id="f-915" unitRef="usd">4292000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-272" decimals="-3" id="f-916" unitRef="usd">1277000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-272" decimals="-3" id="f-917" unitRef="usd">2125000</ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-272" decimals="-3" id="f-918" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-272" decimals="-3" id="f-919" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-241" decimals="-3" id="f-920" unitRef="usd">3444000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-244" decimals="2" id="f-921" unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-273" decimals="-3" id="f-922" unitRef="usd">1726000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-274" decimals="-3" id="f-923" unitRef="usd">15000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-274" decimals="-3" id="f-924" unitRef="usd">0</ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-274" decimals="-3" id="f-925" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-274" decimals="-3" id="f-926" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-244" decimals="-3" id="f-927" unitRef="usd">1741000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-247" decimals="2" id="f-928" unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-275" decimals="-3" id="f-929" unitRef="usd">17048000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-276" decimals="-3" id="f-930" unitRef="usd">-123000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-276" decimals="-3" id="f-931" unitRef="usd">0</ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-276" decimals="-3" id="f-932" unitRef="usd">250000</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-276" decimals="-3" id="f-933" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-247" decimals="-3" id="f-934" unitRef="usd">17175000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-250" decimals="2" id="f-935" unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-277" decimals="-3" id="f-936" unitRef="usd">2847000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-278" decimals="-3" id="f-937" unitRef="usd">117000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-278" decimals="-3" id="f-938" unitRef="usd">0</ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-278" decimals="-3" id="f-939" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-278" decimals="-3" id="f-940" unitRef="usd">200000</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-250" decimals="-3" id="f-941" unitRef="usd">2764000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-253" decimals="2" id="f-942" unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-279" decimals="-3" id="f-943" unitRef="usd">6330000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-280" decimals="-3" id="f-944" unitRef="usd">46000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-280" decimals="-3" id="f-945" unitRef="usd">0</ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-280" decimals="-3" id="f-946" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-280" decimals="-3" id="f-947" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-253" decimals="-3" id="f-948" unitRef="usd">6376000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-256" decimals="2" id="f-949" unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-281" decimals="-3" id="f-950" unitRef="usd">12140000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-282" decimals="-3" id="f-951" unitRef="usd">180000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-282" decimals="-3" id="f-952" unitRef="usd">0</ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-282" decimals="-3" id="f-953" unitRef="usd">0</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-282" decimals="-3" id="f-954" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-256" decimals="-3" id="f-955" unitRef="usd">12320000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-83" decimals="-3" id="f-956" unitRef="usd">44383000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-37" decimals="-3" id="f-957" unitRef="usd">1512000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-37" decimals="-3" id="f-958" unitRef="usd">2125000</ameh:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <ameh:EquityMethodInvestmentsContribution contextRef="c-37" decimals="-3" id="f-959" unitRef="usd">250000</ameh:EquityMethodInvestmentsContribution>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-37" decimals="-3" id="f-960" unitRef="usd">200000</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-94" decimals="-3" id="f-961" unitRef="usd">43820000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-283" decimals="2" id="f-962" unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-270" decimals="-3" id="f-963" unitRef="usd">58000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-240" decimals="-3" id="f-964" unitRef="usd">95000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-238" decimals="-5" id="f-965" unitRef="usd">400000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment contextRef="c-1" decimals="INF" id="f-966" unitRef="usd">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment contextRef="c-38" decimals="INF" id="f-967" unitRef="usd">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <ameh:LoanReceivableTextBlock contextRef="c-1" id="f-968">Loan Receivable and Loan Receivable &#x2013; Related Parties&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loan receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pacific6&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, NMM received a promissory note from 6 Founder LLC, a California limited liability company doing business as Pacific6 Enterprises totaling $0.5&#160;million as a result of the sale of the Company&#x2019;s interest in an equity method investment. Interest accrues at a rate of 5% per annum and is payable monthly through the maturity date of December 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the outstanding loan receivable under the CECL model by assessing the party&#x2019;s ability to pay by reviewing their interest payment history quarterly, financial history annually, and reassessing any identified insolvency risk. If a failure to pay occurs, the Company assesses the terms of the notes and estimates an expected credit loss based on the remittance schedule of the note&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loan receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; related party&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;LaSalle Medical Associates Loan (&#x201c;LMA Loan&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LaSalle Medical Associates (&#x201c;LMA&#x201d;) issued a promissory note to APC-LSMA for a principal amount of $2.1 million with an August 2023 maturity date. The contractual interest rate on the LMA Loan is 1.0% above the prime rate of interest for commercial customers. In March 2023, LMA paid off the full balance of the promissory note and all interest. APC&#x2019;s investment in LMA is accounted for under the equity method based on the 25% equity ownership interest held by APC-LSMA in LMA&#x2019;s IPA line of business (see Note 5 &#x2014; &#x201c;Investments in Other Entities &#x2014; Equity Method&#x201d;)..&lt;/span&gt;&lt;/div&gt;</ameh:LoanReceivableTextBlock>
    <us-gaap:NotesReceivableNet contextRef="c-284" decimals="-5" id="f-969" unitRef="usd">500000</us-gaap:NotesReceivableNet>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-284" decimals="2" id="f-970" unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:NotesReceivableNet contextRef="c-285" decimals="-5" id="f-971" unitRef="usd">2100000</us-gaap:NotesReceivableNet>
    <ameh:FinanceReceivableInterestRateStatedPercentage contextRef="c-285" decimals="3" id="f-972" unitRef="number">0.010</ameh:FinanceReceivableInterestRateStatedPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-286" decimals="2" id="f-973" unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-287" decimals="2" id="f-974" unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c-1" id="f-975">Accounts Payable and Accrued Expenses&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s accounts payable and accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.911%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.329%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and other accruals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitation payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subcontractor IPA payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to related parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other provider payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-976">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s accounts payable and accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.911%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.329%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and other accruals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitation payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subcontractor IPA payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to related parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other provider payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-977" unitRef="usd">9939000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-978" unitRef="usd">10473000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <ameh:SpecialtyCapitationPayableCurrent contextRef="c-4" decimals="-3" id="f-979" unitRef="usd">4543000</ameh:SpecialtyCapitationPayableCurrent>
    <ameh:SpecialtyCapitationPayableCurrent contextRef="c-5" decimals="-3" id="f-980" unitRef="usd">4229000</ameh:SpecialtyCapitationPayableCurrent>
    <ameh:SubcontractorIPAPayable contextRef="c-4" decimals="-3" id="f-981" unitRef="usd">3326000</ameh:SubcontractorIPAPayable>
    <ameh:SubcontractorIPAPayable contextRef="c-5" decimals="-3" id="f-982" unitRef="usd">2415000</ameh:SubcontractorIPAPayable>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-3" id="f-983" unitRef="usd">2680000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-5" decimals="-3" id="f-984" unitRef="usd">2709000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-985" unitRef="usd">3246000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-986" unitRef="usd">3304000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-987" unitRef="usd">647000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-5" decimals="-3" id="f-988" unitRef="usd">531000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-989" unitRef="usd">13393000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-990" unitRef="usd">15301000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-991" unitRef="usd">12130000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-992" unitRef="usd">10600000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-993" unitRef="usd">49904000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-994" unitRef="usd">49562000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock contextRef="c-1" id="f-995">Medical Liabilities&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s medical liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.911%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.914%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical liabilities, beginning of period (restated)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired (see Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Components of medical care costs related to claims incurred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total medical care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for medical care costs related to claims incurred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(336,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,978)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(417,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(258,010)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical liabilities, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense contextRef="c-1" id="f-996">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s medical liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.911%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.914%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical liabilities, beginning of period (restated)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired (see Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Components of medical care costs related to claims incurred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total medical care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for medical care costs related to claims incurred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(336,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,978)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(417,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(258,010)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical liabilities, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-5" decimals="-3" id="f-997" unitRef="usd">81255000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-71" decimals="-3" id="f-998" unitRef="usd">55783000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions contextRef="c-1" decimals="-3" id="f-999" unitRef="usd">4757000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions contextRef="c-38" decimals="-3" id="f-1000" unitRef="usd">1609000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense contextRef="c-1" decimals="-3" id="f-1001" unitRef="usd">441443000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense contextRef="c-38" decimals="-3" id="f-1002" unitRef="usd">313325000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense contextRef="c-1" decimals="-3" id="f-1003" unitRef="usd">-12066000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense contextRef="c-38" decimals="-3" id="f-1004" unitRef="usd">-950000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 contextRef="c-1" decimals="-3" id="f-1005" unitRef="usd">429377000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 contextRef="c-38" decimals="-3" id="f-1006" unitRef="usd">312375000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1 contextRef="c-1" decimals="-3" id="f-1007" unitRef="usd">336231000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1 contextRef="c-38" decimals="-3" id="f-1008" unitRef="usd">204032000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1 contextRef="c-1" decimals="-3" id="f-1009" unitRef="usd">81165000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1 contextRef="c-38" decimals="-3" id="f-1010" unitRef="usd">53978000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense contextRef="c-1" decimals="-3" id="f-1011" unitRef="usd">417396000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense contextRef="c-38" decimals="-3" id="f-1012" unitRef="usd">258010000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease contextRef="c-1" decimals="-3" id="f-1013" unitRef="usd">2054000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease contextRef="c-38" decimals="-3" id="f-1014" unitRef="usd">742000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-4" decimals="-3" id="f-1015" unitRef="usd">100047000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-94" decimals="-3" id="f-1016" unitRef="usd">112499000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-1017">Credit Facility, Bank Loans, and Lines of Credit&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s debt balance consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real Estate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Promissory Note Payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Unamortized financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,845)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of our long-term debt was determined using Level 2 inputs primarily related to comparable market prices. As of June&#160;30, 2023 and December&#160;31, 2022, the carrying value was not materially different from fair value, as the interest rates on the Company&#x2019;s debt approximated rates currently available to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the future commitments of the Company&#x2019;s debt for the years ending December 31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.836%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (excluding the six months ended June 30, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Amended Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Amended Credit Agreement provides for a five-year revolving credit facility to the Company of $400.0 million, which includes a letter of credit sub-facility of up to $25.0 million and a swingline loan sub-facility of $25.0 million, which expires on June&#160;16, 2026. The Company is required to pay an annual agent fee of $50,000 and an annual facility fee of 0.175% to 0.350% on the available commitments under the Amended Credit Agreement, regardless of usage, with the applicable fee determined on a quarterly basis based on the Company&#x2019;s leverage ratio. The Company will pay fees for standby letters of credit at an annual rate equal to 1.25% to 2.50%, as determined on a quarterly basis based on the Company&#x2019;s leverage ratio, plus facing fees and standard fees payable to the issuing bank on the respective letter of credit. The Company is also required to pay customary fees between the Company and Truist Bank, the lead arranger of the Amended Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Amended Credit Agreement, the debt bears interest at an annual rate equal to either, at the Company&#x2019;s option, (a) the Term SOFR Reference Rate, calculated two U.S. Government Securities Business Days prior to the first day of such interest period, as such rate is published by the Term SOFR Administrator (Federal Reserve Bank of New York), adjusted for any Term SOFR Adjustment, plus a spread of from 1.25% to 2.50%, as determined on a quarterly basis based on the Company&#x2019;s leverage ratio, or (b) a base rate, plus a spread of 0.25% to 1.50%, as determined on a quarterly basis based on the Company&#x2019;s leverage ratio.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, the interest rate on the Credit Agreement was 6.68%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Amended Credit Agreement requires the Company to comply with two key financial ratios, each calculated on a consolidated basis. The Company must maintain a maximum consolidated total net leverage ratio of not greater than 3.75 to 1.00 as of the last day of each fiscal quarter, provided that for any fiscal quarter during which the Company or certain subsidiaries consummate a permitted acquisition or investment, the aggregate purchase price is greater than $75.0&#160;million, the maximum consolidated total net leverage ratio may temporarily increase by 0.25 to 1.00 to 4.00 to 1.00. The Company must maintain a minimum consolidated interest coverage ratio of not less than 3.25 to 1.00 as of the last day of each fiscal quarter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Financing Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2019, the Company recorded deferred financing costs of $6.5 million related to its entry into the Credit Facility. In June 2021, the Company recorded additional deferred financing costs of $0.7&#160;million related to its entry into the Amended Credit Facility. Deferred financing costs are recorded as a direct reduction of the carrying amount of the related debt liability using straight-line amortization. The remaining unamortized deferred financing costs related to the Credit Facility and the new costs related to the Amended Credit Facility are amortized over the life of the Amended Credit Facility. At June&#160;30, 2023 and December&#160;31, 2022, the unamortized deferred financing cost was $2.8&#160;million and $3.3&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Real Estate Loans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;MPP&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 3, 2020, MPP entered into a loan agreement with East West Bank with a maturity date of August 5, 2030. As of June&#160;30, 2023, the principal on the loan was $5.8 million with a variable interest rate of 0.50% less than the independent index, which is the daily &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Wall Street Journal&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x201c;Prime Rate.&#x201d; If the index is unavailable, East West Bank may designate a substitute index after notifying MPP. Monthly payments on the principal and any accrued interest rate not yet paid began in September 2020. MPP must maintain a Debt Coverage Ratio (defined as net operating income divided by current portion of long-term debt, plus interest expense) of not less than 1.25 to 1. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AMG Properties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 5, 2020, AMG Properties entered into a loan agreement with East West Bank with a maturity date of August 5, 2030. As of June&#160;30, 2023, the principal on the loan was $0.6 million with a variable interest rate of 0.30% less than the independent index, which is the daily &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Wall Street Journal&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x201c;Prime Rate.&#x201d; If the index is unavailable, East West Bank may designate a substitute index after notifying AMG Properties. Monthly payments on the principal and any accrued interest rate not yet paid began in September 2020. AMG Properties must maintain a Debt Coverage Ratio (defined as net operating income divided by current portion of long-term debt, plus interest expense) of not less than 1.25 to 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ZLL&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 27, 2020, ZLL entered into a loan agreement with East West Bank with a maturity date of August 5, 2030. As of June&#160;30, 2023, the principal on the loan was $0.6 million with a variable interest rate of 0.50% less than the independent index, which is the daily &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Wall Street Journal&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x201c;Prime Rate.&#x201d; If the index is unavailable, East West Bank may designate a substitute index after notifying ZLL. Monthly payments on the principal and any accrued interest rate not yet paid began in September 2020. ZLL must maintain a Debt Coverage Ratio (defined as net operating income divided by current portion of long-term debt, plus interest expense) of not less than 1.25 to 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;120 Hellman LLC &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;25, 2022, 120 Hellman LLC (&#x201c;120 Hellman&#x201d;), a subsidiary of APC, entered into a loan agreement with MUFG Union Bank N.A. with the principal on the loan of $16.3 million and a maturity date of March&#160;1, 2032. The loan was used to purchase property in Monterey Park, California. As of June&#160;30, 2023, the principal on the loan was $15.8 million. The variable interest rate is 2.0% in excess of Daily Simple SOFR, which is the daily rate per annum equal to the secured overnight financing rate as administered by the Federal Reserve Bank of New York. If the index is unavailable, MUFG Union Bank N.A. may designate a substitute index after notifying 120 Hellman. Monthly payments on the principal and interest began on April 1, 2022. Should interest not be paid when due, it shall become part of the principal and bear interest. 120 Hellman must maintain a Cash Flow to Debt Service ratio (defined as net profit after taxes, to which depreciation, amortization and other non-cash items are added and divided by the current portion of long-term debt and capital leases) of not less than 1.25 to 1 and 35% or more of the property must also be occupied by APC. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Construction Loans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, Tag 8 entered into a construction loan agreement with MUFG Union Bank N.A. (&#x201c;Construction Loan&#x201d;). Tag 8 is a VIE consolidated by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Construction Loan allows Tag 8 to borrow up to $10.7 million. In December 2022, the Construction loan was amended to extend the maturity date to March&#160;1, 2024 (&#x201c;Construction Loan Term&#x201d;). If construction is completed and there are no events of default or substantial deterioration in the financial condition of Tag 8 or APC, guarantor on the loan agreement, at the maturity date of the Construction Loan Term, the loan shall convert to an amortizing loan with an amended extended maturity date of March&#160;1, 2034 (&#x201c;Permanent Loan Term&#x201d;). Under the amended Construction Loan, upon conversion to the Permanent Loan Term, monthly principal and interest payments shall be made beginning April&#160;1, 2024. The principal balance will bear interest at the SOFR reference rate. As of June&#160;30, 2023, the likelihood of the construction being completed by the maturity date is probable. The loan balance as of June&#160;30, 2023 was $5.7 million and was recorded as long-term debt, net of current portion and deferred financing costs in the accompanying consolidated balance sheets. Once the loan converts to the Permanent Loan Term, APC, as Tag 8&#x2019;s guarantor, must maintain a Cash Flow Coverage Ratio (defined as consolidated EBITDA minus unfinanced capital expenditures and distributions paid divided by the sum of current portion of long-term debt, plus interest expense) of not less than 1.25 to 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Promissory Note Payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, FYB entered into a promissory note agreement with CCHCA. The principal on the promissory note is $2.0&#160;million, with a maturity date of May&#160;9, 2024. The interest rate is the prime rate plus 1.0%. The prime rate is updated annually on the effective date of the note and published by the Wall Street Journal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Effective Interest Rate&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s average effective interest rate on its total debt during the six months ended June&#160;30, 2023 and 2022, was 5.93% and 2.16%, respectively. Interest expense in the consolidated statements of operations included amortization of deferred debt issuance costs for the three months ended June&#160;30, 2023 and 2022, of $0.2 million and $0.2 million, respectively, and for the  six months ended June&#160;30, 2023 and 2022, of $0.5 million and $0.5 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lines of Credit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;APC Business Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September&#160;10, 2019, the APC Business Loan Agreement with Preferred Bank (the &#x201c;APC Business Loan Agreement&#x201d;) was amended to, among other things, decrease loan availability to $4.1 million, limit the purpose of the indebtedness under the APC Business Loan Agreement to the issuance of standby letters of credit, and include as a permitted lien, the security interest in all of its assets that APC granted to NMM under a Security Agreement dated on or about September 11, 2019, securing APC&#x2019;s obligations to NMM under their management services agreement dated as of July 1, 1999, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Standby Letters of Credit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company established irrevocable standby letters of credit with Truist Bank under the Amended Credit Agreement for a total of $21.1 million for the benefit of CMS. Unless the institution provides notification that the standby letters of credit will be terminated prior to the expiration date, the letters will be automatically extended without amendment for additional one-year periods from the present, or any future expiration date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;APC established irrevocable standby letters of credit with Preferred Bank under the APC Business Loan Agreement for a total of $0.1 million for the benefit of certain health plans. The standby letters of credit are automatically extended without amendment for additional one-year periods from the present or any future expiration date, unless notified by the institution in advance of the expiration date that the letter will be terminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Alpha Care established irrevocable standby letters of credit with Preferred Bank under the APC Business Loan Agreement for a total of $3.8 million for the benefit of certain health plans. The standby letters of credit are automatically extended without amendment for additional one-year periods from the present or any future expiration date, unless notified by the institution in advance of the expiration date that the letter will be terminated.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock contextRef="c-1" id="f-1018">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s debt balance consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real Estate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Promissory Note Payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Unamortized financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,845)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-288" decimals="-3" id="f-1019" unitRef="usd">180000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-289" decimals="-3" id="f-1020" unitRef="usd">180000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-290" decimals="-3" id="f-1021" unitRef="usd">22862000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-291" decimals="-3" id="f-1022" unitRef="usd">23168000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-292" decimals="-3" id="f-1023" unitRef="usd">5749000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-293" decimals="-3" id="f-1024" unitRef="usd">4159000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-294" decimals="-3" id="f-1025" unitRef="usd">2000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-295" decimals="-3" id="f-1026" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-4" decimals="-3" id="f-1027" unitRef="usd">210611000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-5" decimals="-3" id="f-1028" unitRef="usd">207327000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtCurrent contextRef="c-4" decimals="-3" id="f-1029" unitRef="usd">2630000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-5" decimals="-3" id="f-1030" unitRef="usd">619000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-4" decimals="-3" id="f-1031" unitRef="usd">2845000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-5" decimals="-3" id="f-1032" unitRef="usd">3319000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-3" id="f-1033" unitRef="usd">205136000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-5" decimals="-3" id="f-1034" unitRef="usd">203389000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="c-1" id="f-1035">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the future commitments of the Company&#x2019;s debt for the years ending December 31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.836%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (excluding the six months ended June 30, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear contextRef="c-4" decimals="-3" id="f-1036" unitRef="usd">312000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c-4" decimals="-3" id="f-1037" unitRef="usd">2642000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c-4" decimals="-3" id="f-1038" unitRef="usd">7184000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="c-4" decimals="-3" id="f-1039" unitRef="usd">180454000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="c-4" decimals="-3" id="f-1040" unitRef="usd">472000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <ameh:LongTermDebtMaturityAfterYearFour contextRef="c-4" decimals="-3" id="f-1041" unitRef="usd">19547000</ameh:LongTermDebtMaturityAfterYearFour>
    <us-gaap:LineOfCredit contextRef="c-4" decimals="-3" id="f-1042" unitRef="usd">210611000</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentTerm contextRef="c-296" id="f-1043">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-297" decimals="-5" id="f-1044" unitRef="usd">400000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-298" decimals="INF" id="f-1045" unitRef="usd">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-299" decimals="INF" id="f-1046" unitRef="usd">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount contextRef="c-300" decimals="-3" id="f-1047" unitRef="usd">50000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-301"
      decimals="INF"
      id="f-1048"
      unitRef="number">0.00175</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-302"
      decimals="INF"
      id="f-1049"
      unitRef="number">0.00350</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-303"
      decimals="INF"
      id="f-1050"
      unitRef="number">0.0125</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-304"
      decimals="INF"
      id="f-1051"
      unitRef="number">0.0250</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-305"
      decimals="INF"
      id="f-1052"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-306"
      decimals="INF"
      id="f-1053"
      unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-307"
      decimals="INF"
      id="f-1054"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-308"
      decimals="INF"
      id="f-1055"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="c-309"
      decimals="4"
      id="f-1056"
      unitRef="number">0.0668</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <ameh:DebtInstrumentNumberOfKeyFinancialRatios
      contextRef="c-310"
      decimals="INF"
      id="f-1057"
      unitRef="financial_ratio">2</ameh:DebtInstrumentNumberOfKeyFinancialRatios>
    <ameh:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="c-310"
      decimals="INF"
      id="f-1058"
      unitRef="number">3.75</ameh:DebtInstrumentCovenantLeverageRatioMaximum>
    <ameh:DebtCovenantAggregatePurchasePriceMaximum contextRef="c-310" decimals="-5" id="f-1059" unitRef="usd">75000000</ameh:DebtCovenantAggregatePurchasePriceMaximum>
    <ameh:DebtInstrumentCovenantLeverageRatioIncrementalChange
      contextRef="c-310"
      decimals="INF"
      id="f-1060"
      unitRef="number">0.25</ameh:DebtInstrumentCovenantLeverageRatioIncrementalChange>
    <ameh:DebtInstrumentCovenantLeverageRatioAdjustedMaximum
      contextRef="c-310"
      decimals="INF"
      id="f-1061"
      unitRef="number">4.00</ameh:DebtInstrumentCovenantLeverageRatioAdjustedMaximum>
    <ameh:DebtInstrumentCovenantInterestCoverageRatioMinimum
      contextRef="c-311"
      decimals="INF"
      id="f-1062"
      unitRef="number">3.25</ameh:DebtInstrumentCovenantInterestCoverageRatioMinimum>
    <us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet contextRef="c-312" decimals="-5" id="f-1063" unitRef="usd">6500000</us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet>
    <us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet contextRef="c-313" decimals="-5" id="f-1064" unitRef="usd">700000</us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-4" decimals="-5" id="f-1065" unitRef="usd">2800000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-5" decimals="-5" id="f-1066" unitRef="usd">3300000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt contextRef="c-314" decimals="-5" id="f-1067" unitRef="usd">5800000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-315"
      decimals="INF"
      id="f-1068"
      unitRef="number">-0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <ameh:DebtInstrumentCovenantDebtCoverageRatioMinimum
      contextRef="c-316"
      decimals="INF"
      id="f-1069"
      unitRef="number">1.25</ameh:DebtInstrumentCovenantDebtCoverageRatioMinimum>
    <us-gaap:LongTermDebt contextRef="c-317" decimals="-5" id="f-1070" unitRef="usd">600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-318"
      decimals="INF"
      id="f-1071"
      unitRef="number">-0.0030</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <ameh:DebtInstrumentCovenantDebtCoverageRatioMinimum
      contextRef="c-319"
      decimals="INF"
      id="f-1072"
      unitRef="number">1.25</ameh:DebtInstrumentCovenantDebtCoverageRatioMinimum>
    <us-gaap:LongTermDebt contextRef="c-320" decimals="-5" id="f-1073" unitRef="usd">600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-321"
      decimals="INF"
      id="f-1074"
      unitRef="number">-0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <ameh:DebtInstrumentCovenantDebtCoverageRatioMinimum
      contextRef="c-322"
      decimals="INF"
      id="f-1075"
      unitRef="number">1.25</ameh:DebtInstrumentCovenantDebtCoverageRatioMinimum>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-323" decimals="-5" id="f-1076" unitRef="usd">16300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt contextRef="c-324" decimals="-5" id="f-1077" unitRef="usd">15800000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-325"
      decimals="INF"
      id="f-1078"
      unitRef="number">0.020</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <ameh:DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum
      contextRef="c-326"
      decimals="INF"
      id="f-1079"
      unitRef="number">1.25</ameh:DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum>
    <ameh:DebtCovenantThresholdPercentageForOccupationOfProperty
      contextRef="c-323"
      decimals="INF"
      id="f-1080"
      unitRef="number">0.35</ameh:DebtCovenantThresholdPercentageForOccupationOfProperty>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-327" decimals="-5" id="f-1081" unitRef="usd">10700000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt contextRef="c-328" decimals="-5" id="f-1082" unitRef="usd">5700000</us-gaap:LongTermDebt>
    <ameh:DebtInstrumentCovenantCashFlowCoverageRatioMinimum
      contextRef="c-329"
      decimals="INF"
      id="f-1083"
      unitRef="number">1.25</ameh:DebtInstrumentCovenantCashFlowCoverageRatioMinimum>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-330" decimals="-5" id="f-1084" unitRef="usd">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-331"
      decimals="3"
      id="f-1085"
      unitRef="number">0.010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="c-311"
      decimals="4"
      id="f-1086"
      unitRef="number">0.0593</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="c-332"
      decimals="4"
      id="f-1087"
      unitRef="number">0.0216</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:InterestExpense contextRef="c-333" decimals="-5" id="f-1088" unitRef="usd">200000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-334" decimals="-5" id="f-1089" unitRef="usd">200000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-311" decimals="-5" id="f-1090" unitRef="usd">500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-332" decimals="-5" id="f-1091" unitRef="usd">500000</us-gaap:InterestExpense>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-335" decimals="INF" id="f-1092" unitRef="usd">4100000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-336" decimals="-5" id="f-1093" unitRef="usd">21100000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationPeriod contextRef="c-337" id="f-1094">P1Y</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-338" decimals="-5" id="f-1095" unitRef="usd">100000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationPeriod contextRef="c-339" id="f-1096">P1Y</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-340" decimals="-5" id="f-1097" unitRef="usd">3800000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationPeriod contextRef="c-341" id="f-1098">P1Y</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-1099">Mezzanine and Stockholders&#x2019; Equity&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Mezzanine Equity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;APC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the redemption feature of the APC shares is not solely within the control of APC, the equity of APC does not qualify as permanent equity and has been classified as non-controlling interests in APC as mezzanine or temporary equity. APC&#x2019;s shares were not redeemable, and it was not probable that the shares would become redeemable as of June&#160;30, 2023 and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Stockholders&#x2019; Equity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, 140,954 holdback shares have not been issued to certain former NMM shareholders who were NMM shareholders at the time of closing of the 2017 Merger, as they have yet to submit properly completed letters of transmittal to ApolloMed in order to receive their pro rata portion of ApolloMed common stock and warrants as contemplated under the 2017 merger agreement. Pending such receipt, such former NMM shareholders have the right to receive, without interest, their pro rata share of dividends or distributions with a record date after the effectiveness of the 2017 Merger. The consolidated financial statements have treated such shares of common stock as outstanding, given the receipt of the letter of transmittal is considered perfunctory and the Company is legally obligated to issue these shares in connection with the 2017 Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;APC owned 10,299,259 and 10,299,259 shares of ApolloMed&#x2019;s common stock, respectively, as of June&#160;30, 2023 and December&#160;31, 2022. While such shares of ApolloMed&#x2019;s common stock are legally issued and outstanding, they are treated as treasury shares for accounting purposes and excluded from shares of common stock outstanding in the consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2023 the Company bought back 270,081 of its common stock. These are included as treasury stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023 and December&#160;31, 2022, the total treasury stock was 10,569,340 and 10,299,259, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2023 and 2022, APC paid dividends of $0 and $10.0&#160;million, respectively. During the six months ended June&#160;30, 2023 and 2022, APC paid dividends of $0 and $10.0 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2023 and 2022, CDSC paid dividends of $0 and $1.5&#160;million, respectively. During the six months ended June&#160;30, 2023 and 2022, CDSC paid dividends of $0 and $2.9&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <ameh:StockIssuedDuringPeriodSharesMerger
      contextRef="c-1"
      decimals="INF"
      id="f-1100"
      unitRef="shares">140954</ameh:StockIssuedDuringPeriodSharesMerger>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-342"
      decimals="INF"
      id="f-1101"
      unitRef="shares">10299259</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-3"
      decimals="INF"
      id="f-1102"
      unitRef="shares">10299259</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-1"
      decimals="INF"
      id="f-1103"
      unitRef="shares">270081</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-4"
      decimals="INF"
      id="f-1104"
      unitRef="shares">10569340</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-5"
      decimals="INF"
      id="f-1105"
      unitRef="shares">10299259</us-gaap:TreasuryStockCommonShares>
    <us-gaap:Dividends contextRef="c-343" decimals="-5" id="f-1106" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c-344" decimals="-5" id="f-1107" unitRef="usd">10000000</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c-345" decimals="-5" id="f-1108" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c-346" decimals="-5" id="f-1109" unitRef="usd">10000000</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c-347" decimals="-5" id="f-1110" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c-348" decimals="-5" id="f-1111" unitRef="usd">1500000</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c-349" decimals="-5" id="f-1112" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c-350" decimals="-5" id="f-1113" unitRef="usd">2900000</us-gaap:Dividends>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-1114">Stock-Based CompensationThe following table summarizes the stock-based compensation expense recognized under all of the Company&#x2019;s stock plans for the three and six months ended June&#160;30, 2023 and 2022, and associated with the issuance of restricted shares of common stock and vesting of stock options that are included in general and administrative expenses in the accompanying consolidated statements of income (in thousands):&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.186%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422000&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrecognized compensation expense related to total share-based payments outstanding as of June&#160;30, 2023 was $37.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s outstanding stock options consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.853%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contractual&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options outstanding at January&#160;1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.72&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2023, options were exercised for 125,000 shares of the Company&#x2019;s common stock, resulting in proceeds of $1.3 million. During the six months ended June&#160;30, 2022, options were exercised for 38,500 shares of the Company&#x2019;s common stock, resulting in proceeds of $0.7 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company grants restricted stock to officers and employees, which are earned based on service conditions. The grant date fair value of the restricted stock is that day&#x2019;s closing market price of the Company&#x2019;s common stock. During the six months ended June&#160;30, 2023, the Company granted 279,501 shares of restricted stock with performance based conditions and 359,527 shares of restricted stock without performance based conditions. During the six months ended June&#160;30, 2023, the weighted average grant date fair value of restricted stock with and without performance based conditions was $32.95 and 33.15, respectively. As of June&#160;30, 2023, unvested restricted stock awards, including performance based restricted stock awards totaled 1.3 million shares. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All warrants issued by the Company have expired as of December 31, 2022. As a result, there are no outstanding warrants as of June&#160;30, 2023 and December&#160;31, 2022. During the six months ended June&#160;30, 2022, common stock warrants were exercised for 101,953 shares of the Company&#x2019;s common stock, which resulted in proceeds of approximately $1.1 million. The exercise price ranged from $10.00 to $11.00 per share for the exercises during the six months ended June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-1115">The following table summarizes the stock-based compensation expense recognized under all of the Company&#x2019;s stock plans for the three and six months ended June&#160;30, 2023 and 2022, and associated with the issuance of restricted shares of common stock and vesting of stock options that are included in general and administrative expenses in the accompanying consolidated statements of income (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.186%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422000&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-351" decimals="-3" id="f-1116" unitRef="usd">422000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-352" decimals="-3" id="f-1117" unitRef="usd">1141000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-353" decimals="-3" id="f-1118" unitRef="usd">988000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-354" decimals="-3" id="f-1119" unitRef="usd">1921000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-355" decimals="-3" id="f-1120" unitRef="usd">3791000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-356" decimals="-3" id="f-1121" unitRef="usd">2779000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-357" decimals="-3" id="f-1122" unitRef="usd">6670000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-358" decimals="-3" id="f-1123" unitRef="usd">5054000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-36" decimals="-3" id="f-1124" unitRef="usd">4213000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-37" decimals="-3" id="f-1125" unitRef="usd">3920000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-1126" unitRef="usd">7658000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-38" decimals="-3" id="f-1127" unitRef="usd">6975000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-4" decimals="-5" id="f-1128" unitRef="usd">37700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-1129">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s outstanding stock options consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.853%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contractual&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options outstanding at January&#160;1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.72&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-5"
      decimals="INF"
      id="f-1130"
      unitRef="shares">859850</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-5"
      decimals="2"
      id="f-1131"
      unitRef="usdPerShare">25.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-95" id="f-1132">P2Y2M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-5" decimals="-3" id="f-1133" unitRef="usd">10300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="c-1"
      decimals="INF"
      id="f-1134"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-1135"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-1"
      decimals="INF"
      id="f-1136"
      unitRef="shares">125000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-1137"
      unitRef="usdPerShare">10.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-1" decimals="-3" id="f-1138" unitRef="usd">3300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-1"
      decimals="INF"
      id="f-1139"
      unitRef="shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-1140"
      unitRef="usdPerShare">0.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-4"
      decimals="INF"
      id="f-1141"
      unitRef="shares">684850</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-1142"
      unitRef="usdPerShare">30.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-1143">P2Y1M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-4" decimals="-3" id="f-1144" unitRef="usd">7400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-4"
      decimals="INF"
      id="f-1145"
      unitRef="shares">589118</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-1146"
      unitRef="usdPerShare">21.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-1147">P1Y8M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-4" decimals="-3" id="f-1148" unitRef="usd">7100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-1"
      decimals="INF"
      id="f-1149"
      unitRef="shares">125000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-5" id="f-1150" unitRef="usd">1300000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-38"
      decimals="INF"
      id="f-1151"
      unitRef="shares">38500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-359" decimals="-5" id="f-1152" unitRef="usd">700000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-360"
      decimals="INF"
      id="f-1153"
      unitRef="shares">279501</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <ameh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance
      contextRef="c-360"
      decimals="INF"
      id="f-1154"
      unitRef="shares">359527</ameh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-361"
      decimals="2"
      id="f-1155"
      unitRef="usdPerShare">32.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-360"
      decimals="2"
      id="f-1156"
      unitRef="usdPerShare">33.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="c-362"
      decimals="-5"
      id="f-1157"
      unitRef="shares">1300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-5"
      decimals="INF"
      id="f-1158"
      unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-4"
      decimals="INF"
      id="f-1159"
      unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <ameh:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod
      contextRef="c-38"
      decimals="INF"
      id="f-1160"
      unitRef="shares">101953</ameh:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod>
    <ameh:WarrantIssuedDuringPeriodValueStockOptionsExercised contextRef="c-38" decimals="-5" id="f-1161" unitRef="usd">1100000</ameh:WarrantIssuedDuringPeriodValueStockOptionsExercised>
    <ameh:ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice
      contextRef="c-363"
      decimals="2"
      id="f-1162"
      unitRef="usdPerShare">10.00</ameh:ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice>
    <ameh:ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice
      contextRef="c-364"
      decimals="2"
      id="f-1163"
      unitRef="usdPerShare">11.00</ameh:ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-1164">Commitments and Contingencies&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Regulatory Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laws and regulations governing the Medicare program and healthcare generally are complex and subject to interpretation. The Company believes it complies with all applicable laws and regulations and is unaware of any pending or threatened investigations involving allegations of potential wrongdoing. While no regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action, including fines, penalties, and exclusion from the Medicare and Medi-Cal programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a risk-bearing organization, the Company is required to follow regulations of the Department of Managed Health Care (&#x201c;DMHC&#x201d;). The Company must comply with a minimum working capital requirement, tangible net equity (&#x201c;TNE&#x201d;) requirement, cash-to-claims ratio, and claims payment requirements prescribed by the DMHC. TNE is defined as net assets less intangibles, less non-allowable assets (which include amounts due from affiliates), plus subordinated obligations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Many of the Company&#x2019;s payor and provider contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of medical services. Such differing interpretations may not come to light until a substantial period of time has passed following contract implementation. Liabilities for claims disputes are recorded when the loss is probable and can be estimated. Any adjustments to reserves are reflected in current operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Standby Letters of Credit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company established irrevocable standby letters of credit with Truist Bank for a total of $21.1 million for the benefit of CMS (see Note 9 &#x2014; &#x201c;Credit Facility, Bank Loans, and Lines of Credit &#x2014; Standby Letters of Credit&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;APC and Alpha Care established irrevocable standby letters of credit with a Preferred Bank for a total of $0.1 million and $3.8&#160;million, respectively, for the benefit of certain health plans (see Note 9 &#x2014; &#x201c;Credit Facility, Bank Loans, and Lines of Credit &#x2014; Standby Letters of Credit&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company is involved in various legal proceedings and other matters arising in the normal course of its business. The resolution of any claim or litigation is subject to inherent uncertainty and could have a material adverse effect on the Company&#x2019;s financial condition, cash flows, or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liability Insurance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that its insurance coverage is appropriate based upon the Company&#x2019;s claims experience and the nature and risks of the Company&#x2019;s business. In addition to the known incidents that have resulted in the assertion of claims, the Company cannot be certain that its insurance coverage will be adequate to cover liabilities arising out of claims asserted against the Company, the Company&#x2019;s affiliated professional organizations or the Company&#x2019;s affiliated hospitalists in the future where the outcomes of such claims are unfavorable. The Company believes that the ultimate resolution of all pending claims, including liabilities in excess of the Company&#x2019;s insurance coverage, will not have a material adverse effect on the Company&#x2019;s financial position, results of operations, or cash flows; however, there can be no assurance that future claims will not have such a material adverse effect on the Company&#x2019;s business. Contracted physicians are required to obtain their own insurance coverage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company currently maintains liability insurance policies on a claims-made basis, which are intended to cover malpractice liability and certain other claims, the coverage must be renewed annually, and may&#160;not continue to be available to the Company in future years at acceptable costs, and on favorable terms.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-336" decimals="-5" id="f-1165" unitRef="usd">21100000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit contextRef="c-365" decimals="-5" id="f-1166" unitRef="usd">100000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="c-366" decimals="-5" id="f-1167" unitRef="usd">3800000</us-gaap:LineOfCredit>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-1168">Related-Party Transactions&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2023 and 2022, NMM recognized approximately $6.9 million and $4.8 million, respectively in management fees from LMA. During the six months ended June&#160;30, 2023 and 2022, NMM recognized approximately $11.9 million and $11.1 million, respectively. LMA is  accounted for under the equity method based on the 25% equity ownership interest held by APC in LMA&#x2019;s IPA line of business (see Note 5 &#x2014; &#x201c;Investments in Other Entities - Equity Method&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2023 and 2022, NMM recognized approximately $0.5 million and $0.4 million, respectively in management fees from Arroyo Vista Family Health Center (&#x201c;Arroyo Vista&#x201d;). During the six months ended June&#160;30, 2023 and 2022, NMM recognized approximately $1.0 million and $0.9 million, respectively. During the three months ended June&#160;30, 2023 and 2022, the Company paid approximately $0.1 million and $0.1 million, respectively, to Arroyo Vista for services as a provider. During the six months ended June&#160;30, 2023 and 2022, the Company paid approximately $0.2 million and $0.1 million, respectively. Arroyo Vista&#x2019;s chief executive officer is a member of the Company&#x2019;s board of directors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;APC and PMIOC have an Ancillary Service Contract together whereby PMIOC provides covered services on behalf of APC to enrollees of the plans of APC. During the three months ended June&#160;30, 2023 and 2022, APC paid approximately $0.5 million and $0.7 million, respectively, to PMIOC for provider services. During the six months ended June&#160;30, 2023 and 2022, APC paid approximately $1.1 million and $1.4 million, respectively. PMIOC is accounted for under the equity method based on the 40% equity ownership interest held by APC (see Note 5 &#x2014; &#x201c;Investments in Other Entities &#x2014; Equity Method&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended June&#160;30, 2023, the Company paid approximately $0.4 million to Song PC for provider services. As of January 2023, Song PC is accounted for under the equity method accounting as AP-AMH 2 has the ability to exercise significant influence, but not control over Song PC&#x2019;s operations (see Note 5 &#x2014; &#x201c;Investments in Other Entities &#x2014; Equity Method&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2023 and 2022, APC paid approximately $0.1 million and $0.1 million, respectively, to Advanced Diagnostic Surgery Center for services as a provider. During the six months ended June&#160;30, 2023 and 2022, APC paid approximately $0.1 million and $0.1 million, respectively. During the three months ended June&#160;30, 2023 and 2022, Advanced Diagnostic and Surgical Center paid approximately $0.2 million and $0.1 million, respectively, to MPP for rent. During the six months ended June&#160;30, 2023 and 2022, rent to MPP was approximately $0.3 million and $0.3 million, respectively. Advanced Diagnostic Surgery Center shares common ownership with certain board members of ApolloMed and APC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2023 and 2022, APC paid approximately $1,000 and $0.2 million, respectively, to Fulgent Genetics, Inc. for services as a provider. During the six months ended June&#160;30, 2023 and 2022, APC paid approximately $10,000 and $0.3 million, respectively. One of the Company&#x2019;s board members is a board member of Fulgent Genetics, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2023 and 2022, the Company paid approximately $0.6 million and $0.1 million, respectively, to Sunny Village Care Center for services as a provider. During the six months ended June&#160;30, 2023 and 2022, the Company paid approximately $0.8 million and $1.0 million, respectively. During the three and six months ended June&#160;30, 2023, Sunny Village Care Center paid approximately $0.3 million and $0.5 million, respectively, to Tag 6 for rent. Tag 6 was consolidated by APC in August 2022. Sunny Village Care Center shares common ownership with certain ApolloMed officers and board members of ApolloMed and APC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2023, ApolloMed paid $9.5 million to purchase ApolloMed&#x2019;s stock from a board member. During the six months ended June&#160;30, 2022, APC paid $9.3 million, respectively, to purchase ApolloMed&#x2019;s stock from a board member.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2023 and 2022, NMM paid approximately $0.4 million and $0.4 million, respectively, to One MSO for an office lease. During the six months ended June&#160;30, 2023 and 2022, NMM paid approximately $0.7 million and $0.7 million, respectively. One MSO is accounted for under the equity method based on 50% equity ownership interest held by APC (see Note 5 &#x2014; &#x201c;Investments in Other Entities &#x2014; Equity Method&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has agreements with Health Source MSO Inc., a California corporation (&#x201c;HSMSO&#x201d;), Aurion Corporation (&#x201c;Aurion&#x201d;), and AHMC for services provided to the Company. One of the Company&#x2019;s board members is an officer of AHMC, HSMSO, and Aurion. Aurion is also partially owned by one of the Company&#x2019;s board members. The following table sets forth fees incurred and income recognized related to AHMC, HSMSO, and Aurion (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.398%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.762%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.762%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.762%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.764%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;AHMC &#x2013; Risk pool, capitation, claims payment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;HSMSO &#x2013; Management fees, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aurion &#x2013; Management fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and AHMC have a risk-sharing agreement with certain AHMC hospitals to share the surplus and deficits of each of the hospital pools. Under this agreement, during the three months ended June&#160;30, 2023 and 2022, the Company has recognized risk pool revenue of $15.8 million and $13.3 million, respectfully. During the six months ended June&#160;30, 2023 and 2022, the Company has recognized risk pool revenue of  $28.8 million and $25.3 million, respectfully. The Company has a risk pool receivable balance of $73.2 million and $58.7 million as of June&#160;30, 2023 and December&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2023 and 2022, APC paid an aggregate of approximately $9.5 million and $12.3 million, respectively, to board members for provider services which included approximately $1.2 million and $3.3 million, respectively, to APC board members who are also officers of APC. During the six months ended June&#160;30, 2023 and 2022, APC paid an aggregate of approximately $18.8 million and $21.6 million, respectively, to board members for provider services which included approximately $2.6 million and $5.2 million, respectively, to board members who are also officers of APC. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, affiliates wholly owned by the Company&#x2019;s officers, including Dr. Thomas Lam, ApolloMed&#x2019;s Co-CEO and President, are reported in the accompanying consolidated statements of operations on a consolidated basis, together with the Company&#x2019;s subsidiaries, and therefore, the Company does not separately disclose transactions between such affiliates and the Company&#x2019;s subsidiaries as related-party transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For equity method investments and loans receivable from related parties, see Note 5 &#x2014; &#x201c;Investment in Other Entities &#x2014; Equity Method&#x201d; and Note 6 &#x2014; &#x201c;Loan Receivable and Loan Receivable &#x2014; Related Parties,&#x201d; respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-367" decimals="-5" id="f-1169" unitRef="usd">6900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-368" decimals="-5" id="f-1170" unitRef="usd">4800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-369" decimals="-5" id="f-1171" unitRef="usd">11900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-370" decimals="-5" id="f-1172" unitRef="usd">11100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c-286"
      decimals="2"
      id="f-1173"
      unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c-287"
      decimals="2"
      id="f-1174"
      unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-371" decimals="-5" id="f-1175" unitRef="usd">500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-372" decimals="-5" id="f-1176" unitRef="usd">400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-373" decimals="-5" id="f-1177" unitRef="usd">1000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-374" decimals="-5" id="f-1178" unitRef="usd">900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-375" decimals="-5" id="f-1179" unitRef="usd">100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-376" decimals="-5" id="f-1180" unitRef="usd">100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-377" decimals="-5" id="f-1181" unitRef="usd">200000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-378" decimals="-5" id="f-1182" unitRef="usd">100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-379" decimals="-5" id="f-1183" unitRef="usd">500000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-380" decimals="-5" id="f-1184" unitRef="usd">700000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-381" decimals="-5" id="f-1185" unitRef="usd">1100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-382" decimals="-5" id="f-1186" unitRef="usd">1400000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c-383"
      decimals="2"
      id="f-1187"
      unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c-384"
      decimals="2"
      id="f-1188"
      unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-385" decimals="-5" id="f-1189" unitRef="usd">400000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-386" decimals="-5" id="f-1190" unitRef="usd">400000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-387" decimals="-5" id="f-1191" unitRef="usd">100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-388" decimals="-5" id="f-1192" unitRef="usd">100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-389" decimals="-5" id="f-1193" unitRef="usd">100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-390" decimals="-5" id="f-1194" unitRef="usd">100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-391" decimals="-5" id="f-1195" unitRef="usd">200000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-392" decimals="-5" id="f-1196" unitRef="usd">100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-393" decimals="-5" id="f-1197" unitRef="usd">300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-394" decimals="-5" id="f-1198" unitRef="usd">300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-395" decimals="-3" id="f-1199" unitRef="usd">1000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-396" decimals="-5" id="f-1200" unitRef="usd">200000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-397" decimals="-3" id="f-1201" unitRef="usd">10000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-398" decimals="-5" id="f-1202" unitRef="usd">300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-399" decimals="-5" id="f-1203" unitRef="usd">600000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-400" decimals="-5" id="f-1204" unitRef="usd">100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-401" decimals="-5" id="f-1205" unitRef="usd">800000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-402" decimals="-5" id="f-1206" unitRef="usd">1000000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-403" decimals="-5" id="f-1207" unitRef="usd">300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-404" decimals="-5" id="f-1208" unitRef="usd">500000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-405" decimals="-5" id="f-1209" unitRef="usd">9500000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-406" decimals="-5" id="f-1210" unitRef="usd">9300000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-407" decimals="-5" id="f-1211" unitRef="usd">400000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-408" decimals="-5" id="f-1212" unitRef="usd">400000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-409" decimals="-5" id="f-1213" unitRef="usd">700000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-410" decimals="-5" id="f-1214" unitRef="usd">700000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c-411"
      decimals="2"
      id="f-1215"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="c-1" id="f-1216">The following table sets forth fees incurred and income recognized related to AHMC, HSMSO, and Aurion (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.398%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.762%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.762%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.762%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.764%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;AHMC &#x2013; Risk pool, capitation, claims payment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;HSMSO &#x2013; Management fees, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aurion &#x2013; Management fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-412" decimals="-3" id="f-1217" unitRef="usd">11574000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-413" decimals="-3" id="f-1218" unitRef="usd">14419000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-414" decimals="-3" id="f-1219" unitRef="usd">19658000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-415" decimals="-3" id="f-1220" unitRef="usd">25785000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-416" decimals="-3" id="f-1221" unitRef="usd">243000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-417" decimals="-3" id="f-1222" unitRef="usd">-649000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-418" decimals="-3" id="f-1223" unitRef="usd">389000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-419" decimals="-3" id="f-1224" unitRef="usd">-728000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-420" decimals="-3" id="f-1225" unitRef="usd">-100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-421" decimals="-3" id="f-1226" unitRef="usd">-75000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-422" decimals="-3" id="f-1227" unitRef="usd">-150000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-423" decimals="-3" id="f-1228" unitRef="usd">-150000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-424" decimals="-3" id="f-1229" unitRef="usd">11717000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-425" decimals="-3" id="f-1230" unitRef="usd">13695000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-426" decimals="-3" id="f-1231" unitRef="usd">19897000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-427" decimals="-3" id="f-1232" unitRef="usd">24907000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-428" decimals="-5" id="f-1233" unitRef="usd">15800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-429" decimals="-5" id="f-1234" unitRef="usd">13300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-430" decimals="-5" id="f-1235" unitRef="usd">28800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-431" decimals="-5" id="f-1236" unitRef="usd">25300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DeferredCreditsAndOtherLiabilities contextRef="c-432" decimals="-5" id="f-1237" unitRef="usd">73200000</us-gaap:DeferredCreditsAndOtherLiabilities>
    <us-gaap:DeferredCreditsAndOtherLiabilities contextRef="c-433" decimals="-5" id="f-1238" unitRef="usd">58700000</us-gaap:DeferredCreditsAndOtherLiabilities>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-434" decimals="-5" id="f-1239" unitRef="usd">9500000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-435" decimals="-5" id="f-1240" unitRef="usd">12300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-436" decimals="-5" id="f-1241" unitRef="usd">1200000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-437" decimals="-5" id="f-1242" unitRef="usd">3300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-438" decimals="-5" id="f-1243" unitRef="usd">18800000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-439" decimals="-5" id="f-1244" unitRef="usd">21600000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-440" decimals="-5" id="f-1245" unitRef="usd">2600000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-441" decimals="-5" id="f-1246" unitRef="usd">5200000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1247">Income Taxes&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the liability method of accounting for income taxes as set forth in ASC 740&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Under the liability method, deferred taxes are determined based on differences between the financial statement and tax bases of assets and liabilities using enacted tax rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On an interim basis, the Company estimates what its anticipated annual effective tax rate will be and records a quarterly income tax provision in accordance with the estimated annual rate, plus the tax effect of certain discrete items that arise during the quarter. As the fiscal year progresses, the Company refines its estimates based on actual events and financial results during the quarter. This process can result in significant changes to the Company&#x2019;s estimated effective tax rate. When this occurs, the income tax provision is adjusted during the quarter in which the estimates are refined so that the year-to-date provision reflects the estimated annual effective tax rate. These changes, along with adjustments to the Company&#x2019;s deferred taxes and related valuation allowance, may create fluctuations in the overall effective tax rate from quarter to quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, due to the overall cumulative losses incurred in recent years, the Company maintained a full valuation allowance against its deferred tax assets related to loss entities the Company cannot consolidate under the federal tax consolidation rules, as realization of these assets is uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s effective income tax rate for the six months ended June&#160;30, 2023 and 2022, was 41.1% and 34.9%, respectively. The tax rate for the six months ended June&#160;30, 2023, differed from the U.S. federal statutory rate primarily due to state income taxes, tax on dividend distributions and income from flow-through entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, the Company does not have any unrecognized tax benefits related to various federal and state income tax matters. The Company will recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense.&lt;/span&gt;&lt;/div&gt;The Company is subject to U.S. federal income tax as well as income tax in California. The Company and its subsidiaries&#x2019; state and federal income tax returns are open to audit under the statute of limitations for the years ended December 31, 2019 through December&#160;31, 2022, and for the years ended December 31, 2018 through December&#160;31, 2022, respectively.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-1248" unitRef="number">0.411</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-38" decimals="3" id="f-1249" unitRef="number">0.349</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-1250">Earnings Per Share&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated using the weighted average number of shares of the Company&#x2019;s common stock issued and outstanding during a certain period, and is calculated by dividing net income attributable to ApolloMed by the weighted average number of shares of the Company&#x2019;s common stock issued and outstanding during such period. Diluted earnings per share is calculated using the weighted average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period, using the as-if converted method for secured convertible notes, preferred stock, and the treasury stock method for options and common stock warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023 and December&#160;31, 2022, APC held 10,299,259 and 10,299,259 shares of ApolloMed&#x2019;s common stock, respectively, which are treated as treasury shares for accounting purposes and not included in the number of shares of common stock outstanding used to calculate earnings per share. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended June&#160;30, 2023 and 2022, restricted stock of  238,096 and 394,606, respectively, were excluded from the computation of diluted weighted average common shares outstanding because the assumed proceeds, as calculated under the treasury stock method, resulted in these awards being antidilutive. For the six months ended June&#160;30, 2023 and 2022, restricted stock of  246,431 and 257,193 were excluded from the computation of diluted weighted average common shares outstanding for being antidilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and six months ended June&#160;30, 2023, 838,628 of contingently issuable shares were excluded from the computation of diluted weighted average common shares outstanding because these conditions were not achieved as of June&#160;30, 2023. For the three and six months ended June&#160;30, 2022, 242,899 of contingently issuable shares were excluded from the computation of diluted weighted average common shares outstanding because these conditions were not achieved as of June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the earnings per share computations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Restated)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share &#x2013; basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share &#x2013; diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,482,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,858,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,778,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,023,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Restated)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share &#x2013; basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share &#x2013; diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,517,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,815,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,844,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,082,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the shares included in the diluted earnings per share computations:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,482,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,858,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,778,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,023,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,517,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,815,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,844,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,082,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-345"
      decimals="0"
      id="f-1251"
      unitRef="shares">10299259</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-442"
      decimals="0"
      id="f-1252"
      unitRef="shares">10299259</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-443"
      decimals="0"
      id="f-1253"
      unitRef="shares">238096</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-444"
      decimals="0"
      id="f-1254"
      unitRef="shares">394606</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-445"
      decimals="0"
      id="f-1255"
      unitRef="shares">246431</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-446"
      decimals="0"
      id="f-1256"
      unitRef="shares">257193</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-447"
      decimals="0"
      id="f-1257"
      unitRef="shares">838628</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-448"
      decimals="0"
      id="f-1258"
      unitRef="shares">838628</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-1259">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the earnings per share computations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Restated)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share &#x2013; basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share &#x2013; diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,482,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,858,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,778,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,023,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Restated)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share &#x2013; basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share &#x2013; diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,517,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,815,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,844,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,082,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-36"
      decimals="2"
      id="f-1260"
      unitRef="usdPerShare">0.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-37"
      decimals="2"
      id="f-1261"
      unitRef="usdPerShare">0.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-36"
      decimals="2"
      id="f-1262"
      unitRef="usdPerShare">0.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-37"
      decimals="2"
      id="f-1263"
      unitRef="usdPerShare">0.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-36" decimals="0" id="f-1264" unitRef="shares">46482271</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-37" decimals="0" id="f-1265" unitRef="shares">44858657</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-36" decimals="0" id="f-1266" unitRef="shares">46778299</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-37" decimals="0" id="f-1267" unitRef="shares">46023015</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-1268"
      unitRef="usdPerShare">0.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-38"
      decimals="2"
      id="f-1269"
      unitRef="usdPerShare">0.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-1270"
      unitRef="usdPerShare">0.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-38"
      decimals="2"
      id="f-1271"
      unitRef="usdPerShare">0.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-1272" unitRef="shares">46517108</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-38" decimals="0" id="f-1273" unitRef="shares">44815307</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-1274" unitRef="shares">46844044</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-38" decimals="0" id="f-1275" unitRef="shares">46082643</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="c-1" id="f-1276">Below is a summary of the shares included in the diluted earnings per share computations:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,482,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,858,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,778,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,023,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,517,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,815,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,844,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,082,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-36" decimals="0" id="f-1277" unitRef="shares">46482271</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-37" decimals="0" id="f-1278" unitRef="shares">44858657</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-449"
      decimals="0"
      id="f-1279"
      unitRef="shares">252311</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-450"
      decimals="0"
      id="f-1280"
      unitRef="shares">418322</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-451"
      decimals="0"
      id="f-1281"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-452"
      decimals="0"
      id="f-1282"
      unitRef="shares">651725</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-443"
      decimals="0"
      id="f-1283"
      unitRef="shares">40027</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-444"
      decimals="0"
      id="f-1284"
      unitRef="shares">94311</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares contextRef="c-36" decimals="0" id="f-1285" unitRef="shares">3690</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares contextRef="c-37" decimals="0" id="f-1286" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-36" decimals="0" id="f-1287" unitRef="shares">46778299</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-37" decimals="0" id="f-1288" unitRef="shares">46023015</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-1289" unitRef="shares">46517108</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-38" decimals="0" id="f-1290" unitRef="shares">44815307</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-453"
      decimals="0"
      id="f-1291"
      unitRef="shares">254718</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-454"
      decimals="0"
      id="f-1292"
      unitRef="shares">455170</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-455"
      decimals="0"
      id="f-1293"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-456"
      decimals="0"
      id="f-1294"
      unitRef="shares">689240</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-445"
      decimals="0"
      id="f-1295"
      unitRef="shares">70363</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-446"
      decimals="0"
      id="f-1296"
      unitRef="shares">122926</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares contextRef="c-1" decimals="0" id="f-1297" unitRef="shares">1855</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares contextRef="c-38" decimals="0" id="f-1298" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-1299" unitRef="shares">46844044</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-38" decimals="0" id="f-1300" unitRef="shares">46082643</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:VariableInterestEntityDisclosureTextBlock contextRef="c-1" id="f-1301">Variable Interest Entities (VIEs)&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A VIE is defined as a legal entity whose equity owners do not have sufficient equity at risk, or, as a group, the holders of the equity investment at risk lack any of the following three characteristics: decision-making rights, the obligation to absorb losses, or the right to receive the expected residual returns of the entity. The primary beneficiary is identified as the variable interest holder that has both the power to direct the activities of the VIE that most significantly affect the entity&#x2019;s economic performance and the obligation to absorb expected losses or the right to receive benefits from the entity that could potentially be significant to the VIE.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows guidance on the consolidation of VIEs that requires companies to utilize a qualitative approach to determine whether it is the primary beneficiary of a VIE. See Note 2 &#x2014; &#x201c;Basis of Presentation and Summary of Significant Accounting Policies &#x2014; Variable Interest Entities&#x201d; to the accompanying consolidated financial statements for information on how the Company determines VIEs and their treatment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes assets that can only be used to settle the liabilities of APC and its consolidated entities and VIEs, including Alpha Care and Accountable Health Care, and to which the creditors of ApolloMed have no recourse, and liabilities to which the creditors of APC, including Alpha Care and Accountable Health Care, have no recourse to the general credit of ApolloMed, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of the investment in a privately held entity that does not report net asset value per share and amounts due to affiliates, which are eliminated upon consolidation with NMM, are included in the accompanying consolidated balance sheets (in thousands). The assets and liabilities of the Company&#x2019;s other consolidated VIEs were not considered significant. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.853%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Restated)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net &#x2013; related party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.853%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Restated)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loan receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loan receivable &#x2013; related party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount due from affiliates*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, property, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes receivable, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in affiliates*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in other entities &#x2013; equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in privately held entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;846,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiduciary accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount due to affiliates*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net of current portion and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Investment in affiliates includes APC&#x2019;s investment in ApolloMed, which is reflected as treasury shares and eliminated upon consolidation. Amount due from affiliates are receivables with ApolloMed&#x2019;s subsidiaries and consolidated VIEs. Amount due to affiliates are payables with ApolloMed&#x2019;s subsidiaries and consolidated VIEs. As a result, these balances are eliminated upon consolidation and are not reflected on ApolloMed&#x2019;s consolidated balance sheets as of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2023 and December&#160;31, 2022.&lt;/span&gt;</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock contextRef="c-1" id="f-1302">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes assets that can only be used to settle the liabilities of APC and its consolidated entities and VIEs, including Alpha Care and Accountable Health Care, and to which the creditors of ApolloMed have no recourse, and liabilities to which the creditors of APC, including Alpha Care and Accountable Health Care, have no recourse to the general credit of ApolloMed, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of the investment in a privately held entity that does not report net asset value per share and amounts due to affiliates, which are eliminated upon consolidation with NMM, are included in the accompanying consolidated balance sheets (in thousands). The assets and liabilities of the Company&#x2019;s other consolidated VIEs were not considered significant. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.853%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Restated)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net &#x2013; related party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.853%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Restated)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loan receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loan receivable &#x2013; related party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount due from affiliates*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, property, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes receivable, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in affiliates*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in other entities &#x2013; equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in privately held entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;846,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiduciary accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount due to affiliates*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net of current portion and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Investment in affiliates includes APC&#x2019;s investment in ApolloMed, which is reflected as treasury shares and eliminated upon consolidation. Amount due from affiliates are receivables with ApolloMed&#x2019;s subsidiaries and consolidated VIEs. Amount due to affiliates are payables with ApolloMed&#x2019;s subsidiaries and consolidated VIEs. As a result, these balances are eliminated upon consolidation and are not reflected on ApolloMed&#x2019;s consolidated balance sheets as of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2023 and December&#160;31, 2022.&lt;/span&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-457" decimals="-3" id="f-1303" unitRef="usd">79598000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-458" decimals="-3" id="f-1304" unitRef="usd">97669000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-457" decimals="-3" id="f-1305" unitRef="usd">1068000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-458" decimals="-3" id="f-1306" unitRef="usd">4543000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-459" decimals="-3" id="f-1307" unitRef="usd">15187000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-460" decimals="-3" id="f-1308" unitRef="usd">11503000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-461" decimals="-3" id="f-1309" unitRef="usd">76678000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-462" decimals="-3" id="f-1310" unitRef="usd">62190000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:IncomeTaxesReceivable contextRef="c-457" decimals="-3" id="f-1311" unitRef="usd">0</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable contextRef="c-458" decimals="-3" id="f-1312" unitRef="usd">8580000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-457" decimals="-3" id="f-1313" unitRef="usd">586000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-458" decimals="-3" id="f-1314" unitRef="usd">1236000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-457" decimals="-3" id="f-1315" unitRef="usd">9211000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-458" decimals="-3" id="f-1316" unitRef="usd">9289000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-459" decimals="-3" id="f-1317" unitRef="usd">0</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-460" decimals="-3" id="f-1318" unitRef="usd">22000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-461" decimals="-3" id="f-1319" unitRef="usd">0</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-462" decimals="-3" id="f-1320" unitRef="usd">2125000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-457" decimals="-3" id="f-1321" unitRef="usd">0</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-458" decimals="-3" id="f-1322" unitRef="usd">30340000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-457" decimals="-3" id="f-1323" unitRef="usd">182328000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-458" decimals="-3" id="f-1324" unitRef="usd">227497000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-457" decimals="-3" id="f-1325" unitRef="usd">121310000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-458" decimals="-3" id="f-1326" unitRef="usd">106486000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-457" decimals="-3" id="f-1327" unitRef="usd">49439000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-458" decimals="-3" id="f-1328" unitRef="usd">53964000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill contextRef="c-457" decimals="-3" id="f-1329" unitRef="usd">110182000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-458" decimals="-3" id="f-1330" unitRef="usd">111539000</us-gaap:Goodwill>
    <us-gaap:IncomeTaxesReceivableNoncurrent contextRef="c-457" decimals="-3" id="f-1331" unitRef="usd">15943000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:IncomeTaxesReceivableNoncurrent contextRef="c-458" decimals="-3" id="f-1332" unitRef="usd">15943000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:OtherLongTermInvestments contextRef="c-457" decimals="-3" id="f-1333" unitRef="usd">325457000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments contextRef="c-458" decimals="-3" id="f-1334" unitRef="usd">304755000</us-gaap:OtherLongTermInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-457" decimals="-3" id="f-1335" unitRef="usd">32222000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-458" decimals="-3" id="f-1336" unitRef="usd">27561000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-457" decimals="-3" id="f-1337" unitRef="usd">405000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-458" decimals="-3" id="f-1338" unitRef="usd">405000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-457" decimals="-3" id="f-1339" unitRef="usd">4906000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-458" decimals="-3" id="f-1340" unitRef="usd">6503000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-457" decimals="-3" id="f-1341" unitRef="usd">4099000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-458" decimals="-3" id="f-1342" unitRef="usd">4169000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c-457" decimals="-3" id="f-1343" unitRef="usd">663963000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c-458" decimals="-3" id="f-1344" unitRef="usd">631325000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="c-457" decimals="-3" id="f-1345" unitRef="usd">846291000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-458" decimals="-3" id="f-1346" unitRef="usd">858822000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-457" decimals="-3" id="f-1347" unitRef="usd">22014000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-458" decimals="-3" id="f-1348" unitRef="usd">23632000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <ameh:FiduciaryAccountsPayableCurrent contextRef="c-457" decimals="-3" id="f-1349" unitRef="usd">8603000</ameh:FiduciaryAccountsPayableCurrent>
    <ameh:FiduciaryAccountsPayableCurrent contextRef="c-458" decimals="-3" id="f-1350" unitRef="usd">7853000</ameh:FiduciaryAccountsPayableCurrent>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-457" decimals="-3" id="f-1351" unitRef="usd">42923000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-458" decimals="-3" id="f-1352" unitRef="usd">48100000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:TaxesPayableCurrent contextRef="c-457" decimals="-3" id="f-1353" unitRef="usd">13100000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c-458" decimals="-3" id="f-1354" unitRef="usd">0</us-gaap:TaxesPayableCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="c-457" decimals="-3" id="f-1355" unitRef="usd">638000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="c-458" decimals="-3" id="f-1356" unitRef="usd">638000</us-gaap:DividendsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-457" decimals="-3" id="f-1357" unitRef="usd">5428000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-458" decimals="-3" id="f-1358" unitRef="usd">0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-457" decimals="-3" id="f-1359" unitRef="usd">630000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-458" decimals="-3" id="f-1360" unitRef="usd">619000</us-gaap:LongTermDebtCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-457" decimals="-3" id="f-1361" unitRef="usd">591000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-458" decimals="-3" id="f-1362" unitRef="usd">594000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-457" decimals="-3" id="f-1363" unitRef="usd">1463000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-458" decimals="-3" id="f-1364" unitRef="usd">1800000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-457" decimals="-3" id="f-1365" unitRef="usd">95390000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-458" decimals="-3" id="f-1366" unitRef="usd">83236000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-457" decimals="-3" id="f-1367" unitRef="usd">27922000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-458" decimals="-3" id="f-1368" unitRef="usd">26645000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-457" decimals="-3" id="f-1369" unitRef="usd">2467000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-458" decimals="-3" id="f-1370" unitRef="usd">4591000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-457" decimals="-3" id="f-1371" unitRef="usd">1078000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-458" decimals="-3" id="f-1372" unitRef="usd">1275000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-457" decimals="-3" id="f-1373" unitRef="usd">6062000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-458" decimals="-3" id="f-1374" unitRef="usd">7484000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-457" decimals="-3" id="f-1375" unitRef="usd">8680000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-458" decimals="-3" id="f-1376" unitRef="usd">8542000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-457" decimals="-3" id="f-1377" unitRef="usd">46209000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-458" decimals="-3" id="f-1378" unitRef="usd">48537000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-457" decimals="-3" id="f-1379" unitRef="usd">141599000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-458" decimals="-3" id="f-1380" unitRef="usd">131773000</us-gaap:Liabilities>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-1381">Leases&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating and finance leases for corporate offices, physicians&#x2019; offices, and certain equipment. These leases have remaining lease terms of two months to fifteen years. Some of the leases may include options to extend the lease terms for up to ten years, and some of the leases may include options to terminate the leases within one year. As of June&#160;30, 2023 and December&#160;31, 2022, assets recorded under finance leases were $1.6 million and $1.8 million, respectively, and accumulated depreciation associated with finance leases were $1.3 million and $1.0 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also, the Company rents or subleases certain real estate to third parties, which are accounted for as operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leases with an initial term of 12 months or less are not recorded on the balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.549%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.551%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of lease expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease cost, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.697%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.697%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental Cash Flow Information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental Cash Flow Information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.77 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.12 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.11 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are future minimum lease payments under non-cancellable leases for the years ending December 31 (in thousands) below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.911%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.914%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (excluding the six months ended June 30, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, the Company does not have additional operating and finance leases that have not yet commenced.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock contextRef="c-1" id="f-1382">Leases&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating and finance leases for corporate offices, physicians&#x2019; offices, and certain equipment. These leases have remaining lease terms of two months to fifteen years. Some of the leases may include options to extend the lease terms for up to ten years, and some of the leases may include options to terminate the leases within one year. As of June&#160;30, 2023 and December&#160;31, 2022, assets recorded under finance leases were $1.6 million and $1.8 million, respectively, and accumulated depreciation associated with finance leases were $1.3 million and $1.0 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also, the Company rents or subleases certain real estate to third parties, which are accounted for as operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leases with an initial term of 12 months or less are not recorded on the balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.549%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.551%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of lease expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease cost, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.697%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.697%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental Cash Flow Information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental Cash Flow Information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.77 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.12 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.11 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are future minimum lease payments under non-cancellable leases for the years ending December 31 (in thousands) below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.911%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.914%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (excluding the six months ended June 30, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, the Company does not have additional operating and finance leases that have not yet commenced.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeFinanceLeaseRemainingLeaseTerm contextRef="c-463" id="f-1383">P2M</us-gaap:LesseeFinanceLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-463" id="f-1384">P2M</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeFinanceLeaseRemainingLeaseTerm contextRef="c-464" id="f-1385">P15Y</us-gaap:LesseeFinanceLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-464" id="f-1386">P15Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-4" id="f-1387">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeFinanceLeaseRenewalTerm1 contextRef="c-4" id="f-1388">P10Y</us-gaap:LesseeFinanceLeaseRenewalTerm1>
    <ameh:LesseeFinanceLeaseTerminationPeriodIfApplicable contextRef="c-1" id="f-1389">P1Y</ameh:LesseeFinanceLeaseTerminationPeriodIfApplicable>
    <ameh:LesseeOperatingLeaseTerminationPeriodIfApplicable contextRef="c-1" id="f-1390">P1Y</ameh:LesseeOperatingLeaseTerminationPeriodIfApplicable>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-4" decimals="-5" id="f-1391" unitRef="usd">1600000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-5" decimals="-5" id="f-1392" unitRef="usd">1800000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization contextRef="c-4" decimals="-5" id="f-1393" unitRef="usd">1300000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization contextRef="c-5" decimals="-5" id="f-1394" unitRef="usd">1000000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-1395">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.549%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.551%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of lease expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease cost, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.697%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.697%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental Cash Flow Information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental Cash Flow Information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.77 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.12 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.11 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-36" decimals="-3" id="f-1396" unitRef="usd">1816000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-37" decimals="-3" id="f-1397" unitRef="usd">1547000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-36" decimals="-3" id="f-1398" unitRef="usd">149000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-37" decimals="-3" id="f-1399" unitRef="usd">142000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-36" decimals="-3" id="f-1400" unitRef="usd">22000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-37" decimals="-3" id="f-1401" unitRef="usd">18000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:SubleaseIncome contextRef="c-36" decimals="-3" id="f-1402" unitRef="usd">252000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome contextRef="c-37" decimals="-3" id="f-1403" unitRef="usd">206000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost contextRef="c-36" decimals="-3" id="f-1404" unitRef="usd">1735000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-37" decimals="-3" id="f-1405" unitRef="usd">1501000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-1406" unitRef="usd">3568000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-38" decimals="-3" id="f-1407" unitRef="usd">3154000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-1" decimals="-3" id="f-1408" unitRef="usd">303000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-38" decimals="-3" id="f-1409" unitRef="usd">283000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-1" decimals="-3" id="f-1410" unitRef="usd">45000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-38" decimals="-3" id="f-1411" unitRef="usd">37000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:SubleaseIncome contextRef="c-1" decimals="-3" id="f-1412" unitRef="usd">499000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome contextRef="c-38" decimals="-3" id="f-1413" unitRef="usd">332000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-3" id="f-1414" unitRef="usd">3417000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-38" decimals="-3" id="f-1415" unitRef="usd">3142000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments contextRef="c-36" decimals="-3" id="f-1416" unitRef="usd">1937000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-37" decimals="-3" id="f-1417" unitRef="usd">1495000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-36" decimals="-3" id="f-1418" unitRef="usd">149000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-37" decimals="-3" id="f-1419" unitRef="usd">18000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-36" decimals="-3" id="f-1420" unitRef="usd">22000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-37" decimals="-3" id="f-1421" unitRef="usd">142000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-1422" unitRef="usd">3678000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-38" decimals="-3" id="f-1423" unitRef="usd">3042000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-1" decimals="-3" id="f-1424" unitRef="usd">303000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-38" decimals="-3" id="f-1425" unitRef="usd">37000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-1" decimals="-3" id="f-1426" unitRef="usd">45000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-38" decimals="-3" id="f-1427" unitRef="usd">283000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-1428">P6Y9M7D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-94" id="f-1429">P6Y6M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-1430">P3Y1M13D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-94" id="f-1431">P3Y1M9D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="4" id="f-1432" unitRef="number">0.0571</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-94" decimals="4" id="f-1433" unitRef="number">0.0492</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="4" id="f-1434" unitRef="number">0.0508</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-94" decimals="4" id="f-1435" unitRef="number">0.0432</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-1436">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are future minimum lease payments under non-cancellable leases for the years ending December 31 (in thousands) below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.911%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.914%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (excluding the six months ended June 30, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-1437">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are future minimum lease payments under non-cancellable leases for the years ending December 31 (in thousands) below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.911%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.914%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (excluding the six months ended June 30, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-4" decimals="-3" id="f-1438" unitRef="usd">2074000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-4" decimals="-3" id="f-1439" unitRef="usd">343000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="-3" id="f-1440" unitRef="usd">3946000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="-3" id="f-1441" unitRef="usd">632000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="-3" id="f-1442" unitRef="usd">3755000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="-3" id="f-1443" unitRef="usd">469000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="-3" id="f-1444" unitRef="usd">3529000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="-3" id="f-1445" unitRef="usd">214000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-4" decimals="-3" id="f-1446" unitRef="usd">3168000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour contextRef="c-4" decimals="-3" id="f-1447" unitRef="usd">155000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <ameh:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour contextRef="c-4" decimals="-3" id="f-1448" unitRef="usd">9275000</ameh:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <ameh:FinanceLeaseLiabilityToBePaidAfterYearFour contextRef="c-4" decimals="-3" id="f-1449" unitRef="usd">6000</ameh:FinanceLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-4" decimals="-3" id="f-1450" unitRef="usd">25747000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="c-4" decimals="-3" id="f-1451" unitRef="usd">1819000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-3" id="f-1452" unitRef="usd">4868000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-3" id="f-1453" unitRef="usd">150000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-1454" unitRef="usd">20879000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability contextRef="c-4" decimals="-3" id="f-1455" unitRef="usd">1669000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-1456" unitRef="usd">3027000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-1457" unitRef="usd">591000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-1458" unitRef="usd">17852000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-1459" unitRef="usd">1078000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-1460">Segments&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined its operating segments in accordance with ASC 280, &#x201c;Segment Reporting&#x201d; (&#x201c;ASC 280&#x201d;). The Company currently has three reportable segments consisting of: 1) Care Enablement; 2) Care Partners; and 3) Care Delivery (See Note 1 &#x2013; Description of Business). The Company&#x2019;s reportable segments changed from one to three in the first quarter of 2023 as a result of certain changes to the information regularly provided to the Company&#x2019;s chief operating decision makers (&#x201c;CODMs&#x201d;) when reviewing the Company&#x2019;s performance as well as an effort to provide additional transparency to investors and other financial statement users which the Company believes will assist in the evaluation of changes in the operating results of the Company&#x2019;s segments separate from non-operational factors that affect net income, thus providing insight into both operations and other factors impacting reported results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the performance of its operating segments based on segment revenue growth as well as operating income.  Management uses revenue growth and total segment operating income as a measure of the performance of operating businesses separate from non-operating factors. The Company&#x2019;s operations are based in the United States. All revenues of the Company are derived from the United States. Our segments are not evaluated using asset information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Care Enablement segment is an integrated, end-to-end clinical and administrative platform powered by our proprietary technology suite, which provides operational, clinical, financial, technology, management, and strategic services to enable success in the delivering of high-quality, value-based care for providers and payers. Revenue for this segment is primarily comprised of management and software fees, charged as a percentage of gross revenue or on a per-member-per-month basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners with a shared vision for coordinated care delivery. Under relevant accounting guidance, while our IPAs and ACO are two operating segments, they share similar economic characteristics and meet other criteria which permit us to aggregate them into a single reportable segment, which we have done. Revenue for this segment is primarily comprised of capitation and risk pool settlements and incentives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients. Our care delivery organization includes primary care, multi-specialty care, and ancillary care services. Revenue is primarily earned based on fee-for-service reimbursements, capitation, and performance-based incentives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other is not a reportable segment and primarily consists of real estate operations and other entities that are individually immaterial. Revenue is primarily comprised of equipment sales and real estate revenue is presented in other income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, our reportable segments enter into transactions with each other. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues recognized by a segment and expenses incurred by the counterparty are eliminated in consolidation and do not affect consolidated results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate costs are unallocated and primarily include corporate initiatives, corporate infrastructure costs and corporate shared costs, such as finance, human resources, legal, and executives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information about our segments and prior periods have been recast to conform to the current presentation (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.459%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;321,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;348,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38,887)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38,887)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;348,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;292,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,998)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;292,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;297,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;321,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;269,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;269,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;233,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,690)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(896)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;254,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.459%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;636,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;685,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(72,486)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;639,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(72,486)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;685,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;578,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,726)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;589,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(74,693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;636,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;488,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;532,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;463,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Balance includes general and administrative expenses and depreciation and amortization. &lt;/span&gt;&lt;/div&gt;(2) Income from operations for the intersegment elimination represents rental income from segments renting from other segments. Rental income is presented within other income which is not presented in the table.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-1461"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-95"
      decimals="INF"
      id="f-1462"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-47"
      decimals="INF"
      id="f-1463"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-1464">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information about our segments and prior periods have been recast to conform to the current presentation (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.459%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;321,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;348,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38,887)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38,887)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;348,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;292,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,998)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;292,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;297,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;321,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;269,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;269,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;233,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,690)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(896)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;254,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.459%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;636,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;685,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(72,486)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;639,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(72,486)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;685,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;578,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,726)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;589,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(74,693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;636,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;488,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;532,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;463,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Balance includes general and administrative expenses and depreciation and amortization. &lt;/span&gt;&lt;/div&gt;(2) Income from operations for the intersegment elimination represents rental income from segments renting from other segments. Rental income is presented within other income which is not presented in the table.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-465" decimals="-3" id="f-1465" unitRef="usd">12719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-466" decimals="-3" id="f-1466" unitRef="usd">321776000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-467" decimals="-3" id="f-1467" unitRef="usd">13603000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-468" decimals="-3" id="f-1468" unitRef="usd">111000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-469" decimals="-3" id="f-1469" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-470" decimals="-3" id="f-1470" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-471" decimals="-3" id="f-1471" unitRef="usd">348209000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-472" decimals="-3" id="f-1472" unitRef="usd">22256000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-473" decimals="-3" id="f-1473" unitRef="usd">3470000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-474" decimals="-3" id="f-1474" unitRef="usd">13115000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-475" decimals="-3" id="f-1475" unitRef="usd">46000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-476" decimals="-3" id="f-1476" unitRef="usd">-38887000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-477" decimals="-3" id="f-1477" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-478" decimals="-3" id="f-1478" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-479" decimals="-3" id="f-1479" unitRef="usd">34975000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-480" decimals="-3" id="f-1480" unitRef="usd">325246000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-481" decimals="-3" id="f-1481" unitRef="usd">26718000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-482" decimals="-3" id="f-1482" unitRef="usd">157000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-483" decimals="-3" id="f-1483" unitRef="usd">-38887000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-484" decimals="-3" id="f-1484" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-36" decimals="-3" id="f-1485" unitRef="usd">348209000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-479" decimals="-3" id="f-1486" unitRef="usd">15162000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-480" decimals="-3" id="f-1487" unitRef="usd">292119000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-481" decimals="-3" id="f-1488" unitRef="usd">22523000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-482" decimals="-3" id="f-1489" unitRef="usd">70000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-483" decimals="-3" id="f-1490" unitRef="usd">-36998000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-484" decimals="-3" id="f-1491" unitRef="usd">0</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-36" decimals="-3" id="f-1492" unitRef="usd">292876000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-479" decimals="-3" id="f-1493" unitRef="usd">12175000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-480" decimals="-3" id="f-1494" unitRef="usd">5298000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-481" decimals="-3" id="f-1495" unitRef="usd">3626000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-482" decimals="-3" id="f-1496" unitRef="usd">926000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-483" decimals="-3" id="f-1497" unitRef="usd">-2933000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-484" decimals="-3" id="f-1498" unitRef="usd">9212000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-36" decimals="-3" id="f-1499" unitRef="usd">28304000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <us-gaap:CostsAndExpenses contextRef="c-479" decimals="-3" id="f-1500" unitRef="usd">27337000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-480" decimals="-3" id="f-1501" unitRef="usd">297417000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-481" decimals="-3" id="f-1502" unitRef="usd">26149000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-482" decimals="-3" id="f-1503" unitRef="usd">996000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-483" decimals="-3" id="f-1504" unitRef="usd">-39931000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-484" decimals="-3" id="f-1505" unitRef="usd">9212000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-36" decimals="-3" id="f-1506" unitRef="usd">321180000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-479" decimals="-3" id="f-1507" unitRef="usd">7638000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-480" decimals="-3" id="f-1508" unitRef="usd">27829000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-481" decimals="-3" id="f-1509" unitRef="usd">569000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-482" decimals="-3" id="f-1510" unitRef="usd">-839000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-483" decimals="-3" id="f-1511" unitRef="usd">1044000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-484" decimals="-3" id="f-1512" unitRef="usd">-9212000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-36" decimals="-3" id="f-1513" unitRef="usd">27029000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-485" decimals="-3" id="f-1514" unitRef="usd">10225000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-486" decimals="-3" id="f-1515" unitRef="usd">247269000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-487" decimals="-3" id="f-1516" unitRef="usd">11951000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-488" decimals="-3" id="f-1517" unitRef="usd">252000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-489" decimals="-3" id="f-1518" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-490" decimals="-3" id="f-1519" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-491" decimals="-3" id="f-1520" unitRef="usd">269697000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-492" decimals="-3" id="f-1521" unitRef="usd">19333000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-493" decimals="-3" id="f-1522" unitRef="usd">27000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-494" decimals="-3" id="f-1523" unitRef="usd">11400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-495" decimals="-3" id="f-1524" unitRef="usd">21000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-496" decimals="-3" id="f-1525" unitRef="usd">-30781000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-497" decimals="-3" id="f-1526" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-498" decimals="-3" id="f-1527" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-499" decimals="-3" id="f-1528" unitRef="usd">29558000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-500" decimals="-3" id="f-1529" unitRef="usd">247296000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-501" decimals="-3" id="f-1530" unitRef="usd">23351000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-502" decimals="-3" id="f-1531" unitRef="usd">273000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-503" decimals="-3" id="f-1532" unitRef="usd">-30781000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-504" decimals="-3" id="f-1533" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-37" decimals="-3" id="f-1534" unitRef="usd">269697000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-499" decimals="-3" id="f-1535" unitRef="usd">10921000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-500" decimals="-3" id="f-1536" unitRef="usd">233622000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-501" decimals="-3" id="f-1537" unitRef="usd">17135000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-502" decimals="-3" id="f-1538" unitRef="usd">82000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-503" decimals="-3" id="f-1539" unitRef="usd">-31690000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-504" decimals="-3" id="f-1540" unitRef="usd">0</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-37" decimals="-3" id="f-1541" unitRef="usd">230070000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-499" decimals="-3" id="f-1542" unitRef="usd">11315000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-500" decimals="-3" id="f-1543" unitRef="usd">5725000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-501" decimals="-3" id="f-1544" unitRef="usd">2832000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-502" decimals="-3" id="f-1545" unitRef="usd">743000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-503" decimals="-3" id="f-1546" unitRef="usd">-896000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-504" decimals="-3" id="f-1547" unitRef="usd">4526000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-37" decimals="-3" id="f-1548" unitRef="usd">24245000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <us-gaap:CostsAndExpenses contextRef="c-499" decimals="-3" id="f-1549" unitRef="usd">22236000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-500" decimals="-3" id="f-1550" unitRef="usd">239347000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-501" decimals="-3" id="f-1551" unitRef="usd">19967000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-502" decimals="-3" id="f-1552" unitRef="usd">825000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-503" decimals="-3" id="f-1553" unitRef="usd">-32586000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-504" decimals="-3" id="f-1554" unitRef="usd">4526000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-37" decimals="-3" id="f-1555" unitRef="usd">254315000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-499" decimals="-3" id="f-1556" unitRef="usd">7322000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-500" decimals="-3" id="f-1557" unitRef="usd">7949000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-501" decimals="-3" id="f-1558" unitRef="usd">3384000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-502" decimals="-3" id="f-1559" unitRef="usd">-552000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-503" decimals="-3" id="f-1560" unitRef="usd">1805000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-504" decimals="-3" id="f-1561" unitRef="usd">-4526000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-37" decimals="-3" id="f-1562" unitRef="usd">15382000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-505" decimals="-3" id="f-1563" unitRef="usd">22858000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-506" decimals="-3" id="f-1564" unitRef="usd">636413000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-507" decimals="-3" id="f-1565" unitRef="usd">25866000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-508" decimals="-3" id="f-1566" unitRef="usd">316000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-509" decimals="-3" id="f-1567" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-510" decimals="-3" id="f-1568" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-511" decimals="-3" id="f-1569" unitRef="usd">685453000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-512" decimals="-3" id="f-1570" unitRef="usd">42683000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-513" decimals="-3" id="f-1571" unitRef="usd">3486000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-514" decimals="-3" id="f-1572" unitRef="usd">26235000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-515" decimals="-3" id="f-1573" unitRef="usd">82000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-516" decimals="-3" id="f-1574" unitRef="usd">-72486000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-517" decimals="-3" id="f-1575" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-518" decimals="-3" id="f-1576" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-519" decimals="-3" id="f-1577" unitRef="usd">65541000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-520" decimals="-3" id="f-1578" unitRef="usd">639899000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-521" decimals="-3" id="f-1579" unitRef="usd">52101000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-522" decimals="-3" id="f-1580" unitRef="usd">398000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-523" decimals="-3" id="f-1581" unitRef="usd">-72486000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-524" decimals="-3" id="f-1582" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-1583" unitRef="usd">685453000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-519" decimals="-3" id="f-1584" unitRef="usd">30783000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-520" decimals="-3" id="f-1585" unitRef="usd">578197000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-521" decimals="-3" id="f-1586" unitRef="usd">43886000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-522" decimals="-3" id="f-1587" unitRef="usd">133000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-523" decimals="-3" id="f-1588" unitRef="usd">-70726000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-524" decimals="-3" id="f-1589" unitRef="usd">0</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-1590" unitRef="usd">582273000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-519" decimals="-3" id="f-1591" unitRef="usd">21375000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-520" decimals="-3" id="f-1592" unitRef="usd">11552000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-521" decimals="-3" id="f-1593" unitRef="usd">8612000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-522" decimals="-3" id="f-1594" unitRef="usd">1584000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-523" decimals="-3" id="f-1595" unitRef="usd">-3967000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-524" decimals="-3" id="f-1596" unitRef="usd">14621000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-1597" unitRef="usd">53777000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <us-gaap:CostsAndExpenses contextRef="c-519" decimals="-3" id="f-1598" unitRef="usd">52158000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-520" decimals="-3" id="f-1599" unitRef="usd">589749000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-521" decimals="-3" id="f-1600" unitRef="usd">52498000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-522" decimals="-3" id="f-1601" unitRef="usd">1717000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-523" decimals="-3" id="f-1602" unitRef="usd">-74693000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-524" decimals="-3" id="f-1603" unitRef="usd">14621000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-1604" unitRef="usd">636050000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-519" decimals="-3" id="f-1605" unitRef="usd">13383000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-520" decimals="-3" id="f-1606" unitRef="usd">50150000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-521" decimals="-3" id="f-1607" unitRef="usd">-397000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-522" decimals="-3" id="f-1608" unitRef="usd">-1319000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-523" decimals="-3" id="f-1609" unitRef="usd">2207000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-524" decimals="-3" id="f-1610" unitRef="usd">-14621000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-1611" unitRef="usd">49403000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-525" decimals="-3" id="f-1612" unitRef="usd">20912000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-526" decimals="-3" id="f-1613" unitRef="usd">488561000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-527" decimals="-3" id="f-1614" unitRef="usd">23150000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-528" decimals="-3" id="f-1615" unitRef="usd">331000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-529" decimals="-3" id="f-1616" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-530" decimals="-3" id="f-1617" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-531" decimals="-3" id="f-1618" unitRef="usd">532954000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-532" decimals="-3" id="f-1619" unitRef="usd">38036000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-533" decimals="-3" id="f-1620" unitRef="usd">27000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-534" decimals="-3" id="f-1621" unitRef="usd">20527000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-535" decimals="-3" id="f-1622" unitRef="usd">31000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-536" decimals="-3" id="f-1623" unitRef="usd">-58621000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-537" decimals="-3" id="f-1624" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-538" decimals="-3" id="f-1625" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-539" decimals="-3" id="f-1626" unitRef="usd">58948000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-540" decimals="-3" id="f-1627" unitRef="usd">488588000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-541" decimals="-3" id="f-1628" unitRef="usd">43677000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-542" decimals="-3" id="f-1629" unitRef="usd">362000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-543" decimals="-3" id="f-1630" unitRef="usd">-58621000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-544" decimals="-3" id="f-1631" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-38" decimals="-3" id="f-1632" unitRef="usd">532954000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-539" decimals="-3" id="f-1633" unitRef="usd">24437000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-540" decimals="-3" id="f-1634" unitRef="usd">452295000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-541" decimals="-3" id="f-1635" unitRef="usd">33327000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-542" decimals="-3" id="f-1636" unitRef="usd">126000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-543" decimals="-3" id="f-1637" unitRef="usd">-59387000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-544" decimals="-3" id="f-1638" unitRef="usd">0</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-38" decimals="-3" id="f-1639" unitRef="usd">450798000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-539" decimals="-3" id="f-1640" unitRef="usd">15842000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-540" decimals="-3" id="f-1641" unitRef="usd">10938000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-541" decimals="-3" id="f-1642" unitRef="usd">5875000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-542" decimals="-3" id="f-1643" unitRef="usd">1219000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-543" decimals="-3" id="f-1644" unitRef="usd">-1515000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-544" decimals="-3" id="f-1645" unitRef="usd">8203000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-38" decimals="-3" id="f-1646" unitRef="usd">40562000</ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <us-gaap:CostsAndExpenses contextRef="c-539" decimals="-3" id="f-1647" unitRef="usd">40279000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-540" decimals="-3" id="f-1648" unitRef="usd">463233000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-541" decimals="-3" id="f-1649" unitRef="usd">39202000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-542" decimals="-3" id="f-1650" unitRef="usd">1345000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-543" decimals="-3" id="f-1651" unitRef="usd">-60902000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-544" decimals="-3" id="f-1652" unitRef="usd">8203000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-38" decimals="-3" id="f-1653" unitRef="usd">491360000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-539" decimals="-3" id="f-1654" unitRef="usd">18669000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-540" decimals="-3" id="f-1655" unitRef="usd">25355000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-541" decimals="-3" id="f-1656" unitRef="usd">4475000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-542" decimals="-3" id="f-1657" unitRef="usd">-983000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-543" decimals="-3" id="f-1658" unitRef="usd">2281000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-544" decimals="-3" id="f-1659" unitRef="usd">-8203000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-38" decimals="-3" id="f-1660" unitRef="usd">41594000</us-gaap:OperatingIncomeLoss>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-1661">Subsequent Events&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Texas Independent Providers, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 12, 2023, the Company entered into a definitive agreement to acquire assets relating to Texas Independent Providers, LLC (&#x201c;TIP&#x201d;). Through its coordinated network of over 120 primary care providers, TIP provides high-quality primary care services to over 4,500 Medicare Advantage patients in communities throughout Harris County, home to Houston, the largest city in Texas and the fourth-largest city in the United States. The Company anticipates closing this transaction in the third quarter of 2023 and will fund the transaction with cash on hand.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IntraCare Convertible Promissory Note Receivable&lt;/span&gt;&lt;/div&gt;On July 27, 2023, the Company entered into a five-year convertible promissory note with IntraCare as the borrower. The principal on the note is $25.0 million with interest on the outstanding principal amount and unpaid interest at a rate per annum equal to 8.81%, compounded annually. In the event that the convertible promissory note remains outstanding on or after maturity date of July 27, 2028, then the outstanding principal balance and any unpaid accrued interest shall, upon the election of the Company, convert into shares.</us-gaap:SubsequentEventsTextBlock>
    <ameh:NumberOfPrimaryCareProvider
      contextRef="c-545"
      decimals="INF"
      id="f-1662"
      unitRef="careprovider">120</ameh:NumberOfPrimaryCareProvider>
    <ameh:NumberOfPrimaryCareServices
      contextRef="c-545"
      decimals="INF"
      id="f-1663"
      unitRef="primary_care_service">4500</ameh:NumberOfPrimaryCareServices>
    <us-gaap:DebtInstrumentTerm contextRef="c-546" id="f-1664">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-547" decimals="-5" id="f-1665" unitRef="usd">25000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-547"
      decimals="4"
      id="f-1666"
      unitRef="number">0.0881</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-36" id="f-1667">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-36" id="f-1668">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-36" id="f-1669">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-36" id="f-1670">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc xlink:href="#f-69" xlink:label="f-69" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-102"
          xlink:label="f-102"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-70" xlink:label="f-70" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-101"
          xlink:label="f-101"
          xlink:type="locator"/>
        <link:footnote id="fn-1" xlink:label="fn-1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company&#x2019;s consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The consolidated balance sheets include total assets that can be used only to settle obligations of the Company&#x2019;s consolidated VIEs totaling $520.8&#160;million and $523.7&#160;million as of June&#160;30, 2023 and December&#160;31, 2022, respectively, and total liabilities of the Company&#x2019;s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $136.2&#160;million and $131.8&#160;million as of June&#160;30, 2023 and December&#160;31, 2022, respectively. The VIE balances do not include $325.5&#160;million of investment in affiliates and $5.4&#160;million of amounts due to affiliates as of June&#160;30, 2023 and $304.8&#160;million of investment in affiliates and $30.3&#160;million of amounts due from affiliates as of December&#160;31, 2022 as these are eliminated upon consolidation and not presented within the consolidated balance sheets. See Note 16 &#x2014; &#x201c;Variable Interest Entities (VIEs)&#x201d; for further detail.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-69"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-102"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-70"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-101"
          xlink:to="fn-1"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>113
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M"^X+93Z ]TLI]>'&_(/BG'O\'U!+ P04    " "#B@E7 DFFO(,+  "--P
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M1](9K,2"\?([+28 1Q-"T(2$L?81ZFM,)E&:;H3+ME7E!GV(M1*MD!_DZIH
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M?X>"DRLXARKT<X6^GIF,BIZ'"9%D="WX&@DE#=;4A9Y,K0WT6:S>^U0*>,I
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M* %XON P3_F-<E!\B1K]#U!+ P04    " "#B@E7/Z\I?E0(  #Z,   &
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M;6HI5OO!Z@Y6>;G[F?W<.^)H@.*!!Y#] *(/\ <&T/T ^M(9_/T _Z4SL/V
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M9#]3='2+WCG1&VX893Q&$(KI:\9SJ+Y/.B5([$K0XI-Y7FRDTDTG>,5_D5=
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MM?WT1H_94.,?E,:A-+&W>]5ZD/I;]%S&OPBJNT%I.93&H#0.I0D432VGK7U
ML,8_.VYTT6 W!L'N#(+=&@2[-PAA_/,2?X?Q+Y*:7637[#[4Q:JY*.M>F)FN
M=XUS-K=TW;6_G;?S7KNSUP=4NH/2<BB-06D<2A,1\<+$)-Y5'E*WBYYX/Y&
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M9)5ASWXFO6>L8=BJE=++$1K]4 D6"5!SJDK>H4K(S(LH8ME*_@E;:U&/2\T
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M(*X)WOFMJ]C(. "?@'P N%$E/0",I6@].,3@T\)VA>65/CM?,"M^5.NZ:1.
MR&+F/YY?.')N5-8(^;9$)T5NF.M2!=B^>7.)0UUT"S!(R3G3>I1<,0CU6E>X
M=L#U*JO DB.D*0D&6$T@*,"3%;_!J[R$/<2)-L3\\$Z%QK4$%.1=T^"]X-E]
MPI\&(4;D *C&H%[!=63)/---L@[5AN>Y50:B"7A<9;>*@/P\'5"H5]J40%6
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MO0=+E!88(/ 0ETA#WH"$4&(ESC0-!<+8%!<P8"B/G%[1QK.,;R)U_BK''&;
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MN0#7(<LW/N-E,19CE/K#&]J_AR+JUH9C=*7(U';S[R!NB*$MPX"56/@RBXQ
MG8 ;W'[*9:,,*%7?'LRX&4.JL9C,LW%Y:&)Z/!Z%75Y!$X6"3M'(?%';J-LK
M23LQF(NBIWRDBPR4H!N/*9D$NRQ:GR>C_LS8AFY/UJNZ<:8C7*!-G >(9/^;
M.L9RNF$[X:2;U+4U>HT:5B9<MS\QCT<\*>7,U%B(P83_+>HCW%:$>HKB2."#
MK"E<3<3+$E*36A/BV)CCNHZW>(!:T]353+EI-ZWITXU<D:X1$^N2&:Y*&TA5
M"$&4^<T;O(6C!&A#+03V4-<X7-"6:WMT),7N9,V:^%AG!!N=9J&=\'T0GQG
M:MG+-Y?OG)J53HG+2"709E)^%^UT7 XMM,D6"Z1(2RX$-YN30O7L,-M84Y^T
MF[7DORG]@A]1T@$5)668*)<(DEE:_L"N;066/.8=EEZ.ZT!KWT?TYLWZ(3RS
MN&1A;QO07]F*FR$V#!K.S]T,#GP;57XN'I5]S!%*B@B$  <\:. 7,6_P$&;'
M&'9A!*Y'X)?OL^V%ME\>O0+J5YB  FGX*CD\2\_'IW!Q!"'>Y @N3N'.] 0N
MSH[2R<FI;#D%+32=3M/)\7DR@4=/CB;)$;Q[='*>3$]/TNGYN3RHB^3D/)V
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MS./SN5O!C*YG"=%"AQGQ*?C$945P[@/-!IJ&MI7DHF@LW^?=BE@9?Z:%?SX
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M>&.-<[?Z9W7=M9T2 2]PVWUX2TFWD%IZ!$5%WFQ)',-'*QKJ8M3AX-UH!B^
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MOIA. M#][.P/5K5^7FV4I>GGMSOZW:!V#G1?*64/!Q=@_($M?P-02P,$%
M  @ @XH)5^2P "-( P  4@<  !D   !X;"]W;W)K<VAE971S+W-H965T,30N
M>&ULI55MCYLX$/XK(UI5B806,!"2-(F4S?74.W6K55_N/ISN@P.3Q%>PJ6V:
MW7_?,1 V;=.HTGV!L3WS^'D\X_'BJ/0G<T"T\%"5TBR]@[7U/ A,?L"*FQM5
MHZ25G=(5MS34^\#4&GG1!E5EP,)P$E1<2&^U:.?N]6JA&EL*B?<:3%-57#_>
M8JF.2R_R3A/OQ/Y@W42P6M1\C^_1?JSO-8V" :40%4HCE 2-NZ6WCN:WB?-O
M'?X2>#1G-C@E6Z4^N<$?Q=(+'2$L,;<.@=/O"VZP+!T0T?C<8WK#EB[PW#ZA
M_]YJ)RU;;G"CRK]%80]+;^I!@3O>E/:=.K[&7D_J\')5FO8+Q]XW]"!OC%55
M'TP,*B&[/W_HS^%7 E@?P%K>W48MR]^XY:N%5D?0SIO0G-%*;:.)G) N*>^M
MIE5!<79UAX7(>0EO!-^*4EB!9A%8 G;+0=Z#W'8@["<@$[A3TAX,O)(%%M_&
M!T1H8,5.K&[95< _&WD#<>@#"UE\!2\>5,8M7OP3O).Z1Z RAH^RYJ* 3<E%
M98#+P5P7_]&)4\E9>/5 96_0A[4K&Q<I)#S!_+/>&JNII/Z]=%H=F>0R&7?-
MYJ;F.2X]ND<&]1?T5B^>19/PY16IR2 UN8;^JPF]"G*9X@5D^'! V*BJYO+Q
MQ;,IB[*7!JK>KSSSRQ5=8V.Q +4#2T$[55(_$'(/(SI8>U"-H428\1PH]]CF
M?C#N?@3T88M[(:4#(,0:M5 %C(BKY;3+&)[#-/)9FI*1IGXVC2F1GQNAB<'(
M(,);90E\#(F?I1E$_B2<M4*4I.P;AWF2D7.-Q-_0K,;2H8-5D'<5(V3>: *=
MP\;]J7!Z*DD2^4D20QS%?LQ2N*=9W2\:&$7,#R>3,8QF:3B&#\K21A<V3-C,
MC[.,4!C]"84_5BT_5\;_C^ HCB<^BR/BP,+$#V,V_IXDG6 T2<DAC?U9-CWQ
M;"_/*(DR/YXY"2R=^F%$,IZNCP'2ER:0)>QR]E 69WE[#E$8^F&2.8ND)K,9
M7+H*P5F?JU#OVV[NBJN1MFMYP^SP8*R[/OGDWKTV=UQ3_1@H<4>AX4V6>J"[
M#MX-K*K;KKE5EGIP:Q[HT4/M'&A]IZB"^H';8'A&5U\!4$L#!!0    ( (.*
M"5<,7__LJ@\  -DS   9    >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;.U;
M^W/;-A+^5S"NTW%F%%JD'K;SFE&<N$W'3CQQTD[OYGZ 2$C"A2)9D+2M^^OO
MVP7XTBMN)^U=;NZ'Q!()+!:[WSX!/;]+S>=\H50A[I=QDK\X6!1%]O3X. \7
M:BES+\U4@C>SU"QE@:]F?IQG1LF()RWCXZ#?'Q\OI4X.7C[G9]?FY?.T+&*=
MJ&LC\G*YE&;U2L7IW8L#_Z!Z\$'/%P4].'[Y/)-S=:.*3]FUP;?CFDJDERK)
M=9H(HV8O#B;^TU=#&L\#?M;J+F]]%K23:9I^IB]OHQ<'?6)(Q2HLB(+$GUMU
MKN*8"(&-WQS-@WI)FMC^7%&_X+UC+U.9J_,T_D5'Q>+%P>F!B-1,EG'Q(;W[
M4;G]C(A>F,8Y_R_N[-CAV8$(R[Q(EVXR.%CJQ/Z5]TX.K0FG_1T3 C<A8+[M
M0LSE:UG(E\]->B<,C08U^L!;Y=E@3B>DE)O"X*W&O.+EN5&1+L2%#'6LBU5/
MO)+)9W&9RB3O"9E$XA(3<I'.A!WY_+C JC3W.'0KO+(K!#M6&(NK-"D6N7B3
M1"KJSC\&MS7+0<7RJV OP9_*Q!.#?D\$_6"PA]Z@%L& Z0UVT'NMIH5XK?,P
M3O/2*/'WR30O#.#RCVV;M;2&VVF1"3W-,QFJ%P>PD5R96W7P\OOO_''_V1Y.
MAS6GPWW4OXJRONX*8FV"^+A0XCQ=9C)9??_=:>"?/,MA)!#P5,8R"94(4QAT
M7C"- H-G:0S'H).Y.-()GJ1ECG7RQT\%]*QJ/8O7*E3+J3)BX/.30'Q0MVE\
MBR?$GC@4_FF_U^_W6Y\^*!F+-WDA"V7W((*@=SH.1##H^>-3,)I TZ7U#W;
MJ'<R/!/#GC\Z$]<F7>H\3\U*O$M!XEJNY#16(F#BO+W@F?B8%EB%]QCX_=[8
M]\'>26\0G(A+E>=/Q7EIC$H*D:6&%\+&>?11T!L/^H_%T=@_>^S&?DKDDH;]
M2T5BIA-(C"03IB0PC#\=CC!^T!OPC#29/RF465IRAUAVU/,'8_Z$,:=GK V5
M%QK>BPA*;<2MC$M%/*2E$7&7Q)TD9=%W:#D294Z+7ZI;%8M Z"0KP45F0,WH
M> 67'#/9(@6#T+AAX>#E9\02# M5[HD)*[JK2L+1ACI[C(90&K.B52V;Q%"2
M%H+X-UK&6#72LYEB><Z@GM:>@,^<:>@$@[%K83 +RR?\="LH99:9]-Z)QPX/
MK;:PDKR5.N8]88<M$AZ+M<&MA,]@))<%N0_(8JD+Q*T&XUO71D#EERLE32Y4
M$A&MEE@V[&&R3$MLFT5XI.[#N.0I1"/7]V)IO:PB+]L5^&,@8N ']'D(\(Z'
M_'$D3GK^Z9 ^CMEBAB/^<B*&)P%M$3%^!DD*_ZPW&IXXG!_6()\L[5+. TSF
M1BG:-4MGYTO(^U9'D#-M7P+CM^H)20!H(FMFM-LYL\JE=*5/,CT<]OM>'^$P
MCF%0/7&WT.$">B>1@+04L2J(<PQUQ/)R^J0FB,=E1F0/@U%#AF$I14XZ);<(
MXX!;69_8F5*MK.XS;2S46/#^F 4_]MKN4.@<F_RMQ$BVF4P"8K1J4D*N2( (
MTHI-\W!D_1=S5 ^IV7"C^IY_,GI$I/K>8-1_5"&]P6T;BB7T80&W2S<]L#>7
M)HKAB5A&.9C"%G6QL'2S+-8A$R8.6HZ"A"=^*Z7!$Q@.LB3LE7*E:)?UQ7 J
M!N3)Z'3:E=,=A,O2P2H6)_#@231=.;7F+;W*HB4@,F !">,CA.)[@95.X$$X
M[!V^(LL]D<5ESCH!9)E3TA9S"AG:)YD+& [!B"4EC9Y23'6K #:9XLQT [0;
MZ)%QGFY R.:(R*?MDE-5W"G5V0$S]M&4B+H<SJVGC9'!PW49F<SMHON@X2$P
M?1D^]-;&>G9IM1_>HR0%<"G3HR';9)YF!9O9D7S,[S]2J+IY?_$!H9VC !**
M#R#80^"(P]+%H[M4?/)N//%#"HTE['9N%/RZ+C0D](K"&D'\M5QQ.",_;!4T
MTP;L1I(M/2_9I[@]9(@_:<0HXA>\#>@D*Z>Q1OH=">"SR^(D M0TI9(%ECBZ
M4) @=OW!IH4VL\(Z[U"Y_(K*Y3&(1_^$-BE2DW.$YMK$Z)65,R,/GHJK,"+!
MD?#/QCOM8?H85&@6[W\+)_V*"?_/8&)K.M';#/HUM?7H0_G$V!N?/O+V1REG
M9'G'C%R>$Z^<2P3,/JM5E:99:.L4>;*2 $@+D+QMRGO36$?\A'?>M>\EU"NH
MBB[P#^-1X^EEN>S.*S@&)\BONH(AH5">A U0I@2V87 #[V1D54&AI$Y&8ME@
MG#F=H?0!5:>77A6B(Z)2U%#LCA(1S FNS,:_3G@V(E2&-X'8F>M((UNDO K[
MH,(?VI%D30A,M",90M*YMHFQ@1IO505SCCGS.04E3,I*$RX(>9Q9DNEU-GMX
MTHG+-/?W27 )B11JB23=9K?()D ?Z\&N"=6U)/%WZ/[2]R]H$1Y@@X<:JV&Z
M38D<?YT&@S^@00]9))PCQ8B+NH0XYQ+B;0)/F!4VQ0SZR.PZNC,J3 UI/JH(
MK-<@E)R,O5&=,[5J %U0\ED8$EV5LG6+0X_69]N%W?H[EI91Q&C@FFH/%WWO
MY(%<K%EYP\WK7?0IHV\8(@\7P1N$Y!<B5RTZ5=3UBK3)N7M<,<31,-9R:A,W
M6U!11*!>T1/.,EV]1P!(+):,(@#1R+)5#>X41FOS6V3.P9^>)P@S6R?L$ \+
MH5F>D&K!IV=J1[K02'92/+SD>\ FV6\?!MYI)U<_''B#QN*;1"H& YN5_]7U
MM7A/\(-M#WA]\$8/%5MC9/$B;=8OFXA!KOX-&=PORN5/]AEYZ()R"I2D'')F
M8E+.R?Q'1'W0WQ.LX,*PN0PLND#%B_(F1ZU-NG5NX9 XC5R+<11M*>UO_(4-
MA)'*2"U@GC[?U^61C6:1)._V"VII<5,8:OO^E):&S(V";M!_=HT"WV95'C_Q
MGXFWLYKT/=&!RJH:H[<N'/*C*,+T/+&NGH) H8NRJ.;;HA*.3L_8<J #S[8(
MP1<R6E<Y)VN2LK408!F&IFP[418&^<T5M1VD1G1%Q$@PH./K BB$U+WNH;G[
M=UXYX@_LB(^ 0TY8J/T JBGB%5Z 67"30CJ1MA%RNJKZ!>WN3K>KXK*DFE\4
MBRK)U>--=^_7[EY,KGZ@]A/6Y9P5P&V#BZ"[-N*_"\5];_Q[4#SX]E'<5<=?
M!>@U$'P;V/[;Y67MB8.3"L_T])L&\?^ *X8._BKDDKJ_#;CZ05_\J.)XB<>7
ME^<,79F4U'$)1E4BLS[HR&FP]=QID,K\IC+B''YR?=Y["/:O/EW\(#XEM#76
M[SMOXC7MN>U(IE39'S>)DNMR;AC,E41Y)3@Q&P0V#ZTMH<Q=NZDIP=CE4([-
M< 'C*W$MS>>>.)=($%.3:/G'C,YO)4"6C1TV!^P''DP.+*C[T+4L7[-%W6A4
MZ8K[)ELMCN=C ]R26C;-*.ZD4Z/(Y;L)9>FM5)3G43G@&CNL+]?V^5)WQ]MO
MN5M5^[OMMX6VA]IQ+51KJ1@SP8!8N!3=$S>+M(Q;X\A.ILI:]]U")2*BHQ=J
ML2_(D4T56V6&2K2J$KH+4F^PIM:UKG5_<"[SA;B(TSM2#CN'&\B6JG^SU3<
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MT?$\"F=*_^!TX[\%,NWPR\+_K/!3#@P9X/M2XRVX>Z  P\?AXE]02P,$%
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M]BO4<+U.<>&.2AV$39@)B]2WSJP31GS*EEPH]LB+!C88=UR+ELXSW@->2$U
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M4?7TD0FYO*IYM>+&/9\O#-YH7%\F=,XFS/R1C!5<-4HN(8]8K+F,B6*SJ]K
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MD5(X)* )-]9L,!:41V 0^F2/C4Z(YSGM;@L'+:?E]7'0=SKM'@S\MM/MM3/
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M300S!L6PYNV-*L5$7K%N!>]_5O6;YN3[![<_JRBJ"*03F0FY@8G/^WDH2C=
M.E5 BJ-C=(0\28:AT([&HB&AB-4J53;V\Z^BDA-)H'<6J>91I\IQ%*G5U[P*
M44(J;<L [1=-NY4GPQE^U^F]ZH/^S>+;S,&K6]'D<YGX7#Z6/94?#_.QV(/,
M\FQR]BBM+9:3GQ^->?MM<P!]R S^9X!Q-\O+W [L\7%R,^FUX4$>@W6'C+K%
M#,: PG!L^R$-^J-S:)PXI%-BITK$Y"D7G%K'W)A,O[5/(2L4_$FHG8V;NB_B
M/4TX+&UI46LN;BUW/,-Q<AJ>XAA#7]M.69/!/C_NE1WH6PSE+D&F\VT2Z-"
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M6[5UEQO!,<Z1 -97"B^#_0T9&+_<7OP/4$L#!!0    ( (.*"5<LB2C9+08
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MR=;3:%]A82K0VG.U)WNV0;6<@3@;9:&7(BC/?.8JBA/\&FT<J&0G'B0AX,L
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MV('L2TM\NPU?L/LY3K\#4$L#!!0    ( (.*"5=7$,[^@P(  +\'   9
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MN><CW3!%,RX:0_'*]L-;KG1WM<M<3U@0)D#OKSA7.\,(=#,[_@-02P,$%
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M970R."YX;6S-7.ESVT:6_U=0FLR47451AW,X=N(JF;83S5ACK91D=G9K/X!
MD^P(5]" 9,Y?O[_W7E\ 05K.9*OVBT2"?;Q^]]7X[J%N[\Q&J2[Y6!:5^?YH
MTW7-BY,3DVU4F9IYW:@*OZSJMDP[?&W7)Z9I59KSI+(X.3\]_?JD3'5U].H[
M?G;=OOJN[KM"5^JZ34Q?EFF[?:V*^N'[H[,C]^!&KS<=/3AY]5V3KM6MZGYN
MKEM\._&KY+I4E=%UE;1J]?W1Q=F+UV??T 0>\8M6#R;ZG-!1EG5]1U\N\^^/
M3@DB5:BLHR52_+M7"U44M!+@^,TN>N3WI(GQ9[?Z.SX\#K-,C5K4Q3]TWFV^
M/WI^E.1JE?9%=U,__*CL@;ZB];*Z,/PW>;!C3X^2K#==7=K)@*#4E?Q//UI$
M/&;"N9UPSG#+1@SEF[1+7WW7U@])2Z.Q&GW@H_)L *<KHLIMU^)7C7G=J]>I
MT2:I5\EUJXRJNE1P5>7)K=")?KO5ZTJO=)9677*1975?=;I:)]=UH3.M3/+$
M?7KZW4D'H&CID\P"\%H .-\#P-?)55UU&Y.\K7*5#^>?X##^1.?N1*_/#R[X
MU[Z:)\].9\GYZ?FS ^L]\QAZQNL]V[/>U('_^V)INA8<]3]3!Y;UOIQ>C\3L
MA6G23'U_U!#.VWMU].HO?SK[^O3E 6B_]-!^>6CU:7I. ?D[EOEIHR!%65TV
M:;4E?&1U98"2/.U4#MDHTBI3B2B3M$O>J$R52]7*V9Z=,47.DTUJDJ52%62G
MA4#FR:JMRZ3#V@M9^2]_>GY^]LU+DZ1]KFGEP38K76$;G1:) 50*"J(SLV39
M=TE>@S)5W26ZRHH^!ZQ% 4ZN>HS-M<F*VO0X#73);[UN">)MLE:5:C%N2P=3
M#6V0!GHW+9;238%)NF(0?ZX8HEO:FO%S4>(469H\(:C/3U_^/+^=)S]<7%SS
M][.73^?)#MKZZM$G2U+>!3RM+!HM8\]81J&5&:QNTRK%3XS^F)0B4(H$:F(J
MCR-2S$"+>R7$ "LV*2%%5PQLFS,Q'W2W2?R9>#]==3ARN0=<+,US""I=04AZ
MUKXFZ>J$U&AR=GK\'SSLHNUT5JCD.1WP1JW[0G3/[?%_SEG+M#F056QGM)91
MGX4ULZG[ @16"5DJ.A/F_-I78@D\@)]!!@#<JH('@,44GX>6F!QM&3!W7#-F
M[ MARAO5U&V7 "*'F;^=7'B:;E7:6AI.2]*,F&.E"Q6A_/;M@M:[Z-<P'3+\
M6Z'Z/+D48.I&5X0%8+U,*UA>@GG&P@(C!]("LC3_%?/E,$\(.]JP0&!.1;:P
M #*ROFWI633V*6-20[ )30#:&+(@=*(T6:6Z39K8R@3N*U.(*S!:IG>*@?PT
M14C02VT*T!=0,"YBP1XRU"RYZ<%JP/#IV?R EOW*:]FO#JK'ZZ 8@)*%!W:/
MKOW=B['NV*]E8_60#,3;<4P2,0L>[Z V0BC6 1QUJ1ZK59()A>)4[Q/]-+EH
MZJ*HKU0^"Q^]" RAZ)?@&IVVL*VSY.]75YC!?ZXO+A8?9LD'L%SRHTH+</EE
ME<U@E>I[8K/D!Q .#V_KHF<U,TO>OU_(6=_]\S7_USC;+Y=O#2UW?''UH_N?
M -S;ODK>ITO\]N;J!YGV"P1!;9,/Z9U) #!T>T&[](U7\;]\N/K!:?>7."D=
MU:[XF.-=7"]HK[^"Y?'E@C[SG[/D'W5;Y +%6_ U)"UYKWJ(V-7\S1S/Z=@K
MR!0."J <<(NZA1IA=F%H")RKJVE(! ^WBQ\7HH*O?J0I]T\)YWX&!C&4+Y_<
MT\D6CSD4[.*]:@V! RL"]0U)-)I9^#IM.QA9(4VPDXM@(F?)U?4U8X%.V"@8
M!EKSO]Z_GR67"Y#S[/P4Y"\*Z*O!(M%SM]:(Y(LWMPL^S/'[VZN+6?)3NDZ>
M"XKIX]<O^>.3>Z:A#'H4#8MFD\I1&8_B,J1+Z!C+IO2;F/X]=NN@&9VPRWU%
M_,Y6RR"$:ABWW09^5@\?DL57;.YX66R7RH(*5@)KL$D$;_$S<GL,6[.Z;S_#
M(#H=L8)CA5\FC)57/2-KGH&^B!8'+AF?XX%M-B&Z0Z"AV2O+^P8N-W;ES>(I
M )&6$2-+L$^IO$<?)R"\+G6'84R[_5['0>H]POOXOT/V >OVM;=N7Q\T2#_C
MW&"GM[#YY!&8*9/V>2N0' @GBUFSS/IY?E=,?<$I)25TMQU[J=8/,)%_XYT+
MY4#BI8,H61Y,5RN5=0Q<R]X9!00E"3=+&,8K"U6ATZ4N-*DJ_AZ@HX'$G>!W
MVGG?'-F%SOYYZ-@'6ZON5=5;:-3'1E4&7_*>G;0PB>,:\&X-%H_C>K!B:4CZ
M?F4$U/B8;0Z@RUGZ#)8=,^1@6P$D4_J>E"$T);[4L S1ST5=K8\+COQ85T.,
MJ[4FU2F8HF#.@)\,R7BY!!I\2F)=U_F#AJ-ZGQ9]>*SA7>O6NK%9UI)O3=ZM
M-9 QUI\ ;/BMY$@A8B0?TJ/2&97+UW^_\=8D*U)=&EBH7$'@2P<,5E_U17'<
M:G,G#M*&E+1\MX2PO.MQP7L#92YP[EJH+SHN18:%XG57:=;5K2![ Y^[;OD$
M9=JN$4P]G3D/K4L_'D<X@&_U0%[A3. XIC15SNN""7B,F+R64E3']>H8)F/
MEPH38CS-DZL@.DIV(JG#^/T<P=3 WW5-1UQR!H$HN8Z/0HP)&THN+,VOV2+9
M8SOWT3$L4XH  +J@EC/HO'O=UI6E-*:32)M!M/*P48)&@2_3;=:79% R$@:=
MD2S!($&G]AW)*M$J"!8B%,4: +R75L0>4.*.]"[.@B++M!&D9EW/P9#I"YK#
M>C_76*+UP12LF,UPU.: _CFDN+_QBON;@VKW%[@G[(1<DGG"5LE;J"$BZ)0*
M_[UK)1]V"<WQUQ#9NLJ#Y:Z4DFP%Z0,)$2U?1O%QQ&DJA?(IU)HXAK;=BGK6
M$O<];&I":_U02; 7KS&1OQCJ5I*8=:_Y=_'05! E!YSA>-CJY7'X?N]0HRUJ
M!IQ+QJ<3X%JST0VCYD%1+FI@D2CSIPE1Z1IA%G,OP*G!O$7!<-OD@<G@$N^:
MB/@8) P.3R5$ :I/@75K<C1DWHKBKP=6/:UFOGR1L)*#!\PHD,F4FTLMWB5W
M0S+"J/=I.YP7A]<(0',R$X HQ[B@M#G/'NPBAH!:N54W+ZU9D>T@8R1@]J!D
MS=G()HT-&1A[A2[937+J:9O85-J,G-@L1#\SLH:4I""=8L2SC\_H.$0.N4-$
M!T;,=2\3/5<(O78I;MV%EDG"J6 H@IF<#NOO,@%@M<K.&_;18MD&AM"RK'SV
M:4?.G1"7>D80^#Q+5LHY&O/D<A6Q@T^*!I9P')"D2YCFH02F#?QM2D0PJ%$J
M-+":.Z*P(_"&D]GCE@I*+F<:^IE3\#P.EJ -8IY9,=%C*9#(R 8WM, N:<LZ
M5\#W:H? # HQZG9"4F!+05> !YV=<8ST&XBL5]N$.8CC9$ 3(K/[FG$ENW'6
MBY0(PQ5MJE7$/40:"E5ADX: 0=5%A@=[0U!X3SJ&%GF<!%NR-B/@)Z7=\P9'
M/Z9?K:BZ0097R(E-A5D56_Y(L(E':SA0:9YSD$_JHE]RC#=V7ON&_*N74_MK
M,U FS/A571W[$/#>HY0]%W*A6!QAY%L5B0$PU5 M09BR3'^%LX&GWF_P?$":
M2+5/S%-"VV#IIR^)E ,@!0DR10Q<FJPI$P2=E&9W(@ C'F'UQ1H!]*#5=Z5]
MGKP=K"S2 '5OG#2 IX55M[+1%)F'!&WJ!]62] "\]6:$-)S+0(<6"!KER8PH
MFR-"LI%.1-B!=A$N+4G&38@4"K*Q*Z@BXHL)5>2Q#D>/J\9BH/ #I>SPA4QV
M /\V(C;I?;!@D\;@6Q68I]OCKC[&O]B(3FO#<* !5>.M[G1V=TPL[)!T;V68
M8-B21]>0*T!:9,4(#)%2;MT_,V3J&GR\%HT$]*9+4[?+2?S  \[8H-50V&:'
M[Q@@6D)BAVD<NS4 I\[%!86IKD3[QTK4ZQ"G<P(O32H*X6!2,Z2=H-"M>HNJ
MH+? 89ZVN<$F.2.%#^WBIXO;A0^?GI^=SD89[:&.YV@.#".Q)$/8#12$A85"
M6FL.2/GM,P('M/\A__JY]Z^?'ZZ*.A]G$0+32=?Z=RP3>RB]L:HLC?*H4\;5
M&YFID-F0HM2PG#X?LB<58?F!-R.6$&-#GGI+.2;0)/@?K#M*Q(N]U<"[KLG
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M"<ZH.#4?%#13*.J,&)@O;I/P'=ID_RP7#4:%Q (Q4$*Q"04@">7QNQ 5<@?
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MZDCND+HO7=WP^W^A_!#P\$<$'< ^#<#OJ[KNW!?:P+\1^M7_ E!+ P04
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M%_H=*.I;<?UBU+*ZB4Z5P7MMM4P$1RVQ!OC[7"FS>;$;-/\U,?P34$L#!!0
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ME[O/GX8L&5P8$CN=SX+77)8(I:*+::R7AB7GI:KI@@NY@E,A:4>UAN1CSL9
M;<*^37"#)38+U) F?H?!/3ZK^IEVG.K@!))A',9Q?&#=(Z_AB['<8B=-8"P<
M%@Q8&B;%D(A*:E3;W?/.(0\'V0BR,,E',->J$<8HO8/?%4',^<YI&)@']^6Q
M"WA4EK+X&ED2AT62$+U!F+(!W*$Q8[ANM49I8:.T3T2%>^]3%A9I? :G13(Z
MV_M^E[QQ;O]B!4LAZ<3<R93*'1CY#[.<_-,P]1%*KGZQJ)L.[H32YF&2%MXB
MG^$(CD@F[R63_[1D;EOK]$W];82E%]::GQ32T10?"^F'-CBE]6KI&)1O&=B/
M1$?#QW_<(=<&4%8.ZT!)_]/<9:-::I57W"F^E'7K0QR&$2_0= \1NH?HK3[/
MZ-33A#D[(X$4F3=S&(3),'-FX569Y7XQ@&S @$JD>;BD%D(R"O-LL-?222^D
M]_H7'3S:#>J5'TV&CH2(=^]WO]M/O\ONT?_AWHW.;URO!(F^QB6%QN<#ZI/N
MQE&WL&KC1\!"61HHWES3!$?M'.C[4M&]V"]<@OY_@ME_4$L#!!0    ( (.*
M"5<N*[1 2P0  !0*   9    >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;(U6
M;8_B-A#^*U:N.NU**>2%!-@%)'9[I_:D4]'"]515_6"2(5B7V-1VEMW^^LXX
M(84]H/T ?IMY_,SXF=B3O=+?S!; LI>JE&;J;:W=W?7[)MM"Q4U/[4#BRD;I
MBEL<ZJ)O=AIX[IRJLA\%0=JON)#>;.+F%GHV4;4MA82%9J:N*JY?'Z!4^ZD7
M>H>))U%L+4WT9Y,=+V )]LMNH7'4[U!R48$T0DFF83/UYN'=0T+VSN W 7MS
MU&<4R5JI;S3X)9]Z 1&"$C)+"!R;9WB$LB0@I/%7B^EU6Y+C<?^ _M'%CK&L
MN8%'57X5N=U.O9''<MCPNK1/:O\SM/$X@IDJC?MG^\8VC3V6U<:JJG5&!I60
M3<M?VCP<.8R""PY1ZQ YWLU&CN5/W/+91*L]TV2-:-1QH3IO)"<D'<K2:EP5
MZ&=G2ZNR;S\^8%PY>U05GK7A+ETW*[XNP=Q.^A:W(>-^UD(^-)#1!<B4?5;2
M;@W[('/(3_W[2*_C&!TX/D17 3_5LL?BP&=1$,57\.(NYMCAQ9=BWG(-;<P+
M_HH2LVRN-9<%N/X?\[6Q&O7RY[G@&^S!>6RJH3NSXQE,/2P2 _H9O-G[=V$:
MW%]A/NB8#ZZASY98DWE= E,;=AS%R<E]>*$^G.-^%?T\]]46V$:56+Q"%LR2
M*-H*%G^#81:7C=/0VC')CIE PP2+-U.%1/N<U:@)S7A94@CD3-2Y?'W_;A2%
MPWO3@+%=R:7!?;6SL5L-P+C,F1$OK&K4!:0NAMJ 3AO.!#N1[WK<&)4);M%L
M+^S600EC:BXSET&,T6J1T;JA9!J:Q !P@Y8&H3RC%86.:\VDVE%P%#JW#-V8
MD%E9$QDA60$2-"^;_7,L6$%2HB_/(1N&S(@*S[(F=D+/$%&5(G=LC<6&I.@8
M(;RJ@-TX-U4;A#:W=VSEDG)<:FR)V3F9<$FAA!SUEB=!_, &.(>_( AP$/KA
M(,1V/!JYT3@*V=-1FIQO[ _'(8O\X7#,4C\=!BSQ@V3 5LIBY/^I!MS2C\(8
MVQCQ:=>AGR:T7^J/APF[4B=)5R?)_Z\3Q_E7%R];894;GC6Q?W%:/%E?D.[.
M5<[5_2Y7SEMUX[6(ARMS.O)3-9$ 4"N8M+8PNJ*[:TK=L*_NBD&+^3-JK "L
M=-"9P)0N\'S@^_4GH&N9]GI$5= 7K<8#6H&NV,WOP+6Y9?.BT%"@W-H,G%)$
M@7_BLL;;&K70:&B4C/U10J<6)3U42=0+QR25H!=W$ 5FF7BXL*/[B^W!'MHX
M<G831JBE(+@E0%3DP3(^0L>OP@8$X=\D06,<],+@(OK;@$Z^&.EHT(83![TT
MI7!24F1O\):=^_)]YY^,QGX8DGBCL#<<,OR+G']X5L?]HYNZ EVX]P@=?BUM
M<VEWL]V39][<]/^:-^^ESUP7 NF5L$'7H#=$B>KF#=(,K-JY>W^M++XB7'>+
MSS;09(#K&Z7L84 ;= _!V3]02P,$%     @ @XH)5P;"Y$@$ P  C08  !D
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M0PX0OQ9-VVEFOFUUB/I1\,/4K49)I0@;16IBZQ((C/%;C*]L_'PO_CGY4DJ
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M;8G$&>,-DEM6M\#(<3JL=V%@&Q<%0ZK6.\J62Z"!9H?&A]4)\EJ@"?KLMPU
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MDN1K5O,=R;?9"L@YEY)OLLTUHPN6I ;J_))S^;B3-E"N'![]!U!+ P04
M" "#B@E7M#WOS\L%  !?(   &0   'AL+W=O<FMS:&5E=',O<VAE970T,RYX
M;6R]FFUOVS80Q[\*X19%"Z211#\EJ6,@L5HLP]H&S;J]&/:"D6B;B"2J)&4G
M0#_\CI*L!UMF*H#+FT:2>7^2/QV/=U1G6RX>Y)I2A1[C*)&7@[52Z87CR&!-
M8R)/>4H3^&7)14P4W(J5(U-!29@;Q9&#77?BQ(0E@_DL?W8KYC.>J8@E]%8@
MF<4Q$4_7-.+;RX$WV#WXQE9KI1\X\UE*5O2.JN_IK8 [IU()64P3R7B"!%U>
M#JZ\"Q^/M$'>XB]&M[)QC?14[CE_T#<WX>7 U2.B$0V4EB#P9T,7-(JT$HSC
M1RDZJ/K4ALWKG?JG?/(PF7LBZ8)'?[-0K2\'9P,4TB7)(O6-;W^CY83&6B_@
MD<S_1=NRK3M 0285CTMC&$',DN(O>2Q!- PP/F* 2P.\9S \UL.P-!C^JL&H
M-,A1.\54<@X^460^$WR+A&X-:OHBAYE;P_19HM_[G1+P*P,[-;\FDDG$E^A6
M4$D318JWD83HKO $_=L=6R5LR0*2*'05!#Q+%$M6Z)9'+&!4HO?H*@R9MB01
MNDD*;]0Z;WVJ"(OD._0:L03]N>:9!&TY<Q2,78_ "<IQ7A?CQ$?&.42?>:+6
M$GU,0AIVV"_,]I/G['VSO8<- @Y K\CC'?EK;%3\3,0I&GHG"+MXB"1=P6I2
M71,SR_R>)2#CEC+?[WST]O4[@YQOEO-I4(T*F^5:LQY6_C;,]8=']'=>]?5Y
MK_KG#[!%-XK&\M\NARDZ&G5WI./EA4Q)0"\'J79ML:&#^9M7WL3]T 79IIAO
M2:P%>%0!'IG4YU^R^)X*O6H%3;E0Y#ZBN_<GT4^#9UP7PN-<6.\7F_EPYFR:
ME)YMX1^V\*H6K?F,J_F,C?.YBK5C0"A/N60*]HG<422BCP&EL!+1)_]F <%%
M9@)N(A:SSKD9.^GK+(78I(D!3\Y<=X]%5[/1M-&L!612 9D8@4#<>*"[UQID
M N(N+)8WK\ZPYWU  14J7U2*YF&]Y-:%Q-A-7R23@_>N \@>$$L]MK!-*VQ3
M([://S*FGAK(NI 8)?HBF1Z\?F\ZF>XAF1YP&X\;C5I3/:NF>F:<ZJW@,9.2
M0YA-N/8#^IA"F@7+0W%T3Q'D#%%QOV5J#?MR2@7C79OBM;&COD#,HX8=-LYW
MV*Z(:FD<+9SG%<YSX\"^,?F 4@ZI&<28-,I@70F=6L(NI>0)>)12$=4QM>2(
MR%)!!!:5&3S.4Z(DH.B)$M$%VCB$OJ#-\_'.#* MC:,%VG/K9-0U#NTF 7)4
M*B0@?N5^VDW++-,7EU4UWY9:&V$CG_=>*L$J>[)%V:::;TNM31G7E+'147U8
MZ1NB2U9$)$2 $[0D3* -B3+:B=(HUQLE/MQ:\$'Z8:O/-J(ZT?>,:6X#T0ED
M)2S2KL>:Z[N3D]6DOE0[;W!R3]WQ/J?_(UWWZGS=,R?L34[+B,/>\CPEHV)O
M2H6:CEM-3'@XV@=EJ=LVJ+H0\,R5P(+G\4MOM/17DCFS7&]*-M5\6VIME'4)
MX4U>;).P6D985?-MJ;4IUQ6'9RXY>CNLU?+#JIKO'18JWOFQ4M:K*Q7/G/0O
MB%SKJ+=%:QJNJ+Q /U$["91;DL+#KVH-.?47G@! H8E>Z6U7'VC4\5-"5B[!
MG8DN;8C,)8M=1RJ1Y0<@G=BM%CE6U7Q;:NW74U<^WOF+Q0FK%8Y5-=^66OL<
MN*YZL+GJZ9M,FN7ZHBS56L=4WD$R6;9J'?WA8^L?U]4*-N;I\\7><95__+C*
MK-1[UE:K$5MJ;8IU-8+Q2RU3;+50L:KFVU)K4ZX+&FPN:.[67*CWL#?%*.XZ
M@SV!QTI?/QD.U,Q]].9K'O&YBT+RU'G.8VL<;99UT8/-18^U0VQS/[UYC@YB
M(02Y@UAXV&H_$#J-+[(Q%:O\R[9$^7HL/LY63ZNOYU?Y-V.G;EY\>@=4D,5(
M%-$EF+JG4XC!HOB:7=PHGN;?=^^Y4CS.+]>4A%3H!O#[DG.UN]$=5/^G8/X?
M4$L#!!0    ( (.*"5=MO*<S.@,  %,*   9    >&PO=V]R:W-H965T<R]S
M:&5E=#0T+GAM;*U676_;-A3]*X16#"FP1+(D*VEF"XAC=Q]8 :-NVH=A#XQT
M;1&E2)6DXG:_?I>4HMD>XQA=7FR1.N=<WL,K\DZV4GW6%8 A7VLN]#2HC&FN
MPU 7%=147\@&!+Y92U53@T.U"76C@):.5/,PCJ(LK"D303YQ<TN53V1K.!.P
M5$2W=4W5MQEPN9T&H^!QXCW;5,9.A/FDH1M8@;EKE@I'X:!2LAJ$9E(0!>MI
M<#.Z7F06[P ?&6SUSC.QF=Q+^=D.?BNG0607!!P*8Q4H_CW +7!NA7 97WK-
M8 AIB;O/C^IO7>Z8RSW5<"OY)U:::AI<!:2$-6VY>2^WOT*?S]CJ%9)K]TNV
M/38*2-%J(^N>C"NHF>C^Z=?>AQT"ZO@)<4^(#PGI$X2D)R2G1DA[0GIJA'%/
M<*F'7>[.N#DU-)\HN27*HE'-/CCW'1O]8L+6R<HH?,N09_(9U4P3N29+!1J$
MH=WVB9*LNLJQ[U9L(]B:%508<E,4LA6&B0U92LX*!IJ<DQ76;]ERL.A?L#K)
MV1]2Z]<$M590M(H9BSN;@Z&,X_PYN5O-R=FKU^050?2'2K8:@^I):# IN[2P
MZ!.8=0G$3R20D'=2F$J3A2BA]/#GQ_G9$7Z(9@Z.QH^.SN*C@K^WXH(DT4\D
MCN+$LY[;T^FQ+YW_%WWQW='WS$B&\DJ<7O*$GJ]:_KRYUT;A"?&7;[<[O=2O
M9T_-:]W0 J9!8PM6/4"0__C#*(M^]EG]DF+SEQ1;O)#8WJ:DPZ:DQ]3S#])0
M3CA^H+@;"@J)7_??4-J/%;ZTS'PC>OAF?5O4J6=.W=Y##_GY*$FO)N'#KO<>
M5)HDHWW4W(,:7T8'J(4O8GIUE0VP/1_&@P_CHS[8@^I9 XB6W'>LS#KM\<Z:
MH@,'_HN(X\OXP(!G91;/R.REG@VI9T=3OQ/85'"7]&EU0"K@):&& %X->,@W
MH)CT^I*=5!T>5!R-WQR8XT%YJL,7,<Y&Z8%%X<XM68/:N/9$$W= =2?:,#MT
M0#?NXC^8GXVN;T>>^3EV3%V#\Z]\UVZ]HVIC:XW#&D-%%Y>XFZIK8;J!D8V[
MH^^EP1O?/5;8]8&R 'R_EM(\#FR H8_,_P%02P,$%     @ @XH)5]KQSZY=
M!   8!@  !D   !X;"]W;W)K<VAE971S+W-H965T-#4N>&ULM5E;;]LV%/XK
MA%8,+;!%(G6QE-D&:DO%.BR8$;?;P[ '1J)MHI+HD73<_/N1DB);LB(D&?,2
MZ_)]'WDN//8YF1X9_R9VA$CPO<A+,;-V4NZO;5ND.U)@<<7VI%1O-HP76*I;
MOK7%GA.<5:0BMY'C!':!:6G-I]6S%9]/V4'FM"0K#L2A*#!_6)"<'6<6M!X?
MW-+M3NH']GRZQUNR)O+K?L75G=VJ9+0@I:"L!)QL9M9'>)W 0!,JQ)^4',79
M-="FW#'V3=]\SF:6HW=$<I)*+8'5QSU9DCS72FH?_S:B5KNF)IY?/ZI_JHQ7
MQMQA098L_XMF<C>S0@MD9(,/N;QEQU])8Y"O]5*6B^HO.#98QP+I04A6-&2U
M@X*6]2?^WCCBC*!TA@FH(: ^P7N"X#8$][DK> W!>^X*?D.H3+=KVRO'Q5CB
M^92S(^ :K=3T1>7]BJW\14N=*&O)U5NJ>'*^P((*P#9@Q8D@I<1U^,H,K.O4
MT>_6=%O2#4UQ*<''-&6'4M)R"U8LIRDE OP,UBJ!LT-.-#JF F^WG&RQ)!FX
M)?>D/!!P]P 2G.[ "C\P#KX\[ EX'Q.):2X^*(&OZQB\?_<!O .T!%]V["#4
M'L34ELI&O5,[;>Q9U/:@)^QQP0TKY4Z I,Q(-L"/Q_G!"-]6OFT=C!X=O$"C
M@K\=RBO@.C\!Y"!W8#_+Y]/1D#G_;_7DU:MWG.&VV>96>NX3>F>IH=-,)<MC
M>OS]NX*"SY(4XI^AJ->ZWK"NKJ;78H]3,K/V.H_Y/;'F/_X  ^>7(9>;%(M-
MBB6&Q#K!\=K@>&/J\R840]ZOB4%%U%\]]W/7"Y$33>W[<[]>PE 0!=&D"XLO
M84'H>[[;A267,-]%D>^UL(Z5?FNE/VKEDA4%X2G%^9"AH]R7IIE)L=BD6&)(
MK!. H U \$8U(# 9')-BL4FQQ)!8)SB3-CB3U]: FNB?UX P<GIG>WF)\I #
MO5X%N$1-P@@%O0)PB0H]&$R&SW_86AB.6GA#,O5#A@^:.,I\:8*9%(M-BB6&
MQ#KNCUKW1V]T^B.3P3$I%IL42PR)=8(#G5,WX+SV_#?,\^.($()^_T?   YZ
M*/!@KP8,X#PW](*>7C*T[B1 431<!^!9YP.?40GH4).P&*>^--N,JL5&U1)3
M:MT@H%,0T!O5@T;85(A,JL5&U1)3:MT0G7HV.-IUC-8$]^)L!A&$J%\2+F$3
M)W#]?D6XA$$W\'S8KP@#. \]71%.#1 <[X#^D#O"@=Q1GH$]YI*2X0G$J,J+
M,\^D6FQ4+3&EUHW'J56#_EL5!Z.-G%&UV*A:8DJM&Z)3,P='VY'1XA!<-/ P
M=%S8+PX#,,_K-Q;Q ,Q55DSZM6$ YL"P7QKLLXEI0?BV&E4+4(TVZW%6^[0=
MAW^LAL"]YPMXO80#SV,]/J\FM"?Y>O9^@_F6E@+D9*.6<JXF*H"\'F?7-Y+M
MJWGM'9.2%=7ECN",< U0[S>,R<<;O4#[3X7Y?U!+ P04    " "#B@E7V95!
MF"T$  #/&P  &0   'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6RUF5V/XC84
MAO^*E4I5*W4G'WP,,P4D((FZU>X*@=I>5+TPR0&L26)J&]B1^N-K)R$0%-*A
M>^9F((G?Y]A^DY>)/3QR\2*W (I\39-,CJRM4KMGVY;1%E(J'_@.,GUES45*
ME3X4&UON!- X%Z6)[3E.WTXIRZSQ,#\W%^,AWZN$93 71.[3E(K7*23\.+)<
MZW1BP39;94[8X^&.;F )ZK?=7.@CNZ+$+(5,,IX1 >N1-7&?0[=K!'F+WQD<
MY<5W8H:RXOS%''R,1Y9C>@0)1,H@J/XXP R2Q)!T/_XNH595TP@OOY_H83YX
M/9@5E3#CR1\L5MN1-;!(#&NZ3]2"'W^!<D ]PXMX(O._Y%BV=2P2[:7B:2G6
M/4A95GS2K^5$7 @TIUG@E0+O6M"](>B4@LY;*W1+0?>M%7JEH'<MZ-\0]$M!
M/Y_[8K+RF?:IHN.AX$<B3&M-,U]RNW*UGF"6F3MKJ82^RK1.C:=4,DGXFLP%
M2,@4+?S.8K(L[C5S;<DV&5NSB&:*3**([S/%L@V9\X1%#"3Y0);ZCH_W"9C6
M,YXIP59[0Y)$<;*  V1[R*D+B( =Z"K1LM4KF=-7+L@//BC*$OFC)LWR,8,P
MF$AW2!0]6C#Y,K25'K'IMQV5HYL6H_-NC*Y#/NO.;"4)LACB!KW?KN__ESYL
MU[M>"\#65E5^>2>_IEXK\==]]D ZSD_$<[Q.0X=F;Y=[3?/Q;=6#;ZL>MLM]
MB+3<;9+7YK)3W?N=G->]P?NB@_MT;_Y3WHJ3IINL%6.R_UGN: 0C:V<>(G$
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M1Z4F=^X"OHOQK;11V1UKVDFI'\+$7^G4F0!LQ6..73DGU"]Q8>.&8E-L=\6
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M\P6GQ5?0U  HS0.E^:"T )065C3#C_4(JL&FF789 L><(IA,'L)6_T N<\]
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M#K87,EM7#^[?9U)F2?5R)13=RDL!]?DRR^3S1?E;@/UO/V;_ 5!+ P04
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M;ZLV&(;_BL6.IE9J S8)(5T2J4G.M#/I:%5?SM$^NN DJ( SVVG:?S]C*(1
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MM"FU.JS*3$.]FVXW#QUAY=(0'?>L 3S%9=18FU*KXZH,..SFP#^S$AT!CIH
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M]*Q7F*TRZ#ARLH10UBB$=%G3!S8#02O5Z-Q3 6V3>DRA=29, N#]DE*Q'<@
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M??;>+E^_S3**4NUB@%UI=@\PW-N91NI-"1E4E$)I#$63K16YGS^6^^7;T[N
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M_M_JZY]>_2P885<BH>$+QTODKYNMD%Q]V'_;$MQ01'8*O=E=BPIGL'34;B:
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M_BL65YU:Z;J\AKQ<$FDW4+6GJ[K:[<MG+TR"5< YVR3=?W^V8=E "**[?$G
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M8"S86,5S(2D<M#H&K2:,Y_*7KB)JX RKZ+2,$J*#U-W&,BHX(V&HL4PRF8O
MS<8R7I!." >KC\'J9+#OMG?5ILR^7E=-=TU]J*M-UI6"]6YR!6/7<5 JI^'?
M<JPB@FD:1!ZK>,'S<&@#*B**@3_DXAAWD4[RTZJ^S]XOZ_97*,KDP7,O&YAF
M!M/,(IEY&2"Y*P#S"U[9#^9(.4)U,ZAN%LO-3]-)G4[.N[X?CO?F0^@"#^C
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M$*@!F: D_ NP@(SG5!4#X3H<X&D<F-U.X''5KB0+%]Q *D;#;0N BC 6CW)
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M2E1TTR% U]<(,II#@$\NF.0D1 M U]<(<F 5M'1L(<]EBPGMB?0Y9H]/5-1
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M;PLIPH4[MX!(1ZL] !%1X5(*"ZD8'\!N[1!!IQ%A_M,DXNK]E6;1TR0 5;2
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MG>Z_::OGW9,\/U9M6VUV7SZ5R_NR[@7=[Q^JJOWR37^"X^-F;_X/4$L#!!0
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M]A64G8#/YQ*_.>7 =DA50QS\!5!+ P04    " "#B@E79F&U"$8#  #0%
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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MGMV$Z*OL?ET5N;+N+S']5F-,RB\#9L&T8,<PD\/M!S,DG,FU!V$^2C$#9L<
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MQ1C:K@W4-/G3CW2>?F#TZ1=02P,$%     @ @XH)5[3%"JYH @  1R\  !H
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M[HOCYV<]N&Y\R6?SW\"O_@!02P$"% ,4    " "#B@E7!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M (.*"5?;O%Z/[P   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( (.*"5>97)PC$ 8  )PG   3
M  "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ @XH)5P2O
MN ??!0  \QX  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( (.*"5<"2::\@PL  (TW   8
M  " @2,.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "#
MB@E7IX9,1U8&  "5&@  &               @('<&0  >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&UL4$L! A0#%     @ @XH)5S^O*7Y4"   ^C   !@
M         ("!:"   'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0
M   ( (.*"5?.D(=QNA$  /#/   8              " @?(H  !X;"]W;W)K
M<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " "#B@E7&4&BE6D*   $,@
M&               @('B.@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!
M A0#%     @ @XH)5]9M('R9#@  I2@  !@              ("!@44  'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( (.*"5>_%%$$A20
M  -Y   8              " @5!4  !X;"]W;W)K<VAE971S+W-H965T."YX
M;6Q02P$"% ,4    " "#B@E7K<$]W6<(  !/%P  &               @($+
M>0  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ @XH)5_?Y
MOXGC!   U0P  !D              ("!J($  'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"% ,4    " "#B@E74N2;8(L&  ##%   &0
M    @('"A@  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (
M (.*"5?;&&GFQP0  /D*   9              " @82-  !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&UL4$L! A0#%     @ @XH)5Q;;4B<$ P  S 8  !D
M             ("!@I(  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"
M% ,4    " "#B@E7Y+  (T@#  !2!P  &0              @(&]E0  >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( (.*"5<,7__LJ@\
M -DS   9              " @3R9  !X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L! A0#%     @ @XH)5XLE]RU?!0  * X  !D              ("!
M':D  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " "#B@E7
M4:X[2NL%  #L#P  &0              @(&SK@  >&PO=V]R:W-H965T<R]S
M:&5E=#$W+GAM;%!+ 0(4 Q0    ( (.*"5>)=I#[#P@   84   9
M      " @=6T  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%
M  @ @XH)5^'-YV;G"   I"$  !D              ("!&[T  'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " "#B@E7.=+SWCD%  "A#
M&0              @($YQ@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+
M 0(4 Q0    ( (.*"5<6LTA\404  %82   9              " @:G+  !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ @XH)5Y0FX[*H
M"   Q14  !D              ("!,=$  'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6Q02P$"% ,4    " "#B@E7+(DHV2T&  !$&P  &0
M@($0V@  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( (.*
M"5?TSKI/H@L   4>   9              " @73@  !X;"]W;W)K<VAE971S
M+W-H965T,C0N>&UL4$L! A0#%     @ @XH)5YF<_;%/ P  * <  !D
M         ("!3>P  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M    " "#B@E75Q#._H,"  "_!P  &0              @('3[P  >&PO=V]R
M:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( (.*"5=8C2:51 (  (H&
M   9              " @8WR  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL
M4$L! A0#%     @ @XH)5[C.E29J'   '5H  !D              ("!"/4
M 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " "#B@E7+LU
MN6@'  #!%@  &0              @(&I$0$ >&PO=V]R:W-H965T<R]S:&5E
M=#(Y+GAM;%!+ 0(4 Q0    ( (.*"5>[W588K0(  .\%   9
M  " @4@9 0!X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @
M@XH)5^#/ES%G!   "0L  !D              ("!+!P! 'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6Q02P$"% ,4    " "#B@E7<CF@F6@%  "F$   &0
M            @('*( $ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4
M Q0    ( (.*"5>3YDS]$P,  +L&   9              " @6DF 0!X;"]W
M;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ @XH)5](MSX!7 P
M4P<  !D              ("!LRD! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX
M;6Q02P$"% ,4    " "#B@E7Z!<I+*0#   ?"   &0              @(%!
M+0$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( (.*"5<N
M*[1 2P0  !0*   9              " @1PQ 0!X;"]W;W)K<VAE971S+W-H
M965T,S8N>&UL4$L! A0#%     @ @XH)5P;"Y$@$ P  C08  !D
M     ("!GC4! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (.*"5>?V:@=G 8  $4\   9              "
M@61/ 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ @XH)
M5[0][\_+!0  7R   !D              ("!-U8! 'AL+W=O<FMS:&5E=',O
M<VAE970T,RYX;6Q02P$"% ,4    " "#B@E7;;RG,SH#  !3"@  &0
M        @($Y7 $ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0
M   ( (.*"5?:\<^N700  & 8   9              " @:I? 0!X;"]W;W)K
M<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ @XH)5]F509@M!   SQL
M !D              ("!/F0! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q0
M2P$"% ,4    " "#B@E7I/I&'*$+  !)=@  &0              @(&B: $
M>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( (.*"5?UB@(>
MZ0(  ,$&   9              " @7IT 0!X;"]W;W)K<VAE971S+W-H965T
M-#@N>&UL4$L! A0#%     @ @XH)5Z.8J0!2!0  "BT  !D
M ("!FG<! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " "#
MB@E7SX6TB8\"   Y!@  &0              @($C?0$ >&PO=V]R:W-H965T
M<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( (.*"5<)7@VJ]08   <R   9
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M970U-2YX;6Q02P$"% ,4    " "#B@E7$&N*R:4#  "^$0  &0
M    @(&?G@$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    (
M (.*"5<B=#"#4 ,  %,*   9              " @7NB 0!X;"]W;W)K<VAE
M971S+W-H965T-3<N>&UL4$L! A0#%     @ @XH)5PA4"Z/: P  O@T  !D
M             ("! J8! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"
M% ,4    " "#B@E7'.[.'N0#  "L$0  &0              @($3J@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( (.*"5> A20*KP(
M /X&   9              " @2ZN 0!X;"]W;W)K<VAE971S+W-H965T-C N
M>&UL4$L! A0#%     @ @XH)5X)BYX(1'0  EC(" !D              ("!
M%+$! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " "#B@E7
MNPSK!!<$  #X%P  &0              @(%<S@$ >&PO=V]R:W-H965T<R]S
M:&5E=#8R+GAM;%!+ 0(4 Q0    ( (.*"5?5I1PFA@,  ,D0   9
M      " @:K2 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%
M  @ @XH)5T=A3EJS!0  3B0  !D              ("!9]8! 'AL+W=O<FMS
M:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    " "#B@E7?U:=GR0%  !B'0
M&0              @(%1W $ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+
M 0(4 Q0    ( (.*"5=VTSP2\@(  $(*   9              " @:SA 0!X
M;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ @XH)5W*< A@.
M#   M(H  !D              ("!U>0! 'AL+W=O<FMS:&5E=',O<VAE970V
M-RYX;6Q02P$"% ,4    " "#B@E7S3M,,N #  #=%   &0
M@($:\0$ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( (.*
M"5<D.>>#40(  *<%   9              " @3'U 0!X;"]W;W)K<VAE971S
M+W-H965T-CDN>&UL4$L! A0#%     @ @XH)5YO E2#" P  3!8  !D
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M=#<T+GAM;%!+ 0(4 Q0    ( (.*"5<!5R^.@ ,   8-   9
M  " @50: @!X;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @
M@XH)5UR<#]0&!   *1(  !D              ("!"QX" 'AL+W=O<FMS:&5E
M=',O<VAE970W-BYX;6Q02P$"% ,4    " "#B@E7S9Z7I'D$   R%@  &0
M            @(%((@( >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4
M Q0    ( (.*"5>-02+C9@(  -X&   9              " @?@F @!X;"]W
M;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%     @ @XH)5]8;48@3#0
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M96QS+RYR96QS4$L! A0#%     @ @XH)5V&I:#(#!@  Y#0   \
M     ( !J3X" 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( (.*"5>TQ0JN
M: (  $<O   :              "  =E$ @!X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( (.*"5<L 6<[&P(   XN   3
M  "  7E' @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !8 %@ 'Q@  ,5)
$ @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>547</ContextCount>
  <ElementCount>418</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>150</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/Coverpage</Role>
      <ShortName>Cover page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/DescriptionofBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwill</Role>
      <ShortName>Business Combinations, Asset Acquisitions, and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IntangibleAssetsNet</Role>
      <ShortName>Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Investments in Other Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/InvestmentsinOtherEntities</Role>
      <ShortName>Investments in Other Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Loan Receivable and Loan Receivable ??? Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedParties</Role>
      <ShortName>Loan Receivable and Loan Receivable ??? Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Accounts Payable and Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/AccountsPayableandAccruedExpenses</Role>
      <ShortName>Accounts Payable and Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Medical Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/MedicalLiabilities</Role>
      <ShortName>Medical Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCredit</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Mezzanine and Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/MezzanineandStockholdersEquity</Role>
      <ShortName>Mezzanine and Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Related-Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/RelatedPartyTransactions</Role>
      <ShortName>Related-Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Variable Interest Entities (VIEs)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/VariableInterestEntitiesVIEs</Role>
      <ShortName>Variable Interest Entities (VIEs)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Segments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/Segments</Role>
      <ShortName>Segments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954701 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954702 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954703 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillTables</Role>
      <ShortName>Business Combinations, Asset Acquisitions, and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwill</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954704 - Disclosure - Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IntangibleAssetsNetTables</Role>
      <ShortName>Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/IntangibleAssetsNet</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954705 - Disclosure - Investments in Other Entities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/InvestmentsinOtherEntitiesTables</Role>
      <ShortName>Investments in Other Entities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/InvestmentsinOtherEntities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954706 - Disclosure - Accounts Payable and Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/AccountsPayableandAccruedExpensesTables</Role>
      <ShortName>Accounts Payable and Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/AccountsPayableandAccruedExpenses</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954707 - Disclosure - Medical Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/MedicalLiabilitiesTables</Role>
      <ShortName>Medical Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/MedicalLiabilities</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954708 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditTables</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCredit</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954709 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/StockBasedCompensation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954710 - Disclosure - Related-Party Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/RelatedPartyTransactionsTables</Role>
      <ShortName>Related-Party Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/RelatedPartyTransactions</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954711 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/EarningsPerShare</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954712 - Disclosure - Variable Interest Entities (VIEs) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/VariableInterestEntitiesVIEsTables</Role>
      <ShortName>Variable Interest Entities (VIEs) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/VariableInterestEntitiesVIEs</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954713 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/Leases</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954714 - Disclosure - Segments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/SegmentsTables</Role>
      <ShortName>Segments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/Segments</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954715 - Disclosure - Description of Business - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails</Role>
      <ShortName>Description of Business - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954716 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954717 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Gain (Loss) on Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Gain (Loss) on Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954718 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Each Payor Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Each Payor Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954719 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Contributions to Revenue and Receivables by Payor (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Contributions to Revenue and Receivables by Payor (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954720 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954721 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954722 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails</Role>
      <ShortName>Business Combinations, Asset Acquisitions, and Goodwill - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954723 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillScheduleofGoodwillDetails</Role>
      <ShortName>Business Combinations, Asset Acquisitions, and Goodwill - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954724 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets, Net - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954725 - Disclosure - Intangible Assets, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails</Role>
      <ShortName>Intangible Assets, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954726 - Disclosure - Intangible Assets, Net - Schedule of Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails</Role>
      <ShortName>Intangible Assets, Net - Schedule of Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954727 - Disclosure - Investments in Other Entities - Schedule of Equity Method Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails</Role>
      <ShortName>Investments in Other Entities - Schedule of Equity Method Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954728 - Disclosure - Investments in Other Entities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails</Role>
      <ShortName>Investments in Other Entities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954729 - Disclosure - Loan Receivable and Loan Receivable ??? Related Parties - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails</Role>
      <ShortName>Loan Receivable and Loan Receivable ??? Related Parties - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954730 - Disclosure - Accounts Payable and Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails</Role>
      <ShortName>Accounts Payable and Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/AccountsPayableandAccruedExpensesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954731 - Disclosure - Medical Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/MedicalLiabilitiesDetails</Role>
      <ShortName>Medical Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/MedicalLiabilitiesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954732 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954733 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954734 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954735 - Disclosure - Mezzanine and Stockholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Mezzanine and Stockholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954736 - Disclosure - Stock-Based Compensation - Schedule of Share-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Share-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954737 - Disclosure - Stock-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954738 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Transactions Under Stock Option Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Stock Option Transactions Under Stock Option Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954739 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954740 - Disclosure - Related-Party Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails</Role>
      <ShortName>Related-Party Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954741 - Disclosure - Related-Party Transactions - Schedule of Fees Incurred and Revenue Earned from Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails</Role>
      <ShortName>Related-Party Transactions - Schedule of Fees Incurred and Revenue Earned from Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954742 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9954743 - Disclosure - Earnings Per Share - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails</Role>
      <ShortName>Earnings Per Share - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9954744 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share Computations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails</Role>
      <ShortName>Earnings Per Share - Schedule of Earnings Per Share Computations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9954745 - Disclosure - Earnings Per Share - Schedule of Shares Included in the Diluted Earnings Per Share Computations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails</Role>
      <ShortName>Earnings Per Share - Schedule of Shares Included in the Diluted Earnings Per Share Computations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9954746 - Disclosure - Variable Interest Entities (VIEs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails</Role>
      <ShortName>Variable Interest Entities (VIEs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/VariableInterestEntitiesVIEsTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9954747 - Disclosure - Leases - Additional information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LeasesAdditionalinformationDetails</Role>
      <ShortName>Leases - Additional information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9954748 - Disclosure - Leases - Schedule of Components of Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails</Role>
      <ShortName>Leases - Schedule of Components of Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9954749 - Disclosure - Leases - Schedule of Other Information Related to Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails</Role>
      <ShortName>Leases - Schedule of Other Information Related to Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9954750 - Disclosure - Leases - Schedule of Future Minimum Payments Under Non-cancelable Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails</Role>
      <ShortName>Leases - Schedule of Future Minimum Payments Under Non-cancelable Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9954751 - Disclosure - Segments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/SegmentsNarrativeDetails</Role>
      <ShortName>Segments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9954752 - Disclosure - Segments - Schedule of Information about our Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails</Role>
      <ShortName>Segments - Schedule of Information about our Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="ameh-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9954753 - Disclosure - Subsequent Events - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails</Role>
      <ShortName>Subsequent Events - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="ameh-20230630.htm">ameh-20230630.htm</File>
    <File>ameh-20230630.xsd</File>
    <File>ameh-20230630_cal.xml</File>
    <File>ameh-20230630_def.xml</File>
    <File>ameh-20230630_lab.xml</File>
    <File>ameh-20230630_pre.xml</File>
    <File>ameh-nonqualifieddeferre.htm</File>
    <File>ex3112023063010-q.htm</File>
    <File>ex3122023063010-q.htm</File>
    <File>ex3132023063010-q.htm</File>
    <File>ex322023063010-q.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ameh-20230630_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1439">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>118
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ameh-20230630.htm": {
   "axisCustom": 0,
   "axisStandard": 37,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 1439,
    "http://xbrl.sec.gov/dei/2023": 29,
    "http://xbrl.sec.gov/ecd/2023": 4
   },
   "contextCount": 547,
   "dts": {
    "calculationLink": {
     "local": [
      "ameh-20230630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ameh-20230630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ameh-20230630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ameh-20230630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ameh-20230630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ameh-20230630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    }
   },
   "elementCount": 813,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 5,
    "total": 5
   },
   "keyCustom": 57,
   "keyStandard": 361,
   "memberCustom": 80,
   "memberStandard": 52,
   "nsprefix": "ameh",
   "nsuri": "http://www.apollomed.net/20230630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.apollomed.net/role/Coverpage",
     "shortName": "Cover page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Intangible Assets, Net",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.apollomed.net/role/IntangibleAssetsNet",
     "shortName": "Intangible Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ameh:EquityMethodAndOtherEquityInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Investments in Other Entities",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.apollomed.net/role/InvestmentsinOtherEntities",
     "shortName": "Investments in Other Entities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ameh:EquityMethodAndOtherEquityInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ameh:LoanReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Loan Receivable and Loan Receivable \u2013 Related Parties",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedParties",
     "shortName": "Loan Receivable and Loan Receivable \u2013 Related Parties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ameh:LoanReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Accounts Payable and Accrued Expenses",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.apollomed.net/role/AccountsPayableandAccruedExpenses",
     "shortName": "Accounts Payable and Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Medical Liabilities",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.apollomed.net/role/MedicalLiabilities",
     "shortName": "Medical Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCredit",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Mezzanine and Stockholders' Equity",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.apollomed.net/role/MezzanineandStockholdersEquity",
     "shortName": "Mezzanine and Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Stock-Based Compensation",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.apollomed.net/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.apollomed.net/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Related-Party Transactions",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.apollomed.net/role/RelatedPartyTransactions",
     "shortName": "Related-Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.apollomed.net/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Earnings Per Share",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.apollomed.net/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Variable Interest Entities (VIEs)",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.apollomed.net/role/VariableInterestEntitiesVIEs",
     "shortName": "Variable Interest Entities (VIEs)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.apollomed.net/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Segments",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.apollomed.net/role/Segments",
     "shortName": "Segments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.apollomed.net/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "shortName": "Pay vs Performance Disclosure",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "shortName": "Insider Trading Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954701 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "28",
     "role": "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954702 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954703 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillTables",
     "shortName": "Business Combinations, Asset Acquisitions, and Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954704 - Disclosure - Intangible Assets, Net (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.apollomed.net/role/IntangibleAssetsNetTables",
     "shortName": "Intangible Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954705 - Disclosure - Investments in Other Entities (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.apollomed.net/role/InvestmentsinOtherEntitiesTables",
     "shortName": "Investments in Other Entities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954706 - Disclosure - Accounts Payable and Accrued Expenses (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesTables",
     "shortName": "Accounts Payable and Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954707 - Disclosure - Medical Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.apollomed.net/role/MedicalLiabilitiesTables",
     "shortName": "Medical Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954708 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditTables",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954709 - Disclosure - Stock-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.apollomed.net/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954710 - Disclosure - Related-Party Transactions (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.apollomed.net/role/RelatedPartyTransactionsTables",
     "shortName": "Related-Party Transactions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954711 - Disclosure - Earnings Per Share (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.apollomed.net/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954712 - Disclosure - Variable Interest Entities (VIEs) (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.apollomed.net/role/VariableInterestEntitiesVIEsTables",
     "shortName": "Variable Interest Entities (VIEs) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954713 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.apollomed.net/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954714 - Disclosure - Segments (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.apollomed.net/role/SegmentsTables",
     "shortName": "Segments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-47",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954715 - Disclosure - Description of Business - Additional Information (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails",
     "shortName": "Description of Business - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-98",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-47",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954716 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashUninsuredAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954717 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Gain (Loss) on Securities (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Gain (Loss) on Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954718 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Each Payor Type (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Each Payor Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-107",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-123",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954719 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Contributions to Revenue and Receivables by Payor (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Contributions to Revenue and Receivables by Payor (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-123",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954720 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954721 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-200",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ameh:NumberOfPrimaryCareClinics",
      "reportCount": 1,
      "unique": true,
      "unitRef": "clinic",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954722 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill - Additional Information (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails",
     "shortName": "Business Combinations, Asset Acquisitions, and Goodwill - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-200",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ameh:NumberOfPrimaryCareClinics",
      "reportCount": 1,
      "unique": true,
      "unitRef": "clinic",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-66",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS' EQUITY",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-72",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityNetIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954723 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill - Schedule of Goodwill (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillScheduleofGoodwillDetails",
     "shortName": "Business Combinations, Asset Acquisitions, and Goodwill - Schedule of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954724 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
     "shortName": "Intangible Assets, Net - Schedule of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954725 - Disclosure - Intangible Assets, Net - Additional Information (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails",
     "shortName": "Intangible Assets, Net - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954726 - Disclosure - Intangible Assets, Net - Schedule of Future Amortization Expense (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails",
     "shortName": "Intangible Assets, Net - Schedule of Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-55",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954727 - Disclosure - Investments in Other Entities - Schedule of Equity Method Investments (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails",
     "shortName": "Investments in Other Entities - Schedule of Equity Method Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "lang": "en-US",
      "name": "ameh:EquityMethodInvestmentAdditionalInvestment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954728 - Disclosure - Investments in Other Entities - Additional Information (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
     "shortName": "Investments in Other Entities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EquityMethodInvestmentOwnershipPercentage",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-287",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954729 - Disclosure - Loan Receivable and Loan Receivable \u2013 Related Parties - Additional Information (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails",
     "shortName": "Loan Receivable and Loan Receivable \u2013 Related Parties - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-284",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NotesReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954730 - Disclosure - Accounts Payable and Accrued Expenses (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails",
     "shortName": "Accounts Payable and Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954731 - Disclosure - Medical Liabilities (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.apollomed.net/role/MedicalLiabilitiesDetails",
     "shortName": "Medical Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954732 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954733 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954734 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Additional Information (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-316",
      "decimals": "INF",
      "lang": "en-US",
      "name": "ameh:DebtInstrumentCovenantDebtCoverageRatioMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ameh:StockIssuedDuringPeriodSharesMerger",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954735 - Disclosure - Mezzanine and Stockholders' Equity - Additional Information (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails",
     "shortName": "Mezzanine and Stockholders' Equity - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ameh:StockIssuedDuringPeriodSharesMerger",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954736 - Disclosure - Stock-Based Compensation - Schedule of Share-Based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.apollomed.net/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails",
     "shortName": "Stock-Based Compensation - Schedule of Share-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954737 - Disclosure - Stock-Based Compensation - Additional Information (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
     "shortName": "Stock-Based Compensation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954738 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Transactions Under Stock Option Plans (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails",
     "shortName": "Stock-Based Compensation - Schedule of Stock Option Transactions Under Stock Option Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954739 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-365",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954740 - Disclosure - Related-Party Transactions - Additional Information (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
     "shortName": "Related-Party Transactions - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-405",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsForRepurchaseOfCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-424",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954741 - Disclosure - Related-Party Transactions - Schedule of Fees Incurred and Revenue Earned from Related Party Transactions (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails",
     "shortName": "Related-Party Transactions - Schedule of Fees Incurred and Revenue Earned from Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-424",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954742 - Disclosure - Income Taxes - Additional Information (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - Description of Business",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.apollomed.net/role/DescriptionofBusiness",
     "shortName": "Description of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-443",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954743 - Disclosure - Earnings Per Share - Additional Information (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
     "shortName": "Earnings Per Share - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-443",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareBasic",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954744 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share Computations (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.apollomed.net/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails",
     "shortName": "Earnings Per Share - Schedule of Earnings Per Share Computations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954745 - Disclosure - Earnings Per Share - Schedule of Shares Included in the Diluted Earnings Per Share Computations (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails",
     "shortName": "Earnings Per Share - Schedule of Shares Included in the Diluted Earnings Per Share Computations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954746 - Disclosure - Variable Interest Entities (VIEs) (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails",
     "shortName": "Variable Interest Entities (VIEs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-457",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954747 - Disclosure - Leases - Additional information (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.apollomed.net/role/LeasesAdditionalinformationDetails",
     "shortName": "Leases - Additional information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954748 - Disclosure - Leases - Schedule of Components of Lease Expense (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails",
     "shortName": "Leases - Schedule of Components of Lease Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954749 - Disclosure - Leases - Schedule of Other Information Related to Leases (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.apollomed.net/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails",
     "shortName": "Leases - Schedule of Other Information Related to Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954750 - Disclosure - Leases - Schedule of Future Minimum Payments Under Non-cancelable Leases (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails",
     "shortName": "Leases - Schedule of Future Minimum Payments Under Non-cancelable Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-47",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954751 - Disclosure - Segments - Narrative (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.apollomed.net/role/SegmentsNarrativeDetails",
     "shortName": "Segments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954752 - Disclosure - Segments - Schedule of Information about our Segments (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails",
     "shortName": "Segments - Schedule of Information about our Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-36",
      "decimals": "-3",
      "lang": "en-US",
      "name": "ameh:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-545",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ameh:NumberOfPrimaryCareProvider",
      "reportCount": 1,
      "unique": true,
      "unitRef": "careprovider",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954753 - Disclosure - Subsequent Events - Additional Information (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails",
     "shortName": "Subsequent Events - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-545",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ameh:NumberOfPrimaryCareProvider",
      "reportCount": 1,
      "unique": true,
      "unitRef": "careprovider",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwill",
     "shortName": "Business Combinations, Asset Acquisitions, and Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ameh-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 150,
   "tag": {
    "ameh_A120HellmanLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "120 Hellman LLC",
        "label": "120 Hellman LLC [Member]",
        "terseLabel": "120 Hellman LLC"
       }
      }
     },
     "localname": "A120HellmanLLCMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_AAMGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AAMG",
        "label": "AAMG [Member]",
        "terseLabel": "AAMG"
       }
      }
     },
     "localname": "AAMGMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails",
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_AHMCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AHMC [Member]",
        "terseLabel": "AHMC",
        "verboseLabel": "AHMC"
       }
      }
     },
     "localname": "AHMCMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_AMGPropertiesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AMG Properties LLC",
        "label": "AMG Properties LLC [Member]",
        "terseLabel": "AMG Properties LLC"
       }
      }
     },
     "localname": "AMGPropertiesLLCMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_APAMH2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AP-AMH 2",
        "label": "AP-AMH 2 [Member]",
        "terseLabel": "AP-AMH 2"
       }
      }
     },
     "localname": "APAMH2Member",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_APCMGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "APCMG",
        "label": "APCMG [Member]",
        "terseLabel": "APCMG"
       }
      }
     },
     "localname": "APCMGMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_AccountsReceivableAndNetRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable And Net Revenue [Line Items]",
        "terseLabel": "Accounts Receivable And Net Revenue [Line Items]"
       }
      }
     },
     "localname": "AccountsReceivableAndNetRevenueLineItems",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_AccountsReceivableAndNetRevenueTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable And Net Revenue [Table]",
        "terseLabel": "Accounts Receivable And Net Revenue [Table]"
       }
      }
     },
     "localname": "AccountsReceivableAndNetRevenueTable",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_AdvanceDiagnosticSurgeryCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advance Diagnostic Surgery Center [Member]",
        "terseLabel": "Advance Diagnostic Surgery Center"
       }
      }
     },
     "localname": "AdvanceDiagnosticSurgeryCenterMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_AlliedPacificOfCaliforniaIPAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allied Pacific Of California IPA",
        "label": "Allied Pacific Of California IPA [Member]",
        "terseLabel": "Allied Pacific Of California IPA",
        "verboseLabel": "APC"
       }
      }
     },
     "localname": "AlliedPacificOfCaliforniaIPAMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails",
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_AlphaCareMedicalGroupInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alpha Care Medical Group, Inc. [Member]",
        "label": "Alpha Care Medical Group, Inc. [Member]",
        "terseLabel": "Alpha Care Medical Group, Inc."
       }
      }
     },
     "localname": "AlphaCareMedicalGroupInc.Member",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_AmendedCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended Credit Agreement",
        "label": "Amended Credit Agreement [Member]",
        "terseLabel": "Amended Credit Agreement"
       }
      }
     },
     "localname": "AmendedCreditAgreementMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_AmgIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AMG, Inc [Member]",
        "terseLabel": "AMG, Inc"
       }
      }
     },
     "localname": "AmgIncMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_ApcBusinessLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "APC Business Loan Agreement [Member]",
        "terseLabel": "APC Business Loan Agreement"
       }
      }
     },
     "localname": "ApcBusinessLoanAgreementMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_ApcLsmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "APC LSMA [Member]",
        "terseLabel": "APC LSMA"
       }
      }
     },
     "localname": "ApcLsmaMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_ApcShareholdersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "APC Shareholders [Member]",
        "terseLabel": "APC Shareholders"
       }
      }
     },
     "localname": "ApcShareholdersMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_ApcStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "APC Stock Option [Member]",
        "terseLabel": "APC Stock Option"
       }
      }
     },
     "localname": "ApcStockOptionMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_ApolloSunLabsManagementLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Apollo-Sun Labs Management, LLC",
        "label": "Apollo-Sun Labs Management, LLC [Member]",
        "terseLabel": "Apollo-Sun Labs Management, LLC",
        "verboseLabel": "Sun Labs"
       }
      }
     },
     "localname": "ApolloSunLabsManagementLLCMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails",
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_ArroyoVistaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arroyo Vista",
        "label": "Arroyo Vista [Member]",
        "terseLabel": "Arroyo Vista"
       }
      }
     },
     "localname": "ArroyoVistaMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_AssetAcquisitionPercentageOfSharesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Percentage Of Shares Acquired",
        "label": "Asset Acquisition, Percentage Of Shares Acquired",
        "terseLabel": "Asset acquisition, percentage of shares acquired"
       }
      }
     },
     "localname": "AssetAcquisitionPercentageOfSharesAcquired",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ameh_AurionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "xxx_Aurion Member",
        "label": "Aurion [Member]",
        "verboseLabel": "Aurion"
       }
      }
     },
     "localname": "AurionMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_BoardMembersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Board Members",
        "label": "Board Members [Member]",
        "terseLabel": "Board Members"
       }
      }
     },
     "localname": "BoardMembersMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_BoardMembersWhoAreAlsoOfficersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Board Members Who Are Also Officers",
        "label": "Board Members Who Are Also Officers [Member]",
        "terseLabel": "Board Members Who Are Also Officers"
       }
      }
     },
     "localname": "BoardMembersWhoAreAlsoOfficersMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Change in Fair Value Of Equity Interest Purchase Obligation",
        "label": "Business Combination, Change in Fair Value Of Equity Interest Purchase Obligation",
        "terseLabel": "Change in fair value of equity interest"
       }
      }
     },
     "localname": "BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinancialLiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Equity Interest Purchase Obligation, Noncurrent",
        "label": "Business Combination, Equity Interest Purchase Obligation, Noncurrent",
        "terseLabel": "Equity interest purchase obligation, noncurrent",
        "verboseLabel": "Remaining equity interest purchase"
       }
      }
     },
     "localname": "BusinessCombinationEquityInterestPurchaseObligationNoncurrent",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails",
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Equity Interest Purchase Obligation, Period to Purchase",
        "label": "Business Combination, Equity Interest Purchase Obligation, Period to Purchase",
        "terseLabel": "Equity interest purchase obligation, period to purchase"
       }
      }
     },
     "localname": "BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ameh_CAIPAMSOLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CAIPA MSO, LLC",
        "label": "CAIPA MSO, LLC [Member]",
        "terseLabel": "CAIPA MSO, LLC"
       }
      }
     },
     "localname": "CAIPAMSOLLCMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_CDSCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CDSC",
        "label": "CDSC [Member]",
        "terseLabel": "CDSC"
       }
      }
     },
     "localname": "CDSCMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_CareDeliveryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Care Delivery",
        "label": "Care Delivery [Member]",
        "terseLabel": "Care Delivery"
       }
      }
     },
     "localname": "CareDeliveryMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_CareEnablementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Care Enablement",
        "label": "Care Enablement [Member]",
        "terseLabel": "Care Enablement"
       }
      }
     },
     "localname": "CareEnablementMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_CarePartnersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Care Partners",
        "label": "Care Partners [Member]",
        "terseLabel": "Care Partners"
       }
      }
     },
     "localname": "CarePartnersMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_CashPaidForLeaseLiabilitiesAbstractAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid For Lease Liabilities [Abstract]",
        "verboseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashPaidForLeaseLiabilitiesAbstractAbstract",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_CollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collar",
        "label": "Collar [Member]",
        "terseLabel": "Interest rate collar"
       }
      }
     },
     "localname": "CollarMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_CommercialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ameh:CommercialMember",
        "label": "Commercial [Member]",
        "terseLabel": "Commercial"
       }
      }
     },
     "localname": "CommercialMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_ConstructionLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Construction Loan",
        "label": "Construction Loan [Member]",
        "terseLabel": "Construction Loans",
        "verboseLabel": "Construction Loan"
       }
      }
     },
     "localname": "ConstructionLoanMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_ContingentEquitySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Equity Securities",
        "label": "Contingent Equity Securities [Member]",
        "terseLabel": "Contingent equity securities",
        "verboseLabel": "Contingent equity securities"
       }
      }
     },
     "localname": "ContingentEquitySecuritiesMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement [Member]",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_DMGAndSunLabsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DMG And Sun Labs",
        "label": "DMG And Sun Labs [Member]",
        "terseLabel": "DMG And Sun Labs"
       }
      }
     },
     "localname": "DMGAndSunLabsMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_DebtCovenantAggregatePurchasePriceMaximum": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant, Aggregate Purchase Price, Maximum",
        "label": "Debt Covenant, Aggregate Purchase Price, Maximum",
        "terseLabel": "Debt covenant, aggregate purchase price, maximum"
       }
      }
     },
     "localname": "DebtCovenantAggregatePurchasePriceMaximum",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_DebtCovenantThresholdPercentageForOccupationOfProperty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant, Threshold Percentage for Occupation of Property",
        "label": "Debt Covenant, Threshold Percentage for Occupation of Property",
        "terseLabel": "Debt covenant, threshold percentage for occupation of property"
       }
      }
     },
     "localname": "DebtCovenantThresholdPercentageForOccupationOfProperty",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ameh_DebtInstrumentCovenantCashFlowCoverageRatioMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Cash Flow Coverage Ratio, Minimum",
        "label": "Debt Instrument, Covenant, Cash Flow Coverage Ratio, Minimum",
        "terseLabel": "Debt instrument, covenant, cash flow coverage ratio, minimum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantCashFlowCoverageRatioMinimum",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ameh_DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Cash Flow To Debt Service Ratio, Minimum",
        "label": "Debt Instrument, Covenant, Cash Flow To Debt Service Ratio, Minimum",
        "terseLabel": "Debt instrument, covenant, cash flow to debt service ratio, minimum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantCashFlowToDebtServiceRatioMinimum",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ameh_DebtInstrumentCovenantDebtCoverageRatioMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Debt Coverage Ratio, Minimum",
        "label": "Debt Instrument, Covenant, Debt Coverage Ratio, Minimum",
        "terseLabel": "Debt instrument, covenant, debt coverage ratio, minimum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantDebtCoverageRatioMinimum",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ameh_DebtInstrumentCovenantInterestCoverageRatioMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Interest Coverage Ratio, Minimum",
        "label": "Debt Instrument, Covenant, Interest Coverage Ratio, Minimum",
        "terseLabel": "Minimum consolidated interest coverage ratio (not less than)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantInterestCoverageRatioMinimum",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ameh_DebtInstrumentCovenantLeverageRatioAdjustedMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Adjusted Maximum",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Adjusted Maximum",
        "terseLabel": "Debt instrument, covenant, leverage ratio, adjusted maximum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatioAdjustedMaximum",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ameh_DebtInstrumentCovenantLeverageRatioIncrementalChange": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Incremental Change",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Incremental Change",
        "terseLabel": "Consolidated leverage ratio, annual decrease"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatioIncrementalChange",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ameh_DebtInstrumentCovenantLeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "terseLabel": "Maximum consolidated leverage ratio (not greater than)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatioMaximum",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ameh_DebtInstrumentNumberOfKeyFinancialRatios": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number Of Key Financial Ratios",
        "label": "Debt Instrument, Number Of Key Financial Ratios",
        "terseLabel": "Number of key financial ratios"
       }
      }
     },
     "localname": "DebtInstrumentNumberOfKeyFinancialRatios",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ameh_DerivativeCeilingInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Ceiling Interest Rate",
        "label": "Derivative Ceiling Interest Rate",
        "terseLabel": "Derivative, ceiling interest rate"
       }
      }
     },
     "localname": "DerivativeCeilingInterestRate",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ameh_DescriptionOfBusinessLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description Of Business [Line Items]",
        "terseLabel": "Description Of Business [Line Items]"
       }
      }
     },
     "localname": "DescriptionOfBusinessLineItems",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_DescriptionOfBusinessTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description Of Business [Table]",
        "terseLabel": "Description Of Business [Table]"
       }
      }
     },
     "localname": "DescriptionOfBusinessTable",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_DiagnosticAndSurgicalCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostic and Surgical Center",
        "label": "Diagnostic and Surgical Center [Member]",
        "terseLabel": "Diagnostic and Surgical Center"
       }
      }
     },
     "localname": "DiagnosticAndSurgicalCenterMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_DmgMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DMG [Member]",
        "terseLabel": "DMG"
       }
      }
     },
     "localname": "DmgMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails",
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_EarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Earnings Per Share [Table]",
        "label": "Earnings Per Share [Line Items]",
        "terseLabel": "Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareLineItems",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_EarningsPerShareTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share [Table]",
        "label": "Earnings Per Share [Table]",
        "terseLabel": "Earnings Per Share [Table]"
       }
      }
     },
     "localname": "EarningsPerShareTable",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_EquityMethodAndOtherEquityInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method And Other Equity Investments [Text Block]",
        "label": "Equity Method And Other Equity Investments [Text Block]",
        "verboseLabel": "Investments in Other Entities"
       }
      }
     },
     "localname": "EquityMethodAndOtherEquityInvestmentsTextBlock",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ameh_EquityMethodInvestmentAdditionalInvestment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Additional Investment",
        "label": "Equity Method Investment, Additional Investment",
        "terseLabel": "Initial Investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentAdditionalInvestment",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Funding Reclassified to Loan Receivable",
        "label": "Equity Method Investment, Funding Reclassified to Loan Receivable",
        "negatedTerseLabel": "Funding Reclassified To Loan Receivable"
       }
      }
     },
     "localname": "EquityMethodInvestmentFundingReclassifiedToLoanReceivable",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_EquityMethodInvestmentsContribution": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments, Contribution",
        "label": "Equity Method Investments, Contribution",
        "terseLabel": "Funding"
       }
      }
     },
     "localname": "EquityMethodInvestmentsContribution",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_EquityMethodInvestmentsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments [Roll Forward]",
        "label": "Equity Method Investments [Roll Forward]",
        "terseLabel": "Equity Method Investments [Roll Forward]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsRollForward",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_FeesIncurredAndIncomeRecognizedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fees Incurred and Income Recognized",
        "label": "Fees Incurred and Income Recognized [Member]",
        "terseLabel": "Fees Incurred and Income Recognized"
       }
      }
     },
     "localname": "FeesIncurredAndIncomeRecognizedMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_FiduciaryAccountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fiduciary accounts payable, due after one year or beyond the normal operating cycle, if longer.",
        "label": "Fiduciary Accounts Payable Current",
        "terseLabel": "Fiduciary accounts payable",
        "verboseLabel": "Fiduciary accounts payable"
       }
      }
     },
     "localname": "FiduciaryAccountsPayableCurrent",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_FinanceLeaseCostsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Costs",
        "label": "Finance Lease Costs [Abstract]",
        "terseLabel": "Finance lease cost"
       }
      }
     },
     "localname": "FinanceLeaseCostsAbstract",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_FinanceLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, To Be Paid, After Year Four",
        "label": "Finance Lease, Liability, To Be Paid, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_FinanceReceivableInterestRateStatedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Receivable, Interest Rate, Stated Percentage",
        "label": "Finance Receivable, Interest Rate, Stated Percentage",
        "terseLabel": "Note receivable, interest rate"
       }
      }
     },
     "localname": "FinanceReceivableInterestRateStatedPercentage",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ameh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_FiveThreeOneW.CollegeLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Five Three One W. College LLC [Member]",
        "verboseLabel": "531 W. College, LLC"
       }
      }
     },
     "localname": "FiveThreeOneW.CollegeLLCMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_ForYourBenefitIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For Your Benefit Inc.",
        "label": "For Your Benefit Inc. [Member]",
        "terseLabel": "For Your Benefit Inc. (FYB)"
       }
      }
     },
     "localname": "ForYourBenefitIncMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_FulgentGeneticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fulgent Genetics, Inc.",
        "label": "Fulgent Genetics, Inc. [Member]",
        "terseLabel": "Fulgent Genetics, Inc."
       }
      }
     },
     "localname": "FulgentGeneticsIncMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General and Administrative Expenses and Depreciation and Amortization",
        "label": "General and Administrative Expenses and Depreciation and Amortization",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpensesAndDepreciationAndAmortization",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_HSMSOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "xxx_HSMSO Member",
        "label": "HSMSO [Member]",
        "verboseLabel": "HSMSO"
       }
      }
     },
     "localname": "HSMSOMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_HealthCareCapitationRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ameh_HealthCareCapitationRevenueMember",
        "label": "Health Care Capitation Revenue [Member]",
        "verboseLabel": "Capitation, net"
       }
      }
     },
     "localname": "HealthCareCapitationRevenueMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_IncreaseDecreaseInMedicalLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of medical liabilities.",
        "label": "Increase (Decrease) In Medical Liabilities",
        "verboseLabel": "Medical liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInMedicalLiabilities",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_IncreaseDecreaseInOperatingLeaseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents increase in operating lease assets.",
        "label": "Increase (Decrease) In Operating Lease Assets",
        "verboseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseAssets",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the value of prepaid expenses and other current assets.",
        "label": "Increase (Decrease) In Prepaid Expenses And Other Current Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_IntraCareConvertiblePromissoryNoteReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IntraCare Convertible Promissory Note Receivable",
        "label": "IntraCare Convertible Promissory Note Receivable [Member]",
        "terseLabel": "IntraCare Convertible Promissory Note Receivable"
       }
      }
     },
     "localname": "IntraCareConvertiblePromissoryNoteReceivableMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of Investment in privately held entity that does not report net asset value per share .",
        "label": "Investment In Privately Held Entity That Does Not Report Net Asset Value",
        "verboseLabel": "Investments in privately held entities"
       }
      }
     },
     "localname": "InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_JadeHealthCareMedicalGroupIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Jade Health Care Medical Group, Inc.",
        "label": "Jade Health Care Medical Group, Inc. [Member]",
        "terseLabel": "Jade Health Care Medical Group, Inc."
       }
      }
     },
     "localname": "JadeHealthCareMedicalGroupIncMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_JamesSongMDAProfessionalCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "James Song, M.D., A Professional Corporation",
        "label": "James Song, M.D., A Professional Corporation [Member]",
        "terseLabel": "James Song, M.D., A Professional Corporation"
       }
      }
     },
     "localname": "JamesSongMDAProfessionalCorporationMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_LasalleMedicalAssociatesIpaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LaSalle Medical Associates IPA [Member]",
        "terseLabel": "LaSalle Medical Associates \u2013 IPA Line of Business"
       }
      }
     },
     "localname": "LasalleMedicalAssociatesIpaMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_LeaseWeightedAverageDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Weighted Average Discount Rate [Abstract]",
        "verboseLabel": "Weighted Average Discount Rate"
       }
      }
     },
     "localname": "LeaseWeightedAverageDiscountRateAbstract",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_LeaseWeightedAverageRemainingLeaseTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Weighted Average Remaining Lease Term [Abstract]",
        "verboseLabel": "Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "LeaseWeightedAverageRemainingLeaseTermAbstract",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_LesseeFinanceLeaseTerminationPeriodIfApplicable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Finance Lease, Termination Period, If Applicable",
        "label": "Lessee, Finance Lease, Termination Period, If Applicable",
        "terseLabel": "Finance lease, termination period, if applicable"
       }
      }
     },
     "localname": "LesseeFinanceLeaseTerminationPeriodIfApplicable",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ameh_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four",
        "label": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_LesseeOperatingLeaseTerminationPeriodIfApplicable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Termination Period, If Applicable",
        "label": "Lessee, Operating Lease, Termination Period, If Applicable",
        "terseLabel": "Operating lease, termination period, if applicable"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTerminationPeriodIfApplicable",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ameh_LmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LMA [Member]",
        "terseLabel": "LMA"
       }
      }
     },
     "localname": "LmaMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_LoanReceivableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan Receivable",
        "label": "Loan Receivable [Text Block]",
        "verboseLabel": "Loan Receivable and Loan Receivable \u2013 Related Parties"
       }
      }
     },
     "localname": "LoanReceivableTextBlock",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedParties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ameh_LongTermDebtMaturityAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Maturity, After Year Four",
        "label": "Long-Term Debt, Maturity, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturityAfterYearFour",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MPP, AMG Properties, and ZLL, Tag 8, Tag 6 Asset Acquisition",
        "label": "MPP, AMG Properties, and ZLL, Tag 8, Tag 6 Asset Acquisition [Member]",
        "terseLabel": "MPP, AMG Properties, and ZLL Asset Acquisition"
       }
      }
     },
     "localname": "MPPAMGPropertiesAndZLLTag8Tag6AssetAcquisitionMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_ManagementContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management Contracts",
        "label": "Management Contracts [Member]",
        "verboseLabel": "Management contracts"
       }
      }
     },
     "localname": "ManagementContractsMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_MarketableSecuritiesCurrentMaturityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities, Current, Maturity Period",
        "label": "Marketable Securities, Current, Maturity Period",
        "terseLabel": "Short-term marketable securities, maturity period"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrentMaturityPeriod",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ameh_MedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ameh:MedicaidMember",
        "label": "Medicaid [Member]",
        "terseLabel": "Medicaid"
       }
      }
     },
     "localname": "MedicaidMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_MedicalCareCostsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Care Costs [Abstract]",
        "label": "Medical Care Costs [Abstract]",
        "terseLabel": "Components of medical care costs related to claims incurred:"
       }
      }
     },
     "localname": "MedicalCareCostsAbstract",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_MedicalPropertyPartnersLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Property Partners LLC",
        "label": "Medical Property Partners LLC [Member]",
        "terseLabel": "Medical Property Partners LLC"
       }
      }
     },
     "localname": "MedicalPropertyPartnersLLCMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_MedicareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ameh:MedicareMember",
        "label": "Medicare [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "MedicareMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_MemberRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Member Relationships",
        "label": "Member Relationships [Member]",
        "terseLabel": "Member relationships"
       }
      }
     },
     "localname": "MemberRelationshipsMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_MezzanineEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MEZZANINE EQUITY [Abstract]",
        "verboseLabel": "Mezzanine equity"
       }
      }
     },
     "localname": "MezzanineEquityAbstract",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_MezzanineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mezzanine [Member]",
        "terseLabel": "Mezzanine"
       }
      }
     },
     "localname": "MezzanineMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Including Portion Attributable To Noncontrolling Interest And Temporary Equity",
        "label": "Net Income (Loss), Including Portion Attributable To Noncontrolling Interest And Temporary Equity",
        "terseLabel": "Net (loss) income (restated)"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_NetworkMedicalManagementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Network Medical Management [Member]",
        "terseLabel": "NMM"
       }
      }
     },
     "localname": "NetworkMedicalManagementMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_NetworkRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Network Relationships",
        "label": "Network Relationships [Member]",
        "terseLabel": "Network relationships"
       }
      }
     },
     "localname": "NetworkRelationshipsMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Value, Release Of Hold Back Shares",
        "label": "Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Value, Release Of Hold Back Shares",
        "terseLabel": "Dividends"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_NumberOfPrimaryCareClinics": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Primary Care Clinics",
        "label": "Number of Primary Care Clinics",
        "terseLabel": "Number of primary care clinics"
       }
      }
     },
     "localname": "NumberOfPrimaryCareClinics",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ameh_NumberOfPrimaryCareProvider": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Primary Care Provider",
        "label": "Number Of Primary Care Provider",
        "terseLabel": "Number of primary care provider"
       }
      }
     },
     "localname": "NumberOfPrimaryCareProvider",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ameh_NumberOfPrimaryCareServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Primary Care Services",
        "label": "Number Of Primary Care Services",
        "terseLabel": "Number of medicare advantage patients"
       }
      }
     },
     "localname": "NumberOfPrimaryCareServices",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ameh_OfficeLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office Lease",
        "label": "Office Lease [Member]",
        "terseLabel": "Office Lease"
       }
      }
     },
     "localname": "OfficeLeaseMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_OneMSOInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One MSO, Inc. [Member]",
        "label": "One MSO, Inc. [Member]",
        "terseLabel": "One MSO, Inc."
       }
      }
     },
     "localname": "OneMSOInc.Member",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_OneMSOLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One MSO, LLC",
        "label": "One MSO, LLC [Member]",
        "terseLabel": "One MSO, LLC"
       }
      }
     },
     "localname": "OneMSOLLCMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Orma Health, Inc., and Provider Growth Solutions LLC",
        "label": "Orma Health, Inc., and Provider Growth Solutions LLC [Member]",
        "terseLabel": "Orma Health, Inc., and Provider Growth Solutions LLC"
       }
      }
     },
     "localname": "OrmaHealthIncAndProviderGrowthSolutionsLLCMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_OtherThirdPartiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ameh:OtherThirdPartiesMember",
        "label": "Other Third Parties [Member]",
        "terseLabel": "Other third parties"
       }
      }
     },
     "localname": "OtherThirdPartiesMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_Pacific6EnterprisesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pacific6 Enterprises [Member]",
        "label": "Pacific6 Enterprises [Member]",
        "terseLabel": "Pacific6 Enterprises"
       }
      }
     },
     "localname": "Pacific6EnterprisesMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_PacificMedicalImagingAndOncologyCenterIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pacific Medical Imaging and Oncology Center, Inc [Member]",
        "terseLabel": "Pacific Medical Imaging &amp; Oncology Center, Inc."
       }
      }
     },
     "localname": "PacificMedicalImagingAndOncologyCenterIncMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_PatientManagementPlatformMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient Management Platform",
        "label": "Patient Management Platform [Member]",
        "terseLabel": "Patient management platform"
       }
      }
     },
     "localname": "PatientManagementPlatformMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_PaymentsForMedicalCareCostsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Medical Care Costs [Abstract]",
        "label": "Payments For Medical Care Costs [Abstract]",
        "terseLabel": "Payments for medical care costs related to claims incurred:"
       }
      }
     },
     "localname": "PaymentsForMedicalCareCostsAbstract",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_PaymentsToEquityMethodInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Equity Method Investments",
        "label": "Payments to Equity Method Investments",
        "negatedLabel": "Contribution to investment - equity method"
       }
      }
     },
     "localname": "PaymentsToEquityMethodInvestments",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_PayorAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payor A [Member]",
        "label": "Payor A [Member]",
        "terseLabel": "Payor A"
       }
      }
     },
     "localname": "PayorAMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_PayorBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payor B [Member]",
        "label": "Payor B [Member]",
        "terseLabel": "Payor B"
       }
      }
     },
     "localname": "PayorBMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_PayorCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payor C [Member]",
        "label": "Payor C [Member]",
        "terseLabel": "Payor C"
       }
      }
     },
     "localname": "PayorCMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_PerformanceBasedRestrictedStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Based Restricted Stock",
        "label": "Performance Based Restricted Stock [Member]",
        "terseLabel": "Performance Based Restricted Stock"
       }
      }
     },
     "localname": "PerformanceBasedRestrictedStockMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_PmiocMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PMIOC [Member]",
        "terseLabel": "PMIOC"
       }
      }
     },
     "localname": "PmiocMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_PreferredBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Bank [Member]",
        "terseLabel": "Preferred Bank"
       }
      }
     },
     "localname": "PreferredBankMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_PromissoryNotesExpectedToBeCollectedWithinPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Promissory Notes Expected To Be Collected Within Period",
        "label": "Promissory Notes Expected To Be Collected Within Period",
        "terseLabel": "Promissory notes expected to be collected within period"
       }
      }
     },
     "localname": "PromissoryNotesExpectedToBeCollectedWithinPeriod",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ameh_ProviderServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provider Services",
        "label": "Provider Services [Member]",
        "terseLabel": "Provider Services"
       }
      }
     },
     "localname": "ProviderServicesMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_PurchaseOfNonControllingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of Non-Controlling Interest",
        "label": "Purchase of Non-Controlling Interest",
        "negatedTerseLabel": "Purchase of non-controlling interest"
       }
      }
     },
     "localname": "PurchaseOfNonControllingInterest",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Receivables and receivables from related parties.",
        "label": "Receivables, Receivables \u2013 Related Parties, Other Receivables And Loan Receivable - Related Party [Policy Text Block]",
        "verboseLabel": "Receivables, Receivables \u2013 Related Parties, Other Receivables and Loan Receivable - Related Party"
       }
      }
     },
     "localname": "ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivableRelatedPartyPolicyTextBlock",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation Of Cash Cash Equivalents And Restricted Cash",
        "label": "Reconciliation Of Cash Cash Equivalents And Restricted Cash [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_RentPaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rent Payment",
        "label": "Rent Payment [Member]",
        "terseLabel": "Rent Payment"
       }
      }
     },
     "localname": "RentPaymentMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk Pool Surplus Or Deficits, Settlement Period After Performance Year",
        "label": "Risk Pool Surplus Or Deficits, Settlement Period After Performance Year",
        "terseLabel": "Risk pool surplus or deficits, settlement period after risk pool performance year"
       }
      }
     },
     "localname": "RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ameh_SecuredOvernightFinancingRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Overnight Financing Rate",
        "label": "Secured Overnight Financing Rate [Member]",
        "terseLabel": "Secured Overnight Financing Rate"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Contingent on Performance",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Contingent on Performance",
        "terseLabel": "Contingent on performance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value (in millions)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Exercise Price [Abstract]",
        "verboseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based Compensation Arrangement By Share based Payment Award Warrants Exercises In Period",
        "label": "Share based Compensation Arrangement By Share based Payment Award Warrants Exercises In Period",
        "terseLabel": "Warrants exercised (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ameh_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share based Payment Award, Warrant Exercised, Exercise Price",
        "label": "Share-Based Compensation Arrangement By Share based Payment Award, Warrant Exercised, Exercise Price",
        "terseLabel": "Exercise price of warrants exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ameh_ShareholdersAndOfficersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders And Officers [Member]",
        "terseLabel": "APC Shareholders and Officers"
       }
      }
     },
     "localname": "ShareholdersAndOfficersMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_SongPCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Song PC",
        "label": "Song PC [Member]",
        "terseLabel": "Song PC"
       }
      }
     },
     "localname": "SongPCMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_SpecialtyCapitationPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of specialty capitation payable current.",
        "label": "Specialty Capitation Payable Current",
        "verboseLabel": "Capitation payable"
       }
      }
     },
     "localname": "SpecialtyCapitationPayableCurrent",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_StockAwardsAndUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Awards And Units",
        "label": "Stock Awards And Units [Member]",
        "terseLabel": "Restricted stock"
       }
      }
     },
     "localname": "StockAwardsAndUnitsMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_StockIssuedDuringPeriodSharesMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to merger.",
        "label": "Stock Issued During Period, Shares, Merger",
        "terseLabel": "Holdback shares not issued to former shareholders (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesMerger",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ameh_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents number of share issued exercise of option and warrants during the period",
        "label": "Stock issued during the period shares of exercise of option and warrants",
        "verboseLabel": "Shares issued for exercise of options and warrants (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "ameh_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents value of stock issued during the period",
        "label": "Stock issued during the period value of exercise of option and warrants",
        "verboseLabel": "Shares issued for exercise of options and warrants"
       }
      }
     },
     "localname": "StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_SubcontractorIPAPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subcontractor IPA Payable",
        "label": "Subcontractor IPA Payable",
        "verboseLabel": "Subcontractor IPA payable"
       }
      }
     },
     "localname": "SubcontractorIPAPayable",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_SubordinatedLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subordinated Loan Agreement",
        "label": "Subordinated Loan Agreement [Member]",
        "terseLabel": "Subordinated Loan Agreement"
       }
      }
     },
     "localname": "SubordinatedLoanAgreementMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Line Items]",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Table]",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ameh_SunnyVillageCareCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sunny Village Care Center",
        "label": "Sunny Village Care Center [Member]",
        "terseLabel": "Sunny Village Care Center"
       }
      }
     },
     "localname": "SunnyVillageCareCenterMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_Tag6MedicalInvestmentGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tag-6 Medical Investment Group, LLC",
        "label": "Tag-6 Medical Investment Group, LLC [Member]",
        "terseLabel": "Tag-6 Medical Investment Group, LLC"
       }
      }
     },
     "localname": "Tag6MedicalInvestmentGroupLLCMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_Tag8MedicalInvestmentGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tag-8 Medical Investment Group, LLC",
        "label": "Tag-8 Medical Investment Group, LLC [Member]",
        "terseLabel": "Tag-8 Medical Investment Group, LLC"
       }
      }
     },
     "localname": "Tag8MedicalInvestmentGroupLLCMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_TemporaryEquityDividendsImpact": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Dividends Impact",
        "label": "Temporary Equity, Dividends Impact",
        "terseLabel": "Tax impact from dividends"
       }
      }
     },
     "localname": "TemporaryEquityDividendsImpact",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_TemporaryEquityTransferOfCommonControlEntities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Transfer Of Common Control Entities",
        "label": "Temporary Equity, Transfer Of Common Control Entities",
        "terseLabel": "Transfer of common control entities (restated)"
       }
      }
     },
     "localname": "TemporaryEquityTransferOfCommonControlEntities",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_TransferOfCommonControlEntities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer of Common Control Entities",
        "label": "Transfer of Common Control Entities",
        "terseLabel": "Transfer of common control entities (restated)"
       }
      }
     },
     "localname": "TransferOfCommonControlEntities",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_TruistBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Truist Bank",
        "label": "Truist Bank [Member]",
        "terseLabel": "Truist Bank"
       }
      }
     },
     "localname": "TruistBankMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_UnrealizedGainLossFromInvestmentInEquitySecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrealized (Gain) Loss from Investment in Equity Securities",
        "label": "Unrealized (Gain) Loss from Investment in Equity Securities",
        "negatedLabel": "Unrealized loss on investments"
       }
      }
     },
     "localname": "UnrealizedGainLossFromInvestmentInEquitySecurities",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_VOMGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VOMG",
        "label": "VOMG [Member]",
        "terseLabel": "VOMG"
       }
      }
     },
     "localname": "VOMGMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ameh_WarrantIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant Issued During Period Value Stock Options Exercised",
        "label": "Warrant Issued During Period Value Stock Options Exercised",
        "terseLabel": "Proceeds from warrants exercised"
       }
      }
     },
     "localname": "WarrantIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ameh_ZLLPartnersLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZLL Partners LLC",
        "label": "ZLL Partners LLC [Member]",
        "terseLabel": "ZLL Partners LLC"
       }
      }
     },
     "localname": "ZLLPartnersLLCMember",
     "nsuri": "http://www.apollomed.net/20230630",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY",
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails",
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY",
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails",
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r903"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.apollomed.net/role/Coverpage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "auth_ref": [
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "localname": "Additional402vDisclosureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToCompAmt": {
     "auth_ref": [
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "localname": "AdjToCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AdjToCompAxis": {
     "auth_ref": [
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "localname": "AdjToCompAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "auth_ref": [
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "auth_ref": [
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "localname": "AdjToPeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AggtErrCompAmt": {
     "auth_ref": [
      "r910",
      "r921",
      "r931",
      "r956"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "AggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "auth_ref": [
      "r913",
      "r924",
      "r934",
      "r959"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AllAdjToCompMember": {
     "auth_ref": [
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "localname": "AllAdjToCompMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllExecutiveCategoriesMember": {
     "auth_ref": [
      "r952"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "localname": "AllExecutiveCategoriesMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllIndividualsMember": {
     "auth_ref": [
      "r917",
      "r925",
      "r935",
      "r952",
      "r960",
      "r964",
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "localname": "AllIndividualsMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllTradingArrangementsMember": {
     "auth_ref": [
      "r970"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "localname": "AllTradingArrangementsMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AwardExrcPrice": {
     "auth_ref": [
      "r967"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "localname": "AwardExrcPrice",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "perShareItemType"
    },
    "ecd_AwardGrantDateFairValue": {
     "auth_ref": [
      "r968"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "localname": "AwardGrantDateFairValue",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AwardTmgDiscLineItems": {
     "auth_ref": [
      "r963"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "localname": "AwardTmgDiscLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "auth_ref": [
      "r963"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AwardTmgMethodTextBlock": {
     "auth_ref": [
      "r963"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "localname": "AwardTmgMethodTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "auth_ref": [
      "r963"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "auth_ref": [
      "r963"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "localname": "AwardTmgMnpiDiscTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "auth_ref": [
      "r963"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "localname": "AwardTmgPredtrmndFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "auth_ref": [
      "r966"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "localname": "AwardUndrlygSecuritiesAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "auth_ref": [
      "r965"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "AwardsCloseToMnpiDiscIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "auth_ref": [
      "r964"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "localname": "AwardsCloseToMnpiDiscTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "auth_ref": [
      "r964"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "auth_ref": [
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "localname": "ChangedPeerGroupFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CoSelectedMeasureAmt": {
     "auth_ref": [
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "localname": "CoSelectedMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_CoSelectedMeasureName": {
     "auth_ref": [
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "localname": "CoSelectedMeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "auth_ref": [
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "auth_ref": [
      "r948"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "auth_ref": [
      "r950"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "auth_ref": [
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "auth_ref": [
      "r946"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "auth_ref": [
      "r910",
      "r921",
      "r931",
      "r956"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "localname": "ErrCompAnalysisTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompRecoveryTable": {
     "auth_ref": [
      "r907",
      "r918",
      "r928",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "localname": "ErrCompRecoveryTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ExecutiveCategoryAxis": {
     "auth_ref": [
      "r952"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "localname": "ExecutiveCategoryAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "auth_ref": [
      "r914",
      "r925",
      "r935",
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "auth_ref": [
      "r914",
      "r925",
      "r935",
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "auth_ref": [
      "r914",
      "r925",
      "r935",
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "auth_ref": [
      "r914",
      "r925",
      "r935",
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ForgoneRecoveryIndName": {
     "auth_ref": [
      "r914",
      "r925",
      "r935",
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "ForgoneRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_IndividualAxis": {
     "auth_ref": [
      "r917",
      "r925",
      "r935",
      "r952",
      "r960",
      "r964",
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "localname": "IndividualAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_InsiderTradingArrLineItems": {
     "auth_ref": [
      "r970"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "localname": "InsiderTradingArrLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "auth_ref": [
      "r906",
      "r976"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "localname": "InsiderTradingPoliciesProcLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "auth_ref": [
      "r906",
      "r976"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "auth_ref": [
      "r906",
      "r976"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_MeasureAxis": {
     "auth_ref": [
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "localname": "MeasureAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_MeasureName": {
     "auth_ref": [
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "MeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "auth_ref": [
      "r963"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "localname": "MnpiDiscTimedForCompValFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "auth_ref": [
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "auth_ref": [
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "auth_ref": [
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonNeosMember": {
     "auth_ref": [
      "r914",
      "r925",
      "r935",
      "r952",
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "localname": "NonNeosMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "auth_ref": [
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "auth_ref": [
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoMember": {
     "auth_ref": [
      "r952"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "localname": "NonPeoNeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "auth_ref": [
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "localname": "NonRule10b51ArrAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "auth_ref": [
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "localname": "NonRule10b51ArrTrmntdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_OtherPerfMeasureAmt": {
     "auth_ref": [
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "localname": "OtherPerfMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "auth_ref": [
      "r912",
      "r923",
      "r933",
      "r958"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "OutstandingAggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "auth_ref": [
      "r915",
      "r926",
      "r936",
      "r961"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "localname": "OutstandingRecoveryCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryIndName": {
     "auth_ref": [
      "r915",
      "r926",
      "r936",
      "r961"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "OutstandingRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "auth_ref": [
      "r940"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "localname": "PayVsPerformanceDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "auth_ref": [
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "localname": "PeerGroupIssuersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "auth_ref": [
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "auth_ref": [
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "localname": "PeoActuallyPaidCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoMember": {
     "auth_ref": [
      "r952"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "localname": "PeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_PeoName": {
     "auth_ref": [
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "localname": "PeoName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_PeoTotalCompAmt": {
     "auth_ref": [
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "localname": "PeoTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PvpTable": {
     "auth_ref": [
      "r940"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "localname": "PvpTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PvpTableTextBlock": {
     "auth_ref": [
      "r940"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "localname": "PvpTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "auth_ref": [
      "r907",
      "r918",
      "r928",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDateAxis": {
     "auth_ref": [
      "r908",
      "r919",
      "r929",
      "r954"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "localname": "RestatementDateAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDeterminationDate": {
     "auth_ref": [
      "r909",
      "r920",
      "r930",
      "r955"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "localname": "RestatementDeterminationDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "dateItemType"
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "auth_ref": [
      "r916",
      "r927",
      "r937",
      "r962"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "auth_ref": [
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "localname": "Rule10b51ArrAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "auth_ref": [
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "localname": "Rule10b51ArrTrmntdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "auth_ref": [
      "r911",
      "r922",
      "r932",
      "r957"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TabularListTableTextBlock": {
     "auth_ref": [
      "r951"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "localname": "TabularListTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TotalShareholderRtnAmt": {
     "auth_ref": [
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "localname": "TotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "auth_ref": [
      "r950"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TradingArrAxis": {
     "auth_ref": [
      "r970"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "localname": "TradingArrAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TradingArrByIndTable": {
     "auth_ref": [
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "localname": "TradingArrByIndTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrAdoptionDate": {
     "auth_ref": [
      "r973"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "localname": "TrdArrAdoptionDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrDuration": {
     "auth_ref": [
      "r974"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "localname": "TrdArrDuration",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "durationItemType"
    },
    "ecd_TrdArrIndName": {
     "auth_ref": [
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "TrdArrIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrIndTitle": {
     "auth_ref": [
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "localname": "TrdArrIndTitle",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "auth_ref": [
      "r975"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "sharesItemType"
    },
    "ecd_TrdArrTerminationDate": {
     "auth_ref": [
      "r973"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "localname": "TrdArrTerminationDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "auth_ref": [
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "localname": "UndrlygSecurityMktPriceChngPct",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "pureItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r253",
      "r553",
      "r554",
      "r557",
      "r558",
      "r614",
      "r844",
      "r1057",
      "r1060",
      "r1061"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r253",
      "r553",
      "r554",
      "r557",
      "r558",
      "r614",
      "r844",
      "r1057",
      "r1060",
      "r1061"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r253",
      "r298",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r321",
      "r325",
      "r409",
      "r410",
      "r411",
      "r412",
      "r414",
      "r415",
      "r417",
      "r419",
      "r420",
      "r1058",
      "r1059"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r253",
      "r298",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r321",
      "r325",
      "r409",
      "r410",
      "r411",
      "r412",
      "r414",
      "r415",
      "r417",
      "r419",
      "r420",
      "r1058",
      "r1059"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r250",
      "r251",
      "r426",
      "r455",
      "r612",
      "r852",
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r1028",
      "r1095"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Board members"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [
      "r365",
      "r366",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r330",
      "r871",
      "r1064",
      "r1089",
      "r1090"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails",
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r405",
      "r406",
      "r407",
      "r408",
      "r490",
      "r651",
      "r714",
      "r756",
      "r757",
      "r820",
      "r821",
      "r822",
      "r823",
      "r832",
      "r845",
      "r846",
      "r860",
      "r868",
      "r881",
      "r888",
      "r1062",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r405",
      "r406",
      "r407",
      "r408",
      "r490",
      "r651",
      "r714",
      "r756",
      "r757",
      "r820",
      "r821",
      "r822",
      "r823",
      "r832",
      "r845",
      "r846",
      "r860",
      "r868",
      "r881",
      "r888",
      "r1062",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r330",
      "r871",
      "r1064",
      "r1089",
      "r1090"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails",
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r327",
      "r652",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r849",
      "r869",
      "r887",
      "r984",
      "r1054",
      "r1055",
      "r1064",
      "r1089"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r327",
      "r652",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r849",
      "r869",
      "r887",
      "r984",
      "r1054",
      "r1055",
      "r1064",
      "r1089"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r405",
      "r406",
      "r407",
      "r408",
      "r482",
      "r490",
      "r517",
      "r518",
      "r519",
      "r624",
      "r651",
      "r714",
      "r756",
      "r757",
      "r820",
      "r821",
      "r822",
      "r823",
      "r832",
      "r845",
      "r846",
      "r860",
      "r868",
      "r881",
      "r888",
      "r891",
      "r1052",
      "r1062",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r405",
      "r406",
      "r407",
      "r408",
      "r482",
      "r490",
      "r517",
      "r518",
      "r519",
      "r624",
      "r651",
      "r714",
      "r756",
      "r757",
      "r820",
      "r821",
      "r822",
      "r823",
      "r832",
      "r845",
      "r846",
      "r860",
      "r868",
      "r881",
      "r888",
      "r891",
      "r1052",
      "r1062",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r250",
      "r251",
      "r426",
      "r455",
      "r612",
      "r853",
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r365",
      "r366",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r1028",
      "r1076"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses",
        "totalLabel": "Total accounts payable and accrued expenses",
        "verboseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accounts Payable and Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "verboseLabel": "Accounts payable and other accruals"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r842"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "verboseLabel": "Receivables and Receivables-Related Parties"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r331",
      "r332"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Receivables, net",
        "verboseLabel": "Receivables, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r140",
      "r184"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "verboseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r144",
      "r886",
      "r1096"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r525",
      "r526",
      "r527",
      "r736",
      "r1021",
      "r1022",
      "r1023",
      "r1069",
      "r1098"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "verboseLabel": "Additional Paid-in\u00a0Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r293",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "Other Segments"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r521",
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r153",
      "r444",
      "r586",
      "r1013"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance cost"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r9",
      "r66",
      "r71"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities not included in the calculation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r1068"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r1068"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r182",
      "r216",
      "r246",
      "r296",
      "r317",
      "r323",
      "r368",
      "r409",
      "r410",
      "r412",
      "r413",
      "r414",
      "r416",
      "r418",
      "r420",
      "r421",
      "r553",
      "r557",
      "r577",
      "r675",
      "r780",
      "r886",
      "r901",
      "r1058",
      "r1059",
      "r1078"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r210",
      "r225",
      "r246",
      "r368",
      "r409",
      "r410",
      "r412",
      "r413",
      "r414",
      "r416",
      "r418",
      "r420",
      "r421",
      "r553",
      "r557",
      "r577",
      "r886",
      "r1058",
      "r1059",
      "r1078"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets",
        "verboseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r246",
      "r368",
      "r409",
      "r410",
      "r412",
      "r413",
      "r414",
      "r416",
      "r418",
      "r420",
      "r421",
      "r553",
      "r557",
      "r577",
      "r1058",
      "r1059",
      "r1078"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Non-current assets",
        "verboseLabel": "Non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r335",
      "r377",
      "r668",
      "r1029"
     ],
     "calculation": {
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Marketable securities \u2013 certificates of deposit",
        "verboseLabel": "Marketable securities \u2013 certificates of deposit"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r110",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BridgeLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing which is expected to be replaced by a medium to long-term loan. The loan \"bridges\" the gap in time when otherwise no financing would be in place.",
        "label": "Bridge Loan [Member]",
        "terseLabel": "Bridge Loan"
       }
      }
     },
     "localname": "BridgeLoanMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r549",
      "r879",
      "r880"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails",
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r87",
      "r89",
      "r549",
      "r879",
      "r880"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails",
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Interest acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails",
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r4",
      "r91",
      "r551"
     ],
     "calculation": {
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinancialLiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Cash contingent consideration",
        "verboseLabel": "Business combination, contingent consideration, liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails",
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r176",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations, Asset Acquisitions, and Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r135",
      "r163",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "verboseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r47",
      "r212",
      "r850"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r47",
      "r160",
      "r243"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents end of period",
        "periodStartLabel": "Cash and cash equivalents beginning of period",
        "totalLabel": "Total cash, cash equivalents, and restricted cash shown in the statement of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r5",
      "r160"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash flow hedges:"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "verboseLabel": "Supplemental disclosures of non-cash investing and financing activities"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashUninsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash, Uninsured Amount",
        "terseLabel": "Amount deposit accounts exceeded FDIC insured limit"
       }
      }
     },
     "localname": "CashUninsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r13",
      "r893",
      "r894",
      "r895",
      "r898"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of Deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r205",
      "r220",
      "r221",
      "r222",
      "r246",
      "r270",
      "r273",
      "r282",
      "r284",
      "r290",
      "r291",
      "r368",
      "r409",
      "r412",
      "r413",
      "r414",
      "r420",
      "r421",
      "r453",
      "r454",
      "r457",
      "r460",
      "r467",
      "r577",
      "r723",
      "r724",
      "r725",
      "r726",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r766",
      "r789",
      "r812",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r978",
      "r1015",
      "r1024"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [
      "r220",
      "r221",
      "r222",
      "r290",
      "r453",
      "r454",
      "r455",
      "r457",
      "r460",
      "r465",
      "r467",
      "r723",
      "r724",
      "r725",
      "r726",
      "r868",
      "r978",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants outstanding (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r37",
      "r130",
      "r677",
      "r765"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "verboseLabel": "Commitments and contingencies (Note 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r169",
      "r403",
      "r404",
      "r843",
      "r1053"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r889",
      "r890",
      "r891",
      "r893",
      "r894",
      "r895",
      "r898",
      "r1021",
      "r1022",
      "r1069",
      "r1093",
      "r1098"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "verboseLabel": "Common\u00a0Stock\u00a0Outstanding"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r143",
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r15",
      "r143",
      "r766",
      "r786",
      "r1098",
      "r1099"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r143",
      "r679",
      "r886"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value per share; 100,000,000 shares authorized, 46,553,517 and 46,575,699 shares issued and outstanding, excluding 10,569,340 and 10,299,259 treasury shares, as of June\u00a030, 2023 and December\u00a031, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r55",
      "r57",
      "r120",
      "r121",
      "r330",
      "r842"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r55",
      "r57",
      "r120",
      "r121",
      "r330",
      "r720",
      "r842"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r55",
      "r57",
      "r120",
      "r121",
      "r330",
      "r842",
      "r981"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r133",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risks"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r55",
      "r57",
      "r120",
      "r121",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r55",
      "r57",
      "r120",
      "r121",
      "r330",
      "r842"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r95",
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r96",
      "r99",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionLoansMember": {
     "auth_ref": [
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A borrowing arrangement which provides the entity constructing a facility (such as a building and a landfill) with funds to effect construction, generally on a draw down, or as needed, basis.",
        "label": "Construction Loans [Member]",
        "terseLabel": "Construction Loans"
       }
      }
     },
     "localname": "ConstructionLoansMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r469",
      "r470",
      "r481"
     ],
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "verboseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r23",
      "r316",
      "r317",
      "r318",
      "r319",
      "r325",
      "r1027"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate Costs"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r985",
      "r986"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.",
        "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization",
        "terseLabel": "Cost of services, excluding depreciation and amortization",
        "verboseLabel": "Cost of services"
       }
      }
     },
     "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization": {
     "auth_ref": [
      "r1007"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.",
        "label": "Cost, Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total expenses",
        "verboseLabel": "Total expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r56",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r170",
      "r244",
      "r422",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r438",
      "r445",
      "r446",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Credit Facility, Bank Loans, and Lines of Credit"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCredit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r27",
      "r139",
      "r140",
      "r183",
      "r185",
      "r253",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r587",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r1016"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r27",
      "r185",
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Total debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r123",
      "r125",
      "r423",
      "r587",
      "r864",
      "r865"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt, principal sum"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r34",
      "r123",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Average effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r34",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on loan receivable",
        "verboseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [
      "r253",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r447",
      "r587",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r1016"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r35",
      "r253",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r587",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r1016"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r35",
      "r76",
      "r79",
      "r122",
      "r123",
      "r125",
      "r132",
      "r172",
      "r173",
      "r253",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r447",
      "r587",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r1016"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Revolving credit facility term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r124",
      "r434",
      "r450",
      "r864",
      "r865"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Less: Unamortized financing costs",
        "terseLabel": "Unamortized financing costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet": {
     "auth_ref": [
      "r26"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Line of Credit Arrangements, Net",
        "terseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DebtIssuanceCostsLineOfCreditArrangementsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCreditsAndOtherLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total carrying amount as of the balance sheet date of unearned revenue or income, not otherwise specified in the taxonomy, which is expected to be taken into income in future periods and obligations not separately disclosed in the balance sheet (other liabilities).",
        "label": "Deferred Credits and Other Liabilities",
        "terseLabel": "Amount outstanding under agreement"
       }
      }
     },
     "localname": "DeferredCreditsAndOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r532",
      "r533",
      "r676"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability",
        "verboseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "verboseLabel": "Deferred tax"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r9",
      "r301"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r227",
      "r228",
      "r576",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r772",
      "r773",
      "r824",
      "r826",
      "r828",
      "r829",
      "r830",
      "r831",
      "r854",
      "r891",
      "r1094"
     ],
     "calculation": {
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsCurrent": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Current",
        "terseLabel": "Contingent equity securities"
       }
      }
     },
     "localname": "DerivativeAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [
      "r755",
      "r757",
      "r771",
      "r772",
      "r773",
      "r776",
      "r777",
      "r778",
      "r779",
      "r781",
      "r782",
      "r783",
      "r784",
      "r800",
      "r801",
      "r802",
      "r803",
      "r806",
      "r807",
      "r808",
      "r809",
      "r824",
      "r825",
      "r828",
      "r830",
      "r889",
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r24",
      "r112",
      "r149",
      "r226",
      "r854"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "verboseLabel": "Derivative asset, fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFloorInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floor rate on an interest rate derivative such as an interest rate floor or collar. If market rates falls below the floor rate, a payment or receipt is triggered on the contract.",
        "label": "Derivative, Floor Interest Rate",
        "terseLabel": "Derivative, floor interest rate"
       }
      }
     },
     "localname": "DerivativeFloorInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r111",
      "r113",
      "r115",
      "r116",
      "r755",
      "r757",
      "r771",
      "r772",
      "r773",
      "r776",
      "r777",
      "r778",
      "r779",
      "r781",
      "r782",
      "r783",
      "r784",
      "r800",
      "r801",
      "r802",
      "r803",
      "r806",
      "r807",
      "r808",
      "r809",
      "r824",
      "r825",
      "r828",
      "r830",
      "r854",
      "r889",
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r16",
      "r111",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r16",
      "r106",
      "r107",
      "r109",
      "r117",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives designated as hedging instruments"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [
      "r480",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r480",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r1064"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "verboseLabel": "Schedule of Disaggregated Revenue by Each Payor Type"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r491",
      "r494",
      "r522",
      "r523",
      "r524",
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r6",
      "r174"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "verboseLabel": "Dividends paid"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividend payable",
        "verboseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r236",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r268",
      "r270",
      "r282",
      "r283",
      "r284",
      "r288",
      "r569",
      "r570",
      "r670",
      "r690",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Earnings per share \u2013 basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r236",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r270",
      "r282",
      "r283",
      "r284",
      "r288",
      "r569",
      "r570",
      "r670",
      "r690",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Earnings per share \u2013 diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r267",
      "r285",
      "r286",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r1067"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Stock options",
        "verboseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails",
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r15",
      "r206",
      "r232",
      "r233",
      "r234",
      "r254",
      "r255",
      "r256",
      "r258",
      "r264",
      "r266",
      "r289",
      "r369",
      "r370",
      "r468",
      "r525",
      "r526",
      "r527",
      "r542",
      "r543",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r568",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r605",
      "r715",
      "r716",
      "r717",
      "r736",
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY",
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r1036"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Impairment of investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership interest"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentSoldCarryingAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the entity's equity method investment which has been sold.",
        "label": "Equity Method Investment, Amount Sold",
        "negatedTerseLabel": "Distribution"
       }
      }
     },
     "localname": "EquityMethodInvestmentSoldCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r306",
      "r363",
      "r995",
      "r1037"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Investments in other entities \u2013 equity method",
        "verboseLabel": "Investments in other entities \u2013 equity method"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "verboseLabel": "Schedule of Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r217",
      "r575",
      "r851"
     ],
     "calculation": {
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity securities",
        "verboseLabel": "Marketable securities \u2013 equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue": {
     "auth_ref": [
      "r575"
     ],
     "calculation": {
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.",
        "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value",
        "verboseLabel": "Investment in privately held entities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r693",
      "r1035"
     ],
     "calculation": {
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "negatedTotalLabel": "Total losses recognized on equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "auth_ref": [
      "r691",
      "r1035"
     ],
     "calculation": {
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EquitySecuritiesFvNiGainLoss",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "negatedTerseLabel": "Gain on sale of equity securities",
        "terseLabel": "Gains recognized on equity securities sold"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r692",
      "r1035"
     ],
     "calculation": {
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EquitySecuritiesFvNiGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "negatedTerseLabel": "Unrealized losses recognized on equity securities held at end of period"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofGainLossonSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [
      "r571",
      "r572",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r571",
      "r572",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r20",
      "r118",
      "r119",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "verboseLabel": "Schedule of Carrying Amounts and Fair Values of Financial Instruments"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r436",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r572",
      "r621",
      "r622",
      "r623",
      "r864",
      "r865",
      "r876",
      "r877",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r436",
      "r483",
      "r488",
      "r572",
      "r621",
      "r876",
      "r877",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r436",
      "r483",
      "r488",
      "r572",
      "r622",
      "r864",
      "r865",
      "r876",
      "r877",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r436",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r572",
      "r623",
      "r864",
      "r865",
      "r876",
      "r877",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r17",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r573"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Unrealized gain recognized from change in fair value of existing Level 3 liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r17"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r436",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r621",
      "r622",
      "r623",
      "r864",
      "r865",
      "r876",
      "r877",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r12",
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r591",
      "r597",
      "r885"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r593",
      "r600"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r590",
      "r604"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r590"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "netLabel": "Less: current portion",
        "terseLabel": "Finance lease liabilities",
        "verboseLabel": "Finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r1074"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Finance Lease Payments After Adoption of 842"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r590"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term lease liabilities",
        "verboseLabel": "Finance lease liabilities, net of current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r1074"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023 (excluding the six months ended June 30, 2023)"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r592",
      "r600"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "verboseLabel": "Financing cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r589"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Assets recorded under finance leases"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": {
     "auth_ref": [
      "r979",
      "r982"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization",
        "terseLabel": "Accumulated depreciation associated with finance leases"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r591",
      "r597",
      "r885"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of lease expense"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r603",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "verboseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r602",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "verboseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r378",
      "r379",
      "r380",
      "r447",
      "r465",
      "r566",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r689",
      "r861",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r1031",
      "r1032",
      "r1033",
      "r1034"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis": {
     "auth_ref": [
      "r0",
      "r729",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by financial support arrangement provided to a nonconsolidated legal entity that is required to comply with or operate in accordance with requirements that are similar to those included in Rule 2a-7 of the Investment Company Act of 1940 for registered money market funds.",
        "label": "Financial Support to Nonconsolidated Legal Entity [Axis]",
        "terseLabel": "Financial Support to Nonconsolidated Legal Entity [Axis]"
       }
      }
     },
     "localname": "FinancialSupportToNonconsolidatedLegalEntityAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain": {
     "auth_ref": [
      "r0",
      "r729",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial support arrangement provided to a nonconsolidated legal entity that is required to comply with or operate in accordance with requirements that are similar to those included in Rule 2a-7 of the Investment Company Act of 1940 for registered money market funds.",
        "label": "Financial Support to Nonconsolidated Legal Entity [Domain]",
        "terseLabel": "Financial Support to Nonconsolidated Legal Entity [Domain]"
       }
      }
     },
     "localname": "FinancialSupportToNonconsolidatedLegalEntityDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Useful Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r214",
      "r397"
     ],
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      },
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r167"
     ],
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2023 (excluding the six months ended June 30, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r167"
     ],
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r167"
     ],
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r167"
     ],
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r394",
      "r396",
      "r397",
      "r399",
      "r653",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r166",
      "r654"
     ],
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Amortized intangible assets, Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r67",
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r166",
      "r653"
     ],
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestmentsTextBlock": {
     "auth_ref": [
      "r1005",
      "r1006"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of realized and unrealized gain (loss) on investment in security.",
        "label": "Gain (Loss) on Securities [Table Text Block]",
        "terseLabel": "Schedule of Gain (Loss) on Securities"
       }
      }
     },
     "localname": "GainLossOnInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r155",
      "r791"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "verboseLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r213",
      "r381",
      "r667",
      "r862",
      "r886",
      "r1040",
      "r1047"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillScheduleofGoodwillDetails",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r385",
      "r862"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r9",
      "r382",
      "r388",
      "r392",
      "r862"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Impairment of goodwill"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r3",
      "r1046"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOtherMember": {
     "auth_ref": [
      "r1065"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service provided for maintenance, diagnosis and treatment of physical and mental health, classified as other.",
        "label": "Health Care, Other [Member]",
        "terseLabel": "Risk pool settlements and incentives"
       }
      }
     },
     "localname": "HealthCareOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HealthCarePatientServiceMember": {
     "auth_ref": [
      "r1065"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service provided to patient for maintenance, diagnosis and treatment of physical and mental health. Excludes service to resident in health care facility.",
        "label": "Health Care, Patient Service [Member]",
        "terseLabel": "Fee-for-service, net",
        "verboseLabel": "Third Party"
       }
      }
     },
     "localname": "HealthCarePatientServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r16",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r1013",
      "r1050"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "terseLabel": "Impairment of finite-lived intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r150",
      "r189",
      "r296",
      "r316",
      "r322",
      "r325",
      "r671",
      "r685",
      "r858"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r9",
      "r151",
      "r188",
      "r303",
      "r363",
      "r684"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Income from equity method investments",
        "netLabel": "Income (loss) from equity method investments",
        "terseLabel": "Income from equity method investments",
        "verboseLabel": "Allocation of Income (Loss)"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Statement of Operations"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r247",
      "r529",
      "r536",
      "r537",
      "r540",
      "r544",
      "r546",
      "r547",
      "r548",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r195",
      "r202",
      "r265",
      "r266",
      "r304",
      "r534",
      "r545",
      "r694"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r231",
      "r530",
      "r531",
      "r537",
      "r538",
      "r539",
      "r541",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r46",
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r128",
      "r1002"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivableNoncurrent": {
     "auth_ref": [
      "r997"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Noncurrent",
        "terseLabel": "Income taxes receivable, non-current"
       }
      }
     },
     "localname": "IncomeTaxesReceivableNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Receivables, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "verboseLabel": "Income taxes payable/receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueFromRelatedParties": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity.",
        "label": "Increase (Decrease) in Due from Related Parties",
        "negatedLabel": "Receivables, net \u2013 related parties"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of business combinations:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r983",
      "r1012"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayable": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Increase (Decrease) in Other Accounts Payable",
        "verboseLabel": "Fiduciary accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Other receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares": {
     "auth_ref": [
      "r271",
      "r272",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r284"
     ],
     "calculation": {
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares",
        "terseLabel": "Contingently issuable shares (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToContingentlyIssuableShares",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r395",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r168"
     ],
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite lived assets:"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r68",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets, Net"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r213"
     ],
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible Assets, Gross"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r65",
      "r69"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible Assets, Net",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r124",
      "r191",
      "r235",
      "r300",
      "r585",
      "r797",
      "r899",
      "r1097"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r237",
      "r241",
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r848",
      "r896",
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swap",
        "verboseLabel": "Interest rate swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r298",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r321",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Elimination"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r156",
      "r299"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r998"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Investments in affiliates"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r596",
      "r885"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost, net"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Information Related to Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r1071"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Finance Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term, finance"
       }
      }
     },
     "localname": "LesseeFinanceLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeFinanceLeaseRenewalTerm1": {
     "auth_ref": [
      "r1072"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Finance Lease, Renewal Term",
        "terseLabel": "Finance lease option to extend (up to)"
       }
      }
     },
     "localname": "LesseeFinanceLeaseRenewalTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r1074"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Operating Lease Payments After Adoption of 842"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r1074"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023 (excluding the six months ended June 30, 2023)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r1071"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term, operating"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r1072"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating lease option to extend (up to)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r31",
      "r246",
      "r368",
      "r409",
      "r410",
      "r412",
      "r413",
      "r414",
      "r416",
      "r418",
      "r420",
      "r421",
      "r554",
      "r557",
      "r558",
      "r577",
      "r764",
      "r857",
      "r901",
      "r1058",
      "r1078",
      "r1079"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r148",
      "r187",
      "r682",
      "r886",
      "r1017",
      "r1038",
      "r1070"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, mezzanine equity and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "Liabilities, mezzanine equity and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r33",
      "r211",
      "r246",
      "r368",
      "r409",
      "r410",
      "r412",
      "r413",
      "r414",
      "r416",
      "r418",
      "r420",
      "r421",
      "r554",
      "r557",
      "r558",
      "r577",
      "r886",
      "r1058",
      "r1078",
      "r1079"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities",
        "verboseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r27",
      "r136",
      "r137",
      "r138",
      "r141",
      "r246",
      "r368",
      "r409",
      "r410",
      "r412",
      "r413",
      "r414",
      "r416",
      "r418",
      "r420",
      "r421",
      "r554",
      "r557",
      "r558",
      "r577",
      "r1058",
      "r1078",
      "r1079"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Non-current liabilities",
        "verboseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r134",
      "r194"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Medical liabilities, end of period",
        "periodStartLabel": "Medical liabilities, beginning of period (restated)",
        "terseLabel": "Medical liabilities",
        "verboseLabel": "Medical liabilities"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock": {
     "auth_ref": [
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.",
        "label": "Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]",
        "terseLabel": "Medical Liabilities"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions",
        "terseLabel": "Acquired (see Note 3)"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "negatedLabel": "Current period"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "negatedLabel": "Prior periods"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r193"
     ],
     "calculation": {
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total medical care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Medical Liabilities [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of increase (decrease) in the liability for unpaid claims and claims adjustment expense.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease)",
        "terseLabel": "Adjustments"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r27",
      "r185",
      "r1087"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "totalLabel": "Total",
        "verboseLabel": "Amount outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r29",
      "r1016"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Commitment Fee Amount",
        "terseLabel": "Annual agent fee"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Required annual facility fee"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Line of Credit Facility, Expiration Period",
        "terseLabel": "Term of facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r29",
      "r1016"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [
      "r1016"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum loan availability"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r29",
      "r1016"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r27",
      "r185",
      "r435",
      "r451",
      "r864",
      "r865",
      "r1087"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.",
        "label": "Long-Term Debt, Current Maturities",
        "negatedTerseLabel": "Less: Current portion of debt",
        "terseLabel": "Current portion of long-term debt",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r11",
      "r253",
      "r440"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r11",
      "r253",
      "r440"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r11",
      "r253",
      "r440"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r11",
      "r253",
      "r440"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r1020"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2023 (excluding the six months ended June 30, 2023)"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r219"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net of current portion and deferred financing costs",
        "verboseLabel": "Long-term debt, net of current portion and deferred financing costs"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails",
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r35",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails",
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ManagementServiceMember": {
     "auth_ref": [
      "r1065"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractually stipulated right to receive compensation for operating and managing business.",
        "label": "Management Service [Member]",
        "terseLabel": "Management fee income"
       }
      }
     },
     "localname": "ManagementServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r999"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Investment in marketable securities",
        "verboseLabel": "Investments in marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "verboseLabel": "Investments in Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r41",
      "r186",
      "r246",
      "r368",
      "r409",
      "r412",
      "r413",
      "r414",
      "r420",
      "r421",
      "r577",
      "r681",
      "r768"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r94",
      "r174",
      "r179"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedTerseLabel": "Purchase of non-controlling interest"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoanRelatedToPropertySales1": {
     "auth_ref": [
      "r50",
      "r51",
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan related to property sales in noncash investing and financing activities.",
        "label": "Mortgage Loan Related to Property Sales",
        "terseLabel": "Mortgage loan"
       }
      }
     },
     "localname": "MortgageLoanRelatedToPropertySales1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r196",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Description of Business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r240"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r240"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r160",
      "r161",
      "r162"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r152",
      "r162",
      "r190",
      "r209",
      "r229",
      "r230",
      "r234",
      "r246",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r265",
      "r266",
      "r281",
      "r296",
      "r316",
      "r322",
      "r325",
      "r368",
      "r409",
      "r410",
      "r412",
      "r413",
      "r414",
      "r416",
      "r418",
      "r420",
      "r421",
      "r570",
      "r577",
      "r688",
      "r788",
      "r810",
      "r811",
      "r858",
      "r899",
      "r1058"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "totalLabel": "Net income attributable to Apollo Medical Holdings, Inc."
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r105",
      "r180",
      "r229",
      "r230",
      "r265",
      "r266",
      "r687",
      "r1004"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "verboseLabel": "Net income (loss) attributable to non-controlling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": {
     "auth_ref": [
      "r14",
      "r80",
      "r179"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.",
        "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest",
        "verboseLabel": "Sale of non-controlling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": {
     "auth_ref": [
      "r14",
      "r80",
      "r179"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance",
        "terseLabel": "Investment in non-controlling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r92",
      "r468",
      "r1021",
      "r1022",
      "r1023",
      "r1098"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "verboseLabel": "Non-controlling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonrelatedPartyMember": {
     "auth_ref": [
      "r1018",
      "r1019"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Party not related to reporting entity.",
        "label": "Nonrelated Party [Member]",
        "terseLabel": "Nonrelated Party"
       }
      }
     },
     "localname": "NonrelatedPartyMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r331",
      "r332",
      "r669"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.",
        "label": "Financing Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Loans receivable"
       }
      }
     },
     "localname": "NotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableToBanksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a bank.",
        "label": "Notes Payable to Banks [Member]",
        "terseLabel": "Promissory Note Payable"
       }
      }
     },
     "localname": "NotesPayableToBanksMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Notes Receivable [Member]",
        "terseLabel": "Convertible Secured Promissory Note"
       }
      }
     },
     "localname": "NotesReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesReceivableNet": {
     "auth_ref": [
      "r331",
      "r376",
      "r775"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.",
        "label": "Financing Receivable, after Allowance for Credit Loss",
        "terseLabel": "Amount of loan"
       }
      }
     },
     "localname": "NotesReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r1026"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/DescriptionofBusinessAdditionalInformationDetails",
      "http://www.apollomed.net/role/SegmentsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r296",
      "r316",
      "r322",
      "r325",
      "r858"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations",
        "verboseLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r598",
      "r885"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "verboseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r590"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r590"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Less: current portion",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r590"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term lease liabilities",
        "verboseLabel": "Operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r594",
      "r600"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "verboseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r589"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r603",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "verboseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r602",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "verboseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other provider payable"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r224",
      "r886"
     ],
     "calculation": {
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Amount due from affiliates"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r215"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilities": {
     "auth_ref": [
      "r129",
      "r673",
      "r760",
      "r761",
      "r901",
      "r1095"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other.",
        "label": "Other Liabilities",
        "terseLabel": "Due to affiliates"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r32",
      "r886"
     ],
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Amount due to affiliate",
        "verboseLabel": "Due to related parties"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermInvestments": {
     "auth_ref": [
      "r674",
      "r996"
     ],
     "calculation": {
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term investments classified as other.",
        "label": "Other Long-Term Investments",
        "terseLabel": "Investment in affiliates"
       }
      }
     },
     "localname": "OtherLongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Noncurrent Assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r158"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivables": {
     "auth_ref": [
      "r223",
      "r774"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from parties in nontrade transactions, classified as other.",
        "label": "Other Receivables",
        "terseLabel": "Due from affiliates"
       }
      }
     },
     "localname": "OtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables",
        "verboseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r7",
      "r22"
     ],
     "calculation": {
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "negatedTotalLabel": "Total paid"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of shares",
        "terseLabel": "Payments for repurchase of shares"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Payments for business and asset acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedLabel": "Purchase of investments - equity method"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r1030"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchase of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment": {
     "auth_ref": [
      "r1010"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire securities classified as trading securities and held for investment purposes. Excludes payments for trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).",
        "label": "Payment for Acquisition, Trading Security, Held-for-Investment",
        "negatedLabel": "Purchase of investments - privately held"
       }
      }
     },
     "localname": "PaymentsToAcquireTradingSecuritiesHeldforinvestment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r142",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "verboseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r142",
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r142",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "verboseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r142",
      "r766",
      "r786",
      "r1098",
      "r1099"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r142",
      "r678",
      "r886"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r1003"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "verboseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties": {
     "auth_ref": [
      "r1008",
      "r1075"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with collection, whether partial or full, of long-term loans to a related party. Alternate caption: Proceeds from Advances to Affiliates.",
        "label": "Proceeds from Collection of Long-Term Loans to Related Parties",
        "terseLabel": "Proceeds from repayment of loans receivable \u2013 related parties"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfLongtermLoansToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": {
     "auth_ref": [
      "r239",
      "r1009"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.",
        "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital",
        "terseLabel": "Distribution from investment - equity method"
       }
      }
     },
     "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of long-term debt classified as other.",
        "label": "Proceeds from Issuance of Other Long-Term Debt",
        "terseLabel": "Borrowings on loans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsToMinorityShareholders": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.",
        "label": "Proceeds from (Payments to) Noncontrolling Interests",
        "terseLabel": "Proceeds from sale of non-controlling interest"
       }
      }
     },
     "localname": "ProceedsFromPaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sale of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r1011"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from Warrant Exercises",
        "terseLabel": "Proceeds from the exercise of stock options and warrants"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r1065"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other revenue",
        "verboseLabel": "Intersegment"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r209",
      "r229",
      "r230",
      "r238",
      "r246",
      "r257",
      "r265",
      "r266",
      "r296",
      "r316",
      "r322",
      "r325",
      "r368",
      "r409",
      "r410",
      "r412",
      "r413",
      "r414",
      "r416",
      "r418",
      "r420",
      "r421",
      "r552",
      "r555",
      "r556",
      "r570",
      "r577",
      "r671",
      "r686",
      "r735",
      "r788",
      "r810",
      "r811",
      "r858",
      "r883",
      "r884",
      "r900",
      "r1004",
      "r1058"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r982",
      "r1051"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Land, property, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r10",
      "r672",
      "r683",
      "r886"
     ],
     "calculation": {
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Land, property, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealEstateLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan to finance the purchase of real estate, including but not limited to, land or building.",
        "label": "Real Estate Loan [Member]",
        "terseLabel": "Real Estate Loans"
       }
      }
     },
     "localname": "RealEstateLoanMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]",
        "terseLabel": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r489",
      "r609",
      "r610",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r785",
      "r787",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party, Type [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyMember": {
     "auth_ref": [
      "r248",
      "r249",
      "r609",
      "r610",
      "r611",
      "r612",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r785",
      "r787",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family.",
        "label": "Related Party [Member]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r127",
      "r609"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction, Amounts of Transaction",
        "terseLabel": "Related party transaction, amount of transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r609",
      "r610",
      "r1077"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [
      "r792",
      "r793",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r489",
      "r609",
      "r610",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r785",
      "r787",
      "r819",
      "r1077"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party, Type [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r606",
      "r607",
      "r608",
      "r610",
      "r613",
      "r731",
      "r732",
      "r733",
      "r794",
      "r795",
      "r796",
      "r816",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "verboseLabel": "Related-Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for short-term and long-term debt and lease obligation.",
        "label": "Repayments of Debt and Lease Obligation",
        "negatedTerseLabel": "Payment of finance lease obligations"
       }
      }
     },
     "localname": "RepaymentsOfDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r45",
      "r726"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r994",
      "r1014",
      "r1086",
      "r1088"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashEquivalentsCurrent": {
     "auth_ref": [
      "r840",
      "r841",
      "r994",
      "r1014"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash equivalents restricted as to withdrawal or usage, classified as current. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash Equivalents, Current",
        "terseLabel": "Restricted cash \u2013 current"
       }
      }
     },
     "localname": "RestrictedCashEquivalentsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted stock awards",
        "verboseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r145",
      "r174",
      "r680",
      "r718",
      "r719",
      "r727",
      "r767",
      "r886"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r206",
      "r254",
      "r255",
      "r256",
      "r258",
      "r264",
      "r266",
      "r369",
      "r370",
      "r525",
      "r526",
      "r527",
      "r542",
      "r543",
      "r560",
      "r562",
      "r563",
      "r565",
      "r568",
      "r715",
      "r717",
      "r736",
      "r1098"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings [Member]",
        "verboseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r297",
      "r298",
      "r315",
      "r320",
      "r321",
      "r327",
      "r329",
      "r330",
      "r479",
      "r480",
      "r652"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "verboseLabel": "Total revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayorTypeDetails",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r204",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolver Loan",
        "verboseLabel": "Revolver Loan"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r601",
      "r885"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Fixed asset obtained in exchange for finance lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r601",
      "r885"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]"
       }
      }
     },
     "localname": "RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r330",
      "r980"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "verboseLabel": "Net Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r87",
      "r89",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r1025"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share Computations"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Share-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [
      "r246",
      "r365",
      "r366",
      "r367",
      "r368",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r209",
      "r246",
      "r365",
      "r366",
      "r367",
      "r368",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r67",
      "r70",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r67",
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets, Net"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r862",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Change in Carrying Value of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r21",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule of Medical Liabilities"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "terseLabel": "Schedule of Credit Facility"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Future Commitments of Credit Facility"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r126",
      "r127",
      "r792",
      "r793",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "Schedule of Related Party Transactions [Table Text Block]",
        "verboseLabel": "Schedule of Fees Incurred and Revenue Earned from Related Party Transactions"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
        "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]",
        "verboseLabel": "Schedule of Contributions to Revenue and Receivables by Payor"
       }
      }
     },
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r61",
      "r62",
      "r63",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r61",
      "r62",
      "r63",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Information about our Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r492",
      "r493",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r18",
      "r19",
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Transactions Under Stock Option Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r73",
      "r74",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r172",
      "r173",
      "r174",
      "r220",
      "r221",
      "r222",
      "r290",
      "r453",
      "r454",
      "r455",
      "r457",
      "r460",
      "r465",
      "r467",
      "r723",
      "r724",
      "r725",
      "r726",
      "r868",
      "r978",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r97",
      "r98",
      "r100",
      "r102",
      "r103",
      "r553",
      "r554",
      "r557",
      "r558",
      "r632",
      "r633",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "auth_ref": [
      "r97",
      "r98",
      "r100",
      "r102",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "verboseLabel": "Schedule of Assets and Liabilities, Variable Interest Entities"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "verboseLabel": "Schedule of Shares Included in the Diluted Earnings Per Share Computations"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "verboseLabel": "Schedule of Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r293",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r330",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r401",
      "r402",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r862",
      "r984",
      "r1089"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r308",
      "r319",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/Segments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r329",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "verboseLabel": "Reportable Segments"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [
      "r1000",
      "r1001",
      "r1063"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A preferred stock.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Preferred Stock"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [
      "r1000",
      "r1001",
      "r1063"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B preferred stock.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B Preferred Stock"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Restricted stock awards granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [
      "r492",
      "r493",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r513"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Options forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r1066"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r498",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding, ending balance (in shares)",
        "verboseLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "verboseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r498",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding, ending balance (in dollars per share)",
        "periodStartLabel": "Options outstanding, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "verboseLabel": "Options exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Options exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Options forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "verboseLabel": "Options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares",
        "terseLabel": "Number of shares, performance based restricted stock (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Equity, ending balance (in shares)",
        "periodStartLabel": "Equity, beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StandbyLettersOfCreditMember": {
     "auth_ref": [
      "r1",
      "r1056",
      "r1091",
      "r1092"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.",
        "label": "Standby Letters of Credit [Member]",
        "terseLabel": "Standby Letters of Credit"
       }
      }
     },
     "localname": "StandbyLettersOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r208",
      "r293",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r330",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r400",
      "r401",
      "r402",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r862",
      "r984",
      "r1089"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r205",
      "r220",
      "r221",
      "r222",
      "r246",
      "r270",
      "r273",
      "r282",
      "r284",
      "r290",
      "r291",
      "r368",
      "r409",
      "r412",
      "r413",
      "r414",
      "r420",
      "r421",
      "r453",
      "r454",
      "r457",
      "r460",
      "r467",
      "r577",
      "r723",
      "r724",
      "r725",
      "r726",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r766",
      "r789",
      "r812",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r978",
      "r1015",
      "r1024"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r15",
      "r39",
      "r206",
      "r232",
      "r233",
      "r234",
      "r254",
      "r255",
      "r256",
      "r258",
      "r264",
      "r266",
      "r289",
      "r369",
      "r370",
      "r468",
      "r525",
      "r526",
      "r527",
      "r542",
      "r543",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r568",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r605",
      "r715",
      "r716",
      "r717",
      "r736",
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY",
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r289",
      "r652",
      "r721",
      "r747",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r766",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r776",
      "r777",
      "r778",
      "r779",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r787",
      "r790",
      "r791",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r812",
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r289",
      "r652",
      "r721",
      "r747",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r766",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r776",
      "r777",
      "r778",
      "r779",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r787",
      "r790",
      "r791",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r812",
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r50",
      "r51",
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "terseLabel": "Common stock issued in business combination"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r142",
      "r143",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issuance of shares for business acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": {
     "auth_ref": [
      "r15",
      "r142",
      "r143",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares related to Restricted Stock Award forfeited during the period.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited",
        "negatedLabel": "Cancellation of restricted stock awards (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r15",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "terseLabel": "Shares issued for vesting of restricted stock awards (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r15",
      "r142",
      "r143",
      "r174",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Options exercised (in shares)",
        "terseLabel": "Shares issued for exercise of options and warrants (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r15",
      "r39",
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of shares for business acquisition"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": {
     "auth_ref": [
      "r15",
      "r142",
      "r143",
      "r174"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards forfeited during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures",
        "negatedTerseLabel": "Cancellation of restricted stock awards"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "auth_ref": [
      "r15",
      "r142",
      "r143",
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross",
        "terseLabel": "Shares issued for vesting of restricted stock awards"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r84",
      "r142",
      "r143",
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r15",
      "r39",
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Purchase price adjustment from merger"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r15",
      "r142",
      "r143",
      "r174",
      "r736",
      "r812",
      "r836",
      "r900"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Share buy back"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r143",
      "r146",
      "r147",
      "r165",
      "r768",
      "r786",
      "r813",
      "r814",
      "r886",
      "r901",
      "r1017",
      "r1038",
      "r1070",
      "r1098"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.",
        "label": "Equity, Attributable to Parent",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r92",
      "r93",
      "r104",
      "r206",
      "r207",
      "r233",
      "r254",
      "r255",
      "r256",
      "r258",
      "r264",
      "r369",
      "r370",
      "r468",
      "r525",
      "r526",
      "r527",
      "r542",
      "r543",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r568",
      "r578",
      "r579",
      "r583",
      "r605",
      "r716",
      "r717",
      "r734",
      "r768",
      "r786",
      "r813",
      "r814",
      "r838",
      "r900",
      "r1017",
      "r1038",
      "r1070",
      "r1098"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Equity, ending balance",
        "periodStartLabel": "Equity, beginning balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "verboseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r171",
      "r245",
      "r452",
      "r454",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r466",
      "r468",
      "r567",
      "r815",
      "r817",
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity.",
        "label": "Equity [Text Block]",
        "terseLabel": "Mezzanine and Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r599",
      "r885"
     ],
     "calculation": {
      "http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/LeasesScheduleofComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubordinatedDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents domestic or foreign subordinated debt. Subordinated debt has a lower priority of repayment in liquidation of the entity's assets.",
        "label": "Subordinated Debt [Member]",
        "terseLabel": "Subordinated Debt"
       }
      }
     },
     "localname": "SubordinatedDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [
      "r584",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r584",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r584",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r584",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r584",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r615",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "verboseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplementary disclosures of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r713"
     ],
     "calculation": {
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current period"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r713"
     ],
     "calculation": {
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "terseLabel": "Prior periods"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r30"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityAccretionOfDividends": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity during the period due to unpaid dividends.",
        "label": "Temporary Equity, Accretion of Dividends",
        "terseLabel": "Dividends"
       }
      }
     },
     "localname": "TemporaryEquityAccretionOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r38",
      "r246",
      "r368",
      "r577"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Temporary equity, carrying amount, ending balance",
        "periodStartLabel": "Temporary equity, carrying amount, beginning balance",
        "terseLabel": "Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net (loss) income (restated)"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Tradename/trademarks"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r447",
      "r465",
      "r566",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r689",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r1031",
      "r1032",
      "r1033",
      "r1034"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r15",
      "r143",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Purchase of treasury shares (in shares)",
        "verboseLabel": "Treasury stock repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "auth_ref": [
      "r15",
      "r81",
      "r174"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.",
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "negatedTerseLabel": "Purchase of treasury shares"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r9",
      "r806",
      "r807",
      "r808",
      "r809",
      "r827"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "negatedTerseLabel": "Unrealized loss (gain) on interest rate swaps"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "terseLabel": "Unrealized gain (loss) on investments"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r58",
      "r59",
      "r60",
      "r197",
      "r198",
      "r200",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "verboseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "verboseLabel": "Variable Interest Entities (VIEs)"
       }
      }
     },
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEs"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [
      "r553",
      "r554",
      "r557",
      "r558",
      "r632",
      "r633",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r97",
      "r553",
      "r554",
      "r557",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [
      "r889",
      "r890",
      "r893",
      "r894",
      "r895",
      "r898"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r1025"
     ],
     "calculation": {
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Adjustments to weighted average shares of common stock (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r269",
      "r284"
     ],
     "calculation": {
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted average shares of common stock outstanding \u2013 diluted (in shares)",
        "verboseLabel": "Weighted average shares of common stock outstanding \u2013 diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails",
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r268",
      "r284"
     ],
     "calculation": {
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Weighted average shares of common stock outstanding \u2013 basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails",
      "http://www.apollomed.net/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481410/810-10-15-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481410/810-10-15-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1000": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1001": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1002": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1003": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1004": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1005": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1006": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1007": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1008": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1009": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1010": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1011": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1012": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1013": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1014": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1015": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1016": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1017": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1018": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1019": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1020": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1021": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1022": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1023": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1024": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1025": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1026": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1027": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1028": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1029": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1030": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1031": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1032": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1033": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1034": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1035": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1036": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1037": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1038": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1039": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1040": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1041": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1042": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1043": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1044": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1045": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1046": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1047": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1048": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1049": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1050": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1051": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1052": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1053": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org//450/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1054": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1055": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1056": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1057": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1058": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1059": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1060": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1061": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1062": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1063": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1064": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1065": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1066": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1067": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1068": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1069": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1070": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1071": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1072": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1073": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1074": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1075": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1076": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1077": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1078": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1079": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1080": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1081": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1082": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1083": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1084": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1085": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1086": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1087": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1088": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1089": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1090": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1091": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-15",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1092": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-16",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1093": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1094": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(3)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1095": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1096": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(18))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1097": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(i)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1098": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1099": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147481047/942-405-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org//205/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org//235/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org//275/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org//440/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org//470/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org//505/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org//805/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org//810/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org//275/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org//606/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147479359/835-30-S45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org//260/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-26",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-44",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "48",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-48",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "48",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-48",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "51",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-51",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-52",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-53",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-54",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org//280/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-16",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(4)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//350-30/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org//718/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org//740/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iv)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(i)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//842-20/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org//850/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org//855/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(7))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(f))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(17))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//944-40/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(f)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(g)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(h)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(c)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(4)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(f)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(14))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(15))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(17))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(19))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(5)(a)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(9))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13A(Column F))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org//1943274/2147480602/954-210-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "47",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r903": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r904": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r905": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r906": {
   "Name": "Form 20-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "16",
   "Subsection": "J",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r907": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r908": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r909": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r911": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r912": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r913": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r914": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r915": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "iii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r916": {
   "Name": "Form 20-F",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r917": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r918": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r919": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r921": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r922": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r923": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r924": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r925": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r926": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r927": {
   "Name": "Form 40-F",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r928": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r929": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r931": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r932": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r933": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r934": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r935": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r936": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r937": {
   "Name": "Form N-CSR",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r938": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r939": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-24",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r941": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r942": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r943": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r944": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "vi",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r945": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "3",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r946": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "4",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r947": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r948": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r949": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r951": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r952": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r953": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r954": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r955": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r956": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r957": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r958": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r959": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-2AA",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r961": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r962": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r963": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r964": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r965": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "A",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r966": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "C",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r967": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "D",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r968": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "E",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r969": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "F",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r971": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r972": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "A",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r973": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "B",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r974": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "C",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r975": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "D",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r976": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r977": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r987": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r988": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r989": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r990": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r991": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r992": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r993": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r995": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r996": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r997": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r998": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r999": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>119
<FILENAME>0001628280-23-028672-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-028672-xbrl.zip
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M@PL+_5L1V>*[V>4N\:>M'?N%/B&CZ3=ZQ._RNZ,+"\\&S!3@O0N/C]OQ'FP
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M"IV8S&MI3[/%+(5.3OYIGP,_\U+HY 1_D2P 'O&?/.L6U[6+3%5Q!BK+<:N
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M\XGP^:EL#AY:NI+Q<VM%T"BBI2LG%V K(H83+5W)N0!;$3&N:.BR]-GJ&L>
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M:D*P39R^U;5I&-%]GCR0_[I>TR:@AX4 \,4#=\S.LD]-)J05T9$QOA=</X/
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MX0ET=&R?A!XVZ*'@+M!1EN)V2#C)L(_():&C+J6J,;B $EKZ4MPF*5BRC=&
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M+]%D;V\YS'>R*\F4",?>&CZZ@P8L];H-:H5K3C]N33;G3RIX.2/L>&1#I)-
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M*.;! A*,_:D'J^5N_DW]90<V+W1D"BA]4O9M1;+^RSV ,TB3:V(F"]8ZM((
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MUB:D* B=2R!4_ &U[2GU\0& PGF-< '<^ZS!+]>2?(L:\6_JKY*20L6R=Z#
M<+"S[]6W[D@B0@L1''=C0M];[[%N+[.YI\QOAK:Z3F!Y>[096<9YK^+L*Z3K
MN_8X6/W*MAW5PI\#;Q8C]&FAZU'RHT!ZT(UK8K^1B<]6*R>[C]N::@VQ'J_!
MN=?&N ^MB I<PUU(\LQ=>51Y8S\B8_C"YQM@W&$[HG)3X+4S?F[)/+0<.$'#
M@M#9_RUW]_AES10J+\OA53D=_HCV..!C'@Q^B];CC(<%TPT*T0,AK(-8#9Y5
MG-I2*7=3KN;+%2VOUJ?UUG%3;\+R'MY+(ZP%\ME;8W\\<^?O50=!J.#[8U96
MX)B*.VLJC RLEBLLAH:7["DG?8.<XNT?7SR^$^V$RRD26?2@_4149KMVY;5Z
M/:^5ZZLB"J+WQ++B<WOPF^*^.6&I1,.VV9KNI\'$MR!6"1G[V4(,-A_PY+D]
MRC=$8#4HT5KWYFSUG&)>=:_(U?11A*T3-Q:?H]P]-=BD)2?E&T_-B(!GU0],
M=-'.UDP//5;MP!== GK?6U^OO PHA&I1SUBG;-KG$Z_K59I7NN. 2X2_QU\1
M#HOJYB(U",O 'U%_IRF E-6!GW$KQ]7=&G>JSMIC*T<D@\[N>XFRC7N/'JA*
MVE6U?-Q8-;_+3!'1PHW&4_O^OJT\M&[OFHU[Y5O[_O;N\6L'S/ZQN9,UHNK-
MW>-MZU]L_R"^22/;8U'Y<G</'4I=3UX:G^];;$^C9OOQI?7XLGF#4L&>L5Z_
MJA:KASA&M7A5T9/?YZ-:NZJI6O*/O=+*NZTY20,CB:#R>3WNGQI?6P?4\A/C
M1]^#:,(L1 TU#$I[O?5#W('/2&Q?M5[O9+E(V#B(8:-X\1JZ0[UH63A!TQ9E
MX+'@_2\[[ 6N,T(I"(]$="& 9+NY__J1[#Z)G;A>#S 9J?']-%[>H.&]W4"/
M_W><&UAZAG0#@D#!+%]I="'-5+ZXWAOQS,*]Z_[@:^WBL];\(UW#D;J6KD&T
M:UA*5-DNA9N3YW-$#8D_(XT^4)Q=K-U61Y!=[-F6/>RBP@+GYQ?E;M4XI/3/
M(?TO=X^-Q^9=XUZY>V3<0^.%'\B1Y%BTS@E(;R>C-8SC=!V2-@C(%/5*;#PF
MM9F0-IOS\T9?IL4V,NZ^& 14DDK)+Y&9*R("Q?MMV1T4K/1QP2U\)C:X!:IT
M!I0&/IOU=7L*1TU:NQ>=*)/J/H2%*'R"_I8:X1&:>EB>HDD>-<-.FRF_*GE4
MZ;070%%><MJS"$Z)=NH>TNF&)^EU?-#-%[B;<K^7ZFYTK)^I;K_RX/)M,%KA
MJ7!I[DKJPX'R0CB00 0@TS;4$0"O6)5YFT3%/"IT]=T0X('^^2=QX)'<1_"B
MZ8%KPVO\L_N]Y*8-ZVQ9!M^&.[6=8&I36G^,K6 RC<_"$"?57>(@LWZFNQ-B
M0YPD>R(JQ$FR#\F&.)+DP*YO594LAT3% BI*[X8X3>(/V)D_;[XXIB/)KHJ@
M"))LOV"*(,FNI'[\+$F*X-(\I:I+BD"B8@$5U;#:VF?;I)RZ]$,&V-BAH)YJ
M.88T;E%L&*_.TV1U7D;4^4 <TN?>>'K:X*WE&V.^DP2/Y!H.L2>^Q?.?F1,'
MWVZ&NVVQ>YZI/[;#%*D]HF&;9&%?YL%3JITH_I/^0(1*Z\7(O>O'NG>I3B3J
M_ ?;LM *^"8KW%/#!W;\-W/TMNN/^<X\?'5D>':5\FSY/V1LGG5L5$[%?DMS
M%Z)2/?+>)1F<9T2=$&0''FB,>^XGSS6HR9RU#*RSKO@MGEDNWL0X 2L72Y]V
ML71]NE9=+E87)?_VR[?6LURICLO9R0!-R#@MEZIG39WW;&OB,-#F9['*2#OS
M*J^<JH1!6K$ E6I%+7;*#<EA9T2?C(U6OA"VB:>L&,F\MI-SR#*LPJ#2LBP9
MR9@ZOSOAJ2W48_7QQ Y/=XD6F'6H,?:LP*)^7OGN\_-!HGC:SW,:^XX=^^$I
M3V//&!!_PW<5&7AG'44R\,Z62FNR=B1CZKRE/<*K^KZ/7 ><LV.YWIR/EJ%X
MU@$@0_%,J51598%(QM3Y -^!$+Q'(7J>J^:3T7/6%5\IR>@Y2RHM1:ZY+*/G
MC*BSS8\LOW/"DV+A43)>SKK*DW/*,L#"H-)JY)0K,E[.B#I;/P=6UY)G#F1?
MT^_[XFVG5,?'-I_DH.J-Z@][;T&7G?"@[,UX2.@DU74ZR-WH21R?K19S\9?D
M^=GKI/P5DG6?>).5.N;-?5L/GO^._<#J302!Y67 =OVV;?>-':=(NJ#=5RM<
M *ZXGD(,SW4F0U\)!B10AF2B=*DR]JFI6 Y\9OF*Z1ICMOY<\0?$MI4!>:5\
M8RUB_I<P!2E#RG85[?N*3P.V[58P@&? ^ZYW/-AZK<;/>]1UK7Q5KY0..>I:
MJUU5*IO/G3[T3.I*_4K5ZTD>2KWC(!B*Y?Q8Y9X#$*M\H[8-#U*FX$GL9&PT
M7;N_;R[T+D,:;!@&!&*A\7ZCQ 9?T"0>S9@R-_12N7MJY!7""BIZE&_006SE
M@9JLV4K3]491U)19Y3<>OF9-T[9=: SANP:\.U;E5T@V1IE5XK>'9M:4"%V*
M[-3@9NH85YE5W]W3YZ>LZ0^,$'1FCWVV*\:3.QK;W(\6/A,6J#Z12;1;7495
M^O>'K"GT[P^+SC2?;9NT1P.2R3AHVK&+4F?VHIR'KQ<=MSY\97T?L291/WNZ
MG>M</M/)Y\.WK"EOQ)@[,$7EF^N/K ":Y >L4/^RS#-S\0]7ZU2'LST^,SYP
M/A4R:**\4Q=ECV&/M6PJ4KLL538:S7;F%-E0H%=9]Z698^ELVV)LSF#B6X9%
MG.A ']OJN9YCD8M.4)Z:V<LY#0-4"2JUAL2;K"$1,JS,PGWGH9$U?4;=4FZI
M#XT)#^<:@%;#,T8OR5P_-[YE3;N?R41I>)3,YZ%*P_==\-0!S2SUWFS<03#Q
MT,E:B#3M5Z;YH.9M)VM!4M-U#'?L^6QS>-)W7!]:IG3&7I^R,9073V5;I0^=
MK&F4*RT\KS(<(R$0^BL9CCY%?UHPCE+OU3*RZV9O'[YESE"GB0L$1"/B!;R$
MDIW"SLD^<ZX>(;M:S5K.,N=S%U(5IM>..V8KRIRYE#6KBOWZ=)LU<_UJNUW0
M9K2/_XQDN+4\:@0*W^B?& $KH<ZJ5K]ULA?G1L698)N>05F\RSE!1B7-^6<C
M^QGI73-K!LMK^NY8Z.1PS3%F@3@&]:91\$7-D4(ZES$%LV56(\K76BDC[GO!
M@DG$.&18DW\C9M;*Q%B7%NKDUQ2+9798O<\<TWM/.L2V9UK,/@WXD+E,YH&\
MLD4-/RZI;O/A*6N%\;'RHOJ^B?)$O,"A7K;+_!XZG6PJ$D9&/F/&=NU]Y2MJ
M0;%]CPPS.S@^?LU>^<DCM$WY2IWHF&UE?K$@CW[:7I\XUI^9CF(?,U>S^4B#
M-]?[<7%%FT\/=^VLD0=/Q+!Z<R3NW9#T^>X(CJFT'=:*_FPV+<O*[30S-_&R
MAH=GN:<71 K-;)+2&3O*/>EF;?T*ZU83/N:&"OUC1)[KA6<09%.1+Z2O5#*F
M1>A3H3+SM\XK]?F,J!\GGAG.5Y@^:QG49^U"]?F]V<A:_OG=L: Y/I]$@0RE
M8?PQML)MTBZ#4OC>O,NT1K,=Q?Y^U\J8]EZ)9W'"P&(A*_A6!7RK%4RRJL'_
MO;_/F :A1]M<I]SD<H, ^;Z%I<V;7(K=KW+3_I2;-H3<<3M./;?F75CWQKQ[
M?'ENWWYOOK2?_ZT\ME]:J]W>WH-H7TPL@/ONV&Q!$MO:TH";&8L+T6W YC45
MEU$*;Y8/ ZE'>^"1'0,^C7?(_,<8#)UZ]D1YIB/7"Q0(F[ZXWE!1BX5_*('+
MG_G7O]0TK?BIZ0ZA;Y,\_U/]%'_\1I<_&?O+G[AC;_H18ZI\"Z1 /.7-]4Q?
M87';7-O@K4NKS+^Y-C\S.S^M@;H%?_+&OC=7 :5\B-XVW7H@>N4OX?& %H3X
M(![P*I;)U_CXXZYOF1;A*3F[@_1ZEFWQ:WS0XKM.$+@V&GGNR&-7\B ZPQZS
MYJP^<,/8QQX?MPT&?#]NUM5.T--00X_MT;I/'?A4$,V'3BR'<&-6QPT4ML$K
M?0-) LZ@)R#4,#-CJ";P[MG6KB%<Y[4Q=[M)?<.SNNQ3AE]6PVP9UBA$B=M3
M%I;9SF##5Q1/&\7?1)4]RBL?7)/:;&=:]CUX%#02=/8GNQ0>0YE7PJ6#(1[!
MGH9CAYU.&168\._O!@K<_NC%8V4S#AE&=A6POZ'Y/_C"V-G.(+%5+A@B]P1L
M)A'\ +@N:CFAN$"HE@=7_1'(G>VF9KM]EXD2P ;^11E%,\E7RLMVS\9V"XY
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M:C!FAZ?4YCYXZA+C1]]S(9<O1"TU#$I[O?=ZOZZJ6YQ)-7R?!KLLK]S:U5T
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M6TRNDY<!"6Y=ZC^Z07C"Y2,-."=WR!:F%;;9;[YV?*FY#(X1HVV#4TX";2N
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M<<WJ=\GI'#JT/5B.ZX%/B5?[[NU;RI!^YZNEI#Q+2@>OC(-HRQ!U-(C8)!F
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M'U :^-$> Y09M$)\GT9;U<\%\LS<K6#I*;_?M?PKA;ULIX?SY"!Z?# @@6*
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MJ\TDJ^XM$N#J?@9#M%Y9^K)_IVJL4U>;TK4-^NYY[G!5X^O] ;L8)A\L-8$
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MFII7:W(J/*,(VB&?.0I!%;;/#"0K*IHQ7B+HW,G*40"JYFXJ>B5?+$L7E$T
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M0LB=FK664DDUH+&, "(V-^PG8IF%V/\WR<@*X(*H,2!1VTV]IMX;MR6:0YZ
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M,\E3_XFRR*WO_I/S1VG326]T5<V0K<HZR NJ$\)!H&G;!)@E?<37" 8:\*]
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MH<.I!B0BTM2WIZXWH4W$?>HSQ (,J>_YMN]X<#FMR,".=%%S*4#X,@RM:2%
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M/G*2DH(OF 2J*E?_PR*?F-P!*E<;-_B=EF%18GRY^O^:5,YBUN#K<!9'=LI
M+1H$4TS70)^&3?<$]_QKZCNIBY3Z+S9' VWN3,<TKB^(3VWI. EG,=V'$24K
MDT*=-X;,?_]VF^ 4G?D<A\L<?5B>Y U)!N0OG^_P>;?35Y P[/(.PWH3S"5Z
M23 &+9VU2YFK0@%F&=F(6HQ]N2BAV&8^<%.?>I_ZL/MPA-D\!%V>-*"47OLQ
MZY_V"68_X!F*.[*9(W&</6=3ZAMA&A= %$OI\B,%"V&,C#[R(MZV@\(BR]CS
M!"5+WZ= :@!A16WF-7GI*0F/L0!CM"UG<6=*O'>/]M9  X66("1^?O8.:H.-
M[!G2*?F%+EOBYM!/0RU%^ <1@' %"ZP_Q0X[:(%Y02Y@7NJ$O4O CM;LLG/5
M7#PG5YQZM5$UGE-9COF0V8V>W@G^8\VLSZW"!G'KDA7C/+G)O.NQ$Q_0-.TU
M[9V2[RNQM*$'K2!"CQ7^H/F0LO0$@BG.G'GP'1G]52Q-\?<P>(</7](..U^_
MWK$-?_G?3XF3 YM6Q'D::;Z&G,0\>#9,^62F&YY;RY^XR?9HOJE,\UOA#YI[
M17]4D%AQ$V?JLLJJ_$H8'#!7B1W4CW_<L&S;;YD[X"*ZRAN:1YMQ]ZS8%&A/
M;R2,<#DH*3.>LR4^Q#_O;C/^R<?GY[R3\O]\_2I+#W> 3F -0/]P"-PU]Y#,
MYW,):2G*,5U)3E)-J)=2:B<>1ZEUD\GWY1=MA,,TEYK"L3BC^00=Y2A^EJAC
M*[7# G4SS56C&<2LDQL]&&F=>M(@*?=83-5D#R0>JPI%30^8@7[&4B_C:I+-
M];Q8LO4]]->NU\$6--6XX4#6W*";>:?Z*)+'Q(YSG]WI>(B: =-XLK?@*0V/
MX7$XV,!2D;WQQE+0!R-O I?%SN)M\+B!>KUGL.==LUF+G'ZXPMM6%YWD.YD+
M^CYCGXA@&@%M/+"&8%\28+TDP%JRFS6.Q5K)CCC_B!DO8$+[+H7!MZ )!US6
M'DH3ZU,+*1'B3*HNO_M_<G?_3^;N#6PF5J7((IOC%#F\6]MF5F/Z1;;M"%/0
MDG9UB7.$ZTCJG'6?X8IH@2VD5!8DM\$O2FQY9@U+_*Z4ZV'-ZA_MT!G$"]"3
M%<<1JU1!G%,,"^ZB.U]8,&"*>4[F=C",@K1/"\=,D:S*+C:&(N\5@[$N!D_Z
MVF*C:1/&J;EL*6?X_1EA&@UL#UT 46KJM7(>=DNU%4(<MZ<IAFWU>V[/[G<4
MH^_:K8[KJ(NFX9\LO2UY]&KOJ8BQK8VQ62==W[DVDK% ;J:J&GW'5)1VJP/7
MVVVMWU8ZMJZ8+6(0M5.?R,<6'O>UO$0/2Z8JVW&+X\V\8UE_95:S9*H:"D=,
M'%GP[G+_V5P#C]@I1V(&9HD4B:X>9Q*PL#KS;J%7$QWI(S1WZ%%ALZ0#O#6;
M1D:KP9/5T6(""B2:";_LGDF:RUP*',O6!N<Z 7J+>/G\&*O_(E#.XS:W_"8:
M#Z"'17,N(@B'Z8@VP/P7!0!M)S!8 :[8]X$#>^".N!\"78A#O#?:ME>FN7C8
M7"']FF;B#6G$A/5)F&"/&30F&:3DI&< -@6(LR7IM:]!X-(,",S63#_&G LO
MY.Y?QPG1)XU>8>XRR$+]@\=27%T::4$79P+*I/'FIV_?$^7*&=K>* *;W268
M/!@O!@M"I\/A55(+RCI.L+\Y(CCM)K"@[^8=$&B#R1#[WD:T]<%X2-@9;Z>U
M%@,/NZ#1'3!Y@,O@CJN)_>LJ P.L9D6WF<S6$3=,@N<"$6122>B4J*N@?P4V
MZ1Q=$LS>SL"IF>U@0]B;D.O@^N440;$!/U\#W&*/QAP1DZ_9K2!AAAZA/>+2
M]FYLV]D>$90?6#*R!"3D@[7G@.;UYH6!G[:;0I:.YKS\M$\=/H^W#O5"9SI"
M8Q6K77BK8)KXPYW-B*N4L;R0=^>@;6^0/'HD07T<GP!!QCKF(;5-IC2(P!SA
M#C4G70\>$29!"%346&0PB%;(GP)W?E4.\'_PAK]Q8O%GS*OBX>941;+R469B
M=CJFWM/[FJ&X2L<U>XZN=GI63[=4JU/">U[GV'T,'2D&C_29YYV=GD/K*<^"
M-*(TSP8\DL/\-3[AP1J4U"SHQ25&ML(FE0'4+!J25^1E2D?LX/18)&NNN]9"
M.\."B.S\J8>R['7JT>^9T412(1<O+J(1/GYB+@8D<ZVMYV0*3S/%Q=%F-7*V
M3651LZ^TPQ:V,@:Q I?R BI:B> $XX+#.[L-VKF9PVD$I$%;N4F@?B:F9=(]
M0W)"CTJ,S5LTSF55H3)?0(E'2+0JIDUZIK:2D8F'7\)"$IK1I%.4*)DQ!+&B
M.T;;+.(_I;WU@+R39 ^TU7M#+QJP!JN =1>N2U463'Y]2[5"N 2S3?EA>\.5
M*O8Z[+312^M3T#^ *F;2S8I2Z- ;43='?#C/XLD,-&KJS"6+CK I%CU1(^KI
M%W1T8#J:K][,]]GGJ,Y*SQO):Y*F7""YTM1F6NG"5 V949 =%0BS(,QURUUX
M&*^(HJ(W[B5<6!XU29@B$:V8:<RH^ 0#/0_]C!Q.\JM261R+7LGN@;4R?_39
MX_'0B\=+9+.J4AD?XX2= UA-$L;X&=':3<K8R9U-*;^>S=:2'L-90=(/PH7C
MAT6C>$ )'Y"G1=I01O+Z.8KDW4;Q=?DC"LP+($18'K9.H'$IVBBD/V/E-C28
M&H29:-@;K=7G;Z,)-'AZLY*L]*4>R9 [H@;CF2=(9[?SD 2E*&,\ +!ZA $)
MX>ZQ4Z40SLS?O !MH1<<22](! 8-/D;3?A\3IM$P93P.B&4BEU +.:,"H*0-
MII-LN_-HVDM;46:</-,Q^B%N!(Z/@V,OFE/MZ!&)5:9)J/LMD674BX+N''IP
M)PV8$VHA8\P'9J=!,B I\6$D IA5(7V(/B+[SSWZXPW(4$$(AR8$QLR\.(Q-
M5&*-F$ +MYV?<4WYW %(%?9L)7)>]VKR(3OQD]E1/\%.5ORH1S]ZG_7PIB\J
M.A*V%/Y6\?$HZ&$]/?!>OG%7G'GF!T4F'NO%/I%I-VPZJ(R7E">'P)P^S9-E
M44F,4N\[3:_M@_*-9TB!\IU(CTPC94JAA)85.M39LB6)J$I;T,@6-/*2.1GF
M)VUQ&HFG&]@SG-X _V1]3,5&5DHUVQ\! I^[X_.GY_R\0L4M9O<W;LX@HF>Y
MUM 93D[&Z41;JG("?=N+[/DN69@<$?8*Q6E<I( -3@2O'0=9E+5X_WSBO16?
M>S&B@.,\EX7:)M/P)+MR/,R%+%+'0.SY2)6^0NN?J9KH.T ?R0A42.9DR53R
MON"\51N'C-X%+I5'\RU TUZ64EM59&G/5%&V16]1*<LQ$#7O<J/Y!J!^L6P'
MBJK)G-G(D8))%]P[AZZ=93ZY%<ZX-<G (J=L;4Y9^Z1SRM;FB"W.F'=,I^U8
M/=.Q7$.WG;;1;NL]J]4V%$LAEG$"$?ER==WKTA'FP6/U795H)G'4MFFH;:O=
M<_K]3L?NM]LMQ>[K19'_1^3#=8D8-0'J%B!<#Y*YP,12]_6RH,3[@"01AR3J
M'_%V]ZP_-^O+X^#$<=X\,O\%+,$>SC!]B(I7UHJ<59XFWR13::B9SL0O-Y(7
MQO]FLNJBU/M.0RWIO;Q=$ 9Y,3]M87;F39SC,+]Q+/L;\+ />]0J'P![]6;F
M/URYTO:7/M#WQ0,<O,Q""G5@IN?"*FAT9E*D?240P&0E.5X%CQO2O*;LO(,>
MF3-Z.+CPA@\)&CZNP .=JXVY6CAY"<_+!5J+C]E-J.@[3E/')7R#!4IJB\YA
M5[5D'OOR!!_I ZXC;NL5[V*S,I]L:GY07!Z?*T:D@;\)=1BC$E<0\\4<&<9A
MF)^X  $,02R!PCQA8BTV#S<F90-I#T>>E#=)?9Z%0<H",4B/L^R95H\,KNT:
M]61:<4:+N7"Y_.V>WG$T6W5)VS -3>^U'<6QS5;'UAQ'(W8_UW$ES@?)ON5<
M.ZZL!<Y<<L0TXK$1.U,V6T2!2;BX*!\XBH<H)LG>2_*LN4UELP9VA!]CF.P6
MTBZ1DTSJ W7BCH@=37E()Y\5,9<CQV87@_0)L>Q[+KTWSOY>S*D+%C)* S\'
M"Y07<IP]E&7CS$57<5(\IAO@2 R:6D_27%-2"+5JDTSY4.3O<5[YFC9&YY(P
MFDZ%EDYW//SMTGX\V8,DF>64MHROW9!M4U66#MDN&'A_O6:DMIR?J9U3,18U
MC$S/-X1J+/QCO0(?R&YL+]X9;WE?*DB\ZS6^A7*YY78TN/5=_ <CFR >\0W+
MV%Y5<V=IGUCM/G'ZK9YAN&"+M!Q'[UBFJNMVQVJ?BYA ^'!:@E\RD#H]8?&C
M2+F-MT=_(>GVBILKCP*?H&(:_B1PF$U]E]=G8/L+ZJED1[5+J!\J;SFDJ=\X
MG@J>/?3@E:Z4;4V>9)!1XPY+^ODBWO M7-$.I)]^\.YG*Z>2K0 OX<G/4[Q]
M@ /F<]BS*#E501V(*[;2(1ST3%\$P_K2_MJC?8FVMXY]Y[0]G 2!/2!8\1 %
M$O:58&B.M1L^N#>B8WA!W[/]GXE^AX8@W108->RH(K\<0MRX,QL=_$VSI!-=
M[PMQZ7/N^5L>\"IJ-A>-BOIR_Y#XQ>?IK@?RG[S1NJ?8_"*_X)',&8)79&U@
M!Q;B3=AX0+H=/KX KTWV7L0P18V\EAW/*QL?%1T Q9"F$)88(#DH8S#P5L<9
MN&(=AST>A\$O6KD$+%5J,(*Q>L0)2L<_??["6\J49<<<J%JCJVNM=8,.2JW:
MW/^J=5RUT;26KGIQ L9BBCDG2%Y/YU**Y)X>=$31*?;8<IKYC:*D+BBMJHE9
M)B)SB4L@=";3I-TA(X(E#@XZ<C IBJ3$3WEDFFL(5$K'>*0'!5,*G6E(3;D%
M(UTUSD11>)B?KI%N74KW?GHZP\*N1NFNHF17606!NZ(R7Z[0#Y@40_]9,(V6
MD"YO6(J""S029 9G:$=1&A>E?> RBYSS0'+_(QX]V<.>60<T^=XE*/V383%@
M?W _.+V9ELG-MY)%ACS!N/7=$A2P22MQ'?H$4V-B+\IX.(U8)7;<U81.;J%(
MHSH6S9.E#WP%-6U"0P;VFJED*O9!S@PM*!(1=ZQB^)&_@XTAVV3XF*F:C6Y&
MX5O4UYK;G<C+R)<IGUR/V/YH594UQ]3MF^T-$41?@O#%SD+JGO0FZ5^ESZX6
M-D[/SWS899A5JZJMY%=K-;KYM2Z>K@L":RGJPE20L"DS7W%(M*0634G*^ \'
M'NBD($1F)R@"/N=E\P+SIQN-^[$M7+P,9#PA(J[R3: 4)];_>QK@*[CA"((<
MZW*I-0:OCX==#+S0O6*I>;TP^$DM18RQQ"1#PRH^B\>1^%F\C13M'8!MY/*;
MI/)J&+RCFY?Z==^"(0X'9^-(LH'1I#@D]Q:F;D]GA'=UB,APB+^C=4HK1_#9
M9*']WGL"KQDO],HC( :BMA*(:5^#].ML])2A'9&"IM<KGX<Z!^>@A_70%(Q\
M3]BR4"2K[)JLTCGI9)6UR2<+3C]B6FU3Z^B6YIB&8G9ZMMM16Z[A]GLFT5O]
M^FCO)27A@ QSG0XX"R5>L!'\01D.&P.-1@$NFP\9QG+O61#&1=]QO)UVA"&L
MMZL'QR8JM^-I#PP*N*G/YK0G#6N>D\E)* M014F;Z'T#YOB5Z2;<E#[@44_[
MQW%'6,0&6K_2[(,_@B%*H4BF%W],7D*?D[I)'M!.F>7]#F#\D="AFWVWP]#V
M>4(!7P=3GGOI/*/,J#[:48%-8^8..&\3$Z+<"#^^<FS=EQD4F8;K\H+VG=!Y
MR9/)D#<LRNZ6)T^XV0(_MM,LGKDEDEXR1P3),Y+(W<KU>/-M^?< HU-,KMW:
M7[8$X?OS=S$)DNJK7]Z^>:75[_8&<SVK='=5LF@Z(S8_ '=N"/&\4BZ7IESI
M=^IKIDD S!.6D3  @SRZ(]J>(S<U=/5;"[O)LP1?5ML>SSTMY_7"Q7^%93_Y
M&6,D'U+3E,73M66I[190N:U:/<-62,_6E9;:Z7<<MZV;*EGTE/V@4F8T#GRZ
M!WY"L9EW$Q!0KXM0+ 0=U;$C7J-(^YMADZLI\+$;?4P2CWAG4FGH111A!"Z^
MWBH51EDF<0HUE+4PZ?Z="\I8N0P!?U?8S\X>1^0Z_N7&]:+QT)Y=>SZ5._2F
MFWD]"C4N&F0"HN>KHPME7W-EK--IFBT5];%)"/^[\8NYJM:DJMIO$S?_G:$T
M#;.U]&NEJ2[];M5C5:W9Z6SWV-7?Z6WK=!9KZL:%+U9O*LIF"_J-4BZC7N /
MY-G_MZ$W4FN%UOI<*Y)*[8KX><FEG=REVO@77GR3M],6^(FQTN&'!"HL (ZI
M8X\![?_\&?L_4VN)JMJ@:B32:W&_%P":%^_7AH#9E7C22[FHIH?">"+1<UF*
MMWI:X$,E=0/RV6C'NT#N],"F5<%U@J;V2%,G"3FM2&8M>"Y5@\+D,#2WP7/$
M*W=^Y9K#J6<[/[$7C.]><5IT'$+Z_57TC17/1Z+N9<7@:&G_H!;>AM:QM"A'
MRL!#D6H.%<KS_['3%K-;HS55M=K;AS(^('T^ JMOX@2*/1:;.8/TU(6A-KJJ
MK!MY'];'7="!S%X2+:NDR+I7+DHBP1SGRQS6 9E#:W0-6==5P1R".4Z!.=0#
M\H;>Z)JRI0C>$+QQ$KRAMP_(' 9H58;<;N>C;$?ACM)&59_^=RI&E9(:52SL
MN%&L,6=2)9#1RD&F4!#4CUOV;8)\)[!) 'DQT_2]7\2]^HN$01&_F*Q#FJK=
M+ E+;\PUQ92[US-EX95+W2*"K+91WE>3U0:R&%.D9<W2!&6=,65MH?GN(J\L
M(:\N@:JVT1EWEE?M^LFKRW'*_^F'''^;>N9IWC$6FODTKYAE697WU_-("<]C
MT@%1;C#%K*AXYQM']\[4+JT00/464'N/%:0TOK6,ZE06-:@.K35W'0D&%PQ^
MH'C'[@RN*ZB$*&9',+A@<,'@-8O95,#?:F71&\'?@K\%?U?K0ZB P370T#6Y
MI1KGP.'4__ ;+?@I*FDOT=>(=BSY3BL]\6G1W*^TDROVGP0T/&'Y6.;;6]_]
M&MA^^DGF\J6M5G5]L4#,[9&^WFO9EJH:AF6U>V[?:9.^V5%TQ3(Z[IFT4LH
M3I:DS%^L[Z9Z(W'P21S<LD0!/G<IEKTAS#,?2E=S-\Y.KT"VJ(5CF-UT2.8+
MU9.&<>E5L@0D0COQ\Q)39VA[H_DK: >P<1 ,><TT+6&DO9$)&ZT59E&4&8C6
M)X173;*N%:R.,G-U,QYUDWUA4KG)FCG[O#0SZ=_$&NVD<X1XK\9@.*1_GV"E
M\SI$QH0>-X@>,T+/(W@)ILJAI(C%BMY\\2@:HD#)TBVMK9W_K B 21-56FD\
M#H.1%T5!.,.6,\GH*-II*YTF-*9#+>"P7MZU2LX_"M&T# EQ1X82A]US\GQL
M?1Q]YD_^$7PB=_%C_TF?NJ)+UP@+R])C#=-;M,7288E>=(I-"^[62-.(4P)B
M@_:3&[ V'N.A[6?Z\,X]A#,;ZRBQT):$E[53>,T-&X\_ U+!7C^>0X"SB\0#
M?46A+*>-7N=;_A9UC.Q/A\.,Y,F>'*S=JQ>ELN+?4V  VJDDZ5?$>DY%!4TS
M%M\T""($S##NK!+Q#K^Q=$OGJP )C'A/WZ('T>;VK%T@;1C!+W>S G0:TI9W
M6/(>C(D_-ZIE1NP0).5+ L4%X<OOA5M=.LT#.=T!K3Q::$)11M&$IS_#PU_8
MLY_">_[D=!&,Z6ZQI]!SNMC_A;5NPH@F&[95R(@2;53$A\S$NUP$".(YZ7+3
MY$I8EIPR=)3]F*(;SJ4K>-H5I]4H;>7[Y27IA!,2;]0#*/*CC+;8F="I[0[P
M"&O-!R1+19X?D?GK<= /CG:@W>,I]N>_3LDN)C/>-SX"*7.%$3S60I?N=QR2
MD3<=+3SB!.55<5]G.'( #X11?S(C*&Z'G/:/*% HF])CJFV$Y,TC[Q'O@#.*
M6WPMT469L,-I4']A,!1()0C1C@-1X0(C]1"%#D +E)=POD_MW!=TD>^ Y0'M
MV(]?T0Z2Z=2E"?SI<NPZ ]M_9?UTDD>,[1E=/E 7D#WKF)L, J3ZC4M D#FS
MM-5N#+'YCKY 0SB-Z74ZM%'D)7O#9TR'7$;Q$YF--YDMA0WEP)C"0=UZ30>A
M\"<@9)V9 Q>S:4 V8"KX>=5C\\?YD"WL(ASWN<OJ:@M,.=?1*=49*(9H>SU^
M=F3U0)S])/GPD"CB0YPX%<U=E3;10@*2L#,,]F24<.CU).WD"L>#=[X-U]?:
M[MWO"X;</)07IDBQEHE9S,:M\#,4Q'K9P $$=C?]@,ZXMQVN MBO(>&2,#F:
ML],HX-S"P>2,!C(41T]W.PIP^ :V\/^)!QNLA1YXM#<7,( =NLD<C%2((!G3
MZ:;S_<8XN()I!$^" \@#.<![S2>OC18)EAHSTY"KNTE7Q&3J6$:<9%<PUVO;
M"?$C?$H&;'A>@&+E!?@X9-B0C4N+9\7SMO&)D(G5[7EA2=?Q3F>N];(*1SI!
M=,T#XO/P[O/=U^1 C&>,YGK-U_(@*NGX*3G!)'L>H+)T1\&'OZ4Z3BOG0VO;
MMF7KEHJ#.DU;Z1F*[K:)U3=L2^^[[44?VMQ;* VRUU#5>LTP,-$_<YVLU)23
M[I^YMA_F(O%U%&+VM39<I!MNRVEK?3@)+$5M=335MK3ZN&RW.>'6<=:<ZNEZ
MD?WZB@?%A)K(;P2@Q#3R])3JS6)35IK,QGP0 NVTB7^BY@42>D@[Z-+FSJ I
M#>-C*\(9=6"ISA]I3)MB/=) [7^?.X9>B<\G9<7KZ<U/!XD_CD"?M$=LYNB,
M+0W?SX:&)LMGFN'ZEG-C5"7AZ5F0N'-+R,"@4/:7DIOWZ6O@;AS=15_T \^^
M@BB$E2/B%B%M5]-,V]8-6W';&K&(WK.)TFJ;MJD6M:G+^"G8$<NV'"W9<XP(
M"MX4X4DW.C9;G9IJWJ_88B78N&A9]TCL";+0VVZK]G5T\/T2^E\'ET.WJ@.Y
MUU28["O=JZ[55#6M^B9E:K.E=O;246WY2VNW6+V]A_9OI[983:][K[J1Y[I#
M(GK5U0TTM>I5=WJML79J*B:ZU.VUL=7I0683:KI,R&S4@DX3+>C.[)6'KG8K
M]O(<.20>C$8X0,(>+GA21*.4$VR44FX V)J*$^YL^!(&HSON)\'\D3L>B/O\
M"X=B &!NT04>$?>'_:MT]FJ[T=7;<D?)S^0L600K6@P)SCD<YZQ)]3X$YW0:
M74.3E8*\;\$Y@G-JRSF=HW..H32Z%IPYVK+).()S:D1=@G,XYZC*\3E';73;
MAJRVZJ2M';KE71V-N$?B>IAD66S"B3X_&2Y:4X5[""[2&EU-TV2UH.A>])0Z
M)UK3CD]K.O8GU>26D2\ %[1V3K2F'Y_6#+!(];9LM(1<.V]:,XY/:R:<H59+
MUCIUHC413XA54<_=017=U%8]=38RC\]&K4:WU9%5=><>E/5SA0A2RY#:FN:!
MAR UJ]&U%+FEFX+4SIK4CA]4-'!8N]Z2#7-GHT?06JUI[?AA.*/##.P*%%'A
M$ZU4$645[I.!%R:-481[="U''3\\9RK8ZD!6"H:Q"2_"&9&:=OQX%M;YJ(9L
M[)Y])$BMUJ1V_*"/J36ZNBJW!*F=.:D=/^9CZD!JBJRVA6LTFT)^A==?MVBQ
M^9%44H[\[1*M15?BPP'H? 32NK$AAY!'!L@CHRUK2E4F\O'[%(M.Y(+GZ\OS
MQW?!FAB?;77D5J>J5$'!\X+G!<]O.USD$"R/L>2V*1NF+EA>L+Q@^6//+#T$
MSUN-KJEK<L>LJ@KM^#R_T0B25?WZ&LO;TY7J_?7B#(@['9*DZ]>GV:/]KR",
M$1A]FGVGS;EAQR_DE78J6](8S,RU2JQER"[;<VY@8^_P?]$NTC/L,$I[=-)^
M;5YO2COFS_4J&Y,0P1\WWO5)T@'N>O->8:+GUXEUIA(-RBZWY]=1F\:(GE^B
MYY?H^547F(F>7Z+GUUYZ?AFBY]>9O7(/@6AN--7%D4!-J6?:B/EVD[-DBQW7
MSW'RMRIV*G*MF3/"GXYZ),SGMLS5F.;\3;D9#\^)2:XFOJ,K+75*8.HT&##U
MR)L^!@+^<Z]$*UA<L'AI%C<J9?&60EF\)B5?QV?Q/=1EU%?Y^+247R\L3W09
MKYG5\IJ*K32;.U?R5I/T>7Q>$\G->R':5K5$2]/BFXH@6D&T>R1:JUJBQ03[
M3K,MB%80[1Z)METMT6(6MM*L2?G1\8EV/LUC15+'<5,BI+]])1%-?O E5?E/
M.E,XP"'KF02':),$!_J^VFRK9*9'L#K98W'2;/9O.E5>O9'HJ$Z2E(*?8U)(
M2VMJRAZR 5K-=GN[7),CY%G@8C>#0771Y].*?=U2GDD"\AB=KSY0>(H@N0>Q
M@4>QI*L)6 JCA&<<*SL-?'WX3NAT5O?C;NZU4X[M;>=>NR!7=J=:_1DKFMJ[
M>RK.Q94MXB_[(%I=J99H6UB&)XCV(N,O=R+^LIK7U&IY#6MA%.'*%E[!O1*M
M5BW1MH%H-4&T*[R"O\T5;96LX?IB>^$_[.&4//6_>+[MXYS-!S^:A%-:KO4,
M-I@S2['18?CV_"EQ;[$*3U5@U9;5Z;7[MF&WS#;I]_2^TE;UGF(ZJ"TL+^O*
M.O^T SO_Z!.OO0F\SEEMS]$#"\$D43A)C\2.IB&AX$&C/ &;E(';1@[/0^]Y
M4X<G]4A:-Y'43[;FI5M# HB\:()[=^QH0!V:]!?R[ZGW!@P,%\EPKSN%6\,9
M_4Z&)[R!28Q/@%\E ,-/POV6Q)F&'KH\Y:Q?5):& 6PG\Y$LV8X#/ U+&-LS
M]HD#C&K#\^ ;("]7(K_&Q(\(?3^NG4A#0!>1@AZ F,H<^ H7/ S\UZL)"4<@
MK'J3IH3;=^PPG*'W]@T139%+O;K%4!C:4>3U/7BI#7]-PY!O#6_!A5)0XM,0
M7NC*H-[=GCVDRXH&A,!3[) P>+HD9'[D'MP]P8< P?61ZMAB9,D%VN-^YF@0
MA!. X00!-^/KA%UFUK>P(WO$  >7+@5, 5PD>SP.@U\@S"<DLQK<,;QQ!HNU
M0W@K7 ^XQ76#7"?</YZ]-08/0SN_J@\J('W)NS<92)$'1 U/X[ORN*?< ;!X
M$^G?4^"1R:QY>GR5BH=;1KV(CI<)[,T.W4CZ%, _T@=D.4VY^7+[\HG^JMY\
M++[^+G"!Z!R*L>2VVY>[Y*ZVILA2#*9#"\\E("@4GGM>X^J@509R"+$8>C)2
M[1!I#SC-'@XSO _<3AD6:#+]<.C9/6_(J)41/?#SB.W1Y9$>+("&/P!==I:%
M>C8(47X)R$U@(,GU(F<8X+WL8>A"!/8$41'AO2$<W.]!^),R#GL)TD:6+7TJ
M >&?N8?9O6 ZR5XWRAQA38E2#RI3 (C%=Z;W##P2VJ$SF#&^39_.I:3GCZ<3
M"C>\GDN4:<2$&G]AYGDGR,D@4&$+ _L-D$>(+_F!Y QL'T-\(/:_DC<RE%29
M_Z+)$H")_:XGAP7G6\33_-T)S*0)<0:^]^\I%Y!4W'N_I%% ZQ4)UBO2T A#
MF0[,CK$1%/= 3BF2QJ$7H!C]BU)F@AZ0U7B$8&EH+PQLD/>XP@@%.@M>;A9W
MI(B9:UNHM^JBP!4CCV*"P4P]JN2ARI5V \HB10@*C*EONP@OP.R_IP&- 8/F
MS@@#K1T@.'9P,I( 7<&GUDDLD^"SG"!R8&L]JHC0UAE<I\AROH0*R0(;+IH2
M^>X2&7K@^S(TVK'R9AQ$'EYS30/9L.@T7OR?\WH_CS8KZ2UV#S2DZ63Y+?EH
M#_W$\Q$6E/B.)!0T=0&"F9^#I%IO#.;M52\D]L\KNP^KO[:'[_8L:OPVSV#
M70M 70:/^;B]9B7[+VKJD;3VR**2FG2>VU&(V=?:';6E&V[+:6M]J]VS%+75
MT53;TA;-/:='6AW'[!AZJV]8K5;'ZBL&:>FJZ[I:W^PUEKQGK9EXEI)&JY.D
M\7QLIT,61 P*E%CUSJ@X67F2DT)RP3-2H91_X()\2LR_C,[D!Q/^$CD^J@(^
M'@$@-_^ZY*:@!Z"AIF%R5-(W9E\XDSYX3=*44RN%&1^XR9E'AB[:)F"9?F1F
M8:S%Q*\ LPS61%\-&M\85$+0?\)@A*]P@C ,>D'([+I9=CG<S@$):^,W>"45
MBL .<"/;&8ABT) ^\$OG'L96\7%S'>E4&42O!8/\Z6=0EZ6 D/2'Q)D@54U'
M8VXD4V7Z';_FJ*,)6T@<:&"_!U.@J2DUQBG!HHI>3)G41(^2-[([>]0R8/8"
MWM9#DO5\UO6*ZHYO-O 6=7XPCHY?L.B\"=Y]2H %1_S\D;Z=O_"6\O:M[WY-
M69M;=^Z3_QV=.FB>P 7? C^,__R$5L^2'E"6LGC::)V6H9F&YO;UOM$VW5Z_
MIVIZQ^QUM'ZK;:SL&55G,R+OEZ%F9>KMB8VJS1QR=I(O-6\4R%2$C4'JH<J$
MM 4*/LA#I*Q@&J&9^/$<TPP-L]G6MFME)-HYB<5NTGOJ, F<.(!S?;KB%H.O
MYOH 'C W;E4L9<WLJYV2/,LTV#A PN*I88S[MC;&4%6YHY<%7TW =Z_PU?<I
M8<X 2C^P;*< 1H>>C'.,) MFS>R2/UH93^ZSG8I8Y/$665%J)TU9LIAWN,X<
M]1CX9!:[2.+$C5R'G)T3YFJW[\U;QQ=ML=ZI:*7F/>CZZN[O=W8TN/5=_.=S
MFCB4^)?NDPASV9[OEMKH6FVY9=2DE+C*9%/!+^?++\9>^*7O_2+NU5\D#(I8
M16MTN1=<\(K@E=/A%?,(O*(+7A&\4HN]E>&5_9PJ&VAA1@VUL(I<&2=C@Q5E
MV2<-1S!WGN4DLH"C2V@^EJC:WMZFN8V#\U^"\ 48XB6!^CWI3=*_2C,3UG;+
MM-E#'>ID17WU<4R [<AKM5;3JDRK$;15:]I:HS+O@[8L05N70%M[D5H;'(KM
M^AV*E^;D7ZE@8EW39);Y1O1[V%ZU_$R!F7++E[=O7FF.P8$6LM6JDTDFNC <
M7(U<3THKC_6V<L:.,$%'FZN,N]*1*NCH$NAH9VFT_F!K:_4[V"KU-=9<#WS(
M%E=)T;L]WD[7NPQ[2=5;JUGB'JO.: TMRTLK(U2KBU()F[O6-&3M0D,;B%1L
MQR^K:DN0T5F347M_HL@4HN@R:*BS9U'4JI\HJM31=U+:G8.5GJ%PY2WG!T/9
MGTRM+J0B;.9:TY"Z9YG:1HM94VHRC5&0T9[(2-N?*.H(4709-+0F,K6K*.HH
M]1-%9U[SF-9[\AY-957HI>5O9YTI7&[S9R0"UN8]4B*J(&NXHS:Z;4TV]*IL
MO<UP=61G@N VP6UETD KXS:MT35D7=UY4+!@-L%L]=EUM7FQFS';2E.I4WE0
M3G":X+0:[+K*+.'*#C4#5,B6;)G&2? :MS3C5<3@Y2T7*_9F;/",S&YUV)(;
M3#&[=VZ[NSS^!):X'M\U7OPQEG@)SI),E]N]3AD5SZC/,RZLF./V^>[Q=]Z!
M^14'1,2#J6B?:-&YZ5(Z!JC&&E7MTS2"%T3173#J>3ZECKN$:NZR1!-+S5D9
M8ZFZM*'ZQ94$UYPOUZQQ).R9:ZJKXQ9<([CF<%RS)A5^9Z[9P&%@8?P98"(8
M1S#.Z3#.FOS_0S!.NWZ,<R%55]0G<7N[PEZ3/D2$2-^""9'TCZ(8:P4CK:F
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M)H/<81G-GY;1_-F:9+;39Y76Z8RJ=+I26!8AG.4D]J<?$EC&7Z "O-IPPH>
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MI/?$ *1)".;;LCV+<-TR8J]&)HAW^7"3&S.^/)P9<Z:\=+1<@+ NK"*WR+X
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M!WTL^I&B)<TKB45D$G^$2Q ,<=K+. R6S^-@R:(4;#$)QZ&KB!-+\APN91F
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M?>R,%O6-XG@6Q665BW'109Q&DP5T<E?&>5$T5RFM58UK;<ID7X[/)%&D+ I
M28Q6@&(X# Q--ZGF2:]9.+-G'V4<BTUE?Y8G'.53:6$UV9)B5H@E_5':,275
M@E87FF8H%W>$*;*K2T)Z DD;R^'"^I)]X [36BCX_3D.F&."628TBR^MV&?Z
MW)#07Z(5&0\ G#K?LUQB=C]F7V690POBCF?^GTN$/DT%H:6]\8M]5OT-].=A
MK83SP_$GN$,&1'C=<L*4Q;1X(E=VN()7- ]N2&C^2\: R_S"Y87)R4,]VO5P
ME'\X+":GC+*8Y'H[G6&2QK"R*+3QX_PQ>ACP@E?ZH<^F/)]CNE.<^@X'O@ZG
M5?TOPPEZ5FE^#_ZU!9E3XG+R&6A)$Q_670+U:C]TEU,X1);RF. .:A?)"BMT
M:+8F1(3)6G^[+50&.FR :XE6JMC]W-M%6@R!2(VY7JA88Y4[*PG8C&6[HL*)
MSCW)O$EHUL,TOP6%#F6XN63']3:I&\SA;=,!<AZZ1-=+%O()'N^'2+[8W7_K
M -2<<TZKURM<M5I?D=X;S(*":EG4-?WT#4E61,+?!=I9P2. U/X"<PQ_D#(Y
M5J];1F*+*NOJ9ZV<LB=W#+@R(5]'":"*B626T=6Z_YKCQUPG#*DRG_*5](2.
M.W=L;8H>4\Z//G7,MONF9.XS=,RT^ZIM-3]TS.IKDM+$T+%+FKPAKA<\"L(;
M]/ZA@I-%<'<<,W %TS0N="K&EOE9"?NN.\C",L$<-VQ1TM6&)EGPR5:['7X^
M@9H/I-IW(%6"]TE<Y3U5HAYITY#:M("-J$5;*7;_Y".F6J6$K Y]+T+85;9=
M!2$\QOZLK(M<#KRU*0*SE4 V5+5TY;*A;=5OKY%K3<Z)OS EL4G07 YOV3)R
M;5_ETI9 N30U45(.'JC:X+DU."9MM]$*.Y8PZCN4,-8H?]F2D[__@X^=N:PU
M5#_Y*?6XL2Z@FXHG;;E0/&D:^F@T-&S54357TFS+ELRA9+J6[*FJ7ABEEKV-
M%4Q&(L!CL4]MY-87KRZ4C(8.8)AF.HJLZ;KB2,.A:9JCD3$T;<\D=7N=9"["
MC]1_^1G=E^NP_(9440)&97UUJBM+EB,K0UU%4O <R;)=TR"V2AR9N,I9NAKO
M%I6)+>L1KH+;5\1XHIAD7[%><JN-._=S,![=G0A2IR\QR5/7GZBI?<VN_GI?
M?^+N[L1ZW^EJ\VN5E;ZMZN>S6,TVSF6Q6M^VS":\RHD2(:$*D7O>ADOK*L^;
MLG=.)'[_'I'1<K)+;=])E_G9'U4W).W*(M]@0\-HK>YJ!S0Z#./BY*_3&"<%
M0% 1\7N(TR42ZY9JJF46[C6!Y,Z-NT$1C\+C;HIMB_[CK+0GOT*X@-:\!5&N
MP4?Z*<T?$%C^ -,>;W? C&TSQXOF<MYBW@&?M@+XD&?P19YND0VY6ID+4>TX
MA7T+'8]@!F1U$.(P+_-)>6OYGK_\=M?$9M>Q\N"09>>0H[:#^4(=Q8JD;G85
M9W*JU$_TX6?<>6AOE[+:&RBBK!>KY$X7H^54<X54$T_YXEC'L8[SZ@I>K76/
M5Q_;5DQ;9!T])L'<!V69YK<[^Y]:M4?X,X[TC&-GS.0<KZM19;FOZ"<KDOE"
M%B]!^)WUU<:DR[$_7Y_5W*S!UUU/_T;A4AX75J3";/7J>#"+&:!+OMB<QUN&
M6'"520F]-Y#E]<#XS9;%%,K,&UJ, 2*KL)CFL*22MGFBKR(9F]65#>D'-)Q0
M6SW!IK^Z)!IF4]E)'5+K+QRQWAP+LW)1F7Q IC:NL:Z=HJ(5D\MW+^+A:':A
M_ MTD]H89?<&P+PT5>\0\SJ!==5!3?,A&Y&;#AMMSN0ZC\C"%O7-;$5],R4)
M17JE^M:&4<8+4^AI'E%Q,W'BF:*(EMJELA2.5RWH;?LC5C-ZFRDIR%!$VRJB
MVD&UUQS++H%[U5?;3$GM#0S1.MPG?L85=1W5VE@#4.X>W%.ELUI2Z32TG.NZ
M!^V6%H.^2HV[!T_!IV7IR%HFNH+!P#;-#AG8'*^:US(/0*RFM$P3E0)5.D3)
MY$AVH<QK'R43O<V:*)O<-]@U+?.13<\1IIF/< [\ \^7NPA7**90B-R0"H=^
M<^XA/#+[V]*\IFG=3<;&$Z)D=,G*YFC5@NJV/UXUI+K)<A6F<?]@9Y'L6#A6
M4-U*.@WG4$E)L\H[Q+8:K0%3J.K5U>QQ)2T#PQ.&C5]?0=@6G:PP_*H9G4S&
MHIZ"CZ^-RC1NDZZ>YE&5,HTV$Y2+XY"X/ZW;:%53*=L?KRJ5LB(RZ< R#HK*
M<BRZ4.9$M:XBPAB]@=E8'\(..<3.1K-ZCY,)@SD.=,*Y0_#6YU>A"<_+1:A6
M-3"\EFJ%H07N[CHR\]I2>+E=LRJR+YI ?G HDKL:NJTZ[8\X-50GFTU@Y/ZJ
M<T&B8^%0N>:D2+U!B:9]OBZIO0ILC_",;?=M;'XM\9;NS4#G<EC!EJ[NI:K'
MH4T?3 6'V-NVJ,K%><PM]'S?_6 [WF>%$S<G[EK*XA;J;C_TJ6!MA**)EGV(
M,LF)G!/Y51%YBQ(<]/?#Y;?:&YB:J"E-A6E.3-E[3VV)]Q6?G:;T372PS@,V
MLN^6U8G\(-GT@U]6DP[C#4O9+<X0]K9<5-]2=&#F9["HQLFR%A5C+3DQ]W,<
M9FF6S^1F&!+G^XTS@M7?.I,7YS7J_;8ZIL*?W:P!M0H>JU,H%'/C;)L-(U1V
M&XE2O&_KL)*S&4_RGKBTO"D>4<(FR2I\1$G\YAU&E!A]Q6A^Y/%9C2A1^[IL
MG\MBSVI$B=PWE-V&O_ 1)7Q$2:N+Y"-*5D:4)()3 )F93)]0KGD<!Q]34CVF
M)(\L0@%1^)B2_8)^%SI<@R^RDV-*M'Z'\ZCXH)+C^FNOP.EZH9Y31=[J.VVU
M^;VI=+#Y_251S5WH.Y,*?++/D50.WQ ?2<*Y,N?*F[FRWCVN? UVX4[32$YD
M</!G'.D95U1*G+B$-DP<X<T$-U3#M#/>PU2,/6:-R$9+BS'YK)&3Z2%';EFM
M6'S6R+DB5LT2GI/WK%;LWL#614TO9G#QZNC.8MFQD&R/=H*JU!OHNJ@H5H=X
MUQ553TM;AXI<>_%T2[VG59F/$SD!<[..JYNI"A\G<J9X55,UVQ^Q&E+-5)6.
M$U&DHB3EY=>=Q;)C(=D^JIG6&YBBH12G"IYO>?;9:6:;!H=<?&;&%LVLI4$<
M*@[B4'C'P"/S-OO(FAFZ:PW14-4.&9X<KUK0S/9'K*8T,[,WT$5#+KIGN<^L
MLTAV+!S;1S%#AS]V.SU8,^,^L[WQ8Y=A&U?N.E.DEA0T/F;C^"Q..?*(-(V/
MV3A3M*JGGAV 5PVI9QH?LW%^2'8L'*LW9D/C8S9.BQM\S,8VG:RET6<:'[-Q
M"L9VY-EG&A^S<:9H55,I:V'V61&9L%Y"+[8=YTZQSF+1L9"HO%FTAF,V=.[T
MZM:8#>[MBM&]I0%F&I^R<0+>=?#\LB+WXE,VSA)O:FI.QQA0IMD8N^;NJO-!
MHF/A4+GBI$N]@7VPS=8ACQ2?LG$&==F\1_?!K$ _Q90-G4[9T$7-/#AIO=F#
M[7CK$$[<G+AK*8M;J+O]R*>.4S9D2S1*'+I\R@8G<D[DQY;@34S9T''*AB%:
MQF5/V:B<JE$Y&Z%LLL,N]QW;R_HQ".D,A,4X)$28PO7C2" SCWC"WY8S$L]9
MD&@;8%5P9EYQX((0$C=XGM&N2$Y.0@CDYYS,(H)C%OZK#AZKQ@HB%WJHY,70
MU]$Z6N^&PD:&PEIOH/:+F?D"0'N"2\5-UUN_>=3UZ[C^XNBJ9/TBG$\T)RX.
M>9F\BH(_@\7-X<Q\=DJXO95C"V;T=!W79>>+@S%P9@92&FH!@*+P#V:A1GBT
MP9R$K&"H+P@).D7^S_:0J=YIR$<]#*,W,)I%)NNHZS>!G_>+MM@ID.E;#BL\
MLB#A%+B7!X]S%OC,D @O3B3LC0J?OGPL2$AXF1_B8HJ09!HR;0:^-4E+RN!I
MU1/AJZ=]G"7:O<$L*)QX$07\]-5X4CX<&.MP>,,ZI.<:X@$3F 2SYYM\ZW3!
M6X9X^(@-N5_K,(J^L"I/-X7("JE'3^Z8>,L)"48;;)V/R\4R)'F2^L#8SC?4
M"+[!X]]- O=["CL#P$@ HG,4Z>&2],YCD!+;9CE_]>$@8&U32IR+0!AB?\-X
M1!+^&ZZ-3,+X(3T[_&-]/-,5#%2RC+YLM31*9[?''F643@<G50"9+F>+LM$4
MR4J2RS6&4H>"YP@=_?=KB3KU/6]"3F2A4A;]AB269#57%Q*&?E#L\-*\&65;
MO!R7Q '#?8M"^ \R=7"&9/@59#CJ,?^BN2OU/!:&#!JZ*)?D IYOB/(<* ((
M7ZO,).(9C(T2RA=X[K<7,OE!'B@3KDTC="*VJ&A=:O)Y#>W%@4CTO8CD.K)5
M&B42%![?7H+:M*'2@GC9O*0<ES.A#8,+D"/2!D8$:E.'UAO8HM6IHITK$1PF
M%QS'(XZ/P;*^Y:'W!I:HJ5WJ,G -@N,;Q@J<T8*$7'S4I1#X,=Y 'D@1[EIB
MT!U">F\:,8"7::*F=ZE3VAY>Q0N>+&KVS0Z7CC&*#Q;.1&@\]>22W9![P>#B
MV5\[/=4,#+(KHG*X";G/J36<&K52*%B:*H6[]EU7&5JZ,M2&NJQ90\MQ1K:G
MRO9(&:F:9FC_1K_LQK@@/?5X(S=(:;>RE9 ?>H5GB]L;_&2W!*S]'WS$,!<-
M .I]AA3%G[L%P*D(__#GTE^\/I#%./#N9MY7S)]@GWV:_2#1@B9@E,2W+48H
M<* @Y!'!1X9A2B:1'=-6-:*IULC6E9%B6NK0=(:FNQX/SST>DT7HBX4/\,2%
M3Z+-,Z/6D(GAT?;WKZY7-B5C*,OZR%%&FJFKCBVY<.EPI&BJH=GFYHC]2;&"
M/O'6!U'FNSO@B<#.4V"'O!/B*T= ZO(,A'JY&WGLW8RO]OKY:[9AZ289ZD-B
M::XE#SWB&-IP2&S-=75'7\?7@Q/8:$LF\RW<QHYC2E<-N)\L6Q@Z$V?F$IH&
MY4>89A&,UI(J"FD3&V>K;4I0C:&N*4QKFP>1C]?<LB[?/TB6 /'+*BG$PD3*
M;G&&H&DN%]6W%-,%\M2B&B?#MIQOA$$L]W.<ZO5SYYG<#,%4_'Y#K<5;9_+B
MO$:]WU;I!XAG#:A5\%A-1%',C;)I \_;RL/6<%[U7%61-,]PAHHF&:JE*K8S
MTEU'!ZPU-;=7\9[MM++&6SW7&4FZ+!N6JZFR/O0,0S:([CD&L4>.7<E;U^R'
M=(#C<9-^;+NO&_(^.3^RW;=LJ_&<'[NO*GH;F426HNSUV,W?J9;9(1!<Y5I+
M;/F$.D!<D+VNY/O?E;"DOB[ME_EW?&2U^J:VVV%=:SKA+ZB&?7V9D1 GG^S0
M].:\MI>DY@JJ+%+U S77&KN\N//^- .UUID(F4%QS="X ]/#C4LV1@ 3-Y@2
MX<WG((H*V9J'@>5@_GSVH/ZXI,GR'*P-,SBPI4-_N*0X?,VDO))K798>?]&9
M$)^=)V<"5N0#\7!)PET4!5B=!F^@KAGYK?#I\4[X##<BIWNWC."WZ* 1M#O%
MX[J&.S5C)K,E*@_%]E%J/G!2Z$I8[KA+E:Q'$B(,G&>21DENE-299^)4AF)=
MZR]U\R1V/IY+B^G5WO_EQ/,494M$K\*E7#>49\ITW);5U-S*.JSDE"WT.,UQ
MFBO27$4#DD($,B.X.X $/MB99)_5J%TV&Y^!<?$$>-74=W6DE_7^08,>S?F/
M83!M2OBIO8$F6H?GZM4ZMJXTCVW>Y<RE*9>F!TG3Z!X>D?A ZHA1[5K%:*>H
M^:I)^>KH>+,E^A1,O'LG#+%A$FMT46,TG*D?C9Z[1,R<\#CA5?HFVW,!&3AK
M0]35ICI*'*'#Y>56?"EL7K;KCWPWC0%\FCK/F%;YW\YT_E;X.L-U/+\*]]3_
M+F*TLW]U,QMW=_$;+;KX3; @B_60!1<_+]3+G8=Y'+:&(X1$R[0Z5(BW)UWR
MP7D;L,DZCL\VAUAV8\HI1ZTCHU;-^50%W(I@!_#;GM[) BI9&"%6BN['BYCJ
MV49NSV5B9=L,KYY;+8>>\C5P.HZG1\73%MU&5G/1U [C*\>M-9.N-1/"PE9I
MHJ$7<[A.WLOCHE,@=546_MD7[H/)A#P34?C\^5[XGZL;G;R[@\-NS\%A:7 <
M33DXKJ-7EZ)*Q^%..G G4U2L+C5R;#JLR=%)4>5C>S@LH^GP&T>M;GHXBKC5
MM(?#[ V4@R8F=AB#CFTYGB]6MLWP]O9P6-? Z3B>'A5/V_1P-!=[Z#"^<MQ:
ML^E:LR%LB=H0DLE[^AX7&;[.B/#P]/40W\95)&^H2GN^#5MNT+=Q)9Y7]3@Y
M:;8"9H-HRCQYX[*Q:5/7[E9<&[;*0T17C5J'.C1L#1N\%P<,7P[R\'AX5WC=
MOEX-N[GR"8ZG'$];]VK8S<4;.HRO'+?6K+GVK <,.HBV<;!3@^=MU,*%^SOL
M3)6X-7C"1J530V_1J6'U!B43NGC"QB:V=)QT,MNF4VE-]6"O!O?==QJ=*@J<
M6O-J6)+$PT)7C5H'>C4L2>X--/V2$\EX#+PKO&Y/KX8E-=XKC>/IU>-I>UX-
M2VHNU-!A?.6XM6;.M64^6)(&YH,JRI;=(72ZAER-OSGXL*=@]BP*#_WW?5&X
M$Q[#8$2BB*KLPGT0SH.0#A_@F1R53@^K-:>')>F[==KFOMC<>3218;99 '*W
M_G6@DE91\%3;X5%$(;,W4$LHFZ//%:#/P4X-JS>P+QEW> 2\*^QL;Y_&5?02
MXGAZ$K[9@D]#;B[0T&%\Y;BU9JW5L Z**(.A!>624C%VX'-MM?Z-QT.KL',O
M6.*P:=I7E3<&/A0TET.ZQW%&R@HV/A45NREG9!.G>"2?^.:E<@KG%-XNA3?5
M#Z1(U&HCWA9.T9RB.44W0-%M#K^R9.SL)2I2PUW_+Y?<VW!G<!;"6<BIE()]
M?99R6\-Y..O@K(.SCLZPCC;=R(TW&+QX%L+)G9-[,^1^E,'REHR3D7314ILJ
M*C@EA=.(P6\+!UX'_WK^C\%?X$>RY*D3/OLS^FZ]+&T/GD)O3;?(U@K;FSCS
MB-PFO[Q-)+T_HR=,;WH;/SW>-[Y@;:GT?>SKMR^^MQC?VE;?-@U$BSC*$;^8
M?2OW*<:LP9U]ITA]25$JOY;Z<N5WFQYK]U7+;/RILMPW]>JO-SUV\W>JO=]3
M-RY6ZNN&?3Z+U91]%]308EO4F;<#P.S;\HDQZZ3[/RML-?O&CCQK2^2WAOG6
MU5QMLU0]^$4(1D*:2[U#COIY;>\]<0GFG NJ+/YE&/XV4"1%KK'+BSOON\DD
M<&D] A[\%[(0F M9>(-.Y$+O[6L"S4?0+&&UPA_$G3A1Y(]\X@G? N%S &N!
M#XG_ ]6N9D'47-K;F8.=@[5ASN='J0OWFJGZ;\L9$51)%(#S*RN N(:^.Y^=
M)V<"]F4R+OHNB@+7=Q;P!NIED]\*V)CG,]R(\N#=,H+?HNB0!CV5]G:)R=T9
MW&FFD$V3VRMDDZW="MD:.Y[+=OGML/_+\>LIVE&ZJUFRW1NHHJ1JS3KV=F(E
MIRQYYS3'::Y(<^H)4G<4'!LMZFK#F7J72X%737[G1'OUII=5$=^&I)?8#LU;
M_]\"M/TST[\V-<I(C7*)VE9[R%FGXM0=3&;ALI7+U@9SVJ2,AAOO+78N,K53
MU'S5I'QU=-QB@IG2>.^ULQ#-G/ XX55Z*EMS""D:.H0TK76'$.]8MQU+%,22
M1\<%T\9- P*?ILXS!CW_VYG.WPI?9[B.YU?AGCKC10P.]WGCNDI_O]:>OU_1
ML8R:-ZZKQ=6.4^&N&+V!+)KRP07NO-%)I[%IR^R'?9N/*3B#YI+'Q''<J<2=
M)OV/F\V<YL;7=QC3>/NPKF#OOB6C"F]SQ_&T+0G=@OM(Y6WNK@2WCE,,I\K4
MEM .KH7K4!>\COM!*"[HJBS\LR_<!Y,)>29T*J'P/WPN8:6GPVS/TZ$J<!Q\
M+F$][K1O$\Z:W$D%[F2*2LG82#ZGIMOH5#-?IC#R(8(=P&]-.3U4C 1(#23"
M< SJ)D.JF!ER-(>'VGCOH2YBVK$-28Z].SH\BOAH8+W&)<M-CHM'Q<4VG1KF
M-?!.CEMK9EQ[9H-%S0;9;*H,@6=W[(8,7V=$>'CZ>H@[XRH2-W2I17>&W: [
MXTJ<K?IQTM$T6AUERUT:.<)=]\UCTY9JUWU]&!J6\^@'YS)RY#E'Y#F:(T-K
MKN"DPYC&(^)=P=Y],S>TY@HI.)Y> )[6"SALD]&[>SF*B*EAYG11Q]L]U-!A
M?+Q,W*F'.GL-MZQO+.#D>-$TNJ3O74-FQC?G^<;(ZE/2 Q1^AYW-J6N#)VI4
M>S;4]CP;FL$3-6HSJ^.DD6G84UVT>)[&A6/3E@*GO3T;Z+"7F^K'SY'GK)#G
M>)Z-YG+].XQI/"S>%>S=X-G8+E'!RAC(HM98)S6.JE>/JBUF<.CR-;!6CEMK
M]EUK]H2N] :&J)I&A[#I&A(X[N^P'7>2PL$3."K='$9[;@X=9YWS!(YZ;.DX
MB66ZAG:J:-N\?<)EH].6\J9]_1R@F0U4Q>+(<XW(<S0_A][<#-L.8QJ/C'<%
M>_?-X-";2_OG>,KQM'TGQU7T-.*XM6;=M6=-V&!-***J="D?_- 4CQWX8%O-
M@_F$^99 <SFD;1ZGT,.0>@,-6W0V/ ?G)"/F:Q+QYJ5R$N<DWBZ)J\WX;FH2
M/)VT8VN<WCF]<WH_;BY_%<$?=]:6H30]:^MRB;\-WPAG*)RAM*M M)7I96"3
M.]&PN.[ V4<'2(6SCY;TD09*"XV#2PNOA4=P>N;TW(PZ8!^G@LK >4NJ:!T>
M#.@ B=,@PF\+M*/@7\__,?@+_$B6/'7"9W]&WZU3HCTR"M!!9/^3+^WT(SAB
M,B6>\.&G.UEZ\,M=%)%%)"S&SD)P0H(0(I-7/%3XC A#,B,C?R$$(^'N\5YP
M9I[@P^71&*X= RLG8=07TB/;#($\</]O&2W\T>N)@/(QWMUB'!(B3.'Z<220
M&<+C;\L988BH2J*@2(I*-PV_*"*]YSZ8PHI?:8#4? NW4;H0II0P!#\#]M"9
M.#.7()E%?K2 9P,0\0FC8#()7@#WA#?^##X)EK 7+_KU=@\XLAQ3 "-%PI18
M&-8#."?./"*WR2]O$ZW0GU&@T)O>QD^/*0A?L(;T]'WLZ[<OOK<8W]IV7Y-U
MY#!Q""U^,?M6[E/FLT;!\7=VW[24RJ^EOEQ]ZX;'VGU5J[YS_Z?:BKW74S=_
MIUI6AR!P_+7*2E]6]=,NMD7KZBP.ZZ3[EZ6^86@M $#?$ZTV+=;LZU;UM_FG
M;DDJJ&'H=[6LP"S5,W]!T9:F_>]03G%>VWMP0G<LJ++XEV'XVP!U@AI;O+C#
M_@1&A+_2,N2:H7$'NISK4.L*:. +60@L\"J\P=!KP6%Q&&B:RZP\5W#'$2T.
MUF;!^AX,E,2O?\W4C-:?D!A^*X"XAI90GYTG9P)69-(4ZBZ* M=W%O &:N[*
M;P4LF_P,-R*S>[>,X+<H.J1+5*5_IL1%TQG<:::V4FFQA91!IV)LKZUL['@N
MVT>\P_XOQQ&LZ'M-QJCO"39[ U.TM(/+!/=@):=LL\!ICM-<@>:,BF:;&Y(Q
M[@ 2^&!GDGVVM<I'RLBON2J?:R' JZ:^JR.]=A.I;4RC-"R[;=KK$N&=,*&)
M2U,N31LL[L[$J-G<H/HS$Z.=HN:K)N6KH^,6B]_-QCO\G85HYH3'":_2-]F:
M"\A4>@-9$G75/ M:N_#.B#0U[M%Q_9'O9H,AILXSIJK]MS.=OQ6^SG =SZ_"
M/?6_BQCL[//VB94N_A;;)YHJYLCS]HFU](GCM$4PL7VB:%D'=W7E[7,ZC4WU
MA\#MY;/-(9;..S.=*VK5F]M6Q*T(=@"_-=6BT\0(L5H<17(1T]MX+[JN,+Q]
M>R::O&<BQ].F\;1-MQ'OF7@=N*4<IV>B:=-F"?K!S1(ZU#*QX^X/B@NZ*@O_
M[ OWP61"G@F=#B'P,9C5#@Z[/0>')?$QF+4EWW'\MI8,W,D499N/,KQL=*KH
M"=">A\-2^("M<T6MFAZ. FXU[.&PL-^4<HB'H\,8=&S+\7RQLFV&MZ^'P]*N
M@=-Q/#TJGK;HX;":BSUT&%\Y;JW9=.W9$ :U(22SJ490/,-C-V3X.B/IY,L]
M?1M7D;RA*BWZ-LP&?1M7XGDU]AKW7)\O65B98:EJASROW(_?/#95^/%;=&W8
M/$1TU:AUJ$/#EM"A<7"J;(>1A\?#N\+K]O5JV,V53W \Y7C:NE?#;B[>T&%\
MY;BU9LVU9CW8*AV095S2J,MS<&K<WV%GJL2MP1,V*IT:>GM.#5OK#52>L%%/
MY)G'84LZ'<%K6TTU6^*^^VZB4_V93@=Z-6R#AX6N&K4.]FJ8H#%)EYQ(QF/@
M7>%U>WLU&N^5QO'TZO&T3:]&<Z&&#N,KQZTU<ZXM\\&6,/*@BG)C[>IXKL9N
MR/ W!Q_V%,R>1>&A_[XO"G?"8QB,2!11E5VX#\)Y$#H[]FV_UDP.JS6GARW)
MNW7:YK[8G$3<-\.LR)B4WD UE XY6[GKOG%T,8_4&SF'5BJ/"ETU:AWHU+ E
MK3?0#_:U=AAW> 2\*ZQN3Y^&+5U%+R&.IR?AF\W[-&RIN4!#A_&5X]::M7:0
M=6#V!MKA@\8[E(JQ Y]KJ_7O00/6+[LQ\&&@N1S2U8_DC;2 K%51EAJ>''70
M,1[)*;YYJ9S$.8FW2^+JL<MF;*GQ6!8G=T[NG-P/(O<V9V/9LH0YU*9R< 7F
MM=![&]X.SD,X#SF9RK"O3U-N:W@/YQV<=W#>T1W>T:*?66Z\ ^'%\Q!.[YS>
MFZ'WO=J:U3<P<'22+EHEXR_.C\)I2.&WA0.O@W\]_\> ;@KAZL^6-#.P[!.X
M,-G6U F?_1E=GT[IFFU^&/XV2 %!GYN[)SYA3>F;<,_;>1!1'\]M2";P@A_D
M[8OO+<8)!N1NC&$D9;<X0X#(<E%]2S$9D7[BSSSXZU8UTC4?$;/IK#3%6H5/
M_N<X3%8S=Y[)S3 DSO<;9P2KOW4F+\YKU/MM]1#@!-: 6@6/^+QB2"KFQC-C
M/]>.GQ*"KWJNJDB:9SA#19,,U5(5VQGIKJ-+BFIJ;NE;8RPI9HCV*MXB>ZXS
MDG19-BQ74V5]Z!F&;!#=<PQBCQR;L0"XAWAW"WJ],=2'KF-Y1-8LF=BF!0O2
M7*)+LJ2X$KR'(GN&4)2ZX,PGSCPBM\DO;Q/EU)_1DZ,WO5V%'6YDC;CHOMC7
M\0'8=E\Q;#R#.' 7OS@^GCX]GC5.$7]G]VVC^FNI+U??NN&Q=E^7U!:>:FOZ
M7D_=_)UJV8VO59;ZAJ6<SV*!O$Z[V!:MO.T L/J:>>+#.NG^ 0%T53L3;+7Z
MMKS;4[?D,M1P.'2U^L LU6=_$8*1D%8'[%!U<5[;>W!"=RRHLDB5"452E!I;
MO+C#OIM, I=I,W#J7\A"8"$/X0T&/0JMY*\)-!_!#H+5"G\0=^)$D3_RB2=\
M"X3/ :P%/B3^#U2YF@51<UF<9PYV#M9FP?K>C]*(PS53]=^6,R*HDB@4./\U
MM)'Z[#PY$[ MD^GG=U$4N+ZS@#=0G[#\5L ^4Y_A1I0'[Y81_!9%A_2;JO0.
ME3B(.H,[S=1E:G)[=9FRMEM=9F/'<]D.ZAWV?SE>:,4\RIQX6]9[ TU4[(/K
M5_=@):?LX,!ICM-<D>:V-.AL)]4,AY"(BGEP4^UKH<"K)K]SHKUZP_BJB&]#
MCE9LA^:M_V\!VOZ9Z5^;&K$5G"B7J&VU9_9U*JNB@[E77+9RV=I@"J:4T7#C
MK?+.1:9VBIJOFI2OCH[;3(=LJ_RJVZ*9$QXGO$I/96L.(47J#511T[2S(+4+
M;\!(4_P>'1=,&S<-"'R:.L\8]/QO9SI_*WR=X3J>7X5[ZHP7,3C<YWT8*_W]
M6GO^?D7N#30^4;.>.J$>AZLIZ&0S%:-#C5AXWY[FL6E+\OZ^O?04%="GZ!+B
MN',%N-.D_W&CF:-HU]!=C'?#ZPKV[EOAK/"NC1Q/VY+0+;B/%-ZU\3IP2SM.
MZ:9B4EM".[ARLT--'3ON!Z&XH*NR\,^^<!],)N29T"&;PO_P,9N5G@ZS14^'
M!<?!QVS6DWS'Z4RIV,"=3%'2^)C-<T.GFODRA;XD$>P ?FO*Z:'BQ*62#FBU
M$V$X!G63(=5OBM6LPT-MO%56%S'MV(8DQ]X='1Y%?%2P7N/@7NT<%SDNMN[4
M4)L;#]5A?.6XM6;&M68VJ!HU&V3SX"@7'Z]9"QF^SHCP\/3U$'?&521NZ%)[
M[@Q5;]"=<27.5O-(?,G >@Q+.[@ZBKON.XU-6P8N[>W#0%^]S)'G*I'G>(Z,
MY@I..HQI/"+>%>S=-W-#;:Z0@N/I!>!IS8##7D,1R[P<!<34<-R*5-3 =P\U
M=!@?+Q-W:J&.OM>LUMK&@B;3J3W&P;4K/#.C%BY\<YYOC*P^)3U X7?8V9RZ
M-GBB1K5G0VW/LZ$I/%&CMD)F'X=9J;V!(:KJ)<>;.#8IUA;1MZ]G0]-Z ^W@
M<B:..^>(.T=S;&C-I?IW&--X5+PKV+NO8T-K+L6?XRG'T]:S-S3S&O"5X]::
M;=>>+6%16\+LDCYX#<D;]W?8BCM)W^#)&Y4N#J-%%X?=&Y08T3QY8Y/(.TXO
M(9U6$(AR25.4RPDW<712K&;Z)A?Q1P;\L3CR7"7R',W)H3<W;;G#F,:CXEW!
MWGV=''IS*?\<3SF>MN[DT*^BGQ''K37KKCUK0J?6A*IT22$\-+UC!S[85N/@
M@T;%7W9;X<- <SFD;1W'?0D,9*!IHFH5FPT<U'3XH&,\DA=]\U(YB7,2;Y?$
MU2UU7*W,O-)I"RU=;GCJ'*=W3N_72.^U\OBK"/ZX<[9TJ^DY6Y=+_&WX1CA#
MX0RE707B@$8\NMUD(Q[.'SA_X/RA>PI' W6#QL%U@]?"(S@]<WIN1M[;Q^FR
M;> P)56T#O?V=X#$:93@MP4:2@.Z'02I/ULZ=#]_^<WS?PS^ C^234R=\-F?
MT=7HE(R/C!1*@A3Y==*3\67/&.I#U[$\(FN63&S3<G1)<XDNR9+B D/^GWP%
MJ!\!LI I\80//]W)TH-?[J*(+")A,786@A,2A#69O")ZP&=$&)(9&?D+(1@)
M=X_W@C/S!!\NC\9P[1B$ @FC?A&&0HH.&V I*ZN\Z?^6T<(?O;8'7_K$6W\!
MKW-W@/C?''S\4S![%H6'_ON^*-P)CV$P(F!T!S-G(MP'X3P(Z8X[N=^-N_LT
M$_[FP'F%KX(B*2IL[O'F[N&O@B+,EZ$[=B+ #4>HFUJZ&J)H-K74H U!BZFE
M@H\9N? L^$4H'II3>6C"&PR(*]);O%QXO*=_R6]_Q7NF<?FTF[M\$KC. L "
MK_FKX_IDYCG"7RE,(U&XAT,%HIGY3C\#I>.ZJ"M%E)R0;OP<+<Z$^+T 5: C
M2FZ$ @C>CA!"HHN? "Q/<*+LP7 ^]'IGZ$_PAD4@D)\ /3\BM/$TCBATZ$M&
MDR69N404P+X39L&"GE@83(0 >*20V[ELOHV$8$[89J.^\#%F 8MQ2(@PA=O&
MD0";!@C\;3DCC.^KDKB./R%Q UC!?RBDT%V-^_BO>D6_S91I[B+CLD'5AMH;
MZ)8HE6BP>%@4W' :4R!65(-QS50P49R(%O /?2WNENT[ V'D_SPN +63 %#K
M#6R]$0#F\?#;QON&SL0!_ :)1 @E,"K7Z,M",HGI-26Z^.JH/D35U7XK>J.*
MEI'!4.\-I'ZQ988 (F""BW3HVHOXTR^(("97!G\9AK\-*N53%^21K&#7BC'P
M<.$%ME?G6%8RYS]]^;BCP 'L"+^-G=DW,D7N'KY^ N3R0_RNQF1[PZCIF[-.
MNEJS-Y@%!<0J(=7TZ2#QHHBRHQ"95D)/*&Q6Y%1&8%&J..[ \J@V";\H:[A;
M5,D18:F^Z[K*T-*5H3;40=\=6HXSLCU5MD?*2-4T0_LW[G*S%H;H&%L1-V@.
MW\I6HI?YL-#9XO8&/^GM1#[KZMWN#VZ/OLQ2?<_H,^ 7?\8H_&4YA2>[10++
M.9!7HTS?X+)WH!1]SW#,8C@/)T>\.\1*6Q]*KB(;AND1;62#@C@<ZJXI&4/)
M5MT1""8"F#I'3A0N26^ ;Q"R5U 46?^,:BOR6_B(X>.C \8>B1),CC>R=FBE
MYM/6U75&EZ^T7<I/FX(L3$'62?.DICD6#]XV.KF7;:;65W<1@+V$W Z8WY>'
MA_APJ)$U!Q7,CZ( 3#%0T(DP@K\% Y1'9A=\_GR/%DEF8 @3?^HCXD_\1/^/
MM2/!"U!!&BXC6 2P;I"F"=B$#V@ES4.P$,!T"!#J<&4]'<C2-NM 7V#U44:H
M7\BBMOICH_I3U?4\IP,Y ,!H.:&."2INX$')[_<,&*E1D[</X?2K9%=?^)1<
M".HF<"-XRP)?!$P&'UW;%MX\W/P]&2X^S2)@>_CRY-5_P,N>4!7V-AO#8"$-
MRFQAT)MAC[ BYJJ)A+GS2IDFE<635[3F@N7SF (*#F89(BR\>(OOX>QP+X)<
MI51VGMB^90@ > +(CHX,W&RP7("-05,G0*]988\Y _S^P_UG@)5')L(P>0#>
M@=_-0<YD6)4SO0'&>'5(?OCD);[:#S.\@^^I.C7VHP52^9]+>!())Z^B,/)G
M8)#XSB3]$D_/F>!W>((AR=: 6_)1D: Y'_!XL()^@'$/;_:C[X"^(\#6D>-/
MEJ!)Q\L*7'<91F*>+A*P, \"K&,:)92#[">B[X5E ^*ROP3R<TY<9#AN2#P_
M5@N'U$44S&)3"SC2@AEB[IAXRXP:\9F=1*/#1&KJXNR&=(QUHE,MJAQDJ<5
M*6=7).B,QO'9>0)")&DKQ3N0T4"J2!04&1+WX>>'._I!XC_L)+;ON]/<)I/]
M@5B)EJ6:"S"=N\?[F\]/ !$T!/$*']C;')[IT+!Q?<>+I;>M=)C8J+1?'"";
M^EQ>_,48^>#=\AF.B=FN*[*3.:FH9Q7N!?:=\7ZF/3 NF2 *RN7:VL0*&%;S
M>CY2(4(R(-36)I3>0.Z7M&T *1?\8-XT.,DI296A=']XS*!]3M'YC/YR % P
MQ:@0:%/"@Q.ZX]B]B9N?.SYZM9E@&"TGD]1]%PN+=81"4028F;X.?>OW.<4N
M[TW'%P!@8X\YX"<NK<JUOB*]:I]%BPTT3+5^0P^KQ>&RIE8:=2E!E1C 0?+<
M#$?&9.*A@I3R!G9:Z3EBVQ9D2H@%J>WR)B)$0.(6="$N7!1B7I3SK^*CJ(,,
M[1L?W0#IQ6S; MMWPKOZ#?J:Z%$=S]<4<VQ-Z9LZ/C>(?%SQ+16R8$J^??&]
MQ3C)(<C=& ?9I>P69PBJXW)1?4NQX4U^T:IQLC"X8J^=7^[G.$Q6,P=DOAF"
M[OS]QAG!ZF^=R8OS&O5^6STI.*8UH%;!(S[4&)**N?',&D2)8WL)S0.]A G+
MN8L#GX_,^KR;>7?4I/8^QRX+(-3W?N2")0'&2M&1B..95QV)PY$S\HA*C*%D
M:J.1-E0-H$K3!JHDLJ%8ZX[$9 5"O 0J2N)%"!_ H)E%>[D,MZYC4 ]23[&Y
M]'6T"\R^E?M=<>3AZO;/0NW\5N*L24/F\]RY.?&YD?C<: @0[&7B)8K#*)A,
M FI[OZ&AQF )"_.B7V]W4<995@]-",IX)LU  DA,G'E$;I-?WB89NOZ,[H?>
M]':5/2 C64M HB!G7V<\IB\Q/A,7+,=OCK_NTZ_6TJG8=R8P*[7Z:ZDO5WZW
MZ;&RW+?EZELW/7;S=WH[BU45>Z?';BD*KY''W=6V< 5>3O$* VZ"*HE40J$.
MOD-'O(L%1NK95.44(,H*0*YA-,1=&7,-J/I,62S8#WLF<A93-:\K'WF'_5].
MTO&6G..B(D,MM*(V<[\,PT(2P_9D9-/L#6S15NUF<Y&W'^&)6_ER4N2DN$Z*
M^HE)$>P=61(UL^%>(>W1XE4T0G;F_H+9K+&@Y^UWZPHSZEA_FA/T:B]>,XC&
ME+0OO=B]@2;JVL'DPGNP=1BE*IAR.RAE28A2BG*P-M2A/FSGP&2?EL,DX!>$
M-(1Q"*^]C@D,&WEM'IX SI@J:I.#W!NHHJIT:?@"'^5Q5 [;$")AN9FHR57)
MB'R*1SMHL%*M-R*DX)'BBD8-1PR:>7F(?B1[VWJ6B@1A\ D %XU2VQT*3:*4
M1D=$2UQW/2Y"O%_27+U\>J:_)Z.]#GUC"Z.E3K7#O6F6CKJKP@?)7C0N;>&P
M3>&20>T@J5A*S-775GVOL>F1%F?MRUBO0]W8PE@3:/[37XSOX]3BA#9>4\HH
M(K_9&QB:V2&M@BNJ1V:C^V*.U1OH:K$6@.NC+>>ET/P^+&,ELVBUI1+7(&HR
MS0_3^21X)22NCV] E[![ QF4";NI*"]73+N(5ELX:N-H9>- 4AUTU(/9+==1
M:R$%*YB9A\$/'ZNC>(Y $^9_8SDUMLSF]):,4>;ZZ^7@U"YN@.9P2J%Y6D9)
M:[:SUVSIN\V.L]QOV'%EM^*6DW1$ONB,4-XL>L^\[>;XC]H;:+9H-^:./*,6
M\;P)/*?K4\=L6Z-KC=*U;ES"[+C5OO!I>X"5^N!#V@48)VM-V>B#NUN];C54
MO9[ZB3\&X<?E8AF21\ T]_4=:X8? 07]?8:]3.XGCC_=6,AN%PK9W1&1--/0
M'4L=:KID.:[J2HII#HELN^J(K%=R)SUY/N?C2;7+UK>^=>^R]3RP\E !(,6_
M>%AECMTZXK+[##B74[:>](O/1?VNODA=UO2K+U*W98T7J?,B]?V <<D%ZN40
M>"BR45$8$N!;,V2;P$?G\.# $]Y@8RD,0^P[7.RJ#2=N&I5H>MO5EIJVD0D:
MJ2PJ>E,5!)?DU>#D=Q7D9\HGI#],Y=%%TVJ]-IT'GG?.\_ESZ8=@$&7-'=6"
M .<QPO+Q-INI9S?3^UW<79,>!&L&67L6I$UKV$V=IU=>,NJMS;OJ!N[!-C!G
M2#1XQ=#1T]JG\V"6C&=+IR/BQ% WB!91?CB42\\?1[%A4,&[W<&DWS]M[Y3/
M:$AD,^:A]!6]ZTC @D2Q#<[E]KYR^VDYGT_HL$-G\FG&." \$CCI8XB3#[$Y
M2+3$)B&?9M$RQ ;I?\<^YB^AOR!A$JO[%W&:UIEAISCH69-%C;>HN6@,W2;>
MNXRB2F^@8CIZ25OZLU<"SD86/((("&-)<&V5PV\.D@4XGQE^:YCBZ'FT0V\J
MS4>6C&)9<FWG>X<<E1Q'-TF#DR-I"1[2\=+%!.:3(&&CJK_=<5[/DI>+1M\A
M%L !<8#N$=M)?7J?8CN;?2W7Y^\ZJ/R*+:IF4QZ];@2J&C0&KA99F_<"'HRM
MV-<"U!'5;$K[[UA8YPR=@X]LOBD;_LY]@]PW>&V^P<,,PD-9*OOX$:_,W"Y[
M<%83.*MJB$I)^XO==6SN]>LR[C4OSYM"/JLW4"1-E-1B)<E)D(_[\[@_[]CL
M.W6/[*,7VS3;4#:*:C'WTET&YK7)O ]!/5G"GEFB;5K=0+TK],WA8;?BC3M3
M'T>3'#VQ;H&J/@=11)">\)?#(RLR!MME4U3M0T(K=8_PC-3QJT;+;>R^1;S$
MT0>Z)0)G/P.\O 8/6W:FUZ:;GU0U?Z3FT*>9&Q(G(N\)^[<^/=')"9+>I5[,
M7#_O?JRD"OU*,$SK#4RMJ28<#7+EY%T)5#56Q=ZP*K'#,W820X>\X#2+O"SA
M5Z,HF,R\K!RXT2XS.^F6G=,0FNVA5(#!Y;#I+4W06JQ(!#:M8QM&290.[TV_
MSRF>1VDPI\HKI$K[I&1I %G*BJC9#8^4;Y<LV^Y79I])O[(CZB.T_Y/=4)NQ
M]V2XV- [#/#27&\>1AQ[9%N69-E#2QLJINV,)-T;*:JD*C;11NO]M.Y#T)T6
MPD?'I<0C"N^<V7?A<P"[%VGSV<]8DHF*%+MR<V>QW&G% -&4OHF1S7G "CIO
M::J/_X-D#:1^6>WJ%9.$E-WB#$'/72ZJ;RDV[<EC@FH< 1'*&X%AA^X\?/(_
MQZGI,W>>R<T03+?O-\X(5G_K3%Z<UZCWVRKZ ^ZO ;4*'JN-O!1S(X5MZ FW
M'9G6.M?)KJW");8]&FD.T6U@'XHM$<^V+5-RO>ZT;Z-/O/47\#IW!X)>HY)"
M.[W]VN+-X"=[<OQ@L%O*B-RZF"9X'C T8>A,,.T_Z7X7-=7\KMB[ZYS:X1EP
MYYY]ZS9VF+/ZDJZTT Y/M7;K6U=[L2IOA[=#!SCAVEOAO2<NF0Y)**@R!49I
M*[QUYZ)>R[G88 9P>\[%DR[R&EH2_4%^!!-8$%6*#TDTO#2'1-D6+\??H%A;
MHC5HG'V:1:"1H6?AW@G#5P##W10[J==W,.  -4L2I4[-7VDHP,&)Y'*)Q#XB
MD2A2%XGDL@)L53+0F0@?:#]=YAOB.2;5-&%+QZ0)N3=0%-%J;+Y&A\)!'*ER
M2+4E=:E9I,+T/E64C6*^]LGS12[:UK@/Z!$R?-B?T9YOK5H]FE".21-J;Z"+
MIM:EOI*\_K%YG%*/B5,X'$N4]2[AU#6HLX]A,/6C* A?68OIQP/F&U^+_K$E
M_:)9NM!I.O3A9A[7:3N-4UMF;^R.4R/_)_%N_D/"H!2=C-Z AB"5MQU"J&OK
M_\'J$#$"S+N"-9^5VBS_-8'_XC1PN=CHHXLME+I4>'CI>-@8S]X%#VG/#U-4
ME?-H/->UJ'.GGW$-_IS/)(INA;3S51!2\@I&!XO!,V0RM4J;MR5[![/G;R2<
M(K?9;S U,!<;C0Q#;:""^4QEV*4CT;;1?F5(5,035>H-#+GHHCGGIE-GP#3_
M#H>%_/(_Q!-&_LR9N9@9NG]7X?.UJ9MDG*OJ60[&6&: .MIC2*;^<GHW\^BE
M4;3$7-U[!/L74I_)JAB>%"V-]YRZ5(2K90\< >%P]H>H'L2OVR]RKV<1\"+W
M=2.MC0KWLW&DH=YRLP#%I=2*X#6TO(:V :OJ2\ :<.]A6*G8S$;215DM-BWK
M<+%L%VK8KY[X+I7R:IBBAU">AI0'ZH]UE#+U8]6HGTNU(X$%3.D<@Y'CA\(/
M9[(DZ.P+EJ$P61':PHN#Q9#X-SS)$W#P[;/PF?P@$T$1_-E\N8B$>0A/"V&I
M*^,1L*(RI$6-\.5WLL#+7!+UA3M:2(GU8>RHDR(Q6L6=5$O%7\4E4R*MNW1C
M)WV\8%S:+%@(N)/0=R;P?L\?C0AU88["8)K;G2C Q?@,'^O#8/]""'?!0F;T
MT]+R3V<^#X.?,:#8Y3&^PYN<'XX_H;N#O>8>T6^DY/;!62Q#6F;[=90GN6_X
MQI+*6U4_V\K;K)@6IVS0\MHE;!ZK;J=3GS4*3 IO2X\))W7@EZ_8\A>;*>&S
M<D5W5UFD:RE]VVBA[E7K6ZK!ZUXWE'NR"&)9C>=%^T(I W]#?KJ3)25 I,C(
M_RE,X<XQ)4M@HBLUP;7='(>UT.T<Q/;51W?8_^6HHS4,P4QF_D'F<4/AKZ/'
MT)^Y_MR9_$&F#O99";^./OJHD6*+^%+=E(WE:E8O[5#/X#.,3@.[T*XL"'T:
M(ODT^P*/_?9")C_( ^7<]4T[DT:K#^_@RH.1=6E$O[)XXZEH!"7'MY>@/FE8
MO8$IRE:7FF=?B?@PN/@X'FF,0U*_<Z4:-Y;0#N\MSR5'7?(PN>0X&GE\#):E
M=H<F]0::V:7J^&N0#=_&)"2TF267$'5) 'Z,R_#_]0[AF>%Z34F@R2 );%$_
MO+-X\X*@,QGS)VN!=C;9)ZR,:\^ZB^O,.MD+!A?/YK+&[5D?W/I,36FI4NWD
MC=D[$FBD3RQKE%P>>KR;LI!$W##Y[AEL%M37=FKJWKD@:M5NA'D8_/ ]>!E&
M21UA8SQ:L8W-2;$HYE<0'Y;LWGK+\ 50,2*S'+:KO<'(_T%N,"B[CC%"2!M5
MTBQYMMY1W*YZ+9:.8=__JE>H;:Z0L+Z)A),>V0_.3W^ZG+X+PI#&H>^=.7RS
M>-V-Q(W<IK%)!H9L"P0NP+%/X!=1>!G[[E@ >V"RQ%-QA E9@*Z$.XUA$2V'
M-RD\X./E'*%2$PPK'2$_??EX7#A@4P1] QAHHH<C1/@6Q&=A$B#9K&V\YI;M
MDV[9V++EY.3)S[D?LKR3+ %&-FA$U.@+N5;D@A\!H?RYA,MI/@W8DP W^&^V
M!+7&>:9)+H34AI0J;>GZ5@:H^S07XR,A=6IDI1R,S-Y +^^)R! BW5R*!?'^
M*K<';QV2L+A#>0]<6-GB(PDQM0"@G.[D1LEMQ>H-I+YL%HM%?L&CJKU>I>WU
MVKA>52]"_I<D RK+9\KGW2PQ8$J_KY(P(B#ILQ-Z$Q+1-)UE!(L ;/<78_;<
M^1P$,GTPGF8NE0SY@/#GT@GAD\FK,'0BP'CXR;XJ2_>9$-!5X/&8C.4'J]3R
M G1&:03>PJ1=M "L&K[&'#;*L5AGD4,V3.P2@,[@UWV.3FWYZ'1L)=I7FL(T
MK>WE8AE5OPS1: 9>@\<O"O/),J*\ A0)>NK(1>BI SZR3^:L7U*B5_A1M,2K
MAS@Z)GX+<.,Y<7'02T$6%_@Q0"TH,&47M#_0XL(8]89D\4+(R@[HPKZ%2S]:
MT*DU+)MQ0AQ@>F'HS)[92S>16?_\]-*_[\ [\%LV:H,F[Z7)F1LHE !G(:&(
MEY0A23!?4''[QOF5?H\ZJ_#T]>,? M  IH:Z1/@#'B@*@+SN,DY7?0F$O_>?
M^L+O :#8C&K.3\2-?;G".\QZ1?[VWGFEV:Z8<<@P:N2'L%S/H1I+M*2Z7;P'
M-L^1HCW]@FX#D&@.1IH?C>&UP)Q6EWCG 6T EL"E\(HW'PE $';]!X$C /RD
M$X_@/7A _PK"[[_"P^G$,$SD1?T>4"W_L&286$PJH''-0T0Z> 1-CZW-/?0M
MW&/57'B')/U$7_EU]@\G])$4$?9R.>M0&N5T1JMK58_'YA 3AK_"4_ NBD4E
MYUD;/&:KX-%0WVCL*+=9,X>M%0=9'N4H4Q[>+#=6=N+&0CLOWTT45&7\B\64
M_!24ZYX,S/:OC3DK1J&VB[+S*5X,(LS=@HVM_C#SRE$'K#ZC7])[^)>^L"JO
MRX<7KL82KGP G7S6 ^BV#I1;&T!G6+9DV;I&[.%(4TQE."*&/K0MR[05V;"M
M,RK@J/0]QHIRM*(*QY5!DU=F(E92=-Q)PYG\F_+. FG+4H50H$')58GPA7*'
MKZ/_):\?D\?^@4^-BMY,X"2I-[/HP]#-W@"4Q:(#XSMY%=(E,W:/D[T=T/MR
M>B:5(#A-#J-U]!,J1%;MC"F<J("YR@OX/UP_94ZJU?L6-+@U(XLU&8-\%FNB
MX!"P*@I #TA1EVW6@>T]:,RP[<7G>!D4KK%?K12"@-IJO\1S@I@A]R4)A6YL
M#$V<3+>FH!S1Q.U$!HN)=]O#;2Y2%7CU*L$#-1YL/N9_6_$NAX)+0@KE:#F,
M?,\'90&+O #0RRF6?0'TYRC]%PARQP5T9GP6;_5G/TBB7E-'Q_,S>D+@IODR
M=,>HJ]&"-U3Y5TZCGK=N]2PRCW9Z%,D!W"7O?XQ?_XAO3T^BID-3MWL#L\RA
MR01XZM7$G==#T"F<YX),YT'(2@;]&1C;""VPAHZ.J)_PY?BM,[D?HR%>AK*&
M5*'-IBB[AU)[\-+O8LMO ZT9<F^@]<O\K?'"MS >L$4+YYHJ:VY0QG>H&W _
MIE/EM-T D$19NP_RS(<MNQ0@V'-EXTGNS'S6-;QJ:=V9D.=[=("@X^ICVJ7J
M?J5+U=FXEC[-A"<R7[ *3T62;7&%L8?$Q=BX!_@4[WBM+U?]H(FL; XL%EH"
MY6V+.^;DHR[UG5L%Y9BQH:*=48*U23PM5W;M+[#8;A$B8TVBJ:LS@?O")Q9\
M0A-,KH <I@[@.V@CY,: J)X2B-0G4952MALDUU3=#*+OJV"$-<T94-%GXX%*
M[*)R[,734V)^DQ:W.S2\EGR<+(AZ22>^,V21,5:'CYY")(L;&D6-.U91JX1Q
M]I#6O.&5RUR3NLH#S6V^!&^H%QL_GP$1E]Y0 1X*A.SUR*L9A_5'I,+OG4'V
M;K%/IX =MDL="K7P5]L!>]MN()9': RS]ZL&'^5#[;5VJ7=LEUB-V5>WZ:%9
M%&>RWH*A(P*M4EB7#W*O'F1W%ILJE]L/CX^=W,;&17]%:0F&BDH9#' @V(5
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ML3M*\ E&_SABE/[HN CQM\_.3]P<?H_BF'+%O3.%;V9O];U!.DV2WNX.6LB
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M*3VB!$\!WF=/1W,PXV8!(+?A!"Z."&^)[6Y% @_E5@CE&MM#N76B\&KOW +
MIPKNJBT%=[\A3#';(YZ]?0=IDC!;LR2R:ZU'=AV=."J1B6GIFF:ZKN.JBF-*
MGFWHDD*&^GID-WWM#7VOD'_Q'F'=\I>O#M:3#-62/-D<C>!ZS[0439/(R',]
M6W7UD=.=,'#5(X\86"1E>?14:+*4O"^?/U/O\S-H7RBU&V20&>9N3\@W4"N
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MA:\#KB5A' 4!69["8QD2[()&HAU?T)Q+2\WE \):;5V'M$JMY -.1]M=WZ=
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MP29/E<STZ,E3!#LF PYZ?$0!B[,%/N F]!U8^'@:L62(Q>F4OSW!Q1EA0)T
M>0/?WA=<R;Y:7DJUT[]]OE^UPE,#W%LKQU#3HQ4N<I=1(8:7B (=:/I6.I)^
M-EB\(4A 6P"^]6G99D05Q5!4\:7]C&NJMMAVQ\2;!Z 1;3OX_AW+26R>>5=D
M8_T8N:;+KD(D61X9LF81TY9UR3)4RQWICC54-ZJ9(Q26E4-9.0M::Q;6 2!
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M5([,?>'C7I[8=D#?R1T*,R@U0]343;?N?J WNCA+>EK(%&6[( _[8"C'?:D
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M@C%MWDV5/&55R&$%87_TQO@K#P"*=Y\0RS5DQ7(,0]4TP[,THKFZ(BFF)]N
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M;K2Y,:PN<0NCL*7>( H))7\YP.^H_*REY\.2T4;M:$FBEPGL+U"<X_5]X)6
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M:1]E,6U<3%VOL)@M>> Z+54^5O.M-9OUF>%P X9Y)T@K(%2EWD#MRTJ+$N4
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M8W:C)Q 0 E,$2CRO_?*\O*G^4G/CI5O[+72GQ<3W,4E[1Z ![\3PUQSF203
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M)@419!'\MGC2-!LIM14<(8$%A$&^,%4#<>%&H#<!@F<9G%+LO?5! N$C8A*
MF$$\N#0Q#-_T//>I"4)9!."+K/3P]8ZA[^[^D0HHF$/!)D$=%F]L($+BPS(Y
ML4! -8PF:,["QR!P87HP)9<];T) IK%=%]1L_,[).!/-)=PMD).<YV?0OE"*
MPZ43MG_#A.'=,,!-I3OC[E?"7!\>Z+5[<0S8O_Z,*3,X6OC\!TB9"+>IV8S)
MKR1=*&07H.U98W]A">5E,N!LYL,?-SA#,/A%P7-FSHV'6UJX"BL0#<].Z/^7
M42S'-3F9M\$J#I6./BX??1@N+>RGZ5O3W7'':X#TP1Q%.%O#-WHMB&C0T_R;
M9$I0>L^R3^D+0: '07;E0F(O ;*"!^+$:+0OU!\0EC> H)OT-D"?/QG.XX2D
M'+"$#'M;3@C<9#K$.6.%\JK//)%. >^Q2>?8B5KG5"V*"6S@A)H7Q8HWD@5C
MK*D^'Z/]!43Q/8 +/,N?@.*#(B+8LE8KO$O^G/M3IF& S<A>DQ]!G'\"2;!Z
M--7OV%!2S;7,1<K[3ZSUG]#7*'9>_2=*'8]KCDJ%.+8T5%3#'#F:K<JVI5BC
MD3R$'Y;DNN?BJ'Q@FFF(<BJ *:(X0Q;*S"B1*@%%SBT*/K8?4R<#<[VD*@EQ
M8 ^F[-07_D5U"7J4)!,4*S=0R0^(0"8,_!^XT?NQ=X,ZSMOJE?"JA3-U(71R
M4I9%31;F6 SZQS-L%LPN<%;$%/DY)6%"W1/4.4HOP;M9EGS,WHY#@YUGDBI2
MZ"2"<6!D:ZD9>!$3B,P%L?S^K%T&]U$,*XZRTHV2U#*=@X$41"Z=V:JD3_=A
MN#:["XRHF4]E'^Z+N8]'L0/*[-RE1T'39Z.1M[@D567I5R(:4-2_D(:V1&$\
MA[DA80&6+CX\ .4P$-,U)>Z\:'>M%UMQQ\2;!^1QM!YE>5@:X+^_I5\6Q5NT
M=5DA*XJJVC(AIJ5IJJL-35>QK*$W4CR#$,^NV+^E6Q!9;>#"A$.ZFR8KSE-G
M&,UG5(PL'1T,/FCAPLLC+V'*^I!0-Z@+$$%>!R)2XSYUM2Z28-E+V,-7&[M4
M:NFRG8QGT^9%UOJ6>H V+U)?T^P#M'E1K6K]6"YVL'9?-Y4S&:O5M[1#]/HY
M(Q HL%SFN0SV<)35JPVV<1<ENTI?H-3:.4KNEUV6SI&6;8H)$5A%;>'#9HN;
M.BUTZU0GJ9IHM4\F]HY]\C!=EJJ1>BUR4+DE53FM.,&W$SQSB)\!N;LG'5;<
MJE4Z^7+:+6A'78V<9K5H]I!WL'Q(G1;YPX*<C)78=N&)N$<7!*=>3>KEW%^T
M9$$=):C6\3;S5(<EUBFQK::G'WMT!]T0_F6S/8LC(]6H<&&]U:I-NM:1$$/?
M?2@DC79]C*,),-<,G_DO?S:^GR<P/Q)_R%INWF'*4T*\[\[/V@=%#*P,H(AF
M\VI<O,<A9\.N3+H>&QH=8$.L(Z#(HFDV+A3+^9#S85<F78\/S0[P(=;!5T5#
M.H]FI)P-.1NVSH;6 =BP@-.PZ(#<5A$4SF:<S4X^Z7IL9A]XMQOY/XEW\U\2
M%[8GA-</Z*$7Y1UG0<Z"5\F"IG12%H37<Q;D+'C=+"B?WN:#,0Q4S1(5Z3Q\
MH"T5ZSN'2$H^L'DI_=$.P45*![A(Z0T4153T+G6ZNO)F,8> FMH!J*E8=!?T
M)XZT2T9:2<F\HR!-H^Y@6>:M'R\::H<(Q!>@2>\--+X]GAF2?JD'I8U@<@(3
M@-].(KXPJFR)EK59GOY7CK>.XJT>W X=,RUQ89FMN; XS+H,LT/$!&O S.HB
MS([=H^84F:RT.EMVJGXO#TQSK^Z9L\ZAXWQ5]  ;/9RBW;R#_3D%&C@\*\#3
M.G0,K (\80P#5=%%I;EQQ/%Y:?CL0( (QC!0#-&4V^JNR^%Y,? \1.2E ($*
M-N9MJ\D<AU^'X5?/W61MA&-.Z&ZRU!;<31RCW<=H/8@>.HZSVW< K[_&+"L.
MS7)HJATX^&7I9YE\E(TBHSUKVMFVXY4_@S^#/^/PS[BBV@Q8V0.+W&;UOYOX
MM"][=RSU7",I'T=_1)&7W(7>$R/H8E-\3Z8Q5F'']\#O <%?X+J["594957<
MZ^^6!MK!HFPT[E3+^ZUW&'EE3NE3(,_L#11;$>76"F5PZ'42>B7^YE- SZ*9
MU;K2UIETCKQ.(J_$E=P&\@K 9?<&S1.I.; NPDE\ N%F8^S7$&U[,[96VV?,
MX==)N5;B_VT;=+O=P;;<MCN8HZZ#J"MS[9Y"TBG,@K!:*_'5H<.D^Y2_3A]Q
M@]??'J!Y5354_4%"$A>V&,V6H]5!Z7U+KS"N@D9BZ-"_4?MR08,1[#"'3P#%
M0%[NFL45NWDR\S:_%OP8WZ9P0&9? <.'M&D4?)&7#HV%@DK+;\K-,S-Y_GR'
M(;?-H742R&F]@2XJ!0HW1]P%(6Z+'^LDB,,8MV@H_.CC12-NB_^J%<05@,KH
M#6P.J7.#5,N>JY.(,PP%B;:ZZ8[GAVJ["KM6/%8G 9L%8DY4Y,8!;XZX[B)N
MF[?J)("S0;I9HBII'4+<U1RUS7I3\Z.V!TI80G;).*<N;^B2!+QABJK*3^)P
M[-5/66J&/3R$:)NB)G/P<?#53UIJ!CZ%GH %[8!CCV.O=MK2*O8*X*6"D6/S
MP_]7@*T#9BXUDW!:;Z#:HJUN=B3A9U<O"8"MYRXU@YW>DGN'0^^RH%<E@:D9
M\M*.@[+55O8O/WC*G\&?P9]Q_(.G7?;K/H1N-"'"+T&4)+\*HSB:"-&4Q-0Y
MO^'F/>!NV#6Z\-XX3=W9CPQ&X3.#V"< 6'TMP.P-3-%0KZJR&><RSF65'?>M
M<)E%XT:6<E7N4\YFG,TJAR@*V:R D^S>0#<X&W$VNA@VJND1WPBW;/&(5V0H
M6>H-+'63H2[3Z<UYZ;)YJ6%PJ7W-3Y9[ UF4M,;)=%WFLCW.@+9^JE)I<*A2
MZ5L[SU0J6\Y4<FERV=*DYLZ\$2NLLS/7E2O*MK@AW[@YJYT?J[49&FV%OU3J
ML9'.Q&/3M>!H;K8J3,F+YL. K$[WU/$H/D0^1#[$@PVQ)+);/B1[X]J"O=LE
ML#'$I]G(S.)C/..8$.$S7#=.A ^A1SSA[_.0"*HD"HJD*"O[1M/B.RTMZ.X-
M:9_2/A,G?O9#]G"E:,E.LSCW3DQ@41R [@2&45(IIQ4B\B7:8XF^.O$L)'%R
MD0O4/9E%:?Z>!#Z,Z6WKR4-.[7:H_3@;DYA3^<!4?L !)>09Y;SP(? G?DA3
MKCCA#RU,HG@:@?U-!)JBS.E]<'J'=.A <4^@A\B;J9CGV]KC^]B//:H[;&QB
MW'W(W8=+1[U^\K9?NJSU!K(D*LI5=>3F;,C9<,F&I^^^I\MZ;Z!HIJCPE#+.
MA]?*AV8'^!#[>LFBK6^>ON9LR-GP*MC0.D8G>5W&XI7Z51TWYVS&V6S)9B6'
MZ@[;C5R7K:OL1LY9D+/@@@7MDA-WAV9!F[,@9\$K9\&2TWC'L/D4+*9JV*)A
MGT=!RY8Z99U#)"4?/-VK$G'!U"^O1!-V=#L]%^$!(UM4"[H1\ +Q%P2UDK-J
M+7D'%*SSVE@<<R1U&4DE)0V/(K14ZNZ%V7"H73+4#A%H+T"3!D*K<>" (ZG+
MAROMC6#QEL.51Q%?V,].$DVK2:U@CK<N2ZY#QT1WNZ@4HS47%8=9EV%VB)A?
M#9B97839%=0$9;V>8K:ZO-?37JQSZ#A>%3T R_K9HJY?5?5,#L]R>&*GL-/#
MTTZ3&WEG%8[/=7QV( "D8@!(%=7K2OKC\*P"ST-$5@H0B#WUS,:1$PZ_[L.O
MEKL)&Y)UQ]VD*BVXFSA&NX_1>A ]=!QGM^] 5:\RBXI#LT)]M@X<*%&ULTPN
MRD9Q\@)N_!G\&?P9W>AN=0X9@UCK0XA& MS]XKO-?-J7O3N6>JZ1E(^C/Z+(
MP_Z.3XR@BTWQ/9G&<#.M90._!P1_@>ON)A&0X[_T\_J[I4ZK$=C-LRAV(/@,
M-+;+1EZI4_H4R#/0!ZB*AM+6D40.O4Y"K\3?? KHF2#T3%%6VRK!PI'72>25
MN)+;0%X!N*S>P.(B[<R =2 G\2F$F]T;J+)HV)L9UK5]QAQ^G91K)?[?MD&W
MVQVL26V[@SGJ.HBZ,M?N"22=AC%<51(EL_%ADA:1U])AT7T*>Z>/N,'K;PT*
MY!.@Z@\2DM@)!"?T!,>;^*&?S&+:<RM;CE8'I?<MO4$',+6/KO8=+<#D+2W
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M$7[U#W@? .MI!OA*$'A+\,,(?=>?XA>"&X F@X@>PTC D J3=!4R=6OLQYX
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MSUW94[/(MG/'9\JK(\D?G%FUOPH7R+2:3;5MU?RR;8EL]4 VT^RJK<(E=J>
M;#6)/.^$;^4&"RU-;;;E7>@5C^D>]@J#JL5F3^-R--K]G1/\5*:>-U8"%H9C
M1I>A*;8[P#Q4^+?S>%IMB Q#M3I%U:^3ZW-3(GQ::J>U8YOFTX%/N153AJIW
M+%DS55T %;C\YLBZ#YV,.^B+[=H/),V5(6,G>$V:KJM&X9ZK%3-MCQH^3=4L
MW*[NY.!3<K9WUSBH<TA:ZL6!=% 65V>!7G-#_1-CYT//Q\\?G3X+7GQS6NT$
MAJ4:>E&WU,E9?J4J7!WCH*T8Z@B?DF\O-TNZAD "J4 !ZFDW"#X9$YU?8.YG
MLI-.P/0S5+,IK\BN,'BTPFW)3@X\Y<KQKC3+*PZB$S?+HT7LUN)KC[FA^ZE9
MD2L\JA7N2=.LM';YW0OM\3ZTR^-I/M_J6*JY:VYM!;K/[U&B'@]0+4-7N]:.
MYH0$:F75"LW25;.[HQI5C79"$K3KS)>*0;6R:G.Q2P6DRB=7>$QJ<VD5H]^F
MS+=#6++"GJ?,#5(IT,6+1_-* 3E&=<8XH>0"0O@K+PBQ(5N27,">^^,9[D49
ML*G/^@Z5EE)A@#WQ8.7_H1].*0'!ZNBJWI:U 94%D&DUU797%@=46>W5#$TU
MVT=T8\=Q@JFPB2:3$';6<:.QQ1"BT:M&6D-)^L!OS 4->,S%_6#BN$X0^M1P
M-:]&?(1Q<=-2=:,E ^-5A0](EHXA*PJJS&LU0S5V]>G6U'-;0RB9Y627U%#X
MO[PE6@6%_\=<!G]QL5]3J[*C6N9!4W+K:%.6"9ZV+JL.JLQCS[2.*;L!5!<\
M^LEV WA9EN(>@Q"O%"J4*ZSS"H_KPM--68I+/J4=.._Q9+2UC);:?.$5A&5F
MM.W_%K4C *K9U52C)8%Z;+ELFFFJK6Y%X%JZ^GM4H-TU!G9Z:8I2;Y8KK,X*
MCTMO7IVA>$/]W)2A[TT4CV<K>NY)-6HUNZK9E,E8U86/IEI=V:ZGRK*]K7::
MLAU,Q8&DG7@F5O5US5JH2K589%U7> H:)^]6Q/L(*V?"8YOGWKQ7K6"28QQH
MC!-JSK5D8+$_9DXX5R8L''EX+\8C"T*Z)^.4FG99JMZ4R965!8^N=LVB:3 G
M!YZ2FV_J+=FVJ^) :A^4Q57/VEJ')P,GF([M^87KN6PS1LDW%]^4.<5<G0J9
M#VI3E.IQ>FG$9RVUV]0.E&I71U=HB: !Y4EO2]!44TZ=&6JW+1.(JPL@K7!1
MY)&YJ$^\6#B6[9E+QDZF,+BE&H4OOC@YV[O$2'1+^JVJS%.M'6YTK;!CY&7\
MOWK@^=-)7[OUP_49+.,_;*",O2!0//?% 8"Z6DF6:AF&M)*J"!JMJ7;T0]WJ
M6T?8E"S@]&XY)I($4GX:,N6MV$<?U4\GL9Q2\%[>A5UI\!AJRY0V:I79YIFF
MZE8GOX"HL'UZI  R"H0(3B1H7[.\T]4BFW<(\%9FG[[X#NSCJ2_75+-;5(3(
MZO)*@_2LI;:ZQ</2$IR5Y=X=5=NU)$ZV"J@R8,\TO7@7+=DGH*KU/'*%I[#"
MX]*>-_8)Z+&AYS-EZGN/3H!M7>'/2)L.[>>7==ZJFUYE-=5N<\>./754H>H&
M'\-4.[O:,J<#GW)3_EIJ\[#--TK75VL()?/$\S(KHW[*,6HTQG&IA:N=JK=2
M$<2H*"B"AE0$*PL?35>UMH1/E>5N1VWOVM16ZH&' E*[:-FYU -KIK/(,:0>
MN(M[\"M;JMJJ0"BG1(VPJW9WU3ADW+6B,-75MBY3(XXMY-I6=7-'#Z2,I5<9
ML,:.VJH,I]=?YY)C2#UV%W]FHL<J9UBF^4ZQP]!W>K/0[HV9$GJ*Z[FP/S?T
MO3%\_@!O\Z8%I^3O--16X4+KDW.GE=N&J"/;$%54(K?4EG70>V9+URIK"*0S
M73]4A;I4#^48QS#&<:F'V]R<2WKAY1040D_YP@:X6.5W;XR["E3EQNTW=C1!
M^5XO#. E V^&$Y$9^@(K?=6)EJ>HO"WE7"JLN>DMU6B^S&WQHK,I4^V3-"%I
M8B5-6&I;>UFQDZ2)?=!$J8IJ1<FBW'9 G1V=,(<EB]+MSU>CDNJA1"UTAZI9
MO.])B?^K:#2;ZHT[L?T'Q^4;Q]'%=D6OW,XB,OQ[%H3.<,Y_<MP!<\.+<WRI
M)%?VGS@J+/_WEOE]6)S]P)3^R';A?[RAX@&,% M.:+'K[IK#T+=OW6B]YLYI
MQ LGA/G[.>RVV]$\</H.+.4W0/]IH-CN0+FU0V>A]V*E=[P1UI<!PO!O,Y=Q
M$!M-5=&;ND'[A'_HJO+$%)@&@#Y0;+!7J1?&4-$L>D4S%-S$E-%.E&E\7 _\
MN,*1'2JV#U;O<.B,'3O$4> [#(8D/ZF*SX(IZX?.(QO/&\KW$1,SN;-)#_ +
M)IR*0Z=\\:>1-TDO+(0/!FP,G_MS?'G$['$XZN/$<#"/3A].[,D&Z$VGOO?L
M3&#2\5S1&B)\#P<[QE1TVE%#S_Q(1[3YC!:67P^T*$@(=^R1N3.V=F_B95-O
MM+$%V]0+'+P0^L)G8QO/Y<.3,PA'@I6F/Q2BHYE\8O= 4,S"]9^DS@WY$?.K
M0DV6EFD]GOKO*/:.3@%ESWL^LW\""<#J+^SQDST/WKQ?1!; E,RAKCL/@5?B
M)/5VO/^__KGGPZ@KUE15K-S<.V_F Z41'A(70*H/1SX#/@#?C@(%N=!@%:4B
M[;\US$Y#5P19JTC7?6\R!1XQ0#?<6[W5;;2CQX7&!P9@8U/>/L T(*'XMMUI
M6,E4,);>_87SM?@UQXTW@\N;^L"6?#BT)0<A+J-O3X%4D3RBCQK*U=)O\> #
MI3?/,+NW;;W1398T\($H77S-\Q]LU^DK$X:L-A@Y4V3>3^$(5^C!D?<]ES0W
M8MXWMY=<""93P1&"DN9,^5+@(UMYM,<SP'%ZS!V;P(F'C)W#L9X+C@R'"BR[
M)MRR,%X&SO,VK%0Y6K8Z5AI7LFAI&4:CN826VX=?@92:I>\/*].#PT?+"(H[
ML5$RSL:A1+)7$,E77A B7.^%AJ,JU\_]\0P-#>4CF_H,%+$P4FLN)QX<X'_H
MAWJ<QD:2N^;]UP*%] M.*GUQ'K'&5U!&,$"?MWIW@4TN"0FCV="6J=&>,&4*
M.Z'+6==07TMO=*(O.=&AZ62/Q\EKBQ0WF!&A[8D&" L2FDL($=C0R.F/:'+8
MZP3.=>;#F>+<2)DK6$,^>FH>#P;EX^:$0%9';QCK$<BTF@D:%$,@S= 2]GT2
M&%0Z#RK(D7]C+L*#,]P!:/!.$/ID_B@1NM5CWQLI)[U+>W&7+"*JG5BOF;#6
M9<+1N@E?+D8W9EKK1Z5'6U)Z5A!-1K\9,7O0]V9N2-OFS4 ?<AP$C!3,IE,0
MOHH'"R7"@T\X&=6$"O:&#078J&EMLM6 $^[,1!OF C:8NL2&U^2)QZZ)+NW/
M3NWO90S1W$0"9H+'FR@ <1L0&A:%V HX# 8"+&>07C5Z5WW$QW!..V!_S)PI
MWBY$?^' "WN"UQTWM-T'!TU!.PA8&-0$=_<)R0+,K+/)P.^L\#I)0.Z7"8DF
MA)]\;Z)<PZ' ^7QAX0A.]V;%55J5WOF6BS!IGT/<)^/[G/!]IJX,V\5WJB=(
MND(U2]"[H#!.&-RR&\K)M9>5!L_E[=5__:^.KK4_!&L_Q2D^?[EL*)\*G482
M\X%)P)KI>P\NW<V67FZ(E)J:"O>:.D$:!#:?-A.73L9,3N;D$#._\W23EI@/
M@3AL=C0M4J9^!H%Q=2_!QAQ'L#LNFJG]$BXN^(67-UD[7"PL'L3]P<)*K\<F
M\UV)+/26G0)FC=8FIK\CS6A9-^@BT\\L.T5'(]@>7<$A7D$74]!0OKDKV4-(
M(Z=>Q8LS\<?+"=_U%>S$"97+!S@/H@R<JM5H=7Y9V"B0./SBK9A$7Z\KR6@X
M1L-U&0TO@\(+A!XWACIV][<UCY[ *X4FNTJ[F\6^2Y7>8SY2B!2?761=K,DM
MDD%SA9\E5U+(!MP7RW1BS)]@;_R>[?Y4[#[Y%0.E!^K<)-TGX+S'P,AQ'QI*
M=KL^&XY9/PQ2Q&7[+BP*]V('(V7$QD2O"S.HN $&NJCM_V3<0]#'=-NATR=B
M&J)O :50LJ;(BQ#/0QJFZX441NLSYQ&S VI"-3MA5!'>NA:A5EC+V],Y)#I5
M&YT*,N'4K>Z_V7"69Y^I:0@<\7%YI%+[?,!][L":FQNTE%DR/'9=$09&7L4%
M4#(AIU5#I9PVG/XV?N!N\DS%^78VKC#Q!<4C"MH=CF?]<$8.6J1 OOK0Z__$
MP?I$2,*)$+#^S <C 7.;F3+RQ@.^1I&;O^);7%(PL<=CT+** 2)]Y@72(GGV
M%V<[(DF;[W9AI929/0Z\Q4-*\\E9!HO$685+NQW:CL]3&J@V@1++QF/;%]ED
M:6TQ>+*G 5]'=GCA.$D/OC@P/=LT\ YX#FHJ?(U?V7PO2ZLJI'T<%^\@ BL@
MA"/OX(:XBY8_$6<KG["R?L#]\(E.*O.S;#Z1Y]"S7")7ENI&'N&(\\&\)5@/
M%G<, U O-O!19YE=I%*\MK&,K93]ZAPC+W:/61!L9Q9Y-,MZL(J""M8W2LHX
M&A/W6_KZX1V4*&U#H&3A:F-D9RLSSM>X?F*Z6^G;35/EPC0KXW;V0D0EHMTX
MK(%1^"66%@ _@^_1E-ET)DIB1WWU%EDB%HGA(%M.-1K!J$L0I#@^Y1:L>CJ)
M:CLVM0K+68Y,&X3J89!IY8$40*6-WQN973U1I6$DWM)F3R:#UL7*2+'U%3'&
MA5**8-8+G($#)\-09-B!V!K()I$JXJ"/M1X87;1X=^&.(1&"_KYPQU"EM[OC
M!4J"X9LKF'C.'(=%@K8WW-HIM-]<J6C+D8).UKQ.X_F&25,Q@TQBYM1G\(IX
MNRYH_2(XZ\U5[HX\V0,%H:SIB0I1%,P;(KZG ^:"W M;Q@F>)9R#EYD2O*^9
MCL*1(W<]>Y-Q:8Q+&S(N_8K'NZ'5X;H6V#NE))H;RJQ<6 /Y6EYG!3JQM68Z
M)S+= 4+-LBNW^)$(P;HNDK[>:;3)\Y2X6E;X*Y9](<OZ,45^8!K,-TO7Y^;/
MUTR-4!._P^LA>VYSR]B0??L"5,_A&\JZ UX)T5MK%<'30O2%/E&667J?J-U5
MEJRNDJ_+;7T9 ?: V(#]&[>_DS_/V%0<!+IZ?@_>^I1\"9>B61]Z:U/QMV[E
MJ_59!DLS\:&M HLS^,L;I]_7>QU+[YD]2S,[O8YM#[L#0^L.]:%AFBWS7YK5
M;+_9"9HE=<V^9P^4N/?)<6VW[P" ;ID/YP8#]X_!J8^2[@H1Q)TK('K0LP="
M;F0'@A/X#$M%"5<#?A3<N^<$)-L ,:ZP6O_:Q5?PL<I_N+7]T&4^S["A7SZ*
MYFA<ND9S,I2 F&1)B#A-SI9*P[ X@A>IPESQ_+Q3 ."O^"5N]R(Z ]CH!QV/
MJ6U:_'5DJ"M?J&$;?3?CS1<6/\:,(&K\%HV>'8-WE9D 8<S\.+"667GR36\6
MP*$'.%/ @ XQV":2C-SSY+6AW0\]/^#5%Y0\Y;@T("\%['FSD'()HD-0E3LV
MQ% ]VN PI*:0\U7_0/^K-S]\9$'?=Z91E=VO8AGT5/M V^0?=I3SZ!N![/%+
MHGG"@C=W&!-"$,(/'"(SP&-?N8$_82&DWSB!\H\9X #S 9WN&*\W=G%W\$KS
M_!_$>U#5$/7'J=T>!=-''!\B8W\B;[<@(*[Y I9YJ7Y-5+^=Q;'>/,:_1=&,
M;V_VZ<=%.<H9@<*;P48&P;N+%QPKWJ'!]Q Y8ZBM*H63IP&[B/[Q8> $T[$]
MOW!<.A/ZZ,.BWP$]%-GNTS@A?YPX+QI-[L 0]S*(F<7C!CW*](CESTQ0Y9OM
MM8^;#6WMLTW#:EJCJZW_=-.PFY]9QOI)3V.QS4:GTZG18KM&KF&WW"JRM3UT
M=^G5%7V<A6,S0U 39S 8L\/K3$W.^Y!1?>$,ZGJ!0:V]::[ L93R:DY85JL=
M_6KP1"IMMI_J]A/)C7ZE[@]EX.O@66WVKQ]L_QNQ>U,HIB1[[JUR15ZX3*SC
MM-"$3N*7[$GL[1:UO-<?Y!AC;?O^9JJ#_TLFD(NL]R(+W]R6N0:N6@)[M2V9
M\;#DOB!CQ5:/[<*<55NL]AT>AJEVVT7O4%V-M*]ZA\V6*Q<ETM4)Z?2N:EE%
M+UR22">1[D57?*FFUJX]SN6ZK"LO_E4/2%HY7*&,K:Z\+_I(KOS=H#A&D;B7
MW A^;,QTU1:KC;R&;JFZV=KMBKP*W7THL:Y.6*>;;57O2JR36'?(O;7;:M=J
MUA[I<FF.>1&P>E R=KRO]?0TQ^TNQRAYI2*;3I3'*&E+^ASK;(GK+;5=DJ$G
MW3\GBW2&:EB:1#J)=(=42E2C)7V.%=<<-?.4?8[O*2<VE86[O@27_B/S;NN4
MREJKQ<J\6YEW*_-N#YUW^RVN]<BTACN"S$*9@"L3<&4"KDS E8L\E47*!%SI
M(JJ5BZBMM@SI"Y<X=UB<,_2BX5*)<Q+G7N0*UXKF[50/XX[<$7[2?G"9>ROS
MT>K!2?6VVM&[M<]'DTA7)Z1KJUU3XIS$N8,&YKMJIR,3;RNN->HEY4;74&^4
MF;='Q5'K9X1;K:(RO'I&N,2X.F&<H1J=<OP*$N=.%>?.=+6C6>]JC&]'[F@\
MZQB'ADY%M$69;7O,":RU6JS,MCVJ;-M[YUGFVI:O;<D>MR>6.RE3;&6*K4RQ
ME8L\G47*%%OI#ZJ5/ZAEJ98I2_\ETATTU-)1NZ9,[)9(=U!.IUI=H_8X=^3>
M;ZT<4501#[C,LY7I9S5AID97[71ETJ/$ND/NS>QT5*M35'&46">Q[D4ZB:6I
M1F'%I'I8=^2YMD8Y$*JAZBA3;8^*H];/%+=T56M*IZ-$NH,JCX;::M>_X:A$
MNCHA74<U]?JG>!^[T[&<PH^*:(Y+:;>9; M3;[0Q0W;J!4[H>+ K-K9#T,*2
MQ-A?%I-K1%IM,_G$[@7>>!:N_V0Y-X5^<=P!_'5AM @=R] Z+3.3FI/Z[RA.
M3)G:#^R\YS/[Y[D]A-5?V.,G>QZ\>;^PR8GCGF<.==UY+"8HZ^UX_ZNRH65.
M=$W3C&NU6)D3+7.B=T]"E#G1^^@_K)Q]]H)@J3ZHSLF?,D=:YDC+'&F9(RT7
M>2J+E#G2THE7*R>>AHT:ZI\Z*)&N5DC745NR(XU$NH/N[<Q2]4Y+=@>I+H#T
MSHEV!Y&YT3)?L!Y,U&JJ6DE]'V62ZJDBG6ZIAF5)I)-(=TBD,]5VM_Y(=^2)
MT=UR"B9JJ#?*Q.BC8J@UM+^-;KO.UK?$MCIAFZF:[:+26^*<Q+D7<3A3[;3U
M.O.X8_<P:LWNB;H8BS8@WOKP%?9$(UXX(9Q@/T?&2"8.K8C$LL.M=Z/F2F?'
M!=#R?T4_4&7H^4HX8O!_/F/*A*<LLCAED;]L-%4%D\B4)SM0WAI6HZG >L>.
MYZH*_-+W)E,XB8$2>LI;O=MH14\+C:[#6*[BN'V?V0%3WEH-,YD%QM$ZOS12
M*7L.3]G;8?WM9('+RV\WC'VLWG$5+[M4;ZB\;2;#TZ9,V-/W$5OXT!>@L=W!
M\B"X@ZGO3&P?$$89P&NPZLS,$P_0$M#'?H"58I+_E%&FOS(=S0.G[\#KR&>F
M04.Y#'!9*TX*)^?;>DK&LF$RH W\1+/H%<W8. $<G1TJ2"7V<.B,'3O$4> [
MUW//DY]4V',P97VL>QC/&\H2 46D([+H*1U&7VT[5J2R(4M?@?.<#SM;5L-:
MCYY6I]%=PL_M8V>P$S&QE:8")"]M$WGE7KYFI,DVNWRMTVCON'QEP%*KMS)T
MI'>RA(2KR4$>-[>7E24#W$^\ZU4<924SH.VQ9UA+ .@,;\Y\//XBD(1A;5S+
M;!SB)M.'-V+VH \Z2HA3!;/IU/-#&G>!]<W\G/QG+:6O(>,Z* 11G'&M.E!_
M;E9$6]"MAKY!73#W)''?MCMIM00&,O0]*0QZN]'9I#$L<^0=UK]27="ZR>"<
MSUG-O6@,GO]@NTY?F;!)#U!UY$R1))_"442^?<^E9%-B5<@D:?!HTH$"^P=C
MPYG:6(&(']G*HSV>L?,>/?["!F"* #$,&3N'4T'$>W3Z>"8#-FX<(4GD%_#&
M E"SZ&1V.BL4Z)U$O&9I&3%I[$?(6\V-))W2W%^V =U,$QZ,U%T2\SMA_\ '
M">LJO7GEZ* J@HS$[$+H(RO-2K-H-YJUK[RZM:>XD4<<(;<K(CU;B<Z_@ED8
M*YC%+N+?R+H+S#U)_^8F=\%+5K]HT>@95M<Q-K"Z%5P-WK3[?\P<WA, A_SO
M;U]^PX^^>H_$W6C>!?:%3P5#PO&\1P<6VU!V-#QH#5=X.N[\O_Y71]?:'\"L
M<A\\_N$C"T+RDL& 8)[ .NCW$$X4^<P@XC-#SPMA;/[B5_9H#VQ:]'?V; <G
MK3E8>D/;H#@8.]O6&;';R9)2=X&4QEX0%%]\<X-?8*7N:R9^D!>Y"LR,"JTU
MNZ51UFZ$50I=;;2W,^60)][$Q%K?Q 37[PS^\L;I]_5>Q])[9L_2S$ZO8]O#
M[L#0ND-]:)AFR_R79AG:F\KV/LG/94LJWKW^]>;[Q\L72(>2D.>>A<C=P.#H
ML;'W1$Y"GX'5T2>G(% &N2:_PFNB20$P!+Y9HM[+ :X?.*'X;5$)P3=R.?R$
MF_-BLS\N>V"UZ8=CM!MZTWR%]BI&9[=1M[17:9OZWA>K-ZSV*[0$JMIB-V^D
M8[:J= 0;AVUTVZ_2N^>U%IN/$EZ:-KI3-7W>,;HO2E^M5D\+XI3?20RD.Q&1
ME"_0C4@"Y%4;0[TN.(ZD&41^MQM/L@(#)QQY,QAUD*N=TT%PO![XF;-7E#RQ
MHMVERN6CQWCJ$D_+Q].7]G?<Z=5]=6[:]Y05D98;L>#LC@4A!C.+M#D\T%E*
MV+TV[(Y$']RH_:&KC'O37T,^R'J8.M7#:&W5[.BR"$LBW2&13E/U([@*12+N
MJ2&NWE6[[:*M=:J'N!+I:H5TNMK6:\XM]]1"C>.B47%DO$'/!A@B48W)3EKV
M:?>,,=26450KE8U]#JW&J1VKZ.5B%0:2!/3:V];5;N'K,BL,Z.,$DJYV"VL)
M%0/2GIQO-=,27L\5EPOC\^K\U</X,T,U]%KWJSIV )FZ=A3@D2!>"^*6:AC6
M40#Y2 %DMNK+(D_*;7"+13!!5,PCREU"^YDM]6.7VO!VV]14F\VBUY=43!T^
M?BAAT_ C<O-(0*\U3IMJUZC_G01'#B5-5[7"X:V*0>FD? @?V=1G?5X%1R5J
M]L2#U?V'?I >A<+G::JZ6;1;?<54YE, DF$5]497&$@2T.L W5$M\X@ ?:Q
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M-M_81R)%M=WMKW>P-.*% V3D]//7W%P^^(RA8_U(2FXN)]RMF-V>,O6]1V<
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M^,!@C@L_3&S\ZT40J0SG6)\]7U\T^^:FPX1$/TU5F07$%NQ@A!'(J>\$@":
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MC1;O 626XPW0YN /:!N@#TYGO;$#PCAVA"9+O!P HW."$%Z%*<X^,3@WTOP
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MUYU-R*9&T2$/?-.!G_T3L!\$E,(X0WN7X9:"!WQF)'#/4@=_@RB>D!;YV-!
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MR295%R_A7-\5>"V,MN34B/83Y]ARA*3)MDR\<ZU3FLAQ&N6%A3XLG)0&4LK
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MDA"&W?,>V;)L6182R<4J6S9?5%?-6R?1RI'NL'R)1S[*E"Y"=!'J-701YD6
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MBY51M0QKVUBR4T+ND\FK[25#.TZ&)G.?)$-;MBBU3JO+_6%=DVIBS(BC$9O
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M_ ID]4,BL(]TE&SZN>.K8%=0_WP@PA;<1;:0TYG@,RH"1OWTT:<83 0=79W
M =A(-NA_N63X4HXD:9+K(+OJX.=324+=SG(F"2U(W-6)+P%P:?1L3)[X3-"J
M$Y<DOCP>%=#_Y^=O$[?J_"6)';K_/Z;OT%'5Z4L2YK$-9@_4 _F[Q9RKDQ:7
MFON,C.7HX/O/C^TU>I3J=TF1L$T8+T?TZYGZW[G56&K[#4M16D#ZR^DJP0JK
MT*=.U_M5_;TJYS%QW&0-X8J :--EGVPA6?QE\BC7/>#N0[_;:=\T![<WU\U.
M\Z%UV_]T>SOHZS_P4@XH !?RJ??EDZ,) BE65LS+BI@=(1GT>T3(64UHP.0X
MM\<GRPX%ZY4^6-;/&=Y_K2EX_8'\[_WMPZ#?O6L_M+KWMQN!5L &!>OU.K"6
M#*WNG16Q/$)T=W_[^^_-A_;#;?-!?M]M_>-3MW-S^]B__9_/[<%O6T.'L$<A
M?:,/Z:(K2_9EI3O[BQ5U=X3[KM7L?[KK=+]N=M(5<T)!?*L/(G"U%-L:@75#
M?5NP&7#CH^O09Q[U?6V BJE14-Z!'LA\V^5^*"A\6/*Q^,A*.-4(AVOB,Y^/
M>JE)$,_IA],I$7,^ZK.QQT;R;/>"IFWST N8-^YQE]G2HM"&:ZM.4%3?KZ*J
MN@,\TQU:LD<K[A)^2W5J+7NUDF[K) *QU+?X=,@\-1B_Z?M4@O%'R'S5C2^?
MWD?.G>_,U5=(*S-&H;[,01UW8:7[>&&I7JQT-R\4_DE/-4*W+4?NC=G0I>JA
M^ \TT :PB!;#Z/QL%:,EEP@7B85D5"L(GJ@?@"(@A;4KC25Q*S>;H,H.NH8%
M"LAY'I %,XMYEF)G)?QJA$N'$^^1VI0]$2F<<G_(?O%(70@+2PNW$E35N*+H
M7:RB!^RL)3^UKZU^]U__^?[B_/R_K;@S*^ZM1MC&1[K?(_,8!OF-"*ES^SRC
MGE\!3YP3BN&K50P3GE;,5($8L[42OC5"ZYXZX#_J,#)D;K6=L8 4Q>/U*AXQ
M$RO%I49/OR7D](,[8L/4Y]?$^P;["6AF'5"N^"AJH&\^:_)#<7JSBE-$:"6L
M7UC 7.U^L8*G.@#U/FI9(Q#OZ9]_$D].'RRK@-O?)MQUJ/!OI0X<S"LLI[5L
M4,C>YI=6S# RP%(L_V)%3&L$DIJ^-$^I(^T5V.75>+3!*2%'0<GY/12CAN)D
MI5G5" HY[2F+E& IF"VNS'_J5?)KK..!@I)S6Z2XJ;62X5<C9%(:\GP@X."P
ME0FO#4LI Q23G'\A9M50O*PTLQH!TO9L^8 'Y+F2P;JDP1[[18'+ *@M15ZC
M!WU+A#PIQWZ/BOZ$"/U<B!PA^LAS3H&$A25Y6(I)C1[\%R(8V&%M+Z!R(D'B
M#/G2OM47^;5,4$!R=G["SDKX+5PTUL_ LD[!]@XE54SVN#GZS'-V>418HP?;
MIV.E<.BKH D!^G!S1G9"6J?'&PY]^D<H)W#[5.TQKQ*BCSMG*R]96!&/&CWW
M;0*./S2ZJ1/EO+Q\\_K=6>[ WD64T_HY^:M.I\DV@ W@2/XQLA%WA4I&3G/8
MC61$W==*+BK&JZO*PF;L4?QS6LR&0?$Z0EX0X:Z(:CD'%+B<AE0<*:\G+F7Q
M[LKP((Q0E'**U=KP>1W!0B.D%3'3Y8="EPM&:,5=ZPAA/HI:$;-2!BA(N>!$
M03"VCI!H1E$KXE2-*PI>/HA1,4);1V2+PW@5@5S+!,4M%^@HBPC6$9^R^%%%
MA! V&$;Y1,KR8%0=45J->51$IX0<144C<%)'--8%/RHBH\$*1:EZ-*6.H$7A
MCHKP9(A0($I"+'5\VDG\H^I!GR5#GWAIW*6.S[SPHEC3<11_XK8]*.^EQGA#
M \+<+:^@K>6,(I?S-)1<3P-#=M&1E>K)^CGNJTX0;^-BWXDD[&T J,#D_!L[
M\?P?I6M'T@4%^9S0I7STD3"OPWV?>WUJAT+I'3]2S/1&@LI;SE6S(WE+A@>M
M88#6SS#$OUJ2UW*41_';&'2)&1F/!1V#^?A(GZ@7TN'\EMB3'IES ;T=1AHK
M# P5SKU< UX1SLQXK7C UG!NP9 M-69+87>4U4U% K*>54%.\&L$/'[&DM'R
M>IL_G*M'?1B9W6" J.SF[S7O7G8SX[8"OA!?X)H:.XAS),E'(=Y81H@0<_E+
M<ZK"39+#'6'B"W%#<+'?,<G39J#S^8%05<D.I UL/DY,I/,YW?L0Z7CX5CQ^
MQ0UF8$53@#:+25BI61Q%>V.160A(*CQW3PF ['"XYQP*(0E59Y\]/O2I>(J\
M>;,PD#]S#R)#/]S0VNL$T,6PG^2][&)8ROV+3.@TF1MHTXO910-X8:4G:*D9
M6MDIUG.E5,S4VHT;89>=HA*93QK<,&GLZ"W80G!2=GG\S;ZEIKQ'5&1VEF>X
M8O OT@]K*# %V8-+A%9_K"H;&S%'Q4 W:S&+<J[1$6Y-1/YUOE? )?LCY#\6
M\IVH"U7YHB 7Y+F6@'P\\/46]%T8R"<I;5,1L#_50.,4TYUNY&@O*/*Y,)+6
M\H[ZM=(=)RFT-16%LDSS)591P9-[&DRXDVI?71ZV[@H5BERL9WW:>U8VHLZM
MJ/<,Y5$RTG#MZ"38B#TJ ;F "B8!QW-AL]*".Y&"W?6("D8N6K%%2<*CV%2Z
M25-5*K098J"_ROGS->_2U!#%_%V8JK"5<T!QRKF:"Z_3U! 5S9LOJ>!8AJ J
MA#OJ#L4[Y\BM? -G)::6)3^*B@YV]R38,*MK!UVA(I)SW&XI(LLA'*6C'+*=
M:'6[Z N5CYQ[;P/Y."IQFI58=R(66W2!2D/.#XA7<#WBCU_O7.[@ZHY8[O<-
M78,[Z0R5B9R'L/2Z:/:D4+T7-:NSH[ 8LIWL"QNP1K'7+AY\W 4J[0+P>U?=
M[4G?Y/WLR8TU]5O/E;_M?%/8H&]43G+N0MT] II948_92\UJ/-G?U9!J*4]K
M:DWO1M/<D#\J%SEOX=HZU\=-1*<2P4X0WX@Y!O?K*E4+CEAK8)V*]%+JMSW(
MX*2.NF^@\O>A_@!U1H)/RSCL2C!V-Q)4BG)>S+52E E+RZ%9R=CBNPW1/8=H
M>!:,+Q.%6"VE44/92U5KWU%(4H\?*@<Y[V:Z,OQQ_TACN%K09"= 5F**HIES
M1!;43CEBN@;35'K'RB^@8(?1-"OO]]OU@J*><R\6HIY)'\DW2/=\%(4,2.HC
M',=NZ%"'><&$WC WE,?;CQ&2[?I'Q2?GCT3%)QJ0E8P(<E7DF*QX4$?I*I"N
M=367JDJ*#B\4]9S'4:. 4PUQBZHI+4],MD4"$<X*12WG*XRK/64.=5;S0SUZ
M)ND+Y=,9]\ =PD?JMPU# 57YHFCF/'H+-+/WRI-NX)-J4FOW_BH,*DTRI<C&
MIF? HX;;HJS)'@4[G]17!':4\YE6RQ-+.N"+TFY'T..D_'O9P32<]LA<>3N5
M/_N!>S;Q;/G4Y&&V&Q'8J#-,(-[D''F% A'? H@[MY+>8]^][+^Q',!10+;#
MK,)-L!UU=Q22'QLSC"LU/A AY%">JF<#E#% @<PY7!=5(QO6@ENM04G?I%P<
M?V3(PX"'(FFT*6"5F*-@YKRF*3"S-S27Y[CJS)*]I>J%UA'ME1>O[28MHPI3
M%-V<%S7WIK?:.E%_.7WV/Y#9#$Q,^";Z['D\&KOZ2GY#70H2K@ G4SKYUX!*
M&T80,8_RV6[8$W.HY_CMZ8S8P8E<''X@Y%]7)R/B^O3$\B39U0E&YC%7G6E7
M)X$()=7S4+CLPXP*QAT8]-6)$PHULN2W(7'A)+PZL55BY8GE2VP#%JBJ71\%
M#V=7)U%+%M#IB14H+M$W4VF%!7(P;?D+<#\Y+9WOS71\3Z=#*M)3B\88S2S5
MH,HDM$;K!*(!?_GG'QP^)<S3&/!#"(/ICGJ"076<%C@@J7AB-A12+D%G+<W.
M9Q5_XP5T+.TQ?$8=ZON4=F6/!+(?E-:37-&8#_@U[1'F-$<!%;]1(N[DQEPZ
MT4U8X?-GGA\0+_C!DMF<CMN>O5XXLVV,D$\0KEL/A@'?KQ]^<5LCIJ'J_EVO
M'WZVC1'#CFJ\T6W64!46IJZ=@EI K0GQQK3M+8J>=>.+X8D7O1<*>R+GW!VZ
M;!SC5/*(=L7>W%.1#H,6EQH45)!+RKPF,Y"GB$WOR3-8L*6/J ('4X6H.&&\
M*2U B30TO9ZK)D-H$EORS>]$.%_!2I0:[C,5-O/AAFGTAYIVZ1/;5W?[W)=F
M<3A3XVDJ?^E@PD1R\WK]WEK:W(AMMO"5.653*6F\@XDXP8>);"GL<*@@R(JZ
M'(OL5N>L$W1$(4D,+C<A1UY14R,@Z4S)^J&G&A@QX)O[CTVHV>EUY'@1&Z2H
MZ?XFH3^'N$1G5^/US65SJ\3"G#73O/_8$USR@;VITVDA>GI):R,$<9%U'D0:
MR_)% XCVCM(9,;T[YH0VDR*V4@&B!7FQ7KE+ Z4S56]I$7\"NOH=%QDE'NXO
MQ%--_BTWS"JPV),#0?_X(C;L&W%UA_:4C*&.M^=T/9N[?#QO45#!45NZ,ALC
MI+O %,'LCEXT0I[\4L7,J<Y[3]*1$.U0C[]>5:R3R2Z*I<=**?&B.UC^<@?L
MPLR5<]G;@8J_PY'L:W%&F8[XPX^74WSZS4&9]ZC 3TR<SHCE!V;N$I;$X$W6
M!WP69$P?81AQS'>MQ5R5U9[0G85:)MT&^P/$V)%S=TNNII[*Q?!V:!I6#9^*
M+HL*CV'W@B&1$J2ETIR])U!ZY4#D2IXRW^=B_L #NBR'MGX;V(23"8;1:N%Q
MN2?;$#<<TVZ<):Y^E!)7BG85%KM&.^OB@6YU(E-R%<*;=;CK@N(6K]8;*M>5
M7*UW$K4;YB]?O#/@Q02?HHH:S;B>QR.=Q>O=N0E!(XQ4#.5C?91C@(U@!#37
MQ/X6/9?R.)@Y(S38];MXTV9W\3;/M1;\.@IS#/98H8CV$C_P,1.HO/VA[9UH
M9,S14:"6K8Q0EYIR'8%FJRRM[JA%7"9558^1=J^)>% T*(V88DFUX4>YA4AK
M&I3Y4C^Q!N6A9>]&]O2D,N!:E*7W1*E]E-L]")41I]<C\[_U.'?[H9BYH=\5
M-U1*&@O\/@V"J'&TKZL0:,K&@FAHZ<RWY'IXX[E#?.*";J5V0ZF3<)M)T/SV
M#'.WXX1&K%=UA+=]/\R>WM$Y?4_%F):CJT5[: M\8Z=#[%I81&]!%Y<+D=E*
ML\'.S[UW>^BM4"]PT9':$##SMXM_I-@<>MZ]*>.8*S7=Q(A5WN'>>$#%%$SH
MN&CG7#.E#*<TU>70DIH#$5@0)]W&"*Q4#9(1Y"M"?23NM2(+++GD6IZ#BM$9
M:W.ESGVU'3Y26(UV0",#$UEL>L0F>$6*TC-A;<5NONCT;(^:LYG<]59-3C31
M$^%T>%WJGHAO4B3D&):ATCB:F.PLT<!+IUV!P^&G6^@70,]#C.K0Q]_&>DV<
MIN4GZ5E^VT/0WD=7A]9&LS[L)#']'W2^>#NQ\F.7[_+Z#/;C M?/:V_*CX[$
M+JI++;59C8SH]31&',^+(LAQB674CU;2_- +>4#&;Y-@_\+;HIBCP4DM4B/
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MI@_H<W#M2HUA39)$2?M]SB9(NM%:^E&AQ3LNJB8":Y$>6H&_D_;18"(U4WF
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MA6V-D-9H,.K%8) %-V$S9)M<0V#$A.1*B=X[#5[#Z+6BZI:J4,I_$-5.43&
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MP$?_G"_^-?V4'KT^2JLV7QP#_&W]SY[,/WY93-]_6#U20NGSMYW_=?$7+8S
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MJ[+]-)U&%GWH7YR6+CHCN8\E[EKP]T_D?9V^]".@GC%0RN($ZX8!QZP%B<R
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MIP'0Y-*'OW\Q6^$"EZOEI*F@:$(TA/7%@%)3W]$=U&2+RB5G40HSM?A',=*
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M75<;^&:=:;859],]S:>;3]N*'@]\XV5@XVE/$0R[TW4=>"5L>D[=%$,(KBM
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MY>E6<%ZE\Z**YT59\LN@^T2TJ*.*"E0--#\B2D@225.8T$T%3U;#-=5\2QK
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M[M*S]R\Q+?%-G^Y7[??EJ9D\06N;"-I %:KU4A,1:*?T("L:[5T)+G)SZIN
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M0W-D+X7T$,8_R;D3/IR]A6%^.7H&GX<S.!M(H[T(5K+<5=T[YQA8)UD 'WT
M74KS^04;H/S0=&FAGA[<^W<X(T%B?@$3LC _3K]K\U2&:4BG-5KL6IC*4B<O
MU2H*S[5G16/).I&5F5HG%-V-ZH?F4F.E]7!=<%-8 V=E*DIXEF0U^ES=&;U
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M*RK75A%UFE"7^ :T0"D%U]XZ$#T;M\W]K!:!C\[(^#0^([U-;](M*4&; M'
M2;)&M:AYP/7.D8.%+*S@HGE2]HX0CS#\T4XE?0PFN3$'V7G#14B9D<E)QH2H
M8[HT3V23YFS(+LU"MKX%>@23IGM5VZHCL)?,^R#!C:7>9S<;>.<=&1S 1*P3
MM,G[95%89&"+,#%D$EG[.68MD!\YW0ZOW8;AC,[:^:[.X3[H3T9YY?0><!YR
M!!<9YZY&[0PRKU1D$8R-Y&L7N3J4=X-!V@.XXR3DHU!E#W&3U\/1>-*]5G.$
M2QG6DMYWF EL5\D[ (28930LV\#K $QD49&;[J1),9+AJF3K+B!;0CM.OO6I
MGQX*IM?3?2FH"O8]G.%I>4O6PVBVW,F7=7TYF C9LVAH3Z;=.; 856&@94+M
M:(_&UD/D]L%[W(0[F"9[*-[NI/)R.KWX/D ]MUG?$<#),,T6\]1.JJ3^,JFU
MA]$FX44*+!343*>:NQ+UO-D UQ$YMZU+.>^']+B9=P#M]1 >VH"ZNQ39##H$
M'K#VARTNU)9.-0_+9,E4#M'ZA*HTCP#="^@/R;B&NFM8AMY9H#<0?_B$UU^3
MT_+B*T[2<$H[].GG13_J_X#)!&HCL2#!68Z)9=3TJG2M[P$T<\ UV:'68S);
MN0U[P3A.3AU8/0UKX.] WKT-MP-79'0JG03+''/MA.S)LW9UN(("@Z#(&MCN
MHFP?%#\DK1HKIX<J^P]5-!>3;]T:YF_!22+13# /M#*F-L%G1G'R?;OYN#XZ
M!A$@A6PRQM8)G+? .4X"M=9#'^7XWV'K*+V$1EY&]_V\9?* BPHSUA(#$VL!
MDF6UA1!+$;C27DLAFF=P;(GM!V)/*PVMH5*;ZX -)MVR]0CF9^/SVG1L/J%#
M2L>S,IGQ@IYIY3B#X!SS2,PW0=/VV;I\;'>4QTVOGK6VAFAM4A0W>:O=RS$=
M+D)S!J*+@23A7&UV0E^!#Z8.#,XEE&(5M@Z=;@WNAZ35GCI:PZ:]P_"WO0#?
M 2W<2I.R)]H+ AJM8E%A835EA*.Q$'+K$W!;;#\DE_;3T!HJ[1V*WSF,1M(I
M.*QMF1*88DD8+-5NC5I%SKS/DJ%-/EH!$'/K5M[W1_M#TJVU%M<0L*\H_,:H
MV@+Y!2UL4/O:2Z4%<S6BIHL2562&J>P-!Z-#R*VO@O: ^T-2L+D>UW!P_YZO
M=]]B7<3I, \O+^+K0F&4<! 3BJ0].2]8_P KF,\IL!*3SR1+&4OSQI[W1GO<
M##R0%M<0<+\H_7K<UZ_NG]<1I#5;I)H,F[)%_CJ7:2VXOZO\YAV>U8\^+?7?
M^0V6$9X!O82B:*68CX[.@ES('>=<5#$ )Y^\"+-RS[0I4>BQ+.DX&?^X9+P3
M;=:\/?M=1=Q5#R"%%LD%1RP-7?/02/8-N?\Q22R&(,K5_FV;JC$>?_E%3TQK
M*>(U^M_[TN!FEK'742N>.;.!RWHW)IF'.N7&<UO'(&4-S7,T;L_L?K!49:F-
MBBI%QIVLK;(5D%X$9R)+HQ)&WGZ";Q^IRO>1WW=]2FW6WDNGF!+!$R4<;5)%
MU4+"C%E;$4-JW9W[T73MW:?*8P\Q/G37WAM+6%0SC<\_CT=U5MJ\M:5/F1Q=
MDD9*O/8B4G4P;XWM*56'3201FE>!W ;HD?3UW4G1FSBSM\![* %9P;3L0;L%
MJ%V:_.[ AK6 #MOLMP?%K?9V;R;UPU%"!N=*TLS$VL+0&,V\TY;Q[#@ >83:
MM8XN'9 *&SH /Q@3=A!V#PR8&[:=X;+L7BK!6%[/S*+J&"(R)L$YR8I()B43
MBI2M"TAO@#B\3]% .>.6DNVA$]9)SIT0X>PM#//+T;QK\=D"G+4N.U_=6 ..
MZ4)>#91"?PBI>99)Z=CZ>O]60,= @782[^'-?X<S6A_FY?"19?_:Y&-.Y!U[
M7MVF*)"%5,B0<F0 F:+K]6]C'JQ'<@P$:"#C'MI&K7<[%]BDT[[XDAGGY"CI
M0"N-Y#&S) .=>[(4'5N[B[?A.086-)-WP\+&C,/!*_P(\V#6M\ZXT4& 0Q%9
M 5EGXAHB:/&*U71K5;]%O*VX>XKIEX_C+[_21\^U3E]<*7O- Y^PP[>O^!J^
MU17*',6"JMO@V,*CNUN=UY]Z6+=M;_&/&\JNX=E\ P\'+WBJ27M9Q=H"Q]!7
MTC&+1J'7SJB\WRO9OPXW^%N]J7 7D;6>K_(:__E/H)-^V?H]1FZ!^\A4J@/,
M14PLNCK +3M9+UA=A.TJ/E8^^'"GXG[B'3>2S49OJ&TK].<X39-A5QHR+K]=
M3 GL='IEQ+\<E?'DO,NK?5X-N[/I]_BVZX*^^T-:-$#?<VDKO<]]B);K$G5.
M4JND(4HLCDP@38XL_7"P^^/V>.NN/>ST\F%7EP!!I:!S4+67"?E9F6L&43CF
M":K1DFSM5<]VPTMX^W/VMLHOZFMQ6M[AY_&DNR!Z/[\%F X* A2@=RX+P1D)
MW#((63.NP EM.:KF!4";T1QN[VFMW!MV>1N)]Q"JN7QCKC)FWY)]2]#@(YZ6
MOX]GUUO,718H<95XJFX$O9^^5I4 B[H$YD)!F7**-K3.>KX?TN/AT $TU=I(
M64(F%S<.1]TF_'U_BK>+1)C3>#;\"(LE#<?YPWCY-X.2D8?:FA&CKQTLE&
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MR;=:QW7>'=;T"9>S..G#UPYT>/!$KWM#?D3Y7FW$OI+V99,Q-JG@(KT!$G@
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MPV7K0_PHF!?-_;:D?E29.TEN1NMFY2V6/6)6QL$-RKD4:!T E&BTDR4*FZ0
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ME7=2Q9HI:GS)]*XDQ:+*]$M&^O\ZOUQTTNR>X-R]18_K5CN8[),6-&NH;"V
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MF@,#B,FO,/T7+M(C[APP2R)<V*(3-SDS#%@3(S)=@TEIYH-4/O&8([2^'';
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M4U>HB7&]L]GD$,>4FR>*9CZNSR6TT[E3,%/,Y/*!4_(_*DT-\F$ NY:V4ZS
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M.-$M"8=8%R]T?,]:'EUBDOK 5^8/X)\!.6($?0^*:8%,!A!<17N!]YO<E\<
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M<"@SQL(QZ/7)L_!X;!FEPQV/^DH:5::S@B%D<5UM?LABR^R[/XVHY^>UV3(
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M['19G]R$^M9SX(=F']9$J3L=XYP6CE7_:\KT[X=<>^!YBF>@ #ZU)BCC#OJ
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M@N5*U&7\L?GB?'N.A/*"94ZEX5Q[@]C)R8G5QZ'SO:+2L4ZW63PD1S\=>@U
MUG7Y@EOT3(D=.>)=!EN+J-U%WRCYB*_;E'%ITRF/=!I E@C*@W#"IVO!9\C<
M-G-$X!V\4+/H4F&_K9"GR?T![8@L\RMI<["?43E9#1KJS)4JLF=*A;K K.CI
M,C27$B^E9.HN"C?UYBI]'!E;WH\^BJV4Q8_!<&)UF^;LF,2@N]_?W6_)..JD
MHX/23$=-'6G8,V>' U-W$]!!4V\V/Q1=[A:EH/1&;\'DJ4+IONJ4(M057[-!
MF?SHL[[W\/';2I?*;Q@'?4RN(^R;=3->#,VXH5TR)E)SYIIA*Z7;1/ #XEKQ
MCZNNU2QK!85BDW+=#_KNYNB=?B%R[=:+!>[K/2;IJ* HGOB+F_UA8:NQD!CL
M(%(G8S[W\E3*@4Q\\6^18#U-@]O%PPKH2L-1<R^CD87&$L?OUR,"(J9A>B_"
M -L2P8CRRA:MM_L)X<Z8J1"JS, SW%J-T1*!03]A1J/RS>/68K^@9X2LHS;V
M <PC@:+E,0\H;#@)ZNE@O %FKK@<_R6)'J>'#'TU;O_Z_0F)\TD:)O-,I/2/
M_+$/@QJ7?ZV=G;&X^H"^[B-RD*+L,=.2#P876_9&>S?TX:&+%BZ.UMS4Y0QS
M@QI2:A^)A21/9PK/4&?)UGT%!LW&<619_-'N/BVKHJ^LSF7N5-?8PDWJM,FL
M6LC6!^Y.P+.[BX4[;,'D.Q;8GN-M>OW(@AU%B2?T@.C[9K]5\N0Z^P4I=<Y<
MD<7.>\=U[AQE;H'?<EL"E2+6'/!'"+K#+0O^9&6O;..NE^(2TM7 U"_+1\N.
MD<?<.Z&NE5'\4L>2+#LS0Y.)!;U-HSJ//-GIYG^U'")4LS?U<[\ R-XCPV7Z
MHK:0NH9: :$N&#2A2X;)K L-\+-/R_JI0L;9KW?2BYOW"ZR^](D_;SYAEI(D
M=D1#H"=4MN7"XX38!2&671:8\P<KSP)&+9NP@/"ED7W%),(O!;\SN@<)#S#1
MP1?^:#'T](S$G@B\-)O2C=X7TD+^3";3QS$@ CV;2_V.V)6B 193E>K33A](
M;8%(/C2 6LP\7I8<+D)&;V?Z'NP&;S#,7OJC8,KBPA_5+_;::(#C5'B/,0U0
M!:9.#2_.P8"MB,V;A33 "QI@B1ELAH'OL>K0 )7H[8/==]_JC?^<JG:@(49F
M 5)/!=, I[GLP8PPCF4P7I,\-#I?[4@#;%Y<'1I:!<^-Y7@Q[*_KP=WB9 OC
MG@]NB5!;HR8@]]&%B9#ZM!=VR=K?^@CE'HLUE907^R 5Z@ <9P@- AUAU0 Q
M:M)OS&ENAJ[I?Z'GNE@Z)]OK%73OO3M_AQ',MA.<X(5,]O6B<[%E_&1&@:I0
MD (S1@RD=38PEEO')/*!=:*+U=N8\JI3!K:CC]_=D8^Z#3JA#4$^K9(0_7PA
MF\G+(PX>6[+=3[69)Q9=Z1;IJ.J*=U>'02%ML[!(,C_=,^Y^I?96X!=>WZ$!
M3 AK&K?K: #?MCEC^D,!]"><*?/<L:@>2@J=ID0'P\NMHTJ)X&;678.E$\D+
MZE64UBSKPZT07[$.73OM,Z$U?,V![BVPTX.IG$9UN'6D0X[=KL$-6<)UP9;R
MGKK""T.;&<=5575.E7P]>O;.T<.B<5+3"L=<)SFVY^;R2(C%OKXWV%4K(7M"
M,@DQB=;M742%$<'4D[GT=S=,G+F,!+ZF"D^9"(4A+XMFK*@(KWT>3$H)-]([
MG.DRBY7Z=#7@Y!O>)[*3+'M*=O%8J?T-8(CQMA_'.@*ZA$B?OGY*KO-!.4,V
M%F%]T+VGS6ZOEP9@D#M#;4 QTP#%5/HGS=%X&-OP]B'ZW\_[BM( @8$TP-&1
M01EXI5\T]:P9_-&P E*HF^2^ZP3N_(XI!;W8DK5 #SJU]53#$?N4MJ;]F 0]
MJWX=+1P\3G5>P8BU>-CO&5KW().U>NN/B_=_N+5AWR-$?B2L'\*A<'T:?&:,
MDF&*U__,$EAA&3,3X+PWG]AEX!8DP"@0=6$U2O;9-4;-!S%O3>=7$Y _<E1T
M8B,\;(KH4".)?BIF0CT%)#TP)#IT#5VM8\^B ;*(&<8E@9PDJ3&']Q'2;WF3
M/;1$)(,M$N.Z7,-N@S.0;^$GR#(X3DQ1--V &!8)WL"@;4YG)TM+1Z;V)P*Q
MZH*I(^'R\K'KJ]TM2:$*$JO723R+X*_(U9'/OO(_;*A]U-XIEYSE: ?NNM'Z
MV<(:DU 6!E+.FZ01OC !<9(LR SYK2H_)#L)*\9X115C1@/4D:>FRS;@@R4*
M:7(BLHEM8E-0P5DTZ$"+;L]R_#_7C/_OJP7?]F9-P2V3TR=ZHH?'^.1/J\_0
M92 [-R7DJ).VWJ/,SX+"M=(/TS.KK8JWH"%D62^,IKZ&_"*Y.F.6N;.]/DGK
M)7R_[2BSKL,BG)/(-]!V2[VRBL>T>.Y3JHHQ*_73[L&-/&5#%6ZZ832?:7"V
M$S1!O-&U?&D1V55@+-,)/E3EH>A(SY$E08KI7H$UDZZ5&^Z];7K8]J,_'H+]
M:RT4$J:RU4M!_LPM6&:A8NQ77018L>0I/L*WDTEN^;CSQT.FC"Q1_,!3?;,Y
MD;9#J5=<;N][G^Q?/AHK:\0?<X\_M_.K@C_PI=T@%GX*)0)^*V0B.N\E7<T9
ML)O\,VV&$C<.X_\8L/;X4>)C@9B:#JXP=NY'>F]FS_H$0"Y%-/0"E8R<^A":
M@2TJ92\JEX/IGK7=];])UOW3Q1(]TQMR"]C8>\K,85)H6!K.9.LNKS20LYP8
M,S)JLN$6*=MUZ41M:KR*6M>U([&BFQ#"+AWP8ZP'"Y *,KC#C5L/8UZP:$64
MF]@F3? G:#8.==YW&Q$IN*_A''Q2(.RIZNC*RMQ-GNN2B,L<LF8F?1(&^Z)H
M_M[NZP^5F!0&LY#W*V'AY&WP(_0?$B_Z%?Y#XL6>\N\\J$[J57QE:B:9&4?'
M]DO>/DYTCDZM/B.;7$H#Y,(GQJS6/C5=[:O8<J[G-O1Z*$?NPR\T,_I@$\/6
MRS?.KWBC0W:Z* B[GVX:'1+BZS?X6E/FWB4ZY>1E"&!T#WUCB8'DSY(9_!M'
MOXCNEFX1#;J0WY<(J@WS7'JA2,_'N_QSZ*F!N=U4MN:-"!YQX@BR*8_8VZ+$
MCW?/A;ZH^,?95\%W/H/X)/_C'D\_3;-9_DQ>L$U'8?]V]K4E%1=7^U^+>2-S
M:("G(*(HM$7B%U GJDV#CO!O2[]M.D9!S]CO2M5GE<&\$E1*GDXMQBGMO;'2
MCTPVZU>^I#NV.<?2$]'PHT7'U9E9)WR1!D VCP%#\N_:9PE9UV3LFQYT-J&/
MY2,J)_WW784K(#*_Q]0(3+IX8*9^B"SA;K)F;&W:VGKS5)YI(Q=PLJ7/*KC;
M,.T.MQ\[I /^FLJ[,G5:P< !Z6EI.DB^662X0;J1D36I;N,!K>>0';GZ_-:Z
MBI4<OT@SSTGD6#11$$)F,[E#R08&P3C).M!5<.AN2L':3K2XG"N"N;/VJ&@3
MD&_3J5OAD[^0)U5%/T'>>8_A_$O-AX)X.<[.M+47,U0'O!FT>I]5H_E'LW&4
M2!]"M8\&B",KW@"KT/&'3-[_DS;CWX^R]]BXA3^YIJ/S@(V-?TS5'-8BRGA0
M'2HI7?00) XY_( <3E_G!O#Y6O@XF@:HOC4+GBZC 7#&T423J=$I!A30?@JO
MYDN ">+%,A&;H&6DC?T,U70_5!"$QW?F;DJ] +/W2IFJV#3KY3P>FZA=3!1P
M.U!SWG#8]BV5RO+OO#*83UD1+]P"+Z&"#X#_(7@:PRV*25)B)A[RR2"FF$++
M[N1YIOG8)#=I6,S?S[<N+!>W9CJ:;HD:L_]R%*NR20-P^WKA&<R)V=C:0I_F
M_?EBK.(KDLVH&[?.ID97;61(SC\OYFAE6$K<K-S#"L1EGEL[<1/[Z#Y;WT<6
MR<\D2^<+MA<3VNFC1]"2^TM!M)_HYS3 F"@6M&J OSS<C#I$IT1)?./*,H3D
MS5J[FOY6[OL&+X^?EG)*>'RR*?N#\0W5)J!8>FFA2JKM+3V=]^9+JUW9.KJS
MV0S6%38;V>3SP=33U=.0L5-;FKCHJ,^E1!\\WS[V]&E.EZNQ2ZA+2>FS8YT&
MK.O]^2(-U\_YMFL+)/T*)/6C8[P/&B#YZ\,;W,HW1J*IS,@@&N!""LD%XY?F
M6$A?2NKE4*;[[B>"[BCY?92SF'.42@>OCR0(3X,3\&R'-K-#NI1>T@"SD,6=
M58+J^"Q9SSUG!D8/)L%;Y%N(&FD#65PX=B,(I>@KW5=G,4UY-F".FPH1:QF,
MW*F6O_SPW1W]0S&# :(9KQ>7.QN,U+@%81"Y!^><8TN-I?=!3NQ7Q&V7#S3:
M!/\2=U^!.5%*1 F"$XZE+93LA77B;ZSA1LV1-,E8L))RY-RFA19:NH7_5;$*
MA^KHW5P%@RXX[@F2>'78GXX!\$I/5;6#/,I*;&;%<1^GFR<<&#E41^9N?,(T
M%<U:BC1=E+J5OGZMH+@3SH1V !Y,V%HN7F2E>5*)/F'9_*8:,E'))35+-2)J
MS _UW[&*GG(*XU7K0B=PJ'AT@<HPU#/-\R<-"M=U_+S1RF,]2Z,+/?/CZJHG
M)D3,MTFNYLAM\&WPBU[B3;;FFO7Z/$^7:>7 M,",T7%I2<]*[4HVV5%_T?OW
M*P@EV8DO(O2MFE=$ZU[Q._G?UH4](VY@C]?C-5H\C'=#R^LMF[WG"+UER[>R
M9A,/ZHTM-3?;C<;L17(ZY/2.?&*)488UQ,]6*:"X/A@*3JQ/Y4_-53Z/[G4>
M2>!G$[??1"<J+Z*S#S('=IC^J,_SIRL_#80__ADCYGW RI#2/4\>5OUF9=9!
MV'[;7P>L[$Q4P9'C.B=XF7N>I ?%Z5M4Y%!4*!$TP/0<G(4HVM&O)&L+PB4M
MS7B0M;;E+,H&,V@ .G+6572::"786IH%33WCE]PRW-I?PJG.+-!GR4[BD D1
M\0UVN5]![_.X$Z3LUR.!30';?LAE71*N^]Q]L0MOGFM^DPIH@0N7CU-[067(
MJ /K"I4DHC$+(4B%Z]B+:UFEI(?,;5)=9UY#H]2R],-T!42=8@P9[K\\PA>#
M,YHZA)$TR/4OOTD@2<P18,9>UY=+)D60]\:;27BR02^R=P.<MT^?>Z(0&YEU
M"S.U]MGJ"Q':\F2$R("UB3GJ8C3Y_9U=S<3/V+U+TDMF7?*ETO=-.D+OI-BS
M-T,%_>HA[RQ+R"I,^1FAX1&),XL$AQ^4TZ?#LT*^Y&G'#^^@GZ:'B48L_LO
M[E^H$<"UX_]%(A1%M FZFSR%@23AZZS(IV#(386H,&'D<'3O/^75!_2' 1\
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MW@L_",D>WF"KH(6_/&.&0S2.N>+000)VCEJAQNK@"C=AV)WYT9Q?5^\YO6>
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MA.A,.G:)Z@'F^GY=?::8J0#%DFZ6N(?Z3.<#%5Z_L\(@2 1.76+L!614"Z.
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M.%W.&'V$E!CZW$-W$Z_[&O\&%K&Y+FTPCE9&$\5E8,&PMNEB6 +I&JP;QD*
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M8NIAEQ1MF[1#$SENF9HI^<^W8SHE%3+KFER*1;J,$R>#!W>NQ78"^5L%=Z@
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M,5%&!0A%16NG_Y!+UY1Y G<1 [U'X_L1X5F5,SR(47L*,INH3.,2FR$+?S7
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MGYJO_D>LUU#M1<,=][1Y8GHE24A=^$I*N)#*_VD<T3\W;U SF@'>(# ["JW
M&T_9>-^ZE8NL"7Q]JG_$]HSA4*7OP8E9<" ?+C/8)LC2H/;-XT14S ?9_0=M
MF,+HW^[0?T<AU]:V)PS+TFVK>BF1Q,\PX*A>O^UWFNA>_OQW,YWH:Z%"N&+O
M_D9A_LU\?X<I_1\ L:W-NF/+JM\YF=^\,;\-)6''FY7JI\3*JV&BT[=^<^V3
MX1/\IG N_TW[>/3>+AL49AV$O^T_F9Q+CLGX\>)>_CTO4]JTI3W$TI?Z_Z.4
MLUCX4<J9<DL@;J[Q $[>^04UQGLKHE_4QEN!MTQKBMJI $6=K#5P04(;V8\@
M\)72!SJEH#4#NC!^F*J$,T"*!OT<B$H+?$FTB>@RU$\2'.=WT5N/97W=QK9N
M=2>MB.PD(6R=:CZ[3\.[Q=BEQ0]L$8T:$=.9.>,'Z_ ;I<-05@+]G/:89FL9
MY1(6&.P1P^:(X#9='V)?U+XF$WMM)QU>R71U_GY?FX'T!.,MGN$Q<!&0S+V!
MTYP3;XEZT=HZC5/V!C;(DY-^2\^6?M7J-<LP*UZG=5,@U.==W4C#A$8N[W6F
M7(FH66#1=!%DW1:[A;])<'3$H  $6(^6?GDXXX;6K,K 7EED]6F7I3-<MI,B
M:2?>:M_*<P@+ N;;UCB_K6^-9W9(4*ACHZDCY9U"[!TPTW!3G</4/)QC&0WN
M(N_\+Y>3"GF+^(S66?&Q\Y -K8=@,4WPF16N^%9'"/</K_R-IN?FB\; H+)W
M*AE,Q&*1(,-=] S\!Y".T@T[7HYM?4V62O,V5"H?F[;Y_EIUJ:TPS<*]9W_Q
M0YIK<.+#/L5?QF&+50?"VPK]"BV+%UXU=9>2<]50RN4]<*DM[!T7[M.\)A+%
M6X-D*B#MR+M*T/LO"V8N]!P5#&) 40&,7B33.8[Z24&*T%;R3E,=5W$,18FV
MW^\G9H$6=K+CKE(!0)ZB&-"UN3VN\-VBS^.LB%EVOK-[JU6W1ZD $Y=H!<]3
MB6+QJ<;V_57^O>2(7G#Z--95>_T8!&LZ6XIL03&W+BS#6<6[,RKMWM4SR<-R
MKC(5J5S,18_%W5EXI1.:>-,\[;J5/KD7M6R6*9D>T]#(IFGO4JV8.T\Y/$#&
MSF&?-A@FG/F$:G9__N>L%?]>VEZY 7U*(]VT+8A.L&\7N4X%E $OVW$E!BWY
M3(%'/*^M\KK(?"&2Z!'EPI1R3YAY/K;68YI&>YJU"3I@7NB%.?AW*L !WL"-
M&G%$OM@AQY3Y)\[>(:.D')TFBUTV\B.7Z--]B 4L:T;R%;"B",VA,<]5CQD)
MWL8+9Z8[^HD>9);5U? ;J$4W_#]?;O]79C#_*_,!'T%A**01'T/:&R@?QN-"
MYL[&4P%L7NT^&!2SA2H5<(5E5K,S#;1-_-7*2@7$P#A#D&\@<TO&0T"11I(O
M:=?<E%+NKSA_R%0NFAN5NYZ],;BK>3#JH;!$.1U%ZYM],T+JNJ+<X=>\FJBS
M!S^TG\^T;=J6H>WYITXXG/W$RQQ6I!PLN\,H'\9D(QM$!9@KT&-)]PF&&$US
M^H8#WAA,[=E6^&C)AMC/NW<U_3?[%-M2ST14CGZ882H^[W.][ :J?B=RA^.C
M/OY#F'V?,,8B8F_B\*EXYXUGF/:CH@YP4/^1@T/KO3_F!+^'SZ2"L&H](7#L
MDWOT&Y%EL-.$-Y<;'B<+?>_7-8TH9>1Q9IM_GBJKOJ 2'O1909G#\>0.7_SJ
MJG N?13J;4XN9GY.8!!N@A+\%LW'HE$KJU%49;M=3=*'==1)'T92I%8MZ'!#
M'P^1N2,OU&Q"$24#&R.QEP=+WK)(<HR]?,EI;'Q9I[<7NHC.$1_+Q>MCP1L?
ML6!=K'ATR73Y\CXAD3/EJMAN9\))50_GJ_2='V5Y>-BL;50-5=TABS'XW,,$
MJ#V)DVP_0&:<RY==ER]#ACU/NF;1_[3LQ2,O@^US"FU@^_H?0AUM'071$:00
M1MPC*35Y#PY1H\VJVY/0?7/I 7*K0MO"F[C/EV?P_C7(Y8-D-]K$'@8J_O/F
MY 0%X1;SL<6M5<"P76[4][5DGH$K@])KR)L"I'M=YT4*%5OIN!US/M\2<@U@
MF$5G@T=#YO)C-F1)=PGBLZ>2RUP?S&[P3NOX^9D.UD8WV-ZW*97,>M+#5#T+
M25#S'F'3/1.SH(&V0\^,;(UI4\Y# GGE"899%APUV(*O29OQEW]F+JH->2E9
M]9J.RTHT,N%.7WZ7(.G $V3328'/LIOD/DL4$Y[*V*,A2#_6DPSMR</P0(J;
M:NZ..>+ 6'$",&N QN?$8._^L=>BR1>Y\37?#T.H *LM-@(%DS<_*))/^?_8
M>\^PIM9M;3A6$ 0$!024J(!T4 146E2DB8 H$'H$I8F C2:0*$@O$1 0$*(@
MO80.TB)=J5)#+Z&70$()"6E?6._9^^RUEF=?Y[SO]_[XKNO[D3^Y('/.9XYG
MC/L>XQGW^/G%;)S;;D!!_$4\?DU.L^^<VZ1V<='SXP_DY@I@EZ'G\$?H@'"%
M52S8N+YV8$=/'Z-;T]'Q+<DY_-M7VQ[AJ.;2FLM29J'",3I=T 180P>J/$)-
ME;@\ WOWVGAP:H1RR'4TM2K\N42#-'7\>1EGK<C!*TTNP6;&GVQIMP58JMPZ
MS:D=;^40N?-T@&G2;NXJ V53$2A8(@E^ZA&U7G9$@US4OXBFU#,0%'@,*/?W
M#"J:<I*7=DQ\UF!LHVU(*2C+(=\+/&-5+^-&T1 IAI/O7!9J==DFN(_(M\Q&
M\WUWG!YMV1R[D)#&"!6RL ;IAU045.2)]05\@+6%[Q6<5;.DWW$=*0.,0.:1
ME@\OWW ;&DGJ&]8.ZM@:L]ASM5$!7K F@N#)7T]?%4BT]MSMV^[PPDJM8<^;
MNF#/1][Z^CSM37;89S%C  !P!KQ(,6L%WG=C"J")@ONN8B?&K#MZ[':^<;!3
M[:0TA::7:NB &(K9(J@$MN:,VR)([,="Q'XLO!OI@@DBW_>*+I=VFI5IM/C6
M&)2XJRL.F#G9*<F?9J.5PWBQ5\W+[Y2Z2U2*JXX-EF[?>36K+W'"1/>Q?YA8
M?L>_=D=>@XQ*$AQPLE@[W!"$F:*.PR)":T$BS9ZVDPXQO$&./R6%[[=V".L?
ML!N/^)I>?2:O!-$H2Q3OH7 FM"**0&.U5E\M88T6N$*]&PTNV6WQJ-YTO]3[
M*\PG+JQ[7);J7;CZV*J1)_X:?%O6B')SALS!LW1UU"3OD4/.\NN4VOB$>,]G
M^4.[SWYD6%_G? O6O&^4=Y!96%!RJ410N,7.7;6M2V^#MS)WC4(CIZHYQ]YK
M4Y_LLP)"$.Y4(9)06OV^K&H3(YZ?W>$8AEM7X7??N&PH@-Z]3OG.'ICD##_6
M)63S,#'*#)L88IIEJRVL<7YJ_B>HP9W<:O7Q5]L]TPCE6L@DPF$$N:J^.6[/
M7LB3EVYFAFSK\F;$+JNV/TD"&_=P$ /NX>+K'N4N@]%)]CF9EEJ>#MY.5]2?
M.\D_Y1..' C2,CD0('[X!/-"3J^Z3MZENG*MG0.,R$&B(J5 KL 1Y<9Z4*7S
MM1W=#EB)<X7'_(W^';&B2LXU+NW>+VZ3FB6*6\>+2A^6^VA &1&]H1Q4;MSS
M!N7DYS.CF9ZS]HOBD_4SV\DC1KH9A5<HMUIL9[E[CQ3O/_/5\QYD+7ZUEMO(
M;:R=YH%YFD4&74IAILB:[H$V/2%".Y2$LSNUPD_J"- \RNZ^5+?U@95_ANC_
M_W3)7TZ7^#+VW!$X-;<0]A@^S-O*/Q2; [,CIC>K08+EQ3_HETAW==^&GWK_
MWC9)V>A;TG56B?SW69/"0GX:$'\&Z7X.QAJ[X'L(/:4X:WB.7XTZT>+AJ^6X
MPQPL3TJ+8G!M4G8I%6FCC<OGCUYWR; *\[Q"%3TV#[/N_'+,]_)NQE*U[T1"
M1@^O6IL?F$E<-LQ<%@&)&6#@Q/VG/T'Y\/<#(_6;C 54A>V;_Q@,4HE?A+ML
MR*/>*=DUL+Q-$H#SZ G8%$S;!.G:/30Q&_#7=DP_O_N3B=WFXZ_OO[PBU,O
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M1/)-OG 4:,0+'#;TL+X@M ^IWV=M[9R+S5U)6/"]V80\1NL-'D) UNF [W1
MD$H08Y$JU.[^3@&/>H8."("!%@I@XT ZP&UU^P7J&ATP/=5#RH/L,GCZV![U
M#+*!V$_34D!AIZ@71%=K9>F "^T0PB[MP_[B)ZC^%Y,J&>QXS&#V+JH4O8:<
MA?-:Z+QD_Y*Y7,#]KDC]3->1\;4*PB9W[)Q$K*[ I>LDXWH3<M9353Z3//Y+
MDWHB*Q/1*4^*,_2-1<L>N/4^@>KMBRU#Y3OP>00TWC?5[F<1KG8*%V6FI7*Y
M]9=TSN./;(GC!2]<SYJ%NI3(>$Q+4'8UN*GG_1O;V(*#! 4T1':E:0XSP_FW
M\X;BG#8N3DTR=K_[Z;_2"1YY/]NMINJZPB]9$Y;#4\.="3QHQ<VR!Q;M[^24
ME-X;Q[TYY\]\CA/R"]ED(&A&>4!\SL#G)Y?QE@TV&#W%,:.*J!EC^RAQC)FA
MI;C=<>XWYR[S=1];A?1P0SL8MR](DX U=E"#MY7-+@ZLNZF(^+A_&=?S(N]B
MGZOH"K@^FA>I:[Z<K>Q!LKLQFFNP"+U@<QU7AI=<:Y\2E]W2W5#K]\>K5(7^
M@CE!%E",ZQY:V7?,0B!M$((.(%[3(NP/!SM+]IORBFKM6=L#-G<PE_](8KNR
M5A$]*;LN@S'CG4NRQ6=TYE\:0WXH$@Z&!:[NOJ2Q:U!3;(@I9,YEFDJ0I,*@
MVND5_-VM+I5<.N!AW>/R)+'H%U'89T\M$PX]N44V?9Q'XT1O,S'9 RW:<RIK
M5=&;8[AB$HC31C5(R<E%UMMWE^+*6%F_FS-_;J+21>!TID;R:'P6A,-$GYF.
M9%#Q:@+AD.50O-45LMJ:M350->U;Q'SG+Z&VIV8TVXKV2V\.0[ZCB*(.:U@.
MK!79U?<J[NR<B2>_=7'>U]%/O%<Z#EH.6PA9634+RJ9886?B3N5 4A(6#&I!
MV2R4RN:(QO9X%A &%L,P0/BWZ?&+I<TH'+*+]G9_WI+HQ/^NKMN?/E[PUBD6
M6*,J9J@Z\KE;KKW=XE=$JU+L0-":FB]['':P@V*!@U%$ZKEBV^'N\_$. :SQ
M3_WFSG"]4#HPZ+\'AEJ$$(S[?53YVJ+2L>+*KN5: 0S73Q#]VX&[__+CP_L=
M<IH.<'9\X?3R9_6L 2EM?,3A7:I2C'Y_&P# PH(?'2-Z8C1P61%2&\(.%NZ/
MSHR9OC$,.G;.X1D?6\0+(\^&0A4H<,SP^6KUCE*1.S7.:'+LRI*Y6%J]U-[_
M#2VV0]TP9]A(TW]T%9_VO3;T>+^KN(Q0&;7HC!IV-8ZW\(D,6X*TIUR(M7D&
M[!B=$K^ BD><(,+NX>)1?E]7*JXFV>=DC.LX>3MXLOZ1]C7$1)\^JF5RY,Y[
MYG,!D*'Y_7D<EJBW0%P::OKKI!)9+8&:\-6KXP=>$T&+7?1#8L5I<2"9SF1D
MS-:<2U5;^Q<6\'*JP *[0N[TUVWGQ-<%P*[,^EE,51MSRC7;^X/*(*U<<@IM
M:XZQ*"A+M;]Y3AKC,HBI$UHMH&&W&?;:T46*<(+GY(G^([0T-.II# 8OG1ZU
MVI7PDB?10<=$K[DHVO)J)]OK'=]P1B2_0 =\>$"1I .J*FFILGFKN32'KAP)
MTY6!]#('D5U%^.@S[C.X@86]%E#=N?W1MDK_6A_]=P.,6,0*:Z:!#6=]"#'$
MWAG$ :+M%)9_,:R<.5^Z4DNH[>CL5I=L?.'J<6U^G3/B(V=<A[__HXW-O'+.
MR'9>Y/1Z3R5L.@"(N]L%(E008_WPDFU)JJD%N*F&RJ-]HZT^@>)Y3U;.Q]DF
ML7W]Z7+J/I/[B[!U7*&(P76F=>PS5"EH;74&.7)E&A(,%?32E/Q! <TD>P2-
M3W0[5"5.:L:;/88>\!:)T3I_Z[/,K=QL%N5<FB=&:L4[5<ZXOK%/LF1[?1?F
MJ;ZSAI".8F7/H6;E06%S^YELZV,KO]T&?V2,G:EO7%!N/2.N6[K%\ Y\6Z#O
M!*3I9-OQH[KA<:$!IO(Q<2-L/3_R;X?PW/;7'+\P/&5H:'5-Q<I2V@LC5G-'
M9G6/TOG\M!<X0T*!N[\7\1,8H@+*]M*UKN\KMQ#X0XA1N*RVM";P#R%&"?R/
MB$-">0<S3 \RG]LR6MVNH;%+4M\4T%A]P:7$P9DJ2AT'1H14BI;F$CL?;#!X
M^WR?=F.<)_F^A@K\@ZU(&-CI6*(Q3-YY[ZIX9\XL[GW+ [*N\<@.1)3F,/LM
MB-WKSN87-438TGYDU9[]TYO=JZ$Q?R%KZ)&58 V:OH?$8_"O4/R6L$:A[":7
MP_?KVJU+,JIC+RI>F&35.?L^^-C) U5<D9N1QVL& GZHG/!!RUQE/:XOZ.6-
M%49/5I)<W0*;[T0Z#D7AG:AM.[W[$BJEBRT0HO44@,(Q&Y!%!]@!^;R@39:*
MMV"@-=B3RBB89.=H#6%CK.;)(M_W;LDBY(+2A_ECUW3=TT'.$1_2,O[0<!8Y
M\@#/%"*E(OIYZDEUP4YJ8L9R_*;5I+559]'8J#I_O+>PQWE#[INVG3< 7%YY
M<?NS 65G410Q)/$B.JJ^AQ%V[%9H<ILJLHP;2"/1 4_)NG1 QLUVN<S54[6D
M,=?+FT4OXM!O&CNX0[."HS:=_#9@\8MJDB>R#5,<" ]@SXF\9'U?]P&0$VI4
MH!5Q0N&\]]FV<'>?2 WI=3=S_)J-IYI>4=P;J?<M)2(DH\.1-XP!!QI[-6!W
M^[/XGQE-Y\>4;&MA2C]EB8J[[C#6O.Q/ OF2:)@-<GC7FEJ-<E)EG9D,N$J
M$8+(*5I&/F8RY_ND,%9]/1<^TP$>\L=_(*6*S[^:JO+FAMT XFZ AOMI? C"
MI4J\1PY' @8>;JWY#=2#$-4W=ELCUIM9*W:^T'E>)7&-#(F?O7S<=^.4 V2D
MBM<$=*8,GK>Z:;XWXJX: 9?>6Q>Y!6%AH%X2EKBMUD+4PL&;8 =H HXT#AP4
M[O"9Z':SDF=(4;'=XU:B<(R.U'JG6>)P@J>]O52GSM)2&BIU_OH=_?N>;A[0
M\M/9A:9KC$BM<_-W!ZZ4_YHL9T!7U-^@Z_W_@*ZD@C]2<2W\R+63Y/NKUDSU
M:AYP17<#]HGR/DL=GPP=J1S7S3BCL4N;D]</W!9\[&IT2JR+J@1N ^',-X8O
M ,<L"'IU V5YDAW($"![P;J"&WM&37N75W"'<PU(A+.S1_X>7-I8/3']'9.1
MTR&_X*.+/0?"C7)!$P.])+48*C A3<TSI*0\O*GZO37%G0&"Z0!9T /2!,-M
M[@9L_OIK&*JF?J0IK0!+1;%LTZ@0?L?:F-E&\[KZ- (!76"_^RL]0*$X[J9$
MK$;]19+IJ>BW)H<#J(9>L&8>0>E?3]VM)/9Z'O3M*'NMKVU(7S0K6)^)5A>.
MKHXIC/AZR4[XQ,TSX$TM2"_O?CML&((0P%B8EU[F LNR,@H& $N]&8&<3'^Q
M^[<K3.?*.9E[.D,=5/,M/DF6-L^MD[$D1 @)IL#O-;S!VTX5S%MWHBZ./O.0
M&10-\C-&YTYM4#F*L]/"*!'4_[3'W\_.HFJ"-Q<93O$ '1"[N9]U?T2HHP.R
M^%:WD6RH26=8(-2A%9^ $]]#_=A48D0V:Y#JG]P,QQTQ5;%#>TN,]2-94G_]
M:0?\3>GU]<[?"HN%^1SD+A!>MNNT+2H I$4"=A2<,H3TMV'^:FM,:,C?QF?1
M7L&FWT$VX^"!L%T>QN.H[L T!HF5(5.;<L%4'\B>$;SO&HC:#L' /NSW<;]1
M*_K'O2VJ7:+H%Q%%<;$M:E<&;6JK^BA"7ZU6P='F%\J;B\9N;2FU\L7IQMT"
MV-_3E[NQ@(H#A@BJ#-:+>VU9X-7JW G4E\V>6RM)D3T?HOW2%KSYS2"V1S3&
MU]I8#D9, ZXA)X!$!BV:]:1((H9Y@"QCXXX+6Q@>E).-0D$S8MG%X:G>7.R-
MMV])HOZ]9]M+<KL/'$AAIO BARG7OTMXZ6 FMSRLH^D Q:EQJ&?KZ2R5V\]6
M'?,H4Q2.3L:]4T\1_TJA#BVAB!=!:T?R8 TWZ0 G92 ;Z75+@O]VK14QW;PD
M5( L-^;\(4+^W;DD3P.)R\$V";$=K\)N@#* '$3HOB1G5%R&Z<@?DIQG,U)2
MODKN2W)F&T7)W^/F-#K"\AD .!1&ZJ<=TR4?&X8V@DH\@M/'G3P\)E70!;,#
MOA9>V2C')&RETIAR?HRD2.X/&XAT;86D<%ANOQHT ?F=6*/F'24W,+4^XPY4
MVR1M;U9:(/*>T4R*O'RZ?#8'21X0V>X9!M;^F8K[[>$Z5K(NK7M2@)I??X08
M/K,8GE8;VT2[6&GJRO9U02#$3-C,-EYQCBG*=/;9:3FN-W(E,5G5:659]U\M
MY-X<R7I%5BB]^"P",R/R:MMALY]L!_U)$Z&&T0&.;B>\F)HK*L,O)C[#9D[I
MN9[7>_*]AEG6]D"*QYV\E"]CCX(CH[8?JE2@7J&F,8CA<!IO\-J( _[!S7[*
MQBG?*Q/4]+F;U<X3@IJ"KMAH>3C!2;'SJE+;*0.O1>$PBC1RR5J@F\?N;:0G
MOD!D!=7S<E-E568O5;P/PCKX&O9]F/$>=WO^'"]&0=,IB#(C4 D<^PTWU980
M,S*V_%JM\/U*['B#U+*+S8M(9T\Q[7J/5Y5)X'M?ZMTA<6WMOM9A;9RW%'+N
M1!!BG/84[)TT\W,&(K77DYSG8%:GP#U3N#L;4=7!V/,,$+E+-,-TF;F.&2&T
ME5SF=L$%WL_]%#[TF:D.Q!0=[[EBD9A\_5S[38?6V6TVF!RF:/.+^2O16@N#
M065@^:_\W/Y(4ZPP8FI?:[?[R?_)R+SO= " #O@1FD8'H-\!]Z2=S4M\#]$!
M%RXR@*[U"=A2><$36CR(Y;=(E;<A'#DJ.XL(H# Y$][2 <=,"HZD])M/:+FX
ML[UWDR,X6ALD=(7URH@8!@DW7RJ$/DAYTINA;^R0%N:R)VV6(?$B1T%?H"*&
MA'C-8-@G4;9F\C\L9AU"73:$DN]5.H-83"=-&^8+2G,3!M,\)BXYQ:6>_K'9
M$-QEL]#V+ *D\0013 '9S*@>;;O3E_]TNTOV;F547W=W'W?09-_I 0DM?K%_
MU, /M%@B%Y_.RN=\M,T(S4';C;R"H*T,1DO&CU_R\OJ5U>\YL3_<$?S1\Z\
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M/""@Z2>I5]/_=7/]*1*9^+3  7P\X[ G+^=U=^4XXT3U2RRPXZO;I33V@\3
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MD-^..$AV)M8;R,V7T0&L770 \_R'ETUG7 Z.QNN\&4EI1U^<&?P8/W8AH/(
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MAM=6>0J/4YQI1';2#6;V$6HK\CMQC#W'?H>?; )[#:88]PQ6V9?F)#1295#
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M1$#.-]>J/=(LP&X(4P5**0(J:Z/!%0W&652TFW$NQ:#Y-6.'I!FT_&UGH&Z
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M4"&2B_M7>?RW))T%GQJO7WS68,,%^>*R!UQ7'W8:E<H5(U\A.R#$\W L!V\
M37IUBMV=-1PIVGHI'"MN[L1_>AT;/6IDZA]G$G^\5/L.WC',D^L-- .\10><
MG$?=[WQR/ZP,4@?4HNFOSD%_OI^M+_</U-PQ!QG3GO0L<&,8./0>9(2KB3!#
MC:T%XV@S+D*#LBXT])=)?6Y-1(Y&0F6L=Y1F)"MT73/2\Z-=(OA(WJ@8DI<C
M)(6EN$!OU- ):?0Z+D<S_^SUM<%$2C0QH&DO^%WYZCX3J^U7T)/#_,'$S 7"
M==)M]YF8G%*1A/&;<_X<"OHH#3I@&H,<AM-.P;"B_^MP&X*5<K>' (\^.ORT
M/&3 NZ;B=G'6Z*.Q2^,;PB49LY\.0%*XJ2(?%DZTV9P/RR(DC.\A8T$";0_G
M Y$2)Y=H.[W4!@:6^_R_A.4L?^T?C2^U*NG;SA/H,C :*!3ZHX,OLZHF29,E
MNHW?OWNM6<SX<,R-0PKZ]?'[W)7",J"FQO @FFJ\PR,*$W6H8/>06@,_=[98
M*Y%\)1_6+PO3V9$B\=<*FB.>(9]]NMQX5?'*R3-J@N[S90]@+[Y5\(<7F,@G
MC#KY+6Y;X5[.!#(XXSMK;IQU@L)\=\+,6<%^C=(D;%RA2-#HJ4#^6[FYEKD'
M[^3ZZWP_%+;,V$\?LZZ*7]?U@(Z<SBXT+OKCA/K_2R4?OGK97UJAM5?\;&_%
M5X6\&[^3_;R=2^O:\0,4972WPLX1+]&6KF-E0,$IV:[YB<K1=*GO\1PQ$TH
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M28MR $1O\S*TSQO&4'^. 8[L&" Z,#G?L=\%4<?!-![.NE)$),(%$H).-F_
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M"F[_"TN6##J:[B'X'I06^<T9T,\J>J7 >0]K//@]*BF%$!R#:2]LP@&[6PY
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M?A<RR8F,'2R?U81N9?XWV7'"M1C;E<&K^:)MNU]>;SLHI<4EE%ON7 $P[=$
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MU1'M"5U)72*WQNV5WB:_N$R.0&>U.Y"!=Q?[S7RJ[GLN08[WK1E>TH/*OI%
ME8 KQ)'C<.F7%VJ$C2'3B/!28!\J+-O^1T@''>#H 9SVG+Y427*ITD *5&#H
MLF?LM6O(3,QI-O89X1W\#:<;P<\+-XG =;E(MF2"."07];&-&(<Z8E^(B\<;
M3I,7NM'/1;LCC,4ICU+8#OD=K7T-NACD$CXQ4'_:'&DLCN&C'/&'LM>5^_=I
M83KAF:ST3_@1^+OO'2J41_:FX-6XNR97WQ6ORHJZ*.N%BC=S)96HIF;&=3PP
M43KR9O1LQU.!]HPQX8LZ/NOR[#@S,GS%U-,ZR'AQVM?.1.'+B8CRJS?S/DAI
MG#_]QQE&:L3SV.>>-J/YX1$O+69_3LC@\."$HOMUV9,4U=R=P$G<3K&J$5;0
MNV<"%V!?<56XT$U$/>X)G(?X+F[W5&7B.%ZTFU4@RR,G&C1]((E7W1 PQ5\.
MG00]"-!4HJT;X9&T_2D-?"-JP [Z^RF5?I.5=;S7[6CS%3_^6)AOL=1_B*3<
MZI5_PCI@Y(AU^\&DD)T<>I2.D'[?L?>]#&,E)NBQ-!.$SQPDZ#H89NF40I<\
MZ= W@$VF/:<?^%W&UY]&<TR>?.JL:6\!JG^UZO/LALFK\C.)T6N#3M?.:HL;
ME!3P]L4^?W&LYK)XE.3AO+(8KNL<U"(,L-3H6$=(YP+B8"4GF;?O1G&LKM2@
M/E$9]7:J=T@\U: BLIN-BO:(/5MW48$XQ9CU0W?=CV0W4DY+U, -I3#*._A"
MLJ1\/ PWL_R7&JK7O@/A,[\ X2C$3UZ>EPB"RPRM!T4-!+Z5#H\R&J4!YE0L
MF>6KB^%>'^%C@F*LY*F^3- 55D>3EE3R[_@I;0(US!K!_!N/[,^/L&0U."P9
M4\45NLD77G"P_)5IS4;,R(5$#VU/9/(Q987<*/6AJ#=!DYYFHWU+&XL31 R4
MGLY@][:IQSK"U3$A,K5=%TI2%N,^G.C8,WU9?JHU]@C]M7);38 TA8[ZA!B-
MQ15-PO*A=:%^Q\9U%DPA;.1FJ]6E9;E[4<*\>+TG#QXW2S5[JHL=-]O"G?^Q
M]I(?3. >5/#I9AT/M1D1\1!ED36=,//M?J73N@FC/GU#DJP6O89 7%IG %JO
MMJ/G?RQP_U=U7?O(^'?TX/&ML2[#I$:Q%$'7?#;K<XQIA,"$0R?&MD*EN7=M
ML.,DQ/;QFX'HLMS\EU0*,K/"I\W_'4S.416<./5FI;AQI2\68/J ^BC;\]O1
MGK^S(E\A-@X#ED3U]5+TDE7AJO#]TU8>.Q_T/<)3^CX;!=($S&@ZW9 !A1@F
M")Y:,5YI=#HREV\ID0(/[K1RJQ#T9,E&[,/?C5;X9T<&.4 O _K)/@LY($;:
M1@PJ?#L/&X ?)7(ECK7MM.(.Y9V>$=4,T[KRXEU4CYQUU,7F+/%C&Z$<.#VC
M<16:T!@1P]C/!&&COS#8T,5=SHXTOM=J;U0&)G$>3C[^\LN'D;LNCG.::N_;
MF>7T#ZXHQ]-BJ'(R\PILIU]'IX-+2AXE5<T_PMOQP(SP2'@/$Q1;!E$$[BLC
M""+VB]I=<QG D+3(\51S\B==OK&&P'4$CX7I!%[!-*W!SK)$W'UUZ9[TKK.U
M^EM7A;WRXLV*MOD#F&\K8)P"+ND"6'Q?64^YWGBDR>IYLLUK,[441:QC)\)N
MWHBAKW7XR9G2VICL7*T5K2?*4Y<-99;YEJ'5D"=P0?)NPJ F 1&XYGN.O>;A
M[N*BW-PB]GO'6#6&[8MU2:]"O3RM[[;6(H/'KREF)#:-?5Y(_3A"U>PK6S%<
M]>?*;"([OY.3*K1IV?,*EVDU0P8_A^6C:0)4A.RD$8RW4GR@RD6X-OQ(TAB_
M@%%Q<#-],+SEN1YWJ+9,$/:\WG%^OF9_\U& YFV08(3$I[+N^$M5#QO"Y&4W
M*,GO,L>E9Y>6T&>/CQ3EU7!@.?3RE,8TW 8L2?$\E*B38:MFE\JS3E$TAVDY
M9*13<./] P;INA!SQ,E&S!@.LP4Q&T(3!=CBV6M,T(32+&,;87L@H:RZJ)0O
MR%U7LJ94.(H)RK?;M'KIZ5E$'7Y%4N?G*'N5% 5JNOLPSN2;4? -;I.TJ0]'
M^E(<U\8T7@J/':@  #%/Z.L_$? DC":LWC>J26\%4R-0?5=H -8(?%]*XV""
M2@"]YAJ_;L8-*+6/K)AXC%CU.(S"^XV"F-.BA;,F9DRL//I_E0,!0LV:,C@X
MB6@&'Q^-VZ9&^8:9 U]R\&,/SH[=PQWOM:==!@Z5/#Y\=[&>'^^<,W[=<W$E
M3.J)@21E#M7I0E;N)J4P04^-J+<=P'OD9,H7H&%8[WUFFKQS3BC%V4]RED/U
MZIR<YS=NCPE'I&HH?UJ%B=4/^-99/7 =05:LF#)V8V+6A$Z&WSS1";7SQ<!Q
MD8FM]"Y6O?&-]?-_IR]0T_*,G78 3!80(U').>/OEQ3#6\Z^@CMP<N;(016Z
M5MI;95\5S%)?0)*VE5\SO]8K<^71VRW4.>!>7*!G'Z%'0.Y"!,A]NJ7Y:.(A
MM.[)\]QFZH*%]!:.]%CQ&'-K;Y[4R;I<=$9^X-.A&DHBJD=5I05+*AYP(J#:
M ".%Z5+CB\AU&/I'N^HW@.*9#Z[^V>J "W$$A^4:P=W2)%MRW,2IZ7*G&Q9$
MU8>RM5=;2.Y!S;VGT^X)>K'+OK_*GW#H:?06K;NX3(.58-H^P3$A', "1I,P
MNV]7=F:O^=^ !4S 2H]GFR[WSH]K.SE+>#>-X*V=SLOH?)0ZC+UA3X?!VOVT
M0TF4C(?A,!]4;"?<!/QY\IM_PO;GJG'4=3J+M>Y:J\9\'UF7,@:C2>/(Q^0R
ML_S+\$C"*UL!S^*[*WZ87$>-;EKVTME5$OBD)Q_=><BO+&43A&I"D,] QH2Z
M9\$[5'T<T@?"?4W#Z6PW>@SNF@;9&1Y;Q _-M+K_(;VA%Q!R%>G>J.(?_<?=
MBB@G?DS12P0GJDYLQCLMN.#+%5AS-QUR!,[R"5%+*+:_A(/>,$';*VD>WV34
MY&A:9!O1$3,[DT_1X%!\BP4ZYHY20>>@3MXN'MR9X4NEYV^.MRL=#MH);S5:
MZ: >8'1R,YIPA<&/X(<UE2:5&0=[#R.O\SY3/U=+VN.7U6BI?9_5 \FV2D)+
MCN/>H>.,=-6SX[*0.@8XMZ<@9>'<C2L]LA-E>14%23;HLB!U+J'<QK=9Z<=V
M'=3>NO="'5QZ?(_9[$3O,5DI^3I;)H@388+I*H;R?[QCSEX.'EVG+9D!TCH*
M_?AW"!H"!DYS5AY[Q Y@-T&X'4Y6Y5$C(R-0/GO7@GW^J5/#;POR[\4EL=6+
M87:EV^]3M)DYY$A+1 '+!80R.J\S>G!%,[71(L8M-JX9"P)E-1D=3EL_2[0]
MS9/->9LA0>D9&>%_%;B-,E!YDYI>M[!Y-MB-"?I@]>V]4LXGN@5JJ:)2<Z*D
M7G[A5%./J45+IRV&-?V$%*WX V!<BB:KN(P9T60@Y&/*B5ETS"*"$&![)JKX
MSHIJ!]HETIT)DO8<FYK CU@O*OOE%%/0\M7KF_3O'=K$DW=SC<]$RQ4XG'3Q
M.!?T^)U]:Z[2%^]>XV6GKS-MET5-V1T?15WVEK$\"_<*/V%1<RQ';B$18'*>
MM)1S$0'1A0W=T3:(,E@;..<F .!4D9_^O$:_R61YW\RJ&AE]#5F!PP0QB_ ^
MS-K$.7C\&)K:YD) M9)'%!C;($84$9;;>*%AYH<2S MSZNP9((0Y"R=*(TM_
MP(6_^)10%K]OOM8#_(M/)D."DK[+B& S"RAUB@<@ YO>-*V?8?CFPN_R6-JC
M:7O#&?JY ,L=QVW:5*)F2S&\1$&&QG4F".4 H-R834W@_I?HT* K(:R>_>R]
M_TQ(Z*/QIGQY:%0333ZV49<#T2B@"K^JHQ=]$(<[-)6.KS2/+$U?+9&<2?6!
M@?#F_=</@-3,4-]<R&<DQV DS0;4TTH5JE<2$[1CSV./-_3PQH8!1LU]R56_
M-IPRH->$RSPC*Z^Y#7[&)"K1#]9XH[*MW*40'O(O_?O(Z<3%^>B\!H/@%(3D
M1QH_\%Y+(K=_< (M&M$$\$0T/G4K.9,P,CZA^<2NCU0IT3V*0U\OI5ZVQLZ1
M$BECX8N]EZ0"+:&K)T8>P<_T=>$(6CAL-6* C80G6!=O\'IBV4,^<==8'/(M
M"\EQFOA<EJ!D]S;Y\AV!"U(U][4&BTV?RWU<=*@:]ZN\U9J7P^]G6 K 9&5T
MZWK>59.:B3OZIA8=G7-D9\05EBR=0:+^/FX@! #"%DS!3<@^B .8DZ::G]#N
M@ C:O*3K;;A#?YR3R@3)&84.5VI><.*)^Q!QW_H9K[@3%,L$A8BH=L%YR9QF
MWZ<8"7/5)'!_GV*T0D_%<F"-87?_P!?R1!W@/?5E*Q'6HHD_3>R[3G_'&I<C
MX'?^V]-)+Q'9GB6E ^B2"H>&W*=#%.5JPYW&A\/O::^\WR'PZ".(;4U^S\J,
MD:",6<+S7N1X C*>L>87S6=Y^GC+'G1<7R>B*K>:I4I/4!I_4:6 F&ZO]N8S
M_ 9Q0(+)R8+G-D5BQM@RAH=]WJNFI&0-VMV.OG.V?2V_Y+2!E&KVB6W/5? ]
M<%O@%W%;(6-[Z8E^'A,MX?YWL:OUV$T[0G@(R<1LH%^=6C+:_,= ZOR2ROW6
MDD='=S92Z/*H+][=^[.LUYT*G, ET@P5B-%8J5PJC'-IB;&1.7:;U0,#ZOY?
M=^(^9OR4;G./S,ZXK,O'*#_$!'4ZF/309> '?N:7#R&_\R'MH4=A)I<J>9B@
M?MQ;)FC.48DZ 8LE1S)6-6GRJQ"-4>3HS778,U:"2Q/IY][L?SJ/5RW_O@O<
M-_;17\K>TAF_>MB^+/<O,*XMC,'HD9M01D(-K%*)(A^"6U9$5#-!)]><=S"V
M00U8E;"PETC'OVS=J?QS-M(OVW,>OD.V&J!T_TJ*MD.C,9.7>S$+U0@Z;P]=
MTFC5<F*9LD_IK])*9H6X"K]W.'%F59K)_[/2C)8/:$<J>7_'93(31.BK)6J[
M]3&.$.BD1 _!O!>6X="2H%M7=MT[J9QYRDU[J[@W9Y LX14<!5PX+U:/R6HC
MJO@L0R9(6,E9=<?X6>,E9PGH6KJ-3VG=ZZ<!<4$EQ7DQ7_,^\%:5V'9"I[;!
MYZI.99@>"UC@'6=0457I*\Y2;Q97#ZK%:C-X:=VL=.//E"\_ ,1O'60)\"*=
M )W86'1(-W< [V;PDI&U(R(5I9V%*5G16_LU%=W$4SW*K]6#)*SR4KL5 NJ:
M)%XT8< )'J0&VMZ%"?Q& ,9.]L87E>0X1#5DPDEI)C\_QOG(P$<3!H'_XO31
MRPD8.X6RQ^58[/O;YXTH%B>JOV4E-+N;Z@=.=^?AIFP0,6NJ)T*>JKH]O9R<
MFKPQ1YY;A5Q C#UB;$5T'B!K,T%/X,".UP-F/HB-O(\)NGQC3)*Q;Q/!!!U$
MF:9AN#=)D@RXSC)B&OYAW0326#GI(TD[#OX2O2F*W $A1'<#:*X-3/B"^ ,R
M&^8G#NPH!,HB-PON>NN+4!J-53G:JI:E2>$;BA;_S1KI#'XN@*_L@SY!DC4!
M8$RSKG .4ZL(98*0L50<);@'>#%1:LPD\I<E%!$U6UC$)NT8(8X)XF#%\R+Z
M<CHU^W(AJRLP7R;H^&8.>!+FIAKWRQ+1Y-N0Q^ U=;7]B#%P)A-$3%XO/?KG
MAX(-TFGA2YJQO_G]3B9H%SM!C!&260VEB:TQ08R3%FAUL$4M$]31Y+],JYDO
M0,3X-ZY ?UD \LN.._3.IB_T(RD4^0HFZ(6_8?2*?(F(]J\+:/ZRW0^'#_C[
M CP.(K&!6>7ZV,E0WQ!K^G6!OSC2:-1=Q,QDY0;CSO^=9U\:F>^+ %?U\D[L
MK,7!3D7DGEG/LXRVS+D$UP'LX+*GU\"!VZ)+GM:GV"1"YW4=](R_U?:\+['7
M+IP>E#M@5S6R3Z<3T(^WDK^CHD <.KJFG\$#'\3P*BI6.EU(K$4+Y+?>7CE_
M)D07VL+VX)Z&_&7?/!7^%B>S41]U?U> !J+)7BZCR,'''@[GI%::P0?);AUZ
M)15N>)</L(LK6)VIA D_P\Y;TFE"1[U??"QXBIQ\R AKS!7!R:4;E1O0]?-I
M>N1/KIH#EO8UU(ZEARA6QL_Z3YAZ+9W!P4.TA(KPD)^.;@]J[[L>?CV\EM#8
M-^^LI)3,CS\RX R__<P_H<_]4?R1I>,77_+1^E!WZ8\AMK[1 ^&D0D)P2((#
MI[\(8\Y=UG_Y2%#O@6ZYMY<3C(KCM8).B=]R?A&04?>NNOF3%L$[1=Z[M32#
MG_8=#9WUZ[ \7"^C?(9'HN@[&((O (:-M@EO_+NV"CQD.V!;5,A5 ,MI8.P\
M2!39Q!GD]RHB.)K8GQ14%\%L4JXIYP;Z.K9VII>&]Q4?#KW_8*5HN'"32K5E
M?.UE@O*0BUD3F!!NLUO8MK$V*6U' =*(0[B=_-M:0]?F9PQ"_8;"Q0@C_EW:
M5J#/M-W=8/WD5MT<^T1L;ZY[FRL"X>NVH<+GM?^$C_ D(JG)6A4MB5':- KV
M\?60LK3*,\OJ&<"4F"ZK@2-/A-X(XG$>QJ5U(BS46:GJAI"S_VO=NQBNLVEA
MC-<0MO],Z 0"PXS&(HN&, 69U79^DN,Z@RD806]EGM5/RW*6/H4I&I[[6MGW
MM.T=.!!1E7?U6GO;,;:%CXR'C+U^-WL8''[0K^7FK]LFYT? Y3J-"DL?Y+I7
MU8_4&YYH+(OY=GPHJN6E +V-#MPH.W,Q4CX9_);<K1V\"'/$;<,'FHEWS:%/
MO,J[.(5@UZ\R3H]5EBK[#.&;4!/9?(7(^0HK2V&"OE@-=L[WJ:,MUT7XVBL+
M=>;781B>C4^,+)N-C7,B84=1P6K9?Q=D^.\^JV#LQ1T"PB(7!%]\:\T>]?MX
MK7J+6B;[BM)4X2*RX$1# !ZQ0(&LF<5/>*P/7$4%Z?2MJMDH1&:AY[XW"8FI
M_CMI_M?'WON037TRA(ZXQ 2E\U9&H%XLHNYUNQPN?EI>DC.D+7A;.'O/A:J)
M]\NP:T;M,S$;;^1O##5++#6Q<J4L=BS^+8/XWD#= !K:QP3Q04;3(0>5S*\(
MGI*3]8-ZI*4-2DOQ.W+\>\!=P_(EG\QYO:?@;G6$!&ZOJD^6WPWB-'H\\N$"
M'CL3*C_3HR2(/"9*56]=4<RKK-W"]R!?Z"C(!K2E#IXTEL,Y+MV[&$L=1%#M
MB'XVAM\^W%@:I";2N$6!@^KCZJC^5R]^&6H@>A2@ 7@5ZB5O^3%&LHM8,=$9
MY9)YKJXPSN)<A-RHKMM=?4[Q$R[QE59;Q.X:GY<Y94(',4&!3G[L;\D8QDY!
MG_?VRAC;<@+JB<NZKAQ4J7L1+7LN)UWMP"-*P+P[=A35\=+90*RM_43TCH"L
MD"ABN$-?YKBG%=D#QKU3WKJ'?@99C.%@[".[C*K4.(&K&%R=BVO@W;/*X]CZ
M^H%KC4;BL=H2KP;"SY[=O[386I<4>D[X@-&J6>8Q[>9K^*6.@70>GA;A@+"C
M'W[)_I=>D6?L25L +/4T%[W>:"$#SDHGZDX]]+FDC\$QYXHS;OIH;+I@Y,7K
MH) 2<C@^F_>8\,D2/>S!^%L1)\+.[Y!R73?;CR3U@%D!):V84>))P&ICD?+T
M8^#8M;_H <0JY?Q-%Z89S=]T;$*<)1K1(K, BDCW%6."[F?,LF;>4'Z8>0-N
M+)Y39\O@H5^'\_ZBAG,)3%!#,KJZ0V06+OG5N;+FD_>#ZX$WNS_YO4U<W#BN
ME5=+%3K@].GC_2\?ZCG$PAK2WNGIF^7UN\9=FV6D8>Y$#W)=H)<R0=9MG.-'
M IW=<7@NA4&]KLG2J'$GT94C@S+[%< ;]RY6'1Q/D#R:0HJV0,T@&1P=@.H_
M X"*;>1.UPQOX+_?BALS"M_>=J47M]$YN_&DGOO&+<_\HF^7A,+W&7KW*TO8
MWHU@@B[QT*AU!X7R6BT#8&7Q0[!$%P/TT"8R9S+IK6NQQQ$Z>4[> @!+JRQ\
M[DCZ?<!)>@))EH'0#K37D':1>8#%O8SR8>&I1]&<KXU3/,K.^!W1S8.U1EQ,
MDPKE%1T+;#W@XR:JBT:Q/<Z)0 F=V^:C/<C@7#'%B"%YPC*#WRX8>.ILYJWZ
M<[4CR:?.DC:"2<_H;_",@][V)&+Y,4+E^/B@_FZASQ)+1<)I+^/EBRZC;ZZD
M/Q#X[%6*M5 QA*2ZZ\$Z!RQ@4+:G0;P)G3#?>88CS4LX(E6J/.O;,$.811!'
MW'[P]#K0((0C.41H0RDX2%$0AG9(%<,$ZG3GE'\+Q_.=;,R]G#+TQ+R]6:'V
M:+LV6W(C*A<Q^@21GPTID*0=L*G.@ZG;N&:0M^_P,_?8U=W"63:H(/$AI&'C
ME?R1PF=9/!I:0\(UD\ZJ#?R?BTU>)/D_QPT54-LC1(3[4#NE\8K1..#*(G?)
MJ''01%F=1TI0<NX8CEE2LNS+OE\ZCWQO,Z,-X("6TR7:S:;YI/=UZFXYW^^8
M]!28+(M87.;" \1LZS1Q[:*T<H\J'\#_=GB^4FI=J4UHNR>@$R1BX55FG%+<
M8W9 7BH.O:5O?EXZBRTL57#?KLLJX= E7[]65T4QB^?O6^R.5*Y2^-(J-$G]
M]%?OZ'$(!S#83S56NA%/.YG5LB?5>2;,-S0;O'^@1:SNB;Q$P;,2D!SG,P,M
M*=52S+OWO9$FKEF[;\8Z=,Y'UTG=B#]=K..^R  XK.&3'YTWLXBJ4D11'TT.
M-Y"W,691\=Z'(4FVOM#M1]F ^J1?:6BNIYAH4A6?OCFK)Q8FF7>A"56]N82P
M1F'%:I%YB ;('MHEPI,$/7)PC<KN<^A!V;JZ\H_$<OTZT7O[8]7%8W+U/['%
M9D>P<7&&K%@EC68$8TWK**C.1;KSPR2U>X1;\4:+BWV)M-T=\Y5AJ\B!&Z0L
M @R?0K#4)?8]5H+@=XM23T!W/9(8271[<S4!?2+ KR3.;?)>D*&1AKN[YYH]
MPSM'P_W=W#==;=ONX9/K\QYBISY4#9]C5<<D_3:*"=L&J"%_C',+UP"&=.V;
MFLCL9@:2)HGDSFE_Z=C3\TFF(%0E9[@E76,AS\"PR+R./^FM=W_![NC<2C4_
MYZ\(:UP XPAQ)G1)K>,-V:1:A_HJ3R,66N#WK&Y:04Q7.CY*44:E2?3HZ3NP
M5C0^CGK+.Y'TC?ZF_,+$,K>YA6+RJYI/*99*7Y(434&+M_-"GJH/["]2V6J^
M9*$A.!Q*==[1:*'"MYZ<M>&.A><-R_?0AZ')XV8]=][[\OL]@+G-,T'J3!!H
MA34#P0UR_!>PQ(A"C(;B\M]"\I$T;N07UQ=XOIO$;# AT?ZDJ9F.E-FY^:S!
M6/'Z!E.E@L@>T'GB"<%0.=QC1!YT$9<%[T,61 <R!&?S_)-7ZXP6G#<D]!@U
MSA^[ALP<;2*TI\['-DT%&R+D[5^U2F^FHUK]M%I/V^E7J<\/QEGHJ*\X,T&*
M_NCM8RZGQTT&U5=[Z-COW4 F,W'_YX;^*S?T/D15%>*/=:Y(,.&:DPE55R76
MS)O-J(!X%CMHK-0R7!U@:IQ?$"B@SC,XI/CB]@?G =#^!=JFT7HD,7 L 4G,
M'Y,,\Q/,TO%QR2"7:95UND@46NF$C)4\'?.,R,L+WCD98/#H5.,Y:8H9N8J5
MR2I)=*E3V]5CG5_<HRJ6-3R+CL6>5"J/,[U**-,P-@CCO7C!2E]#8<LXYC9A
M1B@SZ,,3W[KAAQ"R-!%R;F*7O*RWD:FV\2:*S$4XW0S(GY::XL\[Q C!C(:!
MT:V0(O3B&YMW]NC$1-A>N-#@X)R%F&_(E*5WY+1LQLPKL9*DZ3#NZ1.W&>X/
M]H=%'G3)S:(@Z $(IV5N1!4 0VQU("+>SKT=-PW13BJ&W7*?<^>+%%1=Q/_0
MS?Y:.9ON$7-!BOC)H-O/A2Y'$R.7C&&B(;O=$?S>D%OY?>4J*-/P%,&%NYY7
MDPX%<.R*RCYH+,2N:6BXL_D\33(BC_U1'=5>9\- N"]N'F,P]:[(9M[L;(J,
M.9>-RG*#YG0I9'5U79,E;?7(R[\'PA:F5"MXKX@ :VR[#7*O-[6VS]!!),EY
M[EU_V_T[_O:T='Z9M,/FZ.:6@"K!N^PQ0;5W%=,U/.RE;O9,2=XK*U*_$I/)
M?KI,(DL-H$J!\4R0(X9\$7Z C!B-BE$>OE0/MRA!T9#S:[-'(-;ATQ&!T\.7
M8>YNTIG]19^E52#AA7U^?N1A%+P+)J"J.]'!/>2?;D8TH"5NG+70C-K=,!DD
M?^)5+_\S&=<WEGFG.A\\DHY!S7X"-XLEC*8'F2Y+CD 195:3,93M3B]4K8\8
MI [*BV.R-EF%5UC5KS^&AS=/,G:<HRHA:FXR< @N594'-J2V/377!:8+\N:0
M6-Z@]HX-/$^M#<?A5UUG[W:L!)7H!8N+/1@G'J_Y^NIABKHRX\IT_T.%'$/%
M]/)DF ^5U9!CCO[*AOX<<A<<Q& KCUK!W>Q<>XJ\&3#OG1G;RYC"SB_M)7+)
MQIX-G;HL93II0'DY%5T(7&Z%<>GV"F/##^4I+CUE^:2/BA/77MHUW(O]/FJ6
M^WN ^[\^X ?._I.[-^Y'Y[316B[YYW&;6P ]D=M'>]57C:$*KB'ILD$8/X?_
MI\6RT51A1-,PJ_H[%Z/-!'7U.VS48]@POZ2&3E:*(?ZM +FS6/+/ F0W_Y_'
M;?\S(:S_/]B?]2UD<31@?1[_ZPL=9'5-CN$V =YZ!Q.T9FJT]@K6%OV3RWR*
M(8YH5:%CF* B\.O[:CU_5G&74_^<B=2!<( &*L"_,D'Y?-'EW"XB"9O!H>[2
M9;*GUWF&G1P>=IXH++[+$_8B<]\5X9MYBG>>.^O!'GGR==HG[!T^/W)/95]V
M;A''4+;"'JYS7 \9T5F$&<9.*$'-Y1&F:",Z>^?54J]0^<$Z$\L.UP/Y9NKP
M-L6EB[?3.)>+:L/F<_)XVI<K<1EDKZ@K&69"I9^L5CH9#DMJ@I''O3*A^TMM
M&0]1?<NJR@!S[(%V_ #' :Y1:S3"13R2DCWG!;;L*3!M].#D1!XY'9G3JB"3
M>V6_^KV[L5*?=V67Z#W3Y+D6IA]FWW&G7O=L^D8#28_^3A&,[1A-B)O8O6>\
MM<E5H.IC?]79JUBES31%DANOUJ ;+[_UY54QVTF]O,N2G0M$*&-''=57FWK
M[]9S<BP39! W%E7"J9X]4#UR[Z$9Y6)RLGI!/G^GN8166$%,L>,5PJ5]]->$
MY9 "@&R3X0V&72[9Z[K2-]%12\VD+JO4D:6#!U3=&D1C/T6\/6XEOO<".P^9
M;_^]&RVNUX[!ETSJ*)[KL/@DZA[-%$WA8'T7G(DVO#*:L84UQ^#5N;\MOT_+
M4_4BLET@FX[IY/C68D=BQMKV--A@/83U5\Z>U?%?RGU'N7>8[T'>^Z:#UB W
M=<E'E8=MP3RJQQQ0WC"S3IKV&YP++S8JT4=X*J.^P19W+S=! SO;?/_:02W5
M0(/%J98.)V6,#JE$E3@]55D1&78T[>WO7H=M%$:6SZQ^OXX,K-Q";'6=CS7W
MAIFD:#VOX4NR<;%#[+5.>!!1#^^TL=E_VJDL<Z P^;(T)1!6!D.COGS V,D/
ML#6D[LTO*J_LD5<D^F9@!\WJ'#<22;$2PV^/:%]0UY8[%,I?M+W>)0E.H(FB
MBZ.6.*9"N[3>7I^=]9(.;#RTL1UC/;KK;E9BZ>Z%:]"EAZCZF6E5JZ>3]5(M
M=J@Z.\HM_P-Z,'>_7TI]J:RTM#3ZYQND5'KJG<[UL^'4Z(/>V_D5\7<=0M[=
M\>7V";=SDXS5WM6E+21^I77\DJ);[F7-$/0W S(?50;>72E*?P97&"#WU1B2
M^/J.5Y-4>E7L><_I-VMH)O2W%*;N;SO@G'=(PD)<)N^0+7+CQIA1'8S+SYGL
MF^&-JD[.*2H<H]N#U;J6=CT:W9^=G<TF'C+?2"PVTM0P-+ Z! ?7'^3\<K>B
M4(E:&K70M [[N+)L#<^M\<FK&Z._Q&%V@Y-9E; =/<*L<)R(_Z'?JQOO!CR=
MJF?&:(3DS82H6F8,SI8&A^Y[D_MU44FG([_&UT?QL2;;S'-U<,K]3LU@;_SD
MEKA$\\_]/GU9 @?BIX[$KEM[9%V,/VWPH<  EP91Q8P6(PMSD W+47 P^<98
MQ46</J&CQO1=CY^ZJV.UUMN^\]YI^<.?]TED.XE!$L6..<0)A:%XV1L\>,KU
MDSY]<OYTI.*;AV"HO,NR9/Q4\N:TAJQ,EVI$^]*BMLQBZX,F)5G$Y:G33JK;
M>?E-$#9>PQ4X'-D6+OUB(C.\]DKY)H,SC94^SOWD?ZN=&J6!730,2XYC)7(C
M]WDP0;OL]YOJ(L8JKDSHE,0.AU\2_WRE\_3%+_LSGC_38N<?=<\V8:0^>9Z6
M(9Q$EDD;IU@ @-W@E_KY7SPK>-CG8'S@>W@]$R3DN-YQ4K^44+&QJ8;)P#:F
MXPEW DX9"5Z-.>D3VAP7I#N;=UI-6OW!^.<"X@&KBWGE][+[ULEJ$8-<(1\N
MIF5I8[6'P5^7:Z)#-L%U.+:Y2G'"2(93MNW#6E%?G>(=@Z*3 1RGI)J_9(F!
MFIN;O^P]/XAJB"8?4:$=T&0<Y*P]Z0VKS?7!<=$N^)!2DMX$>]3'N#7'I#P[
MX)R@\#Z,N/+ET#U*H#@&A57.MQF7%>V[WKV4@RJ@SGZO3#=($ QY=4DL_</A
M^.<!'("6XR'+[[VGY-9Z*5/V-N.@%VRZE$X]N4Y#*O]_[+UW5)/;UBX>MR(J
M*JCT%A40I$6Z A(;342DAB)$1'H3I M$04"Z@(""$*6(U-"1&B%4:5)#A] [
M"24$TFYPG_O=L[?[G'ON]SOW=^^XX_MC.1@,>=]WM;F>9ZXYGYD5G=Y5&DM(
MM*9H?;*BC?Z1G89_<ZSP?V^G&?$AM&-3LH^"I.$'Y38S.;,VXFTJH#611B2@
M;51 VBR""Y%'^V&<XK!7TTV@ @ZT8'Q"4O]5'RY]IM]-* C=S[*UMS&T1PDI
MBR,C$Y=_NM;6_KF#]N+4/+(@[" "DJR+ N^%4@$58/P6QJOO@,"-3A)M:-QF
M_Q/V#PP-FC9YD&(+1X3#5F\>I-A&)4-39/"")*8X?'@(WN<@0Y)@H+ D)K:-
M!-X$O7+ZG#1AE,([E_Y<FREZO7KBMCV'U<FPV&N.Z0O0<Z%"7040,R:(+P+;
MO[UI%Q,L_S:S##WSB7SVX%9FUO\O_=@LI!Y8O1X-8W<3G*"CX,8Z\>+D+FQ=
M<B0C"GII;&EPE2@P+S1+WHZ6:1[6JX'9;+9=H/./^9NVG?:B/QM))F[*.G!'
MY%J-^O0*C)#SN;PZWJE4X60S;O0,+_/UD823!0NLQ$ 5@VDY8)C,_F[(WKE,
MS7F9A&*#Z"S(UM+<;'<WH41:_U*AVT3,H%DM6SL"GG00 7!72?07L]#SNV(4
M2I&&7BUV%BC)I2-D-D17](&XU#VI)AII-H,M56LB>GPHGM.(/2X:T#RSCU>E
M8#0.4OWVM@;_<&D2X](;1G]79/\CZ9<W_70 [W!1CB&H +HO5$"0,CD.^WR&
M-9\*8(YNL\4@SD[00.3YTV$)GO=A<]T?HW2I %Z2")#OZ.3F?-C6,X<LQG>8
M"2!3Z>)^UCC,>+6KX[12^=F<7.65T733]V0W;6C )/8>E"">1>-(3PR*L+#&
M-IEH+A*HJ*\I(86EYFE=+H8* #V_<][S\D*#Y[$.775BJ2'ILW)$D^#:9#TP
M.I6!G%%#YSP-.T1(5L,9A+B4^?>97XUKC4E7]WT?MX&ZHLY4JD,7(P?XSLA"
M4/)&?:TISA*S]*K-*(?-DN#?5W1W%$NNHF;,?9QZEU-72&CXK'L_[701S/GC
M^H#"::MXE\2VA4&L#GQN2_>5^-I#$?;J-<65)B0ZC(C'O3O<))TH$9 (56A6
M? =\$R?2SI 3O-Z^.79?'E'44-]&81A8K;,6!W'=9F"T-5,'=?<X=:>#G3=&
MB?4PK!8L8-,+WK@)L['G#"9(G_KM^"W3%4_A0\)9].U!<I<3'I]HSOM([QDE
M1W'R5_)U0M.@123O[ZZEG@*OK <)E 6'6,6G3F!^">^(]<+&9(M(!IZ8YK#3
M@!PXFY*X5]Q,2V.*13/OE4&0#!5PUAY]='Y_?S9R2PD  /R6)ARD?^?0&1;]
M6SDOKGTGMP=[627H:Y;OY6AX]O5X>Z^32C6VN%?D4Y5LC7^8@ ;V*- #Y\0.
M?? O.X@83@4<_4'I*O&5)\?5:.-.XT5:Q97X[59.O;.=?NZ]*JK8&JNGO]?3
MV5'QI>%V:[ D\^%**H!3Z1#IS.]=XL "@\4HM"[E/HAJ&'5S/>B28N^>':U+
M+S-B&E)BFM<B#D/[D?4;P;+ (Y2S7B;U27KH1$[H*[=PS0.-98.OL;]7>ON9
M:BV<<[P+P U9\+]H99=P]JK0AO;X/FC+@_@>S\T7\*P ![)9K(7N@3H6%VE,
MPH',]!^!-FZT[?4!;&GO1]]D=I30E+%4IX5?IP).>P7/2QUQH>%L[_+[K8 $
M]526*I4W"=H\&<<WS6]3M"$[RL2'_IW[6FN>1%DO%*:Y3'!XE:3_:! W1OO-
MJ>_%[8XN13P,>[H9.@[B+*3:_,U8D3UWPLLI31.,=;1[]TG[0:0Y6O':%ZW,
M9=D).PW\\W?\-IF:BW=ET08<.GHSYV,Z_4>_72MNG/+/E=O0[1L$.5?KS\:N
M^]LV&3U/#\/C"-9[^10R9>O@+K%:R? 7MU0UY;@U;1_?PPF2SB&F-4S&Q.9K
ML=UF7R%H-WZ7.L%OT/(1IPLZ<WH O3=Q%U^Y9EK$@A:A&&!3]RF2-\$QG8"J
MWV]*K<74^HP]')HT.5?\I.T(TXTG[H^^MWZ3ER\N--"AWW2'WO#_=F 1J8#7
ML$+ZQN3K&JBJR/DLC,I76QG8B;$)^:6JM%8^(VY!D5-=0^FC3W-,?<M.\E['
M(5$ND&.J5Z@ VX81&1]\(L)ZF 1WW^$ ,FD<)R;MHW#1)$;05TJ2$.(#%? (
M2+B,1D$)0N @/BK@E1.1"&I.,#C^/-_+;+5B9'NL,C+"25]GGFG*'R^*L0SI
M,$R]R>/' 8UX7%A6.&#*B7.)'0>OK#^7VK9C#W/_F*/C^3.>N+(SX.^/V<KN
M<#B;HAR6"U->-,/(;L_JPQB\S?7LF9^?Z_U6R'D @"YE."PM+6!]->?3^Q=*
MID3[G^5_6"GU2LQL$U<':];,G/E'O#PU; ID<H=F/;4E34I#R\_,?;]7+*GZ
M[GNPN#X7%HJGT(ZV#R2:$0T()!1H$=1!R&(2F\67Z^OAF.>WD)9]D@$RXAC]
M=:MCC!N679Q&-66A_!+H@:<;)QX_NY;=/IXYJ(5X^QQY/7&*Q#VIE!X0?7$W
MJ\=CAPJ@<0"I--I3/\/J=15ICZ<[1X@MQZ]X?R1)_7#B*!4[_L$YOA"R5O%<
M'5)IR4]W)$.HB:G(EC]QCE,(,7[%2_[J70D49J:=?1594#N\Y\]W1J=6U2"W
M^B#I1_M/C,/!%XSE_>.-3/_YWNT59YF?=ZNBVI=V#[A:1-$)J=@;\Y]UM!_V
M#KF$.[62:5@VT!+Y9(ET&P=JFN38$3&Y)HUD'$4&EUK(E.JJ.<^?T7"1O@_U
M962I5&L;)C8BW4__5@4?/G#^ _'.O; G6L,E];1]*6VDU&.-,:&KB%VPSQHM
M,$HR28Z,6-?M3)F+>^2:/>\(?7O(+!+:]4$Y6;$%J'B+X!%-,)CTW^B$%\ZQ
M W/,+50+-@8V*#^=1(W7_R-!];\*3_]2>!J 0"$(U]CP=Y $1Z+6$A7 YC"X
MN8*BG2EBTZ5U\8'RAG8&;_@O2MXQYU-W3 ]--_#P]'**^NT+[6B RM/@%=)"
MBX:NAE"-=6=*0CIQ*LF1SU!0I;%EV67BQ7FU&?*VLUC=$GN:7WK'^;<LVP]!
M2>3;$D&V"LK$XFT___O=L]X<\_0K7M=THQO+S')) ^@.BLV7CSAEV&U@S"\X
MU.\3C05;TOJ:3 6@#I/LO_;6F,+RU+&(IO3V_OQ'2F[&US%"?/V#/'EK9<PM
MPHWZJ;(&%PT"A+J;MB&\X,.J'+<,[99QB3ON\Q6J*FPLNHSZ!AD[JCN?ID"O
MC>F;H,='5B;8T-*PLS:>HTWEZ9D3JMZV+D4C<L.BEC'E59(?S@7K,)X?;(+)
M(+%:C 1A:*,60="@UILM9+"[D9=QL. B7 ^[GM&-]^8PDNMV6G[F[-IS.;H#
M]8F.H064R Z=0 PS4DXP8.%XS _6A6^\PB4U WP5;&Q)+)/[XHBL%T5L6V)#
MZT]4DJYV]&R\JA0NEF A0)F>%HB()B<][-]7%T,VC6["7NX'Z\(?-+?$$TN6
MD>W(Q>?*/Y6\_JC$R;(%7ANF&0AC@A;QV*)\9GE1@=$*1;&\PJH$FY "?N\G
M/?KXB4;P@W:KB!+52WN%QM?7..]"S!<;IE8>V^5<]:I4WX8.AE?[\'&K7$QA
MEX]_DE9=TH^T0XSDUL.*LNK]-%K,Y/OKZM.7"&'LCP^M[R@D'&FQ=^3@ZWB/
M_W R2-_ \\D=3^B")^7$=:*O5R*>"B!_*@.=L8-4A&,T):>?.Y]8.JMR05/\
M&[+56,836MJ:$RFU[MCU6P"?6H\$%> X.3HS#5RC G"7T(W^BK4E>GUBE,[/
MMIP.SJ>3,[,9YMDM/#TF182L/:T\&@H\^&U20=!R+.(X2BRZ K&A#W.#6"Z,
MD\HGMQ2WE!)DS;ZGOD5/D"87Z_P/I .L?/\LI@* K"))7")$010-EP9/7"%T
M9AM/J.9X!6!J9-(Y\N>"Z%ZI7':Z%!KN\%[@ZS"O!U!LE>?V7(KJ;,4W<(#\
M[IH +AVE=!C;A!R1Z6:!MI@[5EWCO2H'3+7U+?,T?'RC5PUSOW7&@P] ,S18
MQJFH0*(LB0W;_8(DX8SW8VPH/S-DXA0E'>N7OI $%=/FM'U8&GM5NTZ=YW4[
M)XG8>')TR)SU!.-$-I( V4.VP4T:O!AM7WN]%[M0D4L%".SS')0*B0"F!_T;
M+K^PX#](#N3!_Z0 @,R,;@CX$VME5/VKJ/"7D[]XR#>A9Y 3-C2Z0;%>'#M'
M.I&:>U!7''E-:>@?Q391'/ZL./"+LN4+TLE?E"UAO\2%$WC^RD$N@.,BST<3
MH//^D?7@;]G+R(.S8BMN[<\]_(^>SK?\3X;G"V.]P%?:@CKV]]_S;RQ<0>?O
M3X,CS\'6N7X6&&B0OZCM/B0ES^L^Y3J#055X:V1PO _F3(98*/_FAG_'EYS&
M\]5?'4-<+,F_Y2&Y"2!-0LQ4B@6JJK-ZW&9_)V+$??NR5$/?36E'[C!>R8)7
MN6<J#:]TW:0_6BN:?B6!GD.+!5B\8SK8Z=?":A%HF">]J)2K)=B' Z=4B>03
M=K#/=,BI_M*$Y&_[-;DN7[RL]O)Y+?6TRE3TGP3XA?('2$B#F-,D5UL%3DQ>
MN5@I3 G+-& YGZ/KJ:.>-7Y=FY!RUS5+[GBN]"KY 8UX?/KC%;T;K!X$GOH2
M1[I0UU?'2;K;;U6)]>L(=_RTDBANIL6HP"U6AN+5C.$_\F;+0<V "E"M+R.8
MT8CIO8)@\YL8',/]Z!P_],YLURKR2GY@7JZV?^X!+V7U\FPTAH63P!:YMG*#
M/I_C<TQ:/"V?VTIV.WN>#..]9A&C#E'189>,/78^,*P22N.NA7(D9E@3L @\
M1)+#>[EW!V]!,]#R]]Z?LY4HIP*NE>);#=NE1/,9 KE*':,%YA,L]I%$2<I@
M*AVY0)&1MVRJTVYDTQ 3IJEZ-T'/5.N.-\-+EK$3C8U-Z6\NS_$?,Y.-.5%)
MTKJ.J3$PD9VMS-Z.'5V@F>R["\OO[WN'M"@+56OEP=JKKE_ZQYYUA"+Y"](.
M1$]IF:0O8^3R&B&ON8VJ&(KE?]22W=*O>NJ;JV%3?#)./3"H%2"BP$(SR>_
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MKI8]@[,IG2$XSW2C3"WJ*5=Z5G<V3JT,SH_L-\_RQ(G?/,)TFR^7SLWM0L^
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M^(1&=7M[90+7<S4+G0W1J$;ABU]$C5X#?E-O@H%HMA0+C 9OF]2!8!B++U0
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M F-U;J%)_JBA-AFLHF=JGBS;LC0<J6T_QXLDL$XD*I4$%5<8(P>M:H<<YZF
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M7FJ KXI1"V.^1+DZN%HY)'<MT??]H[E V8.;'3H 81,\7^%+@[H-+=I4P,Q
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M:EVJC0"%2/E,VPO,L<":1C>)T7)GFG\8/_@\F>Q!HIDQ< W9D$"CL'3S6,;
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MA1!G> MS*TWX]<B#H,".XUO\=T*<A_JUH=V&J^X.EMZ/1:J_WZ<"L&RQP][
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M@M$L/,TT<:=@E6QRZ$7FJXPO/<;N?B;K#33:(KWZJZS[KTX-F'8\J9+&3&_
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MY:_V.#K%Q>\%O[H@S]M3$E^7#4IW98FL CC?^ 80IRL\T%U/WC6)U3 M@=3
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MDFDOE'D 1924$-W 09N>>6RM6D.J'SS"D?X'*?X#RKZ'L/+DD_H$%2C?2/*
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MUG'&AR!HNZC.Q-WZH;V/@8/T!7.88YU+K*2J.Z^_(LOMBYJ\PG<!T\D?H13
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M8L+OJT,"TM1OSB2];,O9]W,<47=D%CK-Z_><UEA9S0O4-T8^WBBE7VR/PCP
MCM/5)YZM&);.?P.[6%9>',9N65!3."P@TIU9)B>R&.-US2&R\%GRA[(7S@LP
M!;SU;+X?._WU_) :WCG&X\L>S*08X2[XK>K^W._QML[G?0+[U*/IZY]',GWK
M;FE%JEYI&.X/,^A(C]3<M$88TP2F$>^YF&6FG@O.?YH];J?&83QE/"G2WL,6
M?K/AYN=CO,??G@3,)5_,T3=O__VCA:[Z.JSU?EC< JY_RN+MG2Z1]I<F>3,9
M GG]IZ[/Q:T2!3'&K<#3"H+V^9[/OR9>Q\H$^"85VUT7#Q!W$U8/R\.6M3T.
MZBNK<<I]Y5XT,Q-A.)A-:Q^7JN:U9/O@X\+Z$51R5Q_X%E3BX#,U%(9/\$BG
M0E9D;.-UIVPGIR>#I:0'P\/GSS99AFH><5'S8I9MCV='>4N^6'GO6#>/226?
M8)M=-SNQ@%UL$F=<$BG_5C3FZ=YNJI%1#& 5='/^?B+=H2AOU4M+YIBBU6S(
MW).*>.%D[#"BXR#7R<G[/33@2BZF'WX#) \\,MS:@ K81[5L %71D!/+'HF\
M6!H'Z\*"T"[1&@B?\\DT&I+.A?E0J2+',)I7G:EQ)!\\\$ 0 R^  1N;:L^I
M#1$A6;>=18:W/&,(ZP^5.%KG]X[U\P?WZY@4"VO0?6,K1LYK(%7PC&C<2TQ^
M0TP5H]_V#6"C-U?X;Q]4W=UC"%,''U196)\72WQEL^+;U("6R3?=5W@4?B8^
M:D.4=3(/A2;#E=[,5!6-,$O%/LTF3,4NP/3)/2C,[9X@*DW?R($H\M@9@1JG
M3MVO[4JH;5CQ7J*[_.C4X+'^,]@-U_<:SYAW?9*?=&;NYJ^-'*A]X94(0BME
M54A_J##72%"N^=V6VNQ)Q=0OPH&)@OQ!:?RB1KJ12CRE=[4:'85+=?4GE_+?
M=.+CK[2:25O;((NY6'NR]\I\G6AXZ]'2:70=U4,4P-<]@P/!=T:3OY.?(-Q#
M =B(CQFC-]:UT$M2**"GO@:67L^GKNT98:9V8%?*@0*PK@J*])3=TPK83/#(
M6G?LB#![J6Q[KV190R=]TK+,=BS_@[1@B_.SN"I?[B_$:OS&P<K&BK]Y/+@#
M\B?+43U2T;!"AV.R_7"?T0K_N<F8.[4AEF>^;?'HJ%UX"8A?>._E!0\B"T(E
ML+)?:\VX0*W<G,-$H(^;FW1TB7=SJE'N=D%13LJX"FFJ/=.5VY(>6[8CU'1%
M8)\SZS<'S/&7#CC_#PYXEPT"M+#QJ?B<)5Y)6C8D#A%[HEN?^9\KKU6J -7Z
MHC PU:T,95@KE!I57DD2Z?"97TC5#WIW@(#I-F?.HG(_I^:$DH@4ARNY'T/X
M/]]%"4O>IKUKJ [IH&+>=T0X]9%/XS\DTX'PRE#X#)C%JYH\1,I^ZO;)-Y[#
MW6&S:R.^6O3CGH],*&32G51&%U94M8J*>KW.OY^=7]?:_J1"$ZA&"-+XQ2]9
M-Y;HYWEND$_N8>?0,0@&<BDFI$7=7JIA"E347%8ILYG3Z'H=.G(F"VV\&_KR
MT%<1MG>R,425W@WR*?MS^Y!0*0(%<&)%/R;3AR&FTF'?<?"MY-6<5X*OZOJ_
MK7ZTN-SXA<?W$I K()_('A&;2G5*?L;'S6*QC^=6XH3Z[K^:E7\GRO$YF.UM
M]#5 )@_B"\_K)67%JO!GO["3#\[.7)_/J M_=E9)FYI<UZ&)5%L[JHX^_QG_
M>M;'E[&QMV>6P>6'3 SJ?O^L_<1$M$'GY]8C2I^A*FED7=!E@31!-?Y.'.>3
MB2(.9>^1%\C'B' @<]I@:E\=,WX %E7<S9Z6LO3D5N>MP#C2C&'=ZIDG(F</
M580M<2PS'H+7'X'QK$JL9,\BN/&RC8X<*E)CKM7J"0XFAXV]/O 1@#$W3[[(
MO:0N<V^=HR84?/II!61.#Y'B 7>I7O'VA,9R@?&N23W*N]5 VA$X00'6 3P-
MMR-9K-4!,%,MY1"N <-IN[Q9U+T!OD>GWVJZH"[;-/55WSX?Z?*FZ,X,)RR-
M>(YJ%Q)0!KRZ&]=T9NI*$I,X^L/W8/ YT]SYJE35XG9[N4CA:[HPZT<BIU;6
M*V3;N'NRL^>>BY_.3&M[F>$Q;20>:82,-PL8F/$4T]AZL@BY3 '$4P "*U!!
M@O"!^'$-UPQCX2J015H<KUGZ!:=!0@#L'8_UM;XC<$DN3*^[19]\G\.L>HE[
MZ&Z7+Q*]P6A+9NH5<4VXU-*CWK]=_5^USU3/.G_YC\H0@(3^Y?SNY_0#+&%)
MBD).X,AM8][U9Y[TBN<XWUU,0;*N_*).F.@._'.FJZ_6# 3/ VK-/XHW&KE/
M'L7?=L,Y4@ UY.G!1^Z+5LNDC[[.(Z7V/U&I['TZDDT[<I&HV0ID7& E,_]]
M7IA*LCXX4)E*N4#_/:;V__RPQ-H_BVI  ZBN()/DK^!#H%I,@Q<%<+*Y]8T3
M",U/[J%B)NYD9X_R;P3]#PM>P[WK%(!)O/N/GJZ/CZU7VXD>P84ZA6QI1H/\
M7:P=5C4IU, 2VXCW?G?E[+*N7F3M"*EF])>6!$7_*F_;,X-XEAEG20'XYY/>
M2_><&F]>L!^6&RH!Q3M!S/4F@&)!A$';"U,7QA/=B6=2D/3%X+YFF.2!KC_<
M>IE,"QME[\X\BAC;!G+!FWZTZ%RM4EA_Z9[S0V+!-Q7JQQ)XIR+DAS\MZ#YF
M5]KN><?"-FS;USL_;N0[(>EXBY>W<_A5CC4*0'4?VK=).JL%S@(F_6,9G;\8
M7!D-^>/RK2@:8C0&$0I511,\(:P/96(\-E6MI>8>H_C8-M.^W=$[E<.F(WC$
MV6P/0R#3*6,;Z_VW".H/,8LAL*'B#O:RR A2E-/:&N'":_ER^HVI758.F ,Q
M2=D+GY-Q-&BX]G+;KBUX8W*M<4$NBUW[2_^Z!Z3:8AM23P%@P%%A0L#3T*L4
M0*)@IIGM/JI7741F@Y'065@R'6RY,K2J>(;J&&:(;%A@8.Y:OJB"XR=CS6I8
M,CS]#@Z'UVY\]LKVJ7P@K4S+9$'W,0.8<I\9 ^QXNQWTBO-V% E"5BU4#9$\
M#]76WE'?+B1XH<7Q0L"O8':\/TJ]&!^4WOC<K=H"-39EBULM5><:Z#ESYZ-@
MRP*;' W?"Q]-O /DS6VR748CG"CH@,3/PX[WF9EJGL(XDG_D1&X5DYA0FF'.
M@C[;LR0QI![\=MUA?"P:&1RG$!?@1U1*\8S2]+> \'?'^K)\EVAG,4CV''OQ
M."?CR"(]H[.Q&W&NS\0%,RV[Z\P.?T4!$%RN6[2>FM[A@C=3 .-)?<VZPZ79
M((:E7>_P5 _[C.5]J/AS-[?G0LT,)7?3$E7=>82R7JF? 0"BP-UA+,*-OFY-
M\.])I$+P:JL=:$^62FUA>,8)(/HD<%-7D<IOT1I/*8!6X8]X*@\^RHX'8CK'
MPM1G]0.<8%,'.;81.X[5,@<YMF!Q>7_9]2G_%O<R$/V7O&^>;F^T=U?:\H7%
M^\BJ(A43S!#WCY M^'=8*WZ#3">*$6Y@O^-Q'5::B\^RO<0DG1Z;VL79EZFG
M:"Y[Z^SX"9I#(4\#VE7N;D(.RCM]H?(9JQ*M:$3 ]>'"C/>WU60RLY33.XM^
M.'P)EZK03G9_.U'/%U'R^!RQ+:56!'3XJ0Y96M"[@P*(*&PT#BD^2115[8,G
M])0J4 '$T7Y\?B[<_O;G)=C)/L<-A>]%[XPTG;T>AT5P0&QK,OEO*DWV.5B9
MO,>XC_A3(SWM46S^K%@A%RX9*]E<MJ5ZHIPN;3I![$SRAY<21GO.,1W CYE/
MJ%#Q)O<-99_W#B'BC:OW0A]M6**F?_0(U4'"<HGWBN#RXI7'[UU.J;7X7<;N
MAC7N!JF@1HO 3GQHZJ,$*;,MC[\XM!UD*0S)^GKRJ\!QRY 8B?9#E]70$0E
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M&"]!6$-GRDZRP+?N/=4C?X_0E@:?XBA/R%BRE!M%8[1H1.9CVZ$#C5IPJH_
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MYB/T2>CG<4N9@9F4"0$(U'+UT!@I&IG0*!>P'6L$V]W& 3DOA-$T&UC2%SB
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M:%#2,:51W!-GU?WX9?0 ! 7BR @7:+[MG!%>DF^7<"P$O3XR7'"Q7J!FNI8
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MLI[\$Y2_9YSQ_R/$N/%_ U!+ P04    " "#B@E7XD2,' QQ 0 [1P\ %0
M &%M96@M,C R,S V,S!?;&%B+GAM;-2]:Y/<.)8E^'U^!3;;;#;++%#)!TB"
M-=T]%JE'EF8D1:RDJI[>M#4W/"/8Z>$>3;I+BOKU"Y!T=_J#)$ '*?:'J@Q%
MD,"YA\3A!7!Q[S__S^]/2_!5Y$6V7OW+3_Z?O9^ 6+$USU8/__+3W[Z\A?BG
M__FO_^V__?/_!>'_^?73>_!ZS;9/8K4!KW)!-H*#;]GF$6P>!?BW=?Y']I6
M^R79R'7^!.&_EK>]6C^_Y-G#XP8$7A#N+MO]-?]+Z"%/,$(@3[&$*. 13'&$
M8,I\D@B68ARCFX>_^!X)J.=',$ZY#U&"&4SCA$'A^21-$\00KAI=9JL__J+_
MCY)" &7>JBC_^2\_/6XVSW_YY9=OW[[]^3O-EW]>YP^_!)X7_K*[^J?Z\N]G
MUW\+RZO]-$U_*?^ZO[3(+EVHFO5_^3\?WG]FC^*)P&Q5;,B*Z0Z*["]%^<OW
M:T8V)>N]N$#K%?I?<'<9U+^"?@!#_\_?"_[3O_XW "HZ\O52?!(2Z/_^[=.[
MUB[37_05OZS$@WZV]R+/UOSSAN2;]X2*I4)?MK9Y>1;_\E.1/3TOQ>YWC[F0
MEYM=YOE1JQIEJE'ZL4;Y3VV=_7(%?$=X-^=8'8 KS?WH"F,7IQ^=P?VB%$*,
M#[C1S=60JQ?JS8I/]>[NN[H:^OB(7;T6ZPU93O!:'+II0%[J7[Q7/]7=Z(8Z
MQ+3LIY;N!E3Q?2-67%1J>=0TR/B__*1^6FP+^$#(\^+S9LW^N'U^S@7+2NG^
MI#]KQ>?;3Y\_B"<J\L5F__XNQ K^[?.NJ[(]R\9^LC!KTS(\<U&LMSD[?-B>
MEI>^5NI#I3]M^)<5>1+%,ZEO4+"U%U!9\J\E8-!$#"K(X&<%NOC3/_]R,-4%
ME\OI:5S^6 ;![Q7D_Z^5RC4[ K?4+L0Z/Z5GS>SI.8S10EE6<B-)04OCZL9^
MT?[;+V*Y*7:_@?HWY4 U[^^7LW?C-M]917+6\YCJ*WYA:^5-/6_@T1.3^?II
MH/F;]<#7JGH0"M9/8)USD2L?^H*)^]=?O1V/B]O[5Q]^J]_RD,2I%\<^]$40
M021]"BE'$0S3F(LT#6C(B(FLG#8\-_4HH9E)Q!E'W4IPC>4C#_@25?^H[K:>
MUS.N\C4<A86C'G[4*V L;6V65@JF_UK*DA>'7BE-9]=/HD!M*'="T_IW.SW9
MZ95R@\2=5'-RGFW>$I8ML\W+!_(]>]H^_;K.\_4W-9]_1=2#4;]?>%X4XRBE
M:BJ-,$2"<TC#@$+)<!QQ+ A+I(TK8]/YW'2IQ@F6:[("Y"O)E&&E 7;NC!7_
M9I[-6*R.K'D:-EA+4 $'.^0W8,?T'CS8H7?G[@SAS)'G8]7UI$[0$%)._:%!
M;0R3LG<KE@M2B->B^N^[U=VSR-6WJ>PA4S/!6UIL<L(VBT0R1L,HA(B' J+(
M8Y"F00JQP 'S(A*&Q,AYLN]Z;C+VZE']2Q0@6X'U#C(@12'4Y(*L.%AFE:QE
MHK@!*['1(Y1N"_54BP*P]1/-5N77O_B+G>Y9/"PSU1OG$8RL>3O0X.<=[#_I
M)[%'#FKHX/<=>(=3/'O&'"F>1<>3ZIT](:=J-Z"% =/ +SE9%5+D2E?73T_K
MU:OU:J/L?+/:E.-T@7P4>HAC&*"8*HE+(TA)&L,@9C1B%(>IH,93PY[.YJ9G
M.[A:IU@)6/VG1 Q$#1G\K#K<Z.5!PZ4G(](-YIH.J1Q9EYHL5EA!#1;LT#JD
MSF*BZI#"B2:OUU!I-[4UY*9SNMO7QG138$-KCJ;%IO<,\R\_B66Y9T/RS4O9
MDY)Q]>IH#_?=1CP5"Y]''F%Q"J-(J.DQYB&DC&"8<I($/,#(PZ&-5]G7X=RT
MM\8+2L"@@1C\7D[N2M"&JUG&I)MYARZI'%E[KV31V@TTI<:1\]?;W:0NGZGQ
MIXZ>\7W#I.;S(\G%K\J!Y$K(GH5J7K=^F^=ZLJ8_6L6O+X=K[LF+_MWM-Y+S
M\O^^J%YO5_Q>O5<?U9OV>OU$LM6"""8X#PEDDBEY\CT!<<((#%D8!1A[">-6
M\C0&R+E)VIO_W&9J%): P>\51DL%&^59&NYQ_N G-/8N2?E4-,K^1V._ 3HB
M=Z[V3,> ..TVZX@DG^W,CMF7G<P+QA=EH[^ISC>OU9?D+<GROY/E5I@(<,?M
M<]-/#0R4R  I]!2HA PT9C,5[:*J6P0=L32)AAU8 0?&KM<R PHN2%$AV)\?
MUE]_47?7*L3X07RZVIQ$.PR,V@U]DTOM1FZ1;Q:53_!!;![7_-WJJR@V0C0^
MS4C(%/.80R]* HA0&$&*E:\E8NX'B!/$,#,9Y?U=S6VP5PBU;-X C=+283+@
MMGO$NV5L]*5_6[*,A[TY#UV.B&JEX82H?QTTP*"#2:3 W-"=(EC<X2Z>XMU*
MC3[5S2<E0+>;?<SO(A8^$UY (4Y#-2'S/ 1)$DB(8DE%*G$0I\&UX10M?<]/
M.BJ8(#?V#(8P;C9M&HG'D07E?5O\Q)Y;C1V0#:C0 P5_W "*'LY&C)]HZ_F'
MAT_T4&(2/='7Q( -Q0^J?48R7@<.1J&,I<=2Z,=)#%$B""1>Y,,X"'SEV6#!
M ]]X__"X[;GIS@Z=Q6[6"5D&^W[#*1A9,G; AD2:GM!@L8<WG(Z)MNPTRK\<
MHW2T17?9],X=N9-;IMN NXSU:+^MY9)AGM/=YE'D[]>KAR\B?SIXQ\6""E\F
M,:?0]U($4<@3J)Z@IV952J<8DW%(C<(9^CJ:FS8=H.F8("*EDG^E^88[[[VT
MFOE"+L@:6<5*B$!CA!HD:*!TY]_T\>#(F6GM9E+/I<_84S>E]_J!<RE1%$*\
MS5;Z!/1['4_U2:S$-[+4W?@+$OHRC75<$Y9*%V)*(1$RA"$F* RI]*676DV?
M.KN;FSK4.,&RC!]</Y<[Q)LUJ(XE@I^WS^I?EF?K>@@WG#TYHW'L"5,)] ;L
MF"RQWH :+=!P'<Z/C%AQ-27J[FS:69"1X6<3'[.[ANG*:R%%KN94[U9L_22^
MD._O#T'.'\5F$4F*<1@&, R8FO^("$,J8@33 (414IH38[+X*G*Z-I66GAYM
M!D6SW_'&Q@XPV)#O^QAPRZ,M?32C)&%$!BED21Q Y*4A)"$2$$>^]*E/D1]@
M&_UV2/(4 CX%Q6:*[9"XD25[SUD%%2BLX'WSA(*"ZTZS#7EQ)-I]O4VJVH:F
MG\JVZ6WVV^7O5D6FKOR2$YUAZ'Z]S)AJ\SY?L_>&H8"&K<SH;:_1@AHNV.$M
M#^9HT()O57^.XP(M>1JT@6S2_F2;R1;&-C>6;6X;*0JP+6#EKIP-%&^^BYQE
M!:%+\7%;KM*EV M%RBFD*(T@XC* V/<\&),PP2014>(;[4V/AG!N'^D:IYI5
M[8&"G[,5*+15UJE+G#]/L^_[#WU*(VMD"1R6R$'3.M P#] 7T+RN-K&*ZKP!
MM94WH&&G\B2V;M9]1W\(4P436N.;5R3A4'JMPP@'=V3O%'W:+H7OT<A7W7_)
MGU8;_G9)'DQ#""_?/3<%UBB!A@G]HS&M%P+TV6-AN'?7P5>_WW@]52/+8#]+
MX'<-V9%_V,W'()>PI<G)O,!NDYJ.7\^50]>D\NRKDI*OXK8\?/]JJ^91J\TB
M2H3RR0(, \801$*Y;5AZZO]2STNY]N="HYCAGG[F-NKUR3WE5>M76%1',-0;
MM,TM3I[V$6NZ-'(U7:,OB>P0@A+B#:@QNEP'Z23!V?K'Y5XF7O?H-/5\O:/[
M\H%:H-R#AX=<I[!4'L.=_"2^BM56'!8Z AUB[+,0\B@,()*>FM"E,841DM27
M.$VCV"A Q[3#N:G#,5X=]%8CON*@:2_IAH+AD,JQE>,Z%NUEQ) :5WK2U]VT
MPF)H_)G"F-XW8/909<'0?N+KM2@^KC>?]+<V%Y\$6W\5^<L7\7WSJS+B#^,9
MA7&+<U.4!G+ %72P6F] 7H$'._06$PUS:@TF'Z.P.O:$I$&H1@T4;/#IA%#P
MNX8.2NRN9B;69 V;K9AW,]T,QMKTHUF-_=T#5[5UAMS']5+=451',51?0ND<
M6ZZ+;2X.0R/U9()UX#%C,88HYA$DB8QAC"*4LB!*B!]99\XVZ7ENZO1!_.,?
M9*6_R7KGIVG&_PTJ0P;DT#9Z!(8+S&,0.[) U2?[W2K08$)<9M$VZG?Z;-HV
M=%S,JFW5P(!3$#IGD%Z;)<LZIEVF*$@$P3 )*8.(Z&672"E1PC 1*5._5+II
M>@[BM/6Y:<P!G\4A@#/*NO7B:B)&UH0#M"$G(L[(L#@3<0TI4YZ*.,7IZ%Q$
MF_F=)R/.;IKN;$0;WJ/3$:T7N3M9>EB=D,R/(I\A& M/0,2(!ZG2)\B1#"@G
M(DE#J^0^G;W-3;O>7S[Z>,5J4#?99EZ1,PI'5KVKV'-R4'2L):#NOG[X8=#>
MQ1^SFX;)R:]U$N?7HF!Y5NY-WZ[XKZ3(BCMYK]ZOW1?E,!F@-,2)]%-(:!!"
ME H=%QU*&%+?9RE-F<^I75RT/0B;<3--J'2)5H^?)MYJHK9]>B+YB_[;Y^QA
ME<F,Z30OMXRMM^7VUCZBSTZ<!CPZ,\4:]W&,+&,[\*"!OGP,EQ_0.!._X0PZ
MDKP! ";5P>$$G8KC%2T-4\R_DSS383N[ _AE6MF&5\!]2I$O*!0L4BX8]S%,
MB?"@CXF7IFHR&=KE5^SI;VY.V [N(=]$!?@*+ZR/<3-5<\CCR!)V'8768F5(
MC"-EZNMM4ADR-/U4<TQO&[@ROJ7J\BI<Z[6@FWH9@; @"%(4P("1%"*2"$CC
MD,.$8XPC[(<L15;+X!>[F9N<-%$"#=-RB?LREX;KV5<S-+)0G)$S1@7(3A)<
M+5A?[F3:U>E.0\^6HKNO'C;RJX.N&5DVSDOM4Q4>EKD7-(Q#+\(IY+K0.1)*
M%&@D?,A\1#GSD!>FRL78%[WM?=$-^[72AI;*ODYK*N@^FJ6)[+3!E&TSL1B!
MPY'58X^X>7:RD7@4'%"[DQ-+FASIBVFODPJ.)16G"F1[NWV&T]=9+IAZG/5'
MTV,1]D*,8"I]#E%"4S6Q4=)#?!\E+/)Y3(QBD,^;GIO3\>M:9^-]*K$9BLH%
MOKIUXSH61I:&'3"'_D2[O5=D'SUI<+)LHY<-:687;;EBR'[TZ\^O=CO1ZGLO
MA1?!6" "$1(88AX1R".&0I]BD5"C*<!)NW,;?AJ9S8;K@:#N(7>%V2./-PUJ
MT%[SP72;7>9!%$RTO]SY\"VWD\_L[-Y(/EP^X1;R&<;CS>/S/]M_QS^0_UCG
MK[;%9OVD1N_M]ZQ8Q"B) A9*2"(>0<08A]B/$B4LOD=2#X<Q,TJZ<KGYV0E*
M#0[\KM%9Y"&_P%S_5_TZ/L96&D,JK+[K[19?\6V_T.ADW_=V@YK?^(ZKAL9V
M[#WY^@C1OOHM%WX2)T$$$Y$&$'$1PE0P"3$E$?,((P'V[39=VSN;W^9J#7#X
M7+^#61%R[L<)4]H7*BD,4@8IH8$BVHL(C7 4Q5;AQ6YXG486QV/5;-'$#5<C
M2^919JD=9V-48NYGPUE 3&M'$T?#]!E\'@K3>\> *=9YO>8JI7%S:661)I'/
M98@A24-?%XLGD!#E06%/!H)3E'IJ\F6DP,9]SD^(:XSVDF'.L\$<SC5W(PO(
MI?+N[U9@Q^7[\;BTF!2ZYG2JNLJ/ F1[?OF>7[[-=6351OTY%\_KO(RS>JXJ
M7F2K\O>[ Y7JIR<=B:5C@Y[.W^\_.YJ-VA#<.4\U:FBZ&:R-74=S6ZL;ASG4
M'\B*5"E0/HO\:\;$;K$$"4DBBJ'0ISE00@0D(5>J[G,1^$PDU+?*&=W2S]P<
MO@-,($4Y;M3,Q<[E:V/4S-]SP-/(6MV@J(8XPIYZ#PV.O+RV7B9U\7I,/?7O
M^BX?)@/W>9V0M#Q 5E6-Q(PDRF\+8$HHA\A#*21Q+" .4,JD%S(L8[L)]85>
MYN? [4&"0J.T&_R7>#0;^%=R,_*@/Y!2PKNI]K]OP+NBV'8D%K,>]QTL.!KS
MEWJ8=+QWF'@ZUKLN'3;.RWB\0CQH_7BSS,J49\K[/-2S8D12'V(2JX^^'S&8
M^J& -/(2%B$>2RIM/OJ=O<WMT]\$"QIH[02@FV S*7!&V^BSMLN,%2,X!$:<
M.)*([KXF%0LCLT]EP^RFP:&WA?C/K6[YJ_H_7>R[+CE+@X!33BC$'F$0!8AK
M\0B@"'C(N QB)2J6T;>7>YJ;<!R @A(IT% M2_KVTVLF'4Y(&UDV!O(U)"ZW
MFPMWH;DM_4P=G=MM[H4 W9X;ADG$&Y*OLM5#<2_R,L'OZVRYW0B^\&E <9((
MR/P$*X%@*4PCA"%&'L8HY3Z./;OY1$M/\YM3[(#J];4J)3KX[_^$ ]__'X!7
MF,MDZ7R]7)*\<95EWO0VYLVTPP&;(RO'GD8%L4I4?@-JE.YDHX<&1Z+1ULND
MDM%CZJE@]%T^3"[^MLH%66;_$/PWI3WOUT5QMVJ67V0ABQ$).?1"7R>7X0'$
M 0F5BOA1B!/!O=@HN8QA?W/S+@YPP8/""WY>*L1_ NL5R S*-PYBW$PN'/(X
MLFPT*/RMI/#]CL)1*F :$N-(2/IZFU10#$T_%1;3VX8)3)U&H/@DF,B^EO4$
MQ&:7W5HD?AA1X</4XPE$&',U?TE#2%/J*S\E81&S*O32U=G<I.6 L;@!JXZ"
M8/:T,I\F2K5]B!F5$$4DA>H7'L3$YSCTDH2GH9VOYXK8:1R^$:DU4V=7=(TL
MS3N8X(#S!A"IWGYPNURNOY7U1N4ZW^7<T=HP0N)V$[8<Z75G5Y.*M8G1ITIM
M=,\PF3XTV5CU0!X1<1 CI<<!A<B3>ON)2QBE(9$H\A,>6<GSI4[F*\L#%Y$N
M,FDF&]?R,[)<V%!C+0)=MCL:_!>[F'30=QEY.M@[K[T^-U^])^)[6-<E%U!@
MC^KDH0B2-/%@%,<I$1S[L:1#$_+-<Z?I_5$>N>'Y]JPVE:ZC9>1Q?<S("-M'
M[=:/D$'O1VP4M1O8E2O/R9905='EH\)Y$N$>,YHRCTD8QXSK) Q$S:WB" 9(
M4AX%* Y8:CD):.EJ?A, A1'6( $I45M. =I(33'S8Z[\(,F3%"H.,4PY)5 0
MDF(/\U#8);EQ0>D4HCD:H8;S*0<TC3V7*B'>@ /(4<Y@]#'A:I[4ULVT<Z0>
M8\_F1WW7VTDL%]FBKIO\^>6)KI<+7V 9\IC#@%,!D4_T)AJ+88(C+ +NQT%H
M="SUK.6YC?==+>\*G=E8/Z>K>W!?1<+(H]G0?N/AVVIK1UD7=4\U5-4/AQ%Z
MWM(D0[+5@-T8;+]@8$QL59.V^+*^966!EZJ@P@>Q>5SSYGY)0"3S<!S#0.I
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M\UW7@BG$O;) ++ 7H3A.,40A\958A0G$49A"I56A8I01Y-M%%4^'?6ZZ5QL
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M,/8]!E$JE++ZL0>3% 4)8Z'TA)&\.D4U.REN&-5(OP!6RF/)5I5IZ@>P>12
MD27;'O*@B-I O8L$"FTB^%E=6?Y4_,ERA]O)$S?<#9_Z.8[]C6@^PL8L=F<1
MT",=-&PJP[5W#T^9!4J[W*6Q&85H5_OR3C!-NX?ODL:S_7ZGC0^4>YT,5M>Z
MOOV>%0M,J)_(%$,>1?I<&*<P36.EXE+$/!+83^V.C!ZU/COYU>" 1@=^U_@L
M#X8>,V<H?T/Y&%O&C*FP%Z)+)KL2E*.VIQ6&2V:=#?"+%PW<N=1#_E=2**^O
MD;>YL8KZZ\OADONJ2D_9?W5PHE&^_D[Y$_F71[*Z>R[KTOZFFM@4[U9U\B O
M$0GR8PS#6!\;)RB$E$H$0X&2@#&1>)Y1CJRI@<]-7CX)!3PKJTL4FS7[ Q!M
M5 $>-&KUR\'^VF1O@N&^Z0R?[]A[K-H>6!ITG$6]836@+Z!Y76UYE7W]9G=D
MKV$]*,U7SCY9@9J &U!1H"<!KG)8_:C'YFH+=RK8TV[W3OPPSK:&I^Y_R'+N
M<IGISIFNDWPG7Y%E)M?*(R;O[F]WR:T#&86,^I"%@?ITQ;$'J1]S*'F*/"\0
M?IQ:+.KV]C>W+TZ%&-20P9T$!]! H;99K^PG.Q6A1WBH3UTC"1%2/]$D#F#D
M89]1ZB4T],P.88] ]S1GL&_O;7(Z&7!JLGCNE*>QYQ4];^2@I?1^&FT6U)W2
M.=6R^M"!;KF\;LQ-]R)[?S,3+K4;VW2\X&Y^FWW-L-?U6_/_;$FNOA/+ET_B
M>9UO%DD:"9P&#/HRCB#R*85$QC%,DC"0:4I%(HAIZ;"6/N;V"=O!!'N<H )J
M7DBLC<UN;77$T<AZ:D^/576Q'@(&%1EK:W.R6F,]1C5+CO5=.L1K_?#;?;Y^
M%F55D??O7]5?*!H&-(T\I)S41#E/V/-@2L)(GR0/XR D(H[-\UY>[F-N0UNA
M! >80.&T^>A?IM'$7[J:G+%]I#->!GE%EPFR\82N)FHJ[\?\1;+T=SH9Z/9Q
M+M\ZH5_3B?W8E^F^=-CR=+TH4+Q=Y^_712&*VQ77/]SR_]A6J7KJ@Q^+6'J1
M3"(*I1]PB(0D,%5S11B)2+LT) XD7JS*$&#^9;TA2[-E9F, 1F]T6KW19S#&
M>ZO+/L SR0Q#0.V)-UO.=<OC5/E+JV,++T YY>!O*\TB>+4DV5,5#5K_>#!A
M=PKI9O>G^R[>K==6K3ETM#AJWN^DJYO6=)PN3]HW,+"</<GROY/E5GP01*<6
MJCK=_?*OF<A5DX\OK]=/)%LMO,1/:$ (] A/(4)4E]+3BX\Q2X/ \U,:6)7-
MM.I];MZ=Q@E*H&"/M!Q['V__#GZO,%MNL-L]#3-U&XWCD17N.GKMJ]4/H<E5
MD7JKOJ>M33^$EK.2](,:&29H?Q7\(5L]O!9%]K"J]G1TL$I 4HE3Y7-YE"<0
MA8Q"K":>$/LR23R)$^P9+2QU=S,WB:I1@@;,08$_+:2:"=#U5(VL- -8LI:7
M;A(<Z4A+)Y,*1K>AI\K0<_4P"?B4/3QN[N3?"G&K/*?-'=TH6=%)AMY\9X]Z
M>U<Y57=J,JCZ6SV\5Y(D]M[T(@@X#R3A,,"<Z52'$J8H\B!AH1]$6/TGM$J
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M:O^E!831*#K.#C#V&LP!*&@B=>;HM#V.JYV?:RB>AT-DS;U++ZF'OO$]IS8
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MN^5H-#)'EB0-&1PP[UVX.PD4;K '#CZ-1JQ%M,88!$\4R>&*:+M #UO".H-
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MNABRSIC%11IS/XU9RF([']86POQ\W)T%>OOOK1"%/H"G-V!YZ>E]$E_%:BO
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MLD4JTD F.%$L$@81X02F@4B@C*6'/5_R6!J%/ET'8VZ2L,,,GBO0U;FH"O;
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M33T/QC@D-$BC@'I&.=Q[^IG;(*^1@KP)U>)@90>CW0/=(4_C+W>5%!VA[/_
M6W'%UZQ\P<L_3,'948<3<^?HX&D_$9U'3CMNG^ZP:;\-1\=,#2X?H(K_[_OW
M.A792LG-^_>O=C/'U(\E55,<GPD&$8V4'F(O@"0,>,H)$;$P6I9K[6%N2J@P
M@AU(H%!:#.R+!!K(W[6TC"Q\IXP,T;R+U%BHW;443:1SQB^/G<1U6=\I;A=O
MG$[6NG ?"5KGA0.D[(/@&2/+^URGI=J\G+]Z-)1^PI& 01A(B%*&( TDAS%/
M_- /B>#,7-;Z>IN;Q-5XP0[P4+WK9=E ^UQR-[(.=M(V1!1[^;,02)<\3B26
MPUY#.^4TI:5317L;F4Y13>TY4E?CFZXJVGK[\+!YD^>ZP/SMTV9 S=;C!N8F
MFLT2I0II7AY9  KO>B76VP)HV&)55$>5;Y]T:85!%5Y/:.R64&<,CBR=+LD;
M6NWU,CG7%GL]:?5'U'J];%A+J=>6BP<GG-:GZLKDBKN*0"^[+(N?Q!/)5JJQ
M._DV*Y3^Z%R]BY@BCT:"P!#Q!*)0KZ]Q+X(LB(2'$&6>()9)IBTAS$U8])L%
M?A;?V7);CH_-HP!%]AT\E1EL]0%&P<'_VJX$"+T;H*^V#*$=\)3,%N?'Y7YD
M2:K![U*R[O'?@,T:4*&<D8S?@+T5^JA 94>9<]IIONF!)+K+,6T+8.J\T@,)
MNI!+>FA+ \\/E#DPWA)6]E1N>\4LXGZ*(BAQY$.4$ 1)2C"DD@0B9AR%<6QU
M7."LB[GI6YVP90=QT/[A!2+-).HZ>D:6($MF[,/Y6XUW%;U_WL&TP?JM!I[%
MYK=?.6!YZ7_IA_IYO7KX\/I6S:JD* KEN)+EJT-MV'H&CQ&7R$L(Q#CA$*4H
M4#]%&'*6),(G/ C\Q'B=R;C;N4E "1QHY#?@PY]?__D&W(*F :!A@<7ZB?EC
M,%B(&H7<D07$AM<A"U3F!%NL5(U"]$1+5DY>9+L5+&NZ.I>RS%N;;DW+VL*C
MQ2W[NZ\]OOZ!;.J W3OY7G7\1>1/.CZE/'%Z*,:(?,]CC,<P1BF#R/,HQ 'E
MD#+$.?))%$96!T-M <SM(] \=/UVJRP0H)F?^I 0<?>5'GJFW?#YF#F08[(^
M\M>A2?@!O/Z7A@\U?E"&L%7GW,?)GCB4/^=GWPV[_T&'X.W(:3\-;]G.,"EL
M%/]>2.G%L8Z72Y-09W3%&&*)?%W^).94L 2)R.:<::-M*P&;+ _C\@#03J":
MK$41XZ&@&(9(2HC"D$/B!1[THX D*& LY+[-MV$H:Q/(_GL7?)EI]4 61I9A
M$P*L9?6"J8X4L]GRI&)XP:13G;MTR4!O3N2JD5_O%6<B5VY'>6J_GLOX01 C
MOTQ-S2/EN&$=XN]%,**)CP03(4NLMB@Z^IK;8*V@@E_!'FR5@<+2%>L@U]#K
M<D/9V Y6"ULCG/HQ(,25Q]31T[3.4;_)9WZ0P2U7NSR'?+BWM-CDA&T6B9 A
M23VF=")6G_.$(HA1Q*&($HXD)9)%PNY$8&=_-D-@FH.!'QO)J5TX2!<XC@1"
MJ8@89+Y79OU6JIRHV35-A!?KS-_8#P>Z3-<Q/,GQC/'YM7:QKF-M.J>KF2 <
M_+[#ZE";C3AQ[YU=Z.M'^6OM9G=X<!TWV6ETD6\67[*-GOZ^6W%=Z&=+EM5A
MS5@&J"QA'E*JDR QB.-834XEBJ(HB2/D&1W6;.UA;CI1@M0K/ >85ONM[51V
MRX,3@D:6A '<&$M!K_U=PU_=W!CZZE^'8=_>[B1#O=>LW?#NO] ^M%3IPZ?M
M4O@>C?S;/+_EZ^>-X&^7Y,$TMK2]A;F-6_U]UU"!Q@I]H-"J/XOR5'$-VSR8
MM(.X[E'LCK.1A[(!7>!WC=E1P:]^4@:%D78T.UD<:;]IS4!2@ZN'U, EN=@%
MI=?+!!&.$ LD@Q[R?8A()&":< P33&,28Y8&U*+J[5G[<QO_&N'^^(--/=MS
MYKJ'N ,^1A[;1U0,"5JXP(E%=,)UW$P4AF#VNEC6[VTUO+MB[_EM$];H;<5\
M7)6W_;)AJT'EP>LR/?[FY8OZ]!0ZD>AZ]7JM0T@7E&*?) &!3""]N>,E,/5(
M"CGQ:!SZ/@L"JQ#/SM[FIF0UV/+M? $-N.#W"K!EY&<WU6:+%LX('%GZKN#.
M>M'"B!-'BQ;=?4VZ:&%D]NFBA=E- QR?V^?U<KG^O%VI05E\("M2^;"' Z!(
MXA")U(.$E%*2^)"&R(<1ID'BJP83Y!F[07V]S4U**KQ0 08:,3A OK$\J-S+
MLR\%"A)"=*X?!A'2M9(0\B!+$TI#Y?E*CLT6\)TS/<T"_HYDEZ0:>*(NB1I9
MG'O>QB&>:B^#%GZK2R8G\F*'CF\[O]:4F$XOM[>1Z7Q>4WN./&#CFP9&4VQI
M(?YSJUI\\U4WFZW$NXUX*A:4>"@(I%0?K#"&*$8II'H!'J>)9)$, C^T2NK=
MUM'</ET'G* $"G[74$&)U;964QNW9KZO"\9&5M9A9-F'4/0PX2I^HJV;:8,G
M>HP]BYSHNWZ8,!R2LA^R7%>UVA<8$T(836 8Z2@KR3 D@:20X9@)+!@1";>+
MF6CO;'[^5E54H8I\SU:@D;S^\\ 4]1U4FRF%&_I&UHJ+1-V "B?XO?[O*)'L
M_?PX4I".CB;5D'Z#3U7$X(YA.O*;6(F<+&]7_)8_9:M,QPMLLJ_BS7>=-D0L
MDB!,DU#/VJB:M2&LMPLX"B$+@D3-XR2A*;,3DYX>YZ<H-6! 5AR0(\A 5)@M
M!:6/<S-5<<CCR-+2)/ 8*ZC!NM,20U8<"4I?;Y.JBJ'II])B>MLP?=DE@?BR
MKDO??LF)3L9RD+&_BB67ZSS;?[<7-$9^%)(4"H)#-;?A(<22JEF.%%&:(I\G
M'.WJ:YMIS@ 41N/GN,KVR#K4++"=-;P<")[S[*L"L'P!C\H,.S$:\H#,!&HL
MTJ<1K1H]4/BJPMM%IA=M;D!MQ<Y+>KD!V@RHKH,'W].=H%W!HB.1&X)@4N&[
M@J)3,;RFJ6$"><M8OA6\><#ZK1!%72-J01(I8XDD]$.>*O\KH)!$DD!.(NJ)
M- K#Q+/SO[H[G)_[=90%0 I;9ZN'7S,I<\?9V&OI%=#CU D:Z@A5Q\Q(<21"
M/9U-JC=FAI]*B^%=]N&<M]](SHM72S44OZP_K)ZSUUG!3H[D&\9U&C0UMP7A
M"C(H,>L%GR_9D]")YCY\O'\'-'SUAVVN!T!IAWFPIPFMW>HQ J-CRX<AF:,D
M-K"D:U!@J$G[DT6(6AC;#!6UN6U Z(3.^'*_#Y/@B<=T[5C) N5^4%^Y'RF-
M(,%!J OR!>J_QF$2S9;G)B,:&[BW"7TXXJE;"*ZR?NP]HLKP(;OL1PQ8[*@/
M96*BW?.^5\%NE_R2L9T[XD<W3+?[?0GGT4[WQ0N&Y@AXT,_QDWA>Y[K^=;62
M7?W_X>.*I2 AI0C&B$JE/214VI/Z, Y#$?W_U+UK;]PZEB[\5P@,,-@-F/WJ
M0E%4SR?'27I\D,1!XMZ-.?M#@5='TV65IU25'<^O?TE)5:6ZJ4@5)>L,,+UM
M1R+7>B@^7"37A<<A9I'C/995O]/; =7R-E<SE0:.>R [O.VV0MXQ')K?:GG!
M5N!Q[K2<8/*68,"FSY%3#3C <)QTP.7EGL<O92E7V], @7D:B2R%29(F$.%$
M6SJ<4>,5R@(E%$(9=<FYM->ZD\DS6M:E3?PVK41U/%O9 \_R**4O)$-O?2JY
MAC@F.:6PKU.1O;;'/00YI=;1F<?)A_KX<XN?)L'X^YP^%8MRE?/OZ^637+[>
M25.=N#%!8U,!(=9S-DB(@$@$'%(F4A@1&DD:49%R^Y3 -CU.;1/3R QV0H-&
M:E"+[>)":X.XQ;;'-XY#T\ E"#VF('+&I]N3UJ:A$;UI'?3:]ZAU>;'?HM_R
M$;LO;I7*YSE=R=*XZN4BIR;5D6:N!:_^>EN(_[/(B]7O^G%S]C5+LXBB1&$H
M0I5I(R%&D,8QA1QA%1.2L!A;A8YXD69J%'3@?D>WZKA9%M>-D)TE,AKN U/6
M(>25ETW-8JL%V"EV ]JJW8"=<C?52Y5^8*.@/P/("\Z>#*;K9!G5P/("VZ%!
MYJ?1?JS[;EWFA2S+N\4SRXOJ$.]N49B-G6Y?_Z0ED'5:\6T)F5E,$L0D"B%)
M,@Q1&A!($YQ!$4<L$JEB*76*^.TAP]08]HZ6/P#?"FU^W$GMQK)]1@2CD.O%
M+X(\B&.(LC"%%",%24IY&&5<[Y-3MU.Y@<=DG#.ZC1)Z.+9:W)P=IIMMKCG'
M7.Q]1LQN-1QX% 9> [?PW[7AWRD [O;A_W01?N=E[@H /2UN?208=4F[ J+#
MA>R:IOJ&XKV\S*O@/CHW'/QQOOCSOE"+Y7/5S3;=(\-Z>Y"%#(;*I"Q5C,-,
MKUDP% &75',G<ZQ.8=?OU):IEMAZ[RQ:O@,+!;A9PY161!NL6TU<H_?LAL/R
M5L,_R$/?:[0D!I5-8&0&+:$'2<GI")2WT#^[7D>.!'2"XC@PT.WU'J>F#X7\
M_/WAON!_;<[K&*8Q58F$<4I#B$220L9H %D8,I4F,:-A9'U">MCZU!A(RP>T
M@#? B.AP\GF$FL4IYS58#$P4>S#T<?,XPL/!U>,:7$9R]W#$Q^UT]YS^G2>Y
M1R^-=VI[3MZ]$]JS#_4SK!Y6/^2R79.$1DR$6$209@F'*,02DD!1**E 2@22
M*Z)<+*C##J9&5._7U4E=W[/2(_SL3)YK4!F:LHQHX)-%.G9G^^6<UIX,E:/F
M1[5(SBEW:'J<?:[?!'Z4SZ8@X/+UP_^L]3[KCBZ7KWHC=ON\6!<K31-U^?6O
MQHE#VS6KU3)GZ\J=Z7%A4I7K;9M64K?_=&]N>&2Y*F<9%0%*X@2FBF)3W55"
M&L@$,BID2(20L>[?@0+\BS@U$JD*&>SDU!NK6E!S)7"K_V2"0GZ\ECG/:5'7
M!*3S7%N;14YO -T/&/DL1<[[%(\=\HL0B4R$E##!RBP*)(),A3&,2*R4RI)(
M!6+V(I?Y0GS76\[5_PO?Q:&X _KZ;/0$LE+T1F_!:U4!K72] 4P^Y45A_L+H
MW-P>O?F0QQ$-TBQ",.:!,JF*,TB)8C!F:6K\L6(5J&;(/Q26D<!3&/"-L&\Z
MW+(04QIK.YOE;4=O8*MG-V@?FD';Z =NFT';J@@:'4%;26-$[JL)MGKZLZ"&
M&P-/-M@  HYJQ0T'\*$=.&!//4ZKWLN2+_,7T]>#VISO5W%-LRR,",*8PQ 9
M<S".]4H@5 *5P@@SFB9A9G4-?*&?J=ET+4G!@P+;2ZXZ^L[E#*<#6XO3+3^(
M#4R??<%R.]"Y#$7GT4['Z^,=\ES68>^XQ^+Q7K.=:8HI5\OJC.]N\5,65/^W
M.0A_7)A__RZ7/W,NOYD=R.>\R)_7SS,A>"(0C6 H#16DF::"D#+(,Z5"%BLJ
MJ%7BRVN$F!Y/,+//V^AA_ YJ36Y:-VW:.!#FN;+6!U3[NAOP7*ODQ"7]1LZ*
M: 8?C\%92$-\WQJ*N^U0["[I'A=U>?A&%?"M'HK/HPV%PPG^"$,RTD'_D$/C
MNHA<A>F%%:9?VV,N/U=I?[ V7==6OP//.Z-EL:I/QK[EY;^^RJ7Y WV2X8R'
M7,8,2XB(,+9JD.@%*L0P8(F*B0PBQ:U*(]IT-K6%:$]6L-3"NATL= )K=T3@
M"ZZ!UXE]I(R<-V GJ;_=N@T<GO;=G5V-NH.V4?IP+VSU3C^Z^$CSY>]TOI:?
M)34N4(:J_IFO?ORC6#!CC1E3^KYX6:_*;])H6-T":BG,K^OE4N^OW]$R+[>.
M;%5;,\I5Q#A-(6&9T#R#%&09R6"0\$!E-$@()>X'XH/(.LTS\7?7'7@/,ZII
M$">!*6Q%,-:C2LR=%R$49CPVF2]%$&?<]<Q[(F,Z_+'WARO.M(<93KLUZ\T'
M:.#%SN@'*J&T);U3$?RI=01M)4&M)=A7\P9L]025HBW_[;I9?^OEH$/A::$=
M1L915^A!83Y<VH?MK.<68D[+\D']DYH"NZN'Y;?\Z<?J08NPHA6)S81>OH,T
M$!";4@Y(8 1))@+]/PGE'(F(I,AI&W&APZEM)1I!2[#8R0A^RPM0_J"ZG[\X
M;BPNP6VYN? (XM ;#".J\?-HA-5?)ZC$O0$M@3UN-"RA\;79N-3=N!L.2^6/
M-AVV[_7)XV?FB28N*>X6SR:5>^U6OBOH_>ZU>H291YJ\QU5JP4::#[_T!BC7
M_[;YX>LRYW*FLDS%&.M]1FQXB4L%LU29ZHD!PEF2Q"1,[#,"#B+CU*AL(YS)
MT\ZK].U_;LA-;A2HJ$TLYG.Z+(&VEVN:LV2Y(<?;XM3^[4=Q8"ZMI(>5AJ"M
M(FCI"-Z]@NHY4*D)-OGC*T5OMBR\U?5F^R.HU'W[D7;)X/CF(SY6+LBW''G'
M1).#CDEWRLIANAXQ^>6@V.VGT1RVJQZ&PI>U">)X4+JA9[HT7D#R3C^;\W(6
M)SA+L410B)A 1".]_^ JAD1RGA'CGAE816)<Z&=J"W8MJ5FH7VI9C?ND!+R6
MUH&I.Z"U6%?] #;PVKC#JA'3>"U*<.<3*X>5R0]F(ZTN/;%S6Q<N(]+)[1VO
MC\?/EW78XUB+QWOPY(&W9%6O7IEN-)$_U^D'M$(?BE43Q4:C-*.1A$&F:1-A
M$L&,ZU]3X[Y.1,*(R25JR9UN?4^-3S?B5J'_E<"@<1X%LA$9_&;\1TT5+9<]
MC^.06'#N<$ /S,/'WN-;U!\4J*4'C?A@(_]P4#M0]G"0CT3C?J%W8_=^X'4R
MOF.3XZT"_73=6QEZ-M$S8XREJ?_NT-2OA=OY-955P.;C#UH\5&ZXY=^KTZ/[
MXFMUL?I/:8X-I;C]*9?T25;_^%Y3Z?;>8Q8)CH(,A9 %,8,H"3DD.):01"E/
M8HJ)$%9Y'R:GV=16NHW @-82@Z=J[R^TS$"96]"?1NJK#OLF-P:V*7:F(N^$
M%FVKXR76'"\USQT<+]7HM/Q:2U"'SZ\T0*!!Z ;4&)E@X!JE&[#]5!N@ZD>
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M65W'NL:!7P3=CD;\0CDPG6R$;0[;ZG"UNFIN2V"?$>"VX'B+_[[8X<C1W[8
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MU>G=?JMK=3+P1:NR7BY-$$+5SV?YS.1R1B.$"3<Y(5@HH%YB-<>32$"9!4'
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M[.8>>]3'].[4:Q'__=]"'/Q')6C]X\,N#M!MFWT,J]WF^"JH!F;V6K8Z0G@
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M+RM]7/+<XIV^9[ET5?D5/:@[6O[X.%_\6=ZR<K6D?#5+8A$1&2$HF'' PT$
M2<I2O9NA@=8]"ECH=+'5U=G4*&0K:^U'5_X E;C@CXW CE=5G4#;'O7X@6]@
M"KD"N1XG-)<A\7;NTM'5R*<IEY4^/B.Q>*=G4N3:AVSS+6,48T4)@R+ 1&\
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M>_SV7Y(N2Y?2@F-_&3;6ZG3'>V@#V*@%*KWV-\@MY<&[5]!^;I,9J,[(W4
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M #: 3]9A3V_FCW5&Y2Y?K'.O]#!^CJ.439J&W4;POCB,;9ZQ3":<"&T.!8&
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M)KB D!A+0I6=EU17)Y,S;"L9P49(\$<MIF-(SDDX+0VJ*T$:VGYRQ<?=5NH
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MFA>Z?[T$W#Z;WV8QI\8'&,,@Q,+4X,20)32$-"!A0$F6ILBJ%EZOWJ?&I^;
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M(I1H8S^C)HN[4B'E49BFL7VYY<ZNIL8?.V%O *_%W2] Y%1>K0OC;O+PB]S
MU+&3$S2"[B)).M-*N6+F5'O.$W:C%9GKB:%K'3D+6"X4C.MJ8<S*<!::')2
MLWGCND3T#^I]_C,7LA#EC"<1E4R$,*0A-S?8"-(L%3!)8Q6PB"18BAXN!">Z
MFJC'P%8^\$+SGLGBVX#:V5M]\1DY];LQL3;R^<_M?D)YSRG<VSV\2:;V$RJ>
M2\A^ZM%^\[Q*A_5I%UG5#LOF6<+"A,(@$@(B3A2D L60"1[10/^.,'?9=IWO
M:FI&4YW%;;XHGJ!)2=4_\JP#7:5($B9A"A$QQ3L(EI F:08%"@26J8IE*-U.
MO/S@.\Z1UQ@(V[&K']0&)MD:KI:4?H.7[;'PQ+D='8U*O9<5/F1@BS?Z$7&=
M<>KA19HBY,73?GC*AO??K^4L2$/.2"@U4S!3^S(3D&(B8(H)$5CPC!MO[\6*
MSNUHP[9C)Y+>=C_<G'@T?0"U7IE,F\]YD3^OGYM(X9=&:C<JL1X!.V(9 M>!
M:6:3IFXK](GPM]4",%E%G?CC'5>H/+&0=;>C<I(K&(<,Y?Q^_UJ5'^>+/_]3
MBB?=S29U&,&9%#*".-:V#")) K5E0Z'BE;&#0L6=:U,>]3(U<[$J:Z6TE."'
M%E.6?W.OAGB,I!W)7(W/P(Q206,$!(V$ \2G=6+@L9;A<1^CURX\J^:I6H7G
M'[X^.O\@0T#[5'^F B5"@0043$J(F+9-F$01U!N>0-" Q22*^L;E=_0[-58X
MO'^J31/YRZ0/=RS[8(N\'6<,@.? +'(0C'^<J^0&M"4?)@[? JH!(O"[>GVS
MV'L+*+JB[FU>[^E@))^,>?--OI@FBZ?W><GGB_VJ!%B0%"6IA#A#%"(3?941
ME&AZ4ED6(IED@5.H@T6?4Z.F1F17/R,+<.T8R#-D [-/(RW8B@MV\@[EAF0/
MD"^')(L>QW5-LH?@R$G)X=4>K@9522WC2"+%^_52M__X0]8IP>LZ6P_JPR^Y
MY'DI']3#2Q7C6XA_TN62&H?[F"A)"=8[I#"-(,(!@UFL(IC&,144BR , H=D
MIU<),[USX5KHRL%)BBK9F&S$-R;4HE*@+NG\9Z.#>VD^#X/837/C#LS0[%?5
M0FP&1%2:@-4/V=3GV)2C-.'31P.U-TZCC8V#3\5H8S22S\7]RA2MU"U6%[+%
MVFSZS'!4@[09PPOC=#S&GCPUO(#=Z<EQ70_C>7IX06+/$\1/B_T/ LW_FUB=
MGW1N/KUOLEPM<[Z2HJH07HC]/[2>;$II%-R4JY3O9?U?_?M\+;0:FWR#QJ'E
M@U*2KV91C&-*50(%PQRB)#-%,;((QBP-:$!8F*6)R_7'N.)/[1+EBUR!O!'?
MY/GDYKS.T$'U@]QIZGZD.>(W87]6.LV1'N$0]@941[$MC4QRB(VRH'[$#/S!
M'_??J%$ &QC ;QL@_G(#MECLDL4:-$ -A]_CWO&'T>,Y\HC"CWY /?[ G#KY
M?@,I_%WZ?Y.%_)/.3;VIF204L9A(R(+8Y R*8OU3BB'*HI0K'".6"9>SJ@O]
M3>V<:G</71^>-^;J:J&-V)749/7;^D7_YIB9X!+H_:_W>T+Y5K?ZC;A5&;IA
M+_-/ #/@'7Z[MS>_NC^ANLV-_:G7KLD.9PJA+@K-<>\7IIS,+ XDP1E-8$)B
M!)'B%#)N\I+I;XB&3.%$.#EWGNQE:GS2Y(#82@G^J.5T3!9Y&E$[VK@:IX')
MPAVBGEG#SD#@-4W881]OD!?LC)JG$X&=>]AC-OV[QCDVC#D*I:!0XB32E@4+
M(*,AA1Q+S0H1BG'@-/^[.IL:#>Q5'>[O>MR);R B$9I<:B2B J)0FV\L"S73
M$A(FE$4R0=S-O=L7PN,<Y(^!,59!RJA,(954V\2Q2"!+D?X5417@+$EBFMDG
MC[H:W]%R1M6U'AJW8U!=<G4X/;CCZNY&<LWW.*[O2,N3]<ZW^[P-(D,6:;A[
M"Q=Z&Z6M2C <ON.VZ$DN9E\6Q=]U\Y]UL^NEWKV7?)E7.\:=?X+%BF;7TM36
M-"TQ_/OM[5?0R Q:0MM1@R6"W>3@'[R!Z:$+-\_.'6[8="21T@TU','%CAHL
MFQ^%'-Q4W="#XUM]7#?,;=@[S3K"F-JR*.L4[.8>[$F:"]IWK[M'&E_YVS_I
M4M279N4_I7%=D^)6&U'T26XNU;XN<RZW.=)P)A0+: 89PU*;UIQ ;?#%, Q2
MDI @)C1V\O 80>;IV8\;J4$C-MC(#2K!7;P)QAAS&X>0B8WCT'XCE<]!I0QH
M*PQ:&H-WKZ#]7*,UJ-0&C=[@PJ?@G-5PO*_"Q15E8E_'2!XKE4Z0=7\EK/E*
MFN?VOI*;S6=RX^,[<?1H&7',NAU?QA!D1/^8$7'==Z,9LV/WW+4?BM5NG[3U
M;OVNY^BZG&4L)CR,*$RBJKP(BB&-&8':%E%A8 P2976@=ZFCJ6U\:EDWF_F6
MDW8MKGVBVTYTN]=WGY@-?;[?$RZGK+@V6/1*DMO9\&@Y<VW4:Z?0M7J^I_.=
MD;98+2NB^I:7_WK4[3074B1"@G%3R0,GIJ8!CB'1% &#0#(4AEF*,Z?:XQU]
M38T4]D0%1E9@A.UYW]<%LMU9J2?H!N:&WJBY^W!=QL.7PU5'3^-Z1UU6^<B5
MR>*5GEF?-KX&NW3[LS"F2A(D8$H"$Y@B!60Q)9H]PBC*XE!%DKLXUI[HPXDF
M1O!^;9>;6=3B:BO.,0'1"2A5EJ5)QA0D0F0:RC2#6<@3F*H,H22-::1"Q]Q.
MUX$YSIG-B5HF/E&UH]HKD1J88G<^6':E==Q3.)U7WU?NIA,]C)NTZ;R*1]F:
M.A[M<7S\68J<T_F=W@)6"8NW!SU)2+4FDD,::0,+97$ ,U.!5\6,"1H+3C+[
M_,+G>IF>D=5XJU3A7\^UU(";XSR3E]R4>)R;S)S&7Y//:?Y<FE #8P4+RPPI
MW:!;G+GZ@')@1FA$!$;&.BMYOP/-LS Y'$+Z@&ND@\-^L+F=[UV"H_-,[NS+
MXYVC79)_[^SKXL-N?%DN5\9^+1?S7!@2J/; N2R;;5/&$6,\B*%*J#8VJ4G"
MD)'JR"K61)KA()$VA-G=S?08<R<IV(CJN"F] &PW*?J#:_BM:!^DK.>W'1!=
M%I-NH64MZ=]VEM*%QD<A #L%-PQ@^70/D^F;-(+F\[RI^' B/.<H(&>[=!&.
M$QQ$>O=D7%,1"23,6,@@UJRA-ZMIG-'8VJRZ1I*I$<F^+L;\XE4 WV'49AW2
MM]R%])D''(R*JT;/PCX;:TP&9JN#X7A0=>CD8?PDN#T17]G+V+MJ7!P,PK'&
M9R2C\8IQ\F12^@"TT^R\JH/Q3%,?..R9KUX:[+&^?95+M5@^&W?6ZE9XUT.5
MDZ%)YAF$F%""8QAE7)N[0J8P"U(.PY2J2/!89818+V1674YMQ6H)W3C[M"98
M);<#_=F!;K'^>(=RX(7F,HJ7\ZOVA=-AV? .ZTCKPQ4?J=LRX 10)]_;M30>
ML3MIML?@;F_VS ^IOZ#:D6==YH4LRTTFQ-M?>3D+&0U"$F*8IHF *.(",H0"
MO?&@G&$1!RI43IDANWJ;&D%O9-,&J9;.\8:\&U>[BQMO: W,P;9 N2=]M '
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M\^M?@*3N$@5 (,W9B-EVV220^4!XE$CD!52BVI+%]Y/':M]\_G+W<:<SAV/
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MZI%+GN],\"J%S8\5/%>^_,23UV;;5M42F5C=FX'>S1_99#;.TT3SE&*8%YI
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M/LSGJ]E\=3Z;SPNSRW='D>#JF#O:D(K<Z-(1E*![HK9Q>[LC<E!N]W[(Y?&
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M;&9.WT^-WG6?.K76NHI#\6WGTOFBNS'DL):R8Y:]VZQ?I6Z]C!N-JW_MN6%
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M%$[.,[2MO1N$\'%6?8"KR(*O:FKCD.TM6AV"\-8_TO0<U&Y6?00 .][W37R
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MBKQ0DD$A"PJQ0!FDI$@@3PJ-2IW0A#G=3[E,-C0NV(@+V+I3Y5,ML$\P_06
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M.:5UJZ6R]T)_-L@I.?>LBY,/!):%G<\>S.Y^M ;+O1FBJ2\NLB)%E"'($I%
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M7.8,8L92R(M"PB)/2IH4@NG<R?)QF6QHV[\2%UAY02,PJ"0>V;(Z?_5)'KL
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MJPMD@ Q#XX^U"B>;KH_ %^5KG 4LBZ/IUBW871MV.SC7\L-*@6/0F[L_8+4
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M_*JNW77G4[NK%74'NSP"DAVSWB%<O[LPESM&'B9T!*QZLI,/,(MD^U[0O]7
M/?=N?U;L!>GW3-5+SP8PHZTAP!;KCA4L%Z7("I@*GEF3,H$DS2340N*R$$12
MY%1]^&CDH5F*ZY08ZY>HZ[RPA<>FW0/-@<U"H>C:B5F)%9+?NP> !U6% M$3
M/[UM_R#XT=(I75NY:.^%_@CHE)Q[K'/R@;"CKPW?7KU\5JOO<_EQ]D/5!MYR
MS"G*68(0S!C&YE2+->1<(4@5X8@FDF9,^UVVGIEI>*;8CG!5E&H5J*9L)T>;
M'+4VPE2E#GBL]/$[R)[#/!%YJDK%;<(T@CC)$>1:9?9RBYEE*!7*4A]/0@3$
M^Z'^5\);)E2D-,MA1E$!,14EY E)8%8@(D4A1:FS<5UA[-O*V-J]H7XX9W?8
MOU$/D]G,AF"_85/;:B$.LES24A#;6H^DYO^QTGZ2S4]49+HLDD)131MDW\]D
MS[BN9^P.53-#=$C='%@10.K8Q*DE!+6(8$?&>,ZE"R!$\AN=FZ57E] %50^]
M/9<>#[,AJEQA)9<?C'CKYBSW\\^3V7QA9JL"[K[/IV8\^Q6'2U(2":F6YGNN
M3!!D*BFJ:I=)H7569DZ]R?VG'MJWWEKR.C=@R:81*H0$+(@;K70#<\=,LX_P
M+VNYP6K^%UO]0IPH?A&1A/PAB\1+'A/W2E7^@!RR5\ (US2VF[#I]A:R:LY=
M:)2:@Y&QS;6Q:#"U9@TUAZ(L3["6QDQ%S*N_P9EYAD95&S%W;M2#.J.?P]6-
MA"*@U3'CA  5V'CN+ Q1^\L=S_(*;>3.JGJZ6]SYQX.NJ68/]VKQ:$,2/K/5
MLR6:&YLB8AL*?C ?G'&IF"S,_T%*4FP.[32%3*,$EEFJ.6&IE 5R]M!>G&YH
MU'!OSNJJRIGQNF&Y!*K3?51$J#J_F9H]0"LLL-*.P%K>$:@DKKM36IFC@NAU
M8141S-ZNKJX%U?=2RQ&C"]=;ET;I\Z++4:.#*R_7MX(NOQX?)_6AU,8=&!/=
MF.=J9DL@?=H$K!.%E294PY)A!7&J!&0I1; 4DF+$-,[<LJJ<9QP:Z^[(#&YL
M#,^NU 'Y >[0.UVMQ06T\RNWJ['TO85RQ^?"[93#0'W>6KGK=7";Y?&B?Z7$
M^_F*37<.AU]7LYO'E6MYQ--O#XT0*BG!CIC@JS+,/ -U#0KW&HAGP&K?]G%P
MZGB?AT+D5=:P'86@6H9GANRM@&&[2KM5"R\\&>A;;OP\'^:+K^II4T_5<L9\
M5N4<C1--=$$5@V5)*,0$2TBY,0>R0ND2H8)S(M;%IAV]RA<G=?I@[Q>;[I@"
MMH):/_*RJG[@Z36^#+4LE3)H*IB7&;7W>A(R20I(F#G\Y@DF>>+GOH\#=)]N
M^[47V493+_K W-%#'Q7)KCWSNR#N?W!K@>LDSHC.>&=T8CGA+T_8K_/=&8 C
MI[O[FWX,+]5D_-Y&>;SLC%57;;E]7BU7K+I$'Y>&951>&HY1HK!E: O(-<HA
MXBK%:9Z)+'4*BG&;;FAT4TN\MRN:(C9+L",V^&4R:_CG+VX$Y(A^._G$Q[1C
MXG&$\WKB\4.FQ3 T ]5\8W[8THSC\+U0C)^J:WKQ?,O_V'<C_^=^?J?FMLK/
MA]DVC-_QW'?F]:'QPT[:UOT<W+V_!;M5C4;@PWR^LITTW4^ YW"[? 2, %G'
MV]\5+;?4$:^3X05P@HZ&Y\;L[6QX0:G=P^&E1T/NYAY9$^].=9DJ2G)8)BR!
M6'$.F4X8)$61$4JH$IEPOX-;#SNTO?[I\XW/_= &'9?+M!"=N[XT^WQS.1'"
M\PKG4,WVJYK-TSU>R1Q*N'_U<O37\/X/'Z;S/VT4E/FQC@0T7[<W,]G<H9N?
MQ6KRHPK!WE9SW_3)Q 0EFN4"YHED$'.60\Y+!8F628DP33'WS ZX5B2?#VY/
MQ3V?GYZF555)-@5R(_!R$^9GFR!,UGI6"9]ZK2E@&U7]VTQ<M;)NWH8^5ZOK
M^Q^[#%:7$6BT 1_W%F6C$-AJM-.DHI/6JK'PC=C&XBIQ>N]N$0.\4TTOHHP;
M6*1$/5@R>3=_9)/96"!!9"HES!6V>?(Z@[2H6O2D!9-<$4$3KZHCNZ,/S?)I
MA%N"WVOY/,,.]Y%S8[A@/#JF*W<H_&MRG%(Y5I&-O;'[K9IQ2JVC,A@G'PK;
MJ+^QQ<1F@Z^#RFLWQY?YZFXQ>62+ES=JIO1$3,R/C86>:2V4+'.895) S"0R
MYA1/H4Y(3E6.-:)>B7_>$@QMPZ\5V 3F@UH%^QV] HT68$<-/T+P7R$WTN@4
M]XZ)Q1ORB(>SJ_&+Q%+^\_?*9,'P'+)=^$"!^13KQF!O7C8__GVB%F:@[R^V
MKMNT2@-(2,$*B@0LB28VQX)#1A(.!>=8(:44UUXTZ#;MT+AOIQ7>1MCJ(/+E
MYK>PK LW]-TH+CZF'?/:-7#ZYV9XH1,K5<-MTGXS-[R .$KD\'O;CY26B]7X
M[7RVG$\GLO+[5P&&S>% "BH)RRA,B75L"5D82\PV&L!<*JQE(9%3EZJV289&
M.'MRUK&NG@>M5DC;>2464%U[B4(P<J8/%Q#:R,*\OT,4YE];DF@=NA=*<%%N
M30!.SX;9(%_5R@RBY'NVL/4NEC="/#\^5X7TWE7&SFK,=))2FG*("MM6)",Y
MY(1RF&:XY%DA-%5>Z9V7IQP:%:PE!JH1V<_2<,#8S<J(BUS'W+ !;2TM^&5'
M7M (?#XNQ]O*<$<GDH7A,&&OUH4[ (>6A<>;47OCU9$M7\U9:S$19K+JL9L_
MV4+^;3%?+L<X2U*.: D356J;TJ0ARV0.LUPP)A%-L>)>[MP@,89&1TUDUJ32
MHPH675_,S#58;+0 RZKE![-Z+/U#X:Y<.D=_<N<+TK7CN<*XU@#4*H!:AW4$
MW0AL]6BZL%2:C$"E2^>=]!RQ[+:;WB4AAM!1SQ$HQZYZKJ,%=M;;ZP7PP7PV
MZWR=,2YDP0M<0I%F'&*I.:18&8LM%1+S/,EY[M3RY=)$0^/$.MGYR> O)D]L
M"I:NK4,N(NI&9#%PZIBJCII_6"FCY7FY A&K(]RY:?IM"7=!V:.><)>>#V.#
MO2[&FY@5DJ&DR$H"M2088D8*2'-LSFVLY(F2:9XJY1>-='*>X848-0("5HGK
M1P.GH61,ZYP4!"::2=NPM( <\02*+.=$%C@MN%>7]JN![,4!%AU&-RJ]&IR.
M>?2@.7LGD4ZM&$2BT--S],J?K6H>DF?[PP&1TA]G9HBWQDQ[.Y\99EI-^%3=
M&1G-P6J^L/=^:EO#OKGPSA4M*"D-B:8\A3B1J2$"2F"9VDKT9<IPX=Y1SW_^
MH5'$1@.PHP+8ZF OR95+(X4HB]-.+SU WC'Q^*(=4C _ ':/@DK=PM]3A:5H
M'WJ_*/UP[%K#^0.&[2_N/USGO02!*X8),\@_*;94RXW=@PHEA-("4F.10RP8
M@JRDTGQU9+GFE&JBO6Y0]H<?VI="+9V+6>2"G9O-&(Y(QYSM#H:WC7A:YTC&
MX<'@O5J%IQ4[- ?//!5X/[&3E?)QIN>+Q^I+Y,-\87CBR5#&RUNV?&;3U8LY
MOC\O;/WZ7V=F^#\7$[NE[A:3>57H[6+#1:9222BQA?^3S)PDC0%).<F@$#BS
MU;XU8WX!ZCT)/C22J00'=><"WX:9?:VUXQ7( %>P8U*L%Z^J1.G2<C/B%4G/
M6,>Z5.E+['ZO87I>C*.+F[[G#RT$<R.EV7W+;^9@HVZM<#\F1I:QR#4I66J^
M0 BQ5SVY@E1G%"9:DK),M4ZY4[W/2Q,-C?J;:B6-L"-0B6L@!6N!?4N]G,&W
MG;YCHM8QW88#%E#8I1V-*TJZG!FXYV(N[>H=EW&Y\+Q_ 1=;*>)&K PO35_N
MV$3^MCQ18-"[KHO?J$-CA-UR)6"M!K!Z@!_+OX)S-2[=J[]X@M[.'-WBW3&7
M!$+=0>F8, B#*LIX3M5;H9DP"';KSP2.<$W_&%4=W#=MU=>%]-X]JS'-F=()
MYY C>V-M.T?PW/Q$,D4S)%&>Y\:BL0*Z'8XO3>C%8YMIN]M<]>[1SRM;0.%Q
M,IL\/C^"J94>/#52AW26:4'<[8@:$\>.^:D1%52RCL!&VA%8S0%7%5/%;CIS
M&9BHW6=:IGN%-C27E3_=C\;AO3"6^:)6MB1%96I))=^\_+I4\N/LUISHV&JO
M%L4VO$,CHG&>0I47&<2Y2"#%/(6)H$FIDZQ4@OM%RO@+,< P&EOT14_G?S:M
MXN9KX8/+\ 0LC1M!=0MWQY1EA <5UFOQ 7\!OU@-P&3V%[!18K?03A?W">$@
M1J*W  %Z);QP@ XI\(J1PDCQUG:/WEYR+L=90FWF9@F19@7$)<\ADXC!(B%(
M(R0+62J?>XC#"89V1#3?*S6+,:W-%XXYC7MRUQ&";LQT#2X=\TXEVDZ<0L14
MA'-:1R**H^%[I8%SRAUN\K//!82J?59R(LR9;!V&AIE(A2W\G6D-L; -!U A
M(-%Y0A*:ZT2[AZ'MCSVTC;N6SB.&Z0"L]HUZ)00=[]&U8"&A7 <P>(1IA</1
M4PB6E?+?]J6,%&5U6O76"*J#5_J+CCHMZU[DTYE'PHR(CS.QL(>V=ZK^[\?9
MO7I\FB_8XJ7NH/YU/IU^F"]LDM.8(<JU3C4D>69KH68"<BDE+$J.9(93C0KL
M8V#X3#XT#EO+#GY92_\78]J#C0*@U@#\;G4 C1*>85->B^-FNW0%><><&1EM
M;^,G!+9(AI'7U+T:32&@'!I406.$YE<NC-5F#F%J4VGG5F]_6:4BC*F0B<AX
M G.%!,2R3"'%(H&E,O_."ZTY\TRP<IEV>(ZBK8!UKM (:%M=ZH<5WS<)TP%V
M-_**#67'I+6#X4V-X;=G_C]*K*S?^C-;VM:]7]2J]@,M%N9552=Q<J7GQCZ\
MU=J\%3.-TQV^:"F=#E/VG-[I#L)QJJ?'NR$M@8U5]TY-S5";:IQ,(&',KA26
M J7V5$@@2?,,IB(17!0%2J5[S_7C\8=F554I&&L1?3KZ'B/G<$2\#H^.V6,/
MBI"SX@E,/,Z+UV'3TYG1[>/BV;3XK.+M+8J/7^NQ(?%9F??;#Y]_++"[QM08
M![>ZJH/1U,#3F2ZX5*4A+*(AILR<%HTZ,$ERK+BA+9Y*GS/B\12#XRPKH2W3
M4Q>""2O<?@))-YOH.GRZYC!/:/R[1YS5/E8_B.,)^NWP<%;!HYX-YY_TKQKZ
MQ2SJK?[,_F>^>/N\7,T?U6*]OPLM,I1PB%!F\]X2!(F2""J-<5&P,LV%4U_<
MUED&M\4;Z0**A9Y'LGU_1\.GZRWN#(U7C="+JE]1)/3\V+U5";VHWFZ9T,L/
M!R;(V8C -VRIY&X$Z,Y)],W+]I$FF*>J=G7[9!_<[5ZYZXA41&02&W*0"4\@
MSB2%A*0,"G-PX3C57&CDYT+I1M#A.5V^!;35[F@1W8R/UU^8CMFMDAY6XH/]
M,.FMCC:T9_>Y1L]U1<!&U=%>$^.N_-3=+DBLU+=NA.PWT:U3H(_2VKJ=+>SK
MX[W6RL8TJ8\S8;Z3[MG/KVQERS&L)K-G,U,3^62F'^.BS)(,9;!(2=79G$'"
MI( 9U[3(TC012>ES*'2?>FB6Y$9R,*E$!ROV$QA9/9WJ'MB[,7DWB';,SELP
M:ZF!$1M8N6T$E-G'55!8U>[X3IDI8Y9$],<K$GEZ3-PK(?H#<DAR 2,$!DZN
M0S+WP]7'A&&:I5@:2]56IB:I@K1D&&).TR)1(DDX]4E5.3./%R7UEJ%2IZ1,
M&R&]P\#/8>K&/A&0ZIAJMA';AUDH$2,LVU&(%6AY9I9^XRW;53T*N[SP>&!6
MB9'5L(N1VSSTL.X0MHY(^&"$_O;,EQ,YV00CV)+0-L]E7**,E@*5L*C"!#1+
M(-7FGX8S2DPE9S+WZM\5+LK0#)RZ5VQU )K,ZN[/6\7,KVK-/'-,PA?*C7_Z
M@;]CBMI78M/<< 0VP5-5L/Q6DW70U%J7B&DG5^,9*_TD7)!^TU"N!NPH'>7Z
M$:\H7'TCS)#+275*M1WW6"*D)BF',L&Y;?O*("]+!JG(*4)ID5+L=&O0-LG0
MF+"2$>P(&=32\"2<;JQV+4@=\Y4W/F$5E\\ $+/@\N$4_==;/J/DR7++YY[U
MKUMRHJ[ ;\L[I19_6\R?G[P+EC@.-[1]?K8^QF]+8*4'E?CNA4E<46TG@8X
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MA. ,\2RF=H?&3OU.[[AX*_0N@_]6;(><46[0=W/(8' .3"B5R* ;S:!'+5Y
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M\CN<C3D,AL6YXC 0#\SA-;JWA^CNY38E"INZN[>#HNMP%#D,RB.=309#V^V
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M#@GIP"1\(&J%VH=NU-PK\UE"$:H27U]WXU;>LU3^K-*>[7M^%%,=*M8^D>8
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M2R!."PDI3Q04$4,XYWD6(:M(PYY^ID<<>S%!):<K/UR&TY8;K@9I<%XXQ6>
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MY(262^&21&DR8-JL0I,1=D+K78O!>P.VL "#"S@"!CRU&LJ@ 0=H=$ %#SC
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MO>U^Y/"E7'Y]7<@(L30RT=^KY^5&?%S0;[8'#JT-3(U5C#>AD10846%TE&#
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MBFG.F_NIO7EG63K-J_&I&<^-$F"KA3D2V^EAYMRI)O;UV/S [Z:W47 ?^EC
M%?+ :3^OQM"K0IQ?CZ-5DKL*D,.*<]<U-&;^D+]1\\QF_>$/N>+SM5S?+Q^K
M9'^S A4\3V6J[?F(0)QB! L9(5.$"+%4*9Y)JP*3 \DW-0[="@ID(ZF'-3C4
M4';3Z00&:&"RK5-[]"1[V*4 N9#L >Q&=Z=FE<*T4O3GCNT863Z"C/&8B3W&
M'^N1TGCTCL0PF3O:N_T?D*RC%[,P^3GZN[DR)<<N.>O6PY1D5"5YKJ#B)JD7
M(3ED+!=0)461"D8CDF*7$__6GJ:VUNX#K[>9ASU3;)Q!:G>N$@2H@=>\/4:[
M!-LALQ%90Q$Z!<99/S\GUT6;NJU)+5I?\&.%?83F+?_OU_E*/JY*W=7F[5%_
M!9O;I3"!FR_FD5FL5*8$3F A$@EQE%)89)F"F",5TRR/%<GM(MO=.[>:$.,F
M_]<-?3=.#74"\UKNRG5*;H5V(Q.'D;!CE\#HCA_VWH@-MG+?@$KRFPKE#[TH
M.W.0.V"!2,FAXU%9RAV04]KR:,']8/:N_%4N)-=S_K.DIE;*[?/&]MSUTKM3
M,U., 4F7>JO12 H:4<'MLTEE9'^(>A&H_C/2:S$:F#)\X7$ZX^S"P.L(\V*#
MHYU0=JES> #9^9R?Q='42HDP)41O,R#/H@CBO##N[UC!B%&NDDC@B"*76V/W
M BEC7 ;7!=]=J@"=P$1DG$NAK2Q"$V1*+^F?4"H@$7$L3"4FQC(WYPAWH,;Q
M>7 ITG,"DIT]-+F"1CT:.]LOEZK47&V;C%F?YK(BIS;%555D#*E5QRSKNX7^
MII_*S\N7N4D*>+\47_18V=H-76U,S7XP,MD;"9WH]!L+H8 9>NY58H)*3E./
MZFG^+,V>X_.7Q_N#(HGK&Z!EG_^8BU?-XYU .ID3-BAYF16=#8]F7MBH=VAF
M6#WO<9UY5R[7F]4K-T>OGTJZ;-)^<*)807@$8T:H7E3C"#*:YA IPF5>R(PA
MJQ2='7U,C0,.I01&3)?<<6TP,A7E!250IE3;)JA D&58P,)(DQ<LBY&EXV8@
M(,<Q5,Z@O!Y)BXO5Z]$9?!MV HM/TIX6?!PN)Z_'::0+1OO/R.U.L!N SGN]
MEE?'NYOKEOWH?JWG48_%XJOD<O[#Q"BLCWY<F-/D1[HR00Q5-<.#W]XNA>E\
M_R\'C[_5(>0'D34XY07.!,Q2S9(X1@S2+$L@D@5F>28S%5N&!XXB[_28]T"1
M&W#PEYW_=*,-:+2_:>K 'CYJSHXK=MK_(X!'+UIZ)8[SS5BL#%/Z#@9>8T)\
M +?]'X!30HZ?\%$X+(=3^CA&K$A\.N-7!W\W:X[^AWJ\7VH(0A46'@ONSF5\
M<"'&,PC&PO/(M!BM4[\#],IMB/5[%K&6RC__)=<F7F)956DV1_M/I?FGQM_(
MR-X6@EQE=J=\\TH7=<Q]5*1<Y(S#C)JJ/7D<FU0J%"8BC546:7.'69VH34^U
MJ>W?M[7CY%X5MZ/RZ4!K>5P_'8$G9 #59>1ZBA#NRLU=*$)X4&ZN!JAVIF@@
M,B>@_U75)#F J3/9Q %6@5-.3&_\ ]VH3$BQ46]U)J1WR\W2!"7T2=LNGU_*
M%5V]U347WIO;"[D4Z_OG%^.:B@GG,LDY9)A'ID!- HNBX) 4,HL*ABCEF7W&
M]LZ^IK:(/M$_P+R2K-X$B*VX+FG%N]&UV*^'PVS@Q68G:%,OQ<1'-[*"6MAP
MN+ED8@^&WU@;4G\<'7.P6R'3G7Z]NXD1,Z];Z7*<=-WN%<]=EUSI;=_MXZI)
MC/BK2>*PO0@K<JEX@2#':0QQH?="A=1[H:Q 41;'%!.$G+9![7U-C5)K4<$M
MV D+*FD=-R<=X%KN%L) -K3YWH)6P'(V#H"$LF<[>AK7P.Q7^<SBLWCE^M21
M^P*$E<GXL-SE,9]AJ:(("T,8+($X%@6D>9%"0G,4,44(4MR%.NRZG1J+[(.,
MN"DGJA;E[\TYK0J40+)C".P()CRP W/-2<+(@YJD]7& N76>]^7AN"I19#],
M R2([.CTIR6&[ >B*R&DQ=M^%&52Y=Y7M^BFW6TWIC+R^]>5GHQ-9'B:R103
MB6 F"PHQRS*3$%+!5"E&%152V97X<NMV:A2U/?J22DE3I5?N:AT#35V.A[&6
MR-LQ4W@\!V8F(S#82WS 349H4$L=+%#>#Z9 S&39Z:C,Y ;$*3,YONWNG?VE
M7'Z1Y;JQ_BW=L8]>FAIU:.'@EP\/EM;+.0;=-'"5^@//]*WF ?<WK>IZN4L?
MMS2:?_1%!0X=HB\_X!GBO9H_2S-!F\^IP%DFD4I@IC<9$*,(01H1"M-<4((8
MX@P)E_7\I/VIS;Y*O&IE<8S'/H'-;C&^ HR!Y^(>AP%.&UK4#A4??=+ZN$'0
MEU4[BW1N><QOSGZ1FSN]$WY<E>8,4[Q[^^M:BOOEQVTQEEMC@E9IM7<I1[(L
M)X6,!!0*"8AQQ"!#3,$L41F-9<11$;E,:W<1IC;S[RZ>)1C;DNYD=^,$CV&Q
MHXUAP1YZE9<;4&&]%=]X(/QB--![I#^!G1)@K\4@.63\00S$4QX"C$IE_@"=
MLMT5+7G<:.MFYQOY26^Z=1\;_>G-V4)68:#;B_;;9U.[ZE_U?;W2Y/)W25<?
M]1<^XURJ)",$2D1B$T =0RJ1A(CGA%-*J$!6M'BM(%,CQZ?O>N-&C80.E[C7
M#$0W$8X)[_ 'KUH+6*D!]GJ 2I&;O:_5H2XWH-(&&'6 T6>D07&X=A]I<$:Z
MDQ]VD-RN[0,@VWFG?TW[XUWX!T#AR!L@1'M>IU>/LM1[=^?SJ\/7IK98F'.<
MQP\/X,N'!Z=#K",HK(ZQ?%$8X2"K 2#\6=8EG7U/LX[:&O,\ZY(2)R=:%Q_Q
M2-\A_O%4&@?-VS_F:^M\'8<O36UZ'52SWY1'?MW_VR%OQQ$L_9/-&Y&!IUH[
M&'K3J$4--.\NJN^7<N.HI?%R;%Q2X"BIQL4'@M;T.BNO\HZNYWR&HR1!!#&(
M"9404Y)#DJ48YHG,BP1'1"K'I%5._;M\S-.OY\6,2L$K0K6,G-UIU6"C,3"U
M.%:#JL0?O!94-VK#5H)JZ7L*=:"Z8;&L M732 BWF4_SI;S?R.?U3" 6YTCI
MU0%C37TQ1Y#P-(<J+S(B41[AW"JPHJ>?J1DO)]X<X#<C*:A$M0R:[P/6CI0"
MP#4P_7@A=:6?RQD.@SBV['OYB9XL9ZIVNZZ</^Y'!W=&5A.]94S4K_/U/]^]
MO9-+_OV9KOY9F>(I$U(H12 I8@(QEP12*A&,".6Q2'/$$B?_N;X.IT801_("
M(S#8R=MGTOLA;D<8(7$<F#FN@="90&QQ"<0DO=V-2BFVRI]RB_5[GM%'35GR
M!W6_%%*U'FVNJQK;LR1'24XC 3G*-.4P1F%1D Q&L41*$B1QX9:7P:G[J1'0
M84WWO?PM9__;.N6.G.0X0'8,-1SL _-58,3=@Y^\@ L5#^76^;@A4E[ G$5-
M^;7B1WU?Y0^Y?#WPJ(F+B&&1Y3!6,H4X2E)(<Y7" BF"<:*H'A&WTZ73+J9W
M@-1(Z,9)9\C9L<XU: S,*UO1!G$?:M,[$"V<-3_JQ&]3[G1JMS[GX;9SO-^Z
M*W7+5.^[9)/[PIA*G^D?\^?7YYDJ<!R3.(5"\ QB11 D681@DN"$"TDC:A=!
M[=COU"R51BR@!W5=+N:B2E&W: 0'E7$)?EF6&_!M):EQ1=A\ITN7HK .0])-
M%@,"/>XIS W8RGT#MI*#2O0;T @_#+X.KC?#X#R2ITU O-W<:MQ1Z_2B<6AN
M/*<9=QV/?&0\7O?<OYKKK?OU^E6*PS"Q^GS^J]02S(U'3O58E5'I8[E24IN5
M8E9PDB<D9I#&DD$LL8249 )J6X]&#.6D8(5;V4%_8:RFUZAE".],F/!B41\,
MZ=W6:B=^<Z5(ZT(7WO>'5XR<Y29WV-$8:<-;85UK<1S >M-<+9I\Q;NAJ1]O
M$O+M] FX_[T:TU![87]!QMT77PW8V1[Y^A9]]\O[Q+-/*[I<TRI'?G4PSA).
M2,PC2 K-H#C+"2RR-(,HQ3F*619I0]OE7+"CKZF9UL<)O@^$];J"Z +9=I<=
M!+K!-]R>J'GLOGOQ"+81;^]IY#UYK\KGV_/^5]P]*A]_O-3'TI;.E-OGIS;'
M'^D;^+$V"Z\J5\]5]IM]*2][3\H='-TSV1>)@:=L)PCACMHO:>_E/KEK9#3/
MR5.Q#YTFSW[GN]_1T_38BR7A&:(,1U"F(M9KKR10_TW"/,5%FBLFL5W>U?8N
MIC8==Q)>X1-T 4C;;<4U\ R^77!"QL/^;U,^F%U_UL'(]GJ;@N=V>.N3'D?:
MCY3/U9Q_EF+.Z>+^F7XSP:Y+\;#DY:+\]G8G34*<^R7?YMJ@>9H++F',8PYQ
MA)$VN(L8YBA17$5I1EAB?:[MV/G4Z* 1'S3R@T8!\._T^>4_P%8)4&MADD+Q
M]JHLUX^,Q?'V@'@/;@-<AMKD^K\$=,"8IFN0ZSQ_=6USO$-83VV/3F)]V_"\
MEML>]=Y^^[:JSBD?]:?WG:[EXVK.Y?:*(DFEH%CF,(J8@IB3#)(H1Q"G&99I
MSD0J<J=;.:MNI\9;U04&WUU:T*WLX*41'KP8Z6_ L]=UD=U06-[&!0=XC,NX
M_8703FRPE1L\UMCZ7<798>MX$Q<<XS$OXD)@[7X-YP19[RV<76OC7L(Y:7AV
M!^?VMA?GK_EJ7E4I>5#O7M?:%EZO]ULJDA.,\P1!GHH"8IQ22'E!H4AB1DG&
M"I'8)TGI[FMZ[+Z3%CPHL)778\MJ [05C8>";W#NO@(Y5PZQP:2'.#J;&),M
M;'0YH0BK5SQ3S6F93?6A<J$?^K9-Z-KLDB3)"RIQ B.4&&*0&2Q0D4">R"32
MF]LB9I8EBVVZ<_FXQ_&[-'D?#L3=92IV3!O7!;'=<58HV ;FA&,Q]XF=PV><
MM $D5%JWKJ[&3>!FH?19JC:;=]JHXW"\-.'\\__\K^V_Z#],&;3_\[_^/U!+
M P04    " "#B@E7AB4V9MWB  #?,@H %0   &%M96@M,C R,S V,S!?<')E
M+GAM;-R]VW9;.9(F?-]/D9/_[: 2YT.M[IXERW:5>VS+8SNK9OJ&"X> S"Z*
M5).4T\JG_P.;E$11I$21H#:RZF!+M+1W'#X$(@*!B'_]7S\N1C]]A^EL.!G_
MV\_L3_3GGV <)VDX/O^WGW_]^I;8G__7O__+O_SK_R#D_[[Z_/ZGUY-X=0'C
M^4^G4_!S2#_]-IQ_^VG^#7[Z^V3ZC^%W_].GD9_GR?2"D'_O?NUT<GD]'9Y_
MF__$*1<W/W;SK],_"RHI1.])<C83R9,BSBI)7&3>0'36:OD_S__,J.>!,D6T
M2XQ(8R-QVD0"E'GGC(S2+AXZ&H[_\>?R1_ S^ G9&\^Z;__MYV_S^>6??_GE
MM]]^^]./,!W]:3(]_X53*GZY^>F?ES_^X\'/_R:ZGV;.N5^Z?[W]T=EPTP_B
M8]DO__?#^R_Q&UQX,AS/YGX<RPMFPS_/N@_?3Z*?=U)_DJZ?MOY$^8[<_!@I
M'Q'&B6!_^C%+/__[O_STTT(<T\D(/D/^J?S]Z^=W]U[I+R>CT>0"TI_&,/^E
M_,0OIQ-$Q*4_+_1VOS^_OH1_^WDVO+@<W7[V;0KYWW[V%_"-%,52+6AYZ_]W
M]\N_W!%P.849HJ9C^#U^L'Q&>=N>Q,"/.8P3++B\><UH$N_]T*C(>#*]^<V1
M#S#J/ATD& ZZ)Y^$V7SJXWQ@979"9D9 ,$>DXXX$F30)VD=P@D4G^7W>"]TS
M)+Q3R0SBG\XGWW_!!_]2Y%&^Z 33">7!ZQ;"V8_NFS7X%7]V(#@%%60D.BE*
M9(J,^&0XD4HYJ9A*/+*#R%Y]VWVJ5Y5Z,HT_3:8)IFA$;E[GI_&!@N_#=_D3
MOUSZ*3Z(Q&_#4;KY[3R=7-30U7Q207(+M2"Y/_^$7&>83B&]7VAE*W,=9W,T
MK=#]9 V-_Y\K/\4GCJX_P^5D.A]X&BRUTI)L-1*>0!*?+2>:JQC >LIEJJ+\
MM1?OA />/@X.D6<CD/@$T^$DO1FGU[@=#ZPRB84@" 17!)(BL2ER$D1FB2O)
M@I)5 ''OM3O!0;0/A_UEV0@8OD[]>#8L@E\"&KS1DG%/E&9 )-7(@S:6))'0
M[T*O*9HZ!F+]S3M!0K8/B8,DVC,JWHSGP_GUV^$(/EY=!)@.G$TJ*H>T&U-\
M:&%(X!&("Z"<L-2[' ]"P_H;=T*!:A<%!TFP">U_AO-A$<)X_A%=]8'7-FN1
M(_$L:_1THL$-SL@25&EN5 K>0@4$W'_K3BC0K:/@ $DV@81W&-9/T81U@O^"
M\H?3R=5X/KT^G23<[,!*R%X3S1QZ/E)ZXJ-V1*" I G!:>$J .-1(G;"B6D=
M)_7DW 1LOOH?[Q**;YB'BWS%TA):(YB7-!(:54(A*2#6>D6B8SE"S-FEP^+.
M1U^_$U1LZU"I(=LF0'*2$JI@MOSK_7 ,;&!8S$D+1I0 W"H!+'&*&L)"A,0L
M,RX=YGIN??5.X'"M@^-0F38*##Z@5'%O!1!M/3(1,P;9QAH"V6;F,P_9J*,
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M\#I(.4W:KWU$.: 94LP^$LMR&?GB!7%1E/9? ,%;IZ%Z9K$.Y?W>(FD(R#T
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M5%,#.-S0"%W'2&G.E 11,NTR:[3C(>+V+P(N3ZZST;7=H0=4]%UA4S]BWT_
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M&FG5CB/FK27*VQQR8#G'VJGJ9PS 9?0/ HL]I-F$!5EM_J5H-B;H3'(*GL@
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M%_)$M>JF=S=2I[.''B<5A=H&*+K;T0L.;LHH-<_>)X9R<):7$;8&%XD&$G0
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M?-41>0,;W>ED-C_+?YE,THK#>+LL7@/250H\4$OX]0@Z=8W3R45I%?M[]_E
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M%&$I23RNA3)&+R7/!0![L@1RC_?V>\6L%U#5U$0#+M@1HAO-$I@L4NE\5N;
M=D7K'@7".:/2:N/9D>.!EPINCW9![H\<W#Y'_0<&MV_&M3H#K8O[8;WKJL2C
M8+A;X!HW'",LR<I=KS+XC7KM$].,LNJ7\)Y)8B/GE,=*+M933P,FN+NX,3N[
MFL_F?ER6V\!819F+B6 8A=XM*Y.T)8T89Z6D,-9*C%<O'5XGHK7L7D65KP>Z
M!\F_F?S<0P'M8[\'UEB#?K G+#A#I -. M- O,Y,!9=0T+6;H=6AO+7<WQ$!
M^_*:[AWEG2M^[S;M/CR?C-.:QS.@U*7@32"4FI*+5T"L$($$KW3@(F<NTDZ1
MTQ&(:RW36!_23:BU 1_@PW \F78+><'1C<Q+FYW/D)"YKKO.P(,/B0=%DG84
MG>L,) AA4.0JAH NMN"U>PON2%IKR<GCF=]CZ*J=]/CF%78CW\+C%S^"L_RI
MT\O-]G/3^B(Y%7RR)"C<2'!+<20$D8F7/((TN+% [7M+A]#;6D[T>)A],:TV
M46O>R?'=;'9U_]1JX>A_1I:FPXB+IONQDR+;OTQ+>XZ@([,L.N(R2")CF64:
MY*(#&94!*-6U.Y_L1VEK:=<CN[K'U60#N_\6+KM3UNU,.D<=E($DV;C2V;;,
M]%6)$Y%<T#:"R-7SK'L1VEHJ]<716E&/?1]+/>#PZS=879)G^<T/F,;A#/>2
ML\OEX*6_^^G4EU[,CI<:=8@D@<1EV4V7\UX2XZE$CT9;B&JG6.L@,OIM3_9B
M4=7+J:K7/?\)7KNU]SBK OUS(2,CB4(J@WLL\=J4Z8?"*_ "O9[=#N /H:+?
MKF<-@+*RHIKP0[\685Y-KSNN%ZON)*(PD9:!%$J527-$">J(M#$09X,A/G@?
M75()0NVK#8^0TW,SM9?<I&LII9V0_1Y'W3JZ80C#N>[[Q:B? 66%N:!( !6(
MS%*3TA:5Q."ID%9RQJJ7M>U(6\]MV7H#8"UUM8/&QYS@F]:&D,KU9AC/%L,X
M.3<T"94(S6")%.7NFS.&6, EIYQ$LU^[!<7SJ=P-H?\\!TS'4V$3>_.CF85N
M0<Z&RSRN\J&T4R#4F-)+$;_RUBEB=4[9Y:P%U,ZY[TS<;J#\0Q\1'5=AC6=_
M[O&5J>8J)HMKC"%?00L2!&12*JHH*.U=JKU][TK;;CC\ISC^.8JZVH7A]E0K
M"C/#L'2;C5YEC;(CL;3>ER)08FWB!'2T03/O0ZH]E6I_:G>#ZC_%J<\+J;2)
MZ8[/S;TN6;U"20S*0#@N)".FY%UE%JS(6!&1K*)>2>=2[6/+ \C=#<#_S,<_
MU97:3O2TPT'M59@-T_"VU*6(QX\C#$($%J7%2!'*'UXS8E-T)(?2[",K'G+U
MP0U[4[L;B/\I3H5>2*5]'PUM9G.U..;U<+:HY2KNT;9:KK\N5' R3D]>0/T,
MH_+HLUQ^YY6_R>8-<-FS+(4@-I3&BBEK8BEE16J>1K0+3*T=C&XKZ6N%I=U6
MRQ__S*H9@3\+0WVOO*>NI'$F633.(,)=-PPBH"]G* F10U;($5_OUK_M<F"%
MVX#LCW^(55/>+01^#^X_6!FDH(D2[2@OA[^<6%\FVUJJR]CD)'WU0JB][I_P
M?XH3J<,4T,@=NDJ7$KA4(H@8"#6EKZT4'I<-HX0EKD2$0)4Y2L./%[I^\D]Q
M@-6#JJN"_*6F%)V>?/GKV_=G?_]RGXO#!A+=/?2XLX>V$%]_S-"IGWU[.YK\
M-KN=**-CN2BL+(F6:U)0@MBT&/I8QEDR61G!J]N [?14&*]8GOEI.BGM*-*K
MZU_1$7TW/KL9!'X2Y\/OG>=P*X&H4@!K!&'&H@0\;@+6@B7<1,948BG2ZOVP
MGTUE(PT,#T70AI&-QU17$X>?*Q-SN4':,W-$"1^+J,HT"Y2<%MRG!%EP6_LN
M^S/'$!\-0L?6]/8QQ<\1>@,1PDGZKZO9O"PV#+D_ V[F<3B">]?VODZ>*THA
MLI6,(M-98I2DLR+!2(RUT?N02= 0H/[<D?I\]'OM^(4AW#L0&E@,KP'?'(>=
MBO'K$2S+5$\NBN_[^Z(<QF69:<9M!SQ']UKR2'R$3%0Y51.4.\%JNS"[T-6O
MO>T?/9,CJ[(!>*[2?I;?#L<>I3P^/YV4WCPY!.H#\F*IDT0*:HC-*9&HL_<0
MM87J?N5C]/1K.YN#8S75-0##+66"D+RFT42BNL64'">AY$>5I")%!=2XZI6>
M^U=S'JUNKCGH55!7 Z!;)*.^0+R:=J)Y^_WC\#/XT?!W2'_QPW'G>WLO/'6)
M$HP%4^E:6P9M1$-B&;2>E0[,U$YN[T)7O_T3F@-D=57V7^+1G1W].IZN<5%.
M-=^-O\-"_._&ZYP/>'8,G0U+&# ,%KGFQ =EB)#,<R^D$7DM0M]R?/?\=_?;
M(*$94+Z$YIHHHKL3;.%MP<_B,LH=G[.!PA#1.HOKS#HH(BSW[''M!1IRAF"\
MM[4+XG<BK-^V",V@]7C*; *C#]?A&09OT^%WE.'W4KGA7(Y:ECKK4O?'2MT?
M^L9$.0T!! \LUT;G$R3UVP"A.5S65&#_N_I=+F'Q]H54O_H?4.J/\.]3_'!8
M;M1K%V*,CIB4RMU2FDKW<4^RPP6H &2HWC3V*9KZ[830'#"KJK")<YZ'50&W
MLEN.H;X5'.C$T5FQI'3B)5(&1:Q+FH#63M(H4^)0?U/?D;I^NR,T!]0CJ;6!
M"/XA9R<QEE[D,Y0[X!919B!R::CA!@66D1WII"4AFD#0DRG;@Z>&RJ-#]2%=
MK75,KH.))Z%WH(*:\"D?<O7Z:MG/<51>\LE/NX".ZJ"DIJ51+H-RR[G<S?>2
MI&1 >XSHJ#V^D=Q(6FO=CU\(?(>KJ5'\G<V_P?1N2<UP35DJ;8[$:BMPOT O
MQ#+01/+ 48 F2UH[<_XT5:TU*'XAU!VDG%X!UV6R'C+T:0J7?IC>_"BI_\[K
M[5@\O9H6/9S,9H#>;W!6^6PXR=DP(GWIIIRC($H+(Z2"I-=O26[)0^[W_M8:
M#%?%VDOII47PW0KR??E^R91+S%L,^$GD978Y !"70!"F*;4Y1Z.MV1-LF][7
M6B?@EP#7P7)O-<0M2^0N]%KP)94+N#R "&F1KQ@$<2@NHH5C%EE%_^"%ML\U
MREKKY?N26^@A2FHG\[<])/KDKXM_4"J*8IQ>(8%#'X:CQ>&0C))%KI [60;%
M 1IP[V(DCD6I;0R)A=HW7?:CM+7^O2\<UU938I/IE6X=KK$Z\-)*ZA,C(F:Q
MF*Y:+KV2['40RFM0U?MA[$99:ZU[7])8'J*D_COT/F3J Z1A]*/5U122CY1K
M7$U!1R*= !("2^C)&AT24*X8V]/I>_BVUCKNOH3+=Z#,&W7XEG9YY=CF9HVH
MH(P%Q0CS,1.9=28>F")E+(MU/JC(:Y=A/X.\YIKNOMS.6D%?C8+Q?E1UL]*N
M!TQ%[91)!&RIWW72$,N#)$8IH9V+C,<7/%^[3UQSS7=?:E^MH*MVO;IR[7J1
M*%JU]]ZX[$0&=%93P!B+!>*40E:#ID)J:A2O/=_Q.?0UUV7W)5V\PS76 !IW
MOY(V"$*64:N:: BT3#XI];N<$6J$SQ%MOC"U;>+NU/5[MO'"%_N.I+3]X3C!
MI79,."Y*(#<+$I3/*:(@%:#1EZ44S4JAB(F>B<APX<?:F9GG4]G(A.\7NGU?
M2UT-V$?T=9>E1,NV_Z^N9L,QS&8P0^87\KP=2!&L\,R;2 3WI4V+ 6*I5T08
ME@4ZREE5G\;\'/J:O+]?#2OK]_>/I;@F2A!0BA$@=;7BIY/1".+B&N+[R?@<
MP7_Q?N+'7?G;O4H+8W/RC&6,T,IH2"Y,:7662&:4YZ2DLZEV@+T7H4W>TC\:
M4(^NRA;-Z <__0=T':=6;N!DZ97G49/@(RTC5%*Y(::(XL:9R%7,M';+_)T(
M:]*Y?#'#>;"JVCG\>\#;UZDOC=#N&/LKC%*>3(>W=VX&.0HI$Y-$.8<!'>^N
M<@L@43D=I!<\N*.#\FDR^ZVWZ1NBE=78QA:_SN2V.V&<JF3*,:8NXL003Q*7
M+!",*Q6UR2B9:K>)V)6V?@MU^D9E#86U"444Z25,Y]>?1GX\/QFGPNEEM\RT
M\T*#YD31$DU:R@FZ(I$P:9RG(3N;:Q]&[TY=O]4[?<.QCM+: .2*S_S%=^4>
M'_R\V/[KL[S17V'9@(0DB?<2UQS/FCC(G&B5+;5>1UD]D?YL(OLMW>DQ[*FO
MPA9"GA4&-^\$KX=%TN,T.YO>:Y3_&5 .XY*BZ,XP!B:YI$24A,5RKB!+8P+G
M+1&)\2"$#E'7'MA4C?A^:X!ZQ/3+J;SO@09W&\TVAR<FC]M):5_MRPEMIHX$
M)00)C/NDN0P:=AMI\.2K^BT3>B&X'4'J3>SJNXMO8+H3,J^),N4X-Y46&(9G
M DX%'GQR4M1N&[$[=3U7"KVPT3N2UMH]C+QM];=!D$9H(4%' B$E]*1=)-8A
MFU9H9BBCRKD7:@7^")7]IC-?^C"REKI:<"F7-O\LW_H1 QDLF) 522QG(GVP
MQ"LE20+)( 7*P!SKS'&%C":/%JMI?DMDO:\:VLF'?X;+6U[*>1,^^>(UA/F
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M?;MMM!P^Q_;^<U=\*2T5:#"$ZY2)I*ETW].<6/2MHHTY,5&[C&(K,7W/&JV
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MF 3AF)'@=6W'<3LU.Z%*_<%054GX#<!H/86VV0-460LOA"4!%! 9DR'>2<!
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M1)7#ML0H\UE5YO5QBIJM\GD.*M9-7$4E-+!5OA[._/GY%,Z7MQZ7CL'7^Y.
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MWZ)'<WP$L-EUY#Y.E_^\-HB-*4YA!,D-V0(Q(GCE$T0;K2TQ"U3MQW$_3L^
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M4FA%^G)=^SN+^3\S+B;:!)FS5>!U[8EF2IV5H@5837\:HX._/TGV$=P=1<:
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M@.2?=[")MT:&4LM@P#-)>RB2DZLF"D1;7$(9C6L^4VL7'<,B[^50,&\LDA'
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M+^:DCNL+\O*JOB2_FRVO%C7'[V_D72S^6$PK$1MO\#\S/G^#*&1)"N.@.)9
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M+?.?D 856 =;1IWKJ-)H 66*D+5-0C%)%F#K<,U3](POT'>@V)_LNGZ$#$:
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M'M:A&1:N1XKOM6&U'L;/?\PG0JIB1)206223)BL)(48++#G-LR"CV3;/:#Z
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M87'R_K?-1J;Y[A:*,MK: @DQT[T6'+B8':2D9'+$MAPZYM7L_/QA;O]V$&C
MM:$%_W_.SAXB5P8RAW)@$%W-:%69D"NT!&.UCISTY8.P\R-BW_7IPSP^M!/Z
MT1P;6N0G7+#_R)>77W%V9P/9&T>;I@U@(1,X6PB.C&'G-4LU8SWJ;ME2NSY]
MF(!.PW-^+,>&%OEGO'";^^K=['N^GE;\VV)^]>UV/YJPFJ0SP!G6>?*%UP!V
MA.B+33H8RWVW!C =%AO&_F\'B-;\'!H?)Y>7TYS.,4[+-'XHIW@Y+?/%;(KO
MSD^VCQQ2^*2C N'K(X>2@NP:3[PRSC.IR5!FW?)>GE]KF,2&ANJB+3<'S:?;
M;.C;%SPE[FTPOT;ZNUG\RQ;J6CJM;:UR"K7-4>649X9<*8S*Q"B]U1VQ\>1"
MP[0#:@F,=GP<P4/BWW$QK<&3C[BZCINKX)SQ(4#4Q8'RL8!+7('T=;:#E9;S
MUL^(]VD84U+4\:DM1W%X9 C9'!X>3/9>:]#!"E":9;*8C #-(H9$FH^EUB5A
M#ZD8-C/A.*D^ 9$#6#RTY?$IQRM:\@/=5;/IQ9?5V^D,9W$ZNZC[V6;^V<B<
M%05LXJ+F5W! 8<FI]LB%8Z:@YYVNEPZ+C0<9APASWB-G1Z!.?L%EOD,]:=:B
M415(FM5&5K4I+-+9R5HK74+*1;3.Y?^9@F$S5AJ!I0%S1P"-\\7TZUWR#2?X
MFE*CK9%L-%:;;FI'>^ Z"BNUT\WK/.Z1,&R2;6-P',/>$:#C;,<8G_7-FZN/
MKFO%/M,9E,L%,!)/?!!"1IL#%\T;@3]"R_"]3ILF9;?@^$B1<U;K9A>;4Z5\
M=BS6$'^NA;+9!'"*.> V.Q5\J:' %T#079K&-W)R?\EW&5]ZJ!B&MGG/MXO6
M9K%;2ZPPE3VI9"$X,4?6AVAA-&1$BT'Z:+#;D\N.#Q\?'@X7W;PA'X?&P>?%
MU72YND.\L$)FG>M8WT V5R@%/-(E6T+)(2;D(:A.(+C_R2,<(]H$ 4=Q< 2W
MR\8GP\M/5]^^S1>KS_,Z"G ^6\XOIVE=*7DO7T4[&5/T!4RT-5_%1-*A59M*
M-"BB--YURM';X[;9E\9.6'.OQ8[I54*O#(';?E?9&*FR &%*[7]/#H!GWI&*
M95%PR9%\B0$Q. 8;J%_4' '1 T0X I ^V27-:&N2<@AF/51#TV6/JI !D&62
M@A<34^LVWD<WJ!L%\ [!PC[MZ_81S A ]O/-<78SY%<%IDTMU-*>LQHVJ?P)
M9&$DM,DP9XWJ8SKJ#E(Z0<N_EINU!;]'!YLZ"6AB!(\N&@\VZMJI@%?#UFE@
M7DA34K'<M&X7_Y"*,74K.U"X3T^AV)?3(\#*+D=H4T/RRWRQF/]1NYGC-_K-
MZL?:)+ B(,BLZLB[),B3Q0R:"4ZN;+;:]=G]^SGZQM0 K0V^>I/.2)%W.O_Z
M=;K.7'N;\\G7^=5L-?'2T<VL!?!DR1@P04.HR4E>:D$_D<+&Y@U*NI$VIIXE
M_>'M6)F\!JB=YT6LLKO($VV=#HDI,)F1_O9.U@EH&JR2D@6;E3>M;?<]R!M3
M'?H+0>Y V8P =C^SZQ=<3I>?B!9,'V9WWT+Y!"TR[<DC$=X+.DZ&0<@N -=)
M)YLSJ>_6#<V[TC:FLL@^;+9&4AD!VG8=I'<S^OR\7*W3NE9TDJ;S]&:6)M9E
MR]%%**8.C.#9$/^4AR)C$+6/B(^M'<@]R!M3PF1_2JZ%;(9^+KK7<>^J!ED^
ME/\O_[@)^GRL<EM.<M3!U")VQDNLA>@1 K<:$B_H<Q36Q&ZU/%U7'%/JPG$8
MZH_1XT+/Z?Q[IKVLSO+WO*#;?KVAC;,SB8:N]Q0,B%+;(<A4T]"M@>"RXB;G
M*#OF6W9?<TR/1LT1U(S98\#0=C,G%Q>+?$'J]/QJ$;_@,I\OIC%O=R6TSID\
M9#"2:U!%)T =%"17<G:"W.74K7"X\Y)C"HXV0E![5H\!0,^<BW>SN%BW?<7+
MTR^U1\LD.1\8 0-BJ4$^+P*X.GZ[2!XP96;*_3FMAZNC!ZMW"Z.R5X6K7B7P
M"B!VDO[K:KG*:7N"E/3><Q.!J?I0914#+VP&1N<'<W',BVYI-_NOW0U>KR),
M_Q+<'R>XMLY%_?[V?K]N"E8[/O*<44%0RM:$M C>: 8E1B\3BZ&H= 2XGEJ[
M&[A>18S^);@_@K#">H?+Y15Y&?ETOEPM[_JR)XM%U<9U[\O?\VH2+),8O0?K
M,=8&R 4<)@:&1V>E5D(U3WS8A[YNZ'M5$?O>Q#,6Z-WPZV\S_#I?K*;_SNG7
MZ3+6=XAS,@JF5U]/9ND!&^IVI4&74E:@F ]TTDBAAYPS<.E\UDXR;_L-J^Y-
M<C> OJKX_DL*<028K3V;/V]Z-D_HN DKA(44D/P@1R9$X")!)A9:AI$LU=9I
MB7?7[X:F5Q6\/YB]PW>LV&TJ;)WJ!V9"*,E)ZQDD78=:<97!!>% !!<1%7?2
MN2.,M,?6[8:95Q%\[YOK(] V/^_N+<;M [U+J$W$!-'7\@4KB54&!0AMN>*Y
MOI6VUCR/T=(-4:\B%-^4[>-T'$]Q^>7MY?R/S_/Z^T]Y\7T:[QT1KUCFY+K0
MSNH>D9QC;\FF%-IG6VJ]3+=14@<2T U/KSTPWU8.8\#:=F>?"13++_/+=)O8
M\7:^^!#CU;>U%#^4;?_2"0O&9,EKP;\G?T4&#2[3!:^-=TJ72,9@WCMDWWW]
M;DA[G0'\GJ0P!J ]?IAV7OG<$%:<5K0?Z4 56P +3^"E=+GX&&R(#?39P<:6
M>.V1_&;<'YW!=3>%X]>KQ71V<9W&,>%U$#H/M;#$D6>B2$$[F2Q@++P8H:0P
MK2OPNU'6#7&O(KC?HTA& +3M/M[\ZUN>+3/=]LD%;S6Q)" Y)EK6CD@"D*Q*
M9$DH[7)C1-TCH1MT7D7HO@631X"1LQU99;25Z6(ME0WNBS0LE"* Y9K%R&2-
M^1H/AC$GC,X^:M48.%WHZH:F5Q6*;RZ.9A#[7W]]P&4B]I_K7ZU_4_^MC[G\
M/_6??_OX[J?/QV_SR\OYUYS^,LNKZ\]_G__];YS1=G&6/JWF\9_5D*0UW_SW
M5:T>3L0 6J(V(B[SQ=?U>K_F%4XOES]O;3G]^NWR60O^B-7^>KO%^YO?+/H
M53UN-_]K55M,I/_WV-+C^R3\/E_EDT!HQKB:9.YU9KE B)$L*A%)G:%$8(DQ
ME11+W+7N>/HT14>76L<O.5U=TME:K_/+C]-+7"ZOJSTQJE@?M>KPPD*^B52
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M)@CUE"%72H$<8B(HJ$ 0IU'"M;_2;#K*R),"G=%8$&7O9EZQB5D4K^-%,,\
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MM-/EMUQK]6GY[:'4BDD28\ &:6) X[ILELL@0 $SDX+$TA=O6[J3D.IH.5?
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MC8_=S&]Q1%DON"(>!2Y &6*P_[7A#C%-'9<!Q\!*3WS>1TL+@9^"4>DSF=V
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M_3IHL!PFDZ]6"[AG>!^!#\"65]/%&H]XK/14?,:O9>;),?V\*?ZUEOVCO;]
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MZ2D/8O@T\=Q@]A#:BL5GY!BLH($5;7Q;Q"[(#E9W@$H.9ULX.^AW25;/MQN
MC-1Z"H8T2N>RM6Y1S!Z?L0N'QU3[DZ77M&RFZR5F>Z$!3"EU1$)JF]J,OQZM
MFM(5S!9C^2%7N:JS^;KIC+D'FFJ]7B OU81$W"-BPKGW@%%R:N,GL"C 7,&E
M3^!+F'$')^X-]FA&_ $97<8F3DO#NAH -MBM-XE_DK9D=S(_+K"L@@H:9\44
M5T^7#99*>;1<'W$/#V!":8-)K=GH</]_NU*&'&PV,(]2:W)+,GNS:;[#DR7#
MD-P*2Q@$$X)@NBMT+,Q8'I5-]P"6R^=L=/0$UA;(N9'*Y#4J!?RSOERR;-?-
MUJT@LNJ!A\^=&X'SLJ20))P(S4-2#N#6.O?.%1C';!E=@\:SE16]/>MSG(^<
MA$Q\UE6[Z26O&FO6<[0YP@Z=GR;!U?J\)\7Z$IRG,8P1M,?E>G%C75/]!,"K
MR.=":8)GR.A8K@F)ZN?)J(,?/#B9/&S@X2*=U^:W"HW^MBBH(/%\6328HIQ(
M\N-< ?2E L&B%E@!#\+8PFW>S"@;HI='#N."LDO*'DT#U:/%0I+TT XI9V8I
MYLU>Z,-11;NJUVTQ_/M  ,O6)1]TEQ$D?FC\!&+NX.00[C70$E81PB'"6G&=
M]ID6'P+E8W2 ::V3'2I0I8SKT0Q_"/;1#F=LHPJ26*V;$YL5':8GTW%-X6CS
M1?? J<R@E[ \;<MEB05!Q6=@(E2'B0HN?G$='&8D+/*F;$E!0,N"CX9$U!UM
MPJ1XJ$5F1(G(P0T9L+BHQ-1DYSA.&%7@@,@CWCA =5[ZX8=!/2KN\+TA\2<^
M^)[?[W$SGS*1CW9^6#_;R;?TLYWT_6PGW\?/=N+\;,[Q^H]\L69UZ;'8UV;K
MAY$/)I(L-R.^:;U8)GZ0*.=*5/ CI8>3\P*$ZCA!1JN#.B>5!>X@ZT#3A53O
MFZ1D'OI=<9_]43>?LJNNGG[*SC]+7O^(=$'25(Y?[.]GJ[WE7G:>HV.A(CF*
M+A;4MAY,+6HTF!\-[1'@;BP[FIP6':1.XURMW&SHG78]1]:)+%G?@LME$P!%
M+?(%[%AI07$>K0=!U9)L7WH2\R)]]B(K*M7,*:=P:U$-J-DAT'_8G/=?6K7M
M^FESG/BHI>2'L!&7%[]>O+JXO+C^(SM]=Y9]H-]=?&"0$/CO<.\ >(,IIL>=
M"ERPL/L@YAZ2,8LX6.G<4['+(Z(:&\=P&=E!]E+*9[(',FW.ZFIA_2OBS#!^
MF%J49RVJ+3$_/0^MBV#&XV#Z/$]-QKQ%$CX/HIUI#;8E@]^O,@DV,M>YN>GN
MT3$<!G:^/X'BI4CRSH%,V*/!A:=.AG6?Q,X&T>$)%N0"59-F0BY!2JGHI*I^
M*!LC'W+2CVUUNZY'W(#^SH5I2Z;^AI0ST=U;ISP/A_>I&CY(*KF8DP<PM2/S
MO%P09UP614>X @&(!(KZ/ !4T)'Q;,PD97X:7I""V0W9!5BT/0G+:0<"^6JP
MQ/1Q4;EJ_/'07N"!F^K]OL.5!M4R8:QREYQ<LP=H)G(='.QYZ-Y Q["_/FW@
M(C8^8LKI]@YB\BRU98,<<@^I_ B8S:YW!;!L:>R/V$%'EED3LH2&'JQN7%J"
M>7 HE!OQ)7\@<AJ\*R:,/<20C&?FBCA+F3[FQ*L@D\M%'"Y'I_:-39R1A+1T
M;+BLLIYJY\GS@.D^2EZK$UZ= 3\2SH;C]RSI@(J$/"+?'VF9K3\P=AZZ8^ES
MU?!U4>9C2SRX)G B+1WDC CF.'L-&JSP(S3FDALTJ(WCK0#JKN^&WA1[3!T^
M.4N;5<#>[ U%9P"Z%!W%T]X3OR W5MO/5?/+HU1Z@ZOA/)3.%;M%V8\IMD0#
MOB&K1<W;9?X)]\I^WO%CQW=5"$U:3+RK3 2C3;NXV[WLM$)1(4[UOFN:YR/!
M@\+[_3-GM<,IY"5IF3;-;X-;74-'=;4@,WZ*OUST$R2#RY =[1$"AX(?(0F=
M9->A*S*2H6'1 ]EO4W603>++G#O=+W2Y( &HZUL@3DZCZ*)/_=1+P=<'%CXO
M\/2-ZG:4":[;Z27H<.>O'1C0$>AK;X' EVM&57J;?Z:_NR.YQ&ROEF/7H5JD
M>;F)O4:[WRBS.^-HU:(0D4A^4"F(7D+T"<)^? V"V7 "=BU9NAPM!CK]I[C'
M\,-+7CQ1ZI(7'^8_;LAVY #7<@GZ]30WURVE>5H=98\V_K!/]RW9;@=@IKVA
M4""3\SPSB8Q[''XZY<UEBKNVZ@4.K(%)A(L;TNB0HW/ D:6,R0;:F!NX,3+L
M_12C[;P'/ZJ;X,FW=!,\Z;L)GGP?-\$3=A,$'IM#1'A[NC,JRYT=SXD(@47"
MW#U-@/C93$JYMTAS!95]BL*.-)0ORHZ5V&-T3U!^)(DZ6;X*-P*O##+_"#R1
MM915%_&<#5FU 6?AE+*TEAV%+U-):>'K>8J1 O/!6N80YLOQD@!I)V9. UE[
M<ZQW1DR*K%DOBA:CV>4..D+@1R^S"Z#'NWJ:*Z_!R][_+F7+3]!3C>)SXRPF
M$JT-$J-+_<I"P.M8R:$X2%G :*.C_>YVAYPI?KZ##N<XS9MB-W0:L,/ !QOQ
M<K7;&('H\,"K$-##L(T>G.C0?LGJ2?- UDRI(E\Q?HK@HM0)[\;P)TY,?I4_
MH)&FYB89F?1P&X3'.%+HN #M>7]!*C',0>Y]U8)P6DP&[KN+'&9+;C2"4 M6
M)XDV\]J$4GW<3;:%UXSZL*Y9%CT>8 \(<AFCK(GYSMII/U^%9Z-*<P=2!<4_
M>RSM$7&6B%.,@]4PH2&E]5@#Q;V;(GGI@:?PO5/P(#K>!]$4"G,7,E )S<:B
MIH*&FPUR]5D.745@V,7G:;'JAE//#'<]0F"0^IXO\9 N'Q)_7(>7X(ZZD][!
MU6>/Q;_$QNX2*=SXLV&N&W+M_M!+C*]Q-1)5<LZ;?.H=)M5Z6;AJ():29:N_
M$?P_]BGW\K:0M#?>./%!;W7K,IOW)1^P%VCHC'TE5E63*9-8">^G61"M1\5S
M;]"]C$CAE.'Y^JKM7O8;@Y$D%-7QL)KZ!5)[6Z;#"$A#DCI%BO)&8B._1$!_
MH7SV CK_IM(H2!+X6DFT205(:P##*H!;\CC@M7]&BF=Z&?K+=XP^%"T5HM3:
MY)#X@7G=V"(#=;5(1HQGDNB:U5(#%"LI[K[%P>"Y]"E1M_T+]OU/;_L7[?O0
MMF^_ZR+0-C*P^# 2.[7A6"Y"R"YRI&#R48NH'"Q(NP#E-9ASRB'!^8;B572:
MB1/0-+ 3T8%#TS'=JE;150IX((9913L*-!LWS;%FI/A,^&Y82W95X.5\X&:4
MDHR)KD5,G[0[L#!X^'%]G]VYU(GR@=JGRJ$B4%'F6@;BLGE4O=/N%?C(9K%O
M\:MN%\E>PNLNNS4F/6HHW< &[G(BA<5ETM Z![U33HXHO[_@C);O9$9Y-0(C
MSYA4YG+*%!P2'RNJF0.O,W'GE#?OSS#BF"'\H/Z>I]_2W_.T[^]Y^GW\/4_9
MW^.X<%S*#Q<1& ^Y_!DP"(\YI7D*D9I$TL3]D1)1(DZY.;#_,VS D+>2UXI$
MIA?F$5AIBL"B!SX[6TN4">_ :W;<._=[2M5DI4E?V\O>4U:TOR_)P+*U5"86
M8%]C#H'*F+HI,8\Q3,NQWWM,)RR79,<^)L3W,/,$S3"\;=;Z\CHTAB<&PN1U
M;]'3O)*PF(]^H&J[H,X%WA/U6#!%'7/V*.AGZ$H:CISQ1Q^KE_ <FVQ@]7+8
M0Z?(F#(=%E4$N72Z$[.VU)>Z_#.QN@?-[1B]VA%!!>1=8!)P-CHX40^4C(3>
M*>"%1\U,*V)"UY3SEZ3R\O0Z>"2(L5Z"5"SV41ER-/KGSNAX9_29$#[CNL(N
MC <@B<#)()58*(H&-[S58MLE(R!20K>DVN,>K6X?6D(KPR/$ ,T"C%=03QJ)
M]FL:JESCY'[C4/S)KG8IZ8RW&V'!P H$%D2A.!W\*DQ,LS/UJ7%F2<1,"WW-
MU%]EQ=E$!#A.69D4("= \2;U%)G. I#+L<=ZW6:FX)A4(VYN 6^'PG6\9<+D
M4+XD>1V';@^J"JGK\Y?4Q9&X.*H10^F@-I#>#_=ON)1P6)YW]$S)7%SY!*L?
MJOI)1I) 8LD?'*XWEE<6]XF(LYQ1*N0\]!WBZALBO4=[1R1L3BB_W97\H+RA
M8+H(I[BJ*Q48Y47%5O569K6XQ SB8? Y[W*DNB0$5:0P/7U?NAG ,K/6)>NK
M"Q17CGA.G\LENYW8=>8@,^,JTVT\Y5SN//LGT"8ZU/HI0G-R<W!Y""=[:+$(
M&4=?$7$9B?&R/;'"]08";16?R<>9I9U)0HV)ZHT]^0T> NK"=5WQ?G@4H#L2
M\IAO$MC;/C=MP$7IC\$4"J4K*\99U,[#I(Y8L_'1[(A6+%W\*)N5>_T21E\"
M'268;(/WID'[X;)#_^17[F?@F8D] )0M0PD3'IL_+E)Q"1/'\-?7K]__!@KW
MZ>7E^]><X(HIKV<75]<?+U[]1C\(<BF.]PZR<\T<4"^[A</<&#HWG7(H4X4;
M#5G-;MO^/H^W]6&3.N9:N-NF+Y;*] I+AUU2;+A?QWN'[M!.N5:5! I,2_*N
M!6\L99+'62%(=H@"1=4LUL?M=&<\,ZF(I8S+>AA63C.)8PYJTU#I/@R1:: %
M;]I,.->@N5@"\&]6 \?#V^G;3N +^D5G*?1OG.LPIH7 L??:)R<;R"Q*!UQ.
MRAO27S!K4B<@C=2<S='/SQ]'1F#O[ONI4/[+5W""O2Q)OVV8N>>_LT6A,M>K
M@"#*9ZF9(KZ-=?EONCY(US^FD^+9MW12/.L[*9Y]'R?%,W92'.\=;:XR-/9]
M+S_50VHZ!I$NP+>WFK"F-U/6)I41F-]0=J:R,<>Y2,#R#0D]H*"@+0N7)R@A
M6LE9(SDED%? 4S;.TW9&]86BME*TA\<<A-:T(U,>F 8<A-_XX:HF6:W>8D6%
MR-" =K4I8%C?9B,RJ?WVAP+<:"B2$*GG)TT,C'+:Y9T/@,>I=2/2R#_G:$.\
MV(I2$#2Q3RY;4(=4R[)?E((6S-G;!/5-59.SZ9I.O7-@&B>$X?BL?UAH >:+
M5AO FD+ C<>C H1HB?2)Q7JY8N@*#D)RP-9D:9,X6%/5Z;Q>-]GH>(>C%VU2
MU/%96;A&S%P(I4]2]H3XC5>J%&#^ 8_\)47',A%W%%1[T+*F.%,PEU3W3;W-
M(O;#/=ICQG2<O:>]/K-7P["CW]61B87<F+VTP\%R3^%I\SK.7))(J>CMI' 9
M&U=.RE1;= Z]I:=+(;DPI3BX@WJ8#JBS*E[_T0F8=8BA-3K8A[^)1PS=80Q%
M)$7]H\/]G9!DF+D.% 2\-,$+9HW8=FN7L0P+&Z'9O(MXPH0<2UIDE/6U:7VZ
M-MW#_MS/# HM&:IY=_OUFIUV]%+N[@K(ODI)2^AH:;%#L4"JY4/L%[1WG!X\
MM#LF2?PDHY[?I^_^@#_?.2.';)L3L&W22IL4C47>#WW4Z?1#"%UBSE-SH+"=
M2=1AT-AV:JV&93@^]SB--\7VE[Z#N\\!.Q!@8?-5H="DCMC3OLE#E%H;H3U@
M/'6<506*8E%KUU7)F!S+.JRLD*J(Y&>W,;S_XF'0TH4>=64@0#95+QJ:>(*%
M ^=OS\^RBW?_.+^Z?GL.VMVOIQ= %>\_9I?OKZ[.@3ZP(\6&U@L#=B^)IK#O
M1'Z7EPLR^@9K4MM> ?+4.^@$>4AYQ>.@1;*-WI1SU-@/7R I247*F%W3%"9F
MB+99"H9/9YPF2$84P[@..5"I'V;>ED('_FLHL,P'.;;3N,(?OBU#'^==QL9T
M6D*#0;I![\J*TMPDH_,ZN86Z*!3SIK/(G"($Z.SF#$-W0N1Z]2EG:6PZAJ!P
MHJ">:RNN%&X?SX 93>Z\#BXY<P/IA,<]UNR.Z=J'$TT]E7B2_-S3E*;?]1!4
MP5="J]: !]9-U!R<^&55.9P;. I6S=PZ1 9X2W73U9(O<B$X:T+A5R3T$[@3
M;6>'6C-A!#U/$<R @RS!<(6-X5L$?Y8L/"F7;UJW'=TQ#*U4VBP&WOM48MVN
M@&64U/NQLMD9! YF!"0.L2A=J=5F0F<M#,%$"*#:)9^ 47U3<P_XWIGD7+C+
M]=Q4FV5[@V/A52,%8UY_P5UUG6<RAHUV4Z'\&8R$>T>4B+1!-WJLZ),OWIS"
M3FJN7/V&-((0A],UM0HCXJSC'"/F)GI ?*A>W$7M"Y,DT2^>)?X3= ?L 0\U
MZ!K@V@Y6@9P(XP0:S>6F.A-%B2;<8M/B;2J)U0KP*D4A3_8.TX@5 2_8()#.
M(U=FW.3>31ZX<*.0"ZF"<;KKM_7]%JXOX0V#^H+?(*/#$2(&SA^];:0PI,6:
M\K<:6#S20MPOWA2]X8<QLW2<K>I%.7WX8=L#/?^6WJ[G?6_7\^_C[7K.WBX1
MM(1A!AK %.Q<-)MG]6IC"P*XS:USQH<@*L/03::]FO,')-$::P5HIZ&B9KF;
M*2]"[@CC!!<;-12+^A'5B8(52PI;3I)FJQ6Z:T0=D L&4=%ED9S&H5P6J/V<
M@W1@PWG#E--[$;.X6I#VW0,>37JHPC0Z[ R9W5$PR8\JSD7>)KA9Z2!IK>Q7
MZ4W@&5Q=S9Z%J>#X&*%EYLP<L'10G19>E)BR(K\_V<O>%66GR(J^*6]%.31<
MYHYCU5C57B,B#N:?D)17-!2PE6RN5<AM*4^W,HMR2261R!I47)S>\AT4E]26
M\8X160]"M,9["/\[1L3BCXHW?A&H?RH[3JG],&(;=S@%3).1C(4']*+<&  2
M=!*5KJV8"-LFPJA!?::Y$R1))_]X471VW.]X+!V9Y5/:!=EAUOH@:XNH**CJ
M<N=%8BAL$N R$*U(532'&B4^"LUSBX688"74]U6 (LTX,^@<X+GP+10-B;^K
MZ&^][.M&[Z-O4 GJ>-N-@X X/Q-(44Z*SDOOE[DIL%7$(G-Z6-O[',ZTJH<4
M#SH%W7AJQ>X#FW9])CF=S02C ^HD!G5!$^)^FF5HT5^\^S7[:_;F_<<WYQ?7
MOWT$<_ZOV?7I_STGM\]3,.SM=#5^G&[M&*O3-5CUMW"*.#,' WJPCSB@HM.4
M3E4.,8HM-L4F)S #5#T%??"1D-YO<0PA* 5,>V=#4"*+2O2( H>Z[">$&A#T
M7"E9[,,GA/G<=KL&]@M%O:_5\#VNM@FP4-R)Z-;N4!FBA3PF827?2:,KZ8UP
M \+64FR%E Y<"*TC6@5P8XQXO SFU1OD^+%!X)GGCXQQ8L88&N1H7YS5=<8Y
MK4!=1[AZT D:,D;^41!J29_U!N8FC4\%AD*^XP$JV^RS&R20-'VLM0F:BX,H
M@3A2$%1*/&M*$\(X)$@>!\ 3N@(9F]0[QQEND[SC+QG0.WLMT'@5KZ!>,*CF
M;"?SO>*<QVN>]?@1;/ Q4A6"E@ 32XHT%>?:<L:Q8)%E(N/&&A/DC/:!;L,&
M' I+'07,15Q8KW-"0:UJ+Y:L$J#J,Z98F@*="!<JAC\,FI3Y)D:;R&$0JH>$
M&XJ)%.#I., <,%A0 7HK8[2Q&M98'Z#[D=]Q4J#&-D(L!GW+T2<43LYP-= S
MI\Z-1LZ_/B:./!M+NMRO5FM8T.-BZ3L.,FF4:8]HZ22[SC]+NJ%)Y>QGLPVP
M\?'&EBH:)M0NR!5S]9RRD /MX$TQ(U%\X3K^14<*=_?-Q6OLA6(?_ZTRY DK
MR>3)WZY/=[PC\JI8S'?/_8,A_Z4WKLYA;"+I 73!L<Y4HEM.[Q+R-45!!,KK
M^SWQ/-S]T$L0ZFOQGI""8/ M>;UC#N8C0 @FQ4N?KW$$[RXJ#Y]KOR,/ZXTN
M&Y/N93F+=92T5>2*.URH;DY3M1AN< K&3@B*_9R76G?C1P6^/=C_ANX4'BQT
MIQSL?Q]_RL&^=F97Q?89&%NG?U"DZOT;3>,<7>W@,\](H14&!L+B5U:8M6)(
M?H40I:3E4D5+2$8C1*P,Q(S+5\E]QLM6D-LI-V^$[)@K8858!ZG1A$4:5X@B
MA1'7#-4"&(>E/Q5<)8/V8R/VQ^PFHIBX5"J(1HVCRI?U<X,M43:F<_C^@A2D
MUEK#Q](VX$ 1OZC<V1 33V^HWU&ZP-$B1'<),?>U[NFJ7C>\4*6E,+A, @X8
MRI@W%)FD6F9J1A/+L6(/\3ID9LI0!]T$SYQLS#OF^[D@*6V$<AX;WT^+DYC>
MYLV-PGT[IX?G;RC@NYI6#:J>XL1=WP(#1;$JTL7#._K=$.]:2)/QYJ(2);AW
M:L9@I; %C"2TDSEZ>6[K=4N9&:#)(K+@Z'^=[(_W]_=W*)I;H'?0L/#$Q[V:
M0EX9S18-<T7$1 _20WP^J8M.&_A. E]S[PN<'-XVW227UN'03S:F9M-N@_)\
MY1-_DF :JNG'U=C<MALE:S^[>@8G*VT1N'7BG"IVG)P5E.M4!DON2BDH2ARY
M:*(+B;J_P=)ES-<1Z^@N74F3%3>LTV<N;K2U<+34,#XU4 H?<V?&L=J9"VKL
MZ<;=EDQ-VKRVOUUMEMRPTN+?<O41:Q8]BRS S$6M:5ET+TPUY<:Y.>JR(7Z&
MB,VQ5@TKVFPS+ZT$CV!GZJ#7QZ8/*DH L1)M$3\,DOA2Q(4PA(U#<]>F5@O)
M>!]=XX(AM9\,%C3V0EX]?OQ[E"3G*P/=%PG6SJ,J<,[/4!&@2RVC#$EOW+EZ
M4&9JDKF$U;^^.@N-<,G*>IDI'-37;]7@+O13 RG'Z=&OA"OM]80+\ 2V7;"L
METW_N'*56*0TYXE9RC@0#,X*[:%PY:;>%AWV"Z?;[VG-+<//+JR3OB=K]>-N
M?(WMD[80]@Z->IT3N!-A7-O&Y8-AGF3A*+GA$0!HNU"1\2;:[,$^+GF_P!Z5
MXL,A)9# P@-5=T"U&T""'AEO-<4!2(G<2>'CK_)^+SN%4(EXJP8,-R;G'^/:
M/L39!WR*C4^UKRN3?.T5^!C\IU?JG5"<?U#+[^!;6GX'"<OOX#M9?@=L]RFM
MD1*+WIC@/#O?X=+U=^<85(J=L![O0>1HO%X*2Y0Z29X")8ZA/AL#=IKJQ&BO
M,1ATZ.!?@=1I7.PN6)E.B\A1.(-':W,,DB-A'O+<<U\R>5V<\8R40[RD7H2<
MFX;W</'7P(>FWGG;JZU T.J@.ZZR83>@1GI=NR_20'G<J<;)+"_NM49$:^\0
M6S^IS5<%_5<QY9G]64%?V?RN+M%I7N4+\N&PXAHV8/:.S=IQBJBETS#DO56%
MU4Q#E5ORN9G7J%&;0 \P"MD7\%=BSX''.ZC>H0:(<*H8+XCE&XYWT^2K6X[0
M:^ZB07OL@T_AE&6ZQBJ:3M=+3*"4BL!4!KZ%JC28&BW-^K:'IS&X6A)61\8Q
M$<FGD!P5,)$>)[R"3:$.49420JF/ZFV\[+%M^XC(2C1L?52,/2[$I'0";GF!
MI1//TZ43*K>"_=N&W_T9=J?[XXU_CV[@:RY&CGF#I08:=</]/N;VF:C+0(I]
M[T1\<$M&^ PQAM2[Q6SQ=R(5X7^S;=4@]@%^)9E]D;S8DLYB;>H[T=D H0TM
M2:MKOI[TOHSV^J2G,^0#&Z2^X-;PLU]!A=M*XPE!5N'OC%.M_3+:4TW'^*^X
M$$C/<-8K]$>88#'D?-<6CH'8FL#[8I92VUV3#L[US21%2U<9C+'!>VVSB0?,
M(34CZ1_!N%)'20NUD(\&ZR'Z+FTY.C7/%/.*U)^OV6N2,A193[J9<7=U>XUO
M*+Y:;>]8MK*0DOO'NX6P#3J)6.28_9*P;M*8ZNVZJU:F][]XPY_MG3@FDW!6
MI+.*7(7GYO@!^AD#]7CT+>P!AUM*9J R5^F.Z?COEH)^(_\]^F\P/39N8,@D
M0RLD-$.^H14RF+XXF+_HTQ?;6Z)"++/GVTH!+:Y);LJ;FX*0UW1^JO$/Q+J2
MP2Y6C:,-:H.H]A?O,QIZ-$>Z/&@> &T1%O^Z,GL35@W13WQ\W;FN!%4 ??E(
MDZH,/'[^R6)V9%4]$ W\- <\[5<&?59\%.$AL'O0&B;D/+8.\KX]QG4KFU%L
M\@7B2SZ(\Q9K?[A=KI5)MNHU,=_M@*0X2> 1# 9B<3^F"^CP6[J #A,NH,/O
MY (ZS$2!?^($BT>_&P"_2XN9?O$/^DT+S 7F.DVZ7"[RM<&;:T)J\\=@BM+*
M/=^NS!O0J^W7=IWV#T>+C$M1J=9))<O@Y28VC4W)D_X3 S1PTW#Y!G4/DGUT
MR4NY0V)RE]-Z)^@M><?;8V>*2JF;.+@!OZ<[9+?8[+J8:<+^,#2B,"76"GLG
MX+HA6SF\H;=VUF^NK;(=]0YBNF.MR^2?&/KA8Q"%8$-W;^K6*;*"-,NN#US
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M5=@I@[YAB;X72 ?";IT(:Y&+J"X>=2!D]Z2+]*E37W:+<S(+3L%XG'@B9A=
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MBZ,]JF*B?_" DH>[.&:%-1Z>(BDZO7$FBW>-3Z;U2FR)G'NXB1E6$BN79)7
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MJ(^@<7W#.N$;!P[ZGGJ?--_7 HG^>/7^[ _\\^_7;R]_^7]02P,$%     @
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M[4T5&<V)OEN6W,\$V.,@B .\4!BR?8)AD5M]A->1@MO]@@BZEHUP_(Z,BEQ
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M.S()5![")K"TE-02<"B)IU) @5!,Z%9J =,"(>;)U-@)H23#)>J1*W0 -C4
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M-SL'0T$]'1/+J4]/<@$+C0E5\]=*!;-2CF3]CA$YJ=F6]5-.JYXV/!Y*F$_
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MZF-%Y&OO""XJ7/=Y:S$$CZ#,$[E]R M>\EKY3E]_/-2O7?X)4$L! A0#%
M  @ @XH)5V(S,-@A# ( S5XA !$              ( !     &%M96@M,C R
M,S V,S N:'1M4$L! A0#%     @ @XH)5V>E1CHL&@  1#,! !$
M     ( !4 P" &%M96@M,C R,S V,S N>'-D4$L! A0#%     @ @XH)5W7V
MU.87+P  P-X! !4              ( !JR8" &%M96@M,C R,S V,S!?8V%L
M+GAM;%!+ 0(4 Q0    ( (.*"5<A0C=$3I4  !(^!@ 5              "
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M,"UQ+FAT;5!+ 0(4 Q0    ( (.*"5?QM@KB*0@  /XK   5
M  "  =21!P!E>#,Q,C(P,C,P-C,P,3 M<2YH=&U02P$"% ,4    " "#B@E7
MBM\%:QT(  !>*P  %0              @ $PF@< 97@S,3,R,#(S,#8S,#$P
M+7$N:'1M4$L! A0#%     @ @XH)5TX=V2<.!0  ?2D  !0
M ( !@*(' &5X,S(R,#(S,#8S,#$P+7$N:'1M4$L%!@     ,  P (0,  ,"G
$!P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
